id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
161893225|NCT00398216|584658424|FG000|Overall Study|Adverse Event|4|||
161893226|NCT00398216|584658425|FG001|Overall Study|Adverse Event|2|||
161893227|NCT00398216|584658426|FG002|Overall Study|Adverse Event|5|||
161893228|NCT00398216|584658427|FG003|Overall Study|Adverse Event|7|||
161893229|NCT00398216|584658428|FG004|Overall Study|Adverse Event|2|||
161893230|NCT00398216|584658424|FG000|Overall Study|Protocol Violation|2|||
161893231|NCT00398216|584658425|FG001|Overall Study|Protocol Violation|4|||
161893232|NCT00398216|584658426|FG002|Overall Study|Protocol Violation|5|||
161893233|NCT00398216|584658427|FG003|Overall Study|Protocol Violation|7|||
161893234|NCT00398216|584658428|FG004|Overall Study|Protocol Violation|5|||
161893235|NCT00398216|584658424|FG000|Overall Study|Lost to Follow-up|1|||
161893236|NCT00398216|584658425|FG001|Overall Study|Lost to Follow-up|6|||
161893237|NCT00398216|584658426|FG002|Overall Study|Lost to Follow-up|4|||
161893238|NCT00398216|584658427|FG003|Overall Study|Lost to Follow-up|4|||
161893239|NCT00398216|584658428|FG004|Overall Study|Lost to Follow-up|1|||
161893240|NCT00398216|584658424|FG000|Overall Study|Death|0|||
161893241|NCT00398216|584658425|FG001|Overall Study|Death|3|||
161893242|NCT00398216|584658426|FG002|Overall Study|Death|0|||
161893243|NCT00398216|584658427|FG003|Overall Study|Death|0|||
161893244|NCT00398216|584658428|FG004|Overall Study|Death|0|||
161893245|NCT00398216|584658424|FG000|Overall Study|Withdrawal by Subject|1|||
161893246|NCT00398216|584658425|FG001|Overall Study|Withdrawal by Subject|0|||
161893247|NCT00398216|584658426|FG002|Overall Study|Withdrawal by Subject|3|||
161779061|NCT01964898|584233825|FG000|Overall Study|ineligible post-randomization|1|||
161893248|NCT00398216|584658427|FG003|Overall Study|Withdrawal by Subject|1|||
161893249|NCT00398216|584658428|FG004|Overall Study|Withdrawal by Subject|2|||
161893250|NCT00398216|584658424|FG000|Overall Study|administrative reasons|3|||
161893251|NCT00398216|584658425|FG001|Overall Study|administrative reasons|4|||
161893252|NCT00398216|584658426|FG002|Overall Study|administrative reasons|4|||
161893253|NCT00398216|584658427|FG003|Overall Study|administrative reasons|3|||
161893254|NCT00398216|584658428|FG004|Overall Study|administrative reasons|3|||
161893255|NCT00398216|584658424|FG000|Overall Study|entrance criteria|0|||
161893256|NCT00398216|584658425|FG001|Overall Study|entrance criteria|0|||
161893257|NCT00398216|584658426|FG002|Overall Study|entrance criteria|0|||
161893258|NCT00398216|584658427|FG003|Overall Study|entrance criteria|0|||
161893259|NCT00398216|584658428|FG004|Overall Study|entrance criteria|2|||
161893260|NCT01048944|584658429|FG000|Overall Study|Protocol Violation|8|||
161893261|NCT01048944|584658430|FG001|Overall Study|Protocol Violation|10|||
161893262|NCT01048944|584658431|FG002|Overall Study|Protocol Violation|10|||
161893263|NCT01048944|584658432|FG003|Overall Study|Protocol Violation|2|||
161893264|NCT01962948|584658433|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
161893265|NCT01962948|584658434|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
161893266|NCT01962948|584658435|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
161893267|NCT01962948|584658436|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
161893268|NCT00376532|584658437|FG000|Overall Study|Lack sufficient blood sample|6|||
161893269|NCT00376532|584658438|FG001|Overall Study|Lack sufficient blood sample|6|||
161893270|NCT01133704|584658439|FG000|Overall Study|Death|44|||
161893271|NCT01133704|584658440|FG001|Overall Study|Death|26|||
161893272|NCT01133704|584658439|FG000|Overall Study|Patient refused to continue|4|||
161893273|NCT01133704|584658440|FG001|Overall Study|Patient refused to continue|0|||
161893274|NCT01133704|584658439|FG000|Overall Study|Study Closure|1|||
161893275|NCT01133704|584658440|FG001|Overall Study|Study Closure|0|||
161893276|NCT02207400|584658441|FG000|Overall Study|Adverse Event|1|||
161893277|NCT02207400|584658442|FG001|Overall Study|Adverse Event|1|||
161893278|NCT02207400|584658441|FG000|Overall Study|Lost to Follow-up|6|||
161893279|NCT02207400|584658442|FG001|Overall Study|Lost to Follow-up|7|||
161893280|NCT02207400|584658441|FG000|Overall Study|Protocol Violation|1|||
161893281|NCT02207400|584658442|FG001|Overall Study|Protocol Violation|1|||
161893282|NCT02207400|584658441|FG000|Overall Study|Withdrawal by Subject|8|||
161893283|NCT02207400|584658442|FG001|Overall Study|Withdrawal by Subject|4|||
161893284|NCT02207400|584658441|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
161893285|NCT02207400|584658442|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
161893286|NCT02849704|584658443|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
161893287|NCT02849704|584658444|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
161893288|NCT02849704|584658443|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
161893289|NCT02849704|584658444|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
161893290|NCT02849704|584658443|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
161893291|NCT02849704|584658444|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
161893292|NCT00314808|584658452|FG000|Overall Study|Disease Progression without AE|4|||
161893293|NCT00314808|584658452|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
161893294|NCT04304508|584658453|FG000|Overall Study|Subject Decision|29|||
161893295|NCT04304508|584658454|FG001|Overall Study|Subject Decision|39|||
161893296|NCT04304508|584658455|FG002|Overall Study|Subject Decision|37|||
162007911|NCT00335777|585086507|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
161893297|NCT04304508|584658456|FG003|Overall Study|Subject Decision|48|||
161893298|NCT04304508|584658453|FG000|Overall Study|Death|6|||
161893299|NCT04304508|584658454|FG001|Overall Study|Death|1|||
161893300|NCT04304508|584658455|FG002|Overall Study|Death|8|||
161893301|NCT04304508|584658456|FG003|Overall Study|Death|5|||
161893302|NCT04304508|584658453|FG000|Overall Study|Non-compliance With Study Drug|3|||
161893303|NCT04304508|584658454|FG001|Overall Study|Non-compliance With Study Drug|1|||
161893304|NCT04304508|584658455|FG002|Overall Study|Non-compliance With Study Drug|2|||
161893305|NCT04304508|584658456|FG003|Overall Study|Non-compliance With Study Drug|0|||
161893306|NCT04304508|584658453|FG000|Overall Study|Switching To Other Therapy|1|||
161893307|NCT04304508|584658454|FG001|Overall Study|Switching To Other Therapy|1|||
161893308|NCT04304508|584658455|FG002|Overall Study|Switching To Other Therapy|1|||
161893309|NCT04304508|584658456|FG003|Overall Study|Switching To Other Therapy|2|||
161893310|NCT04304508|584658453|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
161893311|NCT04304508|584658454|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
161893312|NCT04304508|584658455|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
161893313|NCT04304508|584658456|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
161893314|NCT04304508|584658453|FG000|Overall Study|Withdrawal by Subject|7|||
161893315|NCT04304508|584658454|FG001|Overall Study|Withdrawal by Subject|5|||
161893316|NCT04304508|584658455|FG002|Overall Study|Withdrawal by Subject|11|||
161893317|NCT04304508|584658456|FG003|Overall Study|Withdrawal by Subject|6|||
161893318|NCT04304508|584658453|FG000|Overall Study|Logistical Difficulties|2|||
161893319|NCT04304508|584658454|FG001|Overall Study|Logistical Difficulties|2|||
161893320|NCT04304508|584658455|FG002|Overall Study|Logistical Difficulties|3|||
161893321|NCT04304508|584658456|FG003|Overall Study|Logistical Difficulties|2|||
161893322|NCT04304508|584658453|FG000|Overall Study|Missing Information|1|||
161893323|NCT04304508|584658454|FG001|Overall Study|Missing Information|2|||
161893324|NCT04304508|584658455|FG002|Overall Study|Missing Information|1|||
161893325|NCT04304508|584658456|FG003|Overall Study|Missing Information|3|||
161893326|NCT04304508|584658453|FG000|Overall Study|Other|7|||
161893327|NCT04304508|584658454|FG001|Overall Study|Other|6|||
161893328|NCT04304508|584658455|FG002|Overall Study|Other|5|||
161893329|NCT04304508|584658456|FG003|Overall Study|Other|4|||
161893330|NCT04304508|584658453|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
161893331|NCT04304508|584658454|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
161893332|NCT04304508|584658455|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
161893333|NCT04304508|584658456|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
161893334|NCT04304508|584658453|FG000|Overall Study|Physician Decision|3|||
161893335|NCT04304508|584658454|FG001|Overall Study|Physician Decision|4|||
161893336|NCT04304508|584658455|FG002|Overall Study|Physician Decision|9|||
161893337|NCT04304508|584658456|FG003|Overall Study|Physician Decision|7|||
161893338|NCT04304508|584658453|FG000|Overall Study|Study drug never administered|10|||
161893339|NCT04304508|584658454|FG001|Overall Study|Study drug never administered|4|||
161893340|NCT04304508|584658455|FG002|Overall Study|Study drug never administered|4|||
161893341|NCT04304508|584658456|FG003|Overall Study|Study drug never administered|4|||
161893342|NCT04304508|584658453|FG000|Overall Study|Adverse Event|49|||
161893343|NCT04304508|584658454|FG001|Overall Study|Adverse Event|50|||
161893344|NCT04304508|584658455|FG002|Overall Study|Adverse Event|51|||
161893345|NCT04304508|584658456|FG003|Overall Study|Adverse Event|56|||
161893346|NCT04304508|584658453|FG000|Overall Study|Lost to Follow-up|1|||
161893347|NCT04304508|584658454|FG001|Overall Study|Lost to Follow-up|5|||
161893348|NCT04304508|584658455|FG002|Overall Study|Lost to Follow-up|2|||
161893349|NCT04304508|584658456|FG003|Overall Study|Lost to Follow-up|3|||
161893350|NCT02113007|584658457|FG000|Overall Study|Progressive disease|2|||
161893351|NCT00885378|584658458|FG000|Overall Study|Lack of Efficacy|2|||
161893352|NCT00885378|584658459|FG001|Overall Study|Lack of Efficacy|2|||
161893353|NCT00885378|584658458|FG000|Overall Study|Withdrawal by Subject|1|||
161893354|NCT00885378|584658459|FG001|Overall Study|Withdrawal by Subject|2|||
161893355|NCT00885378|584658458|FG000|Overall Study|Lost to Follow-up|1|||
162237714|NCT03440320|585922848|FG000|Overall Study|Withdrawal by Subject|0|||
162237715|NCT03440320|585922849|FG001|Overall Study|Withdrawal by Subject|1|||
162237716|NCT00001962|585922850|FG000|Overall Study|Lack of Efficacy|18|||
162237717|NCT00001962|585922850|FG000|Overall Study|Lack of Accrual|6|||
162237718|NCT00001962|585922850|FG000|Overall Study|Death|1|||
161779062|NCT01964898|584233826|FG001|Overall Study|ineligible post-randomization|1|||
161779063|NCT01964898|584233825|FG000|Overall Study|did not receive the allocated interventi|2|||
161779064|NCT01964898|584233826|FG001|Overall Study|did not receive the allocated interventi|1|||
161779065|NCT01964898|584233825|FG000|Overall Study|Lost to Follow-up|3|||
161779066|NCT01964898|584233826|FG001|Overall Study|Lost to Follow-up|5|||
161779067|NCT01964898|584233825|FG000|Overall Study|Withdrawal by Subject|1|||
161779068|NCT01964898|584233826|FG001|Overall Study|Withdrawal by Subject|0|||
161779069|NCT02428231|584233829|FG000|Overall Study|Other|10|||
161779070|NCT02428231|584233830|FG001|Overall Study|Other|16|||
161779071|NCT02428231|584233829|FG000|Overall Study|Required Symptomatic Therapy|0|||
161779072|NCT02428231|584233830|FG001|Overall Study|Required Symptomatic Therapy|1|||
161893356|NCT00885378|584658459|FG001|Overall Study|Lost to Follow-up|2|||
161893357|NCT00885378|584658458|FG000|Overall Study|Poor/Noncompliance|2|||
161893358|NCT00885378|584658459|FG001|Overall Study|Poor/Noncompliance|2|||
161893359|NCT00885378|584658458|FG000|Overall Study|Protocol Violation|2|||
161893360|NCT00885378|584658459|FG001|Overall Study|Protocol Violation|0|||
161893361|NCT01775787|584658460|FG000|First 7-10 Days|Adverse Event|0|||
161893362|NCT01775787|584658461|FG001|First 7-10 Days|Adverse Event|1|||
161893363|NCT01775787|584658460|FG000|First 7-10 Days|family emergency|0|||
161893364|NCT01775787|584658461|FG001|First 7-10 Days|family emergency|1|||
161779073|NCT02428231|584233829|FG000|Overall Study|Adverse Event|3|||
161779074|NCT02428231|584233830|FG001|Overall Study|Adverse Event|0|||
161779075|NCT02957682|584233833|FG000|Overall Study|Adverse Event|64|||
161779076|NCT02957682|584233834|FG001|Overall Study|Adverse Event|67|||
161779077|NCT02957682|584233833|FG000|Overall Study|Poor Compliance to Protocol|30|||
161779078|NCT02957682|584233834|FG001|Overall Study|Poor Compliance to Protocol|26|||
161893365|NCT01775787|584658460|FG000|First 7-10 Days|time commitment|0|||
161893366|NCT01775787|584658461|FG001|First 7-10 Days|time commitment|2|||
161893367|NCT01775787|584658460|FG000|First 7-10 Days|concerns with using IV|1|||
161779079|NCT02957682|584233833|FG000|Overall Study|Physician Decision|4|||
161779080|NCT02957682|584233834|FG001|Overall Study|Physician Decision|4|||
161779081|NCT02957682|584233833|FG000|Overall Study|Study Terminated by Sponsor|4|||
161779082|NCT02957682|584233834|FG001|Overall Study|Study Terminated by Sponsor|3|||
161779083|NCT02957682|584233833|FG000|Overall Study|Subject Moved|10|||
161779084|NCT02957682|584233834|FG001|Overall Study|Subject Moved|16|||
161779085|NCT02957682|584233833|FG000|Overall Study|Withdrawal by Subject|64|||
161779086|NCT02957682|584233834|FG001|Overall Study|Withdrawal by Subject|33|||
161779087|NCT02957682|584233833|FG000|Overall Study|Related to IMP Administration|3|||
161779088|NCT02957682|584233834|FG001|Overall Study|Related to IMP Administration|6|||
161779089|NCT02957682|584233833|FG000|Overall Study|Non-disclosed|16|||
161779090|NCT02957682|584233834|FG001|Overall Study|Non-disclosed|12|||
161779091|NCT02957682|584233833|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
161779092|NCT02957682|584233834|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
161779093|NCT02953262|584233835|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
161779094|NCT02953262|584233836|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
161779095|NCT02953262|584233837|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
161779096|NCT02953262|584233838|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
161779097|NCT03284424|584233839|FG000|Overall Study|Death|70|||
161779098|NCT03284424|584233840|FG001|Overall Study|Death|24|||
161779099|NCT03284424|584233839|FG000|Overall Study|Lost to Follow-up|3|||
161779100|NCT03284424|584233840|FG001|Overall Study|Lost to Follow-up|1|||
161779101|NCT03284424|584233839|FG000|Overall Study|Physician Decision|1|||
161779102|NCT03284424|584233840|FG001|Overall Study|Physician Decision|2|||
161893368|NCT01775787|584658461|FG001|First 7-10 Days|concerns with using IV|2|||
161893369|NCT01775787|584658460|FG000|Second 7-10 Days|time commitment|0|||
161893370|NCT01775787|584658461|FG001|Second 7-10 Days|time commitment|1|||
161779103|NCT03284424|584233839|FG000|Overall Study|Withdrawal by Subject|4|||
161779104|NCT03284424|584233840|FG001|Overall Study|Withdrawal by Subject|5|||
161779105|NCT03284424|584233839|FG000|Overall Study|Sponsor's decision|27|||
161779106|NCT03284424|584233840|FG001|Overall Study|Sponsor's decision|22|||
161779107|NCT02406742|584233841|FG000|Overall Study|Progression of Disease|5|||
161779108|NCT02406742|584233842|FG001|Overall Study|Progression of Disease|1|||
161779109|NCT02406742|584233843|FG002|Overall Study|Progression of Disease|6|||
161779110|NCT02406742|584233841|FG000|Overall Study|Adverse Event|3|||
161779111|NCT02406742|584233842|FG001|Overall Study|Adverse Event|0|||
161779112|NCT02406742|584233843|FG002|Overall Study|Adverse Event|2|||
161779113|NCT02406742|584233841|FG000|Overall Study|Death|1|||
161779114|NCT02406742|584233842|FG001|Overall Study|Death|0|||
161779115|NCT02406742|584233843|FG002|Overall Study|Death|0|||
161779116|NCT02406742|584233841|FG000|Overall Study|Lack of Efficacy|0|||
161779117|NCT02406742|584233842|FG001|Overall Study|Lack of Efficacy|0|||
161779118|NCT02406742|584233843|FG002|Overall Study|Lack of Efficacy|1|||
161779119|NCT02406742|584233841|FG000|Overall Study|Withdrawal by Participant|1|||
161779120|NCT02406742|584233842|FG001|Overall Study|Withdrawal by Participant|2|||
161893371|NCT01775787|584658460|FG000|Second 7-10 Days|concerns with using IV|0|||
161893372|NCT01775787|584658461|FG001|Second 7-10 Days|concerns with using IV|1|||
161893373|NCT03091738|584658462|FG000|Overall Study|Adverse Event|1|||
161779121|NCT02406742|584233843|FG002|Overall Study|Withdrawal by Participant|0|||
161779122|NCT02406742|584233841|FG000|Overall Study|Physician Decision|1|||
161779123|NCT02406742|584233842|FG001|Overall Study|Physician Decision|2|||
161893374|NCT03091738|584658462|FG000|Overall Study|Lost to Follow-up|1|||
161893375|NCT04446429|584658469|FG000|Overall Study|Lost to Follow-up|6|||
161893376|NCT04446429|584658470|FG001|Overall Study|Lost to Follow-up|0|||
162237719|NCT00001962|585922850|FG000|Overall Study|Lost to Follow-up|2|||
161893377|NCT05205005|584658471|FG000|Overall Study|Withdrawal by Subject|1|||
161893378|NCT05205005|584658472|FG001|Overall Study|Withdrawal by Subject|0|||
161893379|NCT05205005|584658471|FG000|Overall Study|Adverse Event|1|||
161893380|NCT05205005|584658472|FG001|Overall Study|Adverse Event|0|||
161893381|NCT03042910|584658473|FG000|Overall Study|Adverse Event|1|||
161893382|NCT03042910|584658473|FG000|Overall Study|Disease Progression|2|||
161893383|NCT03042910|584658473|FG000|Overall Study|Withdrawal by Subject|3|||
161893384|NCT03042910|584658473|FG000|Overall Study|Enrolled but not treated|1|||
161893385|NCT02187861|584658474|FG000|Overall Study|Adverse Event|2|||
161893386|NCT02187861|584658475|FG001|Overall Study|Adverse Event|1|||
161893387|NCT02187861|584658476|FG002|Overall Study|Adverse Event|2|||
161893388|NCT02187861|584658477|FG003|Overall Study|Adverse Event|1|||
161893389|NCT02187861|584658474|FG000|Overall Study|Death|0|||
161893390|NCT02187861|584658475|FG001|Overall Study|Death|3|||
161893391|NCT02187861|584658476|FG002|Overall Study|Death|1|||
161893392|NCT02187861|584658477|FG003|Overall Study|Death|2|||
161893393|NCT02187861|584658474|FG000|Overall Study|Physician Decision|0|||
161893394|NCT02187861|584658475|FG001|Overall Study|Physician Decision|1|||
161893395|NCT02187861|584658476|FG002|Overall Study|Physician Decision|0|||
161893396|NCT02187861|584658477|FG003|Overall Study|Physician Decision|3|||
161893397|NCT02187861|584658474|FG000|Overall Study|Progressive Disease|4|||
161893398|NCT02187861|584658475|FG001|Overall Study|Progressive Disease|42|||
161893399|NCT02187861|584658476|FG002|Overall Study|Progressive Disease|19|||
161893400|NCT02187861|584658477|FG003|Overall Study|Progressive Disease|22|||
161893401|NCT02187861|584658474|FG000|Overall Study|Withdrawal by Subject|0|||
161893402|NCT02187861|584658475|FG001|Overall Study|Withdrawal by Subject|0|||
161893403|NCT02187861|584658476|FG002|Overall Study|Withdrawal by Subject|3|||
161893404|NCT02187861|584658477|FG003|Overall Study|Withdrawal by Subject|3|||
161893405|NCT02187861|584658474|FG000|Overall Study|Other|0|||
161893406|NCT02187861|584658475|FG001|Overall Study|Other|1|||
161893407|NCT02187861|584658476|FG002|Overall Study|Other|7|||
161893408|NCT02187861|584658477|FG003|Overall Study|Other|1|||
161893409|NCT01491841|584658479|FG000|Overall Study|Screen Failure|10|||
161893410|NCT01491841|584658479|FG000|Overall Study|Withdrawal by Subject|1|||
161893411|NCT00264290|584658480|FG000|Intervention (8 Weeks)|Adverse Event|1|||
161893412|NCT00264290|584658481|FG001|Intervention (8 Weeks)|Adverse Event|0|||
161893413|NCT04472494|584658482|FG000|Pre-treatment|Other reasons|2|||
161893414|NCT04472494|584658483|FG001|Pre-treatment|Other reasons|0|||
161893415|NCT04472494|584658482|FG000|Treatment|Death|5|||
161893416|NCT04472494|584658483|FG001|Treatment|Death|2|||
161893417|NCT04472494|584658482|FG000|Treatment|Hospital discharge|1|||
161893418|NCT04472494|584658483|FG001|Treatment|Hospital discharge|1|||
161893419|NCT00587795|584658489|FG000|Overall Study|Withdrawal by Subject|1|||
161893420|NCT00587795|584658490|FG001|Overall Study|Withdrawal by Subject|0|||
161893421|NCT01869777|584658491|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
161893422|NCT01951573|584658492|FG000|Washout Period|Adverse Event|0|||
161893423|NCT01951573|584658493|FG001|Washout Period|Adverse Event|1|||
161893424|NCT04399889|584658494|FG000|Overall Study|Death|5|||
161893425|NCT04399889|584658495|FG001|Overall Study|Death|1|||
161893426|NCT04399889|584658496|FG002|Overall Study|Death|1|||
161893427|NCT00707980|584658497|FG000|Overall Study|Adverse Event|49|||
161893428|NCT00707980|584658497|FG000|Overall Study|Lack of Efficacy|35|||
161893429|NCT00707980|584658497|FG000|Overall Study|Non-Compliance with Study Drug|28|||
161893430|NCT00707980|584658497|FG000|Overall Study|Protocol Deviations|19|||
161893431|NCT00707980|584658497|FG000|Overall Study|Withdrawal of Consent|81|||
161893432|NCT00707980|584658497|FG000|Overall Study|Lost to Follow-up|59|||
161893433|NCT00707980|584658497|FG000|Overall Study|Other|39|||
161893434|NCT01152996|584658498|FG000|Overall Study|Withdrawal by Subject|142|||
161893435|NCT01152996|584658498|FG000|Overall Study|Adverse Event|115|||
161893436|NCT01152996|584658498|FG000|Overall Study|Lost to Follow-up|112|||
161893437|NCT01152996|584658498|FG000|Overall Study|Lack of Efficacy|68|||
161893438|NCT01152996|584658498|FG000|Overall Study|Noncompliance|41|||
161893439|NCT01152996|584658498|FG000|Overall Study|Other|36|||
161893440|NCT01152996|584658498|FG000|Overall Study|Protocol Violation|22|||
161893441|NCT01152996|584658498|FG000|Overall Study|Elevated liver enzymes|1|||
161893442|NCT00460239|584658499|FG000|Overall Study|Physician Decision|0|||
161893443|NCT00460239|584658500|FG001|Overall Study|Physician Decision|1|||
161893444|NCT00460239|584658501|FG002|Overall Study|Physician Decision|0|||
161893445|NCT00460239|584658502|FG003|Overall Study|Physician Decision|0|||
161893446|NCT00460239|584658503|FG004|Overall Study|Physician Decision|0|||
161893447|NCT00460239|584658504|FG005|Overall Study|Physician Decision|2|||
161893448|NCT00460239|584658505|FG006|Overall Study|Physician Decision|0|||
161893449|NCT00460239|584658506|FG007|Overall Study|Physician Decision|0|||
161893450|NCT00460239|584658507|FG008|Overall Study|Physician Decision|0|||
161893451|NCT00460239|584658499|FG000|Overall Study|Withdrawal by Subject|0|||
161893452|NCT00460239|584658500|FG001|Overall Study|Withdrawal by Subject|0|||
161893453|NCT00460239|584658501|FG002|Overall Study|Withdrawal by Subject|0|||
161893454|NCT00460239|584658502|FG003|Overall Study|Withdrawal by Subject|0|||
161893455|NCT00460239|584658503|FG004|Overall Study|Withdrawal by Subject|0|||
161893456|NCT00460239|584658504|FG005|Overall Study|Withdrawal by Subject|1|||
161893457|NCT00460239|584658505|FG006|Overall Study|Withdrawal by Subject|0|||
161893458|NCT00460239|584658506|FG007|Overall Study|Withdrawal by Subject|0|||
161893459|NCT00460239|584658507|FG008|Overall Study|Withdrawal by Subject|0|||
161893460|NCT02087943|584658509|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
161893461|NCT02087943|584658510|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
161893462|NCT02087943|584658511|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
161893463|NCT02087943|584658512|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
161893464|NCT02087943|584658513|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
161893465|NCT02087943|584658509|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
161893466|NCT02087943|584658510|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
161893467|NCT02087943|584658511|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
161893468|NCT02087943|584658512|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
161893469|NCT02087943|584658513|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
161893470|NCT02087943|584658509|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
161893471|NCT02087943|584658510|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
161893472|NCT02087943|584658511|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
161893473|NCT02087943|584658512|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
161893474|NCT02087943|584658513|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
161893475|NCT02087943|584658509|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
161893476|NCT02087943|584658510|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
161893477|NCT02087943|584658511|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
161893478|NCT02087943|584658512|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
161893479|NCT02087943|584658513|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
161893480|NCT02087943|584658509|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
161893481|NCT02087943|584658510|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
161893482|NCT02087943|584658511|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
161893483|NCT02087943|584658512|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
161893484|NCT02087943|584658513|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
161893485|NCT02087943|584658509|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
161893486|NCT02087943|584658510|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
161893487|NCT02087943|584658511|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
161893488|NCT02087943|584658512|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
161893489|NCT02087943|584658513|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
161893490|NCT02087943|584658509|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
161893491|NCT02087943|584658510|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
161893492|NCT02087943|584658511|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
161893493|NCT02087943|584658512|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
161893494|NCT02087943|584658513|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
161893495|NCT02087943|584658509|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
161893496|NCT02087943|584658510|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
161893497|NCT02087943|584658511|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
161893498|NCT02087943|584658512|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
161893499|NCT02087943|584658513|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
161893500|NCT02087943|584658509|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
161893501|NCT02087943|584658510|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
161893502|NCT02087943|584658511|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
161893503|NCT02087943|584658512|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
161893504|NCT02087943|584658513|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
161893505|NCT02087943|584658509|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
161893506|NCT02087943|584658510|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
161893507|NCT02087943|584658511|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
161893508|NCT02087943|584658512|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
161893509|NCT02087943|584658513|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
161893510|NCT01690299|584658514|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
161893511|NCT01690299|584658515|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
161893512|NCT01690299|584658516|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
161893513|NCT01690299|584658517|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
161893514|NCT01690299|584658518|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
161893515|NCT01690299|584658519|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
161893516|NCT01690299|584658514|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
161893517|NCT01690299|584658515|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161893518|NCT01690299|584658516|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161893519|NCT01690299|584658517|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161893520|NCT01690299|584658518|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161893521|NCT01690299|584658519|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161893522|NCT01690299|584658514|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
161893523|NCT01690299|584658515|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
161893524|NCT01690299|584658516|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161893525|NCT01690299|584658517|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161893526|NCT01690299|584658518|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
162237720|NCT00001962|585922850|FG000|Overall Study|Adverse Event|1|||
162237721|NCT00604279|585922854|FG000|Overall Study|Lack of Efficacy|22|||
161893527|NCT01690299|584658519|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161893528|NCT01690299|584658514|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
161893529|NCT01690299|584658515|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
161893530|NCT01690299|584658516|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
161893531|NCT01690299|584658517|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
161893532|NCT01690299|584658518|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
161893533|NCT01690299|584658519|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
161893534|NCT01690299|584658514|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
161893535|NCT01690299|584658515|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
161893536|NCT01690299|584658516|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
161893537|NCT01690299|584658517|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
161893538|NCT01690299|584658518|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
161893539|NCT01690299|584658519|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
161893540|NCT01690299|584658514|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
161893541|NCT01690299|584658515|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
161893542|NCT01690299|584658516|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
161893543|NCT01690299|584658517|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
161893544|NCT01690299|584658518|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
161893545|NCT01690299|584658519|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
161893546|NCT01690299|584658514|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
161893547|NCT01690299|584658515|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
161893548|NCT01690299|584658516|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
161893549|NCT01690299|584658517|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
161893550|NCT01690299|584658518|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
161893551|NCT01690299|584658519|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
161893552|NCT01690299|584658514|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
161893553|NCT01690299|584658515|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
161893554|NCT01690299|584658516|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
161893555|NCT01690299|584658517|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
161893556|NCT01690299|584658518|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
161893557|NCT01690299|584658519|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
161893558|NCT01690299|584658514|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
161893559|NCT01690299|584658515|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
161893560|NCT01690299|584658516|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
161893561|NCT01690299|584658517|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
161893562|NCT01690299|584658518|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
161893563|NCT01690299|584658519|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
161893564|NCT01690299|584658514|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161893565|NCT01690299|584658515|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161893566|NCT01690299|584658516|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161893567|NCT01690299|584658517|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161893568|NCT01690299|584658518|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161893569|NCT01690299|584658519|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
161893570|NCT01882803|584658524|FG000|Overall Study|Disease Progression|1|||
161893571|NCT01882803|584658524|FG000|Overall Study|Withdrawal by Subject|9|||
161893572|NCT01882803|584658524|FG000|Overall Study|Death|68|||
161893573|NCT01882803|584658524|FG000|Overall Study|Physician Decision|3|||
161893574|NCT01882803|584658524|FG000|Overall Study|Lost to Follow-up|3|||
161893575|NCT01882803|584658524|FG000|Overall Study|Follow-up Completed|39|||
161893576|NCT01882803|584658524|FG000|Overall Study|Study Terminated by the Sponsor|6|||
161893577|NCT02869893|584658525|FG000|Overall Study|participant aversion to IV|5|||
161779124|NCT02406742|584233843|FG002|Overall Study|Physician Decision|1|||
161779125|NCT02406742|584233841|FG000|Overall Study|Transition to other treatment|2|||
161779126|NCT02406742|584233842|FG001|Overall Study|Transition to other treatment|0|||
161779127|NCT02406742|584233843|FG002|Overall Study|Transition to other treatment|1|||
161779128|NCT02406742|584233841|FG000|Overall Study|Other Reasons|1|||
161779129|NCT02406742|584233842|FG001|Overall Study|Other Reasons|11|||
161779130|NCT02406742|584233843|FG002|Overall Study|Other Reasons|5|||
161779131|NCT00765999|584233844|FG000|Overall Study|Adverse Event|203|||
161779132|NCT00765999|584233844|FG000|Overall Study|Insufficient Therapeutic Response|100|||
161779133|NCT00765999|584233844|FG000|Overall Study|Protocol Violation|95|||
161779134|NCT00765999|584233844|FG000|Overall Study|Consent Withdrawn|202|||
161779135|NCT00765999|584233844|FG000|Overall Study|Lost to Follow-up|131|||
161779136|NCT00765999|584233844|FG000|Overall Study|Study Terminated by Sponsor|2|||
161779137|NCT00765999|584233844|FG000|Overall Study|Other Miscellaneous Reasons|51|||
161779138|NCT02367729|584233847|FG000|Overall Study|Organic disorder diagnosed|2|||
161779139|NCT02367729|584233848|FG001|Overall Study|Organic disorder diagnosed|1|||
161893578|NCT02869893|584658525|FG000|Overall Study|participant fear of MRI scanner|2|||
161893579|NCT01563913|584658526|FG000|Overall Study|Physician Decision|1|||
161893580|NCT01563913|584658527|FG001|Overall Study|Physician Decision|0|||
161893581|NCT01563913|584658526|FG000|Overall Study|Spouse Passed Away|1|||
161893582|NCT01563913|584658527|FG001|Overall Study|Spouse Passed Away|0|||
161893583|NCT03066778|584658528|FG000|Overall Study|Death|195|||
161893584|NCT03066778|584658529|FG001|Overall Study|Death|205|||
161893585|NCT03066778|584658528|FG000|Overall Study|Withdrawal by Subject|5|||
161893586|NCT03066778|584658529|FG001|Overall Study|Withdrawal by Subject|7|||
161893587|NCT00551525|584658530|FG000|Overall Study|Protocol Violation|5|||
161893588|NCT05259917|584658536|FG000|Overall Study|Protocol Violation|0|||
161893589|NCT05259917|584658537|FG001|Overall Study|Protocol Violation|0|||
161893590|NCT05259917|584658538|FG002|Overall Study|Protocol Violation|1|||
161893591|NCT05259917|584658539|FG003|Overall Study|Protocol Violation|0|||
161893592|NCT05259917|584658540|FG004|Overall Study|Protocol Violation|0|||
161893593|NCT05259917|584658541|FG005|Overall Study|Protocol Violation|0|||
161893594|NCT05259917|584658536|FG000|Overall Study|Lost to Follow-up|0|||
161893595|NCT05259917|584658537|FG001|Overall Study|Lost to Follow-up|0|||
161893596|NCT05259917|584658538|FG002|Overall Study|Lost to Follow-up|1|||
161893597|NCT05259917|584658539|FG003|Overall Study|Lost to Follow-up|0|||
161893598|NCT05259917|584658540|FG004|Overall Study|Lost to Follow-up|0|||
161893599|NCT05259917|584658541|FG005|Overall Study|Lost to Follow-up|1|||
161893600|NCT05259917|584658536|FG000|Overall Study|Physician Decision|0|||
161893601|NCT05259917|584658537|FG001|Overall Study|Physician Decision|1|||
161779140|NCT02367729|584233847|FG000|Overall Study|Adverse Event|1|||
161779141|NCT02367729|584233848|FG001|Overall Study|Adverse Event|2|||
161893602|NCT05259917|584658538|FG002|Overall Study|Physician Decision|0|||
161893603|NCT05259917|584658539|FG003|Overall Study|Physician Decision|0|||
161893604|NCT05259917|584658540|FG004|Overall Study|Physician Decision|0|||
161893605|NCT05259917|584658541|FG005|Overall Study|Physician Decision|0|||
161893606|NCT05259917|584658536|FG000|Overall Study|Withdrawal by Subject|0|||
161893607|NCT05259917|584658537|FG001|Overall Study|Withdrawal by Subject|1|||
161893608|NCT05259917|584658538|FG002|Overall Study|Withdrawal by Subject|0|||
161893609|NCT05259917|584658539|FG003|Overall Study|Withdrawal by Subject|0|||
161893610|NCT05259917|584658540|FG004|Overall Study|Withdrawal by Subject|1|||
161893611|NCT05259917|584658541|FG005|Overall Study|Withdrawal by Subject|1|||
161893612|NCT05259917|584658536|FG000|Overall Study|Trial Termination by Sponsor|7|||
161779142|NCT02367729|584233847|FG000|Overall Study|Withdrawal by Subject|0|||
161779143|NCT02367729|584233848|FG001|Overall Study|Withdrawal by Subject|5|||
161779144|NCT00759174|584233849|FG000|Overall Study|Other|0|||
161779145|NCT00759174|584233850|FG001|Overall Study|Other|2|||
161779146|NCT01890109|584233851|FG000|Overall Study|Withdrawal by Subject|0|||
161779147|NCT01890109|584233852|FG001|Overall Study|Withdrawal by Subject|3|||
161893613|NCT05259917|584658537|FG001|Overall Study|Trial Termination by Sponsor|2|||
161893614|NCT05259917|584658538|FG002|Overall Study|Trial Termination by Sponsor|3|||
161893615|NCT05259917|584658539|FG003|Overall Study|Trial Termination by Sponsor|5|||
161893616|NCT05259917|584658540|FG004|Overall Study|Trial Termination by Sponsor|11|||
161893617|NCT05259917|584658541|FG005|Overall Study|Trial Termination by Sponsor|4|||
161893618|NCT05259917|584658536|FG000|Overall Study|Other|1|||
161893619|NCT05259917|584658537|FG001|Overall Study|Other|0|||
161893620|NCT05259917|584658538|FG002|Overall Study|Other|2|||
161893621|NCT05259917|584658539|FG003|Overall Study|Other|0|||
161893622|NCT05259917|584658540|FG004|Overall Study|Other|0|||
161893623|NCT05259917|584658541|FG005|Overall Study|Other|0|||
161893624|NCT00303472|584658546|FG000|Treatment Period|Adverse Event|0|||
161893625|NCT00303472|584658547|FG001|Treatment Period|Adverse Event|0|||
161893626|NCT00303472|584658548|FG002|Treatment Period|Adverse Event|0|||
161893627|NCT00303472|584658549|FG003|Treatment Period|Adverse Event|0|||
161893628|NCT00303472|584658550|FG004|Treatment Period|Adverse Event|1|||
161893629|NCT00303472|584658551|FG005|Treatment Period|Adverse Event|0|||
161893630|NCT00303472|584658552|FG006|Treatment Period|Adverse Event|0|||
161893631|NCT00303472|584658546|FG000|Treatment Period|Death|0|||
161893632|NCT00303472|584658547|FG001|Treatment Period|Death|0|||
161893633|NCT00303472|584658548|FG002|Treatment Period|Death|0|||
161893634|NCT00303472|584658549|FG003|Treatment Period|Death|1|||
161893635|NCT00303472|584658550|FG004|Treatment Period|Death|0|||
161893636|NCT00303472|584658551|FG005|Treatment Period|Death|0|||
161893637|NCT00303472|584658552|FG006|Treatment Period|Death|1|||
161893638|NCT00303472|584658546|FG000|Treatment Period|Withdrawal by Subject|0|||
161893639|NCT00303472|584658547|FG001|Treatment Period|Withdrawal by Subject|0|||
161893640|NCT00303472|584658548|FG002|Treatment Period|Withdrawal by Subject|0|||
161893641|NCT00303472|584658549|FG003|Treatment Period|Withdrawal by Subject|1|||
161893642|NCT00303472|584658550|FG004|Treatment Period|Withdrawal by Subject|0|||
161893643|NCT00303472|584658551|FG005|Treatment Period|Withdrawal by Subject|1|||
161893644|NCT00303472|584658552|FG006|Treatment Period|Withdrawal by Subject|0|||
161893645|NCT00303472|584658546|FG000|Treatment Period|Other|0|||
161779148|NCT01890109|584233851|FG000|Overall Study|Lost to Follow-up|1|||
161893646|NCT00303472|584658547|FG001|Treatment Period|Other|0|||
161893647|NCT00303472|584658548|FG002|Treatment Period|Other|0|||
161893648|NCT00303472|584658549|FG003|Treatment Period|Other|0|||
161893649|NCT00303472|584658550|FG004|Treatment Period|Other|1|||
161893650|NCT00303472|584658551|FG005|Treatment Period|Other|0|||
161893651|NCT00303472|584658552|FG006|Treatment Period|Other|1|||
161893652|NCT00303472|584658546|FG000|Treatment Period|Disease Progression (to AML)|0|||
161893653|NCT00303472|584658547|FG001|Treatment Period|Disease Progression (to AML)|0|||
161893654|NCT00303472|584658548|FG002|Treatment Period|Disease Progression (to AML)|0|||
161893655|NCT00303472|584658549|FG003|Treatment Period|Disease Progression (to AML)|0|||
161893656|NCT00303472|584658550|FG004|Treatment Period|Disease Progression (to AML)|1|||
161893657|NCT00303472|584658551|FG005|Treatment Period|Disease Progression (to AML)|0|||
161893658|NCT00303472|584658552|FG006|Treatment Period|Disease Progression (to AML)|0|||
161893659|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Adverse Event|1|||
161893660|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Adverse Event|0|||
161893661|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Adverse Event|1|||
161893662|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Adverse Event|0|||
161893663|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Adverse Event|0|||
161893664|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Adverse Event|0|||
161893665|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Adverse Event|0|||
161893666|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Death|2|||
161893667|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Death|0|||
161893668|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Death|1|||
161893669|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Death|0|||
161893670|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Death|0|||
161893671|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Death|0|||
161893672|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Death|0|||
161893673|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
161893674|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
161893675|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
161893676|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
161893677|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
161893678|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
161893679|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
161893680|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Physician Decision|0|||
161893681|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Physician Decision|4|||
161893682|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Physician Decision|2|||
161893683|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Physician Decision|3|||
161893684|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Physician Decision|2|||
161893685|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Physician Decision|0|||
161893686|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Physician Decision|0|||
161893687|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
161893688|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
161893689|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
161893690|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
161893691|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
161893692|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
161893693|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
162237722|NCT00604279|585922855|FG001|Overall Study|Lack of Efficacy|9|||
162237723|NCT00604279|585922854|FG000|Overall Study|Lost to Follow-up|9|||
162237724|NCT00604279|585922855|FG001|Overall Study|Lost to Follow-up|14|||
162237725|NCT00604279|585922854|FG000|Overall Study|Pregnancy|2|||
162237726|NCT00604279|585922855|FG001|Overall Study|Pregnancy|0|||
162237727|NCT00604279|585922854|FG000|Overall Study|Protocol Violation|3|||
162237728|NCT00604279|585922855|FG001|Overall Study|Protocol Violation|1|||
162237729|NCT00604279|585922854|FG000|Overall Study|Withdrawal by Subject|16|||
162237730|NCT00604279|585922855|FG001|Overall Study|Withdrawal by Subject|5|||
162237731|NCT00604279|585922854|FG000|Overall Study|Adverse Event|4|||
162237732|NCT00604279|585922855|FG001|Overall Study|Adverse Event|5|||
162237733|NCT00604279|585922854|FG000|Overall Study|Other|8|||
162237734|NCT00604279|585922855|FG001|Overall Study|Other|4|||
162237735|NCT03938545|585922856|FG000|Overall Study|Lost to Follow-up|0|||
162237736|NCT03938545|585922857|FG001|Overall Study|Lost to Follow-up|0|||
162237737|NCT03938545|585922858|FG002|Overall Study|Lost to Follow-up|0|||
162237738|NCT03938545|585922859|FG003|Overall Study|Lost to Follow-up|1|||
162237739|NCT03938545|585922856|FG000|Overall Study|Non-compliance with study drug|0|||
162237740|NCT03938545|585922857|FG001|Overall Study|Non-compliance with study drug|0|||
162122833|NCT01242176|585502340|FG000|Washout Period of 7 Days|Adverse Event|0|||
162122834|NCT01242176|585502341|FG001|Washout Period of 7 Days|Adverse Event|2|||
161893694|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Other|0|||
161893695|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Other|2|||
161893696|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Other|4|||
161893697|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Other|2|||
162237741|NCT03938545|585922858|FG002|Overall Study|Non-compliance with study drug|1|||
161893698|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Other|1|||
161893699|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Other|0|||
162237742|NCT03938545|585922859|FG003|Overall Study|Non-compliance with study drug|0|||
162122835|NCT01242176|585502340|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
162122836|NCT01242176|585502341|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
162122837|NCT00358215|585502342|FG000|Overall Study|Ineligibility determined|4|||
162122838|NCT00358215|585502343|FG001|Overall Study|Ineligibility determined|3|||
162122839|NCT00358215|585502342|FG000|Overall Study|Adverse Event|83|||
162122840|NCT00358215|585502343|FG001|Overall Study|Adverse Event|65|||
162122841|NCT00358215|585502342|FG000|Overall Study|Withdrawal by Subject|111|||
162122842|NCT00358215|585502343|FG001|Overall Study|Withdrawal by Subject|102|||
162122843|NCT00358215|585502342|FG000|Overall Study|Participant request|65|||
162122844|NCT00358215|585502343|FG001|Overall Study|Participant request|64|||
162122845|NCT00358215|585502342|FG000|Overall Study|Physician Decision|47|||
162122846|NCT00358215|585502343|FG001|Overall Study|Physician Decision|39|||
162237743|NCT03938545|585922856|FG000|Overall Study|Pregnancy|1|||
162237744|NCT03938545|585922857|FG001|Overall Study|Pregnancy|0|||
162237745|NCT03938545|585922858|FG002|Overall Study|Pregnancy|0|||
162237746|NCT03938545|585922859|FG003|Overall Study|Pregnancy|0|||
162237747|NCT03938545|585922856|FG000|Overall Study|Study terminated by sponsor|6|||
162237748|NCT03938545|585922857|FG001|Overall Study|Study terminated by sponsor|4|||
162237749|NCT03938545|585922858|FG002|Overall Study|Study terminated by sponsor|2|||
162237750|NCT03938545|585922859|FG003|Overall Study|Study terminated by sponsor|4|||
162237751|NCT03938545|585922856|FG000|Overall Study|Withdrawal by Subject|0|||
162237752|NCT03938545|585922857|FG001|Overall Study|Withdrawal by Subject|1|||
162237753|NCT03938545|585922858|FG002|Overall Study|Withdrawal by Subject|0|||
162237754|NCT03938545|585922859|FG003|Overall Study|Withdrawal by Subject|0|||
162237755|NCT03938545|585922856|FG000|Overall Study|Adverse Event|1|||
162237756|NCT03938545|585922857|FG001|Overall Study|Adverse Event|0|||
162237757|NCT03938545|585922858|FG002|Overall Study|Adverse Event|0|||
162237758|NCT03938545|585922859|FG003|Overall Study|Adverse Event|0|||
162237759|NCT00355056|585922860|FG000|Randomization Period|Early Termination|4|||
161893700|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Other|0|||
161893701|NCT00303472|584658546|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
161893702|NCT00303472|584658547|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161893703|NCT00303472|584658548|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161893704|NCT00303472|584658549|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161893705|NCT00303472|584658550|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161893706|NCT00303472|584658551|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
161893707|NCT00303472|584658552|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161893708|NCT01808222|584658553|FG000|Overall Study|mpMR scan was not performed|1|||
161893709|NCT00621517|584658554|FG000|Overall Study|Lost to Follow-up|3|||
161893710|NCT00621517|584658555|FG001|Overall Study|Lost to Follow-up|3|||
161893711|NCT00621517|584658554|FG000|Overall Study|Withdrawal by Subject|3|||
161893712|NCT00621517|584658555|FG001|Overall Study|Withdrawal by Subject|4|||
161893713|NCT00621517|584658554|FG000|Overall Study|Adverse Event|1|||
162007912|NCT00335777|585086507|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
162007913|NCT00335777|585086507|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
161893714|NCT00621517|584658555|FG001|Overall Study|Adverse Event|0|||
161893715|NCT00856843|584658556|FG000|Overall Study|Withdrawal by Subject|1|||
161893716|NCT00856843|584658557|FG001|Overall Study|Withdrawal by Subject|5|||
162007914|NCT00335777|585086507|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
162007915|NCT00335777|585086507|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
162007916|NCT00992108|585086508|FG000|Overall Study|Lost to Follow-up|0|||
162007917|NCT00992108|585086509|FG001|Overall Study|Lost to Follow-up|1|||
162007918|NCT04639245|585086510|FG000|Overall Study|Death|1|||
162007919|NCT02419001|585086513|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
162007920|NCT02419001|585086514|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
162007921|NCT00535496|585086515|FG000|Overall Study|Lost to Follow-up|0|||
162007922|NCT00535496|585086516|FG001|Overall Study|Lost to Follow-up|1|||
162007923|NCT00535496|585086517|FG002|Overall Study|Lost to Follow-up|0|||
162007924|NCT00535496|585086518|FG003|Overall Study|Lost to Follow-up|0|||
162007925|NCT00535496|585086515|FG000|Overall Study|Not treated with sugammadex|0|||
162007926|NCT00535496|585086516|FG001|Overall Study|Not treated with sugammadex|1|||
162007927|NCT00535496|585086517|FG002|Overall Study|Not treated with sugammadex|0|||
162007928|NCT00535496|585086518|FG003|Overall Study|Not treated with sugammadex|0|||
162007929|NCT01209689|585086524|FG000|Overall Study|Insufficient Therapeutic Response|7|||
162007930|NCT01209689|585086525|FG001|Overall Study|Insufficient Therapeutic Response|2|||
162007931|NCT01209689|585086524|FG000|Overall Study|Refused Treatment|8|||
162007932|NCT01209689|585086525|FG001|Overall Study|Refused Treatment|3|||
162007933|NCT01209689|585086524|FG000|Overall Study|Adverse Event|4|||
162237760|NCT00355056|585922861|FG001|Randomization Period|Early Termination|6|||
162007934|NCT01209689|585086525|FG001|Overall Study|Adverse Event|0|||
162007935|NCT01209689|585086524|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
162007936|NCT01209689|585086525|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
162237761|NCT01060540|585922862|FG000|Overall Study|Withdrawal by Subject|10|||
162237762|NCT01060540|585922863|FG001|Overall Study|Withdrawal by Subject|20|||
162007937|NCT01209689|585086524|FG000|Overall Study|Failure to Return|3|||
162007938|NCT01209689|585086525|FG001|Overall Study|Failure to Return|0|||
162007939|NCT01209689|585086524|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
162007940|NCT01209689|585086525|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
162007941|NCT03780244|585086526|FG000|Overall Study|Lost to Follow-up|1|||
162007942|NCT03780244|585086527|FG001|Overall Study|Lost to Follow-up|0|||
162007943|NCT01083771|585086528|FG000|Overall Study|non-compliant|2|||
162007944|NCT01083771|585086528|FG000|Overall Study|Withdrawal by Subject|3|||
162007945|NCT03175367|585086529|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
162007946|NCT03175367|585086530|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
162237763|NCT01060540|585922862|FG000|Overall Study|Lost to Follow-up|52|||
162237764|NCT01060540|585922863|FG001|Overall Study|Lost to Follow-up|43|||
162237765|NCT01060540|585922862|FG000|Overall Study|Death|2|||
162237766|NCT01060540|585922863|FG001|Overall Study|Death|1|||
162237767|NCT01060540|585922862|FG000|Overall Study|Physician Decision|0|||
162237768|NCT01060540|585922863|FG001|Overall Study|Physician Decision|1|||
162237769|NCT00816400|585922867|FG000|Overall Study|Death|2|||
162237770|NCT00816400|585922868|FG001|Overall Study|Death|3|||
162237771|NCT00816400|585922869|FG002|Overall Study|Death|3|||
162237772|NCT00816400|585922870|FG003|Overall Study|Death|3|||
162237773|NCT00816400|585922871|FG004|Overall Study|Death|2|||
162237774|NCT00816400|585922872|FG005|Overall Study|Death|3|||
162237775|NCT00816400|585922873|FG006|Overall Study|Death|2|||
162237776|NCT00816400|585922874|FG007|Overall Study|Death|5|||
162237777|NCT00816400|585922875|FG008|Overall Study|Death|6|||
162237778|NCT00816400|585922867|FG000|Overall Study|In hospice care at the end of the study|0|||
162237779|NCT00816400|585922868|FG001|Overall Study|In hospice care at the end of the study|0|||
162237780|NCT00816400|585922869|FG002|Overall Study|In hospice care at the end of the study|2|||
162237781|NCT00816400|585922870|FG003|Overall Study|In hospice care at the end of the study|0|||
162237782|NCT00816400|585922871|FG004|Overall Study|In hospice care at the end of the study|0|||
162237783|NCT00816400|585922872|FG005|Overall Study|In hospice care at the end of the study|0|||
162237784|NCT00816400|585922873|FG006|Overall Study|In hospice care at the end of the study|0|||
162237785|NCT00816400|585922874|FG007|Overall Study|In hospice care at the end of the study|0|||
162237786|NCT00816400|585922875|FG008|Overall Study|In hospice care at the end of the study|0|||
162237787|NCT00596427|585922876|FG000|Overall Study|Withdrawal by Subject|2|||
162237788|NCT00596427|585922877|FG001|Overall Study|Withdrawal by Subject|2|||
162237789|NCT00596427|585922876|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
162237790|NCT00596427|585922877|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
162237791|NCT00596427|585922876|FG000|Overall Study|Protocol Violation|1|||
162237792|NCT00596427|585922877|FG001|Overall Study|Protocol Violation|0|||
162237793|NCT02401867|585922878|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
162237794|NCT02401867|585922878|FG000|Analysis|Cervical assay could not be conducted|9|||
162237795|NCT01650246|585922879|FG000|Overall Study|Adverse Event|23|||
162237796|NCT01650246|585922879|FG000|Overall Study|Protocol Violation|5|||
162237797|NCT01650246|585922879|FG000|Overall Study|Sponsor terminated study|53|||
162237798|NCT01650246|585922879|FG000|Overall Study|Lost to Follow-up|5|||
162237799|NCT01650246|585922879|FG000|Overall Study|Withdrawal by Subject|26|||
162237800|NCT01650246|585922879|FG000|Overall Study|Death|1|||
162237801|NCT01650246|585922879|FG000|Overall Study|Lack of Efficacy|30|||
162237802|NCT03435497|585922881|FG000|Overall Study|Lost to Follow-up|1|||
162237803|NCT03435497|585922882|FG001|Overall Study|Lost to Follow-up|0|||
162237804|NCT03435497|585922881|FG000|Overall Study|Death|1|||
162237805|NCT03435497|585922882|FG001|Overall Study|Death|0|||
162237806|NCT03435497|585922881|FG000|Overall Study|Withdrawal by Subject|0|||
162237807|NCT03435497|585922882|FG001|Overall Study|Withdrawal by Subject|4|||
162237808|NCT03435497|585922881|FG000|Overall Study|Wrong survey administered|0|||
162237809|NCT03435497|585922882|FG001|Overall Study|Wrong survey administered|2|||
162237810|NCT04281004|585922885|FG000|Overall Study|Physician Decision|1|||
162237811|NCT04281004|585922886|FG001|Overall Study|Physician Decision|0|||
162237812|NCT00701779|585922887|FG000|Overall Study|Adverse Event|6|||
162237813|NCT00701779|585922887|FG000|Overall Study|Lost to Follow-up|1|||
162237814|NCT00701779|585922887|FG000|Overall Study|Withdrawal by Subject|2|||
162237815|NCT02245672|585922888|FG000|Overall Study|Adverse Event|4|||
162237816|NCT02245672|585922889|FG001|Overall Study|Adverse Event|4|||
162237817|NCT02245672|585922890|FG002|Overall Study|Adverse Event|4|||
162237818|NCT02245672|585922888|FG000|Overall Study|Lost to Follow-up|3|||
162237819|NCT02245672|585922889|FG001|Overall Study|Lost to Follow-up|5|||
162237820|NCT02245672|585922890|FG002|Overall Study|Lost to Follow-up|1|||
162237821|NCT02245672|585922888|FG000|Overall Study|Withdrawal by Subject|6|||
162237822|NCT02245672|585922889|FG001|Overall Study|Withdrawal by Subject|3|||
162237823|NCT02245672|585922890|FG002|Overall Study|Withdrawal by Subject|0|||
162237824|NCT02245672|585922888|FG000|Overall Study|Randomized in error (not treated)|0|||
162237825|NCT02245672|585922889|FG001|Overall Study|Randomized in error (not treated)|1|||
162237826|NCT02245672|585922890|FG002|Overall Study|Randomized in error (not treated)|0|||
162237827|NCT04363801|585922896|FG000|Overall Study|Death|18|||
162237828|NCT04363801|585922897|FG001|Overall Study|Death|14|||
162237829|NCT04363801|585922898|FG002|Overall Study|Death|16|||
162237830|NCT04363801|585922899|FG003|Overall Study|Death|48|||
162237831|NCT04363801|585922900|FG004|Overall Study|Death|38|||
162237832|NCT04363801|585922896|FG000|Overall Study|Withdrawal by Subject|1|||
162237833|NCT04363801|585922897|FG001|Overall Study|Withdrawal by Subject|6|||
162237834|NCT04363801|585922898|FG002|Overall Study|Withdrawal by Subject|1|||
162237835|NCT04363801|585922899|FG003|Overall Study|Withdrawal by Subject|4|||
162237836|NCT04363801|585922900|FG004|Overall Study|Withdrawal by Subject|14|||
162007947|NCT03175367|585086531|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
162007948|NCT03175367|585086532|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
162007949|NCT03175367|585086533|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
162007950|NCT03175367|585086534|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
162237837|NCT04363801|585922896|FG000|Overall Study|Sponsor Decision|6|||
162237838|NCT04363801|585922897|FG001|Overall Study|Sponsor Decision|4|||
162237839|NCT04363801|585922898|FG002|Overall Study|Sponsor Decision|10|||
162237840|NCT04363801|585922899|FG003|Overall Study|Sponsor Decision|33|||
162237841|NCT04363801|585922900|FG004|Overall Study|Sponsor Decision|32|||
162237842|NCT04363801|585922896|FG000|Overall Study|Lost to Follow-up|0|||
162237843|NCT04363801|585922897|FG001|Overall Study|Lost to Follow-up|0|||
162237844|NCT04363801|585922898|FG002|Overall Study|Lost to Follow-up|1|||
162237845|NCT04363801|585922899|FG003|Overall Study|Lost to Follow-up|0|||
162237846|NCT04363801|585922900|FG004|Overall Study|Lost to Follow-up|1|||
162237847|NCT01146054|585922901|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
162237848|NCT01146054|585922901|FG000|Overall Study|Rapid tumor progression|2|||
162237849|NCT01146054|585922901|FG000|Overall Study|Other illness precluded treatment|2|||
162237850|NCT01146054|585922901|FG000|Overall Study|Lost to Follow-up|1|||
162237851|NCT00762970|585922902|FG000|Overall Study|Withdrawal by Subject|7|||
162237852|NCT00762970|585922903|FG001|Overall Study|Withdrawal by Subject|4|||
162237853|NCT00762970|585922904|FG002|Overall Study|Withdrawal by Subject|0|||
162237854|NCT00762970|585922902|FG000|Overall Study|Protocol Violation|3|||
162237855|NCT00762970|585922903|FG001|Overall Study|Protocol Violation|1|||
162237856|NCT00762970|585922904|FG002|Overall Study|Protocol Violation|1|||
162237857|NCT00762970|585922902|FG000|Overall Study|Lost to Follow-up|1|||
162237858|NCT00762970|585922903|FG001|Overall Study|Lost to Follow-up|2|||
162237859|NCT00762970|585922904|FG002|Overall Study|Lost to Follow-up|0|||
162237860|NCT00762970|585922902|FG000|Overall Study|Difficulty of handling lens|1|||
162237861|NCT00762970|585922903|FG001|Overall Study|Difficulty of handling lens|2|||
162237862|NCT00762970|585922904|FG002|Overall Study|Difficulty of handling lens|0|||
162237863|NCT02901041|585922905|FG000|Overall Study|Withdrawal by PI|4|||
162237864|NCT02901041|585922906|FG001|Overall Study|Withdrawal by PI|8|||
162237865|NCT02901041|585922905|FG000|Overall Study|Withdrawal by Subject|7|||
162237866|NCT02901041|585922906|FG001|Overall Study|Withdrawal by Subject|3|||
162237867|NCT01480674|585922907|FG000|Overall Study|Death|23|||
162237868|NCT01480674|585922907|FG000|Overall Study|Lost to Follow-up|2|||
162237869|NCT01480674|585922907|FG000|Overall Study|visit not done|10|||
162237870|NCT03818204|585922908|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237871|NCT03818204|585922909|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237872|NCT03818204|585922910|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237873|NCT03818204|585922911|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237874|NCT03818204|585922912|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
162237875|NCT03818204|585922913|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237876|NCT03818204|585922914|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237877|NCT03818204|585922915|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237878|NCT03818204|585922916|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237879|NCT03818204|585922917|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237880|NCT03818204|585922918|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237881|NCT03818204|585922919|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237882|NCT03818204|585922920|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237883|NCT03818204|585922921|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
162237884|NCT03818204|585922922|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237885|NCT03818204|585922923|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237886|NCT03818204|585922924|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237887|NCT03818204|585922925|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237888|NCT03818204|585922926|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
162237889|NCT03818204|585922908|FG000|Overall Study|Physician Decision|0|||
162237890|NCT03818204|585922909|FG001|Overall Study|Physician Decision|0|||
162237891|NCT03818204|585922910|FG002|Overall Study|Physician Decision|0|||
162237892|NCT03818204|585922911|FG003|Overall Study|Physician Decision|0|||
162237893|NCT03818204|585922912|FG004|Overall Study|Physician Decision|0|||
162237894|NCT03818204|585922913|FG005|Overall Study|Physician Decision|0|||
162237895|NCT03818204|585922914|FG006|Overall Study|Physician Decision|0|||
162237896|NCT03818204|585922915|FG007|Overall Study|Physician Decision|0|||
162237897|NCT03818204|585922916|FG008|Overall Study|Physician Decision|0|||
162007951|NCT03175367|585086535|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
162007952|NCT03175367|585086529|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
162007953|NCT03175367|585086530|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
162007954|NCT03175367|585086531|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
162007955|NCT03175367|585086532|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
162007956|NCT03175367|585086533|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
162007957|NCT03175367|585086534|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
162007958|NCT03175367|585086535|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
162007959|NCT03175367|585086529|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
162007960|NCT03175367|585086530|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
162007961|NCT03175367|585086531|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
162007962|NCT03175367|585086532|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
162007963|NCT03175367|585086533|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
162007964|NCT03175367|585086534|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
162007965|NCT03175367|585086535|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
162007966|NCT03175367|585086529|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
162007967|NCT03175367|585086530|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
162007968|NCT03175367|585086531|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
162007969|NCT03175367|585086532|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
162007970|NCT03175367|585086533|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
162007971|NCT03175367|585086534|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
162007972|NCT03175367|585086535|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
162007973|NCT03175367|585086529|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
162007974|NCT03175367|585086530|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
162007975|NCT03175367|585086531|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
162007976|NCT03175367|585086532|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
162007977|NCT03175367|585086533|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
162007978|NCT03175367|585086534|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
162007979|NCT03175367|585086535|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
162007980|NCT03175367|585086529|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
162007981|NCT03175367|585086530|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
162007982|NCT03175367|585086531|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
162007983|NCT03175367|585086532|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
162007984|NCT03175367|585086533|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
162007985|NCT03175367|585086534|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
162007986|NCT03175367|585086535|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
162007987|NCT03175367|585086529|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
162007988|NCT03175367|585086530|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
162007989|NCT03175367|585086531|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
162007990|NCT03175367|585086532|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
162007991|NCT03175367|585086533|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
162007992|NCT03175367|585086534|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
162007993|NCT03175367|585086535|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
162007994|NCT02851615|585086536|FG000|Overall Study|Cognitive Issue|1|||
162007995|NCT02851615|585086537|FG001|Overall Study|Cognitive Issue|0|||
162007996|NCT02851615|585086536|FG000|Overall Study|Lost to Follow-up|0|||
162007997|NCT02851615|585086537|FG001|Overall Study|Lost to Follow-up|4|||
162007998|NCT02151058|585086539|FG000|Overall Study|Withdrawal by Subject|1|||
162007999|NCT02151058|585086540|FG001|Overall Study|Withdrawal by Subject|1|||
162008000|NCT02151058|585086541|FG002|Overall Study|Withdrawal by Subject|3|||
162008001|NCT02151058|585086539|FG000|Overall Study|Lost to Follow-up|1|||
162008002|NCT02151058|585086540|FG001|Overall Study|Lost to Follow-up|0|||
162008003|NCT02151058|585086541|FG002|Overall Study|Lost to Follow-up|2|||
162008004|NCT00321620|585086543|FG000|Overall Study|Death|269|||
162008005|NCT00321620|585086544|FG001|Overall Study|Death|294|||
162008006|NCT00321620|585086543|FG000|Overall Study|Withdrawal by Subject|164|||
162008007|NCT00321620|585086544|FG001|Overall Study|Withdrawal by Subject|147|||
162008008|NCT00321620|585086543|FG000|Overall Study|Disease progression|113|||
161893717|NCT00856843|584658556|FG000|Overall Study|Lack of Efficacy|1|||
161893718|NCT00856843|584658557|FG001|Overall Study|Lack of Efficacy|0|||
161893719|NCT00583102|584658558|FG000|Overall Study|Adverse Event|3|||
161893720|NCT00628927|584658559|FG000|Overall Study|Problems performing blood draw|6|||
161893721|NCT00628927|584658560|FG001|Overall Study|Problems performing blood draw|0|||
161893722|NCT00628927|584658559|FG000|Overall Study|Lost to Follow-up|1|||
161893723|NCT00628927|584658560|FG001|Overall Study|Lost to Follow-up|0|||
161893724|NCT00628927|584658559|FG000|Overall Study|Equipment failure|1|||
161893725|NCT00628927|584658560|FG001|Overall Study|Equipment failure|0|||
161893726|NCT01738191|584658561|FG000|Overall Study|Withdrawal by Subject|4|||
161893727|NCT01738191|584658562|FG001|Overall Study|Withdrawal by Subject|1|||
161893728|NCT02483572|584658563|FG000|Overall Study|Withdrawal by Subject|1|||
162237898|NCT03818204|585922917|FG009|Overall Study|Physician Decision|0|||
162237899|NCT03818204|585922918|FG010|Overall Study|Physician Decision|0|||
162237900|NCT03818204|585922919|FG011|Overall Study|Physician Decision|0|||
162237901|NCT03818204|585922920|FG012|Overall Study|Physician Decision|0|||
162237902|NCT03818204|585922921|FG013|Overall Study|Physician Decision|0|||
162237903|NCT03818204|585922922|FG014|Overall Study|Physician Decision|1|||
162237904|NCT03818204|585922923|FG015|Overall Study|Physician Decision|0|||
162237905|NCT03818204|585922924|FG016|Overall Study|Physician Decision|0|||
162237906|NCT03818204|585922925|FG017|Overall Study|Physician Decision|0|||
162237907|NCT03818204|585922926|FG018|Overall Study|Physician Decision|0|||
162237908|NCT00887250|585922927|FG000|Overall Study|Adverse Event|3|||
162237909|NCT00887250|585922928|FG001|Overall Study|Adverse Event|0|||
162237910|NCT00887250|585922929|FG002|Overall Study|Adverse Event|7|||
162237911|NCT00887250|585922927|FG000|Overall Study|Lack of Efficacy|9|||
162237912|NCT00887250|585922928|FG001|Overall Study|Lack of Efficacy|6|||
162237913|NCT00887250|585922929|FG002|Overall Study|Lack of Efficacy|1|||
162237914|NCT00887250|585922927|FG000|Overall Study|Lost to Follow-up|2|||
162237915|NCT00887250|585922928|FG001|Overall Study|Lost to Follow-up|3|||
162237916|NCT00887250|585922929|FG002|Overall Study|Lost to Follow-up|1|||
162237917|NCT00887250|585922927|FG000|Overall Study|Protocol Violation|2|||
162237918|NCT00887250|585922928|FG001|Overall Study|Protocol Violation|2|||
162237919|NCT00887250|585922929|FG002|Overall Study|Protocol Violation|1|||
162237920|NCT00887250|585922927|FG000|Overall Study|Withdrawal by Subject|2|||
162237921|NCT00887250|585922928|FG001|Overall Study|Withdrawal by Subject|1|||
162237922|NCT00887250|585922929|FG002|Overall Study|Withdrawal by Subject|2|||
162237923|NCT00887250|585922927|FG000|Overall Study|Patient uncooperative|0|||
162237924|NCT00887250|585922928|FG001|Overall Study|Patient uncooperative|0|||
162237925|NCT00887250|585922929|FG002|Overall Study|Patient uncooperative|1|||
162237926|NCT05754333|585922930|FG000|Overall Study|Miscellaneous|3|||
162237927|NCT05754333|585922931|FG001|Overall Study|Miscellaneous|0|||
162237928|NCT05754333|585922932|FG002|Overall Study|Miscellaneous|0|||
162237929|NCT05754333|585922933|FG003|Overall Study|Miscellaneous|0|||
162237930|NCT05754333|585922930|FG000|Overall Study|Lost to Follow-up|2|||
162237931|NCT05754333|585922931|FG001|Overall Study|Lost to Follow-up|1|||
162237932|NCT05754333|585922932|FG002|Overall Study|Lost to Follow-up|0|||
162237933|NCT05754333|585922933|FG003|Overall Study|Lost to Follow-up|1|||
162237934|NCT03401229|585922939|FG000|Overall Study|Lost to Follow-up|2|||
162237935|NCT03401229|585922940|FG001|Overall Study|Lost to Follow-up|1|||
162237936|NCT03401229|585922939|FG000|Overall Study|Other|1|||
162237937|NCT03401229|585922940|FG001|Overall Study|Other|3|||
162237938|NCT03401229|585922939|FG000|Overall Study|Adverse Event|8|||
162237939|NCT03401229|585922940|FG001|Overall Study|Adverse Event|6|||
162237940|NCT03401229|585922939|FG000|Overall Study|Withdrawal by Subject|29|||
162237941|NCT03401229|585922940|FG001|Overall Study|Withdrawal by Subject|26|||
162237942|NCT03401229|585922939|FG000|Overall Study|COVID-19|0|||
162237943|NCT03401229|585922940|FG001|Overall Study|COVID-19|1|||
162237944|NCT05333224|585922941|FG000|Overall Study - Infants|Lost to Follow-up|1|||
162237945|NCT05333224|585922942|FG001|Overall Study - Infants|Lost to Follow-up|1|||
162237946|NCT01776424|585922946|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
162237947|NCT01776424|585922947|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
162237948|NCT01776424|585922948|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
162237949|NCT01776424|585922946|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
162237950|NCT01776424|585922947|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
162237951|NCT01776424|585922948|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
162237952|NCT01776424|585922946|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
162237953|NCT01776424|585922947|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
162237954|NCT01776424|585922948|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
162237955|NCT01776424|585922946|FG000|LTOLE Part (Open Label)|Refused|5|||
162237956|NCT01776424|585922947|FG001|LTOLE Part (Open Label)|Refused|2|||
162237957|NCT01776424|585922948|FG002|LTOLE Part (Open Label)|Refused|11|||
162237958|NCT01776424|585922946|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
162237959|NCT01776424|585922947|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
162237960|NCT01776424|585922948|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
162237961|NCT00819390|585922950|FG000|Overall Study|Lost to Follow-up|1|||
162237962|NCT00819390|585922951|FG001|Overall Study|Lost to Follow-up|1|||
162237963|NCT00819390|585922952|FG002|Overall Study|Lost to Follow-up|0|||
162237964|NCT00819390|585922953|FG003|Overall Study|Lost to Follow-up|0|||
162237965|NCT00819390|585922950|FG000|Overall Study|Withdrawal by Subject|2|||
162237966|NCT00819390|585922951|FG001|Overall Study|Withdrawal by Subject|0|||
162237967|NCT00819390|585922952|FG002|Overall Study|Withdrawal by Subject|0|||
162237968|NCT00819390|585922953|FG003|Overall Study|Withdrawal by Subject|0|||
162237969|NCT00819390|585922950|FG000|Overall Study|Adverse Event|0|||
162237970|NCT00819390|585922951|FG001|Overall Study|Adverse Event|0|||
162237971|NCT00819390|585922952|FG002|Overall Study|Adverse Event|1|||
162237972|NCT00819390|585922953|FG003|Overall Study|Adverse Event|0|||
162237973|NCT02294227|585922954|FG000|Overall Study|Death|0|||
162237974|NCT02294227|585922955|FG001|Overall Study|Death|0|||
162237975|NCT02294227|585922956|FG002|Overall Study|Death|1|||
162237976|NCT02294227|585922954|FG000|Overall Study|Subject/Guardian Decision|6|||
162237977|NCT02294227|585922955|FG001|Overall Study|Subject/Guardian Decision|3|||
162237978|NCT02294227|585922956|FG002|Overall Study|Subject/Guardian Decision|7|||
162237979|NCT02294227|585922954|FG000|Overall Study|Physician Decision|1|||
162237980|NCT02294227|585922955|FG001|Overall Study|Physician Decision|2|||
162237981|NCT02294227|585922956|FG002|Overall Study|Physician Decision|1|||
162237982|NCT02294227|585922954|FG000|Overall Study|Lost to Follow-up|1|||
162237983|NCT02294227|585922955|FG001|Overall Study|Lost to Follow-up|0|||
162237984|NCT02294227|585922956|FG002|Overall Study|Lost to Follow-up|0|||
162237985|NCT02294227|585922954|FG000|Overall Study|Lack of Efficacy|11|||
162237986|NCT02294227|585922955|FG001|Overall Study|Lack of Efficacy|12|||
162237987|NCT02294227|585922956|FG002|Overall Study|Lack of Efficacy|8|||
162237988|NCT02294227|585922954|FG000|Overall Study|Adverse Event|6|||
162237989|NCT02294227|585922955|FG001|Overall Study|Adverse Event|8|||
162237990|NCT02294227|585922956|FG002|Overall Study|Adverse Event|2|||
162237991|NCT00887432|585922957|FG000|Overall Study|Start Excluded Therapy|3|||
162237992|NCT00887432|585922958|FG001|Overall Study|Start Excluded Therapy|0|||
162237993|NCT00887432|585922957|FG000|Overall Study|Did not complete treatment|6|||
162237994|NCT00887432|585922958|FG001|Overall Study|Did not complete treatment|8|||
162237995|NCT00887432|585922957|FG000|Overall Study|Protocol Violation|2|||
162237996|NCT00887432|585922958|FG001|Overall Study|Protocol Violation|3|||
162237997|NCT00887432|585922957|FG000|Overall Study|Withdrawal by Subject|3|||
162237998|NCT00887432|585922958|FG001|Overall Study|Withdrawal by Subject|2|||
162237999|NCT00887432|585922957|FG000|Overall Study|Lost to Follow-up|1|||
162238000|NCT00887432|585922958|FG001|Overall Study|Lost to Follow-up|0|||
162238001|NCT00887432|585922957|FG000|Overall Study|No reason provided|0|||
162238002|NCT00887432|585922958|FG001|Overall Study|No reason provided|1|||
162238003|NCT00899548|585922959|FG000|Overall Study|Physician Decision|3|||
162238004|NCT00551460|585922960|FG000|Overall Study|Adverse Event|1|||
162238005|NCT00551460|585922960|FG000|Overall Study|Withdrawal by Subject|1|||
162238006|NCT00551460|585922960|FG000|Overall Study|Physician Decision|1|||
162238007|NCT00551460|585922960|FG000|Overall Study|Death|7|||
162238008|NCT00551460|585922960|FG000|Overall Study|Ineligible|4|||
162238009|NCT00551460|585922960|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
162238010|NCT01636960|585922961|FG000|Induction Phase|Adverse Event|2|||
162238011|NCT01636960|585922961|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
162238012|NCT01636960|585922961|FG000|Maintenance Phase|Adverse Event|3|||
162238013|NCT01636960|585922961|FG000|Maintenance Phase|Progressive disease|1|||
162238014|NCT01209780|585922962|FG000|Overall Study|Adverse Event|0|||
162238015|NCT01209780|585922963|FG001|Overall Study|Adverse Event|1|||
162238016|NCT01209780|585922964|FG002|Overall Study|Adverse Event|0|||
162238017|NCT01209780|585922965|FG003|Overall Study|Adverse Event|0|||
162238018|NCT01209780|585922966|FG004|Overall Study|Adverse Event|0|||
162238019|NCT01209780|585922962|FG000|Overall Study|Withdrawal by Subject|9|||
162238020|NCT01209780|585922963|FG001|Overall Study|Withdrawal by Subject|2|||
162238021|NCT01209780|585922964|FG002|Overall Study|Withdrawal by Subject|1|||
162238022|NCT01209780|585922965|FG003|Overall Study|Withdrawal by Subject|1|||
162238023|NCT01209780|585922966|FG004|Overall Study|Withdrawal by Subject|0|||
162238024|NCT01209780|585922962|FG000|Overall Study|Lost to Follow-up|17|||
162238025|NCT01209780|585922963|FG001|Overall Study|Lost to Follow-up|12|||
162238026|NCT01209780|585922964|FG002|Overall Study|Lost to Follow-up|3|||
162238027|NCT01209780|585922965|FG003|Overall Study|Lost to Follow-up|9|||
162238028|NCT01209780|585922966|FG004|Overall Study|Lost to Follow-up|4|||
162238029|NCT01209780|585922962|FG000|Overall Study|Protocol Violation|0|||
162238030|NCT01209780|585922963|FG001|Overall Study|Protocol Violation|1|||
162238031|NCT01209780|585922964|FG002|Overall Study|Protocol Violation|0|||
162238032|NCT01209780|585922965|FG003|Overall Study|Protocol Violation|0|||
162238033|NCT01209780|585922966|FG004|Overall Study|Protocol Violation|0|||
162238034|NCT01209780|585922962|FG000|Overall Study|Inappropriate enrollment|0|||
162238035|NCT01209780|585922963|FG001|Overall Study|Inappropriate enrollment|2|||
162238036|NCT01209780|585922964|FG002|Overall Study|Inappropriate enrollment|0|||
162238037|NCT01209780|585922965|FG003|Overall Study|Inappropriate enrollment|0|||
162238038|NCT01209780|585922966|FG004|Overall Study|Inappropriate enrollment|1|||
162238039|NCT00448123|585922968|FG000|Overall Study|Lost to Follow-up|9|||
162238040|NCT00448123|585922969|FG001|Overall Study|Lost to Follow-up|6|||
162238041|NCT00448123|585922968|FG000|Overall Study|Physician Decision|6|||
162238042|NCT00448123|585922969|FG001|Overall Study|Physician Decision|6|||
162238043|NCT02318797|585922972|FG000|Overall Study|Death|3|||
162238044|NCT02318797|585922973|FG001|Overall Study|Death|6|||
161893729|NCT02483572|584658564|FG001|Overall Study|Withdrawal by Subject|0|||
161893730|NCT02483572|584658563|FG000|Overall Study|Lost to Follow-up|1|||
162238045|NCT02318797|585922972|FG000|Overall Study|Lost to Follow-up|85|||
162238046|NCT02318797|585922973|FG001|Overall Study|Lost to Follow-up|96|||
162238047|NCT02709096|585922978|FG000|Overall Study|non-compliance|1|||
162238048|NCT02709096|585922979|FG001|Overall Study|non-compliance|1|||
162238049|NCT00818649|585922980|FG000|Overall Study|Declining performance status|2|||
162238050|NCT00818649|585922980|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
162238051|NCT00818649|585922980|FG000|Overall Study|Adverse Event|1|||
162238052|NCT00505284|585922981|FG000|Overall Study|Adverse Event|3|||
162238053|NCT00505284|585922982|FG001|Overall Study|Adverse Event|7|||
162238054|NCT00505284|585922983|FG002|Overall Study|Adverse Event|9|||
162238055|NCT00505284|585922984|FG003|Overall Study|Adverse Event|14|||
162238056|NCT00505284|585922985|FG004|Overall Study|Adverse Event|22|||
162238057|NCT00505284|585922981|FG000|Overall Study|Protocol Violation|0|||
162238058|NCT00505284|585922982|FG001|Overall Study|Protocol Violation|1|||
162238059|NCT00505284|585922983|FG002|Overall Study|Protocol Violation|1|||
162238060|NCT00505284|585922984|FG003|Overall Study|Protocol Violation|0|||
162238061|NCT00505284|585922985|FG004|Overall Study|Protocol Violation|0|||
162238062|NCT00505284|585922981|FG000|Overall Study|Withdrawal by Subject|2|||
162238063|NCT00505284|585922982|FG001|Overall Study|Withdrawal by Subject|6|||
162238064|NCT00505284|585922983|FG002|Overall Study|Withdrawal by Subject|1|||
162238065|NCT00505284|585922984|FG003|Overall Study|Withdrawal by Subject|0|||
162238066|NCT00505284|585922985|FG004|Overall Study|Withdrawal by Subject|6|||
162238067|NCT00505284|585922981|FG000|Overall Study|Lack of Efficacy|0|||
162238068|NCT00505284|585922982|FG001|Overall Study|Lack of Efficacy|1|||
162238069|NCT00505284|585922983|FG002|Overall Study|Lack of Efficacy|1|||
162238070|NCT00505284|585922984|FG003|Overall Study|Lack of Efficacy|1|||
162238071|NCT00505284|585922985|FG004|Overall Study|Lack of Efficacy|1|||
162238072|NCT00505284|585922981|FG000|Overall Study|Physician Decision|0|||
162238073|NCT00505284|585922982|FG001|Overall Study|Physician Decision|1|||
162238074|NCT00505284|585922983|FG002|Overall Study|Physician Decision|0|||
162238075|NCT00505284|585922984|FG003|Overall Study|Physician Decision|0|||
162238076|NCT00505284|585922985|FG004|Overall Study|Physician Decision|0|||
162238077|NCT00505284|585922981|FG000|Overall Study|Other|5|||
162238078|NCT00505284|585922982|FG001|Overall Study|Other|0|||
162238079|NCT00505284|585922983|FG002|Overall Study|Other|0|||
162238080|NCT00505284|585922984|FG003|Overall Study|Other|4|||
162238081|NCT00505284|585922985|FG004|Overall Study|Other|4|||
162238082|NCT00940108|585922986|FG000|Overall Study|Adverse Event|2|||
162238083|NCT00940108|585922987|FG001|Overall Study|Adverse Event|4|||
162238084|NCT00940108|585922988|FG002|Overall Study|Adverse Event|0|||
162238085|NCT00940108|585922989|FG003|Overall Study|Adverse Event|2|||
162238086|NCT00940108|585922986|FG000|Overall Study|Withdrew Consent|2|||
162238087|NCT00940108|585922987|FG001|Overall Study|Withdrew Consent|1|||
162238088|NCT00940108|585922988|FG002|Overall Study|Withdrew Consent|0|||
162238089|NCT00940108|585922989|FG003|Overall Study|Withdrew Consent|1|||
162238090|NCT00940108|585922986|FG000|Overall Study|Dose 2 contraindicated|1|||
162238091|NCT00940108|585922987|FG001|Overall Study|Dose 2 contraindicated|1|||
162238092|NCT00940108|585922988|FG002|Overall Study|Dose 2 contraindicated|0|||
162238093|NCT00940108|585922989|FG003|Overall Study|Dose 2 contraindicated|1|||
162238094|NCT00940108|585922986|FG000|Overall Study|Declined further vaccination|0|||
162238095|NCT00940108|585922987|FG001|Overall Study|Declined further vaccination|1|||
162238096|NCT00940108|585922988|FG002|Overall Study|Declined further vaccination|3|||
162238097|NCT00940108|585922989|FG003|Overall Study|Declined further vaccination|0|||
162238098|NCT00940108|585922986|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
162238099|NCT00940108|585922987|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
162238100|NCT00940108|585922988|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
162238101|NCT00940108|585922989|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
162238102|NCT00940108|585922986|FG000|Overall Study|Viral illness after Dose 1|0|||
162238103|NCT00940108|585922987|FG001|Overall Study|Viral illness after Dose 1|1|||
162238104|NCT00940108|585922988|FG002|Overall Study|Viral illness after Dose 1|0|||
162238105|NCT00940108|585922989|FG003|Overall Study|Viral illness after Dose 1|0|||
162238106|NCT00940108|585922986|FG000|Overall Study|Diagnosed with H1N1|0|||
162238107|NCT00940108|585922987|FG001|Overall Study|Diagnosed with H1N1|0|||
162238108|NCT00940108|585922988|FG002|Overall Study|Diagnosed with H1N1|0|||
162238109|NCT00940108|585922989|FG003|Overall Study|Diagnosed with H1N1|1|||
162238110|NCT01740323|585922990|FG000|Overall Study|Adverse Event|1|||
162238111|NCT01740323|585922991|FG001|Overall Study|Adverse Event|0|||
162238112|NCT01740323|585922990|FG000|Overall Study|Randomized but did not take study drug|1|||
162238113|NCT01740323|585922991|FG001|Overall Study|Randomized but did not take study drug|0|||
162238114|NCT06338462|585922992|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
162238115|NCT00928447|585922993|FG000|Overall Study|Withdrawal by Subject|1|||
162238116|NCT00928447|585922993|FG000|Overall Study|Investigator's decision|1|||
162238117|NCT02112708|585923000|FG000|Baseline|Physician Decision|16|||
162238118|NCT02112708|585923001|FG001|Baseline|Physician Decision|11|||
162238119|NCT02112708|585923000|FG000|Baseline|Lost to Follow-up|12|||
161893731|NCT02483572|584658564|FG001|Overall Study|Lost to Follow-up|0|||
161893732|NCT02483572|584658563|FG000|Overall Study|Physician Decision|0|||
161893733|NCT02483572|584658564|FG001|Overall Study|Physician Decision|1|||
161893734|NCT01298141|584658568|FG000|Overall Study|Adverse Event|3|||
162238120|NCT02112708|585923001|FG001|Baseline|Lost to Follow-up|0|||
162238121|NCT02112708|585923000|FG000|4 Month|Death|0|||
162238122|NCT02112708|585923001|FG001|4 Month|Death|1|||
162238123|NCT02112708|585923000|FG000|4 Month|Withdrawal by Subject|12|||
162238124|NCT02112708|585923001|FG001|4 Month|Withdrawal by Subject|0|||
162238125|NCT00953745|585923002|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
162238126|NCT00953745|585923003|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
162238127|NCT00953745|585923002|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
162238128|NCT00953745|585923003|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
162238129|NCT00953745|585923002|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
162238130|NCT00953745|585923003|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
162238131|NCT00953745|585923002|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
162238132|NCT00953745|585923003|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
162238133|NCT00953745|585923002|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
162238134|NCT00953745|585923003|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
162238135|NCT00953745|585923002|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
162238136|NCT00953745|585923003|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
162238137|NCT03756129|585923005|FG000|Overall Study|Adverse Event|1|||
162238138|NCT03756129|585923006|FG001|Overall Study|Adverse Event|1|||
162238139|NCT03756129|585923007|FG002|Overall Study|Adverse Event|0|||
162238140|NCT03756129|585923008|FG003|Overall Study|Adverse Event|2|||
162238141|NCT03756129|585923009|FG004|Overall Study|Adverse Event|0|||
162238142|NCT03756129|585923010|FG005|Overall Study|Adverse Event|0|||
162238143|NCT03756129|585923005|FG000|Overall Study|Withdrawal by Subject|2|||
162238144|NCT03756129|585923006|FG001|Overall Study|Withdrawal by Subject|1|||
162238145|NCT03756129|585923007|FG002|Overall Study|Withdrawal by Subject|3|||
162238146|NCT03756129|585923008|FG003|Overall Study|Withdrawal by Subject|1|||
162238147|NCT03756129|585923009|FG004|Overall Study|Withdrawal by Subject|1|||
162238148|NCT03756129|585923010|FG005|Overall Study|Withdrawal by Subject|3|||
162238149|NCT03756129|585923005|FG000|Overall Study|Lost to Follow-up|0|||
162238150|NCT03756129|585923006|FG001|Overall Study|Lost to Follow-up|0|||
162238151|NCT03756129|585923007|FG002|Overall Study|Lost to Follow-up|0|||
162238152|NCT03756129|585923008|FG003|Overall Study|Lost to Follow-up|0|||
162238153|NCT03756129|585923009|FG004|Overall Study|Lost to Follow-up|0|||
162238154|NCT03756129|585923010|FG005|Overall Study|Lost to Follow-up|1|||
162238155|NCT03756129|585923005|FG000|Overall Study|Physician Decision|0|||
162238156|NCT03756129|585923006|FG001|Overall Study|Physician Decision|0|||
162238157|NCT03756129|585923007|FG002|Overall Study|Physician Decision|0|||
162238158|NCT03756129|585923008|FG003|Overall Study|Physician Decision|0|||
162238159|NCT03756129|585923009|FG004|Overall Study|Physician Decision|0|||
162238160|NCT03756129|585923010|FG005|Overall Study|Physician Decision|1|||
162238161|NCT03432260|585923011|FG000|Overall Study|Lost to Follow-up|1|||
162238162|NCT03432260|585923012|FG001|Overall Study|Lost to Follow-up|1|||
162238163|NCT03432260|585923013|FG002|Overall Study|Lost to Follow-up|0|||
162238164|NCT03432260|585923014|FG003|Overall Study|Lost to Follow-up|0|||
162238165|NCT03432260|585923015|FG004|Overall Study|Lost to Follow-up|1|||
162238166|NCT02186847|585923016|FG000|Overall Study|Protocol Violation|3|||
162238167|NCT02186847|585923017|FG001|Overall Study|Protocol Violation|0|||
162238168|NCT00345293|585923018|FG000|Overall Study|Unable to access line for sample|1|||
162238169|NCT00345293|585923019|FG001|Overall Study|Unable to access line for sample|0|||
162238170|NCT00345293|585923018|FG000|Overall Study|Withdrawal by Subject|1|||
162238171|NCT00345293|585923019|FG001|Overall Study|Withdrawal by Subject|0|||
161893735|NCT01298141|584658568|FG000|Overall Study|Refusal of Required Study Procedures|1|||
161893736|NCT01298141|584658568|FG000|Overall Study|Withdrawal by Subject|6|||
162238172|NCT02647320|585924508|FG000|Overall Study|Adverse Event|0|||
162238173|NCT02647320|585924509|FG001|Overall Study|Adverse Event|1|||
162238174|NCT02647320|585924510|FG002|Overall Study|Adverse Event|3|||
162238175|NCT02647320|585924511|FG003|Overall Study|Adverse Event|2|||
162238176|NCT02647320|585924512|FG004|Overall Study|Adverse Event|1|||
162238177|NCT02647320|585924508|FG000|Overall Study|Protocol Violation|0|||
162238178|NCT02647320|585924509|FG001|Overall Study|Protocol Violation|0|||
162238179|NCT02647320|585924510|FG002|Overall Study|Protocol Violation|3|||
162238180|NCT02647320|585924511|FG003|Overall Study|Protocol Violation|0|||
162238181|NCT02647320|585924512|FG004|Overall Study|Protocol Violation|0|||
162238182|NCT02647320|585924508|FG000|Overall Study|Withdrawal by Subject|7|||
162238183|NCT02647320|585924509|FG001|Overall Study|Withdrawal by Subject|4|||
162238184|NCT02647320|585924510|FG002|Overall Study|Withdrawal by Subject|2|||
162238185|NCT02647320|585924511|FG003|Overall Study|Withdrawal by Subject|2|||
162238186|NCT02647320|585924512|FG004|Overall Study|Withdrawal by Subject|7|||
162238187|NCT02647320|585924508|FG000|Overall Study|Persistent hyperglycemia|0|||
162238188|NCT02647320|585924509|FG001|Overall Study|Persistent hyperglycemia|1|||
162238189|NCT02647320|585924510|FG002|Overall Study|Persistent hyperglycemia|1|||
162238190|NCT02647320|585924511|FG003|Overall Study|Persistent hyperglycemia|1|||
162238191|NCT02647320|585924512|FG004|Overall Study|Persistent hyperglycemia|1|||
162238192|NCT02647320|585924508|FG000|Overall Study|Study terminated by sponsor|1|||
162238193|NCT02647320|585924509|FG001|Overall Study|Study terminated by sponsor|1|||
162238194|NCT02647320|585924510|FG002|Overall Study|Study terminated by sponsor|1|||
162238195|NCT02647320|585924511|FG003|Overall Study|Study terminated by sponsor|1|||
162238196|NCT02647320|585924512|FG004|Overall Study|Study terminated by sponsor|2|||
162238197|NCT02647320|585924508|FG000|Overall Study|Reason not provided|0|||
162238198|NCT02647320|585924509|FG001|Overall Study|Reason not provided|0|||
162238199|NCT02647320|585924510|FG002|Overall Study|Reason not provided|1|||
162238200|NCT02647320|585924511|FG003|Overall Study|Reason not provided|0|||
162238201|NCT02647320|585924512|FG004|Overall Study|Reason not provided|2|||
162238202|NCT02647320|585924508|FG000|Overall Study|Lost to Follow-up|1|||
162238203|NCT02647320|585924509|FG001|Overall Study|Lost to Follow-up|1|||
162238204|NCT02647320|585924510|FG002|Overall Study|Lost to Follow-up|0|||
162238205|NCT02647320|585924511|FG003|Overall Study|Lost to Follow-up|0|||
162238206|NCT02647320|585924512|FG004|Overall Study|Lost to Follow-up|0|||
162238207|NCT02647320|585924508|FG000|Overall Study|Develop anemia|1|||
162238208|NCT02647320|585924509|FG001|Overall Study|Develop anemia|0|||
162238209|NCT02647320|585924510|FG002|Overall Study|Develop anemia|0|||
162238210|NCT02647320|585924511|FG003|Overall Study|Develop anemia|0|||
162238211|NCT02647320|585924512|FG004|Overall Study|Develop anemia|0|||
162238212|NCT02647320|585924508|FG000|Overall Study|Lack of Efficacy|0|||
162238213|NCT02647320|585924509|FG001|Overall Study|Lack of Efficacy|0|||
162238214|NCT02647320|585924510|FG002|Overall Study|Lack of Efficacy|0|||
162238215|NCT02647320|585924511|FG003|Overall Study|Lack of Efficacy|1|||
162238216|NCT02647320|585924512|FG004|Overall Study|Lack of Efficacy|0|||
162238217|NCT02647320|585924508|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
162238218|NCT02647320|585924509|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
162238219|NCT02647320|585924510|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
162238220|NCT02647320|585924511|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
162238221|NCT02647320|585924512|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
162238222|NCT00081770|585924513|FG000|Overall Study|Adverse Event|130|||
162238223|NCT00081770|585924514|FG001|Overall Study|Adverse Event|98|||
162238224|NCT00081770|585924515|FG002|Overall Study|Adverse Event|136|||
162238225|NCT00081770|585924513|FG000|Overall Study|Lack of Efficacy|262|||
161893737|NCT01298141|584658568|FG000|Overall Study|Termination of Study by the Investigator|5|||
161893738|NCT01298141|584658568|FG000|Overall Study|Other|5|||
162238226|NCT00081770|585924514|FG001|Overall Study|Lack of Efficacy|357|||
162238227|NCT00081770|585924515|FG002|Overall Study|Lack of Efficacy|211|||
162238228|NCT00081770|585924513|FG000|Overall Study|Lost to Follow-up|45|||
162238229|NCT00081770|585924514|FG001|Overall Study|Lost to Follow-up|34|||
162238230|NCT00081770|585924515|FG002|Overall Study|Lost to Follow-up|45|||
162238231|NCT00081770|585924513|FG000|Overall Study|Protocol Violation|15|||
162238232|NCT00081770|585924514|FG001|Overall Study|Protocol Violation|10|||
162238233|NCT00081770|585924515|FG002|Overall Study|Protocol Violation|10|||
162238234|NCT00081770|585924513|FG000|Overall Study|Withdrawal by Subject|45|||
162238235|NCT00081770|585924514|FG001|Overall Study|Withdrawal by Subject|40|||
162238236|NCT00081770|585924515|FG002|Overall Study|Withdrawal by Subject|42|||
162238237|NCT00081770|585924513|FG000|Overall Study|Did not meet protocol eligibility|2|||
161893739|NCT01298141|584658568|FG000|Overall Study|Lost to Follow-up|1|||
162238238|NCT00081770|585924514|FG001|Overall Study|Did not meet protocol eligibility|0|||
162238239|NCT00081770|585924515|FG002|Overall Study|Did not meet protocol eligibility|3|||
162238240|NCT00081770|585924513|FG000|Overall Study|Administrative|1|||
162238241|NCT00081770|585924514|FG001|Overall Study|Administrative|0|||
162238242|NCT00081770|585924515|FG002|Overall Study|Administrative|1|||
162238243|NCT00081770|585924513|FG000|Overall Study|Other|2|||
162238244|NCT00081770|585924514|FG001|Overall Study|Other|7|||
162238245|NCT00081770|585924515|FG002|Overall Study|Other|8|||
161893740|NCT01298141|584658568|FG000|Overall Study|Death|6|||
161893741|NCT01298141|584658568|FG000|Overall Study|Not treated|4|||
161893742|NCT00350779|584658569|FG000|Overall Study|Adverse Event|4|||
161893743|NCT00350779|584658570|FG001|Overall Study|Adverse Event|2|||
161893744|NCT00350779|584658569|FG000|Overall Study|Lack of Efficacy|0|||
161893745|NCT00350779|584658570|FG001|Overall Study|Lack of Efficacy|4|||
161893746|NCT00350779|584658569|FG000|Overall Study|Lost to Follow-up|2|||
161893747|NCT00350779|584658570|FG001|Overall Study|Lost to Follow-up|0|||
161893748|NCT00350779|584658569|FG000|Overall Study|Physician Decision|2|||
161893749|NCT00350779|584658570|FG001|Overall Study|Physician Decision|4|||
161893750|NCT00350779|584658569|FG000|Overall Study|Protocol Violation|3|||
161893751|NCT00350779|584658570|FG001|Overall Study|Protocol Violation|1|||
161893752|NCT00350779|584658569|FG000|Overall Study|Withdrawal by Subject|9|||
161893753|NCT00350779|584658570|FG001|Overall Study|Withdrawal by Subject|8|||
161893754|NCT00350779|584658569|FG000|Overall Study|Patient Moved|2|||
161893755|NCT00350779|584658570|FG001|Overall Study|Patient Moved|1|||
161893756|NCT00350779|584658569|FG000|Overall Study|Non-compliance with study procedures|0|||
161893757|NCT00350779|584658570|FG001|Overall Study|Non-compliance with study procedures|1|||
161893758|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
161893759|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893760|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893761|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893762|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893763|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893764|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893765|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893766|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161893767|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
162238246|NCT01072877|585924516|FG000|Overall Study|Lost to Follow-up|1|||
162238247|NCT01072877|585924517|FG001|Overall Study|Lost to Follow-up|1|||
162238248|NCT01072877|585924518|FG002|Overall Study|Lost to Follow-up|0|||
162238249|NCT01072877|585924519|FG003|Overall Study|Lost to Follow-up|2|||
162238250|NCT01072877|585924520|FG004|Overall Study|Lost to Follow-up|0|||
162238251|NCT00601419|585924521|FG000|Overall Study|Lost to Follow-up|3|||
162238252|NCT00601419|585924521|FG000|Overall Study|Missed Visits|1|||
162238253|NCT01217957|585924532|FG000|Phase 1|Withdrawal by Patient|1|||
162238254|NCT01217957|585924533|FG001|Phase 1|Withdrawal by Patient|0|||
162238255|NCT01217957|585924534|FG002|Phase 1|Withdrawal by Patient|1|||
162238256|NCT01217957|585924535|FG003|Phase 1|Withdrawal by Patient|1|||
162238257|NCT01217957|585924536|FG004|Phase 1|Withdrawal by Patient|0|||
162238258|NCT01217957|585924532|FG000|Phase 2|Withdrawal by Patient|0|||
162238259|NCT01217957|585924533|FG001|Phase 2|Withdrawal by Patient|0|||
162238260|NCT01217957|585924534|FG002|Phase 2|Withdrawal by Patient|0|||
162238261|NCT01217957|585924535|FG003|Phase 2|Withdrawal by Patient|0|||
162238262|NCT01217957|585924536|FG004|Phase 2|Withdrawal by Patient|1|||
162238263|NCT00971932|585924537|FG000|Overall Study|Withdrawal by Subject|1|||
162238264|NCT00971932|585924537|FG000|Overall Study|Investigator's decision|2|||
162238265|NCT00971932|585924537|FG000|Overall Study|Ongoing|4|||
162238266|NCT01640054|585924538|FG000|Overall Study|Study-specific disc criteria|1|||
162238267|NCT01640054|585924538|FG000|Overall Study|Lack of Efficacy|3|||
162238268|NCT01640054|585924538|FG000|Overall Study|Adverse Event|2|||
162238269|NCT01206777|585924540|FG000|Overall Study|Death|1|||
162238270|NCT01206777|585924540|FG000|Overall Study|Adverse Event|1|||
162238271|NCT02382016|585924541|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
162238272|NCT02382016|585924542|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
162238273|NCT02382016|585924541|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
162238274|NCT02382016|585924542|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
162238275|NCT02382016|585924541|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
162238276|NCT02382016|585924542|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
162238277|NCT02382016|585924541|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
162238278|NCT02382016|585924542|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
162238279|NCT02382016|585924541|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
162238280|NCT02382016|585924542|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
162238281|NCT02382016|585924541|FG000|Open-label (OL) Treatment Period|Death|4|||
162238282|NCT02382016|585924542|FG001|Open-label (OL) Treatment Period|Death|0|||
162238283|NCT02382016|585924541|FG000|OL Extension Period|Physician Decision|3|||
162238284|NCT02382016|585924542|FG001|OL Extension Period|Physician Decision|0|||
161779149|NCT01890109|584233852|FG001|Overall Study|Lost to Follow-up|2|||
161893768|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
161893769|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
161893770|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
161893771|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
161893772|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
161893773|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
162238285|NCT02382016|585924541|FG000|OL Extension Period|Death|2|||
162238286|NCT02382016|585924542|FG001|OL Extension Period|Death|0|||
162238287|NCT02382016|585924541|FG000|OL Extension Period|Withdrawal by Subject|1|||
162238288|NCT02382016|585924542|FG001|OL Extension Period|Withdrawal by Subject|0|||
162238289|NCT00730171|585924547|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
162238290|NCT00730171|585924547|FG000|Overall Study|Adverse Event|193|||
162238291|NCT00730171|585924547|FG000|Overall Study|Protocol Violation|48|||
162238292|NCT00730171|585924547|FG000|Overall Study|Withdrawal by Subject|202|||
162238293|NCT00730171|585924547|FG000|Overall Study|Lost to Follow-up|121|||
162238294|NCT00730171|585924547|FG000|Overall Study|Insufficient Therapeutic Response|141|||
162238295|NCT00730171|585924547|FG000|Overall Study|Other|61|||
162238296|NCT01729156|585924548|FG000|Overall Study|Withdrawal by Subject|1|||
162238297|NCT01729156|585924549|FG001|Overall Study|Withdrawal by Subject|0|||
162238298|NCT01729156|585924550|FG002|Overall Study|Withdrawal by Subject|0|||
162238299|NCT01256658|585924553|FG000|Period 1|Lost to Follow-up|837|||
162238300|NCT01256658|585924554|FG001|Period 1|Lost to Follow-up|661|||
162238301|NCT01256658|585924553|FG000|Period 1|Withdrawal by Subject|35|||
162238302|NCT01256658|585924554|FG001|Period 1|Withdrawal by Subject|43|||
162238303|NCT01256658|585924553|FG000|Period 1|Death|48|||
162238304|NCT01256658|585924554|FG001|Period 1|Death|44|||
162238305|NCT00719563|585924555|FG000|Overall Study|Adverse Event|16|||
162238306|NCT00719563|585924556|FG001|Overall Study|Adverse Event|13|||
162238307|NCT00719563|585924555|FG000|Overall Study|Medical condition changed|3|||
162238308|NCT00719563|585924556|FG001|Overall Study|Medical condition changed|5|||
162238309|NCT00719563|585924555|FG000|Overall Study|Lack of Efficacy|3|||
162238310|NCT00719563|585924556|FG001|Overall Study|Lack of Efficacy|7|||
162238311|NCT00719563|585924555|FG000|Overall Study|Personal reasons|6|||
162238312|NCT00719563|585924556|FG001|Overall Study|Personal reasons|7|||
162238313|NCT00719563|585924555|FG000|Overall Study|Unknown reasons|4|||
162238314|NCT00719563|585924556|FG001|Overall Study|Unknown reasons|6|||
162238315|NCT00719563|585924555|FG000|Overall Study|Noncompliant|1|||
162238316|NCT00719563|585924556|FG001|Overall Study|Noncompliant|1|||
162238317|NCT00719563|585924555|FG000|Overall Study|Lost to Follow-up|5|||
162238318|NCT00719563|585924556|FG001|Overall Study|Lost to Follow-up|3|||
162238319|NCT01386788|585924559|FG000|Overall Study|Lost to Follow-up|2|||
162238320|NCT00462865|585924562|FG000|Overall Study|Adverse Event|1|||
162238321|NCT02120625|585924563|FG000|Overall Study|Physician Decision|2|||
162238322|NCT04142450|585924564|FG000|Overall Study|Screen Failure|1|||
162238323|NCT04142450|585924564|FG000|Overall Study|Lost to Follow-up|1|||
162238324|NCT00120406|585924565|FG000|Overall Study|Death|9|||
162238325|NCT00120406|585924566|FG001|Overall Study|Death|4|||
162238326|NCT00120406|585924565|FG000|Overall Study|Withdrawal by Subject|5|||
162238327|NCT00120406|585924566|FG001|Overall Study|Withdrawal by Subject|7|||
162238328|NCT00120406|585924565|FG000|Overall Study|Lost to Follow-up|5|||
162238329|NCT00120406|585924566|FG001|Overall Study|Lost to Follow-up|2|||
162238330|NCT00120406|585924565|FG000|Overall Study|received non-study stent|0|||
162238331|NCT00120406|585924566|FG001|Overall Study|received non-study stent|2|||
162238332|NCT00120406|585924565|FG000|Overall Study|patient moved but has not withdrawn|0|||
162238333|NCT00120406|585924566|FG001|Overall Study|patient moved but has not withdrawn|1|||
162238334|NCT06336603|585924567|FG000|Overall Study|Withdrawal by Subject|1|||
161779150|NCT01643928|584233853|FG000|Overall Study|Lost to Follow-up|1|||
161779151|NCT01643928|584233854|FG001|Overall Study|Lost to Follow-up|0|||
162238335|NCT06336603|585924567|FG000|Overall Study|Lost to Follow-up|2|||
162238336|NCT00975507|585924575|FG000|Overall Study|Adverse Event|1|||
162238337|NCT00975507|585924576|FG001|Overall Study|Adverse Event|0|||
162238338|NCT00975507|585924575|FG000|Overall Study|Lost to Follow-up|7|||
161779152|NCT01643928|584233855|FG002|Overall Study|Lost to Follow-up|2|||
161779153|NCT01643928|584233856|FG003|Overall Study|Lost to Follow-up|0|||
162238339|NCT00975507|585924576|FG001|Overall Study|Lost to Follow-up|1|||
162238340|NCT00975507|585924575|FG000|Overall Study|Protocol Violation|2|||
162238341|NCT00975507|585924576|FG001|Overall Study|Protocol Violation|0|||
162238342|NCT00975507|585924575|FG000|Overall Study|Withdrawal by Subject|10|||
162238343|NCT00975507|585924576|FG001|Overall Study|Withdrawal by Subject|3|||
162238344|NCT01295034|585924577|FG000|Overall Study|Lost to Follow-up|5|||
162238345|NCT01295034|585924578|FG001|Overall Study|Lost to Follow-up|5|||
162238346|NCT03249714|585924579|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
162238347|NCT03249714|585924580|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
162238348|NCT03249714|585924579|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
162238349|NCT03249714|585924580|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
162238350|NCT03249714|585924579|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
161779154|NCT01643928|584233857|FG004|Overall Study|Lost to Follow-up|0|||
161779155|NCT01643928|584233853|FG000|Overall Study|Withdrawal by Subject|2|||
161779156|NCT01643928|584233854|FG001|Overall Study|Withdrawal by Subject|0|||
162238351|NCT03249714|585924580|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
162238352|NCT03249714|585924579|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
162238353|NCT03249714|585924580|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
162238354|NCT00824161|585924583|FG000|Overall Study|Withdrawal by Subject|1|||
162238355|NCT00824161|585924583|FG000|Overall Study|Screen Failure|1|||
162238356|NCT00879762|585924584|FG000|Overall Study|Lost to Follow-up|3|||
162238357|NCT00879762|585924585|FG001|Overall Study|Lost to Follow-up|1|||
162238358|NCT04754477|585924588|FG000|Overall Study|Withdrawal by Subject|1|||
162238359|NCT02699983|585924590|FG000|Overall Study|Withdrawal by Subject|1|||
162238360|NCT02699983|585924591|FG001|Overall Study|Withdrawal by Subject|0|||
162238361|NCT03575143|585924592|FG000|Overall Study|Lost to Follow-up|0|||
162238362|NCT03575143|585924593|FG001|Overall Study|Lost to Follow-up|0|||
162238363|NCT03575143|585924594|FG002|Overall Study|Lost to Follow-up|4|||
162238364|NCT03575143|585924592|FG000|Overall Study|Withdrawal by Subject|0|||
162238365|NCT03575143|585924593|FG001|Overall Study|Withdrawal by Subject|0|||
162238366|NCT03575143|585924594|FG002|Overall Study|Withdrawal by Subject|5|||
162238367|NCT03575143|585924592|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
162238368|NCT03575143|585924593|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
162238369|NCT03575143|585924594|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
162238370|NCT01211197|585924598|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162238371|NCT01211197|585924599|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162238372|NCT01211197|585924600|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
162238373|NCT01211197|585924601|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162238374|NCT01211197|585924602|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162238375|NCT01211197|585924603|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162238376|NCT01211197|585924598|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
162238377|NCT01211197|585924599|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
162238378|NCT01211197|585924600|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
162238379|NCT01211197|585924601|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
162238380|NCT01211197|585924602|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
162238381|NCT01211197|585924603|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
162238382|NCT04781387|585924604|FG000|Overall Study|Withdrawal by Subject|1|||
162238383|NCT04781387|585924605|FG001|Overall Study|Withdrawal by Subject|0|||
162238384|NCT04781387|585924606|FG002|Overall Study|Withdrawal by Subject|1|||
162238385|NCT04781387|585924604|FG000|Overall Study|Lost to Follow-up|1|||
162238386|NCT04781387|585924605|FG001|Overall Study|Lost to Follow-up|0|||
162238387|NCT04781387|585924606|FG002|Overall Study|Lost to Follow-up|0|||
162238388|NCT03581825|585924607|FG000|Period 1|Lens Discomfort|1|||
162238389|NCT03581825|585924608|FG001|Period 1|Lens Discomfort|0|||
162238390|NCT03581825|585924607|FG000|Period 2|Unsatisfactory Vision to Test|0|||
162238391|NCT03581825|585924608|FG001|Period 2|Unsatisfactory Vision to Test|1|||
162238392|NCT02533570|585924610|FG000|Overall Study|Adverse Event|0|||
162238393|NCT02533570|585924611|FG001|Overall Study|Adverse Event|1|||
162238394|NCT02533570|585924612|FG002|Overall Study|Adverse Event|1|||
162238395|NCT01163916|585924613|FG000|Overall Study|Withdrawal by Subject|2|||
162238396|NCT01163916|585924614|FG001|Overall Study|Withdrawal by Subject|0|||
162238397|NCT01163916|585924615|FG002|Overall Study|Withdrawal by Subject|2|||
162238398|NCT01163916|585924613|FG000|Overall Study|Adverse Event|2|||
162238399|NCT01163916|585924614|FG001|Overall Study|Adverse Event|0|||
162238400|NCT01163916|585924615|FG002|Overall Study|Adverse Event|1|||
162238401|NCT01163916|585924613|FG000|Overall Study|Lack of Efficacy|2|||
162238402|NCT01163916|585924614|FG001|Overall Study|Lack of Efficacy|0|||
162238403|NCT01163916|585924615|FG002|Overall Study|Lack of Efficacy|1|||
162238404|NCT01163916|585924613|FG000|Overall Study|Other|24|||
162238405|NCT01163916|585924614|FG001|Overall Study|Other|4|||
162238406|NCT01163916|585924615|FG002|Overall Study|Other|16|||
162238407|NCT00529958|585924616|FG000|2-Year Follow-up|Lost to Follow-up|1|||
162238408|NCT00529958|585924617|FG001|2-Year Follow-up|Lost to Follow-up|2|||
162238409|NCT00529958|585924618|FG002|2-Year Follow-up|Lost to Follow-up|2|||
162238410|NCT00529958|585924616|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
162238411|NCT00529958|585924617|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
162238412|NCT00529958|585924618|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
162238413|NCT00529958|585924616|FG000|5-Year Follow-up|Lost to Follow-up|2|||
162238414|NCT00529958|585924617|FG001|5-Year Follow-up|Lost to Follow-up|3|||
162238415|NCT00529958|585924618|FG002|5-Year Follow-up|Lost to Follow-up|1|||
162238416|NCT00529958|585924616|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
162238417|NCT00529958|585924617|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
162238418|NCT00529958|585924618|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
162238419|NCT02337751|585924619|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
161893774|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
162238420|NCT02337751|585924620|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
162238421|NCT02337751|585924619|FG000|Overall Study|Voluntary Withdrawal|6|||
162238422|NCT02337751|585924620|FG001|Overall Study|Voluntary Withdrawal|8|||
162238423|NCT02337751|585924619|FG000|Overall Study|Lack of Efficacy|2|||
162238424|NCT02337751|585924620|FG001|Overall Study|Lack of Efficacy|5|||
162238425|NCT02337751|585924619|FG000|Overall Study|Investigator's Judgement|1|||
162238426|NCT02337751|585924620|FG001|Overall Study|Investigator's Judgement|0|||
162238427|NCT01340651|585924621|FG000|Overall Study|Adverse Event|3|||
162238428|NCT01340651|585924621|FG000|Overall Study|Consent Withdrawn|2|||
162238429|NCT01340651|585924621|FG000|Overall Study|Commercial Supply per Sponsor|12|||
162238430|NCT01315353|585924622|FG000|Overall Study|Death|2|||
162238431|NCT01315353|585924623|FG001|Overall Study|Death|1|||
162238432|NCT01315353|585924624|FG002|Overall Study|Death|0|||
162238433|NCT01315353|585924622|FG000|Overall Study|Withdrawal by Subject|2|||
162238434|NCT01315353|585924623|FG001|Overall Study|Withdrawal by Subject|6|||
162238435|NCT01315353|585924624|FG002|Overall Study|Withdrawal by Subject|1|||
162238436|NCT01315353|585924622|FG000|Overall Study|Lost to Follow-up|13|||
162238437|NCT01315353|585924623|FG001|Overall Study|Lost to Follow-up|6|||
162238438|NCT01315353|585924624|FG002|Overall Study|Lost to Follow-up|6|||
162238439|NCT01315353|585924622|FG000|Overall Study|Unwilling to adhere to requirements|5|||
162238440|NCT01315353|585924623|FG001|Overall Study|Unwilling to adhere to requirements|5|||
162238441|NCT01315353|585924624|FG002|Overall Study|Unwilling to adhere to requirements|4|||
162238442|NCT01315353|585924622|FG000|Overall Study|Site closing|7|||
162238443|NCT01315353|585924623|FG001|Overall Study|Site closing|4|||
162238444|NCT01315353|585924624|FG002|Overall Study|Site closing|0|||
162238445|NCT01315353|585924622|FG000|Overall Study|Taken off study by site in error|0|||
162238446|NCT01315353|585924623|FG001|Overall Study|Taken off study by site in error|1|||
162238447|NCT01315353|585924624|FG002|Overall Study|Taken off study by site in error|0|||
162238448|NCT01315353|585924622|FG000|Overall Study|Inadvertent randomization/assignment|0|||
162238449|NCT01315353|585924623|FG001|Overall Study|Inadvertent randomization/assignment|0|||
162238450|NCT01315353|585924624|FG002|Overall Study|Inadvertent randomization/assignment|2|||
162238451|NCT01009580|585924625|FG000|Overall Study|Adverse Event|4|||
162238452|NCT01009580|585924626|FG001|Overall Study|Adverse Event|4|||
162238453|NCT01009580|585924625|FG000|Overall Study|Lack of Efficacy|0|||
162238454|NCT01009580|585924626|FG001|Overall Study|Lack of Efficacy|1|||
162238455|NCT01009580|585924625|FG000|Overall Study|Protocol Violation|2|||
162238456|NCT01009580|585924626|FG001|Overall Study|Protocol Violation|3|||
162238457|NCT01009580|585924625|FG000|Overall Study|Withdrawal Criteria|4|||
162238458|NCT01009580|585924626|FG001|Overall Study|Withdrawal Criteria|6|||
162238459|NCT01009580|585924625|FG000|Overall Study|Unclassified|17|||
162238460|NCT01009580|585924626|FG001|Overall Study|Unclassified|21|||
162238461|NCT04469270|585924627|FG000|Overall Study|Adverse Event|2|||
162238462|NCT04469270|585924628|FG001|Overall Study|Adverse Event|0|||
162238463|NCT04469270|585924627|FG000|Overall Study|Lost to Follow-up|4|||
162238464|NCT04469270|585924628|FG001|Overall Study|Lost to Follow-up|3|||
162238465|NCT04469270|585924627|FG000|Overall Study|Withdrawal by Subject|7|||
162238466|NCT04469270|585924628|FG001|Overall Study|Withdrawal by Subject|3|||
162238467|NCT04469270|585924627|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
162238468|NCT04469270|585924628|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
162238469|NCT04469270|585924627|FG000|Overall Study|missing|1|||
162238470|NCT04469270|585924628|FG001|Overall Study|missing|0|||
162238471|NCT05572021|585924631|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
162238472|NCT05572021|585924632|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
162238473|NCT03319849|585924633|FG000|Overall Study|Adverse Event|1|||
162238474|NCT03319849|585924634|FG001|Overall Study|Adverse Event|0|||
162238475|NCT03319849|585924633|FG000|Overall Study|Physician Decision|0|||
162238476|NCT03319849|585924634|FG001|Overall Study|Physician Decision|1|||
162238477|NCT03319849|585924633|FG000|Overall Study|Withdrawal by Subject|0|||
162238478|NCT03319849|585924634|FG001|Overall Study|Withdrawal by Subject|1|||
162238479|NCT03319849|585924633|FG000|Overall Study|COVID-19|0|||
162238480|NCT03319849|585924634|FG001|Overall Study|COVID-19|1|||
162238481|NCT03319849|585924633|FG000|Overall Study|Other|1|||
162238482|NCT03319849|585924634|FG001|Overall Study|Other|2|||
162238483|NCT03319849|585924633|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
162238484|NCT03319849|585924634|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
162238485|NCT03319849|585924633|FG000|Overall Study|Lost to Follow-up|0|||
162238486|NCT03319849|585924634|FG001|Overall Study|Lost to Follow-up|2|||
162238487|NCT00112047|585924637|FG000|Randomized Phase|Lost to Follow-up|26|||
162238488|NCT00112047|585924638|FG001|Randomized Phase|Lost to Follow-up|33|||
162238489|NCT00112047|585924637|FG000|Randomized Phase|Adverse Event|10|||
162238490|NCT00112047|585924638|FG001|Randomized Phase|Adverse Event|10|||
162238491|NCT00112047|585924637|FG000|Randomized Phase|Withrawal of consent|10|||
162238492|NCT00112047|585924638|FG001|Randomized Phase|Withrawal of consent|18|||
162238493|NCT00112047|585924637|FG000|Randomized Phase|Sub-optimal virological response|3|||
162238494|NCT00112047|585924638|FG001|Randomized Phase|Sub-optimal virological response|13|||
162238495|NCT00112047|585924637|FG000|Randomized Phase|Noncompliance|8|||
162238496|NCT00112047|585924638|FG001|Randomized Phase|Noncompliance|4|||
162238497|NCT00112047|585924637|FG000|Randomized Phase|Protocol Violation|2|||
162238498|NCT00112047|585924638|FG001|Randomized Phase|Protocol Violation|0|||
162238499|NCT00112047|585924637|FG000|Randomized Phase|Pregnancy|3|||
162238500|NCT00112047|585924638|FG001|Randomized Phase|Pregnancy|1|||
162238501|NCT00112047|585924637|FG000|Randomized Phase|Death|1|||
162238502|NCT00112047|585924638|FG001|Randomized Phase|Death|3|||
162238503|NCT00112047|585924637|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
162238504|NCT00112047|585924638|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
162238505|NCT00112047|585924637|FG000|Randomized Phase|Inability to swallow pills|0|||
161779157|NCT01643928|584233855|FG002|Overall Study|Withdrawal by Subject|0|||
162238506|NCT00112047|585924638|FG001|Randomized Phase|Inability to swallow pills|1|||
162238507|NCT00112047|585924637|FG000|Randomized Phase|Incarceration|3|||
162238508|NCT00112047|585924638|FG001|Randomized Phase|Incarceration|2|||
162238509|NCT00112047|585924637|FG000|Randomized Phase|Moved out of State|0|||
162238510|NCT00112047|585924638|FG001|Randomized Phase|Moved out of State|1|||
162238511|NCT00112047|585924637|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
162238512|NCT00112047|585924638|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
162238513|NCT00112047|585924637|FG000|Randomized Phase|High Hepatitis B DNA|0|||
162238514|NCT00112047|585924638|FG001|Randomized Phase|High Hepatitis B DNA|1|||
162238515|NCT00112047|585924637|FG000|Atripla Phase|Adverse Event|2|||
162238516|NCT00112047|585924638|FG001|Atripla Phase|Adverse Event|1|||
162238517|NCT00112047|585924637|FG000|Atripla Phase|Lost to Follow-up|5|||
162238518|NCT00112047|585924638|FG001|Atripla Phase|Lost to Follow-up|7|||
162238519|NCT00112047|585924637|FG000|Atripla Phase|Pregnancy|0|||
162238520|NCT00112047|585924638|FG001|Atripla Phase|Pregnancy|1|||
162238521|NCT00112047|585924637|FG000|Atripla Phase|Death|0|||
162238522|NCT00112047|585924638|FG001|Atripla Phase|Death|2|||
162238523|NCT00112047|585924637|FG000|Atripla Phase|Withdrew consent|7|||
161779158|NCT01643928|584233856|FG003|Overall Study|Withdrawal by Subject|1|||
161779159|NCT01643928|584233857|FG004|Overall Study|Withdrawal by Subject|0|||
161779160|NCT01643928|584233853|FG000|Overall Study|Pregnancy|0|||
161779161|NCT01643928|584233854|FG001|Overall Study|Pregnancy|0|||
161779162|NCT01643928|584233855|FG002|Overall Study|Pregnancy|0|||
161779163|NCT01643928|584233856|FG003|Overall Study|Pregnancy|1|||
161779164|NCT01643928|584233857|FG004|Overall Study|Pregnancy|0|||
162238524|NCT00112047|585924638|FG001|Atripla Phase|Withdrew consent|7|||
162238525|NCT00112047|585924637|FG000|Atripla Phase|Sub-optimal virological response|0|||
162238526|NCT00112047|585924638|FG001|Atripla Phase|Sub-optimal virological response|1|||
162238527|NCT00112047|585924637|FG000|Atripla Phase|Non-compliance|1|||
162238528|NCT00112047|585924638|FG001|Atripla Phase|Non-compliance|0|||
162238529|NCT00112047|585924637|FG000|Atripla Phase|Other|3|||
162238530|NCT00112047|585924638|FG001|Atripla Phase|Other|1|||
162238531|NCT01307579|585924639|FG000|Overall Study|Death|3|||
162238532|NCT01307579|585924640|FG001|Overall Study|Death|6|||
162238533|NCT01307579|585924639|FG000|Overall Study|Physician Decision|26|||
162238534|NCT01307579|585924640|FG001|Overall Study|Physician Decision|29|||
162238535|NCT01307579|585924639|FG000|Overall Study|Withdrawal by Subject|7|||
162238536|NCT01307579|585924640|FG001|Overall Study|Withdrawal by Subject|3|||
162238537|NCT01307579|585924639|FG000|Overall Study|Institutional diagnosis of IFD|21|||
162238538|NCT01307579|585924640|FG001|Overall Study|Institutional diagnosis of IFD|36|||
162238539|NCT01307579|585924639|FG000|Overall Study|Begin conditioning for HSCT|42|||
162238540|NCT01307579|585924640|FG001|Overall Study|Begin conditioning for HSCT|44|||
162238541|NCT01307579|585924639|FG000|Overall Study|Refractory or relapsed AML|38|||
162238542|NCT01307579|585924640|FG001|Overall Study|Refractory or relapsed AML|23|||
162238543|NCT01307579|585924639|FG000|Overall Study|Ineligible|3|||
162238544|NCT01307579|585924640|FG001|Overall Study|Ineligible|4|||
162238545|NCT05677893|585926347|FG000|Overall Study|Withdrawal by Subject|0|||
162238546|NCT05677893|585926348|FG001|Overall Study|Withdrawal by Subject|0|||
161893775|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
161893776|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
161893777|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
161893778|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
161893779|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
161893780|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
161893781|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
161893782|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
162238547|NCT05677893|585926349|FG002|Overall Study|Withdrawal by Subject|0|||
162238548|NCT05677893|585926350|FG003|Overall Study|Withdrawal by Subject|0|||
161893783|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
161893784|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
161893785|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
162238549|NCT05677893|585926351|FG004|Overall Study|Withdrawal by Subject|1|||
162238550|NCT05677893|585926352|FG005|Overall Study|Withdrawal by Subject|1|||
162238551|NCT05677893|585926353|FG006|Overall Study|Withdrawal by Subject|0|||
162238552|NCT05677893|585926347|FG000|Overall Study|Others|1|||
162238553|NCT05677893|585926348|FG001|Overall Study|Others|0|||
162238554|NCT05677893|585926349|FG002|Overall Study|Others|0|||
162238555|NCT05677893|585926350|FG003|Overall Study|Others|0|||
161779165|NCT01643928|584233853|FG000|Overall Study|Other|5|||
161893786|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
161893787|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
162238556|NCT05677893|585926351|FG004|Overall Study|Others|0|||
162238557|NCT05677893|585926352|FG005|Overall Study|Others|0|||
162238558|NCT05677893|585926353|FG006|Overall Study|Others|0|||
162238559|NCT03217266|585926354|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
162238560|NCT03217266|585926355|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
162238561|NCT03217266|585926356|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
162238562|NCT03217266|585926357|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
161893788|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
161893789|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
161893790|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
161893791|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
161893792|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
161893793|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
161893794|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893795|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893796|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893797|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
161893798|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893799|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
161893800|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893801|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893802|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161893803|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
161893804|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161893805|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
161893806|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161893807|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161893808|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
161893809|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161893810|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161893811|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161893812|NCT00528372|584658571|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
161893813|NCT00528372|584658572|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161893814|NCT00528372|584658573|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161893815|NCT00528372|584658574|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
161893816|NCT00528372|584658575|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161893817|NCT00528372|584658576|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161893818|NCT00528372|584658577|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161893819|NCT00528372|584658578|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
161893820|NCT00528372|584658579|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161893821|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
161893822|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
161893823|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
161893824|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
161893825|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
161893826|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
161893827|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
161893828|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
161893829|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
161893830|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
161893831|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
161893832|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
161893833|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
161893834|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
161893835|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
161893836|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
161893837|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
162008009|NCT00321620|585086544|FG001|Overall Study|Disease progression|117|||
162238563|NCT03217266|585926354|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
161779166|NCT01643928|584233854|FG001|Overall Study|Other|1|||
161779167|NCT01643928|584233855|FG002|Overall Study|Other|1|||
161779168|NCT01643928|584233856|FG003|Overall Study|Other|0|||
161779169|NCT01643928|584233857|FG004|Overall Study|Other|0|||
161779170|NCT01643928|584233853|FG000|Overall Study|Adverse Event|2|||
161779171|NCT01643928|584233854|FG001|Overall Study|Adverse Event|1|||
161779172|NCT01643928|584233855|FG002|Overall Study|Adverse Event|0|||
161779173|NCT01643928|584233856|FG003|Overall Study|Adverse Event|1|||
161779174|NCT01643928|584233857|FG004|Overall Study|Adverse Event|2|||
161779175|NCT00203892|584233860|FG000|Overall Study|Physician Decision|1|||
161779176|NCT00203892|584233861|FG001|Overall Study|Physician Decision|2|||
161779177|NCT00203892|584233862|FG002|Overall Study|Physician Decision|0|||
161779178|NCT00203892|584233860|FG000|Overall Study|Death|1|||
161779179|NCT00203892|584233861|FG001|Overall Study|Death|0|||
161779180|NCT00203892|584233862|FG002|Overall Study|Death|0|||
161779181|NCT00556166|584233864|FG000|Overall Study|Withdrawal by Subject|1|||
161779182|NCT03359473|584233865|FG000|Overall Study|Adverse Event|0|||
161779183|NCT03359473|584233866|FG001|Overall Study|Adverse Event|2|||
161779184|NCT03359473|584233867|FG002|Overall Study|Adverse Event|5|||
161779185|NCT03359473|584233868|FG003|Overall Study|Adverse Event|3|||
161779186|NCT03359473|584233865|FG000|Overall Study|Lost to Follow-up|0|||
161779187|NCT03359473|584233866|FG001|Overall Study|Lost to Follow-up|1|||
161779188|NCT03359473|584233867|FG002|Overall Study|Lost to Follow-up|0|||
161779189|NCT03359473|584233868|FG003|Overall Study|Lost to Follow-up|0|||
161779190|NCT03359473|584233865|FG000|Overall Study|Physician Decision|0|||
161779191|NCT03359473|584233866|FG001|Overall Study|Physician Decision|1|||
161779192|NCT03359473|584233867|FG002|Overall Study|Physician Decision|0|||
161779193|NCT03359473|584233868|FG003|Overall Study|Physician Decision|1|||
161779194|NCT03359473|584233865|FG000|Overall Study|Withdrawal by Subject|1|||
161779195|NCT03359473|584233866|FG001|Overall Study|Withdrawal by Subject|2|||
161779196|NCT03359473|584233867|FG002|Overall Study|Withdrawal by Subject|1|||
161779197|NCT03359473|584233868|FG003|Overall Study|Withdrawal by Subject|0|||
161779198|NCT03359473|584233865|FG000|Overall Study|Protocol-defined stopping criteria|1|||
161779199|NCT03359473|584233866|FG001|Overall Study|Protocol-defined stopping criteria|0|||
161779200|NCT03359473|584233867|FG002|Overall Study|Protocol-defined stopping criteria|0|||
161893838|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
161893839|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
161893840|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
161893841|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
161893842|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
161893843|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
161893844|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
161893845|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
161893846|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
161893847|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
161893848|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
161893849|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
161893850|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
161893851|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
161893852|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
161893853|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
161893854|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
161893855|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
161893856|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
162008010|NCT00321620|585086543|FG000|Overall Study|Adverse Event|43|||
162238564|NCT03217266|585926355|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
162238565|NCT03217266|585926356|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
162238566|NCT03217266|585926357|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
161779201|NCT03359473|584233868|FG003|Overall Study|Protocol-defined stopping criteria|1|||
161779202|NCT03829462|584233874|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
161779203|NCT03829462|584233875|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
161779204|NCT03829462|584233874|FG000|Overall Study|No treatment due to progression disease|0|||
161779205|NCT03829462|584233875|FG001|Overall Study|No treatment due to progression disease|1|||
161779206|NCT03000075|584233885|FG000|Part A|Adverse Event|4|||
161779207|NCT03000075|584233886|FG001|Part A|Adverse Event|0|||
161779208|NCT03000075|584233887|FG002|Part A|Adverse Event|0|||
161779209|NCT03000075|584233888|FG003|Part A|Adverse Event|0|||
161779210|NCT03000075|584233889|FG004|Part A|Adverse Event|0|||
161779211|NCT03000075|584233890|FG005|Part A|Adverse Event|0|||
161779212|NCT03000075|584233891|FG006|Part A|Adverse Event|0|||
161779213|NCT03000075|584233885|FG000|Part B|Not dosed due to AE|0|||
161779214|NCT03000075|584233886|FG001|Part B|Not dosed due to AE|0|||
161779215|NCT03000075|584233887|FG002|Part B|Not dosed due to AE|0|||
161779216|NCT03000075|584233888|FG003|Part B|Not dosed due to AE|0|||
161779217|NCT03000075|584233889|FG004|Part B|Not dosed due to AE|0|||
161779218|NCT03000075|584233890|FG005|Part B|Not dosed due to AE|2|||
161779219|NCT03000075|584233891|FG006|Part B|Not dosed due to AE|1|||
161779220|NCT03000075|584233885|FG000|Part B|Adverse Event|0|||
161779221|NCT03000075|584233886|FG001|Part B|Adverse Event|0|||
161779222|NCT03000075|584233887|FG002|Part B|Adverse Event|0|||
161779223|NCT03000075|584233888|FG003|Part B|Adverse Event|0|||
161779224|NCT03000075|584233889|FG004|Part B|Adverse Event|1|||
161779225|NCT03000075|584233890|FG005|Part B|Adverse Event|0|||
161779226|NCT03000075|584233891|FG006|Part B|Adverse Event|0|||
161779227|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
161779228|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
161779229|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Death|5|||
161893857|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161893858|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
161893859|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
162238567|NCT03217266|585926354|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
162238568|NCT03217266|585926355|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
161893860|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
161893861|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161893862|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161893863|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
161893864|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161893865|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161893866|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893867|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893868|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893869|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893870|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
161893871|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
161893872|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893873|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893874|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161893875|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161893876|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
161893877|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161893878|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161893879|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161893880|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161893881|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
161893882|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161893883|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
161893884|NCT00528372|584658571|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
161893885|NCT00528372|584658572|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
161893886|NCT00528372|584658573|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
161893887|NCT00528372|584658574|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
161893888|NCT00528372|584658575|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
161893889|NCT00528372|584658576|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
161893890|NCT00528372|584658577|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
161893891|NCT00528372|584658578|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
161893892|NCT00528372|584658579|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
161893893|NCT01289574|584658580|FG000|Overall Study|Lack of Efficacy|4|||
161893894|NCT01289574|584658581|FG001|Overall Study|Lack of Efficacy|0|||
161893895|NCT01289574|584658582|FG002|Overall Study|Lack of Efficacy|1|||
161893896|NCT01289574|584658580|FG000|Overall Study|Lost to Follow-up|2|||
161893897|NCT01289574|584658581|FG001|Overall Study|Lost to Follow-up|0|||
161893898|NCT01289574|584658582|FG002|Overall Study|Lost to Follow-up|1|||
161893899|NCT01289574|584658580|FG000|Overall Study|Withdrawal by Subject|1|||
161893900|NCT01289574|584658581|FG001|Overall Study|Withdrawal by Subject|1|||
161893901|NCT01289574|584658582|FG002|Overall Study|Withdrawal by Subject|1|||
161893902|NCT01289574|584658580|FG000|Overall Study|Adverse Event|0|||
161893903|NCT01289574|584658581|FG001|Overall Study|Adverse Event|1|||
161893904|NCT01289574|584658582|FG002|Overall Study|Adverse Event|0|||
161893905|NCT01289574|584658580|FG000|Overall Study|Subject wanted alternate treatment|0|||
161893906|NCT01289574|584658581|FG001|Overall Study|Subject wanted alternate treatment|1|||
161893907|NCT01289574|584658582|FG002|Overall Study|Subject wanted alternate treatment|0|||
161893908|NCT02432144|584658583|FG000|Overall Study|Participant Non-Compliance|1|||
161893909|NCT00262002|584658584|FG000|Overall Study|Adverse Event|2|||
161893910|NCT00262002|584658585|FG001|Overall Study|Adverse Event|1|||
161893911|NCT00262002|584658586|FG002|Overall Study|Adverse Event|0|||
161893912|NCT00262002|584658587|FG003|Overall Study|Adverse Event|0|||
161893913|NCT00262002|584658588|FG004|Overall Study|Adverse Event|0|||
161893914|NCT00262002|584658589|FG005|Overall Study|Adverse Event|1|||
161893915|NCT00262002|584658590|FG006|Overall Study|Adverse Event|0|||
161893916|NCT00262002|584658584|FG000|Overall Study|Withdrawal by Subject|4|||
161893917|NCT00262002|584658585|FG001|Overall Study|Withdrawal by Subject|2|||
161893918|NCT00262002|584658586|FG002|Overall Study|Withdrawal by Subject|0|||
161893919|NCT00262002|584658587|FG003|Overall Study|Withdrawal by Subject|1|||
161893920|NCT00262002|584658588|FG004|Overall Study|Withdrawal by Subject|2|||
162238569|NCT03217266|585926356|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
162238570|NCT03217266|585926357|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
161893921|NCT00262002|584658589|FG005|Overall Study|Withdrawal by Subject|2|||
161893922|NCT00262002|584658590|FG006|Overall Study|Withdrawal by Subject|2|||
161893923|NCT00262002|584658584|FG000|Overall Study|Lost to Follow-up|2|||
162008011|NCT00321620|585086544|FG001|Overall Study|Adverse Event|56|||
162008012|NCT00321620|585086543|FG000|Overall Study|Lost to Follow-up|13|||
162008013|NCT00321620|585086544|FG001|Overall Study|Lost to Follow-up|9|||
162008014|NCT00321620|585086543|FG000|Overall Study|Physician Decision|4|||
161893924|NCT00262002|584658585|FG001|Overall Study|Lost to Follow-up|0|||
161893925|NCT00262002|584658586|FG002|Overall Study|Lost to Follow-up|0|||
161893926|NCT00262002|584658587|FG003|Overall Study|Lost to Follow-up|2|||
161893927|NCT00262002|584658588|FG004|Overall Study|Lost to Follow-up|0|||
161893928|NCT00262002|584658589|FG005|Overall Study|Lost to Follow-up|1|||
161893929|NCT00262002|584658590|FG006|Overall Study|Lost to Follow-up|0|||
161893930|NCT00262002|584658584|FG000|Overall Study|Inapropriate enrollment|0|||
161893931|NCT00262002|584658585|FG001|Overall Study|Inapropriate enrollment|1|||
161893932|NCT00262002|584658586|FG002|Overall Study|Inapropriate enrollment|0|||
161893933|NCT00262002|584658587|FG003|Overall Study|Inapropriate enrollment|0|||
161893934|NCT00262002|584658588|FG004|Overall Study|Inapropriate enrollment|0|||
161893935|NCT00262002|584658589|FG005|Overall Study|Inapropriate enrollment|0|||
161893936|NCT00262002|584658590|FG006|Overall Study|Inapropriate enrollment|0|||
161893937|NCT00262002|584658584|FG000|Overall Study|Protocol Violation|3|||
161893938|NCT00262002|584658585|FG001|Overall Study|Protocol Violation|2|||
161893939|NCT00262002|584658586|FG002|Overall Study|Protocol Violation|0|||
161893940|NCT00262002|584658587|FG003|Overall Study|Protocol Violation|2|||
161893941|NCT00262002|584658588|FG004|Overall Study|Protocol Violation|5|||
161893942|NCT00262002|584658589|FG005|Overall Study|Protocol Violation|3|||
161893943|NCT00262002|584658590|FG006|Overall Study|Protocol Violation|2|||
161893944|NCT00262002|584658584|FG000|Overall Study|Unable to classify|0|||
161893945|NCT00262002|584658585|FG001|Overall Study|Unable to classify|0|||
161893946|NCT00262002|584658586|FG002|Overall Study|Unable to classify|0|||
161893947|NCT00262002|584658587|FG003|Overall Study|Unable to classify|0|||
161893948|NCT00262002|584658588|FG004|Overall Study|Unable to classify|0|||
161893949|NCT00262002|584658589|FG005|Overall Study|Unable to classify|0|||
161893950|NCT00262002|584658590|FG006|Overall Study|Unable to classify|2|||
161893951|NCT01451554|584658591|FG000|Overall Study|Withdrawal by Subject|14|||
161893952|NCT01451554|584658592|FG001|Overall Study|Withdrawal by Subject|9|||
161893953|NCT00958412|584658593|FG000|Overall Study|Study prematurely terminated|18|||
161893954|NCT02552888|584658596|FG000|Overall Study|Lost to Follow-up|1|||
161893955|NCT02552888|584658597|FG001|Overall Study|Lost to Follow-up|1|||
161942159|NCT03038620|584838331|FG000|Overall Study|Withdrawal by Subject|0|||
161942160|NCT03038620|584838332|FG001|Overall Study|Withdrawal by Subject|15|||
161942161|NCT03038620|584838331|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
161942162|NCT03038620|584838332|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
161942163|NCT02082977|584838333|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
161942164|NCT02082977|584838334|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
161942165|NCT02082977|584838335|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
161942166|NCT02082977|584838336|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
161942167|NCT02082977|584838337|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
161942168|NCT02082977|584838338|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
161942169|NCT02082977|584838339|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
161942170|NCT02082977|584838340|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
161942171|NCT02082977|584838341|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
161942172|NCT02082977|584838342|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
161942173|NCT02082977|584838333|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161942174|NCT02082977|584838334|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161942175|NCT02082977|584838335|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161942176|NCT02082977|584838336|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161942177|NCT02082977|584838337|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161942178|NCT02082977|584838338|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161942179|NCT02082977|584838339|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161942180|NCT02082977|584838340|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
161942181|NCT02082977|584838341|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161942182|NCT02082977|584838342|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
161942183|NCT02082977|584838333|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161942184|NCT02082977|584838334|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161942185|NCT02082977|584838335|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161942186|NCT02082977|584838336|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161942187|NCT02082977|584838337|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161942188|NCT02082977|584838338|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
161942189|NCT02082977|584838339|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161942190|NCT02082977|584838340|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161942191|NCT02082977|584838341|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161942192|NCT02082977|584838342|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
161942193|NCT02082977|584838333|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
161942194|NCT02082977|584838334|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
161942195|NCT02082977|584838335|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
161893956|NCT02362425|584660865|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
161893957|NCT02362425|584660866|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
161893958|NCT02362425|584660867|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
161893959|NCT02362425|584660868|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
161893960|NCT02362425|584660865|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
161893961|NCT02362425|584660866|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
161893962|NCT02362425|584660867|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
161893963|NCT02362425|584660868|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
161893964|NCT02362425|584660865|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
161893965|NCT02362425|584660866|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
161893966|NCT02362425|584660867|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
161893967|NCT02362425|584660868|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
161893968|NCT02362425|584660865|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
161893969|NCT02362425|584660866|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
161893970|NCT02362425|584660867|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
161893971|NCT02362425|584660868|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
161893972|NCT02362425|584660865|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
161893973|NCT02362425|584660866|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
161893974|NCT02362425|584660867|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
161893975|NCT02362425|584660868|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
161893976|NCT02362425|584660865|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
161893977|NCT02362425|584660866|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
161893978|NCT02362425|584660867|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
161893979|NCT02362425|584660868|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
161893980|NCT02362425|584660865|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
161893981|NCT02362425|584660866|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
161893982|NCT02362425|584660867|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
161893983|NCT02362425|584660868|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
161893984|NCT02362425|584660865|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
161893985|NCT02362425|584660866|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
161893986|NCT02362425|584660867|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
161893987|NCT02362425|584660868|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
161893988|NCT02688764|584660878|FG000|Overall Study|Adverse Event|3|||
161893989|NCT02688764|584660879|FG001|Overall Study|Adverse Event|3|||
161893990|NCT02688764|584660878|FG000|Overall Study|AE/Kidney transplant|1|||
161893991|NCT02688764|584660879|FG001|Overall Study|AE/Kidney transplant|0|||
161893992|NCT02688764|584660878|FG000|Overall Study|AE/Lack of efficacy|1|||
161893993|NCT02688764|584660879|FG001|Overall Study|AE/Lack of efficacy|0|||
161893994|NCT02688764|584660878|FG000|Overall Study|AE/Non-compl.|1|||
161893995|NCT02688764|584660879|FG001|Overall Study|AE/Non-compl.|0|||
161893996|NCT02688764|584660878|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
162238571|NCT02101034|585926358|FG000|Overall Study|Enrolled but did not start treatment|0|||
161893997|NCT02688764|584660879|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
161893998|NCT02688764|584660878|FG000|Overall Study|AE/Other|0|||
161893999|NCT02688764|584660879|FG001|Overall Study|AE/Other|1|||
161894000|NCT02688764|584660878|FG000|Overall Study|AE/Physician decision|1|||
161894001|NCT02688764|584660879|FG001|Overall Study|AE/Physician decision|0|||
161894002|NCT02688764|584660878|FG000|Overall Study|AE/Withd. parent|3|||
161894003|NCT02688764|584660879|FG001|Overall Study|AE/Withd. parent|0|||
161894004|NCT02688764|584660878|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
161894005|NCT02688764|584660879|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
161894006|NCT02688764|584660878|FG000|Overall Study|AE/Withd. subject|1|||
161894007|NCT02688764|584660879|FG001|Overall Study|AE/Withd. subject|0|||
161894008|NCT02688764|584660878|FG000|Overall Study|Kidney transplant|10|||
161894009|NCT02688764|584660879|FG001|Overall Study|Kidney transplant|4|||
161894010|NCT02688764|584660878|FG000|Overall Study|Lack of Efficacy|3|||
161894011|NCT02688764|584660879|FG001|Overall Study|Lack of Efficacy|2|||
161894012|NCT02688764|584660878|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
161894013|NCT02688764|584660879|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
161894014|NCT02688764|584660878|FG000|Overall Study|Non-compliance with study drug|4|||
161894015|NCT02688764|584660879|FG001|Overall Study|Non-compliance with study drug|0|||
161894016|NCT02688764|584660878|FG000|Overall Study|Non-compl./Physician decision|2|||
161894017|NCT02688764|584660879|FG001|Overall Study|Non-compl./Physician decision|0|||
161894018|NCT02688764|584660878|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
161894019|NCT02688764|584660879|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
161894020|NCT02688764|584660878|FG000|Overall Study|Non-compl./Withd. subject|0|||
161894021|NCT02688764|584660879|FG001|Overall Study|Non-compl./Withd. subject|2|||
161894022|NCT02688764|584660878|FG000|Overall Study|Phosphorus level outside safe range|0|||
161894023|NCT02688764|584660879|FG001|Overall Study|Phosphorus level outside safe range|1|||
162008015|NCT00321620|585086544|FG001|Overall Study|Physician Decision|1|||
161894024|NCT02688764|584660878|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
161894025|NCT02688764|584660879|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
161894026|NCT02688764|584660878|FG000|Overall Study|Study drug taste/Withd. parent|1|||
161894027|NCT02688764|584660879|FG001|Overall Study|Study drug taste/Withd. parent|0|||
161894028|NCT02688764|584660878|FG000|Overall Study|Subject moving out|2|||
161894029|NCT02688764|584660879|FG001|Overall Study|Subject moving out|0|||
161894030|NCT02688764|584660878|FG000|Overall Study|Subject taken off dialysis|1|||
161894031|NCT02688764|584660879|FG001|Overall Study|Subject taken off dialysis|0|||
161894032|NCT02688764|584660878|FG000|Overall Study|Withdrawal by parent|3|||
161894033|NCT02688764|584660879|FG001|Overall Study|Withdrawal by parent|0|||
161894034|NCT02579382|584660880|FG000|Main Study Phase|Lost to Follow-up|0|||
161894035|NCT02579382|584660881|FG001|Main Study Phase|Lost to Follow-up|0|||
161894036|NCT02579382|584660882|FG002|Main Study Phase|Lost to Follow-up|2|||
161894037|NCT02579382|584660883|FG003|Main Study Phase|Lost to Follow-up|0|||
161894038|NCT02579382|584660880|FG000|Main Study Phase|Withdrew Consent|0|||
161894039|NCT02579382|584660881|FG001|Main Study Phase|Withdrew Consent|0|||
161894040|NCT02579382|584660882|FG002|Main Study Phase|Withdrew Consent|0|||
161894041|NCT02579382|584660883|FG003|Main Study Phase|Withdrew Consent|2|||
161894042|NCT02579382|584660880|FG000|Main Study Phase|Lack of Efficacy|0|||
161894043|NCT02579382|584660881|FG001|Main Study Phase|Lack of Efficacy|0|||
161894044|NCT02579382|584660882|FG002|Main Study Phase|Lack of Efficacy|0|||
161894045|NCT02579382|584660883|FG003|Main Study Phase|Lack of Efficacy|1|||
161894046|NCT02579382|584660880|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
161894047|NCT02579382|584660881|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
161894048|NCT02579382|584660882|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
161894049|NCT02579382|584660883|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
161894050|NCT02579382|584660880|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
161894051|NCT02579382|584660881|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
161894052|NCT02579382|584660882|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
161894053|NCT02579382|584660883|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
161894054|NCT02579382|584660880|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
161894055|NCT02579382|584660881|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
161894056|NCT02579382|584660882|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
161894057|NCT02579382|584660883|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
161894058|NCT02579382|584660880|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
161894059|NCT02579382|584660881|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
161894060|NCT02579382|584660882|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
161894061|NCT02579382|584660883|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
161894062|NCT02579382|584660880|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
161894063|NCT02579382|584660881|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
161894064|NCT02579382|584660882|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
161894065|NCT02579382|584660883|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
161894066|NCT02579382|584660880|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
161894067|NCT02579382|584660881|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
161894068|NCT02579382|584660882|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
161894069|NCT02579382|584660883|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
161894070|NCT03026283|584660884|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
161894071|NCT03026283|584660885|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
161894072|NCT03026283|584660886|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
161894073|NCT03026283|584660887|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
161894074|NCT03026283|584660888|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
161894075|NCT03026283|584660889|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
161894076|NCT03026283|584660890|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
161894077|NCT03026283|584660891|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
161894078|NCT03026283|584660884|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
161894079|NCT03026283|584660885|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
161894080|NCT03026283|584660886|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
161894081|NCT03026283|584660887|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
161894082|NCT03026283|584660888|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
161894083|NCT03026283|584660889|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
161894084|NCT03026283|584660890|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
161894085|NCT03026283|584660891|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
161894086|NCT03026283|584660884|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894087|NCT03026283|584660885|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
161894088|NCT03026283|584660886|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894089|NCT03026283|584660887|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894090|NCT03026283|584660888|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894091|NCT03026283|584660889|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894092|NCT03026283|584660890|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894093|NCT03026283|584660891|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161894094|NCT03026283|584660884|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894095|NCT03026283|584660885|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894096|NCT03026283|584660886|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
161894097|NCT03026283|584660887|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894098|NCT03026283|584660888|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894099|NCT03026283|584660889|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894100|NCT03026283|584660890|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894101|NCT03026283|584660891|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161894102|NCT03026283|584660884|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161894103|NCT03026283|584660885|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161894104|NCT03026283|584660886|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161894105|NCT03026283|584660887|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
161894106|NCT03026283|584660888|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
161894107|NCT03026283|584660889|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161894108|NCT03026283|584660890|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161894109|NCT03026283|584660891|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161894110|NCT03026283|584660884|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161894111|NCT03026283|584660885|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161894112|NCT03026283|584660886|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161894113|NCT03026283|584660887|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
161894114|NCT03026283|584660888|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
161894115|NCT03026283|584660889|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
161894116|NCT03026283|584660890|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161894117|NCT03026283|584660891|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161894118|NCT03026283|584660884|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161894119|NCT03026283|584660885|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161894120|NCT03026283|584660886|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161894121|NCT03026283|584660887|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
161894122|NCT03026283|584660888|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161894123|NCT03026283|584660889|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
161894124|NCT03026283|584660890|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161894125|NCT03026283|584660891|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161894126|NCT03026283|584660884|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894127|NCT03026283|584660885|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894128|NCT03026283|584660886|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894129|NCT03026283|584660887|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
161894130|NCT03026283|584660888|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894131|NCT03026283|584660889|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894132|NCT03026283|584660890|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894133|NCT03026283|584660891|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161894134|NCT03026283|584660884|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161894135|NCT03026283|584660885|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161894136|NCT03026283|584660886|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161894137|NCT03026283|584660887|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161894138|NCT03026283|584660888|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
161894139|NCT03026283|584660889|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
161894140|NCT03026283|584660890|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161894141|NCT03026283|584660891|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161894142|NCT00824655|584660892|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
161894143|NCT00824655|584660893|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
161894144|NCT00824655|584660892|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
161894145|NCT00824655|584660893|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
161894146|NCT01826981|584660896|FG000|Overall Study|Lack of Efficacy|0|||
161894147|NCT01826981|584660897|FG001|Overall Study|Lack of Efficacy|1|||
161894148|NCT01826981|584660898|FG002|Overall Study|Lack of Efficacy|0|||
161894149|NCT01826981|584660899|FG003|Overall Study|Lack of Efficacy|0|||
161894150|NCT01826981|584660900|FG004|Overall Study|Lack of Efficacy|5|||
161894151|NCT01826981|584660901|FG005|Overall Study|Lack of Efficacy|0|||
161894152|NCT01826981|584660902|FG006|Overall Study|Lack of Efficacy|0|||
161894153|NCT01826981|584660903|FG007|Overall Study|Lack of Efficacy|8|||
161894154|NCT01826981|584660904|FG008|Overall Study|Lack of Efficacy|7|||
161894155|NCT01826981|584660905|FG009|Overall Study|Lack of Efficacy|0|||
161894156|NCT01826981|584660906|FG010|Overall Study|Lack of Efficacy|1|||
161894157|NCT01826981|584660907|FG011|Overall Study|Lack of Efficacy|0|||
161894158|NCT01826981|584660908|FG012|Overall Study|Lack of Efficacy|0|||
161894159|NCT01826981|584660909|FG013|Overall Study|Lack of Efficacy|3|||
161894160|NCT01826981|584660910|FG014|Overall Study|Lack of Efficacy|0|||
161894161|NCT01826981|584660896|FG000|Overall Study|Lost to Follow-up|0|||
161894162|NCT01826981|584660897|FG001|Overall Study|Lost to Follow-up|0|||
161894163|NCT01826981|584660898|FG002|Overall Study|Lost to Follow-up|0|||
161894164|NCT01826981|584660899|FG003|Overall Study|Lost to Follow-up|0|||
161894165|NCT01826981|584660900|FG004|Overall Study|Lost to Follow-up|1|||
161894166|NCT01826981|584660901|FG005|Overall Study|Lost to Follow-up|1|||
161894167|NCT01826981|584660902|FG006|Overall Study|Lost to Follow-up|0|||
161894168|NCT01826981|584660903|FG007|Overall Study|Lost to Follow-up|1|||
161894169|NCT01826981|584660904|FG008|Overall Study|Lost to Follow-up|0|||
161894170|NCT01826981|584660905|FG009|Overall Study|Lost to Follow-up|1|||
161894171|NCT01826981|584660906|FG010|Overall Study|Lost to Follow-up|1|||
161894172|NCT01826981|584660907|FG011|Overall Study|Lost to Follow-up|1|||
161894173|NCT01826981|584660908|FG012|Overall Study|Lost to Follow-up|1|||
161894174|NCT01826981|584660909|FG013|Overall Study|Lost to Follow-up|0|||
161894175|NCT01826981|584660910|FG014|Overall Study|Lost to Follow-up|0|||
161894176|NCT01826981|584660896|FG000|Overall Study|Withdrew Consent|0|||
161894177|NCT01826981|584660897|FG001|Overall Study|Withdrew Consent|0|||
161894178|NCT01826981|584660898|FG002|Overall Study|Withdrew Consent|0|||
161894179|NCT01826981|584660899|FG003|Overall Study|Withdrew Consent|0|||
161894180|NCT01826981|584660900|FG004|Overall Study|Withdrew Consent|0|||
161894181|NCT01826981|584660901|FG005|Overall Study|Withdrew Consent|0|||
161894182|NCT01826981|584660902|FG006|Overall Study|Withdrew Consent|1|||
161894183|NCT01826981|584660903|FG007|Overall Study|Withdrew Consent|1|||
161894184|NCT01826981|584660904|FG008|Overall Study|Withdrew Consent|0|||
161894185|NCT01826981|584660905|FG009|Overall Study|Withdrew Consent|0|||
161894186|NCT01826981|584660906|FG010|Overall Study|Withdrew Consent|0|||
161894187|NCT01826981|584660907|FG011|Overall Study|Withdrew Consent|1|||
161894188|NCT01826981|584660908|FG012|Overall Study|Withdrew Consent|0|||
161894189|NCT01826981|584660909|FG013|Overall Study|Withdrew Consent|1|||
161894190|NCT01826981|584660910|FG014|Overall Study|Withdrew Consent|0|||
161894191|NCT01826981|584660896|FG000|Overall Study|Adverse Event|0|||
161894192|NCT01826981|584660897|FG001|Overall Study|Adverse Event|0|||
162008016|NCT00321620|585086543|FG000|Overall Study|Noncompliance|14|||
162008017|NCT00321620|585086544|FG001|Overall Study|Noncompliance|7|||
162008018|NCT00321620|585086543|FG000|Overall Study|Protocol deviation|4|||
162008019|NCT00321620|585086544|FG001|Overall Study|Protocol deviation|3|||
162008020|NCT00321620|585086543|FG000|Overall Study|Ineligibility determined|2|||
162008021|NCT00321620|585086544|FG001|Overall Study|Ineligibility determined|3|||
162008022|NCT00321620|585086543|FG000|Overall Study|Participant request|75|||
162008023|NCT00321620|585086544|FG001|Overall Study|Participant request|52|||
162008024|NCT00321620|585086543|FG000|Overall Study|Other|42|||
162008025|NCT00321620|585086544|FG001|Overall Study|Other|33|||
162008026|NCT03198715|585086548|FG000|Overall Study|Death|0|||
162008027|NCT03198715|585086549|FG001|Overall Study|Death|0|||
162008028|NCT03198715|585086550|FG002|Overall Study|Death|1|||
162008029|NCT03198715|585086551|FG003|Overall Study|Death|0|||
161894193|NCT01826981|584660898|FG002|Overall Study|Adverse Event|0|||
161894194|NCT01826981|584660899|FG003|Overall Study|Adverse Event|0|||
161894195|NCT01826981|584660900|FG004|Overall Study|Adverse Event|1|||
161894196|NCT01826981|584660901|FG005|Overall Study|Adverse Event|0|||
161894197|NCT01826981|584660902|FG006|Overall Study|Adverse Event|0|||
161894198|NCT01826981|584660903|FG007|Overall Study|Adverse Event|0|||
161894199|NCT01826981|584660904|FG008|Overall Study|Adverse Event|0|||
161894200|NCT01826981|584660905|FG009|Overall Study|Adverse Event|0|||
161894201|NCT01826981|584660906|FG010|Overall Study|Adverse Event|0|||
161894202|NCT01826981|584660907|FG011|Overall Study|Adverse Event|0|||
161894203|NCT01826981|584660908|FG012|Overall Study|Adverse Event|0|||
161894204|NCT01826981|584660909|FG013|Overall Study|Adverse Event|0|||
161894205|NCT01826981|584660910|FG014|Overall Study|Adverse Event|0|||
161894206|NCT01826981|584660896|FG000|Overall Study|Upper G-I Haemorrhage|0|||
161894207|NCT01826981|584660897|FG001|Overall Study|Upper G-I Haemorrhage|0|||
161894208|NCT01826981|584660898|FG002|Overall Study|Upper G-I Haemorrhage|0|||
161894209|NCT01826981|584660899|FG003|Overall Study|Upper G-I Haemorrhage|0|||
161894210|NCT01826981|584660900|FG004|Overall Study|Upper G-I Haemorrhage|0|||
161894211|NCT01826981|584660901|FG005|Overall Study|Upper G-I Haemorrhage|0|||
161894212|NCT01826981|584660902|FG006|Overall Study|Upper G-I Haemorrhage|0|||
161894213|NCT01826981|584660903|FG007|Overall Study|Upper G-I Haemorrhage|0|||
161894214|NCT01826981|584660904|FG008|Overall Study|Upper G-I Haemorrhage|0|||
161894215|NCT01826981|584660905|FG009|Overall Study|Upper G-I Haemorrhage|0|||
161894216|NCT01826981|584660906|FG010|Overall Study|Upper G-I Haemorrhage|0|||
161894217|NCT01826981|584660907|FG011|Overall Study|Upper G-I Haemorrhage|0|||
161894218|NCT01826981|584660908|FG012|Overall Study|Upper G-I Haemorrhage|0|||
161894219|NCT01826981|584660909|FG013|Overall Study|Upper G-I Haemorrhage|1|||
161894220|NCT01826981|584660910|FG014|Overall Study|Upper G-I Haemorrhage|0|||
161894221|NCT01826981|584660896|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894222|NCT01826981|584660897|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894223|NCT01826981|584660898|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894224|NCT01826981|584660899|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894225|NCT01826981|584660900|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894226|NCT01826981|584660901|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894227|NCT01826981|584660902|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894228|NCT01826981|584660903|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
161894229|NCT01826981|584660904|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894230|NCT01826981|584660905|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894231|NCT01826981|584660906|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894232|NCT01826981|584660907|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894233|NCT01826981|584660908|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894234|NCT01826981|584660909|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894235|NCT01826981|584660910|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
161894236|NCT03746405|584660913|FG000|Overall Study|Withdrawal by Subject|3|||
161894237|NCT03746405|584660914|FG001|Overall Study|Withdrawal by Subject|0|||
161894238|NCT03746405|584660913|FG000|Overall Study|technical difficulties|0|||
161894239|NCT03746405|584660914|FG001|Overall Study|technical difficulties|2|||
161894240|NCT03479008|584660915|FG000|Overall Study|Withdrawal by Subject|3|||
161894241|NCT00412932|584660916|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
161894242|NCT00412932|584660916|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
161894243|NCT00412932|584660916|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
161894244|NCT00412932|584660916|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
161894245|NCT00412932|584660916|FG000|Olmesartan (Olm) 20 mg|Other|1|||
161894246|NCT00412932|584660916|FG000|Olmesartan 40 mg|Adverse Event|4|||
161894247|NCT00412932|584660916|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
161894248|NCT00412932|584660916|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
161894249|NCT00412932|584660916|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
161894250|NCT00412932|584660916|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
161894251|NCT00412932|584660916|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
161894252|NCT00412932|584660916|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
161894253|NCT02630563|584660917|FG000|Overall Study|Administrative|1|||
161894254|NCT00929994|584660918|FG000|Overall Study|Withdrawal by Subject|1|||
161894255|NCT00929994|584660918|FG000|Overall Study|medical issue unrelated to intervention|4|||
161894256|NCT00929994|584660918|FG000|Overall Study|employment|1|||
161894257|NCT02061813|584660920|FG000|Overall Study|Withdrawal by Subject|1|||
161894258|NCT02061813|584660920|FG000|Overall Study|Protocol Violation|2|||
161894259|NCT01705080|584660921|FG000|Overall Study|Missed visit|10|||
161894260|NCT01705080|584660922|FG001|Overall Study|Missed visit|4|||
161894261|NCT01705080|584660923|FG002|Overall Study|Missed visit|1|||
161894262|NCT01705080|584660921|FG000|Overall Study|Death|4|||
161894263|NCT01705080|584660922|FG001|Overall Study|Death|4|||
161894264|NCT01705080|584660923|FG002|Overall Study|Death|6|||
161894265|NCT01705080|584660921|FG000|Overall Study|Withdrawal by Subject|61|||
161894266|NCT01705080|584660922|FG001|Overall Study|Withdrawal by Subject|44|||
161894267|NCT01705080|584660923|FG002|Overall Study|Withdrawal by Subject|9|||
161894268|NCT00667563|584660925|FG000|Overall Study|Protocol Violation|24|||
161894269|NCT03130959|584660928|FG000|Overall Study|Disease progression|19|||
161894270|NCT03130959|584660929|FG001|Overall Study|Disease progression|7|||
161894271|NCT03130959|584660930|FG002|Overall Study|Disease progression|12|||
161894272|NCT03130959|584660931|FG003|Overall Study|Disease progression|7|||
161894273|NCT03130959|584660932|FG004|Overall Study|Disease progression|12|||
161894274|NCT03130959|584660933|FG005|Overall Study|Disease progression|3|||
161894275|NCT03130959|584660934|FG006|Overall Study|Disease progression|6|||
161894276|NCT03130959|584660935|FG007|Overall Study|Disease progression|3|||
161894277|NCT03130959|584660936|FG008|Overall Study|Disease progression|15|||
161894278|NCT03130959|584660937|FG009|Overall Study|Disease progression|8|||
161894279|NCT03130959|584660928|FG000|Overall Study|Study drug toxicity|2|||
161894280|NCT03130959|584660929|FG001|Overall Study|Study drug toxicity|2|||
161894281|NCT03130959|584660930|FG002|Overall Study|Study drug toxicity|1|||
161894282|NCT03130959|584660931|FG003|Overall Study|Study drug toxicity|2|||
161894283|NCT03130959|584660932|FG004|Overall Study|Study drug toxicity|1|||
161894284|NCT03130959|584660933|FG005|Overall Study|Study drug toxicity|1|||
161894285|NCT03130959|584660934|FG006|Overall Study|Study drug toxicity|3|||
161894286|NCT03130959|584660935|FG007|Overall Study|Study drug toxicity|0|||
161894287|NCT03130959|584660936|FG008|Overall Study|Study drug toxicity|3|||
161894288|NCT03130959|584660937|FG009|Overall Study|Study drug toxicity|3|||
162008030|NCT03198715|585086552|FG004|Overall Study|Death|2|||
162008031|NCT03198715|585086548|FG000|Overall Study|Other|0|||
162008032|NCT03198715|585086549|FG001|Overall Study|Other|1|||
162008033|NCT03198715|585086550|FG002|Overall Study|Other|1|||
162008034|NCT03198715|585086551|FG003|Overall Study|Other|0|||
162008035|NCT03198715|585086552|FG004|Overall Study|Other|0|||
162008036|NCT01112917|585086553|FG000|Overall Study|Death|2|||
161894289|NCT03130959|584660928|FG000|Overall Study|Other reasons|0|||
161894290|NCT03130959|584660929|FG001|Overall Study|Other reasons|0|||
161894291|NCT03130959|584660930|FG002|Overall Study|Other reasons|0|||
161894292|NCT03130959|584660931|FG003|Overall Study|Other reasons|0|||
161894293|NCT03130959|584660932|FG004|Overall Study|Other reasons|0|||
162008037|NCT01112917|585086554|FG001|Overall Study|Death|11|||
162008038|NCT01112917|585086553|FG000|Overall Study|Lost to Follow-up|1|||
162008039|NCT01112917|585086554|FG001|Overall Study|Lost to Follow-up|1|||
162008040|NCT01112917|585086553|FG000|Overall Study|Withdrawal by Subject|1|||
162008041|NCT01112917|585086554|FG001|Overall Study|Withdrawal by Subject|3|||
162008042|NCT01112917|585086553|FG000|Overall Study|Unable to Convert Filter|3|||
162008043|NCT01112917|585086554|FG001|Overall Study|Unable to Convert Filter|0|||
162008044|NCT05101122|585086555|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
162008045|NCT05101122|585086555|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
161894294|NCT03130959|584660933|FG005|Overall Study|Other reasons|1|||
161894295|NCT03130959|584660934|FG006|Overall Study|Other reasons|1|||
161894296|NCT03130959|584660935|FG007|Overall Study|Other reasons|0|||
161894297|NCT03130959|584660936|FG008|Overall Study|Other reasons|0|||
161894298|NCT03130959|584660937|FG009|Overall Study|Other reasons|0|||
161894299|NCT03130959|584660928|FG000|Overall Study|Subject request to discontinue therapy|0|||
161894300|NCT03130959|584660929|FG001|Overall Study|Subject request to discontinue therapy|0|||
161894301|NCT03130959|584660930|FG002|Overall Study|Subject request to discontinue therapy|1|||
161894302|NCT03130959|584660931|FG003|Overall Study|Subject request to discontinue therapy|1|||
162008046|NCT05101122|585086555|FG000|AD313 80/5|Withdrawal by Subject|1|||
162008047|NCT05101122|585086555|FG000|AD313 80/10|Physician Decision|1|||
162008048|NCT03131219|585086556|FG000|Initial Evaluation Period|Adverse Event|2|||
161894303|NCT03130959|584660932|FG004|Overall Study|Subject request to discontinue therapy|0|||
161894304|NCT03130959|584660933|FG005|Overall Study|Subject request to discontinue therapy|0|||
161894305|NCT03130959|584660934|FG006|Overall Study|Subject request to discontinue therapy|1|||
161894306|NCT03130959|584660935|FG007|Overall Study|Subject request to discontinue therapy|1|||
161894307|NCT03130959|584660936|FG008|Overall Study|Subject request to discontinue therapy|0|||
161894308|NCT03130959|584660937|FG009|Overall Study|Subject request to discontinue therapy|0|||
161894309|NCT03130959|584660928|FG000|Overall Study|Not reported|0|||
161894310|NCT03130959|584660929|FG001|Overall Study|Not reported|0|||
161894311|NCT03130959|584660930|FG002|Overall Study|Not reported|0|||
161894312|NCT03130959|584660931|FG003|Overall Study|Not reported|1|||
161894313|NCT03130959|584660932|FG004|Overall Study|Not reported|0|||
162008049|NCT03131219|585086557|FG001|Initial Evaluation Period|Adverse Event|0|||
162008050|NCT03131219|585086556|FG000|Initial Evaluation Period|Protocol Violation|1|||
162008051|NCT03131219|585086557|FG001|Initial Evaluation Period|Protocol Violation|0|||
162008052|NCT03131219|585086556|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
162008053|NCT03131219|585086557|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
162008054|NCT03131219|585086556|FG000|Initial Evaluation Period|Physician Decision|1|||
162008055|NCT03131219|585086557|FG001|Initial Evaluation Period|Physician Decision|0|||
162008056|NCT03131219|585086556|FG000|Extension Period|Physician Decision|1|||
162008057|NCT03131219|585086557|FG001|Extension Period|Physician Decision|0|||
162008058|NCT00616759|585086559|FG000|Overall Study|Physician Decision|2|||
162008059|NCT00616759|585086560|FG001|Overall Study|Physician Decision|0|||
162008060|NCT00616759|585086559|FG000|Overall Study|Withdrawal by Subject|1|||
162008061|NCT00616759|585086560|FG001|Overall Study|Withdrawal by Subject|2|||
162008062|NCT02399163|585086563|FG000|Overall Study|Adverse Event|2|||
162008063|NCT02399163|585086563|FG000|Overall Study|Protocol Deviation|2|||
162008064|NCT02399163|585086563|FG000|Overall Study|Withdrawal by Participant|5|||
162008065|NCT04613362|585086568|FG000|3 Month Follow-up|Lost to Follow-up|1|||
162008066|NCT04613362|585086569|FG001|3 Month Follow-up|Lost to Follow-up|2|||
162008067|NCT04613362|585086568|FG000|6 Month Follow-up|Lost to Follow-up|0|||
162008068|NCT04613362|585086569|FG001|6 Month Follow-up|Lost to Follow-up|1|||
162008069|NCT04225897|585086570|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
162008070|NCT04225897|585086571|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
162008071|NCT04225897|585086572|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
162008072|NCT04225897|585086573|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
162008073|NCT04225897|585086574|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
162008074|NCT04225897|585086575|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
162008075|NCT04225897|585086576|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
162008076|NCT04225897|585086577|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
162238572|NCT02101034|585926359|FG001|Overall Study|Enrolled but did not start treatment|0|||
162238573|NCT02101034|585926360|FG002|Overall Study|Enrolled but did not start treatment|1|||
162238574|NCT02101034|585926361|FG003|Overall Study|Enrolled but did not start treatment|0|||
162238575|NCT02101034|585926362|FG004|Overall Study|Enrolled but did not start treatment|0|||
162238576|NCT01101477|585926364|FG000|Overall Study|Protocol Violation|5|||
162238577|NCT01101477|585926365|FG001|Overall Study|Protocol Violation|3|||
162238578|NCT01101477|585926366|FG002|Overall Study|Protocol Violation|1|||
162008077|NCT04225897|585086578|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
162238579|NCT01222507|585926367|FG000|Overall Study|Physician Decision|1|||
162008078|NCT04225897|585086579|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
162008079|NCT04225897|585086580|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
162008080|NCT04225897|585086581|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
162122847|NCT00358215|585502342|FG000|Overall Study|Lost to Follow-up|16|||
162238580|NCT01222507|585926367|FG000|Overall Study|Withdrawal by Subject|1|||
162008081|NCT04225897|585086570|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
162008082|NCT04225897|585086571|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
162008083|NCT04225897|585086572|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
162008084|NCT04225897|585086573|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
162008085|NCT04225897|585086574|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
162008086|NCT04225897|585086575|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
162008087|NCT04225897|585086576|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
162008088|NCT04225897|585086577|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
162008089|NCT04225897|585086578|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
162008090|NCT04225897|585086579|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
162008091|NCT04225897|585086580|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
162008092|NCT04225897|585086581|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
162008093|NCT04225897|585086570|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
162008094|NCT04225897|585086571|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
162008095|NCT04225897|585086572|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
162008096|NCT04225897|585086573|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
162008097|NCT04225897|585086574|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
162008098|NCT04225897|585086575|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
162008099|NCT04225897|585086576|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
162008100|NCT04225897|585086577|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
162008101|NCT04225897|585086578|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
162008102|NCT04225897|585086579|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
162008103|NCT04225897|585086580|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
162008104|NCT04225897|585086581|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
162008105|NCT04225897|585086570|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
162008106|NCT04225897|585086571|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
162008107|NCT04225897|585086572|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
162008108|NCT04225897|585086573|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
162008109|NCT04225897|585086574|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
162008110|NCT04225897|585086575|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
162008111|NCT04225897|585086576|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
162008112|NCT04225897|585086577|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
162008113|NCT04225897|585086578|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
162008114|NCT04225897|585086579|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
162238581|NCT01786174|585926372|FG000|Overall Study|Discontinued Study Drug|2|||
162008115|NCT04225897|585086580|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
162008116|NCT04225897|585086581|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
162008117|NCT00074711|585086583|FG000|Overall Study|Withdrawal by Subject|1|||
162008118|NCT00074711|585086584|FG001|Overall Study|Withdrawal by Subject|1|||
162008119|NCT00074711|585086583|FG000|Overall Study|Lost to Follow-up|10|||
162008120|NCT00074711|585086584|FG001|Overall Study|Lost to Follow-up|8|||
162008121|NCT00074711|585086583|FG000|Overall Study|Participant stopped study drug|4|||
162008122|NCT00074711|585086584|FG001|Overall Study|Participant stopped study drug|6|||
162008123|NCT03466658|585086585|FG000|Overall Study|Withdrawal by Subject|3|||
162008124|NCT01921205|585086586|FG000|Overall Study|Adverse Event|12|||
162008125|NCT01921205|585086587|FG001|Overall Study|Adverse Event|7|||
162008126|NCT01921205|585086586|FG000|Overall Study|Lack of Efficacy|1|||
162008127|NCT01921205|585086587|FG001|Overall Study|Lack of Efficacy|0|||
162008128|NCT01921205|585086586|FG000|Overall Study|Protocol Violation|1|||
162008129|NCT01921205|585086587|FG001|Overall Study|Protocol Violation|3|||
162008130|NCT01921205|585086586|FG000|Overall Study|Lost to Follow-up|1|||
162008131|NCT01921205|585086587|FG001|Overall Study|Lost to Follow-up|1|||
162008132|NCT01921205|585086586|FG000|Overall Study|Withdrawal by Subject|6|||
162008133|NCT01921205|585086587|FG001|Overall Study|Withdrawal by Subject|5|||
162008134|NCT01921205|585086586|FG000|Overall Study|Use Of Prohibited Medication|0|||
162008135|NCT01921205|585086587|FG001|Overall Study|Use Of Prohibited Medication|1|||
162008136|NCT01921205|585086586|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
162008137|NCT01921205|585086587|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
162008138|NCT01921205|585086586|FG000|Overall Study|Non Compliance Of The Parent|0|||
162008139|NCT01921205|585086587|FG001|Overall Study|Non Compliance Of The Parent|1|||
162008140|NCT01921205|585086586|FG000|Overall Study|Non Compliance Of Child|0|||
162008141|NCT01921205|585086587|FG001|Overall Study|Non Compliance Of Child|1|||
162008142|NCT00456846|585086588|FG000|Overall Study|Adverse Event|2|||
162122848|NCT00358215|585502343|FG001|Overall Study|Lost to Follow-up|22|||
162238582|NCT01786174|585926373|FG001|Overall Study|Discontinued Study Drug|0|||
162238583|NCT00995020|585926374|FG000|Overall Study|margin analysis not performed|2|||
162238584|NCT00995020|585926375|FG001|Overall Study|margin analysis not performed|5|||
162238585|NCT00995020|585926374|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
162008143|NCT00456846|585086589|FG001|Overall Study|Adverse Event|15|||
162008144|NCT00456846|585086588|FG000|Overall Study|Physician Decision|11|||
162008145|NCT00456846|585086589|FG001|Overall Study|Physician Decision|6|||
162008146|NCT00456846|585086588|FG000|Overall Study|Protocol Deviation|2|||
162008147|NCT00456846|585086589|FG001|Overall Study|Protocol Deviation|0|||
162008148|NCT00456846|585086588|FG000|Overall Study|Participant Discretion|1|||
162008149|NCT00456846|585086589|FG001|Overall Study|Participant Discretion|5|||
162008150|NCT00456846|585086588|FG000|Overall Study|Other|0|||
162008151|NCT00456846|585086589|FG001|Overall Study|Other|2|||
162008152|NCT00886379|585086590|FG000|Overall Study|Transferred Schools|0|||
162008153|NCT00886379|585086591|FG001|Overall Study|Transferred Schools|0|||
162008154|NCT00886379|585086592|FG002|Overall Study|Transferred Schools|2|||
162008155|NCT00886379|585086593|FG003|Overall Study|Transferred Schools|1|||
162008156|NCT00886379|585086594|FG004|Overall Study|Transferred Schools|1|||
162008157|NCT00886379|585086590|FG000|Overall Study|Final blood draw not obtained|3|||
162008158|NCT00886379|585086591|FG001|Overall Study|Final blood draw not obtained|3|||
162008159|NCT00886379|585086592|FG002|Overall Study|Final blood draw not obtained|4|||
162008160|NCT00886379|585086593|FG003|Overall Study|Final blood draw not obtained|2|||
162008161|NCT00886379|585086594|FG004|Overall Study|Final blood draw not obtained|2|||
162008162|NCT03219723|585086595|FG000|Overall Study|Case Report Forms Uncollected|6|||
162008163|NCT03219723|585086595|FG000|Overall Study|Protocol Deviation|4|||
162008164|NCT03137381|585086596|FG000|Overall Study|Adverse Event|3|||
162008165|NCT03137381|585086597|FG001|Overall Study|Adverse Event|0|||
162008166|NCT03137381|585086598|FG002|Overall Study|Adverse Event|2|||
162008167|NCT03137381|585086599|FG003|Overall Study|Adverse Event|0|||
162008168|NCT03137381|585086596|FG000|Overall Study|Lost to Follow-up|2|||
162008169|NCT03137381|585086597|FG001|Overall Study|Lost to Follow-up|1|||
162008170|NCT03137381|585086598|FG002|Overall Study|Lost to Follow-up|1|||
162008171|NCT03137381|585086599|FG003|Overall Study|Lost to Follow-up|0|||
162008172|NCT03137381|585086596|FG000|Overall Study|Protocol deviation|1|||
162008173|NCT03137381|585086597|FG001|Overall Study|Protocol deviation|1|||
162008174|NCT03137381|585086598|FG002|Overall Study|Protocol deviation|0|||
162008175|NCT03137381|585086599|FG003|Overall Study|Protocol deviation|1|||
162008176|NCT03137381|585086596|FG000|Overall Study|Withdrawal by Investigator|0|||
162008177|NCT03137381|585086597|FG001|Overall Study|Withdrawal by Investigator|1|||
162008178|NCT03137381|585086598|FG002|Overall Study|Withdrawal by Investigator|1|||
162008179|NCT03137381|585086599|FG003|Overall Study|Withdrawal by Investigator|0|||
162008180|NCT03137381|585086596|FG000|Overall Study|Withdrawal by Subject|3|||
162008181|NCT03137381|585086597|FG001|Overall Study|Withdrawal by Subject|4|||
162008182|NCT03137381|585086598|FG002|Overall Study|Withdrawal by Subject|3|||
162008183|NCT03137381|585086599|FG003|Overall Study|Withdrawal by Subject|0|||
162008184|NCT03137381|585086596|FG000|Overall Study|Pregnancy|0|||
162008185|NCT03137381|585086597|FG001|Overall Study|Pregnancy|0|||
162008186|NCT03137381|585086598|FG002|Overall Study|Pregnancy|1|||
162008187|NCT03137381|585086599|FG003|Overall Study|Pregnancy|0|||
162008188|NCT00459316|585086604|FG000|Steps 1 & 2|Other eligibility failure|1|||
162008189|NCT00459316|585086605|FG001|Steps 1 & 2|Other eligibility failure|1|||
162008190|NCT00459316|585086606|FG002|Steps 1 & 2|Other eligibility failure|0|||
162008191|NCT00459316|585086604|FG000|Steps 1 & 2|Death|1|||
162008192|NCT00459316|585086605|FG001|Steps 1 & 2|Death|1|||
162008193|NCT00459316|585086606|FG002|Steps 1 & 2|Death|0|||
162008194|NCT00459316|585086604|FG000|Steps 1 & 2|Not able to get to clinic|7|||
162008195|NCT00459316|585086605|FG001|Steps 1 & 2|Not able to get to clinic|4|||
162008196|NCT00459316|585086606|FG002|Steps 1 & 2|Not able to get to clinic|0|||
162008197|NCT00459316|585086604|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
162008198|NCT00459316|585086605|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
162008199|NCT00459316|585086606|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
162008200|NCT00459316|585086604|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
162008201|NCT00459316|585086605|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
162008202|NCT00459316|585086606|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
162008203|NCT00459316|585086604|FG000|Steps 1 & 2|Lost to Follow-up|5|||
162008204|NCT00459316|585086605|FG001|Steps 1 & 2|Lost to Follow-up|0|||
162008205|NCT00459316|585086606|FG002|Steps 1 & 2|Lost to Follow-up|2|||
162008206|NCT00459316|585086604|FG000|Step 3|Withdrawal by Subject|3|||
162008207|NCT00459316|585086605|FG001|Step 3|Withdrawal by Subject|0|||
162008208|NCT00459316|585086606|FG002|Step 3|Withdrawal by Subject|1|||
162008209|NCT01614886|585086607|FG000|Overall Study|Adverse Event|15|||
162008210|NCT01614886|585086608|FG001|Overall Study|Adverse Event|20|||
162008211|NCT01614886|585086607|FG000|Overall Study|Withdrawal by Subject|4|||
162008212|NCT01614886|585086608|FG001|Overall Study|Withdrawal by Subject|4|||
162008213|NCT01614886|585086607|FG000|Overall Study|Death|1|||
162008214|NCT01614886|585086608|FG001|Overall Study|Death|0|||
162008215|NCT01614886|585086607|FG000|Overall Study|Protocol deviation|0|||
162008216|NCT01614886|585086608|FG001|Overall Study|Protocol deviation|2|||
162008217|NCT04004988|585086610|FG000|Period 1|Physician Decision|2|||
162008218|NCT04004988|585086611|FG001|Period 1|Physician Decision|0|||
162008219|NCT04004988|585086610|FG000|Period 1|Withdrawal by Subject|0|||
162008220|NCT04004988|585086611|FG001|Period 1|Withdrawal by Subject|1|||
162008221|NCT04004988|585086610|FG000|Period 1|Adverse Event|1|||
162008222|NCT04004988|585086611|FG001|Period 1|Adverse Event|2|||
162008223|NCT03873116|585086612|FG000|Part 1|Study drug discontinuation due to rash|0|||
162008224|NCT03873116|585086613|FG001|Part 1|Study drug discontinuation due to rash|0|||
162008225|NCT03873116|585086614|FG002|Part 1|Study drug discontinuation due to rash|0|||
162008226|NCT03873116|585086615|FG003|Part 1|Study drug discontinuation due to rash|0|||
162008227|NCT03873116|585086616|FG004|Part 1|Study drug discontinuation due to rash|0|||
162008228|NCT03873116|585086617|FG005|Part 1|Study drug discontinuation due to rash|1|||
162008229|NCT03873116|585086612|FG000|Part 2|Withdrawal by Subject|0|||
162008230|NCT03873116|585086613|FG001|Part 2|Withdrawal by Subject|0|||
162008231|NCT03873116|585086614|FG002|Part 2|Withdrawal by Subject|1|||
162008232|NCT03873116|585086615|FG003|Part 2|Withdrawal by Subject|0|||
162008233|NCT03873116|585086616|FG004|Part 2|Withdrawal by Subject|0|||
162008234|NCT03873116|585086617|FG005|Part 2|Withdrawal by Subject|0|||
162008235|NCT03873116|585086612|FG000|Part 2|Lab abnormality or AE|0|||
162008236|NCT03873116|585086613|FG001|Part 2|Lab abnormality or AE|0|||
162008237|NCT03873116|585086614|FG002|Part 2|Lab abnormality or AE|0|||
162008238|NCT03873116|585086615|FG003|Part 2|Lab abnormality or AE|0|||
162008239|NCT03873116|585086616|FG004|Part 2|Lab abnormality or AE|1|||
162008240|NCT03873116|585086617|FG005|Part 2|Lab abnormality or AE|0|||
162008241|NCT03873116|585086612|FG000|Part 3|Withdrawal by Subject|0|||
162008242|NCT03873116|585086613|FG001|Part 3|Withdrawal by Subject|0|||
162008243|NCT03873116|585086614|FG002|Part 3|Withdrawal by Subject|0|||
162008244|NCT03873116|585086615|FG003|Part 3|Withdrawal by Subject|0|||
162008245|NCT03873116|585086616|FG004|Part 3|Withdrawal by Subject|1|||
162008246|NCT03873116|585086617|FG005|Part 3|Withdrawal by Subject|0|||
162008247|NCT04682366|585086618|FG000|Overall Study|Lost to Follow-up|1|||
162008248|NCT04682366|585086619|FG001|Overall Study|Lost to Follow-up|1|||
162008249|NCT03125395|585086620|FG000|Overall Study|Adverse Event|2|||
162008250|NCT03125395|585086620|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
162008251|NCT03125395|585086620|FG000|Overall Study|Physician Decision|2|||
162008252|NCT03125395|585086620|FG000|Overall Study|Commercial drug is available|5|||
162008253|NCT02531802|585086621|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
162008254|NCT02531802|585086622|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
162008255|NCT02531802|585086623|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
162008256|NCT02531802|585086624|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
162008257|NCT02531802|585086625|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
162008258|NCT02531802|585086626|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
162008259|NCT02531802|585086627|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
162008260|NCT02531802|585086628|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
162008261|NCT02531802|585086629|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
162008262|NCT02531802|585086630|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
162008263|NCT02531802|585086631|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
162008264|NCT02531802|585086632|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
162008265|NCT02531802|585086633|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
162008266|NCT02531802|585086634|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
162008267|NCT02531802|585086635|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
162008268|NCT02531802|585086636|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
162008269|NCT02531802|585086637|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
162008270|NCT02531802|585086638|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
162008271|NCT02531802|585086639|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
162008272|NCT02531802|585086640|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
162008273|NCT02531802|585086641|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
162008274|NCT02531802|585086621|FG000|Received Vaccination 2|Physician Decision|0|||
162008275|NCT02531802|585086622|FG001|Received Vaccination 2|Physician Decision|0|||
162008276|NCT02531802|585086623|FG002|Received Vaccination 2|Physician Decision|0|||
162008277|NCT02531802|585086624|FG003|Received Vaccination 2|Physician Decision|0|||
162008278|NCT02531802|585086625|FG004|Received Vaccination 2|Physician Decision|0|||
162008279|NCT02531802|585086626|FG005|Received Vaccination 2|Physician Decision|1|||
162008280|NCT02531802|585086627|FG006|Received Vaccination 2|Physician Decision|0|||
162008281|NCT02531802|585086628|FG007|Received Vaccination 2|Physician Decision|0|||
162008282|NCT02531802|585086629|FG008|Received Vaccination 2|Physician Decision|0|||
162008283|NCT02531802|585086630|FG009|Received Vaccination 2|Physician Decision|2|||
162008284|NCT02531802|585086631|FG010|Received Vaccination 2|Physician Decision|0|||
162238586|NCT00995020|585926375|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
162008285|NCT02531802|585086632|FG011|Received Vaccination 2|Physician Decision|0|||
162008286|NCT02531802|585086633|FG012|Received Vaccination 2|Physician Decision|0|||
162008287|NCT02531802|585086634|FG013|Received Vaccination 2|Physician Decision|1|||
162008288|NCT02531802|585086635|FG014|Received Vaccination 2|Physician Decision|0|||
162008289|NCT02531802|585086636|FG015|Received Vaccination 2|Physician Decision|0|||
162008290|NCT02531802|585086637|FG016|Received Vaccination 2|Physician Decision|0|||
162238587|NCT01614197|585926376|FG000|Overall Study|Withdrawal by Subject|0|||
162238588|NCT01614197|585926377|FG001|Overall Study|Withdrawal by Subject|1|||
162008291|NCT02531802|585086638|FG017|Received Vaccination 2|Physician Decision|1|||
162008292|NCT02531802|585086639|FG018|Received Vaccination 2|Physician Decision|0|||
162008293|NCT02531802|585086640|FG019|Received Vaccination 2|Physician Decision|0|||
162008294|NCT02531802|585086641|FG020|Received Vaccination 2|Physician Decision|0|||
162008295|NCT02531802|585086621|FG000|Received Vaccination 2|Adverse Event|0|||
162008296|NCT02531802|585086622|FG001|Received Vaccination 2|Adverse Event|0|||
162008297|NCT02531802|585086623|FG002|Received Vaccination 2|Adverse Event|0|||
162238589|NCT01614197|585926378|FG002|Overall Study|Withdrawal by Subject|0|||
162238590|NCT01614197|585926379|FG003|Overall Study|Withdrawal by Subject|0|||
162008298|NCT02531802|585086624|FG003|Received Vaccination 2|Adverse Event|0|||
162008299|NCT02531802|585086625|FG004|Received Vaccination 2|Adverse Event|0|||
162008300|NCT02531802|585086626|FG005|Received Vaccination 2|Adverse Event|2|||
162008301|NCT02531802|585086627|FG006|Received Vaccination 2|Adverse Event|0|||
162008302|NCT02531802|585086628|FG007|Received Vaccination 2|Adverse Event|0|||
162008303|NCT02531802|585086629|FG008|Received Vaccination 2|Adverse Event|0|||
162008304|NCT02531802|585086630|FG009|Received Vaccination 2|Adverse Event|0|||
162008305|NCT02531802|585086631|FG010|Received Vaccination 2|Adverse Event|0|||
162008306|NCT02531802|585086632|FG011|Received Vaccination 2|Adverse Event|0|||
162008307|NCT02531802|585086633|FG012|Received Vaccination 2|Adverse Event|0|||
162008308|NCT02531802|585086634|FG013|Received Vaccination 2|Adverse Event|0|||
162008309|NCT02531802|585086635|FG014|Received Vaccination 2|Adverse Event|0|||
162008310|NCT02531802|585086636|FG015|Received Vaccination 2|Adverse Event|0|||
162008311|NCT02531802|585086637|FG016|Received Vaccination 2|Adverse Event|0|||
162008312|NCT02531802|585086638|FG017|Received Vaccination 2|Adverse Event|2|||
162008313|NCT02531802|585086639|FG018|Received Vaccination 2|Adverse Event|1|||
162008314|NCT02531802|585086640|FG019|Received Vaccination 2|Adverse Event|0|||
162008315|NCT02531802|585086641|FG020|Received Vaccination 2|Adverse Event|1|||
162008316|NCT02531802|585086621|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
162008317|NCT02531802|585086622|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
162008318|NCT02531802|585086623|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
162008319|NCT02531802|585086624|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
162008320|NCT02531802|585086625|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
162008321|NCT02531802|585086626|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
162008322|NCT02531802|585086627|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
162008323|NCT02531802|585086628|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
162008324|NCT02531802|585086629|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
162008325|NCT02531802|585086630|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
162008326|NCT02531802|585086631|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
162008327|NCT02531802|585086632|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
162008328|NCT02531802|585086633|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
162008329|NCT02531802|585086634|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
162008330|NCT02531802|585086635|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
162008331|NCT02531802|585086636|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
162008332|NCT02531802|585086637|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
162008333|NCT02531802|585086638|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
162008334|NCT02531802|585086639|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
162008335|NCT02531802|585086640|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
162008336|NCT02531802|585086641|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
162008337|NCT00482053|585086642|FG000|Inter-treatment Period|Disease progression|1|||
162008338|NCT04842747|585086646|FG000|Overall Study|Withdrawal by Subject|6|||
162008339|NCT04842747|585086647|FG001|Overall Study|Withdrawal by Subject|2|||
162008340|NCT04842747|585086646|FG000|Overall Study|Lost to Follow-up|1|||
162008341|NCT04842747|585086647|FG001|Overall Study|Lost to Follow-up|2|||
162008342|NCT04842747|585086646|FG000|Overall Study|Physician Decision|1|||
162008343|NCT04842747|585086647|FG001|Overall Study|Physician Decision|0|||
162008344|NCT04842747|585086646|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
162008345|NCT04842747|585086647|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
162008346|NCT02559622|585086649|FG000|Overall Study|Progressive disease|0|||
162008347|NCT02559622|585086650|FG001|Overall Study|Progressive disease|1|||
162008348|NCT02559622|585086651|FG002|Overall Study|Progressive disease|0|||
162008349|NCT02559622|585086652|FG003|Overall Study|Progressive disease|0|||
162008350|NCT02559622|585086649|FG000|Overall Study|Adverse Event|0|||
162008351|NCT02559622|585086650|FG001|Overall Study|Adverse Event|2|||
162238591|NCT03442985|585926380|FG000|Overall Study|Sponsor Request|55|||
162238592|NCT03442985|585926381|FG001|Overall Study|Sponsor Request|60|||
162008352|NCT02559622|585086651|FG002|Overall Study|Adverse Event|2|||
162008353|NCT02559622|585086652|FG003|Overall Study|Adverse Event|2|||
162008354|NCT02559622|585086649|FG000|Overall Study|Patient/guardian decision|1|||
162008355|NCT02559622|585086650|FG001|Overall Study|Patient/guardian decision|2|||
162008356|NCT02559622|585086651|FG002|Overall Study|Patient/guardian decision|0|||
162008357|NCT02559622|585086652|FG003|Overall Study|Patient/guardian decision|1|||
162008358|NCT04011540|585086653|FG000|Overall Study|Lost to Follow-up|9|||
162008359|NCT04011540|585086654|FG001|Overall Study|Lost to Follow-up|6|||
162008360|NCT01668784|585086668|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
162008361|NCT01668784|585086669|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
162008362|NCT01668784|585086668|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
162008363|NCT01668784|585086669|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
162008364|NCT01668784|585086668|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
162008365|NCT01668784|585086669|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
162008366|NCT01668784|585086668|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
162008367|NCT01668784|585086669|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
162008368|NCT01668784|585086668|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
162008369|NCT01668784|585086669|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
162008370|NCT01668784|585086668|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
162008371|NCT01668784|585086669|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
162008372|NCT01668784|585086668|FG000|Treatment Period|Disease Progression|316|||
162008373|NCT01668784|585086669|FG001|Treatment Period|Disease Progression|293|||
162008374|NCT01668784|585086668|FG000|Treatment Period|Study Drug Toxicity|46|||
162008375|NCT01668784|585086669|FG001|Treatment Period|Study Drug Toxicity|53|||
162008376|NCT01668784|585086668|FG000|Treatment Period|Death|1|||
162008377|NCT01668784|585086669|FG001|Treatment Period|Death|1|||
162008378|NCT01668784|585086668|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
162008379|NCT01668784|585086669|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
162008380|NCT01668784|585086668|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
162008381|NCT01668784|585086669|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
162008382|NCT01668784|585086668|FG000|Treatment Period|Withdrawal by Subject|5|||
162008383|NCT01668784|585086669|FG001|Treatment Period|Withdrawal by Subject|3|||
162008384|NCT01668784|585086668|FG000|Treatment Period|Maximal Clinical Benefit|3|||
162008385|NCT01668784|585086669|FG001|Treatment Period|Maximal Clinical Benefit|3|||
162008386|NCT01668784|585086668|FG000|Treatment Period|Other|2|||
162008387|NCT01668784|585086669|FG001|Treatment Period|Other|8|||
162008388|NCT01668784|585086668|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
162008389|NCT01668784|585086669|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
162008390|NCT05386329|585086670|FG000|Overall Study|Lost to Follow-up|3|||
162008391|NCT04973449|585086673|FG000|Overall Study|Withdrawal by Subject|3|||
162008392|NCT04973449|585086674|FG001|Overall Study|Withdrawal by Subject|3|||
162008393|NCT04973449|585086675|FG002|Overall Study|Withdrawal by Subject|2|||
162008394|NCT04973449|585086676|FG003|Overall Study|Withdrawal by Subject|5|||
162008395|NCT04973449|585086677|FG004|Overall Study|Withdrawal by Subject|5|||
162008396|NCT04973449|585086678|FG005|Overall Study|Withdrawal by Subject|4|||
162008397|NCT04973449|585086679|FG006|Overall Study|Withdrawal by Subject|7|||
162008398|NCT04973449|585086680|FG007|Overall Study|Withdrawal by Subject|5|||
162008399|NCT04973449|585086673|FG000|Overall Study|Lost to Follow-up|15|||
162008400|NCT04973449|585086674|FG001|Overall Study|Lost to Follow-up|16|||
162008401|NCT04973449|585086675|FG002|Overall Study|Lost to Follow-up|16|||
162008402|NCT04973449|585086676|FG003|Overall Study|Lost to Follow-up|13|||
162008403|NCT04973449|585086677|FG004|Overall Study|Lost to Follow-up|5|||
162008404|NCT04973449|585086678|FG005|Overall Study|Lost to Follow-up|6|||
162008405|NCT04973449|585086679|FG006|Overall Study|Lost to Follow-up|10|||
162008406|NCT04973449|585086680|FG007|Overall Study|Lost to Follow-up|6|||
162008407|NCT04973449|585086673|FG000|Overall Study|Death|1|||
162008408|NCT04973449|585086674|FG001|Overall Study|Death|0|||
162008409|NCT04973449|585086675|FG002|Overall Study|Death|0|||
162008410|NCT04973449|585086676|FG003|Overall Study|Death|0|||
162008411|NCT04973449|585086677|FG004|Overall Study|Death|0|||
162008412|NCT04973449|585086678|FG005|Overall Study|Death|1|||
162008413|NCT04973449|585086679|FG006|Overall Study|Death|0|||
162008414|NCT04973449|585086680|FG007|Overall Study|Death|0|||
162008415|NCT04973449|585086673|FG000|Overall Study|Other|1|||
162008416|NCT04973449|585086674|FG001|Overall Study|Other|1|||
162008417|NCT04973449|585086675|FG002|Overall Study|Other|2|||
162008418|NCT04973449|585086676|FG003|Overall Study|Other|1|||
162008419|NCT04973449|585086677|FG004|Overall Study|Other|4|||
162008420|NCT04973449|585086678|FG005|Overall Study|Other|0|||
162008421|NCT04973449|585086679|FG006|Overall Study|Other|2|||
162008422|NCT04973449|585086680|FG007|Overall Study|Other|2|||
162008423|NCT03137992|585086681|FG000|Washout Period 1|Adverse Event|1|||
162008424|NCT03137992|585086682|FG001|Washout Period 1|Adverse Event|1|||
162008425|NCT03137992|585086683|FG002|Washout Period 1|Adverse Event|0|||
162008426|NCT03137992|585086684|FG003|Washout Period 1|Adverse Event|0|||
162008427|NCT03137992|585086685|FG004|Washout Period 1|Adverse Event|0|||
162008428|NCT03137992|585086686|FG005|Washout Period 1|Adverse Event|1|||
162008429|NCT03137992|585086681|FG000|Washout Period 1|Withdrawal by Subject|0|||
162008430|NCT03137992|585086682|FG001|Washout Period 1|Withdrawal by Subject|1|||
162008431|NCT03137992|585086683|FG002|Washout Period 1|Withdrawal by Subject|1|||
162008432|NCT03137992|585086684|FG003|Washout Period 1|Withdrawal by Subject|0|||
162008433|NCT03137992|585086685|FG004|Washout Period 1|Withdrawal by Subject|0|||
162008434|NCT03137992|585086686|FG005|Washout Period 1|Withdrawal by Subject|0|||
162008435|NCT03137992|585086681|FG000|Washout Period 1|Principal Investigator Discretion|0|||
161894314|NCT03130959|584660933|FG005|Overall Study|Not reported|1|||
161894315|NCT03130959|584660934|FG006|Overall Study|Not reported|0|||
161894316|NCT03130959|584660935|FG007|Overall Study|Not reported|0|||
161894317|NCT03130959|584660936|FG008|Overall Study|Not reported|0|||
161894318|NCT03130959|584660937|FG009|Overall Study|Not reported|1|||
161894319|NCT03130959|584660928|FG000|Overall Study|Adverse Event unrelated to drug|0|||
161894320|NCT03130959|584660929|FG001|Overall Study|Adverse Event unrelated to drug|0|||
161894321|NCT03130959|584660930|FG002|Overall Study|Adverse Event unrelated to drug|1|||
161894322|NCT03130959|584660931|FG003|Overall Study|Adverse Event unrelated to drug|1|||
161894323|NCT03130959|584660932|FG004|Overall Study|Adverse Event unrelated to drug|1|||
161894324|NCT03130959|584660933|FG005|Overall Study|Adverse Event unrelated to drug|0|||
161894325|NCT03130959|584660934|FG006|Overall Study|Adverse Event unrelated to drug|1|||
161894326|NCT03130959|584660935|FG007|Overall Study|Adverse Event unrelated to drug|0|||
161894327|NCT03130959|584660936|FG008|Overall Study|Adverse Event unrelated to drug|1|||
161894328|NCT03130959|584660937|FG009|Overall Study|Adverse Event unrelated to drug|1|||
161894329|NCT03130959|584660928|FG000|Overall Study|Participant withdrew consent|0|||
161894330|NCT03130959|584660929|FG001|Overall Study|Participant withdrew consent|1|||
161894331|NCT03130959|584660930|FG002|Overall Study|Participant withdrew consent|0|||
161894332|NCT03130959|584660931|FG003|Overall Study|Participant withdrew consent|2|||
161894333|NCT03130959|584660932|FG004|Overall Study|Participant withdrew consent|1|||
161894334|NCT03130959|584660933|FG005|Overall Study|Participant withdrew consent|0|||
161894335|NCT03130959|584660934|FG006|Overall Study|Participant withdrew consent|0|||
161894336|NCT03130959|584660935|FG007|Overall Study|Participant withdrew consent|0|||
161894337|NCT03130959|584660936|FG008|Overall Study|Participant withdrew consent|0|||
161894338|NCT03130959|584660937|FG009|Overall Study|Participant withdrew consent|2|||
161894339|NCT03130959|584660928|FG000|Overall Study|Administrative reason by sponsor|1|||
161894340|NCT03130959|584660929|FG001|Overall Study|Administrative reason by sponsor|0|||
161894341|NCT03130959|584660930|FG002|Overall Study|Administrative reason by sponsor|1|||
161894342|NCT03130959|584660931|FG003|Overall Study|Administrative reason by sponsor|0|||
161894343|NCT03130959|584660932|FG004|Overall Study|Administrative reason by sponsor|0|||
161894344|NCT03130959|584660933|FG005|Overall Study|Administrative reason by sponsor|0|||
161894345|NCT03130959|584660934|FG006|Overall Study|Administrative reason by sponsor|0|||
161894346|NCT03130959|584660935|FG007|Overall Study|Administrative reason by sponsor|0|||
161894347|NCT03130959|584660936|FG008|Overall Study|Administrative reason by sponsor|0|||
161894348|NCT03130959|584660937|FG009|Overall Study|Administrative reason by sponsor|0|||
161894349|NCT03130959|584660928|FG000|Overall Study|Lost to Follow-up|1|||
161894350|NCT03130959|584660929|FG001|Overall Study|Lost to Follow-up|0|||
161894351|NCT03130959|584660930|FG002|Overall Study|Lost to Follow-up|0|||
161894352|NCT03130959|584660931|FG003|Overall Study|Lost to Follow-up|0|||
161894353|NCT03130959|584660932|FG004|Overall Study|Lost to Follow-up|0|||
161894354|NCT03130959|584660933|FG005|Overall Study|Lost to Follow-up|0|||
161894355|NCT03130959|584660934|FG006|Overall Study|Lost to Follow-up|0|||
161894356|NCT03130959|584660935|FG007|Overall Study|Lost to Follow-up|0|||
161894357|NCT03130959|584660936|FG008|Overall Study|Lost to Follow-up|0|||
161894358|NCT03130959|584660937|FG009|Overall Study|Lost to Follow-up|0|||
161894359|NCT02384538|584660950|FG000|Overall Study|Adverse Event|1|||
161894360|NCT02384538|584660951|FG001|Overall Study|Adverse Event|4|||
161894361|NCT02384538|584660950|FG000|Overall Study|Lack of Efficacy|4|||
161894362|NCT02384538|584660951|FG001|Overall Study|Lack of Efficacy|4|||
161894363|NCT02384538|584660950|FG000|Overall Study|Withdrew Consent|0|||
161894364|NCT02384538|584660951|FG001|Overall Study|Withdrew Consent|4|||
161894365|NCT02384538|584660950|FG000|Overall Study|Other|1|||
161894366|NCT02384538|584660951|FG001|Overall Study|Other|3|||
161894367|NCT01301079|584660952|FG000|Overall Study|Lost to Follow-up|2|||
161894368|NCT01301079|584660953|FG001|Overall Study|Lost to Follow-up|2|||
161894369|NCT00313586|584660954|FG000|Overall Study|Disease progression|14|||
161894370|NCT00313586|584660955|FG001|Overall Study|Disease progression|19|||
161894371|NCT00313586|584660956|FG002|Overall Study|Disease progression|10|||
161894372|NCT00313586|584660957|FG003|Overall Study|Disease progression|3|||
161894373|NCT00313586|584660954|FG000|Overall Study|Adverse Event|12|||
161894374|NCT00313586|584660955|FG001|Overall Study|Adverse Event|18|||
161894375|NCT00313586|584660956|FG002|Overall Study|Adverse Event|3|||
161894376|NCT00313586|584660957|FG003|Overall Study|Adverse Event|10|||
161894377|NCT00313586|584660954|FG000|Overall Study|Death|11|||
161894378|NCT00313586|584660955|FG001|Overall Study|Death|8|||
161894379|NCT00313586|584660956|FG002|Overall Study|Death|1|||
161894380|NCT00313586|584660957|FG003|Overall Study|Death|7|||
161894381|NCT00313586|584660954|FG000|Overall Study|Withdrawal by Subject|13|||
161894382|NCT00313586|584660955|FG001|Overall Study|Withdrawal by Subject|6|||
161894383|NCT00313586|584660956|FG002|Overall Study|Withdrawal by Subject|6|||
161894384|NCT00313586|584660957|FG003|Overall Study|Withdrawal by Subject|2|||
161894385|NCT00313586|584660954|FG000|Overall Study|Alternative therapy|3|||
161894386|NCT00313586|584660955|FG001|Overall Study|Alternative therapy|6|||
161894387|NCT00313586|584660956|FG002|Overall Study|Alternative therapy|2|||
161894388|NCT00313586|584660957|FG003|Overall Study|Alternative therapy|0|||
161894389|NCT00313586|584660954|FG000|Overall Study|Other complicating disease|2|||
162008436|NCT03137992|585086682|FG001|Washout Period 1|Principal Investigator Discretion|1|||
162008437|NCT03137992|585086683|FG002|Washout Period 1|Principal Investigator Discretion|0|||
162008438|NCT03137992|585086684|FG003|Washout Period 1|Principal Investigator Discretion|0|||
162008439|NCT03137992|585086685|FG004|Washout Period 1|Principal Investigator Discretion|0|||
162008440|NCT03137992|585086686|FG005|Washout Period 1|Principal Investigator Discretion|0|||
162008441|NCT03137992|585086681|FG000|Washout Period 1|COPD Exacerbation|1|||
162008442|NCT03137992|585086682|FG001|Washout Period 1|COPD Exacerbation|1|||
162008443|NCT03137992|585086683|FG002|Washout Period 1|COPD Exacerbation|1|||
162008444|NCT03137992|585086684|FG003|Washout Period 1|COPD Exacerbation|0|||
162008445|NCT03137992|585086685|FG004|Washout Period 1|COPD Exacerbation|1|||
162008446|NCT03137992|585086686|FG005|Washout Period 1|COPD Exacerbation|1|||
162008447|NCT03137992|585086681|FG000|Washout Period 1|Subject Noncompliance|1|||
162008448|NCT03137992|585086682|FG001|Washout Period 1|Subject Noncompliance|0|||
162008449|NCT03137992|585086683|FG002|Washout Period 1|Subject Noncompliance|0|||
162008450|NCT03137992|585086684|FG003|Washout Period 1|Subject Noncompliance|0|||
162008451|NCT03137992|585086685|FG004|Washout Period 1|Subject Noncompliance|1|||
162008452|NCT03137992|585086686|FG005|Washout Period 1|Subject Noncompliance|0|||
162008453|NCT03137992|585086681|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
162008454|NCT03137992|585086682|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
162008455|NCT03137992|585086683|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
162008456|NCT03137992|585086684|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
162008457|NCT03137992|585086685|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
162008458|NCT03137992|585086686|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
162008459|NCT03137992|585086681|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
162008460|NCT03137992|585086682|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
162008461|NCT03137992|585086683|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
162008462|NCT03137992|585086684|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
162008463|NCT03137992|585086685|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
162008464|NCT03137992|585086686|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
162008465|NCT03137992|585086681|FG000|Period 2 (Visit 3)|Adverse Event|0|||
162008466|NCT03137992|585086682|FG001|Period 2 (Visit 3)|Adverse Event|1|||
162008467|NCT03137992|585086683|FG002|Period 2 (Visit 3)|Adverse Event|0|||
162008468|NCT03137992|585086684|FG003|Period 2 (Visit 3)|Adverse Event|0|||
162008469|NCT03137992|585086685|FG004|Period 2 (Visit 3)|Adverse Event|0|||
162008470|NCT03137992|585086686|FG005|Period 2 (Visit 3)|Adverse Event|0|||
162238593|NCT03442985|585926382|FG002|Overall Study|Sponsor Request|54|||
162238594|NCT03442985|585926380|FG000|Overall Study|Lost to Follow-up|5|||
162238595|NCT03442985|585926381|FG001|Overall Study|Lost to Follow-up|2|||
162238596|NCT03442985|585926382|FG002|Overall Study|Lost to Follow-up|7|||
162238597|NCT03442985|585926380|FG000|Overall Study|Withdrawal by Subject|2|||
162238598|NCT03442985|585926381|FG001|Overall Study|Withdrawal by Subject|3|||
162238599|NCT03442985|585926382|FG002|Overall Study|Withdrawal by Subject|4|||
162238600|NCT03442985|585926380|FG000|Overall Study|Adverse Event|0|||
162238601|NCT03442985|585926381|FG001|Overall Study|Adverse Event|1|||
162238602|NCT03442985|585926382|FG002|Overall Study|Adverse Event|0|||
162238603|NCT00876694|585926384|FG000|Overall Study|Adverse Event|10|||
162238604|NCT00876694|585926385|FG001|Overall Study|Adverse Event|7|||
162238605|NCT00876694|585926384|FG000|Overall Study|Subject withdrew consent|6|||
162238606|NCT00876694|585926385|FG001|Overall Study|Subject withdrew consent|4|||
162238607|NCT00876694|585926384|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162238608|NCT00876694|585926385|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162238609|NCT00876694|585926384|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162238610|NCT00876694|585926385|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162238611|NCT00876694|585926384|FG000|Overall Study|Administrative problems|1|||
162238612|NCT00876694|585926385|FG001|Overall Study|Administrative problems|1|||
162238613|NCT00876694|585926384|FG000|Overall Study|Death|1|||
162238614|NCT00876694|585926385|FG001|Overall Study|Death|0|||
162238615|NCT00288509|585926386|FG000|Treatment Cycle 1|Adverse Event|1|||
162238616|NCT00288509|585926386|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
162238617|NCT00288509|585926386|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
162238618|NCT00288509|585926386|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
162238619|NCT00288509|585926386|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
162238620|NCT00288509|585926386|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
162238621|NCT00288509|585926386|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
162238622|NCT00288509|585926386|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
162238623|NCT00288509|585926386|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
162238624|NCT00288509|585926386|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
162008471|NCT03137992|585086681|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
162238625|NCT00288509|585926386|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
162238626|NCT00288509|585926386|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
162238627|NCT00288509|585926386|FG000|Treatment Cycle 4|Physician Decision|4|||
162008472|NCT03137992|585086682|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
162238628|NCT00288509|585926386|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
162238629|NCT00084266|585926387|FG000|Overall Study|Death|42|||
162238630|NCT00084266|585926388|FG001|Overall Study|Death|39|||
162238631|NCT00084266|585926387|FG000|Overall Study|Adverse Event|8|||
162238632|NCT00084266|585926388|FG001|Overall Study|Adverse Event|5|||
162238633|NCT00084266|585926387|FG000|Overall Study|Lack of Efficacy|2|||
162238634|NCT00084266|585926388|FG001|Overall Study|Lack of Efficacy|4|||
162238635|NCT00084266|585926387|FG000|Overall Study|Lost to Follow-up|5|||
162238636|NCT00084266|585926388|FG001|Overall Study|Lost to Follow-up|3|||
162238637|NCT00084266|585926387|FG000|Overall Study|Participant not willing to participate|3|||
162238638|NCT00084266|585926388|FG001|Overall Study|Participant not willing to participate|8|||
162238639|NCT00084266|585926387|FG000|Overall Study|Other|360|||
162238640|NCT00084266|585926388|FG001|Overall Study|Other|344|||
162238641|NCT00084266|585926387|FG000|Overall Study|Randomized not treated|21|||
162238642|NCT00084266|585926388|FG001|Overall Study|Randomized not treated|20|||
162238643|NCT01215422|585926389|FG000|Overall Study|Relocation|1|||
162238644|NCT01215422|585926390|FG001|Overall Study|Relocation|0|||
162238645|NCT01215422|585926391|FG002|Overall Study|Relocation|0|||
162238646|NCT01215422|585926392|FG003|Overall Study|Relocation|0|||
162238647|NCT01215422|585926389|FG000|Overall Study|Failed intubations|0|||
162238648|NCT01215422|585926390|FG001|Overall Study|Failed intubations|0|||
162238649|NCT01215422|585926391|FG002|Overall Study|Failed intubations|3|||
162238650|NCT01215422|585926392|FG003|Overall Study|Failed intubations|8|||
162238651|NCT01215422|585926389|FG000|Overall Study|Did not complete all intubations|7|||
162238652|NCT01215422|585926390|FG001|Overall Study|Did not complete all intubations|0|||
162238653|NCT01215422|585926391|FG002|Overall Study|Did not complete all intubations|0|||
162238654|NCT01215422|585926392|FG003|Overall Study|Did not complete all intubations|0|||
162238655|NCT02864381|585926399|FG000|Overall Study|Death|58|||
162238656|NCT02864381|585926400|FG001|Overall Study|Death|61|||
162238657|NCT02864381|585926399|FG000|Overall Study|Withdrew Consent|5|||
162238658|NCT02864381|585926400|FG001|Overall Study|Withdrew Consent|6|||
162238659|NCT02864381|585926399|FG000|Overall Study|Reason Unknown|7|||
162238660|NCT02864381|585926400|FG001|Overall Study|Reason Unknown|3|||
162238661|NCT02864381|585926399|FG000|Overall Study|Lost to Follow-up|1|||
162238662|NCT02864381|585926400|FG001|Overall Study|Lost to Follow-up|1|||
162238663|NCT02864381|585926399|FG000|Overall Study|Investigator's Discretion|1|||
162238664|NCT02864381|585926400|FG001|Overall Study|Investigator's Discretion|0|||
162238665|NCT02864381|585926399|FG000|Overall Study|Protocol Violation|0|||
162238666|NCT02864381|585926400|FG001|Overall Study|Protocol Violation|1|||
162238667|NCT02986334|585926402|FG000|Overall Study|Withdrawal by Subject|0|||
162238668|NCT02986334|585926403|FG001|Overall Study|Withdrawal by Subject|1|||
162238669|NCT02986334|585926404|FG002|Overall Study|Withdrawal by Subject|2|||
162238670|NCT02986334|585926402|FG000|Overall Study|Lost to Follow-up|1|||
162238671|NCT02986334|585926403|FG001|Overall Study|Lost to Follow-up|2|||
162238672|NCT02986334|585926404|FG002|Overall Study|Lost to Follow-up|1|||
162238673|NCT02986334|585926402|FG000|Overall Study|Adverse Event|0|||
162238674|NCT02986334|585926403|FG001|Overall Study|Adverse Event|2|||
162238675|NCT02986334|585926404|FG002|Overall Study|Adverse Event|1|||
162238676|NCT02986334|585926402|FG000|Overall Study|non compliance in phone ratings|2|||
162238677|NCT02986334|585926403|FG001|Overall Study|non compliance in phone ratings|1|||
162238678|NCT02986334|585926404|FG002|Overall Study|non compliance in phone ratings|2|||
162238679|NCT02986334|585926402|FG000|Overall Study|undisclosed comorbidities|0|||
162238680|NCT02986334|585926403|FG001|Overall Study|undisclosed comorbidities|1|||
162008473|NCT03137992|585086683|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
162008474|NCT03137992|585086684|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
162008475|NCT03137992|585086685|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
162008476|NCT03137992|585086686|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
162008477|NCT03137992|585086681|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
162008478|NCT03137992|585086682|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
162008479|NCT03137992|585086683|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
162008480|NCT03137992|585086684|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
162008481|NCT03137992|585086685|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
162008482|NCT03137992|585086686|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
162008483|NCT03137992|585086681|FG000|Washout Period 2|COPD Exacerbation|1|||
162008484|NCT03137992|585086682|FG001|Washout Period 2|COPD Exacerbation|1|||
162008485|NCT03137992|585086683|FG002|Washout Period 2|COPD Exacerbation|0|||
162008486|NCT03137992|585086684|FG003|Washout Period 2|COPD Exacerbation|0|||
162008487|NCT03137992|585086685|FG004|Washout Period 2|COPD Exacerbation|1|||
162008488|NCT03137992|585086686|FG005|Washout Period 2|COPD Exacerbation|0|||
162238681|NCT02986334|585926404|FG002|Overall Study|undisclosed comorbidities|1|||
162238682|NCT00667355|585926406|FG000|Overall Study|Adverse Event|5|||
162238683|NCT00667355|585926406|FG000|Overall Study|Lost to Follow-up|1|||
162238684|NCT00667355|585926406|FG000|Overall Study|Other reason was not specified|5|||
162238685|NCT01313637|585926409|FG000|Overall Study|Adverse Event|17|||
162238686|NCT01313637|585926410|FG001|Overall Study|Adverse Event|24|||
162238687|NCT01313637|585926411|FG002|Overall Study|Adverse Event|25|||
162238688|NCT01313637|585926412|FG003|Overall Study|Adverse Event|18|||
162238689|NCT01313637|585926409|FG000|Overall Study|Lack of Efficacy|44|||
162238690|NCT01313637|585926410|FG001|Overall Study|Lack of Efficacy|38|||
162238691|NCT01313637|585926411|FG002|Overall Study|Lack of Efficacy|37|||
162238692|NCT01313637|585926412|FG003|Overall Study|Lack of Efficacy|24|||
162008489|NCT03137992|585086681|FG000|Washout Period 2|Subject Non-compliance|0|||
162008490|NCT03137992|585086682|FG001|Washout Period 2|Subject Non-compliance|1|||
162008491|NCT03137992|585086683|FG002|Washout Period 2|Subject Non-compliance|0|||
162008492|NCT03137992|585086684|FG003|Washout Period 2|Subject Non-compliance|0|||
162008493|NCT03137992|585086685|FG004|Washout Period 2|Subject Non-compliance|0|||
162008494|NCT03137992|585086686|FG005|Washout Period 2|Subject Non-compliance|0|||
162008495|NCT03137992|585086681|FG000|Washout Period 2|Adverse Event|0|||
162008496|NCT03137992|585086682|FG001|Washout Period 2|Adverse Event|0|||
162008497|NCT03137992|585086683|FG002|Washout Period 2|Adverse Event|0|||
162008498|NCT03137992|585086684|FG003|Washout Period 2|Adverse Event|1|||
162008499|NCT03137992|585086685|FG004|Washout Period 2|Adverse Event|1|||
162008500|NCT03137992|585086686|FG005|Washout Period 2|Adverse Event|0|||
162008501|NCT03137992|585086681|FG000|Washout Period 2|Withdrawal by Subject|1|||
162008502|NCT03137992|585086682|FG001|Washout Period 2|Withdrawal by Subject|0|||
162008503|NCT03137992|585086683|FG002|Washout Period 2|Withdrawal by Subject|0|||
162008504|NCT03137992|585086684|FG003|Washout Period 2|Withdrawal by Subject|0|||
162008505|NCT03137992|585086685|FG004|Washout Period 2|Withdrawal by Subject|1|||
162008506|NCT03137992|585086686|FG005|Washout Period 2|Withdrawal by Subject|0|||
162008507|NCT03137992|585086681|FG000|Washout Period 2|Sponsor Decision|0|||
162008508|NCT03137992|585086682|FG001|Washout Period 2|Sponsor Decision|0|||
162008509|NCT03137992|585086683|FG002|Washout Period 2|Sponsor Decision|0|||
162008510|NCT03137992|585086684|FG003|Washout Period 2|Sponsor Decision|0|||
162008511|NCT03137992|585086685|FG004|Washout Period 2|Sponsor Decision|0|||
162008512|NCT03137992|585086686|FG005|Washout Period 2|Sponsor Decision|1|||
162008513|NCT03137992|585086681|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
162008514|NCT03137992|585086682|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
162008515|NCT03137992|585086683|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
162008516|NCT03137992|585086684|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
162008517|NCT03137992|585086685|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
162008518|NCT03137992|585086686|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
162008519|NCT03137992|585086681|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
162008520|NCT03137992|585086682|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
162008521|NCT03137992|585086683|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
162008522|NCT03137992|585086684|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
162008523|NCT03137992|585086685|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
162008524|NCT03137992|585086686|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
162008525|NCT03137992|585086681|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
162008526|NCT03137992|585086682|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
162008527|NCT03137992|585086683|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
162008528|NCT03137992|585086684|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
162008529|NCT03137992|585086685|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
162008530|NCT03137992|585086686|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
162008531|NCT03137992|585086681|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
162008532|NCT03137992|585086682|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
162008533|NCT03137992|585086683|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
162008534|NCT03137992|585086684|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
162008535|NCT03137992|585086685|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
162008536|NCT03137992|585086686|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
162008537|NCT03137992|585086681|FG000|Part 2 (Open-label Extension)|Per study team|1|||
162008538|NCT03137992|585086682|FG001|Part 2 (Open-label Extension)|Per study team|0|||
162008539|NCT03137992|585086683|FG002|Part 2 (Open-label Extension)|Per study team|0|||
162008540|NCT03137992|585086684|FG003|Part 2 (Open-label Extension)|Per study team|0|||
162008541|NCT03137992|585086685|FG004|Part 2 (Open-label Extension)|Per study team|0|||
162008542|NCT03137992|585086686|FG005|Part 2 (Open-label Extension)|Per study team|0|||
162008543|NCT03137992|585086681|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
162008544|NCT03137992|585086682|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
162008545|NCT03137992|585086683|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
162008546|NCT03137992|585086684|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
162008547|NCT03137992|585086685|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
162008548|NCT03137992|585086686|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
162008549|NCT04609319|585086687|FG000|Overall Study|Death|64|||
162008550|NCT04609319|585086688|FG001|Overall Study|Death|49|||
162008551|NCT04609319|585086689|FG002|Overall Study|Death|1|||
162008552|NCT04609319|585086687|FG000|Overall Study|Withdrawal of consent|15|||
162008553|NCT04609319|585086688|FG001|Overall Study|Withdrawal of consent|3|||
162008554|NCT04609319|585086689|FG002|Overall Study|Withdrawal of consent|0|||
162008555|NCT04609319|585086687|FG000|Overall Study|Lost to Follow-up|20|||
162008556|NCT04609319|585086688|FG001|Overall Study|Lost to Follow-up|33|||
162008557|NCT04609319|585086689|FG002|Overall Study|Lost to Follow-up|0|||
162008558|NCT04609319|585086687|FG000|Overall Study|Alive until end of follow-up|60|||
162008559|NCT04609319|585086688|FG001|Overall Study|Alive until end of follow-up|53|||
162008560|NCT04609319|585086689|FG002|Overall Study|Alive until end of follow-up|1|||
162122849|NCT00358215|585502342|FG000|Overall Study|Death|265|||
162008561|NCT03221556|585086690|FG000|Allocation|post-randomization exclusion|0|||
162008562|NCT03221556|585086691|FG001|Allocation|post-randomization exclusion|1|||
162008563|NCT03221556|585086690|FG000|Follow-Up|Withdrawal by Subject|0|||
162008564|NCT03221556|585086691|FG001|Follow-Up|Withdrawal by Subject|1|||
162008565|NCT02532517|585086692|FG000|Overall Study|Did not complete 24-Month visit|4|||
162008566|NCT02532517|585086692|FG000|Overall Study|Failed Angiographic eligibility|1|||
162008567|NCT02532517|585086692|FG000|Overall Study|Lost to Follow-up|4|||
161894390|NCT00313586|584660955|FG001|Overall Study|Other complicating disease|2|||
162008568|NCT02532517|585086692|FG000|Overall Study|Withdrawal by Subject|4|||
162008569|NCT02532517|585086692|FG000|Overall Study|Death|4|||
162008570|NCT02234843|585086693|FG000|Overall Study|Death|1|||
162008571|NCT02234843|585086694|FG001|Overall Study|Death|0|||
162008572|NCT02234843|585086695|FG002|Overall Study|Death|0|||
162008573|NCT02234843|585086696|FG003|Overall Study|Death|0|||
162008574|NCT02234843|585086697|FG004|Overall Study|Death|0|||
162008575|NCT02234843|585086698|FG005|Overall Study|Death|0|||
162008576|NCT02234843|585086699|FG006|Overall Study|Death|0|||
162008577|NCT02234843|585086700|FG007|Overall Study|Death|0|||
162008578|NCT02234843|585086701|FG008|Overall Study|Death|0|||
162008579|NCT02234843|585086702|FG009|Overall Study|Death|0|||
162008580|NCT02234843|585086693|FG000|Overall Study|Protocol Violation|1|||
162008581|NCT02234843|585086694|FG001|Overall Study|Protocol Violation|0|||
162008582|NCT02234843|585086695|FG002|Overall Study|Protocol Violation|1|||
162008583|NCT02234843|585086696|FG003|Overall Study|Protocol Violation|0|||
162008584|NCT02234843|585086697|FG004|Overall Study|Protocol Violation|0|||
162008585|NCT02234843|585086698|FG005|Overall Study|Protocol Violation|0|||
162008586|NCT02234843|585086699|FG006|Overall Study|Protocol Violation|0|||
162008587|NCT02234843|585086700|FG007|Overall Study|Protocol Violation|0|||
162008588|NCT02234843|585086701|FG008|Overall Study|Protocol Violation|0|||
162008589|NCT02234843|585086702|FG009|Overall Study|Protocol Violation|0|||
162008590|NCT02234843|585086693|FG000|Overall Study|Efficacy outcome reached|2|||
162008591|NCT02234843|585086694|FG001|Overall Study|Efficacy outcome reached|0|||
162008592|NCT02234843|585086695|FG002|Overall Study|Efficacy outcome reached|0|||
162008593|NCT02234843|585086696|FG003|Overall Study|Efficacy outcome reached|0|||
162008594|NCT02234843|585086697|FG004|Overall Study|Efficacy outcome reached|0|||
162008595|NCT02234843|585086698|FG005|Overall Study|Efficacy outcome reached|2|||
162008596|NCT02234843|585086699|FG006|Overall Study|Efficacy outcome reached|0|||
162008597|NCT02234843|585086700|FG007|Overall Study|Efficacy outcome reached|0|||
162008598|NCT02234843|585086701|FG008|Overall Study|Efficacy outcome reached|0|||
162008599|NCT02234843|585086702|FG009|Overall Study|Efficacy outcome reached|0|||
162008600|NCT02234843|585086693|FG000|Overall Study|Patient convenience|2|||
161894391|NCT00313586|584660956|FG002|Overall Study|Other complicating disease|0|||
161894392|NCT00313586|584660957|FG003|Overall Study|Other complicating disease|0|||
162008601|NCT02234843|585086694|FG001|Overall Study|Patient convenience|0|||
162008602|NCT02234843|585086695|FG002|Overall Study|Patient convenience|0|||
162008603|NCT02234843|585086696|FG003|Overall Study|Patient convenience|0|||
162008604|NCT02234843|585086697|FG004|Overall Study|Patient convenience|0|||
162008605|NCT02234843|585086698|FG005|Overall Study|Patient convenience|1|||
162008606|NCT02234843|585086699|FG006|Overall Study|Patient convenience|0|||
162008607|NCT02234843|585086700|FG007|Overall Study|Patient convenience|0|||
162008608|NCT02234843|585086701|FG008|Overall Study|Patient convenience|0|||
162008609|NCT02234843|585086702|FG009|Overall Study|Patient convenience|0|||
162008610|NCT02234843|585086693|FG000|Overall Study|Withdrawal by Subject|5|||
162008611|NCT02234843|585086694|FG001|Overall Study|Withdrawal by Subject|1|||
162008612|NCT02234843|585086695|FG002|Overall Study|Withdrawal by Subject|1|||
162008613|NCT02234843|585086696|FG003|Overall Study|Withdrawal by Subject|0|||
162008614|NCT02234843|585086697|FG004|Overall Study|Withdrawal by Subject|0|||
162008615|NCT02234843|585086698|FG005|Overall Study|Withdrawal by Subject|7|||
162008616|NCT02234843|585086699|FG006|Overall Study|Withdrawal by Subject|0|||
162008617|NCT02234843|585086700|FG007|Overall Study|Withdrawal by Subject|0|||
162008618|NCT02234843|585086701|FG008|Overall Study|Withdrawal by Subject|0|||
162008619|NCT02234843|585086702|FG009|Overall Study|Withdrawal by Subject|0|||
162008620|NCT02234843|585086693|FG000|Overall Study|Recovery|1|||
162008621|NCT02234843|585086694|FG001|Overall Study|Recovery|0|||
162008622|NCT02234843|585086695|FG002|Overall Study|Recovery|0|||
162008623|NCT02234843|585086696|FG003|Overall Study|Recovery|0|||
162008624|NCT02234843|585086697|FG004|Overall Study|Recovery|0|||
162008625|NCT02234843|585086698|FG005|Overall Study|Recovery|0|||
162008626|NCT02234843|585086699|FG006|Overall Study|Recovery|0|||
162008627|NCT02234843|585086700|FG007|Overall Study|Recovery|0|||
162008628|NCT02234843|585086701|FG008|Overall Study|Recovery|0|||
162008629|NCT02234843|585086702|FG009|Overall Study|Recovery|0|||
162008630|NCT02234843|585086693|FG000|Overall Study|Other|0|||
162008631|NCT02234843|585086694|FG001|Overall Study|Other|2|||
161894393|NCT00313586|584660954|FG000|Overall Study|Did not achieve HI-major/better response|10|||
162008632|NCT02234843|585086695|FG002|Overall Study|Other|0|||
162008633|NCT02234843|585086696|FG003|Overall Study|Other|1|||
162008634|NCT02234843|585086697|FG004|Overall Study|Other|0|||
162008635|NCT02234843|585086698|FG005|Overall Study|Other|1|||
162008636|NCT02234843|585086699|FG006|Overall Study|Other|0|||
162008637|NCT02234843|585086700|FG007|Overall Study|Other|1|||
162008638|NCT02234843|585086701|FG008|Overall Study|Other|0|||
162008639|NCT02234843|585086702|FG009|Overall Study|Other|0|||
162008640|NCT02234843|585086693|FG000|Overall Study|Physician Decision|4|||
162008641|NCT02234843|585086694|FG001|Overall Study|Physician Decision|1|||
162008642|NCT02234843|585086695|FG002|Overall Study|Physician Decision|0|||
162008643|NCT02234843|585086696|FG003|Overall Study|Physician Decision|1|||
162008644|NCT02234843|585086697|FG004|Overall Study|Physician Decision|0|||
162008645|NCT02234843|585086698|FG005|Overall Study|Physician Decision|0|||
162008646|NCT02234843|585086699|FG006|Overall Study|Physician Decision|0|||
162008647|NCT02234843|585086700|FG007|Overall Study|Physician Decision|1|||
162008648|NCT02234843|585086701|FG008|Overall Study|Physician Decision|0|||
162008649|NCT02234843|585086702|FG009|Overall Study|Physician Decision|0|||
162008650|NCT02234843|585086693|FG000|Overall Study|Adverse Event|5|||
162008651|NCT02234843|585086694|FG001|Overall Study|Adverse Event|1|||
162008652|NCT02234843|585086695|FG002|Overall Study|Adverse Event|1|||
162008653|NCT02234843|585086696|FG003|Overall Study|Adverse Event|3|||
162008654|NCT02234843|585086697|FG004|Overall Study|Adverse Event|2|||
162008655|NCT02234843|585086698|FG005|Overall Study|Adverse Event|1|||
162238693|NCT01313637|585926409|FG000|Overall Study|Protocol Violation|4|||
162238694|NCT01313637|585926410|FG001|Overall Study|Protocol Violation|3|||
162238695|NCT01313637|585926411|FG002|Overall Study|Protocol Violation|11|||
162238696|NCT01313637|585926412|FG003|Overall Study|Protocol Violation|5|||
162238697|NCT01313637|585926409|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
162238698|NCT01313637|585926410|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
162238699|NCT01313637|585926411|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
162238700|NCT01313637|585926412|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
162238701|NCT01313637|585926409|FG000|Overall Study|Lost to Follow-up|0|||
162238702|NCT01313637|585926410|FG001|Overall Study|Lost to Follow-up|2|||
162238703|NCT01313637|585926411|FG002|Overall Study|Lost to Follow-up|1|||
162238704|NCT01313637|585926412|FG003|Overall Study|Lost to Follow-up|3|||
162238705|NCT01313637|585926409|FG000|Overall Study|Withdrawal by Subject|11|||
162238706|NCT01313637|585926410|FG001|Overall Study|Withdrawal by Subject|13|||
162238707|NCT01313637|585926411|FG002|Overall Study|Withdrawal by Subject|18|||
162238708|NCT01313637|585926412|FG003|Overall Study|Withdrawal by Subject|15|||
162238709|NCT00795951|585926415|FG000|Overall Study|Lost to Follow-up|1|||
162238710|NCT00795951|585926415|FG000|Overall Study|Withdrawal by Subject|1|||
162238711|NCT00655863|585926417|FG000|Overall Study|Lost to Follow-up|0|||
162238712|NCT00655863|585926418|FG001|Overall Study|Lost to Follow-up|0|||
162238713|NCT00655863|585926419|FG002|Overall Study|Lost to Follow-up|1|||
162238714|NCT03548987|585926420|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
162238715|NCT03548987|585926421|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
162238716|NCT03548987|585926420|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
162238717|NCT03548987|585926421|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
162238718|NCT03548987|585926420|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
162238719|NCT03548987|585926421|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
162238720|NCT03548987|585926420|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
162238721|NCT03548987|585926421|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
162238722|NCT03548987|585926420|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
162238723|NCT03548987|585926421|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
162238724|NCT03548987|585926420|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
162238725|NCT03548987|585926421|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
162238726|NCT03548987|585926420|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
162238727|NCT03548987|585926421|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
162238728|NCT03548987|585926420|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
162238729|NCT03548987|585926421|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
162008656|NCT02234843|585086699|FG006|Overall Study|Adverse Event|0|||
162008657|NCT02234843|585086700|FG007|Overall Study|Adverse Event|0|||
162238730|NCT03548987|585926420|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
162238731|NCT03548987|585926421|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
162238732|NCT03548987|585926420|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
162238733|NCT03548987|585926421|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
162238734|NCT03548987|585926420|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
162238735|NCT03548987|585926421|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
162238736|NCT03548987|585926420|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
162238737|NCT03548987|585926421|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
162238738|NCT03548987|585926420|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
162238739|NCT03548987|585926421|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
162238740|NCT03548987|585926420|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
162238741|NCT03548987|585926421|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
162238742|NCT04572841|585926422|FG000|Overall Study|Adverse Event|1|||
162008658|NCT02234843|585086701|FG008|Overall Study|Adverse Event|1|||
162008659|NCT02234843|585086702|FG009|Overall Study|Adverse Event|0|||
162008660|NCT02234843|585086693|FG000|Overall Study|Non-compliance with study drug|1|||
162238743|NCT04572841|585926423|FG001|Overall Study|Adverse Event|1|||
162238744|NCT04572841|585926422|FG000|Overall Study|Withdrawal by Subject|2|||
162238745|NCT04572841|585926423|FG001|Overall Study|Withdrawal by Subject|1|||
162238746|NCT00712673|585926428|FG000|Overall Study|Adverse Event|3|||
162238747|NCT00712673|585926429|FG001|Overall Study|Adverse Event|3|||
162238748|NCT00712673|585926430|FG002|Overall Study|Adverse Event|21|||
162238749|NCT00712673|585926431|FG003|Overall Study|Adverse Event|26|||
162238750|NCT00712673|585926428|FG000|Overall Study|Lack of Efficacy|2|||
162238751|NCT00712673|585926429|FG001|Overall Study|Lack of Efficacy|8|||
162238752|NCT00712673|585926430|FG002|Overall Study|Lack of Efficacy|8|||
162238753|NCT00712673|585926431|FG003|Overall Study|Lack of Efficacy|6|||
162238754|NCT00712673|585926428|FG000|Overall Study|Poor Compliance to Protocol|3|||
162238755|NCT00712673|585926429|FG001|Overall Study|Poor Compliance to Protocol|3|||
162238756|NCT00712673|585926430|FG002|Overall Study|Poor Compliance to Protocol|4|||
162238757|NCT00712673|585926431|FG003|Overall Study|Poor Compliance to Protocol|16|||
162238758|NCT00712673|585926428|FG000|Overall Study|Lost to Follow-up|1|||
162238759|NCT00712673|585926429|FG001|Overall Study|Lost to Follow-up|0|||
162238760|NCT00712673|585926430|FG002|Overall Study|Lost to Follow-up|2|||
162238761|NCT00712673|585926431|FG003|Overall Study|Lost to Follow-up|0|||
162238762|NCT00712673|585926428|FG000|Overall Study|Withdrawal by Subject|6|||
162238763|NCT00712673|585926429|FG001|Overall Study|Withdrawal by Subject|7|||
162238764|NCT00712673|585926430|FG002|Overall Study|Withdrawal by Subject|15|||
162238765|NCT00712673|585926431|FG003|Overall Study|Withdrawal by Subject|20|||
162238766|NCT00712673|585926428|FG000|Overall Study|Familial and Personal Reasons|5|||
162238767|NCT00712673|585926429|FG001|Overall Study|Familial and Personal Reasons|0|||
162238768|NCT00712673|585926430|FG002|Overall Study|Familial and Personal Reasons|5|||
162238769|NCT00712673|585926431|FG003|Overall Study|Familial and Personal Reasons|2|||
162238770|NCT00712673|585926428|FG000|Overall Study|Investigator's Decision|1|||
162238771|NCT00712673|585926429|FG001|Overall Study|Investigator's Decision|0|||
162238772|NCT00712673|585926430|FG002|Overall Study|Investigator's Decision|0|||
162238773|NCT00712673|585926431|FG003|Overall Study|Investigator's Decision|0|||
162238774|NCT00712673|585926428|FG000|Overall Study|Protocol Violation|0|||
162238775|NCT00712673|585926429|FG001|Overall Study|Protocol Violation|0|||
162238776|NCT00712673|585926430|FG002|Overall Study|Protocol Violation|2|||
162238777|NCT00712673|585926431|FG003|Overall Study|Protocol Violation|0|||
162238778|NCT01323647|585926432|FG000|Overall Study|Migrated/moved from study area|2|||
162238779|NCT01323647|585926433|FG001|Overall Study|Migrated/moved from study area|0|||
162238780|NCT01323647|585926432|FG000|Overall Study|Withdrawal by Subject|5|||
162238781|NCT01323647|585926433|FG001|Overall Study|Withdrawal by Subject|0|||
162238782|NCT01323647|585926432|FG000|Overall Study|Lost to Follow-up|2|||
162238783|NCT01323647|585926433|FG001|Overall Study|Lost to Follow-up|0|||
162238784|NCT02768870|585926436|FG000|Overall Study|Death|1|||
162238785|NCT02768870|585926436|FG000|Overall Study|Reoperation|6|||
162238786|NCT02768870|585926436|FG000|Overall Study|Lost to Follow-up|1|||
162238787|NCT02768870|585926436|FG000|Overall Study|Exit|4|||
162238788|NCT02963610|585926437|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
162238789|NCT01774110|585926438|FG000|Overall Study|Lost to Follow-up|7|||
162238790|NCT00063154|585926439|FG000|Overall Study|Disease progression|27|||
162238791|NCT00063154|585926439|FG000|Overall Study|Adverse Event|2|||
162238792|NCT00063154|585926439|FG000|Overall Study|Physician Decision|10|||
162238793|NCT00063154|585926439|FG000|Overall Study|Death|3|||
162238794|NCT00063154|585926439|FG000|Overall Study|Reason unspecified|1|||
162238795|NCT00063154|585926439|FG000|Overall Study|Did not receive treatment|8|||
162238796|NCT02203695|585926440|FG000|Overall Study|Patient withdrew consent|1|||
162238797|NCT02203695|585926441|FG001|Overall Study|Patient withdrew consent|1|||
162238798|NCT02203695|585926440|FG000|Overall Study|Started non-study treatment|1|||
162238799|NCT02203695|585926441|FG001|Overall Study|Started non-study treatment|0|||
162238800|NCT01259726|585926442|FG000|Overall Study|Death|1|||
162238801|NCT01259726|585926443|FG001|Overall Study|Death|0|||
162238802|NCT01259726|585926444|FG002|Overall Study|Death|0|||
162238803|NCT01259726|585926445|FG003|Overall Study|Death|0|||
162238804|NCT01259726|585926442|FG000|Overall Study|Physician Decision|2|||
162238805|NCT01259726|585926443|FG001|Overall Study|Physician Decision|0|||
162238806|NCT01259726|585926444|FG002|Overall Study|Physician Decision|1|||
162238807|NCT01259726|585926445|FG003|Overall Study|Physician Decision|1|||
162238808|NCT01259726|585926442|FG000|Overall Study|Withdrawal by Subject|1|||
162238809|NCT01259726|585926443|FG001|Overall Study|Withdrawal by Subject|3|||
162238810|NCT01259726|585926444|FG002|Overall Study|Withdrawal by Subject|2|||
162238811|NCT01259726|585926445|FG003|Overall Study|Withdrawal by Subject|1|||
162238812|NCT01259726|585926442|FG000|Overall Study|Lost to Follow-up|1|||
162238813|NCT01259726|585926443|FG001|Overall Study|Lost to Follow-up|1|||
162238814|NCT01259726|585926444|FG002|Overall Study|Lost to Follow-up|1|||
162238815|NCT01259726|585926445|FG003|Overall Study|Lost to Follow-up|3|||
162238816|NCT00261846|585926446|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
162238817|NCT00261846|585926447|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
162238818|NCT00261846|585926448|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
162238819|NCT00261846|585926449|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162238820|NCT00261846|585926450|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162238821|NCT00261846|585926451|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162238822|NCT00261846|585926452|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162238823|NCT00261846|585926453|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162238824|NCT00261846|585926454|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162238825|NCT00261846|585926455|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162238826|NCT00261846|585926456|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162238827|NCT00261846|585926457|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
162238828|NCT00261846|585926446|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162238829|NCT00261846|585926447|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162238830|NCT00261846|585926448|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162238831|NCT00261846|585926449|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
162238832|NCT00261846|585926450|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162238833|NCT00261846|585926451|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162238834|NCT00261846|585926452|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162238835|NCT00261846|585926453|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162238836|NCT00261846|585926454|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
162238837|NCT00261846|585926455|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162238838|NCT00261846|585926456|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162238839|NCT00261846|585926457|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
162238840|NCT00261846|585926446|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
162238841|NCT00261846|585926447|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
162238842|NCT00261846|585926448|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
162238843|NCT00261846|585926449|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
162238844|NCT00261846|585926450|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
162238845|NCT00261846|585926451|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
162238846|NCT00261846|585926452|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
162238847|NCT00261846|585926453|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
162238848|NCT00261846|585926454|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
162238849|NCT00261846|585926455|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
162238850|NCT00261846|585926456|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
162238851|NCT00261846|585926457|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
162238852|NCT00261846|585926446|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
162238853|NCT00261846|585926447|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
162238854|NCT00261846|585926448|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
162238855|NCT00261846|585926449|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
162238856|NCT00261846|585926450|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
162238857|NCT00261846|585926451|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
162238858|NCT00261846|585926452|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
162238859|NCT00261846|585926453|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
162238860|NCT00261846|585926454|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
162238861|NCT00261846|585926455|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
162238862|NCT00261846|585926456|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
162238863|NCT00261846|585926457|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
162238864|NCT00261846|585926446|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
162238865|NCT00261846|585926447|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
162238866|NCT00261846|585926448|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
162238867|NCT00261846|585926449|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
162238868|NCT00261846|585926450|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
162238869|NCT00261846|585926451|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
162238870|NCT00261846|585926452|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
162238871|NCT00261846|585926453|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
162238872|NCT00261846|585926454|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
162238873|NCT00261846|585926455|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
162238874|NCT00261846|585926456|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
162238875|NCT00261846|585926457|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
162238876|NCT00261846|585926446|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
162238877|NCT00261846|585926447|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
162238878|NCT00261846|585926448|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
162238879|NCT00261846|585926449|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
162238880|NCT00261846|585926450|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
162238881|NCT00261846|585926451|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
162238882|NCT00261846|585926452|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
162238883|NCT00261846|585926453|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
162122850|NCT00358215|585502343|FG001|Overall Study|Death|281|||
162238884|NCT00261846|585926454|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
162238885|NCT00261846|585926455|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
162238886|NCT00261846|585926456|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
162238887|NCT00261846|585926457|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
162238888|NCT00261846|585926446|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
162238889|NCT00261846|585926447|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
162238890|NCT00261846|585926448|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
162238891|NCT00261846|585926449|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
162238892|NCT00261846|585926450|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
162238893|NCT00261846|585926451|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
162238894|NCT00261846|585926452|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
162238895|NCT00261846|585926453|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
162238896|NCT00261846|585926454|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
162238897|NCT00261846|585926455|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
162238898|NCT00261846|585926456|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
162238899|NCT00261846|585926457|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
162238900|NCT01745848|585926462|FG000|Overall Study|Adverse Event|6|||
162238901|NCT00926211|585926470|FG000|Overall Study|Lost to Follow-up|1|||
162238902|NCT00585195|585926473|FG000|Overall Study|Adverse Event|0|||
162238903|NCT00585195|585926474|FG001|Overall Study|Adverse Event|0|||
162238904|NCT00585195|585926475|FG002|Overall Study|Adverse Event|0|||
162238905|NCT00585195|585926476|FG003|Overall Study|Adverse Event|0|||
162238906|NCT00585195|585926477|FG004|Overall Study|Adverse Event|2|||
162238907|NCT00585195|585926478|FG005|Overall Study|Adverse Event|1|||
162238908|NCT00585195|585926479|FG006|Overall Study|Adverse Event|0|||
162238909|NCT00585195|585926480|FG007|Overall Study|Adverse Event|1|||
162238910|NCT00585195|585926481|FG008|Overall Study|Adverse Event|0|||
162238911|NCT00585195|585926482|FG009|Overall Study|Adverse Event|0|||
162238912|NCT00585195|585926483|FG010|Overall Study|Adverse Event|3|||
162238913|NCT00585195|585926484|FG011|Overall Study|Adverse Event|0|||
162238914|NCT00585195|585926485|FG012|Overall Study|Adverse Event|8|||
162238915|NCT00585195|585926486|FG013|Overall Study|Adverse Event|6|||
162238916|NCT00585195|585926487|FG014|Overall Study|Adverse Event|4|||
162238917|NCT00585195|585926488|FG015|Overall Study|Adverse Event|1|||
162238918|NCT00585195|585926489|FG016|Overall Study|Adverse Event|14|||
162238919|NCT00585195|585926490|FG017|Overall Study|Adverse Event|9|||
162238920|NCT00585195|585926491|FG018|Overall Study|Adverse Event|2|||
162238921|NCT00585195|585926492|FG019|Overall Study|Adverse Event|3|||
162238922|NCT00585195|585926493|FG020|Overall Study|Adverse Event|1|||
162238923|NCT00585195|585926473|FG000|Overall Study|Progressive Disease|2|||
162238924|NCT00585195|585926474|FG001|Overall Study|Progressive Disease|2|||
162238925|NCT00585195|585926475|FG002|Overall Study|Progressive Disease|5|||
162238926|NCT00585195|585926476|FG003|Overall Study|Progressive Disease|4|||
162238927|NCT00585195|585926477|FG004|Overall Study|Progressive Disease|6|||
162238928|NCT00585195|585926478|FG005|Overall Study|Progressive Disease|4|||
162238929|NCT00585195|585926479|FG006|Overall Study|Progressive Disease|6|||
162238930|NCT00585195|585926480|FG007|Overall Study|Progressive Disease|3|||
162238931|NCT00585195|585926481|FG008|Overall Study|Progressive Disease|0|||
162238932|NCT00585195|585926482|FG009|Overall Study|Progressive Disease|5|||
162238933|NCT00585195|585926483|FG010|Overall Study|Progressive Disease|2|||
162238934|NCT00585195|585926484|FG011|Overall Study|Progressive Disease|25|||
162238935|NCT00585195|585926485|FG012|Overall Study|Progressive Disease|29|||
162238936|NCT00585195|585926486|FG013|Overall Study|Progressive Disease|26|||
162238937|NCT00585195|585926487|FG014|Overall Study|Progressive Disease|21|||
162238938|NCT00585195|585926488|FG015|Overall Study|Progressive Disease|12|||
162238939|NCT00585195|585926489|FG016|Overall Study|Progressive Disease|94|||
162238940|NCT00585195|585926490|FG017|Overall Study|Progressive Disease|42|||
162238941|NCT00585195|585926491|FG018|Overall Study|Progressive Disease|4|||
162238942|NCT00585195|585926492|FG019|Overall Study|Progressive Disease|9|||
162238943|NCT00585195|585926493|FG020|Overall Study|Progressive Disease|8|||
162238944|NCT00585195|585926473|FG000|Overall Study|Withdrawal by Subject|1|||
162238945|NCT00585195|585926474|FG001|Overall Study|Withdrawal by Subject|1|||
162238946|NCT00585195|585926475|FG002|Overall Study|Withdrawal by Subject|2|||
162238947|NCT00585195|585926476|FG003|Overall Study|Withdrawal by Subject|2|||
162238948|NCT00585195|585926477|FG004|Overall Study|Withdrawal by Subject|0|||
162238949|NCT00585195|585926478|FG005|Overall Study|Withdrawal by Subject|0|||
162238950|NCT00585195|585926479|FG006|Overall Study|Withdrawal by Subject|0|||
162238951|NCT00585195|585926480|FG007|Overall Study|Withdrawal by Subject|1|||
162238952|NCT00585195|585926481|FG008|Overall Study|Withdrawal by Subject|0|||
162238953|NCT00585195|585926482|FG009|Overall Study|Withdrawal by Subject|0|||
162238954|NCT00585195|585926483|FG010|Overall Study|Withdrawal by Subject|3|||
162238955|NCT00585195|585926484|FG011|Overall Study|Withdrawal by Subject|8|||
162238956|NCT00585195|585926485|FG012|Overall Study|Withdrawal by Subject|15|||
162238957|NCT00585195|585926486|FG013|Overall Study|Withdrawal by Subject|0|||
162238958|NCT00585195|585926487|FG014|Overall Study|Withdrawal by Subject|3|||
162238959|NCT00585195|585926488|FG015|Overall Study|Withdrawal by Subject|0|||
162238960|NCT00585195|585926489|FG016|Overall Study|Withdrawal by Subject|7|||
162238961|NCT00585195|585926490|FG017|Overall Study|Withdrawal by Subject|1|||
162238962|NCT00585195|585926491|FG018|Overall Study|Withdrawal by Subject|2|||
162238963|NCT00585195|585926492|FG019|Overall Study|Withdrawal by Subject|2|||
162238964|NCT00585195|585926493|FG020|Overall Study|Withdrawal by Subject|0|||
162238965|NCT00585195|585926473|FG000|Overall Study|Other|0|||
162238966|NCT00585195|585926474|FG001|Overall Study|Other|1|||
162238967|NCT00585195|585926475|FG002|Overall Study|Other|1|||
162238968|NCT00585195|585926476|FG003|Overall Study|Other|1|||
162238969|NCT00585195|585926477|FG004|Overall Study|Other|0|||
162238970|NCT00585195|585926478|FG005|Overall Study|Other|1|||
162238971|NCT00585195|585926479|FG006|Overall Study|Other|0|||
162238972|NCT00585195|585926480|FG007|Overall Study|Other|0|||
162238973|NCT00585195|585926481|FG008|Overall Study|Other|2|||
162238974|NCT00585195|585926482|FG009|Overall Study|Other|1|||
162238975|NCT00585195|585926483|FG010|Overall Study|Other|0|||
162238976|NCT00585195|585926484|FG011|Overall Study|Other|19|||
162238977|NCT00585195|585926485|FG012|Overall Study|Other|24|||
162238978|NCT00585195|585926486|FG013|Overall Study|Other|7|||
162238979|NCT00585195|585926487|FG014|Overall Study|Other|11|||
162238980|NCT00585195|585926488|FG015|Overall Study|Other|3|||
162238981|NCT00585195|585926489|FG016|Overall Study|Other|28|||
162238982|NCT00585195|585926490|FG017|Overall Study|Other|12|||
162238983|NCT00585195|585926491|FG018|Overall Study|Other|10|||
162238984|NCT00585195|585926492|FG019|Overall Study|Other|4|||
162238985|NCT00585195|585926493|FG020|Overall Study|Other|2|||
162238986|NCT00585195|585926473|FG000|Overall Study|Randomized not treated|0|||
162238987|NCT00585195|585926474|FG001|Overall Study|Randomized not treated|0|||
162238988|NCT00585195|585926475|FG002|Overall Study|Randomized not treated|1|||
162238989|NCT00585195|585926476|FG003|Overall Study|Randomized not treated|0|||
162238990|NCT00585195|585926477|FG004|Overall Study|Randomized not treated|1|||
162238991|NCT00585195|585926478|FG005|Overall Study|Randomized not treated|0|||
162238992|NCT00585195|585926479|FG006|Overall Study|Randomized not treated|1|||
162238993|NCT00585195|585926480|FG007|Overall Study|Randomized not treated|0|||
162238994|NCT00585195|585926481|FG008|Overall Study|Randomized not treated|0|||
162238995|NCT00585195|585926482|FG009|Overall Study|Randomized not treated|0|||
162238996|NCT00585195|585926483|FG010|Overall Study|Randomized not treated|2|||
162238997|NCT00585195|585926484|FG011|Overall Study|Randomized not treated|0|||
162238998|NCT00585195|585926485|FG012|Overall Study|Randomized not treated|0|||
162238999|NCT00585195|585926486|FG013|Overall Study|Randomized not treated|0|||
162239000|NCT00585195|585926487|FG014|Overall Study|Randomized not treated|0|||
162239001|NCT00585195|585926488|FG015|Overall Study|Randomized not treated|1|||
162239002|NCT00585195|585926489|FG016|Overall Study|Randomized not treated|0|||
162239003|NCT00585195|585926490|FG017|Overall Study|Randomized not treated|1|||
162239004|NCT00585195|585926491|FG018|Overall Study|Randomized not treated|3|||
162239005|NCT00585195|585926492|FG019|Overall Study|Randomized not treated|0|||
162239006|NCT00585195|585926493|FG020|Overall Study|Randomized not treated|2|||
162239007|NCT00585195|585926473|FG000|Overall Study|Death|0|||
162239008|NCT00585195|585926474|FG001|Overall Study|Death|0|||
162239009|NCT00585195|585926475|FG002|Overall Study|Death|0|||
162239010|NCT00585195|585926476|FG003|Overall Study|Death|0|||
162239011|NCT00585195|585926477|FG004|Overall Study|Death|0|||
162239012|NCT00585195|585926478|FG005|Overall Study|Death|0|||
162239013|NCT00585195|585926479|FG006|Overall Study|Death|0|||
162239014|NCT00585195|585926480|FG007|Overall Study|Death|0|||
162239015|NCT00585195|585926481|FG008|Overall Study|Death|1|||
162239016|NCT00585195|585926482|FG009|Overall Study|Death|0|||
162239017|NCT00585195|585926483|FG010|Overall Study|Death|1|||
162239018|NCT00585195|585926484|FG011|Overall Study|Death|1|||
162239019|NCT00585195|585926485|FG012|Overall Study|Death|7|||
162239020|NCT00585195|585926486|FG013|Overall Study|Death|2|||
162239021|NCT00585195|585926487|FG014|Overall Study|Death|8|||
162239022|NCT00585195|585926488|FG015|Overall Study|Death|2|||
162239023|NCT00585195|585926489|FG016|Overall Study|Death|11|||
162239024|NCT00585195|585926490|FG017|Overall Study|Death|0|||
162239025|NCT00585195|585926491|FG018|Overall Study|Death|0|||
162239026|NCT00585195|585926492|FG019|Overall Study|Death|0|||
162239027|NCT00585195|585926493|FG020|Overall Study|Death|1|||
162239028|NCT00585195|585926473|FG000|Overall Study|Lost to Follow-up|0|||
162239029|NCT00585195|585926474|FG001|Overall Study|Lost to Follow-up|0|||
162239030|NCT00585195|585926475|FG002|Overall Study|Lost to Follow-up|0|||
162239031|NCT00585195|585926476|FG003|Overall Study|Lost to Follow-up|0|||
162239032|NCT00585195|585926477|FG004|Overall Study|Lost to Follow-up|0|||
162239033|NCT00585195|585926478|FG005|Overall Study|Lost to Follow-up|0|||
162239034|NCT00585195|585926479|FG006|Overall Study|Lost to Follow-up|0|||
162239035|NCT00585195|585926480|FG007|Overall Study|Lost to Follow-up|0|||
162239036|NCT00585195|585926481|FG008|Overall Study|Lost to Follow-up|0|||
162239037|NCT00585195|585926482|FG009|Overall Study|Lost to Follow-up|0|||
162239038|NCT00585195|585926483|FG010|Overall Study|Lost to Follow-up|0|||
162239039|NCT00585195|585926484|FG011|Overall Study|Lost to Follow-up|0|||
162239040|NCT00585195|585926485|FG012|Overall Study|Lost to Follow-up|1|||
162239041|NCT00585195|585926486|FG013|Overall Study|Lost to Follow-up|0|||
162239042|NCT00585195|585926487|FG014|Overall Study|Lost to Follow-up|0|||
162239043|NCT00585195|585926488|FG015|Overall Study|Lost to Follow-up|0|||
162239044|NCT00585195|585926489|FG016|Overall Study|Lost to Follow-up|0|||
162239045|NCT00585195|585926490|FG017|Overall Study|Lost to Follow-up|2|||
162239046|NCT00585195|585926491|FG018|Overall Study|Lost to Follow-up|0|||
162239047|NCT00585195|585926492|FG019|Overall Study|Lost to Follow-up|0|||
162239048|NCT00585195|585926493|FG020|Overall Study|Lost to Follow-up|0|||
162239049|NCT00585195|585926473|FG000|Overall Study|Site Terminated by Sponsor|0|||
162239050|NCT00585195|585926474|FG001|Overall Study|Site Terminated by Sponsor|0|||
162239051|NCT00585195|585926475|FG002|Overall Study|Site Terminated by Sponsor|0|||
162239052|NCT00585195|585926476|FG003|Overall Study|Site Terminated by Sponsor|0|||
162239053|NCT00585195|585926477|FG004|Overall Study|Site Terminated by Sponsor|0|||
162239054|NCT00585195|585926478|FG005|Overall Study|Site Terminated by Sponsor|0|||
162239055|NCT00585195|585926479|FG006|Overall Study|Site Terminated by Sponsor|0|||
162239056|NCT00585195|585926480|FG007|Overall Study|Site Terminated by Sponsor|0|||
162239057|NCT00585195|585926481|FG008|Overall Study|Site Terminated by Sponsor|0|||
162239058|NCT00585195|585926482|FG009|Overall Study|Site Terminated by Sponsor|0|||
162239059|NCT00585195|585926483|FG010|Overall Study|Site Terminated by Sponsor|0|||
162239060|NCT00585195|585926484|FG011|Overall Study|Site Terminated by Sponsor|0|||
162239061|NCT00585195|585926485|FG012|Overall Study|Site Terminated by Sponsor|1|||
162239062|NCT00585195|585926486|FG013|Overall Study|Site Terminated by Sponsor|0|||
162239063|NCT00585195|585926487|FG014|Overall Study|Site Terminated by Sponsor|0|||
162239064|NCT00585195|585926488|FG015|Overall Study|Site Terminated by Sponsor|0|||
162239065|NCT00585195|585926489|FG016|Overall Study|Site Terminated by Sponsor|0|||
162239066|NCT00585195|585926490|FG017|Overall Study|Site Terminated by Sponsor|0|||
162239067|NCT00585195|585926491|FG018|Overall Study|Site Terminated by Sponsor|0|||
162239068|NCT00585195|585926492|FG019|Overall Study|Site Terminated by Sponsor|0|||
162239069|NCT00585195|585926493|FG020|Overall Study|Site Terminated by Sponsor|0|||
162239070|NCT00585195|585926473|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
162239071|NCT00585195|585926474|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
162239072|NCT00585195|585926475|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
162239073|NCT00585195|585926476|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
162239074|NCT00585195|585926477|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
162239075|NCT00585195|585926478|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
162239076|NCT00585195|585926479|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
162239077|NCT00585195|585926480|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
162239078|NCT00585195|585926481|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
162239079|NCT00585195|585926482|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
162239080|NCT00585195|585926483|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
162239081|NCT00585195|585926484|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
162239082|NCT00585195|585926485|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
162239083|NCT00585195|585926486|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
162239084|NCT00585195|585926487|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
162239085|NCT00585195|585926488|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
162239086|NCT00585195|585926489|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
162239087|NCT00585195|585926490|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
162239088|NCT00585195|585926491|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
162239089|NCT00585195|585926492|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
162239090|NCT00585195|585926493|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
162239091|NCT00770341|585926494|FG000|Overall Study|Did not meet eligibility criteria|1|||
162239092|NCT00770341|585926495|FG001|Overall Study|Did not meet eligibility criteria|0|||
162239093|NCT00770341|585926496|FG002|Overall Study|Did not meet eligibility criteria|0|||
162239094|NCT00770341|585926494|FG000|Overall Study|Withdrawal by Subject|0|||
162239095|NCT00770341|585926495|FG001|Overall Study|Withdrawal by Subject|1|||
162239096|NCT00770341|585926496|FG002|Overall Study|Withdrawal by Subject|0|||
162239097|NCT00770341|585926494|FG000|Overall Study|Clinical Adverse Event|3|||
162239098|NCT00770341|585926495|FG001|Overall Study|Clinical Adverse Event|1|||
162239099|NCT00770341|585926496|FG002|Overall Study|Clinical Adverse Event|2|||
162239100|NCT00770341|585926494|FG000|Overall Study|Laboratory adverse event|3|||
162239101|NCT00770341|585926495|FG001|Overall Study|Laboratory adverse event|3|||
162239102|NCT00770341|585926496|FG002|Overall Study|Laboratory adverse event|0|||
162239103|NCT00770341|585926494|FG000|Overall Study|Lack of Efficacy|3|||
162239104|NCT00770341|585926495|FG001|Overall Study|Lack of Efficacy|0|||
162239105|NCT00770341|585926496|FG002|Overall Study|Lack of Efficacy|1|||
162239106|NCT00770341|585926494|FG000|Overall Study|Other|1|||
162239107|NCT00770341|585926495|FG001|Overall Study|Other|0|||
162239108|NCT00770341|585926496|FG002|Overall Study|Other|0|||
162239109|NCT00770341|585926494|FG000|Overall Study|Not treated|1|||
162239110|NCT00770341|585926495|FG001|Overall Study|Not treated|0|||
162239111|NCT00770341|585926496|FG002|Overall Study|Not treated|0|||
162239112|NCT02739360|585926497|FG000|Overall Study|Adverse Event|1|||
162239113|NCT02739360|585926497|FG000|Overall Study|Study terminated by Sponsor|2|||
162239114|NCT04873232|585926504|FG000|Overall Study|Lost to Follow-up|1|||
162239115|NCT04873232|585926505|FG001|Overall Study|Lost to Follow-up|4|||
162239116|NCT04873232|585926504|FG000|Overall Study|Withdrawal by Subject|1|||
162239117|NCT04873232|585926505|FG001|Overall Study|Withdrawal by Subject|0|||
162239118|NCT01390181|585928340|FG000|Overall Study|Lost to Follow-up|1|||
162239119|NCT01390181|585928340|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
162239120|NCT00720941|585928345|FG000|Overall Study|Protocol Violation|1|||
162239121|NCT00720941|585928346|FG001|Overall Study|Protocol Violation|2|||
162239122|NCT00720941|585928345|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
162239123|NCT00720941|585928346|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
162239124|NCT00720941|585928345|FG000|Overall Study|Lost to Follow-up|20|||
162239125|NCT00720941|585928346|FG001|Overall Study|Lost to Follow-up|15|||
162239126|NCT00720941|585928345|FG000|Overall Study|Physician Decision|14|||
162239127|NCT00720941|585928346|FG001|Overall Study|Physician Decision|12|||
162239128|NCT00720941|585928345|FG000|Overall Study|Withdrawal by Subject|29|||
162239129|NCT00720941|585928346|FG001|Overall Study|Withdrawal by Subject|36|||
162239130|NCT03511053|585928347|FG000|Overall Study|Withdrawal by Subject|1|||
162239131|NCT03628898|585928349|FG000|Overall Study|Device deficiency|1|||
162239132|NCT00294554|585928352|FG000|Overall Study|Lack of Efficacy|0|||
162239133|NCT00294554|585928353|FG001|Overall Study|Lack of Efficacy|1|||
162239134|NCT00294554|585928352|FG000|Overall Study|Physician Decision|0|||
162239135|NCT00294554|585928353|FG001|Overall Study|Physician Decision|1|||
162239136|NCT02598557|585928354|FG000|Overall Study|Withdrawal by Subject|1|||
162239137|NCT02598557|585928355|FG001|Overall Study|Withdrawal by Subject|0|||
162239138|NCT02598557|585928356|FG002|Overall Study|Withdrawal by Subject|1|||
162239139|NCT02598557|585928354|FG000|Overall Study|Participant did not start treatment|2|||
162239140|NCT02598557|585928355|FG001|Overall Study|Participant did not start treatment|1|||
162239141|NCT02598557|585928356|FG002|Overall Study|Participant did not start treatment|1|||
162239142|NCT02598557|585928354|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
162239143|NCT02598557|585928355|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
162239144|NCT02598557|585928356|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
162239145|NCT02598557|585928354|FG000|Overall Study|Adverse Event|1|||
162239146|NCT02598557|585928355|FG001|Overall Study|Adverse Event|1|||
162239147|NCT02598557|585928356|FG002|Overall Study|Adverse Event|0|||
162239148|NCT01138007|585928357|FG000|Overall Study|Adverse Event|4|||
162239149|NCT01138007|585928358|FG001|Overall Study|Adverse Event|12|||
162239150|NCT01138007|585928359|FG002|Overall Study|Adverse Event|9|||
162239151|NCT01138007|585928357|FG000|Overall Study|Lack of Efficacy|2|||
162239152|NCT01138007|585928358|FG001|Overall Study|Lack of Efficacy|0|||
162239153|NCT01138007|585928359|FG002|Overall Study|Lack of Efficacy|6|||
162239154|NCT01138007|585928357|FG000|Overall Study|Protocol Violation|2|||
162239155|NCT01138007|585928358|FG001|Overall Study|Protocol Violation|3|||
162239156|NCT01138007|585928359|FG002|Overall Study|Protocol Violation|2|||
162239157|NCT01138007|585928357|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
162239158|NCT01138007|585928358|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
162239159|NCT01138007|585928359|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
162239160|NCT01138007|585928357|FG000|Overall Study|Lost to Follow-up|3|||
162239161|NCT01138007|585928358|FG001|Overall Study|Lost to Follow-up|3|||
162239162|NCT01138007|585928359|FG002|Overall Study|Lost to Follow-up|5|||
162239163|NCT01138007|585928357|FG000|Overall Study|Physician Decision|0|||
162239164|NCT01138007|585928358|FG001|Overall Study|Physician Decision|5|||
162239165|NCT01138007|585928359|FG002|Overall Study|Physician Decision|3|||
162239166|NCT01138007|585928357|FG000|Overall Study|Withdrawal by Subject|5|||
162239167|NCT01138007|585928358|FG001|Overall Study|Withdrawal by Subject|6|||
162239168|NCT01138007|585928359|FG002|Overall Study|Withdrawal by Subject|15|||
162239169|NCT04661878|585928360|FG000|Overall Study|Lost to Follow-up|6|||
162239170|NCT04661878|585928361|FG001|Overall Study|Lost to Follow-up|5|||
162239171|NCT03603028|585928362|FG000|Overall Study|Withdrawal by Subject|1|||
162239172|NCT00640016|585928365|FG000|Overall Study|Withdrawal by Subject|0|||
162239173|NCT00640016|585928366|FG001|Overall Study|Withdrawal by Subject|1|||
162239174|NCT00640016|585928367|FG002|Overall Study|Withdrawal by Subject|0|||
162239175|NCT00640016|585928368|FG003|Overall Study|Withdrawal by Subject|0|||
162239176|NCT00640016|585928365|FG000|Overall Study|Study termination|2|||
162239177|NCT00640016|585928366|FG001|Overall Study|Study termination|1|||
162239178|NCT00640016|585928367|FG002|Overall Study|Study termination|3|||
162239179|NCT00640016|585928368|FG003|Overall Study|Study termination|2|||
162239180|NCT00640016|585928365|FG000|Overall Study|Adverse Event|0|||
162239181|NCT00640016|585928366|FG001|Overall Study|Adverse Event|0|||
162239182|NCT00640016|585928367|FG002|Overall Study|Adverse Event|0|||
162239183|NCT00640016|585928368|FG003|Overall Study|Adverse Event|1|||
162239184|NCT00846391|585928369|FG000|Overall Study|Physician Decision|0|||
162239185|NCT00846391|585928370|FG001|Overall Study|Physician Decision|0|||
162239186|NCT00846391|585928371|FG002|Overall Study|Physician Decision|1|||
162239187|NCT00846391|585928369|FG000|Overall Study|Study Terminated by Sponsor|1|||
162239188|NCT00846391|585928370|FG001|Overall Study|Study Terminated by Sponsor|2|||
162239189|NCT00846391|585928371|FG002|Overall Study|Study Terminated by Sponsor|2|||
162239190|NCT01287065|585928372|FG000|Treatment Period 1|Adverse Event|0|||
162239191|NCT01287065|585928373|FG001|Treatment Period 1|Adverse Event|0|||
162239192|NCT01287065|585928374|FG002|Treatment Period 1|Adverse Event|0|||
162122851|NCT00358215|585502342|FG000|Overall Study|Protocol Violation|64|||
162239193|NCT01287065|585928375|FG003|Treatment Period 1|Adverse Event|0|||
162239194|NCT01287065|585928376|FG004|Treatment Period 1|Adverse Event|1|||
162239195|NCT01287065|585928377|FG005|Treatment Period 1|Adverse Event|0|||
162239196|NCT01287065|585928372|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162239197|NCT01287065|585928373|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162239198|NCT01287065|585928374|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162239199|NCT01287065|585928375|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162239200|NCT01287065|585928376|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162239201|NCT01287065|585928377|FG005|Treatment Period 1|Withdrawal by Subject|1|||
162239202|NCT01580969|585928382|FG000|Overall Study|Physician Decision|3|||
162239203|NCT01580969|585928383|FG001|Overall Study|Physician Decision|0|||
162239204|NCT01580969|585928384|FG002|Overall Study|Physician Decision|0|||
162239205|NCT00511472|585928386|FG000|Overall Study|Clinical Adverse Event|1|||
162239206|NCT00511472|585928387|FG001|Overall Study|Clinical Adverse Event|2|||
162239207|NCT00511472|585928386|FG000|Overall Study|Laboratory Adverse Event|0|||
162239208|NCT00511472|585928387|FG001|Overall Study|Laboratory Adverse Event|2|||
162239209|NCT00511472|585928386|FG000|Overall Study|Not reported|2|||
162239210|NCT00511472|585928387|FG001|Overall Study|Not reported|2|||
162239211|NCT02019927|585928388|FG000|Overall Study|Lost to Follow-up|2|||
162239212|NCT02019927|585928389|FG001|Overall Study|Lost to Follow-up|4|||
162239213|NCT02019927|585928390|FG002|Overall Study|Lost to Follow-up|1|||
162239214|NCT02019927|585928391|FG003|Overall Study|Lost to Follow-up|2|||
162239215|NCT02019927|585928392|FG004|Overall Study|Lost to Follow-up|3|||
162239216|NCT02019927|585928393|FG005|Overall Study|Lost to Follow-up|1|||
162239217|NCT03181451|585928400|FG000|Overall Study|Adverse Event|0|||
162239218|NCT03181451|585928401|FG001|Overall Study|Adverse Event|1|||
162239219|NCT03181451|585928402|FG002|Overall Study|Adverse Event|0|||
162239220|NCT03181451|585928400|FG000|Overall Study|Withdrawal by Subject|0|||
162239221|NCT03181451|585928401|FG001|Overall Study|Withdrawal by Subject|1|||
162239222|NCT03181451|585928402|FG002|Overall Study|Withdrawal by Subject|0|||
162239223|NCT01259284|585928409|FG000|Overall Study|Study Termination|2|||
162239224|NCT01259284|585928410|FG001|Overall Study|Study Termination|0|||
162239225|NCT01259284|585928411|FG002|Overall Study|Study Termination|0|||
162239226|NCT00069238|585928412|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
162239227|NCT00069238|585928413|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
162239228|NCT00069238|585928414|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
162239229|NCT00069238|585928412|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
162239230|NCT00069238|585928413|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
162239231|NCT00069238|585928414|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
162239232|NCT00069238|585928412|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
162239233|NCT00069238|585928413|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
162239234|NCT00069238|585928414|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
162239235|NCT01001832|585928416|FG000|Short-term Period|Adverse Event|2|||
162239236|NCT01001832|585928417|FG001|Short-term Period|Adverse Event|3|||
162239237|NCT01001832|585928416|FG000|Long-term Period|Adverse Event|2|||
162239238|NCT01001832|585928417|FG001|Long-term Period|Adverse Event|1|||
162239239|NCT01001832|585928416|FG000|Long-term Period|Withdrawal by Subject|1|||
162239240|NCT01001832|585928417|FG001|Long-term Period|Withdrawal by Subject|0|||
162239241|NCT01001832|585928416|FG000|Long-term Period|Lack of Efficacy|0|||
162239242|NCT01001832|585928417|FG001|Long-term Period|Lack of Efficacy|2|||
162239243|NCT01001832|585928416|FG000|Long-term Period|Other|1|||
162239244|NCT01001832|585928417|FG001|Long-term Period|Other|2|||
162239245|NCT01001832|585928416|FG000|Follow-up Period|Withdrawal by Subject|1|||
162239246|NCT01001832|585928417|FG001|Follow-up Period|Withdrawal by Subject|0|||
162239247|NCT01001832|585928416|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
162239248|NCT01001832|585928417|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
162239249|NCT01001832|585928416|FG000|Follow-up Period|Other|2|||
162239250|NCT01001832|585928417|FG001|Follow-up Period|Other|1|||
162239251|NCT01032382|585928419|FG000|Overall Study|Disease dissemination|1|||
162239252|NCT01032382|585928420|FG001|Overall Study|Disease dissemination|1|||
162239253|NCT01032382|585928419|FG000|Overall Study|Treatment failure|3|||
162239254|NCT01032382|585928420|FG001|Overall Study|Treatment failure|1|||
162239255|NCT01032382|585928419|FG000|Overall Study|Index lesion relapse|1|||
162239256|NCT01032382|585928420|FG001|Overall Study|Index lesion relapse|3|||
162239257|NCT01012713|585928421|FG000|Overall Study|Lack of Efficacy|3|||
162239258|NCT01242800|585928422|FG000|Overall Study|Patient refusal|0|||
162239259|NCT01242800|585928423|FG001|Overall Study|Patient refusal|10|||
162239260|NCT01242800|585928422|FG000|Overall Study|Physician Decision|0|||
162239261|NCT01242800|585928423|FG001|Overall Study|Physician Decision|1|||
162239262|NCT01242800|585928422|FG000|Overall Study|Disease progression|0|||
162239263|NCT01242800|585928423|FG001|Overall Study|Disease progression|3|||
162239264|NCT01242800|585928422|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
162239265|NCT01242800|585928423|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
162239266|NCT01242800|585928422|FG000|Overall Study|Reasons not reported|0|||
162239267|NCT01242800|585928423|FG001|Overall Study|Reasons not reported|4|||
162239268|NCT04508023|585928425|FG000|Overall Study|Withdrawal by Subject|1|||
162239269|NCT04508023|585928426|FG001|Overall Study|Withdrawal by Subject|2|||
162239270|NCT00511901|585928434|FG000|Overall Study|Withdrawal by Subject|1|||
162239271|NCT00511901|585928435|FG001|Overall Study|Withdrawal by Subject|3|||
162239272|NCT02447172|585928436|FG000|Overall Study|Adverse Event|11|||
162239273|NCT02447172|585928437|FG001|Overall Study|Adverse Event|8|||
162239274|NCT02447172|585928438|FG002|Overall Study|Adverse Event|7|||
162239275|NCT02447172|585928436|FG000|Overall Study|Death|3|||
162239276|NCT02447172|585928437|FG001|Overall Study|Death|1|||
162239277|NCT02447172|585928438|FG002|Overall Study|Death|0|||
162239278|NCT02447172|585928436|FG000|Overall Study|Protocol Violation|2|||
162239279|NCT02447172|585928437|FG001|Overall Study|Protocol Violation|1|||
162239280|NCT02447172|585928438|FG002|Overall Study|Protocol Violation|2|||
162239281|NCT02447172|585928436|FG000|Overall Study|Lost to Follow-up|7|||
162239282|NCT02447172|585928437|FG001|Overall Study|Lost to Follow-up|4|||
162239283|NCT02447172|585928438|FG002|Overall Study|Lost to Follow-up|4|||
162239284|NCT02447172|585928436|FG000|Overall Study|Withdrawal by Subject|5|||
162239285|NCT02447172|585928437|FG001|Overall Study|Withdrawal by Subject|1|||
162239286|NCT02447172|585928438|FG002|Overall Study|Withdrawal by Subject|3|||
162239287|NCT02447172|585928436|FG000|Overall Study|protocol specific treatment unrelated|3|||
162239288|NCT02447172|585928437|FG001|Overall Study|protocol specific treatment unrelated|0|||
162239289|NCT02447172|585928438|FG002|Overall Study|protocol specific treatment unrelated|2|||
162239290|NCT03562247|585928442|FG000|Overall Study|Lost to Follow-up|3|||
162239291|NCT03562247|585928443|FG001|Overall Study|Lost to Follow-up|1|||
162239292|NCT03562247|585928444|FG002|Overall Study|Lost to Follow-up|1|||
162239293|NCT00983931|585928445|FG000|14 Day Washout Period|Physician Decision|1|||
162239294|NCT01281969|585928446|FG000|Overall Study|not randomized didn't meet criteria|0|||
162239295|NCT01281969|585928447|FG001|Overall Study|not randomized didn't meet criteria|0|||
162239296|NCT01281969|585928448|FG002|Overall Study|not randomized didn't meet criteria|7|||
162239297|NCT01281969|585928446|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
162239298|NCT01281969|585928447|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
162239299|NCT01281969|585928448|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
162239300|NCT01281969|585928446|FG000|Overall Study|not randomized, child consent not given|0|||
162239301|NCT01281969|585928447|FG001|Overall Study|not randomized, child consent not given|0|||
162239302|NCT01281969|585928448|FG002|Overall Study|not randomized, child consent not given|2|||
162239303|NCT02409368|585928453|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
162239304|NCT02409368|585928454|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
162239305|NCT02409368|585928455|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
162239306|NCT02409368|585928456|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
162239307|NCT02409368|585928453|FG000|ECOG Reclassification|Death|1|||
162239308|NCT02409368|585928454|FG001|ECOG Reclassification|Death|5|||
162239309|NCT02409368|585928455|FG002|ECOG Reclassification|Death|0|||
162239310|NCT02409368|585928456|FG003|ECOG Reclassification|Death|0|||
162239311|NCT02409368|585928453|FG000|ECOG Reclassification|Disease Progression|113|||
162239312|NCT02409368|585928454|FG001|ECOG Reclassification|Disease Progression|382|||
162239313|NCT02409368|585928455|FG002|ECOG Reclassification|Disease Progression|70|||
162239314|NCT02409368|585928456|FG003|ECOG Reclassification|Disease Progression|1|||
162239315|NCT02409368|585928453|FG000|ECOG Reclassification|Lost to Follow-up|1|||
162239316|NCT02409368|585928454|FG001|ECOG Reclassification|Lost to Follow-up|5|||
162239317|NCT02409368|585928455|FG002|ECOG Reclassification|Lost to Follow-up|0|||
162239318|NCT02409368|585928456|FG003|ECOG Reclassification|Lost to Follow-up|0|||
162239319|NCT02409368|585928453|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
162239320|NCT02409368|585928454|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
162239321|NCT02409368|585928455|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
162239322|NCT02409368|585928456|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
162239323|NCT02409368|585928453|FG000|ECOG Reclassification|Poor/non-compliance|0|||
162239324|NCT02409368|585928454|FG001|ECOG Reclassification|Poor/non-compliance|3|||
162239325|NCT02409368|585928455|FG002|ECOG Reclassification|Poor/non-compliance|2|||
162239326|NCT02409368|585928456|FG003|ECOG Reclassification|Poor/non-compliance|0|||
162239327|NCT02409368|585928453|FG000|ECOG Reclassification|Study drug toxicity|17|||
162239328|NCT02409368|585928454|FG001|ECOG Reclassification|Study drug toxicity|42|||
162239329|NCT02409368|585928455|FG002|ECOG Reclassification|Study drug toxicity|7|||
162239330|NCT02409368|585928456|FG003|ECOG Reclassification|Study drug toxicity|0|||
162239331|NCT02409368|585928453|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
162239332|NCT02409368|585928454|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
162239333|NCT02409368|585928455|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
162239334|NCT02409368|585928456|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
162239335|NCT02409368|585928453|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
162239336|NCT02409368|585928454|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
162239337|NCT02409368|585928455|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
162239338|NCT02409368|585928456|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
162239339|NCT02409368|585928453|FG000|ECOG Reclassification|Participant withdrew consent|2|||
162239340|NCT02409368|585928454|FG001|ECOG Reclassification|Participant withdrew consent|3|||
162239341|NCT02409368|585928455|FG002|ECOG Reclassification|Participant withdrew consent|4|||
162239342|NCT02409368|585928456|FG003|ECOG Reclassification|Participant withdrew consent|0|||
162239343|NCT02409368|585928453|FG000|ECOG Reclassification|Other Reasons|5|||
162239344|NCT02409368|585928454|FG001|ECOG Reclassification|Other Reasons|26|||
162239345|NCT02409368|585928455|FG002|ECOG Reclassification|Other Reasons|2|||
162239346|NCT02409368|585928456|FG003|ECOG Reclassification|Other Reasons|0|||
162239347|NCT02409368|585928453|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
162239348|NCT02409368|585928454|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
162239349|NCT02409368|585928455|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
162239350|NCT02409368|585928456|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
162239351|NCT01296347|585928457|FG000|Allocation|Withdrawal by Subject|1|||
162239352|NCT01296347|585928458|FG001|Allocation|Withdrawal by Subject|2|||
162239353|NCT01296347|585928457|FG000|Allocation|Lack of Efficacy|1|||
162239354|NCT01296347|585928458|FG001|Allocation|Lack of Efficacy|2|||
162239355|NCT01296347|585928457|FG000|Allocation|not received infusion|1|||
162239356|NCT01296347|585928458|FG001|Allocation|not received infusion|0|||
162239357|NCT01296347|585928457|FG000|6 Week Follow up|Death|0|||
162239358|NCT01296347|585928458|FG001|6 Week Follow up|Death|1|||
162239359|NCT01296347|585928457|FG000|3 Month Follow up|Death|1|||
162239360|NCT01296347|585928458|FG001|3 Month Follow up|Death|0|||
162239361|NCT01296347|585928457|FG000|3 Month Follow up|Lost to Follow-up|0|||
162239362|NCT01296347|585928458|FG001|3 Month Follow up|Lost to Follow-up|1|||
162239363|NCT01296347|585928457|FG000|6 Month Follow up|Death|2|||
162239364|NCT01296347|585928458|FG001|6 Month Follow up|Death|1|||
162239365|NCT01296347|585928457|FG000|6 Month Follow up|Lost to Follow-up|0|||
162239366|NCT01296347|585928458|FG001|6 Month Follow up|Lost to Follow-up|1|||
162239367|NCT01296347|585928457|FG000|12 Month Follow up|Lost to Follow-up|3|||
162239368|NCT01296347|585928458|FG001|12 Month Follow up|Lost to Follow-up|1|||
162239369|NCT01296347|585928457|FG000|12 Month Follow up|Death|1|||
162239370|NCT01296347|585928458|FG001|12 Month Follow up|Death|1|||
162239371|NCT01296347|585928457|FG000|12 Month Follow up|Withdrawal by Subject|0|||
162239372|NCT01296347|585928458|FG001|12 Month Follow up|Withdrawal by Subject|1|||
162239373|NCT02240693|585928459|FG000|Overall Study|Adverse Event|0|||
162239374|NCT02240693|585928460|FG001|Overall Study|Adverse Event|0|||
162239375|NCT02240693|585928461|FG002|Overall Study|Adverse Event|0|||
162239376|NCT02240693|585928462|FG003|Overall Study|Adverse Event|0|||
162239377|NCT02240693|585928463|FG004|Overall Study|Adverse Event|1|||
162239378|NCT02240693|585928459|FG000|Overall Study|Withdrawal by Subject|0|||
162239379|NCT02240693|585928460|FG001|Overall Study|Withdrawal by Subject|0|||
162239380|NCT02240693|585928461|FG002|Overall Study|Withdrawal by Subject|2|||
162239381|NCT02240693|585928462|FG003|Overall Study|Withdrawal by Subject|1|||
162239382|NCT02240693|585928463|FG004|Overall Study|Withdrawal by Subject|0|||
162239383|NCT02240693|585928459|FG000|Overall Study|Other than specified|0|||
162239384|NCT02240693|585928460|FG001|Overall Study|Other than specified|0|||
162239385|NCT02240693|585928461|FG002|Overall Study|Other than specified|2|||
162239386|NCT02240693|585928462|FG003|Overall Study|Other than specified|0|||
162239387|NCT02240693|585928463|FG004|Overall Study|Other than specified|0|||
162239388|NCT03343301|585928464|FG000|Overall Study|Withdrawal by Subject|1|||
162239389|NCT03343301|585928465|FG001|Overall Study|Withdrawal by Subject|1|||
162239390|NCT03343301|585928464|FG000|Overall Study|Death|0|||
162239391|NCT03343301|585928465|FG001|Overall Study|Death|2|||
162239392|NCT03343301|585928464|FG000|Overall Study|Other|0|||
162239393|NCT03343301|585928465|FG001|Overall Study|Other|6|||
162239394|NCT03343301|585928464|FG000|Overall Study|Missing|2|||
162239395|NCT03343301|585928465|FG001|Overall Study|Missing|0|||
162239396|NCT02668185|585928468|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
162239397|NCT02668185|585928469|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
162239398|NCT02668185|585928468|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
162239399|NCT02668185|585928469|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
162239400|NCT02668185|585928468|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
162239401|NCT02668185|585928469|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
162239402|NCT02668185|585928468|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
162239403|NCT02668185|585928469|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
162239404|NCT01013597|585928470|FG000|Overall Study|Withdrawal by Subject|1|||
162239405|NCT00427895|585928471|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162239406|NCT00427895|585928472|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162239407|NCT00427895|585928473|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162239408|NCT00427895|585928474|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
162239409|NCT00427895|585928475|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162239410|NCT00427895|585928476|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162239411|NCT00427895|585928477|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162239412|NCT00427895|585928478|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
162239413|NCT00427895|585928471|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162239414|NCT00427895|585928472|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162239415|NCT00427895|585928473|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162239416|NCT00427895|585928474|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162239417|NCT00427895|585928475|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162239418|NCT00427895|585928476|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162239419|NCT00427895|585928477|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
162239420|NCT00427895|585928478|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
162239421|NCT00427895|585928471|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
162239422|NCT00427895|585928472|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
162239423|NCT00427895|585928473|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
162239424|NCT00427895|585928474|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
162239425|NCT00427895|585928475|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
162239426|NCT00427895|585928476|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
162239427|NCT00427895|585928477|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
162239428|NCT00427895|585928478|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
162239429|NCT00427895|585928471|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
162239430|NCT00427895|585928472|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
162239431|NCT00427895|585928473|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
162239432|NCT00427895|585928474|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
162239433|NCT00427895|585928475|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
162239434|NCT00427895|585928476|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
162239435|NCT00427895|585928477|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
162239436|NCT00427895|585928478|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
162239437|NCT00427895|585928471|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
162239438|NCT00427895|585928472|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
162239439|NCT00427895|585928473|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
162239440|NCT00427895|585928474|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
162239441|NCT00427895|585928475|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
162239442|NCT00427895|585928476|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
162239443|NCT00427895|585928477|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
162239444|NCT00427895|585928478|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
162239445|NCT00427895|585928471|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
162239446|NCT00427895|585928472|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
162239447|NCT00427895|585928473|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
162239448|NCT00427895|585928474|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
162239449|NCT00427895|585928475|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
162239450|NCT00427895|585928476|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
162239451|NCT00427895|585928477|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
162239452|NCT00427895|585928478|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
162239453|NCT00427895|585928471|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
162239454|NCT00427895|585928472|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
162239455|NCT00427895|585928473|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
162239456|NCT00427895|585928474|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
162239457|NCT00427895|585928475|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
162239458|NCT00427895|585928476|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
162239459|NCT00427895|585928477|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
162239460|NCT00427895|585928478|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
162239461|NCT00427895|585928471|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
162239462|NCT00427895|585928472|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
162239463|NCT00427895|585928473|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
162239464|NCT00427895|585928474|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
162239465|NCT00427895|585928475|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
162239466|NCT00427895|585928476|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
162239467|NCT00427895|585928477|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
162239468|NCT00427895|585928478|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
162239469|NCT00427895|585928471|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162239470|NCT00427895|585928472|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162239471|NCT00427895|585928473|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162239472|NCT00427895|585928474|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
162239473|NCT00427895|585928475|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162239474|NCT00427895|585928476|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162239475|NCT00427895|585928477|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162239476|NCT00427895|585928478|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
162239477|NCT00427895|585928471|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
162239478|NCT00427895|585928472|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
162239479|NCT00427895|585928473|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
162239480|NCT00427895|585928474|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
162239481|NCT00427895|585928475|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
162239482|NCT00427895|585928476|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
162239483|NCT00427895|585928477|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
162239484|NCT00427895|585928478|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
162239485|NCT00427895|585928471|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
162239486|NCT00427895|585928472|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
162239487|NCT00427895|585928473|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
162239488|NCT00427895|585928474|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
162239489|NCT00427895|585928475|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
162239490|NCT00427895|585928476|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
162239491|NCT00427895|585928477|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
162239492|NCT00427895|585928478|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
162239493|NCT00427895|585928471|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
162239494|NCT00427895|585928472|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
162239495|NCT00427895|585928473|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
162239496|NCT00427895|585928474|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
162239497|NCT00427895|585928475|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
162239498|NCT00427895|585928476|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
162239499|NCT00427895|585928477|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
162239500|NCT00427895|585928478|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
162239501|NCT00427895|585928471|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
162239502|NCT00427895|585928472|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
162239503|NCT00427895|585928473|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
162239504|NCT00427895|585928474|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
162239505|NCT00427895|585928475|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
162239506|NCT00427895|585928476|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
162239507|NCT00427895|585928477|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
162239508|NCT00427895|585928478|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
162239509|NCT00427895|585928471|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
162239510|NCT00427895|585928472|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
162239511|NCT00427895|585928473|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
162239512|NCT00427895|585928474|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
162239513|NCT00427895|585928475|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
162239514|NCT00427895|585928476|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
162239515|NCT00427895|585928477|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
162239516|NCT00427895|585928478|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
162239517|NCT00427895|585928471|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162239518|NCT00427895|585928472|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
162239519|NCT00427895|585928473|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162239520|NCT00427895|585928474|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162239521|NCT00427895|585928475|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162239522|NCT00427895|585928476|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162239523|NCT00427895|585928477|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162239524|NCT00427895|585928478|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
162239525|NCT00427895|585928471|FG000|Vax 1/Year 1 Follow-up|Death|1|||
162239526|NCT00427895|585928472|FG001|Vax 1/Year 1 Follow-up|Death|0|||
162239527|NCT00427895|585928473|FG002|Vax 1/Year 1 Follow-up|Death|0|||
162239528|NCT00427895|585928474|FG003|Vax 1/Year 1 Follow-up|Death|0|||
162239529|NCT00427895|585928475|FG004|Vax 1/Year 1 Follow-up|Death|0|||
162239530|NCT00427895|585928476|FG005|Vax 1/Year 1 Follow-up|Death|0|||
162239531|NCT00427895|585928477|FG006|Vax 1/Year 1 Follow-up|Death|0|||
162239532|NCT00427895|585928478|FG007|Vax 1/Year 1 Follow-up|Death|0|||
162239533|NCT00427895|585928471|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
162239534|NCT00427895|585928472|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
162239535|NCT00427895|585928473|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
162239536|NCT00427895|585928474|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
162239537|NCT00427895|585928475|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
162239538|NCT00427895|585928476|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
162239539|NCT00427895|585928477|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
162239540|NCT00427895|585928478|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
162239541|NCT00427895|585928471|FG000|Vax 1/Year 1 Follow-up|Other|0|||
161779230|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Death|2|||
161779231|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
161779232|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
161779233|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
161779234|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
161779235|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
161779236|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
161779237|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Relapse|1|||
161779238|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Relapse|0|||
161779239|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
161779240|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
161779241|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
161779242|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
161779243|NCT00111007|584233892|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
162239542|NCT00427895|585928472|FG001|Vax 1/Year 1 Follow-up|Other|0|||
162239543|NCT00427895|585928473|FG002|Vax 1/Year 1 Follow-up|Other|0|||
162239544|NCT00427895|585928474|FG003|Vax 1/Year 1 Follow-up|Other|2|||
162239545|NCT00427895|585928475|FG004|Vax 1/Year 1 Follow-up|Other|0|||
162239546|NCT00427895|585928476|FG005|Vax 1/Year 1 Follow-up|Other|0|||
162239547|NCT00427895|585928477|FG006|Vax 1/Year 1 Follow-up|Other|0|||
162239548|NCT00427895|585928478|FG007|Vax 1/Year 1 Follow-up|Other|0|||
162239549|NCT00427895|585928471|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
162239550|NCT00427895|585928472|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
162239551|NCT00427895|585928473|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
162239552|NCT00427895|585928474|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
162239553|NCT00427895|585928475|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
162239554|NCT00427895|585928476|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
162239555|NCT00427895|585928477|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
162239556|NCT00427895|585928478|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
162239557|NCT02678247|585928479|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
162239558|NCT02678247|585928480|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
162239559|NCT02678247|585928479|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
162239560|NCT02678247|585928480|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
162239561|NCT02678247|585928479|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
162239562|NCT02678247|585928480|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
162239563|NCT02678247|585928479|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
162239564|NCT02678247|585928480|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
162239565|NCT02678247|585928479|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
162239566|NCT02678247|585928480|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
162239567|NCT02678247|585928479|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
162239568|NCT02678247|585928480|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
162239569|NCT02796560|585928486|FG000|Overall Study|Adverse Event|2|||
162239570|NCT02796560|585928487|FG001|Overall Study|Adverse Event|0|||
162239571|NCT02796560|585928486|FG000|Overall Study|Withdrawal by Subject|2|||
162239572|NCT02796560|585928487|FG001|Overall Study|Withdrawal by Subject|2|||
162239573|NCT03816332|585928489|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
162239574|NCT03816332|585928489|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
162239575|NCT05330312|585928490|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
162239576|NCT05330312|585928491|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
162239577|NCT05330312|585928492|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
162239578|NCT05330312|585928490|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
162239579|NCT05330312|585928491|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
162239580|NCT05330312|585928492|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
162239581|NCT05330312|585928490|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
162239582|NCT05330312|585928491|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
162239583|NCT05330312|585928492|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
162239584|NCT05330312|585928490|FG000|Pivotal Investigation - Part 2|Death|1|||
162239585|NCT05330312|585928491|FG001|Pivotal Investigation - Part 2|Death|4|||
162239586|NCT05330312|585928492|FG002|Pivotal Investigation - Part 2|Death|0|||
162239587|NCT03534284|585928493|FG000|Overall Study|Death|2|||
162239588|NCT03534284|585928494|FG001|Overall Study|Death|3|||
162239589|NCT03534284|585928495|FG002|Overall Study|Death|3|||
162239590|NCT03534284|585928493|FG000|Overall Study|Withdrawal by Subject|5|||
162239591|NCT03534284|585928494|FG001|Overall Study|Withdrawal by Subject|0|||
162122852|NCT00358215|585502343|FG001|Overall Study|Protocol Violation|59|||
162239592|NCT03534284|585928495|FG002|Overall Study|Withdrawal by Subject|0|||
162239593|NCT03316300|585928496|FG000|Overall Study|Withdrawal by Subject|3|||
162239594|NCT03316300|585928497|FG001|Overall Study|Withdrawal by Subject|2|||
162239595|NCT03316300|585928496|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
162239596|NCT03316300|585928497|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
162239597|NCT03316300|585928496|FG000|Overall Study|Adverse Event|1|||
162239598|NCT03316300|585928497|FG001|Overall Study|Adverse Event|0|||
162239599|NCT03316300|585928496|FG000|Overall Study|COVID-19|0|||
162239600|NCT03316300|585928497|FG001|Overall Study|COVID-19|1|||
162239601|NCT04002401|585928498|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
162239602|NCT04002401|585928498|FG000|Overall Study|Death|10|||
162239603|NCT04002401|585928498|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
162239604|NCT04002401|585928498|FG000|Overall Study|Enrolled but Never Treated|1|||
162239605|NCT04002401|585928498|FG000|Overall Study|Lost to Follow-up|1|||
162239606|NCT00423930|585928499|FG000|Overall Study|Withdrawal by Subject|2|||
162239607|NCT02881957|585928504|FG000|Overall Study|Comfort care|0|||
162239608|NCT02881957|585928505|FG001|Overall Study|Comfort care|1|||
162239609|NCT02881957|585928504|FG000|Overall Study|Concurrent trial enrollment|0|||
162239610|NCT02881957|585928505|FG001|Overall Study|Concurrent trial enrollment|1|||
162239611|NCT02881957|585928504|FG000|Overall Study|Discharged within 48 hours|0|||
162239612|NCT02881957|585928505|FG001|Overall Study|Discharged within 48 hours|1|||
162239613|NCT02881957|585928504|FG000|Overall Study|Withdrawal by Subject|2|||
162239614|NCT02881957|585928505|FG001|Overall Study|Withdrawal by Subject|1|||
162239615|NCT02881957|585928504|FG000|Overall Study|Protocol Violation|1|||
162239616|NCT02881957|585928505|FG001|Overall Study|Protocol Violation|0|||
162239617|NCT00081497|585928511|FG000|Overall Study|Adverse Event|2|||
162239618|NCT00081497|585928512|FG001|Overall Study|Adverse Event|0|||
162239619|NCT00081497|585928511|FG000|Overall Study|Death|0|||
162239620|NCT00081497|585928512|FG001|Overall Study|Death|1|||
162239621|NCT00081497|585928511|FG000|Overall Study|Withdrawal by Subject|1|||
162239622|NCT00081497|585928512|FG001|Overall Study|Withdrawal by Subject|0|||
162239623|NCT00081497|585928511|FG000|Overall Study|Non-compliance|0|||
162239624|NCT00081497|585928512|FG001|Overall Study|Non-compliance|1|||
162239625|NCT02390245|585928513|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
162239626|NCT02390245|585928514|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
162239627|NCT02390245|585928515|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
162239628|NCT02390245|585928513|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
162239629|NCT02390245|585928514|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
162239630|NCT02390245|585928515|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
162239631|NCT02425644|585930089|FG000|Overall Study|Lost to Follow-up|2|||
162239632|NCT02425644|585930090|FG001|Overall Study|Lost to Follow-up|3|||
162239633|NCT02425644|585930089|FG000|Overall Study|Withdrawal by Subject|41|||
162239634|NCT02425644|585930090|FG001|Overall Study|Withdrawal by Subject|36|||
162239635|NCT02425644|585930089|FG000|Overall Study|Lack of Efficacy|3|||
162239636|NCT02425644|585930090|FG001|Overall Study|Lack of Efficacy|10|||
162239637|NCT02425644|585930089|FG000|Overall Study|Adverse Event|13|||
162239638|NCT02425644|585930090|FG001|Overall Study|Adverse Event|3|||
162239639|NCT02425644|585930089|FG000|Overall Study|Death|0|||
162239640|NCT02425644|585930090|FG001|Overall Study|Death|2|||
162239641|NCT02425644|585930089|FG000|Overall Study|Other|18|||
162239642|NCT02425644|585930090|FG001|Overall Study|Other|17|||
162239643|NCT02720536|585930091|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
162239644|NCT02720536|585930091|FG000|Overall Study|PR - pregnancy|2|||
162239645|NCT02720536|585930091|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
162239646|NCT02720536|585930091|FG000|Overall Study|PR - death|1|||
162239647|NCT02720536|585930091|FG000|Overall Study|PR - adverse event|1|||
162239648|NCT02720536|585930091|FG000|Overall Study|PR - abnormal lab value(s)|1|||
162239649|NCT02720536|585930091|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
162239650|NCT00985166|585930092|FG000|Overall Study|Lost to Follow-up|3|||
162239651|NCT00985166|585930093|FG001|Overall Study|Lost to Follow-up|2|||
162239652|NCT00985166|585930094|FG002|Overall Study|Lost to Follow-up|2|||
162239653|NCT00985166|585930092|FG000|Overall Study|Withdrawal by Subject|3|||
162239654|NCT00985166|585930093|FG001|Overall Study|Withdrawal by Subject|2|||
162239655|NCT00985166|585930094|FG002|Overall Study|Withdrawal by Subject|0|||
162239656|NCT00985166|585930092|FG000|Overall Study|Test not done|2|||
162239657|NCT00985166|585930093|FG001|Overall Study|Test not done|0|||
162239658|NCT00985166|585930094|FG002|Overall Study|Test not done|4|||
162239659|NCT00985166|585930092|FG000|Overall Study|Other|1|||
162239660|NCT00985166|585930093|FG001|Overall Study|Other|0|||
162239661|NCT00985166|585930094|FG002|Overall Study|Other|1|||
162239662|NCT01028222|585930095|FG000|Overall Study|Protocol deviation|1|||
162239663|NCT01028222|585930096|FG001|Overall Study|Protocol deviation|0|||
162239664|NCT01028222|585930095|FG000|Overall Study|Disease progression|33|||
162239665|NCT01028222|585930096|FG001|Overall Study|Disease progression|9|||
162239666|NCT01028222|585930095|FG000|Overall Study|Administrative problems|1|||
162239667|NCT01028222|585930096|FG001|Overall Study|Administrative problems|1|||
162239668|NCT01028222|585930095|FG000|Overall Study|Lost to Follow-up|0|||
162239669|NCT01028222|585930096|FG001|Overall Study|Lost to Follow-up|1|||
162239670|NCT01028222|585930095|FG000|Overall Study|Withdrawal by Subject|1|||
162239671|NCT01028222|585930096|FG001|Overall Study|Withdrawal by Subject|0|||
162239672|NCT01028222|585930095|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
162239673|NCT01028222|585930096|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
162239674|NCT01028222|585930095|FG000|Overall Study|Adverse Event|2|||
162239675|NCT01028222|585930096|FG001|Overall Study|Adverse Event|0|||
162239676|NCT00146328|585930097|FG000|Overall Study|Adverse Event|39|||
162239677|NCT00146328|585930098|FG001|Overall Study|Adverse Event|48|||
162239678|NCT00146328|585930099|FG002|Overall Study|Adverse Event|79|||
162239679|NCT00146328|585930097|FG000|Overall Study|Protocol Violation|11|||
162239680|NCT00146328|585930098|FG001|Overall Study|Protocol Violation|6|||
162239681|NCT00146328|585930099|FG002|Overall Study|Protocol Violation|12|||
162239682|NCT00146328|585930097|FG000|Overall Study|Lost to Follow-up|7|||
162239683|NCT00146328|585930098|FG001|Overall Study|Lost to Follow-up|4|||
162239684|NCT00146328|585930099|FG002|Overall Study|Lost to Follow-up|7|||
162239685|NCT00146328|585930097|FG000|Overall Study|Withdrawal by Subject|16|||
162239686|NCT00146328|585930098|FG001|Overall Study|Withdrawal by Subject|16|||
162239687|NCT00146328|585930099|FG002|Overall Study|Withdrawal by Subject|22|||
162239688|NCT00146328|585930097|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
162239689|NCT00146328|585930098|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
162239690|NCT00146328|585930099|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
162239691|NCT00146328|585930097|FG000|Overall Study|Trial ended/site closed|8|||
162239692|NCT00146328|585930098|FG001|Overall Study|Trial ended/site closed|2|||
162239693|NCT00146328|585930099|FG002|Overall Study|Trial ended/site closed|19|||
162239694|NCT00146328|585930097|FG000|Overall Study|Patient decision to end|0|||
162239695|NCT00146328|585930098|FG001|Overall Study|Patient decision to end|1|||
162239696|NCT00146328|585930099|FG002|Overall Study|Patient decision to end|6|||
162239697|NCT00146328|585930097|FG000|Overall Study|Enroll into other trial|2|||
161682985|NCT02969915|583890219|FG000|Overall Study|Death|104|||
162239698|NCT00146328|585930098|FG001|Overall Study|Enroll into other trial|4|||
162239699|NCT00146328|585930099|FG002|Overall Study|Enroll into other trial|2|||
162239700|NCT00146328|585930097|FG000|Overall Study|Death|0|||
162239701|NCT00146328|585930098|FG001|Overall Study|Death|1|||
162239702|NCT00146328|585930099|FG002|Overall Study|Death|1|||
162239703|NCT00146328|585930097|FG000|Overall Study|Moved|2|||
162239704|NCT00146328|585930098|FG001|Overall Study|Moved|0|||
162239705|NCT00146328|585930099|FG002|Overall Study|Moved|0|||
162239706|NCT00146328|585930097|FG000|Overall Study|Interaction with other medication|2|||
162239707|NCT00146328|585930098|FG001|Overall Study|Interaction with other medication|0|||
162239708|NCT00146328|585930099|FG002|Overall Study|Interaction with other medication|1|||
162239709|NCT00300781|585930100|FG000|Overall Study|Disease Progression|55|||
162239710|NCT00300781|585930101|FG001|Overall Study|Disease Progression|52|||
162239711|NCT00300781|585930100|FG000|Overall Study|Adverse Event|5|||
162239712|NCT00300781|585930101|FG001|Overall Study|Adverse Event|6|||
162239713|NCT00300781|585930100|FG000|Overall Study|Withdrawal by Subject|1|||
162239714|NCT00300781|585930101|FG001|Overall Study|Withdrawal by Subject|2|||
162239715|NCT00300781|585930100|FG000|Overall Study|Physician Decision|1|||
162239716|NCT00300781|585930101|FG001|Overall Study|Physician Decision|0|||
162239717|NCT00300781|585930100|FG000|Overall Study|Not Recorded|0|||
162239718|NCT00300781|585930101|FG001|Overall Study|Not Recorded|1|||
162239719|NCT00300781|585930100|FG000|Overall Study|Symptomatic Deterioration|1|||
162239720|NCT00300781|585930101|FG001|Overall Study|Symptomatic Deterioration|0|||
162239721|NCT00300781|585930100|FG000|Overall Study|Lost to Follow-up|0|||
162239722|NCT00300781|585930101|FG001|Overall Study|Lost to Follow-up|1|||
162239723|NCT00567268|585930102|FG000|Overall Study|Protocol Violation|7|||
162239724|NCT00567268|585930102|FG000|Overall Study|Lost to Follow-up|36|||
162239725|NCT00567268|585930102|FG000|Overall Study|No Visit After First Day of Treatment|2|||
162239726|NCT00567268|585930102|FG000|Overall Study|No Drug Administration|4|||
162239727|NCT00567268|585930102|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
162239728|NCT01717989|585930103|FG000|Overall Study|Ineligibility determined|6|||
162239729|NCT01717989|585930103|FG000|Overall Study|Protocol deviation|6|||
162239730|NCT01717989|585930103|FG000|Overall Study|Withdrawal by Subject|11|||
162239731|NCT01717989|585930103|FG000|Overall Study|Physician Decision|2|||
162239732|NCT01717989|585930103|FG000|Overall Study|Lost to Follow-up|11|||
162239733|NCT01717989|585930103|FG000|Overall Study|Death|439|||
161894394|NCT00313586|584660955|FG001|Overall Study|Did not achieve HI-major/better response|7|||
161894395|NCT00313586|584660956|FG002|Overall Study|Did not achieve HI-major/better response|2|||
161894396|NCT00313586|584660957|FG003|Overall Study|Did not achieve HI-major/better response|1|||
161894397|NCT00313586|584660954|FG000|Overall Study|Physician Decision|2|||
161894398|NCT00313586|584660955|FG001|Overall Study|Physician Decision|1|||
161894399|NCT00313586|584660956|FG002|Overall Study|Physician Decision|0|||
161894400|NCT00313586|584660957|FG003|Overall Study|Physician Decision|0|||
161894401|NCT00313586|584660954|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
161894402|NCT00313586|584660955|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
161894403|NCT00313586|584660956|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
161894404|NCT00313586|584660957|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
161894405|NCT00313586|584660954|FG000|Overall Study|Lost insurance|0|||
161894406|NCT00313586|584660955|FG001|Overall Study|Lost insurance|1|||
161894407|NCT00313586|584660956|FG002|Overall Study|Lost insurance|0|||
161894408|NCT00313586|584660957|FG003|Overall Study|Lost insurance|0|||
161894409|NCT00313586|584660954|FG000|Overall Study|Moved|0|||
162239734|NCT01717989|585930103|FG000|Overall Study|Protocol-specified criteria|551|||
162239735|NCT01717989|585930103|FG000|Overall Study|Other|40|||
162239736|NCT03224325|585930104|FG000|Overall Study|Adverse Event|1|||
162239737|NCT03224325|585930105|FG001|Overall Study|Adverse Event|0|||
162239738|NCT03224325|585930106|FG002|Overall Study|Adverse Event|0|||
162239739|NCT03224325|585930107|FG003|Overall Study|Adverse Event|0|||
162239740|NCT03224325|585930108|FG004|Overall Study|Adverse Event|0|||
162239741|NCT03224325|585930109|FG005|Overall Study|Adverse Event|0|||
162239742|NCT03224325|585930110|FG006|Overall Study|Adverse Event|1|||
162239743|NCT03224325|585930104|FG000|Overall Study|Withdrawal by Subject|0|||
162239744|NCT03224325|585930105|FG001|Overall Study|Withdrawal by Subject|0|||
162239745|NCT03224325|585930106|FG002|Overall Study|Withdrawal by Subject|0|||
161894410|NCT00313586|584660955|FG001|Overall Study|Moved|1|||
161894411|NCT00313586|584660956|FG002|Overall Study|Moved|0|||
162239746|NCT03224325|585930107|FG003|Overall Study|Withdrawal by Subject|1|||
162239747|NCT03224325|585930108|FG004|Overall Study|Withdrawal by Subject|0|||
162239748|NCT03224325|585930109|FG005|Overall Study|Withdrawal by Subject|0|||
162239749|NCT03224325|585930110|FG006|Overall Study|Withdrawal by Subject|0|||
162239750|NCT02525861|585930116|FG000|Overall Study|Adverse Event|1|||
161894412|NCT00313586|584660957|FG003|Overall Study|Moved|0|||
161894413|NCT00313586|584660954|FG000|Overall Study|Death before starting treatment|1|||
161894414|NCT00313586|584660955|FG001|Overall Study|Death before starting treatment|0|||
161894415|NCT00313586|584660956|FG002|Overall Study|Death before starting treatment|0|||
162239751|NCT02525861|585930117|FG001|Overall Study|Adverse Event|0|||
162239752|NCT02525861|585930116|FG000|Overall Study|Withdrawal by Subject|0|||
162239753|NCT02525861|585930117|FG001|Overall Study|Withdrawal by Subject|1|||
162239754|NCT02525861|585930116|FG000|Overall Study|Physician Decision|0|||
162239755|NCT02525861|585930117|FG001|Overall Study|Physician Decision|1|||
162239756|NCT01117454|585930120|FG000|Overall Study|Pregnancy|0|||
162239757|NCT01117454|585930121|FG001|Overall Study|Pregnancy|1|||
162239758|NCT00888433|585930122|FG000|Overall Study|Withdrawal by Subject|1|||
162239759|NCT00888433|585930123|FG001|Overall Study|Withdrawal by Subject|2|||
162239760|NCT00888433|585930122|FG000|Overall Study|Missed Visit|2|||
162239761|NCT00888433|585930123|FG001|Overall Study|Missed Visit|1|||
162239762|NCT01607554|585930127|FG000|Overall Study|Disease progression|2|||
162239763|NCT03952806|585930131|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
162239764|NCT03952806|585930132|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
162239765|NCT03952806|585930131|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
162239766|NCT03952806|585930132|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
162239767|NCT03952806|585930131|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
162239768|NCT03952806|585930132|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
162239769|NCT03952806|585930131|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
162239770|NCT03952806|585930132|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
162239771|NCT03952806|585930131|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
162239772|NCT03952806|585930132|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
162239773|NCT03952806|585930131|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
162239774|NCT03952806|585930132|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
162239775|NCT03952806|585930131|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
162239776|NCT03952806|585930132|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
162239777|NCT03952806|585930131|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
162239778|NCT03952806|585930132|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
162239779|NCT03952806|585930131|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
162239780|NCT03952806|585930132|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
162239781|NCT03952806|585930131|FG000|OLE Phase (48 Weeks)|Other|16|||
162239782|NCT03952806|585930132|FG001|OLE Phase (48 Weeks)|Other|13|||
162239783|NCT05580588|585930133|FG000|Overall Study|Lack of Efficacy|12|||
162239784|NCT00756470|585930138|FG000|Overall Study|Withdrawal by Subject|1|||
162239785|NCT00756470|585930138|FG000|Overall Study|Adverse Event|4|||
162239786|NCT02875977|585930139|FG000|Overall Study|Lost to Follow-up|42|||
162239787|NCT02875977|585930140|FG001|Overall Study|Lost to Follow-up|29|||
161894416|NCT00313586|584660957|FG003|Overall Study|Death before starting treatment|0|||
161894417|NCT03519919|584660958|FG000|Overall Study|Withdrawal by Subject|1|||
162239788|NCT01079741|585930141|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
162239789|NCT01079741|585930142|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
162239790|NCT01079741|585930143|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
162239791|NCT01079741|585930144|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
162239792|NCT01079741|585930145|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
162239793|NCT01079741|585930141|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
162239794|NCT01079741|585930142|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
162239795|NCT01079741|585930143|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
162239796|NCT01079741|585930144|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
162239797|NCT01079741|585930145|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
162239798|NCT00446992|585930146|FG000|Overall Study|Adverse Event|11|||
162239799|NCT00446992|585930146|FG000|Overall Study|Lost to Follow-up|5|||
162239800|NCT00406653|585930147|FG000|Induction Period|Adverse Event|1|||
162239801|NCT00406653|585930148|FG001|Induction Period|Adverse Event|10|||
162239802|NCT00406653|585930149|FG002|Induction Period|Adverse Event|4|||
162239803|NCT00406653|585930150|FG003|Induction Period|Adverse Event|11|||
162239804|NCT00406653|585930151|FG004|Induction Period|Adverse Event|0|||
162239805|NCT00406653|585930152|FG005|Induction Period|Adverse Event|0|||
162239806|NCT00406653|585930153|FG006|Induction Period|Adverse Event|0|||
162239807|NCT00406653|585930147|FG000|Induction Period|Lack of Efficacy|11|||
162239808|NCT00406653|585930148|FG001|Induction Period|Lack of Efficacy|14|||
162239809|NCT00406653|585930149|FG002|Induction Period|Lack of Efficacy|8|||
162239810|NCT00406653|585930150|FG003|Induction Period|Lack of Efficacy|10|||
162239811|NCT00406653|585930151|FG004|Induction Period|Lack of Efficacy|0|||
162239812|NCT00406653|585930152|FG005|Induction Period|Lack of Efficacy|0|||
162239813|NCT00406653|585930153|FG006|Induction Period|Lack of Efficacy|0|||
162239814|NCT00406653|585930147|FG000|Induction Period|Lost to Follow-up|0|||
162239815|NCT00406653|585930148|FG001|Induction Period|Lost to Follow-up|2|||
162239816|NCT00406653|585930149|FG002|Induction Period|Lost to Follow-up|0|||
162239817|NCT00406653|585930150|FG003|Induction Period|Lost to Follow-up|0|||
162239818|NCT00406653|585930151|FG004|Induction Period|Lost to Follow-up|0|||
162239819|NCT00406653|585930152|FG005|Induction Period|Lost to Follow-up|0|||
162239820|NCT00406653|585930153|FG006|Induction Period|Lost to Follow-up|0|||
162239821|NCT00406653|585930147|FG000|Induction Period|Withdrawal of Consent|2|||
162239822|NCT00406653|585930148|FG001|Induction Period|Withdrawal of Consent|5|||
162239823|NCT00406653|585930149|FG002|Induction Period|Withdrawal of Consent|1|||
162239824|NCT00406653|585930150|FG003|Induction Period|Withdrawal of Consent|2|||
161894418|NCT03519919|584660958|FG000|Overall Study|Lack of Efficacy|1|||
162239825|NCT00406653|585930151|FG004|Induction Period|Withdrawal of Consent|0|||
161894419|NCT03519919|584660958|FG000|Overall Study|Screen Failure|1|||
161894420|NCT03076996|584660959|FG000|Overall Study|Withdrawal by Subject|2|||
161894421|NCT03076996|584660959|FG000|Overall Study|Lost to Follow-up|3|||
161894422|NCT03076996|584660959|FG000|Overall Study|Literacy precluded participation|1|||
161894423|NCT02144077|584660960|FG000|Overall Study|Withdrawal by Subject|3|||
161894424|NCT02144077|584660961|FG001|Overall Study|Withdrawal by Subject|3|||
161894425|NCT02144077|584660960|FG000|Overall Study|Adverse Event|2|||
161894426|NCT02144077|584660961|FG001|Overall Study|Adverse Event|3|||
162239826|NCT00406653|585930152|FG005|Induction Period|Withdrawal of Consent|0|||
162239827|NCT00406653|585930153|FG006|Induction Period|Withdrawal of Consent|0|||
162239828|NCT00406653|585930147|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
162239829|NCT00406653|585930148|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
162239830|NCT00406653|585930149|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
162239831|NCT00406653|585930150|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
162239832|NCT00406653|585930151|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
162239833|NCT00406653|585930152|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
162239834|NCT00406653|585930153|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
162239835|NCT00406653|585930147|FG000|Induction Period|Pregnancy|1|||
162239836|NCT00406653|585930148|FG001|Induction Period|Pregnancy|0|||
162239837|NCT00406653|585930149|FG002|Induction Period|Pregnancy|0|||
162239838|NCT00406653|585930150|FG003|Induction Period|Pregnancy|0|||
162239839|NCT00406653|585930151|FG004|Induction Period|Pregnancy|0|||
162239840|NCT00406653|585930152|FG005|Induction Period|Pregnancy|0|||
162239841|NCT00406653|585930153|FG006|Induction Period|Pregnancy|0|||
162239842|NCT00406653|585930147|FG000|Induction Period|Declined participation but followup done|0|||
162239843|NCT00406653|585930148|FG001|Induction Period|Declined participation but followup done|2|||
161894427|NCT02144077|584660960|FG000|Overall Study|Lost to Follow-up|2|||
161894428|NCT02144077|584660961|FG001|Overall Study|Lost to Follow-up|2|||
161894429|NCT02144077|584660960|FG000|Overall Study|Protocol Violation|1|||
161894430|NCT02144077|584660961|FG001|Overall Study|Protocol Violation|2|||
161894431|NCT02144077|584660960|FG000|Overall Study|Death|0|||
161894432|NCT02144077|584660961|FG001|Overall Study|Death|1|||
161894433|NCT02144077|584660960|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
161894434|NCT02144077|584660961|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
161894435|NCT00943592|584660962|FG000|Overall Study|Death|3|||
161894436|NCT01909973|584660963|FG000|Overall Study|Lost to Follow-up|1|||
161894437|NCT01909973|584660964|FG001|Overall Study|Lost to Follow-up|0|||
161894438|NCT02438280|584660969|FG000|Overall Study|Physician Decision|1|||
161894439|NCT02438280|584660970|FG001|Overall Study|Physician Decision|0|||
161894440|NCT02982863|584660971|FG000|Overall Study|Not eligible patients|809|||
161894441|NCT02982863|584660972|FG001|Overall Study|Not eligible patients|4261|||
161894442|NCT02982863|584660973|FG002|Overall Study|Not eligible patients|1852|||
161894443|NCT02982863|584660974|FG003|Overall Study|Not eligible patients|1400|||
162239844|NCT00406653|585930149|FG002|Induction Period|Declined participation but followup done|1|||
161894444|NCT02982863|584660975|FG004|Overall Study|Not eligible patients|492|||
161894445|NCT03739710|584660976|FG000|Overall Study|Screen Failed|81|||
161894446|NCT04313400|584660980|FG000|Overall Study|Withdrawal by Subject|0|||
161894447|NCT04313400|584660981|FG001|Overall Study|Withdrawal by Subject|0|||
161894448|NCT04313400|584660982|FG002|Overall Study|Withdrawal by Subject|0|||
161894449|NCT04313400|584660983|FG003|Overall Study|Withdrawal by Subject|0|||
161894450|NCT04313400|584660984|FG004|Overall Study|Withdrawal by Subject|0|||
161894451|NCT04313400|584660985|FG005|Overall Study|Withdrawal by Subject|4|||
161894452|NCT04313400|584660986|FG006|Overall Study|Withdrawal by Subject|1|||
162239845|NCT00406653|585930150|FG003|Induction Period|Declined participation but followup done|1|||
162239846|NCT00406653|585930151|FG004|Induction Period|Declined participation but followup done|0|||
162239847|NCT00406653|585930152|FG005|Induction Period|Declined participation but followup done|0|||
162239848|NCT00406653|585930153|FG006|Induction Period|Declined participation but followup done|0|||
162239849|NCT00406653|585930147|FG000|Induction Period|Given prohibited drug|0|||
162239850|NCT00406653|585930148|FG001|Induction Period|Given prohibited drug|1|||
162239851|NCT00406653|585930149|FG002|Induction Period|Given prohibited drug|2|||
162239852|NCT00406653|585930150|FG003|Induction Period|Given prohibited drug|0|||
162239853|NCT00406653|585930151|FG004|Induction Period|Given prohibited drug|0|||
162239854|NCT00406653|585930152|FG005|Induction Period|Given prohibited drug|0|||
161894453|NCT04313400|584660980|FG000|Overall Study|Adverse Event|0|||
161894454|NCT04313400|584660981|FG001|Overall Study|Adverse Event|0|||
161894455|NCT04313400|584660982|FG002|Overall Study|Adverse Event|0|||
161894456|NCT04313400|584660983|FG003|Overall Study|Adverse Event|0|||
161894457|NCT04313400|584660984|FG004|Overall Study|Adverse Event|0|||
162239855|NCT00406653|585930153|FG006|Induction Period|Given prohibited drug|0|||
162239856|NCT00406653|585930147|FG000|Induction Period|Incarcerated|0|||
162239857|NCT00406653|585930148|FG001|Induction Period|Incarcerated|0|||
162239858|NCT00406653|585930149|FG002|Induction Period|Incarcerated|1|||
161894458|NCT04313400|584660985|FG005|Overall Study|Adverse Event|1|||
161894459|NCT04313400|584660986|FG006|Overall Study|Adverse Event|0|||
162239859|NCT00406653|585930150|FG003|Induction Period|Incarcerated|0|||
162239860|NCT00406653|585930151|FG004|Induction Period|Incarcerated|0|||
162239861|NCT00406653|585930152|FG005|Induction Period|Incarcerated|0|||
162239862|NCT00406653|585930153|FG006|Induction Period|Incarcerated|0|||
162239863|NCT00406653|585930147|FG000|Induction Period|Patient relocated|0|||
162239864|NCT00406653|585930148|FG001|Induction Period|Patient relocated|0|||
162239865|NCT00406653|585930149|FG002|Induction Period|Patient relocated|1|||
162239866|NCT00406653|585930150|FG003|Induction Period|Patient relocated|0|||
162239867|NCT00406653|585930151|FG004|Induction Period|Patient relocated|0|||
162239868|NCT00406653|585930152|FG005|Induction Period|Patient relocated|0|||
162239869|NCT00406653|585930153|FG006|Induction Period|Patient relocated|0|||
162239870|NCT00406653|585930147|FG000|Maintenance Period|Adverse Event|0|||
162239871|NCT00406653|585930148|FG001|Maintenance Period|Adverse Event|0|||
162239872|NCT00406653|585930149|FG002|Maintenance Period|Adverse Event|0|||
162239873|NCT00406653|585930150|FG003|Maintenance Period|Adverse Event|0|||
162239874|NCT00406653|585930151|FG004|Maintenance Period|Adverse Event|1|||
162239875|NCT00406653|585930152|FG005|Maintenance Period|Adverse Event|1|||
162239876|NCT00406653|585930153|FG006|Maintenance Period|Adverse Event|0|||
162239877|NCT00406653|585930147|FG000|Maintenance Period|Lack of Efficacy|0|||
162239878|NCT00406653|585930148|FG001|Maintenance Period|Lack of Efficacy|0|||
162239879|NCT00406653|585930149|FG002|Maintenance Period|Lack of Efficacy|0|||
162239880|NCT00406653|585930150|FG003|Maintenance Period|Lack of Efficacy|0|||
162239881|NCT00406653|585930151|FG004|Maintenance Period|Lack of Efficacy|20|||
162239882|NCT00406653|585930152|FG005|Maintenance Period|Lack of Efficacy|26|||
162239883|NCT00406653|585930153|FG006|Maintenance Period|Lack of Efficacy|0|||
162239884|NCT00406653|585930147|FG000|Maintenance Period|Lost to Follow-up|0|||
162239885|NCT00406653|585930148|FG001|Maintenance Period|Lost to Follow-up|0|||
162239886|NCT00406653|585930149|FG002|Maintenance Period|Lost to Follow-up|0|||
162239887|NCT00406653|585930150|FG003|Maintenance Period|Lost to Follow-up|0|||
162239888|NCT00406653|585930151|FG004|Maintenance Period|Lost to Follow-up|2|||
162239889|NCT00406653|585930152|FG005|Maintenance Period|Lost to Follow-up|1|||
162239890|NCT00406653|585930153|FG006|Maintenance Period|Lost to Follow-up|0|||
162239891|NCT00406653|585930147|FG000|Maintenance Period|Withdrawal of Consent|0|||
162239892|NCT00406653|585930148|FG001|Maintenance Period|Withdrawal of Consent|0|||
162239893|NCT00406653|585930149|FG002|Maintenance Period|Withdrawal of Consent|0|||
162239894|NCT00406653|585930150|FG003|Maintenance Period|Withdrawal of Consent|0|||
162239895|NCT00406653|585930151|FG004|Maintenance Period|Withdrawal of Consent|2|||
162239896|NCT00406653|585930152|FG005|Maintenance Period|Withdrawal of Consent|0|||
162239897|NCT00406653|585930153|FG006|Maintenance Period|Withdrawal of Consent|0|||
162239898|NCT00406653|585930147|FG000|Maintenance Period|Pregnancy|0|||
162239899|NCT00406653|585930148|FG001|Maintenance Period|Pregnancy|0|||
162239900|NCT00406653|585930149|FG002|Maintenance Period|Pregnancy|0|||
162239901|NCT00406653|585930150|FG003|Maintenance Period|Pregnancy|0|||
162239902|NCT00406653|585930151|FG004|Maintenance Period|Pregnancy|0|||
162239903|NCT00406653|585930152|FG005|Maintenance Period|Pregnancy|1|||
162239904|NCT00406653|585930153|FG006|Maintenance Period|Pregnancy|0|||
162239905|NCT00406653|585930147|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
162239906|NCT00406653|585930148|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
162239907|NCT00406653|585930149|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
162239908|NCT00406653|585930150|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
162239909|NCT00406653|585930151|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
162239910|NCT00406653|585930152|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
162239911|NCT00406653|585930153|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
162239912|NCT00406653|585930147|FG000|Maintenance Period|Error in disease score evaluation|0|||
162239913|NCT00406653|585930148|FG001|Maintenance Period|Error in disease score evaluation|0|||
162239914|NCT00406653|585930149|FG002|Maintenance Period|Error in disease score evaluation|0|||
162239915|NCT00406653|585930150|FG003|Maintenance Period|Error in disease score evaluation|0|||
162239916|NCT00406653|585930151|FG004|Maintenance Period|Error in disease score evaluation|1|||
162239917|NCT00406653|585930152|FG005|Maintenance Period|Error in disease score evaluation|0|||
162239918|NCT00406653|585930153|FG006|Maintenance Period|Error in disease score evaluation|0|||
162239919|NCT00406653|585930147|FG000|Open-Label Period|Death|0|||
161894460|NCT04313400|584660980|FG000|Overall Study|Lost to Follow-up|0|||
161894461|NCT04313400|584660981|FG001|Overall Study|Lost to Follow-up|0|||
162239920|NCT00406653|585930148|FG001|Open-Label Period|Death|0|||
162239921|NCT00406653|585930149|FG002|Open-Label Period|Death|0|||
162239922|NCT00406653|585930150|FG003|Open-Label Period|Death|0|||
162239923|NCT00406653|585930151|FG004|Open-Label Period|Death|0|||
162239924|NCT00406653|585930152|FG005|Open-Label Period|Death|0|||
162239925|NCT00406653|585930153|FG006|Open-Label Period|Death|1|||
162239926|NCT00406653|585930147|FG000|Open-Label Period|Adverse Event|0|||
162239927|NCT00406653|585930148|FG001|Open-Label Period|Adverse Event|0|||
162239928|NCT00406653|585930149|FG002|Open-Label Period|Adverse Event|0|||
162239929|NCT00406653|585930150|FG003|Open-Label Period|Adverse Event|0|||
162239930|NCT00406653|585930151|FG004|Open-Label Period|Adverse Event|0|||
162239931|NCT00406653|585930152|FG005|Open-Label Period|Adverse Event|0|||
162239932|NCT00406653|585930153|FG006|Open-Label Period|Adverse Event|18|||
162239933|NCT00406653|585930147|FG000|Open-Label Period|Lack of Efficacy|0|||
162239934|NCT00406653|585930148|FG001|Open-Label Period|Lack of Efficacy|0|||
162239935|NCT00406653|585930149|FG002|Open-Label Period|Lack of Efficacy|0|||
162239936|NCT00406653|585930150|FG003|Open-Label Period|Lack of Efficacy|0|||
162239937|NCT00406653|585930151|FG004|Open-Label Period|Lack of Efficacy|0|||
162239938|NCT00406653|585930152|FG005|Open-Label Period|Lack of Efficacy|0|||
162239939|NCT00406653|585930153|FG006|Open-Label Period|Lack of Efficacy|160|||
162239940|NCT00406653|585930147|FG000|Open-Label Period|Lost to Follow-up|0|||
162239941|NCT00406653|585930148|FG001|Open-Label Period|Lost to Follow-up|0|||
162239942|NCT00406653|585930149|FG002|Open-Label Period|Lost to Follow-up|0|||
162239943|NCT00406653|585930150|FG003|Open-Label Period|Lost to Follow-up|0|||
162239944|NCT00406653|585930151|FG004|Open-Label Period|Lost to Follow-up|0|||
162239945|NCT00406653|585930152|FG005|Open-Label Period|Lost to Follow-up|0|||
162239946|NCT00406653|585930153|FG006|Open-Label Period|Lost to Follow-up|6|||
162239947|NCT00406653|585930147|FG000|Open-Label Period|Withdrawal of Consent|0|||
162239948|NCT00406653|585930148|FG001|Open-Label Period|Withdrawal of Consent|0|||
162239949|NCT00406653|585930149|FG002|Open-Label Period|Withdrawal of Consent|0|||
161894462|NCT04313400|584660982|FG002|Overall Study|Lost to Follow-up|0|||
161894463|NCT04313400|584660983|FG003|Overall Study|Lost to Follow-up|0|||
161894464|NCT04313400|584660984|FG004|Overall Study|Lost to Follow-up|0|||
161894465|NCT04313400|584660985|FG005|Overall Study|Lost to Follow-up|1|||
161894466|NCT04313400|584660986|FG006|Overall Study|Lost to Follow-up|0|||
161894467|NCT02091414|584660987|FG000|Overall Study|Withdrawal by Subject|2|||
161894468|NCT02091414|584660987|FG000|Overall Study|Death|2|||
161894469|NCT02521792|584660990|FG000|Overall Study|Study Terminated|6|||
161894470|NCT00902746|584660991|FG000|Overall Study|Protocol Violation|7|||
161894471|NCT00902746|584660991|FG000|Overall Study|Withdrawal by Subject|16|||
161894472|NCT00902746|584660991|FG000|Overall Study|Adverse Event|8|||
161894473|NCT00902746|584660991|FG000|Overall Study|Lost to Follow-up|3|||
161894474|NCT00902746|584660991|FG000|Overall Study|Physician Decision|2|||
161894475|NCT02081001|584660992|FG000|Overall Study|Adverse Event|0|||
161894476|NCT02081001|584660993|FG001|Overall Study|Adverse Event|0|||
161894477|NCT02081001|584660994|FG002|Overall Study|Adverse Event|0|||
161894478|NCT02081001|584660995|FG003|Overall Study|Adverse Event|0|||
161894479|NCT02081001|584660996|FG004|Overall Study|Adverse Event|1|||
161894480|NCT02081001|584660997|FG005|Overall Study|Adverse Event|0|||
161894481|NCT02081001|584660998|FG006|Overall Study|Adverse Event|0|||
161894482|NCT02081001|584660999|FG007|Overall Study|Adverse Event|0|||
161894483|NCT02081001|584661000|FG008|Overall Study|Adverse Event|0|||
161894484|NCT02081001|584661001|FG009|Overall Study|Adverse Event|0|||
161894485|NCT02081001|584661002|FG010|Overall Study|Adverse Event|0|||
161894486|NCT02081001|584661003|FG011|Overall Study|Adverse Event|0|||
161894487|NCT02937636|584661004|FG000|Overall Study|Other (Not specified)|3|||
161894488|NCT02937636|584661005|FG001|Overall Study|Other (Not specified)|2|||
161894489|NCT00359294|584661006|FG000|Overall Study|Progressive disease|1|||
161894490|NCT00359294|584661007|FG001|Overall Study|Progressive disease|1|||
161894491|NCT00359294|584661008|FG002|Overall Study|Progressive disease|2|||
161894492|NCT00359294|584661009|FG003|Overall Study|Progressive disease|3|||
161894493|NCT00359294|584661010|FG004|Overall Study|Progressive disease|2|||
161894494|NCT00359294|584661006|FG000|Overall Study|Withdrawal by Subject|0|||
161894495|NCT00359294|584661007|FG001|Overall Study|Withdrawal by Subject|0|||
161894496|NCT00359294|584661008|FG002|Overall Study|Withdrawal by Subject|0|||
161894497|NCT00359294|584661009|FG003|Overall Study|Withdrawal by Subject|0|||
161894498|NCT00359294|584661010|FG004|Overall Study|Withdrawal by Subject|1|||
161894499|NCT00359294|584661006|FG000|Overall Study|Not treated|0|||
161894500|NCT00359294|584661007|FG001|Overall Study|Not treated|0|||
161894501|NCT00359294|584661008|FG002|Overall Study|Not treated|0|||
161894502|NCT00359294|584661009|FG003|Overall Study|Not treated|1|||
161894503|NCT00359294|584661010|FG004|Overall Study|Not treated|0|||
161894504|NCT00359294|584661006|FG000|Overall Study|Physician Decision|0|||
161894505|NCT00359294|584661007|FG001|Overall Study|Physician Decision|0|||
161894506|NCT00359294|584661008|FG002|Overall Study|Physician Decision|1|||
161894507|NCT00359294|584661009|FG003|Overall Study|Physician Decision|0|||
161894508|NCT00359294|584661010|FG004|Overall Study|Physician Decision|0|||
161894509|NCT04208412|584661011|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
162008661|NCT02234843|585086694|FG001|Overall Study|Non-compliance with study drug|0|||
162239950|NCT00406653|585930150|FG003|Open-Label Period|Withdrawal of Consent|0|||
162239951|NCT00406653|585930151|FG004|Open-Label Period|Withdrawal of Consent|0|||
162239952|NCT00406653|585930152|FG005|Open-Label Period|Withdrawal of Consent|0|||
162239953|NCT00406653|585930153|FG006|Open-Label Period|Withdrawal of Consent|11|||
162239954|NCT00406653|585930147|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
162239955|NCT00406653|585930148|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161894510|NCT04208412|584661012|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
162239956|NCT00406653|585930149|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161894511|NCT04208412|584661011|FG000|Overall Study|Withdrawal by Subject|1|||
161894512|NCT04208412|584661012|FG001|Overall Study|Withdrawal by Subject|0|||
161894513|NCT04208412|584661011|FG000|Overall Study|Lost to Follow-up|0|||
162239957|NCT00406653|585930150|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
162239958|NCT00406653|585930151|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
162239959|NCT00406653|585930152|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
162239960|NCT00406653|585930153|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
162239961|NCT00406653|585930147|FG000|Open-Label Period|Pregnancy|0|||
162239962|NCT00406653|585930148|FG001|Open-Label Period|Pregnancy|0|||
162239963|NCT00406653|585930149|FG002|Open-Label Period|Pregnancy|0|||
162239964|NCT00406653|585930150|FG003|Open-Label Period|Pregnancy|0|||
162239965|NCT00406653|585930151|FG004|Open-Label Period|Pregnancy|0|||
162239966|NCT00406653|585930152|FG005|Open-Label Period|Pregnancy|0|||
161894514|NCT04208412|584661012|FG001|Overall Study|Lost to Follow-up|1|||
161894515|NCT03148067|584661014|FG000|Overall Study|Lost to Follow-up|3|||
161894516|NCT03148067|584661014|FG000|Overall Study|Death|1|||
161894517|NCT00435188|584661016|FG000|Overall Study|Death|1|||
161894518|NCT00435188|584661017|FG001|Overall Study|Death|6|||
161894519|NCT00435188|584661016|FG000|Overall Study|Withdrawal by Subject|16|||
161894520|NCT00435188|584661017|FG001|Overall Study|Withdrawal by Subject|11|||
161894521|NCT00435188|584661016|FG000|Overall Study|Lost to Follow-up|5|||
161894522|NCT00435188|584661017|FG001|Overall Study|Lost to Follow-up|6|||
161894523|NCT02912455|584661018|FG000|Overall Study|Withdrawal by Subject|0|||
161894524|NCT02912455|584661019|FG001|Overall Study|Withdrawal by Subject|1|||
161894525|NCT02912455|584661018|FG000|Overall Study|Lack of Efficacy|0|||
161894526|NCT02912455|584661019|FG001|Overall Study|Lack of Efficacy|1|||
161894527|NCT02912455|584661018|FG000|Overall Study|Lost to Follow-up|2|||
161894528|NCT02912455|584661019|FG001|Overall Study|Lost to Follow-up|1|||
161894529|NCT00073008|584661020|FG000|Overall Study|Missing|6|||
161894530|NCT00073008|584661021|FG001|Overall Study|Missing|6|||
161894531|NCT00073008|584661020|FG000|Overall Study|Withdrawal by Subject|2|||
161894532|NCT00073008|584661021|FG001|Overall Study|Withdrawal by Subject|2|||
161894533|NCT00073008|584661020|FG000|Overall Study|Lost to Follow-up|1|||
161894534|NCT00073008|584661021|FG001|Overall Study|Lost to Follow-up|3|||
161894535|NCT00073008|584661020|FG000|Overall Study|Death|46|||
161894536|NCT00073008|584661021|FG001|Overall Study|Death|47|||
161894537|NCT00073008|584661020|FG000|Overall Study|"Other selected on Case Report Form"|7|||
161894538|NCT00073008|584661021|FG001|Overall Study|"Other selected on Case Report Form"|5|||
161894539|NCT01778751|584661031|FG000|Overall Study|Lost to Follow-up|1|||
161894540|NCT01778751|584661032|FG001|Overall Study|Lost to Follow-up|0|||
161894541|NCT01778751|584661031|FG000|Overall Study|Withdrawal by Subject|0|||
161894542|NCT01778751|584661032|FG001|Overall Study|Withdrawal by Subject|2|||
161894543|NCT01778751|584661031|FG000|Overall Study|Transfered care|1|||
161894544|NCT01778751|584661032|FG001|Overall Study|Transfered care|0|||
161894545|NCT03337048|584661033|FG000|Overall Study|Withdrawal by Subject|2|||
161894546|NCT03337048|584661034|FG001|Overall Study|Withdrawal by Subject|0|||
161894547|NCT03337048|584661035|FG002|Overall Study|Withdrawal by Subject|0|||
161894548|NCT02669667|584661036|FG000|Overall Study|Lost to Follow-up|0|||
161894549|NCT02669667|584661037|FG001|Overall Study|Lost to Follow-up|0|||
161894550|NCT02669667|584661038|FG002|Overall Study|Lost to Follow-up|0|||
161894551|NCT02669667|584661039|FG003|Overall Study|Lost to Follow-up|0|||
161894552|NCT02669667|584661040|FG004|Overall Study|Lost to Follow-up|0|||
161894553|NCT02669667|584661041|FG005|Overall Study|Lost to Follow-up|1|||
161894554|NCT02669667|584661042|FG006|Overall Study|Lost to Follow-up|0|||
161894555|NCT00636961|584661056|FG000|Period 1|Administrative problems|1|||
161894556|NCT00636961|584661057|FG001|Period 1|Administrative problems|1|||
161894557|NCT00636961|584661056|FG000|Period 2|Adverse Event|1|||
162008662|NCT02234843|585086695|FG002|Overall Study|Non-compliance with study drug|0|||
162008663|NCT02234843|585086696|FG003|Overall Study|Non-compliance with study drug|0|||
162008664|NCT02234843|585086697|FG004|Overall Study|Non-compliance with study drug|0|||
162008665|NCT02234843|585086698|FG005|Overall Study|Non-compliance with study drug|1|||
162008666|NCT02234843|585086699|FG006|Overall Study|Non-compliance with study drug|1|||
162008667|NCT02234843|585086700|FG007|Overall Study|Non-compliance with study drug|0|||
162008668|NCT02234843|585086701|FG008|Overall Study|Non-compliance with study drug|0|||
162008669|NCT02234843|585086702|FG009|Overall Study|Non-compliance with study drug|0|||
162008670|NCT02234843|585086693|FG000|Overall Study|Lost to Follow-up|0|||
162008671|NCT02234843|585086694|FG001|Overall Study|Lost to Follow-up|1|||
162008672|NCT02234843|585086695|FG002|Overall Study|Lost to Follow-up|0|||
162008673|NCT02234843|585086696|FG003|Overall Study|Lost to Follow-up|0|||
162008674|NCT02234843|585086697|FG004|Overall Study|Lost to Follow-up|0|||
162008675|NCT02234843|585086698|FG005|Overall Study|Lost to Follow-up|0|||
162008676|NCT02234843|585086699|FG006|Overall Study|Lost to Follow-up|1|||
162008677|NCT02234843|585086700|FG007|Overall Study|Lost to Follow-up|0|||
162008678|NCT02234843|585086701|FG008|Overall Study|Lost to Follow-up|0|||
162008679|NCT02234843|585086702|FG009|Overall Study|Lost to Follow-up|0|||
162008680|NCT04272242|585086709|FG000|Overall Study|Withdrawal by Subject|3|||
162239967|NCT00406653|585930153|FG006|Open-Label Period|Pregnancy|2|||
162008681|NCT04272242|585086709|FG000|Overall Study|Lost to Follow-up|1|||
162008682|NCT04272242|585086709|FG000|Overall Study|Adverse Event|1|||
161894558|NCT00636961|584661057|FG001|Period 2|Adverse Event|0|||
161894559|NCT01428115|584661061|FG000|Overall Study|Lack of Efficacy|3|||
161894560|NCT01428115|584661061|FG000|Overall Study|Lost to Follow-up|10|||
161894561|NCT01428115|584661061|FG000|Overall Study|Pregnancy|1|||
161894562|NCT01428115|584661061|FG000|Overall Study|Protocol Violation|3|||
161894563|NCT01428115|584661061|FG000|Overall Study|Withdrawal by Subject|4|||
161894564|NCT03755518|584661062|FG000|Overall Study|Lack of Efficacy|10|||
161894565|NCT03755518|584661062|FG000|Overall Study|Adverse Event|7|||
161894566|NCT03755518|584661062|FG000|Overall Study|Study Terminated by Sponsor|5|||
161894567|NCT03755518|584661062|FG000|Overall Study|Death|1|||
161894568|NCT03755518|584661062|FG000|Overall Study|Withdrawal by Subject|3|||
161894569|NCT03755518|584661062|FG000|Overall Study|Progressive Disease|4|||
161894570|NCT03755518|584661062|FG000|Overall Study|Bone Marrow Transplant|4|||
161894571|NCT03755518|584661062|FG000|Overall Study|Physicians Decision|1|||
161894572|NCT03755518|584661062|FG000|Overall Study|Relapse|1|||
161894573|NCT03755518|584661062|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
161894574|NCT03755518|584661062|FG000|Overall Study|Withdrawal by PI|1|||
161894575|NCT01714609|584661063|FG000|Overall Study|Protocol Violation|1|||
161894576|NCT01714609|584661064|FG001|Overall Study|Protocol Violation|0|||
161894577|NCT03403621|584661065|FG000|Overall Study|Withdrawal by Subject|2|||
161894578|NCT03403621|584661066|FG001|Overall Study|Withdrawal by Subject|2|||
161894579|NCT00395642|584661068|FG000|Overall Study|Death|4|||
161894580|NCT00395642|584661068|FG000|Overall Study|Lost to Follow-up|1|||
161894581|NCT00395642|584661068|FG000|Overall Study|Physician Decision|7|||
161894582|NCT00395642|584661068|FG000|Overall Study|Withdrawal by Subject|1|||
161894583|NCT02749799|584661072|FG000|Overall Study|Adverse Event|2|||
161894584|NCT02749799|584661072|FG000|Overall Study|Lost to Follow-up|4|||
161894585|NCT02749799|584661072|FG000|Overall Study|Protocol Violation|1|||
161894586|NCT02749799|584661072|FG000|Overall Study|Withdrawal by Subject|1|||
161894587|NCT02070978|584661073|FG000|Overall Study|Adverse Event|6|||
161894588|NCT02070978|584661074|FG001|Overall Study|Adverse Event|2|||
161894589|NCT02070978|584661075|FG002|Overall Study|Adverse Event|0|||
161894590|NCT02070978|584661073|FG000|Overall Study|Lost to Follow-up|1|||
161894591|NCT02070978|584661074|FG001|Overall Study|Lost to Follow-up|3|||
161894592|NCT02070978|584661075|FG002|Overall Study|Lost to Follow-up|4|||
161894593|NCT02070978|584661073|FG000|Overall Study|Withdrawal by Subject|3|||
161894594|NCT02070978|584661074|FG001|Overall Study|Withdrawal by Subject|5|||
161894595|NCT02070978|584661075|FG002|Overall Study|Withdrawal by Subject|3|||
161894596|NCT02070978|584661073|FG000|Overall Study|Protocol Violation|1|||
161894597|NCT02070978|584661074|FG001|Overall Study|Protocol Violation|0|||
161894598|NCT02070978|584661075|FG002|Overall Study|Protocol Violation|3|||
161894599|NCT02070978|584661073|FG000|Overall Study|Lack of Efficacy|0|||
161894600|NCT02070978|584661074|FG001|Overall Study|Lack of Efficacy|1|||
161894601|NCT02070978|584661075|FG002|Overall Study|Lack of Efficacy|0|||
161894602|NCT02070978|584661073|FG000|Overall Study|Death|0|||
161894603|NCT02070978|584661074|FG001|Overall Study|Death|0|||
161894604|NCT02070978|584661075|FG002|Overall Study|Death|2|||
161894605|NCT02070978|584661073|FG000|Overall Study|Un-specified|3|||
161894606|NCT02070978|584661074|FG001|Overall Study|Un-specified|2|||
161894607|NCT02070978|584661075|FG002|Overall Study|Un-specified|2|||
161894608|NCT02070978|584661073|FG000|Overall Study|Terminated by Sponsor|33|||
161894609|NCT02070978|584661074|FG001|Overall Study|Terminated by Sponsor|40|||
161894610|NCT02070978|584661075|FG002|Overall Study|Terminated by Sponsor|39|||
161894611|NCT03951753|584661076|FG000|Overall Study|Adverse Event|1|||
161894612|NCT03951753|584661077|FG001|Overall Study|Adverse Event|0|||
161894613|NCT03951753|584661078|FG002|Overall Study|Adverse Event|3|||
162239968|NCT00406653|585930147|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
162239969|NCT00406653|585930148|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
162239970|NCT00406653|585930149|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
162239971|NCT00406653|585930150|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
162239972|NCT00406653|585930151|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
162239973|NCT00406653|585930152|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
162239974|NCT00406653|585930153|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
162239975|NCT00406653|585930147|FG000|Open-Label Period|Declined participation but followup done|0|||
162239976|NCT00406653|585930148|FG001|Open-Label Period|Declined participation but followup done|0|||
162239977|NCT00406653|585930149|FG002|Open-Label Period|Declined participation but followup done|0|||
161894614|NCT03951753|584661076|FG000|Overall Study|Withdrawal by Subject|3|||
161894615|NCT03951753|584661077|FG001|Overall Study|Withdrawal by Subject|1|||
161894616|NCT03951753|584661078|FG002|Overall Study|Withdrawal by Subject|0|||
161894617|NCT03951753|584661076|FG000|Overall Study|Lost to Follow-up|0|||
161894618|NCT03951753|584661077|FG001|Overall Study|Lost to Follow-up|0|||
161894619|NCT03951753|584661078|FG002|Overall Study|Lost to Follow-up|1|||
161894620|NCT01905592|584661081|FG000|Overall Study|Disease Progression|51|||
161894621|NCT01905592|584661082|FG001|Overall Study|Disease Progression|110|||
161894622|NCT01905592|584661081|FG000|Overall Study|Toxicity|1|||
161894623|NCT01905592|584661082|FG001|Overall Study|Toxicity|16|||
161894624|NCT01905592|584661081|FG000|Overall Study|Physician Decision|0|||
161894625|NCT01905592|584661082|FG001|Overall Study|Physician Decision|2|||
161894626|NCT01905592|584661081|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
162239978|NCT00406653|585930150|FG003|Open-Label Period|Declined participation but followup done|0|||
162239979|NCT00406653|585930151|FG004|Open-Label Period|Declined participation but followup done|0|||
162239980|NCT00406653|585930152|FG005|Open-Label Period|Declined participation but followup done|0|||
162239981|NCT00406653|585930153|FG006|Open-Label Period|Declined participation but followup done|8|||
161894627|NCT01905592|584661082|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
161894628|NCT01905592|584661081|FG000|Overall Study|Protocol Violation|0|||
161894629|NCT01905592|584661082|FG001|Overall Study|Protocol Violation|1|||
161894630|NCT01905592|584661081|FG000|Overall Study|Sponsor's decision|1|||
161894631|NCT01905592|584661082|FG001|Overall Study|Sponsor's decision|1|||
161894632|NCT01905592|584661081|FG000|Overall Study|Not treated|7|||
161894633|NCT01905592|584661082|FG001|Overall Study|Not treated|3|||
161894634|NCT01905592|584661081|FG000|Overall Study|Withdrawal by Subject|10|||
161894635|NCT01905592|584661082|FG001|Overall Study|Withdrawal by Subject|2|||
161894636|NCT02669043|584661083|FG000|Overall Study|Didn't meet I/E criteria|4|||
161894637|NCT01483599|584661085|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
161894638|NCT01483599|584661086|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894639|NCT01483599|584661087|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894640|NCT01483599|584661088|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
161894641|NCT01483599|584661089|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
161894642|NCT01483599|584661090|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
161894643|NCT01483599|584661091|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
161894644|NCT01483599|584661092|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894645|NCT01483599|584661093|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894646|NCT01483599|584661094|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894647|NCT01483599|584661095|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894648|NCT01483599|584661096|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894649|NCT01483599|584661097|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894650|NCT01483599|584661098|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161894651|NCT01483599|584661085|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894652|NCT01483599|584661086|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
161894653|NCT01483599|584661087|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894654|NCT01483599|584661088|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
161894655|NCT01483599|584661089|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894656|NCT01483599|584661090|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894657|NCT01483599|584661091|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
161894658|NCT01483599|584661092|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894659|NCT01483599|584661093|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894660|NCT01483599|584661094|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894661|NCT01483599|584661095|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894662|NCT01483599|584661096|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894663|NCT01483599|584661097|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894664|NCT01483599|584661098|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161894665|NCT01483599|584661085|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
161894666|NCT01483599|584661086|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894667|NCT01483599|584661087|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894668|NCT01483599|584661088|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894669|NCT01483599|584661089|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
162008683|NCT03204188|585086713|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
162239982|NCT00406653|585930147|FG000|Open-Label Period|Discontinued by Sponsor|0|||
162239983|NCT00406653|585930148|FG001|Open-Label Period|Discontinued by Sponsor|0|||
162239984|NCT00406653|585930149|FG002|Open-Label Period|Discontinued by Sponsor|0|||
162239985|NCT00406653|585930150|FG003|Open-Label Period|Discontinued by Sponsor|0|||
162239986|NCT00406653|585930151|FG004|Open-Label Period|Discontinued by Sponsor|0|||
162239987|NCT00406653|585930152|FG005|Open-Label Period|Discontinued by Sponsor|0|||
162239988|NCT00406653|585930153|FG006|Open-Label Period|Discontinued by Sponsor|1|||
162239989|NCT00406653|585930147|FG000|Open-Label Period|Refused followup|0|||
162239990|NCT00406653|585930148|FG001|Open-Label Period|Refused followup|0|||
162239991|NCT00406653|585930149|FG002|Open-Label Period|Refused followup|0|||
162239992|NCT00406653|585930150|FG003|Open-Label Period|Refused followup|0|||
162239993|NCT00406653|585930151|FG004|Open-Label Period|Refused followup|0|||
162239994|NCT00406653|585930152|FG005|Open-Label Period|Refused followup|0|||
162239995|NCT00406653|585930153|FG006|Open-Label Period|Refused followup|1|||
162239996|NCT00731120|585930154|FG000|Overall Study|Adverse Event|7|||
162239997|NCT00731120|585930155|FG001|Overall Study|Adverse Event|6|||
162239998|NCT00731120|585930156|FG002|Overall Study|Adverse Event|8|||
162239999|NCT00731120|585930154|FG000|Overall Study|Lack of Efficacy|4|||
161894670|NCT01483599|584661090|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894671|NCT01483599|584661091|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894672|NCT01483599|584661092|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
162122853|NCT00358215|585502342|FG000|Overall Study|Pregnancy|1|||
162240000|NCT00731120|585930155|FG001|Overall Study|Lack of Efficacy|5|||
162240001|NCT00731120|585930156|FG002|Overall Study|Lack of Efficacy|4|||
162240002|NCT00731120|585930154|FG000|Overall Study|Noncompliance with Study Drug|3|||
162240003|NCT00731120|585930155|FG001|Overall Study|Noncompliance with Study Drug|3|||
162240004|NCT00731120|585930156|FG002|Overall Study|Noncompliance with Study Drug|1|||
162240005|NCT00731120|585930154|FG000|Overall Study|Protocol Deviations|1|||
162240006|NCT00731120|585930155|FG001|Overall Study|Protocol Deviations|6|||
162240007|NCT00731120|585930156|FG002|Overall Study|Protocol Deviations|1|||
162240008|NCT00731120|585930154|FG000|Overall Study|Withdrawal of Consent|13|||
162240009|NCT00731120|585930155|FG001|Overall Study|Withdrawal of Consent|8|||
162240010|NCT00731120|585930156|FG002|Overall Study|Withdrawal of Consent|4|||
162240011|NCT00731120|585930154|FG000|Overall Study|Lost to Follow-up|10|||
162240012|NCT00731120|585930155|FG001|Overall Study|Lost to Follow-up|15|||
162240013|NCT00731120|585930156|FG002|Overall Study|Lost to Follow-up|17|||
162240014|NCT00731120|585930154|FG000|Overall Study|Other|4|||
162240015|NCT00731120|585930155|FG001|Overall Study|Other|0|||
161894673|NCT01483599|584661093|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894674|NCT01483599|584661094|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894675|NCT01483599|584661095|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894676|NCT01483599|584661096|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894677|NCT01483599|584661097|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894678|NCT01483599|584661098|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161894679|NCT01483599|584661085|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
161894680|NCT01483599|584661086|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
161894681|NCT01483599|584661087|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
161894682|NCT01483599|584661088|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
161894683|NCT01483599|584661089|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
161894684|NCT01483599|584661090|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
161894685|NCT01483599|584661091|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
161894686|NCT01483599|584661092|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
161894687|NCT01483599|584661093|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
161894688|NCT01483599|584661094|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
161894689|NCT01483599|584661095|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
161894690|NCT01483599|584661096|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
161894691|NCT01483599|584661097|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
161894692|NCT01483599|584661098|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
161894693|NCT01483599|584661085|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
161894694|NCT01483599|584661086|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
161894695|NCT01483599|584661087|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
161894696|NCT01483599|584661088|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
161894697|NCT01483599|584661089|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
161894698|NCT01483599|584661090|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
161894699|NCT01483599|584661091|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
161894700|NCT01483599|584661092|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
161894701|NCT01483599|584661093|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
161894702|NCT01483599|584661094|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
161894703|NCT01483599|584661095|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
161894704|NCT01483599|584661096|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
161894705|NCT01483599|584661097|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
161894706|NCT01483599|584661098|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
161894707|NCT01483599|584661085|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894708|NCT01483599|584661086|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894709|NCT01483599|584661087|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894710|NCT01483599|584661088|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894711|NCT01483599|584661089|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894712|NCT01483599|584661090|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894713|NCT01483599|584661091|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894714|NCT01483599|584661092|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
161894715|NCT01483599|584661093|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
161894716|NCT01483599|584661094|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894717|NCT01483599|584661095|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161894718|NCT01483599|584661096|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
162240016|NCT00731120|585930156|FG002|Overall Study|Other|1|||
162240017|NCT02434939|585930159|FG000|Overall Study|Lack of Efficacy|34|||
161894719|NCT01483599|584661097|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
161894720|NCT01483599|584661098|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
162008684|NCT03204188|585086713|FG000|Immunotherapy Phase (1 Year)|Death|1|||
162122854|NCT00358215|585502343|FG001|Overall Study|Pregnancy|0|||
162240018|NCT02434939|585930160|FG001|Overall Study|Lack of Efficacy|48|||
162240019|NCT02434939|585930159|FG000|Overall Study|Withdrawal by Subject|3|||
162240020|NCT02434939|585930160|FG001|Overall Study|Withdrawal by Subject|0|||
162240021|NCT02434939|585930159|FG000|Overall Study|Adverse Event|0|||
162240022|NCT02434939|585930160|FG001|Overall Study|Adverse Event|1|||
162240023|NCT01326533|585930162|FG000|Overall Study|Lost to Follow-up|2|||
162240024|NCT01326533|585930163|FG001|Overall Study|Lost to Follow-up|0|||
162240025|NCT01326533|585930162|FG000|Overall Study|Withdrawal by Subject|1|||
162240026|NCT01326533|585930163|FG001|Overall Study|Withdrawal by Subject|0|||
162240027|NCT01326533|585930162|FG000|Overall Study|Adverse Event|1|||
162240028|NCT01326533|585930163|FG001|Overall Study|Adverse Event|0|||
162240029|NCT04079803|585930164|FG000|Overall Study|Withdrawal by Subject|0|||
162240030|NCT04079803|585930165|FG001|Overall Study|Withdrawal by Subject|0|||
162240031|NCT04079803|585930166|FG002|Overall Study|Withdrawal by Subject|1|||
162240032|NCT03353350|585930167|FG000|30-week Core Treatment Period|Protocol Violation|1|||
162240033|NCT03353350|585930168|FG001|30-week Core Treatment Period|Protocol Violation|1|||
162240034|NCT03353350|585930169|FG002|30-week Core Treatment Period|Protocol Violation|1|||
162240035|NCT03353350|585930170|FG003|30-week Core Treatment Period|Protocol Violation|0|||
162240036|NCT03353350|585930167|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
162240037|NCT03353350|585930168|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
162240038|NCT03353350|585930169|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
162240039|NCT03353350|585930170|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
162240040|NCT03353350|585930167|FG000|30-week Core Treatment Period|Adverse Event|0|||
162240041|NCT03353350|585930168|FG001|30-week Core Treatment Period|Adverse Event|4|||
162240042|NCT03353350|585930169|FG002|30-week Core Treatment Period|Adverse Event|2|||
162240043|NCT03353350|585930170|FG003|30-week Core Treatment Period|Adverse Event|3|||
162240044|NCT03353350|585930167|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
162240045|NCT03353350|585930168|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
162240046|NCT03353350|585930169|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
162240047|NCT03353350|585930170|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
162240048|NCT03353350|585930167|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
162240049|NCT03353350|585930168|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
162240050|NCT03353350|585930169|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
162240051|NCT03353350|585930170|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
162240052|NCT03353350|585930167|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
162240053|NCT03353350|585930168|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
162240054|NCT03353350|585930169|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
162240055|NCT03353350|585930170|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
162240056|NCT03353350|585930167|FG000|26-week Treatment Extension Period|Adverse Event|1|||
162240057|NCT03353350|585930168|FG001|26-week Treatment Extension Period|Adverse Event|0|||
162240058|NCT03353350|585930169|FG002|26-week Treatment Extension Period|Adverse Event|0|||
162240059|NCT03353350|585930170|FG003|26-week Treatment Extension Period|Adverse Event|1|||
162240060|NCT03353350|585930167|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
162240061|NCT03353350|585930168|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
162240062|NCT03353350|585930169|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
162240063|NCT03353350|585930170|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
162240064|NCT00807235|585930175|FG000|Overall Study|Adverse Event|1|||
162240065|NCT00807235|585930176|FG001|Overall Study|Adverse Event|0|||
162240066|NCT00985153|585930179|FG000|Overall Study|Lost to Follow-up|16|||
162240067|NCT00985153|585930180|FG001|Overall Study|Lost to Follow-up|19|||
162240068|NCT00985153|585930181|FG002|Overall Study|Lost to Follow-up|17|||
162240069|NCT00985153|585930182|FG003|Overall Study|Lost to Follow-up|20|||
162240070|NCT00985153|585930179|FG000|Overall Study|Protocol Violation|3|||
162240071|NCT00985153|585930180|FG001|Overall Study|Protocol Violation|2|||
162240072|NCT00985153|585930181|FG002|Overall Study|Protocol Violation|4|||
162240073|NCT00985153|585930182|FG003|Overall Study|Protocol Violation|3|||
162240074|NCT00985153|585930179|FG000|Overall Study|Withdrawal by Subject|6|||
162240075|NCT00985153|585930180|FG001|Overall Study|Withdrawal by Subject|11|||
162240076|NCT00985153|585930181|FG002|Overall Study|Withdrawal by Subject|11|||
162240077|NCT00985153|585930182|FG003|Overall Study|Withdrawal by Subject|10|||
162240078|NCT00985153|585930179|FG000|Overall Study|Missed One or More Bleeds|7|||
162240079|NCT00985153|585930180|FG001|Overall Study|Missed One or More Bleeds|7|||
162240080|NCT00985153|585930181|FG002|Overall Study|Missed One or More Bleeds|8|||
162240081|NCT00985153|585930182|FG003|Overall Study|Missed One or More Bleeds|10|||
162240082|NCT00985153|585930179|FG000|Overall Study|Incomplete Safety Follow-up|3|||
162240083|NCT00985153|585930180|FG001|Overall Study|Incomplete Safety Follow-up|5|||
162240084|NCT00985153|585930181|FG002|Overall Study|Incomplete Safety Follow-up|4|||
162240085|NCT00985153|585930182|FG003|Overall Study|Incomplete Safety Follow-up|4|||
162240086|NCT01679405|585930183|FG000|Overall Study|Death|2|||
162240087|NCT01679405|585930184|FG001|Overall Study|Death|5|||
162240088|NCT01536015|585930185|FG000|Overall Study|Adverse Event|1|||
162240089|NCT01536015|585930186|FG001|Overall Study|Adverse Event|4|||
162240090|NCT01536015|585930185|FG000|Overall Study|Lost to Follow-up|0|||
162240091|NCT01536015|585930186|FG001|Overall Study|Lost to Follow-up|1|||
162240092|NCT01536015|585930185|FG000|Overall Study|Inclusion Criterion not met|2|||
162240093|NCT01536015|585930186|FG001|Overall Study|Inclusion Criterion not met|0|||
162240094|NCT01536015|585930185|FG000|Overall Study|Study closure|5|||
162240095|NCT01536015|585930186|FG001|Overall Study|Study closure|5|||
162240096|NCT01668667|585930189|FG000|Overall Study|Adverse Event|3|||
162240097|NCT01668667|585930190|FG001|Overall Study|Adverse Event|6|||
162240098|NCT01668667|585930191|FG002|Overall Study|Adverse Event|4|||
162240099|NCT01668667|585930192|FG003|Overall Study|Adverse Event|4|||
162240100|NCT01668667|585930189|FG000|Overall Study|Lack of Efficacy|3|||
162240101|NCT01668667|585930190|FG001|Overall Study|Lack of Efficacy|2|||
162240102|NCT01668667|585930191|FG002|Overall Study|Lack of Efficacy|2|||
162240103|NCT01668667|585930192|FG003|Overall Study|Lack of Efficacy|3|||
162240104|NCT01668667|585930189|FG000|Overall Study|Protocol Violation|6|||
162240105|NCT01668667|585930190|FG001|Overall Study|Protocol Violation|10|||
162240106|NCT01668667|585930191|FG002|Overall Study|Protocol Violation|12|||
162240107|NCT01668667|585930192|FG003|Overall Study|Protocol Violation|5|||
162240108|NCT01668667|585930189|FG000|Overall Study|Lost to Follow-up|9|||
162240109|NCT01668667|585930190|FG001|Overall Study|Lost to Follow-up|4|||
162240110|NCT01668667|585930191|FG002|Overall Study|Lost to Follow-up|7|||
162240111|NCT01668667|585930192|FG003|Overall Study|Lost to Follow-up|6|||
162240112|NCT01668667|585930189|FG000|Overall Study|Physician Decision|3|||
162240113|NCT01668667|585930190|FG001|Overall Study|Physician Decision|0|||
162240114|NCT01668667|585930191|FG002|Overall Study|Physician Decision|1|||
162240115|NCT01668667|585930192|FG003|Overall Study|Physician Decision|0|||
162240116|NCT01668667|585930189|FG000|Overall Study|Withdrawal by Subject|7|||
162240117|NCT01668667|585930190|FG001|Overall Study|Withdrawal by Subject|4|||
162240118|NCT01668667|585930191|FG002|Overall Study|Withdrawal by Subject|5|||
162240119|NCT01668667|585930192|FG003|Overall Study|Withdrawal by Subject|5|||
162240120|NCT02988622|585930193|FG000|Overall Study|Lost to Follow-up|17|||
162240121|NCT01204398|585930194|FG000|Overall Study|Adverse Event|1|||
162240122|NCT03261700|585930195|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
162240123|NCT03261700|585930196|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
162240124|NCT04640077|585930199|FG000|Period 1|Withdrawal by Subject|4|||
162240125|NCT04640077|585930200|FG001|Period 1|Withdrawal by Subject|5|||
162240126|NCT04640077|585930201|FG002|Period 1|Withdrawal by Subject|0|||
162240127|NCT04640077|585930199|FG000|Period 1|Adverse Event|1|||
162240128|NCT04640077|585930200|FG001|Period 1|Adverse Event|1|||
162240129|NCT04640077|585930201|FG002|Period 1|Adverse Event|0|||
162240130|NCT04640077|585930199|FG000|Period 1|Screen Failure|2|||
162240131|NCT04640077|585930200|FG001|Period 1|Screen Failure|0|||
162240132|NCT04640077|585930201|FG002|Period 1|Screen Failure|0|||
162240133|NCT04640077|585930199|FG000|Period 2|Withdrawal by Subject|0|||
162240134|NCT04640077|585930200|FG001|Period 2|Withdrawal by Subject|0|||
162240135|NCT04640077|585930201|FG002|Period 2|Withdrawal by Subject|18|||
162240136|NCT04640077|585930199|FG000|Period 2|Adverse Event|0|||
162240137|NCT04640077|585930200|FG001|Period 2|Adverse Event|0|||
162240138|NCT04640077|585930201|FG002|Period 2|Adverse Event|6|||
162240139|NCT04640077|585930199|FG000|Period 2|Lost to Follow-up|0|||
162240140|NCT04640077|585930200|FG001|Period 2|Lost to Follow-up|0|||
162240141|NCT04640077|585930201|FG002|Period 2|Lost to Follow-up|2|||
162240142|NCT04640077|585930199|FG000|Period 2|Death|0|||
162240143|NCT04640077|585930200|FG001|Period 2|Death|0|||
162240144|NCT04640077|585930201|FG002|Period 2|Death|2|||
162240145|NCT04640077|585930199|FG000|Period 2|Progressive Disease|0|||
162240146|NCT04640077|585930200|FG001|Period 2|Progressive Disease|0|||
162240147|NCT04640077|585930201|FG002|Period 2|Progressive Disease|1|||
162240148|NCT04640077|585930199|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
162240149|NCT04640077|585930200|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
162240150|NCT04640077|585930201|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
162240151|NCT02041520|585930203|FG000|Overall Study|Adverse Event|2|||
162240152|NCT02041520|585930204|FG001|Overall Study|Adverse Event|1|||
162240153|NCT02041520|585930203|FG000|Overall Study|Withdrawal by Subject|3|||
162240154|NCT02041520|585930204|FG001|Overall Study|Withdrawal by Subject|4|||
162240155|NCT02041520|585930203|FG000|Overall Study|Protocol Violation|1|||
162240156|NCT02041520|585930204|FG001|Overall Study|Protocol Violation|0|||
162240157|NCT02041520|585930203|FG000|Overall Study|Lost to Follow-up|0|||
162240158|NCT02041520|585930204|FG001|Overall Study|Lost to Follow-up|1|||
162240159|NCT02041520|585930203|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
162240160|NCT02041520|585930204|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
162240161|NCT00413972|585930205|FG000|Overall Study|Adverse Event|2|||
162240162|NCT00413972|585930206|FG001|Overall Study|Adverse Event|1|||
162240163|NCT00413972|585930207|FG002|Overall Study|Adverse Event|0|||
162240164|NCT00413972|585930208|FG003|Overall Study|Adverse Event|0|||
162240165|NCT00413972|585930205|FG000|Overall Study|Lost to Follow-up|1|||
162240166|NCT00413972|585930206|FG001|Overall Study|Lost to Follow-up|2|||
162240167|NCT00413972|585930207|FG002|Overall Study|Lost to Follow-up|1|||
162240168|NCT00413972|585930208|FG003|Overall Study|Lost to Follow-up|0|||
162240169|NCT00413972|585930205|FG000|Overall Study|Withdrawal by Subject|4|||
162240170|NCT00413972|585930206|FG001|Overall Study|Withdrawal by Subject|5|||
162240171|NCT00413972|585930207|FG002|Overall Study|Withdrawal by Subject|7|||
162240172|NCT00413972|585930208|FG003|Overall Study|Withdrawal by Subject|2|||
162240173|NCT00413972|585930205|FG000|Overall Study|Protocol Violation|0|||
162240174|NCT00413972|585930206|FG001|Overall Study|Protocol Violation|0|||
162240175|NCT00413972|585930207|FG002|Overall Study|Protocol Violation|2|||
162240176|NCT00413972|585930208|FG003|Overall Study|Protocol Violation|0|||
162240177|NCT00413972|585930205|FG000|Overall Study|Other|0|||
162240178|NCT00413972|585930206|FG001|Overall Study|Other|0|||
162240179|NCT00413972|585930207|FG002|Overall Study|Other|0|||
162240180|NCT00413972|585930208|FG003|Overall Study|Other|1|||
162240181|NCT03164564|585930216|FG000|Overall Study|Death|3|||
162240182|NCT03164564|585930217|FG001|Overall Study|Death|0|||
162240183|NCT03164564|585930216|FG000|Overall Study|Withdrawal by Subject|20|||
162240184|NCT03164564|585930217|FG001|Overall Study|Withdrawal by Subject|15|||
162240185|NCT03164564|585930216|FG000|Overall Study|Lost to Follow-up|2|||
162240186|NCT03164564|585930217|FG001|Overall Study|Lost to Follow-up|0|||
162240187|NCT03164564|585930216|FG000|Overall Study|Physician Decision|0|||
162240188|NCT03164564|585930217|FG001|Overall Study|Physician Decision|1|||
162240189|NCT03164564|585930216|FG000|Overall Study|Adverse Event|0|||
162240190|NCT03164564|585930217|FG001|Overall Study|Adverse Event|1|||
162240191|NCT03164564|585930216|FG000|Overall Study|Ongoing|1586|||
162240192|NCT03164564|585930217|FG001|Overall Study|Ongoing|1586|||
162240193|NCT02656823|585930222|FG000|Overall Study|Adverse Event|3|||
162240194|NCT02656823|585930222|FG000|Overall Study|Lost to Follow-up|2|||
162240195|NCT01910181|585930223|FG000|Overall Study|Death|37|||
162240196|NCT01910181|585930223|FG000|Overall Study|Lost to Follow-up|3|||
162240197|NCT01910181|585930223|FG000|Overall Study|Study Terminated by Sponsor|6|||
162240198|NCT03567434|585930227|FG000|Overall Study|Lost to Follow-up|1|||
162240199|NCT03567434|585930228|FG001|Overall Study|Lost to Follow-up|3|||
162240200|NCT05269355|585930230|FG000|Overall Study|Progressive Disease|104|||
162240201|NCT05269355|585930231|FG001|Overall Study|Progressive Disease|68|||
162240202|NCT05269355|585930230|FG000|Overall Study|Study Terminated by Sponsor|87|||
162240203|NCT05269355|585930231|FG001|Overall Study|Study Terminated by Sponsor|29|||
162240204|NCT05269355|585930230|FG000|Overall Study|Adverse Event|15|||
162240205|NCT05269355|585930231|FG001|Overall Study|Adverse Event|8|||
162240206|NCT05269355|585930230|FG000|Overall Study|Withdrawal by Subject|18|||
162240207|NCT05269355|585930231|FG001|Overall Study|Withdrawal by Subject|5|||
162240208|NCT05269355|585930230|FG000|Overall Study|Physician Decision|6|||
162240209|NCT05269355|585930231|FG001|Overall Study|Physician Decision|4|||
162240210|NCT05269355|585930230|FG000|Overall Study|Death|3|||
162240211|NCT05269355|585930231|FG001|Overall Study|Death|5|||
162240212|NCT05269355|585930230|FG000|Overall Study|Other Than Specified|5|||
162240213|NCT05269355|585930231|FG001|Overall Study|Other Than Specified|1|||
162240214|NCT05269355|585930230|FG000|Overall Study|Randomized But Not Treated|1|||
162240215|NCT05269355|585930231|FG001|Overall Study|Randomized But Not Treated|0|||
162240216|NCT03705832|585930232|FG000|Overall Study|Physician Decision|0|||
162240217|NCT03705832|585930233|FG001|Overall Study|Physician Decision|1|||
162240218|NCT03705832|585930232|FG000|Overall Study|Withdrawal by Subject|1|||
162240219|NCT03705832|585930233|FG001|Overall Study|Withdrawal by Subject|0|||
162240220|NCT01050790|585930234|FG000|Overall Study|Adverse Event|1|||
162240221|NCT01880528|585930235|FG000|Overall Study|Other|1|||
162240222|NCT01880528|585930236|FG001|Overall Study|Other|1|||
162240223|NCT01439360|585930237|FG000|Overall Study|Adverse Event|4|||
162240224|NCT01439360|585930238|FG001|Overall Study|Adverse Event|16|||
162240225|NCT01439360|585930237|FG000|Overall Study|Lost to Follow-up|43|||
162240226|NCT01439360|585930238|FG001|Overall Study|Lost to Follow-up|58|||
162240227|NCT01439360|585930237|FG000|Overall Study|Others|10|||
162240228|NCT01439360|585930238|FG001|Overall Study|Others|5|||
162240229|NCT01439360|585930237|FG000|Overall Study|Protocol Violation|1|||
162240230|NCT01439360|585930238|FG001|Overall Study|Protocol Violation|0|||
162240231|NCT01439360|585930237|FG000|Overall Study|Withdrawal by Subject|140|||
162240232|NCT01439360|585930238|FG001|Overall Study|Withdrawal by Subject|129|||
162240233|NCT02072434|585932438|FG000|Overall Study|Protocol Violation|10|||
162240234|NCT02072434|585932439|FG001|Overall Study|Protocol Violation|9|||
162240235|NCT02072434|585932438|FG000|Overall Study|Physician Decision|5|||
162240236|NCT02072434|585932439|FG001|Overall Study|Physician Decision|10|||
162240237|NCT02072434|585932438|FG000|Overall Study|Adverse event, serious fatal|1|||
162240238|NCT02072434|585932439|FG001|Overall Study|Adverse event, serious fatal|6|||
162240239|NCT02072434|585932438|FG000|Overall Study|Adverse Event|7|||
162240240|NCT02072434|585932439|FG001|Overall Study|Adverse Event|6|||
162240241|NCT02072434|585932438|FG000|Overall Study|Withdrawal by Subject|17|||
162240242|NCT02072434|585932439|FG001|Overall Study|Withdrawal by Subject|29|||
162240243|NCT02072434|585932438|FG000|Overall Study|Other|14|||
162240244|NCT02072434|585932439|FG001|Overall Study|Other|29|||
162240245|NCT02072434|585932438|FG000|Overall Study|Lost to Follow-up|0|||
162240246|NCT02072434|585932439|FG001|Overall Study|Lost to Follow-up|1|||
162240247|NCT02544217|585932440|FG000|Overall Study|Withdrawal by Subject|1|||
162240248|NCT02544217|585932441|FG001|Overall Study|Withdrawal by Subject|1|||
162240249|NCT02544217|585932442|FG002|Overall Study|Withdrawal by Subject|0|||
162240250|NCT02544217|585932443|FG003|Overall Study|Withdrawal by Subject|0|||
162240251|NCT02544217|585932444|FG004|Overall Study|Withdrawal by Subject|0|||
161894721|NCT01483599|584661085|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894722|NCT01483599|584661086|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894723|NCT01483599|584661087|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894724|NCT01483599|584661088|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894725|NCT01483599|584661089|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894726|NCT01483599|584661090|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894727|NCT01483599|584661091|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894728|NCT01483599|584661092|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894729|NCT01483599|584661093|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
161894730|NCT01483599|584661094|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894731|NCT01483599|584661095|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894732|NCT01483599|584661096|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
161894733|NCT01483599|584661097|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161894734|NCT01483599|584661098|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
161894735|NCT01483599|584661085|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894736|NCT01483599|584661086|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894737|NCT01483599|584661087|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894738|NCT01483599|584661088|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894739|NCT01483599|584661089|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894740|NCT01483599|584661090|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894741|NCT01483599|584661091|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894742|NCT01483599|584661092|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894743|NCT01483599|584661093|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
161894744|NCT01483599|584661094|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894745|NCT01483599|584661095|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
161894746|NCT01483599|584661096|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894747|NCT01483599|584661097|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161894748|NCT01483599|584661098|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
161894749|NCT01483599|584661085|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894750|NCT01483599|584661086|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894751|NCT01483599|584661087|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894752|NCT01483599|584661088|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894753|NCT01483599|584661089|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894754|NCT01483599|584661090|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894755|NCT01483599|584661091|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894756|NCT01483599|584661092|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894757|NCT01483599|584661093|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
161894758|NCT01483599|584661094|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894759|NCT01483599|584661095|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894760|NCT01483599|584661096|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161894761|NCT01483599|584661097|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
161894762|NCT01483599|584661098|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
161894763|NCT01483599|584661085|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
161894764|NCT01483599|584661086|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
161894765|NCT01483599|584661087|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
161894766|NCT01483599|584661088|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
161894767|NCT01483599|584661089|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
161894768|NCT01483599|584661090|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
161894769|NCT01483599|584661091|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
161894770|NCT01483599|584661092|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
161894771|NCT01483599|584661093|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
161894772|NCT01483599|584661094|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
161894773|NCT01483599|584661095|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
161894774|NCT01483599|584661096|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
161894775|NCT01483599|584661097|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
161894776|NCT01483599|584661098|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
161894777|NCT02109445|584661099|FG000|Overall Study|Symptomatic deterioration|2|||
161894778|NCT02109445|584661099|FG000|Overall Study|Adverse Event|1|||
161894779|NCT00966355|584661104|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
161894780|NCT00966355|584661105|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
161894781|NCT00966355|584661106|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
161894782|NCT00966355|584661104|FG000|Overall Study|newly diagnosed advanced HCC|11|||
161894783|NCT00966355|584661105|FG001|Overall Study|newly diagnosed advanced HCC|12|||
161894784|NCT00966355|584661106|FG002|Overall Study|newly diagnosed advanced HCC|10|||
162122855|NCT00358215|585502342|FG000|Overall Study|Other|21|||
162122856|NCT00358215|585502343|FG001|Overall Study|Other|14|||
161894785|NCT00966355|584661104|FG000|Overall Study|Lost to Follow-up|5|||
161894786|NCT00966355|584661105|FG001|Overall Study|Lost to Follow-up|4|||
161894787|NCT00966355|584661106|FG002|Overall Study|Lost to Follow-up|3|||
161894788|NCT00401193|584663456|FG000|Overall Study|Adverse Event|1|||
161894789|NCT00401193|584663457|FG001|Overall Study|Adverse Event|3|||
161894790|NCT00401193|584663458|FG002|Overall Study|Adverse Event|1|||
161894791|NCT00401193|584663456|FG000|Overall Study|Protocol Violation|3|||
161894792|NCT00401193|584663457|FG001|Overall Study|Protocol Violation|1|||
161894793|NCT00401193|584663458|FG002|Overall Study|Protocol Violation|1|||
161894794|NCT00401193|584663456|FG000|Overall Study|Lost to Follow-up|6|||
161894795|NCT00401193|584663457|FG001|Overall Study|Lost to Follow-up|5|||
161894796|NCT00401193|584663458|FG002|Overall Study|Lost to Follow-up|1|||
161894797|NCT00401193|584663456|FG000|Overall Study|Withdrawal by Subject|2|||
161894798|NCT00401193|584663457|FG001|Overall Study|Withdrawal by Subject|0|||
161894799|NCT00401193|584663458|FG002|Overall Study|Withdrawal by Subject|1|||
161894800|NCT00401193|584663456|FG000|Overall Study|Other Event|3|||
161894801|NCT00401193|584663457|FG001|Overall Study|Other Event|2|||
161894802|NCT00401193|584663458|FG002|Overall Study|Other Event|2|||
161894803|NCT04378569|584663462|FG000|Overall Study|Adverse Event|0|||
161894804|NCT04378569|584663463|FG001|Overall Study|Adverse Event|0|||
161894805|NCT04378569|584663464|FG002|Overall Study|Adverse Event|2|||
161894806|NCT04378569|584663465|FG003|Overall Study|Adverse Event|0|||
161894807|NCT04378569|584663466|FG004|Overall Study|Adverse Event|3|||
161779244|NCT00111007|584233893|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
161779245|NCT00111007|584233892|FG000|Active Follow-up|Adverse Event|1|||
161779246|NCT00111007|584233893|FG001|Active Follow-up|Adverse Event|0|||
161779247|NCT00111007|584233892|FG000|Active Follow-up|Death|2|||
161779248|NCT00111007|584233893|FG001|Active Follow-up|Death|0|||
161779249|NCT00111007|584233892|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
161779250|NCT00111007|584233893|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
161779251|NCT00111007|584233892|FG000|Long Term Follow-up|Death|34|||
161779252|NCT00111007|584233893|FG001|Long Term Follow-up|Death|39|||
161779253|NCT00111007|584233892|FG000|Long Term Follow-up|Lost to Follow-up|1|||
161779254|NCT00111007|584233893|FG001|Long Term Follow-up|Lost to Follow-up|1|||
161779255|NCT00111007|584233892|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
161779256|NCT00111007|584233893|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
161779257|NCT00111007|584233892|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
161779258|NCT00111007|584233893|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
161779259|NCT00111007|584233892|FG000|Long Term Follow-up|Missing|10|||
161779260|NCT00111007|584233893|FG001|Long Term Follow-up|Missing|3|||
161779261|NCT01495793|584233894|FG000|Overall Study|Lost to Follow-up|1|||
162240252|NCT02544217|585932445|FG005|Overall Study|Withdrawal by Subject|0|||
162240253|NCT02027701|585932447|FG000|Overall Study|Adverse Event|3|||
162240254|NCT02027701|585932447|FG000|Overall Study|Lack of Efficacy|8|||
162240255|NCT02027701|585932447|FG000|Overall Study|Physician Decision|2|||
162240256|NCT02027701|585932447|FG000|Overall Study|Withdrawal by Subject|3|||
162240257|NCT00820027|585932448|FG000|Overall Study|Adverse Event|15|||
162240258|NCT00820027|585932449|FG001|Overall Study|Adverse Event|8|||
162240259|NCT00820027|585932450|FG002|Overall Study|Adverse Event|10|||
162240260|NCT00820027|585932451|FG003|Overall Study|Adverse Event|5|||
162240261|NCT00820027|585932448|FG000|Overall Study|Lack of Efficacy|2|||
162240262|NCT00820027|585932449|FG001|Overall Study|Lack of Efficacy|1|||
162240263|NCT00820027|585932450|FG002|Overall Study|Lack of Efficacy|2|||
162240264|NCT00820027|585932451|FG003|Overall Study|Lack of Efficacy|2|||
162240265|NCT00820027|585932448|FG000|Overall Study|Physician Decision|0|||
162240266|NCT00820027|585932449|FG001|Overall Study|Physician Decision|1|||
161894808|NCT04378569|584663467|FG005|Overall Study|Adverse Event|3|||
161894809|NCT04378569|584663462|FG000|Overall Study|Lost to Follow-up|0|||
161894810|NCT04378569|584663463|FG001|Overall Study|Lost to Follow-up|3|||
161894811|NCT04378569|584663464|FG002|Overall Study|Lost to Follow-up|1|||
161894812|NCT04378569|584663465|FG003|Overall Study|Lost to Follow-up|0|||
161894813|NCT04378569|584663466|FG004|Overall Study|Lost to Follow-up|1|||
161894814|NCT04378569|584663467|FG005|Overall Study|Lost to Follow-up|1|||
161894815|NCT04378569|584663462|FG000|Overall Study|Protocol Violation|0|||
161894816|NCT04378569|584663463|FG001|Overall Study|Protocol Violation|0|||
161894817|NCT04378569|584663464|FG002|Overall Study|Protocol Violation|0|||
162240267|NCT00820027|585932450|FG002|Overall Study|Physician Decision|1|||
162240268|NCT00820027|585932451|FG003|Overall Study|Physician Decision|0|||
162240269|NCT00820027|585932448|FG000|Overall Study|Protocol Violation|3|||
162240270|NCT00820027|585932449|FG001|Overall Study|Protocol Violation|0|||
162240271|NCT00820027|585932450|FG002|Overall Study|Protocol Violation|4|||
162240272|NCT00820027|585932451|FG003|Overall Study|Protocol Violation|0|||
161894818|NCT04378569|584663465|FG003|Overall Study|Protocol Violation|0|||
161894819|NCT04378569|584663466|FG004|Overall Study|Protocol Violation|0|||
161894820|NCT04378569|584663467|FG005|Overall Study|Protocol Violation|1|||
161894821|NCT04378569|584663462|FG000|Overall Study|Withdrawal by Subject|0|||
161894822|NCT04378569|584663463|FG001|Overall Study|Withdrawal by Subject|6|||
161894823|NCT04378569|584663464|FG002|Overall Study|Withdrawal by Subject|7|||
162240273|NCT00820027|585932448|FG000|Overall Study|Withdrawal by Subject|6|||
161894824|NCT04378569|584663465|FG003|Overall Study|Withdrawal by Subject|4|||
161894825|NCT04378569|584663466|FG004|Overall Study|Withdrawal by Subject|5|||
161894826|NCT04378569|584663467|FG005|Overall Study|Withdrawal by Subject|4|||
161894827|NCT04378569|584663462|FG000|Overall Study|Lack of response|0|||
161894828|NCT04378569|584663463|FG001|Overall Study|Lack of response|0|||
161894829|NCT04378569|584663464|FG002|Overall Study|Lack of response|1|||
161894830|NCT04378569|584663465|FG003|Overall Study|Lack of response|0|||
161894831|NCT04378569|584663466|FG004|Overall Study|Lack of response|1|||
161894832|NCT04378569|584663467|FG005|Overall Study|Lack of response|1|||
161894833|NCT01844817|584663468|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
161894834|NCT01844817|584663469|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
161894835|NCT01844817|584663468|FG000|Treatment|Progressive Disease|27|||
161894836|NCT01844817|584663469|FG001|Treatment|Progressive Disease|36|||
161894837|NCT01844817|584663468|FG000|Treatment|Adverse Event|17|||
161894838|NCT01844817|584663469|FG001|Treatment|Adverse Event|9|||
161894839|NCT01844817|584663468|FG000|Treatment|Withdrawal by Subject|10|||
161894840|NCT01844817|584663469|FG001|Treatment|Withdrawal by Subject|6|||
161894841|NCT01844817|584663468|FG000|Treatment|Death|10|||
161894842|NCT01844817|584663469|FG001|Treatment|Death|8|||
161894843|NCT01844817|584663468|FG000|Treatment|Lost to Follow-up|0|||
161894844|NCT01844817|584663469|FG001|Treatment|Lost to Follow-up|1|||
161894845|NCT01844817|584663468|FG000|Treatment|Other|0|||
161894846|NCT01844817|584663469|FG001|Treatment|Other|3|||
161894847|NCT03638466|584663471|FG000|Overall Study|Early Termination|0|||
161894848|NCT03638466|584663472|FG001|Overall Study|Early Termination|1|||
161894849|NCT02576977|584663473|FG000|Overall Study|Adverse Event|13|||
161894850|NCT02576977|584663474|FG001|Overall Study|Adverse Event|2|||
161894851|NCT02576977|584663473|FG000|Overall Study|Death|73|||
161894852|NCT02576977|584663474|FG001|Overall Study|Death|60|||
161894853|NCT02576977|584663473|FG000|Overall Study|Screen failure|1|||
161894854|NCT02576977|584663474|FG001|Overall Study|Screen failure|0|||
161894855|NCT02576977|584663473|FG000|Overall Study|Study Terminated at Selected Sites|27|||
161894856|NCT02576977|584663474|FG001|Overall Study|Study Terminated at Selected Sites|50|||
161894857|NCT02576977|584663473|FG000|Overall Study|Withdrawal by Subject|11|||
161894858|NCT02576977|584663474|FG001|Overall Study|Withdrawal by Subject|11|||
161894859|NCT02576977|584663473|FG000|Overall Study|Final Disposition Unknown|0|||
161894860|NCT02576977|584663474|FG001|Overall Study|Final Disposition Unknown|1|||
161894861|NCT02576977|584663473|FG000|Overall Study|Lost to Follow-up|1|||
161894862|NCT02576977|584663474|FG001|Overall Study|Lost to Follow-up|0|||
161894863|NCT02576977|584663473|FG000|Overall Study|Progressive Disease|0|||
161894864|NCT02576977|584663474|FG001|Overall Study|Progressive Disease|1|||
161894865|NCT02447328|584663479|FG000|Overall Study|Withdrawal by Subject|1|||
161894866|NCT02906579|584663490|FG000|Overall Study|Adverse Event|1|||
161894867|NCT02906579|584663490|FG000|Overall Study|Physician Decision|1|||
161894868|NCT00759655|584663491|FG000|Overall Study|Termination of the study by sponsor|1|||
161894869|NCT02753816|584663492|FG000|Overall Study|Protocol Violation|0|||
161894870|NCT02753816|584663493|FG001|Overall Study|Protocol Violation|1|||
161894871|NCT02753816|584663494|FG002|Overall Study|Protocol Violation|0|||
161894872|NCT01473940|584663495|FG000|Induction Therapy|Death|0|||
161894873|NCT01473940|584663496|FG001|Induction Therapy|Death|0|||
161894874|NCT01473940|584663497|FG002|Induction Therapy|Death|1|||
161894875|NCT01473940|584663498|FG003|Induction Therapy|Death|1|||
161894876|NCT01473940|584663495|FG000|Induction Therapy|Progressive Disease|0|||
161894877|NCT01473940|584663496|FG001|Induction Therapy|Progressive Disease|1|||
161894878|NCT01473940|584663497|FG002|Induction Therapy|Progressive Disease|1|||
161894879|NCT01473940|584663498|FG003|Induction Therapy|Progressive Disease|0|||
161894880|NCT01473940|584663495|FG000|Maintenance Therapy|Progressive Disease|1|||
161894881|NCT01473940|584663496|FG001|Maintenance Therapy|Progressive Disease|2|||
161894882|NCT01473940|584663497|FG002|Maintenance Therapy|Progressive Disease|1|||
161894883|NCT01473940|584663498|FG003|Maintenance Therapy|Progressive Disease|4|||
161894884|NCT00534248|584663499|FG000|Overall Study|Adverse Event|19|||
161894885|NCT00534248|584663500|FG001|Overall Study|Adverse Event|29|||
161894886|NCT00534248|584663499|FG000|Overall Study|Lost to Follow-up|353|||
161894887|NCT00534248|584663500|FG001|Overall Study|Lost to Follow-up|375|||
161894888|NCT00534248|584663499|FG000|Overall Study|Other protocol specified criteria|13|||
161894889|NCT00534248|584663500|FG001|Overall Study|Other protocol specified criteria|3|||
161894890|NCT00534248|584663499|FG000|Overall Study|Physician Decision|10|||
161894891|NCT00534248|584663500|FG001|Overall Study|Physician Decision|7|||
162008685|NCT03204188|585086713|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
162008686|NCT03204188|585086713|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
161894892|NCT00534248|584663499|FG000|Overall Study|Protocol Violation|3|||
161894893|NCT00534248|584663500|FG001|Overall Study|Protocol Violation|4|||
161894894|NCT00534248|584663499|FG000|Overall Study|Withdrawal by Subject|263|||
161894895|NCT00534248|584663500|FG001|Overall Study|Withdrawal by Subject|255|||
161894896|NCT02849171|584663501|FG000|Overall Study|Withdrawal by Subject|1|||
161894897|NCT02849171|584663501|FG000|Overall Study|Not treated|1|||
161894898|NCT03084302|584663508|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
161894899|NCT03084302|584663508|FG000|Overall Study|No valid objective monitor data|6|||
161894900|NCT01704755|584663512|FG000|Overall Study|Adverse Event|4|||
161894901|NCT01704755|584663513|FG001|Overall Study|Adverse Event|1|||
161894902|NCT01704755|584663512|FG000|Overall Study|Lost to Follow-up|3|||
161894903|NCT01704755|584663513|FG001|Overall Study|Lost to Follow-up|4|||
161894904|NCT01704755|584663512|FG000|Overall Study|Withdrew consent|1|||
161894905|NCT01704755|584663513|FG001|Overall Study|Withdrew consent|1|||
161894906|NCT01704755|584663512|FG000|Overall Study|Other (not specified)|3|||
161894907|NCT01704755|584663513|FG001|Overall Study|Other (not specified)|1|||
161894908|NCT01704755|584663512|FG000|Overall Study|Withdrew consent and personal issues|1|||
161894909|NCT01704755|584663513|FG001|Overall Study|Withdrew consent and personal issues|0|||
161894910|NCT02075008|584663520|FG000|Overall Study|Technical problems|1|||
161894911|NCT02075008|584663520|FG000|Overall Study|Pregnancy|1|||
161894912|NCT02075008|584663520|FG000|Overall Study|Physician Decision|1|||
161894913|NCT02075008|584663520|FG000|Overall Study|Lost to Follow-up|1|||
161894914|NCT02075008|584663520|FG000|Overall Study|Lack of Efficacy|1|||
161894915|NCT02075008|584663520|FG000|Overall Study|Death|1|||
161894916|NCT02075008|584663520|FG000|Overall Study|Adverse Event|5|||
161894917|NCT02075008|584663520|FG000|Overall Study|Withdrawal by Subject|6|||
161894918|NCT02075008|584663520|FG000|Overall Study|Study terminated by Sponsor|159|||
161894919|NCT02821416|584663521|FG000|Overall Study|Adverse Event|0|||
161894920|NCT02821416|584663522|FG001|Overall Study|Adverse Event|1|||
161894921|NCT02821416|584663521|FG000|Overall Study|Withdrawal by Subject|2|||
161894922|NCT02821416|584663522|FG001|Overall Study|Withdrawal by Subject|0|||
161894923|NCT02821416|584663521|FG000|Overall Study|Lost to Follow-up|1|||
161894924|NCT02821416|584663522|FG001|Overall Study|Lost to Follow-up|0|||
161894925|NCT01763203|584663529|FG000|Overall Study|Death|4|||
161894926|NCT01763203|584663530|FG001|Overall Study|Death|7|||
161894927|NCT01763203|584663529|FG000|Overall Study|Lost to Follow-up|12|||
161894928|NCT01763203|584663530|FG001|Overall Study|Lost to Follow-up|12|||
161894929|NCT01763203|584663529|FG000|Overall Study|Withdrawal by Subject|8|||
161894930|NCT01763203|584663530|FG001|Overall Study|Withdrawal by Subject|12|||
161894931|NCT01763203|584663529|FG000|Overall Study|Moved out of study region|7|||
161894932|NCT01763203|584663530|FG001|Overall Study|Moved out of study region|10|||
161894933|NCT01763203|584663529|FG000|Overall Study|Physician Decision|2|||
161894934|NCT01763203|584663530|FG001|Overall Study|Physician Decision|1|||
161894935|NCT02256917|584663531|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
161894936|NCT02256917|584663531|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
161894937|NCT02256917|584663531|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
161894938|NCT02256917|584663531|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
161894939|NCT02256917|584663531|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
161894940|NCT02933528|584663532|FG000|Overall Study|Lost to Follow-up|2|||
161894941|NCT01639703|584663533|FG000|Overall Study|Withdrawal by Subject|5|||
161894942|NCT01639703|584663533|FG000|Overall Study|Other reason|7|||
161894943|NCT01753115|584663535|FG000|Overall Study|Lost to Follow-up|3|||
161894944|NCT01753115|584663536|FG001|Overall Study|Lost to Follow-up|6|||
161894945|NCT01753115|584663537|FG002|Overall Study|Lost to Follow-up|8|||
161894946|NCT01753115|584663535|FG000|Overall Study|Withdrawal by Subject|6|||
161894947|NCT01753115|584663536|FG001|Overall Study|Withdrawal by Subject|5|||
161894948|NCT01753115|584663537|FG002|Overall Study|Withdrawal by Subject|6|||
161894949|NCT01753115|584663535|FG000|Overall Study|Subject non-compliant|3|||
161894950|NCT01753115|584663536|FG001|Overall Study|Subject non-compliant|3|||
161894951|NCT01753115|584663537|FG002|Overall Study|Subject non-compliant|0|||
161894952|NCT01753115|584663535|FG000|Overall Study|Used excluded drug|0|||
161894953|NCT01753115|584663536|FG001|Overall Study|Used excluded drug|1|||
161894954|NCT01753115|584663537|FG002|Overall Study|Used excluded drug|0|||
161894955|NCT02782377|584663540|FG000|Overall Study|Physician Decision|5|||
161894956|NCT01188668|584663541|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
161894957|NCT01188668|584663541|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
161894958|NCT01188668|584663541|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
161894959|NCT03882957|584663549|FG000|Overall Study|Did not complete all three arms|1|||
161894960|NCT03762681|584663552|FG000|Part 1|Withdrawal by Subject|0|||
161894961|NCT03762681|584663553|FG001|Part 1|Withdrawal by Subject|0|||
161894962|NCT03762681|584663554|FG002|Part 1|Withdrawal by Subject|0|||
161894963|NCT03762681|584663555|FG003|Part 1|Withdrawal by Subject|1|||
161894964|NCT03762681|584663556|FG004|Part 1|Withdrawal by Subject|0|||
161894965|NCT03762681|584663557|FG005|Part 1|Withdrawal by Subject|0|||
161894966|NCT03762681|584663558|FG006|Part 1|Withdrawal by Subject|0|||
161894967|NCT03762681|584663559|FG007|Part 1|Withdrawal by Subject|0|||
161894968|NCT03762681|584663552|FG000|Part 2a|Pandemic Travel Restrictions|0|||
161894969|NCT03762681|584663553|FG001|Part 2a|Pandemic Travel Restrictions|0|||
161894970|NCT03762681|584663554|FG002|Part 2a|Pandemic Travel Restrictions|0|||
161894971|NCT03762681|584663555|FG003|Part 2a|Pandemic Travel Restrictions|0|||
161894972|NCT03762681|584663556|FG004|Part 2a|Pandemic Travel Restrictions|0|||
161894973|NCT03762681|584663557|FG005|Part 2a|Pandemic Travel Restrictions|0|||
161894974|NCT03762681|584663558|FG006|Part 2a|Pandemic Travel Restrictions|0|||
161894975|NCT03762681|584663559|FG007|Part 2a|Pandemic Travel Restrictions|1|||
161894976|NCT01915771|584663563|FG000|Day 1|Withdrawal by Subject|1|||
161894977|NCT01915771|584663563|FG000|Day 15|Withdrawal by Subject|1|||
161894978|NCT04811664|584663564|FG000|Overall Study|Lost to Follow-up|78|||
161894979|NCT04811664|584663565|FG001|Overall Study|Lost to Follow-up|125|||
161894980|NCT04811664|584663566|FG002|Overall Study|Lost to Follow-up|46|||
161894981|NCT04811664|584663564|FG000|Overall Study|Withdrawal by Subject|39|||
161894982|NCT04811664|584663565|FG001|Overall Study|Withdrawal by Subject|76|||
161894983|NCT04811664|584663566|FG002|Overall Study|Withdrawal by Subject|12|||
161894984|NCT04811664|584663564|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
161894985|NCT04811664|584663565|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
161894986|NCT04811664|584663566|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
161894987|NCT04811664|584663564|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
161894988|NCT04811664|584663565|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
161894989|NCT04811664|584663566|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
161894990|NCT04811664|584663564|FG000|Overall Study|Protocol Violation|0|||
161894991|NCT04811664|584663565|FG001|Overall Study|Protocol Violation|5|||
161894992|NCT04811664|584663566|FG002|Overall Study|Protocol Violation|11|||
161894993|NCT04811664|584663564|FG000|Overall Study|Study Terminated by Sponsor|4|||
161894994|NCT04811664|584663565|FG001|Overall Study|Study Terminated by Sponsor|3|||
161894995|NCT04811664|584663566|FG002|Overall Study|Study Terminated by Sponsor|34|||
161894996|NCT04811664|584663564|FG000|Overall Study|Early Study Closure|3|||
161894997|NCT04811664|584663565|FG001|Overall Study|Early Study Closure|7|||
161894998|NCT04811664|584663566|FG002|Overall Study|Early Study Closure|79|||
162240274|NCT00820027|585932449|FG001|Overall Study|Withdrawal by Subject|4|||
162240275|NCT00820027|585932450|FG002|Overall Study|Withdrawal by Subject|4|||
162240276|NCT00820027|585932451|FG003|Overall Study|Withdrawal by Subject|6|||
162240277|NCT02604433|585932452|FG000|Overall Study|Withdrawal by Subject|37|||
162240278|NCT02604433|585932453|FG001|Overall Study|Withdrawal by Subject|16|||
162240279|NCT02604433|585932452|FG000|Overall Study|Adverse Event|4|||
162240280|NCT02604433|585932453|FG001|Overall Study|Adverse Event|0|||
162240281|NCT02604433|585932452|FG000|Overall Study|Other reasons|3|||
162240282|NCT02604433|585932453|FG001|Overall Study|Other reasons|5|||
162240283|NCT02604433|585932452|FG000|Overall Study|Death|4|||
162240284|NCT02604433|585932453|FG001|Overall Study|Death|1|||
162240285|NCT02604433|585932452|FG000|Overall Study|Transition to Rollover Protocol|169|||
162240286|NCT02604433|585932453|FG001|Overall Study|Transition to Rollover Protocol|82|||
162240287|NCT02604433|585932452|FG000|Overall Study|Physician Decision|1|||
162240288|NCT02604433|585932453|FG001|Overall Study|Physician Decision|1|||
161894999|NCT04811664|584663564|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
162240289|NCT02604433|585932452|FG000|Overall Study|Lack of Efficacy|0|||
162240290|NCT02604433|585932453|FG001|Overall Study|Lack of Efficacy|1|||
162240291|NCT03285178|585932454|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
162240292|NCT03285178|585932455|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
162240293|NCT03285178|585932456|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
162240294|NCT03285178|585932457|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
162240295|NCT03285178|585932458|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
162240296|NCT03285178|585932459|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
162240297|NCT03285178|585932460|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
162240298|NCT03285178|585932454|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
162240299|NCT03285178|585932455|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
162240300|NCT03285178|585932456|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
162240301|NCT03285178|585932457|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
162240302|NCT03285178|585932458|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
162240303|NCT03285178|585932459|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
162240304|NCT03285178|585932460|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
162240305|NCT03285178|585932454|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
162240306|NCT03285178|585932455|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
162240307|NCT03285178|585932456|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
162240308|NCT03285178|585932457|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
162240309|NCT03285178|585932458|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
162240310|NCT03285178|585932459|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
162240311|NCT03285178|585932460|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
161895000|NCT04811664|584663565|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
161895001|NCT04811664|584663566|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
161895002|NCT02717442|584663567|FG000|Overall Study|Study Terminated by Sponsor|31|||
161895003|NCT02717442|584663568|FG001|Overall Study|Study Terminated by Sponsor|29|||
161895004|NCT02717442|584663567|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
162008687|NCT01520506|585088156|FG000|Overall Study|Missed Visit|4|||
161895005|NCT02717442|584663568|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
161895006|NCT02717442|584663567|FG000|Overall Study|Other - Not Specified|2|||
161895007|NCT02717442|584663568|FG001|Overall Study|Other - Not Specified|0|||
161895008|NCT02774005|584663570|FG000|Overall Study|Adverse Event|8|||
161895009|NCT02774005|584663570|FG000|Overall Study|Withdrawal by Subject|23|||
161895010|NCT02774005|584663570|FG000|Overall Study|Lost to Follow-up|7|||
161895011|NCT02774005|584663570|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
161895012|NCT02774005|584663570|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
161895013|NCT02774005|584663570|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
161895014|NCT02774005|584663570|FG000|Overall Study|Death|1|||
161895015|NCT02774005|584663570|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
161895016|NCT02774005|584663570|FG000|Overall Study|Lack of compliance with study medication|4|||
161895017|NCT02774005|584663570|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
161895018|NCT02774005|584663570|FG000|Overall Study|another study|1|||
161895019|NCT02774005|584663570|FG000|Overall Study|cardiologist imposed travel restriction|1|||
162008688|NCT01520506|585088156|FG000|Overall Study|Lost to Follow-up|1|||
162008689|NCT01520506|585088156|FG000|Overall Study|Withdrawal by Subject|1|||
162008690|NCT00906204|585088157|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
162008691|NCT00906204|585088158|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
162008692|NCT00906204|585088157|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
162008693|NCT00906204|585088158|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
162008694|NCT00906204|585088157|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
162240312|NCT03285178|585932454|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
162240313|NCT03285178|585932455|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
162240314|NCT03285178|585932456|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
162240315|NCT03285178|585932457|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
162240316|NCT03285178|585932458|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
162240317|NCT03285178|585932459|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
162240318|NCT03285178|585932460|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
162240319|NCT03285178|585932454|FG000|Single-Blind Run-In Period|Physician Decision|2|||
162240320|NCT03285178|585932455|FG001|Single-Blind Run-In Period|Physician Decision|0|||
162240321|NCT03285178|585932456|FG002|Single-Blind Run-In Period|Physician Decision|0|||
162240322|NCT03285178|585932457|FG003|Single-Blind Run-In Period|Physician Decision|0|||
162240323|NCT03285178|585932458|FG004|Single-Blind Run-In Period|Physician Decision|0|||
162240324|NCT03285178|585932459|FG005|Single-Blind Run-In Period|Physician Decision|0|||
162240325|NCT03285178|585932460|FG006|Single-Blind Run-In Period|Physician Decision|0|||
162240326|NCT03285178|585932454|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
162240327|NCT03285178|585932455|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
162240328|NCT03285178|585932456|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
162240329|NCT03285178|585932457|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
162240330|NCT03285178|585932458|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
162240331|NCT03285178|585932459|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
162240332|NCT03285178|585932460|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
162240333|NCT03285178|585932454|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162240334|NCT03285178|585932455|FG001|Double-Blind Treatment Period|Adverse Event|0|||
162240335|NCT03285178|585932456|FG002|Double-Blind Treatment Period|Adverse Event|0|||
162240336|NCT03285178|585932457|FG003|Double-Blind Treatment Period|Adverse Event|0|||
162240337|NCT03285178|585932458|FG004|Double-Blind Treatment Period|Adverse Event|0|||
162240338|NCT03285178|585932459|FG005|Double-Blind Treatment Period|Adverse Event|0|||
162240339|NCT03285178|585932460|FG006|Double-Blind Treatment Period|Adverse Event|2|||
162240340|NCT03285178|585932454|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162240341|NCT03285178|585932455|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
162240342|NCT03285178|585932456|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
162240343|NCT03285178|585932457|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
162240344|NCT03285178|585932458|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
162240345|NCT03285178|585932459|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
162240346|NCT03285178|585932460|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
162240347|NCT03285178|585932454|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162240348|NCT03285178|585932455|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162008695|NCT00906204|585088158|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
162008696|NCT00906204|585088157|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
162008697|NCT00906204|585088158|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
162008698|NCT00906204|585088157|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
162008699|NCT00906204|585088158|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
162240349|NCT03285178|585932456|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162240350|NCT03285178|585932457|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162240351|NCT03285178|585932458|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162240352|NCT03285178|585932459|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
162240353|NCT03285178|585932460|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162240354|NCT03285178|585932454|FG000|Double-Blind Treatment Period|COVID-19|0|||
162240355|NCT03285178|585932455|FG001|Double-Blind Treatment Period|COVID-19|0|||
162240356|NCT03285178|585932456|FG002|Double-Blind Treatment Period|COVID-19|1|||
162240357|NCT03285178|585932457|FG003|Double-Blind Treatment Period|COVID-19|0|||
162240358|NCT03285178|585932458|FG004|Double-Blind Treatment Period|COVID-19|0|||
162240359|NCT03285178|585932459|FG005|Double-Blind Treatment Period|COVID-19|0|||
162240360|NCT03285178|585932460|FG006|Double-Blind Treatment Period|COVID-19|0|||
162240361|NCT01128894|585932461|FG000|Overall Study|Adverse Event|31|||
162240362|NCT01128894|585932462|FG001|Overall Study|Adverse Event|41|||
162240363|NCT01128894|585932461|FG000|Overall Study|Protocol Violation|2|||
162240364|NCT01128894|585932462|FG001|Overall Study|Protocol Violation|1|||
162240365|NCT01128894|585932461|FG000|Overall Study|Noncompliance|4|||
162240366|NCT01128894|585932462|FG001|Overall Study|Noncompliance|5|||
162240367|NCT01128894|585932461|FG000|Overall Study|Lost to Follow-up|8|||
161779262|NCT01495793|584233894|FG000|Overall Study|Violation of inclusion criteria|1|||
161779263|NCT03014570|584233895|FG000|Overall Study|COVID-19 Restrictions|38|||
161779264|NCT03014570|584233896|FG001|Overall Study|COVID-19 Restrictions|24|||
161779265|NCT03014570|584233895|FG000|Overall Study|Death|70|||
161779266|NCT03014570|584233896|FG001|Overall Study|Death|79|||
161779267|NCT03014570|584233895|FG000|Overall Study|Transfer from facility|11|||
161779268|NCT03014570|584233896|FG001|Overall Study|Transfer from facility|14|||
161779269|NCT03014570|584233895|FG000|Overall Study|Hospitalized|5|||
161779270|NCT03014570|584233896|FG001|Overall Study|Hospitalized|3|||
161779271|NCT03014570|584233895|FG000|Overall Study|Transfer within facility|1|||
161779272|NCT03014570|584233896|FG001|Overall Study|Transfer within facility|0|||
161779273|NCT03014570|584233895|FG000|Overall Study|Site refusal|0|||
161779274|NCT03014570|584233896|FG001|Overall Study|Site refusal|11|||
161779275|NCT02362646|584233897|FG000|Overall Study|Death|15|||
161779276|NCT02362646|584233898|FG001|Overall Study|Death|8|||
161779277|NCT02362646|584233897|FG000|Overall Study|Withdrawal by Subject|2|||
161779278|NCT02362646|584233898|FG001|Overall Study|Withdrawal by Subject|2|||
161779279|NCT02362646|584233897|FG000|Overall Study|received transplant|21|||
161779280|NCT02362646|584233898|FG001|Overall Study|received transplant|14|||
161779281|NCT00929864|584233902|FG000|Overall Study|Death|1|||
161779282|NCT00929864|584233903|FG001|Overall Study|Death|1|||
161779283|NCT00929864|584233902|FG000|Overall Study|Adverse Event|11|||
161895020|NCT00723697|584663571|FG000|Overall Study|Physician questionnaires not received|2|||
161895021|NCT00723697|584663571|FG000|Overall Study|Missing Informed Consent Form|10|||
161895022|NCT00723697|584663571|FG000|Overall Study|Other exclusion criteria applied|6|||
161895023|NCT03275389|584663574|FG000|Overall Study|Lost to Follow-up|10|||
161895024|NCT03275389|584663575|FG001|Overall Study|Lost to Follow-up|10|||
161895025|NCT03275389|584663576|FG002|Overall Study|Lost to Follow-up|19|||
161895026|NCT03275389|584663577|FG003|Overall Study|Lost to Follow-up|12|||
161895027|NCT03275389|584663578|FG004|Overall Study|Lost to Follow-up|11|||
161895028|NCT03275389|584663579|FG005|Overall Study|Lost to Follow-up|12|||
161895029|NCT03275389|584663580|FG006|Overall Study|Lost to Follow-up|21|||
161895030|NCT03275389|584663581|FG007|Overall Study|Lost to Follow-up|15|||
161895031|NCT03275389|584663582|FG008|Overall Study|Lost to Follow-up|12|||
161895032|NCT03275389|584663583|FG009|Overall Study|Lost to Follow-up|14|||
161895033|NCT03275389|584663574|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895034|NCT03275389|584663575|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895035|NCT03275389|584663576|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895036|NCT03275389|584663577|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895037|NCT03275389|584663578|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895038|NCT03275389|584663579|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
161895039|NCT03275389|584663580|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895040|NCT03275389|584663581|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895041|NCT03275389|584663582|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161895042|NCT03275389|584663583|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
161895043|NCT03275389|584663574|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
161895044|NCT03275389|584663575|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161895045|NCT03275389|584663576|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161895046|NCT03275389|584663577|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
161895047|NCT03275389|584663578|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
161895048|NCT03275389|584663579|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
162008700|NCT00696072|585088159|FG000|Overall Study|continuing active treatment|10|||
162008701|NCT00696072|585088160|FG001|Overall Study|continuing active treatment|13|||
162240368|NCT01128894|585932462|FG001|Overall Study|Lost to Follow-up|8|||
161779284|NCT00929864|584233903|FG001|Overall Study|Adverse Event|30|||
161779285|NCT00929864|584233902|FG000|Overall Study|Lack of Efficacy|19|||
162008702|NCT00696072|585088159|FG000|Overall Study|Adverse Event|10|||
162008703|NCT00696072|585088160|FG001|Overall Study|Adverse Event|6|||
162008704|NCT00696072|585088159|FG000|Overall Study|Patient Request|3|||
162008705|NCT00696072|585088160|FG001|Overall Study|Patient Request|7|||
162008706|NCT00696072|585088159|FG000|Overall Study|Investigator Request|1|||
162008707|NCT00696072|585088160|FG001|Overall Study|Investigator Request|4|||
162008708|NCT00696072|585088159|FG000|Overall Study|Sponsor Request|0|||
162008709|NCT00696072|585088160|FG001|Overall Study|Sponsor Request|1|||
161779286|NCT00929864|584233903|FG001|Overall Study|Lack of Efficacy|16|||
161895049|NCT03275389|584663580|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
161895050|NCT03275389|584663581|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
161895051|NCT03275389|584663582|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
161895052|NCT03275389|584663583|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
161895053|NCT03275389|584663574|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895054|NCT03275389|584663575|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161895055|NCT03275389|584663576|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895056|NCT03275389|584663577|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
161895057|NCT03275389|584663578|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895058|NCT03275389|584663579|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895059|NCT03275389|584663580|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161895060|NCT03275389|584663581|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895061|NCT03275389|584663582|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895062|NCT03275389|584663583|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161895063|NCT03275389|584663574|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895064|NCT03275389|584663575|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895065|NCT03275389|584663576|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
162008710|NCT00696072|585088159|FG000|Overall Study|Disease Progression|32|||
162008711|NCT00696072|585088160|FG001|Overall Study|Disease Progression|30|||
162008712|NCT00696072|585088159|FG000|Overall Study|Non-specified|1|||
161779287|NCT00929864|584233902|FG000|Overall Study|Lost to Follow-up|7|||
161779288|NCT00929864|584233903|FG001|Overall Study|Lost to Follow-up|12|||
161779289|NCT00929864|584233902|FG000|Overall Study|Withdrawal by Subject|20|||
161779290|NCT00929864|584233903|FG001|Overall Study|Withdrawal by Subject|9|||
161779291|NCT00929864|584233902|FG000|Overall Study|No longer met criteria|2|||
161779292|NCT00929864|584233903|FG001|Overall Study|No longer met criteria|1|||
161779293|NCT00929864|584233902|FG000|Overall Study|Poor or non-compliance|3|||
161779294|NCT00929864|584233903|FG001|Overall Study|Poor or non-compliance|3|||
161779295|NCT00929864|584233902|FG000|Overall Study|Pregnancy|0|||
161779296|NCT00929864|584233903|FG001|Overall Study|Pregnancy|3|||
161779297|NCT00929864|584233902|FG000|Overall Study|Administrative reason by Sponsor|1|||
161779298|NCT00929864|584233903|FG001|Overall Study|Administrative reason by Sponsor|1|||
161779299|NCT00929864|584233902|FG000|Overall Study|Non-specified|2|||
161779300|NCT00929864|584233903|FG001|Overall Study|Non-specified|7|||
161779301|NCT03428217|584233905|FG000|Overall Study|Death|89|||
161779302|NCT03428217|584233906|FG001|Overall Study|Death|93|||
161779303|NCT03428217|584233905|FG000|Overall Study|Withdrawal by Subject|8|||
161779304|NCT03428217|584233906|FG001|Overall Study|Withdrawal by Subject|7|||
161779305|NCT03428217|584233905|FG000|Overall Study|Lost to Follow-up|1|||
161779306|NCT03428217|584233906|FG001|Overall Study|Lost to Follow-up|3|||
161779307|NCT03428217|584233905|FG000|Overall Study|Study terminated by sponsor|124|||
161779308|NCT03428217|584233906|FG001|Overall Study|Study terminated by sponsor|118|||
161779309|NCT03428217|584233905|FG000|Overall Study|Other, Not Specified|1|||
161779310|NCT03428217|584233906|FG001|Overall Study|Other, Not Specified|0|||
161779311|NCT00621309|584233907|FG000|Overall Study|Withdrawal by Subject|2|||
161779312|NCT00621309|584233908|FG001|Overall Study|Withdrawal by Subject|0|||
161779313|NCT00621309|584233909|FG002|Overall Study|Withdrawal by Subject|1|||
161779314|NCT00621309|584233910|FG003|Overall Study|Withdrawal by Subject|1|||
161779315|NCT00621309|584233911|FG004|Overall Study|Withdrawal by Subject|1|||
161779316|NCT00621309|584233912|FG005|Overall Study|Withdrawal by Subject|1|||
161779317|NCT00905437|584233913|FG000|Overall Study|Adverse Event|3|||
161779318|NCT00905437|584233914|FG001|Overall Study|Adverse Event|2|||
161779319|NCT00905437|584233913|FG000|Overall Study|Lost to Follow-up|0|||
161779320|NCT00905437|584233914|FG001|Overall Study|Lost to Follow-up|1|||
161779321|NCT00905437|584233913|FG000|Overall Study|Withdrawal by Subject|0|||
161779322|NCT00905437|584233914|FG001|Overall Study|Withdrawal by Subject|1|||
161779323|NCT00905437|584233913|FG000|Overall Study|Other|5|||
161779324|NCT00905437|584233914|FG001|Overall Study|Other|6|||
161779325|NCT05246111|584233915|FG000|Period 01|NOT ELIGIBLE IC5|1|||
161779326|NCT05246111|584233916|FG001|Period 01|NOT ELIGIBLE IC5|0|||
161779327|NCT01306968|584233917|FG000|Overall Study|Lost to Follow-up|1|||
161779328|NCT01306968|584233918|FG001|Overall Study|Lost to Follow-up|1|||
161779329|NCT01306968|584233919|FG002|Overall Study|Lost to Follow-up|0|||
161779330|NCT01306968|584233920|FG003|Overall Study|Lost to Follow-up|0|||
161779331|NCT01306968|584233917|FG000|Overall Study|Physician Decision|0|||
161779332|NCT01306968|584233918|FG001|Overall Study|Physician Decision|1|||
161779333|NCT01306968|584233919|FG002|Overall Study|Physician Decision|0|||
161779334|NCT01306968|584233920|FG003|Overall Study|Physician Decision|0|||
161779335|NCT01306968|584233917|FG000|Overall Study|Relocated and left active duty|0|||
161779336|NCT01306968|584233918|FG001|Overall Study|Relocated and left active duty|1|||
161779337|NCT01306968|584233919|FG002|Overall Study|Relocated and left active duty|1|||
161779338|NCT01306968|584233920|FG003|Overall Study|Relocated and left active duty|1|||
161779339|NCT01306968|584233917|FG000|Overall Study|Withdrew - time commitment|0|||
161779340|NCT01306968|584233918|FG001|Overall Study|Withdrew - time commitment|0|||
161779341|NCT01306968|584233919|FG002|Overall Study|Withdrew - time commitment|0|||
161779342|NCT01306968|584233920|FG003|Overall Study|Withdrew - time commitment|2|||
161779343|NCT01306968|584233917|FG000|Overall Study|Withdrew over privacy concerns|0|||
161779344|NCT01306968|584233918|FG001|Overall Study|Withdrew over privacy concerns|0|||
161779345|NCT01306968|584233919|FG002|Overall Study|Withdrew over privacy concerns|0|||
161779346|NCT01306968|584233920|FG003|Overall Study|Withdrew over privacy concerns|1|||
161779347|NCT02736695|584233921|FG000|Overall Study|Ineligible|6|||
161779348|NCT02736695|584233922|FG001|Overall Study|Ineligible|0|||
161779349|NCT01329562|584233925|FG000|Overall Study|Protocol Violation|5|||
161779350|NCT01329562|584233926|FG001|Overall Study|Protocol Violation|3|||
161779351|NCT01329562|584233925|FG000|Overall Study|Lost to Follow-up|1|||
161779352|NCT01329562|584233926|FG001|Overall Study|Lost to Follow-up|1|||
161779353|NCT01329562|584233925|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
161779354|NCT01329562|584233926|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
161779355|NCT01329562|584233925|FG000|Overall Study|Physician Decision|0|||
161779356|NCT01329562|584233926|FG001|Overall Study|Physician Decision|1|||
161779357|NCT03252015|584233927|FG000|Overall Study|Withdrawal by Subject|0|||
161779358|NCT03252015|584233928|FG001|Overall Study|Withdrawal by Subject|1|||
161779359|NCT03252015|584233929|FG002|Overall Study|Withdrawal by Subject|1|||
161779360|NCT03252015|584233930|FG003|Overall Study|Withdrawal by Subject|0|||
161779361|NCT03252015|584233927|FG000|Overall Study|Adverse Event|1|||
161779362|NCT03252015|584233928|FG001|Overall Study|Adverse Event|0|||
161779363|NCT03252015|584233929|FG002|Overall Study|Adverse Event|0|||
161779364|NCT03252015|584233930|FG003|Overall Study|Adverse Event|1|||
161779365|NCT00061568|584233931|FG000|Overall Study|Lost to Follow-up|12|||
161779366|NCT00061568|584233932|FG001|Overall Study|Lost to Follow-up|0|||
161779367|NCT00061568|584233931|FG000|Overall Study|Death|6|||
161779368|NCT00061568|584233932|FG001|Overall Study|Death|0|||
161779369|NCT00061568|584233931|FG000|Overall Study|Withdrawal by Subject|1|||
161779370|NCT00061568|584233932|FG001|Overall Study|Withdrawal by Subject|0|||
161779371|NCT01381068|584233933|FG000|Overall Study|Death|1|||
161779372|NCT01381068|584233934|FG001|Overall Study|Death|0|||
161779373|NCT01907516|584233939|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
161779374|NCT01907516|584233940|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
161779375|NCT01907516|584233939|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
161779376|NCT01907516|584233940|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
161779377|NCT01907516|584233939|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
161779378|NCT01907516|584233940|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
161779379|NCT01907516|584233939|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
161779380|NCT01907516|584233940|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
161779381|NCT01843660|584233944|FG000|Overall Study|Other|30|||
161779382|NCT00526227|584233945|FG000|Overall Study|Device not implanted|1|||
161779383|NCT00526227|584233945|FG000|Overall Study|Death|1|||
161779384|NCT01721369|584233946|FG000|Overall Study|Not initial etiological diagnosis|12|||
161831440|NCT01467479|584424744|FG002|Overall Study|Withdrawal of Consent|7|||
161831441|NCT01467479|584424742|FG000|Overall Study|Study Terminated by Sponsor|1|||
161831442|NCT01467479|584424743|FG001|Overall Study|Study Terminated by Sponsor|3|||
161831443|NCT01467479|584424744|FG002|Overall Study|Study Terminated by Sponsor|3|||
161831444|NCT01467479|584424742|FG000|Overall Study|Other|1|||
161831445|NCT01467479|584424743|FG001|Overall Study|Other|0|||
161831446|NCT01467479|584424744|FG002|Overall Study|Other|0|||
161831447|NCT02284347|584424755|FG000|Overall Study|Lost to Follow-up|2|||
161831448|NCT02284347|584424755|FG000|Overall Study|Withdrawn prior to treatment|1|||
161831449|NCT01730040|584424757|FG000|Overall Study|Randomized but not treated|0|||
161831450|NCT01730040|584424758|FG001|Overall Study|Randomized but not treated|0|||
161831451|NCT01730040|584424759|FG002|Overall Study|Randomized but not treated|0|||
161831452|NCT01730040|584424760|FG003|Overall Study|Randomized but not treated|0|||
161831453|NCT01730040|584424761|FG004|Overall Study|Randomized but not treated|0|||
161831454|NCT01730040|584424762|FG005|Overall Study|Randomized but not treated|1|||
161831455|NCT01730040|584424763|FG006|Overall Study|Randomized but not treated|0|||
161831456|NCT01730040|584424757|FG000|Overall Study|Subject moved|0|||
161831457|NCT01730040|584424758|FG001|Overall Study|Subject moved|0|||
161831458|NCT01730040|584424759|FG002|Overall Study|Subject moved|1|||
161831459|NCT01730040|584424760|FG003|Overall Study|Subject moved|0|||
161831460|NCT01730040|584424761|FG004|Overall Study|Subject moved|0|||
161895066|NCT03275389|584663577|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
162008713|NCT00696072|585088160|FG001|Overall Study|Non-specified|2|||
161831461|NCT01730040|584424762|FG005|Overall Study|Subject moved|0|||
161895067|NCT03275389|584663578|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895068|NCT03275389|584663579|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895069|NCT03275389|584663580|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895070|NCT03275389|584663581|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895071|NCT03275389|584663582|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161895072|NCT03275389|584663583|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
161895073|NCT03275389|584663574|FG000|Overall Study|Other|0|||
161895074|NCT03275389|584663575|FG001|Overall Study|Other|4|||
161895075|NCT03275389|584663576|FG002|Overall Study|Other|3|||
161895076|NCT03275389|584663577|FG003|Overall Study|Other|2|||
161895077|NCT03275389|584663578|FG004|Overall Study|Other|2|||
161895078|NCT03275389|584663579|FG005|Overall Study|Other|2|||
161895079|NCT03275389|584663580|FG006|Overall Study|Other|0|||
161895080|NCT03275389|584663581|FG007|Overall Study|Other|0|||
161895081|NCT03275389|584663582|FG008|Overall Study|Other|1|||
161895082|NCT03275389|584663583|FG009|Overall Study|Other|0|||
161895083|NCT00978341|584663586|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
161895084|NCT00978341|584663587|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
161895085|NCT03035916|584663588|FG000|Overall Study|Puncture failed|0|||
161895086|NCT03035916|584663589|FG001|Overall Study|Puncture failed|2|||
161895087|NCT03035916|584663590|FG002|Overall Study|Puncture failed|0|||
161895088|NCT03885999|584663591|FG000|Overall Study|Adverse Event|1|||
161895089|NCT02452554|584663592|FG000|Overall Study|Death|2|||
161895090|NCT02452554|584663593|FG001|Overall Study|Death|1|||
161895091|NCT02452554|584663594|FG002|Overall Study|Death|0|||
161895092|NCT02452554|584663595|FG003|Overall Study|Death|0|||
161895093|NCT02452554|584663596|FG004|Overall Study|Death|0|||
161895094|NCT02452554|584663597|FG005|Overall Study|Death|0|||
161895095|NCT02452554|584663592|FG000|Overall Study|Lack of Efficacy|13|||
161895096|NCT02452554|584663593|FG001|Overall Study|Lack of Efficacy|14|||
161895097|NCT02452554|584663594|FG002|Overall Study|Lack of Efficacy|9|||
161895098|NCT02452554|584663595|FG003|Overall Study|Lack of Efficacy|1|||
161895099|NCT02452554|584663596|FG004|Overall Study|Lack of Efficacy|5|||
161895100|NCT02452554|584663597|FG005|Overall Study|Lack of Efficacy|8|||
161895101|NCT02452554|584663592|FG000|Overall Study|Physician Decision|0|||
161895102|NCT02452554|584663593|FG001|Overall Study|Physician Decision|1|||
161895103|NCT02452554|584663594|FG002|Overall Study|Physician Decision|0|||
161895104|NCT02452554|584663595|FG003|Overall Study|Physician Decision|0|||
161895105|NCT02452554|584663596|FG004|Overall Study|Physician Decision|0|||
161895106|NCT02452554|584663597|FG005|Overall Study|Physician Decision|0|||
161895107|NCT02452554|584663592|FG000|Overall Study|Withdrawal by Subject|1|||
161895108|NCT02452554|584663593|FG001|Overall Study|Withdrawal by Subject|0|||
161895109|NCT02452554|584663594|FG002|Overall Study|Withdrawal by Subject|2|||
161895110|NCT02452554|584663595|FG003|Overall Study|Withdrawal by Subject|0|||
161895111|NCT02452554|584663596|FG004|Overall Study|Withdrawal by Subject|0|||
161895112|NCT02452554|584663597|FG005|Overall Study|Withdrawal by Subject|1|||
161895113|NCT02452554|584663592|FG000|Overall Study|Ineligible|0|||
161895114|NCT02452554|584663593|FG001|Overall Study|Ineligible|1|||
161895115|NCT02452554|584663594|FG002|Overall Study|Ineligible|0|||
161895116|NCT02452554|584663595|FG003|Overall Study|Ineligible|0|||
161895117|NCT02452554|584663596|FG004|Overall Study|Ineligible|0|||
161895118|NCT02452554|584663597|FG005|Overall Study|Ineligible|0|||
161895119|NCT02452554|584663592|FG000|Overall Study|Never Received Treatment|1|||
161895120|NCT02452554|584663593|FG001|Overall Study|Never Received Treatment|0|||
161895121|NCT02452554|584663594|FG002|Overall Study|Never Received Treatment|0|||
161895122|NCT02452554|584663595|FG003|Overall Study|Never Received Treatment|0|||
162008714|NCT01597596|585088161|FG000|Overall Study|Study terminated by sponsor|1|||
161895123|NCT02452554|584663596|FG004|Overall Study|Never Received Treatment|0|||
161895124|NCT02452554|584663597|FG005|Overall Study|Never Received Treatment|0|||
161895125|NCT01790516|584663598|FG000|Overall Study|Physician Decision|1|||
161895126|NCT01790516|584663599|FG001|Overall Study|Physician Decision|0|||
161895127|NCT01402986|584663600|FG000|Overall Study|Withdrawal by Subject|7|||
161895128|NCT01402986|584663601|FG001|Overall Study|Withdrawal by Subject|10|||
161895129|NCT01402986|584663602|FG002|Overall Study|Withdrawal by Subject|7|||
161895130|NCT01402986|584663603|FG003|Overall Study|Withdrawal by Subject|13|||
161895131|NCT01402986|584663600|FG000|Overall Study|Death|0|||
161895132|NCT01402986|584663601|FG001|Overall Study|Death|0|||
161895133|NCT01402986|584663602|FG002|Overall Study|Death|0|||
161895134|NCT01402986|584663603|FG003|Overall Study|Death|2|||
161895135|NCT01402986|584663600|FG000|Overall Study|Lost to Follow-up|0|||
161895136|NCT01402986|584663601|FG001|Overall Study|Lost to Follow-up|0|||
161895137|NCT01402986|584663602|FG002|Overall Study|Lost to Follow-up|0|||
161895138|NCT01402986|584663603|FG003|Overall Study|Lost to Follow-up|1|||
162008715|NCT01597596|585088162|FG001|Overall Study|Study terminated by sponsor|0|||
161895139|NCT01402986|584663600|FG000|Overall Study|Other|2|||
162008716|NCT01597596|585088161|FG000|Overall Study|Physician Decision|0|||
161895140|NCT01402986|584663601|FG001|Overall Study|Other|5|||
161895141|NCT01402986|584663602|FG002|Overall Study|Other|1|||
161895142|NCT01402986|584663603|FG003|Overall Study|Other|6|||
161895143|NCT01085084|584663604|FG000|Overall Study|Withdrawal by Subject|1|||
161895144|NCT01085084|584663605|FG001|Overall Study|Withdrawal by Subject|0|||
161895145|NCT01085084|584663606|FG002|Overall Study|Withdrawal by Subject|0|||
161895146|NCT01085084|584663604|FG000|Overall Study|Lost to Follow-up|2|||
161895147|NCT01085084|584663605|FG001|Overall Study|Lost to Follow-up|1|||
161895148|NCT01085084|584663606|FG002|Overall Study|Lost to Follow-up|1|||
161895149|NCT01085084|584663604|FG000|Overall Study|Adverse Event|4|||
161895150|NCT01085084|584663605|FG001|Overall Study|Adverse Event|3|||
161895151|NCT01085084|584663606|FG002|Overall Study|Adverse Event|6|||
161895152|NCT01085084|584663604|FG000|Overall Study|Treatment Failure|0|||
161895153|NCT01085084|584663605|FG001|Overall Study|Treatment Failure|1|||
161895154|NCT01085084|584663606|FG002|Overall Study|Treatment Failure|2|||
161895155|NCT03749109|584663607|FG000|Overall Study|Adverse Event|2|||
161895156|NCT03749109|584663608|FG001|Overall Study|Adverse Event|0|||
161895157|NCT03178851|584663609|FG000|Overall Study|Death|48|||
161895158|NCT03178851|584663610|FG001|Overall Study|Death|2|||
161895159|NCT03178851|584663611|FG002|Overall Study|Death|25|||
161895160|NCT03178851|584663609|FG000|Overall Study|Withdrawal by Subject|8|||
161895161|NCT03178851|584663610|FG001|Overall Study|Withdrawal by Subject|0|||
161895162|NCT03178851|584663611|FG002|Overall Study|Withdrawal by Subject|0|||
161895163|NCT03178851|584663609|FG000|Overall Study|Lost to Follow-up|5|||
161895164|NCT03178851|584663610|FG001|Overall Study|Lost to Follow-up|2|||
161895165|NCT03178851|584663611|FG002|Overall Study|Lost to Follow-up|0|||
162008717|NCT01597596|585088162|FG001|Overall Study|Physician Decision|1|||
162008718|NCT00371150|585088163|FG000|Overall Study|Lost to Follow-up|3|||
162008719|NCT00371150|585088164|FG001|Overall Study|Lost to Follow-up|2|||
162008720|NCT00124943|585088166|FG000|Phase II|Adverse Event|0|||
162008721|NCT00124943|585088167|FG001|Phase II|Adverse Event|2|||
162008722|NCT00124943|585088168|FG002|Phase II|Adverse Event|0|||
162008723|NCT00124943|585088169|FG003|Phase II|Adverse Event|1|||
162008724|NCT00124943|585088166|FG000|Phase II|Protocol Violation|0|||
162008725|NCT00124943|585088167|FG001|Phase II|Protocol Violation|0|||
162008726|NCT00124943|585088168|FG002|Phase II|Protocol Violation|0|||
162008727|NCT00124943|585088169|FG003|Phase II|Protocol Violation|1|||
162008728|NCT00124943|585088166|FG000|Phase II|Lost to Follow-up|0|||
162008729|NCT00124943|585088167|FG001|Phase II|Lost to Follow-up|0|||
162008730|NCT00124943|585088168|FG002|Phase II|Lost to Follow-up|0|||
162008731|NCT00124943|585088169|FG003|Phase II|Lost to Follow-up|1|||
162008732|NCT00124943|585088166|FG000|Phase II|Withdrawal by Subject|0|||
162008733|NCT00124943|585088167|FG001|Phase II|Withdrawal by Subject|0|||
162008734|NCT00124943|585088168|FG002|Phase II|Withdrawal by Subject|0|||
162008735|NCT00124943|585088169|FG003|Phase II|Withdrawal by Subject|2|||
162008736|NCT03181932|585088170|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
162008737|NCT03181932|585088171|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
162008738|NCT03181932|585088170|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
162008739|NCT03181932|585088171|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
162008740|NCT03181932|585088170|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
162008741|NCT03181932|585088171|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
162008742|NCT03181932|585088170|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
162008743|NCT03181932|585088171|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
162008744|NCT03181932|585088170|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
162008745|NCT03181932|585088171|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
162008746|NCT03181932|585088170|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
162008747|NCT03181932|585088171|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
162008748|NCT03181932|585088170|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
162008749|NCT03181932|585088171|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
162008750|NCT03181932|585088170|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
162008751|NCT03181932|585088171|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
162008752|NCT03181932|585088170|FG000|Period 2 (Open-label Period)|Reason missing|2|||
162008753|NCT03181932|585088171|FG001|Period 2 (Open-label Period)|Reason missing|0|||
162008754|NCT03304626|585088172|FG000|Overall Study|Adverse Event|1|||
162008755|NCT03304626|585088173|FG001|Overall Study|Adverse Event|0|||
162008756|NCT03304626|585088172|FG000|Overall Study|Lack of Efficacy|1|||
162008757|NCT03304626|585088173|FG001|Overall Study|Lack of Efficacy|1|||
162008758|NCT00408317|585088180|FG000|First Intervention Period|Adverse Event|0|||
162008759|NCT00408317|585088181|FG001|First Intervention Period|Adverse Event|1|||
162240369|NCT01128894|585932461|FG000|Overall Study|Withdrawal by Subject|10|||
161895166|NCT03178851|584663609|FG000|Overall Study|Adverse Event|0|||
161895167|NCT03178851|584663610|FG001|Overall Study|Adverse Event|0|||
161895168|NCT03178851|584663611|FG002|Overall Study|Adverse Event|1|||
161895169|NCT03178851|584663609|FG000|Overall Study|Study Termination by Sponsor|31|||
162008760|NCT00408317|585088180|FG000|Second Intervention Period|Adverse Event|2|||
162008761|NCT00408317|585088181|FG001|Second Intervention Period|Adverse Event|0|||
162008762|NCT00408317|585088180|FG000|Second Intervention Period|Protocol Violation|0|||
162008763|NCT00408317|585088181|FG001|Second Intervention Period|Protocol Violation|1|||
162008764|NCT00408317|585088180|FG000|Second Intervention Period|Withdrawal of consent|0|||
162008765|NCT00408317|585088181|FG001|Second Intervention Period|Withdrawal of consent|1|||
162008766|NCT01747876|585088182|FG000|Overall Study|Adverse Event|1|||
161779385|NCT00858234|584235524|FG000|Overall Study|Adverse Event|6|||
161779386|NCT00858234|584235524|FG000|Overall Study|Progressive disease|2|||
161779387|NCT00858234|584235524|FG000|Overall Study|Status unknown|1|||
161779388|NCT01678924|584235525|FG000|Overall Study|Adverse Event|1|||
161779389|NCT01678924|584235526|FG001|Overall Study|Adverse Event|1|||
161779390|NCT01678924|584235527|FG002|Overall Study|Adverse Event|0|||
161779391|NCT01678924|584235528|FG003|Overall Study|Adverse Event|1|||
161779392|NCT01678924|584235525|FG000|Overall Study|Lack of Efficacy|7|||
161779393|NCT01678924|584235526|FG001|Overall Study|Lack of Efficacy|2|||
161779394|NCT01678924|584235527|FG002|Overall Study|Lack of Efficacy|0|||
161779395|NCT01678924|584235528|FG003|Overall Study|Lack of Efficacy|5|||
161779396|NCT01678924|584235525|FG000|Overall Study|Lost to Follow-up|0|||
161779397|NCT01678924|584235526|FG001|Overall Study|Lost to Follow-up|4|||
161779398|NCT01678924|584235527|FG002|Overall Study|Lost to Follow-up|0|||
161779399|NCT01678924|584235528|FG003|Overall Study|Lost to Follow-up|2|||
161779400|NCT01678924|584235525|FG000|Overall Study|Personal Reasons|2|||
161779401|NCT01678924|584235526|FG001|Overall Study|Personal Reasons|2|||
161779402|NCT01678924|584235527|FG002|Overall Study|Personal Reasons|2|||
161779403|NCT01678924|584235528|FG003|Overall Study|Personal Reasons|7|||
161779404|NCT01678924|584235525|FG000|Overall Study|Withdrawal by Subject|0|||
161779405|NCT01678924|584235526|FG001|Overall Study|Withdrawal by Subject|3|||
161779406|NCT01678924|584235527|FG002|Overall Study|Withdrawal by Subject|0|||
161779407|NCT01678924|584235528|FG003|Overall Study|Withdrawal by Subject|2|||
161895170|NCT03178851|584663610|FG001|Overall Study|Study Termination by Sponsor|7|||
161895171|NCT03178851|584663611|FG002|Overall Study|Study Termination by Sponsor|26|||
161895172|NCT00520767|584663617|FG000|Overall Study|Death|2|||
161895173|NCT04530838|584666216|FG000|Overall Study|Other|2|||
161895174|NCT04530838|584666217|FG001|Overall Study|Other|1|||
161895175|NCT04530838|584666218|FG002|Overall Study|Other|0|||
161895176|NCT04530838|584666216|FG000|Overall Study|Physician Decision|0|||
161895177|NCT04530838|584666217|FG001|Overall Study|Physician Decision|0|||
161895178|NCT04530838|584666218|FG002|Overall Study|Physician Decision|1|||
161895179|NCT04530838|584666216|FG000|Overall Study|Death|0|||
161895180|NCT04530838|584666217|FG001|Overall Study|Death|0|||
161895181|NCT04530838|584666218|FG002|Overall Study|Death|1|||
161895182|NCT04530838|584666216|FG000|Overall Study|Adverse Event|0|||
161895183|NCT04530838|584666217|FG001|Overall Study|Adverse Event|1|||
161895184|NCT04530838|584666218|FG002|Overall Study|Adverse Event|0|||
161895185|NCT04530838|584666216|FG000|Overall Study|No longer meets eligibility criteria|1|||
161895186|NCT04530838|584666217|FG001|Overall Study|No longer meets eligibility criteria|0|||
161895187|NCT04530838|584666218|FG002|Overall Study|No longer meets eligibility criteria|2|||
161895188|NCT04530838|584666216|FG000|Overall Study|Withdrawal by parent/guardian|5|||
161895189|NCT04530838|584666217|FG001|Overall Study|Withdrawal by parent/guardian|2|||
161895190|NCT04530838|584666218|FG002|Overall Study|Withdrawal by parent/guardian|2|||
161895191|NCT02155309|584666223|FG000|Overall Study|Protocol Violation|0|||
161895192|NCT02155309|584666224|FG001|Overall Study|Protocol Violation|0|||
161895193|NCT02155309|584666225|FG002|Overall Study|Protocol Violation|1|||
161895194|NCT02501161|584666227|FG000|Overall Study|Adverse Event|2|||
161895195|NCT02501161|584666228|FG001|Overall Study|Adverse Event|6|||
161895196|NCT02501161|584666227|FG000|Overall Study|Lost to Follow-up|7|||
161895197|NCT02501161|584666228|FG001|Overall Study|Lost to Follow-up|4|||
161895198|NCT02501161|584666227|FG000|Overall Study|Withdrawal by Subject|10|||
161895199|NCT02501161|584666228|FG001|Overall Study|Withdrawal by Subject|15|||
161895200|NCT02501161|584666227|FG000|Overall Study|Other|3|||
161895201|NCT02501161|584666228|FG001|Overall Study|Other|0|||
161895202|NCT04336475|584666229|FG000|Overall Study|pain|1|||
161895203|NCT04336475|584666230|FG001|Overall Study|pain|0|||
161895204|NCT04336475|584666229|FG000|Overall Study|upper respiratory infection|1|||
161895205|NCT04336475|584666230|FG001|Overall Study|upper respiratory infection|0|||
162008767|NCT01747876|585088183|FG001|Overall Study|Adverse Event|0|||
162008768|NCT01747876|585088184|FG002|Overall Study|Adverse Event|2|||
162008769|NCT01747876|585088182|FG000|Overall Study|Withdrawal by Subject|0|||
161779408|NCT01678924|584235525|FG000|Overall Study|Unable to attend scheduled visits|0|||
161831462|NCT01730040|584424763|FG006|Overall Study|Subject moved|1|||
161831463|NCT01730040|584424757|FG000|Overall Study|Physician Decision|0|||
161831464|NCT01730040|584424758|FG001|Overall Study|Physician Decision|0|||
161831465|NCT01730040|584424759|FG002|Overall Study|Physician Decision|0|||
161831466|NCT01730040|584424760|FG003|Overall Study|Physician Decision|0|||
161831467|NCT01730040|584424761|FG004|Overall Study|Physician Decision|0|||
161831468|NCT01730040|584424762|FG005|Overall Study|Physician Decision|1|||
161831469|NCT01730040|584424763|FG006|Overall Study|Physician Decision|1|||
161831470|NCT01730040|584424757|FG000|Overall Study|Other than specified|7|||
161831471|NCT01730040|584424758|FG001|Overall Study|Other than specified|8|||
161831472|NCT01730040|584424759|FG002|Overall Study|Other than specified|5|||
161831473|NCT01730040|584424760|FG003|Overall Study|Other than specified|5|||
161831474|NCT01730040|584424761|FG004|Overall Study|Other than specified|5|||
161831475|NCT01730040|584424762|FG005|Overall Study|Other than specified|4|||
161831476|NCT01730040|584424763|FG006|Overall Study|Other than specified|4|||
162008770|NCT01747876|585088183|FG001|Overall Study|Withdrawal by Subject|1|||
162008771|NCT01747876|585088184|FG002|Overall Study|Withdrawal by Subject|1|||
162008772|NCT01747876|585088182|FG000|Overall Study|Disease progression|4|||
162008773|NCT01747876|585088183|FG001|Overall Study|Disease progression|13|||
162008774|NCT01747876|585088184|FG002|Overall Study|Disease progression|8|||
162008775|NCT01747876|585088182|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
162008776|NCT01747876|585088183|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
162008777|NCT01747876|585088184|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
162008778|NCT03331315|585088191|FG000|Overall Study|Physician Decision|18|||
162008779|NCT03331315|585088192|FG001|Overall Study|Physician Decision|14|||
162008780|NCT00360230|585088193|FG000|Overall Study|Withdrawal by Subject|1|||
162008781|NCT00360230|585088194|FG001|Overall Study|Withdrawal by Subject|1|||
162008782|NCT00360230|585088195|FG002|Overall Study|Withdrawal by Subject|0|||
162008783|NCT00360230|585088196|FG003|Overall Study|Withdrawal by Subject|1|||
162008784|NCT00360230|585088197|FG004|Overall Study|Withdrawal by Subject|1|||
162008785|NCT00360230|585088198|FG005|Overall Study|Withdrawal by Subject|1|||
162008786|NCT00360230|585088199|FG006|Overall Study|Withdrawal by Subject|0|||
162008787|NCT00360230|585088193|FG000|Overall Study|Migrated|4|||
162008788|NCT00360230|585088194|FG001|Overall Study|Migrated|1|||
162008789|NCT00360230|585088195|FG002|Overall Study|Migrated|3|||
162008790|NCT00360230|585088196|FG003|Overall Study|Migrated|1|||
162008791|NCT00360230|585088197|FG004|Overall Study|Migrated|4|||
162008792|NCT00360230|585088198|FG005|Overall Study|Migrated|1|||
162008793|NCT00360230|585088199|FG006|Overall Study|Migrated|1|||
162008794|NCT00360230|585088193|FG000|Overall Study|Other|1|||
162008795|NCT00360230|585088194|FG001|Overall Study|Other|0|||
162008796|NCT00360230|585088195|FG002|Overall Study|Other|0|||
162008797|NCT00360230|585088196|FG003|Overall Study|Other|0|||
162008798|NCT00360230|585088197|FG004|Overall Study|Other|0|||
162008799|NCT00360230|585088198|FG005|Overall Study|Other|0|||
162008800|NCT00360230|585088199|FG006|Overall Study|Other|0|||
162008801|NCT00360230|585088193|FG000|Overall Study|Protocol Violation|0|||
162008802|NCT00360230|585088194|FG001|Overall Study|Protocol Violation|0|||
162008803|NCT00360230|585088195|FG002|Overall Study|Protocol Violation|0|||
162008804|NCT00360230|585088196|FG003|Overall Study|Protocol Violation|0|||
162008805|NCT00360230|585088197|FG004|Overall Study|Protocol Violation|0|||
162008806|NCT00360230|585088198|FG005|Overall Study|Protocol Violation|1|||
162008807|NCT00360230|585088199|FG006|Overall Study|Protocol Violation|0|||
162008808|NCT00360230|585088193|FG000|Overall Study|Death|0|||
162008809|NCT00360230|585088194|FG001|Overall Study|Death|1|||
162008810|NCT00360230|585088195|FG002|Overall Study|Death|0|||
162008811|NCT00360230|585088196|FG003|Overall Study|Death|0|||
162008812|NCT00360230|585088197|FG004|Overall Study|Death|0|||
162008813|NCT00360230|585088198|FG005|Overall Study|Death|1|||
162008814|NCT00360230|585088199|FG006|Overall Study|Death|1|||
162008815|NCT02703597|585088200|FG000|Assignment to Baseline|Lost to Follow-up|17|||
162008816|NCT02703597|585088201|FG001|Assignment to Baseline|Lost to Follow-up|16|||
162008817|NCT02703597|585088200|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
162008818|NCT02703597|585088201|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
162008819|NCT02703597|585088200|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
162008820|NCT02703597|585088201|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
162008821|NCT02703597|585088200|FG000|First Post-test to First Follow-up|Site drop out|0|||
162008822|NCT02703597|585088201|FG001|First Post-test to First Follow-up|Site drop out|58|||
162008823|NCT02703597|585088200|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
162008824|NCT02703597|585088201|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
162008825|NCT02703597|585088200|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
162008826|NCT02703597|585088201|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
162008827|NCT02703597|585088200|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
162008828|NCT02703597|585088201|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
162008829|NCT00481832|585088202|FG000|Enrollment|Physician Decision|8|||
162008830|NCT00481832|585088202|FG000|Enrollment|Unable to collect enough stem cells|2|||
162008831|NCT00481832|585088202|FG000|Inter-transplant Period|Adverse Event|4|||
162008832|NCT00481832|585088202|FG000|Inter-transplant Period|Death|3|||
162008833|NCT00481832|585088202|FG000|Inter-transplant Period|Physician Decision|4|||
162008834|NCT00481832|585088202|FG000|Inter-transplant Period|Disease relapse|11|||
162008835|NCT00481832|585088202|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
162008836|NCT00581308|585088203|FG000|Pre Discharge|Lost to Follow-up|1|||
162008837|NCT00581308|585088203|FG000|Pre Discharge|Device Removed|1|||
162008838|NCT00581308|585088203|FG000|Month 1|Lost to Follow-up|3|||
162008839|NCT00581308|585088203|FG000|Month 1|Withdrawal by Subject|2|||
162008840|NCT00581308|585088203|FG000|Month 1|Device Removed|2|||
162008841|NCT00581308|585088203|FG000|Month 1|Uknown|1|||
162008842|NCT00581308|585088203|FG000|Month 6|Lost to Follow-up|1|||
162008843|NCT00581308|585088203|FG000|Month 6|Withdrawal by Subject|2|||
162008844|NCT00581308|585088203|FG000|Month 12|Death|1|||
162008845|NCT00581308|585088203|FG000|Month 12|Lost to Follow-up|14|||
162008846|NCT00581308|585088203|FG000|Month 12|Withdrawal by Subject|3|||
162008847|NCT00581308|585088203|FG000|Month 12|Device Removed|1|||
162008848|NCT00581308|585088203|FG000|Month 12|Other|1|||
162008849|NCT02006472|585088207|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
162008850|NCT02006472|585088208|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
162008851|NCT02006472|585088209|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
162008852|NCT02006472|585088210|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
162008853|NCT02006472|585088211|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
162008854|NCT02006472|585088207|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
162008855|NCT02006472|585088208|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
162008856|NCT02006472|585088209|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
162008857|NCT02006472|585088210|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
162008858|NCT02006472|585088211|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
162008859|NCT02006472|585088207|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
161895206|NCT04336475|584666229|FG000|Overall Study|Lost to Follow-up|0|||
161895207|NCT04336475|584666230|FG001|Overall Study|Lost to Follow-up|2|||
161895208|NCT02030119|584666233|FG000|Overall Study|Withdrawal by Subject|3|||
161895209|NCT02030119|584666234|FG001|Overall Study|Withdrawal by Subject|1|||
161895210|NCT02030119|584666235|FG002|Overall Study|Withdrawal by Subject|5|||
161895211|NCT02030119|584666236|FG003|Overall Study|Withdrawal by Subject|3|||
162008860|NCT02006472|585088208|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
162008861|NCT02006472|585088209|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
162008862|NCT02006472|585088210|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
162008863|NCT02006472|585088211|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
162008864|NCT02006472|585088207|FG000|Period 1 (Through Week 26)|Other|1|||
162008865|NCT02006472|585088208|FG001|Period 1 (Through Week 26)|Other|5|||
161895212|NCT02030119|584666233|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
161895213|NCT02030119|584666234|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
161895214|NCT02030119|584666235|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
161895215|NCT02030119|584666236|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
161895216|NCT02213380|584666241|FG000|Underwent Randomization|Withdrawal by Subject|2|||
161895217|NCT02213380|584666242|FG001|Underwent Randomization|Withdrawal by Subject|0|||
161895218|NCT02213380|584666241|FG000|Underwent Randomization|Not treated|3|||
161895219|NCT02213380|584666242|FG001|Underwent Randomization|Not treated|3|||
161895220|NCT02213380|584666241|FG000|Per-protocol Analysis|Protocol Violation|32|||
161895221|NCT02213380|584666242|FG001|Per-protocol Analysis|Protocol Violation|36|||
161895222|NCT01465230|584666251|FG000|Overall Study|Withdrawal by Subject|2|||
162008866|NCT02006472|585088209|FG002|Period 1 (Through Week 26)|Other|0|||
162008867|NCT02006472|585088210|FG003|Period 1 (Through Week 26)|Other|2|||
162008868|NCT02006472|585088211|FG004|Period 1 (Through Week 26)|Other|3|||
162008869|NCT02006472|585088207|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
162008870|NCT02006472|585088208|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
162008871|NCT02006472|585088209|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
162008872|NCT02006472|585088210|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
162008873|NCT02006472|585088211|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
162008874|NCT02006472|585088207|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
162008875|NCT02006472|585088208|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
162008876|NCT02006472|585088209|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
162008877|NCT02006472|585088210|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
162008878|NCT02006472|585088211|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
162008879|NCT02006472|585088207|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
162008880|NCT02006472|585088208|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
162008881|NCT02006472|585088209|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
162008882|NCT02006472|585088210|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
162008883|NCT02006472|585088211|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
162008884|NCT02006472|585088207|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
162008885|NCT02006472|585088208|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
162008886|NCT02006472|585088209|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
162008887|NCT02006472|585088210|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
162008888|NCT02006472|585088211|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
162008889|NCT02006472|585088207|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
162008890|NCT02006472|585088208|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
162008891|NCT02006472|585088209|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
162008892|NCT02006472|585088210|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
162008893|NCT02006472|585088211|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
161895223|NCT00905567|584666252|FG000|Washout|Withdrawal by Subject|0|||
161895224|NCT00905567|584666253|FG001|Washout|Withdrawal by Subject|1|||
161895225|NCT01738919|584666259|FG000|Overall Study|Lost to Follow-up|1|||
161895226|NCT01738919|584666260|FG001|Overall Study|Lost to Follow-up|0|||
161895227|NCT01738919|584666259|FG000|Overall Study|Immigrated|0|||
161895228|NCT01738919|584666260|FG001|Overall Study|Immigrated|1|||
161895229|NCT01738919|584666259|FG000|Overall Study|Withdrawal by Subject|0|||
162008894|NCT02006472|585088207|FG000|Period 2 (Through Week 52)|Other|0|||
162008895|NCT02006472|585088208|FG001|Period 2 (Through Week 52)|Other|1|||
162008896|NCT02006472|585088209|FG002|Period 2 (Through Week 52)|Other|0|||
162008897|NCT02006472|585088210|FG003|Period 2 (Through Week 52)|Other|1|||
162008898|NCT02006472|585088211|FG004|Period 2 (Through Week 52)|Other|0|||
162008899|NCT02006472|585088207|FG000|Period 2 (Through Week 52)|Not treated|0|||
162008900|NCT02006472|585088208|FG001|Period 2 (Through Week 52)|Not treated|0|||
162008901|NCT02006472|585088209|FG002|Period 2 (Through Week 52)|Not treated|2|||
162008902|NCT02006472|585088210|FG003|Period 2 (Through Week 52)|Not treated|0|||
162008903|NCT02006472|585088211|FG004|Period 2 (Through Week 52)|Not treated|0|||
162008904|NCT02006472|585088207|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
162008905|NCT02006472|585088208|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
162008906|NCT02006472|585088209|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
162008907|NCT02006472|585088210|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
162008908|NCT02006472|585088211|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
162008909|NCT02006472|585088207|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
162008910|NCT02006472|585088208|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
162008911|NCT02006472|585088209|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
162008912|NCT02006472|585088210|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
162008913|NCT02006472|585088211|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
162008914|NCT04558125|585088212|FG000|Overall Study|Death|1|||
162008915|NCT01710345|585088220|FG000|Overall Study|Adverse Event|0|||
162008916|NCT01710345|585088221|FG001|Overall Study|Adverse Event|2|||
162008917|NCT01710345|585088222|FG002|Overall Study|Adverse Event|0|||
162008918|NCT01710345|585088220|FG000|Overall Study|Lack of Efficacy|2|||
162008919|NCT01710345|585088221|FG001|Overall Study|Lack of Efficacy|3|||
162008920|NCT01710345|585088222|FG002|Overall Study|Lack of Efficacy|1|||
162008921|NCT01710345|585088220|FG000|Overall Study|Drug Dosing Error|1|||
162008922|NCT01710345|585088221|FG001|Overall Study|Drug Dosing Error|0|||
162008923|NCT01710345|585088222|FG002|Overall Study|Drug Dosing Error|0|||
162008924|NCT00449696|585088224|FG000|Overall Study|Other Treatment Required|6|||
162008925|NCT00449696|585088225|FG001|Overall Study|Other Treatment Required|1|||
162008926|NCT00449696|585088224|FG000|Overall Study|Withdrawal by Subject|5|||
162008927|NCT00449696|585088225|FG001|Overall Study|Withdrawal by Subject|5|||
162008928|NCT00449696|585088224|FG000|Overall Study|Lost to Follow-up|2|||
162008929|NCT00449696|585088225|FG001|Overall Study|Lost to Follow-up|3|||
162008930|NCT00449696|585088224|FG000|Overall Study|Others|7|||
162008931|NCT00449696|585088225|FG001|Overall Study|Others|0|||
162008932|NCT01033019|585088228|FG000|Overall Study|Withdrawal by Subject|1|||
162008933|NCT01033019|585088229|FG001|Overall Study|Withdrawal by Subject|0|||
162008934|NCT01339832|585088230|FG000|Overall Study|Lost to Follow-up|3|||
162008935|NCT01339832|585088230|FG000|Overall Study|Death|11|||
162008936|NCT01052493|585088231|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
162008937|NCT01052493|585088232|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
162008938|NCT01052493|585088233|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
162008939|NCT01075243|585088239|FG000|Overall Study|Lost to Follow-up|5|||
162008940|NCT01075243|585088240|FG001|Overall Study|Lost to Follow-up|2|||
162008941|NCT01075243|585088241|FG002|Overall Study|Lost to Follow-up|0|||
162008942|NCT01075243|585088239|FG000|Overall Study|Withdrawal by Subject|1|||
162008943|NCT01075243|585088240|FG001|Overall Study|Withdrawal by Subject|1|||
162008944|NCT01075243|585088241|FG002|Overall Study|Withdrawal by Subject|0|||
162008945|NCT00627393|585088242|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
162008946|NCT00627393|585088243|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
162008947|NCT00627393|585088242|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
162008948|NCT00627393|585088243|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
162008949|NCT00627393|585088242|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
162008950|NCT00627393|585088243|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
162008951|NCT00627393|585088242|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
162008952|NCT00627393|585088243|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
162008953|NCT00551642|585088244|FG000|Treatment Period|Protocol Deviation|6|||
162008954|NCT00551642|585088245|FG001|Treatment Period|Protocol Deviation|11|||
162008955|NCT00551642|585088244|FG000|Treatment Period|Delivery device failure|1|||
162008956|NCT00551642|585088245|FG001|Treatment Period|Delivery device failure|3|||
162008957|NCT00551642|585088244|FG000|Treatment Period|Physician Decision|0|||
161779409|NCT01678924|584235526|FG001|Overall Study|Unable to attend scheduled visits|0|||
161779410|NCT01678924|584235527|FG002|Overall Study|Unable to attend scheduled visits|0|||
161779411|NCT01678924|584235528|FG003|Overall Study|Unable to attend scheduled visits|1|||
161779412|NCT02253654|584235529|FG000|Overall Study|Withdrawal by Subject|12|||
161895230|NCT01738919|584666260|FG001|Overall Study|Withdrawal by Subject|1|||
162008958|NCT00551642|585088245|FG001|Treatment Period|Physician Decision|1|||
162008959|NCT00551642|585088244|FG000|Treatment Period|Death|33|||
162008960|NCT00551642|585088245|FG001|Treatment Period|Death|31|||
162008961|NCT00551642|585088244|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
162008962|NCT00551642|585088245|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
162008963|NCT00551642|585088244|FG000|Treatment Period|Adverse Event|15|||
162008964|NCT00551642|585088245|FG001|Treatment Period|Adverse Event|12|||
162008965|NCT00551642|585088244|FG000|Treatment Period|Withdrawal by Subject|2|||
162008966|NCT00551642|585088245|FG001|Treatment Period|Withdrawal by Subject|1|||
162008967|NCT03337308|585088246|FG000|Overall Study|Adverse Event|2|||
162008968|NCT03337308|585088247|FG001|Overall Study|Adverse Event|3|||
162008969|NCT03337308|585088248|FG002|Overall Study|Adverse Event|3|||
162008970|NCT03337308|585088249|FG003|Overall Study|Adverse Event|1|||
162008971|NCT03337308|585088246|FG000|Overall Study|Lost to Follow-up|1|||
162008972|NCT03337308|585088247|FG001|Overall Study|Lost to Follow-up|2|||
162008973|NCT03337308|585088248|FG002|Overall Study|Lost to Follow-up|0|||
162008974|NCT03337308|585088249|FG003|Overall Study|Lost to Follow-up|0|||
162008975|NCT03337308|585088246|FG000|Overall Study|Withdrawal by Subject|2|||
162008976|NCT03337308|585088247|FG001|Overall Study|Withdrawal by Subject|1|||
162008977|NCT03337308|585088248|FG002|Overall Study|Withdrawal by Subject|2|||
162008978|NCT03337308|585088249|FG003|Overall Study|Withdrawal by Subject|1|||
162008979|NCT03337308|585088246|FG000|Overall Study|Protocol Violation|0|||
162008980|NCT03337308|585088247|FG001|Overall Study|Protocol Violation|1|||
162008981|NCT03337308|585088248|FG002|Overall Study|Protocol Violation|0|||
162008982|NCT03337308|585088249|FG003|Overall Study|Protocol Violation|0|||
162008983|NCT00283296|585088251|FG000|Overall Study|in-home trial not completed|5|||
162008984|NCT03558737|585088252|FG000|Overall Study|Death|1|||
162008985|NCT03558737|585088253|FG001|Overall Study|Death|1|||
162008986|NCT01294553|585088254|FG000|Overall Study|Duplicated Participants|1|||
162008987|NCT01294553|585088254|FG000|Overall Study|Protocol Violation|268|||
162008988|NCT00888134|585088255|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
162008989|NCT00888134|585088255|FG000|Follow-up|being followed for long-term survival|1|||
162008990|NCT00795535|585088256|FG000|Overall Study|incomplete data and technical problems|20|||
162008991|NCT01903460|585088259|FG000|Overall Study|Adverse Event|0|||
162008992|NCT01903460|585088260|FG001|Overall Study|Adverse Event|0|||
162008993|NCT01903460|585088261|FG002|Overall Study|Adverse Event|0|||
162008994|NCT01903460|585088262|FG003|Overall Study|Adverse Event|1|||
162008995|NCT03104868|585088263|FG000|6 Week Follow up|Lost to Follow-up|5|||
162008996|NCT03104868|585088264|FG001|6 Week Follow up|Lost to Follow-up|8|||
162008997|NCT03104868|585088263|FG000|6 Week Follow up|Death|1|||
162008998|NCT03104868|585088264|FG001|6 Week Follow up|Death|1|||
162008999|NCT03104868|585088263|FG000|6 Week Follow up|Withdrawal by Subject|7|||
162009000|NCT03104868|585088264|FG001|6 Week Follow up|Withdrawal by Subject|6|||
162009001|NCT03104868|585088263|FG000|6 Week Follow up|Completed Later Timepoint|24|||
162009002|NCT03104868|585088264|FG001|6 Week Follow up|Completed Later Timepoint|22|||
162009003|NCT03104868|585088263|FG000|6 Month Follow up|Lost to Follow-up|2|||
162009004|NCT03104868|585088264|FG001|6 Month Follow up|Lost to Follow-up|2|||
162009005|NCT03104868|585088263|FG000|6 Month Follow up|Death|0|||
162009006|NCT03104868|585088264|FG001|6 Month Follow up|Death|1|||
162009007|NCT03104868|585088263|FG000|6 Month Follow up|Completed Later Timepoint|22|||
162009008|NCT03104868|585088264|FG001|6 Month Follow up|Completed Later Timepoint|32|||
162009009|NCT03104868|585088263|FG000|12 Month Follow up|Lost to Follow-up|1|||
162009010|NCT03104868|585088264|FG001|12 Month Follow up|Lost to Follow-up|2|||
162009011|NCT03104868|585088263|FG000|12 Month Follow up|Death|0|||
162009012|NCT03104868|585088264|FG001|12 Month Follow up|Death|1|||
162009013|NCT03104868|585088263|FG000|12 Month Follow up|Withdrawal by Subject|0|||
162009014|NCT03104868|585088264|FG001|12 Month Follow up|Withdrawal by Subject|3|||
162009015|NCT03104868|585088263|FG000|12 Month Follow up|Completed Later Timepoint|32|||
162009016|NCT03104868|585088264|FG001|12 Month Follow up|Completed Later Timepoint|29|||
162009017|NCT03104868|585088263|FG000|18 Month Follow up|Lost to Follow-up|7|||
162009018|NCT03104868|585088264|FG001|18 Month Follow up|Lost to Follow-up|11|||
162009019|NCT03104868|585088263|FG000|18 Month Follow up|Death|2|||
162009020|NCT03104868|585088264|FG001|18 Month Follow up|Death|1|||
162009021|NCT03104868|585088263|FG000|18 Month Follow up|Withdrawal by Subject|1|||
162009022|NCT03104868|585088264|FG001|18 Month Follow up|Withdrawal by Subject|2|||
162009023|NCT03104868|585088263|FG000|18 Month Follow up|Graft Loss|1|||
162009024|NCT03104868|585088264|FG001|18 Month Follow up|Graft Loss|1|||
162009025|NCT03104868|585088263|FG000|18 Month Follow up|Completed Later Timepoint|19|||
162009026|NCT03104868|585088264|FG001|18 Month Follow up|Completed Later Timepoint|20|||
162009027|NCT03104868|585088263|FG000|24 Month Follow up|Lost to Follow-up|15|||
162009028|NCT03104868|585088264|FG001|24 Month Follow up|Lost to Follow-up|16|||
162009029|NCT03104868|585088263|FG000|24 Month Follow up|Death|3|||
162122857|NCT00358215|585502342|FG000|Overall Study|Did not receive investigational product|2|||
162009030|NCT03104868|585088264|FG001|24 Month Follow up|Death|2|||
162009031|NCT03104868|585088263|FG000|24 Month Follow up|Withdrawal by Subject|1|||
162009032|NCT03104868|585088264|FG001|24 Month Follow up|Withdrawal by Subject|0|||
162009033|NCT03104868|585088263|FG000|24 Month Follow up|Graft Loss|2|||
162009034|NCT03104868|585088264|FG001|24 Month Follow up|Graft Loss|0|||
162236362|NCT00250679|585916936|FG001|Overall Study|Moved|1|||
162009035|NCT00888173|585088266|FG000|Overall Study|Wrong Primary|1|||
162009036|NCT00888173|585088266|FG000|Overall Study|Ineligible: required test not done|1|||
162009037|NCT01488890|585088267|FG000|Overall Study|Serious adverse event|2|||
162009038|NCT01488890|585088268|FG001|Overall Study|Serious adverse event|0|||
162009039|NCT01488890|585088269|FG002|Overall Study|Serious adverse event|0|||
162009040|NCT01488890|585088270|FG003|Overall Study|Serious adverse event|0|||
162009041|NCT01488890|585088267|FG000|Overall Study|Protocol Violation|3|||
162009042|NCT01488890|585088268|FG001|Overall Study|Protocol Violation|0|||
162009043|NCT01488890|585088269|FG002|Overall Study|Protocol Violation|4|||
162009044|NCT01488890|585088270|FG003|Overall Study|Protocol Violation|0|||
162009045|NCT01488890|585088267|FG000|Overall Study|Lost to Follow-up|13|||
162009046|NCT01488890|585088268|FG001|Overall Study|Lost to Follow-up|10|||
162009047|NCT01488890|585088269|FG002|Overall Study|Lost to Follow-up|20|||
162009048|NCT01488890|585088270|FG003|Overall Study|Lost to Follow-up|3|||
162009049|NCT01488890|585088267|FG000|Overall Study|Withdrawal by Subject|14|||
162009050|NCT01488890|585088268|FG001|Overall Study|Withdrawal by Subject|10|||
162009051|NCT01488890|585088269|FG002|Overall Study|Withdrawal by Subject|11|||
162009052|NCT01488890|585088270|FG003|Overall Study|Withdrawal by Subject|2|||
162009053|NCT00829426|585088271|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
162009054|NCT00829426|585088272|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
162009055|NCT04408989|585088273|FG000|Overall Study|Lost to Follow-up|0|||
162009056|NCT04408989|585088274|FG001|Overall Study|Lost to Follow-up|0|||
162009057|NCT04408989|585088275|FG002|Overall Study|Lost to Follow-up|1|||
162009058|NCT04408989|585088273|FG000|Overall Study|Withdrawal by Subject|0|||
162009059|NCT04408989|585088274|FG001|Overall Study|Withdrawal by Subject|0|||
162009060|NCT04408989|585088275|FG002|Overall Study|Withdrawal by Subject|2|||
162009061|NCT02260934|585088290|FG000|Overall Study|Lost to Follow-up|2|||
162009062|NCT02260934|585088291|FG001|Overall Study|Lost to Follow-up|1|||
162009063|NCT02260934|585088290|FG000|Overall Study|Withdrawal by Subject|0|||
162009064|NCT02260934|585088291|FG001|Overall Study|Withdrawal by Subject|2|||
162009065|NCT02260934|585088290|FG000|Overall Study|Participant Relocated|1|||
162009066|NCT02260934|585088291|FG001|Overall Study|Participant Relocated|0|||
162009067|NCT02260934|585088290|FG000|Overall Study|Site error|0|||
162009068|NCT02260934|585088291|FG001|Overall Study|Site error|1|||
162009069|NCT03605667|585088294|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
162009070|NCT03605667|585088295|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
162009071|NCT03605667|585088294|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
162009072|NCT03605667|585088295|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
162009073|NCT03605667|585088294|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
162009074|NCT03605667|585088295|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
162009075|NCT03605667|585088294|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
162009076|NCT03605667|585088295|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
162009077|NCT03605667|585088294|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
162009078|NCT03605667|585088295|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
162009079|NCT03605667|585088294|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
162009080|NCT03605667|585088295|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
162009081|NCT03605667|585088294|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
162009082|NCT03605667|585088295|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
162009083|NCT03605667|585088294|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
162009084|NCT03605667|585088295|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
162009085|NCT03605667|585088294|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
162009086|NCT03605667|585088295|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
162009087|NCT03605667|585088294|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
162009088|NCT03605667|585088295|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
162009089|NCT03605667|585088294|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
162009090|NCT03605667|585088295|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
162009091|NCT03605667|585088294|FG000|OLE Phase (48 Weeks)|Other|6|||
162009092|NCT03605667|585088295|FG001|OLE Phase (48 Weeks)|Other|8|||
162009093|NCT03605667|585088294|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
162009094|NCT03605667|585088295|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
162009095|NCT03605667|585088294|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
162009096|NCT03605667|585088295|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
162009097|NCT03605667|585088294|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
162009098|NCT03605667|585088295|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
162009099|NCT03605667|585088294|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
162009100|NCT03605667|585088295|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
162009101|NCT03605667|585088294|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
162009102|NCT03605667|585088295|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
162009103|NCT03605667|585088294|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
162009104|NCT03605667|585088295|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
162009105|NCT03605667|585088294|FG000|OLE Phase (48 Weeks)|Death|0|||
162009106|NCT03605667|585088295|FG001|OLE Phase (48 Weeks)|Death|2|||
162009107|NCT03605667|585088294|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
162009108|NCT03605667|585088295|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
162009109|NCT05632211|585088296|FG000|Overall Study|Withdrawal by Subject|2|||
162009110|NCT05632211|585088297|FG001|Overall Study|Withdrawal by Subject|0|||
162009111|NCT05632211|585088298|FG002|Overall Study|Withdrawal by Subject|2|||
162009112|NCT05632211|585088296|FG000|Overall Study|Other reasons|1|||
162009113|NCT05632211|585088297|FG001|Overall Study|Other reasons|1|||
162009114|NCT05632211|585088298|FG002|Overall Study|Other reasons|1|||
162009115|NCT02628873|585088299|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
162009116|NCT02628873|585088300|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
162009117|NCT02628873|585088299|FG000|Second Test (1 Hour)|Physician Decision|1|||
162009118|NCT02628873|585088300|FG001|Second Test (1 Hour)|Physician Decision|0|||
162009119|NCT03597347|585088303|FG000|Overall Study|Withdrawal by Subject|1|||
162009120|NCT03597347|585088304|FG001|Overall Study|Withdrawal by Subject|1|||
162009121|NCT03597347|585088305|FG002|Overall Study|Withdrawal by Subject|0|||
162009122|NCT03597347|585088303|FG000|Overall Study|Withdrawal due to Covid-19|3|||
162009123|NCT03597347|585088304|FG001|Overall Study|Withdrawal due to Covid-19|0|||
162009124|NCT03597347|585088305|FG002|Overall Study|Withdrawal due to Covid-19|0|||
162009125|NCT03597347|585088303|FG000|Overall Study|Sponsor decision to terminate study|3|||
162009126|NCT03597347|585088304|FG001|Overall Study|Sponsor decision to terminate study|2|||
162009127|NCT03597347|585088305|FG002|Overall Study|Sponsor decision to terminate study|4|||
162009128|NCT04606134|585088306|FG000|Overall Study|Adverse Event|0|||
162009129|NCT04606134|585088307|FG001|Overall Study|Adverse Event|1|||
162009130|NCT00107653|585088308|FG000|Overall Study|Adverse Event|24|||
162009131|NCT00107653|585088309|FG001|Overall Study|Adverse Event|43|||
162009132|NCT00107653|585088308|FG000|Overall Study|Insufficient Therapeutic Response|25|||
162009133|NCT00107653|585088309|FG001|Overall Study|Insufficient Therapeutic Response|11|||
162009134|NCT00107653|585088308|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
162009135|NCT00107653|585088309|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
162009136|NCT00107653|585088308|FG000|Overall Study|Protocol Violation|1|||
162009137|NCT00107653|585088309|FG001|Overall Study|Protocol Violation|0|||
162009138|NCT00107653|585088308|FG000|Overall Study|Withdrawal by Subject|12|||
162009139|NCT00107653|585088309|FG001|Overall Study|Withdrawal by Subject|13|||
162009140|NCT00107653|585088308|FG000|Overall Study|Lost to Follow-up|13|||
162009141|NCT00107653|585088309|FG001|Overall Study|Lost to Follow-up|5|||
162009142|NCT00107653|585088308|FG000|Overall Study|Administrative Reasons|3|||
162009143|NCT00107653|585088309|FG001|Overall Study|Administrative Reasons|3|||
162009144|NCT01099267|585088311|FG000|MDS-003 Study|Adverse Event|37|||
162009145|NCT01099267|585088311|FG000|MDS-003 Study|Lack of Efficacy|52|||
162009146|NCT01099267|585088311|FG000|MDS-003 Study|Withdrawal by Subject|8|||
162009147|NCT01099267|585088311|FG000|MDS-003 Study|Lost to Follow-up|1|||
162009148|NCT01099267|585088311|FG000|MDS-003 Study|Death|11|||
162009149|NCT01099267|585088311|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
162009150|NCT01099267|585088311|FG000|MDS-003 Study|Disease Progression|7|||
162009151|NCT01099267|585088311|FG000|MDS-003 Study|Investigator Decision|2|||
162009152|NCT01099267|585088311|FG000|MDS-003 Study|Non-Compliance|2|||
162009153|NCT01099267|585088311|FG000|MDS-003 Study|Loss of Response|1|||
162009154|NCT01099267|585088311|FG000|MDS-003 Study|Secondary Malign Disease|1|||
162009155|NCT04986904|585088312|FG000|Overall Study|Lost to Follow-up|11|||
162009156|NCT04986904|585088312|FG000|Overall Study|Withdrawal by Subject|1|||
162009157|NCT03694353|585088313|FG000|Overall Study|Withdrawal by Subject|1|||
162009158|NCT03694353|585088313|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
162009159|NCT03804528|585088314|FG000|Overall Study|Time Commitment|18|||
162009160|NCT03804528|585088314|FG000|Overall Study|Health Reasons|5|||
162009161|NCT05138653|585088315|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
162009162|NCT05138653|585088316|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009163|NCT05138653|585088317|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009164|NCT05138653|585088318|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009165|NCT05138653|585088319|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009166|NCT05138653|585088320|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009167|NCT05138653|585088321|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009168|NCT05138653|585088322|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009169|NCT05138653|585088323|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009170|NCT05138653|585088324|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009171|NCT05138653|585088325|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009172|NCT05138653|585088326|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009173|NCT05138653|585088327|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009174|NCT05138653|585088328|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009175|NCT05138653|585088329|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009176|NCT05138653|585088330|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
162009177|NCT05138653|585088315|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162009178|NCT05138653|585088316|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
162009179|NCT05138653|585088317|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162009180|NCT05138653|585088318|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162009181|NCT05138653|585088319|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162009182|NCT05138653|585088320|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162009183|NCT05138653|585088321|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162009184|NCT05138653|585088322|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162009185|NCT05138653|585088323|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
162009186|NCT05138653|585088324|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162240370|NCT01128894|585932462|FG001|Overall Study|Withdrawal by Subject|12|||
162009187|NCT05138653|585088325|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162122858|NCT00358215|585502343|FG001|Overall Study|Did not receive investigational product|3|||
162122859|NCT00871351|585502344|FG000|Overall Study|Withdrawal by Subject|1|||
162122860|NCT00871351|585502345|FG001|Overall Study|Withdrawal by Subject|0|||
162122861|NCT00871351|585502346|FG002|Overall Study|Withdrawal by Subject|0|||
162122862|NCT00871351|585502344|FG000|Overall Study|Adverse Event|3|||
162122863|NCT00871351|585502345|FG001|Overall Study|Adverse Event|1|||
162122864|NCT00871351|585502346|FG002|Overall Study|Adverse Event|0|||
162122865|NCT00744237|585502347|FG000|Overall Study|Lack of Efficacy|1|||
162122866|NCT00744237|585502348|FG001|Overall Study|Lack of Efficacy|1|||
162122867|NCT00744237|585502349|FG002|Overall Study|Lack of Efficacy|0|||
162122868|NCT00744237|585502347|FG000|Overall Study|Withdrawal by Subject|9|||
162122869|NCT00744237|585502348|FG001|Overall Study|Withdrawal by Subject|5|||
162122870|NCT00744237|585502349|FG002|Overall Study|Withdrawal by Subject|3|||
162122871|NCT00744237|585502347|FG000|Overall Study|Lost to Follow-up|1|||
162122872|NCT00744237|585502348|FG001|Overall Study|Lost to Follow-up|1|||
162122873|NCT00744237|585502349|FG002|Overall Study|Lost to Follow-up|1|||
162240371|NCT01128894|585932461|FG000|Overall Study|Physician Decision|2|||
162240372|NCT01128894|585932462|FG001|Overall Study|Physician Decision|1|||
162240373|NCT01128894|585932461|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
162240374|NCT01128894|585932462|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
162240375|NCT01128738|585932463|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
162240376|NCT01128738|585932464|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
162240377|NCT01128738|585932463|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
162240378|NCT01128738|585932464|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
162240379|NCT01128738|585932463|FG000|Second TP|Lost to Follow-up|0|||
162240380|NCT01128738|585932464|FG001|Second TP|Lost to Follow-up|1|||
162240381|NCT01128738|585932463|FG000|Second TP|Withdrawal by Subject|0|||
162240382|NCT01128738|585932464|FG001|Second TP|Withdrawal by Subject|2|||
162240383|NCT00973362|585932465|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
162240384|NCT00973362|585932466|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
162240385|NCT00973362|585932465|FG000|Baseline Evaluation|No colposcopy visit|62|||
162240386|NCT00973362|585932466|FG001|Baseline Evaluation|No colposcopy visit|0|||
162240387|NCT00973362|585932465|FG000|Baseline Evaluation|Inevaluable|686|||
162240388|NCT00973362|585932466|FG001|Baseline Evaluation|Inevaluable|223|||
162240389|NCT00973362|585932465|FG000|3-Year Follow-up|Lost to Follow-up|17|||
162240390|NCT00973362|585932466|FG001|3-Year Follow-up|Lost to Follow-up|0|||
162240391|NCT00887679|585932469|FG000|Overall Study|Withdrawal by Subject|1|||
162240392|NCT00887679|585932469|FG000|Overall Study|Lost to Follow-up|4|||
161895231|NCT01738919|584666259|FG000|Overall Study|Not treated in accordance to guidelines|0|||
161895232|NCT01738919|584666260|FG001|Overall Study|Not treated in accordance to guidelines|1|||
161895233|NCT02532257|584666261|FG000|Overall Study|Adverse Event|2|||
161895234|NCT02532257|584666261|FG000|Overall Study|Physician Decision|4|||
161895235|NCT02532257|584666261|FG000|Overall Study|Withdrawal by Subject|3|||
161895236|NCT02532257|584666261|FG000|Overall Study|Progressive Disease|10|||
161895237|NCT02259400|584666262|FG000|Overall Study|Death|0|||
161895238|NCT02259400|584666263|FG001|Overall Study|Death|2|||
161895239|NCT03498313|584666267|FG000|Experimental Period 1|Adverse Event|1|||
161895240|NCT03498313|584666268|FG001|Experimental Period 1|Adverse Event|0|||
161895241|NCT03498313|584666269|FG002|Experimental Period 1|Adverse Event|0|||
161895242|NCT03498313|584666270|FG003|Experimental Period 1|Adverse Event|1|||
161895243|NCT03498313|584666271|FG004|Experimental Period 1|Adverse Event|0|||
161895244|NCT03498313|584666272|FG005|Experimental Period 1|Adverse Event|0|||
161895245|NCT03498313|584666267|FG000|Experimental Period 1|Withdrawal by Subject|0|||
161895246|NCT03498313|584666268|FG001|Experimental Period 1|Withdrawal by Subject|1|||
161895247|NCT03498313|584666269|FG002|Experimental Period 1|Withdrawal by Subject|0|||
161895248|NCT03498313|584666270|FG003|Experimental Period 1|Withdrawal by Subject|0|||
161895249|NCT03498313|584666271|FG004|Experimental Period 1|Withdrawal by Subject|0|||
161895250|NCT03498313|584666272|FG005|Experimental Period 1|Withdrawal by Subject|0|||
161895251|NCT03498313|584666267|FG000|Washout Period 1|Anovulation|1|||
161895252|NCT03498313|584666268|FG001|Washout Period 1|Anovulation|0|||
161895253|NCT03498313|584666269|FG002|Washout Period 1|Anovulation|0|||
161895254|NCT03498313|584666270|FG003|Washout Period 1|Anovulation|0|||
161895255|NCT03498313|584666271|FG004|Washout Period 1|Anovulation|0|||
161895256|NCT03498313|584666272|FG005|Washout Period 1|Anovulation|0|||
161895257|NCT03498313|584666267|FG000|Washout Period 1|Withdrawal by Subject|0|||
161895258|NCT03498313|584666268|FG001|Washout Period 1|Withdrawal by Subject|3|||
161895259|NCT03498313|584666269|FG002|Washout Period 1|Withdrawal by Subject|0|||
161895260|NCT03498313|584666270|FG003|Washout Period 1|Withdrawal by Subject|1|||
161895261|NCT03498313|584666271|FG004|Washout Period 1|Withdrawal by Subject|0|||
161895262|NCT03498313|584666272|FG005|Washout Period 1|Withdrawal by Subject|1|||
161895263|NCT03498313|584666267|FG000|Experimental Period 2|Adverse Event|0|||
161895264|NCT03498313|584666268|FG001|Experimental Period 2|Adverse Event|0|||
161895265|NCT03498313|584666269|FG002|Experimental Period 2|Adverse Event|0|||
161779413|NCT02253654|584235530|FG001|Overall Study|Withdrawal by Subject|4|||
161779414|NCT02253654|584235529|FG000|Overall Study|Decision by Sponsor|1|||
161779415|NCT02253654|584235530|FG001|Overall Study|Decision by Sponsor|1|||
161779416|NCT02253654|584235529|FG000|Overall Study|Lost to Follow-up|2|||
161779417|NCT02253654|584235530|FG001|Overall Study|Lost to Follow-up|5|||
161779418|NCT02253654|584235529|FG000|Overall Study|Death|4|||
161779419|NCT02253654|584235530|FG001|Overall Study|Death|7|||
161779420|NCT02253654|584235529|FG000|Overall Study|Did Not Receive Study Treatment|4|||
161895266|NCT03498313|584666270|FG003|Experimental Period 2|Adverse Event|0|||
161779421|NCT02253654|584235530|FG001|Overall Study|Did Not Receive Study Treatment|1|||
161779422|NCT01614925|584235531|FG000|Overall Study|Withdrawal by Subject|1|||
161779423|NCT01614925|584235532|FG001|Overall Study|Withdrawal by Subject|0|||
161779424|NCT01614925|584235531|FG000|Overall Study|Protocol Violation|3|||
161779425|NCT01614925|584235532|FG001|Overall Study|Protocol Violation|2|||
161779426|NCT01652573|584235543|FG000|Overall Study|Adverse Event|0|||
161779427|NCT01652573|584235544|FG001|Overall Study|Adverse Event|1|||
161895267|NCT03498313|584666271|FG004|Experimental Period 2|Adverse Event|1|||
161895268|NCT03498313|584666272|FG005|Experimental Period 2|Adverse Event|2|||
161895269|NCT03498313|584666267|FG000|Washout Period 2|Physician Decision|1|||
161895270|NCT03498313|584666268|FG001|Washout Period 2|Physician Decision|0|||
161895271|NCT03498313|584666269|FG002|Washout Period 2|Physician Decision|0|||
161895272|NCT03498313|584666270|FG003|Washout Period 2|Physician Decision|1|||
161895273|NCT03498313|584666271|FG004|Washout Period 2|Physician Decision|0|||
161895274|NCT03498313|584666272|FG005|Washout Period 2|Physician Decision|1|||
161895275|NCT03498313|584666267|FG000|Washout Period 2|Withdrawal by Subject|3|||
161895276|NCT03498313|584666268|FG001|Washout Period 2|Withdrawal by Subject|2|||
161895277|NCT03498313|584666269|FG002|Washout Period 2|Withdrawal by Subject|0|||
161895278|NCT03498313|584666270|FG003|Washout Period 2|Withdrawal by Subject|0|||
161895279|NCT03498313|584666271|FG004|Washout Period 2|Withdrawal by Subject|2|||
161895280|NCT03498313|584666272|FG005|Washout Period 2|Withdrawal by Subject|0|||
161895281|NCT03498313|584666267|FG000|Washout Period 2|Anovulation|0|||
161895282|NCT03498313|584666268|FG001|Washout Period 2|Anovulation|0|||
161895283|NCT03498313|584666269|FG002|Washout Period 2|Anovulation|0|||
161895284|NCT03498313|584666270|FG003|Washout Period 2|Anovulation|0|||
161895285|NCT03498313|584666271|FG004|Washout Period 2|Anovulation|0|||
161895286|NCT03498313|584666272|FG005|Washout Period 2|Anovulation|1|||
161895287|NCT02372383|584666276|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
161895288|NCT02372383|584666277|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
161895289|NCT02372383|584666278|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
161895290|NCT00621257|584666279|FG000|Overall Study|Lost to Follow-up|4|||
161895291|NCT00621257|584666280|FG001|Overall Study|Lost to Follow-up|0|||
161895292|NCT00621257|584666281|FG002|Overall Study|Lost to Follow-up|2|||
161895293|NCT00621257|584666282|FG003|Overall Study|Lost to Follow-up|4|||
161895294|NCT00621257|584666283|FG004|Overall Study|Lost to Follow-up|7|||
161895295|NCT00621257|584666279|FG000|Overall Study|Adverse Event|0|||
161895296|NCT00621257|584666280|FG001|Overall Study|Adverse Event|1|||
161895297|NCT00621257|584666281|FG002|Overall Study|Adverse Event|1|||
161895298|NCT00621257|584666282|FG003|Overall Study|Adverse Event|0|||
161895299|NCT00621257|584666283|FG004|Overall Study|Adverse Event|0|||
161895300|NCT00621257|584666279|FG000|Overall Study|Physician Decision|0|||
161895301|NCT00621257|584666280|FG001|Overall Study|Physician Decision|2|||
161895302|NCT00621257|584666281|FG002|Overall Study|Physician Decision|0|||
161895303|NCT00621257|584666282|FG003|Overall Study|Physician Decision|1|||
161895304|NCT00621257|584666283|FG004|Overall Study|Physician Decision|1|||
161895305|NCT00621257|584666279|FG000|Overall Study|Withdrawal by Subject|0|||
161895306|NCT00621257|584666280|FG001|Overall Study|Withdrawal by Subject|0|||
161895307|NCT00621257|584666281|FG002|Overall Study|Withdrawal by Subject|0|||
161895308|NCT00621257|584666282|FG003|Overall Study|Withdrawal by Subject|1|||
161895309|NCT00621257|584666283|FG004|Overall Study|Withdrawal by Subject|1|||
161895310|NCT01255904|584666284|FG000|Overall Study|Physician Decision|1|||
161895311|NCT01255904|584666285|FG001|Overall Study|Physician Decision|4|||
161895312|NCT00694356|584666292|FG000|Overall Study|Adverse Event|1|||
161895313|NCT00694356|584666293|FG001|Overall Study|Adverse Event|0|||
161895314|NCT00694356|584666294|FG002|Overall Study|Adverse Event|0|||
161895315|NCT00694356|584666292|FG000|Overall Study|Progressive Disease|2|||
161895316|NCT00694356|584666293|FG001|Overall Study|Progressive Disease|6|||
161895317|NCT00694356|584666294|FG002|Overall Study|Progressive Disease|6|||
161895318|NCT02756819|584666295|FG000|Overall Study|Lost for observation|23|||
161895319|NCT02756819|584666295|FG000|Overall Study|Patient's unwillingness|16|||
161895320|NCT02756819|584666295|FG000|Overall Study|Insufficient efficacy|2|||
161895321|NCT02756819|584666295|FG000|Overall Study|Adverse Event|2|||
161895322|NCT02756819|584666295|FG000|Overall Study|Reason not Specified|9|||
161895323|NCT00741598|584666296|FG000|Overall Study|Lost to Follow-up|3|||
161895324|NCT00741598|584666297|FG001|Overall Study|Lost to Follow-up|4|||
161895325|NCT00741598|584666296|FG000|Overall Study|Lack of Efficacy|1|||
162009188|NCT05138653|585088326|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161779428|NCT00934622|584235545|FG000|Overall Study|Lost to Follow-up|7|||
161779429|NCT00934622|584235545|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
162009189|NCT05138653|585088327|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162009190|NCT05138653|585088328|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162009191|NCT05138653|585088329|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162009192|NCT05138653|585088330|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
162009193|NCT05138653|585088315|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162009194|NCT05138653|585088316|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
162009195|NCT05138653|585088317|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162009196|NCT05138653|585088318|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162009197|NCT05138653|585088319|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
162009198|NCT05138653|585088320|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162009199|NCT05138653|585088321|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162009200|NCT05138653|585088322|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162009201|NCT05138653|585088323|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162240393|NCT00887679|585932469|FG000|Overall Study|Physician Decision|5|||
162240394|NCT02683941|585932470|FG000|Double-blind Phase|Adverse Event|0|||
162240395|NCT02683941|585932471|FG001|Double-blind Phase|Adverse Event|1|||
162240396|NCT02683941|585932470|FG000|Double-blind Phase|Withdrawal by Subject|4|||
162240397|NCT02683941|585932471|FG001|Double-blind Phase|Withdrawal by Subject|2|||
162240398|NCT02683941|585932470|FG000|Double-blind Phase|Lost to Follow-up|1|||
162240399|NCT02683941|585932471|FG001|Double-blind Phase|Lost to Follow-up|0|||
162240400|NCT02683941|585932470|FG000|Double-blind Phase|Disease Progression|5|||
162240401|NCT02683941|585932471|FG001|Double-blind Phase|Disease Progression|2|||
162240402|NCT02683941|585932470|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
162009202|NCT05138653|585088324|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162009203|NCT05138653|585088325|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162240403|NCT02683941|585932471|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
162240404|NCT02683941|585932470|FG000|Open-label Treatment Phase|Disease Progression|1|||
162240405|NCT02683941|585932471|FG001|Open-label Treatment Phase|Disease Progression|2|||
162240406|NCT02683941|585932470|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
162240407|NCT02683941|585932471|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
162240408|NCT02683941|585932470|FG000|Open-label Treatment Phase|Other|1|||
162240409|NCT02683941|585932471|FG001|Open-label Treatment Phase|Other|0|||
162240410|NCT02683941|585932470|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
162240411|NCT02683941|585932471|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
162240412|NCT02683941|585932470|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
162240413|NCT02683941|585932471|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
162240414|NCT02683941|585932470|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
162240415|NCT02683941|585932471|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
162240416|NCT02683941|585932470|FG000|Open-label Follow-up Phase|Other|8|||
162240417|NCT02683941|585932471|FG001|Open-label Follow-up Phase|Other|1|||
162240418|NCT00325039|585932472|FG000|Overall Study|Lost to Follow-up|18|||
162240419|NCT00325039|585932473|FG001|Overall Study|Lost to Follow-up|14|||
162240420|NCT01009203|585932475|FG000|Overall Study|Withdrawal by Subject|1|||
162240421|NCT01009203|585932475|FG000|Overall Study|Adverse Event|5|||
162240422|NCT01009203|585932475|FG000|Overall Study|Treatment-unrelated death|1|||
162240423|NCT02974088|585932479|FG000|Overall Study|Lost to Follow-up|0|||
162240424|NCT02974088|585932480|FG001|Overall Study|Lost to Follow-up|2|||
162240425|NCT02974088|585932479|FG000|Overall Study|Adverse Event|0|||
162240426|NCT02974088|585932480|FG001|Overall Study|Adverse Event|1|||
162240427|NCT00892723|585932481|FG000|Overall Study|Lost to Follow-up|1|||
162240428|NCT00892723|585932482|FG001|Overall Study|Lost to Follow-up|3|||
162240429|NCT00892723|585932483|FG002|Overall Study|Lost to Follow-up|1|||
162240430|NCT00892723|585932481|FG000|Overall Study|Withdrawal by Subject|1|||
162240431|NCT00892723|585932482|FG001|Overall Study|Withdrawal by Subject|1|||
162240432|NCT00892723|585932483|FG002|Overall Study|Withdrawal by Subject|1|||
162240433|NCT00150969|585932486|FG000|24 Month Main Study|Adverse Event|3|||
162240434|NCT00150969|585932487|FG001|24 Month Main Study|Adverse Event|4|||
162240435|NCT00150969|585932486|FG000|24 Month Main Study|Death|1|||
162240436|NCT00150969|585932487|FG001|24 Month Main Study|Death|1|||
162240437|NCT00150969|585932486|FG000|24 Month Main Study|Lack of Efficacy|1|||
162240438|NCT00150969|585932487|FG001|24 Month Main Study|Lack of Efficacy|8|||
162240439|NCT00150969|585932486|FG000|24 Month Main Study|Lost to Follow-up|3|||
162240440|NCT00150969|585932487|FG001|24 Month Main Study|Lost to Follow-up|2|||
162240441|NCT00150969|585932486|FG000|24 Month Main Study|Protocol Violation|4|||
162240442|NCT00150969|585932487|FG001|24 Month Main Study|Protocol Violation|2|||
162240443|NCT00150969|585932486|FG000|24 Month Main Study|Withdrawal by Subject|7|||
162240444|NCT00150969|585932487|FG001|24 Month Main Study|Withdrawal by Subject|4|||
162240445|NCT00150969|585932486|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
161895326|NCT00741598|584666297|FG001|Overall Study|Lack of Efficacy|2|||
162240446|NCT00150969|585932487|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
162240447|NCT00150969|585932486|FG000|24-48 Month Extension|Lack of Efficacy|0|||
162240448|NCT00150969|585932487|FG001|24-48 Month Extension|Lack of Efficacy|1|||
162240449|NCT00150969|585932486|FG000|24-48 Month Extension|Adverse Event|1|||
162240450|NCT00150969|585932487|FG001|24-48 Month Extension|Adverse Event|3|||
162240451|NCT00150969|585932486|FG000|24-48 Month Extension|Other Reason|81|||
162240452|NCT00150969|585932487|FG001|24-48 Month Extension|Other Reason|91|||
162240453|NCT00146757|585932488|FG000|Overall Study|Death|1|||
162240454|NCT00146757|585932489|FG001|Overall Study|Death|0|||
162240455|NCT00146757|585932488|FG000|Overall Study|Adverse Event|1|||
162240456|NCT00146757|585932489|FG001|Overall Study|Adverse Event|0|||
162240457|NCT00615836|585932490|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
162240458|NCT00615836|585932491|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
162240459|NCT00615836|585932492|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
162240460|NCT00615836|585932493|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
162240461|NCT00615836|585932494|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
162240462|NCT00615836|585932490|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
162240463|NCT00615836|585932491|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
162240464|NCT00615836|585932492|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
162240465|NCT00615836|585932493|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
162240466|NCT00615836|585932494|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
162009204|NCT05138653|585088326|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162009205|NCT05138653|585088327|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162009206|NCT05138653|585088328|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162009207|NCT05138653|585088329|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162009208|NCT05138653|585088330|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
162009209|NCT05138653|585088315|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009210|NCT05138653|585088316|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009211|NCT05138653|585088317|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009212|NCT05138653|585088318|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009213|NCT05138653|585088319|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009214|NCT05138653|585088320|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162240467|NCT00615836|585932490|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
162240468|NCT00615836|585932491|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
162240469|NCT00615836|585932492|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
162240470|NCT00615836|585932493|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
162240471|NCT00615836|585932494|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
162240472|NCT00615836|585932490|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
162240473|NCT00615836|585932491|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
162240474|NCT00615836|585932492|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
162240475|NCT00615836|585932493|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
162240476|NCT00615836|585932494|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
162009215|NCT05138653|585088321|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
162009216|NCT05138653|585088322|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009217|NCT05138653|585088323|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009218|NCT05138653|585088324|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009219|NCT05138653|585088325|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009220|NCT05138653|585088326|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009221|NCT05138653|585088327|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009222|NCT05138653|585088328|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009223|NCT05138653|585088329|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009224|NCT05138653|585088330|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
162009225|NCT05138653|585088315|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162009226|NCT05138653|585088316|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162009227|NCT05138653|585088317|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162009228|NCT05138653|585088318|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162009229|NCT05138653|585088319|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162009230|NCT05138653|585088320|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162009231|NCT05138653|585088321|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162009232|NCT05138653|585088322|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162009233|NCT05138653|585088323|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162240477|NCT00615836|585932490|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
162240478|NCT00615836|585932491|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
162240479|NCT00615836|585932492|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
162240480|NCT00615836|585932493|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
162240481|NCT00615836|585932494|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
161895327|NCT00741598|584666296|FG000|Overall Study|Physician Decision|1|||
162009234|NCT05138653|585088324|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162009235|NCT05138653|585088325|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
162009236|NCT05138653|585088326|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162240482|NCT00615836|585932490|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
162240483|NCT00615836|585932491|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
162240484|NCT00615836|585932492|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
162240485|NCT00615836|585932493|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
162240486|NCT00615836|585932494|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
162240487|NCT00615836|585932490|FG000|Extension Study (FE992026 CS31)|Other|10|||
162240488|NCT00615836|585932491|FG001|Extension Study (FE992026 CS31)|Other|7|||
162240489|NCT00615836|585932492|FG002|Extension Study (FE992026 CS31)|Other|8|||
162240490|NCT00615836|585932493|FG003|Extension Study (FE992026 CS31)|Other|8|||
162240491|NCT00615836|585932494|FG004|Extension Study (FE992026 CS31)|Other|0|||
162240492|NCT00615836|585932490|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
162240493|NCT00615836|585932491|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
162240494|NCT00615836|585932492|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
162240495|NCT00615836|585932493|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
162240496|NCT00615836|585932494|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
162240497|NCT00615836|585932490|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
162240498|NCT00615836|585932491|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
162240499|NCT00615836|585932492|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
162240500|NCT00615836|585932493|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
162240501|NCT00615836|585932494|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
162240502|NCT01630434|585932495|FG000|Overall Study|Donor lungs turned down|1|||
162240503|NCT01630434|585932496|FG001|Overall Study|Donor lungs turned down|0|||
162240504|NCT01630434|585932495|FG000|Overall Study|Protocol Violation|9|||
162240505|NCT01630434|585932496|FG001|Overall Study|Protocol Violation|4|||
162240506|NCT01630434|585932495|FG000|Overall Study|Death|20|||
162240507|NCT01630434|585932496|FG001|Overall Study|Death|26|||
162240508|NCT00687973|585932497|FG000|Overall Study|Adverse Event|18|||
162240509|NCT00687973|585932498|FG001|Overall Study|Adverse Event|28|||
162240510|NCT00687973|585932497|FG000|Overall Study|Lack of Efficacy|2|||
162240511|NCT00687973|585932498|FG001|Overall Study|Lack of Efficacy|3|||
162240512|NCT00687973|585932497|FG000|Overall Study|Protocol Violation|1|||
162240513|NCT00687973|585932498|FG001|Overall Study|Protocol Violation|2|||
162240514|NCT00687973|585932497|FG000|Overall Study|Administrative Reasons|0|||
162240515|NCT00687973|585932498|FG001|Overall Study|Administrative Reasons|2|||
162240516|NCT00687973|585932497|FG000|Overall Study|Withdrawal by Subject|3|||
162240517|NCT00687973|585932498|FG001|Overall Study|Withdrawal by Subject|3|||
162240518|NCT02075541|585932500|FG000|Overall Study|Serious Adverse Event|1|||
162240519|NCT02075541|585932501|FG001|Overall Study|Serious Adverse Event|4|||
162240520|NCT02075541|585932500|FG000|Overall Study|Protocol Violation|1|||
162240521|NCT02075541|585932501|FG001|Overall Study|Protocol Violation|0|||
162240522|NCT02075541|585932500|FG000|Overall Study|Withdrawal by Subject|1|||
162240523|NCT02075541|585932501|FG001|Overall Study|Withdrawal by Subject|3|||
162240524|NCT02075541|585932500|FG000|Overall Study|Sponsor study termination|0|||
162240525|NCT02075541|585932501|FG001|Overall Study|Sponsor study termination|1|||
162240526|NCT02075541|585932500|FG000|Overall Study|Other- unable to perform study procedure|1|||
162240527|NCT02075541|585932501|FG001|Overall Study|Other- unable to perform study procedure|0|||
162240528|NCT02349360|585932502|FG000|Overall Study|Withdrawal by Subject|0|||
162240529|NCT02349360|585932503|FG001|Overall Study|Withdrawal by Subject|1|||
162240530|NCT01054846|585932504|FG000|Overall Study|Lost to Follow-up|76|||
162240531|NCT01054846|585932505|FG001|Overall Study|Lost to Follow-up|17|||
162240532|NCT00394953|585932506|FG000|First Treatment Period|Adverse Event|1|||
162240533|NCT00394953|585932507|FG001|First Treatment Period|Adverse Event|2|||
162240534|NCT00394953|585932506|FG000|First Treatment Period|Death|6|||
162240535|NCT00394953|585932507|FG001|First Treatment Period|Death|7|||
162240536|NCT00394953|585932506|FG000|First Treatment Period|Lack of Efficacy|1|||
162240537|NCT00394953|585932507|FG001|First Treatment Period|Lack of Efficacy|1|||
162240538|NCT00394953|585932506|FG000|First Treatment Period|Withdrawal by Subject|6|||
162240539|NCT00394953|585932507|FG001|First Treatment Period|Withdrawal by Subject|3|||
162240540|NCT00394953|585932506|FG000|First Treatment Period|Lost to Follow-up|0|||
162240541|NCT00394953|585932507|FG001|First Treatment Period|Lost to Follow-up|1|||
162240542|NCT00394953|585932506|FG000|First Treatment Period|Renal transplant|11|||
162240543|NCT00394953|585932507|FG001|First Treatment Period|Renal transplant|7|||
162240544|NCT00394953|585932506|FG000|First Treatment Period|Not defined|4|||
162240545|NCT00394953|585932507|FG001|First Treatment Period|Not defined|1|||
162240546|NCT00394953|585932506|FG000|Second Treatment Period|Adverse Event|2|||
162240547|NCT00394953|585932507|FG001|Second Treatment Period|Adverse Event|5|||
162240548|NCT00394953|585932506|FG000|Second Treatment Period|Death|8|||
162240549|NCT00394953|585932507|FG001|Second Treatment Period|Death|4|||
161779430|NCT00468312|584235548|FG000|Overall Study|Adverse Event|2|||
162240550|NCT00394953|585932506|FG000|Second Treatment Period|Lack of Efficacy|9|||
162240551|NCT00394953|585932507|FG001|Second Treatment Period|Lack of Efficacy|47|||
161779431|NCT00468312|584235549|FG001|Overall Study|Adverse Event|1|||
162240552|NCT00394953|585932506|FG000|Second Treatment Period|Withdrawal by Subject|3|||
162240553|NCT00394953|585932507|FG001|Second Treatment Period|Withdrawal by Subject|3|||
162240554|NCT00394953|585932506|FG000|Second Treatment Period|Lost to Follow-up|0|||
162240555|NCT00394953|585932507|FG001|Second Treatment Period|Lost to Follow-up|1|||
162240556|NCT00394953|585932506|FG000|Second Treatment Period|Renal transplant|4|||
162240557|NCT00394953|585932507|FG001|Second Treatment Period|Renal transplant|6|||
162240558|NCT00394953|585932506|FG000|Second Treatment Period|Not defined|3|||
162240559|NCT00394953|585932507|FG001|Second Treatment Period|Not defined|8|||
162240560|NCT02446886|585932513|FG000|Overall Study|Adverse Event|1|||
162240561|NCT02446886|585932514|FG001|Overall Study|Adverse Event|3|||
162240562|NCT02446886|585932513|FG000|Overall Study|Withdrawal by Subject|1|||
162240563|NCT02446886|585932514|FG001|Overall Study|Withdrawal by Subject|1|||
162240564|NCT03021954|585932522|FG000|Overall Study|Lost to Follow-up|10|||
162240565|NCT03021954|585932523|FG001|Overall Study|Lost to Follow-up|43|||
162240566|NCT03021954|585932522|FG000|Overall Study|Subjects had avulsion trauma|4|||
162240567|NCT03021954|585932523|FG001|Overall Study|Subjects had avulsion trauma|1|||
162240568|NCT02196714|585932526|FG000|Overall Study|Protocol Violation|0|||
162240569|NCT02196714|585932527|FG001|Overall Study|Protocol Violation|0|||
162240570|NCT02196714|585932528|FG002|Overall Study|Protocol Violation|1|||
162240571|NCT02196714|585932529|FG003|Overall Study|Protocol Violation|0|||
162240572|NCT01592864|585932531|FG000|Overall Study|Withdrawal by Subject|0|||
162240573|NCT01592864|585932532|FG001|Overall Study|Withdrawal by Subject|1|||
162240574|NCT04677179|585932537|FG000|Induction Treatment Period|Adverse Event|1|||
162240575|NCT04677179|585932538|FG001|Induction Treatment Period|Adverse Event|0|||
162240576|NCT04677179|585932539|FG002|Induction Treatment Period|Adverse Event|0|||
162240577|NCT04677179|585932540|FG003|Induction Treatment Period|Adverse Event|0|||
162240578|NCT04677179|585932541|FG004|Induction Treatment Period|Adverse Event|0|||
162240579|NCT04677179|585932542|FG005|Induction Treatment Period|Adverse Event|0|||
162240580|NCT04677179|585932543|FG006|Induction Treatment Period|Adverse Event|0|||
162240581|NCT04677179|585932544|FG007|Induction Treatment Period|Adverse Event|0|||
162240582|NCT04677179|585932545|FG008|Induction Treatment Period|Adverse Event|0|||
162240583|NCT04677179|585932546|FG009|Induction Treatment Period|Adverse Event|0|||
162240584|NCT04677179|585932537|FG000|Induction Treatment Period|Physician Decision|1|||
162240585|NCT04677179|585932538|FG001|Induction Treatment Period|Physician Decision|0|||
162240586|NCT04677179|585932539|FG002|Induction Treatment Period|Physician Decision|1|||
162240587|NCT04677179|585932540|FG003|Induction Treatment Period|Physician Decision|0|||
162240588|NCT04677179|585932541|FG004|Induction Treatment Period|Physician Decision|0|||
162240589|NCT04677179|585932542|FG005|Induction Treatment Period|Physician Decision|0|||
162240590|NCT04677179|585932543|FG006|Induction Treatment Period|Physician Decision|0|||
162240591|NCT04677179|585932544|FG007|Induction Treatment Period|Physician Decision|0|||
162240592|NCT04677179|585932545|FG008|Induction Treatment Period|Physician Decision|0|||
162240593|NCT04677179|585932546|FG009|Induction Treatment Period|Physician Decision|0|||
162240594|NCT04677179|585932537|FG000|Induction Treatment Period|Protocol Violation|0|||
162240595|NCT04677179|585932538|FG001|Induction Treatment Period|Protocol Violation|1|||
162240596|NCT04677179|585932539|FG002|Induction Treatment Period|Protocol Violation|0|||
162240597|NCT04677179|585932540|FG003|Induction Treatment Period|Protocol Violation|0|||
162240598|NCT04677179|585932541|FG004|Induction Treatment Period|Protocol Violation|0|||
162240599|NCT04677179|585932542|FG005|Induction Treatment Period|Protocol Violation|0|||
162240600|NCT04677179|585932543|FG006|Induction Treatment Period|Protocol Violation|0|||
162240601|NCT04677179|585932544|FG007|Induction Treatment Period|Protocol Violation|0|||
162240602|NCT04677179|585932545|FG008|Induction Treatment Period|Protocol Violation|0|||
162240603|NCT04677179|585932546|FG009|Induction Treatment Period|Protocol Violation|0|||
162240604|NCT04677179|585932537|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
162240605|NCT04677179|585932538|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
162240606|NCT04677179|585932539|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
162240607|NCT04677179|585932540|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
162240608|NCT04677179|585932541|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
162240609|NCT04677179|585932542|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
162240610|NCT04677179|585932543|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
162240611|NCT04677179|585932544|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
162240612|NCT04677179|585932545|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
162240613|NCT04677179|585932546|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
162240614|NCT04677179|585932537|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
162240615|NCT04677179|585932538|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
162240616|NCT04677179|585932539|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
162240617|NCT04677179|585932540|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
162240618|NCT04677179|585932541|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
162240619|NCT04677179|585932542|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
162240620|NCT04677179|585932543|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
162240621|NCT04677179|585932544|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
162240622|NCT04677179|585932545|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
162240623|NCT04677179|585932546|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
162240624|NCT04677179|585932537|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
162240625|NCT04677179|585932538|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
162240626|NCT04677179|585932539|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
162240627|NCT04677179|585932540|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
162240628|NCT04677179|585932541|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
162240629|NCT04677179|585932542|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
162240630|NCT04677179|585932543|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
162240631|NCT04677179|585932544|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
162240632|NCT04677179|585932545|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
162240633|NCT04677179|585932546|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
162240634|NCT04677179|585932537|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
162240635|NCT04677179|585932538|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
162240636|NCT04677179|585932539|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
162240637|NCT04677179|585932540|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
162240638|NCT04677179|585932541|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
162240639|NCT04677179|585932542|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
162240640|NCT04677179|585932543|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
162240641|NCT04677179|585932544|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
162240642|NCT04677179|585932545|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
162240643|NCT04677179|585932546|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
162240644|NCT04677179|585932537|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
162240645|NCT04677179|585932538|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
162240646|NCT04677179|585932539|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
162240647|NCT04677179|585932540|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
162240648|NCT04677179|585932541|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
162240649|NCT04677179|585932542|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
162240650|NCT04677179|585932543|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
162240651|NCT04677179|585932544|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
162240652|NCT04677179|585932545|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
162240653|NCT04677179|585932546|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
162240654|NCT04677179|585932537|FG000|Extension Treatment Period|Lack of Efficacy|0|||
162240655|NCT04677179|585932538|FG001|Extension Treatment Period|Lack of Efficacy|0|||
162240656|NCT04677179|585932539|FG002|Extension Treatment Period|Lack of Efficacy|0|||
162240657|NCT04677179|585932540|FG003|Extension Treatment Period|Lack of Efficacy|0|||
162240658|NCT04677179|585932541|FG004|Extension Treatment Period|Lack of Efficacy|0|||
162240659|NCT04677179|585932542|FG005|Extension Treatment Period|Lack of Efficacy|0|||
162240660|NCT04677179|585932543|FG006|Extension Treatment Period|Lack of Efficacy|6|||
162240661|NCT04677179|585932544|FG007|Extension Treatment Period|Lack of Efficacy|0|||
162240662|NCT04677179|585932545|FG008|Extension Treatment Period|Lack of Efficacy|0|||
162240663|NCT04677179|585932546|FG009|Extension Treatment Period|Lack of Efficacy|0|||
162240664|NCT04677179|585932537|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
162240665|NCT04677179|585932538|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
162240666|NCT04677179|585932539|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
162240667|NCT04677179|585932540|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
162240668|NCT04677179|585932541|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
162240669|NCT04677179|585932542|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
162240670|NCT04677179|585932543|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
162240671|NCT04677179|585932544|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
162240672|NCT04677179|585932545|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
162240673|NCT04677179|585932546|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
162240674|NCT04677179|585932537|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
162240675|NCT04677179|585932538|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
162240676|NCT04677179|585932539|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
162240677|NCT04677179|585932540|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
162240678|NCT04677179|585932541|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
162240679|NCT04677179|585932542|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
162240680|NCT04677179|585932543|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
162240681|NCT04677179|585932544|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
162240682|NCT04677179|585932545|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
162240683|NCT04677179|585932546|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
162240684|NCT04677179|585932537|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
162240685|NCT04677179|585932538|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
162240686|NCT04677179|585932539|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
162240687|NCT04677179|585932540|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
162240688|NCT04677179|585932541|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
162240689|NCT04677179|585932542|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
162240690|NCT04677179|585932543|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
162240691|NCT04677179|585932544|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
162240692|NCT04677179|585932545|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
162240693|NCT04677179|585932546|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
162240694|NCT04677179|585932537|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162240695|NCT04677179|585932538|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162240696|NCT04677179|585932539|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162240697|NCT04677179|585932540|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162240698|NCT04677179|585932541|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162240699|NCT04677179|585932542|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162240700|NCT04677179|585932543|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162240701|NCT04677179|585932544|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
162240702|NCT04677179|585932545|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
162240703|NCT04677179|585932546|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
162240704|NCT04677179|585932537|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162240705|NCT04677179|585932538|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162240706|NCT04677179|585932539|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161779432|NCT00468312|584235548|FG000|Overall Study|Lack of Efficacy|0|||
161779433|NCT00468312|584235549|FG001|Overall Study|Lack of Efficacy|1|||
161779434|NCT00468312|584235548|FG000|Overall Study|Withdrawal by Subject|0|||
162009237|NCT05138653|585088327|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
162009238|NCT05138653|585088328|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162009239|NCT05138653|585088329|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
162009240|NCT05138653|585088330|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
162009241|NCT05138653|585088315|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009242|NCT05138653|585088316|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009243|NCT05138653|585088317|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009244|NCT05138653|585088318|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009245|NCT05138653|585088319|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009246|NCT05138653|585088320|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009247|NCT05138653|585088321|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009248|NCT05138653|585088322|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009249|NCT05138653|585088323|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009250|NCT05138653|585088324|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009251|NCT05138653|585088325|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009252|NCT05138653|585088326|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009253|NCT05138653|585088327|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009254|NCT05138653|585088328|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009255|NCT05138653|585088329|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
162009256|NCT05138653|585088330|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
162009257|NCT05138653|585088315|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009258|NCT05138653|585088316|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009259|NCT05138653|585088317|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009260|NCT05138653|585088318|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009261|NCT05138653|585088319|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009262|NCT05138653|585088320|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009263|NCT05138653|585088321|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009264|NCT05138653|585088322|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009265|NCT05138653|585088323|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009266|NCT05138653|585088324|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009267|NCT05138653|585088325|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009268|NCT05138653|585088326|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009269|NCT05138653|585088327|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009270|NCT05138653|585088328|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
162240707|NCT04677179|585932540|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162240708|NCT04677179|585932541|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162240709|NCT04677179|585932542|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162240710|NCT04677179|585932543|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162240711|NCT04677179|585932544|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
162240712|NCT04677179|585932545|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162009271|NCT05138653|585088329|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009272|NCT05138653|585088330|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
162009273|NCT00091949|585090067|FG000|Overall Study|Withdrawal by Subject|117|||
162009274|NCT00091949|585090068|FG001|Overall Study|Withdrawal by Subject|110|||
162009275|NCT00091949|585090067|FG000|Overall Study|Lost to Follow-up|58|||
162122874|NCT00744237|585502347|FG000|Overall Study|Protocol Violation|3|||
162240713|NCT04677179|585932546|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
162240714|NCT04677179|585932537|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161779435|NCT00468312|584235549|FG001|Overall Study|Withdrawal by Subject|1|||
161779436|NCT00468312|584235548|FG000|Overall Study|Protocol Violation|2|||
162240715|NCT04677179|585932538|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162240716|NCT04677179|585932539|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162240717|NCT04677179|585932540|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162240718|NCT04677179|585932541|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162240719|NCT04677179|585932542|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162240720|NCT04677179|585932543|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162240721|NCT04677179|585932544|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
162240722|NCT04677179|585932545|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
162240723|NCT04677179|585932546|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
162240724|NCT04677179|585932537|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162240725|NCT04677179|585932538|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162240726|NCT04677179|585932539|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162240727|NCT04677179|585932540|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162240728|NCT04677179|585932541|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162240729|NCT04677179|585932542|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162240730|NCT04677179|585932543|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
162240731|NCT04677179|585932544|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
162240732|NCT04677179|585932545|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
162240733|NCT04677179|585932546|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
162240734|NCT01723254|585932547|FG000|Overall Study|Conflict with work schedule|0|||
162240735|NCT01723254|585932548|FG001|Overall Study|Conflict with work schedule|0|||
162240736|NCT01723254|585932549|FG002|Overall Study|Conflict with work schedule|0|||
162240737|NCT01723254|585932550|FG003|Overall Study|Conflict with work schedule|0|||
162240738|NCT01723254|585932551|FG004|Overall Study|Conflict with work schedule|0|||
162240739|NCT01723254|585932552|FG005|Overall Study|Conflict with work schedule|0|||
162240740|NCT01723254|585932553|FG006|Overall Study|Conflict with work schedule|0|||
162240741|NCT01723254|585932554|FG007|Overall Study|Conflict with work schedule|1|||
162240742|NCT01723254|585932547|FG000|Overall Study|Personal issues|0|||
162240743|NCT01723254|585932548|FG001|Overall Study|Personal issues|0|||
162240744|NCT01723254|585932549|FG002|Overall Study|Personal issues|0|||
162240745|NCT01723254|585932550|FG003|Overall Study|Personal issues|0|||
162240746|NCT01723254|585932551|FG004|Overall Study|Personal issues|0|||
162240747|NCT01723254|585932552|FG005|Overall Study|Personal issues|1|||
162240748|NCT01723254|585932553|FG006|Overall Study|Personal issues|0|||
162240749|NCT01723254|585932554|FG007|Overall Study|Personal issues|0|||
162240750|NCT01723254|585932547|FG000|Overall Study|No longer have time to participate|0|||
162240751|NCT01723254|585932548|FG001|Overall Study|No longer have time to participate|0|||
162240752|NCT01723254|585932549|FG002|Overall Study|No longer have time to participate|0|||
162240753|NCT01723254|585932550|FG003|Overall Study|No longer have time to participate|1|||
162240754|NCT01723254|585932551|FG004|Overall Study|No longer have time to participate|0|||
162240755|NCT01723254|585932552|FG005|Overall Study|No longer have time to participate|0|||
162240756|NCT01723254|585932553|FG006|Overall Study|No longer have time to participate|0|||
162240757|NCT01723254|585932554|FG007|Overall Study|No longer have time to participate|0|||
162240758|NCT01723254|585932547|FG000|Overall Study|Move/Left to another country/city|0|||
162240759|NCT01723254|585932548|FG001|Overall Study|Move/Left to another country/city|0|||
162240760|NCT01723254|585932549|FG002|Overall Study|Move/Left to another country/city|2|||
162240761|NCT01723254|585932550|FG003|Overall Study|Move/Left to another country/city|1|||
162240762|NCT01723254|585932551|FG004|Overall Study|Move/Left to another country/city|1|||
162240763|NCT01723254|585932552|FG005|Overall Study|Move/Left to another country/city|0|||
162240764|NCT01723254|585932553|FG006|Overall Study|Move/Left to another country/city|0|||
162240765|NCT01723254|585932554|FG007|Overall Study|Move/Left to another country/city|0|||
162240766|NCT01723254|585932547|FG000|Overall Study|Protocol Violation|0|||
162240767|NCT01723254|585932548|FG001|Overall Study|Protocol Violation|1|||
162240768|NCT01723254|585932549|FG002|Overall Study|Protocol Violation|0|||
162240769|NCT01723254|585932550|FG003|Overall Study|Protocol Violation|0|||
162240770|NCT01723254|585932551|FG004|Overall Study|Protocol Violation|0|||
162240771|NCT01723254|585932552|FG005|Overall Study|Protocol Violation|0|||
162240772|NCT01723254|585932553|FG006|Overall Study|Protocol Violation|0|||
162240773|NCT01723254|585932554|FG007|Overall Study|Protocol Violation|0|||
162240774|NCT01723254|585932547|FG000|Overall Study|Withdrawal by Subject|1|||
162240775|NCT01723254|585932548|FG001|Overall Study|Withdrawal by Subject|2|||
162240776|NCT01723254|585932549|FG002|Overall Study|Withdrawal by Subject|1|||
162240777|NCT01723254|585932550|FG003|Overall Study|Withdrawal by Subject|0|||
162240778|NCT01723254|585932551|FG004|Overall Study|Withdrawal by Subject|1|||
162240779|NCT01723254|585932552|FG005|Overall Study|Withdrawal by Subject|1|||
162240780|NCT01723254|585932553|FG006|Overall Study|Withdrawal by Subject|1|||
162240781|NCT01723254|585932554|FG007|Overall Study|Withdrawal by Subject|2|||
162240782|NCT01201265|585932555|FG000|Overall Study|Death|14|||
162240783|NCT01201265|585932555|FG000|Overall Study|Insufficient Therapeutic Response|3|||
162240784|NCT01201265|585932555|FG000|Overall Study|Lost to Follow-up|10|||
161682986|NCT02969915|583890220|FG001|Overall Study|Death|125|||
161682987|NCT02969915|583890219|FG000|Overall Study|Lost to Follow-up|108|||
162240785|NCT01201265|585932555|FG000|Overall Study|Withdrawal by Subject|7|||
162240786|NCT01201265|585932555|FG000|Overall Study|Disease Progression|4|||
162240787|NCT01257425|585932556|FG000|Overall Study|Lack of Efficacy|3|||
162240788|NCT01257425|585932557|FG001|Overall Study|Lack of Efficacy|3|||
162240789|NCT01257425|585932556|FG000|Overall Study|Adverse Event|1|||
162240790|NCT01257425|585932557|FG001|Overall Study|Adverse Event|1|||
162240791|NCT01257425|585932556|FG000|Overall Study|Protocol Violation|1|||
162240792|NCT01257425|585932557|FG001|Overall Study|Protocol Violation|1|||
162240793|NCT01257425|585932556|FG000|Overall Study|Withdrawal by Subject|0|||
162240794|NCT01257425|585932557|FG001|Overall Study|Withdrawal by Subject|1|||
162240795|NCT01257425|585932556|FG000|Overall Study|Death|1|||
162240796|NCT01257425|585932557|FG001|Overall Study|Death|0|||
162240797|NCT02254278|585932559|FG000|Overall Study|Protocol Violation|1|||
162240798|NCT02254278|585932560|FG001|Overall Study|Protocol Violation|1|||
162240799|NCT02903368|585932564|FG000|Part 1|Adverse Event|3|||
162240800|NCT02903368|585932565|FG001|Part 1|Adverse Event|0|||
162240801|NCT02903368|585932566|FG002|Part 1|Adverse Event|0|||
162240802|NCT02903368|585932567|FG003|Part 1|Adverse Event|0|||
162240803|NCT02903368|585932564|FG000|Part 1|Withdrawal by Subject|1|||
162240804|NCT02903368|585932565|FG001|Part 1|Withdrawal by Subject|0|||
162240805|NCT02903368|585932566|FG002|Part 1|Withdrawal by Subject|0|||
162240806|NCT02903368|585932567|FG003|Part 1|Withdrawal by Subject|0|||
162240807|NCT02903368|585932564|FG000|Part 2|Adverse Event|0|||
162240808|NCT02903368|585932565|FG001|Part 2|Adverse Event|0|||
162240809|NCT02903368|585932566|FG002|Part 2|Adverse Event|5|||
162240810|NCT02903368|585932567|FG003|Part 2|Adverse Event|0|||
162240811|NCT02903368|585932564|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
162240812|NCT02903368|585932565|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
162240813|NCT02903368|585932566|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
162240814|NCT02903368|585932567|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
162240815|NCT02903368|585932564|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
162240816|NCT02903368|585932565|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
162240817|NCT02903368|585932566|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
162240818|NCT02903368|585932567|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
162240819|NCT02903368|585932564|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
162240820|NCT02903368|585932565|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
162240821|NCT02903368|585932566|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
162240822|NCT02903368|585932567|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
162240823|NCT05437510|585932568|FG000|Overall Study|Adverse Event|2|||
162240824|NCT05437510|585932569|FG001|Overall Study|Adverse Event|1|||
162240825|NCT05437510|585932568|FG000|Overall Study|Protocol Deviation|1|||
162240826|NCT05437510|585932569|FG001|Overall Study|Protocol Deviation|6|||
162240827|NCT05437510|585932568|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
162240828|NCT05437510|585932569|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
162240829|NCT05437510|585932568|FG000|Overall Study|Lost to Follow-up|265|||
162240830|NCT05437510|585932569|FG001|Overall Study|Lost to Follow-up|358|||
162240831|NCT03769181|585934119|FG000|Overall Study|Adverse Event|1|||
162240832|NCT03769181|585934120|FG001|Overall Study|Adverse Event|0|||
162240833|NCT03769181|585934121|FG002|Overall Study|Adverse Event|2|||
162240834|NCT03769181|585934122|FG003|Overall Study|Adverse Event|4|||
162240835|NCT03769181|585934119|FG000|Overall Study|Withdrawal by Subject|1|||
162240836|NCT03769181|585934120|FG001|Overall Study|Withdrawal by Subject|0|||
162240837|NCT03769181|585934121|FG002|Overall Study|Withdrawal by Subject|2|||
162240838|NCT03769181|585934122|FG003|Overall Study|Withdrawal by Subject|1|||
162240839|NCT03769181|585934119|FG000|Overall Study|Progressive disease|9|||
162240840|NCT03769181|585934120|FG001|Overall Study|Progressive disease|7|||
162240841|NCT03769181|585934121|FG002|Overall Study|Progressive disease|13|||
162240842|NCT03769181|585934122|FG003|Overall Study|Progressive disease|6|||
162240843|NCT03769181|585934119|FG000|Overall Study|Other - Unspecified|2|||
162240844|NCT03769181|585934120|FG001|Overall Study|Other - Unspecified|1|||
162240845|NCT03769181|585934121|FG002|Overall Study|Other - Unspecified|0|||
162240846|NCT03769181|585934122|FG003|Overall Study|Other - Unspecified|0|||
162240847|NCT00826111|585934129|FG000|Overall Study|Lost to Follow-up|0|||
162240848|NCT00826111|585934130|FG001|Overall Study|Lost to Follow-up|1|||
162240849|NCT00826111|585934129|FG000|Overall Study|Protocol Violation|1|||
162240850|NCT00826111|585934130|FG001|Overall Study|Protocol Violation|0|||
162240851|NCT00826111|585934129|FG000|Overall Study|Withdrawal by Subject|5|||
162240852|NCT00826111|585934130|FG001|Overall Study|Withdrawal by Subject|0|||
162240853|NCT00826111|585934129|FG000|Overall Study|Physician Decision|1|||
162240854|NCT00826111|585934130|FG001|Overall Study|Physician Decision|1|||
162240855|NCT01195545|585934131|FG000|Overall Study|Protocol Violation|4|||
162240856|NCT01929980|585934132|FG000|Overall Study|Physician Decision|1|||
162240857|NCT00792805|585934133|FG000|Overall Study|Adverse Event|12|||
162240858|NCT00792805|585934134|FG001|Overall Study|Adverse Event|10|||
162240859|NCT00792805|585934135|FG002|Overall Study|Adverse Event|10|||
162240860|NCT00792805|585934133|FG000|Overall Study|Subject withdrew consent|5|||
162240861|NCT00792805|585934134|FG001|Overall Study|Subject withdrew consent|6|||
162240862|NCT00792805|585934135|FG002|Overall Study|Subject withdrew consent|5|||
162240863|NCT00792805|585934133|FG000|Overall Study|Administrative problems|2|||
162240864|NCT00792805|585934134|FG001|Overall Study|Administrative problems|0|||
162240865|NCT00792805|585934135|FG002|Overall Study|Administrative problems|4|||
162240866|NCT00792805|585934133|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162240867|NCT00792805|585934134|FG001|Overall Study|Abnormal test procedure result(s)|2|||
162240868|NCT00792805|585934135|FG002|Overall Study|Abnormal test procedure result(s)|0|||
162240869|NCT00792805|585934133|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162240870|NCT00792805|585934134|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
162240871|NCT00792805|585934135|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
162240872|NCT00792805|585934133|FG000|Overall Study|Lost to Follow-up|1|||
162240873|NCT00792805|585934134|FG001|Overall Study|Lost to Follow-up|1|||
162240874|NCT00792805|585934135|FG002|Overall Study|Lost to Follow-up|6|||
162240875|NCT00792805|585934133|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162240876|NCT00792805|585934134|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162240877|NCT00792805|585934135|FG002|Overall Study|Abnormal laboratory value(s)|1|||
162240878|NCT00792805|585934133|FG000|Overall Study|Protocol deviation|0|||
162240879|NCT00792805|585934134|FG001|Overall Study|Protocol deviation|1|||
162240880|NCT00792805|585934135|FG002|Overall Study|Protocol deviation|1|||
162240881|NCT02276872|585934136|FG000|Overall Study|Adverse Event|1|||
162240882|NCT02276872|585934137|FG001|Overall Study|Adverse Event|0|||
162240883|NCT02276872|585934138|FG002|Overall Study|Adverse Event|0|||
162240884|NCT04175808|585934139|FG000|Part A|Miscellaneous|2|||
162240885|NCT04175808|585934140|FG001|Part A|Miscellaneous|0|||
162240886|NCT04175808|585934141|FG002|Part A|Miscellaneous|0|||
162240887|NCT04175808|585934142|FG003|Part A|Miscellaneous|0|||
162240888|NCT04175808|585934143|FG004|Part A|Miscellaneous|0|||
162240889|NCT04175808|585934144|FG005|Part A|Miscellaneous|0|||
162240890|NCT04175808|585934145|FG006|Part A|Miscellaneous|0|||
162240891|NCT00402363|585934147|FG000|Overall Study|Adverse Event|9|||
162240892|NCT00402363|585934148|FG001|Overall Study|Adverse Event|14|||
162240893|NCT00402363|585934149|FG002|Overall Study|Adverse Event|2|||
162240894|NCT00402363|585934150|FG003|Overall Study|Adverse Event|2|||
162240895|NCT00402363|585934147|FG000|Overall Study|Withdrew Consent|10|||
162240896|NCT00402363|585934148|FG001|Overall Study|Withdrew Consent|5|||
162240897|NCT00402363|585934149|FG002|Overall Study|Withdrew Consent|2|||
162240898|NCT00402363|585934150|FG003|Overall Study|Withdrew Consent|1|||
162240899|NCT00402363|585934147|FG000|Overall Study|Protocol Violation|3|||
162240900|NCT00402363|585934148|FG001|Overall Study|Protocol Violation|5|||
162240901|NCT00402363|585934149|FG002|Overall Study|Protocol Violation|0|||
162240902|NCT00402363|585934150|FG003|Overall Study|Protocol Violation|3|||
162240903|NCT00402363|585934147|FG000|Overall Study|Lost to Follow-up|5|||
162240904|NCT00402363|585934148|FG001|Overall Study|Lost to Follow-up|4|||
162240905|NCT00402363|585934149|FG002|Overall Study|Lost to Follow-up|0|||
162240906|NCT00402363|585934150|FG003|Overall Study|Lost to Follow-up|2|||
162240907|NCT00402363|585934147|FG000|Overall Study|"Captured as Other"|6|||
162240908|NCT00402363|585934148|FG001|Overall Study|"Captured as Other"|2|||
162240909|NCT00402363|585934149|FG002|Overall Study|"Captured as Other"|2|||
162240910|NCT00402363|585934150|FG003|Overall Study|"Captured as Other"|2|||
162240911|NCT00568321|585934159|FG000|Overall Study|Adverse Event|1|||
162240912|NCT00568321|585934160|FG001|Overall Study|Adverse Event|0|||
162240913|NCT00568321|585934161|FG002|Overall Study|Adverse Event|0|||
162240914|NCT00568321|585934159|FG000|Overall Study|Lack of Efficacy|8|||
162240915|NCT00568321|585934160|FG001|Overall Study|Lack of Efficacy|5|||
162240916|NCT00568321|585934161|FG002|Overall Study|Lack of Efficacy|6|||
162240917|NCT00568321|585934159|FG000|Overall Study|Lost to Follow-up|0|||
162240918|NCT00568321|585934160|FG001|Overall Study|Lost to Follow-up|0|||
162240919|NCT00568321|585934161|FG002|Overall Study|Lost to Follow-up|1|||
162240920|NCT00568321|585934159|FG000|Overall Study|Withdrawal by Subject|2|||
162240921|NCT00568321|585934160|FG001|Overall Study|Withdrawal by Subject|0|||
162240922|NCT00568321|585934161|FG002|Overall Study|Withdrawal by Subject|0|||
162240923|NCT00568321|585934159|FG000|Overall Study|Protocol Violation|0|||
162240924|NCT00568321|585934160|FG001|Overall Study|Protocol Violation|0|||
162240925|NCT00568321|585934161|FG002|Overall Study|Protocol Violation|1|||
162240926|NCT00568321|585934159|FG000|Overall Study|Randomized, not treated|2|||
162240927|NCT00568321|585934160|FG001|Overall Study|Randomized, not treated|0|||
162240928|NCT00568321|585934161|FG002|Overall Study|Randomized, not treated|1|||
162240929|NCT00937833|585934162|FG000|Overall Study|Protocol Violation|1|||
162240930|NCT00937833|585934163|FG001|Overall Study|Protocol Violation|2|||
162240931|NCT00937833|585934162|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
162240932|NCT00937833|585934163|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
162240933|NCT00937833|585934162|FG000|Overall Study|Lost to Follow-up|10|||
162240934|NCT00937833|585934163|FG001|Overall Study|Lost to Follow-up|8|||
162240935|NCT00937833|585934162|FG000|Overall Study|Withdrawal by Subject|4|||
162240936|NCT00937833|585934163|FG001|Overall Study|Withdrawal by Subject|6|||
162240937|NCT03278106|585934166|FG000|Overall Study|No protocol treatment|1|||
162240938|NCT02175004|585934167|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
162240939|NCT02175004|585934168|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
162240940|NCT02175004|585934167|FG000|Overall Study|Investigator Judgment|1|||
162240941|NCT02175004|585934168|FG001|Overall Study|Investigator Judgment|4|||
162240942|NCT02175004|585934167|FG000|Overall Study|Voluntary Withdrawal|6|||
162240943|NCT02175004|585934168|FG001|Overall Study|Voluntary Withdrawal|19|||
162240944|NCT02175004|585934167|FG000|Overall Study|Liver Transplant|1|||
162240945|NCT02175004|585934168|FG001|Overall Study|Liver Transplant|0|||
162240946|NCT02175004|585934167|FG000|Overall Study|Disease Progression|1|||
162240947|NCT02175004|585934168|FG001|Overall Study|Disease Progression|0|||
162240948|NCT02175004|585934167|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
162240949|NCT02175004|585934168|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
162240950|NCT00162032|585934170|FG000|Overall Study|Lost to Follow-up|4|||
162240951|NCT00162032|585934171|FG001|Overall Study|Lost to Follow-up|2|||
162240952|NCT00162032|585934170|FG000|Overall Study|Reason not specified|1|||
162240953|NCT00162032|585934171|FG001|Overall Study|Reason not specified|0|||
162240954|NCT01137955|585934172|FG000|Overall Study|Withdrawal by Subject|5|||
162240955|NCT01137955|585934173|FG001|Overall Study|Withdrawal by Subject|4|||
162240956|NCT04263909|585934174|FG000|Overall Study|Physician Decision|1|||
162240957|NCT04263909|585934175|FG001|Overall Study|Physician Decision|0|||
162240958|NCT04263909|585934176|FG002|Overall Study|Physician Decision|0|||
162240959|NCT04263909|585934174|FG000|Overall Study|Adverse Event|3|||
162240960|NCT04263909|585934175|FG001|Overall Study|Adverse Event|0|||
162240961|NCT04263909|585934176|FG002|Overall Study|Adverse Event|0|||
162240962|NCT04263909|585934174|FG000|Overall Study|Protocol Violation|5|||
162240963|NCT04263909|585934175|FG001|Overall Study|Protocol Violation|0|||
162240964|NCT04263909|585934176|FG002|Overall Study|Protocol Violation|0|||
162240965|NCT00068588|585934177|FG000|Overall Study|Adverse Event|0|||
162240966|NCT00068588|585934178|FG001|Overall Study|Adverse Event|0|||
162240967|NCT00068588|585934179|FG002|Overall Study|Adverse Event|2|||
162240968|NCT00068588|585934177|FG000|Overall Study|Withdrawal by Subject|0|||
162240969|NCT00068588|585934178|FG001|Overall Study|Withdrawal by Subject|0|||
162240970|NCT00068588|585934179|FG002|Overall Study|Withdrawal by Subject|1|||
162240971|NCT00068588|585934177|FG000|Overall Study|Poor KPS|0|||
162240972|NCT00068588|585934178|FG001|Overall Study|Poor KPS|0|||
162240973|NCT00068588|585934179|FG002|Overall Study|Poor KPS|1|||
162240974|NCT03840486|585934180|FG000|Overall Study|Withdrawal by Subject|0|||
162240975|NCT03840486|585934181|FG001|Overall Study|Withdrawal by Subject|1|||
162240976|NCT03840486|585934182|FG002|Overall Study|Withdrawal by Subject|0|||
162240977|NCT03840486|585934183|FG003|Overall Study|Withdrawal by Subject|0|||
162240978|NCT03840486|585934184|FG004|Overall Study|Withdrawal by Subject|0|||
162240979|NCT03840486|585934185|FG005|Overall Study|Withdrawal by Subject|0|||
162240980|NCT03840486|585934186|FG006|Overall Study|Withdrawal by Subject|0|||
162240981|NCT03840486|585934187|FG007|Overall Study|Withdrawal by Subject|0|||
162240982|NCT03840486|585934188|FG008|Overall Study|Withdrawal by Subject|0|||
162240983|NCT03840486|585934189|FG009|Overall Study|Withdrawal by Subject|0|||
162240984|NCT03840486|585934190|FG010|Overall Study|Withdrawal by Subject|0|||
162240985|NCT03840486|585934191|FG011|Overall Study|Withdrawal by Subject|0|||
162240986|NCT05116046|585934194|FG000|Overall Study|Withdrawal by parent/guardian|2|||
162240987|NCT05116046|585934195|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162240988|NCT05116046|585934196|FG002|Overall Study|Withdrawal by parent/guardian|1|||
162240989|NCT05116046|585934194|FG000|Overall Study|Study terminated by sponsor|14|||
162240990|NCT05116046|585934195|FG001|Overall Study|Study terminated by sponsor|16|||
162240991|NCT05116046|585934196|FG002|Overall Study|Study terminated by sponsor|1|||
162240992|NCT02076178|585934211|FG000|Oral Phase|Adverse Event|0|||
162240993|NCT02076178|585934212|FG001|Oral Phase|Adverse Event|7|||
162240994|NCT02076178|585934211|FG000|Oral Phase|Withdrawal by Subject|0|||
162240995|NCT02076178|585934212|FG001|Oral Phase|Withdrawal by Subject|4|||
162240996|NCT02076178|585934211|FG000|Oral Phase|Physician Decision|0|||
162240997|NCT02076178|585934212|FG001|Oral Phase|Physician Decision|1|||
162240998|NCT02076178|585934211|FG000|Injection Phase|Protocol defined stopping criteria|1|||
162240999|NCT02076178|585934212|FG001|Injection Phase|Protocol defined stopping criteria|0|||
162241000|NCT02076178|585934211|FG000|Injection Phase|Withdrawal by Subject|0|||
162241001|NCT02076178|585934212|FG001|Injection Phase|Withdrawal by Subject|3|||
162241002|NCT02076178|585934211|FG000|Injection Phase|Physician Decision|0|||
162241003|NCT02076178|585934212|FG001|Injection Phase|Physician Decision|3|||
162241004|NCT02076178|585934211|FG000|Injection Phase|Lost to Follow-up|0|||
162241005|NCT02076178|585934212|FG001|Injection Phase|Lost to Follow-up|1|||
162241006|NCT00343252|585934213|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
162241007|NCT00343252|585934214|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
162241008|NCT00343252|585934213|FG000|6 Months (All Treated Participants)|Death|0|||
162241009|NCT00343252|585934214|FG001|6 Months (All Treated Participants)|Death|2|||
162241010|NCT00343252|585934213|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
162241011|NCT00343252|585934214|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
162241012|NCT00343252|585934213|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
162241013|NCT00343252|585934214|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
162241014|NCT00343252|585934213|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
162241015|NCT00343252|585934214|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
162241016|NCT00343252|585934213|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
162241017|NCT00343252|585934214|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
162241018|NCT00343252|585934213|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
162241019|NCT00343252|585934214|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
162241020|NCT00343252|585934213|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
162241021|NCT00343252|585934214|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
162241022|NCT00343252|585934213|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
162241023|NCT00343252|585934214|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
162241024|NCT00343252|585934213|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
162241025|NCT00343252|585934214|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
162241026|NCT00343252|585934213|FG000|12 Months (All Treated Participants)|Death|3|||
162241027|NCT00343252|585934214|FG001|12 Months (All Treated Participants)|Death|3|||
162241028|NCT00343252|585934213|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
162241029|NCT00343252|585934214|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
162241030|NCT00343252|585934213|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
162241031|NCT00343252|585934214|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
162241032|NCT00343252|585934213|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
162241033|NCT00343252|585934214|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
162241034|NCT00343252|585934213|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
162241035|NCT00343252|585934214|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
162241036|NCT00343252|585934213|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
162241037|NCT00343252|585934214|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
162241038|NCT00343252|585934213|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
162241039|NCT00343252|585934214|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
162241040|NCT00343252|585934213|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
162241041|NCT00343252|585934214|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
162241042|NCT00343252|585934213|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
162241043|NCT00343252|585934214|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
162241044|NCT00343252|585934213|FG000|18 Months (All Treated Participants)|Death|4|||
162241045|NCT00343252|585934214|FG001|18 Months (All Treated Participants)|Death|5|||
162241046|NCT00343252|585934213|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
162241047|NCT00343252|585934214|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
162241048|NCT00343252|585934213|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
162241049|NCT00343252|585934214|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
162241050|NCT00343252|585934213|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
162241051|NCT00343252|585934214|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
162241052|NCT00343252|585934213|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
162241053|NCT00343252|585934214|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
162241054|NCT00343252|585934213|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
162241055|NCT00343252|585934214|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
162241056|NCT00343252|585934213|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
162241057|NCT00343252|585934214|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
162241058|NCT00343252|585934213|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
162241059|NCT00343252|585934214|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
162241060|NCT01026454|585934215|FG000|Second Intervention|Pregnancy|1|||
162241061|NCT01026454|585934216|FG001|Second Intervention|Pregnancy|1|||
162241062|NCT02893930|585934217|FG000|Overall Study|Adverse Event|3|||
162241063|NCT02893930|585934217|FG000|Overall Study|Death|1|||
162241064|NCT02893930|585934217|FG000|Overall Study|Disease progression|5|||
162241065|NCT02893930|585934217|FG000|Overall Study|Withdrawal by Subject|2|||
162241066|NCT02893930|585934217|FG000|Overall Study|Physician Decision|1|||
162241067|NCT02893930|585934217|FG000|Overall Study|Ineligible|1|||
162241068|NCT01971203|585934226|FG000|Overall Study|Protocol Violation|3|||
162241069|NCT01971203|585934227|FG001|Overall Study|Protocol Violation|2|||
162241070|NCT01971203|585934226|FG000|Overall Study|Withdrawal by Subject|5|||
162241071|NCT01971203|585934227|FG001|Overall Study|Withdrawal by Subject|6|||
162241072|NCT01971203|585934226|FG000|Overall Study|Adverse Event|1|||
162241073|NCT01971203|585934227|FG001|Overall Study|Adverse Event|0|||
162241074|NCT03037619|585934228|FG000|Overall Study|Lost to Follow-up|0|||
162241075|NCT03037619|585934229|FG001|Overall Study|Lost to Follow-up|1|||
162241076|NCT00307125|585934234|FG000|Screening Phase|Adverse Event|1|||
162241077|NCT00307125|585934235|FG001|Screening Phase|Adverse Event|0|||
162241078|NCT00307125|585934236|FG002|Screening Phase|Adverse Event|0|||
161682988|NCT02969915|583890220|FG001|Overall Study|Lost to Follow-up|112|||
161682989|NCT02969915|583890219|FG000|Overall Study|Censored due to COVID-19|481|||
161682990|NCT02969915|583890220|FG001|Overall Study|Censored due to COVID-19|471|||
162241079|NCT00307125|585934234|FG000|Screening Phase|Protocol Violation|27|||
162241080|NCT00307125|585934235|FG001|Screening Phase|Protocol Violation|0|||
162241081|NCT00307125|585934236|FG002|Screening Phase|Protocol Violation|0|||
162241082|NCT00307125|585934234|FG000|Screening Phase|Lost to Follow-up|87|||
162241083|NCT00307125|585934235|FG001|Screening Phase|Lost to Follow-up|0|||
162241084|NCT00307125|585934236|FG002|Screening Phase|Lost to Follow-up|0|||
162241085|NCT00307125|585934234|FG000|Screening Phase|Death|10|||
162241086|NCT00307125|585934235|FG001|Screening Phase|Death|0|||
162241087|NCT00307125|585934236|FG002|Screening Phase|Death|0|||
162241088|NCT00307125|585934234|FG000|Screening Phase|Withdrawal by Subject|77|||
162241089|NCT00307125|585934235|FG001|Screening Phase|Withdrawal by Subject|0|||
162241090|NCT00307125|585934236|FG002|Screening Phase|Withdrawal by Subject|0|||
162241091|NCT00307125|585934234|FG000|Screening Phase|Physician Decision|26|||
162241092|NCT00307125|585934235|FG001|Screening Phase|Physician Decision|0|||
162241093|NCT00307125|585934236|FG002|Screening Phase|Physician Decision|0|||
162241094|NCT00307125|585934234|FG000|Screening Phase|Sponsor Decision|4|||
162241095|NCT00307125|585934235|FG001|Screening Phase|Sponsor Decision|0|||
162241096|NCT00307125|585934236|FG002|Screening Phase|Sponsor Decision|0|||
162241097|NCT00307125|585934234|FG000|Screening Phase|Study Terminated|17|||
162241098|NCT00307125|585934235|FG001|Screening Phase|Study Terminated|0|||
162241099|NCT00307125|585934236|FG002|Screening Phase|Study Terminated|0|||
162241100|NCT00307125|585934234|FG000|Screening Phase|Graft Loss|3|||
162241101|NCT00307125|585934235|FG001|Screening Phase|Graft Loss|0|||
162241102|NCT00307125|585934236|FG002|Screening Phase|Graft Loss|0|||
162241103|NCT00307125|585934234|FG000|Screening Phase|Graft Failure|8|||
162241104|NCT00307125|585934235|FG001|Screening Phase|Graft Failure|0|||
162241105|NCT00307125|585934236|FG002|Screening Phase|Graft Failure|0|||
162241106|NCT00307125|585934234|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
162241107|NCT00307125|585934235|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
162241108|NCT00307125|585934236|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
162241109|NCT00307125|585934234|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
162241110|NCT00307125|585934235|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
162241111|NCT00307125|585934236|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
162241112|NCT00307125|585934234|FG000|Screening Phase|Moved or transferred facilities|34|||
162241113|NCT00307125|585934235|FG001|Screening Phase|Moved or transferred facilities|0|||
162241114|NCT00307125|585934236|FG002|Screening Phase|Moved or transferred facilities|0|||
162241115|NCT00307125|585934234|FG000|Screening Phase|Received Pancreas Transplant|8|||
162241116|NCT00307125|585934235|FG001|Screening Phase|Received Pancreas Transplant|0|||
162241117|NCT00307125|585934236|FG002|Screening Phase|Received Pancreas Transplant|0|||
162241118|NCT00307125|585934234|FG000|Screening Phase|Ineligible for pilot|4|||
162241119|NCT00307125|585934235|FG001|Screening Phase|Ineligible for pilot|0|||
162241120|NCT00307125|585934236|FG002|Screening Phase|Ineligible for pilot|0|||
162241121|NCT00307125|585934234|FG000|Screening Phase|Try to get pregnant|1|||
162241122|NCT00307125|585934235|FG001|Screening Phase|Try to get pregnant|0|||
162241123|NCT00307125|585934236|FG002|Screening Phase|Try to get pregnant|0|||
162241124|NCT00307125|585934234|FG000|Screening Phase|Developed acute leukemia|1|||
162241125|NCT00307125|585934235|FG001|Screening Phase|Developed acute leukemia|0|||
162241126|NCT00307125|585934236|FG002|Screening Phase|Developed acute leukemia|0|||
162241127|NCT00307125|585934234|FG000|Screening Phase|Metastatic colon cancer|1|||
162241128|NCT00307125|585934235|FG001|Screening Phase|Metastatic colon cancer|0|||
162241129|NCT00307125|585934236|FG002|Screening Phase|Metastatic colon cancer|0|||
162241130|NCT00307125|585934234|FG000|Screening Phase|Malignancy|1|||
162241131|NCT00307125|585934235|FG001|Screening Phase|Malignancy|0|||
162241132|NCT00307125|585934236|FG002|Screening Phase|Malignancy|0|||
162241133|NCT00307125|585934234|FG000|Screening Phase|PAK|1|||
162241134|NCT00307125|585934235|FG001|Screening Phase|PAK|0|||
162241135|NCT00307125|585934236|FG002|Screening Phase|PAK|0|||
162241136|NCT00307125|585934234|FG000|Screening Phase|Ineligible|1|||
162241137|NCT00307125|585934235|FG001|Screening Phase|Ineligible|0|||
162241138|NCT00307125|585934236|FG002|Screening Phase|Ineligible|0|||
162241139|NCT00307125|585934234|FG000|Screening Phase|Screen Error|1|||
162241140|NCT00307125|585934235|FG001|Screening Phase|Screen Error|0|||
162241141|NCT00307125|585934236|FG002|Screening Phase|Screen Error|0|||
162241142|NCT00307125|585934234|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
162241143|NCT00307125|585934235|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
162241144|NCT00307125|585934236|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
162241145|NCT00307125|585934234|FG000|Screening Phase|AMR and treated with rituximab|1|||
162241146|NCT00307125|585934235|FG001|Screening Phase|AMR and treated with rituximab|0|||
162241147|NCT00307125|585934236|FG002|Screening Phase|AMR and treated with rituximab|0|||
162241148|NCT00307125|585934234|FG000|Screening Phase|Coronary artery bypass|1|||
162241149|NCT00307125|585934235|FG001|Screening Phase|Coronary artery bypass|0|||
162241150|NCT00307125|585934236|FG002|Screening Phase|Coronary artery bypass|0|||
162241151|NCT00307125|585934234|FG000|Pilot Phase|Lost to Follow-up|0|||
161779437|NCT00468312|584235549|FG001|Overall Study|Protocol Violation|1|||
161779438|NCT00468312|584235548|FG000|Overall Study|Did not meet protocol eligibility|0|||
162241152|NCT00307125|585934235|FG001|Pilot Phase|Lost to Follow-up|1|||
162241153|NCT00307125|585934236|FG002|Pilot Phase|Lost to Follow-up|0|||
162241154|NCT00307125|585934234|FG000|Pilot Phase|Withdrawal by Subject|0|||
162241155|NCT00307125|585934235|FG001|Pilot Phase|Withdrawal by Subject|1|||
162241156|NCT00307125|585934236|FG002|Pilot Phase|Withdrawal by Subject|1|||
162241157|NCT02571049|585934237|FG000|Screening|Did not meet entry criteria|2|||
162241158|NCT02571049|585934238|FG001|Screening|Did not meet entry criteria|2|||
162241159|NCT02571049|585934237|FG000|Randomization|No migraine attack|0|||
162241160|NCT02571049|585934238|FG001|Randomization|No migraine attack|1|||
162241161|NCT02571049|585934237|FG000|Randomization|Adverse Event|0|||
162241162|NCT02571049|585934238|FG001|Randomization|Adverse Event|1|||
162241163|NCT01055262|585934241|FG000|Overall Study|Adverse Event|5|||
162241164|NCT01055262|585934241|FG000|Overall Study|Protocol Violation|3|||
162241165|NCT01055262|585934241|FG000|Overall Study|Uncooperativeness|1|||
162241166|NCT03370471|585934242|FG000|Overall Study|Withdrawal by Subject|6|||
162241167|NCT03370471|585934243|FG001|Overall Study|Withdrawal by Subject|1|||
162241168|NCT03370471|585934242|FG000|Overall Study|Unable to access veins for blood draw|0|||
162241169|NCT03370471|585934243|FG001|Overall Study|Unable to access veins for blood draw|1|||
162241170|NCT03370471|585934242|FG000|Overall Study|Screen fail|1|||
162241171|NCT03370471|585934243|FG001|Overall Study|Screen fail|0|||
162241172|NCT00561951|585934246|FG000|Overall Study|Adverse Event|11|||
162241173|NCT00561951|585934247|FG001|Overall Study|Adverse Event|14|||
162241174|NCT00561951|585934248|FG002|Overall Study|Adverse Event|14|||
162241175|NCT00561951|585934246|FG000|Overall Study|Lack of Efficacy|5|||
162241176|NCT00561951|585934247|FG001|Overall Study|Lack of Efficacy|3|||
162241177|NCT00561951|585934248|FG002|Overall Study|Lack of Efficacy|2|||
162241178|NCT00561951|585934246|FG000|Overall Study|Lost to Follow-up|1|||
162241179|NCT00561951|585934247|FG001|Overall Study|Lost to Follow-up|1|||
162241180|NCT00561951|585934248|FG002|Overall Study|Lost to Follow-up|0|||
162241181|NCT00561951|585934246|FG000|Overall Study|Withdrawal by Subject|10|||
162241182|NCT00561951|585934247|FG001|Overall Study|Withdrawal by Subject|9|||
162241183|NCT00561951|585934248|FG002|Overall Study|Withdrawal by Subject|10|||
162241184|NCT00561951|585934246|FG000|Overall Study|Protocol Violation|4|||
162241185|NCT00561951|585934247|FG001|Overall Study|Protocol Violation|3|||
162241186|NCT00561951|585934248|FG002|Overall Study|Protocol Violation|4|||
162241187|NCT00561951|585934246|FG000|Overall Study|Physician Decision|1|||
162241188|NCT00561951|585934247|FG001|Overall Study|Physician Decision|0|||
162241189|NCT00561951|585934248|FG002|Overall Study|Physician Decision|0|||
162241190|NCT00561951|585934246|FG000|Overall Study|Pregnancy|0|||
162241191|NCT00561951|585934247|FG001|Overall Study|Pregnancy|1|||
162241192|NCT00561951|585934248|FG002|Overall Study|Pregnancy|0|||
162241193|NCT00561951|585934246|FG000|Overall Study|Meet Withdrawal Criterion|0|||
162241194|NCT00561951|585934247|FG001|Overall Study|Meet Withdrawal Criterion|1|||
162241195|NCT00561951|585934248|FG002|Overall Study|Meet Withdrawal Criterion|1|||
162241196|NCT00561951|585934246|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
162241197|NCT00561951|585934247|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
162241198|NCT00561951|585934248|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
162241199|NCT01765179|585934249|FG000|Overall Study|Adverse Event|3|||
162241200|NCT01765179|585934249|FG000|Overall Study|Lost to Follow-up|5|||
162241201|NCT01765179|585934249|FG000|Overall Study|Non-compliance with study drug|2|||
162241202|NCT01765179|585934249|FG000|Overall Study|Protocol Violation|1|||
162241203|NCT01765179|585934249|FG000|Overall Study|Withdrawal by Subject|8|||
162241204|NCT01765179|585934249|FG000|Overall Study|Hematocrit >54%|3|||
162241205|NCT01765179|585934249|FG000|Overall Study|prohibited med|1|||
162241206|NCT01765179|585934249|FG000|Overall Study|Out of country unable to finish study|1|||
162241207|NCT01765179|585934249|FG000|Overall Study|lack of venous access|1|||
162241208|NCT01765179|585934249|FG000|Overall Study|work conflict|1|||
162241209|NCT01765179|585934249|FG000|Overall Study|Ca elevated 10.6|1|||
162241210|NCT02640157|585934250|FG000|Overall Study|Adverse Event|2|||
162241211|NCT02640157|585934251|FG001|Overall Study|Adverse Event|2|||
162241212|NCT02640157|585934252|FG002|Overall Study|Adverse Event|1|||
162241213|NCT02640157|585934250|FG000|Overall Study|Withdrew consent|2|||
162241214|NCT02640157|585934251|FG001|Overall Study|Withdrew consent|0|||
162241215|NCT02640157|585934252|FG002|Overall Study|Withdrew consent|2|||
162241216|NCT02640157|585934250|FG000|Overall Study|Lost to Follow-up|9|||
162241217|NCT02640157|585934251|FG001|Overall Study|Lost to Follow-up|2|||
162241218|NCT02640157|585934252|FG002|Overall Study|Lost to Follow-up|7|||
162241219|NCT02640157|585934250|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
162241220|NCT02640157|585934251|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
162241221|NCT02640157|585934252|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
162241222|NCT01596621|585934253|FG000|Overall Study|Death|4|||
162241223|NCT01596621|585934253|FG000|Overall Study|Withdrawal by Subject|9|||
162241224|NCT01596621|585934253|FG000|Overall Study|Disease Progression|49|||
162241225|NCT01596621|585934253|FG000|Overall Study|Lost to Follow-up|3|||
162241226|NCT01596621|585934253|FG000|Overall Study|Other than specified|13|||
161682991|NCT03625687|583890221|FG000|Overall Study|Death|1|||
162241227|NCT00710021|585934254|FG000|Overall Study|Lost to Follow-up|1|||
162241228|NCT00710021|585934255|FG001|Overall Study|Lost to Follow-up|0|||
162241229|NCT00710021|585934256|FG002|Overall Study|Lost to Follow-up|0|||
162241230|NCT00710021|585934254|FG000|Overall Study|Subject's Decision|0|||
162241231|NCT00710021|585934255|FG001|Overall Study|Subject's Decision|1|||
162241232|NCT00710021|585934256|FG002|Overall Study|Subject's Decision|0|||
162241233|NCT00710021|585934254|FG000|Overall Study|Subject misrandomized|0|||
162241234|NCT00710021|585934255|FG001|Overall Study|Subject misrandomized|1|||
162241235|NCT00710021|585934256|FG002|Overall Study|Subject misrandomized|1|||
162241236|NCT00710021|585934254|FG000|Overall Study|Physician Decision|0|||
162241237|NCT00710021|585934255|FG001|Overall Study|Physician Decision|1|||
162241238|NCT00710021|585934256|FG002|Overall Study|Physician Decision|0|||
162241239|NCT00421707|585934257|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
162241240|NCT00421707|585934258|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
162241241|NCT00421707|585934257|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
162241242|NCT00421707|585934258|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
162241243|NCT00421707|585934257|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
162241244|NCT00421707|585934258|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
162241245|NCT00421707|585934257|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
162241246|NCT00421707|585934258|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
162241247|NCT00421707|585934257|FG000|Period 2: Washout|Adverse Event|1|||
162241248|NCT00421707|585934258|FG001|Period 2: Washout|Adverse Event|1|||
162241249|NCT00421707|585934257|FG000|Period 2: Washout|Withdrawal by Subject|0|||
162241250|NCT00421707|585934258|FG001|Period 2: Washout|Withdrawal by Subject|1|||
162241251|NCT00421707|585934257|FG000|Period 2: Washout|Lost to Follow-up|0|||
162241252|NCT00421707|585934258|FG001|Period 2: Washout|Lost to Follow-up|1|||
162241253|NCT00421707|585934257|FG000|Period 2: Washout|Other: Pregnancy|0|||
162241254|NCT00421707|585934258|FG001|Period 2: Washout|Other: Pregnancy|1|||
162241255|NCT00421707|585934257|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
162241256|NCT00421707|585934258|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
162241257|NCT00421707|585934257|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
162241258|NCT00421707|585934258|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
162241259|NCT00421707|585934257|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
162241260|NCT00421707|585934258|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
162241261|NCT01898923|585934261|FG000|Overall Study|Lack of Efficacy|5|||
162241262|NCT01898923|585934262|FG001|Overall Study|Lack of Efficacy|6|||
162241263|NCT01898923|585934261|FG000|Overall Study|Adverse Event|3|||
162241264|NCT01898923|585934262|FG001|Overall Study|Adverse Event|1|||
162241265|NCT01898923|585934261|FG000|Overall Study|Lost to Follow-up|0|||
162241266|NCT01898923|585934262|FG001|Overall Study|Lost to Follow-up|1|||
162241267|NCT01898923|585934261|FG000|Overall Study|Withdrawal by Subject|4|||
162241268|NCT01898923|585934262|FG001|Overall Study|Withdrawal by Subject|7|||
162241269|NCT01898923|585934261|FG000|Overall Study|Physician Decision|3|||
162241270|NCT01898923|585934262|FG001|Overall Study|Physician Decision|4|||
162241271|NCT01898923|585934261|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
162241272|NCT01898923|585934262|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
162241273|NCT00723021|585934263|FG000|Intervention Period 4|Adverse Event|0|||
162241274|NCT00723021|585934264|FG001|Intervention Period 4|Adverse Event|0|||
162241275|NCT00723021|585934265|FG002|Intervention Period 4|Adverse Event|0|||
162241276|NCT00723021|585934266|FG003|Intervention Period 4|Adverse Event|0|||
162241277|NCT00723021|585934267|FG004|Intervention Period 4|Adverse Event|1|||
162241278|NCT00147823|585934271|FG000|Overall Study|Lost to Follow-up|6|||
162241279|NCT00147823|585934272|FG001|Overall Study|Lost to Follow-up|12|||
162241280|NCT00147823|585934271|FG000|Overall Study|Physician Decision|1|||
162241281|NCT00147823|585934272|FG001|Overall Study|Physician Decision|0|||
162241282|NCT00147823|585934271|FG000|Overall Study|Withdrawal by Subject|0|||
162241283|NCT00147823|585934272|FG001|Overall Study|Withdrawal by Subject|1|||
162241284|NCT00147823|585934271|FG000|Overall Study|Did not receive vitoss due to infection|6|||
162241285|NCT00147823|585934272|FG001|Overall Study|Did not receive vitoss due to infection|2|||
162241286|NCT05199571|585936474|FG000|Treatment period|Participant decision|3|||
162241287|NCT05199571|585936474|FG000|Treatment period|Physician Decision|1|||
162241288|NCT05199571|585936474|FG000|Post-treatment follow up period|Participant decision|3|||
162241289|NCT02892344|585936475|FG000|Overall Study|Protocol deviation|3|||
162241290|NCT02892344|585936476|FG001|Overall Study|Protocol deviation|4|||
162241291|NCT02892344|585936475|FG000|Overall Study|Adverse Event|1|||
162241292|NCT02892344|585936476|FG001|Overall Study|Adverse Event|8|||
162241293|NCT02892344|585936475|FG000|Overall Study|Lost to Follow-up|0|||
162241294|NCT02892344|585936476|FG001|Overall Study|Lost to Follow-up|1|||
162241295|NCT02892344|585936475|FG000|Overall Study|Non-compliance with study treatment|0|||
162241296|NCT02892344|585936476|FG001|Overall Study|Non-compliance with study treatment|1|||
162241297|NCT02892344|585936475|FG000|Overall Study|Physician Decision|0|||
162241298|NCT02892344|585936476|FG001|Overall Study|Physician Decision|2|||
162241299|NCT02892344|585936475|FG000|Overall Study|Subject/guardian decision|0|||
162241300|NCT02892344|585936476|FG001|Overall Study|Subject/guardian decision|4|||
162241301|NCT02892344|585936475|FG000|Overall Study|Technical problems|0|||
162241302|NCT02892344|585936476|FG001|Overall Study|Technical problems|1|||
162241303|NCT04500769|585936477|FG000|Overall Study|Withdrawal by Subject|5|||
162241304|NCT01511562|585936478|FG000|Induction|Adverse Event|2|||
162241305|NCT01511562|585936479|FG001|Induction|Adverse Event|0|||
162241306|NCT01511562|585936478|FG000|Induction|Disease Progression|3|||
162241307|NCT01511562|585936479|FG001|Induction|Disease Progression|7|||
162241308|NCT01511562|585936478|FG000|Induction|Death|1|||
162241309|NCT01511562|585936479|FG001|Induction|Death|3|||
162241310|NCT01511562|585936478|FG000|Induction|Withdrawal by Subject|0|||
162241311|NCT01511562|585936479|FG001|Induction|Withdrawal by Subject|4|||
162241312|NCT01511562|585936478|FG000|Induction|Other|3|||
162241313|NCT01511562|585936479|FG001|Induction|Other|0|||
162241314|NCT01511562|585936478|FG000|Consolidation|Withdrawal by Subject|1|||
162241315|NCT01511562|585936479|FG001|Consolidation|Withdrawal by Subject|0|||
162241316|NCT01511562|585936478|FG000|Consolidation|Other|1|||
162241317|NCT01511562|585936479|FG001|Consolidation|Other|0|||
162241318|NCT03938454|585936480|FG000|Overall Study|Protocol Violation|1|||
162241319|NCT03938454|585936480|FG000|Overall Study|Withdrawal by Subject|2|||
162241320|NCT03938454|585936480|FG000|Overall Study|Lost to Follow-up|3|||
162241321|NCT04441905|585936481|FG000|Overall Study|Lost to Follow-up|1|||
162241322|NCT04441905|585936482|FG001|Overall Study|Lost to Follow-up|0|||
162241323|NCT04441905|585936483|FG002|Overall Study|Lost to Follow-up|0|||
162241324|NCT04441905|585936484|FG003|Overall Study|Lost to Follow-up|0|||
162241325|NCT04441905|585936485|FG004|Overall Study|Lost to Follow-up|0|||
162241326|NCT04441905|585936486|FG005|Overall Study|Lost to Follow-up|0|||
162241327|NCT04441905|585936481|FG000|Overall Study|Enrolled but treatment not administered|0|||
162241328|NCT04441905|585936482|FG001|Overall Study|Enrolled but treatment not administered|1|||
162241329|NCT04441905|585936483|FG002|Overall Study|Enrolled but treatment not administered|0|||
162241330|NCT04441905|585936484|FG003|Overall Study|Enrolled but treatment not administered|0|||
162241331|NCT04441905|585936485|FG004|Overall Study|Enrolled but treatment not administered|0|||
162241332|NCT04441905|585936486|FG005|Overall Study|Enrolled but treatment not administered|0|||
162241333|NCT04441905|585936481|FG000|Overall Study|Became ineligible after enrollment|0|||
162241334|NCT04441905|585936482|FG001|Overall Study|Became ineligible after enrollment|0|||
162241335|NCT04441905|585936483|FG002|Overall Study|Became ineligible after enrollment|0|||
162241336|NCT04441905|585936484|FG003|Overall Study|Became ineligible after enrollment|0|||
162241337|NCT04441905|585936485|FG004|Overall Study|Became ineligible after enrollment|1|||
162241338|NCT04441905|585936486|FG005|Overall Study|Became ineligible after enrollment|0|||
162241339|NCT04736199|585936487|FG000|Overall Study|Adverse Event|28|||
162241340|NCT04736199|585936488|FG001|Overall Study|Adverse Event|22|||
162241341|NCT04736199|585936487|FG000|Overall Study|Death|9|||
162241342|NCT04736199|585936488|FG001|Overall Study|Death|3|||
162241343|NCT04736199|585936487|FG000|Overall Study|Lost to Follow-up|4|||
162241344|NCT04736199|585936488|FG001|Overall Study|Lost to Follow-up|1|||
162241345|NCT04736199|585936487|FG000|Overall Study|Physician Decision|5|||
162241346|NCT04736199|585936488|FG001|Overall Study|Physician Decision|9|||
162241347|NCT04736199|585936487|FG000|Overall Study|Withdrawal by Subject|21|||
162241348|NCT04736199|585936488|FG001|Overall Study|Withdrawal by Subject|9|||
162241349|NCT04736199|585936487|FG000|Overall Study|Progressive disease|120|||
162241350|NCT04736199|585936488|FG001|Overall Study|Progressive disease|101|||
162241351|NCT04736199|585936487|FG000|Overall Study|Subject decision|13|||
162241352|NCT04736199|585936488|FG001|Overall Study|Subject decision|13|||
162241353|NCT04736199|585936487|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
162241354|NCT04736199|585936488|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
162241355|NCT04736199|585936487|FG000|Overall Study|Additional primary malignancy|1|||
162241356|NCT04736199|585936488|FG001|Overall Study|Additional primary malignancy|0|||
162241357|NCT04736199|585936487|FG000|Overall Study|Non-compliance with study drug|0|||
162241358|NCT04736199|585936488|FG001|Overall Study|Non-compliance with study drug|1|||
162241359|NCT04736199|585936487|FG000|Overall Study|Other reason|0|||
162241360|NCT04736199|585936488|FG001|Overall Study|Other reason|1|||
162241361|NCT04736199|585936487|FG000|Overall Study|Ongoing with study drug|240|||
162241362|NCT04736199|585936488|FG001|Overall Study|Ongoing with study drug|63|||
162241363|NCT04736199|585936487|FG000|Overall Study|Study drug never administered|3|||
162241364|NCT04736199|585936488|FG001|Overall Study|Study drug never administered|0|||
162241365|NCT03922802|585936489|FG000|Overall Study|Withdrawal by Subject|4|||
162241366|NCT04770753|585936490|FG000|Overall Study|Randomized, never treated|1|||
162241367|NCT04770753|585936491|FG001|Overall Study|Randomized, never treated|1|||
162241368|NCT04770753|585936490|FG000|Overall Study|Withdrawal by Subject|3|||
162241369|NCT04770753|585936491|FG001|Overall Study|Withdrawal by Subject|1|||
162241370|NCT04770753|585936490|FG000|Overall Study|Adverse Event|2|||
161779439|NCT00468312|584235549|FG001|Overall Study|Did not meet protocol eligibility|1|||
162241371|NCT04770753|585936491|FG001|Overall Study|Adverse Event|0|||
161779440|NCT01052038|584235550|FG000|Overall Study|Lost to Follow-up|2|||
162241372|NCT04770753|585936490|FG000|Overall Study|Pregnancy|1|||
162241373|NCT04770753|585936491|FG001|Overall Study|Pregnancy|0|||
162241374|NCT04770753|585936490|FG000|Overall Study|Other un-specified|1|||
162241375|NCT04770753|585936491|FG001|Overall Study|Other un-specified|0|||
162241376|NCT04486716|585936492|FG000|Core Phase|Subject decision|6|||
162241377|NCT04486716|585936492|FG000|Core Phase|Adverse Event|5|||
162241378|NCT04486716|585936492|FG000|Core Phase|Lost to Follow-up|1|||
162241379|NCT04486716|585936492|FG000|Core Phase|Physician Decision|1|||
162241380|NCT04486716|585936492|FG000|Core Phase|Enrolled subjects not treated|9|||
162241381|NCT05176847|585936493|FG000|Overall Study|Lost to Follow-up|23|||
162241382|NCT05176847|585936494|FG001|Overall Study|Lost to Follow-up|36|||
162241383|NCT05176847|585936493|FG000|Overall Study|Withdrawal by Subject|7|||
162241384|NCT05176847|585936494|FG001|Overall Study|Withdrawal by Subject|12|||
162241385|NCT05176847|585936493|FG000|Overall Study|Removed from analysis|1|||
162241386|NCT05176847|585936494|FG001|Overall Study|Removed from analysis|0|||
162241387|NCT02562235|585936495|FG000|Overall Study|Adverse Event|3|||
162241388|NCT04744831|585936496|FG000|Overall Study|Adverse Event|6|||
162241389|NCT04744831|585936497|FG001|Overall Study|Adverse Event|4|||
162241390|NCT04744831|585936496|FG000|Overall Study|Clinical Progression|5|||
162241391|NCT04744831|585936497|FG001|Overall Study|Clinical Progression|5|||
162241392|NCT04744831|585936496|FG000|Overall Study|Death|2|||
162241393|NCT04744831|585936497|FG001|Overall Study|Death|1|||
162241394|NCT04744831|585936496|FG000|Overall Study|Other|5|||
162241395|NCT04744831|585936497|FG001|Overall Study|Other|1|||
162241396|NCT04744831|585936496|FG000|Overall Study|Progressive Disease|63|||
162241397|NCT04744831|585936497|FG001|Overall Study|Progressive Disease|29|||
162241398|NCT04744831|585936496|FG000|Overall Study|Withdrawal by Subject|1|||
162241399|NCT04744831|585936497|FG001|Overall Study|Withdrawal by Subject|0|||
162241400|NCT05888103|585936498|FG000|Overall Study|Participant decision|3|||
162241401|NCT05888103|585936499|FG001|Overall Study|Participant decision|3|||
162241402|NCT04987307|585936500|FG000|Overall Study|Protocol-specified criteria|2|||
162241403|NCT04987307|585936501|FG001|Overall Study|Protocol-specified criteria|0|||
162241404|NCT04987307|585936502|FG002|Overall Study|Protocol-specified criteria|0|||
162241405|NCT04987307|585936503|FG003|Overall Study|Protocol-specified criteria|3|||
162241406|NCT04987307|585936500|FG000|Overall Study|Withdrawal by Subject|34|||
162241407|NCT04987307|585936501|FG001|Overall Study|Withdrawal by Subject|30|||
162241408|NCT04987307|585936502|FG002|Overall Study|Withdrawal by Subject|29|||
162241409|NCT04987307|585936503|FG003|Overall Study|Withdrawal by Subject|35|||
162241410|NCT04987307|585936500|FG000|Overall Study|Decision by sponsor|10|||
162241411|NCT04987307|585936501|FG001|Overall Study|Decision by sponsor|13|||
162241412|NCT04987307|585936502|FG002|Overall Study|Decision by sponsor|11|||
162241413|NCT04987307|585936503|FG003|Overall Study|Decision by sponsor|9|||
162241414|NCT04987307|585936500|FG000|Overall Study|Lost to Follow-up|1|||
162241415|NCT04987307|585936501|FG001|Overall Study|Lost to Follow-up|0|||
162241416|NCT04987307|585936502|FG002|Overall Study|Lost to Follow-up|0|||
162241417|NCT04987307|585936503|FG003|Overall Study|Lost to Follow-up|0|||
162241418|NCT04562480|585936504|FG000|Overall Study|Withdrawal by Subject|1|||
162241419|NCT05369208|585936505|FG000|Core Phase|Prohibited Medication Required|2|||
162241420|NCT05369208|585936505|FG000|Core Phase|Adverse Event|1|||
162241421|NCT05369208|585936505|FG000|Core Phase|Lack of Efficacy|1|||
162241422|NCT02805725|585936507|FG000|Phase I (Dose escalation part)|Clinical progression|0|||
162241423|NCT02805725|585936508|FG001|Phase I (Dose escalation part)|Clinical progression|0|||
162241424|NCT02805725|585936509|FG002|Phase I (Dose escalation part)|Clinical progression|1|||
162241425|NCT02805725|585936510|FG003|Phase I (Dose escalation part)|Clinical progression|0|||
162241426|NCT02805725|585936511|FG004|Phase I (Dose escalation part)|Clinical progression|0|||
162241427|NCT02805725|585936507|FG000|Phase I (Dose escalation part)|Adverse Event|0|||
162241428|NCT02805725|585936508|FG001|Phase I (Dose escalation part)|Adverse Event|0|||
162241429|NCT02805725|585936509|FG002|Phase I (Dose escalation part)|Adverse Event|1|||
162241430|NCT02805725|585936510|FG003|Phase I (Dose escalation part)|Adverse Event|2|||
162241431|NCT02805725|585936511|FG004|Phase I (Dose escalation part)|Adverse Event|0|||
162241432|NCT02805725|585936507|FG000|Phase II|Protocol Violation|0|||
162241433|NCT02805725|585936508|FG001|Phase II|Protocol Violation|0|||
162241434|NCT02805725|585936509|FG002|Phase II|Protocol Violation|0|||
162241435|NCT02805725|585936510|FG003|Phase II|Protocol Violation|0|||
162241436|NCT02805725|585936511|FG004|Phase II|Protocol Violation|6|||
162241437|NCT03650400|585936512|FG000|Overall Study|Study terminated by sponsor|0|||
162241438|NCT03650400|585936513|FG001|Overall Study|Study terminated by sponsor|5|||
162241439|NCT06024096|585936522|FG000|Overall Study|Lost to Follow-up|2|||
162241440|NCT06024096|585936523|FG001|Overall Study|Lost to Follow-up|5|||
162241441|NCT06024096|585936522|FG000|Overall Study|Physician Decision|0|||
162241442|NCT06024096|585936523|FG001|Overall Study|Physician Decision|1|||
162241443|NCT06024096|585936522|FG000|Overall Study|Withdrawal by Subject|2|||
162241444|NCT06024096|585936523|FG001|Overall Study|Withdrawal by Subject|3|||
162241445|NCT05541861|585936524|FG000|Overall Study|Withdrawal by Subject|0|||
162241446|NCT05541861|585936525|FG001|Overall Study|Withdrawal by Subject|0|||
162241447|NCT05541861|585936526|FG002|Overall Study|Withdrawal by Subject|0|||
162241448|NCT05541861|585936527|FG003|Overall Study|Withdrawal by Subject|0|||
162241449|NCT05541861|585936528|FG004|Overall Study|Withdrawal by Subject|0|||
162241450|NCT05541861|585936529|FG005|Overall Study|Withdrawal by Subject|0|||
162241451|NCT05541861|585936530|FG006|Overall Study|Withdrawal by Subject|2|||
162241452|NCT05541861|585936531|FG007|Overall Study|Withdrawal by Subject|0|||
162241453|NCT05541861|585936532|FG008|Overall Study|Withdrawal by Subject|0|||
162241454|NCT05541861|585936524|FG000|Overall Study|Randomized but not dosed|0|||
162241455|NCT05541861|585936525|FG001|Overall Study|Randomized but not dosed|1|||
162241456|NCT05541861|585936526|FG002|Overall Study|Randomized but not dosed|1|||
162241457|NCT05541861|585936527|FG003|Overall Study|Randomized but not dosed|0|||
162241458|NCT05541861|585936528|FG004|Overall Study|Randomized but not dosed|0|||
162241459|NCT05541861|585936529|FG005|Overall Study|Randomized but not dosed|0|||
162241460|NCT05541861|585936530|FG006|Overall Study|Randomized but not dosed|1|||
162241461|NCT05541861|585936531|FG007|Overall Study|Randomized but not dosed|0|||
162241462|NCT05541861|585936532|FG008|Overall Study|Randomized but not dosed|1|||
162241463|NCT05441670|585936533|FG000|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|0|||
162241464|NCT05441670|585936534|FG001|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|2|||
162241465|NCT04452877|585936541|FG000|Overall Study|Adverse Event|5|||
162241466|NCT04452877|585936541|FG000|Overall Study|Lost to Follow-up|1|||
162241467|NCT04452877|585936541|FG000|Overall Study|Physician Decision|4|||
162241468|NCT04452877|585936541|FG000|Overall Study|Progressive Disease|18|||
162241469|NCT04452877|585936541|FG000|Overall Study|Withdrawal by Subject|3|||
162241470|NCT04001829|585936544|FG000|Overall Study|Never start protocol therapy|5|||
162241471|NCT04001829|585936545|FG001|Overall Study|Never start protocol therapy|5|||
162241472|NCT04001829|585936544|FG000|Overall Study|Adverse Event|11|||
162241473|NCT04001829|585936545|FG001|Overall Study|Adverse Event|7|||
162241474|NCT04001829|585936544|FG000|Overall Study|Alternative therapy|1|||
162241475|NCT04001829|585936545|FG001|Overall Study|Alternative therapy|2|||
162241476|NCT04001829|585936544|FG000|Overall Study|Disease progression/relapse|2|||
162241477|NCT04001829|585936545|FG001|Overall Study|Disease progression/relapse|1|||
162241478|NCT04001829|585936544|FG000|Overall Study|Other complicating disease|1|||
162241479|NCT04001829|585936545|FG001|Overall Study|Other complicating disease|0|||
162241480|NCT04001829|585936544|FG000|Overall Study|Withdrawal by Subject|1|||
162241481|NCT04001829|585936545|FG001|Overall Study|Withdrawal by Subject|4|||
162241482|NCT04001829|585936544|FG000|Overall Study|Ineligible|2|||
162241483|NCT04001829|585936545|FG001|Overall Study|Ineligible|2|||
162241484|NCT04001829|585936544|FG000|Overall Study|Reason missing due to delinquent data|1|||
162241485|NCT04001829|585936545|FG001|Overall Study|Reason missing due to delinquent data|0|||
162241486|NCT05678959|585936546|FG000|Overall Study|Study Terminated by Sponsor|76|||
162241487|NCT05678959|585936547|FG001|Overall Study|Study Terminated by Sponsor|76|||
162241488|NCT05678959|585936546|FG000|Overall Study|Physician Decision|2|||
162241489|NCT05678959|585936547|FG001|Overall Study|Physician Decision|3|||
162241490|NCT05678959|585936546|FG000|Overall Study|Adverse Event|1|||
162241491|NCT05678959|585936547|FG001|Overall Study|Adverse Event|1|||
162241492|NCT05678959|585936546|FG000|Overall Study|Guardian Decision|1|||
162241493|NCT05678959|585936547|FG001|Overall Study|Guardian Decision|0|||
162241494|NCT05678959|585936546|FG000|Overall Study|Protocol Deviation|0|||
162241495|NCT05678959|585936547|FG001|Overall Study|Protocol Deviation|1|||
162241496|NCT05678959|585936546|FG000|Overall Study|Subject Decision|1|||
162241497|NCT05678959|585936547|FG001|Overall Study|Subject Decision|0|||
162241498|NCT05678959|585936546|FG000|Overall Study|Technical Problem|0|||
162241499|NCT05678959|585936547|FG001|Overall Study|Technical Problem|1|||
162241500|NCT05859698|585936548|FG000|Overall Study|Adverse Event|1|||
162241501|NCT05859698|585936548|FG000|Overall Study|Death|1|||
162241502|NCT05859698|585936548|FG000|Overall Study|Physician Decision|1|||
162241503|NCT05859698|585936548|FG000|Overall Study|Lost to Follow-up|2|||
162241504|NCT05859698|585936548|FG000|Overall Study|Other Than Specified|2|||
162241505|NCT05859698|585936548|FG000|Overall Study|Withdrawal by Subject|1|||
162241506|NCT05818137|585936549|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
162241507|NCT05818137|585936549|FG000|Extension Treatment Period|Ongoing participants|44|||
162241508|NCT05248945|585936550|FG000|Overall Study|Adverse Event|1|||
162241509|NCT05248945|585936550|FG000|Overall Study|Elevated Gamma-Glutamyl Transferase (GGT)|1|||
162241510|NCT05525975|585936551|FG000|Overall Study|Surgery cancellation|4|||
162241511|NCT05525975|585936552|FG001|Overall Study|Surgery cancellation|5|||
162241512|NCT05525975|585936551|FG000|Overall Study|didn't fill prescription|1|||
162241513|NCT05525975|585936552|FG001|Overall Study|didn't fill prescription|0|||
162241514|NCT05525975|585936551|FG000|Overall Study|Withdrawal by Subject|0|||
162241515|NCT05525975|585936552|FG001|Overall Study|Withdrawal by Subject|3|||
162241516|NCT02065336|585936553|FG000|Extension Phase|Study Terminated by Sponsor|0|||
162241517|NCT02065336|585936554|FG001|Extension Phase|Study Terminated by Sponsor|0|||
162241518|NCT02065336|585936555|FG002|Extension Phase|Study Terminated by Sponsor|0|||
162241519|NCT02065336|585936556|FG003|Extension Phase|Study Terminated by Sponsor|0|||
162241520|NCT02065336|585936557|FG004|Extension Phase|Study Terminated by Sponsor|0|||
162241521|NCT02065336|585936558|FG005|Extension Phase|Study Terminated by Sponsor|0|||
162241522|NCT02065336|585936559|FG006|Extension Phase|Study Terminated by Sponsor|0|||
162241523|NCT02065336|585936560|FG007|Extension Phase|Study Terminated by Sponsor|0|||
162241524|NCT02065336|585936561|FG008|Extension Phase|Study Terminated by Sponsor|2|||
162241525|NCT02065336|585936562|FG009|Extension Phase|Study Terminated by Sponsor|8|||
162241526|NCT05925374|585936563|FG000|Overall Study|Lost to Follow-up|13|||
162241527|NCT03226392|585936564|FG000|Overall Study|Protocol Deviation|1|||
162241528|NCT03226392|585936565|FG001|Overall Study|Protocol Deviation|0|||
162241529|NCT03226392|585936564|FG000|Overall Study|Physician Decision|1|||
162241530|NCT03226392|585936565|FG001|Overall Study|Physician Decision|0|||
162241531|NCT03226392|585936564|FG000|Overall Study|Lost to Follow-up|1|||
162241532|NCT03226392|585936565|FG001|Overall Study|Lost to Follow-up|0|||
162241533|NCT03226392|585936564|FG000|Overall Study|Adverse Event|1|||
162241534|NCT03226392|585936565|FG001|Overall Study|Adverse Event|0|||
162241535|NCT03226392|585936564|FG000|Overall Study|Technical Problems|0|||
162241536|NCT03226392|585936565|FG001|Overall Study|Technical Problems|2|||
162241537|NCT03226392|585936564|FG000|Overall Study|Subject/Guardian Decision|7|||
162241538|NCT03226392|585936565|FG001|Overall Study|Subject/Guardian Decision|6|||
162241539|NCT05900999|585936566|FG000|Overall Study|Withdrawal by Subject|9|||
162241540|NCT05900999|585936566|FG000|Overall Study|transfer to another facility; too complex of a therapy schedule; physician withdrawal|3|||
162241541|NCT05090423|585936567|FG000|Overall Study|Because of the covid-19|3|||
162241542|NCT05090423|585936568|FG001|Overall Study|Because of the covid-19|2|||
162241543|NCT05090423|585936567|FG000|Overall Study|repeated ankle sprain in daily of life|0|||
162241544|NCT05090423|585936568|FG001|Overall Study|repeated ankle sprain in daily of life|1|||
162241545|NCT03056755|585936569|FG000|Core Phase|Progressive disease|89|||
162241546|NCT03056755|585936570|FG001|Core Phase|Progressive disease|88|||
162241547|NCT03056755|585936571|FG002|Core Phase|Progressive disease|90|||
162241548|NCT03056755|585936569|FG000|Core Phase|Adverse Event|20|||
162241549|NCT03056755|585936570|FG001|Core Phase|Adverse Event|14|||
162241550|NCT03056755|585936571|FG002|Core Phase|Adverse Event|13|||
162241551|NCT03056755|585936569|FG000|Core Phase|Physician Decision|7|||
162241552|NCT03056755|585936570|FG001|Core Phase|Physician Decision|13|||
162241553|NCT03056755|585936571|FG002|Core Phase|Physician Decision|5|||
162241554|NCT03056755|585936569|FG000|Core Phase|Subject/guardian decision|5|||
162241555|NCT03056755|585936570|FG001|Core Phase|Subject/guardian decision|8|||
162241556|NCT03056755|585936571|FG002|Core Phase|Subject/guardian decision|4|||
162241557|NCT03056755|585936569|FG000|Core Phase|Death|3|||
162241558|NCT03056755|585936570|FG001|Core Phase|Death|2|||
162241559|NCT03056755|585936571|FG002|Core Phase|Death|4|||
162241560|NCT03056755|585936569|FG000|Core Phase|Protocol deviation|1|||
162241561|NCT03056755|585936570|FG001|Core Phase|Protocol deviation|1|||
162241562|NCT03056755|585936571|FG002|Core Phase|Protocol deviation|0|||
162241563|NCT03056755|585936569|FG000|Core Phase|Technical problems|1|||
162241564|NCT03056755|585936570|FG001|Core Phase|Technical problems|0|||
162241565|NCT03056755|585936571|FG002|Core Phase|Technical problems|0|||
162241566|NCT03056755|585936569|FG000|Extension Phase|Physician Decision|1|||
162241567|NCT03056755|585936570|FG001|Extension Phase|Physician Decision|0|||
162241568|NCT03056755|585936571|FG002|Extension Phase|Physician Decision|3|||
162241569|NCT03056755|585936569|FG000|Extension Phase|Adverse Event|0|||
162241570|NCT03056755|585936570|FG001|Extension Phase|Adverse Event|0|||
162241571|NCT03056755|585936571|FG002|Extension Phase|Adverse Event|1|||
162241572|NCT03056755|585936569|FG000|Extension Phase|Subject/guardian decision|0|||
162241573|NCT03056755|585936570|FG001|Extension Phase|Subject/guardian decision|0|||
162241574|NCT03056755|585936571|FG002|Extension Phase|Subject/guardian decision|1|||
162241575|NCT04667949|585936581|FG000|Overall Study|Adverse Event|0|||
162241576|NCT04667949|585936582|FG001|Overall Study|Adverse Event|2|||
162241577|NCT04667949|585936581|FG000|Overall Study|Lost to Follow-up|0|||
162241578|NCT04667949|585936582|FG001|Overall Study|Lost to Follow-up|1|||
162241579|NCT04667949|585936581|FG000|Overall Study|Physician Decision|0|||
162241580|NCT04667949|585936582|FG001|Overall Study|Physician Decision|2|||
162241581|NCT04667949|585936581|FG000|Overall Study|Subject decision|1|||
162241582|NCT04667949|585936582|FG001|Overall Study|Subject decision|7|||
162241583|NCT05206370|585936583|FG000|Overall Study|Adverse Event|3|||
162241584|NCT05206370|585936584|FG001|Overall Study|Adverse Event|4|||
162241585|NCT05206370|585936585|FG002|Overall Study|Adverse Event|5|||
162241586|NCT05206370|585936583|FG000|Overall Study|Withdrawal by Subject|27|||
162241587|NCT05206370|585936584|FG001|Overall Study|Withdrawal by Subject|30|||
162241588|NCT05206370|585936585|FG002|Overall Study|Withdrawal by Subject|24|||
162241589|NCT05206370|585936583|FG000|Overall Study|Physician Decision|1|||
162241590|NCT05206370|585936584|FG001|Overall Study|Physician Decision|3|||
162241591|NCT05206370|585936585|FG002|Overall Study|Physician Decision|2|||
162241592|NCT05206370|585936583|FG000|Overall Study|Death|0|||
162241593|NCT05206370|585936584|FG001|Overall Study|Death|1|||
162241594|NCT05206370|585936585|FG002|Overall Study|Death|3|||
162241595|NCT05206370|585936583|FG000|Overall Study|Lost to Follow-up|23|||
162241596|NCT05206370|585936584|FG001|Overall Study|Lost to Follow-up|16|||
162241597|NCT05206370|585936585|FG002|Overall Study|Lost to Follow-up|14|||
162241598|NCT05206370|585936583|FG000|Overall Study|Other, Nor Specified|2|||
162241599|NCT05206370|585936584|FG001|Overall Study|Other, Nor Specified|2|||
162241600|NCT05206370|585936585|FG002|Overall Study|Other, Nor Specified|4|||
162241601|NCT05388058|585936586|FG000|Initial Treatment|Withdrawal by Subject|0|||
162241602|NCT05388058|585936587|FG001|Initial Treatment|Withdrawal by Subject|1|||
162241603|NCT05388058|585936586|FG000|Initial Treatment|Ineligible|0|||
162241604|NCT05388058|585936587|FG001|Initial Treatment|Ineligible|1|||
162241605|NCT04998851|585936589|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
162241606|NCT04998851|585936590|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
162241607|NCT04998851|585936589|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
161895328|NCT00741598|584666297|FG001|Overall Study|Physician Decision|1|||
161895329|NCT00741598|584666296|FG000|Overall Study|Pregnancy|1|||
162241608|NCT04998851|585936590|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
162241609|NCT04504630|585936591|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
162241610|NCT04504630|585936592|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
162241611|NCT04504630|585936591|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
162241612|NCT04504630|585936592|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
162241613|NCT04266301|585936595|FG000|Overall Study|Progressive Disease|111|||
162241614|NCT04266301|585936596|FG001|Overall Study|Progressive Disease|92|||
162241615|NCT04266301|585936595|FG000|Overall Study|Adverse Event|41|||
162241616|NCT04266301|585936596|FG001|Overall Study|Adverse Event|43|||
162241617|NCT04266301|585936595|FG000|Overall Study|Death|26|||
162241618|NCT04266301|585936596|FG001|Overall Study|Death|35|||
162241619|NCT04266301|585936595|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
162241620|NCT04266301|585936596|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
162241621|NCT04266301|585936595|FG000|Overall Study|Study Terminated by Sponsor|22|||
162241622|NCT04266301|585936596|FG001|Overall Study|Study Terminated by Sponsor|27|||
162241623|NCT04266301|585936595|FG000|Overall Study|Participant Decision|22|||
162241624|NCT04266301|585936596|FG001|Overall Study|Participant Decision|28|||
162241625|NCT04266301|585936595|FG000|Overall Study|Physician Decision|14|||
162241626|NCT04266301|585936596|FG001|Overall Study|Physician Decision|9|||
162241627|NCT04266301|585936595|FG000|Overall Study|New Therapy for Study Indication|2|||
162241628|NCT04266301|585936596|FG001|Overall Study|New Therapy for Study Indication|4|||
162241629|NCT04266301|585936595|FG000|Overall Study|Protocol Deviation|2|||
162241630|NCT04266301|585936596|FG001|Overall Study|Protocol Deviation|4|||
162241631|NCT04266301|585936595|FG000|Overall Study|Guardian Decision|1|||
162241632|NCT04266301|585936596|FG001|Overall Study|Guardian Decision|0|||
162241633|NCT04266301|585936595|FG000|Overall Study|Lost to Follow-up|1|||
162241634|NCT04266301|585936596|FG001|Overall Study|Lost to Follow-up|0|||
162241635|NCT04266301|585936595|FG000|Overall Study|Participants Not Treated|1|||
162241636|NCT04266301|585936596|FG001|Overall Study|Participants Not Treated|1|||
162241637|NCT03215758|585936599|FG000|Overall Study|Technical Problems|1|||
162241638|NCT03215758|585936600|FG001|Overall Study|Technical Problems|0|||
162241639|NCT03215758|585936599|FG000|Overall Study|Protocol deviation|0|||
162241640|NCT03215758|585936600|FG001|Overall Study|Protocol deviation|1|||
162241641|NCT03215758|585936599|FG000|Overall Study|Physician Decision|0|||
162241642|NCT03215758|585936600|FG001|Overall Study|Physician Decision|1|||
162241643|NCT03215758|585936599|FG000|Overall Study|Death|0|||
162241644|NCT03215758|585936600|FG001|Overall Study|Death|1|||
162241645|NCT03215758|585936599|FG000|Overall Study|Adverse Event|1|||
162241646|NCT03215758|585936600|FG001|Overall Study|Adverse Event|2|||
162241647|NCT03215758|585936599|FG000|Overall Study|Subject/Guardian Decision|3|||
162241648|NCT03215758|585936600|FG001|Overall Study|Subject/Guardian Decision|3|||
162241649|NCT05733286|585936602|FG000|Overall Study|Never received study drug|2|||
162241650|NCT05733286|585936603|FG001|Overall Study|Never received study drug|3|||
162241651|NCT04527549|585936604|FG000|Overall Study|Withdrawal by Subject|1|||
162241652|NCT04527549|585936605|FG001|Overall Study|Withdrawal by Subject|1|||
162241653|NCT02977988|585936615|FG000|Overall Study|Lost to Follow-up|13|||
162241654|NCT02977988|585936616|FG001|Overall Study|Lost to Follow-up|7|||
162241655|NCT05098015|585936617|FG000|Overall Study|Death|1|||
162241656|NCT05098015|585936618|FG001|Overall Study|Death|1|||
162241657|NCT05098015|585936619|FG002|Overall Study|Death|3|||
162241658|NCT05098015|585936620|FG003|Overall Study|Death|0|||
162241659|NCT05098015|585936617|FG000|Overall Study|Lost to Follow-up|1|||
162241660|NCT05098015|585936618|FG001|Overall Study|Lost to Follow-up|1|||
162241661|NCT05098015|585936619|FG002|Overall Study|Lost to Follow-up|3|||
162241662|NCT05098015|585936620|FG003|Overall Study|Lost to Follow-up|3|||
162241663|NCT05098015|585936617|FG000|Overall Study|Withdrawal by Subject|0|||
162241664|NCT05098015|585936618|FG001|Overall Study|Withdrawal by Subject|1|||
162241665|NCT05098015|585936619|FG002|Overall Study|Withdrawal by Subject|0|||
162241666|NCT05098015|585936620|FG003|Overall Study|Withdrawal by Subject|2|||
162241667|NCT04831216|585936621|FG000|Overall Study|Lost to Follow-up|32|||
162241668|NCT05341115|585936622|FG000|Overall Study|Adverse Event|1|||
162241669|NCT05341115|585936622|FG000|Overall Study|Lost to Follow-up|1|||
162241670|NCT06038123|585936628|FG000|Overall Study|Withdrawal by Subject|1|||
162241671|NCT06038123|585936628|FG000|Overall Study|not return due to femur fracture|1|||
162241672|NCT05630001|585936630|FG000|Overall Study|Adverse Event|1|||
162241673|NCT05218499|585936631|FG000|Overall Study|Not treated|1|||
162241674|NCT05218499|585936632|FG001|Overall Study|Not treated|1|||
162241675|NCT05218499|585936633|FG002|Overall Study|Not treated|8|||
162241676|NCT05218499|585936631|FG000|Overall Study|Death|2|||
162241677|NCT05218499|585936632|FG001|Overall Study|Death|0|||
162241678|NCT05218499|585936633|FG002|Overall Study|Death|0|||
162241679|NCT05218499|585936631|FG000|Overall Study|Other than listed|3|||
162241680|NCT05218499|585936632|FG001|Overall Study|Other than listed|7|||
162241681|NCT05218499|585936633|FG002|Overall Study|Other than listed|10|||
162241682|NCT05218499|585936631|FG000|Overall Study|Protocol deviation|5|||
162241683|NCT05218499|585936632|FG001|Overall Study|Protocol deviation|6|||
162241684|NCT05218499|585936633|FG002|Overall Study|Protocol deviation|4|||
162241685|NCT05218499|585936631|FG000|Overall Study|Technical problems|0|||
162241686|NCT05218499|585936632|FG001|Overall Study|Technical problems|1|||
162241687|NCT05218499|585936633|FG002|Overall Study|Technical problems|0|||
162241688|NCT05218499|585936631|FG000|Overall Study|Burden of trial procedures|0|||
162241689|NCT05218499|585936632|FG001|Overall Study|Burden of trial procedures|1|||
162241690|NCT05218499|585936633|FG002|Overall Study|Burden of trial procedures|2|||
162241691|NCT05218499|585936631|FG000|Overall Study|Clinical disease progression|6|||
162241692|NCT05218499|585936632|FG001|Overall Study|Clinical disease progression|6|||
162241693|NCT05218499|585936633|FG002|Overall Study|Clinical disease progression|11|||
162241694|NCT05218499|585936631|FG000|Overall Study|Objective disease progression|44|||
162241695|NCT05218499|585936632|FG001|Overall Study|Objective disease progression|61|||
162241696|NCT05218499|585936633|FG002|Overall Study|Objective disease progression|42|||
162241697|NCT05218499|585936631|FG000|Overall Study|Adverse Event|11|||
162241698|NCT05218499|585936632|FG001|Overall Study|Adverse Event|36|||
162241699|NCT05218499|585936633|FG002|Overall Study|Adverse Event|9|||
162241700|NCT05218499|585936631|FG000|Overall Study|On treatment at time of snapshot|18|||
162241701|NCT05218499|585936632|FG001|Overall Study|On treatment at time of snapshot|29|||
162241702|NCT05218499|585936633|FG002|Overall Study|On treatment at time of snapshot|0|||
162241703|NCT05386680|585936635|FG000|Overall Study|Guardian decision|2|||
162241704|NCT05655832|585936636|FG000|Overall Study|Not mentioned|0|||
162241705|NCT05655832|585936637|FG001|Overall Study|Not mentioned|1|||
162241706|NCT05655832|585936636|FG000|Overall Study|Withdrawal by Subject|0|||
162241707|NCT05655832|585936637|FG001|Overall Study|Withdrawal by Subject|1|||
162241708|NCT05655832|585936636|FG000|Overall Study|Protocol non-compliance|0|||
162241709|NCT05655832|585936637|FG001|Overall Study|Protocol non-compliance|1|||
162241710|NCT03946670|585936638|FG000|Overall Study|Progressive Disease|34|||
162241711|NCT03946670|585936639|FG001|Overall Study|Progressive Disease|27|||
162241712|NCT03946670|585936638|FG000|Overall Study|Adverse Event|7|||
162241713|NCT03946670|585936639|FG001|Overall Study|Adverse Event|10|||
162241714|NCT03946670|585936638|FG000|Overall Study|Physician Decision|6|||
162241715|NCT03946670|585936639|FG001|Overall Study|Physician Decision|5|||
162241716|NCT03946670|585936638|FG000|Overall Study|Death|5|||
162241717|NCT03946670|585936639|FG001|Overall Study|Death|8|||
162241718|NCT03946670|585936638|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
162241719|NCT03946670|585936639|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
162241720|NCT03946670|585936638|FG000|Overall Study|Subject Decision|4|||
162241721|NCT03946670|585936639|FG001|Overall Study|Subject Decision|5|||
162241722|NCT03946670|585936638|FG000|Overall Study|Study Terminated By Sponsor|2|||
162241723|NCT03946670|585936639|FG001|Overall Study|Study Terminated By Sponsor|0|||
162241724|NCT03946670|585936638|FG000|Overall Study|New Therapy For Study Indication|1|||
162241725|NCT03946670|585936639|FG001|Overall Study|New Therapy For Study Indication|0|||
162241726|NCT03946670|585936638|FG000|Overall Study|Not Treated|1|||
162241727|NCT03946670|585936639|FG001|Overall Study|Not Treated|1|||
162241728|NCT04516967|585936640|FG000|Core Phase|Adverse Event|2|||
162241729|NCT04516967|585936641|FG001|Core Phase|Adverse Event|1|||
162241730|NCT04516967|585936642|FG002|Core Phase|Adverse Event|0|||
162241731|NCT04516967|585936640|FG000|Core Phase|Physician Decision|1|||
162241732|NCT04516967|585936641|FG001|Core Phase|Physician Decision|1|||
162241733|NCT04516967|585936642|FG002|Core Phase|Physician Decision|0|||
162241734|NCT04516967|585936640|FG000|Core Phase|Lack of Efficacy|7|||
162241735|NCT04516967|585936641|FG001|Core Phase|Lack of Efficacy|18|||
162241736|NCT04516967|585936642|FG002|Core Phase|Lack of Efficacy|0|||
162241737|NCT04652726|585936643|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
162241738|NCT04652726|585936644|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
162241739|NCT04652726|585936645|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
162241740|NCT04652726|585936643|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
162241741|NCT04652726|585936644|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
162241742|NCT04652726|585936645|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
162241743|NCT03199469|585936646|FG000|Overall Study|Randomized, not treated|0|||
162241744|NCT03199469|585936647|FG001|Overall Study|Randomized, not treated|3|||
162241745|NCT03199469|585936646|FG000|Overall Study|Withdrawal by Subject|1|||
162241746|NCT03199469|585936647|FG001|Overall Study|Withdrawal by Subject|0|||
162241747|NCT03199469|585936646|FG000|Overall Study|Death|1|||
162241748|NCT03199469|585936647|FG001|Overall Study|Death|3|||
162241749|NCT03199469|585936646|FG000|Overall Study|Ongoing|5|||
162241750|NCT03199469|585936647|FG001|Overall Study|Ongoing|14|||
162241751|NCT03470441|585936648|FG000|Overall Study|Death|0|||
162241752|NCT03470441|585936649|FG001|Overall Study|Death|1|||
162241753|NCT03470441|585936650|FG002|Overall Study|Death|1|||
162241754|NCT03470441|585936651|FG003|Overall Study|Death|0|||
162241755|NCT03470441|585936648|FG000|Overall Study|Adverse Event|0|||
162241756|NCT03470441|585936649|FG001|Overall Study|Adverse Event|0|||
162241757|NCT03470441|585936650|FG002|Overall Study|Adverse Event|0|||
162241758|NCT03470441|585936651|FG003|Overall Study|Adverse Event|1|||
162241759|NCT03470441|585936648|FG000|Overall Study|Withdrawal by Subject|1|||
162241760|NCT03470441|585936649|FG001|Overall Study|Withdrawal by Subject|4|||
162241761|NCT03470441|585936650|FG002|Overall Study|Withdrawal by Subject|1|||
162241762|NCT03470441|585936651|FG003|Overall Study|Withdrawal by Subject|3|||
162241763|NCT03780725|585936652|FG000|Overall Study|Progression of disease|3|||
162241764|NCT03780725|585936653|FG001|Overall Study|Progression of disease|4|||
162241765|NCT03780725|585936652|FG000|Overall Study|Adverse Event|0|||
161895330|NCT00741598|584666297|FG001|Overall Study|Pregnancy|0|||
162241766|NCT03780725|585936653|FG001|Overall Study|Adverse Event|1|||
162241767|NCT05916170|585936654|FG000|No Warning Control|Lost to Follow-up|12|||
162241768|NCT05916170|585936654|FG000|No Warning Control|Withdrawal by Subject|15|||
162241769|NCT05916170|585936654|FG000|No Warning Control|Noncompliance with protocol|1|||
162241770|NCT05916170|585936654|FG000|Health Warning Intervention|Lost to Follow-up|15|||
162241771|NCT05916170|585936654|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
162241772|NCT05916170|585936654|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
162241773|NCT04576949|585936655|FG000|Overall Study|Adverse Event|1|||
162241774|NCT04576949|585936656|FG001|Overall Study|Adverse Event|3|||
162241775|NCT04576949|585936657|FG002|Overall Study|Adverse Event|2|||
162241776|NCT04576949|585936655|FG000|Overall Study|Withdrawal by Subject|41|||
162241777|NCT04576949|585936656|FG001|Overall Study|Withdrawal by Subject|26|||
162241778|NCT04576949|585936657|FG002|Overall Study|Withdrawal by Subject|18|||
162241779|NCT04576949|585936655|FG000|Overall Study|Physician Decision|3|||
162241780|NCT04576949|585936656|FG001|Overall Study|Physician Decision|0|||
162241781|NCT04576949|585936657|FG002|Overall Study|Physician Decision|0|||
162241782|NCT04576949|585936655|FG000|Overall Study|Death|0|||
162241783|NCT04576949|585936656|FG001|Overall Study|Death|1|||
162241784|NCT04576949|585936657|FG002|Overall Study|Death|0|||
162241785|NCT04576949|585936655|FG000|Overall Study|Lost to Follow-up|29|||
162241786|NCT04576949|585936656|FG001|Overall Study|Lost to Follow-up|37|||
162241787|NCT04576949|585936657|FG002|Overall Study|Lost to Follow-up|24|||
162241788|NCT04576949|585936655|FG000|Overall Study|Other, Not Specified|2|||
162241789|NCT04576949|585936656|FG001|Overall Study|Other, Not Specified|3|||
162241790|NCT04576949|585936657|FG002|Overall Study|Other, Not Specified|1|||
162241791|NCT04576949|585936655|FG000|Overall Study|Other|1|||
162241792|NCT04576949|585936656|FG001|Overall Study|Other|0|||
162241793|NCT04576949|585936657|FG002|Overall Study|Other|0|||
162241794|NCT02738008|585939013|FG000|Overall Study|Study Terminated by Sponsor|1|||
162241795|NCT02738008|585939014|FG001|Overall Study|Study Terminated by Sponsor|5|||
162241796|NCT02738008|585939015|FG002|Overall Study|Study Terminated by Sponsor|3|||
162241797|NCT02738008|585939013|FG000|Overall Study|Adverse Event|0|||
162241798|NCT02738008|585939014|FG001|Overall Study|Adverse Event|1|||
162241799|NCT02738008|585939015|FG002|Overall Study|Adverse Event|2|||
162241800|NCT03437278|585939016|FG000|Overall Study|Adverse Event|0|||
162241801|NCT03437278|585939017|FG001|Overall Study|Adverse Event|0|||
162241802|NCT03437278|585939018|FG002|Overall Study|Adverse Event|1|||
162241803|NCT03437278|585939016|FG000|Overall Study|Progressive disease|1|||
162241804|NCT03437278|585939017|FG001|Overall Study|Progressive disease|0|||
162241805|NCT03437278|585939018|FG002|Overall Study|Progressive disease|0|||
162241806|NCT03437278|585939016|FG000|Overall Study|Physician Decision|1|||
162241807|NCT03437278|585939017|FG001|Overall Study|Physician Decision|0|||
162241808|NCT03437278|585939018|FG002|Overall Study|Physician Decision|1|||
162241809|NCT03556904|585939019|FG000|Overall Study|Disease Progression after treatment started|3|||
162241810|NCT03556904|585939020|FG001|Overall Study|Disease Progression after treatment started|3|||
162241811|NCT03556904|585939019|FG000|Overall Study|Sponsor Termination|2|||
162241812|NCT03556904|585939020|FG001|Overall Study|Sponsor Termination|2|||
162241813|NCT03556904|585939019|FG000|Overall Study|Physician Decision|2|||
162241814|NCT03556904|585939020|FG001|Overall Study|Physician Decision|0|||
162241815|NCT03556904|585939019|FG000|Overall Study|Withdrawal by Subject|1|||
162241816|NCT03556904|585939020|FG001|Overall Study|Withdrawal by Subject|0|||
162241817|NCT05192382|585939021|FG000|RC Phase (Up to Week 24)|Adverse Event|1|||
162241818|NCT05192382|585939022|FG001|RC Phase (Up to Week 24)|Adverse Event|1|||
162241819|NCT05192382|585939023|FG002|RC Phase (Up to Week 24)|Adverse Event|0|||
162241820|NCT05192382|585939021|FG000|RC Phase (Up to Week 24)|Withdrawal by Subject|1|||
162241821|NCT05192382|585939022|FG001|RC Phase (Up to Week 24)|Withdrawal by Subject|2|||
162241822|NCT05192382|585939023|FG002|RC Phase (Up to Week 24)|Withdrawal by Subject|0|||
162241823|NCT05192382|585939021|FG000|OLE Phase (Up to Week 200)|Discontinued|1|||
162241824|NCT05192382|585939022|FG001|OLE Phase (Up to Week 200)|Discontinued|4|||
162241825|NCT05192382|585939023|FG002|OLE Phase (Up to Week 200)|Discontinued|1|||
162241826|NCT05192382|585939021|FG000|OLE Phase (Up to Week 200)|Ongoing|49|||
162241827|NCT05192382|585939022|FG001|OLE Phase (Up to Week 200)|Ongoing|48|||
162241828|NCT05192382|585939023|FG002|OLE Phase (Up to Week 200)|Ongoing|10|||
162241829|NCT04328727|585939024|FG000|Overall Study|Guardian Decision|1|||
162241830|NCT04328727|585939024|FG000|Overall Study|Participant decision|4|||
162241831|NCT04328727|585939024|FG000|Overall Study|Death|3|||
162241832|NCT02604199|585939025|FG000|Overall Study|Pregnancy|0|||
162241833|NCT02604199|585939026|FG001|Overall Study|Pregnancy|0|||
162241834|NCT02604199|585939027|FG002|Overall Study|Pregnancy|0|||
162241835|NCT02604199|585939028|FG003|Overall Study|Pregnancy|1|||
162241836|NCT02604199|585939025|FG000|Overall Study|Study terminated by sponsor|0|||
162241837|NCT02604199|585939026|FG001|Overall Study|Study terminated by sponsor|2|||
162241838|NCT02604199|585939027|FG002|Overall Study|Study terminated by sponsor|0|||
162241839|NCT02604199|585939028|FG003|Overall Study|Study terminated by sponsor|2|||
162241840|NCT02604199|585939025|FG000|Overall Study|Withdrawal by Subject|0|||
162241841|NCT02604199|585939026|FG001|Overall Study|Withdrawal by Subject|1|||
162241842|NCT02604199|585939027|FG002|Overall Study|Withdrawal by Subject|0|||
162241843|NCT02604199|585939028|FG003|Overall Study|Withdrawal by Subject|0|||
162241844|NCT05411367|585939029|FG000|Overall Study|Adverse Event|9|||
162241845|NCT05411367|585939030|FG001|Overall Study|Adverse Event|3|||
162241846|NCT05411367|585939029|FG000|Overall Study|Protocol Violation|0|||
162241847|NCT05411367|585939030|FG001|Overall Study|Protocol Violation|2|||
162241848|NCT05411367|585939029|FG000|Overall Study|Administrative Reasons|2|||
162241849|NCT05411367|585939030|FG001|Overall Study|Administrative Reasons|1|||
162241850|NCT05411367|585939029|FG000|Overall Study|Withdrawal by Subject|3|||
162241851|NCT05411367|585939030|FG001|Overall Study|Withdrawal by Subject|4|||
162241852|NCT05411367|585939029|FG000|Overall Study|Inclusion Criteria Not Met|0|||
162241853|NCT05411367|585939030|FG001|Overall Study|Inclusion Criteria Not Met|1|||
162241854|NCT02604212|585939031|FG000|Overall Study|Study Terminated by Sponsor|2|||
162241855|NCT02604212|585939032|FG001|Overall Study|Study Terminated by Sponsor|1|||
162241856|NCT02604212|585939033|FG002|Overall Study|Study Terminated by Sponsor|3|||
162241857|NCT02604212|585939034|FG003|Overall Study|Study Terminated by Sponsor|3|||
162241858|NCT02604212|585939031|FG000|Overall Study|Withdrawal by Subject|0|||
162241859|NCT02604212|585939032|FG001|Overall Study|Withdrawal by Subject|0|||
162241860|NCT02604212|585939033|FG002|Overall Study|Withdrawal by Subject|1|||
162241861|NCT02604212|585939034|FG003|Overall Study|Withdrawal by Subject|0|||
162241862|NCT04702776|585939038|FG000|Overall Study|Adverse Event|1|||
162241863|NCT04702776|585939039|FG001|Overall Study|Adverse Event|2|||
162241864|NCT04702776|585939040|FG002|Overall Study|Adverse Event|1|||
162241865|NCT04702776|585939038|FG000|Overall Study|Lost to Follow-up|2|||
162241866|NCT04702776|585939039|FG001|Overall Study|Lost to Follow-up|1|||
162241867|NCT04702776|585939040|FG002|Overall Study|Lost to Follow-up|4|||
162241868|NCT04702776|585939038|FG000|Overall Study|Protocol Violation|2|||
162241869|NCT04702776|585939039|FG001|Overall Study|Protocol Violation|2|||
162241870|NCT04702776|585939040|FG002|Overall Study|Protocol Violation|3|||
162241871|NCT02032823|585939046|FG000|Overall Study|Death|75|||
162241872|NCT02032823|585939047|FG001|Overall Study|Death|109|||
162241873|NCT02032823|585939046|FG000|Overall Study|Lost to Follow-up|18|||
162241874|NCT02032823|585939047|FG001|Overall Study|Lost to Follow-up|17|||
162241875|NCT02032823|585939046|FG000|Overall Study|Withdrawal by Subject|70|||
162241876|NCT02032823|585939047|FG001|Overall Study|Withdrawal by Subject|53|||
162241877|NCT02032823|585939046|FG000|Overall Study|Ongoing study at data cut-off|755|||
162241878|NCT02032823|585939047|FG001|Overall Study|Ongoing study at data cut-off|731|||
162241879|NCT02032823|585939046|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
162241880|NCT02032823|585939047|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
162241881|NCT05431387|585939048|FG000|Overall Study|Adverse Event|1|||
162241882|NCT05431387|585939049|FG001|Overall Study|Adverse Event|0|||
162241883|NCT05431387|585939048|FG000|Overall Study|Withdrawal by Subject|4|||
162241884|NCT05431387|585939049|FG001|Overall Study|Withdrawal by Subject|4|||
162241885|NCT05431387|585939048|FG000|Overall Study|Physician Decision|0|||
162241886|NCT05431387|585939049|FG001|Overall Study|Physician Decision|1|||
162241887|NCT05431387|585939048|FG000|Overall Study|Lost to Follow-up|5|||
162241888|NCT05431387|585939049|FG001|Overall Study|Lost to Follow-up|9|||
162241889|NCT05431387|585939048|FG000|Overall Study|Other, Not Specified|1|||
162241890|NCT05431387|585939049|FG001|Overall Study|Other, Not Specified|4|||
162241891|NCT05243680|585939050|FG000|Overall Study|Adverse Event|1|||
162241892|NCT05243680|585939051|FG001|Overall Study|Adverse Event|1|||
162241893|NCT05243680|585939050|FG000|Overall Study|Lack of Efficacy|1|||
162241894|NCT05243680|585939051|FG001|Overall Study|Lack of Efficacy|1|||
162241895|NCT05243680|585939050|FG000|Overall Study|Lost to Follow-up|5|||
162241896|NCT05243680|585939051|FG001|Overall Study|Lost to Follow-up|4|||
162241897|NCT05243680|585939050|FG000|Overall Study|Physician Decision|1|||
162241898|NCT05243680|585939051|FG001|Overall Study|Physician Decision|0|||
162241899|NCT05243680|585939050|FG000|Overall Study|Withdrawal by Subject|3|||
162241900|NCT05243680|585939051|FG001|Overall Study|Withdrawal by Subject|10|||
162241901|NCT05243680|585939050|FG000|Overall Study|Data integrity and GCP violations|4|||
162241902|NCT05243680|585939051|FG001|Overall Study|Data integrity and GCP violations|8|||
162241903|NCT05358717|585939052|FG000|Overall Study|Adverse Event|0|||
162241904|NCT05358717|585939053|FG001|Overall Study|Adverse Event|1|||
162241905|NCT05358717|585939054|FG002|Overall Study|Adverse Event|1|||
162241906|NCT05358717|585939052|FG000|Overall Study|Death|1|||
162241907|NCT05358717|585939053|FG001|Overall Study|Death|1|||
162241908|NCT05358717|585939054|FG002|Overall Study|Death|0|||
162241909|NCT05358717|585939052|FG000|Overall Study|Withdrawal by Subject|1|||
162241910|NCT05358717|585939053|FG001|Overall Study|Withdrawal by Subject|1|||
162241911|NCT05358717|585939054|FG002|Overall Study|Withdrawal by Subject|2|||
162241912|NCT05358717|585939052|FG000|Overall Study|Study Paused by Sponsor in United States|0|||
162241913|NCT05358717|585939053|FG001|Overall Study|Study Paused by Sponsor in United States|2|||
162241914|NCT05358717|585939054|FG002|Overall Study|Study Paused by Sponsor in United States|0|||
162241915|NCT02411448|585939055|FG000|Overall Study|Withdrawal by Subject|1|||
162241916|NCT02411448|585939056|FG001|Overall Study|Withdrawal by Subject|14|||
162241917|NCT02411448|585939057|FG002|Overall Study|Withdrawal by Subject|9|||
162241918|NCT02411448|585939055|FG000|Overall Study|Other|0|||
162241919|NCT02411448|585939056|FG001|Overall Study|Other|2|||
162241920|NCT02411448|585939057|FG002|Overall Study|Other|0|||
162241921|NCT02411448|585939055|FG000|Overall Study|Did not receive study treatment|0|||
162241922|NCT02411448|585939056|FG001|Overall Study|Did not receive study treatment|3|||
162241923|NCT02411448|585939057|FG002|Overall Study|Did not receive study treatment|0|||
162241924|NCT02411448|585939055|FG000|Overall Study|Alive on study treatment|3|||
162241925|NCT02411448|585939056|FG001|Overall Study|Alive on study treatment|64|||
162241926|NCT02411448|585939057|FG002|Overall Study|Alive on study treatment|43|||
162241927|NCT04257929|585939058|FG000|Overall Study|Adverse Event|1|||
162241928|NCT04257929|585939059|FG001|Overall Study|Adverse Event|0|||
162241929|NCT04257929|585939060|FG002|Overall Study|Adverse Event|1|||
162241930|NCT04257929|585939058|FG000|Overall Study|Withdrawal by Subject|1|||
162241931|NCT04257929|585939059|FG001|Overall Study|Withdrawal by Subject|0|||
162241932|NCT04257929|585939060|FG002|Overall Study|Withdrawal by Subject|0|||
162241933|NCT04257929|585939058|FG000|Overall Study|COVID-19|0|||
162241934|NCT04257929|585939059|FG001|Overall Study|COVID-19|1|||
162241935|NCT04257929|585939060|FG002|Overall Study|COVID-19|1|||
162241936|NCT04257929|585939058|FG000|Overall Study|Lost to Follow-up|0|||
162241937|NCT04257929|585939059|FG001|Overall Study|Lost to Follow-up|0|||
162241938|NCT04257929|585939060|FG002|Overall Study|Lost to Follow-up|1|||
162241939|NCT05642442|585939061|FG000|Overall Study|Adverse Event|0|||
162241940|NCT05642442|585939062|FG001|Overall Study|Adverse Event|1|||
162241941|NCT05642442|585939061|FG000|Overall Study|Lack of Efficacy|0|||
162241942|NCT05642442|585939062|FG001|Overall Study|Lack of Efficacy|1|||
162241943|NCT05642442|585939061|FG000|Overall Study|Withdrawal by Subject|13|||
162241944|NCT05642442|585939062|FG001|Overall Study|Withdrawal by Subject|9|||
162241945|NCT05642442|585939061|FG000|Overall Study|Other|5|||
162241946|NCT05642442|585939062|FG001|Overall Study|Other|2|||
162241947|NCT05642442|585939061|FG000|Overall Study|Lost to Follow-up|0|||
162241948|NCT05642442|585939062|FG001|Overall Study|Lost to Follow-up|1|||
162241949|NCT06066697|585939063|FG000|Overall Study|Lost to Follow-up|5|||
162241950|NCT06066697|585939064|FG001|Overall Study|Lost to Follow-up|0|||
162241951|NCT06036914|585939066|FG000|Overall Study|Withdrawal by Subject|1|||
162241952|NCT06036914|585939067|FG001|Overall Study|Withdrawal by Subject|0|||
162241953|NCT02616562|585939068|FG000|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241954|NCT02616562|585939069|FG001|Main Period (26 Weeks)|Withdrawal by parent/guardian|1|||
162241955|NCT02616562|585939070|FG002|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241956|NCT02616562|585939071|FG003|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241957|NCT02616562|585939072|FG004|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241958|NCT02616562|585939073|FG005|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241959|NCT02616562|585939074|FG006|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241960|NCT02616562|585939075|FG007|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241961|NCT02616562|585939076|FG008|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241962|NCT02616562|585939077|FG009|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241963|NCT02616562|585939078|FG010|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241964|NCT02616562|585939079|FG011|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241965|NCT02616562|585939080|FG012|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241966|NCT02616562|585939081|FG013|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241967|NCT02616562|585939082|FG014|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241968|NCT02616562|585939083|FG015|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241969|NCT02616562|585939084|FG016|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
162241970|NCT02616562|585939068|FG000|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241971|NCT02616562|585939069|FG001|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241972|NCT02616562|585939070|FG002|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241973|NCT02616562|585939071|FG003|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241974|NCT02616562|585939072|FG004|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241975|NCT02616562|585939073|FG005|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241976|NCT02616562|585939074|FG006|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241977|NCT02616562|585939075|FG007|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241978|NCT02616562|585939076|FG008|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241979|NCT02616562|585939077|FG009|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|1|||
162241980|NCT02616562|585939078|FG010|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241981|NCT02616562|585939079|FG011|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241982|NCT02616562|585939080|FG012|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241983|NCT02616562|585939081|FG013|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241984|NCT02616562|585939082|FG014|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241985|NCT02616562|585939083|FG015|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241986|NCT02616562|585939084|FG016|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
162241987|NCT02616562|585939068|FG000|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162241988|NCT02616562|585939069|FG001|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162241989|NCT02616562|585939070|FG002|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162241990|NCT02616562|585939071|FG003|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162241991|NCT02616562|585939072|FG004|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162241992|NCT02616562|585939073|FG005|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162241993|NCT02616562|585939074|FG006|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162241994|NCT02616562|585939075|FG007|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161779441|NCT01052038|584235551|FG001|Overall Study|Lost to Follow-up|3|||
161779442|NCT01052038|584235552|FG002|Overall Study|Lost to Follow-up|1|||
161779443|NCT01052038|584235550|FG000|Overall Study|Protocol Violation|2|||
161779444|NCT01052038|584235551|FG001|Overall Study|Protocol Violation|3|||
161779445|NCT01052038|584235552|FG002|Overall Study|Protocol Violation|3|||
161779446|NCT03349437|584235553|FG000|Screening|Screen Fail|4|||
161779447|NCT03349437|584235554|FG001|Screening|Screen Fail|0|||
161779448|NCT03349437|584235555|FG002|Screening|Screen Fail|0|||
161779449|NCT03349437|584235553|FG000|Screening|Withdrawn|1|||
161779450|NCT03349437|584235554|FG001|Screening|Withdrawn|0|||
161779451|NCT03349437|584235555|FG002|Screening|Withdrawn|0|||
161779452|NCT03343054|584235558|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
161779453|NCT03343054|584235559|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
161779454|NCT03343054|584235560|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
161779455|NCT03343054|584235558|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
161831477|NCT01730040|584424757|FG000|Overall Study|Adverse Event|4|||
161779456|NCT03343054|584235559|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
161779457|NCT03343054|584235560|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
161779458|NCT03343054|584235558|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
161895331|NCT00741598|584666296|FG000|Overall Study|Withdrawal by Subject|3|||
162241995|NCT02616562|585939076|FG008|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
162241996|NCT02616562|585939077|FG009|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
162241997|NCT02616562|585939078|FG010|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162241998|NCT02616562|585939079|FG011|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162241999|NCT02616562|585939080|FG012|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162242000|NCT02616562|585939081|FG013|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162242001|NCT02616562|585939082|FG014|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162242002|NCT02616562|585939083|FG015|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
161682992|NCT04206605|583890226|FG000|Overall Study|Adverse Event|0|||
161682993|NCT04206605|583890227|FG001|Overall Study|Adverse Event|1|||
161682994|NCT04206605|583890226|FG000|Overall Study|Withdrawal by Subject|1|||
161682995|NCT04206605|583890227|FG001|Overall Study|Withdrawal by Subject|0|||
161682996|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
161682997|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
161682998|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Death|0|||
161682999|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Death|1|||
161683000|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
161683001|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
161683002|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
161683003|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
161683004|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
161683005|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
161683006|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
161683007|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
161683008|NCT00843518|583890231|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
161683009|NCT00843518|583890232|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
161683010|NCT01131520|583890233|FG000|Overall Study|Computer problem|1|||
161683011|NCT01131520|583890234|FG001|Overall Study|Computer problem|0|||
161683012|NCT01131520|583890233|FG000|Overall Study|Counselor not available|0|||
161683013|NCT01131520|583890234|FG001|Overall Study|Counselor not available|3|||
161683014|NCT01131520|583890233|FG000|Overall Study|Subject changed history after enrollment|0|||
161683015|NCT01131520|583890234|FG001|Overall Study|Subject changed history after enrollment|1|||
161683016|NCT04066491|583890241|FG000|Overall Study|Randomized, not treated|0|||
161683017|NCT04066491|583890242|FG001|Overall Study|Randomized, not treated|0|||
161683018|NCT04066491|583890243|FG002|Overall Study|Randomized, not treated|2|||
161779459|NCT03343054|584235559|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
161779460|NCT03343054|584235560|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
161779461|NCT03343054|584235558|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
161779462|NCT03343054|584235559|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
161779463|NCT03343054|584235560|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
161779464|NCT05723835|584235566|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
161779465|NCT05723835|584235567|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
161779466|NCT05723835|584235568|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
161779467|NCT05723835|584235569|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
161779468|NCT05723835|584235570|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
161779469|NCT05723835|584235571|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
161779470|NCT05723835|584235572|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
161779471|NCT05723835|584235573|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
161779472|NCT05226286|584235574|FG000|Overall Study|Screen failures prior to implant|62|||
161779473|NCT05226286|584235574|FG000|Overall Study|Withdrawal by Subject|13|||
161779474|NCT05226286|584235574|FG000|Overall Study|Lost to Follow-up|3|||
161779475|NCT05226286|584235574|FG000|Overall Study|Physician Decision|1|||
161779476|NCT05226286|584235574|FG000|Overall Study|Adverse Event|1|||
161779477|NCT05226286|584235574|FG000|Overall Study|Death|1|||
161779478|NCT05226286|584235574|FG000|Overall Study|Device explant with no planned replacement|1|||
161779479|NCT05226286|584235574|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
161779480|NCT05226286|584235574|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
161779481|NCT00602641|584235575|FG000|Overall Study|Never started protocol therapy|6|||
161779482|NCT00602641|584235576|FG001|Overall Study|Never started protocol therapy|2|||
161779483|NCT00602641|584235575|FG000|Overall Study|Still on treatment at time of analysis|8|||
161779484|NCT00602641|584235576|FG001|Overall Study|Still on treatment at time of analysis|15|||
161779485|NCT00602641|584235575|FG000|Overall Study|Adverse Event|62|||
161779486|NCT00602641|584235576|FG001|Overall Study|Adverse Event|53|||
161779487|NCT00602641|584235575|FG000|Overall Study|Disease progression|38|||
161779488|NCT00602641|584235576|FG001|Overall Study|Disease progression|55|||
161779489|NCT00602641|584235575|FG000|Overall Study|Death|6|||
161779490|NCT00602641|584235576|FG001|Overall Study|Death|5|||
161779491|NCT00602641|584235575|FG000|Overall Study|Withdrawal by Subject|15|||
161779492|NCT00602641|584235576|FG001|Overall Study|Withdrawal by Subject|12|||
161779493|NCT00602641|584235575|FG000|Overall Study|Alternative therapy|5|||
161779494|NCT00602641|584235576|FG001|Overall Study|Alternative therapy|2|||
161779495|NCT00602641|584235575|FG000|Overall Study|Other Complicating Disease|5|||
161779496|NCT00602641|584235576|FG001|Overall Study|Other Complicating Disease|2|||
161779497|NCT00602641|584235575|FG000|Overall Study|Physician Decision|5|||
161779498|NCT00602641|584235576|FG001|Overall Study|Physician Decision|4|||
161779499|NCT00602641|584235575|FG000|Overall Study|Administrative Closure|1|||
161779500|NCT00602641|584235576|FG001|Overall Study|Administrative Closure|1|||
161779501|NCT00602641|584235575|FG000|Overall Study|Other|3|||
161779502|NCT00602641|584235576|FG001|Overall Study|Other|1|||
161779503|NCT03901339|584235577|FG000|Overall Study|Death|220|||
161779504|NCT03901339|584235578|FG001|Overall Study|Death|192|||
161779505|NCT03901339|584235577|FG000|Overall Study|Informed consent withdrawn|13|||
161779506|NCT03901339|584235578|FG001|Overall Study|Informed consent withdrawn|40|||
161779507|NCT03901339|584235577|FG000|Overall Study|Sponsor request|30|||
161779508|NCT03901339|584235578|FG001|Overall Study|Sponsor request|23|||
161779509|NCT03901339|584235577|FG000|Overall Study|Reason not specified|5|||
161779510|NCT03901339|584235578|FG001|Overall Study|Reason not specified|7|||
161779511|NCT03901339|584235577|FG000|Overall Study|Lost to Follow-up|4|||
161779512|NCT03901339|584235578|FG001|Overall Study|Lost to Follow-up|7|||
161779513|NCT03901339|584235577|FG000|Overall Study|Covid19|0|||
161779514|NCT03901339|584235578|FG001|Overall Study|Covid19|2|||
161779515|NCT00457418|584235579|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
161779516|NCT00457418|584235579|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
161779517|NCT00457418|584235579|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
161779518|NCT00457418|584235579|FG000|Post PK Maintenance|Adverse Event|10|||
161779519|NCT00457418|584235579|FG000|Post PK Maintenance|Progression of Disease|6|||
161779520|NCT00457418|584235579|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
161779521|NCT00457418|584235579|FG000|Post PK Maintenance|Lost to Follow-up|1|||
161779522|NCT03387735|584235582|FG000|Overall Study|Lost to Follow-up|4|||
161779523|NCT03387735|584235583|FG001|Overall Study|Lost to Follow-up|8|||
162009276|NCT00091949|585090068|FG001|Overall Study|Lost to Follow-up|41|||
162009277|NCT01256788|585090071|FG000|Overall Study|Lost to Follow-up|5|||
162009278|NCT01256788|585090072|FG001|Overall Study|Lost to Follow-up|8|||
162009279|NCT01256788|585090073|FG002|Overall Study|Lost to Follow-up|3|||
162009280|NCT05966142|585090074|FG000|Overall Study|Death|3|||
162009281|NCT05966142|585090075|FG001|Overall Study|Death|3|||
162009282|NCT05966142|585090074|FG000|Overall Study|Lost to Follow-up|55|||
162009283|NCT05966142|585090075|FG001|Overall Study|Lost to Follow-up|52|||
162009284|NCT05966142|585090074|FG000|Overall Study|Physician Decision|1|||
162009285|NCT05966142|585090075|FG001|Overall Study|Physician Decision|0|||
162009286|NCT05966142|585090074|FG000|Overall Study|Withdrawal by Subject|9|||
162009287|NCT05966142|585090075|FG001|Overall Study|Withdrawal by Subject|8|||
162009288|NCT05966142|585090074|FG000|Overall Study|Duplicate Enrollment|1|||
162009289|NCT05966142|585090075|FG001|Overall Study|Duplicate Enrollment|0|||
162009290|NCT05966142|585090074|FG000|Overall Study|Study Logistical Reason|1|||
162009291|NCT05966142|585090075|FG001|Overall Study|Study Logistical Reason|0|||
162009292|NCT05966142|585090074|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
162009293|NCT05966142|585090075|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
162009294|NCT04849364|585090076|FG000|Overall Study|Eligibility criteria not meet|0|||
162009295|NCT04849364|585090077|FG001|Overall Study|Eligibility criteria not meet|1|||
162009296|NCT04849364|585090078|FG002|Overall Study|Eligibility criteria not meet|0|||
162009297|NCT01643668|585090079|FG000|Overall Study|Death|1|||
162009298|NCT00894803|585090080|FG000|Overall Study|Death|20|||
162009299|NCT00894803|585090081|FG001|Overall Study|Death|4|||
162009300|NCT00894803|585090080|FG000|Overall Study|Lost to Follow-up|0|||
162009301|NCT00894803|585090081|FG001|Overall Study|Lost to Follow-up|1|||
162009302|NCT00307801|585090090|FG000|Overall Study|Adverse Event|12|||
162009303|NCT00307801|585090091|FG001|Overall Study|Adverse Event|4|||
162009304|NCT00307801|585090090|FG000|Overall Study|Withdrawal by Subject|9|||
162009305|NCT00307801|585090091|FG001|Overall Study|Withdrawal by Subject|4|||
162009306|NCT00307801|585090090|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
162009307|NCT00307801|585090091|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
162009308|NCT00307801|585090090|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
162009309|NCT00307801|585090091|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
162009310|NCT00307801|585090090|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
162009311|NCT00307801|585090091|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
162009312|NCT00307801|585090090|FG000|Overall Study|Wrong Randomization|1|||
162009313|NCT00307801|585090091|FG001|Overall Study|Wrong Randomization|0|||
162009314|NCT00307801|585090090|FG000|Overall Study|Lack of Efficacy|0|||
162009315|NCT00307801|585090091|FG001|Overall Study|Lack of Efficacy|2|||
162009316|NCT00307801|585090090|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
162009317|NCT00307801|585090091|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
162009318|NCT00307801|585090090|FG000|Overall Study|Frustration with e-diary|1|||
162009319|NCT00307801|585090091|FG001|Overall Study|Frustration with e-diary|0|||
162009320|NCT00307801|585090090|FG000|Overall Study|Protocol Violation|3|||
162009321|NCT00307801|585090091|FG001|Overall Study|Protocol Violation|2|||
162009322|NCT00307801|585090090|FG000|Overall Study|No reason specified|2|||
162009323|NCT00307801|585090091|FG001|Overall Study|No reason specified|0|||
162009324|NCT00307801|585090090|FG000|Overall Study|Pregnancy|0|||
162009325|NCT00307801|585090091|FG001|Overall Study|Pregnancy|1|||
162009326|NCT01217229|585090099|FG000|Overall Study|Adverse Event|1|||
162009327|NCT01217229|585090099|FG000|Overall Study|Disease progression, deterioration|2|||
162009328|NCT01217229|585090099|FG000|Overall Study|Disease progression, Cheson criteria|14|||
162009329|NCT01217229|585090099|FG000|Overall Study|Protocol Violation|1|||
161895332|NCT00741598|584666297|FG001|Overall Study|Withdrawal by Subject|2|||
161683019|NCT00853749|583890247|FG000|Overall Study|Lost to Follow-up|0|||
161683020|NCT00853749|583890248|FG001|Overall Study|Lost to Follow-up|1|||
161683021|NCT01392677|583890251|FG000|Overall Study|Adverse Event|3|||
161683022|NCT01392677|583890252|FG001|Overall Study|Adverse Event|1|||
161683023|NCT01392677|583890251|FG000|Overall Study|Withdrawal by Subject|0|||
161683024|NCT01392677|583890252|FG001|Overall Study|Withdrawal by Subject|2|||
161683025|NCT01392677|583890251|FG000|Overall Study|Incorrect enrollment|2|||
161683026|NCT01392677|583890252|FG001|Overall Study|Incorrect enrollment|3|||
161683027|NCT01392677|583890251|FG000|Overall Study|Other reason|3|||
161683028|NCT01392677|583890252|FG001|Overall Study|Other reason|2|||
161683029|NCT01357577|583890255|FG000|Overall Study|Lost to Follow-up|20|||
161683030|NCT01357577|583890256|FG001|Overall Study|Lost to Follow-up|16|||
161683031|NCT01357577|583890255|FG000|Overall Study|Withdrawal by Subject|16|||
161683032|NCT01357577|583890256|FG001|Overall Study|Withdrawal by Subject|8|||
161683033|NCT01357577|583890255|FG000|Overall Study|look at data in database?|1|||
161683034|NCT01357577|583890256|FG001|Overall Study|look at data in database?|2|||
161683035|NCT05493280|583890257|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
161683036|NCT05493280|583890258|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
161683037|NCT00075400|583891212|FG000|Overall Study|Ineligible: wrong primary|1|||
161683038|NCT00075400|583891212|FG000|Overall Study|Never treated|2|||
161683039|NCT00666458|583891219|FG000|Overall Study|Adverse Event|8|||
161683040|NCT00666458|583891220|FG001|Overall Study|Adverse Event|7|||
161683041|NCT00666458|583891219|FG000|Overall Study|Withdrawal by Subject|5|||
161683042|NCT00666458|583891220|FG001|Overall Study|Withdrawal by Subject|4|||
161683043|NCT00666458|583891219|FG000|Overall Study|Lost to Follow-up|0|||
161683044|NCT00666458|583891220|FG001|Overall Study|Lost to Follow-up|3|||
161683045|NCT00666458|583891219|FG000|Overall Study|Administrative reason by sponsor|1|||
161683046|NCT00666458|583891220|FG001|Overall Study|Administrative reason by sponsor|1|||
161683047|NCT00666458|583891219|FG000|Overall Study|Incorrect enrollment|7|||
161683048|NCT00666458|583891220|FG001|Overall Study|Incorrect enrollment|1|||
161683049|NCT00666458|583891219|FG000|Overall Study|Study specific discontinuation criteria|14|||
161683050|NCT00666458|583891220|FG001|Overall Study|Study specific discontinuation criteria|7|||
161683051|NCT00666458|583891219|FG000|Overall Study|Severe non-compliance to the protocol|1|||
161683052|NCT00666458|583891220|FG001|Overall Study|Severe non-compliance to the protocol|1|||
161683053|NCT00666458|583891219|FG000|Overall Study|Safety reasons|1|||
161779524|NCT03387735|584235582|FG000|Overall Study|Death|4|||
161779525|NCT03387735|584235583|FG001|Overall Study|Death|8|||
161779526|NCT03099161|584235584|FG000|Overall Study|Adverse Event|0|||
161779527|NCT03099161|584235585|FG001|Overall Study|Adverse Event|0|||
161779528|NCT03099161|584235586|FG002|Overall Study|Adverse Event|2|||
161779529|NCT03099161|584235584|FG000|Overall Study|Physician Decision|2|||
161779530|NCT03099161|584235585|FG001|Overall Study|Physician Decision|0|||
161779531|NCT03099161|584235586|FG002|Overall Study|Physician Decision|0|||
161779532|NCT03099161|584235584|FG000|Overall Study|Progressive Disease|1|||
161779533|NCT03099161|584235585|FG001|Overall Study|Progressive Disease|4|||
161779534|NCT03099161|584235586|FG002|Overall Study|Progressive Disease|1|||
161779535|NCT00110084|584235589|FG000|Overall Study|Adverse Event|9|||
161779536|NCT00110084|584235589|FG000|Overall Study|Death|1|||
161779537|NCT00110084|584235589|FG000|Overall Study|Patient Refusal|10|||
161779538|NCT00110084|584235589|FG000|Overall Study|Alternate Therapy|5|||
161779539|NCT00110084|584235589|FG000|Overall Study|Intercurrent Illness|1|||
161779540|NCT00110084|584235589|FG000|Overall Study|Other|2|||
161779541|NCT04854707|584235591|FG000|Overall Study|Lack of Efficacy|78|||
161779542|NCT04854707|584235592|FG001|Overall Study|Lack of Efficacy|59|||
161779543|NCT04854707|584235593|FG002|Overall Study|Lack of Efficacy|30|||
161779544|NCT05302414|584235595|FG000|Pretest to Posttest|Lost to Follow-up|12|||
161779545|NCT05302414|584235596|FG001|Pretest to Posttest|Lost to Follow-up|8|||
161779546|NCT05302414|584235597|FG002|Pretest to Posttest|Lost to Follow-up|8|||
161779547|NCT05302414|584235595|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
161779548|NCT05302414|584235596|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
161779549|NCT05302414|584235597|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
161779550|NCT00742859|584235598|FG000|Overall Study|Adverse Event|5|||
161779551|NCT00742859|584235599|FG001|Overall Study|Adverse Event|6|||
161779552|NCT00742859|584235600|FG002|Overall Study|Adverse Event|3|||
161779553|NCT00742859|584235601|FG003|Overall Study|Adverse Event|1|||
161779554|NCT00742859|584235598|FG000|Overall Study|Death|1|||
161779555|NCT00742859|584235599|FG001|Overall Study|Death|0|||
161779556|NCT00742859|584235600|FG002|Overall Study|Death|0|||
161779557|NCT00742859|584235601|FG003|Overall Study|Death|1|||
161779558|NCT00742859|584235598|FG000|Overall Study|Physician Decision|1|||
161779559|NCT00742859|584235599|FG001|Overall Study|Physician Decision|2|||
161779560|NCT00742859|584235600|FG002|Overall Study|Physician Decision|0|||
161779561|NCT00742859|584235601|FG003|Overall Study|Physician Decision|0|||
161779562|NCT00742859|584235598|FG000|Overall Study|Withdrawal by Subject|4|||
161779563|NCT00742859|584235599|FG001|Overall Study|Withdrawal by Subject|2|||
161779564|NCT00742859|584235600|FG002|Overall Study|Withdrawal by Subject|4|||
161779565|NCT00742859|584235601|FG003|Overall Study|Withdrawal by Subject|1|||
161779566|NCT00742859|584235598|FG000|Overall Study|Endpoint|0|||
161779567|NCT00742859|584235599|FG001|Overall Study|Endpoint|1|||
161779568|NCT00742859|584235600|FG002|Overall Study|Endpoint|1|||
161779569|NCT00742859|584235601|FG003|Overall Study|Endpoint|2|||
161779570|NCT00742859|584235598|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
161779571|NCT00742859|584235599|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
161779572|NCT00742859|584235600|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
161779573|NCT00742859|584235601|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
161779574|NCT00742859|584235598|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
161779575|NCT00742859|584235599|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
161779576|NCT00742859|584235600|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
161779577|NCT00742859|584235601|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
161779578|NCT00742859|584235598|FG000|Overall Study|Sponsor request patient out of town|0|||
161779579|NCT00742859|584235599|FG001|Overall Study|Sponsor request patient out of town|0|||
161779580|NCT00742859|584235600|FG002|Overall Study|Sponsor request patient out of town|1|||
161779581|NCT00742859|584235601|FG003|Overall Study|Sponsor request patient out of town|1|||
161779582|NCT00742859|584235598|FG000|Overall Study|Site error|0|||
161779583|NCT00742859|584235599|FG001|Overall Study|Site error|0|||
161779584|NCT00742859|584235600|FG002|Overall Study|Site error|1|||
161779585|NCT00742859|584235601|FG003|Overall Study|Site error|1|||
161779586|NCT01346501|584235605|FG000|Overall Study|Initiated Other Biological Agents|3|||
161779587|NCT01346501|584235606|FG001|Overall Study|Initiated Other Biological Agents|1|||
161779588|NCT01346501|584235605|FG000|Overall Study|Other|8|||
161779589|NCT01346501|584235606|FG001|Overall Study|Other|12|||
161779590|NCT02564952|584235609|FG000|Overall Study|Adverse Event|6|||
161779591|NCT02564952|584235609|FG000|Overall Study|Lost to Follow-up|1|||
161779592|NCT02564952|584235609|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
161779593|NCT02564952|584235609|FG000|Overall Study|Withdrawal by Subject|1|||
161779594|NCT02564952|584235609|FG000|Overall Study|Low Efficacy|1|||
161779595|NCT02564952|584235609|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
161779596|NCT01071083|584235614|FG000|Overall Study|Adverse Event|1|||
161779597|NCT01071083|584235615|FG001|Overall Study|Adverse Event|0|||
161779598|NCT01071083|584235616|FG002|Overall Study|Adverse Event|1|||
161779599|NCT01071083|584235617|FG003|Overall Study|Adverse Event|0|||
161779600|NCT01071083|584235618|FG004|Overall Study|Adverse Event|1|||
161779601|NCT01071083|584235614|FG000|Overall Study|Withdrawal by Subject|3|||
161779602|NCT01071083|584235615|FG001|Overall Study|Withdrawal by Subject|0|||
161779603|NCT01071083|584235616|FG002|Overall Study|Withdrawal by Subject|2|||
161779604|NCT01071083|584235617|FG003|Overall Study|Withdrawal by Subject|0|||
161779605|NCT01071083|584235618|FG004|Overall Study|Withdrawal by Subject|3|||
161779606|NCT01071083|584235614|FG000|Overall Study|Physician Decision|1|||
161779607|NCT01071083|584235615|FG001|Overall Study|Physician Decision|0|||
161779608|NCT01071083|584235616|FG002|Overall Study|Physician Decision|0|||
161779609|NCT01071083|584235617|FG003|Overall Study|Physician Decision|1|||
161779610|NCT01071083|584235618|FG004|Overall Study|Physician Decision|1|||
161779611|NCT01071083|584235614|FG000|Overall Study|Early Rescue|1|||
161779612|NCT01071083|584235615|FG001|Overall Study|Early Rescue|0|||
161779613|NCT01071083|584235616|FG002|Overall Study|Early Rescue|0|||
161779614|NCT01071083|584235617|FG003|Overall Study|Early Rescue|0|||
161779615|NCT01071083|584235618|FG004|Overall Study|Early Rescue|1|||
161779616|NCT01071083|584235614|FG000|Overall Study|Subject Moved|0|||
161779617|NCT01071083|584235615|FG001|Overall Study|Subject Moved|1|||
161779618|NCT01071083|584235616|FG002|Overall Study|Subject Moved|0|||
161779619|NCT01071083|584235617|FG003|Overall Study|Subject Moved|0|||
161779620|NCT01071083|584235618|FG004|Overall Study|Subject Moved|0|||
161779621|NCT01071083|584235614|FG000|Overall Study|Images Not Usable (Motion)|0|||
161779622|NCT01071083|584235615|FG001|Overall Study|Images Not Usable (Motion)|1|||
161779623|NCT01071083|584235616|FG002|Overall Study|Images Not Usable (Motion)|0|||
161779624|NCT01071083|584235617|FG003|Overall Study|Images Not Usable (Motion)|0|||
161779625|NCT01071083|584235618|FG004|Overall Study|Images Not Usable (Motion)|0|||
161779626|NCT01071083|584235614|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
161779627|NCT01071083|584235615|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
161779628|NCT01071083|584235616|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
161779629|NCT01071083|584235617|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
161779630|NCT01071083|584235618|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
161779631|NCT01071083|584235614|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
161779632|NCT01071083|584235615|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
161779633|NCT01071083|584235616|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
161779634|NCT01071083|584235617|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
161779635|NCT01071083|584235618|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
161779636|NCT01071083|584235614|FG000|Overall Study|Subject Refused to Continue|1|||
161779637|NCT01071083|584235615|FG001|Overall Study|Subject Refused to Continue|0|||
161779638|NCT01071083|584235616|FG002|Overall Study|Subject Refused to Continue|0|||
161779639|NCT01071083|584235617|FG003|Overall Study|Subject Refused to Continue|0|||
161779640|NCT01071083|584235618|FG004|Overall Study|Subject Refused to Continue|0|||
161779641|NCT03972709|584235619|FG000|Overall Study|Withdrawal by Subject|18|||
161779642|NCT03972709|584235620|FG001|Overall Study|Withdrawal by Subject|7|||
161779643|NCT03972709|584235621|FG002|Overall Study|Withdrawal by Subject|14|||
161779644|NCT03972709|584235619|FG000|Overall Study|Study Terminated by Sponsor|48|||
161779645|NCT03972709|584235620|FG001|Overall Study|Study Terminated by Sponsor|25|||
161779646|NCT03972709|584235621|FG002|Overall Study|Study Terminated by Sponsor|50|||
161779647|NCT03972709|584235619|FG000|Overall Study|Physician Decision|1|||
161779648|NCT03972709|584235620|FG001|Overall Study|Physician Decision|0|||
161779649|NCT03972709|584235621|FG002|Overall Study|Physician Decision|0|||
161779650|NCT03972709|584235619|FG000|Overall Study|COVID-19|0|||
161779651|NCT03972709|584235620|FG001|Overall Study|COVID-19|1|||
161779652|NCT03972709|584235621|FG002|Overall Study|COVID-19|1|||
161779653|NCT03972709|584235619|FG000|Overall Study|Lost to Follow-up|6|||
161779654|NCT03972709|584235620|FG001|Overall Study|Lost to Follow-up|1|||
161779655|NCT03972709|584235621|FG002|Overall Study|Lost to Follow-up|2|||
161779656|NCT03972709|584235619|FG000|Overall Study|Death|5|||
161779657|NCT03972709|584235620|FG001|Overall Study|Death|1|||
161779658|NCT03972709|584235621|FG002|Overall Study|Death|4|||
161779659|NCT03972709|584235619|FG000|Overall Study|Adverse Event|3|||
161779660|NCT03972709|584235620|FG001|Overall Study|Adverse Event|1|||
161779661|NCT03972709|584235621|FG002|Overall Study|Adverse Event|4|||
161779662|NCT03972709|584235619|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
161779663|NCT03972709|584235620|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
161779664|NCT03972709|584235621|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
161779665|NCT03972709|584235619|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
161779666|NCT03972709|584235620|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
161779667|NCT03972709|584235621|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
161779668|NCT03972709|584235619|FG000|Overall Study|Subject Unable to be Contacted|0|||
161779669|NCT03972709|584235620|FG001|Overall Study|Subject Unable to be Contacted|1|||
161779670|NCT03972709|584235621|FG002|Overall Study|Subject Unable to be Contacted|0|||
161779671|NCT03972709|584235619|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
161779672|NCT03972709|584235620|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
161779673|NCT03972709|584235621|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
161779674|NCT03972709|584235619|FG000|Overall Study|Subject Moved|0|||
161779675|NCT03972709|584235620|FG001|Overall Study|Subject Moved|1|||
161779676|NCT03972709|584235621|FG002|Overall Study|Subject Moved|0|||
161779677|NCT03972709|584235619|FG000|Overall Study|Missed Study Visits|1|||
161779678|NCT03972709|584235620|FG001|Overall Study|Missed Study Visits|0|||
161779679|NCT03972709|584235621|FG002|Overall Study|Missed Study Visits|0|||
161779680|NCT01339000|584235622|FG000|Overall Study|study closed due to lack of drug supply|1|||
161779681|NCT01339000|584235623|FG001|Overall Study|study closed due to lack of drug supply|0|||
161779682|NCT00728988|584235624|FG000|Overall Study|Not Treated|2|||
161779683|NCT00728988|584235625|FG001|Overall Study|Not Treated|2|||
161779684|NCT00728988|584235624|FG000|Overall Study|Death|1|||
161779685|NCT00728988|584235625|FG001|Overall Study|Death|1|||
161779686|NCT00728988|584235624|FG000|Overall Study|Adverse Event|3|||
161779687|NCT00728988|584235625|FG001|Overall Study|Adverse Event|2|||
161779688|NCT00728988|584235624|FG000|Overall Study|Other|85|||
161779689|NCT00728988|584235625|FG001|Overall Study|Other|77|||
161779690|NCT00728988|584235624|FG000|Overall Study|Withdrawal by Subject|2|||
161779691|NCT00728988|584235625|FG001|Overall Study|Withdrawal by Subject|6|||
161779692|NCT02017535|584235628|FG000|Overall Study|Withdrawal by Subject|1|||
161779693|NCT02017535|584235629|FG001|Overall Study|Withdrawal by Subject|0|||
161779694|NCT02017535|584235630|FG002|Overall Study|Withdrawal by Subject|0|||
161779695|NCT02017535|584235631|FG003|Overall Study|Withdrawal by Subject|0|||
161779696|NCT05511428|584235632|FG000|Overall Study|Withdrawal by Subject|1|||
161779697|NCT05511428|584235632|FG000|Overall Study|Adverse Event|1|||
161779698|NCT04088734|584235633|FG000|Overall Study|Other, Not Specified|5|||
161779699|NCT00664066|584235638|FG000|Overall Study|Study terminated|3|||
161779700|NCT03332212|584235642|FG000|Overall Study|Not treated|0|||
161779701|NCT03332212|584235643|FG001|Overall Study|Not treated|1|||
161779702|NCT03332212|584235644|FG002|Overall Study|Not treated|0|||
161779703|NCT03332212|584235645|FG003|Overall Study|Not treated|0|||
161779704|NCT03332212|584235642|FG000|Overall Study|Adverse Event|0|||
161779705|NCT03332212|584235643|FG001|Overall Study|Adverse Event|0|||
161779706|NCT03332212|584235644|FG002|Overall Study|Adverse Event|0|||
161779707|NCT03332212|584235645|FG003|Overall Study|Adverse Event|1|||
161779708|NCT03332212|584235642|FG000|Overall Study|worsening of disease under study|1|||
161779709|NCT03332212|584235643|FG001|Overall Study|worsening of disease under study|1|||
161779710|NCT03332212|584235644|FG002|Overall Study|worsening of disease under study|0|||
161779711|NCT03332212|584235645|FG003|Overall Study|worsening of disease under study|0|||
161779712|NCT00975000|584235648|FG000|Overall Study|Other|1|||
161779713|NCT00975000|584235649|FG001|Overall Study|Other|0|||
161779714|NCT00975000|584235648|FG000|Overall Study|Adverse Event|1|||
161779715|NCT00975000|584235649|FG001|Overall Study|Adverse Event|1|||
161779716|NCT00975000|584235648|FG000|Overall Study|Withdrawal by Subject|2|||
161779717|NCT00975000|584235649|FG001|Overall Study|Withdrawal by Subject|2|||
161779718|NCT00975000|584235648|FG000|Overall Study|Lost to Follow-up|0|||
161779719|NCT00975000|584235649|FG001|Overall Study|Lost to Follow-up|1|||
161779720|NCT00975000|584235648|FG000|Overall Study|Protocol-specified Criteria|1|||
161779721|NCT00975000|584235649|FG001|Overall Study|Protocol-specified Criteria|0|||
161779722|NCT00975000|584235648|FG000|Overall Study|Non-compliance|0|||
161779723|NCT00975000|584235649|FG001|Overall Study|Non-compliance|1|||
161779724|NCT02392377|584235650|FG000|Overall Study|Withdrawal by Subject|0|||
161779725|NCT02392377|584235651|FG001|Overall Study|Withdrawal by Subject|1|||
161779726|NCT01126359|584235654|FG000|First Intervention (20-minutes)|Physician Decision|0|||
161779727|NCT01126359|584235655|FG001|First Intervention (20-minutes)|Physician Decision|1|||
161779728|NCT00902486|584235656|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
161779729|NCT00902486|584235657|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
161779730|NCT00902486|584235658|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
161779731|NCT00902486|584235659|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
161779732|NCT00902486|584235660|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
161779733|NCT00902486|584235661|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
161779734|NCT00902486|584235656|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
161779735|NCT00902486|584235657|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
161779736|NCT00902486|584235658|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
161779737|NCT00902486|584235659|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
161779738|NCT00902486|584235660|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
161779739|NCT00902486|584235661|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
161779740|NCT00902486|584235656|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
161779741|NCT00902486|584235657|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
161779742|NCT00902486|584235658|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
161779743|NCT00902486|584235659|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
161779744|NCT00902486|584235660|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
161779745|NCT00902486|584235661|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
161779746|NCT00902486|584235656|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161779747|NCT00902486|584235657|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161779748|NCT00902486|584235658|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161779749|NCT00902486|584235659|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
161779750|NCT00902486|584235660|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161779751|NCT00902486|584235661|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161779752|NCT00902486|584235656|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161779753|NCT00902486|584235657|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161779754|NCT00902486|584235658|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161779755|NCT00902486|584235659|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
161779756|NCT00902486|584235660|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161779757|NCT00902486|584235661|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161779758|NCT00902486|584235656|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
161779759|NCT00902486|584235657|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
161779760|NCT00902486|584235658|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
161779761|NCT00902486|584235659|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
161779762|NCT00902486|584235660|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
161779763|NCT00902486|584235661|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
161779764|NCT00902486|584235656|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
161779765|NCT00902486|584235657|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
161779766|NCT00902486|584235658|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
161779767|NCT00902486|584235659|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
161779768|NCT00902486|584235660|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
161779769|NCT00902486|584235661|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
161779770|NCT00902486|584235656|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161779771|NCT00902486|584235657|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161779772|NCT00902486|584235658|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161779773|NCT00902486|584235659|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161779774|NCT00902486|584235660|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161779775|NCT00902486|584235661|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
161779776|NCT00902486|584235656|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161779777|NCT00902486|584235657|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161779778|NCT00902486|584235658|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161779779|NCT00902486|584235659|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
161779780|NCT00902486|584235660|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161779781|NCT00902486|584235661|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161779782|NCT00902486|584235656|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161779783|NCT00902486|584235657|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161779784|NCT00902486|584235658|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
161779785|NCT00902486|584235659|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161779786|NCT00902486|584235660|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161779787|NCT00902486|584235661|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161779788|NCT00902486|584235656|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
161779789|NCT00902486|584235657|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
161779790|NCT00902486|584235658|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
161779791|NCT00902486|584235659|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
161779792|NCT00902486|584235660|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
161779793|NCT00902486|584235661|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
161779794|NCT00209560|584235662|FG000|Overall Study|Lack of Efficacy|1|||
161779795|NCT00209560|584235663|FG001|Overall Study|Lack of Efficacy|0|||
161779796|NCT04439110|584235664|FG000|Overall Study|Ineligible|2|||
161779797|NCT04439110|584235664|FG000|Overall Study|Adverse Event|4|||
161779798|NCT04439110|584235664|FG000|Overall Study|Death|2|||
161779799|NCT04439110|584235664|FG000|Overall Study|Disease proression|25|||
161779800|NCT04439110|584235664|FG000|Overall Study|Withdrawal by Subject|1|||
161779801|NCT04439110|584235664|FG000|Overall Study|Alternative therapy|1|||
161779802|NCT04439110|584235664|FG000|Overall Study|Other complicating disease|1|||
161779803|NCT04439110|584235664|FG000|Overall Study|Personal reasons|1|||
161779804|NCT04439110|584235664|FG000|Overall Study|Still on treatment|1|||
161779805|NCT01298661|584235665|FG000|Overall Study|Withdrawal by Subject|2|||
161779806|NCT01298661|584235666|FG001|Overall Study|Withdrawal by Subject|0|||
161779807|NCT01298661|584235667|FG002|Overall Study|Withdrawal by Subject|2|||
161779808|NCT05257109|584235670|FG000|Overall Study|Withdrawal by Subject|1|||
161779809|NCT05257109|584235671|FG001|Overall Study|Withdrawal by Subject|0|||
161779810|NCT05257109|584235672|FG002|Overall Study|Withdrawal by Subject|0|||
161779811|NCT05257109|584235673|FG003|Overall Study|Withdrawal by Subject|0|||
161779812|NCT01607398|584236984|FG000|Overall Study|Adverse Event|0|||
161779813|NCT01607398|584236985|FG001|Overall Study|Adverse Event|2|||
161779814|NCT01607398|584236984|FG000|Overall Study|Severe COPD|2|||
161779815|NCT01607398|584236985|FG001|Overall Study|Severe COPD|0|||
161779816|NCT03044431|584236988|FG000|Overall Study|Lost to Follow-up|59|||
161779817|NCT02576054|584236989|FG000|Overall Study|Withdrawal by Subject|1|||
161895333|NCT03117361|584666298|FG000|Overall Study|Progressive disease|5|||
161779818|NCT01396161|584236990|FG000|Overall Study|Withdrawal by Subject|0|||
161779819|NCT01396161|584236991|FG001|Overall Study|Withdrawal by Subject|0|||
161779820|NCT01396161|584236992|FG002|Overall Study|Withdrawal by Subject|0|||
161779821|NCT01396161|584236993|FG003|Overall Study|Withdrawal by Subject|0|||
161779822|NCT01396161|584236994|FG004|Overall Study|Withdrawal by Subject|1|||
161779823|NCT01396161|584236995|FG005|Overall Study|Withdrawal by Subject|0|||
161779824|NCT01396161|584236996|FG006|Overall Study|Withdrawal by Subject|0|||
161779825|NCT01396161|584236990|FG000|Overall Study|Other|0|||
161779826|NCT01396161|584236991|FG001|Overall Study|Other|0|||
161779827|NCT01396161|584236992|FG002|Overall Study|Other|0|||
161779828|NCT01396161|584236993|FG003|Overall Study|Other|0|||
161779829|NCT01396161|584236994|FG004|Overall Study|Other|0|||
161779830|NCT01396161|584236995|FG005|Overall Study|Other|0|||
161779831|NCT01396161|584236996|FG006|Overall Study|Other|1|||
161779832|NCT03976076|584236997|FG000|Overall Study|Withdrawal by Subject|2|||
161779833|NCT02962739|584236998|FG000|Overall Study|Withdrawal by Subject|0|||
161779834|NCT02962739|584236999|FG001|Overall Study|Withdrawal by Subject|1|||
161779835|NCT02962739|584237000|FG002|Overall Study|Withdrawal by Subject|0|||
161779836|NCT02962739|584237001|FG003|Overall Study|Withdrawal by Subject|0|||
161779837|NCT02962739|584237002|FG004|Overall Study|Withdrawal by Subject|0|||
161779838|NCT02962739|584237003|FG005|Overall Study|Withdrawal by Subject|0|||
161779839|NCT02962739|584236998|FG000|Overall Study|Protocol Violation|0|||
161779840|NCT02962739|584236999|FG001|Overall Study|Protocol Violation|0|||
161779841|NCT02962739|584237000|FG002|Overall Study|Protocol Violation|1|||
161779842|NCT02962739|584237001|FG003|Overall Study|Protocol Violation|0|||
161779843|NCT02962739|584237002|FG004|Overall Study|Protocol Violation|1|||
161779844|NCT02962739|584237003|FG005|Overall Study|Protocol Violation|0|||
161779845|NCT00414011|584237004|FG000|Overall Study|Physician Decision|3|||
161779846|NCT00414011|584237004|FG000|Overall Study|Withdrawal by Subject|2|||
161779847|NCT00981409|584237009|FG000|Overall Study|Adverse Event|4|||
161779848|NCT00981409|584237010|FG001|Overall Study|Adverse Event|0|||
161779849|NCT00981409|584237009|FG000|Overall Study|Protocol Violation|0|||
161779850|NCT00981409|584237010|FG001|Overall Study|Protocol Violation|1|||
161779851|NCT00981409|584237009|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
161779852|NCT00981409|584237010|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
161779853|NCT00450177|584237011|FG000|Overall Study|Adverse Event|7|||
161779854|NCT00450177|584237012|FG001|Overall Study|Adverse Event|4|||
161779855|NCT00450177|584237011|FG000|Overall Study|Withdrawal by Subject|1|||
161779856|NCT00450177|584237012|FG001|Overall Study|Withdrawal by Subject|6|||
161779857|NCT00450177|584237011|FG000|Overall Study|Withdrawal by Primary Team|1|||
161779858|NCT00450177|584237012|FG001|Overall Study|Withdrawal by Primary Team|1|||
161779859|NCT03869684|584237015|FG000|Overall Study|Adverse Event|0|||
161779860|NCT03869684|584237016|FG001|Overall Study|Adverse Event|3|||
161779861|NCT03869684|584237017|FG002|Overall Study|Adverse Event|1|||
161779862|NCT03869684|584237015|FG000|Overall Study|Withdrawal by Subject|1|||
161779863|NCT03869684|584237016|FG001|Overall Study|Withdrawal by Subject|0|||
161779864|NCT03869684|584237017|FG002|Overall Study|Withdrawal by Subject|0|||
161779865|NCT03869684|584237015|FG000|Overall Study|Lost to Follow-up|1|||
161779866|NCT03869684|584237016|FG001|Overall Study|Lost to Follow-up|0|||
161779867|NCT03869684|584237017|FG002|Overall Study|Lost to Follow-up|0|||
161779868|NCT03869684|584237015|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
161779869|NCT03869684|584237016|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
161779870|NCT03869684|584237017|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
161779871|NCT04056299|584237018|FG000|Overall Study|Sponsor discontinued study|3|||
161779872|NCT04056299|584237019|FG001|Overall Study|Sponsor discontinued study|3|||
161779873|NCT01227954|584237024|FG000|Overall Study|Protocol Violation|6|||
161779874|NCT01227954|584237024|FG000|Overall Study|No protocol treatment|7|||
161779875|NCT00078312|584237027|FG000|Overall Study|Adverse Event|43|||
161779876|NCT00078312|584237027|FG000|Overall Study|Lack of Efficacy|15|||
161779877|NCT00078312|584237027|FG000|Overall Study|Lost to Follow-up|41|||
161779878|NCT00078312|584237027|FG000|Overall Study|Physician Decision|9|||
161779879|NCT00078312|584237027|FG000|Overall Study|Protocol Violation|3|||
161779880|NCT00078312|584237027|FG000|Overall Study|Withdrawal by Subject|33|||
161779881|NCT00078312|584237027|FG000|Overall Study|Miscellaneous|33|||
161779882|NCT03901352|584237028|FG000|Double-blind Phase|Adverse Event|6|||
161779883|NCT03901352|584237029|FG001|Double-blind Phase|Adverse Event|4|||
161779884|NCT03901352|584237028|FG000|Double-blind Phase|Death|1|||
161779885|NCT03901352|584237029|FG001|Double-blind Phase|Death|0|||
161779886|NCT03901352|584237028|FG000|Double-blind Phase|Lack of Efficacy|0|||
161779887|NCT03901352|584237029|FG001|Double-blind Phase|Lack of Efficacy|1|||
161779888|NCT03901352|584237028|FG000|Double-blind Phase|Protocol Violation|0|||
161779889|NCT03901352|584237029|FG001|Double-blind Phase|Protocol Violation|1|||
161779890|NCT03901352|584237028|FG000|Double-blind Phase|Withdrawal by Subject|10|||
161779891|NCT03901352|584237029|FG001|Double-blind Phase|Withdrawal by Subject|8|||
161779892|NCT03901352|584237028|FG000|Open-label Extension Phase|Adverse Event|24|||
161779893|NCT03901352|584237029|FG001|Open-label Extension Phase|Adverse Event|0|||
161779894|NCT03901352|584237028|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
161779895|NCT03901352|584237029|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
161779896|NCT03901352|584237028|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
161779897|NCT03901352|584237029|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
161779898|NCT03901352|584237028|FG000|Open-label Extension Phase|Other|1|||
161779899|NCT03901352|584237029|FG001|Open-label Extension Phase|Other|0|||
161779900|NCT01826201|584237032|FG000|Overall Study|Non compliance with protocol|4|||
161779901|NCT01988337|584237035|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
161779902|NCT02742818|584237036|FG000|Overall Study|Adverse Event|0|||
161779903|NCT02742818|584237037|FG001|Overall Study|Adverse Event|1|||
161779904|NCT02742818|584237036|FG000|Overall Study|Protocol Violation|0|||
161779905|NCT02742818|584237037|FG001|Overall Study|Protocol Violation|1|||
161779906|NCT04701658|584237038|FG000|Overall Study|Lost to Follow-up|6|||
161779907|NCT00756652|584237041|FG000|Original Phase|Withdrawal by Subject|864|||
161779908|NCT00756652|584237042|FG001|Original Phase|Withdrawal by Subject|23|||
161779909|NCT00756652|584237041|FG000|Original Phase|Lost to Follow-up|601|||
161779910|NCT00756652|584237042|FG001|Original Phase|Lost to Follow-up|0|||
161779911|NCT00756652|584237041|FG000|Original Phase|Other Discontinuation|797|||
161779912|NCT00756652|584237042|FG001|Original Phase|Other Discontinuation|5|||
161779913|NCT00756652|584237041|FG000|Original Phase|Participant Noncompliance|18622|||
161779914|NCT00756652|584237042|FG001|Original Phase|Participant Noncompliance|424|||
161779915|NCT00756652|584237041|FG000|Original Phase|Unknown Discontinuation Reason|2|||
161779916|NCT00756652|584237042|FG001|Original Phase|Unknown Discontinuation Reason|0|||
161779917|NCT00756652|584237041|FG000|Original Phase|Participants without data|3259|||
161779918|NCT00756652|584237042|FG001|Original Phase|Participants without data|466|||
161779919|NCT00756652|584237041|FG000|Original Phase|Death|168|||
161779920|NCT00756652|584237042|FG001|Original Phase|Death|1|||
161779921|NCT00756652|584237041|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
161779922|NCT00756652|584237042|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
161779923|NCT00756652|584237041|FG000|Re-Op Phase|Withdrawal by Subject|62|||
161779924|NCT00756652|584237042|FG001|Re-Op Phase|Withdrawal by Subject|0|||
161779925|NCT00756652|584237041|FG000|Re-Op Phase|Death|6|||
161779926|NCT00756652|584237042|FG001|Re-Op Phase|Death|0|||
161779927|NCT00756652|584237041|FG000|Re-Op Phase|Lost to Follow-up|340|||
161779928|NCT00756652|584237042|FG001|Re-Op Phase|Lost to Follow-up|0|||
161779929|NCT00756652|584237041|FG000|Re-Op Phase|Site Closed|2454|||
161779930|NCT00756652|584237042|FG001|Re-Op Phase|Site Closed|0|||
161779931|NCT00756652|584237041|FG000|Re-Op Phase|Withdrawn after explant|14|||
161779932|NCT00756652|584237042|FG001|Re-Op Phase|Withdrawn after explant|0|||
161779933|NCT00038467|584237049|FG000|Overall Study|Adverse Event|170|||
161779934|NCT00038467|584237050|FG001|Overall Study|Adverse Event|145|||
161779935|NCT00038467|584237049|FG000|Overall Study|Withdrawal by Subject|150|||
161779936|NCT00038467|584237050|FG001|Overall Study|Withdrawal by Subject|107|||
161779937|NCT00038467|584237049|FG000|Overall Study|Protocol Violation|19|||
161779938|NCT00038467|584237050|FG001|Overall Study|Protocol Violation|22|||
161779939|NCT00038467|584237049|FG000|Overall Study|Death|22|||
161779940|NCT00038467|584237050|FG001|Overall Study|Death|16|||
161779941|NCT00038467|584237049|FG000|Overall Study|Lost to Follow-up|15|||
161779942|NCT00038467|584237050|FG001|Overall Study|Lost to Follow-up|10|||
161779943|NCT00038467|584237049|FG000|Overall Study|Recurrence|109|||
161779944|NCT00038467|584237050|FG001|Overall Study|Recurrence|179|||
161779945|NCT00038467|584237049|FG000|Overall Study|Randomized, but not treated|31|||
161779946|NCT00038467|584237050|FG001|Overall Study|Randomized, but not treated|35|||
161779947|NCT00038467|584237049|FG000|Overall Study|Other|26|||
161779948|NCT00038467|584237050|FG001|Overall Study|Other|28|||
161779949|NCT01523301|584237051|FG000|Overall Study|Adverse Event|25|||
161779950|NCT01523301|584237052|FG001|Overall Study|Adverse Event|16|||
161779951|NCT01523301|584237051|FG000|Overall Study|Lack of Efficacy|0|||
161779952|NCT01523301|584237052|FG001|Overall Study|Lack of Efficacy|2|||
161779953|NCT01523301|584237051|FG000|Overall Study|Protocol Violation|3|||
161779954|NCT01523301|584237052|FG001|Overall Study|Protocol Violation|4|||
161779955|NCT01523301|584237051|FG000|Overall Study|Lost to Follow-up|1|||
161779956|NCT01523301|584237052|FG001|Overall Study|Lost to Follow-up|0|||
161779957|NCT01523301|584237051|FG000|Overall Study|Withdrawal by Subject|6|||
161779958|NCT01523301|584237052|FG001|Overall Study|Withdrawal by Subject|8|||
161779959|NCT01523301|584237051|FG000|Overall Study|Other Reason|0|||
161779960|NCT01523301|584237052|FG001|Overall Study|Other Reason|2|||
161779961|NCT00481871|584237053|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
161779962|NCT00481871|584237054|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
161779963|NCT00481871|584237055|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
161779964|NCT00481871|584237056|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
161779965|NCT00481871|584237057|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
161779966|NCT03889197|584237061|FG000|Overall Study|Withdrawal by Subject|1|||
161779967|NCT03889197|584237062|FG001|Overall Study|Withdrawal by Subject|0|||
162122875|NCT00744237|585502348|FG001|Overall Study|Protocol Violation|4|||
161779968|NCT03889197|584237061|FG000|Overall Study|Physician Decision|0|||
161779969|NCT03889197|584237062|FG001|Overall Study|Physician Decision|1|||
161779970|NCT03889197|584237061|FG000|Overall Study|met exclusion criteria|0|||
161779971|NCT03889197|584237062|FG001|Overall Study|met exclusion criteria|1|||
161779972|NCT03889197|584237061|FG000|Overall Study|Protocol Violation|1|||
161779973|NCT03889197|584237062|FG001|Overall Study|Protocol Violation|0|||
161779974|NCT03193190|584237068|FG000|Stage 1|Arm Terminated by Sponsor|0|||
161779975|NCT03193190|584237069|FG001|Stage 1|Arm Terminated by Sponsor|0|||
161779976|NCT03193190|584237070|FG002|Stage 1|Arm Terminated by Sponsor|0|||
161779977|NCT03193190|584237071|FG003|Stage 1|Arm Terminated by Sponsor|1|||
161779978|NCT03193190|584237072|FG004|Stage 1|Arm Terminated by Sponsor|0|||
162009330|NCT01217229|585090099|FG000|Overall Study|Disease progression not confirmed|2|||
161779979|NCT03193190|584237073|FG005|Stage 1|Arm Terminated by Sponsor|2|||
161779980|NCT03193190|584237074|FG006|Stage 1|Arm Terminated by Sponsor|0|||
161779981|NCT03193190|584237075|FG007|Stage 1|Arm Terminated by Sponsor|0|||
161779982|NCT03193190|584237076|FG008|Stage 1|Arm Terminated by Sponsor|0|||
161779983|NCT03193190|584237077|FG009|Stage 1|Arm Terminated by Sponsor|0|||
161779984|NCT03193190|584237078|FG010|Stage 1|Arm Terminated by Sponsor|0|||
161779985|NCT03193190|584237079|FG011|Stage 1|Arm Terminated by Sponsor|0|||
161779986|NCT03193190|584237080|FG012|Stage 1|Arm Terminated by Sponsor|0|||
161779987|NCT03193190|584237081|FG013|Stage 1|Arm Terminated by Sponsor|0|||
161779988|NCT03193190|584237082|FG014|Stage 1|Arm Terminated by Sponsor|0|||
161779989|NCT03193190|584237083|FG015|Stage 1|Arm Terminated by Sponsor|0|||
161779990|NCT03193190|584237068|FG000|Stage 1|Death|22|||
161779991|NCT03193190|584237069|FG001|Stage 1|Death|8|||
161779992|NCT03193190|584237070|FG002|Stage 1|Death|23|||
161779993|NCT03193190|584237071|FG003|Stage 1|Death|14|||
161779994|NCT03193190|584237072|FG004|Stage 1|Death|34|||
161779995|NCT03193190|584237073|FG005|Stage 1|Death|28|||
161779996|NCT03193190|584237074|FG006|Stage 1|Death|19|||
161779997|NCT03193190|584237075|FG007|Stage 1|Death|21|||
161779998|NCT03193190|584237076|FG008|Stage 1|Death|14|||
161779999|NCT03193190|584237077|FG009|Stage 1|Death|10|||
161780000|NCT03193190|584237078|FG010|Stage 1|Death|59|||
161780001|NCT03193190|584237079|FG011|Stage 1|Death|14|||
161780002|NCT03193190|584237080|FG012|Stage 1|Death|14|||
161780003|NCT03193190|584237081|FG013|Stage 1|Death|0|||
161780004|NCT03193190|584237082|FG014|Stage 1|Death|0|||
161780005|NCT03193190|584237083|FG015|Stage 1|Death|0|||
161780006|NCT03193190|584237068|FG000|Stage 1|Lost to Follow-up|2|||
161780007|NCT03193190|584237069|FG001|Stage 1|Lost to Follow-up|1|||
161780008|NCT03193190|584237070|FG002|Stage 1|Lost to Follow-up|1|||
161780009|NCT03193190|584237071|FG003|Stage 1|Lost to Follow-up|0|||
161780010|NCT03193190|584237072|FG004|Stage 1|Lost to Follow-up|0|||
161780011|NCT03193190|584237073|FG005|Stage 1|Lost to Follow-up|0|||
161780012|NCT03193190|584237074|FG006|Stage 1|Lost to Follow-up|1|||
161780013|NCT03193190|584237075|FG007|Stage 1|Lost to Follow-up|0|||
161780014|NCT03193190|584237076|FG008|Stage 1|Lost to Follow-up|0|||
161780015|NCT03193190|584237077|FG009|Stage 1|Lost to Follow-up|0|||
161780016|NCT03193190|584237078|FG010|Stage 1|Lost to Follow-up|0|||
161780017|NCT03193190|584237079|FG011|Stage 1|Lost to Follow-up|0|||
161780018|NCT03193190|584237080|FG012|Stage 1|Lost to Follow-up|0|||
161780019|NCT03193190|584237081|FG013|Stage 1|Lost to Follow-up|0|||
161780020|NCT03193190|584237082|FG014|Stage 1|Lost to Follow-up|0|||
161780021|NCT03193190|584237083|FG015|Stage 1|Lost to Follow-up|0|||
161780022|NCT03193190|584237068|FG000|Stage 1|Reason not Specified|1|||
161780023|NCT03193190|584237069|FG001|Stage 1|Reason not Specified|0|||
161780024|NCT03193190|584237070|FG002|Stage 1|Reason not Specified|0|||
161780025|NCT03193190|584237071|FG003|Stage 1|Reason not Specified|1|||
161780026|NCT03193190|584237072|FG004|Stage 1|Reason not Specified|0|||
161780027|NCT03193190|584237073|FG005|Stage 1|Reason not Specified|1|||
161780028|NCT03193190|584237074|FG006|Stage 1|Reason not Specified|2|||
161780029|NCT03193190|584237075|FG007|Stage 1|Reason not Specified|2|||
161780030|NCT03193190|584237076|FG008|Stage 1|Reason not Specified|0|||
161780031|NCT03193190|584237077|FG009|Stage 1|Reason not Specified|1|||
161780032|NCT03193190|584237078|FG010|Stage 1|Reason not Specified|3|||
161780033|NCT03193190|584237079|FG011|Stage 1|Reason not Specified|0|||
161780034|NCT03193190|584237080|FG012|Stage 1|Reason not Specified|1|||
161780035|NCT03193190|584237081|FG013|Stage 1|Reason not Specified|0|||
161780036|NCT03193190|584237082|FG014|Stage 1|Reason not Specified|0|||
161780037|NCT03193190|584237083|FG015|Stage 1|Reason not Specified|0|||
161780038|NCT03193190|584237068|FG000|Stage 1|Physician Decision|0|||
161780039|NCT03193190|584237069|FG001|Stage 1|Physician Decision|0|||
161780040|NCT03193190|584237070|FG002|Stage 1|Physician Decision|0|||
161780041|NCT03193190|584237071|FG003|Stage 1|Physician Decision|0|||
161780042|NCT03193190|584237072|FG004|Stage 1|Physician Decision|0|||
161780043|NCT03193190|584237073|FG005|Stage 1|Physician Decision|0|||
161780044|NCT03193190|584237074|FG006|Stage 1|Physician Decision|0|||
161780045|NCT03193190|584237075|FG007|Stage 1|Physician Decision|0|||
161780046|NCT03193190|584237076|FG008|Stage 1|Physician Decision|0|||
161780047|NCT03193190|584237077|FG009|Stage 1|Physician Decision|0|||
161780048|NCT03193190|584237078|FG010|Stage 1|Physician Decision|0|||
161780049|NCT03193190|584237079|FG011|Stage 1|Physician Decision|1|||
161780050|NCT03193190|584237080|FG012|Stage 1|Physician Decision|0|||
161780051|NCT03193190|584237081|FG013|Stage 1|Physician Decision|0|||
161780052|NCT03193190|584237082|FG014|Stage 1|Physician Decision|0|||
161780053|NCT03193190|584237083|FG015|Stage 1|Physician Decision|0|||
161780054|NCT03193190|584237068|FG000|Stage 1|Progressive Disease|1|||
161780055|NCT03193190|584237069|FG001|Stage 1|Progressive Disease|0|||
161780056|NCT03193190|584237070|FG002|Stage 1|Progressive Disease|0|||
161780057|NCT03193190|584237071|FG003|Stage 1|Progressive Disease|0|||
161780058|NCT03193190|584237072|FG004|Stage 1|Progressive Disease|0|||
161780059|NCT03193190|584237073|FG005|Stage 1|Progressive Disease|0|||
161780060|NCT03193190|584237074|FG006|Stage 1|Progressive Disease|0|||
161780061|NCT03193190|584237075|FG007|Stage 1|Progressive Disease|0|||
161780062|NCT03193190|584237076|FG008|Stage 1|Progressive Disease|0|||
161780063|NCT03193190|584237077|FG009|Stage 1|Progressive Disease|0|||
161780064|NCT03193190|584237078|FG010|Stage 1|Progressive Disease|0|||
161780065|NCT03193190|584237079|FG011|Stage 1|Progressive Disease|0|||
161780066|NCT03193190|584237080|FG012|Stage 1|Progressive Disease|0|||
161780067|NCT03193190|584237081|FG013|Stage 1|Progressive Disease|0|||
161780068|NCT03193190|584237082|FG014|Stage 1|Progressive Disease|0|||
161780069|NCT03193190|584237083|FG015|Stage 1|Progressive Disease|0|||
161780070|NCT03193190|584237068|FG000|Stage 1|Study Terminated By Sponsor|3|||
161780071|NCT03193190|584237069|FG001|Stage 1|Study Terminated By Sponsor|0|||
161780072|NCT03193190|584237070|FG002|Stage 1|Study Terminated By Sponsor|0|||
161780073|NCT03193190|584237071|FG003|Stage 1|Study Terminated By Sponsor|0|||
161780074|NCT03193190|584237072|FG004|Stage 1|Study Terminated By Sponsor|6|||
161780075|NCT03193190|584237073|FG005|Stage 1|Study Terminated By Sponsor|0|||
161780076|NCT03193190|584237074|FG006|Stage 1|Study Terminated By Sponsor|0|||
161780077|NCT03193190|584237075|FG007|Stage 1|Study Terminated By Sponsor|0|||
161780078|NCT03193190|584237076|FG008|Stage 1|Study Terminated By Sponsor|0|||
161780079|NCT03193190|584237077|FG009|Stage 1|Study Terminated By Sponsor|0|||
161780080|NCT03193190|584237078|FG010|Stage 1|Study Terminated By Sponsor|0|||
161780081|NCT03193190|584237079|FG011|Stage 1|Study Terminated By Sponsor|0|||
161780082|NCT03193190|584237080|FG012|Stage 1|Study Terminated By Sponsor|0|||
161780083|NCT03193190|584237081|FG013|Stage 1|Study Terminated By Sponsor|0|||
161780084|NCT03193190|584237082|FG014|Stage 1|Study Terminated By Sponsor|0|||
161780085|NCT03193190|584237083|FG015|Stage 1|Study Terminated By Sponsor|0|||
161780086|NCT03193190|584237068|FG000|Stage 1|Withdrawal by Subject|6|||
161780087|NCT03193190|584237069|FG001|Stage 1|Withdrawal by Subject|0|||
161780088|NCT03193190|584237070|FG002|Stage 1|Withdrawal by Subject|1|||
161780089|NCT03193190|584237071|FG003|Stage 1|Withdrawal by Subject|0|||
161780090|NCT03193190|584237072|FG004|Stage 1|Withdrawal by Subject|2|||
161780091|NCT03193190|584237073|FG005|Stage 1|Withdrawal by Subject|0|||
161780092|NCT03193190|584237074|FG006|Stage 1|Withdrawal by Subject|3|||
161780093|NCT03193190|584237075|FG007|Stage 1|Withdrawal by Subject|2|||
161780094|NCT03193190|584237076|FG008|Stage 1|Withdrawal by Subject|2|||
161780095|NCT03193190|584237077|FG009|Stage 1|Withdrawal by Subject|4|||
161780096|NCT03193190|584237078|FG010|Stage 1|Withdrawal by Subject|9|||
161780097|NCT03193190|584237079|FG011|Stage 1|Withdrawal by Subject|1|||
161780098|NCT03193190|584237080|FG012|Stage 1|Withdrawal by Subject|0|||
161780099|NCT03193190|584237081|FG013|Stage 1|Withdrawal by Subject|0|||
161780100|NCT03193190|584237082|FG014|Stage 1|Withdrawal by Subject|0|||
161780101|NCT03193190|584237083|FG015|Stage 1|Withdrawal by Subject|0|||
161780102|NCT03193190|584237068|FG000|Stage 2|Death|0|||
161780103|NCT03193190|584237069|FG001|Stage 2|Death|0|||
161780104|NCT03193190|584237070|FG002|Stage 2|Death|0|||
161780105|NCT03193190|584237071|FG003|Stage 2|Death|0|||
161780106|NCT03193190|584237072|FG004|Stage 2|Death|0|||
161780107|NCT03193190|584237073|FG005|Stage 2|Death|0|||
162009331|NCT00577889|585090102|FG000|Overall Study|Withdrawal by Subject|1|||
161780108|NCT03193190|584237074|FG006|Stage 2|Death|0|||
161780109|NCT03193190|584237075|FG007|Stage 2|Death|0|||
161780110|NCT03193190|584237076|FG008|Stage 2|Death|0|||
161780111|NCT03193190|584237077|FG009|Stage 2|Death|0|||
161780112|NCT03193190|584237078|FG010|Stage 2|Death|0|||
161780113|NCT03193190|584237079|FG011|Stage 2|Death|0|||
161780114|NCT03193190|584237080|FG012|Stage 2|Death|0|||
161780115|NCT03193190|584237081|FG013|Stage 2|Death|14|||
161780116|NCT03193190|584237082|FG014|Stage 2|Death|4|||
161780117|NCT03193190|584237083|FG015|Stage 2|Death|1|||
161780118|NCT03193190|584237068|FG000|Stage 2|Lost to Follow-up|0|||
161683054|NCT00666458|583891220|FG001|Overall Study|Safety reasons|0|||
161780119|NCT03193190|584237069|FG001|Stage 2|Lost to Follow-up|0|||
161780120|NCT03193190|584237070|FG002|Stage 2|Lost to Follow-up|0|||
161780121|NCT03193190|584237071|FG003|Stage 2|Lost to Follow-up|0|||
161780122|NCT03193190|584237072|FG004|Stage 2|Lost to Follow-up|0|||
161780123|NCT03193190|584237073|FG005|Stage 2|Lost to Follow-up|0|||
161780124|NCT03193190|584237074|FG006|Stage 2|Lost to Follow-up|0|||
161780125|NCT03193190|584237075|FG007|Stage 2|Lost to Follow-up|0|||
161780126|NCT03193190|584237076|FG008|Stage 2|Lost to Follow-up|0|||
161780127|NCT03193190|584237077|FG009|Stage 2|Lost to Follow-up|0|||
161780128|NCT03193190|584237078|FG010|Stage 2|Lost to Follow-up|0|||
161780129|NCT03193190|584237079|FG011|Stage 2|Lost to Follow-up|0|||
161780130|NCT03193190|584237080|FG012|Stage 2|Lost to Follow-up|0|||
161780131|NCT03193190|584237081|FG013|Stage 2|Lost to Follow-up|0|||
161780132|NCT03193190|584237082|FG014|Stage 2|Lost to Follow-up|1|||
161780133|NCT03193190|584237083|FG015|Stage 2|Lost to Follow-up|0|||
161780134|NCT03193190|584237068|FG000|Stage 2|Withdrawal by Subject|0|||
161780135|NCT03193190|584237069|FG001|Stage 2|Withdrawal by Subject|0|||
161780136|NCT03193190|584237070|FG002|Stage 2|Withdrawal by Subject|0|||
161780137|NCT03193190|584237071|FG003|Stage 2|Withdrawal by Subject|0|||
161780138|NCT03193190|584237072|FG004|Stage 2|Withdrawal by Subject|0|||
161780139|NCT03193190|584237073|FG005|Stage 2|Withdrawal by Subject|0|||
161780140|NCT03193190|584237074|FG006|Stage 2|Withdrawal by Subject|0|||
161780141|NCT03193190|584237075|FG007|Stage 2|Withdrawal by Subject|0|||
161780142|NCT03193190|584237076|FG008|Stage 2|Withdrawal by Subject|0|||
161780143|NCT03193190|584237077|FG009|Stage 2|Withdrawal by Subject|0|||
161780144|NCT03193190|584237078|FG010|Stage 2|Withdrawal by Subject|0|||
161780145|NCT03193190|584237079|FG011|Stage 2|Withdrawal by Subject|0|||
161780146|NCT03193190|584237080|FG012|Stage 2|Withdrawal by Subject|0|||
161780147|NCT03193190|584237081|FG013|Stage 2|Withdrawal by Subject|1|||
161780148|NCT03193190|584237082|FG014|Stage 2|Withdrawal by Subject|1|||
161780149|NCT03193190|584237083|FG015|Stage 2|Withdrawal by Subject|0|||
161780150|NCT03532295|584237084|FG000|Overall Study|Did not start treatment|0|||
161780151|NCT03532295|584237085|FG001|Overall Study|Did not start treatment|2|||
161780152|NCT05004181|584237089|FG000|Overall Study|Withdrawal of consent|0|||
161780153|NCT05004181|584237090|FG001|Overall Study|Withdrawal of consent|0|||
161780154|NCT05004181|584237091|FG002|Overall Study|Withdrawal of consent|1|||
161780155|NCT05004181|584237092|FG003|Overall Study|Withdrawal of consent|3|||
161780156|NCT05004181|584237093|FG004|Overall Study|Withdrawal of consent|3|||
161780157|NCT05004181|584237094|FG005|Overall Study|Withdrawal of consent|0|||
161780158|NCT05004181|584237095|FG006|Overall Study|Withdrawal of consent|30|||
161780159|NCT05004181|584237096|FG007|Overall Study|Withdrawal of consent|9|||
161780160|NCT05004181|584237097|FG008|Overall Study|Withdrawal of consent|3|||
161780161|NCT05004181|584237098|FG009|Overall Study|Withdrawal of consent|2|||
161780162|NCT05004181|584237099|FG010|Overall Study|Withdrawal of consent|5|||
161780163|NCT05004181|584237100|FG011|Overall Study|Withdrawal of consent|1|||
161780164|NCT05004181|584237089|FG000|Overall Study|Lost to Follow-up|2|||
161780165|NCT05004181|584237090|FG001|Overall Study|Lost to Follow-up|4|||
161780166|NCT05004181|584237091|FG002|Overall Study|Lost to Follow-up|2|||
161780167|NCT05004181|584237092|FG003|Overall Study|Lost to Follow-up|3|||
161780168|NCT05004181|584237093|FG004|Overall Study|Lost to Follow-up|5|||
161780169|NCT05004181|584237094|FG005|Overall Study|Lost to Follow-up|2|||
161780170|NCT05004181|584237095|FG006|Overall Study|Lost to Follow-up|15|||
161780171|NCT05004181|584237096|FG007|Overall Study|Lost to Follow-up|12|||
161780172|NCT05004181|584237097|FG008|Overall Study|Lost to Follow-up|38|||
161780173|NCT05004181|584237098|FG009|Overall Study|Lost to Follow-up|6|||
161780174|NCT05004181|584237099|FG010|Overall Study|Lost to Follow-up|6|||
161780175|NCT05004181|584237100|FG011|Overall Study|Lost to Follow-up|0|||
161780176|NCT05004181|584237089|FG000|Overall Study|Death|0|||
161780177|NCT05004181|584237090|FG001|Overall Study|Death|0|||
161780178|NCT05004181|584237091|FG002|Overall Study|Death|0|||
161895334|NCT03117361|584666298|FG000|Overall Study|Death|1|||
161780179|NCT05004181|584237092|FG003|Overall Study|Death|0|||
161780180|NCT05004181|584237093|FG004|Overall Study|Death|0|||
161780181|NCT05004181|584237094|FG005|Overall Study|Death|0|||
161780182|NCT05004181|584237095|FG006|Overall Study|Death|1|||
161780183|NCT05004181|584237096|FG007|Overall Study|Death|0|||
161780184|NCT05004181|584237097|FG008|Overall Study|Death|2|||
161780185|NCT05004181|584237098|FG009|Overall Study|Death|0|||
161780186|NCT05004181|584237099|FG010|Overall Study|Death|0|||
161780187|NCT05004181|584237100|FG011|Overall Study|Death|0|||
161895335|NCT03117361|584666298|FG000|Overall Study|Physician Decision|2|||
161780188|NCT05004181|584237089|FG000|Overall Study|Physician Decision|0|||
161780189|NCT05004181|584237090|FG001|Overall Study|Physician Decision|0|||
161780190|NCT05004181|584237091|FG002|Overall Study|Physician Decision|0|||
161780191|NCT05004181|584237092|FG003|Overall Study|Physician Decision|0|||
161780192|NCT05004181|584237093|FG004|Overall Study|Physician Decision|0|||
161780193|NCT05004181|584237094|FG005|Overall Study|Physician Decision|0|||
161780194|NCT05004181|584237095|FG006|Overall Study|Physician Decision|2|||
161780195|NCT05004181|584237096|FG007|Overall Study|Physician Decision|0|||
161780196|NCT05004181|584237097|FG008|Overall Study|Physician Decision|7|||
161780197|NCT05004181|584237098|FG009|Overall Study|Physician Decision|0|||
161780198|NCT05004181|584237099|FG010|Overall Study|Physician Decision|0|||
161780199|NCT05004181|584237100|FG011|Overall Study|Physician Decision|0|||
161780200|NCT05004181|584237089|FG000|Overall Study|Withdrawal by Subject|2|||
161780201|NCT05004181|584237090|FG001|Overall Study|Withdrawal by Subject|3|||
161780202|NCT05004181|584237091|FG002|Overall Study|Withdrawal by Subject|2|||
161780203|NCT05004181|584237092|FG003|Overall Study|Withdrawal by Subject|2|||
161780204|NCT05004181|584237093|FG004|Overall Study|Withdrawal by Subject|4|||
161780205|NCT05004181|584237094|FG005|Overall Study|Withdrawal by Subject|2|||
161780206|NCT05004181|584237095|FG006|Overall Study|Withdrawal by Subject|4|||
161780207|NCT05004181|584237096|FG007|Overall Study|Withdrawal by Subject|22|||
161780208|NCT05004181|584237097|FG008|Overall Study|Withdrawal by Subject|8|||
161780209|NCT05004181|584237098|FG009|Overall Study|Withdrawal by Subject|1|||
161780210|NCT05004181|584237099|FG010|Overall Study|Withdrawal by Subject|3|||
161780211|NCT05004181|584237100|FG011|Overall Study|Withdrawal by Subject|2|||
161780212|NCT05004181|584237089|FG000|Overall Study|Protocol Violation|2|||
161780213|NCT05004181|584237090|FG001|Overall Study|Protocol Violation|3|||
161780214|NCT05004181|584237091|FG002|Overall Study|Protocol Violation|0|||
161780215|NCT05004181|584237092|FG003|Overall Study|Protocol Violation|0|||
161780216|NCT05004181|584237093|FG004|Overall Study|Protocol Violation|1|||
161780217|NCT05004181|584237094|FG005|Overall Study|Protocol Violation|0|||
161780218|NCT05004181|584237095|FG006|Overall Study|Protocol Violation|16|||
161780219|NCT05004181|584237096|FG007|Overall Study|Protocol Violation|18|||
161780220|NCT05004181|584237097|FG008|Overall Study|Protocol Violation|2|||
161780221|NCT05004181|584237098|FG009|Overall Study|Protocol Violation|2|||
161780222|NCT05004181|584237099|FG010|Overall Study|Protocol Violation|2|||
161780223|NCT05004181|584237100|FG011|Overall Study|Protocol Violation|1|||
161895336|NCT03117361|584666298|FG000|Overall Study|On study treatment at the end of study|1|||
161895337|NCT03117361|584666298|FG000|Overall Study|Treatment-related adverse event|1|||
161895338|NCT02072941|584666299|FG000|Overall Study|Withdrawal by Subject|29|||
161895339|NCT02072941|584666300|FG001|Overall Study|Withdrawal by Subject|21|||
161895340|NCT02072941|584666299|FG000|Overall Study|Lost to Follow-up|4|||
161895341|NCT02072941|584666300|FG001|Overall Study|Lost to Follow-up|4|||
161895342|NCT02072941|584666299|FG000|Overall Study|Death|3|||
161895343|NCT02072941|584666300|FG001|Overall Study|Death|2|||
161895344|NCT02072941|584666299|FG000|Overall Study|Removed by Study Staff|2|||
161895345|NCT02072941|584666300|FG001|Overall Study|Removed by Study Staff|2|||
161895346|NCT01247350|584666303|FG000|Overall Study|Adverse Event|0|||
161895347|NCT01247350|584666304|FG001|Overall Study|Adverse Event|0|||
161895348|NCT01247350|584666305|FG002|Overall Study|Adverse Event|1|||
161895349|NCT01247350|584666306|FG003|Overall Study|Adverse Event|0|||
161895350|NCT01247350|584666307|FG004|Overall Study|Adverse Event|0|||
161895351|NCT01247350|584666303|FG000|Overall Study|Withdrawal by Subject|0|||
161895352|NCT01247350|584666304|FG001|Overall Study|Withdrawal by Subject|0|||
161895353|NCT01247350|584666305|FG002|Overall Study|Withdrawal by Subject|0|||
161895354|NCT01247350|584666306|FG003|Overall Study|Withdrawal by Subject|1|||
161895355|NCT01247350|584666307|FG004|Overall Study|Withdrawal by Subject|0|||
161895356|NCT01247350|584666303|FG000|Overall Study|Entry criteria not met|0|||
161895357|NCT01247350|584666304|FG001|Overall Study|Entry criteria not met|0|||
161895358|NCT01247350|584666305|FG002|Overall Study|Entry criteria not met|0|||
161895359|NCT01247350|584666306|FG003|Overall Study|Entry criteria not met|0|||
161895360|NCT01247350|584666307|FG004|Overall Study|Entry criteria not met|1|||
161895361|NCT00169104|584666308|FG000|Overall Study|Withdrawal by Subject|2|||
161895362|NCT00169104|584666309|FG001|Overall Study|Withdrawal by Subject|0|||
161895363|NCT00169104|584666308|FG000|Overall Study|Protocol Violation|0|||
161895364|NCT00169104|584666309|FG001|Overall Study|Protocol Violation|1|||
161895365|NCT00169104|584666308|FG000|Overall Study|Physician Decision|0|||
161895366|NCT00169104|584666309|FG001|Overall Study|Physician Decision|1|||
161895367|NCT00715299|584666315|FG000|Overall Study|Withdrawal by Subject|1|||
161895368|NCT00715299|584666315|FG000|Overall Study|Adverse Event|3|||
161895369|NCT00715299|584666315|FG000|Overall Study|failed the pre-screen exercise test|2|||
161895370|NCT02020889|584666316|FG000|Overall Study|Adverse Event|0|||
161895371|NCT02020889|584666317|FG001|Overall Study|Adverse Event|1|||
161895372|NCT02020889|584666316|FG000|Overall Study|Lack of Efficacy|1|||
161895373|NCT02020889|584666317|FG001|Overall Study|Lack of Efficacy|0|||
161895374|NCT02020889|584666316|FG000|Overall Study|Lost to Follow-up|1|||
161895375|NCT02020889|584666317|FG001|Overall Study|Lost to Follow-up|0|||
161895376|NCT02020889|584666316|FG000|Overall Study|Physician Decision|2|||
161895377|NCT02020889|584666317|FG001|Overall Study|Physician Decision|0|||
161895378|NCT02020889|584666316|FG000|Overall Study|Withdrawal by Subject|3|||
161895379|NCT02020889|584666317|FG001|Overall Study|Withdrawal by Subject|2|||
161895380|NCT01540981|584666318|FG000|Overall Study|Withdrawal by Subject|1|||
161895381|NCT01540981|584666319|FG001|Overall Study|Withdrawal by Subject|0|||
161895382|NCT00809094|584666320|FG000|Overall Study|Lost to Follow-up|0|||
161895383|NCT00809094|584666321|FG001|Overall Study|Lost to Follow-up|1|||
161895384|NCT00232557|584666322|FG000|Overall Study|Lost to Follow-up|3|||
161780224|NCT05004181|584237089|FG000|Overall Study|Not further specified|1|||
161895385|NCT00232557|584666323|FG001|Overall Study|Lost to Follow-up|5|||
161895386|NCT02457195|584666328|FG000|Overall Study|Adverse Event|3|||
161780225|NCT05004181|584237090|FG001|Overall Study|Not further specified|0|||
161780226|NCT05004181|584237091|FG002|Overall Study|Not further specified|0|||
161780227|NCT05004181|584237092|FG003|Overall Study|Not further specified|0|||
161780228|NCT05004181|584237093|FG004|Overall Study|Not further specified|0|||
161780229|NCT05004181|584237094|FG005|Overall Study|Not further specified|0|||
161780230|NCT05004181|584237095|FG006|Overall Study|Not further specified|1|||
161780231|NCT05004181|584237096|FG007|Overall Study|Not further specified|0|||
161780232|NCT05004181|584237097|FG008|Overall Study|Not further specified|2|||
161780233|NCT05004181|584237098|FG009|Overall Study|Not further specified|1|||
161780234|NCT05004181|584237099|FG010|Overall Study|Not further specified|0|||
161780235|NCT05004181|584237100|FG011|Overall Study|Not further specified|1|||
161780236|NCT03868059|584237102|FG000|Overall Study|Adverse Event|3|||
161780237|NCT03868059|584237102|FG000|Overall Study|Lost to Follow-up|3|||
161780238|NCT03868059|584237102|FG000|Overall Study|Withdrawal by Subject|6|||
161780239|NCT04278872|584237103|FG000|Overall Study|Adverse Event|1|||
161780240|NCT04278872|584237104|FG001|Overall Study|Adverse Event|0|||
161780241|NCT04278872|584237103|FG000|Overall Study|Protocol Violation|0|||
161780242|NCT04278872|584237104|FG001|Overall Study|Protocol Violation|1|||
161780243|NCT04278872|584237103|FG000|Overall Study|Study Termination|2|||
161780244|NCT04278872|584237104|FG001|Overall Study|Study Termination|0|||
161780245|NCT01211613|584238454|FG000|Overall Study|Lost to Follow-up|2|||
161780246|NCT01211613|584238455|FG001|Overall Study|Lost to Follow-up|2|||
161780247|NCT01211613|584238456|FG002|Overall Study|Lost to Follow-up|2|||
161780248|NCT01211613|584238454|FG000|Overall Study|Withdrawal by Subject|1|||
161780249|NCT01211613|584238455|FG001|Overall Study|Withdrawal by Subject|0|||
161780250|NCT01211613|584238456|FG002|Overall Study|Withdrawal by Subject|0|||
161780251|NCT03853213|584238457|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
161780252|NCT03853213|584238458|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
161780253|NCT03853213|584238457|FG000|Overall Study|Other (e.g., too busy)|0|||
161780254|NCT03853213|584238458|FG001|Overall Study|Other (e.g., too busy)|2|||
161780255|NCT02239692|584238459|FG000|Overall Study|Incomplete colonoscopy|1|||
161780256|NCT02239692|584238460|FG001|Overall Study|Incomplete colonoscopy|2|||
161780257|NCT02239692|584238459|FG000|Overall Study|Adverse Event|0|||
161780258|NCT02239692|584238460|FG001|Overall Study|Adverse Event|1|||
161780259|NCT02239692|584238459|FG000|Overall Study|Physician Decision|0|||
161780260|NCT02239692|584238460|FG001|Overall Study|Physician Decision|1|||
161780261|NCT02239692|584238459|FG000|Overall Study|Lost to Follow-up|1|||
161780262|NCT02239692|584238460|FG001|Overall Study|Lost to Follow-up|4|||
161780263|NCT02239692|584238459|FG000|Overall Study|Withdrawal by Subject|3|||
161780264|NCT02239692|584238460|FG001|Overall Study|Withdrawal by Subject|5|||
161780265|NCT02239692|584238459|FG000|Overall Study|Other reason|1|||
161780266|NCT02239692|584238460|FG001|Overall Study|Other reason|0|||
161780267|NCT01901146|584238461|FG000|Neoadjuvant Phase|Death|1|||
161780268|NCT01901146|584238462|FG001|Neoadjuvant Phase|Death|2|||
161780269|NCT01901146|584238463|FG002|Neoadjuvant Phase|Death|0|||
161780270|NCT01901146|584238464|FG003|Neoadjuvant Phase|Death|0|||
161780271|NCT01901146|584238465|FG004|Neoadjuvant Phase|Death|0|||
161780272|NCT01901146|584238461|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
161780273|NCT01901146|584238462|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
161780274|NCT01901146|584238463|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
161780275|NCT01901146|584238464|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
161780276|NCT01901146|584238465|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
161780277|NCT01901146|584238461|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
161780278|NCT01901146|584238462|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
161780279|NCT01901146|584238463|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
161780280|NCT01901146|584238464|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
161780281|NCT01901146|584238465|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
161780282|NCT01901146|584238461|FG000|Neoadjuvant Phase|Physician Decision|1|||
161780283|NCT01901146|584238462|FG001|Neoadjuvant Phase|Physician Decision|2|||
161780284|NCT01901146|584238463|FG002|Neoadjuvant Phase|Physician Decision|0|||
161780285|NCT01901146|584238464|FG003|Neoadjuvant Phase|Physician Decision|0|||
161780286|NCT01901146|584238465|FG004|Neoadjuvant Phase|Physician Decision|0|||
161780287|NCT01901146|584238461|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
161780288|NCT01901146|584238462|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
161780289|NCT01901146|584238463|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
161780290|NCT01901146|584238464|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
161780291|NCT01901146|584238465|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
161780292|NCT01901146|584238461|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
161780293|NCT01901146|584238462|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
161780294|NCT01901146|584238463|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
161780295|NCT01901146|584238464|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
161780296|NCT01901146|584238465|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
161780297|NCT01901146|584238461|FG000|Adjuvant Phase|Other|0|||
161895387|NCT02457195|584666328|FG000|Overall Study|Protocol Violation|2|||
161780298|NCT01901146|584238462|FG001|Adjuvant Phase|Other|0|||
161780299|NCT01901146|584238463|FG002|Adjuvant Phase|Other|1|||
161780300|NCT01901146|584238464|FG003|Adjuvant Phase|Other|0|||
161780301|NCT01901146|584238465|FG004|Adjuvant Phase|Other|0|||
161780302|NCT01901146|584238461|FG000|Adjuvant Phase|Death|0|||
161780303|NCT01901146|584238462|FG001|Adjuvant Phase|Death|0|||
161780304|NCT01901146|584238463|FG002|Adjuvant Phase|Death|0|||
161780305|NCT01901146|584238464|FG003|Adjuvant Phase|Death|0|||
161780306|NCT01901146|584238465|FG004|Adjuvant Phase|Death|3|||
161780307|NCT01901146|584238461|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
161780308|NCT01901146|584238462|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
161780309|NCT01901146|584238463|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
161780310|NCT01901146|584238464|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
161780311|NCT01901146|584238465|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
161780312|NCT01901146|584238461|FG000|Adjuvant Phase|Physician Decision|0|||
161780313|NCT01901146|584238462|FG001|Adjuvant Phase|Physician Decision|0|||
161780314|NCT01901146|584238463|FG002|Adjuvant Phase|Physician Decision|9|||
161780315|NCT01901146|584238464|FG003|Adjuvant Phase|Physician Decision|2|||
161780316|NCT01901146|584238465|FG004|Adjuvant Phase|Physician Decision|4|||
161780317|NCT01901146|584238461|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
161780318|NCT01901146|584238462|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
161780319|NCT01901146|584238463|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
161780320|NCT01901146|584238464|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
161780321|NCT01901146|584238465|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
161780322|NCT00297492|584238466|FG000|Set Quit Date|Lost to Follow-up|7|||
161780323|NCT00297492|584238467|FG001|Set Quit Date|Lost to Follow-up|13|||
161780324|NCT00297492|584238468|FG002|Set Quit Date|Lost to Follow-up|5|||
161780325|NCT00297492|584238466|FG000|6 Month Follow-up|Lost to Follow-up|63|||
161780326|NCT00297492|584238467|FG001|6 Month Follow-up|Lost to Follow-up|49|||
161780327|NCT00297492|584238468|FG002|6 Month Follow-up|Lost to Follow-up|27|||
161780328|NCT02675426|584238469|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
161780329|NCT02675426|584238470|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
161780330|NCT02675426|584238471|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
161780331|NCT02675426|584238472|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
161780332|NCT02675426|584238469|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
161780333|NCT02675426|584238470|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
161780334|NCT02675426|584238471|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
161780335|NCT02675426|584238472|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
161780336|NCT02675426|584238469|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
161780337|NCT02675426|584238470|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
161780338|NCT02675426|584238471|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
161780339|NCT02675426|584238472|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
161780340|NCT02675426|584238469|FG000|Period 1: Week 1 to Week 12|Other|2|||
161780341|NCT02675426|584238470|FG001|Period 1: Week 1 to Week 12|Other|1|||
161780342|NCT02675426|584238471|FG002|Period 1: Week 1 to Week 12|Other|0|||
161780343|NCT02675426|584238472|FG003|Period 1: Week 1 to Week 12|Other|2|||
161780344|NCT02675426|584238469|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
161780345|NCT02675426|584238470|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
161780346|NCT02675426|584238471|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
161780347|NCT02675426|584238472|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
161780348|NCT02675426|584238469|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
161780349|NCT02675426|584238470|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
161780350|NCT02675426|584238471|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
161780351|NCT02675426|584238472|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
161780352|NCT02675426|584238469|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
161780353|NCT02675426|584238470|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
161780354|NCT02675426|584238471|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
161780355|NCT02675426|584238472|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
161780356|NCT02675426|584238469|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
161780357|NCT02675426|584238470|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
161780358|NCT02675426|584238471|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
161780359|NCT02675426|584238472|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
161780360|NCT02675426|584238469|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
161780361|NCT02675426|584238470|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
161780362|NCT02675426|584238471|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
161780363|NCT02675426|584238472|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
161780364|NCT02675426|584238469|FG000|Period 2: Week 12 to Week 260|Other|8|||
161780365|NCT02675426|584238470|FG001|Period 2: Week 12 to Week 260|Other|12|||
161780366|NCT02675426|584238471|FG002|Period 2: Week 12 to Week 260|Other|23|||
161780367|NCT02675426|584238472|FG003|Period 2: Week 12 to Week 260|Other|15|||
161780368|NCT01784419|584238475|FG000|Overall Study|Adverse Event|3|||
161780369|NCT02237118|584238476|FG000|Overall Study|Protocol Violation|0|||
161780370|NCT02237118|584238477|FG001|Overall Study|Protocol Violation|1|||
161780371|NCT02237118|584238476|FG000|Overall Study|consent withdrawn|1|||
161780372|NCT02237118|584238477|FG001|Overall Study|consent withdrawn|0|||
161780373|NCT00080288|584238478|FG000|Overall Study|Adverse Event|7|||
161780374|NCT00080288|584238479|FG001|Overall Study|Adverse Event|4|||
161780375|NCT00080288|584238478|FG000|Overall Study|Lost to Follow-up|3|||
161780376|NCT00080288|584238479|FG001|Overall Study|Lost to Follow-up|5|||
161780377|NCT00080288|584238478|FG000|Overall Study|Physician Decision|6|||
161780378|NCT00080288|584238479|FG001|Overall Study|Physician Decision|2|||
161780379|NCT00080288|584238478|FG000|Overall Study|Withdrawal by Subject|3|||
161780380|NCT00080288|584238479|FG001|Overall Study|Withdrawal by Subject|16|||
161780381|NCT00080288|584238478|FG000|Overall Study|Miscellaneous|11|||
161780382|NCT00080288|584238479|FG001|Overall Study|Miscellaneous|11|||
161780383|NCT00569231|584238480|FG000|Overall Study|Study unrelated surgery|1|||
161780384|NCT00569231|584238480|FG000|Overall Study|Airfare expense|2|||
161780385|NCT00569231|584238480|FG000|Overall Study|Withdrawal by Subject|1|||
161780386|NCT00569231|584238480|FG000|Overall Study|Car accident injury|1|||
161780387|NCT00569231|584238480|FG000|Overall Study|Non-compliance|2|||
161780388|NCT03456726|584238481|FG000|Overall Study|Disease Progression|6|||
161780389|NCT03456726|584238482|FG001|Overall Study|Disease Progression|1|||
161780390|NCT03456726|584238481|FG000|Overall Study|Adverse Event|4|||
161780391|NCT03456726|584238482|FG001|Overall Study|Adverse Event|2|||
161780392|NCT03456726|584238481|FG000|Overall Study|Withdrawal by Subject|1|||
161780393|NCT03456726|584238482|FG001|Overall Study|Withdrawal by Subject|0|||
161780394|NCT03456726|584238481|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
161780395|NCT03456726|584238482|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
161780396|NCT04470622|584238483|FG000|Overall Study|Withdrawal by Subject|0|||
161780397|NCT04470622|584238484|FG001|Overall Study|Withdrawal by Subject|1|||
161780398|NCT04470622|584238483|FG000|Overall Study|Screen Failure|0|||
161780399|NCT04470622|584238484|FG001|Overall Study|Screen Failure|1|||
161780400|NCT04470622|584238483|FG000|Overall Study|Death|0|||
161780401|NCT04470622|584238484|FG001|Overall Study|Death|1|||
161780402|NCT03978117|584238487|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
161780403|NCT03978117|584238488|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
161780404|NCT03978117|584238487|FG000|Overall Study|Lost to Follow-up|4|||
161780405|NCT03978117|584238488|FG001|Overall Study|Lost to Follow-up|4|||
161780406|NCT00791154|584238489|FG000|Overall Study|Noncompliance|0|||
161780407|NCT00791154|584238490|FG001|Overall Study|Noncompliance|1|||
161780408|NCT00791154|584238491|FG002|Overall Study|Noncompliance|0|||
161780409|NCT00791154|584238492|FG003|Overall Study|Noncompliance|0|||
161780410|NCT00791154|584238493|FG004|Overall Study|Noncompliance|1|||
161780411|NCT00791154|584238494|FG005|Overall Study|Noncompliance|1|||
161780412|NCT00791154|584238495|FG006|Overall Study|Noncompliance|1|||
161780413|NCT00791154|584238489|FG000|Overall Study|Adverse Event|0|||
161780414|NCT00791154|584238490|FG001|Overall Study|Adverse Event|0|||
161780415|NCT00791154|584238491|FG002|Overall Study|Adverse Event|0|||
161780416|NCT00791154|584238492|FG003|Overall Study|Adverse Event|0|||
161780417|NCT00791154|584238493|FG004|Overall Study|Adverse Event|2|||
161780418|NCT00791154|584238494|FG005|Overall Study|Adverse Event|0|||
161780419|NCT00791154|584238495|FG006|Overall Study|Adverse Event|1|||
161780420|NCT00791154|584238489|FG000|Overall Study|Full Consent withdrawn|1|||
161780421|NCT00791154|584238490|FG001|Overall Study|Full Consent withdrawn|3|||
161780422|NCT00791154|584238491|FG002|Overall Study|Full Consent withdrawn|0|||
161780423|NCT00791154|584238492|FG003|Overall Study|Full Consent withdrawn|0|||
161780424|NCT00791154|584238493|FG004|Overall Study|Full Consent withdrawn|1|||
161780425|NCT00791154|584238494|FG005|Overall Study|Full Consent withdrawn|3|||
161780426|NCT00791154|584238495|FG006|Overall Study|Full Consent withdrawn|1|||
161780427|NCT00791154|584238489|FG000|Overall Study|Lost to Follow-up|0|||
161780428|NCT00791154|584238490|FG001|Overall Study|Lost to Follow-up|0|||
161780429|NCT00791154|584238491|FG002|Overall Study|Lost to Follow-up|0|||
161780430|NCT00791154|584238492|FG003|Overall Study|Lost to Follow-up|1|||
161780431|NCT00791154|584238493|FG004|Overall Study|Lost to Follow-up|2|||
161780432|NCT00791154|584238494|FG005|Overall Study|Lost to Follow-up|0|||
161780433|NCT00791154|584238495|FG006|Overall Study|Lost to Follow-up|4|||
161780434|NCT00791154|584238489|FG000|Overall Study|Death|5|||
161780435|NCT00791154|584238490|FG001|Overall Study|Death|4|||
161780436|NCT00791154|584238491|FG002|Overall Study|Death|4|||
161780437|NCT00791154|584238492|FG003|Overall Study|Death|7|||
161780438|NCT00791154|584238493|FG004|Overall Study|Death|54|||
161780439|NCT00791154|584238494|FG005|Overall Study|Death|54|||
162122876|NCT00744237|585502349|FG002|Overall Study|Protocol Violation|3|||
161780440|NCT00791154|584238495|FG006|Overall Study|Death|52|||
161780441|NCT00791154|584238489|FG000|Overall Study|Other event|0|||
161780442|NCT00791154|584238490|FG001|Overall Study|Other event|0|||
161780443|NCT00791154|584238491|FG002|Overall Study|Other event|2|||
161780444|NCT00791154|584238492|FG003|Overall Study|Other event|0|||
161780445|NCT00791154|584238493|FG004|Overall Study|Other event|2|||
161780446|NCT00791154|584238494|FG005|Overall Study|Other event|4|||
161780447|NCT00791154|584238495|FG006|Overall Study|Other event|2|||
161780448|NCT00953927|584238496|FG000|Overall Study|Lost to Follow-up|61|||
161780449|NCT00953927|584238497|FG001|Overall Study|Lost to Follow-up|65|||
161780450|NCT00953927|584238496|FG000|Overall Study|Withdrawal by Subject|36|||
161780451|NCT00953927|584238497|FG001|Overall Study|Withdrawal by Subject|25|||
161780452|NCT00953927|584238496|FG000|Overall Study|Death|7|||
161780453|NCT00953927|584238497|FG001|Overall Study|Death|4|||
161780454|NCT00953927|584238496|FG000|Overall Study|Other study discontinuation|1|||
161780455|NCT00953927|584238497|FG001|Overall Study|Other study discontinuation|1|||
161780456|NCT01296152|584238500|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
161780457|NCT01268683|584238501|FG000|Overall Study|Lost to Follow-up|1|||
161780458|NCT01268683|584238501|FG000|Overall Study|Death|1|||
161780459|NCT04256759|584238502|FG000|Overall Study|Physician Decision|1|||
161780460|NCT04256759|584238502|FG000|Overall Study|Lack of Efficacy|1|||
161780461|NCT03981614|584238507|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
161780462|NCT03981614|584238508|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
161780463|NCT03981614|584238509|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
161780464|NCT04732728|584238510|FG000|Overall Study|Death|12|||
161780465|NCT04732728|584238510|FG000|Overall Study|Withdrawn|136|||
161780466|NCT05349188|584238511|FG000|Overall Study|Withdrawal by Subject|1|||
161780467|NCT05349188|584238512|FG001|Overall Study|Withdrawal by Subject|0|||
161780468|NCT04971226|584238513|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
161780469|NCT04971226|584238514|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
161780470|NCT04971226|584238515|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
161780471|NCT04971226|584238516|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
161780472|NCT04971226|584238513|FG000|Overall Study|Adverse Event|6|||
161780473|NCT04971226|584238514|FG001|Overall Study|Adverse Event|5|||
161780474|NCT04971226|584238515|FG002|Overall Study|Adverse Event|11|||
161780475|NCT04971226|584238516|FG003|Overall Study|Adverse Event|10|||
161780476|NCT04971226|584238513|FG000|Overall Study|Progressive disease|2|||
161780477|NCT04971226|584238514|FG001|Overall Study|Progressive disease|0|||
161780478|NCT04971226|584238515|FG002|Overall Study|Progressive disease|3|||
161780479|NCT04971226|584238516|FG003|Overall Study|Progressive disease|1|||
161780480|NCT04971226|584238513|FG000|Overall Study|Protocol Deviation|1|||
161780481|NCT04971226|584238514|FG001|Overall Study|Protocol Deviation|0|||
161780482|NCT04971226|584238515|FG002|Overall Study|Protocol Deviation|1|||
161780483|NCT04971226|584238516|FG003|Overall Study|Protocol Deviation|1|||
161780484|NCT04971226|584238513|FG000|Overall Study|Subject Decision|0|||
161780485|NCT04971226|584238514|FG001|Overall Study|Subject Decision|1|||
161780486|NCT04971226|584238515|FG002|Overall Study|Subject Decision|1|||
161780487|NCT04971226|584238516|FG003|Overall Study|Subject Decision|1|||
161780488|NCT04971226|584238513|FG000|Overall Study|Pregnancy|0|||
161780489|NCT04971226|584238514|FG001|Overall Study|Pregnancy|0|||
161780490|NCT04971226|584238515|FG002|Overall Study|Pregnancy|0|||
161780491|NCT04971226|584238516|FG003|Overall Study|Pregnancy|1|||
161780492|NCT04971226|584238513|FG000|Overall Study|Participants not treated|1|||
161780493|NCT04971226|584238514|FG001|Overall Study|Participants not treated|0|||
161780494|NCT04971226|584238515|FG002|Overall Study|Participants not treated|2|||
161780495|NCT04971226|584238516|FG003|Overall Study|Participants not treated|1|||
162009332|NCT00577889|585090103|FG001|Overall Study|Withdrawal by Subject|0|||
162009333|NCT00577889|585090104|FG002|Overall Study|Withdrawal by Subject|0|||
162009334|NCT01523756|585090106|FG000|Baseline Period|Adverse Event|0|||
162009335|NCT01523756|585090107|FG001|Baseline Period|Adverse Event|1|||
162009336|NCT01523756|585090106|FG000|Test Period 1|Adverse Event|1|||
162009337|NCT01523756|585090107|FG001|Test Period 1|Adverse Event|0|||
162009338|NCT01523756|585090106|FG000|Test Period 2|Withdrawal by Subject|0|||
162009339|NCT01523756|585090107|FG001|Test Period 2|Withdrawal by Subject|1|||
162009340|NCT03224819|585090110|FG000|Overall Study|Withdrawal by Subject|0|||
162009341|NCT03224819|585090111|FG001|Overall Study|Withdrawal by Subject|0|||
162009342|NCT03224819|585090112|FG002|Overall Study|Withdrawal by Subject|0|||
162009343|NCT03224819|585090113|FG003|Overall Study|Withdrawal by Subject|0|||
162236363|NCT00250679|585916937|FG002|Overall Study|Moved|0|||
161683055|NCT00666458|583891219|FG000|Overall Study|Medical history of anemia|1|||
162009344|NCT03224819|585090114|FG004|Overall Study|Withdrawal by Subject|0|||
162009345|NCT03224819|585090115|FG005|Overall Study|Withdrawal by Subject|0|||
162009346|NCT03224819|585090116|FG006|Overall Study|Withdrawal by Subject|0|||
162009347|NCT03224819|585090117|FG007|Overall Study|Withdrawal by Subject|0|||
162009348|NCT03224819|585090118|FG008|Overall Study|Withdrawal by Subject|0|||
161780506|NCT06065176|584238527|FG000|Overall Study|Lost to Follow-up|11|||
161780507|NCT06065176|584238528|FG001|Overall Study|Lost to Follow-up|11|||
161780508|NCT06065176|584238529|FG002|Overall Study|Lost to Follow-up|10|||
161780509|NCT06065176|584238527|FG000|Overall Study|Withdrawal by Subject|1|||
161780510|NCT06065176|584238528|FG001|Overall Study|Withdrawal by Subject|1|||
161780511|NCT06065176|584238529|FG002|Overall Study|Withdrawal by Subject|2|||
161780512|NCT06065176|584238527|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
161780513|NCT06065176|584238528|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
161780514|NCT06065176|584238529|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
161780515|NCT04521608|584238530|FG000|Overall Study|Death|8|||
161780516|NCT04521608|584238531|FG001|Overall Study|Death|9|||
161780517|NCT04521608|584238530|FG000|Overall Study|Withdrawal by Subject|25|||
161780518|NCT04521608|584238531|FG001|Overall Study|Withdrawal by Subject|18|||
161780519|NCT04521608|584238530|FG000|Overall Study|Disease Progression|3|||
161780520|NCT04521608|584238531|FG001|Overall Study|Disease Progression|10|||
161780521|NCT04521608|584238530|FG000|Overall Study|Complicating Disease|6|||
161780522|NCT04521608|584238531|FG001|Overall Study|Complicating Disease|3|||
161780523|NCT04521608|584238530|FG000|Overall Study|Lost Contact|25|||
161780524|NCT04521608|584238531|FG001|Overall Study|Lost Contact|27|||
161780525|NCT04521608|584238530|FG000|Overall Study|Ineligible|1|||
161780526|NCT04521608|584238531|FG001|Overall Study|Ineligible|0|||
161780527|NCT04521608|584238530|FG000|Overall Study|Refused Further Study Participation|13|||
161780528|NCT04521608|584238531|FG001|Overall Study|Refused Further Study Participation|7|||
161780529|NCT04083378|584238534|FG000|Overall Study|Death|18|||
161780530|NCT04083378|584238535|FG001|Overall Study|Death|4|||
161780531|NCT04083378|584238534|FG000|Overall Study|Lost to Follow-up|4|||
161780532|NCT04083378|584238535|FG001|Overall Study|Lost to Follow-up|0|||
161780533|NCT00644228|584238536|FG000|Randomization & Eligibility|Ineligible|31|||
161780534|NCT00644228|584238537|FG001|Randomization & Eligibility|Ineligible|21|||
161780535|NCT00644228|584238536|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
161780536|NCT00644228|584238537|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
162009349|NCT03224819|585090119|FG009|Overall Study|Withdrawal by Subject|0|||
162009350|NCT03224819|585090120|FG010|Overall Study|Withdrawal by Subject|0|||
161780537|NCT00644228|584238536|FG000|Randomization & Eligibility|Invalid Consent|0|||
161780538|NCT00644228|584238537|FG001|Randomization & Eligibility|Invalid Consent|1|||
161780539|NCT00644228|584238536|FG000|Induction Therapy|Adverse Event|22|||
161780540|NCT00644228|584238537|FG001|Induction Therapy|Adverse Event|55|||
161780541|NCT00644228|584238536|FG000|Induction Therapy|Withdrawal by Subject|10|||
161780542|NCT00644228|584238537|FG001|Induction Therapy|Withdrawal by Subject|3|||
161780543|NCT00644228|584238536|FG000|Induction Therapy|Progression/Relapse|24|||
161780544|NCT00644228|584238537|FG001|Induction Therapy|Progression/Relapse|12|||
161780545|NCT00644228|584238536|FG000|Induction Therapy|Death|3|||
161780546|NCT00644228|584238537|FG001|Induction Therapy|Death|7|||
161780547|NCT00644228|584238536|FG000|Induction Therapy|Not Protocol-Specified|24|||
161780548|NCT00644228|584238537|FG001|Induction Therapy|Not Protocol-Specified|28|||
161780549|NCT00644228|584238536|FG000|Maintenance|Adverse Event|27|||
161780550|NCT00644228|584238537|FG001|Maintenance|Adverse Event|31|||
161780551|NCT00644228|584238536|FG000|Maintenance|Withdrawal by Subject|6|||
161780552|NCT00644228|584238537|FG001|Maintenance|Withdrawal by Subject|4|||
161780553|NCT00644228|584238536|FG000|Maintenance|Progression/Relapse|67|||
161780554|NCT00644228|584238537|FG001|Maintenance|Progression/Relapse|42|||
161780555|NCT00644228|584238536|FG000|Maintenance|Death|3|||
161780556|NCT00644228|584238537|FG001|Maintenance|Death|3|||
161780557|NCT00644228|584238536|FG000|Maintenance|Not Protocol-Specified|14|||
161780558|NCT00644228|584238537|FG001|Maintenance|Not Protocol-Specified|15|||
161780559|NCT00644228|584238536|FG000|Maintenance|On Treatment|26|||
161780560|NCT00644228|584238537|FG001|Maintenance|On Treatment|40|||
161780561|NCT06078124|584238538|FG000|Overall Study|Lost to Follow-up|14|||
161780562|NCT06078124|584238539|FG001|Overall Study|Lost to Follow-up|14|||
161780563|NCT05824273|584238540|FG000|Overall Study|Lost to Follow-up|16|||
161780564|NCT05824273|584238541|FG001|Overall Study|Lost to Follow-up|13|||
161780565|NCT04050293|584238544|FG000|Overall Study|Lost to Follow-up|1|||
161780566|NCT04050293|584238545|FG001|Overall Study|Lost to Follow-up|2|||
161780567|NCT04050293|584238544|FG000|Overall Study|Withdrawal by Subject|2|||
161780568|NCT04050293|584238545|FG001|Overall Study|Withdrawal by Subject|0|||
161780569|NCT02949219|584238558|FG000|Overall Study|Withdrawal by Subject|1|||
161780570|NCT03494816|584238559|FG000|Overall Study|Protocol Violation|2|||
161780571|NCT03494816|584238559|FG000|Overall Study|Physician Decision|2|||
161780572|NCT03494816|584238559|FG000|Overall Study|Did not start trial treatment|1|||
161780573|NCT03494816|584238559|FG000|Overall Study|Adverse Event|1|||
161780574|NCT00633217|584238573|FG000|Overall Study|Adverse Event|5|||
161780575|NCT00633217|584238574|FG001|Overall Study|Adverse Event|9|||
161780576|NCT00633217|584238573|FG000|Overall Study|Lack of Efficacy|0|||
161780577|NCT00633217|584238574|FG001|Overall Study|Lack of Efficacy|2|||
161780578|NCT00633217|584238573|FG000|Overall Study|Protocol Violation|3|||
161780579|NCT00633217|584238574|FG001|Overall Study|Protocol Violation|7|||
161780580|NCT00633217|584238573|FG000|Overall Study|Lost to Follow-up|2|||
161780581|NCT00633217|584238574|FG001|Overall Study|Lost to Follow-up|2|||
161780582|NCT00633217|584238573|FG000|Overall Study|Investigator Discretion|2|||
161780583|NCT00633217|584238574|FG001|Overall Study|Investigator Discretion|0|||
161780584|NCT00633217|584238573|FG000|Overall Study|Withdrew Consent|3|||
161780585|NCT00633217|584238574|FG001|Overall Study|Withdrew Consent|3|||
161780586|NCT05838755|584238575|FG000|Overall Study|Adverse Event|1|||
161780587|NCT05838755|584238576|FG001|Overall Study|Adverse Event|0|||
161780588|NCT05838755|584238577|FG002|Overall Study|Adverse Event|0|||
161780589|NCT05838755|584238575|FG000|Overall Study|Lack of Efficacy|1|||
161780590|NCT05838755|584238576|FG001|Overall Study|Lack of Efficacy|0|||
161780591|NCT05838755|584238577|FG002|Overall Study|Lack of Efficacy|1|||
161780592|NCT05838755|584238575|FG000|Overall Study|Lost to Follow-up|0|||
161780593|NCT05838755|584238576|FG001|Overall Study|Lost to Follow-up|1|||
161780594|NCT05838755|584238577|FG002|Overall Study|Lost to Follow-up|4|||
161780595|NCT05838755|584238575|FG000|Overall Study|Withdrawal by Subject|0|||
161780596|NCT05838755|584238576|FG001|Overall Study|Withdrawal by Subject|2|||
161780597|NCT05838755|584238577|FG002|Overall Study|Withdrawal by Subject|0|||
161780598|NCT05838755|584238575|FG000|Overall Study|Study terminated by sponsor|26|||
161780599|NCT05838755|584238576|FG001|Overall Study|Study terminated by sponsor|27|||
161780600|NCT05838755|584238577|FG002|Overall Study|Study terminated by sponsor|26|||
161780601|NCT05838755|584238575|FG000|Overall Study|Randomized, not treated|2|||
161780602|NCT05838755|584238576|FG001|Overall Study|Randomized, not treated|0|||
161780603|NCT05838755|584238577|FG002|Overall Study|Randomized, not treated|1|||
161780604|NCT05838755|584238575|FG000|Overall Study|Pregnancy|0|||
161780605|NCT05838755|584238576|FG001|Overall Study|Pregnancy|1|||
161780606|NCT05838755|584238577|FG002|Overall Study|Pregnancy|0|||
161780607|NCT01283282|584238578|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
161780608|NCT01283282|584238579|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
161780609|NCT01283282|584238578|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
161780610|NCT01283282|584238579|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
161780611|NCT01283282|584238578|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
162236364|NCT00250679|585916935|FG000|Overall Study|Non-compliance|1|||
161780612|NCT01283282|584238579|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
161780613|NCT01682681|584238586|FG000|Overall Study|Lack of Efficacy|62|||
161780614|NCT01682681|584238586|FG000|Overall Study|Withdrawal by Subject|1|||
161780615|NCT01682681|584238586|FG000|Overall Study|Moved to other hospital|10|||
161780616|NCT01682681|584238586|FG000|Overall Study|Lost to Follow-up|174|||
161780617|NCT01682681|584238586|FG000|Overall Study|Adverse Event|46|||
161780618|NCT01682681|584238586|FG000|Overall Study|tapering of topiramate|5|||
161780619|NCT01682681|584238586|FG000|Overall Study|Other|21|||
161780620|NCT01682681|584238586|FG000|Overall Study|Low compliance|13|||
161780621|NCT02044094|584238587|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
161780622|NCT02044094|584238587|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
161780623|NCT02044094|584238587|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
161780624|NCT02044094|584238587|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
161780625|NCT02044094|584238587|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
161780626|NCT02044094|584238587|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
161780627|NCT02044094|584238587|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
161780628|NCT02044094|584238587|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
161780629|NCT03205163|584238590|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
161780630|NCT03205163|584238591|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
161780631|NCT00005879|584238592|FG000|Overall Study|Withdrawal by Subject|8|||
161780632|NCT00005879|584238593|FG001|Overall Study|Withdrawal by Subject|10|||
161780633|NCT01238172|584238594|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
161780634|NCT01238172|584238595|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
161780635|NCT01238172|584238594|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
161780636|NCT01238172|584238595|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
161780637|NCT05022121|584238596|FG000|Overall Study|Lack of Efficacy|1|||
161780638|NCT05022121|584238597|FG001|Overall Study|Lack of Efficacy|0|||
161780639|NCT05022121|584238596|FG000|Overall Study|Lost to Follow-up|0|||
161780640|NCT05022121|584238597|FG001|Overall Study|Lost to Follow-up|2|||
161780641|NCT01020773|584240355|FG000|Overall Study|Withdrawal by Subject|4|||
161780642|NCT01020773|584240356|FG001|Overall Study|Withdrawal by Subject|3|||
161780643|NCT03302299|584240357|FG000|Overall Study|Protocol Violation|1|||
161780644|NCT01458132|584240358|FG000|Overall Study|Other|15|||
161780645|NCT01458132|584240359|FG001|Overall Study|Other|3|||
161780646|NCT01788163|584240365|FG000|Overall Study|Other|53|||
161780647|NCT01788163|584240366|FG001|Overall Study|Other|0|||
161780648|NCT01788163|584240367|FG002|Overall Study|Other|0|||
161780649|NCT01788163|584240368|FG003|Overall Study|Other|0|||
161780650|NCT01788163|584240369|FG004|Overall Study|Other|0|||
161780651|NCT01788163|584240370|FG005|Overall Study|Other|7|||
161780652|NCT01788163|584240371|FG006|Overall Study|Other|1|||
161780653|NCT01788163|584240372|FG007|Overall Study|Other|48|||
161780654|NCT01788163|584240373|FG008|Overall Study|Other|15|||
161780655|NCT01788163|584240365|FG000|Overall Study|Withdrawal by Subject|2|||
161780656|NCT01788163|584240366|FG001|Overall Study|Withdrawal by Subject|0|||
161780657|NCT01788163|584240367|FG002|Overall Study|Withdrawal by Subject|0|||
161780658|NCT01788163|584240368|FG003|Overall Study|Withdrawal by Subject|0|||
161780659|NCT01788163|584240369|FG004|Overall Study|Withdrawal by Subject|0|||
161780660|NCT01788163|584240370|FG005|Overall Study|Withdrawal by Subject|0|||
161780661|NCT01788163|584240371|FG006|Overall Study|Withdrawal by Subject|0|||
161780662|NCT01788163|584240372|FG007|Overall Study|Withdrawal by Subject|0|||
161780663|NCT01788163|584240373|FG008|Overall Study|Withdrawal by Subject|1|||
161780664|NCT02803138|584240376|FG000|Overall Study|Failure to return|38|||
161780665|NCT02803138|584240376|FG000|Overall Study|Insufficient virological response|2|||
161780666|NCT02803138|584240376|FG000|Overall Study|Withdrawn consent|1|||
161780667|NCT02803138|584240376|FG000|Overall Study|Death|1|||
161780668|NCT02803138|584240376|FG000|Overall Study|Other, not specified|28|||
161780669|NCT04318535|584240377|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
161780670|NCT04318535|584240378|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
161780671|NCT04318535|584240379|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
161780672|NCT00021229|584240384|FG000|Overall Study|Adverse Event|10|||
161780673|NCT00021229|584240385|FG001|Overall Study|Adverse Event|5|||
161780674|NCT00021229|584240386|FG002|Overall Study|Adverse Event|2|||
161780675|NCT00021229|584240384|FG000|Overall Study|Death|0|||
161780676|NCT00021229|584240385|FG001|Overall Study|Death|1|||
161780677|NCT00021229|584240386|FG002|Overall Study|Death|0|||
162009351|NCT03224819|585090121|FG011|Overall Study|Withdrawal by Subject|0|||
161780678|NCT00021229|584240384|FG000|Overall Study|Withdrawal by Subject|7|||
161780679|NCT00021229|584240385|FG001|Overall Study|Withdrawal by Subject|7|||
161780680|NCT00021229|584240386|FG002|Overall Study|Withdrawal by Subject|1|||
161780681|NCT00021229|584240384|FG000|Overall Study|Progressive Disease|15|||
162009352|NCT03224819|585090122|FG012|Overall Study|Withdrawal by Subject|1|||
161780682|NCT00021229|584240385|FG001|Overall Study|Progressive Disease|19|||
161780683|NCT00021229|584240386|FG002|Overall Study|Progressive Disease|12|||
161780684|NCT00021229|584240384|FG000|Overall Study|Protocol Violation|1|||
161780685|NCT00021229|584240385|FG001|Overall Study|Protocol Violation|1|||
161780686|NCT00021229|584240386|FG002|Overall Study|Protocol Violation|0|||
161780687|NCT00021229|584240384|FG000|Overall Study|Physician Decision|0|||
162009353|NCT03224819|585090123|FG013|Overall Study|Withdrawal by Subject|0|||
161780688|NCT00021229|584240385|FG001|Overall Study|Physician Decision|0|||
161780689|NCT00021229|584240386|FG002|Overall Study|Physician Decision|1|||
161780690|NCT00021229|584240384|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
161780691|NCT00021229|584240385|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
161780692|NCT00021229|584240386|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
161780693|NCT02156466|584240390|FG000|Overall Study|Adverse Event|0|||
161780694|NCT02156466|584240391|FG001|Overall Study|Adverse Event|0|||
161780695|NCT02156466|584240392|FG002|Overall Study|Adverse Event|1|||
161780696|NCT02156466|584240393|FG003|Overall Study|Adverse Event|1|||
161780697|NCT02156466|584240394|FG004|Overall Study|Adverse Event|0|||
161780698|NCT02156466|584240390|FG000|Overall Study|Quantiferon Positivity|0|||
161780699|NCT02156466|584240391|FG001|Overall Study|Quantiferon Positivity|0|||
161780700|NCT02156466|584240392|FG002|Overall Study|Quantiferon Positivity|0|||
161780701|NCT02156466|584240393|FG003|Overall Study|Quantiferon Positivity|1|||
161780702|NCT02156466|584240394|FG004|Overall Study|Quantiferon Positivity|0|||
161780703|NCT03724968|584240395|FG000|Overall Study|Insurance issues|0|||
161780704|NCT03724968|584240396|FG001|Overall Study|Insurance issues|1|||
161780705|NCT03724968|584240395|FG000|Overall Study|Study closed|0|||
161780706|NCT03724968|584240396|FG001|Overall Study|Study closed|1|||
161780707|NCT00306852|584240399|FG000|Overall Study|Death|14|||
161780708|NCT00306852|584240400|FG001|Overall Study|Death|14|||
161780709|NCT00306852|584240399|FG000|Overall Study|Lost to Follow-up|15|||
161780710|NCT00306852|584240400|FG001|Overall Study|Lost to Follow-up|24|||
161780711|NCT00817778|584240401|FG000|Overall Study|Adverse Event|1|||
161780712|NCT00817778|584240402|FG001|Overall Study|Adverse Event|0|||
161780713|NCT00817778|584240401|FG000|Overall Study|Withdrawal by Subject|1|||
161780714|NCT00817778|584240402|FG001|Overall Study|Withdrawal by Subject|1|||
161780715|NCT00817778|584240401|FG000|Overall Study|Protocol Violation|0|||
161780716|NCT00817778|584240402|FG001|Overall Study|Protocol Violation|1|||
161780717|NCT00817778|584240401|FG000|Overall Study|Study-specific discontinuation criteria|0|||
161780718|NCT00817778|584240402|FG001|Overall Study|Study-specific discontinuation criteria|1|||
161780719|NCT00817778|584240401|FG000|Overall Study|Poor venous access|1|||
161780720|NCT00817778|584240402|FG001|Overall Study|Poor venous access|0|||
161780721|NCT01286207|584240403|FG000|Overall Study|Adverse Event|27|||
161780722|NCT01286207|584240404|FG001|Overall Study|Adverse Event|41|||
161780723|NCT01286207|584240405|FG002|Overall Study|Adverse Event|8|||
161780724|NCT01286207|584240403|FG000|Overall Study|Lost to Follow-up|49|||
161780725|NCT01286207|584240404|FG001|Overall Study|Lost to Follow-up|43|||
161780726|NCT01286207|584240405|FG002|Overall Study|Lost to Follow-up|20|||
161780727|NCT01286207|584240403|FG000|Overall Study|Withdrawal by Subject|93|||
161780728|NCT01286207|584240404|FG001|Overall Study|Withdrawal by Subject|79|||
161780729|NCT01286207|584240405|FG002|Overall Study|Withdrawal by Subject|41|||
161780730|NCT01286207|584240403|FG000|Overall Study|Lack of Response|92|||
161780731|NCT01286207|584240404|FG001|Overall Study|Lack of Response|38|||
161780732|NCT01286207|584240405|FG002|Overall Study|Lack of Response|8|||
161780733|NCT01286207|584240403|FG000|Overall Study|Other|37|||
161780734|NCT01286207|584240404|FG001|Overall Study|Other|47|||
161780735|NCT01286207|584240405|FG002|Overall Study|Other|13|||
161780736|NCT02923115|584240406|FG000|Overall Study|Lost to Follow-up|0|||
161780737|NCT02923115|584240407|FG001|Overall Study|Lost to Follow-up|0|||
161780738|NCT02923115|584240408|FG002|Overall Study|Lost to Follow-up|0|||
161780739|NCT02923115|584240409|FG003|Overall Study|Lost to Follow-up|1|||
161780740|NCT02923115|584240410|FG004|Overall Study|Lost to Follow-up|0|||
161780741|NCT02923115|584240411|FG005|Overall Study|Lost to Follow-up|0|||
161780742|NCT02923115|584240406|FG000|Overall Study|Withdrawal by Subject|0|||
161780743|NCT02923115|584240407|FG001|Overall Study|Withdrawal by Subject|1|||
161780744|NCT02923115|584240408|FG002|Overall Study|Withdrawal by Subject|0|||
161780745|NCT02923115|584240409|FG003|Overall Study|Withdrawal by Subject|0|||
161780746|NCT02923115|584240410|FG004|Overall Study|Withdrawal by Subject|0|||
161780747|NCT02923115|584240411|FG005|Overall Study|Withdrawal by Subject|0|||
161780748|NCT02923115|584240406|FG000|Overall Study|Randomized, but not dosed|0|||
161780749|NCT02923115|584240407|FG001|Overall Study|Randomized, but not dosed|0|||
161780750|NCT02923115|584240408|FG002|Overall Study|Randomized, but not dosed|3|||
161780751|NCT02923115|584240409|FG003|Overall Study|Randomized, but not dosed|1|||
161780752|NCT02923115|584240410|FG004|Overall Study|Randomized, but not dosed|5|||
161780753|NCT02923115|584240411|FG005|Overall Study|Randomized, but not dosed|0|||
161780754|NCT01875991|584240414|FG000|Overall Study|Withdrawal by Subject|6|||
161780755|NCT01875991|584240415|FG001|Overall Study|Withdrawal by Subject|6|||
161780756|NCT01875991|584240414|FG000|Overall Study|Sponsor Decision|1|||
161780757|NCT01875991|584240415|FG001|Overall Study|Sponsor Decision|0|||
161780758|NCT03151707|584240416|FG000|Overall Study|Lost to Follow-up|6|||
161780759|NCT04439149|584240418|FG000|Overall Study|Ineligible|1|||
161780760|NCT04439149|584240418|FG000|Overall Study|Never start protocol therapy|1|||
161780761|NCT04439149|584240418|FG000|Overall Study|Adverse Event|4|||
161780762|NCT04439149|584240418|FG000|Overall Study|Disease Progression|14|||
161780763|NCT04439149|584240418|FG000|Overall Study|Complicating disease|1|||
161780764|NCT04439149|584240418|FG000|Overall Study|Withdrawal by Subject|3|||
161780765|NCT02617446|584240419|FG000|Overall Study|Withdrawal by Subject|0|||
161780766|NCT02617446|584240420|FG001|Overall Study|Withdrawal by Subject|2|||
161780767|NCT02617446|584240421|FG002|Overall Study|Withdrawal by Subject|0|||
161780768|NCT02617446|584240419|FG000|Overall Study|Adverse Event|1|||
161780769|NCT02617446|584240420|FG001|Overall Study|Adverse Event|0|||
161780770|NCT02617446|584240421|FG002|Overall Study|Adverse Event|5|||
161780771|NCT02617446|584240419|FG000|Overall Study|Lost to Follow-up|3|||
161780772|NCT02617446|584240420|FG001|Overall Study|Lost to Follow-up|0|||
161780773|NCT02617446|584240421|FG002|Overall Study|Lost to Follow-up|0|||
161780774|NCT02617446|584240419|FG000|Overall Study|Death|0|||
161780775|NCT02617446|584240420|FG001|Overall Study|Death|0|||
161780776|NCT02617446|584240421|FG002|Overall Study|Death|2|||
161780777|NCT05264506|584240432|FG000|Overall Study|Adverse Event|59|||
161780778|NCT05264506|584240432|FG000|Overall Study|Lost to Follow-up|204|||
161780779|NCT05264506|584240432|FG000|Overall Study|Protocol Violation|185|||
161780780|NCT05264506|584240432|FG000|Overall Study|Pregnancy|60|||
161780781|NCT05264506|584240432|FG000|Overall Study|Physician Decision|6|||
161780782|NCT05264506|584240432|FG000|Overall Study|Non-compliance with Study Drug|29|||
161780783|NCT05264506|584240432|FG000|Overall Study|Study termination|677|||
161780784|NCT05264506|584240432|FG000|Overall Study|Withdrawal by Subject|208|||
161780785|NCT05264506|584240432|FG000|Overall Study|Discontinued prior treatment|89|||
161780786|NCT03252756|584240436|FG000|Overall Study|Protocol Violation|2|||
161780787|NCT03252756|584240437|FG001|Overall Study|Protocol Violation|4|||
161780788|NCT03252756|584240436|FG000|Overall Study|COVID-19 Pandemic|1|||
161780789|NCT03252756|584240437|FG001|Overall Study|COVID-19 Pandemic|1|||
161780790|NCT03252756|584240436|FG000|Overall Study|Study Drug Expiration|0|||
161780791|NCT03252756|584240437|FG001|Overall Study|Study Drug Expiration|1|||
161780792|NCT04223193|584240438|FG000|Overall Study|Adverse Event|6|||
161780793|NCT04223193|584240439|FG001|Overall Study|Adverse Event|36|||
161780794|NCT04223193|584240438|FG000|Overall Study|Lack of Efficacy|2|||
161780795|NCT04223193|584240439|FG001|Overall Study|Lack of Efficacy|2|||
161780796|NCT04223193|584240438|FG000|Overall Study|Lost to Follow-up|1|||
161780797|NCT04223193|584240439|FG001|Overall Study|Lost to Follow-up|1|||
161780798|NCT04223193|584240438|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
161780799|NCT04223193|584240439|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
161780800|NCT04223193|584240438|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
161780801|NCT04223193|584240439|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
161780802|NCT04223193|584240438|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161780803|NCT04223193|584240439|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161780804|NCT04223193|584240438|FG000|Overall Study|Physician Decision|0|||
161780805|NCT04223193|584240439|FG001|Overall Study|Physician Decision|1|||
161780806|NCT04223193|584240438|FG000|Overall Study|Protocol Violation|1|||
161780807|NCT04223193|584240439|FG001|Overall Study|Protocol Violation|1|||
161780808|NCT04223193|584240438|FG000|Overall Study|Site Terminated by Sponsor|1|||
161780809|NCT04223193|584240439|FG001|Overall Study|Site Terminated by Sponsor|3|||
161780810|NCT04223193|584240438|FG000|Overall Study|Withdrawal by Subject|5|||
161780811|NCT04223193|584240439|FG001|Overall Study|Withdrawal by Subject|6|||
161780812|NCT04223193|584240438|FG000|Overall Study|Other|3|||
161780813|NCT04223193|584240439|FG001|Overall Study|Other|6|||
161780814|NCT03594175|584240440|FG000|Overall Study|Not treated|8|||
161780815|NCT03594175|584240441|FG001|Overall Study|Not treated|1|||
161780816|NCT03594175|584240442|FG002|Overall Study|Not treated|5|||
161780817|NCT03594175|584240440|FG000|Overall Study|Adverse Event|3|||
161780818|NCT03594175|584240441|FG001|Overall Study|Adverse Event|0|||
161780819|NCT03594175|584240442|FG002|Overall Study|Adverse Event|0|||
161780820|NCT03594175|584240440|FG000|Overall Study|Withdrawal by Subject|3|||
161780821|NCT03594175|584240441|FG001|Overall Study|Withdrawal by Subject|0|||
161780822|NCT03594175|584240442|FG002|Overall Study|Withdrawal by Subject|0|||
161780823|NCT03594175|584240440|FG000|Overall Study|Protocol Violation|2|||
161780824|NCT03594175|584240441|FG001|Overall Study|Protocol Violation|2|||
161780825|NCT03594175|584240442|FG002|Overall Study|Protocol Violation|2|||
161780826|NCT03732677|584240443|FG000|Overall Study|Terminated the study|154|||
161780827|NCT03732677|584240444|FG001|Overall Study|Terminated the study|197|||
161780828|NCT03732677|584240443|FG000|Overall Study|Continuing study off treatment|379|||
161780829|NCT03732677|584240444|FG001|Overall Study|Continuing study off treatment|333|||
161780830|NCT04644237|584240445|FG000|Overall Study|Death|4|||
161780831|NCT04644237|584240446|FG001|Overall Study|Death|2|||
161780832|NCT04644237|584240445|FG000|Overall Study|Adverse Event|18|||
161780833|NCT04644237|584240446|FG001|Overall Study|Adverse Event|19|||
161780834|NCT04644237|584240445|FG000|Overall Study|Progressive Disease|61|||
161780835|NCT04644237|584240446|FG001|Overall Study|Progressive Disease|23|||
161780836|NCT04644237|584240445|FG000|Overall Study|Clinical Progression|4|||
161780837|NCT04644237|584240446|FG001|Overall Study|Clinical Progression|1|||
161780838|NCT04644237|584240445|FG000|Overall Study|Withdrawal by Subject|4|||
161780839|NCT04644237|584240446|FG001|Overall Study|Withdrawal by Subject|2|||
161780840|NCT04644237|584240445|FG000|Overall Study|Physician Decision|4|||
161780841|NCT04644237|584240446|FG001|Overall Study|Physician Decision|0|||
161780842|NCT04644237|584240445|FG000|Overall Study|Other|6|||
161780843|NCT04644237|584240446|FG001|Overall Study|Other|3|||
161780844|NCT04644237|584240445|FG000|Overall Study|Randomized but not Treated|1|||
161780845|NCT04644237|584240446|FG001|Overall Study|Randomized but not Treated|0|||
161780846|NCT03131817|584240447|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
161780847|NCT02061293|584240449|FG000|Overall Study|Elevated Blood Pressure|1|||
161780848|NCT02061293|584240450|FG001|Overall Study|Elevated Blood Pressure|1|||
161780849|NCT04066894|584240452|FG000|Overall Study|Lack of Efficacy|1|||
161780850|NCT04066894|584240452|FG000|Overall Study|Screen Failure|1|||
161780851|NCT01500434|584240453|FG000|Overall Study|Death|1|||
161780852|NCT01500434|584240453|FG000|Overall Study|Withdrawal by Subject|1|||
161780853|NCT01500434|584240453|FG000|Overall Study|Missed 12-month follow-up|5|||
161780854|NCT00096031|584240454|FG000|Overall Study|Adverse Event|3|||
161780855|NCT00096031|584240454|FG000|Overall Study|Lack of Efficacy|42|||
161780856|NCT00096031|584240454|FG000|Overall Study|Death|4|||
161780857|NCT00096031|584240454|FG000|Overall Study|Withdrawal by Subject|1|||
161780858|NCT00096031|584240454|FG000|Overall Study|Ineligible|8|||
161780859|NCT00096031|584240454|FG000|Overall Study|Not protocol specified|5|||
161780860|NCT00483717|584240455|FG000|Overall Study|Protocol Violation|5|||
161780861|NCT00483717|584240456|FG001|Overall Study|Protocol Violation|7|||
161780862|NCT00483717|584240455|FG000|Overall Study|Time of dosing missing|1|||
161780863|NCT00483717|584240456|FG001|Overall Study|Time of dosing missing|1|||
161780864|NCT00483717|584240455|FG000|Overall Study|No treatment for migraine|16|||
161780865|NCT00483717|584240456|FG001|Overall Study|No treatment for migraine|13|||
161780866|NCT00483717|584240455|FG000|Overall Study|Lost to Follow-up|1|||
161780867|NCT00483717|584240456|FG001|Overall Study|Lost to Follow-up|0|||
161780868|NCT00483717|584240455|FG000|Overall Study|Withdrawal by Subject|1|||
161780869|NCT00483717|584240456|FG001|Overall Study|Withdrawal by Subject|0|||
161780870|NCT00083226|584240457|FG000|Overall Study|Lack of Efficacy|19|||
161780871|NCT00083226|584240457|FG000|Overall Study|Adverse Event|9|||
161780872|NCT00083226|584240457|FG000|Overall Study|Death|4|||
161780873|NCT00083226|584240457|FG000|Overall Study|Withdrawal by Subject|4|||
161780874|NCT00083226|584240457|FG000|Overall Study|Other|2|||
161780875|NCT00083226|584240457|FG000|Overall Study|ineligible or not receiving treatment|4|||
161780876|NCT00909857|584240458|FG000|Overall Study|Withdrawal by Subject|6|||
161780877|NCT00909857|584240459|FG001|Overall Study|Withdrawal by Subject|10|||
161780878|NCT00909857|584240458|FG000|Overall Study|Adverse Event|5|||
161780879|NCT00909857|584240459|FG001|Overall Study|Adverse Event|5|||
161780880|NCT00909857|584240458|FG000|Overall Study|Lost to Follow-up|2|||
161780881|NCT00909857|584240459|FG001|Overall Study|Lost to Follow-up|5|||
161780882|NCT00909857|584240458|FG000|Overall Study|Protocol Violation|2|||
161780883|NCT00909857|584240459|FG001|Overall Study|Protocol Violation|1|||
161780884|NCT00909857|584240458|FG000|Overall Study|Pregnancy|1|||
161780885|NCT00909857|584240459|FG001|Overall Study|Pregnancy|0|||
161780886|NCT00909857|584240458|FG000|Overall Study|Other|1|||
161780887|NCT00909857|584240459|FG001|Overall Study|Other|0|||
161780888|NCT00909857|584240458|FG000|Overall Study|Did not receive study medication|19|||
161780889|NCT00909857|584240459|FG001|Overall Study|Did not receive study medication|24|||
161780890|NCT03878108|584240460|FG000|Overall Study|Adverse Event|1|||
161780891|NCT03878108|584240461|FG001|Overall Study|Adverse Event|0|||
161780892|NCT00604175|584240462|FG000|Entry Through Week 28|Death|2|||
161780893|NCT00604175|584240463|FG001|Entry Through Week 28|Death|0|||
161780894|NCT00604175|584240464|FG002|Entry Through Week 28|Death|0|||
161780895|NCT00604175|584240462|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
161780896|NCT00604175|584240463|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
161780897|NCT00604175|584240464|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
161780898|NCT00604175|584240462|FG000|Entry Through Week 28|Lost to Follow-up|4|||
161780899|NCT00604175|584240463|FG001|Entry Through Week 28|Lost to Follow-up|3|||
161780900|NCT00604175|584240464|FG002|Entry Through Week 28|Lost to Follow-up|0|||
161780901|NCT00604175|584240462|FG000|Entry Through Week 28|Ineligible|1|||
161780902|NCT00604175|584240463|FG001|Entry Through Week 28|Ineligible|0|||
161780903|NCT00604175|584240464|FG002|Entry Through Week 28|Ineligible|0|||
161780904|NCT00604175|584240462|FG000|Entry Through Week 28|Did not start intervention|2|||
161780905|NCT00604175|584240463|FG001|Entry Through Week 28|Did not start intervention|0|||
161780906|NCT00604175|584240464|FG002|Entry Through Week 28|Did not start intervention|1|||
161780907|NCT00604175|584240462|FG000|Week 29 Through Week 72|Death|0|||
161780908|NCT00604175|584240463|FG001|Week 29 Through Week 72|Death|0|||
161780909|NCT00604175|584240464|FG002|Week 29 Through Week 72|Death|1|||
161780910|NCT00604175|584240462|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
161780911|NCT00604175|584240463|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
162009354|NCT03224819|585090110|FG000|Overall Study|Sponsor Decision|0|||
161780912|NCT00604175|584240464|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
161780913|NCT00604175|584240462|FG000|Week 29 Through Week 72|Site closure|0|||
161780914|NCT00604175|584240463|FG001|Week 29 Through Week 72|Site closure|1|||
161780915|NCT00604175|584240464|FG002|Week 29 Through Week 72|Site closure|0|||
161780916|NCT00604175|584240462|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
161780917|NCT00604175|584240463|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
161780918|NCT00604175|584240464|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
161780919|NCT03353415|584240465|FG000|Masked CGM Wear|Lost to Follow-up|2|||
161831478|NCT01730040|584424758|FG001|Overall Study|Adverse Event|3|||
161780920|NCT03353415|584240465|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
161780921|NCT00131937|584240466|FG000|Overall Study|Adverse Event|3|||
161780922|NCT00131937|584240466|FG000|Overall Study|Withdrawal by Subject|2|||
161780923|NCT00131937|584240466|FG000|Overall Study|Physician Decision|1|||
161780924|NCT00131937|584240466|FG000|Overall Study|Disease Progression|7|||
161780925|NCT00131937|584240466|FG000|Overall Study|Alternative therapy|1|||
161780926|NCT04647253|584240473|FG000|Overall Study|Death ≤ 365 Days|16|||
161780927|NCT04647253|584240474|FG001|Overall Study|Death ≤ 365 Days|7|||
161780928|NCT04647253|584240473|FG000|Overall Study|Physician Decision|0|||
161780929|NCT04647253|584240474|FG001|Overall Study|Physician Decision|1|||
161780930|NCT04647253|584240473|FG000|Overall Study|Withdrawal by Subject|7|||
161780931|NCT04647253|584240474|FG001|Overall Study|Withdrawal by Subject|2|||
161780932|NCT04647253|584240473|FG000|Overall Study|Missed 12-Month Visit|9|||
161780933|NCT04647253|584240474|FG001|Overall Study|Missed 12-Month Visit|7|||
161780934|NCT04647253|584240473|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
161780935|NCT04647253|584240474|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
161780936|NCT04502862|584240477|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
161780937|NCT04502862|584240478|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
161780938|NCT04502862|584240477|FG000|Overall Study|Withdrawal by Subject|1|||
161780939|NCT04502862|584240478|FG001|Overall Study|Withdrawal by Subject|0|||
161780940|NCT04502862|584240477|FG000|Overall Study|Adverse Event|1|||
161780941|NCT04502862|584240478|FG001|Overall Study|Adverse Event|1|||
161780942|NCT02038959|584241929|FG000|Overall Study|Withdrawal by Subject|6|||
161780943|NCT02038959|584241930|FG001|Overall Study|Withdrawal by Subject|8|||
161780944|NCT00819091|584241936|FG000|Overall Study|Adverse Event|3|||
161780945|NCT00819091|584241937|FG001|Overall Study|Adverse Event|5|||
161780946|NCT00819091|584241936|FG000|Overall Study|Protocol Violation|0|||
161780947|NCT00819091|584241937|FG001|Overall Study|Protocol Violation|1|||
161780948|NCT00819091|584241936|FG000|Overall Study|Lost to Follow-up|2|||
161780949|NCT00819091|584241937|FG001|Overall Study|Lost to Follow-up|0|||
161780950|NCT00819091|584241936|FG000|Overall Study|Withdrawal by Subject|1|||
161780951|NCT00819091|584241937|FG001|Overall Study|Withdrawal by Subject|2|||
161780952|NCT00819091|584241936|FG000|Overall Study|Other|1|||
161780953|NCT00819091|584241937|FG001|Overall Study|Other|2|||
161780954|NCT00545441|584241938|FG000|Overall Study|Fistula draining at 6 months|2|||
161780955|NCT00545441|584241939|FG001|Overall Study|Fistula draining at 6 months|4|||
161780956|NCT00545441|584241938|FG000|Overall Study|Lost to Follow-up|9|||
161780957|NCT00545441|584241939|FG001|Overall Study|Lost to Follow-up|5|||
161780958|NCT00545441|584241938|FG000|Overall Study|Technical failure|0|||
161780959|NCT00545441|584241939|FG001|Overall Study|Technical failure|1|||
161780960|NCT00545441|584241938|FG000|Overall Study|Withdrawal by Subject|1|||
161780961|NCT00545441|584241939|FG001|Overall Study|Withdrawal by Subject|1|||
161780962|NCT00545441|584241938|FG000|Overall Study|Persistence or recurrence of fistula|5|||
161780963|NCT00545441|584241939|FG001|Overall Study|Persistence or recurrence of fistula|2|||
161780964|NCT00545441|584241938|FG000|Overall Study|Patients were not treated|1|||
161780965|NCT00545441|584241939|FG001|Overall Study|Patients were not treated|3|||
161780966|NCT03911960|584241940|FG000|Overall Study|Lost to Follow-up|5|||
161780967|NCT03911960|584241941|FG001|Overall Study|Lost to Follow-up|3|||
161780968|NCT00265239|584241942|FG000|Overall Study|Adverse Event|2|||
161780969|NCT00265239|584241943|FG001|Overall Study|Adverse Event|1|||
161780970|NCT00424515|584241944|FG000|Overall Study|Progressive Disease|10|||
161780971|NCT00424515|584241945|FG001|Overall Study|Progressive Disease|11|||
161780972|NCT00424515|584241944|FG000|Overall Study|Adverse Event|0|||
161780973|NCT00424515|584241945|FG001|Overall Study|Adverse Event|1|||
161780974|NCT00424515|584241944|FG000|Overall Study|Intercurrent Illness|0|||
161780975|NCT00424515|584241945|FG001|Overall Study|Intercurrent Illness|1|||
161780976|NCT00424515|584241944|FG000|Overall Study|Withdrawal by Subject|1|||
161780977|NCT00424515|584241945|FG001|Overall Study|Withdrawal by Subject|0|||
161780978|NCT04071366|584241946|FG000|Part 1: Open-label (29 Days)|Death|4|||
161780979|NCT04071366|584241947|FG001|Part 1: Open-label (29 Days)|Death|2|||
161780980|NCT04071366|584241948|FG002|Part 1: Open-label (29 Days)|Death|8|||
161780981|NCT04071366|584241949|FG003|Part 1: Open-label (29 Days)|Death|0|||
161780982|NCT04071366|584241950|FG004|Part 1: Open-label (29 Days)|Death|0|||
161780983|NCT04071366|584241946|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
161780984|NCT04071366|584241947|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
161780985|NCT04071366|584241948|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
161780986|NCT04071366|584241949|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
161780987|NCT04071366|584241950|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
161780988|NCT04071366|584241946|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
161780989|NCT04071366|584241947|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
161780990|NCT04071366|584241948|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
161780991|NCT04071366|584241949|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
161780992|NCT04071366|584241950|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
161780993|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Death|0|||
161780994|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Death|0|||
161780995|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Death|0|||
161780996|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Death|2|||
161780997|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Death|2|||
161780998|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
161780999|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
161781000|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
161781001|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
161781002|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
161781003|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
161781004|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
161781005|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
161781006|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
161781007|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
161781008|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
161781009|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
161781010|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
161781011|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
161781012|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
161781013|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
161781014|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
161781015|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
161781016|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
161781017|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
161781018|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
161781019|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
161781020|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
161781021|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
161781022|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
161781023|NCT04071366|584241946|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
161781024|NCT04071366|584241947|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
161781025|NCT04071366|584241948|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
161781026|NCT04071366|584241949|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
161781027|NCT04071366|584241950|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
161781028|NCT01858558|584241951|FG000|Overall Study|Death|1|||
161781029|NCT01858558|584241952|FG001|Overall Study|Death|1|||
161781030|NCT01858558|584241951|FG000|Overall Study|Lost to Follow-up|1|||
161781031|NCT01858558|584241952|FG001|Overall Study|Lost to Follow-up|0|||
161781032|NCT01858558|584241951|FG000|Overall Study|Disease progression|3|||
161781033|NCT01858558|584241952|FG001|Overall Study|Disease progression|1|||
161781034|NCT01858558|584241951|FG000|Overall Study|Product contamination|2|||
161781035|NCT01858558|584241952|FG001|Overall Study|Product contamination|0|||
161781036|NCT01858558|584241951|FG000|Overall Study|Failed expansion of cell product|2|||
161781037|NCT01858558|584241952|FG001|Overall Study|Failed expansion of cell product|0|||
161781038|NCT01336608|584241953|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
161781039|NCT01336608|584241954|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161781040|NCT01336608|584241955|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161781041|NCT01336608|584241956|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161781042|NCT01336608|584241953|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
161781043|NCT01336608|584241954|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161781044|NCT01336608|584241955|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161781045|NCT01336608|584241956|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161781046|NCT01336608|584241953|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
161781047|NCT01336608|584241954|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
161781048|NCT01336608|584241955|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
161781049|NCT01336608|584241956|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
161781050|NCT01336608|584241953|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
161781051|NCT01336608|584241954|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
161781052|NCT01336608|584241955|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
161781053|NCT01336608|584241956|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
161781054|NCT01336608|584241953|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
161781055|NCT01336608|584241954|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161781056|NCT01336608|584241955|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161781057|NCT01336608|584241956|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161781058|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
161781059|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
161781060|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
161781061|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
161781062|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161781063|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
161781064|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161781065|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161781066|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
161781067|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
161781068|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
161781069|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
161781070|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
161781071|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
161781072|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
161781073|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
161781074|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
161781075|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
161781076|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
161781077|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
161781078|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161781079|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
161781080|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161781081|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161781082|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
161781083|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
161781084|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
161781085|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
161781086|NCT01336608|584241953|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161781087|NCT01336608|584241954|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
161781088|NCT01336608|584241955|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
161781089|NCT01336608|584241956|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
161781090|NCT00399490|584241961|FG000|Overall Study|Adverse Event|19|||
161781091|NCT00399490|584241961|FG000|Overall Study|Lack of Efficacy|31|||
161781092|NCT00399490|584241961|FG000|Overall Study|Lost to Follow-up|5|||
161781093|NCT00399490|584241961|FG000|Overall Study|Withdrawal by Subject|18|||
161781094|NCT00399490|584241961|FG000|Overall Study|Other|25|||
161781095|NCT02437890|584241962|FG000|Overall Study|Non-compliance to study drug|0|||
161781096|NCT02437890|584241963|FG001|Overall Study|Non-compliance to study drug|1|||
161781097|NCT02437890|584241964|FG002|Overall Study|Non-compliance to study drug|0|||
161781098|NCT02437890|584241965|FG003|Overall Study|Non-compliance to study drug|0|||
161781099|NCT02437890|584241966|FG004|Overall Study|Non-compliance to study drug|1|||
161781100|NCT02437890|584241962|FG000|Overall Study|Sponsor's decision|1|||
161781101|NCT02437890|584241963|FG001|Overall Study|Sponsor's decision|1|||
161781102|NCT02437890|584241964|FG002|Overall Study|Sponsor's decision|4|||
161781103|NCT02437890|584241965|FG003|Overall Study|Sponsor's decision|0|||
161781104|NCT02437890|584241966|FG004|Overall Study|Sponsor's decision|2|||
161781105|NCT02437890|584241962|FG000|Overall Study|Physician Decision|0|||
161781106|NCT02437890|584241963|FG001|Overall Study|Physician Decision|0|||
161781107|NCT02437890|584241964|FG002|Overall Study|Physician Decision|0|||
161781108|NCT02437890|584241965|FG003|Overall Study|Physician Decision|1|||
161781109|NCT02437890|584241966|FG004|Overall Study|Physician Decision|0|||
161781110|NCT02437890|584241962|FG000|Overall Study|Unable to attend visit(s)|1|||
161781111|NCT02437890|584241963|FG001|Overall Study|Unable to attend visit(s)|0|||
161781112|NCT02437890|584241964|FG002|Overall Study|Unable to attend visit(s)|0|||
161781113|NCT02437890|584241965|FG003|Overall Study|Unable to attend visit(s)|0|||
161781114|NCT02437890|584241966|FG004|Overall Study|Unable to attend visit(s)|0|||
161781115|NCT02437890|584241962|FG000|Overall Study|Lack of Efficacy|1|||
161781116|NCT02437890|584241963|FG001|Overall Study|Lack of Efficacy|3|||
161781117|NCT02437890|584241964|FG002|Overall Study|Lack of Efficacy|0|||
161781118|NCT02437890|584241965|FG003|Overall Study|Lack of Efficacy|3|||
161781119|NCT02437890|584241966|FG004|Overall Study|Lack of Efficacy|1|||
161781120|NCT02437890|584241962|FG000|Overall Study|Adverse Event|4|||
161781121|NCT02437890|584241963|FG001|Overall Study|Adverse Event|9|||
161781122|NCT02437890|584241964|FG002|Overall Study|Adverse Event|5|||
161781123|NCT02437890|584241965|FG003|Overall Study|Adverse Event|11|||
161781124|NCT02437890|584241966|FG004|Overall Study|Adverse Event|7|||
161781125|NCT02437890|584241962|FG000|Overall Study|Withdrawal by Subject|1|||
161781126|NCT02437890|584241963|FG001|Overall Study|Withdrawal by Subject|2|||
161781127|NCT02437890|584241964|FG002|Overall Study|Withdrawal by Subject|6|||
161781128|NCT02437890|584241965|FG003|Overall Study|Withdrawal by Subject|5|||
161781129|NCT02437890|584241966|FG004|Overall Study|Withdrawal by Subject|5|||
161781130|NCT02437890|584241962|FG000|Overall Study|Death|0|||
161781131|NCT02437890|584241963|FG001|Overall Study|Death|0|||
161781132|NCT02437890|584241964|FG002|Overall Study|Death|0|||
161781133|NCT02437890|584241965|FG003|Overall Study|Death|2|||
161781134|NCT02437890|584241966|FG004|Overall Study|Death|0|||
161781135|NCT02328547|584241967|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
161781136|NCT02328547|584241968|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
161781137|NCT02328547|584241967|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
161781138|NCT02328547|584241968|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
161781139|NCT00344305|584241969|FG000|Overall Study|Lost to Follow-up|2|||
161781140|NCT00344305|584241970|FG001|Overall Study|Lost to Follow-up|0|||
161781141|NCT00344305|584241969|FG000|Overall Study|Participant was not contacted in window|0|||
161781142|NCT00344305|584241970|FG001|Overall Study|Participant was not contacted in window|1|||
161781143|NCT01422720|584241972|FG000|Overall Study|Adverse Event|16|||
161781144|NCT01422720|584241972|FG000|Overall Study|Lack of Efficacy|1|||
161781145|NCT01422720|584241972|FG000|Overall Study|Withdrawal by Subject|4|||
161781146|NCT01422720|584241972|FG000|Overall Study|Ineligibility|1|||
161781147|NCT01537549|584241981|FG000|Overall Study|Lost to Follow-up|1|||
161781148|NCT01537549|584241981|FG000|Overall Study|Withdrawal by Subject|2|||
161781149|NCT00883740|584241982|FG000|First Intervention|Lost to Follow-up|1|||
161781150|NCT00883740|584241983|FG001|First Intervention|Lost to Follow-up|0|||
161781151|NCT00883740|584241982|FG000|First Intervention|No longer willing to participate|2|||
161781152|NCT00883740|584241983|FG001|First Intervention|No longer willing to participate|0|||
161781153|NCT00883740|584241982|FG000|First Intervention|Protocol Violation|3|||
161781154|NCT00883740|584241983|FG001|First Intervention|Protocol Violation|6|||
161781155|NCT00883740|584241982|FG000|First Intervention|Adverse Event|1|||
161781156|NCT00883740|584241983|FG001|First Intervention|Adverse Event|2|||
161781157|NCT00883740|584241982|FG000|Second Intervention|Protocol Violation|1|||
161781158|NCT00883740|584241983|FG001|Second Intervention|Protocol Violation|0|||
161781159|NCT00883740|584241982|FG000|Second Intervention|No longer willing to participate|0|||
161781160|NCT00883740|584241983|FG001|Second Intervention|No longer willing to participate|1|||
161781161|NCT04840901|584241986|FG000|Overall Study|Lost to Follow-up|3|||
161781162|NCT04840901|584241987|FG001|Overall Study|Lost to Follow-up|1|||
161781163|NCT04840901|584241986|FG000|Overall Study|Moved|1|||
161781164|NCT04840901|584241987|FG001|Overall Study|Moved|0|||
161781165|NCT04840901|584241986|FG000|Overall Study|Unable to comply with study schedule|0|||
161781166|NCT04840901|584241987|FG001|Overall Study|Unable to comply with study schedule|1|||
161781167|NCT04840901|584241986|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
161781168|NCT04840901|584241987|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
161781169|NCT00103259|584241988|FG000|Overall Study|Death|3|||
161781170|NCT00103259|584241989|FG001|Overall Study|Death|2|||
161781171|NCT00103259|584241988|FG000|Overall Study|Withdrawal by Subject|2|||
161781172|NCT00103259|584241989|FG001|Overall Study|Withdrawal by Subject|3|||
161781173|NCT00103259|584241988|FG000|Overall Study|alternative therapy|1|||
161781174|NCT00103259|584241989|FG001|Overall Study|alternative therapy|0|||
161781175|NCT00103259|584241988|FG000|Overall Study|other (reasons were not specified)|2|||
161781176|NCT00103259|584241989|FG001|Overall Study|other (reasons were not specified)|1|||
161781177|NCT00103259|584241988|FG000|Overall Study|ineligible/no protocol therapy|4|||
161781178|NCT00103259|584241989|FG001|Overall Study|ineligible/no protocol therapy|6|||
161781179|NCT03224234|584241990|FG000|Main Study|Lost to Follow-up|5|||
161781180|NCT03224234|584241991|FG001|Main Study|Lost to Follow-up|5|||
161781181|NCT02610842|584241992|FG000|Overall Study|Lost to Follow-up|5|||
161781182|NCT02494583|584241995|FG000|Overall Study|Death|224|||
161781183|NCT02494583|584241996|FG001|Overall Study|Death|214|||
161781184|NCT02494583|584241997|FG002|Overall Study|Death|225|||
161781185|NCT02494583|584241995|FG000|Overall Study|Lost to Follow-up|1|||
161781186|NCT02494583|584241996|FG001|Overall Study|Lost to Follow-up|0|||
161781187|NCT02494583|584241997|FG002|Overall Study|Lost to Follow-up|0|||
161781188|NCT02494583|584241995|FG000|Overall Study|Protocol Violation|1|||
161781189|NCT02494583|584241996|FG001|Overall Study|Protocol Violation|2|||
161781190|NCT02494583|584241997|FG002|Overall Study|Protocol Violation|0|||
161781191|NCT02494583|584241995|FG000|Overall Study|Screen Failure|0|||
161781192|NCT02494583|584241996|FG001|Overall Study|Screen Failure|1|||
161895388|NCT02457195|584666328|FG000|Overall Study|Withdrawal by Subject|4|||
161895389|NCT02328937|584666331|FG000|Period 1|Lost to Follow-up|0|||
161895390|NCT02328937|584666332|FG001|Period 1|Lost to Follow-up|0|||
161895391|NCT02328937|584666333|FG002|Period 1|Lost to Follow-up|0|||
161895392|NCT02328937|584666334|FG003|Period 1|Lost to Follow-up|1|||
161895393|NCT02328937|584666335|FG004|Period 1|Lost to Follow-up|0|||
161895394|NCT02328937|584666336|FG005|Period 1|Lost to Follow-up|0|||
161895395|NCT02328937|584666331|FG000|Period 2|Adverse Event|0|||
161895396|NCT02328937|584666332|FG001|Period 2|Adverse Event|0|||
161895397|NCT02328937|584666333|FG002|Period 2|Adverse Event|1|||
161895398|NCT02328937|584666334|FG003|Period 2|Adverse Event|0|||
161895399|NCT02328937|584666335|FG004|Period 2|Adverse Event|0|||
161895400|NCT02328937|584666336|FG005|Period 2|Adverse Event|0|||
161895401|NCT00435461|584666341|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
161895402|NCT00435461|584666342|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
161895403|NCT00435461|584666343|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
161895404|NCT00435461|584666341|FG000|Overall Study|Protocol Violation|6|||
161895405|NCT00435461|584666342|FG001|Overall Study|Protocol Violation|9|||
161895406|NCT00435461|584666343|FG002|Overall Study|Protocol Violation|10|||
161895407|NCT00435461|584666341|FG000|Overall Study|Participant randomized(inadequate score)|1|||
161895408|NCT00435461|584666342|FG001|Overall Study|Participant randomized(inadequate score)|0|||
161895409|NCT00435461|584666343|FG002|Overall Study|Participant randomized(inadequate score)|0|||
161895410|NCT00435461|584666341|FG000|Overall Study|Compliance less than 80 percent|1|||
161895411|NCT00435461|584666342|FG001|Overall Study|Compliance less than 80 percent|0|||
161895412|NCT00435461|584666343|FG002|Overall Study|Compliance less than 80 percent|0|||
161895413|NCT00435461|584666341|FG000|Overall Study|In error, two study medications switched|1|||
161895414|NCT00435461|584666342|FG001|Overall Study|In error, two study medications switched|0|||
161895415|NCT00435461|584666343|FG002|Overall Study|In error, two study medications switched|0|||
161895416|NCT00435461|584666341|FG000|Overall Study|Lack of Efficacy|2|||
161895417|NCT00435461|584666342|FG001|Overall Study|Lack of Efficacy|1|||
161895418|NCT00435461|584666343|FG002|Overall Study|Lack of Efficacy|0|||
161895419|NCT00435461|584666341|FG000|Overall Study|Withdrawal by Subject|1|||
161895420|NCT00435461|584666342|FG001|Overall Study|Withdrawal by Subject|0|||
161895421|NCT00435461|584666343|FG002|Overall Study|Withdrawal by Subject|2|||
161895422|NCT00435461|584666341|FG000|Overall Study|Randomized in error|1|||
161895423|NCT00435461|584666342|FG001|Overall Study|Randomized in error|0|||
161895424|NCT00435461|584666343|FG002|Overall Study|Randomized in error|0|||
161895425|NCT00435461|584666341|FG000|Overall Study|Participant could not tolerate symptoms|0|||
161895426|NCT00435461|584666342|FG001|Overall Study|Participant could not tolerate symptoms|0|||
161895427|NCT00435461|584666343|FG002|Overall Study|Participant could not tolerate symptoms|1|||
161895428|NCT00435461|584666341|FG000|Overall Study|Participant could not swallow capsule|0|||
161895429|NCT00435461|584666342|FG001|Overall Study|Participant could not swallow capsule|0|||
161895430|NCT00435461|584666343|FG002|Overall Study|Participant could not swallow capsule|1|||
161895431|NCT00435461|584666341|FG000|Overall Study|Pregnancy|2|||
161895432|NCT00435461|584666342|FG001|Overall Study|Pregnancy|0|||
161895433|NCT00435461|584666343|FG002|Overall Study|Pregnancy|0|||
161895434|NCT00435461|584666341|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
161895435|NCT00435461|584666342|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
161895436|NCT00435461|584666343|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
161895437|NCT00435461|584666341|FG000|Overall Study|Participant ended study one day early|1|||
161895438|NCT00435461|584666342|FG001|Overall Study|Participant ended study one day early|0|||
161895439|NCT00435461|584666343|FG002|Overall Study|Participant ended study one day early|0|||
161895440|NCT00435461|584666341|FG000|Overall Study|Noncompliance with study requirements|1|||
161895441|NCT00435461|584666342|FG001|Overall Study|Noncompliance with study requirements|1|||
161895442|NCT00435461|584666343|FG002|Overall Study|Noncompliance with study requirements|1|||
161895443|NCT00435461|584666341|FG000|Overall Study|Adverse Event|1|||
161895444|NCT00435461|584666342|FG001|Overall Study|Adverse Event|2|||
161895445|NCT00435461|584666343|FG002|Overall Study|Adverse Event|6|||
161895446|NCT00435461|584666341|FG000|Overall Study|Non-Compliance of diary|2|||
161895447|NCT00435461|584666342|FG001|Overall Study|Non-Compliance of diary|0|||
161895448|NCT00435461|584666343|FG002|Overall Study|Non-Compliance of diary|1|||
161895449|NCT00435461|584666341|FG000|Overall Study|Lost to Follow-up|1|||
161895450|NCT00435461|584666342|FG001|Overall Study|Lost to Follow-up|1|||
161895451|NCT00435461|584666343|FG002|Overall Study|Lost to Follow-up|2|||
161895452|NCT04676724|584666344|FG000|Overall Study|Adverse Event|2|||
161895453|NCT04676724|584666345|FG001|Overall Study|Adverse Event|0|||
161895454|NCT04676724|584666344|FG000|Overall Study|Lost to Follow-up|1|||
161895455|NCT04676724|584666345|FG001|Overall Study|Lost to Follow-up|0|||
161895456|NCT04676724|584666344|FG000|Overall Study|Physician Decision|0|||
161895457|NCT04676724|584666345|FG001|Overall Study|Physician Decision|1|||
161895458|NCT04676724|584666344|FG000|Overall Study|Withdrawal by Subject|3|||
162009355|NCT03224819|585090111|FG001|Overall Study|Sponsor Decision|0|||
161895459|NCT04676724|584666345|FG001|Overall Study|Withdrawal by Subject|2|||
161895460|NCT00398047|584666351|FG000|Overall Study|all patient progressed before completion|3|||
161895461|NCT02588092|584666358|FG000|Overall Study|Death|4|||
161895462|NCT02588092|584666359|FG001|Overall Study|Death|3|||
161895463|NCT02588092|584666360|FG002|Overall Study|Death|3|||
161895464|NCT02588092|584666361|FG003|Overall Study|Death|3|||
161895465|NCT02588092|584666362|FG004|Overall Study|Death|2|||
161895466|NCT02588092|584666363|FG005|Overall Study|Death|2|||
161895467|NCT02588092|584666364|FG006|Overall Study|Death|2|||
161895468|NCT02588092|584666365|FG007|Overall Study|Death|1|||
161895469|NCT02588092|584666366|FG008|Overall Study|Death|5|||
161895470|NCT02588092|584666367|FG009|Overall Study|Death|2|||
161895471|NCT02588092|584666358|FG000|Overall Study|Withdrawal by Subject|0|||
161895472|NCT02588092|584666359|FG001|Overall Study|Withdrawal by Subject|0|||
161895473|NCT02588092|584666360|FG002|Overall Study|Withdrawal by Subject|0|||
161895474|NCT02588092|584666361|FG003|Overall Study|Withdrawal by Subject|0|||
161895475|NCT02588092|584666362|FG004|Overall Study|Withdrawal by Subject|0|||
161895476|NCT02588092|584666363|FG005|Overall Study|Withdrawal by Subject|1|||
161895477|NCT02588092|584666364|FG006|Overall Study|Withdrawal by Subject|1|||
161895478|NCT02588092|584666365|FG007|Overall Study|Withdrawal by Subject|2|||
161895479|NCT02588092|584666366|FG008|Overall Study|Withdrawal by Subject|0|||
161895480|NCT02588092|584666367|FG009|Overall Study|Withdrawal by Subject|0|||
161895481|NCT02588092|584666358|FG000|Overall Study|Started Another Treatment|0|||
161895482|NCT02588092|584666359|FG001|Overall Study|Started Another Treatment|0|||
161895483|NCT02588092|584666360|FG002|Overall Study|Started Another Treatment|0|||
161895484|NCT02588092|584666361|FG003|Overall Study|Started Another Treatment|0|||
161895485|NCT02588092|584666362|FG004|Overall Study|Started Another Treatment|1|||
161895486|NCT02588092|584666363|FG005|Overall Study|Started Another Treatment|0|||
161895487|NCT02588092|584666364|FG006|Overall Study|Started Another Treatment|0|||
161895488|NCT02588092|584666365|FG007|Overall Study|Started Another Treatment|1|||
161895489|NCT02588092|584666366|FG008|Overall Study|Started Another Treatment|0|||
161895490|NCT02588092|584666367|FG009|Overall Study|Started Another Treatment|0|||
161895491|NCT02588092|584666358|FG000|Overall Study|Sponsor Decision|0|||
161895492|NCT02588092|584666359|FG001|Overall Study|Sponsor Decision|0|||
161895493|NCT02588092|584666360|FG002|Overall Study|Sponsor Decision|0|||
161895494|NCT02588092|584666361|FG003|Overall Study|Sponsor Decision|0|||
161895495|NCT02588092|584666362|FG004|Overall Study|Sponsor Decision|0|||
161895496|NCT02588092|584666363|FG005|Overall Study|Sponsor Decision|0|||
161895497|NCT02588092|584666364|FG006|Overall Study|Sponsor Decision|0|||
161895498|NCT02588092|584666365|FG007|Overall Study|Sponsor Decision|0|||
161895499|NCT02588092|584666366|FG008|Overall Study|Sponsor Decision|1|||
161895500|NCT02588092|584666367|FG009|Overall Study|Sponsor Decision|1|||
161895501|NCT01348100|584666368|FG000|Overall Study|Subject Withdrew Consent|0|||
161895502|NCT01348100|584666369|FG001|Overall Study|Subject Withdrew Consent|0|||
161895503|NCT01348100|584666370|FG002|Overall Study|Subject Withdrew Consent|2|||
161895504|NCT01348100|584666371|FG003|Overall Study|Subject Withdrew Consent|0|||
161895505|NCT01348100|584666372|FG004|Overall Study|Subject Withdrew Consent|1|||
161895506|NCT01348100|584666373|FG005|Overall Study|Subject Withdrew Consent|0|||
161895507|NCT01348100|584666374|FG006|Overall Study|Subject Withdrew Consent|1|||
161895508|NCT01348100|584666368|FG000|Overall Study|Protocol Deviation|0|||
161895509|NCT01348100|584666369|FG001|Overall Study|Protocol Deviation|0|||
161895510|NCT01348100|584666370|FG002|Overall Study|Protocol Deviation|0|||
161895511|NCT01348100|584666371|FG003|Overall Study|Protocol Deviation|1|||
161895512|NCT01348100|584666372|FG004|Overall Study|Protocol Deviation|0|||
161895513|NCT01348100|584666373|FG005|Overall Study|Protocol Deviation|0|||
162242003|NCT02616562|585939084|FG016|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
162242004|NCT02616562|585939068|FG000|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242005|NCT02616562|585939069|FG001|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242006|NCT02616562|585939070|FG002|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242007|NCT02616562|585939071|FG003|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242008|NCT02616562|585939072|FG004|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242009|NCT02616562|585939073|FG005|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242010|NCT02616562|585939074|FG006|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242011|NCT02616562|585939075|FG007|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242012|NCT02616562|585939076|FG008|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242013|NCT02616562|585939077|FG009|Safety Extension Period (104 Weeks)|Lost to Follow-up|1|||
162242014|NCT02616562|585939078|FG010|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242015|NCT02616562|585939079|FG011|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242016|NCT02616562|585939080|FG012|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242017|NCT02616562|585939081|FG013|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242018|NCT02616562|585939082|FG014|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242019|NCT02616562|585939083|FG015|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242020|NCT02616562|585939084|FG016|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
162242021|NCT02616562|585939068|FG000|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
162242022|NCT02616562|585939069|FG001|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
162242023|NCT02616562|585939070|FG002|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161895514|NCT01348100|584666374|FG006|Overall Study|Protocol Deviation|0|||
161895515|NCT01348100|584666368|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161895516|NCT01348100|584666369|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161895517|NCT01348100|584666370|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161895518|NCT01348100|584666371|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161895519|NCT01348100|584666372|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161895520|NCT01348100|584666373|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
161895521|NCT01348100|584666374|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161895522|NCT01348100|584666368|FG000|Overall Study|Lost to Follow-up|0|||
161895523|NCT01348100|584666369|FG001|Overall Study|Lost to Follow-up|0|||
161895524|NCT01348100|584666370|FG002|Overall Study|Lost to Follow-up|0|||
161895525|NCT01348100|584666371|FG003|Overall Study|Lost to Follow-up|0|||
161895526|NCT01348100|584666372|FG004|Overall Study|Lost to Follow-up|0|||
161895527|NCT01348100|584666373|FG005|Overall Study|Lost to Follow-up|0|||
161895528|NCT01348100|584666374|FG006|Overall Study|Lost to Follow-up|1|||
161895529|NCT01348100|584666368|FG000|Overall Study|Administrative Problems|0|||
161895530|NCT01348100|584666369|FG001|Overall Study|Administrative Problems|0|||
161895531|NCT01348100|584666370|FG002|Overall Study|Administrative Problems|0|||
161895532|NCT01348100|584666371|FG003|Overall Study|Administrative Problems|0|||
161895533|NCT01348100|584666372|FG004|Overall Study|Administrative Problems|0|||
161895534|NCT01348100|584666373|FG005|Overall Study|Administrative Problems|1|||
161895535|NCT01348100|584666374|FG006|Overall Study|Administrative Problems|1|||
161895536|NCT00531947|584666377|FG000|Overall Study|Adverse Event|5|||
161895537|NCT00531947|584666378|FG001|Overall Study|Adverse Event|10|||
161895538|NCT00531947|584666377|FG000|Overall Study|Lost to Follow-up|12|||
161895539|NCT00531947|584666378|FG001|Overall Study|Lost to Follow-up|9|||
161895540|NCT00531947|584666377|FG000|Overall Study|Withdrawal by Subject|14|||
161895541|NCT00531947|584666378|FG001|Overall Study|Withdrawal by Subject|19|||
161895542|NCT00531947|584666377|FG000|Overall Study|Protocol Violation|2|||
161895543|NCT00531947|584666378|FG001|Overall Study|Protocol Violation|1|||
161895544|NCT00531947|584666377|FG000|Overall Study|Non-Compliance|4|||
161895545|NCT00531947|584666378|FG001|Overall Study|Non-Compliance|7|||
161895546|NCT00531947|584666377|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
161895547|NCT00531947|584666378|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
161895548|NCT02383355|584666381|FG000|Overall Study|Adverse Event|2|||
161895549|NCT02383355|584666382|FG001|Overall Study|Adverse Event|0|||
161895550|NCT00524680|584666383|FG000|Overall Study|progression|0|||
161895551|NCT00524680|584666384|FG001|Overall Study|progression|0|||
161895552|NCT00524680|584666385|FG002|Overall Study|progression|0|||
161781193|NCT02494583|584241997|FG002|Overall Study|Screen Failure|0|||
161781194|NCT02494583|584241995|FG000|Overall Study|Transferred to Extension Study|15|||
161781195|NCT02494583|584241996|FG001|Overall Study|Transferred to Extension Study|15|||
161781196|NCT02494583|584241997|FG002|Overall Study|Transferred to Extension Study|6|||
161781197|NCT02494583|584241995|FG000|Overall Study|Did Not Continue on Extension Study|8|||
161781198|NCT02494583|584241996|FG001|Overall Study|Did Not Continue on Extension Study|10|||
161781199|NCT02494583|584241997|FG002|Overall Study|Did Not Continue on Extension Study|4|||
161781200|NCT02494583|584241995|FG000|Overall Study|Withdrawal by Subject|7|||
161781201|NCT02494583|584241996|FG001|Overall Study|Withdrawal by Subject|15|||
161781202|NCT02494583|584241997|FG002|Overall Study|Withdrawal by Subject|15|||
161781203|NCT00627458|584242000|FG000|Overall Study|Migrated from study area|1|||
161781204|NCT00627458|584242001|FG001|Overall Study|Migrated from study area|0|||
161781205|NCT00627458|584242002|FG002|Overall Study|Migrated from study area|1|||
161781206|NCT00627458|584242000|FG000|Overall Study|Withdrawal by Subject|2|||
161781207|NCT00627458|584242001|FG001|Overall Study|Withdrawal by Subject|6|||
161781208|NCT00627458|584242002|FG002|Overall Study|Withdrawal by Subject|5|||
161781209|NCT00627458|584242000|FG000|Overall Study|Lost to Follow-up|1|||
161781210|NCT00627458|584242001|FG001|Overall Study|Lost to Follow-up|1|||
161781211|NCT00627458|584242002|FG002|Overall Study|Lost to Follow-up|0|||
161781212|NCT03891875|584242003|FG000|Overall Study|Withdrawal by Subject|20|||
161781213|NCT03891875|584242004|FG001|Overall Study|Withdrawal by Subject|3|||
161781214|NCT03891875|584242003|FG000|Overall Study|Adverse Event|10|||
161781215|NCT03891875|584242004|FG001|Overall Study|Adverse Event|4|||
161781216|NCT03891875|584242003|FG000|Overall Study|Physician Decision|1|||
161781217|NCT03891875|584242004|FG001|Overall Study|Physician Decision|1|||
161781218|NCT03891875|584242003|FG000|Overall Study|Protocol Violation|1|||
161781219|NCT03891875|584242004|FG001|Overall Study|Protocol Violation|0|||
161781220|NCT03891875|584242003|FG000|Overall Study|Lost to Follow-up|1|||
161781221|NCT03891875|584242004|FG001|Overall Study|Lost to Follow-up|0|||
161895553|NCT00524680|584666386|FG003|Overall Study|progression|1|||
161895554|NCT00524680|584666383|FG000|Overall Study|Adverse Event|2|||
161895555|NCT00524680|584666384|FG001|Overall Study|Adverse Event|0|||
161895556|NCT00524680|584666385|FG002|Overall Study|Adverse Event|0|||
161895557|NCT00524680|584666386|FG003|Overall Study|Adverse Event|1|||
161895558|NCT00524680|584666383|FG000|Overall Study|Other|0|||
161895559|NCT00524680|584666384|FG001|Overall Study|Other|1|||
161895560|NCT00524680|584666385|FG002|Overall Study|Other|2|||
161895561|NCT00524680|584666386|FG003|Overall Study|Other|3|||
161895562|NCT00524680|584666383|FG000|Overall Study|Withdrawal by Subject|1|||
161895563|NCT00524680|584666384|FG001|Overall Study|Withdrawal by Subject|0|||
161895564|NCT00524680|584666385|FG002|Overall Study|Withdrawal by Subject|1|||
161895565|NCT00524680|584666386|FG003|Overall Study|Withdrawal by Subject|1|||
161895566|NCT01146561|584666387|FG000|Overall Study|Withdrawal by Subject|1|||
161781222|NCT03891875|584242003|FG000|Overall Study|COVID-19 infection|1|||
161781223|NCT03891875|584242004|FG001|Overall Study|COVID-19 infection|0|||
161781224|NCT00530088|584242009|FG000|Overall Study|Disease Progression|4|||
161781225|NCT00530088|584242009|FG000|Overall Study|Physician Decision|4|||
161895567|NCT01146561|584666387|FG000|Overall Study|Lost to Follow-up|1|||
161895568|NCT00334295|584666396|FG000|Overall Study|Patients received fewer than 3 injection|5|||
161895569|NCT00893971|584666397|FG000|Overall Study|Physician Decision|3|||
161895570|NCT01416155|584666398|FG000|Overall Study|Adverse Event|8|||
161895571|NCT01416155|584666398|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
161895572|NCT01416155|584666398|FG000|Overall Study|Withdrawal by Subject|33|||
161895573|NCT01416155|584666398|FG000|Overall Study|Investigator decision|8|||
161895574|NCT01416155|584666398|FG000|Overall Study|Other|7|||
161895575|NCT00829829|584666402|FG000|Overall Study|Protocol Violation|0|||
161895576|NCT00829829|584666403|FG001|Overall Study|Protocol Violation|3|||
161895577|NCT00829829|584666404|FG002|Overall Study|Protocol Violation|0|||
161895578|NCT00829829|584666402|FG000|Overall Study|Adverse Event|4|||
161895579|NCT00829829|584666403|FG001|Overall Study|Adverse Event|4|||
161895580|NCT00829829|584666404|FG002|Overall Study|Adverse Event|3|||
161895581|NCT00829829|584666402|FG000|Overall Study|Withdrawal by Subject|8|||
161895582|NCT00829829|584666403|FG001|Overall Study|Withdrawal by Subject|4|||
161895583|NCT00829829|584666404|FG002|Overall Study|Withdrawal by Subject|2|||
161895584|NCT00829829|584666402|FG000|Overall Study|Decision by the Sponsor|1|||
161895585|NCT00829829|584666403|FG001|Overall Study|Decision by the Sponsor|0|||
161895586|NCT00829829|584666404|FG002|Overall Study|Decision by the Sponsor|2|||
161895587|NCT00829829|584666402|FG000|Overall Study|Lost to Follow-up|7|||
161895588|NCT00829829|584666403|FG001|Overall Study|Lost to Follow-up|3|||
161781226|NCT00530088|584242009|FG000|Overall Study|Other Not Specified|2|||
161781227|NCT00285012|584242024|FG000|Assigned to Study Treatment (Tx)|Other|2|||
161781228|NCT00285012|584242025|FG001|Assigned to Study Treatment (Tx)|Other|3|||
161781229|NCT00285012|584242024|FG000|Received Study Tx|Death|2|||
161781230|NCT00285012|584242025|FG001|Received Study Tx|Death|1|||
161781231|NCT00285012|584242024|FG000|Received Study Tx|Adverse Event|5|||
161781232|NCT00285012|584242025|FG001|Received Study Tx|Adverse Event|11|||
161781233|NCT00285012|584242024|FG000|Received Study Tx|Lack of Efficacy|0|||
161781234|NCT00285012|584242025|FG001|Received Study Tx|Lack of Efficacy|3|||
161781235|NCT00285012|584242024|FG000|Received Study Tx|Lost to Follow-up|29|||
161781236|NCT00285012|584242025|FG001|Received Study Tx|Lost to Follow-up|31|||
161895589|NCT00829829|584666404|FG002|Overall Study|Lost to Follow-up|3|||
161895590|NCT00829829|584666402|FG000|Overall Study|Other than specified above|2|||
161895591|NCT00829829|584666403|FG001|Overall Study|Other than specified above|2|||
161895592|NCT00829829|584666404|FG002|Overall Study|Other than specified above|1|||
161895593|NCT00382109|584666405|FG000|Overall Study|Adverse Event|3|||
161781237|NCT00285012|584242024|FG000|Received Study Tx|Withdrawal by Subject|31|||
161895594|NCT00382109|584666406|FG001|Overall Study|Adverse Event|0|||
161895595|NCT00382109|584666405|FG000|Overall Study|Physician Decision|6|||
161895596|NCT00382109|584666406|FG001|Overall Study|Physician Decision|1|||
161895597|NCT00382109|584666405|FG000|Overall Study|Withdrawal by Subject|1|||
161895598|NCT00382109|584666406|FG001|Overall Study|Withdrawal by Subject|0|||
161895599|NCT00382109|584666405|FG000|Overall Study|ineligible|2|||
161895600|NCT00382109|584666406|FG001|Overall Study|ineligible|0|||
161895601|NCT00382109|584666405|FG000|Overall Study|Other|0|||
161895602|NCT00382109|584666406|FG001|Overall Study|Other|2|||
161895603|NCT00382109|584666405|FG000|Overall Study|consent withdrawal|0|||
161895604|NCT00382109|584666406|FG001|Overall Study|consent withdrawal|1|||
161895605|NCT05052697|584666407|FG000|Substudy A|Lost to Follow-up|0|||
161895606|NCT05052697|584666408|FG001|Substudy A|Lost to Follow-up|0|||
161895607|NCT05052697|584666409|FG002|Substudy A|Lost to Follow-up|0|||
161895608|NCT05052697|584666410|FG003|Substudy A|Lost to Follow-up|0|||
161895609|NCT05052697|584666411|FG004|Substudy A|Lost to Follow-up|0|||
161895610|NCT05052697|584666412|FG005|Substudy A|Lost to Follow-up|1|||
161781238|NCT00285012|584242025|FG001|Received Study Tx|Withdrawal by Subject|43|||
161781239|NCT00285012|584242024|FG000|Received Study Tx|Other|5|||
161781240|NCT00285012|584242025|FG001|Received Study Tx|Other|5|||
161781241|NCT05631093|584242028|FG000|Overall Study|Death|0|||
161895611|NCT05052697|584666413|FG006|Substudy A|Lost to Follow-up|0|||
161895612|NCT05052697|584666414|FG007|Substudy A|Lost to Follow-up|0|||
161895613|NCT05052697|584666415|FG008|Substudy A|Lost to Follow-up|0|||
161895614|NCT05052697|584666416|FG009|Substudy A|Lost to Follow-up|0|||
161895615|NCT05052697|584666417|FG010|Substudy A|Lost to Follow-up|0|||
161895616|NCT05052697|584666418|FG011|Substudy A|Lost to Follow-up|0|||
161895617|NCT05052697|584666419|FG012|Substudy A|Lost to Follow-up|0|||
161895618|NCT05052697|584666420|FG013|Substudy A|Lost to Follow-up|0|||
161895619|NCT05052697|584666421|FG014|Substudy A|Lost to Follow-up|0|||
161895620|NCT05052697|584666422|FG015|Substudy A|Lost to Follow-up|2|||
161895621|NCT05052697|584666423|FG016|Substudy A|Lost to Follow-up|0|||
161895622|NCT05052697|584666424|FG017|Substudy A|Lost to Follow-up|0|||
161895623|NCT05052697|584666425|FG018|Substudy A|Lost to Follow-up|0|||
161895624|NCT05052697|584666426|FG019|Substudy A|Lost to Follow-up|0|||
161895625|NCT05052697|584666427|FG020|Substudy A|Lost to Follow-up|0|||
161895626|NCT05052697|584666428|FG021|Substudy A|Lost to Follow-up|0|||
161895627|NCT05052697|584666429|FG022|Substudy A|Lost to Follow-up|0|||
161895628|NCT05052697|584666430|FG023|Substudy A|Lost to Follow-up|0|||
161895629|NCT05052697|584666431|FG024|Substudy A|Lost to Follow-up|0|||
161895630|NCT05052697|584666432|FG025|Substudy A|Lost to Follow-up|0|||
161895631|NCT05052697|584666433|FG026|Substudy A|Lost to Follow-up|0|||
161895632|NCT05052697|584666434|FG027|Substudy A|Lost to Follow-up|0|||
161895633|NCT05052697|584666435|FG028|Substudy A|Lost to Follow-up|0|||
161895634|NCT05052697|584666436|FG029|Substudy A|Lost to Follow-up|0|||
161781242|NCT05631093|584242029|FG001|Overall Study|Death|1|||
161781243|NCT05631093|584242028|FG000|Overall Study|Lost to Follow-up|1|||
161781244|NCT05631093|584242029|FG001|Overall Study|Lost to Follow-up|2|||
161781245|NCT05631093|584242028|FG000|Overall Study|Physician Decision|1|||
161781246|NCT05631093|584242029|FG001|Overall Study|Physician Decision|0|||
161895635|NCT05052697|584666437|FG030|Substudy A|Lost to Follow-up|0|||
161895636|NCT05052697|584666438|FG031|Substudy A|Lost to Follow-up|0|||
161895637|NCT05052697|584666439|FG032|Substudy A|Lost to Follow-up|0|||
161895638|NCT05052697|584666440|FG033|Substudy A|Lost to Follow-up|0|||
161895639|NCT05052697|584666407|FG000|Substudy A|No longer met eligibility criteria|0|||
161895640|NCT05052697|584666408|FG001|Substudy A|No longer met eligibility criteria|0|||
161895641|NCT05052697|584666409|FG002|Substudy A|No longer met eligibility criteria|0|||
161895642|NCT05052697|584666410|FG003|Substudy A|No longer met eligibility criteria|0|||
161895643|NCT05052697|584666411|FG004|Substudy A|No longer met eligibility criteria|0|||
161895644|NCT05052697|584666412|FG005|Substudy A|No longer met eligibility criteria|0|||
161781247|NCT05631093|584242028|FG000|Overall Study|Withdrawal by Subject|4|||
161781248|NCT05631093|584242029|FG001|Overall Study|Withdrawal by Subject|1|||
161781249|NCT05631093|584242028|FG000|Overall Study|Ongoing|353|||
161781250|NCT05631093|584242029|FG001|Overall Study|Ongoing|177|||
161781251|NCT05631093|584242028|FG000|Overall Study|Adverse Event|0|||
161781252|NCT05631093|584242029|FG001|Overall Study|Adverse Event|1|||
161781253|NCT02873195|584242030|FG000|Overall Study|Ineligible|5|||
161781254|NCT02873195|584242031|FG001|Overall Study|Ineligible|0|||
161781255|NCT03107715|584242032|FG000|Overall Study|did not deliver at the home hospital|4|||
161781256|NCT03107715|584242033|FG001|Overall Study|did not deliver at the home hospital|6|||
161781257|NCT03107715|584242032|FG000|Overall Study|infant stillborn|0|||
161781258|NCT03107715|584242033|FG001|Overall Study|infant stillborn|1|||
161781259|NCT04822701|584242036|FG000|Overall Study|Not treated|2|||
161781260|NCT04822701|584242037|FG001|Overall Study|Not treated|0|||
161781261|NCT04822701|584242036|FG000|Overall Study|Lost to Follow-up|1|||
161895645|NCT05052697|584666413|FG006|Substudy A|No longer met eligibility criteria|0|||
161895646|NCT05052697|584666414|FG007|Substudy A|No longer met eligibility criteria|0|||
161895647|NCT05052697|584666415|FG008|Substudy A|No longer met eligibility criteria|0|||
161895648|NCT05052697|584666416|FG009|Substudy A|No longer met eligibility criteria|0|||
161895649|NCT05052697|584666417|FG010|Substudy A|No longer met eligibility criteria|0|||
161895650|NCT05052697|584666418|FG011|Substudy A|No longer met eligibility criteria|0|||
161895651|NCT05052697|584666419|FG012|Substudy A|No longer met eligibility criteria|0|||
161895652|NCT05052697|584666420|FG013|Substudy A|No longer met eligibility criteria|1|||
161895653|NCT05052697|584666421|FG014|Substudy A|No longer met eligibility criteria|0|||
161895654|NCT05052697|584666422|FG015|Substudy A|No longer met eligibility criteria|0|||
161895655|NCT05052697|584666423|FG016|Substudy A|No longer met eligibility criteria|0|||
161895656|NCT05052697|584666424|FG017|Substudy A|No longer met eligibility criteria|0|||
161895657|NCT05052697|584666425|FG018|Substudy A|No longer met eligibility criteria|0|||
161895658|NCT05052697|584666426|FG019|Substudy A|No longer met eligibility criteria|0|||
161895659|NCT05052697|584666427|FG020|Substudy A|No longer met eligibility criteria|0|||
161895660|NCT05052697|584666428|FG021|Substudy A|No longer met eligibility criteria|0|||
161895661|NCT05052697|584666429|FG022|Substudy A|No longer met eligibility criteria|0|||
161895662|NCT05052697|584666430|FG023|Substudy A|No longer met eligibility criteria|0|||
161895663|NCT05052697|584666431|FG024|Substudy A|No longer met eligibility criteria|0|||
161895664|NCT05052697|584666432|FG025|Substudy A|No longer met eligibility criteria|0|||
161895665|NCT05052697|584666433|FG026|Substudy A|No longer met eligibility criteria|0|||
161895666|NCT05052697|584666434|FG027|Substudy A|No longer met eligibility criteria|0|||
161895667|NCT05052697|584666435|FG028|Substudy A|No longer met eligibility criteria|0|||
161895668|NCT05052697|584666436|FG029|Substudy A|No longer met eligibility criteria|0|||
161895669|NCT05052697|584666437|FG030|Substudy A|No longer met eligibility criteria|0|||
161895670|NCT05052697|584666438|FG031|Substudy A|No longer met eligibility criteria|0|||
161895671|NCT05052697|584666439|FG032|Substudy A|No longer met eligibility criteria|0|||
161895672|NCT05052697|584666440|FG033|Substudy A|No longer met eligibility criteria|0|||
161895673|NCT05052697|584666407|FG000|Substudy A|Not vaccinated|0|||
161895674|NCT05052697|584666408|FG001|Substudy A|Not vaccinated|0|||
161895675|NCT05052697|584666409|FG002|Substudy A|Not vaccinated|0|||
161895676|NCT05052697|584666410|FG003|Substudy A|Not vaccinated|1|||
161895677|NCT05052697|584666411|FG004|Substudy A|Not vaccinated|0|||
161895678|NCT05052697|584666412|FG005|Substudy A|Not vaccinated|0|||
161895679|NCT05052697|584666413|FG006|Substudy A|Not vaccinated|0|||
161895680|NCT05052697|584666414|FG007|Substudy A|Not vaccinated|0|||
161895681|NCT05052697|584666415|FG008|Substudy A|Not vaccinated|1|||
161895682|NCT05052697|584666416|FG009|Substudy A|Not vaccinated|0|||
161895683|NCT05052697|584666417|FG010|Substudy A|Not vaccinated|0|||
161895684|NCT05052697|584666418|FG011|Substudy A|Not vaccinated|0|||
161895685|NCT05052697|584666419|FG012|Substudy A|Not vaccinated|0|||
161895686|NCT05052697|584666420|FG013|Substudy A|Not vaccinated|0|||
161895687|NCT05052697|584666421|FG014|Substudy A|Not vaccinated|0|||
161895688|NCT05052697|584666422|FG015|Substudy A|Not vaccinated|0|||
161895689|NCT05052697|584666423|FG016|Substudy A|Not vaccinated|0|||
161781262|NCT04822701|584242037|FG001|Overall Study|Lost to Follow-up|0|||
161781263|NCT04822701|584242036|FG000|Overall Study|Withdrawal by Subject|1|||
161781264|NCT04822701|584242037|FG001|Overall Study|Withdrawal by Subject|0|||
161895690|NCT05052697|584666424|FG017|Substudy A|Not vaccinated|0|||
161895691|NCT05052697|584666425|FG018|Substudy A|Not vaccinated|0|||
161895692|NCT05052697|584666426|FG019|Substudy A|Not vaccinated|0|||
161895693|NCT05052697|584666427|FG020|Substudy A|Not vaccinated|0|||
161895694|NCT05052697|584666428|FG021|Substudy A|Not vaccinated|0|||
161895695|NCT05052697|584666429|FG022|Substudy A|Not vaccinated|0|||
161895696|NCT05052697|584666430|FG023|Substudy A|Not vaccinated|0|||
161895697|NCT05052697|584666431|FG024|Substudy A|Not vaccinated|0|||
161895698|NCT05052697|584666432|FG025|Substudy A|Not vaccinated|0|||
161895699|NCT05052697|584666433|FG026|Substudy A|Not vaccinated|0|||
161895700|NCT05052697|584666434|FG027|Substudy A|Not vaccinated|0|||
161895701|NCT05052697|584666435|FG028|Substudy A|Not vaccinated|0|||
161895702|NCT05052697|584666436|FG029|Substudy A|Not vaccinated|0|||
161895703|NCT05052697|584666437|FG030|Substudy A|Not vaccinated|0|||
161895704|NCT05052697|584666438|FG031|Substudy A|Not vaccinated|0|||
161895705|NCT05052697|584666439|FG032|Substudy A|Not vaccinated|0|||
161895706|NCT05052697|584666440|FG033|Substudy A|Not vaccinated|0|||
162009356|NCT03224819|585090112|FG002|Overall Study|Sponsor Decision|0|||
161895707|NCT05052697|584666407|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895708|NCT05052697|584666408|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895709|NCT05052697|584666409|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895710|NCT05052697|584666410|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895711|NCT05052697|584666411|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895712|NCT05052697|584666412|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895713|NCT05052697|584666413|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895714|NCT05052697|584666414|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895715|NCT05052697|584666415|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895716|NCT05052697|584666416|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895717|NCT05052697|584666417|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895718|NCT05052697|584666418|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895719|NCT05052697|584666419|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895720|NCT05052697|584666420|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895721|NCT05052697|584666421|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895722|NCT05052697|584666422|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895723|NCT05052697|584666423|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895724|NCT05052697|584666424|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895725|NCT05052697|584666425|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
161895726|NCT05052697|584666426|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
161895727|NCT05052697|584666427|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895728|NCT05052697|584666428|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
161895729|NCT05052697|584666429|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
161895730|NCT05052697|584666430|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895731|NCT05052697|584666431|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895732|NCT05052697|584666432|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895733|NCT05052697|584666433|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895734|NCT05052697|584666434|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895735|NCT05052697|584666435|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895736|NCT05052697|584666436|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895737|NCT05052697|584666437|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895738|NCT05052697|584666438|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895739|NCT05052697|584666439|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895740|NCT05052697|584666440|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161895741|NCT05052697|584666407|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895742|NCT05052697|584666408|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895743|NCT05052697|584666409|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895744|NCT05052697|584666410|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
161781265|NCT02706353|584242038|FG000|Dose Level 1|Disease Progression|1|||
161781266|NCT02706353|584242039|FG001|Dose Level 1|Disease Progression|0|||
161781267|NCT02706353|584242040|FG002|Dose Level 1|Disease Progression|0|||
161781268|NCT02706353|584242041|FG003|Dose Level 1|Disease Progression|0|||
161781269|NCT02706353|584242042|FG004|Dose Level 1|Disease Progression|0|||
161781270|NCT02706353|584242043|FG005|Dose Level 1|Disease Progression|0|||
161781271|NCT02706353|584242038|FG000|Dose Level 3|Disease Progression|0|||
161781272|NCT02706353|584242039|FG001|Dose Level 3|Disease Progression|0|||
161781273|NCT02706353|584242040|FG002|Dose Level 3|Disease Progression|2|||
161781274|NCT02706353|584242041|FG003|Dose Level 3|Disease Progression|0|||
161781275|NCT02706353|584242042|FG004|Dose Level 3|Disease Progression|0|||
161895745|NCT05052697|584666411|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
162009357|NCT03224819|585090113|FG003|Overall Study|Sponsor Decision|1|||
161781276|NCT02706353|584242043|FG005|Dose Level 3|Disease Progression|0|||
161781277|NCT02706353|584242038|FG000|Dose Level 4|Disease Progression|0|||
161781278|NCT02706353|584242039|FG001|Dose Level 4|Disease Progression|0|||
162009358|NCT03224819|585090114|FG004|Overall Study|Sponsor Decision|1|||
162009359|NCT03224819|585090115|FG005|Overall Study|Sponsor Decision|2|||
162009360|NCT03224819|585090116|FG006|Overall Study|Sponsor Decision|1|||
162009361|NCT03224819|585090117|FG007|Overall Study|Sponsor Decision|1|||
162009362|NCT03224819|585090118|FG008|Overall Study|Sponsor Decision|1|||
162009363|NCT03224819|585090119|FG009|Overall Study|Sponsor Decision|2|||
162009364|NCT03224819|585090120|FG010|Overall Study|Sponsor Decision|1|||
162009365|NCT03224819|585090121|FG011|Overall Study|Sponsor Decision|1|||
162009366|NCT03224819|585090122|FG012|Overall Study|Sponsor Decision|1|||
162009367|NCT03224819|585090123|FG013|Overall Study|Sponsor Decision|0|||
162009368|NCT03224819|585090110|FG000|Overall Study|Lost to Follow-up|0|||
162009369|NCT03224819|585090111|FG001|Overall Study|Lost to Follow-up|0|||
162009370|NCT03224819|585090112|FG002|Overall Study|Lost to Follow-up|0|||
162009371|NCT03224819|585090113|FG003|Overall Study|Lost to Follow-up|0|||
162009372|NCT03224819|585090114|FG004|Overall Study|Lost to Follow-up|0|||
162009373|NCT03224819|585090115|FG005|Overall Study|Lost to Follow-up|0|||
161895746|NCT05052697|584666412|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895747|NCT05052697|584666413|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895748|NCT05052697|584666414|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895749|NCT05052697|584666415|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895750|NCT05052697|584666416|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895751|NCT05052697|584666417|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895752|NCT05052697|584666418|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895753|NCT05052697|584666419|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895754|NCT05052697|584666420|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895755|NCT05052697|584666421|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895756|NCT05052697|584666422|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895757|NCT05052697|584666423|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895758|NCT05052697|584666424|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
161895759|NCT05052697|584666425|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895760|NCT05052697|584666426|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895761|NCT05052697|584666427|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895762|NCT05052697|584666428|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895763|NCT05052697|584666429|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895764|NCT05052697|584666430|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895765|NCT05052697|584666431|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895766|NCT05052697|584666432|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895767|NCT05052697|584666433|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895768|NCT05052697|584666434|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895769|NCT05052697|584666435|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895770|NCT05052697|584666436|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895771|NCT05052697|584666437|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895772|NCT05052697|584666438|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895773|NCT05052697|584666439|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895774|NCT05052697|584666440|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
161895775|NCT05052697|584666407|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895776|NCT05052697|584666408|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895777|NCT05052697|584666409|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895778|NCT05052697|584666410|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895779|NCT05052697|584666411|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895780|NCT05052697|584666412|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895781|NCT05052697|584666413|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895782|NCT05052697|584666414|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895783|NCT05052697|584666415|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895784|NCT05052697|584666416|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895785|NCT05052697|584666417|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895786|NCT05052697|584666418|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895787|NCT05052697|584666419|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895788|NCT05052697|584666420|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895789|NCT05052697|584666421|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895790|NCT05052697|584666422|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895791|NCT05052697|584666423|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895792|NCT05052697|584666424|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895793|NCT05052697|584666425|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895794|NCT05052697|584666426|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
161781279|NCT02706353|584242040|FG002|Dose Level 4|Disease Progression|0|||
161781280|NCT02706353|584242041|FG003|Dose Level 4|Disease Progression|1|||
161781281|NCT02706353|584242042|FG004|Dose Level 4|Disease Progression|0|||
161781282|NCT02706353|584242043|FG005|Dose Level 4|Disease Progression|0|||
161781283|NCT02706353|584242038|FG000|Dose Level 4|Toxicity|0|||
161781284|NCT02706353|584242039|FG001|Dose Level 4|Toxicity|0|||
161781285|NCT02706353|584242040|FG002|Dose Level 4|Toxicity|0|||
161781286|NCT02706353|584242041|FG003|Dose Level 4|Toxicity|1|||
161781287|NCT02706353|584242042|FG004|Dose Level 4|Toxicity|0|||
161781288|NCT02706353|584242043|FG005|Dose Level 4|Toxicity|0|||
161781289|NCT02706353|584242038|FG000|Dose Level 4|Death|0|||
161781290|NCT02706353|584242039|FG001|Dose Level 4|Death|0|||
161781291|NCT02706353|584242040|FG002|Dose Level 4|Death|0|||
161781292|NCT02706353|584242041|FG003|Dose Level 4|Death|1|||
161781293|NCT02706353|584242042|FG004|Dose Level 4|Death|0|||
161781294|NCT02706353|584242043|FG005|Dose Level 4|Death|0|||
161781295|NCT02706353|584242038|FG000|Dose Level 5|Toxicity|0|||
161781296|NCT02706353|584242039|FG001|Dose Level 5|Toxicity|0|||
161781297|NCT02706353|584242040|FG002|Dose Level 5|Toxicity|0|||
161781298|NCT02706353|584242041|FG003|Dose Level 5|Toxicity|0|||
161781299|NCT02706353|584242042|FG004|Dose Level 5|Toxicity|1|||
161781300|NCT02706353|584242043|FG005|Dose Level 5|Toxicity|0|||
161781301|NCT02706353|584242038|FG000|Dose Level 5|Disease Progression|0|||
161781302|NCT02706353|584242039|FG001|Dose Level 5|Disease Progression|0|||
161781303|NCT02706353|584242040|FG002|Dose Level 5|Disease Progression|0|||
161781304|NCT02706353|584242041|FG003|Dose Level 5|Disease Progression|0|||
161781305|NCT02706353|584242042|FG004|Dose Level 5|Disease Progression|3|||
161781306|NCT02706353|584242043|FG005|Dose Level 5|Disease Progression|2|||
161781307|NCT02706353|584242038|FG000|Dose Level 5|Death|0|||
161781308|NCT02706353|584242039|FG001|Dose Level 5|Death|0|||
161781309|NCT02706353|584242040|FG002|Dose Level 5|Death|0|||
161781310|NCT02706353|584242041|FG003|Dose Level 5|Death|0|||
161781311|NCT02706353|584242042|FG004|Dose Level 5|Death|1|||
161781312|NCT02706353|584242043|FG005|Dose Level 5|Death|6|||
161781313|NCT02706353|584242038|FG000|Dose Level 5|Withdrawal by Subject|0|||
161781314|NCT02706353|584242039|FG001|Dose Level 5|Withdrawal by Subject|0|||
161781315|NCT02706353|584242040|FG002|Dose Level 5|Withdrawal by Subject|0|||
161781316|NCT02706353|584242041|FG003|Dose Level 5|Withdrawal by Subject|0|||
161781317|NCT02706353|584242042|FG004|Dose Level 5|Withdrawal by Subject|0|||
161781318|NCT02706353|584242043|FG005|Dose Level 5|Withdrawal by Subject|2|||
161781319|NCT03560466|584242044|FG000|Overall Study|Adverse Event|1|||
161781320|NCT03560466|584242045|FG001|Overall Study|Adverse Event|2|||
161895795|NCT05052697|584666427|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161781321|NCT03560466|584242046|FG002|Overall Study|Adverse Event|0|||
161781322|NCT03560466|584242044|FG000|Overall Study|Poor Compliance to Protocol|0|||
161781323|NCT03560466|584242045|FG001|Overall Study|Poor Compliance to Protocol|2|||
161781324|NCT03560466|584242046|FG002|Overall Study|Poor Compliance to Protocol|0|||
161781325|NCT03560466|584242044|FG000|Overall Study|Other|6|||
161781326|NCT03560466|584242045|FG001|Overall Study|Other|8|||
161781327|NCT03560466|584242046|FG002|Overall Study|Other|1|||
161781328|NCT01190098|584243623|FG000|Overall Study|Adverse Event|2|||
161781329|NCT01190098|584243624|FG001|Overall Study|Adverse Event|0|||
161781330|NCT01190098|584243623|FG000|Overall Study|Patient coomorbidity|0|||
161781331|NCT01190098|584243624|FG001|Overall Study|Patient coomorbidity|1|||
161781332|NCT01190098|584243623|FG000|Overall Study|Lack of transportation|1|||
161895796|NCT05052697|584666428|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895797|NCT05052697|584666429|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895798|NCT05052697|584666430|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895799|NCT05052697|584666431|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895800|NCT05052697|584666432|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895801|NCT05052697|584666433|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895802|NCT05052697|584666434|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895803|NCT05052697|584666435|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895804|NCT05052697|584666436|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895805|NCT05052697|584666437|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895806|NCT05052697|584666438|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895807|NCT05052697|584666439|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895808|NCT05052697|584666440|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161895809|NCT05052697|584666407|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895810|NCT05052697|584666408|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895811|NCT05052697|584666409|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895812|NCT05052697|584666410|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895813|NCT05052697|584666411|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895814|NCT05052697|584666412|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895815|NCT05052697|584666413|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895816|NCT05052697|584666414|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895817|NCT05052697|584666415|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895818|NCT05052697|584666416|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895819|NCT05052697|584666417|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895820|NCT05052697|584666418|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895821|NCT05052697|584666419|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895822|NCT05052697|584666420|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895823|NCT05052697|584666421|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895824|NCT05052697|584666422|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895825|NCT05052697|584666423|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895826|NCT05052697|584666424|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
161895827|NCT05052697|584666425|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895828|NCT05052697|584666426|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895829|NCT05052697|584666427|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895830|NCT05052697|584666428|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895831|NCT05052697|584666429|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895832|NCT05052697|584666430|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895833|NCT05052697|584666431|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895834|NCT05052697|584666432|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
161895835|NCT05052697|584666433|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895836|NCT05052697|584666434|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
161895837|NCT05052697|584666435|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895838|NCT05052697|584666436|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895839|NCT05052697|584666437|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895840|NCT05052697|584666438|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895841|NCT05052697|584666439|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895842|NCT05052697|584666440|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161895843|NCT05052697|584666407|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895844|NCT05052697|584666408|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895845|NCT05052697|584666409|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895846|NCT05052697|584666410|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895847|NCT05052697|584666411|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895848|NCT05052697|584666412|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895849|NCT05052697|584666413|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895850|NCT05052697|584666414|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895851|NCT05052697|584666415|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895852|NCT05052697|584666416|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895853|NCT05052697|584666417|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895854|NCT05052697|584666418|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895855|NCT05052697|584666419|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895856|NCT05052697|584666420|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895857|NCT05052697|584666421|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161781333|NCT01190098|584243624|FG001|Overall Study|Lack of transportation|0|||
161781334|NCT01190098|584243623|FG000|Overall Study|Other|0|||
161781335|NCT01190098|584243624|FG001|Overall Study|Other|1|||
161781336|NCT04723173|584243629|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
161781337|NCT02996448|584243630|FG000|Overall Study|Study terminated due to adverse effects|3|||
161781338|NCT00606801|584243631|FG000|Intervention|Protocol Violation|3|||
161781339|NCT00606801|584243632|FG001|Intervention|Protocol Violation|3|||
161781340|NCT02082262|584243633|FG000|Overall Study|Withdrawal by Subject|3|||
161781341|NCT02082262|584243633|FG000|Overall Study|Adverse Event|48|||
161781342|NCT01726335|584243638|FG000|Overall Study|Lost to Follow-up|2|||
161781343|NCT01726335|584243638|FG000|Overall Study|Withdrawal by Subject|15|||
161781344|NCT01726335|584243638|FG000|Overall Study|Adverse Event|4|||
161781345|NCT01726335|584243638|FG000|Overall Study|Lost to Follow-up|2|||
161781346|NCT01726335|584243638|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
161781347|NCT01586624|584243639|FG000|Overall Study|Adverse Event|3|||
161781348|NCT01586624|584243640|FG001|Overall Study|Adverse Event|0|||
161781349|NCT01586624|584243641|FG002|Overall Study|Adverse Event|2|||
161781350|NCT01586624|584243642|FG003|Overall Study|Adverse Event|1|||
161781351|NCT01586624|584243643|FG004|Overall Study|Adverse Event|3|||
161781352|NCT01586624|584243644|FG005|Overall Study|Adverse Event|3|||
161781353|NCT01586624|584243645|FG006|Overall Study|Adverse Event|2|||
161781354|NCT01586624|584243646|FG007|Overall Study|Adverse Event|3|||
161781355|NCT01586624|584243639|FG000|Overall Study|Physician Decision|0|||
161781356|NCT01586624|584243640|FG001|Overall Study|Physician Decision|1|||
161781357|NCT01586624|584243641|FG002|Overall Study|Physician Decision|1|||
161781358|NCT01586624|584243642|FG003|Overall Study|Physician Decision|0|||
161781359|NCT01586624|584243643|FG004|Overall Study|Physician Decision|2|||
161781360|NCT01586624|584243644|FG005|Overall Study|Physician Decision|0|||
161781361|NCT01586624|584243645|FG006|Overall Study|Physician Decision|1|||
161781362|NCT01586624|584243646|FG007|Overall Study|Physician Decision|1|||
161781363|NCT01586624|584243639|FG000|Overall Study|Withdrawal by Subject|0|||
161781364|NCT01586624|584243640|FG001|Overall Study|Withdrawal by Subject|0|||
161781365|NCT01586624|584243641|FG002|Overall Study|Withdrawal by Subject|0|||
161781366|NCT01586624|584243642|FG003|Overall Study|Withdrawal by Subject|1|||
161781367|NCT01586624|584243643|FG004|Overall Study|Withdrawal by Subject|0|||
161781368|NCT01586624|584243644|FG005|Overall Study|Withdrawal by Subject|0|||
161781369|NCT01586624|584243645|FG006|Overall Study|Withdrawal by Subject|0|||
161895858|NCT05052697|584666422|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895859|NCT05052697|584666423|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895860|NCT05052697|584666424|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895861|NCT05052697|584666425|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895862|NCT05052697|584666426|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895863|NCT05052697|584666427|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895864|NCT05052697|584666428|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895865|NCT05052697|584666429|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895866|NCT05052697|584666430|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161781370|NCT01586624|584243646|FG007|Overall Study|Withdrawal by Subject|0|||
161781371|NCT01586624|584243639|FG000|Overall Study|Evidence of disease progression|1|||
161781372|NCT01586624|584243640|FG001|Overall Study|Evidence of disease progression|3|||
161781373|NCT01586624|584243641|FG002|Overall Study|Evidence of disease progression|2|||
161781374|NCT01586624|584243642|FG003|Overall Study|Evidence of disease progression|5|||
161781375|NCT01586624|584243643|FG004|Overall Study|Evidence of disease progression|3|||
161781376|NCT01586624|584243644|FG005|Overall Study|Evidence of disease progression|5|||
161895867|NCT05052697|584666431|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895868|NCT05052697|584666432|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161781377|NCT01586624|584243645|FG006|Overall Study|Evidence of disease progression|4|||
161781378|NCT01586624|584243646|FG007|Overall Study|Evidence of disease progression|6|||
161781379|NCT01586624|584243639|FG000|Overall Study|Screen failure (no treatment received)|0|||
161781380|NCT01586624|584243640|FG001|Overall Study|Screen failure (no treatment received)|0|||
161781381|NCT01586624|584243641|FG002|Overall Study|Screen failure (no treatment received)|0|||
161895869|NCT05052697|584666433|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895870|NCT05052697|584666434|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895871|NCT05052697|584666435|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
161895872|NCT05052697|584666436|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895873|NCT05052697|584666437|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
161895874|NCT05052697|584666438|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
161895875|NCT05052697|584666439|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
161895876|NCT05052697|584666440|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161895877|NCT05052697|584666407|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895878|NCT05052697|584666408|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895879|NCT05052697|584666409|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895880|NCT05052697|584666410|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895881|NCT05052697|584666411|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895882|NCT05052697|584666412|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895883|NCT05052697|584666413|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895884|NCT05052697|584666414|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895885|NCT05052697|584666415|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895886|NCT05052697|584666416|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895887|NCT05052697|584666417|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895888|NCT05052697|584666418|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895889|NCT05052697|584666419|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895890|NCT05052697|584666420|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895891|NCT05052697|584666421|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895892|NCT05052697|584666422|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895893|NCT05052697|584666423|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895894|NCT05052697|584666424|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895895|NCT05052697|584666425|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895896|NCT05052697|584666426|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895897|NCT05052697|584666427|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895898|NCT05052697|584666428|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895899|NCT05052697|584666429|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895900|NCT05052697|584666430|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895901|NCT05052697|584666431|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895902|NCT05052697|584666432|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895903|NCT05052697|584666433|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895904|NCT05052697|584666434|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895905|NCT05052697|584666435|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
161895906|NCT05052697|584666436|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
161895907|NCT05052697|584666437|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
161895908|NCT05052697|584666438|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
161895909|NCT05052697|584666439|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
161895910|NCT05052697|584666440|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161895911|NCT05052697|584666407|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
162009374|NCT03224819|585090116|FG006|Overall Study|Lost to Follow-up|0|||
161781382|NCT01586624|584243642|FG003|Overall Study|Screen failure (no treatment received)|0|||
161781383|NCT01586624|584243643|FG004|Overall Study|Screen failure (no treatment received)|0|||
161781384|NCT01586624|584243644|FG005|Overall Study|Screen failure (no treatment received)|0|||
161781385|NCT01586624|584243645|FG006|Overall Study|Screen failure (no treatment received)|1|||
161781386|NCT01586624|584243646|FG007|Overall Study|Screen failure (no treatment received)|0|||
161781387|NCT01796860|584243651|FG000|Overall Study|Withdrawal by Subject|3|||
161781388|NCT00647426|584243654|FG000|Overall Study|Withdrawal by Subject|2|||
161781389|NCT02748616|584243662|FG000|Overall Study|Lost to Follow-up|1|||
161781390|NCT02748616|584243662|FG000|Overall Study|Withdrawal by Subject|2|||
161781391|NCT02748616|584243662|FG000|Overall Study|Physician Decision|2|||
161781392|NCT02748616|584243662|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
161781393|NCT00068406|584243663|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
161781394|NCT00068406|584243663|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
161781395|NCT02018042|584243664|FG000|Overall Study|Withdrawal by Subject|1|||
161781396|NCT03231709|584243665|FG000|Treatment Period 1|Reason not Specified|0|||
161781397|NCT03231709|584243666|FG001|Treatment Period 1|Reason not Specified|1|||
161781398|NCT03231709|584243665|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
161781399|NCT03231709|584243666|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
161781400|NCT02609178|584243667|FG000|First Crown|Withdrawal by Subject|0|||
161781401|NCT02609178|584243668|FG001|First Crown|Withdrawal by Subject|0|||
161781402|NCT02609178|584243669|FG002|First Crown|Withdrawal by Subject|1|||
161781403|NCT02609178|584243670|FG003|First Crown|Withdrawal by Subject|1|||
161781404|NCT02609178|584243671|FG004|First Crown|Withdrawal by Subject|0|||
161895912|NCT05052697|584666408|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895913|NCT05052697|584666409|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895914|NCT05052697|584666410|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895915|NCT05052697|584666411|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161781405|NCT02609178|584243672|FG005|First Crown|Withdrawal by Subject|0|||
161781406|NCT02419469|584243673|FG000|Overall Study|Withdrawal by Subject|1|||
161781407|NCT01785875|584243674|FG000|Overall Study|Withdrawal by Subject|41|||
161781408|NCT01785875|584243675|FG001|Overall Study|Withdrawal by Subject|34|||
161781409|NCT01785875|584243676|FG002|Overall Study|Withdrawal by Subject|36|||
161781410|NCT01785875|584243674|FG000|Overall Study|Lost to Follow-up|19|||
161781411|NCT01785875|584243675|FG001|Overall Study|Lost to Follow-up|22|||
161781412|NCT01785875|584243676|FG002|Overall Study|Lost to Follow-up|6|||
161781413|NCT01785875|584243674|FG000|Overall Study|Death|27|||
161781414|NCT01785875|584243675|FG001|Overall Study|Death|16|||
161781415|NCT01785875|584243676|FG002|Overall Study|Death|7|||
161781416|NCT01785875|584243674|FG000|Overall Study|Sponsor Decision|0|||
161781417|NCT01785875|584243675|FG001|Overall Study|Sponsor Decision|2|||
161781418|NCT01785875|584243676|FG002|Overall Study|Sponsor Decision|0|||
161781419|NCT01785875|584243674|FG000|Overall Study|Protocol Specified Criteria|207|||
161781420|NCT01785875|584243675|FG001|Overall Study|Protocol Specified Criteria|214|||
161781421|NCT01785875|584243676|FG002|Overall Study|Protocol Specified Criteria|55|||
161781422|NCT01785875|584243674|FG000|Overall Study|Missing|0|||
161781423|NCT01785875|584243675|FG001|Overall Study|Missing|1|||
161781424|NCT01785875|584243676|FG002|Overall Study|Missing|3|||
161781425|NCT01414062|584243679|FG000|Overall Study|Lost to Follow-up|3|||
161781426|NCT01414062|584243680|FG001|Overall Study|Lost to Follow-up|2|||
161781427|NCT01414062|584243679|FG000|Overall Study|Left Country|1|||
161781428|NCT01414062|584243680|FG001|Overall Study|Left Country|1|||
161781429|NCT01414062|584243679|FG000|Overall Study|Family Disapproval|1|||
161781430|NCT01414062|584243680|FG001|Overall Study|Family Disapproval|0|||
161781431|NCT01414062|584243679|FG000|Overall Study|Withdrawal by Subject|0|||
161781432|NCT01414062|584243680|FG001|Overall Study|Withdrawal by Subject|1|||
161781433|NCT04075292|584243681|FG000|Overall Study|Withdrawal by Subject|1|||
161781434|NCT04075292|584243682|FG001|Overall Study|Withdrawal by Subject|9|||
161781435|NCT04075292|584243681|FG000|Overall Study|Death|2|||
161781436|NCT04075292|584243682|FG001|Overall Study|Death|5|||
161781437|NCT04075292|584243681|FG000|Overall Study|Remained on study at time of DCO|74|||
161781438|NCT04075292|584243682|FG001|Overall Study|Remained on study at time of DCO|64|||
161781439|NCT00902265|584243685|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
161781440|NCT00902265|584243685|FG000|Overall Study|Adverse Event|2|||
161781441|NCT00902265|584243685|FG000|Overall Study|Lack of Efficacy|2|||
161781442|NCT00902265|584243685|FG000|Overall Study|Protocol Violation|1|||
161781443|NCT02866695|584243687|FG000|Overall Study|Adverse Event|1|||
161781444|NCT02866695|584243687|FG000|Overall Study|Lost to Follow-up|1|||
161781445|NCT05016765|584243688|FG000|Overall Study|Lost to Follow-up|4|||
161781446|NCT01988493|584243691|FG000|Overall Study|Randomized but not treated|0|||
161781447|NCT01988493|584243692|FG001|Overall Study|Randomized but not treated|0|||
161781448|NCT01988493|584243693|FG002|Overall Study|Randomized but not treated|0|||
161781449|NCT01988493|584243694|FG003|Overall Study|Randomized but not treated|0|||
161781450|NCT01988493|584243695|FG004|Overall Study|Randomized but not treated|1|||
161781451|NCT00185731|584243700|FG000|Overall Study|Withdrawal by Subject|1|||
161781452|NCT00185731|584243700|FG000|Overall Study|Not Eligible|1|||
161781453|NCT03087773|584243701|FG000|Overall Study|Withdrawal by Subject|8|||
161781454|NCT03087773|584243702|FG001|Overall Study|Withdrawal by Subject|4|||
161781455|NCT03087773|584243701|FG000|Overall Study|Lost to Follow-up|12|||
161781456|NCT03087773|584243702|FG001|Overall Study|Lost to Follow-up|8|||
161781457|NCT05144477|584243705|FG000|Overall Study|Withdrawal by Subject|1|||
161781458|NCT05144477|584243706|FG001|Overall Study|Withdrawal by Subject|1|||
161781459|NCT01787188|584243709|FG000|Overall Study|Adverse Event|2|||
161781460|NCT01787188|584243710|FG001|Overall Study|Adverse Event|4|||
161781461|NCT01787188|584243711|FG002|Overall Study|Adverse Event|6|||
161781462|NCT01787188|584243709|FG000|Overall Study|Lack of Efficacy|7|||
161781463|NCT01787188|584243710|FG001|Overall Study|Lack of Efficacy|3|||
161781464|NCT01787188|584243711|FG002|Overall Study|Lack of Efficacy|5|||
161781465|NCT01787188|584243709|FG000|Overall Study|Non-compliance with Study Drug|0|||
161781466|NCT01787188|584243710|FG001|Overall Study|Non-compliance with Study Drug|1|||
161781467|NCT01787188|584243711|FG002|Overall Study|Non-compliance with Study Drug|0|||
161781468|NCT01787188|584243709|FG000|Overall Study|Withdrawal by Subject|4|||
161781469|NCT01787188|584243710|FG001|Overall Study|Withdrawal by Subject|3|||
161781470|NCT01787188|584243711|FG002|Overall Study|Withdrawal by Subject|2|||
161781471|NCT01787188|584243709|FG000|Overall Study|Protocol Violation|3|||
161781472|NCT01787188|584243710|FG001|Overall Study|Protocol Violation|2|||
161781473|NCT01787188|584243711|FG002|Overall Study|Protocol Violation|3|||
161895916|NCT05052697|584666412|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161781474|NCT01787188|584243709|FG000|Overall Study|Lost to Follow-up|1|||
161781475|NCT01787188|584243710|FG001|Overall Study|Lost to Follow-up|2|||
161781476|NCT01787188|584243711|FG002|Overall Study|Lost to Follow-up|2|||
161781477|NCT01787188|584243709|FG000|Overall Study|Other, including patient moved|0|||
161781478|NCT01787188|584243710|FG001|Overall Study|Other, including patient moved|3|||
161781479|NCT01787188|584243711|FG002|Overall Study|Other, including patient moved|0|||
161781480|NCT00854607|584243712|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
161781481|NCT01783483|584243718|FG000|Overall Study|Death|3|||
161895917|NCT05052697|584666413|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895918|NCT05052697|584666414|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895919|NCT05052697|584666415|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895920|NCT05052697|584666416|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895921|NCT05052697|584666417|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895922|NCT05052697|584666418|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895923|NCT05052697|584666419|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895924|NCT05052697|584666420|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895925|NCT05052697|584666421|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895926|NCT05052697|584666422|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895927|NCT05052697|584666423|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895928|NCT05052697|584666424|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895929|NCT05052697|584666425|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895930|NCT05052697|584666426|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895931|NCT05052697|584666427|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895932|NCT05052697|584666428|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895933|NCT05052697|584666429|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895934|NCT05052697|584666430|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895935|NCT05052697|584666431|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895936|NCT05052697|584666432|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895937|NCT05052697|584666433|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895938|NCT05052697|584666434|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895939|NCT05052697|584666435|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895940|NCT05052697|584666436|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895941|NCT05052697|584666437|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895942|NCT05052697|584666438|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895943|NCT05052697|584666439|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
161895944|NCT05052697|584666440|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161895945|NCT05052697|584666407|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895946|NCT05052697|584666408|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895947|NCT05052697|584666409|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895948|NCT05052697|584666410|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895949|NCT05052697|584666411|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895950|NCT05052697|584666412|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895951|NCT05052697|584666413|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895952|NCT05052697|584666414|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895953|NCT05052697|584666415|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895954|NCT05052697|584666416|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895955|NCT05052697|584666417|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895956|NCT05052697|584666418|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895957|NCT05052697|584666419|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895958|NCT05052697|584666420|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895959|NCT05052697|584666421|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895960|NCT05052697|584666422|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895961|NCT05052697|584666423|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895962|NCT05052697|584666424|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895963|NCT05052697|584666425|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895964|NCT05052697|584666426|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895965|NCT05052697|584666427|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895966|NCT05052697|584666428|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895967|NCT05052697|584666429|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895968|NCT05052697|584666430|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895969|NCT05052697|584666431|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895970|NCT05052697|584666432|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895971|NCT05052697|584666433|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895972|NCT05052697|584666434|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895973|NCT05052697|584666435|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
161895974|NCT05052697|584666436|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
161895975|NCT05052697|584666437|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
161895976|NCT05052697|584666438|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895977|NCT05052697|584666439|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895978|NCT05052697|584666440|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161895979|NCT01249833|584666441|FG000|Overall Study|Lost to Follow-up|0|||
161895980|NCT01249833|584666442|FG001|Overall Study|Lost to Follow-up|1|||
161895981|NCT03796676|584666443|FG000|Overall Study|Adverse Event|2|||
161895982|NCT03796676|584666444|FG001|Overall Study|Adverse Event|1|||
161895983|NCT03796676|584666445|FG002|Overall Study|Adverse Event|2|||
161895984|NCT03796676|584666443|FG000|Overall Study|Lost to Follow-up|2|||
161895985|NCT03796676|584666444|FG001|Overall Study|Lost to Follow-up|1|||
161781482|NCT01783483|584243719|FG001|Overall Study|Death|3|||
161781483|NCT01783483|584243718|FG000|Overall Study|Lost to Follow-up|14|||
161781484|NCT01783483|584243719|FG001|Overall Study|Lost to Follow-up|10|||
161781485|NCT01783483|584243718|FG000|Overall Study|Withdrawal by Subject|2|||
161781486|NCT01783483|584243719|FG001|Overall Study|Withdrawal by Subject|1|||
161781487|NCT01783483|584243718|FG000|Overall Study|Physician Decision|1|||
161781488|NCT01783483|584243719|FG001|Overall Study|Physician Decision|1|||
161781489|NCT02268045|584243720|FG000|Overall Study|Death|4|||
161781490|NCT02268045|584243721|FG001|Overall Study|Death|4|||
161781491|NCT02268045|584243720|FG000|Overall Study|Disease Progression|2|||
161781492|NCT02268045|584243721|FG001|Overall Study|Disease Progression|1|||
161781493|NCT02268045|584243720|FG000|Overall Study|Adverse Event|7|||
161781494|NCT02268045|584243721|FG001|Overall Study|Adverse Event|7|||
161781495|NCT02268045|584243720|FG000|Overall Study|Withdrawal by Subject|2|||
161781496|NCT02268045|584243721|FG001|Overall Study|Withdrawal by Subject|6|||
161781497|NCT02268045|584243720|FG000|Overall Study|Physician Decision|0|||
161781498|NCT02268045|584243721|FG001|Overall Study|Physician Decision|1|||
161781499|NCT02268045|584243720|FG000|Overall Study|Protocol Violation|1|||
161781500|NCT02268045|584243721|FG001|Overall Study|Protocol Violation|1|||
161781501|NCT00835068|584243722|FG000|Overall Study|Death|1|||
161781502|NCT00835068|584243723|FG001|Overall Study|Death|0|||
161781503|NCT00835068|584243722|FG000|Overall Study|Adverse Event|0|||
161781504|NCT00835068|584243723|FG001|Overall Study|Adverse Event|1|||
161781505|NCT00835068|584243722|FG000|Overall Study|Other|8|||
161781506|NCT00835068|584243723|FG001|Overall Study|Other|0|||
161781507|NCT00835068|584243722|FG000|Overall Study|Withdrawal by Subject|1|||
161781508|NCT00835068|584243723|FG001|Overall Study|Withdrawal by Subject|0|||
161781509|NCT01308762|584243724|FG000|Overall Study|Protocol Violation|0|||
161781510|NCT01308762|584243725|FG001|Overall Study|Protocol Violation|1|||
161781511|NCT01308762|584243726|FG002|Overall Study|Protocol Violation|0|||
161781512|NCT00646282|584243727|FG000|Overall Study|Protocol terminated|4|||
161781513|NCT00646282|584243728|FG001|Overall Study|Protocol terminated|4|||
162122877|NCT00744237|585502347|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
162122878|NCT00744237|585502348|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
162122879|NCT00744237|585502349|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
162122880|NCT00744237|585502347|FG000|Overall Study|Dosing Error|1|||
162122881|NCT00744237|585502348|FG001|Overall Study|Dosing Error|0|||
162122882|NCT00744237|585502349|FG002|Overall Study|Dosing Error|1|||
162122883|NCT00744237|585502347|FG000|Overall Study|Study Drug Error|1|||
162122884|NCT00744237|585502348|FG001|Overall Study|Study Drug Error|0|||
162122885|NCT00744237|585502349|FG002|Overall Study|Study Drug Error|0|||
162122886|NCT00744237|585502347|FG000|Overall Study|Prohibited Concomitant Medication|0|||
162122887|NCT00744237|585502348|FG001|Overall Study|Prohibited Concomitant Medication|0|||
162122888|NCT00744237|585502349|FG002|Overall Study|Prohibited Concomitant Medication|1|||
162122889|NCT00744237|585502347|FG000|Overall Study|Poor Compliance|0|||
162122890|NCT00744237|585502348|FG001|Overall Study|Poor Compliance|2|||
162122891|NCT00744237|585502349|FG002|Overall Study|Poor Compliance|0|||
161781514|NCT01556490|584243729|FG000|Randomized Patients Summary|Protocol Violation|22|||
161781515|NCT01556490|584243730|FG001|Randomized Patients Summary|Protocol Violation|23|||
161781516|NCT01556490|584243729|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
161781517|NCT01556490|584243730|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
161781518|NCT02058368|584243732|FG000|Overall Study|Adverse Event|15|||
161781519|NCT02058368|584243733|FG001|Overall Study|Adverse Event|20|||
161781520|NCT02058368|584243732|FG000|Overall Study|Lack of Efficacy|0|||
161781521|NCT02058368|584243733|FG001|Overall Study|Lack of Efficacy|1|||
161781522|NCT02058368|584243732|FG000|Overall Study|Protocol Violation|0|||
161781523|NCT02058368|584243733|FG001|Overall Study|Protocol Violation|4|||
161781524|NCT02058368|584243732|FG000|Overall Study|Lost to Follow-up|2|||
161781525|NCT02058368|584243733|FG001|Overall Study|Lost to Follow-up|0|||
161781526|NCT02058368|584243732|FG000|Overall Study|Physician Decision|2|||
161781527|NCT02058368|584243733|FG001|Overall Study|Physician Decision|3|||
161781528|NCT02058368|584243732|FG000|Overall Study|Withdrawal by Subject|22|||
161781529|NCT02058368|584243733|FG001|Overall Study|Withdrawal by Subject|26|||
161781530|NCT02181842|584243735|FG000|Overall Study|Case Report Forms Uncollected|2|||
161781531|NCT01652872|584243736|FG000|Overall Study|Death|36|||
161781532|NCT01652872|584243737|FG001|Overall Study|Death|39|||
161781533|NCT01652872|584243736|FG000|Overall Study|Lost to Follow-up|28|||
161781534|NCT01652872|584243737|FG001|Overall Study|Lost to Follow-up|23|||
161781535|NCT01652872|584243736|FG000|Overall Study|Decision by sponsor|5|||
161781536|NCT01652872|584243737|FG001|Overall Study|Decision by sponsor|7|||
161781537|NCT01652872|584243736|FG000|Overall Study|Withdrawal by Subject|76|||
161781538|NCT01652872|584243737|FG001|Overall Study|Withdrawal by Subject|84|||
161781539|NCT00758706|584243738|FG000|Overall Study|Adverse Event|4|||
161781540|NCT00758706|584243739|FG001|Overall Study|Adverse Event|4|||
161781541|NCT03985293|584243743|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
161781542|NCT03985293|584243744|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
161781543|NCT03985293|584243745|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
162122892|NCT00744237|585502347|FG000|Overall Study|Administrative. Site Closed|1|||
161781544|NCT03985293|584243746|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
161781545|NCT03985293|584243747|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
161781546|NCT03985293|584243748|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
161781547|NCT03985293|584243743|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
161781548|NCT03985293|584243744|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
161781549|NCT03985293|584243745|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
161781550|NCT03985293|584243746|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
161781551|NCT03985293|584243747|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
161781552|NCT03985293|584243748|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
161781553|NCT03985293|584243743|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
161781554|NCT03985293|584243744|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
161781555|NCT03985293|584243745|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
161781556|NCT03985293|584243746|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
161781557|NCT03985293|584243747|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
161781558|NCT03985293|584243748|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
161781559|NCT03985293|584243743|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
161781560|NCT03985293|584243744|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
161781561|NCT03985293|584243745|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
161781562|NCT03985293|584243746|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
161781563|NCT03985293|584243747|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
161781564|NCT03985293|584243748|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
161781565|NCT03985293|584243743|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
161781566|NCT03985293|584243744|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
161781567|NCT03985293|584243745|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
161781568|NCT03985293|584243746|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
161781569|NCT03985293|584243747|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
161781570|NCT03985293|584243748|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
161781571|NCT03985293|584243743|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
161781572|NCT03985293|584243744|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
161781573|NCT03985293|584243745|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
161781574|NCT03985293|584243746|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
161781575|NCT03985293|584243747|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
161781576|NCT03985293|584243748|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
161781577|NCT03985293|584243743|FG000|FOLLOW-UP|Lost to Follow-up|0|||
161781578|NCT03985293|584243744|FG001|FOLLOW-UP|Lost to Follow-up|0|||
161781579|NCT03985293|584243745|FG002|FOLLOW-UP|Lost to Follow-up|1|||
161781580|NCT03985293|584243746|FG003|FOLLOW-UP|Lost to Follow-up|0|||
161781581|NCT03985293|584243747|FG004|FOLLOW-UP|Lost to Follow-up|0|||
161781582|NCT03985293|584243748|FG005|FOLLOW-UP|Lost to Follow-up|0|||
161781583|NCT02588651|584243749|FG000|Overall Study|Adverse Event|1|||
161781584|NCT02588651|584243749|FG000|Overall Study|Withdrawal by Subject|2|||
161781585|NCT02588651|584243749|FG000|Overall Study|Death|1|||
161781586|NCT02588651|584243749|FG000|Overall Study|Lack of Efficacy|13|||
161781587|NCT02588651|584243749|FG000|Overall Study|Lost to Follow-up|1|||
161781588|NCT02588651|584243749|FG000|Overall Study|Physician Decision|1|||
161781589|NCT02588651|584243749|FG000|Overall Study|Disease progression|2|||
161781590|NCT05899218|584243750|FG000|Overall Study|Lost to Follow-up|2|||
161781591|NCT05899218|584243751|FG001|Overall Study|Lost to Follow-up|2|||
161781592|NCT05899218|584243750|FG000|Overall Study|deemed ineligible out of country|1|||
161781593|NCT05899218|584243751|FG001|Overall Study|deemed ineligible out of country|0|||
161781594|NCT02587325|584243756|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
161781595|NCT02587325|584243757|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
161781596|NCT02587325|584243758|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
161781597|NCT02587325|584243759|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
161781598|NCT02587325|584243760|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
161781599|NCT02587325|584243756|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
161781600|NCT02587325|584243757|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
161781601|NCT02587325|584243758|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
161781602|NCT02587325|584243759|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
161781603|NCT02587325|584243760|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
161781604|NCT02587325|584243756|FG000|32-Week Optional Extension Part|Adverse Event|0|||
161895986|NCT03796676|584666445|FG002|Overall Study|Lost to Follow-up|0|||
161895987|NCT03796676|584666443|FG000|Overall Study|Protocol Violation|0|||
161895988|NCT03796676|584666444|FG001|Overall Study|Protocol Violation|0|||
161781605|NCT02587325|584243757|FG001|32-Week Optional Extension Part|Adverse Event|0|||
161781606|NCT02587325|584243758|FG002|32-Week Optional Extension Part|Adverse Event|1|||
161781607|NCT02587325|584243759|FG003|32-Week Optional Extension Part|Adverse Event|0|||
161781608|NCT02587325|584243760|FG004|32-Week Optional Extension Part|Adverse Event|0|||
161781609|NCT02587325|584243756|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
161781610|NCT02587325|584243757|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
161781611|NCT02587325|584243758|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
161895989|NCT03796676|584666445|FG002|Overall Study|Protocol Violation|1|||
161895990|NCT03796676|584666443|FG000|Overall Study|Withdrawal by Subject|1|||
161895991|NCT03796676|584666444|FG001|Overall Study|Withdrawal by Subject|1|||
161781612|NCT02587325|584243759|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
161781613|NCT02587325|584243760|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
162009375|NCT03224819|585090117|FG007|Overall Study|Lost to Follow-up|0|||
161781614|NCT00390572|584243761|FG000|Overall Study|Lost to Follow-up|8|||
161781615|NCT00390572|584243762|FG001|Overall Study|Lost to Follow-up|4|||
161781616|NCT00390572|584243761|FG000|Overall Study|health condition|0|||
161781617|NCT00390572|584243762|FG001|Overall Study|health condition|1|||
161781618|NCT03078192|584243793|FG000|Overall Study|Withdrawal by Subject|2|||
161781619|NCT03078192|584243794|FG001|Overall Study|Withdrawal by Subject|1|||
161781620|NCT03078192|584243793|FG000|Overall Study|screen failure|0|||
161781621|NCT03078192|584243794|FG001|Overall Study|screen failure|3|||
161781622|NCT01142466|584245748|FG000|Overall Study|Adverse Event|2|||
161781623|NCT01142466|584245749|FG001|Overall Study|Adverse Event|1|||
161781624|NCT01142466|584245748|FG000|Overall Study|Withdrawal by Subject|1|||
161781625|NCT01142466|584245749|FG001|Overall Study|Withdrawal by Subject|1|||
161781626|NCT02414854|584245750|FG000|Overall Study|Adverse Event|9|||
161781627|NCT02414854|584245751|FG001|Overall Study|Adverse Event|7|||
161781628|NCT02414854|584245752|FG002|Overall Study|Adverse Event|1|||
161781629|NCT02414854|584245753|FG003|Overall Study|Adverse Event|12|||
161781630|NCT02414854|584245750|FG000|Overall Study|Poor compliance to protocol|1|||
161781631|NCT02414854|584245751|FG001|Overall Study|Poor compliance to protocol|1|||
161781632|NCT02414854|584245752|FG002|Overall Study|Poor compliance to protocol|2|||
161781633|NCT02414854|584245753|FG003|Overall Study|Poor compliance to protocol|2|||
161781634|NCT02414854|584245750|FG000|Overall Study|Other than specified above|12|||
161781635|NCT02414854|584245751|FG001|Overall Study|Other than specified above|37|||
161781636|NCT02414854|584245752|FG002|Overall Study|Other than specified above|17|||
161781637|NCT02414854|584245753|FG003|Overall Study|Other than specified above|37|||
161781638|NCT01355523|584245754|FG000|Overall Study|Withdrawal by Subject|1|||
161781639|NCT01355523|584245755|FG001|Overall Study|Withdrawal by Subject|4|||
161781640|NCT01355523|584245754|FG000|Overall Study|Lost to Follow-up|0|||
161781641|NCT01355523|584245755|FG001|Overall Study|Lost to Follow-up|2|||
161781642|NCT01355523|584245754|FG000|Overall Study|Protocol Violation|0|||
161781643|NCT01355523|584245755|FG001|Overall Study|Protocol Violation|2|||
161781644|NCT01355523|584245754|FG000|Overall Study|Adverse Event|0|||
161781645|NCT01355523|584245755|FG001|Overall Study|Adverse Event|2|||
161781646|NCT00303316|584245756|FG000|Overall Study|Protocol Violation|1|||
161781647|NCT00303316|584245757|FG001|Overall Study|Protocol Violation|0|||
161781648|NCT00303316|584245756|FG000|Overall Study|Lost to Follow-up|0|||
161781649|NCT00303316|584245757|FG001|Overall Study|Lost to Follow-up|1|||
161781650|NCT00303316|584245756|FG000|Overall Study|Withdrawal by Subject|1|||
161781651|NCT00303316|584245757|FG001|Overall Study|Withdrawal by Subject|2|||
161781652|NCT01074307|584245759|FG000|Overall Study|No primary endpoint evaluation|14|||
161781653|NCT01074307|584245760|FG001|Overall Study|No primary endpoint evaluation|6|||
161781654|NCT01074307|584245759|FG000|Overall Study|Exclusion criterion|0|||
161781655|NCT01074307|584245760|FG001|Overall Study|Exclusion criterion|1|||
161781656|NCT01074307|584245759|FG000|Overall Study|Protocol Violation|8|||
161781657|NCT01074307|584245760|FG001|Overall Study|Protocol Violation|5|||
161781658|NCT01408576|584245765|FG000|Overall Study|Lack of Efficacy|17|||
161781659|NCT01408576|584245766|FG001|Overall Study|Lack of Efficacy|30|||
161781660|NCT01408576|584245767|FG002|Overall Study|Lack of Efficacy|48|||
161781661|NCT01408576|584245765|FG000|Overall Study|Protocol Violation|1|||
161781662|NCT01408576|584245766|FG001|Overall Study|Protocol Violation|2|||
161781663|NCT01408576|584245767|FG002|Overall Study|Protocol Violation|2|||
161781664|NCT01408576|584245765|FG000|Overall Study|Lost to Follow-up|10|||
161781665|NCT01408576|584245766|FG001|Overall Study|Lost to Follow-up|9|||
161781666|NCT01408576|584245767|FG002|Overall Study|Lost to Follow-up|17|||
161781667|NCT01408576|584245765|FG000|Overall Study|Withdrawal by Subject|34|||
161781668|NCT01408576|584245766|FG001|Overall Study|Withdrawal by Subject|60|||
161781669|NCT01408576|584245767|FG002|Overall Study|Withdrawal by Subject|66|||
161781670|NCT01408576|584245765|FG000|Overall Study|Sponsor terminated study|89|||
161781671|NCT01408576|584245766|FG001|Overall Study|Sponsor terminated study|333|||
161781672|NCT01408576|584245767|FG002|Overall Study|Sponsor terminated study|330|||
161781673|NCT01408576|584245765|FG000|Overall Study|AE, serious fatal|4|||
161781674|NCT01408576|584245766|FG001|Overall Study|AE, serious fatal|4|||
161781675|NCT01408576|584245767|FG002|Overall Study|AE, serious fatal|1|||
161781676|NCT01408576|584245765|FG000|Overall Study|SAE, non-fatal|11|||
161781677|NCT01408576|584245766|FG001|Overall Study|SAE, non-fatal|23|||
161781678|NCT01408576|584245767|FG002|Overall Study|SAE, non-fatal|14|||
161781679|NCT01408576|584245765|FG000|Overall Study|AE, non-serious non-fatal|12|||
161781680|NCT01408576|584245766|FG001|Overall Study|AE, non-serious non-fatal|19|||
161781681|NCT01408576|584245767|FG002|Overall Study|AE, non-serious non-fatal|11|||
161781682|NCT01408576|584245765|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
161781683|NCT01408576|584245766|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161781684|NCT01408576|584245767|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161781685|NCT01408576|584245765|FG000|Overall Study|AE, unknown type|0|||
161781686|NCT01408576|584245766|FG001|Overall Study|AE, unknown type|1|||
161781687|NCT01408576|584245767|FG002|Overall Study|AE, unknown type|0|||
161781688|NCT01408576|584245765|FG000|Overall Study|Other|10|||
161781689|NCT01408576|584245766|FG001|Overall Study|Other|16|||
161781690|NCT01408576|584245767|FG002|Overall Study|Other|18|||
161781691|NCT02703454|584245771|FG000|Overall Study|Not treated|1|||
161781692|NCT02703454|584245772|FG001|Overall Study|Not treated|3|||
161781693|NCT02703454|584245771|FG000|Overall Study|Withdrawal by Subject|4|||
161781694|NCT02703454|584245772|FG001|Overall Study|Withdrawal by Subject|3|||
161781695|NCT02703454|584245771|FG000|Overall Study|Lost to Follow-up|1|||
161781696|NCT02703454|584245772|FG001|Overall Study|Lost to Follow-up|2|||
161781697|NCT02703454|584245771|FG000|Overall Study|Study discontinuation|5|||
161781698|NCT02703454|584245772|FG001|Overall Study|Study discontinuation|8|||
161781699|NCT02284373|584245773|FG000|Overall Study|Withdrawal by Subject|0|||
161781700|NCT02284373|584245774|FG001|Overall Study|Withdrawal by Subject|1|||
161781701|NCT02284373|584245775|FG002|Overall Study|Withdrawal by Subject|0|||
161781702|NCT02284373|584245773|FG000|Overall Study|Other|0|||
161781703|NCT02284373|584245774|FG001|Overall Study|Other|1|||
161781704|NCT02284373|584245775|FG002|Overall Study|Other|0|||
161781705|NCT02284373|584245773|FG000|Overall Study|Lost to Follow-up|0|||
161781706|NCT02284373|584245774|FG001|Overall Study|Lost to Follow-up|1|||
161781707|NCT02284373|584245775|FG002|Overall Study|Lost to Follow-up|0|||
161781708|NCT02016755|584245776|FG000|Overall Study|Major amputation of index limb|2|||
161781709|NCT02016755|584245776|FG000|Overall Study|Adverse Event|2|||
161781710|NCT02016755|584245776|FG000|Overall Study|Physician Decision|1|||
161781711|NCT02016755|584245776|FG000|Overall Study|Death|2|||
161781712|NCT02476851|584245777|FG000|Overall Study|Protocol Violation|1|||
161781713|NCT02476851|584245778|FG001|Overall Study|Protocol Violation|1|||
161781714|NCT02360397|584245791|FG000|Overall Study|Incomplete screening|3|||
161781715|NCT02360397|584245791|FG000|Overall Study|Adverse Event|1|||
161781716|NCT03543046|584245798|FG000|Overall Study|Adverse Event|1|||
161781717|NCT03543046|584245799|FG001|Overall Study|Adverse Event|1|||
161781718|NCT03543046|584245798|FG000|Overall Study|Physician Decision|1|||
161781719|NCT03543046|584245799|FG001|Overall Study|Physician Decision|1|||
161781720|NCT03543046|584245798|FG000|Overall Study|Protocol Violation|1|||
161781721|NCT03543046|584245799|FG001|Overall Study|Protocol Violation|0|||
161781722|NCT03174925|584245800|FG000|Overall Study|Elastographic images not retrievable|2|||
161781723|NCT03174925|584245800|FG000|Overall Study|Elastography image not interpretable|1|||
161781724|NCT04247594|584245803|FG000|Overall Study|Withdrawal by Subject|4|||
161781725|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
161781726|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
161781727|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
161781728|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
161781729|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
161781730|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
161781731|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
161781732|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
161781733|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161781734|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161781735|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161781736|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
161781737|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
161781738|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161781739|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161781740|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161781741|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
161781742|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
161781743|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
161781744|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
161781745|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
161781746|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
161781747|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
161781748|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
161781749|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
161781750|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161781751|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
161781752|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161781753|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
161781754|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161781755|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161831479|NCT01730040|584424759|FG002|Overall Study|Adverse Event|5|||
162009376|NCT03224819|585090118|FG008|Overall Study|Lost to Follow-up|1|||
162009377|NCT03224819|585090119|FG009|Overall Study|Lost to Follow-up|0|||
161781756|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161781757|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
161781758|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
161781759|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
161781760|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
161781761|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
161781762|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
161781763|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
161781764|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
161781765|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
161781766|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
161781767|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
161781768|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
161781769|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
161781770|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
161781771|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
161781772|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
161781773|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
161781774|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
161781775|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161781776|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
161781777|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161781778|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161781779|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161781780|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161781781|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
161781782|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
161781783|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
161781784|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
161781785|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
161781786|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
161781787|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
161781788|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
161781789|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
161781790|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
161781791|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
161781792|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
161781793|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
161781794|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
161781795|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
161781796|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
161781797|NCT04440163|584245805|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
161781798|NCT04440163|584245806|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
161781799|NCT04440163|584245807|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
161781800|NCT04440163|584245808|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
161781801|NCT04440163|584245809|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
161781802|NCT04440163|584245810|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
161781803|NCT04440163|584245811|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
161781804|NCT04440163|584245812|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
161781805|NCT04440163|584245805|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
161781806|NCT04440163|584245806|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
161781807|NCT04440163|584245807|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
161781808|NCT04440163|584245808|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
161781809|NCT04440163|584245809|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
161781810|NCT04440163|584245810|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
161781811|NCT04440163|584245811|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
161781812|NCT04440163|584245812|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
161781813|NCT04440163|584245805|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161781814|NCT04440163|584245806|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161781815|NCT04440163|584245807|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161781816|NCT04440163|584245808|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
161781817|NCT04440163|584245809|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161781818|NCT04440163|584245810|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161895992|NCT03796676|584666445|FG002|Overall Study|Withdrawal by Subject|0|||
161781819|NCT04440163|584245811|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161781820|NCT04440163|584245812|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161781821|NCT00589693|584245818|FG000|Overall Study|randomized in error|12|||
161781822|NCT00589693|584245819|FG001|Overall Study|randomized in error|6|||
161781823|NCT00589693|584245818|FG000|Overall Study|Adverse Event|4|||
161781824|NCT00589693|584245819|FG001|Overall Study|Adverse Event|4|||
161781825|NCT00589693|584245818|FG000|Overall Study|Death|26|||
161781826|NCT00589693|584245819|FG001|Overall Study|Death|16|||
161781827|NCT00589693|584245818|FG000|Overall Study|Lack of Efficacy|0|||
161781828|NCT00589693|584245819|FG001|Overall Study|Lack of Efficacy|1|||
161781829|NCT00589693|584245818|FG000|Overall Study|Lost to Follow-up|1|||
161781830|NCT00589693|584245819|FG001|Overall Study|Lost to Follow-up|0|||
161781831|NCT00589693|584245818|FG000|Overall Study|Physician Decision|0|||
161781832|NCT00589693|584245819|FG001|Overall Study|Physician Decision|1|||
161781833|NCT00589693|584245818|FG000|Overall Study|Protocol Violation|1|||
161781834|NCT00589693|584245819|FG001|Overall Study|Protocol Violation|1|||
161781835|NCT01128153|584245820|FG000|Overall Study|Adverse Event|1|||
161781836|NCT01128153|584245821|FG001|Overall Study|Adverse Event|3|||
161781837|NCT01128153|584245820|FG000|Overall Study|Condition under investigation worsened|8|||
161781838|NCT01128153|584245821|FG001|Overall Study|Condition under investigation worsened|7|||
161781839|NCT01128153|584245820|FG000|Overall Study|Withdrawal by Subject|2|||
161781840|NCT01128153|584245821|FG001|Overall Study|Withdrawal by Subject|3|||
161781841|NCT01128153|584245820|FG000|Overall Study|Incorrect enrolment to study|2|||
161781842|NCT01128153|584245821|FG001|Overall Study|Incorrect enrolment to study|1|||
161781843|NCT01128153|584245820|FG000|Overall Study|Protocol Violation|2|||
161781844|NCT01128153|584245821|FG001|Overall Study|Protocol Violation|0|||
161781845|NCT01128153|584245820|FG000|Overall Study|Developed discontinuation criteria|1|||
161781846|NCT01128153|584245821|FG001|Overall Study|Developed discontinuation criteria|1|||
161781847|NCT01954082|584245822|FG000|Overall Study|Study Suspension|42|||
161781848|NCT01954082|584245823|FG001|Overall Study|Study Suspension|36|||
161781849|NCT01954082|584245822|FG000|Overall Study|Adverse Event|10|||
161781850|NCT01954082|584245823|FG001|Overall Study|Adverse Event|4|||
161781851|NCT01954082|584245822|FG000|Overall Study|Intolerance|0|||
161781852|NCT01954082|584245823|FG001|Overall Study|Intolerance|1|||
161781853|NCT01954082|584245822|FG000|Overall Study|Non-compliance|6|||
161781854|NCT01954082|584245823|FG001|Overall Study|Non-compliance|4|||
161781855|NCT01954082|584245822|FG000|Overall Study|Physician Decision|2|||
161781856|NCT01954082|584245823|FG001|Overall Study|Physician Decision|0|||
161781857|NCT01954082|584245822|FG000|Overall Study|Parent Decision|1|||
161781858|NCT01954082|584245823|FG001|Overall Study|Parent Decision|0|||
161781859|NCT01954082|584245822|FG000|Overall Study|Withdrawal by Subject|0|||
161781860|NCT01954082|584245823|FG001|Overall Study|Withdrawal by Subject|1|||
161781861|NCT01954082|584245822|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
161781862|NCT01954082|584245823|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
161781863|NCT01954082|584245822|FG000|Overall Study|Redirection of Care|0|||
161781864|NCT01954082|584245823|FG001|Overall Study|Redirection of Care|2|||
161781865|NCT01954082|584245822|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
161781866|NCT01954082|584245823|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
161895993|NCT03796676|584666443|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
161895994|NCT03796676|584666444|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
161895995|NCT03796676|584666445|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
161895996|NCT01900899|584666448|FG000|Overall Study|Withdrawal by Subject|7|||
161895997|NCT01900899|584666449|FG001|Overall Study|Withdrawal by Subject|1|||
161895998|NCT01900899|584666448|FG000|Overall Study|Migrated from study area|2|||
161895999|NCT01900899|584666449|FG001|Overall Study|Migrated from study area|0|||
161896000|NCT02772809|584666450|FG000|Overall Study|not completed some tasks|6|||
161896001|NCT00534105|584666453|FG000|Overall Study|Lost to Follow-up|23|||
161896002|NCT00534105|584666454|FG001|Overall Study|Lost to Follow-up|39|||
161896003|NCT03034135|584666455|FG000|Overall Study|Withdrawal by Subject|2|||
161896004|NCT03251482|584668296|FG000|Overall Study|Withdrawal by Subject|0|||
161896005|NCT03251482|584668297|FG001|Overall Study|Withdrawal by Subject|1|||
161896006|NCT03251482|584668298|FG002|Overall Study|Withdrawal by Subject|0|||
161896007|NCT03251482|584668299|FG003|Overall Study|Withdrawal by Subject|0|||
161896008|NCT03251482|584668300|FG004|Overall Study|Withdrawal by Subject|0|||
161896009|NCT00803712|584668301|FG000|Overall Study|Noncompliance|3|||
161781867|NCT01954082|584245822|FG000|Overall Study|Comfort Care|0|||
161781868|NCT01954082|584245823|FG001|Overall Study|Comfort Care|1|||
161781869|NCT01954082|584245822|FG000|Overall Study|Infant Moved|0|||
161781870|NCT01954082|584245823|FG001|Overall Study|Infant Moved|1|||
161781871|NCT01954082|584245822|FG000|Overall Study|Randomized not Treated|4|||
161781872|NCT01954082|584245823|FG001|Overall Study|Randomized not Treated|2|||
161781873|NCT01682512|584245824|FG000|Overall Study|Adverse Event|6|||
161781874|NCT01682512|584245825|FG001|Overall Study|Adverse Event|5|||
161781875|NCT01682512|584245826|FG002|Overall Study|Adverse Event|2|||
161781876|NCT01682512|584245824|FG000|Overall Study|Withdrawal by Subject|2|||
161781877|NCT01682512|584245825|FG001|Overall Study|Withdrawal by Subject|6|||
161781878|NCT01682512|584245826|FG002|Overall Study|Withdrawal by Subject|3|||
161781879|NCT01682512|584245824|FG000|Overall Study|Physician Decision|0|||
161781880|NCT01682512|584245825|FG001|Overall Study|Physician Decision|2|||
161781881|NCT01682512|584245826|FG002|Overall Study|Physician Decision|0|||
161781882|NCT01682512|584245824|FG000|Overall Study|Study terminated by sponsor|46|||
161896010|NCT00803712|584668302|FG001|Overall Study|Noncompliance|0|||
161896011|NCT00803712|584668301|FG000|Overall Study|Adverse Event|5|||
161896012|NCT00803712|584668302|FG001|Overall Study|Adverse Event|0|||
161896013|NCT00803712|584668301|FG000|Overall Study|Death|8|||
161896014|NCT00803712|584668302|FG001|Overall Study|Death|7|||
161896015|NCT00803712|584668301|FG000|Overall Study|Lost to Follow-up|3|||
161896016|NCT00803712|584668302|FG001|Overall Study|Lost to Follow-up|1|||
161896017|NCT00803712|584668301|FG000|Overall Study|Withdrawal by Subject|2|||
161896018|NCT00803712|584668302|FG001|Overall Study|Withdrawal by Subject|4|||
161896019|NCT00803712|584668301|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
161896020|NCT00803712|584668302|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
161896021|NCT00803712|584668301|FG000|Overall Study|Protocol criteria (other)|0|||
161896022|NCT00803712|584668302|FG001|Overall Study|Protocol criteria (other)|2|||
161896023|NCT00803712|584668301|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
161896024|NCT00803712|584668302|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
161896025|NCT00803712|584668301|FG000|Overall Study|Administrative decision|2|||
161896026|NCT00803712|584668302|FG001|Overall Study|Administrative decision|3|||
161896027|NCT00803712|584668301|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
161896028|NCT00803712|584668302|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
161896029|NCT02823470|584668303|FG000|Overall Study|Adverse Event|1|||
161896030|NCT02823470|584668304|FG001|Overall Study|Adverse Event|0|||
161896031|NCT02823470|584668303|FG000|Overall Study|Study terminated by sponsor|8|||
161896032|NCT02823470|584668304|FG001|Overall Study|Study terminated by sponsor|15|||
161896033|NCT01310127|584668305|FG000|Overall Study|Protocol Violation|1|||
161896034|NCT01310127|584668306|FG001|Overall Study|Protocol Violation|1|||
161896035|NCT01310127|584668305|FG000|Overall Study|advanced psc cataract outlier|1|||
161896036|NCT01310127|584668306|FG001|Overall Study|advanced psc cataract outlier|0|||
161896037|NCT01490840|584668307|FG000|Phase 1|Lost to Follow-up|1|||
161896038|NCT01490840|584668308|FG001|Phase 1|Lost to Follow-up|0|||
161781883|NCT01682512|584245825|FG001|Overall Study|Study terminated by sponsor|43|||
161781884|NCT01682512|584245826|FG002|Overall Study|Study terminated by sponsor|0|||
161781885|NCT01682512|584245824|FG000|Overall Study|Lost to Follow-up|3|||
161781886|NCT01682512|584245825|FG001|Overall Study|Lost to Follow-up|0|||
161781887|NCT01682512|584245826|FG002|Overall Study|Lost to Follow-up|2|||
161781888|NCT01682512|584245824|FG000|Overall Study|Protocol Violation|2|||
161781889|NCT01682512|584245825|FG001|Overall Study|Protocol Violation|3|||
161781890|NCT01682512|584245826|FG002|Overall Study|Protocol Violation|2|||
161781891|NCT01682512|584245824|FG000|Overall Study|Primary lack of efficacy|10|||
161781892|NCT01682512|584245825|FG001|Overall Study|Primary lack of efficacy|7|||
161781893|NCT01682512|584245826|FG002|Overall Study|Primary lack of efficacy|7|||
161781894|NCT01682512|584245824|FG000|Overall Study|Secondary lack of efficacy|1|||
161781895|NCT01682512|584245825|FG001|Overall Study|Secondary lack of efficacy|1|||
161781896|NCT01682512|584245826|FG002|Overall Study|Secondary lack of efficacy|0|||
161781897|NCT01682512|584245824|FG000|Overall Study|Other than stated above|2|||
161781898|NCT01682512|584245825|FG001|Overall Study|Other than stated above|4|||
161781899|NCT01682512|584245826|FG002|Overall Study|Other than stated above|2|||
161781900|NCT01377233|584245827|FG000|Open-label|Adverse Event|1|||
161781901|NCT01377233|584245828|FG001|Open-label|Adverse Event|0|||
161781902|NCT01377233|584245829|FG002|Open-label|Adverse Event|0|||
161781903|NCT01377233|584245830|FG003|Open-label|Adverse Event|0|||
161781904|NCT01377233|584245831|FG004|Open-label|Adverse Event|0|||
161781905|NCT01377233|584245827|FG000|Open-label|Withdrawal by Subject|3|||
161781906|NCT01377233|584245828|FG001|Open-label|Withdrawal by Subject|0|||
161781907|NCT01377233|584245829|FG002|Open-label|Withdrawal by Subject|0|||
161781908|NCT01377233|584245830|FG003|Open-label|Withdrawal by Subject|0|||
161781909|NCT01377233|584245831|FG004|Open-label|Withdrawal by Subject|0|||
161781910|NCT01377233|584245827|FG000|Double-blind|Adverse Event|0|||
161781911|NCT01377233|584245828|FG001|Double-blind|Adverse Event|1|||
161781912|NCT01377233|584245829|FG002|Double-blind|Adverse Event|2|||
161781913|NCT01377233|584245830|FG003|Double-blind|Adverse Event|2|||
161896039|NCT01490840|584668307|FG000|Phase 1|Adverse Event|2|||
161896040|NCT01490840|584668308|FG001|Phase 1|Adverse Event|1|||
161896041|NCT01490840|584668307|FG000|Phase 1|Withdrawal by Subject|6|||
161896042|NCT01490840|584668308|FG001|Phase 1|Withdrawal by Subject|5|||
161896043|NCT01490840|584668307|FG000|Phase 1|Visit 6a omitted|1|||
161781914|NCT01377233|584245831|FG004|Double-blind|Adverse Event|0|||
161896044|NCT01490840|584668308|FG001|Phase 1|Visit 6a omitted|0|||
161781915|NCT01377233|584245827|FG000|Double-blind|Protocol Violation|0|||
161781916|NCT01377233|584245828|FG001|Double-blind|Protocol Violation|0|||
161781917|NCT01377233|584245829|FG002|Double-blind|Protocol Violation|0|||
161781918|NCT01377233|584245830|FG003|Double-blind|Protocol Violation|0|||
161781919|NCT01377233|584245831|FG004|Double-blind|Protocol Violation|1|||
161896045|NCT01490840|584668307|FG000|Phase 2|Withdrawal by Subject|4|||
161896046|NCT01490840|584668308|FG001|Phase 2|Withdrawal by Subject|3|||
161896047|NCT01490840|584668307|FG000|Phase 2|Permanent interruption of fingolimod|0|||
161896048|NCT01490840|584668308|FG001|Phase 2|Permanent interruption of fingolimod|1|||
161896049|NCT01490840|584668307|FG000|Phase 2|Lost to Follow-up|1|||
161896050|NCT01490840|584668308|FG001|Phase 2|Lost to Follow-up|1|||
161896051|NCT01490840|584668307|FG000|Phase 2|Adverse Event|1|||
161896052|NCT01490840|584668308|FG001|Phase 2|Adverse Event|1|||
161896053|NCT00184002|584668309|FG000|Overall Study|Adverse Event|9|||
161896054|NCT00184002|584668309|FG000|Overall Study|Death|3|||
161896055|NCT00184002|584668309|FG000|Overall Study|Physician Decision|1|||
161896056|NCT00184002|584668309|FG000|Overall Study|Withdrawal by Subject|4|||
161896057|NCT02087670|584668312|FG000|Overall Study|Withdrawal by Subject|3|||
161896058|NCT02087670|584668313|FG001|Overall Study|Withdrawal by Subject|2|||
161896059|NCT00878800|584668315|FG000|Overall Study|Adverse Event|0|||
161896060|NCT00878800|584668316|FG001|Overall Study|Adverse Event|0|||
161896061|NCT00878800|584668317|FG002|Overall Study|Adverse Event|2|||
161896062|NCT00878800|584668318|FG003|Overall Study|Adverse Event|0|||
161896063|NCT00878800|584668319|FG004|Overall Study|Adverse Event|1|||
161896064|NCT00878800|584668315|FG000|Overall Study|Progressive disease|1|||
161896065|NCT00878800|584668316|FG001|Overall Study|Progressive disease|5|||
161896066|NCT00878800|584668317|FG002|Overall Study|Progressive disease|6|||
161896067|NCT00878800|584668318|FG003|Overall Study|Progressive disease|5|||
161896068|NCT00878800|584668319|FG004|Overall Study|Progressive disease|13|||
161896069|NCT00878800|584668315|FG000|Overall Study|Withdrew consent|1|||
161896070|NCT00878800|584668316|FG001|Overall Study|Withdrew consent|1|||
161896071|NCT00878800|584668317|FG002|Overall Study|Withdrew consent|0|||
161896072|NCT00878800|584668318|FG003|Overall Study|Withdrew consent|1|||
161896073|NCT00878800|584668319|FG004|Overall Study|Withdrew consent|1|||
161896074|NCT00878800|584668315|FG000|Overall Study|Death|0|||
161896075|NCT00878800|584668316|FG001|Overall Study|Death|0|||
161896076|NCT00878800|584668317|FG002|Overall Study|Death|1|||
161896077|NCT00878800|584668318|FG003|Overall Study|Death|0|||
161896078|NCT00878800|584668319|FG004|Overall Study|Death|0|||
161896079|NCT00878800|584668315|FG000|Overall Study|Other|1|||
161781920|NCT01377233|584245827|FG000|Double-blind|Withdrawal by Subject|0|||
161896080|NCT00878800|584668316|FG001|Overall Study|Other|1|||
161896081|NCT00878800|584668317|FG002|Overall Study|Other|0|||
161896082|NCT00878800|584668318|FG003|Overall Study|Other|0|||
161896083|NCT00878800|584668319|FG004|Overall Study|Other|1|||
161896084|NCT04819438|584668321|FG000|Overall Study|Withdrawal by Subject|1|||
161896085|NCT04819438|584668322|FG001|Overall Study|Withdrawal by Subject|0|||
161896086|NCT04819438|584668321|FG000|Overall Study|Adverse Event|0|||
161896087|NCT04819438|584668322|FG001|Overall Study|Adverse Event|1|||
161896088|NCT04819438|584668321|FG000|Overall Study|Protocol Violation|0|||
161896089|NCT04819438|584668322|FG001|Overall Study|Protocol Violation|1|||
161896090|NCT03836209|584668323|FG000|Overall Study|Adverse Event|5|||
161896091|NCT03836209|584668324|FG001|Overall Study|Adverse Event|2|||
161781921|NCT01377233|584245828|FG001|Double-blind|Withdrawal by Subject|0|||
161781922|NCT01377233|584245829|FG002|Double-blind|Withdrawal by Subject|0|||
161781923|NCT01377233|584245830|FG003|Double-blind|Withdrawal by Subject|1|||
161781924|NCT01377233|584245831|FG004|Double-blind|Withdrawal by Subject|0|||
161781925|NCT01377233|584245827|FG000|Double-blind|Administrative or other|0|||
161781926|NCT01377233|584245828|FG001|Double-blind|Administrative or other|0|||
161781927|NCT01377233|584245829|FG002|Double-blind|Administrative or other|0|||
161781928|NCT01377233|584245830|FG003|Double-blind|Administrative or other|1|||
161781929|NCT01377233|584245831|FG004|Double-blind|Administrative or other|1|||
161781930|NCT00417027|584245832|FG000|Overall Study|Protocol Violation|0|||
161781931|NCT00417027|584245833|FG001|Overall Study|Protocol Violation|5|||
161781932|NCT00417027|584245834|FG002|Overall Study|Protocol Violation|5|||
161781933|NCT03137082|584245835|FG000|Overall Study|Withdrawal by Subject|1|||
161781934|NCT03137082|584245836|FG001|Overall Study|Withdrawal by Subject|1|||
161781935|NCT03137082|584245835|FG000|Overall Study|Lost to Follow-up|1|||
161781936|NCT03137082|584245836|FG001|Overall Study|Lost to Follow-up|0|||
161781937|NCT00965263|584245841|FG000|Overall Study|Physician Decision|2|||
161781938|NCT00965263|584245842|FG001|Overall Study|Physician Decision|0|||
161781939|NCT00965263|584245841|FG000|Overall Study|Family emergency|0|||
161781940|NCT00965263|584245842|FG001|Overall Study|Family emergency|1|||
161781941|NCT00965263|584245841|FG000|Overall Study|Protocol Violation|0|||
161781942|NCT00965263|584245842|FG001|Overall Study|Protocol Violation|2|||
161896092|NCT03836209|584668323|FG000|Overall Study|Death|4|||
161896093|NCT03836209|584668324|FG001|Overall Study|Death|1|||
161896094|NCT03836209|584668323|FG000|Overall Study|Lack of Efficacy|7|||
161896095|NCT03836209|584668324|FG001|Overall Study|Lack of Efficacy|10|||
161896096|NCT03836209|584668323|FG000|Overall Study|Physician Decision|7|||
161781943|NCT03959137|584245843|FG000|Overall Study|Protocol Violation|6|||
161781944|NCT02756078|584245844|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
161781945|NCT02756078|584245845|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
161781946|NCT02756078|584245844|FG000|Period 1|Lost to Follow-up|0|||
161896097|NCT03836209|584668324|FG001|Overall Study|Physician Decision|11|||
161896098|NCT03836209|584668323|FG000|Overall Study|Protocol Violation|0|||
161896099|NCT03836209|584668324|FG001|Overall Study|Protocol Violation|3|||
161896100|NCT03836209|584668323|FG000|Overall Study|Withdrawal by Subject|2|||
161781947|NCT02756078|584245845|FG001|Period 1|Lost to Follow-up|2|||
161781948|NCT02756078|584245844|FG000|Period 1|Protocol Violation|0|||
161781949|NCT02756078|584245845|FG001|Period 1|Protocol Violation|1|||
161781950|NCT02756078|584245844|FG000|Period 1|Adverse Event|1|||
161781951|NCT02756078|584245845|FG001|Period 1|Adverse Event|10|||
161781952|NCT02756078|584245844|FG000|Period 1|Withdrawal by Subject|6|||
161781953|NCT02756078|584245845|FG001|Period 1|Withdrawal by Subject|6|||
161781954|NCT02756078|584245844|FG000|Period 1|Lens Discomfort|2|||
161781955|NCT02756078|584245845|FG001|Period 1|Lens Discomfort|2|||
161781956|NCT02756078|584245844|FG000|Period 2|Adverse Event|3|||
161781957|NCT02756078|584245845|FG001|Period 2|Adverse Event|5|||
161781958|NCT02756078|584245844|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
161781959|NCT02756078|584245845|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
161781960|NCT02756078|584245844|FG000|Period 2|Withdrawal by Subject|3|||
161781961|NCT02756078|584245845|FG001|Period 2|Withdrawal by Subject|1|||
161781962|NCT00810615|584245846|FG000|Overall Study|Withdrawal by Subject|1|||
161781963|NCT00810615|584245847|FG001|Overall Study|Withdrawal by Subject|1|||
161781964|NCT01766310|584245849|FG000|Overall Study|Lost to Follow-up|1|||
161781965|NCT01766310|584245850|FG001|Overall Study|Lost to Follow-up|3|||
161781966|NCT01591499|584245851|FG000|Baseline Visit|Withdrawal by Subject|0|||
161781967|NCT01591499|584245852|FG001|Baseline Visit|Withdrawal by Subject|2|||
161781968|NCT01591499|584245853|FG002|Baseline Visit|Withdrawal by Subject|0|||
161781969|NCT01591499|584245854|FG003|Baseline Visit|Withdrawal by Subject|2|||
161781970|NCT01591499|584245851|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
161781971|NCT01591499|584245852|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
161781972|NCT01591499|584245853|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
161781973|NCT01591499|584245854|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
161781974|NCT01591499|584245851|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
161781975|NCT01591499|584245852|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
161781976|NCT01591499|584245853|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
161781977|NCT01591499|584245854|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
161781978|NCT02125734|584245855|FG000|Period 2|Adverse Event|0|||
161781979|NCT02125734|584245856|FG001|Period 2|Adverse Event|1|||
161781980|NCT00902278|584245857|FG000|Overall Study|Physician Decision|1|||
161781981|NCT00902278|584245858|FG001|Overall Study|Physician Decision|0|||
161781982|NCT00902278|584245859|FG002|Overall Study|Physician Decision|2|||
161781983|NCT00902278|584245860|FG003|Overall Study|Physician Decision|0|||
161781984|NCT00902278|584245861|FG004|Overall Study|Physician Decision|1|||
161781985|NCT00902278|584245857|FG000|Overall Study|Lost to Follow-up|3|||
161781986|NCT00902278|584245858|FG001|Overall Study|Lost to Follow-up|2|||
161781987|NCT00902278|584245859|FG002|Overall Study|Lost to Follow-up|3|||
161781988|NCT00902278|584245860|FG003|Overall Study|Lost to Follow-up|0|||
161781989|NCT00902278|584245861|FG004|Overall Study|Lost to Follow-up|1|||
161781990|NCT01488071|584245864|FG000|Overall Study|Adverse Event|15|||
161781991|NCT01488071|584245865|FG001|Overall Study|Adverse Event|23|||
161781992|NCT01488071|584245864|FG000|Overall Study|Lack of Efficacy|11|||
161781993|NCT01488071|584245865|FG001|Overall Study|Lack of Efficacy|17|||
161781994|NCT01488071|584245864|FG000|Overall Study|Non-compliance with study drug|2|||
161781995|NCT01488071|584245865|FG001|Overall Study|Non-compliance with study drug|0|||
161781996|NCT01488071|584245864|FG000|Overall Study|Protocol Violation|5|||
161781997|NCT01488071|584245865|FG001|Overall Study|Protocol Violation|7|||
161781998|NCT01488071|584245864|FG000|Overall Study|Withdrawal of Consent|14|||
161781999|NCT01488071|584245865|FG001|Overall Study|Withdrawal of Consent|12|||
161782000|NCT01488071|584245864|FG000|Overall Study|Lost to Follow-up|1|||
161782001|NCT01488071|584245865|FG001|Overall Study|Lost to Follow-up|0|||
161782002|NCT01488071|584245864|FG000|Overall Study|Administrative or Other Reason(s)|5|||
161782003|NCT01488071|584245865|FG001|Overall Study|Administrative or Other Reason(s)|4|||
161782004|NCT02139306|584245866|FG000|Overall Study|Withdrawal by Subject|4|||
161782005|NCT02139306|584245867|FG001|Overall Study|Withdrawal by Subject|6|||
161782006|NCT02139306|584245866|FG000|Overall Study|Adverse Event|3|||
161782007|NCT02139306|584245867|FG001|Overall Study|Adverse Event|4|||
161782008|NCT02139306|584245866|FG000|Overall Study|Physician Decision|0|||
161782009|NCT02139306|584245867|FG001|Overall Study|Physician Decision|1|||
161782010|NCT02139306|584245866|FG000|Overall Study|Other Unspecified|2|||
161782011|NCT02139306|584245867|FG001|Overall Study|Other Unspecified|3|||
161782012|NCT02139306|584245866|FG000|Overall Study|Protocol Violation|4|||
161782013|NCT02139306|584245867|FG001|Overall Study|Protocol Violation|0|||
161782014|NCT04449354|584245868|FG000|Overall Study|Withdrawal by Subject|1|||
161782015|NCT05789420|584245869|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
161782016|NCT05789420|584245869|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
161782017|NCT02278952|584245870|FG000|Overall Study|Insufficient Sample|6|||
161782018|NCT01220128|584245871|FG000|Overall Study|Progressive disease|0|||
161782019|NCT01220128|584245872|FG001|Overall Study|Progressive disease|0|||
161782020|NCT01220128|584245873|FG002|Overall Study|Progressive disease|2|||
161782021|NCT01220128|584245874|FG003|Overall Study|Progressive disease|0|||
161782022|NCT01220128|584245875|FG004|Overall Study|Progressive disease|0|||
161782023|NCT01220128|584245876|FG005|Overall Study|Progressive disease|0|||
161782024|NCT01220128|584245877|FG006|Overall Study|Progressive disease|0|||
161782025|NCT01220128|584245871|FG000|Overall Study|Sponsor study termination|0|||
161782026|NCT01220128|584245872|FG001|Overall Study|Sponsor study termination|1|||
161782027|NCT01220128|584245873|FG002|Overall Study|Sponsor study termination|0|||
161782028|NCT01220128|584245874|FG003|Overall Study|Sponsor study termination|0|||
161782029|NCT01220128|584245875|FG004|Overall Study|Sponsor study termination|0|||
161782030|NCT01220128|584245876|FG005|Overall Study|Sponsor study termination|0|||
161782031|NCT01220128|584245877|FG006|Overall Study|Sponsor study termination|1|||
161782032|NCT01220128|584245871|FG000|Overall Study|Adverse event, serious fatal|2|||
161782033|NCT01220128|584245872|FG001|Overall Study|Adverse event, serious fatal|0|||
161782034|NCT01220128|584245873|FG002|Overall Study|Adverse event, serious fatal|0|||
161782035|NCT01220128|584245874|FG003|Overall Study|Adverse event, serious fatal|0|||
161782036|NCT01220128|584245875|FG004|Overall Study|Adverse event, serious fatal|0|||
161782037|NCT01220128|584245876|FG005|Overall Study|Adverse event, serious fatal|0|||
161782038|NCT01220128|584245877|FG006|Overall Study|Adverse event, serious fatal|1|||
161782039|NCT01220128|584245871|FG000|Overall Study|Adverse event, non-fatal|1|||
161782040|NCT01220128|584245872|FG001|Overall Study|Adverse event, non-fatal|0|||
161782041|NCT01220128|584245873|FG002|Overall Study|Adverse event, non-fatal|0|||
161782042|NCT01220128|584245874|FG003|Overall Study|Adverse event, non-fatal|0|||
161782043|NCT01220128|584245875|FG004|Overall Study|Adverse event, non-fatal|0|||
161782044|NCT01220128|584245876|FG005|Overall Study|Adverse event, non-fatal|0|||
161782045|NCT01220128|584245877|FG006|Overall Study|Adverse event, non-fatal|3|||
161782046|NCT01220128|584245871|FG000|Overall Study|Other|0|||
161782047|NCT01220128|584245872|FG001|Overall Study|Other|0|||
161782048|NCT01220128|584245873|FG002|Overall Study|Other|1|||
161782049|NCT01220128|584245874|FG003|Overall Study|Other|0|||
161782050|NCT01220128|584245875|FG004|Overall Study|Other|0|||
161782051|NCT01220128|584245876|FG005|Overall Study|Other|0|||
161782052|NCT01220128|584245877|FG006|Overall Study|Other|0|||
161782053|NCT01220128|584245871|FG000|Overall Study|Consent withdrawn by subject|1|||
161782054|NCT01220128|584245872|FG001|Overall Study|Consent withdrawn by subject|0|||
161782055|NCT01220128|584245873|FG002|Overall Study|Consent withdrawn by subject|0|||
161782056|NCT01220128|584245874|FG003|Overall Study|Consent withdrawn by subject|0|||
161782057|NCT01220128|584245875|FG004|Overall Study|Consent withdrawn by subject|0|||
161782058|NCT01220128|584245876|FG005|Overall Study|Consent withdrawn by subject|0|||
161782059|NCT01220128|584245877|FG006|Overall Study|Consent withdrawn by subject|0|||
161782060|NCT02913261|584245878|FG000|Overall Study|Technical problems|0|||
161782061|NCT02913261|584245879|FG001|Overall Study|Technical problems|1|||
161782062|NCT02913261|584245878|FG000|Overall Study|Lack of Efficacy|32|||
161782063|NCT02913261|584245879|FG001|Overall Study|Lack of Efficacy|69|||
161782064|NCT02913261|584245878|FG000|Overall Study|Adverse Event|27|||
161782065|NCT02913261|584245879|FG001|Overall Study|Adverse Event|5|||
161782066|NCT02913261|584245878|FG000|Overall Study|Death|25|||
161782067|NCT02913261|584245879|FG001|Overall Study|Death|22|||
161782068|NCT02913261|584245878|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
161782069|NCT02913261|584245879|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
161782070|NCT02913261|584245878|FG000|Overall Study|Disease relapse|8|||
161782071|NCT02913261|584245879|FG001|Overall Study|Disease relapse|13|||
161782072|NCT02913261|584245878|FG000|Overall Study|Physician Decision|8|||
161782073|NCT02913261|584245879|FG001|Overall Study|Physician Decision|9|||
161782074|NCT02913261|584245878|FG000|Overall Study|Subject/guardian decision|4|||
161782075|NCT02913261|584245879|FG001|Overall Study|Subject/guardian decision|6|||
161782076|NCT02913261|584245878|FG000|Overall Study|Graft loss|2|||
161782077|NCT02913261|584245879|FG001|Overall Study|Graft loss|0|||
161782078|NCT02304302|584245882|FG000|Overall Study|Adverse Event|2|||
161782079|NCT02304302|584245883|FG001|Overall Study|Adverse Event|3|||
161782080|NCT02304302|584245882|FG000|Overall Study|Lost to Follow-up|1|||
161782081|NCT02304302|584245883|FG001|Overall Study|Lost to Follow-up|4|||
161782082|NCT02304302|584245882|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
161782083|NCT02304302|584245883|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
161782084|NCT00391118|584245884|FG000|Overall Study|Adverse Event|3|||
161782085|NCT00391118|584245885|FG001|Overall Study|Adverse Event|10|||
161782086|NCT00391118|584245886|FG002|Overall Study|Adverse Event|7|||
161782087|NCT00391118|584245884|FG000|Overall Study|Lost to Follow-up|0|||
161782088|NCT00391118|584245885|FG001|Overall Study|Lost to Follow-up|2|||
161782089|NCT00391118|584245886|FG002|Overall Study|Lost to Follow-up|3|||
161782090|NCT00391118|584245884|FG000|Overall Study|Withdrawal by Subject|0|||
161782091|NCT00391118|584245885|FG001|Overall Study|Withdrawal by Subject|9|||
161782092|NCT00391118|584245886|FG002|Overall Study|Withdrawal by Subject|1|||
161782093|NCT00391118|584245884|FG000|Overall Study|Death|0|||
161782094|NCT00391118|584245885|FG001|Overall Study|Death|1|||
161782095|NCT00391118|584245886|FG002|Overall Study|Death|0|||
161782096|NCT00391118|584245884|FG000|Overall Study|Physician Decision|0|||
161782097|NCT00391118|584245885|FG001|Overall Study|Physician Decision|3|||
161782098|NCT00391118|584245886|FG002|Overall Study|Physician Decision|0|||
161782099|NCT00391118|584245884|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
161782100|NCT00391118|584245885|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
161782101|NCT00391118|584245886|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
161782102|NCT00391118|584245884|FG000|Overall Study|Progressive Disease|7|||
161782103|NCT00391118|584245885|FG001|Overall Study|Progressive Disease|26|||
161782104|NCT00391118|584245886|FG002|Overall Study|Progressive Disease|43|||
161782105|NCT00391118|584245884|FG000|Overall Study|Sponsor Decision|0|||
161782106|NCT00391118|584245885|FG001|Overall Study|Sponsor Decision|1|||
161782107|NCT00391118|584245886|FG002|Overall Study|Sponsor Decision|3|||
161782108|NCT00391118|584245884|FG000|Overall Study|Protocol Violation|1|||
161782109|NCT00391118|584245885|FG001|Overall Study|Protocol Violation|0|||
161782110|NCT00391118|584245886|FG002|Overall Study|Protocol Violation|0|||
161782111|NCT01311505|584245887|FG000|First Intervention Period|Protocol Violation|0|||
161782112|NCT01311505|584245888|FG001|First Intervention Period|Protocol Violation|1|||
161782113|NCT00532779|584245889|FG000|Overall Study|Adverse Event|122|||
161782114|NCT00532779|584245890|FG001|Overall Study|Adverse Event|112|||
161782115|NCT00532779|584245891|FG002|Overall Study|Adverse Event|56|||
161782116|NCT00532779|584245889|FG000|Overall Study|Lost to Follow-up|76|||
161782117|NCT00532779|584245890|FG001|Overall Study|Lost to Follow-up|65|||
161782118|NCT00532779|584245891|FG002|Overall Study|Lost to Follow-up|66|||
161782119|NCT00532779|584245889|FG000|Overall Study|Withdrawal by Subject|63|||
161782120|NCT00532779|584245890|FG001|Overall Study|Withdrawal by Subject|60|||
161782121|NCT00532779|584245891|FG002|Overall Study|Withdrawal by Subject|90|||
161782122|NCT00532779|584245889|FG000|Overall Study|Lack of Efficacy|12|||
161782123|NCT00532779|584245890|FG001|Overall Study|Lack of Efficacy|12|||
161782124|NCT00532779|584245891|FG002|Overall Study|Lack of Efficacy|40|||
161782125|NCT00532779|584245889|FG000|Overall Study|Protocol Violation|5|||
161782126|NCT00532779|584245890|FG001|Overall Study|Protocol Violation|9|||
161782127|NCT00532779|584245891|FG002|Overall Study|Protocol Violation|7|||
161782128|NCT00532779|584245889|FG000|Overall Study|Pregnancy|2|||
161782129|NCT00532779|584245890|FG001|Overall Study|Pregnancy|5|||
161896101|NCT03836209|584668324|FG001|Overall Study|Withdrawal by Subject|10|||
161896102|NCT03836209|584668323|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
161896103|NCT03836209|584668324|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
161896104|NCT05980013|584668325|FG000|Overall Study|Withdrawal by Subject|0|||
161896105|NCT05980013|584668326|FG001|Overall Study|Withdrawal by Subject|1|||
161896106|NCT05980013|584668325|FG000|Overall Study|Device Error|0|||
161896107|NCT05980013|584668326|FG001|Overall Study|Device Error|1|||
161896108|NCT04892446|584668327|FG000|Overall Study|Death|4|||
161896109|NCT04892446|584668328|FG001|Overall Study|Death|4|||
161896110|NCT04892446|584668329|FG002|Overall Study|Death|0|||
161896111|NCT04892446|584668327|FG000|Overall Study|Withdrew consent|3|||
161896112|NCT04892446|584668328|FG001|Overall Study|Withdrew consent|0|||
161896113|NCT04892446|584668329|FG002|Overall Study|Withdrew consent|1|||
161896114|NCT04892446|584668327|FG000|Overall Study|Investigator's discretion|1|||
161896115|NCT04892446|584668328|FG001|Overall Study|Investigator's discretion|1|||
161896116|NCT04892446|584668329|FG002|Overall Study|Investigator's discretion|0|||
161896117|NCT04892446|584668327|FG000|Overall Study|Study terminated by sponsor|0|||
161896118|NCT04892446|584668328|FG001|Overall Study|Study terminated by sponsor|0|||
161896119|NCT04892446|584668329|FG002|Overall Study|Study terminated by sponsor|2|||
161896120|NCT01768559|584668331|FG000|Overall Study|Randomized but not treated|0|||
161896121|NCT01768559|584668332|FG001|Overall Study|Randomized but not treated|0|||
161896122|NCT01768559|584668333|FG002|Overall Study|Randomized but not treated|1|||
161896123|NCT01768559|584668331|FG000|Overall Study|Adverse Event|15|||
161896124|NCT01768559|584668332|FG001|Overall Study|Adverse Event|2|||
161896125|NCT01768559|584668333|FG002|Overall Study|Adverse Event|5|||
161896126|NCT01768559|584668331|FG000|Overall Study|Lack of Efficacy|6|||
161896127|NCT01768559|584668332|FG001|Overall Study|Lack of Efficacy|4|||
161896128|NCT01768559|584668333|FG002|Overall Study|Lack of Efficacy|0|||
161896129|NCT01768559|584668331|FG000|Overall Study|Poor compliance to protocol|0|||
161896130|NCT01768559|584668332|FG001|Overall Study|Poor compliance to protocol|3|||
161896131|NCT01768559|584668333|FG002|Overall Study|Poor compliance to protocol|2|||
161896132|NCT01768559|584668331|FG000|Overall Study|Other than specified|9|||
161896133|NCT01768559|584668332|FG001|Overall Study|Other than specified|8|||
161896134|NCT01768559|584668333|FG002|Overall Study|Other than specified|5|||
161896135|NCT00237692|584668336|FG000|Overall Study|Lost to Follow-up|9|||
161896136|NCT00237692|584668337|FG001|Overall Study|Lost to Follow-up|3|||
161782130|NCT00532779|584245891|FG002|Overall Study|Pregnancy|3|||
161782131|NCT00532779|584245889|FG000|Overall Study|Death|0|||
161782132|NCT00532779|584245890|FG001|Overall Study|Death|1|||
161782133|NCT00532779|584245891|FG002|Overall Study|Death|0|||
161782134|NCT00532779|584245889|FG000|Overall Study|Drug noncompliance, moved, other|14|||
161782135|NCT00532779|584245890|FG001|Overall Study|Drug noncompliance, moved, other|23|||
161782136|NCT00532779|584245891|FG002|Overall Study|Drug noncompliance, moved, other|29|||
161782137|NCT00828516|584245898|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
161782138|NCT00689273|584245899|FG000|Overall Study|Adverse Event|3|||
161896137|NCT00237692|584668338|FG002|Overall Study|Lost to Follow-up|5|||
161896138|NCT00237692|584668339|FG003|Overall Study|Lost to Follow-up|3|||
161896139|NCT00237692|584668336|FG000|Overall Study|Death|1|||
161896140|NCT00237692|584668337|FG001|Overall Study|Death|2|||
161782139|NCT00689273|584245900|FG001|Overall Study|Adverse Event|1|||
161782140|NCT00689273|584245899|FG000|Overall Study|Lack of Efficacy|3|||
161782141|NCT00689273|584245900|FG001|Overall Study|Lack of Efficacy|0|||
161782142|NCT00689273|584245899|FG000|Overall Study|Lost to Follow-up|0|||
161782143|NCT00689273|584245900|FG001|Overall Study|Lost to Follow-up|2|||
161782144|NCT00689273|584245899|FG000|Overall Study|Other|6|||
161782145|NCT00689273|584245900|FG001|Overall Study|Other|2|||
161782146|NCT00689273|584245899|FG000|Overall Study|Randomized but not Treated|1|||
161782147|NCT00689273|584245900|FG001|Overall Study|Randomized but not Treated|0|||
161782148|NCT02787746|584245903|FG000|Overall Study|Adverse Event|42|||
161782149|NCT02787746|584245903|FG000|Overall Study|Withdrawal by Subject|65|||
161782150|NCT02787746|584245903|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
161782151|NCT03703297|584245906|FG000|Overall Study|Death|115|||
161782152|NCT03703297|584245907|FG001|Overall Study|Death|0|||
161782153|NCT03703297|584245908|FG002|Overall Study|Death|144|||
161782154|NCT03703297|584245906|FG000|Overall Study|Withdrawal by Subject|9|||
161782155|NCT03703297|584245907|FG001|Overall Study|Withdrawal by Subject|0|||
161782156|NCT03703297|584245908|FG002|Overall Study|Withdrawal by Subject|11|||
161782157|NCT03703297|584245906|FG000|Overall Study|Ongoing at the time of DCO|140|||
161782158|NCT03703297|584245907|FG001|Overall Study|Ongoing at the time of DCO|200|||
161782159|NCT03703297|584245908|FG002|Overall Study|Ongoing at the time of DCO|111|||
161782160|NCT00700310|584248007|FG000|Overall Study|Adverse Event|6|||
161782161|NCT00700310|584248008|FG001|Overall Study|Adverse Event|10|||
161782162|NCT00700310|584248009|FG002|Overall Study|Adverse Event|5|||
161782163|NCT00700310|584248010|FG003|Overall Study|Adverse Event|11|||
161782164|NCT00700310|584248007|FG000|Overall Study|Lost to Follow-up|4|||
161782165|NCT00700310|584248008|FG001|Overall Study|Lost to Follow-up|1|||
161782166|NCT00700310|584248009|FG002|Overall Study|Lost to Follow-up|0|||
161782167|NCT00700310|584248010|FG003|Overall Study|Lost to Follow-up|1|||
161782168|NCT00700310|584248007|FG000|Overall Study|Withdrawal by Subject|8|||
161782169|NCT00700310|584248008|FG001|Overall Study|Withdrawal by Subject|9|||
161782170|NCT00700310|584248009|FG002|Overall Study|Withdrawal by Subject|8|||
161782171|NCT00700310|584248010|FG003|Overall Study|Withdrawal by Subject|8|||
161782172|NCT00700310|584248007|FG000|Overall Study|Lack of Efficacy|0|||
161782173|NCT00700310|584248008|FG001|Overall Study|Lack of Efficacy|3|||
161782174|NCT00700310|584248009|FG002|Overall Study|Lack of Efficacy|0|||
161782175|NCT00700310|584248010|FG003|Overall Study|Lack of Efficacy|1|||
161782176|NCT00700310|584248007|FG000|Overall Study|Administrative/Other|1|||
161782177|NCT00700310|584248008|FG001|Overall Study|Administrative/Other|3|||
161782178|NCT00700310|584248009|FG002|Overall Study|Administrative/Other|1|||
161782179|NCT00700310|584248010|FG003|Overall Study|Administrative/Other|3|||
161782180|NCT00700310|584248007|FG000|Overall Study|Randomized, Not Treated|2|||
161782181|NCT00700310|584248008|FG001|Overall Study|Randomized, Not Treated|0|||
161782182|NCT00700310|584248009|FG002|Overall Study|Randomized, Not Treated|2|||
161782183|NCT00700310|584248010|FG003|Overall Study|Randomized, Not Treated|2|||
161782184|NCT02162511|584248012|FG000|Overall Study|Lack of Efficacy|0|||
161782185|NCT02162511|584248013|FG001|Overall Study|Lack of Efficacy|0|||
161782186|NCT02162511|584248014|FG002|Overall Study|Lack of Efficacy|2|||
161782187|NCT01160198|584248015|FG000|Overall Study|Withdrawal by Subject|2|||
161782188|NCT01160198|584248016|FG001|Overall Study|Withdrawal by Subject|1|||
161782189|NCT01160198|584248017|FG002|Overall Study|Withdrawal by Subject|0|||
161782190|NCT01160198|584248015|FG000|Overall Study|Adverse Event|0|||
161782191|NCT01160198|584248016|FG001|Overall Study|Adverse Event|1|||
161782192|NCT01160198|584248017|FG002|Overall Study|Adverse Event|0|||
161782193|NCT01160198|584248015|FG000|Overall Study|Lost to Follow-up|0|||
161782194|NCT01160198|584248016|FG001|Overall Study|Lost to Follow-up|1|||
161782195|NCT01160198|584248017|FG002|Overall Study|Lost to Follow-up|0|||
161782196|NCT01160198|584248015|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
161782197|NCT01160198|584248016|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
161782198|NCT01160198|584248017|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
161782199|NCT00802529|584248018|FG000|Overall Study|Lost to Follow-up|0|||
161782200|NCT00802529|584248019|FG001|Overall Study|Lost to Follow-up|1|||
161896141|NCT00237692|584668338|FG002|Overall Study|Death|2|||
161896142|NCT00237692|584668339|FG003|Overall Study|Death|3|||
161782201|NCT00552617|584248021|FG000|Overall Study|Not Treated|0|||
161782202|NCT00552617|584248022|FG001|Overall Study|Not Treated|0|||
161782203|NCT00552617|584248023|FG002|Overall Study|Not Treated|1|||
161782204|NCT00552617|584248024|FG003|Overall Study|Not Treated|0|||
161782205|NCT00552617|584248025|FG004|Overall Study|Not Treated|0|||
161782206|NCT00552617|584248026|FG005|Overall Study|Not Treated|0|||
161782207|NCT00552617|584248027|FG006|Overall Study|Not Treated|0|||
161896143|NCT00237692|584668336|FG000|Overall Study|Excluded - did not meet criteria|4|||
161782208|NCT00552617|584248028|FG007|Overall Study|Not Treated|0|||
161782209|NCT00552617|584248029|FG008|Overall Study|Not Treated|0|||
161782210|NCT00552617|584248030|FG009|Overall Study|Not Treated|1|||
161782211|NCT00552617|584248021|FG000|Overall Study|Lost to Follow-up|0|||
161782212|NCT00552617|584248022|FG001|Overall Study|Lost to Follow-up|0|||
161782213|NCT00552617|584248023|FG002|Overall Study|Lost to Follow-up|0|||
161896144|NCT00237692|584668337|FG001|Overall Study|Excluded - did not meet criteria|3|||
161782214|NCT00552617|584248024|FG003|Overall Study|Lost to Follow-up|1|||
161782215|NCT00552617|584248025|FG004|Overall Study|Lost to Follow-up|0|||
161782216|NCT00552617|584248026|FG005|Overall Study|Lost to Follow-up|2|||
161782217|NCT00552617|584248027|FG006|Overall Study|Lost to Follow-up|0|||
161782218|NCT00552617|584248028|FG007|Overall Study|Lost to Follow-up|0|||
161782219|NCT00552617|584248029|FG008|Overall Study|Lost to Follow-up|2|||
161782220|NCT00552617|584248030|FG009|Overall Study|Lost to Follow-up|0|||
161782221|NCT04651218|584248031|FG000|Overall Study|Withdrawal by Subject|0|||
161782222|NCT04651218|584248032|FG001|Overall Study|Withdrawal by Subject|2|||
161782223|NCT01902134|584248035|FG000|Overall Study|Adverse Event|3|||
161782224|NCT01902134|584248036|FG001|Overall Study|Adverse Event|1|||
161782225|NCT01902134|584248037|FG002|Overall Study|Adverse Event|2|||
161782226|NCT01902134|584248038|FG003|Overall Study|Adverse Event|1|||
161782227|NCT01902134|584248039|FG004|Overall Study|Adverse Event|1|||
161782228|NCT01902134|584248040|FG005|Overall Study|Adverse Event|3|||
161782229|NCT01902134|584248035|FG000|Overall Study|Lack of Efficacy|0|||
161782230|NCT01902134|584248036|FG001|Overall Study|Lack of Efficacy|0|||
161782231|NCT01902134|584248037|FG002|Overall Study|Lack of Efficacy|2|||
161782232|NCT01902134|584248038|FG003|Overall Study|Lack of Efficacy|0|||
161782233|NCT01902134|584248039|FG004|Overall Study|Lack of Efficacy|0|||
161782234|NCT01902134|584248040|FG005|Overall Study|Lack of Efficacy|1|||
161782235|NCT01902134|584248035|FG000|Overall Study|Physician Decision|0|||
161782236|NCT01902134|584248036|FG001|Overall Study|Physician Decision|1|||
161782237|NCT01902134|584248037|FG002|Overall Study|Physician Decision|0|||
161782238|NCT01902134|584248038|FG003|Overall Study|Physician Decision|0|||
161782239|NCT01902134|584248039|FG004|Overall Study|Physician Decision|0|||
161782240|NCT01902134|584248040|FG005|Overall Study|Physician Decision|0|||
161782241|NCT01902134|584248035|FG000|Overall Study|Protocol Violation|0|||
161782242|NCT01902134|584248036|FG001|Overall Study|Protocol Violation|0|||
161782243|NCT01902134|584248037|FG002|Overall Study|Protocol Violation|0|||
161782244|NCT01902134|584248038|FG003|Overall Study|Protocol Violation|0|||
161782245|NCT01902134|584248039|FG004|Overall Study|Protocol Violation|0|||
161896145|NCT00237692|584668338|FG002|Overall Study|Excluded - did not meet criteria|5|||
161896146|NCT00237692|584668339|FG003|Overall Study|Excluded - did not meet criteria|9|||
161896147|NCT00237692|584668336|FG000|Overall Study|Withdrawal by Subject|4|||
161896148|NCT00237692|584668337|FG001|Overall Study|Withdrawal by Subject|6|||
161896149|NCT00237692|584668338|FG002|Overall Study|Withdrawal by Subject|10|||
161896150|NCT00237692|584668339|FG003|Overall Study|Withdrawal by Subject|4|||
161896151|NCT00685360|584668340|FG000|Overall Study|Lost to Follow-up|0|||
161896152|NCT00685360|584668341|FG001|Overall Study|Lost to Follow-up|1|||
161896153|NCT00685360|584668342|FG002|Overall Study|Lost to Follow-up|2|||
161896154|NCT00685360|584668340|FG000|Overall Study|Adverse Event|4|||
161896155|NCT00685360|584668341|FG001|Overall Study|Adverse Event|6|||
161896156|NCT00685360|584668342|FG002|Overall Study|Adverse Event|4|||
161896157|NCT00685360|584668340|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
161896158|NCT00685360|584668341|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
161896159|NCT00685360|584668342|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
161896160|NCT00685360|584668340|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
161896161|NCT00685360|584668341|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
161896162|NCT00685360|584668342|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
161896163|NCT00685360|584668340|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
161896164|NCT00685360|584668341|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
161896165|NCT00685360|584668342|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
161896166|NCT00685360|584668340|FG000|Overall Study|Protocol Deviation|0|||
161896167|NCT00685360|584668341|FG001|Overall Study|Protocol Deviation|1|||
161896168|NCT00685360|584668342|FG002|Overall Study|Protocol Deviation|1|||
161896169|NCT01386944|584668349|FG000|Overall Study|Adverse Event|26|||
161896170|NCT01386944|584668349|FG000|Overall Study|Lack of Efficacy|14|||
161896171|NCT01386944|584668349|FG000|Overall Study|Lost to Follow-up|8|||
161896172|NCT01386944|584668349|FG000|Overall Study|Unspecified reason|8|||
161896173|NCT03883477|584668350|FG000|Overall Study|Death|1|||
161896174|NCT03883477|584668351|FG001|Overall Study|Death|0|||
161896175|NCT03883477|584668350|FG000|Overall Study|Protocol Violation|0|||
161782246|NCT01902134|584248040|FG005|Overall Study|Protocol Violation|1|||
161782247|NCT01902134|584248035|FG000|Overall Study|Withdrawal by Subject|4|||
161782248|NCT01902134|584248036|FG001|Overall Study|Withdrawal by Subject|8|||
161782249|NCT01902134|584248037|FG002|Overall Study|Withdrawal by Subject|9|||
161782250|NCT01902134|584248038|FG003|Overall Study|Withdrawal by Subject|1|||
161896176|NCT03883477|584668351|FG001|Overall Study|Protocol Violation|1|||
161782251|NCT01902134|584248039|FG004|Overall Study|Withdrawal by Subject|5|||
161782252|NCT01902134|584248040|FG005|Overall Study|Withdrawal by Subject|4|||
161782253|NCT01902134|584248035|FG000|Overall Study|no compliance|1|||
161782254|NCT01902134|584248036|FG001|Overall Study|no compliance|0|||
161896177|NCT04186221|584668352|FG000|Overall Study|Death|1|||
161896178|NCT00972283|584668358|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
162009378|NCT03224819|585090120|FG010|Overall Study|Lost to Follow-up|0|||
161782255|NCT01902134|584248037|FG002|Overall Study|no compliance|0|||
161782256|NCT01902134|584248038|FG003|Overall Study|no compliance|0|||
161782257|NCT01902134|584248039|FG004|Overall Study|no compliance|0|||
161782258|NCT01902134|584248040|FG005|Overall Study|no compliance|0|||
161782259|NCT01902134|584248035|FG000|Overall Study|Other|0|||
161782260|NCT01902134|584248036|FG001|Overall Study|Other|1|||
161782261|NCT01902134|584248037|FG002|Overall Study|Other|2|||
161782262|NCT01902134|584248038|FG003|Overall Study|Other|0|||
161782263|NCT01902134|584248039|FG004|Overall Study|Other|1|||
161782264|NCT01902134|584248040|FG005|Overall Study|Other|0|||
161782265|NCT00305110|584248041|FG000|Overall Study|Missing data|29|||
161782266|NCT00337129|584248042|FG000|Overall Study|Adverse Event|4|||
161782267|NCT00337129|584248042|FG000|Overall Study|Withdrawal by Subject|1|||
161782268|NCT00337129|584248042|FG000|Overall Study|Lack of Efficacy|32|||
161782269|NCT00337129|584248042|FG000|Overall Study|Death|2|||
161782270|NCT00337129|584248042|FG000|Overall Study|not protocol specified|1|||
161782271|NCT01272193|584248045|FG000|Overall Study|Adverse Event|1|||
161782272|NCT01272193|584248046|FG001|Overall Study|Adverse Event|1|||
161782273|NCT01272193|584248045|FG000|Overall Study|Lack of Efficacy|0|||
161782274|NCT01272193|584248046|FG001|Overall Study|Lack of Efficacy|3|||
161782275|NCT01272193|584248045|FG000|Overall Study|Withdrawal Criteria|1|||
161782276|NCT01272193|584248046|FG001|Overall Study|Withdrawal Criteria|1|||
161782277|NCT01272193|584248045|FG000|Overall Study|Unclassified|8|||
161782278|NCT01272193|584248046|FG001|Overall Study|Unclassified|7|||
161782279|NCT03578276|584248047|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
161782280|NCT03578276|584248048|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
161782281|NCT01084603|584248058|FG000|Baseline|Withdrawal by Subject|2|||
161782282|NCT01084603|584248058|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
161782283|NCT01084603|584248058|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
161782284|NCT01084603|584248058|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
161782285|NCT01084603|584248058|FG000|Washout Period 4|Adverse Event|1|||
161782286|NCT01508325|584248059|FG000|Overall Study|Withdrawal by Subject|8|||
161782287|NCT01508325|584248060|FG001|Overall Study|Withdrawal by Subject|9|||
161782288|NCT01508325|584248059|FG000|Overall Study|Protocol Violation|0|||
161782289|NCT01508325|584248060|FG001|Overall Study|Protocol Violation|3|||
161782290|NCT01508325|584248059|FG000|Overall Study|Physician Decision|2|||
161782291|NCT01508325|584248060|FG001|Overall Study|Physician Decision|1|||
161782292|NCT01508325|584248059|FG000|Overall Study|Adverse Event|1|||
161782293|NCT01508325|584248060|FG001|Overall Study|Adverse Event|0|||
161782294|NCT01508325|584248059|FG000|Overall Study|Lost to Follow-up|5|||
161782295|NCT01508325|584248060|FG001|Overall Study|Lost to Follow-up|6|||
161782296|NCT01508325|584248059|FG000|Overall Study|Other|2|||
161782297|NCT01508325|584248060|FG001|Overall Study|Other|2|||
161782298|NCT01392170|584248061|FG000|Overall Study|Withdrawal by Subject|1|||
161782299|NCT01392170|584248061|FG000|Overall Study|Ineligible|1|||
161782300|NCT04285983|584248065|FG000|Overall Study|Protocol Violation|6|||
161782301|NCT04936334|584248066|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
161782302|NCT02787785|584248067|FG000|Overall Study|Death|3|||
161782303|NCT02787785|584248068|FG001|Overall Study|Death|4|||
161782304|NCT02787785|584248067|FG000|Overall Study|Lost to Follow-up|1|||
161782305|NCT02787785|584248068|FG001|Overall Study|Lost to Follow-up|1|||
161782306|NCT02787785|584248067|FG000|Overall Study|Withdrawal by Subject|0|||
161782307|NCT02787785|584248068|FG001|Overall Study|Withdrawal by Subject|5|||
161782308|NCT01440595|584248079|FG000|Overall Study|Lost to Follow-up|0|||
161782309|NCT01440595|584248080|FG001|Overall Study|Lost to Follow-up|1|||
161782310|NCT01440595|584248081|FG002|Overall Study|Lost to Follow-up|0|||
161782311|NCT01440595|584248079|FG000|Overall Study|Study terminated by sponsor.|1|||
161782312|NCT01440595|584248080|FG001|Overall Study|Study terminated by sponsor.|2|||
161782313|NCT01440595|584248081|FG002|Overall Study|Study terminated by sponsor.|1|||
161782314|NCT01347879|584248082|FG000|Overall Study|Adverse Event|0|||
161782315|NCT01347879|584248083|FG001|Overall Study|Adverse Event|12|||
161782316|NCT01347879|584248082|FG000|Overall Study|Lost to Follow-up|2|||
161782317|NCT01347879|584248083|FG001|Overall Study|Lost to Follow-up|0|||
161782318|NCT01347879|584248082|FG000|Overall Study|Withdrawal by Subject|3|||
161782319|NCT01347879|584248083|FG001|Overall Study|Withdrawal by Subject|2|||
161782320|NCT01347879|584248082|FG000|Overall Study|Other|2|||
161782321|NCT01347879|584248083|FG001|Overall Study|Other|3|||
161782322|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
161782323|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
161782324|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
161782325|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
161782326|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
161782327|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
161782328|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
161782329|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
161782330|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
161782331|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
161782332|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
161831480|NCT01730040|584424760|FG003|Overall Study|Adverse Event|3|||
161896179|NCT00972283|584668359|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
161896180|NCT00972283|584668358|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
161896181|NCT00972283|584668359|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
161896182|NCT00972283|584668358|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
161896183|NCT00972283|584668359|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
161896184|NCT00972283|584668358|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
161896185|NCT00972283|584668359|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
161896186|NCT00972283|584668358|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
161896187|NCT00972283|584668359|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
161896188|NCT00972283|584668358|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
161896189|NCT00972283|584668359|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
161896190|NCT00972283|584668358|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
161896191|NCT00972283|584668359|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
161896192|NCT00972283|584668358|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
161896193|NCT00972283|584668359|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
161896194|NCT00972283|584668358|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
161896195|NCT00972283|584668359|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
161896196|NCT00972283|584668358|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
161896197|NCT00972283|584668359|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
161896198|NCT03124537|584668360|FG000|Overall Study|Lost to Follow-up|3|||
162122893|NCT00744237|585502348|FG001|Overall Study|Administrative. Site Closed|1|||
161782333|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
161782334|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
161782335|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
161782336|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
161782337|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
161782338|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
161782339|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
161782340|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
161782341|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
161782342|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
161782343|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
161782344|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
161782345|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
161782346|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
161782347|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
161782348|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
161782349|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
161782350|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
161782351|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
161782352|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
161782353|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
161782354|NCT03747939|584248084|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
161782355|NCT03747939|584248085|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
161782356|NCT03747939|584248086|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
161782357|NCT03747939|584248087|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
161782358|NCT03747939|584248084|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
161782359|NCT03747939|584248085|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
161782360|NCT03747939|584248086|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
161782361|NCT03747939|584248087|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
161782362|NCT03747939|584248084|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
161782363|NCT03747939|584248085|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
161782364|NCT03747939|584248086|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
161782365|NCT03747939|584248087|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
161782366|NCT03747939|584248084|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
161782367|NCT03747939|584248085|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
161782368|NCT03747939|584248086|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
161782369|NCT03747939|584248087|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
161782370|NCT03747939|584248084|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
161782371|NCT03747939|584248085|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
161782372|NCT03747939|584248086|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
161896199|NCT03124537|584668361|FG001|Overall Study|Lost to Follow-up|5|||
161896200|NCT03124537|584668360|FG000|Overall Study|App Crash, Incomplete Data|7|||
161782373|NCT03747939|584248087|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
161782374|NCT03747939|584248084|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
161782375|NCT03747939|584248085|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
161782376|NCT03747939|584248086|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
161782377|NCT03747939|584248087|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
161782378|NCT01850108|584248088|FG000|Overall Study|Lost to Follow-up|4|||
161782379|NCT01850108|584248088|FG000|Overall Study|Not eligible|1|||
161782380|NCT01850108|584248088|FG000|Overall Study|Failed engraftment|2|||
161782381|NCT01850108|584248088|FG000|Overall Study|Physician Decision|1|||
161782382|NCT01447628|584248091|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
161782383|NCT01447628|584248092|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
161782384|NCT01447628|584248093|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
161782385|NCT01447628|584248094|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
161782386|NCT03273712|584248101|FG000|Overall Study|Death|5|||
161782387|NCT03273712|584248101|FG000|Overall Study|Adverse Event|1|||
161782388|NCT03273712|584248101|FG000|Overall Study|Disease Progression|1|||
161782389|NCT03496207|584248102|FG000|Base Study|Adverse Event|0|||
161782390|NCT03496207|584248103|FG001|Base Study|Adverse Event|0|||
161782391|NCT03496207|584248104|FG002|Base Study|Adverse Event|1|||
161782392|NCT03496207|584248105|FG003|Base Study|Adverse Event|1|||
161782393|NCT03496207|584248106|FG004|Base Study|Adverse Event|4|||
161782394|NCT03496207|584248102|FG000|Base Study|Death|0|||
161782395|NCT03496207|584248103|FG001|Base Study|Death|0|||
161782396|NCT03496207|584248104|FG002|Base Study|Death|0|||
161782397|NCT03496207|584248105|FG003|Base Study|Death|0|||
161782398|NCT03496207|584248106|FG004|Base Study|Death|1|||
161782399|NCT03496207|584248102|FG000|Base Study|Withdrawal by Subject|0|||
161782400|NCT03496207|584248103|FG001|Base Study|Withdrawal by Subject|0|||
161782401|NCT03496207|584248104|FG002|Base Study|Withdrawal by Subject|1|||
161782402|NCT03496207|584248105|FG003|Base Study|Withdrawal by Subject|0|||
161782403|NCT03496207|584248106|FG004|Base Study|Withdrawal by Subject|1|||
161782404|NCT03496207|584248102|FG000|Extension Period|Adverse Event|0|||
161782405|NCT03496207|584248103|FG001|Extension Period|Adverse Event|0|||
161782406|NCT03496207|584248104|FG002|Extension Period|Adverse Event|0|||
161782407|NCT03496207|584248105|FG003|Extension Period|Adverse Event|1|||
161782408|NCT03496207|584248106|FG004|Extension Period|Adverse Event|1|||
161782409|NCT03496207|584248102|FG000|Extension Period|Death|1|||
161782410|NCT03496207|584248103|FG001|Extension Period|Death|0|||
161782411|NCT03496207|584248104|FG002|Extension Period|Death|0|||
161782412|NCT03496207|584248105|FG003|Extension Period|Death|1|||
161782413|NCT03496207|584248106|FG004|Extension Period|Death|2|||
161782414|NCT03496207|584248102|FG000|Extension Period|Withdrawal by Subject|1|||
161782415|NCT03496207|584248103|FG001|Extension Period|Withdrawal by Subject|0|||
161782416|NCT03496207|584248104|FG002|Extension Period|Withdrawal by Subject|0|||
161782417|NCT03496207|584248105|FG003|Extension Period|Withdrawal by Subject|1|||
161782418|NCT03496207|584248106|FG004|Extension Period|Withdrawal by Subject|1|||
161782419|NCT03496207|584248102|FG000|Extension Period|Elevated hemoglobin levels|0|||
161782420|NCT03496207|584248103|FG001|Extension Period|Elevated hemoglobin levels|0|||
161782421|NCT03496207|584248104|FG002|Extension Period|Elevated hemoglobin levels|0|||
161782422|NCT03496207|584248105|FG003|Extension Period|Elevated hemoglobin levels|0|||
161782423|NCT03496207|584248106|FG004|Extension Period|Elevated hemoglobin levels|1|||
161782424|NCT01542736|584248107|FG000|Overall Study|Death|1|||
161782425|NCT03674827|584248108|FG000|Treatment Phase|Adverse Event|0|||
161782426|NCT03674827|584248109|FG001|Treatment Phase|Adverse Event|0|||
161782427|NCT03674827|584248110|FG002|Treatment Phase|Adverse Event|0|||
161782428|NCT03674827|584248111|FG003|Treatment Phase|Adverse Event|0|||
161782429|NCT03674827|584248112|FG004|Treatment Phase|Adverse Event|0|||
161782430|NCT03674827|584248113|FG005|Treatment Phase|Adverse Event|2|||
161782431|NCT03674827|584248108|FG000|Treatment Phase|Death|2|||
161782432|NCT03674827|584248109|FG001|Treatment Phase|Death|0|||
161782433|NCT03674827|584248110|FG002|Treatment Phase|Death|0|||
161782434|NCT03674827|584248111|FG003|Treatment Phase|Death|0|||
161782435|NCT03674827|584248112|FG004|Treatment Phase|Death|1|||
161782436|NCT03674827|584248113|FG005|Treatment Phase|Death|0|||
161782437|NCT03674827|584248108|FG000|Treatment Phase|Progressive Disease|0|||
161782438|NCT03674827|584248109|FG001|Treatment Phase|Progressive Disease|4|||
161782439|NCT03674827|584248110|FG002|Treatment Phase|Progressive Disease|3|||
161782440|NCT03674827|584248111|FG003|Treatment Phase|Progressive Disease|4|||
161782441|NCT03674827|584248112|FG004|Treatment Phase|Progressive Disease|4|||
161896201|NCT03124537|584668361|FG001|Overall Study|App Crash, Incomplete Data|8|||
161782442|NCT03674827|584248113|FG005|Treatment Phase|Progressive Disease|9|||
161782443|NCT03674827|584248108|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
161782444|NCT03674827|584248109|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
161782445|NCT03674827|584248110|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
161782446|NCT03674827|584248111|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
161782447|NCT03674827|584248112|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
161782448|NCT03674827|584248113|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
161782449|NCT03674827|584248108|FG000|Treatment Phase|Withdrawal by Subject|0|||
161782450|NCT03674827|584248109|FG001|Treatment Phase|Withdrawal by Subject|0|||
161782451|NCT03674827|584248110|FG002|Treatment Phase|Withdrawal by Subject|0|||
161782452|NCT03674827|584248111|FG003|Treatment Phase|Withdrawal by Subject|0|||
161782453|NCT03674827|584248112|FG004|Treatment Phase|Withdrawal by Subject|0|||
161782454|NCT03674827|584248113|FG005|Treatment Phase|Withdrawal by Subject|1|||
161782455|NCT03674827|584248108|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
161782456|NCT03674827|584248109|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
161782457|NCT03674827|584248110|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
161782458|NCT03674827|584248111|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
161782459|NCT03674827|584248112|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
161782460|NCT03674827|584248113|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
161782461|NCT03674827|584248108|FG000|Treatment Phase|Other|0|||
161782462|NCT03674827|584248109|FG001|Treatment Phase|Other|1|||
161782463|NCT03674827|584248110|FG002|Treatment Phase|Other|0|||
161782464|NCT03674827|584248111|FG003|Treatment Phase|Other|0|||
161782465|NCT03674827|584248112|FG004|Treatment Phase|Other|0|||
161782466|NCT03674827|584248113|FG005|Treatment Phase|Other|1|||
161782467|NCT03674827|584248108|FG000|Long-Term Follow-up Phase|Death|2|||
161782468|NCT03674827|584248109|FG001|Long-Term Follow-up Phase|Death|4|||
161782469|NCT03674827|584248110|FG002|Long-Term Follow-up Phase|Death|2|||
161782470|NCT03674827|584248111|FG003|Long-Term Follow-up Phase|Death|3|||
161782471|NCT03674827|584248112|FG004|Long-Term Follow-up Phase|Death|2|||
161782472|NCT03674827|584248113|FG005|Long-Term Follow-up Phase|Death|6|||
161782473|NCT03674827|584248108|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
161782474|NCT03674827|584248109|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
161782475|NCT03674827|584248110|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
161782476|NCT03674827|584248111|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
161782477|NCT03674827|584248112|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
161782478|NCT03674827|584248113|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
161782479|NCT03674827|584248108|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
161896202|NCT00830518|584668364|FG000|Overall Study|Progressive Disease|18|||
161896203|NCT00830518|584668365|FG001|Overall Study|Progressive Disease|8|||
161896204|NCT00830518|584668364|FG000|Overall Study|Symptomatic Deterioration|4|||
161896205|NCT00830518|584668365|FG001|Overall Study|Symptomatic Deterioration|1|||
161896206|NCT00830518|584668364|FG000|Overall Study|Adverse Event|14|||
161896207|NCT00830518|584668365|FG001|Overall Study|Adverse Event|1|||
161896208|NCT00830518|584668364|FG000|Overall Study|Withdrawal by Patient|2|||
161896209|NCT00830518|584668365|FG001|Overall Study|Withdrawal by Patient|0|||
161896210|NCT00830518|584668364|FG000|Overall Study|Reason not Specified|8|||
161896211|NCT00830518|584668365|FG001|Overall Study|Reason not Specified|1|||
161896212|NCT03092791|584668366|FG000|Overall Study|Lost to Follow-up|0|||
161896213|NCT03092791|584668367|FG001|Overall Study|Lost to Follow-up|0|||
161896214|NCT03092791|584668368|FG002|Overall Study|Lost to Follow-up|0|||
161896215|NCT03092791|584668369|FG003|Overall Study|Lost to Follow-up|0|||
161896216|NCT03092791|584668370|FG004|Overall Study|Lost to Follow-up|0|||
161896217|NCT03092791|584668371|FG005|Overall Study|Lost to Follow-up|0|||
161896218|NCT03092791|584668372|FG006|Overall Study|Lost to Follow-up|1|||
161896219|NCT03092791|584668373|FG007|Overall Study|Lost to Follow-up|0|||
161896220|NCT03092791|584668366|FG000|Overall Study|Withdrawal of Consent|0|||
161896221|NCT03092791|584668367|FG001|Overall Study|Withdrawal of Consent|0|||
161896222|NCT03092791|584668368|FG002|Overall Study|Withdrawal of Consent|0|||
161896223|NCT03092791|584668369|FG003|Overall Study|Withdrawal of Consent|0|||
161896224|NCT03092791|584668370|FG004|Overall Study|Withdrawal of Consent|4|||
161896225|NCT03092791|584668371|FG005|Overall Study|Withdrawal of Consent|12|||
161896226|NCT03092791|584668372|FG006|Overall Study|Withdrawal of Consent|6|||
161896227|NCT03092791|584668373|FG007|Overall Study|Withdrawal of Consent|4|||
161896228|NCT03092791|584668366|FG000|Overall Study|Study Termination|0|||
161896229|NCT03092791|584668367|FG001|Overall Study|Study Termination|0|||
161896230|NCT03092791|584668368|FG002|Overall Study|Study Termination|0|||
161896231|NCT03092791|584668369|FG003|Overall Study|Study Termination|0|||
161896232|NCT03092791|584668370|FG004|Overall Study|Study Termination|55|||
161896233|NCT03092791|584668371|FG005|Overall Study|Study Termination|46|||
161896234|NCT03092791|584668372|FG006|Overall Study|Study Termination|53|||
161896235|NCT03092791|584668373|FG007|Overall Study|Study Termination|55|||
161896236|NCT03092791|584668366|FG000|Overall Study|Death|0|||
161896237|NCT03092791|584668367|FG001|Overall Study|Death|0|||
161896238|NCT03092791|584668368|FG002|Overall Study|Death|0|||
161896239|NCT03092791|584668369|FG003|Overall Study|Death|0|||
161896240|NCT03092791|584668370|FG004|Overall Study|Death|0|||
161896241|NCT03092791|584668371|FG005|Overall Study|Death|1|||
161782480|NCT03674827|584248109|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
161782481|NCT03674827|584248110|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
161782482|NCT03674827|584248111|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
161782483|NCT03674827|584248112|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
161896242|NCT03092791|584668372|FG006|Overall Study|Death|0|||
161896243|NCT03092791|584668373|FG007|Overall Study|Death|1|||
161896244|NCT03092791|584668366|FG000|Overall Study|Reason Not Specified|0|||
161896245|NCT03092791|584668367|FG001|Overall Study|Reason Not Specified|0|||
161896246|NCT03092791|584668368|FG002|Overall Study|Reason Not Specified|0|||
161896247|NCT03092791|584668369|FG003|Overall Study|Reason Not Specified|0|||
161896248|NCT03092791|584668370|FG004|Overall Study|Reason Not Specified|1|||
161896249|NCT03092791|584668371|FG005|Overall Study|Reason Not Specified|1|||
161896250|NCT03092791|584668372|FG006|Overall Study|Reason Not Specified|0|||
161896251|NCT03092791|584668373|FG007|Overall Study|Reason Not Specified|0|||
161896252|NCT02182830|584668377|FG000|Overall Study|Not Treated|1|||
161896253|NCT02182830|584668378|FG001|Overall Study|Not Treated|1|||
161896254|NCT02182830|584668377|FG000|Overall Study|Trial stopped, reason missing|3|||
161896255|NCT02182830|584668378|FG001|Overall Study|Trial stopped, reason missing|3|||
161896256|NCT02182830|584668377|FG000|Overall Study|Consent withdrawn|8|||
161896257|NCT02182830|584668378|FG001|Overall Study|Consent withdrawn|8|||
161896258|NCT02182830|584668377|FG000|Overall Study|Lost to Follow-up|3|||
161896259|NCT02182830|584668378|FG001|Overall Study|Lost to Follow-up|3|||
161896260|NCT04399538|584668379|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
161896261|NCT04399538|584668380|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
161896262|NCT04399538|584668381|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
161896263|NCT04399538|584668382|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
161896264|NCT04399538|584668383|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
161896265|NCT04399538|584668379|FG000|Double-Blind Treatment|Adverse Event|0|||
161896266|NCT04399538|584668380|FG001|Double-Blind Treatment|Adverse Event|0|||
161896267|NCT04399538|584668381|FG002|Double-Blind Treatment|Adverse Event|0|||
161896268|NCT04399538|584668382|FG003|Double-Blind Treatment|Adverse Event|0|||
161896269|NCT04399538|584668383|FG004|Double-Blind Treatment|Adverse Event|1|||
161896270|NCT04399538|584668379|FG000|Follow-Up|Adverse Event|0|||
161896271|NCT04399538|584668380|FG001|Follow-Up|Adverse Event|0|||
161896272|NCT04399538|584668381|FG002|Follow-Up|Adverse Event|0|||
161896273|NCT04399538|584668382|FG003|Follow-Up|Adverse Event|0|||
161896274|NCT04399538|584668383|FG004|Follow-Up|Adverse Event|1|||
161896275|NCT04399538|584668379|FG000|Follow-Up|Withdrawal by Subject|0|||
161896276|NCT04399538|584668380|FG001|Follow-Up|Withdrawal by Subject|0|||
161896277|NCT04399538|584668381|FG002|Follow-Up|Withdrawal by Subject|0|||
161896278|NCT04399538|584668382|FG003|Follow-Up|Withdrawal by Subject|2|||
161896279|NCT04399538|584668383|FG004|Follow-Up|Withdrawal by Subject|0|||
161896280|NCT00586898|584668388|FG000|Overall Study|Adverse Event|1|||
161896281|NCT00586898|584668388|FG000|Overall Study|Patiemt Non-compliance|1|||
161896282|NCT00586898|584668388|FG000|Overall Study|Evaluable for Toxicity Only|5|||
161896283|NCT01588405|584668389|FG000|Overall Study|Adverse Event|1|||
161896284|NCT01588405|584668389|FG000|Overall Study|Clinical Worsening|1|||
161896285|NCT03268005|584668390|FG000|Overall Study|Death|2|||
161896286|NCT03268005|584668391|FG001|Overall Study|Death|1|||
161896287|NCT03268005|584668390|FG000|Overall Study|Lost to Follow-up|2|||
161896288|NCT03268005|584668391|FG001|Overall Study|Lost to Follow-up|2|||
161896289|NCT03268005|584668390|FG000|Overall Study|Withdrawal by Subject|11|||
161896290|NCT03268005|584668391|FG001|Overall Study|Withdrawal by Subject|11|||
161896291|NCT01926197|584668393|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
161896292|NCT01926197|584668394|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
161896293|NCT01926197|584668393|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
161896294|NCT01926197|584668394|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
161896295|NCT00492232|584668395|FG000|Placebo Run-in|Adverse Event|0|||
161896296|NCT00492232|584668396|FG001|Placebo Run-in|Adverse Event|2|||
161896297|NCT00492232|584668395|FG000|Placebo Run-in|Protocol Violation|0|||
161896298|NCT00492232|584668396|FG001|Placebo Run-in|Protocol Violation|3|||
161896299|NCT00492232|584668395|FG000|Placebo Run-in|Lost to Follow-up|0|||
161896300|NCT00492232|584668396|FG001|Placebo Run-in|Lost to Follow-up|3|||
161896301|NCT00492232|584668395|FG000|Placebo Run-in|Withdrawal by Subject|0|||
161896302|NCT00492232|584668396|FG001|Placebo Run-in|Withdrawal by Subject|8|||
161896303|NCT00492232|584668395|FG000|Placebo Run-in|Pregnancy|0|||
161896304|NCT00492232|584668396|FG001|Placebo Run-in|Pregnancy|1|||
161896305|NCT00492232|584668395|FG000|Placebo Run-in|Entrance criteria not met|0|||
161896306|NCT00492232|584668396|FG001|Placebo Run-in|Entrance criteria not met|45|||
161896307|NCT00492232|584668395|FG000|Placebo Run-in|Other|0|||
161896308|NCT00492232|584668396|FG001|Placebo Run-in|Other|6|||
161896309|NCT00492232|584668395|FG000|Placebo Run-in|Missing|0|||
161896310|NCT00492232|584668396|FG001|Placebo Run-in|Missing|2|||
161896311|NCT00492232|584668395|FG000|Double-Blind Treatment|Adverse Event|1|||
161896312|NCT00492232|584668396|FG001|Double-Blind Treatment|Adverse Event|2|||
161896313|NCT00492232|584668395|FG000|Double-Blind Treatment|Protocol Violation|3|||
161896314|NCT00492232|584668396|FG001|Double-Blind Treatment|Protocol Violation|7|||
161896315|NCT00492232|584668395|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
161896316|NCT00492232|584668396|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
161896317|NCT00492232|584668395|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
161896318|NCT00492232|584668396|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
161896319|NCT00492232|584668395|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
161896320|NCT00492232|584668396|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
161896321|NCT00492232|584668395|FG000|Double-Blind Treatment|Other|6|||
161896322|NCT00492232|584668396|FG001|Double-Blind Treatment|Other|5|||
161896323|NCT00492232|584668395|FG000|Double-Blind Treatment|Randomized not treated|1|||
161896324|NCT00492232|584668396|FG001|Double-Blind Treatment|Randomized not treated|0|||
161896325|NCT00492232|584668395|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
161782484|NCT03674827|584248113|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
161782485|NCT01289990|584248114|FG000|Overall Study|Death|0|||
161782486|NCT01289990|584248115|FG001|Overall Study|Death|0|||
161782487|NCT01289990|584248116|FG002|Overall Study|Death|0|||
161782488|NCT01289990|584248117|FG003|Overall Study|Death|1|||
161782489|NCT01289990|584248118|FG004|Overall Study|Death|2|||
161782490|NCT01289990|584248119|FG005|Overall Study|Death|1|||
161782491|NCT01289990|584248120|FG006|Overall Study|Death|0|||
161782492|NCT01289990|584248121|FG007|Overall Study|Death|0|||
161782493|NCT01289990|584248122|FG008|Overall Study|Death|0|||
161782494|NCT01289990|584248123|FG009|Overall Study|Death|0|||
161782495|NCT01289990|584248124|FG010|Overall Study|Death|0|||
161782496|NCT01289990|584248125|FG011|Overall Study|Death|1|||
161782497|NCT01289990|584248126|FG012|Overall Study|Death|0|||
161782498|NCT01289990|584248114|FG000|Overall Study|Lost to Follow-up|3|||
161782499|NCT01289990|584248115|FG001|Overall Study|Lost to Follow-up|2|||
161782500|NCT01289990|584248116|FG002|Overall Study|Lost to Follow-up|5|||
161782501|NCT01289990|584248117|FG003|Overall Study|Lost to Follow-up|5|||
161782502|NCT01289990|584248118|FG004|Overall Study|Lost to Follow-up|3|||
161782503|NCT01289990|584248119|FG005|Overall Study|Lost to Follow-up|4|||
161782504|NCT01289990|584248120|FG006|Overall Study|Lost to Follow-up|2|||
161782505|NCT01289990|584248121|FG007|Overall Study|Lost to Follow-up|2|||
161782506|NCT01289990|584248122|FG008|Overall Study|Lost to Follow-up|1|||
161782507|NCT01289990|584248123|FG009|Overall Study|Lost to Follow-up|4|||
161782508|NCT01289990|584248124|FG010|Overall Study|Lost to Follow-up|2|||
161782509|NCT01289990|584248125|FG011|Overall Study|Lost to Follow-up|1|||
161782510|NCT01289990|584248126|FG012|Overall Study|Lost to Follow-up|2|||
161782511|NCT01289990|584248114|FG000|Overall Study|Withdrawal by Subject|15|||
161782512|NCT01289990|584248115|FG001|Overall Study|Withdrawal by Subject|14|||
161782513|NCT01289990|584248116|FG002|Overall Study|Withdrawal by Subject|12|||
161782514|NCT01289990|584248117|FG003|Overall Study|Withdrawal by Subject|13|||
161782515|NCT01289990|584248118|FG004|Overall Study|Withdrawal by Subject|8|||
161782516|NCT01289990|584248119|FG005|Overall Study|Withdrawal by Subject|7|||
161782517|NCT01289990|584248120|FG006|Overall Study|Withdrawal by Subject|13|||
161782518|NCT01289990|584248121|FG007|Overall Study|Withdrawal by Subject|9|||
161782519|NCT01289990|584248122|FG008|Overall Study|Withdrawal by Subject|12|||
161782520|NCT01289990|584248123|FG009|Overall Study|Withdrawal by Subject|13|||
161782521|NCT01289990|584248124|FG010|Overall Study|Withdrawal by Subject|11|||
161782522|NCT01289990|584248125|FG011|Overall Study|Withdrawal by Subject|13|||
161782523|NCT01289990|584248126|FG012|Overall Study|Withdrawal by Subject|16|||
161782524|NCT01289990|584248114|FG000|Overall Study|discontinued in preceding trial|18|||
161782525|NCT01289990|584248115|FG001|Overall Study|discontinued in preceding trial|20|||
161782526|NCT01289990|584248116|FG002|Overall Study|discontinued in preceding trial|41|||
161782527|NCT01289990|584248117|FG003|Overall Study|discontinued in preceding trial|17|||
161782528|NCT01289990|584248118|FG004|Overall Study|discontinued in preceding trial|11|||
161782529|NCT01289990|584248119|FG005|Overall Study|discontinued in preceding trial|12|||
161782530|NCT01289990|584248120|FG006|Overall Study|discontinued in preceding trial|18|||
161782531|NCT01289990|584248121|FG007|Overall Study|discontinued in preceding trial|8|||
161782532|NCT01289990|584248122|FG008|Overall Study|discontinued in preceding trial|17|||
161782533|NCT01289990|584248123|FG009|Overall Study|discontinued in preceding trial|21|||
161782534|NCT01289990|584248124|FG010|Overall Study|discontinued in preceding trial|17|||
161782535|NCT01289990|584248125|FG011|Overall Study|discontinued in preceding trial|17|||
161782536|NCT01289990|584248126|FG012|Overall Study|discontinued in preceding trial|24|||
161782537|NCT01289990|584248114|FG000|Overall Study|did not continue in extension|41|||
161782538|NCT01289990|584248115|FG001|Overall Study|did not continue in extension|45|||
161782539|NCT01289990|584248116|FG002|Overall Study|did not continue in extension|51|||
161782540|NCT01289990|584248117|FG003|Overall Study|did not continue in extension|51|||
161782541|NCT01289990|584248118|FG004|Overall Study|did not continue in extension|48|||
161782542|NCT01289990|584248119|FG005|Overall Study|did not continue in extension|50|||
161782543|NCT01289990|584248120|FG006|Overall Study|did not continue in extension|54|||
161782544|NCT01289990|584248121|FG007|Overall Study|did not continue in extension|36|||
161782545|NCT01289990|584248122|FG008|Overall Study|did not continue in extension|44|||
161782546|NCT01289990|584248123|FG009|Overall Study|did not continue in extension|48|||
161782547|NCT01289990|584248124|FG010|Overall Study|did not continue in extension|45|||
161782548|NCT01289990|584248125|FG011|Overall Study|did not continue in extension|34|||
161782549|NCT01289990|584248126|FG012|Overall Study|did not continue in extension|56|||
161782550|NCT01289990|584248114|FG000|Overall Study|Not treated|0|||
161782551|NCT01289990|584248115|FG001|Overall Study|Not treated|0|||
161782552|NCT01289990|584248116|FG002|Overall Study|Not treated|0|||
161782553|NCT01289990|584248117|FG003|Overall Study|Not treated|0|||
161782554|NCT01289990|584248118|FG004|Overall Study|Not treated|0|||
161782555|NCT01289990|584248119|FG005|Overall Study|Not treated|0|||
161782556|NCT01289990|584248120|FG006|Overall Study|Not treated|1|||
161782557|NCT01289990|584248121|FG007|Overall Study|Not treated|0|||
161782558|NCT01289990|584248122|FG008|Overall Study|Not treated|1|||
161782559|NCT01289990|584248123|FG009|Overall Study|Not treated|0|||
161782560|NCT01289990|584248124|FG010|Overall Study|Not treated|1|||
161782561|NCT01289990|584248125|FG011|Overall Study|Not treated|2|||
161782562|NCT01289990|584248126|FG012|Overall Study|Not treated|0|||
161782563|NCT02441179|584248127|FG000|Overall Study|Withdrawal by Subject|1|||
161782564|NCT02441179|584248128|FG001|Overall Study|Withdrawal by Subject|1|||
161782565|NCT03454672|584248129|FG000|Overall Study|Adverse Event|1|||
161782566|NCT03454672|584248130|FG001|Overall Study|Adverse Event|1|||
161782567|NCT03454672|584248129|FG000|Overall Study|Lost to Follow-up|1|||
161782568|NCT03454672|584248130|FG001|Overall Study|Lost to Follow-up|3|||
161782569|NCT03454672|584248129|FG000|Overall Study|painful|1|||
161782570|NCT03454672|584248130|FG001|Overall Study|painful|2|||
161896326|NCT00492232|584668396|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
161896327|NCT00980655|584668397|FG000|Overall Study|Adverse Event|13|||
161896328|NCT00980655|584668398|FG001|Overall Study|Adverse Event|31|||
161896329|NCT00980655|584668397|FG000|Overall Study|Death|0|||
161896330|NCT00980655|584668398|FG001|Overall Study|Death|7|||
161896331|NCT00980655|584668397|FG000|Overall Study|Protocol Violation|2|||
161896332|NCT00980655|584668398|FG001|Overall Study|Protocol Violation|7|||
161896333|NCT00980655|584668397|FG000|Overall Study|Withdrawal by Subject|0|||
161896334|NCT00980655|584668398|FG001|Overall Study|Withdrawal by Subject|4|||
161896335|NCT00980655|584668397|FG000|Overall Study|Lost to Follow-up|0|||
161896336|NCT00980655|584668398|FG001|Overall Study|Lost to Follow-up|1|||
161896337|NCT00980655|584668397|FG000|Overall Study|Parent/legal guardian request|1|||
161896338|NCT00980655|584668398|FG001|Overall Study|Parent/legal guardian request|0|||
161896339|NCT00980655|584668397|FG000|Overall Study|Other|0|||
161896340|NCT00980655|584668398|FG001|Overall Study|Other|1|||
161896341|NCT04162795|584668399|FG000|Overall Study|Other|16|||
161896342|NCT04162795|584668399|FG000|Overall Study|Screen failures|10|||
161896343|NCT02029274|584668403|FG000|Overall Study|Adverse Event|1|||
161896344|NCT02029274|584668404|FG001|Overall Study|Adverse Event|0|||
161896345|NCT02029274|584668405|FG002|Overall Study|Adverse Event|2|||
161896346|NCT02029274|584668406|FG003|Overall Study|Adverse Event|2|||
161896347|NCT02984267|584668408|FG000|Overall Study|Protocol Violation|1|||
161896348|NCT02984267|584668409|FG001|Overall Study|Protocol Violation|0|||
161896349|NCT02984267|584668408|FG000|Overall Study|Withdrawal by Subject|0|||
161896350|NCT02984267|584668409|FG001|Overall Study|Withdrawal by Subject|1|||
161896351|NCT02685072|584668410|FG000|Treatment Period|Lost to Follow-up|12|||
161896352|NCT02685072|584668411|FG001|Treatment Period|Lost to Follow-up|6|||
161896353|NCT02685072|584668410|FG000|Treatment Period|Withdrawal by Subject|1|||
161896354|NCT02685072|584668411|FG001|Treatment Period|Withdrawal by Subject|3|||
161896355|NCT02685072|584668410|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
161896356|NCT02685072|584668411|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
161896357|NCT01994902|584668412|FG000|Test Period 1|Withdrawal by Subject|3|||
161896358|NCT01994902|584668413|FG001|Test Period 1|Withdrawal by Subject|0|||
161896359|NCT01994902|584668412|FG000|Test Period 1|device deficiency with adverse event|0|||
161896360|NCT01994902|584668413|FG001|Test Period 1|device deficiency with adverse event|1|||
161896361|NCT01994902|584668412|FG000|Test Period 1|Adverse Event|2|||
161896362|NCT01994902|584668413|FG001|Test Period 1|Adverse Event|1|||
161896363|NCT01994902|584668412|FG000|Test Period 1|Lack of Efficacy|0|||
161896364|NCT01994902|584668413|FG001|Test Period 1|Lack of Efficacy|1|||
161896365|NCT01994902|584668412|FG000|Test Period 1|bag too small|1|||
161896366|NCT01994902|584668413|FG001|Test Period 1|bag too small|0|||
161896367|NCT01994902|584668412|FG000|Test Period 2|Withdrawal by Subject|0|||
161896368|NCT01994902|584668413|FG001|Test Period 2|Withdrawal by Subject|2|||
161896369|NCT01994902|584668412|FG000|Test Period 2|Lack of Efficacy|0|||
161896370|NCT01994902|584668413|FG001|Test Period 2|Lack of Efficacy|1|||
161896371|NCT01994902|584668412|FG000|Test Period 2|Other|0|||
161896372|NCT01994902|584668413|FG001|Test Period 2|Other|3|||
161896373|NCT03597139|584668414|FG000|Overall Study|Adverse Event|3|||
161896374|NCT03597139|584668415|FG001|Overall Study|Adverse Event|0|||
161782571|NCT03454672|584248129|FG000|Overall Study|Non-compliance|2|||
161896375|NCT03597139|584668414|FG000|Overall Study|Protocol Non-compliance|1|||
161896376|NCT03597139|584668415|FG001|Overall Study|Protocol Non-compliance|0|||
161896377|NCT00248833|584668419|FG000|Overall Study|Adverse Event|2|||
161896378|NCT00248833|584668420|FG001|Overall Study|Adverse Event|0|||
161896379|NCT00248833|584668421|FG002|Overall Study|Adverse Event|0|||
161896380|NCT00248833|584668419|FG000|Overall Study|Withdrawal by Subject|0|||
161896381|NCT00248833|584668420|FG001|Overall Study|Withdrawal by Subject|1|||
161896382|NCT00248833|584668421|FG002|Overall Study|Withdrawal by Subject|1|||
161896383|NCT00248833|584668419|FG000|Overall Study|Lost to Follow-up|1|||
161896384|NCT00248833|584668420|FG001|Overall Study|Lost to Follow-up|1|||
161896385|NCT00248833|584668421|FG002|Overall Study|Lost to Follow-up|1|||
161782572|NCT03454672|584248130|FG001|Overall Study|Non-compliance|4|||
161896386|NCT00248833|584668419|FG000|Overall Study|Other|0|||
161896387|NCT00248833|584668420|FG001|Overall Study|Other|1|||
161896388|NCT00248833|584668421|FG002|Overall Study|Other|0|||
161896389|NCT02427802|584668425|FG000|Overall Study|Adverse Event|11|||
161782573|NCT03454672|584248129|FG000|Overall Study|personal reasons|3|||
161782574|NCT03454672|584248130|FG001|Overall Study|personal reasons|2|||
161896390|NCT02427802|584668426|FG001|Overall Study|Adverse Event|3|||
161896391|NCT02427802|584668427|FG002|Overall Study|Adverse Event|7|||
161896392|NCT02427802|584668425|FG000|Overall Study|Death|0|||
161896393|NCT02427802|584668426|FG001|Overall Study|Death|4|||
161896394|NCT02427802|584668427|FG002|Overall Study|Death|1|||
161896395|NCT02427802|584668425|FG000|Overall Study|Lost to Follow-up|13|||
161896396|NCT02427802|584668426|FG001|Overall Study|Lost to Follow-up|8|||
161896397|NCT02427802|584668427|FG002|Overall Study|Lost to Follow-up|8|||
161896398|NCT02427802|584668425|FG000|Overall Study|Physician Decision|4|||
161896399|NCT02427802|584668426|FG001|Overall Study|Physician Decision|2|||
161896400|NCT02427802|584668427|FG002|Overall Study|Physician Decision|4|||
161896401|NCT02427802|584668425|FG000|Overall Study|Withdrawal by Subject|10|||
161896402|NCT02427802|584668426|FG001|Overall Study|Withdrawal by Subject|5|||
161896403|NCT02427802|584668427|FG002|Overall Study|Withdrawal by Subject|11|||
161896404|NCT02427802|584668425|FG000|Overall Study|Protocol Violation|3|||
161896405|NCT02427802|584668426|FG001|Overall Study|Protocol Violation|1|||
161896406|NCT02427802|584668427|FG002|Overall Study|Protocol Violation|1|||
161896407|NCT02427802|584668425|FG000|Overall Study|protocol specific treatment unrelated|18|||
161896408|NCT02427802|584668426|FG001|Overall Study|protocol specific treatment unrelated|11|||
161896409|NCT02427802|584668427|FG002|Overall Study|protocol specific treatment unrelated|11|||
161896410|NCT02226120|584668428|FG000|Overall Study|Adverse Event|60|||
161896411|NCT02226120|584668428|FG000|Overall Study|Death|172|||
161896412|NCT02226120|584668428|FG000|Overall Study|Study terminated by sponsor|1|||
161896413|NCT02226120|584668428|FG000|Overall Study|Technical problems|4|||
161896414|NCT02226120|584668428|FG000|Overall Study|Lost to Follow-up|13|||
161896415|NCT02226120|584668428|FG000|Overall Study|Physician Decision|21|||
161896416|NCT02226120|584668428|FG000|Overall Study|Withdrawal by parent/guardian|36|||
161896417|NCT02226120|584668428|FG000|Overall Study|Non-compliance with study drug|10|||
161896418|NCT02226120|584668428|FG000|Overall Study|Protocol deviation|1|||
161896419|NCT02226120|584668428|FG000|Overall Study|missing treatment disposition pages|2|||
161896420|NCT00467558|584668431|FG000|Overall Study|Lost to Follow-up|2|||
161896421|NCT00467558|584668432|FG001|Overall Study|Lost to Follow-up|0|||
161896422|NCT02636439|584668434|FG000|Overall Study|Adverse Event|2|||
161896423|NCT02636439|584668435|FG001|Overall Study|Adverse Event|2|||
161896424|NCT02636439|584668434|FG000|Overall Study|Lost to Follow-up|1|||
161896425|NCT02636439|584668435|FG001|Overall Study|Lost to Follow-up|0|||
161896426|NCT02636439|584668434|FG000|Overall Study|Non-compliance|1|||
161896427|NCT02636439|584668435|FG001|Overall Study|Non-compliance|1|||
161896428|NCT02636439|584668434|FG000|Overall Study|Personal reasons|2|||
161896429|NCT02636439|584668435|FG001|Overall Study|Personal reasons|0|||
161896430|NCT02494401|584668436|FG000|Overall Study|Lost to Follow-up|22|||
161896431|NCT02494401|584668437|FG001|Overall Study|Lost to Follow-up|25|||
161896432|NCT02494401|584668436|FG000|Overall Study|Withdrawal by Subject|3|||
161896433|NCT02494401|584668437|FG001|Overall Study|Withdrawal by Subject|2|||
161896434|NCT05188729|584668438|FG000|Overall Study|Withdrawal by Subject|0|||
161896435|NCT05188729|584668439|FG001|Overall Study|Withdrawal by Subject|0|||
161896436|NCT05188729|584668440|FG002|Overall Study|Withdrawal by Subject|0|||
161896437|NCT05188729|584668441|FG003|Overall Study|Withdrawal by Subject|0|||
161896438|NCT05188729|584668442|FG004|Overall Study|Withdrawal by Subject|0|||
161896439|NCT05188729|584668443|FG005|Overall Study|Withdrawal by Subject|0|||
161896440|NCT05188729|584668444|FG006|Overall Study|Withdrawal by Subject|0|||
161896441|NCT05188729|584668445|FG007|Overall Study|Withdrawal by Subject|0|||
161896442|NCT05188729|584668446|FG008|Overall Study|Withdrawal by Subject|0|||
161896443|NCT05188729|584668447|FG009|Overall Study|Withdrawal by Subject|1|||
161896444|NCT05188729|584668448|FG010|Overall Study|Withdrawal by Subject|0|||
161896445|NCT05188729|584668449|FG011|Overall Study|Withdrawal by Subject|0|||
161896446|NCT05188729|584668450|FG012|Overall Study|Withdrawal by Subject|0|||
161896447|NCT05188729|584668438|FG000|Overall Study|Lost to Follow-up|0|||
161896448|NCT05188729|584668439|FG001|Overall Study|Lost to Follow-up|0|||
161896449|NCT05188729|584668440|FG002|Overall Study|Lost to Follow-up|0|||
161896450|NCT05188729|584668441|FG003|Overall Study|Lost to Follow-up|0|||
161896451|NCT05188729|584668442|FG004|Overall Study|Lost to Follow-up|0|||
161896452|NCT05188729|584668443|FG005|Overall Study|Lost to Follow-up|0|||
161896453|NCT05188729|584668444|FG006|Overall Study|Lost to Follow-up|0|||
161896454|NCT05188729|584668445|FG007|Overall Study|Lost to Follow-up|0|||
161896455|NCT05188729|584668446|FG008|Overall Study|Lost to Follow-up|0|||
161896456|NCT05188729|584668447|FG009|Overall Study|Lost to Follow-up|0|||
161896457|NCT05188729|584668448|FG010|Overall Study|Lost to Follow-up|1|||
161896458|NCT05188729|584668449|FG011|Overall Study|Lost to Follow-up|1|||
161896459|NCT05188729|584668450|FG012|Overall Study|Lost to Follow-up|0|||
161896460|NCT01073163|584669714|FG000|Overall Study|Adverse Event|1|||
161896461|NCT01073163|584669714|FG000|Overall Study|Disease Progression|1|||
161896462|NCT01073163|584669714|FG000|Overall Study|Early termination|1|||
161896463|NCT00802672|584669715|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
161896464|NCT00802672|584669716|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
161896465|NCT00802672|584669717|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
161896466|NCT00802672|584669715|FG000|Overall Study|Adverse Event|1|||
161896467|NCT00802672|584669716|FG001|Overall Study|Adverse Event|1|||
161896468|NCT00802672|584669717|FG002|Overall Study|Adverse Event|1|||
161896469|NCT00802672|584669715|FG000|Overall Study|Protocol Violation|2|||
161896470|NCT00802672|584669716|FG001|Overall Study|Protocol Violation|1|||
161782575|NCT03454672|584248129|FG000|Overall Study|Withdrawal by Subject|1|||
161782576|NCT03454672|584248130|FG001|Overall Study|Withdrawal by Subject|0|||
161782577|NCT05166512|584248131|FG000|Randomized|Lost to Follow-up|2|||
161782578|NCT05166512|584248132|FG001|Randomized|Lost to Follow-up|0|||
161782579|NCT05166512|584248131|FG000|Randomized|Withdrawal by Subject|1|||
161782580|NCT05166512|584248132|FG001|Randomized|Withdrawal by Subject|0|||
161782581|NCT05166512|584248131|FG000|Baseline Data Collection|Lost to Follow-up|0|||
161782582|NCT05166512|584248132|FG001|Baseline Data Collection|Lost to Follow-up|3|||
161782583|NCT05166512|584248131|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
161782584|NCT05166512|584248132|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
161782585|NCT05166512|584248131|FG000|Baseline Data Collection|Protocol Violation|2|||
161782586|NCT05166512|584248132|FG001|Baseline Data Collection|Protocol Violation|0|||
161782587|NCT05166512|584248131|FG000|4 Month Data Collection|Lost to Follow-up|1|||
161782588|NCT05166512|584248132|FG001|4 Month Data Collection|Lost to Follow-up|0|||
161782589|NCT05166512|584248131|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
161782590|NCT05166512|584248132|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
161782591|NCT05166512|584248131|FG000|12 Month Data Collection|Lost to Follow-up|3|||
161782592|NCT05166512|584248132|FG001|12 Month Data Collection|Lost to Follow-up|1|||
161782593|NCT05166512|584248131|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
161782594|NCT05166512|584248132|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
161782595|NCT00420849|584248133|FG000|Overall Study|Lack of Efficacy|154|||
161782596|NCT00420849|584248133|FG000|Overall Study|Adverse Event|107|||
161782597|NCT00420849|584248133|FG000|Overall Study|Withdrawal by Subject|28|||
161782598|NCT00420849|584248133|FG000|Overall Study|Death|18|||
161782599|NCT00420849|584248133|FG000|Overall Study|Other|14|||
161782600|NCT00420849|584248133|FG000|Overall Study|Transplant|8|||
161782601|NCT00420849|584248133|FG000|Overall Study|Protocol Violation|1|||
161782602|NCT00420849|584248133|FG000|Overall Study|Lost to Follow-up|1|||
161782603|NCT00659581|584248134|FG000|Overall Study|Adverse Event|1006|||
161782604|NCT00659581|584248134|FG000|Overall Study|Lack of Efficacy|1183|||
161782605|NCT00659581|584248134|FG000|Overall Study|Other|6393|||
161782606|NCT05473247|584248135|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
161782607|NCT01892020|584248137|FG000|Period 1|Adverse Event|1|||
161782608|NCT01892020|584248138|FG001|Period 1|Adverse Event|1|||
161782609|NCT01892020|584248137|FG000|Period 1|Protocol Violation|2|||
161782610|NCT01892020|584248138|FG001|Period 1|Protocol Violation|4|||
161782611|NCT01892020|584248137|FG000|Period 1|Unclassified|0|||
161782612|NCT01892020|584248138|FG001|Period 1|Unclassified|1|||
161782613|NCT01892020|584248137|FG000|Period 2|Protocol Violation|1|||
161782614|NCT01892020|584248138|FG001|Period 2|Protocol Violation|0|||
161782615|NCT01831596|584248140|FG000|Overall Study|Other|8|||
161782616|NCT02508649|584248141|FG000|Overall Study|Withdrawal by Subject|4|||
161782617|NCT02508649|584248142|FG001|Overall Study|Withdrawal by Subject|6|||
161782618|NCT02508649|584248143|FG002|Overall Study|Withdrawal by Subject|5|||
161782619|NCT02508649|584248144|FG003|Overall Study|Withdrawal by Subject|6|||
161782620|NCT02508649|584248141|FG000|Overall Study|Investigator withdrew the subject|1|||
161782621|NCT02508649|584248142|FG001|Overall Study|Investigator withdrew the subject|2|||
161782622|NCT02508649|584248143|FG002|Overall Study|Investigator withdrew the subject|1|||
161782623|NCT02508649|584248144|FG003|Overall Study|Investigator withdrew the subject|0|||
161782624|NCT02508649|584248141|FG000|Overall Study|Post randomization screening failure|12|||
161782625|NCT02508649|584248142|FG001|Overall Study|Post randomization screening failure|4|||
161782626|NCT02508649|584248143|FG002|Overall Study|Post randomization screening failure|9|||
161782627|NCT02508649|584248144|FG003|Overall Study|Post randomization screening failure|3|||
161782628|NCT02508649|584248141|FG000|Overall Study|Lost to Follow-up|1|||
161782629|NCT02508649|584248142|FG001|Overall Study|Lost to Follow-up|1|||
161782630|NCT02508649|584248143|FG002|Overall Study|Lost to Follow-up|0|||
161782631|NCT02508649|584248144|FG003|Overall Study|Lost to Follow-up|1|||
161782632|NCT00446134|584248145|FG000|Overall Study|Adverse Event|7|||
161782633|NCT00446134|584248146|FG001|Overall Study|Adverse Event|17|||
161782634|NCT00446134|584248147|FG002|Overall Study|Adverse Event|13|||
161782635|NCT00446134|584248148|FG003|Overall Study|Adverse Event|18|||
161782636|NCT00446134|584248145|FG000|Overall Study|Lack of Efficacy|19|||
161782637|NCT00446134|584248146|FG001|Overall Study|Lack of Efficacy|19|||
161782638|NCT00446134|584248147|FG002|Overall Study|Lack of Efficacy|24|||
161782639|NCT00446134|584248148|FG003|Overall Study|Lack of Efficacy|19|||
161782640|NCT00446134|584248145|FG000|Overall Study|Protocol Violation|0|||
161782641|NCT00446134|584248146|FG001|Overall Study|Protocol Violation|2|||
161782642|NCT00446134|584248147|FG002|Overall Study|Protocol Violation|1|||
161782643|NCT00446134|584248148|FG003|Overall Study|Protocol Violation|0|||
161782644|NCT00446134|584248145|FG000|Overall Study|Lost to Follow-up|1|||
161782645|NCT00446134|584248146|FG001|Overall Study|Lost to Follow-up|3|||
161782646|NCT00446134|584248147|FG002|Overall Study|Lost to Follow-up|1|||
161782647|NCT00446134|584248148|FG003|Overall Study|Lost to Follow-up|1|||
161782648|NCT00446134|584248145|FG000|Overall Study|Withdrawal by Subject|3|||
161782649|NCT00446134|584248146|FG001|Overall Study|Withdrawal by Subject|3|||
161896471|NCT00802672|584669717|FG002|Overall Study|Protocol Violation|1|||
161782650|NCT00446134|584248147|FG002|Overall Study|Withdrawal by Subject|1|||
161782651|NCT00446134|584248148|FG003|Overall Study|Withdrawal by Subject|3|||
161782652|NCT00446134|584248145|FG000|Overall Study|Physician Decision|0|||
161782653|NCT00446134|584248146|FG001|Overall Study|Physician Decision|0|||
161782654|NCT00446134|584248147|FG002|Overall Study|Physician Decision|0|||
161782655|NCT00446134|584248148|FG003|Overall Study|Physician Decision|2|||
161782656|NCT00446134|584248145|FG000|Overall Study|Adverse Event-Diarrhea|1|||
161782657|NCT00446134|584248146|FG001|Overall Study|Adverse Event-Diarrhea|1|||
161782658|NCT00446134|584248147|FG002|Overall Study|Adverse Event-Diarrhea|2|||
161782659|NCT00446134|584248148|FG003|Overall Study|Adverse Event-Diarrhea|0|||
161782660|NCT00446134|584248145|FG000|Overall Study|Reason Not Completed|3|||
161782661|NCT00446134|584248146|FG001|Overall Study|Reason Not Completed|0|||
161782662|NCT00446134|584248147|FG002|Overall Study|Reason Not Completed|1|||
161782663|NCT00446134|584248148|FG003|Overall Study|Reason Not Completed|2|||
161782664|NCT00567996|584248152|FG000|Overall Study|Adverse Event|18|||
161782665|NCT00567996|584248153|FG001|Overall Study|Adverse Event|16|||
161782666|NCT00567996|584248154|FG002|Overall Study|Adverse Event|13|||
161782667|NCT00567996|584248152|FG000|Overall Study|Protocol Deviation|9|||
161782668|NCT00567996|584248153|FG001|Overall Study|Protocol Deviation|11|||
161782669|NCT00567996|584248154|FG002|Overall Study|Protocol Deviation|13|||
161782670|NCT00567996|584248152|FG000|Overall Study|Withdrawal by Subject|8|||
161782671|NCT00567996|584248153|FG001|Overall Study|Withdrawal by Subject|12|||
161782672|NCT00567996|584248154|FG002|Overall Study|Withdrawal by Subject|22|||
161782673|NCT00567996|584248152|FG000|Overall Study|Abnormal Lab value(s)|2|||
161782674|NCT00567996|584248153|FG001|Overall Study|Abnormal Lab value(s)|1|||
161782675|NCT00567996|584248154|FG002|Overall Study|Abnormal Lab value(s)|2|||
161782676|NCT00567996|584248152|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161782677|NCT00567996|584248153|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161782678|NCT00567996|584248154|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161782679|NCT00567996|584248152|FG000|Overall Study|Lost to Follow-up|2|||
161782680|NCT00567996|584248153|FG001|Overall Study|Lost to Follow-up|5|||
161782681|NCT00567996|584248154|FG002|Overall Study|Lost to Follow-up|2|||
161782682|NCT00567996|584248152|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161782683|NCT00567996|584248153|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161782684|NCT00567996|584248154|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
161782685|NCT00567996|584248152|FG000|Overall Study|Administrative problems|1|||
161782686|NCT00567996|584248153|FG001|Overall Study|Administrative problems|1|||
161782687|NCT00567996|584248154|FG002|Overall Study|Administrative problems|0|||
161782688|NCT00567996|584248152|FG000|Overall Study|Death|1|||
161782689|NCT00567996|584248153|FG001|Overall Study|Death|0|||
161782690|NCT00567996|584248154|FG002|Overall Study|Death|2|||
161782691|NCT00567996|584248152|FG000|Overall Study|Patient's inability to use the device|0|||
161782692|NCT00567996|584248153|FG001|Overall Study|Patient's inability to use the device|1|||
161782693|NCT00567996|584248154|FG002|Overall Study|Patient's inability to use the device|0|||
161782694|NCT02956005|584248155|FG000|Overall Study|Not eligible|1|||
161782695|NCT02956005|584248155|FG000|Overall Study|Withdrawal by Subject|3|||
162122894|NCT00744237|585502349|FG002|Overall Study|Administrative. Site Closed|1|||
162122895|NCT00744237|585502347|FG000|Overall Study|Adverse Event|9|||
162122896|NCT00744237|585502348|FG001|Overall Study|Adverse Event|13|||
162122897|NCT00744237|585502349|FG002|Overall Study|Adverse Event|5|||
162122898|NCT02032173|585502352|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
162122899|NCT02291289|585502356|FG000|Induction Treatment|Withdrawal by Subject|0|||
162122900|NCT02291289|585502357|FG001|Induction Treatment|Withdrawal by Subject|0|||
162122901|NCT02291289|585502358|FG002|Induction Treatment|Withdrawal by Subject|0|||
161782696|NCT02956005|584248155|FG000|Overall Study|Physician Decision|12|||
161782697|NCT03125629|584248156|FG000|Overall Study|Withdrawal by Subject|2|||
161782698|NCT03125629|584248156|FG000|Overall Study|Equipment malfunction|1|||
161782699|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782700|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782701|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782702|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161782703|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161782704|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782705|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782706|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782707|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782708|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161782709|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782710|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782711|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
162122902|NCT02291289|585502359|FG003|Induction Treatment|Withdrawal by Subject|24|||
162122903|NCT02291289|585502360|FG004|Induction Treatment|Withdrawal by Subject|0|||
161782712|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
161782713|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161782714|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
161782715|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
161782716|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
161782717|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161782718|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782719|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782720|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782721|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782722|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782723|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
161782724|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782725|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782726|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782727|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
161782728|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782729|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782730|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782731|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
161782732|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
161782733|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
161782734|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
161782735|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
161782736|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161782737|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
161782738|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782739|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782740|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782741|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782742|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
161782743|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782744|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782745|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782746|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782747|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782748|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782749|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782750|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782751|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
161782752|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782753|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782754|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
161782755|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161782756|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782757|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782758|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782759|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782760|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782761|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782762|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782763|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782764|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782765|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782766|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
161782767|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782768|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782769|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
161782770|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782771|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161896472|NCT00802672|584669715|FG000|Overall Study|Lost to Follow-up|5|||
161896473|NCT00802672|584669716|FG001|Overall Study|Lost to Follow-up|5|||
161896474|NCT00802672|584669717|FG002|Overall Study|Lost to Follow-up|3|||
161896475|NCT00802672|584669715|FG000|Overall Study|Withdrawal by Subject|1|||
161896476|NCT00802672|584669716|FG001|Overall Study|Withdrawal by Subject|1|||
161782772|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
161782773|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
161782774|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161782775|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161782776|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
161782777|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782778|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161782779|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782780|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782781|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161782782|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782783|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782784|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782785|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161782786|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782787|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161782788|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
161782789|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
161782790|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
161782791|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
161782792|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
161782793|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161782794|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782795|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782796|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
161782797|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782798|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782799|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782800|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782801|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782802|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782803|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782804|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782805|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782806|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782807|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782808|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782809|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161782810|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
161782811|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
161782812|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161782813|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782814|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782815|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782816|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782817|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
161782818|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782819|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782820|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782821|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782822|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
161782823|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782824|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782825|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782826|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782827|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782828|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782829|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782830|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782831|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161782832|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
161782833|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161782834|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161782835|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161782836|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161782837|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
161782838|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161782839|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161782840|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161782841|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161782842|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
161782843|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161782844|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161782845|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
161782846|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161782847|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
161782848|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
161782849|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
161782850|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161782851|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782852|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782853|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782854|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782855|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782856|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782857|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782858|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782859|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782860|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782861|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
161782862|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782863|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782864|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782865|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782866|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782867|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782868|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782869|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161782870|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
161782871|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
161782872|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782873|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782874|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
161782875|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
161782876|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782877|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
161782878|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782879|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
161782880|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782881|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782882|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
161782883|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
161782884|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161782885|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
161782886|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
161782887|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
161782888|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
161782889|NCT01915498|584248159|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
161782890|NCT01915498|584248160|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
161782891|NCT01915498|584248161|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
161782892|NCT01915498|584248162|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
161782893|NCT01915498|584248163|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
161782894|NCT01915498|584248164|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
161782895|NCT01915498|584248165|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
161782896|NCT01915498|584248166|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
161782897|NCT01915498|584248167|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
161782898|NCT01915498|584248168|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
161782899|NCT01915498|584248169|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
161782900|NCT01915498|584248170|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
161831481|NCT01730040|584424761|FG004|Overall Study|Adverse Event|1|||
161782901|NCT01915498|584248171|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
161782902|NCT01915498|584248172|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
161782903|NCT01915498|584248173|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
161782904|NCT01915498|584248174|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
161782905|NCT01915498|584248175|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
161782906|NCT01915498|584248176|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
161782907|NCT01915498|584248177|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
161782908|NCT01915498|584248159|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782909|NCT01915498|584248160|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782910|NCT01915498|584248161|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782911|NCT01915498|584248162|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782912|NCT01915498|584248163|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782913|NCT01915498|584248164|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782914|NCT01915498|584248165|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782915|NCT01915498|584248166|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782916|NCT01915498|584248167|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782917|NCT01915498|584248168|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782918|NCT01915498|584248169|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782919|NCT01915498|584248170|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782920|NCT01915498|584248171|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782921|NCT01915498|584248172|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782922|NCT01915498|584248173|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782923|NCT01915498|584248174|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782924|NCT01915498|584248175|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782925|NCT01915498|584248176|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161782926|NCT01915498|584248177|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
161782927|NCT01915498|584248159|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782928|NCT01915498|584248160|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782929|NCT01915498|584248161|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782930|NCT01915498|584248162|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782931|NCT01915498|584248163|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782932|NCT01915498|584248164|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782933|NCT01915498|584248165|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782934|NCT01915498|584248166|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782935|NCT01915498|584248167|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782936|NCT01915498|584248168|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782937|NCT01915498|584248169|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782938|NCT01915498|584248170|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782939|NCT01915498|584248171|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782940|NCT01915498|584248172|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782941|NCT01915498|584248173|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782942|NCT01915498|584248174|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782943|NCT01915498|584248175|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782944|NCT01915498|584248176|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161782945|NCT01915498|584248177|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
161782946|NCT01915498|584248159|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782947|NCT01915498|584248160|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782948|NCT01915498|584248161|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782949|NCT01915498|584248162|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782950|NCT01915498|584248163|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782951|NCT01915498|584248164|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782952|NCT01915498|584248165|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782953|NCT01915498|584248166|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782954|NCT01915498|584248167|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782955|NCT01915498|584248168|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782956|NCT01915498|584248169|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782957|NCT01915498|584248170|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782958|NCT01915498|584248171|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782959|NCT01915498|584248172|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782960|NCT01915498|584248173|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782961|NCT01915498|584248174|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782962|NCT01915498|584248175|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782963|NCT01915498|584248176|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161782964|NCT01915498|584248177|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
161782965|NCT02524665|584248180|FG000|Overall Study|Lost to Follow-up|1|||
161782966|NCT00314262|584248184|FG000|Overall Study|Adverse Event|2|||
161782967|NCT00314262|584248184|FG000|Overall Study|Withdrawal by Subject|2|||
161782968|NCT00314262|584248184|FG000|Overall Study|Physician Decision|1|||
161782969|NCT01185639|584248185|FG000|Overall Study|Progressed and didn't receive therapy|2|||
161782970|NCT02662556|584248186|FG000|Overall Study|Adverse Event|4|||
161782971|NCT02662556|584248186|FG000|Overall Study|Lack of Efficacy|4|||
161782972|NCT02499406|584249930|FG000|Overall Study|missed 3 treatment sessions|4|||
161782973|NCT01399125|584249931|FG000|Overall Study|Adverse Event|32|||
161782974|NCT01399125|584249932|FG001|Overall Study|Adverse Event|30|||
161782975|NCT01399125|584249931|FG000|Overall Study|Abnormal Lab values|0|||
161782976|NCT01399125|584249932|FG001|Overall Study|Abnormal Lab values|1|||
161782977|NCT01399125|584249931|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161782978|NCT01399125|584249932|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
161782979|NCT01399125|584249931|FG000|Overall Study|Withdrawal by Subject|5|||
161782980|NCT01399125|584249932|FG001|Overall Study|Withdrawal by Subject|8|||
161782981|NCT01399125|584249931|FG000|Overall Study|Lost to Follow-up|2|||
161782982|NCT01399125|584249932|FG001|Overall Study|Lost to Follow-up|3|||
161782983|NCT01399125|584249931|FG000|Overall Study|Administrative Problems|7|||
161782984|NCT01399125|584249932|FG001|Overall Study|Administrative Problems|11|||
161782985|NCT01399125|584249931|FG000|Overall Study|Death|0|||
161782986|NCT01399125|584249932|FG001|Overall Study|Death|1|||
161782987|NCT01399125|584249931|FG000|Overall Study|Protocol Deviation|5|||
161782988|NCT01399125|584249932|FG001|Overall Study|Protocol Deviation|2|||
161782989|NCT00563524|584249935|FG000|Overall Study|Adverse Event|0|||
161782990|NCT00563524|584249936|FG001|Overall Study|Adverse Event|1|||
161782991|NCT00563524|584249937|FG002|Overall Study|Adverse Event|0|||
161782992|NCT00563524|584249938|FG003|Overall Study|Adverse Event|0|||
161782993|NCT00563524|584249939|FG004|Overall Study|Adverse Event|2|||
161782994|NCT00563524|584249940|FG005|Overall Study|Adverse Event|0|||
161782995|NCT00563524|584249935|FG000|Overall Study|Lost to Follow-up|1|||
161782996|NCT00563524|584249936|FG001|Overall Study|Lost to Follow-up|0|||
161782997|NCT00563524|584249937|FG002|Overall Study|Lost to Follow-up|0|||
161782998|NCT00563524|584249938|FG003|Overall Study|Lost to Follow-up|0|||
161782999|NCT00563524|584249939|FG004|Overall Study|Lost to Follow-up|0|||
161783000|NCT00563524|584249940|FG005|Overall Study|Lost to Follow-up|0|||
161783001|NCT00563524|584249935|FG000|Overall Study|Protocol Violation|0|||
161783002|NCT00563524|584249936|FG001|Overall Study|Protocol Violation|1|||
161783003|NCT00563524|584249937|FG002|Overall Study|Protocol Violation|0|||
161783004|NCT00563524|584249938|FG003|Overall Study|Protocol Violation|0|||
161783005|NCT00563524|584249939|FG004|Overall Study|Protocol Violation|0|||
161783006|NCT00563524|584249940|FG005|Overall Study|Protocol Violation|0|||
161783007|NCT00563524|584249935|FG000|Overall Study|Withdrawal by Subject|1|||
161783008|NCT00563524|584249936|FG001|Overall Study|Withdrawal by Subject|1|||
161783009|NCT00563524|584249937|FG002|Overall Study|Withdrawal by Subject|3|||
161783010|NCT00563524|584249938|FG003|Overall Study|Withdrawal by Subject|0|||
161783011|NCT00563524|584249939|FG004|Overall Study|Withdrawal by Subject|0|||
161783012|NCT00563524|584249940|FG005|Overall Study|Withdrawal by Subject|1|||
161783013|NCT01467570|584249942|FG000|Overall Study|Lost to Follow-up|8|||
161783014|NCT01467570|584249943|FG001|Overall Study|Lost to Follow-up|9|||
161783015|NCT02626182|584249952|FG000|Overall Study|Adverse Event|2|||
161783016|NCT02626182|584249953|FG001|Overall Study|Adverse Event|0|||
161783017|NCT02766088|584249958|FG000|Overall Study|Sponsor study termination|498|||
161783018|NCT02766088|584249958|FG000|Overall Study|Migrated/moved from the study area|1|||
161783019|NCT02766088|584249958|FG000|Overall Study|Lost to Follow-up|5|||
161783020|NCT02766088|584249958|FG000|Overall Study|Other|1|||
161783021|NCT02766088|584249958|FG000|Overall Study|Death|1|||
161783022|NCT01222715|584249959|FG000|Overall Study|Adverse Event|0|||
161783023|NCT01222715|584249960|FG001|Overall Study|Adverse Event|4|||
161783024|NCT01222715|584249959|FG000|Overall Study|Death|0|||
161783025|NCT01222715|584249960|FG001|Overall Study|Death|1|||
161783026|NCT01222715|584249959|FG000|Overall Study|Lack of Efficacy|22|||
161896477|NCT00802672|584669717|FG002|Overall Study|Withdrawal by Subject|2|||
161783027|NCT01222715|584249960|FG001|Overall Study|Lack of Efficacy|14|||
161783028|NCT01222715|584249959|FG000|Overall Study|Physician Decision|12|||
161783029|NCT01222715|584249960|FG001|Overall Study|Physician Decision|2|||
161783030|NCT01222715|584249959|FG000|Overall Study|Refusal of further protocol therapy|0|||
161783031|NCT01222715|584249960|FG001|Overall Study|Refusal of further protocol therapy|4|||
161783032|NCT01222715|584249959|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
161783033|NCT01222715|584249960|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
161783034|NCT01222715|584249959|FG000|Overall Study|Ineligible|0|||
161783035|NCT01222715|584249960|FG001|Overall Study|Ineligible|1|||
161783036|NCT01222715|584249959|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
161783037|NCT01222715|584249960|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
161783038|NCT03836729|584249961|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
161783039|NCT00763269|584249968|FG000|Overall Study|Lost to Follow-up|12|||
161783040|NCT00763269|584249969|FG001|Overall Study|Lost to Follow-up|13|||
161783041|NCT00520494|584249975|FG000|Overall Study|Withdrawal by Subject|1|||
161783042|NCT00544557|584249978|FG000|Overall Study|Adverse Event|140|||
161783043|NCT00544557|584249978|FG000|Overall Study|Lack of Efficacy|196|||
161783044|NCT00544557|584249978|FG000|Overall Study|Other|98|||
161783045|NCT00467818|584249979|FG000|Overall Study|Adverse Event|1|||
161783046|NCT00467818|584249980|FG001|Overall Study|Adverse Event|0|||
161783047|NCT00467818|584249979|FG000|Overall Study|Lost to Follow-up|2|||
161783048|NCT00467818|584249980|FG001|Overall Study|Lost to Follow-up|2|||
161783049|NCT01830920|584249982|FG000|Overall Study|Adverse Event|1|||
161783050|NCT01830920|584249983|FG001|Overall Study|Adverse Event|0|||
161783051|NCT01830920|584249984|FG002|Overall Study|Adverse Event|1|||
161783052|NCT01830920|584249985|FG003|Overall Study|Adverse Event|0|||
161783053|NCT01830920|584249986|FG004|Overall Study|Adverse Event|0|||
161783054|NCT01830920|584249982|FG000|Overall Study|Withdrawal by Subject|2|||
161783055|NCT01830920|584249983|FG001|Overall Study|Withdrawal by Subject|2|||
161783056|NCT01830920|584249984|FG002|Overall Study|Withdrawal by Subject|1|||
161783057|NCT01830920|584249985|FG003|Overall Study|Withdrawal by Subject|7|||
161783058|NCT01830920|584249986|FG004|Overall Study|Withdrawal by Subject|1|||
161783059|NCT01830920|584249982|FG000|Overall Study|Death|3|||
161783060|NCT01830920|584249983|FG001|Overall Study|Death|3|||
161783061|NCT01830920|584249984|FG002|Overall Study|Death|5|||
161783062|NCT01830920|584249985|FG003|Overall Study|Death|4|||
161783063|NCT01830920|584249986|FG004|Overall Study|Death|4|||
161783064|NCT01830920|584249982|FG000|Overall Study|Other|15|||
161783065|NCT01830920|584249983|FG001|Overall Study|Other|1|||
161783066|NCT01830920|584249984|FG002|Overall Study|Other|1|||
161783067|NCT01830920|584249985|FG003|Overall Study|Other|5|||
161783068|NCT01830920|584249986|FG004|Overall Study|Other|3|||
161783069|NCT01313728|584249987|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
161783070|NCT02216214|584249988|FG000|Overall Study|Randomized Never Received Study Drug|1|||
161783071|NCT02216214|584249989|FG001|Overall Study|Randomized Never Received Study Drug|0|||
161783072|NCT02216214|584249988|FG000|Overall Study|Adverse Event|10|||
161783073|NCT02216214|584249989|FG001|Overall Study|Adverse Event|8|||
161783074|NCT02216214|584249988|FG000|Overall Study|Lack of Efficacy|2|||
161783075|NCT02216214|584249989|FG001|Overall Study|Lack of Efficacy|2|||
161783076|NCT02216214|584249988|FG000|Overall Study|Lost to Follow-up|3|||
161783077|NCT02216214|584249989|FG001|Overall Study|Lost to Follow-up|2|||
161783078|NCT02216214|584249988|FG000|Overall Study|Protocol Violation|4|||
161783079|NCT02216214|584249989|FG001|Overall Study|Protocol Violation|2|||
161783080|NCT02216214|584249988|FG000|Overall Study|Withdrawal by Subject|22|||
161783081|NCT02216214|584249989|FG001|Overall Study|Withdrawal by Subject|20|||
161783082|NCT02216214|584249988|FG000|Overall Study|Study Terminated By Sponsor|0|||
161783083|NCT02216214|584249989|FG001|Overall Study|Study Terminated By Sponsor|1|||
161783084|NCT02216214|584249988|FG000|Overall Study|Miscellaneous|1|||
161783085|NCT02216214|584249989|FG001|Overall Study|Miscellaneous|1|||
161783086|NCT05354206|584249991|FG000|Overall Study|Withdrawal by Subject|1|||
161783087|NCT05354206|584249992|FG001|Overall Study|Withdrawal by Subject|0|||
161783088|NCT00713830|584249993|FG000|Overall Study|Adverse Event|23|||
161783089|NCT00713830|584249994|FG001|Overall Study|Adverse Event|71|||
161783090|NCT00713830|584249993|FG000|Overall Study|Lack of Efficacy|24|||
161783091|NCT00713830|584249994|FG001|Overall Study|Lack of Efficacy|16|||
161783092|NCT00713830|584249993|FG000|Overall Study|Lost to Follow-up|2|||
161783093|NCT00713830|584249994|FG001|Overall Study|Lost to Follow-up|9|||
161783094|NCT00713830|584249993|FG000|Overall Study|Withdrawal by Subject|13|||
161783095|NCT00713830|584249994|FG001|Overall Study|Withdrawal by Subject|23|||
161783096|NCT00713830|584249993|FG000|Overall Study|Poor Compliance to Protocol|7|||
161783097|NCT00713830|584249994|FG001|Overall Study|Poor Compliance to Protocol|14|||
161783098|NCT00713830|584249993|FG000|Overall Study|Familial and Personal Reasons|9|||
161783099|NCT00713830|584249994|FG001|Overall Study|Familial and Personal Reasons|34|||
161783100|NCT00713830|584249993|FG000|Overall Study|Sponsor Decision|4|||
161783101|NCT00713830|584249994|FG001|Overall Study|Sponsor Decision|10|||
161783102|NCT02702271|584250000|FG000|Overall Study|Death|36|||
161783103|NCT02702271|584250001|FG001|Overall Study|Death|7|||
161783104|NCT02702271|584250000|FG000|Overall Study|Lost to Follow-up|12|||
161783105|NCT02702271|584250001|FG001|Overall Study|Lost to Follow-up|0|||
161783106|NCT02702271|584250000|FG000|Overall Study|Withdrawal by Subject|8|||
161783107|NCT02702271|584250001|FG001|Overall Study|Withdrawal by Subject|1|||
161783108|NCT02702271|584250000|FG000|Overall Study|Physician Decision|2|||
161783109|NCT02702271|584250001|FG001|Overall Study|Physician Decision|0|||
161783110|NCT02702271|584250000|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
161783111|NCT02702271|584250001|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
161783112|NCT01494649|584250002|FG000|Overall Study|Lost to Follow-up|0|||
161783113|NCT01494649|584250003|FG001|Overall Study|Lost to Follow-up|1|||
161783114|NCT00363129|584250006|FG000|Overall Study|Withdrawal by Subject|11|||
161783115|NCT00363129|584250007|FG001|Overall Study|Withdrawal by Subject|18|||
161783116|NCT00363129|584250006|FG000|Overall Study|Adverse Event|8|||
161783117|NCT00363129|584250007|FG001|Overall Study|Adverse Event|3|||
161783118|NCT00363129|584250006|FG000|Overall Study|Alternate Treatment|2|||
161783119|NCT00363129|584250007|FG001|Overall Study|Alternate Treatment|4|||
161783120|NCT00363129|584250006|FG000|Overall Study|Other Medical Problems|2|||
161783121|NCT00363129|584250007|FG001|Overall Study|Other Medical Problems|4|||
161783122|NCT00363129|584250006|FG000|Overall Study|Death|0|||
161783123|NCT00363129|584250007|FG001|Overall Study|Death|1|||
161783124|NCT00363129|584250006|FG000|Overall Study|Other Reasons|6|||
161783125|NCT00363129|584250007|FG001|Overall Study|Other Reasons|3|||
161783126|NCT01345058|584250011|FG000|Overall Study|Withdrawal by Subject|1|||
161783127|NCT01345058|584250012|FG001|Overall Study|Withdrawal by Subject|0|||
161783128|NCT01345058|584250011|FG000|Overall Study|Participant Reported Increase in Events|1|||
161783129|NCT01345058|584250012|FG001|Overall Study|Participant Reported Increase in Events|0|||
161783130|NCT01345058|584250011|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
161783131|NCT01345058|584250012|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
161783132|NCT01345058|584250011|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
161783133|NCT01345058|584250012|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
161783134|NCT01345058|584250011|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
161783135|NCT01345058|584250012|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
161783136|NCT00000135|584250013|FG000|Overall Study|Death|27|||
161783137|NCT00000135|584250014|FG001|Overall Study|Death|14|||
161783138|NCT02149199|584250021|FG000|Overall Study|Study specific withdrawal criteria|4|||
161783139|NCT02149199|584250022|FG001|Overall Study|Study specific withdrawal criteria|21|||
161783140|NCT02149199|584250023|FG002|Overall Study|Study specific withdrawal criteria|6|||
161783141|NCT02149199|584250021|FG000|Overall Study|Other|20|||
161783142|NCT02149199|584250022|FG001|Overall Study|Other|25|||
161783143|NCT02149199|584250023|FG002|Overall Study|Other|20|||
161783144|NCT02149199|584250021|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
161783145|NCT02149199|584250022|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
161783146|NCT02149199|584250023|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
161783147|NCT02149199|584250021|FG000|Overall Study|Withdrawal by Subject|75|||
161783148|NCT02149199|584250022|FG001|Overall Study|Withdrawal by Subject|93|||
161783149|NCT02149199|584250023|FG002|Overall Study|Withdrawal by Subject|77|||
161783150|NCT02149199|584250021|FG000|Overall Study|Protocol Violation|16|||
161783151|NCT02149199|584250022|FG001|Overall Study|Protocol Violation|13|||
161783152|NCT02149199|584250023|FG002|Overall Study|Protocol Violation|15|||
161783153|NCT02149199|584250021|FG000|Overall Study|Lost to Follow-up|3|||
161783154|NCT02149199|584250022|FG001|Overall Study|Lost to Follow-up|12|||
161783155|NCT02149199|584250023|FG002|Overall Study|Lost to Follow-up|11|||
161783156|NCT02149199|584250021|FG000|Overall Study|Death|0|||
161783157|NCT02149199|584250022|FG001|Overall Study|Death|0|||
161783158|NCT02149199|584250023|FG002|Overall Study|Death|1|||
161783159|NCT02149199|584250021|FG000|Overall Study|Adverse Event|6|||
161783160|NCT02149199|584250022|FG001|Overall Study|Adverse Event|15|||
161783161|NCT02149199|584250023|FG002|Overall Study|Adverse Event|9|||
161783162|NCT00743119|584250024|FG000|Overall Study|unreliable|3|||
161783163|NCT00743119|584250024|FG000|Overall Study|Withdrawal by Subject|1|||
161783164|NCT02989610|584250025|FG000|Overall Study|Withdrawal by Subject|20|||
161783165|NCT02989610|584250025|FG000|Overall Study|Departure of PI from Site|8|||
161783166|NCT02989610|584250025|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
161783167|NCT02989610|584250025|FG000|Overall Study|Lost to Follow-up|3|||
161783168|NCT02989610|584250025|FG000|Overall Study|Death|3|||
161783169|NCT02989610|584250025|FG000|Overall Study|System Explant|3|||
161783170|NCT02989610|584250025|FG000|Overall Study|Subject Non-Compliance|2|||
161783171|NCT02989610|584250025|FG000|Overall Study|System Revision|2|||
161783172|NCT02989610|584250025|FG000|Overall Study|PI Left, Study Closing|1|||
161783173|NCT02989610|584250025|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
161783174|NCT02989610|584250025|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
161783175|NCT04881448|584250029|FG000|Overall Study|Study cancelled by sponsor|220|||
161783176|NCT04881448|584250029|FG000|Overall Study|Withdrawal by Subject|2|||
161783177|NCT04881448|584250029|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
161783178|NCT01966107|584250031|FG000|Overall Study|excluded from FAS|21|||
162009379|NCT03224819|585090121|FG011|Overall Study|Lost to Follow-up|0|||
162009380|NCT03224819|585090122|FG012|Overall Study|Lost to Follow-up|0|||
162009381|NCT03224819|585090123|FG013|Overall Study|Lost to Follow-up|0|||
162009382|NCT03224819|585090110|FG000|Overall Study|Death|0|||
162009383|NCT03224819|585090111|FG001|Overall Study|Death|1|||
162009384|NCT03224819|585090112|FG002|Overall Study|Death|0|||
162009385|NCT03224819|585090113|FG003|Overall Study|Death|0|||
162009386|NCT03224819|585090114|FG004|Overall Study|Death|0|||
162009387|NCT03224819|585090115|FG005|Overall Study|Death|0|||
162009388|NCT03224819|585090116|FG006|Overall Study|Death|0|||
162009389|NCT03224819|585090117|FG007|Overall Study|Death|1|||
162009390|NCT03224819|585090118|FG008|Overall Study|Death|0|||
162009391|NCT03224819|585090119|FG009|Overall Study|Death|0|||
162009392|NCT03224819|585090120|FG010|Overall Study|Death|0|||
162009393|NCT03224819|585090121|FG011|Overall Study|Death|1|||
162009394|NCT03224819|585090122|FG012|Overall Study|Death|0|||
162009395|NCT03224819|585090123|FG013|Overall Study|Death|0|||
162009396|NCT03783078|585090124|FG000|Overall Study|Death|31|||
162009397|NCT03783078|585090124|FG000|Overall Study|Sponsor Decision|23|||
162009398|NCT03783078|585090124|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162009399|NCT02059278|585090127|FG000|Overall Study|Adverse Event|1|||
161783179|NCT01966107|584250032|FG001|Overall Study|excluded from FAS|20|||
161783180|NCT01966107|584250031|FG000|Overall Study|discontinued treatment|345|||
161783181|NCT01966107|584250032|FG001|Overall Study|discontinued treatment|372|||
161783182|NCT01966107|584250031|FG000|Overall Study|due to study closure|164|||
161783183|NCT01966107|584250032|FG001|Overall Study|due to study closure|186|||
161783184|NCT01966107|584250031|FG000|Overall Study|withdrew from the study|272|||
161783185|NCT01966107|584250032|FG001|Overall Study|withdrew from the study|303|||
161783186|NCT02200614|584250033|FG000|Double Blind Treatment|Adverse Event|86|||
161783187|NCT02200614|584250034|FG001|Double Blind Treatment|Adverse Event|48|||
161783188|NCT02200614|584250033|FG000|Double Blind Treatment|Confirmed metastasis|120|||
161783189|NCT02200614|584250034|FG001|Double Blind Treatment|Confirmed metastasis|140|||
161783190|NCT02200614|584250033|FG000|Double Blind Treatment|Judgment of the investigator|59|||
161783191|NCT02200614|584250034|FG001|Double Blind Treatment|Judgment of the investigator|99|||
161783192|NCT02200614|584250033|FG000|Double Blind Treatment|Metastasis by local reading|1|||
161783193|NCT02200614|584250034|FG001|Double Blind Treatment|Metastasis by local reading|3|||
161783194|NCT02200614|584250033|FG000|Double Blind Treatment|Other reason|6|||
161783195|NCT02200614|584250034|FG001|Double Blind Treatment|Other reason|2|||
161783196|NCT02200614|584250033|FG000|Double Blind Treatment|Personal reason|77|||
161783197|NCT02200614|584250034|FG001|Double Blind Treatment|Personal reason|85|||
161783198|NCT02200614|584250033|FG000|Double Blind Treatment|Protocol deviation|14|||
161783199|NCT02200614|584250034|FG001|Double Blind Treatment|Protocol deviation|7|||
161783200|NCT02200614|584250033|FG000|Double Blind Treatment|Not treated|1|||
161783201|NCT02200614|584250034|FG001|Double Blind Treatment|Not treated|0|||
161783202|NCT02200614|584250033|FG000|Open Label|Adverse Event|41|||
161783203|NCT02200614|584250034|FG001|Open Label|Adverse Event|11|||
161783204|NCT02200614|584250033|FG000|Open Label|Confirmed metastasis|1|||
161783205|NCT02200614|584250034|FG001|Open Label|Confirmed metastasis|0|||
161783206|NCT02200614|584250033|FG000|Open Label|Judgment of the investigator|29|||
161783207|NCT02200614|584250034|FG001|Open Label|Judgment of the investigator|2|||
161783208|NCT02200614|584250033|FG000|Open Label|Metastasis by local reading|138|||
161783209|NCT02200614|584250034|FG001|Open Label|Metastasis by local reading|27|||
161783210|NCT02200614|584250033|FG000|Open Label|Other reason|22|||
161783211|NCT02200614|584250034|FG001|Open Label|Other reason|4|||
161783212|NCT02200614|584250033|FG000|Open Label|Personal reason|60|||
161783213|NCT02200614|584250034|FG001|Open Label|Personal reason|8|||
161783214|NCT02200614|584250033|FG000|Open Label|Protocol deviation|3|||
161783215|NCT02200614|584250034|FG001|Open Label|Protocol deviation|2|||
161783216|NCT02200614|584250033|FG000|Open Label|Missing|2|||
161783217|NCT02200614|584250034|FG001|Open Label|Missing|2|||
161783218|NCT01898884|584250035|FG000|Multiple Dose Period|Adverse Event|0|||
161783219|NCT01898884|584250036|FG001|Multiple Dose Period|Adverse Event|0|||
161783220|NCT01898884|584250037|FG002|Multiple Dose Period|Adverse Event|0|||
161783221|NCT01898884|584250038|FG003|Multiple Dose Period|Adverse Event|0|||
161783222|NCT01898884|584250039|FG004|Multiple Dose Period|Adverse Event|0|||
161783223|NCT01898884|584250040|FG005|Multiple Dose Period|Adverse Event|0|||
161783224|NCT01898884|584250041|FG006|Multiple Dose Period|Adverse Event|1|||
161783225|NCT01898884|584250042|FG007|Multiple Dose Period|Adverse Event|0|||
161783226|NCT01898884|584250043|FG008|Multiple Dose Period|Adverse Event|0|||
161783227|NCT01898884|584250035|FG000|Multiple Dose Period|Randomized Not Treated|0|||
161783228|NCT01898884|584250036|FG001|Multiple Dose Period|Randomized Not Treated|0|||
161783229|NCT01898884|584250037|FG002|Multiple Dose Period|Randomized Not Treated|0|||
161783230|NCT01898884|584250038|FG003|Multiple Dose Period|Randomized Not Treated|0|||
161783231|NCT01898884|584250039|FG004|Multiple Dose Period|Randomized Not Treated|0|||
161783232|NCT01898884|584250040|FG005|Multiple Dose Period|Randomized Not Treated|0|||
161783233|NCT01898884|584250041|FG006|Multiple Dose Period|Randomized Not Treated|0|||
161783234|NCT01898884|584250042|FG007|Multiple Dose Period|Randomized Not Treated|0|||
161783235|NCT01898884|584250043|FG008|Multiple Dose Period|Randomized Not Treated|1|||
161783236|NCT00434148|584250044|FG000|Overall Study|Adverse Event|18|||
161783237|NCT00434148|584250045|FG001|Overall Study|Adverse Event|18|||
161783238|NCT00434148|584250044|FG000|Overall Study|Lack of Efficacy|25|||
161783239|NCT00434148|584250045|FG001|Overall Study|Lack of Efficacy|28|||
161783240|NCT00434148|584250044|FG000|Overall Study|Withdrawal by Subject|15|||
161783241|NCT00434148|584250045|FG001|Overall Study|Withdrawal by Subject|15|||
161783242|NCT00434148|584250044|FG000|Overall Study|Protocol Violation|4|||
161783243|NCT00434148|584250045|FG001|Overall Study|Protocol Violation|0|||
161783244|NCT00434148|584250044|FG000|Overall Study|Administrative problems|6|||
161783245|NCT00434148|584250045|FG001|Overall Study|Administrative problems|10|||
161783246|NCT00434148|584250044|FG000|Overall Study|Lost to Follow-up|0|||
161783247|NCT00434148|584250045|FG001|Overall Study|Lost to Follow-up|1|||
161783248|NCT00434148|584250044|FG000|Overall Study|Condition no longer requires study drug|1|||
161783249|NCT00434148|584250045|FG001|Overall Study|Condition no longer requires study drug|0|||
161783250|NCT00434148|584250044|FG000|Overall Study|Abnormal test procedure result|0|||
161783251|NCT00434148|584250045|FG001|Overall Study|Abnormal test procedure result|1|||
162009400|NCT02059278|585090128|FG001|Overall Study|Adverse Event|1|||
162009401|NCT02059278|585090127|FG000|Overall Study|Lost to Follow-up|1|||
162009402|NCT02059278|585090128|FG001|Overall Study|Lost to Follow-up|0|||
162009403|NCT02059278|585090127|FG000|Overall Study|Withdrawal by Subject|0|||
162009404|NCT02059278|585090128|FG001|Overall Study|Withdrawal by Subject|3|||
162009405|NCT02059278|585090127|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
162009406|NCT02059278|585090128|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
162009407|NCT03955146|585090129|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
162009408|NCT03955146|585090130|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
162009409|NCT03955146|585090131|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
162009410|NCT03955146|585090132|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
162009411|NCT03955146|585090129|FG000|DB Period (48 Weeks)|Adverse Event|2|||
162009412|NCT03955146|585090130|FG001|DB Period (48 Weeks)|Adverse Event|5|||
162009413|NCT03955146|585090131|FG002|DB Period (48 Weeks)|Adverse Event|1|||
162009414|NCT03955146|585090132|FG003|DB Period (48 Weeks)|Adverse Event|2|||
162009415|NCT03955146|585090129|FG000|DB Period (48 Weeks)|Death|13|||
162009416|NCT03955146|585090130|FG001|DB Period (48 Weeks)|Death|17|||
162009417|NCT03955146|585090131|FG002|DB Period (48 Weeks)|Death|1|||
162009418|NCT03955146|585090132|FG003|DB Period (48 Weeks)|Death|0|||
162009419|NCT03955146|585090129|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
162009420|NCT03955146|585090130|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
162009421|NCT03955146|585090131|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
162009422|NCT03955146|585090132|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
162009423|NCT03955146|585090129|FG000|DB Period (48 Weeks)|Disease Progression|2|||
162009424|NCT03955146|585090130|FG001|DB Period (48 Weeks)|Disease Progression|0|||
162009425|NCT03955146|585090131|FG002|DB Period (48 Weeks)|Disease Progression|0|||
162009426|NCT03955146|585090132|FG003|DB Period (48 Weeks)|Disease Progression|0|||
162009427|NCT03955146|585090129|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
162009428|NCT03955146|585090130|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
162009429|NCT03955146|585090131|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
162009430|NCT03955146|585090132|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
162009431|NCT03955146|585090129|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
162009432|NCT03955146|585090130|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
162009433|NCT03955146|585090131|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
162009434|NCT03955146|585090132|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
162009435|NCT03955146|585090129|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
162009436|NCT03955146|585090130|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
162009437|NCT03955146|585090131|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
162009438|NCT03955146|585090132|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
162009439|NCT03955146|585090129|FG000|DB Period (48 Weeks)|Participant Decision|9|||
162009440|NCT03955146|585090130|FG001|DB Period (48 Weeks)|Participant Decision|12|||
162009441|NCT03955146|585090131|FG002|DB Period (48 Weeks)|Participant Decision|1|||
162009442|NCT03955146|585090132|FG003|DB Period (48 Weeks)|Participant Decision|1|||
162009443|NCT03955146|585090129|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
162009444|NCT03955146|585090130|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
162009445|NCT03955146|585090131|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
162009446|NCT03955146|585090132|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
162009447|NCT03955146|585090129|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
162009448|NCT03955146|585090130|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
162009449|NCT03955146|585090131|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
162009450|NCT03955146|585090132|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
162009451|NCT03955146|585090129|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
162009452|NCT03955146|585090130|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
162009453|NCT03955146|585090131|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
162009454|NCT03955146|585090132|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
162009455|NCT03955146|585090129|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
162009456|NCT03955146|585090130|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
162009457|NCT03955146|585090131|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
162009458|NCT03955146|585090132|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
162009459|NCT03955146|585090129|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
162009460|NCT03955146|585090130|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
162009461|NCT03955146|585090131|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
162009462|NCT03955146|585090132|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
162009463|NCT03955146|585090129|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
162009464|NCT03955146|585090130|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
162009465|NCT03955146|585090131|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
162009466|NCT03955146|585090132|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
162009467|NCT03955146|585090129|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
162009468|NCT03955146|585090130|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
162009469|NCT03955146|585090131|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
162236365|NCT00250679|585916936|FG001|Overall Study|Non-compliance|1|||
161783252|NCT00759759|584250046|FG000|Overall Study|didn't return for period 2|1|||
161783253|NCT00759759|584250047|FG001|Overall Study|didn't return for period 2|0|||
161783254|NCT00759759|584250046|FG000|Overall Study|Didn't receive drug in period 2|1|||
161783255|NCT00759759|584250047|FG001|Overall Study|Didn't receive drug in period 2|0|||
161783256|NCT00759759|584250046|FG000|Overall Study|Withdrawal by Subject|2|||
161783257|NCT00759759|584250047|FG001|Overall Study|Withdrawal by Subject|1|||
161783258|NCT01556165|584250051|FG000|Overall Study|Adverse Event|5|||
161783259|NCT01556165|584250052|FG001|Overall Study|Adverse Event|3|||
161783260|NCT01556165|584250051|FG000|Overall Study|Protocol Violation|0|||
161783261|NCT01556165|584250052|FG001|Overall Study|Protocol Violation|3|||
161783262|NCT01556165|584250051|FG000|Overall Study|Withdrawal of Consent|7|||
161783263|NCT01556165|584250052|FG001|Overall Study|Withdrawal of Consent|1|||
161783264|NCT02531698|584250055|FG000|Overall Study|Adverse Event|2|||
161783265|NCT02531698|584250056|FG001|Overall Study|Adverse Event|1|||
161783266|NCT02531698|584250055|FG000|Overall Study|Withdrawal by Subject|6|||
161783267|NCT02531698|584250056|FG001|Overall Study|Withdrawal by Subject|1|||
161783268|NCT02531698|584250055|FG000|Overall Study|Protocol Violation|2|||
161783269|NCT02531698|584250056|FG001|Overall Study|Protocol Violation|0|||
161783270|NCT02531698|584250055|FG000|Overall Study|Lost to Follow-up|1|||
161783271|NCT02531698|584250056|FG001|Overall Study|Lost to Follow-up|0|||
161783272|NCT01861717|584250057|FG000|Overall Study|Lost to Follow-up|1|||
161783273|NCT01861717|584250057|FG000|Overall Study|Withdrawal by Subject|1|||
161783274|NCT02395536|584250063|FG000|Overall Study|Lost to Follow-up|4|||
161783275|NCT02395536|584250064|FG001|Overall Study|Lost to Follow-up|4|||
161783276|NCT02395536|584250063|FG000|Overall Study|Death|2|||
161783277|NCT02395536|584250064|FG001|Overall Study|Death|0|||
161783278|NCT02395536|584250063|FG000|Overall Study|Physician Decision|4|||
161783279|NCT02395536|584250064|FG001|Overall Study|Physician Decision|6|||
161783280|NCT02395536|584250063|FG000|Overall Study|Withdrawal by Subject|9|||
161783281|NCT02395536|584250064|FG001|Overall Study|Withdrawal by Subject|17|||
161783282|NCT02395536|584250063|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
161783283|NCT02395536|584250064|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
161783284|NCT02395536|584250063|FG000|Overall Study|Insurance issue|0|||
161783285|NCT02395536|584250064|FG001|Overall Study|Insurance issue|1|||
161783286|NCT00701558|584250065|FG000|Overall Study|Death|7|||
161783287|NCT00701558|584250065|FG000|Overall Study|Lost to Follow-up|8|||
161783288|NCT01640964|584250068|FG000|Overall Study|Lost to Follow-up|0|||
161783289|NCT01640964|584250069|FG001|Overall Study|Lost to Follow-up|0|||
161783290|NCT01640964|584250070|FG002|Overall Study|Lost to Follow-up|1|||
161783291|NCT01640964|584250068|FG000|Overall Study|Protocol Deviation|1|||
161783292|NCT01640964|584250069|FG001|Overall Study|Protocol Deviation|1|||
161783293|NCT01640964|584250070|FG002|Overall Study|Protocol Deviation|2|||
161783294|NCT00304954|584252565|FG000|Overall Study|Withdrawal by Subject|0|||
161783295|NCT00304954|584252566|FG001|Overall Study|Withdrawal by Subject|0|||
161783296|NCT00304954|584252567|FG002|Overall Study|Withdrawal by Subject|1|||
161783297|NCT00304954|584252568|FG003|Overall Study|Withdrawal by Subject|0|||
161783298|NCT00304954|584252565|FG000|Overall Study|Adverse Event|1|||
161783299|NCT00304954|584252566|FG001|Overall Study|Adverse Event|0|||
161783300|NCT00304954|584252567|FG002|Overall Study|Adverse Event|0|||
161783301|NCT00304954|584252568|FG003|Overall Study|Adverse Event|0|||
161783302|NCT00350519|584252569|FG000|Overall Study|Death|0|||
161783303|NCT00350519|584252570|FG001|Overall Study|Death|1|||
161783304|NCT00350519|584252569|FG000|Overall Study|Physician Decision|0|||
161783305|NCT00350519|584252570|FG001|Overall Study|Physician Decision|1|||
161783306|NCT00350519|584252569|FG000|Overall Study|Protocol Violation|1|||
161783307|NCT00350519|584252570|FG001|Overall Study|Protocol Violation|2|||
161783308|NCT00350519|584252569|FG000|Overall Study|Withdrawal by Subject|3|||
161783309|NCT00350519|584252570|FG001|Overall Study|Withdrawal by Subject|2|||
161783310|NCT00736099|584252572|FG000|Overall Study|Adverse Event|61|||
161783311|NCT00736099|584252573|FG001|Overall Study|Adverse Event|18|||
161783312|NCT00736099|584252572|FG000|Overall Study|Protocol Violation|10|||
161783313|NCT00736099|584252573|FG001|Overall Study|Protocol Violation|4|||
161783314|NCT00736099|584252572|FG000|Overall Study|Lost to Follow-up|12|||
161783315|NCT00736099|584252573|FG001|Overall Study|Lost to Follow-up|5|||
161783316|NCT00736099|584252572|FG000|Overall Study|Withdrawal by Subject|42|||
161783317|NCT00736099|584252573|FG001|Overall Study|Withdrawal by Subject|13|||
161783318|NCT00736099|584252572|FG000|Overall Study|Lack of Efficacy|15|||
161783319|NCT00736099|584252573|FG001|Overall Study|Lack of Efficacy|8|||
161896478|NCT00802672|584669715|FG000|Overall Study|other|3|||
161896479|NCT00802672|584669716|FG001|Overall Study|other|1|||
161783320|NCT00736099|584252572|FG000|Overall Study|Other reason|43|||
161783321|NCT00736099|584252573|FG001|Overall Study|Other reason|10|||
161783322|NCT00948025|584252574|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
161783323|NCT00948025|584252575|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
161783324|NCT00948025|584252574|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
161783325|NCT00948025|584252575|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
161783326|NCT00948025|584252574|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
161783327|NCT00948025|584252575|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
161896480|NCT00802672|584669717|FG002|Overall Study|other|2|||
161783328|NCT04006847|584252578|FG000|Overall Study|Product issue|1|||
161783329|NCT03555890|584252586|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161783330|NCT03555890|584252587|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161783331|NCT03555890|584252588|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161783332|NCT03555890|584252589|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
161783333|NCT03372369|584252590|FG000|Qualification Period|Withdrawal by Subject|16|||
161783334|NCT03372369|584252591|FG001|Qualification Period|Withdrawal by Subject|13|||
161783335|NCT03372369|584252590|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
161783336|NCT03372369|584252591|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
161783337|NCT03372369|584252590|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
161783338|NCT03372369|584252591|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
161783339|NCT02239601|584252592|FG000|Overall Study|Withdrawal by Subject|3|||
161783340|NCT02239601|584252593|FG001|Overall Study|Withdrawal by Subject|4|||
161783341|NCT02239601|584252592|FG000|Overall Study|Protocol Violation|4|||
161783342|NCT02239601|584252593|FG001|Overall Study|Protocol Violation|2|||
161783343|NCT01383954|584252594|FG000|Overall Study|Lack of Efficacy|2|||
161783344|NCT01383954|584252594|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
161783345|NCT01383954|584252594|FG000|Overall Study|Adverse Event|1|||
161783346|NCT01383954|584252594|FG000|Overall Study|Reason Not Specified|9|||
161783347|NCT01791127|584252595|FG000|Overall Study|Death|356|||
161783348|NCT01791127|584252595|FG000|Overall Study|Patient has withdrawn from study|293|||
161783349|NCT01791127|584252595|FG000|Overall Study|Lost to Follow-up|42|||
161783350|NCT01791127|584252595|FG000|Overall Study|All Siello leads are explanted|31|||
161783351|NCT01791127|584252595|FG000|Overall Study|Completion of 30 day safety registry|1|||
161783352|NCT01791127|584252595|FG000|Overall Study|Study terminated for EP Passion|749|||
161783353|NCT04023994|584252604|FG000|Overall Study|Lost to Follow-up|0|||
161783354|NCT04023994|584252605|FG001|Overall Study|Lost to Follow-up|1|||
161783355|NCT04023994|584252606|FG002|Overall Study|Lost to Follow-up|2|||
161783356|NCT04023994|584252607|FG003|Overall Study|Lost to Follow-up|0|||
161783357|NCT04023994|584252608|FG004|Overall Study|Lost to Follow-up|0|||
161783358|NCT04023994|584252609|FG005|Overall Study|Lost to Follow-up|0|||
161783359|NCT04023994|584252604|FG000|Overall Study|Withdrawal by Subject|0|||
161783360|NCT04023994|584252605|FG001|Overall Study|Withdrawal by Subject|0|||
161783361|NCT04023994|584252606|FG002|Overall Study|Withdrawal by Subject|0|||
161783362|NCT04023994|584252607|FG003|Overall Study|Withdrawal by Subject|1|||
161783363|NCT04023994|584252608|FG004|Overall Study|Withdrawal by Subject|0|||
161783364|NCT04023994|584252609|FG005|Overall Study|Withdrawal by Subject|0|||
161783365|NCT00707174|584252610|FG000|Overall Study|Adverse Event|1|||
161783366|NCT00707174|584252611|FG001|Overall Study|Adverse Event|6|||
161783367|NCT00707174|584252610|FG000|Overall Study|Withdrawal by Subject|4|||
161783368|NCT00707174|584252611|FG001|Overall Study|Withdrawal by Subject|1|||
161783369|NCT01017029|584252612|FG000|Overall Study|Lost to Follow-up|1|||
161783370|NCT01017029|584252613|FG001|Overall Study|Lost to Follow-up|0|||
161783371|NCT01017029|584252612|FG000|Overall Study|Administrative problem|0|||
161783372|NCT01017029|584252613|FG001|Overall Study|Administrative problem|1|||
161783373|NCT01017029|584252612|FG000|Overall Study|Death|3|||
161783374|NCT01017029|584252613|FG001|Overall Study|Death|1|||
161783375|NCT00422058|584252616|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
161783376|NCT00422058|584252617|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
161783377|NCT00422058|584252618|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
161783378|NCT00422058|584252619|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
161783379|NCT00422058|584252620|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
161783380|NCT00422058|584252621|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
161783381|NCT00422058|584252616|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
161783382|NCT00422058|584252617|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
161783383|NCT00422058|584252618|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
161783384|NCT00422058|584252619|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
161783385|NCT00422058|584252620|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
161783386|NCT00422058|584252621|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
161783387|NCT00422058|584252616|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
161783388|NCT00422058|584252617|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
161783389|NCT00422058|584252618|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
161783390|NCT00422058|584252619|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
161783391|NCT00422058|584252620|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
161783392|NCT00422058|584252621|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
161783393|NCT00422058|584252616|FG000|Double-Blind, Week 0-20|Other|11|||
161783394|NCT00422058|584252617|FG001|Double-Blind, Week 0-20|Other|3|||
161783395|NCT00422058|584252618|FG002|Double-Blind, Week 0-20|Other|8|||
161783396|NCT00422058|584252619|FG003|Double-Blind, Week 0-20|Other|8|||
161783397|NCT00422058|584252620|FG004|Double-Blind, Week 0-20|Other|4|||
161783398|NCT00422058|584252621|FG005|Double-Blind, Week 0-20|Other|10|||
161783399|NCT00422058|584252616|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
161783400|NCT00422058|584252617|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
161783401|NCT00422058|584252618|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
161783402|NCT00422058|584252619|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
161783403|NCT00422058|584252620|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
161783404|NCT00422058|584252621|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
161783405|NCT00422058|584252616|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
161783406|NCT00422058|584252617|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
161783407|NCT00422058|584252618|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
161783408|NCT00422058|584252619|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
161783409|NCT00422058|584252620|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
161783410|NCT00422058|584252621|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
161783411|NCT00422058|584252616|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
161783412|NCT00422058|584252617|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
161783413|NCT00422058|584252618|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
161783414|NCT00422058|584252619|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
161783415|NCT00422058|584252620|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
161783416|NCT00422058|584252621|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
161783417|NCT00422058|584252616|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
161783418|NCT00422058|584252617|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
161783419|NCT00422058|584252618|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
161783420|NCT00422058|584252619|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
161783421|NCT00422058|584252620|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
161783422|NCT00422058|584252621|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
161783423|NCT00422058|584252616|FG000|Open-Label Extension, Week 20-104|Other|13|||
161783424|NCT00422058|584252617|FG001|Open-Label Extension, Week 20-104|Other|14|||
161783425|NCT00422058|584252618|FG002|Open-Label Extension, Week 20-104|Other|6|||
161783426|NCT00422058|584252619|FG003|Open-Label Extension, Week 20-104|Other|13|||
161783427|NCT00422058|584252620|FG004|Open-Label Extension, Week 20-104|Other|16|||
161783428|NCT00422058|584252621|FG005|Open-Label Extension, Week 20-104|Other|18|||
161783429|NCT04057118|584252622|FG000|Overall Study|Adverse Event|1|||
161783430|NCT04057118|584252623|FG001|Overall Study|Adverse Event|0|||
161783431|NCT04057118|584252624|FG002|Overall Study|Adverse Event|1|||
161783432|NCT04057118|584252625|FG003|Overall Study|Adverse Event|1|||
161783433|NCT04057118|584252622|FG000|Overall Study|Physician Decision|0|||
161783434|NCT04057118|584252623|FG001|Overall Study|Physician Decision|0|||
161783435|NCT04057118|584252624|FG002|Overall Study|Physician Decision|1|||
161783436|NCT04057118|584252625|FG003|Overall Study|Physician Decision|1|||
161783437|NCT04057118|584252622|FG000|Overall Study|Withdrawal by Subject|2|||
161783438|NCT04057118|584252623|FG001|Overall Study|Withdrawal by Subject|2|||
161783439|NCT04057118|584252624|FG002|Overall Study|Withdrawal by Subject|0|||
161783440|NCT04057118|584252625|FG003|Overall Study|Withdrawal by Subject|2|||
161783441|NCT04057118|584252622|FG000|Overall Study|Not Specific|0|||
161783442|NCT04057118|584252623|FG001|Overall Study|Not Specific|0|||
161783443|NCT04057118|584252624|FG002|Overall Study|Not Specific|1|||
161783444|NCT04057118|584252625|FG003|Overall Study|Not Specific|1|||
161783445|NCT03402126|584252628|FG000|Overall Study|Lost to Follow-up|6|||
161783446|NCT03402126|584252628|FG000|Overall Study|Protocol Violation|10|||
161783447|NCT03402126|584252628|FG000|Overall Study|Sponsor request/Study termination|29|||
161783448|NCT03402126|584252628|FG000|Overall Study|Study product no longer in use|1|||
161783449|NCT03402126|584252628|FG000|Overall Study|Technical problems|1|||
161783450|NCT03402126|584252628|FG000|Overall Study|Withdrawal by Subject|6|||
161783451|NCT03402126|584252628|FG000|Overall Study|Physician Decision|2|||
161783452|NCT03402126|584252628|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
161783453|NCT03402126|584252628|FG000|Overall Study|Death|4|||
161783454|NCT00572156|584252629|FG000|Overall Study|Adverse Event|3|||
161783455|NCT00572156|584252630|FG001|Overall Study|Adverse Event|1|||
161783456|NCT00572156|584252631|FG002|Overall Study|Adverse Event|5|||
161783457|NCT00572156|584252632|FG003|Overall Study|Adverse Event|1|||
161783458|NCT00572156|584252629|FG000|Overall Study|Lost to Follow-up|1|||
161783459|NCT00572156|584252630|FG001|Overall Study|Lost to Follow-up|1|||
161783460|NCT00572156|584252631|FG002|Overall Study|Lost to Follow-up|1|||
161783461|NCT00572156|584252632|FG003|Overall Study|Lost to Follow-up|0|||
161783462|NCT00572156|584252629|FG000|Overall Study|Protocol Violation|1|||
161783463|NCT00572156|584252630|FG001|Overall Study|Protocol Violation|2|||
161783464|NCT00572156|584252631|FG002|Overall Study|Protocol Violation|0|||
161783465|NCT00572156|584252632|FG003|Overall Study|Protocol Violation|2|||
161783466|NCT00572156|584252629|FG000|Overall Study|Patient/Parent Decision|1|||
161783467|NCT00572156|584252630|FG001|Overall Study|Patient/Parent Decision|6|||
161783468|NCT00572156|584252631|FG002|Overall Study|Patient/Parent Decision|4|||
161783469|NCT00572156|584252632|FG003|Overall Study|Patient/Parent Decision|3|||
161783470|NCT00572156|584252629|FG000|Overall Study|Sponsor Decision|20|||
161783471|NCT00572156|584252630|FG001|Overall Study|Sponsor Decision|16|||
161783472|NCT00572156|584252631|FG002|Overall Study|Sponsor Decision|17|||
161783473|NCT00572156|584252632|FG003|Overall Study|Sponsor Decision|19|||
161783474|NCT02261974|584252633|FG000|Overall Study|Withdrawal by Subject|3|||
161783475|NCT02261974|584252634|FG001|Overall Study|Withdrawal by Subject|2|||
161783476|NCT02261974|584252633|FG000|Overall Study|Pregnancy|0|||
161783477|NCT02261974|584252634|FG001|Overall Study|Pregnancy|1|||
161783478|NCT02261974|584252633|FG000|Overall Study|Missed treatment cut-off date|6|||
161783479|NCT02261974|584252634|FG001|Overall Study|Missed treatment cut-off date|3|||
161783480|NCT02261974|584252633|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
161783481|NCT02261974|584252634|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
161783482|NCT02261974|584252633|FG000|Overall Study|Lost to Follow-up|2|||
161783483|NCT02261974|584252634|FG001|Overall Study|Lost to Follow-up|0|||
161783484|NCT02261974|584252633|FG000|Overall Study|Adverse Event|1|||
161783485|NCT02261974|584252634|FG001|Overall Study|Adverse Event|0|||
161783486|NCT02030834|584252635|FG000|Overall Study|Death|4|||
161783487|NCT02030834|584252636|FG001|Overall Study|Death|0|||
161783488|NCT02030834|584252637|FG002|Overall Study|Death|0|||
161783489|NCT02030834|584252635|FG000|Overall Study|Manufacturing failure|2|||
161783490|NCT02030834|584252636|FG001|Overall Study|Manufacturing failure|0|||
161783491|NCT02030834|584252637|FG002|Overall Study|Manufacturing failure|1|||
161783492|NCT02030834|584252635|FG000|Overall Study|Disease progression|2|||
161783493|NCT02030834|584252636|FG001|Overall Study|Disease progression|0|||
161783494|NCT02030834|584252637|FG002|Overall Study|Disease progression|2|||
161783495|NCT02030834|584252635|FG000|Overall Study|Lost to Follow-up|1|||
161783496|NCT02030834|584252636|FG001|Overall Study|Lost to Follow-up|0|||
161783497|NCT02030834|584252637|FG002|Overall Study|Lost to Follow-up|0|||
161783498|NCT02030834|584252635|FG000|Overall Study|Withdrawal by Subject|1|||
161783499|NCT02030834|584252636|FG001|Overall Study|Withdrawal by Subject|0|||
161783500|NCT02030834|584252637|FG002|Overall Study|Withdrawal by Subject|0|||
161783501|NCT02030834|584252635|FG000|Overall Study|Lack of funding|1|||
161783502|NCT02030834|584252636|FG001|Overall Study|Lack of funding|0|||
161783503|NCT02030834|584252637|FG002|Overall Study|Lack of funding|0|||
161783504|NCT03216954|584252640|FG000|Overall Study|Adverse Event|0|||
161783505|NCT03216954|584252641|FG001|Overall Study|Adverse Event|0|||
161783506|NCT03216954|584252642|FG002|Overall Study|Adverse Event|1|||
161783507|NCT03216954|584252643|FG003|Overall Study|Adverse Event|0|||
161783508|NCT03216954|584252644|FG004|Overall Study|Adverse Event|1|||
161783509|NCT03216954|584252640|FG000|Overall Study|Withdrawal by Subject|2|||
161783510|NCT03216954|584252641|FG001|Overall Study|Withdrawal by Subject|0|||
161783511|NCT03216954|584252642|FG002|Overall Study|Withdrawal by Subject|0|||
161783512|NCT03216954|584252643|FG003|Overall Study|Withdrawal by Subject|0|||
161783513|NCT03216954|584252644|FG004|Overall Study|Withdrawal by Subject|0|||
161783514|NCT03216954|584252640|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
161783515|NCT03216954|584252641|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
161783516|NCT03216954|584252642|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
161783517|NCT03216954|584252643|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
161783518|NCT03216954|584252644|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
161783519|NCT04333199|584252647|FG000|Evaluated Patients|Lost to Follow-up|0|||
161783520|NCT04333199|584252648|FG001|Evaluated Patients|Lost to Follow-up|1|||
161783521|NCT04333199|584252649|FG002|Evaluated Patients|Lost to Follow-up|2|||
161783522|NCT00709735|584252650|FG000|Overall Study|Lost to Follow-up|1|||
161783523|NCT00709735|584252651|FG001|Overall Study|Lost to Follow-up|1|||
161783524|NCT00709735|584252650|FG000|Overall Study|Relapse into Opioid Abuse|0|||
161783525|NCT00709735|584252651|FG001|Overall Study|Relapse into Opioid Abuse|1|||
161783526|NCT00709735|584252650|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
161783527|NCT00709735|584252651|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
161783528|NCT01333475|584252653|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
161783529|NCT01333475|584252654|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
161783530|NCT01333475|584252653|FG000|Overall Study|Toxicity|1|||
161783531|NCT01333475|584252654|FG001|Overall Study|Toxicity|3|||
161783532|NCT04440007|584252655|FG000|Overall Study|Adverse Event|0|||
161783533|NCT04440007|584252656|FG001|Overall Study|Adverse Event|1|||
161783534|NCT04440007|584252655|FG000|Overall Study|Lost to Follow-up|1|||
161783535|NCT04440007|584252656|FG001|Overall Study|Lost to Follow-up|3|||
161783536|NCT04440007|584252655|FG000|Overall Study|Death|7|||
161783537|NCT04440007|584252656|FG001|Overall Study|Death|2|||
161783538|NCT04440007|584252655|FG000|Overall Study|Physician Decision|1|||
161783539|NCT04440007|584252656|FG001|Overall Study|Physician Decision|1|||
161783540|NCT04440007|584252655|FG000|Overall Study|Withdrawal by Subject|2|||
161783541|NCT04440007|584252656|FG001|Overall Study|Withdrawal by Subject|1|||
161896481|NCT00703677|584669718|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
161896482|NCT03859648|584669723|FG000|Overall Study|Lost to Follow-up|1|||
161783542|NCT04440007|584252655|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
161783543|NCT04440007|584252656|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
161783544|NCT04440007|584252655|FG000|Overall Study|Discontinued prior to dosing|0|||
161783545|NCT04440007|584252656|FG001|Overall Study|Discontinued prior to dosing|2|||
161896483|NCT03859648|584669723|FG000|Overall Study|Adverse Event|1|||
161896484|NCT01990573|584669731|FG000|Overall Study|Physician Decision|0|||
161783546|NCT01466673|584252657|FG000|Overall Study|Non-compliance with study treatment|2|||
161783547|NCT01466673|584252658|FG001|Overall Study|Non-compliance with study treatment|0|||
161783548|NCT01466673|584252657|FG000|Overall Study|Lost to Follow-up|3|||
161783549|NCT01466673|584252658|FG001|Overall Study|Lost to Follow-up|5|||
161783550|NCT01466673|584252657|FG000|Overall Study|Adverse Event|2|||
161783551|NCT01466673|584252658|FG001|Overall Study|Adverse Event|1|||
161783552|NCT02981602|584252659|FG000|Overall Study|Adverse Event|0|||
161783553|NCT02981602|584252660|FG001|Overall Study|Adverse Event|0|||
161783554|NCT02981602|584252661|FG002|Overall Study|Adverse Event|0|||
161783555|NCT02981602|584252662|FG003|Overall Study|Adverse Event|1|||
161783556|NCT02981602|584252663|FG004|Overall Study|Adverse Event|0|||
161783557|NCT00666718|584252664|FG000|Overall Study|Adverse Event|0|||
161783558|NCT00666718|584252665|FG001|Overall Study|Adverse Event|1|||
161783559|NCT00666718|584252664|FG000|Overall Study|Death|1|||
161783560|NCT00666718|584252665|FG001|Overall Study|Death|0|||
161783561|NCT00666718|584252664|FG000|Overall Study|Lost to Follow-up|1|||
161783562|NCT00666718|584252665|FG001|Overall Study|Lost to Follow-up|0|||
161783563|NCT00666718|584252664|FG000|Overall Study|Entry Criteria Not Met|2|||
161783564|NCT00666718|584252665|FG001|Overall Study|Entry Criteria Not Met|0|||
161783565|NCT00666718|584252664|FG000|Overall Study|Protocol Violation|1|||
161783566|NCT00666718|584252665|FG001|Overall Study|Protocol Violation|3|||
161783567|NCT00666718|584252664|FG000|Overall Study|Withdrawal by Subject|7|||
161783568|NCT00666718|584252665|FG001|Overall Study|Withdrawal by Subject|12|||
161783569|NCT00666718|584252664|FG000|Overall Study|Physician Decision|0|||
161783570|NCT00666718|584252665|FG001|Overall Study|Physician Decision|2|||
161783571|NCT02567266|584252677|FG000|Overall Study|Withdrawal by Subject|10|||
161783572|NCT02567266|584252678|FG001|Overall Study|Withdrawal by Subject|7|||
161783573|NCT02567266|584252679|FG002|Overall Study|Withdrawal by Subject|6|||
161783574|NCT02567266|584252677|FG000|Overall Study|Lost to Follow-up|13|||
161783575|NCT02567266|584252678|FG001|Overall Study|Lost to Follow-up|8|||
161783576|NCT02567266|584252679|FG002|Overall Study|Lost to Follow-up|10|||
161783577|NCT02983227|584252680|FG000|Overall Study|Adverse Event|21|||
161783578|NCT02983227|584252681|FG001|Overall Study|Adverse Event|3|||
161783579|NCT02983227|584252680|FG000|Overall Study|Death|3|||
161783580|NCT02983227|584252681|FG001|Overall Study|Death|0|||
161783581|NCT02983227|584252680|FG000|Overall Study|Lack of Efficacy|8|||
161783582|NCT02983227|584252681|FG001|Overall Study|Lack of Efficacy|1|||
161783583|NCT02983227|584252680|FG000|Overall Study|Lost to Follow-up|3|||
161783584|NCT02983227|584252681|FG001|Overall Study|Lost to Follow-up|0|||
161783585|NCT02983227|584252680|FG000|Overall Study|Multiple Reasons|2|||
161783586|NCT02983227|584252681|FG001|Overall Study|Multiple Reasons|1|||
161783587|NCT02983227|584252680|FG000|Overall Study|Physician Decision|3|||
161783588|NCT02983227|584252681|FG001|Overall Study|Physician Decision|1|||
161783589|NCT02983227|584252680|FG000|Overall Study|Withdrawal by Subject|19|||
161783590|NCT02983227|584252681|FG001|Overall Study|Withdrawal by Subject|8|||
161783591|NCT02164539|584252684|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
161783592|NCT02164539|584252685|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
161783593|NCT02164539|584252686|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
161783594|NCT02164539|584252687|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
161783595|NCT02164539|584252688|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
161783596|NCT02164539|584252689|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
161783597|NCT02164539|584252690|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
161783598|NCT02164539|584252684|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
161783599|NCT02164539|584252685|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
161783600|NCT02164539|584252686|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
161783601|NCT02164539|584252687|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
161783602|NCT02164539|584252688|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
161783603|NCT02164539|584252689|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
161783604|NCT02164539|584252690|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
161783605|NCT02164539|584252684|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
161783606|NCT02164539|584252685|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
161783607|NCT02164539|584252686|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
161783608|NCT02164539|584252687|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
161783609|NCT02164539|584252688|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
161783610|NCT02164539|584252689|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
161783611|NCT02164539|584252690|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
161783612|NCT02164539|584252684|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
161783613|NCT02164539|584252685|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161783614|NCT02164539|584252686|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161783615|NCT02164539|584252687|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161783616|NCT02164539|584252688|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161783617|NCT02164539|584252689|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161896485|NCT01990573|584669732|FG001|Overall Study|Physician Decision|0|||
161783618|NCT02164539|584252690|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161783619|NCT02164539|584252684|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
161783620|NCT02164539|584252685|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
161783621|NCT02164539|584252686|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
161783622|NCT02164539|584252687|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
161783623|NCT02164539|584252688|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
161783624|NCT02164539|584252689|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
161783625|NCT02164539|584252690|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
161783626|NCT02164539|584252684|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
161783627|NCT02164539|584252685|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
161783628|NCT02164539|584252686|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
161783629|NCT02164539|584252687|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
161783630|NCT02164539|584252688|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
161783631|NCT02164539|584252689|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
161783632|NCT02164539|584252690|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
161783633|NCT01255722|584252691|FG000|Overall Study|Adverse Event|0|||
161783634|NCT01255722|584252692|FG001|Overall Study|Adverse Event|1|||
161783635|NCT01255722|584252693|FG002|Overall Study|Adverse Event|1|||
161783636|NCT01255722|584252691|FG000|Overall Study|asymptomatic patient|1|||
161783637|NCT01255722|584252692|FG001|Overall Study|asymptomatic patient|0|||
161783638|NCT01255722|584252693|FG002|Overall Study|asymptomatic patient|0|||
161783639|NCT01255722|584252691|FG000|Overall Study|beta-blocker contraindicated|2|||
161783640|NCT01255722|584252692|FG001|Overall Study|beta-blocker contraindicated|0|||
161783641|NCT01255722|584252693|FG002|Overall Study|beta-blocker contraindicated|0|||
161783642|NCT00527397|584252696|FG000|Overall Study|Adverse Event|3|||
161783643|NCT00527397|584252696|FG000|Overall Study|Lack of Efficacy|1|||
161783644|NCT00527397|584252696|FG000|Overall Study|Protocol Violation|1|||
161783645|NCT00527397|584252696|FG000|Overall Study|Withdrawal by Subject|6|||
161783646|NCT00527397|584252696|FG000|Overall Study|Study terminated by sponsor|13|||
161783647|NCT02065791|584252700|FG000|Overall Study|Closed Site|1|||
161783648|NCT02065791|584252701|FG001|Overall Study|Closed Site|1|||
161783649|NCT02065791|584252700|FG000|Overall Study|Withdrawal by Subject|11|||
161783650|NCT02065791|584252701|FG001|Overall Study|Withdrawal by Subject|5|||
161783651|NCT02065791|584252700|FG000|Overall Study|Lost to Follow-up|13|||
161783652|NCT02065791|584252701|FG001|Overall Study|Lost to Follow-up|9|||
161783653|NCT04529096|584252702|FG000|Overall Study|Adverse Event|6|||
161783654|NCT04529096|584252703|FG001|Overall Study|Adverse Event|1|||
161783655|NCT04529096|584252702|FG000|Overall Study|Lack of Efficacy|1|||
161783656|NCT04529096|584252703|FG001|Overall Study|Lack of Efficacy|0|||
161783657|NCT04529096|584252702|FG000|Overall Study|Lost to Follow-up|1|||
161783658|NCT04529096|584252703|FG001|Overall Study|Lost to Follow-up|1|||
161783659|NCT04529096|584252702|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161783660|NCT04529096|584252703|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161783661|NCT04529096|584252702|FG000|Overall Study|Physician Decision|1|||
161783662|NCT04529096|584252703|FG001|Overall Study|Physician Decision|3|||
161783663|NCT04529096|584252702|FG000|Overall Study|Withdrawal by Subject|5|||
161896486|NCT01990573|584669733|FG002|Overall Study|Physician Decision|1|||
161896487|NCT01025284|584669747|FG000|Overall Study|Investigator Decision|0|||
161783664|NCT04529096|584252703|FG001|Overall Study|Withdrawal by Subject|0|||
161783665|NCT04529499|584252704|FG000|Overall Study|Withdrawal by Subject|9|||
161783666|NCT04529499|584252705|FG001|Overall Study|Withdrawal by Subject|11|||
161783667|NCT04529499|584252704|FG000|Overall Study|Physician Decision|1|||
161783668|NCT04529499|584252705|FG001|Overall Study|Physician Decision|2|||
161783669|NCT04529499|584252704|FG000|Overall Study|Adverse Event|4|||
161783670|NCT04529499|584252705|FG001|Overall Study|Adverse Event|4|||
161783671|NCT04529499|584252704|FG000|Overall Study|Death|14|||
161783672|NCT04529499|584252705|FG001|Overall Study|Death|11|||
161783673|NCT04529499|584252704|FG000|Overall Study|Lost to Follow-up|1|||
161783674|NCT04529499|584252705|FG001|Overall Study|Lost to Follow-up|1|||
161783675|NCT04529499|584252704|FG000|Overall Study|Others|7|||
161783676|NCT04529499|584252705|FG001|Overall Study|Others|11|||
161783677|NCT00683904|584252706|FG000|Dose Level 1|Disease progression|2|||
161783678|NCT00683904|584252707|FG001|Dose Level 1|Disease progression|0|||
161783679|NCT00683904|584252706|FG000|Dose Level 1|Adverse Event|1|||
161783680|NCT00683904|584252707|FG001|Dose Level 1|Adverse Event|0|||
161783681|NCT00683904|584252706|FG000|Dose Level 2|Adverse Event|0|||
161783682|NCT00683904|584252707|FG001|Dose Level 2|Adverse Event|2|||
161783683|NCT03091400|584252708|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
161783684|NCT03091400|584252709|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
161783685|NCT03467971|584252710|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161896488|NCT01025284|584669748|FG001|Overall Study|Investigator Decision|1|||
161783686|NCT03467971|584252711|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161783687|NCT00975884|584252712|FG000|Overall Study|Adverse Event|1|||
161783688|NCT00975884|584252713|FG001|Overall Study|Adverse Event|0|||
161783689|NCT00975884|584252712|FG000|Overall Study|Lost to Follow-up|5|||
161783690|NCT00975884|584252713|FG001|Overall Study|Lost to Follow-up|3|||
161896489|NCT01025284|584669749|FG002|Overall Study|Investigator Decision|0|||
161896490|NCT01025284|584669747|FG000|Overall Study|Withdrawal by Subject|0|||
161783691|NCT00975884|584252712|FG000|Overall Study|Withdrawal by Subject|9|||
161783692|NCT00975884|584252713|FG001|Overall Study|Withdrawal by Subject|9|||
161783693|NCT00975884|584252712|FG000|Overall Study|Other|1|||
161783694|NCT00975884|584252713|FG001|Overall Study|Other|3|||
161783695|NCT03707522|584252714|FG000|Overall Study|Lost to Follow-up|24|||
161783696|NCT03707522|584252715|FG001|Overall Study|Lost to Follow-up|27|||
161783697|NCT03707522|584252716|FG002|Overall Study|Lost to Follow-up|41|||
161783698|NCT03707522|584252717|FG003|Overall Study|Lost to Follow-up|36|||
161783699|NCT00383019|584252718|FG000|Overall Study|Adverse Event|5|||
161783700|NCT00383019|584252719|FG001|Overall Study|Adverse Event|1|||
161783701|NCT00383019|584252718|FG000|Overall Study|Withdrawal by Subject|0|||
161783702|NCT00383019|584252719|FG001|Overall Study|Withdrawal by Subject|1|||
161896491|NCT01025284|584669748|FG001|Overall Study|Withdrawal by Subject|1|||
161896492|NCT01025284|584669749|FG002|Overall Study|Withdrawal by Subject|0|||
161896493|NCT00547248|584669754|FG000|Overall Study|Protocol Violation|0|||
161896494|NCT00547248|584669755|FG001|Overall Study|Protocol Violation|0|||
161896495|NCT00547248|584669756|FG002|Overall Study|Protocol Violation|1|||
161896496|NCT00547248|584669757|FG003|Overall Study|Protocol Violation|1|||
161896497|NCT00547248|584669754|FG000|Overall Study|Migrated/moved from study area|0|||
161896498|NCT00547248|584669755|FG001|Overall Study|Migrated/moved from study area|0|||
161896499|NCT00547248|584669756|FG002|Overall Study|Migrated/moved from study area|2|||
161896500|NCT00547248|584669757|FG003|Overall Study|Migrated/moved from study area|0|||
161896501|NCT00547248|584669754|FG000|Overall Study|Withdrawal by Subject|0|||
161896502|NCT00547248|584669755|FG001|Overall Study|Withdrawal by Subject|0|||
161896503|NCT00547248|584669756|FG002|Overall Study|Withdrawal by Subject|7|||
161896504|NCT00547248|584669757|FG003|Overall Study|Withdrawal by Subject|1|||
161896505|NCT00305227|584669761|FG000|Overall Study|Lost to Follow-up|7|||
161896506|NCT00305227|584669762|FG001|Overall Study|Lost to Follow-up|6|||
161896507|NCT05133323|584669764|FG000|Overall Study|Lack of Efficacy|0|||
161896508|NCT05133323|584669765|FG001|Overall Study|Lack of Efficacy|0|||
161896509|NCT05133323|584669766|FG002|Overall Study|Lack of Efficacy|1|||
161896510|NCT05133323|584669764|FG000|Overall Study|Withdrawal by Subject|2|||
161896511|NCT05133323|584669765|FG001|Overall Study|Withdrawal by Subject|1|||
161896512|NCT05133323|584669766|FG002|Overall Study|Withdrawal by Subject|0|||
161896513|NCT04152083|584669779|FG000|Overall Study|Lost to Follow-up|2|||
161896514|NCT04152083|584669780|FG001|Overall Study|Lost to Follow-up|1|||
161896515|NCT04152083|584669779|FG000|Overall Study|Adverse Event|1|||
161896516|NCT04152083|584669780|FG001|Overall Study|Adverse Event|0|||
161896517|NCT04152083|584669779|FG000|Overall Study|Randomized but not treated|3|||
161896518|NCT04152083|584669780|FG001|Overall Study|Randomized but not treated|2|||
161896519|NCT01042392|584669781|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
161896520|NCT01042392|584669782|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
161896521|NCT01042392|584669783|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
161896522|NCT01042392|584669784|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
161896523|NCT01042392|584669781|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
161896524|NCT01042392|584669782|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
161896525|NCT01042392|584669783|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
161896526|NCT01042392|584669784|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
161896527|NCT01042392|584669781|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
161896528|NCT01042392|584669782|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
161896529|NCT01042392|584669783|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
161896530|NCT01042392|584669784|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
161896531|NCT01042392|584669781|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
161896532|NCT01042392|584669782|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
161896533|NCT01042392|584669783|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
161896534|NCT01042392|584669784|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
161896535|NCT01042392|584669781|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
161896536|NCT01042392|584669782|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
161896537|NCT01042392|584669783|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
161896538|NCT01042392|584669784|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
161896539|NCT01042392|584669781|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
161896540|NCT01042392|584669782|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
161896541|NCT01042392|584669783|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
161896542|NCT01042392|584669784|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
161896543|NCT01042392|584669781|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
161896544|NCT01042392|584669782|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
161896545|NCT01042392|584669783|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
161783703|NCT01619085|584252720|FG000|Overall Study|Adverse Event|231|||
161896546|NCT01042392|584669784|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
161896547|NCT01042392|584669781|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
161783704|NCT01619085|584252720|FG000|Overall Study|Protocol Violation|4|||
161783705|NCT01619085|584252720|FG000|Overall Study|Lost to Follow-up|3|||
161783706|NCT01619085|584252720|FG000|Overall Study|Withdrawal by Subject|45|||
162009470|NCT03955146|585090132|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
161783707|NCT01619085|584252720|FG000|Overall Study|Other than specified|96|||
161783708|NCT01619085|584252720|FG000|Overall Study|Not treated|1|||
161783709|NCT01619085|584252720|FG000|Overall Study|Death|145|||
161783710|NCT02602080|584252723|FG000|Overall Study|Protocol Violation|6|||
161783711|NCT02602080|584252724|FG001|Overall Study|Protocol Violation|1|||
161783712|NCT02602080|584252725|FG002|Overall Study|Protocol Violation|3|||
161783713|NCT04508621|584252730|FG000|Overall Study|Adverse Event|39|||
161783714|NCT04508621|584252731|FG001|Overall Study|Adverse Event|16|||
161783715|NCT04508621|584252730|FG000|Overall Study|Lack of Efficacy|2|||
161783716|NCT04508621|584252731|FG001|Overall Study|Lack of Efficacy|8|||
161783717|NCT04508621|584252730|FG000|Overall Study|Physician Decision|0|||
161783718|NCT04508621|584252731|FG001|Overall Study|Physician Decision|1|||
161783719|NCT04508621|584252730|FG000|Overall Study|Withdrawal by Subject|10|||
161783720|NCT04508621|584252731|FG001|Overall Study|Withdrawal by Subject|14|||
161783721|NCT04508621|584252730|FG000|Overall Study|Lost to Follow-up|12|||
161783722|NCT04508621|584252731|FG001|Overall Study|Lost to Follow-up|9|||
161783723|NCT04508621|584252730|FG000|Overall Study|COVID-19 related crisis|3|||
161783724|NCT04508621|584252731|FG001|Overall Study|COVID-19 related crisis|0|||
161783725|NCT04508621|584252730|FG000|Overall Study|Subject non-compliance|1|||
161783726|NCT04508621|584252731|FG001|Overall Study|Subject non-compliance|0|||
161783727|NCT01066039|584252732|FG000|Overall Study|Adverse Event|6|||
161783728|NCT01066039|584252732|FG000|Overall Study|Withdrawal by Subject|17|||
161783729|NCT01066039|584252732|FG000|Overall Study|Protocol Violation|2|||
161783730|NCT01066039|584252732|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
161783731|NCT01066039|584252732|FG000|Overall Study|Investigator's Request|1|||
161783732|NCT01066039|584252732|FG000|Overall Study|Dropout due to Insulin Administration|1|||
161783733|NCT01066039|584252732|FG000|Overall Study|Additional Antihypertensive Required|4|||
161783734|NCT01066039|584252732|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
161783735|NCT01066039|584252732|FG000|Overall Study|Failure to Control Blood Pressure|1|||
161783736|NCT01066039|584252732|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
161783737|NCT02574260|584252733|FG000|Overall Study|Disease Progression|1|||
161783738|NCT00752895|584252734|FG000|Overall Study|Withdrawal by Subject|8|||
161783739|NCT00752895|584252735|FG001|Overall Study|Withdrawal by Subject|3|||
161783740|NCT03022799|584252736|FG000|Overall Study|Adverse Event|0|||
161783741|NCT03022799|584252737|FG001|Overall Study|Adverse Event|0|||
161783742|NCT03022799|584252738|FG002|Overall Study|Adverse Event|0|||
161783743|NCT03022799|584252739|FG003|Overall Study|Adverse Event|0|||
161783744|NCT03022799|584252740|FG004|Overall Study|Adverse Event|0|||
161783745|NCT03022799|584252741|FG005|Overall Study|Adverse Event|0|||
161783746|NCT03022799|584252742|FG006|Overall Study|Adverse Event|0|||
161783747|NCT03022799|584252743|FG007|Overall Study|Adverse Event|0|||
161783748|NCT03022799|584252744|FG008|Overall Study|Adverse Event|0|||
161783749|NCT03022799|584252745|FG009|Overall Study|Adverse Event|1|||
161783750|NCT03022799|584252746|FG010|Overall Study|Adverse Event|1|||
161783751|NCT03022799|584252747|FG011|Overall Study|Adverse Event|0|||
161783752|NCT03022799|584252748|FG012|Overall Study|Adverse Event|0|||
161783753|NCT00883129|584252751|FG000|Overall Study|Adverse Event|7|||
161783754|NCT00883129|584252752|FG001|Overall Study|Adverse Event|15|||
161783755|NCT00883129|584252751|FG000|Overall Study|Withdrawal by Subject|8|||
161783756|NCT00883129|584252752|FG001|Overall Study|Withdrawal by Subject|9|||
161783757|NCT00883129|584252751|FG000|Overall Study|Non-compliance|3|||
161783758|NCT00883129|584252752|FG001|Overall Study|Non-compliance|6|||
161783759|NCT00883129|584252751|FG000|Overall Study|Lost to Follow-up|1|||
161783760|NCT00883129|584252752|FG001|Overall Study|Lost to Follow-up|2|||
161783761|NCT00883129|584252751|FG000|Overall Study|Death|1|||
161783762|NCT00883129|584252752|FG001|Overall Study|Death|2|||
161783763|NCT00883129|584252751|FG000|Overall Study|Defined Treatment Failure|0|||
161783764|NCT00883129|584252752|FG001|Overall Study|Defined Treatment Failure|2|||
161783765|NCT03273257|584252753|FG000|Overall Study|Death|0|||
161783766|NCT03273257|584252754|FG001|Overall Study|Death|1|||
161783767|NCT03273257|584252753|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
161783768|NCT03273257|584252754|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
161783769|NCT03273257|584252753|FG000|Overall Study|Study terminated|3|||
161783770|NCT03273257|584252754|FG001|Overall Study|Study terminated|2|||
161783771|NCT01416142|584254213|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
161783772|NCT01416142|584254214|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
161783773|NCT01416142|584254215|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
161783774|NCT02464059|584254216|FG000|Overall Study|Lost to Follow-up|6|||
161783775|NCT03591107|584254220|FG000|Overall Study|Same patient in both arms|1|||
161783776|NCT03591107|584254221|FG001|Overall Study|Same patient in both arms|1|||
161783777|NCT03591107|584254220|FG000|Overall Study|Sought care at other clinics|0|||
161783778|NCT03591107|584254221|FG001|Overall Study|Sought care at other clinics|2|||
161783779|NCT03591107|584254220|FG000|Overall Study|Discharged from clinic|0|||
161783780|NCT03591107|584254221|FG001|Overall Study|Discharged from clinic|1|||
161783781|NCT03591107|584254220|FG000|Overall Study|Withdrawal by Subject|0|||
161783782|NCT03591107|584254221|FG001|Overall Study|Withdrawal by Subject|1|||
161783783|NCT00678379|584254222|FG000|Overall Study|Injection performed after tonsillectomy|2|||
161783784|NCT00678379|584254223|FG001|Overall Study|Injection performed after tonsillectomy|0|||
161783785|NCT00678379|584254224|FG002|Overall Study|Injection performed after tonsillectomy|1|||
161783786|NCT00678379|584254222|FG000|Overall Study|Incomplete Data|4|||
161783787|NCT00678379|584254223|FG001|Overall Study|Incomplete Data|3|||
161783788|NCT00678379|584254224|FG002|Overall Study|Incomplete Data|3|||
161783789|NCT01835470|584254225|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
161783790|NCT01835470|584254225|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
161783791|NCT01011907|584254226|FG000|Overall Study|Withdrawal by Subject|13|||
161783792|NCT01011907|584254227|FG001|Overall Study|Withdrawal by Subject|11|||
161783793|NCT01011907|584254226|FG000|Overall Study|Adverse Event|1|||
161783794|NCT01011907|584254227|FG001|Overall Study|Adverse Event|4|||
161783795|NCT01637961|584254232|FG000|Overall Study|Ineligible: wrong primary|1|||
161783796|NCT01637961|584254232|FG000|Overall Study|Ineligible: inadequate pathology|1|||
161783797|NCT04682639|584254233|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
161783798|NCT04682639|584254234|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
161783799|NCT04682639|584254235|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
161783800|NCT04682639|584254236|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
161783801|NCT04682639|584254237|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
161783802|NCT04682639|584254233|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
161783803|NCT04682639|584254234|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
161783804|NCT04682639|584254235|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
161783805|NCT04682639|584254236|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161783806|NCT04682639|584254237|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161783807|NCT04682639|584254233|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
161783808|NCT04682639|584254234|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161783809|NCT04682639|584254235|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161783810|NCT04682639|584254236|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161783811|NCT04682639|584254237|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161783812|NCT04682639|584254233|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
161783813|NCT04682639|584254234|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
161783814|NCT04682639|584254235|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
161783815|NCT04682639|584254236|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
161783816|NCT04682639|584254237|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
161783817|NCT04682639|584254233|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
161783818|NCT04682639|584254234|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
161783819|NCT04682639|584254235|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
161783820|NCT04682639|584254236|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
161783821|NCT04682639|584254237|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
161783822|NCT04682639|584254233|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
161783823|NCT04682639|584254234|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
161783824|NCT04682639|584254235|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
161783825|NCT04682639|584254236|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161783826|NCT04682639|584254237|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161783827|NCT04682639|584254233|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
161783828|NCT04682639|584254234|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
161783829|NCT04682639|584254235|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
161783830|NCT04682639|584254236|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
161783831|NCT04682639|584254237|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
161783832|NCT04682639|584254233|FG000|OLE Period (28 Weeks)|Other|1|||
161783833|NCT04682639|584254234|FG001|OLE Period (28 Weeks)|Other|2|||
161783834|NCT04682639|584254235|FG002|OLE Period (28 Weeks)|Other|0|||
161783835|NCT04682639|584254236|FG003|OLE Period (28 Weeks)|Other|0|||
161783836|NCT04682639|584254237|FG004|OLE Period (28 Weeks)|Other|1|||
161783837|NCT04682639|584254233|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
161783838|NCT04682639|584254234|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
161783839|NCT04682639|584254235|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
161896548|NCT01042392|584669782|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
161896549|NCT01042392|584669783|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
161896550|NCT01042392|584669784|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
161896551|NCT01042392|584669781|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
161896552|NCT01042392|584669782|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
161783840|NCT04682639|584254236|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
161783841|NCT04682639|584254237|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
161783842|NCT04682639|584254233|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
161783843|NCT04682639|584254234|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
161783844|NCT04682639|584254235|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161783845|NCT04682639|584254236|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161783846|NCT04682639|584254237|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161783847|NCT04682639|584254233|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
161783848|NCT04682639|584254234|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
161783849|NCT04682639|584254235|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161783850|NCT04682639|584254236|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161783851|NCT04682639|584254237|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161783852|NCT04682639|584254233|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
161783853|NCT04682639|584254234|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
161783854|NCT04682639|584254235|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
161783855|NCT04682639|584254236|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
161783856|NCT04682639|584254237|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
161783857|NCT02773446|584254238|FG000|First Admission|Withdrawal by Subject|0|||
161783858|NCT02773446|584254239|FG001|First Admission|Withdrawal by Subject|0|||
161783859|NCT02773446|584254240|FG002|First Admission|Withdrawal by Subject|0|||
161783860|NCT02773446|584254241|FG003|First Admission|Withdrawal by Subject|1|||
161783861|NCT02773446|584254242|FG004|First Admission|Withdrawal by Subject|0|||
161783862|NCT02773446|584254243|FG005|First Admission|Withdrawal by Subject|0|||
161783863|NCT02773446|584254238|FG000|First Admission|Lost to Follow-up|1|||
161783864|NCT02773446|584254239|FG001|First Admission|Lost to Follow-up|0|||
161783865|NCT02773446|584254240|FG002|First Admission|Lost to Follow-up|0|||
161783866|NCT02773446|584254241|FG003|First Admission|Lost to Follow-up|0|||
161783867|NCT02773446|584254242|FG004|First Admission|Lost to Follow-up|0|||
161783868|NCT02773446|584254243|FG005|First Admission|Lost to Follow-up|0|||
161783869|NCT01613131|584254244|FG000|Overall Study|Withdrawal by Subject|3|||
161783870|NCT01613131|584254245|FG001|Overall Study|Withdrawal by Subject|5|||
161783871|NCT02454972|584254246|FG000|Overall Study|Progressive disease|17|||
161783872|NCT02454972|584254247|FG001|Overall Study|Progressive disease|16|||
161783873|NCT02454972|584254248|FG002|Overall Study|Progressive disease|59|||
161783874|NCT02454972|584254249|FG003|Overall Study|Progressive disease|23|||
161783875|NCT02454972|584254250|FG004|Overall Study|Progressive disease|16|||
161783876|NCT02454972|584254251|FG005|Overall Study|Progressive disease|12|||
161783877|NCT02454972|584254252|FG006|Overall Study|Progressive disease|19|||
161783878|NCT02454972|584254253|FG007|Overall Study|Progressive disease|27|||
161783879|NCT02454972|584254254|FG008|Overall Study|Progressive disease|0|||
161783880|NCT02454972|584254246|FG000|Overall Study|Death|0|||
161783881|NCT02454972|584254247|FG001|Overall Study|Death|0|||
161783882|NCT02454972|584254248|FG002|Overall Study|Death|5|||
161783883|NCT02454972|584254249|FG003|Overall Study|Death|1|||
161783884|NCT02454972|584254250|FG004|Overall Study|Death|0|||
161783885|NCT02454972|584254251|FG005|Overall Study|Death|0|||
161783886|NCT02454972|584254252|FG006|Overall Study|Death|0|||
161783887|NCT02454972|584254253|FG007|Overall Study|Death|0|||
161783888|NCT02454972|584254254|FG008|Overall Study|Death|95|||
161783889|NCT02454972|584254246|FG000|Overall Study|Physician Decision|0|||
161783890|NCT02454972|584254247|FG001|Overall Study|Physician Decision|1|||
161783891|NCT02454972|584254248|FG002|Overall Study|Physician Decision|2|||
161783892|NCT02454972|584254249|FG003|Overall Study|Physician Decision|1|||
161783893|NCT02454972|584254250|FG004|Overall Study|Physician Decision|2|||
161783894|NCT02454972|584254251|FG005|Overall Study|Physician Decision|0|||
161783895|NCT02454972|584254252|FG006|Overall Study|Physician Decision|0|||
161783896|NCT02454972|584254253|FG007|Overall Study|Physician Decision|1|||
161783897|NCT02454972|584254254|FG008|Overall Study|Physician Decision|0|||
161783898|NCT02454972|584254246|FG000|Overall Study|Non treatment-related adverse event|2|||
161896553|NCT01042392|584669783|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
161783899|NCT02454972|584254247|FG001|Overall Study|Non treatment-related adverse event|0|||
161783900|NCT02454972|584254248|FG002|Overall Study|Non treatment-related adverse event|1|||
161896554|NCT01042392|584669784|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
161896555|NCT03318003|584669785|FG000|Overall Study|Withdrawal by Subject|1|||
161896556|NCT03318003|584669786|FG001|Overall Study|Withdrawal by Subject|1|||
161896557|NCT03318003|584669785|FG000|Overall Study|fetal loss|0|||
161896558|NCT03318003|584669786|FG001|Overall Study|fetal loss|1|||
161896559|NCT00614874|584669790|FG000|Overall Study|Protocol Violation|1|||
161896560|NCT00614874|584669790|FG000|Overall Study|Withdrawal by Subject|1|||
161896561|NCT00807612|584669792|FG000|Overall Study|Death|8|||
162009471|NCT03955146|585090129|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
161783901|NCT02454972|584254249|FG003|Overall Study|Non treatment-related adverse event|0|||
161783902|NCT02454972|584254250|FG004|Overall Study|Non treatment-related adverse event|0|||
161783903|NCT02454972|584254251|FG005|Overall Study|Non treatment-related adverse event|1|||
161783904|NCT02454972|584254252|FG006|Overall Study|Non treatment-related adverse event|0|||
162009472|NCT03955146|585090130|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
161783905|NCT02454972|584254253|FG007|Overall Study|Non treatment-related adverse event|1|||
161783906|NCT02454972|584254254|FG008|Overall Study|Non treatment-related adverse event|0|||
161783907|NCT02454972|584254246|FG000|Overall Study|Treatment-related adverse events|0|||
161783908|NCT02454972|584254247|FG001|Overall Study|Treatment-related adverse events|1|||
161783909|NCT02454972|584254248|FG002|Overall Study|Treatment-related adverse events|1|||
161783910|NCT02454972|584254249|FG003|Overall Study|Treatment-related adverse events|0|||
162009473|NCT03955146|585090131|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
161896562|NCT00807612|584669792|FG000|Overall Study|Study early termination|5|||
161896563|NCT00807612|584669792|FG000|Overall Study|Withdrawal by Subject|1|||
161896564|NCT02768792|584669793|FG000|Overall Study|Adverse Event|1|||
161896565|NCT04607135|584669795|FG000|Overall Study|Physician Decision|1|||
161896566|NCT04607135|584669795|FG000|Overall Study|Withdrawal by Subject|1|||
161896567|NCT04607135|584669795|FG000|Overall Study|Equipment not working|3|||
161783911|NCT02454972|584254250|FG004|Overall Study|Treatment-related adverse events|2|||
161783912|NCT02454972|584254251|FG005|Overall Study|Treatment-related adverse events|0|||
161783913|NCT02454972|584254252|FG006|Overall Study|Treatment-related adverse events|0|||
161783914|NCT02454972|584254253|FG007|Overall Study|Treatment-related adverse events|2|||
161783915|NCT02454972|584254254|FG008|Overall Study|Treatment-related adverse events|0|||
161783916|NCT02454972|584254246|FG000|Overall Study|Patient moves to compassionate use|0|||
161783917|NCT02454972|584254247|FG001|Overall Study|Patient moves to compassionate use|0|||
161783918|NCT02454972|584254248|FG002|Overall Study|Patient moves to compassionate use|0|||
161783919|NCT02454972|584254249|FG003|Overall Study|Patient moves to compassionate use|0|||
161783920|NCT02454972|584254250|FG004|Overall Study|Patient moves to compassionate use|0|||
161783921|NCT02454972|584254251|FG005|Overall Study|Patient moves to compassionate use|0|||
161783922|NCT02454972|584254252|FG006|Overall Study|Patient moves to compassionate use|2|||
161783923|NCT02454972|584254253|FG007|Overall Study|Patient moves to compassionate use|0|||
161783924|NCT02454972|584254254|FG008|Overall Study|Patient moves to compassionate use|0|||
161783925|NCT02454972|584254246|FG000|Overall Study|Withdrawal by Subject|0|||
161783926|NCT02454972|584254247|FG001|Overall Study|Withdrawal by Subject|1|||
161783927|NCT02454972|584254248|FG002|Overall Study|Withdrawal by Subject|5|||
161783928|NCT02454972|584254249|FG003|Overall Study|Withdrawal by Subject|2|||
161783929|NCT02454972|584254250|FG004|Overall Study|Withdrawal by Subject|3|||
161783930|NCT02454972|584254251|FG005|Overall Study|Withdrawal by Subject|2|||
161783931|NCT02454972|584254252|FG006|Overall Study|Withdrawal by Subject|0|||
161783932|NCT02454972|584254253|FG007|Overall Study|Withdrawal by Subject|1|||
161783933|NCT02454972|584254254|FG008|Overall Study|Withdrawal by Subject|2|||
161783934|NCT02454972|584254246|FG000|Overall Study|Multiple delay/holds on treatment|0|||
161783935|NCT02454972|584254247|FG001|Overall Study|Multiple delay/holds on treatment|0|||
161783936|NCT02454972|584254248|FG002|Overall Study|Multiple delay/holds on treatment|0|||
161783937|NCT02454972|584254249|FG003|Overall Study|Multiple delay/holds on treatment|1|||
161783938|NCT02454972|584254250|FG004|Overall Study|Multiple delay/holds on treatment|0|||
161783939|NCT02454972|584254251|FG005|Overall Study|Multiple delay/holds on treatment|0|||
161783940|NCT02454972|584254252|FG006|Overall Study|Multiple delay/holds on treatment|0|||
161783941|NCT02454972|584254253|FG007|Overall Study|Multiple delay/holds on treatment|0|||
161783942|NCT02454972|584254254|FG008|Overall Study|Multiple delay/holds on treatment|0|||
161783943|NCT02454972|584254246|FG000|Overall Study|Never treated|0|||
161783944|NCT02454972|584254247|FG001|Overall Study|Never treated|0|||
161783945|NCT02454972|584254248|FG002|Overall Study|Never treated|3|||
161783946|NCT02454972|584254249|FG003|Overall Study|Never treated|1|||
161783947|NCT02454972|584254250|FG004|Overall Study|Never treated|1|||
161783948|NCT02454972|584254251|FG005|Overall Study|Never treated|0|||
161783949|NCT02454972|584254252|FG006|Overall Study|Never treated|0|||
161783950|NCT02454972|584254253|FG007|Overall Study|Never treated|0|||
161783951|NCT02454972|584254254|FG008|Overall Study|Never treated|5|||
161783952|NCT02454972|584254246|FG000|Overall Study|Lost to Follow-up|0|||
161783953|NCT02454972|584254247|FG001|Overall Study|Lost to Follow-up|0|||
161783954|NCT02454972|584254248|FG002|Overall Study|Lost to Follow-up|0|||
161783955|NCT02454972|584254249|FG003|Overall Study|Lost to Follow-up|0|||
161783956|NCT02454972|584254250|FG004|Overall Study|Lost to Follow-up|0|||
161783957|NCT02454972|584254251|FG005|Overall Study|Lost to Follow-up|0|||
161783958|NCT02454972|584254252|FG006|Overall Study|Lost to Follow-up|0|||
161783959|NCT02454972|584254253|FG007|Overall Study|Lost to Follow-up|0|||
161783960|NCT02454972|584254254|FG008|Overall Study|Lost to Follow-up|2|||
161783961|NCT02454972|584254246|FG000|Overall Study|Study termination|0|||
161783962|NCT02454972|584254247|FG001|Overall Study|Study termination|0|||
161783963|NCT02454972|584254248|FG002|Overall Study|Study termination|0|||
161783964|NCT02454972|584254249|FG003|Overall Study|Study termination|0|||
161783965|NCT02454972|584254250|FG004|Overall Study|Study termination|0|||
161783966|NCT02454972|584254251|FG005|Overall Study|Study termination|0|||
161783967|NCT02454972|584254252|FG006|Overall Study|Study termination|0|||
161783968|NCT02454972|584254253|FG007|Overall Study|Study termination|0|||
161783969|NCT02454972|584254254|FG008|Overall Study|Study termination|6|||
161783970|NCT01020305|584254261|FG000|Overall Study|Adverse Event|2|||
161896568|NCT03465709|584669796|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
161896569|NCT03465709|584669796|FG000|Overall Study|Withdrawal by Subject|3|||
161783971|NCT01070966|584254264|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
161783972|NCT01070966|584254264|FG000|Participants for Safety Evaluation|Off-label use|9|||
161783973|NCT01070966|584254264|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
161783974|NCT01070966|584254264|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
161783975|NCT01070966|584254264|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
161896570|NCT05359952|584669797|FG000|Overall Study|Lost to Follow-up|1|||
161896571|NCT05359952|584669798|FG001|Overall Study|Lost to Follow-up|0|||
161783976|NCT01070966|584254264|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
161783977|NCT01070966|584254264|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
161783978|NCT01070966|584254264|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
161783979|NCT01725113|584254265|FG000|Overall Study|Kidney Transplant|1|||
161783980|NCT01725113|584254266|FG001|Overall Study|Kidney Transplant|1|||
161783981|NCT01725113|584254265|FG000|Overall Study|Withdrawal by Subject|0|||
161783982|NCT01725113|584254266|FG001|Overall Study|Withdrawal by Subject|1|||
161783983|NCT02753400|584254268|FG000|Overall Study|Adverse Event|3|||
161783984|NCT02753400|584254269|FG001|Overall Study|Adverse Event|0|||
161783985|NCT02753400|584254268|FG000|Overall Study|Withdrawal by Subject|2|||
161783986|NCT02753400|584254269|FG001|Overall Study|Withdrawal by Subject|1|||
161783987|NCT03989115|584254270|FG000|Overall Study|Withdrawal by Subject|2|||
161783988|NCT03989115|584254271|FG001|Overall Study|Withdrawal by Subject|1|||
161783989|NCT03989115|584254272|FG002|Overall Study|Withdrawal by Subject|3|||
161783990|NCT03989115|584254273|FG003|Overall Study|Withdrawal by Subject|0|||
161783991|NCT03989115|584254274|FG004|Overall Study|Withdrawal by Subject|17|||
161783992|NCT03989115|584254275|FG005|Overall Study|Withdrawal by Subject|1|||
161783993|NCT03989115|584254276|FG006|Overall Study|Withdrawal by Subject|0|||
161783994|NCT03989115|584254277|FG007|Overall Study|Withdrawal by Subject|0|||
161783995|NCT03989115|584254270|FG000|Overall Study|Sponsor decision to terminate the study|1|||
161783996|NCT03989115|584254271|FG001|Overall Study|Sponsor decision to terminate the study|1|||
161783997|NCT03989115|584254272|FG002|Overall Study|Sponsor decision to terminate the study|0|||
161783998|NCT03989115|584254273|FG003|Overall Study|Sponsor decision to terminate the study|1|||
161783999|NCT03989115|584254274|FG004|Overall Study|Sponsor decision to terminate the study|11|||
161784000|NCT03989115|584254275|FG005|Overall Study|Sponsor decision to terminate the study|0|||
161784001|NCT03989115|584254276|FG006|Overall Study|Sponsor decision to terminate the study|2|||
161784002|NCT03989115|584254277|FG007|Overall Study|Sponsor decision to terminate the study|1|||
161784003|NCT03989115|584254270|FG000|Overall Study|Lost to Follow-up|2|||
161784004|NCT03989115|584254271|FG001|Overall Study|Lost to Follow-up|0|||
161784005|NCT03989115|584254272|FG002|Overall Study|Lost to Follow-up|0|||
161784006|NCT03989115|584254273|FG003|Overall Study|Lost to Follow-up|0|||
161784007|NCT03989115|584254274|FG004|Overall Study|Lost to Follow-up|1|||
161784008|NCT03989115|584254275|FG005|Overall Study|Lost to Follow-up|0|||
161784009|NCT03989115|584254276|FG006|Overall Study|Lost to Follow-up|0|||
161784010|NCT03989115|584254277|FG007|Overall Study|Lost to Follow-up|0|||
161784011|NCT03989115|584254270|FG000|Overall Study|Death|2|||
161784012|NCT03989115|584254271|FG001|Overall Study|Death|2|||
161784013|NCT03989115|584254272|FG002|Overall Study|Death|9|||
161784014|NCT03989115|584254273|FG003|Overall Study|Death|6|||
161896572|NCT00705341|584669799|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
161896573|NCT00705341|584669800|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
161896574|NCT00705341|584669801|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
161896575|NCT00705341|584669802|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
161896576|NCT00705341|584669799|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
161896577|NCT00705341|584669800|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
161784015|NCT03989115|584254274|FG004|Overall Study|Death|31|||
161784016|NCT03989115|584254275|FG005|Overall Study|Death|6|||
161784017|NCT03989115|584254276|FG006|Overall Study|Death|2|||
161784018|NCT03989115|584254277|FG007|Overall Study|Death|3|||
161784019|NCT03989115|584254270|FG000|Overall Study|Other|1|||
161784020|NCT03989115|584254271|FG001|Overall Study|Other|2|||
161784021|NCT03989115|584254272|FG002|Overall Study|Other|0|||
161784022|NCT03989115|584254273|FG003|Overall Study|Other|0|||
161784023|NCT03989115|584254274|FG004|Overall Study|Other|5|||
161784024|NCT03989115|584254275|FG005|Overall Study|Other|0|||
161784025|NCT03989115|584254276|FG006|Overall Study|Other|0|||
161784026|NCT03989115|584254277|FG007|Overall Study|Other|0|||
161784027|NCT01415921|584254278|FG000|Overall Study|Adverse Event|0|||
161784028|NCT01415921|584254279|FG001|Overall Study|Adverse Event|1|||
161784029|NCT01415921|584254278|FG000|Overall Study|Physician Decision|1|||
161784030|NCT01415921|584254279|FG001|Overall Study|Physician Decision|1|||
161784031|NCT01415921|584254278|FG000|Overall Study|Withdrawal by Subject|0|||
161784032|NCT01415921|584254279|FG001|Overall Study|Withdrawal by Subject|1|||
161784033|NCT01415921|584254278|FG000|Overall Study|Other|2|||
161784034|NCT01415921|584254279|FG001|Overall Study|Other|0|||
161784035|NCT02143947|584254280|FG000|Overall Study|Lost to Follow-up|4|||
161784036|NCT02143947|584254281|FG001|Overall Study|Lost to Follow-up|2|||
161784037|NCT00697112|584254286|FG000|Overall Study|Adverse Event|8|||
161784038|NCT00697112|584254286|FG000|Overall Study|Lost to Follow-up|1|||
161784039|NCT00697112|584254286|FG000|Overall Study|Did not meet inclusion criteria|1|||
161896578|NCT00705341|584669801|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
161896579|NCT00705341|584669802|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
161784040|NCT04736576|584254289|FG000|Overall Study|Progressive disease|3|||
161784041|NCT04736576|584254290|FG001|Overall Study|Progressive disease|1|||
161784042|NCT04736576|584254289|FG000|Overall Study|Death|1|||
161784043|NCT04736576|584254290|FG001|Overall Study|Death|0|||
161784044|NCT00720304|584254291|FG000|Overall Study|Withdrawal by Subject|14|||
162009474|NCT03955146|585090132|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
161784045|NCT00720304|584254292|FG001|Overall Study|Withdrawal by Subject|1|||
161784046|NCT00720304|584254291|FG000|Overall Study|Death|1|||
161784047|NCT00720304|584254292|FG001|Overall Study|Death|0|||
161784048|NCT00720304|584254291|FG000|Overall Study|Physician Decision|5|||
161784049|NCT00720304|584254292|FG001|Overall Study|Physician Decision|2|||
161784050|NCT00720304|584254291|FG000|Overall Study|Adverse Event|3|||
161784051|NCT00720304|584254292|FG001|Overall Study|Adverse Event|1|||
161784052|NCT00720304|584254291|FG000|Overall Study|Disease progression|6|||
161784053|NCT00720304|584254292|FG001|Overall Study|Disease progression|1|||
161784054|NCT04330482|584254295|FG000|Overall Study|Lost to Follow-up|2|||
161784055|NCT04330482|584254296|FG001|Overall Study|Lost to Follow-up|1|||
161784056|NCT04330482|584254295|FG000|Overall Study|Withdrawal by Subject|0|||
161784057|NCT04330482|584254296|FG001|Overall Study|Withdrawal by Subject|3|||
161784058|NCT05180630|584254297|FG000|First Intervention|Physician Decision|0|||
161784059|NCT05180630|584254298|FG001|First Intervention|Physician Decision|0|||
161784060|NCT05180630|584254299|FG002|First Intervention|Physician Decision|3|||
161784061|NCT02725671|584254303|FG000|Overall Study|Lost to Follow-up|1|||
161784062|NCT00963599|584254304|FG000|Overall Study|Adverse Event|2|||
161784063|NCT00963599|584254305|FG001|Overall Study|Adverse Event|0|||
161784064|NCT00963599|584254306|FG002|Overall Study|Adverse Event|1|||
161784065|NCT00963599|584254307|FG003|Overall Study|Adverse Event|2|||
161784066|NCT00963599|584254304|FG000|Overall Study|Lack of Efficacy|0|||
161784067|NCT00963599|584254305|FG001|Overall Study|Lack of Efficacy|2|||
161784068|NCT00963599|584254306|FG002|Overall Study|Lack of Efficacy|1|||
161784069|NCT00963599|584254307|FG003|Overall Study|Lack of Efficacy|4|||
161784070|NCT00963599|584254304|FG000|Overall Study|Lost to Follow-up|0|||
161784071|NCT00963599|584254305|FG001|Overall Study|Lost to Follow-up|1|||
161784072|NCT00963599|584254306|FG002|Overall Study|Lost to Follow-up|1|||
161784073|NCT00963599|584254307|FG003|Overall Study|Lost to Follow-up|1|||
161784074|NCT00963599|584254304|FG000|Overall Study|Protocol Violation|2|||
161784075|NCT00963599|584254305|FG001|Overall Study|Protocol Violation|2|||
161784076|NCT00963599|584254306|FG002|Overall Study|Protocol Violation|3|||
161784077|NCT00963599|584254307|FG003|Overall Study|Protocol Violation|4|||
161784078|NCT00963599|584254304|FG000|Overall Study|Withdrawal by Subject|2|||
161784079|NCT00963599|584254305|FG001|Overall Study|Withdrawal by Subject|1|||
161784080|NCT00963599|584254306|FG002|Overall Study|Withdrawal by Subject|3|||
161784081|NCT00963599|584254307|FG003|Overall Study|Withdrawal by Subject|3|||
161784082|NCT00190684|584254310|FG000|Overall Study|Adverse Event|86|||
161784083|NCT00190684|584254310|FG000|Overall Study|Satisfactory response|80|||
161784084|NCT00190684|584254310|FG000|Overall Study|Lack of efficacy|204|||
161784085|NCT00190684|584254310|FG000|Overall Study|Lost to Follow-up|232|||
161784086|NCT00190684|584254310|FG000|Overall Study|Patient moved|60|||
161784087|NCT00190684|584254310|FG000|Overall Study|Patient Decision|432|||
161784088|NCT00190684|584254310|FG000|Overall Study|Clinical relapse|67|||
161784089|NCT00190684|584254310|FG000|Overall Study|Sponsor's decision|17|||
162009475|NCT03955146|585090129|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
162009476|NCT03955146|585090130|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
162009477|NCT03955146|585090131|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
162009478|NCT03955146|585090132|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
162009479|NCT03955146|585090129|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
162009480|NCT03955146|585090130|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
162009481|NCT03955146|585090131|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
162009482|NCT03955146|585090132|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
162009483|NCT03955146|585090129|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
162009484|NCT03955146|585090130|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
162009485|NCT03955146|585090131|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
162009486|NCT03955146|585090132|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
162009487|NCT04363320|585090133|FG000|Overall Study|Lost to Follow-up|43|||
162009488|NCT04363320|585090134|FG001|Overall Study|Lost to Follow-up|42|||
161784090|NCT00190684|584254310|FG000|Overall Study|Physician Decision|84|||
161784091|NCT00190684|584254310|FG000|Overall Study|Protocol Violation|123|||
161784092|NCT00190684|584254310|FG000|Overall Study|Study Period III Completed|103|||
161784093|NCT00190684|584254310|FG000|Overall Study|Study Period V Completed|1|||
161784094|NCT02354976|584254314|FG000|Overall Study|Other - reason not specified|1|||
161784095|NCT02354976|584254315|FG001|Overall Study|Other - reason not specified|0|||
161784096|NCT02354976|584254316|FG002|Overall Study|Other - reason not specified|1|||
161784097|NCT02354976|584254314|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
161784098|NCT02354976|584254315|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
161784099|NCT02354976|584254316|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
161784100|NCT02354976|584254314|FG000|Overall Study|Adverse Event|1|||
161784101|NCT02354976|584254315|FG001|Overall Study|Adverse Event|0|||
161784102|NCT02354976|584254316|FG002|Overall Study|Adverse Event|2|||
161784103|NCT01706770|584254317|FG000|Overall Study|Lost to Follow-up|1|||
161784104|NCT01706770|584254318|FG001|Overall Study|Lost to Follow-up|0|||
161784105|NCT01706770|584254317|FG000|Overall Study|Physician Decision|1|||
161784106|NCT01706770|584254318|FG001|Overall Study|Physician Decision|0|||
161784107|NCT00068445|584254319|FG000|Randomization|Cancel|1|||
161784108|NCT00068445|584254320|FG001|Randomization|Cancel|3|||
161784109|NCT00068445|584254319|FG000|Randomization|Ineligible|1|||
161784110|NCT00068445|584254320|FG001|Randomization|Ineligible|1|||
161784111|NCT00068445|584254319|FG000|Treatment|Refused Further Treatment|13|||
161784112|NCT00068445|584254320|FG001|Treatment|Refused Further Treatment|10|||
161784113|NCT00068445|584254319|FG000|Treatment|Adverse Event|7|||
161784114|NCT00068445|584254320|FG001|Treatment|Adverse Event|1|||
161784115|NCT00068445|584254319|FG000|Treatment|Other (Specifics not available)|9|||
161784116|NCT00068445|584254320|FG001|Treatment|Other (Specifics not available)|5|||
161784117|NCT01155284|584254321|FG000|Overall Study|Withdrawal by Subject|4|||
161784118|NCT01155284|584254322|FG001|Overall Study|Withdrawal by Subject|3|||
161784119|NCT01155284|584254321|FG000|Overall Study|Lost to Follow-up|1|||
161784120|NCT01155284|584254322|FG001|Overall Study|Lost to Follow-up|2|||
161784121|NCT01155284|584254321|FG000|Overall Study|Physician Decision|1|||
161784122|NCT01155284|584254322|FG001|Overall Study|Physician Decision|0|||
161784123|NCT01155284|584254321|FG000|Overall Study|Adverse Event|1|||
161784124|NCT01155284|584254322|FG001|Overall Study|Adverse Event|0|||
161784125|NCT01896700|584254323|FG000|Overall Study|Adverse Event|4|||
161784126|NCT01896700|584254324|FG001|Overall Study|Adverse Event|5|||
161784127|NCT01896700|584254323|FG000|Overall Study|Withdrawal by Subject|0|||
161784128|NCT01896700|584254324|FG001|Overall Study|Withdrawal by Subject|1|||
161896580|NCT03173456|584669805|FG000|Baseline|Medication dispensing system malfunction'|0|||
161896581|NCT03173456|584669806|FG001|Baseline|Medication dispensing system malfunction'|1|||
161784129|NCT00123487|584254325|FG000|Randomized|Death prior to starting treatment|0|||
161784130|NCT00123487|584254326|FG001|Randomized|Death prior to starting treatment|1|||
161784131|NCT00123487|584254325|FG000|Randomized|SAE prior to starting treatment|1|||
161784132|NCT00123487|584254326|FG001|Randomized|SAE prior to starting treatment|0|||
161784133|NCT00123487|584254325|FG000|Treated With Study Drug|Adverse Event|23|||
161784134|NCT00123487|584254326|FG001|Treated With Study Drug|Adverse Event|22|||
161784135|NCT00123487|584254325|FG000|Treated With Study Drug|Disease Progression|141|||
161784136|NCT00123487|584254326|FG001|Treated With Study Drug|Disease Progression|122|||
161784137|NCT00123487|584254325|FG000|Treated With Study Drug|Physician Decision|8|||
161784138|NCT00123487|584254326|FG001|Treated With Study Drug|Physician Decision|9|||
161784139|NCT00123487|584254325|FG000|Treated With Study Drug|Other|59|||
161784140|NCT00123487|584254326|FG001|Treated With Study Drug|Other|58|||
161784141|NCT00123487|584254325|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
161784142|NCT00123487|584254326|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
161784143|NCT00123487|584254325|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
161831482|NCT01730040|584424762|FG005|Overall Study|Adverse Event|1|||
161831483|NCT01730040|584424763|FG006|Overall Study|Adverse Event|2|||
161831484|NCT01730040|584424757|FG000|Overall Study|Poor compliance to protocol|2|||
161831485|NCT01730040|584424758|FG001|Overall Study|Poor compliance to protocol|4|||
161831486|NCT01730040|584424759|FG002|Overall Study|Poor compliance to protocol|0|||
161831487|NCT01730040|584424760|FG003|Overall Study|Poor compliance to protocol|0|||
161831488|NCT01730040|584424761|FG004|Overall Study|Poor compliance to protocol|0|||
161831489|NCT01730040|584424762|FG005|Overall Study|Poor compliance to protocol|0|||
161831490|NCT01730040|584424763|FG006|Overall Study|Poor compliance to protocol|1|||
161831491|NCT00544817|584424766|FG000|Combined Modality|Lack of Efficacy|2|||
161831492|NCT00544817|584424766|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
161831493|NCT00544817|584424766|FG000|Combined Modality|Adverse Event|2|||
161831494|NCT00544817|584424766|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
161831495|NCT00544817|584424766|FG000|No Treatment Interval|Lack of Efficacy|8|||
161831496|NCT00544817|584424766|FG000|No Treatment Interval|Physician Decision|3|||
161831497|NCT00544817|584424766|FG000|No Treatment Interval|Adverse Event|1|||
161831498|NCT00544817|584424766|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
161831499|NCT00544817|584424766|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
161831500|NCT00544817|584424766|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
161831501|NCT01552369|584424767|FG000|Overall Study|Did not consent to extended follow up|8|||
161831502|NCT01552369|584424768|FG001|Overall Study|Did not consent to extended follow up|9|||
161831503|NCT00754013|584424780|FG000|Overall Study|Lost to Follow-up|1|||
161831504|NCT00754013|584424781|FG001|Overall Study|Lost to Follow-up|1|||
161831505|NCT00754013|584424780|FG000|Overall Study|didn't return after study termed|3|||
161831506|NCT00754013|584424781|FG001|Overall Study|didn't return after study termed|4|||
161831507|NCT01432574|584424785|FG000|Overall Study|Moved|2|||
161831508|NCT01432574|584424785|FG000|Overall Study|Not interested|1|||
161831509|NCT03135899|584424792|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
161831510|NCT03135899|584424793|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
161831511|NCT03135899|584424794|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
161831512|NCT03135899|584424795|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
161831513|NCT03135899|584424796|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
161831514|NCT03135899|584424797|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
161896582|NCT03173456|584669807|FG002|Baseline|Medication dispensing system malfunction'|0|||
161896583|NCT03173456|584669808|FG003|Baseline|Medication dispensing system malfunction'|0|||
161896584|NCT03173456|584669809|FG004|Baseline|Medication dispensing system malfunction'|2|||
161896585|NCT03173456|584669805|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
161896586|NCT03173456|584669806|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
161896587|NCT03173456|584669807|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
161896588|NCT03173456|584669808|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
161896589|NCT03173456|584669809|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
161896590|NCT01733121|584669810|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
161896591|NCT01733121|584669811|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
161896592|NCT01733121|584669810|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
161896593|NCT01733121|584669811|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
161896594|NCT01733121|584669810|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
161896595|NCT01733121|584669811|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
161896596|NCT01733121|584669810|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
161896597|NCT01733121|584669811|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
161896598|NCT01737879|584669814|FG000|Overall Study|Death|1|||
161896599|NCT01737879|584669814|FG000|Overall Study|Sponsor decision|40|||
161896600|NCT04978337|584669817|FG000|Overall Study|Withdrawal by Subject|0|||
161896601|NCT04978337|584669818|FG001|Overall Study|Withdrawal by Subject|1|||
161896602|NCT01436227|584669822|FG000|Overall Study|Adverse Event|7|||
161896603|NCT01436227|584669822|FG000|Overall Study|Death|1|||
161896604|NCT01436227|584669822|FG000|Overall Study|Lack of Efficacy|1|||
161896605|NCT01436227|584669822|FG000|Overall Study|Lost to Follow-up|3|||
161896606|NCT01436227|584669822|FG000|Overall Study|Physician Decision|1|||
161896607|NCT01436227|584669822|FG000|Overall Study|Withdrawal by Subject|7|||
161896608|NCT01436227|584669822|FG000|Overall Study|Disease progression, relapse|6|||
161896609|NCT04865419|584669825|FG000|Overall Study|Other|1|||
161896610|NCT04865419|584669826|FG001|Overall Study|Other|2|||
161896611|NCT04865419|584669827|FG002|Overall Study|Other|2|||
161896612|NCT04865419|584669828|FG003|Overall Study|Other|1|||
161896613|NCT04865419|584669829|FG004|Overall Study|Other|3|||
161896614|NCT04865419|584669830|FG005|Overall Study|Other|0|||
161896615|NCT04865419|584669831|FG006|Overall Study|Other|0|||
161896616|NCT04865419|584669832|FG007|Overall Study|Other|1|||
161896617|NCT04865419|584669833|FG008|Overall Study|Other|0|||
161896618|NCT04865419|584669834|FG009|Overall Study|Other|0|||
161896619|NCT04865419|584669835|FG010|Overall Study|Other|0|||
161896620|NCT04865419|584669825|FG000|Overall Study|Withdrawal by Subject|0|||
161896621|NCT04865419|584669826|FG001|Overall Study|Withdrawal by Subject|1|||
161896622|NCT04865419|584669827|FG002|Overall Study|Withdrawal by Subject|1|||
161896623|NCT04865419|584669828|FG003|Overall Study|Withdrawal by Subject|0|||
161896624|NCT04865419|584669829|FG004|Overall Study|Withdrawal by Subject|0|||
161896625|NCT04865419|584669830|FG005|Overall Study|Withdrawal by Subject|0|||
161896626|NCT04865419|584669831|FG006|Overall Study|Withdrawal by Subject|0|||
161896627|NCT04865419|584669832|FG007|Overall Study|Withdrawal by Subject|1|||
161896628|NCT04865419|584669833|FG008|Overall Study|Withdrawal by Subject|2|||
161896629|NCT04865419|584669834|FG009|Overall Study|Withdrawal by Subject|1|||
161896630|NCT04865419|584669835|FG010|Overall Study|Withdrawal by Subject|0|||
161896631|NCT04865419|584669825|FG000|Overall Study|Study terminated by Sponsor|0|||
161896632|NCT04865419|584669826|FG001|Overall Study|Study terminated by Sponsor|0|||
161896633|NCT04865419|584669827|FG002|Overall Study|Study terminated by Sponsor|0|||
161896634|NCT04865419|584669828|FG003|Overall Study|Study terminated by Sponsor|2|||
161896635|NCT04865419|584669829|FG004|Overall Study|Study terminated by Sponsor|2|||
161896636|NCT04865419|584669830|FG005|Overall Study|Study terminated by Sponsor|0|||
161896637|NCT04865419|584669831|FG006|Overall Study|Study terminated by Sponsor|0|||
161896638|NCT04865419|584669832|FG007|Overall Study|Study terminated by Sponsor|0|||
161896639|NCT04865419|584669833|FG008|Overall Study|Study terminated by Sponsor|0|||
161896640|NCT04865419|584669834|FG009|Overall Study|Study terminated by Sponsor|0|||
161896641|NCT04865419|584669835|FG010|Overall Study|Study terminated by Sponsor|1|||
161896642|NCT04865419|584669825|FG000|Overall Study|Death|3|||
161896643|NCT04865419|584669826|FG001|Overall Study|Death|1|||
161896644|NCT04865419|584669827|FG002|Overall Study|Death|4|||
161896645|NCT04865419|584669828|FG003|Overall Study|Death|2|||
161896646|NCT04865419|584669829|FG004|Overall Study|Death|5|||
161896647|NCT04865419|584669830|FG005|Overall Study|Death|2|||
161896648|NCT04865419|584669831|FG006|Overall Study|Death|1|||
161896649|NCT04865419|584669832|FG007|Overall Study|Death|1|||
161896650|NCT04865419|584669833|FG008|Overall Study|Death|2|||
162242024|NCT02616562|585939071|FG003|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161896651|NCT04865419|584669834|FG009|Overall Study|Death|2|||
161896652|NCT04865419|584669835|FG010|Overall Study|Death|1|||
161896653|NCT04865419|584669825|FG000|Overall Study|Lost to Follow-up|0|||
161896654|NCT04865419|584669826|FG001|Overall Study|Lost to Follow-up|0|||
161896655|NCT04865419|584669827|FG002|Overall Study|Lost to Follow-up|0|||
161896656|NCT04865419|584669828|FG003|Overall Study|Lost to Follow-up|0|||
161896657|NCT04865419|584669829|FG004|Overall Study|Lost to Follow-up|0|||
161896658|NCT04865419|584669830|FG005|Overall Study|Lost to Follow-up|0|||
161896659|NCT04865419|584669831|FG006|Overall Study|Lost to Follow-up|0|||
161896660|NCT04865419|584669832|FG007|Overall Study|Lost to Follow-up|0|||
161896661|NCT04865419|584669833|FG008|Overall Study|Lost to Follow-up|0|||
161896662|NCT04865419|584669834|FG009|Overall Study|Lost to Follow-up|1|||
161896663|NCT04865419|584669835|FG010|Overall Study|Lost to Follow-up|0|||
161896664|NCT05446142|584669836|FG000|Period 2|Adverse Event|1|||
161896665|NCT05446142|584669837|FG001|Period 2|Adverse Event|0|||
161896666|NCT05446142|584669838|FG002|Period 2|Adverse Event|0|||
161896667|NCT05446142|584669839|FG003|Period 2|Adverse Event|0|||
161896668|NCT05446142|584669840|FG004|Period 2|Adverse Event|0|||
161896669|NCT05446142|584669841|FG005|Period 2|Adverse Event|0|||
161896670|NCT00547157|584669846|FG000|Overall Study|Other|1|||
161896671|NCT00547157|584669847|FG001|Overall Study|Other|0|||
161896672|NCT00547157|584669846|FG000|Overall Study|Death|38|||
161896673|NCT00547157|584669847|FG001|Overall Study|Death|18|||
161896674|NCT00547157|584669846|FG000|Overall Study|Withdrawal by Subject|3|||
161896675|NCT00547157|584669847|FG001|Overall Study|Withdrawal by Subject|1|||
161896676|NCT00547157|584669846|FG000|Overall Study|Administrative decision|3|||
161896677|NCT00547157|584669847|FG001|Overall Study|Administrative decision|2|||
161896678|NCT00547157|584669846|FG000|Overall Study|Lost to Follow-up|4|||
161896679|NCT00547157|584669847|FG001|Overall Study|Lost to Follow-up|2|||
161896680|NCT03853291|584669848|FG000|Overall Study|Lost to Follow-up|1|||
161896681|NCT03853291|584669849|FG001|Overall Study|Lost to Follow-up|2|||
161896682|NCT03853291|584669850|FG002|Overall Study|Lost to Follow-up|0|||
161896683|NCT03853291|584669851|FG003|Overall Study|Lost to Follow-up|0|||
161896684|NCT03853291|584669852|FG004|Overall Study|Lost to Follow-up|0|||
161896685|NCT03853291|584669853|FG005|Overall Study|Lost to Follow-up|0|||
161896686|NCT03853291|584669848|FG000|Overall Study|Determined to be ineligible|1|||
161896687|NCT03853291|584669849|FG001|Overall Study|Determined to be ineligible|1|||
161896688|NCT03853291|584669850|FG002|Overall Study|Determined to be ineligible|0|||
161896689|NCT03853291|584669851|FG003|Overall Study|Determined to be ineligible|0|||
161896690|NCT03853291|584669852|FG004|Overall Study|Determined to be ineligible|0|||
161896691|NCT03853291|584669853|FG005|Overall Study|Determined to be ineligible|0|||
161896692|NCT01990768|584669854|FG000|Intervention Started|Found to be ineligible|14|||
161896693|NCT01990768|584669855|FG001|Intervention Started|Found to be ineligible|13|||
161896694|NCT01990768|584669856|FG002|Intervention Started|Found to be ineligible|11|||
161896695|NCT01990768|584669854|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
161896696|NCT01990768|584669855|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
161896697|NCT01990768|584669856|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
161896698|NCT01990768|584669854|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
161896699|NCT01990768|584669855|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
161896700|NCT01990768|584669856|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
161896701|NCT01990768|584669854|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
161896702|NCT01990768|584669855|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
161896703|NCT01990768|584669856|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
161896704|NCT01990768|584669854|FG000|Intervention Started|Patient care priority|1|||
161896705|NCT01990768|584669855|FG001|Intervention Started|Patient care priority|2|||
161896706|NCT01990768|584669856|FG002|Intervention Started|Patient care priority|3|||
161896707|NCT01990768|584669854|FG000|Intervention Started|IV lost|2|||
161896708|NCT01990768|584669855|FG001|Intervention Started|IV lost|2|||
161896709|NCT01990768|584669856|FG002|Intervention Started|IV lost|2|||
161896710|NCT01990768|584669854|FG000|Intervention Started|Required CPR|1|||
161896711|NCT01990768|584669855|FG001|Intervention Started|Required CPR|1|||
161896712|NCT01990768|584669856|FG002|Intervention Started|Required CPR|0|||
161896713|NCT01990768|584669854|FG000|Intervention Started|Seizure or hx of seizure|0|||
161896714|NCT01990768|584669855|FG001|Intervention Started|Seizure or hx of seizure|0|||
161896715|NCT01990768|584669856|FG002|Intervention Started|Seizure or hx of seizure|2|||
161896716|NCT01990768|584669854|FG000|Intervention Started|Discovered to be pregnant|0|||
161896717|NCT01990768|584669855|FG001|Intervention Started|Discovered to be pregnant|1|||
161896718|NCT01990768|584669856|FG002|Intervention Started|Discovered to be pregnant|0|||
161896719|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
161896720|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
161896721|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
161896722|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
161896723|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
161896724|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
161896725|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
161896726|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
161896727|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
161896728|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
161896729|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
161896730|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
161896731|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Death|3|||
161896732|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Death|1|||
161896733|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Death|1|||
161896734|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Discharged|2|||
161896735|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Discharged|1|||
161896736|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Discharged|0|||
161896737|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
161896738|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
161896739|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
161896740|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
161896741|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
161896742|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
161896743|NCT01990768|584669854|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
161896744|NCT01990768|584669855|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
161896745|NCT01990768|584669856|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
161896746|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
161896747|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
161896748|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
161896749|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
161896750|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
161896751|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
161896752|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
161896753|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
161896754|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
161896755|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
161896756|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
161896757|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
161896758|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
161896759|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
161896760|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
161896761|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
161896762|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
161896763|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
161896764|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
161896765|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
161896766|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
161896767|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
161896768|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
161896769|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
161896770|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
161896771|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
161896772|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
161896773|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
161896774|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
161896775|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
161896776|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
161896777|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
161896778|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
161896779|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
161896780|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
161896781|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
161896782|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
161896783|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
161896784|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
161896785|NCT01990768|584669854|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
161896786|NCT01990768|584669855|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
161896787|NCT01990768|584669856|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
161896788|NCT01990768|584669854|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
161896789|NCT01990768|584669855|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
161896790|NCT01990768|584669856|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
161896791|NCT01990768|584669854|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
161896792|NCT01990768|584669855|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
161896793|NCT01990768|584669856|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
161896794|NCT01990768|584669854|FG000|6-Month Follow-up|No contact information|5|||
161896795|NCT01990768|584669855|FG001|6-Month Follow-up|No contact information|6|||
161896796|NCT01990768|584669856|FG002|6-Month Follow-up|No contact information|5|||
161896797|NCT01990768|584669854|FG000|6-Month Follow-up|Homeless|4|||
161896798|NCT01990768|584669855|FG001|6-Month Follow-up|Homeless|3|||
161896799|NCT01990768|584669856|FG002|6-Month Follow-up|Homeless|6|||
161896800|NCT01990768|584669854|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
161896801|NCT01990768|584669855|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
161896802|NCT01990768|584669856|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
161896803|NCT01990768|584669854|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
161896804|NCT01990768|584669855|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
161896805|NCT01990768|584669856|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
161896806|NCT01990768|584669854|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
161896807|NCT01990768|584669855|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
161896808|NCT01990768|584669856|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
161896809|NCT02348008|584669857|FG000|Overall Study|Adverse Event|2|||
161896810|NCT02348008|584669858|FG001|Overall Study|Adverse Event|3|||
161896811|NCT02348008|584669859|FG002|Overall Study|Adverse Event|3|||
161896812|NCT02348008|584669857|FG000|Overall Study|Disease Progression|1|||
161896813|NCT02348008|584669858|FG001|Overall Study|Disease Progression|5|||
161896814|NCT02348008|584669859|FG002|Overall Study|Disease Progression|16|||
161896815|NCT02348008|584669857|FG000|Overall Study|Withdrawal by Subject|0|||
161896816|NCT02348008|584669858|FG001|Overall Study|Withdrawal by Subject|1|||
161896817|NCT02348008|584669859|FG002|Overall Study|Withdrawal by Subject|0|||
161896818|NCT02348008|584669857|FG000|Overall Study|Symptomatic Deterioration|0|||
161896819|NCT02348008|584669858|FG001|Overall Study|Symptomatic Deterioration|1|||
161896820|NCT02348008|584669859|FG002|Overall Study|Symptomatic Deterioration|0|||
161896821|NCT00845676|584669863|FG000|Overall Study|Virologic breakthrough at week 20|1|||
161896822|NCT00845676|584669863|FG000|Overall Study|Adverse Event|1|||
161896823|NCT02756364|584669864|FG000|Overall Study|Site Terminated by Sponsor|24|||
161896824|NCT02756364|584669865|FG001|Overall Study|Site Terminated by Sponsor|30|||
161896825|NCT02756364|584669866|FG002|Overall Study|Site Terminated by Sponsor|21|||
161896826|NCT02756364|584669864|FG000|Overall Study|Death|20|||
161896827|NCT02756364|584669865|FG001|Overall Study|Death|15|||
161896828|NCT02756364|584669866|FG002|Overall Study|Death|18|||
161896829|NCT02756364|584669864|FG000|Overall Study|Withdrawal by Patient|2|||
161896830|NCT02756364|584669865|FG001|Overall Study|Withdrawal by Patient|1|||
161896831|NCT02756364|584669866|FG002|Overall Study|Withdrawal by Patient|8|||
161896832|NCT02756364|584669864|FG000|Overall Study|Lost to Follow-up|0|||
161896833|NCT02756364|584669865|FG001|Overall Study|Lost to Follow-up|1|||
161896834|NCT02756364|584669866|FG002|Overall Study|Lost to Follow-up|1|||
161896835|NCT02223364|584669867|FG000|Overall Study|Protocol Violation|3|||
161896836|NCT02223364|584669868|FG001|Overall Study|Protocol Violation|0|||
161896837|NCT02223364|584669869|FG002|Overall Study|Protocol Violation|3|||
161896838|NCT02223364|584669867|FG000|Overall Study|subject expired before surgery|1|||
161896839|NCT02223364|584669868|FG001|Overall Study|subject expired before surgery|0|||
161896840|NCT02223364|584669869|FG002|Overall Study|subject expired before surgery|0|||
161896841|NCT02223364|584669867|FG000|Overall Study|Physician Decision|1|||
161896842|NCT02223364|584669868|FG001|Overall Study|Physician Decision|0|||
161896843|NCT02223364|584669869|FG002|Overall Study|Physician Decision|0|||
161896844|NCT00463801|584671557|FG000|Overall Study|Protocol Violation|1|||
161896845|NCT00463801|584671557|FG000|Overall Study|Lack of Efficacy|2|||
161896846|NCT00463801|584671557|FG000|Overall Study|Adverse Event|4|||
161896847|NCT00463801|584671557|FG000|Overall Study|Lost to Follow-up|5|||
161896848|NCT00463801|584671557|FG000|Overall Study|No longer require therapy|1|||
161896849|NCT00669318|584671558|FG000|Overall Study|Withdrawal by Subject|2|||
161896850|NCT04441788|584671561|FG000|Overall Study|Voluntary Withdrawl|0|||
161896851|NCT04441788|584671562|FG001|Overall Study|Voluntary Withdrawl|1|||
161896852|NCT04441788|584671563|FG002|Overall Study|Voluntary Withdrawl|0|||
161896853|NCT04441788|584671561|FG000|Overall Study|Ineligibility|1|||
161896854|NCT04441788|584671562|FG001|Overall Study|Ineligibility|0|||
161896855|NCT04441788|584671563|FG002|Overall Study|Ineligibility|0|||
161896856|NCT04441788|584671561|FG000|Overall Study|Adverse Event|0|||
161896857|NCT04441788|584671562|FG001|Overall Study|Adverse Event|0|||
161896858|NCT04441788|584671563|FG002|Overall Study|Adverse Event|4|||
161896859|NCT04441788|584671561|FG000|Overall Study|Study Terminated by Sponsor|16|||
161896860|NCT04441788|584671562|FG001|Overall Study|Study Terminated by Sponsor|16|||
161896861|NCT04441788|584671563|FG002|Overall Study|Study Terminated by Sponsor|12|||
161896862|NCT01677182|584671564|FG000|Overall Study|Adverse Event|2|||
161896863|NCT01677182|584671565|FG001|Overall Study|Adverse Event|1|||
161896864|NCT01677182|584671566|FG002|Overall Study|Adverse Event|8|||
161896865|NCT01677182|584671564|FG000|Overall Study|Protocol Violation|5|||
161896866|NCT01677182|584671565|FG001|Overall Study|Protocol Violation|1|||
161896867|NCT01677182|584671566|FG002|Overall Study|Protocol Violation|4|||
161896868|NCT01677182|584671564|FG000|Overall Study|Lost to Follow-up|4|||
161896869|NCT01677182|584671565|FG001|Overall Study|Lost to Follow-up|0|||
161896870|NCT01677182|584671566|FG002|Overall Study|Lost to Follow-up|3|||
161896871|NCT01677182|584671564|FG000|Overall Study|Withdrawal by Subject|7|||
161896872|NCT01677182|584671565|FG001|Overall Study|Withdrawal by Subject|12|||
161896873|NCT01677182|584671566|FG002|Overall Study|Withdrawal by Subject|10|||
161896874|NCT01677182|584671564|FG000|Overall Study|Study termination|12|||
161896875|NCT01677182|584671565|FG001|Overall Study|Study termination|9|||
161896876|NCT01677182|584671566|FG002|Overall Study|Study termination|11|||
161896877|NCT01677182|584671564|FG000|Overall Study|Lack of Efficacy|3|||
161896878|NCT01677182|584671565|FG001|Overall Study|Lack of Efficacy|0|||
161896879|NCT01677182|584671566|FG002|Overall Study|Lack of Efficacy|1|||
161896880|NCT01677182|584671564|FG000|Overall Study|Other reasons|1|||
161896881|NCT01677182|584671565|FG001|Overall Study|Other reasons|5|||
161896882|NCT01677182|584671566|FG002|Overall Study|Other reasons|2|||
161896883|NCT02489448|584671569|FG000|Overall Study|Death|3|||
161896884|NCT02489448|584671569|FG000|Overall Study|Withdrawal by Subject|2|||
161896885|NCT02748057|584671570|FG000|Overall Study|Adverse Event|1|||
161896886|NCT02748057|584671571|FG001|Overall Study|Adverse Event|0|||
161896887|NCT02748057|584671570|FG000|Overall Study|Physician Decision|0|||
161896888|NCT02748057|584671571|FG001|Overall Study|Physician Decision|1|||
161896889|NCT02748057|584671570|FG000|Overall Study|Protocol Violation|2|||
161896890|NCT02748057|584671571|FG001|Overall Study|Protocol Violation|1|||
161896891|NCT02748057|584671570|FG000|Overall Study|Participant Moved|1|||
161896892|NCT02748057|584671571|FG001|Overall Study|Participant Moved|0|||
161896893|NCT02748057|584671570|FG000|Overall Study|Withdrawal by Subject|1|||
161896894|NCT02748057|584671571|FG001|Overall Study|Withdrawal by Subject|0|||
161896895|NCT03335813|584671572|FG000|Overall Study|Withdrawal by Subject|1|||
161896896|NCT02793947|584671573|FG000|Overall Study|Death|1|||
161896897|NCT02793947|584671574|FG001|Overall Study|Death|0|||
161896898|NCT02793947|584671573|FG000|Overall Study|Physician Decision|1|||
161896899|NCT02793947|584671574|FG001|Overall Study|Physician Decision|5|||
161896900|NCT02542397|584671575|FG000|Overall Study|Death|2|||
161896901|NCT02542397|584671575|FG000|Overall Study|Physician Decision|6|||
161896902|NCT02542397|584671575|FG000|Overall Study|Withdrawal by Subject|6|||
161896903|NCT02542397|584671575|FG000|Overall Study|Lost to Follow-up|2|||
161896904|NCT02090283|584671578|FG000|Overall Study|Withdrawal by Subject|6|||
161896905|NCT02090283|584671579|FG001|Overall Study|Withdrawal by Subject|6|||
161896906|NCT02090283|584671580|FG002|Overall Study|Withdrawal by Subject|6|||
161896907|NCT02090283|584671578|FG000|Overall Study|Sponsor Terminated Study|6|||
161896908|NCT02090283|584671579|FG001|Overall Study|Sponsor Terminated Study|6|||
161896909|NCT02090283|584671580|FG002|Overall Study|Sponsor Terminated Study|1|||
161896910|NCT02090283|584671578|FG000|Overall Study|Lost to Follow-up|2|||
161896911|NCT02090283|584671579|FG001|Overall Study|Lost to Follow-up|2|||
161896912|NCT02090283|584671580|FG002|Overall Study|Lost to Follow-up|3|||
161896913|NCT02090283|584671578|FG000|Overall Study|Adverse Event|1|||
161896914|NCT02090283|584671579|FG001|Overall Study|Adverse Event|1|||
161896915|NCT02090283|584671580|FG002|Overall Study|Adverse Event|0|||
161896916|NCT02090283|584671578|FG000|Overall Study|Protocol Violation|2|||
161896917|NCT02090283|584671579|FG001|Overall Study|Protocol Violation|0|||
161896918|NCT02090283|584671580|FG002|Overall Study|Protocol Violation|0|||
161896919|NCT00697593|584671582|FG000|Overall Study|Adverse Event|3|||
161896920|NCT00697593|584671582|FG000|Overall Study|Protocol Violation|1|||
161896921|NCT00697593|584671582|FG000|Overall Study|Lack of Efficacy|3|||
161896922|NCT00697593|584671582|FG000|Overall Study|Suspension of the study by sponsor|12|||
161896923|NCT00281697|584671585|FG000|Overall Study|> 60 days since last dose of study drug|4|||
161896924|NCT00281697|584671586|FG001|Overall Study|> 60 days since last dose of study drug|4|||
161896925|NCT00281697|584671585|FG000|Overall Study|Adverse Event|54|||
161896926|NCT00281697|584671586|FG001|Overall Study|Adverse Event|15|||
161896927|NCT00281697|584671585|FG000|Overall Study|Death|8|||
161896928|NCT00281697|584671586|FG001|Overall Study|Death|3|||
161896929|NCT00281697|584671585|FG000|Overall Study|Disease progression|279|||
161896930|NCT00281697|584671586|FG001|Overall Study|Disease progression|149|||
161896931|NCT00281697|584671585|FG000|Overall Study|Other|5|||
161896932|NCT00281697|584671586|FG001|Overall Study|Other|6|||
161896933|NCT00281697|584671585|FG000|Overall Study|Physician's decision to withdraw|15|||
161896934|NCT00281697|584671586|FG001|Overall Study|Physician's decision to withdraw|12|||
161896935|NCT00281697|584671585|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
161896936|NCT00281697|584671586|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
161896937|NCT00281697|584671585|FG000|Overall Study|Did not receive study drug|3|||
161896938|NCT00281697|584671586|FG001|Overall Study|Did not receive study drug|2|||
161896939|NCT00632125|584671587|FG000|Overall Study|Death|82|||
161896940|NCT00632125|584671587|FG000|Overall Study|Withdrawal by Subject|44|||
162009489|NCT04363320|585090135|FG002|Overall Study|Lost to Follow-up|24|||
162009490|NCT04363320|585090136|FG003|Overall Study|Lost to Follow-up|29|||
161896941|NCT00632125|584671587|FG000|Overall Study|Adverse Event|36|||
161896942|NCT00632125|584671587|FG000|Overall Study|Renal transplantation|17|||
161896943|NCT00632125|584671587|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
161896944|NCT00632125|584671587|FG000|Overall Study|Non-compliance|8|||
161896945|NCT00632125|584671587|FG000|Overall Study|Development of uncontrolled hypertension|5|||
161896946|NCT00632125|584671587|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
161896947|NCT00577772|584671590|FG000|Overall Study|Lost to Follow-up|0|||
161896948|NCT00577772|584671591|FG001|Overall Study|Lost to Follow-up|1|||
161896949|NCT00540644|584671595|FG000|Overall Study|Adverse Event|3|||
162009491|NCT04363320|585090133|FG000|Overall Study|Death|0|||
161896950|NCT00540644|584671596|FG001|Overall Study|Adverse Event|1|||
161896951|NCT00540644|584671595|FG000|Overall Study|Disease Progression|3|||
162009492|NCT04363320|585090134|FG001|Overall Study|Death|0|||
161896952|NCT00540644|584671596|FG001|Overall Study|Disease Progression|1|||
161896953|NCT00540644|584671595|FG000|Overall Study|Physician Decision|0|||
161896954|NCT00540644|584671596|FG001|Overall Study|Physician Decision|5|||
161896955|NCT00540644|584671595|FG000|Overall Study|Withdrawal by Subject|2|||
161896956|NCT00540644|584671596|FG001|Overall Study|Withdrawal by Subject|2|||
161896957|NCT00540644|584671595|FG000|Overall Study|Noncomplilance|1|||
161896958|NCT00540644|584671596|FG001|Overall Study|Noncomplilance|0|||
161896959|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
161896960|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
161896961|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
161896962|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
161896963|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
161896964|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
161896965|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
161896966|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
161896967|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
161896968|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
161896969|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
161896970|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
161896971|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
161896972|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
161896973|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Death|1|||
161896974|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Death|0|||
161896975|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
161896976|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
161896977|NCT00105989|584671597|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
161896978|NCT00105989|584671598|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
161896979|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
161896980|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
161896981|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
161896982|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
161896983|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
161896984|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
161896985|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
161896986|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
161896987|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
161896988|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
161896989|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
161896990|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
161896991|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
161896992|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
161896993|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Death|0|||
161896994|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Death|0|||
161896995|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
161896996|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
161896997|NCT00105989|584671597|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
161896998|NCT00105989|584671598|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
161896999|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
161897000|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
161897001|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
161897002|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
161897003|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
161897004|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
161897005|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
161897006|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
161897007|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
161897008|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
161897009|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
161897010|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
161897011|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
161897012|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
161897013|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
161897014|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
161897015|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
161897016|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
162009493|NCT04363320|585090135|FG002|Overall Study|Death|1|||
162009494|NCT04363320|585090136|FG003|Overall Study|Death|0|||
161897017|NCT00105989|584671597|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
161897018|NCT00105989|584671598|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
161897019|NCT00411450|584671599|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
161897020|NCT01716663|584671600|FG000|Overall Study|Withdrawn prior to procedure|4|||
161897021|NCT01716663|584671600|FG000|Overall Study|Treated with non-study catheter|2|||
161897022|NCT01059773|584671601|FG000|Overall Study|Adverse Event|2|||
161897023|NCT01059773|584671602|FG001|Overall Study|Adverse Event|2|||
161897024|NCT01059773|584671601|FG000|Overall Study|Withdrawal by Subject|1|||
161897025|NCT01059773|584671602|FG001|Overall Study|Withdrawal by Subject|5|||
161897026|NCT01059773|584671601|FG000|Overall Study|Lost to Follow-up|1|||
161897027|NCT01059773|584671602|FG001|Overall Study|Lost to Follow-up|1|||
161897028|NCT01059773|584671601|FG000|Overall Study|Pregnancy|1|||
161897029|NCT01059773|584671602|FG001|Overall Study|Pregnancy|1|||
161897030|NCT01059773|584671601|FG000|Overall Study|Protocol Violation|6|||
161897031|NCT01059773|584671602|FG001|Overall Study|Protocol Violation|2|||
161897032|NCT01059773|584671601|FG000|Overall Study|Physician Decision|5|||
161897033|NCT01059773|584671602|FG001|Overall Study|Physician Decision|4|||
161897034|NCT01059773|584671601|FG000|Overall Study|Lack of Efficacy|3|||
161897035|NCT01059773|584671602|FG001|Overall Study|Lack of Efficacy|3|||
161897036|NCT01059773|584671601|FG000|Overall Study|Death|0|||
161897037|NCT01059773|584671602|FG001|Overall Study|Death|1|||
161897038|NCT01059773|584671601|FG000|Overall Study|Malignancy including squamous cell skin|0|||
161897039|NCT01059773|584671602|FG001|Overall Study|Malignancy including squamous cell skin|1|||
161897040|NCT01059773|584671601|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
161897041|NCT01059773|584671602|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
161897042|NCT01059773|584671601|FG000|Overall Study|Other|1|||
161897043|NCT01059773|584671602|FG001|Overall Study|Other|3|||
161897044|NCT01806168|584671605|FG000|Overall Study|Adverse Event|1|||
161897045|NCT01806168|584671606|FG001|Overall Study|Adverse Event|0|||
161897046|NCT01806168|584671607|FG002|Overall Study|Adverse Event|0|||
161897047|NCT01806168|584671605|FG000|Overall Study|Withdrawal by Subject|0|||
161897048|NCT01806168|584671606|FG001|Overall Study|Withdrawal by Subject|1|||
161897049|NCT01806168|584671607|FG002|Overall Study|Withdrawal by Subject|2|||
161897050|NCT01806168|584671605|FG000|Overall Study|Protocol Violation|0|||
161897051|NCT01806168|584671606|FG001|Overall Study|Protocol Violation|0|||
161897052|NCT01806168|584671607|FG002|Overall Study|Protocol Violation|1|||
161897053|NCT03904420|584671610|FG000|Overall Study|Study terminated|2|||
161897054|NCT03904420|584671611|FG001|Overall Study|Study terminated|2|||
161897055|NCT04435808|584671612|FG000|Overall Study|Study stopped by DSMB|0|||
161897056|NCT04435808|584671613|FG001|Overall Study|Study stopped by DSMB|1|||
161897057|NCT02620787|584671614|FG000|Overall Study|Adverse Event|1|||
161897058|NCT02620787|584671615|FG001|Overall Study|Adverse Event|0|||
161897059|NCT02620787|584671614|FG000|Overall Study|Eligibility Criteria Not Met|1|||
161897060|NCT02620787|584671615|FG001|Overall Study|Eligibility Criteria Not Met|0|||
161897061|NCT02959918|584671617|FG000|Overall Study|Adverse Event|1|||
161897062|NCT02959918|584671618|FG001|Overall Study|Adverse Event|1|||
161897063|NCT02959918|584671619|FG002|Overall Study|Adverse Event|2|||
161897064|NCT02959918|584671620|FG003|Overall Study|Adverse Event|0|||
161897065|NCT02959918|584671621|FG004|Overall Study|Adverse Event|0|||
161897066|NCT02959918|584671622|FG005|Overall Study|Adverse Event|2|||
161897067|NCT02959918|584671623|FG006|Overall Study|Adverse Event|2|||
161897068|NCT02959918|584671624|FG007|Overall Study|Adverse Event|1|||
161897069|NCT02959918|584671625|FG008|Overall Study|Adverse Event|2|||
161897070|NCT02959918|584671626|FG009|Overall Study|Adverse Event|1|||
161897071|NCT02959918|584671627|FG010|Overall Study|Adverse Event|1|||
161897072|NCT02959918|584671628|FG011|Overall Study|Adverse Event|3|||
161897073|NCT02959918|584671629|FG012|Overall Study|Adverse Event|2|||
161897074|NCT02959918|584671630|FG013|Overall Study|Adverse Event|4|||
161897075|NCT02959918|584671617|FG000|Overall Study|Lost to Follow-up|0|||
161897076|NCT02959918|584671618|FG001|Overall Study|Lost to Follow-up|0|||
161897077|NCT02959918|584671619|FG002|Overall Study|Lost to Follow-up|0|||
161897078|NCT02959918|584671620|FG003|Overall Study|Lost to Follow-up|0|||
161897079|NCT02959918|584671621|FG004|Overall Study|Lost to Follow-up|0|||
161897080|NCT02959918|584671622|FG005|Overall Study|Lost to Follow-up|0|||
161897081|NCT02959918|584671623|FG006|Overall Study|Lost to Follow-up|0|||
161897082|NCT02959918|584671624|FG007|Overall Study|Lost to Follow-up|0|||
161897083|NCT02959918|584671625|FG008|Overall Study|Lost to Follow-up|0|||
161897084|NCT02959918|584671626|FG009|Overall Study|Lost to Follow-up|1|||
161897085|NCT02959918|584671627|FG010|Overall Study|Lost to Follow-up|0|||
161897086|NCT02959918|584671628|FG011|Overall Study|Lost to Follow-up|0|||
162242025|NCT02616562|585939072|FG004|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161897087|NCT02959918|584671629|FG012|Overall Study|Lost to Follow-up|1|||
161897088|NCT02959918|584671630|FG013|Overall Study|Lost to Follow-up|0|||
161897089|NCT02959918|584671617|FG000|Overall Study|Withdrawal by Subject|0|||
161897090|NCT02959918|584671618|FG001|Overall Study|Withdrawal by Subject|0|||
161897091|NCT02959918|584671619|FG002|Overall Study|Withdrawal by Subject|1|||
161897092|NCT02959918|584671620|FG003|Overall Study|Withdrawal by Subject|2|||
162242026|NCT02616562|585939073|FG005|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161897093|NCT02959918|584671621|FG004|Overall Study|Withdrawal by Subject|0|||
161897094|NCT02959918|584671622|FG005|Overall Study|Withdrawal by Subject|0|||
161897095|NCT02959918|584671623|FG006|Overall Study|Withdrawal by Subject|1|||
161897096|NCT02959918|584671624|FG007|Overall Study|Withdrawal by Subject|0|||
161897097|NCT02959918|584671625|FG008|Overall Study|Withdrawal by Subject|1|||
161897098|NCT02959918|584671626|FG009|Overall Study|Withdrawal by Subject|1|||
161897099|NCT02959918|584671627|FG010|Overall Study|Withdrawal by Subject|2|||
161897100|NCT02959918|584671628|FG011|Overall Study|Withdrawal by Subject|3|||
161897101|NCT02959918|584671629|FG012|Overall Study|Withdrawal by Subject|1|||
161897102|NCT02959918|584671630|FG013|Overall Study|Withdrawal by Subject|1|||
161897103|NCT02959918|584671617|FG000|Overall Study|Protocol Violation|0|||
161897104|NCT02959918|584671618|FG001|Overall Study|Protocol Violation|0|||
161897105|NCT02959918|584671619|FG002|Overall Study|Protocol Violation|1|||
161897106|NCT02959918|584671620|FG003|Overall Study|Protocol Violation|0|||
161897107|NCT02959918|584671621|FG004|Overall Study|Protocol Violation|0|||
161897108|NCT02959918|584671622|FG005|Overall Study|Protocol Violation|1|||
161897109|NCT02959918|584671623|FG006|Overall Study|Protocol Violation|0|||
161897110|NCT02959918|584671624|FG007|Overall Study|Protocol Violation|0|||
161897111|NCT02959918|584671625|FG008|Overall Study|Protocol Violation|2|||
161897112|NCT02959918|584671626|FG009|Overall Study|Protocol Violation|1|||
161897113|NCT02959918|584671627|FG010|Overall Study|Protocol Violation|0|||
161897114|NCT02959918|584671628|FG011|Overall Study|Protocol Violation|1|||
161897115|NCT02959918|584671629|FG012|Overall Study|Protocol Violation|1|||
161897116|NCT02959918|584671630|FG013|Overall Study|Protocol Violation|0|||
161897117|NCT02959918|584671617|FG000|Overall Study|Stopping Rule Met|1|||
161897118|NCT02959918|584671618|FG001|Overall Study|Stopping Rule Met|0|||
161897119|NCT02959918|584671619|FG002|Overall Study|Stopping Rule Met|3|||
161897120|NCT02959918|584671620|FG003|Overall Study|Stopping Rule Met|4|||
161897121|NCT02959918|584671621|FG004|Overall Study|Stopping Rule Met|5|||
161897122|NCT02959918|584671622|FG005|Overall Study|Stopping Rule Met|3|||
161897123|NCT02959918|584671623|FG006|Overall Study|Stopping Rule Met|2|||
161897124|NCT02959918|584671624|FG007|Overall Study|Stopping Rule Met|4|||
161897125|NCT02959918|584671625|FG008|Overall Study|Stopping Rule Met|1|||
161897126|NCT02959918|584671626|FG009|Overall Study|Stopping Rule Met|1|||
161897127|NCT02959918|584671627|FG010|Overall Study|Stopping Rule Met|3|||
161897128|NCT02959918|584671628|FG011|Overall Study|Stopping Rule Met|5|||
161897129|NCT02959918|584671629|FG012|Overall Study|Stopping Rule Met|2|||
161897130|NCT02959918|584671630|FG013|Overall Study|Stopping Rule Met|1|||
161897131|NCT02959918|584671617|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
161897132|NCT02959918|584671618|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
161897133|NCT02959918|584671619|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
161897134|NCT02959918|584671620|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
161897135|NCT02959918|584671621|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897136|NCT02959918|584671622|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897137|NCT02959918|584671623|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897138|NCT02959918|584671624|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897139|NCT02959918|584671625|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897140|NCT02959918|584671626|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897141|NCT02959918|584671627|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
162009495|NCT00604565|585090137|FG000|Overall Study|Study terminated|0|||
161784144|NCT00123487|584254326|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
161784145|NCT00123487|584254325|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
161784146|NCT00123487|584254326|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
161784147|NCT00423488|584254327|FG000|Overall Study|No evidence of study drug intake|2|||
161784148|NCT00423488|584254328|FG001|Overall Study|No evidence of study drug intake|1|||
161784149|NCT00423488|584254327|FG000|Overall Study|No post baseline data|3|||
161784150|NCT00423488|584254328|FG001|Overall Study|No post baseline data|0|||
161784151|NCT03118765|584254329|FG000|Overall Study|Withdrawal by Subject|0|||
161784152|NCT03118765|584254330|FG001|Overall Study|Withdrawal by Subject|0|||
161784153|NCT03118765|584254331|FG002|Overall Study|Withdrawal by Subject|1|||
161784154|NCT03118765|584254332|FG003|Overall Study|Withdrawal by Subject|0|||
161784155|NCT03118765|584254333|FG004|Overall Study|Withdrawal by Subject|0|||
161784156|NCT03118765|584254329|FG000|Overall Study|Adverse Event|1|||
161784157|NCT03118765|584254330|FG001|Overall Study|Adverse Event|1|||
161784158|NCT03118765|584254331|FG002|Overall Study|Adverse Event|1|||
161784159|NCT03118765|584254332|FG003|Overall Study|Adverse Event|1|||
161784160|NCT03118765|584254333|FG004|Overall Study|Adverse Event|1|||
161784161|NCT03118765|584254329|FG000|Overall Study|Non compliance with Study Procedures|0|||
161784162|NCT03118765|584254330|FG001|Overall Study|Non compliance with Study Procedures|0|||
161784163|NCT03118765|584254331|FG002|Overall Study|Non compliance with Study Procedures|0|||
161784164|NCT03118765|584254332|FG003|Overall Study|Non compliance with Study Procedures|1|||
161784165|NCT03118765|584254333|FG004|Overall Study|Non compliance with Study Procedures|0|||
161897142|NCT02959918|584671628|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897143|NCT02959918|584671629|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
162009496|NCT00604565|585090138|FG001|Overall Study|Study terminated|3|||
161897144|NCT02959918|584671630|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161897145|NCT02959918|584671617|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897146|NCT02959918|584671618|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897147|NCT02959918|584671619|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897148|NCT02959918|584671620|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897149|NCT02959918|584671621|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897150|NCT02959918|584671622|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897151|NCT02959918|584671623|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897152|NCT02959918|584671624|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
161897153|NCT02959918|584671625|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897154|NCT02959918|584671626|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897155|NCT02959918|584671627|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897156|NCT02959918|584671628|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897157|NCT02959918|584671629|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897158|NCT02959918|584671630|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161897159|NCT02959918|584671617|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897160|NCT02959918|584671618|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897161|NCT02959918|584671619|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897162|NCT02959918|584671620|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897163|NCT02959918|584671621|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897164|NCT02959918|584671622|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897165|NCT02959918|584671623|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897166|NCT02959918|584671624|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897167|NCT02959918|584671625|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
161897168|NCT02959918|584671626|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897169|NCT02959918|584671627|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897170|NCT02959918|584671628|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897171|NCT02959918|584671629|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897172|NCT02959918|584671630|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161897173|NCT02959918|584671617|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897174|NCT02959918|584671618|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897175|NCT02959918|584671619|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897176|NCT02959918|584671620|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897177|NCT02959918|584671621|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897178|NCT02959918|584671622|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897179|NCT02959918|584671623|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897180|NCT02959918|584671624|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897181|NCT02959918|584671625|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897182|NCT02959918|584671626|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
161897183|NCT02959918|584671627|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897184|NCT02959918|584671628|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897185|NCT02959918|584671629|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897186|NCT02959918|584671630|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161897187|NCT03061188|584671632|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
161897188|NCT03061188|584671633|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
161897189|NCT03061188|584671634|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
161897190|NCT03061188|584671635|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
161897191|NCT03061188|584671632|FG000|On Follow-up for 3 Years|Death|0|||
161897192|NCT03061188|584671633|FG001|On Follow-up for 3 Years|Death|3|||
161897193|NCT03061188|584671634|FG002|On Follow-up for 3 Years|Death|5|||
161897194|NCT03061188|584671635|FG003|On Follow-up for 3 Years|Death|4|||
161897195|NCT03061188|584671632|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
161897196|NCT03061188|584671633|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
161897197|NCT03061188|584671634|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
161897198|NCT03061188|584671635|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
161897199|NCT01151345|584671637|FG000|First Intervention Period|Protocol Violation|0|||
161897200|NCT01151345|584671638|FG001|First Intervention Period|Protocol Violation|1|||
161897201|NCT01765569|584671639|FG000|Period B|Withdrawal by Subject|1|||
161897202|NCT01765569|584671639|FG000|Period C|Death|1|||
161897203|NCT05415462|584671640|FG000|Overall Study|Death|18|||
161897204|NCT05415462|584671641|FG001|Overall Study|Death|10|||
161897205|NCT05415462|584671640|FG000|Overall Study|Lost to Follow-up|72|||
161897206|NCT05415462|584671641|FG001|Overall Study|Lost to Follow-up|64|||
161897207|NCT05415462|584671640|FG000|Overall Study|Physician Decision|5|||
161897208|NCT05415462|584671641|FG001|Overall Study|Physician Decision|5|||
161897209|NCT05415462|584671640|FG000|Overall Study|Protocol Deviation|1|||
161897210|NCT05415462|584671641|FG001|Overall Study|Protocol Deviation|0|||
161897211|NCT05415462|584671640|FG000|Overall Study|Withdrawal by Subject|129|||
161897212|NCT05415462|584671641|FG001|Overall Study|Withdrawal by Subject|101|||
161897213|NCT05415462|584671640|FG000|Overall Study|Other Than Specified|8|||
161897214|NCT05415462|584671641|FG001|Overall Study|Other Than Specified|8|||
161897215|NCT01030718|584671642|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
161897216|NCT01030718|584671643|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
161897217|NCT01030718|584671644|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
161897218|NCT01030718|584671642|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
161897219|NCT01030718|584671643|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
161897220|NCT01030718|584671644|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
161897221|NCT01030718|584671642|FG000|Studies CA180-031 and -036 Combined|Death|0|||
161897222|NCT01030718|584671643|FG001|Studies CA180-031 and -036 Combined|Death|1|||
161897223|NCT01030718|584671644|FG002|Studies CA180-031 and -036 Combined|Death|0|||
161897224|NCT01030718|584671642|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
161897225|NCT01030718|584671643|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
161897226|NCT01030718|584671644|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
161897227|NCT01030718|584671642|FG000|Study CA180-036 Only|insufficient effect|1|||
161897228|NCT01030718|584671643|FG001|Study CA180-036 Only|insufficient effect|1|||
161897229|NCT01030718|584671644|FG002|Study CA180-036 Only|insufficient effect|5|||
161897230|NCT01030718|584671642|FG000|Study CA180-036 Only|Adverse Event|2|||
161897231|NCT01030718|584671643|FG001|Study CA180-036 Only|Adverse Event|3|||
161897232|NCT01030718|584671644|FG002|Study CA180-036 Only|Adverse Event|0|||
161897233|NCT01030718|584671642|FG000|Study CA180-036 Only|Death|0|||
161897234|NCT01030718|584671643|FG001|Study CA180-036 Only|Death|1|||
161897235|NCT01030718|584671644|FG002|Study CA180-036 Only|Death|0|||
161897236|NCT01030718|584671642|FG000|Study CA180-036 Only|Other Reasons|0|||
161897237|NCT01030718|584671643|FG001|Study CA180-036 Only|Other Reasons|2|||
161897238|NCT01030718|584671644|FG002|Study CA180-036 Only|Other Reasons|0|||
161897239|NCT00423813|584671645|FG000|Overall Study|Adverse Event|11|||
161897240|NCT00423813|584671646|FG001|Overall Study|Adverse Event|30|||
161897241|NCT00423813|584671647|FG002|Overall Study|Adverse Event|40|||
161897242|NCT00423813|584671645|FG000|Overall Study|Withdrawal by Subject|6|||
161897243|NCT00423813|584671646|FG001|Overall Study|Withdrawal by Subject|8|||
161897244|NCT00423813|584671647|FG002|Overall Study|Withdrawal by Subject|5|||
161897245|NCT00423813|584671645|FG000|Overall Study|Lost to Follow-up|5|||
161897246|NCT00423813|584671646|FG001|Overall Study|Lost to Follow-up|4|||
161897247|NCT00423813|584671647|FG002|Overall Study|Lost to Follow-up|4|||
161897248|NCT00423813|584671645|FG000|Overall Study|Lack of Efficacy|23|||
161897249|NCT00423813|584671646|FG001|Overall Study|Lack of Efficacy|18|||
161897250|NCT00423813|584671647|FG002|Overall Study|Lack of Efficacy|19|||
161897251|NCT00423813|584671645|FG000|Overall Study|Physician Decision|2|||
161897252|NCT00423813|584671646|FG001|Overall Study|Physician Decision|0|||
161897253|NCT00423813|584671647|FG002|Overall Study|Physician Decision|0|||
161897254|NCT00423813|584671645|FG000|Overall Study|Sponsor Decision|0|||
161897255|NCT00423813|584671646|FG001|Overall Study|Sponsor Decision|1|||
161897256|NCT00423813|584671647|FG002|Overall Study|Sponsor Decision|0|||
161897257|NCT00423813|584671645|FG000|Overall Study|Protocol Violation|9|||
161897258|NCT00423813|584671646|FG001|Overall Study|Protocol Violation|4|||
161897259|NCT00423813|584671647|FG002|Overall Study|Protocol Violation|4|||
161897260|NCT00423813|584671645|FG000|Overall Study|Pregnancy|0|||
161897261|NCT00423813|584671646|FG001|Overall Study|Pregnancy|0|||
161897262|NCT00423813|584671647|FG002|Overall Study|Pregnancy|1|||
161897263|NCT00423813|584671645|FG000|Overall Study|Subject started night shift work|1|||
161897264|NCT00423813|584671646|FG001|Overall Study|Subject started night shift work|0|||
161897265|NCT00423813|584671647|FG002|Overall Study|Subject started night shift work|0|||
161897266|NCT00423813|584671645|FG000|Overall Study|Will start exclusionary medications|0|||
161897267|NCT00423813|584671646|FG001|Overall Study|Will start exclusionary medications|1|||
161897268|NCT00423813|584671647|FG002|Overall Study|Will start exclusionary medications|0|||
161897269|NCT00423813|584671645|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
161897270|NCT00423813|584671646|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
161897271|NCT00423813|584671647|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
161897272|NCT01904032|584671655|FG000|Overall Study|Adverse Event|3|||
161897273|NCT01904032|584671656|FG001|Overall Study|Adverse Event|1|||
161897274|NCT01904032|584671655|FG000|Overall Study|Lost to Follow-up|4|||
161897275|NCT01904032|584671656|FG001|Overall Study|Lost to Follow-up|2|||
161897276|NCT01658904|584671657|FG000|Overall Study|Principal Investigator discretion|2|||
161897277|NCT01658904|584671658|FG001|Overall Study|Principal Investigator discretion|0|||
161897278|NCT01658904|584671659|FG002|Overall Study|Principal Investigator discretion|0|||
161897279|NCT02998996|584671662|FG000|Overall Study|Lost to Follow-up|0|||
161897280|NCT02998996|584671663|FG001|Overall Study|Lost to Follow-up|0|||
161897281|NCT02998996|584671664|FG002|Overall Study|Lost to Follow-up|1|||
161897282|NCT02998996|584671665|FG003|Overall Study|Lost to Follow-up|0|||
161897283|NCT02998996|584671666|FG004|Overall Study|Lost to Follow-up|0|||
161897284|NCT02998996|584671667|FG005|Overall Study|Lost to Follow-up|0|||
161897285|NCT02998996|584671662|FG000|Overall Study|Pregnancy|0|||
161897286|NCT02998996|584671663|FG001|Overall Study|Pregnancy|1|||
161897287|NCT02998996|584671664|FG002|Overall Study|Pregnancy|0|||
161897288|NCT02998996|584671665|FG003|Overall Study|Pregnancy|0|||
161897289|NCT02998996|584671666|FG004|Overall Study|Pregnancy|0|||
161897290|NCT02998996|584671667|FG005|Overall Study|Pregnancy|0|||
161897291|NCT02998996|584671662|FG000|Overall Study|Family reasons|0|||
161897292|NCT02998996|584671663|FG001|Overall Study|Family reasons|0|||
161897293|NCT02998996|584671664|FG002|Overall Study|Family reasons|0|||
161897294|NCT02998996|584671665|FG003|Overall Study|Family reasons|0|||
161897295|NCT02998996|584671666|FG004|Overall Study|Family reasons|1|||
161897296|NCT02998996|584671667|FG005|Overall Study|Family reasons|0|||
161897297|NCT01087203|584671668|FG000|Overall Study|Lost to Follow-up|2|||
161897298|NCT01087203|584671669|FG001|Overall Study|Lost to Follow-up|0|||
161897299|NCT01087203|584671668|FG000|Overall Study|Withdrawal by Subject|2|||
161897300|NCT01087203|584671669|FG001|Overall Study|Withdrawal by Subject|6|||
161897301|NCT01087203|584671668|FG000|Overall Study|Lack of Efficacy|1|||
161897302|NCT01087203|584671669|FG001|Overall Study|Lack of Efficacy|2|||
161897303|NCT01087203|584671668|FG000|Overall Study|Study terminated by sponsor|27|||
161897304|NCT01087203|584671669|FG001|Overall Study|Study terminated by sponsor|27|||
161897305|NCT04074330|584671673|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
161897306|NCT04074330|584671674|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
161897307|NCT04074330|584671675|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
161897308|NCT04074330|584671676|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
161897309|NCT04074330|584671677|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
161897310|NCT04074330|584671678|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
161897311|NCT04074330|584671679|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
161897312|NCT04074330|584671680|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
161897313|NCT04074330|584671681|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
161897314|NCT04074330|584671682|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
161897315|NCT04074330|584671673|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
161897316|NCT04074330|584671674|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
161897317|NCT04074330|584671675|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
161897318|NCT04074330|584671676|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
161897319|NCT04074330|584671677|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
161897320|NCT04074330|584671678|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
161897321|NCT04074330|584671679|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
161897322|NCT04074330|584671680|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
161897323|NCT04074330|584671681|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
161897324|NCT04074330|584671682|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
161897325|NCT04074330|584671673|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897326|NCT04074330|584671674|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897327|NCT04074330|584671675|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
161897328|NCT04074330|584671676|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897329|NCT04074330|584671677|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897330|NCT04074330|584671678|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897331|NCT04074330|584671679|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897332|NCT04074330|584671680|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897333|NCT04074330|584671681|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897334|NCT04074330|584671682|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161897335|NCT04074330|584671673|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897336|NCT04074330|584671674|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897337|NCT04074330|584671675|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897338|NCT04074330|584671676|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897339|NCT04074330|584671677|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897340|NCT04074330|584671678|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
161897341|NCT04074330|584671679|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897342|NCT04074330|584671680|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
161897343|NCT04074330|584671681|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897344|NCT04074330|584671682|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161897345|NCT04074330|584671673|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
161897346|NCT04074330|584671674|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
161897347|NCT04074330|584671675|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
161897348|NCT04074330|584671676|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161897349|NCT04074330|584671677|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
161897350|NCT04074330|584671678|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
161897351|NCT04074330|584671679|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161897352|NCT04074330|584671680|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161897353|NCT04074330|584671681|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161897354|NCT04074330|584671682|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161897355|NCT04074330|584671673|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161897356|NCT04074330|584671674|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
161897357|NCT04074330|584671675|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
161897358|NCT04074330|584671676|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
161897359|NCT04074330|584671677|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161897360|NCT04074330|584671678|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
161897361|NCT04074330|584671679|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161897362|NCT04074330|584671680|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161897363|NCT04074330|584671681|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161897364|NCT04074330|584671682|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161897365|NCT04074330|584671673|FG000|Dose Expansion (up to 42 Months)|Death|0|||
161897366|NCT04074330|584671674|FG001|Dose Expansion (up to 42 Months)|Death|0|||
161897367|NCT04074330|584671675|FG002|Dose Expansion (up to 42 Months)|Death|0|||
161897368|NCT04074330|584671676|FG003|Dose Expansion (up to 42 Months)|Death|0|||
161897369|NCT04074330|584671677|FG004|Dose Expansion (up to 42 Months)|Death|0|||
161897370|NCT04074330|584671678|FG005|Dose Expansion (up to 42 Months)|Death|0|||
161897371|NCT04074330|584671679|FG006|Dose Expansion (up to 42 Months)|Death|0|||
161897372|NCT04074330|584671680|FG007|Dose Expansion (up to 42 Months)|Death|0|||
161897373|NCT04074330|584671681|FG008|Dose Expansion (up to 42 Months)|Death|1|||
161897374|NCT04074330|584671682|FG009|Dose Expansion (up to 42 Months)|Death|0|||
161897375|NCT04074330|584671673|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897376|NCT04074330|584671674|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897377|NCT04074330|584671675|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897378|NCT04074330|584671676|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897379|NCT04074330|584671677|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897380|NCT04074330|584671678|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897381|NCT04074330|584671679|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897382|NCT04074330|584671680|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161897383|NCT04074330|584671681|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
161897384|NCT04074330|584671682|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
161897385|NCT01429298|584671687|FG000|Overall Study|Protocol Violation|4|||
161897386|NCT01429298|584671688|FG001|Overall Study|Protocol Violation|6|||
161897387|NCT02903420|584671689|FG000|Overall Study|Death|3|||
161897388|NCT00181883|584671692|FG000|Overall Study|Lack of Efficacy|2|||
161897389|NCT00181883|584671692|FG000|Overall Study|Treatment Limiting AEs|3|||
161897390|NCT00181883|584671692|FG000|Overall Study|Withdrawal by Subject|4|||
161897391|NCT00181883|584671692|FG000|Overall Study|Lost to Follow-up|1|||
161897392|NCT05305989|584671693|FG000|Overall Study|Other|3|||
161897393|NCT05305989|584671694|FG001|Overall Study|Other|2|||
161897394|NCT05305989|584671695|FG002|Overall Study|Other|0|||
161897395|NCT05305989|584671693|FG000|Overall Study|Sponsor decision|2|||
161897396|NCT05305989|584671694|FG001|Overall Study|Sponsor decision|1|||
161897397|NCT05305989|584671695|FG002|Overall Study|Sponsor decision|0|||
161897398|NCT05305989|584671693|FG000|Overall Study|Protocol Violation|0|||
161897399|NCT05305989|584671694|FG001|Overall Study|Protocol Violation|1|||
161897400|NCT05305989|584671695|FG002|Overall Study|Protocol Violation|0|||
161897401|NCT05305989|584671693|FG000|Overall Study|Investigator decision|1|||
161897402|NCT05305989|584671694|FG001|Overall Study|Investigator decision|2|||
161897403|NCT05305989|584671695|FG002|Overall Study|Investigator decision|0|||
161897404|NCT05305989|584671693|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
161897405|NCT05305989|584671694|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
161897406|NCT05305989|584671695|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
161897407|NCT05305989|584671693|FG000|Overall Study|Adverse Event|1|||
161897408|NCT05305989|584671694|FG001|Overall Study|Adverse Event|1|||
161897409|NCT05305989|584671695|FG002|Overall Study|Adverse Event|0|||
161897410|NCT05305989|584671693|FG000|Overall Study|Enrolled but never dosed|3|||
161897411|NCT05305989|584671694|FG001|Overall Study|Enrolled but never dosed|2|||
161897412|NCT05305989|584671695|FG002|Overall Study|Enrolled but never dosed|1|||
161897413|NCT03162328|584671696|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
161897414|NCT03162328|584671697|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
161897415|NCT03162328|584671698|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
161897416|NCT03162328|584671696|FG000|Screening Period|Withdrawal by Subject|1|||
161897417|NCT03162328|584671697|FG001|Screening Period|Withdrawal by Subject|0|||
161897418|NCT03162328|584671698|FG002|Screening Period|Withdrawal by Subject|0|||
161897419|NCT03162328|584671696|FG000|Study Period|Withdrawal by Subject|0|||
161897420|NCT03162328|584671697|FG001|Study Period|Withdrawal by Subject|0|||
161897421|NCT03162328|584671698|FG002|Study Period|Withdrawal by Subject|1|||
161897422|NCT00913770|584671699|FG000|Overall Study|Unable to contact|24|||
161897423|NCT00913770|584671700|FG001|Overall Study|Unable to contact|19|||
161897424|NCT00913770|584671701|FG002|Overall Study|Unable to contact|13|||
161897425|NCT00913770|584671699|FG000|Overall Study|Refused|11|||
161897426|NCT00913770|584671700|FG001|Overall Study|Refused|10|||
161897427|NCT00913770|584671701|FG002|Overall Study|Refused|8|||
161897428|NCT01066871|584671703|FG000|Overall Study|Lost to Follow-up|0|||
161897429|NCT01066871|584671704|FG001|Overall Study|Lost to Follow-up|2|||
161897430|NCT01066871|584671705|FG002|Overall Study|Lost to Follow-up|2|||
161897431|NCT01066871|584671706|FG003|Overall Study|Lost to Follow-up|0|||
161897432|NCT01066871|584671703|FG000|Overall Study|Protocol Violation|1|||
161897433|NCT01066871|584671704|FG001|Overall Study|Protocol Violation|0|||
161897434|NCT01066871|584671705|FG002|Overall Study|Protocol Violation|3|||
161897435|NCT01066871|584671706|FG003|Overall Study|Protocol Violation|2|||
161897436|NCT01066871|584671703|FG000|Overall Study|Lack of Efficacy|0|||
161897437|NCT01066871|584671704|FG001|Overall Study|Lack of Efficacy|0|||
161897438|NCT01066871|584671705|FG002|Overall Study|Lack of Efficacy|0|||
161897439|NCT01066871|584671706|FG003|Overall Study|Lack of Efficacy|1|||
161897440|NCT01066871|584671703|FG000|Overall Study|Withdrawal by Subject|3|||
161897441|NCT01066871|584671704|FG001|Overall Study|Withdrawal by Subject|1|||
161897442|NCT01066871|584671705|FG002|Overall Study|Withdrawal by Subject|0|||
161897443|NCT01066871|584671706|FG003|Overall Study|Withdrawal by Subject|0|||
161897444|NCT01066871|584671703|FG000|Overall Study|Other|0|||
161897445|NCT01066871|584671704|FG001|Overall Study|Other|2|||
161897446|NCT01066871|584671705|FG002|Overall Study|Other|1|||
161897447|NCT01066871|584671706|FG003|Overall Study|Other|2|||
161897448|NCT03373461|584671712|FG000|Part 2|Adverse Event|0|||
161897449|NCT03373461|584671713|FG001|Part 2|Adverse Event|1|||
161897450|NCT03373461|584671714|FG002|Part 2|Adverse Event|0|||
161897451|NCT03373461|584671715|FG003|Part 2|Adverse Event|0|||
161897452|NCT03373461|584671716|FG004|Part 2|Adverse Event|1|||
161897453|NCT01366638|584671717|FG000|Overall Study|Withdrawal by Subject|0|||
161897454|NCT01366638|584671718|FG001|Overall Study|Withdrawal by Subject|0|||
161897455|NCT01366638|584671719|FG002|Overall Study|Withdrawal by Subject|6|||
161897456|NCT01366638|584671717|FG000|Overall Study|Other|1|||
161897457|NCT01366638|584671718|FG001|Overall Study|Other|0|||
161897458|NCT01366638|584671719|FG002|Overall Study|Other|0|||
161897459|NCT01554163|584671721|FG000|Overall Study|Adverse Event|3|||
161897460|NCT01554163|584671722|FG001|Overall Study|Adverse Event|0|||
161897461|NCT01554163|584671721|FG000|Overall Study|Lack of Efficacy|1|||
161897462|NCT01554163|584671722|FG001|Overall Study|Lack of Efficacy|0|||
161897463|NCT01554163|584671721|FG000|Overall Study|Lost to Follow-up|1|||
161897464|NCT01554163|584671722|FG001|Overall Study|Lost to Follow-up|0|||
161897465|NCT01554163|584671721|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161897466|NCT01554163|584671722|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161897467|NCT01554163|584671721|FG000|Overall Study|Protocol Violation|0|||
161897468|NCT01554163|584671722|FG001|Overall Study|Protocol Violation|4|||
161897469|NCT01554163|584671721|FG000|Overall Study|Withdrawal by Subject|1|||
161897470|NCT01554163|584671722|FG001|Overall Study|Withdrawal by Subject|5|||
161897471|NCT01554163|584671721|FG000|Overall Study|Not Treated|1|||
161897472|NCT01554163|584671722|FG001|Overall Study|Not Treated|0|||
161897473|NCT01941537|584671723|FG000|Overall Study|Lack of Efficacy|1|||
161897474|NCT01941537|584671724|FG001|Overall Study|Lack of Efficacy|2|||
161897475|NCT01941537|584671723|FG000|Overall Study|Lost to Follow-up|1|||
161897476|NCT01941537|584671724|FG001|Overall Study|Lost to Follow-up|0|||
161897477|NCT01941537|584671723|FG000|Overall Study|Pregnancy|1|||
161897478|NCT01941537|584671724|FG001|Overall Study|Pregnancy|0|||
161897479|NCT01941537|584671723|FG000|Overall Study|Adverse Event|1|||
161897480|NCT01941537|584671724|FG001|Overall Study|Adverse Event|0|||
161897481|NCT01941537|584671723|FG000|Overall Study|Withdrawal by Subject|0|||
161897482|NCT01941537|584671724|FG001|Overall Study|Withdrawal by Subject|1|||
161897483|NCT02634983|584671726|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
161897484|NCT02634983|584671727|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
161897485|NCT02315664|584673362|FG000|Overall Study|Lost to Follow-up|1|||
161897486|NCT02315664|584673363|FG001|Overall Study|Lost to Follow-up|1|||
161897487|NCT02315664|584673362|FG000|Overall Study|Withdrawal by Subject|0|||
161897488|NCT02315664|584673363|FG001|Overall Study|Withdrawal by Subject|3|||
161897489|NCT00667992|584673364|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
161897490|NCT00667992|584673365|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
161897491|NCT00667992|584673364|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
161897492|NCT00667992|584673365|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
161897493|NCT00667992|584673364|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
161897494|NCT00667992|584673365|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
161897495|NCT00667992|584673364|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
161897496|NCT00667992|584673365|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
161897497|NCT00667992|584673364|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
161897498|NCT00667992|584673365|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
161897499|NCT00667992|584673364|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
162009497|NCT00541658|585090139|FG000|Overall Study|Adverse Event|28|||
161784166|NCT03118765|584254329|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
161784167|NCT03118765|584254330|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
161784168|NCT03118765|584254331|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
161784169|NCT03118765|584254332|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
161784170|NCT03118765|584254333|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
161784171|NCT03118765|584254329|FG000|Overall Study|COPD Exacerbation|1|||
161784172|NCT03118765|584254330|FG001|Overall Study|COPD Exacerbation|0|||
161784173|NCT03118765|584254331|FG002|Overall Study|COPD Exacerbation|0|||
161784174|NCT03118765|584254332|FG003|Overall Study|COPD Exacerbation|1|||
161784175|NCT03118765|584254333|FG004|Overall Study|COPD Exacerbation|0|||
161784176|NCT03118765|584254329|FG000|Overall Study|Lost to Follow-up|1|||
161784177|NCT03118765|584254330|FG001|Overall Study|Lost to Follow-up|0|||
161784178|NCT03118765|584254331|FG002|Overall Study|Lost to Follow-up|1|||
161784179|NCT03118765|584254332|FG003|Overall Study|Lost to Follow-up|0|||
161784180|NCT03118765|584254333|FG004|Overall Study|Lost to Follow-up|0|||
161784181|NCT03118765|584254329|FG000|Overall Study|Sponsor Decision|1|||
161784182|NCT03118765|584254330|FG001|Overall Study|Sponsor Decision|0|||
161784183|NCT03118765|584254331|FG002|Overall Study|Sponsor Decision|1|||
161784184|NCT03118765|584254332|FG003|Overall Study|Sponsor Decision|0|||
161784185|NCT03118765|584254333|FG004|Overall Study|Sponsor Decision|1|||
161784186|NCT03070431|584254336|FG000|Overall Study|Withdrawal by Subject|2|||
161784187|NCT03070431|584254336|FG000|Overall Study|Lost to Follow-up|2|||
161784188|NCT00995488|584254342|FG000|Overall Study|Withdrawal by Subject|1|||
161784189|NCT01656967|584254343|FG000|Overall Study|faulty monitor|1|||
161784190|NCT01656967|584254344|FG001|Overall Study|faulty monitor|0|||
161784191|NCT01656967|584254343|FG000|Overall Study|unsuccessful ETT insertion|3|||
161784192|NCT01656967|584254344|FG001|Overall Study|unsuccessful ETT insertion|2|||
161784193|NCT00833976|584255362|FG000|Overall Study|Withdrawal by Subject|5|||
161784194|NCT00833976|584255362|FG000|Overall Study|Lost to Follow-up|4|||
161784195|NCT00833976|584255362|FG000|Overall Study|Did not meet eligibility criteria|41|||
161784196|NCT00833976|584255362|FG000|Overall Study|Physician Decision|1|||
161784197|NCT01246973|584255367|FG000|Overall Study|Other|38|||
161784198|NCT01246973|584255368|FG001|Overall Study|Other|25|||
161784199|NCT01246973|584255367|FG000|Overall Study|Adverse Event|16|||
161784200|NCT01246973|584255368|FG001|Overall Study|Adverse Event|9|||
161784201|NCT01246973|584255367|FG000|Overall Study|Withdrawal by Subject|7|||
161784202|NCT01246973|584255368|FG001|Overall Study|Withdrawal by Subject|13|||
161784203|NCT02598622|584255369|FG000|Overall Study|Withdrawal by Subject|3|||
161784204|NCT02598622|584255370|FG001|Overall Study|Withdrawal by Subject|0|||
161784205|NCT02598622|584255369|FG000|Overall Study|Physician Decision|3|||
161784206|NCT02598622|584255370|FG001|Overall Study|Physician Decision|0|||
161784207|NCT00681824|584255374|FG000|Overall Study|withdrawn by investigator|0|||
161784208|NCT00681824|584255375|FG001|Overall Study|withdrawn by investigator|0|||
161784209|NCT00681824|584255376|FG002|Overall Study|withdrawn by investigator|1|||
161784210|NCT00681824|584255374|FG000|Overall Study|scheduling conflict|1|||
161784211|NCT00681824|584255375|FG001|Overall Study|scheduling conflict|0|||
161784212|NCT00681824|584255376|FG002|Overall Study|scheduling conflict|0|||
161784213|NCT00681824|584255374|FG000|Overall Study|Death|0|||
161784214|NCT00681824|584255375|FG001|Overall Study|Death|1|||
161784215|NCT00681824|584255376|FG002|Overall Study|Death|0|||
161784216|NCT03724916|584255377|FG000|Overall Study|Withdrawal by Subject|0|||
161784217|NCT03724916|584255378|FG001|Overall Study|Withdrawal by Subject|1|||
161784218|NCT03724916|584255379|FG002|Overall Study|Withdrawal by Subject|1|||
161784219|NCT03724916|584255380|FG003|Overall Study|Withdrawal by Subject|2|||
161784220|NCT03724916|584255377|FG000|Overall Study|Randomized but not Treated|1|||
161784221|NCT03724916|584255378|FG001|Overall Study|Randomized but not Treated|0|||
161784222|NCT03724916|584255379|FG002|Overall Study|Randomized but not Treated|0|||
161784223|NCT03724916|584255380|FG003|Overall Study|Randomized but not Treated|0|||
161784224|NCT04575038|584255381|FG000|Overall Study|Withdrawal by Subject|1|||
161784225|NCT04575038|584255382|FG001|Overall Study|Withdrawal by Subject|1|||
161784226|NCT03101293|584255391|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
161784227|NCT03101293|584255392|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
161784228|NCT04388527|584255394|FG000|Overall Study|Death|14|||
161784229|NCT04388527|584255394|FG000|Overall Study|Withdrawal by Subject|2|||
161784230|NCT04388527|584255394|FG000|Overall Study|Lost to Follow-up|1|||
161784231|NCT03333382|584255395|FG000|Overall Study|Lost to Follow-up|1|||
161784232|NCT03333382|584255396|FG001|Overall Study|Lost to Follow-up|0|||
161784233|NCT03471182|584255397|FG000|Overall Study|Withdrawal by Subject|1|||
161784234|NCT03471182|584255398|FG001|Overall Study|Withdrawal by Subject|1|||
161784235|NCT03471182|584255399|FG002|Overall Study|Withdrawal by Subject|0|||
161784236|NCT03471182|584255397|FG000|Overall Study|Technical failure|2|||
161784237|NCT03471182|584255398|FG001|Overall Study|Technical failure|0|||
161784238|NCT03471182|584255399|FG002|Overall Study|Technical failure|0|||
161784239|NCT00331773|584255403|FG000|Overall Study|Withdrawal by Subject|6|||
161784240|NCT00331773|584255404|FG001|Overall Study|Withdrawal by Subject|4|||
161784241|NCT00331773|584255403|FG000|Overall Study|Protocol Violation|10|||
161784242|NCT00331773|584255404|FG001|Overall Study|Protocol Violation|3|||
161897500|NCT00667992|584673365|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
161897501|NCT00667992|584673364|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
161897502|NCT00667992|584673365|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
161897503|NCT00667992|584673364|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
161897504|NCT00667992|584673365|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
161897505|NCT00667992|584673364|FG000|Wash-out|Not within one doubling dilution|4|||
161897506|NCT00667992|584673365|FG001|Wash-out|Not within one doubling dilution|3|||
161897507|NCT00667992|584673364|FG000|Wash-out|Failure to wash-out|2|||
161897508|NCT00667992|584673365|FG001|Wash-out|Failure to wash-out|2|||
161897509|NCT00667992|584673364|FG000|Wash-out|Withdrawal by Subject|1|||
161897510|NCT00667992|584673365|FG001|Wash-out|Withdrawal by Subject|0|||
161897511|NCT00667992|584673364|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
161897512|NCT00667992|584673365|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
161897513|NCT00667992|584673364|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
161897514|NCT00667992|584673365|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
161897515|NCT00762762|584673369|FG000|Overall Study|Did not return for appointments|6|||
161897516|NCT00762762|584673370|FG001|Overall Study|Did not return for appointments|8|||
161897517|NCT02964338|584673373|FG000|Overall Study|Sponsor terminated study for futility|12|||
161897518|NCT02964338|584673374|FG001|Overall Study|Sponsor terminated study for futility|15|||
161897519|NCT02964338|584673375|FG002|Overall Study|Sponsor terminated study for futility|14|||
161897520|NCT02964338|584673373|FG000|Overall Study|Lack of Efficacy|0|||
161897521|NCT02964338|584673374|FG001|Overall Study|Lack of Efficacy|3|||
161897522|NCT02964338|584673375|FG002|Overall Study|Lack of Efficacy|0|||
161897523|NCT02964338|584673373|FG000|Overall Study|Lost to Follow-up|1|||
161897524|NCT02964338|584673374|FG001|Overall Study|Lost to Follow-up|0|||
161897525|NCT02964338|584673375|FG002|Overall Study|Lost to Follow-up|3|||
161897526|NCT02964338|584673373|FG000|Overall Study|Protocol Violation|0|||
161897527|NCT02964338|584673374|FG001|Overall Study|Protocol Violation|1|||
161897528|NCT02964338|584673375|FG002|Overall Study|Protocol Violation|0|||
161897529|NCT02964338|584673373|FG000|Overall Study|Withdrawal by Subject|1|||
161897530|NCT02964338|584673374|FG001|Overall Study|Withdrawal by Subject|3|||
161897531|NCT02964338|584673375|FG002|Overall Study|Withdrawal by Subject|1|||
161897532|NCT02964338|584673373|FG000|Overall Study|Adverse Event|2|||
161897533|NCT02964338|584673374|FG001|Overall Study|Adverse Event|1|||
161897534|NCT02964338|584673375|FG002|Overall Study|Adverse Event|1|||
161897535|NCT02964338|584673373|FG000|Overall Study|Non-compliant with e-diary|0|||
161897536|NCT02964338|584673374|FG001|Overall Study|Non-compliant with e-diary|1|||
161897537|NCT02964338|584673375|FG002|Overall Study|Non-compliant with e-diary|0|||
161897538|NCT02964338|584673373|FG000|Overall Study|Did not meet criteria|1|||
161897539|NCT02964338|584673374|FG001|Overall Study|Did not meet criteria|0|||
161897540|NCT02964338|584673375|FG002|Overall Study|Did not meet criteria|0|||
161897541|NCT03872843|584673376|FG000|Overall Study|Lost to Follow-up|5|||
161897542|NCT03872843|584673377|FG001|Overall Study|Lost to Follow-up|7|||
161897543|NCT02609386|584673378|FG000|Overall Study|Withdrawal by Subject|6|||
161897544|NCT02609386|584673379|FG001|Overall Study|Withdrawal by Subject|1|||
161897545|NCT02609386|584673378|FG000|Overall Study|Lost to Follow-up|3|||
161897546|NCT02609386|584673379|FG001|Overall Study|Lost to Follow-up|5|||
161897547|NCT02609386|584673378|FG000|Overall Study|Death|19|||
161897548|NCT02609386|584673379|FG001|Overall Study|Death|9|||
161897549|NCT02609386|584673378|FG000|Overall Study|Physician Decision|0|||
161897550|NCT02609386|584673379|FG001|Overall Study|Physician Decision|2|||
161897551|NCT00610168|584673380|FG000|Overall Study|Withdrawal by Subject|2|||
161897552|NCT00610168|584673381|FG001|Overall Study|Withdrawal by Subject|0|||
161897553|NCT01029262|584673385|FG000|Overall Study|Adverse Event|9|||
161897554|NCT01029262|584673386|FG001|Overall Study|Adverse Event|52|||
161897555|NCT01029262|584673385|FG000|Overall Study|Lack of therapeutic effect|57|||
161897556|NCT01029262|584673386|FG001|Overall Study|Lack of therapeutic effect|76|||
161897557|NCT01029262|584673385|FG000|Overall Study|Withdrawal by Subject|10|||
161897558|NCT01029262|584673386|FG001|Overall Study|Withdrawal by Subject|17|||
161897559|NCT01029262|584673385|FG000|Overall Study|Protocol Violation|2|||
161897560|NCT01029262|584673386|FG001|Overall Study|Protocol Violation|3|||
161897561|NCT01029262|584673385|FG000|Overall Study|Miscellaneous|1|||
161897562|NCT01029262|584673386|FG001|Overall Study|Miscellaneous|9|||
161897563|NCT01029262|584673385|FG000|Overall Study|Death|0|||
161897564|NCT01029262|584673386|FG001|Overall Study|Death|3|||
161897565|NCT01468454|584673387|FG000|Overall Study|Did not have surgery after PET|9|||
161897566|NCT02896569|584673389|FG000|Overall Study|Lost to Follow-up|2|||
161897567|NCT02896569|584673390|FG001|Overall Study|Lost to Follow-up|1|||
161897568|NCT02896569|584673389|FG000|Overall Study|Physician Decision|1|||
161897569|NCT02896569|584673390|FG001|Overall Study|Physician Decision|3|||
161897570|NCT02896569|584673389|FG000|Overall Study|Adverse Event|0|||
161897571|NCT02896569|584673390|FG001|Overall Study|Adverse Event|1|||
161897572|NCT02896569|584673389|FG000|Overall Study|Withdrawal by Subject|1|||
161897573|NCT02896569|584673390|FG001|Overall Study|Withdrawal by Subject|0|||
161897574|NCT01462630|584673391|FG000|Overall Study|Did not initiate therapy|3|||
161784243|NCT00289731|584255405|FG000|Overall Study|Adverse Event|1|||
161784244|NCT00289731|584255406|FG001|Overall Study|Adverse Event|2|||
161784245|NCT00289731|584255407|FG002|Overall Study|Adverse Event|2|||
161784246|NCT00289731|584255405|FG000|Overall Study|Other|1|||
161784247|NCT00289731|584255406|FG001|Overall Study|Other|0|||
161784248|NCT00289731|584255407|FG002|Overall Study|Other|0|||
161784249|NCT02513459|584255408|FG000|Overall Study|Adverse Event|7|||
161784250|NCT02513459|584255408|FG000|Overall Study|Withdrew consent|5|||
161784251|NCT02513459|584255408|FG000|Overall Study|Loss of efficacy|2|||
161784252|NCT02513459|584255408|FG000|Overall Study|Pregnancy|2|||
161784253|NCT02513459|584255408|FG000|Overall Study|Subject decision|2|||
161784254|NCT02513459|584255408|FG000|Overall Study|Lack of response|1|||
161784255|NCT02513459|584255408|FG000|Overall Study|Reproductive plans|1|||
161784256|NCT02513459|584255408|FG000|Overall Study|Surgery planned-- not done|1|||
161784257|NCT00923195|584255409|FG000|Overall Study|Death|0|||
161784258|NCT00923195|584255410|FG001|Overall Study|Death|1|||
161784259|NCT00525031|584255411|FG000|Overall Study|Disease Progression|1|||
161784260|NCT00525031|584255412|FG001|Overall Study|Disease Progression|1|||
161784261|NCT00787566|584255415|FG000|Overall Study|AE related to chemotherapy|0|||
161784262|NCT00787566|584255416|FG001|Overall Study|AE related to chemotherapy|1|||
161784263|NCT00787566|584255417|FG002|Overall Study|AE related to chemotherapy|0|||
161784264|NCT02140164|584255418|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
161784265|NCT01814761|584255419|FG000|Overall Study|Other Reasons|1|||
161784266|NCT01814761|584255420|FG001|Overall Study|Other Reasons|10|||
161784267|NCT01814761|584255419|FG000|Overall Study|Ocular Adverse Event|6|||
161784268|NCT01814761|584255420|FG001|Overall Study|Ocular Adverse Event|15|||
161784269|NCT01814761|584255419|FG000|Overall Study|Lost to Follow-up|1|||
161784270|NCT01814761|584255420|FG001|Overall Study|Lost to Follow-up|5|||
161784271|NCT00775983|584255421|FG000|Overall Study|Protocol Violation|1|||
161784272|NCT00775983|584255422|FG001|Overall Study|Protocol Violation|2|||
161784273|NCT00660790|584255431|FG000|Baseline to 3 Months|Death|1|||
161784274|NCT00660790|584255431|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
161784275|NCT00660790|584255431|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
161784276|NCT00686374|584255436|FG000|Overall Study|Lack of Efficacy|10|||
161784277|NCT00686374|584255436|FG000|Overall Study|Adverse Event|8|||
161784278|NCT00686374|584255436|FG000|Overall Study|Withdrew consent|5|||
161784279|NCT00686374|584255436|FG000|Overall Study|Lost to Follow-up|1|||
161784280|NCT00686374|584255436|FG000|Overall Study|Missing reason|33|||
161784281|NCT00686374|584255436|FG000|Overall Study|Other, not specified|4|||
161784282|NCT02643966|584255438|FG000|First Screening Round|ineligible|1|||
161784283|NCT02643966|584255438|FG000|First Screening Round|excluded from analysis|2|||
161784284|NCT02643966|584255438|FG000|First Screening Round|Lost to Follow-up|56|||
161784285|NCT02643966|584255438|FG000|First Screening Round|Withdrawal by Subject|28|||
161784286|NCT02643966|584255438|FG000|First Screening Round|Death|1|||
161784287|NCT02643966|584255438|FG000|Between First and Second Screening|Lost to Follow-up|65|||
161784288|NCT02643966|584255438|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
161784289|NCT02643966|584255438|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
161784290|NCT02643966|584255438|FG000|Second Screening Round|Withdrawal by Subject|20|||
161784291|NCT02643966|584255438|FG000|Second Screening Round|Lost to Follow-up|57|||
161784292|NCT02643966|584255438|FG000|Second Screening Round|Physician Decision|2|||
161784293|NCT02643966|584255438|FG000|Second Screening Round|Death|4|||
161784294|NCT02643966|584255438|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
161784295|NCT02643966|584255438|FG000|Between Second and Third Screening|Death|1|||
161784296|NCT02643966|584255438|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
161784297|NCT02643966|584255438|FG000|Third Screening Round|PI excluded|2|||
161784298|NCT02643966|584255438|FG000|Third Screening Round|Lost to Follow-up|241|||
161784299|NCT01493531|584255439|FG000|Overall Study|Adverse Event|4|||
161784300|NCT01493531|584255440|FG001|Overall Study|Adverse Event|12|||
161784301|NCT01493531|584255441|FG002|Overall Study|Adverse Event|9|||
161784302|NCT01493531|584255439|FG000|Overall Study|Gout flare|3|||
161784303|NCT01493531|584255440|FG001|Overall Study|Gout flare|0|||
161784304|NCT01493531|584255441|FG002|Overall Study|Gout flare|2|||
161784305|NCT01493531|584255439|FG000|Overall Study|Protocol Violation|8|||
161784306|NCT01493531|584255440|FG001|Overall Study|Protocol Violation|15|||
161784307|NCT01493531|584255441|FG002|Overall Study|Protocol Violation|12|||
161784308|NCT01493531|584255439|FG000|Overall Study|Sponsor terminated study|5|||
161784309|NCT01493531|584255440|FG001|Overall Study|Sponsor terminated study|2|||
161784310|NCT01493531|584255441|FG002|Overall Study|Sponsor terminated study|3|||
161784311|NCT01493531|584255439|FG000|Overall Study|Lost to Follow-up|5|||
161784312|NCT01493531|584255440|FG001|Overall Study|Lost to Follow-up|7|||
161784313|NCT01493531|584255441|FG002|Overall Study|Lost to Follow-up|11|||
161784314|NCT01493531|584255439|FG000|Overall Study|Withdrawal by Subject|16|||
161784315|NCT01493531|584255440|FG001|Overall Study|Withdrawal by Subject|13|||
161784316|NCT01493531|584255441|FG002|Overall Study|Withdrawal by Subject|11|||
161784317|NCT01493531|584255439|FG000|Overall Study|Death|0|||
161784318|NCT01493531|584255440|FG001|Overall Study|Death|1|||
161784319|NCT01493531|584255441|FG002|Overall Study|Death|0|||
162242027|NCT02616562|585939074|FG006|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161897575|NCT01462630|584673391|FG000|Overall Study|Death|1|||
161897576|NCT01462630|584673391|FG000|Overall Study|Protocol Violation|2|||
161897577|NCT01462630|584673391|FG000|Overall Study|Adverse Event|1|||
161897578|NCT03060291|584673394|FG000|3-month Follow-up|Declined to respond|8|||
161897579|NCT03060291|584673395|FG001|3-month Follow-up|Declined to respond|10|||
161897580|NCT03060291|584673396|FG002|3-month Follow-up|Declined to respond|2|||
161897581|NCT03060291|584673394|FG000|6-month Follow-up|Declined to respond|7|||
161897582|NCT03060291|584673395|FG001|6-month Follow-up|Declined to respond|13|||
161897583|NCT03060291|584673396|FG002|6-month Follow-up|Declined to respond|4|||
161897584|NCT03060291|584673394|FG000|12-month Follow-up|Declined to respond|7|||
161897585|NCT03060291|584673395|FG001|12-month Follow-up|Declined to respond|16|||
161897586|NCT03060291|584673396|FG002|12-month Follow-up|Declined to respond|6|||
161897587|NCT01509664|584673399|FG000|Overall Study|Lost to Follow-up|15|||
161897588|NCT01509664|584673400|FG001|Overall Study|Lost to Follow-up|21|||
161897589|NCT03665077|584673403|FG000|Overall Study|Lost to Follow-up|2|||
161897590|NCT03665077|584673403|FG000|Overall Study|Physician Decision|2|||
161897591|NCT02364388|584673406|FG000|Overall Study|Protocol Violation|1|||
161897592|NCT02364388|584673406|FG000|Overall Study|Technical Failure|3|||
161897593|NCT02364388|584673406|FG000|Overall Study|No OA/US data|2|||
161897594|NCT02364388|584673406|FG000|Overall Study|No Biopsy|2|||
161897595|NCT00837967|584673407|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
161897596|NCT00837967|584673408|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
161897597|NCT02504320|584673412|FG000|Treatment Period 1|Positive Drug Screen|0|||
161897598|NCT02504320|584673413|FG001|Treatment Period 1|Positive Drug Screen|0|||
161897599|NCT02504320|584673414|FG002|Treatment Period 1|Positive Drug Screen|1|||
161897600|NCT02504320|584673415|FG003|Treatment Period 1|Positive Drug Screen|0|||
161897601|NCT02504320|584673412|FG000|Treatment Period 2|Positive Drug Screen|0|||
161897602|NCT02504320|584673413|FG001|Treatment Period 2|Positive Drug Screen|1|||
161897603|NCT02504320|584673414|FG002|Treatment Period 2|Positive Drug Screen|0|||
161897604|NCT02504320|584673415|FG003|Treatment Period 2|Positive Drug Screen|0|||
161897605|NCT02504320|584673412|FG000|Treatment Period 3|Positive Drug Screen|0|||
161897606|NCT02504320|584673413|FG001|Treatment Period 3|Positive Drug Screen|0|||
161897607|NCT02504320|584673414|FG002|Treatment Period 3|Positive Drug Screen|0|||
161897608|NCT02504320|584673415|FG003|Treatment Period 3|Positive Drug Screen|1|||
161897609|NCT02504320|584673412|FG000|Treatment Period 3|Adverse Event|0|||
161897610|NCT02504320|584673413|FG001|Treatment Period 3|Adverse Event|0|||
161897611|NCT02504320|584673414|FG002|Treatment Period 3|Adverse Event|1|||
161897612|NCT02504320|584673415|FG003|Treatment Period 3|Adverse Event|0|||
161897613|NCT02306850|584673418|FG000|Overall Study|Lack of Efficacy|2|||
161897614|NCT02420262|584673419|FG000|Overall Study|Adverse Event|1|||
161897615|NCT02420262|584673420|FG001|Overall Study|Adverse Event|0|||
161897616|NCT02420262|584673419|FG000|Overall Study|Withdrawal by Subject|1|||
161897617|NCT02420262|584673420|FG001|Overall Study|Withdrawal by Subject|4|||
161897618|NCT02420262|584673419|FG000|Overall Study|Unclassified|0|||
161897619|NCT02420262|584673420|FG001|Overall Study|Unclassified|1|||
161897620|NCT01210222|584673421|FG000|Overall Study|Ineligible|2|||
161897621|NCT01210222|584673421|FG000|Overall Study|Never treated|1|||
161897622|NCT00941304|584673422|FG000|Overall Study|Lost to Follow-up|1|||
161897623|NCT00941304|584673423|FG001|Overall Study|Lost to Follow-up|0|||
161897624|NCT00941304|584673424|FG002|Overall Study|Lost to Follow-up|0|||
161897625|NCT00941304|584673425|FG003|Overall Study|Lost to Follow-up|0|||
161897626|NCT00941304|584673426|FG004|Overall Study|Lost to Follow-up|0|||
161897627|NCT03293394|584673427|FG000|Follow-up (6 Months)|Adverse Event|4|||
161897628|NCT03293394|584673428|FG001|Follow-up (6 Months)|Adverse Event|2|||
161897629|NCT02497404|584673429|FG000|Overall Study|Adverse Event|1|||
161897630|NCT01408901|584673430|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
161897631|NCT01408901|584673431|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
161897632|NCT01408901|584673432|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
161897633|NCT01408901|584673433|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
161897634|NCT01408901|584673430|FG000|6-Week Follow-Up|Death|1|||
161897635|NCT01408901|584673431|FG001|6-Week Follow-Up|Death|0|||
161897636|NCT01408901|584673432|FG002|6-Week Follow-Up|Death|0|||
161897637|NCT01408901|584673433|FG003|6-Week Follow-Up|Death|0|||
161897638|NCT01408901|584673430|FG000|6-Week Follow-Up|Cancelled visit|0|||
161897639|NCT01408901|584673431|FG001|6-Week Follow-Up|Cancelled visit|1|||
161897640|NCT01408901|584673432|FG002|6-Week Follow-Up|Cancelled visit|0|||
161897641|NCT01408901|584673433|FG003|6-Week Follow-Up|Cancelled visit|2|||
161897642|NCT01408901|584673430|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
161897643|NCT01408901|584673431|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
161897644|NCT01408901|584673432|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
161897645|NCT01408901|584673433|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
161897646|NCT01408901|584673430|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
161897647|NCT01408901|584673431|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
161897648|NCT01408901|584673432|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
161897649|NCT01408901|584673433|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
161897650|NCT01408901|584673430|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
161897651|NCT01408901|584673431|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
161897652|NCT01408901|584673432|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
161897653|NCT01408901|584673433|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
161897654|NCT01408901|584673430|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
161897655|NCT01408901|584673431|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
161897656|NCT01408901|584673432|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
161897657|NCT01408901|584673433|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
161897658|NCT01408901|584673430|FG000|26-Week Follow-Up|Death|0|||
161897659|NCT01408901|584673431|FG001|26-Week Follow-Up|Death|1|||
161897660|NCT01408901|584673432|FG002|26-Week Follow-Up|Death|0|||
161897661|NCT01408901|584673433|FG003|26-Week Follow-Up|Death|0|||
161897662|NCT02098395|584673436|FG000|Overall Study|Protocol Violation|2|||
161897663|NCT02098395|584673437|FG001|Overall Study|Protocol Violation|2|||
161897664|NCT02098395|584673438|FG002|Overall Study|Protocol Violation|0|||
161897665|NCT02098395|584673439|FG003|Overall Study|Protocol Violation|7|||
161897666|NCT02098395|584673436|FG000|Overall Study|Withdrawal by Subject|10|||
161897667|NCT02098395|584673437|FG001|Overall Study|Withdrawal by Subject|10|||
161897668|NCT02098395|584673438|FG002|Overall Study|Withdrawal by Subject|5|||
161897669|NCT02098395|584673439|FG003|Overall Study|Withdrawal by Subject|13|||
161897670|NCT02098395|584673436|FG000|Overall Study|Adverse Event|12|||
161897671|NCT02098395|584673437|FG001|Overall Study|Adverse Event|19|||
161897672|NCT02098395|584673438|FG002|Overall Study|Adverse Event|34|||
161897673|NCT02098395|584673439|FG003|Overall Study|Adverse Event|2|||
161897674|NCT02098395|584673436|FG000|Overall Study|Lost to Follow-up|2|||
161897675|NCT02098395|584673437|FG001|Overall Study|Lost to Follow-up|1|||
161897676|NCT02098395|584673438|FG002|Overall Study|Lost to Follow-up|0|||
161897677|NCT02098395|584673439|FG003|Overall Study|Lost to Follow-up|3|||
161897678|NCT02098395|584673436|FG000|Overall Study|Unclassified|0|||
161897679|NCT02098395|584673437|FG001|Overall Study|Unclassified|0|||
161897680|NCT02098395|584673438|FG002|Overall Study|Unclassified|3|||
161897681|NCT02098395|584673439|FG003|Overall Study|Unclassified|2|||
161897682|NCT00110357|584673445|FG000|Overall Study|Deterioration without progression|2|||
161897683|NCT00110357|584673446|FG001|Overall Study|Deterioration without progression|0|||
161897684|NCT00110357|584673445|FG000|Overall Study|Disease progression/relapse|20|||
161897685|NCT00110357|584673446|FG001|Overall Study|Disease progression/relapse|15|||
161897686|NCT00110357|584673445|FG000|Overall Study|Study Closure|1|||
161897687|NCT00110357|584673446|FG001|Overall Study|Study Closure|0|||
161897688|NCT00110357|584673445|FG000|Overall Study|Study Drug Toxicity|1|||
161897689|NCT00110357|584673446|FG001|Overall Study|Study Drug Toxicity|3|||
161897690|NCT00110357|584673445|FG000|Overall Study|Withdrawal by Subject|3|||
161897691|NCT00110357|584673446|FG001|Overall Study|Withdrawal by Subject|1|||
161897692|NCT05285787|584673447|FG000|Overall Study|Withdrawal by Subject|1|||
161897693|NCT04004260|584673451|FG000|Overall Study|Withdrawal by Subject|7|||
161897694|NCT04004260|584673452|FG001|Overall Study|Withdrawal by Subject|3|||
161897695|NCT04004260|584673451|FG000|Overall Study|Lost to Follow-up|22|||
161897696|NCT04004260|584673452|FG001|Overall Study|Lost to Follow-up|12|||
161897697|NCT04004260|584673451|FG000|Overall Study|Did not engage in intervention|13|||
161897698|NCT04004260|584673452|FG001|Overall Study|Did not engage in intervention|17|||
161897699|NCT02360280|584673456|FG000|Overall Study|Withdrawal by Subject|2|||
161897700|NCT02360280|584673457|FG001|Overall Study|Withdrawal by Subject|0|||
161897701|NCT02360280|584673456|FG000|Overall Study|Adverse Event|0|||
161897702|NCT02360280|584673457|FG001|Overall Study|Adverse Event|1|||
161897703|NCT02360280|584673456|FG000|Overall Study|Lost to Follow-up|1|||
161897704|NCT02360280|584673457|FG001|Overall Study|Lost to Follow-up|0|||
161897705|NCT00320788|584673458|FG000|Overall Study|Adverse Event|0|||
161897706|NCT00320788|584673459|FG001|Overall Study|Adverse Event|0|||
161897707|NCT00320788|584673460|FG002|Overall Study|Adverse Event|0|||
161897708|NCT00320788|584673461|FG003|Overall Study|Adverse Event|1|||
161897709|NCT00320788|584673462|FG004|Overall Study|Adverse Event|0|||
161897710|NCT00320788|584673458|FG000|Overall Study|Death|0|||
161897711|NCT00320788|584673459|FG001|Overall Study|Death|0|||
161897712|NCT00320788|584673460|FG002|Overall Study|Death|1|||
161897713|NCT00320788|584673461|FG003|Overall Study|Death|0|||
161897714|NCT00320788|584673462|FG004|Overall Study|Death|1|||
161897715|NCT00320788|584673458|FG000|Overall Study|Lost to Follow-up|0|||
161897716|NCT00320788|584673459|FG001|Overall Study|Lost to Follow-up|2|||
161897717|NCT00320788|584673460|FG002|Overall Study|Lost to Follow-up|1|||
161897718|NCT00320788|584673461|FG003|Overall Study|Lost to Follow-up|0|||
161897719|NCT00320788|584673462|FG004|Overall Study|Lost to Follow-up|0|||
161897720|NCT00320788|584673458|FG000|Overall Study|Decision by the Sponsor|1|||
161897721|NCT00320788|584673459|FG001|Overall Study|Decision by the Sponsor|1|||
161897722|NCT00320788|584673460|FG002|Overall Study|Decision by the Sponsor|0|||
161897723|NCT00320788|584673461|FG003|Overall Study|Decision by the Sponsor|0|||
161897724|NCT00320788|584673462|FG004|Overall Study|Decision by the Sponsor|1|||
161897725|NCT00320788|584673458|FG000|Overall Study|Other|1|||
161897726|NCT00320788|584673459|FG001|Overall Study|Other|2|||
161897727|NCT00320788|584673460|FG002|Overall Study|Other|1|||
161897728|NCT00320788|584673461|FG003|Overall Study|Other|1|||
161897729|NCT00320788|584673462|FG004|Overall Study|Other|1|||
161897730|NCT00320788|584673458|FG000|Overall Study|Physician Decision|1|||
161897731|NCT00320788|584673459|FG001|Overall Study|Physician Decision|1|||
161897732|NCT00320788|584673460|FG002|Overall Study|Physician Decision|0|||
161897733|NCT00320788|584673461|FG003|Overall Study|Physician Decision|0|||
161897734|NCT00320788|584673462|FG004|Overall Study|Physician Decision|0|||
161897735|NCT00320788|584673458|FG000|Overall Study|Protocol Violation|0|||
161897736|NCT00320788|584673459|FG001|Overall Study|Protocol Violation|0|||
161897737|NCT00320788|584673460|FG002|Overall Study|Protocol Violation|0|||
161897738|NCT00320788|584673461|FG003|Overall Study|Protocol Violation|0|||
161897739|NCT00320788|584673462|FG004|Overall Study|Protocol Violation|1|||
161897740|NCT00320788|584673458|FG000|Overall Study|Withdrawal by Subject|3|||
161897741|NCT00320788|584673459|FG001|Overall Study|Withdrawal by Subject|0|||
161897742|NCT00320788|584673460|FG002|Overall Study|Withdrawal by Subject|0|||
161897743|NCT00320788|584673461|FG003|Overall Study|Withdrawal by Subject|3|||
161897744|NCT00320788|584673462|FG004|Overall Study|Withdrawal by Subject|1|||
161897745|NCT04633226|584673464|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161897746|NCT04633226|584673464|FG000|Overall Study|Randomized by mistake without study treatment|1|||
161897747|NCT01398358|584673477|FG000|Overall Study|Lost to Follow-up|11|||
161897748|NCT01398358|584673478|FG001|Overall Study|Lost to Follow-up|21|||
161897749|NCT01398358|584673479|FG002|Overall Study|Lost to Follow-up|18|||
161897750|NCT01398358|584673477|FG000|Overall Study|Withdrawal by Subject|3|||
161897751|NCT01398358|584673478|FG001|Overall Study|Withdrawal by Subject|2|||
161897752|NCT01398358|584673479|FG002|Overall Study|Withdrawal by Subject|2|||
161897753|NCT01398358|584673477|FG000|Overall Study|no longer eligible|1|||
161897754|NCT01398358|584673478|FG001|Overall Study|no longer eligible|0|||
161897755|NCT01398358|584673479|FG002|Overall Study|no longer eligible|1|||
161897756|NCT00003896|584673480|FG000|Overall Study|Adverse Event|16|||
161897757|NCT00003896|584673480|FG000|Overall Study|Withdrawal by Subject|1|||
161897758|NCT00003896|584673480|FG000|Overall Study|Lack of Efficacy|1|||
161897759|NCT00003896|584673480|FG000|Overall Study|Death|3|||
161897760|NCT00003896|584673480|FG000|Overall Study|not protocol specified|3|||
161897761|NCT00003896|584673480|FG000|Overall Study|ineligible|5|||
161897762|NCT02559570|584673485|FG000|Overall Study|Adverse Event|0|||
161897763|NCT02559570|584673486|FG001|Overall Study|Adverse Event|2|||
161897764|NCT02559570|584673487|FG002|Overall Study|Adverse Event|0|||
161897765|NCT02559570|584673488|FG003|Overall Study|Adverse Event|1|||
161897766|NCT02559570|584673489|FG004|Overall Study|Adverse Event|0|||
161897767|NCT02559570|584673485|FG000|Overall Study|Withdrawal of Consent|0|||
161897768|NCT02559570|584673486|FG001|Overall Study|Withdrawal of Consent|0|||
161897769|NCT02559570|584673487|FG002|Overall Study|Withdrawal of Consent|1|||
161897770|NCT02559570|584673488|FG003|Overall Study|Withdrawal of Consent|2|||
161897771|NCT02559570|584673489|FG004|Overall Study|Withdrawal of Consent|1|||
161897772|NCT02559570|584673485|FG000|Overall Study|Lost to Follow-up|1|||
161897773|NCT02559570|584673486|FG001|Overall Study|Lost to Follow-up|0|||
161897774|NCT02559570|584673487|FG002|Overall Study|Lost to Follow-up|0|||
161897775|NCT02559570|584673488|FG003|Overall Study|Lost to Follow-up|0|||
161897776|NCT02559570|584673489|FG004|Overall Study|Lost to Follow-up|0|||
161897777|NCT02559570|584673485|FG000|Overall Study|Protocol Violation|1|||
161897778|NCT02559570|584673486|FG001|Overall Study|Protocol Violation|0|||
161897779|NCT02559570|584673487|FG002|Overall Study|Protocol Violation|0|||
161897780|NCT02559570|584673488|FG003|Overall Study|Protocol Violation|0|||
161897781|NCT02559570|584673489|FG004|Overall Study|Protocol Violation|1|||
161897782|NCT02559570|584673485|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161897783|NCT02559570|584673486|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161897784|NCT02559570|584673487|FG002|Overall Study|Other Miscellaneous Reasons|1|||
161897785|NCT02559570|584673488|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161897786|NCT02559570|584673489|FG004|Overall Study|Other Miscellaneous Reasons|0|||
161897787|NCT01903993|584673496|FG000|Overall Study|Death|118|||
161897788|NCT01903993|584673497|FG001|Overall Study|Death|121|||
161897789|NCT01903993|584673496|FG000|Overall Study|Withdrawal by Subject|15|||
161897790|NCT01903993|584673497|FG001|Overall Study|Withdrawal by Subject|4|||
161897791|NCT01903993|584673496|FG000|Overall Study|Lost to Follow-up|2|||
161897792|NCT01903993|584673497|FG001|Overall Study|Lost to Follow-up|3|||
161897793|NCT01903993|584673496|FG000|Overall Study|Study Terminated by Sponsor|8|||
161897794|NCT01903993|584673497|FG001|Overall Study|Study Terminated by Sponsor|14|||
161897795|NCT01903993|584673496|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
161897796|NCT01903993|584673497|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
161897797|NCT00184093|584673500|FG000|Overall Study|Adverse Event|3|||
161897798|NCT00184093|584673500|FG000|Overall Study|Lost to Follow-up|3|||
161897799|NCT00184093|584673500|FG000|Overall Study|Physician Decision|1|||
161897800|NCT00184093|584673500|FG000|Overall Study|Withdrawal by Subject|2|||
161897801|NCT02787083|584673511|FG000|Overall Study|Adverse Event|1|||
161897802|NCT02787083|584673512|FG001|Overall Study|Adverse Event|0|||
161897803|NCT02787083|584673511|FG000|Overall Study|Withdrawal by Subject|2|||
161897804|NCT02787083|584673512|FG001|Overall Study|Withdrawal by Subject|2|||
161897805|NCT02710084|584673513|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
161897806|NCT02710084|584673514|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
161897807|NCT02453256|584673519|FG000|Double Blind Period|Death|1|||
161897808|NCT02453256|584673520|FG001|Double Blind Period|Death|1|||
161897809|NCT02453256|584673519|FG000|Double Blind Period|Adverse Event|3|||
161897810|NCT02453256|584673520|FG001|Double Blind Period|Adverse Event|2|||
162242028|NCT02616562|585939075|FG007|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161897811|NCT02453256|584673519|FG000|Double Blind Period|Withdrawal by Subject|9|||
161897812|NCT02453256|584673520|FG001|Double Blind Period|Withdrawal by Subject|5|||
161897813|NCT02453256|584673519|FG000|Double Blind Period|Other|0|||
161897814|NCT02453256|584673520|FG001|Double Blind Period|Other|1|||
161897815|NCT02453256|584673519|FG000|Open Label Period|Adverse Event|1|||
161897816|NCT02453256|584673520|FG001|Open Label Period|Adverse Event|3|||
161897817|NCT02453256|584673519|FG000|Open Label Period|Death|0|||
161897818|NCT02453256|584673520|FG001|Open Label Period|Death|1|||
161897819|NCT02453256|584673519|FG000|Open Label Period|Lost to Follow-up|1|||
161897820|NCT02453256|584673520|FG001|Open Label Period|Lost to Follow-up|0|||
161897821|NCT02453256|584673519|FG000|Open Label Period|Other|0|||
161897822|NCT02453256|584673520|FG001|Open Label Period|Other|2|||
161897823|NCT02453256|584673519|FG000|Open Label Period|Withdrawal by Subject|5|||
161897824|NCT02453256|584673520|FG001|Open Label Period|Withdrawal by Subject|1|||
161897825|NCT01243177|584673521|FG000|Overall Study|Lack of Efficacy|47|||
161897826|NCT01243177|584673522|FG001|Overall Study|Lack of Efficacy|31|||
161897827|NCT01243177|584673521|FG000|Overall Study|Protocol Violation|11|||
161897828|NCT01243177|584673522|FG001|Overall Study|Protocol Violation|10|||
161897829|NCT01243177|584673521|FG000|Overall Study|Lost to Follow-up|15|||
161897830|NCT01243177|584673522|FG001|Overall Study|Lost to Follow-up|18|||
161897831|NCT01243177|584673521|FG000|Overall Study|Withdrawal by Subject|46|||
161897832|NCT01243177|584673522|FG001|Overall Study|Withdrawal by Subject|38|||
161897833|NCT01243177|584673521|FG000|Overall Study|AE, serious fatal|0|||
161897834|NCT01243177|584673522|FG001|Overall Study|AE, serious fatal|1|||
161897835|NCT01243177|584673521|FG000|Overall Study|SAE, non-fatal|7|||
161897836|NCT01243177|584673522|FG001|Overall Study|SAE, non-fatal|9|||
161897837|NCT01243177|584673521|FG000|Overall Study|AE, non-serious non-fatal|40|||
161897838|NCT01243177|584673522|FG001|Overall Study|AE, non-serious non-fatal|58|||
161897839|NCT01243177|584673521|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
161897840|NCT01243177|584673522|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
161897841|NCT01243177|584673521|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
161897842|NCT01243177|584673522|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
161897843|NCT01243177|584673521|FG000|Overall Study|Other Reason|11|||
161897844|NCT01243177|584673522|FG001|Overall Study|Other Reason|12|||
161897845|NCT05259163|584675471|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
161897846|NCT05259163|584675472|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
161897847|NCT05251233|584675473|FG000|Overall Study|Disease progression - did not start treatment|0|||
161897848|NCT05251233|584675474|FG001|Overall Study|Disease progression - did not start treatment|0|||
161897849|NCT05251233|584675475|FG002|Overall Study|Disease progression - did not start treatment|5|||
161897850|NCT05251233|584675473|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
161897851|NCT05251233|584675474|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
161897852|NCT05251233|584675475|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
161897853|NCT05251233|584675473|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
161897854|NCT05251233|584675474|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
161897855|NCT05251233|584675475|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
161897856|NCT05251233|584675473|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
161897857|NCT05251233|584675474|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
161897858|NCT05251233|584675475|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
161897859|NCT05251233|584675473|FG000|Overall Study|Death - did not start treatment|3|||
161897860|NCT05251233|584675474|FG001|Overall Study|Death - did not start treatment|0|||
161897861|NCT05251233|584675475|FG002|Overall Study|Death - did not start treatment|0|||
161897862|NCT05251233|584675473|FG000|Overall Study|Withdrawal by Subject|2|||
161897863|NCT05251233|584675474|FG001|Overall Study|Withdrawal by Subject|2|||
161897864|NCT05251233|584675475|FG002|Overall Study|Withdrawal by Subject|0|||
161897865|NCT05251233|584675473|FG000|Overall Study|Other complicating disease|2|||
161897866|NCT05251233|584675474|FG001|Overall Study|Other complicating disease|1|||
161897867|NCT05251233|584675475|FG002|Overall Study|Other complicating disease|0|||
161897868|NCT05251233|584675473|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
161897869|NCT05251233|584675474|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
161897870|NCT05251233|584675475|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
161897871|NCT05251233|584675473|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
161897872|NCT05251233|584675474|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
161897873|NCT05251233|584675475|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
161897874|NCT00452439|584675479|FG000|Overall Study|Lost to Follow-up|1|||
161897875|NCT00452439|584675480|FG001|Overall Study|Lost to Follow-up|1|||
161897876|NCT00452439|584675479|FG000|Overall Study|Refused Treatment|4|||
161784320|NCT03835975|584255444|FG000|Overall Study|Lost to Follow-up|1|||
161784321|NCT03835975|584255445|FG001|Overall Study|Lost to Follow-up|1|||
161784322|NCT03835975|584255446|FG002|Overall Study|Lost to Follow-up|0|||
161784323|NCT03835975|584255447|FG003|Overall Study|Lost to Follow-up|0|||
161784324|NCT03835975|584255448|FG004|Overall Study|Lost to Follow-up|0|||
161784325|NCT03835975|584255444|FG000|Overall Study|No longer met eligibility criteria|0|||
161784326|NCT03835975|584255445|FG001|Overall Study|No longer met eligibility criteria|1|||
161784327|NCT03835975|584255446|FG002|Overall Study|No longer met eligibility criteria|0|||
161784328|NCT03835975|584255447|FG003|Overall Study|No longer met eligibility criteria|0|||
161784329|NCT03835975|584255448|FG004|Overall Study|No longer met eligibility criteria|0|||
161784330|NCT03835975|584255444|FG000|Overall Study|Protocol Violation|1|||
161784331|NCT03835975|584255445|FG001|Overall Study|Protocol Violation|1|||
161784332|NCT03835975|584255446|FG002|Overall Study|Protocol Violation|2|||
161784333|NCT03835975|584255447|FG003|Overall Study|Protocol Violation|0|||
161784334|NCT03835975|584255448|FG004|Overall Study|Protocol Violation|0|||
161784335|NCT03835975|584255444|FG000|Overall Study|Withdrawal by Subject|1|||
161784336|NCT03835975|584255445|FG001|Overall Study|Withdrawal by Subject|0|||
161784337|NCT03835975|584255446|FG002|Overall Study|Withdrawal by Subject|1|||
161784338|NCT03835975|584255447|FG003|Overall Study|Withdrawal by Subject|1|||
161784339|NCT03835975|584255448|FG004|Overall Study|Withdrawal by Subject|0|||
161784340|NCT03031431|584255451|FG000|Overall Study|Infant removed by maternal request|1|||
161784341|NCT01612702|584255452|FG000|Overall Study|Protocol Violation|11|||
161784342|NCT01612702|584255453|FG001|Overall Study|Protocol Violation|11|||
161784343|NCT00370396|584255454|FG000|Overall Study|Withdrawal by Subject|0|||
161784344|NCT00370396|584255455|FG001|Overall Study|Withdrawal by Subject|0|||
161784345|NCT00370396|584255456|FG002|Overall Study|Withdrawal by Subject|1|||
161784346|NCT00370396|584255454|FG000|Overall Study|Lost to Follow-up|11|||
161784347|NCT00370396|584255455|FG001|Overall Study|Lost to Follow-up|1|||
161784348|NCT00370396|584255456|FG002|Overall Study|Lost to Follow-up|0|||
161784349|NCT01462695|584255457|FG000|Overall Study|Adverse Event|1|||
161784350|NCT01462695|584255458|FG001|Overall Study|Adverse Event|1|||
161784351|NCT01462695|584255457|FG000|Overall Study|Death|2|||
161784352|NCT01462695|584255458|FG001|Overall Study|Death|0|||
161784353|NCT01462695|584255457|FG000|Overall Study|Lack of Efficacy|6|||
161784354|NCT01462695|584255458|FG001|Overall Study|Lack of Efficacy|12|||
161784355|NCT01462695|584255457|FG000|Overall Study|Physician Decision|5|||
161784356|NCT01462695|584255458|FG001|Overall Study|Physician Decision|0|||
161897877|NCT00452439|584675480|FG001|Overall Study|Refused Treatment|3|||
161897878|NCT00452439|584675479|FG000|Overall Study|Death|3|||
161897879|NCT00452439|584675480|FG001|Overall Study|Death|1|||
161897880|NCT00452439|584675479|FG000|Overall Study|Bone Marrow Transplant|0|||
161897881|NCT00452439|584675480|FG001|Overall Study|Bone Marrow Transplant|1|||
161897882|NCT00452439|584675479|FG000|Overall Study|Too Ill to Continue|0|||
161897883|NCT00452439|584675480|FG001|Overall Study|Too Ill to Continue|1|||
161897884|NCT00452439|584675479|FG000|Overall Study|Failed to achieve complete response|2|||
161897885|NCT00452439|584675480|FG001|Overall Study|Failed to achieve complete response|0|||
161897886|NCT00452439|584675479|FG000|Overall Study|Relapse|3|||
161897887|NCT00452439|584675480|FG001|Overall Study|Relapse|0|||
161897888|NCT00452439|584675479|FG000|Overall Study|Fracture|1|||
161897889|NCT00452439|584675480|FG001|Overall Study|Fracture|0|||
161897890|NCT01381926|584675481|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
161897891|NCT01381926|584675482|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
161897892|NCT01381926|584675481|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
161897893|NCT01381926|584675482|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
161897894|NCT02624947|584675486|FG000|Maternal Participants|Adverse Event|5|||
161897895|NCT02624947|584675487|FG001|Maternal Participants|Adverse Event|0|||
161897896|NCT02624947|584675486|FG000|Maternal Participants|Investigator Decision|5|||
161897897|NCT02624947|584675487|FG001|Maternal Participants|Investigator Decision|3|||
161897898|NCT02624947|584675486|FG000|Maternal Participants|Lost to Follow-up|54|||
161897899|NCT02624947|584675487|FG001|Maternal Participants|Lost to Follow-up|24|||
161897900|NCT02624947|584675486|FG000|Maternal Participants|Non Compliance|8|||
161897901|NCT02624947|584675487|FG001|Maternal Participants|Non Compliance|5|||
161897902|NCT02624947|584675486|FG000|Maternal Participants|Sponsor Request|1|||
161897903|NCT02624947|584675487|FG001|Maternal Participants|Sponsor Request|1|||
161897904|NCT02624947|584675486|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
161897905|NCT02624947|584675487|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
161897906|NCT02624947|584675486|FG000|Maternal Participants|Miscellaneous|23|||
161897907|NCT02624947|584675487|FG001|Maternal Participants|Miscellaneous|15|||
161897908|NCT02624947|584675486|FG000|Infant Participants|Adverse Event|18|||
161897909|NCT02624947|584675487|FG001|Infant Participants|Adverse Event|11|||
161897910|NCT02624947|584675486|FG000|Infant Participants|Investigator Decision|5|||
161897911|NCT02624947|584675487|FG001|Infant Participants|Investigator Decision|4|||
161897912|NCT02624947|584675486|FG000|Infant Participants|Lost to Follow-up|93|||
161897913|NCT02624947|584675487|FG001|Infant Participants|Lost to Follow-up|58|||
161897914|NCT02624947|584675486|FG000|Infant Participants|Non Compliance|17|||
161897915|NCT02624947|584675487|FG001|Infant Participants|Non Compliance|7|||
161897916|NCT02624947|584675486|FG000|Infant Participants|Sponsor Request|0|||
161897917|NCT02624947|584675487|FG001|Infant Participants|Sponsor Request|1|||
161897918|NCT02624947|584675486|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
161897919|NCT02624947|584675487|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
161897920|NCT02624947|584675486|FG000|Infant Participants|Miscellaneous|50|||
161897921|NCT02624947|584675487|FG001|Infant Participants|Miscellaneous|26|||
161897922|NCT00215644|584675490|FG000|Overall Study|Disease Progression|28|||
161897923|NCT00215644|584675491|FG001|Overall Study|Disease Progression|10|||
161897924|NCT00215644|584675490|FG000|Overall Study|Adverse Event|2|||
161897925|NCT00215644|584675491|FG001|Overall Study|Adverse Event|9|||
161897926|NCT00215644|584675490|FG000|Overall Study|Death|1|||
161897927|NCT00215644|584675491|FG001|Overall Study|Death|2|||
161897928|NCT00215644|584675490|FG000|Overall Study|Withdrawal by Subject|1|||
161897929|NCT00215644|584675491|FG001|Overall Study|Withdrawal by Subject|0|||
161897930|NCT00215644|584675490|FG000|Overall Study|Other|3|||
161897931|NCT00215644|584675491|FG001|Overall Study|Other|15|||
161897932|NCT00215644|584675490|FG000|Overall Study|Randomized but Not Treated|1|||
161897933|NCT00215644|584675491|FG001|Overall Study|Randomized but Not Treated|0|||
161897934|NCT02861664|584675494|FG000|Overall Study|Withdrawal of Consent|0|||
161897935|NCT02861664|584675495|FG001|Overall Study|Withdrawal of Consent|1|||
161897936|NCT03512353|584675496|FG000|Overall Study|Sponsor Decision|3|||
161897937|NCT03512353|584675496|FG000|Overall Study|Death|1|||
161897938|NCT01000974|584675497|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
161897939|NCT01000974|584675498|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
161897940|NCT01000974|584675499|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
161897941|NCT01000974|584675497|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
161897942|NCT01000974|584675498|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
161897943|NCT01000974|584675499|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
161897944|NCT01000974|584675497|FG000|Primary Vaccination Phase|Protocol Violation|40|||
161897945|NCT01000974|584675498|FG001|Primary Vaccination Phase|Protocol Violation|3|||
161897946|NCT01000974|584675499|FG002|Primary Vaccination Phase|Protocol Violation|2|||
161897947|NCT01000974|584675497|FG000|Primary Vaccination Phase|Adverse Event|14|||
161897948|NCT01000974|584675498|FG001|Primary Vaccination Phase|Adverse Event|2|||
161897949|NCT01000974|584675499|FG002|Primary Vaccination Phase|Adverse Event|2|||
161897950|NCT01000974|584675497|FG000|Primary Vaccination Phase|Other|4|||
161897951|NCT01000974|584675498|FG001|Primary Vaccination Phase|Other|9|||
161897952|NCT01000974|584675499|FG002|Primary Vaccination Phase|Other|12|||
161897953|NCT01000974|584675497|FG000|Booster Vaccination Phase|Protocol Violation|0|||
161897954|NCT01000974|584675498|FG001|Booster Vaccination Phase|Protocol Violation|0|||
161897955|NCT01000974|584675499|FG002|Booster Vaccination Phase|Protocol Violation|2|||
161897956|NCT01000974|584675497|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
161897957|NCT01000974|584675498|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
161897958|NCT01000974|584675499|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
161897959|NCT01000974|584675497|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
161897960|NCT01000974|584675498|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
161897961|NCT01000974|584675499|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
161897962|NCT01000974|584675497|FG000|Booster Vaccination Phase|Other|24|||
161897963|NCT01000974|584675498|FG001|Booster Vaccination Phase|Other|6|||
161897964|NCT01000974|584675499|FG002|Booster Vaccination Phase|Other|4|||
161897965|NCT01639144|584675502|FG000|Overall Study|Withdrawal by Subject|4|||
161897966|NCT01639144|584675503|FG001|Overall Study|Withdrawal by Subject|2|||
161897967|NCT01639144|584675502|FG000|Overall Study|Physician Decision|2|||
161897968|NCT01639144|584675503|FG001|Overall Study|Physician Decision|0|||
161897969|NCT01639144|584675502|FG000|Overall Study|Met postoperative exclusion criteria|4|||
161897970|NCT01639144|584675503|FG001|Overall Study|Met postoperative exclusion criteria|3|||
161897971|NCT03365934|584675505|FG000|Overall Study|Adverse Event|1|||
161897972|NCT03365934|584675505|FG000|Overall Study|Withdrawal by Subject|1|||
161897973|NCT01307891|584675506|FG000|Overall Study|Progressive Disease|3|||
161897974|NCT01307891|584675507|FG001|Overall Study|Progressive Disease|1|||
161897975|NCT02937740|584675508|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
161897976|NCT02937740|584675509|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
161897977|NCT02937740|584675508|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
161897978|NCT02937740|584675509|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
161897979|NCT02937740|584675508|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
161897980|NCT02937740|584675509|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
161897981|NCT02937740|584675508|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
161897982|NCT02937740|584675509|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
161897983|NCT02937740|584675508|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
161897984|NCT02937740|584675509|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
161897985|NCT02937740|584675508|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
161897986|NCT02937740|584675509|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
161897987|NCT02239640|584675516|FG000|Overall Study|Withdrawal by Subject|3|||
161897988|NCT02239640|584675516|FG000|Overall Study|Lost to Follow-up|72|||
162009498|NCT00541658|585090140|FG001|Overall Study|Adverse Event|37|||
162009499|NCT00541658|585090141|FG002|Overall Study|Adverse Event|25|||
162009500|NCT00541658|585090139|FG000|Overall Study|Physician Decision|0|||
162009501|NCT00541658|585090140|FG001|Overall Study|Physician Decision|0|||
162009502|NCT00541658|585090141|FG002|Overall Study|Physician Decision|4|||
162009503|NCT00541658|585090139|FG000|Overall Study|Lost to Follow-up|3|||
162009504|NCT00541658|585090140|FG001|Overall Study|Lost to Follow-up|3|||
162009505|NCT00541658|585090141|FG002|Overall Study|Lost to Follow-up|6|||
162009506|NCT00541658|585090139|FG000|Overall Study|Protocol Violation|0|||
162009507|NCT00541658|585090140|FG001|Overall Study|Protocol Violation|1|||
162009508|NCT00541658|585090141|FG002|Overall Study|Protocol Violation|1|||
162009509|NCT00541658|585090139|FG000|Overall Study|Withdrawal by Subject|28|||
162009510|NCT00541658|585090140|FG001|Overall Study|Withdrawal by Subject|32|||
162009511|NCT00541658|585090141|FG002|Overall Study|Withdrawal by Subject|32|||
162009512|NCT00541658|585090139|FG000|Overall Study|Took No Study Drug|1|||
162009513|NCT00541658|585090140|FG001|Overall Study|Took No Study Drug|0|||
162009514|NCT00541658|585090141|FG002|Overall Study|Took No Study Drug|0|||
162009515|NCT05194124|585090155|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
162009516|NCT05194124|585090156|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
162009517|NCT05194124|585090157|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
162009518|NCT05194124|585090158|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
162009519|NCT05194124|585090159|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
162009520|NCT05194124|585090160|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
162009521|NCT05194124|585090161|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
162009522|NCT05194124|585090162|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
162009523|NCT05194124|585090163|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
162009524|NCT05194124|585090164|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
162009525|NCT05194124|585090155|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
162009526|NCT05194124|585090156|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
162009527|NCT05194124|585090157|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
162009528|NCT05194124|585090158|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
162009529|NCT05194124|585090159|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
162009530|NCT05194124|585090160|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
162009531|NCT05194124|585090161|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
162009532|NCT05194124|585090162|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
162009533|NCT05194124|585090163|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
162009534|NCT05194124|585090164|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
162009535|NCT05408429|585090169|FG000|Overall Study|Lost to Follow-up|1|||
162009536|NCT05408429|585090170|FG001|Overall Study|Lost to Follow-up|1|||
162009537|NCT05408429|585090171|FG002|Overall Study|Lost to Follow-up|0|||
162009538|NCT05408429|585090169|FG000|Overall Study|Withdrawal by Subject|5|||
162009539|NCT05408429|585090170|FG001|Overall Study|Withdrawal by Subject|0|||
162009540|NCT05408429|585090171|FG002|Overall Study|Withdrawal by Subject|1|||
162009541|NCT03435211|585090172|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
162009542|NCT03642873|585090173|FG000|Third Intervention (1 Day)|Screen failure|0|||
162009543|NCT03642873|585090174|FG001|Third Intervention (1 Day)|Screen failure|0|||
162009544|NCT03642873|585090175|FG002|Third Intervention (1 Day)|Screen failure|0|||
162009545|NCT03642873|585090176|FG003|Third Intervention (1 Day)|Screen failure|0|||
162009546|NCT03642873|585090177|FG004|Third Intervention (1 Day)|Screen failure|1|||
162009547|NCT03642873|585090178|FG005|Third Intervention (1 Day)|Screen failure|0|||
162009548|NCT01253291|585090180|FG000|Overall Study|Withdrawal by Subject|1|||
162009549|NCT01253291|585090181|FG001|Overall Study|Withdrawal by Subject|1|||
162009550|NCT01253291|585090182|FG002|Overall Study|Withdrawal by Subject|0|||
162009551|NCT01253291|585090183|FG003|Overall Study|Withdrawal by Subject|0|||
162009552|NCT01253291|585090184|FG004|Overall Study|Withdrawal by Subject|0|||
162009553|NCT01253291|585090180|FG000|Overall Study|Adverse Event|0|||
162009554|NCT01253291|585090181|FG001|Overall Study|Adverse Event|1|||
162009555|NCT01253291|585090182|FG002|Overall Study|Adverse Event|0|||
162009556|NCT01253291|585090183|FG003|Overall Study|Adverse Event|0|||
162009557|NCT01253291|585090184|FG004|Overall Study|Adverse Event|0|||
162009558|NCT01253291|585090180|FG000|Overall Study|Lack of Efficacy|1|||
161784357|NCT01462695|584255457|FG000|Overall Study|Withdrawal by Subject|2|||
161784358|NCT01462695|584255458|FG001|Overall Study|Withdrawal by Subject|0|||
161784359|NCT01462695|584255457|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
162009559|NCT01253291|585090181|FG001|Overall Study|Lack of Efficacy|0|||
162009560|NCT01253291|585090182|FG002|Overall Study|Lack of Efficacy|0|||
162009561|NCT01253291|585090183|FG003|Overall Study|Lack of Efficacy|0|||
162009562|NCT01253291|585090184|FG004|Overall Study|Lack of Efficacy|0|||
162009563|NCT01253291|585090180|FG000|Overall Study|Physician Decision|2|||
162009564|NCT01253291|585090181|FG001|Overall Study|Physician Decision|0|||
162009565|NCT01253291|585090182|FG002|Overall Study|Physician Decision|0|||
162009566|NCT01253291|585090183|FG003|Overall Study|Physician Decision|0|||
162009567|NCT01253291|585090184|FG004|Overall Study|Physician Decision|2|||
162009568|NCT03312231|585090188|FG000|Overall Study|Lost to Follow-up|2|||
162009569|NCT03312231|585090189|FG001|Overall Study|Lost to Follow-up|6|||
162009570|NCT03312231|585090190|FG002|Overall Study|Lost to Follow-up|1|||
162009571|NCT03312231|585090191|FG003|Overall Study|Lost to Follow-up|3|||
162009572|NCT03312231|585090192|FG004|Overall Study|Lost to Follow-up|1|||
162009573|NCT03312231|585090188|FG000|Overall Study|Withdrawal by Subject|0|||
162009574|NCT03312231|585090189|FG001|Overall Study|Withdrawal by Subject|3|||
162009575|NCT03312231|585090190|FG002|Overall Study|Withdrawal by Subject|1|||
162009576|NCT03312231|585090191|FG003|Overall Study|Withdrawal by Subject|0|||
162009577|NCT03312231|585090192|FG004|Overall Study|Withdrawal by Subject|0|||
162009578|NCT03312231|585090188|FG000|Overall Study|Death|0|||
162009579|NCT03312231|585090189|FG001|Overall Study|Death|1|||
162009580|NCT03312231|585090190|FG002|Overall Study|Death|1|||
162009581|NCT03312231|585090191|FG003|Overall Study|Death|0|||
162009582|NCT03312231|585090192|FG004|Overall Study|Death|0|||
162009583|NCT03312231|585090188|FG000|Overall Study|Study Vaccination not Received|1|||
162009584|NCT03312231|585090189|FG001|Overall Study|Study Vaccination not Received|1|||
161897989|NCT02239640|584675516|FG000|Overall Study|Death|142|||
161897990|NCT02291029|584675523|FG000|Overall Study|Withdrawal by Subject|0|||
161897991|NCT02291029|584675524|FG001|Overall Study|Withdrawal by Subject|0|||
161897992|NCT02291029|584675525|FG002|Overall Study|Withdrawal by Subject|1|||
161897993|NCT02291029|584675526|FG003|Overall Study|Withdrawal by Subject|0|||
161897994|NCT02291029|584675527|FG004|Overall Study|Withdrawal by Subject|0|||
161897995|NCT02291029|584675528|FG005|Overall Study|Withdrawal by Subject|0|||
161897996|NCT02291029|584675523|FG000|Overall Study|Adverse Event|0|||
161897997|NCT02291029|584675524|FG001|Overall Study|Adverse Event|1|||
161897998|NCT02291029|584675525|FG002|Overall Study|Adverse Event|0|||
161897999|NCT02291029|584675526|FG003|Overall Study|Adverse Event|0|||
161898000|NCT02291029|584675527|FG004|Overall Study|Adverse Event|0|||
161898001|NCT02291029|584675528|FG005|Overall Study|Adverse Event|0|||
161898002|NCT02171429|584675529|FG000|Overall Study|Other|0|||
161898003|NCT02171429|584675530|FG001|Overall Study|Other|1|||
161898004|NCT02171429|584675531|FG002|Overall Study|Other|1|||
161898005|NCT02171429|584675529|FG000|Overall Study|Non-Compliance|0|||
161898006|NCT02171429|584675530|FG001|Overall Study|Non-Compliance|0|||
161898007|NCT02171429|584675531|FG002|Overall Study|Non-Compliance|1|||
161898008|NCT02171429|584675529|FG000|Overall Study|Physician Decision|0|||
161898009|NCT02171429|584675530|FG001|Overall Study|Physician Decision|0|||
161898010|NCT02171429|584675531|FG002|Overall Study|Physician Decision|1|||
161898011|NCT02171429|584675529|FG000|Overall Study|Withdrawal by Subject|1|||
161898012|NCT02171429|584675530|FG001|Overall Study|Withdrawal by Subject|1|||
161898013|NCT02171429|584675531|FG002|Overall Study|Withdrawal by Subject|1|||
161898014|NCT02171429|584675529|FG000|Overall Study|Lost to Follow-up|0|||
161898015|NCT02171429|584675530|FG001|Overall Study|Lost to Follow-up|1|||
161898016|NCT02171429|584675531|FG002|Overall Study|Lost to Follow-up|0|||
161898017|NCT02171429|584675529|FG000|Overall Study|Death|0|||
161898018|NCT02171429|584675530|FG001|Overall Study|Death|0|||
161898019|NCT02171429|584675531|FG002|Overall Study|Death|1|||
161898020|NCT00493012|584675533|FG000|Overall Study|Lost to Follow-up|18|||
161898021|NCT00493012|584675534|FG001|Overall Study|Lost to Follow-up|17|||
161898022|NCT01724177|584675535|FG000|Overall Study|Adverse Event|8|||
161898023|NCT01724177|584675535|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
161898024|NCT01724177|584675535|FG000|Overall Study|Nervous participant|1|||
161898025|NCT01724177|584675535|FG000|Overall Study|Serious Adverse Event Related|1|||
161898026|NCT04147247|584675536|FG000|Overall Study|Progressive disease|3|||
161898027|NCT04147247|584675537|FG001|Overall Study|Progressive disease|3|||
161898028|NCT04147247|584675538|FG002|Overall Study|Progressive disease|4|||
161898029|NCT04147247|584675539|FG003|Overall Study|Progressive disease|4|||
161898030|NCT04147247|584675540|FG004|Overall Study|Progressive disease|3|||
161898031|NCT04147247|584675536|FG000|Overall Study|Physician Decision|0|||
161898032|NCT04147247|584675537|FG001|Overall Study|Physician Decision|1|||
161898033|NCT04147247|584675538|FG002|Overall Study|Physician Decision|0|||
162009585|NCT03312231|585090190|FG002|Overall Study|Study Vaccination not Received|1|||
162009586|NCT03312231|585090191|FG003|Overall Study|Study Vaccination not Received|0|||
162242029|NCT02616562|585939076|FG008|Safety Extension Period (104 Weeks)|Protocol Violation|1|||
161898034|NCT04147247|584675539|FG003|Overall Study|Physician Decision|0|||
161898035|NCT04147247|584675540|FG004|Overall Study|Physician Decision|0|||
161898036|NCT04147247|584675536|FG000|Overall Study|Clinical Disease Progression|0|||
161898037|NCT04147247|584675537|FG001|Overall Study|Clinical Disease Progression|0|||
161898038|NCT04147247|584675538|FG002|Overall Study|Clinical Disease Progression|0|||
161898039|NCT04147247|584675539|FG003|Overall Study|Clinical Disease Progression|0|||
161898040|NCT04147247|584675540|FG004|Overall Study|Clinical Disease Progression|1|||
161898041|NCT04147247|584675536|FG000|Overall Study|Adverse Event|0|||
161898042|NCT04147247|584675537|FG001|Overall Study|Adverse Event|0|||
161898043|NCT04147247|584675538|FG002|Overall Study|Adverse Event|1|||
161898044|NCT04147247|584675539|FG003|Overall Study|Adverse Event|0|||
161898045|NCT04147247|584675540|FG004|Overall Study|Adverse Event|1|||
162009587|NCT03312231|585090192|FG004|Overall Study|Study Vaccination not Received|0|||
162009588|NCT03157830|585090196|FG000|Overall Study|Lost to Follow-up|1|||
162009589|NCT03157830|585090196|FG000|Overall Study|Withdrawal by Subject|1|||
162009590|NCT02195518|585090197|FG000|Overall Study|Adverse Event|1|||
162009591|NCT02195518|585090197|FG000|Overall Study|Protocol Violation|4|||
162009592|NCT02195518|585090197|FG000|Overall Study|Pregnancy|2|||
162009593|NCT02195518|585090197|FG000|Overall Study|Withdrawal by Subject|1|||
162009594|NCT02195518|585090197|FG000|Overall Study|Lost to Follow-up|1|||
162009595|NCT00651742|585090203|FG000|Overall Study|Objective Disease Progression|22|||
162009596|NCT00651742|585090203|FG000|Overall Study|Toxicity|3|||
162009597|NCT00651742|585090203|FG000|Overall Study|Investigator Judgment|1|||
162009598|NCT00651742|585090203|FG000|Overall Study|Withdrawal of Consent|1|||
162009599|NCT00651742|585090203|FG000|Overall Study|Enrolled but not treated|1|||
162009600|NCT01074970|585090205|FG000|Overall Study|Never Treated|0|||
162009601|NCT01074970|585090206|FG001|Overall Study|Never Treated|0|||
162009602|NCT01074970|585090207|FG002|Overall Study|Never Treated|8|||
162009603|NCT01074970|585090208|FG003|Overall Study|Never Treated|1|||
162009604|NCT01074970|585090205|FG000|Overall Study|Adverse Event|1|||
162009605|NCT01074970|585090206|FG001|Overall Study|Adverse Event|0|||
162009606|NCT01074970|585090207|FG002|Overall Study|Adverse Event|4|||
162009607|NCT01074970|585090208|FG003|Overall Study|Adverse Event|3|||
162009608|NCT01074970|585090205|FG000|Overall Study|Disease progression during treatment|3|||
162009609|NCT01074970|585090206|FG001|Overall Study|Disease progression during treatment|1|||
162009610|NCT01074970|585090207|FG002|Overall Study|Disease progression during treatment|2|||
162009611|NCT01074970|585090208|FG003|Overall Study|Disease progression during treatment|9|||
162009612|NCT01074970|585090205|FG000|Overall Study|Lost to Follow-up|0|||
162009613|NCT01074970|585090206|FG001|Overall Study|Lost to Follow-up|0|||
162009614|NCT01074970|585090207|FG002|Overall Study|Lost to Follow-up|1|||
162009615|NCT01074970|585090208|FG003|Overall Study|Lost to Follow-up|0|||
162009616|NCT01074970|585090205|FG000|Overall Study|Withdrawal by Subject|0|||
162009617|NCT01074970|585090206|FG001|Overall Study|Withdrawal by Subject|0|||
162009618|NCT01074970|585090207|FG002|Overall Study|Withdrawal by Subject|6|||
162009619|NCT01074970|585090208|FG003|Overall Study|Withdrawal by Subject|4|||
162009620|NCT00734149|585090209|FG000|Overall Study|Withdrawal by Subject|1|||
162009621|NCT04314284|585090210|FG000|Overall Study|Withdrawal by Subject|4|||
162009622|NCT04314284|585090211|FG001|Overall Study|Withdrawal by Subject|7|||
162009623|NCT04314284|585090210|FG000|Overall Study|Consented but did not complete survey|0|||
162009624|NCT04314284|585090211|FG001|Overall Study|Consented but did not complete survey|6|||
162009625|NCT01652235|585090214|FG000|Overall Study|Death|9|||
162009626|NCT01652235|585090214|FG000|Overall Study|Lost to Follow-up|5|||
162009627|NCT01652235|585090214|FG000|Overall Study|Withdrawal by Subject|2|||
162009628|NCT02023086|585090217|FG000|Overall Study|Withdrawal by Subject|2|||
162009629|NCT02023086|585090218|FG001|Overall Study|Withdrawal by Subject|0|||
162009630|NCT04607005|585090219|FG000|Overall Study|Adverse Event|0|||
162009631|NCT04607005|585090220|FG001|Overall Study|Adverse Event|1|||
162009632|NCT04607005|585090219|FG000|Overall Study|Lack of Efficacy|1|||
162009633|NCT04607005|585090220|FG001|Overall Study|Lack of Efficacy|6|||
162009634|NCT04607005|585090219|FG000|Overall Study|Withdrawal by Subject|4|||
162009635|NCT04607005|585090220|FG001|Overall Study|Withdrawal by Subject|9|||
162009636|NCT04607005|585090219|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
162009637|NCT04607005|585090220|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
162009638|NCT03589859|585090221|FG000|Overall Study|Withdrawal by Subject|0|||
162009639|NCT03589859|585090222|FG001|Overall Study|Withdrawal by Subject|6|||
162009640|NCT03043794|585090225|FG000|Overall Study|Lost to Follow-up|1|||
162009641|NCT00626106|585090227|FG000|Overall Study|Withdrawal by Subject|2|||
162009642|NCT00626106|585090228|FG001|Overall Study|Withdrawal by Subject|1|||
162009643|NCT00626106|585090227|FG000|Overall Study|Lost to Follow-up|1|||
162009644|NCT00626106|585090228|FG001|Overall Study|Lost to Follow-up|4|||
162009645|NCT00626106|585090227|FG000|Overall Study|Death|64|||
162009646|NCT00626106|585090228|FG001|Overall Study|Death|19|||
162009647|NCT03472885|585090229|FG000|24-Week Treatment Period|Adverse Event|1|||
162009648|NCT05417438|585090230|FG000|Overall Study|Withdrawal by Subject|3|||
162009649|NCT02201953|585090233|FG000|Overall Study|Randomized but Never Treated|1|||
162009650|NCT02201953|585090234|FG001|Overall Study|Randomized but Never Treated|5|||
162009651|NCT02201953|585090233|FG000|Overall Study|Lack of Efficacy|9|||
162009652|NCT02201953|585090234|FG001|Overall Study|Lack of Efficacy|30|||
162009653|NCT02201953|585090233|FG000|Overall Study|Lost to Follow-up|8|||
162009654|NCT02201953|585090234|FG001|Overall Study|Lost to Follow-up|8|||
162009655|NCT02201953|585090233|FG000|Overall Study|Withdrew Consent|2|||
162009656|NCT02201953|585090234|FG001|Overall Study|Withdrew Consent|5|||
162009657|NCT02201953|585090233|FG000|Overall Study|Adverse Event|0|||
162009658|NCT02201953|585090234|FG001|Overall Study|Adverse Event|5|||
162009659|NCT02201953|585090233|FG000|Overall Study|Death|0|||
162009660|NCT02201953|585090234|FG001|Overall Study|Death|3|||
162009661|NCT01148979|585091876|FG000|Overall Study|Lost to Follow-up|0|||
162009662|NCT01148979|585091877|FG001|Overall Study|Lost to Follow-up|1|||
162009663|NCT00777153|585091878|FG000|Overall Study|Lost to Follow-up|1|||
162009664|NCT00777153|585091879|FG001|Overall Study|Lost to Follow-up|1|||
162009665|NCT00777153|585091880|FG002|Overall Study|Lost to Follow-up|0|||
162009666|NCT00777153|585091878|FG000|Overall Study|Death|85|||
162009667|NCT00777153|585091879|FG001|Overall Study|Death|73|||
162009668|NCT00777153|585091880|FG002|Overall Study|Death|33|||
162009669|NCT00777153|585091878|FG000|Overall Study|Withdrawal by Subject|3|||
162009670|NCT00777153|585091879|FG001|Overall Study|Withdrawal by Subject|4|||
162009671|NCT00777153|585091880|FG002|Overall Study|Withdrawal by Subject|3|||
162009672|NCT00777153|585091878|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
162009673|NCT00777153|585091879|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
162009674|NCT00777153|585091880|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
162009675|NCT02266888|585091891|FG000|Overall Study|Death|2|||
162009676|NCT02266888|585091892|FG001|Overall Study|Death|2|||
162009677|NCT02266888|585091893|FG002|Overall Study|Death|4|||
162009678|NCT02266888|585091894|FG003|Overall Study|Death|2|||
162009679|NCT02266888|585091891|FG000|Overall Study|Physician Decision|0|||
162009680|NCT02266888|585091892|FG001|Overall Study|Physician Decision|1|||
162009681|NCT02266888|585091893|FG002|Overall Study|Physician Decision|2|||
162009682|NCT02266888|585091894|FG003|Overall Study|Physician Decision|2|||
162009683|NCT02266888|585091891|FG000|Overall Study|Study Terminated|5|||
162009684|NCT02266888|585091892|FG001|Overall Study|Study Terminated|1|||
162009685|NCT02266888|585091893|FG002|Overall Study|Study Terminated|0|||
162009686|NCT02266888|585091894|FG003|Overall Study|Study Terminated|0|||
162009687|NCT02266888|585091891|FG000|Overall Study|No Longer Eligible|0|||
162009688|NCT02266888|585091892|FG001|Overall Study|No Longer Eligible|0|||
162009689|NCT02266888|585091893|FG002|Overall Study|No Longer Eligible|0|||
162009690|NCT02266888|585091894|FG003|Overall Study|No Longer Eligible|2|||
162009691|NCT02266888|585091891|FG000|Overall Study|Randomization Closed|0|||
162009692|NCT02266888|585091892|FG001|Overall Study|Randomization Closed|0|||
162009693|NCT02266888|585091893|FG002|Overall Study|Randomization Closed|4|||
162009694|NCT02266888|585091894|FG003|Overall Study|Randomization Closed|0|||
162009695|NCT02266888|585091891|FG000|Overall Study|Personnel unavailable at transplant|0|||
162009696|NCT02266888|585091892|FG001|Overall Study|Personnel unavailable at transplant|0|||
162009697|NCT02266888|585091893|FG002|Overall Study|Personnel unavailable at transplant|0|||
162009698|NCT02266888|585091894|FG003|Overall Study|Personnel unavailable at transplant|1|||
162009699|NCT02266888|585091891|FG000|Overall Study|Transfer of care|0|||
162009700|NCT02266888|585091892|FG001|Overall Study|Transfer of care|0|||
162009701|NCT02266888|585091893|FG002|Overall Study|Transfer of care|1|||
162009702|NCT02266888|585091894|FG003|Overall Study|Transfer of care|0|||
162009703|NCT02224560|585091899|FG000|Overall Study|Protocol Deviation|1|||
162009704|NCT02224560|585091900|FG001|Overall Study|Protocol Deviation|0|||
162009705|NCT02224560|585091901|FG002|Overall Study|Protocol Deviation|0|||
162009706|NCT02224560|585091899|FG000|Overall Study|Withdrawal by Subject|2|||
162009707|NCT02224560|585091900|FG001|Overall Study|Withdrawal by Subject|0|||
162009708|NCT02224560|585091901|FG002|Overall Study|Withdrawal by Subject|1|||
162009709|NCT02224560|585091899|FG000|Overall Study|Met Withdrawal Criteria|1|||
162009710|NCT02224560|585091900|FG001|Overall Study|Met Withdrawal Criteria|0|||
162009711|NCT02224560|585091901|FG002|Overall Study|Met Withdrawal Criteria|0|||
162009712|NCT02224560|585091899|FG000|Overall Study|Adverse Event|4|||
162009713|NCT02224560|585091900|FG001|Overall Study|Adverse Event|1|||
162009714|NCT02224560|585091901|FG002|Overall Study|Adverse Event|1|||
162009715|NCT02224560|585091899|FG000|Overall Study|Withdrawn by Investigator|1|||
162009716|NCT02224560|585091900|FG001|Overall Study|Withdrawn by Investigator|1|||
162009717|NCT02224560|585091901|FG002|Overall Study|Withdrawn by Investigator|0|||
162009718|NCT00728689|585091902|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
162009719|NCT00728689|585091903|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
162009720|NCT01523366|585091904|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162009721|NCT01523366|585091905|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162009722|NCT01523366|585091904|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
162009723|NCT01523366|585091905|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
162009724|NCT02461758|585091906|FG000|Overall Study|Lost to Follow-up|0|||
162009725|NCT02461758|585091907|FG001|Overall Study|Lost to Follow-up|1|||
162009726|NCT02461758|585091908|FG002|Overall Study|Lost to Follow-up|1|||
162009727|NCT02461758|585091909|FG003|Overall Study|Lost to Follow-up|0|||
162009728|NCT04543279|585091911|FG000|Overall Study|Withdrawal by Subject|1|||
162009729|NCT04543279|585091912|FG001|Overall Study|Withdrawal by Subject|0|||
162009730|NCT04543279|585091911|FG000|Overall Study|Adverse Event|1|||
162009731|NCT04543279|585091912|FG001|Overall Study|Adverse Event|0|||
162009732|NCT04543279|585091911|FG000|Overall Study|Physician Decision|1|||
162009733|NCT04543279|585091912|FG001|Overall Study|Physician Decision|0|||
162009734|NCT00929695|585091915|FG000|Overall Study|Death|2|||
162009735|NCT00929695|585091916|FG001|Overall Study|Death|1|||
162009736|NCT00929695|585091915|FG000|Overall Study|Withdrawal by Subject|0|||
162009737|NCT00929695|585091916|FG001|Overall Study|Withdrawal by Subject|2|||
162009738|NCT00929695|585091915|FG000|Overall Study|discharge home|4|||
162009739|NCT00929695|585091916|FG001|Overall Study|discharge home|3|||
162009740|NCT00929695|585091915|FG000|Overall Study|incorrect stratification|2|||
162009741|NCT00929695|585091916|FG001|Overall Study|incorrect stratification|0|||
162009742|NCT04030143|585091917|FG000|Overall Study|Adverse Event|5|||
162009743|NCT04030143|585091918|FG001|Overall Study|Adverse Event|10|||
162009744|NCT04030143|585091917|FG000|Overall Study|Lost to Follow-up|3|||
161898046|NCT00327340|584675545|FG000|Overall Study|Withdrawal by Subject|1|||
161898047|NCT00327340|584675546|FG001|Overall Study|Withdrawal by Subject|5|||
161898048|NCT00327340|584675545|FG000|Overall Study|Physician Decision|1|||
161898049|NCT00327340|584675546|FG001|Overall Study|Physician Decision|1|||
161898050|NCT00327340|584675545|FG000|Overall Study|Disease Progression|10|||
161898051|NCT00327340|584675546|FG001|Overall Study|Disease Progression|19|||
161898052|NCT00327340|584675545|FG000|Overall Study|Symptomatic Disease|0|||
161898053|NCT00327340|584675546|FG001|Overall Study|Symptomatic Disease|2|||
161898054|NCT00327340|584675545|FG000|Overall Study|Adverse Event|3|||
161898055|NCT00327340|584675546|FG001|Overall Study|Adverse Event|3|||
161898056|NCT04085601|584675550|FG000|Overall Study|Lost to Follow-up|1|||
161898057|NCT04085601|584675551|FG001|Overall Study|Lost to Follow-up|0|||
161898058|NCT04085601|584675550|FG000|Overall Study|Death|1|||
161898059|NCT04085601|584675551|FG001|Overall Study|Death|1|||
161898060|NCT00206427|584675552|FG000|Overall Study|Adverse Event|2|||
161898061|NCT03492437|584675553|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161898062|NCT03492437|584675554|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161898063|NCT04534517|584675556|FG000|Overall Study|Adverse Event|1|||
161898064|NCT04534517|584675556|FG000|Overall Study|Withdrawal by Subject|1|||
161898065|NCT04534517|584675556|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
161898066|NCT04534517|584675556|FG000|Overall Study|COVID-19 Related|1|||
161898067|NCT02121795|584675557|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
161898068|NCT02121795|584675558|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
161898069|NCT02121795|584675557|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
161898070|NCT02121795|584675558|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
161898071|NCT02121795|584675557|FG000|Double-Blind Phase|Lost to Follow-up|7|||
161898072|NCT02121795|584675558|FG001|Double-Blind Phase|Lost to Follow-up|4|||
161898073|NCT02121795|584675557|FG000|Double-Blind Phase|Physician Decision|2|||
161898074|NCT02121795|584675558|FG001|Double-Blind Phase|Physician Decision|5|||
161898075|NCT02121795|584675557|FG000|Double-Blind Phase|Adverse Event|5|||
161898076|NCT02121795|584675558|FG001|Double-Blind Phase|Adverse Event|0|||
161898077|NCT02121795|584675557|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
161898078|NCT02121795|584675558|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
161898079|NCT02121795|584675557|FG000|Double-Blind Phase|Protocol Violation|0|||
161898080|NCT02121795|584675558|FG001|Double-Blind Phase|Protocol Violation|3|||
161898081|NCT02121795|584675557|FG000|Double-Blind Phase|Death|1|||
161898082|NCT02121795|584675558|FG001|Double-Blind Phase|Death|1|||
161898083|NCT02121795|584675557|FG000|Open-Label Phase|Physician Decision|8|||
161898084|NCT02121795|584675558|FG001|Open-Label Phase|Physician Decision|8|||
161898085|NCT02121795|584675557|FG000|Open-Label Phase|Withdrawal by Subject|3|||
161898086|NCT02121795|584675558|FG001|Open-Label Phase|Withdrawal by Subject|2|||
161898087|NCT02121795|584675557|FG000|Open-Label Phase|Lost to Follow-up|1|||
161898088|NCT02121795|584675558|FG001|Open-Label Phase|Lost to Follow-up|0|||
161898089|NCT00823264|584675559|FG000|Overall Study|Protocol Violation|2|||
161898090|NCT00823264|584675560|FG001|Overall Study|Protocol Violation|0|||
161898091|NCT01914393|584675561|FG000|Overall Study|Protocol Violation|11|||
161898092|NCT01914393|584675562|FG001|Overall Study|Protocol Violation|3|||
161898093|NCT01914393|584675563|FG002|Overall Study|Protocol Violation|19|||
161898094|NCT01914393|584675561|FG000|Overall Study|Lack of Efficacy|11|||
161898095|NCT01914393|584675562|FG001|Overall Study|Lack of Efficacy|16|||
161898096|NCT01914393|584675563|FG002|Overall Study|Lack of Efficacy|5|||
161898097|NCT01914393|584675561|FG000|Overall Study|no reason given|14|||
161898098|NCT01914393|584675562|FG001|Overall Study|no reason given|8|||
161898099|NCT01914393|584675563|FG002|Overall Study|no reason given|16|||
161898100|NCT01914393|584675561|FG000|Overall Study|Adverse Event|29|||
161898101|NCT01914393|584675562|FG001|Overall Study|Adverse Event|18|||
161898102|NCT01914393|584675563|FG002|Overall Study|Adverse Event|31|||
161898103|NCT01914393|584675561|FG000|Overall Study|Withdrawal by Subject|38|||
161898104|NCT01914393|584675562|FG001|Overall Study|Withdrawal by Subject|20|||
161898105|NCT01914393|584675563|FG002|Overall Study|Withdrawal by Subject|47|||
161898106|NCT01914393|584675561|FG000|Overall Study|Lost to Follow-up|12|||
161898107|NCT01914393|584675562|FG001|Overall Study|Lost to Follow-up|6|||
161898108|NCT01914393|584675563|FG002|Overall Study|Lost to Follow-up|19|||
161898109|NCT01914393|584675561|FG000|Overall Study|subject never dosed|0|||
161898110|NCT01914393|584675562|FG001|Overall Study|subject never dosed|0|||
161898111|NCT01914393|584675563|FG002|Overall Study|subject never dosed|1|||
161898112|NCT00572455|584675564|FG000|Stage I (14 Days)|Adverse Event|0|||
161898113|NCT00572455|584675565|FG001|Stage I (14 Days)|Adverse Event|0|||
161898114|NCT00572455|584675566|FG002|Stage I (14 Days)|Adverse Event|0|||
161898115|NCT00572455|584675567|FG003|Stage I (14 Days)|Adverse Event|0|||
161898116|NCT00572455|584675568|FG004|Stage I (14 Days)|Adverse Event|0|||
161898117|NCT00572455|584675569|FG005|Stage I (14 Days)|Adverse Event|3|||
161898118|NCT00572455|584675570|FG006|Stage I (14 Days)|Adverse Event|0|||
161898119|NCT00572455|584675571|FG007|Stage I (14 Days)|Adverse Event|0|||
161898120|NCT00572455|584675572|FG008|Stage I (14 Days)|Adverse Event|0|||
161898121|NCT00572455|584675573|FG009|Stage I (14 Days)|Adverse Event|0|||
162009745|NCT04030143|585091918|FG001|Overall Study|Lost to Follow-up|7|||
162009746|NCT04030143|585091917|FG000|Overall Study|Protocol Deviation|2|||
162009747|NCT04030143|585091918|FG001|Overall Study|Protocol Deviation|2|||
162009748|NCT04030143|585091917|FG000|Overall Study|Withdrawal by Subject|16|||
162009749|NCT04030143|585091918|FG001|Overall Study|Withdrawal by Subject|18|||
162009750|NCT04030143|585091917|FG000|Overall Study|Physician Decision|1|||
162009751|NCT04030143|585091918|FG001|Overall Study|Physician Decision|1|||
162009752|NCT04030143|585091917|FG000|Overall Study|Due to Covid-19|2|||
162009753|NCT04030143|585091918|FG001|Overall Study|Due to Covid-19|3|||
162009754|NCT04030143|585091917|FG000|Overall Study|Not Due to Covid-19|1|||
162009755|NCT04030143|585091918|FG001|Overall Study|Not Due to Covid-19|1|||
162009756|NCT03216226|585091919|FG000|Overall Study|Adverse Event|3|||
162009757|NCT03216226|585091920|FG001|Overall Study|Adverse Event|0|||
162009758|NCT03216226|585091919|FG000|Overall Study|Protocol Violation|1|||
162009759|NCT03216226|585091920|FG001|Overall Study|Protocol Violation|3|||
162009760|NCT03216226|585091919|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
162009761|NCT03216226|585091920|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
162009762|NCT03216226|585091919|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
162009763|NCT03216226|585091920|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
162009764|NCT03216226|585091919|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
162009765|NCT03216226|585091920|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
162009766|NCT01352715|585091922|FG000|Overall Study|Death|3|||
162009767|NCT01352715|585091923|FG001|Overall Study|Death|3|||
162009768|NCT01352715|585091922|FG000|Overall Study|Lost to Follow-up|5|||
162009769|NCT01352715|585091923|FG001|Overall Study|Lost to Follow-up|7|||
162009770|NCT01352715|585091922|FG000|Overall Study|Withdrawal by Subject|4|||
162009771|NCT01352715|585091923|FG001|Overall Study|Withdrawal by Subject|8|||
162009772|NCT01352715|585091922|FG000|Overall Study|site closure|16|||
162009773|NCT01352715|585091923|FG001|Overall Study|site closure|15|||
162009774|NCT01352715|585091922|FG000|Overall Study|no final visit in closeout period|15|||
162009775|NCT01352715|585091923|FG001|Overall Study|no final visit in closeout period|12|||
162009776|NCT01352715|585091922|FG000|Overall Study|major ineligibility|2|||
162009777|NCT01352715|585091923|FG001|Overall Study|major ineligibility|1|||
162009778|NCT02000440|585091924|FG000|Overall Study|Adverse Event|3|||
162009779|NCT02000440|585091924|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
162009780|NCT02383576|585091926|FG000|Overall Study|Death|53|||
162009781|NCT02383576|585091927|FG001|Overall Study|Death|33|||
162009782|NCT02383576|585091926|FG000|Overall Study|Lost to Follow-up|7|||
162009783|NCT02383576|585091927|FG001|Overall Study|Lost to Follow-up|1|||
162009784|NCT02383576|585091926|FG000|Overall Study|Withdrew Consent|1|||
162009785|NCT02383576|585091927|FG001|Overall Study|Withdrew Consent|6|||
162009786|NCT02383576|585091926|FG000|Overall Study|Investigator's Decision|0|||
162009787|NCT02383576|585091927|FG001|Overall Study|Investigator's Decision|1|||
162009788|NCT02383576|585091926|FG000|Overall Study|Administrative/Other|2|||
162009789|NCT02383576|585091927|FG001|Overall Study|Administrative/Other|4|||
162009790|NCT00871975|585091928|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
162009791|NCT00871975|585091928|FG000|Overall Study|Catheters could not be inserted|1|||
162009792|NCT00871975|585091928|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
162009793|NCT00871975|585091928|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
162009794|NCT01436149|585091932|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
162009795|NCT01436149|585091933|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
162009796|NCT01436149|585091934|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
162009797|NCT01436149|585091932|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
162009798|NCT01436149|585091933|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
162009799|NCT01436149|585091934|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
162009800|NCT01436149|585091932|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
162009801|NCT01436149|585091933|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
162009802|NCT01436149|585091934|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
162009803|NCT01436149|585091932|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
162009804|NCT01436149|585091933|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
162009805|NCT01436149|585091934|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
162009806|NCT01436149|585091932|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
162009807|NCT01436149|585091933|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
162009808|NCT01436149|585091934|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
162009809|NCT01436149|585091932|FG000|Antidepressant Lead-in Phase|Other|119|||
162009810|NCT01436149|585091933|FG001|Antidepressant Lead-in Phase|Other|0|||
162009811|NCT01436149|585091934|FG002|Antidepressant Lead-in Phase|Other|0|||
162242030|NCT02616562|585939077|FG009|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
162009812|NCT01436149|585091932|FG000|Randomized Phase|Adverse Event|9|||
162009813|NCT01436149|585091933|FG001|Randomized Phase|Adverse Event|10|||
162009814|NCT01436149|585091934|FG002|Randomized Phase|Adverse Event|11|||
162009815|NCT01436149|585091932|FG000|Randomized Phase|Protocol Violation|4|||
162009816|NCT01436149|585091933|FG001|Randomized Phase|Protocol Violation|5|||
162009817|NCT01436149|585091934|FG002|Randomized Phase|Protocol Violation|0|||
162009818|NCT01436149|585091932|FG000|Randomized Phase|Withdrawal by Subject|16|||
162009819|NCT01436149|585091933|FG001|Randomized Phase|Withdrawal by Subject|10|||
162009820|NCT01436149|585091934|FG002|Randomized Phase|Withdrawal by Subject|10|||
162009821|NCT01436149|585091932|FG000|Randomized Phase|Lost to Follow-up|34|||
162009822|NCT01436149|585091933|FG001|Randomized Phase|Lost to Follow-up|5|||
162009823|NCT01436149|585091934|FG002|Randomized Phase|Lost to Follow-up|6|||
162009824|NCT01436149|585091932|FG000|Randomized Phase|Lack of Efficacy|0|||
162009825|NCT01436149|585091933|FG001|Randomized Phase|Lack of Efficacy|0|||
162009826|NCT01436149|585091934|FG002|Randomized Phase|Lack of Efficacy|1|||
162009827|NCT01436149|585091932|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
162009828|NCT01436149|585091933|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
162009829|NCT01436149|585091934|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
162009830|NCT01436149|585091932|FG000|Randomized Phase|Other|12|||
162009831|NCT01436149|585091933|FG001|Randomized Phase|Other|5|||
162009832|NCT01436149|585091934|FG002|Randomized Phase|Other|11|||
162009833|NCT01690143|585091935|FG000|Overall Study|Withdrawal by Subject|1|||
162009834|NCT03944577|585091942|FG000|Overall Study|Adverse Event|3|||
162009835|NCT03011099|585091945|FG000|Overall Study|Withdrawal by Subject|0|||
162009836|NCT03011099|585091946|FG001|Overall Study|Withdrawal by Subject|2|||
162009837|NCT01409707|585091947|FG000|Overall Study|Withdrawal by Subject|5|||
162009838|NCT01409707|585091948|FG001|Overall Study|Withdrawal by Subject|17|||
162009839|NCT01409707|585091949|FG002|Overall Study|Withdrawal by Subject|16|||
162009840|NCT03058146|585091950|FG000|Overall Study|Withdrawal by Subject|4|||
162009841|NCT03058146|585091951|FG001|Overall Study|Withdrawal by Subject|1|||
162009842|NCT03058146|585091950|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
162009843|NCT03058146|585091951|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
162009844|NCT00632229|585091952|FG000|Overall Study|Adverse Event|6|||
162009845|NCT00632229|585091953|FG001|Overall Study|Adverse Event|0|||
162009846|NCT00632229|585091952|FG000|Overall Study|Lost to Follow-up|0|||
162009847|NCT00632229|585091953|FG001|Overall Study|Lost to Follow-up|3|||
162009848|NCT00632229|585091952|FG000|Overall Study|Lack of Efficacy|0|||
162009849|NCT00632229|585091953|FG001|Overall Study|Lack of Efficacy|2|||
162009850|NCT00632229|585091952|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
162009851|NCT00632229|585091953|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
162009852|NCT03041181|585091954|FG000|Overall Study|Disease Progression|1|||
162009853|NCT03041181|585091955|FG001|Overall Study|Disease Progression|2|||
162009854|NCT01716234|585091956|FG000|Overall Study|Protocol Violation|0|||
162009855|NCT01716234|585091957|FG001|Overall Study|Protocol Violation|0|||
162009856|NCT01716234|585091958|FG002|Overall Study|Protocol Violation|0|||
162009857|NCT01716234|585091959|FG003|Overall Study|Protocol Violation|1|||
162009858|NCT01716234|585091960|FG004|Overall Study|Protocol Violation|1|||
162009859|NCT01716234|585091961|FG005|Overall Study|Protocol Violation|1|||
162009860|NCT01716234|585091962|FG006|Overall Study|Protocol Violation|0|||
162009861|NCT01716234|585091956|FG000|Overall Study|Lack of Efficacy|0|||
162009862|NCT01716234|585091957|FG001|Overall Study|Lack of Efficacy|0|||
162009863|NCT01716234|585091958|FG002|Overall Study|Lack of Efficacy|0|||
162009864|NCT01716234|585091959|FG003|Overall Study|Lack of Efficacy|1|||
162009865|NCT01716234|585091960|FG004|Overall Study|Lack of Efficacy|0|||
162009866|NCT01716234|585091961|FG005|Overall Study|Lack of Efficacy|0|||
162009867|NCT01716234|585091962|FG006|Overall Study|Lack of Efficacy|0|||
162009868|NCT01716234|585091956|FG000|Overall Study|Did not meet protocol eligibility|0|||
162009869|NCT01716234|585091957|FG001|Overall Study|Did not meet protocol eligibility|0|||
162009870|NCT01716234|585091958|FG002|Overall Study|Did not meet protocol eligibility|1|||
162009871|NCT01716234|585091959|FG003|Overall Study|Did not meet protocol eligibility|0|||
162009872|NCT01716234|585091960|FG004|Overall Study|Did not meet protocol eligibility|0|||
162009873|NCT01716234|585091961|FG005|Overall Study|Did not meet protocol eligibility|4|||
162009874|NCT01716234|585091962|FG006|Overall Study|Did not meet protocol eligibility|0|||
162009875|NCT01716234|585091956|FG000|Overall Study|Adverse Event|7|||
162009876|NCT01716234|585091957|FG001|Overall Study|Adverse Event|10|||
162009877|NCT01716234|585091958|FG002|Overall Study|Adverse Event|2|||
162009878|NCT01716234|585091959|FG003|Overall Study|Adverse Event|8|||
162009879|NCT01716234|585091960|FG004|Overall Study|Adverse Event|3|||
162009880|NCT01716234|585091961|FG005|Overall Study|Adverse Event|6|||
162009881|NCT01716234|585091962|FG006|Overall Study|Adverse Event|0|||
162009882|NCT01716234|585091956|FG000|Overall Study|Withdrawal by Subject|3|||
162009883|NCT01716234|585091957|FG001|Overall Study|Withdrawal by Subject|0|||
162009884|NCT01716234|585091958|FG002|Overall Study|Withdrawal by Subject|2|||
162009885|NCT01716234|585091959|FG003|Overall Study|Withdrawal by Subject|2|||
162009886|NCT01716234|585091960|FG004|Overall Study|Withdrawal by Subject|1|||
162009887|NCT01716234|585091961|FG005|Overall Study|Withdrawal by Subject|3|||
162009888|NCT01716234|585091962|FG006|Overall Study|Withdrawal by Subject|0|||
162009889|NCT02667119|585091963|FG000|Overall Study|Lost to Follow-up|3|||
162009890|NCT02667119|585091964|FG001|Overall Study|Lost to Follow-up|0|||
162009891|NCT01467960|585091965|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
162236366|NCT00250679|585916937|FG002|Overall Study|Non-compliance|0|||
162009892|NCT01467960|585091966|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
162009893|NCT01467960|585091967|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
162009894|NCT01467960|585091968|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
162009895|NCT01467960|585091969|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
162009896|NCT01467960|585091970|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
162009897|NCT00474812|585091971|FG000|Overall Study|Withdrawal by Subject|5|||
162009898|NCT00474812|585091971|FG000|Overall Study|No Initiation of treatment|2|||
162009899|NCT00737672|585091980|FG000|Overall Study|Graft Abandonment|48|||
162009900|NCT00737672|585091981|FG001|Overall Study|Graft Abandonment|56|||
162009901|NCT00737672|585091980|FG000|Overall Study|Death|23|||
162009902|NCT00737672|585091981|FG001|Overall Study|Death|22|||
162009903|NCT00737672|585091980|FG000|Overall Study|Withdrawal by Subject|1|||
162009904|NCT00737672|585091981|FG001|Overall Study|Withdrawal by Subject|2|||
162009905|NCT00737672|585091980|FG000|Overall Study|Lost to Follow-up|1|||
162009906|NCT00737672|585091981|FG001|Overall Study|Lost to Follow-up|0|||
162009907|NCT00737672|585091980|FG000|Overall Study|Miscellaneous|7|||
162009908|NCT00737672|585091981|FG001|Overall Study|Miscellaneous|1|||
162009909|NCT00737672|585091980|FG000|Overall Study|Physician Decision|0|||
162009910|NCT00737672|585091981|FG001|Overall Study|Physician Decision|2|||
162009911|NCT02002598|585091988|FG000|Dose Level 1|Withdrawal by Subject|1|||
162009912|NCT02002598|585091989|FG001|Dose Level 1|Withdrawal by Subject|0|||
162009913|NCT02002598|585091990|FG002|Dose Level 1|Withdrawal by Subject|0|||
162009914|NCT02002598|585091991|FG003|Dose Level 1|Withdrawal by Subject|0|||
162009915|NCT02002598|585091992|FG004|Dose Level 1|Withdrawal by Subject|0|||
162009916|NCT02018562|585091994|FG000|Overall Study|Withdrawal by Subject|2|||
162009917|NCT02018562|585091995|FG001|Overall Study|Withdrawal by Subject|0|||
162009918|NCT02018562|585091994|FG000|Overall Study|Discharged prior to study completion|1|||
162009919|NCT02018562|585091995|FG001|Overall Study|Discharged prior to study completion|0|||
162009920|NCT01838395|585091996|FG000|Overall Study|Withdrawal by Subject|0|||
162009921|NCT01838395|585091997|FG001|Overall Study|Withdrawal by Subject|0|||
162009922|NCT01838395|585091998|FG002|Overall Study|Withdrawal by Subject|0|||
162009923|NCT01838395|585091999|FG003|Overall Study|Withdrawal by Subject|0|||
162009924|NCT01838395|585092000|FG004|Overall Study|Withdrawal by Subject|1|||
162009925|NCT01838395|585092001|FG005|Overall Study|Withdrawal by Subject|0|||
162009926|NCT01838395|585091996|FG000|Overall Study|Death|0|||
162009927|NCT01838395|585091997|FG001|Overall Study|Death|0|||
162009928|NCT01838395|585091998|FG002|Overall Study|Death|1|||
162009929|NCT01838395|585091999|FG003|Overall Study|Death|0|||
162009930|NCT01838395|585092000|FG004|Overall Study|Death|0|||
162009931|NCT01838395|585092001|FG005|Overall Study|Death|0|||
162009932|NCT01838395|585091996|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
162009933|NCT01838395|585091997|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
162009934|NCT01838395|585091998|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
162009935|NCT01838395|585091999|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
162009936|NCT01838395|585092000|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
162009937|NCT01838395|585092001|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
162009938|NCT05972993|585092002|FG000|Overall Study|Lost to Follow-up|2|||
162009939|NCT05972993|585092003|FG001|Overall Study|Lost to Follow-up|0|||
162009940|NCT05972993|585092004|FG002|Overall Study|Lost to Follow-up|1|||
162009941|NCT05972993|585092005|FG003|Overall Study|Lost to Follow-up|0|||
162009942|NCT05972993|585092006|FG004|Overall Study|Lost to Follow-up|0|||
162009943|NCT05972993|585092007|FG005|Overall Study|Lost to Follow-up|0|||
162009944|NCT05972993|585092008|FG006|Overall Study|Lost to Follow-up|0|||
162009945|NCT05972993|585092009|FG007|Overall Study|Lost to Follow-up|2|||
162009946|NCT05972993|585092010|FG008|Overall Study|Lost to Follow-up|0|||
162009947|NCT05720897|585092017|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
162009948|NCT05720897|585092018|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
162009949|NCT00400179|585092019|FG000|Overall Study|Adverse Event|2|||
162009950|NCT00400179|585092020|FG001|Overall Study|Adverse Event|2|||
162009951|NCT00400179|585092019|FG000|Overall Study|Death|1|||
162009952|NCT00400179|585092020|FG001|Overall Study|Death|2|||
162009953|NCT00400179|585092019|FG000|Overall Study|Withdrew Consent|1|||
162009954|NCT00400179|585092020|FG001|Overall Study|Withdrew Consent|5|||
162009955|NCT00400179|585092019|FG000|Overall Study|Disease progression|1|||
162009956|NCT00400179|585092020|FG001|Overall Study|Disease progression|1|||
162009957|NCT00400179|585092019|FG000|Overall Study|Intercurrent illness|0|||
162009958|NCT00400179|585092020|FG001|Overall Study|Intercurrent illness|1|||
162009959|NCT00400179|585092019|FG000|Overall Study|Investigator judgment|0|||
162009960|NCT00400179|585092020|FG001|Overall Study|Investigator judgment|1|||
162009961|NCT00400179|585092019|FG000|Overall Study|Randomization error/patient ineligible|1|||
162009962|NCT00400179|585092020|FG001|Overall Study|Randomization error/patient ineligible|6|||
162009963|NCT04780061|585092021|FG000|Overall Study|Withdrawal by Subject|5|||
162009964|NCT04780061|585092022|FG001|Overall Study|Withdrawal by Subject|8|||
162009965|NCT04780061|585092021|FG000|Overall Study|Adverse Event|2|||
162009966|NCT04780061|585092022|FG001|Overall Study|Adverse Event|2|||
162009967|NCT04780061|585092021|FG000|Overall Study|Lost to Follow-up|1|||
162009968|NCT04780061|585092022|FG001|Overall Study|Lost to Follow-up|5|||
162009969|NCT04050553|585092024|FG000|Period 1|Physician Decision|2|||
162009970|NCT04050553|585092025|FG001|Period 1|Physician Decision|2|||
162009971|NCT04050553|585092024|FG000|Period 1|Adverse Event|1|||
162009972|NCT04050553|585092025|FG001|Period 1|Adverse Event|1|||
162009973|NCT04050553|585092024|FG000|Period 1|Withdrawal by Subject|0|||
162009974|NCT04050553|585092025|FG001|Period 1|Withdrawal by Subject|1|||
162009975|NCT04050553|585092024|FG000|Wash-out|Adverse Event|0|||
162009976|NCT04050553|585092025|FG001|Wash-out|Adverse Event|1|||
162009977|NCT04050553|585092024|FG000|Wash-out|Withdrawal by Subject|0|||
162009978|NCT04050553|585092025|FG001|Wash-out|Withdrawal by Subject|1|||
162009979|NCT01535040|585092026|FG000|Overall Study|Physician Decision|0|||
162009980|NCT01535040|585092027|FG001|Overall Study|Physician Decision|1|||
162009981|NCT01535040|585092026|FG000|Overall Study|Withdrawal by Subject|13|||
162009982|NCT01535040|585092027|FG001|Overall Study|Withdrawal by Subject|10|||
162009983|NCT01535040|585092026|FG000|Overall Study|Never Started|9|||
162009984|NCT01535040|585092027|FG001|Overall Study|Never Started|4|||
162009985|NCT01535040|585092026|FG000|Overall Study|Toxicity|7|||
162009986|NCT01535040|585092027|FG001|Overall Study|Toxicity|5|||
162009987|NCT01535040|585092026|FG000|Overall Study|Multiple Reasons|1|||
162009988|NCT01535040|585092027|FG001|Overall Study|Multiple Reasons|1|||
162009989|NCT00911170|585092037|FG000|Treatment Period|Randomized in error|1|||
162009990|NCT00911170|585092038|FG001|Treatment Period|Randomized in error|1|||
162009991|NCT00911170|585092037|FG000|Treatment Period|Ineligibility determined|1|||
162009992|NCT00911170|585092038|FG001|Treatment Period|Ineligibility determined|3|||
162009993|NCT00911170|585092037|FG000|Treatment Period|Protocol deviation|1|||
162009994|NCT00911170|585092038|FG001|Treatment Period|Protocol deviation|2|||
162009995|NCT00911170|585092037|FG000|Treatment Period|Adverse Event|9|||
162009996|NCT00911170|585092038|FG001|Treatment Period|Adverse Event|10|||
162009997|NCT00911170|585092037|FG000|Treatment Period|Withdrawal by Subject|4|||
162009998|NCT00911170|585092038|FG001|Treatment Period|Withdrawal by Subject|4|||
162009999|NCT00911170|585092037|FG000|Treatment Period|Disease progression|0|||
162010000|NCT00911170|585092038|FG001|Treatment Period|Disease progression|2|||
162010001|NCT00911170|585092037|FG000|Treatment Period|Physician Decision|5|||
162010002|NCT00911170|585092038|FG001|Treatment Period|Physician Decision|5|||
162010003|NCT00911170|585092037|FG000|Treatment Period|Lost to Follow-up|0|||
162010004|NCT00911170|585092038|FG001|Treatment Period|Lost to Follow-up|1|||
162010005|NCT00911170|585092037|FG000|Treatment Period|Death|6|||
162010006|NCT00911170|585092038|FG001|Treatment Period|Death|9|||
162010007|NCT00911170|585092037|FG000|Long Term Follow-Up|Continuing in study|274|||
162010008|NCT00911170|585092038|FG001|Long Term Follow-Up|Continuing in study|269|||
162010009|NCT00911170|585092037|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
162010010|NCT00911170|585092038|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
162010011|NCT00911170|585092037|FG000|Long Term Follow-Up|Physician Decision|5|||
162010012|NCT00911170|585092038|FG001|Long Term Follow-Up|Physician Decision|4|||
162010013|NCT00911170|585092037|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
162010014|NCT00911170|585092038|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
162010015|NCT00911170|585092037|FG000|Long Term Follow-Up|Death|116|||
162010016|NCT00911170|585092038|FG001|Long Term Follow-Up|Death|121|||
162010017|NCT02681523|585092039|FG000|Overall Study|Adverse Event|1|||
162010018|NCT02681523|585092039|FG000|Overall Study|Patient Non-compliance|1|||
162010019|NCT03312634|585093594|FG000|Overall Study|Adverse Event|11|||
162010020|NCT03312634|585093595|FG001|Overall Study|Adverse Event|0|||
162010021|NCT03312634|585093594|FG000|Overall Study|Sponsor request|2|||
162010022|NCT03312634|585093595|FG001|Overall Study|Sponsor request|0|||
162010023|NCT03312634|585093594|FG000|Overall Study|Withdrawal by Subject|31|||
162010024|NCT03312634|585093595|FG001|Overall Study|Withdrawal by Subject|9|||
162010025|NCT03312634|585093594|FG000|Overall Study|Enrolled in an interventional study|0|||
162010026|NCT03312634|585093595|FG001|Overall Study|Enrolled in an interventional study|52|||
162010027|NCT03312634|585093594|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
162010028|NCT03312634|585093595|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
162010029|NCT03312634|585093594|FG000|Overall Study|Death|0|||
162010030|NCT03312634|585093595|FG001|Overall Study|Death|1|||
162010031|NCT03312634|585093594|FG000|Overall Study|Non-compliance|0|||
162010032|NCT03312634|585093595|FG001|Overall Study|Non-compliance|2|||
162010033|NCT03312634|585093594|FG000|Overall Study|Lost to Follow-up|0|||
162010034|NCT03312634|585093595|FG001|Overall Study|Lost to Follow-up|1|||
162122904|NCT02291289|585502361|FG005|Induction Treatment|Withdrawal by Subject|0|||
162122905|NCT02291289|585502362|FG006|Induction Treatment|Withdrawal by Subject|0|||
162010035|NCT03312634|585093594|FG000|Overall Study|Enrolled into non-interventional study|0|||
162010036|NCT03312634|585093595|FG001|Overall Study|Enrolled into non-interventional study|5|||
162122906|NCT02291289|585502363|FG007|Induction Treatment|Withdrawal by Subject|0|||
162122907|NCT02291289|585502364|FG008|Induction Treatment|Withdrawal by Subject|0|||
162122908|NCT02291289|585502365|FG009|Induction Treatment|Withdrawal by Subject|18|||
162010037|NCT03312634|585093594|FG000|Overall Study|Worsening clinical condition|0|||
162010038|NCT03312634|585093595|FG001|Overall Study|Worsening clinical condition|1|||
162010039|NCT03312634|585093594|FG000|Overall Study|Participant did not want to travel|0|||
162010040|NCT03312634|585093595|FG001|Overall Study|Participant did not want to travel|1|||
162010041|NCT03312634|585093594|FG000|Overall Study|Physician Decision|1|||
162010042|NCT03312634|585093595|FG001|Overall Study|Physician Decision|0|||
162010043|NCT03312634|585093594|FG000|Overall Study|Other|13|||
162010044|NCT03312634|585093595|FG001|Overall Study|Other|0|||
162010045|NCT04610281|585093596|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
162010046|NCT04610281|585093597|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
162010047|NCT01942837|585093598|FG000|Overall Study|Death|1|||
162010048|NCT01942837|585093598|FG000|Overall Study|Symptomatic or radiographic progression|49|||
162010049|NCT01942837|585093598|FG000|Overall Study|Adverse Event|6|||
162010050|NCT01942837|585093598|FG000|Overall Study|Physician Decision|3|||
162010051|NCT01942837|585093598|FG000|Overall Study|Withdrawal by Subject|2|||
162010052|NCT01942837|585093598|FG000|Overall Study|Intercurrent Illness|1|||
162010053|NCT01942837|585093598|FG000|Overall Study|On treatment|3|||
162010054|NCT01942837|585093598|FG000|Overall Study|Never initiate the treatment|2|||
162010055|NCT01298648|585093599|FG000|Overall Study|Withdrawal by Subject|2|||
162010056|NCT01298648|585093599|FG000|Overall Study|Lost to Follow-up|21|||
162010057|NCT01458392|585093604|FG000|Overall Study|Death|2|||
162010058|NCT01458392|585093605|FG001|Overall Study|Death|11|||
162010059|NCT01458392|585093606|FG002|Overall Study|Death|22|||
162010060|NCT01458392|585093604|FG000|Overall Study|At the discretion of the sponsor|0|||
162010061|NCT01458392|585093605|FG001|Overall Study|At the discretion of the sponsor|2|||
162010062|NCT01458392|585093606|FG002|Overall Study|At the discretion of the sponsor|7|||
162010063|NCT01458392|585093604|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
162010064|NCT01458392|585093605|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
162010065|NCT01458392|585093606|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
162010066|NCT00918255|585093607|FG000|Overall Study|Adverse Event|1|||
162010067|NCT00918255|585093608|FG001|Overall Study|Adverse Event|0|||
162010068|NCT00918255|585093609|FG002|Overall Study|Adverse Event|0|||
162010069|NCT00918255|585093607|FG000|Overall Study|Withdrawal by Subject|1|||
162010070|NCT00918255|585093608|FG001|Overall Study|Withdrawal by Subject|0|||
162010071|NCT00918255|585093609|FG002|Overall Study|Withdrawal by Subject|2|||
162010072|NCT00918255|585093607|FG000|Overall Study|Lack of Efficacy|1|||
162010073|NCT00918255|585093608|FG001|Overall Study|Lack of Efficacy|0|||
162010074|NCT00918255|585093609|FG002|Overall Study|Lack of Efficacy|0|||
162010075|NCT00918255|585093607|FG000|Overall Study|Lost to Follow-up|1|||
162010076|NCT00918255|585093608|FG001|Overall Study|Lost to Follow-up|0|||
162010077|NCT00918255|585093609|FG002|Overall Study|Lost to Follow-up|2|||
162010078|NCT00918255|585093607|FG000|Overall Study|Exceeded allowed number of interventions|0|||
162010079|NCT00918255|585093608|FG001|Overall Study|Exceeded allowed number of interventions|0|||
162010080|NCT00918255|585093609|FG002|Overall Study|Exceeded allowed number of interventions|1|||
162010081|NCT00918255|585093607|FG000|Overall Study|Non-compliance|1|||
162010082|NCT00918255|585093608|FG001|Overall Study|Non-compliance|0|||
162010083|NCT00918255|585093609|FG002|Overall Study|Non-compliance|0|||
162010084|NCT00918255|585093607|FG000|Overall Study|Investigator discretion|1|||
162010085|NCT00918255|585093608|FG001|Overall Study|Investigator discretion|0|||
162010086|NCT00918255|585093609|FG002|Overall Study|Investigator discretion|0|||
162010087|NCT02038933|585093642|FG000|Overall Study|Disease progression|104|||
162010088|NCT02038933|585093642|FG000|Overall Study|Study drug toxicity|6|||
162010089|NCT02038933|585093642|FG000|Overall Study|Adverse event unrelated to study drug|6|||
162010090|NCT02038933|585093642|FG000|Overall Study|Participant request to discontinue treatment|2|||
162010091|NCT02038933|585093642|FG000|Overall Study|Lost to Follow-up|1|||
162010092|NCT02038933|585093642|FG000|Overall Study|Other reasons|2|||
162010093|NCT03250273|585093643|FG000|Overall Study|Disease Progression|2|||
162010094|NCT03250273|585093644|FG001|Overall Study|Disease Progression|11|||
162010095|NCT03250273|585093643|FG000|Overall Study|Death|0|||
162010096|NCT03250273|585093644|FG001|Overall Study|Death|1|||
162010097|NCT04154904|585093645|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
162010098|NCT04154904|585093646|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
162010099|NCT04154904|585093647|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
162010100|NCT02392624|585093648|FG000|Overall Study|Withdrawal by Subject|15|||
162010101|NCT02392624|585093649|FG001|Overall Study|Withdrawal by Subject|12|||
162010102|NCT02392624|585093650|FG002|Overall Study|Withdrawal by Subject|9|||
162010103|NCT02392624|585093648|FG000|Overall Study|Adverse Event|4|||
162010104|NCT02392624|585093649|FG001|Overall Study|Adverse Event|1|||
162010105|NCT02392624|585093650|FG002|Overall Study|Adverse Event|2|||
162010106|NCT02392624|585093648|FG000|Overall Study|Pregnancy|1|||
162010107|NCT02392624|585093649|FG001|Overall Study|Pregnancy|0|||
162010108|NCT02392624|585093650|FG002|Overall Study|Pregnancy|0|||
162010109|NCT02392624|585093648|FG000|Overall Study|Protocol Violation|0|||
162010110|NCT02392624|585093649|FG001|Overall Study|Protocol Violation|0|||
162010111|NCT02392624|585093650|FG002|Overall Study|Protocol Violation|1|||
162010112|NCT02392624|585093648|FG000|Overall Study|Sponsor/Investigator Decision|2|||
162010113|NCT02392624|585093649|FG001|Overall Study|Sponsor/Investigator Decision|1|||
161784360|NCT01462695|584255458|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
161784361|NCT03196791|584255461|FG000|Overall Study|Protocol Violation|7|||
161784362|NCT03196791|584255462|FG001|Overall Study|Protocol Violation|3|||
161784363|NCT03196791|584255461|FG000|Overall Study|Withdrawal by Subject|3|||
161784364|NCT03196791|584255462|FG001|Overall Study|Withdrawal by Subject|2|||
161784365|NCT00051636|584255464|FG000|Period 1 - Core|Adverse Event|2|||
161784366|NCT00051636|584255465|FG001|Period 1 - Core|Adverse Event|2|||
161784367|NCT00051636|584255464|FG000|Period 1 - Core|Protocol Violation|1|||
161784368|NCT00051636|584255465|FG001|Period 1 - Core|Protocol Violation|0|||
161784369|NCT00051636|584255464|FG000|Period 1 - Core|Withdrawal by Subject|1|||
161784370|NCT00051636|584255465|FG001|Period 1 - Core|Withdrawal by Subject|2|||
161784371|NCT00051636|584255464|FG000|Period 1 - Core|Lost to Follow-up|0|||
161784372|NCT00051636|584255465|FG001|Period 1 - Core|Lost to Follow-up|2|||
161784373|NCT00051636|584255464|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
161784374|NCT00051636|584255465|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
161784375|NCT00051636|584255464|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
161784376|NCT00051636|584255465|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
161784377|NCT00051636|584255464|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
161784378|NCT00051636|584255465|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
161784379|NCT00051636|584255464|FG000|Period 2- Extended Observation Period|Death|4|||
161784380|NCT00051636|584255465|FG001|Period 2- Extended Observation Period|Death|5|||
161784381|NCT00051636|584255464|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
161784382|NCT00051636|584255465|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
161784383|NCT02340078|584255466|FG000|Overall Study|Protocol Violation|1|||
161784384|NCT00944125|584255469|FG000|3 to 6 Months|Withdrawal by Subject|0|||
161784385|NCT00944125|584255470|FG001|3 to 6 Months|Withdrawal by Subject|2|||
161784386|NCT00944125|584255469|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
161784387|NCT00944125|584255470|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
161784388|NCT03338673|584255473|FG000|Overall Study|Lost to Follow-up|1|||
161784389|NCT03338673|584255474|FG001|Overall Study|Lost to Follow-up|1|||
161784390|NCT05788237|584255477|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
161784391|NCT05788237|584255478|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
161784392|NCT05788237|584255479|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
161784393|NCT05788237|584255480|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
161784394|NCT05788237|584255477|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
161784395|NCT05788237|584255478|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
161784396|NCT05788237|584255479|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
161784397|NCT05788237|584255480|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
161784398|NCT05788237|584255477|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
161784399|NCT05788237|584255478|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
161784400|NCT05788237|584255479|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
161784401|NCT05788237|584255480|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
161784402|NCT05788237|584255477|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
161784403|NCT05788237|584255478|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
161784404|NCT05788237|584255479|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
161784405|NCT05788237|584255480|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
161784406|NCT05788237|584255477|FG000|SSA (Approximately 2 Months)|Death|0|||
161784407|NCT05788237|584255478|FG001|SSA (Approximately 2 Months)|Death|1|||
161784408|NCT05788237|584255479|FG002|SSA (Approximately 2 Months)|Death|0|||
161784409|NCT05788237|584255480|FG003|SSA (Approximately 2 Months)|Death|0|||
161784410|NCT05788237|584255477|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
161784411|NCT05788237|584255478|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
161784412|NCT05788237|584255479|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
161784413|NCT05788237|584255480|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
161784414|NCT05788237|584255477|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
161784415|NCT05788237|584255478|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
161784416|NCT05788237|584255479|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
161784417|NCT05788237|584255480|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
161784418|NCT05788237|584255477|FG000|SSB (Approximately 1 Month)|Other|0|||
161784419|NCT05788237|584255478|FG001|SSB (Approximately 1 Month)|Other|0|||
161784420|NCT05788237|584255479|FG002|SSB (Approximately 1 Month)|Other|0|||
161784421|NCT05788237|584255480|FG003|SSB (Approximately 1 Month)|Other|1|||
161784422|NCT04335110|584257319|FG000|Overall Study|Withdrawal by Subject|1|||
161784423|NCT04335110|584257320|FG001|Overall Study|Withdrawal by Subject|1|||
161784424|NCT04335110|584257319|FG000|Overall Study|Death|0|||
161784425|NCT04335110|584257320|FG001|Overall Study|Death|1|||
161898122|NCT00572455|584675574|FG010|Stage I (14 Days)|Adverse Event|0|||
161784426|NCT03451331|584257328|FG000|Overall Study|Withdrawal by Subject|1|||
161784427|NCT03451331|584257329|FG001|Overall Study|Withdrawal by Subject|0|||
161898123|NCT00572455|584675575|FG011|Stage I (14 Days)|Adverse Event|0|||
162242031|NCT02616562|585939078|FG010|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161784428|NCT03451331|584257328|FG000|Overall Study|Unable to start treatment.|1|||
161784429|NCT03451331|584257329|FG001|Overall Study|Unable to start treatment.|1|||
161784430|NCT00618774|584257333|FG000|Overall Study|Adverse Event|5|||
161784431|NCT00618774|584257334|FG001|Overall Study|Adverse Event|3|||
161784432|NCT00618774|584257333|FG000|Overall Study|Withdrawal by Subject|1|||
161784433|NCT00618774|584257334|FG001|Overall Study|Withdrawal by Subject|0|||
161784434|NCT02424565|584257335|FG000|Period 1 (D0)|Protocol Violation|0|||
161784435|NCT02424565|584257336|FG001|Period 1 (D0)|Protocol Violation|1|||
161784436|NCT01808209|584257337|FG000|Overall Study|Lost to Follow-up|0|||
161784437|NCT01808209|584257338|FG001|Overall Study|Lost to Follow-up|1|||
161784438|NCT04228302|584257345|FG000|Overall Study|Adverse Event|0|||
161898124|NCT00572455|584675576|FG012|Stage I (14 Days)|Adverse Event|0|||
161898125|NCT00572455|584675577|FG013|Stage I (14 Days)|Adverse Event|0|||
161784439|NCT04228302|584257346|FG001|Overall Study|Adverse Event|0|||
161784440|NCT04228302|584257347|FG002|Overall Study|Adverse Event|0|||
161898126|NCT00572455|584675564|FG000|Stage I (14 Days)|Other|0|||
161898127|NCT00572455|584675565|FG001|Stage I (14 Days)|Other|0|||
161898128|NCT00572455|584675566|FG002|Stage I (14 Days)|Other|0|||
161898129|NCT00572455|584675567|FG003|Stage I (14 Days)|Other|0|||
161898130|NCT00572455|584675568|FG004|Stage I (14 Days)|Other|1|||
161898131|NCT00572455|584675569|FG005|Stage I (14 Days)|Other|0|||
161898132|NCT00572455|584675570|FG006|Stage I (14 Days)|Other|0|||
161898133|NCT00572455|584675571|FG007|Stage I (14 Days)|Other|0|||
161898134|NCT00572455|584675572|FG008|Stage I (14 Days)|Other|0|||
161898135|NCT00572455|584675573|FG009|Stage I (14 Days)|Other|0|||
161898136|NCT00572455|584675574|FG010|Stage I (14 Days)|Other|0|||
161898137|NCT00572455|584675575|FG011|Stage I (14 Days)|Other|0|||
161898138|NCT00572455|584675576|FG012|Stage I (14 Days)|Other|0|||
161898139|NCT00572455|584675577|FG013|Stage I (14 Days)|Other|0|||
161898140|NCT00572455|584675564|FG000|Stage II (28 Days)|Adverse Event|0|||
161898141|NCT00572455|584675565|FG001|Stage II (28 Days)|Adverse Event|0|||
161898142|NCT00572455|584675566|FG002|Stage II (28 Days)|Adverse Event|0|||
161898143|NCT00572455|584675567|FG003|Stage II (28 Days)|Adverse Event|0|||
161898144|NCT00572455|584675568|FG004|Stage II (28 Days)|Adverse Event|0|||
161898145|NCT00572455|584675569|FG005|Stage II (28 Days)|Adverse Event|0|||
161898146|NCT00572455|584675570|FG006|Stage II (28 Days)|Adverse Event|0|||
161898147|NCT00572455|584675571|FG007|Stage II (28 Days)|Adverse Event|0|||
161898148|NCT00572455|584675572|FG008|Stage II (28 Days)|Adverse Event|1|||
161898149|NCT00572455|584675573|FG009|Stage II (28 Days)|Adverse Event|3|||
161898150|NCT00572455|584675574|FG010|Stage II (28 Days)|Adverse Event|3|||
161898151|NCT00572455|584675575|FG011|Stage II (28 Days)|Adverse Event|4|||
161898152|NCT00572455|584675576|FG012|Stage II (28 Days)|Adverse Event|5|||
161898153|NCT00572455|584675577|FG013|Stage II (28 Days)|Adverse Event|1|||
161898154|NCT00572455|584675564|FG000|Stage II (28 Days)|Death|0|||
161898155|NCT00572455|584675565|FG001|Stage II (28 Days)|Death|0|||
161898156|NCT00572455|584675566|FG002|Stage II (28 Days)|Death|0|||
161898157|NCT00572455|584675567|FG003|Stage II (28 Days)|Death|0|||
161898158|NCT00572455|584675568|FG004|Stage II (28 Days)|Death|0|||
161898159|NCT00572455|584675569|FG005|Stage II (28 Days)|Death|0|||
161898160|NCT00572455|584675570|FG006|Stage II (28 Days)|Death|0|||
161898161|NCT00572455|584675571|FG007|Stage II (28 Days)|Death|0|||
161898162|NCT00572455|584675572|FG008|Stage II (28 Days)|Death|1|||
161898163|NCT00572455|584675573|FG009|Stage II (28 Days)|Death|0|||
161898164|NCT00572455|584675574|FG010|Stage II (28 Days)|Death|0|||
161898165|NCT00572455|584675575|FG011|Stage II (28 Days)|Death|0|||
161898166|NCT00572455|584675576|FG012|Stage II (28 Days)|Death|0|||
161898167|NCT00572455|584675577|FG013|Stage II (28 Days)|Death|0|||
161898168|NCT00572455|584675564|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
161898169|NCT00572455|584675565|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
161898170|NCT00572455|584675566|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
161898171|NCT00572455|584675567|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
161898172|NCT00572455|584675568|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
161898173|NCT00572455|584675569|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
161898174|NCT00572455|584675570|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
161898175|NCT00572455|584675571|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
161898176|NCT00572455|584675572|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
161898177|NCT00572455|584675573|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
161898178|NCT00572455|584675574|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
161898179|NCT00572455|584675575|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
161898180|NCT00572455|584675576|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
161898181|NCT00572455|584675577|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
161898182|NCT00572455|584675564|FG000|Stage II (28 Days)|Other|0|||
161898183|NCT00572455|584675565|FG001|Stage II (28 Days)|Other|0|||
161898184|NCT00572455|584675566|FG002|Stage II (28 Days)|Other|0|||
161898185|NCT00572455|584675567|FG003|Stage II (28 Days)|Other|0|||
161898186|NCT00572455|584675568|FG004|Stage II (28 Days)|Other|0|||
161898187|NCT00572455|584675569|FG005|Stage II (28 Days)|Other|0|||
161898188|NCT00572455|584675570|FG006|Stage II (28 Days)|Other|0|||
161898189|NCT00572455|584675571|FG007|Stage II (28 Days)|Other|0|||
162010114|NCT02392624|585093650|FG002|Overall Study|Sponsor/Investigator Decision|0|||
162010115|NCT02392624|585093648|FG000|Overall Study|Other|49|||
162010116|NCT02392624|585093649|FG001|Overall Study|Other|1|||
162010117|NCT02392624|585093650|FG002|Overall Study|Other|1|||
162010118|NCT00936715|585093651|FG000|Overall Study|Investigators Discretion|1|||
162010119|NCT00936715|585093651|FG000|Overall Study|Protocol Violation|1|||
162010120|NCT00936715|585093651|FG000|Overall Study|Safety or Tolerability Reasons|4|||
162010121|NCT03841604|585093654|FG000|Overall Study|Withdrawal by Subject|3|||
162010122|NCT03841604|585093655|FG001|Overall Study|Withdrawal by Subject|1|||
162010123|NCT03841604|585093654|FG000|Overall Study|Adverse Event|4|||
162010124|NCT03841604|585093655|FG001|Overall Study|Adverse Event|2|||
162010125|NCT03841604|585093654|FG000|Overall Study|Physician Decision|1|||
162010126|NCT03841604|585093655|FG001|Overall Study|Physician Decision|0|||
162010127|NCT03877510|585093656|FG000|Overall Study|Death|6|||
162010128|NCT03877510|585093656|FG000|Overall Study|Lost to Follow-up|2|||
162010129|NCT03877510|585093656|FG000|Overall Study|Non-compliance with study drug|2|||
162010130|NCT03877510|585093656|FG000|Overall Study|Lack of Efficacy|14|||
162010131|NCT03877510|585093656|FG000|Overall Study|Adverse Event|20|||
162010132|NCT03877510|585093656|FG000|Overall Study|Withdrawal by Subject|22|||
162010133|NCT03877510|585093656|FG000|Overall Study|Miscellaneous|1|||
162010134|NCT01337960|585093657|FG000|Overall Study|Lost to Follow-up|1|||
162010135|NCT01337960|585093658|FG001|Overall Study|Lost to Follow-up|0|||
162010136|NCT01337960|585093659|FG002|Overall Study|Lost to Follow-up|0|||
162010137|NCT01337960|585093657|FG000|Overall Study|Withdrawal by Subject|1|||
162010138|NCT01337960|585093658|FG001|Overall Study|Withdrawal by Subject|0|||
162010139|NCT01337960|585093659|FG002|Overall Study|Withdrawal by Subject|0|||
162010140|NCT03763877|585093661|FG000|Overall Study|Withdrawal by Subject|3|||
162010141|NCT03763877|585093662|FG001|Overall Study|Withdrawal by Subject|1|||
162010142|NCT03763877|585093663|FG002|Overall Study|Withdrawal by Subject|3|||
162010143|NCT03763877|585093664|FG003|Overall Study|Withdrawal by Subject|4|||
162010144|NCT03763877|585093661|FG000|Overall Study|Adverse Event|1|||
162010145|NCT03763877|585093662|FG001|Overall Study|Adverse Event|1|||
162010146|NCT03763877|585093663|FG002|Overall Study|Adverse Event|3|||
162010147|NCT03763877|585093664|FG003|Overall Study|Adverse Event|1|||
162010148|NCT03763877|585093661|FG000|Overall Study|Protocol Violation|1|||
162010149|NCT03763877|585093662|FG001|Overall Study|Protocol Violation|1|||
162010150|NCT03763877|585093663|FG002|Overall Study|Protocol Violation|0|||
162010151|NCT03763877|585093664|FG003|Overall Study|Protocol Violation|0|||
162010152|NCT03763877|585093661|FG000|Overall Study|Lost to Follow-up|0|||
162010153|NCT03763877|585093662|FG001|Overall Study|Lost to Follow-up|1|||
162010154|NCT03763877|585093663|FG002|Overall Study|Lost to Follow-up|1|||
162010155|NCT03763877|585093664|FG003|Overall Study|Lost to Follow-up|0|||
162010156|NCT03040336|585093665|FG000|Overall Study|Death|1|||
162010157|NCT03040336|585093666|FG001|Overall Study|Death|0|||
162010158|NCT03040336|585093665|FG000|Overall Study|Withdrawal by Subject|2|||
162010159|NCT03040336|585093666|FG001|Overall Study|Withdrawal by Subject|3|||
162010160|NCT01774721|585093669|FG000|Overall Study|Death|133|||
162010161|NCT01774721|585093670|FG001|Overall Study|Death|152|||
162010162|NCT01774721|585093669|FG000|Overall Study|Withdrawal by Subject|20|||
162010163|NCT01774721|585093670|FG001|Overall Study|Withdrawal by Subject|14|||
162010164|NCT01774721|585093669|FG000|Overall Study|Lost to Follow-up|6|||
162010165|NCT01774721|585093670|FG001|Overall Study|Lost to Follow-up|7|||
162010166|NCT01774721|585093669|FG000|Overall Study|Did not meet eligibility criteria|0|||
162010167|NCT01774721|585093670|FG001|Overall Study|Did not meet eligibility criteria|3|||
162010168|NCT01774721|585093669|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
162010169|NCT01774721|585093670|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
162010170|NCT01774721|585093669|FG000|Overall Study|Study terminated by sponsor|5|||
162010171|NCT01774721|585093670|FG001|Overall Study|Study terminated by sponsor|0|||
162010172|NCT01774721|585093669|FG000|Overall Study|Disease progression|5|||
162010173|NCT01774721|585093670|FG001|Overall Study|Disease progression|0|||
162010174|NCT00084136|585093681|FG000|PI Comparison|Death|10|||
162010175|NCT00084136|585093682|FG001|PI Comparison|Death|9|||
162010176|NCT00084136|585093683|FG002|PI Comparison|Death|0|||
162010177|NCT00084136|585093681|FG000|PI Comparison|Lost to Follow-up|11|||
162010178|NCT00084136|585093682|FG001|PI Comparison|Lost to Follow-up|8|||
162010179|NCT00084136|585093683|FG002|PI Comparison|Lost to Follow-up|0|||
162010180|NCT00084136|585093681|FG000|PI Comparison|Withdrawal by Subject|33|||
162010181|NCT00084136|585093682|FG001|PI Comparison|Withdrawal by Subject|30|||
162010182|NCT00084136|585093683|FG002|PI Comparison|Withdrawal by Subject|0|||
162010183|NCT00084136|585093681|FG000|PI Comparison|Clinic site closed|1|||
162010184|NCT00084136|585093682|FG001|PI Comparison|Clinic site closed|0|||
162010185|NCT00084136|585093683|FG002|PI Comparison|Clinic site closed|0|||
162010186|NCT00084136|585093681|FG000|NRTI Comparison|Death|20|||
162010187|NCT00084136|585093682|FG001|NRTI Comparison|Death|0|||
162010188|NCT00084136|585093683|FG002|NRTI Comparison|Death|18|||
162010189|NCT00084136|585093681|FG000|NRTI Comparison|Lost to Follow-up|14|||
162010190|NCT00084136|585093682|FG001|NRTI Comparison|Lost to Follow-up|0|||
162010191|NCT00084136|585093683|FG002|NRTI Comparison|Lost to Follow-up|12|||
162010192|NCT00084136|585093681|FG000|NRTI Comparison|Withdrawal by Subject|54|||
162010193|NCT00084136|585093682|FG001|NRTI Comparison|Withdrawal by Subject|0|||
162010194|NCT00084136|585093683|FG002|NRTI Comparison|Withdrawal by Subject|38|||
162010195|NCT00084136|585093681|FG000|NRTI Comparison|Clinic site closed|12|||
162010196|NCT00084136|585093682|FG001|NRTI Comparison|Clinic site closed|0|||
162010197|NCT00084136|585093683|FG002|NRTI Comparison|Clinic site closed|14|||
162010198|NCT00084136|585093681|FG000|NRTI Comparison|Not reason above|1|||
162010199|NCT00084136|585093682|FG001|NRTI Comparison|Not reason above|0|||
162010200|NCT00084136|585093683|FG002|NRTI Comparison|Not reason above|0|||
162010201|NCT01524796|585093684|FG000|Overall Study|Adverse Event|13|||
162010202|NCT01524796|585093684|FG000|Overall Study|Lack of Efficacy|3|||
162010203|NCT01524796|585093684|FG000|Overall Study|Lost to Follow-up|1|||
162010204|NCT01524796|585093684|FG000|Overall Study|The price|1|||
162010205|NCT01524796|585093684|FG000|Overall Study|Withdrawal by Subject|4|||
162010206|NCT01524796|585093684|FG000|Overall Study|Move|1|||
162010207|NCT01524796|585093684|FG000|Overall Study|Deterioration of pains|1|||
162010208|NCT01524796|585093684|FG000|Overall Study|Gall stone surgery|1|||
162010209|NCT01524796|585093684|FG000|Overall Study|Nervous about confidentiality|1|||
162010210|NCT01524796|585093684|FG000|Overall Study|Switch to carbamazapine|1|||
162010211|NCT01524796|585093684|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
162122909|NCT02291289|585502366|FG010|Induction Treatment|Withdrawal by Subject|0|||
162122910|NCT02291289|585502367|FG011|Induction Treatment|Withdrawal by Subject|0|||
162122911|NCT02291289|585502368|FG012|Induction Treatment|Withdrawal by Subject|0|||
162122912|NCT02291289|585502356|FG000|Induction Treatment|Adverse Event|0|||
162122913|NCT02291289|585502357|FG001|Induction Treatment|Adverse Event|0|||
162122914|NCT02291289|585502358|FG002|Induction Treatment|Adverse Event|0|||
162122915|NCT02291289|585502359|FG003|Induction Treatment|Adverse Event|3|||
162122916|NCT02291289|585502360|FG004|Induction Treatment|Adverse Event|0|||
162122917|NCT02291289|585502361|FG005|Induction Treatment|Adverse Event|0|||
162122918|NCT02291289|585502362|FG006|Induction Treatment|Adverse Event|0|||
162122919|NCT02291289|585502363|FG007|Induction Treatment|Adverse Event|0|||
162122920|NCT02291289|585502364|FG008|Induction Treatment|Adverse Event|0|||
162122921|NCT02291289|585502365|FG009|Induction Treatment|Adverse Event|1|||
162122922|NCT02291289|585502366|FG010|Induction Treatment|Adverse Event|0|||
162122923|NCT02291289|585502367|FG011|Induction Treatment|Adverse Event|0|||
162122924|NCT02291289|585502368|FG012|Induction Treatment|Adverse Event|0|||
162122925|NCT02291289|585502356|FG000|Induction Treatment|Death|25|||
162122926|NCT02291289|585502357|FG001|Induction Treatment|Death|0|||
162122927|NCT02291289|585502358|FG002|Induction Treatment|Death|0|||
162122928|NCT02291289|585502359|FG003|Induction Treatment|Death|111|||
162122929|NCT02291289|585502360|FG004|Induction Treatment|Death|0|||
162122930|NCT02291289|585502361|FG005|Induction Treatment|Death|0|||
162122931|NCT02291289|585502362|FG006|Induction Treatment|Death|1|||
162122932|NCT02291289|585502363|FG007|Induction Treatment|Death|0|||
162122933|NCT02291289|585502364|FG008|Induction Treatment|Death|0|||
162122934|NCT02291289|585502365|FG009|Induction Treatment|Death|82|||
162122935|NCT02291289|585502366|FG010|Induction Treatment|Death|0|||
162122936|NCT02291289|585502367|FG011|Induction Treatment|Death|0|||
162122937|NCT02291289|585502368|FG012|Induction Treatment|Death|0|||
162122938|NCT02291289|585502356|FG000|Induction Treatment|Lost to Follow-up|1|||
162122939|NCT02291289|585502357|FG001|Induction Treatment|Lost to Follow-up|0|||
162122940|NCT02291289|585502358|FG002|Induction Treatment|Lost to Follow-up|0|||
162122941|NCT02291289|585502359|FG003|Induction Treatment|Lost to Follow-up|12|||
162122942|NCT02291289|585502360|FG004|Induction Treatment|Lost to Follow-up|0|||
162122943|NCT02291289|585502361|FG005|Induction Treatment|Lost to Follow-up|0|||
162122944|NCT02291289|585502362|FG006|Induction Treatment|Lost to Follow-up|0|||
162122945|NCT02291289|585502363|FG007|Induction Treatment|Lost to Follow-up|0|||
162122946|NCT02291289|585502364|FG008|Induction Treatment|Lost to Follow-up|0|||
162122947|NCT02291289|585502365|FG009|Induction Treatment|Lost to Follow-up|9|||
162122948|NCT02291289|585502366|FG010|Induction Treatment|Lost to Follow-up|0|||
162122949|NCT02291289|585502367|FG011|Induction Treatment|Lost to Follow-up|0|||
161784441|NCT04228302|584257348|FG003|Overall Study|Adverse Event|0|||
161784442|NCT04228302|584257349|FG004|Overall Study|Adverse Event|1|||
162122950|NCT02291289|585502368|FG012|Induction Treatment|Lost to Follow-up|0|||
161784443|NCT04228302|584257350|FG005|Overall Study|Adverse Event|0|||
162122951|NCT02291289|585502356|FG000|Induction Treatment|Non-Compliance|0|||
162122952|NCT02291289|585502357|FG001|Induction Treatment|Non-Compliance|0|||
162122953|NCT02291289|585502358|FG002|Induction Treatment|Non-Compliance|0|||
162122954|NCT02291289|585502359|FG003|Induction Treatment|Non-Compliance|1|||
162122955|NCT02291289|585502360|FG004|Induction Treatment|Non-Compliance|0|||
161784444|NCT00685919|584257351|FG000|Overall Study|Withdrawal by Subject|0|||
161784445|NCT00685919|584257352|FG001|Overall Study|Withdrawal by Subject|0|||
162010212|NCT03938259|585093686|FG000|Overall Study|unable to establish baseline for ventilation|1|||
162010213|NCT03938259|585093687|FG001|Overall Study|unable to establish baseline for ventilation|1|||
162010214|NCT01213472|585093688|FG000|Overall Study|Recurrence/Progressive disease|25|||
162010215|NCT01213472|585093688|FG000|Overall Study|Withdrawal by Subject|1|||
162010216|NCT01213472|585093688|FG000|Overall Study|Physician Decision|1|||
162122956|NCT02291289|585502361|FG005|Induction Treatment|Non-Compliance|0|||
162122957|NCT02291289|585502362|FG006|Induction Treatment|Non-Compliance|0|||
162122958|NCT02291289|585502363|FG007|Induction Treatment|Non-Compliance|0|||
162122959|NCT02291289|585502364|FG008|Induction Treatment|Non-Compliance|0|||
162122960|NCT02291289|585502365|FG009|Induction Treatment|Non-Compliance|1|||
162122961|NCT02291289|585502366|FG010|Induction Treatment|Non-Compliance|0|||
162122962|NCT02291289|585502367|FG011|Induction Treatment|Non-Compliance|0|||
162122963|NCT02291289|585502368|FG012|Induction Treatment|Non-Compliance|0|||
162122964|NCT02291289|585502356|FG000|Induction Treatment|Reason Not Specified|0|||
162122965|NCT02291289|585502357|FG001|Induction Treatment|Reason Not Specified|0|||
162122966|NCT02291289|585502358|FG002|Induction Treatment|Reason Not Specified|0|||
162122967|NCT02291289|585502359|FG003|Induction Treatment|Reason Not Specified|4|||
162122968|NCT02291289|585502360|FG004|Induction Treatment|Reason Not Specified|0|||
162122969|NCT02291289|585502361|FG005|Induction Treatment|Reason Not Specified|0|||
162122970|NCT02291289|585502362|FG006|Induction Treatment|Reason Not Specified|0|||
162122971|NCT02291289|585502363|FG007|Induction Treatment|Reason Not Specified|0|||
162122972|NCT02291289|585502364|FG008|Induction Treatment|Reason Not Specified|0|||
162122973|NCT02291289|585502365|FG009|Induction Treatment|Reason Not Specified|7|||
162122974|NCT02291289|585502366|FG010|Induction Treatment|Reason Not Specified|0|||
162122975|NCT02291289|585502367|FG011|Induction Treatment|Reason Not Specified|0|||
162122976|NCT02291289|585502368|FG012|Induction Treatment|Reason Not Specified|0|||
162122977|NCT02291289|585502356|FG000|Induction Treatment|Physician Decision|0|||
162122978|NCT02291289|585502357|FG001|Induction Treatment|Physician Decision|0|||
162122979|NCT02291289|585502358|FG002|Induction Treatment|Physician Decision|0|||
162122980|NCT02291289|585502359|FG003|Induction Treatment|Physician Decision|3|||
162122981|NCT02291289|585502360|FG004|Induction Treatment|Physician Decision|0|||
162122982|NCT02291289|585502361|FG005|Induction Treatment|Physician Decision|0|||
162122983|NCT02291289|585502362|FG006|Induction Treatment|Physician Decision|0|||
162122984|NCT02291289|585502363|FG007|Induction Treatment|Physician Decision|0|||
162122985|NCT02291289|585502364|FG008|Induction Treatment|Physician Decision|0|||
162122986|NCT02291289|585502365|FG009|Induction Treatment|Physician Decision|1|||
162122987|NCT02291289|585502366|FG010|Induction Treatment|Physician Decision|0|||
162122988|NCT02291289|585502367|FG011|Induction Treatment|Physician Decision|0|||
162122989|NCT02291289|585502368|FG012|Induction Treatment|Physician Decision|0|||
162122990|NCT02291289|585502356|FG000|Induction Treatment|Protocol Violation|0|||
162122991|NCT02291289|585502357|FG001|Induction Treatment|Protocol Violation|0|||
162122992|NCT02291289|585502358|FG002|Induction Treatment|Protocol Violation|0|||
162122993|NCT02291289|585502359|FG003|Induction Treatment|Protocol Violation|3|||
162122994|NCT02291289|585502360|FG004|Induction Treatment|Protocol Violation|0|||
162122995|NCT02291289|585502361|FG005|Induction Treatment|Protocol Violation|0|||
162122996|NCT02291289|585502362|FG006|Induction Treatment|Protocol Violation|0|||
162122997|NCT02291289|585502363|FG007|Induction Treatment|Protocol Violation|0|||
162122998|NCT02291289|585502364|FG008|Induction Treatment|Protocol Violation|0|||
162122999|NCT02291289|585502365|FG009|Induction Treatment|Protocol Violation|2|||
162123000|NCT02291289|585502366|FG010|Induction Treatment|Protocol Violation|0|||
162123001|NCT02291289|585502367|FG011|Induction Treatment|Protocol Violation|0|||
162123002|NCT02291289|585502368|FG012|Induction Treatment|Protocol Violation|0|||
162123003|NCT02291289|585502356|FG000|Induction Treatment|Missing|4|||
162123004|NCT02291289|585502357|FG001|Induction Treatment|Missing|0|||
162123005|NCT02291289|585502358|FG002|Induction Treatment|Missing|0|||
162123006|NCT02291289|585502359|FG003|Induction Treatment|Missing|14|||
162123007|NCT02291289|585502360|FG004|Induction Treatment|Missing|0|||
162123008|NCT02291289|585502361|FG005|Induction Treatment|Missing|0|||
162010217|NCT02435992|585093691|FG000|Overall Study|non compliance with protocol|2|||
162010218|NCT02435992|585093692|FG001|Overall Study|non compliance with protocol|0|||
162010219|NCT02435992|585093693|FG002|Overall Study|non compliance with protocol|1|||
162010220|NCT02435992|585093694|FG003|Overall Study|non compliance with protocol|0|||
162010221|NCT02435992|585093695|FG004|Overall Study|non compliance with protocol|0|||
162010222|NCT02435992|585093691|FG000|Overall Study|Adverse Event|11|||
162010223|NCT02435992|585093692|FG001|Overall Study|Adverse Event|6|||
162010224|NCT02435992|585093693|FG002|Overall Study|Adverse Event|12|||
162010225|NCT02435992|585093694|FG003|Overall Study|Adverse Event|0|||
162010226|NCT02435992|585093695|FG004|Overall Study|Adverse Event|0|||
162010227|NCT02435992|585093691|FG000|Overall Study|Lack of Efficacy|4|||
162010228|NCT02435992|585093692|FG001|Overall Study|Lack of Efficacy|10|||
162010229|NCT02435992|585093693|FG002|Overall Study|Lack of Efficacy|9|||
161784446|NCT00685919|584257353|FG002|Overall Study|Withdrawal by Subject|1|||
162010230|NCT02435992|585093694|FG003|Overall Study|Lack of Efficacy|0|||
162010231|NCT02435992|585093695|FG004|Overall Study|Lack of Efficacy|0|||
162010232|NCT02435992|585093691|FG000|Overall Study|Withdrawal by Subject|10|||
162123009|NCT02291289|585502362|FG006|Induction Treatment|Missing|0|||
161784447|NCT00685919|584257354|FG003|Overall Study|Withdrawal by Subject|0|||
161784448|NCT00685919|584257351|FG000|Overall Study|Physician Decision|1|||
162010233|NCT02435992|585093692|FG001|Overall Study|Withdrawal by Subject|8|||
162010234|NCT02435992|585093693|FG002|Overall Study|Withdrawal by Subject|20|||
162010235|NCT02435992|585093694|FG003|Overall Study|Withdrawal by Subject|0|||
162123010|NCT02291289|585502363|FG007|Induction Treatment|Missing|0|||
162123011|NCT02291289|585502364|FG008|Induction Treatment|Missing|0|||
162123012|NCT02291289|585502365|FG009|Induction Treatment|Missing|54|||
162123013|NCT02291289|585502366|FG010|Induction Treatment|Missing|0|||
162123014|NCT02291289|585502367|FG011|Induction Treatment|Missing|0|||
162123015|NCT02291289|585502368|FG012|Induction Treatment|Missing|0|||
162123016|NCT02291289|585502356|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162123017|NCT02291289|585502357|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162123018|NCT02291289|585502358|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162123019|NCT02291289|585502359|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162123020|NCT02291289|585502360|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
162123021|NCT02291289|585502361|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
161784449|NCT00685919|584257352|FG001|Overall Study|Physician Decision|0|||
162123022|NCT02291289|585502362|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162123023|NCT02291289|585502363|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162123024|NCT02291289|585502364|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162123025|NCT02291289|585502365|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162123026|NCT02291289|585502366|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
162123027|NCT02291289|585502367|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
162123028|NCT02291289|585502368|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162123029|NCT02291289|585502356|FG000|Maintenance Treatment Phase|Death|0|||
162123030|NCT02291289|585502357|FG001|Maintenance Treatment Phase|Death|29|||
162123031|NCT02291289|585502358|FG002|Maintenance Treatment Phase|Death|16|||
162123032|NCT02291289|585502359|FG003|Maintenance Treatment Phase|Death|0|||
162123033|NCT02291289|585502360|FG004|Maintenance Treatment Phase|Death|188|||
162123034|NCT02291289|585502361|FG005|Maintenance Treatment Phase|Death|107|||
162123035|NCT02291289|585502362|FG006|Maintenance Treatment Phase|Death|0|||
162123036|NCT02291289|585502363|FG007|Maintenance Treatment Phase|Death|1|||
162123037|NCT02291289|585502364|FG008|Maintenance Treatment Phase|Death|1|||
162123038|NCT02291289|585502365|FG009|Maintenance Treatment Phase|Death|0|||
162123039|NCT02291289|585502366|FG010|Maintenance Treatment Phase|Death|46|||
162123040|NCT02291289|585502367|FG011|Maintenance Treatment Phase|Death|19|||
162123041|NCT02291289|585502368|FG012|Maintenance Treatment Phase|Death|0|||
162123042|NCT02291289|585502356|FG000|Maintenance Treatment Phase|Adverse Event|0|||
162123043|NCT02291289|585502357|FG001|Maintenance Treatment Phase|Adverse Event|0|||
162123044|NCT02291289|585502358|FG002|Maintenance Treatment Phase|Adverse Event|0|||
162123045|NCT02291289|585502359|FG003|Maintenance Treatment Phase|Adverse Event|0|||
162123046|NCT02291289|585502360|FG004|Maintenance Treatment Phase|Adverse Event|1|||
162123047|NCT02291289|585502361|FG005|Maintenance Treatment Phase|Adverse Event|1|||
162123048|NCT02291289|585502362|FG006|Maintenance Treatment Phase|Adverse Event|0|||
162123049|NCT02291289|585502363|FG007|Maintenance Treatment Phase|Adverse Event|0|||
162123050|NCT02291289|585502364|FG008|Maintenance Treatment Phase|Adverse Event|0|||
162123051|NCT02291289|585502365|FG009|Maintenance Treatment Phase|Adverse Event|0|||
162123052|NCT02291289|585502366|FG010|Maintenance Treatment Phase|Adverse Event|0|||
162123053|NCT02291289|585502367|FG011|Maintenance Treatment Phase|Adverse Event|0|||
162123054|NCT02291289|585502368|FG012|Maintenance Treatment Phase|Adverse Event|0|||
162123055|NCT02291289|585502356|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
162123056|NCT02291289|585502357|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
162123057|NCT02291289|585502358|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
162123058|NCT02291289|585502359|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
162123059|NCT02291289|585502360|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
162123060|NCT02291289|585502361|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
162123061|NCT02291289|585502362|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
162123062|NCT02291289|585502363|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
162123063|NCT02291289|585502364|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
162123064|NCT02291289|585502365|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
162123065|NCT02291289|585502366|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
162123066|NCT02291289|585502367|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
161784450|NCT00685919|584257353|FG002|Overall Study|Physician Decision|0|||
161784451|NCT00685919|584257354|FG003|Overall Study|Physician Decision|0|||
161784452|NCT00736333|584257355|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
161784453|NCT00736333|584257355|FG000|Overall Study|Data Missing|2|||
162123067|NCT02291289|585502368|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
162123068|NCT02291289|585502356|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
162123069|NCT02291289|585502357|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
162123070|NCT02291289|585502358|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
162123071|NCT02291289|585502359|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
162123072|NCT02291289|585502360|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
161784454|NCT00736333|584257355|FG000|Overall Study|Tumor Progression|75|||
162123073|NCT02291289|585502361|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
162123074|NCT02291289|585502362|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
162123075|NCT02291289|585502363|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
162123076|NCT02291289|585502364|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
162242032|NCT02616562|585939079|FG011|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161784455|NCT00736333|584257355|FG000|Overall Study|Toxicity|6|||
162123077|NCT02291289|585502365|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
162123078|NCT02291289|585502366|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
162123079|NCT02291289|585502367|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
162123080|NCT02291289|585502368|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
162123081|NCT02291289|585502356|FG000|Maintenance Treatment Phase|Physician Decision|0|||
162123082|NCT02291289|585502357|FG001|Maintenance Treatment Phase|Physician Decision|2|||
162123083|NCT02291289|585502358|FG002|Maintenance Treatment Phase|Physician Decision|0|||
162123084|NCT02291289|585502359|FG003|Maintenance Treatment Phase|Physician Decision|0|||
162123085|NCT02291289|585502360|FG004|Maintenance Treatment Phase|Physician Decision|3|||
162123086|NCT02291289|585502361|FG005|Maintenance Treatment Phase|Physician Decision|0|||
162123087|NCT02291289|585502362|FG006|Maintenance Treatment Phase|Physician Decision|0|||
162123088|NCT02291289|585502363|FG007|Maintenance Treatment Phase|Physician Decision|0|||
162123089|NCT02291289|585502364|FG008|Maintenance Treatment Phase|Physician Decision|0|||
162123090|NCT02291289|585502365|FG009|Maintenance Treatment Phase|Physician Decision|0|||
162123091|NCT02291289|585502366|FG010|Maintenance Treatment Phase|Physician Decision|1|||
162123092|NCT02291289|585502367|FG011|Maintenance Treatment Phase|Physician Decision|3|||
162123093|NCT02291289|585502368|FG012|Maintenance Treatment Phase|Physician Decision|0|||
162123094|NCT02291289|585502356|FG000|Maintenance Treatment Phase|Not Treated|0|||
162123095|NCT02291289|585502357|FG001|Maintenance Treatment Phase|Not Treated|0|||
162123096|NCT02291289|585502358|FG002|Maintenance Treatment Phase|Not Treated|2|||
162123097|NCT02291289|585502359|FG003|Maintenance Treatment Phase|Not Treated|0|||
162123098|NCT02291289|585502360|FG004|Maintenance Treatment Phase|Not Treated|0|||
162123099|NCT02291289|585502361|FG005|Maintenance Treatment Phase|Not Treated|0|||
162123100|NCT02291289|585502362|FG006|Maintenance Treatment Phase|Not Treated|0|||
162123101|NCT02291289|585502363|FG007|Maintenance Treatment Phase|Not Treated|0|||
162123102|NCT02291289|585502364|FG008|Maintenance Treatment Phase|Not Treated|0|||
162123103|NCT02291289|585502365|FG009|Maintenance Treatment Phase|Not Treated|0|||
162123104|NCT02291289|585502366|FG010|Maintenance Treatment Phase|Not Treated|0|||
162123105|NCT02291289|585502367|FG011|Maintenance Treatment Phase|Not Treated|0|||
162123106|NCT02291289|585502368|FG012|Maintenance Treatment Phase|Not Treated|0|||
162123107|NCT02291289|585502356|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162123108|NCT02291289|585502357|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
162123109|NCT02291289|585502358|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162123110|NCT02291289|585502359|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162123111|NCT02291289|585502360|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162123112|NCT02291289|585502361|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162123113|NCT02291289|585502362|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162123114|NCT02291289|585502363|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162123115|NCT02291289|585502364|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162123116|NCT02291289|585502365|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162123117|NCT02291289|585502366|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162123118|NCT02291289|585502367|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162123119|NCT02291289|585502368|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
162123120|NCT02291289|585502356|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
162123121|NCT02291289|585502357|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
162123122|NCT02291289|585502358|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
162123123|NCT02291289|585502359|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
162123124|NCT02291289|585502360|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
162123125|NCT02291289|585502361|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
162123126|NCT02291289|585502362|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
162123127|NCT02291289|585502363|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
162123128|NCT02291289|585502364|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
162123129|NCT02291289|585502365|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
162123130|NCT02291289|585502366|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
162123131|NCT02291289|585502367|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
162123132|NCT02291289|585502368|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
162123133|NCT02291289|585502356|FG000|Early Disease Progression|Death|0|||
162123134|NCT02291289|585502357|FG001|Early Disease Progression|Death|0|||
162123135|NCT02291289|585502358|FG002|Early Disease Progression|Death|0|||
162123136|NCT02291289|585502359|FG003|Early Disease Progression|Death|0|||
162123137|NCT02291289|585502360|FG004|Early Disease Progression|Death|0|||
162123138|NCT02291289|585502361|FG005|Early Disease Progression|Death|0|||
162123139|NCT02291289|585502362|FG006|Early Disease Progression|Death|0|||
162123140|NCT02291289|585502363|FG007|Early Disease Progression|Death|0|||
162123141|NCT02291289|585502364|FG008|Early Disease Progression|Death|0|||
162242033|NCT02616562|585939080|FG012|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
162123142|NCT02291289|585502365|FG009|Early Disease Progression|Death|0|||
162123143|NCT02291289|585502366|FG010|Early Disease Progression|Death|0|||
162123144|NCT02291289|585502367|FG011|Early Disease Progression|Death|0|||
162123145|NCT02291289|585502368|FG012|Early Disease Progression|Death|10|||
162123146|NCT02291289|585502356|FG000|Early Disease Progression|Lost to Follow-up|0|||
162123147|NCT02291289|585502357|FG001|Early Disease Progression|Lost to Follow-up|0|||
162123148|NCT02291289|585502358|FG002|Early Disease Progression|Lost to Follow-up|0|||
162123149|NCT02291289|585502359|FG003|Early Disease Progression|Lost to Follow-up|0|||
162123150|NCT02291289|585502360|FG004|Early Disease Progression|Lost to Follow-up|0|||
162123151|NCT02291289|585502361|FG005|Early Disease Progression|Lost to Follow-up|0|||
162123152|NCT02291289|585502362|FG006|Early Disease Progression|Lost to Follow-up|0|||
162123153|NCT02291289|585502363|FG007|Early Disease Progression|Lost to Follow-up|0|||
162123154|NCT02291289|585502364|FG008|Early Disease Progression|Lost to Follow-up|0|||
162123155|NCT02291289|585502365|FG009|Early Disease Progression|Lost to Follow-up|0|||
162123156|NCT02291289|585502366|FG010|Early Disease Progression|Lost to Follow-up|0|||
162123157|NCT02291289|585502367|FG011|Early Disease Progression|Lost to Follow-up|0|||
162123158|NCT02291289|585502368|FG012|Early Disease Progression|Lost to Follow-up|1|||
162123159|NCT01017120|585502369|FG000|Overall Study|Adverse Event|9|||
162123160|NCT01017120|585502370|FG001|Overall Study|Adverse Event|0|||
162123161|NCT01017120|585502369|FG000|Overall Study|Lost to Follow-up|13|||
162123162|NCT01017120|585502370|FG001|Overall Study|Lost to Follow-up|11|||
162123163|NCT01017120|585502369|FG000|Overall Study|Lack of Efficacy|1|||
162123164|NCT01017120|585502370|FG001|Overall Study|Lack of Efficacy|0|||
162123165|NCT01017120|585502369|FG000|Overall Study|Withdrawal by Subject|39|||
162123166|NCT01017120|585502370|FG001|Overall Study|Withdrawal by Subject|21|||
162123167|NCT01017120|585502369|FG000|Overall Study|Pregnancy|1|||
162123168|NCT01017120|585502370|FG001|Overall Study|Pregnancy|1|||
162123169|NCT01017120|585502369|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
162123170|NCT01017120|585502370|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
162123171|NCT01017120|585502369|FG000|Overall Study|Relocated Out of Town|0|||
162123172|NCT01017120|585502370|FG001|Overall Study|Relocated Out of Town|2|||
162123173|NCT01017120|585502369|FG000|Overall Study|Protocol Violation|1|||
162123174|NCT01017120|585502370|FG001|Overall Study|Protocol Violation|0|||
162123175|NCT01017120|585502369|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
162123176|NCT01017120|585502370|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
162123177|NCT01642602|585502371|FG000|Overall Study|Adverse Event|2|||
162123178|NCT01112514|585502372|FG000|Overall Study|Lost to Follow-up|1|||
162123179|NCT01024959|585502373|FG000|Overall Study|ineligible|12|||
162123180|NCT01024959|585502373|FG000|Overall Study|results not evaluable|12|||
162123181|NCT01024959|585502373|FG000|Overall Study|missing results required for analysis|17|||
162123182|NCT01118455|585502374|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
162123183|NCT01118455|585502375|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
162123184|NCT03377790|585502380|FG000|Overall Study|Withdrawal by Subject|1|||
162123185|NCT03377790|585502381|FG001|Overall Study|Withdrawal by Subject|0|||
162123186|NCT03377790|585502380|FG000|Overall Study|Adverse Event|1|||
162123187|NCT03377790|585502381|FG001|Overall Study|Adverse Event|0|||
162123188|NCT03377790|585502380|FG000|Overall Study|Lost to Follow-up|0|||
162123189|NCT03377790|585502381|FG001|Overall Study|Lost to Follow-up|2|||
162123190|NCT03377790|585502380|FG000|Overall Study|Randomized but not treated|1|||
162123191|NCT03377790|585502381|FG001|Overall Study|Randomized but not treated|0|||
162123192|NCT03377790|585502380|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
162123193|NCT03377790|585502381|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
162123194|NCT01533714|585502382|FG000|Overall Study|Adverse Event|0|||
162123195|NCT01533714|585502383|FG001|Overall Study|Adverse Event|1|||
162123196|NCT01533714|585502384|FG002|Overall Study|Adverse Event|2|||
162123197|NCT01533714|585502385|FG003|Overall Study|Adverse Event|2|||
162123198|NCT01533714|585502386|FG004|Overall Study|Adverse Event|2|||
162123199|NCT01533714|585502387|FG005|Overall Study|Adverse Event|1|||
162123200|NCT01533714|585502382|FG000|Overall Study|Lack of Efficacy|0|||
162123201|NCT01533714|585502383|FG001|Overall Study|Lack of Efficacy|0|||
162123202|NCT01533714|585502384|FG002|Overall Study|Lack of Efficacy|0|||
162123203|NCT01533714|585502385|FG003|Overall Study|Lack of Efficacy|0|||
162123204|NCT01533714|585502386|FG004|Overall Study|Lack of Efficacy|0|||
162123205|NCT01533714|585502387|FG005|Overall Study|Lack of Efficacy|1|||
162123206|NCT01533714|585502382|FG000|Overall Study|Withdrawal by Subject|0|||
162123207|NCT01533714|585502383|FG001|Overall Study|Withdrawal by Subject|1|||
162123208|NCT01533714|585502384|FG002|Overall Study|Withdrawal by Subject|0|||
162123209|NCT01533714|585502385|FG003|Overall Study|Withdrawal by Subject|1|||
162123210|NCT01533714|585502386|FG004|Overall Study|Withdrawal by Subject|1|||
162123211|NCT01533714|585502387|FG005|Overall Study|Withdrawal by Subject|0|||
162123212|NCT01533714|585502382|FG000|Overall Study|Exclusion criteria|0|||
162123213|NCT01533714|585502383|FG001|Overall Study|Exclusion criteria|1|||
162123214|NCT01533714|585502384|FG002|Overall Study|Exclusion criteria|0|||
162123215|NCT01533714|585502385|FG003|Overall Study|Exclusion criteria|0|||
162123216|NCT01533714|585502386|FG004|Overall Study|Exclusion criteria|0|||
162123217|NCT01533714|585502387|FG005|Overall Study|Exclusion criteria|0|||
162123218|NCT01533714|585502382|FG000|Overall Study|Positive for purified protein derivative|0|||
162123219|NCT01533714|585502383|FG001|Overall Study|Positive for purified protein derivative|0|||
162123220|NCT01533714|585502384|FG002|Overall Study|Positive for purified protein derivative|1|||
162123221|NCT01533714|585502385|FG003|Overall Study|Positive for purified protein derivative|0|||
162123222|NCT01533714|585502386|FG004|Overall Study|Positive for purified protein derivative|1|||
162123223|NCT01533714|585502387|FG005|Overall Study|Positive for purified protein derivative|0|||
162123224|NCT01533714|585502382|FG000|Overall Study|Withdrawal criteria|0|||
162123225|NCT01533714|585502383|FG001|Overall Study|Withdrawal criteria|0|||
161784456|NCT00736333|584257355|FG000|Overall Study|Withdrawal by Subject|10|||
161784457|NCT00736333|584257355|FG000|Overall Study|Death|7|||
161784458|NCT00736333|584257355|FG000|Overall Study|Other|4|||
161784459|NCT04991311|584257357|FG000|Overall Study|Adverse Event|1|||
161784460|NCT00054275|584257359|FG000|Overall Study|Withdrawal by Subject|4|||
161784461|NCT00054275|584257359|FG000|Overall Study|Adverse Event|5|||
161784462|NCT00054275|584257359|FG000|Overall Study|Progressive disease in cycle 1|1|||
161784463|NCT00054275|584257359|FG000|Overall Study|Physician Decision|1|||
161784464|NCT01106352|584257360|FG000|Overall Study|Subjects untreated|0|||
161784465|NCT01106352|584257361|FG001|Overall Study|Subjects untreated|0|||
161784466|NCT01106352|584257362|FG002|Overall Study|Subjects untreated|0|||
161784467|NCT01106352|584257363|FG003|Overall Study|Subjects untreated|3|||
161784468|NCT01106352|584257364|FG004|Overall Study|Subjects untreated|4|||
161784469|NCT01106352|584257360|FG000|Overall Study|Sponsor Decision|1|||
161784470|NCT01106352|584257361|FG001|Overall Study|Sponsor Decision|0|||
161784471|NCT01106352|584257362|FG002|Overall Study|Sponsor Decision|0|||
161784472|NCT01106352|584257363|FG003|Overall Study|Sponsor Decision|0|||
161784473|NCT01106352|584257364|FG004|Overall Study|Sponsor Decision|0|||
161784474|NCT01106352|584257360|FG000|Overall Study|Too ill to come in for the visit|0|||
161784475|NCT01106352|584257361|FG001|Overall Study|Too ill to come in for the visit|0|||
161784476|NCT01106352|584257362|FG002|Overall Study|Too ill to come in for the visit|1|||
161784477|NCT01106352|584257363|FG003|Overall Study|Too ill to come in for the visit|0|||
161784478|NCT01106352|584257364|FG004|Overall Study|Too ill to come in for the visit|0|||
161784479|NCT01106352|584257360|FG000|Overall Study|Lost to Follow-up|0|||
161784480|NCT01106352|584257361|FG001|Overall Study|Lost to Follow-up|0|||
161784481|NCT01106352|584257362|FG002|Overall Study|Lost to Follow-up|0|||
161784482|NCT01106352|584257363|FG003|Overall Study|Lost to Follow-up|0|||
161784483|NCT01106352|584257364|FG004|Overall Study|Lost to Follow-up|1|||
161784484|NCT01106352|584257360|FG000|Overall Study|Death|0|||
161784485|NCT01106352|584257361|FG001|Overall Study|Death|0|||
161784486|NCT01106352|584257362|FG002|Overall Study|Death|1|||
161784487|NCT01106352|584257363|FG003|Overall Study|Death|3|||
161784488|NCT01106352|584257364|FG004|Overall Study|Death|1|||
161784489|NCT01106352|584257360|FG000|Overall Study|Disease progression|0|||
161784490|NCT01106352|584257361|FG001|Overall Study|Disease progression|0|||
161784491|NCT01106352|584257362|FG002|Overall Study|Disease progression|0|||
161784492|NCT01106352|584257363|FG003|Overall Study|Disease progression|1|||
161784493|NCT01106352|584257364|FG004|Overall Study|Disease progression|0|||
161784494|NCT01106352|584257360|FG000|Overall Study|Withdrawal by Subject|0|||
161784495|NCT01106352|584257361|FG001|Overall Study|Withdrawal by Subject|0|||
161784496|NCT01106352|584257362|FG002|Overall Study|Withdrawal by Subject|0|||
161784497|NCT01106352|584257363|FG003|Overall Study|Withdrawal by Subject|3|||
161784498|NCT01106352|584257364|FG004|Overall Study|Withdrawal by Subject|2|||
161784499|NCT01106352|584257360|FG000|Overall Study|Went on hospice|0|||
161784500|NCT01106352|584257361|FG001|Overall Study|Went on hospice|0|||
161784501|NCT01106352|584257362|FG002|Overall Study|Went on hospice|0|||
161784502|NCT01106352|584257363|FG003|Overall Study|Went on hospice|1|||
161784503|NCT01106352|584257364|FG004|Overall Study|Went on hospice|0|||
161784504|NCT01106352|584257360|FG000|Overall Study|Subject entered hospice|0|||
161784505|NCT01106352|584257361|FG001|Overall Study|Subject entered hospice|0|||
161784506|NCT01106352|584257362|FG002|Overall Study|Subject entered hospice|0|||
161784507|NCT01106352|584257363|FG003|Overall Study|Subject entered hospice|1|||
161784508|NCT01106352|584257364|FG004|Overall Study|Subject entered hospice|0|||
161784509|NCT01106352|584257360|FG000|Overall Study|Home hospice since July 2013|0|||
161784510|NCT01106352|584257361|FG001|Overall Study|Home hospice since July 2013|0|||
161784511|NCT01106352|584257362|FG002|Overall Study|Home hospice since July 2013|0|||
161784512|NCT01106352|584257363|FG003|Overall Study|Home hospice since July 2013|1|||
161898190|NCT00572455|584675572|FG008|Stage II (28 Days)|Other|1|||
161898191|NCT00572455|584675573|FG009|Stage II (28 Days)|Other|0|||
162123226|NCT01533714|585502384|FG002|Overall Study|Withdrawal criteria|1|||
162242034|NCT02616562|585939081|FG013|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
161784513|NCT01106352|584257364|FG004|Overall Study|Home hospice since July 2013|0|||
161784514|NCT03944707|584257365|FG000|Overall Study|Adverse Event|0|||
161784515|NCT03944707|584257366|FG001|Overall Study|Adverse Event|2|||
161784516|NCT03944707|584257365|FG000|Overall Study|Study terminated by sponsor|12|||
161784517|NCT03944707|584257366|FG001|Overall Study|Study terminated by sponsor|7|||
161784518|NCT03944707|584257365|FG000|Overall Study|Subject decision|0|||
161784519|NCT03944707|584257366|FG001|Overall Study|Subject decision|1|||
161784520|NCT02444182|584257368|FG000|Overall Study|non-compliance|2|||
161898192|NCT00572455|584675574|FG010|Stage II (28 Days)|Other|0|||
161784521|NCT02444182|584257369|FG001|Overall Study|non-compliance|1|||
161784522|NCT02444182|584257368|FG000|Overall Study|Lost to Follow-up|0|||
161784523|NCT02444182|584257369|FG001|Overall Study|Lost to Follow-up|4|||
161784524|NCT01453374|584257370|FG000|Overall Study|Adverse Event|7|||
161784525|NCT01453374|584257370|FG000|Overall Study|Lack of Efficacy|1|||
161784526|NCT01453374|584257370|FG000|Overall Study|Lost to Follow-up|3|||
161898193|NCT00572455|584675575|FG011|Stage II (28 Days)|Other|0|||
162123227|NCT01533714|585502385|FG003|Overall Study|Withdrawal criteria|0|||
162123228|NCT01533714|585502386|FG004|Overall Study|Withdrawal criteria|3|||
162123229|NCT01533714|585502387|FG005|Overall Study|Withdrawal criteria|1|||
162123230|NCT01533714|585502382|FG000|Overall Study|Ineligibility reason|0|||
162123231|NCT01533714|585502383|FG001|Overall Study|Ineligibility reason|0|||
162123232|NCT01533714|585502384|FG002|Overall Study|Ineligibility reason|0|||
162123233|NCT01533714|585502385|FG003|Overall Study|Ineligibility reason|1|||
162123234|NCT01533714|585502386|FG004|Overall Study|Ineligibility reason|0|||
162123235|NCT01533714|585502387|FG005|Overall Study|Ineligibility reason|0|||
162123236|NCT05033743|585502388|FG000|Overall Study|Lost to Follow-up|1|||
162123237|NCT05033743|585502388|FG000|Overall Study|Protocol Violation|2|||
162123238|NCT05033743|585502388|FG000|Overall Study|Withdrawal by Subject|1|||
162123239|NCT02564055|585502389|FG000|Overall Study|Adverse Event|1|||
162123240|NCT02564055|585502390|FG001|Overall Study|Adverse Event|0|||
162123241|NCT02564055|585502391|FG002|Overall Study|Adverse Event|4|||
162123242|NCT02564055|585502392|FG003|Overall Study|Adverse Event|1|||
162123243|NCT02564055|585502393|FG004|Overall Study|Adverse Event|4|||
162123244|NCT02564055|585502394|FG005|Overall Study|Adverse Event|1|||
162123245|NCT02564055|585502389|FG000|Overall Study|Protocol Violation|1|||
162123246|NCT02564055|585502390|FG001|Overall Study|Protocol Violation|0|||
162123247|NCT02564055|585502391|FG002|Overall Study|Protocol Violation|0|||
162123248|NCT02564055|585502392|FG003|Overall Study|Protocol Violation|0|||
162123249|NCT02564055|585502393|FG004|Overall Study|Protocol Violation|0|||
162123250|NCT02564055|585502394|FG005|Overall Study|Protocol Violation|0|||
162123251|NCT02564055|585502389|FG000|Overall Study|Reached stopping criteria|0|||
162123252|NCT02564055|585502390|FG001|Overall Study|Reached stopping criteria|0|||
162123253|NCT02564055|585502391|FG002|Overall Study|Reached stopping criteria|0|||
162123254|NCT02564055|585502392|FG003|Overall Study|Reached stopping criteria|0|||
162123255|NCT02564055|585502393|FG004|Overall Study|Reached stopping criteria|0|||
162123256|NCT02564055|585502394|FG005|Overall Study|Reached stopping criteria|1|||
162123257|NCT02564055|585502389|FG000|Overall Study|Lost to Follow-up|0|||
162123258|NCT02564055|585502390|FG001|Overall Study|Lost to Follow-up|1|||
162123259|NCT02564055|585502391|FG002|Overall Study|Lost to Follow-up|4|||
162123260|NCT02564055|585502392|FG003|Overall Study|Lost to Follow-up|2|||
162123261|NCT02564055|585502393|FG004|Overall Study|Lost to Follow-up|1|||
162123262|NCT02564055|585502394|FG005|Overall Study|Lost to Follow-up|0|||
162123263|NCT02564055|585502389|FG000|Overall Study|Physician Decision|0|||
162123264|NCT02564055|585502390|FG001|Overall Study|Physician Decision|0|||
162123265|NCT02564055|585502391|FG002|Overall Study|Physician Decision|1|||
162123266|NCT02564055|585502392|FG003|Overall Study|Physician Decision|0|||
162123267|NCT02564055|585502393|FG004|Overall Study|Physician Decision|0|||
162123268|NCT02564055|585502394|FG005|Overall Study|Physician Decision|0|||
162123269|NCT02564055|585502389|FG000|Overall Study|Withdrawal by Subject|4|||
162123270|NCT02564055|585502390|FG001|Overall Study|Withdrawal by Subject|4|||
162123271|NCT02564055|585502391|FG002|Overall Study|Withdrawal by Subject|3|||
162123272|NCT02564055|585502392|FG003|Overall Study|Withdrawal by Subject|3|||
162123273|NCT02564055|585502393|FG004|Overall Study|Withdrawal by Subject|10|||
162123274|NCT02564055|585502394|FG005|Overall Study|Withdrawal by Subject|10|||
162123275|NCT00919893|585502397|FG000|Overall Study|Protocol Violation|19|||
162123276|NCT00919893|585502398|FG001|Overall Study|Protocol Violation|9|||
162123277|NCT00365378|585502405|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
162123278|NCT00365378|585502406|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
162123279|NCT00365378|585502407|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
162123280|NCT00365378|585502405|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
162123281|NCT00365378|585502406|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
162123282|NCT00365378|585502407|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
162123283|NCT00365378|585502405|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
162123284|NCT00365378|585502406|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
162123285|NCT00365378|585502407|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
162123286|NCT00365378|585502405|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
162123287|NCT00365378|585502406|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
162123288|NCT00365378|585502407|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
162123289|NCT00365378|585502405|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
162123290|NCT00365378|585502406|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
162123291|NCT00365378|585502407|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
162123292|NCT00365378|585502405|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
162123293|NCT00365378|585502406|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
162123294|NCT00365378|585502407|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
162123295|NCT00365378|585502405|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
162123296|NCT00365378|585502406|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
162123297|NCT00365378|585502407|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
162123298|NCT00365378|585502405|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
162123299|NCT00365378|585502406|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
162123300|NCT00365378|585502407|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
162123301|NCT00365378|585502405|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
162123302|NCT00365378|585502406|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
162123303|NCT00365378|585502407|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
162123304|NCT00365378|585502405|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
162123305|NCT00365378|585502406|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
162123306|NCT00365378|585502407|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
162123307|NCT00365378|585502405|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
162123308|NCT00365378|585502406|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
162123309|NCT00365378|585502407|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
162123310|NCT00365378|585502405|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
162123311|NCT00365378|585502406|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
162123312|NCT00365378|585502407|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
162123313|NCT00365378|585502405|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
162123314|NCT00365378|585502406|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
162123315|NCT00365378|585502407|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
162123316|NCT00365378|585502405|FG000|Extension|Adverse Event|0|||
162123317|NCT00365378|585502406|FG001|Extension|Adverse Event|0|||
162123318|NCT00365378|585502407|FG002|Extension|Adverse Event|1|||
162123319|NCT00365378|585502405|FG000|Extension|Moved|0|||
162123320|NCT00365378|585502406|FG001|Extension|Moved|0|||
162123321|NCT00365378|585502407|FG002|Extension|Moved|8|||
162123322|NCT00365378|585502405|FG000|Extension|Lost to Follow-up|0|||
162123323|NCT00365378|585502406|FG001|Extension|Lost to Follow-up|0|||
162123324|NCT00365378|585502407|FG002|Extension|Lost to Follow-up|57|||
162123325|NCT00365378|585502405|FG000|Extension|Protocol Violation|0|||
162123326|NCT00365378|585502406|FG001|Extension|Protocol Violation|0|||
162123327|NCT00365378|585502407|FG002|Extension|Protocol Violation|2|||
162123328|NCT00365378|585502405|FG000|Extension|Withdrawal by Subject|0|||
162123329|NCT00365378|585502406|FG001|Extension|Withdrawal by Subject|0|||
162123330|NCT00365378|585502407|FG002|Extension|Withdrawal by Subject|98|||
162123331|NCT00365378|585502405|FG000|Extension|Other|0|||
162123332|NCT00365378|585502406|FG001|Extension|Other|0|||
162123333|NCT00365378|585502407|FG002|Extension|Other|31|||
162123334|NCT04741802|585502408|FG000|Overall Study|Death|1|||
162123335|NCT04741802|585502408|FG000|Overall Study|Lost to Follow-up|11|||
162123336|NCT00452413|585502420|FG000|Overall Study|Progressive Disease|4|||
162123337|NCT00452413|585502421|FG001|Overall Study|Progressive Disease|11|||
162123338|NCT00452413|585502422|FG002|Overall Study|Progressive Disease|30|||
162123339|NCT00452413|585502420|FG000|Overall Study|Withdrawal by Subject|0|||
162123340|NCT00452413|585502421|FG001|Overall Study|Withdrawal by Subject|1|||
162123341|NCT00452413|585502422|FG002|Overall Study|Withdrawal by Subject|4|||
162123342|NCT00452413|585502420|FG000|Overall Study|Adverse Event|0|||
162123343|NCT00452413|585502421|FG001|Overall Study|Adverse Event|0|||
162123344|NCT00452413|585502422|FG002|Overall Study|Adverse Event|5|||
162123345|NCT00452413|585502420|FG000|Overall Study|Physician Decision|0|||
162123346|NCT00452413|585502421|FG001|Overall Study|Physician Decision|0|||
162123347|NCT00452413|585502422|FG002|Overall Study|Physician Decision|4|||
162123348|NCT00452413|585502420|FG000|Overall Study|Death due to study disease|0|||
162123349|NCT00452413|585502421|FG001|Overall Study|Death due to study disease|0|||
162123350|NCT00452413|585502422|FG002|Overall Study|Death due to study disease|2|||
162123351|NCT00452413|585502420|FG000|Overall Study|Death due to adverse event (AE)|0|||
162123352|NCT00452413|585502421|FG001|Overall Study|Death due to adverse event (AE)|0|||
162123353|NCT00452413|585502422|FG002|Overall Study|Death due to adverse event (AE)|1|||
162123354|NCT00452413|585502420|FG000|Overall Study|On treatment|0|||
162123355|NCT00452413|585502421|FG001|Overall Study|On treatment|0|||
162123356|NCT00452413|585502422|FG002|Overall Study|On treatment|3|||
162123357|NCT01539863|585502431|FG000|Overall Study|Lost to Follow-up|5|||
162123358|NCT01539863|585502432|FG001|Overall Study|Lost to Follow-up|4|||
162123359|NCT02226172|585502437|FG000|Overall Study|Participant refused further follow-up|4|||
162123360|NCT02226172|585502437|FG000|Overall Study|Other|5|||
162123361|NCT02226172|585502437|FG000|Overall Study|Death|1|||
162123362|NCT02226172|585502437|FG000|Overall Study|Study terminated by sponsor|1|||
162123363|NCT02226172|585502437|FG000|Overall Study|Adverse Event|6|||
162123364|NCT00758160|585502444|FG000|Overall Study|No Longer Requires Study Medication|4|||
162123365|NCT00758160|585502444|FG000|Overall Study|Administration Problems|3|||
162123366|NCT00758160|585502444|FG000|Overall Study|Adverse Event|15|||
162123367|NCT00758160|585502444|FG000|Overall Study|Lack of Efficacy|10|||
162123368|NCT00758160|585502444|FG000|Overall Study|Lost to Follow-up|14|||
162123369|NCT00758160|585502444|FG000|Overall Study|Protocol Violation|12|||
162123370|NCT00758160|585502444|FG000|Overall Study|Withdrawal by Subject|8|||
162123371|NCT01108510|585502448|FG000|Overall Study|Randomized but Not Treated|5|||
161784527|NCT01453374|584257370|FG000|Overall Study|Withdrawal by Subject|5|||
162123372|NCT01108510|585502449|FG001|Overall Study|Randomized but Not Treated|1|||
162123373|NCT01108510|585502448|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
162123374|NCT01108510|585502449|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
162123375|NCT01108510|585502448|FG000|Overall Study|Adverse Event|26|||
162123376|NCT01108510|585502449|FG001|Overall Study|Adverse Event|19|||
162123377|NCT01108510|585502448|FG000|Overall Study|Lost to Follow-up|20|||
162123378|NCT01108510|585502449|FG001|Overall Study|Lost to Follow-up|17|||
162123379|NCT01108510|585502448|FG000|Overall Study|Withdrew Consent|21|||
162123380|NCT01108510|585502449|FG001|Overall Study|Withdrew Consent|15|||
162123381|NCT01108510|585502448|FG000|Overall Study|Investigator's Discretion|12|||
162123382|NCT01108510|585502449|FG001|Overall Study|Investigator's Discretion|10|||
162123383|NCT01108510|585502448|FG000|Overall Study|Participant Noncompliance|5|||
162123384|NCT01108510|585502449|FG001|Overall Study|Participant Noncompliance|7|||
162123385|NCT01108510|585502448|FG000|Overall Study|Lack of Efficacy|3|||
162123386|NCT01108510|585502449|FG001|Overall Study|Lack of Efficacy|0|||
162123387|NCT01108510|585502448|FG000|Overall Study|Pregnancy|0|||
162123388|NCT01108510|585502449|FG001|Overall Study|Pregnancy|3|||
162123389|NCT01108510|585502448|FG000|Overall Study|Death|1|||
162123390|NCT01108510|585502449|FG001|Overall Study|Death|1|||
162123391|NCT01258660|585502450|FG000|Overall Study|Adverse Event|2|||
162123392|NCT01258660|585502451|FG001|Overall Study|Adverse Event|4|||
162123393|NCT01258660|585502450|FG000|Overall Study|Withdrawal by Subject|3|||
162123394|NCT01258660|585502451|FG001|Overall Study|Withdrawal by Subject|0|||
162123395|NCT01258660|585502450|FG000|Overall Study|due to relocation|2|||
162123396|NCT01258660|585502451|FG001|Overall Study|due to relocation|0|||
162123397|NCT01258660|585502450|FG000|Overall Study|Protocol Violation|0|||
162123398|NCT01258660|585502451|FG001|Overall Study|Protocol Violation|1|||
162123399|NCT01258660|585502450|FG000|Overall Study|Invalid for primary analysis data set|4|||
162123400|NCT01258660|585502451|FG001|Overall Study|Invalid for primary analysis data set|6|||
162123401|NCT00582491|585502452|FG000|Overall Study|Withdrawal by Subject|1|||
162123402|NCT00582491|585502453|FG001|Overall Study|Withdrawal by Subject|0|||
162123403|NCT04192630|585502456|FG000|Overall Study|Discontinued before surgery|2|||
161898194|NCT00572455|584675576|FG012|Stage II (28 Days)|Other|0|||
161898195|NCT00572455|584675577|FG013|Stage II (28 Days)|Other|0|||
162123404|NCT04192630|585502457|FG001|Overall Study|Discontinued before surgery|0|||
162123405|NCT04192630|585502456|FG000|Overall Study|Discontinued after surgery|5|||
162123406|NCT04192630|585502457|FG001|Overall Study|Discontinued after surgery|3|||
162123407|NCT01193582|585502458|FG000|Vaccination Series|Withdrawal by Subject|11|||
162123408|NCT01193582|585502459|FG001|Vaccination Series|Withdrawal by Subject|13|||
162123409|NCT01193582|585502460|FG002|Vaccination Series|Withdrawal by Subject|8|||
162123410|NCT01193582|585502461|FG003|Vaccination Series|Withdrawal by Subject|3|||
162123411|NCT01193582|585502458|FG000|12 Month Follow-up|Death|0|||
162123412|NCT01193582|585502459|FG001|12 Month Follow-up|Death|0|||
162123413|NCT01193582|585502460|FG002|12 Month Follow-up|Death|1|||
162123414|NCT01193582|585502461|FG003|12 Month Follow-up|Death|0|||
162123415|NCT01193582|585502458|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
162123416|NCT01193582|585502459|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
161784528|NCT01453374|584257370|FG000|Overall Study|Incarcerated|2|||
161784529|NCT00996918|584257374|FG000|Overall Study|Lack of Efficacy|1|||
161784530|NCT00996918|584257375|FG001|Overall Study|Lack of Efficacy|1|||
161784531|NCT00996918|584257376|FG002|Overall Study|Lack of Efficacy|2|||
161784532|NCT00996918|584257377|FG003|Overall Study|Lack of Efficacy|2|||
161784533|NCT00996918|584257378|FG004|Overall Study|Lack of Efficacy|0|||
161784534|NCT00996918|584257374|FG000|Overall Study|Adverse Event|2|||
161784535|NCT00996918|584257375|FG001|Overall Study|Adverse Event|5|||
161784536|NCT00996918|584257376|FG002|Overall Study|Adverse Event|2|||
161784537|NCT00996918|584257377|FG003|Overall Study|Adverse Event|6|||
161784538|NCT00996918|584257378|FG004|Overall Study|Adverse Event|0|||
161784539|NCT00996918|584257374|FG000|Overall Study|Withdrawal by Subject|1|||
161784540|NCT00996918|584257375|FG001|Overall Study|Withdrawal by Subject|4|||
161784541|NCT00996918|584257376|FG002|Overall Study|Withdrawal by Subject|3|||
161784542|NCT00996918|584257377|FG003|Overall Study|Withdrawal by Subject|3|||
161784543|NCT00996918|584257378|FG004|Overall Study|Withdrawal by Subject|2|||
161784544|NCT00996918|584257374|FG000|Overall Study|Physician Decision|1|||
161784545|NCT00996918|584257375|FG001|Overall Study|Physician Decision|0|||
161784546|NCT00996918|584257376|FG002|Overall Study|Physician Decision|0|||
161784547|NCT00996918|584257377|FG003|Overall Study|Physician Decision|0|||
161784548|NCT00996918|584257378|FG004|Overall Study|Physician Decision|0|||
161784549|NCT00996918|584257374|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
161784550|NCT00996918|584257375|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
161784551|NCT00996918|584257376|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
162123417|NCT01193582|585502460|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
162123418|NCT01193582|585502461|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
162123419|NCT00779584|585502462|FG000|Overall Study|Protocol Violation|0|||
162123420|NCT00779584|585502463|FG001|Overall Study|Protocol Violation|0|||
162123421|NCT00779584|585502464|FG002|Overall Study|Protocol Violation|0|||
162123422|NCT00779584|585502465|FG003|Overall Study|Protocol Violation|0|||
162123423|NCT00779584|585502466|FG004|Overall Study|Protocol Violation|0|||
161784552|NCT00996918|584257377|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
161784553|NCT00996918|584257378|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
161784554|NCT00996918|584257374|FG000|Overall Study|Loss of Caregiver|0|||
161784555|NCT00996918|584257375|FG001|Overall Study|Loss of Caregiver|1|||
161784556|NCT00996918|584257376|FG002|Overall Study|Loss of Caregiver|0|||
162123424|NCT00779584|585502467|FG005|Overall Study|Protocol Violation|1|||
162123425|NCT00779584|585502468|FG006|Overall Study|Protocol Violation|0|||
161898196|NCT00572455|584675564|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
162123426|NCT00779584|585502469|FG007|Overall Study|Protocol Violation|0|||
162123427|NCT00779584|585502470|FG008|Overall Study|Protocol Violation|0|||
162123428|NCT00779584|585502462|FG000|Overall Study|Withdrawal by Subject|1|||
162123429|NCT00779584|585502463|FG001|Overall Study|Withdrawal by Subject|1|||
162123430|NCT00779584|585502464|FG002|Overall Study|Withdrawal by Subject|2|||
162123431|NCT00779584|585502465|FG003|Overall Study|Withdrawal by Subject|0|||
162123432|NCT00779584|585502466|FG004|Overall Study|Withdrawal by Subject|0|||
162123433|NCT00779584|585502467|FG005|Overall Study|Withdrawal by Subject|2|||
162123434|NCT00779584|585502468|FG006|Overall Study|Withdrawal by Subject|1|||
162123435|NCT00779584|585502469|FG007|Overall Study|Withdrawal by Subject|0|||
162123436|NCT00779584|585502470|FG008|Overall Study|Withdrawal by Subject|0|||
162123437|NCT00779584|585502462|FG000|Overall Study|Lost to Follow-up|0|||
162123438|NCT00779584|585502463|FG001|Overall Study|Lost to Follow-up|0|||
162123439|NCT00779584|585502464|FG002|Overall Study|Lost to Follow-up|0|||
162123440|NCT00779584|585502465|FG003|Overall Study|Lost to Follow-up|0|||
162123441|NCT00779584|585502466|FG004|Overall Study|Lost to Follow-up|1|||
162123442|NCT00779584|585502467|FG005|Overall Study|Lost to Follow-up|0|||
162123443|NCT00779584|585502468|FG006|Overall Study|Lost to Follow-up|0|||
162123444|NCT00779584|585502469|FG007|Overall Study|Lost to Follow-up|0|||
162123445|NCT00779584|585502470|FG008|Overall Study|Lost to Follow-up|0|||
162123446|NCT00779584|585502462|FG000|Overall Study|Progression of Disease|0|||
162123447|NCT00779584|585502463|FG001|Overall Study|Progression of Disease|1|||
162123448|NCT00779584|585502464|FG002|Overall Study|Progression of Disease|2|||
162123449|NCT00779584|585502465|FG003|Overall Study|Progression of Disease|6|||
162123450|NCT00779584|585502466|FG004|Overall Study|Progression of Disease|5|||
162123451|NCT00779584|585502467|FG005|Overall Study|Progression of Disease|1|||
162123452|NCT00779584|585502468|FG006|Overall Study|Progression of Disease|4|||
162123453|NCT00779584|585502469|FG007|Overall Study|Progression of Disease|2|||
162123454|NCT00779584|585502470|FG008|Overall Study|Progression of Disease|1|||
162123455|NCT00779584|585502462|FG000|Overall Study|Adverse Event|1|||
162123456|NCT00779584|585502463|FG001|Overall Study|Adverse Event|0|||
162123457|NCT00779584|585502464|FG002|Overall Study|Adverse Event|2|||
162123458|NCT00779584|585502465|FG003|Overall Study|Adverse Event|0|||
162123459|NCT00779584|585502466|FG004|Overall Study|Adverse Event|0|||
162123460|NCT00779584|585502467|FG005|Overall Study|Adverse Event|0|||
162123461|NCT00779584|585502468|FG006|Overall Study|Adverse Event|2|||
162123462|NCT00779584|585502469|FG007|Overall Study|Adverse Event|1|||
162123463|NCT00779584|585502470|FG008|Overall Study|Adverse Event|1|||
162123464|NCT00779584|585502462|FG000|Overall Study|Symptomatic Deterioration|1|||
162123465|NCT00779584|585502463|FG001|Overall Study|Symptomatic Deterioration|1|||
162123466|NCT00779584|585502464|FG002|Overall Study|Symptomatic Deterioration|1|||
162123467|NCT00779584|585502465|FG003|Overall Study|Symptomatic Deterioration|0|||
162123468|NCT00779584|585502466|FG004|Overall Study|Symptomatic Deterioration|0|||
162123469|NCT00779584|585502467|FG005|Overall Study|Symptomatic Deterioration|1|||
162123470|NCT00779584|585502468|FG006|Overall Study|Symptomatic Deterioration|1|||
162123471|NCT00779584|585502469|FG007|Overall Study|Symptomatic Deterioration|0|||
162123472|NCT00779584|585502470|FG008|Overall Study|Symptomatic Deterioration|0|||
162123473|NCT00779584|585502462|FG000|Overall Study|Ongoing in Study|0|||
162123474|NCT00779584|585502463|FG001|Overall Study|Ongoing in Study|0|||
162123475|NCT00779584|585502464|FG002|Overall Study|Ongoing in Study|0|||
162123476|NCT00779584|585502465|FG003|Overall Study|Ongoing in Study|0|||
162123477|NCT00779584|585502466|FG004|Overall Study|Ongoing in Study|1|||
162123478|NCT00779584|585502467|FG005|Overall Study|Ongoing in Study|1|||
162123479|NCT00779584|585502468|FG006|Overall Study|Ongoing in Study|0|||
162123480|NCT00779584|585502469|FG007|Overall Study|Ongoing in Study|0|||
162123481|NCT00779584|585502470|FG008|Overall Study|Ongoing in Study|0|||
162123482|NCT01775930|585502471|FG000|Overall Study|Futility stopping boundary met|1|||
162123483|NCT01208415|585502472|FG000|Overall Study|Death|1|||
162123484|NCT01208415|585502472|FG000|Overall Study|Lost to Follow-up|2|||
162123485|NCT01208415|585502472|FG000|Overall Study|Withdrawal by Subject|3|||
162123486|NCT01208415|585502472|FG000|Overall Study|Device not placed|1|||
162123487|NCT01208415|585502472|FG000|Overall Study|Still be eligible for follow-up|33|||
162123488|NCT02340520|585502473|FG000|Overall Study|Lost to Follow-up|1|||
162123489|NCT02340520|585502473|FG000|Overall Study|Patient did not take drug as specified|1|||
162123490|NCT02340520|585502473|FG000|Overall Study|Withdrawal by Subject|1|||
162123491|NCT01586338|585502475|FG000|Overall Study|Adverse Event|3|||
162123492|NCT01586338|585502475|FG000|Overall Study|Lost to Follow-up|1|||
162123493|NCT01586338|585502475|FG000|Overall Study|Withdrawal by participant|3|||
161784557|NCT00996918|584257377|FG003|Overall Study|Loss of Caregiver|0|||
162123494|NCT01586338|585502475|FG000|Overall Study|Other|1|||
162123495|NCT01868074|585502480|FG000|Overall Study|Lost to Follow-up|3|||
162123496|NCT01868074|585502481|FG001|Overall Study|Lost to Follow-up|2|||
162123497|NCT01868074|585502480|FG000|Overall Study|Withdrawal by Subject|4|||
162123498|NCT01868074|585502481|FG001|Overall Study|Withdrawal by Subject|2|||
162123499|NCT03306043|585502482|FG000|Overall Study|Adverse Event|1|||
162123500|NCT03306043|585502482|FG000|Overall Study|Lost to Follow-up|1|||
162123501|NCT03306043|585502482|FG000|Overall Study|Withdrawal by Subject|2|||
162123502|NCT01544491|585502483|FG000|Overall Study|Withdrawal by Subject|3|||
162123503|NCT01544491|585502484|FG001|Overall Study|Withdrawal by Subject|2|||
162123504|NCT01544491|585502483|FG000|Overall Study|Lost to Follow-up|0|||
162123505|NCT01544491|585502484|FG001|Overall Study|Lost to Follow-up|1|||
162123506|NCT01544491|585502483|FG000|Overall Study|administrative problems|2|||
162123507|NCT01544491|585502484|FG001|Overall Study|administrative problems|0|||
162123508|NCT02494206|585502485|FG000|Overall Study|Adverse Event|1|||
162123509|NCT02494206|585502485|FG000|Overall Study|Disease Progression|1|||
162123510|NCT01013792|585502486|FG000|Overall Study|Study suspended|2|||
162123511|NCT01013792|585502487|FG001|Overall Study|Study suspended|1|||
162123512|NCT01013792|585502486|FG000|Overall Study|Adverse Event|0|||
162123513|NCT01013792|585502487|FG001|Overall Study|Adverse Event|3|||
162123514|NCT01013792|585502486|FG000|Overall Study|Lost to Follow-up|0|||
162123515|NCT01013792|585502487|FG001|Overall Study|Lost to Follow-up|1|||
162123516|NCT01234649|585502488|FG000|Overall Study|Withdrawal by Subject|32|||
162123517|NCT01234649|585502489|FG001|Overall Study|Withdrawal by Subject|26|||
162123518|NCT01234649|585502488|FG000|Overall Study|Pregnancy|6|||
162123519|NCT01234649|585502489|FG001|Overall Study|Pregnancy|6|||
162123520|NCT01234649|585502488|FG000|Overall Study|intolerant to side effects|4|||
162123521|NCT01234649|585502489|FG001|Overall Study|intolerant to side effects|3|||
162123522|NCT01234649|585502488|FG000|Overall Study|Allergic reaction|1|||
162123523|NCT01234649|585502489|FG001|Overall Study|Allergic reaction|0|||
162123524|NCT01234649|585502488|FG000|Overall Study|Lack of Efficacy|0|||
162123525|NCT01234649|585502489|FG001|Overall Study|Lack of Efficacy|3|||
162123526|NCT00680056|585502493|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
162123527|NCT00680056|585502494|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
162123528|NCT00680056|585502493|FG000|Second Intervention|Protocol Violation|3|||
162123529|NCT00680056|585502494|FG001|Second Intervention|Protocol Violation|1|||
162123530|NCT03688711|585502495|FG000|Overall Study|Withdrawal by Subject|0|||
162123531|NCT03688711|585502496|FG001|Overall Study|Withdrawal by Subject|1|||
162123532|NCT05229653|585502497|FG000|Overall Study|Lost to Follow-up|1|||
162123533|NCT05229653|585502498|FG001|Overall Study|Lost to Follow-up|0|||
162123534|NCT01370005|585502499|FG000|Overall Study|Not treated|1|||
162123535|NCT01370005|585502500|FG001|Overall Study|Not treated|0|||
162123536|NCT01370005|585502501|FG002|Overall Study|Not treated|0|||
162123537|NCT01370005|585502499|FG000|Overall Study|Adverse Event|5|||
162123538|NCT01370005|585502500|FG001|Overall Study|Adverse Event|5|||
162123539|NCT01370005|585502501|FG002|Overall Study|Adverse Event|6|||
162123540|NCT01370005|585502499|FG000|Overall Study|Lack of Efficacy|1|||
162123541|NCT01370005|585502500|FG001|Overall Study|Lack of Efficacy|0|||
162123542|NCT01370005|585502501|FG002|Overall Study|Lack of Efficacy|0|||
162123543|NCT01370005|585502499|FG000|Overall Study|Non compliant with protocol|0|||
162123544|NCT01370005|585502500|FG001|Overall Study|Non compliant with protocol|1|||
162123545|NCT01370005|585502501|FG002|Overall Study|Non compliant with protocol|2|||
162123546|NCT01370005|585502499|FG000|Overall Study|Lost to Follow-up|1|||
162123547|NCT01370005|585502500|FG001|Overall Study|Lost to Follow-up|1|||
162123548|NCT01370005|585502501|FG002|Overall Study|Lost to Follow-up|1|||
162123549|NCT01370005|585502499|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
162123550|NCT01370005|585502500|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
162123551|NCT01370005|585502501|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
162123552|NCT01370005|585502499|FG000|Overall Study|Other reason not defined above|3|||
162123553|NCT01370005|585502500|FG001|Overall Study|Other reason not defined above|0|||
162123554|NCT01370005|585502501|FG002|Overall Study|Other reason not defined above|2|||
162123555|NCT03691948|585502502|FG000|Overall Study|Lost to Follow-up|1|||
162123556|NCT03691948|585502503|FG001|Overall Study|Lost to Follow-up|3|||
162123557|NCT02009696|585502504|FG000|Overall Study|Withdrawal by Subject|2|||
162123558|NCT01018563|585502506|FG000|Overall Study|Termination of the study by Sponsor|2|||
162123559|NCT01018563|585502507|FG001|Overall Study|Termination of the study by Sponsor|1|||
162123560|NCT02344537|585502508|FG000|Overall Study|Protocol Violation|1|||
162123561|NCT02344537|585502509|FG001|Overall Study|Protocol Violation|1|||
162123562|NCT02344537|585502508|FG000|Overall Study|Subject started another treatment after wk 6|1|||
162123563|NCT02344537|585502509|FG001|Overall Study|Subject started another treatment after wk 6|0|||
162123564|NCT02344537|585502508|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
162123565|NCT02344537|585502509|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
162123566|NCT05490329|585502512|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
162123567|NCT05490329|585502513|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
162123568|NCT05490329|585502512|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
162123569|NCT05490329|585502513|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
162123570|NCT05490329|585502512|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
162123571|NCT05490329|585502513|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
162123572|NCT04524598|585502514|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
162123573|NCT04524598|585502515|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
162123574|NCT04524598|585502516|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
162123575|NCT04524598|585502517|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
162123576|NCT04524598|585502518|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
162123577|NCT04524598|585502514|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
162123578|NCT04524598|585502515|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
162123579|NCT04524598|585502516|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
162123580|NCT04524598|585502517|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
162123581|NCT04524598|585502518|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
162123582|NCT04524598|585502514|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
162123583|NCT04524598|585502515|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
162123584|NCT04524598|585502516|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
162123585|NCT04524598|585502517|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
162123586|NCT04524598|585502518|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
162123587|NCT04524598|585502514|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
162123588|NCT04524598|585502515|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
162123589|NCT04524598|585502516|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
162123590|NCT04524598|585502517|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
162123591|NCT04524598|585502518|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
162123592|NCT04524598|585502514|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
162123593|NCT04524598|585502515|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
162123594|NCT04524598|585502516|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
162123595|NCT04524598|585502517|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
162123596|NCT04524598|585502518|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
162123597|NCT04524598|585502514|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
162123598|NCT04524598|585502515|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
162123599|NCT04524598|585502516|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
162123600|NCT04524598|585502517|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
162123601|NCT04524598|585502518|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
162123602|NCT04524598|585502514|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
162123603|NCT04524598|585502515|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
162123604|NCT04524598|585502516|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
162123605|NCT04524598|585502517|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
162123606|NCT04524598|585502518|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
162123607|NCT02306122|585502519|FG000|Initial Physician Randomization|Physician Decision|0|||
162123608|NCT02306122|585502520|FG001|Initial Physician Randomization|Physician Decision|0|||
162123609|NCT02306122|585502521|FG002|Initial Physician Randomization|Physician Decision|0|||
162123610|NCT02306122|585502522|FG003|Initial Physician Randomization|Physician Decision|0|||
162123611|NCT02306122|585502523|FG004|Initial Physician Randomization|Physician Decision|0|||
162123612|NCT02306122|585502524|FG005|Initial Physician Randomization|Physician Decision|0|||
162123613|NCT02306122|585502525|FG006|Initial Physician Randomization|Physician Decision|0|||
162123614|NCT02306122|585502526|FG007|Initial Physician Randomization|Physician Decision|0|||
162123615|NCT02306122|585502527|FG008|Initial Physician Randomization|Physician Decision|1|||
162123616|NCT02306122|585502528|FG009|Initial Physician Randomization|Physician Decision|0|||
162123617|NCT02306122|585502529|FG010|Initial Physician Randomization|Physician Decision|0|||
162123618|NCT02322814|585502530|FG000|Overall Study|Death|7|||
162123619|NCT02322814|585502531|FG001|Overall Study|Death|29|||
162123620|NCT02322814|585502532|FG002|Overall Study|Death|32|||
162123621|NCT02322814|585502533|FG003|Overall Study|Death|23|||
162123622|NCT02322814|585502534|FG004|Overall Study|Death|14|||
162123623|NCT02322814|585502530|FG000|Overall Study|Lost to Follow-up|1|||
162123624|NCT02322814|585502531|FG001|Overall Study|Lost to Follow-up|3|||
162123625|NCT02322814|585502532|FG002|Overall Study|Lost to Follow-up|3|||
162123626|NCT02322814|585502533|FG003|Overall Study|Lost to Follow-up|1|||
162123627|NCT02322814|585502534|FG004|Overall Study|Lost to Follow-up|0|||
162123628|NCT02322814|585502530|FG000|Overall Study|Various Reasons|2|||
162123629|NCT02322814|585502531|FG001|Overall Study|Various Reasons|0|||
162123630|NCT02322814|585502532|FG002|Overall Study|Various Reasons|1|||
162123631|NCT02322814|585502533|FG003|Overall Study|Various Reasons|1|||
162123632|NCT02322814|585502534|FG004|Overall Study|Various Reasons|0|||
162123633|NCT02322814|585502530|FG000|Overall Study|Progressive Disease|0|||
162123634|NCT02322814|585502531|FG001|Overall Study|Progressive Disease|0|||
162123635|NCT02322814|585502532|FG002|Overall Study|Progressive Disease|0|||
162123636|NCT02322814|585502533|FG003|Overall Study|Progressive Disease|1|||
162123637|NCT02322814|585502534|FG004|Overall Study|Progressive Disease|1|||
162123638|NCT02322814|585502530|FG000|Overall Study|Protocol Violation|1|||
162123639|NCT02322814|585502531|FG001|Overall Study|Protocol Violation|0|||
162123640|NCT02322814|585502532|FG002|Overall Study|Protocol Violation|0|||
162123641|NCT02322814|585502533|FG003|Overall Study|Protocol Violation|0|||
162123642|NCT02322814|585502534|FG004|Overall Study|Protocol Violation|0|||
162123643|NCT02322814|585502530|FG000|Overall Study|Study Terminated by Sponsor|0|||
162123644|NCT02322814|585502531|FG001|Overall Study|Study Terminated by Sponsor|7|||
162242035|NCT02616562|585939082|FG014|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
162242036|NCT02616562|585939083|FG015|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
162123645|NCT02322814|585502532|FG002|Overall Study|Study Terminated by Sponsor|9|||
162123646|NCT02322814|585502533|FG003|Overall Study|Study Terminated by Sponsor|5|||
162123647|NCT02322814|585502534|FG004|Overall Study|Study Terminated by Sponsor|13|||
162123648|NCT02322814|585502530|FG000|Overall Study|Withdrawal by Subject|5|||
162123649|NCT02322814|585502531|FG001|Overall Study|Withdrawal by Subject|4|||
162123650|NCT02322814|585502532|FG002|Overall Study|Withdrawal by Subject|2|||
162123651|NCT02322814|585502533|FG003|Overall Study|Withdrawal by Subject|1|||
162123652|NCT02322814|585502534|FG004|Overall Study|Withdrawal by Subject|3|||
162123653|NCT02998021|585502540|FG000|Overall Study|Withdrawal by Subject|3|||
162123654|NCT02998021|585502541|FG001|Overall Study|Withdrawal by Subject|1|||
162123655|NCT02998021|585502540|FG000|Overall Study|unsafe home|0|||
162123656|NCT02998021|585502541|FG001|Overall Study|unsafe home|1|||
162123657|NCT03713021|585502542|FG000|Overall Study|Did not have CT sim scan available|6|||
162123658|NCT03713021|585502542|FG000|Overall Study|Not eligible|4|||
162123659|NCT03713021|585502542|FG000|Overall Study|Issues with TraceIT markers|5|||
162236367|NCT00250679|585916935|FG000|Overall Study|various single events: hip surgery,diary|3|||
162236368|NCT00250679|585916936|FG001|Overall Study|various single events: hip surgery,diary|1|||
162236369|NCT00250679|585916937|FG002|Overall Study|various single events: hip surgery,diary|1|||
162236370|NCT00448279|585916939|FG000|Overall Study|Lost to Follow-up|2|||
162236371|NCT00448279|585916940|FG001|Overall Study|Lost to Follow-up|2|||
162236372|NCT00448279|585916939|FG000|Overall Study|Adverse Event|1|||
162236373|NCT00448279|585916940|FG001|Overall Study|Adverse Event|1|||
162236374|NCT00448279|585916939|FG000|Overall Study|Disease progression|16|||
162236375|NCT00448279|585916940|FG001|Overall Study|Disease progression|18|||
162236376|NCT00448279|585916939|FG000|Overall Study|Withdrawal by Subject|4|||
162236377|NCT00448279|585916940|FG001|Overall Study|Withdrawal by Subject|3|||
162236378|NCT00448279|585916939|FG000|Overall Study|Other|6|||
162236379|NCT00448279|585916940|FG001|Overall Study|Other|4|||
162236380|NCT00448279|585916939|FG000|Overall Study|Protocol Violation|0|||
162236381|NCT00448279|585916940|FG001|Overall Study|Protocol Violation|1|||
162236382|NCT03907410|585916941|FG000|Overall Study|Lost to Follow-up|4|||
162236383|NCT03907410|585916942|FG001|Overall Study|Lost to Follow-up|1|||
162236384|NCT03907410|585916943|FG002|Overall Study|Lost to Follow-up|1|||
162236385|NCT03907410|585916941|FG000|Overall Study|Lost to follow-up and research burden|0|||
162236386|NCT03907410|585916942|FG001|Overall Study|Lost to follow-up and research burden|0|||
162236387|NCT03907410|585916943|FG002|Overall Study|Lost to follow-up and research burden|1|||
162236388|NCT04776148|585916944|FG000|Overall Study|Death|249|||
162236389|NCT04776148|585916945|FG001|Overall Study|Death|260|||
162236390|NCT04776148|585916944|FG000|Overall Study|Lost to Follow-up|0|||
162236391|NCT04776148|585916945|FG001|Overall Study|Lost to Follow-up|1|||
162236392|NCT04776148|585916944|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162236393|NCT04776148|585916945|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162236394|NCT04776148|585916944|FG000|Overall Study|Withdrawal by Subject|3|||
162236395|NCT04776148|585916945|FG001|Overall Study|Withdrawal by Subject|4|||
162236396|NCT04776148|585916944|FG000|Overall Study|Sponsor Decision|30|||
162236397|NCT04776148|585916945|FG001|Overall Study|Sponsor Decision|15|||
162236398|NCT01155375|585916946|FG000|Overall Study|Adverse Event|1|||
162236399|NCT01155375|585916947|FG001|Overall Study|Adverse Event|0|||
162236400|NCT00757588|585916948|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
162236401|NCT00757588|585916949|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
162236402|NCT00757588|585916948|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
162236403|NCT00757588|585916949|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
162236404|NCT00757588|585916948|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
162236405|NCT00757588|585916949|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
162236406|NCT00757588|585916948|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
162236407|NCT00757588|585916949|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
162236408|NCT00757588|585916948|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
162236409|NCT00757588|585916949|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
162236410|NCT00757588|585916948|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
162236411|NCT00757588|585916949|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
162236412|NCT00757588|585916948|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
162236413|NCT00757588|585916949|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
162236414|NCT00757588|585916948|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
162236415|NCT00757588|585916949|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
162236416|NCT00757588|585916948|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
162236417|NCT00757588|585916949|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
162236418|NCT00757588|585916948|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
162236419|NCT00757588|585916949|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
162236420|NCT00757588|585916948|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
162242037|NCT02616562|585939084|FG016|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
162236421|NCT00757588|585916949|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
162236422|NCT00757588|585916948|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
162123660|NCT01340482|585503982|FG000|Overall Study|Adverse Event|2|||
162123661|NCT01340482|585503983|FG001|Overall Study|Adverse Event|0|||
162123662|NCT01340482|585503984|FG002|Overall Study|Adverse Event|0|||
162123663|NCT00603265|585503988|FG000|Overall Study|Adverse Event|2|||
162123664|NCT00603265|585503989|FG001|Overall Study|Adverse Event|11|||
162123665|NCT00603265|585503990|FG002|Overall Study|Adverse Event|1|||
162123666|NCT00603265|585503988|FG000|Overall Study|Withdrawal by Subject|1|||
162123667|NCT00603265|585503989|FG001|Overall Study|Withdrawal by Subject|2|||
162123668|NCT00603265|585503990|FG002|Overall Study|Withdrawal by Subject|1|||
162123669|NCT00603265|585503988|FG000|Overall Study|Lack of Efficacy|3|||
162123670|NCT00603265|585503989|FG001|Overall Study|Lack of Efficacy|0|||
162123671|NCT00603265|585503990|FG002|Overall Study|Lack of Efficacy|3|||
162123672|NCT00603265|585503988|FG000|Overall Study|Lost to Follow-up|0|||
162123673|NCT00603265|585503989|FG001|Overall Study|Lost to Follow-up|1|||
162123674|NCT00603265|585503990|FG002|Overall Study|Lost to Follow-up|0|||
162123675|NCT00603265|585503988|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
162123676|NCT00603265|585503989|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
162123677|NCT00603265|585503990|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
162123678|NCT00603265|585503988|FG000|Overall Study|Participant Left Country, No Responses|0|||
162123679|NCT00603265|585503989|FG001|Overall Study|Participant Left Country, No Responses|1|||
162123680|NCT00603265|585503990|FG002|Overall Study|Participant Left Country, No Responses|0|||
162123681|NCT00603265|585503988|FG000|Overall Study|Protocol Violation|1|||
162123682|NCT00603265|585503989|FG001|Overall Study|Protocol Violation|0|||
162123683|NCT00603265|585503990|FG002|Overall Study|Protocol Violation|0|||
162123684|NCT04399551|585503991|FG000|Overall Study|Adverse Event|15|||
162123685|NCT04399551|585503991|FG000|Overall Study|Withdrawal by Subject|6|||
162123686|NCT04399551|585503991|FG000|Overall Study|Physician Decision|3|||
162123687|NCT04399551|585503991|FG000|Overall Study|Lost to Follow-up|2|||
162123688|NCT04399551|585503991|FG000|Overall Study|Protocol Deviation|2|||
162123689|NCT01912781|585503998|FG000|Overall Study|Withdrawal by Subject|2|||
162123690|NCT01912781|585503999|FG001|Overall Study|Withdrawal by Subject|0|||
162123691|NCT01375959|585504003|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
162123692|NCT01375959|585504004|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
162123693|NCT01375959|585504003|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
162123694|NCT01375959|585504004|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
162123695|NCT01375959|585504003|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
162123696|NCT01375959|585504004|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
162123697|NCT04161807|585504008|FG000|Overall Study|Withdrawal by Subject|2|||
162123698|NCT04161807|585504008|FG000|Overall Study|Performed only 1 treatment|2|||
162123699|NCT00708305|585504015|FG000|Period 1|Protocol Violation|1|||
162123700|NCT00708305|585504016|FG001|Period 1|Protocol Violation|0|||
162123701|NCT00708305|585504017|FG002|Period 1|Protocol Violation|1|||
162123702|NCT00708305|585504018|FG003|Period 1|Protocol Violation|0|||
162123703|NCT00708305|585504015|FG000|Period 1|Other Reason|0|||
162123704|NCT00708305|585504016|FG001|Period 1|Other Reason|0|||
162123705|NCT00708305|585504017|FG002|Period 1|Other Reason|0|||
162123706|NCT00708305|585504018|FG003|Period 1|Other Reason|2|||
162123707|NCT00708305|585504015|FG000|Period 2|Lost to Follow-up|0|||
162123708|NCT00708305|585504016|FG001|Period 2|Lost to Follow-up|1|||
162123709|NCT00708305|585504017|FG002|Period 2|Lost to Follow-up|0|||
162123710|NCT00708305|585504018|FG003|Period 2|Lost to Follow-up|0|||
162123711|NCT00708305|585504015|FG000|Period 2|Protocol Violation|0|||
162123712|NCT00708305|585504016|FG001|Period 2|Protocol Violation|1|||
162123713|NCT00708305|585504017|FG002|Period 2|Protocol Violation|0|||
162123714|NCT00708305|585504018|FG003|Period 2|Protocol Violation|0|||
162123715|NCT00708305|585504015|FG000|Period 2|Other Reason|1|||
162123716|NCT00708305|585504016|FG001|Period 2|Other Reason|0|||
162123717|NCT00708305|585504017|FG002|Period 2|Other Reason|0|||
162123718|NCT00708305|585504018|FG003|Period 2|Other Reason|1|||
162123719|NCT00708305|585504015|FG000|Period 3|Protocol Violation|0|||
162123720|NCT00708305|585504016|FG001|Period 3|Protocol Violation|2|||
162123721|NCT00708305|585504017|FG002|Period 3|Protocol Violation|0|||
162123722|NCT00708305|585504018|FG003|Period 3|Protocol Violation|0|||
162123723|NCT00708305|585504015|FG000|Period 3|Other Reason|1|||
161784558|NCT00996918|584257378|FG004|Overall Study|Loss of Caregiver|0|||
162123724|NCT00708305|585504016|FG001|Period 3|Other Reason|0|||
162123725|NCT00708305|585504017|FG002|Period 3|Other Reason|0|||
161784559|NCT00996918|584257374|FG000|Overall Study|Other|3|||
161784560|NCT00996918|584257375|FG001|Overall Study|Other|1|||
161784561|NCT00996918|584257376|FG002|Overall Study|Other|0|||
162123726|NCT00708305|585504018|FG003|Period 3|Other Reason|0|||
162123727|NCT00192023|585504023|FG000|Period III - Double-Blind|Adverse Event|3|||
162123728|NCT00192023|585504024|FG001|Period III - Double-Blind|Adverse Event|0|||
162123729|NCT00192023|585504023|FG000|Period III - Double-Blind|Physician Decision|2|||
161784562|NCT00996918|584257377|FG003|Overall Study|Other|0|||
162123730|NCT00192023|585504024|FG001|Period III - Double-Blind|Physician Decision|0|||
162123731|NCT00192023|585504023|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
162123732|NCT00192023|585504024|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
162123733|NCT00192023|585504023|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
162123734|NCT00192023|585504024|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
162123735|NCT00192023|585504023|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
162123736|NCT00192023|585504024|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
162123737|NCT00192023|585504023|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
162123738|NCT00192023|585504024|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
162123739|NCT00192023|585504023|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
162123740|NCT00192023|585504024|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
162123741|NCT00192023|585504023|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
162123742|NCT00192023|585504024|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
162123743|NCT00192023|585504023|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
162123744|NCT00192023|585504024|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
162123745|NCT00192023|585504023|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
162123746|NCT00192023|585504024|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
162123747|NCT02572817|585504049|FG000|Overall Study|Death|6|||
162123748|NCT02572817|585504050|FG001|Overall Study|Death|3|||
162123749|NCT02572817|585504049|FG000|Overall Study|Lost to Follow-up|3|||
162123750|NCT02572817|585504050|FG001|Overall Study|Lost to Follow-up|3|||
162123751|NCT00896454|585504072|FG000|Overall Study|Death|10|||
162123752|NCT00896454|585504072|FG000|Overall Study|Adverse Event|8|||
162123753|NCT00896454|585504072|FG000|Overall Study|Disease Progression|5|||
162123754|NCT00896454|585504072|FG000|Overall Study|Other|4|||
162123755|NCT00896454|585504072|FG000|Overall Study|Requirement for alternative therapy|3|||
162123756|NCT00896454|585504072|FG000|Overall Study|Ongoing in study|2|||
162123757|NCT00896454|585504072|FG000|Overall Study|Withdrawal by Subject|1|||
162123758|NCT04175912|585504080|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
162123759|NCT04175912|585504081|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
162123760|NCT04175912|585504080|FG000|Overall Study|Adverse Event|0|||
162123761|NCT04175912|585504081|FG001|Overall Study|Adverse Event|3|||
162123762|NCT04175912|585504080|FG000|Overall Study|Never started treatment|3|||
162123763|NCT04175912|585504081|FG001|Overall Study|Never started treatment|3|||
162123764|NCT04175912|585504080|FG000|Overall Study|Death|0|||
162123765|NCT04175912|585504081|FG001|Overall Study|Death|1|||
162123766|NCT00856661|585504083|FG000|Overall Study|Death|15|||
162123767|NCT00856661|585504084|FG001|Overall Study|Death|18|||
162123768|NCT00856661|585504083|FG000|Overall Study|Protocol Violation|2|||
162123769|NCT00856661|585504084|FG001|Overall Study|Protocol Violation|1|||
162123770|NCT00856661|585504083|FG000|Overall Study|Withdrawal by Subject|1|||
162123771|NCT00856661|585504084|FG001|Overall Study|Withdrawal by Subject|2|||
162123772|NCT00856661|585504083|FG000|Overall Study|Lost to Follow-up|1|||
162123773|NCT00856661|585504084|FG001|Overall Study|Lost to Follow-up|3|||
162123774|NCT00856661|585504083|FG000|Overall Study|Physician Judgement|8|||
162123775|NCT00856661|585504084|FG001|Overall Study|Physician Judgement|5|||
162123776|NCT03936777|585504085|FG000|Overall Study|Adverse Event|3|||
162123777|NCT03936777|585504085|FG000|Overall Study|Death|3|||
162123778|NCT03936777|585504085|FG000|Overall Study|Lack of Efficacy|24|||
162123779|NCT03936777|585504085|FG000|Overall Study|Lost to Follow-up|3|||
162123780|NCT03936777|585504085|FG000|Overall Study|Physician Decision|1|||
162123781|NCT03936777|585504085|FG000|Overall Study|Withdrawal by Subject|11|||
162123782|NCT03936777|585504085|FG000|Overall Study|Subjected Weaned of ZX008|1|||
162123783|NCT03936777|585504085|FG000|Overall Study|Missing|6|||
162123784|NCT02301156|585504086|FG000|Overall Study|Adverse Event|13|||
162123785|NCT02301156|585504087|FG001|Overall Study|Adverse Event|14|||
162123786|NCT02301156|585504086|FG000|Overall Study|Death|1|||
162123787|NCT02301156|585504087|FG001|Overall Study|Death|5|||
162123788|NCT02301156|585504086|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
162123789|NCT02301156|585504087|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
162123790|NCT02301156|585504086|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
162123791|NCT02301156|585504087|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
162242038|NCT02616562|585939068|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162123792|NCT02301156|585504086|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
162123793|NCT02301156|585504087|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
162123794|NCT02301156|585504086|FG000|Overall Study|Reason not Specified|6|||
162123795|NCT02301156|585504087|FG001|Overall Study|Reason not Specified|3|||
162123796|NCT03734991|585504092|FG000|Overall Study|Adverse Event|4|||
162123797|NCT03734991|585504093|FG001|Overall Study|Adverse Event|0|||
162123798|NCT03734991|585504092|FG000|Overall Study|Lost to Follow-up|4|||
162123799|NCT03734991|585504093|FG001|Overall Study|Lost to Follow-up|0|||
162123800|NCT03734991|585504092|FG000|Overall Study|Physician Decision|0|||
162123801|NCT03734991|585504093|FG001|Overall Study|Physician Decision|1|||
162123802|NCT03734991|585504092|FG000|Overall Study|Pregnancy|1|||
162123803|NCT03734991|585504093|FG001|Overall Study|Pregnancy|0|||
162123804|NCT03734991|585504092|FG000|Overall Study|Withdrawal by Subject|6|||
162123805|NCT03734991|585504093|FG001|Overall Study|Withdrawal by Subject|3|||
162123806|NCT03734991|585504092|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
162123807|NCT03734991|585504093|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
162123808|NCT03734991|585504092|FG000|Overall Study|Other|2|||
162123809|NCT03734991|585504093|FG001|Overall Study|Other|2|||
162123810|NCT02638623|585504094|FG000|Overall Study|Surgery timing|5|||
162123811|NCT02638623|585504095|FG001|Overall Study|Surgery timing|6|||
162123812|NCT02638623|585504094|FG000|Overall Study|Not given intervention|2|||
162123813|NCT02638623|585504095|FG001|Overall Study|Not given intervention|0|||
162123814|NCT03797326|585504101|FG000|Overall Study|Lost to Follow-up|1|||
162123815|NCT03797326|585504102|FG001|Overall Study|Lost to Follow-up|0|||
162123816|NCT03797326|585504103|FG002|Overall Study|Lost to Follow-up|0|||
162123817|NCT03797326|585504104|FG003|Overall Study|Lost to Follow-up|1|||
162123818|NCT03797326|585504105|FG004|Overall Study|Lost to Follow-up|0|||
162123819|NCT03797326|585504106|FG005|Overall Study|Lost to Follow-up|0|||
162123820|NCT03797326|585504107|FG006|Overall Study|Lost to Follow-up|0|||
162123821|NCT03797326|585504108|FG007|Overall Study|Lost to Follow-up|0|||
162123822|NCT03797326|585504101|FG000|Overall Study|Withdrawal by Subject|0|||
162123823|NCT03797326|585504102|FG001|Overall Study|Withdrawal by Subject|0|||
162123824|NCT03797326|585504103|FG002|Overall Study|Withdrawal by Subject|1|||
162123825|NCT03797326|585504104|FG003|Overall Study|Withdrawal by Subject|3|||
162123826|NCT03797326|585504105|FG004|Overall Study|Withdrawal by Subject|0|||
162123827|NCT03797326|585504106|FG005|Overall Study|Withdrawal by Subject|2|||
162123828|NCT03797326|585504107|FG006|Overall Study|Withdrawal by Subject|2|||
162123829|NCT03797326|585504108|FG007|Overall Study|Withdrawal by Subject|3|||
162123830|NCT03797326|585504101|FG000|Overall Study|Sponsor Decision|3|||
162123831|NCT03797326|585504102|FG001|Overall Study|Sponsor Decision|3|||
162123832|NCT03797326|585504103|FG002|Overall Study|Sponsor Decision|3|||
162123833|NCT03797326|585504104|FG003|Overall Study|Sponsor Decision|6|||
162123834|NCT03797326|585504105|FG004|Overall Study|Sponsor Decision|0|||
162123835|NCT03797326|585504106|FG005|Overall Study|Sponsor Decision|3|||
162123836|NCT03797326|585504107|FG006|Overall Study|Sponsor Decision|3|||
162123837|NCT03797326|585504108|FG007|Overall Study|Sponsor Decision|2|||
162123838|NCT03797326|585504101|FG000|Overall Study|Death|27|||
162123839|NCT03797326|585504102|FG001|Overall Study|Death|28|||
162123840|NCT03797326|585504103|FG002|Overall Study|Death|95|||
162123841|NCT03797326|585504104|FG003|Overall Study|Death|95|||
162123842|NCT03797326|585504105|FG004|Overall Study|Death|30|||
162123843|NCT03797326|585504106|FG005|Overall Study|Death|96|||
162123844|NCT03797326|585504107|FG006|Overall Study|Death|97|||
162123845|NCT03797326|585504108|FG007|Overall Study|Death|98|||
162123846|NCT03797326|585504101|FG000|Overall Study|Enrolled in error|0|||
162123847|NCT03797326|585504102|FG001|Overall Study|Enrolled in error|0|||
162123848|NCT03797326|585504103|FG002|Overall Study|Enrolled in error|3|||
162123849|NCT03797326|585504104|FG003|Overall Study|Enrolled in error|2|||
162123850|NCT03797326|585504105|FG004|Overall Study|Enrolled in error|2|||
162123851|NCT03797326|585504106|FG005|Overall Study|Enrolled in error|1|||
162123852|NCT03797326|585504107|FG006|Overall Study|Enrolled in error|1|||
162123853|NCT03797326|585504108|FG007|Overall Study|Enrolled in error|0|||
162123854|NCT03012061|585504109|FG000|Overall Study|Withdrawal by Subject|1|||
162123855|NCT03012061|585504110|FG001|Overall Study|Withdrawal by Subject|5|||
162123856|NCT03012061|585504111|FG002|Overall Study|Withdrawal by Subject|4|||
162123857|NCT03012061|585504109|FG000|Overall Study|Investigator Site Closed|1|||
162123858|NCT03012061|585504110|FG001|Overall Study|Investigator Site Closed|2|||
162123859|NCT03012061|585504111|FG002|Overall Study|Investigator Site Closed|0|||
162123860|NCT03012061|585504109|FG000|Overall Study|Lost to Follow-up|2|||
162123861|NCT03012061|585504110|FG001|Overall Study|Lost to Follow-up|1|||
162123862|NCT03012061|585504111|FG002|Overall Study|Lost to Follow-up|0|||
162123863|NCT03012061|585504109|FG000|Overall Study|Study closed/ Terminated|0|||
162123864|NCT03012061|585504110|FG001|Overall Study|Study closed/ Terminated|0|||
162123865|NCT03012061|585504111|FG002|Overall Study|Study closed/ Terminated|1|||
162123866|NCT03012061|585504109|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
161898197|NCT00572455|584675565|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
161898198|NCT00572455|584675566|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
161898199|NCT00572455|584675567|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
161898200|NCT00572455|584675568|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
162123867|NCT03012061|585504110|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
162123868|NCT03012061|585504111|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
162123869|NCT03012061|585504109|FG000|Overall Study|Protocol Violation|0|||
162123870|NCT03012061|585504110|FG001|Overall Study|Protocol Violation|0|||
162123871|NCT03012061|585504111|FG002|Overall Study|Protocol Violation|2|||
162123872|NCT03012061|585504109|FG000|Overall Study|Lack of Efficacy|0|||
162123873|NCT03012061|585504110|FG001|Overall Study|Lack of Efficacy|1|||
162123874|NCT03012061|585504111|FG002|Overall Study|Lack of Efficacy|0|||
162123875|NCT03012061|585504109|FG000|Overall Study|Adverse Event|2|||
162123876|NCT03012061|585504110|FG001|Overall Study|Adverse Event|0|||
162123877|NCT03012061|585504111|FG002|Overall Study|Adverse Event|0|||
162123878|NCT04152343|585504112|FG000|Overall Study|Transplanted|5|||
162123879|NCT04152343|585504112|FG000|Overall Study|Death|20|||
162123880|NCT04152343|585504112|FG000|Overall Study|Lost to Follow-up|3|||
162123881|NCT01965938|585504113|FG000|Overall Study|Withdrawal by Subject|1|||
162123882|NCT01965938|585504114|FG001|Overall Study|Withdrawal by Subject|0|||
162123883|NCT01164228|585504115|FG000|Overall Study|Progression|24|||
162123884|NCT01164228|585504116|FG001|Overall Study|Progression|25|||
162123885|NCT01164228|585504115|FG000|Overall Study|Adverse Event|13|||
162123886|NCT01164228|585504116|FG001|Overall Study|Adverse Event|7|||
162123887|NCT01164228|585504115|FG000|Overall Study|Death|1|||
162123888|NCT01164228|585504116|FG001|Overall Study|Death|1|||
162123889|NCT01164228|585504115|FG000|Overall Study|Withdrawal by Subject|2|||
162123890|NCT01164228|585504116|FG001|Overall Study|Withdrawal by Subject|0|||
162123891|NCT01164228|585504115|FG000|Overall Study|Physician Decision|1|||
162123892|NCT01164228|585504116|FG001|Overall Study|Physician Decision|2|||
162123893|NCT01164228|585504115|FG000|Overall Study|Symptomatic deterioration|1|||
162123894|NCT01164228|585504116|FG001|Overall Study|Symptomatic deterioration|0|||
162123895|NCT01164228|585504115|FG000|Overall Study|Never started treatment|1|||
162123896|NCT01164228|585504116|FG001|Overall Study|Never started treatment|3|||
162123897|NCT01164228|585504115|FG000|Overall Study|Ineligible|1|||
162123898|NCT01164228|585504116|FG001|Overall Study|Ineligible|0|||
162123899|NCT03342053|585504118|FG000|Overall Study|Adverse Event|2|||
162123900|NCT03342053|585504119|FG001|Overall Study|Adverse Event|0|||
162123901|NCT03342053|585504118|FG000|Overall Study|Withdrawal by Subject|0|||
162123902|NCT03342053|585504119|FG001|Overall Study|Withdrawal by Subject|1|||
162123903|NCT02294474|585504120|FG000|Overall Study|Adverse Event|7|||
162123904|NCT02294474|585504121|FG001|Overall Study|Adverse Event|7|||
162123905|NCT02294474|585504120|FG000|Overall Study|Lack of Efficacy|2|||
162123906|NCT02294474|585504121|FG001|Overall Study|Lack of Efficacy|1|||
162123907|NCT02294474|585504120|FG000|Overall Study|Protocol Violation|4|||
162123908|NCT02294474|585504121|FG001|Overall Study|Protocol Violation|2|||
162123909|NCT02294474|585504120|FG000|Overall Study|Other than specified above|12|||
162123910|NCT02294474|585504121|FG001|Overall Study|Other than specified above|12|||
162123911|NCT02961374|585504122|FG000|Overall Study|Adverse Event|4|||
162123912|NCT00171873|585504125|FG000|Overall Study|Withdrawal by Subject|4|||
162123913|NCT00171873|585504126|FG001|Overall Study|Withdrawal by Subject|2|||
162123914|NCT00171873|585504125|FG000|Overall Study|Adverse Event|5|||
162123915|NCT00171873|585504126|FG001|Overall Study|Adverse Event|0|||
162123916|NCT00171873|585504125|FG000|Overall Study|Switched to Octreotide|0|||
162123917|NCT00171873|585504126|FG001|Overall Study|Switched to Octreotide|1|||
162123918|NCT02041923|585504127|FG000|Overall Study|Lost to Follow-up|26|||
162123919|NCT02041923|585504128|FG001|Overall Study|Lost to Follow-up|30|||
162123920|NCT00309608|585504131|FG000|Overall Study|Adverse Event|1|||
162123921|NCT00309608|585504132|FG001|Overall Study|Adverse Event|5|||
162123922|NCT00309608|585504133|FG002|Overall Study|Adverse Event|3|||
162123923|NCT00309608|585504134|FG003|Overall Study|Adverse Event|2|||
162123924|NCT00309608|585504135|FG004|Overall Study|Adverse Event|3|||
162123925|NCT00309608|585504131|FG000|Overall Study|Protocol Violation|2|||
162123926|NCT00309608|585504132|FG001|Overall Study|Protocol Violation|0|||
162123927|NCT00309608|585504133|FG002|Overall Study|Protocol Violation|0|||
162123928|NCT00309608|585504134|FG003|Overall Study|Protocol Violation|0|||
162123929|NCT00309608|585504135|FG004|Overall Study|Protocol Violation|0|||
162123930|NCT00309608|585504131|FG000|Overall Study|Lost to Follow-up|0|||
162123931|NCT00309608|585504132|FG001|Overall Study|Lost to Follow-up|0|||
162123932|NCT00309608|585504133|FG002|Overall Study|Lost to Follow-up|2|||
162123933|NCT00309608|585504134|FG003|Overall Study|Lost to Follow-up|0|||
162123934|NCT00309608|585504135|FG004|Overall Study|Lost to Follow-up|1|||
162123935|NCT00309608|585504131|FG000|Overall Study|Withdrawal by Subject|1|||
162123936|NCT00309608|585504132|FG001|Overall Study|Withdrawal by Subject|4|||
162123937|NCT00309608|585504133|FG002|Overall Study|Withdrawal by Subject|2|||
162123938|NCT00309608|585504134|FG003|Overall Study|Withdrawal by Subject|0|||
162123939|NCT00309608|585504135|FG004|Overall Study|Withdrawal by Subject|0|||
162123940|NCT00309608|585504131|FG000|Overall Study|Other incl. Lack of efficacy|10|||
162123941|NCT00309608|585504132|FG001|Overall Study|Other incl. Lack of efficacy|4|||
162123942|NCT00309608|585504133|FG002|Overall Study|Other incl. Lack of efficacy|3|||
162123943|NCT00309608|585504134|FG003|Overall Study|Other incl. Lack of efficacy|4|||
162123944|NCT00309608|585504135|FG004|Overall Study|Other incl. Lack of efficacy|0|||
162123945|NCT00127413|585504136|FG000|Overall Study|Lost to Follow-up|6|||
162123946|NCT00127413|585504137|FG001|Overall Study|Lost to Follow-up|4|||
162123947|NCT00127413|585504138|FG002|Overall Study|Lost to Follow-up|8|||
162123948|NCT00127413|585504139|FG003|Overall Study|Lost to Follow-up|2|||
162123949|NCT01282476|585506108|FG000|Overall Study|Death|11|||
162123950|NCT00592319|585506111|FG000|Overall Study|Lost to Follow-up|0|||
162123951|NCT00592319|585506112|FG001|Overall Study|Lost to Follow-up|3|||
162123952|NCT01087723|585506114|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
162123953|NCT01087723|585506115|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
162123954|NCT01087723|585506114|FG000|Overall Study|Withdrawal by Subject|10|||
162123955|NCT01087723|585506115|FG001|Overall Study|Withdrawal by Subject|13|||
162123956|NCT01087723|585506114|FG000|Overall Study|Physician Decision|2|||
162123957|NCT01087723|585506115|FG001|Overall Study|Physician Decision|0|||
162123958|NCT01087723|585506114|FG000|Overall Study|Lost to Follow-up|1|||
162123959|NCT01087723|585506115|FG001|Overall Study|Lost to Follow-up|4|||
162123960|NCT01087723|585506114|FG000|Overall Study|Reason Not Specified|1|||
162123961|NCT01087723|585506115|FG001|Overall Study|Reason Not Specified|2|||
162123962|NCT01868035|585506116|FG000|Overall Study|Lost to Follow-up|3|||
162123963|NCT01868035|585506116|FG000|Overall Study|Withdrawal by Subject|1|||
162123964|NCT01868035|585506116|FG000|Overall Study|Progressive Disease|2|||
162123965|NCT01868035|585506116|FG000|Overall Study|Non-compliance|1|||
162123966|NCT01757665|585506121|FG000|Overall Study|Still on Study - Visit Completed|240|||
162123967|NCT01757665|585506122|FG001|Overall Study|Still on Study - Visit Completed|30|||
162123968|NCT01757665|585506121|FG000|Overall Study|Still on Study - Visit Pending|398|||
162123969|NCT01757665|585506122|FG001|Overall Study|Still on Study - Visit Pending|40|||
162123970|NCT01757665|585506121|FG000|Overall Study|Still on Study - Missed Visit|14|||
162123971|NCT01757665|585506122|FG001|Overall Study|Still on Study - Missed Visit|1|||
162123972|NCT01757665|585506121|FG000|Overall Study|Death|25|||
162123973|NCT01757665|585506122|FG001|Overall Study|Death|8|||
162123974|NCT01757665|585506121|FG000|Overall Study|Explant|1|||
162123975|NCT01757665|585506122|FG001|Overall Study|Explant|2|||
162123976|NCT01757665|585506121|FG000|Overall Study|Withdrawal by Subject|10|||
162123977|NCT01757665|585506122|FG001|Overall Study|Withdrawal by Subject|0|||
162123978|NCT01757665|585506121|FG000|Overall Study|Lost to Follow-up|1|||
162123979|NCT01757665|585506122|FG001|Overall Study|Lost to Follow-up|1|||
162123980|NCT01757665|585506121|FG000|Overall Study|Not Implanted with Device|5|||
162123981|NCT01757665|585506122|FG001|Overall Study|Not Implanted with Device|1|||
162123982|NCT01912222|585506125|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
162123983|NCT01912222|585506126|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
162123984|NCT01912222|585506127|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
162123985|NCT01912222|585506125|FG000|Part B: Treatment Period|Progressive disease|10|||
162123986|NCT01912222|585506126|FG001|Part B: Treatment Period|Progressive disease|12|||
162123987|NCT01912222|585506127|FG002|Part B: Treatment Period|Progressive disease|15|||
162123988|NCT01912222|585506125|FG000|Part B: Treatment Period|Adverse Event|1|||
162123989|NCT01912222|585506126|FG001|Part B: Treatment Period|Adverse Event|2|||
162123990|NCT01912222|585506127|FG002|Part B: Treatment Period|Adverse Event|3|||
162123991|NCT01912222|585506125|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
162123992|NCT01912222|585506126|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
162123993|NCT01912222|585506127|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
162123994|NCT00154063|585506128|FG000|Overall Study|Adverse Event|4|||
162123995|NCT00154063|585506129|FG001|Overall Study|Adverse Event|8|||
162123996|NCT00154063|585506128|FG000|Overall Study|Protocol Violation|1|||
162123997|NCT00154063|585506129|FG001|Overall Study|Protocol Violation|1|||
162123998|NCT00154063|585506128|FG000|Overall Study|Investigator or Sponsor Request|0|||
162123999|NCT00154063|585506129|FG001|Overall Study|Investigator or Sponsor Request|1|||
162124000|NCT00154063|585506128|FG000|Overall Study|Withdrawal by Subject|4|||
162124001|NCT00154063|585506129|FG001|Overall Study|Withdrawal by Subject|9|||
162124002|NCT00154063|585506128|FG000|Overall Study|Other|3|||
162124003|NCT00154063|585506129|FG001|Overall Study|Other|3|||
162124004|NCT01804673|585506130|FG000|Overall Study|Adverse Event|4|||
162124005|NCT01804673|585506130|FG000|Overall Study|Withdrawal by Subject|1|||
162124006|NCT01804673|585506130|FG000|Overall Study|Lack of Efficacy|9|||
162124007|NCT01804673|585506130|FG000|Overall Study|Change to Oral Therapy|37|||
162124008|NCT01804673|585506130|FG000|Overall Study|No Further Therapy Required|84|||
162124009|NCT01804673|585506130|FG000|Overall Study|Use of Prohibited Medication|1|||
162124010|NCT01804673|585506130|FG000|Overall Study|Other|4|||
162124011|NCT01857934|585506138|FG000|Overall Study|Relapse or progression|2|||
162124012|NCT01857934|585506138|FG000|Overall Study|Unacceptable toxicity|3|||
162124013|NCT01857934|585506138|FG000|Overall Study|Unwillingness or inability to comply|2|||
162124014|NCT01857934|585506138|FG000|Overall Study|Physician Decision|3|||
162124015|NCT04012814|585506145|FG000|Overall Study|Lost to Follow-up|4|||
162124016|NCT04012814|585506145|FG000|Overall Study|Withdrawal by Subject|2|||
162124017|NCT04012814|585506145|FG000|Overall Study|Protocol Violation|1|||
162124018|NCT04012814|585506145|FG000|Overall Study|Adverse Event|1|||
162124019|NCT04789577|585506146|FG000|Overall Study|Withdrawal by Subject|1|||
162124020|NCT04789577|585506147|FG001|Overall Study|Withdrawal by Subject|1|||
162124021|NCT04789577|585506148|FG002|Overall Study|Withdrawal by Subject|1|||
162124022|NCT04789577|585506149|FG003|Overall Study|Withdrawal by Subject|3|||
162124023|NCT04789577|585506150|FG004|Overall Study|Withdrawal by Subject|1|||
162124024|NCT04789577|585506151|FG005|Overall Study|Withdrawal by Subject|7|||
162124025|NCT04789577|585506152|FG006|Overall Study|Withdrawal by Subject|1|||
162124026|NCT04789577|585506146|FG000|Overall Study|Lost to Follow-up|7|||
162124027|NCT04789577|585506147|FG001|Overall Study|Lost to Follow-up|12|||
162124028|NCT04789577|585506148|FG002|Overall Study|Lost to Follow-up|7|||
162124029|NCT04789577|585506149|FG003|Overall Study|Lost to Follow-up|10|||
162124030|NCT04789577|585506150|FG004|Overall Study|Lost to Follow-up|8|||
162124031|NCT04789577|585506151|FG005|Overall Study|Lost to Follow-up|6|||
162124032|NCT04789577|585506152|FG006|Overall Study|Lost to Follow-up|10|||
162124033|NCT04789577|585506146|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
162124034|NCT04789577|585506147|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
162124035|NCT04789577|585506148|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
162124036|NCT04789577|585506149|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
162124037|NCT04789577|585506150|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
162124038|NCT04789577|585506151|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
162124039|NCT04789577|585506152|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
162124040|NCT04789577|585506146|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
162124041|NCT04789577|585506147|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
162124042|NCT04789577|585506148|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
162124043|NCT04789577|585506149|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
162124044|NCT04789577|585506150|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
162124045|NCT04789577|585506151|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
162124046|NCT04789577|585506152|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
162124047|NCT02441946|585506153|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
162124048|NCT02441946|585506154|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
162124049|NCT02441946|585506155|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
162124050|NCT02441946|585506153|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
162124051|NCT02441946|585506154|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
162124052|NCT02441946|585506155|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
162124053|NCT02441946|585506153|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
162124054|NCT02441946|585506154|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
162124055|NCT02441946|585506155|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
162124056|NCT02441946|585506153|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
162124057|NCT02441946|585506154|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
162124058|NCT02441946|585506155|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
162124059|NCT02441946|585506153|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
162124060|NCT02441946|585506154|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
162124061|NCT02441946|585506155|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
162124062|NCT02441946|585506153|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
162124063|NCT02441946|585506154|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
162124064|NCT02441946|585506155|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
162124065|NCT02441946|585506153|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
162124066|NCT02441946|585506154|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
162124067|NCT02441946|585506155|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
162124068|NCT02441946|585506153|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
162124069|NCT02441946|585506154|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
162124070|NCT02441946|585506155|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
162124071|NCT02441946|585506153|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
162124072|NCT02441946|585506154|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
162124073|NCT02441946|585506155|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
162124074|NCT02441946|585506153|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
162124075|NCT02441946|585506154|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
162124076|NCT02441946|585506155|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
162124077|NCT02441946|585506153|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
162124078|NCT02441946|585506154|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
162124079|NCT02441946|585506155|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161784563|NCT00996918|584257378|FG004|Overall Study|Other|0|||
161784564|NCT01965535|584257381|FG000|Overall Study|Lack of Efficacy|2|||
161784565|NCT01965535|584257382|FG001|Overall Study|Lack of Efficacy|1|||
161784566|NCT00829439|584257384|FG000|Overall Study|Adverse Event|0|||
161784567|NCT00829439|584257385|FG001|Overall Study|Adverse Event|0|||
161784568|NCT00829439|584257386|FG002|Overall Study|Adverse Event|1|||
161784569|NCT00829439|584257387|FG003|Overall Study|Adverse Event|0|||
161784570|NCT02525562|584257388|FG000|Overall Study|Death|9|||
161784571|NCT02525562|584257389|FG001|Overall Study|Death|0|||
161784572|NCT02525562|584257390|FG002|Overall Study|Death|0|||
161784573|NCT02525562|584257388|FG000|Overall Study|Lost to Follow-up|19|||
161784574|NCT02525562|584257389|FG001|Overall Study|Lost to Follow-up|0|||
161784575|NCT02525562|584257390|FG002|Overall Study|Lost to Follow-up|0|||
161784576|NCT02525562|584257388|FG000|Overall Study|Withdrawal by Subject|37|||
161784577|NCT02525562|584257389|FG001|Overall Study|Withdrawal by Subject|0|||
161784578|NCT02525562|584257390|FG002|Overall Study|Withdrawal by Subject|0|||
161784579|NCT02525562|584257388|FG000|Overall Study|Revision/Removal of Study Device|4|||
161784580|NCT02525562|584257389|FG001|Overall Study|Revision/Removal of Study Device|0|||
162124080|NCT00579982|585506160|FG000|Overall Study|Adverse Event|4|||
161784581|NCT02525562|584257390|FG002|Overall Study|Revision/Removal of Study Device|0|||
161784582|NCT02525562|584257388|FG000|Overall Study|Study Closed by Sponsor|154|||
161784583|NCT02525562|584257389|FG001|Overall Study|Study Closed by Sponsor|0|||
161784584|NCT02525562|584257390|FG002|Overall Study|Study Closed by Sponsor|0|||
161784585|NCT00886782|584257391|FG000|Overall Study|Disease progression|3|||
162124081|NCT00579982|585506160|FG000|Overall Study|Protocol Violation|4|||
162124082|NCT00988351|585506162|FG000|Overall Study|Withdrawal by Subject|8|||
162124083|NCT00988351|585506163|FG001|Overall Study|Withdrawal by Subject|0|||
162124084|NCT00988351|585506162|FG000|Overall Study|Lost to Follow-up|6|||
162124085|NCT00988351|585506163|FG001|Overall Study|Lost to Follow-up|9|||
162124086|NCT00988351|585506162|FG000|Overall Study|not using CPAP|5|||
162124087|NCT00988351|585506163|FG001|Overall Study|not using CPAP|3|||
162124088|NCT02038764|585506164|FG000|Overall Study|Adverse Event|0|||
162124089|NCT02038764|585506165|FG001|Overall Study|Adverse Event|0|||
162124090|NCT02038764|585506166|FG002|Overall Study|Adverse Event|1|||
162124091|NCT02038764|585506167|FG003|Overall Study|Adverse Event|0|||
162124092|NCT02038764|585506168|FG004|Overall Study|Adverse Event|0|||
162124093|NCT02038764|585506164|FG000|Overall Study|Lost to Follow-up|0|||
162124094|NCT02038764|585506165|FG001|Overall Study|Lost to Follow-up|1|||
162124095|NCT02038764|585506166|FG002|Overall Study|Lost to Follow-up|0|||
162124096|NCT02038764|585506167|FG003|Overall Study|Lost to Follow-up|0|||
162124097|NCT02038764|585506168|FG004|Overall Study|Lost to Follow-up|0|||
162124098|NCT02038764|585506164|FG000|Overall Study|Withdrawal by Subject|0|||
162124099|NCT02038764|585506165|FG001|Overall Study|Withdrawal by Subject|0|||
162124100|NCT02038764|585506166|FG002|Overall Study|Withdrawal by Subject|0|||
162124101|NCT02038764|585506167|FG003|Overall Study|Withdrawal by Subject|0|||
162124102|NCT02038764|585506168|FG004|Overall Study|Withdrawal by Subject|1|||
162124103|NCT02038764|585506164|FG000|Overall Study|Other|1|||
162124104|NCT02038764|585506165|FG001|Overall Study|Other|0|||
162124105|NCT02038764|585506166|FG002|Overall Study|Other|1|||
162124106|NCT02038764|585506167|FG003|Overall Study|Other|0|||
162124107|NCT02038764|585506168|FG004|Overall Study|Other|0|||
162124108|NCT04297241|585506173|FG000|Overall Study|Withdrawal by Subject|1|||
162124109|NCT04297241|585506173|FG000|Overall Study|Adverse Event|1|||
162124110|NCT04297241|585506173|FG000|Overall Study|Physician Decision|3|||
162124111|NCT02836613|585506178|FG000|Overall Study|Accidental drowning|1|||
162124112|NCT02836613|585506179|FG001|Overall Study|Accidental drowning|0|||
162124113|NCT02836613|585506178|FG000|Overall Study|Lost to Follow-up|0|||
162124114|NCT02836613|585506179|FG001|Overall Study|Lost to Follow-up|1|||
162124115|NCT02836613|585506178|FG000|Overall Study|Withdrawal by Subject|0|||
162124116|NCT02836613|585506179|FG001|Overall Study|Withdrawal by Subject|2|||
162124117|NCT01464255|585506180|FG000|Overall Study|unresolve corneal staining|0|||
162124118|NCT01464255|585506181|FG001|Overall Study|unresolve corneal staining|1|||
162124119|NCT01799720|585506182|FG000|Overall Study|Withdrawal by Subject|3|||
162124120|NCT01799720|585506183|FG001|Overall Study|Withdrawal by Subject|0|||
162124121|NCT01799720|585506184|FG002|Overall Study|Withdrawal by Subject|0|||
162124122|NCT01799720|585506182|FG000|Overall Study|Protocol Violation|0|||
162124123|NCT01799720|585506183|FG001|Overall Study|Protocol Violation|1|||
162124124|NCT01799720|585506184|FG002|Overall Study|Protocol Violation|0|||
162124125|NCT01799720|585506182|FG000|Overall Study|Pregnancy|0|||
162124126|NCT01799720|585506183|FG001|Overall Study|Pregnancy|0|||
162124127|NCT01799720|585506184|FG002|Overall Study|Pregnancy|1|||
162124128|NCT04654468|585506193|FG000|Overall Study|Death|1|||
162124129|NCT04654468|585506193|FG000|Overall Study|Ongoing in the Study|50|||
162124130|NCT01155661|585506194|FG000|Overall Study|Adverse Event|101|||
162124131|NCT01155661|585506194|FG000|Overall Study|Death|1|||
162124132|NCT01155661|585506194|FG000|Overall Study|Lack of Efficacy|32|||
162124133|NCT01155661|585506194|FG000|Overall Study|Lost to Follow-up|22|||
162124134|NCT01155661|585506194|FG000|Overall Study|Physician Decision|3|||
162124135|NCT01155661|585506194|FG000|Overall Study|Protocol Violation|35|||
162124136|NCT01155661|585506194|FG000|Overall Study|Withdrawal by Subject|73|||
162124137|NCT01155661|585506194|FG000|Overall Study|Sponsor Decision|13|||
162124138|NCT05064735|585506204|FG000|Overall Study|Withdrawal by Subject|7|||
162124139|NCT05064735|585506205|FG001|Overall Study|Withdrawal by Subject|8|||
162124140|NCT05064735|585506204|FG000|Overall Study|Lost to Follow-up|7|||
162124141|NCT05064735|585506205|FG001|Overall Study|Lost to Follow-up|2|||
162124142|NCT05064735|585506204|FG000|Overall Study|Physician Decision|2|||
162124143|NCT05064735|585506205|FG001|Overall Study|Physician Decision|1|||
162124144|NCT05064735|585506204|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
162124145|NCT05064735|585506205|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
162124146|NCT05064735|585506204|FG000|Overall Study|Site Closure|7|||
162124147|NCT05064735|585506205|FG001|Overall Study|Site Closure|2|||
162124148|NCT04844970|585506210|FG000|Overall Study|Adverse Event|0|||
162124149|NCT04844970|585506211|FG001|Overall Study|Adverse Event|1|||
162124150|NCT04844970|585506210|FG000|Overall Study|Withdrawal by Subject|2|||
162124151|NCT04844970|585506211|FG001|Overall Study|Withdrawal by Subject|0|||
162124152|NCT03169881|585506212|FG000|Overall Study|Incomplete Follow-up|10|||
162124153|NCT03169881|585506213|FG001|Overall Study|Incomplete Follow-up|15|||
162124154|NCT03169881|585506212|FG000|Overall Study|Lost to Follow-up|18|||
162124155|NCT03169881|585506213|FG001|Overall Study|Lost to Follow-up|20|||
162124156|NCT03169881|585506212|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
162124157|NCT03169881|585506213|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
162124158|NCT00447954|585506214|FG000|Overall Study|Adverse Event|0|||
162124159|NCT00447954|585506215|FG001|Overall Study|Adverse Event|2|||
162124160|NCT00447954|585506216|FG002|Overall Study|Adverse Event|0|||
162124161|NCT00447954|585506214|FG000|Overall Study|Withdrawal by Subject|0|||
162124162|NCT00447954|585506215|FG001|Overall Study|Withdrawal by Subject|1|||
162124163|NCT00447954|585506216|FG002|Overall Study|Withdrawal by Subject|1|||
161784586|NCT00886782|584257392|FG001|Overall Study|Disease progression|3|||
161784587|NCT00886782|584257393|FG002|Overall Study|Disease progression|3|||
161784588|NCT00886782|584257391|FG000|Overall Study|Study drug toxicity|0|||
161784589|NCT00886782|584257392|FG001|Overall Study|Study drug toxicity|0|||
161784590|NCT00886782|584257393|FG002|Overall Study|Study drug toxicity|1|||
161784591|NCT00886782|584257391|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
161784592|NCT00886782|584257392|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
161784593|NCT00886782|584257393|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
161784594|NCT01946282|584257394|FG000|Year 1|Did not return FIT kit|4186|||
161784595|NCT01946282|584257395|FG001|Year 1|Did not return FIT kit|608|||
161784596|NCT01946282|584257396|FG002|Year 1|Did not return FIT kit|654|||
161784597|NCT01946282|584257394|FG000|Year 2|Did not return FIT kit|803|||
161784598|NCT01946282|584257395|FG001|Year 2|Did not return FIT kit|131|||
161784599|NCT01946282|584257396|FG002|Year 2|Did not return FIT kit|115|||
161784600|NCT01946282|584257394|FG000|Year 3|Did not return FIT kit|288|||
161784601|NCT01946282|584257395|FG001|Year 3|Did not return FIT kit|43|||
161784602|NCT01946282|584257396|FG002|Year 3|Did not return FIT kit|30|||
161784603|NCT00078819|584257397|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
161784604|NCT00078819|584257398|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
161784605|NCT00078819|584257399|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
161784606|NCT00078819|584257400|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
161784607|NCT00078819|584257397|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
161784608|NCT00078819|584257398|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
161784609|NCT00078819|584257399|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
161784610|NCT00078819|584257400|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
161784611|NCT00078819|584257397|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
161784612|NCT00078819|584257398|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
161784613|NCT00078819|584257399|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
161784614|NCT00078819|584257400|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
161784615|NCT00078819|584257397|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
161784616|NCT00078819|584257398|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
161784617|NCT00078819|584257399|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
161784618|NCT00078819|584257400|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
161784619|NCT00078819|584257397|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
161784620|NCT00078819|584257398|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
161784621|NCT00078819|584257399|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
161784622|NCT00078819|584257400|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
161784623|NCT00078819|584257397|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
161784624|NCT00078819|584257398|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
161784625|NCT00078819|584257399|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
161784626|NCT00078819|584257400|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
161784627|NCT00078819|584257397|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
161784628|NCT00078819|584257398|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
161784629|NCT00078819|584257399|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
161784630|NCT00078819|584257400|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
161784631|NCT00078819|584257397|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
161784632|NCT00078819|584257398|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
161784633|NCT00078819|584257399|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
161784634|NCT00078819|584257400|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
161784635|NCT04130919|584257401|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
161784636|NCT04130919|584257402|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
161784637|NCT04130919|584257403|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
161784638|NCT04130919|584257404|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
161784639|NCT04130919|584257405|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
161784640|NCT04130919|584257406|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
161784641|NCT04130919|584257401|FG000|Blinded Treatment Phase|Adverse Event|0|||
161784642|NCT04130919|584257402|FG001|Blinded Treatment Phase|Adverse Event|0|||
161784643|NCT04130919|584257403|FG002|Blinded Treatment Phase|Adverse Event|1|||
161784644|NCT04130919|584257404|FG003|Blinded Treatment Phase|Adverse Event|0|||
161784645|NCT04130919|584257405|FG004|Blinded Treatment Phase|Adverse Event|0|||
161784646|NCT04130919|584257406|FG005|Blinded Treatment Phase|Adverse Event|0|||
161784647|NCT04130919|584257401|FG000|Blinded Treatment Phase|Disease worsening|0|||
161784648|NCT04130919|584257402|FG001|Blinded Treatment Phase|Disease worsening|0|||
161784649|NCT04130919|584257403|FG002|Blinded Treatment Phase|Disease worsening|1|||
161898201|NCT00572455|584675569|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
161784650|NCT04130919|584257404|FG003|Blinded Treatment Phase|Disease worsening|0|||
161784651|NCT04130919|584257405|FG004|Blinded Treatment Phase|Disease worsening|0|||
161784652|NCT04130919|584257406|FG005|Blinded Treatment Phase|Disease worsening|0|||
161898202|NCT00572455|584675570|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
161784653|NCT04130919|584257401|FG000|Blinded Treatment Phase|Investigator's decision|0|||
161784654|NCT04130919|584257402|FG001|Blinded Treatment Phase|Investigator's decision|1|||
161784655|NCT04130919|584257403|FG002|Blinded Treatment Phase|Investigator's decision|0|||
161784656|NCT04130919|584257404|FG003|Blinded Treatment Phase|Investigator's decision|0|||
161784657|NCT04130919|584257405|FG004|Blinded Treatment Phase|Investigator's decision|0|||
161784658|NCT04130919|584257406|FG005|Blinded Treatment Phase|Investigator's decision|0|||
161784659|NCT04130919|584257401|FG000|Blinded Treatment Phase|Withdrew consent|1|||
161784660|NCT04130919|584257402|FG001|Blinded Treatment Phase|Withdrew consent|0|||
161784661|NCT04130919|584257403|FG002|Blinded Treatment Phase|Withdrew consent|0|||
161784662|NCT04130919|584257404|FG003|Blinded Treatment Phase|Withdrew consent|0|||
161784663|NCT04130919|584257405|FG004|Blinded Treatment Phase|Withdrew consent|0|||
161784664|NCT04130919|584257406|FG005|Blinded Treatment Phase|Withdrew consent|0|||
161784665|NCT04130919|584257401|FG000|Open-label Treatment Phase|Withdrew consent|0|||
161784666|NCT04130919|584257402|FG001|Open-label Treatment Phase|Withdrew consent|0|||
161784667|NCT04130919|584257403|FG002|Open-label Treatment Phase|Withdrew consent|0|||
161784668|NCT04130919|584257404|FG003|Open-label Treatment Phase|Withdrew consent|1|||
161784669|NCT04130919|584257405|FG004|Open-label Treatment Phase|Withdrew consent|1|||
161784670|NCT04130919|584257406|FG005|Open-label Treatment Phase|Withdrew consent|1|||
161784671|NCT04130919|584257401|FG000|Open-label Treatment Phase|Disease worsening|0|||
161784672|NCT04130919|584257402|FG001|Open-label Treatment Phase|Disease worsening|0|||
161784673|NCT04130919|584257403|FG002|Open-label Treatment Phase|Disease worsening|0|||
161784674|NCT04130919|584257404|FG003|Open-label Treatment Phase|Disease worsening|1|||
161784675|NCT04130919|584257405|FG004|Open-label Treatment Phase|Disease worsening|0|||
161784676|NCT04130919|584257406|FG005|Open-label Treatment Phase|Disease worsening|1|||
161784677|NCT04130919|584257401|FG000|Open-label Treatment Phase|Investigator's decision|0|||
161784678|NCT04130919|584257402|FG001|Open-label Treatment Phase|Investigator's decision|0|||
161784679|NCT04130919|584257403|FG002|Open-label Treatment Phase|Investigator's decision|0|||
161784680|NCT04130919|584257404|FG003|Open-label Treatment Phase|Investigator's decision|1|||
161784681|NCT04130919|584257405|FG004|Open-label Treatment Phase|Investigator's decision|0|||
161784682|NCT04130919|584257406|FG005|Open-label Treatment Phase|Investigator's decision|0|||
161784683|NCT04130919|584257401|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
161784684|NCT04130919|584257402|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
161784685|NCT04130919|584257403|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
161784686|NCT04130919|584257404|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
161784687|NCT04130919|584257405|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
161784688|NCT04130919|584257406|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
161784689|NCT04130919|584257401|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161784690|NCT04130919|584257402|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161784691|NCT04130919|584257403|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161784692|NCT04130919|584257404|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161784693|NCT04130919|584257405|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
161784694|NCT04130919|584257406|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161784695|NCT03012815|584257407|FG000|Overall Study|Lost to Follow-up|1|||
161784696|NCT03012815|584257408|FG001|Overall Study|Lost to Follow-up|0|||
161784697|NCT03012815|584257407|FG000|Overall Study|Physician Decision|3|||
161784698|NCT03012815|584257408|FG001|Overall Study|Physician Decision|2|||
161784699|NCT03012815|584257407|FG000|Overall Study|Adverse Event|1|||
161784700|NCT03012815|584257408|FG001|Overall Study|Adverse Event|0|||
161784701|NCT02400905|584257410|FG000|Overall Study|Death|24|||
161784702|NCT02400905|584257410|FG000|Overall Study|Lost to Follow-up|18|||
161784703|NCT02400905|584257410|FG000|Overall Study|Withdrawal by Subject|16|||
161784704|NCT02400905|584257410|FG000|Overall Study|Physician Decision|4|||
161784705|NCT02400905|584257410|FG000|Overall Study|Other|1|||
161784706|NCT00879970|584257411|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
161784707|NCT00879970|584257412|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
161784708|NCT00879970|584257413|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
161784709|NCT00879970|584257414|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
161784710|NCT00879970|584257415|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
161784711|NCT00879970|584257411|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
161784712|NCT00879970|584257412|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
161784713|NCT00879970|584257413|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
161784714|NCT00879970|584257414|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
161784715|NCT00879970|584257415|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
161784716|NCT00879970|584257411|FG000|Period 1 TZD Randomization|Death|2|||
161784717|NCT00879970|584257412|FG001|Period 1 TZD Randomization|Death|1|||
161784718|NCT00879970|584257413|FG002|Period 1 TZD Randomization|Death|0|||
161898203|NCT00572455|584675571|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
161784719|NCT00879970|584257414|FG003|Period 1 TZD Randomization|Death|0|||
161784720|NCT00879970|584257415|FG004|Period 1 TZD Randomization|Death|0|||
161898204|NCT00572455|584675572|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
161784721|NCT00879970|584257411|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
161784722|NCT00879970|584257412|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
161784723|NCT00879970|584257413|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
161784724|NCT00879970|584257414|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
161784725|NCT00879970|584257415|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
161784726|NCT00879970|584257411|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
161784727|NCT00879970|584257412|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
161784728|NCT00879970|584257413|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
161784729|NCT00879970|584257414|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
161784730|NCT00879970|584257415|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
161784731|NCT00879970|584257411|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
161784732|NCT00879970|584257412|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
161784733|NCT00879970|584257413|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
161784734|NCT00879970|584257414|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
161784735|NCT00879970|584257415|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
161784736|NCT00879970|584257411|FG000|Period 2 Vitamin D Randomization|Death|0|||
161784737|NCT00879970|584257412|FG001|Period 2 Vitamin D Randomization|Death|0|||
161784738|NCT00879970|584257413|FG002|Period 2 Vitamin D Randomization|Death|0|||
161784739|NCT00879970|584257414|FG003|Period 2 Vitamin D Randomization|Death|2|||
161784740|NCT00879970|584257415|FG004|Period 2 Vitamin D Randomization|Death|0|||
161784741|NCT01749033|584257419|FG000|Overall Study|Did not receive allocated intervention|3|||
161784742|NCT01749033|584257420|FG001|Overall Study|Did not receive allocated intervention|3|||
161784743|NCT01749033|584257421|FG002|Overall Study|Did not receive allocated intervention|0|||
161784744|NCT01749033|584257419|FG000|Overall Study|Lost to Follow-up|0|||
161784745|NCT01749033|584257420|FG001|Overall Study|Lost to Follow-up|2|||
161784746|NCT01749033|584257421|FG002|Overall Study|Lost to Follow-up|1|||
161784747|NCT01256398|584257422|FG000|Overall Study|Withdrawal by Subject|1|||
161784748|NCT01039584|584257423|FG000|Overall Study|Withdrawal by Subject|4|||
161784749|NCT01039584|584257424|FG001|Overall Study|Withdrawal by Subject|2|||
161784750|NCT01039584|584257425|FG002|Overall Study|Withdrawal by Subject|1|||
161784751|NCT01039584|584257423|FG000|Overall Study|Protocol Violation|10|||
161784752|NCT01039584|584257424|FG001|Overall Study|Protocol Violation|4|||
161784753|NCT01039584|584257425|FG002|Overall Study|Protocol Violation|6|||
161784754|NCT01039584|584257423|FG000|Overall Study|Lost to Follow-up|5|||
161784755|NCT01039584|584257424|FG001|Overall Study|Lost to Follow-up|3|||
161784756|NCT01039584|584257425|FG002|Overall Study|Lost to Follow-up|4|||
161784757|NCT01039584|584257423|FG000|Overall Study|Negative Baseline culture for Candida|59|||
161784758|NCT01039584|584257424|FG001|Overall Study|Negative Baseline culture for Candida|59|||
161784759|NCT01039584|584257425|FG002|Overall Study|Negative Baseline culture for Candida|24|||
161784760|NCT01039584|584257423|FG000|Overall Study|Lack of Efficacy|7|||
161784761|NCT01039584|584257424|FG001|Overall Study|Lack of Efficacy|6|||
161784762|NCT01039584|584257425|FG002|Overall Study|Lack of Efficacy|10|||
161784763|NCT01039584|584257423|FG000|Overall Study|other|1|||
161784764|NCT01039584|584257424|FG001|Overall Study|other|3|||
161784765|NCT01039584|584257425|FG002|Overall Study|other|1|||
161784766|NCT01039584|584257423|FG000|Overall Study|Pap smear with significant pathology|10|||
161784767|NCT01039584|584257424|FG001|Overall Study|Pap smear with significant pathology|10|||
161784768|NCT01039584|584257425|FG002|Overall Study|Pap smear with significant pathology|3|||
161784769|NCT01039584|584257423|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
161784770|NCT01039584|584257424|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
161784771|NCT01039584|584257425|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
161784772|NCT01174368|584257428|FG000|Overall Study|Withdrawal by Subject|1|||
161784773|NCT00479765|584257429|FG000|Overall Study|study terminated|4|||
161784774|NCT04380701|584257432|FG000|Overall Study|Pregnancy|0|||
161784775|NCT04380701|584257433|FG001|Overall Study|Pregnancy|0|||
161784776|NCT04380701|584257434|FG002|Overall Study|Pregnancy|0|||
161784777|NCT04380701|584257435|FG003|Overall Study|Pregnancy|0|||
161784778|NCT04380701|584257436|FG004|Overall Study|Pregnancy|0|||
161784779|NCT04380701|584257437|FG005|Overall Study|Pregnancy|0|||
161784780|NCT04380701|584257438|FG006|Overall Study|Pregnancy|0|||
161784781|NCT04380701|584257439|FG007|Overall Study|Pregnancy|0|||
161784782|NCT04380701|584257440|FG008|Overall Study|Pregnancy|0|||
162124164|NCT00447954|585506214|FG000|Overall Study|Lost to Follow-up|0|||
161784783|NCT04380701|584257441|FG009|Overall Study|Pregnancy|0|||
161784784|NCT04380701|584257442|FG010|Overall Study|Pregnancy|0|||
162124165|NCT00447954|585506215|FG001|Overall Study|Lost to Follow-up|1|||
162124166|NCT00447954|585506216|FG002|Overall Study|Lost to Follow-up|0|||
161784785|NCT04380701|584257443|FG011|Overall Study|Pregnancy|0|||
161784786|NCT04380701|584257444|FG012|Overall Study|Pregnancy|0|||
161784787|NCT04380701|584257445|FG013|Overall Study|Pregnancy|0|||
161784788|NCT04380701|584257446|FG014|Overall Study|Pregnancy|0|||
161784789|NCT04380701|584257447|FG015|Overall Study|Pregnancy|0|||
161784790|NCT04380701|584257448|FG016|Overall Study|Pregnancy|0|||
161784791|NCT04380701|584257449|FG017|Overall Study|Pregnancy|0|||
161784792|NCT04380701|584257450|FG018|Overall Study|Pregnancy|0|||
161784793|NCT04380701|584257451|FG019|Overall Study|Pregnancy|0|||
161784794|NCT04380701|584257452|FG020|Overall Study|Pregnancy|0|||
161784795|NCT04380701|584257453|FG021|Overall Study|Pregnancy|0|||
161784796|NCT04380701|584257454|FG022|Overall Study|Pregnancy|0|||
161784797|NCT04380701|584257455|FG023|Overall Study|Pregnancy|0|||
161784798|NCT04380701|584257456|FG024|Overall Study|Pregnancy|0|||
161784799|NCT04380701|584257457|FG025|Overall Study|Pregnancy|0|||
161784800|NCT04380701|584257458|FG026|Overall Study|Pregnancy|0|||
161784801|NCT04380701|584257459|FG027|Overall Study|Pregnancy|0|||
161784802|NCT04380701|584257460|FG028|Overall Study|Pregnancy|0|||
161784803|NCT04380701|584257461|FG029|Overall Study|Pregnancy|0|||
161784804|NCT04380701|584257462|FG030|Overall Study|Pregnancy|0|||
161784805|NCT04380701|584257463|FG031|Overall Study|Pregnancy|0|||
161784806|NCT04380701|584257464|FG032|Overall Study|Pregnancy|1|||
161784807|NCT04380701|584257465|FG033|Overall Study|Pregnancy|0|||
161784808|NCT04380701|584257432|FG000|Overall Study|Lost to Follow-up|0|||
161784809|NCT04380701|584257433|FG001|Overall Study|Lost to Follow-up|0|||
161784810|NCT04380701|584257434|FG002|Overall Study|Lost to Follow-up|0|||
161784811|NCT04380701|584257435|FG003|Overall Study|Lost to Follow-up|0|||
161784812|NCT04380701|584257436|FG004|Overall Study|Lost to Follow-up|0|||
161784813|NCT04380701|584257437|FG005|Overall Study|Lost to Follow-up|0|||
161784814|NCT04380701|584257438|FG006|Overall Study|Lost to Follow-up|0|||
161784815|NCT04380701|584257439|FG007|Overall Study|Lost to Follow-up|0|||
161784816|NCT04380701|584257440|FG008|Overall Study|Lost to Follow-up|0|||
161784817|NCT04380701|584257441|FG009|Overall Study|Lost to Follow-up|0|||
161784818|NCT04380701|584257442|FG010|Overall Study|Lost to Follow-up|0|||
161784819|NCT04380701|584257443|FG011|Overall Study|Lost to Follow-up|0|||
161784820|NCT04380701|584257444|FG012|Overall Study|Lost to Follow-up|0|||
161784821|NCT04380701|584257445|FG013|Overall Study|Lost to Follow-up|0|||
161784822|NCT04380701|584257446|FG014|Overall Study|Lost to Follow-up|0|||
161784823|NCT04380701|584257447|FG015|Overall Study|Lost to Follow-up|0|||
161784824|NCT04380701|584257448|FG016|Overall Study|Lost to Follow-up|0|||
161784825|NCT04380701|584257449|FG017|Overall Study|Lost to Follow-up|0|||
161784826|NCT04380701|584257450|FG018|Overall Study|Lost to Follow-up|0|||
161784827|NCT04380701|584257451|FG019|Overall Study|Lost to Follow-up|0|||
161784828|NCT04380701|584257452|FG020|Overall Study|Lost to Follow-up|1|||
161784829|NCT04380701|584257453|FG021|Overall Study|Lost to Follow-up|0|||
161784830|NCT04380701|584257454|FG022|Overall Study|Lost to Follow-up|0|||
161784831|NCT04380701|584257455|FG023|Overall Study|Lost to Follow-up|1|||
161784832|NCT04380701|584257456|FG024|Overall Study|Lost to Follow-up|0|||
161784833|NCT04380701|584257457|FG025|Overall Study|Lost to Follow-up|0|||
161784834|NCT04380701|584257458|FG026|Overall Study|Lost to Follow-up|0|||
161784835|NCT04380701|584257459|FG027|Overall Study|Lost to Follow-up|0|||
161784836|NCT04380701|584257460|FG028|Overall Study|Lost to Follow-up|0|||
161784837|NCT04380701|584257461|FG029|Overall Study|Lost to Follow-up|1|||
161784838|NCT04380701|584257462|FG030|Overall Study|Lost to Follow-up|0|||
161784839|NCT04380701|584257463|FG031|Overall Study|Lost to Follow-up|0|||
161784840|NCT04380701|584257464|FG032|Overall Study|Lost to Follow-up|0|||
162124167|NCT00447954|585506214|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
162124168|NCT00447954|585506215|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
162124169|NCT00447954|585506216|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
162124170|NCT02090634|585506217|FG000|Overall Study|Lost to Follow-up|0|||
162124171|NCT02090634|585506218|FG001|Overall Study|Lost to Follow-up|1|||
162124172|NCT02090634|585506217|FG000|Overall Study|Death|0|||
162124173|NCT02090634|585506218|FG001|Overall Study|Death|1|||
162124174|NCT02090634|585506217|FG000|Overall Study|Protocol Violation|3|||
161784841|NCT04380701|584257465|FG033|Overall Study|Lost to Follow-up|1|||
161784842|NCT04380701|584257432|FG000|Overall Study|Private reason(s)|0|||
161784843|NCT04380701|584257433|FG001|Overall Study|Private reason(s)|0|||
161784844|NCT04380701|584257434|FG002|Overall Study|Private reason(s)|0|||
161784845|NCT04380701|584257435|FG003|Overall Study|Private reason(s)|0|||
161784846|NCT04380701|584257436|FG004|Overall Study|Private reason(s)|0|||
161784847|NCT04380701|584257437|FG005|Overall Study|Private reason(s)|0|||
161784848|NCT04380701|584257438|FG006|Overall Study|Private reason(s)|1|||
161784849|NCT04380701|584257439|FG007|Overall Study|Private reason(s)|0|||
161784850|NCT04380701|584257440|FG008|Overall Study|Private reason(s)|1|||
161784851|NCT04380701|584257441|FG009|Overall Study|Private reason(s)|1|||
162124175|NCT02090634|585506218|FG001|Overall Study|Protocol Violation|1|||
162124176|NCT02090634|585506217|FG000|Overall Study|Adverse Event|2|||
161784852|NCT04380701|584257442|FG010|Overall Study|Private reason(s)|0|||
161784853|NCT04380701|584257443|FG011|Overall Study|Private reason(s)|0|||
161784854|NCT04380701|584257444|FG012|Overall Study|Private reason(s)|0|||
161784855|NCT04380701|584257445|FG013|Overall Study|Private reason(s)|0|||
161784856|NCT04380701|584257446|FG014|Overall Study|Private reason(s)|0|||
162124177|NCT02090634|585506218|FG001|Overall Study|Adverse Event|0|||
162124178|NCT03757234|585506219|FG000|Overall Study|Adverse Event|0|||
161784857|NCT04380701|584257447|FG015|Overall Study|Private reason(s)|0|||
161784858|NCT04380701|584257448|FG016|Overall Study|Private reason(s)|0|||
161784859|NCT04380701|584257449|FG017|Overall Study|Private reason(s)|0|||
161784860|NCT04380701|584257450|FG018|Overall Study|Private reason(s)|0|||
161784861|NCT04380701|584257451|FG019|Overall Study|Private reason(s)|0|||
161784862|NCT04380701|584257452|FG020|Overall Study|Private reason(s)|0|||
161784863|NCT04380701|584257453|FG021|Overall Study|Private reason(s)|0|||
161784864|NCT04380701|584257454|FG022|Overall Study|Private reason(s)|0|||
161784865|NCT04380701|584257455|FG023|Overall Study|Private reason(s)|1|||
161784866|NCT04380701|584257456|FG024|Overall Study|Private reason(s)|0|||
161784867|NCT04380701|584257457|FG025|Overall Study|Private reason(s)|0|||
161784868|NCT04380701|584257458|FG026|Overall Study|Private reason(s)|0|||
161784869|NCT04380701|584257459|FG027|Overall Study|Private reason(s)|0|||
161784870|NCT04380701|584257460|FG028|Overall Study|Private reason(s)|0|||
161784871|NCT04380701|584257461|FG029|Overall Study|Private reason(s)|1|||
161784872|NCT04380701|584257462|FG030|Overall Study|Private reason(s)|0|||
161784873|NCT04380701|584257463|FG031|Overall Study|Private reason(s)|0|||
161784874|NCT04380701|584257464|FG032|Overall Study|Private reason(s)|0|||
161784875|NCT04380701|584257465|FG033|Overall Study|Private reason(s)|0|||
161784876|NCT04380701|584257432|FG000|Overall Study|Withdrawal by Subject|0|||
161784877|NCT04380701|584257433|FG001|Overall Study|Withdrawal by Subject|0|||
161784878|NCT04380701|584257434|FG002|Overall Study|Withdrawal by Subject|0|||
161784879|NCT04380701|584257435|FG003|Overall Study|Withdrawal by Subject|0|||
161784880|NCT04380701|584257436|FG004|Overall Study|Withdrawal by Subject|0|||
161784881|NCT04380701|584257437|FG005|Overall Study|Withdrawal by Subject|0|||
161784882|NCT04380701|584257438|FG006|Overall Study|Withdrawal by Subject|1|||
161784883|NCT04380701|584257439|FG007|Overall Study|Withdrawal by Subject|1|||
161784884|NCT04380701|584257440|FG008|Overall Study|Withdrawal by Subject|0|||
161784885|NCT04380701|584257441|FG009|Overall Study|Withdrawal by Subject|0|||
161784886|NCT04380701|584257442|FG010|Overall Study|Withdrawal by Subject|0|||
161784887|NCT04380701|584257443|FG011|Overall Study|Withdrawal by Subject|1|||
161784888|NCT04380701|584257444|FG012|Overall Study|Withdrawal by Subject|0|||
161784889|NCT04380701|584257445|FG013|Overall Study|Withdrawal by Subject|1|||
161784890|NCT04380701|584257446|FG014|Overall Study|Withdrawal by Subject|0|||
161784891|NCT04380701|584257447|FG015|Overall Study|Withdrawal by Subject|0|||
161784892|NCT04380701|584257448|FG016|Overall Study|Withdrawal by Subject|1|||
161784893|NCT04380701|584257449|FG017|Overall Study|Withdrawal by Subject|0|||
161784894|NCT04380701|584257450|FG018|Overall Study|Withdrawal by Subject|0|||
161784895|NCT04380701|584257451|FG019|Overall Study|Withdrawal by Subject|0|||
161784896|NCT04380701|584257452|FG020|Overall Study|Withdrawal by Subject|0|||
161784897|NCT04380701|584257453|FG021|Overall Study|Withdrawal by Subject|0|||
161784898|NCT04380701|584257454|FG022|Overall Study|Withdrawal by Subject|2|||
161784899|NCT04380701|584257455|FG023|Overall Study|Withdrawal by Subject|2|||
161784900|NCT04380701|584257456|FG024|Overall Study|Withdrawal by Subject|1|||
161784901|NCT04380701|584257457|FG025|Overall Study|Withdrawal by Subject|1|||
161784902|NCT04380701|584257458|FG026|Overall Study|Withdrawal by Subject|0|||
161784903|NCT04380701|584257459|FG027|Overall Study|Withdrawal by Subject|0|||
161784904|NCT04380701|584257460|FG028|Overall Study|Withdrawal by Subject|0|||
161784905|NCT04380701|584257461|FG029|Overall Study|Withdrawal by Subject|0|||
161784906|NCT04380701|584257462|FG030|Overall Study|Withdrawal by Subject|0|||
161784907|NCT04380701|584257463|FG031|Overall Study|Withdrawal by Subject|0|||
161784908|NCT04380701|584257464|FG032|Overall Study|Withdrawal by Subject|0|||
161784909|NCT04380701|584257465|FG033|Overall Study|Withdrawal by Subject|0|||
161784910|NCT04380701|584257432|FG000|Overall Study|Adverse Event|0|||
161784911|NCT04380701|584257433|FG001|Overall Study|Adverse Event|0|||
161784912|NCT04380701|584257434|FG002|Overall Study|Adverse Event|0|||
161784913|NCT04380701|584257435|FG003|Overall Study|Adverse Event|0|||
161784914|NCT04380701|584257436|FG004|Overall Study|Adverse Event|0|||
161784915|NCT04380701|584257437|FG005|Overall Study|Adverse Event|1|||
161784916|NCT04380701|584257438|FG006|Overall Study|Adverse Event|0|||
161784917|NCT04380701|584257439|FG007|Overall Study|Adverse Event|0|||
161784918|NCT04380701|584257440|FG008|Overall Study|Adverse Event|0|||
161784919|NCT04380701|584257441|FG009|Overall Study|Adverse Event|0|||
161784920|NCT04380701|584257442|FG010|Overall Study|Adverse Event|0|||
161784921|NCT04380701|584257443|FG011|Overall Study|Adverse Event|0|||
161784922|NCT04380701|584257444|FG012|Overall Study|Adverse Event|0|||
161784923|NCT04380701|584257445|FG013|Overall Study|Adverse Event|0|||
161784924|NCT04380701|584257446|FG014|Overall Study|Adverse Event|0|||
161784925|NCT04380701|584257447|FG015|Overall Study|Adverse Event|1|||
161784926|NCT04380701|584257448|FG016|Overall Study|Adverse Event|0|||
161784927|NCT04380701|584257449|FG017|Overall Study|Adverse Event|0|||
161784928|NCT04380701|584257450|FG018|Overall Study|Adverse Event|0|||
161784929|NCT04380701|584257451|FG019|Overall Study|Adverse Event|1|||
161784930|NCT04380701|584257452|FG020|Overall Study|Adverse Event|0|||
161784931|NCT04380701|584257453|FG021|Overall Study|Adverse Event|0|||
161784932|NCT04380701|584257454|FG022|Overall Study|Adverse Event|0|||
161784933|NCT04380701|584257455|FG023|Overall Study|Adverse Event|0|||
161784934|NCT04380701|584257456|FG024|Overall Study|Adverse Event|0|||
161784935|NCT04380701|584257457|FG025|Overall Study|Adverse Event|0|||
161784936|NCT04380701|584257458|FG026|Overall Study|Adverse Event|0|||
161784937|NCT04380701|584257459|FG027|Overall Study|Adverse Event|0|||
161784938|NCT04380701|584257460|FG028|Overall Study|Adverse Event|0|||
161784939|NCT04380701|584257461|FG029|Overall Study|Adverse Event|0|||
162124179|NCT03757234|585506220|FG001|Overall Study|Adverse Event|0|||
162124180|NCT03757234|585506221|FG002|Overall Study|Adverse Event|0|||
162124181|NCT03757234|585506222|FG003|Overall Study|Adverse Event|0|||
162124182|NCT03757234|585506223|FG004|Overall Study|Adverse Event|1|||
162124183|NCT03757234|585506219|FG000|Overall Study|Lost to Follow-up|1|||
162124184|NCT03757234|585506220|FG001|Overall Study|Lost to Follow-up|0|||
162124185|NCT03757234|585506221|FG002|Overall Study|Lost to Follow-up|0|||
162124186|NCT03757234|585506222|FG003|Overall Study|Lost to Follow-up|0|||
162124187|NCT03757234|585506223|FG004|Overall Study|Lost to Follow-up|1|||
162124188|NCT03757234|585506219|FG000|Overall Study|Withdrawal by Subject|1|||
162124189|NCT03757234|585506220|FG001|Overall Study|Withdrawal by Subject|1|||
162124190|NCT03757234|585506221|FG002|Overall Study|Withdrawal by Subject|0|||
162124191|NCT03757234|585506222|FG003|Overall Study|Withdrawal by Subject|1|||
162124192|NCT03757234|585506223|FG004|Overall Study|Withdrawal by Subject|2|||
162124193|NCT03757234|585506219|FG000|Overall Study|Other|1|||
162124194|NCT03757234|585506220|FG001|Overall Study|Other|1|||
162124195|NCT03757234|585506221|FG002|Overall Study|Other|0|||
162124196|NCT03757234|585506222|FG003|Overall Study|Other|0|||
162124197|NCT03757234|585506223|FG004|Overall Study|Other|0|||
162124198|NCT04908449|585506228|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
162124199|NCT04908449|585506229|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
162124200|NCT04908449|585506228|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
162124201|NCT04908449|585506229|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
162124202|NCT02401308|585506230|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
162124203|NCT02401308|585506231|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
162124204|NCT02736968|585506232|FG000|Overall Study|Lost to Follow-up|0|||
162124205|NCT02736968|585506233|FG001|Overall Study|Lost to Follow-up|0|||
162124206|NCT02736968|585506234|FG002|Overall Study|Lost to Follow-up|0|||
162124207|NCT02736968|585506235|FG003|Overall Study|Lost to Follow-up|0|||
162124208|NCT02736968|585506236|FG004|Overall Study|Lost to Follow-up|0|||
162124209|NCT02736968|585506237|FG005|Overall Study|Lost to Follow-up|0|||
162124210|NCT02736968|585506238|FG006|Overall Study|Lost to Follow-up|5|||
162124211|NCT02736968|585506239|FG007|Overall Study|Lost to Follow-up|2|||
162124212|NCT02736968|585506232|FG000|Overall Study|COVID-19 Pandemic|0|||
162124213|NCT02736968|585506233|FG001|Overall Study|COVID-19 Pandemic|0|||
162124214|NCT02736968|585506234|FG002|Overall Study|COVID-19 Pandemic|0|||
162124215|NCT02736968|585506235|FG003|Overall Study|COVID-19 Pandemic|0|||
162124216|NCT02736968|585506236|FG004|Overall Study|COVID-19 Pandemic|0|||
162124217|NCT02736968|585506237|FG005|Overall Study|COVID-19 Pandemic|0|||
162124218|NCT02736968|585506238|FG006|Overall Study|COVID-19 Pandemic|2|||
162124219|NCT02736968|585506239|FG007|Overall Study|COVID-19 Pandemic|0|||
162124220|NCT02736968|585506232|FG000|Overall Study|Withdrawal by Subject|0|||
162124221|NCT02736968|585506233|FG001|Overall Study|Withdrawal by Subject|0|||
162124222|NCT02736968|585506234|FG002|Overall Study|Withdrawal by Subject|0|||
162124223|NCT02736968|585506235|FG003|Overall Study|Withdrawal by Subject|0|||
162124224|NCT02736968|585506236|FG004|Overall Study|Withdrawal by Subject|0|||
162124225|NCT02736968|585506237|FG005|Overall Study|Withdrawal by Subject|0|||
162124226|NCT02736968|585506238|FG006|Overall Study|Withdrawal by Subject|1|||
162124227|NCT02736968|585506239|FG007|Overall Study|Withdrawal by Subject|0|||
162124228|NCT02023879|585506240|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
162124229|NCT02023879|585506241|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
162124230|NCT02023879|585506242|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
162124231|NCT02023879|585506240|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
162124232|NCT02023879|585506241|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
162124233|NCT02023879|585506242|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
162124234|NCT02023879|585506240|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
162124235|NCT02023879|585506241|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
162124236|NCT02023879|585506242|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
161784940|NCT04380701|584257462|FG030|Overall Study|Adverse Event|0|||
161784941|NCT04380701|584257463|FG031|Overall Study|Adverse Event|0|||
161784942|NCT04380701|584257464|FG032|Overall Study|Adverse Event|0|||
161784943|NCT04380701|584257465|FG033|Overall Study|Adverse Event|0|||
161784944|NCT04380701|584257432|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
161784945|NCT04380701|584257433|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
162124237|NCT02023879|585506240|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
162124238|NCT02023879|585506241|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
162124239|NCT02023879|585506242|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
162124240|NCT02023879|585506240|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
162124241|NCT02023879|585506241|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
162124242|NCT02023879|585506242|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
161784946|NCT04380701|584257434|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
161784947|NCT04380701|584257435|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
162124243|NCT02023879|585506240|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
162124244|NCT02023879|585506241|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
162124245|NCT02023879|585506242|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
162124246|NCT02023879|585506240|FG000|Extension Open Label Treatment|Adverse Event|1|||
162124247|NCT02023879|585506241|FG001|Extension Open Label Treatment|Adverse Event|7|||
162124248|NCT02023879|585506242|FG002|Extension Open Label Treatment|Adverse Event|3|||
162124249|NCT02023879|585506240|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
162124250|NCT02023879|585506241|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
162124251|NCT02023879|585506242|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
162124252|NCT02023879|585506240|FG000|Extension Open Label Treatment|Participant moved|1|||
162124253|NCT02023879|585506241|FG001|Extension Open Label Treatment|Participant moved|2|||
162124254|NCT02023879|585506242|FG002|Extension Open Label Treatment|Participant moved|0|||
162124255|NCT02023879|585506240|FG000|Extension Open Label Treatment|Other than specified above|2|||
162124256|NCT02023879|585506241|FG001|Extension Open Label Treatment|Other than specified above|7|||
162124257|NCT02023879|585506242|FG002|Extension Open Label Treatment|Other than specified above|2|||
162124258|NCT00874432|585506243|FG000|Overall Study|Withdrawal by Subject|1|||
162124259|NCT00874432|585506244|FG001|Overall Study|Withdrawal by Subject|0|||
162124260|NCT00874432|585506245|FG002|Overall Study|Withdrawal by Subject|0|||
162124261|NCT00874432|585506246|FG003|Overall Study|Withdrawal by Subject|0|||
162124262|NCT00874432|585506243|FG000|Overall Study|Physician Decision|1|||
162124263|NCT00874432|585506244|FG001|Overall Study|Physician Decision|0|||
162124264|NCT00874432|585506245|FG002|Overall Study|Physician Decision|0|||
162124265|NCT00874432|585506246|FG003|Overall Study|Physician Decision|0|||
162124266|NCT00874432|585506243|FG000|Overall Study|Other|1|||
162124267|NCT00874432|585506244|FG001|Overall Study|Other|2|||
162124268|NCT00874432|585506245|FG002|Overall Study|Other|8|||
162124269|NCT00874432|585506246|FG003|Overall Study|Other|3|||
162124270|NCT05256381|585506247|FG000|Overall Study|Withdrawal by Subject|4|||
162124271|NCT05256381|585506248|FG001|Overall Study|Withdrawal by Subject|0|||
162124272|NCT05256381|585506249|FG002|Overall Study|Withdrawal by Subject|2|||
162124273|NCT05256381|585506250|FG003|Overall Study|Withdrawal by Subject|2|||
162124274|NCT05256381|585506251|FG004|Overall Study|Withdrawal by Subject|8|||
162124275|NCT05256381|585506252|FG005|Overall Study|Withdrawal by Subject|6|||
162124276|NCT05256381|585506247|FG000|Overall Study|Physician Decision|0|||
162124277|NCT05256381|585506248|FG001|Overall Study|Physician Decision|0|||
162124278|NCT05256381|585506249|FG002|Overall Study|Physician Decision|1|||
162124279|NCT05256381|585506250|FG003|Overall Study|Physician Decision|0|||
162124280|NCT05256381|585506251|FG004|Overall Study|Physician Decision|2|||
162124281|NCT05256381|585506252|FG005|Overall Study|Physician Decision|0|||
162124282|NCT05256381|585506247|FG000|Overall Study|Death|17|||
162124283|NCT05256381|585506248|FG001|Overall Study|Death|3|||
162124284|NCT05256381|585506249|FG002|Overall Study|Death|4|||
162124285|NCT05256381|585506250|FG003|Overall Study|Death|5|||
162124286|NCT05256381|585506251|FG004|Overall Study|Death|24|||
162124287|NCT05256381|585506252|FG005|Overall Study|Death|21|||
162124288|NCT05256381|585506247|FG000|Overall Study|Other, not specified|0|||
162124289|NCT05256381|585506248|FG001|Overall Study|Other, not specified|0|||
162124290|NCT05256381|585506249|FG002|Overall Study|Other, not specified|0|||
162124291|NCT05256381|585506250|FG003|Overall Study|Other, not specified|0|||
162124292|NCT05256381|585506251|FG004|Overall Study|Other, not specified|2|||
162124293|NCT05256381|585506252|FG005|Overall Study|Other, not specified|1|||
162124294|NCT05256381|585506247|FG000|Overall Study|Study terminated by sponsor|18|||
162124295|NCT05256381|585506248|FG001|Overall Study|Study terminated by sponsor|5|||
162124296|NCT05256381|585506249|FG002|Overall Study|Study terminated by sponsor|5|||
162124297|NCT05256381|585506250|FG003|Overall Study|Study terminated by sponsor|5|||
162124298|NCT05256381|585506251|FG004|Overall Study|Study terminated by sponsor|18|||
162124299|NCT05256381|585506252|FG005|Overall Study|Study terminated by sponsor|11|||
162124300|NCT05256381|585506247|FG000|Overall Study|Lost to Follow-up|1|||
162124301|NCT05256381|585506248|FG001|Overall Study|Lost to Follow-up|0|||
162124302|NCT05256381|585506249|FG002|Overall Study|Lost to Follow-up|0|||
162124303|NCT05256381|585506250|FG003|Overall Study|Lost to Follow-up|0|||
162124304|NCT05256381|585506251|FG004|Overall Study|Lost to Follow-up|1|||
162124305|NCT05256381|585506252|FG005|Overall Study|Lost to Follow-up|0|||
162124306|NCT01518946|585506255|FG000|Open-label Phase|Other|4|||
162124307|NCT01518946|585506256|FG001|Open-label Phase|Other|0|||
162124308|NCT01518946|585506257|FG002|Open-label Phase|Other|0|||
162124309|NCT01518946|585506255|FG000|Randomized Phase (First Intervention)|Other|0|||
162124310|NCT01518946|585506256|FG001|Randomized Phase (First Intervention)|Other|1|||
162124311|NCT01518946|585506257|FG002|Randomized Phase (First Intervention)|Other|0|||
162124312|NCT03918239|585507888|FG000|Overall Study|Lost to Follow-up|3|||
162124313|NCT03918239|585507889|FG001|Overall Study|Lost to Follow-up|1|||
162124314|NCT03918239|585507888|FG000|Overall Study|Pregnancy|0|||
162124315|NCT03918239|585507889|FG001|Overall Study|Pregnancy|2|||
162124316|NCT03918239|585507888|FG000|Overall Study|Withdrawal by Subject|3|||
162124317|NCT03918239|585507889|FG001|Overall Study|Withdrawal by Subject|3|||
162124318|NCT03918239|585507888|FG000|Overall Study|positive urine drug screening results|4|||
162124319|NCT03918239|585507889|FG001|Overall Study|positive urine drug screening results|1|||
162124320|NCT01984424|585507894|FG000|Overall Study|Withdrawal by Subject|3|||
162124321|NCT01984424|585507895|FG001|Overall Study|Withdrawal by Subject|5|||
162124322|NCT01984424|585507894|FG000|Overall Study|Sponsor Decision|0|||
162124323|NCT01984424|585507895|FG001|Overall Study|Sponsor Decision|1|||
162124324|NCT01984424|585507894|FG000|Overall Study|Lost to Follow-up|0|||
162124325|NCT01984424|585507895|FG001|Overall Study|Lost to Follow-up|1|||
162124326|NCT01807221|585507898|FG000|Overall Study|Progressive disease|1|||
162124327|NCT01807221|585507899|FG001|Overall Study|Progressive disease|0|||
162124328|NCT01807221|585507900|FG002|Overall Study|Progressive disease|1|||
162124329|NCT01807221|585507901|FG003|Overall Study|Progressive disease|0|||
162124330|NCT01807221|585507902|FG004|Overall Study|Progressive disease|0|||
162124331|NCT01807221|585507903|FG005|Overall Study|Progressive disease|0|||
162124332|NCT01807221|585507898|FG000|Overall Study|Death|7|||
162124333|NCT01807221|585507899|FG001|Overall Study|Death|9|||
162124334|NCT01807221|585507900|FG002|Overall Study|Death|4|||
162124335|NCT01807221|585507901|FG003|Overall Study|Death|2|||
162124336|NCT01807221|585507902|FG004|Overall Study|Death|1|||
162124337|NCT01807221|585507903|FG005|Overall Study|Death|6|||
162124338|NCT01807221|585507898|FG000|Overall Study|Physician Decision|2|||
162124339|NCT01807221|585507899|FG001|Overall Study|Physician Decision|1|||
162124340|NCT01807221|585507900|FG002|Overall Study|Physician Decision|0|||
162124341|NCT01807221|585507901|FG003|Overall Study|Physician Decision|0|||
162124342|NCT01807221|585507902|FG004|Overall Study|Physician Decision|0|||
162124343|NCT01807221|585507903|FG005|Overall Study|Physician Decision|0|||
162124344|NCT01807221|585507898|FG000|Overall Study|Adverse Event|33|||
162124345|NCT01807221|585507899|FG001|Overall Study|Adverse Event|22|||
162124346|NCT01807221|585507900|FG002|Overall Study|Adverse Event|26|||
162124347|NCT01807221|585507901|FG003|Overall Study|Adverse Event|25|||
162124348|NCT01807221|585507902|FG004|Overall Study|Adverse Event|18|||
162124349|NCT01807221|585507903|FG005|Overall Study|Adverse Event|21|||
162124350|NCT01807221|585507898|FG000|Overall Study|Protocol Violation|0|||
162124351|NCT01807221|585507899|FG001|Overall Study|Protocol Violation|2|||
162124352|NCT01807221|585507900|FG002|Overall Study|Protocol Violation|1|||
162124353|NCT01807221|585507901|FG003|Overall Study|Protocol Violation|2|||
162124354|NCT01807221|585507902|FG004|Overall Study|Protocol Violation|0|||
162124355|NCT01807221|585507903|FG005|Overall Study|Protocol Violation|1|||
162124356|NCT01807221|585507898|FG000|Overall Study|Non-compliance|1|||
162124357|NCT01807221|585507899|FG001|Overall Study|Non-compliance|2|||
162124358|NCT01807221|585507900|FG002|Overall Study|Non-compliance|0|||
162124359|NCT01807221|585507901|FG003|Overall Study|Non-compliance|1|||
162124360|NCT01807221|585507902|FG004|Overall Study|Non-compliance|0|||
162124361|NCT01807221|585507903|FG005|Overall Study|Non-compliance|0|||
162124362|NCT01807221|585507898|FG000|Overall Study|Logistical difficulties|0|||
162124363|NCT01807221|585507899|FG001|Overall Study|Logistical difficulties|1|||
162124364|NCT01807221|585507900|FG002|Overall Study|Logistical difficulties|0|||
162124365|NCT01807221|585507901|FG003|Overall Study|Logistical difficulties|0|||
162124366|NCT01807221|585507902|FG004|Overall Study|Logistical difficulties|1|||
162124367|NCT01807221|585507903|FG005|Overall Study|Logistical difficulties|0|||
162124368|NCT01807221|585507898|FG000|Overall Study|Withdrawal by Subject|33|||
162124369|NCT01807221|585507899|FG001|Overall Study|Withdrawal by Subject|15|||
162124370|NCT01807221|585507900|FG002|Overall Study|Withdrawal by Subject|8|||
162124371|NCT01807221|585507901|FG003|Overall Study|Withdrawal by Subject|14|||
162124372|NCT01807221|585507902|FG004|Overall Study|Withdrawal by Subject|16|||
162124373|NCT01807221|585507903|FG005|Overall Study|Withdrawal by Subject|13|||
162124374|NCT01807221|585507898|FG000|Overall Study|Sponsor decision|2|||
161784948|NCT04380701|584257436|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
161784949|NCT04380701|584257437|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
161784950|NCT04380701|584257438|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
161784951|NCT04380701|584257439|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
161784952|NCT04380701|584257440|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
162124375|NCT01807221|585507899|FG001|Overall Study|Sponsor decision|0|||
162124376|NCT01807221|585507900|FG002|Overall Study|Sponsor decision|1|||
162124377|NCT01807221|585507901|FG003|Overall Study|Sponsor decision|1|||
162124378|NCT01807221|585507902|FG004|Overall Study|Sponsor decision|0|||
162124379|NCT01807221|585507903|FG005|Overall Study|Sponsor decision|0|||
162124380|NCT01807221|585507898|FG000|Overall Study|Lost to Follow-up|1|||
162124381|NCT01807221|585507899|FG001|Overall Study|Lost to Follow-up|0|||
162124382|NCT01807221|585507900|FG002|Overall Study|Lost to Follow-up|2|||
162124383|NCT01807221|585507901|FG003|Overall Study|Lost to Follow-up|1|||
162124384|NCT01807221|585507902|FG004|Overall Study|Lost to Follow-up|0|||
162124385|NCT01807221|585507903|FG005|Overall Study|Lost to Follow-up|0|||
162124386|NCT00594906|585507906|FG000|Overall Study|Physician Decision|1|||
162124387|NCT00594906|585507907|FG001|Overall Study|Physician Decision|0|||
162124388|NCT00594906|585507906|FG000|Overall Study|Physician Decision|0|||
162124389|NCT00594906|585507907|FG001|Overall Study|Physician Decision|1|||
162124390|NCT00594906|585507906|FG000|Overall Study|Death|0|||
162124391|NCT00594906|585507907|FG001|Overall Study|Death|1|||
162124392|NCT01027364|585507913|FG000|Overall Study|Adverse Event|1|||
162124393|NCT01027364|585507914|FG001|Overall Study|Adverse Event|0|||
162124394|NCT01027364|585507915|FG002|Overall Study|Adverse Event|1|||
162124395|NCT01027364|585507916|FG003|Overall Study|Adverse Event|0|||
162124396|NCT01027364|585507913|FG000|Overall Study|Lost to Follow-up|1|||
162124397|NCT01027364|585507914|FG001|Overall Study|Lost to Follow-up|0|||
162124398|NCT01027364|585507915|FG002|Overall Study|Lost to Follow-up|0|||
162124399|NCT01027364|585507916|FG003|Overall Study|Lost to Follow-up|0|||
162124400|NCT01027364|585507913|FG000|Overall Study|Protocol Violation|1|||
162124401|NCT01027364|585507914|FG001|Overall Study|Protocol Violation|0|||
162124402|NCT01027364|585507915|FG002|Overall Study|Protocol Violation|0|||
162124403|NCT01027364|585507916|FG003|Overall Study|Protocol Violation|1|||
162124404|NCT01027364|585507913|FG000|Overall Study|Withdrawal by Subject|1|||
162124405|NCT01027364|585507914|FG001|Overall Study|Withdrawal by Subject|2|||
162124406|NCT01027364|585507915|FG002|Overall Study|Withdrawal by Subject|0|||
162124407|NCT01027364|585507916|FG003|Overall Study|Withdrawal by Subject|0|||
162124408|NCT01394250|585507917|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
162124409|NCT01394250|585507918|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
162124410|NCT01394250|585507917|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
162124411|NCT01394250|585507918|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
162124412|NCT03772314|585507921|FG000|Overall Study|Adverse Event|7|||
162124413|NCT03772314|585507922|FG001|Overall Study|Adverse Event|2|||
162124414|NCT01613027|585507923|FG000|Overall Study|Lost to Follow-up|5|||
162124415|NCT01613027|585507923|FG000|Overall Study|Switched Physician|1|||
162124416|NCT01613027|585507923|FG000|Overall Study|Lack of Efficacy|1|||
162124417|NCT01613027|585507923|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
162124418|NCT04267614|585507926|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
162124419|NCT04267614|585507926|FG000|Overall Study|Lost to Follow-up|115|||
162124420|NCT03632434|585507934|FG000|Overall Study|Withdrawal by Subject|2|||
162124421|NCT02141659|585507936|FG000|Overall Study|Major Protocol Deviation|0|||
162124422|NCT02141659|585507937|FG001|Overall Study|Major Protocol Deviation|1|||
162124423|NCT02141659|585507938|FG002|Overall Study|Major Protocol Deviation|0|||
162124424|NCT02141659|585507939|FG003|Overall Study|Major Protocol Deviation|0|||
162124425|NCT02141659|585507940|FG004|Overall Study|Major Protocol Deviation|0|||
162124426|NCT02141659|585507941|FG005|Overall Study|Major Protocol Deviation|0|||
162124427|NCT02141659|585507936|FG000|Overall Study|Lack of Efficacy|0|||
162124428|NCT02141659|585507937|FG001|Overall Study|Lack of Efficacy|0|||
162124429|NCT02141659|585507938|FG002|Overall Study|Lack of Efficacy|0|||
162124430|NCT02141659|585507939|FG003|Overall Study|Lack of Efficacy|0|||
162124431|NCT02141659|585507940|FG004|Overall Study|Lack of Efficacy|0|||
162124432|NCT02141659|585507941|FG005|Overall Study|Lack of Efficacy|1|||
162124433|NCT02141659|585507936|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
162124434|NCT02141659|585507937|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
162124435|NCT02141659|585507938|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
162124436|NCT02141659|585507939|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
162124437|NCT02141659|585507940|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
162124438|NCT02141659|585507941|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
162124439|NCT00305864|585507950|FG000|Overall Study|Ineligible / No protocol treatment|0|||
162124440|NCT00305864|585507951|FG001|Overall Study|Ineligible / No protocol treatment|1|||
162124441|NCT00305864|585507952|FG002|Overall Study|Ineligible / No protocol treatment|1|||
162124442|NCT00305864|585507953|FG003|Overall Study|Ineligible / No protocol treatment|13|||
162124443|NCT04276090|585507954|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
162124444|NCT04276090|585507955|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
162124445|NCT02303626|585507958|FG000|Overall Study|Lack of Efficacy|1|||
162124446|NCT02303626|585507959|FG001|Overall Study|Lack of Efficacy|0|||
162124447|NCT02303626|585507960|FG002|Overall Study|Lack of Efficacy|1|||
162124448|NCT02303626|585507958|FG000|Overall Study|Adverse Event|0|||
162124449|NCT02303626|585507959|FG001|Overall Study|Adverse Event|2|||
162124450|NCT02303626|585507960|FG002|Overall Study|Adverse Event|0|||
162124451|NCT02303626|585507958|FG000|Overall Study|Protocol Violation|0|||
162124452|NCT02303626|585507959|FG001|Overall Study|Protocol Violation|1|||
162124453|NCT02303626|585507960|FG002|Overall Study|Protocol Violation|0|||
162124454|NCT02303626|585507958|FG000|Overall Study|Pregnancy|0|||
162124455|NCT02303626|585507959|FG001|Overall Study|Pregnancy|0|||
162124456|NCT02303626|585507960|FG002|Overall Study|Pregnancy|1|||
162124457|NCT02303626|585507958|FG000|Overall Study|Subject Non-Compliance|0|||
162124458|NCT02303626|585507959|FG001|Overall Study|Subject Non-Compliance|0|||
162124459|NCT02303626|585507960|FG002|Overall Study|Subject Non-Compliance|1|||
162124460|NCT05407311|585507961|FG000|Overall Study|Withdrawal by Subject|5|||
162124461|NCT05407311|585507961|FG000|Overall Study|Protocol Violation|3|||
162124462|NCT05407311|585507961|FG000|Overall Study|Physician Decision|1|||
162124463|NCT05407311|585507961|FG000|Overall Study|Non-compliance|1|||
162124464|NCT01265823|585507962|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
162124465|NCT01265823|585507962|FG000|Overall Study|Failure to Return|4|||
162124466|NCT01265823|585507962|FG000|Overall Study|Protocol Violation|1|||
162124467|NCT01265823|585507962|FG000|Overall Study|Participant Request|1|||
162124468|NCT00882921|585507963|FG000|Overall Study|Death|2|||
162124469|NCT00882921|585507963|FG000|Overall Study|Other|3|||
162124470|NCT00882921|585507963|FG000|Overall Study|Lost to Follow-up|2|||
162124471|NCT00882921|585507963|FG000|Overall Study|Termination By Investigator|3|||
162124472|NCT00882921|585507963|FG000|Overall Study|Withdrawal Of Consent|1|||
162124473|NCT01263106|585507964|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
162124474|NCT01263106|585507965|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
162124475|NCT05027074|585507973|FG000|Overall Study|Death|47|||
162124476|NCT05027074|585507974|FG001|Overall Study|Death|42|||
162124477|NCT05027074|585507975|FG002|Overall Study|Death|39|||
162124478|NCT05027074|585507973|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162124479|NCT05027074|585507974|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162124480|NCT05027074|585507975|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162124481|NCT05027074|585507973|FG000|Overall Study|Site Terminated By Sponsor|3|||
162124482|NCT05027074|585507974|FG001|Overall Study|Site Terminated By Sponsor|0|||
162124483|NCT05027074|585507975|FG002|Overall Study|Site Terminated By Sponsor|2|||
162124484|NCT05027074|585507973|FG000|Overall Study|Withdrawal by Subject|13|||
162124485|NCT05027074|585507974|FG001|Overall Study|Withdrawal by Subject|8|||
162124486|NCT05027074|585507975|FG002|Overall Study|Withdrawal by Subject|10|||
162124487|NCT05027074|585507973|FG000|Overall Study|Lost to Follow-up|2|||
162124488|NCT05027074|585507974|FG001|Overall Study|Lost to Follow-up|4|||
162124489|NCT05027074|585507975|FG002|Overall Study|Lost to Follow-up|3|||
162124490|NCT05027074|585507973|FG000|Overall Study|Status Not Recorded|0|||
162124491|NCT05027074|585507974|FG001|Overall Study|Status Not Recorded|0|||
162124492|NCT05027074|585507975|FG002|Overall Study|Status Not Recorded|1|||
162124493|NCT02180438|585507981|FG000|Overall Study|Lost to Follow-up|1|||
162124494|NCT00785707|585507982|FG000|Overall Study|Lost to Follow-up|7|||
162124495|NCT00147225|585507988|FG000|Overall Study|Withdrawal by Subject|1|||
162124496|NCT00147225|585507989|FG001|Overall Study|Withdrawal by Subject|0|||
162124497|NCT00147225|585507990|FG002|Overall Study|Withdrawal by Subject|1|||
162124498|NCT00147225|585507991|FG003|Overall Study|Withdrawal by Subject|0|||
162124499|NCT00147225|585507992|FG004|Overall Study|Withdrawal by Subject|0|||
162124500|NCT00147225|585507993|FG005|Overall Study|Withdrawal by Subject|1|||
162124501|NCT00147225|585507988|FG000|Overall Study|Adverse Event|0|||
162124502|NCT00147225|585507989|FG001|Overall Study|Adverse Event|0|||
162124503|NCT00147225|585507990|FG002|Overall Study|Adverse Event|1|||
162124504|NCT00147225|585507991|FG003|Overall Study|Adverse Event|1|||
162124505|NCT00147225|585507992|FG004|Overall Study|Adverse Event|0|||
162124506|NCT00147225|585507993|FG005|Overall Study|Adverse Event|0|||
162124507|NCT00147225|585507988|FG000|Overall Study|Screen Failure|0|||
162124508|NCT00147225|585507989|FG001|Overall Study|Screen Failure|0|||
162124509|NCT00147225|585507990|FG002|Overall Study|Screen Failure|0|||
162124510|NCT00147225|585507991|FG003|Overall Study|Screen Failure|0|||
162124511|NCT00147225|585507992|FG004|Overall Study|Screen Failure|1|||
162124512|NCT00147225|585507993|FG005|Overall Study|Screen Failure|0|||
162124513|NCT00147225|585507988|FG000|Overall Study|Chemotherapy Changed|0|||
162124514|NCT00147225|585507989|FG001|Overall Study|Chemotherapy Changed|0|||
162124515|NCT00147225|585507990|FG002|Overall Study|Chemotherapy Changed|0|||
162124516|NCT00147225|585507991|FG003|Overall Study|Chemotherapy Changed|0|||
162124517|NCT00147225|585507992|FG004|Overall Study|Chemotherapy Changed|0|||
162124518|NCT00147225|585507993|FG005|Overall Study|Chemotherapy Changed|1|||
162124519|NCT01032044|585507996|FG000|Overall Study|Protocol Violation|14|||
162124520|NCT01032044|585507997|FG001|Overall Study|Protocol Violation|8|||
162124521|NCT01032044|585507996|FG000|Overall Study|Adverse Event|0|||
162124522|NCT01032044|585507997|FG001|Overall Study|Adverse Event|1|||
162124523|NCT01032044|585507996|FG000|Overall Study|Lost to Follow-up|11|||
162124524|NCT01032044|585507997|FG001|Overall Study|Lost to Follow-up|11|||
162124525|NCT01567865|585508004|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
162124526|NCT01567865|585508005|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
162124527|NCT01567865|585508006|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
162124528|NCT01567865|585508007|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
162124529|NCT01567865|585508004|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
162124530|NCT01567865|585508005|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
162124531|NCT01567865|585508006|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
161784953|NCT04380701|584257441|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
162124532|NCT01567865|585508007|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
162124533|NCT01051063|585508020|FG000|Overall Study|Death|2|||
162124534|NCT01051063|585508021|FG001|Overall Study|Death|2|||
162124535|NCT01051063|585508020|FG000|Overall Study|Withdrawal by Subject|1|||
162124536|NCT01051063|585508021|FG001|Overall Study|Withdrawal by Subject|1|||
162124537|NCT01051063|585508020|FG000|Overall Study|Termination of the study|5|||
162124538|NCT01051063|585508021|FG001|Overall Study|Termination of the study|0|||
162124539|NCT01051063|585508020|FG000|Overall Study|Moved from the study site area|1|||
162124540|NCT01051063|585508021|FG001|Overall Study|Moved from the study site area|0|||
162124541|NCT01051063|585508020|FG000|Overall Study|Other|1|||
162124542|NCT01051063|585508021|FG001|Overall Study|Other|0|||
162124543|NCT01051063|585508020|FG000|Overall Study|Lost to Follow-up|0|||
162124544|NCT01051063|585508021|FG001|Overall Study|Lost to Follow-up|1|||
162124545|NCT05569954|585508022|FG000|Overall Study|Lost to Follow-up|3|||
162124546|NCT05569954|585508023|FG001|Overall Study|Lost to Follow-up|4|||
162124547|NCT05569954|585508022|FG000|Overall Study|Protocol Violation|1|||
162124548|NCT05569954|585508023|FG001|Overall Study|Protocol Violation|2|||
162124549|NCT05569954|585508022|FG000|Overall Study|Withdrawal by Subject|4|||
162124550|NCT05569954|585508023|FG001|Overall Study|Withdrawal by Subject|2|||
162124551|NCT03857841|585508033|FG000|Overall Study|Death|1|||
162124552|NCT03857841|585508034|FG001|Overall Study|Death|0|||
162124553|NCT03857841|585508035|FG002|Overall Study|Death|0|||
162124554|NCT03857841|585508036|FG003|Overall Study|Death|0|||
162124555|NCT03857841|585508033|FG000|Overall Study|Study Terminated by Sponsor|1|||
162124556|NCT03857841|585508034|FG001|Overall Study|Study Terminated by Sponsor|0|||
162124557|NCT03857841|585508035|FG002|Overall Study|Study Terminated by Sponsor|0|||
162124558|NCT03857841|585508036|FG003|Overall Study|Study Terminated by Sponsor|0|||
162124559|NCT00384059|585508037|FG000|Infant Series|Not consented|2|||
162124560|NCT00384059|585508038|FG001|Infant Series|Not consented|6|||
162124561|NCT00384059|585508037|FG000|Infant Series|Withdrawal by Subject|2|||
162124562|NCT00384059|585508038|FG001|Infant Series|Withdrawal by Subject|2|||
162124563|NCT00384059|585508037|FG000|Infant Series|Adverse Event|1|||
162124564|NCT00384059|585508038|FG001|Infant Series|Adverse Event|2|||
162124565|NCT00384059|585508037|FG000|Infant Series|Protocol Violation|1|||
162124566|NCT00384059|585508038|FG001|Infant Series|Protocol Violation|2|||
162124567|NCT00384059|585508037|FG000|Infant Series|Lost to Follow-up|0|||
162124568|NCT00384059|585508038|FG001|Infant Series|Lost to Follow-up|1|||
162124569|NCT00384059|585508037|FG000|After Infant Series|Protocol Violation|2|||
162124570|NCT00384059|585508038|FG001|After Infant Series|Protocol Violation|3|||
162124571|NCT00384059|585508037|FG000|After Infant Series|Withdrawal by Subject|2|||
162124572|NCT00384059|585508038|FG001|After Infant Series|Withdrawal by Subject|2|||
162124573|NCT00384059|585508037|FG000|After Infant Series|Failed to Return|0|||
162124574|NCT00384059|585508038|FG001|After Infant Series|Failed to Return|2|||
162124575|NCT00384059|585508037|FG000|After Infant Series|Adverse Event|0|||
162124576|NCT00384059|585508038|FG001|After Infant Series|Adverse Event|1|||
162124577|NCT00384059|585508037|FG000|After Infant Series|Physician Decision|0|||
162124578|NCT00384059|585508038|FG001|After Infant Series|Physician Decision|1|||
162124579|NCT00384059|585508037|FG000|After Infant Series|Lost to Follow-up|0|||
162124580|NCT00384059|585508038|FG001|After Infant Series|Lost to Follow-up|1|||
162124581|NCT00384059|585508037|FG000|Toddler Dose|Lost to Follow-up|1|||
162124582|NCT00384059|585508038|FG001|Toddler Dose|Lost to Follow-up|1|||
162124583|NCT00384059|585508037|FG000|Toddler Dose|Failed to return|0|||
162124584|NCT00384059|585508038|FG001|Toddler Dose|Failed to return|1|||
162124585|NCT00381641|585508041|FG000|Overall Study|Withdrawal by Subject|0|||
162124586|NCT00381641|585508042|FG001|Overall Study|Withdrawal by Subject|2|||
162124587|NCT00802737|585509924|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
162124588|NCT00802737|585509925|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
162124589|NCT00802737|585509926|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
162124590|NCT00802737|585509924|FG000|Overall Study|Death|6|||
162124591|NCT00802737|585509925|FG001|Overall Study|Death|5|||
162124592|NCT00802737|585509926|FG002|Overall Study|Death|1|||
162124593|NCT00802737|585509924|FG000|Overall Study|Adverse Event|1|||
162124594|NCT00802737|585509925|FG001|Overall Study|Adverse Event|0|||
162124595|NCT00802737|585509926|FG002|Overall Study|Adverse Event|0|||
162124596|NCT00802737|585509924|FG000|Overall Study|Received Prohibited Therapy|1|||
162124597|NCT00802737|585509925|FG001|Overall Study|Received Prohibited Therapy|0|||
162124598|NCT00802737|585509926|FG002|Overall Study|Received Prohibited Therapy|0|||
162124599|NCT00802737|585509924|FG000|Overall Study|Ongoing CLL-Treatment|0|||
162124600|NCT00802737|585509925|FG001|Overall Study|Ongoing CLL-Treatment|1|||
162124601|NCT00802737|585509926|FG002|Overall Study|Ongoing CLL-Treatment|0|||
162124602|NCT00802737|585509924|FG000|Overall Study|Participant too Unwell|0|||
162124603|NCT00802737|585509925|FG001|Overall Study|Participant too Unwell|2|||
162124604|NCT00802737|585509926|FG002|Overall Study|Participant too Unwell|0|||
162124605|NCT03864926|585509929|FG000|Overall Study|Death|0|||
162124606|NCT03864926|585509930|FG001|Overall Study|Death|2|||
162124607|NCT00445601|585509931|FG000|Overall Study|Withdrawal by Subject|11|||
162124608|NCT00445601|585509932|FG001|Overall Study|Withdrawal by Subject|11|||
162124609|NCT00445601|585509931|FG000|Overall Study|TURBT Complication|12|||
162124610|NCT00445601|585509932|FG001|Overall Study|TURBT Complication|8|||
162124611|NCT00445601|585509931|FG000|Overall Study|Incorrect Disease Status|6|||
162124612|NCT00445601|585509932|FG001|Overall Study|Incorrect Disease Status|6|||
162124613|NCT00445601|585509931|FG000|Overall Study|Drug Delivery Issue|2|||
162124614|NCT00445601|585509932|FG001|Overall Study|Drug Delivery Issue|2|||
162124615|NCT00445601|585509931|FG000|Overall Study|Adverse Event|2|||
162124616|NCT00445601|585509932|FG001|Overall Study|Adverse Event|0|||
162124617|NCT00445601|585509931|FG000|Overall Study|Death prior to TURBT|0|||
162124618|NCT00445601|585509932|FG001|Overall Study|Death prior to TURBT|1|||
162124619|NCT00619476|585509933|FG000|Overall Study|Adverse Event|12|||
162124620|NCT00619476|585509934|FG001|Overall Study|Adverse Event|6|||
162124621|NCT00619476|585509935|FG002|Overall Study|Adverse Event|12|||
162124622|NCT00619476|585509936|FG003|Overall Study|Adverse Event|16|||
161784954|NCT04380701|584257442|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
161784955|NCT04380701|584257443|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
161784956|NCT04380701|584257444|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
161784957|NCT04380701|584257445|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
161784958|NCT04380701|584257446|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
161784959|NCT04380701|584257447|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
161784960|NCT04380701|584257448|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
161784961|NCT04380701|584257449|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
162124623|NCT00619476|585509933|FG000|Overall Study|Lack of Efficacy|6|||
162124624|NCT00619476|585509934|FG001|Overall Study|Lack of Efficacy|1|||
162124625|NCT00619476|585509935|FG002|Overall Study|Lack of Efficacy|1|||
162124626|NCT00619476|585509936|FG003|Overall Study|Lack of Efficacy|4|||
162124627|NCT00619476|585509933|FG000|Overall Study|Protocol Violation|5|||
162124628|NCT00619476|585509934|FG001|Overall Study|Protocol Violation|4|||
162124629|NCT00619476|585509935|FG002|Overall Study|Protocol Violation|4|||
162124630|NCT00619476|585509936|FG003|Overall Study|Protocol Violation|9|||
162124631|NCT00619476|585509933|FG000|Overall Study|Lost to Follow-up|1|||
161784962|NCT04380701|584257450|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
161784963|NCT04380701|584257451|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
161784964|NCT04380701|584257452|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
161784965|NCT04380701|584257453|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
162124632|NCT00619476|585509934|FG001|Overall Study|Lost to Follow-up|2|||
162124633|NCT00619476|585509935|FG002|Overall Study|Lost to Follow-up|0|||
162124634|NCT00619476|585509936|FG003|Overall Study|Lost to Follow-up|1|||
162124635|NCT00619476|585509933|FG000|Overall Study|Investigator Discretion|2|||
162124636|NCT00619476|585509934|FG001|Overall Study|Investigator Discretion|2|||
162124637|NCT00619476|585509935|FG002|Overall Study|Investigator Discretion|2|||
162124638|NCT00619476|585509936|FG003|Overall Study|Investigator Discretion|0|||
162124639|NCT00619476|585509933|FG000|Overall Study|Withdrawal by Subject|5|||
162124640|NCT00619476|585509934|FG001|Overall Study|Withdrawal by Subject|7|||
162124641|NCT00619476|585509935|FG002|Overall Study|Withdrawal by Subject|5|||
162124642|NCT00619476|585509936|FG003|Overall Study|Withdrawal by Subject|4|||
162124643|NCT01091428|585509937|FG000|Phase 1|Progressive Disease|24|||
162124644|NCT01091428|585509938|FG001|Phase 1|Progressive Disease|8|||
162124645|NCT01091428|585509939|FG002|Phase 1|Progressive Disease|0|||
162124646|NCT01091428|585509940|FG003|Phase 1|Progressive Disease|0|||
162124647|NCT01091428|585509937|FG000|Phase 1|Symptomatic Deterioration|3|||
162124648|NCT01091428|585509938|FG001|Phase 1|Symptomatic Deterioration|2|||
162124649|NCT01091428|585509939|FG002|Phase 1|Symptomatic Deterioration|0|||
162124650|NCT01091428|585509940|FG003|Phase 1|Symptomatic Deterioration|0|||
162124651|NCT01091428|585509937|FG000|Phase 1|Adverse Event|2|||
162124652|NCT01091428|585509938|FG001|Phase 1|Adverse Event|0|||
162124653|NCT01091428|585509939|FG002|Phase 1|Adverse Event|0|||
162124654|NCT01091428|585509940|FG003|Phase 1|Adverse Event|0|||
162124655|NCT01091428|585509937|FG000|Phase 1|Withdrawal by Subject|7|||
162124656|NCT01091428|585509938|FG001|Phase 1|Withdrawal by Subject|0|||
162124657|NCT01091428|585509939|FG002|Phase 1|Withdrawal by Subject|0|||
162124658|NCT01091428|585509940|FG003|Phase 1|Withdrawal by Subject|0|||
162124659|NCT01091428|585509937|FG000|Phase 1|Reason not specified|0|||
162124660|NCT01091428|585509938|FG001|Phase 1|Reason not specified|1|||
162124661|NCT01091428|585509939|FG002|Phase 1|Reason not specified|0|||
161784966|NCT04380701|584257454|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
161784967|NCT04380701|584257455|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
161784968|NCT04380701|584257456|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
161784969|NCT04380701|584257457|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
161784970|NCT04380701|584257458|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
161784971|NCT04380701|584257459|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
162124662|NCT01091428|585509940|FG003|Phase 1|Reason not specified|0|||
162124663|NCT01091428|585509937|FG000|Phase 1|Single-Patient IND|2|||
162124664|NCT01091428|585509938|FG001|Phase 1|Single-Patient IND|0|||
162124665|NCT01091428|585509939|FG002|Phase 1|Single-Patient IND|0|||
162124666|NCT01091428|585509940|FG003|Phase 1|Single-Patient IND|0|||
162124667|NCT01091428|585509937|FG000|Phase 2|Progressive Disease|0|||
162124668|NCT01091428|585509938|FG001|Phase 2|Progressive Disease|0|||
162124669|NCT01091428|585509939|FG002|Phase 2|Progressive Disease|44|||
162124670|NCT01091428|585509940|FG003|Phase 2|Progressive Disease|46|||
162124671|NCT01091428|585509937|FG000|Phase 2|Symptomatic Deterioration|0|||
162124672|NCT01091428|585509938|FG001|Phase 2|Symptomatic Deterioration|0|||
162124673|NCT01091428|585509939|FG002|Phase 2|Symptomatic Deterioration|1|||
162124674|NCT01091428|585509940|FG003|Phase 2|Symptomatic Deterioration|6|||
162124675|NCT01091428|585509937|FG000|Phase 2|Adverse Event|0|||
162124676|NCT01091428|585509938|FG001|Phase 2|Adverse Event|0|||
162124677|NCT01091428|585509939|FG002|Phase 2|Adverse Event|12|||
162124678|NCT01091428|585509940|FG003|Phase 2|Adverse Event|5|||
162124679|NCT01091428|585509937|FG000|Phase 2|Withdrawal by Subject|0|||
162124680|NCT01091428|585509938|FG001|Phase 2|Withdrawal by Subject|0|||
162124681|NCT01091428|585509939|FG002|Phase 2|Withdrawal by Subject|9|||
162124682|NCT01091428|585509940|FG003|Phase 2|Withdrawal by Subject|8|||
162124683|NCT01091428|585509937|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
162124684|NCT01091428|585509938|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
162124685|NCT01091428|585509939|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
162124686|NCT01091428|585509940|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
162124687|NCT01091428|585509937|FG000|Phase 2|Reason not specified|0|||
162124688|NCT01091428|585509938|FG001|Phase 2|Reason not specified|0|||
162124689|NCT01091428|585509939|FG002|Phase 2|Reason not specified|4|||
162124690|NCT01091428|585509940|FG003|Phase 2|Reason not specified|3|||
162124691|NCT01091428|585509937|FG000|Phase 2|Physician Decision|0|||
162124692|NCT01091428|585509938|FG001|Phase 2|Physician Decision|0|||
162124693|NCT01091428|585509939|FG002|Phase 2|Physician Decision|2|||
162124694|NCT01091428|585509940|FG003|Phase 2|Physician Decision|0|||
162124695|NCT01625910|585509945|FG000|Overall Study|Lost to Follow-up|3|||
162124696|NCT01625910|585509946|FG001|Overall Study|Lost to Follow-up|4|||
162124697|NCT02959138|585509947|FG000|Overall Study|Enrolled but Never Treated|0|||
162124698|NCT02959138|585509948|FG001|Overall Study|Enrolled but Never Treated|1|||
162124699|NCT02959138|585509949|FG002|Overall Study|Enrolled but Never Treated|0|||
162124700|NCT02391038|585509950|FG000|Overall Study|Progressive disease|3|||
162124701|NCT02391038|585509951|FG001|Overall Study|Progressive disease|3|||
162124702|NCT02391038|585509952|FG002|Overall Study|Progressive disease|6|||
162124703|NCT04213989|585509953|FG000|Overall Study|Withdrawal by Subject|3|||
162124704|NCT04213989|585509954|FG001|Overall Study|Withdrawal by Subject|2|||
162124705|NCT04213989|585509953|FG000|Overall Study|Physician Decision|1|||
162124706|NCT04213989|585509954|FG001|Overall Study|Physician Decision|0|||
162124707|NCT04213989|585509953|FG000|Overall Study|Lost to Follow-up|0|||
162124708|NCT04213989|585509954|FG001|Overall Study|Lost to Follow-up|4|||
162124709|NCT01327547|585509955|FG000|Overall Study|Adverse Event|4|||
162124710|NCT01327547|585509956|FG001|Overall Study|Adverse Event|1|||
162124711|NCT01327547|585509955|FG000|Overall Study|Death|1|||
162124712|NCT01327547|585509956|FG001|Overall Study|Death|2|||
162124713|NCT01327547|585509955|FG000|Overall Study|Lost to Follow-up|6|||
162124714|NCT01327547|585509956|FG001|Overall Study|Lost to Follow-up|6|||
162124715|NCT01327547|585509955|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
162124716|NCT01327547|585509956|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
162124717|NCT01327547|585509955|FG000|Overall Study|Withdrawal by Subject|3|||
162124718|NCT01327547|585509956|FG001|Overall Study|Withdrawal by Subject|7|||
162124719|NCT01327547|585509955|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
162124720|NCT01327547|585509956|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
162124721|NCT01327547|585509955|FG000|Overall Study|Protocol Violation|1|||
162124722|NCT01327547|585509956|FG001|Overall Study|Protocol Violation|0|||
162124723|NCT01327547|585509955|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
162124724|NCT01327547|585509956|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
162124725|NCT01327547|585509955|FG000|Overall Study|Required prohibited medication|2|||
162124726|NCT01327547|585509956|FG001|Overall Study|Required prohibited medication|0|||
162124727|NCT01327547|585509955|FG000|Overall Study|Non-compliance with study procedures|1|||
162124728|NCT01327547|585509956|FG001|Overall Study|Non-compliance with study procedures|0|||
162124729|NCT01327547|585509955|FG000|Overall Study|By investigator in subject's interest|0|||
162124730|NCT01327547|585509956|FG001|Overall Study|By investigator in subject's interest|1|||
162124731|NCT03390036|585509959|FG000|Overall Study|Lost to Follow-up|1|||
162124732|NCT03390036|585509960|FG001|Overall Study|Lost to Follow-up|0|||
162124733|NCT03390036|585509961|FG002|Overall Study|Lost to Follow-up|0|||
162124734|NCT03390036|585509959|FG000|Overall Study|Lack of Efficacy|1|||
162124735|NCT03390036|585509960|FG001|Overall Study|Lack of Efficacy|0|||
162124736|NCT03390036|585509961|FG002|Overall Study|Lack of Efficacy|0|||
162124737|NCT01681368|585509964|FG000|Overall Study|Refused further treatment|1|||
162124738|NCT01681368|585509964|FG000|Overall Study|Refused further follow up|1|||
162124739|NCT06017999|585509967|FG000|Overall Study|Withdrawal by Subject|0|||
161784972|NCT04380701|584257460|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
161784973|NCT04380701|584257461|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
162124740|NCT06017999|585509968|FG001|Overall Study|Withdrawal by Subject|4|||
162124741|NCT06017999|585509969|FG002|Overall Study|Withdrawal by Subject|3|||
162124742|NCT06017999|585509967|FG000|Overall Study|Adverse Event|2|||
162124743|NCT06017999|585509968|FG001|Overall Study|Adverse Event|1|||
162124744|NCT06017999|585509969|FG002|Overall Study|Adverse Event|1|||
162124745|NCT06017999|585509967|FG000|Overall Study|Lost to Follow-up|0|||
161784974|NCT04380701|584257462|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
161784975|NCT04380701|584257463|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
162124746|NCT06017999|585509968|FG001|Overall Study|Lost to Follow-up|0|||
162124747|NCT06017999|585509969|FG002|Overall Study|Lost to Follow-up|1|||
162124748|NCT06017999|585509967|FG000|Overall Study|Physician Decision|1|||
162124749|NCT06017999|585509968|FG001|Overall Study|Physician Decision|1|||
162124750|NCT06017999|585509969|FG002|Overall Study|Physician Decision|0|||
162124751|NCT06017999|585509967|FG000|Overall Study|Non-Compliance|0|||
162124752|NCT06017999|585509968|FG001|Overall Study|Non-Compliance|0|||
162124753|NCT06017999|585509969|FG002|Overall Study|Non-Compliance|1|||
162124754|NCT06017999|585509967|FG000|Overall Study|Lack of Efficacy|1|||
162124755|NCT06017999|585509968|FG001|Overall Study|Lack of Efficacy|0|||
162124756|NCT06017999|585509969|FG002|Overall Study|Lack of Efficacy|7|||
162124757|NCT06017999|585509967|FG000|Overall Study|COVID Positive|0|||
162124758|NCT06017999|585509968|FG001|Overall Study|COVID Positive|1|||
162124759|NCT06017999|585509969|FG002|Overall Study|COVID Positive|0|||
162124760|NCT06017999|585509967|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
162124761|NCT06017999|585509968|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
162124762|NCT06017999|585509969|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
162124763|NCT01155388|585509970|FG000|Overall Study|Adverse Event|1|||
162124764|NCT01155388|585509971|FG001|Overall Study|Adverse Event|0|||
162124765|NCT03943589|585509972|FG000|Overall Study|Death|1|||
162124766|NCT03943589|585509972|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
162124767|NCT04329104|585509973|FG000|Efficacy Study|Withdrawal by Subject|0|||
162124768|NCT04329104|585509974|FG001|Efficacy Study|Withdrawal by Subject|0|||
162124769|NCT04329104|585509975|FG002|Efficacy Study|Withdrawal by Subject|0|||
162124770|NCT04329104|585509976|FG003|Efficacy Study|Withdrawal by Subject|5|||
162124771|NCT04329104|585509977|FG004|Efficacy Study|Withdrawal by Subject|6|||
162124772|NCT04329104|585509978|FG005|Efficacy Study|Withdrawal by Subject|8|||
162124773|NCT03884231|585509979|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
162124774|NCT03884231|585509979|FG000|Overall Study|Subject Withdrew Consent|1|||
162124775|NCT03884231|585509979|FG000|Overall Study|MRI Scan Not Performed|1|||
162124776|NCT00900627|585509980|FG000|Overall Study|Condition under investigation worsened|4|||
162124777|NCT00900627|585509981|FG001|Overall Study|Condition under investigation worsened|0|||
162124778|NCT00900627|585509982|FG002|Overall Study|Condition under investigation worsened|5|||
162124779|NCT00900627|585509983|FG003|Overall Study|Condition under investigation worsened|3|||
162124780|NCT00900627|585509984|FG004|Overall Study|Condition under investigation worsened|0|||
162124781|NCT00900627|585509985|FG005|Overall Study|Condition under investigation worsened|0|||
162124782|NCT00900627|585509980|FG000|Overall Study|Withdrawal by Subject|1|||
162124783|NCT00900627|585509981|FG001|Overall Study|Withdrawal by Subject|0|||
162124784|NCT00900627|585509982|FG002|Overall Study|Withdrawal by Subject|1|||
162124785|NCT00900627|585509983|FG003|Overall Study|Withdrawal by Subject|0|||
162124786|NCT00900627|585509984|FG004|Overall Study|Withdrawal by Subject|1|||
162124787|NCT00900627|585509985|FG005|Overall Study|Withdrawal by Subject|2|||
162124788|NCT00900627|585509980|FG000|Overall Study|Adverse Event|1|||
162124789|NCT00900627|585509981|FG001|Overall Study|Adverse Event|2|||
162124790|NCT00900627|585509982|FG002|Overall Study|Adverse Event|0|||
162124791|NCT00900627|585509983|FG003|Overall Study|Adverse Event|3|||
162124792|NCT00900627|585509984|FG004|Overall Study|Adverse Event|0|||
162124793|NCT00900627|585509985|FG005|Overall Study|Adverse Event|0|||
162124794|NCT00900627|585509980|FG000|Overall Study|Death|0|||
162124795|NCT00900627|585509981|FG001|Overall Study|Death|0|||
162124796|NCT00900627|585509982|FG002|Overall Study|Death|0|||
162124797|NCT00900627|585509983|FG003|Overall Study|Death|0|||
162124798|NCT00900627|585509984|FG004|Overall Study|Death|28|||
162124799|NCT00900627|585509985|FG005|Overall Study|Death|24|||
162124800|NCT00373295|585509986|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
162124801|NCT00373295|585509987|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
162124802|NCT00373295|585509988|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
162124803|NCT00373295|585509989|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
162124804|NCT00373295|585509990|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
162124805|NCT00373295|585509991|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
162124806|NCT00830947|585509992|FG000|Overall Study|Lost to Follow-up|4|||
162124807|NCT00830947|585509993|FG001|Overall Study|Lost to Follow-up|4|||
162124808|NCT01474512|585510005|FG000|Induction Period|Adverse Event|6|||
162124809|NCT01474512|585510006|FG001|Induction Period|Adverse Event|10|||
162124810|NCT01474512|585510007|FG002|Induction Period|Adverse Event|10|||
162124811|NCT01474512|585510008|FG003|Induction Period|Adverse Event|0|||
162124812|NCT01474512|585510009|FG004|Induction Period|Adverse Event|0|||
162124813|NCT01474512|585510010|FG005|Induction Period|Adverse Event|0|||
162124814|NCT01474512|585510011|FG006|Induction Period|Adverse Event|0|||
162124815|NCT01474512|585510012|FG007|Induction Period|Adverse Event|0|||
161784976|NCT04380701|584257464|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
161784977|NCT04380701|584257465|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
161784978|NCT04380701|584257432|FG000|Overall Study|Physician Decision|0|||
162124816|NCT01474512|585510013|FG008|Induction Period|Adverse Event|0|||
162124817|NCT01474512|585510014|FG009|Induction Period|Adverse Event|0|||
162124818|NCT01474512|585510015|FG010|Induction Period|Adverse Event|0|||
162124819|NCT01474512|585510016|FG011|Induction Period|Adverse Event|0|||
162124820|NCT01474512|585510017|FG012|Induction Period|Adverse Event|0|||
162124821|NCT01474512|585510018|FG013|Induction Period|Adverse Event|0|||
162124822|NCT01474512|585510019|FG014|Induction Period|Adverse Event|0|||
162124823|NCT01474512|585510020|FG015|Induction Period|Adverse Event|0|||
162124824|NCT01474512|585510021|FG016|Induction Period|Adverse Event|0|||
162124825|NCT01474512|585510022|FG017|Induction Period|Adverse Event|0|||
162124826|NCT01474512|585510005|FG000|Induction Period|Lack of Efficacy|7|||
162124827|NCT01474512|585510006|FG001|Induction Period|Lack of Efficacy|1|||
162124828|NCT01474512|585510007|FG002|Induction Period|Lack of Efficacy|0|||
162124829|NCT01474512|585510008|FG003|Induction Period|Lack of Efficacy|0|||
162124830|NCT01474512|585510009|FG004|Induction Period|Lack of Efficacy|0|||
162124831|NCT01474512|585510010|FG005|Induction Period|Lack of Efficacy|0|||
162124832|NCT01474512|585510011|FG006|Induction Period|Lack of Efficacy|0|||
162124833|NCT01474512|585510012|FG007|Induction Period|Lack of Efficacy|0|||
162124834|NCT01474512|585510013|FG008|Induction Period|Lack of Efficacy|0|||
162124835|NCT01474512|585510014|FG009|Induction Period|Lack of Efficacy|0|||
162124836|NCT01474512|585510015|FG010|Induction Period|Lack of Efficacy|0|||
162124837|NCT01474512|585510016|FG011|Induction Period|Lack of Efficacy|0|||
162124838|NCT01474512|585510017|FG012|Induction Period|Lack of Efficacy|0|||
162124839|NCT01474512|585510018|FG013|Induction Period|Lack of Efficacy|0|||
162124840|NCT01474512|585510019|FG014|Induction Period|Lack of Efficacy|0|||
162124841|NCT01474512|585510020|FG015|Induction Period|Lack of Efficacy|0|||
162124842|NCT01474512|585510021|FG016|Induction Period|Lack of Efficacy|0|||
162124843|NCT01474512|585510022|FG017|Induction Period|Lack of Efficacy|0|||
162124844|NCT01474512|585510005|FG000|Induction Period|Withdrawal by Subject|6|||
162124845|NCT01474512|585510006|FG001|Induction Period|Withdrawal by Subject|6|||
162124846|NCT01474512|585510007|FG002|Induction Period|Withdrawal by Subject|5|||
162124847|NCT01474512|585510008|FG003|Induction Period|Withdrawal by Subject|0|||
162124848|NCT01474512|585510009|FG004|Induction Period|Withdrawal by Subject|0|||
162124849|NCT01474512|585510010|FG005|Induction Period|Withdrawal by Subject|0|||
162124850|NCT01474512|585510011|FG006|Induction Period|Withdrawal by Subject|0|||
162124851|NCT01474512|585510012|FG007|Induction Period|Withdrawal by Subject|0|||
162124852|NCT01474512|585510013|FG008|Induction Period|Withdrawal by Subject|0|||
162124853|NCT01474512|585510014|FG009|Induction Period|Withdrawal by Subject|0|||
162124854|NCT01474512|585510015|FG010|Induction Period|Withdrawal by Subject|0|||
162124855|NCT01474512|585510016|FG011|Induction Period|Withdrawal by Subject|0|||
162124856|NCT01474512|585510017|FG012|Induction Period|Withdrawal by Subject|0|||
162124857|NCT01474512|585510018|FG013|Induction Period|Withdrawal by Subject|0|||
162124858|NCT01474512|585510019|FG014|Induction Period|Withdrawal by Subject|0|||
162124859|NCT01474512|585510020|FG015|Induction Period|Withdrawal by Subject|0|||
162124860|NCT01474512|585510021|FG016|Induction Period|Withdrawal by Subject|0|||
162124861|NCT01474512|585510022|FG017|Induction Period|Withdrawal by Subject|0|||
162124862|NCT01474512|585510005|FG000|Induction Period|Protocol Violation|3|||
162124863|NCT01474512|585510006|FG001|Induction Period|Protocol Violation|6|||
162124864|NCT01474512|585510007|FG002|Induction Period|Protocol Violation|0|||
162124865|NCT01474512|585510008|FG003|Induction Period|Protocol Violation|0|||
162124866|NCT01474512|585510009|FG004|Induction Period|Protocol Violation|0|||
162124867|NCT01474512|585510010|FG005|Induction Period|Protocol Violation|0|||
162124868|NCT01474512|585510011|FG006|Induction Period|Protocol Violation|0|||
162124869|NCT01474512|585510012|FG007|Induction Period|Protocol Violation|0|||
162124870|NCT01474512|585510013|FG008|Induction Period|Protocol Violation|0|||
162124871|NCT01474512|585510014|FG009|Induction Period|Protocol Violation|0|||
162124872|NCT01474512|585510015|FG010|Induction Period|Protocol Violation|0|||
162124873|NCT01474512|585510016|FG011|Induction Period|Protocol Violation|0|||
162124874|NCT01474512|585510017|FG012|Induction Period|Protocol Violation|0|||
162124875|NCT01474512|585510018|FG013|Induction Period|Protocol Violation|0|||
162124876|NCT01474512|585510019|FG014|Induction Period|Protocol Violation|0|||
162124877|NCT01474512|585510020|FG015|Induction Period|Protocol Violation|0|||
162124878|NCT01474512|585510021|FG016|Induction Period|Protocol Violation|0|||
162124879|NCT01474512|585510022|FG017|Induction Period|Protocol Violation|0|||
162124880|NCT01474512|585510005|FG000|Induction Period|Sponsor Decision|1|||
162124881|NCT01474512|585510006|FG001|Induction Period|Sponsor Decision|1|||
162124882|NCT01474512|585510007|FG002|Induction Period|Sponsor Decision|1|||
162124883|NCT01474512|585510008|FG003|Induction Period|Sponsor Decision|0|||
162124884|NCT01474512|585510009|FG004|Induction Period|Sponsor Decision|0|||
162124885|NCT01474512|585510010|FG005|Induction Period|Sponsor Decision|0|||
162124886|NCT01474512|585510011|FG006|Induction Period|Sponsor Decision|0|||
162124887|NCT01474512|585510012|FG007|Induction Period|Sponsor Decision|0|||
162124888|NCT01474512|585510013|FG008|Induction Period|Sponsor Decision|0|||
162124889|NCT01474512|585510014|FG009|Induction Period|Sponsor Decision|0|||
162124890|NCT01474512|585510015|FG010|Induction Period|Sponsor Decision|0|||
161784979|NCT04380701|584257433|FG001|Overall Study|Physician Decision|0|||
161784980|NCT04380701|584257434|FG002|Overall Study|Physician Decision|0|||
161784981|NCT04380701|584257435|FG003|Overall Study|Physician Decision|0|||
162124891|NCT01474512|585510016|FG011|Induction Period|Sponsor Decision|0|||
162124892|NCT01474512|585510017|FG012|Induction Period|Sponsor Decision|0|||
162124893|NCT01474512|585510018|FG013|Induction Period|Sponsor Decision|0|||
162124894|NCT01474512|585510019|FG014|Induction Period|Sponsor Decision|0|||
162124895|NCT01474512|585510020|FG015|Induction Period|Sponsor Decision|0|||
162124896|NCT01474512|585510021|FG016|Induction Period|Sponsor Decision|0|||
162124897|NCT01474512|585510022|FG017|Induction Period|Sponsor Decision|0|||
162124898|NCT01474512|585510005|FG000|Induction Period|Lost to Follow-up|1|||
162124899|NCT01474512|585510006|FG001|Induction Period|Lost to Follow-up|0|||
162124900|NCT01474512|585510007|FG002|Induction Period|Lost to Follow-up|2|||
162124901|NCT01474512|585510008|FG003|Induction Period|Lost to Follow-up|0|||
162124902|NCT01474512|585510009|FG004|Induction Period|Lost to Follow-up|0|||
162124903|NCT01474512|585510010|FG005|Induction Period|Lost to Follow-up|0|||
162124904|NCT01474512|585510011|FG006|Induction Period|Lost to Follow-up|0|||
161784982|NCT04380701|584257436|FG004|Overall Study|Physician Decision|0|||
162124905|NCT01474512|585510012|FG007|Induction Period|Lost to Follow-up|0|||
162124906|NCT01474512|585510013|FG008|Induction Period|Lost to Follow-up|0|||
162124907|NCT01474512|585510014|FG009|Induction Period|Lost to Follow-up|0|||
162124908|NCT01474512|585510015|FG010|Induction Period|Lost to Follow-up|0|||
162124909|NCT01474512|585510016|FG011|Induction Period|Lost to Follow-up|0|||
162124910|NCT01474512|585510017|FG012|Induction Period|Lost to Follow-up|0|||
162124911|NCT01474512|585510018|FG013|Induction Period|Lost to Follow-up|0|||
162124912|NCT01474512|585510019|FG014|Induction Period|Lost to Follow-up|0|||
162124913|NCT01474512|585510020|FG015|Induction Period|Lost to Follow-up|0|||
162124914|NCT01474512|585510021|FG016|Induction Period|Lost to Follow-up|0|||
162124915|NCT01474512|585510022|FG017|Induction Period|Lost to Follow-up|0|||
162124916|NCT01474512|585510005|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124917|NCT01474512|585510006|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124918|NCT01474512|585510007|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124919|NCT01474512|585510008|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
162124920|NCT01474512|585510009|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
162124921|NCT01474512|585510010|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
162124922|NCT01474512|585510011|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
162124923|NCT01474512|585510012|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124924|NCT01474512|585510013|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124925|NCT01474512|585510014|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124926|NCT01474512|585510015|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124927|NCT01474512|585510016|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124928|NCT01474512|585510017|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124929|NCT01474512|585510018|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124930|NCT01474512|585510019|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124931|NCT01474512|585510020|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124932|NCT01474512|585510021|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124933|NCT01474512|585510022|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
162124934|NCT01474512|585510005|FG000|Maintenance Period|Adverse Event|0|||
162124935|NCT01474512|585510006|FG001|Maintenance Period|Adverse Event|0|||
162124936|NCT01474512|585510007|FG002|Maintenance Period|Adverse Event|0|||
162124937|NCT01474512|585510008|FG003|Maintenance Period|Adverse Event|4|||
162124938|NCT01474512|585510009|FG004|Maintenance Period|Adverse Event|2|||
162124939|NCT01474512|585510010|FG005|Maintenance Period|Adverse Event|7|||
162124940|NCT01474512|585510011|FG006|Maintenance Period|Adverse Event|0|||
162124941|NCT01474512|585510012|FG007|Maintenance Period|Adverse Event|19|||
162124942|NCT01474512|585510013|FG008|Maintenance Period|Adverse Event|1|||
162124943|NCT01474512|585510014|FG009|Maintenance Period|Adverse Event|3|||
162124944|NCT01474512|585510015|FG010|Maintenance Period|Adverse Event|0|||
162124945|NCT01474512|585510016|FG011|Maintenance Period|Adverse Event|0|||
162124946|NCT01474512|585510017|FG012|Maintenance Period|Adverse Event|0|||
162124947|NCT01474512|585510018|FG013|Maintenance Period|Adverse Event|0|||
162124948|NCT01474512|585510019|FG014|Maintenance Period|Adverse Event|0|||
162124949|NCT01474512|585510020|FG015|Maintenance Period|Adverse Event|0|||
162124950|NCT01474512|585510021|FG016|Maintenance Period|Adverse Event|0|||
162124951|NCT01474512|585510022|FG017|Maintenance Period|Adverse Event|0|||
162124952|NCT01474512|585510005|FG000|Maintenance Period|Withdrawal by Subject|0|||
162124953|NCT01474512|585510006|FG001|Maintenance Period|Withdrawal by Subject|0|||
162124954|NCT01474512|585510007|FG002|Maintenance Period|Withdrawal by Subject|0|||
162124955|NCT01474512|585510008|FG003|Maintenance Period|Withdrawal by Subject|6|||
162124956|NCT01474512|585510009|FG004|Maintenance Period|Withdrawal by Subject|2|||
162124957|NCT01474512|585510010|FG005|Maintenance Period|Withdrawal by Subject|3|||
162124958|NCT01474512|585510011|FG006|Maintenance Period|Withdrawal by Subject|1|||
162124959|NCT01474512|585510012|FG007|Maintenance Period|Withdrawal by Subject|6|||
162124960|NCT01474512|585510013|FG008|Maintenance Period|Withdrawal by Subject|3|||
162124961|NCT01474512|585510014|FG009|Maintenance Period|Withdrawal by Subject|1|||
162124962|NCT01474512|585510015|FG010|Maintenance Period|Withdrawal by Subject|0|||
161784983|NCT04380701|584257437|FG005|Overall Study|Physician Decision|0|||
161784984|NCT04380701|584257438|FG006|Overall Study|Physician Decision|0|||
162124963|NCT01474512|585510016|FG011|Maintenance Period|Withdrawal by Subject|0|||
162124964|NCT01474512|585510017|FG012|Maintenance Period|Withdrawal by Subject|0|||
162124965|NCT01474512|585510018|FG013|Maintenance Period|Withdrawal by Subject|0|||
162124966|NCT01474512|585510019|FG014|Maintenance Period|Withdrawal by Subject|0|||
162124967|NCT01474512|585510020|FG015|Maintenance Period|Withdrawal by Subject|0|||
162124968|NCT01474512|585510021|FG016|Maintenance Period|Withdrawal by Subject|0|||
162124969|NCT01474512|585510022|FG017|Maintenance Period|Withdrawal by Subject|0|||
162124970|NCT01474512|585510005|FG000|Maintenance Period|Lost to Follow-up|0|||
162124971|NCT01474512|585510006|FG001|Maintenance Period|Lost to Follow-up|0|||
162124972|NCT01474512|585510007|FG002|Maintenance Period|Lost to Follow-up|0|||
162124973|NCT01474512|585510008|FG003|Maintenance Period|Lost to Follow-up|3|||
162124974|NCT01474512|585510009|FG004|Maintenance Period|Lost to Follow-up|3|||
162124975|NCT01474512|585510010|FG005|Maintenance Period|Lost to Follow-up|0|||
162124976|NCT01474512|585510011|FG006|Maintenance Period|Lost to Follow-up|0|||
162124977|NCT01474512|585510012|FG007|Maintenance Period|Lost to Follow-up|2|||
162124978|NCT01474512|585510013|FG008|Maintenance Period|Lost to Follow-up|1|||
162124979|NCT01474512|585510014|FG009|Maintenance Period|Lost to Follow-up|1|||
162124980|NCT01474512|585510015|FG010|Maintenance Period|Lost to Follow-up|0|||
162124981|NCT01474512|585510016|FG011|Maintenance Period|Lost to Follow-up|0|||
162124982|NCT01474512|585510017|FG012|Maintenance Period|Lost to Follow-up|0|||
162124983|NCT01474512|585510018|FG013|Maintenance Period|Lost to Follow-up|0|||
162124984|NCT01474512|585510019|FG014|Maintenance Period|Lost to Follow-up|0|||
162124985|NCT01474512|585510020|FG015|Maintenance Period|Lost to Follow-up|0|||
162124986|NCT01474512|585510021|FG016|Maintenance Period|Lost to Follow-up|0|||
162124987|NCT01474512|585510022|FG017|Maintenance Period|Lost to Follow-up|0|||
162124988|NCT01474512|585510005|FG000|Maintenance Period|Death|0|||
162124989|NCT01474512|585510006|FG001|Maintenance Period|Death|0|||
162124990|NCT01474512|585510007|FG002|Maintenance Period|Death|0|||
162124991|NCT01474512|585510008|FG003|Maintenance Period|Death|0|||
162124992|NCT01474512|585510009|FG004|Maintenance Period|Death|0|||
162124993|NCT01474512|585510010|FG005|Maintenance Period|Death|2|||
162124994|NCT01474512|585510011|FG006|Maintenance Period|Death|0|||
162124995|NCT01474512|585510012|FG007|Maintenance Period|Death|0|||
162124996|NCT01474512|585510013|FG008|Maintenance Period|Death|0|||
162124997|NCT01474512|585510014|FG009|Maintenance Period|Death|0|||
162124998|NCT01474512|585510015|FG010|Maintenance Period|Death|0|||
162124999|NCT01474512|585510016|FG011|Maintenance Period|Death|0|||
162125000|NCT01474512|585510017|FG012|Maintenance Period|Death|0|||
162125001|NCT01474512|585510018|FG013|Maintenance Period|Death|0|||
162125002|NCT01474512|585510019|FG014|Maintenance Period|Death|0|||
162125003|NCT01474512|585510020|FG015|Maintenance Period|Death|0|||
162125004|NCT01474512|585510021|FG016|Maintenance Period|Death|0|||
162125005|NCT01474512|585510022|FG017|Maintenance Period|Death|0|||
162125006|NCT01474512|585510005|FG000|Maintenance Period|Physician Decision|0|||
162125007|NCT01474512|585510006|FG001|Maintenance Period|Physician Decision|0|||
162125008|NCT01474512|585510007|FG002|Maintenance Period|Physician Decision|0|||
162125009|NCT01474512|585510008|FG003|Maintenance Period|Physician Decision|0|||
162125010|NCT01474512|585510009|FG004|Maintenance Period|Physician Decision|0|||
162125011|NCT01474512|585510010|FG005|Maintenance Period|Physician Decision|1|||
162125012|NCT01474512|585510011|FG006|Maintenance Period|Physician Decision|0|||
162125013|NCT01474512|585510012|FG007|Maintenance Period|Physician Decision|2|||
162125014|NCT01474512|585510013|FG008|Maintenance Period|Physician Decision|0|||
162125015|NCT01474512|585510014|FG009|Maintenance Period|Physician Decision|0|||
162125016|NCT01474512|585510015|FG010|Maintenance Period|Physician Decision|0|||
162125017|NCT01474512|585510016|FG011|Maintenance Period|Physician Decision|0|||
162125018|NCT01474512|585510017|FG012|Maintenance Period|Physician Decision|0|||
162125019|NCT01474512|585510018|FG013|Maintenance Period|Physician Decision|0|||
162125020|NCT01474512|585510019|FG014|Maintenance Period|Physician Decision|0|||
162125021|NCT01474512|585510020|FG015|Maintenance Period|Physician Decision|0|||
162125022|NCT01474512|585510021|FG016|Maintenance Period|Physician Decision|0|||
162125023|NCT01474512|585510022|FG017|Maintenance Period|Physician Decision|0|||
162125024|NCT01474512|585510005|FG000|Maintenance Period|Clinical Relapse|0|||
162125025|NCT01474512|585510006|FG001|Maintenance Period|Clinical Relapse|0|||
162125026|NCT01474512|585510007|FG002|Maintenance Period|Clinical Relapse|0|||
162125027|NCT01474512|585510008|FG003|Maintenance Period|Clinical Relapse|1|||
162125028|NCT01474512|585510009|FG004|Maintenance Period|Clinical Relapse|0|||
162125029|NCT01474512|585510010|FG005|Maintenance Period|Clinical Relapse|0|||
162125030|NCT01474512|585510011|FG006|Maintenance Period|Clinical Relapse|0|||
162125031|NCT01474512|585510012|FG007|Maintenance Period|Clinical Relapse|0|||
162125032|NCT01474512|585510013|FG008|Maintenance Period|Clinical Relapse|0|||
162125033|NCT01474512|585510014|FG009|Maintenance Period|Clinical Relapse|0|||
162125034|NCT01474512|585510015|FG010|Maintenance Period|Clinical Relapse|0|||
162125035|NCT01474512|585510016|FG011|Maintenance Period|Clinical Relapse|0|||
162125036|NCT01474512|585510017|FG012|Maintenance Period|Clinical Relapse|0|||
162125037|NCT01474512|585510018|FG013|Maintenance Period|Clinical Relapse|0|||
162125038|NCT01474512|585510019|FG014|Maintenance Period|Clinical Relapse|0|||
162125039|NCT01474512|585510020|FG015|Maintenance Period|Clinical Relapse|0|||
162125040|NCT01474512|585510021|FG016|Maintenance Period|Clinical Relapse|0|||
162125041|NCT01474512|585510022|FG017|Maintenance Period|Clinical Relapse|0|||
162125042|NCT01474512|585510005|FG000|Maintenance Period|Lack of Efficacy|0|||
162125043|NCT01474512|585510006|FG001|Maintenance Period|Lack of Efficacy|0|||
162125044|NCT01474512|585510007|FG002|Maintenance Period|Lack of Efficacy|0|||
162125045|NCT01474512|585510008|FG003|Maintenance Period|Lack of Efficacy|1|||
162125046|NCT01474512|585510009|FG004|Maintenance Period|Lack of Efficacy|0|||
162125047|NCT01474512|585510010|FG005|Maintenance Period|Lack of Efficacy|0|||
162125048|NCT01474512|585510011|FG006|Maintenance Period|Lack of Efficacy|0|||
162125049|NCT01474512|585510012|FG007|Maintenance Period|Lack of Efficacy|11|||
162125050|NCT01474512|585510013|FG008|Maintenance Period|Lack of Efficacy|11|||
162125051|NCT01474512|585510014|FG009|Maintenance Period|Lack of Efficacy|12|||
162125052|NCT01474512|585510015|FG010|Maintenance Period|Lack of Efficacy|0|||
162125053|NCT01474512|585510016|FG011|Maintenance Period|Lack of Efficacy|0|||
162125054|NCT01474512|585510017|FG012|Maintenance Period|Lack of Efficacy|0|||
162125055|NCT01474512|585510018|FG013|Maintenance Period|Lack of Efficacy|0|||
162125056|NCT01474512|585510019|FG014|Maintenance Period|Lack of Efficacy|0|||
162125057|NCT01474512|585510020|FG015|Maintenance Period|Lack of Efficacy|0|||
162125058|NCT01474512|585510021|FG016|Maintenance Period|Lack of Efficacy|0|||
162125059|NCT01474512|585510022|FG017|Maintenance Period|Lack of Efficacy|0|||
162125060|NCT01474512|585510005|FG000|Maintenance Period|Protocol Violation|0|||
162125061|NCT01474512|585510006|FG001|Maintenance Period|Protocol Violation|0|||
162125062|NCT01474512|585510007|FG002|Maintenance Period|Protocol Violation|0|||
162125063|NCT01474512|585510008|FG003|Maintenance Period|Protocol Violation|1|||
162125064|NCT01474512|585510009|FG004|Maintenance Period|Protocol Violation|0|||
162125065|NCT01474512|585510010|FG005|Maintenance Period|Protocol Violation|0|||
162125066|NCT01474512|585510011|FG006|Maintenance Period|Protocol Violation|0|||
162125067|NCT01474512|585510012|FG007|Maintenance Period|Protocol Violation|1|||
162125068|NCT01474512|585510013|FG008|Maintenance Period|Protocol Violation|0|||
162125069|NCT01474512|585510014|FG009|Maintenance Period|Protocol Violation|1|||
162125070|NCT01474512|585510015|FG010|Maintenance Period|Protocol Violation|0|||
162125071|NCT01474512|585510016|FG011|Maintenance Period|Protocol Violation|0|||
162125072|NCT01474512|585510017|FG012|Maintenance Period|Protocol Violation|0|||
162125073|NCT01474512|585510018|FG013|Maintenance Period|Protocol Violation|0|||
162125074|NCT01474512|585510019|FG014|Maintenance Period|Protocol Violation|0|||
162125075|NCT01474512|585510020|FG015|Maintenance Period|Protocol Violation|0|||
162125076|NCT01474512|585510021|FG016|Maintenance Period|Protocol Violation|0|||
162125077|NCT01474512|585510022|FG017|Maintenance Period|Protocol Violation|0|||
162125078|NCT01474512|585510005|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
162125079|NCT01474512|585510006|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
162125080|NCT01474512|585510007|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
162125081|NCT01474512|585510008|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
162125082|NCT01474512|585510009|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
162125083|NCT01474512|585510010|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
162125084|NCT01474512|585510011|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
162125085|NCT01474512|585510012|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
162125086|NCT01474512|585510013|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
162125087|NCT01474512|585510014|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
162125088|NCT01474512|585510015|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
162125089|NCT01474512|585510016|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
162125090|NCT01474512|585510017|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
162125091|NCT01474512|585510018|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
162125092|NCT01474512|585510019|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
162125093|NCT01474512|585510020|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
162125094|NCT01474512|585510021|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
162125095|NCT01474512|585510022|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
162125096|NCT01474512|585510005|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
162125097|NCT01474512|585510006|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
162125098|NCT01474512|585510007|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
162125099|NCT01474512|585510008|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
162125100|NCT01474512|585510009|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
162125101|NCT01474512|585510010|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
162125102|NCT01474512|585510011|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
162125103|NCT01474512|585510012|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
162125104|NCT01474512|585510013|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
162125105|NCT01474512|585510014|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
162125106|NCT01474512|585510015|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
162125107|NCT01474512|585510016|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
162125108|NCT01474512|585510017|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
162125109|NCT01474512|585510018|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
162125110|NCT01474512|585510019|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
162125111|NCT01474512|585510020|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
162125112|NCT01474512|585510021|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
162125113|NCT01474512|585510022|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
162125114|NCT01474512|585510005|FG000|Long-Term Extension Period|Adverse Event|0|||
162125115|NCT01474512|585510006|FG001|Long-Term Extension Period|Adverse Event|0|||
162125116|NCT01474512|585510007|FG002|Long-Term Extension Period|Adverse Event|0|||
162125117|NCT01474512|585510008|FG003|Long-Term Extension Period|Adverse Event|0|||
162125118|NCT01474512|585510009|FG004|Long-Term Extension Period|Adverse Event|0|||
162125119|NCT01474512|585510010|FG005|Long-Term Extension Period|Adverse Event|0|||
162125120|NCT01474512|585510011|FG006|Long-Term Extension Period|Adverse Event|0|||
162125121|NCT01474512|585510012|FG007|Long-Term Extension Period|Adverse Event|0|||
162125122|NCT01474512|585510013|FG008|Long-Term Extension Period|Adverse Event|0|||
162125123|NCT01474512|585510014|FG009|Long-Term Extension Period|Adverse Event|0|||
162125124|NCT01474512|585510015|FG010|Long-Term Extension Period|Adverse Event|0|||
162125125|NCT01474512|585510016|FG011|Long-Term Extension Period|Adverse Event|1|||
162125126|NCT01474512|585510017|FG012|Long-Term Extension Period|Adverse Event|57|||
162125127|NCT01474512|585510018|FG013|Long-Term Extension Period|Adverse Event|58|||
162125128|NCT01474512|585510019|FG014|Long-Term Extension Period|Adverse Event|0|||
162125129|NCT01474512|585510020|FG015|Long-Term Extension Period|Adverse Event|0|||
162125130|NCT01474512|585510021|FG016|Long-Term Extension Period|Adverse Event|0|||
162125131|NCT01474512|585510022|FG017|Long-Term Extension Period|Adverse Event|0|||
162125132|NCT01474512|585510005|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
162125133|NCT01474512|585510006|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
162125134|NCT01474512|585510007|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
162125135|NCT01474512|585510008|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
162125136|NCT01474512|585510009|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
162125137|NCT01474512|585510010|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
162125138|NCT01474512|585510011|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
162125139|NCT01474512|585510012|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
162125140|NCT01474512|585510013|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
162125141|NCT01474512|585510014|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
162125142|NCT01474512|585510015|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
162125143|NCT01474512|585510016|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
162125144|NCT01474512|585510017|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
162125145|NCT01474512|585510018|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
162125146|NCT01474512|585510019|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
162125147|NCT01474512|585510020|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
162125148|NCT01474512|585510021|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
162125149|NCT01474512|585510022|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
162125150|NCT01474512|585510005|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
162125151|NCT01474512|585510006|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
162125152|NCT01474512|585510007|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
162125153|NCT01474512|585510008|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
162125154|NCT01474512|585510009|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
162125155|NCT01474512|585510010|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
162125156|NCT01474512|585510011|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
162125157|NCT01474512|585510012|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
162125158|NCT01474512|585510013|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
162125159|NCT01474512|585510014|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
162125160|NCT01474512|585510015|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
162125161|NCT01474512|585510016|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
162125162|NCT01474512|585510017|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
162125163|NCT01474512|585510018|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
162125164|NCT01474512|585510019|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
162125165|NCT01474512|585510020|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
162125166|NCT01474512|585510021|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
162125167|NCT01474512|585510022|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
162125168|NCT01474512|585510005|FG000|Long-Term Extension Period|Physician Decision|0|||
162125169|NCT01474512|585510006|FG001|Long-Term Extension Period|Physician Decision|0|||
162125170|NCT01474512|585510007|FG002|Long-Term Extension Period|Physician Decision|0|||
162125171|NCT01474512|585510008|FG003|Long-Term Extension Period|Physician Decision|0|||
162125172|NCT01474512|585510009|FG004|Long-Term Extension Period|Physician Decision|0|||
162125173|NCT01474512|585510010|FG005|Long-Term Extension Period|Physician Decision|0|||
162125174|NCT01474512|585510011|FG006|Long-Term Extension Period|Physician Decision|0|||
162125175|NCT01474512|585510012|FG007|Long-Term Extension Period|Physician Decision|0|||
162125176|NCT01474512|585510013|FG008|Long-Term Extension Period|Physician Decision|0|||
162125177|NCT01474512|585510014|FG009|Long-Term Extension Period|Physician Decision|0|||
162125178|NCT01474512|585510015|FG010|Long-Term Extension Period|Physician Decision|0|||
162125179|NCT01474512|585510016|FG011|Long-Term Extension Period|Physician Decision|0|||
162125180|NCT01474512|585510017|FG012|Long-Term Extension Period|Physician Decision|21|||
162125181|NCT01474512|585510018|FG013|Long-Term Extension Period|Physician Decision|21|||
162125182|NCT01474512|585510019|FG014|Long-Term Extension Period|Physician Decision|0|||
162125183|NCT01474512|585510020|FG015|Long-Term Extension Period|Physician Decision|0|||
161784985|NCT04380701|584257439|FG007|Overall Study|Physician Decision|0|||
161784986|NCT04380701|584257440|FG008|Overall Study|Physician Decision|0|||
161784987|NCT04380701|584257441|FG009|Overall Study|Physician Decision|0|||
161784988|NCT04380701|584257442|FG010|Overall Study|Physician Decision|0|||
161784989|NCT04380701|584257443|FG011|Overall Study|Physician Decision|0|||
161784990|NCT04380701|584257444|FG012|Overall Study|Physician Decision|0|||
162125184|NCT01474512|585510021|FG016|Long-Term Extension Period|Physician Decision|0|||
162125185|NCT01474512|585510022|FG017|Long-Term Extension Period|Physician Decision|0|||
162125186|NCT01474512|585510005|FG000|Long-Term Extension Period|Clinical Relapse|0|||
162125187|NCT01474512|585510006|FG001|Long-Term Extension Period|Clinical Relapse|0|||
162125188|NCT01474512|585510007|FG002|Long-Term Extension Period|Clinical Relapse|0|||
162125189|NCT01474512|585510008|FG003|Long-Term Extension Period|Clinical Relapse|0|||
161784991|NCT04380701|584257445|FG013|Overall Study|Physician Decision|0|||
162125190|NCT01474512|585510009|FG004|Long-Term Extension Period|Clinical Relapse|0|||
162125191|NCT01474512|585510010|FG005|Long-Term Extension Period|Clinical Relapse|0|||
162125192|NCT01474512|585510011|FG006|Long-Term Extension Period|Clinical Relapse|0|||
162125193|NCT01474512|585510012|FG007|Long-Term Extension Period|Clinical Relapse|0|||
162125194|NCT01474512|585510013|FG008|Long-Term Extension Period|Clinical Relapse|0|||
162125195|NCT01474512|585510014|FG009|Long-Term Extension Period|Clinical Relapse|0|||
162125196|NCT01474512|585510015|FG010|Long-Term Extension Period|Clinical Relapse|0|||
162125197|NCT01474512|585510016|FG011|Long-Term Extension Period|Clinical Relapse|0|||
162125198|NCT01474512|585510017|FG012|Long-Term Extension Period|Clinical Relapse|9|||
162125199|NCT01474512|585510018|FG013|Long-Term Extension Period|Clinical Relapse|9|||
162125200|NCT01474512|585510019|FG014|Long-Term Extension Period|Clinical Relapse|0|||
162125201|NCT01474512|585510020|FG015|Long-Term Extension Period|Clinical Relapse|0|||
162125202|NCT01474512|585510021|FG016|Long-Term Extension Period|Clinical Relapse|0|||
162125203|NCT01474512|585510022|FG017|Long-Term Extension Period|Clinical Relapse|0|||
162125204|NCT01474512|585510005|FG000|Long-Term Extension Period|Death|0|||
162125205|NCT01474512|585510006|FG001|Long-Term Extension Period|Death|0|||
162125206|NCT01474512|585510007|FG002|Long-Term Extension Period|Death|0|||
162125207|NCT01474512|585510008|FG003|Long-Term Extension Period|Death|0|||
162125208|NCT01474512|585510009|FG004|Long-Term Extension Period|Death|0|||
162125209|NCT01474512|585510010|FG005|Long-Term Extension Period|Death|0|||
162125210|NCT01474512|585510011|FG006|Long-Term Extension Period|Death|0|||
162125211|NCT01474512|585510012|FG007|Long-Term Extension Period|Death|0|||
162125212|NCT01474512|585510013|FG008|Long-Term Extension Period|Death|0|||
162125213|NCT01474512|585510014|FG009|Long-Term Extension Period|Death|0|||
162125214|NCT01474512|585510015|FG010|Long-Term Extension Period|Death|0|||
162125215|NCT01474512|585510016|FG011|Long-Term Extension Period|Death|0|||
162125216|NCT01474512|585510017|FG012|Long-Term Extension Period|Death|9|||
162125217|NCT01474512|585510018|FG013|Long-Term Extension Period|Death|9|||
161784992|NCT04380701|584257446|FG014|Overall Study|Physician Decision|0|||
161784993|NCT04380701|584257447|FG015|Overall Study|Physician Decision|0|||
161784994|NCT04380701|584257448|FG016|Overall Study|Physician Decision|0|||
161784995|NCT04380701|584257449|FG017|Overall Study|Physician Decision|0|||
161784996|NCT04380701|584257450|FG018|Overall Study|Physician Decision|0|||
161784997|NCT04380701|584257451|FG019|Overall Study|Physician Decision|0|||
161784998|NCT04380701|584257452|FG020|Overall Study|Physician Decision|0|||
161784999|NCT04380701|584257453|FG021|Overall Study|Physician Decision|0|||
161785000|NCT04380701|584257454|FG022|Overall Study|Physician Decision|0|||
161785001|NCT04380701|584257455|FG023|Overall Study|Physician Decision|0|||
161785002|NCT04380701|584257456|FG024|Overall Study|Physician Decision|2|||
161785003|NCT04380701|584257457|FG025|Overall Study|Physician Decision|0|||
161785004|NCT04380701|584257458|FG026|Overall Study|Physician Decision|0|||
161785005|NCT04380701|584257459|FG027|Overall Study|Physician Decision|0|||
161785006|NCT04380701|584257460|FG028|Overall Study|Physician Decision|0|||
161785007|NCT04380701|584257461|FG029|Overall Study|Physician Decision|0|||
161785008|NCT04380701|584257462|FG030|Overall Study|Physician Decision|0|||
161785009|NCT04380701|584257463|FG031|Overall Study|Physician Decision|0|||
161785010|NCT04380701|584257464|FG032|Overall Study|Physician Decision|0|||
161785011|NCT04380701|584257465|FG033|Overall Study|Physician Decision|0|||
161785012|NCT04380701|584257432|FG000|Overall Study|Death|0|||
161785013|NCT04380701|584257433|FG001|Overall Study|Death|0|||
161785014|NCT04380701|584257434|FG002|Overall Study|Death|0|||
161785015|NCT04380701|584257435|FG003|Overall Study|Death|0|||
161785016|NCT04380701|584257436|FG004|Overall Study|Death|0|||
161785017|NCT04380701|584257437|FG005|Overall Study|Death|0|||
161785018|NCT04380701|584257438|FG006|Overall Study|Death|0|||
161785019|NCT04380701|584257439|FG007|Overall Study|Death|0|||
161785020|NCT04380701|584257440|FG008|Overall Study|Death|0|||
161785021|NCT04380701|584257441|FG009|Overall Study|Death|0|||
161785022|NCT04380701|584257442|FG010|Overall Study|Death|0|||
161785023|NCT04380701|584257443|FG011|Overall Study|Death|0|||
161785024|NCT04380701|584257444|FG012|Overall Study|Death|0|||
161785025|NCT04380701|584257445|FG013|Overall Study|Death|0|||
161785026|NCT04380701|584257446|FG014|Overall Study|Death|0|||
161785027|NCT04380701|584257447|FG015|Overall Study|Death|0|||
161785028|NCT04380701|584257448|FG016|Overall Study|Death|0|||
161785029|NCT04380701|584257449|FG017|Overall Study|Death|0|||
161785030|NCT04380701|584257450|FG018|Overall Study|Death|0|||
161785031|NCT04380701|584257451|FG019|Overall Study|Death|0|||
162125218|NCT01474512|585510019|FG014|Long-Term Extension Period|Death|0|||
161785032|NCT04380701|584257452|FG020|Overall Study|Death|0|||
161785033|NCT04380701|584257453|FG021|Overall Study|Death|0|||
161785034|NCT04380701|584257454|FG022|Overall Study|Death|0|||
162125219|NCT01474512|585510020|FG015|Long-Term Extension Period|Death|0|||
162125220|NCT01474512|585510021|FG016|Long-Term Extension Period|Death|0|||
161785035|NCT04380701|584257455|FG023|Overall Study|Death|0|||
161785036|NCT04380701|584257456|FG024|Overall Study|Death|1|||
162125221|NCT01474512|585510022|FG017|Long-Term Extension Period|Death|0|||
162125222|NCT01474512|585510005|FG000|Long-Term Extension Period|Sponsor Decision|0|||
161785037|NCT04380701|584257457|FG025|Overall Study|Death|0|||
161785038|NCT04380701|584257458|FG026|Overall Study|Death|0|||
161785039|NCT04380701|584257459|FG027|Overall Study|Death|0|||
161785040|NCT04380701|584257460|FG028|Overall Study|Death|0|||
162125223|NCT01474512|585510006|FG001|Long-Term Extension Period|Sponsor Decision|0|||
162125224|NCT01474512|585510007|FG002|Long-Term Extension Period|Sponsor Decision|0|||
162125225|NCT01474512|585510008|FG003|Long-Term Extension Period|Sponsor Decision|0|||
162125226|NCT01474512|585510009|FG004|Long-Term Extension Period|Sponsor Decision|0|||
162125227|NCT01474512|585510010|FG005|Long-Term Extension Period|Sponsor Decision|0|||
162125228|NCT01474512|585510011|FG006|Long-Term Extension Period|Sponsor Decision|0|||
162125229|NCT01474512|585510012|FG007|Long-Term Extension Period|Sponsor Decision|0|||
162125230|NCT01474512|585510013|FG008|Long-Term Extension Period|Sponsor Decision|0|||
162125231|NCT01474512|585510014|FG009|Long-Term Extension Period|Sponsor Decision|0|||
162125232|NCT01474512|585510015|FG010|Long-Term Extension Period|Sponsor Decision|0|||
162125233|NCT01474512|585510016|FG011|Long-Term Extension Period|Sponsor Decision|0|||
162125234|NCT01474512|585510017|FG012|Long-Term Extension Period|Sponsor Decision|6|||
162125235|NCT01474512|585510018|FG013|Long-Term Extension Period|Sponsor Decision|6|||
162125236|NCT01474512|585510019|FG014|Long-Term Extension Period|Sponsor Decision|0|||
162125237|NCT01474512|585510020|FG015|Long-Term Extension Period|Sponsor Decision|0|||
162125238|NCT01474512|585510021|FG016|Long-Term Extension Period|Sponsor Decision|0|||
162125239|NCT01474512|585510022|FG017|Long-Term Extension Period|Sponsor Decision|0|||
162125240|NCT01474512|585510005|FG000|Long-Term Extension Period|Protocol Violation|0|||
162125241|NCT01474512|585510006|FG001|Long-Term Extension Period|Protocol Violation|0|||
162125242|NCT01474512|585510007|FG002|Long-Term Extension Period|Protocol Violation|0|||
162125243|NCT01474512|585510008|FG003|Long-Term Extension Period|Protocol Violation|0|||
162125244|NCT01474512|585510009|FG004|Long-Term Extension Period|Protocol Violation|0|||
162125245|NCT01474512|585510010|FG005|Long-Term Extension Period|Protocol Violation|0|||
162125246|NCT01474512|585510011|FG006|Long-Term Extension Period|Protocol Violation|0|||
162125247|NCT01474512|585510012|FG007|Long-Term Extension Period|Protocol Violation|0|||
162125248|NCT01474512|585510013|FG008|Long-Term Extension Period|Protocol Violation|0|||
162125249|NCT01474512|585510014|FG009|Long-Term Extension Period|Protocol Violation|0|||
162125250|NCT01474512|585510015|FG010|Long-Term Extension Period|Protocol Violation|0|||
162125251|NCT01474512|585510016|FG011|Long-Term Extension Period|Protocol Violation|0|||
162125252|NCT01474512|585510017|FG012|Long-Term Extension Period|Protocol Violation|5|||
162125253|NCT01474512|585510018|FG013|Long-Term Extension Period|Protocol Violation|5|||
162125254|NCT01474512|585510019|FG014|Long-Term Extension Period|Protocol Violation|0|||
162125255|NCT01474512|585510020|FG015|Long-Term Extension Period|Protocol Violation|0|||
162125256|NCT01474512|585510021|FG016|Long-Term Extension Period|Protocol Violation|0|||
162125257|NCT01474512|585510022|FG017|Long-Term Extension Period|Protocol Violation|0|||
162125258|NCT01474512|585510005|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125259|NCT01474512|585510006|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125260|NCT01474512|585510007|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125261|NCT01474512|585510008|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125262|NCT01474512|585510009|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125263|NCT01474512|585510010|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125264|NCT01474512|585510011|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125265|NCT01474512|585510012|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125266|NCT01474512|585510013|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125267|NCT01474512|585510014|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125268|NCT01474512|585510015|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125269|NCT01474512|585510016|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125270|NCT01474512|585510017|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
162125271|NCT01474512|585510018|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
162125272|NCT01474512|585510019|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125273|NCT01474512|585510020|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125274|NCT01474512|585510021|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125275|NCT01474512|585510022|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
162125276|NCT01474512|585510005|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125277|NCT01474512|585510006|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125278|NCT01474512|585510007|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125279|NCT01474512|585510008|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125280|NCT01474512|585510009|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161785041|NCT04380701|584257461|FG029|Overall Study|Death|0|||
161785042|NCT04380701|584257462|FG030|Overall Study|Death|0|||
161785043|NCT04380701|584257463|FG031|Overall Study|Death|0|||
161785044|NCT04380701|584257464|FG032|Overall Study|Death|0|||
161785045|NCT04380701|584257465|FG033|Overall Study|Death|0|||
162125281|NCT01474512|585510010|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125282|NCT01474512|585510011|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125283|NCT01474512|585510012|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161785046|NCT04380701|584257432|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785047|NCT04380701|584257433|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785048|NCT04380701|584257434|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162125284|NCT01474512|585510013|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125285|NCT01474512|585510014|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125286|NCT01474512|585510015|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125287|NCT01474512|585510016|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
162125288|NCT01474512|585510017|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125289|NCT01474512|585510018|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125290|NCT01474512|585510019|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125291|NCT01474512|585510020|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125292|NCT01474512|585510021|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125293|NCT01474512|585510022|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
162125294|NCT01474512|585510005|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
162125295|NCT01474512|585510006|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
162125296|NCT01474512|585510007|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
162125297|NCT01474512|585510008|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
162125298|NCT01474512|585510009|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
162125299|NCT01474512|585510010|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
162125300|NCT01474512|585510011|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
161898205|NCT00572455|584675573|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
162125301|NCT01474512|585510012|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
162125302|NCT01474512|585510013|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
162125303|NCT01474512|585510014|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
162125304|NCT01474512|585510015|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
162125305|NCT01474512|585510016|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
162125306|NCT01474512|585510017|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
162125307|NCT01474512|585510018|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
162125308|NCT01474512|585510019|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
162125309|NCT01474512|585510020|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
162125310|NCT01474512|585510021|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
162125311|NCT01474512|585510022|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
162125312|NCT01474512|585510005|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125313|NCT01474512|585510006|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125314|NCT01474512|585510007|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125315|NCT01474512|585510008|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125316|NCT01474512|585510009|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125317|NCT01474512|585510010|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125318|NCT01474512|585510011|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125319|NCT01474512|585510012|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125320|NCT01474512|585510013|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125321|NCT01474512|585510014|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125322|NCT01474512|585510015|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125323|NCT01474512|585510016|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125324|NCT01474512|585510017|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125325|NCT01474512|585510018|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
162125326|NCT01474512|585510019|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
162125327|NCT01474512|585510020|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
162125328|NCT01474512|585510021|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
162125329|NCT01474512|585510022|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
162125330|NCT01474512|585510005|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125331|NCT01474512|585510006|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125332|NCT01474512|585510007|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125333|NCT01474512|585510008|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125334|NCT01474512|585510009|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125335|NCT01474512|585510010|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125336|NCT01474512|585510011|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125337|NCT01474512|585510012|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125338|NCT01474512|585510013|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125339|NCT01474512|585510014|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125340|NCT01474512|585510015|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125341|NCT01474512|585510016|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125342|NCT01474512|585510017|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125343|NCT01474512|585510018|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
162125344|NCT01474512|585510019|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
162125345|NCT01474512|585510020|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
162125346|NCT01474512|585510021|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
162125347|NCT01474512|585510022|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
162125348|NCT01474512|585510005|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161898206|NCT00572455|584675574|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
162125349|NCT01474512|585510006|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125350|NCT01474512|585510007|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125351|NCT01474512|585510008|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125352|NCT01474512|585510009|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161785049|NCT04380701|584257435|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785050|NCT04380701|584257436|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785051|NCT04380701|584257437|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785052|NCT04380701|584257438|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785053|NCT04380701|584257439|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785054|NCT04380701|584257440|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785055|NCT04380701|584257441|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785056|NCT04380701|584257442|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785057|NCT04380701|584257443|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785058|NCT04380701|584257444|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785059|NCT04380701|584257445|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785060|NCT04380701|584257446|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785061|NCT04380701|584257447|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785062|NCT04380701|584257448|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785063|NCT04380701|584257449|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785064|NCT04380701|584257450|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785065|NCT04380701|584257451|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785066|NCT04380701|584257452|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785067|NCT04380701|584257453|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
161785068|NCT04380701|584257454|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
161785069|NCT04380701|584257455|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
161785070|NCT04380701|584257456|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
161785071|NCT04380701|584257457|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785072|NCT04380701|584257458|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785073|NCT04380701|584257459|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
162010236|NCT02435992|585093695|FG004|Overall Study|Withdrawal by Subject|0|||
162010237|NCT02435992|585093691|FG000|Overall Study|Other Reason|1|||
162010238|NCT02435992|585093692|FG001|Overall Study|Other Reason|0|||
162010239|NCT02435992|585093693|FG002|Overall Study|Other Reason|0|||
162010240|NCT02435992|585093694|FG003|Overall Study|Other Reason|0|||
162010241|NCT02435992|585093695|FG004|Overall Study|Other Reason|0|||
162010242|NCT02435992|585093691|FG000|Overall Study|Physician Decision|0|||
162010243|NCT02435992|585093692|FG001|Overall Study|Physician Decision|0|||
162010244|NCT02435992|585093693|FG002|Overall Study|Physician Decision|1|||
162010245|NCT02435992|585093694|FG003|Overall Study|Physician Decision|0|||
162010246|NCT02435992|585093695|FG004|Overall Study|Physician Decision|0|||
162010247|NCT01210313|585093709|FG000|Overall Study|Withdrawal by Subject|3|||
162010248|NCT01210313|585093709|FG000|Overall Study|Adverse Event|2|||
162010249|NCT01210313|585093709|FG000|Overall Study|Distant recurrence|4|||
162010250|NCT01210313|585093709|FG000|Overall Study|Non-compliance|7|||
162010251|NCT03773978|585093712|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
162010252|NCT03773978|585093713|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
162010253|NCT03773978|585093712|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
162010254|NCT03773978|585093713|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
162010255|NCT03773978|585093712|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
162010256|NCT03773978|585093713|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
162010257|NCT03773978|585093712|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
162010258|NCT03773978|585093713|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
162010259|NCT03773978|585093712|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
162010260|NCT03773978|585093713|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
162010261|NCT03773978|585093712|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
162010262|NCT03773978|585093713|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
162010263|NCT03773978|585093712|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
162010264|NCT03773978|585093713|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
162010265|NCT03773978|585093712|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
162010266|NCT03773978|585093713|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
162010267|NCT03773978|585093712|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
162010268|NCT03773978|585093713|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
162010269|NCT03773978|585093712|FG000|DBW Period|Adverse Event|2|||
162010270|NCT03773978|585093713|FG001|DBW Period|Adverse Event|2|||
162010271|NCT03773978|585093712|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
162010272|NCT03773978|585093713|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
162010273|NCT03773978|585093712|FG000|DBW Period|Withdrawal by Subject|2|||
162010274|NCT03773978|585093713|FG001|DBW Period|Withdrawal by Subject|1|||
162010275|NCT03773978|585093712|FG000|DBW Period|Due to epidemic or pandemic|5|||
162010276|NCT03773978|585093713|FG001|DBW Period|Due to epidemic or pandemic|6|||
162010277|NCT03773978|585093712|FG000|DBW Period|Study team decision|1|||
162125353|NCT01474512|585510010|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
161785074|NCT04380701|584257460|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785075|NCT04380701|584257461|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785076|NCT04380701|584257462|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785077|NCT04380701|584257463|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785078|NCT04380701|584257464|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785079|NCT04380701|584257465|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161785080|NCT03550794|584257466|FG000|Overall Study|No longer met inclusion criteria|1|||
161898207|NCT00572455|584675575|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
161898208|NCT00572455|584675576|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
161898209|NCT00572455|584675577|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
161898210|NCT02465437|584675578|FG000|Overall Study|Physician Decision|0|||
161898211|NCT02465437|584675579|FG001|Overall Study|Physician Decision|0|||
161898212|NCT02465437|584675580|FG002|Overall Study|Physician Decision|1|||
161898213|NCT02465437|584675581|FG003|Overall Study|Physician Decision|0|||
161898214|NCT02465437|584675578|FG000|Overall Study|Withdrawal by Subject|1|||
161898215|NCT02465437|584675579|FG001|Overall Study|Withdrawal by Subject|0|||
161898216|NCT02465437|584675580|FG002|Overall Study|Withdrawal by Subject|0|||
161898217|NCT02465437|584675581|FG003|Overall Study|Withdrawal by Subject|1|||
161898218|NCT02465437|584675578|FG000|Overall Study|Adverse Event|0|||
161898219|NCT02465437|584675579|FG001|Overall Study|Adverse Event|1|||
161898220|NCT02465437|584675580|FG002|Overall Study|Adverse Event|0|||
161898221|NCT02465437|584675581|FG003|Overall Study|Adverse Event|0|||
161898222|NCT03280056|584675584|FG000|Overall Study|Withdrawal by Subject|12|||
161898223|NCT03280056|584675585|FG001|Overall Study|Withdrawal by Subject|14|||
161898224|NCT03280056|584675584|FG000|Overall Study|Death|9|||
161898225|NCT03280056|584675585|FG001|Overall Study|Death|2|||
161898226|NCT03280056|584675584|FG000|Overall Study|Adverse Event|1|||
161898227|NCT03280056|584675585|FG001|Overall Study|Adverse Event|3|||
161898228|NCT03280056|584675584|FG000|Overall Study|Lost to Follow-up|1|||
161898229|NCT03280056|584675585|FG001|Overall Study|Lost to Follow-up|1|||
161898230|NCT03280056|584675584|FG000|Overall Study|Physician Decision|0|||
161898231|NCT03280056|584675585|FG001|Overall Study|Physician Decision|1|||
161898232|NCT03280056|584675584|FG000|Overall Study|Early Discontinuation|1|||
161898233|NCT03280056|584675585|FG001|Overall Study|Early Discontinuation|0|||
161898234|NCT01135524|584675591|FG000|Overall Study|Withdrawal by Subject|14|||
161898235|NCT01135524|584675591|FG000|Overall Study|Adverse Event|20|||
161898236|NCT01135524|584675591|FG000|Overall Study|Lost to Follow-up|3|||
161898237|NCT01135524|584675591|FG000|Overall Study|Administrative|151|||
161898238|NCT01135524|584675591|FG000|Overall Study|Lack of Efficacy|8|||
161898239|NCT00613821|584675592|FG000|Overall Study|Withdrawal by Subject|1|||
161898240|NCT00613821|584675593|FG001|Overall Study|Withdrawal by Subject|0|||
161898241|NCT00613821|584675592|FG000|Overall Study|Physician Decision|1|||
161898242|NCT00613821|584675593|FG001|Overall Study|Physician Decision|1|||
161898243|NCT02907463|584675594|FG000|Overall Study|Lost to Follow-up|17|||
161898244|NCT02907463|584675594|FG000|Overall Study|Death|10|||
161898245|NCT02907463|584675594|FG000|Overall Study|Withdrawal by Subject|4|||
161898246|NCT02907463|584675594|FG000|Overall Study|MIS Approach was not used|2|||
161898247|NCT02907463|584675594|FG000|Overall Study|Not Implanted with Study Device|2|||
161898248|NCT02907463|584675594|FG000|Overall Study|Device Explanted|1|||
161898249|NCT02907463|584675594|FG000|Overall Study|Missing Exit Form|1|||
161898250|NCT01266824|584675595|FG000|Overall Study|Study terminated prior to completion|2|||
161898251|NCT01266824|584675596|FG001|Overall Study|Study terminated prior to completion|3|||
161898252|NCT02302846|584675597|FG000|Overall Study|Withdrawal by Subject|1|||
161898253|NCT00397189|584675598|FG000|3 Weeks Period|Lost to Follow-up|5|||
161898254|NCT00397189|584675599|FG001|3 Weeks Period|Lost to Follow-up|4|||
161898255|NCT00397189|584675598|FG000|3 Weeks Period|Adverse Event|3|||
161898256|NCT00397189|584675599|FG001|3 Weeks Period|Adverse Event|2|||
161898257|NCT00397189|584675598|FG000|3 Weeks Period|Withdrawal by Subject|13|||
161898258|NCT00397189|584675599|FG001|3 Weeks Period|Withdrawal by Subject|9|||
161898259|NCT00397189|584675598|FG000|3 Weeks Period|Physician Decision|0|||
161898260|NCT00397189|584675599|FG001|3 Weeks Period|Physician Decision|2|||
161898261|NCT00397189|584675598|FG000|3 Weeks Period|Protocol Violation|0|||
161898262|NCT00397189|584675599|FG001|3 Weeks Period|Protocol Violation|3|||
161898263|NCT00397189|584675598|FG000|3 Weeks Period|Other|0|||
161898264|NCT00397189|584675599|FG001|3 Weeks Period|Other|2|||
161898265|NCT01447407|584675602|FG000|Overall Study|Withdrawal by Subject|2|||
161898266|NCT01447407|584675603|FG001|Overall Study|Withdrawal by Subject|0|||
161898267|NCT01447407|584675604|FG002|Overall Study|Withdrawal by Subject|0|||
161898268|NCT01447407|584675605|FG003|Overall Study|Withdrawal by Subject|1|||
161898269|NCT01447407|584675602|FG000|Overall Study|Physician Decision|0|||
161898270|NCT01447407|584675603|FG001|Overall Study|Physician Decision|0|||
161898271|NCT01447407|584675604|FG002|Overall Study|Physician Decision|1|||
161898272|NCT01447407|584675605|FG003|Overall Study|Physician Decision|1|||
161898273|NCT00141518|584675608|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
161898274|NCT00141518|584675609|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
161898275|NCT00141518|584675610|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
162125354|NCT01474512|585510011|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125355|NCT01474512|585510012|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125356|NCT01474512|585510013|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125357|NCT01474512|585510014|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125358|NCT01474512|585510015|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125359|NCT01474512|585510016|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125360|NCT01474512|585510017|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125361|NCT01474512|585510018|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125362|NCT01474512|585510019|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125363|NCT01474512|585510020|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
162125364|NCT01474512|585510021|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
162125365|NCT01474512|585510022|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
162125366|NCT01474512|585510005|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
162125367|NCT01474512|585510006|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
162125368|NCT01474512|585510007|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
162125369|NCT01474512|585510008|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
162125370|NCT01474512|585510009|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
162125371|NCT01474512|585510010|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
162125372|NCT01474512|585510011|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
162125373|NCT01474512|585510012|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
162125374|NCT01474512|585510013|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
162125375|NCT01474512|585510014|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
162125376|NCT01474512|585510015|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
162125377|NCT01474512|585510016|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
162125378|NCT01474512|585510017|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
162125379|NCT01474512|585510018|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
162125380|NCT01474512|585510019|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
162125381|NCT01474512|585510020|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
162125382|NCT01474512|585510021|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
162125383|NCT01474512|585510022|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
162125384|NCT01474512|585510005|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125385|NCT01474512|585510006|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125386|NCT01474512|585510007|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125387|NCT01474512|585510008|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125388|NCT01474512|585510009|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125389|NCT01474512|585510010|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125390|NCT01474512|585510011|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125391|NCT01474512|585510012|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125392|NCT01474512|585510013|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125393|NCT01474512|585510014|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125394|NCT01474512|585510015|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125395|NCT01474512|585510016|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125396|NCT01474512|585510017|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125397|NCT01474512|585510018|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
161785081|NCT03550794|584257467|FG001|Overall Study|No longer met inclusion criteria|2|||
161785082|NCT03550794|584257466|FG000|Overall Study|Goals of care changed|1|||
161785083|NCT03550794|584257467|FG001|Overall Study|Goals of care changed|0|||
161785084|NCT03550794|584257466|FG000|Overall Study|Withdrawal by Subject|2|||
161785085|NCT03550794|584257467|FG001|Overall Study|Withdrawal by Subject|0|||
161785086|NCT03550794|584257466|FG000|Overall Study|Death|0|||
161785087|NCT03550794|584257467|FG001|Overall Study|Death|1|||
161785088|NCT01864525|584257468|FG000|Overall Study|Adverse Event|1|||
161785089|NCT01864525|584257469|FG001|Overall Study|Adverse Event|0|||
161785090|NCT01890785|584257470|FG000|Third Intervention|Withdrawal by Subject|0|||
161785091|NCT01890785|584257471|FG001|Third Intervention|Withdrawal by Subject|1|||
161785092|NCT01890785|584257472|FG002|Third Intervention|Withdrawal by Subject|0|||
161785093|NCT01890785|584257473|FG003|Third Intervention|Withdrawal by Subject|0|||
161785094|NCT01890785|584257474|FG004|Third Intervention|Withdrawal by Subject|0|||
162125398|NCT01474512|585510019|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125399|NCT01474512|585510020|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
162125400|NCT01474512|585510021|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
161785095|NCT01890785|584257475|FG005|Third Intervention|Withdrawal by Subject|0|||
162125401|NCT01474512|585510022|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
162125402|NCT01474512|585510005|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
162125403|NCT01474512|585510006|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
161785096|NCT03296553|584257476|FG000|Overall Study|Withdrawal by Subject|1|||
161785097|NCT03296553|584257477|FG001|Overall Study|Withdrawal by Subject|1|||
161785098|NCT03296553|584257476|FG000|Overall Study|Death|1|||
161785099|NCT03296553|584257477|FG001|Overall Study|Death|0|||
161785100|NCT00558519|584257478|FG000|Overall Study|Ph+|20|||
161785101|NCT00558519|584257478|FG000|Overall Study|Ineligible|1|||
161785102|NCT00558519|584257478|FG000|Overall Study|Insufficient data|1|||
162125404|NCT01474512|585510007|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
162125405|NCT01474512|585510008|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
162125406|NCT01474512|585510009|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
162125407|NCT01474512|585510010|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
162125408|NCT01474512|585510011|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
162125409|NCT01474512|585510012|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
162125410|NCT01474512|585510013|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
162125411|NCT01474512|585510014|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
162125412|NCT01474512|585510015|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
162125413|NCT01474512|585510016|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
162125414|NCT01474512|585510017|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
162125415|NCT01474512|585510018|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
162125416|NCT01474512|585510019|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
162125417|NCT01474512|585510020|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
162125418|NCT01474512|585510021|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
162125419|NCT01474512|585510022|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
162125420|NCT01474512|585510005|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125421|NCT01474512|585510006|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125422|NCT01474512|585510007|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125423|NCT01474512|585510008|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125424|NCT01474512|585510009|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125425|NCT01474512|585510010|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125426|NCT01474512|585510011|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125427|NCT01474512|585510012|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125428|NCT01474512|585510013|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125429|NCT01474512|585510014|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125430|NCT01474512|585510015|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125431|NCT01474512|585510016|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125432|NCT01474512|585510017|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125433|NCT01474512|585510018|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125434|NCT01474512|585510019|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
162125435|NCT01474512|585510020|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125436|NCT01474512|585510021|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
162125437|NCT01474512|585510022|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
162125438|NCT01474512|585510005|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125439|NCT01474512|585510006|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125440|NCT01474512|585510007|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125441|NCT01474512|585510008|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125442|NCT01474512|585510009|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125443|NCT01474512|585510010|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125444|NCT01474512|585510011|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125445|NCT01474512|585510012|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125446|NCT01474512|585510013|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125447|NCT01474512|585510014|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125448|NCT01474512|585510015|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125449|NCT01474512|585510016|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125450|NCT01474512|585510017|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125451|NCT01474512|585510018|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125452|NCT01474512|585510019|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
162125453|NCT01474512|585510020|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125454|NCT01474512|585510021|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
162125455|NCT01474512|585510022|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
162125456|NCT01474512|585510005|FG000|Post-Treatment Follow-Up|Death|0|||
162125457|NCT01474512|585510006|FG001|Post-Treatment Follow-Up|Death|0|||
162125458|NCT01474512|585510007|FG002|Post-Treatment Follow-Up|Death|0|||
162125459|NCT01474512|585510008|FG003|Post-Treatment Follow-Up|Death|0|||
162125460|NCT01474512|585510009|FG004|Post-Treatment Follow-Up|Death|0|||
162125461|NCT01474512|585510010|FG005|Post-Treatment Follow-Up|Death|0|||
162125462|NCT01474512|585510011|FG006|Post-Treatment Follow-Up|Death|0|||
162125463|NCT01474512|585510012|FG007|Post-Treatment Follow-Up|Death|0|||
162125464|NCT01474512|585510013|FG008|Post-Treatment Follow-Up|Death|0|||
162125465|NCT01474512|585510014|FG009|Post-Treatment Follow-Up|Death|0|||
162125466|NCT01474512|585510015|FG010|Post-Treatment Follow-Up|Death|0|||
162125467|NCT01474512|585510016|FG011|Post-Treatment Follow-Up|Death|0|||
162125468|NCT01474512|585510017|FG012|Post-Treatment Follow-Up|Death|0|||
162125469|NCT01474512|585510018|FG013|Post-Treatment Follow-Up|Death|0|||
162125470|NCT01474512|585510019|FG014|Post-Treatment Follow-Up|Death|0|||
162125471|NCT01474512|585510020|FG015|Post-Treatment Follow-Up|Death|0|||
162125472|NCT01474512|585510021|FG016|Post-Treatment Follow-Up|Death|1|||
162125473|NCT01474512|585510022|FG017|Post-Treatment Follow-Up|Death|0|||
162125474|NCT01118962|585510027|FG000|Overall Study|Adverse Event|2|||
162125475|NCT01118962|585510027|FG000|Overall Study|Lack of Efficacy|1|||
162125476|NCT01118962|585510027|FG000|Overall Study|Protocol Violation|1|||
162125477|NCT01118962|585510027|FG000|Overall Study|Withdrawal by Subject|4|||
161785103|NCT00558519|584257478|FG000|Overall Study|Never received treatment|1|||
161785104|NCT00065065|584257479|FG000|Overall Study|Adverse Event|3|||
161785105|NCT00065065|584257480|FG001|Overall Study|Adverse Event|2|||
161785106|NCT00065065|584257479|FG000|Overall Study|Withdrawal by Subject|1|||
161785107|NCT00065065|584257480|FG001|Overall Study|Withdrawal by Subject|5|||
161785108|NCT00065065|584257479|FG000|Overall Study|Lack of Efficacy|4|||
161785109|NCT00065065|584257480|FG001|Overall Study|Lack of Efficacy|11|||
161785110|NCT00065065|584257479|FG000|Overall Study|Other|2|||
161785111|NCT00065065|584257480|FG001|Overall Study|Other|2|||
161785112|NCT01050673|584257481|FG000|Overall Study|Physician Decision|4|||
161785113|NCT01050673|584257482|FG001|Overall Study|Physician Decision|5|||
161785114|NCT03077828|584257487|FG000|Treatment Cycles|Death|1|||
162125478|NCT01118962|585510027|FG000|Overall Study|Pregnancy|1|||
162125479|NCT01118962|585510027|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
162125480|NCT01089556|585510028|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
162125481|NCT01089556|585510029|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
162125482|NCT01089556|585510030|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
162125483|NCT01089556|585510031|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
162125484|NCT01089556|585510032|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
162125485|NCT01089556|585510033|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
162125486|NCT01089556|585510028|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
161785115|NCT03077828|584257487|FG000|Treatment Cycles|Withdrawal by Subject|1|||
161785116|NCT03077828|584257487|FG000|Treatment Cycles|Screen Fail|2|||
162125487|NCT01089556|585510029|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
161785117|NCT03077828|584257487|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
161785118|NCT03077828|584257487|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
162125488|NCT01089556|585510030|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
162125489|NCT01089556|585510031|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
162125490|NCT01089556|585510032|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
162125491|NCT01089556|585510033|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
162125492|NCT01089556|585510028|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
162125493|NCT01089556|585510029|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
162125494|NCT01089556|585510030|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
162125495|NCT01089556|585510031|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
162125496|NCT01089556|585510032|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
162125497|NCT01089556|585510033|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
162125498|NCT01089556|585510028|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
162125499|NCT01089556|585510029|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
162125500|NCT01089556|585510030|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
162125501|NCT01089556|585510031|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
162125502|NCT01089556|585510032|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
162125503|NCT01089556|585510033|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
161785119|NCT03077828|584257487|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
161785120|NCT03077828|584257487|FG000|Follow-up|Patients still in follow-up|15|||
161785121|NCT02392559|584257488|FG000|Overall Study|Withdrawal by Subject|0|||
161785122|NCT02392559|584257489|FG001|Overall Study|Withdrawal by Subject|1|||
162125504|NCT01089556|585510028|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
162125505|NCT01089556|585510029|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
162125506|NCT01089556|585510030|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
162125507|NCT01089556|585510031|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
162125508|NCT01089556|585510032|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
162125509|NCT01089556|585510033|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
161785123|NCT03125915|584257495|FG000|1 Month Follow up|Lost to Follow-up|3|||
161785124|NCT03125915|584257496|FG001|1 Month Follow up|Lost to Follow-up|3|||
161785125|NCT03125915|584257497|FG002|1 Month Follow up|Lost to Follow-up|2|||
161785126|NCT03125915|584257498|FG003|1 Month Follow up|Lost to Follow-up|3|||
161785127|NCT03125915|584257495|FG000|3 Month Follow-up|Lost to Follow-up|6|||
161785128|NCT03125915|584257496|FG001|3 Month Follow-up|Lost to Follow-up|4|||
161785129|NCT03125915|584257497|FG002|3 Month Follow-up|Lost to Follow-up|4|||
162125510|NCT01089556|585510028|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
162125511|NCT01089556|585510029|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
162125512|NCT01089556|585510030|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
162125513|NCT01089556|585510031|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
162125514|NCT01089556|585510032|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
162125515|NCT01089556|585510033|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
162125516|NCT01089556|585510028|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
161785130|NCT03125915|584257498|FG003|3 Month Follow-up|Lost to Follow-up|2|||
161785131|NCT03125915|584257495|FG000|6 Month Follow-up|Lost to Follow-up|7|||
161785132|NCT03125915|584257496|FG001|6 Month Follow-up|Lost to Follow-up|3|||
161785133|NCT03125915|584257497|FG002|6 Month Follow-up|Lost to Follow-up|6|||
161785134|NCT03125915|584257498|FG003|6 Month Follow-up|Lost to Follow-up|3|||
162125517|NCT01089556|585510029|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
162125518|NCT01089556|585510030|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
162125519|NCT01089556|585510031|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
162125520|NCT01089556|585510032|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
162125521|NCT01089556|585510033|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
162125522|NCT01089556|585510028|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
162125523|NCT01089556|585510029|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
162125524|NCT01089556|585510030|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
162125525|NCT01089556|585510031|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
162125526|NCT01089556|585510032|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
162125527|NCT01089556|585510033|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
162125528|NCT01089556|585510028|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
162125529|NCT01089556|585510029|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
162125530|NCT01089556|585510030|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
162125531|NCT01089556|585510031|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
162125532|NCT01089556|585510032|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
162125533|NCT01089556|585510033|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
162125534|NCT01089556|585510028|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
162125535|NCT01089556|585510029|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
162125536|NCT01089556|585510030|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
162125537|NCT01089556|585510031|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
162125538|NCT01089556|585510032|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
162125539|NCT01089556|585510033|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
162125540|NCT01089556|585510028|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
162125541|NCT01089556|585510029|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
162125542|NCT01089556|585510030|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
162125543|NCT01089556|585510031|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
162125544|NCT01089556|585510032|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
162125545|NCT01089556|585510033|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
162125546|NCT01089556|585510028|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
162125547|NCT01089556|585510029|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
162125548|NCT01089556|585510030|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
162125549|NCT01089556|585510031|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
162125550|NCT01089556|585510032|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
162125551|NCT01089556|585510033|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
162125552|NCT01089556|585510028|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
162125553|NCT01089556|585510029|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
162125554|NCT01089556|585510030|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
162125555|NCT01089556|585510031|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
162125556|NCT01089556|585510032|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
162125557|NCT01089556|585510033|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
162125558|NCT01089556|585510028|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
162125559|NCT01089556|585510029|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
162125560|NCT01089556|585510030|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
162125561|NCT01089556|585510031|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
162125562|NCT01089556|585510032|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
162125563|NCT01089556|585510033|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
162125564|NCT01089556|585510028|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
162125565|NCT01089556|585510029|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
162125566|NCT01089556|585510030|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
162125567|NCT01089556|585510031|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
162125568|NCT01089556|585510032|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
162125569|NCT01089556|585510033|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
162125570|NCT02222896|585510034|FG000|Abdomen|Did not qualify|34|||
162125571|NCT02222896|585510035|FG001|Abdomen|Did not qualify|10|||
162125572|NCT02222896|585510036|FG002|Abdomen|Did not qualify|32|||
162125573|NCT02222896|585510034|FG000|Groin|Did not qualify|43|||
162125574|NCT02222896|585510035|FG001|Groin|Did not qualify|9|||
162125575|NCT02222896|585510036|FG002|Groin|Did not qualify|40|||
162125576|NCT01865617|585510038|FG000|Overall Study|Death|27|||
162125577|NCT01865617|585510039|FG001|Overall Study|Death|3|||
162125578|NCT01865617|585510040|FG002|Overall Study|Death|1|||
162125579|NCT01865617|585510041|FG003|Overall Study|Death|1|||
162125580|NCT01865617|585510042|FG004|Overall Study|Death|5|||
162125581|NCT01865617|585510043|FG005|Overall Study|Death|1|||
162125582|NCT01865617|585510044|FG006|Overall Study|Death|11|||
162125583|NCT01865617|585510045|FG007|Overall Study|Death|1|||
162125584|NCT01865617|585510046|FG008|Overall Study|Death|11|||
162125585|NCT01865617|585510047|FG009|Overall Study|Death|3|||
162125586|NCT01865617|585510048|FG010|Overall Study|Death|32|||
162125587|NCT01865617|585510049|FG011|Overall Study|Death|6|||
162125588|NCT01865617|585510050|FG012|Overall Study|Death|13|||
162125589|NCT01865617|585510038|FG000|Overall Study|Lost to Follow-up|2|||
162125590|NCT01865617|585510039|FG001|Overall Study|Lost to Follow-up|0|||
162125591|NCT01865617|585510040|FG002|Overall Study|Lost to Follow-up|0|||
162125592|NCT01865617|585510041|FG003|Overall Study|Lost to Follow-up|0|||
162125593|NCT01865617|585510042|FG004|Overall Study|Lost to Follow-up|0|||
162125594|NCT01865617|585510043|FG005|Overall Study|Lost to Follow-up|0|||
162125595|NCT01865617|585510044|FG006|Overall Study|Lost to Follow-up|0|||
162125596|NCT01865617|585510045|FG007|Overall Study|Lost to Follow-up|0|||
162125597|NCT01865617|585510046|FG008|Overall Study|Lost to Follow-up|0|||
162125598|NCT01865617|585510047|FG009|Overall Study|Lost to Follow-up|0|||
162125599|NCT01865617|585510048|FG010|Overall Study|Lost to Follow-up|0|||
162125600|NCT01865617|585510049|FG011|Overall Study|Lost to Follow-up|0|||
162125601|NCT01865617|585510050|FG012|Overall Study|Lost to Follow-up|0|||
162125602|NCT01865617|585510038|FG000|Overall Study|Withdrawal by Subject|1|||
162125603|NCT01865617|585510039|FG001|Overall Study|Withdrawal by Subject|0|||
162125604|NCT01865617|585510040|FG002|Overall Study|Withdrawal by Subject|0|||
162125605|NCT01865617|585510041|FG003|Overall Study|Withdrawal by Subject|0|||
162125606|NCT01865617|585510042|FG004|Overall Study|Withdrawal by Subject|0|||
162125607|NCT01865617|585510043|FG005|Overall Study|Withdrawal by Subject|0|||
162125608|NCT01865617|585510044|FG006|Overall Study|Withdrawal by Subject|0|||
162125609|NCT01865617|585510045|FG007|Overall Study|Withdrawal by Subject|0|||
162125610|NCT01865617|585510046|FG008|Overall Study|Withdrawal by Subject|0|||
162125611|NCT01865617|585510047|FG009|Overall Study|Withdrawal by Subject|0|||
162125612|NCT01865617|585510048|FG010|Overall Study|Withdrawal by Subject|0|||
162125613|NCT01865617|585510049|FG011|Overall Study|Withdrawal by Subject|0|||
162125614|NCT01865617|585510050|FG012|Overall Study|Withdrawal by Subject|0|||
162125615|NCT01865617|585510038|FG000|Overall Study|Patient proceeded to new therapy|0|||
162125616|NCT01865617|585510039|FG001|Overall Study|Patient proceeded to new therapy|0|||
162125617|NCT01865617|585510040|FG002|Overall Study|Patient proceeded to new therapy|0|||
162125618|NCT01865617|585510041|FG003|Overall Study|Patient proceeded to new therapy|0|||
162125619|NCT01865617|585510042|FG004|Overall Study|Patient proceeded to new therapy|2|||
162125620|NCT01865617|585510043|FG005|Overall Study|Patient proceeded to new therapy|0|||
162125621|NCT01865617|585510044|FG006|Overall Study|Patient proceeded to new therapy|0|||
162125622|NCT01865617|585510045|FG007|Overall Study|Patient proceeded to new therapy|0|||
162125623|NCT01865617|585510046|FG008|Overall Study|Patient proceeded to new therapy|0|||
162125624|NCT01865617|585510047|FG009|Overall Study|Patient proceeded to new therapy|0|||
162125625|NCT01865617|585510048|FG010|Overall Study|Patient proceeded to new therapy|0|||
162125626|NCT01865617|585510049|FG011|Overall Study|Patient proceeded to new therapy|0|||
162125627|NCT01865617|585510050|FG012|Overall Study|Patient proceeded to new therapy|0|||
162125628|NCT01865617|585510038|FG000|Overall Study|Other|0|||
162125629|NCT01865617|585510039|FG001|Overall Study|Other|0|||
162125630|NCT01865617|585510040|FG002|Overall Study|Other|0|||
162125631|NCT01865617|585510041|FG003|Overall Study|Other|0|||
162125632|NCT01865617|585510042|FG004|Overall Study|Other|0|||
162125633|NCT01865617|585510043|FG005|Overall Study|Other|0|||
162125634|NCT01865617|585510044|FG006|Overall Study|Other|1|||
162125635|NCT01865617|585510045|FG007|Overall Study|Other|0|||
162125636|NCT01865617|585510046|FG008|Overall Study|Other|0|||
162125637|NCT01865617|585510047|FG009|Overall Study|Other|0|||
162125638|NCT01865617|585510048|FG010|Overall Study|Other|0|||
162125639|NCT01865617|585510049|FG011|Overall Study|Other|0|||
162125640|NCT01865617|585510050|FG012|Overall Study|Other|0|||
162125641|NCT02500979|585510051|FG000|Period 1|Hyperglycemia|1|||
162125642|NCT02500979|585510052|FG001|Period 1|Hyperglycemia|0|||
162125643|NCT02500979|585510051|FG000|Period 1|Severe non-compliance to protocol|0|||
162125644|NCT02500979|585510052|FG001|Period 1|Severe non-compliance to protocol|1|||
162125645|NCT02500979|585510051|FG000|Period 1|Adverse Event|1|||
162125646|NCT02500979|585510052|FG001|Period 1|Adverse Event|0|||
162125647|NCT02500979|585510051|FG000|Period 1|Subject decision|2|||
162125648|NCT02500979|585510052|FG001|Period 1|Subject decision|0|||
162125649|NCT02500979|585510051|FG000|Period 2|Change in risk|1|||
162125650|NCT02500979|585510052|FG001|Period 2|Change in risk|0|||
162125651|NCT00119262|585510053|FG000|Overall Study|Lack of Efficacy|0|||
162125652|NCT00119262|585510054|FG001|Overall Study|Lack of Efficacy|3|||
162125653|NCT00119262|585510053|FG000|Overall Study|Withdrawal by Subject|12|||
162125654|NCT00119262|585510054|FG001|Overall Study|Withdrawal by Subject|11|||
162125655|NCT00119262|585510053|FG000|Overall Study|Adverse Event|33|||
162125656|NCT00119262|585510054|FG001|Overall Study|Adverse Event|35|||
162125657|NCT00119262|585510053|FG000|Overall Study|other disease|0|||
162125658|NCT00119262|585510054|FG001|Overall Study|other disease|2|||
162125659|NCT00119262|585510053|FG000|Overall Study|ineligble|1|||
162125660|NCT00119262|585510054|FG001|Overall Study|ineligble|2|||
162125661|NCT00119262|585510053|FG000|Overall Study|others|0|||
162125662|NCT00119262|585510054|FG001|Overall Study|others|5|||
162125663|NCT03853317|585510055|FG000|Overall Study|Progressive Disease|5|||
162125664|NCT03853317|585510055|FG000|Overall Study|Adverse Event|1|||
162125665|NCT03853317|585510055|FG000|Overall Study|Death|1|||
162125666|NCT03853317|585510055|FG000|Overall Study|other event|2|||
162125667|NCT01927731|585510057|FG000|Overall Study|Graft Failure|1|||
162125668|NCT01927731|585510058|FG001|Overall Study|Graft Failure|2|||
162125669|NCT01927731|585510057|FG000|Overall Study|Physician Decision|2|||
162125670|NCT01927731|585510058|FG001|Overall Study|Physician Decision|3|||
162125671|NCT01927731|585510057|FG000|Overall Study|Withdrawal by Subject|0|||
162125672|NCT01927731|585510058|FG001|Overall Study|Withdrawal by Subject|2|||
162125673|NCT01927731|585510057|FG000|Overall Study|Death|0|||
162125674|NCT01927731|585510058|FG001|Overall Study|Death|3|||
162125675|NCT03881059|585510059|FG000|Treatment Period - Part A|Adverse Event|1|||
162125676|NCT03881059|585510060|FG001|Treatment Period - Part A|Adverse Event|3|||
162125677|NCT03881059|585510061|FG002|Treatment Period - Part A|Adverse Event|4|||
162125678|NCT03881059|585510059|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
162125679|NCT03881059|585510060|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
162125680|NCT03881059|585510061|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
162125681|NCT03881059|585510059|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
162125682|NCT03881059|585510060|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
162125683|NCT03881059|585510061|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
162125684|NCT03881059|585510059|FG000|Treatment Period - Part A|Other reasons|2|||
162125685|NCT03881059|585510060|FG001|Treatment Period - Part A|Other reasons|1|||
162125686|NCT03881059|585510061|FG002|Treatment Period - Part A|Other reasons|0|||
162125687|NCT03881059|585510059|FG000|Treatment Period - Part B|Adverse Event|0|||
162125688|NCT03881059|585510060|FG001|Treatment Period - Part B|Adverse Event|0|||
162125689|NCT03881059|585510061|FG002|Treatment Period - Part B|Adverse Event|3|||
162125690|NCT03881059|585510059|FG000|Treatment Period - Part B|Death|0|||
162125691|NCT03881059|585510060|FG001|Treatment Period - Part B|Death|1|||
162125692|NCT03881059|585510061|FG002|Treatment Period - Part B|Death|1|||
162125693|NCT03881059|585510059|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
162125694|NCT03881059|585510060|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
162125695|NCT03881059|585510061|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
162125696|NCT03881059|585510059|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
162125697|NCT03881059|585510060|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
162125698|NCT03881059|585510061|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
162125699|NCT03881059|585510059|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
162125700|NCT03881059|585510060|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
162125701|NCT03881059|585510061|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
162125702|NCT03881059|585510059|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
162125703|NCT03881059|585510060|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
162125704|NCT03881059|585510061|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
162125705|NCT03881059|585510059|FG000|Treatment Period - Part B|Other reasons|4|||
162125706|NCT03881059|585510060|FG001|Treatment Period - Part B|Other reasons|3|||
162125707|NCT03881059|585510061|FG002|Treatment Period - Part B|Other reasons|3|||
162125708|NCT02065570|585510062|FG000|Induction Study|Adverse Event|5|||
162125709|NCT02065570|585510063|FG001|Induction Study|Adverse Event|12|||
162125710|NCT02065570|585510064|FG002|Induction Study|Adverse Event|0|||
162125711|NCT02065570|585510065|FG003|Induction Study|Adverse Event|0|||
162125712|NCT02065570|585510062|FG000|Induction Study|Withdrawal by Subject|2|||
162125713|NCT02065570|585510063|FG001|Induction Study|Withdrawal by Subject|3|||
162125714|NCT02065570|585510064|FG002|Induction Study|Withdrawal by Subject|0|||
162125715|NCT02065570|585510065|FG003|Induction Study|Withdrawal by Subject|0|||
162125716|NCT02065570|585510062|FG000|Induction Study|Lost to Follow-up|1|||
162125717|NCT02065570|585510063|FG001|Induction Study|Lost to Follow-up|1|||
162125718|NCT02065570|585510064|FG002|Induction Study|Lost to Follow-up|0|||
162125719|NCT02065570|585510065|FG003|Induction Study|Lost to Follow-up|0|||
162125720|NCT02065570|585510062|FG000|Induction Study|Other, Not Specified|6|||
162125721|NCT02065570|585510063|FG001|Induction Study|Other, Not Specified|5|||
162125722|NCT02065570|585510064|FG002|Induction Study|Other, Not Specified|0|||
162125723|NCT02065570|585510065|FG003|Induction Study|Other, Not Specified|0|||
162125724|NCT02065570|585510062|FG000|Maintenance Study|Adverse Event|0|||
162125725|NCT02065570|585510063|FG001|Maintenance Study|Adverse Event|0|||
162125726|NCT02065570|585510064|FG002|Maintenance Study|Adverse Event|8|||
162125727|NCT02065570|585510065|FG003|Maintenance Study|Adverse Event|8|||
162125728|NCT02065570|585510062|FG000|Maintenance Study|Withdrawal by Subject|0|||
162125729|NCT02065570|585510063|FG001|Maintenance Study|Withdrawal by Subject|0|||
162125730|NCT02065570|585510064|FG002|Maintenance Study|Withdrawal by Subject|1|||
162125731|NCT02065570|585510065|FG003|Maintenance Study|Withdrawal by Subject|4|||
162125732|NCT02065570|585510062|FG000|Maintenance Study|Lost to Follow-up|0|||
162125733|NCT02065570|585510063|FG001|Maintenance Study|Lost to Follow-up|0|||
162125734|NCT02065570|585510064|FG002|Maintenance Study|Lost to Follow-up|2|||
161785135|NCT04816877|584257499|FG000|Overall Study|Withdrawal by Subject|1|||
162125735|NCT02065570|585510065|FG003|Maintenance Study|Lost to Follow-up|2|||
162125736|NCT02065570|585510062|FG000|Maintenance Study|Other, Not Specified|0|||
162125737|NCT02065570|585510063|FG001|Maintenance Study|Other, Not Specified|0|||
162125738|NCT02065570|585510064|FG002|Maintenance Study|Other, Not Specified|11|||
161785136|NCT04816877|584257500|FG001|Overall Study|Withdrawal by Subject|0|||
161785137|NCT02176642|584257504|FG000|Overall Study|Withdrawal by Subject|0|||
162125739|NCT02065570|585510065|FG003|Maintenance Study|Other, Not Specified|5|||
162125740|NCT02743793|585510066|FG000|Overall Study|Death|1|||
162125741|NCT02743793|585510067|FG001|Overall Study|Death|1|||
162125742|NCT02743793|585510066|FG000|Overall Study|Withdrawal by Subject|0|||
162125743|NCT02743793|585510067|FG001|Overall Study|Withdrawal by Subject|1|||
162125744|NCT02743793|585510066|FG000|Overall Study|Screen Failure|4|||
162125745|NCT02743793|585510067|FG001|Overall Study|Screen Failure|0|||
162125746|NCT02743793|585510066|FG000|Overall Study|No Primary Care Physician|0|||
162125747|NCT02743793|585510067|FG001|Overall Study|No Primary Care Physician|1|||
162125748|NCT02743793|585510066|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
162125749|NCT02743793|585510067|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
162125750|NCT02743793|585510066|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
162125751|NCT02743793|585510067|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
162125752|NCT00786474|585510072|FG000|Overall Study|Death|5|||
162125753|NCT00786474|585510073|FG001|Overall Study|Death|4|||
162125754|NCT00786474|585510072|FG000|Overall Study|Withdrawal by Subject|23|||
162125755|NCT00786474|585510073|FG001|Overall Study|Withdrawal by Subject|31|||
162125756|NCT00786474|585510072|FG000|Overall Study|Lost to Follow-up|3|||
162125757|NCT00786474|585510073|FG001|Overall Study|Lost to Follow-up|3|||
162125758|NCT00786474|585510072|FG000|Overall Study|Physician Decision|2|||
162125759|NCT00786474|585510073|FG001|Overall Study|Physician Decision|1|||
162125760|NCT00786474|585510072|FG000|Overall Study|Other|4|||
162125761|NCT00786474|585510073|FG001|Overall Study|Other|4|||
162125762|NCT04642469|585510074|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
162125763|NCT04642469|585510075|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
162125764|NCT04642469|585510074|FG000|Overall Study|Death|1|||
162125765|NCT04642469|585510075|FG001|Overall Study|Death|2|||
162125766|NCT04642469|585510074|FG000|Overall Study|Study/site closed following amendment 1|11|||
162125767|NCT04642469|585510075|FG001|Overall Study|Study/site closed following amendment 1|11|||
162125768|NCT04642469|585510074|FG000|Overall Study|Other|1|||
162125769|NCT04642469|585510075|FG001|Overall Study|Other|1|||
162125770|NCT04642469|585510074|FG000|Overall Study|Withdrawal by Subject|1|||
162125771|NCT04642469|585510075|FG001|Overall Study|Withdrawal by Subject|0|||
162125772|NCT02733042|585510076|FG000|Overall Study|Adverse Event|1|||
162125773|NCT02733042|585510077|FG001|Overall Study|Adverse Event|0|||
162125774|NCT02733042|585510078|FG002|Overall Study|Adverse Event|1|||
162125775|NCT02733042|585510079|FG003|Overall Study|Adverse Event|1|||
162125776|NCT02733042|585510080|FG004|Overall Study|Adverse Event|0|||
162125777|NCT02733042|585510081|FG005|Overall Study|Adverse Event|0|||
162125778|NCT02733042|585510082|FG006|Overall Study|Adverse Event|0|||
162125779|NCT02733042|585510083|FG007|Overall Study|Adverse Event|0|||
162125780|NCT02733042|585510084|FG008|Overall Study|Adverse Event|0|||
162125781|NCT02733042|585510085|FG009|Overall Study|Adverse Event|0|||
162125782|NCT02733042|585510086|FG010|Overall Study|Adverse Event|2|||
162125783|NCT02733042|585510087|FG011|Overall Study|Adverse Event|2|||
162125784|NCT02733042|585510088|FG012|Overall Study|Adverse Event|0|||
162125785|NCT02733042|585510089|FG013|Overall Study|Adverse Event|2|||
162125786|NCT02733042|585510090|FG014|Overall Study|Adverse Event|0|||
162125787|NCT02733042|585510091|FG015|Overall Study|Adverse Event|0|||
162125788|NCT02733042|585510092|FG016|Overall Study|Adverse Event|0|||
162125789|NCT02733042|585510093|FG017|Overall Study|Adverse Event|1|||
162125790|NCT02733042|585510094|FG018|Overall Study|Adverse Event|0|||
162125791|NCT02733042|585510076|FG000|Overall Study|Progressive Disease|2|||
162125792|NCT02733042|585510077|FG001|Overall Study|Progressive Disease|1|||
162125793|NCT02733042|585510078|FG002|Overall Study|Progressive Disease|3|||
162125794|NCT02733042|585510079|FG003|Overall Study|Progressive Disease|1|||
162125795|NCT02733042|585510080|FG004|Overall Study|Progressive Disease|2|||
162125796|NCT02733042|585510081|FG005|Overall Study|Progressive Disease|3|||
162125797|NCT02733042|585510082|FG006|Overall Study|Progressive Disease|0|||
162125798|NCT02733042|585510083|FG007|Overall Study|Progressive Disease|3|||
162125799|NCT02733042|585510084|FG008|Overall Study|Progressive Disease|3|||
162125800|NCT02733042|585510085|FG009|Overall Study|Progressive Disease|2|||
162125801|NCT02733042|585510086|FG010|Overall Study|Progressive Disease|2|||
162125802|NCT02733042|585510087|FG011|Overall Study|Progressive Disease|2|||
162125803|NCT02733042|585510088|FG012|Overall Study|Progressive Disease|8|||
162125804|NCT02733042|585510089|FG013|Overall Study|Progressive Disease|1|||
161898276|NCT00141518|584675608|FG000|Overall Study|Adverse Event|7|||
162125805|NCT02733042|585510090|FG014|Overall Study|Progressive Disease|4|||
162125806|NCT02733042|585510091|FG015|Overall Study|Progressive Disease|7|||
162125807|NCT02733042|585510092|FG016|Overall Study|Progressive Disease|2|||
162125808|NCT02733042|585510093|FG017|Overall Study|Progressive Disease|3|||
162125809|NCT02733042|585510094|FG018|Overall Study|Progressive Disease|4|||
162125810|NCT02733042|585510076|FG000|Overall Study|Withdrawal by Subject|0|||
162125811|NCT02733042|585510077|FG001|Overall Study|Withdrawal by Subject|1|||
162125812|NCT02733042|585510078|FG002|Overall Study|Withdrawal by Subject|2|||
162125813|NCT02733042|585510079|FG003|Overall Study|Withdrawal by Subject|1|||
162125814|NCT02733042|585510080|FG004|Overall Study|Withdrawal by Subject|1|||
162125815|NCT02733042|585510081|FG005|Overall Study|Withdrawal by Subject|0|||
162125816|NCT02733042|585510082|FG006|Overall Study|Withdrawal by Subject|0|||
162125817|NCT02733042|585510083|FG007|Overall Study|Withdrawal by Subject|0|||
162125818|NCT02733042|585510084|FG008|Overall Study|Withdrawal by Subject|1|||
162125819|NCT02733042|585510085|FG009|Overall Study|Withdrawal by Subject|1|||
162125820|NCT02733042|585510086|FG010|Overall Study|Withdrawal by Subject|0|||
162125821|NCT02733042|585510087|FG011|Overall Study|Withdrawal by Subject|2|||
161785138|NCT02176642|584257505|FG001|Overall Study|Withdrawal by Subject|1|||
161785139|NCT01309828|584257506|FG000|Overall Study|Adverse Event|10|||
161785140|NCT01309828|584257507|FG001|Overall Study|Adverse Event|11|||
161785141|NCT01309828|584257506|FG000|Overall Study|Voluntary Withdrawal|5|||
161785142|NCT01309828|584257507|FG001|Overall Study|Voluntary Withdrawal|4|||
161785143|NCT01309828|584257506|FG000|Overall Study|Major Protocol Deviation|0|||
161785144|NCT01309828|584257507|FG001|Overall Study|Major Protocol Deviation|1|||
161785145|NCT01309828|584257506|FG000|Overall Study|Other|1|||
161785146|NCT01309828|584257507|FG001|Overall Study|Other|0|||
161785147|NCT00295620|584257508|FG000|Overall Study|Lost to Follow-up|9|||
161785148|NCT00295620|584257509|FG001|Overall Study|Lost to Follow-up|5|||
161785149|NCT00295620|584257508|FG000|Overall Study|Withdrawal by Subject|37|||
161785150|NCT00295620|584257509|FG001|Overall Study|Withdrawal by Subject|50|||
161785151|NCT00295620|584257508|FG000|Overall Study|Death|206|||
161785152|NCT00295620|584257509|FG001|Overall Study|Death|207|||
161785153|NCT00295620|584257508|FG000|Overall Study|Other reasons|10|||
161785154|NCT00295620|584257509|FG001|Overall Study|Other reasons|9|||
161785155|NCT00295620|584257508|FG000|Overall Study|Discontinuation by sponsor|580|||
161785156|NCT00295620|584257509|FG001|Overall Study|Discontinuation by sponsor|593|||
161785157|NCT00295620|584257508|FG000|Overall Study|Protocol Violation|30|||
161785158|NCT00295620|584257509|FG001|Overall Study|Protocol Violation|32|||
161785159|NCT00217971|584257510|FG000|Overall Study|Adverse Event|1|||
161785160|NCT00217971|584257511|FG001|Overall Study|Adverse Event|1|||
161785161|NCT00217971|584257510|FG000|Overall Study|Lost to Follow-up|15|||
161785162|NCT00217971|584257511|FG001|Overall Study|Lost to Follow-up|19|||
161785163|NCT00217971|584257510|FG000|Overall Study|Physician Decision|0|||
161785164|NCT00217971|584257511|FG001|Overall Study|Physician Decision|1|||
161785165|NCT00217971|584257510|FG000|Overall Study|Withdrawal by Subject|7|||
161785166|NCT00217971|584257511|FG001|Overall Study|Withdrawal by Subject|12|||
161785167|NCT00217971|584257510|FG000|Overall Study|non compliant|1|||
161785168|NCT00217971|584257511|FG001|Overall Study|non compliant|0|||
161785169|NCT00808015|584257512|FG000|Overall Study|Death|1|||
161785170|NCT00808015|584257512|FG000|Overall Study|Lack of Efficacy|58|||
161785171|NCT00808015|584257512|FG000|Overall Study|Lost to Follow-up|76|||
161785172|NCT00808015|584257512|FG000|Overall Study|Participants not willing to participate|158|||
161785173|NCT00808015|584257512|FG000|Overall Study|Adverse Event|22|||
162010278|NCT03773978|585093713|FG001|DBW Period|Study team decision|0|||
162010279|NCT03113487|585093714|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
162010280|NCT03777982|585093715|FG000|Overall Study|Physician Decision|0|||
162010281|NCT03777982|585093716|FG001|Overall Study|Physician Decision|1|||
162010282|NCT01502293|585093717|FG000|Overall Study|Progressive Disease|20|||
162010283|NCT01502293|585093718|FG001|Overall Study|Progressive Disease|12|||
162010284|NCT01502293|585093719|FG002|Overall Study|Progressive Disease|2|||
162010285|NCT01502293|585093717|FG000|Overall Study|Withdrawal by Subject|3|||
162010286|NCT01502293|585093718|FG001|Overall Study|Withdrawal by Subject|3|||
162010287|NCT01502293|585093719|FG002|Overall Study|Withdrawal by Subject|1|||
162010288|NCT01502293|585093717|FG000|Overall Study|Adverse Event|0|||
162010289|NCT01502293|585093718|FG001|Overall Study|Adverse Event|2|||
162010290|NCT01502293|585093719|FG002|Overall Study|Adverse Event|0|||
162010291|NCT01502293|585093717|FG000|Overall Study|Reason Not Specified|2|||
162010292|NCT01502293|585093718|FG001|Overall Study|Reason Not Specified|0|||
162010293|NCT01502293|585093719|FG002|Overall Study|Reason Not Specified|0|||
162010294|NCT01502293|585093717|FG000|Overall Study|Physician Decision|0|||
162010295|NCT01502293|585093718|FG001|Overall Study|Physician Decision|0|||
162010296|NCT01502293|585093719|FG002|Overall Study|Physician Decision|1|||
162010297|NCT00391586|585093721|FG000|Overall Study|Progressive disease|13|||
162010298|NCT00391586|585093721|FG000|Overall Study|Adverse Event|5|||
162010299|NCT00391586|585093721|FG000|Overall Study|Physician Decision|2|||
162010300|NCT00391586|585093721|FG000|Overall Study|Death|4|||
162010301|NCT00198822|585093722|FG000|Overall Study|Lost to Follow-up|14|||
162010302|NCT00198822|585093723|FG001|Overall Study|Lost to Follow-up|20|||
162010303|NCT00198822|585093724|FG002|Overall Study|Lost to Follow-up|21|||
162010304|NCT00521079|585093728|FG000|Overall Study|Adverse Event|7|||
162010305|NCT00521079|585093729|FG001|Overall Study|Adverse Event|1|||
162010306|NCT00521079|585093728|FG000|Overall Study|Lost to Follow-up|2|||
162010307|NCT00521079|585093729|FG001|Overall Study|Lost to Follow-up|1|||
162010308|NCT00521079|585093728|FG000|Overall Study|Withdrawal by Subject|5|||
162010309|NCT00521079|585093729|FG001|Overall Study|Withdrawal by Subject|3|||
162010310|NCT04672239|585093732|FG000|Week 2 Survey|Failed survey check items|1|||
162010311|NCT04672239|585093733|FG001|Week 2 Survey|Failed survey check items|2|||
162010312|NCT04672239|585093734|FG002|Week 2 Survey|Failed survey check items|3|||
162010313|NCT04672239|585093732|FG000|Week 2 Survey|Partially completed survey|7|||
162010314|NCT04672239|585093733|FG001|Week 2 Survey|Partially completed survey|1|||
162010315|NCT04672239|585093734|FG002|Week 2 Survey|Partially completed survey|4|||
162010316|NCT04672239|585093732|FG000|Week 2 Survey|Withdrawal by Subject|0|||
162010317|NCT04672239|585093733|FG001|Week 2 Survey|Withdrawal by Subject|1|||
162010318|NCT04672239|585093734|FG002|Week 2 Survey|Withdrawal by Subject|0|||
162125822|NCT02733042|585510088|FG012|Overall Study|Withdrawal by Subject|1|||
162125823|NCT02733042|585510089|FG013|Overall Study|Withdrawal by Subject|1|||
162125824|NCT02733042|585510090|FG014|Overall Study|Withdrawal by Subject|0|||
162125825|NCT02733042|585510091|FG015|Overall Study|Withdrawal by Subject|0|||
162125826|NCT02733042|585510092|FG016|Overall Study|Withdrawal by Subject|0|||
162125827|NCT02733042|585510093|FG017|Overall Study|Withdrawal by Subject|0|||
162125828|NCT02733042|585510094|FG018|Overall Study|Withdrawal by Subject|0|||
162125829|NCT02733042|585510076|FG000|Overall Study|Other Reasons|0|||
162125830|NCT02733042|585510077|FG001|Overall Study|Other Reasons|0|||
162125831|NCT02733042|585510078|FG002|Overall Study|Other Reasons|1|||
162125832|NCT02733042|585510079|FG003|Overall Study|Other Reasons|0|||
162125833|NCT02733042|585510080|FG004|Overall Study|Other Reasons|0|||
162125834|NCT02733042|585510081|FG005|Overall Study|Other Reasons|0|||
162125835|NCT02733042|585510082|FG006|Overall Study|Other Reasons|0|||
162125836|NCT02733042|585510083|FG007|Overall Study|Other Reasons|0|||
162125837|NCT02733042|585510084|FG008|Overall Study|Other Reasons|0|||
162125838|NCT02733042|585510085|FG009|Overall Study|Other Reasons|1|||
162125839|NCT02733042|585510086|FG010|Overall Study|Other Reasons|1|||
162125840|NCT02733042|585510087|FG011|Overall Study|Other Reasons|0|||
162125841|NCT02733042|585510088|FG012|Overall Study|Other Reasons|0|||
162125842|NCT02733042|585510089|FG013|Overall Study|Other Reasons|0|||
162125843|NCT02733042|585510090|FG014|Overall Study|Other Reasons|0|||
162125844|NCT02733042|585510091|FG015|Overall Study|Other Reasons|1|||
162125845|NCT02733042|585510092|FG016|Overall Study|Other Reasons|0|||
162125846|NCT02733042|585510093|FG017|Overall Study|Other Reasons|1|||
162125847|NCT02733042|585510094|FG018|Overall Study|Other Reasons|0|||
162125848|NCT02733042|585510076|FG000|Overall Study|Death|0|||
162125849|NCT02733042|585510077|FG001|Overall Study|Death|0|||
162125850|NCT02733042|585510078|FG002|Overall Study|Death|0|||
162125851|NCT02733042|585510079|FG003|Overall Study|Death|0|||
162125852|NCT02733042|585510080|FG004|Overall Study|Death|0|||
162125853|NCT02733042|585510081|FG005|Overall Study|Death|0|||
162125854|NCT02733042|585510082|FG006|Overall Study|Death|1|||
162125855|NCT02733042|585510083|FG007|Overall Study|Death|0|||
162125856|NCT02733042|585510084|FG008|Overall Study|Death|1|||
162125857|NCT02733042|585510085|FG009|Overall Study|Death|0|||
162125858|NCT02733042|585510086|FG010|Overall Study|Death|1|||
162125859|NCT02733042|585510087|FG011|Overall Study|Death|0|||
162125860|NCT02733042|585510088|FG012|Overall Study|Death|0|||
162125861|NCT02733042|585510089|FG013|Overall Study|Death|0|||
162125862|NCT02733042|585510090|FG014|Overall Study|Death|1|||
162125863|NCT02733042|585510091|FG015|Overall Study|Death|2|||
162125864|NCT02733042|585510092|FG016|Overall Study|Death|0|||
162125865|NCT02733042|585510093|FG017|Overall Study|Death|0|||
162125866|NCT02733042|585510094|FG018|Overall Study|Death|0|||
162125867|NCT01088529|585510096|FG000|Overall Study|Did not receive study treatment|0|||
162125868|NCT01088529|585510097|FG001|Overall Study|Did not receive study treatment|1|||
162125869|NCT02838628|585510099|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
162125870|NCT02838628|585510100|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
162125871|NCT02838628|585510099|FG000|Recurrence Follow-up Period|Adverse Event|1|||
162125872|NCT02838628|585510100|FG001|Recurrence Follow-up Period|Adverse Event|0|||
162125873|NCT02838628|585510099|FG000|Recurrence Follow-up Period|Non-compliance|0|||
162125874|NCT02838628|585510100|FG001|Recurrence Follow-up Period|Non-compliance|1|||
162125875|NCT02838628|585510099|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
162125876|NCT02838628|585510100|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
162125877|NCT02838628|585510099|FG000|Recurrence Follow-up Period|Other un-specified|1|||
162125878|NCT02838628|585510100|FG001|Recurrence Follow-up Period|Other un-specified|1|||
162125879|NCT05832437|585510101|FG000|Overall Study|time off work|1|||
162125880|NCT05832437|585510102|FG001|Overall Study|time off work|0|||
162125881|NCT05832437|585510103|FG002|Overall Study|time off work|0|||
161785174|NCT00808015|584257512|FG000|Overall Study|Other|25|||
161785175|NCT00808015|584257512|FG000|Overall Study|Enrolled but not treated|4|||
161785176|NCT00084617|584257524|FG000|Overall Study|Withdrawal by Subject|7|||
161785177|NCT00084617|584257524|FG000|Overall Study|Lack of Efficacy|1|||
162125882|NCT05832437|585510104|FG003|Overall Study|time off work|0|||
162125883|NCT04159415|585510105|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
161785178|NCT00084617|584257524|FG000|Overall Study|Protocol Violation|1|||
162125884|NCT04159415|585510106|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162125885|NCT04159415|585510107|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
161785179|NCT01625286|584257525|FG000|Overall Study|Adverse Event|0|||
162125886|NCT04159415|585510108|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162125887|NCT04159415|585510109|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162125888|NCT04159415|585510110|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162125889|NCT04159415|585510111|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
162125890|NCT04159415|585510112|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
161785180|NCT01625286|584257526|FG001|Overall Study|Adverse Event|0|||
161898277|NCT00141518|584675609|FG001|Overall Study|Adverse Event|5|||
161898278|NCT00141518|584675610|FG002|Overall Study|Adverse Event|2|||
161898279|NCT00141518|584675608|FG000|Overall Study|Withdrawal by Subject|2|||
161898280|NCT00141518|584675609|FG001|Overall Study|Withdrawal by Subject|0|||
161898281|NCT00141518|584675610|FG002|Overall Study|Withdrawal by Subject|2|||
161898282|NCT00141518|584675608|FG000|Overall Study|Protocol Violation|1|||
161898283|NCT00141518|584675609|FG001|Overall Study|Protocol Violation|1|||
161898284|NCT00141518|584675610|FG002|Overall Study|Protocol Violation|2|||
161898285|NCT00141518|584675608|FG000|Overall Study|Lack of Efficacy|5|||
161898286|NCT00141518|584675609|FG001|Overall Study|Lack of Efficacy|0|||
161898287|NCT00141518|584675610|FG002|Overall Study|Lack of Efficacy|0|||
161898288|NCT01001910|584675611|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
161898289|NCT03200548|584675612|FG000|Overall Study|Withdrawal by Subject|5|||
161898290|NCT03200548|584675613|FG001|Overall Study|Withdrawal by Subject|11|||
161898291|NCT03200548|584675614|FG002|Overall Study|Withdrawal by Subject|7|||
161898292|NCT03200548|584675615|FG003|Overall Study|Withdrawal by Subject|6|||
161898293|NCT01048541|584675619|FG000|Overall Study|Withdrawal by Subject|1|||
161898294|NCT01048541|584675620|FG001|Overall Study|Withdrawal by Subject|0|||
161898295|NCT01411852|584675622|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
161898296|NCT01411852|584675623|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
161898297|NCT01411852|584675622|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
161898298|NCT01411852|584675623|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
161898299|NCT01411852|584675622|FG000|Prehospital Intervention Phase|Found to be under age|0|||
161898300|NCT01411852|584675623|FG001|Prehospital Intervention Phase|Found to be under age|1|||
161898301|NCT01411852|584675622|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
161898302|NCT01411852|584675623|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
161898303|NCT01411852|584675622|FG000|Hospital Intervention Phase|Severe head injury|5|||
161898304|NCT01411852|584675623|FG001|Hospital Intervention Phase|Severe head injury|4|||
161898305|NCT01411852|584675622|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
161898306|NCT01411852|584675623|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
161898307|NCT01411852|584675622|FG000|Hospital Intervention Phase|Miscommunication error|1|||
161898308|NCT01411852|584675623|FG001|Hospital Intervention Phase|Miscommunication error|2|||
161898309|NCT01411852|584675622|FG000|Hospital Intervention Phase|CPR administered|3|||
161898310|NCT01411852|584675623|FG001|Hospital Intervention Phase|CPR administered|1|||
161898311|NCT01411852|584675622|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
161898312|NCT01411852|584675623|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
161898313|NCT01411852|584675622|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
161898314|NCT01411852|584675623|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
161898315|NCT01411852|584675622|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
161898316|NCT01411852|584675623|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
161898317|NCT01411852|584675622|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
161898318|NCT01411852|584675623|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
161898319|NCT01411852|584675622|FG000|Hospital Intervention Phase|Other ineligible|2|||
161898320|NCT01411852|584675623|FG001|Hospital Intervention Phase|Other ineligible|2|||
161898321|NCT01411852|584675622|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
161898322|NCT01411852|584675623|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
161898323|NCT01411852|584675622|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
161898324|NCT01411852|584675623|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
161898325|NCT01411852|584675622|FG000|Hospital Intervention Phase|Vascular access failed|1|||
161898326|NCT01411852|584675623|FG001|Hospital Intervention Phase|Vascular access failed|0|||
161898327|NCT05095311|584675624|FG000|Overall Study|Lost to Follow-up|7|||
161898328|NCT05095311|584675625|FG001|Overall Study|Lost to Follow-up|0|||
161898329|NCT05095311|584675626|FG002|Overall Study|Lost to Follow-up|0|||
161898330|NCT03283930|584675627|FG000|Overall Study|Scheduling conflict|8|||
161898331|NCT03283930|584675628|FG001|Overall Study|Scheduling conflict|10|||
161898332|NCT03283930|584675627|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
161898333|NCT03283930|584675628|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
161898334|NCT03283930|584675627|FG000|Overall Study|Technical software issue|2|||
161898335|NCT03283930|584675628|FG001|Overall Study|Technical software issue|2|||
161898336|NCT00805129|584675629|FG000|Overall Study|Not treated|1|||
161898337|NCT00571662|584675630|FG000|Overall Study|Withdrawal by Subject|2|||
161898338|NCT00571662|584675630|FG000|Overall Study|psychiatric instability|1|||
161898339|NCT00571662|584675630|FG000|Overall Study|Adverse Event|5|||
161898340|NCT02588664|584675631|FG000|Overall Study|Death|56|||
161898341|NCT02588664|584675632|FG001|Overall Study|Death|55|||
161898342|NCT02588664|584675631|FG000|Overall Study|Lost to Follow-up|1305|||
161898343|NCT02588664|584675632|FG001|Overall Study|Lost to Follow-up|990|||
161898344|NCT03681184|584675633|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
161898345|NCT03681184|584675634|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
161898346|NCT02500719|584675635|FG000|Overall Study|Lost to Follow-up|2|||
161898347|NCT02500719|584675636|FG001|Overall Study|Lost to Follow-up|3|||
162125891|NCT04159415|585510113|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162125892|NCT04159415|585510114|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
162125893|NCT04159415|585510105|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162125894|NCT04159415|585510106|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
161785181|NCT01625286|584257527|FG002|Overall Study|Adverse Event|0|||
161785182|NCT01625286|584257528|FG003|Overall Study|Adverse Event|0|||
161785183|NCT01625286|584257529|FG004|Overall Study|Adverse Event|1|||
161785184|NCT01625286|584257530|FG005|Overall Study|Adverse Event|2|||
161785185|NCT01625286|584257531|FG006|Overall Study|Adverse Event|1|||
161785186|NCT01625286|584257525|FG000|Overall Study|Death|0|||
161785187|NCT01625286|584257526|FG001|Overall Study|Death|0|||
161785188|NCT01625286|584257527|FG002|Overall Study|Death|1|||
161785189|NCT01625286|584257528|FG003|Overall Study|Death|1|||
161785190|NCT01625286|584257529|FG004|Overall Study|Death|0|||
161785191|NCT01625286|584257530|FG005|Overall Study|Death|11|||
161785192|NCT01625286|584257531|FG006|Overall Study|Death|16|||
162125895|NCT04159415|585510107|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162125896|NCT04159415|585510108|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162125897|NCT04159415|585510109|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162125898|NCT04159415|585510110|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162125899|NCT04159415|585510111|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162125900|NCT04159415|585510112|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
162125901|NCT04159415|585510113|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162125902|NCT04159415|585510114|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
162125903|NCT04159415|585510105|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162125904|NCT04159415|585510106|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162125905|NCT04159415|585510107|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162125906|NCT04159415|585510108|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162125907|NCT04159415|585510109|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162125908|NCT04159415|585510110|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162125909|NCT04159415|585510111|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162125910|NCT04159415|585510112|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
162125911|NCT04159415|585510113|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162125912|NCT04159415|585510114|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
162125913|NCT04159415|585510105|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162125914|NCT04159415|585510106|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162125915|NCT04159415|585510107|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162125916|NCT04159415|585510108|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162125917|NCT04159415|585510109|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162125918|NCT04159415|585510110|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162125919|NCT04159415|585510111|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162125920|NCT04159415|585510112|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162125921|NCT04159415|585510113|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
162125922|NCT04159415|585510114|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
162125923|NCT00337662|585510115|FG000|Study Period II|Lost to Follow-up|0|||
162125924|NCT00337662|585510116|FG001|Study Period II|Lost to Follow-up|0|||
162125925|NCT00337662|585510117|FG002|Study Period II|Lost to Follow-up|0|||
162125926|NCT00337662|585510118|FG003|Study Period II|Lost to Follow-up|35|||
162125927|NCT00337662|585510115|FG000|Study Period II|Withdrawal by Subject|0|||
162125928|NCT00337662|585510116|FG001|Study Period II|Withdrawal by Subject|0|||
162125929|NCT00337662|585510117|FG002|Study Period II|Withdrawal by Subject|0|||
162125930|NCT00337662|585510118|FG003|Study Period II|Withdrawal by Subject|20|||
162125931|NCT00337662|585510115|FG000|Study Period II|Adverse Event|0|||
162125932|NCT00337662|585510116|FG001|Study Period II|Adverse Event|0|||
162125933|NCT00337662|585510117|FG002|Study Period II|Adverse Event|0|||
161785193|NCT01625286|584257525|FG000|Overall Study|Withdrawal by Subject|0|||
161785194|NCT01625286|584257526|FG001|Overall Study|Withdrawal by Subject|1|||
161785195|NCT01625286|584257527|FG002|Overall Study|Withdrawal by Subject|0|||
161785196|NCT01625286|584257528|FG003|Overall Study|Withdrawal by Subject|1|||
161785197|NCT01625286|584257529|FG004|Overall Study|Withdrawal by Subject|0|||
161785198|NCT01625286|584257530|FG005|Overall Study|Withdrawal by Subject|0|||
161785199|NCT01625286|584257531|FG006|Overall Study|Withdrawal by Subject|1|||
161785200|NCT01625286|584257525|FG000|Overall Study|Any reason not specifically recorded|0|||
161898348|NCT02500719|584675635|FG000|Overall Study|Trauma history|1|||
161898349|NCT02500719|584675636|FG001|Overall Study|Trauma history|0|||
161898350|NCT02500719|584675635|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
161898351|NCT02500719|584675636|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
161898352|NCT02500719|584675635|FG000|Overall Study|Did not meet criteria for PTSD|0|||
161898353|NCT02500719|584675636|FG001|Overall Study|Did not meet criteria for PTSD|1|||
161898354|NCT02500719|584675635|FG000|Overall Study|Claustrophobia|0|||
161898355|NCT02500719|584675636|FG001|Overall Study|Claustrophobia|1|||
161898356|NCT02500719|584675635|FG000|Overall Study|History of head trauma|0|||
161898357|NCT02500719|584675636|FG001|Overall Study|History of head trauma|1|||
161898358|NCT00154375|584675637|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
161898359|NCT00154375|584675638|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
161898360|NCT00154375|584675637|FG000|Overall Study|Adverse Event|18|||
161898361|NCT00154375|584675638|FG001|Overall Study|Adverse Event|20|||
161898362|NCT00154375|584675637|FG000|Overall Study|Withdrawal by Subject|14|||
161898363|NCT00154375|584675638|FG001|Overall Study|Withdrawal by Subject|10|||
161898364|NCT00154375|584675637|FG000|Overall Study|Death|5|||
161898365|NCT00154375|584675638|FG001|Overall Study|Death|13|||
161898366|NCT00154375|584675637|FG000|Overall Study|Study drug no longer required|5|||
161898367|NCT00154375|584675638|FG001|Overall Study|Study drug no longer required|3|||
161898368|NCT00154375|584675637|FG000|Overall Study|Lost to Follow-up|2|||
161898369|NCT00154375|584675638|FG001|Overall Study|Lost to Follow-up|1|||
161898370|NCT00154375|584675637|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161898371|NCT00154375|584675638|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161898372|NCT00154375|584675637|FG000|Overall Study|Protocol Violation|0|||
161898373|NCT00154375|584675638|FG001|Overall Study|Protocol Violation|1|||
161898374|NCT00154375|584675637|FG000|Overall Study|Suspected progression of disease|44|||
161898375|NCT00154375|584675638|FG001|Overall Study|Suspected progression of disease|30|||
161898376|NCT00792116|584675639|FG000|Overall Study|Lost to Follow-up|0|||
161898377|NCT00792116|584675640|FG001|Overall Study|Lost to Follow-up|1|||
161898378|NCT00792116|584675639|FG000|Overall Study|Discontnued intervention|1|||
161898379|NCT00792116|584675640|FG001|Overall Study|Discontnued intervention|0|||
161898380|NCT00103285|584677791|FG000|Induction|Adverse Event|14|||
161898381|NCT00103285|584677792|FG001|Induction|Adverse Event|0|||
161898382|NCT00103285|584677793|FG002|Induction|Adverse Event|0|||
161898383|NCT00103285|584677794|FG003|Induction|Adverse Event|0|||
161898384|NCT00103285|584677795|FG004|Induction|Adverse Event|0|||
161898385|NCT00103285|584677796|FG005|Induction|Adverse Event|0|||
161898386|NCT00103285|584677797|FG006|Induction|Adverse Event|0|||
161898387|NCT00103285|584677798|FG007|Induction|Adverse Event|0|||
161898388|NCT00103285|584677791|FG000|Induction|Death|24|||
161898389|NCT00103285|584677792|FG001|Induction|Death|0|||
161898390|NCT00103285|584677793|FG002|Induction|Death|0|||
161898391|NCT00103285|584677794|FG003|Induction|Death|0|||
161898392|NCT00103285|584677795|FG004|Induction|Death|0|||
161898393|NCT00103285|584677796|FG005|Induction|Death|0|||
161898394|NCT00103285|584677797|FG006|Induction|Death|0|||
161898395|NCT00103285|584677798|FG007|Induction|Death|0|||
161898396|NCT00103285|584677791|FG000|Induction|Physician Decision|103|||
161898397|NCT00103285|584677792|FG001|Induction|Physician Decision|0|||
161898398|NCT00103285|584677793|FG002|Induction|Physician Decision|0|||
161898399|NCT00103285|584677794|FG003|Induction|Physician Decision|0|||
161898400|NCT00103285|584677795|FG004|Induction|Physician Decision|0|||
161898401|NCT00103285|584677796|FG005|Induction|Physician Decision|0|||
161898402|NCT00103285|584677797|FG006|Induction|Physician Decision|0|||
161898403|NCT00103285|584677798|FG007|Induction|Physician Decision|0|||
161898404|NCT00103285|584677791|FG000|Induction|Withdrawal by Subject|1|||
161898405|NCT00103285|584677792|FG001|Induction|Withdrawal by Subject|0|||
161898406|NCT00103285|584677793|FG002|Induction|Withdrawal by Subject|0|||
161898407|NCT00103285|584677794|FG003|Induction|Withdrawal by Subject|0|||
161898408|NCT00103285|584677795|FG004|Induction|Withdrawal by Subject|0|||
161898409|NCT00103285|584677796|FG005|Induction|Withdrawal by Subject|0|||
161898410|NCT00103285|584677797|FG006|Induction|Withdrawal by Subject|0|||
161898411|NCT00103285|584677798|FG007|Induction|Withdrawal by Subject|0|||
161898412|NCT00103285|584677791|FG000|Induction|Ineligible|43|||
161898413|NCT00103285|584677792|FG001|Induction|Ineligible|0|||
161898414|NCT00103285|584677793|FG002|Induction|Ineligible|0|||
161898415|NCT00103285|584677794|FG003|Induction|Ineligible|0|||
161898416|NCT00103285|584677795|FG004|Induction|Ineligible|0|||
161898417|NCT00103285|584677796|FG005|Induction|Ineligible|0|||
161898418|NCT00103285|584677797|FG006|Induction|Ineligible|0|||
161898419|NCT00103285|584677798|FG007|Induction|Ineligible|0|||
161898420|NCT00103285|584677791|FG000|Induction|Refusal|906|||
161898421|NCT00103285|584677792|FG001|Induction|Refusal|0|||
161898422|NCT00103285|584677793|FG002|Induction|Refusal|0|||
161898423|NCT00103285|584677794|FG003|Induction|Refusal|0|||
161898424|NCT00103285|584677795|FG004|Induction|Refusal|0|||
161898425|NCT00103285|584677796|FG005|Induction|Refusal|0|||
161898426|NCT00103285|584677797|FG006|Induction|Refusal|0|||
161898427|NCT00103285|584677798|FG007|Induction|Refusal|0|||
161898428|NCT00103285|584677791|FG000|Induction|Other|258|||
161898429|NCT00103285|584677792|FG001|Induction|Other|0|||
161898430|NCT00103285|584677793|FG002|Induction|Other|0|||
161785201|NCT01625286|584257526|FG001|Overall Study|Any reason not specifically recorded|0|||
161785202|NCT01625286|584257527|FG002|Overall Study|Any reason not specifically recorded|0|||
161785203|NCT01625286|584257528|FG003|Overall Study|Any reason not specifically recorded|0|||
161785204|NCT01625286|584257529|FG004|Overall Study|Any reason not specifically recorded|0|||
161785205|NCT01625286|584257530|FG005|Overall Study|Any reason not specifically recorded|1|||
161785206|NCT01625286|584257531|FG006|Overall Study|Any reason not specifically recorded|0|||
161785207|NCT01625286|584257525|FG000|Overall Study|Progressive disease|6|||
161785208|NCT01625286|584257526|FG001|Overall Study|Progressive disease|3|||
161785209|NCT01625286|584257527|FG002|Overall Study|Progressive disease|4|||
161785210|NCT01625286|584257528|FG003|Overall Study|Progressive disease|5|||
161785211|NCT01625286|584257529|FG004|Overall Study|Progressive disease|5|||
161785212|NCT01625286|584257530|FG005|Overall Study|Progressive disease|0|||
161785213|NCT01625286|584257531|FG006|Overall Study|Progressive disease|0|||
161785214|NCT01625286|584257525|FG000|Overall Study|Lost to Follow-up|0|||
161785215|NCT01625286|584257526|FG001|Overall Study|Lost to Follow-up|0|||
161785216|NCT01625286|584257527|FG002|Overall Study|Lost to Follow-up|0|||
161785217|NCT01625286|584257528|FG003|Overall Study|Lost to Follow-up|0|||
161785218|NCT01625286|584257529|FG004|Overall Study|Lost to Follow-up|0|||
161785219|NCT01625286|584257530|FG005|Overall Study|Lost to Follow-up|0|||
161785220|NCT01625286|584257531|FG006|Overall Study|Lost to Follow-up|1|||
161785221|NCT04355767|584257532|FG000|Overall Study|Withdrawal by Subject|2|||
161785222|NCT04355767|584257533|FG001|Overall Study|Withdrawal by Subject|2|||
161785223|NCT04355767|584257532|FG000|Overall Study|Death|5|||
161785224|NCT04355767|584257533|FG001|Overall Study|Death|1|||
161785225|NCT04523831|584257540|FG000|Overall Study|Lost to Follow-up|15|||
161785226|NCT04523831|584257541|FG001|Overall Study|Lost to Follow-up|17|||
161785227|NCT04523831|584257540|FG000|Overall Study|Death|0|||
161785228|NCT04523831|584257541|FG001|Overall Study|Death|3|||
161785229|NCT04523831|584257540|FG000|Overall Study|Adverse Event|2|||
161785230|NCT04523831|584257541|FG001|Overall Study|Adverse Event|0|||
161785231|NCT00995930|584257542|FG000|Overall Study|Protocol deviation|2|||
161785232|NCT00995930|584257543|FG001|Overall Study|Protocol deviation|5|||
161785233|NCT00995930|584257542|FG000|Overall Study|Death|0|||
161785234|NCT00995930|584257543|FG001|Overall Study|Death|1|||
161898431|NCT00103285|584677794|FG003|Induction|Other|0|||
161898432|NCT00103285|584677795|FG004|Induction|Other|0|||
162010319|NCT04672239|585093732|FG000|Week 2 Survey|Lost to Follow-up|3|||
162010320|NCT04672239|585093733|FG001|Week 2 Survey|Lost to Follow-up|2|||
162010321|NCT04672239|585093734|FG002|Week 2 Survey|Lost to Follow-up|5|||
162010322|NCT04672239|585093732|FG000|Week 6 Survey|Failed survey check items|2|||
162010323|NCT04672239|585093733|FG001|Week 6 Survey|Failed survey check items|2|||
162010324|NCT04672239|585093734|FG002|Week 6 Survey|Failed survey check items|2|||
162010325|NCT04672239|585093732|FG000|Week 6 Survey|Partially completed survey|3|||
162010326|NCT04672239|585093733|FG001|Week 6 Survey|Partially completed survey|3|||
162010327|NCT04672239|585093734|FG002|Week 6 Survey|Partially completed survey|2|||
162010328|NCT04672239|585093732|FG000|Week 6 Survey|Withdrawal by Subject|1|||
162010329|NCT04672239|585093733|FG001|Week 6 Survey|Withdrawal by Subject|1|||
162010330|NCT04672239|585093734|FG002|Week 6 Survey|Withdrawal by Subject|1|||
162010331|NCT04672239|585093732|FG000|Week 6 Survey|Withdrawn by PI|0|||
162010332|NCT04672239|585093733|FG001|Week 6 Survey|Withdrawn by PI|1|||
162010333|NCT04672239|585093734|FG002|Week 6 Survey|Withdrawn by PI|0|||
162010334|NCT04672239|585093732|FG000|Week 6 Survey|Lost to Follow-up|12|||
162010335|NCT04672239|585093733|FG001|Week 6 Survey|Lost to Follow-up|2|||
162010336|NCT04672239|585093734|FG002|Week 6 Survey|Lost to Follow-up|5|||
162010337|NCT04672239|585093732|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
162010338|NCT04672239|585093733|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
162010339|NCT04672239|585093734|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
162010340|NCT04672239|585093732|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
162010341|NCT04672239|585093733|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
162010342|NCT04672239|585093734|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
162010343|NCT04672239|585093732|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
162010344|NCT04672239|585093733|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
162010345|NCT04672239|585093734|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
162010346|NCT04672239|585093732|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
162010347|NCT04672239|585093733|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
162010348|NCT04672239|585093734|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
162010349|NCT04672239|585093732|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
162010350|NCT04672239|585093733|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
162010351|NCT04672239|585093734|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
162010352|NCT04672239|585093732|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
162010353|NCT04672239|585093733|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
162010354|NCT04672239|585093734|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
162010355|NCT04672239|585093732|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
162010356|NCT04672239|585093733|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
162010357|NCT04672239|585093734|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
161785235|NCT00995930|584257542|FG000|Overall Study|Administrative problems|4|||
161785236|NCT00995930|584257543|FG001|Overall Study|Administrative problems|2|||
161785237|NCT00995930|584257542|FG000|Overall Study|Lost to Follow-up|1|||
161785238|NCT00995930|584257543|FG001|Overall Study|Lost to Follow-up|2|||
161785239|NCT00995930|584257542|FG000|Overall Study|Withdrawal by Subject|3|||
161785240|NCT00995930|584257543|FG001|Overall Study|Withdrawal by Subject|4|||
161785241|NCT00995930|584257542|FG000|Overall Study|Adverse Event|11|||
161785242|NCT00995930|584257543|FG001|Overall Study|Adverse Event|14|||
161785243|NCT00550420|584259178|FG000|Overall Study|Adverse Event|28|||
161785244|NCT00550420|584259178|FG000|Overall Study|Lost to Follow-up|8|||
161785245|NCT00550420|584259178|FG000|Overall Study|Protocol Violation|11|||
161785246|NCT00550420|584259178|FG000|Overall Study|Withdrawal by Subject|30|||
161785247|NCT00550420|584259178|FG000|Overall Study|Still in study at termination|206|||
161785248|NCT00550420|584259178|FG000|Overall Study|Missing|2|||
161785249|NCT00550420|584259178|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
161785250|NCT00550420|584259178|FG000|Overall Study|Investigators opinion|1|||
161785251|NCT00550420|584259178|FG000|Overall Study|Lack of curative effect|1|||
161785252|NCT00550420|584259178|FG000|Overall Study|Unethical stop of enrollment|2|||
161785253|NCT00550420|584259178|FG000|Overall Study|Caregiver's decision to withdraw|1|||
161785254|NCT00550420|584259178|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
161785255|NCT00550420|584259178|FG000|Overall Study|Exclusion criteria|1|||
161785256|NCT00550420|584259178|FG000|Overall Study|Prohibited medicine|1|||
161785257|NCT01169649|584259186|FG000|Overall Study|Patient Not Treated|3|||
161785258|NCT00534092|584259187|FG000|Overall Study|Lost to Follow-up|1|||
161785259|NCT00534092|584259188|FG001|Overall Study|Lost to Follow-up|0|||
161785260|NCT00534092|584259187|FG000|Overall Study|personal reasons/family concerns|1|||
161785261|NCT00534092|584259188|FG001|Overall Study|personal reasons/family concerns|0|||
161785262|NCT02919475|584259189|FG000|Overall Study|Adverse Event|3|||
161785263|NCT02919475|584259190|FG001|Overall Study|Adverse Event|3|||
161898433|NCT00103285|584677796|FG005|Induction|Other|0|||
162125934|NCT00337662|585510118|FG003|Study Period II|Adverse Event|16|||
162125935|NCT00337662|585510115|FG000|Study Period II|Physician Decision|0|||
162125936|NCT00337662|585510116|FG001|Study Period II|Physician Decision|0|||
162125937|NCT00337662|585510117|FG002|Study Period II|Physician Decision|0|||
162125938|NCT00337662|585510118|FG003|Study Period II|Physician Decision|13|||
162125939|NCT00337662|585510115|FG000|Study Period II|Entry Criteria Not Met|0|||
162125940|NCT00337662|585510116|FG001|Study Period II|Entry Criteria Not Met|0|||
162125941|NCT00337662|585510117|FG002|Study Period II|Entry Criteria Not Met|0|||
162125942|NCT00337662|585510118|FG003|Study Period II|Entry Criteria Not Met|6|||
162125943|NCT00337662|585510115|FG000|Study Period II|Protocol Violation|0|||
162125944|NCT00337662|585510116|FG001|Study Period II|Protocol Violation|0|||
162125945|NCT00337662|585510117|FG002|Study Period II|Protocol Violation|0|||
162125946|NCT00337662|585510118|FG003|Study Period II|Protocol Violation|6|||
162125947|NCT00337662|585510115|FG000|Study Period II|Lack of Efficacy|0|||
162125948|NCT00337662|585510116|FG001|Study Period II|Lack of Efficacy|0|||
162125949|NCT00337662|585510117|FG002|Study Period II|Lack of Efficacy|0|||
162125950|NCT00337662|585510118|FG003|Study Period II|Lack of Efficacy|7|||
162125951|NCT00337662|585510115|FG000|Study Period II|Sponsor Decision|0|||
162125952|NCT00337662|585510116|FG001|Study Period II|Sponsor Decision|0|||
162125953|NCT00337662|585510117|FG002|Study Period II|Sponsor Decision|0|||
162125954|NCT00337662|585510118|FG003|Study Period II|Sponsor Decision|2|||
162125955|NCT00337662|585510115|FG000|Study Period II|Parent/Caregiver Decision|0|||
162125956|NCT00337662|585510116|FG001|Study Period II|Parent/Caregiver Decision|0|||
162125957|NCT00337662|585510117|FG002|Study Period II|Parent/Caregiver Decision|0|||
162125958|NCT00337662|585510118|FG003|Study Period II|Parent/Caregiver Decision|1|||
162125959|NCT00337662|585510115|FG000|Study Period III|Lost to Follow-up|14|||
162125960|NCT00337662|585510116|FG001|Study Period III|Lost to Follow-up|16|||
162125961|NCT00337662|585510117|FG002|Study Period III|Lost to Follow-up|14|||
162125962|NCT00337662|585510118|FG003|Study Period III|Lost to Follow-up|0|||
162125963|NCT00337662|585510115|FG000|Study Period III|Withdrawal by Subject|18|||
162125964|NCT00337662|585510116|FG001|Study Period III|Withdrawal by Subject|14|||
161785264|NCT02919475|584259191|FG002|Overall Study|Adverse Event|3|||
161785265|NCT02919475|584259192|FG003|Overall Study|Adverse Event|9|||
161785266|NCT02919475|584259193|FG004|Overall Study|Adverse Event|2|||
161898434|NCT00103285|584677797|FG006|Induction|Other|0|||
162125965|NCT00337662|585510117|FG002|Study Period III|Withdrawal by Subject|12|||
162125966|NCT00337662|585510118|FG003|Study Period III|Withdrawal by Subject|0|||
162125967|NCT00337662|585510115|FG000|Study Period III|Adverse Event|9|||
162125968|NCT00337662|585510116|FG001|Study Period III|Adverse Event|10|||
162125969|NCT00337662|585510117|FG002|Study Period III|Adverse Event|8|||
161785267|NCT02919475|584259189|FG000|Overall Study|Death|0|||
161785268|NCT02919475|584259190|FG001|Overall Study|Death|1|||
161785269|NCT02919475|584259191|FG002|Overall Study|Death|0|||
161785270|NCT02919475|584259192|FG003|Overall Study|Death|0|||
161785271|NCT02919475|584259193|FG004|Overall Study|Death|0|||
161898435|NCT00103285|584677798|FG007|Induction|Other|0|||
162125970|NCT00337662|585510118|FG003|Study Period III|Adverse Event|0|||
162125971|NCT00337662|585510115|FG000|Study Period III|Protocol Violation|3|||
162125972|NCT00337662|585510116|FG001|Study Period III|Protocol Violation|8|||
162125973|NCT00337662|585510117|FG002|Study Period III|Protocol Violation|2|||
162125974|NCT00337662|585510118|FG003|Study Period III|Protocol Violation|0|||
162125975|NCT00337662|585510115|FG000|Study Period III|Physician Decision|6|||
162125976|NCT00337662|585510116|FG001|Study Period III|Physician Decision|5|||
162125977|NCT00337662|585510117|FG002|Study Period III|Physician Decision|0|||
162125978|NCT00337662|585510118|FG003|Study Period III|Physician Decision|0|||
162125979|NCT00337662|585510115|FG000|Study Period III|Entry Criteria Not Met|4|||
162125980|NCT00337662|585510116|FG001|Study Period III|Entry Criteria Not Met|1|||
162125981|NCT00337662|585510117|FG002|Study Period III|Entry Criteria Not Met|3|||
162125982|NCT00337662|585510118|FG003|Study Period III|Entry Criteria Not Met|0|||
162125983|NCT00337662|585510115|FG000|Study Period III|Lack of Efficacy|4|||
162125984|NCT00337662|585510116|FG001|Study Period III|Lack of Efficacy|4|||
162125985|NCT00337662|585510117|FG002|Study Period III|Lack of Efficacy|2|||
162125986|NCT00337662|585510118|FG003|Study Period III|Lack of Efficacy|0|||
162125987|NCT00337662|585510115|FG000|Study Period III|Parent/Caregiver Decision|0|||
162125988|NCT00337662|585510116|FG001|Study Period III|Parent/Caregiver Decision|0|||
162125989|NCT00337662|585510117|FG002|Study Period III|Parent/Caregiver Decision|2|||
162125990|NCT00337662|585510118|FG003|Study Period III|Parent/Caregiver Decision|0|||
162125991|NCT00337662|585510115|FG000|Study Period III|Sponsor Decision|1|||
162125992|NCT00337662|585510116|FG001|Study Period III|Sponsor Decision|0|||
162125993|NCT00337662|585510117|FG002|Study Period III|Sponsor Decision|1|||
162125994|NCT00337662|585510118|FG003|Study Period III|Sponsor Decision|0|||
162125995|NCT00337662|585510115|FG000|Study Period III|Clinical Relapse|1|||
162125996|NCT00337662|585510116|FG001|Study Period III|Clinical Relapse|0|||
162125997|NCT00337662|585510117|FG002|Study Period III|Clinical Relapse|0|||
162125998|NCT00337662|585510118|FG003|Study Period III|Clinical Relapse|0|||
162125999|NCT03391960|585510129|FG000|Overall Study|Protocol Violation|0|||
162126000|NCT03391960|585510130|FG001|Overall Study|Protocol Violation|0|||
162126001|NCT01702428|585511384|FG000|Overall Study|Adverse Event|2|||
162126002|NCT01702428|585511385|FG001|Overall Study|Adverse Event|0|||
162126003|NCT01702428|585511386|FG002|Overall Study|Adverse Event|0|||
162126004|NCT01702428|585511387|FG003|Overall Study|Adverse Event|0|||
162126005|NCT01702428|585511384|FG000|Overall Study|Lost to Follow-up|33|||
162126006|NCT01702428|585511385|FG001|Overall Study|Lost to Follow-up|41|||
162126007|NCT01702428|585511386|FG002|Overall Study|Lost to Follow-up|37|||
162126008|NCT01702428|585511387|FG003|Overall Study|Lost to Follow-up|44|||
162126009|NCT01702428|585511384|FG000|Overall Study|Parents cannot assist to site|1|||
162126010|NCT01702428|585511385|FG001|Overall Study|Parents cannot assist to site|0|||
162126011|NCT01702428|585511386|FG002|Overall Study|Parents cannot assist to site|1|||
162126012|NCT01702428|585511387|FG003|Overall Study|Parents cannot assist to site|0|||
162126013|NCT01702428|585511384|FG000|Overall Study|Lost Coverage|0|||
162126014|NCT01702428|585511385|FG001|Overall Study|Lost Coverage|0|||
162126015|NCT01702428|585511386|FG002|Overall Study|Lost Coverage|0|||
162126016|NCT01702428|585511387|FG003|Overall Study|Lost Coverage|1|||
162126017|NCT01702428|585511384|FG000|Overall Study|Lost Health Plan|3|||
162126018|NCT01702428|585511385|FG001|Overall Study|Lost Health Plan|5|||
162126019|NCT01702428|585511386|FG002|Overall Study|Lost Health Plan|0|||
162126020|NCT01702428|585511387|FG003|Overall Study|Lost Health Plan|2|||
162126021|NCT01702428|585511384|FG000|Overall Study|Mother transferred care|0|||
162126022|NCT01702428|585511385|FG001|Overall Study|Mother transferred care|1|||
162126023|NCT01702428|585511386|FG002|Overall Study|Mother transferred care|0|||
162126024|NCT01702428|585511387|FG003|Overall Study|Mother transferred care|0|||
162126025|NCT01702428|585511384|FG000|Overall Study|Parents too busy|1|||
162126026|NCT01702428|585511385|FG001|Overall Study|Parents too busy|0|||
162126027|NCT01702428|585511386|FG002|Overall Study|Parents too busy|0|||
162126028|NCT01702428|585511387|FG003|Overall Study|Parents too busy|0|||
162126029|NCT01702428|585511384|FG000|Overall Study|Protocol Violation|3|||
162126030|NCT01702428|585511385|FG001|Overall Study|Protocol Violation|0|||
162126031|NCT01702428|585511386|FG002|Overall Study|Protocol Violation|1|||
162126032|NCT01702428|585511387|FG003|Overall Study|Protocol Violation|0|||
162126033|NCT01702428|585511384|FG000|Overall Study|Withdrawal by Subject|21|||
162126034|NCT01702428|585511385|FG001|Overall Study|Withdrawal by Subject|23|||
162126035|NCT01702428|585511386|FG002|Overall Study|Withdrawal by Subject|14|||
162126036|NCT01702428|585511387|FG003|Overall Study|Withdrawal by Subject|10|||
162126037|NCT02091869|585511388|FG000|Overall Study|Withdrawal by Subject|0|||
162126038|NCT02091869|585511389|FG001|Overall Study|Withdrawal by Subject|3|||
162126039|NCT03685708|585511393|FG000|Overall Study|Withdrawal by Subject|0|||
162126040|NCT03685708|585511394|FG001|Overall Study|Withdrawal by Subject|0|||
162126041|NCT03685708|585511395|FG002|Overall Study|Withdrawal by Subject|1|||
162126042|NCT03685708|585511393|FG000|Overall Study|Screen Fail|0|||
162126043|NCT03685708|585511394|FG001|Overall Study|Screen Fail|1|||
162126044|NCT03685708|585511395|FG002|Overall Study|Screen Fail|1|||
162126045|NCT03685708|585511393|FG000|Overall Study|COVID 19 Pandemic|1|||
162126046|NCT03685708|585511394|FG001|Overall Study|COVID 19 Pandemic|1|||
162126047|NCT03685708|585511395|FG002|Overall Study|COVID 19 Pandemic|6|||
162126048|NCT03685708|585511393|FG000|Overall Study|Disease Progression|0|||
162126049|NCT03685708|585511394|FG001|Overall Study|Disease Progression|0|||
162126050|NCT03685708|585511395|FG002|Overall Study|Disease Progression|1|||
162126051|NCT02771210|585511397|FG000|Period 1|Adverse Event|5|||
162126052|NCT02771210|585511398|FG001|Period 1|Adverse Event|3|||
162126053|NCT02771210|585511397|FG000|Period 1|Lack of Efficacy|3|||
162126054|NCT02771210|585511398|FG001|Period 1|Lack of Efficacy|6|||
162126055|NCT02771210|585511397|FG000|Period 1|Lost to Follow-up|2|||
162126056|NCT02771210|585511398|FG001|Period 1|Lost to Follow-up|0|||
162126057|NCT02771210|585511397|FG000|Period 1|Physician Decision|0|||
162126058|NCT02771210|585511398|FG001|Period 1|Physician Decision|1|||
162126059|NCT02771210|585511397|FG000|Period 1|Withdrawal by Subject|0|||
162126060|NCT02771210|585511398|FG001|Period 1|Withdrawal by Subject|3|||
162126061|NCT02771210|585511397|FG000|Period 1|Withdrawal of informed consent|1|||
161898436|NCT00103285|584677791|FG000|Response Assignment|Adverse Event|0|||
161898437|NCT00103285|584677792|FG001|Response Assignment|Adverse Event|8|||
161898438|NCT00103285|584677793|FG002|Response Assignment|Adverse Event|3|||
161898439|NCT00103285|584677794|FG003|Response Assignment|Adverse Event|2|||
161898440|NCT00103285|584677795|FG004|Response Assignment|Adverse Event|3|||
161898441|NCT00103285|584677796|FG005|Response Assignment|Adverse Event|1|||
161898442|NCT00103285|584677797|FG006|Response Assignment|Adverse Event|1|||
161898443|NCT00103285|584677798|FG007|Response Assignment|Adverse Event|2|||
161898444|NCT00103285|584677791|FG000|Response Assignment|Death|0|||
161898445|NCT00103285|584677792|FG001|Response Assignment|Death|5|||
161898446|NCT00103285|584677793|FG002|Response Assignment|Death|2|||
161898447|NCT00103285|584677794|FG003|Response Assignment|Death|2|||
161898448|NCT00103285|584677795|FG004|Response Assignment|Death|3|||
161898449|NCT00103285|584677796|FG005|Response Assignment|Death|1|||
161898450|NCT00103285|584677797|FG006|Response Assignment|Death|0|||
161898451|NCT00103285|584677798|FG007|Response Assignment|Death|8|||
161898452|NCT00103285|584677791|FG000|Response Assignment|Lost to Follow-up|0|||
161898453|NCT00103285|584677792|FG001|Response Assignment|Lost to Follow-up|9|||
161898454|NCT00103285|584677793|FG002|Response Assignment|Lost to Follow-up|5|||
161898455|NCT00103285|584677794|FG003|Response Assignment|Lost to Follow-up|5|||
161898456|NCT00103285|584677795|FG004|Response Assignment|Lost to Follow-up|1|||
161898457|NCT00103285|584677796|FG005|Response Assignment|Lost to Follow-up|2|||
161898458|NCT00103285|584677797|FG006|Response Assignment|Lost to Follow-up|2|||
161898459|NCT00103285|584677798|FG007|Response Assignment|Lost to Follow-up|5|||
161898460|NCT00103285|584677791|FG000|Response Assignment|Physician Decision|0|||
161898461|NCT00103285|584677792|FG001|Response Assignment|Physician Decision|13|||
161898462|NCT00103285|584677793|FG002|Response Assignment|Physician Decision|14|||
161898463|NCT00103285|584677794|FG003|Response Assignment|Physician Decision|9|||
161898464|NCT00103285|584677795|FG004|Response Assignment|Physician Decision|13|||
161898465|NCT00103285|584677796|FG005|Response Assignment|Physician Decision|7|||
161898466|NCT00103285|584677797|FG006|Response Assignment|Physician Decision|4|||
161898467|NCT00103285|584677798|FG007|Response Assignment|Physician Decision|35|||
161898468|NCT00103285|584677791|FG000|Response Assignment|Protocol Violation|0|||
161898469|NCT00103285|584677792|FG001|Response Assignment|Protocol Violation|2|||
161898470|NCT00103285|584677793|FG002|Response Assignment|Protocol Violation|0|||
161898471|NCT00103285|584677794|FG003|Response Assignment|Protocol Violation|0|||
161898472|NCT00103285|584677795|FG004|Response Assignment|Protocol Violation|0|||
161898473|NCT00103285|584677796|FG005|Response Assignment|Protocol Violation|0|||
161898474|NCT00103285|584677797|FG006|Response Assignment|Protocol Violation|0|||
161898475|NCT00103285|584677798|FG007|Response Assignment|Protocol Violation|0|||
161898476|NCT00103285|584677791|FG000|Response Assignment|Withdrawal by Subject|0|||
161898477|NCT00103285|584677792|FG001|Response Assignment|Withdrawal by Subject|4|||
161898478|NCT00103285|584677793|FG002|Response Assignment|Withdrawal by Subject|1|||
161898479|NCT00103285|584677794|FG003|Response Assignment|Withdrawal by Subject|1|||
161898480|NCT00103285|584677795|FG004|Response Assignment|Withdrawal by Subject|2|||
161898481|NCT00103285|584677796|FG005|Response Assignment|Withdrawal by Subject|2|||
161898482|NCT00103285|584677797|FG006|Response Assignment|Withdrawal by Subject|0|||
161898483|NCT00103285|584677798|FG007|Response Assignment|Withdrawal by Subject|2|||
161898484|NCT00103285|584677791|FG000|Response Assignment|Ineligible|0|||
161898485|NCT00103285|584677792|FG001|Response Assignment|Ineligible|8|||
161898486|NCT00103285|584677793|FG002|Response Assignment|Ineligible|6|||
161898487|NCT00103285|584677794|FG003|Response Assignment|Ineligible|2|||
162126062|NCT02771210|585511398|FG001|Period 1|Withdrawal of informed consent|5|||
162126063|NCT02771210|585511397|FG000|Period 2|Adverse Event|1|||
161898488|NCT00103285|584677795|FG004|Response Assignment|Ineligible|0|||
161898489|NCT00103285|584677796|FG005|Response Assignment|Ineligible|3|||
161898490|NCT00103285|584677797|FG006|Response Assignment|Ineligible|1|||
162126064|NCT02771210|585511398|FG001|Period 2|Adverse Event|0|||
162126065|NCT02771210|585511397|FG000|Period 2|Lack of Efficacy|0|||
161898491|NCT00103285|584677798|FG007|Response Assignment|Ineligible|5|||
161898492|NCT00103285|584677791|FG000|Response Assignment|Refusal|0|||
161898493|NCT00103285|584677792|FG001|Response Assignment|Refusal|53|||
161898494|NCT00103285|584677793|FG002|Response Assignment|Refusal|5|||
161898495|NCT00103285|584677794|FG003|Response Assignment|Refusal|3|||
161898496|NCT00103285|584677795|FG004|Response Assignment|Refusal|25|||
162126066|NCT02771210|585511398|FG001|Period 2|Lack of Efficacy|1|||
162126067|NCT02771210|585511397|FG000|Period 2|Withdrawal by Subject|1|||
162126068|NCT02771210|585511398|FG001|Period 2|Withdrawal by Subject|0|||
162126069|NCT02771210|585511397|FG000|Period 2|Withdrawal of informed consent|0|||
162126070|NCT02771210|585511398|FG001|Period 2|Withdrawal of informed consent|2|||
162126071|NCT04397523|585511399|FG000|Overall Study|Lost to Follow-up|3|||
162126072|NCT04397523|585511399|FG000|Overall Study|Transfer from/to other hospital|8|||
162126073|NCT01275196|585511400|FG000|Overall Study|Adverse Event|3|||
162126074|NCT01275196|585511401|FG001|Overall Study|Adverse Event|5|||
162126075|NCT01275196|585511400|FG000|Overall Study|Withdrawal by Subject|4|||
162126076|NCT01275196|585511401|FG001|Overall Study|Withdrawal by Subject|5|||
162126077|NCT01275196|585511400|FG000|Overall Study|Lost to Follow-up|1|||
162126078|NCT01275196|585511401|FG001|Overall Study|Lost to Follow-up|0|||
162126079|NCT01275196|585511400|FG000|Overall Study|Disease Progression|6|||
162126080|NCT01275196|585511401|FG001|Overall Study|Disease Progression|5|||
162126081|NCT01275196|585511400|FG000|Overall Study|Protocol Violation|1|||
162126082|NCT01275196|585511401|FG001|Overall Study|Protocol Violation|0|||
162126083|NCT01275196|585511400|FG000|Overall Study|Suboptimal response/treatment failure|5|||
162126084|NCT01275196|585511401|FG001|Overall Study|Suboptimal response/treatment failure|6|||
162126085|NCT01744496|585511404|FG000|Titration Period|Adverse Event|2|||
162126086|NCT01744496|585511405|FG001|Titration Period|Adverse Event|1|||
162126087|NCT01744496|585511404|FG000|Titration Period|Personal reasons|0|||
162126088|NCT01744496|585511405|FG001|Titration Period|Personal reasons|1|||
162126089|NCT01744496|585511404|FG000|Maintenance Period|Adverse Event|1|||
162126090|NCT01744496|585511405|FG001|Maintenance Period|Adverse Event|3|||
162126091|NCT01744496|585511404|FG000|Maintenance Period|Protocol Violation|1|||
162126092|NCT01744496|585511405|FG001|Maintenance Period|Protocol Violation|0|||
162126093|NCT01744496|585511404|FG000|Maintenance Period|Withdrawal by Subject|1|||
162126094|NCT01744496|585511405|FG001|Maintenance Period|Withdrawal by Subject|1|||
162126095|NCT01744496|585511404|FG000|Maintenance Period|Subject left town|1|||
162126096|NCT01744496|585511405|FG001|Maintenance Period|Subject left town|0|||
162126097|NCT01316692|585511408|FG000|Overall Study|Adverse Event|5|||
162126098|NCT01316692|585511408|FG000|Overall Study|Disease Progression|7|||
162126099|NCT01380990|585511409|FG000|Overall Study|Treatment Failure|1|||
162126100|NCT01380990|585511410|FG001|Overall Study|Treatment Failure|0|||
162126101|NCT01380990|585511409|FG000|Overall Study|Death|0|||
162126102|NCT01380990|585511410|FG001|Overall Study|Death|1|||
162126103|NCT01964521|585511411|FG000|Overall Study|Lost to Follow-up|4|||
162126104|NCT01463293|585511412|FG000|Overall Study|Lost to Follow-up|1|||
162126105|NCT01463293|585511413|FG001|Overall Study|Lost to Follow-up|4|||
162126106|NCT01463293|585511414|FG002|Overall Study|Lost to Follow-up|5|||
162126107|NCT01463293|585511412|FG000|Overall Study|Adverse Event|1|||
162126108|NCT01463293|585511413|FG001|Overall Study|Adverse Event|2|||
162126109|NCT01463293|585511414|FG002|Overall Study|Adverse Event|0|||
162126110|NCT01463293|585511412|FG000|Overall Study|Withdrawal by Subject|4|||
162126111|NCT01463293|585511413|FG001|Overall Study|Withdrawal by Subject|10|||
162126112|NCT01463293|585511414|FG002|Overall Study|Withdrawal by Subject|5|||
162126113|NCT01463293|585511412|FG000|Overall Study|Other|0|||
162126114|NCT01463293|585511413|FG001|Overall Study|Other|0|||
162126115|NCT01463293|585511414|FG002|Overall Study|Other|2|||
162126116|NCT01284140|585511415|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
162126117|NCT01284140|585511416|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
162126118|NCT01284140|585511415|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
162126119|NCT01284140|585511416|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
162126120|NCT02796963|585511417|FG000|Overall Study|Lost to Follow-up|89|||
162126121|NCT02796963|585511418|FG001|Overall Study|Lost to Follow-up|76|||
162126122|NCT02796963|585511419|FG002|Overall Study|Lost to Follow-up|69|||
162126123|NCT02796963|585511420|FG003|Overall Study|Lost to Follow-up|72|||
162126124|NCT03192215|585511421|FG000|Overall Study|Death|28|||
162126125|NCT03192215|585511422|FG001|Overall Study|Death|23|||
162126126|NCT03192215|585511421|FG000|Overall Study|Lost to Follow-up|10|||
162126127|NCT03192215|585511422|FG001|Overall Study|Lost to Follow-up|15|||
162126128|NCT03192215|585511421|FG000|Overall Study|Withdrawal by Subject|49|||
162126129|NCT03192215|585511422|FG001|Overall Study|Withdrawal by Subject|48|||
162126130|NCT03192215|585511421|FG000|Overall Study|Other as reported in analysis|4|||
162126131|NCT03192215|585511422|FG001|Overall Study|Other as reported in analysis|1|||
162126132|NCT01551303|585511432|FG000|Overall Study|failed awareness check on vision test|4|||
162126133|NCT01551303|585511433|FG001|Overall Study|failed awareness check on vision test|7|||
162126134|NCT02589392|585511441|FG000|Overall Study|Adverse Event|1|||
162126135|NCT02589392|585511442|FG001|Overall Study|Adverse Event|1|||
162126136|NCT02589392|585511441|FG000|Overall Study|Withdrawal by Subject|1|||
162126137|NCT02589392|585511442|FG001|Overall Study|Withdrawal by Subject|2|||
162126138|NCT02589392|585511441|FG000|Overall Study|Protocol Violation|1|||
162126139|NCT02589392|585511442|FG001|Overall Study|Protocol Violation|1|||
162126140|NCT02589392|585511441|FG000|Overall Study|Lost to Follow-up|2|||
162126141|NCT02589392|585511442|FG001|Overall Study|Lost to Follow-up|2|||
162126142|NCT02589392|585511441|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
162126143|NCT02589392|585511442|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
162126144|NCT00322374|585511444|FG000|Starting Dose|Physician Decision|2|||
162126145|NCT00322374|585511445|FG001|Starting Dose|Physician Decision|0|||
161785272|NCT02919475|584259189|FG000|Overall Study|Lost to Follow-up|0|||
161785273|NCT02919475|584259190|FG001|Overall Study|Lost to Follow-up|0|||
161785274|NCT02919475|584259191|FG002|Overall Study|Lost to Follow-up|0|||
161785275|NCT02919475|584259192|FG003|Overall Study|Lost to Follow-up|1|||
161785276|NCT02919475|584259193|FG004|Overall Study|Lost to Follow-up|0|||
161785277|NCT02919475|584259189|FG000|Overall Study|Withdrawal by Subject|2|||
161785278|NCT02919475|584259190|FG001|Overall Study|Withdrawal by Subject|3|||
161785279|NCT02919475|584259191|FG002|Overall Study|Withdrawal by Subject|1|||
161785280|NCT02919475|584259192|FG003|Overall Study|Withdrawal by Subject|2|||
161785281|NCT02919475|584259193|FG004|Overall Study|Withdrawal by Subject|2|||
161785282|NCT02919475|584259189|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161785283|NCT02919475|584259190|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161785284|NCT02919475|584259191|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161785285|NCT02919475|584259192|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161785286|NCT02919475|584259193|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161785287|NCT02323295|584259194|FG000|Overall Study|Adverse Event|0|||
161785288|NCT02323295|584259195|FG001|Overall Study|Adverse Event|1|||
161785289|NCT02323295|584259194|FG000|Overall Study|Withdrawal by Subject|0|||
161785290|NCT02323295|584259195|FG001|Overall Study|Withdrawal by Subject|1|||
161785291|NCT02323295|584259194|FG000|Overall Study|Patient did not have surgery as planned.|0|||
161785292|NCT02323295|584259195|FG001|Overall Study|Patient did not have surgery as planned.|1|||
161785293|NCT02370784|584259196|FG000|Overall Study|Patient started prohibited medication|0|||
161785294|NCT02370784|584259197|FG001|Overall Study|Patient started prohibited medication|1|||
161785295|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
161785296|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
161785297|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
161785298|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
161785299|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
161785300|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
161785301|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
161785302|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
161785303|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
161785304|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
161785305|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
161785306|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
161785307|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
161785308|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
161785309|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
161785310|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
161785311|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
161785312|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
161785313|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
161785314|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
161785315|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
161785316|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
161785317|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
161785318|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
161785319|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
161785320|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
161785321|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
161785322|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
161785323|NCT01872689|584259199|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
161785324|NCT01872689|584259200|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
161785325|NCT01872689|584259201|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
161785326|NCT01872689|584259202|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
161785327|NCT01872689|584259199|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
161785328|NCT01872689|584259200|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
161785329|NCT01872689|584259201|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
161785330|NCT01872689|584259202|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
161785331|NCT01872689|584259199|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
161785332|NCT01872689|584259200|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
161785333|NCT01872689|584259201|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
161785334|NCT01872689|584259202|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
161898497|NCT00103285|584677796|FG005|Response Assignment|Refusal|15|||
161898498|NCT00103285|584677797|FG006|Response Assignment|Refusal|30|||
161898499|NCT00103285|584677798|FG007|Response Assignment|Refusal|10|||
161898500|NCT00103285|584677791|FG000|Response Assignment|Other|0|||
161898501|NCT00103285|584677792|FG001|Response Assignment|Other|30|||
162010358|NCT04123470|585093737|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
161785335|NCT01872689|584259199|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
161785336|NCT01872689|584259200|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
161785337|NCT01872689|584259201|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
161785338|NCT01872689|584259202|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
161785339|NCT01872689|584259199|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
161785340|NCT01872689|584259200|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
161785341|NCT01872689|584259201|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
161785342|NCT01872689|584259202|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
161785343|NCT01872689|584259199|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
161785344|NCT01872689|584259200|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
161785345|NCT01872689|584259201|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
161785346|NCT01872689|584259202|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
161785347|NCT01872689|584259199|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
161785348|NCT01872689|584259200|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
161785349|NCT01872689|584259201|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
161785350|NCT01872689|584259202|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
161785351|NCT01456052|584259203|FG000|Overall Study|Adverse Event|1|||
161785352|NCT01456052|584259204|FG001|Overall Study|Adverse Event|1|||
161785353|NCT01456052|584259205|FG002|Overall Study|Adverse Event|2|||
161785354|NCT01456052|584259203|FG000|Overall Study|Consent withdrawn|0|||
161785355|NCT01456052|584259204|FG001|Overall Study|Consent withdrawn|2|||
161785356|NCT01456052|584259205|FG002|Overall Study|Consent withdrawn|1|||
161785357|NCT01456052|584259203|FG000|Overall Study|Protocol Violation|0|||
161785358|NCT01456052|584259204|FG001|Overall Study|Protocol Violation|1|||
161785359|NCT01456052|584259205|FG002|Overall Study|Protocol Violation|0|||
161785360|NCT01456052|584259203|FG000|Overall Study|Physician Decision|1|||
161785361|NCT01456052|584259204|FG001|Overall Study|Physician Decision|0|||
161785362|NCT01456052|584259205|FG002|Overall Study|Physician Decision|1|||
161785363|NCT01456052|584259203|FG000|Overall Study|Treatment Failure|0|||
161785364|NCT01456052|584259204|FG001|Overall Study|Treatment Failure|1|||
161785365|NCT01456052|584259205|FG002|Overall Study|Treatment Failure|1|||
161785366|NCT02762565|584259208|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
161785367|NCT01113710|584259209|FG000|Overall Study|Adverse Event|64|||
161785368|NCT01113710|584259209|FG000|Overall Study|Lack of Efficacy|41|||
161785369|NCT01113710|584259209|FG000|Overall Study|No Information Available|40|||
161785370|NCT01113710|584259209|FG000|Overall Study|Withdrawal by Subject|28|||
161785371|NCT01113710|584259209|FG000|Overall Study|Lost to Follow-up|20|||
161785372|NCT01113710|584259209|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
161785373|NCT01113710|584259209|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
161785374|NCT01113710|584259209|FG000|Overall Study|Lack of Patient's Compliance|8|||
161785375|NCT01113710|584259209|FG000|Overall Study|Other|7|||
161785376|NCT01113710|584259209|FG000|Overall Study|Adverse Event/Other|5|||
161785377|NCT01113710|584259209|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
161785378|NCT01113710|584259209|FG000|Overall Study|Lack of Efficacy/Other|4|||
161785379|NCT01113710|584259209|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
161785380|NCT01113710|584259209|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
161785381|NCT01113710|584259209|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
161785382|NCT01113710|584259209|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
161785383|NCT01113710|584259209|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
161785384|NCT01113710|584259209|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
161785385|NCT01113710|584259209|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
161785386|NCT01113710|584259209|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
161785387|NCT01113710|584259209|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
161785388|NCT01113710|584259209|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
161785389|NCT01113710|584259209|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
161785390|NCT01113710|584259209|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
161785391|NCT01113710|584259209|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
161785392|NCT02770716|584259211|FG000|Overall Study|Death|101|||
162126146|NCT00322374|585511446|FG002|Starting Dose|Physician Decision|0|||
162126147|NCT00322374|585511447|FG003|Starting Dose|Physician Decision|0|||
162126148|NCT00322374|585511444|FG000|Starting Dose|Study Drug Toxicity|4|||
162126149|NCT00322374|585511445|FG001|Starting Dose|Study Drug Toxicity|0|||
161785393|NCT02770716|584259212|FG001|Overall Study|Death|45|||
161785394|NCT02770716|584259211|FG000|Overall Study|Withdrawal by Subject|4|||
161785395|NCT02770716|584259212|FG001|Overall Study|Withdrawal by Subject|2|||
162126150|NCT00322374|585511446|FG002|Starting Dose|Study Drug Toxicity|0|||
162126151|NCT00322374|585511447|FG003|Starting Dose|Study Drug Toxicity|0|||
162126152|NCT00322374|585511444|FG000|First Escalation|Documented Disease Progression|0|||
162126153|NCT00322374|585511445|FG001|First Escalation|Documented Disease Progression|6|||
162126154|NCT00322374|585511446|FG002|First Escalation|Documented Disease Progression|0|||
162126155|NCT00322374|585511447|FG003|First Escalation|Documented Disease Progression|0|||
162126156|NCT00322374|585511444|FG000|First Escalation|Physician Decision|0|||
161785396|NCT02770716|584259211|FG000|Overall Study|Lost to Follow-up|1|||
161785397|NCT02770716|584259212|FG001|Overall Study|Lost to Follow-up|0|||
161785398|NCT02770716|584259211|FG000|Overall Study|Various reasons|6|||
162126157|NCT00322374|585511445|FG001|First Escalation|Physician Decision|12|||
162126158|NCT00322374|585511446|FG002|First Escalation|Physician Decision|0|||
162126159|NCT00322374|585511447|FG003|First Escalation|Physician Decision|0|||
162126160|NCT00322374|585511444|FG000|First Escalation|Study Drug Toxicity|0|||
162126161|NCT00322374|585511445|FG001|First Escalation|Study Drug Toxicity|11|||
162126162|NCT00322374|585511446|FG002|First Escalation|Study Drug Toxicity|0|||
162126163|NCT00322374|585511447|FG003|First Escalation|Study Drug Toxicity|0|||
162126164|NCT00322374|585511444|FG000|First Escalation|Participant Request|0|||
162126165|NCT00322374|585511445|FG001|First Escalation|Participant Request|1|||
162126166|NCT00322374|585511446|FG002|First Escalation|Participant Request|0|||
162126167|NCT00322374|585511447|FG003|First Escalation|Participant Request|0|||
162126168|NCT00322374|585511444|FG000|Second Escalation|Physician Decision|0|||
162126169|NCT00322374|585511445|FG001|Second Escalation|Physician Decision|0|||
162126170|NCT00322374|585511446|FG002|Second Escalation|Physician Decision|5|||
162126171|NCT00322374|585511447|FG003|Second Escalation|Physician Decision|0|||
162126172|NCT00322374|585511444|FG000|Second Escalation|Study Drug Toxicity|0|||
162126173|NCT00322374|585511445|FG001|Second Escalation|Study Drug Toxicity|0|||
162126174|NCT00322374|585511446|FG002|Second Escalation|Study Drug Toxicity|1|||
162126175|NCT00322374|585511447|FG003|Second Escalation|Study Drug Toxicity|0|||
162126176|NCT03382600|585511448|FG000|Overall Study|Adverse Event|3|||
162126177|NCT03382600|585511449|FG001|Overall Study|Adverse Event|3|||
162126178|NCT03382600|585511448|FG000|Overall Study|Clinical Disease Progression|2|||
162126179|NCT03382600|585511449|FG001|Overall Study|Clinical Disease Progression|4|||
162126180|NCT03382600|585511448|FG000|Overall Study|Radiological Progression|40|||
162126181|NCT03382600|585511449|FG001|Overall Study|Radiological Progression|31|||
162126182|NCT03382600|585511448|FG000|Overall Study|Withdrawal by Subject|0|||
162126183|NCT03382600|585511449|FG001|Overall Study|Withdrawal by Subject|1|||
162126184|NCT03382600|585511448|FG000|Overall Study|Other|9|||
162126185|NCT03382600|585511449|FG001|Overall Study|Other|7|||
162126186|NCT02269943|585511450|FG000|Treatment Period|Death|0|||
162126187|NCT02269943|585511451|FG001|Treatment Period|Death|1|||
162126188|NCT02269943|585511450|FG000|Treatment Period|Adverse Event|1|||
162126189|NCT02269943|585511451|FG001|Treatment Period|Adverse Event|10|||
161785399|NCT02770716|584259212|FG001|Overall Study|Various reasons|2|||
161785400|NCT01042977|584259213|FG000|Overall Study|Adverse Event|4|||
162010359|NCT04123470|585093738|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
162010360|NCT04123470|585093737|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
162010361|NCT04123470|585093738|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
162010362|NCT04123470|585093737|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
162010363|NCT04123470|585093738|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
162010364|NCT04123470|585093737|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
162010365|NCT04123470|585093738|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
162010366|NCT03866577|585093739|FG000|Overall Study|Protocol Violation|0|||
162010367|NCT03866577|585093740|FG001|Overall Study|Protocol Violation|0|||
162010368|NCT03866577|585093741|FG002|Overall Study|Protocol Violation|0|||
162010369|NCT03866577|585093742|FG003|Overall Study|Protocol Violation|0|||
162010370|NCT03866577|585093743|FG004|Overall Study|Protocol Violation|0|||
162010371|NCT03866577|585093744|FG005|Overall Study|Protocol Violation|0|||
162010372|NCT03866577|585093745|FG006|Overall Study|Protocol Violation|0|||
162010373|NCT03866577|585093746|FG007|Overall Study|Protocol Violation|0|||
162010374|NCT03866577|585093747|FG008|Overall Study|Protocol Violation|0|||
162010375|NCT03866577|585093748|FG009|Overall Study|Protocol Violation|0|||
162010376|NCT03866577|585093749|FG010|Overall Study|Protocol Violation|0|||
162010377|NCT03866577|585093750|FG011|Overall Study|Protocol Violation|1|||
162010378|NCT03866577|585093751|FG012|Overall Study|Protocol Violation|0|||
162010379|NCT03866577|585093739|FG000|Overall Study|Withdrawal by Subject|0|||
162010380|NCT03866577|585093740|FG001|Overall Study|Withdrawal by Subject|0|||
162010381|NCT03866577|585093741|FG002|Overall Study|Withdrawal by Subject|0|||
162010382|NCT03866577|585093742|FG003|Overall Study|Withdrawal by Subject|0|||
162010383|NCT03866577|585093743|FG004|Overall Study|Withdrawal by Subject|0|||
162010384|NCT03866577|585093744|FG005|Overall Study|Withdrawal by Subject|0|||
162010385|NCT03866577|585093745|FG006|Overall Study|Withdrawal by Subject|0|||
162010386|NCT03866577|585093746|FG007|Overall Study|Withdrawal by Subject|0|||
162010387|NCT03866577|585093747|FG008|Overall Study|Withdrawal by Subject|1|||
162010388|NCT03866577|585093748|FG009|Overall Study|Withdrawal by Subject|1|||
162010389|NCT03866577|585093749|FG010|Overall Study|Withdrawal by Subject|0|||
162010390|NCT03866577|585093750|FG011|Overall Study|Withdrawal by Subject|0|||
162010391|NCT03866577|585093751|FG012|Overall Study|Withdrawal by Subject|0|||
162126190|NCT02269943|585511450|FG000|Treatment Period|Progressive Disease|5|||
162126191|NCT02269943|585511451|FG001|Treatment Period|Progressive Disease|17|||
162126192|NCT02269943|585511450|FG000|Treatment Period|Symptomatic Deterioration|0|||
162126193|NCT02269943|585511451|FG001|Treatment Period|Symptomatic Deterioration|2|||
162126194|NCT02269943|585511450|FG000|Follow-Up Survival Period|Death|3|||
161785401|NCT01042977|584259214|FG001|Overall Study|Adverse Event|12|||
161785402|NCT01042977|584259213|FG000|Overall Study|Death|2|||
161785403|NCT01042977|584259214|FG001|Overall Study|Death|1|||
161785404|NCT01042977|584259213|FG000|Overall Study|Withdrawal by Subject|8|||
161785405|NCT01042977|584259214|FG001|Overall Study|Withdrawal by Subject|16|||
161785406|NCT01042977|584259213|FG000|Overall Study|Lost to Follow-up|0|||
161785407|NCT01042977|584259214|FG001|Overall Study|Lost to Follow-up|2|||
161785408|NCT01042977|584259213|FG000|Overall Study|Poor/non-compliance|3|||
161785409|NCT01042977|584259214|FG001|Overall Study|Poor/non-compliance|4|||
161785410|NCT01042977|584259213|FG000|Overall Study|Subject no longer meets study criteria|15|||
161785411|NCT01042977|584259214|FG001|Overall Study|Subject no longer meets study criteria|13|||
161785412|NCT01042977|584259213|FG000|Overall Study|Incorrect enrollment|6|||
161785413|NCT01042977|584259214|FG001|Overall Study|Incorrect enrollment|4|||
161785414|NCT01042977|584259213|FG000|Overall Study|Safety|0|||
161785415|NCT01042977|584259214|FG001|Overall Study|Safety|2|||
161785416|NCT01042977|584259213|FG000|Overall Study|Administrative reason by sponsor|0|||
161785417|NCT01042977|584259214|FG001|Overall Study|Administrative reason by sponsor|1|||
161785418|NCT01042977|584259213|FG000|Overall Study|Various|3|||
161785419|NCT01042977|584259214|FG001|Overall Study|Various|0|||
161785420|NCT02499354|584259215|FG000|Overall Study|Withdrawal by Subject|1|||
161785421|NCT02499354|584259216|FG001|Overall Study|Withdrawal by Subject|0|||
161785422|NCT01677910|584259218|FG000|Double-Blind Treatment Period|Adverse Event|6|||
161785423|NCT01677910|584259219|FG001|Double-Blind Treatment Period|Adverse Event|2|||
161785424|NCT01677910|584259220|FG002|Double-Blind Treatment Period|Adverse Event|3|||
161785425|NCT01677910|584259221|FG003|Double-Blind Treatment Period|Adverse Event|0|||
161785426|NCT01677910|584259218|FG000|Double-Blind Treatment Period|Physician Decision|0|||
161785427|NCT01677910|584259219|FG001|Double-Blind Treatment Period|Physician Decision|0|||
161785428|NCT01677910|584259220|FG002|Double-Blind Treatment Period|Physician Decision|1|||
161785429|NCT01677910|584259221|FG003|Double-Blind Treatment Period|Physician Decision|0|||
161785430|NCT01677910|584259218|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
161785431|NCT01677910|584259219|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
161785432|NCT01677910|584259220|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
161785433|NCT01677910|584259221|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
161785434|NCT01677910|584259218|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
161785435|NCT01677910|584259219|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
161785436|NCT01677910|584259220|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
161785437|NCT01677910|584259221|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
161785438|NCT01677910|584259218|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
161785439|NCT01677910|584259219|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
161785440|NCT01677910|584259220|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
161785441|NCT01677910|584259221|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
161785442|NCT01677910|584259218|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161785443|NCT01677910|584259219|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161785444|NCT01677910|584259220|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161785445|NCT01677910|584259221|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
161785446|NCT01677910|584259218|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161785447|NCT01677910|584259219|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161785448|NCT01677910|584259220|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161785449|NCT01677910|584259221|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
161785450|NCT01677910|584259218|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161785451|NCT01677910|584259219|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161785452|NCT01677910|584259220|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161785453|NCT01677910|584259221|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
161785454|NCT01677910|584259218|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
161785455|NCT01677910|584259219|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
161785456|NCT01677910|584259220|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
161785457|NCT01677910|584259221|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
161785458|NCT01677910|584259218|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
161785459|NCT01677910|584259219|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
161785460|NCT01677910|584259220|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
161785461|NCT01677910|584259221|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
161785462|NCT01703741|584259223|FG000|Overall Study|Withdrawal by Subject|6|||
161785463|NCT01703741|584259223|FG000|Overall Study|Adverse Event|2|||
161785464|NCT01703741|584259223|FG000|Overall Study|Physician Decision|2|||
161785465|NCT01703741|584259223|FG000|Overall Study|Protocol Violation|1|||
161785466|NCT01703741|584259223|FG000|Overall Study|Lost to Follow-up|3|||
161785467|NCT01703741|584259223|FG000|Overall Study|Subject did not want to continue|2|||
161785468|NCT01703741|584259223|FG000|Overall Study|Subject cannot comply with study visits|1|||
161785469|NCT01703741|584259223|FG000|Overall Study|Subject started testosterone injections|1|||
161785470|NCT01170364|584259224|FG000|Overall Study|Protocol Violation|4|||
161785471|NCT01170364|584259225|FG001|Overall Study|Protocol Violation|1|||
161785472|NCT04132232|584259226|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
161785473|NCT04132232|584259227|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
161785474|NCT04132232|584259226|FG000|Overall Study|Lost to Follow-up|6|||
161785475|NCT04132232|584259227|FG001|Overall Study|Lost to Follow-up|7|||
161785476|NCT00368537|584259229|FG000|Randomization|No study drug dosed|13|||
161785477|NCT00368537|584259230|FG001|Randomization|No study drug dosed|6|||
161785478|NCT00368537|584259229|FG000|Baseline Participants|Lost to Follow-up|16|||
161785479|NCT00368537|584259230|FG001|Baseline Participants|Lost to Follow-up|17|||
161785480|NCT00368537|584259229|FG000|Baseline Participants|Withdrawal by Subject|6|||
161785481|NCT00368537|584259230|FG001|Baseline Participants|Withdrawal by Subject|4|||
161785482|NCT00368537|584259229|FG000|Baseline Participants|Death|1|||
161785483|NCT00368537|584259230|FG001|Baseline Participants|Death|2|||
161785484|NCT00368537|584259229|FG000|Baseline Participants|No susceptibility|1|||
161785485|NCT00368537|584259230|FG001|Baseline Participants|No susceptibility|0|||
161785486|NCT00368537|584259229|FG000|Baseline Participants|Patient uncompliant|0|||
161785487|NCT00368537|584259230|FG001|Baseline Participants|Patient uncompliant|1|||
161785488|NCT01368276|584259240|FG000|Overall Study|Death|1|||
161785489|NCT01368276|584259241|FG001|Overall Study|Death|10|||
161785490|NCT01427920|584259244|FG000|Overall Study|Adverse Event|1|||
161785491|NCT01427920|584259245|FG001|Overall Study|Adverse Event|2|||
161785492|NCT01427920|584259244|FG000|Overall Study|Lack of Efficacy|1|||
161785493|NCT01427920|584259245|FG001|Overall Study|Lack of Efficacy|0|||
161785494|NCT01427920|584259244|FG000|Overall Study|Protocol Violation|1|||
161785495|NCT01427920|584259245|FG001|Overall Study|Protocol Violation|3|||
161785496|NCT01427920|584259244|FG000|Overall Study|Withdrawal Criteria|4|||
161785497|NCT01427920|584259245|FG001|Overall Study|Withdrawal Criteria|4|||
161785498|NCT01427920|584259244|FG000|Overall Study|Unclassified|2|||
161785499|NCT01427920|584259245|FG001|Overall Study|Unclassified|8|||
161785500|NCT03341273|584259246|FG000|Overall Study|Lost to Follow-up|7|||
161785501|NCT03341273|584259247|FG001|Overall Study|Lost to Follow-up|7|||
161785502|NCT03341273|584259246|FG000|Overall Study|Withdrawal by Subject|4|||
161785503|NCT03341273|584259247|FG001|Overall Study|Withdrawal by Subject|2|||
161785504|NCT03341273|584259246|FG000|Overall Study|Physician Decision|1|||
161785505|NCT03341273|584259247|FG001|Overall Study|Physician Decision|0|||
161785506|NCT03341273|584259246|FG000|Overall Study|Protocol Violation|0|||
161785507|NCT03341273|584259247|FG001|Overall Study|Protocol Violation|1|||
161785508|NCT03341273|584259246|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
161785509|NCT03341273|584259247|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
161785510|NCT03341273|584259246|FG000|Overall Study|Became ineligible after enrollment|1|||
161785511|NCT03341273|584259247|FG001|Overall Study|Became ineligible after enrollment|0|||
161785512|NCT03341273|584259246|FG000|Overall Study|Not Eligible at Enrollment|0|||
161785513|NCT03341273|584259247|FG001|Overall Study|Not Eligible at Enrollment|1|||
161785514|NCT03341273|584259246|FG000|Overall Study|Participant incarcerated|1|||
161785515|NCT03341273|584259247|FG001|Overall Study|Participant incarcerated|0|||
161785516|NCT01717456|584259254|FG000|End of Treatment|Physician Decision|0|||
161785517|NCT01717456|584259255|FG001|End of Treatment|Physician Decision|1|||
161785518|NCT01717456|584259254|FG000|End of Treatment|Lost to Follow-up|0|||
161785519|NCT01717456|584259255|FG001|End of Treatment|Lost to Follow-up|1|||
161785520|NCT01717456|584259254|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
161785521|NCT01717456|584259255|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
161785522|NCT02732561|584259256|FG000|Overall Study|Lost to Follow-up|1|||
161785523|NCT02732561|584259257|FG001|Overall Study|Lost to Follow-up|1|||
161785524|NCT02732561|584259256|FG000|Overall Study|Withdrawal by Subject|1|||
161785525|NCT02732561|584259257|FG001|Overall Study|Withdrawal by Subject|0|||
161785526|NCT03066440|584259260|FG000|Overall Study|Physician Decision|1|||
161785527|NCT03066440|584259261|FG001|Overall Study|Physician Decision|1|||
161785528|NCT03066440|584259260|FG000|Overall Study|Protocol Violation|0|||
161785529|NCT03066440|584259261|FG001|Overall Study|Protocol Violation|2|||
161785530|NCT00755937|584259262|FG000|Recruitment|Unknown if infliximab received|164|||
161785531|NCT00755937|584259262|FG000|Observational Follow-up|Lost to Follow-up|148|||
161785532|NCT03876873|584259263|FG000|Overall Study|Physician Decision|0|||
162010392|NCT03866577|585093739|FG000|Overall Study|Not qualified for IVIg infusion|0|||
161785533|NCT03876873|584259264|FG001|Overall Study|Physician Decision|1|||
161785534|NCT03547531|584259265|FG000|Overall Study|not coming in data collection : sick|2|||
161785535|NCT03547531|584259266|FG001|Overall Study|not coming in data collection : sick|2|||
161785536|NCT03547531|584259265|FG000|Overall Study|having family occasion|0|||
161785537|NCT03547531|584259266|FG001|Overall Study|having family occasion|2|||
161785538|NCT02117479|584259276|FG000|Overall Study|Death|13|||
161785539|NCT02117479|584259277|FG001|Overall Study|Death|8|||
161785540|NCT02117479|584259276|FG000|Overall Study|Adverse Event|8|||
161785541|NCT02117479|584259277|FG001|Overall Study|Adverse Event|16|||
161785542|NCT02117479|584259276|FG000|Overall Study|Subject decision|8|||
161785543|NCT02117479|584259277|FG001|Overall Study|Subject decision|9|||
161785544|NCT02117479|584259276|FG000|Overall Study|Disease progression|104|||
161785545|NCT02117479|584259277|FG001|Overall Study|Disease progression|108|||
161785546|NCT02117479|584259276|FG000|Overall Study|Noncompliance with study treatment|1|||
162010393|NCT03866577|585093740|FG001|Overall Study|Not qualified for IVIg infusion|0|||
161785547|NCT02117479|584259277|FG001|Overall Study|Noncompliance with study treatment|0|||
161785548|NCT02117479|584259276|FG000|Overall Study|Study terminated by the sponsor|4|||
161785549|NCT02117479|584259277|FG001|Overall Study|Study terminated by the sponsor|6|||
161785550|NCT02117479|584259276|FG000|Overall Study|Physician Decision|7|||
161785551|NCT02117479|584259277|FG001|Overall Study|Physician Decision|2|||
161785552|NCT02117479|584259276|FG000|Overall Study|Other unspecified|11|||
161785553|NCT02117479|584259277|FG001|Overall Study|Other unspecified|7|||
161785554|NCT01959230|584259280|FG000|Overall Study|Failure to follow study procedures|0|||
161785555|NCT01959230|584259281|FG001|Overall Study|Failure to follow study procedures|1|||
161785556|NCT01959230|584259280|FG000|Overall Study|Administrative reasons|2|||
161785557|NCT01959230|584259281|FG001|Overall Study|Administrative reasons|0|||
161785558|NCT01959230|584259280|FG000|Overall Study|Withdrawal by Subject|2|||
161785559|NCT01959230|584259281|FG001|Overall Study|Withdrawal by Subject|0|||
161785560|NCT00751998|584259284|FG000|Overall Study|Lost to Follow-up|7|||
161785561|NCT00751998|584259284|FG000|Overall Study|Death|11|||
161785562|NCT00751998|584259284|FG000|Overall Study|Withdrawal by Subject|2|||
161785563|NCT01223196|584259286|FG000|Overall Study|Lost to Follow-up|2|||
161785564|NCT01223196|584259287|FG001|Overall Study|Lost to Follow-up|0|||
161785565|NCT01223196|584259286|FG000|Overall Study|Physician Decision|1|||
161785566|NCT01223196|584259287|FG001|Overall Study|Physician Decision|0|||
161785567|NCT01223196|584259286|FG000|Overall Study|Withdrawal by Subject|1|||
161785568|NCT01223196|584259287|FG001|Overall Study|Withdrawal by Subject|0|||
161785569|NCT02629133|584259288|FG000|Overall Study|Lost to Follow-up|3|||
161785570|NCT02629133|584259289|FG001|Overall Study|Lost to Follow-up|1|||
161785571|NCT02629133|584259288|FG000|Overall Study|Withdrawal by Subject|1|||
161785572|NCT02629133|584259289|FG001|Overall Study|Withdrawal by Subject|1|||
161785573|NCT01238822|584259290|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
161785574|NCT02598193|584259291|FG000|Overall Study|Adverse Event|13|||
161785575|NCT02598193|584259291|FG000|Overall Study|Withdrawal by Subject|1|||
161785576|NCT02598193|584259291|FG000|Overall Study|Listed in active lung transplant list|1|||
161785577|NCT02598193|584259291|FG000|Overall Study|Does not want to take Nintedanib|1|||
161785578|NCT00447694|584259294|FG000|Overall Study|Adverse Event|2|||
161785579|NCT00447694|584259294|FG000|Overall Study|Abnormal laboratory value|1|||
161785580|NCT00447694|584259294|FG000|Overall Study|Abnormal test procedure result|1|||
161785581|NCT00447694|584259294|FG000|Overall Study|Withdrawal by Subject|2|||
161785582|NCT01169987|584259295|FG000|Overall Study|Withdrawal by Subject|3|||
161785583|NCT01169987|584259295|FG000|Overall Study|Lost to Follow-up|24|||
161785584|NCT01169987|584259295|FG000|Overall Study|Other|4|||
161785585|NCT00386100|584259297|FG000|Overall Study|Did not receive study medication|6|||
161785586|NCT00386100|584259298|FG001|Overall Study|Did not receive study medication|4|||
161785587|NCT00386100|584259297|FG000|Overall Study|Adverse Event|15|||
161785588|NCT00386100|584259298|FG001|Overall Study|Adverse Event|25|||
161785589|NCT00386100|584259297|FG000|Overall Study|Death|0|||
161785590|NCT00386100|584259298|FG001|Overall Study|Death|1|||
161785591|NCT00386100|584259297|FG000|Overall Study|Insufficient therapeutic effect|30|||
161785592|NCT00386100|584259298|FG001|Overall Study|Insufficient therapeutic effect|6|||
161785593|NCT00386100|584259297|FG000|Overall Study|Lost to Follow-up|29|||
161785594|NCT00386100|584259298|FG001|Overall Study|Lost to Follow-up|29|||
161785595|NCT00386100|584259297|FG000|Overall Study|Non-compliance|18|||
161785596|NCT00386100|584259298|FG001|Overall Study|Non-compliance|19|||
161785597|NCT00386100|584259297|FG000|Overall Study|Protocol Violation|5|||
161785598|NCT00386100|584259298|FG001|Overall Study|Protocol Violation|3|||
161785599|NCT00386100|584259297|FG000|Overall Study|Withdrawal by Subject|32|||
161785600|NCT00386100|584259298|FG001|Overall Study|Withdrawal by Subject|31|||
161785601|NCT00386100|584259297|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
161785602|NCT00386100|584259298|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
161785603|NCT00386100|584259297|FG000|Overall Study|BMD <2.5|1|||
161785604|NCT00386100|584259298|FG001|Overall Study|BMD <2.5|0|||
161785605|NCT00386100|584259297|FG000|Overall Study|Consecutive elevated Hba1C|1|||
161785606|NCT00386100|584259298|FG001|Overall Study|Consecutive elevated Hba1C|0|||
161785607|NCT00386100|584259297|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
161785608|NCT00386100|584259298|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
161785609|NCT00386100|584259297|FG000|Overall Study|Laboratory findings|1|||
162126195|NCT02269943|585511451|FG001|Follow-Up Survival Period|Death|16|||
161785610|NCT00386100|584259298|FG001|Overall Study|Laboratory findings|0|||
161785611|NCT00386100|584259297|FG000|Overall Study|Participant's concern due to CPK levels|1|||
162126196|NCT02269943|585511450|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
161785612|NCT00386100|584259298|FG001|Overall Study|Participant's concern due to CPK levels|0|||
161785613|NCT00386100|584259297|FG000|Overall Study|Participant moving out of state|2|||
161785614|NCT00386100|584259298|FG001|Overall Study|Participant moving out of state|0|||
161785615|NCT00386100|584259297|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
161785616|NCT00386100|584259298|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
161785617|NCT00386100|584259297|FG000|Overall Study|Didn't meet entry criteria|1|||
161785618|NCT00386100|584259298|FG001|Overall Study|Didn't meet entry criteria|1|||
161785619|NCT00386100|584259297|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
161785620|NCT00386100|584259298|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
161785621|NCT00386100|584259297|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
161785622|NCT00386100|584259298|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
161785623|NCT00386100|584259297|FG000|Overall Study|Bad metabolic control & patient security|1|||
161785624|NCT00386100|584259298|FG001|Overall Study|Bad metabolic control & patient security|0|||
161785625|NCT00386100|584259297|FG000|Overall Study|Bone loss by DXA bone scan|1|||
161785626|NCT00386100|584259298|FG001|Overall Study|Bone loss by DXA bone scan|0|||
161785627|NCT00386100|584259297|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
161785628|NCT00386100|584259298|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
161785629|NCT00386100|584259297|FG000|Overall Study|7.6% bone loss|1|||
161785630|NCT00386100|584259298|FG001|Overall Study|7.6% bone loss|0|||
161785631|NCT00386100|584259297|FG000|Overall Study|Osteoporosis|0|||
161785632|NCT00386100|584259298|FG001|Overall Study|Osteoporosis|1|||
161785633|NCT00386100|584259297|FG000|Overall Study|Positive pregnancy test|1|||
161785634|NCT00386100|584259298|FG001|Overall Study|Positive pregnancy test|3|||
161785635|NCT00386100|584259297|FG000|Overall Study|Out of country for 5 months|1|||
161785636|NCT00386100|584259298|FG001|Overall Study|Out of country for 5 months|0|||
161785637|NCT00386100|584259297|FG000|Overall Study|Hb1Ac >8%|0|||
161785638|NCT00386100|584259298|FG001|Overall Study|Hb1Ac >8%|1|||
161785639|NCT00386100|584259297|FG000|Overall Study|Participant randomized in error|1|||
161785640|NCT00386100|584259298|FG001|Overall Study|Participant randomized in error|0|||
161785641|NCT00061945|584259302|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
161785642|NCT00061945|584259303|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
161785643|NCT00061945|584259302|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
161785644|NCT00061945|584259303|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
161785645|NCT00061945|584259302|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
161785646|NCT00061945|584259303|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
161785647|NCT00061945|584259302|FG000|Course IV: Alemtuzumab|Early exits|6|||
161785648|NCT00061945|584259303|FG001|Course IV: Alemtuzumab|Early exits|15|||
161785649|NCT03672396|584259304|FG000|Overall Study|Withdrawal by Subject|4|||
161785650|NCT03672396|584259304|FG000|Overall Study|Physician Decision|1|||
161785651|NCT03672396|584259304|FG000|Overall Study|Adverse Event|1|||
161785652|NCT03001011|584259309|FG000|Overall Study|Adverse Event|9|||
161785653|NCT03001011|584259310|FG001|Overall Study|Adverse Event|3|||
161785654|NCT03001011|584259309|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
161785655|NCT03001011|584259310|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
161785656|NCT03001011|584259309|FG000|Overall Study|Other than specified above|3|||
161785657|NCT03001011|584259310|FG001|Overall Study|Other than specified above|8|||
161785658|NCT04363736|584259311|FG000|Overall Study|Withdrawal by Subject|1|||
161785659|NCT04363736|584259312|FG001|Overall Study|Withdrawal by Subject|0|||
161785660|NCT04363736|584259311|FG000|Overall Study|Lost to Follow-up|10|||
161785661|NCT04363736|584259312|FG001|Overall Study|Lost to Follow-up|7|||
161785662|NCT04363736|584259311|FG000|Overall Study|Death|8|||
161785663|NCT04363736|584259312|FG001|Overall Study|Death|6|||
161785664|NCT03797222|584259313|FG000|Overall Study|Withdrawal by Subject|1|||
161785665|NCT01021137|584259314|FG000|Overall Study|Lost to Follow-up|9|||
161785666|NCT01021137|584259315|FG001|Overall Study|Lost to Follow-up|4|||
161785667|NCT01021137|584259316|FG002|Overall Study|Lost to Follow-up|2|||
161785668|NCT01021137|584259317|FG003|Overall Study|Lost to Follow-up|6|||
161785669|NCT01021137|584259314|FG000|Overall Study|Withdrawal by Subject|1|||
161785670|NCT01021137|584259315|FG001|Overall Study|Withdrawal by Subject|0|||
161785671|NCT01021137|584259316|FG002|Overall Study|Withdrawal by Subject|0|||
161785672|NCT01021137|584259317|FG003|Overall Study|Withdrawal by Subject|3|||
161785673|NCT00725725|584259318|FG000|Overall Study|Adverse Event|1|||
161785674|NCT00725725|584259319|FG001|Overall Study|Adverse Event|3|||
161785675|NCT00725725|584259320|FG002|Overall Study|Adverse Event|2|||
161785676|NCT00725725|584259318|FG000|Overall Study|Lost to Follow-up|2|||
161785677|NCT00725725|584259319|FG001|Overall Study|Lost to Follow-up|0|||
161785678|NCT00725725|584259320|FG002|Overall Study|Lost to Follow-up|2|||
161785679|NCT00725725|584259318|FG000|Overall Study|Withdrawal by Subject|1|||
161785680|NCT00725725|584259319|FG001|Overall Study|Withdrawal by Subject|0|||
161785681|NCT00725725|584259320|FG002|Overall Study|Withdrawal by Subject|1|||
161785682|NCT00725725|584259318|FG000|Overall Study|Protocol Violation|0|||
161785683|NCT00725725|584259319|FG001|Overall Study|Protocol Violation|1|||
161785684|NCT00725725|584259320|FG002|Overall Study|Protocol Violation|0|||
161785685|NCT00729365|584259322|FG000|Overall Study|Physician Decision|33|||
161785686|NCT00729365|584259323|FG001|Overall Study|Physician Decision|6|||
161785687|NCT00729365|584259324|FG002|Overall Study|Physician Decision|7|||
161785688|NCT02556632|584259325|FG000|Overall Study|Lost to Follow-up|1|||
161785689|NCT02556632|584259326|FG001|Overall Study|Lost to Follow-up|0|||
161785690|NCT02556632|584259327|FG002|Overall Study|Lost to Follow-up|0|||
161785691|NCT02556632|584259325|FG000|Overall Study|Disliked Intervention|1|||
161785692|NCT02556632|584259326|FG001|Overall Study|Disliked Intervention|1|||
161785693|NCT02556632|584259327|FG002|Overall Study|Disliked Intervention|1|||
161785694|NCT02556632|584259325|FG000|Overall Study|No Reason|1|||
161785695|NCT02556632|584259326|FG001|Overall Study|No Reason|0|||
161785696|NCT02556632|584259327|FG002|Overall Study|No Reason|1|||
161785697|NCT02556632|584259325|FG000|Overall Study|Personal Issues|0|||
161785698|NCT02556632|584259326|FG001|Overall Study|Personal Issues|1|||
161785699|NCT02556632|584259327|FG002|Overall Study|Personal Issues|1|||
161785700|NCT02556632|584259325|FG000|Overall Study|Changed Mind|0|||
161785701|NCT02556632|584259326|FG001|Overall Study|Changed Mind|1|||
161785702|NCT02556632|584259327|FG002|Overall Study|Changed Mind|0|||
161785703|NCT02556632|584259325|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
161785704|NCT02556632|584259326|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
161785705|NCT02556632|584259327|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
161785706|NCT02556632|584259325|FG000|Overall Study|Unrelated Adverse Event|1|||
161785707|NCT02556632|584259326|FG001|Overall Study|Unrelated Adverse Event|0|||
161785708|NCT02556632|584259327|FG002|Overall Study|Unrelated Adverse Event|3|||
161785709|NCT02556632|584259325|FG000|Overall Study|Related Adverse Event|0|||
161785710|NCT02556632|584259326|FG001|Overall Study|Related Adverse Event|1|||
161785711|NCT02556632|584259327|FG002|Overall Study|Related Adverse Event|0|||
161785712|NCT02556632|584259325|FG000|Overall Study|Possibly Related Adverse Event|0|||
161785713|NCT02556632|584259326|FG001|Overall Study|Possibly Related Adverse Event|0|||
161785714|NCT02556632|584259327|FG002|Overall Study|Possibly Related Adverse Event|1|||
161785715|NCT02556632|584259325|FG000|Overall Study|Did Not Start RT|0|||
161785716|NCT02556632|584259326|FG001|Overall Study|Did Not Start RT|1|||
161785717|NCT02556632|584259327|FG002|Overall Study|Did Not Start RT|0|||
161785718|NCT02556632|584259325|FG000|Overall Study|Ineligible|0|||
161785719|NCT02556632|584259326|FG001|Overall Study|Ineligible|1|||
161785720|NCT02556632|584259327|FG002|Overall Study|Ineligible|0|||
161785721|NCT02556632|584259325|FG000|Overall Study|Disliked Study Procedures|0|||
161785722|NCT02556632|584259326|FG001|Overall Study|Disliked Study Procedures|0|||
161785723|NCT02556632|584259327|FG002|Overall Study|Disliked Study Procedures|1|||
161785724|NCT02556632|584259325|FG000|Overall Study|Treatment or Change Delay|0|||
161785725|NCT02556632|584259326|FG001|Overall Study|Treatment or Change Delay|0|||
161785726|NCT02556632|584259327|FG002|Overall Study|Treatment or Change Delay|1|||
161785727|NCT00928135|584259328|FG000|Overall Study|Withdrawal by Subject|1|||
161785728|NCT00928135|584259329|FG001|Overall Study|Withdrawal by Subject|0|||
161785729|NCT01999322|584259330|FG000|Overall Study|Adverse Event|1|||
161785730|NCT01999322|584259331|FG001|Overall Study|Adverse Event|0|||
161785731|NCT01963676|584260701|FG000|Overall Study|Withdrawal by Subject|1|||
161785732|NCT01963676|584260702|FG001|Overall Study|Withdrawal by Subject|0|||
161785733|NCT00766506|584260703|FG000|Overall Study|Use rescue medication after 3 hours|3|||
161785734|NCT00766506|584260704|FG001|Overall Study|Use rescue medication after 3 hours|0|||
161785735|NCT00766506|584260703|FG000|Overall Study|Other|2|||
161785736|NCT00766506|584260704|FG001|Overall Study|Other|2|||
161785737|NCT03053622|584260705|FG000|Overall Study|Lost to Follow-up|0|||
161785738|NCT03053622|584260706|FG001|Overall Study|Lost to Follow-up|0|||
161785739|NCT03053622|584260707|FG002|Overall Study|Lost to Follow-up|0|||
161785740|NCT03053622|584260708|FG003|Overall Study|Lost to Follow-up|1|||
161785741|NCT01246986|584260709|FG000|Overall Study|Lost to Follow-up|0|||
161785742|NCT01246986|584260710|FG001|Overall Study|Lost to Follow-up|1|||
161785743|NCT01246986|584260711|FG002|Overall Study|Lost to Follow-up|3|||
161785744|NCT01246986|584260712|FG003|Overall Study|Lost to Follow-up|0|||
161785745|NCT01246986|584260713|FG004|Overall Study|Lost to Follow-up|0|||
161785746|NCT01246986|584260714|FG005|Overall Study|Lost to Follow-up|1|||
161785747|NCT01246986|584260715|FG006|Overall Study|Lost to Follow-up|0|||
161785748|NCT01246986|584260709|FG000|Overall Study|Withdrawal by Subject|3|||
161785749|NCT01246986|584260710|FG001|Overall Study|Withdrawal by Subject|4|||
161785750|NCT01246986|584260711|FG002|Overall Study|Withdrawal by Subject|3|||
161785751|NCT01246986|584260712|FG003|Overall Study|Withdrawal by Subject|0|||
161785752|NCT01246986|584260713|FG004|Overall Study|Withdrawal by Subject|4|||
161785753|NCT01246986|584260714|FG005|Overall Study|Withdrawal by Subject|0|||
161785754|NCT01246986|584260715|FG006|Overall Study|Withdrawal by Subject|0|||
161785755|NCT01440647|584260720|FG000|Overall Study|Death|2|||
161785756|NCT01440647|584260721|FG001|Overall Study|Death|3|||
161785757|NCT01406873|584260735|FG000|Overall Study|Withdrawal by Subject|1|||
161785758|NCT01406873|584260736|FG001|Overall Study|Withdrawal by Subject|1|||
161785759|NCT03990389|584260737|FG000|Overall Study|Lost to Follow-up|3|||
161785760|NCT03990389|584260738|FG001|Overall Study|Lost to Follow-up|0|||
161785761|NCT00207714|584260739|FG000|Overall Study|Adverse Event|6|||
161785762|NCT00207714|584260740|FG001|Overall Study|Adverse Event|2|||
161785763|NCT00207714|584260741|FG002|Overall Study|Adverse Event|4|||
161785764|NCT00207714|584260742|FG003|Overall Study|Adverse Event|3|||
161785765|NCT00207714|584260743|FG004|Overall Study|Adverse Event|1|||
161785766|NCT00207714|584260739|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
161785767|NCT00207714|584260740|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161785768|NCT00207714|584260741|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
161785769|NCT00207714|584260742|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
161785770|NCT00207714|584260743|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
161785771|NCT00207714|584260739|FG000|Overall Study|Other|3|||
161785772|NCT00207714|584260740|FG001|Overall Study|Other|2|||
161785773|NCT00207714|584260741|FG002|Overall Study|Other|5|||
161785774|NCT00207714|584260742|FG003|Overall Study|Other|1|||
161785775|NCT00207714|584260743|FG004|Overall Study|Other|0|||
161785776|NCT03627195|584260744|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
161785777|NCT03627195|584260745|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161785778|NCT03627195|584260746|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161785779|NCT03627195|584260747|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161785780|NCT03627195|584260748|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161785781|NCT03627195|584260749|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161785782|NCT02595528|584260751|FG000|Overall Study|Withdrawal by Subject|1|||
161785783|NCT02595528|584260752|FG001|Overall Study|Withdrawal by Subject|2|||
161785784|NCT02595528|584260753|FG002|Overall Study|Withdrawal by Subject|1|||
161785785|NCT02595528|584260754|FG003|Overall Study|Withdrawal by Subject|3|||
161785786|NCT02595528|584260751|FG000|Overall Study|Lost to Follow-up|1|||
161785787|NCT02595528|584260752|FG001|Overall Study|Lost to Follow-up|1|||
161785788|NCT02595528|584260753|FG002|Overall Study|Lost to Follow-up|0|||
161785789|NCT02595528|584260754|FG003|Overall Study|Lost to Follow-up|1|||
161785790|NCT03202511|584260755|FG000|Overall Study|Withdrawal by Subject|1|||
161785791|NCT03202511|584260756|FG001|Overall Study|Withdrawal by Subject|0|||
161785792|NCT00686790|584260757|FG000|Overall Study|Adverse Event|2|||
161785793|NCT00686790|584260757|FG000|Overall Study|Withdrawal by Subject|1|||
161785794|NCT00686790|584260757|FG000|Overall Study|Death|1|||
161785795|NCT00686790|584260757|FG000|Overall Study|Lost to Follow-up|12|||
161785796|NCT00096382|584260760|FG000|Overall Study|Not treated|1|||
161785797|NCT00096382|584260761|FG001|Overall Study|Not treated|0|||
161785798|NCT00096382|584260760|FG000|Overall Study|Death during treatment|1|||
161785799|NCT00096382|584260761|FG001|Overall Study|Death during treatment|0|||
161785800|NCT03862625|584260762|FG000|Overall Study|Lost to Follow-up|0|||
161785801|NCT03862625|584260763|FG001|Overall Study|Lost to Follow-up|1|||
161785802|NCT02082912|584260764|FG000|Overall Study|Physician Decision|0|||
161785803|NCT02082912|584260765|FG001|Overall Study|Physician Decision|1|||
161785804|NCT02614703|584260766|FG000|Overall Study|Withdrawal by Subject|7|||
161785805|NCT02614703|584260767|FG001|Overall Study|Withdrawal by Subject|1|||
161785806|NCT01977352|584260776|FG000|Overall Study|Lost to Follow-up|1|||
161785807|NCT01977352|584260777|FG001|Overall Study|Lost to Follow-up|2|||
161785808|NCT00409188|584260783|FG000|Overall Study|Ongoing at data cut-off|383|||
161785809|NCT00409188|584260784|FG001|Overall Study|Ongoing at data cut-off|175|||
161785810|NCT01835132|584260785|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
161785811|NCT00856778|584260786|FG000|Overall Study|Adverse Event|7|||
161785812|NCT00856778|584260786|FG000|Overall Study|Withdrawal by Subject|10|||
161785813|NCT00856778|584260786|FG000|Overall Study|Study deviation|2|||
161785814|NCT00856778|584260786|FG000|Overall Study|Lost to Follow-up|5|||
161785815|NCT01681771|584260787|FG000|Overall Study|Lost to Follow-up|4|||
161785816|NCT01681771|584260788|FG001|Overall Study|Lost to Follow-up|2|||
161785817|NCT00265083|584260789|FG000|Overall Study|Adverse Event|5|||
161785818|NCT00265083|584260790|FG001|Overall Study|Adverse Event|13|||
161785819|NCT00265083|584260791|FG002|Overall Study|Adverse Event|15|||
161785820|NCT00265083|584260789|FG000|Overall Study|Lost to Follow-up|3|||
161785821|NCT00265083|584260790|FG001|Overall Study|Lost to Follow-up|4|||
161785822|NCT00265083|584260791|FG002|Overall Study|Lost to Follow-up|4|||
161785823|NCT00265083|584260789|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
161785824|NCT00265083|584260790|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
161785825|NCT00265083|584260791|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
161785826|NCT00265083|584260789|FG000|Overall Study|Other|1|||
161785827|NCT00265083|584260790|FG001|Overall Study|Other|12|||
161785828|NCT00265083|584260791|FG002|Overall Study|Other|9|||
161785829|NCT03208933|584260795|FG000|Overall Study|Death|3|||
161785830|NCT03208933|584260795|FG000|Overall Study|Withdrawal by Subject|3|||
161785831|NCT03208933|584260795|FG000|Overall Study|Adverse Event|1|||
161785832|NCT03208933|584260795|FG000|Overall Study|Lost to Follow-up|2|||
161785833|NCT03208933|584260795|FG000|Overall Study|Physician Decision|3|||
161785834|NCT03208933|584260795|FG000|Overall Study|Protocol Violation|1|||
161785835|NCT00854620|584260796|FG000|Overall Study|Adverse Event|1|||
161785836|NCT04242186|584260800|FG000|Overall Study|Death|5|||
161785837|NCT00782275|584260803|FG000|Overall Study|Adverse Event|11|||
162126197|NCT02269943|585511451|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
161785838|NCT00782275|584260803|FG000|Overall Study|Withdrawal by Subject|1|||
161785839|NCT00782275|584260803|FG000|Overall Study|Progressive Disease|21|||
161785840|NCT00782275|584260803|FG000|Overall Study|Physician Decision|4|||
161785841|NCT00782275|584260803|FG000|Overall Study|Not started treatment|1|||
161785842|NCT00782275|584260803|FG000|Overall Study|Other|3|||
161785843|NCT04378010|584260804|FG000|Overall Study|Adverse Event|8|||
161785844|NCT04378010|584260805|FG001|Overall Study|Adverse Event|14|||
161785845|NCT04378010|584260806|FG002|Overall Study|Adverse Event|4|||
161785846|NCT04378010|584260804|FG000|Overall Study|Withdrawal by Subject|0|||
161785847|NCT04378010|584260805|FG001|Overall Study|Withdrawal by Subject|2|||
161785848|NCT04378010|584260806|FG002|Overall Study|Withdrawal by Subject|1|||
161785849|NCT04378010|584260804|FG000|Overall Study|Protocol Violation|2|||
161785850|NCT04378010|584260805|FG001|Overall Study|Protocol Violation|1|||
161785851|NCT04378010|584260806|FG002|Overall Study|Protocol Violation|4|||
161785852|NCT04378010|584260804|FG000|Overall Study|Study terminated by Sponsor|22|||
161785853|NCT04378010|584260805|FG001|Overall Study|Study terminated by Sponsor|16|||
161785854|NCT04378010|584260806|FG002|Overall Study|Study terminated by Sponsor|22|||
161785855|NCT04378010|584260804|FG000|Overall Study|Subject inability to complete study visit|0|||
161785856|NCT04378010|584260805|FG001|Overall Study|Subject inability to complete study visit|0|||
161785857|NCT04378010|584260806|FG002|Overall Study|Subject inability to complete study visit|1|||
161785858|NCT04378010|584260804|FG000|Overall Study|Subject never dosed|0|||
161785859|NCT04378010|584260805|FG001|Overall Study|Subject never dosed|1|||
161785860|NCT04378010|584260806|FG002|Overall Study|Subject never dosed|0|||
161785861|NCT01792284|584260807|FG000|Lead-in Period|Adverse Event|15|||
161785862|NCT01792284|584260808|FG001|Lead-in Period|Adverse Event|0|||
161785863|NCT01792284|584260809|FG002|Lead-in Period|Adverse Event|0|||
161785864|NCT01792284|584260807|FG000|Lead-in Period|Lost to Follow-up|2|||
161785865|NCT01792284|584260808|FG001|Lead-in Period|Lost to Follow-up|0|||
161785866|NCT01792284|584260809|FG002|Lead-in Period|Lost to Follow-up|0|||
161785867|NCT01792284|584260807|FG000|Lead-in Period|Protocol Violation|1|||
161785868|NCT01792284|584260808|FG001|Lead-in Period|Protocol Violation|0|||
161785869|NCT01792284|584260809|FG002|Lead-in Period|Protocol Violation|0|||
161785870|NCT01792284|584260807|FG000|Lead-in Period|Withdrawal by Subject|10|||
161785871|NCT01792284|584260808|FG001|Lead-in Period|Withdrawal by Subject|0|||
161785872|NCT01792284|584260809|FG002|Lead-in Period|Withdrawal by Subject|0|||
161785873|NCT01792284|584260807|FG000|Lead-in Period|Physician Decision|1|||
161785874|NCT01792284|584260808|FG001|Lead-in Period|Physician Decision|0|||
161785875|NCT01792284|584260809|FG002|Lead-in Period|Physician Decision|0|||
161785876|NCT01792284|584260807|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
161785877|NCT01792284|584260808|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
161785878|NCT01792284|584260809|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
161785879|NCT01792284|584260807|FG000|Randomization Period 1|Withdrawal by Subject|0|||
161785880|NCT01792284|584260808|FG001|Randomization Period 1|Withdrawal by Subject|1|||
161785881|NCT01792284|584260809|FG002|Randomization Period 1|Withdrawal by Subject|1|||
161785882|NCT01792284|584260807|FG000|Randomization Period 1|Physician Decision|0|||
161785883|NCT01792284|584260808|FG001|Randomization Period 1|Physician Decision|1|||
161785884|NCT01792284|584260809|FG002|Randomization Period 1|Physician Decision|1|||
161785885|NCT01792284|584260807|FG000|Randomization Period 1|Adverse Event|0|||
161785886|NCT01792284|584260808|FG001|Randomization Period 1|Adverse Event|0|||
161785887|NCT01792284|584260809|FG002|Randomization Period 1|Adverse Event|2|||
161785888|NCT01792284|584260807|FG000|Randomization Period 1|Lost to Follow-up|0|||
161785889|NCT01792284|584260808|FG001|Randomization Period 1|Lost to Follow-up|0|||
161785890|NCT01792284|584260809|FG002|Randomization Period 1|Lost to Follow-up|1|||
161785891|NCT01792284|584260807|FG000|Randomization Period 2|Protocol Violation|0|||
161785892|NCT01792284|584260808|FG001|Randomization Period 2|Protocol Violation|1|||
161785893|NCT01792284|584260809|FG002|Randomization Period 2|Protocol Violation|0|||
161785894|NCT01792284|584260807|FG000|Randomization Period 2|Withdrawal by Subject|0|||
161785895|NCT01792284|584260808|FG001|Randomization Period 2|Withdrawal by Subject|2|||
161785896|NCT01792284|584260809|FG002|Randomization Period 2|Withdrawal by Subject|0|||
161785897|NCT02019979|584260810|FG000|Overall Study|study terminated|14|||
161785898|NCT00379587|584260812|FG000|Overall Study|Lost to Follow-up|2|||
161785899|NCT03237611|584260813|FG000|Overall Study|Withdrawal by Subject|1|||
161785900|NCT03237611|584260813|FG000|Overall Study|Ineligible|1|||
161785901|NCT00275028|584260817|FG000|Overall Study|Withdrew consent before treatment began|1|||
161785902|NCT00275028|584260817|FG000|Overall Study|Withdrawal by Subject|5|||
161785903|NCT00275028|584260817|FG000|Overall Study|Adverse Event|9|||
162010394|NCT03866577|585093741|FG002|Overall Study|Not qualified for IVIg infusion|0|||
162010395|NCT03866577|585093742|FG003|Overall Study|Not qualified for IVIg infusion|0|||
162010396|NCT03866577|585093743|FG004|Overall Study|Not qualified for IVIg infusion|0|||
162010397|NCT03866577|585093744|FG005|Overall Study|Not qualified for IVIg infusion|0|||
162010398|NCT03866577|585093745|FG006|Overall Study|Not qualified for IVIg infusion|0|||
162010399|NCT03866577|585093746|FG007|Overall Study|Not qualified for IVIg infusion|0|||
162010400|NCT03866577|585093747|FG008|Overall Study|Not qualified for IVIg infusion|0|||
162010401|NCT03866577|585093748|FG009|Overall Study|Not qualified for IVIg infusion|1|||
162010402|NCT03866577|585093749|FG010|Overall Study|Not qualified for IVIg infusion|0|||
162010403|NCT03866577|585093750|FG011|Overall Study|Not qualified for IVIg infusion|0|||
162010404|NCT03866577|585093751|FG012|Overall Study|Not qualified for IVIg infusion|0|||
162010405|NCT04825678|585093752|FG000|Overall Study|Decision by Sponsor|2|||
162010406|NCT04825678|585093753|FG001|Overall Study|Decision by Sponsor|3|||
162010407|NCT04825678|585093752|FG000|Overall Study|Withdrawal of Consent From Study|7|||
162010408|NCT04825678|585093753|FG001|Overall Study|Withdrawal of Consent From Study|9|||
162010409|NCT04825678|585093752|FG000|Overall Study|Lost to Follow-up|3|||
161785904|NCT00275028|584260817|FG000|Overall Study|Progressive Disease|30|||
161785905|NCT00275028|584260817|FG000|Overall Study|Physician Decision|2|||
161785906|NCT04356573|584260826|FG000|Overall Study|Didn't Qualify|1|||
161785907|NCT04356573|584260827|FG001|Overall Study|Didn't Qualify|0|||
162010410|NCT04825678|585093753|FG001|Overall Study|Lost to Follow-up|4|||
162010411|NCT04825678|585093752|FG000|Overall Study|Never Received Investigational Product|1|||
162010412|NCT04825678|585093753|FG001|Overall Study|Never Received Investigational Product|1|||
161785908|NCT01244815|584260830|FG000|Overall Study|Not Treated|0|||
161785909|NCT01244815|584260831|FG001|Overall Study|Not Treated|1|||
161785910|NCT01244815|584260832|FG002|Overall Study|Not Treated|0|||
161785911|NCT01244815|584260833|FG003|Overall Study|Not Treated|0|||
161785912|NCT01244815|584260830|FG000|Overall Study|Adverse Event|4|||
161785913|NCT01244815|584260831|FG001|Overall Study|Adverse Event|7|||
161785914|NCT01244815|584260832|FG002|Overall Study|Adverse Event|5|||
161785915|NCT01244815|584260833|FG003|Overall Study|Adverse Event|5|||
161785916|NCT01244815|584260830|FG000|Overall Study|Treatment Failure|0|||
161785917|NCT01244815|584260831|FG001|Overall Study|Treatment Failure|0|||
161785918|NCT01244815|584260832|FG002|Overall Study|Treatment Failure|0|||
161785919|NCT01244815|584260833|FG003|Overall Study|Treatment Failure|1|||
161785920|NCT01244815|584260830|FG000|Overall Study|Lost to Follow-up|3|||
161785921|NCT01244815|584260831|FG001|Overall Study|Lost to Follow-up|2|||
161785922|NCT01244815|584260832|FG002|Overall Study|Lost to Follow-up|3|||
161785923|NCT01244815|584260833|FG003|Overall Study|Lost to Follow-up|2|||
161785924|NCT01244815|584260830|FG000|Overall Study|Withdrawal by Subject|0|||
161785925|NCT01244815|584260831|FG001|Overall Study|Withdrawal by Subject|2|||
161785926|NCT01244815|584260832|FG002|Overall Study|Withdrawal by Subject|0|||
161785927|NCT01244815|584260833|FG003|Overall Study|Withdrawal by Subject|3|||
161785928|NCT01244815|584260830|FG000|Overall Study|Protocol Violation|7|||
161785929|NCT01244815|584260831|FG001|Overall Study|Protocol Violation|4|||
161785930|NCT01244815|584260832|FG002|Overall Study|Protocol Violation|3|||
161785931|NCT01244815|584260833|FG003|Overall Study|Protocol Violation|1|||
161785932|NCT01244815|584260830|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
161785933|NCT01244815|584260831|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
161898502|NCT00103285|584677793|FG002|Response Assignment|Other|48|||
161898503|NCT00103285|584677794|FG003|Response Assignment|Other|38|||
161898504|NCT00103285|584677795|FG004|Response Assignment|Other|37|||
161898505|NCT00103285|584677796|FG005|Response Assignment|Other|17|||
161898506|NCT00103285|584677797|FG006|Response Assignment|Other|11|||
161898507|NCT00103285|584677798|FG007|Response Assignment|Other|53|||
161898508|NCT03654729|584677812|FG000|Overall Study|Death|9|||
161898509|NCT03654729|584677813|FG001|Overall Study|Death|9|||
161898510|NCT03654729|584677814|FG002|Overall Study|Death|16|||
161898511|NCT03654729|584677812|FG000|Overall Study|Withdrawal by Subject|8|||
161898512|NCT03654729|584677813|FG001|Overall Study|Withdrawal by Subject|6|||
161898513|NCT03654729|584677814|FG002|Overall Study|Withdrawal by Subject|4|||
161785934|NCT01244815|584260832|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
161785935|NCT01244815|584260833|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
161785936|NCT02041494|584260835|FG000|Overall Study|Death|1|||
161785937|NCT02041494|584260836|FG001|Overall Study|Death|3|||
161785938|NCT02041494|584260835|FG000|Overall Study|Lost to Follow-up|2|||
161785939|NCT02041494|584260836|FG001|Overall Study|Lost to Follow-up|6|||
161785940|NCT02041494|584260835|FG000|Overall Study|study terminated|16|||
161785941|NCT02041494|584260836|FG001|Overall Study|study terminated|11|||
161785942|NCT02487979|584260841|FG000|Overall Study|Physician Decision|2|||
161785943|NCT02487979|584260841|FG000|Overall Study|Withdrawal by Subject|2|||
161785944|NCT02487979|584260841|FG000|Overall Study|Progressive Disease|17|||
161785945|NCT02410837|584260842|FG000|Overall Study|Death|387|||
161785946|NCT02410837|584260842|FG000|Overall Study|Lost to Follow-up|50|||
161785947|NCT02410837|584260842|FG000|Overall Study|Withdrawal by Subject|44|||
161785948|NCT02410837|584260842|FG000|Overall Study|Physician Decision|6|||
161785949|NCT02410837|584260842|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
161785950|NCT00849524|584260847|FG000|Overall Study|Lack of Efficacy|3|||
161785951|NCT01825876|584260848|FG000|Period 2|Withdrawal by Subject|0|||
161785952|NCT01825876|584260849|FG001|Period 2|Withdrawal by Subject|1|||
161785953|NCT01027884|584260853|FG000|Overall Study|Adverse Event|2|||
161785954|NCT01027884|584260854|FG001|Overall Study|Adverse Event|1|||
161785955|NCT01027884|584260853|FG000|Overall Study|Protocol Violation|1|||
161785956|NCT01027884|584260854|FG001|Overall Study|Protocol Violation|0|||
161785957|NCT01027884|584260853|FG000|Overall Study|Non-compliance|1|||
161785958|NCT01027884|584260854|FG001|Overall Study|Non-compliance|1|||
161785959|NCT01027884|584260853|FG000|Overall Study|Withdrawal by Subject|0|||
161785960|NCT01027884|584260854|FG001|Overall Study|Withdrawal by Subject|1|||
161785961|NCT01027884|584260853|FG000|Overall Study|Lost to Follow-up|0|||
161898514|NCT03654729|584677812|FG000|Overall Study|Study terminated by Sponsor|3|||
161898515|NCT03654729|584677813|FG001|Overall Study|Study terminated by Sponsor|5|||
161785962|NCT01027884|584260854|FG001|Overall Study|Lost to Follow-up|1|||
161785963|NCT01027884|584260853|FG000|Overall Study|Spinal fixation surgery|0|||
161785964|NCT01027884|584260854|FG001|Overall Study|Spinal fixation surgery|3|||
161785965|NCT03636542|584260856|FG000|Overall Study|Lost to Follow-up|1|||
161785966|NCT03636542|584260857|FG001|Overall Study|Lost to Follow-up|1|||
161785967|NCT03636542|584260856|FG000|Overall Study|Physician Decision|0|||
161898516|NCT03654729|584677814|FG002|Overall Study|Study terminated by Sponsor|4|||
161898517|NCT03654729|584677812|FG000|Overall Study|Not reported|2|||
161785968|NCT03636542|584260857|FG001|Overall Study|Physician Decision|1|||
161785969|NCT03636542|584260856|FG000|Overall Study|Withdrawal by Subject|1|||
161898518|NCT03654729|584677813|FG001|Overall Study|Not reported|4|||
161898519|NCT03654729|584677814|FG002|Overall Study|Not reported|5|||
161785970|NCT03636542|584260857|FG001|Overall Study|Withdrawal by Subject|0|||
161785971|NCT00845026|584260858|FG000|Study Period III|Adverse Event|23|||
161785972|NCT00845026|584260859|FG001|Study Period III|Adverse Event|19|||
161785973|NCT00845026|584260858|FG000|Study Period III|Perceived lack of efficacy|27|||
161785974|NCT00845026|584260859|FG001|Study Period III|Perceived lack of efficacy|15|||
161785975|NCT00845026|584260858|FG000|Study Period III|Withdrawal by Subject|19|||
161785976|NCT00845026|584260859|FG001|Study Period III|Withdrawal by Subject|15|||
161785977|NCT00845026|584260858|FG000|Study Period III|Entry Criteria not met|8|||
161785978|NCT00845026|584260859|FG001|Study Period III|Entry Criteria not met|11|||
161785979|NCT00845026|584260858|FG000|Study Period III|Lost to Follow-up|4|||
161785980|NCT00845026|584260859|FG001|Study Period III|Lost to Follow-up|5|||
161785981|NCT00845026|584260858|FG000|Study Period III|Protocol Violation|8|||
161785982|NCT00845026|584260859|FG001|Study Period III|Protocol Violation|1|||
161785983|NCT00845026|584260858|FG000|Study Period III|Scheduled conflict|3|||
161785984|NCT00845026|584260859|FG001|Study Period III|Scheduled conflict|1|||
161785985|NCT00845026|584260858|FG000|Study Period III|Subject is moving or has moved|2|||
161785986|NCT00845026|584260859|FG001|Study Period III|Subject is moving or has moved|4|||
161785987|NCT00845026|584260858|FG000|Study Period III|Transportation issues|1|||
161785988|NCT00845026|584260859|FG001|Study Period III|Transportation issues|1|||
161785989|NCT00845026|584260858|FG000|Study Period IV|Adverse Event|4|||
161785990|NCT00845026|584260859|FG001|Study Period IV|Adverse Event|0|||
161785991|NCT00845026|584260858|FG000|Study Period IV|Perceived lack of efficacy|2|||
161785992|NCT00845026|584260859|FG001|Study Period IV|Perceived lack of efficacy|1|||
161785993|NCT00845026|584260858|FG000|Study Period IV|Protocol Violation|3|||
161785994|NCT00845026|584260859|FG001|Study Period IV|Protocol Violation|1|||
161785995|NCT00845026|584260858|FG000|Study Period IV|Lost to Follow-up|1|||
161785996|NCT00845026|584260859|FG001|Study Period IV|Lost to Follow-up|0|||
161785997|NCT00845026|584260858|FG000|Study Period IV|Withdrawal by Subject|4|||
161785998|NCT00845026|584260859|FG001|Study Period IV|Withdrawal by Subject|1|||
161785999|NCT00845026|584260858|FG000|Study Period IV|Entry Criteria Not Met|1|||
161786000|NCT00845026|584260859|FG001|Study Period IV|Entry Criteria Not Met|0|||
161786001|NCT00845026|584260858|FG000|Study Period IV|Subject is moving or has moved|0|||
161786002|NCT00845026|584260859|FG001|Study Period IV|Subject is moving or has moved|1|||
161786003|NCT00845026|584260858|FG000|Study Period IV|Scheduling conflict|1|||
161786004|NCT00845026|584260859|FG001|Study Period IV|Scheduling conflict|0|||
161786005|NCT01325532|584260860|FG000|Overall Study|Withdrawal by Subject|2|||
161786006|NCT01325532|584260861|FG001|Overall Study|Withdrawal by Subject|0|||
161786007|NCT04556838|584260868|FG000|Overall Study|Withdrawal by Subject|3|||
161786008|NCT04556838|584260869|FG001|Overall Study|Withdrawal by Subject|1|||
161786009|NCT04556838|584260870|FG002|Overall Study|Withdrawal by Subject|2|||
161786010|NCT04556838|584260868|FG000|Overall Study|Adverse Event|0|||
161786011|NCT04556838|584260869|FG001|Overall Study|Adverse Event|1|||
161786012|NCT04556838|584260870|FG002|Overall Study|Adverse Event|1|||
161786013|NCT04556838|584260868|FG000|Overall Study|Lost to Follow-up|0|||
161786014|NCT04556838|584260869|FG001|Overall Study|Lost to Follow-up|0|||
161786015|NCT04556838|584260870|FG002|Overall Study|Lost to Follow-up|2|||
161786016|NCT04556838|584260868|FG000|Overall Study|Subject travel|0|||
161786017|NCT04556838|584260869|FG001|Overall Study|Subject travel|1|||
162126198|NCT02269943|585511450|FG000|Follow-Up Survival Period|Alive|2|||
162126199|NCT02269943|585511451|FG001|Follow-Up Survival Period|Alive|8|||
162126200|NCT02066532|585511456|FG000|Phase II|Withdrawal by Subject|1|||
162126201|NCT02066532|585511457|FG001|Phase II|Withdrawal by Subject|0|||
162126202|NCT02066532|585511458|FG002|Phase II|Withdrawal by Subject|0|||
162126203|NCT02066532|585511459|FG003|Phase II|Withdrawal by Subject|0|||
162126204|NCT05033080|585511460|FG000|Overall Study|Adverse Event|4|||
162126205|NCT05033080|585511461|FG001|Overall Study|Adverse Event|4|||
162126206|NCT05033080|585511460|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
162126207|NCT05033080|585511461|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
162126208|NCT05033080|585511460|FG000|Overall Study|Lost to Follow-up|1|||
162126209|NCT05033080|585511461|FG001|Overall Study|Lost to Follow-up|0|||
162126210|NCT05033080|585511460|FG000|Overall Study|Other non-compliance|0|||
162126211|NCT05033080|585511461|FG001|Overall Study|Other non-compliance|1|||
162126212|NCT05033080|585511460|FG000|Overall Study|Physician Decision|0|||
162126213|NCT05033080|585511461|FG001|Overall Study|Physician Decision|1|||
162126214|NCT05033080|585511460|FG000|Overall Study|Other|1|||
161786018|NCT04556838|584260870|FG002|Overall Study|Subject travel|0|||
161786019|NCT04556838|584260868|FG000|Overall Study|Physician Decision|1|||
161786020|NCT04556838|584260869|FG001|Overall Study|Physician Decision|0|||
161786021|NCT04556838|584260870|FG002|Overall Study|Physician Decision|0|||
162126215|NCT05033080|585511461|FG001|Overall Study|Other|1|||
162126216|NCT05376371|585511462|FG000|Overall Study|change in release date|10|||
162126217|NCT03560245|585511463|FG000|Overall Study|Withdrawal by Subject|3|||
161786022|NCT01458119|584260871|FG000|Overall Study|Physician Decision|4|||
161786023|NCT01458119|584260871|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
162126218|NCT03560245|585511464|FG001|Overall Study|Withdrawal by Subject|2|||
162126219|NCT03560245|585511463|FG000|Overall Study|Adverse Event|1|||
162126220|NCT03560245|585511464|FG001|Overall Study|Adverse Event|1|||
161786024|NCT01458119|584260871|FG000|Overall Study|Pregnancy|1|||
161786025|NCT01458119|584260871|FG000|Overall Study|Death|2|||
161786026|NCT01458119|584260871|FG000|Overall Study|Adverse Event|1|||
161786027|NCT01458119|584260871|FG000|Overall Study|Consent Withdrawn by Participant|8|||
161786028|NCT01458119|584260871|FG000|Overall Study|Non-compliance With Study Drug|3|||
161786029|NCT00382291|584263155|FG000|Overall Study|Adverse Event|1|||
161786030|NCT00382291|584263156|FG001|Overall Study|Adverse Event|2|||
161786031|NCT00382291|584263157|FG002|Overall Study|Adverse Event|2|||
161786032|NCT00382291|584263155|FG000|Overall Study|Protocol Violation|1|||
161786033|NCT00382291|584263156|FG001|Overall Study|Protocol Violation|0|||
161786034|NCT00382291|584263157|FG002|Overall Study|Protocol Violation|0|||
161786035|NCT00382291|584263155|FG000|Overall Study|Temporary study suspension|2|||
161786036|NCT00382291|584263156|FG001|Overall Study|Temporary study suspension|2|||
161786037|NCT00382291|584263157|FG002|Overall Study|Temporary study suspension|5|||
161786038|NCT00382291|584263155|FG000|Overall Study|Withdrawal by Subject|0|||
161786039|NCT00382291|584263156|FG001|Overall Study|Withdrawal by Subject|2|||
161786040|NCT00382291|584263157|FG002|Overall Study|Withdrawal by Subject|0|||
161786041|NCT00382291|584263155|FG000|Overall Study|Physician Decision|0|||
161786042|NCT00382291|584263156|FG001|Overall Study|Physician Decision|1|||
161786043|NCT00382291|584263157|FG002|Overall Study|Physician Decision|0|||
161786044|NCT00382291|584263155|FG000|Overall Study|Lack of Efficacy|0|||
161786045|NCT00382291|584263156|FG001|Overall Study|Lack of Efficacy|0|||
161786046|NCT00382291|584263157|FG002|Overall Study|Lack of Efficacy|1|||
161786047|NCT01326702|584263158|FG000|Overall Study|Other|1|||
161786048|NCT01326702|584263159|FG001|Overall Study|Other|0|||
161786049|NCT01326702|584263160|FG002|Overall Study|Other|0|||
161786050|NCT01326702|584263161|FG003|Overall Study|Other|0|||
161786051|NCT01326702|584263162|FG004|Overall Study|Other|0|||
161786052|NCT01326702|584263163|FG005|Overall Study|Other|1|||
161786053|NCT01326702|584263164|FG006|Overall Study|Other|0|||
161786054|NCT01326702|584263158|FG000|Overall Study|progressive disease|1|||
161786055|NCT01326702|584263159|FG001|Overall Study|progressive disease|1|||
161786056|NCT01326702|584263160|FG002|Overall Study|progressive disease|3|||
161786057|NCT01326702|584263161|FG003|Overall Study|progressive disease|1|||
161786058|NCT01326702|584263162|FG004|Overall Study|progressive disease|3|||
161786059|NCT01326702|584263163|FG005|Overall Study|progressive disease|2|||
161786060|NCT01326702|584263164|FG006|Overall Study|progressive disease|3|||
161786061|NCT01326702|584263158|FG000|Overall Study|Death|0|||
161786062|NCT01326702|584263159|FG001|Overall Study|Death|1|||
161786063|NCT01326702|584263160|FG002|Overall Study|Death|0|||
161786064|NCT01326702|584263161|FG003|Overall Study|Death|0|||
161786065|NCT01326702|584263162|FG004|Overall Study|Death|0|||
161786066|NCT01326702|584263163|FG005|Overall Study|Death|0|||
161786067|NCT01326702|584263164|FG006|Overall Study|Death|0|||
161786068|NCT01326702|584263158|FG000|Overall Study|Adverse Event|0|||
161786069|NCT01326702|584263159|FG001|Overall Study|Adverse Event|0|||
161786070|NCT01326702|584263160|FG002|Overall Study|Adverse Event|1|||
161786071|NCT01326702|584263161|FG003|Overall Study|Adverse Event|1|||
161786072|NCT01326702|584263162|FG004|Overall Study|Adverse Event|0|||
161786073|NCT01326702|584263163|FG005|Overall Study|Adverse Event|3|||
161786074|NCT01326702|584263164|FG006|Overall Study|Adverse Event|1|||
161786075|NCT01326702|584263158|FG000|Overall Study|Withdrawal by Subject|0|||
161786076|NCT01326702|584263159|FG001|Overall Study|Withdrawal by Subject|0|||
161786077|NCT01326702|584263160|FG002|Overall Study|Withdrawal by Subject|1|||
161786078|NCT01326702|584263161|FG003|Overall Study|Withdrawal by Subject|0|||
161786079|NCT01326702|584263162|FG004|Overall Study|Withdrawal by Subject|1|||
161786080|NCT01326702|584263163|FG005|Overall Study|Withdrawal by Subject|1|||
161786081|NCT01326702|584263164|FG006|Overall Study|Withdrawal by Subject|3|||
161786082|NCT01326702|584263158|FG000|Overall Study|Not Treated|0|||
161786083|NCT01326702|584263159|FG001|Overall Study|Not Treated|0|||
161786084|NCT01326702|584263160|FG002|Overall Study|Not Treated|0|||
161786085|NCT01326702|584263161|FG003|Overall Study|Not Treated|1|||
161786086|NCT01326702|584263162|FG004|Overall Study|Not Treated|0|||
161786087|NCT01326702|584263163|FG005|Overall Study|Not Treated|1|||
161786088|NCT01326702|584263164|FG006|Overall Study|Not Treated|0|||
161786089|NCT02266706|584263165|FG000|Overall Study|Withdrawal by Subject|0|||
161786090|NCT02266706|584263166|FG001|Overall Study|Withdrawal by Subject|1|||
161786091|NCT02266706|584263167|FG002|Overall Study|Withdrawal by Subject|1|||
161786092|NCT02266706|584263168|FG003|Overall Study|Withdrawal by Subject|0|||
161786093|NCT02266706|584263169|FG004|Overall Study|Withdrawal by Subject|0|||
161786094|NCT02266706|584263170|FG005|Overall Study|Withdrawal by Subject|1|||
161786095|NCT02266706|584263171|FG006|Overall Study|Withdrawal by Subject|0|||
161786096|NCT02266706|584263172|FG007|Overall Study|Withdrawal by Subject|0|||
161786097|NCT02266706|584263173|FG008|Overall Study|Withdrawal by Subject|0|||
161786098|NCT02266706|584263165|FG000|Overall Study|Screen failure|0|||
161786099|NCT02266706|584263166|FG001|Overall Study|Screen failure|0|||
161786100|NCT02266706|584263167|FG002|Overall Study|Screen failure|0|||
161786101|NCT02266706|584263168|FG003|Overall Study|Screen failure|0|||
161786102|NCT02266706|584263169|FG004|Overall Study|Screen failure|0|||
161786103|NCT02266706|584263170|FG005|Overall Study|Screen failure|1|||
161786104|NCT02266706|584263171|FG006|Overall Study|Screen failure|1|||
161786105|NCT02266706|584263172|FG007|Overall Study|Screen failure|0|||
161786106|NCT02266706|584263173|FG008|Overall Study|Screen failure|0|||
161786107|NCT02266706|584263165|FG000|Overall Study|Enrollment in another study|0|||
161786108|NCT02266706|584263166|FG001|Overall Study|Enrollment in another study|0|||
161786109|NCT02266706|584263167|FG002|Overall Study|Enrollment in another study|0|||
161786110|NCT02266706|584263168|FG003|Overall Study|Enrollment in another study|1|||
161786111|NCT02266706|584263169|FG004|Overall Study|Enrollment in another study|0|||
161786112|NCT02266706|584263170|FG005|Overall Study|Enrollment in another study|0|||
161786113|NCT02266706|584263171|FG006|Overall Study|Enrollment in another study|0|||
161786114|NCT02266706|584263172|FG007|Overall Study|Enrollment in another study|0|||
161786115|NCT02266706|584263173|FG008|Overall Study|Enrollment in another study|0|||
161786116|NCT02270983|584263174|FG000|Overall Study|Adverse Event|3|||
161786117|NCT02270983|584263175|FG001|Overall Study|Adverse Event|2|||
161786118|NCT02270983|584263176|FG002|Overall Study|Adverse Event|6|||
161786119|NCT02270983|584263174|FG000|Overall Study|Lack of Efficacy|2|||
161786120|NCT02270983|584263175|FG001|Overall Study|Lack of Efficacy|1|||
161786121|NCT02270983|584263176|FG002|Overall Study|Lack of Efficacy|1|||
161786122|NCT02270983|584263174|FG000|Overall Study|Withdrawal by Subject|1|||
161786123|NCT02270983|584263175|FG001|Overall Study|Withdrawal by Subject|0|||
161786124|NCT02270983|584263176|FG002|Overall Study|Withdrawal by Subject|2|||
161786125|NCT02270983|584263174|FG000|Overall Study|Lost to Follow-up|1|||
161786126|NCT02270983|584263175|FG001|Overall Study|Lost to Follow-up|1|||
161786127|NCT02270983|584263176|FG002|Overall Study|Lost to Follow-up|2|||
161786128|NCT02270983|584263174|FG000|Overall Study|Protocol Violation|1|||
161786129|NCT02270983|584263175|FG001|Overall Study|Protocol Violation|1|||
161786130|NCT02270983|584263176|FG002|Overall Study|Protocol Violation|1|||
161786131|NCT02270983|584263174|FG000|Overall Study|family emergency|0|||
161786132|NCT02270983|584263175|FG001|Overall Study|family emergency|1|||
161786133|NCT02270983|584263176|FG002|Overall Study|family emergency|0|||
161786134|NCT02270983|584263174|FG000|Overall Study|study procedure non-compliance|1|||
161786135|NCT02270983|584263175|FG001|Overall Study|study procedure non-compliance|0|||
161786136|NCT02270983|584263176|FG002|Overall Study|study procedure non-compliance|0|||
161786137|NCT02270983|584263174|FG000|Overall Study|moved away from study site|0|||
161786138|NCT02270983|584263175|FG001|Overall Study|moved away from study site|1|||
161786139|NCT02270983|584263176|FG002|Overall Study|moved away from study site|0|||
161786140|NCT04741503|584263180|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
161786141|NCT04741503|584263181|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
161786142|NCT04741503|584263182|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
161786143|NCT04741503|584263180|FG000|Initial Enrollment|Overquotas removed|0|||
161786144|NCT04741503|584263181|FG001|Initial Enrollment|Overquotas removed|0|||
161786145|NCT04741503|584263182|FG002|Initial Enrollment|Overquotas removed|186|||
161786146|NCT04741503|584263180|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
161786147|NCT04741503|584263181|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
161786148|NCT04741503|584263182|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
161786149|NCT03840811|584263185|FG000|Overall Study|Lost to Follow-up|0|||
161786150|NCT03840811|584263186|FG001|Overall Study|Lost to Follow-up|0|||
161786151|NCT03840811|584263187|FG002|Overall Study|Lost to Follow-up|1|||
161786152|NCT04313283|584263190|FG000|Overall Study|did not complete intervention|4|||
161786153|NCT04126733|584263191|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
161786154|NCT04126733|584263191|FG000|Treatment Period|Adverse Event|8|||
161786155|NCT04126733|584263191|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
161786156|NCT04126733|584263191|FG000|Treatment Period|Physician Decision|5|||
161786157|NCT04126733|584263191|FG000|Treatment Period|Death|1|||
161786158|NCT04126733|584263191|FG000|Treatment Period|Other Reasons|2|||
161786159|NCT04126733|584263191|FG000|Active Follow-up Period|Death|13|||
161786160|NCT04126733|584263191|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
161786161|NCT04126733|584263191|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
161786162|NCT04126733|584263191|FG000|Active Follow-up Period|Other Reasons|1|||
161786163|NCT04126733|584263191|FG000|Long-term Follow-up Period|Death|22|||
161786164|NCT04126733|584263191|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
161786165|NCT04126733|584263191|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
161786166|NCT00837577|584263192|FG000|Double-blind Period|Clinical Adverse Event|1|||
161786167|NCT00837577|584263193|FG001|Double-blind Period|Clinical Adverse Event|0|||
161786168|NCT00837577|584263192|FG000|Double-blind Period|Withdrawal by Subject|1|||
161786169|NCT00837577|584263193|FG001|Double-blind Period|Withdrawal by Subject|0|||
161786170|NCT00837577|584263192|FG000|Open-label Period|Clinical Adverse Event|2|||
161786171|NCT00837577|584263193|FG001|Open-label Period|Clinical Adverse Event|2|||
161786172|NCT00837577|584263192|FG000|Open-label Period|Laboratory Adverse Event|0|||
161786173|NCT00837577|584263193|FG001|Open-label Period|Laboratory Adverse Event|1|||
161786174|NCT00837577|584263192|FG000|Open-label Period|Lack of Efficacy|4|||
161786175|NCT00837577|584263193|FG001|Open-label Period|Lack of Efficacy|3|||
161786176|NCT00837577|584263192|FG000|Open-label Period|Withdrawal by Subject|1|||
162126221|NCT03560245|585511463|FG000|Overall Study|Protocol Violation|1|||
162126222|NCT03560245|585511464|FG001|Overall Study|Protocol Violation|0|||
162126223|NCT03560245|585511463|FG000|Overall Study|Death|0|||
162126224|NCT03560245|585511464|FG001|Overall Study|Death|1|||
162126225|NCT03560245|585511463|FG000|Overall Study|Lost to Follow-up|0|||
162126226|NCT03560245|585511464|FG001|Overall Study|Lost to Follow-up|1|||
162126227|NCT03560245|585511463|FG000|Overall Study|Physician Decision|0|||
162126228|NCT03560245|585511464|FG001|Overall Study|Physician Decision|1|||
162126229|NCT03560245|585511463|FG000|Overall Study|Other|0|||
162126230|NCT03560245|585511464|FG001|Overall Study|Other|1|||
162126231|NCT00960752|585511469|FG000|Overall Study|Adverse Event|0|||
162126232|NCT00960752|585511470|FG001|Overall Study|Adverse Event|0|||
162126233|NCT00960752|585511471|FG002|Overall Study|Adverse Event|1|||
162126234|NCT00960752|585511469|FG000|Overall Study|Progression|0|||
162126235|NCT00960752|585511470|FG001|Overall Study|Progression|0|||
162126236|NCT00960752|585511471|FG002|Overall Study|Progression|1|||
162126237|NCT02058290|585511475|FG000|Overall Study|Protocol Violation|2|||
162126238|NCT02058290|585511476|FG001|Overall Study|Protocol Violation|1|||
162126239|NCT02058290|585511475|FG000|Overall Study|Physician Decision|1|||
162126240|NCT02058290|585511476|FG001|Overall Study|Physician Decision|0|||
162126241|NCT02058290|585511475|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
162126242|NCT02058290|585511476|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
162126243|NCT02058290|585511475|FG000|Overall Study|Withdrawal by Subject|0|||
162126244|NCT02058290|585511476|FG001|Overall Study|Withdrawal by Subject|1|||
162126245|NCT00105586|585511480|FG000|Overall Study|Adverse Event|4|||
162126246|NCT00105586|585511481|FG001|Overall Study|Adverse Event|3|||
162126247|NCT00105586|585511480|FG000|Overall Study|Physician Decision|13|||
162126248|NCT00105586|585511481|FG001|Overall Study|Physician Decision|13|||
162126249|NCT02262260|585511484|FG000|Overall Study|Adverse Event|4|||
162126250|NCT02262260|585511485|FG001|Overall Study|Adverse Event|1|||
162126251|NCT02262260|585511484|FG000|Overall Study|Withdrawal of consent|4|||
162126252|NCT02262260|585511485|FG001|Overall Study|Withdrawal of consent|2|||
162126253|NCT02262260|585511484|FG000|Overall Study|Lost to Follow-up|1|||
162126254|NCT02262260|585511485|FG001|Overall Study|Lost to Follow-up|2|||
162126255|NCT02262260|585511484|FG000|Overall Study|Protocol deviation|2|||
162126256|NCT02262260|585511485|FG001|Overall Study|Protocol deviation|5|||
162126257|NCT01794117|585511486|FG000|Overall Study|Adverse Event|1|||
162126258|NCT01794117|585511487|FG001|Overall Study|Adverse Event|0|||
162126259|NCT01794117|585511488|FG002|Overall Study|Adverse Event|0|||
162126260|NCT01794117|585511489|FG003|Overall Study|Adverse Event|0|||
162126261|NCT01794117|585511486|FG000|Overall Study|Participant noncompliance|0|||
162126262|NCT01794117|585511487|FG001|Overall Study|Participant noncompliance|1|||
162126263|NCT01794117|585511488|FG002|Overall Study|Participant noncompliance|0|||
162126264|NCT01794117|585511489|FG003|Overall Study|Participant noncompliance|0|||
162126265|NCT01794117|585511486|FG000|Overall Study|Refused further treatment|0|||
162126266|NCT01794117|585511487|FG001|Overall Study|Refused further treatment|2|||
162126267|NCT01794117|585511488|FG002|Overall Study|Refused further treatment|0|||
162126268|NCT01794117|585511489|FG003|Overall Study|Refused further treatment|0|||
162126269|NCT03406702|585511490|FG000|Overall Study|Missed Day 27 Dosing|1|||
162126270|NCT01233609|585511493|FG000|Overall Study|Death|1|||
162126271|NCT01233609|585511494|FG001|Overall Study|Death|0|||
162126272|NCT01233609|585511493|FG000|Overall Study|Lost to Follow-up|3|||
162126273|NCT01233609|585511494|FG001|Overall Study|Lost to Follow-up|1|||
162126274|NCT01233609|585511493|FG000|Overall Study|Adverse Event|2|||
162126275|NCT01233609|585511494|FG001|Overall Study|Adverse Event|1|||
162126276|NCT01233609|585511493|FG000|Overall Study|Withdrawal by Subject|3|||
162126277|NCT01233609|585511494|FG001|Overall Study|Withdrawal by Subject|0|||
162126278|NCT00735644|585511495|FG000|Overall Study|Did not receive study vaccine|0|||
162126279|NCT00735644|585511496|FG001|Overall Study|Did not receive study vaccine|1|||
162126280|NCT00735644|585511497|FG002|Overall Study|Did not receive study vaccine|0|||
162126281|NCT00735644|585511498|FG003|Overall Study|Did not receive study vaccine|0|||
162126282|NCT00735644|585511499|FG004|Overall Study|Did not receive study vaccine|0|||
162126283|NCT00735644|585511495|FG000|Overall Study|Withdrawal by Subject|0|||
162126284|NCT00735644|585511496|FG001|Overall Study|Withdrawal by Subject|1|||
162126285|NCT00735644|585511497|FG002|Overall Study|Withdrawal by Subject|1|||
162126286|NCT00735644|585511498|FG003|Overall Study|Withdrawal by Subject|1|||
162126287|NCT00735644|585511499|FG004|Overall Study|Withdrawal by Subject|0|||
162126288|NCT01040780|585512852|FG000|Overall Study|Protocol Violation|1|||
162126289|NCT01040780|585512853|FG001|Overall Study|Protocol Violation|3|||
162126290|NCT03681639|585512854|FG000|Overall Study|Death|4|||
162126291|NCT03681639|585512854|FG000|Overall Study|Lost to Follow-up|2|||
162126292|NCT03681639|585512854|FG000|Overall Study|Withdrawal by Subject|1|||
162126293|NCT03681639|585512854|FG000|Overall Study|Adverse Event|2|||
162126294|NCT00654940|585512855|FG000|Period 1|Adverse Event|0|||
162126295|NCT00654940|585512856|FG001|Period 1|Adverse Event|1|||
162126296|NCT00654940|585512855|FG000|Period 1|Intolerable Pain Level|1|||
162126297|NCT00654940|585512856|FG001|Period 1|Intolerable Pain Level|0|||
162126298|NCT00581113|585512862|FG000|Overall Study|Withdrawal by Subject|0|||
162126299|NCT00581113|585512863|FG001|Overall Study|Withdrawal by Subject|1|||
161786177|NCT00837577|584263193|FG001|Open-label Period|Withdrawal by Subject|2|||
161786178|NCT00837577|584263192|FG000|Open-label Period|Other Reason|1|||
161786179|NCT00837577|584263193|FG001|Open-label Period|Other Reason|1|||
161786180|NCT03670537|584263196|FG000|Overall Study|Protocol Violation|1|||
161786181|NCT02059187|584263199|FG000|Overall Study|Adverse Event|0|||
161786182|NCT02059187|584263200|FG001|Overall Study|Adverse Event|3|||
161786183|NCT02059187|584263199|FG000|Overall Study|Death|1|||
161786184|NCT02059187|584263200|FG001|Overall Study|Death|1|||
161786185|NCT02059187|584263199|FG000|Overall Study|Lost to Follow-up|9|||
161786186|NCT02059187|584263200|FG001|Overall Study|Lost to Follow-up|8|||
161786187|NCT02059187|584263199|FG000|Overall Study|Non-compliance with study drug|1|||
161786188|NCT02059187|584263200|FG001|Overall Study|Non-compliance with study drug|0|||
161786189|NCT02059187|584263199|FG000|Overall Study|Physician Decision|1|||
161786190|NCT02059187|584263200|FG001|Overall Study|Physician Decision|2|||
161786191|NCT02059187|584263199|FG000|Overall Study|Protocol Violation|1|||
161786192|NCT02059187|584263200|FG001|Overall Study|Protocol Violation|0|||
161786193|NCT02059187|584263199|FG000|Overall Study|Withdrawal by Subject|12|||
161786194|NCT02059187|584263200|FG001|Overall Study|Withdrawal by Subject|8|||
161786195|NCT03751020|584263201|FG000|Overall Study|Withdrawal by Subject|2|||
161786196|NCT03751020|584263202|FG001|Overall Study|Withdrawal by Subject|0|||
161786197|NCT03751020|584263203|FG002|Overall Study|Withdrawal by Subject|0|||
161786198|NCT03751020|584263201|FG000|Overall Study|Lost to Follow-up|7|||
161786199|NCT03751020|584263202|FG001|Overall Study|Lost to Follow-up|4|||
161786200|NCT03751020|584263203|FG002|Overall Study|Lost to Follow-up|10|||
161786201|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
161786202|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
161786203|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
161786204|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
161786205|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
161786206|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
161786207|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
161786208|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
161786209|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
161786210|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
161786211|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
161786212|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
161786213|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
161786214|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
161786215|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
161786216|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
161786217|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
161786218|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
161786219|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
161786220|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
161786221|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
161786222|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
161786223|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
161786224|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
161786225|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
161786226|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
161786227|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
161786228|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
161786229|NCT00528879|584263204|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
161786230|NCT00528879|584263205|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
161786231|NCT00528879|584263206|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
161786232|NCT00528879|584263207|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
161786233|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
161786234|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
161786235|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
161786236|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
161786237|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
161786238|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
161786239|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
161786240|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
161786241|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
161786242|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
161786243|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
161898520|NCT03654729|584677812|FG000|Overall Study|Progressive disease|3|||
161898521|NCT03654729|584677813|FG001|Overall Study|Progressive disease|0|||
161786244|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
161786245|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
161786246|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
161786247|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
161786248|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
161786249|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
161786250|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
161786251|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
161786252|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
161786253|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
161786254|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
161786255|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
161786256|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
161786257|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
161786258|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
161786259|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
161786260|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
161786261|NCT00528879|584263204|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
161786262|NCT00528879|584263205|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
161786263|NCT00528879|584263206|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
161786264|NCT00528879|584263207|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
161786265|NCT01159769|584263208|FG000|Overall Study|Adverse Event|1|||
161786266|NCT02555618|584263209|FG000|Overall Study|Sponsor's Circumstances|1|||
161786267|NCT02555618|584263210|FG001|Overall Study|Sponsor's Circumstances|0|||
161786268|NCT02217345|584263211|FG000|Overall Study|Lost to Follow-up|2|||
161786269|NCT02217345|584263212|FG001|Overall Study|Lost to Follow-up|1|||
161786270|NCT02217345|584263211|FG000|Overall Study|Withdrawal by Subject|3|||
161786271|NCT02217345|584263212|FG001|Overall Study|Withdrawal by Subject|2|||
161786272|NCT02217345|584263211|FG000|Overall Study|Adverse Event|2|||
161786273|NCT02217345|584263212|FG001|Overall Study|Adverse Event|1|||
161786274|NCT02217345|584263211|FG000|Overall Study|Physician Decision|0|||
161786275|NCT02217345|584263212|FG001|Overall Study|Physician Decision|1|||
161786276|NCT00971204|584263213|FG000|Overall Study|Did not meet all criteria-not treated|14|||
161786277|NCT00971204|584263213|FG000|Overall Study|Lost to Follow-up|10|||
161786278|NCT02624518|584263214|FG000|Overall Study|Physician Decision|1|||
161786279|NCT02729194|584263215|FG000|Overall Study|Withdrawal by Subject|3|||
161786280|NCT00272961|584263216|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
161786281|NCT00272961|584263217|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
161786282|NCT00272961|584263218|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
161786283|NCT00272961|584263219|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
161786284|NCT00272961|584263220|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
161786285|NCT00272961|584263216|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
161786286|NCT00272961|584263217|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
161786287|NCT00272961|584263218|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
161786288|NCT00272961|584263219|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
161786289|NCT00272961|584263220|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
161786290|NCT00272961|584263216|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
161786291|NCT00272961|584263217|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
161786292|NCT00272961|584263218|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
161786293|NCT00272961|584263219|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
161786294|NCT00272961|584263220|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
161786295|NCT00272961|584263216|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
161786296|NCT00272961|584263217|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
161786297|NCT00272961|584263218|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
161786298|NCT00272961|584263219|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
161786299|NCT00272961|584263220|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
161786300|NCT00272961|584263216|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
161786301|NCT00272961|584263217|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
161786302|NCT00272961|584263218|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
161786303|NCT00272961|584263219|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
161786304|NCT00272961|584263220|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
161786305|NCT00272961|584263216|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
161786306|NCT00272961|584263217|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
161786307|NCT00272961|584263218|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
161786308|NCT00272961|584263219|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
161786309|NCT00272961|584263220|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
161786310|NCT00272961|584263216|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
161786311|NCT00272961|584263217|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
161786312|NCT00272961|584263218|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
161786313|NCT00272961|584263219|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
161786314|NCT00272961|584263220|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
161786315|NCT00272961|584263216|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
161786316|NCT00272961|584263217|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
161786317|NCT00272961|584263218|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
161786318|NCT00272961|584263219|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
161786319|NCT00272961|584263220|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
161786320|NCT01507831|584263221|FG000|Overall Study|Randomized but not treated|0|||
161786321|NCT01507831|584263222|FG001|Overall Study|Randomized but not treated|3|||
161786322|NCT01507831|584263221|FG000|Overall Study|Adverse Event|48|||
161786323|NCT01507831|584263222|FG001|Overall Study|Adverse Event|113|||
161786324|NCT01507831|584263221|FG000|Overall Study|Death|6|||
161786325|NCT01507831|584263222|FG001|Overall Study|Death|2|||
161786326|NCT01507831|584263221|FG000|Overall Study|Poor compliance to protocol|38|||
161786327|NCT01507831|584263222|FG001|Overall Study|Poor compliance to protocol|60|||
161786328|NCT01507831|584263221|FG000|Overall Study|Physician Decision|0|||
161786329|NCT01507831|584263222|FG001|Overall Study|Physician Decision|4|||
161786330|NCT01507831|584263221|FG000|Overall Study|Participant moved|5|||
161786331|NCT01507831|584263222|FG001|Overall Study|Participant moved|19|||
161786332|NCT01507831|584263221|FG000|Overall Study|Consent withdrawn by participant|34|||
161786333|NCT01507831|584263222|FG001|Overall Study|Consent withdrawn by participant|72|||
161786334|NCT01507831|584263221|FG000|Overall Study|Related to study drug administration|5|||
161786335|NCT01507831|584263222|FG001|Overall Study|Related to study drug administration|14|||
161786336|NCT01507831|584263221|FG000|Overall Study|Last visit outside protocol visit window|51|||
161786337|NCT01507831|584263222|FG001|Overall Study|Last visit outside protocol visit window|143|||
161786338|NCT01507831|584263221|FG000|Overall Study|Selection criteria finally not met|0|||
161786339|NCT01507831|584263222|FG001|Overall Study|Selection criteria finally not met|1|||
161786340|NCT01507831|584263221|FG000|Overall Study|Site closure|0|||
161786341|NCT01507831|584263222|FG001|Overall Study|Site closure|3|||
161786342|NCT01507831|584263221|FG000|Overall Study|Potential lost to follow-up|3|||
161786343|NCT01507831|584263222|FG001|Overall Study|Potential lost to follow-up|0|||
161786344|NCT01507831|584263221|FG000|Overall Study|Other|3|||
161786345|NCT01507831|584263222|FG001|Overall Study|Other|6|||
161786346|NCT03652961|584263223|FG000|Overall Study|Lost to Follow-up|3|||
161786347|NCT03652961|584263223|FG000|Overall Study|Screen Failure|1|||
161786348|NCT01280981|584263226|FG000|Overall Study|Withdrawal by Subject|11|||
161786349|NCT01280981|584263226|FG000|Overall Study|Protocol Violation|2|||
161786350|NCT01280981|584263226|FG000|Overall Study|Lack of Efficacy|13|||
161786351|NCT01280981|584263226|FG000|Overall Study|Lost to Follow-up|3|||
161786352|NCT01280981|584263226|FG000|Overall Study|Adverse Event|6|||
161786353|NCT01280981|584263226|FG000|Overall Study|Irregular or discontinued menses|3|||
161786354|NCT01280981|584263226|FG000|Overall Study|Failed to return|45|||
161786355|NCT01280981|584263226|FG000|Overall Study|Non-compliance with protocol|3|||
161786356|NCT01280981|584263226|FG000|Overall Study|Withdrawal of consent|3|||
161786357|NCT01280981|584263226|FG000|Overall Study|Elective surgery|2|||
161786358|NCT01280981|584263226|FG000|Overall Study|Study site closure|1|||
161786359|NCT01252238|584263229|FG000|Overall Study|Sponsor terminated study|4|||
161786360|NCT01252238|584263230|FG001|Overall Study|Sponsor terminated study|4|||
161786361|NCT01252238|584263231|FG002|Overall Study|Sponsor terminated study|4|||
161786362|NCT01610167|584263232|FG000|Overall Study|Scheduling conflict.|0|||
161786363|NCT01610167|584263233|FG001|Overall Study|Scheduling conflict.|0|||
162126300|NCT01818141|585512864|FG000|Overall Study|Withdrawal by Subject|2|||
162126301|NCT01818141|585512865|FG001|Overall Study|Withdrawal by Subject|0|||
162126302|NCT01818141|585512864|FG000|Overall Study|No baseline C.diff colonies|1|||
162126303|NCT01818141|585512865|FG001|Overall Study|No baseline C.diff colonies|1|||
162126304|NCT01818141|585512864|FG000|Overall Study|Lost to Follow-up|0|||
162126305|NCT01818141|585512865|FG001|Overall Study|Lost to Follow-up|2|||
162126306|NCT04834362|585512866|FG000|Overall Study|Death|1|||
162126307|NCT04834362|585512867|FG001|Overall Study|Death|2|||
162126308|NCT00329719|585512870|FG000|Overall Study|Lost to Follow-up|0|||
161786364|NCT01610167|584263234|FG002|Overall Study|Scheduling conflict.|2|||
161786365|NCT03276962|584263239|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
161786366|NCT03276962|584263240|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
161786367|NCT03276962|584263241|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
161786368|NCT03276962|584263242|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
161786369|NCT03276962|584263243|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
161786370|NCT03276962|584263239|FG000|Overall Study|Protocol Deviation|2|||
161786371|NCT03276962|584263240|FG001|Overall Study|Protocol Deviation|0|||
161786372|NCT03276962|584263241|FG002|Overall Study|Protocol Deviation|1|||
161786373|NCT03276962|584263242|FG003|Overall Study|Protocol Deviation|2|||
161786374|NCT03276962|584263243|FG004|Overall Study|Protocol Deviation|1|||
162126309|NCT00329719|585512871|FG001|Overall Study|Lost to Follow-up|0|||
161786375|NCT03276962|584263239|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
162126310|NCT00329719|585512872|FG002|Overall Study|Lost to Follow-up|0|||
161786376|NCT03276962|584263240|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
161786377|NCT03276962|584263241|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
161786378|NCT03276962|584263242|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
161786379|NCT03276962|584263243|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
161786380|NCT03276962|584263239|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
161786381|NCT03276962|584263240|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
161786382|NCT03276962|584263241|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
161786383|NCT03276962|584263242|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
161786384|NCT03276962|584263243|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
161786385|NCT03276962|584263239|FG000|Overall Study|Lost to Follow-up|10|||
161786386|NCT03276962|584263240|FG001|Overall Study|Lost to Follow-up|10|||
161786387|NCT03276962|584263241|FG002|Overall Study|Lost to Follow-up|4|||
161786388|NCT03276962|584263242|FG003|Overall Study|Lost to Follow-up|6|||
161786389|NCT03276962|584263243|FG004|Overall Study|Lost to Follow-up|10|||
161786390|NCT03276962|584263239|FG000|Overall Study|Other|0|||
161786391|NCT03276962|584263240|FG001|Overall Study|Other|2|||
161786392|NCT03276962|584263241|FG002|Overall Study|Other|0|||
161786393|NCT03276962|584263242|FG003|Overall Study|Other|2|||
161786394|NCT03276962|584263243|FG004|Overall Study|Other|1|||
161786395|NCT01358708|584263244|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
161786396|NCT01358708|584263245|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161786397|NCT01358708|584263244|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
161786398|NCT01358708|584263245|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
161786399|NCT03056001|584263249|FG000|Overall Study|Death|24|||
161786400|NCT01364298|584263252|FG000|Overall Study|Adverse Event|3|||
161786401|NCT01364298|584263253|FG001|Overall Study|Adverse Event|4|||
161786402|NCT01364298|584263252|FG000|Overall Study|Lack of adherence to treatment|1|||
161786403|NCT01364298|584263253|FG001|Overall Study|Lack of adherence to treatment|3|||
161786404|NCT01364298|584263252|FG000|Overall Study|Lack of Efficacy|1|||
161786405|NCT01364298|584263253|FG001|Overall Study|Lack of Efficacy|0|||
161786406|NCT01364298|584263252|FG000|Overall Study|Lost to Follow-up|5|||
161786407|NCT01364298|584263253|FG001|Overall Study|Lost to Follow-up|10|||
161786408|NCT01364298|584263252|FG000|Overall Study|Withdrawal by Subject|3|||
161786409|NCT01364298|584263253|FG001|Overall Study|Withdrawal by Subject|3|||
161786410|NCT01364298|584263252|FG000|Overall Study|Other|1|||
161786411|NCT01364298|584263253|FG001|Overall Study|Other|3|||
161786412|NCT03712228|584263254|FG000|Treatment Period 1|Lack of Efficacy|0|||
161786413|NCT03712228|584263255|FG001|Treatment Period 1|Lack of Efficacy|0|||
161786414|NCT03712228|584263256|FG002|Treatment Period 1|Lack of Efficacy|0|||
161786415|NCT03712228|584263257|FG003|Treatment Period 1|Lack of Efficacy|0|||
161786416|NCT03712228|584263258|FG004|Treatment Period 1|Lack of Efficacy|0|||
161786417|NCT03712228|584263259|FG005|Treatment Period 1|Lack of Efficacy|1|||
161786418|NCT03712228|584263254|FG000|Treatment Period 2|Pregnancy|0|||
161786419|NCT03712228|584263255|FG001|Treatment Period 2|Pregnancy|0|||
161786420|NCT03712228|584263256|FG002|Treatment Period 2|Pregnancy|0|||
161786421|NCT03712228|584263257|FG003|Treatment Period 2|Pregnancy|1|||
161786422|NCT03712228|584263258|FG004|Treatment Period 2|Pregnancy|0|||
161786423|NCT03712228|584263259|FG005|Treatment Period 2|Pregnancy|0|||
161786424|NCT03712228|584263254|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161786425|NCT03712228|584263255|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161786426|NCT03712228|584263256|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161786427|NCT03712228|584263257|FG003|Treatment Period 2|Withdrawal by Subject|1|||
161786428|NCT03712228|584263258|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161786429|NCT03712228|584263259|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161786430|NCT01964105|584263260|FG000|Overall Study|Lost to Follow-up|2|||
161786431|NCT01964105|584263261|FG001|Overall Study|Lost to Follow-up|13|||
161786432|NCT01964105|584263262|FG002|Overall Study|Lost to Follow-up|0|||
161786433|NCT01254045|584263265|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
161786434|NCT01254045|584263266|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161786435|NCT01254045|584263267|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161786436|NCT01254045|584263268|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161786437|NCT01254045|584263269|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161786438|NCT01254045|584263270|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161786439|NCT00597207|584263271|FG000|Overall Study|Lost to Follow-up|5|||
161786440|NCT00597207|584263272|FG001|Overall Study|Lost to Follow-up|7|||
161786441|NCT00520351|584263273|FG000|First Intervention|Withdrawal by Subject|1|||
161786442|NCT00520351|584263274|FG001|First Intervention|Withdrawal by Subject|1|||
161786443|NCT04288115|584263283|FG000|Overall Study|Withdrawal by Subject|0|||
161786444|NCT04288115|584263284|FG001|Overall Study|Withdrawal by Subject|1|||
161786445|NCT04288115|584263283|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
161786446|NCT04288115|584263284|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
161786447|NCT02766400|584263287|FG000|Overall Study|Death|1|||
161786448|NCT02766400|584263288|FG001|Overall Study|Death|2|||
161786449|NCT02766400|584263287|FG000|Overall Study|Withdrawal by Subject|1|||
161786450|NCT02766400|584263288|FG001|Overall Study|Withdrawal by Subject|0|||
161786451|NCT03499249|584263289|FG000|Overall Study|Physician Decision|1|||
161786452|NCT01374906|584263290|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161786453|NCT01374906|584263291|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161786454|NCT01374906|584263290|FG000|Overall Study|Administrative problems|2|||
161786455|NCT01374906|584263291|FG001|Overall Study|Administrative problems|2|||
161786456|NCT01374906|584263290|FG000|Overall Study|Adverse Event|10|||
161786457|NCT01374906|584263291|FG001|Overall Study|Adverse Event|11|||
161786458|NCT01374906|584263290|FG000|Overall Study|Death|0|||
161786459|NCT01374906|584263291|FG001|Overall Study|Death|2|||
161786460|NCT01374906|584263290|FG000|Overall Study|Protocol Violation|2|||
161786461|NCT01374906|584263291|FG001|Overall Study|Protocol Violation|2|||
161786462|NCT01374906|584263290|FG000|Overall Study|Withdrawal by Subject|15|||
161786463|NCT01374906|584263291|FG001|Overall Study|Withdrawal by Subject|9|||
161786464|NCT01374906|584263290|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
161786465|NCT01374906|584263291|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
161786466|NCT02475980|584263296|FG000|Overall Study|Lost to Follow-up|4|||
161786467|NCT02475980|584263296|FG000|Overall Study|Withdrawal by Subject|1|||
161786468|NCT01529749|584263301|FG000|Overall Study|Lost to Follow-up|0|||
161786469|NCT01529749|584263302|FG001|Overall Study|Lost to Follow-up|1|||
161786470|NCT01529749|584263303|FG002|Overall Study|Lost to Follow-up|1|||
161786471|NCT01529749|584263304|FG003|Overall Study|Lost to Follow-up|0|||
161786472|NCT01529749|584263301|FG000|Overall Study|Physician Decision|0|||
161786473|NCT01529749|584263302|FG001|Overall Study|Physician Decision|0|||
161786474|NCT01529749|584263303|FG002|Overall Study|Physician Decision|0|||
161786475|NCT01529749|584263304|FG003|Overall Study|Physician Decision|1|||
161786476|NCT01529749|584263301|FG000|Overall Study|Withdrawal by Subject|0|||
161786477|NCT01529749|584263302|FG001|Overall Study|Withdrawal by Subject|1|||
161786478|NCT01529749|584263303|FG002|Overall Study|Withdrawal by Subject|1|||
161786479|NCT01529749|584263304|FG003|Overall Study|Withdrawal by Subject|0|||
161786480|NCT01529749|584263301|FG000|Overall Study|Protocol Violation|0|||
161786481|NCT01529749|584263302|FG001|Overall Study|Protocol Violation|0|||
161786482|NCT01529749|584263303|FG002|Overall Study|Protocol Violation|0|||
161786483|NCT01529749|584263304|FG003|Overall Study|Protocol Violation|1|||
161786484|NCT00789828|584263305|FG000|Core Period (48 Weeks)|Administrative problems|0|||
161786485|NCT00789828|584263306|FG001|Core Period (48 Weeks)|Administrative problems|1|||
161786486|NCT00789828|584263305|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
161786487|NCT00789828|584263306|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
161786488|NCT00789828|584263305|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
161786489|NCT00789828|584263306|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
161786490|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
161786491|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
161786492|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
161786493|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
161786494|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
161786495|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
161786496|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
161786497|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
161786498|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|Death|1|||
161786499|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|Death|0|||
161786500|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
161786501|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
161786502|NCT00789828|584263305|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
161786503|NCT00789828|584263306|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
161786504|NCT02623426|584263307|FG000|Overall Study|Lost to Follow-up|0|||
161786505|NCT02623426|584263308|FG001|Overall Study|Lost to Follow-up|0|||
161786506|NCT02623426|584263309|FG002|Overall Study|Lost to Follow-up|1|||
161786507|NCT02623426|584263307|FG000|Overall Study|Withdrawal by Subject|1|||
161786508|NCT02623426|584263308|FG001|Overall Study|Withdrawal by Subject|2|||
161786509|NCT02623426|584263309|FG002|Overall Study|Withdrawal by Subject|2|||
161786510|NCT02094937|584263310|FG000|8 Weeks in Period 1|Adverse Event|9|||
162126311|NCT00329719|585512873|FG003|Overall Study|Lost to Follow-up|1|||
162126312|NCT01668147|585512876|FG000|Overall Study|Withdrawal by Subject|6|||
162126313|NCT01809210|585512877|FG000|Overall Study|Withdrawal by Subject|0|||
161786511|NCT02094937|584263311|FG001|8 Weeks in Period 1|Adverse Event|0|||
161786512|NCT02094937|584263312|FG002|8 Weeks in Period 1|Adverse Event|0|||
162126314|NCT01809210|585512878|FG001|Overall Study|Withdrawal by Subject|0|||
161786513|NCT02094937|584263313|FG003|8 Weeks in Period 1|Adverse Event|0|||
161786514|NCT02094937|584263310|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
161786515|NCT02094937|584263311|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
161786516|NCT02094937|584263312|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
161786517|NCT02094937|584263313|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
161786518|NCT02094937|584263310|FG000|8 Weeks in Period 1|Protocol Violation|2|||
161786519|NCT02094937|584263311|FG001|8 Weeks in Period 1|Protocol Violation|0|||
161786520|NCT02094937|584263312|FG002|8 Weeks in Period 1|Protocol Violation|0|||
161786521|NCT02094937|584263313|FG003|8 Weeks in Period 1|Protocol Violation|0|||
161786522|NCT02094937|584263310|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
161786523|NCT02094937|584263311|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
161786524|NCT02094937|584263312|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
161786525|NCT02094937|584263313|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
161786526|NCT02094937|584263310|FG000|8 Weeks in Period 1|Physician Decision|1|||
161786527|NCT02094937|584263311|FG001|8 Weeks in Period 1|Physician Decision|0|||
161786528|NCT02094937|584263312|FG002|8 Weeks in Period 1|Physician Decision|0|||
161786529|NCT02094937|584263313|FG003|8 Weeks in Period 1|Physician Decision|0|||
161786530|NCT02094937|584263310|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
161786531|NCT02094937|584263311|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
161786532|NCT02094937|584263312|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
161786533|NCT02094937|584263313|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
161786534|NCT02094937|584263310|FG000|12 Weeks in Period 2|Adverse Event|0|||
161786535|NCT02094937|584263311|FG001|12 Weeks in Period 2|Adverse Event|2|||
161786536|NCT02094937|584263312|FG002|12 Weeks in Period 2|Adverse Event|4|||
161786537|NCT02094937|584263313|FG003|12 Weeks in Period 2|Adverse Event|1|||
161786538|NCT02094937|584263310|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
161786539|NCT02094937|584263311|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
161786540|NCT02094937|584263312|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
161786541|NCT02094937|584263313|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
161786542|NCT02094937|584263310|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
161786543|NCT02094937|584263311|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
161786544|NCT02094937|584263312|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
161786545|NCT02094937|584263313|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
161786546|NCT02094937|584263310|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
161786547|NCT02094937|584263311|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
161786548|NCT02094937|584263312|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
161786549|NCT02094937|584263313|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
161786550|NCT02094937|584263310|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
161786551|NCT02094937|584263311|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
161786552|NCT02094937|584263312|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
161786553|NCT02094937|584263313|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
161786554|NCT01133392|584263314|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
161786555|NCT01133392|584263315|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
161786556|NCT01133392|584263314|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
161786557|NCT01133392|584263315|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
161786558|NCT03751124|584263316|FG000|Overall Study|Adverse Event|4|||
161786559|NCT03751124|584263317|FG001|Overall Study|Adverse Event|3|||
161786560|NCT03751124|584263316|FG000|Overall Study|Protocol Deviation|0|||
161786561|NCT03751124|584263317|FG001|Overall Study|Protocol Deviation|1|||
161786562|NCT03751124|584263316|FG000|Overall Study|Lost to Follow-up|6|||
161786563|NCT03751124|584263317|FG001|Overall Study|Lost to Follow-up|4|||
161786564|NCT03751124|584263316|FG000|Overall Study|Withdrawal by Subject|6|||
161786565|NCT03751124|584263317|FG001|Overall Study|Withdrawal by Subject|8|||
161786566|NCT03751124|584263316|FG000|Overall Study|Lack of Efficacy|1|||
161786567|NCT03751124|584263317|FG001|Overall Study|Lack of Efficacy|1|||
161786568|NCT03751124|584263316|FG000|Overall Study|Pregnancy|0|||
161786569|NCT03751124|584263317|FG001|Overall Study|Pregnancy|1|||
161786570|NCT03751124|584263316|FG000|Overall Study|Other|9|||
161786571|NCT03751124|584263317|FG001|Overall Study|Other|9|||
161786572|NCT03751124|584263316|FG000|Overall Study|Participants who did not receive any study drug|0|||
161786573|NCT03751124|584263317|FG001|Overall Study|Participants who did not receive any study drug|1|||
161786574|NCT00555399|584263320|FG000|Overall Study|Withdrawal by Subject|0|||
161786575|NCT00555399|584263321|FG001|Overall Study|Withdrawal by Subject|0|||
161786576|NCT00555399|584263322|FG002|Overall Study|Withdrawal by Subject|1|||
161786577|NCT00555399|584263323|FG003|Overall Study|Withdrawal by Subject|0|||
161786578|NCT00555399|584263324|FG004|Overall Study|Withdrawal by Subject|0|||
161786579|NCT00555399|584263325|FG005|Overall Study|Withdrawal by Subject|0|||
161786580|NCT00555399|584263326|FG006|Overall Study|Withdrawal by Subject|0|||
161898522|NCT03654729|584677814|FG002|Overall Study|Progressive disease|0|||
161786581|NCT00555399|584263327|FG007|Overall Study|Withdrawal by Subject|0|||
161786582|NCT00555399|584263328|FG008|Overall Study|Withdrawal by Subject|0|||
161786583|NCT00555399|584263329|FG009|Overall Study|Withdrawal by Subject|0|||
161786584|NCT00555399|584263330|FG010|Overall Study|Withdrawal by Subject|0|||
161786585|NCT00555399|584263331|FG011|Overall Study|Withdrawal by Subject|1|||
161786586|NCT00555399|584263320|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
161786587|NCT00555399|584263321|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
161786588|NCT00555399|584263322|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
161898523|NCT03654729|584677812|FG000|Overall Study|Lost to Follow-up|2|||
161898524|NCT03654729|584677813|FG001|Overall Study|Lost to Follow-up|0|||
161898525|NCT03654729|584677814|FG002|Overall Study|Lost to Follow-up|0|||
161786589|NCT00555399|584263323|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
161786590|NCT00555399|584263324|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
161786591|NCT00555399|584263325|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
161786592|NCT00555399|584263326|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
161786593|NCT00555399|584263327|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
161786594|NCT00555399|584263328|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
161786595|NCT00555399|584263329|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
161786596|NCT00555399|584263330|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
161786597|NCT00555399|584263331|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
161786598|NCT05458895|584263332|FG000|Overall Study|Withdrawal by Subject|8|||
161786599|NCT05458895|584263332|FG000|Overall Study|Lost to Follow-up|17|||
161786600|NCT05458895|584263332|FG000|Overall Study|Pregnancy|2|||
161786601|NCT05458895|584263332|FG000|Overall Study|Withdrawal by Study Team|1|||
161786602|NCT04639310|584263333|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
161786603|NCT04639310|584263334|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
161786604|NCT05166421|584263335|FG000|Overall Study|Other|3|||
161786605|NCT05166421|584263336|FG001|Overall Study|Other|1|||
161786606|NCT05166421|584263337|FG002|Overall Study|Other|1|||
162126315|NCT01809210|585512879|FG002|Overall Study|Withdrawal by Subject|1|||
162126316|NCT01809210|585512880|FG003|Overall Study|Withdrawal by Subject|1|||
162126317|NCT01809210|585512881|FG004|Overall Study|Withdrawal by Subject|1|||
161786607|NCT05166421|584263335|FG000|Overall Study|Withdrawal by Subject|5|||
161786608|NCT05166421|584263336|FG001|Overall Study|Withdrawal by Subject|3|||
161786609|NCT05166421|584263337|FG002|Overall Study|Withdrawal by Subject|6|||
161786610|NCT05166421|584263335|FG000|Overall Study|Lost to Follow-up|4|||
161786611|NCT05166421|584263336|FG001|Overall Study|Lost to Follow-up|1|||
161786612|NCT05166421|584263337|FG002|Overall Study|Lost to Follow-up|7|||
161786613|NCT03770000|584265355|FG000|Overall Study|Premature discontinuation due to PD|0|||
161786614|NCT03770000|584265356|FG001|Overall Study|Premature discontinuation due to PD|0|||
161786615|NCT03770000|584265357|FG002|Overall Study|Premature discontinuation due to PD|1|||
161786616|NCT03770000|584265358|FG003|Overall Study|Premature discontinuation due to PD|3|||
161786617|NCT03770000|584265359|FG004|Overall Study|Premature discontinuation due to PD|2|||
161786618|NCT02290028|584265360|FG000|Overall Study|Death|217|||
161786619|NCT02290028|584265360|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
161786620|NCT02290028|584265360|FG000|Overall Study|No longer under care of study physician|76|||
161786621|NCT02290028|584265360|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
161786622|NCT02290028|584265360|FG000|Overall Study|Withdrawal by Subject|52|||
161786623|NCT02290028|584265360|FG000|Overall Study|Study site closure|44|||
161786624|NCT02290028|584265360|FG000|Overall Study|Lost to Follow-up|34|||
161786625|NCT02290028|584265360|FG000|Overall Study|Miscellaneous|10|||
161786626|NCT02290028|584265360|FG000|Overall Study|Transition to EP PASSION|1295|||
161786627|NCT02290028|584265360|FG000|Overall Study|Planned study completion at 12 months|257|||
161786628|NCT00833547|584265361|FG000|Overall Study|Withdrawal by Subject|2|||
161786629|NCT00833547|584265362|FG001|Overall Study|Withdrawal by Subject|2|||
161786630|NCT01375010|584265365|FG000|Overall Study|Lost to Follow-up|8|||
161786631|NCT01375010|584265366|FG001|Overall Study|Lost to Follow-up|2|||
161786632|NCT01375010|584265365|FG000|Overall Study|Withdrawal by Subject|4|||
161786633|NCT01375010|584265366|FG001|Overall Study|Withdrawal by Subject|2|||
161786634|NCT02402933|584265368|FG000|Overall Study|Withdrawal by Subject|4|||
161786635|NCT02402933|584265368|FG000|Overall Study|Discontinued; Site Termination|10|||
161786636|NCT00830063|584265369|FG000|Overall Study|Adverse Event|7|||
161786637|NCT00830063|584265370|FG001|Overall Study|Adverse Event|13|||
161786638|NCT00830063|584265371|FG002|Overall Study|Adverse Event|16|||
161786639|NCT00830063|584265372|FG003|Overall Study|Adverse Event|13|||
161898526|NCT03654729|584677812|FG000|Overall Study|Physician Decision|2|||
162126318|NCT01809210|585512882|FG005|Overall Study|Withdrawal by Subject|0|||
162126319|NCT01809210|585512883|FG006|Overall Study|Withdrawal by Subject|4|||
162126320|NCT01809210|585512877|FG000|Overall Study|Death|1|||
162126321|NCT01809210|585512878|FG001|Overall Study|Death|1|||
162126322|NCT01809210|585512879|FG002|Overall Study|Death|2|||
162126323|NCT01809210|585512880|FG003|Overall Study|Death|0|||
162126324|NCT01809210|585512881|FG004|Overall Study|Death|1|||
162126325|NCT01809210|585512882|FG005|Overall Study|Death|3|||
162126326|NCT01809210|585512883|FG006|Overall Study|Death|1|||
162126327|NCT00224133|585512886|FG000|Overall Study|Adverse Event|93|||
161786640|NCT00830063|584265369|FG000|Overall Study|Death|1|||
161898527|NCT03654729|584677813|FG001|Overall Study|Physician Decision|0|||
161898528|NCT03654729|584677814|FG002|Overall Study|Physician Decision|0|||
161898529|NCT03654729|584677812|FG000|Overall Study|Protocol Violation|1|||
161786641|NCT00830063|584265370|FG001|Overall Study|Death|0|||
161786642|NCT00830063|584265371|FG002|Overall Study|Death|0|||
161786643|NCT00830063|584265372|FG003|Overall Study|Death|0|||
161786644|NCT00830063|584265369|FG000|Overall Study|Lost to Follow-up|0|||
162126328|NCT00224133|585512886|FG000|Overall Study|Protocol Violation|6|||
162126329|NCT00224133|585512886|FG000|Overall Study|Withdrawal by Subject|33|||
161786645|NCT00830063|584265370|FG001|Overall Study|Lost to Follow-up|0|||
161786646|NCT00830063|584265371|FG002|Overall Study|Lost to Follow-up|3|||
161786647|NCT00830063|584265372|FG003|Overall Study|Lost to Follow-up|1|||
161786648|NCT00830063|584265369|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
161786649|NCT00830063|584265370|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
161786650|NCT00830063|584265371|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
161786651|NCT00830063|584265372|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
161786652|NCT00830063|584265369|FG000|Overall Study|Lack of Efficacy|51|||
161786653|NCT00830063|584265370|FG001|Overall Study|Lack of Efficacy|23|||
161786654|NCT00830063|584265371|FG002|Overall Study|Lack of Efficacy|25|||
161786655|NCT00830063|584265372|FG003|Overall Study|Lack of Efficacy|32|||
161786656|NCT00830063|584265369|FG000|Overall Study|Other|5|||
161786657|NCT00830063|584265370|FG001|Overall Study|Other|5|||
161786658|NCT00830063|584265371|FG002|Overall Study|Other|8|||
161786659|NCT00830063|584265372|FG003|Overall Study|Other|6|||
161786660|NCT00830063|584265369|FG000|Overall Study|Withdrawal by Subject|16|||
161786661|NCT00830063|584265370|FG001|Overall Study|Withdrawal by Subject|10|||
161786662|NCT00830063|584265371|FG002|Overall Study|Withdrawal by Subject|16|||
161786663|NCT00830063|584265372|FG003|Overall Study|Withdrawal by Subject|13|||
161786664|NCT00830063|584265369|FG000|Overall Study|Protocol Violation|1|||
161786665|NCT00830063|584265370|FG001|Overall Study|Protocol Violation|0|||
161786666|NCT00830063|584265371|FG002|Overall Study|Protocol Violation|3|||
161786667|NCT00830063|584265372|FG003|Overall Study|Protocol Violation|2|||
161786668|NCT00830063|584265369|FG000|Overall Study|Randomized But Not Treated|0|||
161786669|NCT00830063|584265370|FG001|Overall Study|Randomized But Not Treated|2|||
161786670|NCT00830063|584265371|FG002|Overall Study|Randomized But Not Treated|0|||
161786671|NCT00830063|584265372|FG003|Overall Study|Randomized But Not Treated|2|||
161786672|NCT01847313|584265373|FG000|Overall Study|Death|0|||
161786673|NCT01847313|584265374|FG001|Overall Study|Death|1|||
161786674|NCT01847313|584265373|FG000|Overall Study|Withdrawal by Subject|0|||
161786675|NCT01847313|584265374|FG001|Overall Study|Withdrawal by Subject|1|||
161786676|NCT00598559|584265375|FG000|Overall Study|Adverse Event|11|||
161786677|NCT00598559|584265376|FG001|Overall Study|Adverse Event|7|||
161786678|NCT00598559|584265377|FG002|Overall Study|Adverse Event|0|||
161786679|NCT00598559|584265375|FG000|Overall Study|Withdrawal by Subject|2|||
161786680|NCT00598559|584265376|FG001|Overall Study|Withdrawal by Subject|2|||
161786681|NCT00598559|584265377|FG002|Overall Study|Withdrawal by Subject|0|||
162126330|NCT00224133|585512886|FG000|Overall Study|Lack of Efficacy|58|||
162126331|NCT00224133|585512886|FG000|Overall Study|Lost to Follow-up|21|||
162126332|NCT00224133|585512886|FG000|Overall Study|Physician Decision|1|||
162126333|NCT00224133|585512886|FG000|Overall Study|Other|14|||
162126334|NCT01238575|585512890|FG000|Overall Study|Lack of Efficacy|2|||
162126335|NCT01238575|585512891|FG001|Overall Study|Lack of Efficacy|4|||
162126336|NCT01238575|585512890|FG000|Overall Study|Adverse Event|2|||
161786682|NCT00598559|584265375|FG000|Overall Study|Protocol Non-compliance|1|||
161786683|NCT00598559|584265376|FG001|Overall Study|Protocol Non-compliance|0|||
161786684|NCT00598559|584265377|FG002|Overall Study|Protocol Non-compliance|0|||
162126337|NCT01238575|585512891|FG001|Overall Study|Adverse Event|0|||
162126338|NCT00593554|585512893|FG000|Overall Study|Death|1|||
162126339|NCT00593554|585512894|FG001|Overall Study|Death|2|||
162126340|NCT00593554|585512893|FG000|Overall Study|Physician Decision|0|||
162126341|NCT00593554|585512894|FG001|Overall Study|Physician Decision|1|||
162126342|NCT00593554|585512893|FG000|Overall Study|Withdrawal by Subject|1|||
162126343|NCT00593554|585512894|FG001|Overall Study|Withdrawal by Subject|0|||
162126344|NCT00593554|585512893|FG000|Overall Study|Disease Progression|1|||
162126345|NCT00593554|585512894|FG001|Overall Study|Disease Progression|2|||
162126346|NCT00795132|585512897|FG000|Overall Study|Death|1|||
162126347|NCT00795132|585512897|FG000|Overall Study|Relapse|2|||
162126348|NCT00358150|585512902|FG000|Overall Study|Adverse Event|3|||
162126349|NCT00358150|585512902|FG000|Overall Study|Withdrawal by Subject|1|||
162126350|NCT00358150|585512902|FG000|Overall Study|Undefined|3|||
162126351|NCT04747275|585512903|FG000|Overall Study|Study terminated|0|||
162126352|NCT04747275|585512904|FG001|Overall Study|Study terminated|1|||
162126353|NCT03268590|585512907|FG000|Overall Study|Previously unknown exclusion criteria|1|||
162126354|NCT00531011|585512908|FG000|Overall Study|Withdrawal by Subject|2|||
161786685|NCT00598559|584265375|FG000|Overall Study|Early discharge from hospital|9|||
161786686|NCT00598559|584265376|FG001|Overall Study|Early discharge from hospital|12|||
161786687|NCT00598559|584265377|FG002|Overall Study|Early discharge from hospital|3|||
161786688|NCT00598559|584265375|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
161786689|NCT00598559|584265376|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
161786690|NCT00598559|584265377|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
161898530|NCT03654729|584677813|FG001|Overall Study|Protocol Violation|1|||
161786691|NCT01059071|584265378|FG000|Overall Study|Lack of Efficacy|1|||
161786692|NCT01059071|584265379|FG001|Overall Study|Lack of Efficacy|4|||
161786693|NCT01059071|584265380|FG002|Overall Study|Lack of Efficacy|2|||
161786694|NCT01059071|584265381|FG003|Overall Study|Lack of Efficacy|3|||
161786695|NCT01059071|584265378|FG000|Overall Study|Withdrawal by Subject|1|||
162126355|NCT00531011|585512909|FG001|Overall Study|Withdrawal by Subject|4|||
161786696|NCT01059071|584265379|FG001|Overall Study|Withdrawal by Subject|0|||
161786697|NCT01059071|584265380|FG002|Overall Study|Withdrawal by Subject|0|||
161786698|NCT01059071|584265381|FG003|Overall Study|Withdrawal by Subject|2|||
161786699|NCT01059071|584265378|FG000|Overall Study|Physician Decision|0|||
161786700|NCT01059071|584265379|FG001|Overall Study|Physician Decision|0|||
161786701|NCT01059071|584265380|FG002|Overall Study|Physician Decision|0|||
161786702|NCT01059071|584265381|FG003|Overall Study|Physician Decision|1|||
161786703|NCT02962882|584265382|FG000|Overall Study|Adverse Event|2|||
161786704|NCT02962882|584265382|FG000|Overall Study|Withdrawal by Subject|2|||
161786705|NCT02962882|584265382|FG000|Overall Study|Transfer from ICU|32|||
161786706|NCT03763331|584265387|FG000|Overall Study|Lost to Follow-up|1|||
161786707|NCT03763331|584265388|FG001|Overall Study|Lost to Follow-up|0|||
161786708|NCT03763331|584265387|FG000|Overall Study|Withdrawal by Subject|1|||
161786709|NCT03763331|584265388|FG001|Overall Study|Withdrawal by Subject|0|||
161786710|NCT03763331|584265387|FG000|Overall Study|Non-compliance|0|||
161786711|NCT03763331|584265388|FG001|Overall Study|Non-compliance|3|||
161786712|NCT01155063|584265389|FG000|Overall Study|Adverse Event|1|||
161786713|NCT01155063|584265389|FG000|Overall Study|Withdrawal by Subject|1|||
161786714|NCT01155063|584265389|FG000|Overall Study|Study terminated by sponsor|87|||
161786715|NCT00936884|584265390|FG000|Double-blind|Withdrawal by Subject|6|||
161786716|NCT00936884|584265391|FG001|Double-blind|Withdrawal by Subject|4|||
161786717|NCT00936884|584265392|FG002|Double-blind|Withdrawal by Subject|0|||
161786718|NCT00936884|584265390|FG000|Double-blind|Death|2|||
161786719|NCT00936884|584265391|FG001|Double-blind|Death|1|||
161786720|NCT00936884|584265392|FG002|Double-blind|Death|0|||
161786721|NCT00936884|584265390|FG000|Double-blind|Lack of Efficacy|1|||
161786722|NCT00936884|584265391|FG001|Double-blind|Lack of Efficacy|1|||
161786723|NCT00936884|584265392|FG002|Double-blind|Lack of Efficacy|0|||
161786724|NCT00936884|584265390|FG000|Double-blind|Adverse Event|1|||
161786725|NCT00936884|584265391|FG001|Double-blind|Adverse Event|0|||
161786726|NCT00936884|584265392|FG002|Double-blind|Adverse Event|0|||
161786727|NCT00936884|584265390|FG000|Double-blind|Physician Decision|1|||
161786728|NCT00936884|584265391|FG001|Double-blind|Physician Decision|0|||
161786729|NCT00936884|584265392|FG002|Double-blind|Physician Decision|0|||
161786730|NCT00936884|584265390|FG000|Double-blind|No post baseline diary entry|1|||
161786731|NCT00936884|584265391|FG001|Double-blind|No post baseline diary entry|0|||
161786732|NCT00936884|584265392|FG002|Double-blind|No post baseline diary entry|0|||
161786733|NCT00936884|584265390|FG000|Double-blind|Did not receive study drug|0|||
161786734|NCT00936884|584265391|FG001|Double-blind|Did not receive study drug|1|||
161786735|NCT00936884|584265392|FG002|Double-blind|Did not receive study drug|0|||
161786736|NCT01663714|584265393|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
161786737|NCT01663714|584265393|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
161786738|NCT01663714|584265393|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
161786739|NCT01663714|584265393|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
161786740|NCT01663714|584265393|FG000|Long-Term Follow-Up|Death|4|||
161786741|NCT01663714|584265393|FG000|Long-Term Follow-Up|Non-compliance|1|||
161786742|NCT00597584|584265394|FG000|Overall Study|Adverse Event|4|||
161786743|NCT00597584|584265395|FG001|Overall Study|Adverse Event|2|||
161786744|NCT00597584|584265394|FG000|Overall Study|Death|53|||
161786745|NCT00597584|584265395|FG001|Overall Study|Death|30|||
161786746|NCT00597584|584265394|FG000|Overall Study|Lack of Efficacy|1|||
161786747|NCT00597584|584265395|FG001|Overall Study|Lack of Efficacy|0|||
161786748|NCT00597584|584265394|FG000|Overall Study|Lost to Follow-up|2|||
161786749|NCT00597584|584265395|FG001|Overall Study|Lost to Follow-up|4|||
161786750|NCT00597584|584265394|FG000|Overall Study|Physician Decision|3|||
161786751|NCT00597584|584265395|FG001|Overall Study|Physician Decision|0|||
161786752|NCT00597584|584265394|FG000|Overall Study|Pregnancy|2|||
161786753|NCT00597584|584265395|FG001|Overall Study|Pregnancy|0|||
161786754|NCT00597584|584265394|FG000|Overall Study|Withdrawal by Subject|44|||
161786755|NCT00597584|584265395|FG001|Overall Study|Withdrawal by Subject|12|||
161786756|NCT00597584|584265394|FG000|Overall Study|Discontinued Dialysis|0|||
161786757|NCT00597584|584265395|FG001|Overall Study|Discontinued Dialysis|1|||
161786758|NCT00597584|584265394|FG000|Overall Study|Lost ability to consent|1|||
161786759|NCT00597584|584265395|FG001|Overall Study|Lost ability to consent|1|||
161786760|NCT00597584|584265394|FG000|Overall Study|Never dosed|1|||
161786761|NCT00597584|584265395|FG001|Overall Study|Never dosed|0|||
161786762|NCT00597584|584265394|FG000|Overall Study|Relocation|8|||
161786763|NCT00597584|584265395|FG001|Overall Study|Relocation|6|||
161786764|NCT00597584|584265394|FG000|Overall Study|Renal transplant|9|||
161786765|NCT00597584|584265395|FG001|Overall Study|Renal transplant|7|||
161786766|NCT02280421|584265396|FG000|Washout (2 Weeks)|Adverse Event|0|||
161786767|NCT02280421|584265397|FG001|Washout (2 Weeks)|Adverse Event|1|||
161786768|NCT02280421|584265396|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
161786769|NCT02280421|584265397|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
161786770|NCT02791659|584265409|FG000|Overall Study|Protocol Violation|0|||
161786771|NCT02791659|584265410|FG001|Overall Study|Protocol Violation|1|||
161786772|NCT00881959|584265411|FG000|Overall Study|Lost to Follow-up|2|||
161786773|NCT00881959|584265412|FG001|Overall Study|Lost to Follow-up|4|||
161786774|NCT01904383|584265413|FG000|Overall Study|CRF not collected|117|||
161786775|NCT01904383|584265413|FG000|Overall Study|Reason not listed|147|||
161786776|NCT01904383|584265413|FG000|Overall Study|Lost to Follow-up|674|||
161786777|NCT01904383|584265413|FG000|Overall Study|Lack of Efficacy|370|||
161786778|NCT01904383|584265413|FG000|Overall Study|Improvement|141|||
161786779|NCT01904383|584265413|FG000|Overall Study|Adverse Event|271|||
161786780|NCT01904383|584265413|FG000|Overall Study|No patient visit after entry|54|||
161786781|NCT00472446|584265414|FG000|Overall Study|Protocol Violation|0|||
161786782|NCT00472446|584265415|FG001|Overall Study|Protocol Violation|0|||
161786783|NCT00472446|584265416|FG002|Overall Study|Protocol Violation|0|||
161786784|NCT00472446|584265417|FG003|Overall Study|Protocol Violation|1|||
161786785|NCT00472446|584265414|FG000|Overall Study|Reintervention|0|||
161786786|NCT00472446|584265415|FG001|Overall Study|Reintervention|0|||
161786787|NCT00472446|584265416|FG002|Overall Study|Reintervention|1|||
161786788|NCT00472446|584265417|FG003|Overall Study|Reintervention|1|||
161786789|NCT00472446|584265414|FG000|Overall Study|Questionnaires not returned|5|||
161786790|NCT00472446|584265415|FG001|Overall Study|Questionnaires not returned|6|||
161786791|NCT00472446|584265416|FG002|Overall Study|Questionnaires not returned|6|||
161786792|NCT00472446|584265417|FG003|Overall Study|Questionnaires not returned|4|||
161786793|NCT03211156|584265418|FG000|Overall Study|Withdrawal by Subject|0|||
161786794|NCT03211156|584265419|FG001|Overall Study|Withdrawal by Subject|2|||
161786795|NCT03211156|584265418|FG000|Overall Study|Lost to Follow-up|1|||
161786796|NCT03211156|584265419|FG001|Overall Study|Lost to Follow-up|1|||
161786797|NCT03211156|584265418|FG000|Overall Study|Adverse Event|1|||
161786798|NCT03211156|584265419|FG001|Overall Study|Adverse Event|0|||
161786799|NCT03870997|584265433|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
161786800|NCT03870997|584265434|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
161786801|NCT03870997|584265435|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
161786802|NCT03870997|584265436|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
161786803|NCT03870997|584265437|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
161786804|NCT03870997|584265438|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
161786805|NCT03726437|584265439|FG000|Overall Study|Lost to Follow-up|85|||
161786806|NCT03726437|584265440|FG001|Overall Study|Lost to Follow-up|76|||
161786807|NCT01889862|584265449|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
161786808|NCT01889862|584265450|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
161786809|NCT01889862|584265451|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
161786810|NCT01889862|584265452|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
161786811|NCT01889862|584265453|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
161786812|NCT01889862|584265449|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
161786813|NCT01889862|584265450|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
161786814|NCT01889862|584265451|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
161786815|NCT01889862|584265452|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
161786816|NCT01889862|584265453|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
161786817|NCT01889862|584265449|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
161786818|NCT01889862|584265450|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
161786819|NCT01889862|584265451|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
161786820|NCT01889862|584265452|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
161786821|NCT01889862|584265453|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
161786822|NCT01889862|584265449|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
161786823|NCT01889862|584265450|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
161786824|NCT01889862|584265451|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
161786825|NCT01889862|584265452|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
161786826|NCT01889862|584265453|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
161786827|NCT01889862|584265449|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
161786828|NCT01889862|584265450|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
161786829|NCT01889862|584265451|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
161786830|NCT01889862|584265452|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
161786831|NCT01889862|584265453|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
161786832|NCT01889862|584265449|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
161786833|NCT01889862|584265450|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
161786834|NCT01889862|584265451|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
161786835|NCT01889862|584265452|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
161786836|NCT01889862|584265453|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
161786837|NCT01889862|584265449|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
161786838|NCT01889862|584265450|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
162126356|NCT00531011|585512908|FG000|Overall Study|Death|1|||
161786839|NCT01889862|584265451|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
161786840|NCT01889862|584265452|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
161786841|NCT01889862|584265453|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
161786842|NCT01889862|584265449|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
161786843|NCT01889862|584265450|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
161786844|NCT01889862|584265451|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
161786845|NCT01889862|584265452|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
161786846|NCT01889862|584265453|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
161786847|NCT01889862|584265449|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
161786848|NCT01889862|584265450|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
161786849|NCT01889862|584265451|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
161786850|NCT01889862|584265452|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
161786851|NCT01889862|584265453|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
161786852|NCT01889862|584265449|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
161786853|NCT01889862|584265450|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
161786854|NCT01889862|584265451|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
161786855|NCT01889862|584265452|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
161786856|NCT01889862|584265453|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
161786857|NCT00033631|584265454|FG000|Overall Study|Protocol Violation|14|||
161786858|NCT00033631|584265455|FG001|Overall Study|Protocol Violation|11|||
161786859|NCT00033631|584265454|FG000|Overall Study|Withdrawal by Subject|4|||
161786860|NCT00033631|584265455|FG001|Overall Study|Withdrawal by Subject|4|||
161786861|NCT00667719|584265456|FG000|Overall Study|Adverse Event|39|||
161786862|NCT00667719|584265456|FG000|Overall Study|Abnormal Test Procedure|1|||
161786863|NCT00667719|584265456|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161786864|NCT00667719|584265456|FG000|Overall Study|Protocol Violation|3|||
161786865|NCT00667719|584265456|FG000|Overall Study|Withdrawal by Subject|17|||
161786866|NCT00667719|584265456|FG000|Overall Study|Lost to Follow-up|8|||
161786867|NCT01827371|584265457|FG000|Overall Study|Adverse Event|0|||
161786868|NCT01827371|584265458|FG001|Overall Study|Adverse Event|0|||
161786869|NCT01827371|584265459|FG002|Overall Study|Adverse Event|4|||
161786870|NCT01827371|584265460|FG003|Overall Study|Adverse Event|2|||
161786871|NCT01827371|584265457|FG000|Overall Study|Lost to Follow-up|0|||
161786872|NCT01827371|584265458|FG001|Overall Study|Lost to Follow-up|2|||
161786873|NCT01827371|584265459|FG002|Overall Study|Lost to Follow-up|0|||
161786874|NCT01827371|584265460|FG003|Overall Study|Lost to Follow-up|4|||
161786875|NCT01827371|584265457|FG000|Overall Study|Protocol Violation|1|||
161786876|NCT01827371|584265458|FG001|Overall Study|Protocol Violation|0|||
161786877|NCT01827371|584265459|FG002|Overall Study|Protocol Violation|0|||
161786878|NCT01827371|584265460|FG003|Overall Study|Protocol Violation|0|||
161786879|NCT01827371|584265457|FG000|Overall Study|Withdrawal by Subject|1|||
161786880|NCT01827371|584265458|FG001|Overall Study|Withdrawal by Subject|2|||
161786881|NCT01827371|584265459|FG002|Overall Study|Withdrawal by Subject|2|||
161786882|NCT01827371|584265460|FG003|Overall Study|Withdrawal by Subject|3|||
161786883|NCT01827371|584265457|FG000|Overall Study|Physician Decision|0|||
161786884|NCT01827371|584265458|FG001|Overall Study|Physician Decision|1|||
161786885|NCT01827371|584265459|FG002|Overall Study|Physician Decision|0|||
161786886|NCT01827371|584265460|FG003|Overall Study|Physician Decision|1|||
161786887|NCT01827371|584265457|FG000|Overall Study|Temporary study halt to vaccinations|11|||
161786888|NCT01827371|584265458|FG001|Overall Study|Temporary study halt to vaccinations|2|||
161786889|NCT01827371|584265459|FG002|Overall Study|Temporary study halt to vaccinations|5|||
161786890|NCT01827371|584265460|FG003|Overall Study|Temporary study halt to vaccinations|13|||
161786891|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786892|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786893|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786894|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
161786895|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786896|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786897|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786898|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786899|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786900|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161786901|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161786902|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161786903|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Adverse Event|1|||
161786904|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Adverse Event|1|||
161786905|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Adverse Event|1|||
161786906|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Adverse Event|1|||
161786907|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Adverse Event|0|||
161786908|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Adverse Event|0|||
161786909|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Adverse Event|0|||
161786910|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Adverse Event|0|||
161786911|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
161786912|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
161786913|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
161786914|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
161786915|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
161786916|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
161786917|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
161786918|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
161898531|NCT03654729|584677814|FG002|Overall Study|Protocol Violation|0|||
161786919|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
161786920|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
161786921|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161786922|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
161786923|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
161786924|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
161786925|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
161786926|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
161786927|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
161786928|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
161786929|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
161786930|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
161786931|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
161786932|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
161786933|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786934|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786935|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786936|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786937|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786938|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
161786939|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786940|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161786941|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786942|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786943|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786944|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786945|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
161786946|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
161786947|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786948|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786949|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786950|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161786951|NCT00950599|584265461|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
161786952|NCT00950599|584265462|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
161786953|NCT00950599|584265463|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
161786954|NCT00950599|584265464|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
161786955|NCT00950599|584265465|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
161786956|NCT00950599|584265466|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
161786957|NCT00950599|584265467|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
161786958|NCT00950599|584265468|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
161786959|NCT00950599|584265469|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
161786960|NCT00950599|584265470|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
161786961|NCT00950599|584265461|FG000|Follow-Up Period|Adverse Event|0|||
161786962|NCT00950599|584265462|FG001|Follow-Up Period|Adverse Event|0|||
161786963|NCT00950599|584265463|FG002|Follow-Up Period|Adverse Event|0|||
161786964|NCT00950599|584265464|FG003|Follow-Up Period|Adverse Event|0|||
161786965|NCT00950599|584265465|FG004|Follow-Up Period|Adverse Event|0|||
161786966|NCT00950599|584265466|FG005|Follow-Up Period|Adverse Event|0|||
161786967|NCT00950599|584265467|FG006|Follow-Up Period|Adverse Event|0|||
161786968|NCT00950599|584265468|FG007|Follow-Up Period|Adverse Event|0|||
161786969|NCT00950599|584265469|FG008|Follow-Up Period|Adverse Event|1|||
161786970|NCT00950599|584265470|FG009|Follow-Up Period|Adverse Event|0|||
161786971|NCT00950599|584265461|FG000|Follow-Up Period|Lack of Efficacy|0|||
161786972|NCT00950599|584265462|FG001|Follow-Up Period|Lack of Efficacy|0|||
161786973|NCT00950599|584265463|FG002|Follow-Up Period|Lack of Efficacy|0|||
161786974|NCT00950599|584265464|FG003|Follow-Up Period|Lack of Efficacy|0|||
161786975|NCT00950599|584265465|FG004|Follow-Up Period|Lack of Efficacy|0|||
161786976|NCT00950599|584265466|FG005|Follow-Up Period|Lack of Efficacy|0|||
161786977|NCT00950599|584265467|FG006|Follow-Up Period|Lack of Efficacy|0|||
161786978|NCT00950599|584265468|FG007|Follow-Up Period|Lack of Efficacy|0|||
161786979|NCT00950599|584265469|FG008|Follow-Up Period|Lack of Efficacy|3|||
161786980|NCT00950599|584265470|FG009|Follow-Up Period|Lack of Efficacy|0|||
161786981|NCT00950599|584265461|FG000|Follow-Up Period|Lost to Follow-up|0|||
161786982|NCT00950599|584265462|FG001|Follow-Up Period|Lost to Follow-up|0|||
161786983|NCT00950599|584265463|FG002|Follow-Up Period|Lost to Follow-up|0|||
161786984|NCT00950599|584265464|FG003|Follow-Up Period|Lost to Follow-up|0|||
161786985|NCT00950599|584265465|FG004|Follow-Up Period|Lost to Follow-up|0|||
161786986|NCT00950599|584265466|FG005|Follow-Up Period|Lost to Follow-up|0|||
161786987|NCT00950599|584265467|FG006|Follow-Up Period|Lost to Follow-up|0|||
161786988|NCT00950599|584265468|FG007|Follow-Up Period|Lost to Follow-up|0|||
161786989|NCT00950599|584265469|FG008|Follow-Up Period|Lost to Follow-up|5|||
161786990|NCT00950599|584265470|FG009|Follow-Up Period|Lost to Follow-up|1|||
161786991|NCT00950599|584265461|FG000|Follow-Up Period|Physician Decision|0|||
161786992|NCT00950599|584265462|FG001|Follow-Up Period|Physician Decision|0|||
161786993|NCT00950599|584265463|FG002|Follow-Up Period|Physician Decision|0|||
161786994|NCT00950599|584265464|FG003|Follow-Up Period|Physician Decision|0|||
161786995|NCT00950599|584265465|FG004|Follow-Up Period|Physician Decision|0|||
161786996|NCT00950599|584265466|FG005|Follow-Up Period|Physician Decision|0|||
161786997|NCT00950599|584265467|FG006|Follow-Up Period|Physician Decision|0|||
161786998|NCT00950599|584265468|FG007|Follow-Up Period|Physician Decision|0|||
161786999|NCT00950599|584265469|FG008|Follow-Up Period|Physician Decision|1|||
161787000|NCT00950599|584265470|FG009|Follow-Up Period|Physician Decision|0|||
161787001|NCT00950599|584265461|FG000|Follow-Up Period|Poor/Noncompliance|0|||
161787002|NCT00950599|584265462|FG001|Follow-Up Period|Poor/Noncompliance|0|||
161787003|NCT00950599|584265463|FG002|Follow-Up Period|Poor/Noncompliance|0|||
161787004|NCT00950599|584265464|FG003|Follow-Up Period|Poor/Noncompliance|0|||
161787005|NCT00950599|584265465|FG004|Follow-Up Period|Poor/Noncompliance|0|||
161787006|NCT00950599|584265466|FG005|Follow-Up Period|Poor/Noncompliance|0|||
161787007|NCT00950599|584265467|FG006|Follow-Up Period|Poor/Noncompliance|0|||
161787008|NCT00950599|584265468|FG007|Follow-Up Period|Poor/Noncompliance|0|||
161787009|NCT00950599|584265469|FG008|Follow-Up Period|Poor/Noncompliance|1|||
161787010|NCT00950599|584265470|FG009|Follow-Up Period|Poor/Noncompliance|0|||
161787011|NCT00950599|584265461|FG000|Follow-Up Period|Subject withdrew Consent|0|||
161787012|NCT00950599|584265462|FG001|Follow-Up Period|Subject withdrew Consent|0|||
161787013|NCT00950599|584265463|FG002|Follow-Up Period|Subject withdrew Consent|0|||
161787014|NCT00950599|584265464|FG003|Follow-Up Period|Subject withdrew Consent|0|||
161787015|NCT00950599|584265465|FG004|Follow-Up Period|Subject withdrew Consent|0|||
161787016|NCT00950599|584265466|FG005|Follow-Up Period|Subject withdrew Consent|0|||
161787017|NCT00950599|584265467|FG006|Follow-Up Period|Subject withdrew Consent|0|||
161787018|NCT00950599|584265468|FG007|Follow-Up Period|Subject withdrew Consent|0|||
161787019|NCT00950599|584265469|FG008|Follow-Up Period|Subject withdrew Consent|2|||
161787020|NCT00950599|584265470|FG009|Follow-Up Period|Subject withdrew Consent|1|||
161787021|NCT01361607|584265471|FG000|Overall Study|Adverse Event|38|||
161787022|NCT01361607|584265472|FG001|Overall Study|Adverse Event|29|||
161787023|NCT01361607|584265471|FG000|Overall Study|Withdrawal by Subject|19|||
161787024|NCT01361607|584265472|FG001|Overall Study|Withdrawal by Subject|8|||
161787025|NCT01361607|584265471|FG000|Overall Study|Withdrawal by Investigator|5|||
161787026|NCT01361607|584265472|FG001|Overall Study|Withdrawal by Investigator|3|||
161787027|NCT01361607|584265471|FG000|Overall Study|Lost to Follow-up|1|||
161787028|NCT01361607|584265472|FG001|Overall Study|Lost to Follow-up|0|||
161787029|NCT01361607|584265471|FG000|Overall Study|Met Withdrawal Criteria|1|||
161787030|NCT01361607|584265472|FG001|Overall Study|Met Withdrawal Criteria|1|||
161787031|NCT02741271|584265483|FG000|Overall Study|Lost to Follow-up|2|||
161787032|NCT02741271|584265484|FG001|Overall Study|Lost to Follow-up|0|||
161787033|NCT02741271|584265483|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161787034|NCT02741271|584265484|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161787035|NCT00373685|584265485|FG000|Overall Study|Death|2|||
161787036|NCT00373685|584265486|FG001|Overall Study|Death|1|||
161787037|NCT00373685|584265485|FG000|Overall Study|Adverse Event|278|||
161787038|NCT00373685|584265486|FG001|Overall Study|Adverse Event|253|||
161787039|NCT00373685|584265485|FG000|Overall Study|Insufficient clinical response|169|||
161787040|NCT00373685|584265486|FG001|Overall Study|Insufficient clinical response|119|||
161787041|NCT00373685|584265485|FG000|Overall Study|Did not meet entrance criteria|167|||
161787042|NCT00373685|584265486|FG001|Overall Study|Did not meet entrance criteria|184|||
161787043|NCT00373685|584265485|FG000|Overall Study|Lost to follow up|83|||
161787044|NCT00373685|584265486|FG001|Overall Study|Lost to follow up|103|||
161787045|NCT00373685|584265485|FG000|Overall Study|No longer willing to participate|337|||
161787046|NCT00373685|584265486|FG001|Overall Study|No longer willing to participate|352|||
161787047|NCT00373685|584265485|FG000|Overall Study|Other|149|||
161787048|NCT00373685|584265486|FG001|Overall Study|Other|146|||
161787049|NCT00373685|584265485|FG000|Overall Study|Protocol Violation|191|||
161787050|NCT00373685|584265486|FG001|Overall Study|Protocol Violation|182|||
161787051|NCT00373685|584265485|FG000|Overall Study|Final Status Unknown|12|||
161787052|NCT00373685|584265486|FG001|Overall Study|Final Status Unknown|4|||
161787053|NCT00373685|584265485|FG000|Overall Study|Randomized, not treated|51|||
161787054|NCT00373685|584265486|FG001|Overall Study|Randomized, not treated|77|||
161787055|NCT02570165|584265487|FG000|Overall Study|Adverse Event|1|||
161787056|NCT02570165|584265488|FG001|Overall Study|Adverse Event|0|||
161787057|NCT02570165|584265489|FG002|Overall Study|Adverse Event|2|||
161787058|NCT02570165|584265490|FG003|Overall Study|Adverse Event|0|||
161787059|NCT02570165|584265491|FG004|Overall Study|Adverse Event|0|||
161787060|NCT02570165|584265492|FG005|Overall Study|Adverse Event|0|||
161787061|NCT02570165|584265493|FG006|Overall Study|Adverse Event|0|||
161787062|NCT02570165|584265487|FG000|Overall Study|Lack of Efficacy|0|||
161787063|NCT02570165|584265488|FG001|Overall Study|Lack of Efficacy|1|||
161787064|NCT02570165|584265489|FG002|Overall Study|Lack of Efficacy|0|||
161787065|NCT02570165|584265490|FG003|Overall Study|Lack of Efficacy|0|||
161787066|NCT02570165|584265491|FG004|Overall Study|Lack of Efficacy|4|||
161787067|NCT02570165|584265492|FG005|Overall Study|Lack of Efficacy|0|||
161787068|NCT02570165|584265493|FG006|Overall Study|Lack of Efficacy|0|||
161787069|NCT02570165|584265487|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
161787070|NCT02570165|584265488|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
161787071|NCT02570165|584265489|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
161787072|NCT02570165|584265490|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
161787073|NCT02570165|584265491|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
161787074|NCT02570165|584265492|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
161787075|NCT02570165|584265493|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
161787076|NCT02570165|584265487|FG000|Overall Study|Lost to Follow-up|0|||
161787077|NCT02570165|584265488|FG001|Overall Study|Lost to Follow-up|0|||
161787078|NCT02570165|584265489|FG002|Overall Study|Lost to Follow-up|1|||
161787079|NCT02570165|584265490|FG003|Overall Study|Lost to Follow-up|1|||
161787080|NCT02570165|584265491|FG004|Overall Study|Lost to Follow-up|0|||
161787081|NCT02570165|584265492|FG005|Overall Study|Lost to Follow-up|0|||
161787082|NCT02570165|584265493|FG006|Overall Study|Lost to Follow-up|0|||
161787083|NCT02570165|584265487|FG000|Overall Study|Physician Decision|0|||
161787084|NCT02570165|584265488|FG001|Overall Study|Physician Decision|1|||
161787085|NCT02570165|584265489|FG002|Overall Study|Physician Decision|0|||
161787086|NCT02570165|584265490|FG003|Overall Study|Physician Decision|0|||
161787087|NCT02570165|584265491|FG004|Overall Study|Physician Decision|0|||
161787088|NCT02570165|584265492|FG005|Overall Study|Physician Decision|0|||
161787089|NCT02570165|584265493|FG006|Overall Study|Physician Decision|0|||
161787090|NCT02570165|584265487|FG000|Overall Study|Withdrawal by Subject|0|||
161787091|NCT02570165|584265488|FG001|Overall Study|Withdrawal by Subject|0|||
161787092|NCT02570165|584265489|FG002|Overall Study|Withdrawal by Subject|0|||
161787093|NCT02570165|584265490|FG003|Overall Study|Withdrawal by Subject|2|||
161787094|NCT02570165|584265491|FG004|Overall Study|Withdrawal by Subject|1|||
161787095|NCT02570165|584265492|FG005|Overall Study|Withdrawal by Subject|0|||
161787096|NCT02570165|584265493|FG006|Overall Study|Withdrawal by Subject|0|||
161787097|NCT02570165|584265487|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
161787098|NCT02570165|584265488|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
161787099|NCT02570165|584265489|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
161787100|NCT02570165|584265490|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
161787101|NCT02570165|584265491|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
161787102|NCT02570165|584265492|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
161787103|NCT02570165|584265493|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
161787104|NCT02570165|584265487|FG000|Overall Study|Withdrawal Request by GSK|0|||
161787105|NCT02570165|584265488|FG001|Overall Study|Withdrawal Request by GSK|0|||
161787106|NCT02570165|584265489|FG002|Overall Study|Withdrawal Request by GSK|2|||
161787107|NCT02570165|584265490|FG003|Overall Study|Withdrawal Request by GSK|0|||
161787108|NCT02570165|584265491|FG004|Overall Study|Withdrawal Request by GSK|0|||
161787109|NCT02570165|584265492|FG005|Overall Study|Withdrawal Request by GSK|0|||
161787110|NCT02570165|584265493|FG006|Overall Study|Withdrawal Request by GSK|0|||
161787111|NCT01953783|584265494|FG000|Overall Study|Progressive disease|2|||
161787112|NCT01789281|584265495|FG000|Overall Study|Disease progression|15|||
161787113|NCT01789281|584265496|FG001|Overall Study|Disease progression|4|||
161787114|NCT01789281|584265495|FG000|Overall Study|Adverse Event|5|||
161787115|NCT01789281|584265496|FG001|Overall Study|Adverse Event|5|||
161787116|NCT01789281|584265495|FG000|Overall Study|Withdrawal by Subject|1|||
161787117|NCT01789281|584265496|FG001|Overall Study|Withdrawal by Subject|0|||
161787118|NCT01789281|584265495|FG000|Overall Study|Lost to Follow-up|1|||
161787119|NCT01789281|584265496|FG001|Overall Study|Lost to Follow-up|0|||
161787120|NCT01789281|584265495|FG000|Overall Study|Administrative problems|0|||
161787121|NCT01789281|584265496|FG001|Overall Study|Administrative problems|1|||
161787122|NCT00411762|584265498|FG000|Overall Study|Withdrawal by Subject|5|||
161787123|NCT04428502|584265499|FG000|Overall Study|Did not meet entrance criteria|14|||
161787124|NCT02295280|584265501|FG000|Overall Study|Adverse Event|0|||
161787125|NCT02295280|584265502|FG001|Overall Study|Adverse Event|1|||
161787126|NCT02875067|584265503|FG000|Overall Study|Withdrawal by Subject|1|||
161787127|NCT02875067|584265503|FG000|Overall Study|Withdrawal by Termination of Study|5|||
161787128|NCT01430104|584265504|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
161787129|NCT02713243|584265506|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
161787130|NCT02713243|584265507|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
161787131|NCT02713243|584265506|FG000|Overall Study|Administrative problems|0|||
161787132|NCT02713243|584265507|FG001|Overall Study|Administrative problems|1|||
161787133|NCT02713243|584265506|FG000|Overall Study|Protocol deviation|0|||
161787134|NCT02713243|584265507|FG001|Overall Study|Protocol deviation|1|||
161787135|NCT03056352|584265508|FG000|Overall Study|Lost to Follow-up|1|||
161787136|NCT02971605|584265509|FG000|Overall Study|Withdrawal by Subject|1|||
161787137|NCT00435825|584265524|FG000|Overall Study|Abnormality of Laboratory Test|0|||
161787138|NCT00435825|584265525|FG001|Overall Study|Abnormality of Laboratory Test|1|||
161787139|NCT00435825|584265526|FG002|Overall Study|Abnormality of Laboratory Test|0|||
161787140|NCT00435825|584265527|FG003|Overall Study|Abnormality of Laboratory Test|0|||
161787141|NCT00435825|584265524|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161787142|NCT00435825|584265525|FG001|Overall Study|Insufficient Therapeutic Response|1|||
161787143|NCT00435825|584265526|FG002|Overall Study|Insufficient Therapeutic Response|0|||
161787144|NCT00435825|584265527|FG003|Overall Study|Insufficient Therapeutic Response|3|||
161787145|NCT00435825|584265524|FG000|Overall Study|Other Protocol Violation|1|||
161787146|NCT00435825|584265525|FG001|Overall Study|Other Protocol Violation|0|||
161787147|NCT00435825|584265526|FG002|Overall Study|Other Protocol Violation|0|||
161787148|NCT00435825|584265527|FG003|Overall Study|Other Protocol Violation|0|||
161787149|NCT00435825|584265524|FG000|Overall Study|Refused treatment|2|||
161787150|NCT00435825|584265525|FG001|Overall Study|Refused treatment|0|||
161787151|NCT00435825|584265526|FG002|Overall Study|Refused treatment|0|||
161787152|NCT00435825|584265527|FG003|Overall Study|Refused treatment|5|||
161787153|NCT00435825|584265524|FG000|Overall Study|Failure to return|5|||
161787154|NCT00435825|584265525|FG001|Overall Study|Failure to return|0|||
161787155|NCT00435825|584265526|FG002|Overall Study|Failure to return|4|||
161787156|NCT00435825|584265527|FG003|Overall Study|Failure to return|0|||
161787157|NCT00435825|584265524|FG000|Overall Study|Did not receive study drug|1|||
161787158|NCT00435825|584265525|FG001|Overall Study|Did not receive study drug|0|||
161787159|NCT00435825|584265526|FG002|Overall Study|Did not receive study drug|2|||
161787160|NCT00435825|584265527|FG003|Overall Study|Did not receive study drug|0|||
161787161|NCT00435825|584265524|FG000|Overall Study|Did not enter follow-up|0|||
161787162|NCT00435825|584265525|FG001|Overall Study|Did not enter follow-up|4|||
161787163|NCT00435825|584265526|FG002|Overall Study|Did not enter follow-up|1|||
161787164|NCT00435825|584265527|FG003|Overall Study|Did not enter follow-up|3|||
161787165|NCT00435825|584265524|FG000|Overall Study|Did not complete full follow-up period|6|||
161787166|NCT00435825|584265525|FG001|Overall Study|Did not complete full follow-up period|6|||
161787167|NCT00435825|584265526|FG002|Overall Study|Did not complete full follow-up period|4|||
161787168|NCT00435825|584265527|FG003|Overall Study|Did not complete full follow-up period|5|||
161787169|NCT03033069|584265528|FG000|Overall Study|Adverse Event|6|||
161787170|NCT03033069|584265529|FG001|Overall Study|Adverse Event|7|||
161787171|NCT03033069|584265530|FG002|Overall Study|Adverse Event|4|||
161787172|NCT03033069|584265531|FG003|Overall Study|Adverse Event|6|||
161787173|NCT03033069|584265528|FG000|Overall Study|Lack of Efficacy|0|||
161787174|NCT03033069|584265529|FG001|Overall Study|Lack of Efficacy|0|||
161898532|NCT03654729|584677812|FG000|Overall Study|Non-compliance with study drug|0|||
161898533|NCT03654729|584677813|FG001|Overall Study|Non-compliance with study drug|1|||
161898534|NCT03654729|584677814|FG002|Overall Study|Non-compliance with study drug|0|||
161898535|NCT03654729|584677812|FG000|Overall Study|Site terminated by Sponsor|1|||
161787175|NCT03033069|584265530|FG002|Overall Study|Lack of Efficacy|1|||
161787176|NCT03033069|584265531|FG003|Overall Study|Lack of Efficacy|0|||
161787177|NCT03033069|584265528|FG000|Overall Study|Lost to Follow-up|6|||
161787178|NCT03033069|584265529|FG001|Overall Study|Lost to Follow-up|5|||
161787179|NCT03033069|584265530|FG002|Overall Study|Lost to Follow-up|5|||
161787180|NCT03033069|584265531|FG003|Overall Study|Lost to Follow-up|6|||
161787181|NCT03033069|584265528|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161787182|NCT03033069|584265529|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161787183|NCT03033069|584265530|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161787184|NCT03033069|584265531|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161787185|NCT03033069|584265528|FG000|Overall Study|Protocol Deviation|0|||
161787186|NCT03033069|584265529|FG001|Overall Study|Protocol Deviation|1|||
161787187|NCT03033069|584265530|FG002|Overall Study|Protocol Deviation|0|||
161787188|NCT03033069|584265531|FG003|Overall Study|Protocol Deviation|0|||
161787189|NCT03033069|584265528|FG000|Overall Study|Withdrawal by Subject|10|||
161787190|NCT03033069|584265529|FG001|Overall Study|Withdrawal by Subject|10|||
161787191|NCT03033069|584265530|FG002|Overall Study|Withdrawal by Subject|11|||
161787192|NCT03033069|584265531|FG003|Overall Study|Withdrawal by Subject|6|||
161787193|NCT03033069|584265528|FG000|Overall Study|Withdrawal By Caregiver|1|||
161787194|NCT03033069|584265529|FG001|Overall Study|Withdrawal By Caregiver|0|||
161787195|NCT03033069|584265530|FG002|Overall Study|Withdrawal By Caregiver|0|||
161787196|NCT03033069|584265531|FG003|Overall Study|Withdrawal By Caregiver|0|||
161787197|NCT03033069|584265528|FG000|Overall Study|Reason not Specified|0|||
161787198|NCT03033069|584265529|FG001|Overall Study|Reason not Specified|1|||
161787199|NCT03033069|584265530|FG002|Overall Study|Reason not Specified|0|||
161787200|NCT03033069|584265531|FG003|Overall Study|Reason not Specified|1|||
161787201|NCT00430638|584265532|FG000|Overall Study|Adverse Event|15|||
161787202|NCT00430638|584265533|FG001|Overall Study|Adverse Event|15|||
161787203|NCT00430638|584265532|FG000|Overall Study|Uncontrolled blood pressure|48|||
161787204|NCT00430638|584265533|FG001|Overall Study|Uncontrolled blood pressure|13|||
161898536|NCT03654729|584677813|FG001|Overall Study|Site terminated by Sponsor|0|||
161787205|NCT00430638|584265532|FG000|Overall Study|Lost to Follow-up|1|||
161787206|NCT00430638|584265533|FG001|Overall Study|Lost to Follow-up|7|||
161787207|NCT00430638|584265532|FG000|Overall Study|Protocol Violation|6|||
161898537|NCT03654729|584677814|FG002|Overall Study|Site terminated by Sponsor|0|||
161787208|NCT00430638|584265533|FG001|Overall Study|Protocol Violation|4|||
161787209|NCT00430638|584265532|FG000|Overall Study|Withdrawal by Subject|4|||
161787210|NCT00430638|584265533|FG001|Overall Study|Withdrawal by Subject|6|||
161787211|NCT00430638|584265532|FG000|Overall Study|Non-compliant|2|||
161787212|NCT00430638|584265533|FG001|Overall Study|Non-compliant|1|||
161787213|NCT00430638|584265532|FG000|Overall Study|Other|2|||
161787214|NCT00430638|584265533|FG001|Overall Study|Other|2|||
161787215|NCT02367781|584265536|FG000|Overall Study|Withdrawal by Subject|20|||
161787216|NCT02367781|584265537|FG001|Overall Study|Withdrawal by Subject|13|||
161787217|NCT02367781|584265536|FG000|Overall Study|Protocol Violation|0|||
161787218|NCT02367781|584265537|FG001|Overall Study|Protocol Violation|1|||
161787219|NCT02367781|584265536|FG000|Overall Study|Physician Decision|7|||
161787220|NCT02367781|584265537|FG001|Overall Study|Physician Decision|0|||
161787221|NCT02367781|584265536|FG000|Overall Study|Randomized in Error|5|||
161787222|NCT02367781|584265537|FG001|Overall Study|Randomized in Error|4|||
161787223|NCT02367781|584265536|FG000|Overall Study|Non-Compliance|1|||
161787224|NCT02367781|584265537|FG001|Overall Study|Non-Compliance|0|||
161787225|NCT02367781|584265536|FG000|Overall Study|Lost to Follow-up|1|||
161787226|NCT02367781|584265537|FG001|Overall Study|Lost to Follow-up|2|||
161787227|NCT02367781|584265536|FG000|Overall Study|Death|330|||
161787228|NCT02367781|584265537|FG001|Overall Study|Death|176|||
161787229|NCT02367781|584265536|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
161787230|NCT02367781|584265537|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
161787231|NCT02367781|584265536|FG000|Overall Study|Prolonged Hospitalization|1|||
161787232|NCT02367781|584265537|FG001|Overall Study|Prolonged Hospitalization|0|||
161787233|NCT02367781|584265536|FG000|Overall Study|Death Prior First Dose|1|||
161787234|NCT02367781|584265537|FG001|Overall Study|Death Prior First Dose|0|||
161787235|NCT02367781|584265536|FG000|Overall Study|Administrative-Change Facility|1|||
161787236|NCT02367781|584265537|FG001|Overall Study|Administrative-Change Facility|0|||
161787237|NCT02367781|584265536|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
161787238|NCT02367781|584265537|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
161787239|NCT02367781|584265536|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
161787240|NCT02367781|584265537|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
161787241|NCT02367781|584265536|FG000|Overall Study|Study Terminated by Sponsor|3|||
161787242|NCT02367781|584265537|FG001|Overall Study|Study Terminated by Sponsor|1|||
161787243|NCT02367781|584265536|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
161787244|NCT02367781|584265537|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
161787245|NCT02367781|584265536|FG000|Overall Study|Sponsor Decision|2|||
161787246|NCT02367781|584265537|FG001|Overall Study|Sponsor Decision|0|||
161787247|NCT02367781|584265536|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
161787248|NCT02367781|584265537|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
161787249|NCT03262233|584266625|FG000|Overall Study|Withdrawal by Subject|12|||
161787250|NCT03262233|584266626|FG001|Overall Study|Withdrawal by Subject|8|||
161787251|NCT03262233|584266627|FG002|Overall Study|Withdrawal by Subject|21|||
161787252|NCT03262233|584266628|FG003|Overall Study|Withdrawal by Subject|13|||
161787253|NCT03262233|584266625|FG000|Overall Study|Declined due to shock|1|||
161787254|NCT03262233|584266626|FG001|Overall Study|Declined due to shock|2|||
161787255|NCT03262233|584266627|FG002|Overall Study|Declined due to shock|2|||
161787256|NCT03262233|584266628|FG003|Overall Study|Declined due to shock|3|||
161787257|NCT03262233|584266625|FG000|Overall Study|Protocol Violation|5|||
161787258|NCT03262233|584266626|FG001|Overall Study|Protocol Violation|10|||
161787259|NCT03262233|584266627|FG002|Overall Study|Protocol Violation|2|||
161787260|NCT03262233|584266628|FG003|Overall Study|Protocol Violation|13|||
161787261|NCT03262233|584266625|FG000|Overall Study|data collection artifact|0|||
161787262|NCT03262233|584266626|FG001|Overall Study|data collection artifact|1|||
161787263|NCT03262233|584266627|FG002|Overall Study|data collection artifact|0|||
161787264|NCT03262233|584266628|FG003|Overall Study|data collection artifact|0|||
161787265|NCT03877237|584266629|FG000|Overall Study|Adverse Event|1|||
161787266|NCT03877237|584266630|FG001|Overall Study|Adverse Event|2|||
161787267|NCT03877237|584266629|FG000|Overall Study|Death|3|||
161787268|NCT03877237|584266630|FG001|Overall Study|Death|2|||
161787269|NCT03877237|584266629|FG000|Overall Study|Physician Decision|1|||
161787270|NCT03877237|584266630|FG001|Overall Study|Physician Decision|0|||
162010413|NCT03818256|585093754|FG000|Overall Study|Withdrawal by Subject|2|||
162010414|NCT03818256|585093755|FG001|Overall Study|Withdrawal by Subject|2|||
162010415|NCT03818256|585093754|FG000|Overall Study|Adverse Event|3|||
162010416|NCT03818256|585093755|FG001|Overall Study|Adverse Event|1|||
162010417|NCT03818256|585093754|FG000|Overall Study|Lost to Follow-up|0|||
161787271|NCT03877237|584266629|FG000|Overall Study|Withdrawal by Subject|0|||
161787272|NCT03877237|584266630|FG001|Overall Study|Withdrawal by Subject|2|||
161787273|NCT00566098|584266632|FG000|Collection of MILs|Withdrawal by Subject|1|||
161787274|NCT00566098|584266632|FG000|Collection of MILs|Relapsed|1|||
161787275|NCT00566098|584266632|FG000|Generation of MILs Product|Relapsed|1|||
161787276|NCT00566098|584266632|FG000|Administration of ASCT+MILs|Death|10|||
161787277|NCT00566098|584266632|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
161787278|NCT02236754|584266633|FG000|Overall Study|Withdrawal by Subject|1|||
161787279|NCT02236754|584266634|FG001|Overall Study|Withdrawal by Subject|0|||
161787280|NCT01270841|584266635|FG000|Overall Study|Adverse Event|0|||
161787281|NCT01270841|584266636|FG001|Overall Study|Adverse Event|1|||
161787282|NCT01270841|584266637|FG002|Overall Study|Adverse Event|0|||
161787283|NCT01270841|584266638|FG003|Overall Study|Adverse Event|3|||
161787284|NCT01270841|584266635|FG000|Overall Study|Withdrawal by Subject|3|||
161787285|NCT01270841|584266636|FG001|Overall Study|Withdrawal by Subject|2|||
161787286|NCT01270841|584266637|FG002|Overall Study|Withdrawal by Subject|3|||
161787287|NCT01270841|584266638|FG003|Overall Study|Withdrawal by Subject|3|||
161787288|NCT01270841|584266635|FG000|Overall Study|Lost to Follow-up|3|||
161787289|NCT01270841|584266636|FG001|Overall Study|Lost to Follow-up|1|||
161787290|NCT01270841|584266637|FG002|Overall Study|Lost to Follow-up|4|||
161787291|NCT01270841|584266638|FG003|Overall Study|Lost to Follow-up|2|||
161787292|NCT01270841|584266635|FG000|Overall Study|Physician Decision|0|||
161787293|NCT01270841|584266636|FG001|Overall Study|Physician Decision|1|||
161787294|NCT01270841|584266637|FG002|Overall Study|Physician Decision|0|||
161787295|NCT01270841|584266638|FG003|Overall Study|Physician Decision|0|||
161787296|NCT01270841|584266635|FG000|Overall Study|Did not qualify|6|||
161787297|NCT01270841|584266636|FG001|Overall Study|Did not qualify|3|||
161787298|NCT01270841|584266637|FG002|Overall Study|Did not qualify|4|||
161787299|NCT01270841|584266638|FG003|Overall Study|Did not qualify|5|||
161787300|NCT01270841|584266635|FG000|Overall Study|Protocol Violation|1|||
161787301|NCT01270841|584266636|FG001|Overall Study|Protocol Violation|5|||
161787302|NCT01270841|584266637|FG002|Overall Study|Protocol Violation|0|||
161787303|NCT01270841|584266638|FG003|Overall Study|Protocol Violation|0|||
161787304|NCT01270841|584266635|FG000|Overall Study|Enrolled in error|0|||
161787305|NCT01270841|584266636|FG001|Overall Study|Enrolled in error|1|||
161787306|NCT01270841|584266637|FG002|Overall Study|Enrolled in error|0|||
161787307|NCT01270841|584266638|FG003|Overall Study|Enrolled in error|0|||
161787308|NCT00515073|584266641|FG000|Overall Study|Withdrawal by Subject|1|||
161787309|NCT00515073|584266641|FG000|Overall Study|Physician Decision|1|||
161787310|NCT02764489|584266642|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
161787311|NCT02764489|584266643|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
161787312|NCT02764489|584266642|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
161787313|NCT02764489|584266643|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
161787314|NCT02764489|584266642|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
161787315|NCT02764489|584266643|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
161787316|NCT02764489|584266642|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
161787317|NCT02764489|584266643|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
161787318|NCT01625845|584266644|FG000|Overall Study|Adverse Event|1|||
161787319|NCT01625845|584266645|FG001|Overall Study|Adverse Event|2|||
161787320|NCT01625845|584266644|FG000|Overall Study|Lost to Follow-up|2|||
161787321|NCT01625845|584266645|FG001|Overall Study|Lost to Follow-up|1|||
161787322|NCT01625845|584266644|FG000|Overall Study|Withdrawal by Subject|2|||
161787323|NCT01625845|584266645|FG001|Overall Study|Withdrawal by Subject|0|||
161787324|NCT01294592|584266646|FG000|Overall Study|Adverse Event|28|||
161787325|NCT01294592|584266647|FG001|Overall Study|Adverse Event|13|||
161787326|NCT01294592|584266646|FG000|Overall Study|Lack of Efficacy|7|||
161787327|NCT01294592|584266647|FG001|Overall Study|Lack of Efficacy|5|||
161787328|NCT01294592|584266646|FG000|Overall Study|Protocol Violation|1|||
161787329|NCT01294592|584266647|FG001|Overall Study|Protocol Violation|7|||
161787330|NCT01294592|584266646|FG000|Overall Study|Lost to Follow-up|7|||
161787331|NCT01294592|584266647|FG001|Overall Study|Lost to Follow-up|9|||
161787332|NCT01294592|584266646|FG000|Overall Study|Physician Decision|6|||
161787333|NCT01294592|584266647|FG001|Overall Study|Physician Decision|11|||
161787334|NCT01294592|584266646|FG000|Overall Study|Withdrawal by Subject|28|||
161787335|NCT01294592|584266647|FG001|Overall Study|Withdrawal by Subject|28|||
161787336|NCT02853929|584266648|FG000|Overall Study|Lost to Follow-up|3|||
161787337|NCT02853929|584266649|FG001|Overall Study|Lost to Follow-up|0|||
161787338|NCT02853929|584266648|FG000|Overall Study|Withdrawal by Subject|1|||
161787339|NCT02853929|584266649|FG001|Overall Study|Withdrawal by Subject|0|||
161787340|NCT02853929|584266648|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
161787341|NCT02853929|584266649|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
161787342|NCT00623623|584266650|FG000|Overall Study|Previous enrolment into this study|1|||
161787343|NCT00623623|584266651|FG001|Overall Study|Previous enrolment into this study|1|||
161787344|NCT00693784|584266652|FG000|Overall Study|Lost to Follow-up|2|||
161787345|NCT00693784|584266652|FG000|Overall Study|Withdrawal by Subject|2|||
161787346|NCT02265952|584266653|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
161787347|NCT02265952|584266654|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
161787348|NCT02265952|584266653|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
161787349|NCT02265952|584266654|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
161787350|NCT00326885|584266657|FG000|Overall Study|Adverse Event|1|||
161787351|NCT00326885|584266657|FG000|Overall Study|Withdrawal by Subject|3|||
161787352|NCT00326885|584266657|FG000|Overall Study|Physician Decision|1|||
161787353|NCT00326885|584266657|FG000|Overall Study|Hospice withdrew consent|2|||
161787354|NCT00738673|584266669|FG000|Overall Study|Adverse Event|1|||
161787355|NCT00738673|584266670|FG001|Overall Study|Adverse Event|0|||
161787356|NCT00738673|584266669|FG000|Overall Study|Lack of Efficacy|19|||
161787357|NCT00738673|584266670|FG001|Overall Study|Lack of Efficacy|8|||
161787358|NCT00738673|584266669|FG000|Overall Study|Protocol Violation|1|||
161787359|NCT00738673|584266670|FG001|Overall Study|Protocol Violation|2|||
161787360|NCT00738673|584266669|FG000|Overall Study|Withdrawal by Subject|3|||
161787361|NCT00738673|584266670|FG001|Overall Study|Withdrawal by Subject|1|||
161787362|NCT02736227|584266671|FG000|Overall Study|Withdrawal by Subject|0|||
161787363|NCT02736227|584266672|FG001|Overall Study|Withdrawal by Subject|0|||
161787364|NCT02736227|584266673|FG002|Overall Study|Withdrawal by Subject|1|||
161787365|NCT02736227|584266671|FG000|Overall Study|Physician Decision|0|||
161787366|NCT02736227|584266672|FG001|Overall Study|Physician Decision|0|||
161787367|NCT02736227|584266673|FG002|Overall Study|Physician Decision|5|||
161787368|NCT02736227|584266671|FG000|Overall Study|Non Compliant|0|||
161787369|NCT02736227|584266672|FG001|Overall Study|Non Compliant|0|||
161787370|NCT02736227|584266673|FG002|Overall Study|Non Compliant|2|||
161787371|NCT01205529|584266674|FG000|Overall Study|Procedure Cancelled|4|||
161787372|NCT01205529|584266674|FG000|Overall Study|Withdrawal by Subject|2|||
161787373|NCT01205529|584266674|FG000|Overall Study|Physician Decision|4|||
161787374|NCT01205529|584266674|FG000|Overall Study|Unstable post op|15|||
161787375|NCT01205529|584266674|FG000|Overall Study|No longer met criteria|30|||
161787376|NCT04133519|584266677|FG000|Overall Study|Withdrawal by Subject|5|||
161787377|NCT04133519|584266678|FG001|Overall Study|Withdrawal by Subject|4|||
161787378|NCT04133519|584266677|FG000|Overall Study|Protocol Violation|0|||
161787379|NCT04133519|584266678|FG001|Overall Study|Protocol Violation|1|||
161787380|NCT04133519|584266677|FG000|Overall Study|Never started treatment|1|||
161787381|NCT04133519|584266678|FG001|Overall Study|Never started treatment|1|||
161787382|NCT03840135|584266679|FG000|Overall Study|Protocol Violation|6|||
161787383|NCT03840135|584266680|FG001|Overall Study|Protocol Violation|1|||
161787384|NCT03840135|584266679|FG000|Overall Study|Withdrawal by Subject|1|||
161787385|NCT03840135|584266680|FG001|Overall Study|Withdrawal by Subject|0|||
161787386|NCT00323609|584266681|FG000|Overall Study|Death|16|||
161787387|NCT00323609|584266682|FG001|Overall Study|Death|21|||
161787388|NCT00323609|584266683|FG002|Overall Study|Death|0|||
161787389|NCT00323609|584266684|FG003|Overall Study|Death|0|||
161787390|NCT00323609|584266681|FG000|Overall Study|Lost to Follow-up|9|||
161787391|NCT00323609|584266682|FG001|Overall Study|Lost to Follow-up|10|||
161787392|NCT00323609|584266683|FG002|Overall Study|Lost to Follow-up|0|||
161787393|NCT00323609|584266684|FG003|Overall Study|Lost to Follow-up|0|||
161787394|NCT00323609|584266681|FG000|Overall Study|Physician Decision|2|||
161787395|NCT00323609|584266682|FG001|Overall Study|Physician Decision|0|||
161787396|NCT00323609|584266683|FG002|Overall Study|Physician Decision|0|||
161787397|NCT00323609|584266684|FG003|Overall Study|Physician Decision|1|||
161787398|NCT00323609|584266681|FG000|Overall Study|Withdrawal by Subject|11|||
161787399|NCT00323609|584266682|FG001|Overall Study|Withdrawal by Subject|23|||
161787400|NCT00323609|584266683|FG002|Overall Study|Withdrawal by Subject|4|||
161787401|NCT00323609|584266684|FG003|Overall Study|Withdrawal by Subject|4|||
161787402|NCT00323609|584266681|FG000|Overall Study|Other non-VCF-related medical condition|3|||
161787403|NCT00323609|584266682|FG001|Overall Study|Other non-VCF-related medical condition|2|||
161787404|NCT00323609|584266683|FG002|Overall Study|Other non-VCF-related medical condition|0|||
161787405|NCT00323609|584266684|FG003|Overall Study|Other non-VCF-related medical condition|0|||
161787406|NCT00323609|584266681|FG000|Overall Study|Sponsor discontinued trial|29|||
161787407|NCT00323609|584266682|FG001|Overall Study|Sponsor discontinued trial|29|||
161787408|NCT00323609|584266683|FG002|Overall Study|Sponsor discontinued trial|0|||
161787409|NCT00323609|584266684|FG003|Overall Study|Sponsor discontinued trial|0|||
161787410|NCT00323609|584266681|FG000|Overall Study|Unrelenting or severe back pain|1|||
161787411|NCT00323609|584266682|FG001|Overall Study|Unrelenting or severe back pain|1|||
161787412|NCT00323609|584266683|FG002|Overall Study|Unrelenting or severe back pain|0|||
161787413|NCT00323609|584266684|FG003|Overall Study|Unrelenting or severe back pain|0|||
161787414|NCT00323609|584266681|FG000|Overall Study|Logistical withdrawal|9|||
161787415|NCT00323609|584266682|FG001|Overall Study|Logistical withdrawal|5|||
161787416|NCT00323609|584266683|FG002|Overall Study|Logistical withdrawal|0|||
161787417|NCT00323609|584266684|FG003|Overall Study|Logistical withdrawal|1|||
162126357|NCT00531011|585512909|FG001|Overall Study|Death|0|||
162126358|NCT00531011|585512908|FG000|Overall Study|Lost to Follow-up|1|||
162126359|NCT00531011|585512909|FG001|Overall Study|Lost to Follow-up|0|||
162126360|NCT00531011|585512908|FG000|Overall Study|Physician Decision|0|||
162126361|NCT00531011|585512909|FG001|Overall Study|Physician Decision|3|||
162126362|NCT04254679|585512934|FG000|Overall Study|Protocol Violation|1|||
161787418|NCT00323609|584266681|FG000|Overall Study|Other reason|11|||
161787419|NCT00323609|584266682|FG001|Overall Study|Other reason|8|||
161787420|NCT00323609|584266683|FG002|Overall Study|Other reason|4|||
161787421|NCT00323609|584266684|FG003|Overall Study|Other reason|9|||
162126363|NCT04254679|585512935|FG001|Overall Study|Protocol Violation|1|||
161787422|NCT00068237|584266687|FG000|Overall Study|Ineligible|3|||
161787423|NCT00068237|584266687|FG000|Overall Study|No protocol treatment received|2|||
161787424|NCT05288673|584266688|FG000|Overall Study|Consent withdrawn by subject|0|||
161787425|NCT05288673|584266689|FG001|Overall Study|Consent withdrawn by subject|0|||
161787426|NCT05288673|584266690|FG002|Overall Study|Consent withdrawn by subject|1|||
161787427|NCT00571922|584266691|FG000|Overall Study|Completion unknown|36|||
162126364|NCT04254679|585512934|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
161787428|NCT00571922|584266692|FG001|Overall Study|Completion unknown|36|||
161787429|NCT01154153|584266695|FG000|Overall Study|Poor compliance to protocol|2|||
161787430|NCT01154153|584266696|FG001|Overall Study|Poor compliance to protocol|0|||
161787431|NCT01154153|584266695|FG000|Overall Study|Unable to use labs|2|||
161787432|NCT01154153|584266696|FG001|Overall Study|Unable to use labs|3|||
161787433|NCT01154153|584266695|FG000|Overall Study|Withdrew consent|1|||
161787434|NCT01154153|584266696|FG001|Overall Study|Withdrew consent|0|||
161787435|NCT00964223|584266697|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
161787436|NCT03439293|584266698|FG000|Overall Study|Death|22|||
161787437|NCT03439293|584266698|FG000|Overall Study|Withdrawal by Subject|8|||
161787438|NCT03439293|584266698|FG000|Overall Study|Lost to Follow-up|2|||
161787439|NCT03439293|584266698|FG000|Overall Study|Reason Not Specified|28|||
161787440|NCT03439293|584266698|FG000|Overall Study|Missing|1|||
161787441|NCT03404206|584266701|FG000|Overall Study|Withdrawal by Subject|1|||
161787442|NCT03404206|584266702|FG001|Overall Study|Withdrawal by Subject|1|||
161787443|NCT03404206|584266703|FG002|Overall Study|Withdrawal by Subject|0|||
161787444|NCT03404206|584266701|FG000|Overall Study|Lost to Follow-up|3|||
161787445|NCT03404206|584266702|FG001|Overall Study|Lost to Follow-up|1|||
161787446|NCT03404206|584266703|FG002|Overall Study|Lost to Follow-up|0|||
161787447|NCT05478603|584266704|FG000|Overall Study|Withdrawal by Subject|0|||
161787448|NCT05478603|584266705|FG001|Overall Study|Withdrawal by Subject|1|||
161787449|NCT05478603|584266706|FG002|Overall Study|Withdrawal by Subject|0|||
161787450|NCT05478603|584266707|FG003|Overall Study|Withdrawal by Subject|0|||
161787451|NCT03634488|584266710|FG000|Overall Study|Death|1|||
161787452|NCT03634488|584266711|FG001|Overall Study|Death|0|||
161787453|NCT03634488|584266712|FG002|Overall Study|Death|0|||
161787454|NCT03634488|584266710|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
161787455|NCT03634488|584266711|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
161787456|NCT03634488|584266712|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
161787457|NCT00869089|584266713|FG000|Overall Study|Lost to Follow-up|1|||
161787458|NCT00869089|584266713|FG000|Overall Study|Withdrawal by Subject|1|||
161787459|NCT00869089|584266713|FG000|Overall Study|Screen Fail|1|||
161787460|NCT01169844|584266721|FG000|Overall Study|Adverse Event|0|||
161787461|NCT01169844|584266722|FG001|Overall Study|Adverse Event|1|||
161787462|NCT01169844|584266721|FG000|Overall Study|Patient withdrew consent|4|||
161787463|NCT01169844|584266722|FG001|Overall Study|Patient withdrew consent|0|||
161787464|NCT01169844|584266721|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161787465|NCT01169844|584266722|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161787466|NCT05003167|584266726|FG000|Overall Study|Withdrawal by Subject|1|||
161787467|NCT01010230|584266727|FG000|Overall Study|Withdrawal by Subject|6|||
161787468|NCT01010230|584266728|FG001|Overall Study|Withdrawal by Subject|5|||
161787469|NCT01010230|584266727|FG000|Overall Study|Lost to Follow-up|4|||
161787470|NCT01010230|584266728|FG001|Overall Study|Lost to Follow-up|2|||
161787471|NCT00530439|584266729|FG000|Overall Study|GDM|9|||
161787472|NCT00530439|584266730|FG001|Overall Study|GDM|3|||
161787473|NCT00530439|584266729|FG000|Overall Study|Withdraw|18|||
161787474|NCT00530439|584266730|FG001|Overall Study|Withdraw|14|||
161787475|NCT00530439|584266729|FG000|Overall Study|Missed abortion|1|||
161787476|NCT00530439|584266730|FG001|Overall Study|Missed abortion|4|||
161787477|NCT00530439|584266729|FG000|Overall Study|Misclassification|2|||
161787478|NCT00530439|584266730|FG001|Overall Study|Misclassification|0|||
161787479|NCT00530439|584266729|FG000|Overall Study|Twin pregnancy|0|||
161787480|NCT00530439|584266730|FG001|Overall Study|Twin pregnancy|2|||
161787481|NCT00530439|584266729|FG000|Overall Study|Severe malformation/abortion|0|||
161787482|NCT00530439|584266730|FG001|Overall Study|Severe malformation/abortion|3|||
161787483|NCT00378482|584266735|FG000|Overall Study|Lost to Follow-up|1|||
161787484|NCT00378482|584266735|FG000|Overall Study|Lack of Efficacy|8|||
161787485|NCT00378482|584266735|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
161787486|NCT00378482|584266735|FG000|Overall Study|Withdrawal by Subject|4|||
161787487|NCT00378482|584266735|FG000|Overall Study|Adverse Event|9|||
161787488|NCT00343642|584268541|FG000|Overall Study|Lost to Follow-up|0|||
161787489|NCT00343642|584268542|FG001|Overall Study|Lost to Follow-up|1|||
161787490|NCT00343642|584268543|FG002|Overall Study|Lost to Follow-up|0|||
161787491|NCT00343642|584268541|FG000|Overall Study|Pregnancy|1|||
161787492|NCT00343642|584268542|FG001|Overall Study|Pregnancy|0|||
161787493|NCT00343642|584268543|FG002|Overall Study|Pregnancy|2|||
161787494|NCT00343642|584268541|FG000|Overall Study|Withdrawal by Subject|2|||
161787495|NCT00343642|584268542|FG001|Overall Study|Withdrawal by Subject|3|||
161787496|NCT00343642|584268543|FG002|Overall Study|Withdrawal by Subject|4|||
161787497|NCT00343642|584268541|FG000|Overall Study|Adverse Event|0|||
161787498|NCT00343642|584268542|FG001|Overall Study|Adverse Event|0|||
161787499|NCT00343642|584268543|FG002|Overall Study|Adverse Event|1|||
161787500|NCT00343642|584268541|FG000|Overall Study|Flare up|6|||
161787501|NCT00343642|584268542|FG001|Overall Study|Flare up|4|||
162010418|NCT03818256|585093755|FG001|Overall Study|Lost to Follow-up|5|||
161787502|NCT00343642|584268543|FG002|Overall Study|Flare up|0|||
161787503|NCT00860574|584268546|FG000|Overall Study|Death|2|||
161787504|NCT00860574|584268546|FG000|Overall Study|Relapse|1|||
161787505|NCT02496221|584268547|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
161787506|NCT02496221|584268548|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
161787507|NCT02496221|584268547|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
161787508|NCT02496221|584268548|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
161787509|NCT02496221|584268547|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
161787510|NCT02496221|584268548|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
161787511|NCT01335399|584268549|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
161787512|NCT01335399|584268550|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
161787513|NCT01335399|584268549|FG000|Pre-treatment Period|Participant request to discontinue|0|||
161787514|NCT01335399|584268550|FG001|Pre-treatment Period|Participant request to discontinue|1|||
161787515|NCT01335399|584268549|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
161787516|NCT01335399|584268550|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
161787517|NCT01335399|584268549|FG000|Pre-treatment Period|Consent withdrawal|3|||
161787518|NCT01335399|584268550|FG001|Pre-treatment Period|Consent withdrawal|0|||
161787519|NCT01335399|584268549|FG000|Treatment Period|Disease progression|117|||
161787520|NCT01335399|584268550|FG001|Treatment Period|Disease progression|145|||
161787521|NCT01335399|584268549|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
161787522|NCT01335399|584268550|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
161787523|NCT01335399|584268549|FG000|Treatment Period|Study drug toxicity|52|||
161787524|NCT01335399|584268550|FG001|Treatment Period|Study drug toxicity|64|||
161787525|NCT01335399|584268549|FG000|Treatment Period|Participant request to discontinue|30|||
161787526|NCT01335399|584268550|FG001|Treatment Period|Participant request to discontinue|22|||
161787527|NCT01335399|584268549|FG000|Treatment Period|Other reasons|30|||
161787528|NCT01335399|584268550|FG001|Treatment Period|Other reasons|30|||
161787529|NCT01335399|584268549|FG000|Treatment Period|Consent withdrawal|10|||
161787530|NCT01335399|584268550|FG001|Treatment Period|Consent withdrawal|7|||
161787531|NCT01335399|584268549|FG000|Treatment Period|Death|7|||
161787532|NCT01335399|584268550|FG001|Treatment Period|Death|6|||
161787533|NCT01335399|584268549|FG000|Treatment Period|Poor/Non-compliance|3|||
161787534|NCT01335399|584268550|FG001|Treatment Period|Poor/Non-compliance|4|||
161787535|NCT01335399|584268549|FG000|Treatment Period|Lost to Follow-up|2|||
161787536|NCT01335399|584268550|FG001|Treatment Period|Lost to Follow-up|2|||
161787537|NCT01335399|584268549|FG000|Treatment Period|Maximum clinical benefit|1|||
161787538|NCT01335399|584268550|FG001|Treatment Period|Maximum clinical benefit|1|||
161787539|NCT01335399|584268549|FG000|Treatment Period|No longer meet study criteria|1|||
161787540|NCT01335399|584268550|FG001|Treatment Period|No longer meet study criteria|1|||
161787541|NCT01335399|584268549|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
161787542|NCT01335399|584268550|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
161787543|NCT01120600|584268553|FG000|Overall Study|Adverse Event|7|||
161787544|NCT01120600|584268554|FG001|Overall Study|Adverse Event|7|||
161787545|NCT01120600|584268553|FG000|Overall Study|Excessive Bone Loss|0|||
161787546|NCT01120600|584268554|FG001|Overall Study|Excessive Bone Loss|4|||
161787547|NCT01120600|584268553|FG000|Overall Study|Lost to Follow-up|1|||
161787548|NCT01120600|584268554|FG001|Overall Study|Lost to Follow-up|3|||
161787549|NCT01120600|584268553|FG000|Overall Study|Physician Decision|1|||
161787550|NCT01120600|584268554|FG001|Overall Study|Physician Decision|3|||
161787551|NCT01120600|584268553|FG000|Overall Study|Protocol Violation|0|||
161787552|NCT01120600|584268554|FG001|Overall Study|Protocol Violation|4|||
161787553|NCT01120600|584268553|FG000|Overall Study|Withdrawal by Subject|10|||
161787554|NCT01120600|584268554|FG001|Overall Study|Withdrawal by Subject|11|||
161787555|NCT01165242|584268557|FG000|Overall Study|Unreachable Subjects|1|||
161787556|NCT01165242|584268558|FG001|Overall Study|Unreachable Subjects|0|||
161787557|NCT01165242|584268559|FG002|Overall Study|Unreachable Subjects|0|||
161787558|NCT01165242|584268557|FG000|Overall Study|Incarcerated Subjects|0|||
161787559|NCT01165242|584268558|FG001|Overall Study|Incarcerated Subjects|1|||
161787560|NCT01165242|584268559|FG002|Overall Study|Incarcerated Subjects|0|||
161787561|NCT01165242|584268557|FG000|Overall Study|Visit 2 Declined by Subject|0|||
161787562|NCT01165242|584268558|FG001|Overall Study|Visit 2 Declined by Subject|0|||
161787563|NCT01165242|584268559|FG002|Overall Study|Visit 2 Declined by Subject|1|||
161787564|NCT01165242|584268557|FG000|Overall Study|Withdrawal by Subject|0|||
161898538|NCT00588146|584677823|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
161787565|NCT01165242|584268558|FG001|Overall Study|Withdrawal by Subject|2|||
161787566|NCT01165242|584268559|FG002|Overall Study|Withdrawal by Subject|2|||
161898539|NCT00588146|584677824|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
161787567|NCT01165242|584268557|FG000|Overall Study|Extended Holiday|0|||
161787568|NCT01165242|584268558|FG001|Overall Study|Extended Holiday|0|||
161787569|NCT01165242|584268559|FG002|Overall Study|Extended Holiday|1|||
161787570|NCT01165242|584268557|FG000|Overall Study|Lost to Follow-up|9|||
161787571|NCT01165242|584268558|FG001|Overall Study|Lost to Follow-up|7|||
161787572|NCT01165242|584268559|FG002|Overall Study|Lost to Follow-up|10|||
161787573|NCT03372083|584268560|FG000|Overall Study|Adverse Event|3|||
161898540|NCT02100839|584677825|FG000|Multiple Ascending Dose|Adverse Event|2|||
161787574|NCT03372083|584268560|FG000|Overall Study|Physician Decision|1|||
161787575|NCT03372083|584268560|FG000|Overall Study|Withdrawal by Subject|1|||
161787576|NCT01690520|584268561|FG000|Overall Study|Death|25|||
161787577|NCT01690520|584268562|FG001|Overall Study|Death|21|||
161787578|NCT01690520|584268561|FG000|Overall Study|Lost to Follow-up|2|||
161787579|NCT01690520|584268562|FG001|Overall Study|Lost to Follow-up|3|||
161787580|NCT01690520|584268561|FG000|Overall Study|Withdrawal by Subject|2|||
161787581|NCT01690520|584268562|FG001|Overall Study|Withdrawal by Subject|0|||
161787582|NCT01690520|584268561|FG000|Overall Study|Relapse|0|||
161787583|NCT01690520|584268562|FG001|Overall Study|Relapse|1|||
161787584|NCT01690520|584268561|FG000|Overall Study|Other|0|||
161787585|NCT01690520|584268562|FG001|Overall Study|Other|1|||
161787586|NCT01690520|584268561|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
161787587|NCT01690520|584268562|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
161787588|NCT02544633|584268565|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
161787589|NCT02544633|584268566|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
161787590|NCT02544633|584268567|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
161787591|NCT02544633|584268568|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
161787592|NCT02544633|584268565|FG000|Treatment Period|Adverse Event|7|||
161787593|NCT02544633|584268566|FG001|Treatment Period|Adverse Event|4|||
161787594|NCT02544633|584268567|FG002|Treatment Period|Adverse Event|0|||
161787595|NCT02544633|584268568|FG003|Treatment Period|Adverse Event|5|||
161787596|NCT02544633|584268565|FG000|Treatment Period|Lack of Efficacy|17|||
161787597|NCT02544633|584268566|FG001|Treatment Period|Lack of Efficacy|11|||
161787598|NCT02544633|584268567|FG002|Treatment Period|Lack of Efficacy|5|||
161787599|NCT02544633|584268568|FG003|Treatment Period|Lack of Efficacy|5|||
161787600|NCT02544633|584268565|FG000|Treatment Period|Global Deterioration of Health|3|||
161787601|NCT02544633|584268566|FG001|Treatment Period|Global Deterioration of Health|3|||
161787602|NCT02544633|584268567|FG002|Treatment Period|Global Deterioration of Health|0|||
161787603|NCT02544633|584268568|FG003|Treatment Period|Global Deterioration of Health|1|||
161787604|NCT02544633|584268565|FG000|Treatment Period|Withdrawal by Subject|1|||
161787605|NCT02544633|584268566|FG001|Treatment Period|Withdrawal by Subject|0|||
161787606|NCT02544633|584268567|FG002|Treatment Period|Withdrawal by Subject|0|||
161787607|NCT02544633|584268568|FG003|Treatment Period|Withdrawal by Subject|0|||
161787608|NCT02544633|584268565|FG000|Treatment Period|Lost to Follow-up|0|||
161787609|NCT02544633|584268566|FG001|Treatment Period|Lost to Follow-up|1|||
161787610|NCT02544633|584268567|FG002|Treatment Period|Lost to Follow-up|0|||
161787611|NCT02544633|584268568|FG003|Treatment Period|Lost to Follow-up|0|||
161787612|NCT02544633|584268565|FG000|Treatment Period|Death|0|||
161787613|NCT02544633|584268566|FG001|Treatment Period|Death|0|||
161787614|NCT02544633|584268567|FG002|Treatment Period|Death|1|||
161787615|NCT02544633|584268568|FG003|Treatment Period|Death|0|||
161787616|NCT02544633|584268565|FG000|Treatment Period|Non-compliance|0|||
161787617|NCT02544633|584268566|FG001|Treatment Period|Non-compliance|0|||
161787618|NCT02544633|584268567|FG002|Treatment Period|Non-compliance|1|||
161787619|NCT02544633|584268568|FG003|Treatment Period|Non-compliance|0|||
161787620|NCT02544633|584268565|FG000|Treatment Period|Clinical Disease Progression|0|||
161787621|NCT02544633|584268566|FG001|Treatment Period|Clinical Disease Progression|0|||
161787622|NCT02544633|584268567|FG002|Treatment Period|Clinical Disease Progression|0|||
161787623|NCT02544633|584268568|FG003|Treatment Period|Clinical Disease Progression|1|||
161787624|NCT02544633|584268565|FG000|Survival Follow-up Period|Death|12|||
161787625|NCT02544633|584268566|FG001|Survival Follow-up Period|Death|14|||
161787626|NCT02544633|584268567|FG002|Survival Follow-up Period|Death|3|||
161787627|NCT02544633|584268568|FG003|Survival Follow-up Period|Death|9|||
161787628|NCT02544633|584268565|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
161787629|NCT02544633|584268566|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
161787630|NCT02544633|584268567|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
161787631|NCT02544633|584268568|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
161787632|NCT02544633|584268565|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
161787633|NCT02544633|584268566|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
161787634|NCT02544633|584268567|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
161787635|NCT02544633|584268568|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
161787636|NCT02544633|584268565|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
161787637|NCT02544633|584268566|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
161787638|NCT02544633|584268567|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
161787639|NCT02544633|584268568|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
161787640|NCT02092961|584268569|FG000|Overall Study|Not reported|1|||
161787641|NCT02092961|584268570|FG001|Overall Study|Not reported|0|||
161787642|NCT02092961|584268571|FG002|Overall Study|Not reported|1|||
161787643|NCT02092961|584268569|FG000|Overall Study|Study stopped|13|||
161787644|NCT02092961|584268570|FG001|Overall Study|Study stopped|9|||
161787645|NCT02092961|584268571|FG002|Overall Study|Study stopped|12|||
161787646|NCT02092961|584268569|FG000|Overall Study|Lack of therapeutic response|2|||
161787647|NCT02092961|584268570|FG001|Overall Study|Lack of therapeutic response|1|||
161787648|NCT02092961|584268571|FG002|Overall Study|Lack of therapeutic response|3|||
161787649|NCT02092961|584268569|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
161787650|NCT02092961|584268570|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
161787651|NCT02092961|584268571|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
161787652|NCT02092961|584268569|FG000|Overall Study|Adverse Event|2|||
161787653|NCT02092961|584268570|FG001|Overall Study|Adverse Event|4|||
161787654|NCT02092961|584268571|FG002|Overall Study|Adverse Event|0|||
161787655|NCT01623830|584268574|FG000|Overall Study|Withdrawal by Subject|6|||
161787656|NCT01623830|584268575|FG001|Overall Study|Withdrawal by Subject|7|||
161787657|NCT01623830|584268574|FG000|Overall Study|Exclusion from Study|1|||
161787658|NCT01623830|584268575|FG001|Overall Study|Exclusion from Study|2|||
161787659|NCT02468557|584268576|FG000|Overall Study|Adverse Event|1|||
161787660|NCT02468557|584268576|FG000|Overall Study|Death|1|||
161787661|NCT02468557|584268576|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
161787662|NCT02468557|584268576|FG000|Overall Study|All Enrolled but Never Dosed|4|||
161787663|NCT01605461|584268577|FG000|Overall Study|Lost to Follow-up|3|||
161787664|NCT01605461|584268577|FG000|Overall Study|Withdrawal by Subject|1|||
161787665|NCT02024698|584268578|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
161787666|NCT02024698|584268579|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
161787667|NCT03322462|584268580|FG000|Overall Study|Technical difficulties|2|||
161787668|NCT03322462|584268580|FG000|Overall Study|Other|1|||
161787669|NCT01859390|584268589|FG000|Overall Study|Insufficient Sputum Collected|1|||
161787670|NCT01859390|584268590|FG001|Overall Study|Insufficient Sputum Collected|3|||
161787671|NCT01859390|584268589|FG000|Overall Study|Sample Missing Collection Date|0|||
161787672|NCT01859390|584268590|FG001|Overall Study|Sample Missing Collection Date|1|||
161787673|NCT01859390|584268589|FG000|Overall Study|Tube Cracked|0|||
161787674|NCT01859390|584268590|FG001|Overall Study|Tube Cracked|2|||
161787675|NCT01859390|584268589|FG000|Overall Study|Shipment Error|0|||
161787676|NCT01859390|584268590|FG001|Overall Study|Shipment Error|1|||
161787677|NCT02451670|584268591|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
161787678|NCT02451670|584268592|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
161787679|NCT00463866|584268596|FG000|Overall Study|Adverse Event|70|||
161787680|NCT00463866|584268597|FG001|Overall Study|Adverse Event|93|||
161787681|NCT00463866|584268596|FG000|Overall Study|Withdrawal by Subject|81|||
161787682|NCT00463866|584268597|FG001|Overall Study|Withdrawal by Subject|79|||
161787683|NCT00463866|584268596|FG000|Overall Study|Lost to Follow-up|46|||
161787684|NCT00463866|584268597|FG001|Overall Study|Lost to Follow-up|55|||
161787685|NCT00463866|584268596|FG000|Overall Study|Incorrect Enrolment|64|||
161787686|NCT00463866|584268597|FG001|Overall Study|Incorrect Enrolment|66|||
161787687|NCT00463866|584268596|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
161787688|NCT00463866|584268597|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
161787689|NCT00463866|584268596|FG000|Overall Study|Safety Reason|1|||
161787690|NCT00463866|584268597|FG001|Overall Study|Safety Reason|3|||
161787691|NCT00463866|584268596|FG000|Overall Study|Mis-Randomization of subject|0|||
161787692|NCT00463866|584268597|FG001|Overall Study|Mis-Randomization of subject|1|||
161787693|NCT00463866|584268596|FG000|Overall Study|Other|22|||
161787694|NCT00463866|584268597|FG001|Overall Study|Other|22|||
161787695|NCT01084005|584268598|FG000|Overall Study|Adverse Event|1|||
161787696|NCT01084005|584268599|FG001|Overall Study|Adverse Event|8|||
161787697|NCT01084005|584268598|FG000|Overall Study|Protocol Violation|3|||
161787698|NCT01084005|584268599|FG001|Overall Study|Protocol Violation|7|||
161787699|NCT01084005|584268598|FG000|Overall Study|Withdrawal by Subject|1|||
161787700|NCT01084005|584268599|FG001|Overall Study|Withdrawal by Subject|1|||
161787701|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
161787702|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161787703|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161787704|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161787705|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161787706|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161787707|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161787708|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
161898541|NCT02100839|584677826|FG001|Multiple Ascending Dose|Adverse Event|0|||
162126365|NCT04254679|585512935|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
162126366|NCT04076020|585512944|FG000|Overall Study|Death|4|||
162126367|NCT04076020|585512945|FG001|Overall Study|Death|6|||
161787709|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161787710|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161787711|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161787712|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161787713|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161787714|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161787715|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
161787716|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
161898542|NCT02100839|584677825|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
161787717|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
161787718|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
161787719|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
161787720|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
161787721|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
161787722|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
161787723|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161787724|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161787725|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161787726|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161787727|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161787728|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161787729|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
161787730|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161787731|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161787732|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161787733|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161787734|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161787735|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161787736|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
161787737|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
161787738|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
161787739|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
161787740|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
161787741|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
161787742|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
162126368|NCT04076020|585512944|FG000|Overall Study|Withdrawal by Subject|12|||
162126369|NCT04076020|585512945|FG001|Overall Study|Withdrawal by Subject|8|||
162126370|NCT03230864|585512947|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
162126371|NCT03230864|585512948|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
162126372|NCT03230864|585512949|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
161787743|NCT00606684|584268600|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
161787744|NCT00606684|584268601|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161787745|NCT00606684|584268602|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161787746|NCT00606684|584268603|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161787747|NCT00606684|584268604|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161787748|NCT00606684|584268605|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161787749|NCT00606684|584268606|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161787750|NCT00606684|584268600|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161787751|NCT00606684|584268601|FG001|Double-Blind Treatment Period|Adverse Event|3|||
161787752|NCT00606684|584268602|FG002|Double-Blind Treatment Period|Adverse Event|2|||
161787753|NCT00606684|584268603|FG003|Double-Blind Treatment Period|Adverse Event|4|||
161787754|NCT00606684|584268604|FG004|Double-Blind Treatment Period|Adverse Event|2|||
161787755|NCT00606684|584268605|FG005|Double-Blind Treatment Period|Adverse Event|0|||
161787756|NCT00606684|584268606|FG006|Double-Blind Treatment Period|Adverse Event|1|||
161787757|NCT00606684|584268600|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
161787758|NCT00606684|584268601|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
161787759|NCT00606684|584268602|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
161787760|NCT00606684|584268603|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
161787761|NCT00606684|584268604|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
161787762|NCT00606684|584268605|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
161787763|NCT00606684|584268606|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
161787764|NCT00606684|584268600|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
161787765|NCT00606684|584268601|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
161787766|NCT00606684|584268602|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
161787767|NCT00606684|584268603|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
161787768|NCT00606684|584268604|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
161787769|NCT00606684|584268605|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
161787770|NCT00606684|584268606|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
161787771|NCT00606684|584268600|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
162010419|NCT03818256|585093754|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
161787772|NCT00606684|584268601|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
161787773|NCT00606684|584268602|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
161787774|NCT00606684|584268603|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
161787775|NCT00606684|584268604|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
161787776|NCT00606684|584268605|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
161787777|NCT00606684|584268606|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
161787778|NCT00606684|584268600|FG000|Double-Blind Treatment Period|Physician Decision|0|||
161787779|NCT00606684|584268601|FG001|Double-Blind Treatment Period|Physician Decision|5|||
161787780|NCT00606684|584268602|FG002|Double-Blind Treatment Period|Physician Decision|1|||
161787781|NCT00606684|584268603|FG003|Double-Blind Treatment Period|Physician Decision|0|||
161787782|NCT00606684|584268604|FG004|Double-Blind Treatment Period|Physician Decision|3|||
161787783|NCT00606684|584268605|FG005|Double-Blind Treatment Period|Physician Decision|1|||
161787784|NCT00606684|584268606|FG006|Double-Blind Treatment Period|Physician Decision|2|||
161787785|NCT00606684|584268600|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161787786|NCT00606684|584268601|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161787787|NCT00606684|584268602|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161787788|NCT00606684|584268603|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161787789|NCT00606684|584268604|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161787790|NCT00606684|584268605|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161787791|NCT00606684|584268606|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161787792|NCT03568500|584268607|FG000|Overall Study|Lost to Follow-up|1|||
161787793|NCT03568500|584268608|FG001|Overall Study|Lost to Follow-up|1|||
161787794|NCT03568500|584268609|FG002|Overall Study|Lost to Follow-up|2|||
161787795|NCT03568500|584268607|FG000|Overall Study|Adverse Event|1|||
161787796|NCT03568500|584268608|FG001|Overall Study|Adverse Event|1|||
161787797|NCT03568500|584268609|FG002|Overall Study|Adverse Event|2|||
161787798|NCT03568500|584268607|FG000|Overall Study|Physician Decision|1|||
161787799|NCT03568500|584268608|FG001|Overall Study|Physician Decision|0|||
161787800|NCT03568500|584268609|FG002|Overall Study|Physician Decision|0|||
161787801|NCT03568500|584268607|FG000|Overall Study|Withdrawal by Subject|4|||
161787802|NCT03568500|584268608|FG001|Overall Study|Withdrawal by Subject|2|||
161787803|NCT03568500|584268609|FG002|Overall Study|Withdrawal by Subject|0|||
161787804|NCT03568500|584268607|FG000|Overall Study|Technical Problems|2|||
161787805|NCT03568500|584268608|FG001|Overall Study|Technical Problems|1|||
161787806|NCT03568500|584268609|FG002|Overall Study|Technical Problems|0|||
161787807|NCT03568500|584268607|FG000|Overall Study|Participant Noncompliance|1|||
161787808|NCT03568500|584268608|FG001|Overall Study|Participant Noncompliance|1|||
161787809|NCT03568500|584268609|FG002|Overall Study|Participant Noncompliance|0|||
161787810|NCT00827827|584268614|FG000|Overall Study|Lost to Follow-up|3|||
161787811|NCT00827827|584268615|FG001|Overall Study|Lost to Follow-up|0|||
161787812|NCT00827827|584268614|FG000|Overall Study|Fall at home- hospitalization|1|||
161787813|NCT00827827|584268615|FG001|Overall Study|Fall at home- hospitalization|0|||
161787814|NCT00827827|584268614|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
161787815|NCT00827827|584268615|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
161787816|NCT00827827|584268614|FG000|Overall Study|Gout|1|||
161787817|NCT00827827|584268615|FG001|Overall Study|Gout|0|||
161787818|NCT00827827|584268614|FG000|Overall Study|Transportation issues|1|||
161787819|NCT00827827|584268615|FG001|Overall Study|Transportation issues|0|||
161787820|NCT00827827|584268614|FG000|Overall Study|Burned with water at home|1|||
161787821|NCT00827827|584268615|FG001|Overall Study|Burned with water at home|0|||
161787822|NCT00295854|584268616|FG000|Overall Study|Adverse Event|7|||
161787823|NCT00295854|584268617|FG001|Overall Study|Adverse Event|7|||
161787824|NCT00295854|584268618|FG002|Overall Study|Adverse Event|6|||
161787825|NCT00295854|584268616|FG000|Overall Study|Protocol Violation|1|||
161787826|NCT00295854|584268617|FG001|Overall Study|Protocol Violation|1|||
161787827|NCT00295854|584268618|FG002|Overall Study|Protocol Violation|1|||
161787828|NCT00295854|584268616|FG000|Overall Study|Lost to Follow-up|2|||
161787829|NCT00295854|584268617|FG001|Overall Study|Lost to Follow-up|0|||
161787830|NCT00295854|584268618|FG002|Overall Study|Lost to Follow-up|1|||
161787831|NCT00295854|584268616|FG000|Overall Study|Withdrawal by Subject|3|||
161787832|NCT00295854|584268617|FG001|Overall Study|Withdrawal by Subject|7|||
161787833|NCT00295854|584268618|FG002|Overall Study|Withdrawal by Subject|4|||
161787834|NCT00295854|584268616|FG000|Overall Study|did not continue to meet criteria|1|||
161787835|NCT00295854|584268617|FG001|Overall Study|did not continue to meet criteria|1|||
161787836|NCT00295854|584268618|FG002|Overall Study|did not continue to meet criteria|2|||
162026089|NCT00369629|585152887|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
161787837|NCT00295854|584268616|FG000|Overall Study|required a prohibited medication|1|||
161787838|NCT00295854|584268617|FG001|Overall Study|required a prohibited medication|0|||
161787839|NCT00295854|584268618|FG002|Overall Study|required a prohibited medication|0|||
161787840|NCT00295854|584268616|FG000|Overall Study|Other|3|||
161787841|NCT00295854|584268617|FG001|Overall Study|Other|5|||
161787842|NCT00295854|584268618|FG002|Overall Study|Other|1|||
161787843|NCT01967888|584268620|FG000|Overall Study|Lost to Follow-up|6|||
161787844|NCT01967888|584268621|FG001|Overall Study|Lost to Follow-up|4|||
161787845|NCT01967888|584268620|FG000|Overall Study|Withdrawal by Subject|1|||
162026090|NCT00369629|585152884|FG000|Completed 4 More Cycles|Progressive disease|2|||
162026091|NCT00369629|585152885|FG001|Completed 4 More Cycles|Progressive disease|1|||
162026092|NCT00369629|585152886|FG002|Completed 4 More Cycles|Progressive disease|2|||
162026093|NCT00369629|585152887|FG003|Completed 4 More Cycles|Progressive disease|0|||
162026094|NCT00369629|585152884|FG000|Follow up for 1 Year|Death|2|||
161787846|NCT01967888|584268621|FG001|Overall Study|Withdrawal by Subject|1|||
161787847|NCT01967888|584268620|FG000|Overall Study|Did Not Have Transplant|1|||
161787848|NCT01967888|584268621|FG001|Overall Study|Did Not Have Transplant|0|||
161787849|NCT01967888|584268620|FG000|Overall Study|Research visit not done, data recorded|1|||
161787850|NCT01967888|584268621|FG001|Overall Study|Research visit not done, data recorded|0|||
161787851|NCT01967888|584268620|FG000|Overall Study|Subject excluded after randomization|1|||
161787852|NCT01967888|584268621|FG001|Overall Study|Subject excluded after randomization|0|||
161787853|NCT01967888|584268620|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
161787854|NCT01967888|584268621|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
161787855|NCT01967888|584268620|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
161787856|NCT01967888|584268621|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
161787857|NCT03175120|584268625|FG000|Overall Study|Adverse Event|2|||
161787858|NCT03175120|584268626|FG001|Overall Study|Adverse Event|2|||
161787859|NCT03175120|584268625|FG000|Overall Study|Protocol Violation|5|||
161787860|NCT03175120|584268626|FG001|Overall Study|Protocol Violation|2|||
161787861|NCT03175120|584268625|FG000|Overall Study|Lost to Follow-up|1|||
161787862|NCT03175120|584268626|FG001|Overall Study|Lost to Follow-up|0|||
161787863|NCT03175120|584268625|FG000|Overall Study|Withdrawal by Subject|2|||
161787864|NCT03175120|584268626|FG001|Overall Study|Withdrawal by Subject|5|||
161787865|NCT03175120|584268625|FG000|Overall Study|Other|2|||
161787866|NCT03175120|584268626|FG001|Overall Study|Other|3|||
161787867|NCT04120194|584268627|FG000|Overall Study|Lost to Follow-up|11|||
161787868|NCT04120194|584268628|FG001|Overall Study|Lost to Follow-up|8|||
161787869|NCT04120194|584268627|FG000|Overall Study|Adverse Event|4|||
161787870|NCT04120194|584268628|FG001|Overall Study|Adverse Event|5|||
161787871|NCT04120194|584268627|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
161787872|NCT04120194|584268628|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
161787873|NCT04120194|584268627|FG000|Overall Study|Miscellaneous|4|||
161787874|NCT04120194|584268628|FG001|Overall Study|Miscellaneous|5|||
161787875|NCT02622074|584268629|FG000|Overall Study|Death|4|||
161787876|NCT02622074|584268630|FG001|Overall Study|Death|0|||
161787877|NCT02622074|584268631|FG002|Overall Study|Death|0|||
161787878|NCT02622074|584268632|FG003|Overall Study|Death|1|||
161787879|NCT02622074|584268633|FG004|Overall Study|Death|1|||
161787880|NCT02622074|584268634|FG005|Overall Study|Death|0|||
161787881|NCT02622074|584268629|FG000|Overall Study|Withdrawal by Subject|0|||
161787882|NCT02622074|584268630|FG001|Overall Study|Withdrawal by Subject|1|||
161787883|NCT02622074|584268631|FG002|Overall Study|Withdrawal by Subject|0|||
161787884|NCT02622074|584268632|FG003|Overall Study|Withdrawal by Subject|0|||
161787885|NCT02622074|584268633|FG004|Overall Study|Withdrawal by Subject|0|||
161787886|NCT02622074|584268634|FG005|Overall Study|Withdrawal by Subject|0|||
161787887|NCT02114931|584268635|FG000|Overall Study|Withdrawal by Subject|15|||
161787888|NCT02114931|584268636|FG001|Overall Study|Withdrawal by Subject|18|||
161787889|NCT02114931|584268635|FG000|Overall Study|Adverse Event|4|||
161787890|NCT02114931|584268636|FG001|Overall Study|Adverse Event|6|||
161787891|NCT02114931|584268635|FG000|Overall Study|Lost to Follow-up|3|||
161787892|NCT02114931|584268636|FG001|Overall Study|Lost to Follow-up|3|||
161787893|NCT02114931|584268635|FG000|Overall Study|Physician Decision|1|||
161787894|NCT02114931|584268636|FG001|Overall Study|Physician Decision|2|||
161787895|NCT02114931|584268635|FG000|Overall Study|Other|2|||
161787896|NCT02114931|584268636|FG001|Overall Study|Other|1|||
161787897|NCT03565211|584268640|FG000|Overall Study|Withdrawal by Subject|2|||
161787898|NCT03565211|584268640|FG000|Overall Study|Lost to Follow-up|1|||
161787899|NCT03565211|584268640|FG000|Overall Study|Adverse Event|44|||
161787900|NCT03565211|584268640|FG000|Overall Study|Personal issues|1|||
161787901|NCT00986154|584268641|FG000|Overall Study|Death|136|||
161787902|NCT00986154|584268642|FG001|Overall Study|Death|127|||
161787903|NCT00986154|584268641|FG000|Overall Study|Lost to Follow-up|7|||
161787904|NCT00986154|584268642|FG001|Overall Study|Lost to Follow-up|4|||
161787905|NCT00986154|584268641|FG000|Overall Study|Withdrawal by Subject|32|||
161787906|NCT00986154|584268642|FG001|Overall Study|Withdrawal by Subject|33|||
161898543|NCT02100839|584677826|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
161898544|NCT03272347|584677828|FG000|Overall Study|Death|0|||
161787907|NCT00986154|584268641|FG000|Overall Study|investigator/subject decide not continue|6|||
161787908|NCT00986154|584268642|FG001|Overall Study|investigator/subject decide not continue|3|||
161787909|NCT00986154|584268641|FG000|Overall Study|never received study drug|25|||
161787910|NCT00986154|584268642|FG001|Overall Study|never received study drug|27|||
161787911|NCT00267007|584268643|FG000|Overall Study|Withdrawal by Subject|6|||
161787912|NCT00267007|584268644|FG001|Overall Study|Withdrawal by Subject|0|||
161787913|NCT00267007|584268643|FG000|Overall Study|Lost to Follow-up|1|||
161787914|NCT00267007|584268644|FG001|Overall Study|Lost to Follow-up|0|||
161787915|NCT00267007|584268643|FG000|Overall Study|Non-compliance|0|||
161787916|NCT00267007|584268644|FG001|Overall Study|Non-compliance|1|||
161787917|NCT00267007|584268643|FG000|Overall Study|Adverse Event|1|||
161787918|NCT00267007|584268644|FG001|Overall Study|Adverse Event|0|||
161787919|NCT01684722|584268651|FG000|Overall Study|Lost to Follow-up|78|||
161787920|NCT01684722|584268652|FG001|Overall Study|Lost to Follow-up|56|||
161898545|NCT03272347|584677829|FG001|Overall Study|Death|0|||
161787921|NCT01684722|584268653|FG002|Overall Study|Lost to Follow-up|75|||
161787922|NCT01684722|584268654|FG003|Overall Study|Lost to Follow-up|89|||
161787923|NCT01684722|584268651|FG000|Overall Study|Death|19|||
161787924|NCT01684722|584268652|FG001|Overall Study|Death|21|||
161787925|NCT01684722|584268653|FG002|Overall Study|Death|19|||
161787926|NCT01684722|584268654|FG003|Overall Study|Death|21|||
161787927|NCT01664494|584268655|FG000|Overall Study|Withdrawal by Subject|27|||
161787928|NCT01664494|584268655|FG000|Overall Study|Death|18|||
161787929|NCT01664494|584268655|FG000|Overall Study|Other|49|||
161787930|NCT01664494|584268655|FG000|Overall Study|Lost to Follow-up|99|||
161787931|NCT00219557|584268656|FG000|Phase 1|Lack of Efficacy|3|||
161787932|NCT00219557|584268657|FG001|Phase 1|Lack of Efficacy|0|||
161787933|NCT00219557|584268658|FG002|Phase 1|Lack of Efficacy|0|||
161787934|NCT00219557|584268656|FG000|Phase 1|Adverse Event|2|||
161787935|NCT00219557|584268657|FG001|Phase 1|Adverse Event|0|||
161787936|NCT00219557|584268658|FG002|Phase 1|Adverse Event|0|||
161787937|NCT00219557|584268656|FG000|Phase 1|Withdrawal by Subject|1|||
161787938|NCT00219557|584268657|FG001|Phase 1|Withdrawal by Subject|0|||
161787939|NCT00219557|584268658|FG002|Phase 1|Withdrawal by Subject|0|||
161787940|NCT00219557|584268656|FG000|Phase 1|Started chemotherapy at other institute|1|||
161787941|NCT00219557|584268657|FG001|Phase 1|Started chemotherapy at other institute|0|||
161787942|NCT00219557|584268658|FG002|Phase 1|Started chemotherapy at other institute|0|||
161787943|NCT00219557|584268656|FG000|Phase 2|Lack of Efficacy|0|||
161787944|NCT00219557|584268657|FG001|Phase 2|Lack of Efficacy|21|||
161787945|NCT00219557|584268658|FG002|Phase 2|Lack of Efficacy|15|||
161787946|NCT00219557|584268656|FG000|Phase 2|Adverse Event|0|||
161787947|NCT00219557|584268657|FG001|Phase 2|Adverse Event|22|||
161787948|NCT00219557|584268658|FG002|Phase 2|Adverse Event|2|||
161787949|NCT00219557|584268656|FG000|Phase 2|Death|0|||
161787950|NCT00219557|584268657|FG001|Phase 2|Death|8|||
161787951|NCT00219557|584268658|FG002|Phase 2|Death|2|||
161787952|NCT00219557|584268656|FG000|Phase 2|Other|0|||
161787953|NCT00219557|584268657|FG001|Phase 2|Other|8|||
161787954|NCT00219557|584268658|FG002|Phase 2|Other|6|||
161787955|NCT00219557|584268656|FG000|Phase 2|Withdrawal by Subject|0|||
161787956|NCT00219557|584268657|FG001|Phase 2|Withdrawal by Subject|9|||
161787957|NCT00219557|584268658|FG002|Phase 2|Withdrawal by Subject|5|||
161787958|NCT00219557|584268656|FG000|Phase 2|Treatment not received|0|||
161787959|NCT00219557|584268657|FG001|Phase 2|Treatment not received|1|||
161787960|NCT00219557|584268658|FG002|Phase 2|Treatment not received|3|||
161787961|NCT03063632|584268659|FG000|Overall Study|Death|4|||
161787962|NCT03063632|584268660|FG001|Overall Study|Death|6|||
161787963|NCT03063632|584268659|FG000|Overall Study|Lost to Follow-up|0|||
161787964|NCT03063632|584268660|FG001|Overall Study|Lost to Follow-up|1|||
161787965|NCT03063632|584268659|FG000|Overall Study|Withdrawal by Subject|0|||
161787966|NCT03063632|584268660|FG001|Overall Study|Withdrawal by Subject|2|||
161787967|NCT03063632|584268659|FG000|Overall Study|Physician Decision|2|||
161787968|NCT03063632|584268660|FG001|Overall Study|Physician Decision|0|||
161787969|NCT03063632|584268659|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
161787970|NCT03063632|584268660|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
161787971|NCT01612156|584268661|FG000|Overall Study|Protocol Violation|2|||
161787972|NCT01612156|584268662|FG001|Overall Study|Protocol Violation|0|||
161787973|NCT00410410|584268663|FG000|Induction Period (IP)|Death|1|||
161787974|NCT00410410|584268664|FG001|Induction Period (IP)|Death|0|||
161787975|NCT00410410|584268665|FG002|Induction Period (IP)|Death|0|||
161787976|NCT00410410|584268666|FG003|Induction Period (IP)|Death|0|||
161787977|NCT00410410|584268667|FG004|Induction Period (IP)|Death|0|||
161787978|NCT00410410|584268668|FG005|Induction Period (IP)|Death|0|||
161787979|NCT00410410|584268669|FG006|Induction Period (IP)|Death|0|||
161787980|NCT00410410|584268670|FG007|Induction Period (IP)|Death|0|||
161787981|NCT00410410|584268671|FG008|Induction Period (IP)|Death|0|||
161787982|NCT00410410|584268663|FG000|Induction Period (IP)|Adverse Event|3|||
161787983|NCT00410410|584268664|FG001|Induction Period (IP)|Adverse Event|4|||
161787984|NCT00410410|584268665|FG002|Induction Period (IP)|Adverse Event|2|||
161787985|NCT00410410|584268666|FG003|Induction Period (IP)|Adverse Event|4|||
161787986|NCT00410410|584268667|FG004|Induction Period (IP)|Adverse Event|1|||
161787987|NCT00410410|584268668|FG005|Induction Period (IP)|Adverse Event|0|||
161787988|NCT00410410|584268669|FG006|Induction Period (IP)|Adverse Event|0|||
161787989|NCT00410410|584268670|FG007|Induction Period (IP)|Adverse Event|0|||
161787990|NCT00410410|584268671|FG008|Induction Period (IP)|Adverse Event|0|||
161787991|NCT00410410|584268663|FG000|Induction Period (IP)|Lack of Efficacy|26|||
161787992|NCT00410410|584268664|FG001|Induction Period (IP)|Lack of Efficacy|24|||
161787993|NCT00410410|584268665|FG002|Induction Period (IP)|Lack of Efficacy|8|||
161787994|NCT00410410|584268666|FG003|Induction Period (IP)|Lack of Efficacy|8|||
161787995|NCT00410410|584268667|FG004|Induction Period (IP)|Lack of Efficacy|7|||
161787996|NCT00410410|584268668|FG005|Induction Period (IP)|Lack of Efficacy|7|||
161787997|NCT00410410|584268669|FG006|Induction Period (IP)|Lack of Efficacy|0|||
161787998|NCT00410410|584268670|FG007|Induction Period (IP)|Lack of Efficacy|0|||
161787999|NCT00410410|584268671|FG008|Induction Period (IP)|Lack of Efficacy|0|||
161788000|NCT00410410|584268663|FG000|Induction Period (IP)|Lost to Follow-up|2|||
161788001|NCT00410410|584268664|FG001|Induction Period (IP)|Lost to Follow-up|2|||
161788002|NCT00410410|584268665|FG002|Induction Period (IP)|Lost to Follow-up|2|||
161788003|NCT00410410|584268666|FG003|Induction Period (IP)|Lost to Follow-up|3|||
161788004|NCT00410410|584268667|FG004|Induction Period (IP)|Lost to Follow-up|0|||
161788005|NCT00410410|584268668|FG005|Induction Period (IP)|Lost to Follow-up|1|||
161788006|NCT00410410|584268669|FG006|Induction Period (IP)|Lost to Follow-up|0|||
161788007|NCT00410410|584268670|FG007|Induction Period (IP)|Lost to Follow-up|0|||
161788008|NCT00410410|584268671|FG008|Induction Period (IP)|Lost to Follow-up|0|||
161788009|NCT00410410|584268663|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
161788010|NCT00410410|584268664|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
161788011|NCT00410410|584268665|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
161788012|NCT00410410|584268666|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
161788013|NCT00410410|584268667|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
161788014|NCT00410410|584268668|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
161788015|NCT00410410|584268669|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
161788016|NCT00410410|584268670|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
161788017|NCT00410410|584268671|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
161788018|NCT00410410|584268663|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788019|NCT00410410|584268664|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788020|NCT00410410|584268665|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
161788021|NCT00410410|584268666|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788022|NCT00410410|584268667|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788023|NCT00410410|584268668|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788024|NCT00410410|584268669|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788025|NCT00410410|584268670|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788026|NCT00410410|584268671|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161788027|NCT00410410|584268663|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788028|NCT00410410|584268664|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788029|NCT00410410|584268665|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788030|NCT00410410|584268666|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788031|NCT00410410|584268667|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
161788032|NCT00410410|584268668|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
161788033|NCT00410410|584268669|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788034|NCT00410410|584268670|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788035|NCT00410410|584268671|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161788036|NCT00410410|584268663|FG000|Induction Period (IP)|Other|0|||
161788037|NCT00410410|584268664|FG001|Induction Period (IP)|Other|0|||
161788038|NCT00410410|584268665|FG002|Induction Period (IP)|Other|1|||
161788039|NCT00410410|584268666|FG003|Induction Period (IP)|Other|0|||
161788040|NCT00410410|584268667|FG004|Induction Period (IP)|Other|0|||
161788041|NCT00410410|584268668|FG005|Induction Period (IP)|Other|0|||
161788042|NCT00410410|584268669|FG006|Induction Period (IP)|Other|0|||
161788043|NCT00410410|584268670|FG007|Induction Period (IP)|Other|0|||
161788044|NCT00410410|584268671|FG008|Induction Period (IP)|Other|0|||
161788045|NCT00410410|584268663|FG000|Maintenance Period (MP)|Death|0|||
161788046|NCT00410410|584268664|FG001|Maintenance Period (MP)|Death|0|||
161788047|NCT00410410|584268665|FG002|Maintenance Period (MP)|Death|0|||
161788048|NCT00410410|584268666|FG003|Maintenance Period (MP)|Death|0|||
161788049|NCT00410410|584268667|FG004|Maintenance Period (MP)|Death|0|||
161788050|NCT00410410|584268668|FG005|Maintenance Period (MP)|Death|0|||
161788051|NCT00410410|584268669|FG006|Maintenance Period (MP)|Death|1|||
161788052|NCT00410410|584268670|FG007|Maintenance Period (MP)|Death|0|||
161788053|NCT00410410|584268671|FG008|Maintenance Period (MP)|Death|0|||
161788054|NCT00410410|584268663|FG000|Maintenance Period (MP)|Adverse Event|0|||
161788055|NCT00410410|584268664|FG001|Maintenance Period (MP)|Adverse Event|0|||
161788056|NCT00410410|584268665|FG002|Maintenance Period (MP)|Adverse Event|0|||
162010420|NCT03818256|585093755|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
162010421|NCT03818256|585093754|FG000|Overall Study|Not reporting for scheduled visits|1|||
162010422|NCT03818256|585093755|FG001|Overall Study|Not reporting for scheduled visits|0|||
162010423|NCT03818256|585093754|FG000|Overall Study|Non-compliant with investigational product|1|||
162010424|NCT03818256|585093755|FG001|Overall Study|Non-compliant with investigational product|0|||
162010425|NCT01342211|585093756|FG000|Overall Study|Lost to Follow-up|0|||
162010426|NCT01342211|585093757|FG001|Overall Study|Lost to Follow-up|0|||
162010427|NCT01342211|585093758|FG002|Overall Study|Lost to Follow-up|0|||
162010428|NCT01342211|585093759|FG003|Overall Study|Lost to Follow-up|1|||
162010429|NCT01342211|585093760|FG004|Overall Study|Lost to Follow-up|0|||
162010430|NCT01342211|585093756|FG000|Overall Study|Adverse Event|0|||
162010431|NCT01342211|585093757|FG001|Overall Study|Adverse Event|0|||
162010432|NCT01342211|585093758|FG002|Overall Study|Adverse Event|0|||
162010433|NCT01342211|585093759|FG003|Overall Study|Adverse Event|0|||
162010434|NCT01342211|585093760|FG004|Overall Study|Adverse Event|1|||
162010435|NCT01342211|585093756|FG000|Overall Study|Withdrawal by Subject|0|||
162010436|NCT01342211|585093757|FG001|Overall Study|Withdrawal by Subject|0|||
162026095|NCT00369629|585152885|FG001|Follow up for 1 Year|Death|1|||
161788057|NCT00410410|584268666|FG003|Maintenance Period (MP)|Adverse Event|0|||
161788058|NCT00410410|584268667|FG004|Maintenance Period (MP)|Adverse Event|0|||
161788059|NCT00410410|584268668|FG005|Maintenance Period (MP)|Adverse Event|0|||
161788060|NCT00410410|584268669|FG006|Maintenance Period (MP)|Adverse Event|1|||
161788061|NCT00410410|584268670|FG007|Maintenance Period (MP)|Adverse Event|3|||
161788062|NCT00410410|584268671|FG008|Maintenance Period (MP)|Adverse Event|0|||
161788063|NCT00410410|584268663|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
161788064|NCT00410410|584268664|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
161788065|NCT00410410|584268665|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
161788066|NCT00410410|584268666|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
161788067|NCT00410410|584268667|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
161788068|NCT00410410|584268668|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
161788069|NCT00410410|584268669|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
161788070|NCT00410410|584268670|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
161788071|NCT00410410|584268671|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
161788072|NCT00410410|584268663|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
161788073|NCT00410410|584268664|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
161788074|NCT00410410|584268665|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
161788075|NCT00410410|584268666|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
161788076|NCT00410410|584268667|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
161788077|NCT00410410|584268668|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
161788078|NCT00410410|584268669|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
161788079|NCT00410410|584268670|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
161788080|NCT00410410|584268671|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
161788081|NCT00410410|584268663|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788082|NCT00410410|584268664|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788083|NCT00410410|584268665|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788084|NCT00410410|584268666|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788085|NCT00410410|584268667|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788086|NCT00410410|584268668|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788087|NCT00410410|584268669|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
161788088|NCT00410410|584268670|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
161788089|NCT00410410|584268671|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
161788090|NCT00410410|584268663|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788091|NCT00410410|584268664|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788092|NCT00410410|584268665|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788093|NCT00410410|584268666|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788094|NCT00410410|584268667|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788095|NCT00410410|584268668|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788096|NCT00410410|584268669|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
161788097|NCT00410410|584268670|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
161788098|NCT00410410|584268671|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161788099|NCT00410410|584268663|FG000|Open-Label Period (OL)|Death|0|||
161788100|NCT00410410|584268664|FG001|Open-Label Period (OL)|Death|0|||
161788101|NCT00410410|584268665|FG002|Open-Label Period (OL)|Death|0|||
161788102|NCT00410410|584268666|FG003|Open-Label Period (OL)|Death|0|||
161788103|NCT00410410|584268667|FG004|Open-Label Period (OL)|Death|0|||
161788104|NCT00410410|584268668|FG005|Open-Label Period (OL)|Death|0|||
161788105|NCT00410410|584268669|FG006|Open-Label Period (OL)|Death|0|||
161788106|NCT00410410|584268670|FG007|Open-Label Period (OL)|Death|0|||
161788107|NCT00410410|584268671|FG008|Open-Label Period (OL)|Death|1|||
161788108|NCT00410410|584268663|FG000|Open-Label Period (OL)|Adverse Event|0|||
161788109|NCT00410410|584268664|FG001|Open-Label Period (OL)|Adverse Event|0|||
161788110|NCT00410410|584268665|FG002|Open-Label Period (OL)|Adverse Event|0|||
161788111|NCT00410410|584268666|FG003|Open-Label Period (OL)|Adverse Event|0|||
161788112|NCT00410410|584268667|FG004|Open-Label Period (OL)|Adverse Event|0|||
161788113|NCT00410410|584268668|FG005|Open-Label Period (OL)|Adverse Event|0|||
161788114|NCT00410410|584268669|FG006|Open-Label Period (OL)|Adverse Event|0|||
161788115|NCT00410410|584268670|FG007|Open-Label Period (OL)|Adverse Event|0|||
161788116|NCT00410410|584268671|FG008|Open-Label Period (OL)|Adverse Event|10|||
161788117|NCT00410410|584268663|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
161788118|NCT00410410|584268664|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
161788119|NCT00410410|584268665|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
161788120|NCT00410410|584268666|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
161788121|NCT00410410|584268667|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
161788122|NCT00410410|584268668|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
161788123|NCT00410410|584268669|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
162010437|NCT01342211|585093758|FG002|Overall Study|Withdrawal by Subject|0|||
161788124|NCT00410410|584268670|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
161788125|NCT00410410|584268671|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
161788126|NCT00410410|584268663|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
161788127|NCT00410410|584268664|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
162010438|NCT01342211|585093759|FG003|Overall Study|Withdrawal by Subject|1|||
162010439|NCT01342211|585093760|FG004|Overall Study|Withdrawal by Subject|0|||
161788128|NCT00410410|584268665|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
161788129|NCT00410410|584268666|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
161788130|NCT00410410|584268667|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
161788131|NCT00410410|584268668|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
161788132|NCT00410410|584268669|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
161788133|NCT00410410|584268670|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
161788134|NCT00410410|584268671|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
161788135|NCT00410410|584268663|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788136|NCT00410410|584268664|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788137|NCT00410410|584268665|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788138|NCT00410410|584268666|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788139|NCT00410410|584268667|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788140|NCT00410410|584268668|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788141|NCT00410410|584268669|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788142|NCT00410410|584268670|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
161788143|NCT00410410|584268671|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
161788144|NCT00410410|584268663|FG000|Open-Label Period (OL)|Pregnancy|0|||
161788145|NCT00410410|584268664|FG001|Open-Label Period (OL)|Pregnancy|0|||
161788146|NCT00410410|584268665|FG002|Open-Label Period (OL)|Pregnancy|0|||
161788147|NCT00410410|584268666|FG003|Open-Label Period (OL)|Pregnancy|0|||
161788148|NCT00410410|584268667|FG004|Open-Label Period (OL)|Pregnancy|0|||
161788149|NCT00410410|584268668|FG005|Open-Label Period (OL)|Pregnancy|0|||
161788150|NCT00410410|584268669|FG006|Open-Label Period (OL)|Pregnancy|0|||
161788151|NCT00410410|584268670|FG007|Open-Label Period (OL)|Pregnancy|0|||
161788152|NCT00410410|584268671|FG008|Open-Label Period (OL)|Pregnancy|1|||
161788153|NCT00410410|584268663|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788154|NCT00410410|584268664|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788155|NCT00410410|584268665|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788156|NCT00410410|584268666|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788157|NCT00410410|584268667|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788158|NCT00410410|584268668|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788159|NCT00410410|584268669|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788160|NCT00410410|584268670|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161788161|NCT00410410|584268671|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
161788162|NCT00410410|584268663|FG000|Open-Label Period (OL)|Other|0|||
161788163|NCT00410410|584268664|FG001|Open-Label Period (OL)|Other|0|||
161788164|NCT00410410|584268665|FG002|Open-Label Period (OL)|Other|0|||
161788165|NCT00410410|584268666|FG003|Open-Label Period (OL)|Other|0|||
161788166|NCT00410410|584268667|FG004|Open-Label Period (OL)|Other|0|||
161788167|NCT00410410|584268668|FG005|Open-Label Period (OL)|Other|0|||
161788168|NCT00410410|584268669|FG006|Open-Label Period (OL)|Other|0|||
161788169|NCT00410410|584268670|FG007|Open-Label Period (OL)|Other|0|||
161788170|NCT00410410|584268671|FG008|Open-Label Period (OL)|Other|7|||
161788171|NCT01783496|584268672|FG000|Overall Study|Lost to Follow-up|0|||
161788172|NCT01783496|584268673|FG001|Overall Study|Lost to Follow-up|0|||
161788173|NCT01783496|584268674|FG002|Overall Study|Lost to Follow-up|0|||
161788174|NCT01783496|584268675|FG003|Overall Study|Lost to Follow-up|2|||
161788175|NCT01783496|584268676|FG004|Overall Study|Lost to Follow-up|0|||
161788176|NCT01783496|584268677|FG005|Overall Study|Lost to Follow-up|1|||
161788177|NCT01783496|584268672|FG000|Overall Study|Withdrawal by Subject|1|||
161788178|NCT01783496|584268673|FG001|Overall Study|Withdrawal by Subject|0|||
161788179|NCT01783496|584268674|FG002|Overall Study|Withdrawal by Subject|0|||
161788180|NCT01783496|584268675|FG003|Overall Study|Withdrawal by Subject|0|||
161788181|NCT01783496|584268676|FG004|Overall Study|Withdrawal by Subject|0|||
161788182|NCT01783496|584268677|FG005|Overall Study|Withdrawal by Subject|0|||
161788183|NCT01023269|584268678|FG000|Overall Study|early termination of the study|2|||
161788184|NCT01023269|584268679|FG001|Overall Study|early termination of the study|0|||
161788185|NCT00106028|584268680|FG000|Overall Study|Adverse Event|3|||
162126373|NCT03230864|585512950|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
162126374|NCT03230864|585512947|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
162126375|NCT03230864|585512948|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
162126376|NCT03230864|585512949|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
162126377|NCT03230864|585512950|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
162126378|NCT03230864|585512947|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
162126379|NCT03230864|585512948|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
162126380|NCT03230864|585512949|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
162126381|NCT03230864|585512950|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
162126382|NCT03230864|585512947|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
161788186|NCT00106028|584268681|FG001|Overall Study|Adverse Event|2|||
161788187|NCT00106028|584268680|FG000|Overall Study|Protocol Violation|1|||
161788188|NCT00106028|584268681|FG001|Overall Study|Protocol Violation|1|||
161788189|NCT00106028|584268680|FG000|Overall Study|Withdrawal by Subject|2|||
161788190|NCT00106028|584268681|FG001|Overall Study|Withdrawal by Subject|8|||
161788191|NCT00106028|584268680|FG000|Overall Study|Lost to Follow-up|0|||
161788192|NCT00106028|584268681|FG001|Overall Study|Lost to Follow-up|1|||
161788193|NCT00947011|584268682|FG000|Overall Study|Study was terminated,PI left institution|12|||
161788194|NCT05266456|584268685|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
161788195|NCT05266456|584268686|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
161788196|NCT05266456|584268687|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
161788197|NCT05266456|584268688|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
161788198|NCT05266456|584268685|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
161788199|NCT05266456|584268686|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
161788200|NCT05266456|584268687|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
161788201|NCT05266456|584268688|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
161788202|NCT05266456|584268685|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
161788203|NCT05266456|584268686|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
161788204|NCT05266456|584268687|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
161788205|NCT05266456|584268688|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
161788206|NCT05266456|584268685|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
161788207|NCT05266456|584268686|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
161788208|NCT05266456|584268687|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
161788209|NCT05266456|584268688|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
161788210|NCT05266456|584268685|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
161788211|NCT05266456|584268686|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
161788212|NCT05266456|584268687|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
161788213|NCT05266456|584268688|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
161788214|NCT02746705|584268695|FG000|Overall Study|Physician Decision|1|||
161788215|NCT02746705|584268696|FG001|Overall Study|Physician Decision|1|||
161788216|NCT02746705|584268695|FG000|Overall Study|Lost to Follow-up|1|||
161788217|NCT02746705|584268696|FG001|Overall Study|Lost to Follow-up|0|||
161788218|NCT02746705|584268695|FG000|Overall Study|outlier scores deemed not valid|0|||
161788219|NCT02746705|584268696|FG001|Overall Study|outlier scores deemed not valid|1|||
161788220|NCT00479401|584268697|FG000|Overall Study|Adverse Event|24|||
161788221|NCT00479401|584268698|FG001|Overall Study|Adverse Event|20|||
161788222|NCT00479401|584268699|FG002|Overall Study|Adverse Event|4|||
161788223|NCT00479401|584268697|FG000|Overall Study|Lack of Efficacy|2|||
161788224|NCT00479401|584268698|FG001|Overall Study|Lack of Efficacy|2|||
161788225|NCT00479401|584268699|FG002|Overall Study|Lack of Efficacy|4|||
161788226|NCT00479401|584268697|FG000|Overall Study|Protocol Violation|2|||
161788227|NCT00479401|584268698|FG001|Overall Study|Protocol Violation|1|||
161788228|NCT00479401|584268699|FG002|Overall Study|Protocol Violation|1|||
161788229|NCT00479401|584268697|FG000|Overall Study|Lost to Follow-up|1|||
161788230|NCT00479401|584268698|FG001|Overall Study|Lost to Follow-up|1|||
161788231|NCT00479401|584268699|FG002|Overall Study|Lost to Follow-up|1|||
161788232|NCT00479401|584268697|FG000|Overall Study|Withdrawal by Subject|16|||
161788233|NCT00479401|584268698|FG001|Overall Study|Withdrawal by Subject|10|||
161788234|NCT00479401|584268699|FG002|Overall Study|Withdrawal by Subject|2|||
161788235|NCT00479401|584268697|FG000|Overall Study|Exclusion criteria, relocation|4|||
161788236|NCT00479401|584268698|FG001|Overall Study|Exclusion criteria, relocation|3|||
161788237|NCT00479401|584268699|FG002|Overall Study|Exclusion criteria, relocation|0|||
161788238|NCT01504867|584268700|FG000|Overall Study|Inclusion criteria not met|2|||
161788239|NCT01504867|584268701|FG001|Overall Study|Inclusion criteria not met|2|||
161788240|NCT01504867|584268700|FG000|Overall Study|Consent revoked|5|||
161788241|NCT01504867|584268701|FG001|Overall Study|Consent revoked|1|||
161788242|NCT02473510|584268704|FG000|Overall Study|Lost to Follow-up|1|||
161788243|NCT02473510|584268705|FG001|Overall Study|Lost to Follow-up|2|||
161788244|NCT00990093|584268706|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
161788245|NCT00990093|584268707|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
161788246|NCT00990093|584268706|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
161788247|NCT00990093|584268707|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
161788248|NCT00990093|584268706|FG000|Test Period 1 (1-14 Days)|Other|1|||
161788249|NCT00990093|584268707|FG001|Test Period 1 (1-14 Days)|Other|0|||
161788250|NCT00990093|584268706|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
161788251|NCT00990093|584268707|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
161788252|NCT00990093|584268706|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
161788253|NCT00990093|584268707|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
161788254|NCT00990093|584268706|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
161788255|NCT00990093|584268707|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
161788256|NCT00990093|584268706|FG000|Test Period 2 (15-28 Days)|Other|0|||
161788257|NCT00990093|584268707|FG001|Test Period 2 (15-28 Days)|Other|1|||
161788258|NCT03185949|584268708|FG000|ITT Analysis|Withdrawal by Subject|4|||
161788259|NCT03185949|584268709|FG001|ITT Analysis|Withdrawal by Subject|3|||
161788260|NCT03185949|584268708|FG000|PP Analysis|Protocol Violation|2|||
161788261|NCT03185949|584268709|FG001|PP Analysis|Protocol Violation|2|||
161788262|NCT03185949|584268708|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
161788263|NCT03185949|584268709|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
161788264|NCT00928252|584270576|FG000|Overall Study|Physician Decision|3|||
161788265|NCT02257632|584270577|FG000|Overall Study|Withdrawal by Subject|0|||
161788266|NCT02257632|584270578|FG001|Overall Study|Withdrawal by Subject|1|||
161788267|NCT02257632|584270577|FG000|Overall Study|Adverse Event|1|||
161788268|NCT02257632|584270578|FG001|Overall Study|Adverse Event|2|||
161788269|NCT01393990|584270582|FG000|Overall Study|Adverse Event|0|||
161788270|NCT01393990|584270583|FG001|Overall Study|Adverse Event|0|||
161788271|NCT01393990|584270584|FG002|Overall Study|Adverse Event|0|||
161788272|NCT01393990|584270585|FG003|Overall Study|Adverse Event|0|||
161788273|NCT01393990|584270586|FG004|Overall Study|Adverse Event|0|||
161788274|NCT01393990|584270587|FG005|Overall Study|Adverse Event|0|||
161788275|NCT01393990|584270588|FG006|Overall Study|Adverse Event|0|||
161788276|NCT01393990|584270589|FG007|Overall Study|Adverse Event|0|||
161788277|NCT01393990|584270590|FG008|Overall Study|Adverse Event|0|||
161788278|NCT01393990|584270591|FG009|Overall Study|Adverse Event|0|||
161788279|NCT01393990|584270592|FG010|Overall Study|Adverse Event|0|||
161788280|NCT01393990|584270593|FG011|Overall Study|Adverse Event|0|||
161788281|NCT01393990|584270594|FG012|Overall Study|Adverse Event|0|||
161788282|NCT01393990|584270595|FG013|Overall Study|Adverse Event|0|||
161788283|NCT01393990|584270596|FG014|Overall Study|Adverse Event|1|||
161788284|NCT01393990|584270597|FG015|Overall Study|Adverse Event|1|||
161788285|NCT01393990|584270598|FG016|Overall Study|Adverse Event|0|||
161788286|NCT01393990|584270599|FG017|Overall Study|Adverse Event|0|||
161788287|NCT01393990|584270582|FG000|Overall Study|Progressive Disease|1|||
161788288|NCT01393990|584270583|FG001|Overall Study|Progressive Disease|0|||
161788289|NCT01393990|584270584|FG002|Overall Study|Progressive Disease|0|||
161788290|NCT01393990|584270585|FG003|Overall Study|Progressive Disease|1|||
161788291|NCT01393990|584270586|FG004|Overall Study|Progressive Disease|1|||
161788292|NCT01393990|584270587|FG005|Overall Study|Progressive Disease|1|||
161788293|NCT01393990|584270588|FG006|Overall Study|Progressive Disease|1|||
161788294|NCT01393990|584270589|FG007|Overall Study|Progressive Disease|1|||
161788295|NCT01393990|584270590|FG008|Overall Study|Progressive Disease|3|||
161788296|NCT01393990|584270591|FG009|Overall Study|Progressive Disease|1|||
161788297|NCT01393990|584270592|FG010|Overall Study|Progressive Disease|0|||
161788298|NCT01393990|584270593|FG011|Overall Study|Progressive Disease|0|||
161788299|NCT01393990|584270594|FG012|Overall Study|Progressive Disease|0|||
161788300|NCT01393990|584270595|FG013|Overall Study|Progressive Disease|1|||
161788301|NCT01393990|584270596|FG014|Overall Study|Progressive Disease|6|||
161788302|NCT01393990|584270597|FG015|Overall Study|Progressive Disease|1|||
161788303|NCT01393990|584270598|FG016|Overall Study|Progressive Disease|0|||
161788304|NCT01393990|584270599|FG017|Overall Study|Progressive Disease|0|||
161788305|NCT01393990|584270582|FG000|Overall Study|Death|0|||
161788306|NCT01393990|584270583|FG001|Overall Study|Death|0|||
161788307|NCT01393990|584270584|FG002|Overall Study|Death|0|||
161788308|NCT01393990|584270585|FG003|Overall Study|Death|0|||
161788309|NCT01393990|584270586|FG004|Overall Study|Death|1|||
161788310|NCT01393990|584270587|FG005|Overall Study|Death|0|||
161788311|NCT01393990|584270588|FG006|Overall Study|Death|0|||
161788312|NCT01393990|584270589|FG007|Overall Study|Death|0|||
161788313|NCT01393990|584270590|FG008|Overall Study|Death|0|||
161788314|NCT01393990|584270591|FG009|Overall Study|Death|0|||
161788315|NCT01393990|584270592|FG010|Overall Study|Death|0|||
161788316|NCT01393990|584270593|FG011|Overall Study|Death|0|||
161788317|NCT01393990|584270594|FG012|Overall Study|Death|0|||
161788318|NCT01393990|584270595|FG013|Overall Study|Death|1|||
161788319|NCT01393990|584270596|FG014|Overall Study|Death|1|||
161788320|NCT01393990|584270597|FG015|Overall Study|Death|0|||
161788321|NCT01393990|584270598|FG016|Overall Study|Death|0|||
161788322|NCT01393990|584270599|FG017|Overall Study|Death|0|||
161788323|NCT01393990|584270582|FG000|Overall Study|Withdrawal by Subject|0|||
161788324|NCT01393990|584270583|FG001|Overall Study|Withdrawal by Subject|0|||
161788325|NCT01393990|584270584|FG002|Overall Study|Withdrawal by Subject|0|||
161788326|NCT01393990|584270585|FG003|Overall Study|Withdrawal by Subject|0|||
161788327|NCT01393990|584270586|FG004|Overall Study|Withdrawal by Subject|0|||
161788328|NCT01393990|584270587|FG005|Overall Study|Withdrawal by Subject|0|||
161788329|NCT01393990|584270588|FG006|Overall Study|Withdrawal by Subject|0|||
161788330|NCT01393990|584270589|FG007|Overall Study|Withdrawal by Subject|0|||
161788331|NCT01393990|584270590|FG008|Overall Study|Withdrawal by Subject|0|||
161788332|NCT01393990|584270591|FG009|Overall Study|Withdrawal by Subject|0|||
161788333|NCT01393990|584270592|FG010|Overall Study|Withdrawal by Subject|0|||
161788334|NCT01393990|584270593|FG011|Overall Study|Withdrawal by Subject|0|||
161788335|NCT01393990|584270594|FG012|Overall Study|Withdrawal by Subject|0|||
161788336|NCT01393990|584270595|FG013|Overall Study|Withdrawal by Subject|0|||
161788337|NCT01393990|584270596|FG014|Overall Study|Withdrawal by Subject|1|||
161788338|NCT01393990|584270597|FG015|Overall Study|Withdrawal by Subject|1|||
161788339|NCT01393990|584270598|FG016|Overall Study|Withdrawal by Subject|0|||
161788340|NCT01393990|584270599|FG017|Overall Study|Withdrawal by Subject|0|||
161788341|NCT00331630|584270604|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
161788342|NCT00331630|584270604|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
161788343|NCT00331630|584270604|FG000|Follow up for 5 Years|Death|5|||
161788344|NCT00331630|584270604|FG000|Follow up for 5 Years|Data collection was stopped|24|||
161788345|NCT00720798|584270605|FG000|Overall Study|Adverse Event|304|||
161788346|NCT00720798|584270605|FG000|Overall Study|Death|39|||
161788347|NCT00720798|584270605|FG000|Overall Study|Insufficient Therapeutic Response|129|||
161788348|NCT00720798|584270605|FG000|Overall Study|Protocol Violation|4|||
161788349|NCT00720798|584270605|FG000|Overall Study|Refused Treatment|151|||
161788350|NCT00720798|584270605|FG000|Overall Study|Failure to Return|46|||
161788351|NCT00720798|584270605|FG000|Overall Study|Reason not Specified|83|||
161788352|NCT02806232|584270608|FG000|Overall Study|Lost to Follow-up|1|||
161788353|NCT02806232|584270609|FG001|Overall Study|Lost to Follow-up|2|||
161788354|NCT02806232|584270610|FG002|Overall Study|Lost to Follow-up|1|||
161788355|NCT02806232|584270611|FG003|Overall Study|Lost to Follow-up|0|||
161788356|NCT02806232|584270612|FG004|Overall Study|Lost to Follow-up|0|||
161788357|NCT02806232|584270613|FG005|Overall Study|Lost to Follow-up|1|||
161788358|NCT02806232|584270614|FG006|Overall Study|Lost to Follow-up|0|||
161788359|NCT02806232|584270615|FG007|Overall Study|Lost to Follow-up|0|||
161788360|NCT02806232|584270616|FG008|Overall Study|Lost to Follow-up|0|||
161788361|NCT02806232|584270608|FG000|Overall Study|Withdrawal by Subject|0|||
161788362|NCT02806232|584270609|FG001|Overall Study|Withdrawal by Subject|2|||
161788363|NCT02806232|584270610|FG002|Overall Study|Withdrawal by Subject|0|||
161788364|NCT02806232|584270611|FG003|Overall Study|Withdrawal by Subject|0|||
161788365|NCT02806232|584270612|FG004|Overall Study|Withdrawal by Subject|2|||
161788366|NCT02806232|584270613|FG005|Overall Study|Withdrawal by Subject|1|||
161788367|NCT02806232|584270614|FG006|Overall Study|Withdrawal by Subject|0|||
161788368|NCT02806232|584270615|FG007|Overall Study|Withdrawal by Subject|0|||
161788369|NCT02806232|584270616|FG008|Overall Study|Withdrawal by Subject|0|||
161788370|NCT00434161|584270617|FG000|Overall Study|Adverse Event|5|||
161788371|NCT00434161|584270618|FG001|Overall Study|Adverse Event|1|||
161788372|NCT00434161|584270619|FG002|Overall Study|Adverse Event|4|||
161788373|NCT00434161|584270617|FG000|Overall Study|Lost to Follow-up|0|||
161788374|NCT00434161|584270618|FG001|Overall Study|Lost to Follow-up|1|||
161788375|NCT00434161|584270619|FG002|Overall Study|Lost to Follow-up|0|||
161788376|NCT00434161|584270617|FG000|Overall Study|Death|1|||
161788377|NCT00434161|584270618|FG001|Overall Study|Death|0|||
161788378|NCT00434161|584270619|FG002|Overall Study|Death|1|||
161788379|NCT00434161|584270617|FG000|Overall Study|Non-Compliance|1|||
161788380|NCT00434161|584270618|FG001|Overall Study|Non-Compliance|1|||
161788381|NCT00434161|584270619|FG002|Overall Study|Non-Compliance|0|||
161788382|NCT00434161|584270617|FG000|Overall Study|Withdrawal by Subject|2|||
161788383|NCT00434161|584270618|FG001|Overall Study|Withdrawal by Subject|0|||
161788384|NCT00434161|584270619|FG002|Overall Study|Withdrawal by Subject|3|||
161788385|NCT00434161|584270617|FG000|Overall Study|Logistical error study assessments|1|||
161788386|NCT00434161|584270618|FG001|Overall Study|Logistical error study assessments|0|||
161788387|NCT00434161|584270619|FG002|Overall Study|Logistical error study assessments|3|||
161788388|NCT01312779|584270620|FG000|Overall Study|Withdrawal by Subject|2|||
161788389|NCT01312779|584270620|FG000|Overall Study|Death|3|||
161788390|NCT01312779|584270620|FG000|Overall Study|Not Implanted with Device|27|||
161788391|NCT00506753|584270621|FG000|Overall Study|Lost to Follow-up|21|||
161788392|NCT00506753|584270622|FG001|Overall Study|Lost to Follow-up|15|||
161788393|NCT02482805|584270628|FG000|Overall Study|Lost to Follow-up|4|||
161788394|NCT02482805|584270629|FG001|Overall Study|Lost to Follow-up|4|||
161788395|NCT02482805|584270630|FG002|Overall Study|Lost to Follow-up|0|||
161788396|NCT01267266|584270632|FG000|Enrollment Phase|Withdrawal by Subject|2|||
161788397|NCT01267266|584270633|FG001|Enrollment Phase|Withdrawal by Subject|0|||
161788398|NCT01267266|584270632|FG000|Lead-in Phase|Lack of Efficacy|20|||
161788399|NCT01267266|584270633|FG001|Lead-in Phase|Lack of Efficacy|0|||
161788400|NCT01267266|584270632|FG000|Lead-in Phase|Adverse Event|2|||
161788401|NCT01267266|584270633|FG001|Lead-in Phase|Adverse Event|0|||
161788402|NCT01267266|584270632|FG000|Lead-in Phase|Withdrawal by Subject|1|||
161788403|NCT01267266|584270633|FG001|Lead-in Phase|Withdrawal by Subject|0|||
161788404|NCT03549130|584270635|FG000|Overall Study|Adverse Event|0|||
161788405|NCT03549130|584270636|FG001|Overall Study|Adverse Event|1|||
161788406|NCT03549130|584270635|FG000|Overall Study|Lost to Follow-up|0|||
161788407|NCT03549130|584270636|FG001|Overall Study|Lost to Follow-up|1|||
161788408|NCT01078623|584270637|FG000|Treatment Period 1|Adverse Event|1|||
161788409|NCT01078623|584270638|FG001|Treatment Period 1|Adverse Event|1|||
162126383|NCT03230864|585512948|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
161788410|NCT01078623|584270639|FG002|Treatment Period 1|Adverse Event|1|||
161788411|NCT01078623|584270640|FG003|Treatment Period 1|Adverse Event|0|||
161788412|NCT01078623|584270641|FG004|Treatment Period 1|Adverse Event|0|||
161788413|NCT01078623|584270642|FG005|Treatment Period 1|Adverse Event|0|||
161788414|NCT01078623|584270643|FG006|Treatment Period 1|Adverse Event|1|||
161788415|NCT01078623|584270644|FG007|Treatment Period 1|Adverse Event|0|||
161788416|NCT01078623|584270645|FG008|Treatment Period 1|Adverse Event|1|||
161788417|NCT01078623|584270646|FG009|Treatment Period 1|Adverse Event|1|||
161788418|NCT01078623|584270647|FG010|Treatment Period 1|Adverse Event|0|||
161788419|NCT01078623|584270648|FG011|Treatment Period 1|Adverse Event|0|||
161788420|NCT01078623|584270649|FG012|Treatment Period 1|Adverse Event|0|||
161788421|NCT01078623|584270650|FG013|Treatment Period 1|Adverse Event|0|||
161788422|NCT01078623|584270651|FG014|Treatment Period 1|Adverse Event|0|||
161788423|NCT01078623|584270652|FG015|Treatment Period 1|Adverse Event|0|||
162126384|NCT03230864|585512949|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
162126385|NCT03230864|585512950|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
162126386|NCT03230864|585512947|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
162126387|NCT03230864|585512948|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
162126388|NCT03230864|585512949|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
162126389|NCT03230864|585512950|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
162126390|NCT03230864|585512947|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
162126391|NCT03230864|585512948|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
162126392|NCT03230864|585512949|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
162126393|NCT03230864|585512950|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
161788424|NCT01078623|584270653|FG016|Treatment Period 1|Adverse Event|0|||
162126394|NCT03230864|585512947|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
162126395|NCT03230864|585512948|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
162126396|NCT03230864|585512949|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
162126397|NCT03230864|585512950|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
162126398|NCT03230864|585512947|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
162126399|NCT03230864|585512948|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
162126400|NCT03230864|585512949|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
162126401|NCT03230864|585512950|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
162126402|NCT03230864|585512947|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
162126403|NCT03230864|585512948|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
162126404|NCT03230864|585512949|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
162126405|NCT03230864|585512950|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
162126406|NCT03230864|585512947|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
162126407|NCT03230864|585512948|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
162126408|NCT03230864|585512949|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
162126409|NCT03230864|585512950|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
162126410|NCT03537261|585512960|FG000|Overall Study|Lost to Follow-up|4|||
162126411|NCT03537261|585512961|FG001|Overall Study|Lost to Follow-up|5|||
162126412|NCT03537261|585512960|FG000|Overall Study|Withdrawal by Subject|4|||
162126413|NCT03537261|585512961|FG001|Overall Study|Withdrawal by Subject|6|||
162126414|NCT03537261|585512960|FG000|Overall Study|Did not return study questionnaires|0|||
162126415|NCT03537261|585512961|FG001|Overall Study|Did not return study questionnaires|1|||
162126416|NCT00502996|585512964|FG000|Overall Study|Lost to Follow-up|9|||
162126417|NCT00502996|585512964|FG000|Overall Study|Protocol Violation|2|||
162126418|NCT00502996|585512964|FG000|Overall Study|Treatment failure|25|||
162126419|NCT00502996|585512964|FG000|Overall Study|Withdrawal Informed Consent|6|||
162126420|NCT00502996|585512964|FG000|Overall Study|Adverse Event|2|||
162126421|NCT01729728|585512965|FG000|Overall Study|Adverse Event|0|||
162126422|NCT01729728|585512966|FG001|Overall Study|Adverse Event|6|||
162126423|NCT01729728|585512967|FG002|Overall Study|Adverse Event|0|||
162126424|NCT01729728|585512965|FG000|Overall Study|Protocol Violation|1|||
162126425|NCT01729728|585512966|FG001|Overall Study|Protocol Violation|0|||
162126426|NCT01729728|585512967|FG002|Overall Study|Protocol Violation|1|||
162126427|NCT02001974|585512980|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
162126428|NCT02001974|585512981|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
162126429|NCT02001974|585512982|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
162126430|NCT02001974|585512980|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
162126431|NCT02001974|585512981|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
162126432|NCT02001974|585512982|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
162126433|NCT02001974|585512980|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
161788425|NCT01078623|584270654|FG017|Treatment Period 1|Adverse Event|0|||
161788426|NCT01078623|584270655|FG018|Treatment Period 1|Adverse Event|0|||
161788427|NCT01078623|584270656|FG019|Treatment Period 1|Adverse Event|0|||
161788428|NCT01078623|584270637|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161788429|NCT01078623|584270638|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161788430|NCT01078623|584270639|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161788431|NCT01078623|584270640|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161788432|NCT01078623|584270641|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161788433|NCT01078623|584270642|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161788434|NCT01078623|584270643|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161788435|NCT01078623|584270644|FG007|Treatment Period 1|Withdrawal by Subject|1|||
162126434|NCT02001974|585512981|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
162126435|NCT02001974|585512982|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
162126436|NCT02001974|585512980|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
162126437|NCT02001974|585512981|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
162126438|NCT02001974|585512982|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
161788436|NCT01078623|584270645|FG008|Treatment Period 1|Withdrawal by Subject|0|||
161788437|NCT01078623|584270646|FG009|Treatment Period 1|Withdrawal by Subject|0|||
161788438|NCT01078623|584270647|FG010|Treatment Period 1|Withdrawal by Subject|1|||
161788439|NCT01078623|584270648|FG011|Treatment Period 1|Withdrawal by Subject|0|||
161788440|NCT01078623|584270649|FG012|Treatment Period 1|Withdrawal by Subject|0|||
161788441|NCT01078623|584270650|FG013|Treatment Period 1|Withdrawal by Subject|0|||
161788442|NCT01078623|584270651|FG014|Treatment Period 1|Withdrawal by Subject|0|||
161788443|NCT01078623|584270652|FG015|Treatment Period 1|Withdrawal by Subject|0|||
161788444|NCT01078623|584270653|FG016|Treatment Period 1|Withdrawal by Subject|0|||
161788445|NCT01078623|584270654|FG017|Treatment Period 1|Withdrawal by Subject|0|||
161788446|NCT01078623|584270655|FG018|Treatment Period 1|Withdrawal by Subject|0|||
161788447|NCT01078623|584270656|FG019|Treatment Period 1|Withdrawal by Subject|0|||
161788448|NCT01078623|584270637|FG000|Treatment Period 1|Protocol Violation|0|||
161788449|NCT01078623|584270638|FG001|Treatment Period 1|Protocol Violation|0|||
161788450|NCT01078623|584270639|FG002|Treatment Period 1|Protocol Violation|0|||
161788451|NCT01078623|584270640|FG003|Treatment Period 1|Protocol Violation|0|||
161788452|NCT01078623|584270641|FG004|Treatment Period 1|Protocol Violation|0|||
161788453|NCT01078623|584270642|FG005|Treatment Period 1|Protocol Violation|1|||
161788454|NCT01078623|584270643|FG006|Treatment Period 1|Protocol Violation|0|||
161788455|NCT01078623|584270644|FG007|Treatment Period 1|Protocol Violation|0|||
161788456|NCT01078623|584270645|FG008|Treatment Period 1|Protocol Violation|0|||
161788457|NCT01078623|584270646|FG009|Treatment Period 1|Protocol Violation|0|||
161788458|NCT01078623|584270647|FG010|Treatment Period 1|Protocol Violation|0|||
161788459|NCT01078623|584270648|FG011|Treatment Period 1|Protocol Violation|0|||
161788460|NCT01078623|584270649|FG012|Treatment Period 1|Protocol Violation|0|||
161788461|NCT01078623|584270650|FG013|Treatment Period 1|Protocol Violation|0|||
161788462|NCT01078623|584270651|FG014|Treatment Period 1|Protocol Violation|0|||
161788463|NCT01078623|584270652|FG015|Treatment Period 1|Protocol Violation|0|||
161788464|NCT01078623|584270653|FG016|Treatment Period 1|Protocol Violation|0|||
161788465|NCT01078623|584270654|FG017|Treatment Period 1|Protocol Violation|0|||
161788466|NCT01078623|584270655|FG018|Treatment Period 1|Protocol Violation|0|||
161788467|NCT01078623|584270656|FG019|Treatment Period 1|Protocol Violation|0|||
161788468|NCT01078623|584270637|FG000|Treatment Period 2|Adverse Event|0|||
161788469|NCT01078623|584270638|FG001|Treatment Period 2|Adverse Event|0|||
161788470|NCT01078623|584270639|FG002|Treatment Period 2|Adverse Event|0|||
161788471|NCT01078623|584270640|FG003|Treatment Period 2|Adverse Event|0|||
161788472|NCT01078623|584270641|FG004|Treatment Period 2|Adverse Event|0|||
161788473|NCT01078623|584270642|FG005|Treatment Period 2|Adverse Event|0|||
161788474|NCT01078623|584270643|FG006|Treatment Period 2|Adverse Event|1|||
161788475|NCT01078623|584270644|FG007|Treatment Period 2|Adverse Event|0|||
161788476|NCT01078623|584270645|FG008|Treatment Period 2|Adverse Event|0|||
161788477|NCT01078623|584270646|FG009|Treatment Period 2|Adverse Event|0|||
161788478|NCT01078623|584270647|FG010|Treatment Period 2|Adverse Event|0|||
161788479|NCT01078623|584270648|FG011|Treatment Period 2|Adverse Event|0|||
161788480|NCT01078623|584270649|FG012|Treatment Period 2|Adverse Event|0|||
161788481|NCT01078623|584270650|FG013|Treatment Period 2|Adverse Event|0|||
161788482|NCT01078623|584270651|FG014|Treatment Period 2|Adverse Event|0|||
161788483|NCT01078623|584270652|FG015|Treatment Period 2|Adverse Event|0|||
161788484|NCT01078623|584270653|FG016|Treatment Period 2|Adverse Event|0|||
161788485|NCT01078623|584270654|FG017|Treatment Period 2|Adverse Event|0|||
161788486|NCT01078623|584270655|FG018|Treatment Period 2|Adverse Event|1|||
161788487|NCT01078623|584270656|FG019|Treatment Period 2|Adverse Event|0|||
161788488|NCT01078623|584270637|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161788489|NCT01078623|584270638|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161788490|NCT01078623|584270639|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161788491|NCT01078623|584270640|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161788492|NCT01078623|584270641|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161788493|NCT01078623|584270642|FG005|Treatment Period 2|Withdrawal by Subject|1|||
161788494|NCT01078623|584270643|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161788495|NCT01078623|584270644|FG007|Treatment Period 2|Withdrawal by Subject|0|||
161788496|NCT01078623|584270645|FG008|Treatment Period 2|Withdrawal by Subject|0|||
161788497|NCT01078623|584270646|FG009|Treatment Period 2|Withdrawal by Subject|0|||
161788498|NCT01078623|584270647|FG010|Treatment Period 2|Withdrawal by Subject|0|||
161788499|NCT01078623|584270648|FG011|Treatment Period 2|Withdrawal by Subject|0|||
161788500|NCT01078623|584270649|FG012|Treatment Period 2|Withdrawal by Subject|0|||
161788501|NCT01078623|584270650|FG013|Treatment Period 2|Withdrawal by Subject|0|||
161788502|NCT01078623|584270651|FG014|Treatment Period 2|Withdrawal by Subject|0|||
161788503|NCT01078623|584270652|FG015|Treatment Period 2|Withdrawal by Subject|0|||
161788504|NCT01078623|584270653|FG016|Treatment Period 2|Withdrawal by Subject|0|||
161788505|NCT01078623|584270654|FG017|Treatment Period 2|Withdrawal by Subject|0|||
161788506|NCT01078623|584270655|FG018|Treatment Period 2|Withdrawal by Subject|0|||
161788507|NCT01078623|584270656|FG019|Treatment Period 2|Withdrawal by Subject|0|||
161788508|NCT01078623|584270637|FG000|Treatment Period 3|Adverse Event|0|||
161788509|NCT01078623|584270638|FG001|Treatment Period 3|Adverse Event|0|||
161788510|NCT01078623|584270639|FG002|Treatment Period 3|Adverse Event|0|||
161788511|NCT01078623|584270640|FG003|Treatment Period 3|Adverse Event|0|||
161788512|NCT01078623|584270641|FG004|Treatment Period 3|Adverse Event|1|||
161788513|NCT01078623|584270642|FG005|Treatment Period 3|Adverse Event|0|||
161788514|NCT01078623|584270643|FG006|Treatment Period 3|Adverse Event|0|||
161788515|NCT01078623|584270644|FG007|Treatment Period 3|Adverse Event|0|||
161788516|NCT01078623|584270645|FG008|Treatment Period 3|Adverse Event|0|||
161788517|NCT01078623|584270646|FG009|Treatment Period 3|Adverse Event|0|||
161788518|NCT01078623|584270647|FG010|Treatment Period 3|Adverse Event|0|||
161788519|NCT01078623|584270648|FG011|Treatment Period 3|Adverse Event|0|||
161788520|NCT01078623|584270649|FG012|Treatment Period 3|Adverse Event|0|||
161788521|NCT01078623|584270650|FG013|Treatment Period 3|Adverse Event|1|||
161788522|NCT01078623|584270651|FG014|Treatment Period 3|Adverse Event|0|||
162126439|NCT00993317|585512983|FG000|Overall Study|Adverse Event|2|||
162126440|NCT00993317|585512984|FG001|Overall Study|Adverse Event|4|||
162126441|NCT00993317|585512983|FG000|Overall Study|Lack of Efficacy|18|||
162126442|NCT00993317|585512984|FG001|Overall Study|Lack of Efficacy|18|||
162126443|NCT00993317|585512983|FG000|Overall Study|Withdrawal by Subject|0|||
162126444|NCT00993317|585512984|FG001|Overall Study|Withdrawal by Subject|2|||
162126445|NCT00993317|585512983|FG000|Overall Study|Investigator's opinion|0|||
162126446|NCT00993317|585512984|FG001|Overall Study|Investigator's opinion|1|||
162126447|NCT00993317|585512983|FG000|Overall Study|Early study termination at the site|1|||
162126448|NCT00993317|585512984|FG001|Overall Study|Early study termination at the site|0|||
162126449|NCT00672958|585512985|FG000|Overall Study|Adverse Event|11|||
162126450|NCT00672958|585512986|FG001|Overall Study|Adverse Event|9|||
162126451|NCT00672958|585512985|FG000|Overall Study|Lack of Efficacy|6|||
162126452|NCT00672958|585512986|FG001|Overall Study|Lack of Efficacy|11|||
162126453|NCT00672958|585512985|FG000|Overall Study|Non-compliance with study drug|2|||
162126454|NCT00672958|585512986|FG001|Overall Study|Non-compliance with study drug|3|||
162126455|NCT00672958|585512985|FG000|Overall Study|Protocol deviations|11|||
162126456|NCT00672958|585512986|FG001|Overall Study|Protocol deviations|5|||
162126457|NCT00672958|585512985|FG000|Overall Study|Voluntary withdrawal|12|||
162126458|NCT00672958|585512986|FG001|Overall Study|Voluntary withdrawal|8|||
162126459|NCT00672958|585512985|FG000|Overall Study|Lost to Follow-up|22|||
162126460|NCT00672958|585512986|FG001|Overall Study|Lost to Follow-up|17|||
162126461|NCT00672958|585512985|FG000|Overall Study|Reason not specified|0|||
162126462|NCT00672958|585512986|FG001|Overall Study|Reason not specified|3|||
162126463|NCT04422639|585512987|FG000|Overall Study|Death|1|||
162126464|NCT04422639|585512988|FG001|Overall Study|Death|0|||
162126465|NCT04422639|585512987|FG000|Overall Study|study closed prior to completion of FU visits|0|||
162126466|NCT04422639|585512988|FG001|Overall Study|study closed prior to completion of FU visits|2|||
162126467|NCT02374593|585512989|FG000|Overall Study|non-compliant|2|||
162126468|NCT02374593|585512990|FG001|Overall Study|non-compliant|0|||
162126469|NCT00655551|585512998|FG000|All Periods Combined|Adverse Event|0|||
162126470|NCT00655551|585512999|FG001|All Periods Combined|Adverse Event|3|||
162126471|NCT00655551|585513000|FG002|All Periods Combined|Adverse Event|4|||
162126472|NCT00655551|585512998|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
162126473|NCT00655551|585512999|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
162126474|NCT00655551|585513000|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
162126475|NCT00655551|585512998|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
162126476|NCT00655551|585512999|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
162126477|NCT00655551|585513000|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
162126478|NCT00655551|585512998|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
162126479|NCT00655551|585512999|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
162126480|NCT00655551|585513000|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
162126481|NCT02855164|585513002|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
161788523|NCT01078623|584270652|FG015|Treatment Period 3|Adverse Event|0|||
161788524|NCT01078623|584270653|FG016|Treatment Period 3|Adverse Event|0|||
161788525|NCT01078623|584270654|FG017|Treatment Period 3|Adverse Event|0|||
161788526|NCT01078623|584270655|FG018|Treatment Period 3|Adverse Event|0|||
161788527|NCT01078623|584270656|FG019|Treatment Period 3|Adverse Event|0|||
161788528|NCT01078623|584270637|FG000|Treatment Period 4|Adverse Event|0|||
162126482|NCT02855164|585513003|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
162126483|NCT02855164|585513004|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
162126484|NCT02855164|585513005|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
162126485|NCT02855164|585513006|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
162126486|NCT02855164|585513007|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
162126487|NCT02855164|585513008|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
162126488|NCT02855164|585513009|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
162126489|NCT02855164|585513002|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
162126490|NCT02855164|585513003|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
162126491|NCT02855164|585513004|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
162126492|NCT02855164|585513005|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
162126493|NCT02855164|585513006|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
162126494|NCT02855164|585513007|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
162126495|NCT02855164|585513008|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
161788529|NCT01078623|584270638|FG001|Treatment Period 4|Adverse Event|0|||
161788530|NCT01078623|584270639|FG002|Treatment Period 4|Adverse Event|1|||
161788531|NCT01078623|584270640|FG003|Treatment Period 4|Adverse Event|0|||
161788532|NCT01078623|584270641|FG004|Treatment Period 4|Adverse Event|0|||
161788533|NCT01078623|584270642|FG005|Treatment Period 4|Adverse Event|0|||
161788534|NCT01078623|584270643|FG006|Treatment Period 4|Adverse Event|0|||
161788535|NCT01078623|584270644|FG007|Treatment Period 4|Adverse Event|0|||
161788536|NCT01078623|584270645|FG008|Treatment Period 4|Adverse Event|0|||
161788537|NCT01078623|584270646|FG009|Treatment Period 4|Adverse Event|0|||
161788538|NCT01078623|584270647|FG010|Treatment Period 4|Adverse Event|0|||
161788539|NCT01078623|584270648|FG011|Treatment Period 4|Adverse Event|0|||
161788540|NCT01078623|584270649|FG012|Treatment Period 4|Adverse Event|0|||
161788541|NCT01078623|584270650|FG013|Treatment Period 4|Adverse Event|0|||
161788542|NCT01078623|584270651|FG014|Treatment Period 4|Adverse Event|0|||
161788543|NCT01078623|584270652|FG015|Treatment Period 4|Adverse Event|0|||
161788544|NCT01078623|584270653|FG016|Treatment Period 4|Adverse Event|0|||
161788545|NCT01078623|584270654|FG017|Treatment Period 4|Adverse Event|0|||
161788546|NCT01078623|584270655|FG018|Treatment Period 4|Adverse Event|0|||
161788547|NCT01078623|584270656|FG019|Treatment Period 4|Adverse Event|0|||
161788548|NCT01078623|584270637|FG000|Treatment Period 4|Withdrawal by Subject|0|||
161788549|NCT01078623|584270638|FG001|Treatment Period 4|Withdrawal by Subject|0|||
161788550|NCT01078623|584270639|FG002|Treatment Period 4|Withdrawal by Subject|0|||
161788551|NCT01078623|584270640|FG003|Treatment Period 4|Withdrawal by Subject|0|||
161788552|NCT01078623|584270641|FG004|Treatment Period 4|Withdrawal by Subject|0|||
161788553|NCT01078623|584270642|FG005|Treatment Period 4|Withdrawal by Subject|0|||
161788554|NCT01078623|584270643|FG006|Treatment Period 4|Withdrawal by Subject|0|||
161788555|NCT01078623|584270644|FG007|Treatment Period 4|Withdrawal by Subject|0|||
161788556|NCT01078623|584270645|FG008|Treatment Period 4|Withdrawal by Subject|0|||
161788557|NCT01078623|584270646|FG009|Treatment Period 4|Withdrawal by Subject|0|||
161788558|NCT01078623|584270647|FG010|Treatment Period 4|Withdrawal by Subject|0|||
161788559|NCT01078623|584270648|FG011|Treatment Period 4|Withdrawal by Subject|0|||
161788560|NCT01078623|584270649|FG012|Treatment Period 4|Withdrawal by Subject|0|||
161788561|NCT01078623|584270650|FG013|Treatment Period 4|Withdrawal by Subject|0|||
161788562|NCT01078623|584270651|FG014|Treatment Period 4|Withdrawal by Subject|0|||
161788563|NCT01078623|584270652|FG015|Treatment Period 4|Withdrawal by Subject|1|||
161788564|NCT01078623|584270653|FG016|Treatment Period 4|Withdrawal by Subject|0|||
161788565|NCT01078623|584270654|FG017|Treatment Period 4|Withdrawal by Subject|0|||
161788566|NCT01078623|584270655|FG018|Treatment Period 4|Withdrawal by Subject|0|||
161788567|NCT01078623|584270656|FG019|Treatment Period 4|Withdrawal by Subject|0|||
161788568|NCT02480010|584270663|FG000|Overall Study|Adverse Event|3|||
161788569|NCT02480010|584270664|FG001|Overall Study|Adverse Event|1|||
161788570|NCT02480010|584270663|FG000|Overall Study|Death|1|||
161788571|NCT02480010|584270664|FG001|Overall Study|Death|0|||
161788572|NCT02480010|584270663|FG000|Overall Study|Insufficient therapeutic response|31|||
161788573|NCT02480010|584270664|FG001|Overall Study|Insufficient therapeutic response|29|||
161788574|NCT02480010|584270663|FG000|Overall Study|Refused Treatment|0|||
161788575|NCT02480010|584270664|FG001|Overall Study|Refused Treatment|3|||
161788576|NCT01759381|584270671|FG000|Overall Study|Death|1|||
161788577|NCT01759381|584270672|FG001|Overall Study|Death|0|||
161788578|NCT03377556|584270685|FG000|Overall Study|Adverse Event|5|||
161788579|NCT03377556|584270685|FG000|Overall Study|Refusal unrelated to adverse events|1|||
161788580|NCT03377556|584270685|FG000|Overall Study|Progression/relapse|38|||
161788581|NCT03377556|584270685|FG000|Overall Study|Death|3|||
161788582|NCT00910858|584270686|FG000|Pharmacokinetic Phase|Adverse Event|1|||
161788583|NCT00910858|584270687|FG001|Pharmacokinetic Phase|Adverse Event|0|||
161788584|NCT00910858|584270688|FG002|Pharmacokinetic Phase|Adverse Event|0|||
161788585|NCT00910858|584270686|FG000|Monotherapy Phase|Adverse Event|3|||
161788586|NCT00910858|584270687|FG001|Monotherapy Phase|Adverse Event|2|||
161788587|NCT00910858|584270688|FG002|Monotherapy Phase|Adverse Event|0|||
161788588|NCT00910858|584270686|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
161788589|NCT00910858|584270687|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
161788590|NCT00910858|584270688|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
161788591|NCT00910858|584270686|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
161788592|NCT00910858|584270687|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
161788593|NCT00910858|584270688|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
161788594|NCT00910858|584270686|FG000|Monotherapy Phase|Protocol Violation|1|||
161898546|NCT03272347|584677830|FG002|Overall Study|Death|0|||
162126496|NCT02855164|585513009|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
162126497|NCT02855164|585513002|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
161788595|NCT00910858|584270687|FG001|Monotherapy Phase|Protocol Violation|0|||
161788596|NCT00910858|584270688|FG002|Monotherapy Phase|Protocol Violation|0|||
161788597|NCT00910858|584270686|FG000|Monotherapy Phase|Other|3|||
161788598|NCT00910858|584270687|FG001|Monotherapy Phase|Other|4|||
161788599|NCT00910858|584270688|FG002|Monotherapy Phase|Other|2|||
161788600|NCT00910858|584270686|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
161788601|NCT00910858|584270687|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
161788602|NCT00910858|584270688|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
161788603|NCT00910858|584270686|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
161788604|NCT00910858|584270687|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
161788605|NCT00910858|584270688|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
161898547|NCT03272347|584677831|FG003|Overall Study|Death|1|||
161788606|NCT00910858|584270686|FG000|Combined Treatment Phase|Protocol Violation|1|||
161788607|NCT00910858|584270687|FG001|Combined Treatment Phase|Protocol Violation|0|||
161788608|NCT00910858|584270688|FG002|Combined Treatment Phase|Protocol Violation|0|||
161788609|NCT00910858|584270686|FG000|Combined Treatment Phase|Other|0|||
161788610|NCT00910858|584270687|FG001|Combined Treatment Phase|Other|2|||
161788611|NCT00910858|584270688|FG002|Combined Treatment Phase|Other|1|||
161788612|NCT00447603|584270695|FG000|Screening|Withdrawal by Subject|1|||
161788613|NCT00447603|584270696|FG001|Screening|Withdrawal by Subject|0|||
161788614|NCT00447603|584270697|FG002|Screening|Withdrawal by Subject|0|||
161788615|NCT00447603|584270695|FG000|Screening|Protocol Violation|1|||
161788616|NCT00447603|584270696|FG001|Screening|Protocol Violation|0|||
161788617|NCT00447603|584270697|FG002|Screening|Protocol Violation|0|||
161788618|NCT00447603|584270695|FG000|Screening|Screen Failure|4|||
161788619|NCT00447603|584270696|FG001|Screening|Screen Failure|0|||
161788620|NCT00447603|584270697|FG002|Screening|Screen Failure|0|||
161788621|NCT00447603|584270695|FG000|Screening|Study Terminated by Sponsor|15|||
161788622|NCT00447603|584270696|FG001|Screening|Study Terminated by Sponsor|0|||
161788623|NCT00447603|584270697|FG002|Screening|Study Terminated by Sponsor|0|||
161788624|NCT00447603|584270695|FG000|Filter Period|Adverse Event|0|||
161788625|NCT00447603|584270696|FG001|Filter Period|Adverse Event|0|||
161788626|NCT00447603|584270697|FG002|Filter Period|Adverse Event|1|||
161788627|NCT00447603|584270695|FG000|Filter Period|Screen Failure|0|||
161788628|NCT00447603|584270696|FG001|Filter Period|Screen Failure|3|||
161788629|NCT00447603|584270697|FG002|Filter Period|Screen Failure|4|||
161788630|NCT00447603|584270695|FG000|Filter Period|Study terminated by Sponsor|0|||
161788631|NCT00447603|584270696|FG001|Filter Period|Study terminated by Sponsor|1|||
161788632|NCT00447603|584270697|FG002|Filter Period|Study terminated by Sponsor|10|||
161788633|NCT01907737|584270708|FG000|Overall Study|Withdrawal by Subject|1|||
161788634|NCT01165684|584270709|FG000|Overall Study|Adverse Event|1|||
161788635|NCT01165684|584270710|FG001|Overall Study|Adverse Event|1|||
161788636|NCT01165684|584270709|FG000|Overall Study|Lack of Efficacy|2|||
161788637|NCT01165684|584270710|FG001|Overall Study|Lack of Efficacy|1|||
161788638|NCT01165684|584270709|FG000|Overall Study|Protocol Violation|7|||
161788639|NCT01165684|584270710|FG001|Overall Study|Protocol Violation|15|||
161788640|NCT01165684|584270709|FG000|Overall Study|Withdrawal Criteria|2|||
161788641|NCT01165684|584270710|FG001|Overall Study|Withdrawal Criteria|13|||
161788642|NCT01165684|584270709|FG000|Overall Study|Unclassified|16|||
161788643|NCT01165684|584270710|FG001|Overall Study|Unclassified|22|||
161788644|NCT01886300|584270731|FG000|Overall Study|Trial terminated by sponsor|16|||
161788645|NCT00901628|584270732|FG000|Overall Study|disconnection of catheter|4|||
161788646|NCT00901628|584270733|FG001|Overall Study|disconnection of catheter|8|||
161788647|NCT00901628|584270732|FG000|Overall Study|disconnection of drain|0|||
161788648|NCT00901628|584270733|FG001|Overall Study|disconnection of drain|1|||
161788649|NCT00901628|584270732|FG000|Overall Study|peroneal nerve palsy|0|||
161788650|NCT00901628|584270733|FG001|Overall Study|peroneal nerve palsy|1|||
161788651|NCT00608205|584270734|FG000|Overall Study|Adverse Event|3|||
161788652|NCT00608205|584270735|FG001|Overall Study|Adverse Event|2|||
161788653|NCT00608205|584270734|FG000|Overall Study|Patient non-compliant|0|||
161788654|NCT00608205|584270735|FG001|Overall Study|Patient non-compliant|1|||
161788655|NCT02008721|584270738|FG000|Overall Study|Withdrawal by Subject|5|||
161788656|NCT02008721|584270739|FG001|Overall Study|Withdrawal by Subject|1|||
161788657|NCT02008721|584270738|FG000|Overall Study|Death|4|||
161788658|NCT02008721|584270739|FG001|Overall Study|Death|2|||
161788659|NCT02008721|584270738|FG000|Overall Study|Adverse Event|3|||
161788660|NCT02008721|584270739|FG001|Overall Study|Adverse Event|5|||
161788661|NCT02008721|584270738|FG000|Overall Study|Protocol Violation|3|||
161788662|NCT02008721|584270739|FG001|Overall Study|Protocol Violation|2|||
161788663|NCT01797120|584270742|FG000|Overall Study|Disesae progression|37|||
161788664|NCT01797120|584270743|FG001|Overall Study|Disesae progression|49|||
161788665|NCT01797120|584270742|FG000|Overall Study|Adverse Event|13|||
161788666|NCT01797120|584270743|FG001|Overall Study|Adverse Event|5|||
161788667|NCT01797120|584270742|FG000|Overall Study|Withdrawal by Subject|6|||
161788668|NCT01797120|584270743|FG001|Overall Study|Withdrawal by Subject|6|||
161788669|NCT01797120|584270742|FG000|Overall Study|Symptomatic progression|2|||
161788670|NCT01797120|584270743|FG001|Overall Study|Symptomatic progression|1|||
161788671|NCT01797120|584270742|FG000|Overall Study|Non-compliance|1|||
161788672|NCT01797120|584270743|FG001|Overall Study|Non-compliance|0|||
161788673|NCT01797120|584270742|FG000|Overall Study|Physician Decision|3|||
161788674|NCT01797120|584270743|FG001|Overall Study|Physician Decision|0|||
161788675|NCT01797120|584270742|FG000|Overall Study|still on treatment|2|||
161788676|NCT01797120|584270743|FG001|Overall Study|still on treatment|4|||
161788677|NCT01797120|584270742|FG000|Overall Study|never start protocol therapy|2|||
161788678|NCT01797120|584270743|FG001|Overall Study|never start protocol therapy|0|||
161788679|NCT01003886|584270744|FG000|Overall Study|Lack of Efficacy|5|||
161788680|NCT01003886|584270744|FG000|Overall Study|Lost to Follow-up|169|||
161788681|NCT01003886|584270744|FG000|Overall Study|Withdrawal by Subject|39|||
161788682|NCT01003886|584270744|FG000|Overall Study|Other|14|||
161788683|NCT01003886|584270744|FG000|Overall Study|Adverse Event|3|||
161788684|NCT00909727|584270762|FG000|Overall Study|Adverse Event|1|||
161788685|NCT00909727|584270763|FG001|Overall Study|Adverse Event|0|||
161788686|NCT00909727|584270762|FG000|Overall Study|Wrong Genotype|1|||
161788687|NCT00909727|584270763|FG001|Overall Study|Wrong Genotype|0|||
161788688|NCT00909727|584270762|FG000|Overall Study|Withdrawal of Consent|1|||
161788689|NCT00909727|584270763|FG001|Overall Study|Withdrawal of Consent|0|||
161788690|NCT00909727|584270762|FG000|Overall Study|Prohibited Medication|1|||
161788691|NCT00909727|584270763|FG001|Overall Study|Prohibited Medication|0|||
161788692|NCT05751629|584270764|FG000|Overall Study|Withdrawal by Subject|6|||
161788693|NCT05751629|584270764|FG000|Overall Study|Death|25|||
161788694|NCT05751629|584270764|FG000|Overall Study|Study Site Closed|9|||
161788695|NCT05751629|584270764|FG000|Overall Study|Physician Decision|1|||
161788696|NCT01909466|584270766|FG000|Overall Study|Lost to Follow-up|5|||
161788697|NCT01909466|584270767|FG001|Overall Study|Lost to Follow-up|7|||
161788698|NCT01909466|584270766|FG000|Overall Study|Adverse Event|3|||
161788699|NCT01909466|584270767|FG001|Overall Study|Adverse Event|4|||
161788700|NCT01909466|584270766|FG000|Overall Study|Met Withdrawal Criteria|0|||
161788701|NCT01909466|584270767|FG001|Overall Study|Met Withdrawal Criteria|3|||
161788702|NCT01909466|584270766|FG000|Overall Study|Physician Decision|2|||
161788703|NCT01909466|584270767|FG001|Overall Study|Physician Decision|0|||
161788704|NCT01909466|584270766|FG000|Overall Study|Withdrawal by Subject|11|||
161788705|NCT01909466|584270767|FG001|Overall Study|Withdrawal by Subject|9|||
161788706|NCT01909466|584270766|FG000|Overall Study|Lack of Efficacy|1|||
161788707|NCT01909466|584270767|FG001|Overall Study|Lack of Efficacy|0|||
161788708|NCT00772577|584270773|FG000|Overall Study|Adverse Event|6|||
161788709|NCT00772577|584270774|FG001|Overall Study|Adverse Event|3|||
161788710|NCT00772577|584270773|FG000|Overall Study|Abnormal laboratory values|0|||
161788711|NCT00772577|584270774|FG001|Overall Study|Abnormal laboratory values|1|||
161788712|NCT00772577|584270773|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161788713|NCT00772577|584270774|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
161788714|NCT00772577|584270773|FG000|Overall Study|Patient withdrew consent|8|||
161788715|NCT00772577|584270774|FG001|Overall Study|Patient withdrew consent|5|||
161788716|NCT00772577|584270773|FG000|Overall Study|Lost to Follow-up|4|||
161788717|NCT00772577|584270774|FG001|Overall Study|Lost to Follow-up|3|||
161788718|NCT00772577|584270773|FG000|Overall Study|Administrative problems|2|||
161788719|NCT00772577|584270774|FG001|Overall Study|Administrative problems|1|||
161788720|NCT00772577|584270773|FG000|Overall Study|Protocol Deviation|3|||
161788721|NCT00772577|584270774|FG001|Overall Study|Protocol Deviation|2|||
161788722|NCT00672620|584270775|FG000|Overall Study|Adverse Event|7|||
161788723|NCT00672620|584270776|FG001|Overall Study|Adverse Event|7|||
161788724|NCT00672620|584270777|FG002|Overall Study|Adverse Event|12|||
161788725|NCT00672620|584270778|FG003|Overall Study|Adverse Event|17|||
161788726|NCT00672620|584270775|FG000|Overall Study|Lack of Efficacy|1|||
161788727|NCT00672620|584270776|FG001|Overall Study|Lack of Efficacy|2|||
161788728|NCT00672620|584270777|FG002|Overall Study|Lack of Efficacy|2|||
161788729|NCT00672620|584270778|FG003|Overall Study|Lack of Efficacy|0|||
161788730|NCT00672620|584270775|FG000|Overall Study|Noncompliance with Study Drug|3|||
161788731|NCT00672620|584270776|FG001|Overall Study|Noncompliance with Study Drug|4|||
161788732|NCT00672620|584270777|FG002|Overall Study|Noncompliance with Study Drug|0|||
161788733|NCT00672620|584270778|FG003|Overall Study|Noncompliance with Study Drug|2|||
161788734|NCT00672620|584270775|FG000|Overall Study|Protocol Deviations|5|||
161788735|NCT00672620|584270776|FG001|Overall Study|Protocol Deviations|7|||
161788736|NCT00672620|584270777|FG002|Overall Study|Protocol Deviations|2|||
161788737|NCT00672620|584270778|FG003|Overall Study|Protocol Deviations|5|||
161788738|NCT00672620|584270775|FG000|Overall Study|Withdrawal of Consent|6|||
161788739|NCT00672620|584270776|FG001|Overall Study|Withdrawal of Consent|12|||
161788740|NCT00672620|584270777|FG002|Overall Study|Withdrawal of Consent|5|||
161788741|NCT00672620|584270778|FG003|Overall Study|Withdrawal of Consent|6|||
161788742|NCT00672620|584270775|FG000|Overall Study|Lost to Follow-up|8|||
161788743|NCT00672620|584270776|FG001|Overall Study|Lost to Follow-up|19|||
161788744|NCT00672620|584270777|FG002|Overall Study|Lost to Follow-up|8|||
161788745|NCT00672620|584270778|FG003|Overall Study|Lost to Follow-up|11|||
161788746|NCT00672620|584270775|FG000|Overall Study|Reason not Specified|3|||
161788747|NCT00672620|584270776|FG001|Overall Study|Reason not Specified|3|||
161788748|NCT00672620|584270777|FG002|Overall Study|Reason not Specified|2|||
161788749|NCT00672620|584270778|FG003|Overall Study|Reason not Specified|1|||
161788750|NCT02965820|584270779|FG000|Period 2, Second 30 Days|Adverse Event|1|||
161788751|NCT02965820|584270780|FG001|Period 2, Second 30 Days|Adverse Event|1|||
161788752|NCT01567306|584270781|FG000|Overall Study|Protocol Violation|2|||
161788753|NCT01567306|584270782|FG001|Overall Study|Protocol Violation|2|||
161788754|NCT01567306|584270783|FG002|Overall Study|Protocol Violation|0|||
161788755|NCT01567306|584270784|FG003|Overall Study|Protocol Violation|3|||
161788756|NCT01567306|584270785|FG004|Overall Study|Protocol Violation|1|||
161788757|NCT01567306|584270786|FG005|Overall Study|Protocol Violation|1|||
161788758|NCT01567306|584270781|FG000|Overall Study|Change site living|1|||
161788759|NCT01567306|584270782|FG001|Overall Study|Change site living|0|||
161788760|NCT01567306|584270783|FG002|Overall Study|Change site living|0|||
161788761|NCT01567306|584270784|FG003|Overall Study|Change site living|0|||
161788762|NCT01567306|584270785|FG004|Overall Study|Change site living|0|||
161788763|NCT01567306|584270786|FG005|Overall Study|Change site living|0|||
161788764|NCT01567306|584270781|FG000|Overall Study|Adverse Event|0|||
162126498|NCT02855164|585513003|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
162126499|NCT02855164|585513004|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
162126500|NCT02855164|585513005|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
162126501|NCT02855164|585513006|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
162126502|NCT02855164|585513007|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
162126503|NCT02855164|585513008|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
162126504|NCT02855164|585513009|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
162126505|NCT02855164|585513002|FG000|Part C (Randomized Set)|Adverse Event|0|||
162126506|NCT02855164|585513003|FG001|Part C (Randomized Set)|Adverse Event|0|||
162126507|NCT02855164|585513004|FG002|Part C (Randomized Set)|Adverse Event|0|||
162126508|NCT02855164|585513005|FG003|Part C (Randomized Set)|Adverse Event|0|||
162126509|NCT02855164|585513006|FG004|Part C (Randomized Set)|Adverse Event|0|||
162126510|NCT02855164|585513007|FG005|Part C (Randomized Set)|Adverse Event|5|||
162126511|NCT02855164|585513008|FG006|Part C (Randomized Set)|Adverse Event|9|||
162126512|NCT02855164|585513009|FG007|Part C (Randomized Set)|Adverse Event|2|||
162126513|NCT02855164|585513002|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
162126514|NCT02855164|585513003|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
162126515|NCT02855164|585513004|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
162126516|NCT02855164|585513005|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
162126517|NCT02855164|585513006|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
162126518|NCT02855164|585513007|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
162126519|NCT02855164|585513008|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
162126520|NCT02855164|585513009|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
161788765|NCT01567306|584270782|FG001|Overall Study|Adverse Event|0|||
161788766|NCT01567306|584270783|FG002|Overall Study|Adverse Event|0|||
161788767|NCT01567306|584270784|FG003|Overall Study|Adverse Event|2|||
162126521|NCT02855164|585513002|FG000|Part C (Randomized Set)|Physician Decision|0|||
162126522|NCT02855164|585513003|FG001|Part C (Randomized Set)|Physician Decision|0|||
162126523|NCT02855164|585513004|FG002|Part C (Randomized Set)|Physician Decision|0|||
162126524|NCT02855164|585513005|FG003|Part C (Randomized Set)|Physician Decision|0|||
162126525|NCT02855164|585513006|FG004|Part C (Randomized Set)|Physician Decision|0|||
162126526|NCT02855164|585513007|FG005|Part C (Randomized Set)|Physician Decision|1|||
162126527|NCT02855164|585513008|FG006|Part C (Randomized Set)|Physician Decision|0|||
162126528|NCT02855164|585513009|FG007|Part C (Randomized Set)|Physician Decision|1|||
162126529|NCT02855164|585513002|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
162126530|NCT02855164|585513003|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
162126531|NCT02855164|585513004|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
162126532|NCT02855164|585513005|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
162126533|NCT02855164|585513006|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
162126534|NCT02855164|585513007|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
162126535|NCT02855164|585513008|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
162126536|NCT02855164|585513009|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
162126537|NCT02169830|585515198|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
162126538|NCT02169830|585515199|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
162126539|NCT02169830|585515200|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
162126540|NCT02169830|585515198|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
162126541|NCT02169830|585515199|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
162126542|NCT02169830|585515200|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
162126543|NCT02169830|585515198|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
162126544|NCT02169830|585515199|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
162126545|NCT02169830|585515200|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
162126546|NCT02169830|585515198|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
162126547|NCT02169830|585515199|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
162126548|NCT02169830|585515200|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
162126549|NCT02169830|585515198|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
162126550|NCT02169830|585515199|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
162126551|NCT02169830|585515200|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
162126552|NCT03204695|585515201|FG000|Overall Study|Death|1|||
162126553|NCT03204695|585515201|FG000|Overall Study|Participant was treated with another device|1|||
162126554|NCT03204695|585515201|FG000|Overall Study|Physician Decision|2|||
162126555|NCT04781647|585515205|FG000|Overall Study|Study terminated by Sponsor|11|||
161788768|NCT01567306|584270785|FG004|Overall Study|Adverse Event|4|||
162126556|NCT04781647|585515206|FG001|Overall Study|Study terminated by Sponsor|9|||
162126557|NCT04781647|585515207|FG002|Overall Study|Study terminated by Sponsor|9|||
162126558|NCT04781647|585515205|FG000|Overall Study|Withdrawal by Subject|1|||
162126559|NCT04781647|585515206|FG001|Overall Study|Withdrawal by Subject|2|||
162126560|NCT04781647|585515207|FG002|Overall Study|Withdrawal by Subject|0|||
162126561|NCT04781647|585515205|FG000|Overall Study|Adverse Event|0|||
162126562|NCT04781647|585515206|FG001|Overall Study|Adverse Event|1|||
162126563|NCT04781647|585515207|FG002|Overall Study|Adverse Event|1|||
161788769|NCT01567306|584270786|FG005|Overall Study|Adverse Event|1|||
161898548|NCT03272347|584677828|FG000|Overall Study|Lost to Follow-up|1|||
161898549|NCT03272347|584677829|FG001|Overall Study|Lost to Follow-up|3|||
161898550|NCT03272347|584677830|FG002|Overall Study|Lost to Follow-up|5|||
161898551|NCT03272347|584677831|FG003|Overall Study|Lost to Follow-up|1|||
161898552|NCT03272347|584677828|FG000|Overall Study|Physician Decision|4|||
161898553|NCT03272347|584677829|FG001|Overall Study|Physician Decision|2|||
161898554|NCT03272347|584677830|FG002|Overall Study|Physician Decision|5|||
161898555|NCT03272347|584677831|FG003|Overall Study|Physician Decision|4|||
161898556|NCT03272347|584677828|FG000|Overall Study|Screen Failure|1|||
161898557|NCT03272347|584677829|FG001|Overall Study|Screen Failure|0|||
161898558|NCT03272347|584677830|FG002|Overall Study|Screen Failure|0|||
161898559|NCT03272347|584677831|FG003|Overall Study|Screen Failure|0|||
161898560|NCT03272347|584677828|FG000|Overall Study|Withdrawal by Subject|5|||
161898561|NCT03272347|584677829|FG001|Overall Study|Withdrawal by Subject|1|||
161898562|NCT03272347|584677830|FG002|Overall Study|Withdrawal by Subject|2|||
161898563|NCT03272347|584677831|FG003|Overall Study|Withdrawal by Subject|1|||
161898564|NCT01971567|584677832|FG000|Overall Study|Withdrawal by Subject|3|||
161898565|NCT01971567|584677833|FG001|Overall Study|Withdrawal by Subject|2|||
161898566|NCT01971567|584677832|FG000|Overall Study|Lost to Follow-up|1|||
161898567|NCT01971567|584677833|FG001|Overall Study|Lost to Follow-up|0|||
161898568|NCT00391872|584677834|FG000|Overall Study|Protocol Violation|7|||
161898569|NCT00391872|584677835|FG001|Overall Study|Protocol Violation|2|||
161898570|NCT00391872|584677834|FG000|Overall Study|Withdrawal by Subject|296|||
161898571|NCT00391872|584677835|FG001|Overall Study|Withdrawal by Subject|249|||
161898572|NCT00391872|584677834|FG000|Overall Study|Reason unknown|2|||
161898573|NCT00391872|584677835|FG001|Overall Study|Reason unknown|4|||
161898574|NCT00391872|584677834|FG000|Overall Study|Lost to Follow-up|2|||
161898575|NCT00391872|584677835|FG001|Overall Study|Lost to Follow-up|0|||
161898576|NCT04826484|584677836|FG000|Overall Study|Lost to Follow-up|2|||
161898577|NCT04826484|584677837|FG001|Overall Study|Lost to Follow-up|0|||
161898578|NCT01239394|584677838|FG000|Overall Study|Adverse Event|1|||
161898579|NCT00905632|584677840|FG000|Overall Study|Adverse Event|0|||
161898580|NCT00905632|584677841|FG001|Overall Study|Adverse Event|0|||
161898581|NCT00905632|584677842|FG002|Overall Study|Adverse Event|0|||
161898582|NCT00905632|584677843|FG003|Overall Study|Adverse Event|0|||
161898583|NCT00905632|584677844|FG004|Overall Study|Adverse Event|0|||
161898584|NCT00905632|584677845|FG005|Overall Study|Adverse Event|1|||
161898585|NCT00905632|584677846|FG006|Overall Study|Adverse Event|4|||
161898586|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
161898587|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
161898588|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
161898589|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
161898590|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
161898591|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
161898592|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
161898593|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
161898594|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
161898595|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
161898596|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
161898597|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
161898598|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
161898599|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
161898600|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
161898601|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
161898602|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
161898603|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
161898604|NCT03569098|584677847|FG000|Double-Blind Treatment Cycle 1|Other|1|||
161898605|NCT03569098|584677848|FG001|Double-Blind Treatment Cycle 1|Other|0|||
161898606|NCT03569098|584677849|FG002|Double-Blind Treatment Cycle 1|Other|1|||
161898607|NCT03569098|584677847|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
161898608|NCT03569098|584677848|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
162126564|NCT04781647|585515205|FG000|Overall Study|Protocol Violation|1|||
161898609|NCT03569098|584677849|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
161898610|NCT03569098|584677847|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
161898611|NCT03569098|584677848|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
161898612|NCT03569098|584677849|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
161898613|NCT03569098|584677847|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
161898614|NCT03569098|584677848|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
161898615|NCT03569098|584677849|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
161898616|NCT03569098|584677847|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
161898617|NCT03569098|584677848|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
161898618|NCT03569098|584677849|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
161898619|NCT03569098|584677847|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
161898620|NCT03569098|584677848|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
161788770|NCT01567306|584270781|FG000|Overall Study|Lost to Follow-up|0|||
161788771|NCT01567306|584270782|FG001|Overall Study|Lost to Follow-up|0|||
161788772|NCT01567306|584270783|FG002|Overall Study|Lost to Follow-up|0|||
161788773|NCT01567306|584270784|FG003|Overall Study|Lost to Follow-up|0|||
161788774|NCT01567306|584270785|FG004|Overall Study|Lost to Follow-up|2|||
161788775|NCT01567306|584270786|FG005|Overall Study|Lost to Follow-up|0|||
161788776|NCT01567306|584270781|FG000|Overall Study|Withdrawal by Subject|0|||
161788777|NCT01567306|584270782|FG001|Overall Study|Withdrawal by Subject|0|||
161788778|NCT01567306|584270783|FG002|Overall Study|Withdrawal by Subject|0|||
161788779|NCT01567306|584270784|FG003|Overall Study|Withdrawal by Subject|0|||
161788780|NCT01567306|584270785|FG004|Overall Study|Withdrawal by Subject|0|||
161788781|NCT01567306|584270786|FG005|Overall Study|Withdrawal by Subject|1|||
161788782|NCT04272775|584270794|FG000|Overall Study|Study Terminated by Sponsor|1|||
161788783|NCT04272775|584270795|FG001|Overall Study|Study Terminated by Sponsor|0|||
161788784|NCT04272775|584270794|FG000|Overall Study|Protocol Violation|0|||
161788785|NCT04272775|584270795|FG001|Overall Study|Protocol Violation|1|||
161788786|NCT04272775|584270794|FG000|Overall Study|Symptomatic Deterioration|1|||
161788787|NCT04272775|584270795|FG001|Overall Study|Symptomatic Deterioration|1|||
161788788|NCT04272775|584270794|FG000|Overall Study|Withdrawal by Subject|1|||
161788789|NCT04272775|584270795|FG001|Overall Study|Withdrawal by Subject|2|||
161788790|NCT04272775|584270794|FG000|Overall Study|Adverse Event|1|||
161788791|NCT04272775|584270795|FG001|Overall Study|Adverse Event|2|||
161788792|NCT04272775|584270794|FG000|Overall Study|Progressive Disease|3|||
161788793|NCT04272775|584270795|FG001|Overall Study|Progressive Disease|1|||
161788794|NCT02063698|584270798|FG000|Overall Study|did not complete booklet for days 2-8|1|||
162126565|NCT04781647|585515206|FG001|Overall Study|Protocol Violation|0|||
162126566|NCT04781647|585515207|FG002|Overall Study|Protocol Violation|0|||
162126567|NCT04781647|585515205|FG000|Overall Study|Pregnancy|0|||
162126568|NCT04781647|585515206|FG001|Overall Study|Pregnancy|0|||
162126569|NCT04781647|585515207|FG002|Overall Study|Pregnancy|1|||
162126570|NCT04781647|585515205|FG000|Overall Study|Virology rebounded|1|||
162126571|NCT04781647|585515206|FG001|Overall Study|Virology rebounded|0|||
162126572|NCT04781647|585515207|FG002|Overall Study|Virology rebounded|0|||
162126573|NCT00777803|585515208|FG000|Overall Study|Lost to Follow-up|12|||
162126574|NCT00777803|585515209|FG001|Overall Study|Lost to Follow-up|5|||
162126575|NCT00777803|585515208|FG000|Overall Study|Adverse Event|1|||
162126576|NCT00777803|585515209|FG001|Overall Study|Adverse Event|0|||
162126577|NCT00777803|585515208|FG000|Overall Study|Non-compliance|2|||
162126578|NCT00777803|585515209|FG001|Overall Study|Non-compliance|2|||
162126579|NCT01755689|585515210|FG000|Overall Study|Withdrawal by Subject|1|||
162126580|NCT01755689|585515211|FG001|Overall Study|Withdrawal by Subject|3|||
162126581|NCT01755689|585515212|FG002|Overall Study|Withdrawal by Subject|2|||
162126582|NCT01755689|585515213|FG003|Overall Study|Withdrawal by Subject|1|||
162126583|NCT01755689|585515214|FG004|Overall Study|Withdrawal by Subject|1|||
162126584|NCT01755689|585515210|FG000|Overall Study|Migrated/moved from study area|0|||
162126585|NCT01755689|585515211|FG001|Overall Study|Migrated/moved from study area|1|||
162126586|NCT01755689|585515212|FG002|Overall Study|Migrated/moved from study area|1|||
162126587|NCT01755689|585515213|FG003|Overall Study|Migrated/moved from study area|1|||
162126588|NCT01755689|585515214|FG004|Overall Study|Migrated/moved from study area|1|||
162126589|NCT01755689|585515210|FG000|Overall Study|Lost to Follow-up|1|||
162126590|NCT01755689|585515211|FG001|Overall Study|Lost to Follow-up|0|||
162126591|NCT01755689|585515212|FG002|Overall Study|Lost to Follow-up|1|||
162126592|NCT01755689|585515213|FG003|Overall Study|Lost to Follow-up|0|||
162126593|NCT01755689|585515214|FG004|Overall Study|Lost to Follow-up|2|||
162126594|NCT01755689|585515210|FG000|Overall Study|Pregnancy|1|||
162126595|NCT01755689|585515211|FG001|Overall Study|Pregnancy|1|||
162126596|NCT01755689|585515212|FG002|Overall Study|Pregnancy|2|||
162126597|NCT01755689|585515213|FG003|Overall Study|Pregnancy|4|||
162126598|NCT01755689|585515214|FG004|Overall Study|Pregnancy|2|||
162126599|NCT02930122|585515217|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
162126600|NCT02930122|585515218|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
162126601|NCT01995357|585515219|FG000|Period 5|Lack of Efficacy|1|||
161788795|NCT02063698|584270799|FG001|Overall Study|did not complete booklet for days 2-8|2|||
161788796|NCT02124746|584270800|FG000|Overall Study|Adverse Event|2|||
162126602|NCT01995357|585515220|FG001|Period 5|Lack of Efficacy|0|||
161788797|NCT02124746|584270801|FG001|Overall Study|Adverse Event|1|||
161788798|NCT02124746|584270802|FG002|Overall Study|Adverse Event|2|||
161788799|NCT02124746|584270800|FG000|Overall Study|Death|2|||
162126603|NCT01995357|585515221|FG002|Period 5|Lack of Efficacy|0|||
162126604|NCT01995357|585515222|FG003|Period 5|Lack of Efficacy|0|||
162126605|NCT01995357|585515223|FG004|Period 5|Lack of Efficacy|0|||
162126606|NCT01995357|585515224|FG005|Period 5|Lack of Efficacy|0|||
162126607|NCT01995357|585515219|FG000|Period 5|Adverse Event|1|||
162126608|NCT01995357|585515220|FG001|Period 5|Adverse Event|0|||
162126609|NCT01995357|585515221|FG002|Period 5|Adverse Event|1|||
162126610|NCT01995357|585515222|FG003|Period 5|Adverse Event|0|||
162126611|NCT01995357|585515223|FG004|Period 5|Adverse Event|0|||
162126612|NCT01995357|585515224|FG005|Period 5|Adverse Event|0|||
162126613|NCT02609659|585515225|FG000|Overall Study|Adverse Event|1|||
162126614|NCT02609659|585515225|FG000|Overall Study|Lost to Follow-up|6|||
162126615|NCT02609659|585515225|FG000|Overall Study|Other|1|||
162126616|NCT01004250|585515228|FG000|Induction Therapy Period|Adverse Event|10|||
162126617|NCT01004250|585515228|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
162126618|NCT01004250|585515228|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
162126619|NCT01004250|585515228|FG000|Induction Therapy Period|Physician Decision|2|||
162126620|NCT01004250|585515228|FG000|Maintenance Therapy Period|Adverse Event|15|||
162126621|NCT01004250|585515228|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
162126622|NCT01004250|585515228|FG000|Maintenance Therapy Period|Protocol Violation|1|||
162126623|NCT01004250|585515228|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
162126624|NCT01004250|585515228|FG000|Maintenance Therapy Period|Physician Decision|4|||
162126625|NCT01004250|585515228|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
162126626|NCT01853254|585515229|FG000|Overall Study|Abnormal Laboratory Test|1|||
162126627|NCT01853254|585515229|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
162126628|NCT01853254|585515229|FG000|Overall Study|Death|1|||
162126629|NCT01853254|585515229|FG000|Overall Study|Failure to Return|43|||
162126630|NCT01853254|585515229|FG000|Overall Study|Insufficient Therapeutic Response|22|||
162126631|NCT01853254|585515229|FG000|Overall Study|Refusal of Treatment|1|||
162126632|NCT01853254|585515229|FG000|Overall Study|Other Protocol Violation|1|||
162126633|NCT01853254|585515229|FG000|Overall Study|Withdrawal of Consent|16|||
162126634|NCT01853254|585515229|FG000|Overall Study|Administrative/Other|16|||
162126635|NCT02462083|585515230|FG000|Overall Study|Sponsor request|39|||
162126636|NCT02462083|585515230|FG000|Overall Study|Withdrawal by Subject|87|||
162126637|NCT02462083|585515230|FG000|Overall Study|Lost to Follow-up|41|||
162126638|NCT02462083|585515230|FG000|Overall Study|Lack of Efficacy|151|||
162126639|NCT02462083|585515230|FG000|Overall Study|Pregnancy|1|||
162126640|NCT02462083|585515230|FG000|Overall Study|Protocol Violation|6|||
162126641|NCT02462083|585515230|FG000|Overall Study|Adverse Event|33|||
162126642|NCT02462083|585515230|FG000|Overall Study|Worsening condition|16|||
162126643|NCT02462083|585515230|FG000|Overall Study|Other than specified|45|||
162126644|NCT02711995|585515233|FG000|Washout (90 Days)|Conflicting medication|1|||
162126645|NCT01115998|585515236|FG000|Overall Study|Lost to Follow-up|6|||
162126646|NCT01115998|585515237|FG001|Overall Study|Lost to Follow-up|6|||
162126647|NCT01383993|585515241|FG000|Overall Study|Adverse Event|1|||
162126648|NCT01383993|585515242|FG001|Overall Study|Adverse Event|1|||
162126649|NCT01383993|585515243|FG002|Overall Study|Adverse Event|0|||
162126650|NCT01383993|585515241|FG000|Overall Study|Withdrawal by Subject|0|||
162126651|NCT01383993|585515242|FG001|Overall Study|Withdrawal by Subject|0|||
161788800|NCT02124746|584270801|FG001|Overall Study|Death|1|||
161788801|NCT02124746|584270802|FG002|Overall Study|Death|3|||
161788802|NCT02124746|584270800|FG000|Overall Study|Lack of Efficacy|3|||
161788803|NCT02124746|584270801|FG001|Overall Study|Lack of Efficacy|2|||
161788804|NCT02124746|584270802|FG002|Overall Study|Lack of Efficacy|2|||
161788805|NCT02124746|584270800|FG000|Overall Study|Physician Decision|6|||
161788806|NCT02124746|584270801|FG001|Overall Study|Physician Decision|4|||
161788807|NCT02124746|584270802|FG002|Overall Study|Physician Decision|5|||
161788808|NCT02124746|584270800|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161788809|NCT02124746|584270801|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161788810|NCT02124746|584270802|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161788811|NCT02124746|584270800|FG000|Overall Study|Withdrawal by Subject|3|||
161788812|NCT02124746|584270801|FG001|Overall Study|Withdrawal by Subject|3|||
161788813|NCT02124746|584270802|FG002|Overall Study|Withdrawal by Subject|0|||
161788814|NCT02124746|584270800|FG000|Overall Study|Study Terminated by Sponsor|0|||
161788815|NCT02124746|584270801|FG001|Overall Study|Study Terminated by Sponsor|0|||
161788816|NCT02124746|584270802|FG002|Overall Study|Study Terminated by Sponsor|6|||
161788817|NCT02124746|584270800|FG000|Overall Study|Disease Progression|3|||
161788818|NCT02124746|584270801|FG001|Overall Study|Disease Progression|6|||
161788819|NCT02124746|584270802|FG002|Overall Study|Disease Progression|4|||
161788820|NCT03124381|584270803|FG000|Overall Study|Lost to Follow-up|1|||
161788821|NCT03124381|584270804|FG001|Overall Study|Lost to Follow-up|1|||
162126652|NCT01383993|585515243|FG002|Overall Study|Withdrawal by Subject|1|||
162126653|NCT01383993|585515241|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
162126654|NCT01383993|585515242|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
161788822|NCT03124381|584270803|FG000|Overall Study|Withdrawal by Subject|6|||
161788823|NCT03124381|584270804|FG001|Overall Study|Withdrawal by Subject|3|||
161788824|NCT03124381|584270803|FG000|Overall Study|Protocol Violation|0|||
161788825|NCT03124381|584270804|FG001|Overall Study|Protocol Violation|1|||
161788826|NCT03124381|584270803|FG000|Overall Study|Adverse Event|1|||
161788827|NCT03124381|584270804|FG001|Overall Study|Adverse Event|1|||
161788828|NCT03124381|584270803|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
162126655|NCT01383993|585515243|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
162126656|NCT01489020|585515248|FG000|Overall Study|Withdrawal by Subject|1|||
162126657|NCT01489020|585515249|FG001|Overall Study|Withdrawal by Subject|0|||
162126658|NCT01489020|585515250|FG002|Overall Study|Withdrawal by Subject|0|||
162126659|NCT01489020|585515251|FG003|Overall Study|Withdrawal by Subject|0|||
161788829|NCT03124381|584270804|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
162126660|NCT01489020|585515252|FG004|Overall Study|Withdrawal by Subject|0|||
162126661|NCT01489020|585515253|FG005|Overall Study|Withdrawal by Subject|0|||
162126662|NCT01489020|585515248|FG000|Overall Study|Adverse Event|0|||
162126663|NCT01489020|585515249|FG001|Overall Study|Adverse Event|0|||
162126664|NCT01489020|585515250|FG002|Overall Study|Adverse Event|3|||
162126665|NCT01489020|585515251|FG003|Overall Study|Adverse Event|0|||
162126666|NCT01489020|585515252|FG004|Overall Study|Adverse Event|3|||
162126667|NCT01489020|585515253|FG005|Overall Study|Adverse Event|0|||
162126668|NCT01489020|585515248|FG000|Overall Study|Concomitant disease|0|||
162126669|NCT01489020|585515249|FG001|Overall Study|Concomitant disease|0|||
162126670|NCT01489020|585515250|FG002|Overall Study|Concomitant disease|0|||
162126671|NCT01489020|585515251|FG003|Overall Study|Concomitant disease|0|||
162126672|NCT01489020|585515252|FG004|Overall Study|Concomitant disease|3|||
162126673|NCT01489020|585515253|FG005|Overall Study|Concomitant disease|0|||
162126674|NCT02451930|585515255|FG000|Overall Study|Death|0|||
162126675|NCT02451930|585515256|FG001|Overall Study|Death|15|||
162126676|NCT02451930|585515255|FG000|Overall Study|Lost to Follow-up|0|||
162126677|NCT02451930|585515256|FG001|Overall Study|Lost to Follow-up|3|||
162126678|NCT02451930|585515255|FG000|Overall Study|Sponsor Decision|2|||
162126679|NCT02451930|585515256|FG001|Overall Study|Sponsor Decision|10|||
162126680|NCT02451930|585515255|FG000|Overall Study|Withdrawal by Subject|0|||
162126681|NCT02451930|585515256|FG001|Overall Study|Withdrawal by Subject|1|||
162126682|NCT02451930|585515255|FG000|Overall Study|Other|0|||
162126683|NCT02451930|585515256|FG001|Overall Study|Other|1|||
162126684|NCT00962585|585515257|FG000|Overall Study|Adverse Event|0|||
162126685|NCT00962585|585515258|FG001|Overall Study|Adverse Event|2|||
162126686|NCT00962585|585515259|FG002|Overall Study|Adverse Event|1|||
162126687|NCT00962585|585515260|FG003|Overall Study|Adverse Event|0|||
162126688|NCT00962585|585515257|FG000|Overall Study|Lost to Follow-up|3|||
162126689|NCT00962585|585515258|FG001|Overall Study|Lost to Follow-up|0|||
162126690|NCT00962585|585515259|FG002|Overall Study|Lost to Follow-up|1|||
162126691|NCT00962585|585515260|FG003|Overall Study|Lost to Follow-up|0|||
162126692|NCT00962585|585515257|FG000|Overall Study|Protocol Violation|0|||
162126693|NCT00962585|585515258|FG001|Overall Study|Protocol Violation|0|||
162126694|NCT00962585|585515259|FG002|Overall Study|Protocol Violation|1|||
162126695|NCT00962585|585515260|FG003|Overall Study|Protocol Violation|0|||
162126696|NCT00962585|585515257|FG000|Overall Study|Withdrawal by Subject|1|||
162126697|NCT00962585|585515258|FG001|Overall Study|Withdrawal by Subject|0|||
162126698|NCT00962585|585515259|FG002|Overall Study|Withdrawal by Subject|0|||
162126699|NCT00962585|585515260|FG003|Overall Study|Withdrawal by Subject|0|||
162126700|NCT00962585|585515257|FG000|Overall Study|Withdrew Consent|2|||
162126701|NCT00962585|585515258|FG001|Overall Study|Withdrew Consent|0|||
162126702|NCT00962585|585515259|FG002|Overall Study|Withdrew Consent|0|||
162126703|NCT00962585|585515260|FG003|Overall Study|Withdrew Consent|0|||
162126704|NCT00262743|585515263|FG000|Overall Study|Adverse Event|0|||
162126705|NCT00262743|585515264|FG001|Overall Study|Adverse Event|9|||
162126706|NCT00262743|585515263|FG000|Overall Study|Disease progression|0|||
162126707|NCT00262743|585515264|FG001|Overall Study|Disease progression|3|||
162126708|NCT02485353|585515265|FG000|Overall Study|Death|1|||
162126709|NCT02485353|585515265|FG000|Overall Study|Disease Progression|1|||
162126710|NCT02823964|585515270|FG000|Overall Study|Adverse Event|2|||
162126711|NCT02823964|585515270|FG000|Overall Study|Physician Decision|1|||
162126712|NCT02823964|585515270|FG000|Overall Study|Lack of Efficacy|1|||
162126713|NCT02823964|585515270|FG000|Overall Study|Withdrawal by Subject|1|||
162126714|NCT00610675|585515273|FG000|Overall Study|Untreated|4|||
162126715|NCT00610675|585515273|FG000|Overall Study|Adverse Event|67|||
162126716|NCT00610675|585515273|FG000|Overall Study|Insufficient Effect|31|||
162126717|NCT00610675|585515273|FG000|Overall Study|Withdrawal by Subject|28|||
162126718|NCT00610675|585515273|FG000|Overall Study|Reasons unrelated to trial|27|||
162126719|NCT00610675|585515273|FG000|Overall Study|Lack of Compliance|7|||
162126720|NCT00610675|585515273|FG000|Overall Study|Lost to Follow-up|31|||
162126721|NCT00610675|585515273|FG000|Overall Study|Other reason (not specified)|25|||
162126722|NCT00983619|585515276|FG000|Overall Study|Lost to Follow-up|0|||
162126723|NCT00983619|585515277|FG001|Overall Study|Lost to Follow-up|1|||
162126724|NCT00983619|585515278|FG002|Overall Study|Lost to Follow-up|0|||
162126725|NCT00983619|585515279|FG003|Overall Study|Lost to Follow-up|0|||
162126726|NCT00983619|585515280|FG004|Overall Study|Lost to Follow-up|0|||
162126727|NCT00983619|585515281|FG005|Overall Study|Lost to Follow-up|2|||
162126728|NCT00983619|585515282|FG006|Overall Study|Lost to Follow-up|0|||
162126729|NCT00983619|585515283|FG007|Overall Study|Lost to Follow-up|0|||
162126730|NCT00983619|585515284|FG008|Overall Study|Lost to Follow-up|0|||
162126731|NCT00983619|585515285|FG009|Overall Study|Lost to Follow-up|0|||
162126732|NCT00983619|585515286|FG010|Overall Study|Lost to Follow-up|0|||
162126733|NCT00983619|585515287|FG011|Overall Study|Lost to Follow-up|2|||
162126734|NCT00983619|585515276|FG000|Overall Study|Withdrawal by Subject|2|||
162126735|NCT00983619|585515277|FG001|Overall Study|Withdrawal by Subject|1|||
162126736|NCT00983619|585515278|FG002|Overall Study|Withdrawal by Subject|1|||
162126737|NCT00983619|585515279|FG003|Overall Study|Withdrawal by Subject|3|||
162126738|NCT00983619|585515280|FG004|Overall Study|Withdrawal by Subject|1|||
162126739|NCT00983619|585515281|FG005|Overall Study|Withdrawal by Subject|23|||
162126740|NCT00983619|585515282|FG006|Overall Study|Withdrawal by Subject|0|||
162126741|NCT00983619|585515283|FG007|Overall Study|Withdrawal by Subject|0|||
162126742|NCT00983619|585515284|FG008|Overall Study|Withdrawal by Subject|0|||
162126743|NCT00983619|585515285|FG009|Overall Study|Withdrawal by Subject|0|||
162126744|NCT00983619|585515286|FG010|Overall Study|Withdrawal by Subject|1|||
162126745|NCT00983619|585515287|FG011|Overall Study|Withdrawal by Subject|1|||
162126746|NCT00983619|585515276|FG000|Overall Study|Death|0|||
162126747|NCT00983619|585515277|FG001|Overall Study|Death|2|||
162126748|NCT00983619|585515278|FG002|Overall Study|Death|2|||
162126749|NCT00983619|585515279|FG003|Overall Study|Death|1|||
162126750|NCT00983619|585515280|FG004|Overall Study|Death|2|||
162126751|NCT00983619|585515281|FG005|Overall Study|Death|30|||
162126752|NCT00983619|585515282|FG006|Overall Study|Death|1|||
162126753|NCT00983619|585515283|FG007|Overall Study|Death|0|||
162126754|NCT00983619|585515284|FG008|Overall Study|Death|1|||
162126755|NCT00983619|585515285|FG009|Overall Study|Death|2|||
162126756|NCT00983619|585515286|FG010|Overall Study|Death|9|||
162126757|NCT00983619|585515287|FG011|Overall Study|Death|8|||
162126758|NCT00983619|585515276|FG000|Overall Study|Other|1|||
162126759|NCT00983619|585515277|FG001|Overall Study|Other|0|||
162126760|NCT00983619|585515278|FG002|Overall Study|Other|0|||
162126761|NCT00983619|585515279|FG003|Overall Study|Other|1|||
162126762|NCT00983619|585515280|FG004|Overall Study|Other|0|||
162126763|NCT00983619|585515281|FG005|Overall Study|Other|12|||
162126764|NCT00983619|585515282|FG006|Overall Study|Other|2|||
162126765|NCT00983619|585515283|FG007|Overall Study|Other|2|||
162126766|NCT00983619|585515284|FG008|Overall Study|Other|0|||
162126767|NCT00983619|585515285|FG009|Overall Study|Other|1|||
162126768|NCT00983619|585515286|FG010|Overall Study|Other|1|||
162126769|NCT00983619|585515287|FG011|Overall Study|Other|0|||
162126770|NCT04844918|585515290|FG000|Overall Study|Adverse Event|7|||
162126771|NCT04844918|585515291|FG001|Overall Study|Adverse Event|8|||
162126772|NCT04844918|585515292|FG002|Overall Study|Adverse Event|5|||
162126773|NCT04844918|585515290|FG000|Overall Study|Physician Decision|0|||
162126774|NCT04844918|585515291|FG001|Overall Study|Physician Decision|1|||
162126775|NCT04844918|585515292|FG002|Overall Study|Physician Decision|0|||
162126776|NCT04844918|585515290|FG000|Overall Study|Withdrawal by Subject|6|||
161788830|NCT02533999|584270810|FG000|Overall Study|Lost to Follow-up|3|||
161788831|NCT02533999|584270811|FG001|Overall Study|Lost to Follow-up|5|||
161788832|NCT02533999|584270810|FG000|Overall Study|Protocol Violation|3|||
162126777|NCT04844918|585515291|FG001|Overall Study|Withdrawal by Subject|3|||
162126778|NCT04844918|585515292|FG002|Overall Study|Withdrawal by Subject|3|||
162126779|NCT04844918|585515290|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
162126780|NCT04844918|585515291|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
162126781|NCT04844918|585515292|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
162126782|NCT01009047|585515293|FG000|Overall Study|Adverse Event|5|||
162126783|NCT01009047|585515294|FG001|Overall Study|Adverse Event|0|||
162126784|NCT01009047|585515293|FG000|Overall Study|Lost to Follow-up|0|||
162126785|NCT01009047|585515294|FG001|Overall Study|Lost to Follow-up|2|||
162126786|NCT01009047|585515293|FG000|Overall Study|Lack of Efficacy|4|||
162126787|NCT01009047|585515294|FG001|Overall Study|Lack of Efficacy|11|||
162126788|NCT01009047|585515293|FG000|Overall Study|Withdrawal by consent|16|||
162126789|NCT01009047|585515294|FG001|Overall Study|Withdrawal by consent|11|||
162126790|NCT01009047|585515293|FG000|Overall Study|Other|3|||
162126791|NCT01009047|585515294|FG001|Overall Study|Other|2|||
162126792|NCT02443103|585515297|FG000|Overall Study|Adverse Event|2|||
162126793|NCT02443103|585515297|FG000|Overall Study|Noncompliance|1|||
162126794|NCT01630590|585515299|FG000|Overall Study|Adverse Event|9|||
162126795|NCT01630590|585515299|FG000|Overall Study|Lack of Efficacy|37|||
162126796|NCT01630590|585515299|FG000|Overall Study|Withdrawal by Subject|4|||
161788833|NCT02533999|584270811|FG001|Overall Study|Protocol Violation|0|||
161788834|NCT02533999|584270810|FG000|Overall Study|Adverse Event|0|||
161788835|NCT02533999|584270811|FG001|Overall Study|Adverse Event|1|||
162126797|NCT01630590|585515299|FG000|Overall Study|2nd primary tumor|2|||
162126798|NCT01630590|585515299|FG000|Overall Study|Automobile accident|1|||
162126799|NCT01630590|585515299|FG000|Overall Study|Maximum benefit|4|||
162126800|NCT02366936|585515300|FG000|Overall Study|Withdrawal by Subject|2|||
162126801|NCT02366936|585515300|FG000|Overall Study|Lost to Follow-up|4|||
162126802|NCT02366936|585515300|FG000|Overall Study|Physician Decision|2|||
162126803|NCT01751113|585515301|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
162126804|NCT01751113|585515302|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
162126805|NCT01751113|585515303|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
162126806|NCT01751113|585515304|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
162126807|NCT01751113|585515305|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
162126808|NCT01751113|585515306|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
162126809|NCT01751113|585515301|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
162126810|NCT01751113|585515302|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
162126811|NCT01751113|585515303|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
162126812|NCT01751113|585515304|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
162126813|NCT01751113|585515305|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
162126814|NCT01751113|585515306|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
162126815|NCT02878213|585515307|FG000|Overall Study|Withdrawal by Subject|2|||
162126816|NCT02878213|585515307|FG000|Overall Study|Adverse Event|1|||
162126817|NCT00363896|585515308|FG000|Overall Study|Withdrawal by Subject|29|||
162126818|NCT00363896|585515309|FG001|Overall Study|Withdrawal by Subject|16|||
162126819|NCT00363896|585515308|FG000|Overall Study|Adverse Event|24|||
162126820|NCT00363896|585515309|FG001|Overall Study|Adverse Event|13|||
162126821|NCT00363896|585515308|FG000|Overall Study|COPD exacerbation|13|||
162126822|NCT00363896|585515309|FG001|Overall Study|COPD exacerbation|7|||
162126823|NCT00363896|585515308|FG000|Overall Study|Lack of Efficacy|12|||
162126824|NCT00363896|585515309|FG001|Overall Study|Lack of Efficacy|8|||
162126825|NCT00363896|585515308|FG000|Overall Study|Protocol Violation|6|||
162126826|NCT00363896|585515309|FG001|Overall Study|Protocol Violation|1|||
162126827|NCT00363896|585515308|FG000|Overall Study|Lost to Follow-up|3|||
162126828|NCT00363896|585515309|FG001|Overall Study|Lost to Follow-up|0|||
162126829|NCT00363896|585515308|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
162126830|NCT00363896|585515309|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
162126831|NCT00363896|585515308|FG000|Overall Study|Other|1|||
162126832|NCT00363896|585515309|FG001|Overall Study|Other|2|||
162126833|NCT01558674|585515310|FG000|Part 1|Study Terminated by Sponsor|10|||
162126834|NCT01558674|585515311|FG001|Part 1|Study Terminated by Sponsor|0|||
162126835|NCT01558674|585515310|FG000|Part 1|Withdrawal by Subject|1|||
162126836|NCT01558674|585515311|FG001|Part 1|Withdrawal by Subject|0|||
162126837|NCT01555021|585515316|FG000|Overall Study|Lost to Follow-up|1|||
162126838|NCT01555021|585515317|FG001|Overall Study|Lost to Follow-up|2|||
162126839|NCT01313923|585515321|FG000|Overall Study|Physician Decision|3|||
162126840|NCT02471404|585515322|FG000|Overall Study|Adverse Event|7|||
162126841|NCT02471404|585515323|FG001|Overall Study|Adverse Event|1|||
162126842|NCT02471404|585515324|FG002|Overall Study|Adverse Event|2|||
162126843|NCT02471404|585515322|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
162126844|NCT02471404|585515323|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
162126845|NCT02471404|585515324|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
162126846|NCT02471404|585515322|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
162126847|NCT02471404|585515323|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
162126848|NCT02471404|585515324|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
162126849|NCT02471404|585515322|FG000|Overall Study|Lost to Follow-up|1|||
162126850|NCT02471404|585515323|FG001|Overall Study|Lost to Follow-up|1|||
162126851|NCT02471404|585515324|FG002|Overall Study|Lost to Follow-up|3|||
162126852|NCT02471404|585515322|FG000|Overall Study|Protocol Violation|1|||
162126853|NCT02471404|585515323|FG001|Overall Study|Protocol Violation|0|||
162126854|NCT02471404|585515324|FG002|Overall Study|Protocol Violation|0|||
162126855|NCT02471404|585515322|FG000|Overall Study|Withdrawal by Subject|8|||
162126856|NCT02471404|585515323|FG001|Overall Study|Withdrawal by Subject|4|||
162126857|NCT02471404|585515324|FG002|Overall Study|Withdrawal by Subject|5|||
162126858|NCT02471404|585515322|FG000|Overall Study|Other reasons not specified|10|||
162126859|NCT02471404|585515323|FG001|Overall Study|Other reasons not specified|7|||
161788836|NCT02533999|584270810|FG000|Overall Study|Randomized but intervention not received|0|||
161788837|NCT02533999|584270811|FG001|Overall Study|Randomized but intervention not received|1|||
161788838|NCT01154127|584270812|FG000|Period 1 (21 Days)|Adverse Event|3|||
161788839|NCT01154127|584270813|FG001|Period 1 (21 Days)|Adverse Event|4|||
161788840|NCT01154127|584270812|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
161788841|NCT01154127|584270813|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
161788842|NCT01154127|584270812|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
161788843|NCT01154127|584270813|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
161788844|NCT01154127|584270812|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
161788845|NCT01154127|584270813|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
161788846|NCT01154127|584270812|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
161788847|NCT01154127|584270813|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
162126860|NCT02471404|585515324|FG002|Overall Study|Other reasons not specified|12|||
162126861|NCT01388530|585515325|FG000|Overall Study|Lost to Follow-up|5|||
162126862|NCT02204293|585515326|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
162126863|NCT02204293|585515327|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
162126864|NCT02204293|585515328|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
162126865|NCT02204293|585515329|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
162126866|NCT02204293|585515330|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
161788848|NCT01697449|584270814|FG000|Overall Study|Disease progression|47|||
161788849|NCT01697449|584270814|FG000|Overall Study|Adverse Event|7|||
162126867|NCT02204293|585515331|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
162126868|NCT02204293|585515326|FG000|Core Study Part I|Adverse Event|1|||
162126869|NCT02204293|585515327|FG001|Core Study Part I|Adverse Event|0|||
162126870|NCT02204293|585515328|FG002|Core Study Part I|Adverse Event|0|||
162126871|NCT02204293|585515329|FG003|Core Study Part I|Adverse Event|0|||
162126872|NCT02204293|585515330|FG004|Core Study Part I|Adverse Event|0|||
161788850|NCT01697449|584270814|FG000|Overall Study|Lost to Follow-up|5|||
161788851|NCT01697449|584270814|FG000|Overall Study|Withdrawal by Subject|2|||
161788852|NCT01697449|584270814|FG000|Overall Study|Physician Decision|1|||
161788853|NCT01697449|584270814|FG000|Overall Study|Death|2|||
161788854|NCT01697449|584270814|FG000|Overall Study|Other|1|||
161788855|NCT01697449|584270814|FG000|Overall Study|Missing|25|||
161788856|NCT01123980|584270817|FG000|Overall Study|Adverse Event|1|||
161788857|NCT01123980|584270818|FG001|Overall Study|Adverse Event|1|||
161788858|NCT01123980|584270817|FG000|Overall Study|Lack of Efficacy|1|||
161788859|NCT01123980|584270818|FG001|Overall Study|Lack of Efficacy|0|||
161788860|NCT01123980|584270817|FG000|Overall Study|Physician Decision|0|||
161788861|NCT01123980|584270818|FG001|Overall Study|Physician Decision|1|||
161788862|NCT01123980|584270817|FG000|Overall Study|Lost to Follow-up|0|||
161788863|NCT01123980|584270818|FG001|Overall Study|Lost to Follow-up|6|||
161788864|NCT01123980|584270817|FG000|Overall Study|Protocol Violation|6|||
161788865|NCT01123980|584270818|FG001|Overall Study|Protocol Violation|6|||
161788866|NCT01123980|584270817|FG000|Overall Study|Withdrawal by Subject|5|||
161788867|NCT01123980|584270818|FG001|Overall Study|Withdrawal by Subject|3|||
161788868|NCT01123980|584270817|FG000|Overall Study|Unclassified|6|||
161788869|NCT01123980|584270818|FG001|Overall Study|Unclassified|7|||
161788870|NCT04385199|584270819|FG000|Overall Study|Withdrawal by Subject|1|||
161788871|NCT04385199|584270820|FG001|Overall Study|Withdrawal by Subject|0|||
161788872|NCT02557672|584270821|FG000|Overall Study|Withdrawal by Subject|4|||
161788873|NCT02557672|584270822|FG001|Overall Study|Withdrawal by Subject|2|||
161788874|NCT03705169|584270823|FG000|Overall Study|Lost to Follow-up|0|||
161788875|NCT03705169|584270824|FG001|Overall Study|Lost to Follow-up|0|||
161788876|NCT03705169|584270825|FG002|Overall Study|Lost to Follow-up|0|||
161788877|NCT03705169|584270826|FG003|Overall Study|Lost to Follow-up|2|||
161788878|NCT03705169|584270827|FG004|Overall Study|Lost to Follow-up|0|||
161788879|NCT03705169|584270828|FG005|Overall Study|Lost to Follow-up|2|||
161788880|NCT03705169|584270829|FG006|Overall Study|Lost to Follow-up|1|||
161788881|NCT03705169|584270830|FG007|Overall Study|Lost to Follow-up|0|||
161788882|NCT03705169|584270831|FG008|Overall Study|Lost to Follow-up|0|||
161788883|NCT03705169|584270832|FG009|Overall Study|Lost to Follow-up|1|||
161788884|NCT03705169|584270823|FG000|Overall Study|Adverse Event|0|||
161788885|NCT03705169|584270824|FG001|Overall Study|Adverse Event|0|||
161788886|NCT03705169|584270825|FG002|Overall Study|Adverse Event|0|||
161788887|NCT03705169|584270826|FG003|Overall Study|Adverse Event|1|||
161788888|NCT03705169|584270827|FG004|Overall Study|Adverse Event|0|||
161788889|NCT03705169|584270828|FG005|Overall Study|Adverse Event|0|||
161788890|NCT03705169|584270829|FG006|Overall Study|Adverse Event|0|||
161788891|NCT03705169|584270830|FG007|Overall Study|Adverse Event|0|||
161788892|NCT03705169|584270831|FG008|Overall Study|Adverse Event|0|||
161788893|NCT03705169|584270832|FG009|Overall Study|Adverse Event|0|||
161788894|NCT03705169|584270823|FG000|Overall Study|Site Closure|0|||
161788895|NCT03705169|584270824|FG001|Overall Study|Site Closure|0|||
161788896|NCT03705169|584270825|FG002|Overall Study|Site Closure|0|||
161788897|NCT03705169|584270826|FG003|Overall Study|Site Closure|1|||
161788898|NCT03705169|584270827|FG004|Overall Study|Site Closure|0|||
161788899|NCT03705169|584270828|FG005|Overall Study|Site Closure|0|||
161788900|NCT03705169|584270829|FG006|Overall Study|Site Closure|0|||
161788901|NCT03705169|584270830|FG007|Overall Study|Site Closure|0|||
161788902|NCT03705169|584270831|FG008|Overall Study|Site Closure|0|||
161788903|NCT03705169|584270832|FG009|Overall Study|Site Closure|0|||
161788904|NCT03705169|584270823|FG000|Overall Study|Did not receive study treatment|0|||
161788905|NCT03705169|584270824|FG001|Overall Study|Did not receive study treatment|0|||
161788906|NCT03705169|584270825|FG002|Overall Study|Did not receive study treatment|0|||
161788907|NCT03705169|584270826|FG003|Overall Study|Did not receive study treatment|1|||
161788908|NCT03705169|584270827|FG004|Overall Study|Did not receive study treatment|0|||
161788909|NCT03705169|584270828|FG005|Overall Study|Did not receive study treatment|0|||
161788910|NCT03705169|584270829|FG006|Overall Study|Did not receive study treatment|0|||
161788911|NCT03705169|584270830|FG007|Overall Study|Did not receive study treatment|0|||
161788912|NCT03705169|584270831|FG008|Overall Study|Did not receive study treatment|0|||
161788913|NCT03705169|584270832|FG009|Overall Study|Did not receive study treatment|0|||
161788914|NCT03705169|584270823|FG000|Overall Study|Concerns about study visit compliance|0|||
161788915|NCT03705169|584270824|FG001|Overall Study|Concerns about study visit compliance|0|||
161788916|NCT03705169|584270825|FG002|Overall Study|Concerns about study visit compliance|0|||
161788917|NCT03705169|584270826|FG003|Overall Study|Concerns about study visit compliance|1|||
161788918|NCT03705169|584270827|FG004|Overall Study|Concerns about study visit compliance|0|||
161788919|NCT03705169|584270828|FG005|Overall Study|Concerns about study visit compliance|0|||
161788920|NCT03705169|584270829|FG006|Overall Study|Concerns about study visit compliance|0|||
161788921|NCT03705169|584270830|FG007|Overall Study|Concerns about study visit compliance|0|||
161788922|NCT03705169|584270831|FG008|Overall Study|Concerns about study visit compliance|0|||
161788923|NCT03705169|584270832|FG009|Overall Study|Concerns about study visit compliance|0|||
161788924|NCT01133821|584272760|FG000|Overall Study|Lost to Follow-up|8|||
161788925|NCT01133821|584272761|FG001|Overall Study|Lost to Follow-up|11|||
161788926|NCT01133821|584272760|FG000|Overall Study|Withdrawal by Subject|8|||
161788927|NCT01133821|584272761|FG001|Overall Study|Withdrawal by Subject|3|||
161788928|NCT01133821|584272760|FG000|Overall Study|preferred other treatment|1|||
161788929|NCT01133821|584272761|FG001|Overall Study|preferred other treatment|1|||
161788930|NCT01133821|584272760|FG000|Overall Study|Protocol Violation|0|||
161788931|NCT01133821|584272761|FG001|Overall Study|Protocol Violation|1|||
161788932|NCT01133821|584272760|FG000|Overall Study|Refused participation|1|||
161788933|NCT01133821|584272761|FG001|Overall Study|Refused participation|3|||
161788934|NCT03342898|584272762|FG000|Overall Study|Adverse Event|3|||
161788935|NCT03342898|584272763|FG001|Overall Study|Adverse Event|1|||
161788936|NCT03342898|584272764|FG002|Overall Study|Adverse Event|0|||
161788937|NCT03342898|584272762|FG000|Overall Study|Lost to Follow-up|44|||
161788938|NCT03342898|584272763|FG001|Overall Study|Lost to Follow-up|40|||
161788939|NCT03342898|584272764|FG002|Overall Study|Lost to Follow-up|42|||
161788940|NCT03342898|584272762|FG000|Overall Study|Withdrawal of Consent|5|||
161788941|NCT03342898|584272763|FG001|Overall Study|Withdrawal of Consent|9|||
161788942|NCT03342898|584272764|FG002|Overall Study|Withdrawal of Consent|11|||
161788943|NCT03342898|584272762|FG000|Overall Study|Death|0|||
161788944|NCT03342898|584272763|FG001|Overall Study|Death|1|||
161788945|NCT03342898|584272764|FG002|Overall Study|Death|1|||
161788946|NCT03342898|584272762|FG000|Overall Study|Reason not Specified|2|||
161788947|NCT03342898|584272763|FG001|Overall Study|Reason not Specified|2|||
161788948|NCT03342898|584272764|FG002|Overall Study|Reason not Specified|0|||
161788949|NCT03997448|584272765|FG000|Study Treatment|Disease Progression|1|||
161788950|NCT03997448|584272765|FG000|Study Treatment|Symptomatic Deterioration|1|||
161788951|NCT03997448|584272765|FG000|Follow up|Death|2|||
161788952|NCT03997448|584272765|FG000|Follow up|study terminated|1|||
161788953|NCT01621490|584272766|FG000|Overall Study|Subject no longer meets study criteria|0|||
161788954|NCT01621490|584272767|FG001|Overall Study|Subject no longer meets study criteria|0|||
161788955|NCT01621490|584272768|FG002|Overall Study|Subject no longer meets study criteria|0|||
161788956|NCT01621490|584272769|FG003|Overall Study|Subject no longer meets study criteria|0|||
161788957|NCT01621490|584272770|FG004|Overall Study|Subject no longer meets study criteria|1|||
161788958|NCT01621490|584272771|FG005|Overall Study|Subject no longer meets study criteria|0|||
161788959|NCT01621490|584272772|FG006|Overall Study|Subject no longer meets study criteria|0|||
161788960|NCT01621490|584272773|FG007|Overall Study|Subject no longer meets study criteria|0|||
161788961|NCT01621490|584272774|FG008|Overall Study|Subject no longer meets study criteria|0|||
161788962|NCT01621490|584272775|FG009|Overall Study|Subject no longer meets study criteria|0|||
161788963|NCT01621490|584272776|FG010|Overall Study|Subject no longer meets study criteria|0|||
161788964|NCT01621490|584272766|FG000|Overall Study|Maximum clinical benefit|3|||
161788965|NCT01621490|584272767|FG001|Overall Study|Maximum clinical benefit|2|||
161788966|NCT01621490|584272768|FG002|Overall Study|Maximum clinical benefit|0|||
161788967|NCT01621490|584272769|FG003|Overall Study|Maximum clinical benefit|0|||
161788968|NCT01621490|584272770|FG004|Overall Study|Maximum clinical benefit|0|||
161788969|NCT01621490|584272771|FG005|Overall Study|Maximum clinical benefit|0|||
161788970|NCT01621490|584272772|FG006|Overall Study|Maximum clinical benefit|1|||
161788971|NCT01621490|584272773|FG007|Overall Study|Maximum clinical benefit|2|||
161788972|NCT01621490|584272774|FG008|Overall Study|Maximum clinical benefit|2|||
161788973|NCT01621490|584272775|FG009|Overall Study|Maximum clinical benefit|0|||
161788974|NCT01621490|584272776|FG010|Overall Study|Maximum clinical benefit|0|||
161788975|NCT01621490|584272766|FG000|Overall Study|Withdrawal by Subject|1|||
161788976|NCT01621490|584272767|FG001|Overall Study|Withdrawal by Subject|0|||
161788977|NCT01621490|584272768|FG002|Overall Study|Withdrawal by Subject|0|||
161788978|NCT01621490|584272769|FG003|Overall Study|Withdrawal by Subject|0|||
161788979|NCT01621490|584272770|FG004|Overall Study|Withdrawal by Subject|0|||
161788980|NCT01621490|584272771|FG005|Overall Study|Withdrawal by Subject|1|||
161788981|NCT01621490|584272772|FG006|Overall Study|Withdrawal by Subject|0|||
161788982|NCT01621490|584272773|FG007|Overall Study|Withdrawal by Subject|0|||
161788983|NCT01621490|584272774|FG008|Overall Study|Withdrawal by Subject|0|||
161788984|NCT01621490|584272775|FG009|Overall Study|Withdrawal by Subject|0|||
161788985|NCT01621490|584272776|FG010|Overall Study|Withdrawal by Subject|0|||
161788986|NCT01621490|584272766|FG000|Overall Study|Subject request to discontinue study|1|||
161788987|NCT01621490|584272767|FG001|Overall Study|Subject request to discontinue study|3|||
161788988|NCT01621490|584272768|FG002|Overall Study|Subject request to discontinue study|1|||
161788989|NCT01621490|584272769|FG003|Overall Study|Subject request to discontinue study|1|||
161788990|NCT01621490|584272770|FG004|Overall Study|Subject request to discontinue study|0|||
161788991|NCT01621490|584272771|FG005|Overall Study|Subject request to discontinue study|2|||
161788992|NCT01621490|584272772|FG006|Overall Study|Subject request to discontinue study|1|||
161788993|NCT01621490|584272773|FG007|Overall Study|Subject request to discontinue study|0|||
161788994|NCT01621490|584272774|FG008|Overall Study|Subject request to discontinue study|1|||
161788995|NCT01621490|584272775|FG009|Overall Study|Subject request to discontinue study|0|||
161788996|NCT01621490|584272776|FG010|Overall Study|Subject request to discontinue study|0|||
161788997|NCT01621490|584272766|FG000|Overall Study|Adverse event unrelated to study drug|1|||
161788998|NCT01621490|584272767|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161788999|NCT01621490|584272768|FG002|Overall Study|Adverse event unrelated to study drug|0|||
161789000|NCT01621490|584272769|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161789001|NCT01621490|584272770|FG004|Overall Study|Adverse event unrelated to study drug|0|||
162026096|NCT00369629|585152886|FG002|Follow up for 1 Year|Death|1|||
161789002|NCT01621490|584272771|FG005|Overall Study|Adverse event unrelated to study drug|0|||
161789003|NCT01621490|584272772|FG006|Overall Study|Adverse event unrelated to study drug|0|||
161789004|NCT01621490|584272773|FG007|Overall Study|Adverse event unrelated to study drug|2|||
161789005|NCT01621490|584272774|FG008|Overall Study|Adverse event unrelated to study drug|0|||
161789006|NCT01621490|584272775|FG009|Overall Study|Adverse event unrelated to study drug|0|||
161789007|NCT01621490|584272776|FG010|Overall Study|Adverse event unrelated to study drug|0|||
161789008|NCT01621490|584272766|FG000|Overall Study|Disease progression|27|||
161789009|NCT01621490|584272767|FG001|Overall Study|Disease progression|28|||
161789010|NCT01621490|584272768|FG002|Overall Study|Disease progression|1|||
161789011|NCT01621490|584272769|FG003|Overall Study|Disease progression|5|||
161789012|NCT01621490|584272770|FG004|Overall Study|Disease progression|3|||
161789013|NCT01621490|584272771|FG005|Overall Study|Disease progression|8|||
161789014|NCT01621490|584272772|FG006|Overall Study|Disease progression|7|||
161789015|NCT01621490|584272773|FG007|Overall Study|Disease progression|1|||
161789016|NCT01621490|584272774|FG008|Overall Study|Disease progression|4|||
161789017|NCT01621490|584272775|FG009|Overall Study|Disease progression|1|||
161789018|NCT01621490|584272776|FG010|Overall Study|Disease progression|1|||
161789019|NCT01621490|584272766|FG000|Overall Study|Study drug toxicity|1|||
161789020|NCT01621490|584272767|FG001|Overall Study|Study drug toxicity|4|||
161789021|NCT01621490|584272768|FG002|Overall Study|Study drug toxicity|5|||
161789022|NCT01621490|584272769|FG003|Overall Study|Study drug toxicity|3|||
161789023|NCT01621490|584272770|FG004|Overall Study|Study drug toxicity|1|||
161789024|NCT01621490|584272771|FG005|Overall Study|Study drug toxicity|10|||
161789025|NCT01621490|584272772|FG006|Overall Study|Study drug toxicity|1|||
161789026|NCT01621490|584272773|FG007|Overall Study|Study drug toxicity|4|||
161789027|NCT01621490|584272774|FG008|Overall Study|Study drug toxicity|1|||
161789028|NCT01621490|584272775|FG009|Overall Study|Study drug toxicity|0|||
161789029|NCT01621490|584272776|FG010|Overall Study|Study drug toxicity|0|||
161789030|NCT01621490|584272766|FG000|Overall Study|Death|0|||
161789031|NCT01621490|584272767|FG001|Overall Study|Death|0|||
161789032|NCT01621490|584272768|FG002|Overall Study|Death|0|||
161789033|NCT01621490|584272769|FG003|Overall Study|Death|0|||
161789034|NCT01621490|584272770|FG004|Overall Study|Death|0|||
161789035|NCT01621490|584272771|FG005|Overall Study|Death|0|||
161789036|NCT01621490|584272772|FG006|Overall Study|Death|0|||
161789037|NCT01621490|584272773|FG007|Overall Study|Death|0|||
161789038|NCT01621490|584272774|FG008|Overall Study|Death|1|||
161789039|NCT01621490|584272775|FG009|Overall Study|Death|0|||
161789040|NCT01621490|584272776|FG010|Overall Study|Death|0|||
161789041|NCT01621490|584272766|FG000|Overall Study|Other reasons|7|||
161789042|NCT01621490|584272767|FG001|Overall Study|Other reasons|6|||
161789043|NCT01621490|584272768|FG002|Overall Study|Other reasons|4|||
161789044|NCT01621490|584272769|FG003|Overall Study|Other reasons|1|||
161789045|NCT01621490|584272770|FG004|Overall Study|Other reasons|1|||
161789046|NCT01621490|584272771|FG005|Overall Study|Other reasons|3|||
161789047|NCT01621490|584272772|FG006|Overall Study|Other reasons|1|||
161789048|NCT01621490|584272773|FG007|Overall Study|Other reasons|1|||
161789049|NCT01621490|584272774|FG008|Overall Study|Other reasons|1|||
161789050|NCT01621490|584272775|FG009|Overall Study|Other reasons|0|||
161789051|NCT01621490|584272776|FG010|Overall Study|Other reasons|0|||
162126873|NCT02204293|585515331|FG005|Core Study Part I|Adverse Event|0|||
162126874|NCT02204293|585515326|FG000|Core Study Part I|Physician Decision|0|||
162126875|NCT02204293|585515327|FG001|Core Study Part I|Physician Decision|3|||
161789052|NCT00461500|584272777|FG000|Overall Study|Adverse Event|1|||
161789053|NCT00461500|584272778|FG001|Overall Study|Adverse Event|0|||
161789054|NCT00461500|584272777|FG000|Overall Study|Lack of Efficacy|0|||
161789055|NCT00461500|584272778|FG001|Overall Study|Lack of Efficacy|1|||
161789056|NCT00461500|584272777|FG000|Overall Study|Expired Drug Treatment|1|||
161789057|NCT00461500|584272778|FG001|Overall Study|Expired Drug Treatment|1|||
161789058|NCT00461500|584272777|FG000|Overall Study|Study Stopped|1|||
161789059|NCT00461500|584272778|FG001|Overall Study|Study Stopped|2|||
161789060|NCT00461500|584272777|FG000|Overall Study|Drug Treatment Misuse|1|||
161789061|NCT00461500|584272778|FG001|Overall Study|Drug Treatment Misuse|0|||
161789062|NCT00461500|584272777|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
161789063|NCT00461500|584272778|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
161789064|NCT00461500|584272777|FG000|Overall Study|Lost to Follow-up|2|||
161789065|NCT00461500|584272778|FG001|Overall Study|Lost to Follow-up|2|||
161789066|NCT01806597|584272779|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
161789067|NCT01806597|584272780|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
161789068|NCT01806597|584272781|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
161789069|NCT01806597|584272782|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
161789070|NCT01806597|584272783|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
161789071|NCT01806597|584272784|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
161789072|NCT01806597|584272779|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
161789073|NCT01806597|584272780|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
161789074|NCT01806597|584272781|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
161789075|NCT01806597|584272782|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
161789076|NCT01806597|584272783|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
161789077|NCT01806597|584272784|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
161789078|NCT01806597|584272779|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161789079|NCT01806597|584272780|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
161789080|NCT01806597|584272781|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161789081|NCT01806597|584272782|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161789082|NCT01806597|584272783|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161789083|NCT01806597|584272784|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161789084|NCT01806597|584272779|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
161789085|NCT01806597|584272780|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
161789086|NCT01806597|584272781|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
161789087|NCT01806597|584272782|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
161789088|NCT01806597|584272783|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
161789089|NCT01806597|584272784|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
161789090|NCT01806597|584272779|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161789091|NCT01806597|584272780|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
161789092|NCT01806597|584272781|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161789093|NCT01806597|584272782|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161789094|NCT01806597|584272783|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161789095|NCT01806597|584272784|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161789096|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
161789097|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
161789098|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
161789099|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
161789100|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
161789101|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
161789102|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
161789103|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
161789104|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
161789105|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
161789106|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
161789107|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
161789108|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
161789109|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161789110|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161789111|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161789112|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161789113|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161789114|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
161789115|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
161789116|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
161789117|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
161789118|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
161789119|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
161789120|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
161789121|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161789122|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161789123|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161789124|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161789125|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161789126|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
161789127|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
161789128|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
161789129|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
161789130|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
161789131|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
161789132|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
161789133|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
162026097|NCT00369629|585152887|FG003|Follow up for 1 Year|Death|0|||
162026098|NCT00369629|585152884|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
162026099|NCT00369629|585152885|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
162026100|NCT00369629|585152886|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
162026101|NCT00369629|585152887|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
162026102|NCT00369629|585152884|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
162026103|NCT00369629|585152885|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
161789134|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
161789135|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
161789136|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
161789137|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
161789138|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
161789139|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
161789140|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
161789141|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
161789142|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
161789143|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
161789144|NCT01806597|584272779|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
161789145|NCT01806597|584272780|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161789146|NCT01806597|584272781|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161789147|NCT01806597|584272782|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161789148|NCT01806597|584272783|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161789149|NCT01806597|584272784|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161789150|NCT01806597|584272779|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161789151|NCT01806597|584272780|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161789152|NCT01806597|584272781|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161789153|NCT01806597|584272782|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161789154|NCT01806597|584272783|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161789155|NCT01806597|584272784|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
161789156|NCT01806597|584272779|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161789157|NCT01806597|584272780|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161789158|NCT01806597|584272781|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161789159|NCT01806597|584272782|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161789160|NCT01806597|584272783|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161789161|NCT01806597|584272784|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
162126876|NCT02204293|585515328|FG002|Core Study Part I|Physician Decision|0|||
162126877|NCT02204293|585515329|FG003|Core Study Part I|Physician Decision|0|||
162126878|NCT02204293|585515330|FG004|Core Study Part I|Physician Decision|0|||
162126879|NCT02204293|585515331|FG005|Core Study Part I|Physician Decision|0|||
162126880|NCT02204293|585515326|FG000|LTE Phase|Study Suspended|0|||
162126881|NCT02204293|585515327|FG001|LTE Phase|Study Suspended|0|||
162126882|NCT02204293|585515328|FG002|LTE Phase|Study Suspended|0|||
162126883|NCT02204293|585515329|FG003|LTE Phase|Study Suspended|0|||
162126884|NCT02204293|585515330|FG004|LTE Phase|Study Suspended|0|||
162126885|NCT02204293|585515331|FG005|LTE Phase|Study Suspended|7|||
162126886|NCT02420327|585515332|FG000|Overall Study|Adverse Event|7|||
161789162|NCT01806597|584272779|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161789163|NCT01806597|584272780|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161789164|NCT01806597|584272781|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161789165|NCT01806597|584272782|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161789166|NCT01806597|584272783|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161789167|NCT01806597|584272784|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
161789168|NCT01806597|584272779|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161789169|NCT01806597|584272780|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161789170|NCT01806597|584272781|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161789171|NCT01806597|584272782|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161789172|NCT01806597|584272783|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161789173|NCT01806597|584272784|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
161789174|NCT01806597|584272779|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161789175|NCT01806597|584272780|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161789176|NCT01806597|584272781|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161789177|NCT01806597|584272782|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161789178|NCT01806597|584272783|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161789179|NCT01806597|584272784|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
161789180|NCT01144663|584272785|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
161789181|NCT01144663|584272786|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
161789182|NCT01144663|584272787|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
161789183|NCT01144663|584272788|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
162126887|NCT02420327|585515332|FG000|Overall Study|Pregnancy|1|||
162126888|NCT02420327|585515332|FG000|Overall Study|Withdrawal by Subject|6|||
162126889|NCT02420327|585515332|FG000|Overall Study|Lost to Follow-up|1|||
162126890|NCT02420327|585515332|FG000|Overall Study|Protocol Violation|1|||
162126891|NCT01225835|585515335|FG000|Overall Study|Completed protocol|2|||
162126892|NCT01225835|585515336|FG001|Overall Study|Completed protocol|1|||
161789184|NCT01144663|584272785|FG000|Primary Vaccination Phase|Adverse Event|1|||
161789185|NCT01144663|584272786|FG001|Primary Vaccination Phase|Adverse Event|0|||
161789186|NCT01144663|584272787|FG002|Primary Vaccination Phase|Adverse Event|0|||
161789187|NCT01144663|584272788|FG003|Primary Vaccination Phase|Adverse Event|1|||
161789188|NCT01144663|584272785|FG000|Primary Vaccination Phase|Protocol Violation|2|||
161789189|NCT01144663|584272786|FG001|Primary Vaccination Phase|Protocol Violation|0|||
161789190|NCT01144663|584272787|FG002|Primary Vaccination Phase|Protocol Violation|1|||
161789191|NCT01144663|584272788|FG003|Primary Vaccination Phase|Protocol Violation|0|||
161789192|NCT01144663|584272785|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
161789193|NCT01144663|584272786|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
161789194|NCT01144663|584272787|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
161789195|NCT01144663|584272788|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
161789196|NCT01144663|584272785|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
161789197|NCT01144663|584272786|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
161789198|NCT01144663|584272787|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
161789199|NCT01144663|584272788|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
161789200|NCT01144663|584272785|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
161789201|NCT01144663|584272786|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
161789202|NCT01144663|584272787|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
161789203|NCT01144663|584272788|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
161789204|NCT01144663|584272785|FG000|Primary Vaccination Phase|Other|0|||
161789205|NCT01144663|584272786|FG001|Primary Vaccination Phase|Other|1|||
161789206|NCT01144663|584272787|FG002|Primary Vaccination Phase|Other|0|||
161789207|NCT01144663|584272788|FG003|Primary Vaccination Phase|Other|2|||
161789208|NCT01144663|584272785|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
161789209|NCT01144663|584272786|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
161789210|NCT01144663|584272787|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
161789211|NCT01144663|584272788|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
161789212|NCT01144663|584272785|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
161789213|NCT01144663|584272786|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
161789214|NCT01144663|584272787|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
161789215|NCT01144663|584272788|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
161789216|NCT01144663|584272785|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
161789217|NCT01144663|584272786|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
161789218|NCT01144663|584272787|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
161789219|NCT01144663|584272788|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
161789220|NCT01144663|584272785|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
161789221|NCT01144663|584272786|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
161789222|NCT01144663|584272787|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
161789223|NCT01144663|584272788|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
161789224|NCT01144663|584272785|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
161789225|NCT01144663|584272786|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
161789226|NCT01144663|584272787|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
161789227|NCT01144663|584272788|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
161789228|NCT01144663|584272785|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
161789229|NCT01144663|584272786|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
161789230|NCT01144663|584272787|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
161789231|NCT01144663|584272788|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
161789232|NCT01335477|584272790|FG000|Overall Study|Adverse Event|30|||
161789233|NCT01335477|584272791|FG001|Overall Study|Adverse Event|42|||
161789234|NCT01335477|584272790|FG000|Overall Study|Non compliant with protocol|0|||
161789235|NCT01335477|584272791|FG001|Overall Study|Non compliant with protocol|2|||
161789236|NCT01335477|584272790|FG000|Overall Study|Lost to Follow-up|1|||
161789237|NCT01335477|584272791|FG001|Overall Study|Lost to Follow-up|2|||
161789238|NCT01335477|584272790|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
161789239|NCT01335477|584272791|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
161789240|NCT01335477|584272790|FG000|Overall Study|Not treated|1|||
161789241|NCT01335477|584272791|FG001|Overall Study|Not treated|2|||
161789242|NCT01335477|584272790|FG000|Overall Study|Reason other than those stated above|2|||
161789243|NCT01335477|584272791|FG001|Overall Study|Reason other than those stated above|2|||
161789244|NCT01473758|584272794|FG000|Cycle 1|Adverse Event|10|||
161789245|NCT01473758|584272795|FG001|Cycle 1|Adverse Event|2|||
161789246|NCT01473758|584272796|FG002|Cycle 1|Adverse Event|0|||
161789247|NCT01473758|584272797|FG003|Cycle 1|Adverse Event|0|||
161789248|NCT01473758|584272794|FG000|Cycle 1|Withdrawal by Subject|1|||
161789249|NCT01473758|584272795|FG001|Cycle 1|Withdrawal by Subject|1|||
161789250|NCT01473758|584272796|FG002|Cycle 1|Withdrawal by Subject|0|||
161789251|NCT01473758|584272797|FG003|Cycle 1|Withdrawal by Subject|0|||
161789252|NCT01473758|584272794|FG000|Cycle 2|Adverse Event|0|||
161789253|NCT01473758|584272795|FG001|Cycle 2|Adverse Event|0|||
161789254|NCT01473758|584272796|FG002|Cycle 2|Adverse Event|5|||
161789255|NCT01473758|584272797|FG003|Cycle 2|Adverse Event|0|||
161789256|NCT02763579|584272798|FG000|Global Period|Death|167|||
161789257|NCT02763579|584272799|FG001|Global Period|Death|151|||
161789258|NCT02763579|584272800|FG002|Global Period|Death|0|||
161789259|NCT02763579|584272801|FG003|Global Period|Death|0|||
161789260|NCT02763579|584272798|FG000|Global Period|Lost to Follow-up|2|||
161789261|NCT02763579|584272799|FG001|Global Period|Lost to Follow-up|4|||
161789262|NCT02763579|584272800|FG002|Global Period|Lost to Follow-up|0|||
161789263|NCT02763579|584272801|FG003|Global Period|Lost to Follow-up|0|||
161789264|NCT02763579|584272798|FG000|Global Period|Physician Decision|0|||
161789265|NCT02763579|584272799|FG001|Global Period|Physician Decision|2|||
161789266|NCT02763579|584272800|FG002|Global Period|Physician Decision|0|||
161789267|NCT02763579|584272801|FG003|Global Period|Physician Decision|0|||
161789268|NCT02763579|584272798|FG000|Global Period|Study Terminated By Sponsor|21|||
161789269|NCT02763579|584272799|FG001|Global Period|Study Terminated By Sponsor|26|||
161789270|NCT02763579|584272800|FG002|Global Period|Study Terminated By Sponsor|0|||
161789271|NCT02763579|584272801|FG003|Global Period|Study Terminated By Sponsor|0|||
161789272|NCT02763579|584272798|FG000|Global Period|Withdrawal by Subject|12|||
161789273|NCT02763579|584272799|FG001|Global Period|Withdrawal by Subject|18|||
161789274|NCT02763579|584272800|FG002|Global Period|Withdrawal by Subject|0|||
161789275|NCT02763579|584272801|FG003|Global Period|Withdrawal by Subject|0|||
161789276|NCT02763579|584272798|FG000|China Period|Death|0|||
161789277|NCT02763579|584272799|FG001|China Period|Death|0|||
161789278|NCT02763579|584272800|FG002|China Period|Death|46|||
161789279|NCT02763579|584272801|FG003|China Period|Death|48|||
161789280|NCT02763579|584272798|FG000|China Period|Lost to Follow-up|0|||
161789281|NCT02763579|584272799|FG001|China Period|Lost to Follow-up|0|||
161789282|NCT02763579|584272800|FG002|China Period|Lost to Follow-up|1|||
161789283|NCT02763579|584272801|FG003|China Period|Lost to Follow-up|1|||
161789284|NCT02763579|584272798|FG000|China Period|Physician Decision|0|||
161789285|NCT02763579|584272799|FG001|China Period|Physician Decision|0|||
161789286|NCT02763579|584272800|FG002|China Period|Physician Decision|0|||
161789287|NCT02763579|584272801|FG003|China Period|Physician Decision|1|||
161789288|NCT02763579|584272798|FG000|China Period|Study Terminated By Sponsor|0|||
161789289|NCT02763579|584272799|FG001|China Period|Study Terminated By Sponsor|0|||
161789290|NCT02763579|584272800|FG002|China Period|Study Terminated By Sponsor|3|||
161789291|NCT02763579|584272801|FG003|China Period|Study Terminated By Sponsor|4|||
161789292|NCT02763579|584272798|FG000|China Period|Withdrawal by Subject|0|||
161789293|NCT02763579|584272799|FG001|China Period|Withdrawal by Subject|0|||
161789294|NCT02763579|584272800|FG002|China Period|Withdrawal by Subject|3|||
161789295|NCT02763579|584272801|FG003|China Period|Withdrawal by Subject|3|||
161789296|NCT00829413|584272805|FG000|Overall Study|No study drug admimnistered|13|||
161789297|NCT00829413|584272805|FG000|Overall Study|Training Patients|67|||
161789298|NCT00829413|584272805|FG000|Overall Study|No truth standard procedure available|9|||
161789299|NCT00829413|584272805|FG000|Overall Study|Technically inadequate truth standard|2|||
161789300|NCT00829413|584272805|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
161789301|NCT00891774|584272813|FG000|Overall Study|Lost to Follow-up|5|||
161789302|NCT00891774|584272813|FG000|Overall Study|Illness (Self/Mother)|3|||
161789303|NCT00891774|584272813|FG000|Overall Study|Withdrawal by Subject|2|||
161789304|NCT00891774|584272813|FG000|Overall Study|Protocol Violation|4|||
161789305|NCT03255031|584272815|FG000|Overall Study|Adverse Event|5|||
161789306|NCT03255031|584272816|FG001|Overall Study|Adverse Event|3|||
161789307|NCT03255031|584272815|FG000|Overall Study|Physician Decision|2|||
161898621|NCT03569098|584677849|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
161898622|NCT03569098|584677847|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
161898623|NCT03569098|584677848|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
162126893|NCT01225835|585515335|FG000|Overall Study|Did not meet hCG criterion|2|||
161898624|NCT03569098|584677849|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
161898625|NCT02581488|584677854|FG000|Overall Study|Adverse Event|6|||
161898626|NCT02581488|584677855|FG001|Overall Study|Adverse Event|7|||
161898627|NCT02581488|584677854|FG000|Overall Study|Lost to Follow-up|1|||
161898628|NCT02581488|584677855|FG001|Overall Study|Lost to Follow-up|0|||
161898629|NCT02581488|584677854|FG000|Overall Study|Withdrawal by Subject|1|||
161898630|NCT02581488|584677855|FG001|Overall Study|Withdrawal by Subject|0|||
161898631|NCT02581488|584677854|FG000|Overall Study|Non-Compliance|1|||
161898632|NCT02581488|584677855|FG001|Overall Study|Non-Compliance|0|||
161898633|NCT02581488|584677854|FG000|Overall Study|Protocol Violation|0|||
161898634|NCT02581488|584677855|FG001|Overall Study|Protocol Violation|4|||
161898635|NCT00522548|584677856|FG000|Overall Study|Adverse Event|2|||
161898636|NCT00522548|584677857|FG001|Overall Study|Adverse Event|2|||
161898637|NCT00522548|584677856|FG000|Overall Study|Withdrawal by Subject|0|||
161898638|NCT00522548|584677857|FG001|Overall Study|Withdrawal by Subject|2|||
161898639|NCT02915159|584677858|FG000|Overall Study|Participant no longer meets criteria|2|||
162126894|NCT01225835|585515336|FG001|Overall Study|Did not meet hCG criterion|0|||
162126895|NCT01225835|585515335|FG000|Overall Study|Adverse Event|2|||
161789308|NCT03255031|584272816|FG001|Overall Study|Physician Decision|1|||
161789309|NCT03255031|584272815|FG000|Overall Study|Withdrawal by Subject|9|||
161789310|NCT03255031|584272816|FG001|Overall Study|Withdrawal by Subject|3|||
161789311|NCT01809314|584272817|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
162126896|NCT01225835|585515336|FG001|Overall Study|Adverse Event|1|||
162126897|NCT01225835|585515335|FG000|Overall Study|Other|1|||
162126898|NCT01225835|585515336|FG001|Overall Study|Other|1|||
162126899|NCT01146574|585515337|FG000|Overall Study|Death|0|||
162126900|NCT01146574|585515338|FG001|Overall Study|Death|1|||
162126901|NCT01146574|585515339|FG002|Overall Study|Death|1|||
162126902|NCT01146574|585515340|FG003|Overall Study|Death|0|||
162126903|NCT01146574|585515341|FG004|Overall Study|Death|0|||
162126904|NCT01146574|585515342|FG005|Overall Study|Death|0|||
162126905|NCT01146574|585515343|FG006|Overall Study|Death|0|||
162126906|NCT01146574|585515337|FG000|Overall Study|Other reasons|0|||
162126907|NCT01146574|585515338|FG001|Overall Study|Other reasons|0|||
162126908|NCT01146574|585515339|FG002|Overall Study|Other reasons|3|||
162126909|NCT01146574|585515340|FG003|Overall Study|Other reasons|0|||
162126910|NCT01146574|585515341|FG004|Overall Study|Other reasons|0|||
162126911|NCT01146574|585515342|FG005|Overall Study|Other reasons|0|||
162126912|NCT01146574|585515343|FG006|Overall Study|Other reasons|0|||
162126913|NCT01146574|585515337|FG000|Overall Study|Kidney transplant|0|||
162126914|NCT01146574|585515338|FG001|Overall Study|Kidney transplant|0|||
162126915|NCT01146574|585515339|FG002|Overall Study|Kidney transplant|1|||
162126916|NCT01146574|585515340|FG003|Overall Study|Kidney transplant|1|||
162126917|NCT01146574|585515341|FG004|Overall Study|Kidney transplant|0|||
162126918|NCT01146574|585515342|FG005|Overall Study|Kidney transplant|0|||
162126919|NCT01146574|585515343|FG006|Overall Study|Kidney transplant|0|||
162126920|NCT01146574|585515337|FG000|Overall Study|Withdrew consent|0|||
162126921|NCT01146574|585515338|FG001|Overall Study|Withdrew consent|0|||
162126922|NCT01146574|585515339|FG002|Overall Study|Withdrew consent|1|||
162126923|NCT01146574|585515340|FG003|Overall Study|Withdrew consent|1|||
162126924|NCT01146574|585515341|FG004|Overall Study|Withdrew consent|2|||
162126925|NCT01146574|585515342|FG005|Overall Study|Withdrew consent|1|||
162126926|NCT01146574|585515343|FG006|Overall Study|Withdrew consent|1|||
162126927|NCT03051659|585515344|FG000|Treatment Period|Withdrawal by Subject|0|||
162126928|NCT03051659|585515345|FG001|Treatment Period|Withdrawal by Subject|2|||
162126929|NCT03051659|585515344|FG000|Survival Follow-up|Lost to Follow-up|23|||
162126930|NCT03051659|585515345|FG001|Survival Follow-up|Lost to Follow-up|22|||
162126931|NCT01266993|585515346|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
162126932|NCT01266993|585515347|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
162126933|NCT01266993|585515346|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
162126934|NCT01266993|585515347|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
162126935|NCT04779242|585515348|FG000|Overall Study|Adverse Event|1|||
162126936|NCT04779242|585515349|FG001|Overall Study|Adverse Event|1|||
162126937|NCT04779242|585515348|FG000|Overall Study|Lost to Follow-up|2|||
162126938|NCT04779242|585515349|FG001|Overall Study|Lost to Follow-up|4|||
162126939|NCT04779242|585515348|FG000|Overall Study|Withdrawal by Subject|7|||
162126940|NCT04779242|585515349|FG001|Overall Study|Withdrawal by Subject|9|||
162126941|NCT04779242|585515348|FG000|Overall Study|Death|6|||
162126942|NCT04779242|585515349|FG001|Overall Study|Death|6|||
162126943|NCT04779242|585515348|FG000|Overall Study|COVID-19 related reasons|2|||
162126944|NCT04779242|585515349|FG001|Overall Study|COVID-19 related reasons|1|||
162126945|NCT04779242|585515348|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
162126946|NCT04779242|585515349|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
162126947|NCT04779242|585515348|FG000|Overall Study|Martial Law in Ukraine|2|||
162126948|NCT04779242|585515349|FG001|Overall Study|Martial Law in Ukraine|3|||
162126949|NCT00849680|585515354|FG000|Overall Study|Adverse Event|0|||
162126950|NCT00849680|585515355|FG001|Overall Study|Adverse Event|0|||
162126951|NCT00849680|585515356|FG002|Overall Study|Adverse Event|0|||
162126952|NCT00849680|585515357|FG003|Overall Study|Adverse Event|0|||
162126953|NCT00849680|585515358|FG004|Overall Study|Adverse Event|0|||
162126954|NCT00849680|585515359|FG005|Overall Study|Adverse Event|0|||
162126955|NCT00849680|585515360|FG006|Overall Study|Adverse Event|2|||
162126956|NCT00849680|585515361|FG007|Overall Study|Adverse Event|0|||
162126957|NCT00849680|585515354|FG000|Overall Study|Lost to Follow-up|7|||
162126958|NCT00849680|585515355|FG001|Overall Study|Lost to Follow-up|3|||
162126959|NCT00849680|585515356|FG002|Overall Study|Lost to Follow-up|12|||
162126960|NCT00849680|585515357|FG003|Overall Study|Lost to Follow-up|11|||
162126961|NCT00849680|585515358|FG004|Overall Study|Lost to Follow-up|8|||
162126962|NCT00849680|585515359|FG005|Overall Study|Lost to Follow-up|11|||
162126963|NCT00849680|585515360|FG006|Overall Study|Lost to Follow-up|12|||
162126964|NCT00849680|585515361|FG007|Overall Study|Lost to Follow-up|5|||
162126965|NCT00849680|585515354|FG000|Overall Study|Subject moved|1|||
162126966|NCT00849680|585515355|FG001|Overall Study|Subject moved|0|||
162126967|NCT00849680|585515356|FG002|Overall Study|Subject moved|3|||
162126968|NCT00849680|585515357|FG003|Overall Study|Subject moved|1|||
162126969|NCT00849680|585515358|FG004|Overall Study|Subject moved|0|||
162126970|NCT00849680|585515359|FG005|Overall Study|Subject moved|2|||
162126971|NCT00849680|585515360|FG006|Overall Study|Subject moved|2|||
162126972|NCT00849680|585515361|FG007|Overall Study|Subject moved|2|||
162126973|NCT00849680|585515354|FG000|Overall Study|Withdrawal by Subject|2|||
162126974|NCT00849680|585515355|FG001|Overall Study|Withdrawal by Subject|0|||
162126975|NCT00849680|585515356|FG002|Overall Study|Withdrawal by Subject|0|||
162126976|NCT00849680|585515357|FG003|Overall Study|Withdrawal by Subject|2|||
162126977|NCT00849680|585515358|FG004|Overall Study|Withdrawal by Subject|2|||
162126978|NCT00849680|585515359|FG005|Overall Study|Withdrawal by Subject|2|||
162126979|NCT00849680|585515360|FG006|Overall Study|Withdrawal by Subject|1|||
162126980|NCT00849680|585515361|FG007|Overall Study|Withdrawal by Subject|1|||
162126981|NCT00849680|585515354|FG000|Overall Study|Subject unable to comply with protocol|1|||
162126982|NCT00849680|585515355|FG001|Overall Study|Subject unable to comply with protocol|0|||
162126983|NCT00849680|585515356|FG002|Overall Study|Subject unable to comply with protocol|0|||
162126984|NCT00849680|585515357|FG003|Overall Study|Subject unable to comply with protocol|0|||
162126985|NCT00849680|585515358|FG004|Overall Study|Subject unable to comply with protocol|0|||
162126986|NCT00849680|585515359|FG005|Overall Study|Subject unable to comply with protocol|0|||
162126987|NCT00849680|585515360|FG006|Overall Study|Subject unable to comply with protocol|0|||
162126988|NCT00849680|585515361|FG007|Overall Study|Subject unable to comply with protocol|0|||
161789312|NCT01809314|584272817|FG000|Overall Study|Adverse Event|6|||
161789313|NCT01809314|584272817|FG000|Overall Study|Insufficient Therapeutic Response|14|||
161789314|NCT01809314|584272817|FG000|Overall Study|Lost to Follow-up|724|||
161789315|NCT01092702|584272818|FG000|Overall Study|Withdrawal by Subject|7|||
161789316|NCT01092702|584272818|FG000|Overall Study|Lost to Follow-up|2|||
161789317|NCT00863057|584272821|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
161789318|NCT00863057|584272822|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
161789319|NCT00863057|584272823|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
161789320|NCT00863057|584272824|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
161789321|NCT00863057|584272821|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
161789322|NCT00863057|584272822|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
161789323|NCT00863057|584272823|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
161789324|NCT00863057|584272824|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
161789325|NCT00863057|584272821|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
161789326|NCT00863057|584272822|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
161789327|NCT00863057|584272823|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
161789328|NCT00863057|584272824|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
161789329|NCT00863057|584272821|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
161789330|NCT00863057|584272822|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
161789331|NCT00863057|584272823|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
161789332|NCT00863057|584272824|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
161789333|NCT00545233|584272828|FG000|Overall Study|Adverse Event|10|||
161789334|NCT00545233|584272829|FG001|Overall Study|Adverse Event|5|||
161789335|NCT00545233|584272828|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
161789336|NCT00545233|584272829|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
161789337|NCT00545233|584272828|FG000|Overall Study|Protocol Violation|2|||
161789338|NCT00545233|584272829|FG001|Overall Study|Protocol Violation|0|||
161789339|NCT00545233|584272828|FG000|Overall Study|Refused Treatment|9|||
161789340|NCT00545233|584272829|FG001|Overall Study|Refused Treatment|7|||
161789341|NCT00545233|584272828|FG000|Overall Study|Failure to Return|4|||
161789342|NCT00545233|584272829|FG001|Overall Study|Failure to Return|6|||
161789343|NCT00545233|584272828|FG000|Overall Study|Insufficient response|14|||
161789344|NCT00545233|584272829|FG001|Overall Study|Insufficient response|15|||
161789345|NCT00545233|584272828|FG000|Overall Study|Physician Decision|2|||
161789346|NCT00545233|584272829|FG001|Overall Study|Physician Decision|1|||
161789347|NCT06371079|584272830|FG000|Overall Study|Missing data|88|||
161789348|NCT06371079|584272831|FG001|Overall Study|Missing data|247|||
161789349|NCT01238211|584272832|FG000|Overall Study|Continues active treatment|31|||
161789350|NCT01238211|584272832|FG000|Overall Study|Adverse Event|7|||
161789351|NCT01238211|584272832|FG000|Overall Study|Death|4|||
161789352|NCT01238211|584272832|FG000|Overall Study|Relapse/Progression|2|||
161789353|NCT01238211|584272832|FG000|Overall Study|Withdrawal by Subject|7|||
161789354|NCT01238211|584272832|FG000|Overall Study|Non-protocol treatment|4|||
161789355|NCT01238211|584272832|FG000|Overall Study|Investigator/Patient Decision|3|||
161789356|NCT00449930|584272833|FG000|Overall Study|Adverse Event|9|||
161789357|NCT00449930|584272834|FG001|Overall Study|Adverse Event|19|||
161789358|NCT00449930|584272833|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
161789359|NCT00449930|584272834|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
161789360|NCT00449930|584272833|FG000|Overall Study|Lack of Efficacy|10|||
161789361|NCT00449930|584272834|FG001|Overall Study|Lack of Efficacy|1|||
161789362|NCT00449930|584272833|FG000|Overall Study|Lost to Follow-up|9|||
161789363|NCT00449930|584272834|FG001|Overall Study|Lost to Follow-up|14|||
162126989|NCT04285229|585515362|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
162126990|NCT04285229|585515363|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161789364|NCT00449930|584272833|FG000|Overall Study|Physician Decision|1|||
161789365|NCT00449930|584272834|FG001|Overall Study|Physician Decision|2|||
161789366|NCT00449930|584272833|FG000|Overall Study|Protocol Violation|14|||
161789367|NCT00449930|584272834|FG001|Overall Study|Protocol Violation|15|||
162126991|NCT04285229|585515364|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161789368|NCT00449930|584272833|FG000|Overall Study|Withdrawal by Subject|16|||
161789369|NCT00449930|584272834|FG001|Overall Study|Withdrawal by Subject|23|||
162010440|NCT01342211|585093756|FG000|Overall Study|Randomized, but not Treated|0|||
162010441|NCT01342211|585093757|FG001|Overall Study|Randomized, but not Treated|2|||
162010442|NCT01342211|585093758|FG002|Overall Study|Randomized, but not Treated|0|||
162010443|NCT01342211|585093759|FG003|Overall Study|Randomized, but not Treated|0|||
162010444|NCT01342211|585093760|FG004|Overall Study|Randomized, but not Treated|1|||
162010445|NCT05430854|585093761|FG000|Overall Study|Trial terminated by Sponsor|39|||
162010446|NCT05430854|585093762|FG001|Overall Study|Trial terminated by Sponsor|50|||
162010447|NCT05430854|585093763|FG002|Overall Study|Trial terminated by Sponsor|46|||
162010448|NCT05430854|585093761|FG000|Overall Study|Withdrawal by Subject|0|||
162010449|NCT05430854|585093762|FG001|Overall Study|Withdrawal by Subject|3|||
162010450|NCT05430854|585093763|FG002|Overall Study|Withdrawal by Subject|0|||
162010451|NCT02749422|585093766|FG000|Overall Study|Lost to Follow-up|0|||
162010452|NCT02749422|585093767|FG001|Overall Study|Lost to Follow-up|2|||
162010453|NCT02749422|585093766|FG000|Overall Study|Ineligible|0|||
162010454|NCT02749422|585093767|FG001|Overall Study|Ineligible|1|||
162010455|NCT01824836|585093768|FG000|Overall Study|Adverse Event|48|||
162010456|NCT01824836|585093768|FG000|Overall Study|Withdrawal by Subject|63|||
162010457|NCT01824836|585093768|FG000|Overall Study|Other complicating disease|116|||
162010458|NCT01824836|585093768|FG000|Overall Study|Disease progression|5|||
162010459|NCT01824836|585093768|FG000|Overall Study|Alternative therapy|2|||
162010460|NCT01824836|585093768|FG000|Overall Study|Depression|1|||
162010461|NCT01824836|585093768|FG000|Overall Study|Non-compliance|3|||
162010462|NCT01824836|585093768|FG000|Overall Study|Patient regained ovarian function|3|||
162010463|NCT01824836|585093768|FG000|Overall Study|Lost to Follow-up|8|||
162010464|NCT01824836|585093768|FG000|Overall Study|Physician Decision|2|||
162010465|NCT01824836|585093768|FG000|Overall Study|Research office was closed|3|||
162010466|NCT01824836|585093768|FG000|Overall Study|Relocation|3|||
162010467|NCT01824836|585093768|FG000|Overall Study|Insurance-related issue|1|||
162010468|NCT01824836|585093768|FG000|Overall Study|Transportation issue|1|||
162010469|NCT01824836|585093768|FG000|Overall Study|Patient transferred care|1|||
162010470|NCT01824836|585093768|FG000|Overall Study|Unknown reasons|4|||
162010471|NCT01824836|585093768|FG000|Overall Study|Never started treatment|16|||
162010472|NCT03253393|585093772|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
162010473|NCT03253393|585093773|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
162010474|NCT03253393|585093774|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
162010475|NCT02079246|585095892|FG000|OLEX|Withdrawal before treatment|1|||
162010476|NCT02079246|585095893|FG001|OLEX|Withdrawal before treatment|0|||
162010477|NCT02079246|585095892|FG000|OLEX|Death|11|||
162010478|NCT02079246|585095893|FG001|OLEX|Death|0|||
162010479|NCT02079246|585095892|FG000|OLEX|Adverse Event|66|||
162010480|NCT02079246|585095893|FG001|OLEX|Adverse Event|0|||
162010481|NCT02079246|585095892|FG000|OLEX|Withdrawal by Subject|60|||
162010482|NCT02079246|585095893|FG001|OLEX|Withdrawal by Subject|0|||
162010483|NCT02079246|585095892|FG000|OLEX|Lost to Follow-up|6|||
162010484|NCT02079246|585095893|FG001|OLEX|Lost to Follow-up|0|||
162010485|NCT02079246|585095892|FG000|OLEX|Protocol Violation|6|||
162010486|NCT02079246|585095893|FG001|OLEX|Protocol Violation|0|||
162010487|NCT02079246|585095892|FG000|OLEX|Lack of Efficacy|3|||
162010488|NCT02079246|585095893|FG001|OLEX|Lack of Efficacy|0|||
162010489|NCT02079246|585095892|FG000|OLEX|Results of the lead-in studies|58|||
162010490|NCT02079246|585095893|FG001|OLEX|Results of the lead-in studies|0|||
162010491|NCT02079246|585095892|FG000|OLEX|Other: Disallowed medication|8|||
162010492|NCT02079246|585095893|FG001|OLEX|Other: Disallowed medication|0|||
162010493|NCT02079246|585095892|FG000|OLEX|Other: Insufficient compliance|2|||
162010494|NCT02079246|585095893|FG001|OLEX|Other: Insufficient compliance|0|||
162010495|NCT02079246|585095892|FG000|OLEX|Other: Caregiver unavailable|3|||
162010496|NCT02079246|585095893|FG001|OLEX|Other: Caregiver unavailable|0|||
162010497|NCT02079246|585095892|FG000|OLEX|Other: Coordinator decision|1|||
162010498|NCT02079246|585095893|FG001|OLEX|Other: Coordinator decision|0|||
162010499|NCT02079246|585095892|FG000|OLEX|Other: Worsening of condition|1|||
162010500|NCT02079246|585095893|FG001|OLEX|Other: Worsening of condition|0|||
162010501|NCT02079246|585095892|FG000|OLEX|Other: Moved to nursing home|1|||
162010502|NCT02079246|585095893|FG001|OLEX|Other: Moved to nursing home|0|||
162010503|NCT02079246|585095892|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
162010504|NCT02079246|585095893|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
162010505|NCT02079246|585095892|FG000|OLEX-MEM|Adverse Event|0|||
162010506|NCT02079246|585095893|FG001|OLEX-MEM|Adverse Event|6|||
162010507|NCT02079246|585095892|FG000|OLEX-MEM|Withdrawal by Subject|0|||
162010508|NCT02079246|585095893|FG001|OLEX-MEM|Withdrawal by Subject|7|||
162010509|NCT02079246|585095892|FG000|OLEX-MEM|Protocol Violation|0|||
162010510|NCT02079246|585095893|FG001|OLEX-MEM|Protocol Violation|2|||
162010511|NCT02079246|585095892|FG000|OLEX-MEM|Lost to Follow-up|0|||
161789370|NCT00449930|584272833|FG000|Overall Study|Glycemic discontinuation criteria|1|||
162010512|NCT02079246|585095893|FG001|OLEX-MEM|Lost to Follow-up|1|||
162010513|NCT02079246|585095892|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
162010514|NCT02079246|585095893|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
162010515|NCT03591406|585095898|FG000|Overall Study|Adverse Event|5|||
162010516|NCT03591406|585095899|FG001|Overall Study|Adverse Event|3|||
162126992|NCT04285229|585515365|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162126993|NCT04285229|585515366|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162126994|NCT04285229|585515367|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162126995|NCT04285229|585515362|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
162126996|NCT04285229|585515363|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
162126997|NCT04285229|585515364|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
162126998|NCT04285229|585515365|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
162126999|NCT04285229|585515366|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
162127000|NCT04285229|585515367|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
162127001|NCT04285229|585515362|FG000|Extended Treatment Period|Adverse Event|0|||
162127002|NCT04285229|585515363|FG001|Extended Treatment Period|Adverse Event|0|||
162127003|NCT04285229|585515364|FG002|Extended Treatment Period|Adverse Event|0|||
162127004|NCT04285229|585515365|FG003|Extended Treatment Period|Adverse Event|1|||
162127005|NCT04285229|585515366|FG004|Extended Treatment Period|Adverse Event|0|||
162127006|NCT04285229|585515367|FG005|Extended Treatment Period|Adverse Event|0|||
162127007|NCT04285229|585515362|FG000|Extended Treatment Period|Physician Decision|0|||
162127008|NCT04285229|585515363|FG001|Extended Treatment Period|Physician Decision|0|||
162127009|NCT04285229|585515364|FG002|Extended Treatment Period|Physician Decision|1|||
162127010|NCT04285229|585515365|FG003|Extended Treatment Period|Physician Decision|0|||
162127011|NCT04285229|585515366|FG004|Extended Treatment Period|Physician Decision|0|||
162127012|NCT04285229|585515367|FG005|Extended Treatment Period|Physician Decision|0|||
162127013|NCT04285229|585515362|FG000|Follow-up Period|Adverse Event|0|||
162127014|NCT04285229|585515363|FG001|Follow-up Period|Adverse Event|0|||
162127015|NCT04285229|585515364|FG002|Follow-up Period|Adverse Event|0|||
162127016|NCT04285229|585515365|FG003|Follow-up Period|Adverse Event|0|||
162010517|NCT03591406|585095898|FG000|Overall Study|Protocol Violation|2|||
162010518|NCT03591406|585095899|FG001|Overall Study|Protocol Violation|1|||
162010519|NCT03591406|585095898|FG000|Overall Study|Withdrawal by Subject|0|||
162010520|NCT03591406|585095899|FG001|Overall Study|Withdrawal by Subject|5|||
162010521|NCT01389596|585095900|FG000|Overall Study|Protocol Violation|3|||
162010522|NCT01389596|585095901|FG001|Overall Study|Protocol Violation|4|||
162010523|NCT01389596|585095902|FG002|Overall Study|Protocol Violation|3|||
162010524|NCT01389596|585095900|FG000|Overall Study|Withdrawal by Subject|1|||
162010525|NCT01389596|585095901|FG001|Overall Study|Withdrawal by Subject|2|||
162010526|NCT01389596|585095902|FG002|Overall Study|Withdrawal by Subject|2|||
162010527|NCT01389596|585095900|FG000|Overall Study|Insufficient Clinical Response|3|||
162010528|NCT01389596|585095901|FG001|Overall Study|Insufficient Clinical Response|4|||
162010529|NCT01389596|585095902|FG002|Overall Study|Insufficient Clinical Response|5|||
162010530|NCT01389596|585095900|FG000|Overall Study|Adverse Event|1|||
162010531|NCT01389596|585095901|FG001|Overall Study|Adverse Event|4|||
162010532|NCT01389596|585095902|FG002|Overall Study|Adverse Event|0|||
162010533|NCT01389596|585095900|FG000|Overall Study|Death|0|||
162010534|NCT01389596|585095901|FG001|Overall Study|Death|1|||
162010535|NCT01389596|585095902|FG002|Overall Study|Death|0|||
162010536|NCT01389596|585095900|FG000|Overall Study|Other Unspecified|2|||
162010537|NCT01389596|585095901|FG001|Overall Study|Other Unspecified|1|||
162010538|NCT01389596|585095902|FG002|Overall Study|Other Unspecified|0|||
162010539|NCT01709084|585095903|FG000|Overall Study|Lost to Follow-up|4|||
162010540|NCT01709084|585095904|FG001|Overall Study|Lost to Follow-up|7|||
162010541|NCT01709084|585095903|FG000|Overall Study|Withdrawal by Subject|2|||
162010542|NCT01709084|585095904|FG001|Overall Study|Withdrawal by Subject|2|||
162010543|NCT01709084|585095903|FG000|Overall Study|Adverse Event|5|||
162010544|NCT01709084|585095904|FG001|Overall Study|Adverse Event|0|||
162010545|NCT01709084|585095903|FG000|Overall Study|Other|5|||
162010546|NCT01709084|585095904|FG001|Overall Study|Other|3|||
162010547|NCT01709084|585095903|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
162010548|NCT01709084|585095904|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
162010549|NCT01709084|585095903|FG000|Overall Study|Not Treated|0|||
162010550|NCT01709084|585095904|FG001|Overall Study|Not Treated|2|||
162010551|NCT00214201|585095905|FG000|Overall Study|Withdrawal by Subject|2|||
162010552|NCT00214201|585095906|FG001|Overall Study|Withdrawal by Subject|0|||
162010553|NCT00214201|585095905|FG000|Overall Study|Death|0|||
162010554|NCT00214201|585095906|FG001|Overall Study|Death|2|||
162010555|NCT00463567|585095910|FG000|Overall Study|Adverse Event|29|||
162010556|NCT00463567|585095911|FG001|Overall Study|Adverse Event|26|||
162010557|NCT00463567|585095912|FG002|Overall Study|Adverse Event|17|||
162010558|NCT00463567|585095913|FG003|Overall Study|Adverse Event|46|||
162010559|NCT00463567|585095914|FG004|Overall Study|Adverse Event|10|||
162127017|NCT04285229|585515366|FG004|Follow-up Period|Adverse Event|1|||
162127018|NCT04285229|585515367|FG005|Follow-up Period|Adverse Event|4|||
162127019|NCT04285229|585515362|FG000|Follow-up Period|Withdrawal by Subject|0|||
162127020|NCT04285229|585515363|FG001|Follow-up Period|Withdrawal by Subject|0|||
162010560|NCT00463567|585095915|FG005|Overall Study|Adverse Event|10|||
162010561|NCT00463567|585095916|FG006|Overall Study|Adverse Event|4|||
162010562|NCT00463567|585095910|FG000|Overall Study|Withdrawal by Subject|29|||
162010563|NCT00463567|585095911|FG001|Overall Study|Withdrawal by Subject|22|||
162010564|NCT00463567|585095912|FG002|Overall Study|Withdrawal by Subject|20|||
162127021|NCT04285229|585515364|FG002|Follow-up Period|Withdrawal by Subject|0|||
162127022|NCT04285229|585515365|FG003|Follow-up Period|Withdrawal by Subject|0|||
162127023|NCT04285229|585515366|FG004|Follow-up Period|Withdrawal by Subject|0|||
162127024|NCT04285229|585515367|FG005|Follow-up Period|Withdrawal by Subject|5|||
162127025|NCT04285229|585515362|FG000|Follow-up Period|Covid-19|0|||
162127026|NCT04285229|585515363|FG001|Follow-up Period|Covid-19|0|||
162127027|NCT04285229|585515364|FG002|Follow-up Period|Covid-19|0|||
162127028|NCT04285229|585515365|FG003|Follow-up Period|Covid-19|0|||
162127029|NCT04285229|585515366|FG004|Follow-up Period|Covid-19|0|||
162127030|NCT04285229|585515367|FG005|Follow-up Period|Covid-19|2|||
162127031|NCT04285229|585515362|FG000|Follow-up Period|Physician Decision|0|||
162127032|NCT04285229|585515363|FG001|Follow-up Period|Physician Decision|0|||
162127033|NCT04285229|585515364|FG002|Follow-up Period|Physician Decision|0|||
162127034|NCT04285229|585515365|FG003|Follow-up Period|Physician Decision|0|||
162127035|NCT04285229|585515366|FG004|Follow-up Period|Physician Decision|0|||
162127036|NCT04285229|585515367|FG005|Follow-up Period|Physician Decision|1|||
162127037|NCT00514046|585515374|FG000|Overall Study|transferred to another protocol|2|||
162127038|NCT00514046|585515375|FG001|Overall Study|transferred to another protocol|1|||
162127039|NCT00514046|585515376|FG002|Overall Study|transferred to another protocol|3|||
162127040|NCT00514046|585515377|FG003|Overall Study|transferred to another protocol|0|||
162127041|NCT00514046|585515378|FG004|Overall Study|transferred to another protocol|1|||
162127042|NCT00514046|585515379|FG005|Overall Study|transferred to another protocol|0|||
162127043|NCT00514046|585515380|FG006|Overall Study|transferred to another protocol|0|||
162127044|NCT00514046|585515381|FG007|Overall Study|transferred to another protocol|0|||
162127045|NCT00514046|585515382|FG008|Overall Study|transferred to another protocol|0|||
162127046|NCT00514046|585515374|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
162127047|NCT00514046|585515375|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
162127048|NCT00514046|585515376|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
162127049|NCT00514046|585515377|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
162127050|NCT00514046|585515378|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
162127051|NCT00514046|585515379|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
162127052|NCT00514046|585515380|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
162127053|NCT00514046|585515381|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
162127054|NCT00514046|585515382|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
162127055|NCT00514046|585515374|FG000|Overall Study|Disease progression on study|0|||
162127056|NCT00514046|585515375|FG001|Overall Study|Disease progression on study|0|||
162127057|NCT00514046|585515376|FG002|Overall Study|Disease progression on study|2|||
162127058|NCT00514046|585515377|FG003|Overall Study|Disease progression on study|0|||
162127059|NCT00514046|585515378|FG004|Overall Study|Disease progression on study|0|||
162127060|NCT00514046|585515379|FG005|Overall Study|Disease progression on study|1|||
162127061|NCT00514046|585515380|FG006|Overall Study|Disease progression on study|0|||
162127062|NCT00514046|585515381|FG007|Overall Study|Disease progression on study|0|||
162127063|NCT00514046|585515382|FG008|Overall Study|Disease progression on study|0|||
162127064|NCT00876460|585515383|FG000|Combination Therapy Phase|Progressive disease|2|||
162127065|NCT00876460|585515384|FG001|Combination Therapy Phase|Progressive disease|3|||
162127066|NCT00876460|585515385|FG002|Combination Therapy Phase|Progressive disease|3|||
162127067|NCT00876460|585515386|FG003|Combination Therapy Phase|Progressive disease|3|||
162127068|NCT00876460|585515387|FG004|Combination Therapy Phase|Progressive disease|3|||
162127069|NCT00876460|585515388|FG005|Combination Therapy Phase|Progressive disease|1|||
162127070|NCT00876460|585515389|FG006|Combination Therapy Phase|Progressive disease|1|||
162127071|NCT00876460|585515390|FG007|Combination Therapy Phase|Progressive disease|1|||
162127072|NCT00876460|585515383|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
162127073|NCT00876460|585515384|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
162127074|NCT00876460|585515385|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
162127075|NCT00876460|585515386|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
162127076|NCT00876460|585515387|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
162127077|NCT00876460|585515388|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
162127078|NCT00876460|585515389|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
162127079|NCT00876460|585515390|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
162127080|NCT00876460|585515383|FG000|Combination Therapy Phase|Adverse Event|0|||
162127081|NCT00876460|585515384|FG001|Combination Therapy Phase|Adverse Event|2|||
162127082|NCT00876460|585515385|FG002|Combination Therapy Phase|Adverse Event|0|||
162127083|NCT00876460|585515386|FG003|Combination Therapy Phase|Adverse Event|2|||
162127084|NCT00876460|585515387|FG004|Combination Therapy Phase|Adverse Event|2|||
162127085|NCT00876460|585515388|FG005|Combination Therapy Phase|Adverse Event|0|||
162127086|NCT00876460|585515389|FG006|Combination Therapy Phase|Adverse Event|3|||
162127087|NCT00876460|585515390|FG007|Combination Therapy Phase|Adverse Event|2|||
162127088|NCT00876460|585515383|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
162127089|NCT00876460|585515384|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
162127090|NCT00876460|585515385|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
162127091|NCT00876460|585515386|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
162127092|NCT00876460|585515387|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
162127093|NCT00876460|585515388|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
162127094|NCT00876460|585515389|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
162127095|NCT00876460|585515390|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
162127096|NCT00876460|585515383|FG000|Combination Therapy Phase|Other reason not defined above|0|||
162127097|NCT00876460|585515384|FG001|Combination Therapy Phase|Other reason not defined above|0|||
162127098|NCT00876460|585515385|FG002|Combination Therapy Phase|Other reason not defined above|0|||
162127099|NCT00876460|585515386|FG003|Combination Therapy Phase|Other reason not defined above|0|||
162127100|NCT00876460|585515387|FG004|Combination Therapy Phase|Other reason not defined above|0|||
162127101|NCT00876460|585515388|FG005|Combination Therapy Phase|Other reason not defined above|0|||
162127102|NCT00876460|585515389|FG006|Combination Therapy Phase|Other reason not defined above|1|||
162127103|NCT00876460|585515390|FG007|Combination Therapy Phase|Other reason not defined above|2|||
162127104|NCT00876460|585515383|FG000|Combination Therapy Phase|Not treated|0|||
162127105|NCT00876460|585515384|FG001|Combination Therapy Phase|Not treated|0|||
162127106|NCT00876460|585515385|FG002|Combination Therapy Phase|Not treated|0|||
162127107|NCT00876460|585515386|FG003|Combination Therapy Phase|Not treated|0|||
162127108|NCT00876460|585515387|FG004|Combination Therapy Phase|Not treated|0|||
162127109|NCT00876460|585515388|FG005|Combination Therapy Phase|Not treated|0|||
162127110|NCT00876460|585515389|FG006|Combination Therapy Phase|Not treated|1|||
162127111|NCT00876460|585515390|FG007|Combination Therapy Phase|Not treated|0|||
162127112|NCT00876460|585515383|FG000|Mono Therapy Phase|Progressive disease|0|||
162127113|NCT00876460|585515384|FG001|Mono Therapy Phase|Progressive disease|0|||
162127114|NCT00876460|585515385|FG002|Mono Therapy Phase|Progressive disease|0|||
162127115|NCT00876460|585515386|FG003|Mono Therapy Phase|Progressive disease|0|||
162127116|NCT00876460|585515387|FG004|Mono Therapy Phase|Progressive disease|2|||
162127117|NCT00876460|585515388|FG005|Mono Therapy Phase|Progressive disease|0|||
162127118|NCT00876460|585515389|FG006|Mono Therapy Phase|Progressive disease|1|||
161789371|NCT00449930|584272834|FG001|Overall Study|Glycemic discontinuation criteria|1|||
161789372|NCT00575328|584272836|FG000|Overall Study|Adverse Event|1|||
161789373|NCT00575328|584272837|FG001|Overall Study|Adverse Event|1|||
161789374|NCT00575328|584272836|FG000|Overall Study|Lost to Follow-up|2|||
162127119|NCT00876460|585515390|FG007|Mono Therapy Phase|Progressive disease|3|||
162127120|NCT00876460|585515383|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
162127121|NCT00876460|585515384|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
162127122|NCT00876460|585515385|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
162127123|NCT00876460|585515386|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
162127124|NCT00876460|585515387|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
162127125|NCT00876460|585515388|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
162127126|NCT00876460|585515389|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
162127127|NCT00876460|585515390|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
162127128|NCT00876460|585515383|FG000|Mono Therapy Phase|Adverse Event|0|||
162127129|NCT00876460|585515384|FG001|Mono Therapy Phase|Adverse Event|0|||
162127130|NCT00876460|585515385|FG002|Mono Therapy Phase|Adverse Event|0|||
162127131|NCT00876460|585515386|FG003|Mono Therapy Phase|Adverse Event|1|||
162127132|NCT00876460|585515387|FG004|Mono Therapy Phase|Adverse Event|0|||
162127133|NCT00876460|585515388|FG005|Mono Therapy Phase|Adverse Event|0|||
162127134|NCT00876460|585515389|FG006|Mono Therapy Phase|Adverse Event|0|||
162127135|NCT00876460|585515390|FG007|Mono Therapy Phase|Adverse Event|0|||
162127136|NCT00383240|585515395|FG000|Overall Study|Adverse Event|4|||
162127137|NCT00383240|585515396|FG001|Overall Study|Adverse Event|6|||
162127138|NCT00383240|585515397|FG002|Overall Study|Adverse Event|9|||
162127139|NCT00383240|585515398|FG003|Overall Study|Adverse Event|7|||
162127140|NCT00383240|585515395|FG000|Overall Study|Treatment Failure|8|||
162127141|NCT00383240|585515396|FG001|Overall Study|Treatment Failure|13|||
162127142|NCT00383240|585515397|FG002|Overall Study|Treatment Failure|47|||
162127143|NCT00383240|585515398|FG003|Overall Study|Treatment Failure|46|||
162127144|NCT00383240|585515395|FG000|Overall Study|Lost to Follow-up|3|||
162127145|NCT00383240|585515396|FG001|Overall Study|Lost to Follow-up|0|||
162127146|NCT00383240|585515397|FG002|Overall Study|Lost to Follow-up|0|||
162127147|NCT00383240|585515398|FG003|Overall Study|Lost to Follow-up|2|||
162127148|NCT00383240|585515395|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
162127149|NCT00383240|585515396|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
162127150|NCT00383240|585515397|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
162127151|NCT00383240|585515398|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
162127152|NCT00383240|585515395|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
162127153|NCT00383240|585515396|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
162127154|NCT00383240|585515397|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
162127155|NCT00383240|585515398|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
162127156|NCT00383240|585515395|FG000|Overall Study|Protocol Violation|4|||
161789375|NCT00575328|584272837|FG001|Overall Study|Lost to Follow-up|1|||
162127157|NCT00383240|585515396|FG001|Overall Study|Protocol Violation|5|||
162127158|NCT00383240|585515397|FG002|Overall Study|Protocol Violation|9|||
162127159|NCT00383240|585515398|FG003|Overall Study|Protocol Violation|6|||
162127160|NCT00383240|585515395|FG000|Overall Study|Did not meet protocol eligibility|9|||
162127161|NCT00383240|585515396|FG001|Overall Study|Did not meet protocol eligibility|4|||
162127162|NCT00383240|585515397|FG002|Overall Study|Did not meet protocol eligibility|9|||
162127163|NCT00383240|585515398|FG003|Overall Study|Did not meet protocol eligibility|3|||
162127164|NCT00383240|585515395|FG000|Overall Study|Administrative|1|||
162127165|NCT00383240|585515396|FG001|Overall Study|Administrative|1|||
162127166|NCT00383240|585515397|FG002|Overall Study|Administrative|0|||
162127167|NCT00383240|585515398|FG003|Overall Study|Administrative|0|||
162127168|NCT02049710|585515399|FG000|Overall Study|Lost to Follow-up|319|||
162127169|NCT02049710|585515400|FG001|Overall Study|Lost to Follow-up|324|||
162127170|NCT00003458|585515401|FG000|Overall Study|Not evaluable|4|||
162127171|NCT06385483|585515405|FG000|Overall Study|Withdrawal by Subject|2|||
162127172|NCT06385483|585515405|FG000|Overall Study|Never start protocol therapy|2|||
162127173|NCT06385483|585515405|FG000|Overall Study|Disease progression|15|||
162127174|NCT01216293|585515406|FG000|Main Study|Adverse Event|1|||
162127175|NCT01216293|585515407|FG001|Main Study|Adverse Event|4|||
162127176|NCT01216293|585515408|FG002|Main Study|Adverse Event|2|||
162127177|NCT01216293|585515406|FG000|Main Study|Major Protocol Deviation|1|||
162127178|NCT01216293|585515407|FG001|Main Study|Major Protocol Deviation|0|||
162127179|NCT01216293|585515408|FG002|Main Study|Major Protocol Deviation|1|||
162127180|NCT01216293|585515406|FG000|Main Study|Lost to Follow-up|3|||
162127181|NCT01216293|585515407|FG001|Main Study|Lost to Follow-up|1|||
162127182|NCT01216293|585515408|FG002|Main Study|Lost to Follow-up|0|||
162127183|NCT01216293|585515406|FG000|Main Study|Voluntary Withdrawal|2|||
162127184|NCT01216293|585515407|FG001|Main Study|Voluntary Withdrawal|2|||
162127185|NCT01216293|585515408|FG002|Main Study|Voluntary Withdrawal|2|||
162127186|NCT01216293|585515406|FG000|Main Study|Other Reason Not Specified|0|||
162127187|NCT01216293|585515407|FG001|Main Study|Other Reason Not Specified|1|||
162127188|NCT01216293|585515408|FG002|Main Study|Other Reason Not Specified|1|||
162127189|NCT01216293|585515406|FG000|Main Study|Randomized, Not Treated|1|||
162127190|NCT01216293|585515407|FG001|Main Study|Randomized, Not Treated|0|||
162127191|NCT01216293|585515408|FG002|Main Study|Randomized, Not Treated|0|||
162127192|NCT01216293|585515406|FG000|Calcium Absorption Substudy|Adverse Event|0|||
162127193|NCT01216293|585515407|FG001|Calcium Absorption Substudy|Adverse Event|2|||
162127194|NCT01216293|585515408|FG002|Calcium Absorption Substudy|Adverse Event|0|||
162127195|NCT01216293|585515406|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
162127196|NCT01216293|585515407|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
162127197|NCT01216293|585515408|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
162127198|NCT01216293|585515406|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
162127199|NCT01216293|585515407|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
162127200|NCT01216293|585515408|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
162127201|NCT04714216|585517088|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
162127202|NCT04714216|585517088|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
162127203|NCT01349829|585517089|FG000|Overall Study|Lost to Follow-up|4|||
162127204|NCT01349829|585517090|FG001|Overall Study|Lost to Follow-up|8|||
162127205|NCT01349829|585517089|FG000|Overall Study|Consent withdrawal|3|||
162127206|NCT01349829|585517090|FG001|Overall Study|Consent withdrawal|8|||
162127207|NCT01349829|585517089|FG000|Overall Study|Migrated/moved|2|||
162127208|NCT01349829|585517090|FG001|Overall Study|Migrated/moved|7|||
162127209|NCT02555371|585517091|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
162127210|NCT02555371|585517092|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
162127211|NCT02555371|585517093|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
162127212|NCT02555371|585517094|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
162127213|NCT02555371|585517095|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
162127214|NCT02555371|585517091|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
162127215|NCT02555371|585517092|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
162127216|NCT02555371|585517093|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
162127217|NCT02555371|585517094|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
162127218|NCT02555371|585517095|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
162127219|NCT02555371|585517091|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
162127220|NCT02555371|585517092|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
162127221|NCT02555371|585517093|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
162127222|NCT02555371|585517094|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
162127223|NCT02555371|585517095|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
162127224|NCT02555371|585517091|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
162127225|NCT02555371|585517092|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
162127226|NCT02555371|585517093|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
162127227|NCT02555371|585517094|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
162127228|NCT02555371|585517095|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
162127229|NCT02555371|585517091|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
162127230|NCT02555371|585517092|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
162127231|NCT02555371|585517093|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
162127232|NCT02555371|585517094|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
162127233|NCT02555371|585517095|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
162127234|NCT02555371|585517091|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
162127235|NCT02555371|585517092|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
162127236|NCT02555371|585517093|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
162127237|NCT02555371|585517094|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
162127238|NCT02555371|585517095|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
162127239|NCT02555371|585517091|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
162127240|NCT02555371|585517092|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
162127241|NCT02555371|585517093|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
162127242|NCT02555371|585517094|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
162127243|NCT02555371|585517095|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
162127244|NCT02555371|585517091|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
162127245|NCT02555371|585517092|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
162127246|NCT02555371|585517093|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
162127247|NCT02555371|585517094|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
162127248|NCT02555371|585517095|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
162127249|NCT02555371|585517091|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
162127250|NCT02555371|585517092|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
162127251|NCT02555371|585517093|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
162127252|NCT02555371|585517094|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
162127253|NCT02555371|585517095|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
162127254|NCT02555371|585517091|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
162127255|NCT02555371|585517092|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
162127256|NCT02555371|585517093|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
162127257|NCT02555371|585517094|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
162127258|NCT02555371|585517095|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
162127259|NCT02555371|585517091|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
162127260|NCT02555371|585517092|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
162127261|NCT02555371|585517093|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
162127262|NCT02555371|585517094|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
162127263|NCT02555371|585517095|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
162127264|NCT02555371|585517091|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
162127265|NCT02555371|585517092|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
162127266|NCT02555371|585517093|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
162127267|NCT02555371|585517094|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
162127268|NCT02555371|585517095|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
162127269|NCT02555371|585517091|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
162127270|NCT02555371|585517092|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
162127271|NCT02555371|585517093|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
162127272|NCT02555371|585517094|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
162127273|NCT02555371|585517095|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
162127274|NCT02555371|585517091|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
162127275|NCT02555371|585517092|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
162127276|NCT02555371|585517093|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
162127277|NCT02555371|585517094|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
162127278|NCT02555371|585517095|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
162127279|NCT03095599|585517096|FG000|Overall Study|Withdrawal by Subject|1|||
162127280|NCT03095599|585517097|FG001|Overall Study|Withdrawal by Subject|0|||
162127281|NCT03095599|585517096|FG000|Overall Study|Lost to Follow-up|1|||
162127282|NCT03095599|585517097|FG001|Overall Study|Lost to Follow-up|0|||
162127283|NCT03095599|585517096|FG000|Overall Study|Withdrawal prior to vaccination|1|||
162127284|NCT03095599|585517097|FG001|Overall Study|Withdrawal prior to vaccination|0|||
162127285|NCT00742885|585517098|FG000|Overall Study|Lost to Follow-up|1|||
162127286|NCT00742885|585517099|FG001|Overall Study|Lost to Follow-up|0|||
162127287|NCT03615482|585517102|FG000|Overall Study|Death|1|||
162127288|NCT03615482|585517103|FG001|Overall Study|Death|0|||
162127289|NCT03615482|585517102|FG000|Overall Study|Lost to Follow-up|7|||
162127290|NCT03615482|585517103|FG001|Overall Study|Lost to Follow-up|7|||
162127291|NCT03615482|585517102|FG000|Overall Study|Physician Decision|2|||
162127292|NCT03615482|585517103|FG001|Overall Study|Physician Decision|3|||
162127293|NCT03615482|585517102|FG000|Overall Study|Withdrawal by Subject|7|||
162127294|NCT03615482|585517103|FG001|Overall Study|Withdrawal by Subject|7|||
162127295|NCT00163215|585517108|FG000|Overall Study|Lack of Efficacy|3|||
162127296|NCT00163215|585517108|FG000|Overall Study|Withdrawal by Subject|5|||
162127297|NCT00163215|585517108|FG000|Overall Study|Other|7|||
162127298|NCT01950273|585517119|FG000|Overall Study|Protocol Violation|1|||
162127299|NCT01950273|585517120|FG001|Overall Study|Protocol Violation|0|||
162127300|NCT01950273|585517119|FG000|Overall Study|Withdrawal by Subject|2|||
162127301|NCT01950273|585517120|FG001|Overall Study|Withdrawal by Subject|0|||
162127302|NCT01950273|585517119|FG000|Overall Study|Other not defined above|1|||
162127303|NCT01950273|585517120|FG001|Overall Study|Other not defined above|0|||
162127304|NCT04430335|585517123|FG000|Overall Study|Withdrawal by Subject|1|||
162127305|NCT00179010|585517126|FG000|Overall Study|Muscle probe defective|1|||
162127306|NCT00179010|585517127|FG001|Overall Study|Muscle probe defective|1|||
162127307|NCT00179010|585517126|FG000|Overall Study|Failure to place arterial line|0|||
162127308|NCT00179010|585517127|FG001|Overall Study|Failure to place arterial line|1|||
162127309|NCT03249376|585517142|FG000|Overall Study|Adverse Event|11|||
162127310|NCT03249376|585517143|FG001|Overall Study|Adverse Event|5|||
162127311|NCT03249376|585517142|FG000|Overall Study|Lack of Efficacy|2|||
162127312|NCT03249376|585517143|FG001|Overall Study|Lack of Efficacy|4|||
162127313|NCT03249376|585517142|FG000|Overall Study|Protocol Violation|3|||
162127314|NCT03249376|585517143|FG001|Overall Study|Protocol Violation|2|||
162127315|NCT03249376|585517142|FG000|Overall Study|Physician Decision|0|||
162127316|NCT03249376|585517143|FG001|Overall Study|Physician Decision|2|||
162127317|NCT03249376|585517142|FG000|Overall Study|Withdrawal by Subject|3|||
162127318|NCT03249376|585517143|FG001|Overall Study|Withdrawal by Subject|9|||
162127319|NCT03249376|585517142|FG000|Overall Study|LTFU|2|||
162127320|NCT03249376|585517143|FG001|Overall Study|LTFU|1|||
162127321|NCT00627042|585517147|FG000|Overall Study|Withdrawal by Subject|2|||
162127322|NCT00794820|585517155|FG000|Overall Study|Adverse Event|11|||
162127323|NCT00794820|585517155|FG000|Overall Study|Secondary Malignancies|2|||
162127324|NCT00794820|585517155|FG000|Overall Study|Resistant Disease|2|||
162127325|NCT00794820|585517155|FG000|Overall Study|Ineligible/Screen Failure|1|||
162127326|NCT00432679|585517159|FG000|Overall Study|Adverse Event|2|||
162127327|NCT00432679|585517160|FG001|Overall Study|Adverse Event|1|||
162127328|NCT00432679|585517159|FG000|Overall Study|Withdrawal by Subject|3|||
162127329|NCT00432679|585517160|FG001|Overall Study|Withdrawal by Subject|2|||
162127330|NCT03405662|585517162|FG000|Overall Study|COVID-19 restriction|1|||
162127331|NCT03405662|585517163|FG001|Overall Study|COVID-19 restriction|0|||
162127332|NCT03405662|585517162|FG000|Overall Study|unblinding|0|||
162127333|NCT03405662|585517163|FG001|Overall Study|unblinding|1|||
162127334|NCT03405662|585517162|FG000|Overall Study|placement in memory care facility|0|||
162127335|NCT03405662|585517163|FG001|Overall Study|placement in memory care facility|2|||
162127336|NCT00280293|585517164|FG000|Overall Study|Protocol Violation|3|||
162127337|NCT00280293|585517165|FG001|Overall Study|Protocol Violation|0|||
162127338|NCT00280293|585517164|FG000|Overall Study|Physician Decision|5|||
162127339|NCT00280293|585517165|FG001|Overall Study|Physician Decision|4|||
162127340|NCT00280293|585517164|FG000|Overall Study|Lost to Follow-up|14|||
162127341|NCT00280293|585517165|FG001|Overall Study|Lost to Follow-up|12|||
162127342|NCT00280293|585517164|FG000|Overall Study|Withdrawal by Subject|3|||
162127343|NCT00280293|585517165|FG001|Overall Study|Withdrawal by Subject|5|||
162127344|NCT00280293|585517164|FG000|Overall Study|Incarceration/Legal Reasons|1|||
162127345|NCT00280293|585517165|FG001|Overall Study|Incarceration/Legal Reasons|1|||
162127346|NCT00280293|585517164|FG000|Overall Study|Adverse Event|0|||
162127347|NCT00280293|585517165|FG001|Overall Study|Adverse Event|1|||
162127348|NCT01177813|585517166|FG000|Overall Study|Adverse Event|8|||
162127349|NCT01177813|585517167|FG001|Overall Study|Adverse Event|2|||
162127350|NCT01177813|585517168|FG002|Overall Study|Adverse Event|4|||
162127351|NCT01177813|585517169|FG003|Overall Study|Adverse Event|6|||
162127352|NCT01177813|585517170|FG004|Overall Study|Adverse Event|3|||
162127353|NCT01177813|585517166|FG000|Overall Study|Lack of Efficacy|1|||
162127354|NCT01177813|585517167|FG001|Overall Study|Lack of Efficacy|0|||
162127355|NCT01177813|585517168|FG002|Overall Study|Lack of Efficacy|0|||
162127356|NCT01177813|585517169|FG003|Overall Study|Lack of Efficacy|0|||
162127357|NCT01177813|585517170|FG004|Overall Study|Lack of Efficacy|0|||
162127358|NCT01177813|585517166|FG000|Overall Study|Protocol Violation|3|||
162127359|NCT01177813|585517167|FG001|Overall Study|Protocol Violation|2|||
162127360|NCT01177813|585517168|FG002|Overall Study|Protocol Violation|2|||
162127361|NCT01177813|585517169|FG003|Overall Study|Protocol Violation|0|||
162127362|NCT01177813|585517170|FG004|Overall Study|Protocol Violation|1|||
162127363|NCT01177813|585517166|FG000|Overall Study|Lost to Follow-up|12|||
162127364|NCT01177813|585517167|FG001|Overall Study|Lost to Follow-up|5|||
162127365|NCT01177813|585517168|FG002|Overall Study|Lost to Follow-up|6|||
162127366|NCT01177813|585517169|FG003|Overall Study|Lost to Follow-up|3|||
162127367|NCT01177813|585517170|FG004|Overall Study|Lost to Follow-up|0|||
162127368|NCT01177813|585517166|FG000|Overall Study|Withdrawal by Subject|12|||
162127369|NCT01177813|585517167|FG001|Overall Study|Withdrawal by Subject|7|||
162127370|NCT01177813|585517168|FG002|Overall Study|Withdrawal by Subject|6|||
162127371|NCT01177813|585517169|FG003|Overall Study|Withdrawal by Subject|5|||
162127372|NCT01177813|585517170|FG004|Overall Study|Withdrawal by Subject|3|||
162127373|NCT01177813|585517166|FG000|Overall Study|Other reason not defined above|5|||
162127374|NCT01177813|585517167|FG001|Overall Study|Other reason not defined above|2|||
162127375|NCT01177813|585517168|FG002|Overall Study|Other reason not defined above|2|||
162127376|NCT01177813|585517169|FG003|Overall Study|Other reason not defined above|3|||
162127377|NCT01177813|585517170|FG004|Overall Study|Other reason not defined above|2|||
162127378|NCT01458249|585517173|FG000|Overall Study|Not treated|1|||
162127379|NCT01458249|585517173|FG000|Overall Study|Adverse Event|4|||
162127380|NCT01458249|585517173|FG000|Overall Study|Other|2|||
162127381|NCT01458249|585517173|FG000|Overall Study|Ongoing|1|||
162127382|NCT02056119|585517176|FG000|Overall Study|Death|1|||
162127383|NCT02056119|585517177|FG001|Overall Study|Death|2|||
162127384|NCT02056119|585517176|FG000|Overall Study|Intubated for less than 24 hrs|2|||
162127385|NCT02056119|585517177|FG001|Overall Study|Intubated for less than 24 hrs|7|||
162127386|NCT02056119|585517176|FG000|Overall Study|No aerosol treatments were given.|3|||
162127387|NCT02056119|585517177|FG001|Overall Study|No aerosol treatments were given.|2|||
162127388|NCT02056119|585517176|FG000|Overall Study|Received Metaneb treatment|0|||
162127389|NCT02056119|585517177|FG001|Overall Study|Received Metaneb treatment|2|||
162127390|NCT02056119|585517176|FG000|Overall Study|Protocol Violation|4|||
162127391|NCT02056119|585517177|FG001|Overall Study|Protocol Violation|7|||
162127392|NCT01348854|585517178|FG000|Overall Study|Lost to Follow-up|2|||
162127393|NCT01348854|585517179|FG001|Overall Study|Lost to Follow-up|1|||
162127394|NCT01348854|585517178|FG000|Overall Study|Withdrawal by Subject|1|||
162127395|NCT01348854|585517179|FG001|Overall Study|Withdrawal by Subject|0|||
162127396|NCT03220737|585517180|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
162127397|NCT03220737|585517181|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
162127398|NCT03220737|585517182|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
162127399|NCT03220737|585517183|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
162127400|NCT03220737|585517184|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
162127401|NCT03220737|585517185|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
162127402|NCT03220737|585517186|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
162127403|NCT03220737|585517180|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
162127404|NCT03220737|585517181|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
162127405|NCT03220737|585517182|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
162127406|NCT03220737|585517183|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
162127407|NCT03220737|585517184|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
162127408|NCT03220737|585517185|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
162127409|NCT03220737|585517186|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
162127410|NCT03220737|585517180|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
162127411|NCT03220737|585517181|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
162127412|NCT03220737|585517182|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
162127413|NCT03220737|585517183|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
162127414|NCT03220737|585517184|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
162127415|NCT03220737|585517185|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
162127416|NCT03220737|585517186|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
162127417|NCT03220737|585517180|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
162127418|NCT03220737|585517181|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
162127419|NCT03220737|585517182|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
162127420|NCT03220737|585517183|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
162127421|NCT03220737|585517184|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
162127422|NCT03220737|585517185|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
162127423|NCT03220737|585517186|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
162127424|NCT03220737|585517180|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
162127425|NCT03220737|585517181|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
162127426|NCT03220737|585517182|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
162127427|NCT03220737|585517183|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
162127428|NCT03220737|585517184|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
162127429|NCT03220737|585517185|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
162127430|NCT03220737|585517186|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
162127431|NCT03220737|585517180|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
162127432|NCT03220737|585517181|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
162127433|NCT03220737|585517182|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
162127434|NCT03220737|585517183|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
162127435|NCT03220737|585517184|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
162127436|NCT03220737|585517185|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
162127437|NCT03220737|585517186|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
162127438|NCT03220737|585517180|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
162127439|NCT03220737|585517181|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
162127440|NCT03220737|585517182|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
162127441|NCT03220737|585517183|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
162127442|NCT03220737|585517184|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
162127443|NCT03220737|585517185|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
162127444|NCT03220737|585517186|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
162127445|NCT03220737|585517180|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
162127446|NCT03220737|585517181|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
162127447|NCT03220737|585517182|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
162127448|NCT03220737|585517183|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
162127449|NCT03220737|585517184|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
161898640|NCT02915159|584677859|FG001|Overall Study|Participant no longer meets criteria|0|||
161898641|NCT02915159|584677858|FG000|Overall Study|poor/non-compliance|1|||
161898642|NCT02915159|584677859|FG001|Overall Study|poor/non-compliance|0|||
161898643|NCT02915159|584677858|FG000|Overall Study|Participant withdrew consent|5|||
162010565|NCT00463567|585095913|FG003|Overall Study|Withdrawal by Subject|37|||
162010566|NCT00463567|585095914|FG004|Overall Study|Withdrawal by Subject|6|||
162010567|NCT00463567|585095915|FG005|Overall Study|Withdrawal by Subject|5|||
162010568|NCT00463567|585095916|FG006|Overall Study|Withdrawal by Subject|1|||
162010569|NCT00463567|585095910|FG000|Overall Study|Protocol Deviation|13|||
162010570|NCT00463567|585095911|FG001|Overall Study|Protocol Deviation|9|||
162010571|NCT00463567|585095912|FG002|Overall Study|Protocol Deviation|14|||
162010572|NCT00463567|585095913|FG003|Overall Study|Protocol Deviation|11|||
162010573|NCT00463567|585095914|FG004|Overall Study|Protocol Deviation|1|||
162010574|NCT00463567|585095915|FG005|Overall Study|Protocol Deviation|1|||
162010575|NCT00463567|585095916|FG006|Overall Study|Protocol Deviation|2|||
162010576|NCT00463567|585095910|FG000|Overall Study|Lost to Follow-up|12|||
162010577|NCT00463567|585095911|FG001|Overall Study|Lost to Follow-up|6|||
162010578|NCT00463567|585095912|FG002|Overall Study|Lost to Follow-up|13|||
162010579|NCT00463567|585095913|FG003|Overall Study|Lost to Follow-up|8|||
162010580|NCT00463567|585095914|FG004|Overall Study|Lost to Follow-up|1|||
162010581|NCT00463567|585095915|FG005|Overall Study|Lost to Follow-up|1|||
162010582|NCT00463567|585095916|FG006|Overall Study|Lost to Follow-up|1|||
162010583|NCT00463567|585095910|FG000|Overall Study|Administrative problems|5|||
162010584|NCT00463567|585095911|FG001|Overall Study|Administrative problems|3|||
162010585|NCT00463567|585095912|FG002|Overall Study|Administrative problems|6|||
162010586|NCT00463567|585095913|FG003|Overall Study|Administrative problems|9|||
162010587|NCT00463567|585095914|FG004|Overall Study|Administrative problems|3|||
161898644|NCT02915159|584677859|FG001|Overall Study|Participant withdrew consent|1|||
161898645|NCT02915159|584677858|FG000|Overall Study|Request to discontinue treatment|1|||
161898646|NCT02915159|584677859|FG001|Overall Study|Request to discontinue treatment|2|||
161898647|NCT02915159|584677858|FG000|Overall Study|Adverse Event|2|||
161898648|NCT02915159|584677859|FG001|Overall Study|Adverse Event|2|||
161898649|NCT02915159|584677858|FG000|Overall Study|Lack of Efficacy|0|||
161898650|NCT02915159|584677859|FG001|Overall Study|Lack of Efficacy|3|||
161898651|NCT00856999|584677860|FG000|Overall Study|Withdrawal by Subject|5|||
161898652|NCT00003483|584677861|FG000|Overall Study|Not evaluable|1|||
161898653|NCT01308463|584677862|FG000|Overall Study|Study Discontinued|23|||
161898654|NCT01308463|584677862|FG000|Overall Study|Death|4|||
161898655|NCT01308463|584677862|FG000|Overall Study|Revision|2|||
161898656|NCT00103662|584677863|FG000|Overall Study|Entered Rescue Procedure|0|||
161898657|NCT00103662|584677864|FG001|Overall Study|Entered Rescue Procedure|7|||
161898658|NCT00103662|584677863|FG000|Overall Study|Death|7|||
161898659|NCT00103662|584677864|FG001|Overall Study|Death|7|||
161898660|NCT00103662|584677863|FG000|Overall Study|Elective Withdrawal|5|||
161898661|NCT00103662|584677864|FG001|Overall Study|Elective Withdrawal|5|||
161898662|NCT00103662|584677863|FG000|Overall Study|Lost to Follow-up|0|||
161898663|NCT00103662|584677864|FG001|Overall Study|Lost to Follow-up|1|||
161898664|NCT00103662|584677863|FG000|Overall Study|Other|6|||
161898665|NCT00103662|584677864|FG001|Overall Study|Other|9|||
161898666|NCT00103662|584677863|FG000|Overall Study|Failed mobilization|0|||
161898667|NCT00103662|584677864|FG001|Overall Study|Failed mobilization|4|||
161898668|NCT00103662|584677863|FG000|Overall Study|Intercurrent illness|1|||
161898669|NCT00103662|584677864|FG001|Overall Study|Intercurrent illness|0|||
161898670|NCT03373760|584677867|FG000|Overall Study|Adverse Event|8|||
161898671|NCT03373760|584677867|FG000|Overall Study|Disease Progression|46|||
161898672|NCT03373760|584677867|FG000|Overall Study|Death|4|||
161898673|NCT00872521|584677878|FG000|Completed PAD Induction|Patient choice|0|||
161898674|NCT00872521|584677879|FG001|Completed PAD Induction|Patient choice|1|||
161898675|NCT00872521|584677880|FG002|Completed PAD Induction|Patient choice|0|||
161898676|NCT00872521|584677878|FG000|Completed PAD Induction|Disease progression|0|||
161898677|NCT00872521|584677879|FG001|Completed PAD Induction|Disease progression|2|||
161898678|NCT00872521|584677880|FG002|Completed PAD Induction|Disease progression|0|||
161898679|NCT00872521|584677878|FG000|Completed PAD Induction|Adverse Event|4|||
161898680|NCT00872521|584677879|FG001|Completed PAD Induction|Adverse Event|0|||
161898681|NCT00872521|584677880|FG002|Completed PAD Induction|Adverse Event|0|||
161898682|NCT00872521|584677878|FG000|Completed PAD Induction|Death|1|||
161898683|NCT00872521|584677879|FG001|Completed PAD Induction|Death|1|||
161898684|NCT00872521|584677880|FG002|Completed PAD Induction|Death|0|||
161898685|NCT00872521|584677878|FG000|Primary Endpoint Analysis|Other|1|||
161898686|NCT00872521|584677879|FG001|Primary Endpoint Analysis|Other|2|||
161898687|NCT00872521|584677880|FG002|Primary Endpoint Analysis|Other|0|||
161898688|NCT00872521|584677878|FG000|Primary Endpoint Analysis|Patient choice|0|||
161898689|NCT00872521|584677879|FG001|Primary Endpoint Analysis|Patient choice|1|||
161898690|NCT00872521|584677880|FG002|Primary Endpoint Analysis|Patient choice|0|||
162010588|NCT00463567|585095915|FG005|Overall Study|Administrative problems|2|||
161898691|NCT00872521|584677878|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
161898692|NCT00872521|584677879|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
161898693|NCT00872521|584677880|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
162127450|NCT03220737|585517185|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
162127451|NCT03220737|585517186|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
162127452|NCT04011384|585517192|FG000|Overall Study|Withdrawal by Subject|2|||
162127453|NCT04011384|585517193|FG001|Overall Study|Withdrawal by Subject|0|||
162127454|NCT04716881|585517194|FG000|Overall Study|Adverse Event|1|||
162127455|NCT04716881|585517194|FG000|Overall Study|Lost to Follow-up|1|||
162127456|NCT04147260|585517197|FG000|Overall Study|Adverse Event|1|||
162127457|NCT04147260|585517198|FG001|Overall Study|Adverse Event|0|||
162127458|NCT04147260|585517199|FG002|Overall Study|Adverse Event|1|||
162127459|NCT04147260|585517200|FG003|Overall Study|Adverse Event|2|||
162127460|NCT04147260|585517201|FG004|Overall Study|Adverse Event|0|||
162127461|NCT04147260|585517197|FG000|Overall Study|Withdrawal by Subject|0|||
162127462|NCT04147260|585517198|FG001|Overall Study|Withdrawal by Subject|0|||
162127463|NCT04147260|585517199|FG002|Overall Study|Withdrawal by Subject|1|||
162127464|NCT04147260|585517200|FG003|Overall Study|Withdrawal by Subject|1|||
162127465|NCT04147260|585517201|FG004|Overall Study|Withdrawal by Subject|0|||
162127466|NCT02207374|585517204|FG000|Overall Study|Withdrawal by Subject|5|||
162127467|NCT02207374|585517205|FG001|Overall Study|Withdrawal by Subject|9|||
162127468|NCT02207374|585517206|FG002|Overall Study|Withdrawal by Subject|4|||
162127469|NCT02207374|585517204|FG000|Overall Study|Death|1|||
162127470|NCT02207374|585517205|FG001|Overall Study|Death|0|||
162127471|NCT02207374|585517206|FG002|Overall Study|Death|1|||
162127472|NCT02207374|585517204|FG000|Overall Study|Missing follow-up information|0|||
162127473|NCT02207374|585517205|FG001|Overall Study|Missing follow-up information|1|||
162127474|NCT02207374|585517206|FG002|Overall Study|Missing follow-up information|1|||
162127475|NCT02087150|585517207|FG000|Overall Study|Death|0|||
162127476|NCT02087150|585517208|FG001|Overall Study|Death|1|||
162127477|NCT02087150|585517209|FG002|Overall Study|Death|0|||
162127478|NCT02087150|585517207|FG000|Overall Study|Lost to Follow-up|6|||
162127479|NCT02087150|585517208|FG001|Overall Study|Lost to Follow-up|13|||
162127480|NCT02087150|585517209|FG002|Overall Study|Lost to Follow-up|7|||
162127481|NCT02087150|585517207|FG000|Overall Study|Withdrawal by Subject|2|||
162127482|NCT02087150|585517208|FG001|Overall Study|Withdrawal by Subject|5|||
162127483|NCT02087150|585517209|FG002|Overall Study|Withdrawal by Subject|3|||
162127484|NCT02087150|585517207|FG000|Overall Study|Physician Decision|0|||
162127485|NCT02087150|585517208|FG001|Overall Study|Physician Decision|1|||
162127486|NCT02087150|585517209|FG002|Overall Study|Physician Decision|0|||
162127487|NCT02087150|585517207|FG000|Overall Study|Procedure not done|1|||
162127488|NCT02087150|585517208|FG001|Overall Study|Procedure not done|13|||
162127489|NCT02087150|585517209|FG002|Overall Study|Procedure not done|0|||
162127490|NCT02087150|585517207|FG000|Overall Study|F/U not completed w/in study window|0|||
162127491|NCT02087150|585517208|FG001|Overall Study|F/U not completed w/in study window|0|||
162127492|NCT02087150|585517209|FG002|Overall Study|F/U not completed w/in study window|1|||
162127493|NCT02087150|585517207|FG000|Overall Study|Other|1|||
162127494|NCT02087150|585517208|FG001|Overall Study|Other|0|||
162127495|NCT02087150|585517209|FG002|Overall Study|Other|0|||
162127496|NCT02087150|585517207|FG000|Overall Study|Pt moved out of town|0|||
162127497|NCT02087150|585517208|FG001|Overall Study|Pt moved out of town|1|||
162127498|NCT02087150|585517209|FG002|Overall Study|Pt moved out of town|0|||
162127499|NCT00785538|585517210|FG000|Treatment Period|Adverse Event|1|||
162127500|NCT00785538|585517211|FG001|Treatment Period|Adverse Event|2|||
162127501|NCT00785538|585517212|FG002|Treatment Period|Adverse Event|2|||
162127502|NCT00785538|585517213|FG003|Treatment Period|Adverse Event|0|||
162127503|NCT00785538|585517210|FG000|Treatment Period|Withdrawal by Subject|0|||
162127504|NCT00785538|585517211|FG001|Treatment Period|Withdrawal by Subject|0|||
162127505|NCT00785538|585517212|FG002|Treatment Period|Withdrawal by Subject|0|||
162127506|NCT00785538|585517213|FG003|Treatment Period|Withdrawal by Subject|1|||
162127507|NCT00683449|585517214|FG000|Overall Study|Lost to Follow-up|0|||
162127508|NCT00683449|585517215|FG001|Overall Study|Lost to Follow-up|1|||
162127509|NCT00683449|585517216|FG002|Overall Study|Lost to Follow-up|0|||
162127510|NCT00683449|585517217|FG003|Overall Study|Lost to Follow-up|0|||
162127511|NCT00683449|585517218|FG004|Overall Study|Lost to Follow-up|0|||
162127512|NCT01000376|585517224|FG000|Cycle 1 Day 1|Adverse Event|1|||
162127513|NCT01000376|585517225|FG001|Cycle 1 Day 1|Adverse Event|0|||
162127514|NCT01000376|585517224|FG000|Cycle 1 Day 1|Progressive Disease|1|||
162127515|NCT01000376|585517225|FG001|Cycle 1 Day 1|Progressive Disease|0|||
162127516|NCT00507026|585517226|FG000|Overall Study|Lack of Efficacy|6|||
162127517|NCT00507026|585517227|FG001|Overall Study|Lack of Efficacy|4|||
162127518|NCT00507026|585517228|FG002|Overall Study|Lack of Efficacy|21|||
162127519|NCT00507026|585517226|FG000|Overall Study|Withdrawal by Subject|2|||
162127520|NCT00507026|585517227|FG001|Overall Study|Withdrawal by Subject|0|||
161789376|NCT02868281|584272838|FG000|Overall Study|Adverse Event|2|||
162127521|NCT00507026|585517228|FG002|Overall Study|Withdrawal by Subject|0|||
162127522|NCT00507026|585517226|FG000|Overall Study|Investigator Decision|1|||
162127523|NCT00507026|585517227|FG001|Overall Study|Investigator Decision|0|||
162127524|NCT00507026|585517228|FG002|Overall Study|Investigator Decision|0|||
162127525|NCT00507026|585517226|FG000|Overall Study|Adverse Event|2|||
161789377|NCT02868281|584272839|FG001|Overall Study|Adverse Event|2|||
162127526|NCT00507026|585517227|FG001|Overall Study|Adverse Event|0|||
162127527|NCT00507026|585517228|FG002|Overall Study|Adverse Event|0|||
162127528|NCT00507026|585517226|FG000|Overall Study|Protocol Violation|1|||
162127529|NCT00507026|585517227|FG001|Overall Study|Protocol Violation|0|||
162127530|NCT00507026|585517228|FG002|Overall Study|Protocol Violation|0|||
162127531|NCT00507026|585517226|FG000|Overall Study|Other|1|||
162127532|NCT00507026|585517227|FG001|Overall Study|Other|0|||
162127533|NCT00507026|585517228|FG002|Overall Study|Other|0|||
162127534|NCT04230980|585517229|FG000|Overall Study|Lost to Follow-up|1|||
162127535|NCT04230980|585517230|FG001|Overall Study|Lost to Follow-up|2|||
162127536|NCT04230980|585517229|FG000|Overall Study|Adverse Event|0|||
162127537|NCT04230980|585517230|FG001|Overall Study|Adverse Event|1|||
162127538|NCT01680458|585517235|FG000|Overall Study|Protocol Violation|3|||
162127539|NCT02138747|585517236|FG000|Treatment Period 1|Adverse Event|10|||
162127540|NCT02138747|585517237|FG001|Treatment Period 1|Adverse Event|14|||
162127541|NCT02138747|585517238|FG002|Treatment Period 1|Adverse Event|2|||
162127542|NCT02138747|585517239|FG003|Treatment Period 1|Adverse Event|1|||
162127543|NCT02138747|585517236|FG000|Treatment Period 1|Lost to Follow-up|0|||
162127544|NCT02138747|585517237|FG001|Treatment Period 1|Lost to Follow-up|1|||
162127545|NCT02138747|585517238|FG002|Treatment Period 1|Lost to Follow-up|1|||
162127546|NCT02138747|585517239|FG003|Treatment Period 1|Lost to Follow-up|0|||
162127547|NCT02138747|585517236|FG000|Treatment Period 1|Protocol Violation|0|||
162127548|NCT02138747|585517237|FG001|Treatment Period 1|Protocol Violation|2|||
162127549|NCT02138747|585517238|FG002|Treatment Period 1|Protocol Violation|0|||
162127550|NCT02138747|585517239|FG003|Treatment Period 1|Protocol Violation|0|||
162127551|NCT02138747|585517236|FG000|Treatment Period 1|Withdrawal by Subject|8|||
162127552|NCT02138747|585517237|FG001|Treatment Period 1|Withdrawal by Subject|4|||
162127553|NCT02138747|585517238|FG002|Treatment Period 1|Withdrawal by Subject|1|||
162127554|NCT02138747|585517239|FG003|Treatment Period 1|Withdrawal by Subject|3|||
162127555|NCT02138747|585517236|FG000|Treatment Period 1|Other - Miscellaneous|2|||
162127556|NCT02138747|585517237|FG001|Treatment Period 1|Other - Miscellaneous|4|||
162127557|NCT02138747|585517238|FG002|Treatment Period 1|Other - Miscellaneous|0|||
162127558|NCT02138747|585517239|FG003|Treatment Period 1|Other - Miscellaneous|0|||
162127559|NCT02138747|585517236|FG000|Treatment Period 2|Adverse Event|6|||
162127560|NCT02138747|585517237|FG001|Treatment Period 2|Adverse Event|3|||
162127561|NCT02138747|585517238|FG002|Treatment Period 2|Adverse Event|1|||
162127562|NCT02138747|585517239|FG003|Treatment Period 2|Adverse Event|1|||
162127563|NCT02138747|585517236|FG000|Treatment Period 2|Lost to Follow-up|2|||
162127564|NCT02138747|585517237|FG001|Treatment Period 2|Lost to Follow-up|0|||
162127565|NCT02138747|585517238|FG002|Treatment Period 2|Lost to Follow-up|0|||
162127566|NCT02138747|585517239|FG003|Treatment Period 2|Lost to Follow-up|0|||
162127567|NCT02138747|585517236|FG000|Treatment Period 2|Protocol Violation|1|||
162127568|NCT02138747|585517237|FG001|Treatment Period 2|Protocol Violation|0|||
162127569|NCT02138747|585517238|FG002|Treatment Period 2|Protocol Violation|0|||
162127570|NCT02138747|585517239|FG003|Treatment Period 2|Protocol Violation|0|||
162127571|NCT02138747|585517236|FG000|Treatment Period 2|Withdrawal by Subject|5|||
162127572|NCT02138747|585517237|FG001|Treatment Period 2|Withdrawal by Subject|4|||
162127573|NCT02138747|585517238|FG002|Treatment Period 2|Withdrawal by Subject|1|||
162127574|NCT02138747|585517239|FG003|Treatment Period 2|Withdrawal by Subject|2|||
162127575|NCT02138747|585517236|FG000|Treatment Period 2|Other - Miscellaneous|3|||
162127576|NCT02138747|585517237|FG001|Treatment Period 2|Other - Miscellaneous|0|||
162127577|NCT02138747|585517238|FG002|Treatment Period 2|Other - Miscellaneous|0|||
162127578|NCT02138747|585517239|FG003|Treatment Period 2|Other - Miscellaneous|0|||
162127579|NCT02302066|585517240|FG000|Overall Study|Adverse Event|1|||
162127580|NCT02302066|585517241|FG001|Overall Study|Adverse Event|1|||
162127581|NCT02302066|585517242|FG002|Overall Study|Adverse Event|3|||
162127582|NCT02302066|585517243|FG003|Overall Study|Adverse Event|0|||
162127583|NCT02302066|585517240|FG000|Overall Study|Lost to Follow-up|4|||
162127584|NCT02302066|585517241|FG001|Overall Study|Lost to Follow-up|5|||
162127585|NCT02302066|585517242|FG002|Overall Study|Lost to Follow-up|24|||
162127586|NCT02302066|585517243|FG003|Overall Study|Lost to Follow-up|7|||
162127587|NCT02302066|585517240|FG000|Overall Study|Withdrawal by Subject|25|||
162127588|NCT02302066|585517241|FG001|Overall Study|Withdrawal by Subject|58|||
162127589|NCT02302066|585517242|FG002|Overall Study|Withdrawal by Subject|124|||
162127590|NCT02302066|585517243|FG003|Overall Study|Withdrawal by Subject|33|||
161789378|NCT02868281|584272838|FG000|Overall Study|Protocol Violation|13|||
162127591|NCT02302066|585517240|FG000|Overall Study|Pregnancy|2|||
162127592|NCT02302066|585517241|FG001|Overall Study|Pregnancy|10|||
162127593|NCT02302066|585517242|FG002|Overall Study|Pregnancy|12|||
162127594|NCT02302066|585517243|FG003|Overall Study|Pregnancy|0|||
162127595|NCT02302066|585517240|FG000|Overall Study|Reason Not Specified|1|||
162127596|NCT02302066|585517241|FG001|Overall Study|Reason Not Specified|1|||
162127597|NCT02302066|585517242|FG002|Overall Study|Reason Not Specified|9|||
162127598|NCT02302066|585517243|FG003|Overall Study|Reason Not Specified|1|||
162127599|NCT04793464|585517248|FG000|Overall Study|Lost to Follow-up|458|||
162127600|NCT04793464|585517249|FG001|Overall Study|Lost to Follow-up|168|||
162127601|NCT04793464|585517250|FG002|Overall Study|Lost to Follow-up|5|||
162127602|NCT04793464|585517248|FG000|Overall Study|Withdrawal by Subject|43|||
162127603|NCT04793464|585517249|FG001|Overall Study|Withdrawal by Subject|15|||
162127604|NCT04793464|585517250|FG002|Overall Study|Withdrawal by Subject|0|||
162127605|NCT02696902|585517254|FG000|Overall Study|Lost to Follow-up|0|||
162127606|NCT02696902|585517255|FG001|Overall Study|Lost to Follow-up|1|||
162127607|NCT02696902|585517256|FG002|Overall Study|Lost to Follow-up|1|||
162127608|NCT02696902|585517254|FG000|Overall Study|Withdrawal by Subject|0|||
162127609|NCT02696902|585517255|FG001|Overall Study|Withdrawal by Subject|0|||
162127610|NCT02696902|585517256|FG002|Overall Study|Withdrawal by Subject|1|||
162127611|NCT02696902|585517254|FG000|Overall Study|Death|19|||
162127612|NCT02696902|585517255|FG001|Overall Study|Death|3|||
162127613|NCT02696902|585517256|FG002|Overall Study|Death|24|||
162127614|NCT02696902|585517254|FG000|Overall Study|Participant not fit post-randomization|0|||
162127615|NCT02696902|585517255|FG001|Overall Study|Participant not fit post-randomization|0|||
162127616|NCT02696902|585517256|FG002|Overall Study|Participant not fit post-randomization|1|||
162127617|NCT02696902|585517254|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
162127618|NCT02696902|585517255|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
162127619|NCT02696902|585517256|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
162127620|NCT02696902|585517254|FG000|Overall Study|Principal investigator's decision|1|||
162127621|NCT02696902|585517255|FG001|Overall Study|Principal investigator's decision|0|||
162127622|NCT02696902|585517256|FG002|Overall Study|Principal investigator's decision|0|||
162127623|NCT02696902|585517254|FG000|Overall Study|Sponsor's decision|1|||
162127624|NCT02696902|585517255|FG001|Overall Study|Sponsor's decision|0|||
162127625|NCT02696902|585517256|FG002|Overall Study|Sponsor's decision|0|||
162127626|NCT02696902|585517254|FG000|Overall Study|Transferred to other hospital|1|||
162127627|NCT02696902|585517255|FG001|Overall Study|Transferred to other hospital|0|||
162127628|NCT02696902|585517256|FG002|Overall Study|Transferred to other hospital|0|||
162127629|NCT00845871|585517260|FG000|Assessment Period|Adverse Event|2|||
162127630|NCT00845871|585517260|FG000|Assessment Period|Abnormal laboratory values|1|||
162127631|NCT00845871|585517260|FG000|Assessment Period|Abnormal test procedure results|1|||
162127632|NCT00845871|585517260|FG000|Assessment Period|Patient withdrew consent|3|||
162127633|NCT01857622|585517261|FG000|Overall Study|Adverse Event|5|||
162127634|NCT01857622|585517262|FG001|Overall Study|Adverse Event|0|||
162127635|NCT01857622|585517263|FG002|Overall Study|Adverse Event|2|||
162127636|NCT01857622|585517261|FG000|Overall Study|Physician Decision|1|||
162127637|NCT01857622|585517262|FG001|Overall Study|Physician Decision|0|||
162127638|NCT01857622|585517263|FG002|Overall Study|Physician Decision|0|||
162127639|NCT01857622|585517261|FG000|Overall Study|Protocol Violation|4|||
162127640|NCT01857622|585517262|FG001|Overall Study|Protocol Violation|1|||
162127641|NCT01857622|585517263|FG002|Overall Study|Protocol Violation|0|||
162127642|NCT01857622|585517261|FG000|Overall Study|Withdrawal by Subject|1|||
162127643|NCT01857622|585517262|FG001|Overall Study|Withdrawal by Subject|0|||
162127644|NCT01857622|585517263|FG002|Overall Study|Withdrawal by Subject|0|||
162127645|NCT01291225|585517266|FG000|Overall Study|Lost to Follow-up|85|||
162127646|NCT01291225|585517267|FG001|Overall Study|Lost to Follow-up|39|||
162127647|NCT01734434|585517268|FG000|Overall Study|Death Infant|3|||
162127648|NCT01734434|585517269|FG001|Overall Study|Death Infant|1|||
162127649|NCT01734434|585517270|FG002|Overall Study|Death Infant|17|||
162127650|NCT01734434|585517271|FG003|Overall Study|Death Infant|5|||
162127651|NCT01734434|585517268|FG000|Overall Study|Lost to Follow-up|2|||
162127652|NCT01734434|585517269|FG001|Overall Study|Lost to Follow-up|9|||
162127653|NCT01734434|585517270|FG002|Overall Study|Lost to Follow-up|67|||
162127654|NCT01734434|585517271|FG003|Overall Study|Lost to Follow-up|11|||
162127655|NCT01734434|585517268|FG000|Overall Study|No Live Birth|1|||
162127656|NCT01734434|585517269|FG001|Overall Study|No Live Birth|2|||
162127657|NCT01734434|585517270|FG002|Overall Study|No Live Birth|32|||
162127658|NCT01734434|585517271|FG003|Overall Study|No Live Birth|6|||
162127659|NCT01734434|585517268|FG000|Overall Study|Withdrawal by Subject|4|||
162127660|NCT01734434|585517269|FG001|Overall Study|Withdrawal by Subject|0|||
162127661|NCT01734434|585517270|FG002|Overall Study|Withdrawal by Subject|8|||
162127662|NCT01734434|585517271|FG003|Overall Study|Withdrawal by Subject|1|||
162127663|NCT01734434|585517268|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
162127664|NCT01734434|585517269|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
162127665|NCT01734434|585517270|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
162127666|NCT01734434|585517271|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
162127667|NCT01734434|585517268|FG000|Overall Study|Subject Not Reachable|0|||
162127668|NCT01734434|585517269|FG001|Overall Study|Subject Not Reachable|0|||
162127669|NCT01734434|585517270|FG002|Overall Study|Subject Not Reachable|1|||
162127670|NCT01734434|585517271|FG003|Overall Study|Subject Not Reachable|0|||
162127671|NCT01734434|585517268|FG000|Overall Study|Treatment Defaulter|0|||
162127672|NCT01734434|585517269|FG001|Overall Study|Treatment Defaulter|0|||
162127673|NCT01734434|585517270|FG002|Overall Study|Treatment Defaulter|1|||
162127674|NCT01734434|585517271|FG003|Overall Study|Treatment Defaulter|0|||
162127675|NCT01734434|585517268|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
161789379|NCT02868281|584272839|FG001|Overall Study|Protocol Violation|10|||
162127676|NCT01734434|585517269|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
162127677|NCT01734434|585517270|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
162127678|NCT01734434|585517271|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
162127679|NCT01734434|585517268|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
162127680|NCT01734434|585517269|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
162127681|NCT01734434|585517270|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
162127682|NCT01734434|585517271|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
162127683|NCT00513019|585519640|FG000|Overall Study|Adverse Event|1|||
162127684|NCT00513019|585519641|FG001|Overall Study|Adverse Event|0|||
162127685|NCT00513019|585519640|FG000|Overall Study|Withdrawal by Subject|4|||
162127686|NCT00513019|585519641|FG001|Overall Study|Withdrawal by Subject|5|||
162127687|NCT04129580|585519642|FG000|Overall Study|Lost to Follow-up|14|||
162127688|NCT04129580|585519643|FG001|Overall Study|Lost to Follow-up|25|||
162127689|NCT00322868|585519644|FG000|Overall Study|disease progression|1|||
162127690|NCT01852162|585519645|FG000|Overall Study|Adverse Event|1|||
162127691|NCT01852162|585519646|FG001|Overall Study|Adverse Event|0|||
162127692|NCT01852162|585519645|FG000|Overall Study|Withdrawal by Subject|3|||
162127693|NCT01852162|585519646|FG001|Overall Study|Withdrawal by Subject|1|||
162127694|NCT01500226|585519649|FG000|Overall Study|Adverse Event|31|||
162127695|NCT01500226|585519650|FG001|Overall Study|Adverse Event|38|||
162127696|NCT01500226|585519649|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
162127697|NCT01500226|585519650|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
162127698|NCT01500226|585519649|FG000|Overall Study|Withdrawal by Subject|93|||
162127699|NCT01500226|585519650|FG001|Overall Study|Withdrawal by Subject|96|||
162127700|NCT01500226|585519649|FG000|Overall Study|Death|12|||
162127701|NCT01500226|585519650|FG001|Overall Study|Death|4|||
162127702|NCT01500226|585519649|FG000|Overall Study|Disease Progression|16|||
162127703|NCT01500226|585519650|FG001|Overall Study|Disease Progression|14|||
162127704|NCT01500226|585519649|FG000|Overall Study|Protocol Violation|53|||
162127705|NCT01500226|585519650|FG001|Overall Study|Protocol Violation|39|||
162127706|NCT01500226|585519649|FG000|Overall Study|Physician Decision|17|||
162127707|NCT01500226|585519650|FG001|Overall Study|Physician Decision|15|||
162127708|NCT01500226|585519649|FG000|Overall Study|Lack of Efficacy|14|||
162127709|NCT01500226|585519650|FG001|Overall Study|Lack of Efficacy|30|||
162127710|NCT01500226|585519649|FG000|Overall Study|Lost to Follow-up|9|||
162127711|NCT01500226|585519650|FG001|Overall Study|Lost to Follow-up|5|||
162127712|NCT01500226|585519649|FG000|Overall Study|Other Reasons|19|||
162127713|NCT01500226|585519650|FG001|Overall Study|Other Reasons|16|||
162127714|NCT02955277|585519651|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
162127715|NCT02955277|585519652|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
162127716|NCT02955277|585519651|FG000|Post to Follow-up|Lost to Follow-up|8|||
162127717|NCT02955277|585519652|FG001|Post to Follow-up|Lost to Follow-up|11|||
162127718|NCT04212169|585519655|FG000|Overall Study|Adverse Event|0|||
162127719|NCT04212169|585519656|FG001|Overall Study|Adverse Event|0|||
162127720|NCT04212169|585519657|FG002|Overall Study|Adverse Event|0|||
162127721|NCT04212169|585519658|FG003|Overall Study|Adverse Event|2|||
162127722|NCT04212169|585519655|FG000|Overall Study|Lost to Follow-up|1|||
162127723|NCT04212169|585519656|FG001|Overall Study|Lost to Follow-up|0|||
162127724|NCT04212169|585519657|FG002|Overall Study|Lost to Follow-up|0|||
162127725|NCT04212169|585519658|FG003|Overall Study|Lost to Follow-up|2|||
162127726|NCT04212169|585519655|FG000|Overall Study|Withdrawal by Subject|10|||
162127727|NCT04212169|585519656|FG001|Overall Study|Withdrawal by Subject|2|||
162127728|NCT04212169|585519657|FG002|Overall Study|Withdrawal by Subject|5|||
162127729|NCT04212169|585519658|FG003|Overall Study|Withdrawal by Subject|7|||
162127730|NCT04212169|585519655|FG000|Overall Study|Other reason, unspecified|3|||
162127731|NCT04212169|585519656|FG001|Overall Study|Other reason, unspecified|1|||
162127732|NCT04212169|585519657|FG002|Overall Study|Other reason, unspecified|0|||
161898694|NCT00872521|584677878|FG000|Primary Endpoint Analysis|Patient response missing|0|||
161898695|NCT00872521|584677879|FG001|Primary Endpoint Analysis|Patient response missing|0|||
161898696|NCT00872521|584677880|FG002|Primary Endpoint Analysis|Patient response missing|1|||
161898697|NCT00872521|584677878|FG000|Completed 3-month Follow up|Other|0|||
161898698|NCT00872521|584677879|FG001|Completed 3-month Follow up|Other|2|||
161898699|NCT00872521|584677880|FG002|Completed 3-month Follow up|Other|0|||
161898700|NCT00872521|584677878|FG000|Completed 3-month Follow up|Physician Decision|0|||
161898701|NCT00872521|584677879|FG001|Completed 3-month Follow up|Physician Decision|1|||
161898702|NCT00872521|584677880|FG002|Completed 3-month Follow up|Physician Decision|0|||
162127733|NCT04212169|585519658|FG003|Overall Study|Other reason, unspecified|2|||
162127734|NCT02176928|585519659|FG000|Overall Study|Lost to Follow-up|2|||
162127735|NCT02176928|585519660|FG001|Overall Study|Lost to Follow-up|4|||
162127736|NCT02018861|585519665|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
162127737|NCT02018861|585519666|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
162127738|NCT02018861|585519667|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
162127739|NCT02018861|585519668|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
162127740|NCT02018861|585519669|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
162127741|NCT02018861|585519670|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
162127742|NCT02018861|585519671|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
162127743|NCT02018861|585519672|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
162127744|NCT02018861|585519673|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
162127745|NCT02018861|585519674|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
162127746|NCT02018861|585519665|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162127747|NCT02018861|585519666|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162127748|NCT02018861|585519667|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162127749|NCT02018861|585519668|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
162127750|NCT02018861|585519669|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
162127751|NCT02018861|585519670|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162127752|NCT02018861|585519671|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162127753|NCT02018861|585519672|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162127754|NCT02018861|585519673|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162127755|NCT02018861|585519674|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
162127756|NCT02018861|585519665|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
162127757|NCT02018861|585519666|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
162127758|NCT02018861|585519667|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
162127759|NCT02018861|585519668|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
162127760|NCT02018861|585519669|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
162127761|NCT02018861|585519670|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
162127762|NCT02018861|585519671|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
162127763|NCT02018861|585519672|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
162127764|NCT02018861|585519673|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
162127765|NCT02018861|585519674|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
162127766|NCT02018861|585519665|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
162127767|NCT02018861|585519666|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162127768|NCT02018861|585519667|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162127769|NCT02018861|585519668|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
162127770|NCT02018861|585519669|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
162127771|NCT02018861|585519670|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162127772|NCT02018861|585519671|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162127773|NCT02018861|585519672|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162127774|NCT02018861|585519673|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162127775|NCT02018861|585519674|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
162127776|NCT02018861|585519665|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162127777|NCT02018861|585519666|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162127778|NCT02018861|585519667|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
162127779|NCT02018861|585519668|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
162127780|NCT02018861|585519669|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162127781|NCT02018861|585519670|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162127782|NCT02018861|585519671|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162127783|NCT02018861|585519672|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162127784|NCT02018861|585519673|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162127785|NCT02018861|585519674|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
162127786|NCT02018861|585519665|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162127787|NCT02018861|585519666|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162127788|NCT02018861|585519667|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162127789|NCT02018861|585519668|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162127790|NCT02018861|585519669|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
162127791|NCT02018861|585519670|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162127792|NCT02018861|585519671|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162127793|NCT02018861|585519672|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162127794|NCT02018861|585519673|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162127795|NCT02018861|585519674|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
162127796|NCT02018861|585519665|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162127797|NCT02018861|585519666|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162127798|NCT02018861|585519667|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162127799|NCT02018861|585519668|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
162127800|NCT02018861|585519669|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
162127801|NCT02018861|585519670|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
162127802|NCT02018861|585519671|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162127803|NCT02018861|585519672|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162127804|NCT02018861|585519673|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162127805|NCT02018861|585519674|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
162127806|NCT02018861|585519665|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162127807|NCT02018861|585519666|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162127808|NCT02018861|585519667|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162127809|NCT02018861|585519668|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
162127810|NCT02018861|585519669|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
162127811|NCT02018861|585519670|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162127812|NCT02018861|585519671|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162127813|NCT02018861|585519672|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162127814|NCT02018861|585519673|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162127815|NCT02018861|585519674|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
162127816|NCT02018861|585519665|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162127817|NCT02018861|585519666|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162127818|NCT02018861|585519667|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162127819|NCT02018861|585519668|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162127820|NCT02018861|585519669|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162127821|NCT02018861|585519670|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162127822|NCT02018861|585519671|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
162127823|NCT02018861|585519672|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
162127824|NCT02018861|585519673|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162127825|NCT02018861|585519674|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
162127826|NCT02018861|585519665|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162127827|NCT02018861|585519666|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162127828|NCT02018861|585519667|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162127829|NCT02018861|585519668|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162127830|NCT02018861|585519669|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162127831|NCT02018861|585519670|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162127832|NCT02018861|585519671|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
162127833|NCT02018861|585519672|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
162127834|NCT02018861|585519673|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162127835|NCT02018861|585519674|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
162127836|NCT02018861|585519665|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162127837|NCT02018861|585519666|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162127838|NCT02018861|585519667|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162127839|NCT02018861|585519668|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162127840|NCT02018861|585519669|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162127841|NCT02018861|585519670|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162127842|NCT02018861|585519671|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162127843|NCT02018861|585519672|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162127844|NCT02018861|585519673|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
162127845|NCT02018861|585519674|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
162127846|NCT02018861|585519665|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162127847|NCT02018861|585519666|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162127848|NCT02018861|585519667|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162127849|NCT02018861|585519668|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162127850|NCT02018861|585519669|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162127851|NCT02018861|585519670|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162127852|NCT02018861|585519671|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162127853|NCT02018861|585519672|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162127854|NCT02018861|585519673|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
162127855|NCT02018861|585519674|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
162127856|NCT02018861|585519665|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162127857|NCT02018861|585519666|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162127858|NCT02018861|585519667|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162127859|NCT02018861|585519668|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162127860|NCT02018861|585519669|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162127861|NCT02018861|585519670|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162127862|NCT02018861|585519671|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162127863|NCT02018861|585519672|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162127864|NCT02018861|585519673|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
162127865|NCT02018861|585519674|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
162127866|NCT01642186|585519675|FG000|Overall Study|Death|0|||
162127867|NCT01642186|585519676|FG001|Overall Study|Death|2|||
162127868|NCT01642186|585519677|FG002|Overall Study|Death|2|||
162127869|NCT01642186|585519675|FG000|Overall Study|Lost to Follow-up|0|||
162127870|NCT01642186|585519676|FG001|Overall Study|Lost to Follow-up|0|||
162127871|NCT01642186|585519677|FG002|Overall Study|Lost to Follow-up|1|||
162127872|NCT00590980|585519680|FG000|Overall Study|Did not meet all inclusion criteria|10|||
162127873|NCT00504348|585519681|FG000|Overall Study|Adverse Event|3|||
162127874|NCT00504348|585519681|FG000|Overall Study|Lack of Efficacy|4|||
162127875|NCT00504348|585519681|FG000|Overall Study|Physician Decision|1|||
162127876|NCT00506285|585519684|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
162127877|NCT00506285|585519685|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
162127878|NCT00506285|585519684|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
162127879|NCT00506285|585519685|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
162127880|NCT00506285|585519684|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
162127881|NCT00506285|585519685|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
162127882|NCT00506285|585519684|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
162127883|NCT00506285|585519685|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
162127884|NCT00506285|585519684|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
162127885|NCT00506285|585519685|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
162127886|NCT01023308|585519688|FG000|Overall Study|Abnormal test proceedure results|3|||
162127887|NCT01023308|585519689|FG001|Overall Study|Abnormal test proceedure results|8|||
162127888|NCT01023308|585519688|FG000|Overall Study|Administrative problems|2|||
162127889|NCT01023308|585519689|FG001|Overall Study|Administrative problems|1|||
162127890|NCT01023308|585519688|FG000|Overall Study|Adverse Event|130|||
162127891|NCT01023308|585519689|FG001|Overall Study|Adverse Event|66|||
162127892|NCT01023308|585519688|FG000|Overall Study|Death|21|||
162127893|NCT01023308|585519689|FG001|Overall Study|Death|17|||
162127894|NCT01023308|585519688|FG000|Overall Study|Disease progression|82|||
162127895|NCT01023308|585519689|FG001|Overall Study|Disease progression|153|||
162127896|NCT01023308|585519688|FG000|Overall Study|New Cancer therapy|4|||
162127897|NCT01023308|585519689|FG001|Overall Study|New Cancer therapy|7|||
162127898|NCT01023308|585519688|FG000|Overall Study|Protocol Violation|3|||
162127899|NCT01023308|585519689|FG001|Overall Study|Protocol Violation|4|||
162127900|NCT01023308|585519688|FG000|Overall Study|Untreated|5|||
162127901|NCT01023308|585519689|FG001|Overall Study|Untreated|5|||
162127902|NCT01023308|585519688|FG000|Overall Study|Lost to Follow-up|1|||
162127903|NCT01023308|585519689|FG001|Overall Study|Lost to Follow-up|0|||
162127904|NCT01023308|585519688|FG000|Overall Study|Withdrawal by Subject|34|||
162127905|NCT01023308|585519689|FG001|Overall Study|Withdrawal by Subject|18|||
162127906|NCT00551213|585519690|FG000|Overall Study|Adverse Event|6|||
162127907|NCT00551213|585519691|FG001|Overall Study|Adverse Event|3|||
162127908|NCT00551213|585519690|FG000|Overall Study|Progressive Disease|41|||
162127909|NCT00551213|585519691|FG001|Overall Study|Progressive Disease|12|||
162127910|NCT00551213|585519690|FG000|Overall Study|Withdrawal by Subject|2|||
162127911|NCT00551213|585519691|FG001|Overall Study|Withdrawal by Subject|0|||
162127912|NCT00551213|585519690|FG000|Overall Study|Not Treated|1|||
162127913|NCT00551213|585519691|FG001|Overall Study|Not Treated|2|||
162127914|NCT01890967|585519692|FG000|Overall Study|Adverse Event|3|||
162127915|NCT01890967|585519693|FG001|Overall Study|Adverse Event|3|||
162127916|NCT01890967|585519694|FG002|Overall Study|Adverse Event|3|||
162127917|NCT01890967|585519695|FG003|Overall Study|Adverse Event|2|||
162127918|NCT01890967|585519696|FG004|Overall Study|Adverse Event|1|||
162127919|NCT01890967|585519697|FG005|Overall Study|Adverse Event|7|||
162127920|NCT01890967|585519692|FG000|Overall Study|Death|1|||
162127921|NCT01890967|585519693|FG001|Overall Study|Death|0|||
162127922|NCT01890967|585519694|FG002|Overall Study|Death|0|||
162127923|NCT01890967|585519695|FG003|Overall Study|Death|0|||
162127924|NCT01890967|585519696|FG004|Overall Study|Death|0|||
162127925|NCT01890967|585519697|FG005|Overall Study|Death|0|||
162127926|NCT01890967|585519692|FG000|Overall Study|Lost to Follow-up|1|||
162127927|NCT01890967|585519693|FG001|Overall Study|Lost to Follow-up|1|||
162127928|NCT01890967|585519694|FG002|Overall Study|Lost to Follow-up|1|||
162127929|NCT01890967|585519695|FG003|Overall Study|Lost to Follow-up|1|||
162127930|NCT01890967|585519696|FG004|Overall Study|Lost to Follow-up|0|||
162127931|NCT01890967|585519697|FG005|Overall Study|Lost to Follow-up|1|||
162127932|NCT01890967|585519692|FG000|Overall Study|Protocol Violation|0|||
162127933|NCT01890967|585519693|FG001|Overall Study|Protocol Violation|3|||
161789380|NCT02868281|584272838|FG000|Overall Study|Lost to Follow-up|3|||
161789381|NCT02868281|584272839|FG001|Overall Study|Lost to Follow-up|6|||
161789382|NCT02868281|584272838|FG000|Overall Study|Withdrawal by Subject|11|||
162127934|NCT01890967|585519694|FG002|Overall Study|Protocol Violation|3|||
162127935|NCT01890967|585519695|FG003|Overall Study|Protocol Violation|2|||
162127936|NCT01890967|585519696|FG004|Overall Study|Protocol Violation|4|||
162127937|NCT01890967|585519697|FG005|Overall Study|Protocol Violation|1|||
162127938|NCT01890967|585519692|FG000|Overall Study|Sponsor Decision|2|||
162127939|NCT01890967|585519693|FG001|Overall Study|Sponsor Decision|0|||
162127940|NCT01890967|585519694|FG002|Overall Study|Sponsor Decision|1|||
162127941|NCT01890967|585519695|FG003|Overall Study|Sponsor Decision|3|||
162127942|NCT01890967|585519696|FG004|Overall Study|Sponsor Decision|2|||
162127943|NCT01890967|585519697|FG005|Overall Study|Sponsor Decision|3|||
162127944|NCT01890967|585519692|FG000|Overall Study|Withdrawal by Subject|3|||
162127945|NCT01890967|585519693|FG001|Overall Study|Withdrawal by Subject|4|||
162127946|NCT01890967|585519694|FG002|Overall Study|Withdrawal by Subject|2|||
162127947|NCT01890967|585519695|FG003|Overall Study|Withdrawal by Subject|3|||
162127948|NCT01890967|585519696|FG004|Overall Study|Withdrawal by Subject|3|||
162127949|NCT01890967|585519697|FG005|Overall Study|Withdrawal by Subject|1|||
162127950|NCT01646320|585519698|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
162127951|NCT01646320|585519699|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
162127952|NCT01646320|585519698|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
162127953|NCT01646320|585519699|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
162127954|NCT01646320|585519698|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
162127955|NCT01646320|585519699|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
162127956|NCT01646320|585519698|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
162127957|NCT01646320|585519699|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
162127958|NCT01646320|585519698|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
162127959|NCT01646320|585519699|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
162127960|NCT01646320|585519698|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
162127961|NCT01646320|585519699|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
162127962|NCT01646320|585519698|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
162127963|NCT01646320|585519699|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
162127964|NCT01646320|585519698|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
162127965|NCT01646320|585519699|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
162127966|NCT01646320|585519698|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
162127967|NCT01646320|585519699|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
162127968|NCT01646320|585519698|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
162127969|NCT01646320|585519699|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
162127970|NCT01646320|585519698|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
162127971|NCT01646320|585519699|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
162127972|NCT02892409|585519700|FG000|Overall Study|Adverse Event|1|||
162127973|NCT02892409|585519701|FG001|Overall Study|Adverse Event|0|||
162127974|NCT02892409|585519700|FG000|Overall Study|Withdrawal by Subject|2|||
162127975|NCT02892409|585519701|FG001|Overall Study|Withdrawal by Subject|1|||
162127976|NCT02254421|585519702|FG000|Overall Study|Randomized but Not Treated|1|||
162127977|NCT02254421|585519703|FG001|Overall Study|Randomized but Not Treated|0|||
162127978|NCT02254421|585519702|FG000|Overall Study|Death|0|||
162127979|NCT02254421|585519703|FG001|Overall Study|Death|2|||
162127980|NCT02254421|585519702|FG000|Overall Study|Withdrew Consent|1|||
162127981|NCT02254421|585519703|FG001|Overall Study|Withdrew Consent|1|||
162127982|NCT00867490|585519704|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
162127983|NCT00867490|585519704|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
162127984|NCT00867490|585519704|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
162127985|NCT00867490|585519704|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
162127986|NCT00867490|585519704|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
162127987|NCT01154036|585519713|FG000|Phase I|Physician Decision|0|||
162127988|NCT01154036|585519714|FG001|Phase I|Physician Decision|1|||
162127989|NCT01154036|585519715|FG002|Phase I|Physician Decision|0|||
162127990|NCT01154036|585519716|FG003|Phase I|Physician Decision|0|||
162127991|NCT01154036|585519717|FG004|Phase I|Physician Decision|0|||
162127992|NCT01154036|585519718|FG005|Phase I|Physician Decision|0|||
162127993|NCT01154036|585519719|FG006|Phase I|Physician Decision|0|||
162127994|NCT01154036|585519720|FG007|Phase I|Physician Decision|0|||
162127995|NCT01154036|585519713|FG000|Phase I|Lost to Follow-up|0|||
162127996|NCT01154036|585519714|FG001|Phase I|Lost to Follow-up|3|||
162127997|NCT01154036|585519715|FG002|Phase I|Lost to Follow-up|6|||
162127998|NCT01154036|585519716|FG003|Phase I|Lost to Follow-up|0|||
162127999|NCT01154036|585519717|FG004|Phase I|Lost to Follow-up|0|||
162128000|NCT01154036|585519718|FG005|Phase I|Lost to Follow-up|0|||
162128001|NCT01154036|585519719|FG006|Phase I|Lost to Follow-up|0|||
162128002|NCT01154036|585519720|FG007|Phase I|Lost to Follow-up|0|||
162128003|NCT01154036|585519713|FG000|Phase I|Protocol Violation|0|||
162128004|NCT01154036|585519714|FG001|Phase I|Protocol Violation|3|||
162128005|NCT01154036|585519715|FG002|Phase I|Protocol Violation|9|||
162128006|NCT01154036|585519716|FG003|Phase I|Protocol Violation|0|||
162128007|NCT01154036|585519717|FG004|Phase I|Protocol Violation|0|||
162128008|NCT01154036|585519718|FG005|Phase I|Protocol Violation|0|||
162128009|NCT01154036|585519719|FG006|Phase I|Protocol Violation|0|||
162128010|NCT01154036|585519720|FG007|Phase I|Protocol Violation|0|||
162128011|NCT01154036|585519713|FG000|Phase I|Withdrawal by Subject|2|||
162128012|NCT01154036|585519714|FG001|Phase I|Withdrawal by Subject|10|||
162128013|NCT01154036|585519715|FG002|Phase I|Withdrawal by Subject|29|||
162128014|NCT01154036|585519716|FG003|Phase I|Withdrawal by Subject|0|||
162128015|NCT01154036|585519717|FG004|Phase I|Withdrawal by Subject|0|||
162128016|NCT01154036|585519718|FG005|Phase I|Withdrawal by Subject|0|||
162128017|NCT01154036|585519719|FG006|Phase I|Withdrawal by Subject|0|||
162128018|NCT01154036|585519720|FG007|Phase I|Withdrawal by Subject|0|||
162128019|NCT01154036|585519713|FG000|Phase I|Adverse Event|1|||
162128020|NCT01154036|585519714|FG001|Phase I|Adverse Event|11|||
162128021|NCT01154036|585519715|FG002|Phase I|Adverse Event|12|||
162128022|NCT01154036|585519716|FG003|Phase I|Adverse Event|0|||
162128023|NCT01154036|585519717|FG004|Phase I|Adverse Event|0|||
162128024|NCT01154036|585519718|FG005|Phase I|Adverse Event|0|||
162128025|NCT01154036|585519719|FG006|Phase I|Adverse Event|0|||
162128026|NCT01154036|585519720|FG007|Phase I|Adverse Event|0|||
162128027|NCT01154036|585519713|FG000|Phase II|Adverse Event|0|||
162128028|NCT01154036|585519714|FG001|Phase II|Adverse Event|0|||
162128029|NCT01154036|585519715|FG002|Phase II|Adverse Event|0|||
162128030|NCT01154036|585519716|FG003|Phase II|Adverse Event|0|||
162128031|NCT01154036|585519717|FG004|Phase II|Adverse Event|1|||
162128032|NCT01154036|585519718|FG005|Phase II|Adverse Event|1|||
162128033|NCT01154036|585519719|FG006|Phase II|Adverse Event|1|||
162128034|NCT01154036|585519720|FG007|Phase II|Adverse Event|1|||
162128035|NCT01154036|585519713|FG000|Phase II|Physician Decision|0|||
162128036|NCT01154036|585519714|FG001|Phase II|Physician Decision|0|||
162128037|NCT01154036|585519715|FG002|Phase II|Physician Decision|0|||
162128038|NCT01154036|585519716|FG003|Phase II|Physician Decision|0|||
162128039|NCT01154036|585519717|FG004|Phase II|Physician Decision|0|||
162128040|NCT01154036|585519718|FG005|Phase II|Physician Decision|0|||
162128041|NCT01154036|585519719|FG006|Phase II|Physician Decision|1|||
162128042|NCT01154036|585519720|FG007|Phase II|Physician Decision|0|||
162128043|NCT01154036|585519713|FG000|Phase II|Lost to Follow-up|0|||
162128044|NCT01154036|585519714|FG001|Phase II|Lost to Follow-up|0|||
162128045|NCT01154036|585519715|FG002|Phase II|Lost to Follow-up|0|||
162128046|NCT01154036|585519716|FG003|Phase II|Lost to Follow-up|1|||
162128047|NCT01154036|585519717|FG004|Phase II|Lost to Follow-up|2|||
162128048|NCT01154036|585519718|FG005|Phase II|Lost to Follow-up|0|||
162128049|NCT01154036|585519719|FG006|Phase II|Lost to Follow-up|2|||
162128050|NCT01154036|585519720|FG007|Phase II|Lost to Follow-up|1|||
162128051|NCT01154036|585519713|FG000|Phase II|Protocol Violation|0|||
162128052|NCT01154036|585519714|FG001|Phase II|Protocol Violation|0|||
162128053|NCT01154036|585519715|FG002|Phase II|Protocol Violation|0|||
162128054|NCT01154036|585519716|FG003|Phase II|Protocol Violation|0|||
162128055|NCT01154036|585519717|FG004|Phase II|Protocol Violation|1|||
162128056|NCT01154036|585519718|FG005|Phase II|Protocol Violation|2|||
162128057|NCT01154036|585519719|FG006|Phase II|Protocol Violation|0|||
162128058|NCT01154036|585519720|FG007|Phase II|Protocol Violation|0|||
162128059|NCT01154036|585519713|FG000|Phase II|Withdrawal by Subject|0|||
162128060|NCT01154036|585519714|FG001|Phase II|Withdrawal by Subject|0|||
162128061|NCT01154036|585519715|FG002|Phase II|Withdrawal by Subject|0|||
162128062|NCT01154036|585519716|FG003|Phase II|Withdrawal by Subject|0|||
162128063|NCT01154036|585519717|FG004|Phase II|Withdrawal by Subject|4|||
162128064|NCT01154036|585519718|FG005|Phase II|Withdrawal by Subject|2|||
162128065|NCT01154036|585519719|FG006|Phase II|Withdrawal by Subject|5|||
162128066|NCT01154036|585519720|FG007|Phase II|Withdrawal by Subject|4|||
162128067|NCT02264574|585519721|FG000|Overall Study|Death|21|||
162128068|NCT02264574|585519722|FG001|Overall Study|Death|21|||
162128069|NCT02264574|585519721|FG000|Overall Study|Withdrawal by Subject|8|||
162128070|NCT02264574|585519722|FG001|Overall Study|Withdrawal by Subject|6|||
162128071|NCT02264574|585519721|FG000|Overall Study|Other, Not Specified|0|||
162128072|NCT02264574|585519722|FG001|Overall Study|Other, Not Specified|3|||
162128073|NCT02080520|585519723|FG000|Overall Study|Self-reported symptoms|5|||
162128074|NCT02080520|585519724|FG001|Overall Study|Self-reported symptoms|6|||
162128075|NCT02080520|585519723|FG000|Overall Study|Unable to contact|2|||
162128076|NCT02080520|585519724|FG001|Overall Study|Unable to contact|1|||
162128077|NCT02080520|585519723|FG000|Overall Study|Initiated aspirin|2|||
162128078|NCT02080520|585519724|FG001|Overall Study|Initiated aspirin|0|||
162128079|NCT02080520|585519723|FG000|Overall Study|Atrial fibrillation|1|||
162128080|NCT02080520|585519724|FG001|Overall Study|Atrial fibrillation|1|||
162128081|NCT02080520|585519723|FG000|Overall Study|Cancer|1|||
162128082|NCT02080520|585519724|FG001|Overall Study|Cancer|2|||
162128083|NCT02080520|585519723|FG000|Overall Study|Not interested in study|1|||
162128084|NCT02080520|585519724|FG001|Overall Study|Not interested in study|3|||
162128085|NCT02080520|585519723|FG000|Overall Study|Too busy|1|||
162128086|NCT02080520|585519724|FG001|Overall Study|Too busy|1|||
162128087|NCT02080520|585519723|FG000|Overall Study|Work-related injury|1|||
162128088|NCT02080520|585519724|FG001|Overall Study|Work-related injury|0|||
162128089|NCT02080520|585519723|FG000|Overall Study|Personal reasons|0|||
162128090|NCT02080520|585519724|FG001|Overall Study|Personal reasons|3|||
162128091|NCT00390455|585519725|FG000|Overall Study|Adverse Event|17|||
162128092|NCT00390455|585519726|FG001|Overall Study|Adverse Event|3|||
162128093|NCT00390455|585519725|FG000|Overall Study|Withdrawal by Subject|8|||
162128094|NCT00390455|585519726|FG001|Overall Study|Withdrawal by Subject|8|||
162128095|NCT00390455|585519725|FG000|Overall Study|Alternate Treatment|0|||
162128096|NCT00390455|585519726|FG001|Overall Study|Alternate Treatment|1|||
162128097|NCT00390455|585519725|FG000|Overall Study|Other Medical Reasons|7|||
162128098|NCT00390455|585519726|FG001|Overall Study|Other Medical Reasons|11|||
162128099|NCT01591460|585519729|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
162128100|NCT01591460|585519729|FG000|Overall Study|Futility Rule (Week 12)|7|||
162128101|NCT01591460|585519729|FG000|Overall Study|Futility Rule (Week 24)|3|||
162128102|NCT01591460|585519729|FG000|Overall Study|Rebound or Breakthrough|3|||
162128103|NCT01591460|585519729|FG000|Overall Study|Treatment Discontinued by Error|1|||
162128104|NCT01591460|585519729|FG000|Overall Study|Lost to Follow-up|1|||
162128105|NCT01591460|585519729|FG000|Overall Study|Noncompliance|1|||
162128106|NCT01591460|585519729|FG000|Overall Study|Participant Refusal|3|||
162128107|NCT01591460|585519729|FG000|Overall Study|Withdrawal by Subject|1|||
162128108|NCT01591460|585519729|FG000|Overall Study|Protocol Violation|1|||
162128109|NCT04102540|585519734|FG000|Overall Study|Withdrawn by PI|2|||
162128110|NCT04102540|585519734|FG000|Overall Study|Lost to Follow-up|6|||
162128111|NCT01686932|585519737|FG000|Period 1|Adverse Event|1|||
162128112|NCT01686932|585519738|FG001|Period 1|Adverse Event|1|||
162128113|NCT04827134|585519741|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
162128114|NCT04827134|585519742|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
162128115|NCT04827134|585519743|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
162128116|NCT04827134|585519744|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
162128117|NCT00924469|585519753|FG000|Overall Study|Adverse Event|2|||
162128118|NCT00924469|585519754|FG001|Overall Study|Adverse Event|0|||
162128119|NCT00924469|585519753|FG000|Overall Study|Withdrawal by Subject|0|||
162128120|NCT00924469|585519754|FG001|Overall Study|Withdrawal by Subject|1|||
162128121|NCT00924469|585519753|FG000|Overall Study|Lost to Follow-up|0|||
162128122|NCT00924469|585519754|FG001|Overall Study|Lost to Follow-up|1|||
162128123|NCT01651936|585519756|FG000|Base Study|Adverse Event|3|||
162128124|NCT01651936|585519757|FG001|Base Study|Adverse Event|0|||
162128125|NCT01651936|585519758|FG002|Base Study|Adverse Event|0|||
162128126|NCT01651936|585519756|FG000|Base Study|Withdrawal by Subject|1|||
162128127|NCT01651936|585519757|FG001|Base Study|Withdrawal by Subject|1|||
162128128|NCT01651936|585519758|FG002|Base Study|Withdrawal by Subject|0|||
162128129|NCT01651936|585519756|FG000|Base Study|Early Escape|2|||
162128130|NCT01651936|585519757|FG001|Base Study|Early Escape|8|||
162128131|NCT01651936|585519758|FG002|Base Study|Early Escape|0|||
162128132|NCT01651936|585519756|FG000|Base Study|Study terminated by sponsor|21|||
162128133|NCT01651936|585519757|FG001|Base Study|Study terminated by sponsor|16|||
162128134|NCT01651936|585519758|FG002|Base Study|Study terminated by sponsor|0|||
162128135|NCT01651936|585519756|FG000|Extension Study|Lack of Efficacy|0|||
162128136|NCT01651936|585519757|FG001|Extension Study|Lack of Efficacy|0|||
162128137|NCT01651936|585519758|FG002|Extension Study|Lack of Efficacy|1|||
162128138|NCT01651936|585519756|FG000|Extension Study|Study terminated by sponsor|0|||
162128139|NCT01651936|585519757|FG001|Extension Study|Study terminated by sponsor|0|||
162128140|NCT01651936|585519758|FG002|Extension Study|Study terminated by sponsor|13|||
162128141|NCT03044353|585519759|FG000|Overall Study|Adverse Event|0|||
162128142|NCT03044353|585519760|FG001|Overall Study|Adverse Event|1|||
162128143|NCT03044353|585519761|FG002|Overall Study|Adverse Event|0|||
162128144|NCT03358329|585519762|FG000|Overall Study|Lost to Follow-up|2|||
162128145|NCT03358329|585519762|FG000|Overall Study|Withdrawal by Subject|2|||
162128146|NCT03875911|585519765|FG000|Overall Study|Lost to Follow-up|3|||
162128147|NCT03875911|585519766|FG001|Overall Study|Lost to Follow-up|6|||
162128148|NCT03875911|585519767|FG002|Overall Study|Lost to Follow-up|2|||
162128149|NCT03875911|585519765|FG000|Overall Study|Surgery cancelled|1|||
162128150|NCT03875911|585519766|FG001|Overall Study|Surgery cancelled|0|||
162128151|NCT03875911|585519767|FG002|Overall Study|Surgery cancelled|1|||
162128152|NCT03875911|585519765|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
162128153|NCT03875911|585519766|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
162128154|NCT03875911|585519767|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
162128155|NCT05284019|585519768|FG000|Overall Study|Study terminated|2|||
162128156|NCT05284019|585519769|FG001|Overall Study|Study terminated|2|||
162128157|NCT05284019|585519770|FG002|Overall Study|Study terminated|2|||
162128158|NCT05284019|585519771|FG003|Overall Study|Study terminated|5|||
162128159|NCT05284019|585519772|FG004|Overall Study|Study terminated|15|||
162128160|NCT05284019|585519768|FG000|Overall Study|Withdrawal by Subject|0|||
162128161|NCT05284019|585519769|FG001|Overall Study|Withdrawal by Subject|0|||
162128162|NCT05284019|585519770|FG002|Overall Study|Withdrawal by Subject|0|||
162128163|NCT05284019|585519771|FG003|Overall Study|Withdrawal by Subject|1|||
162128164|NCT05284019|585519772|FG004|Overall Study|Withdrawal by Subject|1|||
162128165|NCT05284019|585519768|FG000|Overall Study|Lost to Follow-up|1|||
162128166|NCT05284019|585519769|FG001|Overall Study|Lost to Follow-up|0|||
162128167|NCT05284019|585519770|FG002|Overall Study|Lost to Follow-up|0|||
162128168|NCT05284019|585519771|FG003|Overall Study|Lost to Follow-up|2|||
162128169|NCT05284019|585519772|FG004|Overall Study|Lost to Follow-up|1|||
162128170|NCT01990300|585519773|FG000|Overall Study|Case Report Forms Uncollected|89|||
162128171|NCT01990300|585519773|FG000|Overall Study|Protocol Deviation|53|||
162128172|NCT01231503|585519774|FG000|Overall Study|Adverse Event|0|||
162128173|NCT01231503|585519775|FG001|Overall Study|Adverse Event|0|||
162128174|NCT01231503|585519776|FG002|Overall Study|Adverse Event|0|||
162128175|NCT01231503|585519777|FG003|Overall Study|Adverse Event|0|||
162128176|NCT01231503|585519778|FG004|Overall Study|Adverse Event|0|||
162128177|NCT01231503|585519779|FG005|Overall Study|Adverse Event|1|||
162128178|NCT01231503|585519780|FG006|Overall Study|Adverse Event|0|||
162128179|NCT01231503|585519781|FG007|Overall Study|Adverse Event|0|||
162128180|NCT01231503|585519774|FG000|Overall Study|Adverse event, serious fatal|0|||
162128181|NCT01231503|585519775|FG001|Overall Study|Adverse event, serious fatal|0|||
162128182|NCT01231503|585519776|FG002|Overall Study|Adverse event, serious fatal|1|||
162128183|NCT01231503|585519777|FG003|Overall Study|Adverse event, serious fatal|1|||
162128184|NCT01231503|585519778|FG004|Overall Study|Adverse event, serious fatal|0|||
162128185|NCT01231503|585519779|FG005|Overall Study|Adverse event, serious fatal|1|||
162128186|NCT01231503|585519780|FG006|Overall Study|Adverse event, serious fatal|0|||
162128187|NCT01231503|585519781|FG007|Overall Study|Adverse event, serious fatal|0|||
162128188|NCT01231503|585519774|FG000|Overall Study|Withdrawal by Subject|6|||
162128189|NCT01231503|585519775|FG001|Overall Study|Withdrawal by Subject|3|||
162128190|NCT01231503|585519776|FG002|Overall Study|Withdrawal by Subject|3|||
162128191|NCT01231503|585519777|FG003|Overall Study|Withdrawal by Subject|1|||
162128192|NCT01231503|585519778|FG004|Overall Study|Withdrawal by Subject|3|||
162128193|NCT01231503|585519779|FG005|Overall Study|Withdrawal by Subject|5|||
162128194|NCT01231503|585519780|FG006|Overall Study|Withdrawal by Subject|1|||
162128195|NCT01231503|585519781|FG007|Overall Study|Withdrawal by Subject|2|||
162128196|NCT01231503|585519774|FG000|Overall Study|Lost to Follow-up|8|||
162128197|NCT01231503|585519775|FG001|Overall Study|Lost to Follow-up|10|||
162128198|NCT01231503|585519776|FG002|Overall Study|Lost to Follow-up|8|||
162128199|NCT01231503|585519777|FG003|Overall Study|Lost to Follow-up|5|||
162128200|NCT01231503|585519778|FG004|Overall Study|Lost to Follow-up|7|||
162128201|NCT01231503|585519779|FG005|Overall Study|Lost to Follow-up|9|||
162128202|NCT01231503|585519780|FG006|Overall Study|Lost to Follow-up|6|||
162128203|NCT01231503|585519781|FG007|Overall Study|Lost to Follow-up|6|||
162128204|NCT01231503|585519774|FG000|Overall Study|Protocol Violation|0|||
162128205|NCT01231503|585519775|FG001|Overall Study|Protocol Violation|0|||
162128206|NCT01231503|585519776|FG002|Overall Study|Protocol Violation|0|||
162128207|NCT01231503|585519777|FG003|Overall Study|Protocol Violation|1|||
162128208|NCT01231503|585519778|FG004|Overall Study|Protocol Violation|0|||
162128209|NCT01231503|585519779|FG005|Overall Study|Protocol Violation|0|||
162128210|NCT01231503|585519780|FG006|Overall Study|Protocol Violation|0|||
162128211|NCT01231503|585519781|FG007|Overall Study|Protocol Violation|0|||
162128212|NCT02293837|585519782|FG000|Overall Study|Lost to Follow-up|0|||
162128213|NCT02293837|585519783|FG001|Overall Study|Lost to Follow-up|2|||
162128214|NCT02293837|585519784|FG002|Overall Study|Lost to Follow-up|1|||
162128215|NCT02293837|585519785|FG003|Overall Study|Lost to Follow-up|0|||
162128216|NCT02293837|585519782|FG000|Overall Study|Withdrawal by Subject|2|||
162128217|NCT02293837|585519783|FG001|Overall Study|Withdrawal by Subject|1|||
162128218|NCT02293837|585519784|FG002|Overall Study|Withdrawal by Subject|2|||
162128219|NCT02293837|585519785|FG003|Overall Study|Withdrawal by Subject|1|||
162128220|NCT02293837|585519782|FG000|Overall Study|COVID-19 Related|1|||
162128221|NCT02293837|585519783|FG001|Overall Study|COVID-19 Related|1|||
162128222|NCT02293837|585519784|FG002|Overall Study|COVID-19 Related|0|||
162128223|NCT02293837|585519785|FG003|Overall Study|COVID-19 Related|0|||
162128224|NCT02293837|585519782|FG000|Overall Study|Participant ill and could not be infused|0|||
162128225|NCT02293837|585519783|FG001|Overall Study|Participant ill and could not be infused|0|||
162128226|NCT02293837|585519784|FG002|Overall Study|Participant ill and could not be infused|1|||
162128227|NCT02293837|585519785|FG003|Overall Study|Participant ill and could not be infused|0|||
162128228|NCT01076088|585519786|FG000|Overall Study|Adverse Event|1|||
162128229|NCT01076088|585519787|FG001|Overall Study|Adverse Event|6|||
162128230|NCT01076088|585519788|FG002|Overall Study|Adverse Event|3|||
162128231|NCT01076088|585519789|FG003|Overall Study|Adverse Event|2|||
162128232|NCT01076088|585519790|FG004|Overall Study|Adverse Event|3|||
162128233|NCT01076088|585519791|FG005|Overall Study|Adverse Event|3|||
162128234|NCT01076088|585519786|FG000|Overall Study|Lost to Follow-up|1|||
162128235|NCT01076088|585519787|FG001|Overall Study|Lost to Follow-up|1|||
162128236|NCT01076088|585519788|FG002|Overall Study|Lost to Follow-up|0|||
162128237|NCT01076088|585519789|FG003|Overall Study|Lost to Follow-up|1|||
162128238|NCT01076088|585519790|FG004|Overall Study|Lost to Follow-up|1|||
162128239|NCT01076088|585519791|FG005|Overall Study|Lost to Follow-up|2|||
162128240|NCT01076088|585519786|FG000|Overall Study|Non-compliance with study drug|0|||
162128241|NCT01076088|585519787|FG001|Overall Study|Non-compliance with study drug|0|||
162128242|NCT01076088|585519788|FG002|Overall Study|Non-compliance with study drug|0|||
162128243|NCT01076088|585519789|FG003|Overall Study|Non-compliance with study drug|1|||
162128244|NCT01076088|585519790|FG004|Overall Study|Non-compliance with study drug|0|||
162128245|NCT01076088|585519791|FG005|Overall Study|Non-compliance with study drug|0|||
162128246|NCT01076088|585519786|FG000|Overall Study|Physician Decision|1|||
162128247|NCT01076088|585519787|FG001|Overall Study|Physician Decision|3|||
162128248|NCT01076088|585519788|FG002|Overall Study|Physician Decision|0|||
162128249|NCT01076088|585519789|FG003|Overall Study|Physician Decision|1|||
162128250|NCT01076088|585519790|FG004|Overall Study|Physician Decision|1|||
162128251|NCT01076088|585519791|FG005|Overall Study|Physician Decision|0|||
162128252|NCT01076088|585519786|FG000|Overall Study|Withdrawal by Subject|8|||
162128253|NCT01076088|585519787|FG001|Overall Study|Withdrawal by Subject|8|||
162128254|NCT01076088|585519788|FG002|Overall Study|Withdrawal by Subject|14|||
162128255|NCT01076088|585519789|FG003|Overall Study|Withdrawal by Subject|10|||
161789383|NCT02868281|584272839|FG001|Overall Study|Withdrawal by Subject|15|||
161789384|NCT02868281|584272838|FG000|Overall Study|Physician Decision|2|||
162128256|NCT01076088|585519790|FG004|Overall Study|Withdrawal by Subject|11|||
162128257|NCT01076088|585519791|FG005|Overall Study|Withdrawal by Subject|17|||
162128258|NCT01076088|585519786|FG000|Overall Study|Other protocol specified criteria|0|||
162128259|NCT01076088|585519787|FG001|Overall Study|Other protocol specified criteria|0|||
162128260|NCT01076088|585519788|FG002|Overall Study|Other protocol specified criteria|0|||
162128261|NCT01076088|585519789|FG003|Overall Study|Other protocol specified criteria|0|||
162128262|NCT01076088|585519790|FG004|Overall Study|Other protocol specified criteria|0|||
162128263|NCT01076088|585519791|FG005|Overall Study|Other protocol specified criteria|1|||
162128264|NCT03285113|585519792|FG000|Overall Study|Unable to implant leads|2|||
162128265|NCT03053492|585519793|FG000|Overall Study|Adverse Event|1|||
162128266|NCT03053492|585519794|FG001|Overall Study|Adverse Event|1|||
162128267|NCT03053492|585519793|FG000|Overall Study|Withdrawal by Subject|7|||
162128268|NCT03053492|585519794|FG001|Overall Study|Withdrawal by Subject|5|||
162128269|NCT01448044|585519799|FG000|Treatment Period|Adverse Event|4|||
162128270|NCT01448044|585519800|FG001|Treatment Period|Adverse Event|3|||
162128271|NCT01448044|585519799|FG000|Treatment Period|Lack of Efficacy|5|||
162128272|NCT01448044|585519800|FG001|Treatment Period|Lack of Efficacy|12|||
162128273|NCT01448044|585519799|FG000|Treatment Period|Subject requested discontinue study drug|1|||
162128274|NCT01448044|585519800|FG001|Treatment Period|Subject requested discontinue study drug|0|||
162128275|NCT01448044|585519799|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
162128276|NCT01448044|585519800|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
162128277|NCT01448044|585519799|FG000|Treatment Period|Participant does not meet study criteria|1|||
162128278|NCT01448044|585519800|FG001|Treatment Period|Participant does not meet study criteria|0|||
162128279|NCT01448044|585519799|FG000|Treatment Period|Lost to Follow-up|2|||
162128280|NCT01448044|585519800|FG001|Treatment Period|Lost to Follow-up|1|||
162128281|NCT01448044|585519799|FG000|Treatment Period|Other reason|2|||
162128282|NCT01448044|585519800|FG001|Treatment Period|Other reason|0|||
162128283|NCT01448044|585519799|FG000|Follow Up Period|Withdrawal by Subject|1|||
162128284|NCT01448044|585519800|FG001|Follow Up Period|Withdrawal by Subject|1|||
162128285|NCT01448044|585519799|FG000|Follow Up Period|Lost to Follow-up|6|||
162128286|NCT01448044|585519800|FG001|Follow Up Period|Lost to Follow-up|2|||
162128287|NCT01448044|585519799|FG000|Follow Up Period|Other|5|||
162128288|NCT01448044|585519800|FG001|Follow Up Period|Other|11|||
162128289|NCT01010217|585519802|FG000|Overall Study|Lost to Follow-up|4|||
162128290|NCT01010217|585519803|FG001|Overall Study|Lost to Follow-up|5|||
162128291|NCT01010217|585519804|FG002|Overall Study|Lost to Follow-up|1|||
162128292|NCT01010217|585519805|FG003|Overall Study|Lost to Follow-up|0|||
162128293|NCT01010217|585519806|FG004|Overall Study|Lost to Follow-up|0|||
162128294|NCT01010217|585519802|FG000|Overall Study|Withdrawal by Subject|1|||
162128295|NCT01010217|585519803|FG001|Overall Study|Withdrawal by Subject|0|||
162128296|NCT01010217|585519804|FG002|Overall Study|Withdrawal by Subject|0|||
162128297|NCT01010217|585519805|FG003|Overall Study|Withdrawal by Subject|0|||
162128298|NCT01010217|585519806|FG004|Overall Study|Withdrawal by Subject|0|||
162128299|NCT01010217|585519802|FG000|Overall Study|Physician Decision|0|||
162128300|NCT01010217|585519803|FG001|Overall Study|Physician Decision|0|||
162128301|NCT01010217|585519804|FG002|Overall Study|Physician Decision|0|||
162128302|NCT01010217|585519805|FG003|Overall Study|Physician Decision|6|||
162128303|NCT01010217|585519806|FG004|Overall Study|Physician Decision|3|||
162128304|NCT02061761|585519807|FG000|Overall Study|Disease progression|2|||
162128305|NCT02061761|585519808|FG001|Overall Study|Disease progression|8|||
162128306|NCT02061761|585519809|FG002|Overall Study|Disease progression|4|||
162128307|NCT02061761|585519810|FG003|Overall Study|Disease progression|5|||
162128308|NCT02061761|585519811|FG004|Overall Study|Disease progression|9|||
162128309|NCT02061761|585519812|FG005|Overall Study|Disease progression|3|||
162128310|NCT02061761|585519813|FG006|Overall Study|Disease progression|1|||
162128311|NCT02061761|585519814|FG007|Overall Study|Disease progression|2|||
162128312|NCT02061761|585519815|FG008|Overall Study|Disease progression|28|||
162128313|NCT02061761|585519807|FG000|Overall Study|Study Drug toxicity|0|||
162128314|NCT02061761|585519808|FG001|Overall Study|Study Drug toxicity|0|||
162128315|NCT02061761|585519809|FG002|Overall Study|Study Drug toxicity|0|||
162128316|NCT02061761|585519810|FG003|Overall Study|Study Drug toxicity|0|||
162128317|NCT02061761|585519811|FG004|Overall Study|Study Drug toxicity|0|||
162128318|NCT02061761|585519812|FG005|Overall Study|Study Drug toxicity|1|||
162128319|NCT02061761|585519813|FG006|Overall Study|Study Drug toxicity|0|||
162128320|NCT02061761|585519814|FG007|Overall Study|Study Drug toxicity|2|||
162128321|NCT02061761|585519815|FG008|Overall Study|Study Drug toxicity|6|||
162128322|NCT02061761|585519807|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
161898703|NCT00872521|584677878|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
162128323|NCT02061761|585519808|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
162128324|NCT02061761|585519809|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
162128325|NCT02061761|585519810|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
162128326|NCT02061761|585519811|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
162128327|NCT02061761|585519812|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
162128328|NCT02061761|585519813|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
162128329|NCT02061761|585519814|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
162128330|NCT02061761|585519815|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
162128331|NCT02061761|585519807|FG000|Overall Study|Participant request to discontinue study treatment|0|||
162128332|NCT02061761|585519808|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162128333|NCT02061761|585519809|FG002|Overall Study|Participant request to discontinue study treatment|2|||
162128334|NCT02061761|585519810|FG003|Overall Study|Participant request to discontinue study treatment|2|||
162128335|NCT02061761|585519811|FG004|Overall Study|Participant request to discontinue study treatment|0|||
162128336|NCT02061761|585519812|FG005|Overall Study|Participant request to discontinue study treatment|1|||
162128337|NCT02061761|585519813|FG006|Overall Study|Participant request to discontinue study treatment|0|||
162128338|NCT02061761|585519814|FG007|Overall Study|Participant request to discontinue study treatment|0|||
162128339|NCT02061761|585519815|FG008|Overall Study|Participant request to discontinue study treatment|2|||
162128340|NCT02061761|585519807|FG000|Overall Study|Withdrawal by Subject|0|||
162128341|NCT02061761|585519808|FG001|Overall Study|Withdrawal by Subject|0|||
162128342|NCT02061761|585519809|FG002|Overall Study|Withdrawal by Subject|0|||
162128343|NCT02061761|585519810|FG003|Overall Study|Withdrawal by Subject|0|||
162128344|NCT02061761|585519811|FG004|Overall Study|Withdrawal by Subject|0|||
162128345|NCT02061761|585519812|FG005|Overall Study|Withdrawal by Subject|0|||
162128346|NCT02061761|585519813|FG006|Overall Study|Withdrawal by Subject|0|||
162128347|NCT02061761|585519814|FG007|Overall Study|Withdrawal by Subject|0|||
162128348|NCT02061761|585519815|FG008|Overall Study|Withdrawal by Subject|2|||
162128349|NCT02061761|585519807|FG000|Overall Study|Maximum clinical benefit|0|||
162128350|NCT02061761|585519808|FG001|Overall Study|Maximum clinical benefit|0|||
162128351|NCT02061761|585519809|FG002|Overall Study|Maximum clinical benefit|0|||
162128352|NCT02061761|585519810|FG003|Overall Study|Maximum clinical benefit|1|||
162128353|NCT02061761|585519811|FG004|Overall Study|Maximum clinical benefit|0|||
162128354|NCT02061761|585519812|FG005|Overall Study|Maximum clinical benefit|0|||
162128355|NCT02061761|585519813|FG006|Overall Study|Maximum clinical benefit|0|||
162128356|NCT02061761|585519814|FG007|Overall Study|Maximum clinical benefit|0|||
162128357|NCT02061761|585519815|FG008|Overall Study|Maximum clinical benefit|6|||
162128358|NCT02061761|585519807|FG000|Overall Study|Participant no longer meets study criteria|0|||
162128359|NCT02061761|585519808|FG001|Overall Study|Participant no longer meets study criteria|0|||
162128360|NCT02061761|585519809|FG002|Overall Study|Participant no longer meets study criteria|0|||
162128361|NCT02061761|585519810|FG003|Overall Study|Participant no longer meets study criteria|0|||
162128362|NCT02061761|585519811|FG004|Overall Study|Participant no longer meets study criteria|0|||
162128363|NCT02061761|585519812|FG005|Overall Study|Participant no longer meets study criteria|0|||
162128364|NCT02061761|585519813|FG006|Overall Study|Participant no longer meets study criteria|0|||
162128365|NCT02061761|585519814|FG007|Overall Study|Participant no longer meets study criteria|0|||
162128366|NCT02061761|585519815|FG008|Overall Study|Participant no longer meets study criteria|1|||
162128367|NCT02061761|585519807|FG000|Overall Study|Other reasons|0|||
162128368|NCT02061761|585519808|FG001|Overall Study|Other reasons|0|||
162128369|NCT02061761|585519809|FG002|Overall Study|Other reasons|0|||
162128370|NCT02061761|585519810|FG003|Overall Study|Other reasons|0|||
162128371|NCT02061761|585519811|FG004|Overall Study|Other reasons|2|||
162128372|NCT02061761|585519812|FG005|Overall Study|Other reasons|0|||
162128373|NCT02061761|585519813|FG006|Overall Study|Other reasons|0|||
162128374|NCT02061761|585519814|FG007|Overall Study|Other reasons|0|||
162128375|NCT02061761|585519815|FG008|Overall Study|Other reasons|6|||
162128376|NCT01024751|585519816|FG000|Enrolled Participants|Ineligible at baseline|3|||
162128377|NCT01024751|585519817|FG001|Enrolled Participants|Ineligible at baseline|4|||
162128378|NCT01024751|585519816|FG000|Eligible Participants|Withdrawal by Subject|0|||
162128379|NCT01024751|585519817|FG001|Eligible Participants|Withdrawal by Subject|1|||
162128380|NCT01024751|585519816|FG000|Eligible Participants|Lost to Follow-up|0|||
162128381|NCT01024751|585519817|FG001|Eligible Participants|Lost to Follow-up|1|||
162128382|NCT01024751|585519816|FG000|Eligible Participants|Ineligible|0|||
162128383|NCT01024751|585519817|FG001|Eligible Participants|Ineligible|1|||
162128384|NCT00577720|585519822|FG000|Overall Study|Adverse Event|2|||
162128385|NCT00577720|585519823|FG001|Overall Study|Adverse Event|1|||
162128386|NCT00577720|585519824|FG002|Overall Study|Adverse Event|0|||
162128387|NCT00577720|585519825|FG003|Overall Study|Adverse Event|4|||
162128388|NCT00577720|585519822|FG000|Overall Study|Lost to Follow-up|0|||
162128389|NCT00577720|585519823|FG001|Overall Study|Lost to Follow-up|0|||
162128390|NCT00577720|585519824|FG002|Overall Study|Lost to Follow-up|1|||
162128391|NCT00577720|585519825|FG003|Overall Study|Lost to Follow-up|0|||
162128392|NCT00577720|585519822|FG000|Overall Study|Protocol Violation|0|||
162128393|NCT00577720|585519823|FG001|Overall Study|Protocol Violation|0|||
162128394|NCT00577720|585519824|FG002|Overall Study|Protocol Violation|0|||
162128395|NCT00577720|585519825|FG003|Overall Study|Protocol Violation|1|||
162128396|NCT00577720|585519822|FG000|Overall Study|Withdrawal by Subject|2|||
162128397|NCT00577720|585519823|FG001|Overall Study|Withdrawal by Subject|0|||
162128398|NCT00577720|585519824|FG002|Overall Study|Withdrawal by Subject|0|||
162128399|NCT00577720|585519825|FG003|Overall Study|Withdrawal by Subject|2|||
162128400|NCT03246672|585519826|FG000|Overall Study|Lost to Follow-up|2|||
162128401|NCT03260504|585519827|FG000|Overall Study|Adverse Event|0|||
161898704|NCT00872521|584677879|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
162128402|NCT03260504|585519828|FG001|Overall Study|Adverse Event|1|||
162128403|NCT00967018|585519829|FG000|Overall Study|Adverse Event|2|||
162128404|NCT00967018|585519829|FG000|Overall Study|Physician Decision|7|||
162128405|NCT00967018|585519829|FG000|Overall Study|Lost to Follow-up|2|||
162128406|NCT00967018|585519829|FG000|Overall Study|Withdrawal by Subject|1|||
162128407|NCT00967018|585519829|FG000|Overall Study|Miscellaneous Reasons|9|||
162128408|NCT04318093|585519840|FG000|Overall Study|Adverse Event|2|||
162128409|NCT04318093|585519841|FG001|Overall Study|Adverse Event|2|||
162128410|NCT04318093|585519840|FG000|Overall Study|Participant withdrew consent|1|||
162128411|NCT04318093|585519841|FG001|Overall Study|Participant withdrew consent|0|||
162128412|NCT04318093|585519840|FG000|Overall Study|Other reasons|0|||
162128413|NCT04318093|585519841|FG001|Overall Study|Other reasons|1|||
162128414|NCT01370603|585519842|FG000|Period 1|Adverse Event|5|||
162128415|NCT01370603|585519843|FG001|Period 1|Adverse Event|3|||
162128416|NCT01370603|585519842|FG000|Period 1|Lost to Follow-up|2|||
162128417|NCT01370603|585519843|FG001|Period 1|Lost to Follow-up|0|||
162128418|NCT01370603|585519842|FG000|Period 1|Protocol Violation|2|||
162128419|NCT01370603|585519843|FG001|Period 1|Protocol Violation|2|||
162128420|NCT01370603|585519842|FG000|Period 1|Withdrawal by Subject|5|||
162128421|NCT01370603|585519843|FG001|Period 1|Withdrawal by Subject|5|||
162128422|NCT01370603|585519842|FG000|Crossover Washout|Adverse Event|2|||
162128423|NCT01370603|585519843|FG001|Crossover Washout|Adverse Event|1|||
162128424|NCT01370603|585519842|FG000|Crossover Washout|Lost to Follow-up|2|||
162128425|NCT01370603|585519843|FG001|Crossover Washout|Lost to Follow-up|0|||
162128426|NCT01370603|585519842|FG000|Crossover Washout|Protocol Violation|1|||
162128427|NCT01370603|585519843|FG001|Crossover Washout|Protocol Violation|0|||
162128428|NCT01370603|585519842|FG000|Crossover Washout|Withdrawal by Subject|4|||
162128429|NCT01370603|585519843|FG001|Crossover Washout|Withdrawal by Subject|1|||
162128430|NCT01370603|585519842|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
162128431|NCT01370603|585519843|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
162128432|NCT01370603|585519842|FG000|Period 2|Adverse Event|1|||
162128433|NCT01370603|585519843|FG001|Period 2|Adverse Event|4|||
162128434|NCT01370603|585519842|FG000|Period 2|Lost to Follow-up|1|||
162128435|NCT01370603|585519843|FG001|Period 2|Lost to Follow-up|0|||
162128436|NCT01370603|585519842|FG000|Period 2|Withdrawal by Subject|1|||
162128437|NCT01370603|585519843|FG001|Period 2|Withdrawal by Subject|0|||
162128438|NCT02819479|585521434|FG000|Overall Study|Adverse Event|2|||
162128439|NCT02718417|585521435|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
162128440|NCT02718417|585521436|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
162128441|NCT02718417|585521437|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
162128442|NCT02718417|585521435|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
162128443|NCT02718417|585521436|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
162128444|NCT02718417|585521437|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
162128445|NCT02718417|585521435|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
162128446|NCT02718417|585521436|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
162128447|NCT02718417|585521437|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
162128448|NCT02718417|585521435|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
162128449|NCT02718417|585521436|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
162128450|NCT02718417|585521437|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
162128451|NCT02718417|585521435|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
162128452|NCT02718417|585521436|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
162128453|NCT02718417|585521437|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
162128454|NCT02718417|585521435|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
162128455|NCT02718417|585521436|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
162128456|NCT02718417|585521437|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
162128457|NCT02718417|585521435|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
162128458|NCT02718417|585521436|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
162128459|NCT02718417|585521437|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
162128460|NCT02718417|585521435|FG000|Chemotherapy Phase (CP)|Other|2|||
162128461|NCT02718417|585521436|FG001|Chemotherapy Phase (CP)|Other|0|||
162128462|NCT02718417|585521437|FG002|Chemotherapy Phase (CP)|Other|1|||
162128463|NCT02718417|585521435|FG000|Maintenance Phase (MP)|Adverse Event|21|||
161789385|NCT02868281|584272839|FG001|Overall Study|Physician Decision|0|||
162128464|NCT02718417|585521436|FG001|Maintenance Phase (MP)|Adverse Event|26|||
162128465|NCT02718417|585521437|FG002|Maintenance Phase (MP)|Adverse Event|0|||
162128466|NCT02718417|585521435|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
162128467|NCT02718417|585521436|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
162128468|NCT02718417|585521437|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
162128469|NCT02718417|585521435|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
162128470|NCT02718417|585521436|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
162128471|NCT02718417|585521437|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
162128472|NCT02718417|585521435|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
162128473|NCT02718417|585521436|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
162128474|NCT02718417|585521437|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
162128475|NCT02718417|585521435|FG000|Maintenance Phase (MP)|Physician's decision|6|||
162128476|NCT02718417|585521436|FG001|Maintenance Phase (MP)|Physician's decision|7|||
162128477|NCT02718417|585521437|FG002|Maintenance Phase (MP)|Physician's decision|0|||
162128478|NCT02718417|585521435|FG000|Maintenance Phase (MP)|Progressive disease|100|||
162128479|NCT02718417|585521436|FG001|Maintenance Phase (MP)|Progressive disease|88|||
162128480|NCT02718417|585521437|FG002|Maintenance Phase (MP)|Progressive disease|0|||
162128481|NCT02718417|585521435|FG000|Maintenance Phase (MP)|Other|2|||
162128482|NCT02718417|585521436|FG001|Maintenance Phase (MP)|Other|1|||
162128483|NCT02718417|585521437|FG002|Maintenance Phase (MP)|Other|0|||
162128484|NCT02718417|585521435|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
162128485|NCT02718417|585521436|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
162128486|NCT02718417|585521437|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
162128487|NCT02718417|585521435|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
162128488|NCT02718417|585521436|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
162128489|NCT02718417|585521437|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
162128490|NCT02718417|585521435|FG000|Observation Phase (OP)|Adverse Event|0|||
162128491|NCT02718417|585521436|FG001|Observation Phase (OP)|Adverse Event|0|||
162128492|NCT02718417|585521437|FG002|Observation Phase (OP)|Adverse Event|1|||
162128493|NCT02718417|585521435|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
162128494|NCT02718417|585521436|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
162128495|NCT02718417|585521437|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
162128496|NCT02718417|585521435|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
162128497|NCT02718417|585521436|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
162128498|NCT02718417|585521437|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
162128499|NCT02718417|585521435|FG000|Observation Phase (OP)|Physician Decision|0|||
162128500|NCT02718417|585521436|FG001|Observation Phase (OP)|Physician Decision|0|||
162128501|NCT02718417|585521437|FG002|Observation Phase (OP)|Physician Decision|9|||
162128502|NCT02718417|585521435|FG000|Observation Phase (OP)|Progressive disease|0|||
162128503|NCT02718417|585521436|FG001|Observation Phase (OP)|Progressive disease|0|||
162128504|NCT02718417|585521437|FG002|Observation Phase (OP)|Progressive disease|92|||
162128505|NCT02718417|585521435|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
162128506|NCT02718417|585521436|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
162128507|NCT02718417|585521437|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
162128508|NCT02718417|585521435|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
162128509|NCT02718417|585521436|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
162128510|NCT02718417|585521437|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
162128511|NCT02718417|585521435|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
162128512|NCT02718417|585521436|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
162128513|NCT02718417|585521437|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
162128514|NCT02718417|585521435|FG000|Observation Phase (OP)|Other|0|||
162128515|NCT02718417|585521436|FG001|Observation Phase (OP)|Other|0|||
162128516|NCT02718417|585521437|FG002|Observation Phase (OP)|Other|7|||
162128517|NCT02718417|585521435|FG000|Follow-up Phase|Adverse Event|3|||
162128518|NCT02718417|585521436|FG001|Follow-up Phase|Adverse Event|1|||
162128519|NCT02718417|585521437|FG002|Follow-up Phase|Adverse Event|1|||
162128520|NCT02718417|585521435|FG000|Follow-up Phase|Other|4|||
162128521|NCT02718417|585521436|FG001|Follow-up Phase|Other|6|||
162128522|NCT02718417|585521437|FG002|Follow-up Phase|Other|4|||
162128523|NCT02718417|585521435|FG000|Follow-up Phase|Withdrawal by Subject|19|||
162128524|NCT02718417|585521436|FG001|Follow-up Phase|Withdrawal by Subject|17|||
162128525|NCT02718417|585521437|FG002|Follow-up Phase|Withdrawal by Subject|5|||
162128526|NCT02718417|585521435|FG000|Follow-up Phase|Study terminated by sponsor|100|||
162128527|NCT02718417|585521436|FG001|Follow-up Phase|Study terminated by sponsor|138|||
162128528|NCT02718417|585521437|FG002|Follow-up Phase|Study terminated by sponsor|6|||
162128529|NCT02718417|585521435|FG000|Follow-up Phase|Lost to Follow-up|2|||
162128530|NCT02718417|585521436|FG001|Follow-up Phase|Lost to Follow-up|3|||
162128531|NCT02718417|585521437|FG002|Follow-up Phase|Lost to Follow-up|0|||
162128532|NCT02718417|585521435|FG000|Follow-up Phase|Death leading to discontinuation|7|||
162128533|NCT02718417|585521436|FG001|Follow-up Phase|Death leading to discontinuation|7|||
162128534|NCT02718417|585521437|FG002|Follow-up Phase|Death leading to discontinuation|3|||
162128535|NCT02718417|585521435|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
162128536|NCT02718417|585521436|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
162128537|NCT02718417|585521437|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
162128538|NCT02718417|585521435|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
162128539|NCT02718417|585521436|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
162128540|NCT02718417|585521437|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
162128541|NCT02718417|585521435|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
161898705|NCT00872521|584677880|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
161898706|NCT05225558|584677881|FG000|Overall Study|Withdrawal by Subject|4|||
162128542|NCT02718417|585521436|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
162128543|NCT02718417|585521437|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
162128544|NCT02718417|585521435|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
162128545|NCT02718417|585521436|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
162128546|NCT02718417|585521437|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
162128547|NCT02718417|585521435|FG000|Long-term Follow-up Phase|Other|0|||
162128548|NCT02718417|585521436|FG001|Long-term Follow-up Phase|Other|2|||
162128549|NCT02718417|585521437|FG002|Long-term Follow-up Phase|Other|0|||
162128550|NCT02406261|585521438|FG000|Period 1|Lost to Follow-up|2|||
162128551|NCT02406261|585521439|FG001|Period 1|Lost to Follow-up|0|||
162128552|NCT02406261|585521438|FG000|Period 1|Adverse Event|1|||
162128553|NCT02406261|585521439|FG001|Period 1|Adverse Event|0|||
162128554|NCT02406261|585521438|FG000|Period 2|Physician Decision|0|||
162128555|NCT02406261|585521439|FG001|Period 2|Physician Decision|1|||
162128556|NCT02406261|585521438|FG000|Period 2|Protocol Violation|0|||
162128557|NCT02406261|585521439|FG001|Period 2|Protocol Violation|1|||
162128558|NCT02406261|585521438|FG000|Period 2|Withdrawal by Subject|0|||
162128559|NCT02406261|585521439|FG001|Period 2|Withdrawal by Subject|1|||
162128560|NCT01567163|585521443|FG000|Overall Study|Progressive Disease|2|||
162128561|NCT01567163|585521443|FG000|Overall Study|Lost to Follow-up|2|||
162128562|NCT01720797|585521444|FG000|Overall Study|Withdrawal by Subject|3|||
162128563|NCT01720797|585521445|FG001|Overall Study|Withdrawal by Subject|0|||
162128564|NCT00393094|585521449|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
162128565|NCT00393094|585521449|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
162128566|NCT02019602|585521450|FG000|Screening Period|Ineligibility|4|||
162128567|NCT02019602|585521451|FG001|Screening Period|Ineligibility|0|||
162128568|NCT02019602|585521450|FG000|Screening Period|Adverse Event|1|||
162128569|NCT02019602|585521451|FG001|Screening Period|Adverse Event|0|||
162128570|NCT03207711|585521454|FG000|Overall Study|Withdrawal by Subject|1|||
162128571|NCT03207711|585521455|FG001|Overall Study|Withdrawal by Subject|2|||
162128572|NCT02372058|585521458|FG000|Overall Study|Withdrawal by Subject|3|||
162128573|NCT02788006|585521462|FG000|Overall Study|Patient not treated|1|||
162128574|NCT00318149|585521463|FG000|Overall Study|Adverse Event|0|||
162128575|NCT00318149|585521464|FG001|Overall Study|Adverse Event|0|||
162128576|NCT00318149|585521465|FG002|Overall Study|Adverse Event|0|||
162128577|NCT00318149|585521466|FG003|Overall Study|Adverse Event|0|||
162128578|NCT00318149|585521467|FG004|Overall Study|Adverse Event|0|||
162128579|NCT00318149|585521468|FG005|Overall Study|Adverse Event|2|||
162128580|NCT03541642|585521471|FG000|Overall Study|Withdrawal by Subject|1|||
162128581|NCT03541642|585521472|FG001|Overall Study|Withdrawal by Subject|2|||
162128582|NCT03541642|585521471|FG000|Overall Study|Lost to Follow-up|16|||
162128583|NCT03541642|585521472|FG001|Overall Study|Lost to Follow-up|12|||
162128584|NCT03541642|585521471|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
162128585|NCT03541642|585521472|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
162128586|NCT03050398|585521477|FG000|Overall Study|Study terminated by sponsor|8|||
162128587|NCT05108649|585521478|FG000|Overall Study|Lost to Follow-up|0|||
162128588|NCT05108649|585521479|FG001|Overall Study|Lost to Follow-up|4|||
162128589|NCT05108649|585521480|FG002|Overall Study|Lost to Follow-up|3|||
162128590|NCT05108649|585521481|FG003|Overall Study|Lost to Follow-up|6|||
162128591|NCT05108649|585521478|FG000|Overall Study|Not Interested|1|||
161789386|NCT02868281|584272838|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
161789387|NCT02868281|584272839|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
161789388|NCT02868281|584272838|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
161789389|NCT02868281|584272839|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
161789390|NCT02868281|584272838|FG000|Overall Study|Long journey/moving away|1|||
161789391|NCT02868281|584272839|FG001|Overall Study|Long journey/moving away|1|||
161789392|NCT01722266|584272844|FG000|Overall Study|Withdrawal by Subject|1|||
161789393|NCT01722266|584272845|FG001|Overall Study|Withdrawal by Subject|2|||
161789394|NCT01722266|584272846|FG002|Overall Study|Withdrawal by Subject|0|||
161789395|NCT01722266|584272847|FG003|Overall Study|Withdrawal by Subject|0|||
161789396|NCT01722266|584272844|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
161789397|NCT01722266|584272845|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
161789398|NCT01722266|584272846|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
162128592|NCT05108649|585521479|FG001|Overall Study|Not Interested|1|||
162128593|NCT05108649|585521480|FG002|Overall Study|Not Interested|0|||
162128594|NCT05108649|585521481|FG003|Overall Study|Not Interested|1|||
162128595|NCT05108649|585521478|FG000|Overall Study|Out of area|0|||
162128596|NCT05108649|585521479|FG001|Overall Study|Out of area|0|||
162128597|NCT05108649|585521480|FG002|Overall Study|Out of area|0|||
162128598|NCT05108649|585521481|FG003|Overall Study|Out of area|1|||
162128599|NCT05108649|585521478|FG000|Overall Study|PI decision|1|||
161789399|NCT01722266|584272847|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
161789400|NCT01722266|584272844|FG000|Overall Study|Dropped out due to Nausea|0|||
161789401|NCT01722266|584272845|FG001|Overall Study|Dropped out due to Nausea|0|||
162128600|NCT05108649|585521479|FG001|Overall Study|PI decision|0|||
162128601|NCT05108649|585521480|FG002|Overall Study|PI decision|0|||
162128602|NCT05108649|585521481|FG003|Overall Study|PI decision|0|||
162128603|NCT05108649|585521478|FG000|Overall Study|Significant Non-Compliance|0|||
162128604|NCT05108649|585521479|FG001|Overall Study|Significant Non-Compliance|1|||
162128605|NCT05108649|585521480|FG002|Overall Study|Significant Non-Compliance|0|||
162128606|NCT05108649|585521481|FG003|Overall Study|Significant Non-Compliance|0|||
162128607|NCT05108649|585521478|FG000|Overall Study|Unable to adhere to study protocol|0|||
162128608|NCT05108649|585521479|FG001|Overall Study|Unable to adhere to study protocol|2|||
162128609|NCT05108649|585521480|FG002|Overall Study|Unable to adhere to study protocol|0|||
162128610|NCT05108649|585521481|FG003|Overall Study|Unable to adhere to study protocol|0|||
162128611|NCT03523871|585521482|FG000|Overall Study|Death|1|||
162128612|NCT01083160|585521483|FG000|Overall Study|Adverse Event|1|||
162128613|NCT01951092|585521484|FG000|Overall Study|Lost to Follow-up|10|||
162128614|NCT01951092|585521484|FG000|Overall Study|Incarceration|1|||
162128615|NCT01951092|585521484|FG000|Overall Study|Transfer of Care|1|||
162128616|NCT00918749|585521485|FG000|Overall Study|Adverse Event|1|||
162128617|NCT00918749|585521486|FG001|Overall Study|Adverse Event|0|||
162128618|NCT00918749|585521487|FG002|Overall Study|Adverse Event|1|||
162128619|NCT00918749|585521485|FG000|Overall Study|Lost to Follow-up|0|||
162128620|NCT00918749|585521486|FG001|Overall Study|Lost to Follow-up|0|||
162128621|NCT00918749|585521487|FG002|Overall Study|Lost to Follow-up|1|||
162128622|NCT00918749|585521485|FG000|Overall Study|Withdrawal by Subject|5|||
162128623|NCT00918749|585521486|FG001|Overall Study|Withdrawal by Subject|3|||
162128624|NCT00918749|585521487|FG002|Overall Study|Withdrawal by Subject|5|||
162128625|NCT00918749|585521485|FG000|Overall Study|No Study Medication Taken|1|||
162128626|NCT00918749|585521486|FG001|Overall Study|No Study Medication Taken|0|||
162128627|NCT00918749|585521487|FG002|Overall Study|No Study Medication Taken|0|||
162128628|NCT01712789|585521488|FG000|Overall Study|Lack of Efficacy|2|||
162128629|NCT01712789|585521488|FG000|Overall Study|Lost to Follow-up|1|||
162128630|NCT01712789|585521488|FG000|Overall Study|Progressive Disease|504|||
162128631|NCT01712789|585521488|FG000|Overall Study|Death|57|||
162128632|NCT01712789|585521488|FG000|Overall Study|Adverse Event|52|||
162128633|NCT01712789|585521488|FG000|Overall Study|Miscellaneous|31|||
162128634|NCT01712789|585521488|FG000|Overall Study|Withdrawal by Subject|21|||
162128635|NCT01712789|585521488|FG000|Overall Study|Transition to Commercial Treatment|8|||
162128636|NCT01712789|585521488|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
162128637|NCT00219141|585521489|FG000|Overall Study|Adverse Event|4|||
162128638|NCT00219141|585521490|FG001|Overall Study|Adverse Event|10|||
162128639|NCT00219141|585521491|FG002|Overall Study|Adverse Event|5|||
162128640|NCT00219141|585521489|FG000|Overall Study|Lack of Efficacy|3|||
162128641|NCT00219141|585521490|FG001|Overall Study|Lack of Efficacy|2|||
162128642|NCT00219141|585521491|FG002|Overall Study|Lack of Efficacy|0|||
162128643|NCT00219141|585521489|FG000|Overall Study|Administrative problems|0|||
162128644|NCT00219141|585521490|FG001|Overall Study|Administrative problems|1|||
162128645|NCT00219141|585521491|FG002|Overall Study|Administrative problems|0|||
162128646|NCT00219141|585521489|FG000|Overall Study|Lost to Follow-up|2|||
162128647|NCT00219141|585521490|FG001|Overall Study|Lost to Follow-up|4|||
162128648|NCT00219141|585521491|FG002|Overall Study|Lost to Follow-up|1|||
162128649|NCT00219141|585521489|FG000|Overall Study|Protocol Violation|3|||
162128650|NCT00219141|585521490|FG001|Overall Study|Protocol Violation|1|||
162128651|NCT00219141|585521491|FG002|Overall Study|Protocol Violation|1|||
162128652|NCT00219141|585521489|FG000|Overall Study|Withdrawal by Subject|1|||
162128653|NCT00219141|585521490|FG001|Overall Study|Withdrawal by Subject|3|||
162128654|NCT00219141|585521491|FG002|Overall Study|Withdrawal by Subject|5|||
162128655|NCT00219141|585521489|FG000|Overall Study|Condition no longer requires study drug|1|||
162128656|NCT00219141|585521490|FG001|Overall Study|Condition no longer requires study drug|0|||
162128657|NCT00219141|585521491|FG002|Overall Study|Condition no longer requires study drug|0|||
162128658|NCT00972179|585521492|FG000|Overall Study|Noncompliance|1|||
162128659|NCT00972179|585521493|FG001|Overall Study|Noncompliance|0|||
162128660|NCT00972179|585521494|FG002|Overall Study|Noncompliance|0|||
162128661|NCT00972179|585521495|FG003|Overall Study|Noncompliance|0|||
162128662|NCT00972179|585521496|FG004|Overall Study|Noncompliance|1|||
162128663|NCT00972179|585521497|FG005|Overall Study|Noncompliance|0|||
162128664|NCT00972179|585521498|FG006|Overall Study|Noncompliance|1|||
162128665|NCT00972179|585521492|FG000|Overall Study|Withdrawal by Subject|0|||
162128666|NCT00972179|585521493|FG001|Overall Study|Withdrawal by Subject|3|||
162128667|NCT00972179|585521494|FG002|Overall Study|Withdrawal by Subject|0|||
162128668|NCT00972179|585521495|FG003|Overall Study|Withdrawal by Subject|1|||
162128669|NCT00972179|585521496|FG004|Overall Study|Withdrawal by Subject|0|||
162128670|NCT00972179|585521497|FG005|Overall Study|Withdrawal by Subject|0|||
162128671|NCT00972179|585521498|FG006|Overall Study|Withdrawal by Subject|2|||
162128672|NCT00972179|585521492|FG000|Overall Study|Administrative Decision|0|||
162128673|NCT00972179|585521493|FG001|Overall Study|Administrative Decision|0|||
162128674|NCT00972179|585521494|FG002|Overall Study|Administrative Decision|0|||
162128675|NCT00972179|585521495|FG003|Overall Study|Administrative Decision|0|||
162128676|NCT00972179|585521496|FG004|Overall Study|Administrative Decision|1|||
162128677|NCT00972179|585521497|FG005|Overall Study|Administrative Decision|0|||
162128678|NCT00972179|585521498|FG006|Overall Study|Administrative Decision|0|||
162128679|NCT00972179|585521492|FG000|Overall Study|Lost to Follow-up|0|||
162128680|NCT00972179|585521493|FG001|Overall Study|Lost to Follow-up|0|||
162128681|NCT00972179|585521494|FG002|Overall Study|Lost to Follow-up|1|||
162128682|NCT00972179|585521495|FG003|Overall Study|Lost to Follow-up|0|||
162128683|NCT00972179|585521496|FG004|Overall Study|Lost to Follow-up|0|||
162128684|NCT00972179|585521497|FG005|Overall Study|Lost to Follow-up|3|||
162128685|NCT00972179|585521498|FG006|Overall Study|Lost to Follow-up|1|||
162128686|NCT03018106|585521499|FG000|Overall Study|Lost to Follow-up|0|||
162128687|NCT03018106|585521500|FG001|Overall Study|Lost to Follow-up|1|||
162128688|NCT03055832|585521501|FG000|Week 2|Withdrawal by Subject|1|||
162128689|NCT03055832|585521502|FG001|Week 2|Withdrawal by Subject|0|||
162128690|NCT00136916|585521503|FG000|Overall Study|Never received study treatment|3|||
162128691|NCT00136916|585521504|FG001|Overall Study|Never received study treatment|5|||
162128692|NCT00136916|585521503|FG000|Overall Study|Death|1|||
162128693|NCT00136916|585521504|FG001|Overall Study|Death|3|||
162128694|NCT00136916|585521503|FG000|Overall Study|Adverse Event|27|||
162128695|NCT00136916|585521504|FG001|Overall Study|Adverse Event|8|||
162128696|NCT00136916|585521503|FG000|Overall Study|Laboratory abnormality|0|||
162128697|NCT00136916|585521504|FG001|Overall Study|Laboratory abnormality|1|||
162128698|NCT00136916|585521503|FG000|Overall Study|Lack of Efficacy|13|||
162128699|NCT00136916|585521504|FG001|Overall Study|Lack of Efficacy|3|||
162128700|NCT00136916|585521503|FG000|Overall Study|Lost to Follow-up|12|||
162128701|NCT00136916|585521504|FG001|Overall Study|Lost to Follow-up|14|||
162128702|NCT00136916|585521503|FG000|Overall Study|Withdrawal by Subject|44|||
162128703|NCT00136916|585521504|FG001|Overall Study|Withdrawal by Subject|46|||
162128704|NCT00136916|585521503|FG000|Overall Study|Other|22|||
162128705|NCT00136916|585521504|FG001|Overall Study|Other|24|||
162128706|NCT00136916|585521503|FG000|Overall Study|Discontinued in follow up period|3|||
162128707|NCT00136916|585521504|FG001|Overall Study|Discontinued in follow up period|0|||
162128708|NCT01994720|585521505|FG000|Overall Study|Withdrawal by Subject|46|||
162128709|NCT01994720|585521506|FG001|Overall Study|Withdrawal by Subject|56|||
162128710|NCT01991197|585521507|FG000|Overall Study|Lost to Follow-up|1|||
162128711|NCT01991197|585521508|FG001|Overall Study|Lost to Follow-up|1|||
162128712|NCT01991197|585521507|FG000|Overall Study|Physician Decision|0|||
162128713|NCT01991197|585521508|FG001|Overall Study|Physician Decision|2|||
162128714|NCT01991197|585521507|FG000|Overall Study|Withdrawal by Subject|2|||
162128715|NCT01991197|585521508|FG001|Overall Study|Withdrawal by Subject|0|||
162128716|NCT01012973|585521509|FG000|Overall Study|Adverse Event|5|||
162128717|NCT01012973|585521510|FG001|Overall Study|Adverse Event|5|||
162128718|NCT01012973|585521509|FG000|Overall Study|Lack of Efficacy|0|||
162128719|NCT01012973|585521510|FG001|Overall Study|Lack of Efficacy|5|||
162128720|NCT01012973|585521509|FG000|Overall Study|Lost to Follow-up|1|||
162128721|NCT01012973|585521510|FG001|Overall Study|Lost to Follow-up|0|||
162128722|NCT01012973|585521509|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
162128723|NCT01012973|585521510|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
162128724|NCT01012973|585521509|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
162128725|NCT01012973|585521510|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
162128726|NCT01012973|585521509|FG000|Overall Study|Protocol Violation|5|||
162128727|NCT01012973|585521510|FG001|Overall Study|Protocol Violation|2|||
162128728|NCT01012973|585521509|FG000|Overall Study|Withdrawal by Subject|4|||
162128729|NCT01012973|585521510|FG001|Overall Study|Withdrawal by Subject|6|||
162128730|NCT02213055|585521511|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
162128731|NCT02213055|585521512|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
162128732|NCT02213055|585521511|FG000|Overall Study|Protocol was not Followed during Study|1|||
162128733|NCT02213055|585521512|FG001|Overall Study|Protocol was not Followed during Study|0|||
162128734|NCT02213055|585521511|FG000|Overall Study|Documentation Issue at Enrollment|1|||
162128735|NCT02213055|585521512|FG001|Overall Study|Documentation Issue at Enrollment|0|||
162128736|NCT02213055|585521511|FG000|Overall Study|Documentation Issue during Study|10|||
162128737|NCT02213055|585521512|FG001|Overall Study|Documentation Issue during Study|0|||
162128738|NCT02213055|585521511|FG000|Overall Study|Did not have Live Lice|8|||
162128739|NCT02213055|585521512|FG001|Overall Study|Did not have Live Lice|0|||
162128740|NCT02213055|585521511|FG000|Overall Study|Had another Treatment during the Study|3|||
162128741|NCT02213055|585521512|FG001|Overall Study|Had another Treatment during the Study|0|||
162128742|NCT02213055|585521511|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
162128743|NCT02213055|585521512|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
162128744|NCT02213055|585521511|FG000|Overall Study|Did not Return to School|5|||
162128745|NCT02213055|585521512|FG001|Overall Study|Did not Return to School|0|||
162128746|NCT01932996|585521513|FG000|Overall Study|Protocol Violation|2|||
162128747|NCT01932996|585521514|FG001|Overall Study|Protocol Violation|0|||
162128748|NCT00846742|585521517|FG000|Overall Study|Withdrawal by Subject|1|||
162128749|NCT05868954|585521523|FG000|Overall Study|Lost to Follow-up|0|||
162128750|NCT05868954|585521524|FG001|Overall Study|Lost to Follow-up|1|||
162128751|NCT05868954|585521523|FG000|Overall Study|Withdrawal by Subject|2|||
162128752|NCT05868954|585521524|FG001|Overall Study|Withdrawal by Subject|2|||
162128753|NCT05868954|585521523|FG000|Overall Study|Participant delivered|1|||
162128754|NCT05868954|585521524|FG001|Overall Study|Participant delivered|1|||
162128755|NCT05868954|585521523|FG000|Overall Study|Miscarriage|0|||
162128756|NCT05868954|585521524|FG001|Overall Study|Miscarriage|1|||
162128757|NCT01435798|585521529|FG000|Overall Study|Withdrawal by Subject|1|||
162128758|NCT03257995|585521533|FG000|Overall Study|Adverse Event|0|||
162128759|NCT03257995|585521534|FG001|Overall Study|Adverse Event|1|||
162128760|NCT03257995|585521535|FG002|Overall Study|Adverse Event|0|||
162128761|NCT03257995|585521536|FG003|Overall Study|Adverse Event|0|||
162128762|NCT03257995|585521537|FG004|Overall Study|Adverse Event|0|||
162128763|NCT03257995|585521538|FG005|Overall Study|Adverse Event|0|||
162128764|NCT03257995|585521533|FG000|Overall Study|Protocol deviation|0|||
162128765|NCT03257995|585521534|FG001|Overall Study|Protocol deviation|0|||
162128766|NCT03257995|585521535|FG002|Overall Study|Protocol deviation|0|||
162128767|NCT03257995|585521536|FG003|Overall Study|Protocol deviation|0|||
162128768|NCT03257995|585521537|FG004|Overall Study|Protocol deviation|0|||
162128769|NCT03257995|585521538|FG005|Overall Study|Protocol deviation|2|||
162128770|NCT04170296|585521543|FG000|Overall Study|Adverse Event|1|||
162128771|NCT04170296|585521544|FG001|Overall Study|Adverse Event|0|||
162128772|NCT04170296|585521543|FG000|Overall Study|Withdrawal by Subject|3|||
162128773|NCT04170296|585521544|FG001|Overall Study|Withdrawal by Subject|2|||
162128774|NCT04170296|585521543|FG000|Overall Study|Lost to Follow-up|4|||
162128775|NCT04170296|585521544|FG001|Overall Study|Lost to Follow-up|2|||
162128776|NCT03567993|585521545|FG000|Overall Study|Lost to Follow-up|4|||
162128777|NCT03567993|585521546|FG001|Overall Study|Lost to Follow-up|2|||
162128778|NCT03567993|585521545|FG000|Overall Study|Death|1|||
162128779|NCT03567993|585521546|FG001|Overall Study|Death|1|||
162128780|NCT03567993|585521545|FG000|Overall Study|Withdrawal by Subject|1|||
162128781|NCT03567993|585521546|FG001|Overall Study|Withdrawal by Subject|0|||
162128782|NCT00903786|585521547|FG000|Overall Study|Physician Decision|6|||
162128783|NCT00903786|585521547|FG000|Overall Study|Lack of Efficacy|5|||
162128784|NCT00903786|585521547|FG000|Overall Study|Reason other than lack of efficacy|4|||
162128785|NCT02285595|585521548|FG000|Overall Study|Lost to Follow-up|14|||
162128786|NCT02285595|585521548|FG000|Overall Study|Withdrawal by Subject|1|||
162128787|NCT01960790|585521549|FG000|Overall Study|Survey forms could not be recovered|3|||
162128788|NCT01960790|585521549|FG000|Overall Study|Treat with Humira outside survey period|3|||
162128789|NCT01960790|585521549|FG000|Overall Study|Transferred to another hospital|4|||
162128790|NCT01960790|585521549|FG000|Overall Study|Unevaluable for safety|1|||
162128791|NCT00064025|585521550|FG000|Overall Study|Ineligible|4|||
162128792|NCT00064025|585521550|FG000|Overall Study|Inevaluable|3|||
162128793|NCT02468934|585521551|FG000|Overall Study|Withdrawal by Subject|4|||
162128794|NCT02468934|585521551|FG000|Overall Study|Screen Failure|3|||
162128795|NCT00547911|585521556|FG000|Overall Study|Adverse Event|0|||
162128796|NCT00547911|585521557|FG001|Overall Study|Adverse Event|0|||
162128797|NCT00547911|585521558|FG002|Overall Study|Adverse Event|0|||
162128798|NCT00547911|585521559|FG003|Overall Study|Adverse Event|1|||
162128799|NCT00547911|585521560|FG004|Overall Study|Adverse Event|0|||
162128800|NCT00547911|585521561|FG005|Overall Study|Adverse Event|0|||
162128801|NCT02133924|585521562|FG000|Overall Study|Death|38|||
162128802|NCT02133924|585521562|FG000|Overall Study|Physician Decision|1|||
162128803|NCT02133924|585521562|FG000|Overall Study|Withdrawal by Subject|3|||
162128804|NCT01644474|585521564|FG000|Overall Study|Poor compliance to protocol|1|||
162128805|NCT01644474|585521565|FG001|Overall Study|Poor compliance to protocol|0|||
162128806|NCT01644474|585521564|FG000|Overall Study|Consent withdrawn by participant|0|||
162128807|NCT01644474|585521565|FG001|Overall Study|Consent withdrawn by participant|1|||
162128808|NCT01644474|585521564|FG000|Overall Study|Participant moved|0|||
162128809|NCT01644474|585521565|FG001|Overall Study|Participant moved|1|||
162128810|NCT01644474|585521564|FG000|Overall Study|Adverse Event|4|||
162128811|NCT01644474|585521565|FG001|Overall Study|Adverse Event|5|||
162128812|NCT01644474|585521564|FG000|Overall Study|Site scheduling error|1|||
162128813|NCT01644474|585521565|FG001|Overall Study|Site scheduling error|1|||
162128814|NCT01644474|585521564|FG000|Overall Study|Protocol Violation|1|||
162128815|NCT01644474|585521565|FG001|Overall Study|Protocol Violation|0|||
162128816|NCT01163747|585521571|FG000|Overall Study|Adverse Event|0|||
162128817|NCT01163747|585521572|FG001|Overall Study|Adverse Event|5|||
162128818|NCT01163747|585521571|FG000|Overall Study|Insufficient Therapeutic Response|0|||
162128819|NCT01163747|585521572|FG001|Overall Study|Insufficient Therapeutic Response|1|||
162128820|NCT01163747|585521571|FG000|Overall Study|Protocol Violation|0|||
162128821|NCT01163747|585521572|FG001|Overall Study|Protocol Violation|1|||
162128822|NCT01163747|585521571|FG000|Overall Study|Refused Treatment|6|||
162128823|NCT01163747|585521572|FG001|Overall Study|Refused Treatment|4|||
162128824|NCT02044458|585521573|FG000|Overall Study|Protocol Violation|3|||
162128825|NCT02044458|585521574|FG001|Overall Study|Protocol Violation|8|||
162128826|NCT01268059|585523135|FG000|Overall Study|Lost to Follow-up|0|||
162128827|NCT01268059|585523136|FG001|Overall Study|Lost to Follow-up|1|||
162128828|NCT01268059|585523137|FG002|Overall Study|Lost to Follow-up|0|||
162128829|NCT01268059|585523138|FG003|Overall Study|Lost to Follow-up|0|||
162128830|NCT01268059|585523135|FG000|Overall Study|Withdrawal by Subject|7|||
162128831|NCT01268059|585523136|FG001|Overall Study|Withdrawal by Subject|4|||
162128832|NCT01268059|585523137|FG002|Overall Study|Withdrawal by Subject|0|||
162128833|NCT01268059|585523138|FG003|Overall Study|Withdrawal by Subject|0|||
162128834|NCT01268059|585523135|FG000|Overall Study|Death|20|||
162128835|NCT01268059|585523136|FG001|Overall Study|Death|30|||
162128836|NCT01268059|585523137|FG002|Overall Study|Death|3|||
162128837|NCT01268059|585523138|FG003|Overall Study|Death|5|||
162128838|NCT01268059|585523135|FG000|Overall Study|Progression of disease|1|||
162128839|NCT01268059|585523136|FG001|Overall Study|Progression of disease|0|||
162128840|NCT01268059|585523137|FG002|Overall Study|Progression of disease|0|||
162128841|NCT01268059|585523138|FG003|Overall Study|Progression of disease|0|||
162128842|NCT03660943|585523139|FG000|Overall Study|Adverse Event|5|||
162128843|NCT03660943|585523140|FG001|Overall Study|Adverse Event|3|||
162128844|NCT03660943|585523139|FG000|Overall Study|Death|0|||
162128845|NCT03660943|585523140|FG001|Overall Study|Death|2|||
162128846|NCT03660943|585523139|FG000|Overall Study|Lost to Follow-up|7|||
162128847|NCT03660943|585523140|FG001|Overall Study|Lost to Follow-up|3|||
162128848|NCT03660943|585523139|FG000|Overall Study|Protocol Violation|3|||
162128849|NCT03660943|585523140|FG001|Overall Study|Protocol Violation|5|||
162128850|NCT03660943|585523139|FG000|Overall Study|Withdrawal by Subject|8|||
162128851|NCT03660943|585523140|FG001|Overall Study|Withdrawal by Subject|15|||
162128852|NCT03660943|585523139|FG000|Overall Study|Lack of Efficacy|9|||
162128853|NCT03660943|585523140|FG001|Overall Study|Lack of Efficacy|12|||
162128854|NCT03660943|585523139|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
162128855|NCT03660943|585523140|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
162128856|NCT03699124|585523141|FG000|Overall Study|Adverse Event|6|||
162128857|NCT03699124|585523142|FG001|Overall Study|Adverse Event|5|||
162128858|NCT03699124|585523143|FG002|Overall Study|Adverse Event|2|||
162128859|NCT03699124|585523141|FG000|Overall Study|Death|0|||
162128860|NCT03699124|585523142|FG001|Overall Study|Death|2|||
162128861|NCT03699124|585523143|FG002|Overall Study|Death|0|||
162128862|NCT03699124|585523141|FG000|Overall Study|Lost to Follow-up|20|||
162128863|NCT03699124|585523142|FG001|Overall Study|Lost to Follow-up|16|||
162128864|NCT03699124|585523143|FG002|Overall Study|Lost to Follow-up|15|||
162128865|NCT03699124|585523141|FG000|Overall Study|Protocol Violation|1|||
162128866|NCT03699124|585523142|FG001|Overall Study|Protocol Violation|0|||
162128867|NCT03699124|585523143|FG002|Overall Study|Protocol Violation|0|||
162128868|NCT03699124|585523141|FG000|Overall Study|Withdrawal by Subject|13|||
162128869|NCT03699124|585523142|FG001|Overall Study|Withdrawal by Subject|14|||
162128870|NCT03699124|585523143|FG002|Overall Study|Withdrawal by Subject|13|||
162128871|NCT03699124|585523141|FG000|Overall Study|Other reasons|5|||
162128872|NCT03699124|585523142|FG001|Overall Study|Other reasons|3|||
162128873|NCT03699124|585523143|FG002|Overall Study|Other reasons|10|||
162128874|NCT00724061|585523149|FG000|Dose Escalation Phase|Adverse Event|2|||
162128875|NCT00724061|585523149|FG000|Dose Escalation Phase|Disease Progression|3|||
162128876|NCT01536145|585523152|FG000|Overall Study|Progressive disease|3|||
162128877|NCT01536145|585523153|FG001|Overall Study|Progressive disease|4|||
162128878|NCT01536145|585523154|FG002|Overall Study|Progressive disease|1|||
162128879|NCT01536145|585523155|FG003|Overall Study|Progressive disease|2|||
162128880|NCT01536145|585523156|FG004|Overall Study|Progressive disease|1|||
162128881|NCT01536145|585523157|FG005|Overall Study|Progressive disease|2|||
162128882|NCT01536145|585523158|FG006|Overall Study|Progressive disease|1|||
162128883|NCT01536145|585523159|FG007|Overall Study|Progressive disease|2|||
162128884|NCT01536145|585523160|FG008|Overall Study|Progressive disease|1|||
162128885|NCT01536145|585523161|FG009|Overall Study|Progressive disease|3|||
162128886|NCT01536145|585523162|FG010|Overall Study|Progressive disease|3|||
162128887|NCT01536145|585523152|FG000|Overall Study|Withdrawal by Subject|0|||
162128888|NCT01536145|585523153|FG001|Overall Study|Withdrawal by Subject|0|||
162128889|NCT01536145|585523154|FG002|Overall Study|Withdrawal by Subject|1|||
162128890|NCT01536145|585523155|FG003|Overall Study|Withdrawal by Subject|0|||
162128891|NCT01536145|585523156|FG004|Overall Study|Withdrawal by Subject|0|||
162128892|NCT01536145|585523157|FG005|Overall Study|Withdrawal by Subject|1|||
162128893|NCT01536145|585523158|FG006|Overall Study|Withdrawal by Subject|0|||
162128894|NCT01536145|585523159|FG007|Overall Study|Withdrawal by Subject|0|||
162128895|NCT01536145|585523160|FG008|Overall Study|Withdrawal by Subject|2|||
162128896|NCT01536145|585523161|FG009|Overall Study|Withdrawal by Subject|0|||
162128897|NCT01536145|585523162|FG010|Overall Study|Withdrawal by Subject|2|||
162128898|NCT01536145|585523152|FG000|Overall Study|Other|0|||
162128899|NCT01536145|585523153|FG001|Overall Study|Other|0|||
162128900|NCT01536145|585523154|FG002|Overall Study|Other|0|||
162128901|NCT01536145|585523155|FG003|Overall Study|Other|0|||
162128902|NCT01536145|585523156|FG004|Overall Study|Other|1|||
162128903|NCT01536145|585523157|FG005|Overall Study|Other|0|||
162128904|NCT01536145|585523158|FG006|Overall Study|Other|0|||
162128905|NCT01536145|585523159|FG007|Overall Study|Other|0|||
162128906|NCT01536145|585523160|FG008|Overall Study|Other|0|||
162128907|NCT01536145|585523161|FG009|Overall Study|Other|3|||
162128908|NCT01536145|585523162|FG010|Overall Study|Other|2|||
162128909|NCT01536145|585523152|FG000|Overall Study|Death|0|||
162128910|NCT01536145|585523153|FG001|Overall Study|Death|0|||
162128911|NCT01536145|585523154|FG002|Overall Study|Death|0|||
162128912|NCT01536145|585523155|FG003|Overall Study|Death|0|||
162128913|NCT01536145|585523156|FG004|Overall Study|Death|0|||
162128914|NCT01536145|585523157|FG005|Overall Study|Death|0|||
162128915|NCT01536145|585523158|FG006|Overall Study|Death|1|||
162128916|NCT01536145|585523159|FG007|Overall Study|Death|0|||
162128917|NCT01536145|585523160|FG008|Overall Study|Death|0|||
162128918|NCT01536145|585523161|FG009|Overall Study|Death|0|||
162128919|NCT01536145|585523162|FG010|Overall Study|Death|0|||
162128920|NCT01536145|585523152|FG000|Overall Study|Adverse Event|0|||
162128921|NCT01536145|585523153|FG001|Overall Study|Adverse Event|0|||
161789402|NCT01722266|584272846|FG002|Overall Study|Dropped out due to Nausea|2|||
161789403|NCT01722266|584272847|FG003|Overall Study|Dropped out due to Nausea|0|||
161789404|NCT03811249|584272848|FG000|Overall Study|Withdrawal by Subject|44|||
161789405|NCT03811249|584272848|FG000|Overall Study|Missed Visit|24|||
161789406|NCT00124449|584272849|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
161789407|NCT00124449|584272850|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
161789408|NCT00124449|584272849|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
161789409|NCT00124449|584272850|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
161789410|NCT00124449|584272849|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
161789411|NCT00124449|584272850|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
161789412|NCT00124449|584272849|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
161789413|NCT00124449|584272850|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
161789414|NCT00124449|584272849|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
161789415|NCT00124449|584272850|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
161789416|NCT00124449|584272849|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
161789417|NCT00124449|584272850|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
161789418|NCT00124449|584272849|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
161789419|NCT00124449|584272850|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
161789420|NCT00124449|584272849|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
161789421|NCT00124449|584272850|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
161789422|NCT00124449|584272849|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
161789423|NCT00124449|584272850|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
161789424|NCT00124449|584272849|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
161789425|NCT00124449|584272850|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
161789426|NCT00124449|584272849|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
161789427|NCT00124449|584272850|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
161789428|NCT00124449|584272849|FG000|18-Month Untreated Observation Period|Relocated|1|||
161789429|NCT00124449|584272850|FG001|18-Month Untreated Observation Period|Relocated|0|||
161789430|NCT03210259|584272860|FG000|12-Week Run-in Period|Adverse Event|1|||
161789431|NCT03210259|584272861|FG001|12-Week Run-in Period|Adverse Event|0|||
161789432|NCT03210259|584272862|FG002|12-Week Run-in Period|Adverse Event|0|||
161789433|NCT03210259|584272860|FG000|12-Week Run-in Period|Death|1|||
161789434|NCT03210259|584272861|FG001|12-Week Run-in Period|Death|0|||
161789435|NCT03210259|584272862|FG002|12-Week Run-in Period|Death|0|||
161789436|NCT03210259|584272860|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
161789437|NCT03210259|584272861|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
161789438|NCT03210259|584272862|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
161789439|NCT03210259|584272860|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
161789440|NCT03210259|584272861|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
161789441|NCT03210259|584272862|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
161789442|NCT03210259|584272860|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
161789443|NCT03210259|584272861|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
161789444|NCT03210259|584272862|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
161789445|NCT03210259|584272860|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
161789446|NCT03210259|584272861|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
161789447|NCT03210259|584272862|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
161789448|NCT03210259|584272860|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
161789449|NCT03210259|584272861|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
161789450|NCT03210259|584272862|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
161789451|NCT03210259|584272860|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
161789452|NCT03210259|584272861|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
161789453|NCT03210259|584272862|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
161789454|NCT03210259|584272860|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
161789455|NCT03210259|584272861|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
161789456|NCT03210259|584272862|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
161898707|NCT05225558|584677882|FG001|Overall Study|Withdrawal by Subject|3|||
161898708|NCT05225558|584677881|FG000|Overall Study|Adverse Event|1|||
161898709|NCT05225558|584677882|FG001|Overall Study|Adverse Event|0|||
162128922|NCT01536145|585523154|FG002|Overall Study|Adverse Event|0|||
162128923|NCT01536145|585523155|FG003|Overall Study|Adverse Event|0|||
162128924|NCT01536145|585523156|FG004|Overall Study|Adverse Event|0|||
162128925|NCT01536145|585523157|FG005|Overall Study|Adverse Event|0|||
162128926|NCT01536145|585523158|FG006|Overall Study|Adverse Event|0|||
162128927|NCT01536145|585523159|FG007|Overall Study|Adverse Event|2|||
162128928|NCT01536145|585523160|FG008|Overall Study|Adverse Event|0|||
162128929|NCT01536145|585523161|FG009|Overall Study|Adverse Event|0|||
162128930|NCT01536145|585523162|FG010|Overall Study|Adverse Event|3|||
162128931|NCT00088205|585523165|FG000|Overall Study|Adverse Event|4|||
162128932|NCT00088205|585523165|FG000|Overall Study|Progressive Disease|51|||
162128933|NCT00088205|585523165|FG000|Overall Study|Physician Decision|1|||
162128934|NCT00088205|585523165|FG000|Overall Study|Death Due to Study Disease|4|||
162128935|NCT05199233|585523166|FG000|Overall Study|Lack of Efficacy|1|||
162128936|NCT00688259|585523169|FG000|Overall Study|Lost to Follow-up|2|||
162128937|NCT00688259|585523170|FG001|Overall Study|Lost to Follow-up|4|||
162128938|NCT00688259|585523169|FG000|Overall Study|Physician Decision|1|||
162128939|NCT00688259|585523170|FG001|Overall Study|Physician Decision|0|||
162128940|NCT00688259|585523169|FG000|Overall Study|Withdrawal by Subject|2|||
162128941|NCT00688259|585523170|FG001|Overall Study|Withdrawal by Subject|0|||
162128942|NCT00688259|585523169|FG000|Overall Study|Declined Interview|2|||
162128943|NCT00688259|585523170|FG001|Overall Study|Declined Interview|3|||
162128944|NCT00688259|585523169|FG000|Overall Study|Hospitalized at Follow-up|0|||
162128945|NCT00688259|585523170|FG001|Overall Study|Hospitalized at Follow-up|1|||
162128946|NCT02491892|585523173|FG000|Overall Study|Adverse Event|1|||
162128947|NCT02491892|585523174|FG001|Overall Study|Adverse Event|1|||
162128948|NCT02491892|585523173|FG000|Overall Study|Death|1|||
162128949|NCT02491892|585523174|FG001|Overall Study|Death|1|||
162128950|NCT02491892|585523173|FG000|Overall Study|Lack of Efficacy|37|||
162128951|NCT02491892|585523174|FG001|Overall Study|Lack of Efficacy|36|||
162128952|NCT02491892|585523173|FG000|Overall Study|Refused Treatment|1|||
162128953|NCT02491892|585523174|FG001|Overall Study|Refused Treatment|0|||
162128954|NCT02491892|585523173|FG000|Overall Study|Lost to Follow-up|1|||
162128955|NCT02491892|585523174|FG001|Overall Study|Lost to Follow-up|0|||
162128956|NCT02982720|585523175|FG000|Overall Study|Adverse Event|3|||
162128957|NCT02982720|585523175|FG000|Overall Study|Death|1|||
162128958|NCT01734850|585523180|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
162128959|NCT01734850|585523181|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
162128960|NCT01734850|585523182|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
162128961|NCT01734850|585523180|FG000|Overall Study|Not infused due to manufacturing failure|0|||
162128962|NCT01734850|585523181|FG001|Overall Study|Not infused due to manufacturing failure|0|||
162128963|NCT01734850|585523182|FG002|Overall Study|Not infused due to manufacturing failure|1|||
162128964|NCT03824938|585523183|FG000|Overall Study|Withdrawal by Subject|2|||
162128965|NCT03824938|585523184|FG001|Overall Study|Withdrawal by Subject|1|||
162128966|NCT03824938|585523185|FG002|Overall Study|Withdrawal by Subject|0|||
162128967|NCT03824938|585523186|FG003|Overall Study|Withdrawal by Subject|2|||
162128968|NCT03824938|585523187|FG004|Overall Study|Withdrawal by Subject|0|||
162128969|NCT03824938|585523188|FG005|Overall Study|Withdrawal by Subject|1|||
162128970|NCT03824938|585523183|FG000|Overall Study|Lost to Follow-up|0|||
162128971|NCT03824938|585523184|FG001|Overall Study|Lost to Follow-up|1|||
162128972|NCT03824938|585523185|FG002|Overall Study|Lost to Follow-up|0|||
162128973|NCT03824938|585523186|FG003|Overall Study|Lost to Follow-up|0|||
162128974|NCT03824938|585523187|FG004|Overall Study|Lost to Follow-up|1|||
162128975|NCT03824938|585523188|FG005|Overall Study|Lost to Follow-up|0|||
162128976|NCT00287469|585523189|FG000|Overall Study|serious adverse event|1|||
162128977|NCT00287469|585523190|FG001|Overall Study|serious adverse event|6|||
162128978|NCT00287469|585523189|FG000|Overall Study|Adverse Event|1|||
162128979|NCT00287469|585523190|FG001|Overall Study|Adverse Event|1|||
162128980|NCT00287469|585523189|FG000|Overall Study|moved from area|144|||
162128981|NCT00287469|585523190|FG001|Overall Study|moved from area|138|||
162128982|NCT00287469|585523189|FG000|Overall Study|Lost to Follow-up|74|||
162128983|NCT00287469|585523190|FG001|Overall Study|Lost to Follow-up|69|||
162128984|NCT01058863|585523191|FG000|Overall Study|Lost to Follow-up|1|||
162128985|NCT01058863|585523191|FG000|Overall Study|Withdrawal by Subject|1|||
162128986|NCT01058863|585523191|FG000|Overall Study|Sponsor requested withdrawal|1|||
162128987|NCT01058863|585523191|FG000|Overall Study|Randomized in error|1|||
162128988|NCT03653416|585523192|FG000|Overall Study|Protocol Violation|6|||
162128989|NCT03653416|585523193|FG001|Overall Study|Protocol Violation|1|||
162128990|NCT03619174|585523194|FG000|Overall Study|Lost to Follow-up|3|||
162128991|NCT03619174|585523195|FG001|Overall Study|Lost to Follow-up|0|||
162128992|NCT03619174|585523194|FG000|Overall Study|Withdrawal by Subject|4|||
162128993|NCT03619174|585523195|FG001|Overall Study|Withdrawal by Subject|3|||
162128994|NCT03619174|585523194|FG000|Overall Study|Pregnancy|1|||
161898710|NCT05225558|584677881|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
162128995|NCT03619174|585523195|FG001|Overall Study|Pregnancy|1|||
162128996|NCT03619174|585523194|FG000|Overall Study|Discomfort during treatment|1|||
162128997|NCT03619174|585523195|FG001|Overall Study|Discomfort during treatment|0|||
162128998|NCT02448719|585523201|FG000|Overall Study|Withdrawal by Subject|0|||
162128999|NCT02448719|585523202|FG001|Overall Study|Withdrawal by Subject|0|||
162129000|NCT02448719|585523203|FG002|Overall Study|Withdrawal by Subject|0|||
161942196|NCT02082977|584838336|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
162129001|NCT02448719|585523204|FG003|Overall Study|Withdrawal by Subject|0|||
162129002|NCT02448719|585523205|FG004|Overall Study|Withdrawal by Subject|1|||
162129003|NCT02448719|585523206|FG005|Overall Study|Withdrawal by Subject|0|||
162129004|NCT02448719|585523207|FG006|Overall Study|Withdrawal by Subject|0|||
162129005|NCT02448719|585523208|FG007|Overall Study|Withdrawal by Subject|0|||
162129006|NCT02448719|585523209|FG008|Overall Study|Withdrawal by Subject|0|||
162129007|NCT02448719|585523210|FG009|Overall Study|Withdrawal by Subject|0|||
162129008|NCT02448719|585523211|FG010|Overall Study|Withdrawal by Subject|0|||
162129009|NCT01556763|585523215|FG000|Overall Study|Withdrawal by Subject|0|||
162129010|NCT01556763|585523216|FG001|Overall Study|Withdrawal by Subject|1|||
162129011|NCT01556763|585523217|FG002|Overall Study|Withdrawal by Subject|0|||
162129012|NCT02258464|585523218|FG000|Overall Study|Progressive disease (PD)|9|||
162129013|NCT02258464|585523219|FG001|Overall Study|Progressive disease (PD)|17|||
162129014|NCT02258464|585523218|FG000|Overall Study|Study drug never administered|1|||
162129015|NCT02258464|585523219|FG001|Overall Study|Study drug never administered|1|||
162129016|NCT02258464|585523218|FG000|Overall Study|AE not related to clinical PD|1|||
162129017|NCT02258464|585523219|FG001|Overall Study|AE not related to clinical PD|3|||
162129018|NCT02258464|585523218|FG000|Overall Study|Withdrawal by Subject|5|||
162129019|NCT02258464|585523219|FG001|Overall Study|Withdrawal by Subject|4|||
162129020|NCT02258464|585523218|FG000|Overall Study|AE related to clinical PD|1|||
162129021|NCT02258464|585523219|FG001|Overall Study|AE related to clinical PD|0|||
162129022|NCT00932646|585523220|FG000|Overall Study|Adverse Event|2|||
162129023|NCT00932646|585523221|FG001|Overall Study|Adverse Event|1|||
162129024|NCT00932646|585523222|FG002|Overall Study|Adverse Event|1|||
162129025|NCT00932646|585523223|FG003|Overall Study|Adverse Event|1|||
162129026|NCT00932646|585523220|FG000|Overall Study|Lost to Follow-up|2|||
162129027|NCT00932646|585523221|FG001|Overall Study|Lost to Follow-up|1|||
162129028|NCT00932646|585523222|FG002|Overall Study|Lost to Follow-up|0|||
162129029|NCT00932646|585523223|FG003|Overall Study|Lost to Follow-up|0|||
162129030|NCT00932646|585523220|FG000|Overall Study|Withdrawal by Subject|1|||
162129031|NCT00932646|585523221|FG001|Overall Study|Withdrawal by Subject|1|||
162129032|NCT00932646|585523222|FG002|Overall Study|Withdrawal by Subject|3|||
162129033|NCT00932646|585523223|FG003|Overall Study|Withdrawal by Subject|0|||
162129034|NCT00653263|585523224|FG000|Overall Study|Withdrawal by Subject|1|||
162129035|NCT00653263|585523224|FG000|Overall Study|Physician Decision|1|||
162129036|NCT00776100|585523225|FG000|Overall Study|Disease Progression|1|||
162129037|NCT00776100|585523226|FG001|Overall Study|Disease Progression|0|||
162129038|NCT04759885|585523233|FG000|Overall Study|Other|1|||
162129039|NCT04759885|585523234|FG001|Overall Study|Other|0|||
162129040|NCT04759885|585523235|FG002|Overall Study|Other|2|||
162129041|NCT04759885|585523236|FG003|Overall Study|Other|0|||
162129042|NCT04759885|585523237|FG004|Overall Study|Other|0|||
162129043|NCT04759885|585523233|FG000|Overall Study|Withdrawal by Subject|0|||
162129044|NCT04759885|585523234|FG001|Overall Study|Withdrawal by Subject|0|||
162129045|NCT04759885|585523235|FG002|Overall Study|Withdrawal by Subject|1|||
162129046|NCT04759885|585523236|FG003|Overall Study|Withdrawal by Subject|9|||
162129047|NCT04759885|585523237|FG004|Overall Study|Withdrawal by Subject|6|||
162129048|NCT04759885|585523233|FG000|Overall Study|Adverse Event|0|||
162129049|NCT04759885|585523234|FG001|Overall Study|Adverse Event|0|||
162129050|NCT04759885|585523235|FG002|Overall Study|Adverse Event|0|||
162129051|NCT04759885|585523236|FG003|Overall Study|Adverse Event|3|||
162129052|NCT04759885|585523237|FG004|Overall Study|Adverse Event|0|||
162129053|NCT04759885|585523233|FG000|Overall Study|Physician Decision|0|||
162129054|NCT04759885|585523234|FG001|Overall Study|Physician Decision|0|||
162129055|NCT04759885|585523235|FG002|Overall Study|Physician Decision|0|||
162129056|NCT04759885|585523236|FG003|Overall Study|Physician Decision|2|||
162129057|NCT04759885|585523237|FG004|Overall Study|Physician Decision|0|||
162129058|NCT00195715|585523238|FG000|Overall Study|Adverse Event|122|||
162129059|NCT00195715|585523238|FG000|Overall Study|Withdrawal by Subject|58|||
162129060|NCT00195715|585523238|FG000|Overall Study|Lost to Follow-up|27|||
162129061|NCT00195715|585523238|FG000|Overall Study|Protocol Violation|13|||
162129062|NCT00195715|585523238|FG000|Overall Study|Lack of Efficacy|93|||
162129063|NCT00195715|585523238|FG000|Overall Study|Pregnancy|14|||
162129064|NCT00195715|585523238|FG000|Overall Study|Investigative site closure|8|||
162129065|NCT00195715|585523238|FG000|Overall Study|Subject moved/relocated|7|||
162129066|NCT00195715|585523238|FG000|Overall Study|Subject non-compliance|6|||
162129067|NCT00195715|585523238|FG000|Overall Study|Subject started commercial Humira|5|||
162129068|NCT00195715|585523238|FG000|Overall Study|Subject choice|3|||
162129069|NCT00195715|585523238|FG000|Overall Study|Loss of response/no improvement|3|||
162129070|NCT00195715|585523238|FG000|Overall Study|Sponsor stopped study|1|||
162129071|NCT00195715|585523238|FG000|Overall Study|Administrative reasons|2|||
162129072|NCT00195715|585523238|FG000|Overall Study|Investigator's decision|2|||
162129073|NCT00195715|585523238|FG000|Overall Study|Subject wants to get pregnant|4|||
162129074|NCT00195715|585523238|FG000|Overall Study|Use of prohibited medication|2|||
162129075|NCT00195715|585523238|FG000|Overall Study|Planned surgery|2|||
162129076|NCT00195715|585523238|FG000|Overall Study|Increased infection rate|1|||
162129077|NCT00195715|585523238|FG000|Overall Study|Ineligible|1|||
162129078|NCT00195715|585523238|FG000|Overall Study|Colonic stricture|1|||
162129079|NCT00195715|585523238|FG000|Overall Study|Sponsor discontinued trial|1|||
162129080|NCT00195715|585523238|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
162129081|NCT05822921|585523243|FG000|Overall Study|Lost to Follow-up|1|||
162129082|NCT05822921|585523244|FG001|Overall Study|Lost to Follow-up|1|||
162129083|NCT01267253|585523247|FG000|Overall Study|Ineligible - required test not done|1|||
162129084|NCT01267253|585523247|FG000|Overall Study|Inevaluable-never received study treatme|2|||
162129085|NCT00996580|585523248|FG000|Overall Study|Adverse Event|466|||
162129086|NCT00996580|585523248|FG000|Overall Study|Lost to Follow-up|480|||
162129087|NCT00996580|585523248|FG000|Overall Study|Noncompliance with the protocol|137|||
162129088|NCT00996580|585523248|FG000|Overall Study|Physician Decision|5|||
162129089|NCT00996580|585523248|FG000|Overall Study|Pregnancy|68|||
162129090|NCT00996580|585523248|FG000|Overall Study|Protocol Violation|16|||
162129091|NCT00996580|585523248|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
162129092|NCT00996580|585523248|FG000|Overall Study|Withdrawal by Subject|217|||
162129093|NCT00996580|585523248|FG000|Overall Study|Other|29|||
162129094|NCT02036515|585523249|FG000|Overall Study|Adverse Event|1|||
162129095|NCT02036515|585523250|FG001|Overall Study|Adverse Event|1|||
162129096|NCT02036515|585523251|FG002|Overall Study|Adverse Event|2|||
162129097|NCT02036515|585523249|FG000|Overall Study|Lost to Follow-up|0|||
162129098|NCT02036515|585523250|FG001|Overall Study|Lost to Follow-up|2|||
162129099|NCT02036515|585523251|FG002|Overall Study|Lost to Follow-up|0|||
162129100|NCT02036515|585523249|FG000|Overall Study|Non-compliance with study drug|0|||
162129101|NCT02036515|585523250|FG001|Overall Study|Non-compliance with study drug|0|||
162129102|NCT02036515|585523251|FG002|Overall Study|Non-compliance with study drug|2|||
162129103|NCT02036515|585523249|FG000|Overall Study|Screen failure|0|||
162129104|NCT02036515|585523250|FG001|Overall Study|Screen failure|2|||
162129105|NCT02036515|585523251|FG002|Overall Study|Screen failure|0|||
162129106|NCT02036515|585523249|FG000|Overall Study|Withdrawal by Subject|4|||
162129107|NCT02036515|585523250|FG001|Overall Study|Withdrawal by Subject|7|||
162129108|NCT02036515|585523251|FG002|Overall Study|Withdrawal by Subject|9|||
162129109|NCT02036515|585523249|FG000|Overall Study|Hyperglycemia|0|||
162129110|NCT02036515|585523250|FG001|Overall Study|Hyperglycemia|0|||
162129111|NCT02036515|585523251|FG002|Overall Study|Hyperglycemia|1|||
162129112|NCT02218489|585523258|FG000|Overall Study|Withdrawal by Subject|4|||
162129113|NCT02218489|585523259|FG001|Overall Study|Withdrawal by Subject|3|||
162129114|NCT02218489|585523258|FG000|Overall Study|Lost to Follow-up|1|||
162129115|NCT02218489|585523259|FG001|Overall Study|Lost to Follow-up|0|||
162129116|NCT04039503|585523260|FG000|Overall Study|Adverse Event|3|||
162129117|NCT04039503|585523261|FG001|Overall Study|Adverse Event|0|||
162129118|NCT04039503|585523262|FG002|Overall Study|Adverse Event|2|||
162129119|NCT04039503|585523263|FG003|Overall Study|Adverse Event|0|||
162129120|NCT04039503|585523260|FG000|Overall Study|Lost to Follow-up|0|||
162129121|NCT04039503|585523261|FG001|Overall Study|Lost to Follow-up|0|||
162129122|NCT04039503|585523262|FG002|Overall Study|Lost to Follow-up|1|||
162129123|NCT04039503|585523263|FG003|Overall Study|Lost to Follow-up|0|||
162129124|NCT04039503|585523260|FG000|Overall Study|Protocol Violation|0|||
162129125|NCT04039503|585523261|FG001|Overall Study|Protocol Violation|1|||
162129126|NCT04039503|585523262|FG002|Overall Study|Protocol Violation|2|||
162129127|NCT04039503|585523263|FG003|Overall Study|Protocol Violation|1|||
162129128|NCT04039503|585523260|FG000|Overall Study|Withdrawal by Subject|4|||
162129129|NCT04039503|585523261|FG001|Overall Study|Withdrawal by Subject|3|||
162129130|NCT04039503|585523262|FG002|Overall Study|Withdrawal by Subject|5|||
162129131|NCT04039503|585523263|FG003|Overall Study|Withdrawal by Subject|2|||
162129132|NCT02601937|585523270|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
162129133|NCT02601937|585523271|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
162129134|NCT02601937|585523272|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
162129135|NCT02601937|585523273|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
162129136|NCT02601937|585523274|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
162129137|NCT02601937|585523275|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
162129138|NCT02601937|585523276|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
162129139|NCT02601937|585523277|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
162129140|NCT02601937|585523278|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
162129141|NCT02601937|585523279|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
162129142|NCT02601937|585523280|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
162129143|NCT02601937|585523270|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
162129144|NCT02601937|585523271|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162129145|NCT02601937|585523272|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162129146|NCT02601937|585523273|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162129147|NCT02601937|585523274|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162129148|NCT02601937|585523275|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162129149|NCT02601937|585523276|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
162129150|NCT02601937|585523277|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162129151|NCT02601937|585523278|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162129152|NCT02601937|585523279|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162129153|NCT02601937|585523280|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
162129154|NCT02601937|585523270|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162129155|NCT02601937|585523271|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162129156|NCT02601937|585523272|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
162129157|NCT02601937|585523273|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162129158|NCT02601937|585523274|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162129159|NCT02601937|585523275|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162129160|NCT02601937|585523276|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162129161|NCT02601937|585523277|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162129162|NCT02601937|585523278|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162129163|NCT02601937|585523279|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162129164|NCT02601937|585523280|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
162129165|NCT02601937|585523270|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
162129166|NCT02601937|585523271|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
162129167|NCT02601937|585523272|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
162129168|NCT02601937|585523273|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
162129169|NCT02601937|585523274|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
162129170|NCT02601937|585523275|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
162129171|NCT02601937|585523276|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
162129172|NCT02601937|585523277|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
162129173|NCT02601937|585523278|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
162129174|NCT02601937|585523279|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
162129175|NCT02601937|585523280|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
162129176|NCT02601937|585523270|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162129177|NCT02601937|585523271|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162129178|NCT02601937|585523272|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162129179|NCT02601937|585523273|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162129180|NCT02601937|585523274|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162129181|NCT02601937|585523275|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162129182|NCT02601937|585523276|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162129183|NCT02601937|585523277|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162129184|NCT02601937|585523278|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162129185|NCT02601937|585523279|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
162129186|NCT02601937|585523280|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
162129187|NCT02601937|585523270|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162129188|NCT02601937|585523271|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162129189|NCT02601937|585523272|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162129190|NCT02601937|585523273|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162129191|NCT02601937|585523274|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162129192|NCT02601937|585523275|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162129193|NCT02601937|585523276|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162129194|NCT02601937|585523277|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
162129195|NCT02601937|585523278|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162129196|NCT02601937|585523279|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162129197|NCT02601937|585523280|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
162129198|NCT02601937|585523270|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162129199|NCT02601937|585523271|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162129200|NCT02601937|585523272|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162129201|NCT02601937|585523273|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162129202|NCT02601937|585523274|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162129203|NCT02601937|585523275|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162129204|NCT02601937|585523276|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162129205|NCT02601937|585523277|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162129206|NCT02601937|585523278|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
162129207|NCT02601937|585523279|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
162129208|NCT02601937|585523280|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
162129209|NCT02601937|585523270|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162129210|NCT02601937|585523271|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162129211|NCT02601937|585523272|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162129212|NCT02601937|585523273|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162129213|NCT02601937|585523274|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162129214|NCT02601937|585523275|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162129215|NCT02601937|585523276|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
162129216|NCT02601937|585523277|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
162010589|NCT00463567|585095916|FG006|Overall Study|Administrative problems|2|||
162010590|NCT00463567|585095910|FG000|Overall Study|Lack of Efficacy|4|||
162010591|NCT00463567|585095911|FG001|Overall Study|Lack of Efficacy|9|||
162010592|NCT00463567|585095912|FG002|Overall Study|Lack of Efficacy|9|||
162010593|NCT00463567|585095913|FG003|Overall Study|Lack of Efficacy|17|||
162010594|NCT00463567|585095914|FG004|Overall Study|Lack of Efficacy|1|||
162010595|NCT00463567|585095915|FG005|Overall Study|Lack of Efficacy|0|||
162010596|NCT00463567|585095916|FG006|Overall Study|Lack of Efficacy|1|||
162010597|NCT00463567|585095910|FG000|Overall Study|Abnormal lab value(s)|1|||
162010598|NCT00463567|585095911|FG001|Overall Study|Abnormal lab value(s)|1|||
162010599|NCT00463567|585095912|FG002|Overall Study|Abnormal lab value(s)|2|||
162010600|NCT00463567|585095913|FG003|Overall Study|Abnormal lab value(s)|1|||
162010601|NCT00463567|585095914|FG004|Overall Study|Abnormal lab value(s)|1|||
162010602|NCT00463567|585095915|FG005|Overall Study|Abnormal lab value(s)|0|||
162010603|NCT00463567|585095916|FG006|Overall Study|Abnormal lab value(s)|0|||
162010604|NCT00463567|585095910|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162010605|NCT00463567|585095911|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162010606|NCT00463567|585095912|FG002|Overall Study|Abnormal test procedure result(s)|6|||
162010607|NCT00463567|585095913|FG003|Overall Study|Abnormal test procedure result(s)|2|||
162010608|NCT00463567|585095914|FG004|Overall Study|Abnormal test procedure result(s)|0|||
162010609|NCT00463567|585095915|FG005|Overall Study|Abnormal test procedure result(s)|2|||
162010610|NCT00463567|585095916|FG006|Overall Study|Abnormal test procedure result(s)|0|||
162010611|NCT00463567|585095910|FG000|Overall Study|Death|1|||
162010612|NCT00463567|585095911|FG001|Overall Study|Death|0|||
162010613|NCT00463567|585095912|FG002|Overall Study|Death|2|||
162010614|NCT00463567|585095913|FG003|Overall Study|Death|0|||
162010615|NCT00463567|585095914|FG004|Overall Study|Death|0|||
162010616|NCT00463567|585095915|FG005|Overall Study|Death|0|||
162010617|NCT00463567|585095916|FG006|Overall Study|Death|0|||
162010618|NCT01712399|585095921|FG000|Overall Study|Lost to Follow-up|1|||
162010619|NCT01712399|585095921|FG000|Overall Study|Withdrawal by Subject|39|||
162010620|NCT01712399|585095921|FG000|Overall Study|Death|1|||
162010621|NCT01712399|585095921|FG000|Overall Study|Adverse Event|11|||
162010622|NCT01712399|585095921|FG000|Overall Study|Study closure|345|||
162010623|NCT01705509|585095927|FG000|Inclusion CPET|Screen Failure|5|||
162010624|NCT01705509|585095927|FG000|Inclusion CPET|Withdrawal by Subject|2|||
162010625|NCT01705509|585095927|FG000|CPET w/ Ranexa|Screen Failure|2|||
162010626|NCT00904033|585095928|FG000|Overall Study|Withdrawal by Subject|1|||
162010627|NCT00904033|585095929|FG001|Overall Study|Withdrawal by Subject|1|||
162010628|NCT00904033|585095930|FG002|Overall Study|Withdrawal by Subject|0|||
162010629|NCT00904033|585095931|FG003|Overall Study|Withdrawal by Subject|0|||
162010630|NCT00904033|585095928|FG000|Overall Study|Physician Decision|0|||
162010631|NCT00904033|585095929|FG001|Overall Study|Physician Decision|0|||
162010632|NCT00904033|585095930|FG002|Overall Study|Physician Decision|1|||
162010633|NCT00904033|585095931|FG003|Overall Study|Physician Decision|0|||
162010634|NCT00904033|585095928|FG000|Overall Study|Unable to obtain final blood draw|0|||
162010635|NCT00904033|585095929|FG001|Overall Study|Unable to obtain final blood draw|0|||
162010636|NCT00904033|585095930|FG002|Overall Study|Unable to obtain final blood draw|0|||
162010637|NCT00904033|585095931|FG003|Overall Study|Unable to obtain final blood draw|2|||
162010638|NCT01357850|585095932|FG000|Overall Study|Lost to Follow-up|1|||
162010639|NCT01357850|585095933|FG001|Overall Study|Lost to Follow-up|0|||
162010640|NCT01357850|585095934|FG002|Overall Study|Lost to Follow-up|0|||
162010641|NCT01357850|585095935|FG003|Overall Study|Lost to Follow-up|0|||
162010642|NCT02736890|585095936|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
162010643|NCT02736890|585095937|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
162010644|NCT02736890|585095936|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
162010645|NCT02736890|585095937|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
162010646|NCT01803607|585095939|FG000|Overall Study|Adverse Event|5|||
162010647|NCT01803607|585095940|FG001|Overall Study|Adverse Event|3|||
162010648|NCT01803607|585095939|FG000|Overall Study|Lack of Efficacy|0|||
162010649|NCT01803607|585095940|FG001|Overall Study|Lack of Efficacy|1|||
162010650|NCT01803607|585095939|FG000|Overall Study|Protocol Violation|3|||
162010651|NCT01803607|585095940|FG001|Overall Study|Protocol Violation|2|||
162010652|NCT01803607|585095939|FG000|Overall Study|Study terminated by sponsor|54|||
162010653|NCT01803607|585095940|FG001|Overall Study|Study terminated by sponsor|56|||
162010654|NCT01803607|585095939|FG000|Overall Study|Withdrawal by Subject|6|||
162010655|NCT01803607|585095940|FG001|Overall Study|Withdrawal by Subject|5|||
162010656|NCT03077412|585095941|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
162010657|NCT03077412|585095942|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
162010658|NCT03077412|585095943|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
162010659|NCT03077412|585095941|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
162010660|NCT03077412|585095942|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
162010661|NCT03077412|585095943|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
162010662|NCT03077412|585095941|FG000|Overall Study|Adverse Event|1|||
162010663|NCT03077412|585095942|FG001|Overall Study|Adverse Event|2|||
162129217|NCT02601937|585523278|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
162129218|NCT02601937|585523279|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
162129219|NCT02601937|585523280|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
162129220|NCT02601937|585523270|FG000|Period 2: Dose Expansion Cohort|Other|0|||
162129221|NCT02601937|585523271|FG001|Period 2: Dose Expansion Cohort|Other|0|||
162129222|NCT02601937|585523272|FG002|Period 2: Dose Expansion Cohort|Other|0|||
162129223|NCT02601937|585523273|FG003|Period 2: Dose Expansion Cohort|Other|0|||
162129224|NCT02601937|585523274|FG004|Period 2: Dose Expansion Cohort|Other|0|||
162129225|NCT02601937|585523275|FG005|Period 2: Dose Expansion Cohort|Other|0|||
162129226|NCT02601937|585523276|FG006|Period 2: Dose Expansion Cohort|Other|0|||
162129227|NCT02601937|585523277|FG007|Period 2: Dose Expansion Cohort|Other|0|||
162129228|NCT02601937|585523278|FG008|Period 2: Dose Expansion Cohort|Other|2|||
162129229|NCT02601937|585523279|FG009|Period 2: Dose Expansion Cohort|Other|2|||
162129230|NCT02601937|585523280|FG010|Period 2: Dose Expansion Cohort|Other|0|||
162129231|NCT02601937|585523270|FG000|Period 2: Dose Expansion Cohort|Death|0|||
162129232|NCT02601937|585523271|FG001|Period 2: Dose Expansion Cohort|Death|0|||
162129233|NCT02601937|585523272|FG002|Period 2: Dose Expansion Cohort|Death|0|||
162129234|NCT02601937|585523273|FG003|Period 2: Dose Expansion Cohort|Death|0|||
162129235|NCT02601937|585523274|FG004|Period 2: Dose Expansion Cohort|Death|0|||
162129236|NCT02601937|585523275|FG005|Period 2: Dose Expansion Cohort|Death|0|||
162129237|NCT02601937|585523276|FG006|Period 2: Dose Expansion Cohort|Death|0|||
162129238|NCT02601937|585523277|FG007|Period 2: Dose Expansion Cohort|Death|0|||
162129239|NCT02601937|585523278|FG008|Period 2: Dose Expansion Cohort|Death|1|||
162129240|NCT02601937|585523279|FG009|Period 2: Dose Expansion Cohort|Death|0|||
162129241|NCT02601937|585523280|FG010|Period 2: Dose Expansion Cohort|Death|0|||
162129242|NCT02924389|585523282|FG000|Overall Study|Lost to Follow-up|1|||
162129243|NCT02924389|585523283|FG001|Overall Study|Lost to Follow-up|0|||
162129244|NCT02924389|585523282|FG000|Overall Study|Physician Decision|2|||
162129245|NCT02924389|585523283|FG001|Overall Study|Physician Decision|0|||
162129246|NCT02924389|585523282|FG000|Overall Study|Withdrawal by Subject|3|||
162129247|NCT02924389|585523283|FG001|Overall Study|Withdrawal by Subject|0|||
162129248|NCT02924389|585523282|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
162129249|NCT02924389|585523283|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
162129250|NCT03038672|585524468|FG000|Initial Treatment|Unacceptable chemistry|0|||
162129251|NCT03038672|585524469|FG001|Initial Treatment|Unacceptable chemistry|1|||
162129252|NCT03038672|585524468|FG000|Initial Treatment|Progression prior to treatment|1|||
162129253|NCT03038672|585524469|FG001|Initial Treatment|Progression prior to treatment|0|||
162129254|NCT03038672|585524468|FG000|Initial Treatment|No treatment per protocol|1|||
162129255|NCT03038672|585524469|FG001|Initial Treatment|No treatment per protocol|0|||
162129256|NCT05220501|585524470|FG000|Overall Study|Withdrawal by Subject|11|||
162129257|NCT05220501|585524471|FG001|Overall Study|Withdrawal by Subject|21|||
162129258|NCT05220501|585524472|FG002|Overall Study|Withdrawal by Subject|32|||
162129259|NCT05220501|585524470|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
162129260|NCT05220501|585524471|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
162129261|NCT05220501|585524472|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
162129262|NCT02692235|585524473|FG000|Overall Study|Withdrawal by Subject|2|||
162129263|NCT02692235|585524474|FG001|Overall Study|Withdrawal by Subject|1|||
162129264|NCT02692235|585524473|FG000|Overall Study|Adverse Event|1|||
162129265|NCT02692235|585524474|FG001|Overall Study|Adverse Event|2|||
162129266|NCT00802841|585524475|FG000|Overall Study|Administrative problems|1|||
162129267|NCT00802841|585524476|FG001|Overall Study|Administrative problems|0|||
162129268|NCT00802841|585524475|FG000|Overall Study|Lost to Follow-up|2|||
162129269|NCT00802841|585524476|FG001|Overall Study|Lost to Follow-up|1|||
162129270|NCT00802841|585524475|FG000|Overall Study|Death|1|||
162129271|NCT00802841|585524476|FG001|Overall Study|Death|2|||
162129272|NCT00802841|585524475|FG000|Overall Study|Adverse Event|8|||
162129273|NCT00802841|585524476|FG001|Overall Study|Adverse Event|2|||
162129274|NCT00802841|585524475|FG000|Overall Study|Disease progression|7|||
162129275|NCT00802841|585524476|FG001|Overall Study|Disease progression|3|||
162129276|NCT00802841|585524475|FG000|Overall Study|Withdrawal by Subject|9|||
162129277|NCT00802841|585524476|FG001|Overall Study|Withdrawal by Subject|5|||
162129278|NCT00802841|585524475|FG000|Overall Study|Protocol deviation|2|||
162129279|NCT00802841|585524476|FG001|Overall Study|Protocol deviation|6|||
162129280|NCT00802841|585524475|FG000|Overall Study|Treatment duration completed|66|||
162129281|NCT00802841|585524476|FG001|Overall Study|Treatment duration completed|76|||
162129282|NCT01929993|585524478|FG000|Overall Study|Protocol Violation|4|||
162129283|NCT01929993|585524479|FG001|Overall Study|Protocol Violation|6|||
162129284|NCT01929993|585524478|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
162129285|NCT01929993|585524479|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
162129286|NCT03595683|585524480|FG000|Overall Study|Adverse Event|1|||
162129287|NCT03595683|585524481|FG001|Overall Study|Adverse Event|0|||
162129288|NCT03595683|585524480|FG000|Overall Study|Pursue alternative therapy|1|||
162129289|NCT03595683|585524481|FG001|Overall Study|Pursue alternative therapy|1|||
162129290|NCT03595683|585524480|FG000|Overall Study|Progressive disease|1|||
162129291|NCT03595683|585524481|FG001|Overall Study|Progressive disease|3|||
162129292|NCT01021878|585524482|FG000|Overall Study|Lost to Follow-up|4|||
162129293|NCT01021878|585524483|FG001|Overall Study|Lost to Follow-up|3|||
162129294|NCT01021878|585524482|FG000|Overall Study|Death|0|||
162129295|NCT01021878|585524483|FG001|Overall Study|Death|1|||
162129296|NCT01021878|585524482|FG000|Overall Study|Adverse Event|6|||
162129297|NCT01021878|585524483|FG001|Overall Study|Adverse Event|5|||
162129298|NCT01021878|585524482|FG000|Overall Study|Transplantation|6|||
162129299|NCT01021878|585524483|FG001|Overall Study|Transplantation|1|||
162129300|NCT03158948|585524485|FG000|Overall Study|Death|1|||
162129301|NCT03158948|585524486|FG001|Overall Study|Death|1|||
162129302|NCT03158948|585524487|FG002|Overall Study|Death|3|||
162129303|NCT03158948|585524488|FG003|Overall Study|Death|2|||
162129304|NCT03158948|585524485|FG000|Overall Study|Physician Decision|0|||
162129305|NCT03158948|585524486|FG001|Overall Study|Physician Decision|0|||
162129306|NCT03158948|585524487|FG002|Overall Study|Physician Decision|0|||
162129307|NCT03158948|585524488|FG003|Overall Study|Physician Decision|1|||
162129308|NCT00472186|585524489|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
162129309|NCT00472186|585524490|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
162129310|NCT05876351|585524491|FG000|Overall Study|Other than specified|2|||
162129311|NCT05876351|585524491|FG000|Overall Study|Study specific discontinuation criteria|1|||
162129312|NCT00997243|585524492|FG000|Overall Study|Early termination of study by sponsor|7|||
162129313|NCT03415022|585524495|FG000|Overall Study|Withdrawal by Subject|1|||
162129314|NCT03415022|585524496|FG001|Overall Study|Withdrawal by Subject|2|||
162129315|NCT03415022|585524495|FG000|Overall Study|COVID-19 Suspension|2|||
162129316|NCT03415022|585524496|FG001|Overall Study|COVID-19 Suspension|3|||
162129317|NCT03415022|585524495|FG000|Overall Study|Lost to Follow-up|2|||
162129318|NCT03415022|585524496|FG001|Overall Study|Lost to Follow-up|0|||
162129319|NCT02086552|585524499|FG000|Overall Study|Withdrawal by Subject|1|||
162129320|NCT02206152|585524500|FG000|Pre-Randomization|Withdrawal by Subject|2|||
162129321|NCT00478608|585524501|FG000|Overall Study|Adverse Event|1|||
162129322|NCT00478608|585524501|FG000|Overall Study|Serious Adverse Event|14|||
162129323|NCT00478608|585524501|FG000|Overall Study|Withdrawal by Subject|2|||
162129324|NCT00478608|585524501|FG000|Overall Study|Protocol Violation|3|||
162129325|NCT01349907|585524502|FG000|Overall Study|Adverse Event|37|||
162129326|NCT01349907|585524503|FG001|Overall Study|Adverse Event|11|||
162129327|NCT01349907|585524502|FG000|Overall Study|Treatment failure|13|||
162129328|NCT01349907|585524503|FG001|Overall Study|Treatment failure|4|||
162129329|NCT01349907|585524502|FG000|Overall Study|Lost to Follow-up|25|||
162129330|NCT01349907|585524503|FG001|Overall Study|Lost to Follow-up|6|||
162129331|NCT01349907|585524502|FG000|Overall Study|Withdrawal by Subject|30|||
162129332|NCT01349907|585524503|FG001|Overall Study|Withdrawal by Subject|8|||
162129333|NCT01349907|585524502|FG000|Overall Study|Protocol Violation|33|||
162129334|NCT01349907|585524503|FG001|Overall Study|Protocol Violation|13|||
162129335|NCT01349907|585524502|FG000|Overall Study|Administrative|1|||
162129336|NCT01349907|585524503|FG001|Overall Study|Administrative|1|||
162129337|NCT03583541|585524511|FG000|Overall Study|Lost to Follow-up|31|||
162129338|NCT03583541|585524512|FG001|Overall Study|Lost to Follow-up|65|||
162129339|NCT00884286|585524514|FG000|Overall Study|Progressive disease|21|||
162129340|NCT00884286|585524515|FG001|Overall Study|Progressive disease|28|||
162129341|NCT00884286|585524514|FG000|Overall Study|Toxicity|4|||
162129342|NCT00884286|585524515|FG001|Overall Study|Toxicity|1|||
162129343|NCT00884286|585524514|FG000|Overall Study|Death|2|||
162129344|NCT00884286|585524515|FG001|Overall Study|Death|2|||
162129345|NCT00884286|585524514|FG000|Overall Study|Physician Decision|1|||
162129346|NCT00884286|585524515|FG001|Overall Study|Physician Decision|0|||
162129347|NCT00884286|585524514|FG000|Overall Study|Septic shock|1|||
162129348|NCT00884286|585524515|FG001|Overall Study|Septic shock|0|||
162129349|NCT00884286|585524514|FG000|Overall Study|Thrombus in right auricle|1|||
162129350|NCT00884286|585524515|FG001|Overall Study|Thrombus in right auricle|0|||
162129351|NCT00884286|585524514|FG000|Overall Study|Not treated|2|||
162129352|NCT00884286|585524515|FG001|Overall Study|Not treated|1|||
162129353|NCT00884286|585524514|FG000|Overall Study|Comprised lung carcinoma|0|||
162010664|NCT03077412|585095943|FG002|Overall Study|Adverse Event|2|||
162129354|NCT00884286|585524515|FG001|Overall Study|Comprised lung carcinoma|1|||
162129355|NCT01196104|585524516|FG000|Overall Study|Lost to Follow-up|1|||
162129356|NCT01196104|585524517|FG001|Overall Study|Lost to Follow-up|0|||
162129357|NCT01196104|585524516|FG000|Overall Study|Physician Decision|0|||
162129358|NCT01196104|585524517|FG001|Overall Study|Physician Decision|1|||
162129359|NCT01196104|585524516|FG000|Overall Study|Withdrawal by Subject|3|||
162129360|NCT01196104|585524517|FG001|Overall Study|Withdrawal by Subject|3|||
162129361|NCT01196104|585524516|FG000|Overall Study|Various|0|||
162129362|NCT01196104|585524517|FG001|Overall Study|Various|1|||
162129363|NCT00594932|585524523|FG000|First 3 Months|Withdrawal by Subject|1|||
162129364|NCT00594932|585524524|FG001|First 3 Months|Withdrawal by Subject|3|||
162129365|NCT00594932|585524523|FG000|Final 3 Months|Withdrawal by Subject|4|||
162129366|NCT00594932|585524524|FG001|Final 3 Months|Withdrawal by Subject|3|||
162129367|NCT01094171|585524525|FG000|Overall Study|Lost to Follow-up|2|||
162129368|NCT01094171|585524525|FG000|Overall Study|Informed consent withdrawal|4|||
162129369|NCT01094171|585524525|FG000|Overall Study|Migration from the study area|3|||
162129370|NCT01094171|585524525|FG000|Overall Study|Other|1|||
162129371|NCT00065468|585524531|FG000|Overall Study|Death|172|||
162129372|NCT00065468|585524532|FG001|Overall Study|Death|169|||
162129373|NCT00065468|585524533|FG002|Overall Study|Death|171|||
162129374|NCT00065468|585524531|FG000|Overall Study|Withdrawal by Subject|3|||
162129375|NCT00065468|585524532|FG001|Overall Study|Withdrawal by Subject|4|||
162129376|NCT00065468|585524533|FG002|Overall Study|Withdrawal by Subject|5|||
162129377|NCT00065468|585524531|FG000|Overall Study|Lost to Follow-up|5|||
162129378|NCT00065468|585524532|FG001|Overall Study|Lost to Follow-up|3|||
162129379|NCT00065468|585524533|FG002|Overall Study|Lost to Follow-up|2|||
162129380|NCT00065468|585524531|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
162129381|NCT00065468|585524532|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
162129382|NCT00065468|585524533|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
162129383|NCT00065468|585524531|FG000|Overall Study|Disease progression|0|||
162129384|NCT00065468|585524532|FG001|Overall Study|Disease progression|0|||
162129385|NCT00065468|585524533|FG002|Overall Study|Disease progression|1|||
162129386|NCT00065468|585524531|FG000|Overall Study|Other|14|||
162129387|NCT00065468|585524532|FG001|Overall Study|Other|24|||
162129388|NCT00065468|585524533|FG002|Overall Study|Other|18|||
162129389|NCT04496167|585524534|FG000|Overall Study|Adverse Event|6|||
162129390|NCT04496167|585524535|FG001|Overall Study|Adverse Event|2|||
162129391|NCT04496167|585524534|FG000|Overall Study|Withdrawal by Subject|7|||
162129392|NCT04496167|585524535|FG001|Overall Study|Withdrawal by Subject|6|||
162129393|NCT04496167|585524534|FG000|Overall Study|Lost to Follow-up|3|||
162129394|NCT04496167|585524535|FG001|Overall Study|Lost to Follow-up|5|||
162129395|NCT04496167|585524534|FG000|Overall Study|Not Treated|1|||
162129396|NCT04496167|585524535|FG001|Overall Study|Not Treated|2|||
162129397|NCT04496167|585524534|FG000|Overall Study|Other Than Specified|1|||
162129398|NCT04496167|585524535|FG001|Overall Study|Other Than Specified|1|||
162129399|NCT00681187|585524536|FG000|Overall Study|Withdrawal by Subject|1|||
162129400|NCT00681187|585524537|FG001|Overall Study|Withdrawal by Subject|0|||
162129401|NCT00681187|585524536|FG000|Overall Study|Death|0|||
162129402|NCT00681187|585524537|FG001|Overall Study|Death|1|||
162129403|NCT00681187|585524536|FG000|Overall Study|Adverse Event|0|||
162129404|NCT00681187|585524537|FG001|Overall Study|Adverse Event|1|||
162129405|NCT00598481|585524538|FG000|Treatment|Physician Decision|1|||
162129406|NCT04707391|585524544|FG000|Overall Study|Adverse Event|5|||
162129407|NCT04707391|585524545|FG001|Overall Study|Adverse Event|8|||
162129408|NCT04707391|585524544|FG000|Overall Study|Lost to Follow-up|44|||
162129409|NCT04707391|585524545|FG001|Overall Study|Lost to Follow-up|31|||
162129410|NCT04707391|585524544|FG000|Overall Study|Protocol Violation|1|||
162129411|NCT04707391|585524545|FG001|Overall Study|Protocol Violation|5|||
162129412|NCT04707391|585524544|FG000|Overall Study|Withdrawal by Subject|27|||
162129413|NCT04707391|585524545|FG001|Overall Study|Withdrawal by Subject|25|||
162129414|NCT04707391|585524544|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
162129415|NCT04707391|585524545|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
162129416|NCT04707391|585524544|FG000|Overall Study|Other|0|||
162129417|NCT04707391|585524545|FG001|Overall Study|Other|2|||
162129418|NCT03785340|585524546|FG000|Overall Study|Lost to Follow-up|2|||
162129419|NCT03785340|585524547|FG001|Overall Study|Lost to Follow-up|0|||
162129420|NCT03785340|585524546|FG000|Overall Study|Adverse Event|1|||
162129421|NCT03785340|585524547|FG001|Overall Study|Adverse Event|0|||
162129422|NCT02500316|585524548|FG000|Overall Study|Adverse Event|3|||
162129423|NCT02500316|585524548|FG000|Overall Study|Lost to Follow-up|2|||
162129424|NCT02500316|585524548|FG000|Overall Study|Protocol Violation|1|||
162129425|NCT02500316|585524548|FG000|Overall Study|Withdrawal by Subject|15|||
162129426|NCT02500316|585524548|FG000|Overall Study|Final height achieved|5|||
161789457|NCT03210259|584272860|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
161789458|NCT03210259|584272861|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
162129427|NCT02500316|585524548|FG000|Overall Study|Due to war activity|1|||
162129428|NCT01406717|585524551|FG000|Overall Study|Subject non-compliance|4|||
162129429|NCT01406717|585524552|FG001|Overall Study|Subject non-compliance|3|||
162129430|NCT01406717|585524551|FG000|Overall Study|Protocol Violation|5|||
162129431|NCT01406717|585524552|FG001|Overall Study|Protocol Violation|1|||
162129432|NCT01406717|585524551|FG000|Overall Study|Lost to Follow-up|14|||
162129433|NCT01406717|585524552|FG001|Overall Study|Lost to Follow-up|8|||
162129434|NCT01406717|585524551|FG000|Overall Study|Withdrawal by Subject|19|||
162129435|NCT01406717|585524552|FG001|Overall Study|Withdrawal by Subject|15|||
162129436|NCT01406717|585524551|FG000|Overall Study|Adverse Event|1|||
162129437|NCT01406717|585524552|FG001|Overall Study|Adverse Event|2|||
162129438|NCT01406717|585524551|FG000|Overall Study|Lack of Efficacy|0|||
162129439|NCT01406717|585524552|FG001|Overall Study|Lack of Efficacy|1|||
162129440|NCT01406717|585524551|FG000|Overall Study|Non-completion of visit activity|0|||
162129441|NCT01406717|585524552|FG001|Overall Study|Non-completion of visit activity|1|||
162129442|NCT02040090|585524553|FG000|Overall Study|Adverse Event|2|||
162129443|NCT02040090|585524554|FG001|Overall Study|Adverse Event|0|||
162129444|NCT02040090|585524553|FG000|Overall Study|Physician Decision|1|||
162129445|NCT02040090|585524554|FG001|Overall Study|Physician Decision|0|||
162129446|NCT02040090|585524553|FG000|Overall Study|Withdrawal by Subject|0|||
162129447|NCT02040090|585524554|FG001|Overall Study|Withdrawal by Subject|1|||
162129448|NCT02040090|585524553|FG000|Overall Study|Lost to Follow-up|0|||
162129449|NCT02040090|585524554|FG001|Overall Study|Lost to Follow-up|1|||
162129450|NCT02275533|585524557|FG000|Overall Study|Protocol Violation|2|||
162129451|NCT02275533|585524558|FG001|Overall Study|Protocol Violation|0|||
162129452|NCT02275533|585524557|FG000|Overall Study|Never received study treatment|1|||
162129453|NCT02275533|585524558|FG001|Overall Study|Never received study treatment|0|||
162129454|NCT01570868|585524559|FG000|Overall Study|Adverse Event|8|||
162129455|NCT01570868|585524560|FG001|Overall Study|Adverse Event|1|||
162129456|NCT01570868|585524559|FG000|Overall Study|FDA Recommendation|23|||
162129457|NCT01570868|585524560|FG001|Overall Study|FDA Recommendation|3|||
162129458|NCT01570868|585524559|FG000|Overall Study|Physician Decision|10|||
162129459|NCT01570868|585524560|FG001|Overall Study|Physician Decision|4|||
162129460|NCT01570868|585524559|FG000|Overall Study|Lost to Follow-up|1|||
162129461|NCT01570868|585524560|FG001|Overall Study|Lost to Follow-up|0|||
162129462|NCT01570868|585524559|FG000|Overall Study|Withdrawal by Subject|1|||
162129463|NCT01570868|585524560|FG001|Overall Study|Withdrawal by Subject|0|||
162129464|NCT03370276|585524561|FG000|Overall Study|Death|0|||
162129465|NCT03370276|585524562|FG001|Overall Study|Death|2|||
162129466|NCT03370276|585524563|FG002|Overall Study|Death|5|||
162129467|NCT00895843|585524567|FG000|Overall Study|Protocol Violation|12|||
162129468|NCT00895843|585524568|FG001|Overall Study|Protocol Violation|12|||
162129469|NCT04963062|585524569|FG000|Overall Study|withdrew by the study team|4|||
162129470|NCT04963062|585524570|FG001|Overall Study|withdrew by the study team|2|||
162129471|NCT00544544|585524571|FG000|Overall Study|Withdrawal by Subject|1|||
162129472|NCT00544544|585524571|FG000|Overall Study|Adverse Event|1|||
162129473|NCT00544544|585524571|FG000|Overall Study|Lost to Follow-up|1|||
162129474|NCT04145349|585526269|FG000|Overall Study|Withdrawal by Subject|3|||
162129475|NCT04145349|585526270|FG001|Overall Study|Withdrawal by Subject|0|||
162129476|NCT04145349|585526269|FG000|Overall Study|Lost to Follow-up|0|||
162129477|NCT04145349|585526270|FG001|Overall Study|Lost to Follow-up|1|||
162129478|NCT04145349|585526269|FG000|Overall Study|On study treatment (Ongoing)|0|||
162129479|NCT04145349|585526270|FG001|Overall Study|On study treatment (Ongoing)|1|||
162129480|NCT05567952|585526271|FG000|Overall Study|Lost to Follow-up|3|||
162129481|NCT05567952|585526272|FG001|Overall Study|Lost to Follow-up|2|||
162129482|NCT05567952|585526271|FG000|Overall Study|Withdrawal by Subject|6|||
162129483|NCT05567952|585526272|FG001|Overall Study|Withdrawal by Subject|3|||
162129484|NCT05567952|585526271|FG000|Overall Study|Other|3|||
162129485|NCT05567952|585526272|FG001|Overall Study|Other|1|||
162129486|NCT03280563|585526274|FG000|Stage 1|Death|2|||
162129487|NCT03280563|585526275|FG001|Stage 1|Death|1|||
162129488|NCT03280563|585526276|FG002|Stage 1|Death|0|||
162129489|NCT03280563|585526277|FG003|Stage 1|Death|0|||
162129490|NCT03280563|585526278|FG004|Stage 1|Death|0|||
162129491|NCT03280563|585526279|FG005|Stage 1|Death|3|||
162129492|NCT03280563|585526280|FG006|Stage 1|Death|0|||
162129493|NCT03280563|585526281|FG007|Stage 1|Death|0|||
162129494|NCT03280563|585526282|FG008|Stage 1|Death|0|||
162129495|NCT03280563|585526274|FG000|Stage 1|Study Ended by Sponsor|0|||
162129496|NCT03280563|585526275|FG001|Stage 1|Study Ended by Sponsor|0|||
162129497|NCT03280563|585526276|FG002|Stage 1|Study Ended by Sponsor|1|||
162129498|NCT03280563|585526277|FG003|Stage 1|Study Ended by Sponsor|0|||
162129499|NCT03280563|585526278|FG004|Stage 1|Study Ended by Sponsor|0|||
162129500|NCT03280563|585526279|FG005|Stage 1|Study Ended by Sponsor|1|||
162129501|NCT03280563|585526280|FG006|Stage 1|Study Ended by Sponsor|0|||
162129502|NCT03280563|585526281|FG007|Stage 1|Study Ended by Sponsor|0|||
162129503|NCT03280563|585526282|FG008|Stage 1|Study Ended by Sponsor|0|||
162129504|NCT03280563|585526274|FG000|Stage 1|Withdrawal by Subject|5|||
162129505|NCT03280563|585526275|FG001|Stage 1|Withdrawal by Subject|1|||
162129506|NCT03280563|585526276|FG002|Stage 1|Withdrawal by Subject|2|||
162129507|NCT03280563|585526277|FG003|Stage 1|Withdrawal by Subject|0|||
162129508|NCT03280563|585526278|FG004|Stage 1|Withdrawal by Subject|0|||
162129509|NCT03280563|585526279|FG005|Stage 1|Withdrawal by Subject|2|||
162129510|NCT03280563|585526280|FG006|Stage 1|Withdrawal by Subject|0|||
162129511|NCT03280563|585526281|FG007|Stage 1|Withdrawal by Subject|0|||
162129512|NCT03280563|585526282|FG008|Stage 1|Withdrawal by Subject|0|||
162129513|NCT03280563|585526274|FG000|Stage 1|Reason Not Specified|0|||
162129514|NCT03280563|585526275|FG001|Stage 1|Reason Not Specified|0|||
162129515|NCT03280563|585526276|FG002|Stage 1|Reason Not Specified|0|||
162129516|NCT03280563|585526277|FG003|Stage 1|Reason Not Specified|0|||
162129517|NCT03280563|585526278|FG004|Stage 1|Reason Not Specified|0|||
162129518|NCT03280563|585526279|FG005|Stage 1|Reason Not Specified|1|||
162129519|NCT03280563|585526280|FG006|Stage 1|Reason Not Specified|0|||
162129520|NCT03280563|585526281|FG007|Stage 1|Reason Not Specified|0|||
162129521|NCT03280563|585526282|FG008|Stage 1|Reason Not Specified|0|||
162129522|NCT03280563|585526274|FG000|Stage 1|Physician Decision|0|||
162129523|NCT03280563|585526275|FG001|Stage 1|Physician Decision|1|||
162129524|NCT03280563|585526276|FG002|Stage 1|Physician Decision|0|||
162129525|NCT03280563|585526277|FG003|Stage 1|Physician Decision|0|||
162129526|NCT03280563|585526278|FG004|Stage 1|Physician Decision|0|||
162129527|NCT03280563|585526279|FG005|Stage 1|Physician Decision|0|||
162129528|NCT03280563|585526280|FG006|Stage 1|Physician Decision|0|||
162129529|NCT03280563|585526281|FG007|Stage 1|Physician Decision|0|||
162129530|NCT03280563|585526282|FG008|Stage 1|Physician Decision|0|||
162129531|NCT03280563|585526274|FG000|Stage 2|Death|0|||
162129532|NCT03280563|585526275|FG001|Stage 2|Death|0|||
162129533|NCT03280563|585526276|FG002|Stage 2|Death|0|||
162129534|NCT03280563|585526277|FG003|Stage 2|Death|0|||
162129535|NCT03280563|585526278|FG004|Stage 2|Death|0|||
162129536|NCT03280563|585526279|FG005|Stage 2|Death|0|||
162129537|NCT03280563|585526280|FG006|Stage 2|Death|0|||
162129538|NCT03280563|585526281|FG007|Stage 2|Death|1|||
162129539|NCT03280563|585526282|FG008|Stage 2|Death|0|||
162129540|NCT03280563|585526274|FG000|Stage 2|Progressive Disease|0|||
162129541|NCT03280563|585526275|FG001|Stage 2|Progressive Disease|0|||
162129542|NCT03280563|585526276|FG002|Stage 2|Progressive Disease|0|||
162129543|NCT03280563|585526277|FG003|Stage 2|Progressive Disease|0|||
162129544|NCT03280563|585526278|FG004|Stage 2|Progressive Disease|0|||
162129545|NCT03280563|585526279|FG005|Stage 2|Progressive Disease|0|||
162129546|NCT03280563|585526280|FG006|Stage 2|Progressive Disease|2|||
162129547|NCT03280563|585526281|FG007|Stage 2|Progressive Disease|0|||
162129548|NCT03280563|585526282|FG008|Stage 2|Progressive Disease|0|||
162129549|NCT03280563|585526274|FG000|Long-term Survival Follow-up|Death|10|||
162129550|NCT03280563|585526275|FG001|Long-term Survival Follow-up|Death|14|||
162129551|NCT03280563|585526276|FG002|Long-term Survival Follow-up|Death|15|||
162129552|NCT03280563|585526277|FG003|Long-term Survival Follow-up|Death|3|||
162129553|NCT03280563|585526278|FG004|Long-term Survival Follow-up|Death|6|||
162129554|NCT03280563|585526279|FG005|Long-term Survival Follow-up|Death|18|||
162129555|NCT03280563|585526280|FG006|Long-term Survival Follow-up|Death|11|||
162129556|NCT03280563|585526281|FG007|Long-term Survival Follow-up|Death|1|||
162129557|NCT03280563|585526282|FG008|Long-term Survival Follow-up|Death|3|||
162129558|NCT03280563|585526274|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
162129559|NCT03280563|585526275|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
162129560|NCT03280563|585526276|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
162129561|NCT03280563|585526277|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
162129562|NCT03280563|585526278|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
162129563|NCT03280563|585526279|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
162129564|NCT03280563|585526280|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
162129565|NCT03280563|585526281|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
162129566|NCT03280563|585526282|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
162129567|NCT03280563|585526274|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
162129568|NCT03280563|585526275|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
162129569|NCT03280563|585526276|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
162129570|NCT03280563|585526277|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
162129571|NCT03280563|585526278|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
162129572|NCT03280563|585526279|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
162129573|NCT03280563|585526280|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
162129574|NCT03280563|585526281|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
161789459|NCT03210259|584272862|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
161789460|NCT03210259|584272860|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
161789461|NCT03210259|584272861|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
161789462|NCT03210259|584272862|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
161789463|NCT05017493|584272863|FG000|Overall Study|Withdrawal by Subject|26|||
161789464|NCT05017493|584272864|FG001|Overall Study|Withdrawal by Subject|0|||
161789465|NCT05017493|584272863|FG000|Overall Study|Physician Decision|15|||
161789466|NCT05017493|584272864|FG001|Overall Study|Physician Decision|0|||
161789467|NCT05017493|584272863|FG000|Overall Study|Protocol Violation|81|||
161789468|NCT05017493|584272864|FG001|Overall Study|Protocol Violation|0|||
161789469|NCT03940586|584272868|FG000|Overall Study|Death|3|||
161789470|NCT03940586|584272869|FG001|Overall Study|Death|2|||
161789471|NCT03940586|584272870|FG002|Overall Study|Death|0|||
161789472|NCT03940586|584272868|FG000|Overall Study|Physician Decision|1|||
161789473|NCT03940586|584272869|FG001|Overall Study|Physician Decision|0|||
161789474|NCT03940586|584272870|FG002|Overall Study|Physician Decision|1|||
161789475|NCT03940586|584272868|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
161789476|NCT03940586|584272869|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
161789477|NCT03940586|584272870|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
161789478|NCT03940586|584272868|FG000|Overall Study|Not Treated|0|||
162129575|NCT03280563|585526282|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
162129576|NCT03280563|585526274|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
162129577|NCT03280563|585526275|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
162129578|NCT03280563|585526276|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
162129579|NCT03280563|585526277|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
162129580|NCT03280563|585526278|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
162129581|NCT03280563|585526279|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
161789479|NCT03940586|584272869|FG001|Overall Study|Not Treated|2|||
162129582|NCT03280563|585526280|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
162129583|NCT03280563|585526281|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
162129584|NCT03280563|585526282|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
162129585|NCT04423393|585526283|FG000|Overall Study|Withdrawal by Subject|0|||
162129586|NCT04423393|585526284|FG001|Overall Study|Withdrawal by Subject|0|||
162129587|NCT04423393|585526285|FG002|Overall Study|Withdrawal by Subject|0|||
162129588|NCT04423393|585526286|FG003|Overall Study|Withdrawal by Subject|0|||
162129589|NCT04423393|585526287|FG004|Overall Study|Withdrawal by Subject|0|||
162129590|NCT04423393|585526288|FG005|Overall Study|Withdrawal by Subject|1|||
162129591|NCT04423393|585526289|FG006|Overall Study|Withdrawal by Subject|0|||
162129592|NCT04423393|585526290|FG007|Overall Study|Withdrawal by Subject|0|||
162129593|NCT04423393|585526291|FG008|Overall Study|Withdrawal by Subject|0|||
162129594|NCT04423393|585526292|FG009|Overall Study|Withdrawal by Subject|0|||
162129595|NCT04423393|585526293|FG010|Overall Study|Withdrawal by Subject|0|||
162129596|NCT04423393|585526294|FG011|Overall Study|Withdrawal by Subject|0|||
162129597|NCT04423393|585526295|FG012|Overall Study|Withdrawal by Subject|0|||
162129598|NCT04423393|585526296|FG013|Overall Study|Withdrawal by Subject|1|||
162129599|NCT04423393|585526297|FG014|Overall Study|Withdrawal by Subject|0|||
162129600|NCT04423393|585526298|FG015|Overall Study|Withdrawal by Subject|0|||
162129601|NCT04423393|585526299|FG016|Overall Study|Withdrawal by Subject|0|||
162129602|NCT04423393|585526300|FG017|Overall Study|Withdrawal by Subject|0|||
162129603|NCT04423393|585526283|FG000|Overall Study|Sponsor Decision|0|||
162129604|NCT04423393|585526284|FG001|Overall Study|Sponsor Decision|0|||
162129605|NCT04423393|585526285|FG002|Overall Study|Sponsor Decision|0|||
162129606|NCT04423393|585526286|FG003|Overall Study|Sponsor Decision|0|||
162129607|NCT04423393|585526287|FG004|Overall Study|Sponsor Decision|0|||
162129608|NCT04423393|585526288|FG005|Overall Study|Sponsor Decision|0|||
162129609|NCT04423393|585526289|FG006|Overall Study|Sponsor Decision|0|||
162129610|NCT04423393|585526290|FG007|Overall Study|Sponsor Decision|0|||
162129611|NCT04423393|585526291|FG008|Overall Study|Sponsor Decision|0|||
162129612|NCT04423393|585526292|FG009|Overall Study|Sponsor Decision|0|||
162129613|NCT04423393|585526293|FG010|Overall Study|Sponsor Decision|0|||
162129614|NCT04423393|585526294|FG011|Overall Study|Sponsor Decision|0|||
162129615|NCT04423393|585526295|FG012|Overall Study|Sponsor Decision|0|||
162129616|NCT04423393|585526296|FG013|Overall Study|Sponsor Decision|1|||
162129617|NCT04423393|585526297|FG014|Overall Study|Sponsor Decision|0|||
162129618|NCT04423393|585526298|FG015|Overall Study|Sponsor Decision|0|||
162129619|NCT04423393|585526299|FG016|Overall Study|Sponsor Decision|0|||
162129620|NCT04423393|585526300|FG017|Overall Study|Sponsor Decision|0|||
162129621|NCT00432159|585526301|FG000|Overall Study|Death|0|||
162129622|NCT00432159|585526302|FG001|Overall Study|Death|1|||
162129623|NCT00432159|585526303|FG002|Overall Study|Death|0|||
162129624|NCT00432159|585526304|FG003|Overall Study|Death|0|||
162129625|NCT00432159|585526305|FG004|Overall Study|Death|0|||
162129626|NCT00432159|585526301|FG000|Overall Study|Failure|9|||
162129627|NCT00432159|585526302|FG001|Overall Study|Failure|5|||
162129628|NCT00432159|585526303|FG002|Overall Study|Failure|3|||
162129629|NCT00432159|585526304|FG003|Overall Study|Failure|2|||
162129630|NCT00432159|585526305|FG004|Overall Study|Failure|3|||
162129631|NCT00432159|585526301|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
162129632|NCT00432159|585526302|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
162129633|NCT00432159|585526303|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
162129634|NCT00432159|585526304|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
162129635|NCT00432159|585526305|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
162129636|NCT00107380|585526306|FG000|Overall Study|Adverse Event|7|||
162129637|NCT00107380|585526306|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
162129638|NCT00107380|585526306|FG000|Overall Study|Progression/relapse|4|||
162129639|NCT00107380|585526306|FG000|Overall Study|Death|3|||
162129640|NCT00107380|585526306|FG000|Overall Study|Other - not protocol specified|7|||
162129641|NCT00107380|585526306|FG000|Overall Study|Ineligible|2|||
162129642|NCT03673098|585526307|FG000|Overall Study|Lost to Follow-up|2|||
162129643|NCT03673098|585526308|FG001|Overall Study|Lost to Follow-up|3|||
162129644|NCT03673098|585526307|FG000|Overall Study|Withdrawal by Subject|6|||
162129645|NCT03673098|585526308|FG001|Overall Study|Withdrawal by Subject|1|||
162129646|NCT03673098|585526307|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
162129647|NCT03673098|585526308|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
162129648|NCT03850444|585526309|FG000|Overall Study|Adverse Event|16|||
162129649|NCT03850444|585526310|FG001|Overall Study|Adverse Event|10|||
162129650|NCT03850444|585526309|FG000|Overall Study|Death|87|||
162129651|NCT03850444|585526310|FG001|Overall Study|Death|107|||
162129652|NCT03850444|585526309|FG000|Overall Study|Lost to Follow-up|1|||
162129653|NCT03850444|585526310|FG001|Overall Study|Lost to Follow-up|1|||
162129654|NCT03850444|585526309|FG000|Overall Study|Withdrawal by Subject|1|||
162129655|NCT03850444|585526310|FG001|Overall Study|Withdrawal by Subject|5|||
162129656|NCT03850444|585526309|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
162129657|NCT03850444|585526310|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
162129658|NCT01518257|585526313|FG000|Overall Study|Lost to Follow-up|1|||
162129659|NCT01518257|585526314|FG001|Overall Study|Lost to Follow-up|0|||
162129660|NCT01518257|585526313|FG000|Overall Study|Other Miscellaneous Reason|1|||
162129661|NCT01518257|585526314|FG001|Overall Study|Other Miscellaneous Reason|0|||
162129662|NCT01155726|585526316|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
162129663|NCT01155726|585526317|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
162129664|NCT01155726|585526318|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
162129665|NCT01155726|585526319|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
162129666|NCT02424344|585526323|FG000|Overall Study|Lack of Efficacy|0|||
162129667|NCT02424344|585526324|FG001|Overall Study|Lack of Efficacy|1|||
162129668|NCT02424344|585526323|FG000|Overall Study|Withdrawal by Subject|2|||
162129669|NCT02424344|585526324|FG001|Overall Study|Withdrawal by Subject|1|||
162129670|NCT02424344|585526323|FG000|Overall Study|Lost to Follow-up|1|||
162129671|NCT02424344|585526324|FG001|Overall Study|Lost to Follow-up|0|||
162129672|NCT02424344|585526323|FG000|Overall Study|Adverse Event|4|||
162129673|NCT02424344|585526324|FG001|Overall Study|Adverse Event|8|||
162129674|NCT04730947|585526325|FG000|Overall Study|Withdrawal by Subject|0|||
162129675|NCT04730947|585526326|FG001|Overall Study|Withdrawal by Subject|1|||
162129676|NCT02123966|585526327|FG000|Overall Study|Intercurrent Illness|1|||
162129677|NCT05257837|585526328|FG000|Overall Study|Excluded (did not find the guns)|4|||
162129678|NCT05257837|585526329|FG001|Overall Study|Excluded (did not find the guns)|2|||
162129679|NCT05257837|585526330|FG002|Overall Study|Excluded (did not find the guns)|4|||
162129680|NCT05257837|585526331|FG003|Overall Study|Excluded (did not find the guns)|0|||
162129681|NCT02561455|585526332|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
162129682|NCT02561455|585526333|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
162129683|NCT02561455|585526334|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
162129684|NCT02561455|585526335|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
162129685|NCT02561455|585526332|FG000|Overall Study|Withdrawal by Subject|1|||
162129686|NCT02561455|585526333|FG001|Overall Study|Withdrawal by Subject|0|||
162129687|NCT02561455|585526334|FG002|Overall Study|Withdrawal by Subject|1|||
162129688|NCT02561455|585526335|FG003|Overall Study|Withdrawal by Subject|0|||
162129689|NCT02561455|585526332|FG000|Overall Study|Disease Progression|0|||
162129690|NCT02561455|585526333|FG001|Overall Study|Disease Progression|1|||
162129691|NCT02561455|585526334|FG002|Overall Study|Disease Progression|0|||
162129692|NCT02561455|585526335|FG003|Overall Study|Disease Progression|0|||
162129693|NCT03639675|585526338|FG000|Overall Study|Withdrawal by Subject|1|||
162129694|NCT05675709|585526339|FG000|Overall Study|incomplete outcome data|2|||
162129695|NCT05675709|585526340|FG001|Overall Study|incomplete outcome data|8|||
162129696|NCT05343455|585526343|FG000|Overall Study|Withdrawal by Subject|4|||
162129697|NCT05343455|585526344|FG001|Overall Study|Withdrawal by Subject|9|||
162129698|NCT05343455|585526345|FG002|Overall Study|Withdrawal by Subject|7|||
162129699|NCT05343455|585526343|FG000|Overall Study|Adverse Event|2|||
162129700|NCT05343455|585526344|FG001|Overall Study|Adverse Event|1|||
162129701|NCT05343455|585526345|FG002|Overall Study|Adverse Event|2|||
162129702|NCT05343455|585526343|FG000|Overall Study|Lost to Follow-up|1|||
162129703|NCT05343455|585526344|FG001|Overall Study|Lost to Follow-up|1|||
162129704|NCT05343455|585526345|FG002|Overall Study|Lost to Follow-up|3|||
162129705|NCT05343455|585526343|FG000|Overall Study|Pregnancy|1|||
162129706|NCT05343455|585526344|FG001|Overall Study|Pregnancy|0|||
162129707|NCT05343455|585526345|FG002|Overall Study|Pregnancy|0|||
162129708|NCT05343455|585526343|FG000|Overall Study|Physician Decision|0|||
162129709|NCT05343455|585526344|FG001|Overall Study|Physician Decision|0|||
162129710|NCT05343455|585526345|FG002|Overall Study|Physician Decision|1|||
162129711|NCT05343455|585526343|FG000|Overall Study|Protocol Violation|0|||
162129712|NCT05343455|585526344|FG001|Overall Study|Protocol Violation|1|||
162129713|NCT05343455|585526345|FG002|Overall Study|Protocol Violation|1|||
162129714|NCT01254565|585526347|FG000|Overall Study|Non-compliance to Study Procedures|0|||
162129715|NCT01254565|585526348|FG001|Overall Study|Non-compliance to Study Procedures|0|||
162129716|NCT01254565|585526349|FG002|Overall Study|Non-compliance to Study Procedures|0|||
162129717|NCT01254565|585526350|FG003|Overall Study|Non-compliance to Study Procedures|0|||
162129718|NCT01254565|585526351|FG004|Overall Study|Non-compliance to Study Procedures|1|||
162129719|NCT01254565|585526352|FG005|Overall Study|Non-compliance to Study Procedures|0|||
162129720|NCT01254565|585526347|FG000|Overall Study|Did not Receive Treatment|1|||
162129721|NCT01254565|585526348|FG001|Overall Study|Did not Receive Treatment|1|||
162129722|NCT01254565|585526349|FG002|Overall Study|Did not Receive Treatment|0|||
162129723|NCT01254565|585526350|FG003|Overall Study|Did not Receive Treatment|0|||
162129724|NCT01254565|585526351|FG004|Overall Study|Did not Receive Treatment|3|||
162129725|NCT01254565|585526352|FG005|Overall Study|Did not Receive Treatment|4|||
162129726|NCT01254565|585526347|FG000|Overall Study|Other|0|||
162129727|NCT01254565|585526348|FG001|Overall Study|Other|0|||
162129728|NCT01254565|585526349|FG002|Overall Study|Other|0|||
162129729|NCT01254565|585526350|FG003|Overall Study|Other|1|||
162129730|NCT01254565|585526351|FG004|Overall Study|Other|0|||
162129731|NCT01254565|585526352|FG005|Overall Study|Other|0|||
162129732|NCT03354637|585526357|FG000|Double-blind Period|Protocol Violation|2|||
162129733|NCT03354637|585526358|FG001|Double-blind Period|Protocol Violation|0|||
162129734|NCT03354637|585526359|FG002|Double-blind Period|Protocol Violation|0|||
161789480|NCT03940586|584272870|FG002|Overall Study|Not Treated|0|||
162129735|NCT03354637|585526357|FG000|Double-blind Period|Adverse Event|1|||
162129736|NCT03354637|585526358|FG001|Double-blind Period|Adverse Event|2|||
162129737|NCT03354637|585526359|FG002|Double-blind Period|Adverse Event|0|||
162129738|NCT03354637|585526357|FG000|Double-blind Period|Lost to Follow-up|3|||
162129739|NCT03354637|585526358|FG001|Double-blind Period|Lost to Follow-up|4|||
162129740|NCT03354637|585526359|FG002|Double-blind Period|Lost to Follow-up|3|||
162129741|NCT03354637|585526357|FG000|Double-blind Period|Withdrawal by Subject|10|||
162129742|NCT03354637|585526358|FG001|Double-blind Period|Withdrawal by Subject|6|||
162129743|NCT03354637|585526359|FG002|Double-blind Period|Withdrawal by Subject|4|||
162129744|NCT03354637|585526357|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
162129745|NCT03354637|585526358|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
162129746|NCT03354637|585526359|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
162129747|NCT03354637|585526357|FG000|Open Label Extension|Adverse Event|0|||
162129748|NCT03354637|585526358|FG001|Open Label Extension|Adverse Event|0|||
162129749|NCT03354637|585526359|FG002|Open Label Extension|Adverse Event|1|||
162129750|NCT03354637|585526357|FG000|Open Label Extension|Lost to Follow-up|0|||
162129751|NCT03354637|585526358|FG001|Open Label Extension|Lost to Follow-up|0|||
162129752|NCT03354637|585526359|FG002|Open Label Extension|Lost to Follow-up|2|||
162129753|NCT03354637|585526357|FG000|Open Label Extension|Withdrawal by Subject|0|||
162129754|NCT03354637|585526358|FG001|Open Label Extension|Withdrawal by Subject|0|||
162129755|NCT03354637|585526359|FG002|Open Label Extension|Withdrawal by Subject|5|||
162129756|NCT03354637|585526357|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
162129757|NCT03354637|585526358|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
162129758|NCT03354637|585526359|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
162129759|NCT03354637|585526357|FG000|Open Label Extension|Subject Noncompliance|0|||
162129760|NCT03354637|585526358|FG001|Open Label Extension|Subject Noncompliance|0|||
162129761|NCT03354637|585526359|FG002|Open Label Extension|Subject Noncompliance|1|||
162129762|NCT03354637|585526357|FG000|Open Label Extension|Lack of Efficacy|0|||
162129763|NCT03354637|585526358|FG001|Open Label Extension|Lack of Efficacy|0|||
162129764|NCT03354637|585526359|FG002|Open Label Extension|Lack of Efficacy|1|||
162129765|NCT03354637|585526357|FG000|Open Label Extension|Physician Decision|0|||
162129766|NCT03354637|585526358|FG001|Open Label Extension|Physician Decision|0|||
162129767|NCT03354637|585526359|FG002|Open Label Extension|Physician Decision|1|||
162129768|NCT02726399|585526362|FG000|Overall Study|Participant Non-Compliance|1|||
162129769|NCT02726399|585526362|FG000|Overall Study|Adverse Event|2|||
162129770|NCT02726399|585526362|FG000|Overall Study|Progression of disease|4|||
162129771|NCT04006366|585526365|FG000|Overall Study|Withdrawal by Subject|1|||
162129772|NCT03468426|585526366|FG000|Overall Study|Progressive disease|3|||
162129773|NCT03468426|585526367|FG001|Overall Study|Progressive disease|0|||
162129774|NCT03468426|585526368|FG002|Overall Study|Progressive disease|4|||
162129775|NCT03468426|585526369|FG003|Overall Study|Progressive disease|20|||
162129776|NCT03468426|585526370|FG004|Overall Study|Progressive disease|23|||
162129777|NCT03468426|585526371|FG005|Overall Study|Progressive disease|15|||
162129778|NCT03468426|585526372|FG006|Overall Study|Progressive disease|24|||
162129779|NCT03468426|585526373|FG007|Overall Study|Progressive disease|27|||
162129780|NCT03468426|585526374|FG008|Overall Study|Progressive disease|13|||
162129781|NCT03468426|585526375|FG009|Overall Study|Progressive disease|13|||
162129782|NCT03468426|585526376|FG010|Overall Study|Progressive disease|0|||
162129783|NCT03468426|585526366|FG000|Overall Study|Other adverse event or clinical progression|0|||
162129784|NCT03468426|585526367|FG001|Overall Study|Other adverse event or clinical progression|1|||
162129785|NCT03468426|585526368|FG002|Overall Study|Other adverse event or clinical progression|3|||
162129786|NCT03468426|585526369|FG003|Overall Study|Other adverse event or clinical progression|14|||
162129787|NCT03468426|585526370|FG004|Overall Study|Other adverse event or clinical progression|10|||
162129788|NCT03468426|585526371|FG005|Overall Study|Other adverse event or clinical progression|8|||
162129789|NCT03468426|585526372|FG006|Overall Study|Other adverse event or clinical progression|5|||
162129790|NCT03468426|585526373|FG007|Overall Study|Other adverse event or clinical progression|4|||
162129791|NCT03468426|585526374|FG008|Overall Study|Other adverse event or clinical progression|6|||
162129792|NCT03468426|585526375|FG009|Overall Study|Other adverse event or clinical progression|11|||
162129793|NCT03468426|585526376|FG010|Overall Study|Other adverse event or clinical progression|0|||
162129794|NCT03468426|585526366|FG000|Overall Study|Refused to continue taking trial medication|0|||
162129795|NCT03468426|585526367|FG001|Overall Study|Refused to continue taking trial medication|0|||
162129796|NCT03468426|585526368|FG002|Overall Study|Refused to continue taking trial medication|0|||
162129797|NCT03468426|585526369|FG003|Overall Study|Refused to continue taking trial medication|2|||
162129798|NCT03468426|585526370|FG004|Overall Study|Refused to continue taking trial medication|0|||
162129799|NCT03468426|585526371|FG005|Overall Study|Refused to continue taking trial medication|3|||
161789481|NCT04304950|584272871|FG000|Overall Study|Lost to Follow-up|1|||
162129800|NCT03468426|585526372|FG006|Overall Study|Refused to continue taking trial medication|0|||
162129801|NCT03468426|585526373|FG007|Overall Study|Refused to continue taking trial medication|0|||
162129802|NCT03468426|585526374|FG008|Overall Study|Refused to continue taking trial medication|1|||
162129803|NCT03468426|585526375|FG009|Overall Study|Refused to continue taking trial medication|0|||
162129804|NCT03468426|585526376|FG010|Overall Study|Refused to continue taking trial medication|0|||
162129805|NCT03468426|585526366|FG000|Overall Study|Other than listed|0|||
162129806|NCT03468426|585526367|FG001|Overall Study|Other than listed|1|||
162129807|NCT03468426|585526368|FG002|Overall Study|Other than listed|0|||
162129808|NCT03468426|585526369|FG003|Overall Study|Other than listed|0|||
162129809|NCT03468426|585526370|FG004|Overall Study|Other than listed|2|||
162129810|NCT03468426|585526371|FG005|Overall Study|Other than listed|2|||
162129811|NCT03468426|585526372|FG006|Overall Study|Other than listed|0|||
162129812|NCT03468426|585526373|FG007|Overall Study|Other than listed|0|||
162129813|NCT03468426|585526374|FG008|Overall Study|Other than listed|4|||
162129814|NCT03468426|585526375|FG009|Overall Study|Other than listed|4|||
162129815|NCT03468426|585526376|FG010|Overall Study|Other than listed|1|||
162129816|NCT03468426|585526366|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162129817|NCT03468426|585526367|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162129818|NCT03468426|585526368|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162129819|NCT03468426|585526369|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162129820|NCT03468426|585526370|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162129821|NCT03468426|585526371|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162129822|NCT03468426|585526372|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162129823|NCT03468426|585526373|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162129824|NCT03468426|585526374|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162129825|NCT03468426|585526375|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162129826|NCT03468426|585526376|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162129827|NCT03468426|585526366|FG000|Overall Study|missing reason|0|||
162129828|NCT03468426|585526367|FG001|Overall Study|missing reason|0|||
162129829|NCT03468426|585526368|FG002|Overall Study|missing reason|0|||
162129830|NCT03468426|585526369|FG003|Overall Study|missing reason|0|||
162129831|NCT03468426|585526370|FG004|Overall Study|missing reason|0|||
162129832|NCT03468426|585526371|FG005|Overall Study|missing reason|0|||
162129833|NCT03468426|585526372|FG006|Overall Study|missing reason|0|||
162129834|NCT03468426|585526373|FG007|Overall Study|missing reason|0|||
162129835|NCT03468426|585526374|FG008|Overall Study|missing reason|0|||
162129836|NCT03468426|585526375|FG009|Overall Study|missing reason|1|||
162129837|NCT03468426|585526376|FG010|Overall Study|missing reason|0|||
162129838|NCT01440049|585526378|FG000|Overall Study|Adverse Event|5|||
162129839|NCT02268552|585526379|FG000|Part 1|Death|1|||
162129840|NCT02268552|585526380|FG001|Part 1|Death|1|||
162129841|NCT02268552|585526381|FG002|Part 1|Death|1|||
162129842|NCT02268552|585526382|FG003|Part 1|Death|2|||
162129843|NCT02268552|585526383|FG004|Part 1|Death|0|||
162129844|NCT02268552|585526384|FG005|Part 1|Death|0|||
162129845|NCT02268552|585526385|FG006|Part 1|Death|0|||
162129846|NCT02268552|585526379|FG000|Part 1|Subject/guardian decision|0|||
162129847|NCT02268552|585526380|FG001|Part 1|Subject/guardian decision|0|||
162129848|NCT02268552|585526381|FG002|Part 1|Subject/guardian decision|0|||
162129849|NCT02268552|585526382|FG003|Part 1|Subject/guardian decision|1|||
162129850|NCT02268552|585526383|FG004|Part 1|Subject/guardian decision|0|||
162129851|NCT02268552|585526384|FG005|Part 1|Subject/guardian decision|0|||
162129852|NCT02268552|585526385|FG006|Part 1|Subject/guardian decision|0|||
162129853|NCT02268552|585526379|FG000|Part 2|Death|0|||
162129854|NCT02268552|585526380|FG001|Part 2|Death|0|||
162129855|NCT02268552|585526381|FG002|Part 2|Death|0|||
162129856|NCT02268552|585526382|FG003|Part 2|Death|0|||
162129857|NCT02268552|585526383|FG004|Part 2|Death|0|||
162129858|NCT02268552|585526384|FG005|Part 2|Death|0|||
162129859|NCT02268552|585526385|FG006|Part 2|Death|2|||
162129860|NCT02268552|585526379|FG000|Part 2|Subject/guardian decision|0|||
162129861|NCT02268552|585526380|FG001|Part 2|Subject/guardian decision|0|||
162129862|NCT02268552|585526381|FG002|Part 2|Subject/guardian decision|0|||
162129863|NCT02268552|585526382|FG003|Part 2|Subject/guardian decision|0|||
162129864|NCT02268552|585526383|FG004|Part 2|Subject/guardian decision|0|||
162129865|NCT02268552|585526384|FG005|Part 2|Subject/guardian decision|0|||
162129866|NCT02268552|585526385|FG006|Part 2|Subject/guardian decision|1|||
161789482|NCT04304950|584272872|FG001|Overall Study|Lost to Follow-up|1|||
162129867|NCT02268552|585526379|FG000|Part 3 Extension|Death|0|||
162129868|NCT02268552|585526380|FG001|Part 3 Extension|Death|1|||
161789483|NCT02006147|584272873|FG000|Overall Study|Protocol Violation|1|||
162129869|NCT02268552|585526381|FG002|Part 3 Extension|Death|1|||
162129870|NCT02268552|585526382|FG003|Part 3 Extension|Death|1|||
162129871|NCT02268552|585526383|FG004|Part 3 Extension|Death|1|||
162129872|NCT02268552|585526384|FG005|Part 3 Extension|Death|1|||
162129873|NCT02268552|585526385|FG006|Part 3 Extension|Death|0|||
162129874|NCT02268552|585526379|FG000|Part 3 Extension|Early termination of trial|1|||
162129875|NCT02268552|585526380|FG001|Part 3 Extension|Early termination of trial|0|||
162129876|NCT02268552|585526381|FG002|Part 3 Extension|Early termination of trial|0|||
162129877|NCT02268552|585526382|FG003|Part 3 Extension|Early termination of trial|0|||
162129878|NCT02268552|585526383|FG004|Part 3 Extension|Early termination of trial|2|||
162129879|NCT02268552|585526384|FG005|Part 3 Extension|Early termination of trial|9|||
162129880|NCT02268552|585526385|FG006|Part 3 Extension|Early termination of trial|11|||
162129881|NCT02268552|585526379|FG000|Part 3 Extension|Subject/guardian decision|0|||
162129882|NCT02268552|585526380|FG001|Part 3 Extension|Subject/guardian decision|0|||
162129883|NCT02268552|585526381|FG002|Part 3 Extension|Subject/guardian decision|0|||
162129884|NCT02268552|585526382|FG003|Part 3 Extension|Subject/guardian decision|0|||
162129885|NCT02268552|585526383|FG004|Part 3 Extension|Subject/guardian decision|0|||
162129886|NCT02268552|585526384|FG005|Part 3 Extension|Subject/guardian decision|0|||
162129887|NCT02268552|585526385|FG006|Part 3 Extension|Subject/guardian decision|1|||
162129888|NCT04168385|585526387|FG000|Overall Study|Withdrawal by Subject|1|||
162129889|NCT04168385|585526388|FG001|Overall Study|Withdrawal by Subject|0|||
162129890|NCT04168385|585526387|FG000|Overall Study|Adverse Event|2|||
162129891|NCT04168385|585526388|FG001|Overall Study|Adverse Event|1|||
162129892|NCT04168385|585526387|FG000|Overall Study|Liver transplant|3|||
162129893|NCT04168385|585526388|FG001|Overall Study|Liver transplant|1|||
162129894|NCT04168385|585526387|FG000|Overall Study|Listed for liver transplant|1|||
162129895|NCT04168385|585526388|FG001|Overall Study|Listed for liver transplant|0|||
162129896|NCT02139982|585526389|FG000|Overall Study|Lack of Efficacy|0|||
162129897|NCT02139982|585526390|FG001|Overall Study|Lack of Efficacy|1|||
162129898|NCT02139982|585526391|FG002|Overall Study|Lack of Efficacy|0|||
162129899|NCT02139982|585526392|FG003|Overall Study|Lack of Efficacy|1|||
162129900|NCT02139982|585526393|FG004|Overall Study|Lack of Efficacy|0|||
162129901|NCT02139982|585526394|FG005|Overall Study|Lack of Efficacy|0|||
162129902|NCT02139982|585526395|FG006|Overall Study|Lack of Efficacy|0|||
162129903|NCT02139982|585526396|FG007|Overall Study|Lack of Efficacy|0|||
162129904|NCT02139982|585526397|FG008|Overall Study|Lack of Efficacy|0|||
162129905|NCT02139982|585526398|FG009|Overall Study|Lack of Efficacy|0|||
162129906|NCT02748512|585526401|FG000|Overall Study|Lost to Follow-up|1|||
162129907|NCT02748512|585526402|FG001|Overall Study|Lost to Follow-up|1|||
162129908|NCT01310868|585526417|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
162129909|NCT01708187|585526420|FG000|Overall Study|Lost to Follow-up|0|||
162129910|NCT01708187|585526421|FG001|Overall Study|Lost to Follow-up|1|||
162129911|NCT02117544|585526422|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
162129912|NCT02117544|585526423|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
162129913|NCT02408549|585526425|FG000|Overall Study|Adverse Event|15|||
162129914|NCT02408549|585526425|FG000|Overall Study|Death|4|||
162129915|NCT02408549|585526425|FG000|Overall Study|Lack of Efficacy|17|||
162129916|NCT02408549|585526425|FG000|Overall Study|Protocol Violation|4|||
162129917|NCT02408549|585526425|FG000|Overall Study|Lost to Follow-up|6|||
162129918|NCT02408549|585526425|FG000|Overall Study|Consent withdrawn|30|||
162129919|NCT02408549|585526425|FG000|Overall Study|Neurology research program closing at site|1|||
162129920|NCT02408549|585526425|FG000|Overall Study|Site closure|1|||
162129921|NCT02408549|585526425|FG000|Overall Study|Pregnancy|1|||
162129922|NCT02408549|585526425|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
162129923|NCT02408549|585526425|FG000|Overall Study|Subject moved to another place, far from site|1|||
162129924|NCT02408549|585526425|FG000|Overall Study|Study terminated at site|1|||
162129925|NCT00231894|585526426|FG000|Overall Study|Withdrawal by Subject|1|||
162129926|NCT00231894|585526427|FG001|Overall Study|Withdrawal by Subject|1|||
162129927|NCT02025205|585526428|FG000|Overall Study|Withdrawal by Subject|1|||
162129928|NCT02025205|585526429|FG001|Overall Study|Withdrawal by Subject|1|||
162129929|NCT02025205|585526428|FG000|Overall Study|Protocol Violation|2|||
162129930|NCT02025205|585526429|FG001|Overall Study|Protocol Violation|1|||
162129931|NCT02025205|585526428|FG000|Overall Study|Death|0|||
162129932|NCT02025205|585526429|FG001|Overall Study|Death|1|||
162129933|NCT01232556|585526432|FG000|Overall Study|Withdrawal by Subject|21|||
162129934|NCT01232556|585526433|FG001|Overall Study|Withdrawal by Subject|17|||
162129935|NCT01232556|585526432|FG000|Overall Study|Death|97|||
162129936|NCT01232556|585526433|FG001|Overall Study|Death|97|||
162129937|NCT01232556|585526432|FG000|Overall Study|Lost to Follow-up|0|||
162129938|NCT01232556|585526433|FG001|Overall Study|Lost to Follow-up|2|||
161789484|NCT02006147|584272874|FG001|Overall Study|Protocol Violation|1|||
161789485|NCT02006147|584272875|FG002|Overall Study|Protocol Violation|0|||
161789486|NCT02006147|584272876|FG003|Overall Study|Protocol Violation|0|||
161789487|NCT02006147|584272873|FG000|Overall Study|Withdrawal by Subject|0|||
161789488|NCT02006147|584272874|FG001|Overall Study|Withdrawal by Subject|1|||
161789489|NCT02006147|584272875|FG002|Overall Study|Withdrawal by Subject|0|||
161789490|NCT02006147|584272876|FG003|Overall Study|Withdrawal by Subject|0|||
161789491|NCT02006147|584272873|FG000|Overall Study|Withdrawal by Sponsor|1|||
161789492|NCT02006147|584272874|FG001|Overall Study|Withdrawal by Sponsor|0|||
162129939|NCT01232556|585526432|FG000|Overall Study|Terminated by Sponsor|35|||
162129940|NCT01232556|585526433|FG001|Overall Study|Terminated by Sponsor|51|||
162129941|NCT01232556|585526432|FG000|Overall Study|Other|6|||
161789493|NCT02006147|584272875|FG002|Overall Study|Withdrawal by Sponsor|0|||
161789494|NCT02006147|584272876|FG003|Overall Study|Withdrawal by Sponsor|0|||
161898711|NCT05225558|584677882|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
162129942|NCT01232556|585526433|FG001|Overall Study|Other|4|||
161789495|NCT00345683|584272881|FG000|Overall Study|Lost to Follow-up|19|||
162129943|NCT04172987|585526434|FG000|Lead In Period|Adverse Event|1|||
162129944|NCT04172987|585526434|FG000|Lead In Period|Protocol Violation|1|||
162129945|NCT04172987|585526434|FG000|Period 1|Physician Decision|1|||
162129946|NCT04172987|585526434|FG000|Period 2|Adverse Event|5|||
162129947|NCT04172987|585526434|FG000|Period 2|Dosing Termination by Sponsor|4|||
161789496|NCT00345683|584272882|FG001|Overall Study|Lost to Follow-up|7|||
161789497|NCT00345683|584272881|FG000|Overall Study|Other|6|||
161789498|NCT00345683|584272882|FG001|Overall Study|Other|2|||
161789499|NCT03182686|584272883|FG000|Overall Study|Lost to Follow-up|2|||
161789500|NCT03182686|584272884|FG001|Overall Study|Lost to Follow-up|0|||
161789501|NCT03182686|584272883|FG000|Overall Study|Adverse Event|2|||
161789502|NCT03182686|584272884|FG001|Overall Study|Adverse Event|0|||
161789503|NCT03182686|584272883|FG000|Overall Study|Withdrawal by Subject|3|||
161789504|NCT03182686|584272884|FG001|Overall Study|Withdrawal by Subject|0|||
161789505|NCT01337050|584272885|FG000|Overall Study|Death|0|||
161789506|NCT01337050|584272886|FG001|Overall Study|Death|0|||
161789507|NCT01337050|584272887|FG002|Overall Study|Death|4|||
161789508|NCT01337050|584272885|FG000|Overall Study|Other|4|||
161789509|NCT01337050|584272886|FG001|Overall Study|Other|6|||
161789510|NCT01337050|584272887|FG002|Overall Study|Other|8|||
161789511|NCT01337050|584272885|FG000|Overall Study|Participants refused further follow-up|0|||
161789512|NCT01337050|584272886|FG001|Overall Study|Participants refused further follow-up|7|||
161789513|NCT01337050|584272887|FG002|Overall Study|Participants refused further follow-up|7|||
161789514|NCT00003102|584272888|FG000|Overall Study|Physician Decision|1|||
161789515|NCT00003102|584272889|FG001|Overall Study|Physician Decision|1|||
161789516|NCT00003102|584272890|FG002|Overall Study|Physician Decision|0|||
161789517|NCT00003102|584272888|FG000|Overall Study|Progressive Disease|0|||
161789518|NCT00003102|584272889|FG001|Overall Study|Progressive Disease|1|||
161789519|NCT00003102|584272890|FG002|Overall Study|Progressive Disease|0|||
161789520|NCT00003102|584272888|FG000|Overall Study|Adverse Event|0|||
161789521|NCT00003102|584272889|FG001|Overall Study|Adverse Event|1|||
161789522|NCT00003102|584272890|FG002|Overall Study|Adverse Event|1|||
161789523|NCT00003102|584272888|FG000|Overall Study|Death|0|||
161789524|NCT00003102|584272889|FG001|Overall Study|Death|0|||
161789525|NCT00003102|584272890|FG002|Overall Study|Death|1|||
161789526|NCT05037409|584272891|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
161789527|NCT05037409|584272892|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
161789528|NCT05037409|584272893|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
161789529|NCT01559818|584272896|FG000|Overall Study|Physician Decision|1|||
161789530|NCT01559818|584272896|FG000|Overall Study|Pregnancy|1|||
162129948|NCT01603121|585526435|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
162129949|NCT01603121|585526436|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
162129950|NCT01848834|585526437|FG000|Overall Study|Adverse Event|3|||
161789531|NCT01559818|584272896|FG000|Overall Study|Study terminated by Sponsor|4|||
161789532|NCT01559818|584272896|FG000|Overall Study|Withdrawal by Subject|1|||
161789533|NCT01512979|584272898|FG000|Overall Study|Adverse Event|2|||
161789534|NCT01512979|584272899|FG001|Overall Study|Adverse Event|2|||
161789535|NCT01512979|584272898|FG000|Overall Study|Protocol Violation|1|||
161789536|NCT01512979|584272899|FG001|Overall Study|Protocol Violation|4|||
161789537|NCT01512979|584272898|FG000|Overall Study|Lost to Follow-up|2|||
161789538|NCT01512979|584272899|FG001|Overall Study|Lost to Follow-up|5|||
161789539|NCT01512979|584272898|FG000|Overall Study|Withdrawal by Subject|1|||
161789540|NCT01512979|584272899|FG001|Overall Study|Withdrawal by Subject|2|||
161789541|NCT01512979|584272898|FG000|Overall Study|Reason other than stated above|13|||
161789542|NCT01512979|584272899|FG001|Overall Study|Reason other than stated above|9|||
161789543|NCT00125359|584272900|FG000|Overall Study|Death|4|||
161789544|NCT00125359|584272900|FG000|Overall Study|Adverse Event|5|||
161789545|NCT00125359|584272900|FG000|Overall Study|Physician Decision|14|||
161789546|NCT00529568|584272901|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
161789547|NCT00529568|584272902|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
161789548|NCT00529568|584272903|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
161789549|NCT00529568|584272901|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
161789550|NCT00529568|584272902|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
161789551|NCT00529568|584272903|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
161789552|NCT00529568|584272901|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
161789553|NCT00529568|584272902|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
161789554|NCT00529568|584272903|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
161789555|NCT00529568|584272901|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
161789556|NCT00529568|584272902|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
161789557|NCT00529568|584272903|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
161789558|NCT00529568|584272901|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
161898712|NCT05225558|584677881|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
161898713|NCT05225558|584677882|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
161898714|NCT00313846|584677885|FG000|Overall Study|Withdrawal by Subject|2|||
162129951|NCT01848834|585526438|FG001|Overall Study|Adverse Event|11|||
162129952|NCT01848834|585526439|FG002|Overall Study|Adverse Event|3|||
162129953|NCT01848834|585526440|FG003|Overall Study|Adverse Event|5|||
161789559|NCT00529568|584272902|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
161789560|NCT00529568|584272903|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
161789561|NCT00529568|584272901|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
161789562|NCT00529568|584272902|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
161789563|NCT00529568|584272903|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
161789564|NCT00529568|584272901|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
162129954|NCT01848834|585526441|FG004|Overall Study|Adverse Event|9|||
162129955|NCT01848834|585526437|FG000|Overall Study|Death|2|||
162129956|NCT01848834|585526438|FG001|Overall Study|Death|11|||
162129957|NCT01848834|585526439|FG002|Overall Study|Death|1|||
162129958|NCT01848834|585526440|FG003|Overall Study|Death|8|||
162129959|NCT01848834|585526441|FG004|Overall Study|Death|27|||
162129960|NCT01848834|585526437|FG000|Overall Study|Excluded Medication|5|||
162129961|NCT01848834|585526438|FG001|Overall Study|Excluded Medication|4|||
162129962|NCT01848834|585526439|FG002|Overall Study|Excluded Medication|3|||
162129963|NCT01848834|585526440|FG003|Overall Study|Excluded Medication|6|||
162129964|NCT01848834|585526441|FG004|Overall Study|Excluded Medication|6|||
162129965|NCT01848834|585526437|FG000|Overall Study|Lost to Follow-up|5|||
162129966|NCT01848834|585526438|FG001|Overall Study|Lost to Follow-up|5|||
162129967|NCT01848834|585526439|FG002|Overall Study|Lost to Follow-up|3|||
162129968|NCT01848834|585526440|FG003|Overall Study|Lost to Follow-up|0|||
162129969|NCT01848834|585526441|FG004|Overall Study|Lost to Follow-up|3|||
162129970|NCT01848834|585526437|FG000|Overall Study|Physician Decision|1|||
162129971|NCT01848834|585526438|FG001|Overall Study|Physician Decision|3|||
162129972|NCT01848834|585526439|FG002|Overall Study|Physician Decision|4|||
162129973|NCT01848834|585526440|FG003|Overall Study|Physician Decision|0|||
162129974|NCT01848834|585526441|FG004|Overall Study|Physician Decision|11|||
162129975|NCT01848834|585526437|FG000|Overall Study|Protocol Violation|0|||
162129976|NCT01848834|585526438|FG001|Overall Study|Protocol Violation|0|||
162129977|NCT01848834|585526439|FG002|Overall Study|Protocol Violation|0|||
162129978|NCT01848834|585526440|FG003|Overall Study|Protocol Violation|0|||
162129979|NCT01848834|585526441|FG004|Overall Study|Protocol Violation|1|||
162129980|NCT01848834|585526437|FG000|Overall Study|Sponsor Decision|1|||
162129981|NCT01848834|585526438|FG001|Overall Study|Sponsor Decision|1|||
162129982|NCT01848834|585526439|FG002|Overall Study|Sponsor Decision|0|||
162129983|NCT01848834|585526440|FG003|Overall Study|Sponsor Decision|1|||
161789565|NCT00529568|584272902|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
161789566|NCT00529568|584272903|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
162129984|NCT01848834|585526441|FG004|Overall Study|Sponsor Decision|1|||
162129985|NCT01848834|585526437|FG000|Overall Study|Withdrawal by Subject|2|||
162129986|NCT01848834|585526438|FG001|Overall Study|Withdrawal by Subject|13|||
162129987|NCT01848834|585526439|FG002|Overall Study|Withdrawal by Subject|10|||
162129988|NCT01848834|585526440|FG003|Overall Study|Withdrawal by Subject|6|||
162129989|NCT01848834|585526441|FG004|Overall Study|Withdrawal by Subject|36|||
162129990|NCT02584855|585526442|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
162129991|NCT02584855|585526443|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
162129992|NCT02584855|585526444|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
162129993|NCT02584855|585526445|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
162129994|NCT02584855|585526446|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
162129995|NCT02584855|585526447|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
162129996|NCT02584855|585526442|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
162129997|NCT02584855|585526443|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
162129998|NCT02584855|585526444|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
162129999|NCT02584855|585526445|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
162130000|NCT02584855|585526446|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
161789567|NCT00529568|584272901|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
161789568|NCT00529568|584272902|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
161789569|NCT00529568|584272903|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
161789570|NCT00529568|584272901|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
161898715|NCT00313846|584677886|FG001|Overall Study|Withdrawal by Subject|0|||
162130001|NCT02584855|585526447|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
162130002|NCT02584855|585526442|FG000|Open-Label Treatment Period|Adverse Event|14|||
162130003|NCT02584855|585526443|FG001|Open-Label Treatment Period|Adverse Event|0|||
162130004|NCT02584855|585526444|FG002|Open-Label Treatment Period|Adverse Event|0|||
161789571|NCT00529568|584272902|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
161789572|NCT00529568|584272903|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
161789573|NCT00529568|584272901|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
162130005|NCT02584855|585526445|FG003|Open-Label Treatment Period|Adverse Event|0|||
162130006|NCT02584855|585526446|FG004|Open-Label Treatment Period|Adverse Event|0|||
162130007|NCT02584855|585526447|FG005|Open-Label Treatment Period|Adverse Event|0|||
162130008|NCT02584855|585526442|FG000|Open-Label Treatment Period|Death|2|||
162130009|NCT02584855|585526443|FG001|Open-Label Treatment Period|Death|0|||
162130010|NCT02584855|585526444|FG002|Open-Label Treatment Period|Death|0|||
162130011|NCT02584855|585526445|FG003|Open-Label Treatment Period|Death|0|||
162130012|NCT02584855|585526446|FG004|Open-Label Treatment Period|Death|0|||
162130013|NCT02584855|585526447|FG005|Open-Label Treatment Period|Death|0|||
161789574|NCT00529568|584272902|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
161789575|NCT00529568|584272903|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
161789576|NCT00529568|584272901|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
161789577|NCT00529568|584272902|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
161789578|NCT00529568|584272903|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
161789579|NCT04049552|584272904|FG000|Overall Study|Lost to Follow-up|1|||
161789580|NCT04147611|584272906|FG000|Overall Study|Physician Decision|0|||
161789581|NCT04147611|584272907|FG001|Overall Study|Physician Decision|1|||
161789582|NCT01585831|584272910|FG000|Overall Study|Physician Decision|0|||
161789583|NCT01585831|584272911|FG001|Overall Study|Physician Decision|1|||
161789584|NCT01585831|584272910|FG000|Overall Study|Withdrawal by Subject|2|||
161789585|NCT01585831|584272911|FG001|Overall Study|Withdrawal by Subject|1|||
161789586|NCT01225991|584272912|FG000|Overall Study|Withdrawal by Subject|6|||
161789587|NCT02133352|584272913|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
161789588|NCT04444752|584272914|FG000|Overall Study|Adverse Event|1|||
161789589|NCT04444752|584272915|FG001|Overall Study|Adverse Event|0|||
161789590|NCT04444752|584272916|FG002|Overall Study|Adverse Event|0|||
161789591|NCT04444752|584272917|FG003|Overall Study|Adverse Event|2|||
161789592|NCT04444752|584272914|FG000|Overall Study|Lost to Follow-up|2|||
161789593|NCT04444752|584272915|FG001|Overall Study|Lost to Follow-up|6|||
161789594|NCT04444752|584272916|FG002|Overall Study|Lost to Follow-up|2|||
161789595|NCT04444752|584272917|FG003|Overall Study|Lost to Follow-up|5|||
161789596|NCT04444752|584272914|FG000|Overall Study|Physician Decision|0|||
161789597|NCT04444752|584272915|FG001|Overall Study|Physician Decision|0|||
161789598|NCT04444752|584272916|FG002|Overall Study|Physician Decision|0|||
161789599|NCT04444752|584272917|FG003|Overall Study|Physician Decision|2|||
161789600|NCT04444752|584272914|FG000|Overall Study|Pregnancy|0|||
161789601|NCT04444752|584272915|FG001|Overall Study|Pregnancy|0|||
161789602|NCT04444752|584272916|FG002|Overall Study|Pregnancy|0|||
161789603|NCT04444752|584272917|FG003|Overall Study|Pregnancy|1|||
161789604|NCT04444752|584272914|FG000|Overall Study|Withdrawal by Subject|6|||
162130014|NCT02584855|585526442|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
162130015|NCT02584855|585526443|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
162130016|NCT02584855|585526444|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
162130017|NCT02584855|585526445|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
162130018|NCT02584855|585526446|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
162130019|NCT02584855|585526447|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
162130020|NCT02584855|585526442|FG000|Open-Label Treatment Period|Protocol Violation|1|||
162130021|NCT02584855|585526443|FG001|Open-Label Treatment Period|Protocol Violation|0|||
162130022|NCT02584855|585526444|FG002|Open-Label Treatment Period|Protocol Violation|0|||
162130023|NCT02584855|585526445|FG003|Open-Label Treatment Period|Protocol Violation|0|||
162130024|NCT02584855|585526446|FG004|Open-Label Treatment Period|Protocol Violation|0|||
162130025|NCT02584855|585526447|FG005|Open-Label Treatment Period|Protocol Violation|0|||
162130026|NCT02584855|585526442|FG000|Open-Label Treatment Period|No PI Available|2|||
162130027|NCT02584855|585526443|FG001|Open-Label Treatment Period|No PI Available|0|||
162130028|NCT02584855|585526444|FG002|Open-Label Treatment Period|No PI Available|0|||
162130029|NCT02584855|585526445|FG003|Open-Label Treatment Period|No PI Available|0|||
162130030|NCT02584855|585526446|FG004|Open-Label Treatment Period|No PI Available|0|||
162130031|NCT02584855|585526447|FG005|Open-Label Treatment Period|No PI Available|0|||
162130032|NCT02584855|585526442|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
162130033|NCT02584855|585526443|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
162130034|NCT02584855|585526444|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
162130035|NCT02584855|585526445|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
162130036|NCT02584855|585526446|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
162130037|NCT02584855|585526447|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
162130038|NCT02584855|585526442|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
162130039|NCT02584855|585526443|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
161789605|NCT04444752|584272915|FG001|Overall Study|Withdrawal by Subject|5|||
161789606|NCT04444752|584272916|FG002|Overall Study|Withdrawal by Subject|3|||
161789607|NCT04444752|584272917|FG003|Overall Study|Withdrawal by Subject|4|||
161789608|NCT04444752|584272914|FG000|Overall Study|Protocol Violation|1|||
162130040|NCT02584855|585526444|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
162130041|NCT02584855|585526445|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
162130042|NCT02584855|585526446|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
162130043|NCT02584855|585526447|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
161789609|NCT04444752|584272915|FG001|Overall Study|Protocol Violation|1|||
161789610|NCT04444752|584272916|FG002|Overall Study|Protocol Violation|0|||
161789611|NCT04444752|584272917|FG003|Overall Study|Protocol Violation|0|||
161789612|NCT04444752|584272914|FG000|Overall Study|Patient moving out of town|1|||
161789613|NCT04444752|584272915|FG001|Overall Study|Patient moving out of town|0|||
161789614|NCT04444752|584272916|FG002|Overall Study|Patient moving out of town|0|||
162130044|NCT02584855|585526442|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
162130045|NCT02584855|585526443|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
161789615|NCT04444752|584272917|FG003|Overall Study|Patient moving out of town|1|||
161789616|NCT04444752|584272914|FG000|Overall Study|Lack of Efficacy|0|||
161789617|NCT04444752|584272915|FG001|Overall Study|Lack of Efficacy|0|||
161789618|NCT04444752|584272916|FG002|Overall Study|Lack of Efficacy|0|||
161789619|NCT04444752|584272917|FG003|Overall Study|Lack of Efficacy|1|||
161789620|NCT04444752|584272914|FG000|Overall Study|Death|0|||
161789621|NCT04444752|584272915|FG001|Overall Study|Death|0|||
161789622|NCT04444752|584272916|FG002|Overall Study|Death|1|||
161789623|NCT04444752|584272917|FG003|Overall Study|Death|0|||
161789624|NCT00579254|584272918|FG000|Overall Study|Lost to Follow-up|39|||
161789625|NCT00579254|584272918|FG000|Overall Study|Discontinued when study terminated|73|||
161789626|NCT00433381|584274760|FG000|Overall Study|Ineligible / no protocol treatment|3|||
161789627|NCT00433381|584274761|FG001|Overall Study|Ineligible / no protocol treatment|3|||
161789628|NCT01387282|584274762|FG000|Overall Study|Death|47|||
161789629|NCT01387282|584274763|FG001|Overall Study|Death|16|||
161789630|NCT01387282|584274762|FG000|Overall Study|Other|5|||
161789631|NCT01387282|584274763|FG001|Overall Study|Other|1|||
161789632|NCT01387282|584274762|FG000|Overall Study|Unrelated AE|6|||
161789633|NCT01387282|584274763|FG001|Overall Study|Unrelated AE|4|||
162130046|NCT02584855|585526444|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
162130047|NCT02584855|585526445|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
162130048|NCT02584855|585526446|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
162130049|NCT02584855|585526447|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
162130050|NCT02584855|585526442|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
162130051|NCT02584855|585526443|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
162130052|NCT02584855|585526444|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
162130053|NCT02584855|585526445|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
162130054|NCT02584855|585526446|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
162130055|NCT02584855|585526447|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
162130056|NCT02584855|585526442|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
162130057|NCT02584855|585526443|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
162130058|NCT02584855|585526444|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
162130059|NCT02584855|585526445|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
162130060|NCT02584855|585526446|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
162130061|NCT02584855|585526447|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
162130062|NCT02584855|585526442|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162130063|NCT02584855|585526443|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162130064|NCT02584855|585526444|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162130065|NCT02584855|585526445|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162130066|NCT02584855|585526446|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
162130067|NCT02584855|585526447|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162130068|NCT02584855|585526442|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
162130069|NCT02584855|585526443|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
162130070|NCT02584855|585526444|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
162130071|NCT02584855|585526445|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
162130072|NCT02584855|585526446|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
162130073|NCT02584855|585526447|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
162130074|NCT02337478|585526448|FG000|Overall Study|Lack of Efficacy|5|||
162130075|NCT02611830|585526449|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
162130076|NCT02611830|585526450|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
162130077|NCT02611830|585526451|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
162130078|NCT02611830|585526452|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
162130079|NCT02611830|585526449|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
162130080|NCT02611830|585526450|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
162130081|NCT02611830|585526451|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
162130082|NCT02611830|585526452|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
162130083|NCT02611830|585526449|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
162130084|NCT02611830|585526450|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
162130085|NCT02611830|585526451|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
162130086|NCT02611830|585526452|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
162130087|NCT02611830|585526449|FG000|OL Induction Phase|Lack of Efficacy|9|||
162130088|NCT02611830|585526450|FG001|OL Induction Phase|Lack of Efficacy|0|||
162130089|NCT02611830|585526451|FG002|OL Induction Phase|Lack of Efficacy|0|||
161789634|NCT01387282|584274762|FG000|Overall Study|Withdrawal by patient|33|||
161789635|NCT01387282|584274763|FG001|Overall Study|Withdrawal by patient|23|||
161789636|NCT01387282|584274762|FG000|Overall Study|Study drug-related AE|2|||
161789637|NCT01387282|584274763|FG001|Overall Study|Study drug-related AE|2|||
161789638|NCT01387282|584274762|FG000|Overall Study|Lost to Follow-up|4|||
161789639|NCT01387282|584274763|FG001|Overall Study|Lost to Follow-up|1|||
161789640|NCT00458302|584274764|FG000|Overall Study|Adverse Event|4|||
161789641|NCT00458302|584274765|FG001|Overall Study|Adverse Event|14|||
161789642|NCT00458302|584274764|FG000|Overall Study|Pregnancy|2|||
161789643|NCT00458302|584274765|FG001|Overall Study|Pregnancy|1|||
161789644|NCT00458302|584274764|FG000|Overall Study|Protocol Violation|0|||
161789645|NCT00458302|584274765|FG001|Overall Study|Protocol Violation|2|||
161789646|NCT00458302|584274764|FG000|Overall Study|Withdrawal by Subject|6|||
161789647|NCT00458302|584274765|FG001|Overall Study|Withdrawal by Subject|4|||
161789648|NCT00458302|584274764|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
161789649|NCT00458302|584274765|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
161789650|NCT00458302|584274764|FG000|Overall Study|Study Termination By Sponsor|1|||
161789651|NCT00458302|584274765|FG001|Overall Study|Study Termination By Sponsor|0|||
161789652|NCT00458302|584274764|FG000|Overall Study|Lost to Follow-up|2|||
161789653|NCT00458302|584274765|FG001|Overall Study|Lost to Follow-up|0|||
161789654|NCT00458302|584274764|FG000|Overall Study|Other|4|||
161789655|NCT00458302|584274765|FG001|Overall Study|Other|2|||
161789656|NCT01513551|584274768|FG000|Overall Study|Death|0|||
161789657|NCT01513551|584274769|FG001|Overall Study|Death|1|||
161789658|NCT01513551|584274770|FG002|Overall Study|Death|0|||
161789659|NCT01513551|584274768|FG000|Overall Study|Lost to Follow-up|3|||
161789660|NCT01513551|584274769|FG001|Overall Study|Lost to Follow-up|5|||
161789661|NCT01513551|584274770|FG002|Overall Study|Lost to Follow-up|2|||
161789662|NCT01513551|584274768|FG000|Overall Study|Withdrawal by Subject|1|||
161789663|NCT01513551|584274769|FG001|Overall Study|Withdrawal by Subject|0|||
161789664|NCT01513551|584274770|FG002|Overall Study|Withdrawal by Subject|2|||
161789665|NCT01513551|584274768|FG000|Overall Study|Randomized but not vaccinated|0|||
161789666|NCT01513551|584274769|FG001|Overall Study|Randomized but not vaccinated|0|||
161789667|NCT01513551|584274770|FG002|Overall Study|Randomized but not vaccinated|1|||
161789668|NCT02038634|584274773|FG000|Overall Study|Lost to Follow-up|0|||
161789669|NCT02038634|584274774|FG001|Overall Study|Lost to Follow-up|1|||
161789670|NCT01706198|584274775|FG000|Overall Study|Adverse Event|12|||
161789671|NCT01706198|584274776|FG001|Overall Study|Adverse Event|15|||
161789672|NCT01706198|584274775|FG000|Overall Study|Protocol Violation|7|||
161789673|NCT01706198|584274776|FG001|Overall Study|Protocol Violation|5|||
161789674|NCT01706198|584274775|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
161789675|NCT01706198|584274776|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
161789676|NCT01706198|584274775|FG000|Overall Study|Lost to Follow-up|97|||
161789677|NCT01706198|584274776|FG001|Overall Study|Lost to Follow-up|93|||
161789678|NCT01706198|584274775|FG000|Overall Study|Physician Decision|23|||
161789679|NCT01706198|584274776|FG001|Overall Study|Physician Decision|37|||
161789680|NCT01706198|584274775|FG000|Overall Study|Withdrawal by Subject|23|||
161789681|NCT01706198|584274776|FG001|Overall Study|Withdrawal by Subject|31|||
161789682|NCT00549198|584274777|FG000|Overall Study|Adverse Event|28|||
161789683|NCT00549198|584274778|FG001|Overall Study|Adverse Event|26|||
161789684|NCT00549198|584274777|FG000|Overall Study|Insufficient Viral Load Response|4|||
161789685|NCT00549198|584274778|FG001|Overall Study|Insufficient Viral Load Response|2|||
161789686|NCT00549198|584274777|FG000|Overall Study|Protocol-defined Virological Failure|7|||
161789687|NCT00549198|584274778|FG001|Overall Study|Protocol-defined Virological Failure|0|||
161789688|NCT00549198|584274777|FG000|Overall Study|Non-compliance|2|||
161789689|NCT00549198|584274778|FG001|Overall Study|Non-compliance|4|||
161789690|NCT00549198|584274777|FG000|Overall Study|Lost to Follow-up|7|||
161789691|NCT00549198|584274778|FG001|Overall Study|Lost to Follow-up|8|||
161789692|NCT00549198|584274777|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
161789693|NCT00549198|584274778|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
161789694|NCT00549198|584274777|FG000|Overall Study|Protocol Violation|7|||
161789695|NCT00549198|584274778|FG001|Overall Study|Protocol Violation|2|||
161789696|NCT00549198|584274777|FG000|Overall Study|Investigator Decision|4|||
161789697|NCT00549198|584274778|FG001|Overall Study|Investigator Decision|3|||
161789698|NCT00549198|584274777|FG000|Overall Study|Withdrawal by Subject|7|||
161789699|NCT00549198|584274778|FG001|Overall Study|Withdrawal by Subject|7|||
161789700|NCT00549198|584274777|FG000|Overall Study|Disease Progression|1|||
161789701|NCT00549198|584274778|FG001|Overall Study|Disease Progression|0|||
161789702|NCT00549198|584274777|FG000|Overall Study|Participant Moved|2|||
161789703|NCT00549198|584274778|FG001|Overall Study|Participant Moved|0|||
161789704|NCT00549198|584274777|FG000|Overall Study|Participant not able to perform Week 96|1|||
161789705|NCT00549198|584274778|FG001|Overall Study|Participant not able to perform Week 96|0|||
161789706|NCT00549198|584274777|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
161789707|NCT00549198|584274778|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
161789708|NCT00549198|584274777|FG000|Overall Study|Prohibited Medication|1|||
161789709|NCT00549198|584274778|FG001|Overall Study|Prohibited Medication|2|||
161789710|NCT00549198|584274777|FG000|Overall Study|Participant planning pregnancy|1|||
161789711|NCT00549198|584274778|FG001|Overall Study|Participant planning pregnancy|0|||
161789712|NCT00549198|584274777|FG000|Overall Study|Participant overweight, no scan possible|1|||
161789713|NCT00549198|584274778|FG001|Overall Study|Participant overweight, no scan possible|0|||
161789714|NCT00549198|584274777|FG000|Overall Study|No scan facilities|0|||
161789715|NCT00549198|584274778|FG001|Overall Study|No scan facilities|2|||
161789716|NCT00549198|584274777|FG000|Overall Study|Pregnancy|0|||
161789717|NCT00549198|584274778|FG001|Overall Study|Pregnancy|3|||
161789718|NCT00549198|584274777|FG000|Overall Study|Not Exposed to Study Drug|3|||
161789719|NCT00549198|584274778|FG001|Overall Study|Not Exposed to Study Drug|4|||
161789720|NCT01034137|584274790|FG000|Overall Study|Adverse Event|9|||
161789721|NCT01034137|584274791|FG001|Overall Study|Adverse Event|10|||
161789722|NCT01034137|584274792|FG002|Overall Study|Adverse Event|8|||
161789723|NCT01034137|584274790|FG000|Overall Study|Withdrawal by Subject|4|||
161789724|NCT01034137|584274791|FG001|Overall Study|Withdrawal by Subject|3|||
161789725|NCT01034137|584274792|FG002|Overall Study|Withdrawal by Subject|3|||
161789726|NCT01034137|584274790|FG000|Overall Study|Lack of Efficacy|9|||
161789727|NCT01034137|584274791|FG001|Overall Study|Lack of Efficacy|4|||
161789728|NCT01034137|584274792|FG002|Overall Study|Lack of Efficacy|13|||
161789729|NCT01034137|584274790|FG000|Overall Study|Protocol Violation|2|||
161789730|NCT01034137|584274791|FG001|Overall Study|Protocol Violation|2|||
161789731|NCT01034137|584274792|FG002|Overall Study|Protocol Violation|1|||
161789732|NCT01034137|584274790|FG000|Overall Study|Refused treatment or did not cooperate|2|||
161789733|NCT01034137|584274791|FG001|Overall Study|Refused treatment or did not cooperate|0|||
161789734|NCT01034137|584274792|FG002|Overall Study|Refused treatment or did not cooperate|1|||
161789735|NCT01034137|584274790|FG000|Overall Study|Administrative or other|2|||
161789736|NCT01034137|584274791|FG001|Overall Study|Administrative or other|3|||
161789737|NCT01034137|584274792|FG002|Overall Study|Administrative or other|4|||
161789738|NCT03572933|584274793|FG000|Overall Study|Adverse Event|4|||
161789739|NCT03572933|584274794|FG001|Overall Study|Adverse Event|1|||
161789740|NCT03572933|584274793|FG000|Overall Study|Withdrawal by Subject|0|||
161789741|NCT03572933|584274794|FG001|Overall Study|Withdrawal by Subject|1|||
161789742|NCT01764854|584274795|FG000|Overall Study|Adverse Event|0|||
161789743|NCT01764854|584274796|FG001|Overall Study|Adverse Event|0|||
161789744|NCT01764854|584274797|FG002|Overall Study|Adverse Event|2|||
161789745|NCT01764854|584274798|FG003|Overall Study|Adverse Event|0|||
161789746|NCT01764854|584274795|FG000|Overall Study|Withdrawal by Subject|0|||
161789747|NCT01764854|584274796|FG001|Overall Study|Withdrawal by Subject|0|||
161789748|NCT01764854|584274797|FG002|Overall Study|Withdrawal by Subject|1|||
161789749|NCT01764854|584274798|FG003|Overall Study|Withdrawal by Subject|0|||
161789750|NCT01764854|584274795|FG000|Overall Study|relocation|0|||
161789751|NCT01764854|584274796|FG001|Overall Study|relocation|0|||
161789752|NCT01764854|584274797|FG002|Overall Study|relocation|2|||
161789753|NCT01764854|584274798|FG003|Overall Study|relocation|0|||
161789754|NCT01764854|584274795|FG000|Overall Study|Protocol Violation|0|||
161789755|NCT01764854|584274796|FG001|Overall Study|Protocol Violation|0|||
161789756|NCT01764854|584274797|FG002|Overall Study|Protocol Violation|1|||
161789757|NCT01764854|584274798|FG003|Overall Study|Protocol Violation|2|||
161789758|NCT03273387|584274799|FG000|Overall Study|Death|2|||
161789759|NCT03273387|584274800|FG001|Overall Study|Death|2|||
161789760|NCT03273387|584274799|FG000|Overall Study|Withdrawal by Subject|1|||
161789761|NCT03273387|584274800|FG001|Overall Study|Withdrawal by Subject|1|||
161789762|NCT01405950|584274801|FG000|Overall Study|Withdrawal by Subject|1|||
161789763|NCT01405950|584274802|FG001|Overall Study|Withdrawal by Subject|0|||
161789764|NCT01405950|584274803|FG002|Overall Study|Withdrawal by Subject|0|||
161789765|NCT01405950|584274804|FG003|Overall Study|Withdrawal by Subject|0|||
161789766|NCT01381900|584274805|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
161789767|NCT01381900|584274806|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
161789768|NCT01381900|584274807|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
161789769|NCT01381900|584274805|FG000|Overall Study|Adverse Event|4|||
161789770|NCT01381900|584274806|FG001|Overall Study|Adverse Event|6|||
161789771|NCT01381900|584274807|FG002|Overall Study|Adverse Event|7|||
161789772|NCT01381900|584274805|FG000|Overall Study|Noncompliance with study drug|0|||
161789773|NCT01381900|584274806|FG001|Overall Study|Noncompliance with study drug|0|||
161789774|NCT01381900|584274807|FG002|Overall Study|Noncompliance with study drug|1|||
161789775|NCT01381900|584274805|FG000|Overall Study|Physician Decision|0|||
161789776|NCT01381900|584274806|FG001|Overall Study|Physician Decision|1|||
161789777|NCT01381900|584274807|FG002|Overall Study|Physician Decision|1|||
161789778|NCT01381900|584274805|FG000|Overall Study|Protocol Violation|0|||
161789779|NCT01381900|584274806|FG001|Overall Study|Protocol Violation|1|||
161789780|NCT01381900|584274807|FG002|Overall Study|Protocol Violation|1|||
161789781|NCT01381900|584274805|FG000|Overall Study|Withdrawal by Subject|0|||
161898716|NCT00313846|584677885|FG000|Overall Study|Adverse Event|1|||
161898717|NCT00313846|584677886|FG001|Overall Study|Adverse Event|8|||
161789782|NCT01381900|584274806|FG001|Overall Study|Withdrawal by Subject|0|||
161789783|NCT01381900|584274807|FG002|Overall Study|Withdrawal by Subject|1|||
161789784|NCT01381900|584274805|FG000|Overall Study|Early withdraw|3|||
161789785|NCT01381900|584274806|FG001|Overall Study|Early withdraw|1|||
161789786|NCT01381900|584274807|FG002|Overall Study|Early withdraw|1|||
161789787|NCT02668783|584274808|FG000|Overall Study|Pregnancy|0|||
161789788|NCT02668783|584274809|FG001|Overall Study|Pregnancy|1|||
161789789|NCT02668783|584274808|FG000|Overall Study|Protocol Violation|2|||
161789790|NCT02668783|584274809|FG001|Overall Study|Protocol Violation|1|||
161789791|NCT02668783|584274808|FG000|Overall Study|Study terminated by sponsor|9|||
161789792|NCT02668783|584274809|FG001|Overall Study|Study terminated by sponsor|10|||
161789793|NCT02668783|584274808|FG000|Overall Study|Subject moved|1|||
161789794|NCT02668783|584274809|FG001|Overall Study|Subject moved|0|||
161789795|NCT02668783|584274808|FG000|Overall Study|Withdrawal by Subject|1|||
161789796|NCT02668783|584274809|FG001|Overall Study|Withdrawal by Subject|0|||
161789797|NCT02891200|584274810|FG000|Overall Study|Lost to Follow-up|31|||
161789798|NCT02891200|584274811|FG001|Overall Study|Lost to Follow-up|36|||
161789799|NCT02891200|584274810|FG000|Overall Study|Death|10|||
161789800|NCT02891200|584274811|FG001|Overall Study|Death|9|||
161789801|NCT02891200|584274810|FG000|Overall Study|Withdrawal by Subject|1|||
161789802|NCT02891200|584274811|FG001|Overall Study|Withdrawal by Subject|4|||
161789803|NCT04480463|584274812|FG000|Overall Study|Death|0|||
161789804|NCT04480463|584274813|FG001|Overall Study|Death|1|||
161789805|NCT04480463|584274812|FG000|Overall Study|Adverse Event|6|||
161789806|NCT04480463|584274813|FG001|Overall Study|Adverse Event|8|||
161789807|NCT04480463|584274812|FG000|Overall Study|Lost to Follow-up|3|||
161789808|NCT04480463|584274813|FG001|Overall Study|Lost to Follow-up|2|||
161789809|NCT04480463|584274812|FG000|Overall Study|Physician Decision|2|||
161789810|NCT04480463|584274813|FG001|Overall Study|Physician Decision|5|||
161789811|NCT04480463|584274812|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
161789812|NCT04480463|584274813|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
161789813|NCT04480463|584274812|FG000|Overall Study|Protocol Violation|2|||
161789814|NCT04480463|584274813|FG001|Overall Study|Protocol Violation|1|||
161789815|NCT04480463|584274812|FG000|Overall Study|Withdrawal by Subject|6|||
161789816|NCT04480463|584274813|FG001|Overall Study|Withdrawal by Subject|7|||
161789817|NCT04480463|584274812|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
161789818|NCT04480463|584274813|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
161789819|NCT04480463|584274812|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
161789820|NCT04480463|584274813|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
161789821|NCT04480463|584274812|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
161789822|NCT04480463|584274813|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
161789823|NCT04480463|584274812|FG000|Overall Study|Other|6|||
161789824|NCT04480463|584274813|FG001|Overall Study|Other|4|||
161789825|NCT00673361|584274814|FG000|Overall Study|Screen Failure|2|||
161789826|NCT01799590|584274816|FG000|Overall Study|Adverse Event|13|||
162130090|NCT02611830|585526452|FG003|OL Induction Phase|Lack of Efficacy|0|||
162130091|NCT02611830|585526449|FG000|OL Induction Phase|Reason not specified|3|||
162130092|NCT02611830|585526450|FG001|OL Induction Phase|Reason not specified|0|||
162130093|NCT02611830|585526451|FG002|OL Induction Phase|Reason not specified|0|||
162130094|NCT02611830|585526452|FG003|OL Induction Phase|Reason not specified|0|||
162130095|NCT02611830|585526449|FG000|Maintenance Phase|Lack of Efficacy|0|||
162130096|NCT02611830|585526450|FG001|Maintenance Phase|Lack of Efficacy|29|||
161789827|NCT01799590|584274817|FG001|Overall Study|Adverse Event|7|||
161789828|NCT01799590|584274818|FG002|Overall Study|Adverse Event|5|||
161789829|NCT01799590|584274816|FG000|Overall Study|Pregnancy|2|||
161789830|NCT01799590|584274817|FG001|Overall Study|Pregnancy|0|||
161789831|NCT01799590|584274818|FG002|Overall Study|Pregnancy|0|||
161789832|NCT01799590|584274816|FG000|Overall Study|Lack of Efficacy|3|||
161789833|NCT01799590|584274817|FG001|Overall Study|Lack of Efficacy|1|||
161789834|NCT01799590|584274818|FG002|Overall Study|Lack of Efficacy|3|||
161789835|NCT01799590|584274816|FG000|Overall Study|Participants convenience|4|||
161789836|NCT01799590|584274817|FG001|Overall Study|Participants convenience|4|||
161789837|NCT01799590|584274818|FG002|Overall Study|Participants convenience|2|||
161789838|NCT01799590|584274816|FG000|Overall Study|Aggravation of complications|0|||
161789839|NCT01799590|584274817|FG001|Overall Study|Aggravation of complications|1|||
161789840|NCT01799590|584274818|FG002|Overall Study|Aggravation of complications|1|||
161789841|NCT01799590|584274816|FG000|Overall Study|Using drugs with restricted days of use|0|||
161789842|NCT01799590|584274817|FG001|Overall Study|Using drugs with restricted days of use|3|||
161789843|NCT01799590|584274818|FG002|Overall Study|Using drugs with restricted days of use|2|||
162130097|NCT02611830|585526451|FG002|Maintenance Phase|Lack of Efficacy|18|||
161789844|NCT01799590|584274816|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
161789845|NCT01799590|584274817|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
161789846|NCT01799590|584274818|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
161789847|NCT01799590|584274816|FG000|Overall Study|Other|3|||
161789848|NCT01799590|584274817|FG001|Overall Study|Other|0|||
161789849|NCT01799590|584274818|FG002|Overall Study|Other|1|||
161789850|NCT00294723|584274819|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
161789851|NCT00294723|584274820|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
161789852|NCT00294723|584274821|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
161789853|NCT00294723|584274819|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
161789854|NCT00294723|584274820|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
162130098|NCT02611830|585526452|FG003|Maintenance Phase|Lack of Efficacy|6|||
161789855|NCT00294723|584274821|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
161789856|NCT00294723|584274819|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
161898718|NCT00313846|584677885|FG000|Overall Study|Administrative|2|||
162130099|NCT02611830|585526449|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
162130100|NCT02611830|585526450|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
162130101|NCT02611830|585526451|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
162130102|NCT02611830|585526452|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
162130103|NCT02611830|585526449|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
162130104|NCT02611830|585526450|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
162130105|NCT02611830|585526451|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
162130106|NCT02611830|585526452|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
162130107|NCT02611830|585526449|FG000|Maintenance Phase|Lost to Follow-up|0|||
162130108|NCT02611830|585526450|FG001|Maintenance Phase|Lost to Follow-up|0|||
162130109|NCT02611830|585526451|FG002|Maintenance Phase|Lost to Follow-up|0|||
162130110|NCT02611830|585526452|FG003|Maintenance Phase|Lost to Follow-up|1|||
162130111|NCT02611830|585526449|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
162130112|NCT02611830|585526450|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
162130113|NCT02611830|585526451|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
162130114|NCT02611830|585526452|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
162130115|NCT02611830|585526449|FG000|Maintenance Phase|Pregnancy|0|||
162130116|NCT02611830|585526450|FG001|Maintenance Phase|Pregnancy|0|||
162130117|NCT02611830|585526451|FG002|Maintenance Phase|Pregnancy|1|||
162130118|NCT02611830|585526452|FG003|Maintenance Phase|Pregnancy|0|||
162130119|NCT02611830|585526449|FG000|Maintenance Phase|Reason not specified|0|||
162130120|NCT02611830|585526450|FG001|Maintenance Phase|Reason not specified|1|||
162130121|NCT02611830|585526451|FG002|Maintenance Phase|Reason not specified|4|||
162130122|NCT02611830|585526452|FG003|Maintenance Phase|Reason not specified|0|||
162130123|NCT01987830|585526463|FG000|Overall Study|Never received baseline scan|1|||
162130124|NCT01021332|585527991|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
162130125|NCT01021332|585527991|FG000|Overall Study|Adverse Event|43|||
162130126|NCT01021332|585527991|FG000|Overall Study|Lack of Efficacy|19|||
162130127|NCT01021332|585527991|FG000|Overall Study|Withdrawal of Consent|23|||
162130128|NCT01021332|585527991|FG000|Overall Study|Lost to Follow-up|4|||
162130129|NCT01021332|585527991|FG000|Overall Study|Protocol Violation|9|||
162130130|NCT01021332|585527991|FG000|Overall Study|Miscellaneous|3|||
162130131|NCT00826280|585527992|FG000|Overall Study|Randomized but drug not received|1|||
162130132|NCT00826280|585527993|FG001|Overall Study|Randomized but drug not received|0|||
162130133|NCT00826280|585527994|FG002|Overall Study|Randomized but drug not received|1|||
162130134|NCT00826280|585527992|FG000|Overall Study|Adverse Event|1|||
162130135|NCT00826280|585527993|FG001|Overall Study|Adverse Event|3|||
162130136|NCT00826280|585527994|FG002|Overall Study|Adverse Event|0|||
162130137|NCT00826280|585527992|FG000|Overall Study|Lost to Follow-up|0|||
162130138|NCT00826280|585527993|FG001|Overall Study|Lost to Follow-up|1|||
162130139|NCT00826280|585527994|FG002|Overall Study|Lost to Follow-up|0|||
162130140|NCT00826280|585527992|FG000|Overall Study|Sponsor discontinued subject or study|1|||
162130141|NCT00826280|585527993|FG001|Overall Study|Sponsor discontinued subject or study|0|||
162130142|NCT00826280|585527994|FG002|Overall Study|Sponsor discontinued subject or study|0|||
162130143|NCT00826280|585527992|FG000|Overall Study|Reversible ischemic defect not present|43|||
162130144|NCT00826280|585527993|FG001|Overall Study|Reversible ischemic defect not present|40|||
162130145|NCT00826280|585527994|FG002|Overall Study|Reversible ischemic defect not present|44|||
162130146|NCT00826280|585527992|FG000|Overall Study|Interpretation Failure|1|||
162130147|NCT00826280|585527993|FG001|Overall Study|Interpretation Failure|0|||
162130148|NCT00826280|585527994|FG002|Overall Study|Interpretation Failure|0|||
162130149|NCT00826280|585527992|FG000|Overall Study|Machine Failure|1|||
162130150|NCT00826280|585527993|FG001|Overall Study|Machine Failure|1|||
162130151|NCT00826280|585527994|FG002|Overall Study|Machine Failure|0|||
162130152|NCT00826280|585527992|FG000|Overall Study|One or more non-interpretable scan|0|||
162130153|NCT00826280|585527993|FG001|Overall Study|One or more non-interpretable scan|1|||
162130154|NCT00826280|585527994|FG002|Overall Study|One or more non-interpretable scan|1|||
161789857|NCT00294723|584274820|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
161789858|NCT00294723|584274821|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
161789859|NCT00294723|584274819|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
162130155|NCT00738530|585528001|FG000|Overall Study|Death|220|||
162130156|NCT00738530|585528002|FG001|Overall Study|Death|224|||
162130157|NCT00738530|585528001|FG000|Overall Study|Lost to Follow-up|8|||
162130158|NCT00738530|585528002|FG001|Overall Study|Lost to Follow-up|6|||
162130159|NCT00738530|585528001|FG000|Overall Study|Withdrawal by Subject|6|||
162130160|NCT00738530|585528002|FG001|Overall Study|Withdrawal by Subject|8|||
162130161|NCT01656759|585528003|FG000|Overall Study|Protocol Violation|2|||
162130162|NCT01656759|585528004|FG001|Overall Study|Protocol Violation|3|||
162130163|NCT01628510|585528005|FG000|Overall Study|Withdrawal by Subject|0|||
161789860|NCT00294723|584274820|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
161789861|NCT00294723|584274821|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
161789862|NCT00294723|584274819|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
162130164|NCT01628510|585528006|FG001|Overall Study|Withdrawal by Subject|4|||
162130165|NCT01628510|585528005|FG000|Overall Study|Death|3|||
162130166|NCT01628510|585528006|FG001|Overall Study|Death|1|||
161789863|NCT00294723|584274820|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
161789864|NCT00294723|584274821|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
161789865|NCT00294723|584274819|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
161789866|NCT00294723|584274820|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
161789867|NCT00294723|584274821|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
161789868|NCT00294723|584274819|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
161789869|NCT00294723|584274820|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
161789870|NCT00294723|584274821|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
161789871|NCT00294723|584274819|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
161789872|NCT00294723|584274820|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
161789873|NCT00294723|584274821|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
161789874|NCT00294723|584274819|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
161789875|NCT00294723|584274820|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
161789876|NCT00294723|584274821|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
161789877|NCT00294723|584274819|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
161789878|NCT00294723|584274820|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
161789879|NCT00294723|584274821|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
161789880|NCT00294723|584274819|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
161789881|NCT00294723|584274820|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
161789882|NCT00294723|584274821|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
161789883|NCT00294723|584274819|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
161789884|NCT00294723|584274820|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
161789885|NCT00294723|584274821|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
161789886|NCT01769378|584274824|FG000|Overall Study|Adverse Event|10|||
161789887|NCT01769378|584274825|FG001|Overall Study|Adverse Event|0|||
161789888|NCT01769378|584274824|FG000|Overall Study|Entry criteria not met|1|||
161789889|NCT01769378|584274825|FG001|Overall Study|Entry criteria not met|0|||
161789890|NCT01769378|584274824|FG000|Overall Study|Protocol Violation|1|||
161789891|NCT01769378|584274825|FG001|Overall Study|Protocol Violation|1|||
161789892|NCT01769378|584274824|FG000|Overall Study|Withdrawal by Subject|10|||
161789893|NCT01769378|584274825|FG001|Overall Study|Withdrawal by Subject|3|||
161789894|NCT01769378|584274824|FG000|Overall Study|Sponsor Decision|1|||
161789895|NCT01769378|584274825|FG001|Overall Study|Sponsor Decision|0|||
161789896|NCT01769378|584274824|FG000|Overall Study|Lost to Follow-up|2|||
161789897|NCT01769378|584274825|FG001|Overall Study|Lost to Follow-up|0|||
161789898|NCT01977092|584274826|FG000|Overall Study|Death|3|||
161789899|NCT01977092|584274827|FG001|Overall Study|Death|4|||
161789900|NCT01977092|584274826|FG000|Overall Study|Lost to Follow-up|23|||
161789901|NCT01977092|584274827|FG001|Overall Study|Lost to Follow-up|14|||
161789902|NCT01977092|584274826|FG000|Overall Study|Withdrawal by Subject|2|||
161789903|NCT01977092|584274827|FG001|Overall Study|Withdrawal by Subject|1|||
161789904|NCT01977092|584274826|FG000|Overall Study|In prison|3|||
161789905|NCT01977092|584274827|FG001|Overall Study|In prison|11|||
161789906|NCT01958281|584274828|FG000|Overall Study|Lack of Efficacy|5|||
161789907|NCT01958281|584274829|FG001|Overall Study|Lack of Efficacy|2|||
161789908|NCT01958281|584274830|FG002|Overall Study|Lack of Efficacy|0|||
161789909|NCT01958281|584274828|FG000|Overall Study|Adverse Event|0|||
161789910|NCT01958281|584274829|FG001|Overall Study|Adverse Event|2|||
161898719|NCT00313846|584677886|FG001|Overall Study|Administrative|3|||
161898720|NCT01896193|584677889|FG000|Overall Study|Lack of Efficacy|20|||
161898721|NCT01896193|584677890|FG001|Overall Study|Lack of Efficacy|11|||
161789911|NCT01958281|584274830|FG002|Overall Study|Adverse Event|0|||
161789912|NCT01958281|584274828|FG000|Overall Study|Withdrew Consent|1|||
161789913|NCT01958281|584274829|FG001|Overall Study|Withdrew Consent|0|||
161789914|NCT01958281|584274830|FG002|Overall Study|Withdrew Consent|0|||
161789915|NCT03038113|584274831|FG000|Overall Study|Withdrawal by Subject|0|||
161789916|NCT03038113|584274832|FG001|Overall Study|Withdrawal by Subject|0|||
161789917|NCT03038113|584274833|FG002|Overall Study|Withdrawal by Subject|1|||
161789918|NCT03038113|584274834|FG003|Overall Study|Withdrawal by Subject|0|||
161789919|NCT03038113|584274835|FG004|Overall Study|Withdrawal by Subject|0|||
161789920|NCT03038113|584274836|FG005|Overall Study|Withdrawal by Subject|0|||
161789921|NCT03038113|584274837|FG006|Overall Study|Withdrawal by Subject|0|||
161789922|NCT03038113|584274838|FG007|Overall Study|Withdrawal by Subject|0|||
161789923|NCT03038113|584274839|FG008|Overall Study|Withdrawal by Subject|0|||
161789924|NCT03038113|584274840|FG009|Overall Study|Withdrawal by Subject|0|||
161789925|NCT03038113|584274841|FG010|Overall Study|Withdrawal by Subject|0|||
161789926|NCT03038113|584274842|FG011|Overall Study|Withdrawal by Subject|0|||
161789927|NCT03038113|584274843|FG012|Overall Study|Withdrawal by Subject|0|||
161789928|NCT03038113|584274844|FG013|Overall Study|Withdrawal by Subject|1|||
161789929|NCT03038113|584274831|FG000|Overall Study|Lost to Follow-up|0|||
161789930|NCT03038113|584274832|FG001|Overall Study|Lost to Follow-up|0|||
161789931|NCT03038113|584274833|FG002|Overall Study|Lost to Follow-up|0|||
161789932|NCT03038113|584274834|FG003|Overall Study|Lost to Follow-up|0|||
161898722|NCT01896193|584677889|FG000|Overall Study|Protocol Violation|0|||
161789933|NCT03038113|584274835|FG004|Overall Study|Lost to Follow-up|0|||
161789934|NCT03038113|584274836|FG005|Overall Study|Lost to Follow-up|0|||
161789935|NCT03038113|584274837|FG006|Overall Study|Lost to Follow-up|1|||
161789936|NCT03038113|584274838|FG007|Overall Study|Lost to Follow-up|0|||
161789937|NCT03038113|584274839|FG008|Overall Study|Lost to Follow-up|0|||
161789938|NCT03038113|584274840|FG009|Overall Study|Lost to Follow-up|0|||
161789939|NCT03038113|584274841|FG010|Overall Study|Lost to Follow-up|0|||
161789940|NCT03038113|584274842|FG011|Overall Study|Lost to Follow-up|0|||
161789941|NCT03038113|584274843|FG012|Overall Study|Lost to Follow-up|0|||
161789942|NCT03038113|584274844|FG013|Overall Study|Lost to Follow-up|0|||
161789943|NCT03882047|584274845|FG000|Overall Study|Adverse Event|0|||
161789944|NCT03882047|584274846|FG001|Overall Study|Adverse Event|2|||
161789945|NCT03882047|584274847|FG002|Overall Study|Adverse Event|2|||
161789946|NCT03882047|584274845|FG000|Overall Study|Treatment Failure|3|||
161789947|NCT03882047|584274846|FG001|Overall Study|Treatment Failure|3|||
161789948|NCT03882047|584274847|FG002|Overall Study|Treatment Failure|12|||
161789949|NCT03882047|584274845|FG000|Overall Study|Lost to Follow-up|0|||
161789950|NCT03882047|584274846|FG001|Overall Study|Lost to Follow-up|1|||
161789951|NCT03882047|584274847|FG002|Overall Study|Lost to Follow-up|0|||
161789952|NCT03882047|584274845|FG000|Overall Study|Did Not Wish to Continue|1|||
161789953|NCT03882047|584274846|FG001|Overall Study|Did Not Wish to Continue|4|||
161789954|NCT03882047|584274847|FG002|Overall Study|Did Not Wish to Continue|1|||
161789955|NCT03882047|584274845|FG000|Overall Study|Noncompliance With Protocol|2|||
161789956|NCT03882047|584274846|FG001|Overall Study|Noncompliance With Protocol|0|||
161789957|NCT03882047|584274847|FG002|Overall Study|Noncompliance With Protocol|0|||
161789958|NCT03882047|584274845|FG000|Overall Study|Did Not Meet Eligibility|0|||
161789959|NCT03882047|584274846|FG001|Overall Study|Did Not Meet Eligibility|0|||
161789960|NCT03882047|584274847|FG002|Overall Study|Did Not Meet Eligibility|1|||
161789961|NCT00175019|584274849|FG000|Overall Study|Adverse Event|54|||
161789962|NCT00175019|584274850|FG001|Overall Study|Adverse Event|22|||
161789963|NCT00175019|584274851|FG002|Overall Study|Adverse Event|2|||
161789964|NCT00175019|584274849|FG000|Overall Study|Protocol Violation|6|||
161789965|NCT00175019|584274850|FG001|Overall Study|Protocol Violation|3|||
161789966|NCT00175019|584274851|FG002|Overall Study|Protocol Violation|3|||
161789967|NCT00175019|584274849|FG000|Overall Study|Lost to Follow-up|42|||
161789968|NCT00175019|584274850|FG001|Overall Study|Lost to Follow-up|39|||
161789969|NCT00175019|584274851|FG002|Overall Study|Lost to Follow-up|9|||
161789970|NCT00175019|584274849|FG000|Overall Study|Did not continue under Amendment 4|1|||
161789971|NCT00175019|584274850|FG001|Overall Study|Did not continue under Amendment 4|1|||
161789972|NCT00175019|584274851|FG002|Overall Study|Did not continue under Amendment 4|2|||
161789973|NCT00175019|584274849|FG000|Overall Study|Personal Reason(s)|39|||
161789974|NCT00175019|584274850|FG001|Overall Study|Personal Reason(s)|31|||
161789975|NCT00175019|584274851|FG002|Overall Study|Personal Reason(s)|8|||
161789976|NCT00175019|584274849|FG000|Overall Study|Therapeutic Failure|10|||
161789977|NCT00175019|584274850|FG001|Overall Study|Therapeutic Failure|38|||
161789978|NCT00175019|584274851|FG002|Overall Study|Therapeutic Failure|22|||
161789979|NCT00175019|584274849|FG000|Overall Study|Gout Flare|2|||
161789980|NCT00175019|584274850|FG001|Overall Study|Gout Flare|3|||
161789981|NCT00175019|584274851|FG002|Overall Study|Gout Flare|0|||
161789982|NCT00175019|584274849|FG000|Overall Study|Reason Not Specified|40|||
161789983|NCT00175019|584274850|FG001|Overall Study|Reason Not Specified|34|||
161789984|NCT00175019|584274851|FG002|Overall Study|Reason Not Specified|11|||
161789985|NCT00475852|584274857|FG000|Overall Study|Death|444|||
161789986|NCT00475852|584274858|FG001|Overall Study|Death|456|||
161789987|NCT00475852|584274857|FG000|Overall Study|Withdrawal by Subject|19|||
161789988|NCT00475852|584274858|FG001|Overall Study|Withdrawal by Subject|24|||
161789989|NCT00475852|584274857|FG000|Overall Study|Lost to Follow-up|54|||
161789990|NCT00475852|584274858|FG001|Overall Study|Lost to Follow-up|68|||
161789991|NCT00297479|584274859|FG000|Overall Study|Lost to Follow-up|37|||
161789992|NCT00297479|584274860|FG001|Overall Study|Lost to Follow-up|54|||
161789993|NCT00297479|584274861|FG002|Overall Study|Lost to Follow-up|51|||
161789994|NCT03263819|584274862|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
161789995|NCT03263819|584274863|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
161789996|NCT00686920|584274865|FG000|Overall Study|Death|45|||
161789997|NCT00686920|584274866|FG001|Overall Study|Death|14|||
161789998|NCT00686920|584274865|FG000|Overall Study|Liver Transplant|23|||
162130167|NCT04179461|585528007|FG000|Overall Study|Lost to Follow-up|4|||
162130168|NCT03160079|585528015|FG000|Overall Study|Adverse Event|2|||
161789999|NCT00686920|584274866|FG001|Overall Study|Liver Transplant|8|||
161790000|NCT00686920|584274865|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
161790001|NCT00686920|584274866|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
161790002|NCT00686920|584274865|FG000|Overall Study|Withdrawal by Subject|23|||
161790003|NCT00686920|584274866|FG001|Overall Study|Withdrawal by Subject|5|||
161790004|NCT00686920|584274865|FG000|Overall Study|Protocol Violation|2|||
161790005|NCT00686920|584274866|FG001|Overall Study|Protocol Violation|1|||
161790006|NCT00686920|584274865|FG000|Overall Study|Adverse Event|10|||
161790007|NCT00686920|584274866|FG001|Overall Study|Adverse Event|2|||
161790008|NCT00686920|584274865|FG000|Overall Study|Personal Reason|0|||
161790009|NCT00686920|584274866|FG001|Overall Study|Personal Reason|1|||
161790010|NCT00686920|584274865|FG000|Overall Study|Lost to Follow-up|15|||
161790011|NCT00686920|584274866|FG001|Overall Study|Lost to Follow-up|3|||
162130169|NCT03160079|585528016|FG001|Overall Study|Adverse Event|0|||
161790012|NCT00686920|584274865|FG000|Overall Study|Moved to Another State|1|||
161790013|NCT00686920|584274866|FG001|Overall Study|Moved to Another State|0|||
161790014|NCT00686920|584274865|FG000|Overall Study|Transferred to Nursing Home|1|||
161790015|NCT00686920|584274866|FG001|Overall Study|Transferred to Nursing Home|0|||
161790016|NCT00686920|584274865|FG000|Overall Study|Noncompliance|9|||
161790017|NCT00686920|584274866|FG001|Overall Study|Noncompliance|0|||
161790018|NCT00686920|584274865|FG000|Overall Study|Principal Investigator Decision|2|||
161790019|NCT00686920|584274866|FG001|Overall Study|Principal Investigator Decision|0|||
161790020|NCT00814658|584274870|FG000|Overall Study|Lost to Follow-up|0|||
162130170|NCT03160079|585528015|FG000|Overall Study|Disease Progression|1|||
162130171|NCT03160079|585528016|FG001|Overall Study|Disease Progression|0|||
162130172|NCT03160079|585528015|FG000|Overall Study|Physician Decision|1|||
162130173|NCT03160079|585528016|FG001|Overall Study|Physician Decision|0|||
162130174|NCT03259373|585528028|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
162130175|NCT03259373|585528029|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
162130176|NCT03259373|585528028|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
162130177|NCT03259373|585528029|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
162130178|NCT03259373|585528028|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
162130179|NCT03259373|585528029|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
162130180|NCT03259373|585528028|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
162130181|NCT03259373|585528029|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
162130182|NCT03259373|585528028|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
162130183|NCT03259373|585528029|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
162130184|NCT03259373|585528028|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
162130185|NCT03259373|585528029|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
162130186|NCT01513967|585528033|FG000|Overall Study|Pregnancy|0|||
162130187|NCT01513967|585528034|FG001|Overall Study|Pregnancy|0|||
162130188|NCT01513967|585528035|FG002|Overall Study|Pregnancy|0|||
162130189|NCT01513967|585528036|FG003|Overall Study|Pregnancy|0|||
162130190|NCT01513967|585528037|FG004|Overall Study|Pregnancy|0|||
161790021|NCT00814658|584274871|FG001|Overall Study|Lost to Follow-up|1|||
161790022|NCT00814658|584274870|FG000|Overall Study|Physician Decision|1|||
161790023|NCT00814658|584274871|FG001|Overall Study|Physician Decision|0|||
161790024|NCT00814658|584274870|FG000|Overall Study|Adverse Event|3|||
161790025|NCT00814658|584274871|FG001|Overall Study|Adverse Event|3|||
161790026|NCT01141283|584274872|FG000|Overall Study|Adverse Event|56|||
161790027|NCT01141283|584274872|FG000|Overall Study|Lost to Follow-up|4|||
161790028|NCT01141283|584274872|FG000|Overall Study|Withdrawal by Subject|14|||
161790029|NCT01141283|584274872|FG000|Overall Study|Administrative|4|||
161790030|NCT01141283|584274872|FG000|Overall Study|Lack of Efficacy|10|||
161790031|NCT02974114|584274875|FG000|Overall Study|Other (Not specified)|0|||
161790032|NCT02974114|584274876|FG001|Overall Study|Other (Not specified)|1|||
161790033|NCT02974114|584274877|FG002|Overall Study|Other (Not specified)|2|||
162130191|NCT01513967|585528038|FG005|Overall Study|Pregnancy|0|||
162130192|NCT01513967|585528039|FG006|Overall Study|Pregnancy|1|||
162130193|NCT01513967|585528040|FG007|Overall Study|Pregnancy|0|||
162130194|NCT01513967|585528033|FG000|Overall Study|missed a study visit|0|||
162130195|NCT01513967|585528034|FG001|Overall Study|missed a study visit|0|||
162130196|NCT01513967|585528035|FG002|Overall Study|missed a study visit|0|||
162130197|NCT01513967|585528036|FG003|Overall Study|missed a study visit|0|||
162130198|NCT01513967|585528037|FG004|Overall Study|missed a study visit|0|||
162130199|NCT01513967|585528038|FG005|Overall Study|missed a study visit|0|||
162130200|NCT01513967|585528039|FG006|Overall Study|missed a study visit|1|||
162130201|NCT01513967|585528040|FG007|Overall Study|missed a study visit|0|||
162130202|NCT01513967|585528033|FG000|Overall Study|excluded due to positive drug screen|0|||
162130203|NCT01513967|585528034|FG001|Overall Study|excluded due to positive drug screen|0|||
162130204|NCT01513967|585528035|FG002|Overall Study|excluded due to positive drug screen|0|||
162130205|NCT01513967|585528036|FG003|Overall Study|excluded due to positive drug screen|0|||
161790034|NCT01335464|584274881|FG000|Overall Study|Adverse Event|15|||
161790035|NCT01335464|584274882|FG001|Overall Study|Adverse Event|25|||
161790036|NCT01335464|584274881|FG000|Overall Study|Non compliant with protocol|2|||
161790037|NCT01335464|584274882|FG001|Overall Study|Non compliant with protocol|0|||
161790038|NCT01335464|584274881|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
161790039|NCT01335464|584274882|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
161790040|NCT01335464|584274881|FG000|Overall Study|Not treated|2|||
161790041|NCT01335464|584274882|FG001|Overall Study|Not treated|0|||
161790042|NCT01335464|584274881|FG000|Overall Study|Reason other than those stated above|1|||
161790043|NCT01335464|584274882|FG001|Overall Study|Reason other than those stated above|1|||
161790044|NCT00096486|584274887|FG000|Overall Study|Withdrawal by Subject|0|||
161790045|NCT00096486|584274888|FG001|Overall Study|Withdrawal by Subject|0|||
161790046|NCT00096486|584274889|FG002|Overall Study|Withdrawal by Subject|1|||
161790047|NCT00096486|584274890|FG003|Overall Study|Withdrawal by Subject|1|||
161790048|NCT00096486|584274887|FG000|Overall Study|Not Treated|0|||
161790049|NCT00096486|584274888|FG001|Overall Study|Not Treated|0|||
161790050|NCT00096486|584274889|FG002|Overall Study|Not Treated|1|||
161790051|NCT00096486|584274890|FG003|Overall Study|Not Treated|1|||
161790052|NCT01201356|584274891|FG000|Overall Study|Adverse Event|170|||
161790053|NCT01201356|584274891|FG000|Overall Study|Abnormal laboratory value(s)|51|||
161790054|NCT01201356|584274891|FG000|Overall Study|Abnormal test procedure result(s)|3|||
161790055|NCT01201356|584274891|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
161790056|NCT01201356|584274891|FG000|Overall Study|Condition no longer requires study drug|12|||
161790057|NCT01201356|584274891|FG000|Overall Study|Withdrawal by Subject|144|||
161790058|NCT01201356|584274891|FG000|Overall Study|Lost to Follow-up|50|||
161790059|NCT01201356|584274891|FG000|Overall Study|administrative problems|74|||
161790060|NCT01201356|584274891|FG000|Overall Study|Death|16|||
161790061|NCT01201356|584274891|FG000|Overall Study|Protocol Violation|12|||
161790062|NCT00738920|584274893|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
161790063|NCT00738920|584274894|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
161790064|NCT00738920|584274895|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
161790065|NCT00738920|584274893|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
161790066|NCT00738920|584274894|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
161790067|NCT00738920|584274895|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
161790068|NCT00738920|584274893|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
161790069|NCT00738920|584274894|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
161790070|NCT00738920|584274895|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
161790071|NCT00738920|584274893|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
161790072|NCT00738920|584274894|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
161790073|NCT00738920|584274895|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
161790074|NCT00738920|584274893|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
161790075|NCT00738920|584274894|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
161790076|NCT00738920|584274895|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
161790077|NCT00738920|584274893|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
161790078|NCT00738920|584274894|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
161790079|NCT00738920|584274895|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
161790080|NCT00738920|584274893|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
161790081|NCT00738920|584274894|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
161790082|NCT00738920|584274895|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
161790083|NCT00738920|584274893|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
161790084|NCT00738920|584274894|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
161790085|NCT00738920|584274895|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
161790086|NCT00738920|584274893|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
161790087|NCT00738920|584274894|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
161790088|NCT00738920|584274895|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
161790089|NCT00738920|584274893|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
161790090|NCT00738920|584274894|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
161790091|NCT00738920|584274895|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
161790092|NCT00585039|584274898|FG000|Overall Study|medication spilled|2|||
161790093|NCT00585039|584274899|FG001|Overall Study|medication spilled|0|||
161790094|NCT02173301|584274900|FG000|Overall Study|Adverse Event|7|||
161790095|NCT02173301|584274901|FG001|Overall Study|Adverse Event|8|||
161790096|NCT02173301|584274902|FG002|Overall Study|Adverse Event|13|||
161790097|NCT02173301|584274903|FG003|Overall Study|Adverse Event|5|||
161790098|NCT02173301|584274900|FG000|Overall Study|Withdrawal by Subject|8|||
161790099|NCT02173301|584274901|FG001|Overall Study|Withdrawal by Subject|10|||
161790100|NCT02173301|584274902|FG002|Overall Study|Withdrawal by Subject|4|||
161790101|NCT02173301|584274903|FG003|Overall Study|Withdrawal by Subject|8|||
161790102|NCT02173301|584274900|FG000|Overall Study|Lost to Follow-up|4|||
161790103|NCT02173301|584274901|FG001|Overall Study|Lost to Follow-up|4|||
161790104|NCT02173301|584274902|FG002|Overall Study|Lost to Follow-up|2|||
161790105|NCT02173301|584274903|FG003|Overall Study|Lost to Follow-up|2|||
161790106|NCT02173301|584274900|FG000|Overall Study|Protocol Violation|0|||
162130206|NCT01513967|585528037|FG004|Overall Study|excluded due to positive drug screen|0|||
162130207|NCT01513967|585528038|FG005|Overall Study|excluded due to positive drug screen|0|||
161790107|NCT02173301|584274901|FG001|Overall Study|Protocol Violation|1|||
161790108|NCT02173301|584274902|FG002|Overall Study|Protocol Violation|0|||
161790109|NCT02173301|584274903|FG003|Overall Study|Protocol Violation|0|||
162130208|NCT01513967|585528039|FG006|Overall Study|excluded due to positive drug screen|0|||
161790110|NCT02173301|584274900|FG000|Overall Study|Physician Decision|0|||
161790111|NCT02173301|584274901|FG001|Overall Study|Physician Decision|0|||
161790112|NCT02173301|584274902|FG002|Overall Study|Physician Decision|1|||
161790113|NCT02173301|584274903|FG003|Overall Study|Physician Decision|0|||
161790114|NCT02173301|584274900|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
161790115|NCT02173301|584274901|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
161790116|NCT02173301|584274902|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
161790117|NCT02173301|584274903|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
161790118|NCT04079842|584274904|FG000|Overall Study|Request of subject|2|||
161790119|NCT04079842|584274904|FG000|Overall Study|Unable to draw Arterial samples|1|||
161790120|NCT02904200|584274905|FG000|Overall Study|Withdrawal by Subject|1|||
161790121|NCT02904200|584274906|FG001|Overall Study|Withdrawal by Subject|0|||
161790122|NCT04582266|584276819|FG000|Overall Study|Lost to Follow-up|7|||
161790123|NCT04582266|584276820|FG001|Overall Study|Lost to Follow-up|5|||
161790124|NCT04582266|584276819|FG000|Overall Study|Withdrawal by Subject|1|||
161790125|NCT04582266|584276820|FG001|Overall Study|Withdrawal by Subject|0|||
161790126|NCT04582266|584276819|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
161790127|NCT04582266|584276820|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
161790128|NCT02049359|584276821|FG000|Overall Study|Lost to Follow-up|26|||
161790129|NCT02049359|584276822|FG001|Overall Study|Lost to Follow-up|19|||
161790130|NCT00387712|584276825|FG000|Overall Study|Physician Decision|6|||
161790131|NCT00387712|584276826|FG001|Overall Study|Physician Decision|4|||
161790132|NCT00387712|584276825|FG000|Overall Study|Lost to Follow-up|17|||
161790133|NCT00387712|584276826|FG001|Overall Study|Lost to Follow-up|20|||
161790134|NCT00387712|584276825|FG000|Overall Study|Withdrawal by Subject|6|||
161790135|NCT00387712|584276826|FG001|Overall Study|Withdrawal by Subject|12|||
161790136|NCT01772368|584276828|FG000|Overall Study|Adverse Event|1|||
161790137|NCT01772368|584276828|FG000|Overall Study|Withdrawal by Subject|3|||
161790138|NCT01772368|584276828|FG000|Overall Study|Protocol Violation|2|||
161790139|NCT01772368|584276828|FG000|Overall Study|Other|1|||
161790140|NCT00112489|584276832|FG000|Overall Study|Refused further treatment|8|||
161790141|NCT00112489|584276832|FG000|Overall Study|Adverse Event|12|||
161790142|NCT00112489|584276832|FG000|Overall Study|Death|2|||
161790143|NCT00112489|584276832|FG000|Overall Study|Other, Not Specified|9|||
161790144|NCT00112489|584276832|FG000|Overall Study|Patient never treated|2|||
161790145|NCT00112489|584276832|FG000|Overall Study|Ineligible|7|||
161790146|NCT02231710|584276837|FG000|Overall Study|Physician Decision|1|||
161790147|NCT01339910|584276838|FG000|Overall Study|Withdrawal by Subject|1|||
161790148|NCT01339910|584276839|FG001|Overall Study|Withdrawal by Subject|0|||
161790149|NCT01339910|584276838|FG000|Overall Study|Physician Decision|1|||
161790150|NCT01339910|584276839|FG001|Overall Study|Physician Decision|0|||
161790151|NCT01339910|584276838|FG000|Overall Study|Disease relapse|1|||
161790152|NCT01339910|584276839|FG001|Overall Study|Disease relapse|4|||
161790153|NCT01399723|584276840|FG000|Overall Study|Lost to Follow-up|0|||
161790154|NCT01399723|584276841|FG001|Overall Study|Lost to Follow-up|1|||
161790155|NCT02322879|584276842|FG000|First Intervention|Physician Decision|1|||
161790156|NCT02322879|584276843|FG001|First Intervention|Physician Decision|0|||
161790157|NCT00124020|584276850|FG000|Overall Study|Death|67|||
161790158|NCT00124020|584276851|FG001|Overall Study|Death|71|||
161790159|NCT00124020|584276850|FG000|Overall Study|Withdrawal by Subject|13|||
161790160|NCT00124020|584276851|FG001|Overall Study|Withdrawal by Subject|11|||
161790161|NCT00124020|584276850|FG000|Overall Study|Lost to Follow-up|5|||
161790162|NCT00124020|584276851|FG001|Overall Study|Lost to Follow-up|8|||
161790163|NCT00124020|584276850|FG000|Overall Study|Other|1|||
161790164|NCT00124020|584276851|FG001|Overall Study|Other|1|||
162130209|NCT01513967|585528040|FG007|Overall Study|excluded due to positive drug screen|2|||
162130210|NCT01513967|585528033|FG000|Overall Study|Physician Decision|0|||
162130211|NCT01513967|585528034|FG001|Overall Study|Physician Decision|0|||
162130212|NCT01513967|585528035|FG002|Overall Study|Physician Decision|0|||
162130213|NCT01513967|585528036|FG003|Overall Study|Physician Decision|0|||
162130214|NCT01513967|585528037|FG004|Overall Study|Physician Decision|0|||
162130215|NCT01513967|585528038|FG005|Overall Study|Physician Decision|1|||
162130216|NCT01513967|585528039|FG006|Overall Study|Physician Decision|0|||
161790165|NCT00124020|584276850|FG000|Overall Study|Transfer to another hospital|2|||
161790166|NCT00124020|584276851|FG001|Overall Study|Transfer to another hospital|0|||
161790167|NCT00268346|584276852|FG000|Overall Study|Adverse Event|0|||
161790168|NCT00268346|584276853|FG001|Overall Study|Adverse Event|1|||
161790169|NCT00268346|584276852|FG000|Overall Study|Death|0|||
161790170|NCT00268346|584276853|FG001|Overall Study|Death|1|||
161790171|NCT00268346|584276852|FG000|Overall Study|Withdrawal by Subject|0|||
161790172|NCT00268346|584276853|FG001|Overall Study|Withdrawal by Subject|1|||
161790173|NCT00752791|584276856|FG000|Overall Study|Adverse Event|7|||
161790174|NCT00752791|584276856|FG000|Overall Study|Withdrawal by Subject|1|||
161790175|NCT00752791|584276856|FG000|Overall Study|Physician Decision|1|||
161790176|NCT00752791|584276856|FG000|Overall Study|Death|1|||
161790177|NCT00752791|584276856|FG000|Overall Study|Renal transplant|3|||
162130217|NCT01513967|585528040|FG007|Overall Study|Physician Decision|0|||
161790178|NCT00752791|584276856|FG000|Overall Study|Switched to hemodialysis|2|||
161790179|NCT00752791|584276856|FG000|Overall Study|Protocol deviation|1|||
161790180|NCT02784106|584276861|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
161790181|NCT02784106|584276862|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
161790182|NCT02784106|584276863|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
161790183|NCT02784106|584276864|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
161790184|NCT02784106|584276861|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
161790185|NCT02784106|584276862|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
161790186|NCT02784106|584276863|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161790187|NCT02784106|584276864|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161790188|NCT02784106|584276861|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
161790189|NCT02784106|584276862|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
161790190|NCT02784106|584276863|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
161790191|NCT02784106|584276864|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
161790192|NCT02784106|584276861|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
161790193|NCT02784106|584276862|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161790194|NCT02784106|584276863|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161790195|NCT02784106|584276864|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161790196|NCT02784106|584276861|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
161790197|NCT02784106|584276862|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
161790198|NCT02784106|584276863|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
161790199|NCT02784106|584276864|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
161790200|NCT02784106|584276861|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
161790201|NCT02784106|584276862|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
161790202|NCT02784106|584276863|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
161790203|NCT02784106|584276864|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
161790204|NCT02927847|584276866|FG000|Overall Study|Lost to Follow-up|1|||
161790205|NCT02927847|584276867|FG001|Overall Study|Lost to Follow-up|0|||
161790206|NCT02927847|584276866|FG000|Overall Study|Withdrawal by Subject|4|||
161790207|NCT02927847|584276867|FG001|Overall Study|Withdrawal by Subject|2|||
161790208|NCT02927847|584276866|FG000|Overall Study|PI withdrawn due to missed visits|1|||
161790209|NCT02927847|584276867|FG001|Overall Study|PI withdrawn due to missed visits|1|||
161790210|NCT00553540|584276868|FG000|Overall Study|discharged after first visit|2|||
161790211|NCT00553540|584276869|FG001|Overall Study|discharged after first visit|5|||
161790212|NCT01755858|584276872|FG000|Overall Study|Adverse Event|1|||
161790213|NCT01755858|584276873|FG001|Overall Study|Adverse Event|1|||
161790214|NCT02087046|584276878|FG000|Overall Study|Adverse Event|4|||
161790215|NCT02087046|584276878|FG000|Overall Study|Death|1|||
161790216|NCT02087046|584276878|FG000|Overall Study|Lost to Follow-up|3|||
161790217|NCT02087046|584276878|FG000|Overall Study|Withdrawal by Subject|2|||
161790218|NCT02087046|584276878|FG000|Overall Study|Physician Decision|1|||
161790219|NCT02444533|584276879|FG000|Overall Study|Not able to complete forms|0|||
161790220|NCT02444533|584276880|FG001|Overall Study|Not able to complete forms|2|||
161790221|NCT02444533|584276879|FG000|Overall Study|Only gave post-procedure complications|2|||
161790222|NCT02444533|584276880|FG001|Overall Study|Only gave post-procedure complications|2|||
161790223|NCT01155583|584276881|FG000|Phase I|Screen failure - did not start treatment|0|||
161790224|NCT01155583|584276882|FG001|Phase I|Screen failure - did not start treatment|0|||
161790225|NCT01155583|584276883|FG002|Phase I|Screen failure - did not start treatment|0|||
161790226|NCT01155583|584276884|FG003|Phase I|Screen failure - did not start treatment|0|||
161790227|NCT01155583|584276885|FG004|Phase I|Screen failure - did not start treatment|1|||
161790228|NCT01155583|584276886|FG005|Phase I|Screen failure - did not start treatment|0|||
161790229|NCT01155583|584276887|FG006|Phase I|Screen failure - did not start treatment|0|||
161790230|NCT01155583|584276888|FG007|Phase I|Screen failure - did not start treatment|2|||
161790231|NCT01155583|584276889|FG008|Phase I|Screen failure - did not start treatment|0|||
161790232|NCT01155583|584276881|FG000|Phase I|Withdrawal by Subject|0|||
161790233|NCT01155583|584276882|FG001|Phase I|Withdrawal by Subject|0|||
161790234|NCT01155583|584276883|FG002|Phase I|Withdrawal by Subject|0|||
161790235|NCT01155583|584276884|FG003|Phase I|Withdrawal by Subject|0|||
161790236|NCT01155583|584276885|FG004|Phase I|Withdrawal by Subject|0|||
161790237|NCT01155583|584276886|FG005|Phase I|Withdrawal by Subject|0|||
161790238|NCT01155583|584276887|FG006|Phase I|Withdrawal by Subject|0|||
161790239|NCT01155583|584276888|FG007|Phase I|Withdrawal by Subject|1|||
161790240|NCT01155583|584276889|FG008|Phase I|Withdrawal by Subject|0|||
161790241|NCT00602030|584276890|FG000|Lead-in Phase|Disease Progression|2|||
161790242|NCT00602030|584276891|FG001|Lead-in Phase|Disease Progression|3|||
161790243|NCT00602030|584276892|FG002|Lead-in Phase|Disease Progression|0|||
161790244|NCT00602030|584276893|FG003|Lead-in Phase|Disease Progression|0|||
161790245|NCT00602030|584276894|FG004|Lead-in Phase|Disease Progression|0|||
161790246|NCT00602030|584276890|FG000|Lead-in Phase|Adverse Event|0|||
161790247|NCT00602030|584276891|FG001|Lead-in Phase|Adverse Event|2|||
161790248|NCT00602030|584276892|FG002|Lead-in Phase|Adverse Event|0|||
161790249|NCT00602030|584276893|FG003|Lead-in Phase|Adverse Event|0|||
161790250|NCT00602030|584276894|FG004|Lead-in Phase|Adverse Event|0|||
161790251|NCT00602030|584276890|FG000|Double-blind Phase|Disease progression|0|||
161790252|NCT00602030|584276891|FG001|Double-blind Phase|Disease progression|0|||
161790253|NCT00602030|584276892|FG002|Double-blind Phase|Disease progression|33|||
161790254|NCT00602030|584276893|FG003|Double-blind Phase|Disease progression|30|||
161790255|NCT00602030|584276894|FG004|Double-blind Phase|Disease progression|0|||
161790256|NCT00602030|584276890|FG000|Double-blind Phase|Adverse Event|0|||
161790257|NCT00602030|584276891|FG001|Double-blind Phase|Adverse Event|0|||
161790258|NCT00602030|584276892|FG002|Double-blind Phase|Adverse Event|9|||
161790259|NCT00602030|584276893|FG003|Double-blind Phase|Adverse Event|18|||
161790260|NCT00602030|584276894|FG004|Double-blind Phase|Adverse Event|0|||
161790261|NCT00602030|584276890|FG000|Double-blind Phase|Consent withdrawal|0|||
161790262|NCT00602030|584276891|FG001|Double-blind Phase|Consent withdrawal|0|||
161790263|NCT00602030|584276892|FG002|Double-blind Phase|Consent withdrawal|4|||
161790264|NCT00602030|584276893|FG003|Double-blind Phase|Consent withdrawal|3|||
161790265|NCT00602030|584276894|FG004|Double-blind Phase|Consent withdrawal|0|||
161790266|NCT00602030|584276890|FG000|Double-blind Phase|Death|0|||
161790267|NCT00602030|584276891|FG001|Double-blind Phase|Death|0|||
161790268|NCT00602030|584276892|FG002|Double-blind Phase|Death|3|||
161790269|NCT00602030|584276893|FG003|Double-blind Phase|Death|3|||
161790270|NCT00602030|584276894|FG004|Double-blind Phase|Death|0|||
161790271|NCT00602030|584276890|FG000|Double-blind Phase|Administrative decision|0|||
161790272|NCT00602030|584276891|FG001|Double-blind Phase|Administrative decision|0|||
161790273|NCT00602030|584276892|FG002|Double-blind Phase|Administrative decision|0|||
161790274|NCT00602030|584276893|FG003|Double-blind Phase|Administrative decision|2|||
161790275|NCT00602030|584276894|FG004|Double-blind Phase|Administrative decision|0|||
161790276|NCT00602030|584276890|FG000|Double-blind Phase|Ineligibility|0|||
161790277|NCT00602030|584276891|FG001|Double-blind Phase|Ineligibility|0|||
161790278|NCT00602030|584276892|FG002|Double-blind Phase|Ineligibility|0|||
161790279|NCT00602030|584276893|FG003|Double-blind Phase|Ineligibility|1|||
161790280|NCT00602030|584276894|FG004|Double-blind Phase|Ineligibility|0|||
161790281|NCT00602030|584276890|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
161790282|NCT00602030|584276891|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
161790283|NCT00602030|584276892|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
161790284|NCT00602030|584276893|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
161790285|NCT00602030|584276894|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
161790286|NCT00602030|584276890|FG000|Double-blind Phase|Reason not specified|0|||
161790287|NCT00602030|584276891|FG001|Double-blind Phase|Reason not specified|0|||
161790288|NCT00602030|584276892|FG002|Double-blind Phase|Reason not specified|4|||
161790289|NCT00602030|584276893|FG003|Double-blind Phase|Reason not specified|2|||
161790290|NCT00602030|584276894|FG004|Double-blind Phase|Reason not specified|0|||
161790291|NCT00602030|584276890|FG000|Crossover Phase|Disease Progression|0|||
161790292|NCT00602030|584276891|FG001|Crossover Phase|Disease Progression|0|||
161790293|NCT00602030|584276892|FG002|Crossover Phase|Disease Progression|0|||
161790294|NCT00602030|584276893|FG003|Crossover Phase|Disease Progression|0|||
161790295|NCT00602030|584276894|FG004|Crossover Phase|Disease Progression|11|||
161790296|NCT00602030|584276890|FG000|Crossover Phase|Adverse Event|0|||
161790297|NCT00602030|584276891|FG001|Crossover Phase|Adverse Event|0|||
161790298|NCT00602030|584276892|FG002|Crossover Phase|Adverse Event|0|||
161790299|NCT00602030|584276893|FG003|Crossover Phase|Adverse Event|0|||
161790300|NCT00602030|584276894|FG004|Crossover Phase|Adverse Event|3|||
161790301|NCT00602030|584276890|FG000|Crossover Phase|Consent withdrawal|0|||
161790302|NCT00602030|584276891|FG001|Crossover Phase|Consent withdrawal|0|||
161790303|NCT00602030|584276892|FG002|Crossover Phase|Consent withdrawal|0|||
161790304|NCT00602030|584276893|FG003|Crossover Phase|Consent withdrawal|0|||
161790305|NCT00602030|584276894|FG004|Crossover Phase|Consent withdrawal|2|||
161790306|NCT01580020|584276895|FG000|Overall Study|Lack of Efficacy|0|||
161790307|NCT01580020|584276896|FG001|Overall Study|Lack of Efficacy|5|||
161790308|NCT01580020|584276897|FG002|Overall Study|Lack of Efficacy|0|||
161790309|NCT01580020|584276898|FG003|Overall Study|Lack of Efficacy|1|||
161790310|NCT01580020|584276895|FG000|Overall Study|Withdrawal by Subject|0|||
161790311|NCT01580020|584276896|FG001|Overall Study|Withdrawal by Subject|1|||
161790312|NCT01580020|584276897|FG002|Overall Study|Withdrawal by Subject|1|||
161790313|NCT01580020|584276898|FG003|Overall Study|Withdrawal by Subject|0|||
161790314|NCT01580020|584276895|FG000|Overall Study|Adverse Event|1|||
161790315|NCT01580020|584276896|FG001|Overall Study|Adverse Event|1|||
161790316|NCT01580020|584276897|FG002|Overall Study|Adverse Event|1|||
161790317|NCT01580020|584276898|FG003|Overall Study|Adverse Event|1|||
161790318|NCT01580020|584276895|FG000|Overall Study|Administrative Problems|0|||
161790319|NCT01580020|584276896|FG001|Overall Study|Administrative Problems|0|||
161790320|NCT01580020|584276897|FG002|Overall Study|Administrative Problems|1|||
162130218|NCT05764239|585528043|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
161790321|NCT01580020|584276898|FG003|Overall Study|Administrative Problems|0|||
161790322|NCT01580020|584276895|FG000|Overall Study|Lost to Follow-up|0|||
161790323|NCT01580020|584276896|FG001|Overall Study|Lost to Follow-up|0|||
161790324|NCT01580020|584276897|FG002|Overall Study|Lost to Follow-up|1|||
161790325|NCT01580020|584276898|FG003|Overall Study|Lost to Follow-up|0|||
161790326|NCT01208402|584276902|FG000|Overall Study|Withdrawal by Subject|1|||
161790327|NCT01208402|584276903|FG001|Overall Study|Withdrawal by Subject|0|||
161790328|NCT01571635|584276904|FG000|Overall Study|Adverse Event|3|||
161790329|NCT01571635|584276905|FG001|Overall Study|Adverse Event|0|||
161790330|NCT01571635|584276906|FG002|Overall Study|Adverse Event|2|||
161790331|NCT01571635|584276907|FG003|Overall Study|Adverse Event|3|||
161790332|NCT01571635|584276908|FG004|Overall Study|Adverse Event|5|||
161790333|NCT01571635|584276904|FG000|Overall Study|Other reasons|2|||
161790334|NCT01571635|584276905|FG001|Overall Study|Other reasons|1|||
161790335|NCT01571635|584276906|FG002|Overall Study|Other reasons|2|||
161790336|NCT01571635|584276907|FG003|Overall Study|Other reasons|2|||
161790337|NCT01571635|584276908|FG004|Overall Study|Other reasons|1|||
161790338|NCT01571635|584276904|FG000|Overall Study|Study terminated by sponsor|0|||
161790339|NCT01571635|584276905|FG001|Overall Study|Study terminated by sponsor|4|||
161790340|NCT01571635|584276906|FG002|Overall Study|Study terminated by sponsor|1|||
161790341|NCT01571635|584276907|FG003|Overall Study|Study terminated by sponsor|3|||
161790342|NCT01571635|584276908|FG004|Overall Study|Study terminated by sponsor|1|||
161790343|NCT01571635|584276904|FG000|Overall Study|Withdrew consent|1|||
161790344|NCT01571635|584276905|FG001|Overall Study|Withdrew consent|1|||
161790345|NCT01571635|584276906|FG002|Overall Study|Withdrew consent|2|||
161790346|NCT01571635|584276907|FG003|Overall Study|Withdrew consent|3|||
161790347|NCT01571635|584276908|FG004|Overall Study|Withdrew consent|0|||
161790348|NCT01571635|584276904|FG000|Overall Study|Lack of Efficacy|0|||
161790349|NCT01571635|584276905|FG001|Overall Study|Lack of Efficacy|2|||
161790350|NCT01571635|584276906|FG002|Overall Study|Lack of Efficacy|0|||
161790351|NCT01571635|584276907|FG003|Overall Study|Lack of Efficacy|1|||
161790352|NCT01571635|584276908|FG004|Overall Study|Lack of Efficacy|2|||
161790353|NCT01783730|584276912|FG000|Overall Study|Failed to meet inclusion criteria|6|||
161790354|NCT01841359|584276913|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
161790355|NCT01841359|584276913|FG000|Overall Study|Concommitant medical issues|2|||
161790356|NCT01841359|584276913|FG000|Overall Study|Adverse Event|3|||
161790357|NCT01841359|584276913|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
161790358|NCT02151461|584276914|FG000|Overall Study|Adverse Event|5|||
161790359|NCT02151461|584276915|FG001|Overall Study|Adverse Event|1|||
161790360|NCT02151461|584276916|FG002|Overall Study|Adverse Event|0|||
161790361|NCT02151461|584276917|FG003|Overall Study|Adverse Event|2|||
161790362|NCT02151461|584276914|FG000|Overall Study|Lost to Follow-up|0|||
161790363|NCT02151461|584276915|FG001|Overall Study|Lost to Follow-up|0|||
161790364|NCT02151461|584276916|FG002|Overall Study|Lost to Follow-up|1|||
161790365|NCT02151461|584276917|FG003|Overall Study|Lost to Follow-up|1|||
161790366|NCT02151461|584276914|FG000|Overall Study|Withdrawal by Subject|1|||
161790367|NCT02151461|584276915|FG001|Overall Study|Withdrawal by Subject|0|||
161790368|NCT02151461|584276916|FG002|Overall Study|Withdrawal by Subject|1|||
161790369|NCT02151461|584276917|FG003|Overall Study|Withdrawal by Subject|1|||
161790370|NCT02151461|584276914|FG000|Overall Study|Treatment discontinuation|0|||
161790371|NCT02151461|584276915|FG001|Overall Study|Treatment discontinuation|0|||
161790372|NCT02151461|584276916|FG002|Overall Study|Treatment discontinuation|1|||
161790373|NCT02151461|584276917|FG003|Overall Study|Treatment discontinuation|0|||
161790374|NCT02168270|584276918|FG000|Overall Study|Lack of Efficacy|4|||
161790375|NCT01738581|584276919|FG000|Overall Study|Lost to Follow-up|1|||
161790376|NCT01738581|584276920|FG001|Overall Study|Lost to Follow-up|0|||
161790377|NCT00947856|584276927|FG000|Treatment Period|Progressive Disease|33|||
161790378|NCT00947856|584276928|FG001|Treatment Period|Progressive Disease|12|||
161790379|NCT00947856|584276927|FG000|Treatment Period|Adverse Event|15|||
161790380|NCT00947856|584276928|FG001|Treatment Period|Adverse Event|9|||
161790381|NCT00947856|584276927|FG000|Treatment Period|Physician Decision|14|||
161790382|NCT00947856|584276928|FG001|Treatment Period|Physician Decision|6|||
161790383|NCT00947856|584276927|FG000|Treatment Period|Study Stopped by Sponsor|4|||
161790384|NCT00947856|584276928|FG001|Treatment Period|Study Stopped by Sponsor|4|||
161790385|NCT00947856|584276927|FG000|Treatment Period|Withdrawal by Subject|12|||
161790386|NCT00947856|584276928|FG001|Treatment Period|Withdrawal by Subject|1|||
161790387|NCT00947856|584276927|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
161790388|NCT00947856|584276928|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
161790389|NCT00947856|584276927|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
161790390|NCT00947856|584276928|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
161790391|NCT00947856|584276927|FG000|Follow-up Period|Lost to Follow-up|7|||
162130219|NCT05764239|585528043|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
161790392|NCT00947856|584276928|FG001|Follow-up Period|Lost to Follow-up|0|||
161790393|NCT00947856|584276927|FG000|Follow-up Period|Patient unavailable for site visits|1|||
161790394|NCT00947856|584276928|FG001|Follow-up Period|Patient unavailable for site visits|0|||
161790395|NCT00947856|584276927|FG000|Follow-up Period|Withdrawal by Subject|1|||
161790396|NCT00947856|584276928|FG001|Follow-up Period|Withdrawal by Subject|0|||
161790397|NCT02191579|584276929|FG000|Treatment 1|Multiple Reasons Specified|27|||
161790398|NCT02191579|584276930|FG001|Treatment 1|Multiple Reasons Specified|58|||
161790399|NCT02191579|584276929|FG000|Treatment 2|Multiple Reasons Specified|0|||
161790400|NCT02191579|584276930|FG001|Treatment 2|Multiple Reasons Specified|25|||
161790401|NCT02280356|584276933|FG000|Overall Study|Not Treated|2|||
161790402|NCT02280356|584276933|FG000|Overall Study|Withdrawal by Subject|1|||
161790403|NCT02280356|584276933|FG000|Overall Study|Not evaluable|2|||
161790404|NCT01086215|584276934|FG000|Overall Study|Death|14|||
161790405|NCT01086215|584276935|FG001|Overall Study|Death|8|||
161790406|NCT01086215|584276936|FG002|Overall Study|Death|8|||
161790407|NCT01086215|584276937|FG003|Overall Study|Death|1|||
161790408|NCT01086215|584276934|FG000|Overall Study|Lost to Follow-up|22|||
161790409|NCT01086215|584276935|FG001|Overall Study|Lost to Follow-up|39|||
161790410|NCT01086215|584276936|FG002|Overall Study|Lost to Follow-up|18|||
161790411|NCT01086215|584276937|FG003|Overall Study|Lost to Follow-up|2|||
161790412|NCT01965652|584276938|FG000|Overall Study|Adverse Event|40|||
161790413|NCT01965652|584276939|FG001|Overall Study|Adverse Event|37|||
161790414|NCT01965652|584276938|FG000|Overall Study|Withdrawal by Subject|62|||
161790415|NCT01965652|584276939|FG001|Overall Study|Withdrawal by Subject|69|||
161790416|NCT01965652|584276938|FG000|Overall Study|Lost to Follow-up|53|||
161790417|NCT01965652|584276939|FG001|Overall Study|Lost to Follow-up|40|||
161790418|NCT01965652|584276938|FG000|Overall Study|Protocol Violation|34|||
161790419|NCT01965652|584276939|FG001|Overall Study|Protocol Violation|38|||
161790420|NCT01965652|584276938|FG000|Overall Study|Death|3|||
161790421|NCT01965652|584276939|FG001|Overall Study|Death|4|||
161790422|NCT01965652|584276938|FG000|Overall Study|Other - Miscellaneous|18|||
161790423|NCT01965652|584276939|FG001|Overall Study|Other - Miscellaneous|21|||
161790424|NCT01965652|584276938|FG000|Overall Study|Pregnancy|0|||
161790425|NCT01965652|584276939|FG001|Overall Study|Pregnancy|1|||
161790426|NCT01121900|584276944|FG000|First Intervention Period|Adverse Event|1|||
161790427|NCT01121900|584276945|FG001|First Intervention Period|Adverse Event|1|||
161790428|NCT01121900|584276944|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161790429|NCT01121900|584276945|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161790430|NCT03493698|584276946|FG000|Treatment Period C|Adverse Event|1|||
161790431|NCT03493698|584276946|FG000|Treatment Period C|Withdrawal by Subject|1|||
161790432|NCT00408876|584276947|FG000|Overall Study|Adverse Event|9|||
161790433|NCT00408876|584276948|FG001|Overall Study|Adverse Event|17|||
161790434|NCT00408876|584276949|FG002|Overall Study|Adverse Event|27|||
161790435|NCT00408876|584276950|FG003|Overall Study|Adverse Event|10|||
161790436|NCT00408876|584276947|FG000|Overall Study|Withdrawal by Subject|3|||
161790437|NCT00408876|584276948|FG001|Overall Study|Withdrawal by Subject|6|||
161790438|NCT00408876|584276949|FG002|Overall Study|Withdrawal by Subject|6|||
161790439|NCT00408876|584276950|FG003|Overall Study|Withdrawal by Subject|14|||
161790440|NCT00408876|584276947|FG000|Overall Study|Lack of Efficacy|2|||
161790441|NCT00408876|584276948|FG001|Overall Study|Lack of Efficacy|4|||
161790442|NCT00408876|584276949|FG002|Overall Study|Lack of Efficacy|5|||
161790443|NCT00408876|584276950|FG003|Overall Study|Lack of Efficacy|6|||
161790444|NCT00408876|584276947|FG000|Overall Study|Lost to Follow-up|1|||
161790445|NCT00408876|584276948|FG001|Overall Study|Lost to Follow-up|6|||
161790446|NCT00408876|584276949|FG002|Overall Study|Lost to Follow-up|5|||
161790447|NCT00408876|584276950|FG003|Overall Study|Lost to Follow-up|2|||
161790448|NCT00408876|584276947|FG000|Overall Study|Protocol Violation|0|||
161790449|NCT00408876|584276948|FG001|Overall Study|Protocol Violation|3|||
161790450|NCT00408876|584276949|FG002|Overall Study|Protocol Violation|4|||
161790451|NCT00408876|584276950|FG003|Overall Study|Protocol Violation|3|||
161790452|NCT00408876|584276947|FG000|Overall Study|Physician Decision|1|||
161790453|NCT00408876|584276948|FG001|Overall Study|Physician Decision|0|||
161790454|NCT00408876|584276949|FG002|Overall Study|Physician Decision|3|||
161790455|NCT00408876|584276950|FG003|Overall Study|Physician Decision|0|||
161790456|NCT00291330|584276951|FG000|Overall Study|Adverse Event|47|||
161790457|NCT00291330|584276952|FG001|Overall Study|Adverse Event|40|||
161790458|NCT00291330|584276951|FG000|Overall Study|Protocol Violation|13|||
161790459|NCT00291330|584276952|FG001|Overall Study|Protocol Violation|20|||
161790460|NCT00291330|584276951|FG000|Overall Study|Lost to Follow-up|16|||
161790461|NCT00291330|584276952|FG001|Overall Study|Lost to Follow-up|11|||
161790462|NCT00291330|584276951|FG000|Overall Study|Withdrawal by Subject|22|||
161790463|NCT00291330|584276952|FG001|Overall Study|Withdrawal by Subject|25|||
161790464|NCT00291330|584276951|FG000|Overall Study|Other|3|||
161790465|NCT00291330|584276952|FG001|Overall Study|Other|1|||
161790466|NCT04071626|584276956|FG000|Overall Study|Withdrawal by Subject|1|||
161790467|NCT04071626|584276957|FG001|Overall Study|Withdrawal by Subject|1|||
161790468|NCT04071626|584276956|FG000|Overall Study|Protocol Violation|0|||
161790469|NCT04071626|584276957|FG001|Overall Study|Protocol Violation|1|||
161790470|NCT00931385|584276958|FG000|Overall Study|Adverse Event|2|||
161790471|NCT00931385|584276959|FG001|Overall Study|Adverse Event|1|||
161790472|NCT00931385|584276960|FG002|Overall Study|Adverse Event|0|||
161790473|NCT00931385|584276961|FG003|Overall Study|Adverse Event|3|||
161790474|NCT00931385|584276958|FG000|Overall Study|Protocol Violation|0|||
161790475|NCT00931385|584276959|FG001|Overall Study|Protocol Violation|0|||
161790476|NCT00931385|584276960|FG002|Overall Study|Protocol Violation|1|||
161790477|NCT00931385|584276961|FG003|Overall Study|Protocol Violation|0|||
161790478|NCT00931385|584276958|FG000|Overall Study|Withdrawal by Subject|0|||
161790479|NCT00931385|584276959|FG001|Overall Study|Withdrawal by Subject|1|||
161790480|NCT00931385|584276960|FG002|Overall Study|Withdrawal by Subject|0|||
161790481|NCT00931385|584276961|FG003|Overall Study|Withdrawal by Subject|1|||
161790482|NCT00931385|584276958|FG000|Overall Study|Lost to Follow-up|0|||
161790483|NCT00931385|584276959|FG001|Overall Study|Lost to Follow-up|0|||
161790484|NCT00931385|584276960|FG002|Overall Study|Lost to Follow-up|0|||
161790485|NCT00931385|584276961|FG003|Overall Study|Lost to Follow-up|1|||
161790486|NCT02230085|584276964|FG000|Overall Study|Physician Decision|1|||
161790487|NCT02230085|584276964|FG000|Overall Study|Withdrawal by Subject|3|||
161790488|NCT00580983|584276965|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
161790489|NCT00811070|584276966|FG000|Overall Study|Death|0|||
161790490|NCT00811070|584276967|FG001|Overall Study|Death|0|||
161790491|NCT00811070|584276968|FG002|Overall Study|Death|0|||
161790492|NCT00811070|584276969|FG003|Overall Study|Death|2|||
161790493|NCT00811070|584276970|FG004|Overall Study|Death|5|||
161790494|NCT00811070|584276971|FG005|Overall Study|Death|0|||
161790495|NCT00811070|584276966|FG000|Overall Study|Other|1|||
161790496|NCT00811070|584276967|FG001|Overall Study|Other|0|||
161790497|NCT00811070|584276968|FG002|Overall Study|Other|0|||
161790498|NCT00811070|584276969|FG003|Overall Study|Other|0|||
161790499|NCT00811070|584276970|FG004|Overall Study|Other|0|||
161790500|NCT00811070|584276971|FG005|Overall Study|Other|0|||
161790501|NCT00811070|584276966|FG000|Overall Study|Withdrawal by Subject|0|||
161790502|NCT00811070|584276967|FG001|Overall Study|Withdrawal by Subject|1|||
161790503|NCT00811070|584276968|FG002|Overall Study|Withdrawal by Subject|0|||
161790504|NCT00811070|584276969|FG003|Overall Study|Withdrawal by Subject|0|||
161790505|NCT00811070|584276970|FG004|Overall Study|Withdrawal by Subject|0|||
161790506|NCT00811070|584276971|FG005|Overall Study|Withdrawal by Subject|0|||
161790507|NCT00811070|584276966|FG000|Overall Study|Physician Decision|0|||
161790508|NCT00811070|584276967|FG001|Overall Study|Physician Decision|0|||
161790509|NCT00811070|584276968|FG002|Overall Study|Physician Decision|0|||
161790510|NCT00811070|584276969|FG003|Overall Study|Physician Decision|0|||
161790511|NCT00811070|584276970|FG004|Overall Study|Physician Decision|0|||
161790512|NCT00811070|584276971|FG005|Overall Study|Physician Decision|1|||
161790513|NCT00665626|584276974|FG000|Overall Study|Lack of Efficacy|8|||
161790514|NCT00665626|584276975|FG001|Overall Study|Lack of Efficacy|5|||
161790515|NCT00665626|584276974|FG000|Overall Study|Lost to Follow-up|0|||
161790516|NCT00665626|584276975|FG001|Overall Study|Lost to Follow-up|2|||
161790517|NCT00665626|584276974|FG000|Overall Study|Withdrawal by Subject|0|||
161790518|NCT00665626|584276975|FG001|Overall Study|Withdrawal by Subject|1|||
161790519|NCT00665626|584276974|FG000|Overall Study|Protocol Violation|0|||
161790520|NCT00665626|584276975|FG001|Overall Study|Protocol Violation|2|||
161790521|NCT00665626|584276974|FG000|Overall Study|Adverse Event|1|||
161790522|NCT00665626|584276975|FG001|Overall Study|Adverse Event|9|||
161790523|NCT00665626|584276974|FG000|Overall Study|Due to exclusion criteria|0|||
161790524|NCT00665626|584276975|FG001|Overall Study|Due to exclusion criteria|1|||
161790525|NCT00665626|584276974|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
161790526|NCT00665626|584276975|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
161790527|NCT00665626|584276974|FG000|Overall Study|Unably to comply with dosing regimen|0|||
161790528|NCT00665626|584276975|FG001|Overall Study|Unably to comply with dosing regimen|1|||
161790529|NCT00665626|584276974|FG000|Overall Study|Death|1|||
161790530|NCT00665626|584276975|FG001|Overall Study|Death|0|||
161790531|NCT02046369|584276976|FG000|Overall Study|Adverse Event|3|||
161790532|NCT02046369|584276977|FG001|Overall Study|Adverse Event|3|||
161790533|NCT02046369|584276976|FG000|Overall Study|Lack of Efficacy|3|||
161790534|NCT02046369|584276977|FG001|Overall Study|Lack of Efficacy|3|||
161790535|NCT02046369|584276976|FG000|Overall Study|Lost to Follow-up|3|||
161790536|NCT02046369|584276977|FG001|Overall Study|Lost to Follow-up|3|||
161790537|NCT02046369|584276976|FG000|Overall Study|Protocol Violation|1|||
161790538|NCT02046369|584276977|FG001|Overall Study|Protocol Violation|2|||
161790539|NCT02046369|584276976|FG000|Overall Study|Withdrawal by Subject|3|||
162130220|NCT05764239|585528043|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
161790540|NCT02046369|584276977|FG001|Overall Study|Withdrawal by Subject|6|||
161790541|NCT02046369|584276976|FG000|Overall Study|never received study drug|0|||
161790542|NCT02046369|584276977|FG001|Overall Study|never received study drug|1|||
161790543|NCT02046369|584276976|FG000|Overall Study|non compliance|1|||
161898723|NCT01896193|584677890|FG001|Overall Study|Protocol Violation|1|||
161790544|NCT02046369|584276977|FG001|Overall Study|non compliance|0|||
161790545|NCT03120520|584276978|FG000|Overall Study|Lost to Follow-up|1|||
161790546|NCT03120520|584276979|FG001|Overall Study|Lost to Follow-up|1|||
161790547|NCT03120520|584276980|FG002|Overall Study|Lost to Follow-up|1|||
161790548|NCT03120520|584276981|FG003|Overall Study|Lost to Follow-up|1|||
161790549|NCT03120520|584276978|FG000|Overall Study|Withdrawal by Subject|3|||
161790550|NCT03120520|584276979|FG001|Overall Study|Withdrawal by Subject|2|||
161790551|NCT03120520|584276980|FG002|Overall Study|Withdrawal by Subject|3|||
161790552|NCT03120520|584276981|FG003|Overall Study|Withdrawal by Subject|2|||
161790553|NCT03120520|584276978|FG000|Overall Study|Other|0|||
161790554|NCT03120520|584276979|FG001|Overall Study|Other|1|||
161790555|NCT03120520|584276980|FG002|Overall Study|Other|0|||
161790556|NCT03120520|584276981|FG003|Overall Study|Other|0|||
161790557|NCT01025193|584276983|FG000|Overall Study|Protocol Violation|1|||
161790558|NCT01025193|584276983|FG000|Overall Study|Adverse Event|3|||
161790559|NCT04345471|584276984|FG000|Overall Study|Adverse Event|8|||
161790560|NCT04345471|584276985|FG001|Overall Study|Adverse Event|5|||
161790561|NCT04345471|584276986|FG002|Overall Study|Adverse Event|6|||
161790562|NCT04345471|584276984|FG000|Overall Study|Lack of Efficacy|1|||
161790563|NCT04345471|584276985|FG001|Overall Study|Lack of Efficacy|1|||
161790564|NCT04345471|584276986|FG002|Overall Study|Lack of Efficacy|0|||
161790565|NCT04345471|584276984|FG000|Overall Study|Protocol Violation|0|||
161790566|NCT04345471|584276985|FG001|Overall Study|Protocol Violation|1|||
161790567|NCT04345471|584276986|FG002|Overall Study|Protocol Violation|2|||
161790568|NCT04345471|584276984|FG000|Overall Study|Withdrawal by Subject|10|||
161790569|NCT04345471|584276985|FG001|Overall Study|Withdrawal by Subject|5|||
161790570|NCT04345471|584276986|FG002|Overall Study|Withdrawal by Subject|10|||
161790571|NCT02378506|584276991|FG000|Overall Study|Lack of Efficacy|3|||
161790572|NCT02378506|584276991|FG000|Overall Study|Withdrawal by Subject|4|||
161790573|NCT02378506|584276991|FG000|Overall Study|Protocol Violation|2|||
161790574|NCT02378506|584276991|FG000|Overall Study|Death|1|||
161790575|NCT02378506|584276991|FG000|Overall Study|Adverse Event|14|||
161790576|NCT02378506|584276991|FG000|Overall Study|Randomized But Not Treated|1|||
161790577|NCT00185211|584276992|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
161790578|NCT00185211|584276993|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
161790579|NCT00185211|584276992|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
161790580|NCT00185211|584276993|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
161790581|NCT00185211|584276992|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
161790582|NCT00185211|584276993|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
161790583|NCT00185211|584276992|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
161790584|NCT00185211|584276993|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
161790585|NCT00185211|584276992|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
161790586|NCT00185211|584276993|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
161790587|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
161790588|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
161790589|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
161790590|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
161790591|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
161790592|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
161790593|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
161790594|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
161790595|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
161790596|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
161790597|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
161790598|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
161790599|NCT00185211|584276992|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
161790600|NCT00185211|584276993|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
161790601|NCT01759537|584276994|FG000|Overall Study|Death|1|||
161790602|NCT01759537|584276995|FG001|Overall Study|Death|1|||
161790603|NCT01759537|584276994|FG000|Overall Study|Pregnancy|1|||
161790604|NCT01759537|584276995|FG001|Overall Study|Pregnancy|1|||
161790605|NCT01759537|584276994|FG000|Overall Study|Lost to Follow-up|9|||
161790606|NCT01759537|584276995|FG001|Overall Study|Lost to Follow-up|9|||
161790607|NCT01759537|584276994|FG000|Overall Study|Accident involving jaw fracture|1|||
161790608|NCT01759537|584276995|FG001|Overall Study|Accident involving jaw fracture|1|||
161790609|NCT01759537|584276994|FG000|Overall Study|Subcrestal implant too coronal|1|||
161790610|NCT01759537|584276995|FG001|Overall Study|Subcrestal implant too coronal|1|||
161790611|NCT01015612|584276996|FG000|Overall Study|Death|113|||
161790612|NCT01015612|584276996|FG000|Overall Study|Withdrawal by Subject|40|||
161790613|NCT00420290|584276997|FG000|Overall Study|Adverse Event|3|||
161790614|NCT00420290|584276998|FG001|Overall Study|Adverse Event|1|||
161790615|NCT00420290|584276997|FG000|Overall Study|Withdrawal by Subject|0|||
161790616|NCT00420290|584276998|FG001|Overall Study|Withdrawal by Subject|2|||
161790617|NCT00420290|584276997|FG000|Overall Study|did not meet inclusion/exclusion|1|||
161790618|NCT00420290|584276998|FG001|Overall Study|did not meet inclusion/exclusion|1|||
161790619|NCT00972153|584277001|FG000|Overall Study|Equipment malfunction during case|0|||
161790620|NCT00972153|584277002|FG001|Overall Study|Equipment malfunction during case|1|||
161790621|NCT00972153|584277003|FG002|Overall Study|Equipment malfunction during case|0|||
161790622|NCT01077713|584277004|FG000|Overall Study|Withdrawal by Subject|1|||
161790623|NCT01077713|584277005|FG001|Overall Study|Withdrawal by Subject|2|||
161790624|NCT01077713|584277004|FG000|Overall Study|Progressive Disease (PD)|0|||
161790625|NCT01077713|584277005|FG001|Overall Study|Progressive Disease (PD)|1|||
161790626|NCT01077713|584277004|FG000|Overall Study|Death|28|||
161790627|NCT01077713|584277005|FG001|Overall Study|Death|29|||
161790628|NCT01077713|584277004|FG000|Overall Study|Lost to Follow-up|1|||
161790629|NCT01077713|584277005|FG001|Overall Study|Lost to Follow-up|1|||
161790630|NCT01077713|584277004|FG000|Overall Study|Adverse Event|2|||
161790631|NCT01077713|584277005|FG001|Overall Study|Adverse Event|1|||
161790632|NCT01077713|584277004|FG000|Overall Study|Other|4|||
161790633|NCT01077713|584277005|FG001|Overall Study|Other|2|||
161790634|NCT04136626|584277006|FG000|Treatment Phase|Withdrawal by Subject|1|||
161790635|NCT04136626|584277007|FG001|Treatment Phase|Withdrawal by Subject|9|||
161790636|NCT04136626|584277006|FG000|Treatment Phase|Adverse Event|1|||
161790637|NCT04136626|584277007|FG001|Treatment Phase|Adverse Event|0|||
161790638|NCT04136626|584277006|FG000|Treatment Phase|Lost to Follow-up|1|||
161790639|NCT04136626|584277007|FG001|Treatment Phase|Lost to Follow-up|5|||
161790640|NCT04136626|584277006|FG000|12-month Follow-up|Lost to Follow-up|8|||
161790641|NCT04136626|584277007|FG001|12-month Follow-up|Lost to Follow-up|7|||
161790642|NCT01466686|584278529|FG000|Overall Study|Withdrawal by Subject|1|||
161790643|NCT02043366|584278533|FG000|Overall Study|Lost to Follow-up|2|||
161790644|NCT02043366|584278534|FG001|Overall Study|Lost to Follow-up|2|||
161790645|NCT02043366|584278535|FG002|Overall Study|Lost to Follow-up|2|||
161790646|NCT02043366|584278536|FG003|Overall Study|Lost to Follow-up|2|||
161790647|NCT02043366|584278537|FG004|Overall Study|Lost to Follow-up|2|||
161790648|NCT02043366|584278538|FG005|Overall Study|Lost to Follow-up|2|||
161790649|NCT01489956|584278539|FG000|Overall Study|Lost to Follow-up|1|||
161790650|NCT01489956|584278540|FG001|Overall Study|Lost to Follow-up|0|||
161790651|NCT01489956|584278541|FG002|Overall Study|Lost to Follow-up|0|||
161790652|NCT01489956|584278539|FG000|Overall Study|Withdrawal by Subject|0|||
161790653|NCT01489956|584278540|FG001|Overall Study|Withdrawal by Subject|0|||
161790654|NCT01489956|584278541|FG002|Overall Study|Withdrawal by Subject|1|||
161790655|NCT00723554|584278543|FG000|Overall Study|Adverse Event|12|||
161790656|NCT00723554|584278543|FG000|Overall Study|Investigator's judgement|5|||
161790657|NCT00723554|584278543|FG000|Overall Study|Inhaled medication other than iloprost|4|||
161790658|NCT00723554|584278543|FG000|Overall Study|Withdrawal of consent|3|||
161790659|NCT00723554|584278543|FG000|Overall Study|Other|3|||
161790660|NCT00723554|584278543|FG000|Overall Study|Lost to Follow-up|1|||
161790661|NCT00723554|584278543|FG000|Overall Study|Non-compliance|1|||
161790662|NCT01405820|584278544|FG000|Randomized Treatment Period|Adverse Event|3|||
161790663|NCT01405820|584278545|FG001|Randomized Treatment Period|Adverse Event|3|||
161790664|NCT01405820|584278546|FG002|Randomized Treatment Period|Adverse Event|3|||
161790665|NCT01405820|584278547|FG003|Randomized Treatment Period|Adverse Event|0|||
161790666|NCT01405820|584278548|FG004|Randomized Treatment Period|Adverse Event|2|||
161790667|NCT01405820|584278549|FG005|Randomized Treatment Period|Adverse Event|1|||
161790668|NCT01405820|584278544|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
161790669|NCT01405820|584278545|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
161790670|NCT01405820|584278546|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
161790671|NCT01405820|584278547|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
161790672|NCT01405820|584278548|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
161790673|NCT01405820|584278549|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
161790674|NCT01405820|584278544|FG000|Randomized Treatment Period|Other|2|||
161790675|NCT01405820|584278545|FG001|Randomized Treatment Period|Other|2|||
161790676|NCT01405820|584278546|FG002|Randomized Treatment Period|Other|1|||
161790677|NCT01405820|584278547|FG003|Randomized Treatment Period|Other|1|||
161790678|NCT01405820|584278548|FG004|Randomized Treatment Period|Other|0|||
161790679|NCT01405820|584278549|FG005|Randomized Treatment Period|Other|0|||
161790680|NCT01405820|584278544|FG000|Randomized Treatment Period|Physician Decision|0|||
161790681|NCT01405820|584278545|FG001|Randomized Treatment Period|Physician Decision|2|||
161790682|NCT01405820|584278546|FG002|Randomized Treatment Period|Physician Decision|1|||
162130221|NCT05764239|585528043|FG000|DEP (Part 1)|Adverse Event|1|||
162130222|NCT05764239|585528043|FG000|DEP (Part 1)|Lost to Follow-up|1|||
162130223|NCT05764239|585528043|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
162130224|NCT05764239|585528043|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
162130225|NCT05764239|585528043|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
162130226|NCT05764239|585528043|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
162130227|NCT00057811|585528047|FG000|Overall Study|Lack of Efficacy|1|||
162130228|NCT00057811|585528048|FG001|Overall Study|Lack of Efficacy|4|||
162130229|NCT00057811|585528047|FG000|Overall Study|Physician Decision|1|||
162130230|NCT00057811|585528048|FG001|Overall Study|Physician Decision|0|||
162130231|NCT00057811|585528047|FG000|Overall Study|Withdrawal by Subject|3|||
162130232|NCT00057811|585528048|FG001|Overall Study|Withdrawal by Subject|4|||
161790683|NCT01405820|584278547|FG003|Randomized Treatment Period|Physician Decision|0|||
161790684|NCT01405820|584278548|FG004|Randomized Treatment Period|Physician Decision|0|||
161790685|NCT01405820|584278549|FG005|Randomized Treatment Period|Physician Decision|0|||
161790686|NCT01405820|584278544|FG000|Randomized Treatment Period|Rescue|0|||
161790687|NCT01405820|584278545|FG001|Randomized Treatment Period|Rescue|1|||
161790688|NCT01405820|584278546|FG002|Randomized Treatment Period|Rescue|13|||
161790689|NCT01405820|584278547|FG003|Randomized Treatment Period|Rescue|10|||
161790690|NCT01405820|584278548|FG004|Randomized Treatment Period|Rescue|8|||
161790691|NCT01405820|584278549|FG005|Randomized Treatment Period|Rescue|8|||
161790692|NCT01405820|584278544|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
161898724|NCT01896193|584677889|FG000|Overall Study|Withdrew Consent|1|||
161898725|NCT01896193|584677890|FG001|Overall Study|Withdrew Consent|0|||
161898726|NCT02592447|584677891|FG000|Overall Study|Lost to Follow-up|1|||
162130233|NCT00057811|585528047|FG000|Overall Study|Ineligible|4|||
162130234|NCT00057811|585528048|FG001|Overall Study|Ineligible|2|||
162130235|NCT00057811|585528047|FG000|Overall Study|Inevaluable|1|||
162130236|NCT00057811|585528048|FG001|Overall Study|Inevaluable|2|||
162130237|NCT00556374|585528049|FG000|Overall Study|Withdrawal by Subject|235|||
162130238|NCT00556374|585528050|FG001|Overall Study|Withdrawal by Subject|205|||
162130239|NCT00556374|585528049|FG000|Overall Study|Death|158|||
162130240|NCT00556374|585528050|FG001|Overall Study|Death|127|||
162130241|NCT00556374|585528049|FG000|Overall Study|Lost to Follow-up|24|||
162130242|NCT00556374|585528050|FG001|Overall Study|Lost to Follow-up|17|||
162130243|NCT00556374|585528049|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
162130244|NCT00556374|585528050|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
162130245|NCT04131907|585528051|FG000|Overall Study|Adverse Event|2|||
162130246|NCT04131907|585528052|FG001|Overall Study|Adverse Event|0|||
162130247|NCT04131907|585528053|FG002|Overall Study|Adverse Event|0|||
162130248|NCT04131907|585528051|FG000|Overall Study|Physician Decision|4|||
162130249|NCT04131907|585528052|FG001|Overall Study|Physician Decision|22|||
162130250|NCT04131907|585528053|FG002|Overall Study|Physician Decision|0|||
162130251|NCT04131907|585528051|FG000|Overall Study|Withdrawal by Subject|2|||
162130252|NCT04131907|585528052|FG001|Overall Study|Withdrawal by Subject|0|||
162130253|NCT04131907|585528053|FG002|Overall Study|Withdrawal by Subject|1|||
162130254|NCT04131907|585528051|FG000|Overall Study|Treatment failure|2|||
162130255|NCT04131907|585528052|FG001|Overall Study|Treatment failure|0|||
162130256|NCT04131907|585528053|FG002|Overall Study|Treatment failure|1|||
162130257|NCT05294419|585528054|FG000|Overall Study|Protocol Violation|4|||
162130258|NCT05294419|585528055|FG001|Overall Study|Protocol Violation|0|||
162130259|NCT05294419|585528056|FG002|Overall Study|Protocol Violation|0|||
162130260|NCT05294419|585528054|FG000|Overall Study|Lost to Follow-up|6|||
162130261|NCT05294419|585528055|FG001|Overall Study|Lost to Follow-up|0|||
162130262|NCT05294419|585528056|FG002|Overall Study|Lost to Follow-up|0|||
162130263|NCT05294419|585528054|FG000|Overall Study|Results voided after publishing|2|||
162130264|NCT05294419|585528055|FG001|Overall Study|Results voided after publishing|0|||
162130265|NCT05294419|585528056|FG002|Overall Study|Results voided after publishing|0|||
162130266|NCT00847301|585528057|FG000|Overall Study|Adverse Event|35|||
162130267|NCT00847301|585528057|FG000|Overall Study|Switch to other anticoagulants|16|||
162130268|NCT00847301|585528057|FG000|Overall Study|Lost to Follow-up|1|||
162130269|NCT00847301|585528057|FG000|Overall Study|No prescription after hospital discharge|1|||
162130270|NCT00847301|585528057|FG000|Overall Study|Other reason not defined above|1|||
162130271|NCT00442286|585528058|FG000|Overall Study|Death|2|||
162130272|NCT00442286|585528059|FG001|Overall Study|Death|2|||
162130273|NCT00442286|585528058|FG000|Overall Study|Lost to Follow-up|1|||
162130274|NCT00442286|585528059|FG001|Overall Study|Lost to Follow-up|0|||
162130275|NCT00442286|585528058|FG000|Overall Study|Withdrawal by Subject|2|||
162130276|NCT00442286|585528059|FG001|Overall Study|Withdrawal by Subject|0|||
162130277|NCT00442286|585528058|FG000|Overall Study|System explanted|1|||
162130278|NCT00442286|585528059|FG001|Overall Study|System explanted|0|||
162130279|NCT00442286|585528058|FG000|Overall Study|Patient Injury|1|||
162130280|NCT00442286|585528059|FG001|Overall Study|Patient Injury|0|||
162130281|NCT00641186|585528060|FG000|Overall Study|Adverse Event|3|||
162130282|NCT05221749|585528063|FG000|Overall Study|Lost to Follow-up|2|||
161790693|NCT01405820|584278545|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
161790694|NCT01405820|584278546|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
161790695|NCT01405820|584278547|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
161790696|NCT01405820|584278548|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
161790697|NCT01405820|584278549|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
161790698|NCT01405820|584278544|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
161790699|NCT01405820|584278545|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
161790700|NCT01405820|584278546|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
161790701|NCT01405820|584278547|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
161790702|NCT01405820|584278548|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
161790703|NCT01405820|584278549|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
161790704|NCT01405820|584278544|FG000|Randomized Treatment Period|Death|0|||
161790705|NCT01405820|584278545|FG001|Randomized Treatment Period|Death|0|||
162130283|NCT05221749|585528064|FG001|Overall Study|Lost to Follow-up|3|||
162130284|NCT03428815|585528065|FG000|Overall Study|Lost to Follow-up|2|||
162130285|NCT03428815|585528066|FG001|Overall Study|Lost to Follow-up|2|||
162130286|NCT03428815|585528065|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
161790706|NCT01405820|584278546|FG002|Randomized Treatment Period|Death|0|||
161790707|NCT01405820|584278547|FG003|Randomized Treatment Period|Death|1|||
161790708|NCT01405820|584278548|FG004|Randomized Treatment Period|Death|0|||
161790709|NCT01405820|584278549|FG005|Randomized Treatment Period|Death|0|||
162130287|NCT03428815|585528066|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
162130288|NCT03428815|585528065|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
162130289|NCT03428815|585528066|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
162130290|NCT02404493|585528067|FG000|Overall Study|Adverse Event|1|||
162130291|NCT02404493|585528068|FG001|Overall Study|Adverse Event|1|||
161790710|NCT01405820|584278544|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161790711|NCT01405820|584278545|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161790712|NCT01405820|584278546|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161790713|NCT01405820|584278547|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
161790714|NCT01405820|584278548|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161790715|NCT01405820|584278549|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161790716|NCT01405820|584278544|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
161790717|NCT01405820|584278545|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
161790718|NCT01405820|584278546|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
161790719|NCT01405820|584278547|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
161790720|NCT01405820|584278548|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
161790721|NCT01405820|584278549|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
161790722|NCT01405820|584278544|FG000|Open-Label Treatment Period|Other|1|||
161790723|NCT01405820|584278545|FG001|Open-Label Treatment Period|Other|1|||
161790724|NCT01405820|584278546|FG002|Open-Label Treatment Period|Other|1|||
161790725|NCT01405820|584278547|FG003|Open-Label Treatment Period|Other|1|||
161790726|NCT01405820|584278548|FG004|Open-Label Treatment Period|Other|1|||
161790727|NCT01405820|584278549|FG005|Open-Label Treatment Period|Other|1|||
161790728|NCT01405820|584278544|FG000|Open-Label Treatment Period|Physician Decision|0|||
161790729|NCT01405820|584278545|FG001|Open-Label Treatment Period|Physician Decision|0|||
161790730|NCT01405820|584278546|FG002|Open-Label Treatment Period|Physician Decision|1|||
161790731|NCT01405820|584278547|FG003|Open-Label Treatment Period|Physician Decision|2|||
161790732|NCT01405820|584278548|FG004|Open-Label Treatment Period|Physician Decision|1|||
161790733|NCT01405820|584278549|FG005|Open-Label Treatment Period|Physician Decision|0|||
161790734|NCT01405820|584278544|FG000|Open-Label Treatment Period|Adverse Event|0|||
161790735|NCT01405820|584278545|FG001|Open-Label Treatment Period|Adverse Event|0|||
161790736|NCT01405820|584278546|FG002|Open-Label Treatment Period|Adverse Event|0|||
161790737|NCT01405820|584278547|FG003|Open-Label Treatment Period|Adverse Event|1|||
161790738|NCT01405820|584278548|FG004|Open-Label Treatment Period|Adverse Event|0|||
161790739|NCT01405820|584278549|FG005|Open-Label Treatment Period|Adverse Event|0|||
161790740|NCT03222141|584278552|FG000|Overall Study|Death|15|||
161790741|NCT03222141|584278552|FG000|Overall Study|Lost to Follow-up|3|||
161790742|NCT01894984|584278556|FG000|Overall Study|Other|314|||
161790743|NCT01894984|584278557|FG001|Overall Study|Other|175|||
161790744|NCT00827359|584278558|FG000|Overall Study|Progressive Diseas|19|||
161790745|NCT00827359|584278558|FG000|Overall Study|Unacceptable Toxicity|5|||
161790746|NCT00827359|584278558|FG000|Overall Study|Ineligible|1|||
161790747|NCT02436135|584278559|FG000|Overall Study|Progressive Disease|3|||
161790748|NCT02436135|584278560|FG001|Overall Study|Progressive Disease|1|||
161790749|NCT02436135|584278559|FG000|Overall Study|Investigator Discretion|1|||
161790750|NCT02436135|584278560|FG001|Overall Study|Investigator Discretion|2|||
161790751|NCT02436135|584278559|FG000|Overall Study|Adverse Event|1|||
161790752|NCT02436135|584278560|FG001|Overall Study|Adverse Event|0|||
161790753|NCT02436135|584278559|FG000|Overall Study|Withdrawal by Participant|1|||
161790754|NCT02436135|584278560|FG001|Overall Study|Withdrawal by Participant|0|||
161790755|NCT02436135|584278559|FG000|Overall Study|Study Terminated By Sponsor|0|||
161790756|NCT02436135|584278560|FG001|Overall Study|Study Terminated By Sponsor|1|||
161790757|NCT01427803|584278561|FG000|Overall Study|Lost to Follow-up|32|||
161790758|NCT01427803|584278562|FG001|Overall Study|Lost to Follow-up|26|||
161790759|NCT01427803|584278561|FG000|Overall Study|Withdrawal by Subject|20|||
161790760|NCT01427803|584278562|FG001|Overall Study|Withdrawal by Subject|0|||
161790761|NCT01427803|584278561|FG000|Overall Study|Unable to complete full treatment period|6|||
161790762|NCT01427803|584278562|FG001|Overall Study|Unable to complete full treatment period|0|||
161790763|NCT01427803|584278561|FG000|Overall Study|Protocol Violation|1|||
161790764|NCT01427803|584278562|FG001|Overall Study|Protocol Violation|0|||
161790765|NCT01427803|584278561|FG000|Overall Study|Physician Decision|3|||
161790766|NCT01427803|584278562|FG001|Overall Study|Physician Decision|0|||
161790767|NCT01427803|584278561|FG000|Overall Study|did not take product|1|||
161790768|NCT01427803|584278562|FG001|Overall Study|did not take product|0|||
161790769|NCT01698320|584278566|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
161790770|NCT01698320|584278567|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
161790771|NCT01698320|584278568|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
161790772|NCT01698320|584278566|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
161790773|NCT01698320|584278567|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
161790774|NCT01698320|584278568|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
161790775|NCT01698320|584278566|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
161790776|NCT01698320|584278567|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
161790777|NCT01698320|584278568|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
161790778|NCT01698320|584278566|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
161790779|NCT01698320|584278567|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
161790780|NCT01698320|584278568|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
161790781|NCT01698320|584278566|FG000|12-Week Double-Blind Period|Adverse Event|0|||
161790782|NCT01698320|584278567|FG001|12-Week Double-Blind Period|Adverse Event|1|||
161898727|NCT02592447|584677892|FG001|Overall Study|Lost to Follow-up|0|||
161790783|NCT01698320|584278568|FG002|12-Week Double-Blind Period|Adverse Event|1|||
161790784|NCT01698320|584278566|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
161790785|NCT01698320|584278567|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
161790786|NCT01698320|584278568|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
161790787|NCT01698320|584278566|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
161790788|NCT01698320|584278567|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
161790789|NCT01698320|584278568|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
161790790|NCT01698320|584278566|FG000|12-Week Double-Blind Period|Pregnancy|0|||
161790791|NCT01698320|584278567|FG001|12-Week Double-Blind Period|Pregnancy|1|||
161790792|NCT01698320|584278568|FG002|12-Week Double-Blind Period|Pregnancy|1|||
161790793|NCT01698320|584278566|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
161790794|NCT01698320|584278567|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
161790795|NCT01698320|584278568|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
161790796|NCT01698320|584278566|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
161790797|NCT01698320|584278567|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
161790798|NCT01698320|584278568|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
161790799|NCT01698320|584278566|FG000|40-Week Open-Label Period|Adverse Event|0|||
161790800|NCT01698320|584278567|FG001|40-Week Open-Label Period|Adverse Event|3|||
161790801|NCT01698320|584278568|FG002|40-Week Open-Label Period|Adverse Event|2|||
161790802|NCT01698320|584278566|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
161790803|NCT01698320|584278567|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
161790804|NCT01698320|584278568|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
161790805|NCT01698320|584278566|FG000|40-Week Open-Label Period|Pregnancy|0|||
161790806|NCT01698320|584278567|FG001|40-Week Open-Label Period|Pregnancy|2|||
161790807|NCT01698320|584278568|FG002|40-Week Open-Label Period|Pregnancy|1|||
161790808|NCT01698320|584278566|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
161790809|NCT01698320|584278567|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
161790810|NCT01698320|584278568|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
161790811|NCT01698320|584278566|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
161790812|NCT01698320|584278567|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
161790813|NCT01698320|584278568|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
161790814|NCT01107535|584278569|FG000|Overall Study|Death|5|||
161790815|NCT03567057|584278570|FG000|Overall Study|Adverse Event|56|||
161790816|NCT03567057|584278571|FG001|Overall Study|Adverse Event|53|||
161790817|NCT03567057|584278572|FG002|Overall Study|Adverse Event|28|||
161790818|NCT03567057|584278570|FG000|Overall Study|Withdrawal by Subject|22|||
161790819|NCT03567057|584278571|FG001|Overall Study|Withdrawal by Subject|24|||
161790820|NCT03567057|584278572|FG002|Overall Study|Withdrawal by Subject|13|||
161790821|NCT03567057|584278570|FG000|Overall Study|Lost to Follow-up|3|||
161790822|NCT03567057|584278571|FG001|Overall Study|Lost to Follow-up|5|||
161790823|NCT03567057|584278572|FG002|Overall Study|Lost to Follow-up|2|||
161790824|NCT03567057|584278570|FG000|Overall Study|COVID-19 pandemic|4|||
161790825|NCT03567057|584278571|FG001|Overall Study|COVID-19 pandemic|3|||
161790826|NCT03567057|584278572|FG002|Overall Study|COVID-19 pandemic|0|||
161790827|NCT03567057|584278570|FG000|Overall Study|Non-compliance with study drug|4|||
161790828|NCT03567057|584278571|FG001|Overall Study|Non-compliance with study drug|2|||
161790829|NCT03567057|584278572|FG002|Overall Study|Non-compliance with study drug|0|||
161790830|NCT03567057|584278570|FG000|Overall Study|Lack of Efficacy|3|||
161790831|NCT03567057|584278571|FG001|Overall Study|Lack of Efficacy|0|||
161790832|NCT03567057|584278572|FG002|Overall Study|Lack of Efficacy|1|||
161790833|NCT03567057|584278570|FG000|Overall Study|Death|1|||
161790834|NCT03567057|584278571|FG001|Overall Study|Death|0|||
161790835|NCT03567057|584278572|FG002|Overall Study|Death|0|||
161790836|NCT03567057|584278570|FG000|Overall Study|Physician Decision|1|||
161790837|NCT03567057|584278571|FG001|Overall Study|Physician Decision|0|||
161790838|NCT03567057|584278572|FG002|Overall Study|Physician Decision|0|||
161790839|NCT03567057|584278570|FG000|Overall Study|Unstable medical condition|1|||
161790840|NCT03567057|584278571|FG001|Overall Study|Unstable medical condition|0|||
161790841|NCT03567057|584278572|FG002|Overall Study|Unstable medical condition|0|||
161790842|NCT03567057|584278570|FG000|Overall Study|Medical history event|0|||
161790843|NCT03567057|584278571|FG001|Overall Study|Medical history event|0|||
161790844|NCT03567057|584278572|FG002|Overall Study|Medical history event|1|||
161790845|NCT03567057|584278570|FG000|Overall Study|Other|0|||
161790846|NCT03567057|584278571|FG001|Overall Study|Other|0|||
161790847|NCT03567057|584278572|FG002|Overall Study|Other|1|||
161790848|NCT00886483|584278579|FG000|Overall Study|Lost to Follow-up|0|||
161790849|NCT00886483|584278580|FG001|Overall Study|Lost to Follow-up|1|||
161790850|NCT00886483|584278579|FG000|Overall Study|Pursue medications|1|||
161790851|NCT00886483|584278580|FG001|Overall Study|Pursue medications|2|||
161790852|NCT00886483|584278579|FG000|Overall Study|Distance to center, poor grades|1|||
161790853|NCT00886483|584278580|FG001|Overall Study|Distance to center, poor grades|0|||
161790854|NCT01001169|584278581|FG000|Overall Study|Withdrawal by Subject|2|||
161790855|NCT01001169|584278582|FG001|Overall Study|Withdrawal by Subject|1|||
161790856|NCT02040766|584278583|FG000|Overall Study|Adverse Event|1|||
161790857|NCT02040766|584278584|FG001|Overall Study|Adverse Event|1|||
161790858|NCT02040766|584278585|FG002|Overall Study|Adverse Event|1|||
161790859|NCT02040766|584278586|FG003|Overall Study|Adverse Event|0|||
161790860|NCT02040766|584278587|FG004|Overall Study|Adverse Event|2|||
161790861|NCT02040766|584278583|FG000|Overall Study|Withdrawal by Subject|4|||
161790862|NCT02040766|584278584|FG001|Overall Study|Withdrawal by Subject|3|||
161790863|NCT02040766|584278585|FG002|Overall Study|Withdrawal by Subject|2|||
161790864|NCT02040766|584278586|FG003|Overall Study|Withdrawal by Subject|3|||
161790865|NCT02040766|584278587|FG004|Overall Study|Withdrawal by Subject|2|||
161790866|NCT02040766|584278583|FG000|Overall Study|Non-compliance|0|||
161790867|NCT02040766|584278584|FG001|Overall Study|Non-compliance|1|||
161790868|NCT02040766|584278585|FG002|Overall Study|Non-compliance|0|||
161790869|NCT02040766|584278586|FG003|Overall Study|Non-compliance|0|||
161790870|NCT02040766|584278587|FG004|Overall Study|Non-compliance|0|||
161790871|NCT02040766|584278583|FG000|Overall Study|Protocol Violation|2|||
161790872|NCT02040766|584278584|FG001|Overall Study|Protocol Violation|1|||
161790873|NCT02040766|584278585|FG002|Overall Study|Protocol Violation|2|||
161790874|NCT02040766|584278586|FG003|Overall Study|Protocol Violation|3|||
161790875|NCT02040766|584278587|FG004|Overall Study|Protocol Violation|0|||
161790876|NCT02040766|584278583|FG000|Overall Study|Lost to Follow-up|4|||
161790877|NCT02040766|584278584|FG001|Overall Study|Lost to Follow-up|1|||
161790878|NCT02040766|584278585|FG002|Overall Study|Lost to Follow-up|3|||
161790879|NCT02040766|584278586|FG003|Overall Study|Lost to Follow-up|1|||
161790880|NCT02040766|584278587|FG004|Overall Study|Lost to Follow-up|4|||
161790881|NCT02040766|584278583|FG000|Overall Study|Not reported|1|||
161790882|NCT02040766|584278584|FG001|Overall Study|Not reported|0|||
161790883|NCT02040766|584278585|FG002|Overall Study|Not reported|0|||
161790884|NCT02040766|584278586|FG003|Overall Study|Not reported|0|||
161790885|NCT02040766|584278587|FG004|Overall Study|Not reported|0|||
161790886|NCT02040766|584278583|FG000|Overall Study|Lack of Efficacy|6|||
161790887|NCT02040766|584278584|FG001|Overall Study|Lack of Efficacy|3|||
161790888|NCT02040766|584278585|FG002|Overall Study|Lack of Efficacy|4|||
161790889|NCT02040766|584278586|FG003|Overall Study|Lack of Efficacy|6|||
161790890|NCT02040766|584278587|FG004|Overall Study|Lack of Efficacy|5|||
161790891|NCT01271933|584278588|FG000|Single-Blind Phase|Lack of Efficacy|37|||
161790892|NCT01271933|584278589|FG001|Single-Blind Phase|Lack of Efficacy|0|||
161790893|NCT01271933|584278590|FG002|Single-Blind Phase|Lack of Efficacy|0|||
161790894|NCT01271933|584278588|FG000|Single-Blind Phase|Lost to Follow-up|10|||
161790895|NCT01271933|584278589|FG001|Single-Blind Phase|Lost to Follow-up|0|||
161790896|NCT01271933|584278590|FG002|Single-Blind Phase|Lost to Follow-up|0|||
161790897|NCT01271933|584278588|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
161790898|NCT01271933|584278589|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
161790899|NCT01271933|584278590|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
161790900|NCT01271933|584278588|FG000|Single-Blind Phase|Protocol Violation|3|||
161790901|NCT01271933|584278589|FG001|Single-Blind Phase|Protocol Violation|0|||
161790902|NCT01271933|584278590|FG002|Single-Blind Phase|Protocol Violation|0|||
161790903|NCT01271933|584278588|FG000|Single-Blind Phase|Adverse Event|52|||
161790904|NCT01271933|584278589|FG001|Single-Blind Phase|Adverse Event|0|||
161790905|NCT01271933|584278590|FG002|Single-Blind Phase|Adverse Event|0|||
161790906|NCT01271933|584278588|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
161790907|NCT01271933|584278589|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
161790908|NCT01271933|584278590|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
161790909|NCT01271933|584278588|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
161790910|NCT01271933|584278589|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
162130292|NCT04140890|585528069|FG000|Overall Study|Withdrawal by Subject|0|||
162130293|NCT04140890|585528070|FG001|Overall Study|Withdrawal by Subject|1|||
162130294|NCT01700348|585528073|FG000|Overall Study|Withdrawal by Subject|22|||
162130295|NCT01700348|585528073|FG000|Overall Study|Lost to Follow-up|1|||
162130296|NCT02102464|585528074|FG000|Randomized Study|Withdrawal by Subject|0|||
162130297|NCT02102464|585528075|FG001|Randomized Study|Withdrawal by Subject|1|||
162130298|NCT02102464|585528076|FG002|Randomized Study|Withdrawal by Subject|0|||
162130299|NCT02388074|585528077|FG000|Overall Study|Lost in Transit|2|||
162130300|NCT02388074|585528077|FG000|Overall Study|Sample Not Returned|1|||
162130301|NCT01778062|585528080|FG000|Overall Study|Adverse Event|1|||
162130302|NCT01778062|585528081|FG001|Overall Study|Adverse Event|3|||
162130303|NCT01778062|585528080|FG000|Overall Study|Consent Withdrawal|1|||
162130304|NCT01778062|585528081|FG001|Overall Study|Consent Withdrawal|5|||
161790911|NCT01271933|584278590|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
161790912|NCT01271933|584278588|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
162130305|NCT01778062|585528080|FG000|Overall Study|major protocol deviation|4|||
162130306|NCT01778062|585528081|FG001|Overall Study|major protocol deviation|3|||
162130307|NCT03958630|585528082|FG000|Overall Study|Withdrawal by Subject|0|||
162130308|NCT03958630|585528083|FG001|Overall Study|Withdrawal by Subject|0|||
162130309|NCT03958630|585528084|FG002|Overall Study|Withdrawal by Subject|1|||
161790913|NCT01271933|584278589|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
161790914|NCT01271933|584278590|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
161790915|NCT01271933|584278588|FG000|Double-Blind Phase|Randomized but not treated|0|||
161790916|NCT01271933|584278589|FG001|Double-Blind Phase|Randomized but not treated|0|||
161790917|NCT01271933|584278590|FG002|Double-Blind Phase|Randomized but not treated|1|||
161790918|NCT01271933|584278588|FG000|Double-Blind Phase|Lack of Efficacy|0|||
161790919|NCT01271933|584278589|FG001|Double-Blind Phase|Lack of Efficacy|6|||
161790920|NCT01271933|584278590|FG002|Double-Blind Phase|Lack of Efficacy|9|||
161790921|NCT01271933|584278588|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161790922|NCT01271933|584278589|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161790923|NCT01271933|584278590|FG002|Double-Blind Phase|Lost to Follow-up|1|||
161790924|NCT01271933|584278588|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161790925|NCT01271933|584278589|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
161790926|NCT01271933|584278590|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
161790927|NCT01271933|584278588|FG000|Double-Blind Phase|Adverse Event|0|||
161790928|NCT01271933|584278589|FG001|Double-Blind Phase|Adverse Event|3|||
161790929|NCT01271933|584278590|FG002|Double-Blind Phase|Adverse Event|0|||
161790930|NCT01271933|584278588|FG000|Double-Blind Phase|Participant request-personal reason|0|||
161790931|NCT01271933|584278589|FG001|Double-Blind Phase|Participant request-personal reason|1|||
161790932|NCT01271933|584278590|FG002|Double-Blind Phase|Participant request-personal reason|0|||
161790933|NCT01138150|584278591|FG000|Overall Study|blood unable to be processed|0|||
161790934|NCT01138150|584278592|FG001|Overall Study|blood unable to be processed|1|||
161790935|NCT01138150|584278591|FG000|Overall Study|Physician Decision|1|||
161790936|NCT01138150|584278592|FG001|Overall Study|Physician Decision|0|||
161790937|NCT01620983|584278593|FG000|Overall Study|Lost to Follow-up|8|||
161790938|NCT01620983|584278594|FG001|Overall Study|Lost to Follow-up|4|||
161790939|NCT01620983|584278595|FG002|Overall Study|Lost to Follow-up|9|||
161790940|NCT01620983|584278593|FG000|Overall Study|Withdrawal by Subject|6|||
161790941|NCT01620983|584278594|FG001|Overall Study|Withdrawal by Subject|8|||
161790942|NCT01620983|584278595|FG002|Overall Study|Withdrawal by Subject|1|||
161790943|NCT01620983|584278593|FG000|Overall Study|Death|2|||
161790944|NCT01620983|584278594|FG001|Overall Study|Death|0|||
161790945|NCT01620983|584278595|FG002|Overall Study|Death|0|||
161790946|NCT01620983|584278593|FG000|Overall Study|Physician Decision|3|||
161790947|NCT01620983|584278594|FG001|Overall Study|Physician Decision|10|||
161790948|NCT01620983|584278595|FG002|Overall Study|Physician Decision|5|||
161790949|NCT00798889|584278597|FG000|Overall Study|Adverse Event|53|||
161790950|NCT00798889|584278597|FG000|Overall Study|Protocol Violation|2|||
161790951|NCT00798889|584278597|FG000|Overall Study|Withdrawal by Subject|31|||
161790952|NCT00798889|584278597|FG000|Overall Study|Lost to Follow-up|1|||
161790953|NCT00798889|584278597|FG000|Overall Study|Lack of Efficacy|213|||
161790954|NCT00798889|584278597|FG000|Overall Study|Decision of Sponsor|11|||
161790955|NCT00798889|584278597|FG000|Overall Study|Enrolled, Not treated|3|||
161790956|NCT00617461|584278598|FG000|First Treatment Intervention Period|Adverse Event|2|||
161790957|NCT00617461|584278599|FG001|First Treatment Intervention Period|Adverse Event|0|||
161790958|NCT00617461|584278598|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
161790959|NCT00617461|584278599|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
161790960|NCT00617461|584278598|FG000|First Treatment Intervention Period|Protocol Violation|2|||
161790961|NCT00617461|584278599|FG001|First Treatment Intervention Period|Protocol Violation|1|||
161790962|NCT00617461|584278598|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
161790963|NCT00617461|584278599|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
161790964|NCT00617461|584278598|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
161790965|NCT00617461|584278599|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
161790966|NCT00617461|584278598|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
161790967|NCT00617461|584278599|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
161790968|NCT00617461|584278598|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
161790969|NCT00617461|584278599|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
161790970|NCT00617461|584278598|FG000|Second Treatment Intervention Period|Adverse Event|0|||
161790971|NCT00617461|584278599|FG001|Second Treatment Intervention Period|Adverse Event|1|||
161790972|NCT00617461|584278598|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
161790973|NCT00617461|584278599|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
161790974|NCT00617461|584278598|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
161790975|NCT00617461|584278599|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
161790976|NCT00617461|584278598|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
161790977|NCT00617461|584278599|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
161790978|NCT01724359|584278600|FG000|Overall Study|Adverse Event|10|||
161790979|NCT01724359|584278600|FG000|Overall Study|Death|1|||
161790980|NCT01724359|584278600|FG000|Overall Study|Other|20|||
161790981|NCT05085964|584278601|FG000|Overall Study|Premature termination of study|21|||
162130310|NCT03958630|585528082|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
162130311|NCT03958630|585528083|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
161790982|NCT05085964|584278602|FG001|Overall Study|Premature termination of study|0|||
161790983|NCT03156270|584278609|FG000|Overall Study|Failed pre-treatment screening|1|||
161790984|NCT03156270|584278609|FG000|Overall Study|Lost to Follow-up|1|||
161790985|NCT00591253|584278610|FG000|Overall Study|Adverse Event|3|||
162130312|NCT03958630|585528084|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
162130313|NCT01824472|585528091|FG000|Overall Study|Lost to Follow-up|0|||
161790986|NCT00591253|584278611|FG001|Overall Study|Adverse Event|3|||
161790987|NCT00591253|584278612|FG002|Overall Study|Adverse Event|1|||
161790988|NCT00591253|584278610|FG000|Overall Study|Protocol Violation|2|||
161790989|NCT00591253|584278611|FG001|Overall Study|Protocol Violation|2|||
161790990|NCT00591253|584278612|FG002|Overall Study|Protocol Violation|2|||
161790991|NCT00591253|584278610|FG000|Overall Study|Lost to Follow-up|2|||
161790992|NCT00591253|584278611|FG001|Overall Study|Lost to Follow-up|4|||
161790993|NCT00591253|584278612|FG002|Overall Study|Lost to Follow-up|0|||
161790994|NCT00591253|584278610|FG000|Overall Study|Withdrawal by Subject|1|||
161790995|NCT00591253|584278611|FG001|Overall Study|Withdrawal by Subject|7|||
161790996|NCT00591253|584278612|FG002|Overall Study|Withdrawal by Subject|6|||
161790997|NCT00591253|584278610|FG000|Overall Study|Lack of Efficacy|1|||
161790998|NCT00591253|584278611|FG001|Overall Study|Lack of Efficacy|0|||
161790999|NCT00591253|584278612|FG002|Overall Study|Lack of Efficacy|3|||
161791000|NCT00591253|584278610|FG000|Overall Study|Other|5|||
161791001|NCT00591253|584278611|FG001|Overall Study|Other|5|||
161791002|NCT00591253|584278612|FG002|Overall Study|Other|3|||
161791003|NCT00252187|584278613|FG000|Overall Study|Adverse Event|3|||
161791004|NCT00252187|584278614|FG001|Overall Study|Adverse Event|1|||
161791005|NCT00252187|584278613|FG000|Overall Study|Withdrawal by Subject|1|||
161791006|NCT00252187|584278614|FG001|Overall Study|Withdrawal by Subject|0|||
161791007|NCT01752920|584278617|FG000|Overall Study|Adverse Event|1|||
161791008|NCT01752920|584278618|FG001|Overall Study|Adverse Event|0|||
161791009|NCT01752920|584278619|FG002|Overall Study|Adverse Event|5|||
161791010|NCT01752920|584278620|FG003|Overall Study|Adverse Event|10|||
161791011|NCT01752920|584278617|FG000|Overall Study|Clinical Disease Progression|6|||
161791012|NCT01752920|584278618|FG001|Overall Study|Clinical Disease Progression|4|||
161791013|NCT01752920|584278619|FG002|Overall Study|Clinical Disease Progression|1|||
161791014|NCT01752920|584278620|FG003|Overall Study|Clinical Disease Progression|13|||
161791015|NCT01752920|584278617|FG000|Overall Study|Physician Decision|1|||
161791016|NCT01752920|584278618|FG001|Overall Study|Physician Decision|0|||
161791017|NCT01752920|584278619|FG002|Overall Study|Physician Decision|0|||
161791018|NCT01752920|584278620|FG003|Overall Study|Physician Decision|3|||
161791019|NCT01752920|584278617|FG000|Overall Study|Radiographic Disease Progression|20|||
161791020|NCT01752920|584278618|FG001|Overall Study|Radiographic Disease Progression|7|||
161791021|NCT01752920|584278619|FG002|Overall Study|Radiographic Disease Progression|12|||
161791022|NCT01752920|584278620|FG003|Overall Study|Radiographic Disease Progression|29|||
161791023|NCT01752920|584278617|FG000|Overall Study|Study Terminated by Sponsor|0|||
161791024|NCT01752920|584278618|FG001|Overall Study|Study Terminated by Sponsor|0|||
161791025|NCT01752920|584278619|FG002|Overall Study|Study Terminated by Sponsor|0|||
161791026|NCT01752920|584278620|FG003|Overall Study|Study Terminated by Sponsor|1|||
161791027|NCT01752920|584278617|FG000|Overall Study|Withdrawal by Subject|0|||
161791028|NCT01752920|584278618|FG001|Overall Study|Withdrawal by Subject|1|||
161791029|NCT01752920|584278619|FG002|Overall Study|Withdrawal by Subject|0|||
161791030|NCT01752920|584278620|FG003|Overall Study|Withdrawal by Subject|1|||
161791031|NCT01752920|584278617|FG000|Overall Study|Lack of clinical benefit|1|||
161791032|NCT01752920|584278618|FG001|Overall Study|Lack of clinical benefit|1|||
161791033|NCT01752920|584278619|FG002|Overall Study|Lack of clinical benefit|1|||
161791034|NCT01752920|584278620|FG003|Overall Study|Lack of clinical benefit|1|||
161791035|NCT00771901|584278621|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
161791036|NCT00771901|584278622|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
161791037|NCT00771901|584278623|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
161791038|NCT02862535|584278624|FG000|Overall Study|Death|7|||
161791039|NCT02862535|584278625|FG001|Overall Study|Death|3|||
161791040|NCT02862535|584278626|FG002|Overall Study|Death|2|||
161791041|NCT02862535|584278627|FG003|Overall Study|Death|5|||
161791042|NCT02862535|584278624|FG000|Overall Study|Study Terminated by Sponsor|1|||
161791043|NCT02862535|584278625|FG001|Overall Study|Study Terminated by Sponsor|3|||
161791044|NCT02862535|584278626|FG002|Overall Study|Study Terminated by Sponsor|8|||
161791045|NCT02862535|584278627|FG003|Overall Study|Study Terminated by Sponsor|5|||
161791046|NCT02862535|584278624|FG000|Overall Study|Enrolled, not Treated|1|||
161791047|NCT02862535|584278625|FG001|Overall Study|Enrolled, not Treated|0|||
161791048|NCT02862535|584278626|FG002|Overall Study|Enrolled, not Treated|0|||
161791049|NCT02862535|584278627|FG003|Overall Study|Enrolled, not Treated|1|||
161791050|NCT00566709|584278633|FG000|Overall Study|Protocol Violation|5|||
161791051|NCT00566709|584278634|FG001|Overall Study|Protocol Violation|0|||
161791052|NCT03443869|584278635|FG000|Overall Study|Death|3|||
161791053|NCT03443869|584278636|FG001|Overall Study|Death|3|||
161791054|NCT03443869|584278635|FG000|Overall Study|Withdrawal by Subject|34|||
161791055|NCT03443869|584278636|FG001|Overall Study|Withdrawal by Subject|22|||
161791056|NCT03443869|584278635|FG000|Overall Study|Lost to Follow-up|1|||
161791057|NCT03443869|584278636|FG001|Overall Study|Lost to Follow-up|2|||
161791058|NCT03443869|584278635|FG000|Overall Study|Physician Decision|3|||
161791059|NCT03443869|584278636|FG001|Overall Study|Physician Decision|3|||
161791060|NCT03443869|584278635|FG000|Overall Study|Other|4|||
161898728|NCT02592447|584677891|FG000|Overall Study|Ineligible after randomization|1|||
161791061|NCT03443869|584278636|FG001|Overall Study|Other|4|||
161791062|NCT02390219|584278637|FG000|Overall Study|Death|1|||
161791063|NCT02390219|584278637|FG000|Overall Study|Physician Decision|1|||
161791064|NCT02390219|584278637|FG000|Overall Study|Adverse Event|6|||
161791065|NCT02390219|584278637|FG000|Overall Study|Withdrawal by Subject|1|||
161791066|NCT02390219|584278637|FG000|Overall Study|Lost to Follow-up|2|||
161791067|NCT02390219|584278637|FG000|Overall Study|Other|2|||
161791068|NCT00299728|584278638|FG000|Overall Study|Lost to Follow-up|0|||
161791069|NCT00299728|584278639|FG001|Overall Study|Lost to Follow-up|1|||
161791070|NCT00299728|584278638|FG000|Overall Study|Withdrawal by Subject|0|||
161791071|NCT00299728|584278639|FG001|Overall Study|Withdrawal by Subject|1|||
161791072|NCT00299728|584278638|FG000|Overall Study|Progressive disease|0|||
161791073|NCT00299728|584278639|FG001|Overall Study|Progressive disease|1|||
161791074|NCT01855126|584278642|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
161791075|NCT01855126|584278643|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
162130314|NCT01824472|585528092|FG001|Overall Study|Lost to Follow-up|0|||
162130315|NCT01824472|585528093|FG002|Overall Study|Lost to Follow-up|1|||
162130316|NCT01824472|585528091|FG000|Overall Study|Withdrawal by Subject|1|||
162130317|NCT01824472|585528092|FG001|Overall Study|Withdrawal by Subject|5|||
162130318|NCT01824472|585528093|FG002|Overall Study|Withdrawal by Subject|3|||
162130319|NCT01824472|585528091|FG000|Overall Study|Ineligible post randomization&screening|0|||
162130320|NCT01824472|585528092|FG001|Overall Study|Ineligible post randomization&screening|2|||
162130321|NCT01824472|585528093|FG002|Overall Study|Ineligible post randomization&screening|0|||
162130322|NCT01815736|585528094|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
162130323|NCT01815736|585528095|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
162130324|NCT01815736|585528094|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
162130325|NCT01815736|585528095|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
162130326|NCT01815736|585528094|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
162130327|NCT01815736|585528095|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
162130328|NCT01815736|585528094|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
162130329|NCT01815736|585528095|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
162130330|NCT01815736|585528094|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
162130331|NCT01815736|585528095|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
162130332|NCT01815736|585528094|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
162130333|NCT01815736|585528095|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
162130334|NCT01815736|585528094|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
162130335|NCT01815736|585528095|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
162130336|NCT01815736|585528094|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
162130337|NCT01815736|585528095|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
162130338|NCT01815736|585528094|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
162130339|NCT01815736|585528095|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
162130340|NCT01815736|585528094|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
162130341|NCT01815736|585528095|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
162130342|NCT01815736|585528094|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
162130343|NCT01815736|585528095|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
162130344|NCT01815736|585528094|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
162130345|NCT01815736|585528095|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
162130346|NCT01815736|585528094|FG000|Extension Treatment Phase- After Week 96|Death|1|||
162130347|NCT01815736|585528095|FG001|Extension Treatment Phase- After Week 96|Death|0|||
162130348|NCT03387514|585528099|FG000|Overall Study|Withdrawal by Subject|2|||
162130349|NCT03387514|585528099|FG000|Overall Study|Physician Decision|1|||
162130350|NCT03387514|585528099|FG000|Overall Study|Lost to Follow-up|2|||
162130351|NCT03040687|585528104|FG000|Overall Study|Withdrawal by Subject|1|||
162130352|NCT03040687|585528105|FG001|Overall Study|Withdrawal by Subject|0|||
162130353|NCT03040687|585528106|FG002|Overall Study|Withdrawal by Subject|0|||
162130354|NCT03317379|585528107|FG000|Overall Study|Lost to Follow-up|0|||
162130355|NCT03317379|585528108|FG001|Overall Study|Lost to Follow-up|3|||
162130356|NCT03317379|585528109|FG002|Overall Study|Lost to Follow-up|2|||
162130357|NCT02846558|585528110|FG000|Overall Study|Adverse Event|1|||
162130358|NCT02846558|585528111|FG001|Overall Study|Adverse Event|0|||
162130359|NCT02846558|585528112|FG002|Overall Study|Adverse Event|0|||
161791076|NCT01855126|584278642|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
161898729|NCT02592447|584677892|FG001|Overall Study|Ineligible after randomization|0|||
162130360|NCT02846558|585528113|FG003|Overall Study|Adverse Event|0|||
162130361|NCT02846558|585528110|FG000|Overall Study|Withdrawal by Subject|5|||
162130362|NCT02846558|585528111|FG001|Overall Study|Withdrawal by Subject|4|||
162130363|NCT02846558|585528112|FG002|Overall Study|Withdrawal by Subject|2|||
162130364|NCT02846558|585528113|FG003|Overall Study|Withdrawal by Subject|2|||
162130365|NCT02846558|585528110|FG000|Overall Study|Lost to Follow-up|2|||
162130366|NCT02846558|585528111|FG001|Overall Study|Lost to Follow-up|0|||
162130367|NCT02846558|585528112|FG002|Overall Study|Lost to Follow-up|0|||
161898730|NCT02592447|584677891|FG000|Overall Study|Withdrawal by Subject|0|||
161791077|NCT01855126|584278643|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
161791078|NCT01360632|584278644|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
161791079|NCT01360632|584278645|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
161791080|NCT01360632|584278646|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
161791081|NCT01360632|584278647|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
161791082|NCT01360632|584278648|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
161791083|NCT01360632|584278644|FG000|Phase A (8 Weeks)|Adverse Event|60|||
161791084|NCT01360632|584278645|FG001|Phase A (8 Weeks)|Adverse Event|0|||
161791085|NCT01360632|584278646|FG002|Phase A (8 Weeks)|Adverse Event|0|||
161791086|NCT01360632|584278647|FG003|Phase A (8 Weeks)|Adverse Event|0|||
161791087|NCT01360632|584278648|FG004|Phase A (8 Weeks)|Adverse Event|0|||
161791088|NCT01360632|584278644|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
161791089|NCT01360632|584278645|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
161791090|NCT01360632|584278646|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
161791091|NCT01360632|584278647|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
161791092|NCT01360632|584278648|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
161791093|NCT01360632|584278644|FG000|Phase A (8 Weeks)|Physician Decision|10|||
161791094|NCT01360632|584278645|FG001|Phase A (8 Weeks)|Physician Decision|0|||
161791095|NCT01360632|584278646|FG002|Phase A (8 Weeks)|Physician Decision|0|||
161791096|NCT01360632|584278647|FG003|Phase A (8 Weeks)|Physician Decision|0|||
161791097|NCT01360632|584278648|FG004|Phase A (8 Weeks)|Physician Decision|0|||
161791098|NCT01360632|584278644|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
161791099|NCT01360632|584278645|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
161791100|NCT01360632|584278646|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
161791101|NCT01360632|584278647|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
161791102|NCT01360632|584278648|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
161791103|NCT01360632|584278644|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
161791104|NCT01360632|584278645|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
161791105|NCT01360632|584278646|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
161791106|NCT01360632|584278647|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
161791107|NCT01360632|584278648|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
161791108|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
161791109|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
161791110|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
161791111|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
161791112|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
161791113|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Adverse Event|0|||
161791114|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Adverse Event|3|||
161791115|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Adverse Event|9|||
161791116|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Adverse Event|3|||
161791117|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Adverse Event|0|||
161791118|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161791119|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161791120|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
161791121|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
161791122|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161791123|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Physician Decision|0|||
161791124|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Physician Decision|0|||
161791125|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Physician Decision|0|||
161791126|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Physician Decision|1|||
161791127|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Physician Decision|0|||
161791128|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
161791129|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
161791130|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
161791131|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
161791132|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
161791133|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
161791134|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
161791135|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
161791136|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
161791137|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
161791138|NCT01360632|584278644|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
161791139|NCT01360632|584278645|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
161791140|NCT01360632|584278646|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
161791141|NCT01360632|584278647|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
161791142|NCT01360632|584278648|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
161791143|NCT01360632|584278644|FG000|Phase A+|Lost to Follow-up|0|||
161791144|NCT01360632|584278645|FG001|Phase A+|Lost to Follow-up|0|||
161791145|NCT01360632|584278646|FG002|Phase A+|Lost to Follow-up|0|||
161791146|NCT01360632|584278647|FG003|Phase A+|Lost to Follow-up|0|||
161791147|NCT01360632|584278648|FG004|Phase A+|Lost to Follow-up|2|||
161791148|NCT01360632|584278644|FG000|Phase A+|Adverse Event|0|||
161791149|NCT01360632|584278645|FG001|Phase A+|Adverse Event|0|||
161898731|NCT02592447|584677892|FG001|Overall Study|Withdrawal by Subject|1|||
161791150|NCT01360632|584278646|FG002|Phase A+|Adverse Event|0|||
161791151|NCT01360632|584278647|FG003|Phase A+|Adverse Event|0|||
161791152|NCT01360632|584278648|FG004|Phase A+|Adverse Event|2|||
161791153|NCT01360632|584278644|FG000|Phase A+|Met Withdrawal Criteria|0|||
161791154|NCT01360632|584278645|FG001|Phase A+|Met Withdrawal Criteria|0|||
161791155|NCT01360632|584278646|FG002|Phase A+|Met Withdrawal Criteria|0|||
161791156|NCT01360632|584278647|FG003|Phase A+|Met Withdrawal Criteria|0|||
161791157|NCT01360632|584278648|FG004|Phase A+|Met Withdrawal Criteria|7|||
161791158|NCT01360632|584278644|FG000|Phase A+|Physician Decision|0|||
161791159|NCT01360632|584278645|FG001|Phase A+|Physician Decision|0|||
161791160|NCT01360632|584278646|FG002|Phase A+|Physician Decision|0|||
161791161|NCT01360632|584278647|FG003|Phase A+|Physician Decision|0|||
161791162|NCT01360632|584278648|FG004|Phase A+|Physician Decision|3|||
161791163|NCT01360632|584278644|FG000|Phase A+|Withdrawal by Subject|0|||
161791164|NCT01360632|584278645|FG001|Phase A+|Withdrawal by Subject|0|||
161791165|NCT01360632|584278646|FG002|Phase A+|Withdrawal by Subject|0|||
161791166|NCT01360632|584278647|FG003|Phase A+|Withdrawal by Subject|0|||
161791167|NCT01360632|584278648|FG004|Phase A+|Withdrawal by Subject|8|||
161791168|NCT01360632|584278644|FG000|Phase A+|Protocol Deviation|0|||
161791169|NCT01360632|584278645|FG001|Phase A+|Protocol Deviation|0|||
161791170|NCT01360632|584278646|FG002|Phase A+|Protocol Deviation|0|||
161791171|NCT01360632|584278647|FG003|Phase A+|Protocol Deviation|0|||
161791172|NCT01360632|584278648|FG004|Phase A+|Protocol Deviation|3|||
161791173|NCT01298596|584278651|FG000|Overall Study|Withdrawal by Subject|1|||
161791174|NCT01298596|584278652|FG001|Overall Study|Withdrawal by Subject|1|||
161791175|NCT01298596|584278651|FG000|Overall Study|Death|5|||
161791176|NCT01298596|584278652|FG001|Overall Study|Death|3|||
161791177|NCT01298596|584278651|FG000|Overall Study|Lost to Follow-up|6|||
161791178|NCT01298596|584278652|FG001|Overall Study|Lost to Follow-up|14|||
161791179|NCT01298596|584278651|FG000|Overall Study|Referred for further management|16|||
161791180|NCT01298596|584278652|FG001|Overall Study|Referred for further management|15|||
161791181|NCT01629693|584278653|FG000|Overall Study|Lost to Follow-up|2|||
161791182|NCT01629693|584278654|FG001|Overall Study|Lost to Follow-up|4|||
161791183|NCT01629693|584278653|FG000|Overall Study|Withdrawal by Subject|2|||
161791184|NCT01629693|584278654|FG001|Overall Study|Withdrawal by Subject|2|||
161791185|NCT01629693|584278653|FG000|Overall Study|Adverse Event|1|||
161791186|NCT01629693|584278654|FG001|Overall Study|Adverse Event|0|||
161791187|NCT01629693|584278653|FG000|Overall Study|Investigator decision|0|||
161791188|NCT01629693|584278654|FG001|Overall Study|Investigator decision|1|||
161791189|NCT01629693|584278653|FG000|Overall Study|Poor comfort of study lenses|0|||
161791190|NCT01629693|584278654|FG001|Overall Study|Poor comfort of study lenses|2|||
161791191|NCT01629693|584278653|FG000|Overall Study|Subject decision unrelated to AE|0|||
161791192|NCT01629693|584278654|FG001|Overall Study|Subject decision unrelated to AE|1|||
161791193|NCT03740100|584278655|FG000|Overall Study|Adverse Event|1|||
161791194|NCT03740100|584278655|FG000|Overall Study|Death|1|||
161791195|NCT03387059|584278661|FG000|Overall Study|Study termination|5|||
161791196|NCT03387059|584278662|FG001|Overall Study|Study termination|4|||
161791197|NCT01606137|584278663|FG000|Overall Study|Adverse Event|85|||
161791198|NCT01606137|584278663|FG000|Overall Study|Withdrawal by Subject|74|||
161791199|NCT01606137|584278663|FG000|Overall Study|Lack of Efficacy|56|||
161791200|NCT01606137|584278663|FG000|Overall Study|Lost to Follow-up|15|||
161791201|NCT01606137|584278663|FG000|Overall Study|Protocol Violation|1|||
161791202|NCT01606137|584278663|FG000|Overall Study|Patient non-compliance|9|||
161791203|NCT01606137|584278663|FG000|Overall Study|Death|1|||
161791204|NCT01606137|584278663|FG000|Overall Study|Decreased/no pain|4|||
161791205|NCT01606137|584278663|FG000|Overall Study|Issues with driving|4|||
161791206|NCT01606137|584278663|FG000|Overall Study|multiple sclerosis less stable|1|||
161791207|NCT01606137|584278663|FG000|Overall Study|Increased bilirubin|1|||
161791208|NCT01606137|584278663|FG000|Overall Study|Spray causes nausea|1|||
161791209|NCT01606137|584278663|FG000|Overall Study|Not enough improvement|4|||
161791210|NCT01606137|584278663|FG000|Overall Study|Wanted to try another treatment|1|||
161791211|NCT01606137|584278663|FG000|Overall Study|Patient leaving country|1|||
161791212|NCT01606137|584278663|FG000|Overall Study|Personal reasons|1|||
161791213|NCT01606137|584278663|FG000|Overall Study|Unable to tolerate study med. taste|1|||
161791214|NCT01606137|584278663|FG000|Overall Study|Patient moving|1|||
161791215|NCT01606137|584278663|FG000|Overall Study|Unable to collect consistent data|1|||
161791216|NCT01715415|584278669|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
161791217|NCT01715415|584278670|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
161791218|NCT01715415|584278669|FG000|Double-blind Treatment|Adverse Event|3|||
161791219|NCT01715415|584278670|FG001|Double-blind Treatment|Adverse Event|0|||
161791220|NCT01715415|584278669|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
161791221|NCT01715415|584278670|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
161791222|NCT01715415|584278669|FG000|Double-blind Treatment|Other|1|||
161791223|NCT01715415|584278670|FG001|Double-blind Treatment|Other|0|||
161791224|NCT01715415|584278669|FG000|Open-label Treatment|Adverse Event|0|||
161791225|NCT01715415|584278670|FG001|Open-label Treatment|Adverse Event|1|||
161791226|NCT01715415|584278669|FG000|Open-label Treatment|Subject Noncompliant|0|||
161791227|NCT01715415|584278670|FG001|Open-label Treatment|Subject Noncompliant|1|||
161791228|NCT04578548|584278671|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
161791229|NCT04578548|584278672|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
161791230|NCT04578548|584278671|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
161791231|NCT04578548|584278672|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
161791232|NCT04578548|584278671|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
161791233|NCT04578548|584278672|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
161791234|NCT04578548|584278671|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
161791235|NCT04578548|584278672|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
161791236|NCT04578548|584278671|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
161791237|NCT04578548|584278672|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
161791238|NCT04578548|584278671|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
161791239|NCT04578548|584278672|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
161791240|NCT01241461|584280250|FG000|Overall Study|Progressive Disease|3|||
161791241|NCT01241461|584280251|FG001|Overall Study|Progressive Disease|6|||
161791242|NCT01379781|584280252|FG000|Overall Study|Lost to Follow-up|11|||
161791243|NCT01379781|584280253|FG001|Overall Study|Lost to Follow-up|8|||
161791244|NCT02247479|584280254|FG000|Overall Study|Adverse Event|8|||
161791245|NCT02247479|584280255|FG001|Overall Study|Adverse Event|9|||
161791246|NCT02247479|584280256|FG002|Overall Study|Adverse Event|8|||
161791247|NCT02247479|584280254|FG000|Overall Study|Death|5|||
161791248|NCT02247479|584280255|FG001|Overall Study|Death|4|||
161791249|NCT02247479|584280256|FG002|Overall Study|Death|6|||
161791250|NCT02247479|584280254|FG000|Overall Study|Lost to Follow-up|3|||
161791251|NCT02247479|584280255|FG001|Overall Study|Lost to Follow-up|3|||
161791252|NCT02247479|584280256|FG002|Overall Study|Lost to Follow-up|1|||
161791253|NCT02247479|584280254|FG000|Overall Study|Non-compliance|0|||
161791254|NCT02247479|584280255|FG001|Overall Study|Non-compliance|0|||
161791255|NCT02247479|584280256|FG002|Overall Study|Non-compliance|1|||
161791256|NCT02247479|584280254|FG000|Overall Study|Withdrawal by Subject|25|||
161791257|NCT02247479|584280255|FG001|Overall Study|Withdrawal by Subject|29|||
161791258|NCT02247479|584280256|FG002|Overall Study|Withdrawal by Subject|24|||
161791259|NCT02247479|584280254|FG000|Overall Study|Study Terminated by Sponsor|98|||
161791260|NCT02247479|584280255|FG001|Overall Study|Study Terminated by Sponsor|88|||
161791261|NCT02247479|584280256|FG002|Overall Study|Study Terminated by Sponsor|94|||
161791262|NCT02247479|584280254|FG000|Overall Study|Physician Decision|1|||
161791263|NCT02247479|584280255|FG001|Overall Study|Physician Decision|0|||
161791264|NCT02247479|584280256|FG002|Overall Study|Physician Decision|2|||
161791265|NCT02247479|584280254|FG000|Overall Study|Unspecified Reason|2|||
161791266|NCT02247479|584280255|FG001|Overall Study|Unspecified Reason|5|||
161791267|NCT02247479|584280256|FG002|Overall Study|Unspecified Reason|2|||
161791268|NCT03740698|584280257|FG000|Overall Study|Physician Decision|0|||
161791269|NCT03740698|584280258|FG001|Overall Study|Physician Decision|1|||
161791270|NCT03740698|584280259|FG002|Overall Study|Physician Decision|1|||
161791271|NCT05216978|584280269|FG000|Overall Study|Withdrawal by Subject|3|||
161791272|NCT05216978|584280269|FG000|Overall Study|Lost to Follow-up|5|||
161791273|NCT00658320|584280271|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
161791274|NCT00658320|584280272|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
161791275|NCT00658320|584280271|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
161791276|NCT00658320|584280272|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
161791277|NCT00658320|584280271|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
161791278|NCT00658320|584280272|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
161791279|NCT00658320|584280271|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
161791280|NCT00658320|584280272|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
161791281|NCT02410252|584280280|FG000|Overall Study|Withdrawal by Subject|4|||
161791282|NCT02410252|584280280|FG000|Overall Study|Physician Decision|2|||
161791283|NCT03433001|584280292|FG000|Overall Study|Lack of Efficacy|109|||
161791284|NCT03433001|584280292|FG000|Overall Study|Adverse Event|69|||
161791285|NCT03433001|584280292|FG000|Overall Study|Withdrawal by Subject|10|||
161791286|NCT03433001|584280292|FG000|Overall Study|Death|12|||
161791287|NCT03433001|584280292|FG000|Overall Study|Lost to Follow-up|4|||
161791288|NCT03433001|584280292|FG000|Overall Study|Other|25|||
161791289|NCT01007916|584280296|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
161791290|NCT01007916|584280297|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
161791291|NCT01007916|584280296|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
161791292|NCT01007916|584280297|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
161791293|NCT01299038|584280298|FG000|Overall Study|Withdrawal by Subject|1|||
161791294|NCT01299038|584280299|FG001|Overall Study|Withdrawal by Subject|0|||
161791295|NCT01162499|584280304|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
161791296|NCT01162499|584280305|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
161791297|NCT03347695|584280322|FG000|Overall Study|Death|0|||
161791298|NCT03347695|584280323|FG001|Overall Study|Death|4|||
161791299|NCT03347695|584280322|FG000|Overall Study|Lost to Follow-up|0|||
161791300|NCT03347695|584280323|FG001|Overall Study|Lost to Follow-up|1|||
161791301|NCT04633837|584280326|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
161791302|NCT04633837|584280327|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
161791303|NCT02884206|584280330|FG000|Valsartan Run-in Period|Death|1|||
161791304|NCT02884206|584280331|FG001|Valsartan Run-in Period|Death|0|||
161791305|NCT02884206|584280332|FG002|Valsartan Run-in Period|Death|0|||
161791306|NCT02884206|584280330|FG000|Valsartan Run-in Period|Adverse Event|31|||
161791307|NCT02884206|584280331|FG001|Valsartan Run-in Period|Adverse Event|0|||
161791308|NCT02884206|584280332|FG002|Valsartan Run-in Period|Adverse Event|0|||
161791309|NCT02884206|584280330|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
161791310|NCT02884206|584280331|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
161791311|NCT02884206|584280332|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
161791312|NCT02884206|584280330|FG000|Valsartan Run-in Period|Protocol deviation|4|||
161791313|NCT02884206|584280331|FG001|Valsartan Run-in Period|Protocol deviation|0|||
161791314|NCT02884206|584280332|FG002|Valsartan Run-in Period|Protocol deviation|0|||
161791315|NCT02884206|584280330|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
161791316|NCT02884206|584280331|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
161791317|NCT02884206|584280332|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
161791318|NCT02884206|584280330|FG000|Valsartan Run-in Period|Physician Decision|1|||
161791319|NCT02884206|584280331|FG001|Valsartan Run-in Period|Physician Decision|0|||
161791320|NCT02884206|584280332|FG002|Valsartan Run-in Period|Physician Decision|0|||
161791321|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Adverse Event|38|||
161791322|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Adverse Event|0|||
161791323|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Adverse Event|0|||
161791324|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Death|2|||
161791325|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Death|0|||
161791326|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Death|0|||
161791327|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
161791328|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
161791329|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
161791330|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
161791331|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
161791332|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
161791333|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
161791334|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
161791335|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
161791336|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Physician Decision|1|||
161791337|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Physician Decision|0|||
161791338|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Physician Decision|0|||
161791339|NCT02884206|584280330|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
161791340|NCT02884206|584280331|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
161791341|NCT02884206|584280332|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
161791342|NCT02884206|584280330|FG000|Double-Blind Period|Death|0|||
161791343|NCT02884206|584280331|FG001|Double-Blind Period|Death|28|||
161791344|NCT02884206|584280332|FG002|Double-Blind Period|Death|39|||
161791345|NCT02884206|584280330|FG000|Double-Blind Period|Patient/guardian decision|0|||
161791346|NCT02884206|584280331|FG001|Double-Blind Period|Patient/guardian decision|10|||
161791347|NCT02884206|584280332|FG002|Double-Blind Period|Patient/guardian decision|13|||
161791348|NCT02884206|584280330|FG000|Double-Blind Period|Lost to Follow-up|0|||
161791349|NCT02884206|584280331|FG001|Double-Blind Period|Lost to Follow-up|4|||
161791350|NCT02884206|584280332|FG002|Double-Blind Period|Lost to Follow-up|4|||
161791351|NCT02884206|584280330|FG000|Double-Blind Period|Physician Decision|0|||
161791352|NCT02884206|584280331|FG001|Double-Blind Period|Physician Decision|2|||
161791353|NCT02884206|584280332|FG002|Double-Blind Period|Physician Decision|0|||
161791354|NCT02884206|584280330|FG000|Double-Blind Period|Adverse Event|0|||
161791355|NCT02884206|584280331|FG001|Double-Blind Period|Adverse Event|0|||
161791356|NCT02884206|584280332|FG002|Double-Blind Period|Adverse Event|3|||
161791357|NCT02884206|584280330|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
161791358|NCT02884206|584280331|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
161791359|NCT02884206|584280332|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
161791360|NCT04467697|584280333|FG000|Overall Study|Adverse Event|2|||
161791361|NCT04467697|584280333|FG000|Overall Study|Lost to Follow-up|6|||
161791362|NCT04467697|584280333|FG000|Overall Study|Withdrawal by Subject|9|||
161791363|NCT04467697|584280333|FG000|Overall Study|Protocol Violation|3|||
161791364|NCT03907280|584280334|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
161791365|NCT03907280|584280335|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
161791366|NCT03907280|584280336|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
161791367|NCT03487796|584280340|FG000|Overall Study|Lost to Follow-up|18|||
161791368|NCT03487796|584280341|FG001|Overall Study|Lost to Follow-up|6|||
161791369|NCT00613574|584280342|FG000|Overall Study|Adverse Event|3|||
161791370|NCT00613574|584280342|FG000|Overall Study|Lost to Follow-up|2|||
161791371|NCT00613574|584280342|FG000|Overall Study|Other|1|||
161791372|NCT00582036|584280345|FG000|Overall Study|Withdrawal by Subject|0|||
161791373|NCT00582036|584280346|FG001|Overall Study|Withdrawal by Subject|1|||
161791374|NCT02711956|584280347|FG000|Overall Study|Adverse Event|0|||
161791375|NCT02711956|584280348|FG001|Overall Study|Adverse Event|0|||
161791376|NCT02711956|584280349|FG002|Overall Study|Adverse Event|0|||
161791377|NCT02711956|584280350|FG003|Overall Study|Adverse Event|1|||
161791378|NCT02711956|584280351|FG004|Overall Study|Adverse Event|2|||
161791379|NCT02711956|584280352|FG005|Overall Study|Adverse Event|0|||
161791380|NCT02711956|584280353|FG006|Overall Study|Adverse Event|0|||
161791381|NCT02711956|584280354|FG007|Overall Study|Adverse Event|1|||
161791382|NCT02711956|584280355|FG008|Overall Study|Adverse Event|1|||
161791383|NCT02711956|584280356|FG009|Overall Study|Adverse Event|1|||
161791384|NCT02711956|584280357|FG010|Overall Study|Adverse Event|1|||
161791385|NCT02711956|584280358|FG011|Overall Study|Adverse Event|0|||
161791386|NCT02711956|584280359|FG012|Overall Study|Adverse Event|0|||
161791387|NCT02711956|584280360|FG013|Overall Study|Adverse Event|0|||
161791388|NCT02711956|584280361|FG014|Overall Study|Adverse Event|2|||
161791389|NCT02711956|584280347|FG000|Overall Study|Physician Decision|0|||
161791390|NCT02711956|584280348|FG001|Overall Study|Physician Decision|0|||
161791391|NCT02711956|584280349|FG002|Overall Study|Physician Decision|0|||
161791392|NCT02711956|584280350|FG003|Overall Study|Physician Decision|2|||
161791393|NCT02711956|584280351|FG004|Overall Study|Physician Decision|0|||
161791394|NCT02711956|584280352|FG005|Overall Study|Physician Decision|0|||
161791395|NCT02711956|584280353|FG006|Overall Study|Physician Decision|0|||
161791396|NCT02711956|584280354|FG007|Overall Study|Physician Decision|0|||
161791397|NCT02711956|584280355|FG008|Overall Study|Physician Decision|0|||
161791398|NCT02711956|584280356|FG009|Overall Study|Physician Decision|0|||
161791399|NCT02711956|584280357|FG010|Overall Study|Physician Decision|0|||
161791400|NCT02711956|584280358|FG011|Overall Study|Physician Decision|0|||
161791401|NCT02711956|584280359|FG012|Overall Study|Physician Decision|0|||
161791402|NCT02711956|584280360|FG013|Overall Study|Physician Decision|0|||
161791403|NCT02711956|584280361|FG014|Overall Study|Physician Decision|0|||
161791404|NCT02711956|584280347|FG000|Overall Study|Withdrawal by Subject|0|||
161791405|NCT02711956|584280348|FG001|Overall Study|Withdrawal by Subject|0|||
161791406|NCT02711956|584280349|FG002|Overall Study|Withdrawal by Subject|0|||
161791407|NCT02711956|584280350|FG003|Overall Study|Withdrawal by Subject|0|||
161791408|NCT02711956|584280351|FG004|Overall Study|Withdrawal by Subject|0|||
161791409|NCT02711956|584280352|FG005|Overall Study|Withdrawal by Subject|0|||
161791410|NCT02711956|584280353|FG006|Overall Study|Withdrawal by Subject|1|||
161791411|NCT02711956|584280354|FG007|Overall Study|Withdrawal by Subject|0|||
161791412|NCT02711956|584280355|FG008|Overall Study|Withdrawal by Subject|0|||
161791413|NCT02711956|584280356|FG009|Overall Study|Withdrawal by Subject|0|||
161791414|NCT02711956|584280357|FG010|Overall Study|Withdrawal by Subject|0|||
161791415|NCT02711956|584280358|FG011|Overall Study|Withdrawal by Subject|1|||
161791416|NCT02711956|584280359|FG012|Overall Study|Withdrawal by Subject|6|||
161791417|NCT02711956|584280360|FG013|Overall Study|Withdrawal by Subject|0|||
161791418|NCT02711956|584280361|FG014|Overall Study|Withdrawal by Subject|1|||
161791419|NCT02711956|584280347|FG000|Overall Study|Clinical progression|1|||
161791420|NCT02711956|584280348|FG001|Overall Study|Clinical progression|0|||
161791421|NCT02711956|584280349|FG002|Overall Study|Clinical progression|0|||
161791422|NCT02711956|584280350|FG003|Overall Study|Clinical progression|0|||
161791423|NCT02711956|584280351|FG004|Overall Study|Clinical progression|0|||
161791424|NCT02711956|584280352|FG005|Overall Study|Clinical progression|0|||
161791425|NCT02711956|584280353|FG006|Overall Study|Clinical progression|1|||
161791426|NCT02711956|584280354|FG007|Overall Study|Clinical progression|0|||
161791427|NCT02711956|584280355|FG008|Overall Study|Clinical progression|1|||
161791428|NCT02711956|584280356|FG009|Overall Study|Clinical progression|0|||
161791429|NCT02711956|584280357|FG010|Overall Study|Clinical progression|0|||
161791430|NCT02711956|584280358|FG011|Overall Study|Clinical progression|2|||
161791431|NCT02711956|584280359|FG012|Overall Study|Clinical progression|4|||
161791432|NCT02711956|584280360|FG013|Overall Study|Clinical progression|1|||
161791433|NCT02711956|584280361|FG014|Overall Study|Clinical progression|1|||
161791434|NCT02711956|584280347|FG000|Overall Study|Radiographic progression|1|||
161791435|NCT02711956|584280348|FG001|Overall Study|Radiographic progression|1|||
161791436|NCT02711956|584280349|FG002|Overall Study|Radiographic progression|2|||
161791437|NCT02711956|584280350|FG003|Overall Study|Radiographic progression|0|||
161898732|NCT03428100|584677893|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
161898733|NCT03428100|584677894|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161791438|NCT02711956|584280351|FG004|Overall Study|Radiographic progression|1|||
161791439|NCT02711956|584280352|FG005|Overall Study|Radiographic progression|0|||
161791440|NCT02711956|584280353|FG006|Overall Study|Radiographic progression|0|||
161791441|NCT02711956|584280354|FG007|Overall Study|Radiographic progression|0|||
161791442|NCT02711956|584280355|FG008|Overall Study|Radiographic progression|2|||
161898734|NCT03428100|584677895|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
161898735|NCT03428100|584677896|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
161791443|NCT02711956|584280356|FG009|Overall Study|Radiographic progression|1|||
161791444|NCT02711956|584280357|FG010|Overall Study|Radiographic progression|0|||
161791445|NCT02711956|584280358|FG011|Overall Study|Radiographic progression|5|||
161791446|NCT02711956|584280359|FG012|Overall Study|Radiographic progression|3|||
161791447|NCT02711956|584280360|FG013|Overall Study|Radiographic progression|0|||
161791448|NCT02711956|584280361|FG014|Overall Study|Radiographic progression|1|||
162130368|NCT02846558|585528113|FG003|Overall Study|Lost to Follow-up|0|||
161791449|NCT02711956|584280347|FG000|Overall Study|PSA progression with clinical progression|0|||
161791450|NCT02711956|584280348|FG001|Overall Study|PSA progression with clinical progression|0|||
161791451|NCT02711956|584280349|FG002|Overall Study|PSA progression with clinical progression|0|||
161791452|NCT02711956|584280350|FG003|Overall Study|PSA progression with clinical progression|0|||
161791453|NCT02711956|584280351|FG004|Overall Study|PSA progression with clinical progression|1|||
161791454|NCT02711956|584280352|FG005|Overall Study|PSA progression with clinical progression|0|||
161791455|NCT02711956|584280353|FG006|Overall Study|PSA progression with clinical progression|0|||
161791456|NCT02711956|584280354|FG007|Overall Study|PSA progression with clinical progression|0|||
161791457|NCT02711956|584280355|FG008|Overall Study|PSA progression with clinical progression|0|||
161791458|NCT02711956|584280356|FG009|Overall Study|PSA progression with clinical progression|0|||
161791459|NCT02711956|584280357|FG010|Overall Study|PSA progression with clinical progression|0|||
161791460|NCT02711956|584280358|FG011|Overall Study|PSA progression with clinical progression|0|||
161791461|NCT02711956|584280359|FG012|Overall Study|PSA progression with clinical progression|1|||
161791462|NCT02711956|584280360|FG013|Overall Study|PSA progression with clinical progression|1|||
161791463|NCT02711956|584280361|FG014|Overall Study|PSA progression with clinical progression|0|||
161791464|NCT02711956|584280347|FG000|Overall Study|PSA progression with radiographic progression|0|||
161791465|NCT02711956|584280348|FG001|Overall Study|PSA progression with radiographic progression|1|||
161791466|NCT02711956|584280349|FG002|Overall Study|PSA progression with radiographic progression|0|||
161791467|NCT02711956|584280350|FG003|Overall Study|PSA progression with radiographic progression|0|||
161791468|NCT02711956|584280351|FG004|Overall Study|PSA progression with radiographic progression|0|||
161791469|NCT02711956|584280352|FG005|Overall Study|PSA progression with radiographic progression|2|||
161791470|NCT02711956|584280353|FG006|Overall Study|PSA progression with radiographic progression|2|||
161791471|NCT02711956|584280354|FG007|Overall Study|PSA progression with radiographic progression|1|||
161791472|NCT02711956|584280355|FG008|Overall Study|PSA progression with radiographic progression|0|||
161791473|NCT02711956|584280356|FG009|Overall Study|PSA progression with radiographic progression|1|||
161791474|NCT02711956|584280357|FG010|Overall Study|PSA progression with radiographic progression|0|||
161791475|NCT02711956|584280358|FG011|Overall Study|PSA progression with radiographic progression|1|||
161791476|NCT02711956|584280359|FG012|Overall Study|PSA progression with radiographic progression|2|||
161791477|NCT02711956|584280360|FG013|Overall Study|PSA progression with radiographic progression|3|||
161791478|NCT02711956|584280361|FG014|Overall Study|PSA progression with radiographic progression|3|||
161791479|NCT05487456|584280362|FG000|Overall Study|Withdrawal by Subject|0|||
161791480|NCT05487456|584280363|FG001|Overall Study|Withdrawal by Subject|0|||
161791481|NCT05487456|584280364|FG002|Overall Study|Withdrawal by Subject|1|||
161791482|NCT05487456|584280365|FG003|Overall Study|Withdrawal by Subject|0|||
161791483|NCT03294538|584280370|FG000|Overall Study|Adverse Event|0|||
161791484|NCT03294538|584280371|FG001|Overall Study|Adverse Event|1|||
161791485|NCT03294538|584280372|FG002|Overall Study|Adverse Event|1|||
161791486|NCT03294538|584280370|FG000|Overall Study|Lost to Follow-up|1|||
161791487|NCT03294538|584280371|FG001|Overall Study|Lost to Follow-up|0|||
161791488|NCT03294538|584280372|FG002|Overall Study|Lost to Follow-up|0|||
161791489|NCT03294538|584280370|FG000|Overall Study|Outside of Visit Window|4|||
161791490|NCT03294538|584280371|FG001|Overall Study|Outside of Visit Window|4|||
161791491|NCT03294538|584280372|FG002|Overall Study|Outside of Visit Window|1|||
161791492|NCT01090765|584280374|FG000|Overall Study|Patient withdrew consent|0|||
161791493|NCT01090765|584280375|FG001|Overall Study|Patient withdrew consent|0|||
161791494|NCT01090765|584280376|FG002|Overall Study|Patient withdrew consent|0|||
161791495|NCT01090765|584280377|FG003|Overall Study|Patient withdrew consent|0|||
161791496|NCT01090765|584280378|FG004|Overall Study|Patient withdrew consent|1|||
161791497|NCT01090765|584280379|FG005|Overall Study|Patient withdrew consent|1|||
161791498|NCT01090765|584280374|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
161791499|NCT01090765|584280375|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
161791500|NCT01090765|584280376|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
161791501|NCT01090765|584280377|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
161791502|NCT01090765|584280378|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
161791503|NCT01090765|584280379|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
161791504|NCT01090765|584280374|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
161791505|NCT01090765|584280375|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
161791506|NCT01090765|584280376|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
161791507|NCT01090765|584280377|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
161791508|NCT01090765|584280378|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
161791509|NCT01090765|584280379|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
161791510|NCT01787825|584280380|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
161791511|NCT01787825|584280381|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
161791512|NCT01787825|584280380|FG000|Overall Study|Data Not Analyzable|5|||
161791513|NCT01787825|584280381|FG001|Overall Study|Data Not Analyzable|1|||
161791514|NCT00718159|584280386|FG000|Overall Study|Progressive Disease|3|||
161791515|NCT00718159|584280387|FG001|Overall Study|Progressive Disease|3|||
162130369|NCT04157686|585528114|FG000|Overall Study|Adverse Event|1|||
161791516|NCT00718159|584280388|FG002|Overall Study|Progressive Disease|2|||
161791517|NCT00718159|584280389|FG003|Overall Study|Progressive Disease|0|||
161791518|NCT00718159|584280390|FG004|Overall Study|Progressive Disease|6|||
161791519|NCT00718159|584280391|FG005|Overall Study|Progressive Disease|0|||
161791520|NCT00718159|584280392|FG006|Overall Study|Progressive Disease|0|||
161791521|NCT00718159|584280386|FG000|Overall Study|Death due to Adverse Event|0|||
161791522|NCT00718159|584280387|FG001|Overall Study|Death due to Adverse Event|0|||
161791523|NCT00718159|584280388|FG002|Overall Study|Death due to Adverse Event|0|||
161791524|NCT00718159|584280389|FG003|Overall Study|Death due to Adverse Event|2|||
161791525|NCT00718159|584280390|FG004|Overall Study|Death due to Adverse Event|2|||
161791526|NCT00718159|584280391|FG005|Overall Study|Death due to Adverse Event|0|||
161791527|NCT00718159|584280392|FG006|Overall Study|Death due to Adverse Event|0|||
161791528|NCT00718159|584280386|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
161791529|NCT00718159|584280387|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
161791530|NCT00718159|584280388|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
161791531|NCT00718159|584280389|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
161791532|NCT00718159|584280390|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
161791533|NCT00718159|584280391|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
161791534|NCT00718159|584280392|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
161791535|NCT00718159|584280386|FG000|Overall Study|Investigator Decision|0|||
161791536|NCT00718159|584280387|FG001|Overall Study|Investigator Decision|0|||
161791537|NCT00718159|584280388|FG002|Overall Study|Investigator Decision|0|||
161791538|NCT00718159|584280389|FG003|Overall Study|Investigator Decision|0|||
161791539|NCT00718159|584280390|FG004|Overall Study|Investigator Decision|0|||
161791540|NCT00718159|584280391|FG005|Overall Study|Investigator Decision|1|||
161791541|NCT00718159|584280392|FG006|Overall Study|Investigator Decision|1|||
161791542|NCT01238848|584280394|FG000|Overall Study|Physician Decision|13|||
161791543|NCT01238848|584280395|FG001|Overall Study|Physician Decision|5|||
161791544|NCT03412019|584280396|FG000|Overall Study|Withdrawal by Subject|1|||
161791545|NCT03412019|584280397|FG001|Overall Study|Withdrawal by Subject|1|||
161791546|NCT00415532|584280398|FG000|Treatment Period|Adverse Event|2|||
161791547|NCT00415532|584280399|FG001|Treatment Period|Adverse Event|3|||
161791548|NCT00415532|584280398|FG000|Treatment Period|Death|2|||
161791549|NCT00415532|584280399|FG001|Treatment Period|Death|1|||
161791550|NCT00415532|584280398|FG000|Treatment Period|Lost to Follow-up|1|||
161791551|NCT00415532|584280399|FG001|Treatment Period|Lost to Follow-up|1|||
161791552|NCT00415532|584280398|FG000|Treatment Period|Protocol Violation|1|||
161791553|NCT00415532|584280399|FG001|Treatment Period|Protocol Violation|0|||
161791554|NCT00415532|584280398|FG000|Treatment Period|Withdrawal by Subject|6|||
161791555|NCT00415532|584280399|FG001|Treatment Period|Withdrawal by Subject|6|||
161791556|NCT00415532|584280398|FG000|Treatment Period|Other|2|||
161791557|NCT00415532|584280399|FG001|Treatment Period|Other|2|||
161791558|NCT00415532|584280398|FG000|Treatment Period|Ineligibility determined|1|||
161791559|NCT00415532|584280399|FG001|Treatment Period|Ineligibility determined|1|||
161791560|NCT00415532|584280398|FG000|Treatment Period|Noncompliance|1|||
161791561|NCT00415532|584280399|FG001|Treatment Period|Noncompliance|1|||
161791562|NCT00415532|584280398|FG000|Treatment Period|Requirement for alternative therapy|1|||
161791563|NCT00415532|584280399|FG001|Treatment Period|Requirement for alternative therapy|0|||
161791564|NCT00415532|584280398|FG000|Safety Follow Up Period|Adverse Event|1|||
161791565|NCT00415532|584280399|FG001|Safety Follow Up Period|Adverse Event|3|||
161791566|NCT00415532|584280398|FG000|Safety Follow Up Period|Death|3|||
161791567|NCT00415532|584280399|FG001|Safety Follow Up Period|Death|0|||
161791568|NCT00415532|584280398|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
161791569|NCT00415532|584280399|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
161791570|NCT00415532|584280398|FG000|Safety Follow Up Period|Other|1|||
161791571|NCT00415532|584280399|FG001|Safety Follow Up Period|Other|4|||
161791572|NCT00415532|584280398|FG000|Safety Follow Up Period|Ineligibility determined|1|||
161791573|NCT00415532|584280399|FG001|Safety Follow Up Period|Ineligibility determined|1|||
161791574|NCT00415532|584280398|FG000|Safety Follow Up Period|Noncompliance|1|||
161791575|NCT00415532|584280399|FG001|Safety Follow Up Period|Noncompliance|0|||
161791576|NCT00415532|584280398|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
161791577|NCT00415532|584280399|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
161791578|NCT01952574|584280400|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
161791579|NCT01952574|584280401|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
161791580|NCT01952574|584280402|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
161791581|NCT01952574|584280403|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
161791582|NCT01952574|584280404|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161791583|NCT01952574|584280405|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161791584|NCT01952574|584280406|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161791585|NCT01952574|584280400|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
161791586|NCT01952574|584280401|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
161791587|NCT01952574|584280402|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
161898736|NCT03428100|584677897|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898737|NCT03428100|584677898|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161791588|NCT01952574|584280403|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
161791589|NCT01952574|584280404|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
161791590|NCT01952574|584280405|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
161791591|NCT01952574|584280406|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
161791592|NCT01952574|584280400|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
161791593|NCT01952574|584280401|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
161791594|NCT01952574|584280402|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
161791595|NCT01952574|584280403|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
161898738|NCT03428100|584677899|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898739|NCT03428100|584677900|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898740|NCT03428100|584677901|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898741|NCT03428100|584677902|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898742|NCT03428100|584677903|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898743|NCT03428100|584677904|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898744|NCT03428100|584677905|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898745|NCT03428100|584677906|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898746|NCT03428100|584677907|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898747|NCT03428100|584677908|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898748|NCT03428100|584677909|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898749|NCT03428100|584677910|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898750|NCT03428100|584677911|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161898751|NCT03428100|584677893|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
161898752|NCT03428100|584677894|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
161898753|NCT03428100|584677895|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
161898754|NCT03428100|584677896|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
161898755|NCT03428100|584677897|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898756|NCT03428100|584677898|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898757|NCT03428100|584677899|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898758|NCT03428100|584677900|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898759|NCT03428100|584677901|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898760|NCT03428100|584677902|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898761|NCT03428100|584677903|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898762|NCT03428100|584677904|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898763|NCT03428100|584677905|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898764|NCT03428100|584677906|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898765|NCT03428100|584677907|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898766|NCT03428100|584677908|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898767|NCT03428100|584677909|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898768|NCT03428100|584677910|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898769|NCT03428100|584677911|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161898770|NCT03428100|584677893|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898771|NCT03428100|584677894|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
161898772|NCT03428100|584677895|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
161898773|NCT03428100|584677896|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898774|NCT03428100|584677897|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898775|NCT03428100|584677898|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898776|NCT03428100|584677899|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898777|NCT03428100|584677900|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898778|NCT03428100|584677901|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898779|NCT03428100|584677902|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898780|NCT03428100|584677903|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898781|NCT03428100|584677904|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898782|NCT03428100|584677905|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898783|NCT03428100|584677906|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898784|NCT03428100|584677907|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898785|NCT03428100|584677908|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898786|NCT03428100|584677909|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898787|NCT03428100|584677910|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898788|NCT03428100|584677911|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161898789|NCT03428100|584677893|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
161898790|NCT03428100|584677894|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898791|NCT03428100|584677895|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898792|NCT03428100|584677896|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
162130370|NCT04157686|585528115|FG001|Overall Study|Adverse Event|0|||
161791596|NCT01952574|584280404|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
161791597|NCT01952574|584280405|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
161791598|NCT01952574|584280406|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
161791599|NCT01952574|584280400|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
161791600|NCT01952574|584280401|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
161791601|NCT01952574|584280402|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
161791602|NCT01952574|584280403|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
161791603|NCT01952574|584280404|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
161791604|NCT01952574|584280405|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
161791605|NCT01952574|584280406|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
161791606|NCT01952574|584280400|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
161791607|NCT01952574|584280401|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
161791608|NCT01952574|584280402|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
161791609|NCT01952574|584280403|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
161791610|NCT01952574|584280404|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
161791611|NCT01952574|584280405|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
161791612|NCT01952574|584280406|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
161791613|NCT01952574|584280400|FG000|Open-label Treatment Phase|Missing|0|||
161791614|NCT01952574|584280401|FG001|Open-label Treatment Phase|Missing|0|||
161791615|NCT01952574|584280402|FG002|Open-label Treatment Phase|Missing|0|||
161791616|NCT01952574|584280403|FG003|Open-label Treatment Phase|Missing|0|||
161791617|NCT01952574|584280404|FG004|Open-label Treatment Phase|Missing|4|||
161791618|NCT01952574|584280405|FG005|Open-label Treatment Phase|Missing|0|||
161791619|NCT01952574|584280406|FG006|Open-label Treatment Phase|Missing|0|||
161791620|NCT01952574|584280400|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
161791621|NCT01952574|584280401|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
161791622|NCT01952574|584280402|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
161791623|NCT01952574|584280403|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
161791624|NCT01952574|584280404|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
161791625|NCT01952574|584280405|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
161791626|NCT01952574|584280406|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
161791627|NCT01952574|584280400|FG000|Open-label Treatment Phase|Death|0|||
161791628|NCT01952574|584280401|FG001|Open-label Treatment Phase|Death|0|||
161791629|NCT01952574|584280402|FG002|Open-label Treatment Phase|Death|0|||
161791630|NCT01952574|584280403|FG003|Open-label Treatment Phase|Death|0|||
161791631|NCT01952574|584280404|FG004|Open-label Treatment Phase|Death|1|||
161791632|NCT01952574|584280405|FG005|Open-label Treatment Phase|Death|0|||
161791633|NCT01952574|584280406|FG006|Open-label Treatment Phase|Death|0|||
161791634|NCT01952574|584280400|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161791635|NCT01952574|584280401|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161791636|NCT01952574|584280402|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161791637|NCT01952574|584280403|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161791638|NCT01952574|584280404|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161791639|NCT01952574|584280405|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
161791640|NCT01952574|584280406|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161791641|NCT01952574|584280400|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
161791642|NCT01952574|584280401|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
161791643|NCT01952574|584280402|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
161791644|NCT01952574|584280403|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
161791645|NCT01952574|584280404|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
161791646|NCT01952574|584280405|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
161791647|NCT01952574|584280406|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
161791648|NCT01821625|584280414|FG000|Overall Study|Withdrawal by Subject|2|||
161791649|NCT01821625|584280414|FG000|Overall Study|Lack of Efficacy|2|||
161791650|NCT01821625|584280414|FG000|Overall Study|Adverse Event|1|||
161791651|NCT01821625|584280414|FG000|Overall Study|Medical contraindication|1|||
161791652|NCT01620489|584280416|FG000|Overall Study|Adverse Event|17|||
161791653|NCT01620489|584280417|FG001|Overall Study|Adverse Event|4|||
161791654|NCT01620489|584280416|FG000|Overall Study|Protocol Violation|0|||
161791655|NCT01620489|584280417|FG001|Overall Study|Protocol Violation|3|||
161791656|NCT01620489|584280416|FG000|Overall Study|Withdrawal Criteria|17|||
161791657|NCT01620489|584280417|FG001|Overall Study|Withdrawal Criteria|25|||
161791658|NCT01620489|584280416|FG000|Overall Study|Unclassified|1|||
161791659|NCT01620489|584280417|FG001|Overall Study|Unclassified|2|||
161791660|NCT00871169|584280418|FG000|Overall Study|Protocol Violation|1|||
161791661|NCT00871169|584280418|FG000|Overall Study|Patient did not receive study treatment|2|||
161791662|NCT00593333|584280419|FG000|Overall Study|Lost to Follow-up|10|||
161791663|NCT00593333|584280420|FG001|Overall Study|Lost to Follow-up|11|||
161791664|NCT01328054|584280421|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
161791665|NCT01328054|584280422|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
161791666|NCT01328054|584280421|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
161791667|NCT01328054|584280422|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
161791668|NCT01328054|584280421|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
161791669|NCT01328054|584280422|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
161791670|NCT01829295|584280423|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
161791671|NCT01829295|584280424|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
161791672|NCT01829295|584280425|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
161791673|NCT01829295|584280426|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
161791674|NCT01829295|584280423|FG000|6-12 Months|Adverse Event|0|||
161791675|NCT01829295|584280424|FG001|6-12 Months|Adverse Event|0|||
161791676|NCT01829295|584280425|FG002|6-12 Months|Adverse Event|3|||
161791677|NCT01829295|584280426|FG003|6-12 Months|Adverse Event|2|||
161791678|NCT01829295|584280423|FG000|6-12 Months|Lost to Follow-up|2|||
161791679|NCT01829295|584280424|FG001|6-12 Months|Lost to Follow-up|0|||
161791680|NCT01829295|584280425|FG002|6-12 Months|Lost to Follow-up|0|||
161791681|NCT01829295|584280426|FG003|6-12 Months|Lost to Follow-up|0|||
161791682|NCT01829295|584280423|FG000|6-12 Months|Withdrawal by Subject|2|||
161791683|NCT01829295|584280424|FG001|6-12 Months|Withdrawal by Subject|2|||
161791684|NCT01829295|584280425|FG002|6-12 Months|Withdrawal by Subject|0|||
161791685|NCT01829295|584280426|FG003|6-12 Months|Withdrawal by Subject|0|||
161791686|NCT02629965|584280429|FG000|Period 1|Adverse Event|1|||
161791687|NCT02629965|584280430|FG001|Period 1|Adverse Event|0|||
161791688|NCT02629965|584280429|FG000|Period 1|Unexpected worsening of disease|2|||
161791689|NCT02629965|584280430|FG001|Period 1|Unexpected worsening of disease|0|||
161791690|NCT02629965|584280429|FG000|Period 1|Other than listed above|1|||
161791691|NCT02629965|584280430|FG001|Period 1|Other than listed above|2|||
161791692|NCT02629965|584280429|FG000|Period 2|Adverse Event|1|||
161791693|NCT02629965|584280430|FG001|Period 2|Adverse Event|0|||
161791694|NCT00254397|584280432|FG000|Overall Study|Disease Progression|4|||
161791695|NCT00254397|584280433|FG001|Overall Study|Disease Progression|1|||
161791696|NCT00254397|584280434|FG002|Overall Study|Disease Progression|16|||
161791697|NCT00254397|584280435|FG003|Overall Study|Disease Progression|23|||
161791698|NCT00254397|584280432|FG000|Overall Study|Non-Compliant|0|||
161791699|NCT00254397|584280433|FG001|Overall Study|Non-Compliant|0|||
161791700|NCT00254397|584280434|FG002|Overall Study|Non-Compliant|0|||
161791701|NCT00254397|584280435|FG003|Overall Study|Non-Compliant|1|||
161791702|NCT00254397|584280432|FG000|Overall Study|Adverse Event|2|||
161898793|NCT03428100|584677897|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898794|NCT03428100|584677898|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898795|NCT03428100|584677899|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898796|NCT03428100|584677900|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898797|NCT03428100|584677901|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898798|NCT03428100|584677902|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898799|NCT03428100|584677903|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898800|NCT03428100|584677904|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898801|NCT03428100|584677905|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898802|NCT03428100|584677906|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898803|NCT03428100|584677907|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898804|NCT03428100|584677908|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898805|NCT03428100|584677909|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898806|NCT03428100|584677910|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898807|NCT03428100|584677911|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161898808|NCT03428100|584677893|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898809|NCT03428100|584677894|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
161898810|NCT03428100|584677895|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898811|NCT03428100|584677896|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898812|NCT03428100|584677897|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898813|NCT03428100|584677898|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898814|NCT03428100|584677899|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898815|NCT03428100|584677900|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898816|NCT03428100|584677901|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898817|NCT03428100|584677902|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898818|NCT03428100|584677903|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898819|NCT03428100|584677904|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898820|NCT03428100|584677905|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161791703|NCT00254397|584280433|FG001|Overall Study|Adverse Event|0|||
161791704|NCT00254397|584280434|FG002|Overall Study|Adverse Event|3|||
161791705|NCT00254397|584280435|FG003|Overall Study|Adverse Event|1|||
161791706|NCT05028751|584280443|FG000|Overall Study|Study Terminated by Sponsor|3|||
161898821|NCT03428100|584677906|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161791707|NCT05028751|584280444|FG001|Overall Study|Study Terminated by Sponsor|0|||
161791708|NCT05028751|584280445|FG002|Overall Study|Study Terminated by Sponsor|0|||
161791709|NCT05028751|584280446|FG003|Overall Study|Study Terminated by Sponsor|0|||
161791710|NCT05028751|584280443|FG000|Overall Study|Death|9|||
161791711|NCT05028751|584280444|FG001|Overall Study|Death|3|||
161791712|NCT05028751|584280445|FG002|Overall Study|Death|2|||
161791713|NCT05028751|584280446|FG003|Overall Study|Death|4|||
161791714|NCT05028751|584280443|FG000|Overall Study|Withdrawal by Subject|0|||
161791715|NCT05028751|584280444|FG001|Overall Study|Withdrawal by Subject|0|||
161791716|NCT05028751|584280445|FG002|Overall Study|Withdrawal by Subject|1|||
161791717|NCT05028751|584280446|FG003|Overall Study|Withdrawal by Subject|0|||
161791718|NCT05028751|584280443|FG000|Overall Study|Miscellaneous|2|||
161791719|NCT05028751|584280444|FG001|Overall Study|Miscellaneous|0|||
161791720|NCT05028751|584280445|FG002|Overall Study|Miscellaneous|0|||
161791721|NCT05028751|584280446|FG003|Overall Study|Miscellaneous|0|||
161791722|NCT03586830|584280448|FG000|Overall Study|Site terminated by Sponsor|1|||
161791723|NCT03586830|584280449|FG001|Overall Study|Site terminated by Sponsor|4|||
161791724|NCT03586830|584280450|FG002|Overall Study|Site terminated by Sponsor|3|||
161791725|NCT03586830|584280451|FG003|Overall Study|Site terminated by Sponsor|3|||
161791726|NCT03586830|584280448|FG000|Overall Study|Lost to Follow-up|0|||
161791727|NCT03586830|584280449|FG001|Overall Study|Lost to Follow-up|2|||
161791728|NCT03586830|584280450|FG002|Overall Study|Lost to Follow-up|2|||
161791729|NCT03586830|584280451|FG003|Overall Study|Lost to Follow-up|1|||
161791730|NCT03586830|584280448|FG000|Overall Study|Withdrawal by Subject|1|||
161791731|NCT03586830|584280449|FG001|Overall Study|Withdrawal by Subject|0|||
161791732|NCT03586830|584280450|FG002|Overall Study|Withdrawal by Subject|3|||
161791733|NCT03586830|584280451|FG003|Overall Study|Withdrawal by Subject|1|||
161791734|NCT00395083|584280452|FG000|Overall Study|Withdrawal by Subject|6|||
161791735|NCT00395083|584280453|FG001|Overall Study|Withdrawal by Subject|5|||
161791736|NCT00395083|584280452|FG000|Overall Study|Developed another disease|4|||
161791737|NCT00395083|584280453|FG001|Overall Study|Developed another disease|3|||
161791738|NCT00628745|584280458|FG000|Overall Study|Withdrawal by Subject|63|||
161791739|NCT00628745|584280459|FG001|Overall Study|Withdrawal by Subject|3|||
161791740|NCT00628745|584280460|FG002|Overall Study|Withdrawal by Subject|9|||
161791741|NCT00628745|584280461|FG003|Overall Study|Withdrawal by Subject|2|||
161791742|NCT00628745|584280462|FG004|Overall Study|Withdrawal by Subject|69|||
161791743|NCT00628745|584280458|FG000|Overall Study|Does not meet inclusion criteria|0|||
161791744|NCT00628745|584280459|FG001|Overall Study|Does not meet inclusion criteria|12|||
161791745|NCT00628745|584280460|FG002|Overall Study|Does not meet inclusion criteria|0|||
161791746|NCT00628745|584280461|FG003|Overall Study|Does not meet inclusion criteria|0|||
161791747|NCT00628745|584280462|FG004|Overall Study|Does not meet inclusion criteria|18|||
161791748|NCT00628745|584280458|FG000|Overall Study|Participation in an interventional clinical trial|81|||
161791749|NCT00628745|584280459|FG001|Overall Study|Participation in an interventional clinical trial|4|||
161791750|NCT00628745|584280460|FG002|Overall Study|Participation in an interventional clinical trial|7|||
161791751|NCT00628745|584280461|FG003|Overall Study|Participation in an interventional clinical trial|0|||
161791752|NCT00628745|584280462|FG004|Overall Study|Participation in an interventional clinical trial|63|||
161791753|NCT00628745|584280458|FG000|Overall Study|Physician Decision|8|||
161791754|NCT00628745|584280459|FG001|Overall Study|Physician Decision|4|||
161791755|NCT00628745|584280460|FG002|Overall Study|Physician Decision|3|||
161791756|NCT00628745|584280461|FG003|Overall Study|Physician Decision|0|||
161791757|NCT00628745|584280462|FG004|Overall Study|Physician Decision|30|||
161791758|NCT00628745|584280458|FG000|Overall Study|Lost to Follow-up|109|||
161791759|NCT00628745|584280459|FG001|Overall Study|Lost to Follow-up|7|||
161791760|NCT00628745|584280460|FG002|Overall Study|Lost to Follow-up|7|||
161791761|NCT00628745|584280461|FG003|Overall Study|Lost to Follow-up|0|||
161791762|NCT00628745|584280462|FG004|Overall Study|Lost to Follow-up|498|||
161791763|NCT00628745|584280458|FG000|Overall Study|Death|197|||
161791764|NCT00628745|584280459|FG001|Overall Study|Death|81|||
161791765|NCT00628745|584280460|FG002|Overall Study|Death|12|||
161791766|NCT00628745|584280461|FG003|Overall Study|Death|4|||
161791767|NCT00628745|584280462|FG004|Overall Study|Death|939|||
161791768|NCT00628745|584280458|FG000|Overall Study|Participant transferred to another THAOS site|6|||
161791769|NCT00628745|584280459|FG001|Overall Study|Participant transferred to another THAOS site|0|||
161791770|NCT00628745|584280460|FG002|Overall Study|Participant transferred to another THAOS site|0|||
161791771|NCT00628745|584280461|FG003|Overall Study|Participant transferred to another THAOS site|0|||
161791772|NCT00628745|584280462|FG004|Overall Study|Participant transferred to another THAOS site|7|||
161791773|NCT00628745|584280458|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
161791774|NCT00628745|584280459|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
161791775|NCT00628745|584280460|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
161791776|NCT00628745|584280461|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
162130371|NCT04157686|585528116|FG002|Overall Study|Adverse Event|1|||
161791777|NCT00628745|584280462|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
161791778|NCT00628745|584280458|FG000|Overall Study|Site closure|152|||
161791779|NCT00628745|584280459|FG001|Overall Study|Site closure|146|||
161791780|NCT00628745|584280460|FG002|Overall Study|Site closure|6|||
161791781|NCT00628745|584280461|FG003|Overall Study|Site closure|8|||
161791782|NCT00628745|584280462|FG004|Overall Study|Site closure|691|||
161791783|NCT00628745|584280458|FG000|Overall Study|Duplicate participant|0|||
161791784|NCT00628745|584280459|FG001|Overall Study|Duplicate participant|0|||
161791785|NCT00628745|584280460|FG002|Overall Study|Duplicate participant|0|||
161791786|NCT00628745|584280461|FG003|Overall Study|Duplicate participant|0|||
161791787|NCT00628745|584280462|FG004|Overall Study|Duplicate participant|1|||
161791788|NCT00628745|584280458|FG000|Overall Study|Missing|4|||
161791789|NCT00628745|584280459|FG001|Overall Study|Missing|3|||
161791790|NCT00628745|584280460|FG002|Overall Study|Missing|0|||
161791791|NCT00628745|584280461|FG003|Overall Study|Missing|0|||
161791792|NCT00628745|584280462|FG004|Overall Study|Missing|10|||
161791793|NCT00628745|584280458|FG000|Overall Study|Othe reasons|987|||
161791794|NCT00628745|584280459|FG001|Overall Study|Othe reasons|373|||
161791795|NCT00628745|584280460|FG002|Overall Study|Othe reasons|105|||
161791796|NCT00628745|584280461|FG003|Overall Study|Othe reasons|1|||
161791797|NCT00628745|584280462|FG004|Overall Study|Othe reasons|1772|||
161791798|NCT00982410|584282240|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
161791799|NCT00982410|584282241|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
161791800|NCT00982410|584282240|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
161791801|NCT00982410|584282241|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
161791802|NCT00982410|584282240|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
161791803|NCT00982410|584282241|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
161791804|NCT00982410|584282240|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
161791805|NCT00982410|584282241|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
161791806|NCT00982410|584282240|FG000|6-month Follow-up Assessment|participant no transportation|1|||
161791807|NCT00982410|584282241|FG001|6-month Follow-up Assessment|participant no transportation|0|||
161791808|NCT00982410|584282240|FG000|6-month Follow-up Assessment|incarceration|0|||
161791809|NCT00982410|584282241|FG001|6-month Follow-up Assessment|incarceration|2|||
161791810|NCT00982410|584282240|FG000|6-month Follow-up Assessment|patent surgery|0|||
161791811|NCT00982410|584282241|FG001|6-month Follow-up Assessment|patent surgery|1|||
161791812|NCT00982410|584282240|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
161791813|NCT00982410|584282241|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
161791814|NCT00982410|584282240|FG000|12-month Follow-up Assessment|Death|0|||
161791815|NCT00982410|584282241|FG001|12-month Follow-up Assessment|Death|2|||
161791816|NCT00982410|584282240|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
161791817|NCT00982410|584282241|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
161791818|NCT00982410|584282240|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
161791819|NCT00982410|584282241|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
161791820|NCT00982410|584282240|FG000|12-month Follow-up Assessment|incarceration|2|||
161791821|NCT00982410|584282241|FG001|12-month Follow-up Assessment|incarceration|1|||
161791822|NCT00982410|584282240|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
161791823|NCT00982410|584282241|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
161791824|NCT02034799|584282244|FG000|Overall Study|Withdrawal by Subject|0|||
161791825|NCT02034799|584282245|FG001|Overall Study|Withdrawal by Subject|2|||
161791826|NCT02034799|584282244|FG000|Overall Study|Lost to Follow-up|0|||
161791827|NCT02034799|584282245|FG001|Overall Study|Lost to Follow-up|1|||
161791828|NCT02034799|584282244|FG000|Overall Study|Death|2|||
161791829|NCT02034799|584282245|FG001|Overall Study|Death|1|||
161791830|NCT03381248|584282253|FG000|0-6 Months|Withdrawal by Subject|4|||
161791831|NCT03381248|584282254|FG001|0-6 Months|Withdrawal by Subject|1|||
161791832|NCT03381248|584282253|FG000|0-6 Months|Lost to Follow-up|3|||
161791833|NCT03381248|584282254|FG001|0-6 Months|Lost to Follow-up|2|||
161791834|NCT03381248|584282253|FG000|0-6 Months|Lack of Efficacy|1|||
161791835|NCT03381248|584282254|FG001|0-6 Months|Lack of Efficacy|0|||
161791836|NCT03381248|584282253|FG000|0-6 Months|Adverse Event|1|||
161791837|NCT03381248|584282254|FG001|0-6 Months|Adverse Event|0|||
161791838|NCT03381248|584282253|FG000|0-6 Months|Protocol Violation|2|||
161791839|NCT03381248|584282254|FG001|0-6 Months|Protocol Violation|1|||
161791840|NCT03381248|584282253|FG000|0-6 Months|Physician Decision|1|||
161791841|NCT03381248|584282254|FG001|0-6 Months|Physician Decision|0|||
161791842|NCT03381248|584282253|FG000|0-6 Months|Planning another procedure|1|||
161791843|NCT03381248|584282254|FG001|0-6 Months|Planning another procedure|2|||
161791844|NCT03381248|584282253|FG000|6-12 Months|Withdrawal by Subject|1|||
161791845|NCT03381248|584282254|FG001|6-12 Months|Withdrawal by Subject|3|||
161791846|NCT03381248|584282253|FG000|6-12 Months|Lost to Follow-up|0|||
161791847|NCT03381248|584282254|FG001|6-12 Months|Lost to Follow-up|2|||
161791848|NCT03381248|584282253|FG000|6-12 Months|Protocol Violation|3|||
161791849|NCT03381248|584282254|FG001|6-12 Months|Protocol Violation|2|||
161791850|NCT03381248|584282253|FG000|6-12 Months|Planning another procedure|6|||
161791851|NCT03381248|584282254|FG001|6-12 Months|Planning another procedure|2|||
161791852|NCT03381248|584282253|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
161791853|NCT03381248|584282254|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
161791854|NCT03381248|584282253|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
161791855|NCT03381248|584282254|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
161791856|NCT03381248|584282253|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
161791857|NCT03381248|584282254|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
161791858|NCT05188521|584282259|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
161791859|NCT05188521|584282260|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
161791860|NCT01341639|584282261|FG000|Infant Series|Protocol Violation|1|||
161791861|NCT01341639|584282262|FG001|Infant Series|Protocol Violation|0|||
161791862|NCT01341639|584282261|FG000|Infant Series|Not Vaccinated|0|||
161791863|NCT01341639|584282262|FG001|Infant Series|Not Vaccinated|1|||
161791864|NCT01341639|584282261|FG000|Infant Series|Adverse Event|0|||
161791865|NCT01341639|584282262|FG001|Infant Series|Adverse Event|5|||
161791866|NCT01341639|584282261|FG000|Infant Series|Withdrawal by Subject|11|||
161791867|NCT01341639|584282262|FG001|Infant Series|Withdrawal by Subject|8|||
161791868|NCT01341639|584282261|FG000|Infant Series|Lost to Follow-up|0|||
161791869|NCT01341639|584282262|FG001|Infant Series|Lost to Follow-up|2|||
161791870|NCT01341639|584282261|FG000|Infant Series|Site 0048 Participants|17|||
161791871|NCT01341639|584282262|FG001|Infant Series|Site 0048 Participants|16|||
161791872|NCT01341639|584282261|FG000|Interim Period|Withdrawal by Subject|6|||
161791873|NCT01341639|584282262|FG001|Interim Period|Withdrawal by Subject|7|||
161791874|NCT01341639|584282261|FG000|Interim Period|Lost to Follow-up|2|||
161791875|NCT01341639|584282262|FG001|Interim Period|Lost to Follow-up|0|||
161791876|NCT01341639|584282261|FG000|Interim Period|Physician Decision|0|||
161791877|NCT01341639|584282262|FG001|Interim Period|Physician Decision|1|||
161791878|NCT01341639|584282261|FG000|Interim Period|Protocol Violation|0|||
161791879|NCT01341639|584282262|FG001|Interim Period|Protocol Violation|1|||
161791880|NCT01341639|584282261|FG000|Post-Treatment|Withdrawal by Subject|0|||
161791881|NCT01341639|584282262|FG001|Post-Treatment|Withdrawal by Subject|1|||
161791882|NCT01341639|584282261|FG000|Post-Treatment|Adverse Event|0|||
161791883|NCT01341639|584282262|FG001|Post-Treatment|Adverse Event|2|||
161791884|NCT02224456|584282263|FG000|Overall Study|Lack of Efficacy|1|||
161791885|NCT02224456|584282263|FG000|Overall Study|Lost to Follow-up|15|||
161791886|NCT02224456|584282263|FG000|Overall Study|Withdrawal by Subject|9|||
161791887|NCT02224456|584282263|FG000|Overall Study|Physician Decision|3|||
161791888|NCT02224456|584282263|FG000|Overall Study|Death|2|||
161791889|NCT02224456|584282263|FG000|Overall Study|Pregnancy|4|||
161791890|NCT02224456|584282263|FG000|Overall Study|Protocol Violation|1|||
161791891|NCT02224456|584282263|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
161791892|NCT01590433|584282264|FG000|Overall Study|Lost to Follow-up|20|||
161791893|NCT01590433|584282265|FG001|Overall Study|Lost to Follow-up|8|||
161791894|NCT01590433|584282264|FG000|Overall Study|Withdrawal by Subject|21|||
161791895|NCT01590433|584282265|FG001|Overall Study|Withdrawal by Subject|11|||
161791896|NCT01590433|584282264|FG000|Overall Study|Adverse Event|11|||
161791897|NCT01590433|584282265|FG001|Overall Study|Adverse Event|3|||
161791898|NCT00322556|584282266|FG000|Overall Study|Adverse Event|1|||
161791899|NCT00322556|584282266|FG000|Overall Study|Withdrawal by Subject|1|||
161791900|NCT00322556|584282266|FG000|Overall Study|Lost to Follow-up|3|||
161791901|NCT00322556|584282266|FG000|Overall Study|Other Reason|7|||
161791902|NCT00555009|584282267|FG000|Overall Study|Withdrawal by Subject|0|||
161791903|NCT00555009|584282268|FG001|Overall Study|Withdrawal by Subject|1|||
161791904|NCT00555009|584282267|FG000|Overall Study|Terminated by Sponsor|2|||
161791905|NCT00555009|584282268|FG001|Overall Study|Terminated by Sponsor|5|||
161791906|NCT02040428|584282269|FG000|Overall Study|Death|4|||
161791907|NCT02040428|584282270|FG001|Overall Study|Death|3|||
161791908|NCT02040428|584282269|FG000|Overall Study|Withdrawal by Subject|1|||
161791909|NCT02040428|584282270|FG001|Overall Study|Withdrawal by Subject|1|||
161791910|NCT02058628|584282271|FG000|Overall Study|Adverse Event|1|||
161791911|NCT02058628|584282272|FG001|Overall Study|Adverse Event|0|||
161791912|NCT02058628|584282271|FG000|Overall Study|Withdrawal by Subject|2|||
161791913|NCT02058628|584282272|FG001|Overall Study|Withdrawal by Subject|2|||
161791914|NCT02058628|584282271|FG000|Overall Study|Lost to Follow-up|2|||
161791915|NCT02058628|584282272|FG001|Overall Study|Lost to Follow-up|4|||
161791916|NCT02058628|584282271|FG000|Overall Study|Not in time schedule|0|||
161791917|NCT02058628|584282272|FG001|Overall Study|Not in time schedule|1|||
161791918|NCT02058628|584282271|FG000|Overall Study|The visit date was not in timeline|0|||
161791919|NCT02058628|584282272|FG001|Overall Study|The visit date was not in timeline|1|||
161791920|NCT02058628|584282271|FG000|Overall Study|A lot of time for study for participant|1|||
161791921|NCT02058628|584282272|FG001|Overall Study|A lot of time for study for participant|0|||
161791922|NCT02058628|584282271|FG000|Overall Study|Non compliance|1|||
161791923|NCT02058628|584282272|FG001|Overall Study|Non compliance|0|||
161791924|NCT00832078|584282273|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
161791925|NCT00832078|584282274|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
161791926|NCT00832078|584282273|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
161791927|NCT00832078|584282274|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
161791928|NCT02961920|584282277|FG000|Overall Study|did not achive stydy protocol schedule|1|||
161791929|NCT02961920|584282278|FG001|Overall Study|did not achive stydy protocol schedule|1|||
161791930|NCT01452529|584282279|FG000|Run-in Period|Adverse Event|96|||
161791931|NCT01452529|584282280|FG001|Run-in Period|Adverse Event|0|||
161791932|NCT01452529|584282281|FG002|Run-in Period|Adverse Event|0|||
161791933|NCT01452529|584282279|FG000|Run-in Period|Withdrawal by Subject|49|||
161791934|NCT01452529|584282280|FG001|Run-in Period|Withdrawal by Subject|0|||
161791935|NCT01452529|584282281|FG002|Run-in Period|Withdrawal by Subject|0|||
161791936|NCT01452529|584282279|FG000|Run-in Period|Lost to Follow-up|19|||
161791937|NCT01452529|584282280|FG001|Run-in Period|Lost to Follow-up|0|||
161791938|NCT01452529|584282281|FG002|Run-in Period|Lost to Follow-up|0|||
161791939|NCT01452529|584282279|FG000|Run-in Period|Lack of Efficacy|46|||
161791940|NCT01452529|584282280|FG001|Run-in Period|Lack of Efficacy|0|||
161791941|NCT01452529|584282281|FG002|Run-in Period|Lack of Efficacy|0|||
161791942|NCT01452529|584282279|FG000|Run-in Period|Confirmed or suspected diversion|23|||
161791943|NCT01452529|584282280|FG001|Run-in Period|Confirmed or suspected diversion|0|||
161791944|NCT01452529|584282281|FG002|Run-in Period|Confirmed or suspected diversion|0|||
161791945|NCT01452529|584282279|FG000|Run-in Period|Administrative|21|||
161791946|NCT01452529|584282280|FG001|Run-in Period|Administrative|0|||
161791947|NCT01452529|584282281|FG002|Run-in Period|Administrative|0|||
161791948|NCT01452529|584282279|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
161791949|NCT01452529|584282280|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
161791950|NCT01452529|584282281|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
161791951|NCT01452529|584282279|FG000|Double-blind (DB) Period|Adverse Event|0|||
161791952|NCT01452529|584282280|FG001|Double-blind (DB) Period|Adverse Event|18|||
161791953|NCT01452529|584282281|FG002|Double-blind (DB) Period|Adverse Event|11|||
161791954|NCT01452529|584282279|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
161791955|NCT01452529|584282280|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
161791956|NCT01452529|584282281|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
161791957|NCT01452529|584282279|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
161791958|NCT01452529|584282280|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
161791959|NCT01452529|584282281|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
161791960|NCT01452529|584282279|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
161791961|NCT01452529|584282280|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
161791962|NCT01452529|584282281|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
161791963|NCT01452529|584282279|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
161791964|NCT01452529|584282280|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
161791965|NCT01452529|584282281|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
161791966|NCT01452529|584282279|FG000|Double-blind (DB) Period|Administrative|0|||
161791967|NCT01452529|584282280|FG001|Double-blind (DB) Period|Administrative|11|||
161791968|NCT01452529|584282281|FG002|Double-blind (DB) Period|Administrative|7|||
161791969|NCT03551730|584282282|FG000|Overall Study|Adverse Event|1|||
161791970|NCT03551730|584282283|FG001|Overall Study|Adverse Event|0|||
161791971|NCT03551730|584282284|FG002|Overall Study|Adverse Event|0|||
161791972|NCT03551730|584282285|FG003|Overall Study|Adverse Event|0|||
161791973|NCT00671879|584282286|FG000|Overall Study|Withdrawal by Subject|0|||
161791974|NCT00671879|584282287|FG001|Overall Study|Withdrawal by Subject|4|||
161791975|NCT00671879|584282288|FG002|Overall Study|Withdrawal by Subject|6|||
161791976|NCT04527471|584282291|FG000|Overall Study|Adverse Event|1|||
161791977|NCT04527471|584282292|FG001|Overall Study|Adverse Event|0|||
161791978|NCT04527471|584282291|FG000|Overall Study|Lost to Follow-up|1|||
161791979|NCT04527471|584282292|FG001|Overall Study|Lost to Follow-up|0|||
161791980|NCT01628120|584282303|FG000|Overall Study|Withdrawal by Subject|7|||
161791981|NCT01628120|584282303|FG000|Overall Study|Adverse Event|12|||
161791982|NCT01628120|584282303|FG000|Overall Study|Lost to Follow-up|1|||
161791983|NCT01628120|584282303|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
161791984|NCT01628120|584282303|FG000|Overall Study|Non-compliant with Study Procedures|1|||
161791985|NCT01628120|584282303|FG000|Overall Study|Not Treated|3|||
161791986|NCT01628120|584282303|FG000|Overall Study|Sponsor Decision|5|||
161791987|NCT01628120|584282303|FG000|Overall Study|Switched Dialysis Method|2|||
161791988|NCT01628120|584282303|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
161791989|NCT01628120|584282303|FG000|Overall Study|Moved or Relocated|5|||
161791990|NCT01628120|584282303|FG000|Overall Study|Kidney Transplant|2|||
161791991|NCT01628120|584282303|FG000|Overall Study|Use of Standard of Care|1|||
161791992|NCT01165996|584282304|FG000|Overall Study|Death|1|||
161791993|NCT01165996|584282304|FG000|Overall Study|Physician Decision|1|||
161791994|NCT00096265|584282305|FG000|Overall Study|Ineligible|1|||
161791995|NCT00096265|584282306|FG001|Overall Study|Ineligible|0|||
161791996|NCT00096265|584282307|FG002|Overall Study|Ineligible|0|||
161791997|NCT01506323|584282308|FG000|Overall Study|Lost to Follow-up|5|||
161791998|NCT01506323|584282309|FG001|Overall Study|Lost to Follow-up|4|||
161791999|NCT01506323|584282308|FG000|Overall Study|Withdrawal by Subject|4|||
161792000|NCT01506323|584282309|FG001|Overall Study|Withdrawal by Subject|4|||
161792001|NCT01506323|584282308|FG000|Overall Study|Lack of Efficacy|1|||
161792002|NCT01506323|584282309|FG001|Overall Study|Lack of Efficacy|3|||
161792003|NCT01506323|584282308|FG000|Overall Study|Moved out of area|5|||
161792004|NCT01506323|584282309|FG001|Overall Study|Moved out of area|2|||
161792005|NCT01506323|584282308|FG000|Overall Study|Schedule or Transportation conflict|8|||
161792006|NCT01506323|584282309|FG001|Overall Study|Schedule or Transportation conflict|0|||
161792007|NCT01506323|584282308|FG000|Overall Study|Started another treatment|1|||
161792008|NCT01506323|584282309|FG001|Overall Study|Started another treatment|0|||
161792009|NCT02232074|584282312|FG000|Overall Study|Withdrawal by Subject|5|||
161792010|NCT02232074|584282313|FG001|Overall Study|Withdrawal by Subject|3|||
161792011|NCT02232074|584282312|FG000|Overall Study|No legal concerns at baseline|36|||
162130372|NCT04157686|585528117|FG003|Overall Study|Adverse Event|0|||
162130373|NCT04157686|585528118|FG004|Overall Study|Adverse Event|1|||
162130374|NCT04157686|585528119|FG005|Overall Study|Adverse Event|0|||
162130375|NCT04157686|585528120|FG006|Overall Study|Adverse Event|0|||
162130376|NCT04157686|585528121|FG007|Overall Study|Adverse Event|0|||
162130377|NCT04157686|585528114|FG000|Overall Study|Pregnancy|0|||
162130378|NCT04157686|585528115|FG001|Overall Study|Pregnancy|1|||
162130379|NCT04157686|585528116|FG002|Overall Study|Pregnancy|3|||
162130380|NCT04157686|585528117|FG003|Overall Study|Pregnancy|0|||
162130381|NCT04157686|585528118|FG004|Overall Study|Pregnancy|0|||
162130382|NCT04157686|585528119|FG005|Overall Study|Pregnancy|0|||
162130383|NCT04157686|585528120|FG006|Overall Study|Pregnancy|3|||
162130384|NCT04157686|585528121|FG007|Overall Study|Pregnancy|0|||
162130385|NCT04157686|585528114|FG000|Overall Study|Lost to Follow-up|1|||
162130386|NCT04157686|585528115|FG001|Overall Study|Lost to Follow-up|2|||
162130387|NCT04157686|585528116|FG002|Overall Study|Lost to Follow-up|8|||
162130388|NCT04157686|585528117|FG003|Overall Study|Lost to Follow-up|6|||
162130389|NCT04157686|585528118|FG004|Overall Study|Lost to Follow-up|6|||
162130390|NCT04157686|585528119|FG005|Overall Study|Lost to Follow-up|3|||
162130391|NCT04157686|585528120|FG006|Overall Study|Lost to Follow-up|7|||
162130392|NCT04157686|585528121|FG007|Overall Study|Lost to Follow-up|9|||
162130393|NCT04157686|585528114|FG000|Overall Study|Lack of Efficacy|0|||
162130394|NCT04157686|585528115|FG001|Overall Study|Lack of Efficacy|0|||
162130395|NCT04157686|585528116|FG002|Overall Study|Lack of Efficacy|0|||
162130396|NCT04157686|585528117|FG003|Overall Study|Lack of Efficacy|0|||
162130397|NCT04157686|585528118|FG004|Overall Study|Lack of Efficacy|0|||
162130398|NCT04157686|585528119|FG005|Overall Study|Lack of Efficacy|2|||
162130399|NCT04157686|585528120|FG006|Overall Study|Lack of Efficacy|0|||
162130400|NCT04157686|585528121|FG007|Overall Study|Lack of Efficacy|1|||
162130401|NCT04157686|585528114|FG000|Overall Study|Withdrawal by Subject|10|||
162130402|NCT04157686|585528115|FG001|Overall Study|Withdrawal by Subject|10|||
162130403|NCT04157686|585528116|FG002|Overall Study|Withdrawal by Subject|12|||
162130404|NCT04157686|585528117|FG003|Overall Study|Withdrawal by Subject|20|||
162130405|NCT04157686|585528118|FG004|Overall Study|Withdrawal by Subject|12|||
162130406|NCT04157686|585528119|FG005|Overall Study|Withdrawal by Subject|11|||
162130407|NCT04157686|585528120|FG006|Overall Study|Withdrawal by Subject|18|||
162130408|NCT04157686|585528121|FG007|Overall Study|Withdrawal by Subject|24|||
162130409|NCT04157686|585528114|FG000|Overall Study|Physician Decision|0|||
162130410|NCT04157686|585528115|FG001|Overall Study|Physician Decision|0|||
162130411|NCT04157686|585528116|FG002|Overall Study|Physician Decision|1|||
162130412|NCT04157686|585528117|FG003|Overall Study|Physician Decision|0|||
162130413|NCT04157686|585528118|FG004|Overall Study|Physician Decision|1|||
162130414|NCT04157686|585528119|FG005|Overall Study|Physician Decision|0|||
162130415|NCT04157686|585528120|FG006|Overall Study|Physician Decision|3|||
162130416|NCT04157686|585528121|FG007|Overall Study|Physician Decision|0|||
162130417|NCT04157686|585528114|FG000|Overall Study|Death|0|||
162130418|NCT04157686|585528115|FG001|Overall Study|Death|0|||
162130419|NCT04157686|585528116|FG002|Overall Study|Death|0|||
162130420|NCT04157686|585528117|FG003|Overall Study|Death|2|||
162130421|NCT04157686|585528118|FG004|Overall Study|Death|0|||
162130422|NCT04157686|585528119|FG005|Overall Study|Death|0|||
162130423|NCT04157686|585528120|FG006|Overall Study|Death|0|||
162130424|NCT04157686|585528121|FG007|Overall Study|Death|0|||
162130425|NCT04157686|585528114|FG000|Overall Study|Protocol Violation|0|||
162130426|NCT04157686|585528115|FG001|Overall Study|Protocol Violation|0|||
162130427|NCT04157686|585528116|FG002|Overall Study|Protocol Violation|0|||
162130428|NCT04157686|585528117|FG003|Overall Study|Protocol Violation|0|||
162130429|NCT04157686|585528118|FG004|Overall Study|Protocol Violation|1|||
162130430|NCT04157686|585528119|FG005|Overall Study|Protocol Violation|0|||
162130431|NCT04157686|585528120|FG006|Overall Study|Protocol Violation|0|||
162130432|NCT04157686|585528121|FG007|Overall Study|Protocol Violation|0|||
161792012|NCT02232074|584282313|FG001|Overall Study|No legal concerns at baseline|41|||
161792013|NCT02232074|584282312|FG000|Overall Study|deemed ineligible|0|||
161792014|NCT02232074|584282313|FG001|Overall Study|deemed ineligible|1|||
162130433|NCT04157686|585528114|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
162130434|NCT04157686|585528115|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
162130435|NCT04157686|585528116|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
162130436|NCT04157686|585528117|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
162130437|NCT04157686|585528118|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
162130438|NCT04157686|585528119|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
162130439|NCT04157686|585528120|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
162130440|NCT04157686|585528121|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
162130441|NCT04445155|585528122|FG000|Overall Study|Lost to Follow-up|11|||
162130442|NCT04445155|585528123|FG001|Overall Study|Lost to Follow-up|2|||
162130443|NCT04445155|585528124|FG002|Overall Study|Lost to Follow-up|3|||
162130444|NCT04445155|585528125|FG003|Overall Study|Lost to Follow-up|0|||
162130445|NCT04445155|585528122|FG000|Overall Study|Withdrawal by Subject|8|||
162130446|NCT04445155|585528123|FG001|Overall Study|Withdrawal by Subject|0|||
162130447|NCT04445155|585528124|FG002|Overall Study|Withdrawal by Subject|0|||
161792015|NCT01927757|584282314|FG000|Overall Study|Withdrawal by Subject|14|||
161792016|NCT01927757|584282314|FG000|Overall Study|Lost to Follow-up|2|||
161792017|NCT01927757|584282314|FG000|Overall Study|Decision by Sponsor|2|||
161898822|NCT03428100|584677907|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
162130448|NCT04445155|585528125|FG003|Overall Study|Withdrawal by Subject|0|||
161792018|NCT01927757|584282314|FG000|Overall Study|Other|1|||
161792019|NCT01927757|584282314|FG000|Overall Study|Ethical Reasons|4|||
161792020|NCT00444795|584282316|FG000|Overall Study|Not Treated|1|||
161792021|NCT00444795|584282316|FG000|Overall Study|Treated Prior to the Contract Date|2|||
162130449|NCT04445155|585528122|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
162130450|NCT04445155|585528123|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
162130451|NCT04445155|585528124|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
162130452|NCT04445155|585528125|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
161792022|NCT00988169|584282317|FG000|Overall Study|Withdrawal by Subject|1|||
161792023|NCT00704418|584282318|FG000|Overall Study|Withdrawal by Subject|2|||
162130453|NCT04445155|585528122|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
162130454|NCT04445155|585528123|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
162130455|NCT04445155|585528124|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
162130456|NCT04445155|585528125|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
162130457|NCT01556243|585528130|FG000|Overall Study|Ineligible|34|||
162130458|NCT01556243|585528130|FG000|Overall Study|Converted to mastectomy|14|||
162130459|NCT01556243|585528130|FG000|Overall Study|Unable to achieve negative margins|2|||
162130460|NCT01556243|585528130|FG000|Overall Study|Withdrawal by Subject|16|||
162130461|NCT01388543|585528131|FG000|Day 14|Adverse Event|1|||
162130462|NCT01388543|585528132|FG001|Day 14|Adverse Event|4|||
162130463|NCT04684914|585528133|FG000|Overall Study|Withdrawal by Subject|1|||
162130464|NCT04684914|585528134|FG001|Overall Study|Withdrawal by Subject|0|||
162130465|NCT04684914|585528133|FG000|Overall Study|Discontinued before receiving study treatment|1|||
162130466|NCT04684914|585528134|FG001|Overall Study|Discontinued before receiving study treatment|2|||
162130467|NCT03363659|585528135|FG000|Overall Study|Adverse Event|1|||
162130468|NCT03363659|585528135|FG000|Overall Study|Screen fail|1|||
162130469|NCT03363659|585528135|FG000|Overall Study|Withdrawal by Subject|1|||
162130470|NCT02353832|585528136|FG000|Overall Study|Ineligible after enrollment|1|||
162130471|NCT02353832|585528136|FG000|Overall Study|Lost to Follow-up|1|||
162130472|NCT00904150|585528137|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
162130473|NCT00904150|585528138|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
162130474|NCT00904150|585528137|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
162130475|NCT00904150|585528138|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
162130476|NCT01671748|585528139|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
162130477|NCT01671748|585528140|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
162130478|NCT01671748|585528139|FG000|4 Week run-in Phase|Adverse Event|1|||
162130479|NCT01671748|585528140|FG001|4 Week run-in Phase|Adverse Event|0|||
162130480|NCT01671748|585528139|FG000|4 Week run-in Phase|Not eligible|9|||
162130481|NCT01671748|585528140|FG001|4 Week run-in Phase|Not eligible|0|||
162130482|NCT03872388|585528143|FG000|Overall Study|Disease Progression|0|||
162130483|NCT03872388|585528144|FG001|Overall Study|Disease Progression|0|||
162130484|NCT03872388|585528145|FG002|Overall Study|Disease Progression|0|||
162130485|NCT03872388|585528146|FG003|Overall Study|Disease Progression|0|||
162130486|NCT03872388|585528147|FG004|Overall Study|Disease Progression|0|||
162130487|NCT03872388|585528148|FG005|Overall Study|Disease Progression|0|||
162130488|NCT03872388|585528149|FG006|Overall Study|Disease Progression|1|||
162130489|NCT03872388|585528150|FG007|Overall Study|Disease Progression|1|||
162130490|NCT04191135|585528151|FG000|Induction Treatment|Not Treated|2|||
162130491|NCT04191135|585528152|FG001|Induction Treatment|Not Treated|0|||
162130492|NCT04191135|585528153|FG002|Induction Treatment|Not Treated|0|||
162130493|NCT04191135|585528151|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
162130494|NCT04191135|585528152|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
162130495|NCT04191135|585528153|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
162130496|NCT04191135|585528151|FG000|Induction Treatment|Adverse Event|25|||
162130497|NCT04191135|585528152|FG001|Induction Treatment|Adverse Event|0|||
161792024|NCT00704418|584282319|FG001|Overall Study|Withdrawal by Subject|0|||
161792025|NCT00704418|584282318|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
161792026|NCT00704418|584282319|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
161792027|NCT02637076|584282320|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
161792028|NCT02637076|584282321|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
161792029|NCT02637076|584282320|FG000|Overall Study|Withdrawal by Subject|0|||
161792030|NCT02637076|584282321|FG001|Overall Study|Withdrawal by Subject|4|||
162130498|NCT04191135|585528153|FG002|Induction Treatment|Adverse Event|0|||
162130499|NCT04191135|585528151|FG000|Induction Treatment|Clinical Progression|8|||
162130500|NCT04191135|585528152|FG001|Induction Treatment|Clinical Progression|0|||
161792031|NCT00130520|584282322|FG000|Overall Study|Adverse Event|11|||
161792032|NCT00130520|584282322|FG000|Overall Study|Death|1|||
161792033|NCT00130520|584282322|FG000|Overall Study|Physician Decision|1|||
161792034|NCT00130520|584282322|FG000|Overall Study|Withdrawal by Subject|1|||
161792035|NCT00130520|584282322|FG000|Overall Study|Disease Progression|23|||
161792036|NCT00130520|584282322|FG000|Overall Study|Protocol non-compliance|1|||
161792037|NCT00130520|584282322|FG000|Overall Study|Did not meet re-treatment criteria|1|||
161792038|NCT01464827|584282323|FG000|Overall Study|Adverse Event|0|||
161792039|NCT01464827|584282324|FG001|Overall Study|Adverse Event|0|||
161792040|NCT01464827|584282325|FG002|Overall Study|Adverse Event|0|||
161792041|NCT01464827|584282326|FG003|Overall Study|Adverse Event|0|||
161792042|NCT01464827|584282327|FG004|Overall Study|Adverse Event|0|||
161792043|NCT01464827|584282328|FG005|Overall Study|Adverse Event|0|||
161792044|NCT01464827|584282329|FG006|Overall Study|Adverse Event|0|||
161792045|NCT01464827|584282330|FG007|Overall Study|Adverse Event|0|||
161792046|NCT01464827|584282331|FG008|Overall Study|Adverse Event|0|||
161792047|NCT01464827|584282332|FG009|Overall Study|Adverse Event|0|||
161792048|NCT01464827|584282333|FG010|Overall Study|Adverse Event|0|||
161792049|NCT01464827|584282334|FG011|Overall Study|Adverse Event|0|||
161792050|NCT01464827|584282335|FG012|Overall Study|Adverse Event|1|||
161792051|NCT01464827|584282336|FG013|Overall Study|Adverse Event|0|||
161792052|NCT01464827|584282323|FG000|Overall Study|Withdrawal by Subject|1|||
161792053|NCT01464827|584282324|FG001|Overall Study|Withdrawal by Subject|0|||
161792054|NCT01464827|584282325|FG002|Overall Study|Withdrawal by Subject|0|||
161792055|NCT01464827|584282326|FG003|Overall Study|Withdrawal by Subject|0|||
161792056|NCT01464827|584282327|FG004|Overall Study|Withdrawal by Subject|1|||
161792057|NCT01464827|584282328|FG005|Overall Study|Withdrawal by Subject|0|||
161792058|NCT01464827|584282329|FG006|Overall Study|Withdrawal by Subject|0|||
161792059|NCT01464827|584282330|FG007|Overall Study|Withdrawal by Subject|1|||
161792060|NCT01464827|584282331|FG008|Overall Study|Withdrawal by Subject|0|||
161792061|NCT01464827|584282332|FG009|Overall Study|Withdrawal by Subject|0|||
161792062|NCT01464827|584282333|FG010|Overall Study|Withdrawal by Subject|0|||
161792063|NCT01464827|584282334|FG011|Overall Study|Withdrawal by Subject|0|||
161792064|NCT01464827|584282335|FG012|Overall Study|Withdrawal by Subject|0|||
161792065|NCT01464827|584282336|FG013|Overall Study|Withdrawal by Subject|0|||
161792066|NCT01464827|584282323|FG000|Overall Study|Lost to Follow-up|0|||
161792067|NCT01464827|584282324|FG001|Overall Study|Lost to Follow-up|2|||
161792068|NCT01464827|584282325|FG002|Overall Study|Lost to Follow-up|0|||
161792069|NCT01464827|584282326|FG003|Overall Study|Lost to Follow-up|2|||
161792070|NCT01464827|584282327|FG004|Overall Study|Lost to Follow-up|3|||
161792071|NCT01464827|584282328|FG005|Overall Study|Lost to Follow-up|1|||
161792072|NCT01464827|584282329|FG006|Overall Study|Lost to Follow-up|2|||
161792073|NCT01464827|584282330|FG007|Overall Study|Lost to Follow-up|2|||
161792074|NCT01464827|584282331|FG008|Overall Study|Lost to Follow-up|0|||
161792075|NCT01464827|584282332|FG009|Overall Study|Lost to Follow-up|0|||
161792076|NCT01464827|584282333|FG010|Overall Study|Lost to Follow-up|0|||
161792077|NCT01464827|584282334|FG011|Overall Study|Lost to Follow-up|1|||
161792078|NCT01464827|584282335|FG012|Overall Study|Lost to Follow-up|0|||
161792079|NCT01464827|584282336|FG013|Overall Study|Lost to Follow-up|1|||
161792080|NCT01464827|584282323|FG000|Overall Study|Other|2|||
161792081|NCT01464827|584282324|FG001|Overall Study|Other|3|||
162130501|NCT04191135|585528153|FG002|Induction Treatment|Clinical Progression|0|||
162130502|NCT04191135|585528151|FG000|Induction Treatment|Excluded Medication|1|||
161792082|NCT01464827|584282325|FG002|Overall Study|Other|0|||
161792083|NCT01464827|584282326|FG003|Overall Study|Other|2|||
161792084|NCT01464827|584282327|FG004|Overall Study|Other|3|||
161792085|NCT01464827|584282328|FG005|Overall Study|Other|0|||
161792086|NCT01464827|584282329|FG006|Overall Study|Other|1|||
161792087|NCT01464827|584282330|FG007|Overall Study|Other|0|||
161792088|NCT01464827|584282331|FG008|Overall Study|Other|3|||
162130503|NCT04191135|585528152|FG001|Induction Treatment|Excluded Medication|0|||
162130504|NCT04191135|585528153|FG002|Induction Treatment|Excluded Medication|0|||
161792089|NCT01464827|584282332|FG009|Overall Study|Other|1|||
162130505|NCT04191135|585528151|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
162130506|NCT04191135|585528152|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
161898823|NCT03428100|584677908|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898824|NCT03428100|584677909|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898825|NCT03428100|584677910|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
162130507|NCT04191135|585528153|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
161792090|NCT01464827|584282333|FG010|Overall Study|Other|2|||
161792091|NCT01464827|584282334|FG011|Overall Study|Other|0|||
161792092|NCT01464827|584282335|FG012|Overall Study|Other|1|||
161792093|NCT01464827|584282336|FG013|Overall Study|Other|0|||
161792094|NCT01464827|584282323|FG000|Overall Study|Not Treated|0|||
161792095|NCT01464827|584282324|FG001|Overall Study|Not Treated|2|||
161792096|NCT01464827|584282325|FG002|Overall Study|Not Treated|0|||
161792097|NCT01464827|584282326|FG003|Overall Study|Not Treated|0|||
161792098|NCT01464827|584282327|FG004|Overall Study|Not Treated|1|||
161792099|NCT01464827|584282328|FG005|Overall Study|Not Treated|0|||
162130508|NCT04191135|585528151|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
162130509|NCT04191135|585528152|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
162130510|NCT04191135|585528153|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
162130511|NCT04191135|585528151|FG000|Induction Treatment|Physician Decision|2|||
162130512|NCT04191135|585528152|FG001|Induction Treatment|Physician Decision|0|||
162130513|NCT04191135|585528153|FG002|Induction Treatment|Physician Decision|0|||
162130514|NCT04191135|585528151|FG000|Induction Treatment|Progressive Disease|135|||
162130515|NCT04191135|585528152|FG001|Induction Treatment|Progressive Disease|0|||
162130516|NCT04191135|585528153|FG002|Induction Treatment|Progressive Disease|0|||
162130517|NCT04191135|585528151|FG000|Induction Treatment|Protocol Violation|10|||
162130518|NCT04191135|585528152|FG001|Induction Treatment|Protocol Violation|0|||
162130519|NCT04191135|585528153|FG002|Induction Treatment|Protocol Violation|0|||
162130520|NCT04191135|585528151|FG000|Induction Treatment|Withdrawal by Subject|4|||
162130521|NCT04191135|585528152|FG001|Induction Treatment|Withdrawal by Subject|0|||
162130522|NCT04191135|585528153|FG002|Induction Treatment|Withdrawal by Subject|0|||
162130523|NCT04191135|585528151|FG000|Randomized Treatment|Death|0|||
162130524|NCT04191135|585528152|FG001|Randomized Treatment|Death|50|||
162130525|NCT04191135|585528153|FG002|Randomized Treatment|Death|54|||
162130526|NCT04191135|585528151|FG000|Randomized Treatment|Lost to Follow-up|0|||
162130527|NCT04191135|585528152|FG001|Randomized Treatment|Lost to Follow-up|0|||
162130528|NCT04191135|585528153|FG002|Randomized Treatment|Lost to Follow-up|1|||
162130529|NCT04191135|585528151|FG000|Randomized Treatment|Withdrawal by Subject|0|||
162130530|NCT04191135|585528152|FG001|Randomized Treatment|Withdrawal by Subject|2|||
162130531|NCT04191135|585528153|FG002|Randomized Treatment|Withdrawal by Subject|0|||
162130532|NCT04191135|585528151|FG000|Randomized Treatment|Ongoing in Trial|0|||
162130533|NCT04191135|585528152|FG001|Randomized Treatment|Ongoing in Trial|83|||
162130534|NCT04191135|585528153|FG002|Randomized Treatment|Ongoing in Trial|81|||
162130535|NCT02107274|585529884|FG000|Treatment vs. Placebo|Adverse Event|3|||
162130536|NCT02107274|585529885|FG001|Treatment vs. Placebo|Adverse Event|0|||
162130537|NCT02107274|585529884|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
162130538|NCT02107274|585529885|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
162130539|NCT02107274|585529884|FG000|Control Phase|Lost to Follow-up|1|||
162130540|NCT02107274|585529885|FG001|Control Phase|Lost to Follow-up|1|||
162130541|NCT02107274|585529884|FG000|Control Phase|Death|2|||
162130542|NCT02107274|585529885|FG001|Control Phase|Death|0|||
162130543|NCT02107274|585529884|FG000|Control Phase|Adverse Event|0|||
162130544|NCT02107274|585529885|FG001|Control Phase|Adverse Event|1|||
162130545|NCT05305040|585529888|FG000|Overall Study|Not Dosed|37|||
161792100|NCT01464827|584282329|FG006|Overall Study|Not Treated|1|||
161792101|NCT01464827|584282330|FG007|Overall Study|Not Treated|0|||
161792102|NCT01464827|584282331|FG008|Overall Study|Not Treated|0|||
161792103|NCT01464827|584282332|FG009|Overall Study|Not Treated|2|||
161792104|NCT01464827|584282333|FG010|Overall Study|Not Treated|0|||
161792105|NCT01464827|584282334|FG011|Overall Study|Not Treated|1|||
161792106|NCT01464827|584282335|FG012|Overall Study|Not Treated|0|||
161792107|NCT01464827|584282336|FG013|Overall Study|Not Treated|2|||
161792108|NCT01075763|584282337|FG000|Overall Study|Lost to Follow-up|2|||
161792109|NCT01075763|584282338|FG001|Overall Study|Lost to Follow-up|1|||
161792110|NCT01075763|584282337|FG000|Overall Study|Lack of Efficacy|0|||
161792111|NCT01075763|584282338|FG001|Overall Study|Lack of Efficacy|1|||
161792112|NCT01075763|584282337|FG000|Overall Study|Withdrawal by Subject|2|||
161792113|NCT01075763|584282338|FG001|Overall Study|Withdrawal by Subject|2|||
161792114|NCT00586521|584282339|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
161792115|NCT03083483|584282343|FG000|Overall Study|Adverse Event|1|||
161792116|NCT03083483|584282344|FG001|Overall Study|Adverse Event|1|||
161792117|NCT03083483|584282345|FG002|Overall Study|Adverse Event|1|||
161792118|NCT03083483|584282343|FG000|Overall Study|Lost to Follow-up|2|||
161792119|NCT03083483|584282344|FG001|Overall Study|Lost to Follow-up|1|||
161792120|NCT03083483|584282345|FG002|Overall Study|Lost to Follow-up|1|||
162130546|NCT05305040|585529889|FG001|Overall Study|Not Dosed|37|||
162130547|NCT05305040|585529888|FG000|Overall Study|Study Closure|34|||
162130548|NCT05305040|585529889|FG001|Overall Study|Study Closure|46|||
162130549|NCT05305040|585529888|FG000|Overall Study|Death|14|||
162130550|NCT05305040|585529889|FG001|Overall Study|Death|13|||
162130551|NCT05305040|585529888|FG000|Overall Study|Withdrawal by Subject|15|||
162130552|NCT05305040|585529889|FG001|Overall Study|Withdrawal by Subject|10|||
162130553|NCT05305040|585529888|FG000|Overall Study|Other|13|||
162130554|NCT05305040|585529889|FG001|Overall Study|Other|10|||
162130555|NCT05305040|585529888|FG000|Overall Study|Primary Malignancy Relapse|3|||
162130556|NCT05305040|585529889|FG001|Overall Study|Primary Malignancy Relapse|4|||
162130557|NCT05305040|585529888|FG000|Overall Study|Adverse Event|3|||
161792121|NCT03083483|584282343|FG000|Overall Study|technological issues|1|||
161792122|NCT03083483|584282344|FG001|Overall Study|technological issues|0|||
161792123|NCT03083483|584282345|FG002|Overall Study|technological issues|1|||
161792124|NCT02710071|584282346|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
161792125|NCT02710071|584282347|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
162130558|NCT05305040|585529889|FG001|Overall Study|Adverse Event|3|||
162130559|NCT05305040|585529888|FG000|Overall Study|Lost to Follow-up|2|||
161792126|NCT02710071|584282346|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
161792127|NCT02710071|584282347|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
161792128|NCT04604184|584282354|FG000|Overall Study|Adverse Event|5|||
161792129|NCT04604184|584282355|FG001|Overall Study|Adverse Event|5|||
161792130|NCT04604184|584282354|FG000|Overall Study|Death|2|||
161792131|NCT04604184|584282355|FG001|Overall Study|Death|1|||
161792132|NCT04604184|584282354|FG000|Overall Study|Withdrawal by Subject|1|||
161792133|NCT04604184|584282355|FG001|Overall Study|Withdrawal by Subject|3|||
161792134|NCT04604184|584282354|FG000|Overall Study|Not treated|2|||
161792135|NCT04604184|584282355|FG001|Overall Study|Not treated|2|||
161898826|NCT03428100|584677911|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161898827|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161898828|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161898829|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161792136|NCT04604184|584282354|FG000|Overall Study|Due to sponsor decision|9|||
161792137|NCT04604184|584282355|FG001|Overall Study|Due to sponsor decision|7|||
161792138|NCT04604184|584282354|FG000|Overall Study|Physician Decision|0|||
161792139|NCT04604184|584282355|FG001|Overall Study|Physician Decision|1|||
161792140|NCT04604184|584282354|FG000|Overall Study|Transfer to healthcare|1|||
161792141|NCT04604184|584282355|FG001|Overall Study|Transfer to healthcare|0|||
161792142|NCT01751412|584282356|FG000|Overall Study|Disease Progression Before Treatment|1|||
161792143|NCT03734237|584282357|FG000|Overall Study|Lost to Follow-up|1|||
161792144|NCT03734237|584282358|FG001|Overall Study|Lost to Follow-up|3|||
161792145|NCT03734237|584282359|FG002|Overall Study|Lost to Follow-up|0|||
161792146|NCT03734237|584282357|FG000|Overall Study|Withdrawal by Subject|7|||
161792147|NCT03734237|584282358|FG001|Overall Study|Withdrawal by Subject|9|||
161792148|NCT03734237|584282359|FG002|Overall Study|Withdrawal by Subject|10|||
161792149|NCT01844583|584282360|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
161792150|NCT01844583|584282361|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
161792151|NCT01625377|584282362|FG000|Overall Study|Death|1|||
161792152|NCT01625377|584282363|FG001|Overall Study|Death|1|||
161792153|NCT01625377|584282362|FG000|Overall Study|Administrative Problem|1|||
161792154|NCT01625377|584282363|FG001|Overall Study|Administrative Problem|1|||
161792155|NCT01625377|584282362|FG000|Overall Study|Protocol Violation|0|||
161792156|NCT01625377|584282363|FG001|Overall Study|Protocol Violation|3|||
161792157|NCT01625377|584282362|FG000|Overall Study|Adverse Event|3|||
161792158|NCT01625377|584282363|FG001|Overall Study|Adverse Event|16|||
161792159|NCT01625377|584282362|FG000|Overall Study|Graft loss|1|||
161792160|NCT01625377|584282363|FG001|Overall Study|Graft loss|0|||
161792161|NCT01625377|584282362|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161792162|NCT01625377|584282363|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161792163|NCT01625377|584282362|FG000|Overall Study|Abnormal laboratory values|1|||
161792164|NCT01625377|584282363|FG001|Overall Study|Abnormal laboratory values|0|||
161792165|NCT00958256|584282365|FG000|Overall Study|Adverse Event|3|||
161792166|NCT05431153|584282366|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161792167|NCT05431153|584282367|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161792168|NCT05431153|584282368|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161792169|NCT05431153|584282369|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161792170|NCT05431153|584282370|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
161792171|NCT05431153|584282371|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161792172|NCT00678392|584282372|FG000|Overall Study|Adverse Event|0|||
161792173|NCT00678392|584282373|FG001|Overall Study|Adverse Event|6|||
161792174|NCT00678392|584282372|FG000|Overall Study|Death|280|||
161792175|NCT00678392|584282373|FG001|Overall Study|Death|269|||
161792176|NCT00678392|584282372|FG000|Overall Study|Lost to Follow-up|15|||
161792177|NCT00678392|584282373|FG001|Overall Study|Lost to Follow-up|13|||
161792178|NCT00678392|584282372|FG000|Overall Study|Objective Progression or Relapse|3|||
161792179|NCT00678392|584282373|FG001|Overall Study|Objective Progression or Relapse|8|||
161792180|NCT00678392|584282372|FG000|Overall Study|Sponsor's Decision|1|||
161792181|NCT00678392|584282373|FG001|Overall Study|Sponsor's Decision|2|||
161792182|NCT00678392|584282372|FG000|Overall Study|Withdrawal by Subject|4|||
161792183|NCT00678392|584282373|FG001|Overall Study|Withdrawal by Subject|4|||
161792184|NCT00678392|584282372|FG000|Overall Study|Randomized But Not Treated|2|||
161898830|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161898831|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161792185|NCT00678392|584282373|FG001|Overall Study|Randomized But Not Treated|7|||
161792186|NCT00678392|584282372|FG000|Overall Study|Other|56|||
161792187|NCT00678392|584282373|FG001|Overall Study|Other|53|||
161898832|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
162130560|NCT05305040|585529889|FG001|Overall Study|Lost to Follow-up|1|||
161792188|NCT03341507|584282374|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
161792189|NCT00989261|584282376|FG000|Overall Study|Still in follow up|12|||
161792190|NCT00989261|584282377|FG001|Overall Study|Still in follow up|21|||
161792191|NCT00989261|584282376|FG000|Overall Study|Withdrawal by Subject|0|||
161792192|NCT00989261|584282377|FG001|Overall Study|Withdrawal by Subject|1|||
161792193|NCT00989261|584282376|FG000|Overall Study|Lost to Follow-up|3|||
161792194|NCT00989261|584282377|FG001|Overall Study|Lost to Follow-up|0|||
161792195|NCT00782509|584282378|FG000|Overall Study|Adverse Event|20|||
161792196|NCT00782509|584282379|FG001|Overall Study|Adverse Event|10|||
161792197|NCT00782509|584282380|FG002|Overall Study|Adverse Event|20|||
161792198|NCT00782509|584282378|FG000|Overall Study|Lost to Follow-up|1|||
161792199|NCT00782509|584282379|FG001|Overall Study|Lost to Follow-up|2|||
161792200|NCT00782509|584282380|FG002|Overall Study|Lost to Follow-up|3|||
161792201|NCT00782509|584282378|FG000|Overall Study|Withdrawal by Subject|3|||
161792202|NCT00782509|584282379|FG001|Overall Study|Withdrawal by Subject|5|||
161792203|NCT00782509|584282380|FG002|Overall Study|Withdrawal by Subject|8|||
161792204|NCT00782509|584282378|FG000|Overall Study|Non compliance with protocol|2|||
161792205|NCT00782509|584282379|FG001|Overall Study|Non compliance with protocol|0|||
161792206|NCT00782509|584282380|FG002|Overall Study|Non compliance with protocol|0|||
161792207|NCT00782509|584282378|FG000|Overall Study|Other reasons not stated above|5|||
161792208|NCT00782509|584282379|FG001|Overall Study|Other reasons not stated above|2|||
161792209|NCT00782509|584282380|FG002|Overall Study|Other reasons not stated above|3|||
161792210|NCT00782509|584282378|FG000|Overall Study|Lack of Efficacy|10|||
161792211|NCT00782509|584282379|FG001|Overall Study|Lack of Efficacy|5|||
161792212|NCT00782509|584282380|FG002|Overall Study|Lack of Efficacy|2|||
161792213|NCT01401478|584282391|FG000|Overall Study|Study drug not available|6|||
161792214|NCT01401478|584282391|FG000|Overall Study|Adverse Event|5|||
161792215|NCT01401478|584282391|FG000|Overall Study|Hyperphosphatemia|5|||
161792216|NCT01401478|584282391|FG000|Overall Study|Lost to Follow-up|5|||
161792217|NCT01401478|584282391|FG000|Overall Study|Kidney transplantation|3|||
161792218|NCT01401478|584282391|FG000|Overall Study|Withdrawal by Subject|3|||
161792219|NCT01401478|584282391|FG000|Overall Study|Blood samples not available|1|||
161792220|NCT01401478|584282391|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
161792221|NCT01401478|584282391|FG000|Overall Study|Low intact parathyroid hormone|1|||
161792222|NCT01401478|584282391|FG000|Overall Study|Serious adverse event|1|||
161792223|NCT01814137|584282393|FG000|Overall Study|Adverse Event|0|||
161792224|NCT01814137|584282394|FG001|Overall Study|Adverse Event|1|||
161792225|NCT01814137|584282393|FG000|Overall Study|Withdrawal by Subject|2|||
161792226|NCT01814137|584282394|FG001|Overall Study|Withdrawal by Subject|2|||
161792227|NCT01814137|584282393|FG000|Overall Study|Physician Decision|1|||
161792228|NCT01814137|584282394|FG001|Overall Study|Physician Decision|1|||
161792229|NCT01814137|584282393|FG000|Overall Study|Unclassified|2|||
161792230|NCT01814137|584282394|FG001|Overall Study|Unclassified|1|||
161792231|NCT01798485|584282395|FG000|Overall Study|Adverse Event|32|||
161792232|NCT01798485|584282396|FG001|Overall Study|Adverse Event|40|||
161792233|NCT01798485|584282395|FG000|Overall Study|Withdrawal by Subject|27|||
161792234|NCT01798485|584282396|FG001|Overall Study|Withdrawal by Subject|31|||
161792235|NCT01798485|584282395|FG000|Overall Study|Lost to Follow-up|0|||
161792236|NCT01798485|584282396|FG001|Overall Study|Lost to Follow-up|3|||
161792237|NCT01798485|584282395|FG000|Overall Study|Physician Decision|14|||
161792238|NCT01798485|584282396|FG001|Overall Study|Physician Decision|10|||
161792239|NCT01798485|584282395|FG000|Overall Study|Objective Disease Progression|152|||
161792240|NCT01798485|584282396|FG001|Overall Study|Objective Disease Progression|106|||
161792241|NCT01798485|584282395|FG000|Overall Study|Death|25|||
161792242|NCT01798485|584282396|FG001|Overall Study|Death|22|||
161792243|NCT01798485|584282395|FG000|Overall Study|Sponsor Decision|61|||
161792244|NCT01798485|584282396|FG001|Overall Study|Sponsor Decision|54|||
161792245|NCT01798485|584282395|FG000|Overall Study|Clinical Progression|35|||
161792246|NCT01798485|584282396|FG001|Overall Study|Clinical Progression|24|||
161792247|NCT00770991|584282397|FG000|Overall Study|Physician Decision|2|||
161792248|NCT00770991|584282398|FG001|Overall Study|Physician Decision|0|||
161792249|NCT00770991|584282397|FG000|Overall Study|Withdrawal by Subject|1|||
161792250|NCT00770991|584282398|FG001|Overall Study|Withdrawal by Subject|0|||
161792251|NCT00770991|584282397|FG000|Overall Study|Adverse Event|1|||
161792252|NCT00770991|584282398|FG001|Overall Study|Adverse Event|5|||
161792253|NCT00770991|584282397|FG000|Overall Study|Pregnancy|1|||
161792254|NCT00770991|584282398|FG001|Overall Study|Pregnancy|0|||
161792255|NCT03687125|584282399|FG000|Overall Study|Progressive Disease|2|||
161792256|NCT03687125|584282400|FG001|Overall Study|Progressive Disease|1|||
161792257|NCT03687125|584282399|FG000|Overall Study|Protocol Violation|1|||
161792258|NCT03687125|584282400|FG001|Overall Study|Protocol Violation|0|||
161792259|NCT00633152|584284347|FG000|Overall Study|Adverse Event|1|||
161792260|NCT00633152|584284348|FG001|Overall Study|Adverse Event|0|||
161792261|NCT00633152|584284347|FG000|Overall Study|Randomized, did not receive study drug|5|||
161792262|NCT00633152|584284348|FG001|Overall Study|Randomized, did not receive study drug|2|||
161792263|NCT00633152|584284347|FG000|Overall Study|Withdrawal by Subject|1|||
161792264|NCT00633152|584284348|FG001|Overall Study|Withdrawal by Subject|1|||
161792265|NCT00633152|584284347|FG000|Overall Study|Lost to Follow-up|4|||
161792266|NCT00633152|584284348|FG001|Overall Study|Lost to Follow-up|1|||
161792267|NCT00633152|584284347|FG000|Overall Study|Miscellaneous Other|3|||
161792268|NCT00633152|584284348|FG001|Overall Study|Miscellaneous Other|2|||
161792269|NCT02180061|584284349|FG000|Overall Study|Adverse Event|4|||
161792270|NCT02180061|584284350|FG001|Overall Study|Adverse Event|2|||
161792271|NCT02180061|584284349|FG000|Overall Study|Clinical Progression|5|||
161792272|NCT02180061|584284350|FG001|Overall Study|Clinical Progression|1|||
161792273|NCT02180061|584284349|FG000|Overall Study|Progressive Disease|15|||
161792274|NCT02180061|584284350|FG001|Overall Study|Progressive Disease|5|||
161792275|NCT02180061|584284349|FG000|Overall Study|Physician Decision|1|||
161792276|NCT02180061|584284350|FG001|Overall Study|Physician Decision|0|||
161792277|NCT01579474|584284351|FG000|Overall Study|Adverse Event|1|||
161792278|NCT01579474|584284352|FG001|Overall Study|Adverse Event|13|||
161792279|NCT01579474|584284353|FG002|Overall Study|Adverse Event|2|||
161792280|NCT01579474|584284354|FG003|Overall Study|Adverse Event|0|||
161792281|NCT01579474|584284355|FG004|Overall Study|Adverse Event|0|||
161792282|NCT01579474|584284356|FG005|Overall Study|Adverse Event|1|||
161792283|NCT01579474|584284351|FG000|Overall Study|Lack of Efficacy|1|||
161792284|NCT01579474|584284352|FG001|Overall Study|Lack of Efficacy|0|||
161792285|NCT01579474|584284353|FG002|Overall Study|Lack of Efficacy|0|||
161792286|NCT01579474|584284354|FG003|Overall Study|Lack of Efficacy|0|||
161792287|NCT01579474|584284355|FG004|Overall Study|Lack of Efficacy|1|||
161792288|NCT01579474|584284356|FG005|Overall Study|Lack of Efficacy|0|||
161792289|NCT01579474|584284351|FG000|Overall Study|Withdrawal by Subject|1|||
161792290|NCT01579474|584284352|FG001|Overall Study|Withdrawal by Subject|0|||
161792291|NCT01579474|584284353|FG002|Overall Study|Withdrawal by Subject|0|||
161792292|NCT01579474|584284354|FG003|Overall Study|Withdrawal by Subject|0|||
161792293|NCT01579474|584284355|FG004|Overall Study|Withdrawal by Subject|0|||
161792294|NCT01579474|584284356|FG005|Overall Study|Withdrawal by Subject|0|||
161792295|NCT02295774|584284357|FG000|Overall Study|Physician Decision|1|||
161792296|NCT02295774|584284357|FG000|Overall Study|Withdrawal by Subject|2|||
161792297|NCT03532009|584284361|FG000|Overall Study|Other|1|||
161792298|NCT03532009|584284362|FG001|Overall Study|Other|1|||
161792299|NCT03532009|584284361|FG000|Overall Study|Death|1|||
161792300|NCT03532009|584284362|FG001|Overall Study|Death|1|||
161792301|NCT03532009|584284361|FG000|Overall Study|Withdrawal by Patient|0|||
161792302|NCT03532009|584284362|FG001|Overall Study|Withdrawal by Patient|2|||
161792303|NCT00368966|584284363|FG000|Infant Series|Withdrawal by Subject|11|||
161792304|NCT00368966|584284364|FG001|Infant Series|Withdrawal by Subject|6|||
161792305|NCT00368966|584284363|FG000|Infant Series|Protocol Violation|2|||
161792306|NCT00368966|584284364|FG001|Infant Series|Protocol Violation|1|||
161792307|NCT00368966|584284363|FG000|Infant Series|Lost to Follow-up|2|||
161792308|NCT00368966|584284364|FG001|Infant Series|Lost to Follow-up|0|||
161792309|NCT00368966|584284363|FG000|Infant Series|Randomization error|0|||
161792310|NCT00368966|584284364|FG001|Infant Series|Randomization error|1|||
161792311|NCT00368966|584284363|FG000|Infant Series|Failed to meet eligibility criteria|0|||
161792312|NCT00368966|584284364|FG001|Infant Series|Failed to meet eligibility criteria|1|||
161792313|NCT00368966|584284363|FG000|Infant Series|Adverse Event|0|||
161792314|NCT00368966|584284364|FG001|Infant Series|Adverse Event|1|||
161792315|NCT00368966|584284363|FG000|Infant Series|Failed to return|1|||
161792316|NCT00368966|584284364|FG001|Infant Series|Failed to return|0|||
161792317|NCT00368966|584284363|FG000|After Infant|Failed to return|3|||
161792318|NCT00368966|584284364|FG001|After Infant|Failed to return|1|||
161792319|NCT00368966|584284363|FG000|After Infant|Adverse Event|1|||
161792320|NCT00368966|584284364|FG001|After Infant|Adverse Event|2|||
161792321|NCT00368966|584284363|FG000|After Infant|Withdrawal by Subject|1|||
161792322|NCT00368966|584284364|FG001|After Infant|Withdrawal by Subject|1|||
161792323|NCT00368966|584284363|FG000|After Infant|Death|1|||
161792324|NCT00368966|584284364|FG001|After Infant|Death|0|||
161792325|NCT00368966|584284363|FG000|After Infant|Lost to Follow-up|0|||
161792326|NCT00368966|584284364|FG001|After Infant|Lost to Follow-up|1|||
161792327|NCT00368966|584284363|FG000|Toddler Dose|Withdrawal by Subject|1|||
161792328|NCT00368966|584284364|FG001|Toddler Dose|Withdrawal by Subject|1|||
161792329|NCT00368966|584284363|FG000|Toddler Dose|Lost to Follow-up|0|||
161792330|NCT00368966|584284364|FG001|Toddler Dose|Lost to Follow-up|2|||
161792331|NCT02866175|584284365|FG000|Overall Study|Adverse Event|56|||
161792332|NCT02866175|584284366|FG001|Overall Study|Adverse Event|54|||
161792333|NCT02866175|584284365|FG000|Overall Study|Withdrawal by Subject|31|||
161792334|NCT02866175|584284366|FG001|Overall Study|Withdrawal by Subject|52|||
161792335|NCT02866175|584284365|FG000|Overall Study|Death|30|||
161792336|NCT02866175|584284366|FG001|Overall Study|Death|23|||
161792337|NCT02866175|584284365|FG000|Overall Study|Other|7|||
161792338|NCT02866175|584284366|FG001|Overall Study|Other|14|||
161792339|NCT02866175|584284365|FG000|Overall Study|Progressive disease|1|||
161792340|NCT02866175|584284366|FG001|Overall Study|Progressive disease|1|||
161792341|NCT02866175|584284365|FG000|Overall Study|Lost to Follow-up|2|||
161792342|NCT02866175|584284366|FG001|Overall Study|Lost to Follow-up|0|||
161792343|NCT02866175|584284365|FG000|Overall Study|Lack of Efficacy|0|||
161792344|NCT02866175|584284366|FG001|Overall Study|Lack of Efficacy|1|||
161792345|NCT02866175|584284365|FG000|Overall Study|Physician Decision|3|||
161792346|NCT02866175|584284366|FG001|Overall Study|Physician Decision|15|||
161792347|NCT02866175|584284365|FG000|Overall Study|Did not receive treatment|5|||
161792348|NCT02866175|584284366|FG001|Overall Study|Did not receive treatment|15|||
161792349|NCT01694485|584284373|FG000|Overall Study|Withdrawal by Subject|20|||
161792350|NCT01694485|584284374|FG001|Overall Study|Withdrawal by Subject|6|||
161792351|NCT01694485|584284375|FG002|Overall Study|Withdrawal by Subject|7|||
161792352|NCT01694485|584284376|FG003|Overall Study|Withdrawal by Subject|25|||
161792353|NCT01694485|584284377|FG004|Overall Study|Withdrawal by Subject|18|||
161792354|NCT01694485|584284373|FG000|Overall Study|Sponsor Decision|3|||
161792355|NCT01694485|584284374|FG001|Overall Study|Sponsor Decision|0|||
161792356|NCT01694485|584284375|FG002|Overall Study|Sponsor Decision|0|||
161792357|NCT01694485|584284376|FG003|Overall Study|Sponsor Decision|2|||
161792358|NCT01694485|584284377|FG004|Overall Study|Sponsor Decision|0|||
161792359|NCT01694485|584284373|FG000|Overall Study|Lost to Follow-up|9|||
161792360|NCT01694485|584284374|FG001|Overall Study|Lost to Follow-up|1|||
161792361|NCT01694485|584284375|FG002|Overall Study|Lost to Follow-up|6|||
161792362|NCT01694485|584284376|FG003|Overall Study|Lost to Follow-up|10|||
161792363|NCT01694485|584284377|FG004|Overall Study|Lost to Follow-up|7|||
161792364|NCT01694485|584284373|FG000|Overall Study|Death|1|||
161792365|NCT01694485|584284374|FG001|Overall Study|Death|0|||
162130561|NCT05305040|585529888|FG000|Overall Study|Graft versus host disease|2|||
161792366|NCT01694485|584284375|FG002|Overall Study|Death|0|||
161792367|NCT01694485|584284376|FG003|Overall Study|Death|1|||
161792368|NCT01694485|584284377|FG004|Overall Study|Death|0|||
161792369|NCT02907203|584284378|FG000|Overall Study|Death|1|||
161792370|NCT02907203|584284378|FG000|Overall Study|Lost to Follow-up|3|||
161792371|NCT02907203|584284378|FG000|Overall Study|Withdrawal by Subject|3|||
161792372|NCT02907203|584284378|FG000|Overall Study|Surgical bypass|1|||
161792373|NCT01418352|584284379|FG000|Overall Study|Lost to Follow-up|2|||
161792374|NCT01418352|584284380|FG001|Overall Study|Lost to Follow-up|0|||
161792375|NCT01418352|584284381|FG002|Overall Study|Lost to Follow-up|0|||
161792376|NCT01418352|584284382|FG003|Overall Study|Lost to Follow-up|0|||
161792377|NCT01418352|584284379|FG000|Overall Study|Adverse Event|0|||
161792378|NCT01418352|584284380|FG001|Overall Study|Adverse Event|1|||
161792379|NCT01418352|584284381|FG002|Overall Study|Adverse Event|0|||
161792380|NCT01418352|584284382|FG003|Overall Study|Adverse Event|0|||
161792381|NCT01418352|584284379|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
161792382|NCT01418352|584284380|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
161792383|NCT01418352|584284381|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
161792384|NCT01418352|584284382|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
161792385|NCT01418352|584284379|FG000|Overall Study|Subject Withdrew Consent|0|||
161792386|NCT01418352|584284380|FG001|Overall Study|Subject Withdrew Consent|1|||
161792387|NCT01418352|584284381|FG002|Overall Study|Subject Withdrew Consent|2|||
161792388|NCT01418352|584284382|FG003|Overall Study|Subject Withdrew Consent|1|||
161792389|NCT01418352|584284379|FG000|Overall Study|Protocol Deviation|0|||
161792390|NCT01418352|584284380|FG001|Overall Study|Protocol Deviation|0|||
161792391|NCT01418352|584284381|FG002|Overall Study|Protocol Deviation|1|||
161792392|NCT01418352|584284382|FG003|Overall Study|Protocol Deviation|0|||
161792393|NCT01418352|584284379|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
161792394|NCT01418352|584284380|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
161792395|NCT01418352|584284381|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
161792396|NCT01418352|584284382|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
161792397|NCT00619619|584284383|FG000|Overall Study|Physician Decision|0|||
161792398|NCT00619619|584284384|FG001|Overall Study|Physician Decision|0|||
161792399|NCT00619619|584284385|FG002|Overall Study|Physician Decision|1|||
161792400|NCT00619619|584284386|FG003|Overall Study|Physician Decision|0|||
161792401|NCT00619619|584284387|FG004|Overall Study|Physician Decision|0|||
161792402|NCT00619619|584284388|FG005|Overall Study|Physician Decision|0|||
161792403|NCT00619619|584284389|FG006|Overall Study|Physician Decision|0|||
161792404|NCT00619619|584284390|FG007|Overall Study|Physician Decision|0|||
161792405|NCT00619619|584284383|FG000|Overall Study|Protocol Violation|0|||
161792406|NCT00619619|584284384|FG001|Overall Study|Protocol Violation|0|||
161792407|NCT00619619|584284385|FG002|Overall Study|Protocol Violation|0|||
161792408|NCT00619619|584284386|FG003|Overall Study|Protocol Violation|1|||
161792409|NCT00619619|584284387|FG004|Overall Study|Protocol Violation|0|||
161792410|NCT00619619|584284388|FG005|Overall Study|Protocol Violation|0|||
161792411|NCT00619619|584284389|FG006|Overall Study|Protocol Violation|1|||
161792412|NCT00619619|584284390|FG007|Overall Study|Protocol Violation|1|||
161792413|NCT00619619|584284383|FG000|Overall Study|Adverse Event|0|||
161792414|NCT00619619|584284384|FG001|Overall Study|Adverse Event|0|||
161792415|NCT00619619|584284385|FG002|Overall Study|Adverse Event|0|||
161792416|NCT00619619|584284386|FG003|Overall Study|Adverse Event|0|||
161792417|NCT00619619|584284387|FG004|Overall Study|Adverse Event|2|||
161792418|NCT00619619|584284388|FG005|Overall Study|Adverse Event|0|||
161792419|NCT00619619|584284389|FG006|Overall Study|Adverse Event|0|||
161792420|NCT00619619|584284390|FG007|Overall Study|Adverse Event|2|||
161792421|NCT01992107|584284391|FG000|Overall Study|Administrative reasons|2|||
161792422|NCT01992107|584284392|FG001|Overall Study|Administrative reasons|0|||
161792423|NCT01992107|584284393|FG002|Overall Study|Administrative reasons|0|||
161792424|NCT01992107|584284391|FG000|Overall Study|Adverse Event|0|||
161792425|NCT01992107|584284392|FG001|Overall Study|Adverse Event|1|||
161792426|NCT01992107|584284393|FG002|Overall Study|Adverse Event|0|||
161792427|NCT01992107|584284391|FG000|Overall Study|Lost to Follow-up|46|||
161792428|NCT01992107|584284392|FG001|Overall Study|Lost to Follow-up|22|||
161792429|NCT01992107|584284393|FG002|Overall Study|Lost to Follow-up|26|||
161792430|NCT01992107|584284391|FG000|Overall Study|noncompliance and were unavailable|7|||
161792431|NCT01992107|584284392|FG001|Overall Study|noncompliance and were unavailable|3|||
161792432|NCT01992107|584284393|FG002|Overall Study|noncompliance and were unavailable|2|||
161792433|NCT01992107|584284391|FG000|Overall Study|Withdrawal by Subject|13|||
161792434|NCT01992107|584284392|FG001|Overall Study|Withdrawal by Subject|7|||
161792435|NCT01992107|584284393|FG002|Overall Study|Withdrawal by Subject|8|||
161792436|NCT02022007|584284394|FG000|Overall Study|Withdrawal by Subject|1|||
161792437|NCT02022007|584284395|FG001|Overall Study|Withdrawal by Subject|1|||
161792438|NCT02022007|584284396|FG002|Overall Study|Withdrawal by Subject|1|||
161792439|NCT02022007|584284394|FG000|Overall Study|Noncompliant|0|||
161792440|NCT02022007|584284395|FG001|Overall Study|Noncompliant|0|||
161792441|NCT02022007|584284396|FG002|Overall Study|Noncompliant|1|||
161792442|NCT01214603|584284398|FG000|Overall Study|Adverse Event|0|||
161792443|NCT01214603|584284399|FG001|Overall Study|Adverse Event|0|||
161792444|NCT01214603|584284400|FG002|Overall Study|Adverse Event|1|||
161792445|NCT01214603|584284398|FG000|Overall Study|Death|1|||
161792446|NCT01214603|584284399|FG001|Overall Study|Death|0|||
161792447|NCT01214603|584284400|FG002|Overall Study|Death|0|||
161792448|NCT01214603|584284398|FG000|Overall Study|Progressive Disease|4|||
161792449|NCT01214603|584284399|FG001|Overall Study|Progressive Disease|1|||
161792450|NCT01214603|584284400|FG002|Overall Study|Progressive Disease|3|||
161792451|NCT01507896|584284401|FG000|Overall Study|Withdrawal by Subject|1|||
161792452|NCT01507896|584284401|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
161792453|NCT00490061|584284402|FG000|Overall Study|Physician Decision|1|||
161792454|NCT00952484|584284403|FG000|Overall Study|Withdrawal by Subject|0|||
161792455|NCT00952484|584284404|FG001|Overall Study|Withdrawal by Subject|1|||
161792456|NCT00952484|584284405|FG002|Overall Study|Withdrawal by Subject|0|||
161792457|NCT02750306|584284410|FG000|Overall Study|Withdrawal by Subject|5|||
161792458|NCT02750306|584284411|FG001|Overall Study|Withdrawal by Subject|2|||
161792459|NCT02750306|584284410|FG000|Overall Study|Protocol Violation|1|||
161792460|NCT02750306|584284411|FG001|Overall Study|Protocol Violation|0|||
161792461|NCT00585351|584284415|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
161792462|NCT00585351|584284416|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
161792463|NCT00585351|584284417|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
161792464|NCT00585351|584284418|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
161792465|NCT00585351|584284419|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
161792466|NCT00585351|584284420|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
161792467|NCT00585351|584284421|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
161792468|NCT00585351|584284422|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
161792469|NCT00585351|584284415|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
161792470|NCT00585351|584284416|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
161792471|NCT00585351|584284417|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
161792472|NCT00585351|584284418|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
161792473|NCT00585351|584284419|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
161792474|NCT00585351|584284420|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
161792475|NCT00585351|584284421|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
161792476|NCT00585351|584284422|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
161792477|NCT00585351|584284415|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
161792478|NCT00585351|584284416|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
161792479|NCT00585351|584284417|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
161792480|NCT00585351|584284418|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
161792481|NCT00585351|584284419|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
161792482|NCT00585351|584284420|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
161792483|NCT00585351|584284421|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
161792484|NCT00585351|584284422|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
161792485|NCT00585351|584284415|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
161792486|NCT00585351|584284416|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
161792487|NCT00585351|584284417|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161792488|NCT00585351|584284418|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161792489|NCT00585351|584284419|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161792490|NCT00585351|584284420|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161792491|NCT00585351|584284421|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161792492|NCT00585351|584284422|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
162010665|NCT03077412|585095941|FG000|Overall Study|Investigator's Discretion|0|||
162010666|NCT03077412|585095942|FG001|Overall Study|Investigator's Discretion|1|||
161792493|NCT00585351|584284415|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161792494|NCT00585351|584284416|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161792495|NCT00585351|584284417|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
162010667|NCT03077412|585095943|FG002|Overall Study|Investigator's Discretion|1|||
161792496|NCT00585351|584284418|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161792497|NCT00585351|584284419|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161792498|NCT00585351|584284420|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161792499|NCT00585351|584284421|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
161792500|NCT00585351|584284422|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
161792501|NCT00585351|584284415|FG000|Enrollment Period (Intervention)|Death|0|||
161792502|NCT00585351|584284416|FG001|Enrollment Period (Intervention)|Death|0|||
161792503|NCT00585351|584284417|FG002|Enrollment Period (Intervention)|Death|0|||
161792504|NCT00585351|584284418|FG003|Enrollment Period (Intervention)|Death|0|||
161792505|NCT00585351|584284419|FG004|Enrollment Period (Intervention)|Death|1|||
161792506|NCT00585351|584284420|FG005|Enrollment Period (Intervention)|Death|0|||
161792507|NCT00585351|584284421|FG006|Enrollment Period (Intervention)|Death|1|||
161792508|NCT00585351|584284422|FG007|Enrollment Period (Intervention)|Death|0|||
161792509|NCT00585351|584284415|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161792510|NCT00585351|584284416|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161792511|NCT00585351|584284417|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161792512|NCT00585351|584284418|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161792513|NCT00585351|584284419|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
161792514|NCT00585351|584284420|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
161792515|NCT00585351|584284421|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161792516|NCT00585351|584284422|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161792517|NCT00192296|584284423|FG000|Overall Study|Withdrawal by Subject|0|||
161792518|NCT00192296|584284424|FG001|Overall Study|Withdrawal by Subject|1|||
161792519|NCT00192296|584284425|FG002|Overall Study|Withdrawal by Subject|0|||
161792520|NCT00192296|584284426|FG003|Overall Study|Withdrawal by Subject|0|||
161792521|NCT02536378|584284433|FG000|Overall Study|Physician Decision|0|||
161792522|NCT02536378|584284434|FG001|Overall Study|Physician Decision|2|||
161792523|NCT02536378|584284433|FG000|Overall Study|Withdrawal by Subject|0|||
161792524|NCT02536378|584284434|FG001|Overall Study|Withdrawal by Subject|1|||
161792525|NCT02536378|584284433|FG000|Overall Study|Death|1|||
161792526|NCT02536378|584284434|FG001|Overall Study|Death|2|||
161792527|NCT02536378|584284433|FG000|Overall Study|Patient refused further follow up|6|||
161792528|NCT02536378|584284434|FG001|Overall Study|Patient refused further follow up|2|||
161792529|NCT00457665|584284440|FG000|12 Months|Drug allergy|1|||
161792530|NCT00457665|584284441|FG001|12 Months|Drug allergy|1|||
161792531|NCT00457665|584284440|FG000|12 Months|High HIV viral load|5|||
161792532|NCT00457665|584284441|FG001|12 Months|High HIV viral load|1|||
161792533|NCT00457665|584284440|FG000|12 Months|Lipodystrophy|2|||
161792534|NCT00457665|584284441|FG001|12 Months|Lipodystrophy|0|||
161792535|NCT00457665|584284440|FG000|12 Months|Withdrawal by Subject|0|||
161792536|NCT00457665|584284441|FG001|12 Months|Withdrawal by Subject|2|||
161792537|NCT00457665|584284440|FG000|12 Months|Abnormal Liver function tests|0|||
161792538|NCT00457665|584284441|FG001|12 Months|Abnormal Liver function tests|5|||
161792539|NCT00457665|584284440|FG000|24 Months|Withdrawal by Subject|3|||
161792540|NCT00457665|584284441|FG001|24 Months|Withdrawal by Subject|2|||
161792541|NCT00457665|584284440|FG000|24 Months|Lipodystrophy|1|||
161792542|NCT00457665|584284441|FG001|24 Months|Lipodystrophy|1|||
161792543|NCT00457665|584284440|FG000|24 Months|Abnormal liver function tests|1|||
161792544|NCT00457665|584284441|FG001|24 Months|Abnormal liver function tests|5|||
161792545|NCT00446654|584284442|FG000|Overall Study|Withdrawal by Subject|1|||
161792546|NCT00446654|584284443|FG001|Overall Study|Withdrawal by Subject|0|||
161792547|NCT00446654|584284442|FG000|Overall Study|Adverse Event|1|||
161792548|NCT00446654|584284443|FG001|Overall Study|Adverse Event|0|||
161792549|NCT02535000|584284445|FG000|Overall Study|Cancellation of surgery.|1|||
161792550|NCT02535000|584284446|FG001|Overall Study|Cancellation of surgery.|2|||
161792551|NCT04317781|584284447|FG000|Overall Study|Adverse Event|1|||
161792552|NCT04317781|584284447|FG000|Overall Study|Disease relapse|1|||
161792553|NCT04317781|584284447|FG000|Overall Study|Withdrawal by Subject|1|||
161792554|NCT01875445|584284453|FG000|Overall Study|Lost to Follow-up|5|||
161792555|NCT01875445|584284454|FG001|Overall Study|Lost to Follow-up|0|||
161792556|NCT01875445|584284453|FG000|Overall Study|Withdrawal by Subject|2|||
161792557|NCT01875445|584284454|FG001|Overall Study|Withdrawal by Subject|0|||
161792558|NCT01102777|584284455|FG000|Overall Study|Death|2|||
161792559|NCT01102777|584284456|FG001|Overall Study|Death|6|||
161792560|NCT01102777|584284455|FG000|Overall Study|Lost to Follow-up|7|||
161792561|NCT01102777|584284456|FG001|Overall Study|Lost to Follow-up|10|||
162130562|NCT05305040|585529889|FG001|Overall Study|Graft versus host disease|0|||
161792562|NCT00706706|584284457|FG000|Overall Study|Death|53|||
161792563|NCT00706706|584284457|FG000|Overall Study|Lost to Follow-up|7|||
161792564|NCT00706706|584284457|FG000|Overall Study|Study endpoint had reached|45|||
161792565|NCT02175966|584284462|FG000|Follow-up Period|Lack of Efficacy|10|||
161792566|NCT02175966|584284463|FG001|Follow-up Period|Lack of Efficacy|6|||
161792567|NCT00210626|584284464|FG000|Overall Study|Adverse Event|1|||
161792568|NCT00210626|584284465|FG001|Overall Study|Adverse Event|2|||
161792569|NCT00210626|584284464|FG000|Overall Study|Protocol Violation|1|||
161792570|NCT00210626|584284465|FG001|Overall Study|Protocol Violation|5|||
161792571|NCT00210626|584284464|FG000|Overall Study|Lost to Follow-up|11|||
161792572|NCT00210626|584284465|FG001|Overall Study|Lost to Follow-up|11|||
161792573|NCT00210626|584284464|FG000|Overall Study|Death|1|||
161792574|NCT00210626|584284465|FG001|Overall Study|Death|0|||
161792575|NCT00210626|584284464|FG000|Overall Study|Withdrawal by Subject|29|||
161792576|NCT00210626|584284465|FG001|Overall Study|Withdrawal by Subject|20|||
161792577|NCT00210626|584284464|FG000|Overall Study|Physician Decision|0|||
161792578|NCT00210626|584284465|FG001|Overall Study|Physician Decision|2|||
161792579|NCT00210626|584284464|FG000|Overall Study|Sponser Request|1|||
161792580|NCT00210626|584284465|FG001|Overall Study|Sponser Request|0|||
161792581|NCT00210626|584284464|FG000|Overall Study|Other|4|||
161792582|NCT00210626|584284465|FG001|Overall Study|Other|5|||
161792583|NCT03469271|584284466|FG000|Overall Study|Withdrawal by Subject|2|||
161792584|NCT03469271|584284467|FG001|Overall Study|Withdrawal by Subject|0|||
161792585|NCT03469271|584284468|FG002|Overall Study|Withdrawal by Subject|0|||
161792586|NCT03469271|584284469|FG003|Overall Study|Withdrawal by Subject|1|||
161792587|NCT03760510|584284470|FG000|Overall Study|Not ventilated for 24 hours|105|||
161792588|NCT03760510|584284471|FG001|Overall Study|Not ventilated for 24 hours|97|||
161792589|NCT03361956|584284472|FG000|Overall Study|Adverse Event|1|||
161792590|NCT03361956|584284473|FG001|Overall Study|Adverse Event|0|||
161792591|NCT03361956|584284474|FG002|Overall Study|Adverse Event|1|||
161792592|NCT03361956|584284475|FG003|Overall Study|Adverse Event|1|||
161792593|NCT03361956|584284476|FG004|Overall Study|Adverse Event|0|||
161792594|NCT03361956|584284472|FG000|Overall Study|Other|0|||
161792595|NCT03361956|584284473|FG001|Overall Study|Other|0|||
161792596|NCT03361956|584284474|FG002|Overall Study|Other|0|||
161792597|NCT03361956|584284475|FG003|Overall Study|Other|1|||
161792598|NCT03361956|584284476|FG004|Overall Study|Other|0|||
161792599|NCT03361956|584284472|FG000|Overall Study|Withdrawal by Subject|2|||
161792600|NCT03361956|584284473|FG001|Overall Study|Withdrawal by Subject|2|||
161792601|NCT03361956|584284474|FG002|Overall Study|Withdrawal by Subject|2|||
161792602|NCT03361956|584284475|FG003|Overall Study|Withdrawal by Subject|0|||
161792603|NCT03361956|584284476|FG004|Overall Study|Withdrawal by Subject|3|||
161792604|NCT03361956|584284472|FG000|Overall Study|Disease Relapse|0|||
161792605|NCT03361956|584284473|FG001|Overall Study|Disease Relapse|0|||
161792606|NCT03361956|584284474|FG002|Overall Study|Disease Relapse|1|||
161792607|NCT03361956|584284475|FG003|Overall Study|Disease Relapse|0|||
161792608|NCT03361956|584284476|FG004|Overall Study|Disease Relapse|0|||
161792609|NCT03361956|584284472|FG000|Overall Study|Physician Decision|0|||
161792610|NCT03361956|584284473|FG001|Overall Study|Physician Decision|2|||
161792611|NCT03361956|584284474|FG002|Overall Study|Physician Decision|0|||
161792612|NCT03361956|584284475|FG003|Overall Study|Physician Decision|1|||
161792613|NCT03361956|584284476|FG004|Overall Study|Physician Decision|0|||
161792614|NCT03361956|584284472|FG000|Overall Study|Lost to Follow-up|0|||
161792615|NCT03361956|584284473|FG001|Overall Study|Lost to Follow-up|0|||
161792616|NCT03361956|584284474|FG002|Overall Study|Lost to Follow-up|1|||
161792617|NCT03361956|584284475|FG003|Overall Study|Lost to Follow-up|1|||
161792618|NCT03361956|584284476|FG004|Overall Study|Lost to Follow-up|2|||
161792619|NCT00871728|584284478|FG000|Overall Study|Adverse Event|1|||
161792620|NCT00871728|584284478|FG000|Overall Study|Protocol Violation|7|||
161792621|NCT00871728|584284478|FG000|Overall Study|Lost to Follow-up|2|||
161792622|NCT00871728|584284478|FG000|Overall Study|Failed to Visit Hospital|4|||
161792623|NCT00871728|584284478|FG000|Overall Study|Participant Non-compliance|1|||
161792624|NCT00871728|584284478|FG000|Overall Study|Withdrawal of Informed Consent|5|||
161792625|NCT04147715|584284479|FG000|Overall Study|Adverse Event|0|||
161792626|NCT04147715|584284480|FG001|Overall Study|Adverse Event|0|||
161792627|NCT04147715|584284481|FG002|Overall Study|Adverse Event|0|||
161792628|NCT04147715|584284482|FG003|Overall Study|Adverse Event|0|||
161792629|NCT04147715|584284483|FG004|Overall Study|Adverse Event|0|||
161792630|NCT04147715|584284484|FG005|Overall Study|Adverse Event|0|||
161898833|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161898834|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
161898835|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161898836|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161898837|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161898838|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161792631|NCT04147715|584284485|FG006|Overall Study|Adverse Event|0|||
161898839|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
162010668|NCT03077412|585095941|FG000|Overall Study|Withdrew Consent|0|||
161792632|NCT04147715|584284486|FG007|Overall Study|Adverse Event|2|||
161792633|NCT04147715|584284487|FG008|Overall Study|Adverse Event|1|||
161792634|NCT04147715|584284488|FG009|Overall Study|Adverse Event|0|||
161792635|NCT04147715|584284489|FG010|Overall Study|Adverse Event|0|||
161792636|NCT04147715|584284490|FG011|Overall Study|Adverse Event|0|||
161792637|NCT02418910|584284494|FG000|Overall Study|Lost to Follow-up|3|||
161792638|NCT02418910|584284494|FG000|Overall Study|Withdrawal by Subject|4|||
161792639|NCT02472977|584284499|FG000|Overall Study|Disease progression|4|||
161792640|NCT02472977|584284500|FG001|Overall Study|Disease progression|25|||
161792641|NCT02472977|584284501|FG002|Overall Study|Disease progression|6|||
161792642|NCT02472977|584284499|FG000|Overall Study|Withdrawal by Subject|0|||
161792643|NCT02472977|584284500|FG001|Overall Study|Withdrawal by Subject|1|||
161792644|NCT02472977|584284501|FG002|Overall Study|Withdrawal by Subject|0|||
161792645|NCT02472977|584284499|FG000|Overall Study|Study drug toxicity|2|||
161792646|NCT02472977|584284500|FG001|Overall Study|Study drug toxicity|0|||
161792647|NCT02472977|584284501|FG002|Overall Study|Study drug toxicity|2|||
161792648|NCT02472977|584284499|FG000|Overall Study|Subject request to discontinue treatment|0|||
161792649|NCT02472977|584284500|FG001|Overall Study|Subject request to discontinue treatment|1|||
161792650|NCT02472977|584284501|FG002|Overall Study|Subject request to discontinue treatment|0|||
161792651|NCT02330081|584284506|FG000|Overall Study|Adverse Event|1|||
161792652|NCT02330081|584284506|FG000|Overall Study|Donation did not meet criteria|1|||
161792653|NCT02330081|584284506|FG000|Overall Study|Protocol Violation|6|||
161792654|NCT02277769|584284507|FG000|Overall Study|Protocol Violation|3|||
161792655|NCT02277769|584284508|FG001|Overall Study|Protocol Violation|3|||
161792656|NCT02277769|584284509|FG002|Overall Study|Protocol Violation|5|||
161792657|NCT02277769|584284507|FG000|Overall Study|Lack of Efficacy|17|||
161792658|NCT02277769|584284508|FG001|Overall Study|Lack of Efficacy|0|||
161792659|NCT02277769|584284509|FG002|Overall Study|Lack of Efficacy|4|||
161792660|NCT02277769|584284507|FG000|Overall Study|Adverse Event|14|||
161792661|NCT02277769|584284508|FG001|Overall Study|Adverse Event|2|||
161792662|NCT02277769|584284509|FG002|Overall Study|Adverse Event|4|||
161792663|NCT02277769|584284507|FG000|Overall Study|Other than specified above|12|||
161792664|NCT02277769|584284508|FG001|Overall Study|Other than specified above|8|||
161792665|NCT02277769|584284509|FG002|Overall Study|Other than specified above|5|||
161792666|NCT03775681|584284513|FG000|Overall Study|Physician Decision|3|||
161792667|NCT02123459|584284516|FG000|Washout Period (1 Day)|Adverse Event|1|||
161792668|NCT02123459|584284517|FG001|Washout Period (1 Day)|Adverse Event|0|||
161792669|NCT02196506|584284518|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
161792670|NCT02196506|584284519|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
161792671|NCT02196506|584284520|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
161792672|NCT02196506|584284521|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
161792673|NCT02196506|584284518|FG000|Phase A|Withdrawal by Subject|34|||
161792674|NCT02196506|584284519|FG001|Phase A|Withdrawal by Subject|0|||
161792675|NCT02196506|584284520|FG002|Phase A|Withdrawal by Subject|0|||
161792676|NCT02196506|584284521|FG003|Phase A|Withdrawal by Subject|0|||
161792677|NCT02196506|584284518|FG000|Phase A|Adverse Event|22|||
161792678|NCT02196506|584284519|FG001|Phase A|Adverse Event|0|||
161792679|NCT02196506|584284520|FG002|Phase A|Adverse Event|0|||
161792680|NCT02196506|584284521|FG003|Phase A|Adverse Event|0|||
161792681|NCT02196506|584284518|FG000|Phase A|Lost to Follow-up|9|||
161792682|NCT02196506|584284519|FG001|Phase A|Lost to Follow-up|0|||
161792683|NCT02196506|584284520|FG002|Phase A|Lost to Follow-up|0|||
161792684|NCT02196506|584284521|FG003|Phase A|Lost to Follow-up|0|||
161792685|NCT02196506|584284518|FG000|Phase A|Protocol deviation|12|||
161792686|NCT02196506|584284519|FG001|Phase A|Protocol deviation|0|||
161792687|NCT02196506|584284520|FG002|Phase A|Protocol deviation|0|||
161792688|NCT02196506|584284521|FG003|Phase A|Protocol deviation|0|||
161792689|NCT02196506|584284518|FG000|Phase A|Participant withdrawn by investigator|10|||
161792690|NCT02196506|584284519|FG001|Phase A|Participant withdrawn by investigator|0|||
161792691|NCT02196506|584284520|FG002|Phase A|Participant withdrawn by investigator|0|||
161792692|NCT02196506|584284521|FG003|Phase A|Participant withdrawn by investigator|0|||
161792693|NCT02196506|584284518|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
161792694|NCT02196506|584284519|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
161792695|NCT02196506|584284520|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
161792696|NCT02196506|584284521|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
161792697|NCT02196506|584284518|FG000|Phase B|Lack of Efficacy|0|||
161792698|NCT02196506|584284519|FG001|Phase B|Lack of Efficacy|1|||
161792699|NCT02196506|584284520|FG002|Phase B|Lack of Efficacy|2|||
161792700|NCT02196506|584284521|FG003|Phase B|Lack of Efficacy|0|||
161792701|NCT02196506|584284518|FG000|Phase B|Withdrawal by Participant|0|||
161792702|NCT02196506|584284519|FG001|Phase B|Withdrawal by Participant|8|||
161792703|NCT02196506|584284520|FG002|Phase B|Withdrawal by Participant|1|||
161792704|NCT02196506|584284521|FG003|Phase B|Withdrawal by Participant|0|||
161792705|NCT02196506|584284518|FG000|Phase B|Adverse Event|0|||
161792706|NCT02196506|584284519|FG001|Phase B|Adverse Event|4|||
161792707|NCT02196506|584284520|FG002|Phase B|Adverse Event|1|||
161898840|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161792708|NCT02196506|584284521|FG003|Phase B|Adverse Event|0|||
161792709|NCT02196506|584284518|FG000|Phase B|Lost to Follow-up|0|||
161792710|NCT02196506|584284519|FG001|Phase B|Lost to Follow-up|2|||
161792711|NCT02196506|584284520|FG002|Phase B|Lost to Follow-up|1|||
161792712|NCT02196506|584284521|FG003|Phase B|Lost to Follow-up|0|||
161792713|NCT02196506|584284518|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
161792714|NCT02196506|584284519|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
161792715|NCT02196506|584284520|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
161792716|NCT02196506|584284521|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
161792717|NCT02196506|584284518|FG000|Phase A+|Withdrawal by Participant|0|||
161792718|NCT02196506|584284519|FG001|Phase A+|Withdrawal by Participant|0|||
161792719|NCT02196506|584284520|FG002|Phase A+|Withdrawal by Participant|0|||
161792720|NCT02196506|584284521|FG003|Phase A+|Withdrawal by Participant|5|||
161792721|NCT02196506|584284518|FG000|Phase A+|Adverse Event|0|||
161792722|NCT02196506|584284519|FG001|Phase A+|Adverse Event|0|||
161792723|NCT02196506|584284520|FG002|Phase A+|Adverse Event|0|||
161792724|NCT02196506|584284521|FG003|Phase A+|Adverse Event|1|||
161792725|NCT02196506|584284518|FG000|Phase A+|Lost to Follow-up|0|||
161792726|NCT02196506|584284519|FG001|Phase A+|Lost to Follow-up|0|||
161792727|NCT02196506|584284520|FG002|Phase A+|Lost to Follow-up|0|||
161792728|NCT02196506|584284521|FG003|Phase A+|Lost to Follow-up|6|||
161792729|NCT02196506|584284518|FG000|Phase A+|Participant withdrawn by investigator|0|||
161792730|NCT02196506|584284519|FG001|Phase A+|Participant withdrawn by investigator|0|||
161792731|NCT02196506|584284520|FG002|Phase A+|Participant withdrawn by investigator|0|||
161792732|NCT02196506|584284521|FG003|Phase A+|Participant withdrawn by investigator|1|||
161792733|NCT01070394|584284522|FG000|Overall Study|Adverse Event|6|||
161792734|NCT01070394|584284522|FG000|Overall Study|Withdrawal by Subject|1|||
161792735|NCT01098240|584284523|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
161792736|NCT01098240|584284524|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
161792737|NCT01098240|584284525|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
161792738|NCT01098240|584284523|FG000|Open-Label Phase|Protocol Violation|4|||
161792739|NCT01098240|584284524|FG001|Open-Label Phase|Protocol Violation|0|||
161792740|NCT01098240|584284525|FG002|Open-Label Phase|Protocol Violation|0|||
161792741|NCT01098240|584284523|FG000|Open-Label Phase|Lost to Follow-up|13|||
161792742|NCT01098240|584284524|FG001|Open-Label Phase|Lost to Follow-up|0|||
161792743|NCT01098240|584284525|FG002|Open-Label Phase|Lost to Follow-up|0|||
161792744|NCT01098240|584284523|FG000|Open-Label Phase|Other|19|||
161792745|NCT01098240|584284524|FG001|Open-Label Phase|Other|0|||
161792746|NCT01098240|584284525|FG002|Open-Label Phase|Other|0|||
161792747|NCT01098240|584284523|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
161792748|NCT01098240|584284524|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161792749|NCT01098240|584284525|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161792750|NCT01098240|584284523|FG000|Open-Label Phase|Pregnancy|1|||
161792751|NCT01098240|584284524|FG001|Open-Label Phase|Pregnancy|0|||
161792752|NCT01098240|584284525|FG002|Open-Label Phase|Pregnancy|0|||
161792753|NCT01098240|584284523|FG000|Open-Label Phase|Withdrawal by Subject|9|||
161792754|NCT01098240|584284524|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161792755|NCT01098240|584284525|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161792756|NCT01098240|584284523|FG000|Open-Label Phase|Adverse Event|12|||
161792757|NCT01098240|584284524|FG001|Open-Label Phase|Adverse Event|0|||
161792758|NCT01098240|584284525|FG002|Open-Label Phase|Adverse Event|0|||
161792759|NCT01098240|584284523|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
161792760|NCT01098240|584284524|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
161792761|NCT01098240|584284525|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
161792762|NCT01098240|584284523|FG000|Double-Blind Phase|Protocol Violation|0|||
161792763|NCT01098240|584284524|FG001|Double-Blind Phase|Protocol Violation|2|||
161792764|NCT01098240|584284525|FG002|Double-Blind Phase|Protocol Violation|4|||
161792765|NCT01098240|584284523|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161792766|NCT01098240|584284524|FG001|Double-Blind Phase|Lost to Follow-up|2|||
161792767|NCT01098240|584284525|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161792768|NCT01098240|584284523|FG000|Double-Blind Phase|Other|0|||
161792769|NCT01098240|584284524|FG001|Double-Blind Phase|Other|2|||
161792770|NCT01098240|584284525|FG002|Double-Blind Phase|Other|2|||
161792771|NCT01098240|584284523|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
161792772|NCT01098240|584284524|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
161792773|NCT01098240|584284525|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
161792774|NCT01098240|584284523|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
161792775|NCT01098240|584284524|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
161792776|NCT01098240|584284525|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
162010669|NCT03077412|585095942|FG001|Overall Study|Withdrew Consent|2|||
161792777|NCT01098240|584284523|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161792778|NCT01098240|584284524|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
161792779|NCT01098240|584284525|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
161792780|NCT01098240|584284523|FG000|Double-Blind Phase|Adverse Event|0|||
161792781|NCT01098240|584284524|FG001|Double-Blind Phase|Adverse Event|3|||
161792782|NCT01098240|584284525|FG002|Double-Blind Phase|Adverse Event|3|||
161792783|NCT00066807|584284526|FG000|Overall Study|Study was terminated early|14|||
161792784|NCT00066807|584284527|FG001|Overall Study|Study was terminated early|15|||
161792785|NCT03507439|584284528|FG000|Overall Study|Other|2|||
161792786|NCT03507439|584284529|FG001|Overall Study|Other|1|||
161792787|NCT03507439|584284528|FG000|Overall Study|Withdrawal by Subject|1|||
161792788|NCT03507439|584284529|FG001|Overall Study|Withdrawal by Subject|0|||
161792789|NCT03507439|584284528|FG000|Overall Study|Death|1|||
161792790|NCT03507439|584284529|FG001|Overall Study|Death|1|||
161792791|NCT00874757|584284530|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
161792792|NCT03346538|584285919|FG000|Overall Study|Physician Decision|0|||
161792793|NCT03346538|584285920|FG001|Overall Study|Physician Decision|1|||
161792794|NCT03346538|584285921|FG002|Overall Study|Physician Decision|0|||
161792795|NCT03346538|584285919|FG000|Overall Study|Withdrawal by Subject|3|||
161792796|NCT03346538|584285920|FG001|Overall Study|Withdrawal by Subject|2|||
161792797|NCT03346538|584285921|FG002|Overall Study|Withdrawal by Subject|0|||
161792798|NCT03346538|584285919|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
161792799|NCT03346538|584285920|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
161792800|NCT03346538|584285921|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
161792801|NCT04014959|584285923|FG000|Baseline MRI and Assessments|Physician Decision|2|||
161792802|NCT04014959|584285923|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
161792803|NCT04014959|584285923|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
161792804|NCT02004847|584285925|FG000|Overall Study|Protocol Violation|1|||
161792805|NCT02004847|584285926|FG001|Overall Study|Protocol Violation|1|||
161792806|NCT02220920|584285927|FG000|Overall Study|Adverse Event|1|||
161792807|NCT02220920|584285928|FG001|Overall Study|Adverse Event|0|||
161792808|NCT02220920|584285927|FG000|Overall Study|Lack of Efficacy|0|||
161792809|NCT02220920|584285928|FG001|Overall Study|Lack of Efficacy|1|||
161792810|NCT02220920|584285927|FG000|Overall Study|Withdrawal by Subject|1|||
161792811|NCT02220920|584285928|FG001|Overall Study|Withdrawal by Subject|0|||
161792812|NCT02220920|584285927|FG000|Overall Study|Conflict with the stopping criteria|1|||
161792813|NCT02220920|584285928|FG001|Overall Study|Conflict with the stopping criteria|2|||
161792814|NCT01132118|584285932|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
161792815|NCT01132118|584285933|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
161792816|NCT01132118|584285932|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
161792817|NCT01132118|584285933|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
161792818|NCT01132118|584285932|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
161792819|NCT01132118|584285933|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
161792820|NCT01644890|584285934|FG000|Overall Study|Adverse Event|7|||
161792821|NCT01644890|584285935|FG001|Overall Study|Adverse Event|20|||
161792822|NCT01644890|584285934|FG000|Overall Study|Death|1|||
161792823|NCT01644890|584285935|FG001|Overall Study|Death|3|||
161792824|NCT01644890|584285934|FG000|Overall Study|Physician Decision|3|||
161792825|NCT01644890|584285935|FG001|Overall Study|Physician Decision|9|||
161792826|NCT01644890|584285934|FG000|Overall Study|Protocol Violation|6|||
161792827|NCT01644890|584285935|FG001|Overall Study|Protocol Violation|7|||
161792828|NCT01644890|584285934|FG000|Overall Study|Withdrawal by Subject|19|||
161792829|NCT01644890|584285935|FG001|Overall Study|Withdrawal by Subject|27|||
161792830|NCT01644890|584285934|FG000|Overall Study|Progression Disease|160|||
161792831|NCT01644890|584285935|FG001|Overall Study|Progression Disease|131|||
161792832|NCT01644890|584285934|FG000|Overall Study|Clinical Progression|6|||
161792833|NCT01644890|584285935|FG001|Overall Study|Clinical Progression|6|||
161792834|NCT01644890|584285934|FG000|Overall Study|> 28 days since last dose of study drug|6|||
161792835|NCT01644890|584285935|FG001|Overall Study|> 28 days since last dose of study drug|3|||
161792836|NCT01644890|584285934|FG000|Overall Study|Other|8|||
161792837|NCT01644890|584285935|FG001|Overall Study|Other|9|||
161792838|NCT01413204|584285938|FG000|Overall Study|Adverse Event|1|||
161792839|NCT01413204|584285939|FG001|Overall Study|Adverse Event|2|||
161792840|NCT01413204|584285940|FG002|Overall Study|Adverse Event|2|||
161792841|NCT01413204|584285938|FG000|Overall Study|Physician Decision|3|||
161792842|NCT01413204|584285939|FG001|Overall Study|Physician Decision|0|||
161792843|NCT01413204|584285940|FG002|Overall Study|Physician Decision|2|||
161792844|NCT01413204|584285938|FG000|Overall Study|Withdrawal by Subject|1|||
161792845|NCT01413204|584285939|FG001|Overall Study|Withdrawal by Subject|4|||
161792846|NCT01413204|584285940|FG002|Overall Study|Withdrawal by Subject|4|||
161792847|NCT01413204|584285938|FG000|Overall Study|Clearly not eligible for the study|0|||
161792848|NCT01413204|584285939|FG001|Overall Study|Clearly not eligible for the study|0|||
161792849|NCT01413204|584285940|FG002|Overall Study|Clearly not eligible for the study|1|||
161792850|NCT01413204|584285938|FG000|Overall Study|Fasting plasma glucose level increased|1|||
161792851|NCT01413204|584285939|FG001|Overall Study|Fasting plasma glucose level increased|0|||
161792852|NCT01413204|584285940|FG002|Overall Study|Fasting plasma glucose level increased|10|||
161792853|NCT00313703|584285942|FG000|Overall Study|Lost to Follow-up|11|||
161792854|NCT00313703|584285943|FG001|Overall Study|Lost to Follow-up|2|||
161792855|NCT00313703|584285944|FG002|Overall Study|Lost to Follow-up|5|||
161792856|NCT00313703|584285945|FG003|Overall Study|Lost to Follow-up|12|||
161792857|NCT02497391|584285946|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
161792858|NCT02497391|584285947|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
161792859|NCT02497391|584285948|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
161792860|NCT02497391|584285949|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
161792861|NCT02497391|584285950|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
161792862|NCT02497391|584285951|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
161792863|NCT02497391|584285946|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
162010670|NCT03077412|585095943|FG002|Overall Study|Withdrew Consent|0|||
161792864|NCT02497391|584285947|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
161792865|NCT02497391|584285948|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
161792866|NCT02497391|584285949|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
161792867|NCT02497391|584285950|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
161792868|NCT02497391|584285951|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
161792869|NCT02497391|584285946|FG000|Period 3 (14 Days)|Adverse Event|0|||
161792870|NCT02497391|584285947|FG001|Period 3 (14 Days)|Adverse Event|1|||
161792871|NCT02497391|584285948|FG002|Period 3 (14 Days)|Adverse Event|0|||
161792872|NCT02497391|584285949|FG003|Period 3 (14 Days)|Adverse Event|0|||
161792873|NCT02497391|584285950|FG004|Period 3 (14 Days)|Adverse Event|0|||
161792874|NCT02497391|584285951|FG005|Period 3 (14 Days)|Adverse Event|0|||
161792875|NCT02497391|584285946|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
161792876|NCT02497391|584285947|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
161792877|NCT02497391|584285948|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
161792878|NCT02497391|584285949|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
161792879|NCT02497391|584285950|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
161792880|NCT02497391|584285951|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
161792881|NCT02497391|584285946|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
161792882|NCT02497391|584285947|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
161792883|NCT02497391|584285948|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
161792884|NCT02497391|584285949|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
161792885|NCT02497391|584285950|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
161792886|NCT02497391|584285951|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
161792887|NCT03031899|584285954|FG000|Overall Study|Protocol Violation|1|||
161792888|NCT03031899|584285954|FG000|Overall Study|lesion disappeared after stopping habit|1|||
161792889|NCT01664052|584285955|FG000|Phase 1|No device placement|6|||
161792890|NCT01664052|584285956|FG001|Phase 1|No device placement|0|||
161792891|NCT01664052|584285955|FG000|Phase 1|No HSG 1 hr post placement|1|||
161792892|NCT01664052|584285956|FG001|Phase 1|No HSG 1 hr post placement|0|||
161792893|NCT01664052|584285955|FG000|Phase 2|No device placement|0|||
161792894|NCT01664052|584285956|FG001|Phase 2|No device placement|4|||
161792895|NCT01060670|584285957|FG000|Run In|screen failure|0|||
161792896|NCT01060670|584285958|FG001|Run In|screen failure|238|||
161792897|NCT03705351|584285964|FG000|Overall Study|Study termination|3|||
161792898|NCT03705351|584285964|FG000|Overall Study|Death|1|||
161792899|NCT03705351|584285964|FG000|Overall Study|Lack of Efficacy|2|||
161792900|NCT03705351|584285964|FG000|Overall Study|Withdrawal by Subject|1|||
161792901|NCT00056160|584285971|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
161792902|NCT00056160|584285972|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
161792903|NCT00056160|584285971|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
161792904|NCT00056160|584285972|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
161792905|NCT00056160|584285971|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
161792906|NCT00056160|584285972|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
161792907|NCT00056160|584285971|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
161792908|NCT00056160|584285972|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
161792909|NCT00056160|584285971|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
161792910|NCT00056160|584285972|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
161792911|NCT00056160|584285971|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
161792912|NCT00056160|584285972|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
161792913|NCT00056160|584285971|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
161792914|NCT00056160|584285972|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
161792915|NCT00056160|584285971|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
161792916|NCT00056160|584285972|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
161792917|NCT00056160|584285971|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
161792918|NCT00056160|584285972|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
161792919|NCT00056160|584285971|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
161792920|NCT00056160|584285972|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
161792921|NCT00056160|584285971|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
161792922|NCT00056160|584285972|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
161792923|NCT00056160|584285971|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
161792924|NCT00056160|584285972|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
161792925|NCT00056160|584285971|FG000|Final Follow-up|Transferred into expanded access study.|3|||
161792926|NCT00056160|584285972|FG001|Final Follow-up|Transferred into expanded access study.|0|||
161792927|NCT00056160|584285971|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
161792928|NCT00056160|584285972|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
161792929|NCT00056160|584285971|FG000|Final Follow-up|Adverse Event|1|||
161792930|NCT00056160|584285972|FG001|Final Follow-up|Adverse Event|0|||
161792931|NCT01469364|584285973|FG000|Overall Study|Adverse Event|1|||
161792932|NCT01469364|584285973|FG000|Overall Study|Withdrawal by Subject|1|||
161792933|NCT02811861|584285977|FG000|Overall Study|Radiological Disease Progression|123|||
161792934|NCT02811861|584285978|FG001|Overall Study|Radiological Disease Progression|97|||
161792935|NCT02811861|584285979|FG002|Overall Study|Radiological Disease Progression|174|||
161792936|NCT02811861|584285977|FG000|Overall Study|Clinical Disease Progression|20|||
161792937|NCT02811861|584285978|FG001|Overall Study|Clinical Disease Progression|19|||
161792938|NCT02811861|584285979|FG002|Overall Study|Clinical Disease Progression|22|||
161792939|NCT02811861|584285977|FG000|Overall Study|Adverse Event|63|||
161792940|NCT02811861|584285978|FG001|Overall Study|Adverse Event|60|||
161792941|NCT02811861|584285979|FG002|Overall Study|Adverse Event|41|||
161792942|NCT02811861|584285977|FG000|Overall Study|Lost to Follow-up|0|||
161792943|NCT02811861|584285978|FG001|Overall Study|Lost to Follow-up|0|||
161792944|NCT02811861|584285979|FG002|Overall Study|Lost to Follow-up|1|||
161792945|NCT02811861|584285977|FG000|Overall Study|Subject Choice|29|||
161792946|NCT02811861|584285978|FG001|Overall Study|Subject Choice|17|||
161792947|NCT02811861|584285979|FG002|Overall Study|Subject Choice|23|||
161792948|NCT02811861|584285977|FG000|Overall Study|Withdrawal by Subject|4|||
161792949|NCT02811861|584285978|FG001|Overall Study|Withdrawal by Subject|4|||
161792950|NCT02811861|584285979|FG002|Overall Study|Withdrawal by Subject|9|||
161792951|NCT02811861|584285977|FG000|Overall Study|Other|4|||
161792952|NCT02811861|584285978|FG001|Overall Study|Other|13|||
161792953|NCT02811861|584285979|FG002|Overall Study|Other|3|||
161792954|NCT02811861|584285977|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
161792955|NCT02811861|584285978|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
161792956|NCT02811861|584285979|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
161792957|NCT02811861|584285977|FG000|Overall Study|Randomized but not treated|2|||
161792958|NCT02811861|584285978|FG001|Overall Study|Randomized but not treated|3|||
161792959|NCT02811861|584285979|FG002|Overall Study|Randomized but not treated|17|||
161792960|NCT04081337|584285983|FG000|Overall Study|Adverse Event|0|||
161792961|NCT04081337|584285984|FG001|Overall Study|Adverse Event|1|||
161792962|NCT04081337|584285983|FG000|Overall Study|Withdrawal by Subject|2|||
161792963|NCT04081337|584285984|FG001|Overall Study|Withdrawal by Subject|0|||
161792964|NCT04081337|584285983|FG000|Overall Study|Physician Decision|1|||
161792965|NCT04081337|584285984|FG001|Overall Study|Physician Decision|2|||
161792966|NCT04081337|584285983|FG000|Overall Study|Lost to Follow-up|1|||
161792967|NCT04081337|584285984|FG001|Overall Study|Lost to Follow-up|0|||
161792968|NCT06624072|584285985|FG000|Washout Period 1 (7 days)|Adverse Event|0|||
161792969|NCT06624072|584285986|FG001|Washout Period 1 (7 days)|Adverse Event|0|||
161792970|NCT06624072|584285987|FG002|Washout Period 1 (7 days)|Adverse Event|1|||
161792971|NCT00416520|584286000|FG000|Open-label Period|Adverse Event|28|||
161792972|NCT00416520|584286001|FG001|Open-label Period|Adverse Event|10|||
161792973|NCT00416520|584286002|FG002|Open-label Period|Adverse Event|0|||
161792974|NCT00416520|584286003|FG003|Open-label Period|Adverse Event|0|||
161898841|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161898842|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161898843|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
161898844|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161898845|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161898846|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
161898847|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
161898848|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
161898849|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
161898850|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
161898851|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
161898852|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
161898853|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
161898854|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
161898855|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
161898856|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
161898857|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
161898858|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
161898859|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
161898860|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
161898861|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
161898862|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
161898863|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
161898864|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
161898865|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161898866|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161792975|NCT00416520|584286000|FG000|Open-label Period|Death|2|||
161792976|NCT00416520|584286001|FG001|Open-label Period|Death|1|||
161792977|NCT00416520|584286002|FG002|Open-label Period|Death|0|||
161792978|NCT00416520|584286003|FG003|Open-label Period|Death|0|||
161898867|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161898868|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161792979|NCT00416520|584286000|FG000|Open-label Period|Lack of Efficacy|8|||
161792980|NCT00416520|584286001|FG001|Open-label Period|Lack of Efficacy|1|||
161792981|NCT00416520|584286002|FG002|Open-label Period|Lack of Efficacy|0|||
161792982|NCT00416520|584286003|FG003|Open-label Period|Lack of Efficacy|0|||
161792983|NCT00416520|584286000|FG000|Open-label Period|Protocol Violation|3|||
161792984|NCT00416520|584286001|FG001|Open-label Period|Protocol Violation|3|||
161898869|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
161898870|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
161792985|NCT00416520|584286002|FG002|Open-label Period|Protocol Violation|0|||
161792986|NCT00416520|584286003|FG003|Open-label Period|Protocol Violation|0|||
161792987|NCT00416520|584286000|FG000|Open-label Period|Withdrawal by Subject|16|||
161792988|NCT00416520|584286001|FG001|Open-label Period|Withdrawal by Subject|5|||
161792989|NCT00416520|584286002|FG002|Open-label Period|Withdrawal by Subject|0|||
161792990|NCT00416520|584286003|FG003|Open-label Period|Withdrawal by Subject|0|||
161792991|NCT00416520|584286000|FG000|Open-label Period|Other Reasons|3|||
161792992|NCT00416520|584286001|FG001|Open-label Period|Other Reasons|12|||
161792993|NCT00416520|584286002|FG002|Open-label Period|Other Reasons|0|||
161792994|NCT00416520|584286003|FG003|Open-label Period|Other Reasons|0|||
161792995|NCT00416520|584286000|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
161792996|NCT00416520|584286001|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
161792997|NCT00416520|584286002|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
161792998|NCT00416520|584286003|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
161792999|NCT00416520|584286000|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
161793000|NCT00416520|584286001|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
161793001|NCT00416520|584286002|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
161793002|NCT00416520|584286003|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
161793003|NCT00416520|584286000|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
161793004|NCT00416520|584286001|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
161793005|NCT00416520|584286002|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
161793006|NCT00416520|584286003|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
161793007|NCT01387737|584286004|FG000|Overall Study|Adverse Event|20|||
161793008|NCT01387737|584286005|FG001|Overall Study|Adverse Event|30|||
161793009|NCT01387737|584286004|FG000|Overall Study|Lack of Efficacy|1|||
161793010|NCT01387737|584286005|FG001|Overall Study|Lack of Efficacy|0|||
161793011|NCT01387737|584286004|FG000|Overall Study|Physician Decision|3|||
161793012|NCT01387737|584286005|FG001|Overall Study|Physician Decision|10|||
161793013|NCT01387737|584286004|FG000|Overall Study|Withdrawal by Subject|27|||
161793014|NCT01387737|584286005|FG001|Overall Study|Withdrawal by Subject|31|||
161793015|NCT01387737|584286004|FG000|Overall Study|Clearly not eligible for the study|1|||
161793016|NCT01387737|584286005|FG001|Overall Study|Clearly not eligible for the study|3|||
161793017|NCT00449072|584286007|FG000|Overall Study|Adverse Event|3|||
161793018|NCT00449072|584286008|FG001|Overall Study|Adverse Event|1|||
161793019|NCT00449072|584286007|FG000|Overall Study|Protocol Violation|14|||
161793020|NCT00449072|584286008|FG001|Overall Study|Protocol Violation|12|||
161793021|NCT00449072|584286007|FG000|Overall Study|Lost to Follow-up|5|||
161793022|NCT00449072|584286008|FG001|Overall Study|Lost to Follow-up|7|||
161793023|NCT00449072|584286007|FG000|Overall Study|Withdrawal by Subject|11|||
161793024|NCT00449072|584286008|FG001|Overall Study|Withdrawal by Subject|8|||
161793025|NCT00449072|584286007|FG000|Overall Study|Lack of Efficacy|1|||
161793026|NCT00449072|584286008|FG001|Overall Study|Lack of Efficacy|1|||
161793027|NCT00449072|584286007|FG000|Overall Study|Physician Decision|1|||
161793028|NCT00449072|584286008|FG001|Overall Study|Physician Decision|0|||
161793029|NCT00449072|584286007|FG000|Overall Study|Not treated|0|||
161793030|NCT00449072|584286008|FG001|Overall Study|Not treated|1|||
161793031|NCT00449072|584286007|FG000|Overall Study|Excluded medication|0|||
161793032|NCT00449072|584286008|FG001|Overall Study|Excluded medication|2|||
161793033|NCT00449072|584286007|FG000|Overall Study|Non-compliance|2|||
161793034|NCT00449072|584286008|FG001|Overall Study|Non-compliance|5|||
161793035|NCT00449072|584286007|FG000|Overall Study|Sponsor decision|1|||
161793036|NCT00449072|584286008|FG001|Overall Study|Sponsor decision|3|||
161793037|NCT00449072|584286007|FG000|Overall Study|Relocation|3|||
161793038|NCT00449072|584286008|FG001|Overall Study|Relocation|2|||
161793039|NCT05002569|584286011|FG000|Randomized|Withdrew Consent|3|||
161793040|NCT05002569|584286012|FG001|Randomized|Withdrew Consent|0|||
161793041|NCT05002569|584286011|FG000|Randomized|No longer meets study criteria|0|||
161793042|NCT05002569|584286012|FG001|Randomized|No longer meets study criteria|1|||
161793043|NCT05002569|584286011|FG000|Randomized|AE unrelated to study drug|1|||
161793044|NCT05002569|584286012|FG001|Randomized|AE unrelated to study drug|0|||
161793045|NCT05002569|584286011|FG000|Treatment Period|Requested to Discontinue|26|||
161793046|NCT05002569|584286012|FG001|Treatment Period|Requested to Discontinue|5|||
161793047|NCT05002569|584286011|FG000|Treatment Period|Withdrew Consent|7|||
161793048|NCT05002569|584286012|FG001|Treatment Period|Withdrew Consent|1|||
161793049|NCT05002569|584286011|FG000|Treatment Period|Study Drug Toxicity|114|||
161793050|NCT05002569|584286012|FG001|Treatment Period|Study Drug Toxicity|64|||
161793051|NCT05002569|584286011|FG000|Treatment Period|AE unrelated to study drug|6|||
161793052|NCT05002569|584286012|FG001|Treatment Period|AE unrelated to study drug|12|||
161793053|NCT05002569|584286011|FG000|Treatment Period|Disease Recurrence|102|||
161793054|NCT05002569|584286012|FG001|Treatment Period|Disease Recurrence|128|||
161793055|NCT05002569|584286011|FG000|Treatment Period|Other Reasons|4|||
161793056|NCT05002569|584286012|FG001|Treatment Period|Other Reasons|7|||
161793057|NCT05002569|584286011|FG000|Treatment Period|Death|1|||
161793058|NCT05002569|584286012|FG001|Treatment Period|Death|1|||
161793059|NCT05002569|584286011|FG000|Follow Up|Death|78|||
161793060|NCT05002569|584286012|FG001|Follow Up|Death|69|||
161793061|NCT05002569|584286011|FG000|Follow Up|Lost to Follow-up|3|||
161793062|NCT05002569|584286012|FG001|Follow Up|Lost to Follow-up|3|||
161793063|NCT05002569|584286011|FG000|Follow Up|Withdrew consent|17|||
161793064|NCT05002569|584286012|FG001|Follow Up|Withdrew consent|16|||
161793065|NCT05002569|584286011|FG000|Follow Up|Other Reasons|444|||
161793066|NCT05002569|584286012|FG001|Follow Up|Other Reasons|452|||
161793067|NCT04041570|584286020|FG000|Overall Study|Moved from Area|0|||
161793068|NCT04041570|584286021|FG001|Overall Study|Moved from Area|2|||
161793069|NCT05211336|584286022|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
161793070|NCT05211336|584286023|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
161793071|NCT05211336|584286022|FG000|Overall Study|Progressive disease|0|||
161793072|NCT05211336|584286023|FG001|Overall Study|Progressive disease|4|||
161793073|NCT05211336|584286022|FG000|Overall Study|Death due to myocardial infarction|0|||
161793074|NCT05211336|584286023|FG001|Overall Study|Death due to myocardial infarction|1|||
161793075|NCT05211336|584286022|FG000|Overall Study|Death due to unknown cause|0|||
161793076|NCT05211336|584286023|FG001|Overall Study|Death due to unknown cause|1|||
161793077|NCT05211336|584286022|FG000|Overall Study|Worsening kidney function and quality of response|0|||
161793078|NCT05211336|584286023|FG001|Overall Study|Worsening kidney function and quality of response|1|||
161793079|NCT02337829|584286024|FG000|Overall Study|Death|0|||
161793080|NCT02337829|584286025|FG001|Overall Study|Death|1|||
161793081|NCT02337829|584286026|FG002|Overall Study|Death|0|||
161793082|NCT02337829|584286027|FG003|Overall Study|Death|0|||
161793083|NCT02337829|584286024|FG000|Overall Study|Study terminated by sponsor|12|||
161793084|NCT02337829|584286025|FG001|Overall Study|Study terminated by sponsor|10|||
161793085|NCT02337829|584286026|FG002|Overall Study|Study terminated by sponsor|5|||
161793086|NCT02337829|584286027|FG003|Overall Study|Study terminated by sponsor|6|||
161793087|NCT02337829|584286024|FG000|Overall Study|discontinued for other reasons|6|||
161793088|NCT02337829|584286025|FG001|Overall Study|discontinued for other reasons|3|||
161793089|NCT02337829|584286026|FG002|Overall Study|discontinued for other reasons|1|||
161793090|NCT02337829|584286027|FG003|Overall Study|discontinued for other reasons|4|||
161793091|NCT00542386|584286030|FG000|Overall Study|Adverse Event|1|||
161793092|NCT00542386|584286031|FG001|Overall Study|Adverse Event|7|||
161793093|NCT00542386|584286032|FG002|Overall Study|Adverse Event|7|||
161793094|NCT00542386|584286033|FG003|Overall Study|Adverse Event|8|||
161793095|NCT00542386|584286034|FG004|Overall Study|Adverse Event|13|||
161793096|NCT00542386|584286035|FG005|Overall Study|Adverse Event|4|||
161793097|NCT00542386|584286030|FG000|Overall Study|Death|0|||
161793098|NCT00542386|584286031|FG001|Overall Study|Death|0|||
161793099|NCT00542386|584286032|FG002|Overall Study|Death|1|||
161793100|NCT00542386|584286033|FG003|Overall Study|Death|2|||
161793101|NCT00542386|584286034|FG004|Overall Study|Death|1|||
161793102|NCT00542386|584286035|FG005|Overall Study|Death|2|||
161793103|NCT00542386|584286030|FG000|Overall Study|Lack of Efficacy|32|||
161793104|NCT00542386|584286031|FG001|Overall Study|Lack of Efficacy|12|||
161793105|NCT00542386|584286032|FG002|Overall Study|Lack of Efficacy|10|||
161793106|NCT00542386|584286033|FG003|Overall Study|Lack of Efficacy|13|||
161793107|NCT00542386|584286034|FG004|Overall Study|Lack of Efficacy|7|||
161793108|NCT00542386|584286035|FG005|Overall Study|Lack of Efficacy|31|||
161793109|NCT00542386|584286030|FG000|Overall Study|Physician Decision|1|||
161793110|NCT00542386|584286031|FG001|Overall Study|Physician Decision|0|||
161793111|NCT00542386|584286032|FG002|Overall Study|Physician Decision|0|||
161793112|NCT00542386|584286033|FG003|Overall Study|Physician Decision|1|||
161793113|NCT00542386|584286034|FG004|Overall Study|Physician Decision|0|||
161793114|NCT00542386|584286035|FG005|Overall Study|Physician Decision|0|||
161793115|NCT00542386|584286030|FG000|Overall Study|Protocol Violation|0|||
161793116|NCT00542386|584286031|FG001|Overall Study|Protocol Violation|0|||
161793117|NCT00542386|584286032|FG002|Overall Study|Protocol Violation|1|||
161793118|NCT00542386|584286033|FG003|Overall Study|Protocol Violation|0|||
161793119|NCT00542386|584286034|FG004|Overall Study|Protocol Violation|0|||
161793120|NCT00542386|584286035|FG005|Overall Study|Protocol Violation|4|||
161793121|NCT00542386|584286030|FG000|Overall Study|Withdrawal by Subject|5|||
161793122|NCT00542386|584286031|FG001|Overall Study|Withdrawal by Subject|8|||
161793123|NCT00542386|584286032|FG002|Overall Study|Withdrawal by Subject|10|||
161793124|NCT00542386|584286033|FG003|Overall Study|Withdrawal by Subject|11|||
161793125|NCT00542386|584286034|FG004|Overall Study|Withdrawal by Subject|15|||
161793126|NCT00542386|584286035|FG005|Overall Study|Withdrawal by Subject|7|||
161793127|NCT00542386|584286030|FG000|Overall Study|Other Reasons|4|||
161793128|NCT00542386|584286031|FG001|Overall Study|Other Reasons|1|||
161793129|NCT00542386|584286032|FG002|Overall Study|Other Reasons|4|||
161793130|NCT00542386|584286033|FG003|Overall Study|Other Reasons|3|||
161793131|NCT00542386|584286034|FG004|Overall Study|Other Reasons|4|||
161793132|NCT00542386|584286035|FG005|Overall Study|Other Reasons|2|||
161793133|NCT02227849|584286038|FG000|Overall Study|Adverse Event|4|||
161793134|NCT02227849|584286038|FG000|Overall Study|Physician Decision|1|||
161793135|NCT02227849|584286038|FG000|Overall Study|Withdrawal by Subject|3|||
161793136|NCT00616928|584286039|FG000|Overall Study|Adverse Event|6|||
161793137|NCT00616928|584286040|FG001|Overall Study|Adverse Event|3|||
161793138|NCT00616928|584286041|FG002|Overall Study|Adverse Event|2|||
161793139|NCT00616928|584286042|FG003|Overall Study|Adverse Event|2|||
161793140|NCT00616928|584286039|FG000|Overall Study|Other|51|||
161793141|NCT00616928|584286040|FG001|Overall Study|Other|8|||
161793142|NCT00616928|584286041|FG002|Overall Study|Other|15|||
161793143|NCT00616928|584286042|FG003|Overall Study|Other|5|||
161793144|NCT00616928|584286039|FG000|Overall Study|Lost to Follow-up|5|||
161793145|NCT00616928|584286040|FG001|Overall Study|Lost to Follow-up|7|||
161793146|NCT00616928|584286041|FG002|Overall Study|Lost to Follow-up|0|||
161793147|NCT00616928|584286042|FG003|Overall Study|Lost to Follow-up|0|||
161793148|NCT00895583|584286043|FG000|Overall Study|Adverse Event|28|||
161793149|NCT00895583|584286044|FG001|Overall Study|Adverse Event|4|||
161793150|NCT00895583|584286043|FG000|Overall Study|Death|2|||
161793151|NCT00895583|584286044|FG001|Overall Study|Death|1|||
161793152|NCT00895583|584286043|FG000|Overall Study|Physician Decision|3|||
161793153|NCT00895583|584286044|FG001|Overall Study|Physician Decision|1|||
161793154|NCT00895583|584286043|FG000|Overall Study|Lost to Follow-up|1|||
161793155|NCT00895583|584286044|FG001|Overall Study|Lost to Follow-up|3|||
161793156|NCT00895583|584286043|FG000|Overall Study|Protocol Violation|1|||
161793157|NCT00895583|584286044|FG001|Overall Study|Protocol Violation|0|||
161793158|NCT00895583|584286043|FG000|Overall Study|Withdrawal by Subject|4|||
161793159|NCT00895583|584286044|FG001|Overall Study|Withdrawal by Subject|2|||
161793160|NCT00895583|584286043|FG000|Overall Study|Lack of Efficacy|5|||
161793161|NCT00895583|584286044|FG001|Overall Study|Lack of Efficacy|0|||
161793162|NCT00895583|584286043|FG000|Overall Study|Other|0|||
161793163|NCT00895583|584286044|FG001|Overall Study|Other|1|||
161793164|NCT04535583|584286053|FG000|Overall Study|Lost to Follow-up|1|||
161793165|NCT04535583|584286053|FG000|Overall Study|Physician Decision|1|||
161793166|NCT04535583|584286053|FG000|Overall Study|Withdrawal by Subject|1|||
161793167|NCT01078090|584286054|FG000|Overall Study|Lost to Follow-up|2363|||
161793168|NCT01078090|584286054|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
161793169|NCT01078090|584286054|FG000|Overall Study|Lack of Efficacy|1193|||
161793170|NCT01078090|584286054|FG000|Overall Study|ADR and lack of efficacy|61|||
161793171|NCT01078090|584286054|FG000|Overall Study|Other|523|||
161793172|NCT01748890|584286056|FG000|Overall Study|Insufficient recruitment for analysis|4|||
161793173|NCT02669264|584286057|FG000|Overall Study|Death|5|||
161793174|NCT02669264|584286058|FG001|Overall Study|Death|5|||
161793175|NCT02669264|584286059|FG002|Overall Study|Death|3|||
161793176|NCT02669264|584286060|FG003|Overall Study|Death|3|||
161793177|NCT02669264|584286061|FG004|Overall Study|Death|3|||
161793178|NCT02669264|584286062|FG005|Overall Study|Death|6|||
161793179|NCT02669264|584286063|FG006|Overall Study|Death|3|||
161793180|NCT02669264|584286057|FG000|Overall Study|Withdrawal by Subject|0|||
161793181|NCT02669264|584286058|FG001|Overall Study|Withdrawal by Subject|1|||
161793182|NCT02669264|584286059|FG002|Overall Study|Withdrawal by Subject|0|||
161793183|NCT02669264|584286060|FG003|Overall Study|Withdrawal by Subject|0|||
161793184|NCT02669264|584286061|FG004|Overall Study|Withdrawal by Subject|1|||
161793185|NCT02669264|584286062|FG005|Overall Study|Withdrawal by Subject|0|||
161793186|NCT02669264|584286063|FG006|Overall Study|Withdrawal by Subject|0|||
161793187|NCT02669264|584286057|FG000|Overall Study|Lost to Follow-up|0|||
162130563|NCT05305040|585529888|FG000|Overall Study|Investigator's Decision|1|||
162130564|NCT05305040|585529889|FG001|Overall Study|Investigator's Decision|1|||
161793188|NCT02669264|584286058|FG001|Overall Study|Lost to Follow-up|0|||
161793189|NCT02669264|584286059|FG002|Overall Study|Lost to Follow-up|0|||
161793190|NCT02669264|584286060|FG003|Overall Study|Lost to Follow-up|0|||
161793191|NCT02669264|584286061|FG004|Overall Study|Lost to Follow-up|1|||
161793192|NCT02669264|584286062|FG005|Overall Study|Lost to Follow-up|0|||
161793193|NCT02669264|584286063|FG006|Overall Study|Lost to Follow-up|0|||
161793194|NCT02669264|584286057|FG000|Overall Study|Miscellaneous|0|||
161793195|NCT02669264|584286058|FG001|Overall Study|Miscellaneous|0|||
161793196|NCT02669264|584286059|FG002|Overall Study|Miscellaneous|0|||
161793197|NCT02669264|584286060|FG003|Overall Study|Miscellaneous|0|||
161793198|NCT02669264|584286061|FG004|Overall Study|Miscellaneous|0|||
161793199|NCT02669264|584286062|FG005|Overall Study|Miscellaneous|0|||
161793200|NCT02669264|584286063|FG006|Overall Study|Miscellaneous|2|||
161793201|NCT03035227|584286064|FG000|Overall Study|study stopped due to PI leaving institut|1|||
162130565|NCT05305040|585529888|FG000|Overall Study|COVID-19 Reasons|1|||
162130566|NCT05305040|585529889|FG001|Overall Study|COVID-19 Reasons|0|||
162130567|NCT02206685|585529890|FG000|Overall Study|Surgery cancelled/changed|2|||
162130568|NCT02206685|585529891|FG001|Overall Study|Surgery cancelled/changed|3|||
161793202|NCT03035227|584286065|FG001|Overall Study|study stopped due to PI leaving institut|1|||
161793203|NCT02100956|584286066|FG000|At Least One Week Between Injections|Adverse Event|0|||
161793204|NCT02100956|584286067|FG001|At Least One Week Between Injections|Adverse Event|1|||
161793205|NCT03529955|584286068|FG000|Overall Study|Adverse Event|1|||
161793206|NCT03529955|584286068|FG000|Overall Study|Lack of Efficacy|1|||
161793207|NCT03016078|584286072|FG000|Overall Study|Protocol Violation|1|||
161793208|NCT03016078|584286072|FG000|Overall Study|Protocol Violation|1|||
161793209|NCT00707954|584286958|FG000|Overall Study|Physician Decision|0|||
161793210|NCT00707954|584286959|FG001|Overall Study|Physician Decision|0|||
161793211|NCT00707954|584286960|FG002|Overall Study|Physician Decision|0|||
161793212|NCT00707954|584286961|FG003|Overall Study|Physician Decision|0|||
161793213|NCT00707954|584286962|FG004|Overall Study|Physician Decision|1|||
161793214|NCT06509100|584286965|FG000|Overall Study|Withdrawal by Subject|1|||
161793215|NCT06509100|584286965|FG000|Overall Study|Lost to Follow-up|1|||
161793216|NCT05245617|584286969|FG000|Overall Study|Withdrawal by Subject|1|||
161793217|NCT03425331|584286970|FG000|Overall Study|Withdrawal by Subject|1|||
161793218|NCT03425331|584286970|FG000|Overall Study|Death|1|||
161793219|NCT03425331|584286970|FG000|Overall Study|Adverse Event|1|||
161793220|NCT03425331|584286970|FG000|Overall Study|Disease Progression|2|||
161793221|NCT03433274|584286971|FG000|Overall Study|Withdrawal by Subject|2|||
161793222|NCT03433274|584286971|FG000|Overall Study|Missed visit|5|||
161793223|NCT03433274|584286971|FG000|Overall Study|Death|23|||
161793224|NCT00441584|584286972|FG000|Overall Study|Lack of Efficacy|79|||
161793225|NCT00441584|584286972|FG000|Overall Study|Withdrawal by Subject|8|||
161793226|NCT00441584|584286972|FG000|Overall Study|Adverse Event|6|||
161793227|NCT00441584|584286972|FG000|Overall Study|Protocol Violation|5|||
161793228|NCT00441584|584286972|FG000|Overall Study|Lost to Follow-up|4|||
161793229|NCT00441584|584286972|FG000|Overall Study|Failure to meet eligibility criteria|3|||
161793230|NCT04864405|584286973|FG000|Overall Study|Withdrawal by Subject|4|||
161793231|NCT04864405|584286974|FG001|Overall Study|Withdrawal by Subject|6|||
161793232|NCT04864405|584286973|FG000|Overall Study|Did not want endocrine therapy|3|||
161793233|NCT04864405|584286974|FG001|Overall Study|Did not want endocrine therapy|5|||
161793234|NCT04029090|584286975|FG000|Overall Study|Protocol Violation|1|||
161793235|NCT04029090|584286976|FG001|Overall Study|Protocol Violation|0|||
161793236|NCT04029090|584286977|FG002|Overall Study|Protocol Violation|0|||
161793237|NCT04029090|584286975|FG000|Overall Study|Withdrawal by Subject|0|||
161793238|NCT04029090|584286976|FG001|Overall Study|Withdrawal by Subject|1|||
161793239|NCT04029090|584286977|FG002|Overall Study|Withdrawal by Subject|0|||
161793240|NCT00506441|584286978|FG000|Period 1; Open-label Period|Adverse Event|21|||
161793241|NCT00506441|584286979|FG001|Period 1; Open-label Period|Adverse Event|0|||
161793242|NCT00506441|584286978|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
161793243|NCT00506441|584286979|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
161793244|NCT00506441|584286978|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
161793245|NCT00506441|584286979|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
161793246|NCT00506441|584286978|FG000|Period 1; Open-label Period|Physician Decision|5|||
161793247|NCT00506441|584286979|FG001|Period 1; Open-label Period|Physician Decision|0|||
161793248|NCT00506441|584286978|FG000|Period 1; Open-label Period|Protocol Violation|9|||
161793249|NCT00506441|584286979|FG001|Period 1; Open-label Period|Protocol Violation|0|||
161793250|NCT00506441|584286978|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
161793251|NCT00506441|584286979|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
161793252|NCT00506441|584286978|FG000|Period 1; Open-label Period|Other Reasons|13|||
161793253|NCT00506441|584286979|FG001|Period 1; Open-label Period|Other Reasons|0|||
161793254|NCT00506441|584286978|FG000|Period 2; Double-blind Period|Adverse Event|0|||
161793255|NCT00506441|584286979|FG001|Period 2; Double-blind Period|Adverse Event|1|||
161793256|NCT00506441|584286978|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
161793257|NCT00506441|584286979|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
161793258|NCT00506441|584286978|FG000|Period 2; Double-blind Period|Physician Decision|1|||
161793259|NCT00506441|584286979|FG001|Period 2; Double-blind Period|Physician Decision|1|||
161793260|NCT00506441|584286978|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
161793261|NCT00506441|584286979|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
161793262|NCT00506441|584286978|FG000|Period 2; Double-blind Period|Other Reason|1|||
161793263|NCT00506441|584286979|FG001|Period 2; Double-blind Period|Other Reason|1|||
161793264|NCT00501046|584286980|FG000|Overall Study|Adverse Event|21|||
161793265|NCT00501046|584286981|FG001|Overall Study|Adverse Event|25|||
161793266|NCT00501046|584286980|FG000|Overall Study|Death|23|||
161793267|NCT00501046|584286981|FG001|Overall Study|Death|30|||
161793268|NCT00501046|584286980|FG000|Overall Study|Lost to Follow-up|14|||
161793269|NCT00501046|584286981|FG001|Overall Study|Lost to Follow-up|13|||
161793270|NCT00501046|584286980|FG000|Overall Study|Physician Decision|7|||
161793271|NCT00501046|584286981|FG001|Overall Study|Physician Decision|2|||
161793272|NCT00501046|584286980|FG000|Overall Study|Pregnancy|0|||
161793273|NCT00501046|584286981|FG001|Overall Study|Pregnancy|3|||
161898871|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
161793274|NCT00501046|584286980|FG000|Overall Study|Protocol Violation|2|||
161793275|NCT00501046|584286981|FG001|Overall Study|Protocol Violation|1|||
161793276|NCT00501046|584286980|FG000|Overall Study|Withdrawal by Subject|84|||
161793277|NCT00501046|584286981|FG001|Overall Study|Withdrawal by Subject|83|||
161793278|NCT00501046|584286980|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
161793279|NCT00501046|584286981|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
161793280|NCT05056727|584286982|FG000|Initiation Phase|Lost to Follow-up|1|||
162010671|NCT02351856|585095947|FG000|Overall Study|Adverse Event|2|||
161793281|NCT05056727|584286983|FG001|Initiation Phase|Lost to Follow-up|0|||
161793282|NCT05056727|584286984|FG002|Initiation Phase|Lost to Follow-up|0|||
161793283|NCT05056727|584286985|FG003|Initiation Phase|Lost to Follow-up|0|||
161793284|NCT05056727|584286982|FG000|Initiation Phase|Study-specific; Study terminated; Other|20|||
161793285|NCT05056727|584286983|FG001|Initiation Phase|Study-specific; Study terminated; Other|0|||
161793286|NCT05056727|584286984|FG002|Initiation Phase|Study-specific; Study terminated; Other|0|||
161793287|NCT05056727|584286985|FG003|Initiation Phase|Study-specific; Study terminated; Other|0|||
161793288|NCT05056727|584286982|FG000|Initiation Phase|Withdrawal by Subject|9|||
161793289|NCT05056727|584286983|FG001|Initiation Phase|Withdrawal by Subject|0|||
161793290|NCT05056727|584286984|FG002|Initiation Phase|Withdrawal by Subject|0|||
161793291|NCT05056727|584286985|FG003|Initiation Phase|Withdrawal by Subject|0|||
161793292|NCT05056727|584286982|FG000|Initiation Phase|Physician Decision|4|||
161793293|NCT05056727|584286983|FG001|Initiation Phase|Physician Decision|0|||
161793294|NCT05056727|584286984|FG002|Initiation Phase|Physician Decision|0|||
161793295|NCT05056727|584286985|FG003|Initiation Phase|Physician Decision|0|||
161793296|NCT05056727|584286982|FG000|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
161793297|NCT05056727|584286983|FG001|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|237|||
161793298|NCT05056727|584286984|FG002|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
161793299|NCT05056727|584286985|FG003|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
161793300|NCT05056727|584286982|FG000|Run-in Phase|Death|0|||
161793301|NCT05056727|584286983|FG001|Run-in Phase|Death|3|||
161793302|NCT05056727|584286984|FG002|Run-in Phase|Death|0|||
161793303|NCT05056727|584286985|FG003|Run-in Phase|Death|0|||
161793304|NCT05056727|584286982|FG000|Run-in Phase|Withdrawal by Subject|0|||
161793305|NCT05056727|584286983|FG001|Run-in Phase|Withdrawal by Subject|25|||
161793306|NCT05056727|584286984|FG002|Run-in Phase|Withdrawal by Subject|0|||
161793307|NCT05056727|584286985|FG003|Run-in Phase|Withdrawal by Subject|0|||
161793308|NCT05056727|584286982|FG000|Run-in Phase|Physician Decision|0|||
161793309|NCT05056727|584286983|FG001|Run-in Phase|Physician Decision|20|||
161793310|NCT05056727|584286984|FG002|Run-in Phase|Physician Decision|0|||
161793311|NCT05056727|584286985|FG003|Run-in Phase|Physician Decision|0|||
161793312|NCT05056727|584286982|FG000|Run-in Phase|Lost to Follow-up|0|||
161793313|NCT05056727|584286983|FG001|Run-in Phase|Lost to Follow-up|1|||
161793314|NCT05056727|584286984|FG002|Run-in Phase|Lost to Follow-up|0|||
161793315|NCT05056727|584286985|FG003|Run-in Phase|Lost to Follow-up|0|||
161793316|NCT05056727|584286982|FG000|Maintenance Phase|Site terminated; Study terminated; Other|0|||
161793317|NCT05056727|584286983|FG001|Maintenance Phase|Site terminated; Study terminated; Other|0|||
161793318|NCT05056727|584286984|FG002|Maintenance Phase|Site terminated; Study terminated; Other|332|||
161793319|NCT05056727|584286985|FG003|Maintenance Phase|Site terminated; Study terminated; Other|314|||
161793320|NCT05056727|584286982|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161793321|NCT05056727|584286983|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161793322|NCT05056727|584286984|FG002|Maintenance Phase|Withdrawal by Subject|19|||
161793323|NCT05056727|584286985|FG003|Maintenance Phase|Withdrawal by Subject|21|||
161793324|NCT05056727|584286982|FG000|Maintenance Phase|Physician Decision|0|||
161793325|NCT05056727|584286983|FG001|Maintenance Phase|Physician Decision|0|||
161793326|NCT05056727|584286984|FG002|Maintenance Phase|Physician Decision|4|||
161793327|NCT05056727|584286985|FG003|Maintenance Phase|Physician Decision|16|||
161793328|NCT05056727|584286982|FG000|Maintenance Phase|Lost to Follow-up|0|||
161793329|NCT05056727|584286983|FG001|Maintenance Phase|Lost to Follow-up|0|||
161793330|NCT05056727|584286984|FG002|Maintenance Phase|Lost to Follow-up|2|||
161793331|NCT05056727|584286985|FG003|Maintenance Phase|Lost to Follow-up|2|||
161793332|NCT05056727|584286982|FG000|Maintenance Phase|Death|0|||
161793333|NCT05056727|584286983|FG001|Maintenance Phase|Death|0|||
161793334|NCT05056727|584286984|FG002|Maintenance Phase|Death|4|||
161793335|NCT05056727|584286985|FG003|Maintenance Phase|Death|2|||
161793336|NCT02622113|584286986|FG000|Overall Study|Adverse Event|4|||
161793337|NCT02622113|584286987|FG001|Overall Study|Adverse Event|4|||
161793338|NCT02622113|584286986|FG000|Overall Study|Physician Decision|0|||
161793339|NCT02622113|584286987|FG001|Overall Study|Physician Decision|1|||
161793340|NCT02622113|584286986|FG000|Overall Study|Withdrawal by Subject|0|||
161793341|NCT02622113|584286987|FG001|Overall Study|Withdrawal by Subject|2|||
161793342|NCT02622113|584286986|FG000|Overall Study|Stopping Criteria|1|||
161793343|NCT02622113|584286987|FG001|Overall Study|Stopping Criteria|3|||
161793344|NCT03289208|584286989|FG000|Overall Study|Adverse Event|1|||
161793345|NCT03289208|584286990|FG001|Overall Study|Adverse Event|0|||
161793346|NCT03289208|584286991|FG002|Overall Study|Adverse Event|0|||
161793347|NCT01840605|584286993|FG000|Overall Study|Adverse Event|0|||
161793348|NCT01840605|584286994|FG001|Overall Study|Adverse Event|1|||
161793349|NCT01840605|584286993|FG000|Overall Study|Physician Decision|2|||
161793350|NCT01840605|584286994|FG001|Overall Study|Physician Decision|1|||
161793351|NCT04969939|584286995|FG000|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161793352|NCT04969939|584286996|FG001|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161793353|NCT04969939|584286997|FG002|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161793354|NCT04969939|584286998|FG003|Part 2a: Run in Period (32 Weeks)|Adverse Event|4|||
161793355|NCT04969939|584286999|FG004|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161793356|NCT04969939|584287000|FG005|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161793357|NCT04969939|584287001|FG006|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161793358|NCT04969939|584286995|FG000|Part 2a: Run in Period (32 Weeks)|Other|0|||
161793359|NCT04969939|584286996|FG001|Part 2a: Run in Period (32 Weeks)|Other|0|||
161793360|NCT04969939|584286997|FG002|Part 2a: Run in Period (32 Weeks)|Other|0|||
161793361|NCT04969939|584286998|FG003|Part 2a: Run in Period (32 Weeks)|Other|5|||
161793362|NCT04969939|584286999|FG004|Part 2a: Run in Period (32 Weeks)|Other|0|||
162130569|NCT02206685|585529890|FG000|Overall Study|Withdrawal by Subject|1|||
162130570|NCT02206685|585529891|FG001|Overall Study|Withdrawal by Subject|2|||
162130571|NCT02206685|585529890|FG000|Overall Study|Protocol Violation|2|||
162130572|NCT02206685|585529891|FG001|Overall Study|Protocol Violation|2|||
162130573|NCT01195675|585529892|FG000|Overall Study|Adverse Event|1|||
162130574|NCT01195675|585529892|FG000|Overall Study|Withdrawal by Subject|2|||
162130575|NCT01174550|585529893|FG000|Overall Study|Death|75|||
162130576|NCT01174550|585529894|FG001|Overall Study|Death|74|||
162130577|NCT01174550|585529893|FG000|Overall Study|Lost to Follow-up|652|||
162130578|NCT01174550|585529894|FG001|Overall Study|Lost to Follow-up|510|||
162130579|NCT01174550|585529893|FG000|Overall Study|Withdrawal by Subject|543|||
162130580|NCT01174550|585529894|FG001|Overall Study|Withdrawal by Subject|289|||
162130581|NCT01536262|585529895|FG000|Overall Study|Adverse Event|6|||
162130582|NCT01536262|585529896|FG001|Overall Study|Adverse Event|1|||
162130583|NCT01536262|585529897|FG002|Overall Study|Adverse Event|2|||
162130584|NCT01536262|585529895|FG000|Overall Study|Withdrawal by Subject|1|||
162130585|NCT01536262|585529896|FG001|Overall Study|Withdrawal by Subject|1|||
162130586|NCT01536262|585529897|FG002|Overall Study|Withdrawal by Subject|0|||
162130587|NCT01536262|585529895|FG000|Overall Study|Other than stated above|1|||
162130588|NCT01536262|585529896|FG001|Overall Study|Other than stated above|0|||
162130589|NCT01536262|585529897|FG002|Overall Study|Other than stated above|0|||
162130590|NCT01460381|585529901|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
162130591|NCT01460381|585529902|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
162130592|NCT01097655|585529903|FG000|Overall Study|Withdrawal by Subject|1|||
162130593|NCT01097655|585529903|FG000|Overall Study|Subject Documented Twice|1|||
162130594|NCT01097655|585529903|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
162130595|NCT01033643|585529904|FG000|Overall Study|Withdrew Consent|0|||
162130596|NCT01033643|585529905|FG001|Overall Study|Withdrew Consent|3|||
162130597|NCT01033643|585529906|FG002|Overall Study|Withdrew Consent|0|||
162130598|NCT01033643|585529907|FG003|Overall Study|Withdrew Consent|0|||
162130599|NCT01033643|585529908|FG004|Overall Study|Withdrew Consent|0|||
162130600|NCT01033643|585529909|FG005|Overall Study|Withdrew Consent|1|||
162130601|NCT03527277|585529910|FG000|Overall Study|Withdrawal by Subject|5|||
162130602|NCT03527277|585529911|FG001|Overall Study|Withdrawal by Subject|0|||
162130603|NCT03527277|585529910|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
162130604|NCT03527277|585529911|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
162130605|NCT03527277|585529910|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
162130606|NCT03527277|585529911|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
162130607|NCT01781611|585529912|FG000|Overall Study|Adverse Event|4|||
162130608|NCT01781611|585529913|FG001|Overall Study|Adverse Event|0|||
162130609|NCT02652130|585529914|FG000|Overall Study|Death|1|||
162130610|NCT00354029|585529915|FG000|Overall Study|Protocol Violation|4|||
162130611|NCT00354029|585529916|FG001|Overall Study|Protocol Violation|2|||
162130612|NCT00839917|585529920|FG000|Overall Study|Lost to Follow-up|1|||
162130613|NCT00839917|585529921|FG001|Overall Study|Lost to Follow-up|0|||
162130614|NCT00839917|585529920|FG000|Overall Study|Did not receive vaccine|0|||
162130615|NCT00839917|585529921|FG001|Overall Study|Did not receive vaccine|1|||
162130616|NCT00765362|585529922|FG000|Overall Study|Death|9|||
162130617|NCT00765362|585529922|FG000|Overall Study|Adverse Event|2|||
162130618|NCT00765362|585529922|FG000|Overall Study|Protocol Violation|18|||
162130619|NCT00765362|585529922|FG000|Overall Study|Withdrawal by Subject|13|||
162130620|NCT00765362|585529922|FG000|Overall Study|Lost to Follow-up|95|||
162130621|NCT04466618|585529935|FG000|Overall Study|Withdrawal by Subject|0|||
162130622|NCT04466618|585529936|FG001|Overall Study|Withdrawal by Subject|1|||
162130623|NCT02800928|585529937|FG000|Overall Study|Withdrawal by Subject|1|||
162130624|NCT02800928|585529938|FG001|Overall Study|Withdrawal by Subject|1|||
162130625|NCT02800928|585529937|FG000|Overall Study|Protocol Violation|1|||
162130626|NCT02800928|585529938|FG001|Overall Study|Protocol Violation|1|||
162130627|NCT02886728|585529946|FG000|Overall Study|Withdrew Consent|31|||
162130628|NCT02886728|585529947|FG001|Overall Study|Withdrew Consent|13|||
162130629|NCT02886728|585529948|FG002|Overall Study|Withdrew Consent|11|||
162130630|NCT02886728|585529949|FG003|Overall Study|Withdrew Consent|47|||
161793363|NCT04969939|584287000|FG005|Part 2a: Run in Period (32 Weeks)|Other|0|||
161793364|NCT04969939|584287001|FG006|Part 2a: Run in Period (32 Weeks)|Other|0|||
162010672|NCT02351856|585095947|FG000|Overall Study|Physician Decision|5|||
162130631|NCT02886728|585529946|FG000|Overall Study|Lost to Follow-up|12|||
162130632|NCT02886728|585529947|FG001|Overall Study|Lost to Follow-up|6|||
162130633|NCT02886728|585529948|FG002|Overall Study|Lost to Follow-up|13|||
162130634|NCT02886728|585529949|FG003|Overall Study|Lost to Follow-up|12|||
162130635|NCT02886728|585529946|FG000|Overall Study|Adverse Event|13|||
162130636|NCT02886728|585529947|FG001|Overall Study|Adverse Event|5|||
162130637|NCT02886728|585529948|FG002|Overall Study|Adverse Event|5|||
162130638|NCT02886728|585529949|FG003|Overall Study|Adverse Event|11|||
162130639|NCT02886728|585529946|FG000|Overall Study|Investigator's Discretion|11|||
162130640|NCT02886728|585529947|FG001|Overall Study|Investigator's Discretion|7|||
162130641|NCT02886728|585529948|FG002|Overall Study|Investigator's Discretion|5|||
162130642|NCT02886728|585529949|FG003|Overall Study|Investigator's Discretion|11|||
161793365|NCT04969939|584286995|FG000|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161793366|NCT04969939|584286996|FG001|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161793367|NCT04969939|584286997|FG002|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161793368|NCT04969939|584286998|FG003|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|2|||
161793369|NCT04969939|584286999|FG004|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161793370|NCT04969939|584287000|FG005|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161793371|NCT04969939|584287001|FG006|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161793372|NCT04969939|584286995|FG000|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161793373|NCT04969939|584286996|FG001|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161793374|NCT04969939|584286997|FG002|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161793375|NCT04969939|584286998|FG003|Part 2a: Run in Period (32 Weeks)|Pregnancy|1|||
161793376|NCT04969939|584286999|FG004|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161793377|NCT04969939|584287000|FG005|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161793378|NCT04969939|584287001|FG006|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161793379|NCT04969939|584286995|FG000|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161793380|NCT04969939|584286996|FG001|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161793381|NCT04969939|584286997|FG002|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161793382|NCT04969939|584286998|FG003|Part 2a: Run in Period (32 Weeks)|Protocol Violation|1|||
161793383|NCT04969939|584286999|FG004|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161793384|NCT04969939|584287000|FG005|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161793385|NCT04969939|584287001|FG006|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161793386|NCT04969939|584286995|FG000|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161793387|NCT04969939|584286996|FG001|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161793388|NCT04969939|584286997|FG002|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161793389|NCT04969939|584286998|FG003|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
162130643|NCT02886728|585529946|FG000|Overall Study|Death|3|||
162130644|NCT02886728|585529947|FG001|Overall Study|Death|1|||
162130645|NCT02886728|585529948|FG002|Overall Study|Death|0|||
162130646|NCT02886728|585529949|FG003|Overall Study|Death|0|||
162130647|NCT02886728|585529946|FG000|Overall Study|Protocol Violation|0|||
162130648|NCT02886728|585529947|FG001|Overall Study|Protocol Violation|0|||
161793390|NCT04969939|584286999|FG004|Part 2b (16 Weeks)|Withdrawal by Subject|3|||
161793391|NCT04969939|584287000|FG005|Part 2b (16 Weeks)|Withdrawal by Subject|1|||
161793392|NCT04969939|584287001|FG006|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161793393|NCT05308472|584287002|FG000|Overall Study|Adverse Event|0|||
161793394|NCT05308472|584287003|FG001|Overall Study|Adverse Event|0|||
162130649|NCT02886728|585529948|FG002|Overall Study|Protocol Violation|0|||
162130650|NCT02886728|585529949|FG003|Overall Study|Protocol Violation|4|||
162130651|NCT02886728|585529946|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162130652|NCT02886728|585529947|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162130653|NCT02886728|585529948|FG002|Overall Study|Non-Compliance with Study Drug|1|||
162130654|NCT02886728|585529949|FG003|Overall Study|Non-Compliance with Study Drug|0|||
162130655|NCT02886728|585529946|FG000|Overall Study|Pregnancy|0|||
162130656|NCT02886728|585529947|FG001|Overall Study|Pregnancy|0|||
162130657|NCT02886728|585529948|FG002|Overall Study|Pregnancy|1|||
162130658|NCT02886728|585529949|FG003|Overall Study|Pregnancy|0|||
162130659|NCT02886728|585529946|FG000|Overall Study|Randomized but Not Dosed|1|||
162130660|NCT02886728|585529947|FG001|Overall Study|Randomized but Not Dosed|0|||
162130661|NCT02886728|585529948|FG002|Overall Study|Randomized but Not Dosed|0|||
162130662|NCT02886728|585529949|FG003|Overall Study|Randomized but Not Dosed|2|||
162130663|NCT00109928|585529950|FG000|Overall Study|Adverse Event|2|||
162130664|NCT00109928|585529950|FG000|Overall Study|Progression|6|||
161793395|NCT05308472|584287004|FG002|Overall Study|Adverse Event|3|||
161793396|NCT02717611|584287012|FG000|Overall Study|Death|13|||
161793397|NCT02717611|584287012|FG000|Overall Study|Withdrawal by Subject|6|||
161793398|NCT02717611|584287012|FG000|Overall Study|Active, not recruiting|40|||
161793399|NCT02717611|584287012|FG000|Overall Study|Complicating disease|1|||
161793400|NCT05182606|584287015|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|29|||
161793401|NCT02619682|584287016|FG000|Overall Study|Withdrawal by Subject|3|||
161793402|NCT02619682|584287016|FG000|Overall Study|Lack of Efficacy|8|||
161793403|NCT02619682|584287016|FG000|Overall Study|new secondary cancer|1|||
161793404|NCT02619682|584287016|FG000|Overall Study|post surgery complications|2|||
161793405|NCT01861522|584287017|FG000|Overall Study|Adverse Event|1|||
161793406|NCT01861522|584287018|FG001|Overall Study|Adverse Event|0|||
161793407|NCT01861522|584287017|FG000|Overall Study|Withdrawal by Subject|2|||
161793408|NCT01861522|584287018|FG001|Overall Study|Withdrawal by Subject|0|||
161793409|NCT00500682|584287019|FG000|Overall Study|Adverse Event|37|||
161793410|NCT00500682|584287020|FG001|Overall Study|Adverse Event|29|||
161793411|NCT00500682|584287019|FG000|Overall Study|Death|25|||
161793412|NCT00500682|584287020|FG001|Overall Study|Death|16|||
162130665|NCT00109928|585529950|FG000|Overall Study|Death|2|||
162130666|NCT00109928|585529950|FG000|Overall Study|not protocol specified|2|||
162130667|NCT00109928|585529950|FG000|Overall Study|not eligible|1|||
162130668|NCT01364727|585529951|FG000|Overall Study|Not Eligible|2|||
162130669|NCT01676220|585529952|FG000|Overall Study|Randomized But Not Treated|4|||
162130670|NCT01676220|585529953|FG001|Overall Study|Randomized But Not Treated|1|||
162130671|NCT01676220|585529952|FG000|Overall Study|Adverse Event|10|||
162130672|NCT01676220|585529953|FG001|Overall Study|Adverse Event|8|||
162130673|NCT01676220|585529952|FG000|Overall Study|Lack of Efficacy|2|||
162130674|NCT01676220|585529953|FG001|Overall Study|Lack of Efficacy|5|||
162130675|NCT01676220|585529952|FG000|Overall Study|Protocol Violation|11|||
162130676|NCT01676220|585529953|FG001|Overall Study|Protocol Violation|12|||
162130677|NCT01676220|585529952|FG000|Overall Study|Received Rescue Therapy|14|||
162130678|NCT01676220|585529953|FG001|Overall Study|Received Rescue Therapy|22|||
162130679|NCT01676220|585529952|FG000|Overall Study|Personal Reason|34|||
162130680|NCT01676220|585529953|FG001|Overall Study|Personal Reason|45|||
162130681|NCT01676220|585529952|FG000|Overall Study|Lost to Follow-up|11|||
162130682|NCT01676220|585529953|FG001|Overall Study|Lost to Follow-up|18|||
162130683|NCT01676220|585529952|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
162130684|NCT01676220|585529953|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
162130685|NCT01676220|585529952|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
162130686|NCT01676220|585529953|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
162130687|NCT01676220|585529952|FG000|Overall Study|Perceived Lack of Efficacy|3|||
162130688|NCT01676220|585529953|FG001|Overall Study|Perceived Lack of Efficacy|1|||
162130689|NCT01676220|585529952|FG000|Overall Study|Non Serious Hypoglycemia|2|||
162130690|NCT01676220|585529953|FG001|Overall Study|Non Serious Hypoglycemia|0|||
162130691|NCT01676220|585529952|FG000|Overall Study|No More Need of Insulin|1|||
162130692|NCT01676220|585529953|FG001|Overall Study|No More Need of Insulin|0|||
162130693|NCT02411591|585529954|FG000|Overall Study|Adverse Event|0|||
162130694|NCT02411591|585529955|FG001|Overall Study|Adverse Event|4|||
162130695|NCT02411591|585529956|FG002|Overall Study|Adverse Event|2|||
162130696|NCT02411591|585529954|FG000|Overall Study|Withdrawal by Subject|0|||
162130697|NCT02411591|585529955|FG001|Overall Study|Withdrawal by Subject|3|||
162130698|NCT02411591|585529956|FG002|Overall Study|Withdrawal by Subject|0|||
162130699|NCT02411591|585529954|FG000|Overall Study|Physician Decision|0|||
162130700|NCT02411591|585529955|FG001|Overall Study|Physician Decision|3|||
162130701|NCT02411591|585529956|FG002|Overall Study|Physician Decision|1|||
162130702|NCT00750893|585529959|FG000|Overall Study|Adverse Event|5|||
162130703|NCT00750893|585529959|FG000|Overall Study|Withdrawal by Subject|10|||
162130704|NCT00750893|585529959|FG000|Overall Study|Lost to Follow-up|510|||
162130705|NCT00750893|585529959|FG000|Overall Study|Other|17|||
162130706|NCT00661258|585529967|FG000|Overall Study|Death|1|||
162130707|NCT00661258|585529968|FG001|Overall Study|Death|0|||
162130708|NCT00661258|585529967|FG000|Overall Study|caught by police and in detox center|2|||
162130709|NCT00661258|585529968|FG001|Overall Study|caught by police and in detox center|1|||
162130710|NCT01628874|585529969|FG000|Overall Study|Physician Decision|1|||
162130711|NCT01628874|585529970|FG001|Overall Study|Physician Decision|1|||
162130712|NCT01628874|585529969|FG000|Overall Study|Age >4 months|4|||
162130713|NCT01628874|585529970|FG001|Overall Study|Age >4 months|2|||
162130714|NCT00873093|585529971|FG000|Overall Study|Adverse Event|0|||
162130715|NCT00873093|585529972|FG001|Overall Study|Adverse Event|2|||
162130716|NCT00873093|585529973|FG002|Overall Study|Adverse Event|0|||
162130717|NCT00873093|585529974|FG003|Overall Study|Adverse Event|0|||
162130718|NCT00873093|585529975|FG004|Overall Study|Adverse Event|0|||
162130719|NCT00873093|585529971|FG000|Overall Study|Death|0|||
162130720|NCT00873093|585529972|FG001|Overall Study|Death|3|||
162130721|NCT00873093|585529973|FG002|Overall Study|Death|2|||
162130722|NCT00873093|585529974|FG003|Overall Study|Death|0|||
162130723|NCT00873093|585529975|FG004|Overall Study|Death|0|||
162130724|NCT00873093|585529971|FG000|Overall Study|Physician Decision|0|||
162130725|NCT00873093|585529972|FG001|Overall Study|Physician Decision|17|||
162130726|NCT00873093|585529973|FG002|Overall Study|Physician Decision|10|||
162130727|NCT00873093|585529974|FG003|Overall Study|Physician Decision|10|||
162130728|NCT00873093|585529975|FG004|Overall Study|Physician Decision|2|||
162130729|NCT00873093|585529971|FG000|Overall Study|Withdrawal by Subject|1|||
162130730|NCT00873093|585529972|FG001|Overall Study|Withdrawal by Subject|4|||
162130731|NCT00873093|585529973|FG002|Overall Study|Withdrawal by Subject|4|||
162130732|NCT00873093|585529974|FG003|Overall Study|Withdrawal by Subject|0|||
162130733|NCT00873093|585529975|FG004|Overall Study|Withdrawal by Subject|0|||
162130734|NCT00873093|585529971|FG000|Overall Study|Ineligible|0|||
162130735|NCT00873093|585529972|FG001|Overall Study|Ineligible|1|||
162130736|NCT00873093|585529973|FG002|Overall Study|Ineligible|0|||
162130737|NCT00873093|585529974|FG003|Overall Study|Ineligible|1|||
162130738|NCT00873093|585529975|FG004|Overall Study|Ineligible|0|||
162130739|NCT01152554|585529977|FG000|Overall Study|Withdrawal by Subject|73|||
162130740|NCT01152554|585529978|FG001|Overall Study|Withdrawal by Subject|28|||
162130741|NCT01152554|585529977|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
162130742|NCT01152554|585529978|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
162130743|NCT01152554|585529977|FG000|Overall Study|Adverse Event|67|||
162130744|NCT01152554|585529978|FG001|Overall Study|Adverse Event|14|||
162130745|NCT01152554|585529977|FG000|Overall Study|Severe non-compliance to protocol|36|||
162130746|NCT01152554|585529978|FG001|Overall Study|Severe non-compliance to protocol|14|||
162130747|NCT01152554|585529977|FG000|Overall Study|Condition under investigation worsened|5|||
162130748|NCT01152554|585529978|FG001|Overall Study|Condition under investigation worsened|2|||
162130749|NCT01152554|585529977|FG000|Overall Study|Lack of Efficacy|20|||
162130750|NCT01152554|585529978|FG001|Overall Study|Lack of Efficacy|3|||
162130751|NCT01152554|585529977|FG000|Overall Study|Study-specific withdrawal criteria|17|||
162130752|NCT01152554|585529978|FG001|Overall Study|Study-specific withdrawal criteria|8|||
162130753|NCT01152554|585529977|FG000|Overall Study|Lost to Follow-up|87|||
162130754|NCT01152554|585529978|FG001|Overall Study|Lost to Follow-up|32|||
162130755|NCT01152554|585529977|FG000|Overall Study|Other|28|||
162130756|NCT01152554|585529978|FG001|Overall Study|Other|8|||
162130757|NCT01152554|585529977|FG000|Overall Study|Death|1|||
162130758|NCT01152554|585529978|FG001|Overall Study|Death|1|||
162130759|NCT00146640|585529979|FG000|Overall Study|Adverse Event|12|||
162130760|NCT00146640|585529980|FG001|Overall Study|Adverse Event|10|||
162130761|NCT00146640|585529979|FG000|Overall Study|Medical Reasons|3|||
162130762|NCT00146640|585529980|FG001|Overall Study|Medical Reasons|0|||
162130763|NCT00146640|585529979|FG000|Overall Study|Non-Medical Reasons|8|||
162130764|NCT00146640|585529980|FG001|Overall Study|Non-Medical Reasons|4|||
162130765|NCT03486899|585529981|FG000|Overall Study|Lost to Follow-up|4|||
161793413|NCT00500682|584287019|FG000|Overall Study|Lost to Follow-up|11|||
161793414|NCT00500682|584287020|FG001|Overall Study|Lost to Follow-up|11|||
162130766|NCT03486899|585529982|FG001|Overall Study|Lost to Follow-up|1|||
162130767|NCT03486899|585529983|FG002|Overall Study|Lost to Follow-up|4|||
162130768|NCT03486899|585529984|FG003|Overall Study|Lost to Follow-up|3|||
162130769|NCT03486899|585529981|FG000|Overall Study|Death|1|||
162130770|NCT03486899|585529982|FG001|Overall Study|Death|0|||
162130771|NCT03486899|585529983|FG002|Overall Study|Death|0|||
162130772|NCT03486899|585529984|FG003|Overall Study|Death|1|||
162130773|NCT03486899|585529981|FG000|Overall Study|Adverse Event|0|||
162130774|NCT03486899|585529982|FG001|Overall Study|Adverse Event|2|||
162130775|NCT03486899|585529983|FG002|Overall Study|Adverse Event|0|||
162130776|NCT03486899|585529984|FG003|Overall Study|Adverse Event|2|||
162130777|NCT03486899|585529981|FG000|Overall Study|Withdrawal by Subject|3|||
162130778|NCT03486899|585529982|FG001|Overall Study|Withdrawal by Subject|7|||
162130779|NCT03486899|585529983|FG002|Overall Study|Withdrawal by Subject|4|||
162130780|NCT03486899|585529984|FG003|Overall Study|Withdrawal by Subject|3|||
162130781|NCT03486899|585529981|FG000|Overall Study|Other Reasons|0|||
162130782|NCT03486899|585529982|FG001|Overall Study|Other Reasons|1|||
162130783|NCT03486899|585529983|FG002|Overall Study|Other Reasons|0|||
162130784|NCT03486899|585529984|FG003|Overall Study|Other Reasons|1|||
162130785|NCT01439711|585529985|FG000|Overall Study|Ineligible|13|||
162130786|NCT01439711|585529985|FG000|Overall Study|Cancel|3|||
162130787|NCT01439711|585529985|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
162130788|NCT01439711|585529985|FG000|Overall Study|Adverse Event|5|||
162130789|NCT01439711|585529985|FG000|Overall Study|Withdrawal by Subject|3|||
162130790|NCT01439711|585529985|FG000|Overall Study|Progression During Active Tx|3|||
162130791|NCT01439711|585529985|FG000|Overall Study|Noncompliance|3|||
162130792|NCT01439711|585529985|FG000|Overall Study|No MRI|9|||
161793415|NCT00500682|584287019|FG000|Overall Study|Physician Decision|6|||
162130793|NCT04242875|585529986|FG000|Overall Study|Adverse Event|2|||
162130794|NCT02397460|585529987|FG000|Treatment Period 2|Adverse Event|0|||
162130795|NCT02397460|585529988|FG001|Treatment Period 2|Adverse Event|0|||
162130796|NCT02397460|585529989|FG002|Treatment Period 2|Adverse Event|0|||
162130797|NCT02397460|585529990|FG003|Treatment Period 2|Adverse Event|0|||
162130798|NCT02397460|585529991|FG004|Treatment Period 2|Adverse Event|0|||
162130799|NCT02397460|585529992|FG005|Treatment Period 2|Adverse Event|0|||
162130800|NCT02397460|585529993|FG006|Treatment Period 2|Adverse Event|0|||
162130801|NCT02397460|585529994|FG007|Treatment Period 2|Adverse Event|1|||
162130802|NCT02397460|585529987|FG000|Treatment Period 4|Adverse Event|0|||
162130803|NCT02397460|585529988|FG001|Treatment Period 4|Adverse Event|1|||
162130804|NCT02397460|585529989|FG002|Treatment Period 4|Adverse Event|0|||
162130805|NCT02397460|585529990|FG003|Treatment Period 4|Adverse Event|0|||
162130806|NCT02397460|585529991|FG004|Treatment Period 4|Adverse Event|0|||
162130807|NCT02397460|585529992|FG005|Treatment Period 4|Adverse Event|0|||
162130808|NCT02397460|585529993|FG006|Treatment Period 4|Adverse Event|0|||
162130809|NCT02397460|585529994|FG007|Treatment Period 4|Adverse Event|0|||
161793416|NCT00500682|584287020|FG001|Overall Study|Physician Decision|10|||
161793417|NCT00500682|584287019|FG000|Overall Study|Pregnancy|2|||
161793418|NCT00500682|584287020|FG001|Overall Study|Pregnancy|0|||
161793419|NCT00500682|584287019|FG000|Overall Study|Protocol Violation|1|||
161793420|NCT00500682|584287020|FG001|Overall Study|Protocol Violation|3|||
161793421|NCT00500682|584287019|FG000|Overall Study|Withdrawal by Subject|80|||
162130810|NCT02397460|585529987|FG000|Treatment Period 4|Physician Decision|0|||
162130811|NCT02397460|585529988|FG001|Treatment Period 4|Physician Decision|0|||
162130812|NCT02397460|585529989|FG002|Treatment Period 4|Physician Decision|0|||
162130813|NCT02397460|585529990|FG003|Treatment Period 4|Physician Decision|0|||
162130814|NCT02397460|585529991|FG004|Treatment Period 4|Physician Decision|1|||
162130815|NCT02397460|585529992|FG005|Treatment Period 4|Physician Decision|0|||
162130816|NCT02397460|585529993|FG006|Treatment Period 4|Physician Decision|0|||
162130817|NCT02397460|585529994|FG007|Treatment Period 4|Physician Decision|0|||
162130818|NCT01723826|585529998|FG000|Overall Study|Adverse Event|4|||
162130819|NCT01723826|585529999|FG001|Overall Study|Adverse Event|1|||
162130820|NCT01723826|585530000|FG002|Overall Study|Adverse Event|4|||
162130821|NCT01723826|585530001|FG003|Overall Study|Adverse Event|5|||
162130822|NCT01723826|585529998|FG000|Overall Study|Death according to AE eCRF|2|||
162130823|NCT01723826|585529999|FG001|Overall Study|Death according to AE eCRF|3|||
162130824|NCT01723826|585530000|FG002|Overall Study|Death according to AE eCRF|3|||
162130825|NCT01723826|585530001|FG003|Overall Study|Death according to AE eCRF|7|||
162130826|NCT01723826|585529998|FG000|Overall Study|Lost to Follow-up|1|||
162130827|NCT01723826|585529999|FG001|Overall Study|Lost to Follow-up|3|||
162130828|NCT01723826|585530000|FG002|Overall Study|Lost to Follow-up|1|||
162130829|NCT01723826|585530001|FG003|Overall Study|Lost to Follow-up|1|||
162130830|NCT01723826|585529998|FG000|Overall Study|Non-compliance|0|||
162130831|NCT01723826|585529999|FG001|Overall Study|Non-compliance|1|||
162130832|NCT01723826|585530000|FG002|Overall Study|Non-compliance|3|||
162130833|NCT01723826|585530001|FG003|Overall Study|Non-compliance|3|||
162130834|NCT01723826|585529998|FG000|Overall Study|Non-compliance With Study Drug|0|||
162130835|NCT01723826|585529999|FG001|Overall Study|Non-compliance With Study Drug|1|||
162130836|NCT01723826|585530000|FG002|Overall Study|Non-compliance With Study Drug|0|||
162130837|NCT01723826|585530001|FG003|Overall Study|Non-compliance With Study Drug|0|||
162130838|NCT01723826|585529998|FG000|Overall Study|Other Reason|8|||
162130839|NCT01723826|585529999|FG001|Overall Study|Other Reason|6|||
162130840|NCT01723826|585530000|FG002|Overall Study|Other Reason|12|||
162130841|NCT01723826|585530001|FG003|Overall Study|Other Reason|14|||
162130842|NCT01723826|585529998|FG000|Overall Study|Physician Decision|1|||
162130843|NCT01723826|585529999|FG001|Overall Study|Physician Decision|3|||
162130844|NCT01723826|585530000|FG002|Overall Study|Physician Decision|4|||
162130845|NCT01723826|585530001|FG003|Overall Study|Physician Decision|11|||
162130846|NCT01723826|585529998|FG000|Overall Study|Protocol Violation|1|||
162130847|NCT01723826|585529999|FG001|Overall Study|Protocol Violation|1|||
162130848|NCT01723826|585530000|FG002|Overall Study|Protocol Violation|3|||
162130849|NCT01723826|585530001|FG003|Overall Study|Protocol Violation|1|||
162130850|NCT01723826|585529998|FG000|Overall Study|Withdrawal by Subject|10|||
162130851|NCT01723826|585529999|FG001|Overall Study|Withdrawal by Subject|17|||
162130852|NCT01723826|585530000|FG002|Overall Study|Withdrawal by Subject|27|||
162130853|NCT01723826|585530001|FG003|Overall Study|Withdrawal by Subject|48|||
162130854|NCT01767129|585530002|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
162130855|NCT01767129|585530003|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
161793422|NCT00500682|584287020|FG001|Overall Study|Withdrawal by Subject|74|||
161793423|NCT00500682|584287019|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
161793424|NCT00500682|584287020|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
161793425|NCT01680159|584287021|FG000|Screening Period|Not meet criteria for dose-up period|7|||
161793426|NCT01680159|584287021|FG000|Increased Dose Period|Adverse Event|6|||
161793427|NCT01680159|584287021|FG000|Increased Dose Period|Withdrawal by Subject|2|||
161793428|NCT01995058|584287022|FG000|Overall Study|Sponsor Decision to terminate study|14|||
161793429|NCT01995058|584287023|FG001|Overall Study|Sponsor Decision to terminate study|12|||
162130856|NCT01473420|585530007|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
162130857|NCT01473420|585530008|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
162130858|NCT01473420|585530007|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
162130859|NCT01473420|585530008|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
162130860|NCT01473420|585530007|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
162130861|NCT01473420|585530008|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
162130862|NCT01473420|585530007|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
162130863|NCT01473420|585530008|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
162130864|NCT01473420|585530007|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
162130865|NCT01473420|585530008|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
162130866|NCT01473420|585530007|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
162130867|NCT01473420|585530008|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
162130868|NCT01473420|585530007|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
162130869|NCT01473420|585530008|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
162130870|NCT01473420|585530007|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
162130871|NCT01473420|585530008|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
162130872|NCT01473420|585530007|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
162130873|NCT01473420|585530008|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
162130874|NCT01473420|585530007|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
162130875|NCT01473420|585530008|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
162130876|NCT01473420|585530007|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
161793430|NCT01995058|584287024|FG002|Overall Study|Sponsor Decision to terminate study|12|||
162130877|NCT01473420|585530008|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
162130878|NCT01473420|585530007|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
162130879|NCT01473420|585530008|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
162130880|NCT01473420|585530007|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
162130881|NCT01473420|585530008|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
162130882|NCT02906202|585530015|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
162130883|NCT04213846|585531758|FG000|Overall Study|Withdrawal by Subject|7|||
162130884|NCT04213846|585531759|FG001|Overall Study|Withdrawal by Subject|6|||
162130885|NCT04213846|585531758|FG000|Overall Study|Lost to Follow-up|15|||
161793431|NCT01995058|584287025|FG003|Overall Study|Sponsor Decision to terminate study|10|||
161793432|NCT01995058|584287022|FG000|Overall Study|Progressive Disease|0|||
161793433|NCT01995058|584287023|FG001|Overall Study|Progressive Disease|1|||
161793434|NCT01995058|584287024|FG002|Overall Study|Progressive Disease|1|||
161793435|NCT01995058|584287025|FG003|Overall Study|Progressive Disease|1|||
161793436|NCT01995058|584287022|FG000|Overall Study|Adverse Event|0|||
162130886|NCT04213846|585531759|FG001|Overall Study|Lost to Follow-up|21|||
162130887|NCT04096365|585531768|FG000|Overall Study|Adverse Event|1|||
162130888|NCT02401529|585531771|FG000|Overall Study|Lost to Follow-up|2|||
162130889|NCT02401529|585531772|FG001|Overall Study|Lost to Follow-up|1|||
162130890|NCT02401529|585531771|FG000|Overall Study|Physician Decision|2|||
162130891|NCT02401529|585531772|FG001|Overall Study|Physician Decision|6|||
162130892|NCT02401529|585531771|FG000|Overall Study|Protocol Violation|5|||
162130893|NCT02401529|585531772|FG001|Overall Study|Protocol Violation|0|||
162130894|NCT01939158|585531775|FG000|Overall Study|Adverse Event|1|||
162130895|NCT01939158|585531776|FG001|Overall Study|Adverse Event|0|||
162130896|NCT01939158|585531777|FG002|Overall Study|Adverse Event|0|||
162130897|NCT01939158|585531778|FG003|Overall Study|Adverse Event|0|||
162130898|NCT01939158|585531775|FG000|Overall Study|Withdrawal by Subject|22|||
162130899|NCT01939158|585531776|FG001|Overall Study|Withdrawal by Subject|25|||
162130900|NCT01939158|585531777|FG002|Overall Study|Withdrawal by Subject|15|||
162130901|NCT01939158|585531778|FG003|Overall Study|Withdrawal by Subject|17|||
162130902|NCT01939158|585531775|FG000|Overall Study|Migrated/moved from study area|5|||
162130903|NCT01939158|585531776|FG001|Overall Study|Migrated/moved from study area|7|||
162130904|NCT01939158|585531777|FG002|Overall Study|Migrated/moved from study area|3|||
162130905|NCT01939158|585531778|FG003|Overall Study|Migrated/moved from study area|6|||
162130906|NCT01939158|585531775|FG000|Overall Study|Lost to Follow-up|18|||
162130907|NCT01939158|585531776|FG001|Overall Study|Lost to Follow-up|17|||
162130908|NCT01939158|585531777|FG002|Overall Study|Lost to Follow-up|17|||
162130909|NCT01939158|585531778|FG003|Overall Study|Lost to Follow-up|17|||
162130910|NCT01939158|585531775|FG000|Overall Study|Death|0|||
162130911|NCT01939158|585531776|FG001|Overall Study|Death|0|||
162130912|NCT01939158|585531777|FG002|Overall Study|Death|1|||
162130913|NCT01939158|585531778|FG003|Overall Study|Death|1|||
162130914|NCT01939158|585531775|FG000|Overall Study|No longer meets eligibility criteria|0|||
162130915|NCT01939158|585531776|FG001|Overall Study|No longer meets eligibility criteria|0|||
162130916|NCT01939158|585531777|FG002|Overall Study|No longer meets eligibility criteria|1|||
161793437|NCT01995058|584287023|FG001|Overall Study|Adverse Event|0|||
161793438|NCT01995058|584287024|FG002|Overall Study|Adverse Event|0|||
161793439|NCT01995058|584287025|FG003|Overall Study|Adverse Event|1|||
161793440|NCT01995058|584287022|FG000|Overall Study|Lack of Efficacy|0|||
161793441|NCT01995058|584287023|FG001|Overall Study|Lack of Efficacy|0|||
161793442|NCT01995058|584287024|FG002|Overall Study|Lack of Efficacy|0|||
161793443|NCT01995058|584287025|FG003|Overall Study|Lack of Efficacy|1|||
161793444|NCT01995058|584287022|FG000|Overall Study|No Treatment Given|0|||
161793445|NCT01995058|584287023|FG001|Overall Study|No Treatment Given|0|||
161793446|NCT01995058|584287024|FG002|Overall Study|No Treatment Given|0|||
161793447|NCT01995058|584287025|FG003|Overall Study|No Treatment Given|1|||
162130917|NCT01939158|585531778|FG003|Overall Study|No longer meets eligibility criteria|0|||
162130918|NCT01939158|585531775|FG000|Overall Study|Other|1|||
162130919|NCT01939158|585531776|FG001|Overall Study|Other|3|||
162130920|NCT01939158|585531777|FG002|Overall Study|Other|4|||
162130921|NCT01939158|585531778|FG003|Overall Study|Other|3|||
162130922|NCT05310084|585531779|FG000|Overall Study|Withdrawal by Subject|2|||
162130923|NCT05310084|585531780|FG001|Overall Study|Withdrawal by Subject|3|||
162130924|NCT05310084|585531779|FG000|Overall Study|Participant availability|0|||
162130925|NCT05310084|585531780|FG001|Overall Study|Participant availability|4|||
162130926|NCT05310084|585531779|FG000|Overall Study|Lost to Follow-up|1|||
162130927|NCT05310084|585531780|FG001|Overall Study|Lost to Follow-up|1|||
162130928|NCT05310084|585531779|FG000|Overall Study|Adverse Event|1|||
162130929|NCT05310084|585531780|FG001|Overall Study|Adverse Event|1|||
162130930|NCT05310084|585531779|FG000|Overall Study|Randomized but not vaccinated|4|||
162130931|NCT05310084|585531780|FG001|Overall Study|Randomized but not vaccinated|2|||
161793448|NCT03611309|584287031|FG000|Overall Study|Lost to Follow-up|16|||
161793449|NCT03611309|584287032|FG001|Overall Study|Lost to Follow-up|8|||
161793450|NCT03611309|584287031|FG000|Overall Study|Withdrawal by Subject|5|||
161793451|NCT03611309|584287032|FG001|Overall Study|Withdrawal by Subject|5|||
161793452|NCT03611309|584287031|FG000|Overall Study|Physician Decision|0|||
161793453|NCT03611309|584287032|FG001|Overall Study|Physician Decision|2|||
161793454|NCT00772382|584287033|FG000|Overall Study|Adverse Event|19|||
161793455|NCT00772382|584287033|FG000|Overall Study|Death|6|||
162130932|NCT02065245|585531782|FG000|Infusion 1|Lost to Follow-up|0|||
162130933|NCT02065245|585531783|FG001|Infusion 1|Lost to Follow-up|0|||
162130934|NCT02065245|585531784|FG002|Infusion 1|Lost to Follow-up|0|||
162130935|NCT02065245|585531785|FG003|Infusion 1|Lost to Follow-up|0|||
162130936|NCT02065245|585531786|FG004|Infusion 1|Lost to Follow-up|0|||
161793456|NCT00772382|584287033|FG000|Overall Study|Lack of Efficacy|4|||
161793457|NCT00772382|584287033|FG000|Overall Study|Physician Decision|5|||
161793458|NCT00772382|584287033|FG000|Overall Study|Protocol Violation|1|||
161793459|NCT00772382|584287033|FG000|Overall Study|Withdrawal by Subject|10|||
161793460|NCT00772382|584287033|FG000|Overall Study|Other Reasons|10|||
161793461|NCT04526899|584287034|FG000|Overall Study|Withdrawal by Subject|3|||
161793462|NCT04526899|584287035|FG001|Overall Study|Withdrawal by Subject|2|||
161793463|NCT04526899|584287036|FG002|Overall Study|Withdrawal by Subject|2|||
161793464|NCT04526899|584287034|FG000|Overall Study|Lost to Follow-up|3|||
161793465|NCT04526899|584287035|FG001|Overall Study|Lost to Follow-up|3|||
161793466|NCT04526899|584287036|FG002|Overall Study|Lost to Follow-up|1|||
161793467|NCT04526899|584287034|FG000|Overall Study|Investigator's decision|1|||
161793468|NCT04526899|584287035|FG001|Overall Study|Investigator's decision|0|||
161793469|NCT04526899|584287036|FG002|Overall Study|Investigator's decision|0|||
161793470|NCT04526899|584287034|FG000|Overall Study|Death|33|||
161793471|NCT04526899|584287035|FG001|Overall Study|Death|17|||
161793472|NCT04526899|584287036|FG002|Overall Study|Death|13|||
161793473|NCT04526899|584287034|FG000|Overall Study|Other|1|||
161793474|NCT04526899|584287035|FG001|Overall Study|Other|0|||
161793475|NCT04526899|584287036|FG002|Overall Study|Other|0|||
161793476|NCT04526899|584287034|FG000|Overall Study|On-Treatment|19|||
161898872|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
162130937|NCT02065245|585531787|FG005|Infusion 1|Lost to Follow-up|0|||
162130938|NCT02065245|585531788|FG006|Infusion 1|Lost to Follow-up|1|||
162130939|NCT02065245|585531782|FG000|Infusion 1|Death|0|||
162130940|NCT02065245|585531783|FG001|Infusion 1|Death|0|||
162130941|NCT02065245|585531784|FG002|Infusion 1|Death|1|||
162130942|NCT02065245|585531785|FG003|Infusion 1|Death|0|||
162130943|NCT02065245|585531786|FG004|Infusion 1|Death|1|||
162130944|NCT02065245|585531787|FG005|Infusion 1|Death|0|||
162130945|NCT02065245|585531788|FG006|Infusion 1|Death|0|||
162130946|NCT02065245|585531782|FG000|Infusion 2|Death|0|||
162130947|NCT02065245|585531783|FG001|Infusion 2|Death|0|||
162130948|NCT02065245|585531784|FG002|Infusion 2|Death|0|||
162130949|NCT02065245|585531785|FG003|Infusion 2|Death|0|||
162130950|NCT02065245|585531786|FG004|Infusion 2|Death|0|||
162130951|NCT02065245|585531787|FG005|Infusion 2|Death|0|||
162130952|NCT02065245|585531788|FG006|Infusion 2|Death|1|||
162130953|NCT02065245|585531782|FG000|Infusion 3|Lost to Follow-up|1|||
162130954|NCT02065245|585531783|FG001|Infusion 3|Lost to Follow-up|1|||
162130955|NCT02065245|585531784|FG002|Infusion 3|Lost to Follow-up|0|||
162130956|NCT02065245|585531785|FG003|Infusion 3|Lost to Follow-up|0|||
162130957|NCT02065245|585531786|FG004|Infusion 3|Lost to Follow-up|0|||
162130958|NCT02065245|585531787|FG005|Infusion 3|Lost to Follow-up|0|||
162130959|NCT02065245|585531788|FG006|Infusion 3|Lost to Follow-up|0|||
162130960|NCT01598987|585531789|FG000|Baseline to Month 12|Administrative problems|2|||
162130961|NCT01598987|585531789|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
162130962|NCT01598987|585531789|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
162130963|NCT01598987|585531789|FG000|Baseline to 24 Month|Administrative problems|2|||
162130964|NCT01598987|585531789|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
162130965|NCT00924664|585531790|FG000|Overall Study|Adverse Event|23|||
162130966|NCT00924664|585531791|FG001|Overall Study|Adverse Event|39|||
162130967|NCT00924664|585531790|FG000|Overall Study|Lack of Efficacy|10|||
162130968|NCT00924664|585531791|FG001|Overall Study|Lack of Efficacy|15|||
162130969|NCT00924664|585531790|FG000|Overall Study|Lost to Follow-up|10|||
162130970|NCT00924664|585531791|FG001|Overall Study|Lost to Follow-up|12|||
162130971|NCT00924664|585531790|FG000|Overall Study|Withdrawal by Subject|47|||
162130972|NCT00924664|585531791|FG001|Overall Study|Withdrawal by Subject|71|||
162130973|NCT00924664|585531790|FG000|Overall Study|Protocol Violation|2|||
161793477|NCT04526899|584287035|FG001|Overall Study|On-Treatment|10|||
161793478|NCT04526899|584287036|FG002|Overall Study|On-Treatment|12|||
161793479|NCT04526899|584287034|FG000|Overall Study|Survival Follow-up|34|||
161793480|NCT04526899|584287035|FG001|Overall Study|Survival Follow-up|14|||
161793481|NCT04526899|584287036|FG002|Overall Study|Survival Follow-up|16|||
161898873|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161898874|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161898875|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161898876|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161898877|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
162130974|NCT00924664|585531791|FG001|Overall Study|Protocol Violation|5|||
162130975|NCT00924664|585531790|FG000|Overall Study|Pregnancy|1|||
162130976|NCT00924664|585531791|FG001|Overall Study|Pregnancy|1|||
162130977|NCT00924664|585531790|FG000|Overall Study|Death|0|||
162130978|NCT00924664|585531791|FG001|Overall Study|Death|2|||
162130979|NCT00924664|585531790|FG000|Overall Study|Study terminated by sponsor|199|||
162130980|NCT00924664|585531791|FG001|Overall Study|Study terminated by sponsor|330|||
162130981|NCT00924664|585531790|FG000|Overall Study|Other|29|||
162130982|NCT00924664|585531791|FG001|Overall Study|Other|52|||
162130983|NCT00924664|585531790|FG000|Overall Study|Randomized but not Treated|1|||
162130984|NCT00924664|585531791|FG001|Overall Study|Randomized but not Treated|0|||
162130985|NCT03531905|585531792|FG000|Overall Study|Withdrawal by Subject|3|||
162130986|NCT03531905|585531793|FG001|Overall Study|Withdrawal by Subject|3|||
162130987|NCT03531905|585531794|FG002|Overall Study|Withdrawal by Subject|2|||
162130988|NCT03531905|585531792|FG000|Overall Study|Lost to Follow-up|2|||
162130989|NCT03531905|585531793|FG001|Overall Study|Lost to Follow-up|2|||
162130990|NCT03531905|585531794|FG002|Overall Study|Lost to Follow-up|1|||
162130991|NCT03531905|585531792|FG000|Overall Study|Participant was out of town|1|||
162130992|NCT03531905|585531793|FG001|Overall Study|Participant was out of town|0|||
162130993|NCT03531905|585531794|FG002|Overall Study|Participant was out of town|0|||
162130994|NCT03531905|585531792|FG000|Overall Study|Could not speak with the participant|1|||
162130995|NCT03531905|585531793|FG001|Overall Study|Could not speak with the participant|0|||
162130996|NCT03531905|585531794|FG002|Overall Study|Could not speak with the participant|0|||
162130997|NCT01036087|585531795|FG000|Overall Study|Adverse Event|2|||
162130998|NCT01036087|585531795|FG000|Overall Study|Lack of Efficacy|1|||
162130999|NCT01616563|585531798|FG000|Overall Study|Lost to Follow-up|40|||
162131000|NCT01333943|585531804|FG000|Overall Study|Known neuropathy|1|||
162131001|NCT01333943|585531805|FG001|Overall Study|Known neuropathy|0|||
162131002|NCT02459587|585531812|FG000|3-Month Follow-up Assessment|Death|0|||
161898878|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
161898879|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
161898880|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
161898881|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161898882|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161898883|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
161898884|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898885|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898886|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898887|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898888|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898889|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898890|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898891|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
161898892|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898893|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898894|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898895|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
161898896|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
161898897|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898898|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
161898899|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898900|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898901|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
161898902|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161898903|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
161898904|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
161898905|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
161898906|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
161898907|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
161898908|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
161898909|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
161898910|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
161898911|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
161898912|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
161898913|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
161898914|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
161898915|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
161898916|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
161898917|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
162131003|NCT02459587|585531813|FG001|3-Month Follow-up Assessment|Death|2|||
162131004|NCT02459587|585531812|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
162131005|NCT02459587|585531813|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
162131006|NCT02459587|585531812|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
162131007|NCT02459587|585531813|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
162131008|NCT02459587|585531812|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
162131009|NCT02459587|585531813|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
162131010|NCT02459587|585531812|FG000|6-month Follow-up Assessment|Death|2|||
162131011|NCT02459587|585531813|FG001|6-month Follow-up Assessment|Death|1|||
162131012|NCT02459587|585531812|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
162131013|NCT02459587|585531813|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
162131014|NCT02459587|585531812|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
162131015|NCT02459587|585531813|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
162131016|NCT02459587|585531812|FG000|12-month Follow-up Assessment|Death|2|||
162131017|NCT02459587|585531813|FG001|12-month Follow-up Assessment|Death|0|||
162131018|NCT02459587|585531812|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
162131019|NCT02459587|585531813|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
162131020|NCT02459587|585531812|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
162131021|NCT02459587|585531813|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
162131022|NCT02459587|585531812|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
162131023|NCT02459587|585531813|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
162131024|NCT02028884|585531816|FG000|Double-blind Period|Adverse Event|5|||
162131025|NCT02028884|585531817|FG001|Double-blind Period|Adverse Event|3|||
162131026|NCT02028884|585531818|FG002|Double-blind Period|Adverse Event|0|||
162131027|NCT02028884|585531816|FG000|Double-blind Period|Eligibility Violation|1|||
162131028|NCT02028884|585531817|FG001|Double-blind Period|Eligibility Violation|0|||
162131029|NCT02028884|585531818|FG002|Double-blind Period|Eligibility Violation|0|||
162131030|NCT02028884|585531816|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
162131031|NCT02028884|585531817|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
162131032|NCT02028884|585531818|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
162131033|NCT02028884|585531816|FG000|Double-blind Period|Withdrawal by Subject|2|||
162131034|NCT02028884|585531817|FG001|Double-blind Period|Withdrawal by Subject|0|||
162131035|NCT02028884|585531818|FG002|Double-blind Period|Withdrawal by Subject|0|||
162131036|NCT02028884|585531816|FG000|Open-label Extension Period|Adverse Event|3|||
162131037|NCT02028884|585531817|FG001|Open-label Extension Period|Adverse Event|1|||
162131038|NCT02028884|585531818|FG002|Open-label Extension Period|Adverse Event|0|||
162131039|NCT02028884|585531816|FG000|Open-label Extension Period|Lack of Efficacy|3|||
162131040|NCT02028884|585531817|FG001|Open-label Extension Period|Lack of Efficacy|0|||
162131041|NCT02028884|585531818|FG002|Open-label Extension Period|Lack of Efficacy|0|||
162131042|NCT02028884|585531816|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
162131043|NCT02028884|585531817|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
162131044|NCT02028884|585531818|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
162131045|NCT02028884|585531816|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
162131046|NCT02028884|585531817|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
162131047|NCT02028884|585531818|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
162131048|NCT02028884|585531816|FG000|Open-label Extension Period|Switched to another treatment option|3|||
162131049|NCT02028884|585531817|FG001|Open-label Extension Period|Switched to another treatment option|0|||
162131050|NCT02028884|585531818|FG002|Open-label Extension Period|Switched to another treatment option|0|||
162131051|NCT02297503|585531819|FG000|Overall Study|Withdrawal by Subject|1|||
162131052|NCT02297503|585531820|FG001|Overall Study|Withdrawal by Subject|1|||
162131053|NCT02297503|585531819|FG000|Overall Study|Protocol Violation|1|||
162131054|NCT02297503|585531820|FG001|Overall Study|Protocol Violation|0|||
162131055|NCT02297503|585531819|FG000|Overall Study|Pregnancy|0|||
162131056|NCT02297503|585531820|FG001|Overall Study|Pregnancy|1|||
162131057|NCT02297503|585531819|FG000|Overall Study|Lost to Follow-up|0|||
162131058|NCT02297503|585531820|FG001|Overall Study|Lost to Follow-up|1|||
162131059|NCT02297503|585531819|FG000|Overall Study|Medical reason|0|||
162131060|NCT02297503|585531820|FG001|Overall Study|Medical reason|1|||
162131061|NCT00519779|585531821|FG000|Overall Study|Withdrawal by Subject|0|||
162131062|NCT00519779|585531822|FG001|Overall Study|Withdrawal by Subject|1|||
162131063|NCT01123161|585531823|FG000|Overall Study|Lost to Follow-up|1|||
162131064|NCT01123161|585531824|FG001|Overall Study|Lost to Follow-up|0|||
162131065|NCT01123161|585531823|FG000|Overall Study|Withdrawal by Subject|1|||
162131066|NCT01123161|585531824|FG001|Overall Study|Withdrawal by Subject|0|||
162131067|NCT04320615|585531830|FG000|Overall Study|Withdrawal by Subject|4|||
162131068|NCT04320615|585531831|FG001|Overall Study|Withdrawal by Subject|10|||
162131069|NCT04320615|585531830|FG000|Overall Study|Physician Decision|2|||
162131070|NCT04320615|585531831|FG001|Overall Study|Physician Decision|0|||
162131071|NCT04320615|585531830|FG000|Overall Study|Other|2|||
162131072|NCT04320615|585531831|FG001|Overall Study|Other|0|||
162131073|NCT04320615|585531830|FG000|Overall Study|Lost to Follow-up|5|||
162131074|NCT04320615|585531831|FG001|Overall Study|Lost to Follow-up|23|||
162131075|NCT04320615|585531830|FG000|Overall Study|Death|35|||
162131076|NCT04320615|585531831|FG001|Overall Study|Death|71|||
162131077|NCT03990363|585531832|FG000|Overall Study|Withdrawal by Subject|10|||
162131078|NCT03990363|585531833|FG001|Overall Study|Withdrawal by Subject|9|||
162131079|NCT03990363|585531834|FG002|Overall Study|Withdrawal by Subject|18|||
162131080|NCT03990363|585531835|FG003|Overall Study|Withdrawal by Subject|11|||
162131081|NCT03990363|585531836|FG004|Overall Study|Withdrawal by Subject|9|||
162131082|NCT03990363|585531832|FG000|Overall Study|Physician Decision|1|||
162131083|NCT03990363|585531833|FG001|Overall Study|Physician Decision|0|||
162131084|NCT03990363|585531834|FG002|Overall Study|Physician Decision|0|||
162131085|NCT03990363|585531835|FG003|Overall Study|Physician Decision|0|||
162131086|NCT03990363|585531836|FG004|Overall Study|Physician Decision|0|||
162131087|NCT03990363|585531832|FG000|Overall Study|Adverse Event|1|||
162131088|NCT03990363|585531833|FG001|Overall Study|Adverse Event|3|||
162131089|NCT03990363|585531834|FG002|Overall Study|Adverse Event|2|||
162131090|NCT03990363|585531835|FG003|Overall Study|Adverse Event|2|||
162131091|NCT03990363|585531836|FG004|Overall Study|Adverse Event|0|||
162131092|NCT03990363|585531832|FG000|Overall Study|Death|14|||
162131093|NCT03990363|585531833|FG001|Overall Study|Death|8|||
162131094|NCT03990363|585531834|FG002|Overall Study|Death|14|||
162131095|NCT03990363|585531835|FG003|Overall Study|Death|10|||
162131096|NCT03990363|585531836|FG004|Overall Study|Death|11|||
162131097|NCT03990363|585531832|FG000|Overall Study|Failure to meet randomization criteria|0|||
162131098|NCT03990363|585531833|FG001|Overall Study|Failure to meet randomization criteria|1|||
162131099|NCT03990363|585531834|FG002|Overall Study|Failure to meet randomization criteria|1|||
162131100|NCT03990363|585531835|FG003|Overall Study|Failure to meet randomization criteria|0|||
162131101|NCT03990363|585531836|FG004|Overall Study|Failure to meet randomization criteria|0|||
162131102|NCT03990363|585531832|FG000|Overall Study|Lost to Follow-up|0|||
162131103|NCT03990363|585531833|FG001|Overall Study|Lost to Follow-up|0|||
162131104|NCT03990363|585531834|FG002|Overall Study|Lost to Follow-up|0|||
162131105|NCT03990363|585531835|FG003|Overall Study|Lost to Follow-up|1|||
162131106|NCT03990363|585531836|FG004|Overall Study|Lost to Follow-up|2|||
162131107|NCT03990363|585531832|FG000|Overall Study|Non-compliance with study drug|2|||
162131108|NCT03990363|585531833|FG001|Overall Study|Non-compliance with study drug|1|||
162131109|NCT03990363|585531834|FG002|Overall Study|Non-compliance with study drug|2|||
162131110|NCT03990363|585531835|FG003|Overall Study|Non-compliance with study drug|0|||
162131111|NCT03990363|585531836|FG004|Overall Study|Non-compliance with study drug|0|||
162131112|NCT03990363|585531832|FG000|Overall Study|Study terminated by sponsor|0|||
162131113|NCT03990363|585531833|FG001|Overall Study|Study terminated by sponsor|1|||
162131114|NCT03990363|585531834|FG002|Overall Study|Study terminated by sponsor|0|||
162131115|NCT03990363|585531835|FG003|Overall Study|Study terminated by sponsor|0|||
162131116|NCT03990363|585531836|FG004|Overall Study|Study terminated by sponsor|0|||
162131117|NCT03990363|585531832|FG000|Overall Study|Site terminated by sponsor|2|||
162131118|NCT03990363|585531833|FG001|Overall Study|Site terminated by sponsor|1|||
162131119|NCT03990363|585531834|FG002|Overall Study|Site terminated by sponsor|2|||
162131120|NCT03990363|585531835|FG003|Overall Study|Site terminated by sponsor|0|||
162131121|NCT03990363|585531836|FG004|Overall Study|Site terminated by sponsor|2|||
162131122|NCT03990363|585531832|FG000|Overall Study|Not categorized|5|||
162131123|NCT03990363|585531833|FG001|Overall Study|Not categorized|5|||
162131124|NCT03990363|585531834|FG002|Overall Study|Not categorized|3|||
162131125|NCT03990363|585531835|FG003|Overall Study|Not categorized|2|||
162131126|NCT03990363|585531836|FG004|Overall Study|Not categorized|2|||
162131127|NCT01349660|585531837|FG000|Overall Study|Still Receiving Study Treatment|0|||
162131128|NCT01349660|585531838|FG001|Overall Study|Still Receiving Study Treatment|0|||
162131129|NCT01349660|585531839|FG002|Overall Study|Still Receiving Study Treatment|1|||
162131130|NCT01349660|585531837|FG000|Overall Study|Disease Progression|2|||
162131131|NCT01349660|585531838|FG001|Overall Study|Disease Progression|4|||
162131132|NCT01349660|585531839|FG002|Overall Study|Disease Progression|50|||
162131133|NCT01349660|585531837|FG000|Overall Study|Adverse Event|1|||
162131134|NCT01349660|585531838|FG001|Overall Study|Adverse Event|1|||
162131135|NCT01349660|585531839|FG002|Overall Study|Adverse Event|12|||
162131136|NCT01349660|585531837|FG000|Overall Study|Withdrawal by Subject|2|||
162131137|NCT01349660|585531838|FG001|Overall Study|Withdrawal by Subject|0|||
162131138|NCT01349660|585531839|FG002|Overall Study|Withdrawal by Subject|9|||
162131139|NCT01349660|585531837|FG000|Overall Study|Death|1|||
162131140|NCT01349660|585531838|FG001|Overall Study|Death|1|||
162131141|NCT01349660|585531839|FG002|Overall Study|Death|0|||
162131142|NCT01349660|585531837|FG000|Overall Study|Non-Permitted Interventions|0|||
162131143|NCT01349660|585531838|FG001|Overall Study|Non-Permitted Interventions|0|||
162131144|NCT01349660|585531839|FG002|Overall Study|Non-Permitted Interventions|2|||
162131145|NCT01349660|585531837|FG000|Overall Study|Study Compliance|0|||
162131146|NCT01349660|585531838|FG001|Overall Study|Study Compliance|0|||
162131147|NCT01349660|585531839|FG002|Overall Study|Study Compliance|1|||
162131148|NCT01349660|585531837|FG000|Overall Study|Declining Performance Status|0|||
162131149|NCT01349660|585531838|FG001|Overall Study|Declining Performance Status|0|||
162131150|NCT01349660|585531839|FG002|Overall Study|Declining Performance Status|1|||
162131151|NCT01563978|585531841|FG000|Overall Study|Physician Decision|1|||
162131152|NCT01563978|585531842|FG001|Overall Study|Physician Decision|0|||
162131153|NCT01563978|585531841|FG000|Overall Study|Lost to Follow-up|1|||
162131154|NCT01563978|585531842|FG001|Overall Study|Lost to Follow-up|0|||
162131155|NCT01563978|585531841|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
162131156|NCT01563978|585531842|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
162131157|NCT01563978|585531841|FG000|Overall Study|Adverse Event|1|||
162131158|NCT01563978|585531842|FG001|Overall Study|Adverse Event|2|||
162131159|NCT04630756|585531843|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
162131160|NCT04630756|585531844|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
162131161|NCT04630756|585531845|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
162131162|NCT05593211|585531847|FG000|Overall Study|Withdrawal by Subject|1|||
162131163|NCT03225846|585531848|FG000|Overall Study|Adverse Event|0|||
161898918|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
162131164|NCT03225846|585531849|FG001|Overall Study|Adverse Event|0|||
162131165|NCT03225846|585531850|FG002|Overall Study|Adverse Event|0|||
162131166|NCT03225846|585531851|FG003|Overall Study|Adverse Event|0|||
162131167|NCT03225846|585531852|FG004|Overall Study|Adverse Event|0|||
162131168|NCT03225846|585531853|FG005|Overall Study|Adverse Event|0|||
162131169|NCT03225846|585531854|FG006|Overall Study|Adverse Event|6|||
162131170|NCT03225846|585531848|FG000|Overall Study|Withdrawal by Subject|0|||
162131171|NCT03225846|585531849|FG001|Overall Study|Withdrawal by Subject|1|||
162131172|NCT03225846|585531850|FG002|Overall Study|Withdrawal by Subject|0|||
162131173|NCT03225846|585531851|FG003|Overall Study|Withdrawal by Subject|0|||
162131174|NCT03225846|585531852|FG004|Overall Study|Withdrawal by Subject|0|||
162131175|NCT03225846|585531853|FG005|Overall Study|Withdrawal by Subject|0|||
162131176|NCT03225846|585531854|FG006|Overall Study|Withdrawal by Subject|0|||
162131177|NCT03225846|585531848|FG000|Overall Study|Death|0|||
162131178|NCT03225846|585531849|FG001|Overall Study|Death|1|||
162131179|NCT03225846|585531850|FG002|Overall Study|Death|0|||
162131180|NCT03225846|585531851|FG003|Overall Study|Death|0|||
162131181|NCT03225846|585531852|FG004|Overall Study|Death|0|||
162131182|NCT03225846|585531853|FG005|Overall Study|Death|0|||
162131183|NCT03225846|585531854|FG006|Overall Study|Death|0|||
162131184|NCT03225846|585531848|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
162131185|NCT03225846|585531849|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
162131186|NCT03225846|585531850|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
162131187|NCT03225846|585531851|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
162131188|NCT03225846|585531852|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
162131189|NCT03225846|585531853|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
162131190|NCT03225846|585531854|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
162131191|NCT03225846|585531848|FG000|Overall Study|Patient decision|0|||
162131192|NCT03225846|585531849|FG001|Overall Study|Patient decision|0|||
162131193|NCT03225846|585531850|FG002|Overall Study|Patient decision|0|||
162131194|NCT03225846|585531851|FG003|Overall Study|Patient decision|0|||
162131195|NCT03225846|585531852|FG004|Overall Study|Patient decision|0|||
162131196|NCT03225846|585531853|FG005|Overall Study|Patient decision|0|||
162131197|NCT03225846|585531854|FG006|Overall Study|Patient decision|1|||
162131198|NCT04248465|585531855|FG000|Randomized-Controlled Period|Death|12|||
162131199|NCT04248465|585531856|FG001|Randomized-Controlled Period|Death|5|||
162131200|NCT04248465|585531855|FG000|Randomized-Controlled Period|Adverse Event|2|||
162131201|NCT04248465|585531856|FG001|Randomized-Controlled Period|Adverse Event|0|||
161793482|NCT05576012|584287041|FG000|Overall Study|Physician Decision|0|||
161793483|NCT05576012|584287042|FG001|Overall Study|Physician Decision|0|||
161793484|NCT05576012|584287043|FG002|Overall Study|Physician Decision|0|||
161793485|NCT05576012|584287044|FG003|Overall Study|Physician Decision|0|||
161793486|NCT05576012|584287045|FG004|Overall Study|Physician Decision|0|||
161793487|NCT05576012|584287046|FG005|Overall Study|Physician Decision|0|||
161793488|NCT05576012|584287047|FG006|Overall Study|Physician Decision|0|||
161793489|NCT05576012|584287048|FG007|Overall Study|Physician Decision|0|||
161793490|NCT05576012|584287049|FG008|Overall Study|Physician Decision|1|||
161793491|NCT05576012|584287050|FG009|Overall Study|Physician Decision|0|||
161793492|NCT03731182|584287717|FG000|Overall Study|Lost to Follow-up|2|||
161793493|NCT03731182|584287718|FG001|Overall Study|Lost to Follow-up|0|||
161793494|NCT03731182|584287717|FG000|Overall Study|Physician Decision|1|||
161793495|NCT03731182|584287718|FG001|Overall Study|Physician Decision|0|||
161793496|NCT03731182|584287717|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
161793497|NCT03731182|584287718|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
161793498|NCT03036579|584287725|FG000|2 Years|Lost to Follow-up|1|||
161793499|NCT03036579|584287726|FG001|2 Years|Lost to Follow-up|0|||
161793500|NCT03036579|584287725|FG000|3 Years|Lost to Follow-up|0|||
161793501|NCT03036579|584287726|FG001|3 Years|Lost to Follow-up|1|||
161793502|NCT02352337|584287727|FG000|Overall Study|Patients never treated|4|||
161793503|NCT02352337|584287728|FG001|Overall Study|Patients never treated|1|||
161793504|NCT02352337|584287729|FG002|Overall Study|Patients never treated|2|||
161793505|NCT02458638|584287732|FG000|Overall Study|Death|309|||
161793506|NCT02458638|584287732|FG000|Overall Study|End of Cohort/End of Study|67|||
161898919|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
161898920|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
161898921|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
162131202|NCT04248465|585531855|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
162131203|NCT04248465|585531856|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
162131204|NCT04248465|585531855|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
162131205|NCT04248465|585531856|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
162131206|NCT04248465|585531855|FG000|Randomized-Controlled Period|Physician Decision|1|||
161793507|NCT02458638|584287732|FG000|Overall Study|Lost to Follow-up|31|||
161793508|NCT02458638|584287732|FG000|Overall Study|Other Reasons|4|||
161793509|NCT02458638|584287732|FG000|Overall Study|Physician Decision|1|||
161793510|NCT02458638|584287732|FG000|Overall Study|Withdrawal by Subject|47|||
161793511|NCT00576901|584287744|FG000|Overall Study|Withdrawal by Subject|1|||
161793512|NCT00576901|584287744|FG000|Overall Study|Disease course|1|||
162131207|NCT04248465|585531856|FG001|Randomized-Controlled Period|Physician Decision|1|||
162131208|NCT04248465|585531855|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
162131209|NCT04248465|585531856|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
162131210|NCT04248465|585531855|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
162131211|NCT04248465|585531856|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
162131212|NCT04248465|585531855|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
162131213|NCT04248465|585531856|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
162131214|NCT05708846|585531857|FG000|Overall Study|Death|5|||
162131215|NCT05708846|585531857|FG000|Overall Study|Withdrawal by Subject|20|||
162131216|NCT03621982|585531858|FG000|Overall Study|Withdrawal by Subject|1|||
162131217|NCT03621982|585531859|FG001|Overall Study|Withdrawal by Subject|0|||
162131218|NCT03621982|585531860|FG002|Overall Study|Withdrawal by Subject|0|||
162131219|NCT03621982|585531861|FG003|Overall Study|Withdrawal by Subject|1|||
162131220|NCT03621982|585531862|FG004|Overall Study|Withdrawal by Subject|0|||
162131221|NCT03621982|585531863|FG005|Overall Study|Withdrawal by Subject|1|||
162131222|NCT03621982|585531864|FG006|Overall Study|Withdrawal by Subject|1|||
162131223|NCT03621982|585531865|FG007|Overall Study|Withdrawal by Subject|0|||
162131224|NCT03621982|585531866|FG008|Overall Study|Withdrawal by Subject|1|||
162131225|NCT03621982|585531867|FG009|Overall Study|Withdrawal by Subject|0|||
162131226|NCT03621982|585531868|FG010|Overall Study|Withdrawal by Subject|2|||
162131227|NCT03621982|585531869|FG011|Overall Study|Withdrawal by Subject|1|||
162131228|NCT03621982|585531870|FG012|Overall Study|Withdrawal by Subject|2|||
162131229|NCT03621982|585531871|FG013|Overall Study|Withdrawal by Subject|2|||
161793513|NCT00576901|584287744|FG000|Overall Study|Protocol Violation|1|||
161793514|NCT02398188|584287745|FG000|Overall Study|Adverse Event|2|||
161793515|NCT02398188|584287746|FG001|Overall Study|Adverse Event|3|||
161793516|NCT02398188|584287745|FG000|Overall Study|Lost to Follow-up|5|||
161793517|NCT02398188|584287746|FG001|Overall Study|Lost to Follow-up|0|||
161793518|NCT02398188|584287745|FG000|Overall Study|Non-compliance|4|||
161793519|NCT02398188|584287746|FG001|Overall Study|Non-compliance|4|||
161793520|NCT02398188|584287745|FG000|Overall Study|Protocol Violation|6|||
161898922|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898923|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
162131230|NCT03621982|585531858|FG000|Overall Study|Investigator/Sponsor decision|0|||
162131231|NCT03621982|585531859|FG001|Overall Study|Investigator/Sponsor decision|0|||
162131232|NCT03621982|585531860|FG002|Overall Study|Investigator/Sponsor decision|0|||
162131233|NCT03621982|585531861|FG003|Overall Study|Investigator/Sponsor decision|0|||
162131234|NCT03621982|585531862|FG004|Overall Study|Investigator/Sponsor decision|0|||
162131235|NCT03621982|585531863|FG005|Overall Study|Investigator/Sponsor decision|0|||
162131236|NCT03621982|585531864|FG006|Overall Study|Investigator/Sponsor decision|0|||
162131237|NCT03621982|585531865|FG007|Overall Study|Investigator/Sponsor decision|0|||
162131238|NCT03621982|585531866|FG008|Overall Study|Investigator/Sponsor decision|0|||
162131239|NCT03621982|585531867|FG009|Overall Study|Investigator/Sponsor decision|0|||
162131240|NCT03621982|585531868|FG010|Overall Study|Investigator/Sponsor decision|0|||
162131241|NCT03621982|585531869|FG011|Overall Study|Investigator/Sponsor decision|4|||
162131242|NCT03621982|585531870|FG012|Overall Study|Investigator/Sponsor decision|0|||
162131243|NCT03621982|585531871|FG013|Overall Study|Investigator/Sponsor decision|2|||
162131244|NCT03621982|585531858|FG000|Overall Study|Death|2|||
162131245|NCT03621982|585531859|FG001|Overall Study|Death|4|||
162131246|NCT03621982|585531860|FG002|Overall Study|Death|4|||
162131247|NCT03621982|585531861|FG003|Overall Study|Death|3|||
162131248|NCT03621982|585531862|FG004|Overall Study|Death|8|||
162131249|NCT03621982|585531863|FG005|Overall Study|Death|4|||
162131250|NCT03621982|585531864|FG006|Overall Study|Death|6|||
162131251|NCT03621982|585531865|FG007|Overall Study|Death|3|||
162131252|NCT03621982|585531866|FG008|Overall Study|Death|0|||
162131253|NCT03621982|585531867|FG009|Overall Study|Death|3|||
162131254|NCT03621982|585531868|FG010|Overall Study|Death|8|||
162131255|NCT03621982|585531869|FG011|Overall Study|Death|4|||
162131256|NCT03621982|585531870|FG012|Overall Study|Death|2|||
162131257|NCT03621982|585531871|FG013|Overall Study|Death|2|||
162131258|NCT03621982|585531858|FG000|Overall Study|Lost to Follow-up|0|||
162131259|NCT03621982|585531859|FG001|Overall Study|Lost to Follow-up|0|||
162131260|NCT03621982|585531860|FG002|Overall Study|Lost to Follow-up|1|||
162131261|NCT03621982|585531861|FG003|Overall Study|Lost to Follow-up|0|||
162131262|NCT03621982|585531862|FG004|Overall Study|Lost to Follow-up|0|||
162131263|NCT03621982|585531863|FG005|Overall Study|Lost to Follow-up|0|||
162131264|NCT03621982|585531864|FG006|Overall Study|Lost to Follow-up|1|||
162131265|NCT03621982|585531865|FG007|Overall Study|Lost to Follow-up|0|||
162131266|NCT03621982|585531866|FG008|Overall Study|Lost to Follow-up|0|||
162131267|NCT03621982|585531867|FG009|Overall Study|Lost to Follow-up|1|||
162131268|NCT03621982|585531868|FG010|Overall Study|Lost to Follow-up|0|||
161898924|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
162131269|NCT03621982|585531869|FG011|Overall Study|Lost to Follow-up|0|||
162131270|NCT03621982|585531870|FG012|Overall Study|Lost to Follow-up|0|||
162131271|NCT03621982|585531871|FG013|Overall Study|Lost to Follow-up|0|||
162131272|NCT00238420|585531872|FG000|Overall Study|Protocol Violation|1|||
162131273|NCT00238420|585531873|FG001|Overall Study|Protocol Violation|1|||
162131274|NCT01254890|585531876|FG000|Overall Study|Ineligible|0|||
162131275|NCT01254890|585531877|FG001|Overall Study|Ineligible|3|||
162131276|NCT01254890|585531876|FG000|Overall Study|Withdrawal by Subject|1|||
162131277|NCT01254890|585531877|FG001|Overall Study|Withdrawal by Subject|2|||
162131278|NCT01254890|585531876|FG000|Overall Study|Disease Progression|0|||
162131279|NCT01254890|585531877|FG001|Overall Study|Disease Progression|5|||
162131280|NCT02419755|585531888|FG000|Overall Study|Death|1|||
162131281|NCT02419755|585531889|FG001|Overall Study|Death|3|||
161898925|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898926|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
162131282|NCT02419755|585531888|FG000|Overall Study|Relapse|0|||
162131283|NCT02419755|585531889|FG001|Overall Study|Relapse|1|||
162131284|NCT02419755|585531888|FG000|Overall Study|Ineligible|1|||
162131285|NCT02419755|585531889|FG001|Overall Study|Ineligible|0|||
162131286|NCT02419755|585531888|FG000|Overall Study|Withdrawal by Subject|1|||
162131287|NCT02419755|585531889|FG001|Overall Study|Withdrawal by Subject|0|||
162131288|NCT00810641|585531892|FG000|Overall Study|Withdrawal by Subject|0|||
162131289|NCT00810641|585531893|FG001|Overall Study|Withdrawal by Subject|1|||
162131290|NCT00810641|585531894|FG002|Overall Study|Withdrawal by Subject|2|||
162131291|NCT02325713|585531897|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131292|NCT02325713|585531898|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131293|NCT02325713|585531899|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131294|NCT02325713|585531900|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131295|NCT02325713|585531901|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131296|NCT02325713|585531902|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131297|NCT02325713|585531903|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131298|NCT02325713|585531904|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131299|NCT02325713|585531905|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131300|NCT02325713|585531906|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131301|NCT02325713|585531907|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
162131302|NCT02325713|585531908|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131303|NCT02325713|585531909|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131304|NCT02325713|585531910|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131305|NCT02325713|585531911|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131306|NCT02325713|585531912|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
162131307|NCT02325713|585531897|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
162131308|NCT02325713|585531898|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131309|NCT02325713|585531899|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131310|NCT02325713|585531900|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131311|NCT02325713|585531901|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131312|NCT02325713|585531902|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131313|NCT02325713|585531903|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131314|NCT02325713|585531904|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131315|NCT02325713|585531905|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131316|NCT02325713|585531906|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131317|NCT02325713|585531907|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131318|NCT02325713|585531908|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131319|NCT02325713|585531909|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131320|NCT02325713|585531910|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131321|NCT02325713|585531911|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131322|NCT02325713|585531912|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
162131323|NCT02325713|585531897|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131324|NCT02325713|585531898|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131325|NCT02325713|585531899|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131326|NCT02325713|585531900|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131327|NCT02325713|585531901|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131328|NCT02325713|585531902|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131329|NCT02325713|585531903|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131330|NCT02325713|585531904|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131331|NCT02325713|585531905|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131332|NCT02325713|585531906|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
162131333|NCT02325713|585531907|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161898927|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898928|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
162131334|NCT02325713|585531908|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131335|NCT02325713|585531909|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131336|NCT02325713|585531910|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131337|NCT02325713|585531911|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131338|NCT02325713|585531912|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
162131339|NCT01213173|585531914|FG000|Overall Study|Protocol Violation|2|||
162131340|NCT01213173|585531915|FG001|Overall Study|Protocol Violation|0|||
162131341|NCT01213173|585531914|FG000|Overall Study|Adverse Event|4|||
162131342|NCT01213173|585531915|FG001|Overall Study|Adverse Event|8|||
162131343|NCT01213173|585531914|FG000|Overall Study|Withdrawal by Subject|5|||
162131344|NCT01213173|585531915|FG001|Overall Study|Withdrawal by Subject|5|||
162131345|NCT01213173|585531914|FG000|Overall Study|Incorrect Enrollment|1|||
162131346|NCT01213173|585531915|FG001|Overall Study|Incorrect Enrollment|3|||
162131347|NCT02253316|585531916|FG000|Consolidation|Progression|4|||
162131348|NCT02253316|585531917|FG001|Consolidation|Progression|0|||
162131349|NCT02253316|585531918|FG002|Consolidation|Progression|0|||
162131350|NCT02253316|585531916|FG000|Consolidation|Non-Compliance|1|||
162131351|NCT02253316|585531917|FG001|Consolidation|Non-Compliance|0|||
162131352|NCT02253316|585531918|FG002|Consolidation|Non-Compliance|0|||
162131353|NCT02253316|585531916|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
162131354|NCT02253316|585531917|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
162131355|NCT02253316|585531918|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
162131356|NCT02253316|585531916|FG000|Consolidation|Secondary Malignancy|2|||
162131357|NCT02253316|585531917|FG001|Consolidation|Secondary Malignancy|0|||
162131358|NCT02253316|585531918|FG002|Consolidation|Secondary Malignancy|0|||
162131359|NCT02253316|585531916|FG000|Consolidation|Adverse Event|7|||
162131360|NCT02253316|585531917|FG001|Consolidation|Adverse Event|0|||
162131361|NCT02253316|585531918|FG002|Consolidation|Adverse Event|0|||
162131362|NCT02253316|585531916|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
162131363|NCT02253316|585531917|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
162131364|NCT02253316|585531918|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
162131365|NCT02253316|585531916|FG000|Maintenance|Physician Decision|0|||
162131366|NCT02253316|585531917|FG001|Maintenance|Physician Decision|7|||
162131367|NCT02253316|585531918|FG002|Maintenance|Physician Decision|16|||
162131368|NCT02253316|585531916|FG000|Maintenance|Non-Compliance|0|||
162131369|NCT02253316|585531917|FG001|Maintenance|Non-Compliance|1|||
162131370|NCT02253316|585531918|FG002|Maintenance|Non-Compliance|1|||
162131371|NCT02253316|585531916|FG000|Maintenance|Secondary Malignancy|0|||
162131372|NCT02253316|585531917|FG001|Maintenance|Secondary Malignancy|2|||
162131373|NCT02253316|585531918|FG002|Maintenance|Secondary Malignancy|6|||
162131374|NCT02253316|585531916|FG000|Maintenance|Adverse Event|0|||
162131375|NCT02253316|585531917|FG001|Maintenance|Adverse Event|8|||
162131376|NCT02253316|585531918|FG002|Maintenance|Adverse Event|12|||
162131377|NCT02253316|585531916|FG000|Maintenance|Still receiving active treatment|0|||
162131378|NCT02253316|585531917|FG001|Maintenance|Still receiving active treatment|4|||
162131379|NCT02253316|585531918|FG002|Maintenance|Still receiving active treatment|0|||
162131380|NCT02684903|585531919|FG000|Overall Study|COVID-19 shutdown of lab|4|||
162131381|NCT02684903|585531920|FG001|Overall Study|COVID-19 shutdown of lab|6|||
162131382|NCT02684903|585531919|FG000|Overall Study|Lost to Follow-up|31|||
162131383|NCT02684903|585531920|FG001|Overall Study|Lost to Follow-up|41|||
162131384|NCT06403605|585531925|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
162131385|NCT06403605|585531926|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
162131386|NCT06403605|585531925|FG000|Follow-up|Adverse Event|4|||
162131387|NCT06403605|585531926|FG001|Follow-up|Adverse Event|2|||
162131388|NCT06403605|585531925|FG000|Follow-up|Withdrawal by Subject|2|||
162131389|NCT06403605|585531926|FG001|Follow-up|Withdrawal by Subject|3|||
162131390|NCT06403605|585531925|FG000|Follow-up|Lost to Follow-up|1|||
162131391|NCT06403605|585531926|FG001|Follow-up|Lost to Follow-up|0|||
162131392|NCT06403605|585531925|FG000|Follow-up|Death|1|||
162131393|NCT06403605|585531926|FG001|Follow-up|Death|0|||
162131394|NCT06403605|585531925|FG000|Follow-up|Other reasons|0|||
162131395|NCT06403605|585531926|FG001|Follow-up|Other reasons|4|||
162131396|NCT07083843|585531927|FG000|Intervention period.|Withdrawal by Subject|1|||
162131397|NCT07083843|585531928|FG001|Intervention period.|Withdrawal by Subject|0|||
162131398|NCT07083843|585531927|FG000|Intervention period.|Death|0|||
162131399|NCT07083843|585531928|FG001|Intervention period.|Death|1|||
162131400|NCT00394095|585533539|FG000|Screening|Withdrawal by Subject|1|||
161793521|NCT02398188|584287746|FG001|Overall Study|Protocol Violation|10|||
161793522|NCT02398188|584287745|FG000|Overall Study|Sponsor Decision|2|||
161793523|NCT02398188|584287746|FG001|Overall Study|Sponsor Decision|1|||
161793524|NCT02398188|584287745|FG000|Overall Study|Pregnancy|1|||
161793525|NCT02398188|584287746|FG001|Overall Study|Pregnancy|0|||
161793526|NCT02398188|584287745|FG000|Overall Study|Withdrawal by Subject|7|||
161793527|NCT02398188|584287746|FG001|Overall Study|Withdrawal by Subject|16|||
162131401|NCT00394095|585533540|FG001|Screening|Withdrawal by Subject|0|||
162131402|NCT00394095|585533539|FG000|Randomized|Withdrawal by Subject|5|||
162131403|NCT00394095|585533540|FG001|Randomized|Withdrawal by Subject|1|||
162131404|NCT00394095|585533539|FG000|Randomized|Adverse Event|1|||
162131405|NCT00394095|585533540|FG001|Randomized|Adverse Event|1|||
162131406|NCT00394095|585533539|FG000|Randomized|Overdose|1|||
162131407|NCT00394095|585533540|FG001|Randomized|Overdose|0|||
161793528|NCT01259869|584287747|FG000|Overall Study|Duplicated registration|1|||
162131408|NCT00394095|585533539|FG000|Randomized|Lost to Follow-up|1|||
162131409|NCT00394095|585533540|FG001|Randomized|Lost to Follow-up|2|||
162131410|NCT00072475|585533551|FG000|Overall Study|Adverse Event|44|||
162131411|NCT00072475|585533551|FG000|Overall Study|Death|3|||
162131412|NCT00072475|585533551|FG000|Overall Study|Withdrawal by Subject|46|||
162131413|NCT00072475|585533551|FG000|Overall Study|Patient/Investigator Decision|4|||
162131414|NCT03303105|585533552|FG000|Overall Study|Adverse Event|0|||
162131415|NCT03303105|585533553|FG001|Overall Study|Adverse Event|2|||
162131416|NCT03303105|585533552|FG000|Overall Study|Lack of Efficacy|1|||
162131417|NCT03303105|585533553|FG001|Overall Study|Lack of Efficacy|0|||
162131418|NCT03303105|585533552|FG000|Overall Study|Protocol Violation|1|||
162131419|NCT03303105|585533553|FG001|Overall Study|Protocol Violation|0|||
162131420|NCT03303105|585533552|FG000|Overall Study|Withdrawal by Subject|0|||
162131421|NCT03303105|585533553|FG001|Overall Study|Withdrawal by Subject|2|||
162131422|NCT03566680|585533569|FG000|Overall Study|Pregnancy|1|||
162131423|NCT03566680|585533569|FG000|Overall Study|Lost to Follow-up|13|||
162131424|NCT03566680|585533569|FG000|Overall Study|Withdrawal by Subject|3|||
162131425|NCT02724020|585533571|FG000|Overall Study|Death|16|||
162131426|NCT02724020|585533572|FG001|Overall Study|Death|18|||
162131427|NCT02724020|585533573|FG002|Overall Study|Death|19|||
162131428|NCT02724020|585533571|FG000|Overall Study|Lost to Follow-up|0|||
162131429|NCT02724020|585533572|FG001|Overall Study|Lost to Follow-up|3|||
162131430|NCT02724020|585533573|FG002|Overall Study|Lost to Follow-up|0|||
162131431|NCT02724020|585533571|FG000|Overall Study|Site Terminated by Sponsor|15|||
162131432|NCT02724020|585533572|FG001|Overall Study|Site Terminated by Sponsor|8|||
162131433|NCT02724020|585533573|FG002|Overall Study|Site Terminated by Sponsor|8|||
162131434|NCT02724020|585533571|FG000|Overall Study|Withdrawal by Subject|1|||
162131435|NCT02724020|585533572|FG001|Overall Study|Withdrawal by Subject|3|||
162131436|NCT02724020|585533573|FG002|Overall Study|Withdrawal by Subject|5|||
162131437|NCT02179918|585533574|FG000|Overall Study|Death|0|||
162131438|NCT02179918|585533575|FG001|Overall Study|Death|0|||
162131439|NCT02179918|585533576|FG002|Overall Study|Death|0|||
162131440|NCT02179918|585533577|FG003|Overall Study|Death|1|||
162131441|NCT02179918|585533578|FG004|Overall Study|Death|0|||
162131442|NCT02179918|585533574|FG000|Overall Study|Lost to Follow-up|0|||
162131443|NCT02179918|585533575|FG001|Overall Study|Lost to Follow-up|0|||
162131444|NCT02179918|585533576|FG002|Overall Study|Lost to Follow-up|1|||
162131445|NCT02179918|585533577|FG003|Overall Study|Lost to Follow-up|0|||
162131446|NCT02179918|585533578|FG004|Overall Study|Lost to Follow-up|0|||
162131447|NCT02179918|585533574|FG000|Overall Study|Progressive Disease|4|||
162131448|NCT02179918|585533575|FG001|Overall Study|Progressive Disease|1|||
161793529|NCT00220701|584287748|FG000|Overall Study|Lost to Follow-up|5|||
161793530|NCT00220701|584287749|FG001|Overall Study|Lost to Follow-up|4|||
162131449|NCT02179918|585533576|FG002|Overall Study|Progressive Disease|1|||
162131450|NCT02179918|585533577|FG003|Overall Study|Progressive Disease|2|||
162131451|NCT02179918|585533578|FG004|Overall Study|Progressive Disease|6|||
162131452|NCT02179918|585533574|FG000|Overall Study|Other|0|||
162131453|NCT02179918|585533575|FG001|Overall Study|Other|1|||
162131454|NCT02179918|585533576|FG002|Overall Study|Other|0|||
162131455|NCT02179918|585533577|FG003|Overall Study|Other|0|||
162131456|NCT02179918|585533578|FG004|Overall Study|Other|1|||
162131457|NCT02179918|585533574|FG000|Overall Study|Subject refused further follow-up|0|||
162131458|NCT02179918|585533575|FG001|Overall Study|Subject refused further follow-up|1|||
162131459|NCT02179918|585533576|FG002|Overall Study|Subject refused further follow-up|0|||
162131460|NCT02179918|585533577|FG003|Overall Study|Subject refused further follow-up|0|||
162131461|NCT02179918|585533578|FG004|Overall Study|Subject refused further follow-up|1|||
162131462|NCT02954575|585533581|FG000|Overall Study|Withdrawal by Subject|2|||
162131463|NCT02954575|585533581|FG000|Overall Study|Adverse Event|1|||
162131464|NCT04227340|585533582|FG000|Overall Study|Withdrawal by Subject|3|||
162131465|NCT01066156|585533585|FG000|Overall Study|ineligible|2|||
162131466|NCT01066156|585533585|FG000|Overall Study|Lost to Follow-up|7|||
162131467|NCT01066156|585533585|FG000|Overall Study|Withdrawal by Subject|1|||
162131468|NCT00570661|585533586|FG000|Overall Study|Disease worsening|5|||
162131469|NCT00570661|585533586|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
162131470|NCT00570661|585533586|FG000|Overall Study|Adverse Event|1|||
162131471|NCT01734382|585533590|FG000|Part 1|Adverse Event|2|||
162131472|NCT01734382|585533591|FG001|Part 1|Adverse Event|0|||
162131473|NCT01734382|585533592|FG002|Part 1|Adverse Event|0|||
162131474|NCT01734382|585533590|FG000|Part 2|Adverse Event|0|||
162131475|NCT01734382|585533591|FG001|Part 2|Adverse Event|0|||
162131476|NCT01734382|585533592|FG002|Part 2|Adverse Event|1|||
162131477|NCT01734382|585533590|FG000|Part 2|Lack of Efficacy|0|||
162131478|NCT01734382|585533591|FG001|Part 2|Lack of Efficacy|1|||
162131479|NCT01734382|585533592|FG002|Part 2|Lack of Efficacy|1|||
162131480|NCT01734382|585533590|FG000|Part 2|Other|0|||
162131481|NCT01734382|585533591|FG001|Part 2|Other|0|||
162131482|NCT01734382|585533592|FG002|Part 2|Other|1|||
162131483|NCT01734382|585533590|FG000|Part 2|Physician Decision|0|||
162131484|NCT01734382|585533591|FG001|Part 2|Physician Decision|0|||
162131485|NCT01734382|585533592|FG002|Part 2|Physician Decision|3|||
162131486|NCT01734382|585533590|FG000|Part 2|Protocol Violation|0|||
162131487|NCT01734382|585533591|FG001|Part 2|Protocol Violation|1|||
162131488|NCT01734382|585533592|FG002|Part 2|Protocol Violation|0|||
162131489|NCT01734382|585533590|FG000|Part 2|Withdrawal by Subject|0|||
162131490|NCT01734382|585533591|FG001|Part 2|Withdrawal by Subject|0|||
162131491|NCT01734382|585533592|FG002|Part 2|Withdrawal by Subject|1|||
162131492|NCT04537949|585533593|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
162131493|NCT04537949|585533594|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
162131494|NCT04537949|585533595|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
162131495|NCT04537949|585533596|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
162131496|NCT04537949|585533597|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
162131497|NCT04537949|585533598|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
162131498|NCT04537949|585533599|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
162131499|NCT04537949|585533600|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
162131500|NCT04537949|585533593|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
162131501|NCT04537949|585533594|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
162131502|NCT04537949|585533595|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
162131503|NCT04537949|585533596|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
161793531|NCT01612000|584287751|FG000|Overall Study|Lost to Follow-up|6|||
161793532|NCT01612000|584287752|FG001|Overall Study|Lost to Follow-up|4|||
161793533|NCT01612000|584287753|FG002|Overall Study|Lost to Follow-up|4|||
162131504|NCT04537949|585533597|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
162131505|NCT04537949|585533598|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
162131506|NCT04537949|585533599|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
162131507|NCT04537949|585533600|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
162131508|NCT04537949|585533593|FG000|Follow-up Phase|Lost to Follow-up|0|||
162131509|NCT04537949|585533594|FG001|Follow-up Phase|Lost to Follow-up|3|||
161793534|NCT01612000|584287754|FG003|Overall Study|Lost to Follow-up|8|||
161793535|NCT01612000|584287751|FG000|Overall Study|Physician Decision|0|||
161793536|NCT01612000|584287752|FG001|Overall Study|Physician Decision|0|||
161793537|NCT01612000|584287753|FG002|Overall Study|Physician Decision|1|||
161793538|NCT01612000|584287754|FG003|Overall Study|Physician Decision|0|||
161793539|NCT01612000|584287751|FG000|Overall Study|Withdrawal by Subject|3|||
162131510|NCT04537949|585533595|FG002|Follow-up Phase|Lost to Follow-up|0|||
162131511|NCT04537949|585533596|FG003|Follow-up Phase|Lost to Follow-up|0|||
162131512|NCT04537949|585533597|FG004|Follow-up Phase|Lost to Follow-up|0|||
162131513|NCT04537949|585533598|FG005|Follow-up Phase|Lost to Follow-up|0|||
162131514|NCT04537949|585533599|FG006|Follow-up Phase|Lost to Follow-up|0|||
162131515|NCT04537949|585533600|FG007|Follow-up Phase|Lost to Follow-up|0|||
162131516|NCT04537949|585533593|FG000|Follow-up Phase|personal reasons|0|||
162131517|NCT04537949|585533594|FG001|Follow-up Phase|personal reasons|0|||
162131518|NCT04537949|585533595|FG002|Follow-up Phase|personal reasons|0|||
162131519|NCT04537949|585533596|FG003|Follow-up Phase|personal reasons|1|||
162131520|NCT04537949|585533597|FG004|Follow-up Phase|personal reasons|1|||
162131521|NCT04537949|585533598|FG005|Follow-up Phase|personal reasons|0|||
162131522|NCT04537949|585533599|FG006|Follow-up Phase|personal reasons|0|||
162131523|NCT04537949|585533600|FG007|Follow-up Phase|personal reasons|0|||
162131524|NCT04537949|585533593|FG000|Follow-up Phase|Withdrawal by Subject|0|||
162131525|NCT04537949|585533594|FG001|Follow-up Phase|Withdrawal by Subject|0|||
162131526|NCT04537949|585533595|FG002|Follow-up Phase|Withdrawal by Subject|0|||
162131527|NCT04537949|585533596|FG003|Follow-up Phase|Withdrawal by Subject|0|||
162131528|NCT04537949|585533597|FG004|Follow-up Phase|Withdrawal by Subject|1|||
162131529|NCT04537949|585533598|FG005|Follow-up Phase|Withdrawal by Subject|0|||
162131530|NCT04537949|585533599|FG006|Follow-up Phase|Withdrawal by Subject|0|||
162131531|NCT04537949|585533600|FG007|Follow-up Phase|Withdrawal by Subject|0|||
162131532|NCT04003974|585533601|FG000|Overall Study|Missing|1|||
162131533|NCT04003974|585533602|FG001|Overall Study|Missing|0|||
162131534|NCT04003974|585533601|FG000|Overall Study|Withdrawal by Subject|0|||
162131535|NCT04003974|585533602|FG001|Overall Study|Withdrawal by Subject|2|||
162131536|NCT02400307|585533603|FG000|Overall Study|Enrolled and Never Dosed|1|||
162131537|NCT02400307|585533604|FG001|Overall Study|Enrolled and Never Dosed|0|||
162131538|NCT02015663|585533608|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
162131539|NCT02015663|585533609|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
162131540|NCT02015663|585533608|FG000|Overall Study|Withdrawal by Subject|1|||
162131541|NCT02015663|585533609|FG001|Overall Study|Withdrawal by Subject|0|||
162131542|NCT02015663|585533608|FG000|Overall Study|Protocol Violation|0|||
162131543|NCT02015663|585533609|FG001|Overall Study|Protocol Violation|1|||
162131544|NCT02015663|585533608|FG000|Overall Study|Adverse Event|3|||
162131545|NCT02015663|585533609|FG001|Overall Study|Adverse Event|0|||
162131546|NCT02015663|585533608|FG000|Overall Study|Administrative problems|10|||
162131547|NCT02015663|585533609|FG001|Overall Study|Administrative problems|11|||
162131548|NCT02059161|585533611|FG000|Overall Study|Pregnancy|0|||
162131549|NCT02059161|585533612|FG001|Overall Study|Pregnancy|2|||
162131550|NCT02059161|585533611|FG000|Overall Study|Adverse Event|2|||
162131551|NCT02059161|585533612|FG001|Overall Study|Adverse Event|6|||
162131552|NCT02059161|585533611|FG000|Overall Study|Lost to Follow-up|20|||
162131553|NCT02059161|585533612|FG001|Overall Study|Lost to Follow-up|12|||
162131554|NCT02059161|585533611|FG000|Overall Study|Physician Decision|4|||
162131555|NCT02059161|585533612|FG001|Overall Study|Physician Decision|4|||
162131556|NCT02059161|585533611|FG000|Overall Study|Protocol Violation|1|||
162131557|NCT02059161|585533612|FG001|Overall Study|Protocol Violation|1|||
162131558|NCT02059161|585533611|FG000|Overall Study|Withdrawal by Subject|16|||
162131559|NCT02059161|585533612|FG001|Overall Study|Withdrawal by Subject|13|||
162131560|NCT02059161|585533611|FG000|Overall Study|Randomized in error, no study drug|0|||
162131561|NCT02059161|585533612|FG001|Overall Study|Randomized in error, no study drug|1|||
162131562|NCT02059161|585533611|FG000|Overall Study|Non-compliance with study drug|6|||
162131563|NCT02059161|585533612|FG001|Overall Study|Non-compliance with study drug|2|||
162131564|NCT03389893|585533613|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
162131565|NCT03389893|585533614|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
162131566|NCT03389893|585533615|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
162131567|NCT03389893|585533616|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
162131568|NCT03389893|585533613|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
162131569|NCT03389893|585533614|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
162131570|NCT03389893|585533615|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
162131571|NCT03389893|585533616|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
162131572|NCT03389893|585533613|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
162131573|NCT03389893|585533614|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
162131574|NCT03389893|585533615|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
162131575|NCT03389893|585533616|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
162131576|NCT03389893|585533613|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
162131577|NCT03389893|585533614|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
162131578|NCT03389893|585533615|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
162131579|NCT03389893|585533616|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
162131580|NCT01719861|585533619|FG000|Cycle 1|Death|4|||
162131581|NCT01719861|585533619|FG000|Cycle 2|Death|1|||
162131582|NCT00958009|585533620|FG000|Overall Study|Adverse Event|1|||
162131583|NCT00958009|585533620|FG000|Overall Study|Subject found device difficult to use|1|||
162131584|NCT02034435|585533633|FG000|Overall Study|Withdrawal by Subject|1|||
162131585|NCT02034435|585533634|FG001|Overall Study|Withdrawal by Subject|0|||
162131586|NCT02034435|585533635|FG002|Overall Study|Withdrawal by Subject|0|||
162131587|NCT02034435|585533636|FG003|Overall Study|Withdrawal by Subject|0|||
162131588|NCT02034435|585533633|FG000|Overall Study|Illness|0|||
162131589|NCT02034435|585533634|FG001|Overall Study|Illness|2|||
162131590|NCT02034435|585533635|FG002|Overall Study|Illness|0|||
162131591|NCT02034435|585533636|FG003|Overall Study|Illness|0|||
162131592|NCT02034435|585533633|FG000|Overall Study|Inadequate IV access|1|||
162131593|NCT02034435|585533634|FG001|Overall Study|Inadequate IV access|0|||
162131594|NCT02034435|585533635|FG002|Overall Study|Inadequate IV access|0|||
162131595|NCT02034435|585533636|FG003|Overall Study|Inadequate IV access|1|||
162131596|NCT02839681|585533639|FG000|Overall Study|Death|2|||
162131597|NCT01347645|585533643|FG000|Overall Study|Death|1|||
162131598|NCT01347645|585533644|FG001|Overall Study|Death|5|||
162131599|NCT01347645|585533645|FG002|Overall Study|Death|2|||
162131600|NCT01347645|585533646|FG003|Overall Study|Death|7|||
162131601|NCT01347645|585533647|FG004|Overall Study|Death|7|||
162131602|NCT01347645|585533643|FG000|Overall Study|Lost to Follow-up|1|||
162131603|NCT01347645|585533644|FG001|Overall Study|Lost to Follow-up|1|||
162131604|NCT01347645|585533645|FG002|Overall Study|Lost to Follow-up|0|||
162131605|NCT01347645|585533646|FG003|Overall Study|Lost to Follow-up|1|||
162131606|NCT01347645|585533647|FG004|Overall Study|Lost to Follow-up|1|||
162131607|NCT01347645|585533643|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
162131608|NCT01347645|585533644|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
162131609|NCT01347645|585533645|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
162131610|NCT01347645|585533646|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
162131611|NCT01347645|585533647|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
162131612|NCT01347645|585533643|FG000|Overall Study|Other|1|||
162131613|NCT01347645|585533644|FG001|Overall Study|Other|0|||
162131614|NCT01347645|585533645|FG002|Overall Study|Other|0|||
162131615|NCT01347645|585533646|FG003|Overall Study|Other|0|||
162131616|NCT01347645|585533647|FG004|Overall Study|Other|1|||
162131617|NCT01347645|585533643|FG000|Overall Study|Withdrawal by Subject|0|||
162131618|NCT01347645|585533644|FG001|Overall Study|Withdrawal by Subject|0|||
162131619|NCT01347645|585533645|FG002|Overall Study|Withdrawal by Subject|0|||
162131620|NCT01347645|585533646|FG003|Overall Study|Withdrawal by Subject|3|||
162131621|NCT01347645|585533647|FG004|Overall Study|Withdrawal by Subject|3|||
162131622|NCT01347645|585533643|FG000|Overall Study|Physician Decision|0|||
162131623|NCT01347645|585533644|FG001|Overall Study|Physician Decision|0|||
162131624|NCT01347645|585533645|FG002|Overall Study|Physician Decision|0|||
162131625|NCT01347645|585533646|FG003|Overall Study|Physician Decision|0|||
162131626|NCT01347645|585533647|FG004|Overall Study|Physician Decision|1|||
162131627|NCT01347645|585533643|FG000|Overall Study|Adverse Event|0|||
162131628|NCT01347645|585533644|FG001|Overall Study|Adverse Event|0|||
162131629|NCT01347645|585533645|FG002|Overall Study|Adverse Event|0|||
162131630|NCT01347645|585533646|FG003|Overall Study|Adverse Event|1|||
162131631|NCT01347645|585533647|FG004|Overall Study|Adverse Event|1|||
162131632|NCT00388362|585533648|FG000|Enrolled|Ineligible|1|||
161793540|NCT01612000|584287752|FG001|Overall Study|Withdrawal by Subject|1|||
161793541|NCT01612000|584287753|FG002|Overall Study|Withdrawal by Subject|2|||
161793542|NCT01612000|584287754|FG003|Overall Study|Withdrawal by Subject|2|||
161793543|NCT03843359|584287755|FG000|Escalation Phase|Lost to Follow-up|0|||
161793544|NCT03843359|584287756|FG001|Escalation Phase|Lost to Follow-up|0|||
161793545|NCT03843359|584287757|FG002|Escalation Phase|Lost to Follow-up|0|||
161793546|NCT03843359|584287758|FG003|Escalation Phase|Lost to Follow-up|0|||
162131633|NCT00388362|585533648|FG000|Enrolled|Adverse Event|9|||
162131634|NCT00388362|585533648|FG000|Enrolled|Death|1|||
162131635|NCT00388362|585533648|FG000|Enrolled|Loss insurance|1|||
162131636|NCT00388362|585533648|FG000|Enrolled|Withdrawal by Subject|1|||
162131637|NCT00388362|585533648|FG000|Remained on Study Median of 514 Days|Death|2|||
162131638|NCT01141660|585533649|FG000|Overall Study|Physician Decision|0|||
162131639|NCT01141660|585533650|FG001|Overall Study|Physician Decision|12|||
162131640|NCT00209027|585533652|FG000|Overall Study|study terminated|10|||
162131641|NCT00209027|585533653|FG001|Overall Study|study terminated|0|||
162131642|NCT02335268|585533654|FG000|Overall Study|Physician Decision|5|||
162131643|NCT02335268|585533655|FG001|Overall Study|Physician Decision|1|||
162131644|NCT02335268|585533654|FG000|Overall Study|Lack of Efficacy|2|||
162131645|NCT02335268|585533655|FG001|Overall Study|Lack of Efficacy|1|||
162131646|NCT02335268|585533654|FG000|Overall Study|Adverse Event|5|||
162131647|NCT02335268|585533655|FG001|Overall Study|Adverse Event|2|||
162131648|NCT02335268|585533654|FG000|Overall Study|increase blasts|2|||
162131649|NCT02335268|585533655|FG001|Overall Study|increase blasts|0|||
162131650|NCT02335268|585533654|FG000|Overall Study|Withdrawal by Subject|3|||
162131651|NCT02335268|585533655|FG001|Overall Study|Withdrawal by Subject|2|||
162131652|NCT05893797|585533658|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
162131653|NCT05893797|585533658|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
162131654|NCT05893797|585533658|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
162131655|NCT05893797|585533658|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
162131656|NCT04770220|585533659|FG000|Overall Study|Adverse Event|2|||
162131657|NCT04770220|585533660|FG001|Overall Study|Adverse Event|11|||
162131658|NCT04770220|585533659|FG000|Overall Study|Withdrawal by Subject|5|||
162131659|NCT04770220|585533660|FG001|Overall Study|Withdrawal by Subject|11|||
162131660|NCT04770220|585533659|FG000|Overall Study|Lost to Follow-up|4|||
162131661|NCT04770220|585533660|FG001|Overall Study|Lost to Follow-up|3|||
162131662|NCT04770220|585533659|FG000|Overall Study|not otherwise specified|2|||
162131663|NCT04770220|585533660|FG001|Overall Study|not otherwise specified|3|||
162131664|NCT04770220|585533659|FG000|Overall Study|Physician Decision|1|||
162131665|NCT04770220|585533660|FG001|Overall Study|Physician Decision|3|||
162131666|NCT04894903|585533662|FG000|Overall Study|Death|1|||
162131667|NCT04894903|585533663|FG001|Overall Study|Death|0|||
162131668|NCT04894903|585533662|FG000|Overall Study|Pregnancy|1|||
162131669|NCT04894903|585533663|FG001|Overall Study|Pregnancy|0|||
162131670|NCT04894903|585533662|FG000|Overall Study|Withdrawal by Subject|1|||
162131671|NCT04894903|585533663|FG001|Overall Study|Withdrawal by Subject|1|||
162131672|NCT04894903|585533662|FG000|Overall Study|moved or exited health system|1|||
162131673|NCT04894903|585533663|FG001|Overall Study|moved or exited health system|3|||
162131674|NCT01923428|585533664|FG000|Overall Study|Adverse Event|8|||
162131675|NCT01923428|585533665|FG001|Overall Study|Adverse Event|6|||
162131676|NCT01923428|585533666|FG002|Overall Study|Adverse Event|3|||
162131677|NCT01923428|585533667|FG003|Overall Study|Adverse Event|3|||
162131678|NCT01923428|585533664|FG000|Overall Study|Withdrawal by Subject|5|||
162131679|NCT01923428|585533665|FG001|Overall Study|Withdrawal by Subject|3|||
162131680|NCT01923428|585533666|FG002|Overall Study|Withdrawal by Subject|0|||
162131681|NCT01923428|585533667|FG003|Overall Study|Withdrawal by Subject|4|||
162131682|NCT01923428|585533664|FG000|Overall Study|Lost to Follow-up|2|||
162131683|NCT01923428|585533665|FG001|Overall Study|Lost to Follow-up|1|||
162131684|NCT01923428|585533666|FG002|Overall Study|Lost to Follow-up|5|||
162131685|NCT01923428|585533667|FG003|Overall Study|Lost to Follow-up|0|||
162131686|NCT01923428|585533664|FG000|Overall Study|Protocol Violation|3|||
162131687|NCT01923428|585533665|FG001|Overall Study|Protocol Violation|0|||
162131688|NCT01923428|585533666|FG002|Overall Study|Protocol Violation|2|||
162131689|NCT01923428|585533667|FG003|Overall Study|Protocol Violation|1|||
162131690|NCT01923428|585533664|FG000|Overall Study|Non Compliance to treatment|1|||
162131691|NCT01923428|585533665|FG001|Overall Study|Non Compliance to treatment|2|||
162131692|NCT01923428|585533666|FG002|Overall Study|Non Compliance to treatment|0|||
162131693|NCT01923428|585533667|FG003|Overall Study|Non Compliance to treatment|1|||
162131694|NCT01923428|585533664|FG000|Overall Study|Lack of Efficacy|0|||
162131695|NCT01923428|585533665|FG001|Overall Study|Lack of Efficacy|0|||
162131696|NCT01923428|585533666|FG002|Overall Study|Lack of Efficacy|1|||
162131697|NCT01923428|585533667|FG003|Overall Study|Lack of Efficacy|1|||
162131698|NCT02550873|585533668|FG000|Randomized Double Blind|Adverse Event|3|||
162131699|NCT02550873|585533669|FG001|Randomized Double Blind|Adverse Event|1|||
162131700|NCT02550873|585533670|FG002|Randomized Double Blind|Adverse Event|0|||
162131701|NCT02550873|585533668|FG000|Randomized Double Blind|Disease progression|1|||
162131702|NCT02550873|585533669|FG001|Randomized Double Blind|Disease progression|1|||
162131703|NCT02550873|585533670|FG002|Randomized Double Blind|Disease progression|0|||
162131704|NCT02550873|585533668|FG000|Open Label Extension|Study ongoing|0|||
162131705|NCT02550873|585533669|FG001|Open Label Extension|Study ongoing|0|||
162131706|NCT02550873|585533670|FG002|Open Label Extension|Study ongoing|111|||
162131707|NCT01822353|585533671|FG000|Overall Study|Adverse Event|1|||
162131708|NCT01822353|585533672|FG001|Overall Study|Adverse Event|3|||
162131709|NCT01822353|585533673|FG002|Overall Study|Adverse Event|1|||
162131710|NCT01822353|585533671|FG000|Overall Study|Pregnancy|0|||
162131711|NCT01822353|585533672|FG001|Overall Study|Pregnancy|1|||
162131712|NCT01822353|585533673|FG002|Overall Study|Pregnancy|0|||
162131713|NCT01822353|585533671|FG000|Overall Study|Withdrawal by Subject|3|||
162131714|NCT01822353|585533672|FG001|Overall Study|Withdrawal by Subject|1|||
162131715|NCT01822353|585533673|FG002|Overall Study|Withdrawal by Subject|0|||
162131716|NCT03873246|585533675|FG000|Overall Study|Adverse Event|1|||
162131717|NCT03873246|585533676|FG001|Overall Study|Adverse Event|3|||
162131718|NCT03873246|585533677|FG002|Overall Study|Adverse Event|3|||
162131719|NCT03873246|585533675|FG000|Overall Study|Lost to Follow-up|4|||
162131720|NCT03873246|585533676|FG001|Overall Study|Lost to Follow-up|4|||
162131721|NCT03873246|585533677|FG002|Overall Study|Lost to Follow-up|5|||
162131722|NCT03873246|585533675|FG000|Overall Study|Protocol Violation|0|||
162131723|NCT03873246|585533676|FG001|Overall Study|Protocol Violation|1|||
162131724|NCT03873246|585533677|FG002|Overall Study|Protocol Violation|0|||
162131725|NCT03873246|585533675|FG000|Overall Study|Withdrawal by Subject|0|||
162131726|NCT03873246|585533676|FG001|Overall Study|Withdrawal by Subject|4|||
162131727|NCT03873246|585533677|FG002|Overall Study|Withdrawal by Subject|1|||
162131728|NCT00885495|585533678|FG000|Overall Study|Adverse Event|1|||
162131729|NCT00885495|585533679|FG001|Overall Study|Adverse Event|2|||
162131730|NCT00885495|585533678|FG000|Overall Study|Protocol Violation|0|||
162131731|NCT00885495|585533679|FG001|Overall Study|Protocol Violation|1|||
162131732|NCT00885495|585533678|FG000|Overall Study|Withdrawal by Subject|1|||
162131733|NCT00885495|585533679|FG001|Overall Study|Withdrawal by Subject|0|||
162131734|NCT02107443|585533680|FG000|Overall Study|Death|42|||
162131735|NCT02107443|585533681|FG001|Overall Study|Death|30|||
162131736|NCT02107443|585533680|FG000|Overall Study|Study Protocol Violation|3|||
162131737|NCT02107443|585533681|FG001|Overall Study|Study Protocol Violation|1|||
162131738|NCT02107443|585533680|FG000|Overall Study|Registered but Not Eligible|0|||
162131739|NCT02107443|585533681|FG001|Overall Study|Registered but Not Eligible|1|||
162131740|NCT02107443|585533680|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
162131741|NCT02107443|585533681|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
161898929|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898930|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898931|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898932|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898933|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898934|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898935|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898936|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
162131742|NCT02107443|585533680|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
162131743|NCT02107443|585533681|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
162131744|NCT02107443|585533680|FG000|Overall Study|Withdrawal: Changed Mind|2|||
162131745|NCT02107443|585533681|FG001|Overall Study|Withdrawal: Changed Mind|0|||
162131746|NCT02107443|585533680|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
162131747|NCT02107443|585533681|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
162131748|NCT02107443|585533680|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
162131749|NCT02107443|585533681|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
162131750|NCT02107443|585533680|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
162131751|NCT02107443|585533681|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
162131752|NCT02107443|585533680|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
162131753|NCT02107443|585533681|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
162131754|NCT02107443|585533680|FG000|Overall Study|Withdrawal: Other Medical|9|||
162131755|NCT02107443|585533681|FG001|Overall Study|Withdrawal: Other Medical|5|||
162131756|NCT02107443|585533680|FG000|Overall Study|Withdrawal: Disease Progression|4|||
162131757|NCT02107443|585533681|FG001|Overall Study|Withdrawal: Disease Progression|2|||
162131758|NCT02107443|585533680|FG000|Overall Study|Withdrawal: Personal Issues|0|||
162131759|NCT02107443|585533681|FG001|Overall Study|Withdrawal: Personal Issues|3|||
162131760|NCT00946647|585533682|FG000|Phase 1 Part|Adverse Event|2|||
162131761|NCT00946647|585533683|FG001|Phase 1 Part|Adverse Event|5|||
162131762|NCT00946647|585533684|FG002|Phase 1 Part|Adverse Event|3|||
162131763|NCT00946647|585533685|FG003|Phase 1 Part|Adverse Event|0|||
162131764|NCT00946647|585533686|FG004|Phase 1 Part|Adverse Event|0|||
162131765|NCT00946647|585533682|FG000|Phase 1 Part|Disease progression|3|||
162131766|NCT00946647|585533683|FG001|Phase 1 Part|Disease progression|6|||
162131767|NCT00946647|585533684|FG002|Phase 1 Part|Disease progression|1|||
162131768|NCT00946647|585533685|FG003|Phase 1 Part|Disease progression|0|||
162131769|NCT00946647|585533686|FG004|Phase 1 Part|Disease progression|0|||
162131770|NCT00946647|585533682|FG000|Phase 1 Part|Withdrawal by Subject|1|||
162131771|NCT00946647|585533683|FG001|Phase 1 Part|Withdrawal by Subject|4|||
162131772|NCT00946647|585533684|FG002|Phase 1 Part|Withdrawal by Subject|3|||
162131773|NCT00946647|585533685|FG003|Phase 1 Part|Withdrawal by Subject|0|||
162131774|NCT00946647|585533686|FG004|Phase 1 Part|Withdrawal by Subject|0|||
162131775|NCT00946647|585533682|FG000|Phase 1 Part|Abnormal values|0|||
162131776|NCT00946647|585533683|FG001|Phase 1 Part|Abnormal values|2|||
162131777|NCT00946647|585533684|FG002|Phase 1 Part|Abnormal values|0|||
162131778|NCT00946647|585533685|FG003|Phase 1 Part|Abnormal values|0|||
162131779|NCT00946647|585533686|FG004|Phase 1 Part|Abnormal values|0|||
162131780|NCT00946647|585533682|FG000|Phase 1 Part|Reason missing|0|||
162131781|NCT00946647|585533683|FG001|Phase 1 Part|Reason missing|1|||
162131782|NCT00946647|585533684|FG002|Phase 1 Part|Reason missing|0|||
162131783|NCT00946647|585533685|FG003|Phase 1 Part|Reason missing|0|||
162131784|NCT00946647|585533686|FG004|Phase 1 Part|Reason missing|0|||
162131785|NCT00946647|585533682|FG000|Phase ll Part|Untreated|0|||
162131786|NCT00946647|585533683|FG001|Phase ll Part|Untreated|0|||
162131787|NCT00946647|585533684|FG002|Phase ll Part|Untreated|0|||
162131788|NCT00946647|585533685|FG003|Phase ll Part|Untreated|0|||
162131789|NCT00946647|585533686|FG004|Phase ll Part|Untreated|2|||
162131790|NCT00946647|585533682|FG000|Phase ll Part|Adverse Event|0|||
162131791|NCT00946647|585533683|FG001|Phase ll Part|Adverse Event|0|||
162131792|NCT00946647|585533684|FG002|Phase ll Part|Adverse Event|0|||
162131793|NCT00946647|585533685|FG003|Phase ll Part|Adverse Event|10|||
162131794|NCT00946647|585533686|FG004|Phase ll Part|Adverse Event|6|||
162131795|NCT00946647|585533682|FG000|Phase ll Part|Withdrawal by Subject|0|||
162131796|NCT00946647|585533683|FG001|Phase ll Part|Withdrawal by Subject|0|||
162131797|NCT00946647|585533684|FG002|Phase ll Part|Withdrawal by Subject|0|||
162131798|NCT00946647|585533685|FG003|Phase ll Part|Withdrawal by Subject|8|||
162131799|NCT00946647|585533686|FG004|Phase ll Part|Withdrawal by Subject|6|||
162131800|NCT00946647|585533682|FG000|Phase ll Part|Administrative problems|0|||
162131801|NCT00946647|585533683|FG001|Phase ll Part|Administrative problems|0|||
162131802|NCT00946647|585533684|FG002|Phase ll Part|Administrative problems|0|||
162131803|NCT00946647|585533685|FG003|Phase ll Part|Administrative problems|3|||
162131804|NCT00946647|585533686|FG004|Phase ll Part|Administrative problems|8|||
162131805|NCT00946647|585533682|FG000|Phase ll Part|Death|0|||
162131806|NCT00946647|585533683|FG001|Phase ll Part|Death|0|||
162131807|NCT00946647|585533684|FG002|Phase ll Part|Death|0|||
162131808|NCT00946647|585533685|FG003|Phase ll Part|Death|7|||
162131809|NCT00946647|585533686|FG004|Phase ll Part|Death|4|||
162131810|NCT00946647|585533682|FG000|Phase ll Part|Disease progression|0|||
162131811|NCT00946647|585533683|FG001|Phase ll Part|Disease progression|0|||
162131812|NCT00946647|585533684|FG002|Phase ll Part|Disease progression|0|||
162131813|NCT00946647|585533685|FG003|Phase ll Part|Disease progression|6|||
162131814|NCT00946647|585533686|FG004|Phase ll Part|Disease progression|14|||
162131815|NCT00946647|585533682|FG000|Phase ll Part|Protocol Violation|0|||
162131816|NCT00946647|585533683|FG001|Phase ll Part|Protocol Violation|0|||
162131817|NCT00946647|585533684|FG002|Phase ll Part|Protocol Violation|0|||
162131818|NCT00946647|585533685|FG003|Phase ll Part|Protocol Violation|4|||
162131819|NCT00946647|585533686|FG004|Phase ll Part|Protocol Violation|2|||
162131820|NCT00946647|585533682|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
162131821|NCT00946647|585533683|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
162131822|NCT00946647|585533684|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
162131823|NCT00946647|585533685|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
162131824|NCT00946647|585533686|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
162131825|NCT01368211|585533687|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
162131826|NCT01368211|585533688|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
162131827|NCT04988477|585533693|FG000|Overall Study|Death|1|||
162131828|NCT04988477|585533694|FG001|Overall Study|Death|0|||
162131829|NCT04988477|585533695|FG002|Overall Study|Death|0|||
162131830|NCT04988477|585533693|FG000|Overall Study|Lost to Follow-up|5|||
162131831|NCT04988477|585533694|FG001|Overall Study|Lost to Follow-up|2|||
162131832|NCT04988477|585533695|FG002|Overall Study|Lost to Follow-up|0|||
162131833|NCT04988477|585533693|FG000|Overall Study|Withdrawal by Subject|2|||
162131834|NCT04988477|585533694|FG001|Overall Study|Withdrawal by Subject|0|||
162131835|NCT04988477|585533695|FG002|Overall Study|Withdrawal by Subject|0|||
162131836|NCT04034238|585535036|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
162131837|NCT04034238|585535037|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
162131838|NCT04034238|585535038|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
162131839|NCT04034238|585535039|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
162131840|NCT04034238|585535036|FG000|Dose Escalation Phase|Screen failures|0|||
162131841|NCT04034238|585535037|FG001|Dose Escalation Phase|Screen failures|0|||
162131842|NCT04034238|585535038|FG002|Dose Escalation Phase|Screen failures|0|||
162131843|NCT04034238|585535039|FG003|Dose Escalation Phase|Screen failures|2|||
162131844|NCT04034238|585535036|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
162131845|NCT04034238|585535037|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
162131846|NCT04034238|585535038|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
162131847|NCT04034238|585535039|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
162131848|NCT04034238|585535036|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
162131849|NCT04034238|585535037|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
162131850|NCT04034238|585535038|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
162131851|NCT04034238|585535039|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
162131852|NCT02153788|585535042|FG000|Overall Study|Physician Decision|2|||
161898937|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898938|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898939|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161898940|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
161898941|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
161898942|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
161898943|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
161898944|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
161898945|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
162131853|NCT02153788|585535043|FG001|Overall Study|Physician Decision|1|||
162131854|NCT01106287|585535044|FG000|Overall Study|Adverse Event|1|||
162131855|NCT01106287|585535045|FG001|Overall Study|Adverse Event|0|||
162131856|NCT01106287|585535046|FG002|Overall Study|Adverse Event|0|||
162131857|NCT01106287|585535047|FG003|Overall Study|Adverse Event|0|||
162131858|NCT01450943|585535050|FG000|Overall Study|Screen failure, loss to follow-up|2|||
162131859|NCT01450943|585535051|FG001|Overall Study|Screen failure, loss to follow-up|7|||
162131860|NCT01450943|585535052|FG002|Overall Study|Screen failure, loss to follow-up|6|||
162131861|NCT01345292|585535053|FG000|Overall Study|Withdrawal by Subject|2|||
162131862|NCT01345292|585535054|FG001|Overall Study|Withdrawal by Subject|0|||
162131863|NCT01345292|585535055|FG002|Overall Study|Withdrawal by Subject|1|||
162131864|NCT04822298|585535059|FG000|Overall Study|Death|3|||
162131865|NCT00465361|585535062|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
162131866|NCT05406791|585535063|FG000|Overall Study|Lost to Follow-up|13|||
162131867|NCT05406791|585535064|FG001|Overall Study|Lost to Follow-up|10|||
162131868|NCT01625338|585535065|FG000|Overall Study|Enrolled but not Treated|0|||
162131869|NCT01625338|585535066|FG001|Overall Study|Enrolled but not Treated|0|||
162131870|NCT01625338|585535067|FG002|Overall Study|Enrolled but not Treated|1|||
162131871|NCT01625338|585535065|FG000|Overall Study|Efficacy Failure|27|||
162131872|NCT01625338|585535066|FG001|Overall Study|Efficacy Failure|39|||
162131873|NCT01625338|585535067|FG002|Overall Study|Efficacy Failure|31|||
162131874|NCT01625338|585535065|FG000|Overall Study|Lost to Follow-up|3|||
162131875|NCT01625338|585535066|FG001|Overall Study|Lost to Follow-up|3|||
162131876|NCT01625338|585535067|FG002|Overall Study|Lost to Follow-up|2|||
162131877|NCT01625338|585535065|FG000|Overall Study|Investigator Decision|0|||
162131878|NCT01625338|585535066|FG001|Overall Study|Investigator Decision|2|||
162131879|NCT01625338|585535067|FG002|Overall Study|Investigator Decision|1|||
162131880|NCT01625338|585535065|FG000|Overall Study|Subject Withdrew Consent|1|||
162131881|NCT01625338|585535066|FG001|Overall Study|Subject Withdrew Consent|0|||
162131882|NCT01625338|585535067|FG002|Overall Study|Subject Withdrew Consent|2|||
162131883|NCT01625338|585535065|FG000|Overall Study|Adverse Event|1|||
162131884|NCT01625338|585535066|FG001|Overall Study|Adverse Event|0|||
162131885|NCT01625338|585535067|FG002|Overall Study|Adverse Event|1|||
162131886|NCT01625338|585535065|FG000|Overall Study|Study Discontinued by Sponsor|0|||
162131887|NCT01625338|585535066|FG001|Overall Study|Study Discontinued by Sponsor|0|||
161898946|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
161898947|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
161898948|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
161898949|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
161898950|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
161898951|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
161898952|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
161898953|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
161898954|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
162131888|NCT01625338|585535067|FG002|Overall Study|Study Discontinued by Sponsor|1|||
162131889|NCT01789203|585535068|FG000|Overall Study|Adverse Event|2|||
162131890|NCT01789203|585535069|FG001|Overall Study|Adverse Event|2|||
162131891|NCT01789203|585535068|FG000|Overall Study|Withdrawal by Subject|1|||
162131892|NCT01789203|585535069|FG001|Overall Study|Withdrawal by Subject|0|||
162131893|NCT01789203|585535068|FG000|Overall Study|Death|1|||
162131894|NCT01789203|585535069|FG001|Overall Study|Death|0|||
162131895|NCT01789203|585535068|FG000|Overall Study|Protocol Violation|2|||
162131896|NCT01789203|585535069|FG001|Overall Study|Protocol Violation|1|||
162131897|NCT01789203|585535068|FG000|Overall Study|Other|1|||
162131898|NCT01789203|585535069|FG001|Overall Study|Other|1|||
162131899|NCT01789203|585535068|FG000|Overall Study|patient non-adherent|2|||
162131900|NCT01789203|585535069|FG001|Overall Study|patient non-adherent|0|||
161793547|NCT03843359|584287759|FG004|Escalation Phase|Lost to Follow-up|0|||
162131901|NCT00515086|585535076|FG000|Overall Study|Adverse Event|1|||
162131902|NCT00515086|585535077|FG001|Overall Study|Adverse Event|1|||
162131903|NCT00515086|585535078|FG002|Overall Study|Adverse Event|2|||
162131904|NCT00515086|585535079|FG003|Overall Study|Adverse Event|3|||
162131905|NCT00515086|585535076|FG000|Overall Study|Administrative|1|||
162131906|NCT00515086|585535077|FG001|Overall Study|Administrative|1|||
162131907|NCT00515086|585535078|FG002|Overall Study|Administrative|0|||
162131908|NCT00515086|585535079|FG003|Overall Study|Administrative|0|||
162131909|NCT00515086|585535076|FG000|Overall Study|Withdrawal by Subject|1|||
162131910|NCT00515086|585535077|FG001|Overall Study|Withdrawal by Subject|0|||
162131911|NCT00515086|585535078|FG002|Overall Study|Withdrawal by Subject|0|||
162131912|NCT00515086|585535079|FG003|Overall Study|Withdrawal by Subject|1|||
162131913|NCT00515086|585535076|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
162131914|NCT00515086|585535077|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
162131915|NCT00515086|585535078|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
162131916|NCT00515086|585535079|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
162131917|NCT00515086|585535076|FG000|Overall Study|Lost to Follow-up|1|||
162131918|NCT00515086|585535077|FG001|Overall Study|Lost to Follow-up|0|||
162131919|NCT00515086|585535078|FG002|Overall Study|Lost to Follow-up|0|||
162131920|NCT00515086|585535079|FG003|Overall Study|Lost to Follow-up|0|||
162131921|NCT00515086|585535076|FG000|Overall Study|Study drug no longer required|0|||
162131922|NCT00515086|585535077|FG001|Overall Study|Study drug no longer required|1|||
162131923|NCT00515086|585535078|FG002|Overall Study|Study drug no longer required|0|||
162131924|NCT00515086|585535079|FG003|Overall Study|Study drug no longer required|0|||
162131925|NCT00515086|585535076|FG000|Overall Study|Death|2|||
162131926|NCT00515086|585535077|FG001|Overall Study|Death|0|||
162131927|NCT00515086|585535078|FG002|Overall Study|Death|0|||
162131928|NCT00515086|585535079|FG003|Overall Study|Death|0|||
162131929|NCT02403674|585535082|FG000|Base Study|Death|1|||
162131930|NCT02403674|585535083|FG001|Base Study|Death|4|||
162131931|NCT02403674|585535082|FG000|Base Study|Adverse Event|11|||
162131932|NCT02403674|585535083|FG001|Base Study|Adverse Event|26|||
162131933|NCT02403674|585535082|FG000|Base Study|Lack of Efficacy|31|||
162131934|NCT02403674|585535083|FG001|Base Study|Lack of Efficacy|23|||
162131935|NCT02403674|585535082|FG000|Base Study|Lost to Follow-up|6|||
162131936|NCT02403674|585535083|FG001|Base Study|Lost to Follow-up|8|||
162131937|NCT02403674|585535082|FG000|Base Study|Withdrawal by Subject|10|||
162131938|NCT02403674|585535083|FG001|Base Study|Withdrawal by Subject|17|||
162131939|NCT02403674|585535082|FG000|Base Study|Physician Decision|2|||
162131940|NCT02403674|585535083|FG001|Base Study|Physician Decision|2|||
162131941|NCT02403674|585535082|FG000|Base Study|Pregnancy|2|||
162131942|NCT02403674|585535083|FG001|Base Study|Pregnancy|2|||
162131943|NCT02403674|585535082|FG000|Base Study|Protocol Violation|8|||
162131944|NCT02403674|585535083|FG001|Base Study|Protocol Violation|4|||
162131945|NCT02403674|585535082|FG000|Base Study|Non-Compliance with study drug|1|||
162131946|NCT02403674|585535083|FG001|Base Study|Non-Compliance with study drug|4|||
162131947|NCT02403674|585535082|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
162131948|NCT02403674|585535083|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
162131949|NCT02403674|585535082|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
162131950|NCT02403674|585535083|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
162131951|NCT02403674|585535082|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
162131952|NCT02403674|585535083|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
162131953|NCT02403674|585535082|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
162131954|NCT02403674|585535083|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
161793548|NCT03843359|584287760|FG005|Escalation Phase|Lost to Follow-up|0|||
161793549|NCT03843359|584287761|FG006|Escalation Phase|Lost to Follow-up|0|||
161793550|NCT03843359|584287762|FG007|Escalation Phase|Lost to Follow-up|0|||
162131955|NCT02403674|585535082|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
162131956|NCT02403674|585535083|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
162131957|NCT02403674|585535082|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
162131958|NCT02403674|585535083|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
162131959|NCT02403674|585535082|FG000|Study Extension 1 (Open-Label)|Death|1|||
162131960|NCT02403674|585535083|FG001|Study Extension 1 (Open-Label)|Death|0|||
162131961|NCT02403674|585535082|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
162131962|NCT02403674|585535083|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
162131963|NCT02403674|585535082|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
162131964|NCT02403674|585535083|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
162131965|NCT02403674|585535082|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
162131966|NCT02403674|585535083|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
162131967|NCT02403674|585535082|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
162131968|NCT02403674|585535083|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
162131969|NCT02403674|585535082|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
162131970|NCT02403674|585535083|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
162131971|NCT02403674|585535082|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
162131972|NCT02403674|585535083|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
162131973|NCT02403674|585535082|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
162131974|NCT02403674|585535083|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
162131975|NCT02403674|585535082|FG000|Study Extension 2 (Open-Label)|Death|2|||
162131976|NCT02403674|585535083|FG001|Study Extension 2 (Open-Label)|Death|2|||
162131977|NCT02403674|585535082|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
162131978|NCT02403674|585535083|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
162131979|NCT02403674|585535082|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
162131980|NCT02403674|585535083|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
162131981|NCT02403674|585535082|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
162131982|NCT02403674|585535083|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
162131983|NCT02403674|585535082|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
162131984|NCT02403674|585535083|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
162131985|NCT02403674|585535082|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
162131986|NCT02403674|585535083|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
162131987|NCT02403674|585535082|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
162131988|NCT02403674|585535083|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
162131989|NCT02403674|585535082|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
162131990|NCT02403674|585535083|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
162131991|NCT03487666|585535086|FG000|Overall Study|Disease progression|4|||
162131992|NCT03487666|585535087|FG001|Overall Study|Disease progression|2|||
162131993|NCT03487666|585535088|FG002|Overall Study|Disease progression|0|||
162131994|NCT03487666|585535086|FG000|Overall Study|Adverse Event|0|||
162131995|NCT03487666|585535087|FG001|Overall Study|Adverse Event|0|||
162131996|NCT03487666|585535088|FG002|Overall Study|Adverse Event|1|||
162131997|NCT03201757|585535089|FG000|Overall Study|Withdrawal by Subject|133|||
162131998|NCT03201757|585535089|FG000|Overall Study|Adverse Event|44|||
162131999|NCT03201757|585535089|FG000|Overall Study|Lost to Follow-up|37|||
162132000|NCT03201757|585535089|FG000|Overall Study|Pregnancy|2|||
162132001|NCT03201757|585535089|FG000|Overall Study|Lack of Efficacy|1|||
162132002|NCT03201757|585535089|FG000|Overall Study|Protocol Violation|20|||
162132003|NCT03201757|585535089|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
162132004|NCT03201757|585535089|FG000|Overall Study|Not Yet Determined|5|||
162132005|NCT03201757|585535089|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
162132006|NCT03201757|585535089|FG000|Overall Study|Other|20|||
162132007|NCT01254305|585535093|FG000|Overall Study|Adverse Event|6|||
162132008|NCT01254305|585535094|FG001|Overall Study|Adverse Event|3|||
162132009|NCT01254305|585535095|FG002|Overall Study|Adverse Event|2|||
162132010|NCT01254305|585535093|FG000|Overall Study|Lack of Efficacy|1|||
162132011|NCT01254305|585535094|FG001|Overall Study|Lack of Efficacy|0|||
162132012|NCT01254305|585535095|FG002|Overall Study|Lack of Efficacy|1|||
162132013|NCT01254305|585535093|FG000|Overall Study|Protocol Violation|1|||
162132014|NCT01254305|585535094|FG001|Overall Study|Protocol Violation|7|||
162132015|NCT01254305|585535095|FG002|Overall Study|Protocol Violation|3|||
162132016|NCT01254305|585535093|FG000|Overall Study|Withdrawal by Subject|4|||
162132017|NCT01254305|585535094|FG001|Overall Study|Withdrawal by Subject|2|||
162132018|NCT01254305|585535095|FG002|Overall Study|Withdrawal by Subject|4|||
162132019|NCT01254305|585535093|FG000|Overall Study|Lost to Follow-up|10|||
162132020|NCT01254305|585535094|FG001|Overall Study|Lost to Follow-up|6|||
162132021|NCT01254305|585535095|FG002|Overall Study|Lost to Follow-up|5|||
162132022|NCT01254305|585535093|FG000|Overall Study|Other Reasons|0|||
162132023|NCT01254305|585535094|FG001|Overall Study|Other Reasons|0|||
162132024|NCT01254305|585535095|FG002|Overall Study|Other Reasons|2|||
162132025|NCT03930186|585535096|FG000|Weeks 0 to 16|Adverse Event|6|||
162132026|NCT03930186|585535096|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
162132027|NCT03930186|585535096|FG000|Weeks 16 to 32|Adverse Event|1|||
161898955|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
161898956|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
162132028|NCT03930186|585535096|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
162242039|NCT02616562|585939069|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162242040|NCT02616562|585939070|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161898957|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
161898958|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
162132029|NCT03019458|585535099|FG000|Overall Study|Death|0|||
162242041|NCT02616562|585939071|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162132030|NCT03019458|585535100|FG001|Overall Study|Death|1|||
162132031|NCT00557505|585535101|FG000|Overall Study|Death|0|||
162132032|NCT00557505|585535102|FG001|Overall Study|Death|0|||
162132033|NCT00557505|585535103|FG002|Overall Study|Death|0|||
162132034|NCT00557505|585535104|FG003|Overall Study|Death|0|||
162132035|NCT00557505|585535105|FG004|Overall Study|Death|0|||
162132036|NCT00557505|585535106|FG005|Overall Study|Death|0|||
162132037|NCT00557505|585535107|FG006|Overall Study|Death|0|||
162132038|NCT00557505|585535108|FG007|Overall Study|Death|0|||
162132039|NCT00557505|585535109|FG008|Overall Study|Death|1|||
162132040|NCT00557505|585535101|FG000|Overall Study|Adverse Event|0|||
162132041|NCT00557505|585535102|FG001|Overall Study|Adverse Event|0|||
162132042|NCT00557505|585535103|FG002|Overall Study|Adverse Event|1|||
162132043|NCT00557505|585535104|FG003|Overall Study|Adverse Event|0|||
162132044|NCT00557505|585535105|FG004|Overall Study|Adverse Event|0|||
162132045|NCT00557505|585535106|FG005|Overall Study|Adverse Event|0|||
162132046|NCT00557505|585535107|FG006|Overall Study|Adverse Event|1|||
162132047|NCT00557505|585535108|FG007|Overall Study|Adverse Event|0|||
162132048|NCT00557505|585535109|FG008|Overall Study|Adverse Event|0|||
162132049|NCT00557505|585535101|FG000|Overall Study|Global deterioration of health|1|||
162132050|NCT00557505|585535102|FG001|Overall Study|Global deterioration of health|0|||
162132051|NCT00557505|585535103|FG002|Overall Study|Global deterioration of health|0|||
162132052|NCT00557505|585535104|FG003|Overall Study|Global deterioration of health|0|||
162132053|NCT00557505|585535105|FG004|Overall Study|Global deterioration of health|0|||
162132054|NCT00557505|585535106|FG005|Overall Study|Global deterioration of health|0|||
162132055|NCT00557505|585535107|FG006|Overall Study|Global deterioration of health|0|||
162132056|NCT00557505|585535108|FG007|Overall Study|Global deterioration of health|0|||
162132057|NCT00557505|585535109|FG008|Overall Study|Global deterioration of health|0|||
162132058|NCT00557505|585535101|FG000|Overall Study|Objective progression or relapse|2|||
162132059|NCT00557505|585535102|FG001|Overall Study|Objective progression or relapse|3|||
162132060|NCT00557505|585535103|FG002|Overall Study|Objective progression or relapse|3|||
162132061|NCT00557505|585535104|FG003|Overall Study|Objective progression or relapse|2|||
162132062|NCT00557505|585535105|FG004|Overall Study|Objective progression or relapse|2|||
162132063|NCT00557505|585535106|FG005|Overall Study|Objective progression or relapse|3|||
162132064|NCT00557505|585535107|FG006|Overall Study|Objective progression or relapse|2|||
162132065|NCT00557505|585535108|FG007|Overall Study|Objective progression or relapse|5|||
162132066|NCT00557505|585535109|FG008|Overall Study|Objective progression or relapse|15|||
162132067|NCT00557505|585535101|FG000|Overall Study|Withdrawal by Subject|0|||
162132068|NCT00557505|585535102|FG001|Overall Study|Withdrawal by Subject|0|||
162132069|NCT00557505|585535103|FG002|Overall Study|Withdrawal by Subject|0|||
162132070|NCT00557505|585535104|FG003|Overall Study|Withdrawal by Subject|1|||
162132071|NCT00557505|585535105|FG004|Overall Study|Withdrawal by Subject|0|||
162132072|NCT00557505|585535106|FG005|Overall Study|Withdrawal by Subject|0|||
162132073|NCT00557505|585535107|FG006|Overall Study|Withdrawal by Subject|0|||
162132074|NCT00557505|585535108|FG007|Overall Study|Withdrawal by Subject|0|||
162132075|NCT00557505|585535109|FG008|Overall Study|Withdrawal by Subject|1|||
162132076|NCT01403987|585535115|FG000|Overall Study|Residents forgot their secret PIN|18|||
162132077|NCT01403987|585535116|FG001|Overall Study|Residents forgot their secret PIN|17|||
162132078|NCT01403987|585535117|FG002|Overall Study|Residents forgot their secret PIN|18|||
162132079|NCT00751790|585535121|FG000|Overall Study|Lost to Follow-up|1|||
162132080|NCT00751790|585535121|FG000|Overall Study|Death|3|||
162132081|NCT00751790|585535121|FG000|Overall Study|Withdrawal by Subject|1|||
162132082|NCT04004208|585535122|FG000|Overall Study|Withdrawal by parent/guardian|1|||
162132083|NCT04004208|585535123|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162132084|NCT04004208|585535122|FG000|Overall Study|Death|3|||
162132085|NCT04004208|585535123|FG001|Overall Study|Death|0|||
162132086|NCT04004208|585535122|FG000|Overall Study|COVID-19 pandemic|1|||
162132087|NCT04004208|585535123|FG001|Overall Study|COVID-19 pandemic|0|||
162132088|NCT04004208|585535122|FG000|Overall Study|Physician Decision|1|||
162132089|NCT04004208|585535123|FG001|Overall Study|Physician Decision|0|||
162132090|NCT04004208|585535122|FG000|Overall Study|Adverse Event|1|||
162132091|NCT04004208|585535123|FG001|Overall Study|Adverse Event|1|||
162132092|NCT01782326|585535124|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
162132093|NCT01782326|585535125|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
162132094|NCT01782326|585535124|FG000|Planned Treatment Epoch|Death|29|||
162132095|NCT01782326|585535125|FG001|Planned Treatment Epoch|Death|30|||
162132096|NCT01782326|585535124|FG000|Planned Treatment Epoch|Physician Decision|18|||
162132097|NCT01782326|585535125|FG001|Planned Treatment Epoch|Physician Decision|16|||
162132098|NCT01782326|585535124|FG000|Planned Treatment Epoch|Protocol deviation|2|||
162132099|NCT01782326|585535125|FG001|Planned Treatment Epoch|Protocol deviation|3|||
162132100|NCT01782326|585535124|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
162132101|NCT01782326|585535125|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
162132102|NCT01782326|585535124|FG000|Planned Treatment Epoch|Technical problems|0|||
162132103|NCT01782326|585535125|FG001|Planned Treatment Epoch|Technical problems|4|||
162132104|NCT01782326|585535124|FG000|Double-blind Treatment|Adverse Event|129|||
162132105|NCT01782326|585535125|FG001|Double-blind Treatment|Adverse Event|145|||
162132106|NCT01782326|585535124|FG000|Double-blind Treatment|Subject/guardian decision|111|||
162132107|NCT01782326|585535125|FG001|Double-blind Treatment|Subject/guardian decision|125|||
162132108|NCT01782326|585535124|FG000|Double-blind Treatment|Lack of Efficacy|17|||
162132109|NCT01782326|585535125|FG001|Double-blind Treatment|Lack of Efficacy|22|||
162132110|NCT01782326|585535124|FG000|Double-blind Treatment|Physician Decision|13|||
161898959|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
161898960|NCT03428100|584677893|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898961|NCT03428100|584677894|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898962|NCT03428100|584677895|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898963|NCT03428100|584677896|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898964|NCT03428100|584677897|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
161898965|NCT03428100|584677898|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898966|NCT03428100|584677899|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
161898967|NCT03428100|584677900|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
161898968|NCT03428100|584677901|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898969|NCT03428100|584677902|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
161898970|NCT03428100|584677903|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
161898971|NCT03428100|584677904|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
161898972|NCT03428100|584677905|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
161898973|NCT03428100|584677906|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
161898974|NCT03428100|584677907|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
161898975|NCT03428100|584677908|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898976|NCT03428100|584677909|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
161898977|NCT03428100|584677910|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
161898978|NCT03428100|584677911|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161898979|NCT01300247|584677913|FG000|Overall Study|Death|1|||
161898980|NCT01300247|584677914|FG001|Overall Study|Death|1|||
161898981|NCT01300247|584677913|FG000|Overall Study|Lost to Follow-up|2|||
161898982|NCT01300247|584677914|FG001|Overall Study|Lost to Follow-up|0|||
161898983|NCT01300247|584677913|FG000|Overall Study|Withdrawal by Subject|1|||
161898984|NCT01300247|584677914|FG001|Overall Study|Withdrawal by Subject|0|||
161898985|NCT01300247|584677913|FG000|Overall Study|Non-Compliance|0|||
161898986|NCT01300247|584677914|FG001|Overall Study|Non-Compliance|1|||
161898987|NCT00922116|584677915|FG000|Overall Study|Adverse Event|4|||
161898988|NCT00922116|584677915|FG000|Overall Study|Death|1|||
161898989|NCT00922116|584677915|FG000|Overall Study|Lost to Follow-up|1|||
161898990|NCT00922116|584677915|FG000|Overall Study|Withdrawal by Subject|4|||
161898991|NCT00922116|584677915|FG000|Overall Study|Other|5|||
161898992|NCT02258659|584677916|FG000|Overall Study|Withdrawal by Subject|1|||
161898993|NCT03990051|584677917|FG000|Masked Period|Lost to Follow-up|1|||
161898994|NCT03990051|584677918|FG001|Masked Period|Lost to Follow-up|0|||
161898995|NCT03990051|584677917|FG000|Long Term Period|Death|1|||
161898996|NCT03990051|584677918|FG001|Long Term Period|Death|1|||
161898997|NCT03990051|584677917|FG000|Long Term Period|Lost to Follow-up|7|||
161898998|NCT03990051|584677918|FG001|Long Term Period|Lost to Follow-up|2|||
161898999|NCT00272844|584677919|FG000|Overall Study|Withdrawal by Subject|5|||
161899000|NCT03193047|584677920|FG000|Overall Study|Physician Decision|1|||
161899001|NCT03193047|584677921|FG001|Overall Study|Physician Decision|0|||
161899002|NCT03193047|584677920|FG000|Overall Study|Participant Left State|1|||
161899003|NCT03193047|584677921|FG001|Overall Study|Participant Left State|0|||
161899004|NCT03743025|584677925|FG000|Overall Study|Surgery was cancelled|2|||
161899005|NCT03743025|584677926|FG001|Overall Study|Surgery was cancelled|1|||
161899006|NCT00791700|584677927|FG000|Overall Study|Insufficient clinical response|1|||
161899007|NCT00791700|584677928|FG001|Overall Study|Insufficient clinical response|4|||
161899008|NCT00791700|584677929|FG002|Overall Study|Insufficient clinical response|1|||
161899009|NCT00791700|584677930|FG003|Overall Study|Insufficient clinical response|8|||
161899010|NCT00791700|584677927|FG000|Overall Study|No longer willing to participate|1|||
162132111|NCT01782326|585535125|FG001|Double-blind Treatment|Physician Decision|16|||
162132112|NCT01782326|585535124|FG000|Double-blind Treatment|Protocol deviation|8|||
162132113|NCT01782326|585535125|FG001|Double-blind Treatment|Protocol deviation|7|||
162132114|NCT01782326|585535124|FG000|Double-blind Treatment|Technical problems|0|||
162132115|NCT01782326|585535125|FG001|Double-blind Treatment|Technical problems|5|||
162132116|NCT00087490|585535127|FG000|Overall Study|Death|6|||
162132117|NCT00087490|585535128|FG001|Overall Study|Death|4|||
162132118|NCT00087490|585535127|FG000|Overall Study|Adverse Event|3|||
162132119|NCT00087490|585535128|FG001|Overall Study|Adverse Event|8|||
162132120|NCT00087490|585535127|FG000|Overall Study|Lack of Efficacy|0|||
161793551|NCT03843359|584287763|FG008|Escalation Phase|Lost to Follow-up|1|||
161793552|NCT03843359|584287764|FG009|Escalation Phase|Lost to Follow-up|0|||
161793553|NCT03843359|584287765|FG010|Escalation Phase|Lost to Follow-up|0|||
161793554|NCT03843359|584287766|FG011|Escalation Phase|Lost to Follow-up|0|||
161793555|NCT03843359|584287767|FG012|Escalation Phase|Lost to Follow-up|0|||
161793556|NCT03843359|584287768|FG013|Escalation Phase|Lost to Follow-up|0|||
161793557|NCT03843359|584287769|FG014|Escalation Phase|Lost to Follow-up|0|||
161793558|NCT03843359|584287770|FG015|Escalation Phase|Lost to Follow-up|0|||
161899011|NCT00791700|584677928|FG001|Overall Study|No longer willing to participate|1|||
161899012|NCT00791700|584677929|FG002|Overall Study|No longer willing to participate|0|||
161899013|NCT00791700|584677930|FG003|Overall Study|No longer willing to participate|8|||
161899014|NCT00791700|584677927|FG000|Overall Study|Non-compliance with study treatment|0|||
161899015|NCT00791700|584677928|FG001|Overall Study|Non-compliance with study treatment|2|||
161899016|NCT00791700|584677929|FG002|Overall Study|Non-compliance with study treatment|0|||
161899017|NCT00791700|584677930|FG003|Overall Study|Non-compliance with study treatment|4|||
161899018|NCT00791700|584677927|FG000|Overall Study|Withdrawn due to pregnancy|0|||
161899019|NCT00791700|584677928|FG001|Overall Study|Withdrawn due to pregnancy|0|||
161899020|NCT00791700|584677929|FG002|Overall Study|Withdrawn due to pregnancy|0|||
161899021|NCT00791700|584677930|FG003|Overall Study|Withdrawn due to pregnancy|1|||
161899022|NCT00791700|584677927|FG000|Overall Study|Other|0|||
161899023|NCT00791700|584677928|FG001|Overall Study|Other|1|||
161899024|NCT00791700|584677929|FG002|Overall Study|Other|0|||
161899025|NCT00791700|584677930|FG003|Overall Study|Other|1|||
161899026|NCT00791700|584677927|FG000|Overall Study|Death|0|||
161899027|NCT00791700|584677928|FG001|Overall Study|Death|0|||
162132121|NCT00087490|585535128|FG001|Overall Study|Lack of Efficacy|2|||
162132122|NCT00087490|585535127|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
162132123|NCT00087490|585535128|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
162132124|NCT00087490|585535127|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
162132125|NCT00087490|585535128|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
162132126|NCT00087490|585535127|FG000|Overall Study|Randomized but not treated|7|||
162132127|NCT00087490|585535128|FG001|Overall Study|Randomized but not treated|18|||
162132128|NCT01925170|585535131|FG000|Overall Study|Unverified cancer status|53|||
162132129|NCT01077024|585535132|FG000|Overall Study|Lost to Follow-up|20|||
162132130|NCT01077024|585535133|FG001|Overall Study|Lost to Follow-up|14|||
162132131|NCT01077024|585535132|FG000|Overall Study|Withdrawal by Subject|0|||
162132132|NCT01077024|585535133|FG001|Overall Study|Withdrawal by Subject|2|||
162132133|NCT01077024|585535132|FG000|Overall Study|Incarcerated|7|||
162132134|NCT01077024|585535133|FG001|Overall Study|Incarcerated|8|||
162132135|NCT01077024|585535132|FG000|Overall Study|Other|4|||
162132136|NCT01077024|585535133|FG001|Overall Study|Other|4|||
162132137|NCT02300311|585535137|FG000|Overall Study|Other than the reason specified|1|||
162132138|NCT02300311|585535138|FG001|Overall Study|Other than the reason specified|0|||
162132139|NCT02300311|585535137|FG000|Overall Study|Refused to continue taking medication|18|||
162132140|NCT02300311|585535138|FG001|Overall Study|Refused to continue taking medication|0|||
162132141|NCT00848211|585535139|FG000|Overall Study|Protocol Violation|0|||
162132142|NCT00848211|585535140|FG001|Overall Study|Protocol Violation|1|||
162132143|NCT00848211|585535141|FG002|Overall Study|Protocol Violation|1|||
162132144|NCT00848211|585535142|FG003|Overall Study|Protocol Violation|0|||
162132145|NCT00848211|585535139|FG000|Overall Study|Adverse Event|0|||
162132146|NCT00848211|585535140|FG001|Overall Study|Adverse Event|0|||
162132147|NCT00848211|585535141|FG002|Overall Study|Adverse Event|0|||
162132148|NCT00848211|585535142|FG003|Overall Study|Adverse Event|0|||
162132149|NCT00772928|585535143|FG000|Overall Study|Lost to Follow-up|9|||
162132150|NCT00772928|585535144|FG001|Overall Study|Lost to Follow-up|6|||
162132151|NCT00772928|585535143|FG000|Overall Study|Protocol Violation|10|||
162132152|NCT00772928|585535144|FG001|Overall Study|Protocol Violation|12|||
162132153|NCT00772928|585535143|FG000|Overall Study|Withdrawal by Subject|25|||
162132154|NCT00772928|585535144|FG001|Overall Study|Withdrawal by Subject|22|||
162132155|NCT00772928|585535143|FG000|Overall Study|Did not receive vaccine|0|||
162132156|NCT00772928|585535144|FG001|Overall Study|Did not receive vaccine|1|||
162132157|NCT03100838|585535146|FG000|Overall Study|Adverse Event|1|||
162132158|NCT03100838|585535147|FG001|Overall Study|Adverse Event|0|||
162132159|NCT03100838|585535148|FG002|Overall Study|Adverse Event|0|||
162132160|NCT03100838|585535149|FG003|Overall Study|Adverse Event|0|||
162132161|NCT03100838|585535146|FG000|Overall Study|Physician Decision|1|||
162132162|NCT03100838|585535147|FG001|Overall Study|Physician Decision|1|||
162132163|NCT03100838|585535148|FG002|Overall Study|Physician Decision|1|||
162132164|NCT03100838|585535149|FG003|Overall Study|Physician Decision|1|||
162132165|NCT03100838|585535146|FG000|Overall Study|Pregnancy|0|||
162132166|NCT03100838|585535147|FG001|Overall Study|Pregnancy|1|||
162132167|NCT03100838|585535148|FG002|Overall Study|Pregnancy|0|||
162132168|NCT03100838|585535149|FG003|Overall Study|Pregnancy|0|||
162132169|NCT03100838|585535146|FG000|Overall Study|Lost to Follow-up|0|||
162132170|NCT03100838|585535147|FG001|Overall Study|Lost to Follow-up|0|||
162132171|NCT03100838|585535148|FG002|Overall Study|Lost to Follow-up|1|||
162132172|NCT03100838|585535149|FG003|Overall Study|Lost to Follow-up|0|||
162132173|NCT00801242|585535150|FG000|Overall Study|Adverse Event|10|||
162132174|NCT00801242|585535150|FG000|Overall Study|Withdrawal by Subject|13|||
162132175|NCT00801242|585535150|FG000|Overall Study|Protocol Violation|5|||
161899028|NCT00791700|584677929|FG002|Overall Study|Death|0|||
162132176|NCT00801242|585535150|FG000|Overall Study|Physician Decision|3|||
162132177|NCT00801242|585535150|FG000|Overall Study|Lost to Follow-up|1|||
162132178|NCT00801242|585535150|FG000|Overall Study|Miscellaneous reasons|20|||
162132179|NCT00184028|585535151|FG000|Overall Study|Death|1|||
161899029|NCT00791700|584677930|FG003|Overall Study|Death|1|||
161899030|NCT00791700|584677927|FG000|Overall Study|Lost to Follow-up|4|||
161899031|NCT00791700|584677928|FG001|Overall Study|Lost to Follow-up|3|||
162132180|NCT00184028|585535151|FG000|Overall Study|Lack of Efficacy|4|||
162132181|NCT00184028|585535151|FG000|Overall Study|Adverse Event|2|||
162132182|NCT00184028|585535151|FG000|Overall Study|Withdrawal by Subject|1|||
162132183|NCT00184028|585535151|FG000|Overall Study|Non-compliance|2|||
162132184|NCT00994279|585535152|FG000|Overall Study|Withdrawal by Subject|2|||
162132185|NCT00994279|585535153|FG001|Overall Study|Withdrawal by Subject|2|||
162132186|NCT00994279|585535152|FG000|Overall Study|Toxicity|1|||
162132187|NCT00994279|585535153|FG001|Overall Study|Toxicity|0|||
162132188|NCT00994279|585535152|FG000|Overall Study|Multiple reasons|1|||
162132189|NCT00994279|585535153|FG001|Overall Study|Multiple reasons|3|||
162132190|NCT01606189|585535154|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
162132191|NCT01606189|585535155|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
162132192|NCT01606189|585535156|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
162132193|NCT01606189|585535157|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
162132194|NCT01606189|585535158|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
162132195|NCT01606189|585535159|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
161899032|NCT00791700|584677929|FG002|Overall Study|Lost to Follow-up|4|||
161899033|NCT00791700|584677930|FG003|Overall Study|Lost to Follow-up|6|||
161899034|NCT00791700|584677927|FG000|Overall Study|Adverse Event|0|||
161899035|NCT00791700|584677928|FG001|Overall Study|Adverse Event|0|||
161899036|NCT00791700|584677929|FG002|Overall Study|Adverse Event|1|||
161899037|NCT00791700|584677930|FG003|Overall Study|Adverse Event|1|||
161899038|NCT00996034|584677931|FG000|Overall Study|Lost to Follow-up|2|||
161899039|NCT00996034|584677931|FG000|Overall Study|withdrawn by PI|1|||
161899040|NCT01720524|584677932|FG000|Part A|Insufficient Clinical Response|2|||
161899041|NCT01720524|584677933|FG001|Part A|Insufficient Clinical Response|4|||
161899042|NCT01720524|584677932|FG000|Part A|Adverse Event|2|||
161899043|NCT01720524|584677933|FG001|Part A|Adverse Event|2|||
161899044|NCT01720524|584677932|FG000|Part A|Death|2|||
161899045|NCT01720524|584677933|FG001|Part A|Death|1|||
162132196|NCT01606189|585535154|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
162132197|NCT01606189|585535155|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
162132198|NCT01606189|585535156|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
162132199|NCT01606189|585535157|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
162132200|NCT01606189|585535158|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
162132201|NCT01606189|585535159|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
162132202|NCT01857323|585535160|FG000|Overall Study|Adverse Event|1|||
162132203|NCT01857323|585535160|FG000|Overall Study|Withdrawal by Subject|3|||
162132204|NCT01857323|585535160|FG000|Overall Study|Non-compliance|1|||
162132205|NCT01857323|585535160|FG000|Overall Study|Protocol Violation|6|||
162132206|NCT01857323|585535160|FG000|Overall Study|Lost to Follow-up|1|||
162132207|NCT01857323|585535160|FG000|Overall Study|Other|4|||
162132208|NCT01857323|585535160|FG000|Overall Study|Did not complete 180 doses|48|||
162132209|NCT01400893|585535161|FG000|Overall Study|Death|27|||
162132210|NCT01400893|585535162|FG001|Overall Study|Death|21|||
162132211|NCT01400893|585535161|FG000|Overall Study|Lost to Follow-up|0|||
162132212|NCT01400893|585535162|FG001|Overall Study|Lost to Follow-up|6|||
162132213|NCT00519636|585535163|FG000|Treatment Period 1|Adverse Event|1|||
162132214|NCT00519636|585535164|FG001|Treatment Period 1|Adverse Event|0|||
162132215|NCT00519636|585535165|FG002|Treatment Period 1|Adverse Event|1|||
162132216|NCT00519636|585535166|FG003|Treatment Period 1|Adverse Event|0|||
162132217|NCT00519636|585535163|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
162132218|NCT00519636|585535164|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
161899046|NCT01720524|584677932|FG000|Part A|Lost to Follow-up|0|||
161899047|NCT01720524|584677933|FG001|Part A|Lost to Follow-up|1|||
161899048|NCT01720524|584677932|FG000|Part A|Missed 28 day follow-up visit|1|||
161899049|NCT01720524|584677933|FG001|Part A|Missed 28 day follow-up visit|1|||
161899050|NCT01720524|584677932|FG000|Part A|Withdrawal by Subject|0|||
161899051|NCT01720524|584677933|FG001|Part A|Withdrawal by Subject|1|||
161899052|NCT01720524|584677932|FG000|Part A|Other|0|||
161899053|NCT01720524|584677933|FG001|Part A|Other|1|||
161899054|NCT01720524|584677932|FG000|Part A|Lost to Follow-up|0|||
161899055|NCT01720524|584677933|FG001|Part A|Lost to Follow-up|1|||
161899056|NCT01720524|584677932|FG000|Part B|No longer willing to participate in study|1|||
161899057|NCT01720524|584677933|FG001|Part B|No longer willing to participate in study|4|||
161899058|NCT01720524|584677932|FG000|Part B|Other|2|||
161899059|NCT01720524|584677933|FG001|Part B|Other|0|||
161899060|NCT01720524|584677932|FG000|Part B|Lost to Follow-up|2|||
162132219|NCT00519636|585535165|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
162132220|NCT00519636|585535166|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
161899061|NCT01720524|584677933|FG001|Part B|Lost to Follow-up|3|||
161899062|NCT01720524|584677932|FG000|Part B|Death|0|||
161899063|NCT01720524|584677933|FG001|Part B|Death|2|||
161899064|NCT00527826|584677937|FG000|Overall Study|Adverse Event|10|||
161899065|NCT00527826|584677938|FG001|Overall Study|Adverse Event|10|||
161899066|NCT00527826|584677937|FG000|Overall Study|Lost to Follow-up|3|||
161899067|NCT00527826|584677938|FG001|Overall Study|Lost to Follow-up|2|||
161899068|NCT00527826|584677937|FG000|Overall Study|Withdrawal by Subject|5|||
161899069|NCT00527826|584677938|FG001|Overall Study|Withdrawal by Subject|8|||
162132221|NCT00519636|585535163|FG000|Washout Period|Adverse Event|2|||
162132222|NCT00519636|585535164|FG001|Washout Period|Adverse Event|1|||
162132223|NCT00519636|585535165|FG002|Washout Period|Adverse Event|1|||
162132224|NCT00519636|585535166|FG003|Washout Period|Adverse Event|0|||
162132225|NCT00519636|585535163|FG000|Washout Period|Lost to Follow-up|1|||
162132226|NCT00519636|585535164|FG001|Washout Period|Lost to Follow-up|0|||
162132227|NCT00519636|585535165|FG002|Washout Period|Lost to Follow-up|0|||
162132228|NCT00519636|585535166|FG003|Washout Period|Lost to Follow-up|0|||
162132229|NCT00519636|585535163|FG000|Washout Period|Protocol Violation|0|||
162132230|NCT00519636|585535164|FG001|Washout Period|Protocol Violation|0|||
162132231|NCT00519636|585535165|FG002|Washout Period|Protocol Violation|1|||
162132232|NCT00519636|585535166|FG003|Washout Period|Protocol Violation|2|||
162132233|NCT00519636|585535163|FG000|Washout Period|Withdrawal by Subject|1|||
162132234|NCT00519636|585535164|FG001|Washout Period|Withdrawal by Subject|0|||
162132235|NCT00519636|585535165|FG002|Washout Period|Withdrawal by Subject|1|||
162132236|NCT00519636|585535166|FG003|Washout Period|Withdrawal by Subject|0|||
162132237|NCT00519636|585535163|FG000|Washout Period|Failed to meet continuation criteria|14|||
162132238|NCT00519636|585535164|FG001|Washout Period|Failed to meet continuation criteria|11|||
162132239|NCT00519636|585535165|FG002|Washout Period|Failed to meet continuation criteria|9|||
161899070|NCT00527826|584677937|FG000|Overall Study|Inclusion Criteria Not Met|3|||
162132240|NCT00519636|585535166|FG003|Washout Period|Failed to meet continuation criteria|3|||
162132241|NCT00519636|585535163|FG000|Washout Period|Out of pollen area > 48 hours|1|||
162132242|NCT00519636|585535164|FG001|Washout Period|Out of pollen area > 48 hours|0|||
162132243|NCT00519636|585535165|FG002|Washout Period|Out of pollen area > 48 hours|0|||
162132244|NCT00519636|585535166|FG003|Washout Period|Out of pollen area > 48 hours|0|||
162132245|NCT00519636|585535163|FG000|Washout Period|Participating in study at another site|1|||
162132246|NCT00519636|585535164|FG001|Washout Period|Participating in study at another site|0|||
162132247|NCT00519636|585535165|FG002|Washout Period|Participating in study at another site|0|||
162132248|NCT00519636|585535166|FG003|Washout Period|Participating in study at another site|0|||
162132249|NCT00519636|585535163|FG000|Washout Period|Non-compliant|0|||
162132250|NCT00519636|585535164|FG001|Washout Period|Non-compliant|1|||
162132251|NCT00519636|585535165|FG002|Washout Period|Non-compliant|0|||
162132252|NCT00519636|585535166|FG003|Washout Period|Non-compliant|0|||
162132253|NCT00519636|585535163|FG000|Washout Period|Per doctors request|0|||
162132254|NCT00519636|585535164|FG001|Washout Period|Per doctors request|1|||
162132255|NCT00519636|585535165|FG002|Washout Period|Per doctors request|0|||
162132256|NCT00519636|585535166|FG003|Washout Period|Per doctors request|0|||
162132257|NCT00519636|585535163|FG000|Washout Period|Subject randomized in error|0|||
162132258|NCT00519636|585535164|FG001|Washout Period|Subject randomized in error|0|||
162132259|NCT00519636|585535165|FG002|Washout Period|Subject randomized in error|1|||
162132260|NCT00519636|585535166|FG003|Washout Period|Subject randomized in error|0|||
162132261|NCT00519636|585535163|FG000|Washout Period|Prohibited medications|0|||
162132262|NCT00519636|585535164|FG001|Washout Period|Prohibited medications|0|||
162132263|NCT00519636|585535165|FG002|Washout Period|Prohibited medications|1|||
162132264|NCT00519636|585535166|FG003|Washout Period|Prohibited medications|0|||
162132265|NCT00519636|585535163|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
162132266|NCT00519636|585535164|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
162132267|NCT00519636|585535165|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
162132268|NCT00519636|585535166|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
162132269|NCT00519636|585535163|FG000|Treatment Period 2|Subject randomized in error|0|||
162132270|NCT00519636|585535164|FG001|Treatment Period 2|Subject randomized in error|1|||
162132271|NCT00519636|585535165|FG002|Treatment Period 2|Subject randomized in error|0|||
162132272|NCT00519636|585535166|FG003|Treatment Period 2|Subject randomized in error|0|||
162132273|NCT00519636|585535163|FG000|Treatment Period 2|Per doctors request|0|||
162132274|NCT00519636|585535164|FG001|Treatment Period 2|Per doctors request|0|||
162132275|NCT00519636|585535165|FG002|Treatment Period 2|Per doctors request|1|||
162132276|NCT00519636|585535166|FG003|Treatment Period 2|Per doctors request|0|||
162132277|NCT00519636|585535163|FG000|Treatment Period 2|Subject misrandomized|0|||
162132278|NCT00519636|585535164|FG001|Treatment Period 2|Subject misrandomized|0|||
162132279|NCT00519636|585535165|FG002|Treatment Period 2|Subject misrandomized|0|||
162132280|NCT00519636|585535166|FG003|Treatment Period 2|Subject misrandomized|1|||
162132281|NCT00519636|585535163|FG000|Post Study Period|Subject randomized in error|0|||
162132282|NCT00519636|585535164|FG001|Post Study Period|Subject randomized in error|0|||
162132283|NCT00519636|585535165|FG002|Post Study Period|Subject randomized in error|0|||
162132284|NCT00519636|585535166|FG003|Post Study Period|Subject randomized in error|1|||
162132285|NCT04504916|585535167|FG000|Overall Study|Study terminated|7|||
162132286|NCT04504916|585535168|FG001|Overall Study|Study terminated|8|||
162132287|NCT04504916|585535167|FG000|Overall Study|Death|54|||
162132288|NCT04504916|585535168|FG001|Overall Study|Death|18|||
162132289|NCT04504916|585535167|FG000|Overall Study|Lost to Follow-up|1|||
162132290|NCT04504916|585535168|FG001|Overall Study|Lost to Follow-up|1|||
162132291|NCT04504916|585535167|FG000|Overall Study|Withdrawal by Subject|8|||
161899071|NCT00527826|584677938|FG001|Overall Study|Inclusion Criteria Not Met|3|||
162132292|NCT04504916|585535168|FG001|Overall Study|Withdrawal by Subject|4|||
161899072|NCT00527826|584677937|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
161899073|NCT00527826|584677938|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
161899074|NCT00527826|584677937|FG000|Overall Study|Additional Intake of Viani forte|0|||
161899075|NCT00527826|584677938|FG001|Overall Study|Additional Intake of Viani forte|1|||
161899076|NCT00527826|584677937|FG000|Overall Study|Participant moved away|0|||
161899077|NCT00527826|584677938|FG001|Overall Study|Participant moved away|1|||
161899078|NCT00158262|584677939|FG000|Overall Study|Lost to Follow-up|1|||
161899079|NCT00158262|584677940|FG001|Overall Study|Lost to Follow-up|1|||
161899080|NCT02080364|584677944|FG000|Baseline Period|Protocol Violation|2|||
161899081|NCT02080364|584677945|FG001|Baseline Period|Protocol Violation|1|||
161899082|NCT02080364|584677946|FG002|Baseline Period|Protocol Violation|0|||
161899083|NCT02080364|584677947|FG003|Baseline Period|Protocol Violation|0|||
161899084|NCT02080364|584677944|FG000|Baseline Period|Other|0|||
161899085|NCT02080364|584677945|FG001|Baseline Period|Other|1|||
161899086|NCT02080364|584677946|FG002|Baseline Period|Other|1|||
161899087|NCT02080364|584677947|FG003|Baseline Period|Other|0|||
161899088|NCT02080364|584677944|FG000|Treatment Period|Adverse Event|10|||
161899089|NCT02080364|584677945|FG001|Treatment Period|Adverse Event|15|||
161899090|NCT02080364|584677946|FG002|Treatment Period|Adverse Event|11|||
161899091|NCT02080364|584677947|FG003|Treatment Period|Adverse Event|14|||
161899092|NCT02080364|584677944|FG000|Treatment Period|Lost to Follow-up|2|||
161899093|NCT02080364|584677945|FG001|Treatment Period|Lost to Follow-up|3|||
161899094|NCT02080364|584677946|FG002|Treatment Period|Lost to Follow-up|5|||
161899095|NCT02080364|584677947|FG003|Treatment Period|Lost to Follow-up|0|||
161899096|NCT02080364|584677944|FG000|Treatment Period|Protocol Violation|5|||
161899097|NCT02080364|584677945|FG001|Treatment Period|Protocol Violation|3|||
161899098|NCT02080364|584677946|FG002|Treatment Period|Protocol Violation|5|||
161899099|NCT02080364|584677947|FG003|Treatment Period|Protocol Violation|1|||
161899100|NCT02080364|584677944|FG000|Treatment Period|Withdrawal by Subject|16|||
161899101|NCT02080364|584677945|FG001|Treatment Period|Withdrawal by Subject|16|||
161899102|NCT02080364|584677946|FG002|Treatment Period|Withdrawal by Subject|15|||
161899103|NCT02080364|584677947|FG003|Treatment Period|Withdrawal by Subject|10|||
161899104|NCT02080364|584677944|FG000|Treatment Period|Study Terminated by Sponsor|0|||
161899105|NCT02080364|584677945|FG001|Treatment Period|Study Terminated by Sponsor|0|||
161899106|NCT02080364|584677946|FG002|Treatment Period|Study Terminated by Sponsor|180|||
161899107|NCT02080364|584677947|FG003|Treatment Period|Study Terminated by Sponsor|183|||
161899108|NCT02080364|584677944|FG000|Treatment Period|Other|14|||
161899109|NCT02080364|584677945|FG001|Treatment Period|Other|12|||
161899110|NCT02080364|584677946|FG002|Treatment Period|Other|21|||
161899111|NCT02080364|584677947|FG003|Treatment Period|Other|16|||
161899112|NCT00784719|584677948|FG000|Overall Study|Adverse Event|0|||
161899113|NCT00784719|584677949|FG001|Overall Study|Adverse Event|2|||
161899114|NCT00784719|584677950|FG002|Overall Study|Adverse Event|0|||
161899115|NCT00784719|584677951|FG003|Overall Study|Adverse Event|0|||
161899116|NCT00784719|584677952|FG004|Overall Study|Adverse Event|1|||
161899117|NCT00784719|584677953|FG005|Overall Study|Adverse Event|1|||
161899118|NCT00784719|584677954|FG006|Overall Study|Adverse Event|1|||
161899119|NCT00784719|584677948|FG000|Overall Study|Lost to Follow-up|0|||
161899120|NCT00784719|584677949|FG001|Overall Study|Lost to Follow-up|0|||
161899121|NCT00784719|584677950|FG002|Overall Study|Lost to Follow-up|0|||
161899122|NCT00784719|584677951|FG003|Overall Study|Lost to Follow-up|0|||
161899123|NCT00784719|584677952|FG004|Overall Study|Lost to Follow-up|1|||
161899124|NCT00784719|584677953|FG005|Overall Study|Lost to Follow-up|1|||
162132293|NCT04504916|585535167|FG000|Overall Study|Did not agree to follow-up|0|||
161899125|NCT00784719|584677954|FG006|Overall Study|Lost to Follow-up|0|||
161899126|NCT00784719|584677948|FG000|Overall Study|Other|2|||
161899127|NCT00784719|584677949|FG001|Overall Study|Other|1|||
161899128|NCT00784719|584677950|FG002|Overall Study|Other|1|||
161899129|NCT00784719|584677951|FG003|Overall Study|Other|0|||
161899130|NCT00784719|584677952|FG004|Overall Study|Other|2|||
161899131|NCT00784719|584677953|FG005|Overall Study|Other|1|||
162132294|NCT04504916|585535168|FG001|Overall Study|Did not agree to follow-up|1|||
162132295|NCT03057834|585535169|FG000|Overall Study|Withdrawal by Subject|25|||
161899132|NCT00784719|584677954|FG006|Overall Study|Other|3|||
161899133|NCT00784719|584677948|FG000|Overall Study|Withdrawal by Subject|1|||
161899134|NCT00784719|584677949|FG001|Overall Study|Withdrawal by Subject|0|||
161899135|NCT00784719|584677950|FG002|Overall Study|Withdrawal by Subject|0|||
161899136|NCT00784719|584677951|FG003|Overall Study|Withdrawal by Subject|0|||
161899137|NCT00784719|584677952|FG004|Overall Study|Withdrawal by Subject|2|||
161899138|NCT00784719|584677953|FG005|Overall Study|Withdrawal by Subject|0|||
162132296|NCT03057834|585535170|FG001|Overall Study|Withdrawal by Subject|29|||
162132297|NCT00003509|585535172|FG000|Overall Study|Not evaluable|5|||
162132298|NCT03803774|585535173|FG000|Dose Escalation|Withdrawal by Subject|0|||
161899139|NCT00784719|584677954|FG006|Overall Study|Withdrawal by Subject|1|||
161899140|NCT01189461|584677958|FG000|Overall Study|Lack of Efficacy|13|||
161899141|NCT01189461|584677958|FG000|Overall Study|Lost to Follow-up|1|||
162132299|NCT03803774|585535174|FG001|Dose Escalation|Withdrawal by Subject|0|||
161899142|NCT01189461|584677958|FG000|Overall Study|Withdrawal by Subject|6|||
161899143|NCT01189461|584677958|FG000|Overall Study|Protocol Violation|1|||
161899144|NCT01189461|584677958|FG000|Overall Study|Adverse Event|2|||
161899145|NCT01189461|584677958|FG000|Overall Study|Did not meet entrance criteria|3|||
161899146|NCT01189461|584677958|FG000|Overall Study|Other|8|||
161899147|NCT01919164|584679254|FG000|Overall Study|Adverse Event|6|||
161899148|NCT01919164|584679255|FG001|Overall Study|Adverse Event|4|||
161899149|NCT01919164|584679256|FG002|Overall Study|Adverse Event|9|||
161899150|NCT01919164|584679257|FG003|Overall Study|Adverse Event|3|||
161899151|NCT01919164|584679258|FG004|Overall Study|Adverse Event|2|||
161899152|NCT01919164|584679254|FG000|Overall Study|Lost to Follow-up|2|||
161899153|NCT01919164|584679255|FG001|Overall Study|Lost to Follow-up|2|||
161899154|NCT01919164|584679256|FG002|Overall Study|Lost to Follow-up|2|||
161899155|NCT01919164|584679257|FG003|Overall Study|Lost to Follow-up|0|||
161899156|NCT01919164|584679258|FG004|Overall Study|Lost to Follow-up|4|||
161899157|NCT01919164|584679254|FG000|Overall Study|Death|1|||
161899158|NCT01919164|584679255|FG001|Overall Study|Death|0|||
161899159|NCT01919164|584679256|FG002|Overall Study|Death|0|||
161899160|NCT01919164|584679257|FG003|Overall Study|Death|0|||
161899161|NCT01919164|584679258|FG004|Overall Study|Death|0|||
161899162|NCT01919164|584679254|FG000|Overall Study|Protocol Violation|6|||
161899163|NCT01919164|584679255|FG001|Overall Study|Protocol Violation|0|||
161899164|NCT01919164|584679256|FG002|Overall Study|Protocol Violation|3|||
161899165|NCT01919164|584679257|FG003|Overall Study|Protocol Violation|2|||
161899166|NCT01919164|584679258|FG004|Overall Study|Protocol Violation|2|||
161899167|NCT01919164|584679254|FG000|Overall Study|Disease progression|2|||
161899168|NCT01919164|584679255|FG001|Overall Study|Disease progression|2|||
161899169|NCT01919164|584679256|FG002|Overall Study|Disease progression|1|||
161899170|NCT01919164|584679257|FG003|Overall Study|Disease progression|2|||
161899171|NCT01919164|584679258|FG004|Overall Study|Disease progression|1|||
161899172|NCT01919164|584679254|FG000|Overall Study|Withdrew consent|13|||
161899173|NCT01919164|584679255|FG001|Overall Study|Withdrew consent|13|||
161899174|NCT01919164|584679256|FG002|Overall Study|Withdrew consent|14|||
161899175|NCT01919164|584679257|FG003|Overall Study|Withdrew consent|14|||
161899176|NCT01919164|584679258|FG004|Overall Study|Withdrew consent|9|||
161899177|NCT01919164|584679254|FG000|Overall Study|Other Un-specified|13|||
161899178|NCT01919164|584679255|FG001|Overall Study|Other Un-specified|9|||
161899179|NCT01919164|584679256|FG002|Overall Study|Other Un-specified|8|||
161899180|NCT01919164|584679257|FG003|Overall Study|Other Un-specified|7|||
161899181|NCT01919164|584679258|FG004|Overall Study|Other Un-specified|15|||
161899182|NCT01409915|584679262|FG000|Overall Study|Adverse Event|0|||
161899183|NCT01409915|584679263|FG001|Overall Study|Adverse Event|2|||
161899184|NCT01409915|584679262|FG000|Overall Study|Withdrawal by Subject|0|||
161899185|NCT01409915|584679263|FG001|Overall Study|Withdrawal by Subject|1|||
161899186|NCT01409915|584679262|FG000|Overall Study|Protocol Violation|1|||
161899187|NCT01409915|584679263|FG001|Overall Study|Protocol Violation|0|||
161899188|NCT01845597|584679265|FG000|Overall Study|Death|8|||
161899189|NCT01845597|584679265|FG000|Overall Study|Lost to Follow-up|22|||
162132300|NCT03803774|585535175|FG002|Dose Escalation|Withdrawal by Subject|0|||
161899190|NCT04194489|584679270|FG000|Overall Study|Withdrawal by Subject|5|||
161899191|NCT04194489|584679270|FG000|Overall Study|Lost to Follow-up|48|||
161899192|NCT02485483|584679271|FG000|Overall Study|Depression at baseline|15|||
161899193|NCT02485483|584679272|FG001|Overall Study|Depression at baseline|0|||
161899194|NCT02485483|584679271|FG000|Overall Study|Discontinued after baseline|39|||
161899195|NCT02485483|584679272|FG001|Overall Study|Discontinued after baseline|0|||
161899196|NCT00377637|584679273|FG000|Induction Phase|Adverse Event|12|||
161899197|NCT00377637|584679274|FG001|Induction Phase|Adverse Event|21|||
161899198|NCT00377637|584679275|FG002|Induction Phase|Adverse Event|0|||
161899199|NCT00377637|584679276|FG003|Induction Phase|Adverse Event|0|||
161899200|NCT00377637|584679273|FG000|Induction Phase|Deterioration/serum creatinine|2|||
161899201|NCT00377637|584679274|FG001|Induction Phase|Deterioration/serum creatinine|0|||
161899202|NCT00377637|584679275|FG002|Induction Phase|Deterioration/serum creatinine|0|||
162132301|NCT03803774|585535176|FG003|Dose Escalation|Withdrawal by Subject|1|||
162132302|NCT03803774|585535177|FG004|Dose Escalation|Withdrawal by Subject|0|||
162132303|NCT03077620|585535182|FG000|Overall Study|Unable to place lumbar catheter|1|||
162132304|NCT03077620|585535183|FG001|Overall Study|Unable to place lumbar catheter|0|||
162132305|NCT03077620|585535184|FG002|Overall Study|Unable to place lumbar catheter|1|||
162132306|NCT03077620|585535185|FG003|Overall Study|Unable to place lumbar catheter|0|||
162132307|NCT03077620|585535182|FG000|Overall Study|Withdrawal by Subject|0|||
162132308|NCT03077620|585535183|FG001|Overall Study|Withdrawal by Subject|1|||
162132309|NCT03077620|585535184|FG002|Overall Study|Withdrawal by Subject|0|||
162132310|NCT03077620|585535185|FG003|Overall Study|Withdrawal by Subject|0|||
162132311|NCT03077620|585535182|FG000|Overall Study|Physician Decision|0|||
161899203|NCT00377637|584679276|FG003|Induction Phase|Deterioration/serum creatinine|0|||
161899204|NCT00377637|584679273|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
161899205|NCT00377637|584679274|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
161899206|NCT00377637|584679275|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
161899207|NCT00377637|584679276|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
161899208|NCT00377637|584679273|FG000|Induction Phase|Lost to Follow-up|2|||
161899209|NCT00377637|584679274|FG001|Induction Phase|Lost to Follow-up|1|||
161899210|NCT00377637|584679275|FG002|Induction Phase|Lost to Follow-up|0|||
161899211|NCT00377637|584679276|FG003|Induction Phase|Lost to Follow-up|0|||
161899212|NCT00377637|584679273|FG000|Induction Phase|Death|1|||
161899213|NCT00377637|584679274|FG001|Induction Phase|Death|3|||
161899214|NCT00377637|584679275|FG002|Induction Phase|Death|0|||
161899215|NCT00377637|584679276|FG003|Induction Phase|Death|0|||
161899216|NCT00377637|584679273|FG000|Induction Phase|Withdrawal by Subject|5|||
161899217|NCT00377637|584679274|FG001|Induction Phase|Withdrawal by Subject|6|||
161899218|NCT00377637|584679275|FG002|Induction Phase|Withdrawal by Subject|0|||
161899219|NCT00377637|584679276|FG003|Induction Phase|Withdrawal by Subject|0|||
161899220|NCT00377637|584679273|FG000|Induction Phase|Physician Decision|3|||
161899221|NCT00377637|584679274|FG001|Induction Phase|Physician Decision|1|||
161899222|NCT00377637|584679275|FG002|Induction Phase|Physician Decision|0|||
161899223|NCT00377637|584679276|FG003|Induction Phase|Physician Decision|0|||
161899224|NCT00377637|584679273|FG000|Induction Phase|Sponsor decision|1|||
161899225|NCT00377637|584679274|FG001|Induction Phase|Sponsor decision|2|||
161899226|NCT00377637|584679275|FG002|Induction Phase|Sponsor decision|0|||
161899227|NCT00377637|584679276|FG003|Induction Phase|Sponsor decision|0|||
161899228|NCT00377637|584679273|FG000|Induction Phase|Non-Compliance|1|||
161899229|NCT00377637|584679274|FG001|Induction Phase|Non-Compliance|0|||
161899230|NCT00377637|584679275|FG002|Induction Phase|Non-Compliance|0|||
161899231|NCT00377637|584679276|FG003|Induction Phase|Non-Compliance|0|||
161899232|NCT00377637|584679273|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
161899233|NCT00377637|584679274|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
161899234|NCT00377637|584679275|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
161899235|NCT00377637|584679276|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
161899236|NCT00377637|584679273|FG000|Maintenance Phase|Adverse Event|0|||
161899237|NCT00377637|584679274|FG001|Maintenance Phase|Adverse Event|0|||
161899238|NCT00377637|584679275|FG002|Maintenance Phase|Adverse Event|29|||
161899239|NCT00377637|584679276|FG003|Maintenance Phase|Adverse Event|43|||
161899240|NCT00377637|584679273|FG000|Maintenance Phase|Physician Decision|0|||
161899241|NCT00377637|584679274|FG001|Maintenance Phase|Physician Decision|0|||
161899242|NCT00377637|584679275|FG002|Maintenance Phase|Physician Decision|5|||
161899243|NCT00377637|584679276|FG003|Maintenance Phase|Physician Decision|4|||
161899244|NCT00377637|584679273|FG000|Maintenance Phase|Lost to Follow-up|0|||
161899245|NCT00377637|584679274|FG001|Maintenance Phase|Lost to Follow-up|0|||
161899246|NCT00377637|584679275|FG002|Maintenance Phase|Lost to Follow-up|3|||
161899247|NCT00377637|584679276|FG003|Maintenance Phase|Lost to Follow-up|1|||
161899248|NCT00377637|584679273|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161899249|NCT00377637|584679274|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161899250|NCT00377637|584679275|FG002|Maintenance Phase|Withdrawal by Subject|3|||
161899251|NCT00377637|584679276|FG003|Maintenance Phase|Withdrawal by Subject|3|||
161899252|NCT00377637|584679273|FG000|Maintenance Phase|Sponsor decision|0|||
161899253|NCT00377637|584679274|FG001|Maintenance Phase|Sponsor decision|0|||
161899254|NCT00377637|584679275|FG002|Maintenance Phase|Sponsor decision|2|||
161899255|NCT00377637|584679276|FG003|Maintenance Phase|Sponsor decision|3|||
161899256|NCT00377637|584679273|FG000|Maintenance Phase|Non-compliance|0|||
161899257|NCT00377637|584679274|FG001|Maintenance Phase|Non-compliance|0|||
161899258|NCT00377637|584679275|FG002|Maintenance Phase|Non-compliance|1|||
161899259|NCT00377637|584679276|FG003|Maintenance Phase|Non-compliance|1|||
161899260|NCT00377637|584679273|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
161899261|NCT00377637|584679274|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
161899262|NCT00377637|584679275|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
161899263|NCT00377637|584679276|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
161899264|NCT00377637|584679273|FG000|Maintenance Phase|Death|0|||
161899265|NCT00377637|584679274|FG001|Maintenance Phase|Death|0|||
161899266|NCT00377637|584679275|FG002|Maintenance Phase|Death|0|||
161899267|NCT00377637|584679276|FG003|Maintenance Phase|Death|1|||
161899268|NCT03506438|584679277|FG000|Overall Study|Lost to Follow-up|8|||
161899269|NCT03506438|584679278|FG001|Overall Study|Lost to Follow-up|7|||
161899270|NCT03506438|584679279|FG002|Overall Study|Lost to Follow-up|8|||
161899271|NCT03506438|584679280|FG003|Overall Study|Lost to Follow-up|7|||
161899272|NCT03506438|584679281|FG004|Overall Study|Lost to Follow-up|0|||
161899273|NCT03506438|584679282|FG005|Overall Study|Lost to Follow-up|0|||
161899274|NCT04155463|584679283|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
161899275|NCT04155463|584679284|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
161899276|NCT00113295|584679285|FG000|Overall Study|Adverse Event|4|||
161899277|NCT00113295|584679286|FG001|Overall Study|Adverse Event|1|||
161899278|NCT00113295|584679285|FG000|Overall Study|Unrelated Medical Illness|1|||
161899279|NCT00113295|584679286|FG001|Overall Study|Unrelated Medical Illness|0|||
161899280|NCT01089127|584679289|FG000|Overall Study|Adverse Event|5|||
161899281|NCT01089127|584679290|FG001|Overall Study|Adverse Event|1|||
161899282|NCT01089127|584679291|FG002|Overall Study|Adverse Event|1|||
161899283|NCT01089127|584679292|FG003|Overall Study|Adverse Event|0|||
161899284|NCT01089127|584679293|FG004|Overall Study|Adverse Event|0|||
161899285|NCT01089127|584679294|FG005|Overall Study|Adverse Event|1|||
162132312|NCT03077620|585535183|FG001|Overall Study|Physician Decision|0|||
162132313|NCT03077620|585535184|FG002|Overall Study|Physician Decision|1|||
162132314|NCT03077620|585535185|FG003|Overall Study|Physician Decision|0|||
162132315|NCT00245011|585535187|FG000|Overall Study|Lack of Efficacy|1|||
162132316|NCT00550173|585535188|FG000|Overall Study|Death|45|||
162132317|NCT00550173|585535189|FG001|Overall Study|Death|38|||
162132318|NCT00550173|585535190|FG002|Overall Study|Death|50|||
162132319|NCT00550173|585535188|FG000|Overall Study|Physician Decision|1|||
162132320|NCT00550173|585535189|FG001|Overall Study|Physician Decision|2|||
162132321|NCT00550173|585535190|FG002|Overall Study|Physician Decision|2|||
162132322|NCT00550173|585535188|FG000|Overall Study|Withdrawal by Subject|9|||
162132323|NCT00550173|585535189|FG001|Overall Study|Withdrawal by Subject|12|||
162132324|NCT00550173|585535190|FG002|Overall Study|Withdrawal by Subject|17|||
162132325|NCT00550173|585535188|FG000|Overall Study|Sponsor Decision|13|||
162132326|NCT00550173|585535189|FG001|Overall Study|Sponsor Decision|7|||
162132327|NCT00550173|585535190|FG002|Overall Study|Sponsor Decision|1|||
162132328|NCT00550173|585535188|FG000|Overall Study|Lost to Follow-up|4|||
162132329|NCT00550173|585535189|FG001|Overall Study|Lost to Follow-up|4|||
162132330|NCT00550173|585535190|FG002|Overall Study|Lost to Follow-up|3|||
162132331|NCT00031447|585536708|FG000|Overall Study|Lost to Follow-up|0|||
162132332|NCT00031447|585536709|FG001|Overall Study|Lost to Follow-up|1|||
162132333|NCT00031447|585536708|FG000|Overall Study|Non-compliant|1|||
162132334|NCT00031447|585536709|FG001|Overall Study|Non-compliant|1|||
162132335|NCT00031447|585536708|FG000|Overall Study|Re-activation of Disease|2|||
162132336|NCT00031447|585536709|FG001|Overall Study|Re-activation of Disease|1|||
162132337|NCT00031447|585536708|FG000|Overall Study|Disruption of blinded study drug supply|7|||
162132338|NCT00031447|585536709|FG001|Overall Study|Disruption of blinded study drug supply|4|||
162132339|NCT01636362|585536713|FG000|Overall Study|Physician Decision|6|||
162132340|NCT01636362|585536713|FG000|Overall Study|Subject healed, not returning|1|||
162132341|NCT01636362|585536713|FG000|Overall Study|Withdrawal by Subject|1|||
162132342|NCT01244763|585536714|FG000|Overall Study|Adverse Event|1|||
162132343|NCT01244763|585536715|FG001|Overall Study|Adverse Event|0|||
162132344|NCT01244763|585536716|FG002|Overall Study|Adverse Event|0|||
162132345|NCT01244763|585536717|FG003|Overall Study|Adverse Event|0|||
162132346|NCT01244763|585536718|FG004|Overall Study|Adverse Event|0|||
162132347|NCT01244763|585536719|FG005|Overall Study|Adverse Event|1|||
162132348|NCT01244763|585536714|FG000|Overall Study|Death|1|||
162132349|NCT01244763|585536715|FG001|Overall Study|Death|0|||
162132350|NCT01244763|585536716|FG002|Overall Study|Death|1|||
162132351|NCT01244763|585536717|FG003|Overall Study|Death|0|||
162132352|NCT01244763|585536718|FG004|Overall Study|Death|2|||
162132353|NCT01244763|585536719|FG005|Overall Study|Death|0|||
162132354|NCT01244763|585536714|FG000|Overall Study|Physician Decision|0|||
162132355|NCT01244763|585536715|FG001|Overall Study|Physician Decision|0|||
162132356|NCT01244763|585536716|FG002|Overall Study|Physician Decision|1|||
162132357|NCT01244763|585536717|FG003|Overall Study|Physician Decision|0|||
162132358|NCT01244763|585536718|FG004|Overall Study|Physician Decision|0|||
162132359|NCT01244763|585536719|FG005|Overall Study|Physician Decision|0|||
162132360|NCT01244763|585536714|FG000|Overall Study|Withdrawal by Subject|1|||
162132361|NCT01244763|585536715|FG001|Overall Study|Withdrawal by Subject|2|||
162132362|NCT01244763|585536716|FG002|Overall Study|Withdrawal by Subject|0|||
162132363|NCT01244763|585536717|FG003|Overall Study|Withdrawal by Subject|1|||
162132364|NCT01244763|585536718|FG004|Overall Study|Withdrawal by Subject|1|||
162132365|NCT01244763|585536719|FG005|Overall Study|Withdrawal by Subject|2|||
162132366|NCT01244763|585536714|FG000|Overall Study|Lost to Follow-up|0|||
162132367|NCT01244763|585536715|FG001|Overall Study|Lost to Follow-up|1|||
162132368|NCT01244763|585536716|FG002|Overall Study|Lost to Follow-up|0|||
162132369|NCT01244763|585536717|FG003|Overall Study|Lost to Follow-up|0|||
162132370|NCT01244763|585536718|FG004|Overall Study|Lost to Follow-up|0|||
162132371|NCT01244763|585536719|FG005|Overall Study|Lost to Follow-up|0|||
162132372|NCT01244763|585536714|FG000|Overall Study|Enrolled into the Extension Study|0|||
162132373|NCT01244763|585536715|FG001|Overall Study|Enrolled into the Extension Study|0|||
162132374|NCT01244763|585536716|FG002|Overall Study|Enrolled into the Extension Study|0|||
162132375|NCT01244763|585536717|FG003|Overall Study|Enrolled into the Extension Study|0|||
162132376|NCT01244763|585536718|FG004|Overall Study|Enrolled into the Extension Study|0|||
162132377|NCT01244763|585536719|FG005|Overall Study|Enrolled into the Extension Study|1|||
162132378|NCT02271594|585536720|FG000|Overall Study|Study closed; recruiting failure|19|||
162132379|NCT02271594|585536721|FG001|Overall Study|Study closed; recruiting failure|12|||
162132380|NCT01561079|585536724|FG000|Overall Study|Physician Decision|17|||
162132381|NCT01561079|585536724|FG000|Overall Study|Withdrawal by Subject|59|||
162132382|NCT01561079|585536724|FG000|Overall Study|Protocol Violation|2|||
162132383|NCT03330119|585536725|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
162132384|NCT03330119|585536726|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
162132385|NCT00550732|585536733|FG000|Overall Study|Death|4|||
162132386|NCT00550732|585536733|FG000|Overall Study|Withdrawal by Subject|2|||
162132387|NCT00550732|585536733|FG000|Overall Study|Physician Decision|2|||
162132388|NCT00550732|585536733|FG000|Overall Study|Lost to Follow-up|1|||
162132389|NCT00550732|585536733|FG000|Overall Study|Palliative care|1|||
161899286|NCT01089127|584679289|FG000|Overall Study|Subject withdrew consent|0|||
161899287|NCT01089127|584679290|FG001|Overall Study|Subject withdrew consent|1|||
161899288|NCT01089127|584679291|FG002|Overall Study|Subject withdrew consent|1|||
161899289|NCT01089127|584679292|FG003|Overall Study|Subject withdrew consent|1|||
161899290|NCT01089127|584679293|FG004|Overall Study|Subject withdrew consent|0|||
161899291|NCT01089127|584679294|FG005|Overall Study|Subject withdrew consent|2|||
161899292|NCT01089127|584679289|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161899293|NCT01089127|584679290|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161899294|NCT01089127|584679291|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161899295|NCT01089127|584679292|FG003|Overall Study|Abnormal test procedure result(s)|0|||
161899296|NCT01089127|584679293|FG004|Overall Study|Abnormal test procedure result(s)|0|||
161899297|NCT01089127|584679294|FG005|Overall Study|Abnormal test procedure result(s)|0|||
161899298|NCT01089127|584679289|FG000|Overall Study|Lost to Follow-up|1|||
161899299|NCT01089127|584679290|FG001|Overall Study|Lost to Follow-up|1|||
161899300|NCT01089127|584679291|FG002|Overall Study|Lost to Follow-up|0|||
161899301|NCT01089127|584679292|FG003|Overall Study|Lost to Follow-up|0|||
161899302|NCT01089127|584679293|FG004|Overall Study|Lost to Follow-up|1|||
161899303|NCT01089127|584679294|FG005|Overall Study|Lost to Follow-up|0|||
161899304|NCT01089127|584679289|FG000|Overall Study|Protocol deviation|0|||
161899305|NCT01089127|584679290|FG001|Overall Study|Protocol deviation|1|||
161899306|NCT01089127|584679291|FG002|Overall Study|Protocol deviation|0|||
161899307|NCT01089127|584679292|FG003|Overall Study|Protocol deviation|0|||
161899308|NCT01089127|584679293|FG004|Overall Study|Protocol deviation|1|||
161899309|NCT01089127|584679294|FG005|Overall Study|Protocol deviation|0|||
161899310|NCT00875563|584679296|FG000|Overall Study|Death|4|||
161899311|NCT00875563|584679296|FG000|Overall Study|Withdrawal by Subject|7|||
161899312|NCT00875563|584679296|FG000|Overall Study|No long-term (3-5 year) consent|6|||
161899313|NCT00875563|584679296|FG000|Overall Study|Still be eligible for follow-up|7|||
161899314|NCT00511810|584679297|FG000|Overall Study|Lost to Follow-up|1|||
161899315|NCT00511810|584679298|FG001|Overall Study|Lost to Follow-up|2|||
161899316|NCT00511810|584679297|FG000|Overall Study|Lack of Efficacy|0|||
161899317|NCT00511810|584679298|FG001|Overall Study|Lack of Efficacy|2|||
161899318|NCT00511810|584679297|FG000|Overall Study|Refused second scn|0|||
161899319|NCT00511810|584679298|FG001|Overall Study|Refused second scn|1|||
161899320|NCT00618826|584679300|FG000|Overall Study|Adverse Event|1|||
161899321|NCT03231306|584679303|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
161899322|NCT03231306|584679303|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
161899323|NCT03231306|584679303|FG000|Overall Study|Treatment delay > 21 days|2|||
161899324|NCT03231306|584679303|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
161899325|NCT03231306|584679303|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
161899326|NCT03231306|584679303|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
161899327|NCT03231306|584679303|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
161899328|NCT03231306|584679303|FG000|Overall Study|More than 1 Reason|2|||
161899329|NCT01808261|584679304|FG000|Overall Study|Physician Decision|0|||
161899330|NCT01808261|584679305|FG001|Overall Study|Physician Decision|2|||
161899331|NCT01808261|584679304|FG000|Overall Study|Study Closed/Terminated|25|||
161899332|NCT01808261|584679305|FG001|Overall Study|Study Closed/Terminated|23|||
161899333|NCT01808261|584679304|FG000|Overall Study|Adverse event, non-fatal|2|||
161899334|NCT01808261|584679305|FG001|Overall Study|Adverse event, non-fatal|0|||
161899335|NCT01808261|584679304|FG000|Overall Study|Consent withdrawn by subject|6|||
161899336|NCT01808261|584679305|FG001|Overall Study|Consent withdrawn by subject|7|||
161899337|NCT01808261|584679304|FG000|Overall Study|Lost to Follow-up|3|||
161899338|NCT01808261|584679305|FG001|Overall Study|Lost to Follow-up|1|||
161899339|NCT02585713|584679308|FG000|Overall Study|Withdrew prior to treatment|2|||
161899340|NCT02585713|584679309|FG001|Overall Study|Withdrew prior to treatment|7|||
161899341|NCT02585713|584679308|FG000|Overall Study|Other|3|||
161899342|NCT02585713|584679309|FG001|Overall Study|Other|1|||
161899343|NCT04501952|584679314|FG000|Overall Study|Adverse Event|0|||
161899344|NCT04501952|584679315|FG001|Overall Study|Adverse Event|3|||
161899345|NCT04501952|584679314|FG000|Overall Study|Investigator's Discretion|0|||
161899346|NCT04501952|584679315|FG001|Overall Study|Investigator's Discretion|1|||
161899347|NCT04501952|584679314|FG000|Overall Study|Protocol Violation|1|||
161899348|NCT04501952|584679315|FG001|Overall Study|Protocol Violation|1|||
161899349|NCT04501952|584679314|FG000|Overall Study|Withdrew Consent|5|||
161899350|NCT04501952|584679315|FG001|Overall Study|Withdrew Consent|4|||
161899351|NCT04501952|584679314|FG000|Overall Study|Lost to Follow-up|7|||
161899352|NCT04501952|584679315|FG001|Overall Study|Lost to Follow-up|2|||
161899353|NCT04501952|584679314|FG000|Overall Study|Randomized and Never Treated|13|||
161899354|NCT04501952|584679315|FG001|Overall Study|Randomized and Never Treated|9|||
161899355|NCT02609984|584679317|FG000|Overall Study|Death|29|||
161899356|NCT02609984|584679318|FG001|Overall Study|Death|26|||
161899357|NCT02609984|584679317|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
161899358|NCT02609984|584679318|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
161899359|NCT02609984|584679317|FG000|Overall Study|Lost to Follow-up|1|||
162132390|NCT00550732|585536733|FG000|Overall Study|Adverse Event|1|||
161899360|NCT02609984|584679318|FG001|Overall Study|Lost to Follow-up|2|||
161899361|NCT02609984|584679317|FG000|Overall Study|Withdrawal by Subject|0|||
161899362|NCT02609984|584679318|FG001|Overall Study|Withdrawal by Subject|1|||
161899363|NCT02609984|584679317|FG000|Overall Study|Disease Progression|2|||
161899364|NCT02609984|584679318|FG001|Overall Study|Disease Progression|0|||
161899365|NCT02256839|584679320|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
161899366|NCT02256839|584679321|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
161899367|NCT01843803|584679322|FG000|Overall Study|not a Veteran, did not see provider|1|||
161899368|NCT01843803|584679323|FG001|Overall Study|not a Veteran, did not see provider|3|||
161899369|NCT00436826|584679329|FG000|Double Blind Period (DBP)|Adverse Event|2|||
161899370|NCT00436826|584679330|FG001|Double Blind Period (DBP)|Adverse Event|0|||
161899371|NCT00436826|584679331|FG002|Double Blind Period (DBP)|Adverse Event|0|||
161899372|NCT00436826|584679332|FG003|Double Blind Period (DBP)|Adverse Event|0|||
161899373|NCT00436826|584679333|FG004|Double Blind Period (DBP)|Adverse Event|0|||
161899374|NCT00436826|584679334|FG005|Double Blind Period (DBP)|Adverse Event|0|||
161899375|NCT00436826|584679329|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
161899376|NCT00436826|584679330|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
161899377|NCT00436826|584679331|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
161899378|NCT00436826|584679332|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
161899379|NCT00436826|584679333|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
161899380|NCT00436826|584679334|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
161899381|NCT00436826|584679329|FG000|Double Blind Period (DBP)|Other|10|||
161899382|NCT00436826|584679330|FG001|Double Blind Period (DBP)|Other|11|||
161899383|NCT00436826|584679331|FG002|Double Blind Period (DBP)|Other|0|||
161899384|NCT00436826|584679332|FG003|Double Blind Period (DBP)|Other|0|||
161899385|NCT00436826|584679333|FG004|Double Blind Period (DBP)|Other|0|||
161899386|NCT00436826|584679334|FG005|Double Blind Period (DBP)|Other|0|||
161899387|NCT00436826|584679329|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161899388|NCT00436826|584679330|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161899389|NCT00436826|584679331|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161899390|NCT00436826|584679332|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
161899391|NCT00436826|584679333|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161899392|NCT00436826|584679334|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161899393|NCT00436826|584679329|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
161899394|NCT00436826|584679330|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
161899395|NCT00436826|584679331|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
161899396|NCT00436826|584679332|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
161899397|NCT00436826|584679333|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
161899398|NCT00436826|584679334|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
161899399|NCT00436826|584679329|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
161899400|NCT00436826|584679330|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
161899401|NCT00436826|584679331|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
161899402|NCT00436826|584679332|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
161899403|NCT00436826|584679333|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
161899404|NCT00436826|584679334|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
161899405|NCT03382418|584679337|FG000|Overall Study|Withdrawal by Subject|1|||
161899406|NCT03382418|584679338|FG001|Overall Study|Withdrawal by Subject|0|||
161899407|NCT03382418|584679339|FG002|Overall Study|Withdrawal by Subject|0|||
161899408|NCT03382418|584679337|FG000|Overall Study|Lost to Follow-up|2|||
161899409|NCT03382418|584679338|FG001|Overall Study|Lost to Follow-up|3|||
161899410|NCT03382418|584679339|FG002|Overall Study|Lost to Follow-up|0|||
161899411|NCT02716584|584679347|FG000|Overall Study|Lost to Follow-up|8|||
162132391|NCT01323660|585536734|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
162132392|NCT01323660|585536735|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
162132393|NCT01323660|585536736|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
162132394|NCT01323660|585536737|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
162132395|NCT01323660|585536738|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
162132396|NCT01323660|585536739|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
162132397|NCT01323660|585536734|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
162132398|NCT01323660|585536735|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
162132399|NCT01323660|585536736|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
161899412|NCT02716584|584679348|FG001|Overall Study|Lost to Follow-up|5|||
161899413|NCT00420628|584679349|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
161899414|NCT00420628|584679350|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
162132400|NCT01323660|585536737|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
162132401|NCT01323660|585536738|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
161899415|NCT00420628|584679349|FG000|Overall Study|Lost to Follow-up|3|||
161899416|NCT00420628|584679350|FG001|Overall Study|Lost to Follow-up|2|||
161899417|NCT00420628|584679349|FG000|Overall Study|Adverse Event|1|||
161899418|NCT00420628|584679350|FG001|Overall Study|Adverse Event|0|||
161899419|NCT00282152|584679358|FG000|Overall Study|Withdrawal by Subject|1|||
161899420|NCT00282152|584679359|FG001|Overall Study|Withdrawal by Subject|0|||
161899421|NCT00585325|584679360|FG000|Overall Study|Withdrawal by Subject|1|||
162132402|NCT01323660|585536739|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
162132403|NCT01323660|585536734|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
162132404|NCT01323660|585536735|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
161899422|NCT00585325|584679361|FG001|Overall Study|Withdrawal by Subject|1|||
161899423|NCT03301831|584679362|FG000|Overall Study|Lost to Follow-up|5|||
161899424|NCT03301831|584679363|FG001|Overall Study|Lost to Follow-up|3|||
161899425|NCT03301831|584679362|FG000|Overall Study|Protocol Violation|4|||
161899426|NCT03301831|584679363|FG001|Overall Study|Protocol Violation|0|||
161899427|NCT03301831|584679362|FG000|Overall Study|Withdrawal by Subject|11|||
161899428|NCT03301831|584679363|FG001|Overall Study|Withdrawal by Subject|0|||
161899429|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
161899430|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
161899431|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
161899432|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
161899433|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
161899434|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
161899435|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
161899436|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
161899437|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
161899438|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
161899439|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
161899440|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
161899441|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
161899442|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
161899443|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
161899444|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
161899445|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
161899446|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
161899447|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
161899448|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
161899449|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
161899450|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
161899451|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
161899452|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
161899453|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
161899454|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
161899455|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
161899456|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
161899457|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
161899458|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
162132405|NCT01323660|585536736|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
162132406|NCT01323660|585536737|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
162132407|NCT01323660|585536738|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
162132408|NCT01323660|585536739|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
162132409|NCT01323660|585536734|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162132410|NCT01323660|585536735|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162132411|NCT01323660|585536736|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162132412|NCT01323660|585536737|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162132413|NCT01323660|585536738|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
162132414|NCT01323660|585536739|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
162132415|NCT01323660|585536734|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162132416|NCT01323660|585536735|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162132417|NCT01323660|585536736|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162132418|NCT01323660|585536737|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162132419|NCT01323660|585536738|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
162132420|NCT01323660|585536739|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162132421|NCT01323660|585536734|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
162132422|NCT01323660|585536735|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162132423|NCT01323660|585536736|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
162132424|NCT01323660|585536737|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
162132425|NCT01323660|585536738|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
161899459|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
161899460|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
161899461|NCT03538691|584679364|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
161899462|NCT03538691|584679365|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
161899463|NCT03538691|584679366|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
161899464|NCT03538691|584679367|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
161899465|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
161899466|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
161899467|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
161899468|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
161899469|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
161899470|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
161899471|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
161899472|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
161899473|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
161899474|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
161899475|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
161899476|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
161899477|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
161899478|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
162132426|NCT01323660|585536739|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162132427|NCT01323660|585536734|FG000|Washout Period (14 Days)|Adverse Event|0|||
162132428|NCT01323660|585536735|FG001|Washout Period (14 Days)|Adverse Event|0|||
162132429|NCT01323660|585536736|FG002|Washout Period (14 Days)|Adverse Event|0|||
162132430|NCT01323660|585536737|FG003|Washout Period (14 Days)|Adverse Event|0|||
162132431|NCT01323660|585536738|FG004|Washout Period (14 Days)|Adverse Event|1|||
162132432|NCT01323660|585536739|FG005|Washout Period (14 Days)|Adverse Event|0|||
162132433|NCT01323660|585536734|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
162132434|NCT01323660|585536735|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
162132435|NCT01323660|585536736|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
162132436|NCT01323660|585536737|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
162132437|NCT01323660|585536738|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
162132438|NCT01323660|585536739|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
162132439|NCT01323660|585536734|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
162132440|NCT01323660|585536735|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
162132441|NCT01323660|585536736|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
162132442|NCT01323660|585536737|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
162132443|NCT01323660|585536738|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
162132444|NCT01323660|585536739|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
162132445|NCT01323660|585536734|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
162132446|NCT01323660|585536735|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
162132447|NCT01323660|585536736|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
162132448|NCT01323660|585536737|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
162132449|NCT01323660|585536738|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
162132450|NCT01323660|585536739|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
162132451|NCT01323660|585536734|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
162132452|NCT01323660|585536735|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
162132453|NCT01323660|585536736|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
161899479|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
161899480|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
161899481|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
161899482|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
161899483|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
161899484|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
161899485|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
162132454|NCT01323660|585536737|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
162132455|NCT01323660|585536738|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
162132456|NCT01323660|585536739|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
162132457|NCT01323660|585536734|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
162132458|NCT01323660|585536735|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
162132459|NCT01323660|585536736|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
162132460|NCT01323660|585536737|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
162132461|NCT01323660|585536738|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
162132462|NCT01323660|585536739|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
162132463|NCT01323660|585536734|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162132464|NCT01323660|585536735|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162132465|NCT01323660|585536736|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161899486|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
161899487|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
161899488|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
161899489|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
161899490|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
161899491|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
161899492|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
161899493|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
161899494|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
161899495|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
161899496|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
161899497|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
161899498|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
161899499|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
161899500|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
161899501|NCT03538691|584679364|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161899502|NCT03538691|584679365|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
161899503|NCT03538691|584679366|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161899504|NCT03538691|584679367|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161899505|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
161899506|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
161899507|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
161899508|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
161899509|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
161899510|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
161899511|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
161899512|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
161899513|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
161899514|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
161899515|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
161899516|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
161899517|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
161899518|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
161899519|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
161899520|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
161899521|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
161899522|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
161899523|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
161899524|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
161899525|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
161899526|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
161899527|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
161899528|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
161899529|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
161899530|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
161899531|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
161899532|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
161899533|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
161899534|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
161899535|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
161899536|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
161899537|NCT03538691|584679364|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161899538|NCT03538691|584679365|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161899539|NCT03538691|584679366|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
161899540|NCT03538691|584679367|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
161899541|NCT01124292|584679369|FG000|Overall Study|Lost to Follow-up|2|||
161899542|NCT01124292|584679370|FG001|Overall Study|Lost to Follow-up|4|||
161899543|NCT01124292|584679371|FG002|Overall Study|Lost to Follow-up|3|||
161899544|NCT01124292|584679369|FG000|Overall Study|Physician Decision|0|||
162010673|NCT02351856|585095947|FG000|Overall Study|Study terminated by sponsor|1|||
162010674|NCT03038100|585095958|FG000|Overall Study|Death|289|||
162010675|NCT03038100|585095959|FG001|Overall Study|Death|272|||
162132466|NCT01323660|585536737|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162132467|NCT01323660|585536738|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
162132468|NCT01323660|585536739|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162132469|NCT00926393|585536743|FG000|Overall Study|Withdrawal by Subject|1|||
162010676|NCT03038100|585095958|FG000|Overall Study|Lost to Follow-up|9|||
162010677|NCT03038100|585095959|FG001|Overall Study|Lost to Follow-up|10|||
162010678|NCT03038100|585095958|FG000|Overall Study|Protocol Deviation|1|||
162010679|NCT03038100|585095959|FG001|Overall Study|Protocol Deviation|4|||
162010680|NCT03038100|585095958|FG000|Overall Study|Withdrawal by Subject|45|||
162010681|NCT03038100|585095959|FG001|Overall Study|Withdrawal by Subject|51|||
162010682|NCT03038100|585095958|FG000|Overall Study|Study Terminated By Sponsor|305|||
162010683|NCT03038100|585095959|FG001|Overall Study|Study Terminated By Sponsor|311|||
162010684|NCT03038100|585095958|FG000|Overall Study|Physician Decision|1|||
162010685|NCT03038100|585095959|FG001|Overall Study|Physician Decision|3|||
162010686|NCT01936870|585095961|FG000|Overall Study|No Visit After Treatment|176|||
162010687|NCT01936870|585095961|FG000|Overall Study|Protocol Violation|12|||
162010688|NCT01936870|585095961|FG000|Overall Study|No Drug Administration|1|||
162010689|NCT00248040|585095962|FG000|Overall Study|transplantectomy|2|||
162010690|NCT00248040|585095963|FG001|Overall Study|transplantectomy|1|||
162010691|NCT00248040|585095964|FG002|Overall Study|transplantectomy|3|||
162010692|NCT00248040|585095962|FG000|Overall Study|transplant cancelled post treat start|1|||
162010693|NCT00248040|585095963|FG001|Overall Study|transplant cancelled post treat start|0|||
162010694|NCT00248040|585095964|FG002|Overall Study|transplant cancelled post treat start|0|||
162010695|NCT00248040|585095962|FG000|Overall Study|Death|0|||
162010696|NCT00248040|585095963|FG001|Overall Study|Death|0|||
162010697|NCT00248040|585095964|FG002|Overall Study|Death|1|||
162010698|NCT00118417|585095965|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
162010699|NCT00118417|585095966|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
162010700|NCT00118417|585095965|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
162010701|NCT00118417|585095966|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
162010702|NCT00118417|585095965|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
162010703|NCT00118417|585095966|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
162010704|NCT00118417|585095965|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
162010705|NCT00118417|585095966|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
162010706|NCT00118417|585095965|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
162010707|NCT00118417|585095966|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
162010708|NCT02978781|585095967|FG000|Part A|Adverse Event|1|||
162010709|NCT02978781|585095968|FG001|Part A|Adverse Event|1|||
162010710|NCT02978781|585095969|FG002|Part A|Adverse Event|0|||
162010711|NCT02978781|585095970|FG003|Part A|Adverse Event|0|||
162010712|NCT02978781|585095971|FG004|Part A|Adverse Event|0|||
162010713|NCT02978781|585095967|FG000|Part A|Withdrawal by Subject|0|||
162010714|NCT02978781|585095968|FG001|Part A|Withdrawal by Subject|1|||
162010715|NCT02978781|585095969|FG002|Part A|Withdrawal by Subject|0|||
162010716|NCT02978781|585095970|FG003|Part A|Withdrawal by Subject|0|||
162010717|NCT02978781|585095971|FG004|Part A|Withdrawal by Subject|0|||
162010718|NCT02978781|585095967|FG000|Part B|Withdrawal by Subject|0|||
162010719|NCT02978781|585095968|FG001|Part B|Withdrawal by Subject|0|||
162010720|NCT02978781|585095969|FG002|Part B|Withdrawal by Subject|0|||
162010721|NCT02978781|585095970|FG003|Part B|Withdrawal by Subject|1|||
162010722|NCT02978781|585095971|FG004|Part B|Withdrawal by Subject|0|||
162010723|NCT02978781|585095967|FG000|Part C|Adverse Event|0|||
162010724|NCT02978781|585095968|FG001|Part C|Adverse Event|0|||
162010725|NCT02978781|585095969|FG002|Part C|Adverse Event|0|||
162010726|NCT02978781|585095970|FG003|Part C|Adverse Event|0|||
162010727|NCT02978781|585095971|FG004|Part C|Adverse Event|2|||
162010728|NCT02978781|585095967|FG000|Part C|Withdrawal by Subject|0|||
162010729|NCT02978781|585095968|FG001|Part C|Withdrawal by Subject|0|||
162010730|NCT02978781|585095969|FG002|Part C|Withdrawal by Subject|0|||
162010731|NCT02978781|585095970|FG003|Part C|Withdrawal by Subject|0|||
162010732|NCT02978781|585095971|FG004|Part C|Withdrawal by Subject|1|||
162010733|NCT02978781|585095967|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
162010734|NCT02978781|585095968|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
162010735|NCT02978781|585095969|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
162010736|NCT02978781|585095970|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
162010737|NCT02978781|585095971|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
162010738|NCT01383356|585095972|FG000|Period 1|Adverse Event|5|||
162010739|NCT01383356|585095973|FG001|Period 1|Adverse Event|3|||
162010740|NCT01383356|585095972|FG000|Period 1|Non-compliance|3|||
162010741|NCT01383356|585095973|FG001|Period 1|Non-compliance|0|||
162010742|NCT01383356|585095972|FG000|Period 1|Out of Range Mid-study-Test|0|||
162010743|NCT01383356|585095973|FG001|Period 1|Out of Range Mid-study-Test|1|||
162010744|NCT01383356|585095972|FG000|Period 1|Personal|0|||
162010745|NCT01383356|585095973|FG001|Period 1|Personal|2|||
162010746|NCT02054104|585095975|FG000|Overall Study|Did not want to continue due to college classes|1|||
162132470|NCT00926393|585536744|FG001|Overall Study|Withdrawal by Subject|2|||
162132471|NCT00926393|585536743|FG000|Overall Study|Adverse Event|1|||
162132472|NCT00926393|585536744|FG001|Overall Study|Adverse Event|1|||
162132473|NCT00180674|585536747|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
162132474|NCT00180674|585536747|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
162132475|NCT03302910|585536748|FG000|Overall Study|Protocol Violation|1|||
162132476|NCT03302910|585536749|FG001|Overall Study|Protocol Violation|0|||
162132477|NCT01106976|585536752|FG000|Overall Study|Lost to Follow-up|8|||
162132478|NCT01477749|585536755|FG000|Overall Study|Physician Decision|4|||
162132479|NCT01094743|585536762|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
162132480|NCT02851511|585536763|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
162132481|NCT02851511|585536764|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
162132482|NCT02851511|585536765|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
162132483|NCT02851511|585536766|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
162132484|NCT02851511|585536763|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
162132485|NCT02851511|585536764|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
162132486|NCT02851511|585536765|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
162132487|NCT02851511|585536766|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
162132488|NCT02851511|585536763|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
162132489|NCT02851511|585536764|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
162132490|NCT02851511|585536765|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
162132491|NCT02851511|585536766|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
162132492|NCT02851511|585536763|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
162132493|NCT02851511|585536764|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
162132494|NCT02851511|585536765|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
162132495|NCT02851511|585536766|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
162132496|NCT02851511|585536763|FG000|Phase I|Physician Decision|0|||
162132497|NCT02851511|585536764|FG001|Phase I|Physician Decision|0|||
162132498|NCT02851511|585536765|FG002|Phase I|Physician Decision|0|||
162132499|NCT02851511|585536766|FG003|Phase I|Physician Decision|1|||
162132500|NCT02851511|585536763|FG000|Phase I|Withdrawal by Subject|2|||
162132501|NCT02851511|585536764|FG001|Phase I|Withdrawal by Subject|1|||
162132502|NCT02851511|585536765|FG002|Phase I|Withdrawal by Subject|0|||
162132503|NCT02851511|585536766|FG003|Phase I|Withdrawal by Subject|3|||
162132504|NCT02851511|585536763|FG000|Phase II|Physician Decision|18|||
162132505|NCT02851511|585536764|FG001|Phase II|Physician Decision|16|||
162132506|NCT02851511|585536765|FG002|Phase II|Physician Decision|0|||
162132507|NCT02851511|585536766|FG003|Phase II|Physician Decision|0|||
162132508|NCT02851511|585536763|FG000|Phase II|Withdrawal by Subject|18|||
162132509|NCT02851511|585536764|FG001|Phase II|Withdrawal by Subject|16|||
162132510|NCT02851511|585536765|FG002|Phase II|Withdrawal by Subject|0|||
162132511|NCT02851511|585536766|FG003|Phase II|Withdrawal by Subject|0|||
162132512|NCT02851511|585536763|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
162132513|NCT02851511|585536764|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
162132514|NCT02851511|585536765|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
162132515|NCT02851511|585536766|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
162132516|NCT02851511|585536763|FG000|Phase II|Lost to Follow-up|0|||
162132517|NCT02851511|585536764|FG001|Phase II|Lost to Follow-up|1|||
162132518|NCT02851511|585536765|FG002|Phase II|Lost to Follow-up|0|||
162132519|NCT02851511|585536766|FG003|Phase II|Lost to Follow-up|0|||
162132520|NCT04990440|585536769|FG000|Overall Study|Sponsor's Decision|0|||
162132521|NCT04990440|585536770|FG001|Overall Study|Sponsor's Decision|0|||
162132522|NCT04990440|585536771|FG002|Overall Study|Sponsor's Decision|1|||
162132523|NCT03278028|585536782|FG000|Overall Study|Lost to Follow-up|1|||
162132524|NCT03278028|585536783|FG001|Overall Study|Lost to Follow-up|0|||
162132525|NCT03278028|585536782|FG000|Overall Study|Withdrawal by Subject|3|||
162132526|NCT03278028|585536783|FG001|Overall Study|Withdrawal by Subject|1|||
162132527|NCT03278028|585536782|FG000|Overall Study|Pregnancy|0|||
162132528|NCT03278028|585536783|FG001|Overall Study|Pregnancy|1|||
162132529|NCT02118714|585536787|FG000|Overall Study|Lost to Follow-up|2|||
162132530|NCT02118714|585536787|FG000|Overall Study|Protocol Violation|1|||
162132531|NCT03023332|585536792|FG000|Overall Study|Withdrawal by Subject|10|||
162132532|NCT03023332|585536793|FG001|Overall Study|Withdrawal by Subject|5|||
162132533|NCT03023332|585536794|FG002|Overall Study|Withdrawal by Subject|4|||
162132534|NCT03023332|585536795|FG003|Overall Study|Withdrawal by Subject|7|||
162132535|NCT03023332|585536792|FG000|Overall Study|Lost to Follow-up|13|||
162132536|NCT03023332|585536793|FG001|Overall Study|Lost to Follow-up|16|||
161899545|NCT01124292|584679370|FG001|Overall Study|Physician Decision|3|||
162132537|NCT03023332|585536794|FG002|Overall Study|Lost to Follow-up|8|||
162132538|NCT03023332|585536795|FG003|Overall Study|Lost to Follow-up|13|||
162132539|NCT03023332|585536792|FG000|Overall Study|Death|1|||
162132540|NCT03023332|585536793|FG001|Overall Study|Death|0|||
162132541|NCT03023332|585536794|FG002|Overall Study|Death|0|||
162132542|NCT03023332|585536795|FG003|Overall Study|Death|0|||
162132543|NCT02412761|585536796|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162132544|NCT02412761|585536797|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
162132545|NCT02412761|585536798|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
162132546|NCT02412761|585536799|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161899546|NCT01124292|584679371|FG002|Overall Study|Physician Decision|2|||
161899547|NCT01124292|584679369|FG000|Overall Study|Withdrawal by Subject|0|||
161899548|NCT01124292|584679370|FG001|Overall Study|Withdrawal by Subject|6|||
161899549|NCT01124292|584679371|FG002|Overall Study|Withdrawal by Subject|2|||
161899550|NCT01124292|584679369|FG000|Overall Study|medical issue unrelated to the study|0|||
161899551|NCT01124292|584679370|FG001|Overall Study|medical issue unrelated to the study|0|||
161899552|NCT01124292|584679371|FG002|Overall Study|medical issue unrelated to the study|2|||
161899553|NCT01124292|584679369|FG000|Overall Study|piercing track closed|0|||
161899554|NCT01124292|584679370|FG001|Overall Study|piercing track closed|2|||
161899555|NCT01124292|584679371|FG002|Overall Study|piercing track closed|1|||
161899556|NCT00481767|584679372|FG000|Overall Study|Withdrawal by Subject|16|||
161899557|NCT00481767|584679373|FG001|Overall Study|Withdrawal by Subject|11|||
161899558|NCT00481767|584679372|FG000|Overall Study|Lost to Follow-up|16|||
161899559|NCT00481767|584679373|FG001|Overall Study|Lost to Follow-up|10|||
161899560|NCT00636636|584679374|FG000|Overall Study|Other reason|4|||
161899561|NCT00636636|584679375|FG001|Overall Study|Other reason|6|||
161899562|NCT00636636|584679374|FG000|Overall Study|Adverse Event|19|||
161899563|NCT00636636|584679375|FG001|Overall Study|Adverse Event|8|||
161899564|NCT00636636|584679374|FG000|Overall Study|Lack of Efficacy|7|||
161899565|NCT00636636|584679375|FG001|Overall Study|Lack of Efficacy|12|||
161899566|NCT00636636|584679374|FG000|Overall Study|Protocol Violation|2|||
161899567|NCT00636636|584679375|FG001|Overall Study|Protocol Violation|2|||
161899568|NCT00636636|584679374|FG000|Overall Study|Lost to Follow-up|0|||
161899569|NCT00636636|584679375|FG001|Overall Study|Lost to Follow-up|1|||
161899570|NCT00636636|584679374|FG000|Overall Study|Death|0|||
161899571|NCT00636636|584679375|FG001|Overall Study|Death|1|||
161899572|NCT00636636|584679374|FG000|Overall Study|Withdrawal by Subject|4|||
161899573|NCT00636636|584679375|FG001|Overall Study|Withdrawal by Subject|9|||
161899574|NCT00524173|584679376|FG000|Overall Study|Lost to Follow-up|0|||
161899575|NCT00524173|584679377|FG001|Overall Study|Lost to Follow-up|1|||
161899576|NCT00524173|584679376|FG000|Overall Study|Death|1|||
161899577|NCT00524173|584679377|FG001|Overall Study|Death|0|||
161899578|NCT00524173|584679376|FG000|Overall Study|Had not reached endpoint at study close|4|||
161899579|NCT00524173|584679377|FG001|Overall Study|Had not reached endpoint at study close|1|||
161899580|NCT03300180|584679378|FG000|Baseline|Withdrawal by Subject|4|||
161899581|NCT03300180|584679379|FG001|Baseline|Withdrawal by Subject|6|||
161899582|NCT03300180|584679380|FG002|Baseline|Withdrawal by Subject|4|||
161899583|NCT03300180|584679378|FG000|6 Month Outcome|Withdrawal by Subject|12|||
161899584|NCT03300180|584679379|FG001|6 Month Outcome|Withdrawal by Subject|12|||
161899585|NCT03300180|584679380|FG002|6 Month Outcome|Withdrawal by Subject|19|||
161899586|NCT03300180|584679378|FG000|6 Month Outcome|Death|2|||
161899587|NCT03300180|584679379|FG001|6 Month Outcome|Death|4|||
161899588|NCT03300180|584679380|FG002|6 Month Outcome|Death|3|||
161899589|NCT03300180|584679378|FG000|6 Month Outcome|Missed Assessment|43|||
161899590|NCT03300180|584679379|FG001|6 Month Outcome|Missed Assessment|52|||
161899591|NCT03300180|584679380|FG002|6 Month Outcome|Missed Assessment|46|||
161899592|NCT03300180|584679378|FG000|12 Month Outcome|Withdrawal by Subject|3|||
161899593|NCT03300180|584679379|FG001|12 Month Outcome|Withdrawal by Subject|6|||
161899594|NCT03300180|584679380|FG002|12 Month Outcome|Withdrawal by Subject|6|||
161899595|NCT03300180|584679378|FG000|12 Month Outcome|Death|9|||
161899596|NCT03300180|584679379|FG001|12 Month Outcome|Death|6|||
161899597|NCT03300180|584679380|FG002|12 Month Outcome|Death|6|||
161899598|NCT03300180|584679378|FG000|12 Month Outcome|Missed Assessment|62|||
161899599|NCT03300180|584679379|FG001|12 Month Outcome|Missed Assessment|59|||
161899600|NCT03300180|584679380|FG002|12 Month Outcome|Missed Assessment|58|||
161899601|NCT03300180|584679378|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
161899602|NCT03300180|584679379|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
161899603|NCT03300180|584679380|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
161899604|NCT03300180|584679378|FG000|18 Month Outcome Assessment|Death|8|||
161899605|NCT03300180|584679379|FG001|18 Month Outcome Assessment|Death|5|||
161899606|NCT03300180|584679380|FG002|18 Month Outcome Assessment|Death|5|||
161899607|NCT03300180|584679378|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
161899608|NCT03300180|584679379|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
161899609|NCT03300180|584679380|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
161899610|NCT03300180|584679378|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
161899611|NCT03300180|584679379|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
161899612|NCT03300180|584679380|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
161899613|NCT03300180|584679378|FG000|24 Month Outcome Assessment|Death|13|||
161899614|NCT03300180|584679379|FG001|24 Month Outcome Assessment|Death|13|||
161899615|NCT03300180|584679380|FG002|24 Month Outcome Assessment|Death|3|||
161899616|NCT03300180|584679378|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
161899617|NCT03300180|584679379|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
161899618|NCT03300180|584679380|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
162132547|NCT02412761|585536800|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162132548|NCT02412761|585536801|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161899619|NCT02557516|584679383|FG000|Overall Study|Adverse Event|1|||
161899620|NCT02557516|584679384|FG001|Overall Study|Adverse Event|0|||
162132549|NCT02013687|585536802|FG000|Overall Study|Lost to Follow-up|0|||
161793559|NCT03843359|584287755|FG000|Escalation Phase|Physician Decision|0|||
161793560|NCT03843359|584287756|FG001|Escalation Phase|Physician Decision|0|||
161793561|NCT03843359|584287757|FG002|Escalation Phase|Physician Decision|1|||
161793562|NCT03843359|584287758|FG003|Escalation Phase|Physician Decision|0|||
161793563|NCT03843359|584287759|FG004|Escalation Phase|Physician Decision|0|||
161793564|NCT03843359|584287760|FG005|Escalation Phase|Physician Decision|1|||
162132550|NCT02013687|585536803|FG001|Overall Study|Lost to Follow-up|0|||
162132551|NCT02013687|585536804|FG002|Overall Study|Lost to Follow-up|1|||
162132552|NCT02013687|585536805|FG003|Overall Study|Lost to Follow-up|0|||
162132553|NCT02013687|585536802|FG000|Overall Study|Protocol Violation|0|||
162132554|NCT02013687|585536803|FG001|Overall Study|Protocol Violation|0|||
162132555|NCT02013687|585536804|FG002|Overall Study|Protocol Violation|0|||
162132556|NCT02013687|585536805|FG003|Overall Study|Protocol Violation|1|||
162132557|NCT02013687|585536802|FG000|Overall Study|Withdrawal by Subject|0|||
162132558|NCT02013687|585536803|FG001|Overall Study|Withdrawal by Subject|0|||
162132559|NCT02013687|585536804|FG002|Overall Study|Withdrawal by Subject|0|||
162132560|NCT02013687|585536805|FG003|Overall Study|Withdrawal by Subject|1|||
162132561|NCT02013687|585536802|FG000|Overall Study|Missed visits due to patient travel|0|||
162132562|NCT02013687|585536803|FG001|Overall Study|Missed visits due to patient travel|0|||
162132563|NCT02013687|585536804|FG002|Overall Study|Missed visits due to patient travel|1|||
162132564|NCT02013687|585536805|FG003|Overall Study|Missed visits due to patient travel|0|||
162132565|NCT05968482|585536806|FG000|First Crossover Period|Withdrawal by Subject|0|||
162132566|NCT05968482|585536807|FG001|First Crossover Period|Withdrawal by Subject|0|||
162132567|NCT05968482|585536808|FG002|First Crossover Period|Withdrawal by Subject|1|||
162132568|NCT05968482|585536809|FG003|First Crossover Period|Withdrawal by Subject|0|||
162132569|NCT05968482|585536810|FG004|First Crossover Period|Withdrawal by Subject|0|||
162132570|NCT05968482|585536811|FG005|First Crossover Period|Withdrawal by Subject|0|||
162132571|NCT05968482|585536806|FG000|First Crossover Period|Adverse Event|0|||
162132572|NCT05968482|585536807|FG001|First Crossover Period|Adverse Event|0|||
162132573|NCT05968482|585536808|FG002|First Crossover Period|Adverse Event|0|||
162132574|NCT05968482|585536809|FG003|First Crossover Period|Adverse Event|0|||
162132575|NCT05968482|585536810|FG004|First Crossover Period|Adverse Event|0|||
162132576|NCT05968482|585536811|FG005|First Crossover Period|Adverse Event|1|||
162132577|NCT05968482|585536806|FG000|Second Crossover Period|Withdrawal by Subject|0|||
162132578|NCT05968482|585536807|FG001|Second Crossover Period|Withdrawal by Subject|0|||
162132579|NCT05968482|585536808|FG002|Second Crossover Period|Withdrawal by Subject|0|||
162132580|NCT05968482|585536809|FG003|Second Crossover Period|Withdrawal by Subject|0|||
162132581|NCT05968482|585536810|FG004|Second Crossover Period|Withdrawal by Subject|1|||
162132582|NCT05968482|585536811|FG005|Second Crossover Period|Withdrawal by Subject|0|||
162132583|NCT05968482|585536806|FG000|Third Crossover Period|Adverse Event|0|||
162132584|NCT05968482|585536807|FG001|Third Crossover Period|Adverse Event|0|||
162132585|NCT05968482|585536808|FG002|Third Crossover Period|Adverse Event|0|||
162132586|NCT05968482|585536809|FG003|Third Crossover Period|Adverse Event|0|||
162132587|NCT05968482|585536810|FG004|Third Crossover Period|Adverse Event|1|||
162132588|NCT05968482|585536811|FG005|Third Crossover Period|Adverse Event|0|||
162132589|NCT05968482|585536806|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
162132590|NCT05968482|585536807|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
162132591|NCT05968482|585536808|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
162132592|NCT05968482|585536809|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
162132593|NCT05968482|585536810|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
162132594|NCT05968482|585536811|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
162132595|NCT02559817|585536812|FG000|Treatment Period|Adverse Event|1|||
162132596|NCT02559817|585536813|FG001|Treatment Period|Adverse Event|0|||
162132597|NCT02559817|585536814|FG002|Treatment Period|Adverse Event|1|||
162132598|NCT02559817|585536815|FG003|Treatment Period|Adverse Event|0|||
162132599|NCT02559817|585536816|FG004|Treatment Period|Adverse Event|0|||
162132600|NCT02559817|585536812|FG000|Treatment Period|Lack of Efficacy|0|||
162132601|NCT02559817|585536813|FG001|Treatment Period|Lack of Efficacy|1|||
162132602|NCT02559817|585536814|FG002|Treatment Period|Lack of Efficacy|0|||
162132603|NCT02559817|585536815|FG003|Treatment Period|Lack of Efficacy|0|||
162132604|NCT02559817|585536816|FG004|Treatment Period|Lack of Efficacy|0|||
162132605|NCT02559817|585536812|FG000|Treatment Period|Lost to Follow-up|0|||
162132606|NCT02559817|585536813|FG001|Treatment Period|Lost to Follow-up|1|||
162132607|NCT02559817|585536814|FG002|Treatment Period|Lost to Follow-up|0|||
162132608|NCT02559817|585536815|FG003|Treatment Period|Lost to Follow-up|1|||
162132609|NCT02559817|585536816|FG004|Treatment Period|Lost to Follow-up|0|||
162132610|NCT02559817|585536812|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
162132611|NCT02559817|585536813|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
162132612|NCT02559817|585536814|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
162132613|NCT02559817|585536815|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
161793565|NCT03843359|584287761|FG006|Escalation Phase|Physician Decision|0|||
162132614|NCT02559817|585536816|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
162132615|NCT02559817|585536812|FG000|Treatment Period|Protocol Violation|0|||
162132616|NCT02559817|585536813|FG001|Treatment Period|Protocol Violation|0|||
162132617|NCT02559817|585536814|FG002|Treatment Period|Protocol Violation|0|||
162132618|NCT02559817|585536815|FG003|Treatment Period|Protocol Violation|1|||
162132619|NCT02559817|585536816|FG004|Treatment Period|Protocol Violation|0|||
162132620|NCT00419003|585536817|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
162132621|NCT00419003|585536818|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
162132622|NCT00419003|585536817|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
162132623|NCT00419003|585536818|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
162132624|NCT02687919|585536819|FG000|Overall Study|Withdrawal by Subject|6|||
162132625|NCT02687919|585536820|FG001|Overall Study|Withdrawal by Subject|6|||
162132626|NCT02687919|585536819|FG000|Overall Study|Protocol Violation|2|||
162132627|NCT02687919|585536820|FG001|Overall Study|Protocol Violation|0|||
162132628|NCT01653847|585536821|FG000|Overall Study|Withdrawal by Subject|1|||
162132629|NCT01653847|585536822|FG001|Overall Study|Withdrawal by Subject|0|||
162132630|NCT02554513|585536823|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
162132631|NCT02554513|585536824|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
162132632|NCT02303574|585536825|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162132633|NCT02303574|585536826|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162132634|NCT02303574|585536827|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
162132635|NCT02303574|585536828|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162132636|NCT02303574|585536829|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162132637|NCT02303574|585536830|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162132638|NCT02303574|585536831|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162132639|NCT02303574|585536832|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
161793566|NCT03843359|584287762|FG007|Escalation Phase|Physician Decision|0|||
161793567|NCT03843359|584287763|FG008|Escalation Phase|Physician Decision|0|||
161793568|NCT03843359|584287764|FG009|Escalation Phase|Physician Decision|0|||
161793569|NCT03843359|584287765|FG010|Escalation Phase|Physician Decision|0|||
161793570|NCT03843359|584287766|FG011|Escalation Phase|Physician Decision|0|||
161793571|NCT03843359|584287767|FG012|Escalation Phase|Physician Decision|0|||
161793572|NCT03843359|584287768|FG013|Escalation Phase|Physician Decision|0|||
161793573|NCT03843359|584287769|FG014|Escalation Phase|Physician Decision|0|||
161793574|NCT03843359|584287770|FG015|Escalation Phase|Physician Decision|0|||
161793575|NCT03843359|584287755|FG000|Escalation Phase|Investigator site closed|0|||
161793576|NCT03843359|584287756|FG001|Escalation Phase|Investigator site closed|1|||
161793577|NCT03843359|584287757|FG002|Escalation Phase|Investigator site closed|0|||
161793578|NCT03843359|584287758|FG003|Escalation Phase|Investigator site closed|1|||
161793579|NCT03843359|584287759|FG004|Escalation Phase|Investigator site closed|1|||
161793580|NCT03843359|584287760|FG005|Escalation Phase|Investigator site closed|0|||
161793581|NCT03843359|584287761|FG006|Escalation Phase|Investigator site closed|1|||
161793582|NCT03843359|584287762|FG007|Escalation Phase|Investigator site closed|0|||
161793583|NCT03843359|584287763|FG008|Escalation Phase|Investigator site closed|2|||
161793584|NCT03843359|584287764|FG009|Escalation Phase|Investigator site closed|0|||
161793585|NCT03843359|584287765|FG010|Escalation Phase|Investigator site closed|0|||
161793586|NCT03843359|584287766|FG011|Escalation Phase|Investigator site closed|0|||
161793587|NCT03843359|584287767|FG012|Escalation Phase|Investigator site closed|0|||
161793588|NCT03843359|584287768|FG013|Escalation Phase|Investigator site closed|0|||
161793589|NCT03843359|584287769|FG014|Escalation Phase|Investigator site closed|0|||
161793590|NCT03843359|584287770|FG015|Escalation Phase|Investigator site closed|0|||
161793591|NCT03843359|584287755|FG000|Escalation Phase|Ongoing at the time of analysis|0|||
161793592|NCT03843359|584287756|FG001|Escalation Phase|Ongoing at the time of analysis|0|||
161793593|NCT03843359|584287757|FG002|Escalation Phase|Ongoing at the time of analysis|0|||
161793594|NCT03843359|584287758|FG003|Escalation Phase|Ongoing at the time of analysis|0|||
161793595|NCT03843359|584287759|FG004|Escalation Phase|Ongoing at the time of analysis|0|||
161793596|NCT03843359|584287760|FG005|Escalation Phase|Ongoing at the time of analysis|0|||
161793597|NCT03843359|584287761|FG006|Escalation Phase|Ongoing at the time of analysis|0|||
161793598|NCT03843359|584287762|FG007|Escalation Phase|Ongoing at the time of analysis|0|||
161793599|NCT03843359|584287763|FG008|Escalation Phase|Ongoing at the time of analysis|1|||
161793600|NCT03843359|584287764|FG009|Escalation Phase|Ongoing at the time of analysis|0|||
161793601|NCT03843359|584287765|FG010|Escalation Phase|Ongoing at the time of analysis|0|||
161793602|NCT03843359|584287766|FG011|Escalation Phase|Ongoing at the time of analysis|1|||
161793603|NCT03843359|584287767|FG012|Escalation Phase|Ongoing at the time of analysis|1|||
161793604|NCT03843359|584287768|FG013|Escalation Phase|Ongoing at the time of analysis|0|||
161793605|NCT03843359|584287769|FG014|Escalation Phase|Ongoing at the time of analysis|0|||
161793606|NCT03843359|584287770|FG015|Escalation Phase|Ongoing at the time of analysis|0|||
161793607|NCT03843359|584287755|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793608|NCT03843359|584287756|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793609|NCT03843359|584287757|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|7|||
161793610|NCT03843359|584287758|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162132640|NCT02303574|585536833|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
162132641|NCT02303574|585536834|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
161793611|NCT03843359|584287759|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
161793612|NCT03843359|584287760|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793613|NCT03843359|584287761|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793614|NCT03843359|584287762|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793615|NCT03843359|584287763|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793616|NCT03843359|584287764|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793617|NCT03843359|584287765|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793618|NCT03843359|584287766|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793619|NCT03843359|584287767|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793620|NCT03843359|584287768|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793621|NCT03843359|584287769|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793622|NCT03843359|584287770|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161793623|NCT03843359|584287755|FG000|Crossover|Withdrawal by Subject|0|||
161793624|NCT03843359|584287756|FG001|Crossover|Withdrawal by Subject|0|||
161793625|NCT03843359|584287757|FG002|Crossover|Withdrawal by Subject|0|||
161793626|NCT03843359|584287758|FG003|Crossover|Withdrawal by Subject|0|||
161793627|NCT03843359|584287759|FG004|Crossover|Withdrawal by Subject|0|||
161793628|NCT03843359|584287760|FG005|Crossover|Withdrawal by Subject|0|||
161793629|NCT03843359|584287761|FG006|Crossover|Withdrawal by Subject|0|||
161793630|NCT03843359|584287762|FG007|Crossover|Withdrawal by Subject|0|||
161793631|NCT03843359|584287763|FG008|Crossover|Withdrawal by Subject|0|||
161793632|NCT03843359|584287764|FG009|Crossover|Withdrawal by Subject|0|||
161793633|NCT03843359|584287765|FG010|Crossover|Withdrawal by Subject|0|||
161793634|NCT03843359|584287766|FG011|Crossover|Withdrawal by Subject|0|||
161793635|NCT03843359|584287767|FG012|Crossover|Withdrawal by Subject|0|||
161793636|NCT03843359|584287768|FG013|Crossover|Withdrawal by Subject|0|||
161793637|NCT03843359|584287769|FG014|Crossover|Withdrawal by Subject|0|||
161793638|NCT03843359|584287770|FG015|Crossover|Withdrawal by Subject|1|||
161793639|NCT03843359|584287755|FG000|Crossover|Investigator site closed|0|||
161793640|NCT03843359|584287756|FG001|Crossover|Investigator site closed|0|||
161793641|NCT03843359|584287757|FG002|Crossover|Investigator site closed|0|||
161793642|NCT03843359|584287758|FG003|Crossover|Investigator site closed|0|||
161793643|NCT03843359|584287759|FG004|Crossover|Investigator site closed|0|||
161793644|NCT03843359|584287760|FG005|Crossover|Investigator site closed|0|||
161793645|NCT03843359|584287761|FG006|Crossover|Investigator site closed|0|||
161793646|NCT03843359|584287762|FG007|Crossover|Investigator site closed|0|||
161793647|NCT03843359|584287763|FG008|Crossover|Investigator site closed|0|||
161793648|NCT03843359|584287764|FG009|Crossover|Investigator site closed|0|||
161793649|NCT03843359|584287765|FG010|Crossover|Investigator site closed|0|||
161793650|NCT03843359|584287766|FG011|Crossover|Investigator site closed|0|||
161793651|NCT03843359|584287767|FG012|Crossover|Investigator site closed|0|||
161793652|NCT03843359|584287768|FG013|Crossover|Investigator site closed|0|||
161793653|NCT03843359|584287769|FG014|Crossover|Investigator site closed|2|||
161793654|NCT03843359|584287770|FG015|Crossover|Investigator site closed|2|||
161793655|NCT03843359|584287755|FG000|Crossover|Ongoing at the time of analysis|0|||
161793656|NCT03843359|584287756|FG001|Crossover|Ongoing at the time of analysis|0|||
161793657|NCT03843359|584287757|FG002|Crossover|Ongoing at the time of analysis|0|||
161793658|NCT03843359|584287758|FG003|Crossover|Ongoing at the time of analysis|0|||
161793659|NCT03843359|584287759|FG004|Crossover|Ongoing at the time of analysis|0|||
161793660|NCT03843359|584287760|FG005|Crossover|Ongoing at the time of analysis|0|||
161793661|NCT03843359|584287761|FG006|Crossover|Ongoing at the time of analysis|0|||
161793662|NCT03843359|584287762|FG007|Crossover|Ongoing at the time of analysis|0|||
161793663|NCT03843359|584287763|FG008|Crossover|Ongoing at the time of analysis|0|||
161793664|NCT03843359|584287764|FG009|Crossover|Ongoing at the time of analysis|0|||
161793665|NCT03843359|584287765|FG010|Crossover|Ongoing at the time of analysis|0|||
161793666|NCT03843359|584287766|FG011|Crossover|Ongoing at the time of analysis|0|||
161793667|NCT03843359|584287767|FG012|Crossover|Ongoing at the time of analysis|0|||
161793668|NCT03843359|584287768|FG013|Crossover|Ongoing at the time of analysis|1|||
161793669|NCT03843359|584287769|FG014|Crossover|Ongoing at the time of analysis|0|||
161793670|NCT03843359|584287770|FG015|Crossover|Ongoing at the time of analysis|0|||
161793671|NCT03075527|584287771|FG000|Overall Study|Death|1|||
161793672|NCT03075527|584287771|FG000|Overall Study|Withdrawal by Subject|1|||
161793673|NCT03075527|584287771|FG000|Overall Study|Physician Decision|3|||
161793674|NCT03075527|584287771|FG000|Overall Study|Progression/Relapse|14|||
161793675|NCT05359003|584287772|FG000|Overall Study|Withdrawal by Subject|1|||
161793676|NCT05359003|584287773|FG001|Overall Study|Withdrawal by Subject|3|||
161793677|NCT06202521|584287776|FG000|Overall Study|Withdrawal by Subject|0|||
161793678|NCT06202521|584287777|FG001|Overall Study|Withdrawal by Subject|1|||
161793679|NCT06202521|584287778|FG002|Overall Study|Withdrawal by Subject|0|||
161793680|NCT06202521|584287779|FG003|Overall Study|Withdrawal by Subject|1|||
161793681|NCT06202521|584287776|FG000|Overall Study|Adverse Event|0|||
161793682|NCT06202521|584287777|FG001|Overall Study|Adverse Event|0|||
161793683|NCT06202521|584287778|FG002|Overall Study|Adverse Event|1|||
161793684|NCT06202521|584287779|FG003|Overall Study|Adverse Event|0|||
161793685|NCT03996005|584287793|FG000|Overall Study|Withdrawal by Subject|1|||
161793686|NCT02623959|584289277|FG000|Overall Study|Progression|0|||
161793687|NCT02623959|584289278|FG001|Overall Study|Progression|1|||
161793688|NCT00135707|584289279|FG000|Overall Study|Lost to Follow-up|94|||
161793689|NCT00135707|584289280|FG001|Overall Study|Lost to Follow-up|89|||
161793690|NCT00135707|584289279|FG000|Overall Study|Withdrawal by Subject|0|||
161793691|NCT00135707|584289280|FG001|Overall Study|Withdrawal by Subject|1|||
161793692|NCT00135707|584289279|FG000|Overall Study|Institutional review board request|1|||
161793693|NCT00135707|584289280|FG001|Overall Study|Institutional review board request|0|||
161793694|NCT00620763|584289287|FG000|Period: First Intervention|Withdrawal by Subject|0|||
161899621|NCT02557516|584679385|FG002|Overall Study|Adverse Event|2|||
161793695|NCT00620763|584289288|FG001|Period: First Intervention|Withdrawal by Subject|2|||
161793696|NCT00620763|584289287|FG000|Period: First Intervention|Protocol Violation|0|||
161793697|NCT00620763|584289288|FG001|Period: First Intervention|Protocol Violation|3|||
161793698|NCT00620763|584289287|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
161899622|NCT02557516|584679386|FG003|Overall Study|Adverse Event|1|||
161899623|NCT02557516|584679383|FG000|Overall Study|Disease progression|0|||
161793699|NCT00620763|584289288|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
161793700|NCT00729859|584289291|FG000|Overall Study|Adverse Event|0|||
161793701|NCT00729859|584289292|FG001|Overall Study|Adverse Event|1|||
161899624|NCT02557516|584679384|FG001|Overall Study|Disease progression|2|||
161899625|NCT02557516|584679385|FG002|Overall Study|Disease progression|0|||
161899626|NCT02557516|584679386|FG003|Overall Study|Disease progression|0|||
161899627|NCT02557516|584679383|FG000|Overall Study|Physician Decision|0|||
161899628|NCT02557516|584679384|FG001|Overall Study|Physician Decision|2|||
161899629|NCT02557516|584679385|FG002|Overall Study|Physician Decision|0|||
161899630|NCT02557516|584679386|FG003|Overall Study|Physician Decision|0|||
161899631|NCT02557516|584679383|FG000|Overall Study|Sponsor decision|0|||
161899632|NCT02557516|584679384|FG001|Overall Study|Sponsor decision|1|||
161899633|NCT02557516|584679385|FG002|Overall Study|Sponsor decision|2|||
161899634|NCT02557516|584679386|FG003|Overall Study|Sponsor decision|8|||
161899635|NCT01972464|584679387|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
161899636|NCT01972464|584679388|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
161899637|NCT01972464|584679387|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
161899638|NCT01972464|584679388|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
161899639|NCT01972464|584679387|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
161899640|NCT01972464|584679388|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
161899641|NCT01972464|584679387|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
161899642|NCT01972464|584679388|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
161899643|NCT01957579|584680966|FG000|Overall Study|Withdrawal of concent|0|||
161899644|NCT01957579|584680967|FG001|Overall Study|Withdrawal of concent|1|||
161899645|NCT01957579|584680968|FG002|Overall Study|Withdrawal of concent|0|||
161899646|NCT01957579|584680969|FG003|Overall Study|Withdrawal of concent|0|||
161899647|NCT01957579|584680966|FG000|Overall Study|Death|0|||
161899648|NCT01957579|584680967|FG001|Overall Study|Death|0|||
161899649|NCT01957579|584680968|FG002|Overall Study|Death|2|||
161899650|NCT01957579|584680969|FG003|Overall Study|Death|0|||
161899651|NCT02019550|584680970|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
161899652|NCT02019550|584680971|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
161899653|NCT02750332|584680972|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161899654|NCT02750332|584680973|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161899655|NCT02922153|584680974|FG000|Overall Study|Death|8|||
161899656|NCT02922153|584680975|FG001|Overall Study|Death|1|||
161899657|NCT02922153|584680974|FG000|Overall Study|Lost to Follow-up|1|||
161899658|NCT02922153|584680975|FG001|Overall Study|Lost to Follow-up|0|||
161899659|NCT02922153|584680974|FG000|Overall Study|Physician Decision|1|||
161899660|NCT02922153|584680975|FG001|Overall Study|Physician Decision|1|||
161899661|NCT01128296|584680976|FG000|Overall Study|Physician Decision|0|||
161899662|NCT01128296|584680977|FG001|Overall Study|Physician Decision|0|||
161899663|NCT01128296|584680978|FG002|Overall Study|Physician Decision|0|||
161793702|NCT00729859|584289293|FG002|Overall Study|Adverse Event|0|||
161793703|NCT00729859|584289291|FG000|Overall Study|Withdrawal by Subject|0|||
161793704|NCT00729859|584289292|FG001|Overall Study|Withdrawal by Subject|1|||
161793705|NCT00729859|584289293|FG002|Overall Study|Withdrawal by Subject|0|||
161793706|NCT01689974|584289297|FG000|Overall Study|Termination of Study|5|||
161793707|NCT01689974|584289298|FG001|Overall Study|Termination of Study|5|||
161793708|NCT00681863|584289299|FG000|Overall Study|Adverse Event|1|||
161793709|NCT00681863|584289299|FG000|Overall Study|Lost to Follow-up|2|||
161793710|NCT00681863|584289299|FG000|Overall Study|Lack of Efficacy|2|||
161793711|NCT00681863|584289299|FG000|Overall Study|Other|18|||
161793712|NCT01388647|584289302|FG000|Overall Study|Adverse Event|1|||
161899664|NCT01128296|584680979|FG003|Overall Study|Physician Decision|0|||
161899665|NCT01128296|584680980|FG004|Overall Study|Physician Decision|0|||
161899666|NCT01128296|584680981|FG005|Overall Study|Physician Decision|3|||
161793713|NCT01388647|584289303|FG001|Overall Study|Adverse Event|2|||
161793714|NCT01006707|584289304|FG000|Study Session 1|Lost to Follow-up|2|||
161793715|NCT01006707|584289305|FG001|Study Session 1|Lost to Follow-up|0|||
161793716|NCT01006707|584289306|FG002|Study Session 1|Lost to Follow-up|0|||
161793717|NCT01006707|584289304|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
161793718|NCT01006707|584289305|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
161793719|NCT01006707|584289306|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
161793720|NCT00760383|584289307|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
161793721|NCT00760383|584289308|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
161793722|NCT01336894|584289310|FG000|Follow-up|Study terminated prematurely|2|||
161793723|NCT01336894|584289311|FG001|Follow-up|Study terminated prematurely|7|||
161793724|NCT05034731|584289312|FG000|Overall Study|Screen fail|1|||
161793725|NCT05034731|584289313|FG001|Overall Study|Screen fail|1|||
161793726|NCT03937466|584289314|FG000|Overall Study|not eligbile after the 2-week diary|9|||
161793727|NCT03937466|584289314|FG000|Overall Study|never returned their diary|6|||
161793728|NCT03937466|584289314|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
161793729|NCT03937466|584289314|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
161793730|NCT00622908|584289315|FG000|Overall Study|Protocol Violation|1|||
161793731|NCT00622908|584289316|FG001|Overall Study|Protocol Violation|0|||
161793732|NCT00622908|584289315|FG000|Overall Study|Adverse Event|0|||
161793733|NCT00622908|584289316|FG001|Overall Study|Adverse Event|1|||
161793734|NCT00622908|584289315|FG000|Overall Study|Lack of Efficacy|1|||
161793735|NCT00622908|584289316|FG001|Overall Study|Lack of Efficacy|7|||
162132642|NCT02303574|585536825|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
161793736|NCT00622908|584289315|FG000|Overall Study|Lost to Follow-up|1|||
161793737|NCT00622908|584289316|FG001|Overall Study|Lost to Follow-up|0|||
161793738|NCT00622908|584289315|FG000|Overall Study|Refusal|0|||
162132643|NCT02303574|585536826|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162132644|NCT02303574|585536827|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162132645|NCT02303574|585536828|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162132646|NCT02303574|585536829|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162132647|NCT02303574|585536830|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162132648|NCT02303574|585536831|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162132649|NCT02303574|585536832|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
162132650|NCT02303574|585536833|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162132651|NCT02303574|585536834|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
162132652|NCT00859014|585536839|FG000|Overall Study|Death|4|||
162132653|NCT00859014|585536839|FG000|Overall Study|Lost to Follow-up|1|||
162132654|NCT04796935|585536840|FG000|Overall Study|Withdrawal by Subject|0|||
162132655|NCT04796935|585536841|FG001|Overall Study|Withdrawal by Subject|1|||
162132656|NCT04796935|585536840|FG000|Overall Study|Physician Decision|0|||
162132657|NCT04796935|585536841|FG001|Overall Study|Physician Decision|1|||
162132658|NCT04796935|585536840|FG000|Overall Study|Device not available|1|||
162132659|NCT04796935|585536841|FG001|Overall Study|Device not available|0|||
162132660|NCT04796935|585536840|FG000|Overall Study|Trained provider not available|1|||
162132661|NCT04796935|585536841|FG001|Overall Study|Trained provider not available|0|||
162132662|NCT00052962|585536842|FG000|Overall Study|Not evaluable|0|||
162132663|NCT00052962|585536843|FG001|Overall Study|Not evaluable|2|||
162132664|NCT00052962|585536842|FG000|Overall Study|Not randomized/not evaluable|1|||
162132665|NCT00052962|585536843|FG001|Overall Study|Not randomized/not evaluable|0|||
162132666|NCT01414166|585536844|FG000|Overall Study|Adverse Event|10|||
162132667|NCT01414166|585536845|FG001|Overall Study|Adverse Event|2|||
162132668|NCT01414166|585536844|FG000|Overall Study|Lost to Follow-up|4|||
162132669|NCT01414166|585536845|FG001|Overall Study|Lost to Follow-up|1|||
162132670|NCT01414166|585536844|FG000|Overall Study|Non-compliance with study drug|2|||
162132671|NCT01414166|585536845|FG001|Overall Study|Non-compliance with study drug|0|||
162132672|NCT01414166|585536844|FG000|Overall Study|Physician Decision|2|||
162132673|NCT01414166|585536845|FG001|Overall Study|Physician Decision|0|||
162132674|NCT01414166|585536844|FG000|Overall Study|Protocol Violation|2|||
162132675|NCT01414166|585536845|FG001|Overall Study|Protocol Violation|0|||
162132676|NCT01414166|585536844|FG000|Overall Study|Study terminated by Sponsor|68|||
162132677|NCT01414166|585536845|FG001|Overall Study|Study terminated by Sponsor|75|||
162132678|NCT01414166|585536844|FG000|Overall Study|Withdrawal by Subject|3|||
162132679|NCT01414166|585536845|FG001|Overall Study|Withdrawal by Subject|5|||
162132680|NCT03782727|585536846|FG000|Overall Study|Lost to Follow-up|32|||
162132681|NCT05489224|585536847|FG000|Treatment Period I|Withdrawal by Subject|6|||
162132682|NCT05489224|585536848|FG001|Treatment Period I|Withdrawal by Subject|5|||
162132683|NCT05489224|585536849|FG002|Treatment Period I|Withdrawal by Subject|0|||
162132684|NCT05489224|585536847|FG000|Treatment Period I|Adverse Event|3|||
162132685|NCT05489224|585536848|FG001|Treatment Period I|Adverse Event|11|||
162132686|NCT05489224|585536849|FG002|Treatment Period I|Adverse Event|0|||
162132687|NCT05489224|585536847|FG000|Treatment Period I|Lost to Follow-up|0|||
161793739|NCT00622908|584289316|FG001|Overall Study|Refusal|1|||
161793740|NCT00622908|584289315|FG000|Overall Study|Termination by study sponser|0|||
161793741|NCT00622908|584289316|FG001|Overall Study|Termination by study sponser|1|||
161793742|NCT01725451|584289324|FG000|Period 1|Withdrawal by Subject|1|||
161793743|NCT01725451|584289325|FG001|Period 1|Withdrawal by Subject|0|||
161793744|NCT01725451|584289326|FG002|Period 1|Withdrawal by Subject|0|||
161793745|NCT01725451|584289327|FG003|Period 1|Withdrawal by Subject|0|||
161793746|NCT01725451|584289324|FG000|Washout From Period 3|Protocol Violation|0|||
161793747|NCT01725451|584289325|FG001|Washout From Period 3|Protocol Violation|0|||
161793748|NCT01725451|584289326|FG002|Washout From Period 3|Protocol Violation|1|||
161793749|NCT01725451|584289327|FG003|Washout From Period 3|Protocol Violation|0|||
161793750|NCT01725451|584289324|FG000|Washout From Period 3|Adverse Event|0|||
161793751|NCT01725451|584289325|FG001|Washout From Period 3|Adverse Event|1|||
161793752|NCT01725451|584289326|FG002|Washout From Period 3|Adverse Event|0|||
161793753|NCT01725451|584289327|FG003|Washout From Period 3|Adverse Event|0|||
161793754|NCT01725451|584289324|FG000|Period 4|Adverse Event|0|||
161793755|NCT01725451|584289325|FG001|Period 4|Adverse Event|0|||
161793756|NCT01725451|584289326|FG002|Period 4|Adverse Event|1|||
161793757|NCT01725451|584289327|FG003|Period 4|Adverse Event|0|||
161793758|NCT00358826|584289331|FG000|Core Study|Adverse Event|1|||
161793759|NCT00358826|584289332|FG001|Core Study|Adverse Event|3|||
161793760|NCT00358826|584289333|FG002|Core Study|Adverse Event|1|||
161793761|NCT00358826|584289334|FG003|Core Study|Adverse Event|1|||
161793762|NCT00358826|584289335|FG004|Core Study|Adverse Event|0|||
161793763|NCT00358826|584289336|FG005|Core Study|Adverse Event|0|||
161793764|NCT00358826|584289337|FG006|Core Study|Adverse Event|0|||
161793765|NCT00358826|584289338|FG007|Core Study|Adverse Event|0|||
161793766|NCT00358826|584289331|FG000|Core Study|Withdrawal by Subject|2|||
161793767|NCT00358826|584289332|FG001|Core Study|Withdrawal by Subject|2|||
161793768|NCT00358826|584289333|FG002|Core Study|Withdrawal by Subject|0|||
161793769|NCT00358826|584289334|FG003|Core Study|Withdrawal by Subject|0|||
161793770|NCT00358826|584289335|FG004|Core Study|Withdrawal by Subject|0|||
161793771|NCT00358826|584289336|FG005|Core Study|Withdrawal by Subject|0|||
161793772|NCT00358826|584289337|FG006|Core Study|Withdrawal by Subject|0|||
161793773|NCT00358826|584289338|FG007|Core Study|Withdrawal by Subject|0|||
161793774|NCT00358826|584289331|FG000|Core Study|Lost to Follow-up|0|||
161793775|NCT00358826|584289332|FG001|Core Study|Lost to Follow-up|0|||
161793776|NCT00358826|584289333|FG002|Core Study|Lost to Follow-up|0|||
161793777|NCT00358826|584289334|FG003|Core Study|Lost to Follow-up|1|||
161793778|NCT00358826|584289335|FG004|Core Study|Lost to Follow-up|0|||
161793779|NCT00358826|584289336|FG005|Core Study|Lost to Follow-up|0|||
161793780|NCT00358826|584289337|FG006|Core Study|Lost to Follow-up|0|||
161793781|NCT00358826|584289338|FG007|Core Study|Lost to Follow-up|0|||
161793782|NCT00358826|584289331|FG000|Core Study|Physician Decision|0|||
161793783|NCT00358826|584289332|FG001|Core Study|Physician Decision|0|||
161793784|NCT00358826|584289333|FG002|Core Study|Physician Decision|1|||
161793785|NCT00358826|584289334|FG003|Core Study|Physician Decision|0|||
161793786|NCT00358826|584289335|FG004|Core Study|Physician Decision|0|||
161793787|NCT00358826|584289336|FG005|Core Study|Physician Decision|0|||
161793788|NCT00358826|584289337|FG006|Core Study|Physician Decision|0|||
161793789|NCT00358826|584289338|FG007|Core Study|Physician Decision|0|||
161793790|NCT00358826|584289331|FG000|MDCT Substudy|Adverse Event|0|||
161793791|NCT00358826|584289332|FG001|MDCT Substudy|Adverse Event|0|||
161793792|NCT00358826|584289333|FG002|MDCT Substudy|Adverse Event|0|||
161793793|NCT00358826|584289334|FG003|MDCT Substudy|Adverse Event|0|||
161793794|NCT00358826|584289335|FG004|MDCT Substudy|Adverse Event|1|||
161793795|NCT00358826|584289336|FG005|MDCT Substudy|Adverse Event|0|||
161793796|NCT00358826|584289337|FG006|MDCT Substudy|Adverse Event|0|||
161793797|NCT00358826|584289338|FG007|MDCT Substudy|Adverse Event|0|||
161793798|NCT00358826|584289331|FG000|MDCT Substudy|Lost to Follow-up|0|||
161793799|NCT00358826|584289332|FG001|MDCT Substudy|Lost to Follow-up|0|||
161793800|NCT00358826|584289333|FG002|MDCT Substudy|Lost to Follow-up|0|||
161793801|NCT00358826|584289334|FG003|MDCT Substudy|Lost to Follow-up|0|||
161793802|NCT00358826|584289335|FG004|MDCT Substudy|Lost to Follow-up|0|||
161793803|NCT00358826|584289336|FG005|MDCT Substudy|Lost to Follow-up|1|||
161793804|NCT00358826|584289337|FG006|MDCT Substudy|Lost to Follow-up|0|||
161793805|NCT00358826|584289338|FG007|MDCT Substudy|Lost to Follow-up|0|||
161793806|NCT00358826|584289331|FG000|MDCT Substudy|Withdrawal by Subject|0|||
161793807|NCT00358826|584289332|FG001|MDCT Substudy|Withdrawal by Subject|0|||
161793808|NCT00358826|584289333|FG002|MDCT Substudy|Withdrawal by Subject|0|||
161793809|NCT00358826|584289334|FG003|MDCT Substudy|Withdrawal by Subject|0|||
161793810|NCT00358826|584289335|FG004|MDCT Substudy|Withdrawal by Subject|0|||
161793811|NCT00358826|584289336|FG005|MDCT Substudy|Withdrawal by Subject|1|||
161793812|NCT00358826|584289337|FG006|MDCT Substudy|Withdrawal by Subject|0|||
161793813|NCT00358826|584289338|FG007|MDCT Substudy|Withdrawal by Subject|0|||
161793814|NCT00903383|584289342|FG000|Overall Study|Adverse Event|1|||
161793815|NCT00903383|584289343|FG001|Overall Study|Adverse Event|2|||
161793816|NCT00903383|584289344|FG002|Overall Study|Adverse Event|3|||
161793817|NCT00903383|584289345|FG003|Overall Study|Adverse Event|1|||
161793818|NCT00903383|584289342|FG000|Overall Study|Physician Decision|1|||
161793819|NCT00903383|584289343|FG001|Overall Study|Physician Decision|2|||
161793820|NCT00903383|584289344|FG002|Overall Study|Physician Decision|0|||
161793821|NCT00903383|584289345|FG003|Overall Study|Physician Decision|0|||
161793822|NCT00903383|584289342|FG000|Overall Study|Lost to Follow-up|0|||
161793823|NCT00903383|584289343|FG001|Overall Study|Lost to Follow-up|0|||
161793824|NCT00903383|584289344|FG002|Overall Study|Lost to Follow-up|0|||
161793825|NCT00903383|584289345|FG003|Overall Study|Lost to Follow-up|1|||
161793826|NCT00903383|584289342|FG000|Overall Study|Decision of Sponsor|1|||
161793827|NCT00903383|584289343|FG001|Overall Study|Decision of Sponsor|0|||
161793828|NCT00903383|584289344|FG002|Overall Study|Decision of Sponsor|0|||
161793829|NCT00903383|584289345|FG003|Overall Study|Decision of Sponsor|0|||
161793830|NCT00903383|584289342|FG000|Overall Study|Withdrawal by Subject|4|||
161793831|NCT00903383|584289343|FG001|Overall Study|Withdrawal by Subject|1|||
161793832|NCT00903383|584289344|FG002|Overall Study|Withdrawal by Subject|0|||
161793833|NCT00903383|584289345|FG003|Overall Study|Withdrawal by Subject|2|||
161793834|NCT00903383|584289342|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
161793835|NCT00903383|584289343|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
161793836|NCT00903383|584289344|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
161793837|NCT00903383|584289345|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
161793838|NCT00903383|584289342|FG000|Overall Study|Patient Decision|0|||
161793839|NCT00903383|584289343|FG001|Overall Study|Patient Decision|0|||
161793840|NCT00903383|584289344|FG002|Overall Study|Patient Decision|0|||
161793841|NCT00903383|584289345|FG003|Overall Study|Patient Decision|1|||
161793842|NCT00283686|584289348|FG000|Overall Study|Death|1|||
161793843|NCT00283686|584289349|FG001|Overall Study|Death|1|||
161793844|NCT00283686|584289350|FG002|Overall Study|Death|1|||
161793845|NCT00283686|584289351|FG003|Overall Study|Death|0|||
161793846|NCT00283686|584289348|FG000|Overall Study|Lost to Follow-up|21|||
161793847|NCT00283686|584289349|FG001|Overall Study|Lost to Follow-up|31|||
161793848|NCT00283686|584289350|FG002|Overall Study|Lost to Follow-up|26|||
161793849|NCT00283686|584289351|FG003|Overall Study|Lost to Follow-up|20|||
161793850|NCT00283686|584289348|FG000|Overall Study|Less than full participation|7|||
161793851|NCT00283686|584289349|FG001|Overall Study|Less than full participation|9|||
161793852|NCT00283686|584289350|FG002|Overall Study|Less than full participation|6|||
161793853|NCT00283686|584289351|FG003|Overall Study|Less than full participation|12|||
161793854|NCT02087059|584289352|FG000|Overall Study|Disease Progression|1|||
161793855|NCT02087059|584289352|FG000|Overall Study|Adverse Event|5|||
161793856|NCT02087059|584289352|FG000|Overall Study|Lost to Follow-up|1|||
161793857|NCT01851590|584289354|FG000|Overall Study|Withdrawal by Subject|0|||
161793858|NCT01851590|584289355|FG001|Overall Study|Withdrawal by Subject|0|||
161793859|NCT01851590|584289356|FG002|Overall Study|Withdrawal by Subject|1|||
161793860|NCT01851590|584289354|FG000|Overall Study|Adverse Event|0|||
161793861|NCT01851590|584289355|FG001|Overall Study|Adverse Event|0|||
161793862|NCT01851590|584289356|FG002|Overall Study|Adverse Event|2|||
161793863|NCT01851590|584289354|FG000|Overall Study|Lack of Efficacy|0|||
161793864|NCT01851590|584289355|FG001|Overall Study|Lack of Efficacy|1|||
161793865|NCT01851590|584289356|FG002|Overall Study|Lack of Efficacy|0|||
161793866|NCT00696709|584289357|FG000|Overall Study|Withdrawal by Subject|1|||
161793867|NCT00696709|584289358|FG001|Overall Study|Withdrawal by Subject|2|||
161793868|NCT00696709|584289359|FG002|Overall Study|Withdrawal by Subject|1|||
161793869|NCT00696709|584289360|FG003|Overall Study|Withdrawal by Subject|4|||
161793870|NCT00696709|584289361|FG004|Overall Study|Withdrawal by Subject|3|||
161793871|NCT00696709|584289357|FG000|Overall Study|Protocol Violation|1|||
161793872|NCT00696709|584289358|FG001|Overall Study|Protocol Violation|0|||
161793873|NCT00696709|584289359|FG002|Overall Study|Protocol Violation|0|||
161793874|NCT00696709|584289360|FG003|Overall Study|Protocol Violation|0|||
161793875|NCT00696709|584289361|FG004|Overall Study|Protocol Violation|0|||
161793876|NCT00696709|584289357|FG000|Overall Study|Lost to Follow-up|1|||
161793877|NCT00696709|584289358|FG001|Overall Study|Lost to Follow-up|1|||
161899667|NCT01128296|584680976|FG000|Overall Study|Withdrawal by Subject|0|||
161899668|NCT01128296|584680977|FG001|Overall Study|Withdrawal by Subject|0|||
161899669|NCT01128296|584680978|FG002|Overall Study|Withdrawal by Subject|0|||
161899670|NCT01128296|584680979|FG003|Overall Study|Withdrawal by Subject|0|||
161899671|NCT01128296|584680980|FG004|Overall Study|Withdrawal by Subject|0|||
161899672|NCT01128296|584680981|FG005|Overall Study|Withdrawal by Subject|2|||
161899673|NCT01714544|584680982|FG000|Overall Study|Lost to Follow-up|1|||
161899674|NCT01714544|584680982|FG000|Overall Study|Physician Decision|1|||
161899675|NCT01714544|584680982|FG000|Overall Study|Withdrawal by Subject|1|||
161899676|NCT01053741|584680983|FG000|2nd Study Intervention|Physician Decision|0|||
161899677|NCT01053741|584680984|FG001|2nd Study Intervention|Physician Decision|1|||
161899678|NCT00666211|584680985|FG000|Overall Study|Withdrawal by Subject|10|||
161793878|NCT00696709|584289359|FG002|Overall Study|Lost to Follow-up|0|||
161793879|NCT00696709|584289360|FG003|Overall Study|Lost to Follow-up|0|||
161793880|NCT00696709|584289361|FG004|Overall Study|Lost to Follow-up|0|||
161793881|NCT00696709|584289357|FG000|Overall Study|Adverse Event|0|||
161793882|NCT00696709|584289358|FG001|Overall Study|Adverse Event|0|||
161793883|NCT00696709|584289359|FG002|Overall Study|Adverse Event|0|||
161793884|NCT00696709|584289360|FG003|Overall Study|Adverse Event|1|||
161793885|NCT00696709|584289361|FG004|Overall Study|Adverse Event|0|||
161793886|NCT00310856|584289362|FG000|Overall Study|Withdrawal by Subject|2|||
161793887|NCT00310856|584289363|FG001|Overall Study|Withdrawal by Subject|2|||
161899679|NCT00666211|584680986|FG001|Overall Study|Withdrawal by Subject|13|||
161899680|NCT00666211|584680985|FG000|Overall Study|went off medication, no more pain|1|||
161899681|NCT00666211|584680986|FG001|Overall Study|went off medication, no more pain|0|||
161899682|NCT00666211|584680985|FG000|Overall Study|patient non-compliant|6|||
161793888|NCT00310856|584289364|FG002|Overall Study|Withdrawal by Subject|2|||
161793889|NCT00310856|584289362|FG000|Overall Study|Lost to Follow-up|1|||
161793890|NCT00310856|584289363|FG001|Overall Study|Lost to Follow-up|2|||
161793891|NCT00310856|584289364|FG002|Overall Study|Lost to Follow-up|6|||
161793892|NCT00310856|584289362|FG000|Overall Study|Inappropriate enrollment|1|||
161793893|NCT00310856|584289363|FG001|Overall Study|Inappropriate enrollment|1|||
161793894|NCT00310856|584289364|FG002|Overall Study|Inappropriate enrollment|0|||
161793895|NCT00310856|584289362|FG000|Overall Study|Unable to classify|1|||
161793896|NCT00310856|584289363|FG001|Overall Study|Unable to classify|0|||
161793897|NCT00310856|584289364|FG002|Overall Study|Unable to classify|0|||
161793898|NCT01306253|584289368|FG000|Overall Study|Lost to Follow-up|1|||
161793899|NCT01306253|584289369|FG001|Overall Study|Lost to Follow-up|1|||
161793900|NCT01261325|584289370|FG000|Overall Study|Lack of Efficacy|1|||
161793901|NCT01261325|584289371|FG001|Overall Study|Lack of Efficacy|1|||
161793902|NCT01261325|584289372|FG002|Overall Study|Lack of Efficacy|0|||
161793903|NCT01261325|584289370|FG000|Overall Study|Withdrawal by Subject|2|||
161793904|NCT01261325|584289371|FG001|Overall Study|Withdrawal by Subject|2|||
161793905|NCT01261325|584289372|FG002|Overall Study|Withdrawal by Subject|4|||
161793906|NCT01261325|584289370|FG000|Overall Study|SAE, non-fatal|1|||
161793907|NCT01261325|584289371|FG001|Overall Study|SAE, non-fatal|5|||
161793908|NCT01261325|584289372|FG002|Overall Study|SAE, non-fatal|1|||
161793909|NCT01261325|584289370|FG000|Overall Study|AE, non-serious non-fatal|9|||
161793910|NCT01261325|584289371|FG001|Overall Study|AE, non-serious non-fatal|15|||
161793911|NCT01261325|584289372|FG002|Overall Study|AE, non-serious non-fatal|13|||
161793912|NCT01261325|584289370|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
161793913|NCT01261325|584289371|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161793914|NCT01261325|584289372|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161793915|NCT01261325|584289370|FG000|Overall Study|Non Compliance|2|||
161793916|NCT01261325|584289371|FG001|Overall Study|Non Compliance|0|||
161793917|NCT01261325|584289372|FG002|Overall Study|Non Compliance|0|||
161793918|NCT01261325|584289370|FG000|Overall Study|Patient Randomized by Mistake|0|||
161793919|NCT01261325|584289371|FG001|Overall Study|Patient Randomized by Mistake|1|||
161793920|NCT01261325|584289372|FG002|Overall Study|Patient Randomized by Mistake|0|||
161793921|NCT01261325|584289370|FG000|Overall Study|Erroneously Randomized|1|||
161899683|NCT00666211|584680986|FG001|Overall Study|patient non-compliant|6|||
161899684|NCT00666211|584680985|FG000|Overall Study|disease progression|1|||
161899685|NCT00666211|584680986|FG001|Overall Study|disease progression|8|||
161899686|NCT00666211|584680985|FG000|Overall Study|Lost to Follow-up|2|||
161899687|NCT00666211|584680986|FG001|Overall Study|Lost to Follow-up|0|||
161899688|NCT00666211|584680985|FG000|Overall Study|toxicity|0|||
161899689|NCT00666211|584680986|FG001|Overall Study|toxicity|2|||
161899690|NCT00666211|584680985|FG000|Overall Study|hospital admission|0|||
161899691|NCT00666211|584680986|FG001|Overall Study|hospital admission|5|||
161899692|NCT00666211|584680985|FG000|Overall Study|Death|0|||
161899693|NCT00666211|584680986|FG001|Overall Study|Death|2|||
161899694|NCT00666211|584680985|FG000|Overall Study|off tx for other complicating disease|0|||
161899695|NCT00666211|584680986|FG001|Overall Study|off tx for other complicating disease|1|||
161899696|NCT00666211|584680985|FG000|Overall Study|Physician Decision|0|||
161899697|NCT00666211|584680986|FG001|Overall Study|Physician Decision|1|||
161899698|NCT00003537|584680995|FG000|Overall Study|Not evalauable|1|||
161899699|NCT01001520|584680996|FG000|Medication Period 1|Withdrawal by Subject|2|||
161899700|NCT01001520|584680997|FG001|Medication Period 1|Withdrawal by Subject|2|||
161899701|NCT01001520|584680996|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
161899702|NCT01001520|584680997|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
161899703|NCT01001520|584680996|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
161899704|NCT01001520|584680997|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
161899705|NCT01001520|584680996|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
161899706|NCT01001520|584680997|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
161899707|NCT01001520|584680996|FG000|Washout Period|Withdrawal by Subject|2|||
161899708|NCT01001520|584680997|FG001|Washout Period|Withdrawal by Subject|1|||
161899709|NCT01001520|584680996|FG000|Medication Period 2|Withdrawal by Subject|0|||
161793922|NCT01261325|584289371|FG001|Overall Study|Erroneously Randomized|0|||
161793923|NCT01261325|584289372|FG002|Overall Study|Erroneously Randomized|0|||
161793924|NCT01261325|584289370|FG000|Overall Study|Screen Failure|1|||
161899710|NCT01001520|584680997|FG001|Medication Period 2|Withdrawal by Subject|3|||
161899711|NCT04668209|584680998|FG000|Overall Study|Withdrawal by Subject|2|||
161793925|NCT01261325|584289371|FG001|Overall Study|Screen Failure|0|||
161793926|NCT01261325|584289372|FG002|Overall Study|Screen Failure|0|||
161793927|NCT01261325|584289370|FG000|Overall Study|Randomized in Error|0|||
161793928|NCT01261325|584289371|FG001|Overall Study|Randomized in Error|0|||
161793929|NCT01261325|584289372|FG002|Overall Study|Randomized in Error|1|||
161793930|NCT01261325|584289370|FG000|Overall Study|Protocol Violation|0|||
161899712|NCT04668209|584680999|FG001|Overall Study|Withdrawal by Subject|2|||
161899713|NCT04668209|584680998|FG000|Overall Study|Lost to Follow-up|3|||
161899714|NCT04668209|584680999|FG001|Overall Study|Lost to Follow-up|4|||
161899715|NCT04668209|584680998|FG000|Overall Study|Subject Expired|2|||
161899716|NCT04668209|584680999|FG001|Overall Study|Subject Expired|0|||
161899717|NCT04668209|584680998|FG000|Overall Study|Withdrawn from study|0|||
161899718|NCT04668209|584680999|FG001|Overall Study|Withdrawn from study|1|||
161899719|NCT04668209|584680998|FG000|Overall Study|Adverse Event|0|||
161899720|NCT04668209|584680999|FG001|Overall Study|Adverse Event|1|||
161899721|NCT01004978|584681002|FG000|Overall Study|Disease progression|31|||
161899722|NCT01004978|584681003|FG001|Overall Study|Disease progression|48|||
161899723|NCT01004978|584681002|FG000|Overall Study|Adverse Event|42|||
161899724|NCT01004978|584681003|FG001|Overall Study|Adverse Event|22|||
161899725|NCT01004978|584681002|FG000|Overall Study|Death|3|||
161899726|NCT01004978|584681003|FG001|Overall Study|Death|2|||
161899727|NCT01004978|584681002|FG000|Overall Study|Withdrawal by Subject|16|||
161899728|NCT01004978|584681003|FG001|Overall Study|Withdrawal by Subject|16|||
161899729|NCT01004978|584681002|FG000|Overall Study|Alternative therapy|4|||
161899730|NCT01004978|584681003|FG001|Overall Study|Alternative therapy|8|||
161899731|NCT01004978|584681002|FG000|Overall Study|Physician Decision|6|||
161899732|NCT01004978|584681003|FG001|Overall Study|Physician Decision|3|||
161899733|NCT01004978|584681002|FG000|Overall Study|Other complicating disease|2|||
161899734|NCT01004978|584681003|FG001|Overall Study|Other complicating disease|2|||
161899735|NCT01004978|584681002|FG000|Overall Study|Protocol Violation|2|||
161899736|NCT01004978|584681003|FG001|Overall Study|Protocol Violation|3|||
161899737|NCT01004978|584681002|FG000|Overall Study|Non-compliance|3|||
161899738|NCT01004978|584681003|FG001|Overall Study|Non-compliance|2|||
161899739|NCT01004978|584681002|FG000|Overall Study|Ineligible|1|||
161899740|NCT01004978|584681003|FG001|Overall Study|Ineligible|0|||
161899741|NCT01004978|584681002|FG000|Overall Study|Unblinded|0|||
161899742|NCT01004978|584681003|FG001|Overall Study|Unblinded|1|||
161899743|NCT01004978|584681002|FG000|Overall Study|Performance status worsening|0|||
161899744|NCT01004978|584681003|FG001|Overall Study|Performance status worsening|1|||
161899745|NCT01004978|584681002|FG000|Overall Study|Never started treatment|8|||
161899746|NCT01004978|584681003|FG001|Overall Study|Never started treatment|9|||
161899747|NCT00369915|584681004|FG000|Overall Study|expected side effects|2|||
161899748|NCT00369915|584681005|FG001|Overall Study|expected side effects|1|||
161899749|NCT00369915|584681004|FG000|Overall Study|Withdrawal by Subject|4|||
161899750|NCT00369915|584681005|FG001|Overall Study|Withdrawal by Subject|1|||
161899751|NCT00369915|584681004|FG000|Overall Study|W/drawl by investigators|0|||
161899752|NCT00369915|584681005|FG001|Overall Study|W/drawl by investigators|1|||
161899753|NCT01719380|584681008|FG000|Overall Study|Adverse Event|0|||
161899754|NCT01719380|584681009|FG001|Overall Study|Adverse Event|0|||
161899755|NCT01719380|584681010|FG002|Overall Study|Adverse Event|1|||
161899756|NCT01719380|584681011|FG003|Overall Study|Adverse Event|2|||
161899757|NCT01719380|584681012|FG004|Overall Study|Adverse Event|0|||
161899758|NCT01719380|584681013|FG005|Overall Study|Adverse Event|1|||
161899759|NCT01719380|584681014|FG006|Overall Study|Adverse Event|0|||
161899760|NCT01719380|584681015|FG007|Overall Study|Adverse Event|1|||
161899761|NCT01719380|584681016|FG008|Overall Study|Adverse Event|4|||
161899762|NCT01719380|584681017|FG009|Overall Study|Adverse Event|3|||
161899763|NCT01719380|584681008|FG000|Overall Study|Death|0|||
161899764|NCT01719380|584681009|FG001|Overall Study|Death|1|||
161899765|NCT01719380|584681010|FG002|Overall Study|Death|0|||
161899766|NCT01719380|584681011|FG003|Overall Study|Death|0|||
161899767|NCT01719380|584681012|FG004|Overall Study|Death|0|||
161899768|NCT01719380|584681013|FG005|Overall Study|Death|0|||
161899769|NCT01719380|584681014|FG006|Overall Study|Death|0|||
161899770|NCT01719380|584681015|FG007|Overall Study|Death|0|||
161899771|NCT01719380|584681016|FG008|Overall Study|Death|3|||
161899772|NCT01719380|584681017|FG009|Overall Study|Death|3|||
161899773|NCT01719380|584681008|FG000|Overall Study|Participant/Guardian Decision|0|||
161899774|NCT01719380|584681009|FG001|Overall Study|Participant/Guardian Decision|0|||
161899775|NCT01719380|584681010|FG002|Overall Study|Participant/Guardian Decision|1|||
161899776|NCT01719380|584681011|FG003|Overall Study|Participant/Guardian Decision|0|||
161899777|NCT01719380|584681012|FG004|Overall Study|Participant/Guardian Decision|0|||
161899778|NCT01719380|584681013|FG005|Overall Study|Participant/Guardian Decision|0|||
161899779|NCT01719380|584681014|FG006|Overall Study|Participant/Guardian Decision|0|||
161899780|NCT01719380|584681015|FG007|Overall Study|Participant/Guardian Decision|0|||
161899781|NCT01719380|584681016|FG008|Overall Study|Participant/Guardian Decision|2|||
161899782|NCT01719380|584681017|FG009|Overall Study|Participant/Guardian Decision|2|||
161899783|NCT01719380|584681008|FG000|Overall Study|Physician Decision|0|||
161899784|NCT01719380|584681009|FG001|Overall Study|Physician Decision|0|||
161899785|NCT01719380|584681010|FG002|Overall Study|Physician Decision|2|||
161899786|NCT01719380|584681011|FG003|Overall Study|Physician Decision|0|||
161899787|NCT01719380|584681012|FG004|Overall Study|Physician Decision|0|||
161899788|NCT01719380|584681013|FG005|Overall Study|Physician Decision|0|||
161899789|NCT01719380|584681014|FG006|Overall Study|Physician Decision|0|||
161899790|NCT01719380|584681015|FG007|Overall Study|Physician Decision|0|||
161899791|NCT01719380|584681016|FG008|Overall Study|Physician Decision|1|||
161899792|NCT01719380|584681017|FG009|Overall Study|Physician Decision|1|||
161899793|NCT01719380|584681008|FG000|Overall Study|Lack of Efficacy|2|||
161899794|NCT01719380|584681009|FG001|Overall Study|Lack of Efficacy|6|||
161899795|NCT01719380|584681010|FG002|Overall Study|Lack of Efficacy|5|||
161899796|NCT01719380|584681011|FG003|Overall Study|Lack of Efficacy|6|||
161899797|NCT01719380|584681012|FG004|Overall Study|Lack of Efficacy|3|||
161899798|NCT01719380|584681013|FG005|Overall Study|Lack of Efficacy|7|||
161899799|NCT01719380|584681014|FG006|Overall Study|Lack of Efficacy|10|||
161899800|NCT01719380|584681015|FG007|Overall Study|Lack of Efficacy|6|||
161899801|NCT01719380|584681016|FG008|Overall Study|Lack of Efficacy|39|||
161899802|NCT01719380|584681017|FG009|Overall Study|Lack of Efficacy|42|||
161899803|NCT01719380|584681008|FG000|Overall Study|Progressive Disease|0|||
161899804|NCT01719380|584681009|FG001|Overall Study|Progressive Disease|0|||
161899805|NCT01719380|584681010|FG002|Overall Study|Progressive Disease|0|||
161899806|NCT01719380|584681011|FG003|Overall Study|Progressive Disease|0|||
161899807|NCT01719380|584681012|FG004|Overall Study|Progressive Disease|0|||
161899808|NCT01719380|584681013|FG005|Overall Study|Progressive Disease|0|||
161899809|NCT01719380|584681014|FG006|Overall Study|Progressive Disease|0|||
161899810|NCT01719380|584681015|FG007|Overall Study|Progressive Disease|0|||
161899811|NCT01719380|584681016|FG008|Overall Study|Progressive Disease|1|||
161899812|NCT01719380|584681017|FG009|Overall Study|Progressive Disease|0|||
161899813|NCT01096160|584681020|FG000|Overall Study|Adverse Event|0|||
161899814|NCT01096160|584681021|FG001|Overall Study|Adverse Event|0|||
161899815|NCT01096160|584681022|FG002|Overall Study|Adverse Event|1|||
161899816|NCT01096160|584681023|FG003|Overall Study|Adverse Event|0|||
161899817|NCT01096160|584681024|FG004|Overall Study|Adverse Event|0|||
161899818|NCT01096160|584681025|FG005|Overall Study|Adverse Event|0|||
161899819|NCT01096160|584681026|FG006|Overall Study|Adverse Event|0|||
161899820|NCT01096160|584681027|FG007|Overall Study|Adverse Event|0|||
161899821|NCT01096160|584681028|FG008|Overall Study|Adverse Event|0|||
161899822|NCT01096160|584681029|FG009|Overall Study|Adverse Event|1|||
161899823|NCT01096160|584681020|FG000|Overall Study|Met stopping criteria per protocol|0|||
161899824|NCT01096160|584681021|FG001|Overall Study|Met stopping criteria per protocol|0|||
161899825|NCT01096160|584681022|FG002|Overall Study|Met stopping criteria per protocol|0|||
161899826|NCT01096160|584681023|FG003|Overall Study|Met stopping criteria per protocol|0|||
161899827|NCT01096160|584681024|FG004|Overall Study|Met stopping criteria per protocol|1|||
161899828|NCT01096160|584681025|FG005|Overall Study|Met stopping criteria per protocol|0|||
161899829|NCT01096160|584681026|FG006|Overall Study|Met stopping criteria per protocol|2|||
161899830|NCT01096160|584681027|FG007|Overall Study|Met stopping criteria per protocol|0|||
161899831|NCT01096160|584681028|FG008|Overall Study|Met stopping criteria per protocol|2|||
161899832|NCT01096160|584681029|FG009|Overall Study|Met stopping criteria per protocol|0|||
161899833|NCT02028507|584681030|FG000|Overall Study|Progressive Disease|122|||
161899834|NCT02028507|584681031|FG001|Overall Study|Progressive Disease|90|||
161899835|NCT02028507|584681032|FG002|Overall Study|Progressive Disease|102|||
161899836|NCT02028507|584681033|FG003|Overall Study|Progressive Disease|89|||
161899837|NCT02028507|584681030|FG000|Overall Study|Adverse Event|8|||
161899838|NCT02028507|584681031|FG001|Overall Study|Adverse Event|25|||
161899839|NCT02028507|584681032|FG002|Overall Study|Adverse Event|3|||
161899840|NCT02028507|584681033|FG003|Overall Study|Adverse Event|16|||
162132688|NCT05489224|585536848|FG001|Treatment Period I|Lost to Follow-up|1|||
162132689|NCT05489224|585536849|FG002|Treatment Period I|Lost to Follow-up|0|||
162132690|NCT05489224|585536847|FG000|Treatment Period I|Physician Decision|0|||
162132691|NCT05489224|585536848|FG001|Treatment Period I|Physician Decision|1|||
162132692|NCT05489224|585536849|FG002|Treatment Period I|Physician Decision|0|||
162132693|NCT05489224|585536847|FG000|Treatment Period II up to Week 32|Ongoing|222|||
162132694|NCT05489224|585536848|FG001|Treatment Period II up to Week 32|Ongoing|107|||
162132695|NCT05489224|585536849|FG002|Treatment Period II up to Week 32|Ongoing|107|||
162132696|NCT05489224|585536847|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
162132697|NCT05489224|585536848|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
162132698|NCT05489224|585536849|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
162132699|NCT05489224|585536847|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
162132700|NCT05489224|585536848|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
162132701|NCT05489224|585536849|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
162132702|NCT04887285|585536850|FG000|Overall Study|Lost to Follow-up|0|||
162132703|NCT04887285|585536851|FG001|Overall Study|Lost to Follow-up|2|||
161899841|NCT02028507|584681030|FG000|Overall Study|Withdrawal by Subject|6|||
161899842|NCT02028507|584681031|FG001|Overall Study|Withdrawal by Subject|8|||
161899843|NCT02028507|584681032|FG002|Overall Study|Withdrawal by Subject|5|||
161899844|NCT02028507|584681033|FG003|Overall Study|Withdrawal by Subject|9|||
161899845|NCT02028507|584681030|FG000|Overall Study|Protocol Violation|2|||
161899846|NCT02028507|584681031|FG001|Overall Study|Protocol Violation|4|||
161899847|NCT02028507|584681032|FG002|Overall Study|Protocol Violation|1|||
161899848|NCT02028507|584681033|FG003|Overall Study|Protocol Violation|3|||
161899849|NCT02028507|584681030|FG000|Overall Study|Physician Decision|0|||
161899850|NCT02028507|584681031|FG001|Overall Study|Physician Decision|4|||
161899851|NCT02028507|584681032|FG002|Overall Study|Physician Decision|0|||
161899852|NCT02028507|584681033|FG003|Overall Study|Physician Decision|0|||
161899853|NCT02028507|584681030|FG000|Overall Study|Death|1|||
161899854|NCT02028507|584681031|FG001|Overall Study|Death|0|||
161899855|NCT02028507|584681032|FG002|Overall Study|Death|1|||
161899856|NCT02028507|584681033|FG003|Overall Study|Death|3|||
161899857|NCT02028507|584681030|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
161899858|NCT02028507|584681031|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
161899859|NCT02028507|584681032|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
161899860|NCT02028507|584681033|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
161899861|NCT02028507|584681030|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
161899862|NCT02028507|584681031|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
161899863|NCT02028507|584681032|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
161899864|NCT02028507|584681033|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
161899865|NCT02028507|584681030|FG000|Overall Study|Randomized But Not Treated|3|||
161899866|NCT02028507|584681031|FG001|Overall Study|Randomized But Not Treated|6|||
161899867|NCT02028507|584681032|FG002|Overall Study|Randomized But Not Treated|0|||
161899868|NCT02028507|584681033|FG003|Overall Study|Randomized But Not Treated|4|||
161793931|NCT01261325|584289371|FG001|Overall Study|Protocol Violation|3|||
161793932|NCT01261325|584289372|FG002|Overall Study|Protocol Violation|1|||
161793933|NCT01261325|584289370|FG000|Overall Study|Lost to Follow-up|0|||
161793934|NCT01261325|584289371|FG001|Overall Study|Lost to Follow-up|1|||
161793935|NCT01261325|584289372|FG002|Overall Study|Lost to Follow-up|3|||
161793936|NCT01261325|584289370|FG000|Overall Study|AE, serious fatal|0|||
161793937|NCT01261325|584289371|FG001|Overall Study|AE, serious fatal|0|||
161793938|NCT01261325|584289372|FG002|Overall Study|AE, serious fatal|2|||
161793939|NCT00543439|584289373|FG000|Period 1|Adverse Event|0|||
161793940|NCT00543439|584289374|FG001|Period 1|Adverse Event|2|||
161793941|NCT00543439|584289375|FG002|Period 1|Adverse Event|1|||
161793942|NCT00543439|584289373|FG000|Period 1|Withdrawal by Subject|1|||
161793943|NCT00543439|584289374|FG001|Period 1|Withdrawal by Subject|1|||
161793944|NCT00543439|584289375|FG002|Period 1|Withdrawal by Subject|0|||
161793945|NCT00543439|584289373|FG000|Period 1|Physician Decision|0|||
161793946|NCT00543439|584289374|FG001|Period 1|Physician Decision|0|||
161793947|NCT00543439|584289375|FG002|Period 1|Physician Decision|1|||
161793948|NCT00543439|584289373|FG000|Period 2|Protocol Violation|1|||
161793949|NCT00543439|584289374|FG001|Period 2|Protocol Violation|0|||
161793950|NCT00543439|584289375|FG002|Period 2|Protocol Violation|1|||
161793951|NCT00543439|584289373|FG000|Period 2|Adverse Event|0|||
161793952|NCT00543439|584289374|FG001|Period 2|Adverse Event|1|||
161793953|NCT00543439|584289375|FG002|Period 2|Adverse Event|1|||
161793954|NCT01211769|584289378|FG000|Overall Study|Lost to Follow-up|7|||
161793955|NCT01211769|584289379|FG001|Overall Study|Lost to Follow-up|9|||
161793956|NCT01211769|584289380|FG002|Overall Study|Lost to Follow-up|5|||
161793957|NCT01211769|584289381|FG003|Overall Study|Lost to Follow-up|9|||
161793958|NCT01211769|584289378|FG000|Overall Study|Physician Decision|2|||
161793959|NCT01211769|584289379|FG001|Overall Study|Physician Decision|0|||
161793960|NCT01211769|584289380|FG002|Overall Study|Physician Decision|2|||
161793961|NCT01211769|584289381|FG003|Overall Study|Physician Decision|1|||
161793962|NCT01211769|584289378|FG000|Overall Study|Adverse Event|0|||
161793963|NCT01211769|584289379|FG001|Overall Study|Adverse Event|1|||
161793964|NCT01211769|584289380|FG002|Overall Study|Adverse Event|1|||
161899869|NCT02028507|584681030|FG000|Overall Study|Enzyme defect|0|||
161899870|NCT02028507|584681031|FG001|Overall Study|Enzyme defect|0|||
161899871|NCT02028507|584681032|FG002|Overall Study|Enzyme defect|0|||
161899872|NCT02028507|584681033|FG003|Overall Study|Enzyme defect|1|||
161899873|NCT02028507|584681030|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
161899874|NCT02028507|584681031|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
161899875|NCT02028507|584681032|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
161899876|NCT02028507|584681033|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
162132704|NCT04887285|585536852|FG002|Overall Study|Lost to Follow-up|3|||
161793965|NCT01211769|584289381|FG003|Overall Study|Adverse Event|1|||
161793966|NCT00146770|584289386|FG000|Overall Study|Adverse Event|2|||
161793967|NCT00146770|584289387|FG001|Overall Study|Adverse Event|0|||
161793968|NCT00146770|584289386|FG000|Overall Study|Pregnancy|1|||
161793969|NCT00146770|584289387|FG001|Overall Study|Pregnancy|0|||
161793970|NCT00146770|584289386|FG000|Overall Study|Withdrawal by Subject|2|||
161793971|NCT00146770|584289387|FG001|Overall Study|Withdrawal by Subject|0|||
161793972|NCT02826603|584289390|FG000|Overall Study|Adverse Event|17|||
161793973|NCT02826603|584289391|FG001|Overall Study|Adverse Event|9|||
161793974|NCT02826603|584289390|FG000|Overall Study|Lack of Efficacy|4|||
161793975|NCT02826603|584289391|FG001|Overall Study|Lack of Efficacy|9|||
161899877|NCT02028507|584681030|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
161899878|NCT02028507|584681031|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
161793976|NCT02826603|584289390|FG000|Overall Study|Lost to Follow-up|13|||
161793977|NCT02826603|584289391|FG001|Overall Study|Lost to Follow-up|12|||
161793978|NCT02826603|584289390|FG000|Overall Study|Noncompliance with treatment|0|||
161793979|NCT02826603|584289391|FG001|Overall Study|Noncompliance with treatment|2|||
161793980|NCT02826603|584289390|FG000|Overall Study|Physician Decision|1|||
162132705|NCT04640571|585536853|FG000|Overall Study|Withdrawal by Subject|0|||
161793981|NCT02826603|584289391|FG001|Overall Study|Physician Decision|7|||
161793982|NCT02826603|584289390|FG000|Overall Study|Pregnancy|1|||
161793983|NCT02826603|584289391|FG001|Overall Study|Pregnancy|2|||
161793984|NCT02826603|584289390|FG000|Overall Study|Protocol Violation|3|||
161793985|NCT02826603|584289391|FG001|Overall Study|Protocol Violation|3|||
161793986|NCT02826603|584289390|FG000|Overall Study|Withdrawal by Subject|20|||
161793987|NCT02826603|584289391|FG001|Overall Study|Withdrawal by Subject|19|||
161793988|NCT02826603|584289390|FG000|Overall Study|Death|2|||
161793989|NCT02826603|584289391|FG001|Overall Study|Death|0|||
161793990|NCT02826603|584289390|FG000|Overall Study|New therapy for study indication|0|||
161793991|NCT02826603|584289391|FG001|Overall Study|New therapy for study indication|1|||
161793992|NCT02668302|584289392|FG000|Overall Study|Withdrawal by Subject|1|||
161793993|NCT02668302|584289393|FG001|Overall Study|Withdrawal by Subject|0|||
161793994|NCT03558997|584289394|FG000|Overall Study|Adverse Event|0|||
161793995|NCT03558997|584289395|FG001|Overall Study|Adverse Event|2|||
161793996|NCT03558997|584289396|FG002|Overall Study|Adverse Event|5|||
161793997|NCT03558997|584289397|FG003|Overall Study|Adverse Event|1|||
161793998|NCT03558997|584289394|FG000|Overall Study|Physician Decision|0|||
162132706|NCT04640571|585536854|FG001|Overall Study|Withdrawal by Subject|0|||
162132707|NCT04640571|585536855|FG002|Overall Study|Withdrawal by Subject|0|||
162132708|NCT04640571|585536856|FG003|Overall Study|Withdrawal by Subject|0|||
162132709|NCT04640571|585536857|FG004|Overall Study|Withdrawal by Subject|0|||
162132710|NCT04640571|585536858|FG005|Overall Study|Withdrawal by Subject|2|||
162132711|NCT00832780|585536859|FG000|Overall Study|Death|16|||
162132712|NCT00832780|585536859|FG000|Overall Study|Lost to Follow-up|4|||
162132713|NCT00832780|585536859|FG000|Overall Study|no reason given|2|||
162132714|NCT00832780|585536859|FG000|Overall Study|other complicating condition|2|||
162132715|NCT00832780|585536859|FG000|Overall Study|Physician Decision|1|||
162132716|NCT05705167|585536860|FG000|Overall Study|Randomised but not Treated|0|||
162132717|NCT05705167|585536861|FG001|Overall Study|Randomised but not Treated|2|||
162132718|NCT05705167|585536862|FG002|Overall Study|Randomised but not Treated|0|||
162132719|NCT05705167|585536863|FG003|Overall Study|Randomised but not Treated|7|||
162132720|NCT05705167|585536864|FG004|Overall Study|Randomised but not Treated|0|||
162132721|NCT05705167|585536865|FG005|Overall Study|Randomised but not Treated|0|||
162132722|NCT05705167|585536866|FG006|Overall Study|Randomised but not Treated|0|||
162132723|NCT05705167|585536860|FG000|Overall Study|Death|0|||
162132724|NCT05705167|585536861|FG001|Overall Study|Death|0|||
162132725|NCT05705167|585536862|FG002|Overall Study|Death|3|||
162132726|NCT05705167|585536863|FG003|Overall Study|Death|0|||
162132727|NCT05705167|585536864|FG004|Overall Study|Death|1|||
162132728|NCT05705167|585536865|FG005|Overall Study|Death|1|||
162132729|NCT05705167|585536866|FG006|Overall Study|Death|1|||
162132730|NCT05705167|585536860|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
162132731|NCT05705167|585536861|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
162132732|NCT05705167|585536862|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
161793999|NCT03558997|584289395|FG001|Overall Study|Physician Decision|0|||
161794000|NCT03558997|584289396|FG002|Overall Study|Physician Decision|1|||
161794001|NCT03558997|584289397|FG003|Overall Study|Physician Decision|0|||
161794002|NCT03558997|584289394|FG000|Overall Study|Withdrawal by Subject|1|||
161794003|NCT03558997|584289395|FG001|Overall Study|Withdrawal by Subject|0|||
161794004|NCT03558997|584289396|FG002|Overall Study|Withdrawal by Subject|1|||
161794005|NCT03558997|584289397|FG003|Overall Study|Withdrawal by Subject|1|||
161794006|NCT03558997|584289394|FG000|Overall Study|Lost to Follow-up|0|||
161794007|NCT03558997|584289395|FG001|Overall Study|Lost to Follow-up|0|||
161794008|NCT03558997|584289396|FG002|Overall Study|Lost to Follow-up|1|||
161794009|NCT03558997|584289397|FG003|Overall Study|Lost to Follow-up|0|||
161794010|NCT00526890|584289401|FG000|Overall Study|Adverse Event|2|||
161794011|NCT04128696|584289402|FG000|Overall Study|Lost to Follow-up|3|||
161794012|NCT04128696|584289403|FG001|Overall Study|Lost to Follow-up|7|||
161794013|NCT04128696|584289402|FG000|Overall Study|Withdrawal by Subject|12|||
161794014|NCT04128696|584289403|FG001|Overall Study|Withdrawal by Subject|11|||
161794015|NCT04128696|584289402|FG000|Overall Study|Study Closed/Terminated|26|||
161794016|NCT04128696|584289403|FG001|Overall Study|Study Closed/Terminated|38|||
161794017|NCT04128696|584289402|FG000|Overall Study|Physician Decision|2|||
161794018|NCT04128696|584289403|FG001|Overall Study|Physician Decision|3|||
161794019|NCT03280537|584289408|FG000|Overall Study|Withdrawal by Subject|2|||
161794020|NCT03280537|584289409|FG001|Overall Study|Withdrawal by Subject|4|||
161794021|NCT01588106|584289410|FG000|Overall Study|Withdrawal by Subject|5|||
161794022|NCT01588106|584289411|FG001|Overall Study|Withdrawal by Subject|4|||
162132733|NCT05705167|585536863|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
162132734|NCT05705167|585536864|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
162132735|NCT05705167|585536865|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
162132736|NCT05705167|585536866|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
161794023|NCT03083132|584289412|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
161794024|NCT03083132|584289413|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
162132737|NCT03658811|585536869|FG000|Overall Study|Lost to Follow-up|3|||
162132738|NCT04060680|585536870|FG000|Overall Study|Unsuccessful implant|17|||
162132739|NCT04060680|585536871|FG001|Overall Study|Unsuccessful implant|2|||
162132740|NCT04060680|585536870|FG000|Overall Study|Adverse Event|3|||
162132741|NCT04060680|585536871|FG001|Overall Study|Adverse Event|0|||
162132742|NCT04060680|585536870|FG000|Overall Study|Death|2|||
162132743|NCT04060680|585536871|FG001|Overall Study|Death|0|||
162132744|NCT04060680|585536870|FG000|Overall Study|Study product no longer in use|1|||
162132745|NCT04060680|585536871|FG001|Overall Study|Study product no longer in use|0|||
162132746|NCT04060680|585536870|FG000|Overall Study|Withdrawal by Subject|1|||
162132747|NCT04060680|585536871|FG001|Overall Study|Withdrawal by Subject|0|||
161794025|NCT03083132|584289412|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
161794026|NCT03083132|584289413|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
161794027|NCT03083132|584289412|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
161794028|NCT03083132|584289413|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
161794029|NCT03118739|584289414|FG000|Overall Study|Physician Decision|0|||
161794030|NCT03118739|584289415|FG001|Overall Study|Physician Decision|1|||
161794031|NCT03118739|584289414|FG000|Overall Study|Withdrawal by Subject|5|||
161794032|NCT03118739|584289415|FG001|Overall Study|Withdrawal by Subject|3|||
161794033|NCT03118739|584289414|FG000|Overall Study|Lost to Follow-up|2|||
161794034|NCT03118739|584289415|FG001|Overall Study|Lost to Follow-up|0|||
161794035|NCT02995837|584289416|FG000|Overall Study|Lost to Follow-up|9|||
161794036|NCT02995837|584289417|FG001|Overall Study|Lost to Follow-up|8|||
161794037|NCT01859702|584289418|FG000|Overall Study|Protocol deviation|3|||
161794038|NCT01859702|584289418|FG000|Overall Study|Adverse Event|2|||
161794039|NCT01893138|584289419|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161794040|NCT01893138|584289420|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161794041|NCT01893138|584289419|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
161794042|NCT01893138|584289420|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
161794043|NCT01893138|584289419|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
161794044|NCT01893138|584289420|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
161794045|NCT01893138|584289419|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
161794046|NCT01893138|584289420|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
161794047|NCT01893138|584289419|FG000|Open Label - Unblinded Period|Adverse Event|1|||
161794048|NCT01893138|584289420|FG001|Open Label - Unblinded Period|Adverse Event|0|||
161794049|NCT01326026|584289421|FG000|Overall Study|Adverse Event|4|||
161794050|NCT01326026|584289422|FG001|Overall Study|Adverse Event|3|||
161794051|NCT01326026|584289421|FG000|Overall Study|Withdrawal Criteria|5|||
161794052|NCT01326026|584289422|FG001|Overall Study|Withdrawal Criteria|7|||
161794053|NCT01326026|584289421|FG000|Overall Study|Other|3|||
161794054|NCT01326026|584289422|FG001|Overall Study|Other|3|||
161794055|NCT04567615|584289426|FG000|Randomization|Participant withdrew consent|1|||
161794056|NCT04567615|584289427|FG001|Randomization|Participant withdrew consent|0|||
161794057|NCT04567615|584289428|FG002|Randomization|Participant withdrew consent|0|||
161794058|NCT04567615|584289426|FG000|Randomization|Adverse event unrelated to study drug|0|||
161794059|NCT04567615|584289427|FG001|Randomization|Adverse event unrelated to study drug|1|||
161794060|NCT04567615|584289428|FG002|Randomization|Adverse event unrelated to study drug|0|||
161794061|NCT04567615|584289426|FG000|Treatment Period|Participant Withdrew Consent|2|||
161794062|NCT04567615|584289427|FG001|Treatment Period|Participant Withdrew Consent|5|||
161794063|NCT04567615|584289428|FG002|Treatment Period|Participant Withdrew Consent|1|||
161794064|NCT04567615|584289426|FG000|Treatment Period|Death|1|||
161794065|NCT04567615|584289427|FG001|Treatment Period|Death|2|||
161794066|NCT04567615|584289428|FG002|Treatment Period|Death|0|||
161794067|NCT04567615|584289426|FG000|Treatment Period|Lost to Follow-up|0|||
161794068|NCT04567615|584289427|FG001|Treatment Period|Lost to Follow-up|1|||
161794069|NCT04567615|584289428|FG002|Treatment Period|Lost to Follow-up|0|||
161794070|NCT04567615|584289426|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161794071|NCT04567615|584289427|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
161794072|NCT04567615|584289428|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161794073|NCT04567615|584289426|FG000|Treatment Period|Disease Progression|85|||
161794074|NCT04567615|584289427|FG001|Treatment Period|Disease Progression|63|||
161794075|NCT04567615|584289428|FG002|Treatment Period|Disease Progression|16|||
161794076|NCT04567615|584289426|FG000|Treatment Period|Study Drug Toxicity|3|||
161794077|NCT04567615|584289427|FG001|Treatment Period|Study Drug Toxicity|10|||
161794078|NCT04567615|584289428|FG002|Treatment Period|Study Drug Toxicity|4|||
161794079|NCT04567615|584289426|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
162132748|NCT00495469|585538926|FG000|Overall Study|Adverse Event|0|||
161794080|NCT04567615|584289427|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
161794081|NCT04567615|584289428|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
161794082|NCT04567615|584289426|FG000|Treatment Period|Other Reasons|1|||
161794083|NCT04567615|584289427|FG001|Treatment Period|Other Reasons|2|||
161794084|NCT04567615|584289428|FG002|Treatment Period|Other Reasons|0|||
161794085|NCT04567615|584289426|FG000|Treatment Period|Still On-going Treatment|21|||
161794086|NCT04567615|584289427|FG001|Treatment Period|Still On-going Treatment|22|||
162132749|NCT00495469|585538927|FG001|Overall Study|Adverse Event|1|||
161794087|NCT04567615|584289428|FG002|Treatment Period|Still On-going Treatment|2|||
161794088|NCT04317053|584289429|FG000|Overall Study|Withdrawn (screen failure)|4|||
161794089|NCT04317053|584289430|FG001|Overall Study|Withdrawn (screen failure)|2|||
161794090|NCT01022112|584289431|FG000|Overall Study|Adverse Event|1|||
161794091|NCT01022112|584289432|FG001|Overall Study|Adverse Event|2|||
161794092|NCT01022112|584289433|FG002|Overall Study|Adverse Event|0|||
161794093|NCT01022112|584289434|FG003|Overall Study|Adverse Event|1|||
161794094|NCT01022112|584289435|FG004|Overall Study|Adverse Event|0|||
161794095|NCT01022112|584289431|FG000|Overall Study|Lack of Efficacy|1|||
161794096|NCT01022112|584289432|FG001|Overall Study|Lack of Efficacy|0|||
161794097|NCT01022112|584289433|FG002|Overall Study|Lack of Efficacy|0|||
161794098|NCT01022112|584289434|FG003|Overall Study|Lack of Efficacy|0|||
161794099|NCT01022112|584289435|FG004|Overall Study|Lack of Efficacy|1|||
161794100|NCT01022112|584289431|FG000|Overall Study|Physician Decision|0|||
161794101|NCT01022112|584289432|FG001|Overall Study|Physician Decision|0|||
161794102|NCT01022112|584289433|FG002|Overall Study|Physician Decision|1|||
161794103|NCT01022112|584289434|FG003|Overall Study|Physician Decision|0|||
161794104|NCT01022112|584289435|FG004|Overall Study|Physician Decision|1|||
161794105|NCT01022112|584289431|FG000|Overall Study|Withdrawal by Subject|0|||
161794106|NCT01022112|584289432|FG001|Overall Study|Withdrawal by Subject|1|||
161794107|NCT01022112|584289433|FG002|Overall Study|Withdrawal by Subject|2|||
161794108|NCT01022112|584289434|FG003|Overall Study|Withdrawal by Subject|2|||
161794109|NCT01022112|584289435|FG004|Overall Study|Withdrawal by Subject|1|||
161794110|NCT01022112|584289431|FG000|Overall Study|Fasting plasma glucose level increased|1|||
161794111|NCT01022112|584289432|FG001|Overall Study|Fasting plasma glucose level increased|0|||
161794112|NCT01022112|584289433|FG002|Overall Study|Fasting plasma glucose level increased|0|||
161794113|NCT01022112|584289434|FG003|Overall Study|Fasting plasma glucose level increased|0|||
161794114|NCT01022112|584289435|FG004|Overall Study|Fasting plasma glucose level increased|7|||
161794115|NCT00289458|584289436|FG000|Overall Study|Death|1|||
161794116|NCT00289458|584289437|FG001|Overall Study|Death|0|||
161794117|NCT00289458|584289438|FG002|Overall Study|Death|0|||
161794118|NCT00289458|584289436|FG000|Overall Study|Physician Decision|3|||
161794119|NCT00289458|584289437|FG001|Overall Study|Physician Decision|4|||
161794120|NCT00289458|584289438|FG002|Overall Study|Physician Decision|2|||
161794121|NCT00289458|584289436|FG000|Overall Study|Withdrawal by Subject|2|||
161794122|NCT00289458|584289437|FG001|Overall Study|Withdrawal by Subject|2|||
161794123|NCT00289458|584289438|FG002|Overall Study|Withdrawal by Subject|4|||
161794124|NCT04274192|584289439|FG000|Overall Study|Protocol Violation|1|||
161794125|NCT04274192|584289440|FG001|Overall Study|Protocol Violation|0|||
161794126|NCT07174544|584289441|FG000|Overall Study|Lost to Follow-up|43|||
161794127|NCT07174544|584289442|FG001|Overall Study|Lost to Follow-up|15|||
161794128|NCT03419234|584289443|FG000|Overall Study|Disease progression|37|||
161794129|NCT03419234|584289444|FG001|Overall Study|Disease progression|36|||
161794130|NCT03419234|584289443|FG000|Overall Study|Adverse Event|6|||
161794131|NCT03419234|584289444|FG001|Overall Study|Adverse Event|9|||
161794132|NCT03419234|584289443|FG000|Overall Study|Withdrawal by Subject|9|||
162132750|NCT00495469|585538928|FG002|Overall Study|Adverse Event|3|||
162132751|NCT00495469|585538929|FG003|Overall Study|Adverse Event|0|||
162132752|NCT00495469|585538930|FG004|Overall Study|Adverse Event|1|||
162132753|NCT00495469|585538931|FG005|Overall Study|Adverse Event|1|||
162132754|NCT00495469|585538932|FG006|Overall Study|Adverse Event|1|||
162132755|NCT00495469|585538926|FG000|Overall Study|Lost to Follow-up|1|||
162132756|NCT00495469|585538927|FG001|Overall Study|Lost to Follow-up|1|||
162132757|NCT00495469|585538928|FG002|Overall Study|Lost to Follow-up|3|||
162132758|NCT00495469|585538929|FG003|Overall Study|Lost to Follow-up|1|||
162132759|NCT00495469|585538930|FG004|Overall Study|Lost to Follow-up|0|||
162132760|NCT00495469|585538931|FG005|Overall Study|Lost to Follow-up|0|||
162132761|NCT00495469|585538932|FG006|Overall Study|Lost to Follow-up|0|||
162132762|NCT00495469|585538926|FG000|Overall Study|Protocol Violation|0|||
162132763|NCT00495469|585538927|FG001|Overall Study|Protocol Violation|0|||
162132764|NCT00495469|585538928|FG002|Overall Study|Protocol Violation|0|||
162132765|NCT00495469|585538929|FG003|Overall Study|Protocol Violation|0|||
162132766|NCT00495469|585538930|FG004|Overall Study|Protocol Violation|1|||
162132767|NCT00495469|585538931|FG005|Overall Study|Protocol Violation|2|||
161794133|NCT03419234|584289444|FG001|Overall Study|Withdrawal by Subject|7|||
161794134|NCT03419234|584289443|FG000|Overall Study|Death|5|||
161794135|NCT03419234|584289444|FG001|Overall Study|Death|1|||
161794136|NCT03419234|584289443|FG000|Overall Study|Alternative therapy|4|||
161794137|NCT03419234|584289444|FG001|Overall Study|Alternative therapy|2|||
161794138|NCT03419234|584289443|FG000|Overall Study|PSA progression|8|||
161794139|NCT03419234|584289444|FG001|Overall Study|PSA progression|10|||
161794140|NCT03419234|584289443|FG000|Overall Study|Rising PSA and bone issues|3|||
161794141|NCT03419234|584289444|FG001|Overall Study|Rising PSA and bone issues|2|||
161794142|NCT03419234|584289443|FG000|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|10|||
162132768|NCT00495469|585538932|FG006|Overall Study|Protocol Violation|0|||
162132769|NCT00495469|585538926|FG000|Overall Study|Withdrawal by Subject|5|||
162132770|NCT00495469|585538927|FG001|Overall Study|Withdrawal by Subject|3|||
162132771|NCT00495469|585538928|FG002|Overall Study|Withdrawal by Subject|1|||
161899879|NCT02028507|584681032|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
161899880|NCT02028507|584681033|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
161899881|NCT03361306|584681034|FG000|Overall Study|Death|6|||
161899882|NCT01556932|584681035|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
161899883|NCT01556932|584681036|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
161899884|NCT02105285|584681041|FG000|Overall Study|Adverse Event|1|||
161899885|NCT02105285|584681042|FG001|Overall Study|Adverse Event|1|||
161899886|NCT02105285|584681043|FG002|Overall Study|Adverse Event|0|||
161899887|NCT02105285|584681041|FG000|Overall Study|Protocol Violation|0|||
161899888|NCT02105285|584681042|FG001|Overall Study|Protocol Violation|1|||
161899889|NCT02105285|584681043|FG002|Overall Study|Protocol Violation|0|||
161899890|NCT02105285|584681041|FG000|Overall Study|Withdrawal by Subject|1|||
161899891|NCT02105285|584681042|FG001|Overall Study|Withdrawal by Subject|0|||
161899892|NCT02105285|584681043|FG002|Overall Study|Withdrawal by Subject|0|||
161899893|NCT01421641|584681044|FG000|Overall Study|Protocol Violation|2|||
161899894|NCT01421641|584681045|FG001|Overall Study|Protocol Violation|2|||
161899895|NCT02420119|584681046|FG000|Overall Study|insufficient laboratory data|5|||
161899896|NCT01502033|584681047|FG000|Overall Study|1 participant had scalp discomfort|1|||
161899897|NCT01502033|584681047|FG000|Overall Study|1 participant had worsening depression|1|||
161899898|NCT01502033|584681047|FG000|Overall Study|1 participant went back to school|1|||
161899899|NCT02983045|584681048|FG000|Overall Study|Withdrawal by Subject|0|||
161899900|NCT02983045|584681049|FG001|Overall Study|Withdrawal by Subject|1|||
161899901|NCT02983045|584681050|FG002|Overall Study|Withdrawal by Subject|0|||
161899902|NCT02983045|584681051|FG003|Overall Study|Withdrawal by Subject|5|||
161899903|NCT02983045|584681052|FG004|Overall Study|Withdrawal by Subject|0|||
161899904|NCT02983045|584681053|FG005|Overall Study|Withdrawal by Subject|72|||
161899905|NCT02983045|584681054|FG006|Overall Study|Withdrawal by Subject|0|||
161899906|NCT02983045|584681055|FG007|Overall Study|Withdrawal by Subject|0|||
161899907|NCT02983045|584681056|FG008|Overall Study|Withdrawal by Subject|0|||
161899908|NCT02983045|584681057|FG009|Overall Study|Withdrawal by Subject|2|||
161899909|NCT02983045|584681048|FG000|Overall Study|Lost to Follow-up|0|||
161899910|NCT02983045|584681049|FG001|Overall Study|Lost to Follow-up|0|||
161899911|NCT02983045|584681050|FG002|Overall Study|Lost to Follow-up|0|||
161899912|NCT02983045|584681051|FG003|Overall Study|Lost to Follow-up|0|||
161899913|NCT02983045|584681052|FG004|Overall Study|Lost to Follow-up|0|||
161899914|NCT02983045|584681053|FG005|Overall Study|Lost to Follow-up|10|||
161899915|NCT02983045|584681054|FG006|Overall Study|Lost to Follow-up|0|||
161899916|NCT02983045|584681055|FG007|Overall Study|Lost to Follow-up|0|||
161899917|NCT02983045|584681056|FG008|Overall Study|Lost to Follow-up|0|||
161899918|NCT02983045|584681057|FG009|Overall Study|Lost to Follow-up|0|||
161899919|NCT00991289|584681058|FG000|Overall Study|Adverse Event|1|||
161899920|NCT00991289|584681058|FG000|Overall Study|Physician Decision|2|||
161899921|NCT00991289|584681058|FG000|Overall Study|Withdrawal by Subject|3|||
161899922|NCT00991289|584681058|FG000|Overall Study|Lost to Follow-up|4|||
161899923|NCT00991289|584681058|FG000|Overall Study|Protocol Violation|2|||
161899924|NCT01051817|584681073|FG000|Overall Study|Adverse Event|0|||
161899925|NCT01051817|584681074|FG001|Overall Study|Adverse Event|2|||
161899926|NCT01051817|584681073|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
161899927|NCT01051817|584681074|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
161899928|NCT01051817|584681073|FG000|Overall Study|Withdrawal by Subject|3|||
161899929|NCT01051817|584681074|FG001|Overall Study|Withdrawal by Subject|5|||
161899930|NCT01051817|584681073|FG000|Overall Study|Protocol Violation|0|||
161899931|NCT01051817|584681074|FG001|Overall Study|Protocol Violation|1|||
161899932|NCT02472886|584681076|FG000|Overall Study|Lack of Efficacy|0|||
161899933|NCT02472886|584681077|FG001|Overall Study|Lack of Efficacy|2|||
161899934|NCT02472886|584681078|FG002|Overall Study|Lack of Efficacy|1|||
161899935|NCT04346199|584681079|FG000|Overall Study|Death|8|||
161899936|NCT04346199|584681080|FG001|Overall Study|Death|9|||
161899937|NCT04346199|584681079|FG000|Overall Study|Lost to Follow-up|0|||
161899938|NCT04346199|584681080|FG001|Overall Study|Lost to Follow-up|1|||
161899939|NCT04346199|584681079|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
161899940|NCT04346199|584681080|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
161899941|NCT04346199|584681079|FG000|Overall Study|Withdrawal by Subject|5|||
161899942|NCT04346199|584681080|FG001|Overall Study|Withdrawal by Subject|1|||
161899943|NCT00627926|584681081|FG000|Overall Study|Adverse Event|26|||
161899944|NCT00627926|584681082|FG001|Overall Study|Adverse Event|37|||
161899945|NCT00627926|584681083|FG002|Overall Study|Adverse Event|36|||
161899946|NCT00627926|584681081|FG000|Overall Study|Death|1|||
161899947|NCT00627926|584681082|FG001|Overall Study|Death|0|||
161899948|NCT00627926|584681083|FG002|Overall Study|Death|0|||
161899949|NCT00627926|584681081|FG000|Overall Study|Lost to Follow-up|4|||
161899950|NCT00627926|584681082|FG001|Overall Study|Lost to Follow-up|3|||
161899951|NCT00627926|584681083|FG002|Overall Study|Lost to Follow-up|4|||
161899952|NCT00627926|584681081|FG000|Overall Study|Withdrawal by Subject|2|||
161899953|NCT00627926|584681082|FG001|Overall Study|Withdrawal by Subject|1|||
161899954|NCT00627926|584681083|FG002|Overall Study|Withdrawal by Subject|0|||
161899955|NCT00627926|584681081|FG000|Overall Study|Lack of Efficacy|118|||
161899956|NCT00627926|584681082|FG001|Overall Study|Lack of Efficacy|40|||
161899957|NCT00627926|584681083|FG002|Overall Study|Lack of Efficacy|38|||
161899958|NCT00627926|584681081|FG000|Overall Study|Noncompliance/unspecified|8|||
161899959|NCT00627926|584681082|FG001|Overall Study|Noncompliance/unspecified|23|||
161899960|NCT00627926|584681083|FG002|Overall Study|Noncompliance/unspecified|17|||
161899961|NCT03414229|584681084|FG000|Overall Study|Adverse Event|1|||
161899962|NCT03414229|584681085|FG001|Overall Study|Adverse Event|0|||
161899963|NCT03414229|584681086|FG002|Overall Study|Adverse Event|2|||
161899964|NCT03414229|584681087|FG003|Overall Study|Adverse Event|1|||
161899965|NCT03414229|584681084|FG000|Overall Study|Lack of Efficacy|7|||
161899966|NCT03414229|584681085|FG001|Overall Study|Lack of Efficacy|4|||
161899967|NCT03414229|584681086|FG002|Overall Study|Lack of Efficacy|1|||
161899968|NCT03414229|584681087|FG003|Overall Study|Lack of Efficacy|9|||
161899969|NCT03414229|584681084|FG000|Overall Study|Change in therapy|1|||
161899970|NCT03414229|584681085|FG001|Overall Study|Change in therapy|0|||
161899971|NCT03414229|584681086|FG002|Overall Study|Change in therapy|0|||
161899972|NCT03414229|584681087|FG003|Overall Study|Change in therapy|0|||
161899973|NCT03414229|584681084|FG000|Overall Study|Pregnancy|0|||
161899974|NCT03414229|584681085|FG001|Overall Study|Pregnancy|0|||
161899975|NCT03414229|584681086|FG002|Overall Study|Pregnancy|1|||
161899976|NCT03414229|584681087|FG003|Overall Study|Pregnancy|0|||
161899977|NCT03414229|584681084|FG000|Overall Study|Withdrawal by Subject|0|||
161899978|NCT03414229|584681085|FG001|Overall Study|Withdrawal by Subject|1|||
161899979|NCT03414229|584681086|FG002|Overall Study|Withdrawal by Subject|1|||
161899980|NCT03414229|584681087|FG003|Overall Study|Withdrawal by Subject|0|||
161899981|NCT04533438|584681088|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
161899982|NCT04533438|584681089|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
161899983|NCT05568797|584681092|FG000|Overall Study|Adverse Event|0|||
161899984|NCT05568797|584681093|FG001|Overall Study|Adverse Event|8|||
161794143|NCT03419234|584289444|FG001|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|16|||
161794144|NCT03419234|584289443|FG000|Overall Study|Physician Decision|12|||
161794145|NCT03419234|584289444|FG001|Overall Study|Physician Decision|11|||
161794146|NCT03419234|584289443|FG000|Overall Study|Second malignancy|1|||
161794147|NCT03419234|584289444|FG001|Overall Study|Second malignancy|0|||
161794148|NCT03419234|584289443|FG000|Overall Study|Insurance status change/patient could not afford|2|||
161794149|NCT03419234|584289444|FG001|Overall Study|Insurance status change/patient could not afford|1|||
161794150|NCT03419234|584289443|FG000|Overall Study|Non-compliance|1|||
161794151|NCT03419234|584289444|FG001|Overall Study|Non-compliance|3|||
161794152|NCT03419234|584289443|FG000|Overall Study|Mistakenly off treatment|1|||
161794153|NCT03419234|584289444|FG001|Overall Study|Mistakenly off treatment|0|||
161794154|NCT03419234|584289443|FG000|Overall Study|Transition to hospice|1|||
161794155|NCT03419234|584289444|FG001|Overall Study|Transition to hospice|0|||
161794156|NCT03419234|584289443|FG000|Overall Study|Still on treatment|9|||
161794157|NCT03419234|584289444|FG001|Overall Study|Still on treatment|8|||
161794158|NCT03419234|584289443|FG000|Overall Study|Never received protocol therapy|2|||
161794159|NCT03419234|584289444|FG001|Overall Study|Never received protocol therapy|4|||
161794160|NCT03419234|584289443|FG000|Overall Study|Other complicating disease|0|||
161794161|NCT03419234|584289444|FG001|Overall Study|Other complicating disease|1|||
161794162|NCT03419234|584289443|FG000|Overall Study|patient switched from prednisone to another steroid|0|||
161794163|NCT03419234|584289444|FG001|Overall Study|patient switched from prednisone to another steroid|1|||
161794164|NCT04680052|584290947|FG000|Overall Study|Ongoing|244|||
161794165|NCT04680052|584290948|FG001|Overall Study|Ongoing|229|||
161794166|NCT04680052|584290949|FG002|Overall Study|Ongoing|39|||
161794167|NCT04680052|584290950|FG003|Overall Study|Ongoing|46|||
161794168|NCT04680052|584290947|FG000|Overall Study|Death|15|||
161794169|NCT04680052|584290948|FG001|Overall Study|Death|22|||
161794170|NCT04680052|584290949|FG002|Overall Study|Death|7|||
161794171|NCT04680052|584290950|FG003|Overall Study|Death|1|||
161794172|NCT04680052|584290947|FG000|Overall Study|Lost to Follow-up|3|||
161794173|NCT04680052|584290948|FG001|Overall Study|Lost to Follow-up|2|||
161899985|NCT05568797|584681092|FG000|Overall Study|Lost to Follow-up|2|||
161899986|NCT05568797|584681093|FG001|Overall Study|Lost to Follow-up|3|||
161899987|NCT05568797|584681092|FG000|Overall Study|Withdrawal by Subject|1|||
161899988|NCT05568797|584681093|FG001|Overall Study|Withdrawal by Subject|10|||
161899989|NCT05568797|584681092|FG000|Overall Study|Other|2|||
162010747|NCT02054104|585095976|FG001|Overall Study|Did not want to continue due to college classes|0|||
162010748|NCT02054104|585095975|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
161794174|NCT04680052|584290949|FG002|Overall Study|Lost to Follow-up|0|||
161794175|NCT04680052|584290950|FG003|Overall Study|Lost to Follow-up|1|||
161794176|NCT04680052|584290947|FG000|Overall Study|Withdrawal by Subject|11|||
161899990|NCT05568797|584681093|FG001|Overall Study|Other|2|||
161899991|NCT02401035|584681095|FG000|Overall Study|Withdrawal by Subject|1|||
161899992|NCT02401035|584681096|FG001|Overall Study|Withdrawal by Subject|0|||
161899993|NCT00869128|584681097|FG000|Overall Study|lack of Compliance|6|||
161899994|NCT00869128|584681098|FG001|Overall Study|lack of Compliance|6|||
161899995|NCT00985686|584681104|FG000|Overall Study|Lost to Follow-up|1|||
161794177|NCT04680052|584290948|FG001|Overall Study|Withdrawal by Subject|19|||
161794178|NCT04680052|584290949|FG002|Overall Study|Withdrawal by Subject|7|||
161794179|NCT04680052|584290950|FG003|Overall Study|Withdrawal by Subject|5|||
161794180|NCT04680052|584290947|FG000|Overall Study|Missing|0|||
161794181|NCT04680052|584290948|FG001|Overall Study|Missing|1|||
161794182|NCT04680052|584290949|FG002|Overall Study|Missing|0|||
161794183|NCT04680052|584290950|FG003|Overall Study|Missing|0|||
161794184|NCT04680052|584290947|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
161794185|NCT04680052|584290948|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
161794186|NCT04680052|584290949|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
161794187|NCT04680052|584290950|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
161794188|NCT04680052|584290947|FG000|Overall Study|Physician Decision|0|||
161794189|NCT04680052|584290948|FG001|Overall Study|Physician Decision|1|||
161794190|NCT04680052|584290949|FG002|Overall Study|Physician Decision|0|||
161794191|NCT04680052|584290950|FG003|Overall Study|Physician Decision|0|||
161794192|NCT00759148|584290952|FG000|Overall Study|Adverse Event|1|||
161794193|NCT00759148|584290953|FG001|Overall Study|Adverse Event|6|||
161794194|NCT00759148|584290952|FG000|Overall Study|Withdrawal by Subject|3|||
161794195|NCT00759148|584290953|FG001|Overall Study|Withdrawal by Subject|7|||
161794196|NCT00759148|584290952|FG000|Overall Study|Lost to Follow-up|3|||
161794197|NCT00759148|584290953|FG001|Overall Study|Lost to Follow-up|9|||
161794198|NCT00759148|584290952|FG000|Overall Study|Treatment Failure|6|||
161794199|NCT00759148|584290953|FG001|Overall Study|Treatment Failure|10|||
161794200|NCT00759148|584290952|FG000|Overall Study|Reason not given|1|||
161794201|NCT00759148|584290953|FG001|Overall Study|Reason not given|0|||
161794202|NCT01073020|584290954|FG000|Overall Study|Withdrawal by Subject|6|||
161794203|NCT01073020|584290955|FG001|Overall Study|Withdrawal by Subject|4|||
161794204|NCT01073020|584290956|FG002|Overall Study|Withdrawal by Subject|1|||
161794205|NCT01073020|584290957|FG003|Overall Study|Withdrawal by Subject|2|||
161794206|NCT01073020|584290954|FG000|Overall Study|Physician Decision|1|||
161794207|NCT01073020|584290955|FG001|Overall Study|Physician Decision|0|||
161794208|NCT01073020|584290956|FG002|Overall Study|Physician Decision|2|||
161794209|NCT01073020|584290957|FG003|Overall Study|Physician Decision|0|||
161794210|NCT01073020|584290954|FG000|Overall Study|Death|0|||
161794211|NCT01073020|584290955|FG001|Overall Study|Death|1|||
161794212|NCT01073020|584290956|FG002|Overall Study|Death|0|||
161794213|NCT01073020|584290957|FG003|Overall Study|Death|0|||
161794214|NCT00094302|584290960|FG000|Overall Study|Lost to Follow-up|43|||
161794215|NCT00094302|584290961|FG001|Overall Study|Lost to Follow-up|41|||
161794216|NCT00094302|584290960|FG000|Overall Study|Physician Decision|5|||
161794217|NCT00094302|584290961|FG001|Overall Study|Physician Decision|8|||
161794218|NCT00094302|584290960|FG000|Overall Study|Withdrawal by Subject|103|||
161794219|NCT00094302|584290961|FG001|Overall Study|Withdrawal by Subject|111|||
161794220|NCT00094302|584290960|FG000|Overall Study|Death|266|||
161794221|NCT00094302|584290961|FG001|Overall Study|Death|246|||
161794222|NCT03329027|584290964|FG000|Overall Study|Lost to Follow-up|1|||
161794223|NCT03329027|584290965|FG001|Overall Study|Lost to Follow-up|0|||
161794224|NCT03329027|584290966|FG002|Overall Study|Lost to Follow-up|1|||
161794225|NCT03329027|584290964|FG000|Overall Study|Protocol Violation|9|||
161794226|NCT03329027|584290965|FG001|Overall Study|Protocol Violation|5|||
161794227|NCT03329027|584290966|FG002|Overall Study|Protocol Violation|7|||
161794228|NCT02761980|584290971|FG000|Overall Study|Adverse Event|4|||
161794229|NCT02761980|584290972|FG001|Overall Study|Adverse Event|6|||
161794230|NCT02761980|584290973|FG002|Overall Study|Adverse Event|5|||
161794231|NCT02761980|584290974|FG003|Overall Study|Adverse Event|6|||
161794232|NCT02761980|584290971|FG000|Overall Study|Withdrawal by Subject|0|||
161794233|NCT02761980|584290972|FG001|Overall Study|Withdrawal by Subject|1|||
161794234|NCT02761980|584290973|FG002|Overall Study|Withdrawal by Subject|0|||
161794235|NCT02761980|584290974|FG003|Overall Study|Withdrawal by Subject|0|||
161794236|NCT02761980|584290971|FG000|Overall Study|Other|0|||
161794237|NCT02761980|584290972|FG001|Overall Study|Other|0|||
161794238|NCT02761980|584290973|FG002|Overall Study|Other|1|||
161794239|NCT02761980|584290974|FG003|Overall Study|Other|0|||
161794240|NCT00101582|584290979|FG000|Overall Study|Ineligibility determined|0|||
161794241|NCT00101582|584290980|FG001|Overall Study|Ineligibility determined|1|||
161794242|NCT00101582|584290979|FG000|Overall Study|Adverse Event|1|||
161794243|NCT00101582|584290980|FG001|Overall Study|Adverse Event|4|||
161794244|NCT00101582|584290979|FG000|Overall Study|Withdrawal by Subject|6|||
161794245|NCT00101582|584290980|FG001|Overall Study|Withdrawal by Subject|4|||
161794246|NCT00101582|584290979|FG000|Overall Study|Physician Decision|1|||
161794247|NCT00101582|584290980|FG001|Overall Study|Physician Decision|0|||
161794248|NCT00101582|584290979|FG000|Overall Study|Death|3|||
161794249|NCT00101582|584290980|FG001|Overall Study|Death|5|||
161794250|NCT00101582|584290979|FG000|Overall Study|Other|0|||
161794251|NCT00101582|584290980|FG001|Overall Study|Other|1|||
161794252|NCT01907087|584290981|FG000|Overall Study|Withdrawal by Subject|1|||
161794253|NCT01919190|584290982|FG000|Overall Study|Intra-op findings, etc.|3|||
161794254|NCT01919190|584290983|FG001|Overall Study|Intra-op findings, etc.|0|||
161794255|NCT03355742|584290984|FG000|Overall Study|Lost to Follow-up|4|||
161899996|NCT00985686|584681105|FG001|Overall Study|Lost to Follow-up|1|||
161899997|NCT00985686|584681106|FG002|Overall Study|Lost to Follow-up|0|||
161899998|NCT00985686|584681107|FG003|Overall Study|Lost to Follow-up|2|||
161899999|NCT01118663|584681108|FG000|Overall Study|Adverse Event|2|||
161900000|NCT01118663|584681109|FG001|Overall Study|Adverse Event|1|||
161900001|NCT01118663|584681108|FG000|Overall Study|Withdrawal by Subject|0|||
161900002|NCT01118663|584681109|FG001|Overall Study|Withdrawal by Subject|1|||
161900003|NCT03046953|584681116|FG000|Overall Study|Relapse/progressive disease|21|||
161900004|NCT03046953|584681116|FG000|Overall Study|Death|2|||
161900005|NCT03046953|584681116|FG000|Overall Study|Withdrawal by Subject|3|||
161900006|NCT04039204|584681117|FG000|Overall Study|Withdrawal by Subject|0|||
161900007|NCT04039204|584681118|FG001|Overall Study|Withdrawal by Subject|2|||
161900008|NCT00396383|584681126|FG000|Overall Study|Death|2|||
161900009|NCT00396383|584681126|FG000|Overall Study|Lost to Follow-up|1|||
161900010|NCT02385110|584681129|FG000|Overall Study|Early Death|1|||
161900011|NCT02385110|584681130|FG001|Overall Study|Early Death|0|||
161900012|NCT03472521|584681131|FG000|Overall Study|Lost to Follow-up|3|||
161900013|NCT03472521|584681132|FG001|Overall Study|Lost to Follow-up|2|||
161900014|NCT03472521|584681131|FG000|Overall Study|Discontinued intervention|3|||
161900015|NCT03472521|584681132|FG001|Overall Study|Discontinued intervention|1|||
161900016|NCT00534638|584681133|FG000|Overall Study|Withdrawal by Subject|3|||
161900017|NCT00534638|584681134|FG001|Overall Study|Withdrawal by Subject|4|||
161900018|NCT00534638|584681133|FG000|Overall Study|Migrated/moved from study area|13|||
161900019|NCT00534638|584681134|FG001|Overall Study|Migrated/moved from study area|11|||
161900020|NCT00534638|584681133|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
161900021|NCT00534638|584681134|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
161900022|NCT00534638|584681133|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
161900023|NCT00534638|584681134|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
161900024|NCT00534638|584681133|FG000|Overall Study|Other|1685|||
161900025|NCT00534638|584681134|FG001|Overall Study|Other|902|||
161900026|NCT01237327|584681135|FG000|Overall Study|Protocol Violation: Core Study|1|||
161900027|NCT01237327|584681136|FG001|Overall Study|Protocol Violation: Core Study|0|||
161900028|NCT01237327|584681135|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
161900029|NCT01237327|584681136|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
161900030|NCT01237327|584681135|FG000|Overall Study|Progression of Disease: Core Study|18|||
161900031|NCT01237327|584681136|FG001|Overall Study|Progression of Disease: Core Study|22|||
161900032|NCT01237327|584681135|FG000|Overall Study|Progression of Disease: Extension Study|15|||
161794256|NCT03355742|584290984|FG000|Overall Study|Withdrawal by Subject|29|||
161794257|NCT03355742|584290984|FG000|Overall Study|Physician Decision|6|||
161794258|NCT03355742|584290984|FG000|Overall Study|Death|55|||
161794259|NCT03355742|584290984|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
161794260|NCT02207621|584290986|FG000|Overall Study|Adverse Event|71|||
161794261|NCT02207621|584290987|FG001|Overall Study|Adverse Event|15|||
161794262|NCT02207621|584290988|FG002|Overall Study|Adverse Event|132|||
161794263|NCT02207621|584290986|FG000|Overall Study|Withdrawal by Subject|9|||
161794264|NCT02207621|584290987|FG001|Overall Study|Withdrawal by Subject|9|||
161794265|NCT02207621|584290988|FG002|Overall Study|Withdrawal by Subject|13|||
161794266|NCT02207621|584290986|FG000|Overall Study|Non-Compliant|3|||
161794267|NCT02207621|584290987|FG001|Overall Study|Non-Compliant|3|||
161794268|NCT02207621|584290988|FG002|Overall Study|Non-Compliant|1|||
161794269|NCT02207621|584290986|FG000|Overall Study|Lost to Follow-up|1|||
161794270|NCT02207621|584290987|FG001|Overall Study|Lost to Follow-up|0|||
161794271|NCT02207621|584290988|FG002|Overall Study|Lost to Follow-up|3|||
161794272|NCT02207621|584290986|FG000|Overall Study|Lack of Efficacy|10|||
161794273|NCT02207621|584290987|FG001|Overall Study|Lack of Efficacy|2|||
161794274|NCT02207621|584290988|FG002|Overall Study|Lack of Efficacy|4|||
161794275|NCT02207621|584290986|FG000|Overall Study|Disallowed Concurrent Medication|2|||
161794276|NCT02207621|584290987|FG001|Overall Study|Disallowed Concurrent Medication|5|||
161794277|NCT02207621|584290988|FG002|Overall Study|Disallowed Concurrent Medication|2|||
161794278|NCT02207621|584290986|FG000|Overall Study|Physician Decision|1|||
161794279|NCT02207621|584290987|FG001|Overall Study|Physician Decision|2|||
161794280|NCT02207621|584290988|FG002|Overall Study|Physician Decision|2|||
161900033|NCT01237327|584681136|FG001|Overall Study|Progression of Disease: Extension Study|13|||
161900034|NCT01237327|584681135|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
161900035|NCT01237327|584681136|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
161794281|NCT02207621|584290986|FG000|Overall Study|Protocol Violation|4|||
161794282|NCT02207621|584290987|FG001|Overall Study|Protocol Violation|10|||
161794283|NCT02207621|584290988|FG002|Overall Study|Protocol Violation|6|||
161794284|NCT02207621|584290986|FG000|Overall Study|Death|2|||
161794285|NCT02207621|584290987|FG001|Overall Study|Death|0|||
161794286|NCT02207621|584290988|FG002|Overall Study|Death|0|||
161794287|NCT02207621|584290986|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
161900036|NCT01237327|584681135|FG000|Overall Study|Withdrawal by Subject|1|||
161900037|NCT01237327|584681136|FG001|Overall Study|Withdrawal by Subject|3|||
161900038|NCT01237327|584681135|FG000|Overall Study|Lost to Follow-up|3|||
161900039|NCT01237327|584681136|FG001|Overall Study|Lost to Follow-up|0|||
161794288|NCT02207621|584290987|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
161794289|NCT02207621|584290988|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
161794290|NCT02848599|584290989|FG000|Overall Study|Protocol Violation|7|||
161794291|NCT02848599|584290990|FG001|Overall Study|Protocol Violation|9|||
161900040|NCT04980014|584682886|FG000|Overall Study|Participants who are Duplicated|1|||
161900041|NCT04980014|584682886|FG000|Overall Study|Follow-up Failure|13|||
161900042|NCT04980014|584682886|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
162132772|NCT00495469|585538929|FG003|Overall Study|Withdrawal by Subject|3|||
162132773|NCT00495469|585538930|FG004|Overall Study|Withdrawal by Subject|3|||
162132774|NCT00495469|585538931|FG005|Overall Study|Withdrawal by Subject|2|||
161794292|NCT01829464|584290999|FG000|Overall Study|Adverse Event|1|||
161794293|NCT01829464|584291000|FG001|Overall Study|Adverse Event|0|||
161794294|NCT01829464|584291001|FG002|Overall Study|Adverse Event|0|||
161794295|NCT01829464|584290999|FG000|Overall Study|Lost to Follow-up|0|||
161794296|NCT01829464|584291000|FG001|Overall Study|Lost to Follow-up|0|||
161794297|NCT01829464|584291001|FG002|Overall Study|Lost to Follow-up|1|||
161794298|NCT01829464|584290999|FG000|Overall Study|Withdrawal by Subject|2|||
161794299|NCT01829464|584291000|FG001|Overall Study|Withdrawal by Subject|0|||
161794300|NCT01829464|584291001|FG002|Overall Study|Withdrawal by Subject|0|||
161794301|NCT01829464|584290999|FG000|Overall Study|Study terminated by sponsor|25|||
161794302|NCT01829464|584291000|FG001|Overall Study|Study terminated by sponsor|28|||
161794303|NCT01829464|584291001|FG002|Overall Study|Study terminated by sponsor|25|||
161794304|NCT01829464|584290999|FG000|Overall Study|Lack of Efficacy|0|||
161794305|NCT01829464|584291000|FG001|Overall Study|Lack of Efficacy|1|||
161794306|NCT01829464|584291001|FG002|Overall Study|Lack of Efficacy|0|||
161794307|NCT00635778|584291006|FG000|Overall Study|Adverse Event|1|||
161794308|NCT00635778|584291007|FG001|Overall Study|Adverse Event|0|||
161794309|NCT00635778|584291008|FG002|Overall Study|Adverse Event|0|||
161794310|NCT00635778|584291009|FG003|Overall Study|Adverse Event|3|||
161794311|NCT00635778|584291010|FG004|Overall Study|Adverse Event|3|||
161794312|NCT00635778|584291011|FG005|Overall Study|Adverse Event|6|||
161794313|NCT00635778|584291012|FG006|Overall Study|Adverse Event|1|||
161794314|NCT00635778|584291006|FG000|Overall Study|Withdrawal by Subject|0|||
161794315|NCT00635778|584291007|FG001|Overall Study|Withdrawal by Subject|0|||
161794316|NCT00635778|584291008|FG002|Overall Study|Withdrawal by Subject|0|||
161794317|NCT00635778|584291009|FG003|Overall Study|Withdrawal by Subject|1|||
161794318|NCT00635778|584291010|FG004|Overall Study|Withdrawal by Subject|0|||
161794319|NCT00635778|584291011|FG005|Overall Study|Withdrawal by Subject|1|||
161794320|NCT00635778|584291012|FG006|Overall Study|Withdrawal by Subject|1|||
162132775|NCT00495469|585538932|FG006|Overall Study|Withdrawal by Subject|3|||
162132776|NCT00495469|585538926|FG000|Overall Study|Lack of Efficacy|0|||
162132777|NCT00495469|585538927|FG001|Overall Study|Lack of Efficacy|0|||
162132778|NCT00495469|585538928|FG002|Overall Study|Lack of Efficacy|0|||
162132779|NCT00495469|585538929|FG003|Overall Study|Lack of Efficacy|0|||
162132780|NCT00495469|585538930|FG004|Overall Study|Lack of Efficacy|0|||
162132781|NCT00495469|585538931|FG005|Overall Study|Lack of Efficacy|0|||
162132782|NCT00495469|585538932|FG006|Overall Study|Lack of Efficacy|1|||
162132783|NCT00495469|585538926|FG000|Overall Study|Liver function test abnormality|0|||
162132784|NCT00495469|585538927|FG001|Overall Study|Liver function test abnormality|1|||
162132785|NCT00495469|585538928|FG002|Overall Study|Liver function test abnormality|0|||
162132786|NCT00495469|585538929|FG003|Overall Study|Liver function test abnormality|0|||
162132787|NCT00495469|585538930|FG004|Overall Study|Liver function test abnormality|0|||
162132788|NCT00495469|585538931|FG005|Overall Study|Liver function test abnormality|0|||
162132789|NCT00495469|585538932|FG006|Overall Study|Liver function test abnormality|0|||
162132790|NCT00495469|585538926|FG000|Overall Study|ST depression at randomisation in ECG|0|||
162132791|NCT00495469|585538927|FG001|Overall Study|ST depression at randomisation in ECG|1|||
162132792|NCT00495469|585538928|FG002|Overall Study|ST depression at randomisation in ECG|0|||
162132793|NCT00495469|585538929|FG003|Overall Study|ST depression at randomisation in ECG|0|||
162132794|NCT00495469|585538930|FG004|Overall Study|ST depression at randomisation in ECG|0|||
162132795|NCT00495469|585538931|FG005|Overall Study|ST depression at randomisation in ECG|0|||
162132796|NCT00495469|585538932|FG006|Overall Study|ST depression at randomisation in ECG|0|||
162132797|NCT00051311|585538933|FG000|Overall Study|Starting new study|0|||
162132798|NCT00051311|585538934|FG001|Overall Study|Starting new study|1|||
161794321|NCT00635778|584291006|FG000|Overall Study|Progressive disease|0|||
161794322|NCT00635778|584291007|FG001|Overall Study|Progressive disease|3|||
161794323|NCT00635778|584291008|FG002|Overall Study|Progressive disease|3|||
161794324|NCT00635778|584291009|FG003|Overall Study|Progressive disease|4|||
162132799|NCT00051311|585538933|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
162132800|NCT00051311|585538934|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
161794325|NCT00635778|584291010|FG004|Overall Study|Progressive disease|5|||
162132801|NCT00051311|585538933|FG000|Overall Study|Death of recipient|8|||
161794326|NCT00635778|584291011|FG005|Overall Study|Progressive disease|14|||
161794327|NCT00635778|584291012|FG006|Overall Study|Progressive disease|4|||
161794328|NCT00812253|584291013|FG000|Overall Study|Withdrawal by Subject|3|||
161794329|NCT00812253|584291014|FG001|Overall Study|Withdrawal by Subject|2|||
161794330|NCT00812253|584291013|FG000|Overall Study|Protocol Violation|1|||
161794331|NCT00812253|584291014|FG001|Overall Study|Protocol Violation|1|||
161794332|NCT00812253|584291013|FG000|Overall Study|Lost to Follow-up|2|||
161794333|NCT00812253|584291014|FG001|Overall Study|Lost to Follow-up|0|||
161794334|NCT04903288|584291015|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
161794335|NCT04903288|584291015|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
161794336|NCT04903288|584291015|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
161794337|NCT04903288|584291015|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
161794338|NCT00634907|584291023|FG000|Overall Study|Withdrawal by Subject|3|||
161794339|NCT00634907|584291024|FG001|Overall Study|Withdrawal by Subject|0|||
161794340|NCT00634907|584291023|FG000|Overall Study|Physician Decision|3|||
161794341|NCT00634907|584291024|FG001|Overall Study|Physician Decision|9|||
161794342|NCT00634907|584291023|FG000|Overall Study|Withdrawal by Subject|11|||
161794343|NCT00634907|584291024|FG001|Overall Study|Withdrawal by Subject|8|||
161794344|NCT01180244|584291030|FG000|Overall Study|Lack of Efficacy|0|||
161794345|NCT01180244|584291031|FG001|Overall Study|Lack of Efficacy|7|||
161794346|NCT01180244|584291030|FG000|Overall Study|Physician Decision|3|||
161794347|NCT01180244|584291031|FG001|Overall Study|Physician Decision|0|||
161794348|NCT01180244|584291030|FG000|Overall Study|Adverse Event|1|||
161794349|NCT01180244|584291031|FG001|Overall Study|Adverse Event|0|||
161794350|NCT01180244|584291030|FG000|Overall Study|Withdrawal by Subject|0|||
161794351|NCT01180244|584291031|FG001|Overall Study|Withdrawal by Subject|1|||
161794352|NCT01180244|584291030|FG000|Overall Study|Protocol Violation|1|||
161794353|NCT01180244|584291031|FG001|Overall Study|Protocol Violation|0|||
161794354|NCT01180244|584291030|FG000|Overall Study|Lost to Follow-up|1|||
161794355|NCT01180244|584291031|FG001|Overall Study|Lost to Follow-up|0|||
161794356|NCT01338636|584291032|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
161794357|NCT02385526|584291033|FG000|Overall Study|Withdrawal by Subject|0|||
161794358|NCT02385526|584291034|FG001|Overall Study|Withdrawal by Subject|2|||
161794359|NCT02385526|584291035|FG002|Overall Study|Withdrawal by Subject|0|||
161794360|NCT02385526|584291033|FG000|Overall Study|Lost to Follow-up|0|||
161794361|NCT02385526|584291034|FG001|Overall Study|Lost to Follow-up|1|||
161794362|NCT02385526|584291035|FG002|Overall Study|Lost to Follow-up|0|||
161794363|NCT02385526|584291033|FG000|Overall Study|Physician Decision|1|||
161794364|NCT02385526|584291034|FG001|Overall Study|Physician Decision|0|||
161794365|NCT02385526|584291035|FG002|Overall Study|Physician Decision|0|||
161794366|NCT02385526|584291033|FG000|Overall Study|Protocol Violation|1|||
161794367|NCT02385526|584291034|FG001|Overall Study|Protocol Violation|0|||
161794368|NCT02385526|584291035|FG002|Overall Study|Protocol Violation|0|||
161794369|NCT01595009|584291038|FG000|Core|Patients completed per protocol|85|||
161794370|NCT01595009|584291039|FG001|Core|Patients completed per protocol|44|||
161794371|NCT01595009|584291040|FG002|Core|Patients completed per protocol|0|||
161794372|NCT01595009|584291041|FG003|Core|Patients completed per protocol|0|||
161794373|NCT01595009|584291038|FG000|Core|Adverse Event|19|||
161794374|NCT01595009|584291039|FG001|Core|Adverse Event|23|||
161794375|NCT01595009|584291040|FG002|Core|Adverse Event|0|||
161794376|NCT01595009|584291041|FG003|Core|Adverse Event|0|||
161794377|NCT01595009|584291038|FG000|Core|Disease progression|14|||
161794378|NCT01595009|584291039|FG001|Core|Disease progression|26|||
161794379|NCT01595009|584291040|FG002|Core|Disease progression|0|||
161794380|NCT01595009|584291041|FG003|Core|Disease progression|0|||
161794381|NCT01595009|584291038|FG000|Core|Withdrawal by Subject|4|||
161794382|NCT01595009|584291039|FG001|Core|Withdrawal by Subject|17|||
161794383|NCT01595009|584291040|FG002|Core|Withdrawal by Subject|0|||
161794384|NCT01595009|584291041|FG003|Core|Withdrawal by Subject|0|||
161794385|NCT01595009|584291038|FG000|Core|Death|3|||
161794386|NCT01595009|584291039|FG001|Core|Death|6|||
161794387|NCT01595009|584291040|FG002|Core|Death|0|||
161794388|NCT01595009|584291041|FG003|Core|Death|0|||
161794389|NCT01595009|584291038|FG000|Core|Lost to Follow-up|1|||
161794390|NCT01595009|584291039|FG001|Core|Lost to Follow-up|2|||
161794391|NCT01595009|584291040|FG002|Core|Lost to Follow-up|0|||
161794392|NCT01595009|584291041|FG003|Core|Lost to Follow-up|0|||
161794393|NCT01595009|584291038|FG000|Core|Protocol deviation|0|||
161794394|NCT01595009|584291039|FG001|Core|Protocol deviation|1|||
161794395|NCT01595009|584291040|FG002|Core|Protocol deviation|0|||
161794396|NCT01595009|584291041|FG003|Core|Protocol deviation|0|||
161794397|NCT01595009|584291038|FG000|Core|Administrative problems|0|||
161794398|NCT01595009|584291039|FG001|Core|Administrative problems|1|||
161794399|NCT01595009|584291040|FG002|Core|Administrative problems|0|||
161794400|NCT01595009|584291041|FG003|Core|Administrative problems|0|||
161794401|NCT01595009|584291038|FG000|Extension|Administrative problems|0|||
161794402|NCT01595009|584291039|FG001|Extension|Administrative problems|0|||
161794403|NCT01595009|584291040|FG002|Extension|Administrative problems|0|||
161794404|NCT01595009|584291041|FG003|Extension|Administrative problems|1|||
161794405|NCT01595009|584291038|FG000|Extension|Patients completed per protocol|0|||
161794406|NCT01595009|584291039|FG001|Extension|Patients completed per protocol|0|||
161794407|NCT01595009|584291040|FG002|Extension|Patients completed per protocol|0|||
161794408|NCT01595009|584291041|FG003|Extension|Patients completed per protocol|2|||
161794409|NCT01595009|584291038|FG000|Extension|Disease progression|0|||
161794410|NCT01595009|584291039|FG001|Extension|Disease progression|0|||
162132802|NCT00051311|585538934|FG001|Overall Study|Death of recipient|8|||
162132803|NCT00051311|585538933|FG000|Overall Study|Recipient taken off study|4|||
162132804|NCT00051311|585538934|FG001|Overall Study|Recipient taken off study|4|||
162132805|NCT04170023|585538935|FG000|LTE Period|Withdrawal by Subject|1|||
162132806|NCT04170023|585538936|FG001|LTE Period|Withdrawal by Subject|0|||
162132807|NCT04170023|585538937|FG002|LTE Period|Withdrawal by Subject|0|||
162132808|NCT04170023|585538935|FG000|LTE Period|Study Termination|11|||
162132809|NCT04170023|585538936|FG001|LTE Period|Study Termination|11|||
162132810|NCT04170023|585538937|FG002|LTE Period|Study Termination|5|||
162132811|NCT03712098|585538938|FG000|Overall Study|Lost to Follow-up|3|||
162132812|NCT03712098|585538939|FG001|Overall Study|Lost to Follow-up|7|||
162132813|NCT03712098|585538938|FG000|Overall Study|Withdrawal by Subject|9|||
162132814|NCT03712098|585538939|FG001|Overall Study|Withdrawal by Subject|4|||
162132815|NCT03712098|585538938|FG000|Overall Study|Protocol Violation|2|||
162132816|NCT03712098|585538939|FG001|Overall Study|Protocol Violation|1|||
162132817|NCT02256969|585538940|FG000|Overall Study|Screenfailed or withdrew|2|||
162132818|NCT02256969|585538941|FG001|Overall Study|Screenfailed or withdrew|1|||
162132819|NCT02256969|585538942|FG002|Overall Study|Screenfailed or withdrew|1|||
162132820|NCT00372567|585538943|FG000|Phase 3 Study|Adverse Event|5|||
162132821|NCT00372567|585538944|FG001|Phase 3 Study|Adverse Event|1|||
162132822|NCT00372567|585538945|FG002|Phase 3 Study|Adverse Event|1|||
162132823|NCT00372567|585538943|FG000|Phase 3 Study|Death|1|||
162132824|NCT00372567|585538944|FG001|Phase 3 Study|Death|1|||
161794411|NCT01595009|584291040|FG002|Extension|Disease progression|4|||
161794412|NCT01595009|584291041|FG003|Extension|Disease progression|7|||
161794413|NCT01595009|584291038|FG000|Extension|Adverse Event|0|||
162132825|NCT00372567|585538945|FG002|Phase 3 Study|Death|0|||
162132826|NCT00372567|585538943|FG000|Phase 3 Study|Protocol Violation|0|||
162132827|NCT00372567|585538944|FG001|Phase 3 Study|Protocol Violation|0|||
162132828|NCT00372567|585538945|FG002|Phase 3 Study|Protocol Violation|1|||
162132829|NCT00372567|585538943|FG000|Phase 3 Study|Objective progression or relapse|10|||
162132830|NCT00372567|585538944|FG001|Phase 3 Study|Objective progression or relapse|13|||
162132831|NCT00372567|585538945|FG002|Phase 3 Study|Objective progression or relapse|4|||
162132832|NCT00372567|585538943|FG000|Phase 3 Study|Global deterioration of health status|0|||
162132833|NCT00372567|585538944|FG001|Phase 3 Study|Global deterioration of health status|1|||
162132834|NCT00372567|585538945|FG002|Phase 3 Study|Global deterioration of health status|0|||
162132835|NCT00372567|585538943|FG000|Phase 3 Study|Other|2|||
162132836|NCT00372567|585538944|FG001|Phase 3 Study|Other|2|||
162132837|NCT00372567|585538945|FG002|Phase 3 Study|Other|1|||
162132838|NCT00372567|585538943|FG000|Phase 3 Study|study terminated by sponsor|13|||
162132839|NCT00372567|585538944|FG001|Phase 3 Study|study terminated by sponsor|8|||
162132840|NCT00372567|585538945|FG002|Phase 3 Study|study terminated by sponsor|5|||
162132841|NCT00953160|585538948|FG000|Overall Study|Lost to Follow-up|23|||
162132842|NCT00953160|585538948|FG000|Overall Study|Withdrawal by Subject|4|||
162132843|NCT03836664|585538953|FG000|Overall Study|Didn't complete forms and lost drug|3|||
161794414|NCT01595009|584291039|FG001|Extension|Adverse Event|0|||
161794415|NCT01595009|584291040|FG002|Extension|Adverse Event|0|||
161794416|NCT01595009|584291041|FG003|Extension|Adverse Event|1|||
161794417|NCT01842958|584291044|FG000|Overall Study|Lost to Follow-up|1|||
161794418|NCT01842958|584291045|FG001|Overall Study|Lost to Follow-up|1|||
161794419|NCT01829477|584291046|FG000|Overall Study|Study Terminated by Sponsor|15|||
161794420|NCT01829477|584291047|FG001|Overall Study|Study Terminated by Sponsor|15|||
161794421|NCT01829477|584291046|FG000|Overall Study|Withdrawal by Subject|1|||
161794422|NCT01829477|584291047|FG001|Overall Study|Withdrawal by Subject|0|||
161794423|NCT03465891|584291049|FG000|Overall Study|Withdrawal by Subject|0|||
161794424|NCT03465891|584291050|FG001|Overall Study|Withdrawal by Subject|1|||
161794425|NCT03465891|584291049|FG000|Overall Study|Disease progression|1|||
161794426|NCT03465891|584291050|FG001|Overall Study|Disease progression|0|||
161794427|NCT02737306|584291052|FG000|Overall Study|Adverse Event|3|||
161794428|NCT02737306|584291053|FG001|Overall Study|Adverse Event|0|||
161794429|NCT02737306|584291052|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
161794430|NCT02737306|584291053|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
161794431|NCT03361423|584291054|FG000|Overall Study|Withdrawal by Subject|4|||
161794432|NCT03361423|584291055|FG001|Overall Study|Withdrawal by Subject|3|||
161942197|NCT02082977|584838337|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
162132844|NCT03836664|585538954|FG001|Overall Study|Didn't complete forms and lost drug|3|||
162132845|NCT01427907|585538955|FG000|Overall Study|Withdrawal by Subject|3|||
162132846|NCT01427907|585538956|FG001|Overall Study|Withdrawal by Subject|4|||
161794433|NCT03361423|584291054|FG000|Overall Study|Did not treat|19|||
161794434|NCT03361423|584291055|FG001|Overall Study|Did not treat|18|||
161794435|NCT03361423|584291054|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
161794436|NCT03361423|584291055|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
161794437|NCT03361423|584291054|FG000|Overall Study|Missing data|4|||
161794438|NCT03361423|584291055|FG001|Overall Study|Missing data|1|||
161794439|NCT00818623|584291056|FG000|Overall Study|Adverse Event|1|||
162132847|NCT00425503|585538959|FG000|Overall Study|Adverse Event|2|||
162132848|NCT00425503|585538959|FG000|Overall Study|Protocol Violation|1|||
161794440|NCT00818623|584291057|FG001|Overall Study|Adverse Event|0|||
161794441|NCT00818623|584291058|FG002|Overall Study|Adverse Event|1|||
161794442|NCT00818623|584291059|FG003|Overall Study|Adverse Event|0|||
161794443|NCT00818623|584291060|FG004|Overall Study|Adverse Event|0|||
161794444|NCT00818623|584291061|FG005|Overall Study|Adverse Event|1|||
161794445|NCT00818623|584291062|FG006|Overall Study|Adverse Event|0|||
161794446|NCT00818623|584291063|FG007|Overall Study|Adverse Event|0|||
161794447|NCT00818623|584291056|FG000|Overall Study|Bad prostate specific antigen response|0|||
161794448|NCT00818623|584291057|FG001|Overall Study|Bad prostate specific antigen response|3|||
161794449|NCT00818623|584291058|FG002|Overall Study|Bad prostate specific antigen response|2|||
161794450|NCT00818623|584291059|FG003|Overall Study|Bad prostate specific antigen response|5|||
161794451|NCT00818623|584291060|FG004|Overall Study|Bad prostate specific antigen response|0|||
161794452|NCT00818623|584291061|FG005|Overall Study|Bad prostate specific antigen response|1|||
161794453|NCT00818623|584291062|FG006|Overall Study|Bad prostate specific antigen response|0|||
161794454|NCT00818623|584291063|FG007|Overall Study|Bad prostate specific antigen response|0|||
161794455|NCT00818623|584291056|FG000|Overall Study|Withdrawal by Subject|0|||
161794456|NCT00818623|584291057|FG001|Overall Study|Withdrawal by Subject|1|||
161794457|NCT00818623|584291058|FG002|Overall Study|Withdrawal by Subject|1|||
161794458|NCT00818623|584291059|FG003|Overall Study|Withdrawal by Subject|0|||
161794459|NCT00818623|584291060|FG004|Overall Study|Withdrawal by Subject|0|||
161794460|NCT00818623|584291061|FG005|Overall Study|Withdrawal by Subject|1|||
161794461|NCT00818623|584291062|FG006|Overall Study|Withdrawal by Subject|1|||
161794462|NCT00818623|584291063|FG007|Overall Study|Withdrawal by Subject|1|||
161794463|NCT00818623|584291056|FG000|Overall Study|Protocol Violation|1|||
161794464|NCT00818623|584291057|FG001|Overall Study|Protocol Violation|0|||
161794465|NCT00818623|584291058|FG002|Overall Study|Protocol Violation|0|||
161794466|NCT00818623|584291059|FG003|Overall Study|Protocol Violation|0|||
161794467|NCT00818623|584291060|FG004|Overall Study|Protocol Violation|1|||
161794468|NCT00818623|584291061|FG005|Overall Study|Protocol Violation|0|||
161794469|NCT00818623|584291062|FG006|Overall Study|Protocol Violation|1|||
161794470|NCT00818623|584291063|FG007|Overall Study|Protocol Violation|0|||
161794471|NCT00818623|584291056|FG000|Overall Study|Need of additional treatment|0|||
161794472|NCT00818623|584291057|FG001|Overall Study|Need of additional treatment|0|||
161794473|NCT00818623|584291058|FG002|Overall Study|Need of additional treatment|0|||
161794474|NCT00818623|584291059|FG003|Overall Study|Need of additional treatment|0|||
161794475|NCT00818623|584291060|FG004|Overall Study|Need of additional treatment|1|||
161794476|NCT00818623|584291061|FG005|Overall Study|Need of additional treatment|0|||
161794477|NCT00818623|584291062|FG006|Overall Study|Need of additional treatment|0|||
161794478|NCT00818623|584291063|FG007|Overall Study|Need of additional treatment|0|||
161794479|NCT00818623|584291056|FG000|Overall Study|Lack of trial drug at site|0|||
161794480|NCT00818623|584291057|FG001|Overall Study|Lack of trial drug at site|0|||
161794481|NCT00818623|584291058|FG002|Overall Study|Lack of trial drug at site|0|||
161794482|NCT00818623|584291059|FG003|Overall Study|Lack of trial drug at site|0|||
161794483|NCT00818623|584291060|FG004|Overall Study|Lack of trial drug at site|2|||
161794484|NCT00818623|584291061|FG005|Overall Study|Lack of trial drug at site|0|||
161794485|NCT00818623|584291062|FG006|Overall Study|Lack of trial drug at site|1|||
161794486|NCT00818623|584291063|FG007|Overall Study|Lack of trial drug at site|0|||
161794487|NCT00818623|584291056|FG000|Overall Study|Disease progression|0|||
161794488|NCT00818623|584291057|FG001|Overall Study|Disease progression|0|||
161794489|NCT00818623|584291058|FG002|Overall Study|Disease progression|0|||
161794490|NCT00818623|584291059|FG003|Overall Study|Disease progression|0|||
161794491|NCT00818623|584291060|FG004|Overall Study|Disease progression|0|||
161794492|NCT00818623|584291061|FG005|Overall Study|Disease progression|0|||
161794493|NCT00818623|584291062|FG006|Overall Study|Disease progression|1|||
161794494|NCT00818623|584291063|FG007|Overall Study|Disease progression|0|||
161794495|NCT00299156|584291064|FG000|Period 2 (Randomized)|Screen Failure|0|||
161794496|NCT00299156|584291065|FG001|Period 2 (Randomized)|Screen Failure|1|||
161794497|NCT00299156|584291066|FG002|Period 2 (Randomized)|Screen Failure|0|||
161794498|NCT01166568|584291067|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
161794499|NCT01166568|584291068|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
161794500|NCT01166568|584291069|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
161794501|NCT01166568|584291067|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
161794502|NCT01166568|584291068|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
161794503|NCT01166568|584291069|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
161794504|NCT01166568|584291067|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
161794505|NCT01166568|584291068|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
161794506|NCT01166568|584291069|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
161794507|NCT02015793|584291072|FG000|Overall Study|Adverse Event|3|||
161794508|NCT02015793|584291073|FG001|Overall Study|Adverse Event|3|||
161794509|NCT02015793|584291072|FG000|Overall Study|Withdrawal by Subject|1|||
161794510|NCT02015793|584291073|FG001|Overall Study|Withdrawal by Subject|1|||
161794511|NCT00320593|584291074|FG000|Overall Study|Lost to Follow-up|3|||
161794512|NCT00320593|584291075|FG001|Overall Study|Lost to Follow-up|0|||
161794513|NCT00320593|584291074|FG000|Overall Study|Moved to another state|1|||
161794514|NCT00320593|584291075|FG001|Overall Study|Moved to another state|0|||
161794515|NCT00320593|584291074|FG000|Overall Study|Withdrawal by Subject|2|||
161794516|NCT00320593|584291075|FG001|Overall Study|Withdrawal by Subject|1|||
161794517|NCT00320593|584291074|FG000|Overall Study|Withdrawal by clinical center|1|||
161794518|NCT00320593|584291075|FG001|Overall Study|Withdrawal by clinical center|0|||
161794519|NCT01076166|584291076|FG000|Overall Study|Adverse Event|3|||
161794520|NCT01076166|584291076|FG000|Overall Study|Symptoms improved/resolved|6|||
161794521|NCT00321711|584291079|FG000|Part A|Adverse Event|3|||
161794522|NCT00321711|584291080|FG001|Part A|Adverse Event|3|||
161794523|NCT00321711|584291081|FG002|Part A|Adverse Event|2|||
161794524|NCT00321711|584291082|FG003|Part A|Adverse Event|0|||
161794525|NCT00321711|584291083|FG004|Part A|Adverse Event|0|||
161794526|NCT00321711|584291079|FG000|Part A|Withdrawal by Subject|1|||
161794527|NCT00321711|584291080|FG001|Part A|Withdrawal by Subject|1|||
161794528|NCT00321711|584291081|FG002|Part A|Withdrawal by Subject|1|||
161794529|NCT00321711|584291082|FG003|Part A|Withdrawal by Subject|0|||
161794530|NCT00321711|584291083|FG004|Part A|Withdrawal by Subject|0|||
161794531|NCT00321711|584291079|FG000|Part A|Disease progression|0|||
161794532|NCT00321711|584291080|FG001|Part A|Disease progression|1|||
161794533|NCT00321711|584291081|FG002|Part A|Disease progression|0|||
161794534|NCT00321711|584291082|FG003|Part A|Disease progression|0|||
161794535|NCT00321711|584291083|FG004|Part A|Disease progression|0|||
161794536|NCT00321711|584291079|FG000|Part A|Requirement for alternative therapy|0|||
161794537|NCT00321711|584291080|FG001|Part A|Requirement for alternative therapy|2|||
161794538|NCT00321711|584291081|FG002|Part A|Requirement for alternative therapy|1|||
161794539|NCT00321711|584291082|FG003|Part A|Requirement for alternative therapy|0|||
161794540|NCT00321711|584291083|FG004|Part A|Requirement for alternative therapy|0|||
161794541|NCT00321711|584291079|FG000|Part A|Physician Decision|0|||
161794542|NCT00321711|584291080|FG001|Part A|Physician Decision|1|||
161794543|NCT00321711|584291081|FG002|Part A|Physician Decision|3|||
161794544|NCT00321711|584291082|FG003|Part A|Physician Decision|0|||
161794545|NCT00321711|584291083|FG004|Part A|Physician Decision|0|||
161794546|NCT00321711|584291079|FG000|Part A|Other|1|||
161794547|NCT00321711|584291080|FG001|Part A|Other|2|||
161794548|NCT00321711|584291081|FG002|Part A|Other|3|||
161794549|NCT00321711|584291082|FG003|Part A|Other|0|||
161794550|NCT00321711|584291083|FG004|Part A|Other|0|||
161794551|NCT00321711|584291079|FG000|Part A|Protocol deviation|0|||
161794552|NCT00321711|584291080|FG001|Part A|Protocol deviation|0|||
161794553|NCT00321711|584291081|FG002|Part A|Protocol deviation|1|||
161794554|NCT00321711|584291082|FG003|Part A|Protocol deviation|0|||
161794555|NCT00321711|584291083|FG004|Part A|Protocol deviation|0|||
161794556|NCT00321711|584291079|FG000|Part B|Noncompliance|0|||
161794557|NCT00321711|584291080|FG001|Part B|Noncompliance|0|||
161794558|NCT00321711|584291081|FG002|Part B|Noncompliance|0|||
161794559|NCT00321711|584291082|FG003|Part B|Noncompliance|0|||
161794560|NCT00321711|584291083|FG004|Part B|Noncompliance|1|||
161794561|NCT00321711|584291079|FG000|Part B|Adverse Event|0|||
161794562|NCT00321711|584291080|FG001|Part B|Adverse Event|0|||
161794563|NCT00321711|584291081|FG002|Part B|Adverse Event|0|||
161794564|NCT00321711|584291082|FG003|Part B|Adverse Event|2|||
161794565|NCT00321711|584291083|FG004|Part B|Adverse Event|1|||
161794566|NCT00321711|584291079|FG000|Part B|Disease progression|0|||
161794567|NCT00321711|584291080|FG001|Part B|Disease progression|0|||
161794568|NCT00321711|584291081|FG002|Part B|Disease progression|0|||
161794569|NCT00321711|584291082|FG003|Part B|Disease progression|1|||
161794570|NCT00321711|584291083|FG004|Part B|Disease progression|0|||
161794571|NCT00321711|584291079|FG000|Part B|Physician Decision|0|||
161794572|NCT00321711|584291080|FG001|Part B|Physician Decision|0|||
161794573|NCT00321711|584291081|FG002|Part B|Physician Decision|0|||
161794574|NCT00321711|584291082|FG003|Part B|Physician Decision|1|||
161794575|NCT00321711|584291083|FG004|Part B|Physician Decision|2|||
161794576|NCT00321711|584291079|FG000|Part B|Death|0|||
161794577|NCT00321711|584291080|FG001|Part B|Death|0|||
162132849|NCT03890120|585538961|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
162132850|NCT03890120|585538962|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
162132851|NCT03890120|585538963|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
162132852|NCT03890120|585538964|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
162132853|NCT03890120|585538961|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
161794578|NCT00321711|584291081|FG002|Part B|Death|0|||
161794579|NCT00321711|584291082|FG003|Part B|Death|2|||
161794580|NCT00321711|584291083|FG004|Part B|Death|1|||
161794581|NCT01709383|584291088|FG000|Overall Study|Lost to Follow-up|1|||
161794582|NCT01709383|584291089|FG001|Overall Study|Lost to Follow-up|0|||
161794583|NCT03264066|584291090|FG000|Overall Study|Adverse Event|1|||
161794584|NCT03264066|584291091|FG001|Overall Study|Adverse Event|1|||
161794585|NCT03264066|584291092|FG002|Overall Study|Adverse Event|0|||
161794586|NCT03264066|584291093|FG003|Overall Study|Adverse Event|0|||
161794587|NCT03264066|584291094|FG004|Overall Study|Adverse Event|0|||
161794588|NCT03264066|584291095|FG005|Overall Study|Adverse Event|0|||
161794589|NCT03264066|584291090|FG000|Overall Study|Death|12|||
161794590|NCT03264066|584291091|FG001|Overall Study|Death|12|||
162132854|NCT03890120|585538962|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
162132855|NCT03890120|585538963|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
162132856|NCT03890120|585538964|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
162132857|NCT03890120|585538961|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
162132858|NCT03890120|585538962|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
161794591|NCT03264066|584291092|FG002|Overall Study|Death|8|||
161794592|NCT03264066|584291093|FG003|Overall Study|Death|10|||
161794593|NCT03264066|584291094|FG004|Overall Study|Death|6|||
161794594|NCT03264066|584291095|FG005|Overall Study|Death|1|||
161794595|NCT03264066|584291090|FG000|Overall Study|Lost to Follow-up|1|||
161794596|NCT03264066|584291091|FG001|Overall Study|Lost to Follow-up|0|||
161794597|NCT03264066|584291092|FG002|Overall Study|Lost to Follow-up|0|||
161794598|NCT03264066|584291093|FG003|Overall Study|Lost to Follow-up|0|||
161794599|NCT03264066|584291094|FG004|Overall Study|Lost to Follow-up|0|||
161794600|NCT03264066|584291095|FG005|Overall Study|Lost to Follow-up|0|||
161794601|NCT03264066|584291090|FG000|Overall Study|Progressive Disease|0|||
161794602|NCT03264066|584291091|FG001|Overall Study|Progressive Disease|2|||
161794603|NCT03264066|584291092|FG002|Overall Study|Progressive Disease|1|||
161794604|NCT03264066|584291093|FG003|Overall Study|Progressive Disease|0|||
161794605|NCT03264066|584291094|FG004|Overall Study|Progressive Disease|0|||
161794606|NCT03264066|584291095|FG005|Overall Study|Progressive Disease|0|||
161794607|NCT03264066|584291090|FG000|Overall Study|Study Terminated by Sponsor|5|||
161794608|NCT03264066|584291091|FG001|Overall Study|Study Terminated by Sponsor|5|||
161794609|NCT03264066|584291092|FG002|Overall Study|Study Terminated by Sponsor|8|||
161794610|NCT03264066|584291093|FG003|Overall Study|Study Terminated by Sponsor|5|||
161794611|NCT03264066|584291094|FG004|Overall Study|Study Terminated by Sponsor|1|||
161794612|NCT03264066|584291095|FG005|Overall Study|Study Terminated by Sponsor|2|||
161794613|NCT03264066|584291090|FG000|Overall Study|Withdrawal by Subject|1|||
161794614|NCT03264066|584291091|FG001|Overall Study|Withdrawal by Subject|0|||
161794615|NCT03264066|584291092|FG002|Overall Study|Withdrawal by Subject|0|||
161794616|NCT03264066|584291093|FG003|Overall Study|Withdrawal by Subject|5|||
161794617|NCT03264066|584291094|FG004|Overall Study|Withdrawal by Subject|0|||
161794618|NCT03264066|584291095|FG005|Overall Study|Withdrawal by Subject|0|||
161794619|NCT01484028|584291096|FG000|Period 1|Lost to Follow-up|0|||
161794620|NCT01484028|584291097|FG001|Period 1|Lost to Follow-up|1|||
161794621|NCT01484028|584291098|FG002|Period 1|Lost to Follow-up|0|||
161794622|NCT01484028|584291099|FG003|Period 1|Lost to Follow-up|0|||
161794623|NCT01484028|584291096|FG000|Period 1|Non-Compliance to Protocol|0|||
161794624|NCT01484028|584291097|FG001|Period 1|Non-Compliance to Protocol|1|||
161794625|NCT01484028|584291098|FG002|Period 1|Non-Compliance to Protocol|0|||
161794626|NCT01484028|584291099|FG003|Period 1|Non-Compliance to Protocol|1|||
161794627|NCT01484028|584291096|FG000|Period 1|Lens Discomfort|0|||
161794628|NCT01484028|584291097|FG001|Period 1|Lens Discomfort|1|||
161794629|NCT01484028|584291098|FG002|Period 1|Lens Discomfort|0|||
161794630|NCT01484028|584291099|FG003|Period 1|Lens Discomfort|0|||
161794631|NCT01193517|584291113|FG000|Overall Study|Early Progression|1|||
161794632|NCT01193517|584291114|FG001|Overall Study|Early Progression|0|||
161794633|NCT01193517|584291115|FG002|Overall Study|Early Progression|0|||
161794634|NCT00905489|584291116|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
161794635|NCT00905489|584291116|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
161794636|NCT00905489|584291116|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
161794637|NCT00583596|584291117|FG000|Overall Study|Lost to Follow-up|110|||
161794638|NCT00583596|584291117|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
161794639|NCT00583596|584291117|FG000|Overall Study|Death|2|||
161794640|NCT00583596|584291117|FG000|Overall Study|Withdrawal by Subject|6|||
161794641|NCT00583596|584291117|FG000|Overall Study|Lost to Follow-up|94|||
161794642|NCT00583596|584291117|FG000|Overall Study|Data not complete|1|||
161794643|NCT00583596|584291117|FG000|Overall Study|Not consented|15|||
161794644|NCT00583596|584291117|FG000|Overall Study|Outside f-up window|26|||
161794645|NCT04828161|584292262|FG000|Overall Study|Withdrawal by Subject|0|||
161794646|NCT04828161|584292263|FG001|Overall Study|Withdrawal by Subject|3|||
161794647|NCT04828161|584292264|FG002|Overall Study|Withdrawal by Subject|3|||
161794648|NCT04828161|584292265|FG003|Overall Study|Withdrawal by Subject|4|||
161794649|NCT04828161|584292262|FG000|Overall Study|Lost to Follow-up|1|||
161794650|NCT04828161|584292263|FG001|Overall Study|Lost to Follow-up|4|||
161794651|NCT04828161|584292264|FG002|Overall Study|Lost to Follow-up|2|||
161794652|NCT04828161|584292265|FG003|Overall Study|Lost to Follow-up|2|||
162132859|NCT03890120|585538963|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
162242042|NCT02616562|585939072|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162242043|NCT02616562|585939073|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161794653|NCT04828161|584292262|FG000|Overall Study|Other|2|||
161794654|NCT04828161|584292263|FG001|Overall Study|Other|0|||
161794655|NCT04828161|584292264|FG002|Overall Study|Other|2|||
161794656|NCT04828161|584292265|FG003|Overall Study|Other|0|||
161794657|NCT04828161|584292262|FG000|Overall Study|Death|0|||
161794658|NCT04828161|584292263|FG001|Overall Study|Death|0|||
161794659|NCT04828161|584292264|FG002|Overall Study|Death|0|||
161794660|NCT04828161|584292265|FG003|Overall Study|Death|2|||
161900043|NCT04980014|584682886|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
161900044|NCT04980014|584682886|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
161900045|NCT00940888|584682887|FG000|Overall Study|Unsuccessful Implant|4|||
161900046|NCT00940888|584682887|FG000|Overall Study|Death|461|||
161900047|NCT00940888|584682887|FG000|Overall Study|Withdrawn - Non-Death|364|||
161900048|NCT00940888|584682887|FG000|Overall Study|Lost to Follow-up|6|||
161900049|NCT02250300|584682891|FG000|Expansion Phase|Death|6|||
161900050|NCT02250300|584682892|FG001|Expansion Phase|Death|7|||
161900051|NCT02250300|584682893|FG002|Expansion Phase|Death|0|||
161900052|NCT02250300|584682894|FG003|Expansion Phase|Death|0|||
161900053|NCT00715559|584682896|FG000|Overall Study|medication not tolerated - nausea|1|||
161900054|NCT00758498|584682897|FG000|Overall Study|Adverse Event|2|||
161900055|NCT00758498|584682898|FG001|Overall Study|Adverse Event|2|||
161900056|NCT00758498|584682899|FG002|Overall Study|Adverse Event|3|||
161900057|NCT00758498|584682897|FG000|Overall Study|Subject legally detained out of state|1|||
161900058|NCT00758498|584682898|FG001|Overall Study|Subject legally detained out of state|0|||
161900059|NCT00758498|584682899|FG002|Overall Study|Subject legally detained out of state|0|||
161900060|NCT00758498|584682897|FG000|Overall Study|Withdrawal by Subject|0|||
161900061|NCT00758498|584682898|FG001|Overall Study|Withdrawal by Subject|0|||
161900062|NCT00758498|584682899|FG002|Overall Study|Withdrawal by Subject|1|||
161900063|NCT00758498|584682897|FG000|Overall Study|Noncompliance to study procedures|0|||
161900064|NCT00758498|584682898|FG001|Overall Study|Noncompliance to study procedures|0|||
161900065|NCT00758498|584682899|FG002|Overall Study|Noncompliance to study procedures|1|||
161900066|NCT01516736|584682901|FG000|Overall Study|Withdrawal by Subject|10|||
161900067|NCT01516736|584682902|FG001|Overall Study|Withdrawal by Subject|4|||
161900068|NCT01516736|584682901|FG000|Overall Study|Adverse Event|4|||
161900069|NCT01516736|584682902|FG001|Overall Study|Adverse Event|5|||
161900070|NCT01516736|584682901|FG000|Overall Study|Death|3|||
161900071|NCT01516736|584682902|FG001|Overall Study|Death|1|||
161900072|NCT01516736|584682901|FG000|Overall Study|Physician Decision|2|||
161900073|NCT01516736|584682902|FG001|Overall Study|Physician Decision|1|||
161900074|NCT01516736|584682901|FG000|Overall Study|Lack of Efficacy|1|||
161900075|NCT01516736|584682902|FG001|Overall Study|Lack of Efficacy|0|||
161900076|NCT01516736|584682901|FG000|Overall Study|Protocol Violation|0|||
161900077|NCT01516736|584682902|FG001|Overall Study|Protocol Violation|1|||
161900078|NCT01516736|584682901|FG000|Overall Study|Other (not specified)|0|||
161900079|NCT01516736|584682902|FG001|Overall Study|Other (not specified)|1|||
161900080|NCT02781818|584682903|FG000|Overall Study|Lost to Follow-up|4|||
161900081|NCT02781818|584682904|FG001|Overall Study|Lost to Follow-up|2|||
161900082|NCT02781818|584682905|FG002|Overall Study|Lost to Follow-up|1|||
161900083|NCT00524771|584682906|FG000|Overall Study|Protocol Violation|220|||
161900084|NCT00524771|584682907|FG001|Overall Study|Protocol Violation|585|||
161900085|NCT01877668|584682908|FG000|Overall Study|Death|0|||
161900086|NCT01877668|584682909|FG001|Overall Study|Death|0|||
161900087|NCT01877668|584682910|FG002|Overall Study|Death|0|||
161900088|NCT01877668|584682911|FG003|Overall Study|Death|1|||
161900089|NCT01877668|584682912|FG004|Overall Study|Death|0|||
161900090|NCT01877668|584682908|FG000|Overall Study|No longer met study criteria|1|||
161900091|NCT01877668|584682909|FG001|Overall Study|No longer met study criteria|0|||
161900092|NCT01877668|584682910|FG002|Overall Study|No longer met study criteria|1|||
161900093|NCT01877668|584682911|FG003|Overall Study|No longer met study criteria|0|||
161900094|NCT01877668|584682912|FG004|Overall Study|No longer met study criteria|0|||
161900095|NCT01877668|584682908|FG000|Overall Study|Insufficient clinical response|0|||
161900096|NCT01877668|584682909|FG001|Overall Study|Insufficient clinical response|1|||
161900097|NCT01877668|584682910|FG002|Overall Study|Insufficient clinical response|2|||
161900098|NCT01877668|584682911|FG003|Overall Study|Insufficient clinical response|2|||
161900099|NCT01877668|584682912|FG004|Overall Study|Insufficient clinical response|0|||
161900100|NCT01877668|584682908|FG000|Overall Study|Lost to Follow-up|0|||
161900101|NCT01877668|584682909|FG001|Overall Study|Lost to Follow-up|2|||
161900102|NCT01877668|584682910|FG002|Overall Study|Lost to Follow-up|1|||
161900103|NCT01877668|584682911|FG003|Overall Study|Lost to Follow-up|0|||
161900104|NCT01877668|584682912|FG004|Overall Study|Lost to Follow-up|0|||
161900105|NCT01877668|584682908|FG000|Overall Study|Withdrawal by Subject|2|||
161900106|NCT01877668|584682909|FG001|Overall Study|Withdrawal by Subject|0|||
161900107|NCT01877668|584682910|FG002|Overall Study|Withdrawal by Subject|3|||
161900108|NCT01877668|584682911|FG003|Overall Study|Withdrawal by Subject|2|||
161900109|NCT01877668|584682912|FG004|Overall Study|Withdrawal by Subject|2|||
161900110|NCT01877668|584682908|FG000|Overall Study|Other|1|||
161900111|NCT01877668|584682909|FG001|Overall Study|Other|1|||
161900112|NCT01877668|584682910|FG002|Overall Study|Other|1|||
161900113|NCT01877668|584682911|FG003|Overall Study|Other|1|||
161900114|NCT01877668|584682912|FG004|Overall Study|Other|3|||
161900115|NCT01877668|584682908|FG000|Overall Study|Protocol Violation|1|||
161900116|NCT01877668|584682909|FG001|Overall Study|Protocol Violation|1|||
161900117|NCT01877668|584682910|FG002|Overall Study|Protocol Violation|0|||
161900118|NCT01877668|584682911|FG003|Overall Study|Protocol Violation|0|||
161900119|NCT01877668|584682912|FG004|Overall Study|Protocol Violation|3|||
161794661|NCT03093454|584292266|FG000|Overall Study|Withdrawal by Subject|1|||
161794662|NCT03093454|584292267|FG001|Overall Study|Withdrawal by Subject|1|||
161794663|NCT03093454|584292266|FG000|Overall Study|Scheduling conflict|3|||
161794664|NCT03093454|584292267|FG001|Overall Study|Scheduling conflict|1|||
161794665|NCT03093454|584292266|FG000|Overall Study|Physician Decision|2|||
161794666|NCT03093454|584292267|FG001|Overall Study|Physician Decision|1|||
161794667|NCT02524379|584292268|FG000|Overall Study|Death|1|||
161794668|NCT01884025|584292269|FG000|Overall Study|Lost to Follow-up|3|||
161794669|NCT01884025|584292270|FG001|Overall Study|Lost to Follow-up|4|||
161794670|NCT03209570|584292271|FG000|Overall Study|Death|1|||
161794671|NCT03209570|584292272|FG001|Overall Study|Death|0|||
161794672|NCT03209570|584292271|FG000|Overall Study|Incomplete Data|8|||
161794673|NCT03209570|584292272|FG001|Overall Study|Incomplete Data|10|||
161794674|NCT03209570|584292271|FG000|Overall Study|Protocol Violation|1|||
161794675|NCT03209570|584292272|FG001|Overall Study|Protocol Violation|0|||
161794676|NCT03209570|584292271|FG000|Overall Study|Withdrawal by Subject|0|||
161794677|NCT03209570|584292272|FG001|Overall Study|Withdrawal by Subject|3|||
161794678|NCT00755326|584292274|FG000|Overall Study|Lost to Follow-up|2|||
161794679|NCT00755326|584292275|FG001|Overall Study|Lost to Follow-up|3|||
161794680|NCT02623829|584292281|FG000|Overall Study|Lost to Follow-up|1|||
161794681|NCT02623829|584292282|FG001|Overall Study|Lost to Follow-up|1|||
161794682|NCT00662025|584292283|FG000|Overall Study|Objective progression or relapse|51|||
161794683|NCT00662025|584292283|FG000|Overall Study|Adverse Event|7|||
161794684|NCT00662025|584292283|FG000|Overall Study|Withdrawal by Subject|1|||
161794685|NCT00662025|584292283|FG000|Overall Study|Results of other clinical study|2|||
161794686|NCT00662025|584292283|FG000|Overall Study|Target lesion cannot be evaluated|1|||
161794687|NCT00662025|584292283|FG000|Overall Study|Domestic circumstances|1|||
161794688|NCT01333033|584292287|FG000|Overall Study|Ineligible|0|||
161794689|NCT01333033|584292288|FG001|Overall Study|Ineligible|0|||
161794690|NCT01333033|584292289|FG002|Overall Study|Ineligible|0|||
161794691|NCT01333033|584292290|FG003|Overall Study|Ineligible|0|||
161794692|NCT01333033|584292291|FG004|Overall Study|Ineligible|6|||
161794693|NCT01333033|584292292|FG005|Overall Study|Ineligible|8|||
161794694|NCT01333033|584292287|FG000|Overall Study|Withdrawal by Subject|0|||
161794695|NCT01333033|584292288|FG001|Overall Study|Withdrawal by Subject|0|||
161794696|NCT01333033|584292289|FG002|Overall Study|Withdrawal by Subject|0|||
161794697|NCT01333033|584292290|FG003|Overall Study|Withdrawal by Subject|0|||
161794698|NCT01333033|584292291|FG004|Overall Study|Withdrawal by Subject|4|||
161794699|NCT01333033|584292292|FG005|Overall Study|Withdrawal by Subject|2|||
161794700|NCT01333033|584292287|FG000|Overall Study|PET inevaluable|0|||
161794701|NCT01333033|584292288|FG001|Overall Study|PET inevaluable|0|||
161794702|NCT01333033|584292289|FG002|Overall Study|PET inevaluable|0|||
161794703|NCT01333033|584292290|FG003|Overall Study|PET inevaluable|0|||
161794704|NCT01333033|584292291|FG004|Overall Study|PET inevaluable|2|||
161794705|NCT01333033|584292292|FG005|Overall Study|PET inevaluable|4|||
161794706|NCT01333033|584292287|FG000|Overall Study|Adverse Event|0|||
161794707|NCT01333033|584292288|FG001|Overall Study|Adverse Event|0|||
161794708|NCT01333033|584292289|FG002|Overall Study|Adverse Event|0|||
161794709|NCT01333033|584292290|FG003|Overall Study|Adverse Event|0|||
161794710|NCT01333033|584292291|FG004|Overall Study|Adverse Event|2|||
161794711|NCT01333033|584292292|FG005|Overall Study|Adverse Event|1|||
161794712|NCT01333033|584292287|FG000|Overall Study|Progression|0|||
161794713|NCT01333033|584292288|FG001|Overall Study|Progression|0|||
161794714|NCT01333033|584292289|FG002|Overall Study|Progression|0|||
161794715|NCT01333033|584292290|FG003|Overall Study|Progression|0|||
161794716|NCT01333033|584292291|FG004|Overall Study|Progression|0|||
161794717|NCT01333033|584292292|FG005|Overall Study|Progression|1|||
161794718|NCT01333033|584292287|FG000|Overall Study|MD Decision|0|||
161794719|NCT01333033|584292288|FG001|Overall Study|MD Decision|0|||
161794720|NCT01333033|584292289|FG002|Overall Study|MD Decision|0|||
161794721|NCT01333033|584292290|FG003|Overall Study|MD Decision|0|||
161794722|NCT01333033|584292291|FG004|Overall Study|MD Decision|0|||
161794723|NCT01333033|584292292|FG005|Overall Study|MD Decision|2|||
161794724|NCT02162758|584292307|FG000|Overall Study|Study termination|0|||
161794725|NCT02162758|584292308|FG001|Overall Study|Study termination|1|||
161794726|NCT03213210|584292309|FG000|Overall Study|Lost to Follow-up|2|||
161794727|NCT03213210|584292309|FG000|Overall Study|Study termination|3|||
161794728|NCT02843074|584292315|FG000|Overall Study|Withdrawal by Subject|5|||
161794729|NCT02843074|584292315|FG000|Overall Study|Progressive disease|1|||
161794730|NCT02843074|584292315|FG000|Overall Study|Physician Decision|1|||
161794731|NCT02843074|584292315|FG000|Overall Study|Lost to Follow-up|1|||
161794732|NCT02843074|584292315|FG000|Overall Study|Death|9|||
161794733|NCT01564758|584292316|FG000|Overall Study|Death|8|||
161794734|NCT01564758|584292316|FG000|Overall Study|Adverse Event|3|||
161794735|NCT01564758|584292316|FG000|Overall Study|Other|3|||
161794736|NCT01186978|584292317|FG000|Overall Study|Withdrawal by Subject|1|||
161794737|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
161794738|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
161794739|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
161794740|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
161794741|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
161900120|NCT01877668|584682908|FG000|Overall Study|Adverse event related to study drug|2|||
161900121|NCT01877668|584682909|FG001|Overall Study|Adverse event related to study drug|2|||
161900122|NCT01877668|584682910|FG002|Overall Study|Adverse event related to study drug|2|||
161900123|NCT01877668|584682911|FG003|Overall Study|Adverse event related to study drug|2|||
161900124|NCT01877668|584682912|FG004|Overall Study|Adverse event related to study drug|1|||
161900125|NCT01877668|584682908|FG000|Overall Study|Adverse event unrelated to study drug|4|||
161900126|NCT01877668|584682909|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161900127|NCT01877668|584682910|FG002|Overall Study|Adverse event unrelated to study drug|2|||
161900128|NCT01877668|584682911|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161900129|NCT01877668|584682912|FG004|Overall Study|Adverse event unrelated to study drug|1|||
161900130|NCT02317991|584682913|FG000|Overall Study|Adverse Event|12|||
161900131|NCT02317991|584682913|FG000|Overall Study|Death|4|||
161900132|NCT02317991|584682913|FG000|Overall Study|Withdrawal by Subject|8|||
161900133|NCT02317991|584682913|FG000|Overall Study|Progressive Disease|41|||
161900134|NCT01223404|584682914|FG000|First Intervention (1 Day)|Adverse Event|0|||
161900135|NCT01223404|584682915|FG001|First Intervention (1 Day)|Adverse Event|0|||
161900136|NCT01223404|584682916|FG002|First Intervention (1 Day)|Adverse Event|0|||
161900137|NCT01223404|584682917|FG003|First Intervention (1 Day)|Adverse Event|1|||
161900138|NCT01223404|584682918|FG004|First Intervention (1 Day)|Adverse Event|0|||
161900139|NCT01223404|584682919|FG005|First Intervention (1 Day)|Adverse Event|0|||
161900140|NCT01223404|584682914|FG000|Second Intervention (1 Day)|Adverse Event|1|||
161900141|NCT01223404|584682915|FG001|Second Intervention (1 Day)|Adverse Event|0|||
161900142|NCT01223404|584682916|FG002|Second Intervention (1 Day)|Adverse Event|0|||
161900143|NCT01223404|584682917|FG003|Second Intervention (1 Day)|Adverse Event|0|||
161900144|NCT01223404|584682918|FG004|Second Intervention (1 Day)|Adverse Event|0|||
161900145|NCT01223404|584682919|FG005|Second Intervention (1 Day)|Adverse Event|0|||
161900146|NCT01223404|584682914|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161900147|NCT01223404|584682915|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161900148|NCT01223404|584682916|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161900149|NCT01223404|584682917|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
161900150|NCT01223404|584682918|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161900151|NCT01223404|584682919|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161900152|NCT00707057|584682920|FG000|Overall Study|Withdrawal by Subject|8|||
161900153|NCT00707057|584682921|FG001|Overall Study|Withdrawal by Subject|3|||
161900154|NCT00707057|584682920|FG000|Overall Study|Dosed incorrectly|0|||
161900155|NCT00707057|584682921|FG001|Overall Study|Dosed incorrectly|1|||
161900156|NCT02492165|584682922|FG000|Overall Study|Withdrawal by Subject|0|||
161900157|NCT02492165|584682923|FG001|Overall Study|Withdrawal by Subject|1|||
161900158|NCT02492165|584682924|FG002|Overall Study|Withdrawal by Subject|0|||
161900159|NCT02492165|584682925|FG003|Overall Study|Withdrawal by Subject|0|||
161900160|NCT01697800|584682926|FG000|Overall Study|Death|0|||
161900161|NCT01697800|584682927|FG001|Overall Study|Death|1|||
161900162|NCT00954122|584682928|FG000|Overall Study|Withdrawal by Subject|5|||
161900163|NCT00954122|584682928|FG000|Overall Study|Adverse Event|1|||
161900164|NCT00954122|584682928|FG000|Overall Study|Safety Reason|1|||
161900165|NCT00956839|584682938|FG000|Overall Study|Lost to Follow-up|3|||
161794742|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
161794743|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
161794744|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
161794745|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
161794746|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
161794747|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
161794748|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
161794749|NCT01227668|584292318|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
161794750|NCT01227668|584292319|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
161794751|NCT01227668|584292318|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
161794752|NCT01227668|584292319|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
161794753|NCT01227668|584292318|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
161794754|NCT01227668|584292319|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
161900166|NCT00956839|584682939|FG001|Overall Study|Lost to Follow-up|0|||
161900167|NCT00956839|584682940|FG002|Overall Study|Lost to Follow-up|3|||
161900168|NCT00619827|584682944|FG000|Overall Study|Adverse Event|1|||
161900169|NCT00619827|584682945|FG001|Overall Study|Adverse Event|2|||
161900170|NCT00619827|584682944|FG000|Overall Study|Withdrawal by Subject|2|||
161900171|NCT00619827|584682945|FG001|Overall Study|Withdrawal by Subject|2|||
161900172|NCT02806713|584682946|FG000|Overall Study|Urethral injury during procedure|1|||
161900173|NCT02806713|584682947|FG001|Overall Study|Urethral injury during procedure|0|||
161900174|NCT02806713|584682946|FG000|Overall Study|cancelled surgery|1|||
162132860|NCT03890120|585538964|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
161900175|NCT02806713|584682947|FG001|Overall Study|cancelled surgery|2|||
161900176|NCT02999789|584682948|FG000|Overall Study|Withdrawal by Subject|0|||
161900177|NCT02999789|584682949|FG001|Overall Study|Withdrawal by Subject|1|||
161900178|NCT02999789|584682948|FG000|Overall Study|Became ineligible|1|||
161794755|NCT01227668|584292318|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
161794756|NCT01227668|584292319|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
161794757|NCT01227668|584292318|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
161794758|NCT01227668|584292319|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
161794759|NCT01227668|584292318|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
161794760|NCT01227668|584292319|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
161794761|NCT02115256|584292329|FG000|Overall Study|Withdrawal by Subject|0|||
161794762|NCT02115256|584292330|FG001|Overall Study|Withdrawal by Subject|1|||
161794763|NCT01789320|584292333|FG000|Overall Study|Re-enrolled into study|1|||
161794764|NCT01789320|584292333|FG000|Overall Study|Lost to Follow-up|1|||
161794765|NCT01533428|584292346|FG000|Overall Study|Adverse Event|0|||
161794766|NCT01533428|584292347|FG001|Overall Study|Adverse Event|1|||
161794767|NCT01533428|584292346|FG000|Overall Study|Lost to Follow-up|2|||
161794768|NCT01533428|584292347|FG001|Overall Study|Lost to Follow-up|1|||
161794769|NCT01533428|584292346|FG000|Overall Study|Withdrawal by Subject|7|||
161794770|NCT01533428|584292347|FG001|Overall Study|Withdrawal by Subject|6|||
161794771|NCT01688037|584292348|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
162132861|NCT03890120|585538961|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
162132862|NCT03890120|585538962|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
162132863|NCT03890120|585538963|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
161794772|NCT01688037|584292349|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
161794773|NCT01688037|584292350|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
161794774|NCT01688037|584292348|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
161794775|NCT01688037|584292349|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
161794776|NCT01688037|584292350|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
161900179|NCT02999789|584682949|FG001|Overall Study|Became ineligible|2|||
161900180|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
161900181|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
161900182|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
161900183|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
161900184|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
161900185|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
161900186|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
161900187|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
161900188|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
161900189|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
161900190|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
161900191|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
161900192|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
161900193|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
161900194|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
161900195|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
161900196|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
161794777|NCT01688037|584292348|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
161794778|NCT01688037|584292349|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
161794779|NCT01688037|584292350|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
161794780|NCT01688037|584292348|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
161900197|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
161900198|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
162132864|NCT03890120|585538964|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
161900199|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
161900200|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
161900201|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
161900202|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
161900203|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
161900204|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
162132865|NCT03890120|585538961|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
162132866|NCT03890120|585538962|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
162132867|NCT03890120|585538963|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
162132868|NCT03890120|585538964|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
162132869|NCT03890120|585538961|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
162132870|NCT03890120|585538962|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
161794781|NCT01688037|584292349|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
161900205|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
161794782|NCT01688037|584292350|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
161794783|NCT01688037|584292348|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
161794784|NCT01688037|584292349|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
161900206|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
162132871|NCT03890120|585538963|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
161900207|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
161900208|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
161900209|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
161900210|NCT01111565|584682950|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
161900211|NCT01111565|584682951|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
161900212|NCT01111565|584682952|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
161900213|NCT01111565|584682953|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
161900214|NCT01111565|584682954|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
161900215|NCT01111565|584682950|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161900216|NCT01111565|584682951|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161900217|NCT01111565|584682952|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161900218|NCT01111565|584682953|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
161900219|NCT01111565|584682954|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161900220|NCT01111565|584682950|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161900221|NCT01111565|584682951|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161900222|NCT01111565|584682952|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
161900223|NCT01111565|584682953|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161900224|NCT01111565|584682954|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161900225|NCT01111565|584682950|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
161900226|NCT01111565|584682951|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
161900227|NCT01111565|584682952|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
161900228|NCT01111565|584682953|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
161900229|NCT01111565|584682954|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
161900230|NCT01111565|584682950|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
161900231|NCT01111565|584682951|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
161900232|NCT01111565|584682952|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
161900233|NCT01111565|584682953|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
161900234|NCT01111565|584682954|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
161900235|NCT01111565|584682950|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
161900236|NCT01111565|584682951|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
161900237|NCT01111565|584682952|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
161900238|NCT01111565|584682953|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
161900239|NCT01111565|584682954|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
161900240|NCT02824224|584682955|FG000|Overall Study|Discontinued, IUS expulsion|0|||
161900241|NCT02824224|584682956|FG001|Overall Study|Discontinued, IUS expulsion|1|||
161900242|NCT02824224|584682955|FG000|Overall Study|Did not show up for allocation visit|2|||
161900243|NCT02824224|584682956|FG001|Overall Study|Did not show up for allocation visit|0|||
161900244|NCT00368108|584682959|FG000|Overall Study|Adverse Event|38|||
161900245|NCT00368108|584682960|FG001|Overall Study|Adverse Event|26|||
161900246|NCT00368108|584682961|FG002|Overall Study|Adverse Event|44|||
161900247|NCT00368108|584682959|FG000|Overall Study|Abnormal Laboratory Value|0|||
161900248|NCT00368108|584682960|FG001|Overall Study|Abnormal Laboratory Value|0|||
161900249|NCT00368108|584682961|FG002|Overall Study|Abnormal Laboratory Value|3|||
161900250|NCT00368108|584682959|FG000|Overall Study|Protocol Violation|5|||
161900251|NCT00368108|584682960|FG001|Overall Study|Protocol Violation|9|||
161900252|NCT00368108|584682961|FG002|Overall Study|Protocol Violation|9|||
161900253|NCT00368108|584682959|FG000|Overall Study|Withdrawal by Subject|9|||
161900254|NCT00368108|584682960|FG001|Overall Study|Withdrawal by Subject|3|||
161900255|NCT00368108|584682961|FG002|Overall Study|Withdrawal by Subject|5|||
161900256|NCT00368108|584682959|FG000|Overall Study|Lack of Efficacy|7|||
161900257|NCT00368108|584682960|FG001|Overall Study|Lack of Efficacy|8|||
161900258|NCT00368108|584682961|FG002|Overall Study|Lack of Efficacy|5|||
161900259|NCT00368108|584682959|FG000|Overall Study|Physician Decision|2|||
161900260|NCT00368108|584682960|FG001|Overall Study|Physician Decision|0|||
161900261|NCT00368108|584682961|FG002|Overall Study|Physician Decision|1|||
161900262|NCT00368108|584682959|FG000|Overall Study|Other|3|||
161900263|NCT00368108|584682960|FG001|Overall Study|Other|7|||
161900264|NCT00368108|584682961|FG002|Overall Study|Other|1|||
161900265|NCT02299388|584682966|FG000|Overall Study|Withdrawal by Subject|0|||
161900266|NCT02299388|584682967|FG001|Overall Study|Withdrawal by Subject|1|||
161900267|NCT01093586|584682972|FG000|Overall Study|Failed to engraft|3|||
161900268|NCT03442088|584682973|FG000|Overall Study|Adverse Event|1|||
162132872|NCT03890120|585538964|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
162132873|NCT03890120|585538961|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
162132874|NCT03890120|585538962|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
161900269|NCT03442088|584682973|FG000|Overall Study|Lack of Efficacy|2|||
161900270|NCT03442088|584682973|FG000|Overall Study|Lost to Follow-up|2|||
162132875|NCT03890120|585538963|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
161900271|NCT00357877|584682976|FG000|Overall Study|Death|2|||
161794785|NCT01688037|584292350|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
161794786|NCT01688037|584292348|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
161794787|NCT01688037|584292349|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
161794788|NCT01688037|584292350|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
161794789|NCT01688037|584292348|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
161794790|NCT01688037|584292349|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
161794791|NCT01688037|584292350|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
161794792|NCT01688037|584292348|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
161794793|NCT01688037|584292349|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
161794794|NCT01688037|584292350|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
161794795|NCT01688037|584292348|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
161794796|NCT01688037|584292349|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
161794797|NCT01688037|584292350|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
161794798|NCT01688037|584292348|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
161794799|NCT01688037|584292349|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
161794800|NCT01688037|584292350|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
161794801|NCT02102490|584292356|FG000|Overall Study|Death|6|||
161794802|NCT02102490|584292356|FG000|Overall Study|Lost to Follow-up|1|||
161794803|NCT00095199|584292357|FG000|Overall Study|Adverse Event|40|||
161794804|NCT00095199|584292358|FG001|Overall Study|Adverse Event|22|||
161794805|NCT00095199|584292359|FG002|Overall Study|Adverse Event|26|||
161794806|NCT00095199|584292360|FG003|Overall Study|Adverse Event|11|||
161794807|NCT00095199|584292357|FG000|Overall Study|Progressive disease|213|||
161794808|NCT00095199|584292358|FG001|Overall Study|Progressive disease|179|||
161794809|NCT00095199|584292359|FG002|Overall Study|Progressive disease|105|||
161794810|NCT00095199|584292360|FG003|Overall Study|Progressive disease|98|||
161794811|NCT00095199|584292357|FG000|Overall Study|Death|10|||
161794812|NCT00095199|584292358|FG001|Overall Study|Death|6|||
161794813|NCT00095199|584292359|FG002|Overall Study|Death|11|||
161794814|NCT00095199|584292360|FG003|Overall Study|Death|9|||
161794815|NCT00095199|584292357|FG000|Overall Study|Withdrawal by Subject|21|||
161794816|NCT00095199|584292358|FG001|Overall Study|Withdrawal by Subject|16|||
161794817|NCT00095199|584292359|FG002|Overall Study|Withdrawal by Subject|13|||
161794818|NCT00095199|584292360|FG003|Overall Study|Withdrawal by Subject|22|||
161794819|NCT00095199|584292357|FG000|Overall Study|Protocol Violation|4|||
161794820|NCT00095199|584292358|FG001|Overall Study|Protocol Violation|4|||
161794821|NCT00095199|584292359|FG002|Overall Study|Protocol Violation|2|||
161794822|NCT00095199|584292360|FG003|Overall Study|Protocol Violation|0|||
161794823|NCT00095199|584292357|FG000|Overall Study|Liver function test results elevated|0|||
161794824|NCT00095199|584292358|FG001|Overall Study|Liver function test results elevated|0|||
161794825|NCT00095199|584292359|FG002|Overall Study|Liver function test results elevated|1|||
161794826|NCT00095199|584292360|FG003|Overall Study|Liver function test results elevated|1|||
161794827|NCT00095199|584292357|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
161794828|NCT00095199|584292358|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
161794829|NCT00095199|584292359|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
161794830|NCT00095199|584292360|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
161794831|NCT00095199|584292357|FG000|Overall Study|Physician Decision|5|||
161794832|NCT00095199|584292358|FG001|Overall Study|Physician Decision|6|||
161794833|NCT00095199|584292359|FG002|Overall Study|Physician Decision|1|||
161794834|NCT00095199|584292360|FG003|Overall Study|Physician Decision|1|||
161794835|NCT00095199|584292357|FG000|Overall Study|Not eligible|1|||
161794836|NCT00095199|584292358|FG001|Overall Study|Not eligible|7|||
161794837|NCT00095199|584292359|FG002|Overall Study|Not eligible|0|||
161794838|NCT00095199|584292360|FG003|Overall Study|Not eligible|1|||
161794839|NCT00095199|584292357|FG000|Overall Study|Started Palliative Radiotherapy|1|||
161794840|NCT00095199|584292358|FG001|Overall Study|Started Palliative Radiotherapy|0|||
161794841|NCT00095199|584292359|FG002|Overall Study|Started Palliative Radiotherapy|0|||
161794842|NCT00095199|584292360|FG003|Overall Study|Started Palliative Radiotherapy|0|||
161794843|NCT00095199|584292357|FG000|Overall Study|Started radiotherapy regimen|0|||
161794844|NCT00095199|584292358|FG001|Overall Study|Started radiotherapy regimen|1|||
161794845|NCT00095199|584292359|FG002|Overall Study|Started radiotherapy regimen|0|||
161794846|NCT00095199|584292360|FG003|Overall Study|Started radiotherapy regimen|0|||
161794847|NCT00095199|584292357|FG000|Overall Study|Primary tumor removed in other surgery|0|||
161794848|NCT00095199|584292358|FG001|Overall Study|Primary tumor removed in other surgery|1|||
161794849|NCT00095199|584292359|FG002|Overall Study|Primary tumor removed in other surgery|0|||
161794850|NCT00095199|584292360|FG003|Overall Study|Primary tumor removed in other surgery|0|||
161794851|NCT00095199|584292357|FG000|Overall Study|Data inadvertently lost by site|1|||
161794852|NCT00095199|584292358|FG001|Overall Study|Data inadvertently lost by site|0|||
161794853|NCT00095199|584292359|FG002|Overall Study|Data inadvertently lost by site|0|||
161794854|NCT00095199|584292360|FG003|Overall Study|Data inadvertently lost by site|0|||
161794855|NCT03896490|584292395|FG000|Overall Study|Withdrawal by Subject|1|||
161794856|NCT03896490|584292396|FG001|Overall Study|Withdrawal by Subject|1|||
161794857|NCT00385541|584292399|FG000|Overall Study|severe pain, clinician requested unblind|0|||
161900272|NCT00357877|584682977|FG001|Overall Study|Death|1|||
161900273|NCT00357877|584682976|FG000|Overall Study|Lost to Follow-up|20|||
161900274|NCT00357877|584682977|FG001|Overall Study|Lost to Follow-up|23|||
161900275|NCT00357877|584682976|FG000|Overall Study|Withdrawal by Subject|3|||
161900276|NCT00357877|584682977|FG001|Overall Study|Withdrawal by Subject|3|||
161900277|NCT00357877|584682976|FG000|Overall Study|Administrative withdrawal|1|||
161900278|NCT00357877|584682977|FG001|Overall Study|Administrative withdrawal|1|||
161900279|NCT00357877|584682976|FG000|Overall Study|Other|0|||
161900280|NCT00357877|584682977|FG001|Overall Study|Other|2|||
161900281|NCT01051557|584682978|FG000|Overall Study|Physician Decision|1|||
161900282|NCT01051557|584682979|FG001|Overall Study|Physician Decision|0|||
161900283|NCT01051557|584682980|FG002|Overall Study|Physician Decision|0|||
161900284|NCT01051557|584682981|FG003|Overall Study|Physician Decision|0|||
161900285|NCT01051557|584682982|FG004|Overall Study|Physician Decision|0|||
161900286|NCT01051557|584682983|FG005|Overall Study|Physician Decision|0|||
161900287|NCT01051557|584682984|FG006|Overall Study|Physician Decision|0|||
161900288|NCT01051557|584682978|FG000|Overall Study|disease progression|3|||
161900289|NCT01051557|584682979|FG001|Overall Study|disease progression|3|||
161900290|NCT01051557|584682980|FG002|Overall Study|disease progression|5|||
161900291|NCT01051557|584682981|FG003|Overall Study|disease progression|2|||
161900292|NCT01051557|584682982|FG004|Overall Study|disease progression|4|||
161900293|NCT01051557|584682983|FG005|Overall Study|disease progression|3|||
161900294|NCT01051557|584682984|FG006|Overall Study|disease progression|1|||
161900295|NCT01051557|584682978|FG000|Overall Study|Withdrawal by Subject|0|||
161900296|NCT01051557|584682979|FG001|Overall Study|Withdrawal by Subject|0|||
161900297|NCT01051557|584682980|FG002|Overall Study|Withdrawal by Subject|1|||
161900298|NCT01051557|584682981|FG003|Overall Study|Withdrawal by Subject|0|||
161900299|NCT01051557|584682982|FG004|Overall Study|Withdrawal by Subject|2|||
161900300|NCT01051557|584682983|FG005|Overall Study|Withdrawal by Subject|0|||
161900301|NCT01051557|584682984|FG006|Overall Study|Withdrawal by Subject|1|||
161900302|NCT01051557|584682978|FG000|Overall Study|Adverse Event|0|||
161900303|NCT01051557|584682979|FG001|Overall Study|Adverse Event|0|||
161900304|NCT01051557|584682980|FG002|Overall Study|Adverse Event|0|||
161900305|NCT01051557|584682981|FG003|Overall Study|Adverse Event|1|||
161900306|NCT01051557|584682982|FG004|Overall Study|Adverse Event|1|||
161900307|NCT01051557|584682983|FG005|Overall Study|Adverse Event|3|||
161900308|NCT01051557|584682984|FG006|Overall Study|Adverse Event|4|||
161900309|NCT00613366|584682991|FG000|Overall Study|Withdrawal by Subject|3|||
161900310|NCT00613366|584682992|FG001|Overall Study|Withdrawal by Subject|2|||
161900311|NCT00943397|584682993|FG000|Overall Study|Adverse Event|0|||
161900312|NCT00943397|584682994|FG001|Overall Study|Adverse Event|6|||
161900313|NCT00943397|584682993|FG000|Overall Study|Lost to Follow-up|0|||
161900314|NCT00943397|584682994|FG001|Overall Study|Lost to Follow-up|4|||
161900315|NCT00943397|584682993|FG000|Overall Study|Protocol Violation|2|||
161900316|NCT00943397|584682994|FG001|Overall Study|Protocol Violation|5|||
161900317|NCT00943397|584682993|FG000|Overall Study|Withdrawal by Subject|1|||
161900318|NCT00943397|584682994|FG001|Overall Study|Withdrawal by Subject|1|||
161900319|NCT00943397|584682993|FG000|Overall Study|Site terminated and other|12|||
161900320|NCT00943397|584682994|FG001|Overall Study|Site terminated and other|56|||
161900321|NCT04878055|584682995|FG000|Overall Study|Patient transferred in another department|0|||
161900322|NCT04878055|584682996|FG001|Overall Study|Patient transferred in another department|2|||
161900323|NCT04878055|584682995|FG000|Overall Study|Physician Decision|1|||
161900324|NCT04878055|584682996|FG001|Overall Study|Physician Decision|1|||
161900325|NCT04878055|584682995|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
161900326|NCT04878055|584682996|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
161900327|NCT04878055|584682995|FG000|Overall Study|Adverse Event|12|||
161900328|NCT04878055|584682996|FG001|Overall Study|Adverse Event|7|||
161900329|NCT04878055|584682995|FG000|Overall Study|Other|5|||
161900330|NCT04878055|584682996|FG001|Overall Study|Other|0|||
161900331|NCT04878055|584682995|FG000|Overall Study|Withdrawal by Subject|7|||
161900332|NCT04878055|584682996|FG001|Overall Study|Withdrawal by Subject|3|||
162010749|NCT02054104|585095976|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
162132876|NCT03890120|585538964|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
162132877|NCT03890120|585538961|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
162132878|NCT03890120|585538962|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
161900333|NCT04878055|584682995|FG000|Overall Study|Lost to Follow-up|10|||
161900334|NCT04878055|584682996|FG001|Overall Study|Lost to Follow-up|1|||
161900335|NCT01968811|584682997|FG000|Overall Study|Protocol Violation|4|||
161900336|NCT01968811|584682997|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
161900337|NCT01178125|584682998|FG000|Overall Study|Lost to Follow-up|397|||
161900338|NCT01178125|584682998|FG000|Overall Study|Adverse Event|244|||
161900339|NCT01178125|584682998|FG000|Overall Study|Withdrawal by Subject|209|||
161900340|NCT01178125|584682998|FG000|Overall Study|Noncompliance|184|||
161900341|NCT01178125|584682998|FG000|Overall Study|Pregnancy|55|||
161900342|NCT01178125|584682998|FG000|Overall Study|Other Reason|39|||
161900343|NCT01178125|584682998|FG000|Overall Study|Sponsor Decision|28|||
161900344|NCT01178125|584682998|FG000|Overall Study|Protocol Violation|17|||
161900345|NCT01178125|584682998|FG000|Overall Study|Investigator Decision|5|||
162132879|NCT03890120|585538963|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
162132880|NCT03890120|585538964|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
162132881|NCT03890120|585538961|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
162132882|NCT03890120|585538962|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
162132883|NCT03890120|585538963|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
162132884|NCT03890120|585538964|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
162132885|NCT03890120|585538961|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
162132886|NCT03890120|585538962|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
162132887|NCT03890120|585538963|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
162132888|NCT03890120|585538964|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
162132889|NCT03890120|585538961|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
162132890|NCT03890120|585538962|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
162132891|NCT03890120|585538963|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
162132892|NCT03890120|585538964|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
162132893|NCT03890120|585538961|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
162132894|NCT03890120|585538962|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
162132895|NCT03890120|585538963|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
162132896|NCT03890120|585538964|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
162132897|NCT03890120|585538961|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
162132898|NCT03890120|585538962|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
162132899|NCT03890120|585538963|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
162132900|NCT03890120|585538964|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
162132901|NCT01052662|585538965|FG000|Overall Study|Lost to Follow-up|15|||
162132902|NCT01052662|585538966|FG001|Overall Study|Lost to Follow-up|13|||
162132903|NCT01052662|585538967|FG002|Overall Study|Lost to Follow-up|18|||
162132904|NCT01052662|585538965|FG000|Overall Study|Withdrawal by Subject|3|||
162132905|NCT01052662|585538966|FG001|Overall Study|Withdrawal by Subject|2|||
162132906|NCT01052662|585538967|FG002|Overall Study|Withdrawal by Subject|1|||
162132907|NCT01052662|585538965|FG000|Overall Study|Pharmacy issue|1|||
162132908|NCT01052662|585538966|FG001|Overall Study|Pharmacy issue|3|||
162132909|NCT01052662|585538967|FG002|Overall Study|Pharmacy issue|3|||
162132910|NCT01052662|585538965|FG000|Overall Study|Adverse Event|1|||
162132911|NCT01052662|585538966|FG001|Overall Study|Adverse Event|1|||
162132912|NCT01052662|585538967|FG002|Overall Study|Adverse Event|0|||
162132913|NCT01052662|585538965|FG000|Overall Study|Legal Problem|2|||
162132914|NCT01052662|585538966|FG001|Overall Study|Legal Problem|0|||
162132915|NCT01052662|585538967|FG002|Overall Study|Legal Problem|0|||
162132916|NCT01052662|585538965|FG000|Overall Study|Administrative|0|||
162132917|NCT01052662|585538966|FG001|Overall Study|Administrative|3|||
162132918|NCT01052662|585538967|FG002|Overall Study|Administrative|0|||
162132919|NCT00479674|585538968|FG000|Overall Study|Adverse Event|18|||
162132920|NCT00479674|585538968|FG000|Overall Study|Withdrawal by Subject|6|||
162132921|NCT00479674|585538968|FG000|Overall Study|Physician Decision|14|||
162132922|NCT00479674|585538968|FG000|Overall Study|none provided|3|||
162132923|NCT02478359|585538970|FG000|Overall Study|Disenrolled from health plan|106|||
162132924|NCT02478359|585538971|FG001|Overall Study|Disenrolled from health plan|65|||
162132925|NCT03293485|585538973|FG000|Overall Study|Death|1|||
162132926|NCT03293485|585538973|FG000|Overall Study|Screen Failure|2|||
162132927|NCT03293485|585538973|FG000|Overall Study|Withdrawal by Subject|2|||
162132928|NCT01818700|585538974|FG000|Overall Study|Adverse Event|67|||
162132929|NCT01818700|585538974|FG000|Overall Study|Lack of Efficacy|2|||
162132930|NCT01818700|585538974|FG000|Overall Study|Lost to Follow-up|5|||
162132931|NCT01818700|585538974|FG000|Overall Study|Withdrawal by Subject|27|||
162132932|NCT01818700|585538974|FG000|Overall Study|Protocol Violation|2|||
162132933|NCT01818700|585538974|FG000|Overall Study|Other|1|||
162132934|NCT01627340|585538977|FG000|Overall Study|Adverse Event|1|||
162132935|NCT01627340|585538978|FG001|Overall Study|Adverse Event|0|||
162132936|NCT01627340|585538977|FG000|Overall Study|Lost to Follow-up|8|||
162132937|NCT01627340|585538978|FG001|Overall Study|Lost to Follow-up|4|||
162132938|NCT01627340|585538977|FG000|Overall Study|Pregnancy|1|||
162132939|NCT01627340|585538978|FG001|Overall Study|Pregnancy|0|||
162132940|NCT01627340|585538977|FG000|Overall Study|Withdrawal by Subject|2|||
162132941|NCT01627340|585538978|FG001|Overall Study|Withdrawal by Subject|0|||
162132942|NCT01272011|585538979|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
162132943|NCT01272011|585538980|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
162132944|NCT01272011|585538981|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
162132945|NCT02240680|585538984|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
161900346|NCT00268983|584683006|FG000|Overall Study|Death|3|||
161900347|NCT00268983|584683007|FG001|Overall Study|Death|0|||
161900348|NCT00249873|584683008|FG000|Overall Study|Not treated|7|||
162132946|NCT02240680|585538985|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
162132947|NCT02240680|585538986|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
162132948|NCT02240680|585538987|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
162132949|NCT02240680|585538984|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
162132950|NCT02240680|585538985|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
162132951|NCT02240680|585538986|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
162132952|NCT02240680|585538987|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
162132953|NCT02240680|585538984|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
162132954|NCT02240680|585538985|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
162132955|NCT02240680|585538986|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
162132956|NCT02240680|585538987|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
162132957|NCT02240680|585538984|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
162132958|NCT02240680|585538985|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
162132959|NCT02240680|585538986|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
162132960|NCT02240680|585538987|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
162132961|NCT02240680|585538984|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
162132962|NCT02240680|585538985|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
162132963|NCT02240680|585538986|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
162132964|NCT02240680|585538987|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
162132965|NCT02240680|585538984|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
162132966|NCT02240680|585538985|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
162132967|NCT02240680|585538986|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
162132968|NCT02240680|585538987|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
162132969|NCT02240680|585538984|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
162132970|NCT02240680|585538985|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
162132971|NCT02240680|585538986|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
162132972|NCT02240680|585538987|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
162132973|NCT02240680|585538984|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
162132974|NCT02240680|585538985|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
162132975|NCT02240680|585538986|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
162132976|NCT02240680|585538987|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
162132977|NCT01657032|585538988|FG000|Overall Study|Lost to Follow-up|0|||
162132978|NCT01657032|585538989|FG001|Overall Study|Lost to Follow-up|7|||
162132979|NCT03633903|585538990|FG000|Overall Study|Withdrawal by Subject|1|||
162132980|NCT03633903|585538991|FG001|Overall Study|Withdrawal by Subject|2|||
162132981|NCT03633903|585538990|FG000|Overall Study|Lost to Follow-up|5|||
162132982|NCT03633903|585538991|FG001|Overall Study|Lost to Follow-up|5|||
162132983|NCT03379233|585538998|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
162132984|NCT03379233|585538999|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
162132985|NCT00965484|585539000|FG000|Overall Study|Protocol Violation|1|||
162132986|NCT00965484|585539000|FG000|Overall Study|Withdrawal by Subject|1|||
162132987|NCT02531438|585539001|FG000|Overall Study|Adverse Event|7|||
162132988|NCT02531438|585539002|FG001|Overall Study|Adverse Event|9|||
162132989|NCT02531438|585539001|FG000|Overall Study|Lost to Follow-up|0|||
162132990|NCT02531438|585539002|FG001|Overall Study|Lost to Follow-up|3|||
162132991|NCT02531438|585539001|FG000|Overall Study|Withdrawal by Subject|7|||
162132992|NCT02531438|585539002|FG001|Overall Study|Withdrawal by Subject|8|||
162132993|NCT02531438|585539001|FG000|Overall Study|Physician Decision|0|||
162132994|NCT02531438|585539002|FG001|Overall Study|Physician Decision|1|||
162132995|NCT02531438|585539001|FG000|Overall Study|Death|6|||
162132996|NCT02531438|585539002|FG001|Overall Study|Death|3|||
162132997|NCT02531438|585539001|FG000|Overall Study|Randomized, but Not Treated|4|||
162132998|NCT02531438|585539002|FG001|Overall Study|Randomized, but Not Treated|0|||
162132999|NCT02531438|585539001|FG000|Overall Study|Missed EOT/PTE Visit|5|||
162133000|NCT02531438|585539002|FG001|Overall Study|Missed EOT/PTE Visit|2|||
162133001|NCT02531438|585539001|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
162133002|NCT02531438|585539002|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
162133003|NCT01813422|585539003|FG000|Overall Study|Withdrawal by Subject|14|||
162133004|NCT01813422|585539004|FG001|Overall Study|Withdrawal by Subject|8|||
162133005|NCT01813422|585539003|FG000|Overall Study|Death|2|||
162133006|NCT01813422|585539004|FG001|Overall Study|Death|3|||
162133007|NCT01813422|585539003|FG000|Overall Study|Sponsor Decision|2|||
162133008|NCT01813422|585539004|FG001|Overall Study|Sponsor Decision|1|||
162133009|NCT01813422|585539003|FG000|Overall Study|Lost to Follow-up|2|||
162133010|NCT01813422|585539004|FG001|Overall Study|Lost to Follow-up|4|||
162133011|NCT01653743|585539007|FG000|Overall Study|Withdrawal by Subject|1|||
162133012|NCT01653743|585539008|FG001|Overall Study|Withdrawal by Subject|0|||
162133013|NCT01653743|585539007|FG000|Overall Study|Investigator discretion|3|||
162133014|NCT01653743|585539008|FG001|Overall Study|Investigator discretion|0|||
162133015|NCT02015195|585539010|FG000|Overall Study|Adverse Event|0|||
162133016|NCT02015195|585539011|FG001|Overall Study|Adverse Event|0|||
162133017|NCT02015195|585539012|FG002|Overall Study|Adverse Event|0|||
162133018|NCT02015195|585539013|FG003|Overall Study|Adverse Event|1|||
162133019|NCT02015195|585539014|FG004|Overall Study|Adverse Event|0|||
162133020|NCT02015195|585539015|FG005|Overall Study|Adverse Event|0|||
162133021|NCT02015195|585539016|FG006|Overall Study|Adverse Event|0|||
162133022|NCT00783718|585539025|FG000|Induction Phase|Adverse Event|4|||
162133023|NCT00783718|585539026|FG001|Induction Phase|Adverse Event|0|||
162133024|NCT00783718|585539027|FG002|Induction Phase|Adverse Event|7|||
162133025|NCT00783718|585539028|FG003|Induction Phase|Adverse Event|0|||
162133026|NCT00783718|585539029|FG004|Induction Phase|Adverse Event|0|||
162133027|NCT00783718|585539030|FG005|Induction Phase|Adverse Event|0|||
162133028|NCT00783718|585539031|FG006|Induction Phase|Adverse Event|0|||
162133029|NCT00783718|585539025|FG000|Induction Phase|Protocol Violation|1|||
162133030|NCT00783718|585539026|FG001|Induction Phase|Protocol Violation|1|||
162133031|NCT00783718|585539027|FG002|Induction Phase|Protocol Violation|6|||
162133032|NCT00783718|585539028|FG003|Induction Phase|Protocol Violation|0|||
162133033|NCT00783718|585539029|FG004|Induction Phase|Protocol Violation|0|||
162133034|NCT00783718|585539030|FG005|Induction Phase|Protocol Violation|0|||
162133035|NCT00783718|585539031|FG006|Induction Phase|Protocol Violation|0|||
162133036|NCT00783718|585539025|FG000|Induction Phase|Lack of Efficacy|5|||
162133037|NCT00783718|585539026|FG001|Induction Phase|Lack of Efficacy|2|||
162133038|NCT00783718|585539027|FG002|Induction Phase|Lack of Efficacy|14|||
162133039|NCT00783718|585539028|FG003|Induction Phase|Lack of Efficacy|0|||
162133040|NCT00783718|585539029|FG004|Induction Phase|Lack of Efficacy|0|||
162133041|NCT00783718|585539030|FG005|Induction Phase|Lack of Efficacy|0|||
162133042|NCT00783718|585539031|FG006|Induction Phase|Lack of Efficacy|0|||
162133043|NCT00783718|585539025|FG000|Induction Phase|Withdrawal by Subject|3|||
162133044|NCT00783718|585539026|FG001|Induction Phase|Withdrawal by Subject|4|||
162133045|NCT00783718|585539027|FG002|Induction Phase|Withdrawal by Subject|8|||
162133046|NCT00783718|585539028|FG003|Induction Phase|Withdrawal by Subject|0|||
162133047|NCT00783718|585539029|FG004|Induction Phase|Withdrawal by Subject|0|||
162133048|NCT00783718|585539030|FG005|Induction Phase|Withdrawal by Subject|0|||
162133049|NCT00783718|585539031|FG006|Induction Phase|Withdrawal by Subject|0|||
162133050|NCT00783718|585539025|FG000|Induction Phase|Lost to Follow-up|1|||
162133051|NCT00783718|585539026|FG001|Induction Phase|Lost to Follow-up|0|||
162133052|NCT00783718|585539027|FG002|Induction Phase|Lost to Follow-up|1|||
162133053|NCT00783718|585539028|FG003|Induction Phase|Lost to Follow-up|0|||
162133054|NCT00783718|585539029|FG004|Induction Phase|Lost to Follow-up|0|||
162133055|NCT00783718|585539030|FG005|Induction Phase|Lost to Follow-up|0|||
162133056|NCT00783718|585539031|FG006|Induction Phase|Lost to Follow-up|0|||
162133057|NCT00783718|585539025|FG000|Maintenance Phase|Adverse Event|12|||
162133058|NCT00783718|585539026|FG001|Maintenance Phase|Adverse Event|0|||
162133059|NCT00783718|585539027|FG002|Maintenance Phase|Adverse Event|0|||
162133060|NCT00783718|585539028|FG003|Maintenance Phase|Adverse Event|15|||
162133061|NCT00783718|585539029|FG004|Maintenance Phase|Adverse Event|7|||
162133062|NCT00783718|585539030|FG005|Maintenance Phase|Adverse Event|6|||
162133063|NCT00783718|585539031|FG006|Maintenance Phase|Adverse Event|16|||
162133064|NCT00783718|585539025|FG000|Maintenance Phase|Protocol Violation|1|||
162133065|NCT00783718|585539026|FG001|Maintenance Phase|Protocol Violation|0|||
162133066|NCT00783718|585539027|FG002|Maintenance Phase|Protocol Violation|0|||
162133067|NCT00783718|585539028|FG003|Maintenance Phase|Protocol Violation|0|||
162133068|NCT00783718|585539029|FG004|Maintenance Phase|Protocol Violation|0|||
162133069|NCT00783718|585539030|FG005|Maintenance Phase|Protocol Violation|0|||
162133070|NCT00783718|585539031|FG006|Maintenance Phase|Protocol Violation|2|||
162133071|NCT00783718|585539025|FG000|Maintenance Phase|Lack of Efficacy|83|||
162133072|NCT00783718|585539026|FG001|Maintenance Phase|Lack of Efficacy|0|||
162133073|NCT00783718|585539027|FG002|Maintenance Phase|Lack of Efficacy|0|||
162133074|NCT00783718|585539028|FG003|Maintenance Phase|Lack of Efficacy|61|||
162133075|NCT00783718|585539029|FG004|Maintenance Phase|Lack of Efficacy|31|||
162133076|NCT00783718|585539030|FG005|Maintenance Phase|Lack of Efficacy|33|||
162133077|NCT00783718|585539031|FG006|Maintenance Phase|Lack of Efficacy|155|||
162133078|NCT00783718|585539025|FG000|Maintenance Phase|Withdrawal by Subject|6|||
162133079|NCT00783718|585539026|FG001|Maintenance Phase|Withdrawal by Subject|0|||
162133080|NCT00783718|585539027|FG002|Maintenance Phase|Withdrawal by Subject|0|||
162133081|NCT00783718|585539028|FG003|Maintenance Phase|Withdrawal by Subject|2|||
162133082|NCT00783718|585539029|FG004|Maintenance Phase|Withdrawal by Subject|5|||
162133083|NCT00783718|585539030|FG005|Maintenance Phase|Withdrawal by Subject|2|||
162133084|NCT00783718|585539031|FG006|Maintenance Phase|Withdrawal by Subject|20|||
162133085|NCT00783718|585539025|FG000|Maintenance Phase|Lost to Follow-up|3|||
162133086|NCT00783718|585539026|FG001|Maintenance Phase|Lost to Follow-up|0|||
162133087|NCT00783718|585539027|FG002|Maintenance Phase|Lost to Follow-up|0|||
162133088|NCT00783718|585539028|FG003|Maintenance Phase|Lost to Follow-up|0|||
162133089|NCT00783718|585539029|FG004|Maintenance Phase|Lost to Follow-up|2|||
162133090|NCT00783718|585539030|FG005|Maintenance Phase|Lost to Follow-up|0|||
162133091|NCT00783718|585539031|FG006|Maintenance Phase|Lost to Follow-up|2|||
162133092|NCT00577629|585539032|FG000|Treatment Period|Death|1|||
162133093|NCT00577629|585539032|FG000|Long Term Follow-Up|Death|15|||
162133094|NCT00577629|585539032|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
162133095|NCT00577629|585539032|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
162133096|NCT00577629|585539032|FG000|Long Term Follow-Up|Physician Decision|1|||
162133097|NCT02929108|585539035|FG000|Overall Study|Hospice patient death|100|||
162133098|NCT02929108|585539036|FG001|Overall Study|Hospice patient death|64|||
162133099|NCT02929108|585539037|FG002|Overall Study|Hospice patient death|28|||
162133100|NCT02929108|585539038|FG003|Overall Study|Hospice patient death|46|||
162133101|NCT02929108|585539039|FG004|Overall Study|Hospice patient death|55|||
162133102|NCT02929108|585539040|FG005|Overall Study|Hospice patient death|28|||
162133103|NCT02929108|585539041|FG006|Overall Study|Hospice patient death|78|||
162133104|NCT01027871|585539042|FG000|Overall Study|Physician Decision|1|||
162133105|NCT01027871|585539043|FG001|Overall Study|Physician Decision|5|||
162133106|NCT01027871|585539044|FG002|Overall Study|Physician Decision|0|||
162133107|NCT01027871|585539042|FG000|Overall Study|Protocol Violation|0|||
162133108|NCT01027871|585539043|FG001|Overall Study|Protocol Violation|2|||
162133109|NCT01027871|585539044|FG002|Overall Study|Protocol Violation|2|||
162133110|NCT01027871|585539042|FG000|Overall Study|Withdrawal by Subject|1|||
162133111|NCT01027871|585539043|FG001|Overall Study|Withdrawal by Subject|2|||
162133112|NCT01027871|585539044|FG002|Overall Study|Withdrawal by Subject|2|||
162133113|NCT01027871|585539042|FG000|Overall Study|Adverse Event|0|||
162133114|NCT01027871|585539043|FG001|Overall Study|Adverse Event|2|||
162133115|NCT01027871|585539044|FG002|Overall Study|Adverse Event|2|||
162133116|NCT01027871|585539042|FG000|Overall Study|Sponsor Decision|0|||
162133117|NCT01027871|585539043|FG001|Overall Study|Sponsor Decision|2|||
162133118|NCT01027871|585539044|FG002|Overall Study|Sponsor Decision|0|||
162133119|NCT01027871|585539042|FG000|Overall Study|Discontinued Prior to Treatment|0|||
162133120|NCT01027871|585539043|FG001|Overall Study|Discontinued Prior to Treatment|0|||
162133121|NCT01027871|585539044|FG002|Overall Study|Discontinued Prior to Treatment|1|||
162133122|NCT02820051|585539051|FG000|Overall Study|Lost to Follow-up|7|||
162133123|NCT02820051|585539052|FG001|Overall Study|Lost to Follow-up|4|||
162133124|NCT01670500|585539056|FG000|Overall Study|Withdrawal by Subject|1|||
162133125|NCT01670500|585539057|FG001|Overall Study|Withdrawal by Subject|0|||
162133126|NCT04955626|585539058|FG000|Blinded Period|Lost to Follow-up|28|||
162133127|NCT04955626|585539059|FG001|Blinded Period|Lost to Follow-up|28|||
162133128|NCT04955626|585539060|FG002|Blinded Period|Lost to Follow-up|7|||
162133129|NCT04955626|585539061|FG003|Blinded Period|Lost to Follow-up|14|||
162133130|NCT04955626|585539062|FG004|Blinded Period|Lost to Follow-up|3|||
162133131|NCT04955626|585539063|FG005|Blinded Period|Lost to Follow-up|2|||
162133132|NCT04955626|585539064|FG006|Blinded Period|Lost to Follow-up|6|||
162133133|NCT04955626|585539065|FG007|Blinded Period|Lost to Follow-up|4|||
162133134|NCT04955626|585539066|FG008|Blinded Period|Lost to Follow-up|5|||
162133135|NCT04955626|585539067|FG009|Blinded Period|Lost to Follow-up|8|||
162133136|NCT04955626|585539068|FG010|Blinded Period|Lost to Follow-up|10|||
162133137|NCT04955626|585539069|FG011|Blinded Period|Lost to Follow-up|32|||
162133138|NCT04955626|585539070|FG012|Blinded Period|Lost to Follow-up|0|||
162133139|NCT04955626|585539071|FG013|Blinded Period|Lost to Follow-up|0|||
162133140|NCT04955626|585539072|FG014|Blinded Period|Lost to Follow-up|0|||
162133141|NCT04955626|585539073|FG015|Blinded Period|Lost to Follow-up|12|||
162133142|NCT04955626|585539074|FG016|Blinded Period|Lost to Follow-up|2|||
162133143|NCT04955626|585539075|FG017|Blinded Period|Lost to Follow-up|5|||
162133144|NCT04955626|585539076|FG018|Blinded Period|Lost to Follow-up|0|||
162133145|NCT04955626|585539077|FG019|Blinded Period|Lost to Follow-up|0|||
162133146|NCT04955626|585539078|FG020|Blinded Period|Lost to Follow-up|0|||
162133147|NCT04955626|585539079|FG021|Blinded Period|Lost to Follow-up|0|||
162133148|NCT04955626|585539080|FG022|Blinded Period|Lost to Follow-up|0|||
162133149|NCT04955626|585539081|FG023|Blinded Period|Lost to Follow-up|0|||
162133150|NCT04955626|585539082|FG024|Blinded Period|Lost to Follow-up|3|||
162133151|NCT04955626|585539083|FG025|Blinded Period|Lost to Follow-up|1|||
162133152|NCT04955626|585539084|FG026|Blinded Period|Lost to Follow-up|2|||
162133153|NCT04955626|585539085|FG027|Blinded Period|Lost to Follow-up|2|||
162133154|NCT04955626|585539086|FG028|Blinded Period|Lost to Follow-up|2|||
162133155|NCT04955626|585539087|FG029|Blinded Period|Lost to Follow-up|0|||
162133156|NCT04955626|585539088|FG030|Blinded Period|Lost to Follow-up|0|||
162133157|NCT04955626|585539089|FG031|Blinded Period|Lost to Follow-up|0|||
162133158|NCT04955626|585539090|FG032|Blinded Period|Lost to Follow-up|0|||
162133159|NCT04955626|585539091|FG033|Blinded Period|Lost to Follow-up|0|||
162133160|NCT04955626|585539092|FG034|Blinded Period|Lost to Follow-up|0|||
162133161|NCT04955626|585539093|FG035|Blinded Period|Lost to Follow-up|0|||
162133162|NCT04955626|585539058|FG000|Blinded Period|Protocol Violation|5|||
162133163|NCT04955626|585539059|FG001|Blinded Period|Protocol Violation|14|||
162133164|NCT04955626|585539060|FG002|Blinded Period|Protocol Violation|0|||
162133165|NCT04955626|585539061|FG003|Blinded Period|Protocol Violation|1|||
162133166|NCT04955626|585539062|FG004|Blinded Period|Protocol Violation|2|||
162133167|NCT04955626|585539063|FG005|Blinded Period|Protocol Violation|2|||
162133168|NCT04955626|585539064|FG006|Blinded Period|Protocol Violation|0|||
162133169|NCT04955626|585539065|FG007|Blinded Period|Protocol Violation|0|||
162133170|NCT04955626|585539066|FG008|Blinded Period|Protocol Violation|0|||
162133171|NCT04955626|585539067|FG009|Blinded Period|Protocol Violation|4|||
162133172|NCT04955626|585539068|FG010|Blinded Period|Protocol Violation|6|||
162133173|NCT04955626|585539069|FG011|Blinded Period|Protocol Violation|1|||
162133174|NCT04955626|585539070|FG012|Blinded Period|Protocol Violation|0|||
162133175|NCT04955626|585539071|FG013|Blinded Period|Protocol Violation|0|||
162133176|NCT04955626|585539072|FG014|Blinded Period|Protocol Violation|2|||
162133177|NCT04955626|585539073|FG015|Blinded Period|Protocol Violation|6|||
162133178|NCT04955626|585539074|FG016|Blinded Period|Protocol Violation|4|||
162133179|NCT04955626|585539075|FG017|Blinded Period|Protocol Violation|6|||
162133180|NCT04955626|585539076|FG018|Blinded Period|Protocol Violation|0|||
162133181|NCT04955626|585539077|FG019|Blinded Period|Protocol Violation|1|||
162133182|NCT04955626|585539078|FG020|Blinded Period|Protocol Violation|0|||
162133183|NCT04955626|585539079|FG021|Blinded Period|Protocol Violation|1|||
162133184|NCT04955626|585539080|FG022|Blinded Period|Protocol Violation|0|||
162133185|NCT04955626|585539081|FG023|Blinded Period|Protocol Violation|0|||
162133186|NCT04955626|585539082|FG024|Blinded Period|Protocol Violation|4|||
162133187|NCT04955626|585539083|FG025|Blinded Period|Protocol Violation|6|||
162133188|NCT04955626|585539084|FG026|Blinded Period|Protocol Violation|5|||
162133189|NCT04955626|585539085|FG027|Blinded Period|Protocol Violation|3|||
162133190|NCT04955626|585539086|FG028|Blinded Period|Protocol Violation|4|||
162133191|NCT04955626|585539087|FG029|Blinded Period|Protocol Violation|3|||
162133192|NCT04955626|585539088|FG030|Blinded Period|Protocol Violation|0|||
162133193|NCT04955626|585539089|FG031|Blinded Period|Protocol Violation|0|||
162133194|NCT04955626|585539090|FG032|Blinded Period|Protocol Violation|0|||
162133195|NCT04955626|585539091|FG033|Blinded Period|Protocol Violation|0|||
162133196|NCT04955626|585539092|FG034|Blinded Period|Protocol Violation|0|||
162133197|NCT04955626|585539093|FG035|Blinded Period|Protocol Violation|0|||
162133198|NCT04955626|585539058|FG000|Blinded Period|Death|0|||
162133199|NCT04955626|585539059|FG001|Blinded Period|Death|2|||
162133200|NCT04955626|585539060|FG002|Blinded Period|Death|0|||
162133201|NCT04955626|585539061|FG003|Blinded Period|Death|0|||
162133202|NCT04955626|585539062|FG004|Blinded Period|Death|0|||
162133203|NCT04955626|585539063|FG005|Blinded Period|Death|0|||
162133204|NCT04955626|585539064|FG006|Blinded Period|Death|0|||
162133205|NCT04955626|585539065|FG007|Blinded Period|Death|2|||
162133206|NCT04955626|585539066|FG008|Blinded Period|Death|1|||
162133207|NCT04955626|585539067|FG009|Blinded Period|Death|1|||
162133208|NCT04955626|585539068|FG010|Blinded Period|Death|0|||
162133209|NCT04955626|585539069|FG011|Blinded Period|Death|2|||
162133210|NCT04955626|585539070|FG012|Blinded Period|Death|0|||
162133211|NCT04955626|585539071|FG013|Blinded Period|Death|0|||
162133212|NCT04955626|585539072|FG014|Blinded Period|Death|0|||
162133213|NCT04955626|585539073|FG015|Blinded Period|Death|0|||
162133214|NCT04955626|585539074|FG016|Blinded Period|Death|0|||
162133215|NCT04955626|585539075|FG017|Blinded Period|Death|0|||
162133216|NCT04955626|585539076|FG018|Blinded Period|Death|0|||
162133217|NCT04955626|585539077|FG019|Blinded Period|Death|0|||
162133218|NCT04955626|585539078|FG020|Blinded Period|Death|0|||
162133219|NCT04955626|585539079|FG021|Blinded Period|Death|0|||
162133220|NCT04955626|585539080|FG022|Blinded Period|Death|0|||
162133221|NCT04955626|585539081|FG023|Blinded Period|Death|1|||
162133222|NCT04955626|585539082|FG024|Blinded Period|Death|0|||
162133223|NCT04955626|585539083|FG025|Blinded Period|Death|0|||
162133224|NCT04955626|585539084|FG026|Blinded Period|Death|1|||
162133225|NCT04955626|585539085|FG027|Blinded Period|Death|1|||
162133226|NCT04955626|585539086|FG028|Blinded Period|Death|0|||
162133227|NCT04955626|585539087|FG029|Blinded Period|Death|1|||
162133228|NCT04955626|585539088|FG030|Blinded Period|Death|0|||
162133229|NCT04955626|585539089|FG031|Blinded Period|Death|0|||
162133230|NCT04955626|585539090|FG032|Blinded Period|Death|0|||
162133231|NCT04955626|585539091|FG033|Blinded Period|Death|0|||
162133232|NCT04955626|585539092|FG034|Blinded Period|Death|0|||
162133233|NCT04955626|585539093|FG035|Blinded Period|Death|0|||
162133234|NCT04955626|585539058|FG000|Blinded Period|Adverse Event|0|||
162133235|NCT04955626|585539059|FG001|Blinded Period|Adverse Event|1|||
162133236|NCT04955626|585539060|FG002|Blinded Period|Adverse Event|1|||
162133237|NCT04955626|585539061|FG003|Blinded Period|Adverse Event|1|||
162133238|NCT04955626|585539062|FG004|Blinded Period|Adverse Event|0|||
162133239|NCT04955626|585539063|FG005|Blinded Period|Adverse Event|0|||
162133240|NCT04955626|585539064|FG006|Blinded Period|Adverse Event|0|||
162133241|NCT04955626|585539065|FG007|Blinded Period|Adverse Event|0|||
162133242|NCT04955626|585539066|FG008|Blinded Period|Adverse Event|0|||
162133243|NCT04955626|585539067|FG009|Blinded Period|Adverse Event|1|||
162133244|NCT04955626|585539068|FG010|Blinded Period|Adverse Event|1|||
162133245|NCT04955626|585539069|FG011|Blinded Period|Adverse Event|0|||
162133246|NCT04955626|585539070|FG012|Blinded Period|Adverse Event|0|||
162133247|NCT04955626|585539071|FG013|Blinded Period|Adverse Event|0|||
162133248|NCT04955626|585539072|FG014|Blinded Period|Adverse Event|0|||
162133249|NCT04955626|585539073|FG015|Blinded Period|Adverse Event|0|||
162133250|NCT04955626|585539074|FG016|Blinded Period|Adverse Event|0|||
162133251|NCT04955626|585539075|FG017|Blinded Period|Adverse Event|0|||
162133252|NCT04955626|585539076|FG018|Blinded Period|Adverse Event|1|||
162133253|NCT04955626|585539077|FG019|Blinded Period|Adverse Event|0|||
162133254|NCT04955626|585539078|FG020|Blinded Period|Adverse Event|0|||
162133255|NCT04955626|585539079|FG021|Blinded Period|Adverse Event|0|||
162133256|NCT04955626|585539080|FG022|Blinded Period|Adverse Event|0|||
162133257|NCT04955626|585539081|FG023|Blinded Period|Adverse Event|0|||
162133258|NCT04955626|585539082|FG024|Blinded Period|Adverse Event|0|||
162133259|NCT04955626|585539083|FG025|Blinded Period|Adverse Event|0|||
162133260|NCT04955626|585539084|FG026|Blinded Period|Adverse Event|1|||
162133261|NCT04955626|585539085|FG027|Blinded Period|Adverse Event|0|||
162133262|NCT04955626|585539086|FG028|Blinded Period|Adverse Event|0|||
162133263|NCT04955626|585539087|FG029|Blinded Period|Adverse Event|0|||
162133264|NCT04955626|585539088|FG030|Blinded Period|Adverse Event|0|||
162133265|NCT04955626|585539089|FG031|Blinded Period|Adverse Event|0|||
162133266|NCT04955626|585539090|FG032|Blinded Period|Adverse Event|0|||
162133267|NCT04955626|585539091|FG033|Blinded Period|Adverse Event|0|||
162133268|NCT04955626|585539092|FG034|Blinded Period|Adverse Event|0|||
162133269|NCT04955626|585539093|FG035|Blinded Period|Adverse Event|0|||
162133270|NCT04955626|585539058|FG000|Blinded Period|No longer meets eligibility criteria|1|||
162133271|NCT04955626|585539059|FG001|Blinded Period|No longer meets eligibility criteria|2|||
162133272|NCT04955626|585539060|FG002|Blinded Period|No longer meets eligibility criteria|0|||
162133273|NCT04955626|585539061|FG003|Blinded Period|No longer meets eligibility criteria|1|||
162133274|NCT04955626|585539062|FG004|Blinded Period|No longer meets eligibility criteria|0|||
162133275|NCT04955626|585539063|FG005|Blinded Period|No longer meets eligibility criteria|0|||
162133276|NCT04955626|585539064|FG006|Blinded Period|No longer meets eligibility criteria|0|||
162133277|NCT04955626|585539065|FG007|Blinded Period|No longer meets eligibility criteria|0|||
162133278|NCT04955626|585539066|FG008|Blinded Period|No longer meets eligibility criteria|1|||
162133279|NCT04955626|585539067|FG009|Blinded Period|No longer meets eligibility criteria|0|||
162133280|NCT04955626|585539068|FG010|Blinded Period|No longer meets eligibility criteria|1|||
162133281|NCT04955626|585539069|FG011|Blinded Period|No longer meets eligibility criteria|1|||
162133282|NCT04955626|585539070|FG012|Blinded Period|No longer meets eligibility criteria|0|||
162133283|NCT04955626|585539071|FG013|Blinded Period|No longer meets eligibility criteria|0|||
162133284|NCT04955626|585539072|FG014|Blinded Period|No longer meets eligibility criteria|0|||
162133285|NCT04955626|585539073|FG015|Blinded Period|No longer meets eligibility criteria|3|||
162133286|NCT04955626|585539074|FG016|Blinded Period|No longer meets eligibility criteria|0|||
162133287|NCT04955626|585539075|FG017|Blinded Period|No longer meets eligibility criteria|2|||
162133288|NCT04955626|585539076|FG018|Blinded Period|No longer meets eligibility criteria|0|||
162133289|NCT04955626|585539077|FG019|Blinded Period|No longer meets eligibility criteria|0|||
162133290|NCT04955626|585539078|FG020|Blinded Period|No longer meets eligibility criteria|0|||
162133291|NCT04955626|585539079|FG021|Blinded Period|No longer meets eligibility criteria|0|||
162133292|NCT04955626|585539080|FG022|Blinded Period|No longer meets eligibility criteria|0|||
162133293|NCT04955626|585539081|FG023|Blinded Period|No longer meets eligibility criteria|0|||
162133294|NCT04955626|585539082|FG024|Blinded Period|No longer meets eligibility criteria|1|||
162133295|NCT04955626|585539083|FG025|Blinded Period|No longer meets eligibility criteria|0|||
162133296|NCT04955626|585539084|FG026|Blinded Period|No longer meets eligibility criteria|0|||
162133297|NCT04955626|585539085|FG027|Blinded Period|No longer meets eligibility criteria|1|||
162133298|NCT04955626|585539086|FG028|Blinded Period|No longer meets eligibility criteria|0|||
162133299|NCT04955626|585539087|FG029|Blinded Period|No longer meets eligibility criteria|0|||
162133300|NCT04955626|585539088|FG030|Blinded Period|No longer meets eligibility criteria|0|||
161794858|NCT00385541|584292400|FG001|Overall Study|severe pain, clinician requested unblind|1|||
161794859|NCT00929708|584292401|FG000|Overall Study|Protocol Violation|2|||
161794860|NCT00929708|584292402|FG001|Overall Study|Protocol Violation|1|||
161794861|NCT00929708|584292403|FG002|Overall Study|Protocol Violation|1|||
161794862|NCT00929708|584292404|FG003|Overall Study|Protocol Violation|1|||
161794863|NCT00929708|584292405|FG004|Overall Study|Protocol Violation|1|||
161794864|NCT00929708|584292401|FG000|Overall Study|Withdrawal by Subject|2|||
161794865|NCT00929708|584292402|FG001|Overall Study|Withdrawal by Subject|0|||
161794866|NCT00929708|584292403|FG002|Overall Study|Withdrawal by Subject|0|||
162133301|NCT04955626|585539089|FG031|Blinded Period|No longer meets eligibility criteria|0|||
162133302|NCT04955626|585539090|FG032|Blinded Period|No longer meets eligibility criteria|0|||
162133303|NCT04955626|585539091|FG033|Blinded Period|No longer meets eligibility criteria|0|||
162133304|NCT04955626|585539092|FG034|Blinded Period|No longer meets eligibility criteria|0|||
162133305|NCT04955626|585539093|FG035|Blinded Period|No longer meets eligibility criteria|0|||
162133306|NCT04955626|585539058|FG000|Blinded Period|Other|54|||
162133307|NCT04955626|585539059|FG001|Blinded Period|Other|3|||
162133308|NCT04955626|585539060|FG002|Blinded Period|Other|4|||
162133309|NCT04955626|585539061|FG003|Blinded Period|Other|2|||
162133310|NCT04955626|585539062|FG004|Blinded Period|Other|0|||
162133311|NCT04955626|585539063|FG005|Blinded Period|Other|0|||
162133312|NCT04955626|585539064|FG006|Blinded Period|Other|2|||
162133313|NCT04955626|585539065|FG007|Blinded Period|Other|2|||
162133314|NCT04955626|585539066|FG008|Blinded Period|Other|1|||
162133315|NCT04955626|585539067|FG009|Blinded Period|Other|0|||
162133316|NCT04955626|585539068|FG010|Blinded Period|Other|1|||
162133317|NCT04955626|585539069|FG011|Blinded Period|Other|1|||
162133318|NCT04955626|585539070|FG012|Blinded Period|Other|0|||
162133319|NCT04955626|585539071|FG013|Blinded Period|Other|0|||
162133320|NCT04955626|585539072|FG014|Blinded Period|Other|0|||
162133321|NCT04955626|585539073|FG015|Blinded Period|Other|0|||
162133322|NCT04955626|585539074|FG016|Blinded Period|Other|0|||
162133323|NCT04955626|585539075|FG017|Blinded Period|Other|1|||
161794867|NCT00929708|584292404|FG003|Overall Study|Withdrawal by Subject|2|||
161794868|NCT00929708|584292405|FG004|Overall Study|Withdrawal by Subject|1|||
161794869|NCT00929708|584292401|FG000|Overall Study|Adverse Event|0|||
161794870|NCT00929708|584292402|FG001|Overall Study|Adverse Event|0|||
162133324|NCT04955626|585539076|FG018|Blinded Period|Other|0|||
162133325|NCT04955626|585539077|FG019|Blinded Period|Other|0|||
162133326|NCT04955626|585539078|FG020|Blinded Period|Other|0|||
162133327|NCT04955626|585539079|FG021|Blinded Period|Other|0|||
162133328|NCT04955626|585539080|FG022|Blinded Period|Other|0|||
162133329|NCT04955626|585539081|FG023|Blinded Period|Other|0|||
162133330|NCT04955626|585539082|FG024|Blinded Period|Other|0|||
162133331|NCT04955626|585539083|FG025|Blinded Period|Other|0|||
162133332|NCT04955626|585539084|FG026|Blinded Period|Other|2|||
162133333|NCT04955626|585539085|FG027|Blinded Period|Other|0|||
162133334|NCT04955626|585539086|FG028|Blinded Period|Other|0|||
162133335|NCT04955626|585539087|FG029|Blinded Period|Other|0|||
162133336|NCT04955626|585539088|FG030|Blinded Period|Other|0|||
162133337|NCT04955626|585539089|FG031|Blinded Period|Other|0|||
161900349|NCT00249873|584683009|FG001|Overall Study|Not treated|8|||
161900350|NCT00249873|584683008|FG000|Overall Study|Significant thrombocytopenia|9|||
161900351|NCT00249873|584683009|FG001|Overall Study|Significant thrombocytopenia|8|||
161900352|NCT00249873|584683008|FG000|Overall Study|Severe allergic reaction|8|||
161900353|NCT00249873|584683009|FG001|Overall Study|Severe allergic reaction|1|||
161900354|NCT00249873|584683008|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
161900355|NCT00249873|584683009|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
161900356|NCT00249873|584683008|FG000|Overall Study|Other Serious Adverse Event|86|||
161900357|NCT00249873|584683009|FG001|Overall Study|Other Serious Adverse Event|97|||
161900358|NCT00249873|584683008|FG000|Overall Study|Qualifying condition not present|20|||
161900359|NCT00249873|584683009|FG001|Overall Study|Qualifying condition not present|23|||
161900360|NCT00249873|584683008|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
161900361|NCT00249873|584683009|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
161900362|NCT00249873|584683008|FG000|Overall Study|Withdrawal by Subject|504|||
161900363|NCT00249873|584683009|FG001|Overall Study|Withdrawal by Subject|466|||
161900364|NCT00249873|584683008|FG000|Overall Study|Lost to Follow-up|4|||
161900365|NCT00249873|584683009|FG001|Overall Study|Lost to Follow-up|7|||
161900366|NCT00249873|584683008|FG000|Overall Study|Minor bleeding|99|||
161900367|NCT00249873|584683009|FG001|Overall Study|Minor bleeding|37|||
161900368|NCT00249873|584683008|FG000|Overall Study|Non-compliance|41|||
161900369|NCT00249873|584683009|FG001|Overall Study|Non-compliance|46|||
161900370|NCT00249873|584683008|FG000|Overall Study|Other non serious Adverse Event|112|||
162133338|NCT04955626|585539090|FG032|Blinded Period|Other|0|||
162133339|NCT04955626|585539091|FG033|Blinded Period|Other|0|||
162133340|NCT04955626|585539092|FG034|Blinded Period|Other|0|||
162133341|NCT04955626|585539093|FG035|Blinded Period|Other|0|||
162133342|NCT04955626|585539058|FG000|Blinded Period|Physician Decision|1|||
162133343|NCT04955626|585539059|FG001|Blinded Period|Physician Decision|1|||
162133344|NCT04955626|585539060|FG002|Blinded Period|Physician Decision|0|||
162133345|NCT04955626|585539061|FG003|Blinded Period|Physician Decision|3|||
162133346|NCT04955626|585539062|FG004|Blinded Period|Physician Decision|0|||
162133347|NCT04955626|585539063|FG005|Blinded Period|Physician Decision|0|||
162133348|NCT04955626|585539064|FG006|Blinded Period|Physician Decision|1|||
162133349|NCT04955626|585539065|FG007|Blinded Period|Physician Decision|1|||
162133350|NCT04955626|585539066|FG008|Blinded Period|Physician Decision|0|||
162133351|NCT04955626|585539067|FG009|Blinded Period|Physician Decision|0|||
162133352|NCT04955626|585539068|FG010|Blinded Period|Physician Decision|0|||
162133353|NCT04955626|585539069|FG011|Blinded Period|Physician Decision|5|||
162133354|NCT04955626|585539070|FG012|Blinded Period|Physician Decision|0|||
162133355|NCT04955626|585539071|FG013|Blinded Period|Physician Decision|0|||
162133356|NCT04955626|585539072|FG014|Blinded Period|Physician Decision|0|||
162133357|NCT04955626|585539073|FG015|Blinded Period|Physician Decision|0|||
162133358|NCT04955626|585539074|FG016|Blinded Period|Physician Decision|0|||
162133359|NCT04955626|585539075|FG017|Blinded Period|Physician Decision|0|||
162133360|NCT04955626|585539076|FG018|Blinded Period|Physician Decision|0|||
162133361|NCT04955626|585539077|FG019|Blinded Period|Physician Decision|0|||
162133362|NCT04955626|585539078|FG020|Blinded Period|Physician Decision|0|||
162133363|NCT04955626|585539079|FG021|Blinded Period|Physician Decision|0|||
161900371|NCT00249873|584683009|FG001|Overall Study|Other non serious Adverse Event|108|||
161900372|NCT00249873|584683008|FG000|Overall Study|Other contraindicated medication|1|||
162133364|NCT04955626|585539080|FG022|Blinded Period|Physician Decision|0|||
162133365|NCT04955626|585539081|FG023|Blinded Period|Physician Decision|0|||
162133366|NCT04955626|585539082|FG024|Blinded Period|Physician Decision|0|||
162133367|NCT04955626|585539083|FG025|Blinded Period|Physician Decision|0|||
162133368|NCT04955626|585539084|FG026|Blinded Period|Physician Decision|0|||
162133369|NCT04955626|585539085|FG027|Blinded Period|Physician Decision|0|||
162133370|NCT04955626|585539086|FG028|Blinded Period|Physician Decision|0|||
162133371|NCT04955626|585539087|FG029|Blinded Period|Physician Decision|0|||
162133372|NCT04955626|585539088|FG030|Blinded Period|Physician Decision|0|||
162133373|NCT04955626|585539089|FG031|Blinded Period|Physician Decision|0|||
161900373|NCT00249873|584683009|FG001|Overall Study|Other contraindicated medication|0|||
161900374|NCT00249873|584683008|FG000|Overall Study|Patient not wish to continue after May08|3|||
161900375|NCT00249873|584683009|FG001|Overall Study|Patient not wish to continue after May08|4|||
162133374|NCT04955626|585539090|FG032|Blinded Period|Physician Decision|0|||
162133375|NCT04955626|585539091|FG033|Blinded Period|Physician Decision|0|||
162133376|NCT04955626|585539092|FG034|Blinded Period|Physician Decision|0|||
161900376|NCT00249873|584683008|FG000|Overall Study|Physician withdrew consent|59|||
161900377|NCT00249873|584683009|FG001|Overall Study|Physician withdrew consent|60|||
161900378|NCT00249873|584683008|FG000|Overall Study|Open label clopidogrel required|31|||
161900379|NCT00249873|584683009|FG001|Overall Study|Open label clopidogrel required|42|||
161900380|NCT00249873|584683008|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
161900381|NCT00249873|584683009|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
161900382|NCT00249873|584683008|FG000|Overall Study|Oral anticoagulant required|159|||
162133377|NCT04955626|585539093|FG035|Blinded Period|Physician Decision|0|||
162133378|NCT04955626|585539058|FG000|Blinded Period|Withdrawal by Subject|26|||
162133379|NCT04955626|585539059|FG001|Blinded Period|Withdrawal by Subject|62|||
162133380|NCT04955626|585539060|FG002|Blinded Period|Withdrawal by Subject|14|||
162133381|NCT04955626|585539061|FG003|Blinded Period|Withdrawal by Subject|16|||
162133382|NCT04955626|585539062|FG004|Blinded Period|Withdrawal by Subject|1|||
162133383|NCT04955626|585539063|FG005|Blinded Period|Withdrawal by Subject|2|||
162133384|NCT04955626|585539064|FG006|Blinded Period|Withdrawal by Subject|9|||
162133385|NCT04955626|585539065|FG007|Blinded Period|Withdrawal by Subject|5|||
162133386|NCT04955626|585539066|FG008|Blinded Period|Withdrawal by Subject|3|||
162133387|NCT04955626|585539067|FG009|Blinded Period|Withdrawal by Subject|15|||
162133388|NCT04955626|585539068|FG010|Blinded Period|Withdrawal by Subject|11|||
162133389|NCT04955626|585539069|FG011|Blinded Period|Withdrawal by Subject|7|||
162133390|NCT04955626|585539070|FG012|Blinded Period|Withdrawal by Subject|2|||
162133391|NCT04955626|585539071|FG013|Blinded Period|Withdrawal by Subject|0|||
162133392|NCT04955626|585539072|FG014|Blinded Period|Withdrawal by Subject|1|||
162133393|NCT04955626|585539073|FG015|Blinded Period|Withdrawal by Subject|11|||
162133394|NCT04955626|585539074|FG016|Blinded Period|Withdrawal by Subject|2|||
162133395|NCT04955626|585539075|FG017|Blinded Period|Withdrawal by Subject|5|||
162133396|NCT04955626|585539076|FG018|Blinded Period|Withdrawal by Subject|0|||
162133397|NCT04955626|585539077|FG019|Blinded Period|Withdrawal by Subject|0|||
162133398|NCT04955626|585539078|FG020|Blinded Period|Withdrawal by Subject|1|||
162133399|NCT04955626|585539079|FG021|Blinded Period|Withdrawal by Subject|0|||
162133400|NCT04955626|585539080|FG022|Blinded Period|Withdrawal by Subject|0|||
162133401|NCT04955626|585539081|FG023|Blinded Period|Withdrawal by Subject|0|||
162133402|NCT04955626|585539082|FG024|Blinded Period|Withdrawal by Subject|5|||
162133403|NCT04955626|585539083|FG025|Blinded Period|Withdrawal by Subject|1|||
162133404|NCT04955626|585539084|FG026|Blinded Period|Withdrawal by Subject|5|||
162133405|NCT04955626|585539085|FG027|Blinded Period|Withdrawal by Subject|1|||
162133406|NCT04955626|585539086|FG028|Blinded Period|Withdrawal by Subject|4|||
162133407|NCT04955626|585539087|FG029|Blinded Period|Withdrawal by Subject|2|||
162133408|NCT04955626|585539088|FG030|Blinded Period|Withdrawal by Subject|0|||
162133409|NCT04955626|585539089|FG031|Blinded Period|Withdrawal by Subject|0|||
162133410|NCT04955626|585539090|FG032|Blinded Period|Withdrawal by Subject|0|||
162133411|NCT04955626|585539091|FG033|Blinded Period|Withdrawal by Subject|0|||
162133412|NCT04955626|585539092|FG034|Blinded Period|Withdrawal by Subject|0|||
162133413|NCT04955626|585539093|FG035|Blinded Period|Withdrawal by Subject|0|||
162133414|NCT04955626|585539058|FG000|Blinded Period|Refused further study procedures|0|||
162133415|NCT04955626|585539059|FG001|Blinded Period|Refused further study procedures|0|||
162133416|NCT04955626|585539060|FG002|Blinded Period|Refused further study procedures|0|||
162133417|NCT04955626|585539061|FG003|Blinded Period|Refused further study procedures|0|||
162133418|NCT04955626|585539062|FG004|Blinded Period|Refused further study procedures|0|||
162133419|NCT04955626|585539063|FG005|Blinded Period|Refused further study procedures|0|||
162133420|NCT04955626|585539064|FG006|Blinded Period|Refused further study procedures|1|||
162133421|NCT04955626|585539065|FG007|Blinded Period|Refused further study procedures|0|||
162133422|NCT04955626|585539066|FG008|Blinded Period|Refused further study procedures|0|||
162133423|NCT04955626|585539067|FG009|Blinded Period|Refused further study procedures|0|||
162133424|NCT04955626|585539068|FG010|Blinded Period|Refused further study procedures|0|||
162133425|NCT04955626|585539069|FG011|Blinded Period|Refused further study procedures|2|||
162133426|NCT04955626|585539070|FG012|Blinded Period|Refused further study procedures|0|||
162133427|NCT04955626|585539071|FG013|Blinded Period|Refused further study procedures|0|||
162133428|NCT04955626|585539072|FG014|Blinded Period|Refused further study procedures|0|||
162133429|NCT04955626|585539073|FG015|Blinded Period|Refused further study procedures|0|||
162133430|NCT04955626|585539074|FG016|Blinded Period|Refused further study procedures|0|||
161900383|NCT00249873|584683009|FG001|Overall Study|Oral anticoagulant required|157|||
161900384|NCT00249873|584683008|FG000|Overall Study|Study drug intolerance|5|||
161900385|NCT00249873|584683009|FG001|Overall Study|Study drug intolerance|0|||
162133431|NCT04955626|585539075|FG017|Blinded Period|Refused further study procedures|0|||
162133432|NCT04955626|585539076|FG018|Blinded Period|Refused further study procedures|0|||
162133433|NCT04955626|585539077|FG019|Blinded Period|Refused further study procedures|0|||
162133434|NCT04955626|585539078|FG020|Blinded Period|Refused further study procedures|0|||
162133435|NCT04955626|585539079|FG021|Blinded Period|Refused further study procedures|0|||
162133436|NCT04955626|585539080|FG022|Blinded Period|Refused further study procedures|0|||
162133437|NCT04955626|585539081|FG023|Blinded Period|Refused further study procedures|0|||
161900386|NCT00249873|584683008|FG000|Overall Study|Surgery/ procedure|9|||
161900387|NCT00249873|584683009|FG001|Overall Study|Surgery/ procedure|9|||
162133438|NCT04955626|585539082|FG024|Blinded Period|Refused further study procedures|0|||
162133439|NCT04955626|585539083|FG025|Blinded Period|Refused further study procedures|0|||
162133440|NCT04955626|585539084|FG026|Blinded Period|Refused further study procedures|0|||
162133441|NCT04955626|585539085|FG027|Blinded Period|Refused further study procedures|0|||
162133442|NCT04955626|585539086|FG028|Blinded Period|Refused further study procedures|0|||
161794871|NCT00929708|584292403|FG002|Overall Study|Adverse Event|0|||
161794872|NCT00929708|584292404|FG003|Overall Study|Adverse Event|0|||
161794873|NCT00929708|584292405|FG004|Overall Study|Adverse Event|3|||
161794874|NCT00929708|584292401|FG000|Overall Study|Physician Decision|0|||
161794875|NCT00929708|584292402|FG001|Overall Study|Physician Decision|2|||
161794876|NCT00929708|584292403|FG002|Overall Study|Physician Decision|2|||
161794877|NCT00929708|584292404|FG003|Overall Study|Physician Decision|2|||
161794878|NCT00929708|584292405|FG004|Overall Study|Physician Decision|1|||
161794879|NCT00929708|584292401|FG000|Overall Study|Lost to Follow-up|0|||
161794880|NCT00929708|584292402|FG001|Overall Study|Lost to Follow-up|0|||
161794881|NCT00929708|584292403|FG002|Overall Study|Lost to Follow-up|0|||
161794882|NCT00929708|584292404|FG003|Overall Study|Lost to Follow-up|1|||
161794883|NCT00929708|584292405|FG004|Overall Study|Lost to Follow-up|0|||
161794884|NCT03495869|584292406|FG000|Overall Study|Lost to Follow-up|4|||
161794885|NCT03495869|584292407|FG001|Overall Study|Lost to Follow-up|17|||
161794886|NCT03495869|584292408|FG002|Overall Study|Lost to Follow-up|8|||
161794887|NCT03495869|584292409|FG003|Overall Study|Lost to Follow-up|14|||
161794888|NCT03495869|584292406|FG000|Overall Study|Withdrawal by Subject|0|||
161794889|NCT03495869|584292407|FG001|Overall Study|Withdrawal by Subject|3|||
161794890|NCT03495869|584292408|FG002|Overall Study|Withdrawal by Subject|0|||
161794891|NCT03495869|584292409|FG003|Overall Study|Withdrawal by Subject|3|||
161794892|NCT03495869|584292406|FG000|Overall Study|Dropped from study|0|||
161794893|NCT03495869|584292407|FG001|Overall Study|Dropped from study|7|||
161794894|NCT03495869|584292408|FG002|Overall Study|Dropped from study|2|||
161794895|NCT03495869|584292409|FG003|Overall Study|Dropped from study|4|||
161794896|NCT02154529|584292410|FG000|Overall Study|Death|1|||
161794897|NCT02154529|584292411|FG001|Overall Study|Death|1|||
161794898|NCT02154529|584292412|FG002|Overall Study|Death|5|||
161794899|NCT02154529|584292413|FG003|Overall Study|Death|1|||
161794900|NCT02154529|584292410|FG000|Overall Study|Termination of study by sponsor|2|||
161794901|NCT02154529|584292411|FG001|Overall Study|Termination of study by sponsor|2|||
161794902|NCT02154529|584292412|FG002|Overall Study|Termination of study by sponsor|3|||
161794903|NCT02154529|584292413|FG003|Overall Study|Termination of study by sponsor|1|||
161794904|NCT02154529|584292410|FG000|Overall Study|Lost to Follow-up|1|||
161794905|NCT02154529|584292411|FG001|Overall Study|Lost to Follow-up|0|||
161794906|NCT02154529|584292412|FG002|Overall Study|Lost to Follow-up|0|||
161794907|NCT02154529|584292413|FG003|Overall Study|Lost to Follow-up|0|||
161794908|NCT05440097|584293604|FG000|Overall Study|Withdrawal by Subject|154|||
161794909|NCT05440097|584293604|FG000|Overall Study|Death|2|||
161794910|NCT05440097|584293604|FG000|Overall Study|Physician Decision|2|||
161794911|NCT05440097|584293604|FG000|Overall Study|Lost to Follow-up|56|||
161794912|NCT05440097|584293604|FG000|Overall Study|"Include enrolled by mistake and withdrawed by mistake."|15|||
161794913|NCT02081599|584293605|FG000|Period 1：Double-blind Period|Adverse Event|3|||
161794914|NCT02081599|584293606|FG001|Period 1：Double-blind Period|Adverse Event|0|||
161794915|NCT02081599|584293605|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
161794916|NCT02081599|584293606|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
161794917|NCT02081599|584293605|FG000|Period 1：Double-blind Period|Physician Decision|1|||
161794918|NCT02081599|584293606|FG001|Period 1：Double-blind Period|Physician Decision|0|||
161794919|NCT02081599|584293605|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
161794920|NCT02081599|584293606|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
161794921|NCT02081599|584293605|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
161794922|NCT02081599|584293606|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
161794923|NCT02081599|584293605|FG000|Period 1：Double-blind Period|stopping criteria|1|||
161794924|NCT02081599|584293606|FG001|Period 1：Double-blind Period|stopping criteria|0|||
161794925|NCT02081599|584293605|FG000|Period 2：Open-label Period|Adverse Event|1|||
161794926|NCT02081599|584293606|FG001|Period 2：Open-label Period|Adverse Event|0|||
161794927|NCT02081599|584293605|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
161794928|NCT02081599|584293606|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
161794929|NCT02081599|584293605|FG000|Period 2：Open-label Period|Physician Decision|1|||
161794930|NCT02081599|584293606|FG001|Period 2：Open-label Period|Physician Decision|0|||
161794931|NCT02081599|584293605|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
161794932|NCT02081599|584293606|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
161794933|NCT02146430|584293616|FG000|Overall Study|Protocol Violation|5|||
161794934|NCT02146430|584293617|FG001|Overall Study|Protocol Violation|4|||
161794935|NCT02146430|584293618|FG002|Overall Study|Protocol Violation|8|||
161794936|NCT02146430|584293619|FG003|Overall Study|Protocol Violation|6|||
161794937|NCT02146430|584293616|FG000|Overall Study|Lack of Efficacy|13|||
161794938|NCT02146430|584293617|FG001|Overall Study|Lack of Efficacy|11|||
161794939|NCT02146430|584293618|FG002|Overall Study|Lack of Efficacy|8|||
161794940|NCT02146430|584293619|FG003|Overall Study|Lack of Efficacy|5|||
161794941|NCT02146430|584293616|FG000|Overall Study|Adverse Event|20|||
161900388|NCT00249873|584683008|FG000|Overall Study|Event related to cardiac condition|12|||
161900389|NCT00249873|584683009|FG001|Overall Study|Event related to cardiac condition|21|||
161900390|NCT00249873|584683008|FG000|Overall Study|Thromboembolic/outcome event|82|||
161900391|NCT00249873|584683009|FG001|Overall Study|Thromboembolic/outcome event|122|||
161900392|NCT02532374|584683010|FG000|Overall Study|Withdrawal by Subject|1|||
161900393|NCT02532374|584683010|FG000|Overall Study|Physician Decision|1|||
161900394|NCT02762084|584683011|FG000|Overall Study|Withdrawal by Subject|1|||
161900395|NCT02762084|584683012|FG001|Overall Study|Withdrawal by Subject|0|||
161900396|NCT02762084|584683013|FG002|Overall Study|Withdrawal by Subject|0|||
161900397|NCT02762084|584683011|FG000|Overall Study|Adverse Event|0|||
161900398|NCT02762084|584683012|FG001|Overall Study|Adverse Event|0|||
161900399|NCT02762084|584683013|FG002|Overall Study|Adverse Event|1|||
161900400|NCT02659943|584683014|FG000|Overall Study|Switched to alternative treatment|1|||
161900401|NCT02659943|584683015|FG001|Overall Study|Switched to alternative treatment|1|||
161900402|NCT02659943|584683016|FG002|Overall Study|Switched to alternative treatment|0|||
161900403|NCT02659943|584683017|FG003|Overall Study|Switched to alternative treatment|2|||
161900404|NCT02659943|584683018|FG004|Overall Study|Switched to alternative treatment|1|||
161900405|NCT02659943|584683019|FG005|Overall Study|Switched to alternative treatment|0|||
161900406|NCT02659943|584683020|FG006|Overall Study|Switched to alternative treatment|1|||
161900407|NCT02659943|584683014|FG000|Overall Study|Disease progression on study|0|||
161900408|NCT02659943|584683015|FG001|Overall Study|Disease progression on study|1|||
161900409|NCT02659943|584683016|FG002|Overall Study|Disease progression on study|1|||
161900410|NCT02659943|584683017|FG003|Overall Study|Disease progression on study|1|||
161900411|NCT02659943|584683018|FG004|Overall Study|Disease progression on study|1|||
161900412|NCT02659943|584683019|FG005|Overall Study|Disease progression on study|4|||
161900413|NCT02659943|584683020|FG006|Overall Study|Disease progression on study|0|||
161900414|NCT02659943|584683014|FG000|Overall Study|Patient's condition per principal investigator|0|||
161900415|NCT02659943|584683015|FG001|Overall Study|Patient's condition per principal investigator|0|||
161900416|NCT02659943|584683016|FG002|Overall Study|Patient's condition per principal investigator|0|||
161900417|NCT02659943|584683017|FG003|Overall Study|Patient's condition per principal investigator|0|||
161900418|NCT02659943|584683018|FG004|Overall Study|Patient's condition per principal investigator|0|||
161900419|NCT02659943|584683019|FG005|Overall Study|Patient's condition per principal investigator|1|||
161900420|NCT02659943|584683020|FG006|Overall Study|Patient's condition per principal investigator|0|||
161900421|NCT02659943|584683014|FG000|Overall Study|Ineligible|0|||
161900422|NCT02659943|584683015|FG001|Overall Study|Ineligible|0|||
161900423|NCT02659943|584683016|FG002|Overall Study|Ineligible|0|||
161900424|NCT02659943|584683017|FG003|Overall Study|Ineligible|0|||
161900425|NCT02659943|584683018|FG004|Overall Study|Ineligible|0|||
161900426|NCT02659943|584683019|FG005|Overall Study|Ineligible|0|||
161900427|NCT02659943|584683020|FG006|Overall Study|Ineligible|1|||
161900428|NCT02659943|584683014|FG000|Overall Study|No longer meets eligibility|0|||
161900429|NCT02659943|584683015|FG001|Overall Study|No longer meets eligibility|0|||
161900430|NCT02659943|584683016|FG002|Overall Study|No longer meets eligibility|0|||
161900431|NCT02659943|584683017|FG003|Overall Study|No longer meets eligibility|0|||
161900432|NCT02659943|584683018|FG004|Overall Study|No longer meets eligibility|0|||
161900433|NCT02659943|584683019|FG005|Overall Study|No longer meets eligibility|0|||
161900434|NCT02659943|584683020|FG006|Overall Study|No longer meets eligibility|1|||
161900435|NCT02659943|584683014|FG000|Overall Study|No treatment, per protocol|0|||
161900436|NCT02659943|584683015|FG001|Overall Study|No treatment, per protocol|0|||
161900437|NCT02659943|584683016|FG002|Overall Study|No treatment, per protocol|0|||
161900438|NCT02659943|584683017|FG003|Overall Study|No treatment, per protocol|0|||
161900439|NCT02659943|584683018|FG004|Overall Study|No treatment, per protocol|0|||
161900440|NCT02659943|584683019|FG005|Overall Study|No treatment, per protocol|0|||
161900441|NCT02659943|584683020|FG006|Overall Study|No treatment, per protocol|3|||
161900442|NCT03478371|584683021|FG000|Overall Study|non-compliance|1|||
161900443|NCT03478371|584683021|FG000|Overall Study|Lost to Follow-up|4|||
161900444|NCT00627497|584683025|FG000|Overall Study|Lost to Follow-up|1|||
161900445|NCT00627497|584683026|FG001|Overall Study|Lost to Follow-up|1|||
161900446|NCT00627497|584683027|FG002|Overall Study|Lost to Follow-up|0|||
161900447|NCT00627497|584683028|FG003|Overall Study|Lost to Follow-up|0|||
161900448|NCT04767373|584683031|FG000|Overall Study|Death|6|||
161900449|NCT04767373|584683032|FG001|Overall Study|Death|3|||
161900450|NCT04767373|584683031|FG000|Overall Study|Lost to Follow-up|67|||
161900451|NCT04767373|584683032|FG001|Overall Study|Lost to Follow-up|35|||
161900452|NCT04767373|584683031|FG000|Overall Study|Physician Decision|15|||
161900453|NCT04767373|584683032|FG001|Overall Study|Physician Decision|4|||
161900454|NCT04767373|584683031|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161900455|NCT04767373|584683032|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161900456|NCT04767373|584683031|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
161900457|NCT04767373|584683032|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
161900458|NCT04767373|584683031|FG000|Overall Study|Other|1|||
161900459|NCT04767373|584683032|FG001|Overall Study|Other|2|||
161900460|NCT00099632|584683037|FG000|Overall Study|Lost to Follow-up|1|||
161900461|NCT00099632|584683038|FG001|Overall Study|Lost to Follow-up|0|||
161900462|NCT00099632|584683039|FG002|Overall Study|Lost to Follow-up|3|||
162133443|NCT04955626|585539087|FG029|Blinded Period|Refused further study procedures|0|||
162133444|NCT04955626|585539088|FG030|Blinded Period|Refused further study procedures|0|||
162133445|NCT04955626|585539089|FG031|Blinded Period|Refused further study procedures|0|||
162133446|NCT04955626|585539090|FG032|Blinded Period|Refused further study procedures|0|||
162133447|NCT04955626|585539091|FG033|Blinded Period|Refused further study procedures|0|||
162133448|NCT04955626|585539092|FG034|Blinded Period|Refused further study procedures|0|||
162133449|NCT04955626|585539093|FG035|Blinded Period|Refused further study procedures|0|||
162133450|NCT04955626|585539058|FG000|Blinded Period|Participants entered open label period|4544|||
162133451|NCT04955626|585539059|FG001|Blinded Period|Participants entered open label period|4906|||
162133452|NCT04955626|585539060|FG002|Blinded Period|Participants entered open label period|0|||
162133453|NCT04955626|585539061|FG003|Blinded Period|Participants entered open label period|0|||
162133454|NCT04955626|585539062|FG004|Blinded Period|Participants entered open label period|0|||
162133455|NCT04955626|585539063|FG005|Blinded Period|Participants entered open label period|0|||
162133456|NCT04955626|585539064|FG006|Blinded Period|Participants entered open label period|0|||
162133457|NCT04955626|585539065|FG007|Blinded Period|Participants entered open label period|0|||
162133458|NCT04955626|585539066|FG008|Blinded Period|Participants entered open label period|0|||
162133459|NCT04955626|585539067|FG009|Blinded Period|Participants entered open label period|0|||
162133460|NCT04955626|585539068|FG010|Blinded Period|Participants entered open label period|0|||
162133461|NCT04955626|585539069|FG011|Blinded Period|Participants entered open label period|0|||
162133462|NCT04955626|585539070|FG012|Blinded Period|Participants entered open label period|0|||
162133463|NCT04955626|585539071|FG013|Blinded Period|Participants entered open label period|0|||
162133464|NCT04955626|585539072|FG014|Blinded Period|Participants entered open label period|0|||
162133465|NCT04955626|585539073|FG015|Blinded Period|Participants entered open label period|0|||
162133466|NCT04955626|585539074|FG016|Blinded Period|Participants entered open label period|0|||
162133467|NCT04955626|585539075|FG017|Blinded Period|Participants entered open label period|0|||
162133468|NCT04955626|585539076|FG018|Blinded Period|Participants entered open label period|0|||
162133469|NCT04955626|585539077|FG019|Blinded Period|Participants entered open label period|0|||
162133470|NCT04955626|585539078|FG020|Blinded Period|Participants entered open label period|0|||
162133471|NCT04955626|585539079|FG021|Blinded Period|Participants entered open label period|0|||
162133472|NCT04955626|585539080|FG022|Blinded Period|Participants entered open label period|0|||
162133473|NCT04955626|585539081|FG023|Blinded Period|Participants entered open label period|0|||
162133474|NCT04955626|585539082|FG024|Blinded Period|Participants entered open label period|0|||
162133475|NCT04955626|585539083|FG025|Blinded Period|Participants entered open label period|0|||
162133476|NCT04955626|585539084|FG026|Blinded Period|Participants entered open label period|0|||
162133477|NCT04955626|585539085|FG027|Blinded Period|Participants entered open label period|0|||
162133478|NCT04955626|585539086|FG028|Blinded Period|Participants entered open label period|0|||
162133479|NCT04955626|585539087|FG029|Blinded Period|Participants entered open label period|0|||
162133480|NCT04955626|585539088|FG030|Blinded Period|Participants entered open label period|0|||
162133481|NCT04955626|585539089|FG031|Blinded Period|Participants entered open label period|0|||
162133482|NCT04955626|585539090|FG032|Blinded Period|Participants entered open label period|0|||
162133483|NCT04955626|585539091|FG033|Blinded Period|Participants entered open label period|0|||
162133484|NCT04955626|585539092|FG034|Blinded Period|Participants entered open label period|0|||
162133485|NCT04955626|585539093|FG035|Blinded Period|Participants entered open label period|0|||
162133486|NCT04955626|585539058|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
162133487|NCT04955626|585539059|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
162133488|NCT04955626|585539060|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
162133489|NCT04955626|585539061|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
162133490|NCT04955626|585539062|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
162133491|NCT04955626|585539063|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
162133492|NCT04955626|585539064|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
162133493|NCT04955626|585539065|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
162133494|NCT04955626|585539066|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
162133495|NCT04955626|585539067|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
162133496|NCT04955626|585539068|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
162133497|NCT04955626|585539069|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
162133498|NCT04955626|585539070|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
161794942|NCT02146430|584293617|FG001|Overall Study|Adverse Event|40|||
161794943|NCT02146430|584293618|FG002|Overall Study|Adverse Event|32|||
161794944|NCT02146430|584293619|FG003|Overall Study|Adverse Event|49|||
161794945|NCT02146430|584293616|FG000|Overall Study|Reason missing or not reported|2|||
161794946|NCT02146430|584293617|FG001|Overall Study|Reason missing or not reported|3|||
161794947|NCT02146430|584293618|FG002|Overall Study|Reason missing or not reported|4|||
161794948|NCT02146430|584293619|FG003|Overall Study|Reason missing or not reported|5|||
161794949|NCT02146430|584293616|FG000|Overall Study|Withdrawal by Subject|27|||
161794950|NCT02146430|584293617|FG001|Overall Study|Withdrawal by Subject|29|||
161794951|NCT02146430|584293618|FG002|Overall Study|Withdrawal by Subject|30|||
161794952|NCT02146430|584293619|FG003|Overall Study|Withdrawal by Subject|34|||
161794953|NCT03312530|584293620|FG000|Overall Study|Death|5|||
162133499|NCT04955626|585539071|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
162133500|NCT04955626|585539072|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
162133501|NCT04955626|585539073|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
162133502|NCT04955626|585539074|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
162133503|NCT04955626|585539075|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
162133504|NCT04955626|585539076|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
162133505|NCT04955626|585539077|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
162133506|NCT04955626|585539078|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
162133507|NCT04955626|585539079|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
162133508|NCT04955626|585539080|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
162133509|NCT04955626|585539081|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
162133510|NCT04955626|585539082|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
162133511|NCT04955626|585539083|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
162133512|NCT04955626|585539084|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
162133513|NCT04955626|585539085|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
162133514|NCT04955626|585539086|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
162133515|NCT04955626|585539087|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
162133516|NCT04955626|585539088|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
162133517|NCT04955626|585539089|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
162133518|NCT04955626|585539090|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
162133519|NCT04955626|585539091|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
162133520|NCT04955626|585539092|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
162133521|NCT04955626|585539093|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
162133522|NCT04955626|585539058|FG000|Blinded Period|Medication error|0|||
162133523|NCT04955626|585539059|FG001|Blinded Period|Medication error|0|||
162133524|NCT04955626|585539060|FG002|Blinded Period|Medication error|0|||
162133525|NCT04955626|585539061|FG003|Blinded Period|Medication error|0|||
161794954|NCT03312530|584293621|FG001|Overall Study|Death|5|||
161794955|NCT03312530|584293622|FG002|Overall Study|Death|4|||
161794956|NCT03312530|584293623|FG003|Overall Study|Death|10|||
161794957|NCT03312530|584293624|FG004|Overall Study|Death|8|||
161794958|NCT03312530|584293620|FG000|Overall Study|Lost to Follow-up|0|||
161794959|NCT03312530|584293621|FG001|Overall Study|Lost to Follow-up|0|||
161794960|NCT03312530|584293622|FG002|Overall Study|Lost to Follow-up|0|||
161794961|NCT03312530|584293623|FG003|Overall Study|Lost to Follow-up|1|||
161794962|NCT03312530|584293624|FG004|Overall Study|Lost to Follow-up|0|||
161794963|NCT03312530|584293620|FG000|Overall Study|Participant in another sponsor study.|0|||
161794964|NCT03312530|584293621|FG001|Overall Study|Participant in another sponsor study.|0|||
161794965|NCT03312530|584293622|FG002|Overall Study|Participant in another sponsor study.|0|||
161794966|NCT03312530|584293623|FG003|Overall Study|Participant in another sponsor study.|1|||
161794967|NCT03312530|584293624|FG004|Overall Study|Participant in another sponsor study.|0|||
161794968|NCT03312530|584293620|FG000|Overall Study|Study terminated by sponsor|1|||
161794969|NCT03312530|584293621|FG001|Overall Study|Study terminated by sponsor|0|||
161794970|NCT03312530|584293622|FG002|Overall Study|Study terminated by sponsor|2|||
161794971|NCT03312530|584293623|FG003|Overall Study|Study terminated by sponsor|3|||
161794972|NCT03312530|584293624|FG004|Overall Study|Study terminated by sponsor|7|||
161794973|NCT03312530|584293620|FG000|Overall Study|Withdrawal by Subject|0|||
161794974|NCT03312530|584293621|FG001|Overall Study|Withdrawal by Subject|1|||
161794975|NCT03312530|584293622|FG002|Overall Study|Withdrawal by Subject|0|||
161794976|NCT03312530|584293623|FG003|Overall Study|Withdrawal by Subject|0|||
161794977|NCT03312530|584293624|FG004|Overall Study|Withdrawal by Subject|0|||
161794978|NCT03312530|584293620|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
161794979|NCT03312530|584293621|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
161794980|NCT03312530|584293622|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
161794981|NCT03312530|584293623|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
161794982|NCT03312530|584293624|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
161794983|NCT03093324|584293625|FG000|Overall Study|Adverse Event|4|||
161794984|NCT03093324|584293626|FG001|Overall Study|Adverse Event|15|||
161794985|NCT03093324|584293625|FG000|Overall Study|Lost to Follow-up|1|||
161794986|NCT03093324|584293626|FG001|Overall Study|Lost to Follow-up|0|||
161794987|NCT03093324|584293625|FG000|Overall Study|Protocol Deviation|2|||
161794988|NCT03093324|584293626|FG001|Overall Study|Protocol Deviation|2|||
161794989|NCT03093324|584293625|FG000|Overall Study|Withdrawal by Subject|2|||
162133526|NCT04955626|585539062|FG004|Blinded Period|Medication error|0|||
162133527|NCT04955626|585539063|FG005|Blinded Period|Medication error|0|||
161794990|NCT03093324|584293626|FG001|Overall Study|Withdrawal by Subject|2|||
161794991|NCT01767597|584293627|FG000|Overall Study|Incomplete intervention|3|||
161794992|NCT01767597|584293628|FG001|Overall Study|Incomplete intervention|1|||
161794993|NCT01767597|584293627|FG000|Overall Study|Withdrawal by Subject|1|||
161794994|NCT01767597|584293628|FG001|Overall Study|Withdrawal by Subject|0|||
161794995|NCT05342753|584293629|FG000|Overall Study|Withdrawal by Subject|6|||
162133528|NCT04955626|585539064|FG006|Blinded Period|Medication error|0|||
162133529|NCT04955626|585539065|FG007|Blinded Period|Medication error|0|||
162133530|NCT04955626|585539066|FG008|Blinded Period|Medication error|0|||
162133531|NCT04955626|585539067|FG009|Blinded Period|Medication error|0|||
162133532|NCT04955626|585539068|FG010|Blinded Period|Medication error|2|||
162133533|NCT04955626|585539069|FG011|Blinded Period|Medication error|0|||
162133534|NCT04955626|585539070|FG012|Blinded Period|Medication error|0|||
162133535|NCT04955626|585539071|FG013|Blinded Period|Medication error|0|||
162133536|NCT04955626|585539072|FG014|Blinded Period|Medication error|0|||
162133537|NCT04955626|585539073|FG015|Blinded Period|Medication error|0|||
162133538|NCT04955626|585539074|FG016|Blinded Period|Medication error|0|||
162133539|NCT04955626|585539075|FG017|Blinded Period|Medication error|0|||
162133540|NCT04955626|585539076|FG018|Blinded Period|Medication error|0|||
162133541|NCT04955626|585539077|FG019|Blinded Period|Medication error|0|||
162133542|NCT04955626|585539078|FG020|Blinded Period|Medication error|0|||
162133543|NCT04955626|585539079|FG021|Blinded Period|Medication error|0|||
162133544|NCT04955626|585539080|FG022|Blinded Period|Medication error|0|||
162133545|NCT04955626|585539081|FG023|Blinded Period|Medication error|0|||
162133546|NCT04955626|585539082|FG024|Blinded Period|Medication error|0|||
162133547|NCT04955626|585539083|FG025|Blinded Period|Medication error|0|||
162133548|NCT04955626|585539084|FG026|Blinded Period|Medication error|0|||
162133549|NCT04955626|585539085|FG027|Blinded Period|Medication error|0|||
162133550|NCT04955626|585539086|FG028|Blinded Period|Medication error|4|||
162133551|NCT04955626|585539087|FG029|Blinded Period|Medication error|0|||
162133552|NCT04955626|585539088|FG030|Blinded Period|Medication error|0|||
162133553|NCT04955626|585539089|FG031|Blinded Period|Medication error|0|||
162133554|NCT04955626|585539090|FG032|Blinded Period|Medication error|0|||
162133555|NCT04955626|585539091|FG033|Blinded Period|Medication error|0|||
162133556|NCT04955626|585539092|FG034|Blinded Period|Medication error|0|||
162133557|NCT04955626|585539093|FG035|Blinded Period|Medication error|0|||
162133558|NCT04955626|585539058|FG000|Open-Label Period|Lost to Follow-up|109|||
162133559|NCT04955626|585539059|FG001|Open-Label Period|Lost to Follow-up|41|||
162133560|NCT04955626|585539060|FG002|Open-Label Period|Lost to Follow-up|0|||
162133561|NCT04955626|585539061|FG003|Open-Label Period|Lost to Follow-up|0|||
162133562|NCT04955626|585539062|FG004|Open-Label Period|Lost to Follow-up|0|||
162133563|NCT04955626|585539063|FG005|Open-Label Period|Lost to Follow-up|0|||
162133564|NCT04955626|585539064|FG006|Open-Label Period|Lost to Follow-up|0|||
162133565|NCT04955626|585539065|FG007|Open-Label Period|Lost to Follow-up|0|||
162133566|NCT04955626|585539066|FG008|Open-Label Period|Lost to Follow-up|0|||
162133567|NCT04955626|585539067|FG009|Open-Label Period|Lost to Follow-up|0|||
162133568|NCT04955626|585539068|FG010|Open-Label Period|Lost to Follow-up|0|||
162133569|NCT04955626|585539069|FG011|Open-Label Period|Lost to Follow-up|0|||
162133570|NCT04955626|585539070|FG012|Open-Label Period|Lost to Follow-up|0|||
162133571|NCT04955626|585539071|FG013|Open-Label Period|Lost to Follow-up|0|||
162133572|NCT04955626|585539072|FG014|Open-Label Period|Lost to Follow-up|0|||
162133573|NCT04955626|585539073|FG015|Open-Label Period|Lost to Follow-up|0|||
162133574|NCT04955626|585539074|FG016|Open-Label Period|Lost to Follow-up|0|||
162133575|NCT04955626|585539075|FG017|Open-Label Period|Lost to Follow-up|0|||
162133576|NCT04955626|585539076|FG018|Open-Label Period|Lost to Follow-up|0|||
162133577|NCT04955626|585539077|FG019|Open-Label Period|Lost to Follow-up|0|||
162133578|NCT04955626|585539078|FG020|Open-Label Period|Lost to Follow-up|0|||
162133579|NCT04955626|585539079|FG021|Open-Label Period|Lost to Follow-up|0|||
162133580|NCT04955626|585539080|FG022|Open-Label Period|Lost to Follow-up|0|||
162133581|NCT04955626|585539081|FG023|Open-Label Period|Lost to Follow-up|0|||
162133582|NCT04955626|585539082|FG024|Open-Label Period|Lost to Follow-up|0|||
162133583|NCT04955626|585539083|FG025|Open-Label Period|Lost to Follow-up|0|||
162133584|NCT04955626|585539084|FG026|Open-Label Period|Lost to Follow-up|0|||
162133585|NCT04955626|585539085|FG027|Open-Label Period|Lost to Follow-up|0|||
162133586|NCT04955626|585539086|FG028|Open-Label Period|Lost to Follow-up|0|||
162133587|NCT04955626|585539087|FG029|Open-Label Period|Lost to Follow-up|0|||
162133588|NCT04955626|585539088|FG030|Open-Label Period|Lost to Follow-up|0|||
162133589|NCT04955626|585539089|FG031|Open-Label Period|Lost to Follow-up|0|||
162133590|NCT04955626|585539090|FG032|Open-Label Period|Lost to Follow-up|0|||
162133591|NCT04955626|585539091|FG033|Open-Label Period|Lost to Follow-up|0|||
162133592|NCT04955626|585539092|FG034|Open-Label Period|Lost to Follow-up|0|||
162133593|NCT04955626|585539093|FG035|Open-Label Period|Lost to Follow-up|0|||
162133594|NCT04955626|585539058|FG000|Open-Label Period|Protocol Violation|377|||
162133595|NCT04955626|585539059|FG001|Open-Label Period|Protocol Violation|48|||
162133596|NCT04955626|585539060|FG002|Open-Label Period|Protocol Violation|0|||
162133597|NCT04955626|585539061|FG003|Open-Label Period|Protocol Violation|0|||
162133598|NCT04955626|585539062|FG004|Open-Label Period|Protocol Violation|0|||
162133599|NCT04955626|585539063|FG005|Open-Label Period|Protocol Violation|0|||
162133600|NCT04955626|585539064|FG006|Open-Label Period|Protocol Violation|0|||
162133601|NCT04955626|585539065|FG007|Open-Label Period|Protocol Violation|0|||
162133602|NCT04955626|585539066|FG008|Open-Label Period|Protocol Violation|0|||
162133603|NCT04955626|585539067|FG009|Open-Label Period|Protocol Violation|0|||
162133604|NCT04955626|585539068|FG010|Open-Label Period|Protocol Violation|0|||
162133605|NCT04955626|585539069|FG011|Open-Label Period|Protocol Violation|0|||
162133606|NCT04955626|585539070|FG012|Open-Label Period|Protocol Violation|0|||
162133607|NCT04955626|585539071|FG013|Open-Label Period|Protocol Violation|0|||
162133608|NCT04955626|585539072|FG014|Open-Label Period|Protocol Violation|0|||
162133609|NCT04955626|585539073|FG015|Open-Label Period|Protocol Violation|0|||
162133610|NCT04955626|585539074|FG016|Open-Label Period|Protocol Violation|0|||
162133611|NCT04955626|585539075|FG017|Open-Label Period|Protocol Violation|0|||
162133612|NCT04955626|585539076|FG018|Open-Label Period|Protocol Violation|0|||
162133613|NCT04955626|585539077|FG019|Open-Label Period|Protocol Violation|0|||
162133614|NCT04955626|585539078|FG020|Open-Label Period|Protocol Violation|0|||
162133615|NCT04955626|585539079|FG021|Open-Label Period|Protocol Violation|0|||
162133616|NCT04955626|585539080|FG022|Open-Label Period|Protocol Violation|0|||
162133617|NCT04955626|585539081|FG023|Open-Label Period|Protocol Violation|0|||
162133618|NCT04955626|585539082|FG024|Open-Label Period|Protocol Violation|0|||
161794996|NCT05342753|584293629|FG000|Overall Study|Lost to Follow-up|1|||
161794997|NCT00836927|584293630|FG000|Overall Study|Progressive disease|2|||
161794998|NCT00836927|584293631|FG001|Overall Study|Progressive disease|0|||
161794999|NCT00836927|584293632|FG002|Overall Study|Progressive disease|0|||
161795000|NCT00836927|584293633|FG003|Overall Study|Progressive disease|1|||
161795001|NCT00836927|584293634|FG004|Overall Study|Progressive disease|1|||
161795002|NCT00836927|584293630|FG000|Overall Study|Withdrawal by Subject|1|||
161795003|NCT00836927|584293631|FG001|Overall Study|Withdrawal by Subject|0|||
161795004|NCT00836927|584293632|FG002|Overall Study|Withdrawal by Subject|0|||
161795005|NCT00836927|584293633|FG003|Overall Study|Withdrawal by Subject|0|||
161795006|NCT00836927|584293634|FG004|Overall Study|Withdrawal by Subject|0|||
161795007|NCT00614055|584293637|FG000|Overall Study|Adverse Event|1|||
161795008|NCT00614055|584293638|FG001|Overall Study|Adverse Event|0|||
161795009|NCT00614055|584293639|FG002|Overall Study|Adverse Event|0|||
161795010|NCT00614055|584293637|FG000|Overall Study|Protocol Violation|2|||
161795011|NCT00614055|584293638|FG001|Overall Study|Protocol Violation|2|||
161795012|NCT00614055|584293639|FG002|Overall Study|Protocol Violation|1|||
161795013|NCT00614055|584293637|FG000|Overall Study|Lack of Efficacy|0|||
161795014|NCT00614055|584293638|FG001|Overall Study|Lack of Efficacy|0|||
161795015|NCT00614055|584293639|FG002|Overall Study|Lack of Efficacy|2|||
161795016|NCT00614055|584293637|FG000|Overall Study|Unclassified|1|||
161795017|NCT00614055|584293638|FG001|Overall Study|Unclassified|4|||
161795018|NCT00614055|584293639|FG002|Overall Study|Unclassified|2|||
161795019|NCT04583579|584293642|FG000|Overall Study|Lost to Follow-up|4|||
161795020|NCT02006706|584293644|FG000|Overall Study|Lost to Follow-up|1|||
161795021|NCT05590585|584293645|FG000|Overall Study|Lost to Follow-up|3|||
161795022|NCT05590585|584293645|FG000|Overall Study|Withdrawal by Subject|1|||
161795023|NCT01673009|584293646|FG000|Overall Study|Physician Decision|5|||
161795024|NCT01673009|584293646|FG000|Overall Study|Withdrawal by Subject|8|||
161795025|NCT04161144|584293648|FG000|Overall Study|Withdrawal by Subject|0|||
161795026|NCT04161144|584293649|FG001|Overall Study|Withdrawal by Subject|1|||
161795027|NCT04161144|584293648|FG000|Overall Study|Protocol Violation|1|||
161795028|NCT04161144|584293649|FG001|Overall Study|Protocol Violation|0|||
161795029|NCT04700449|584293652|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
161795030|NCT04700449|584293653|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
161795031|NCT04700449|584293654|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
161795032|NCT04700449|584293655|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
161795033|NCT04700449|584293652|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
161795034|NCT04700449|584293653|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
161795035|NCT04700449|584293654|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
161795036|NCT04700449|584293655|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
161795037|NCT04700449|584293652|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
161795038|NCT04700449|584293653|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
161795039|NCT04700449|584293654|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
161795040|NCT04700449|584293655|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
161795041|NCT04700449|584293652|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
162133619|NCT04955626|585539083|FG025|Open-Label Period|Protocol Violation|0|||
162133620|NCT04955626|585539084|FG026|Open-Label Period|Protocol Violation|0|||
162133621|NCT04955626|585539085|FG027|Open-Label Period|Protocol Violation|0|||
162242044|NCT02616562|585939074|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
161795042|NCT04700449|584293653|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
161795043|NCT04700449|584293654|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
161795044|NCT04700449|584293655|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
161795045|NCT04700449|584293652|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
161795046|NCT04700449|584293653|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
161795047|NCT04700449|584293654|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
161795048|NCT04700449|584293655|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
161795049|NCT04700449|584293652|FG000|Stage 1: Double-Blind Period|Other|0|||
161795050|NCT04700449|584293653|FG001|Stage 1: Double-Blind Period|Other|0|||
161795051|NCT04700449|584293654|FG002|Stage 1: Double-Blind Period|Other|1|||
161795052|NCT04700449|584293655|FG003|Stage 1: Double-Blind Period|Other|0|||
161900463|NCT00099632|584683040|FG003|Overall Study|Lost to Follow-up|1|||
162133622|NCT04955626|585539086|FG028|Open-Label Period|Protocol Violation|0|||
162133623|NCT04955626|585539087|FG029|Open-Label Period|Protocol Violation|0|||
162133624|NCT04955626|585539088|FG030|Open-Label Period|Protocol Violation|0|||
162133625|NCT04955626|585539089|FG031|Open-Label Period|Protocol Violation|0|||
162133626|NCT04955626|585539090|FG032|Open-Label Period|Protocol Violation|0|||
162133627|NCT04955626|585539091|FG033|Open-Label Period|Protocol Violation|0|||
162133628|NCT04955626|585539092|FG034|Open-Label Period|Protocol Violation|0|||
162133629|NCT04955626|585539093|FG035|Open-Label Period|Protocol Violation|0|||
162133630|NCT04955626|585539058|FG000|Open-Label Period|Death|5|||
162133631|NCT04955626|585539059|FG001|Open-Label Period|Death|5|||
162133632|NCT04955626|585539060|FG002|Open-Label Period|Death|0|||
162133633|NCT04955626|585539061|FG003|Open-Label Period|Death|0|||
161795053|NCT04700449|584293652|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
161795054|NCT04700449|584293653|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
161795055|NCT04700449|584293654|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
161795056|NCT04700449|584293655|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
161795057|NCT04700449|584293652|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
161795058|NCT04700449|584293653|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
161795059|NCT04700449|584293654|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
161795060|NCT04700449|584293655|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
161795061|NCT04700449|584293652|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
161795062|NCT04700449|584293653|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
161795063|NCT04700449|584293654|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
161795064|NCT04700449|584293655|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
161795065|NCT04700449|584293652|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
161795066|NCT04700449|584293653|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
161795067|NCT04700449|584293654|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
161795068|NCT04700449|584293655|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
161795069|NCT04700449|584293652|FG000|Stage 2 Sub-study 1|Other|1|||
161795070|NCT04700449|584293653|FG001|Stage 2 Sub-study 1|Other|2|||
161795071|NCT04700449|584293654|FG002|Stage 2 Sub-study 1|Other|0|||
161795072|NCT04700449|584293655|FG003|Stage 2 Sub-study 1|Other|0|||
161795073|NCT04700449|584293652|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
161795074|NCT04700449|584293653|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
161795075|NCT04700449|584293654|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
161795076|NCT04700449|584293655|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
161795077|NCT04700449|584293652|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
161795078|NCT04700449|584293653|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
161795079|NCT04700449|584293654|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
161795080|NCT04700449|584293655|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
161795081|NCT04700449|584293652|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
161795082|NCT04700449|584293653|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
161795083|NCT04700449|584293654|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
161795084|NCT04700449|584293655|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
161795085|NCT04700449|584293652|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
161795086|NCT04700449|584293653|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
161795087|NCT04700449|584293654|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
161795088|NCT04700449|584293655|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
161795089|NCT04700449|584293652|FG000|Stage 2 Sub-study 2|Other|0|||
161795090|NCT04700449|584293653|FG001|Stage 2 Sub-study 2|Other|0|||
161795091|NCT04700449|584293654|FG002|Stage 2 Sub-study 2|Other|0|||
161795092|NCT04700449|584293655|FG003|Stage 2 Sub-study 2|Other|5|||
161795093|NCT06041646|584293656|FG000|Overall Study|Withdrawal by Subject|1|||
161795094|NCT01000337|584293657|FG000|Overall Study|Lost to Follow-up|4|||
161795095|NCT01000337|584293658|FG001|Overall Study|Lost to Follow-up|3|||
161795096|NCT02173704|584293659|FG000|Overall Study|Adverse Event|1|||
161900464|NCT00099632|584683041|FG004|Overall Study|Lost to Follow-up|1|||
162133634|NCT04955626|585539062|FG004|Open-Label Period|Death|0|||
162133635|NCT04955626|585539063|FG005|Open-Label Period|Death|0|||
162133636|NCT04955626|585539064|FG006|Open-Label Period|Death|0|||
161795097|NCT02173704|584293660|FG001|Overall Study|Adverse Event|0|||
161795098|NCT02173704|584293659|FG000|Overall Study|Lost to Follow-up|1|||
161795099|NCT02173704|584293660|FG001|Overall Study|Lost to Follow-up|0|||
161795100|NCT02173704|584293659|FG000|Overall Study|Other|1|||
161795101|NCT02173704|584293660|FG001|Overall Study|Other|0|||
161795102|NCT02173704|584293659|FG000|Overall Study|Protocol Violation|1|||
161795103|NCT02173704|584293660|FG001|Overall Study|Protocol Violation|0|||
161795104|NCT02173704|584293659|FG000|Overall Study|Withdrawal by Subject|9|||
161795105|NCT02173704|584293660|FG001|Overall Study|Withdrawal by Subject|4|||
161795106|NCT03901963|584293661|FG000|Overall Study|Lost to Follow-up|1|||
161795107|NCT03901963|584293662|FG001|Overall Study|Lost to Follow-up|1|||
161795108|NCT03901963|584293661|FG000|Overall Study|Physician Decision|1|||
161795109|NCT03901963|584293662|FG001|Overall Study|Physician Decision|2|||
161795110|NCT03901963|584293661|FG000|Overall Study|Protocol Violation|1|||
161795111|NCT03901963|584293662|FG001|Overall Study|Protocol Violation|1|||
161795112|NCT03901963|584293661|FG000|Overall Study|Withdrawal by Subject|4|||
161795113|NCT03901963|584293662|FG001|Overall Study|Withdrawal by Subject|11|||
161900465|NCT00099632|584683042|FG005|Overall Study|Lost to Follow-up|0|||
162133637|NCT04955626|585539065|FG007|Open-Label Period|Death|0|||
162133638|NCT04955626|585539066|FG008|Open-Label Period|Death|0|||
161795114|NCT03901963|584293661|FG000|Overall Study|Ongoing|84|||
161795115|NCT03901963|584293662|FG001|Overall Study|Ongoing|73|||
161795116|NCT03901963|584293661|FG000|Overall Study|Randomized but not treated|3|||
161795117|NCT03901963|584293662|FG001|Overall Study|Randomized but not treated|3|||
161795118|NCT02854436|584293663|FG000|Overall Study|Adverse Event|1|||
161795119|NCT02854436|584293663|FG000|Overall Study|Death|208|||
161795120|NCT02854436|584293663|FG000|Overall Study|Lost to Follow-up|5|||
161795121|NCT02854436|584293663|FG000|Overall Study|Withdrawal by Subject|24|||
161795122|NCT02854436|584293663|FG000|Overall Study|Other|45|||
161795123|NCT02854436|584293663|FG000|Overall Study|Physician Decision|6|||
161795124|NCT04956666|584293664|FG000|Overall Study|Adverse Event|18|||
162010750|NCT02054104|585095975|FG000|Overall Study|No evidence of immunologic response|2|||
162133639|NCT04955626|585539067|FG009|Open-Label Period|Death|0|||
162133640|NCT04955626|585539068|FG010|Open-Label Period|Death|0|||
162133641|NCT04955626|585539069|FG011|Open-Label Period|Death|0|||
162133642|NCT04955626|585539070|FG012|Open-Label Period|Death|0|||
162133643|NCT04955626|585539071|FG013|Open-Label Period|Death|0|||
162133644|NCT04955626|585539072|FG014|Open-Label Period|Death|0|||
162133645|NCT04955626|585539073|FG015|Open-Label Period|Death|0|||
162133646|NCT04955626|585539074|FG016|Open-Label Period|Death|0|||
162133647|NCT04955626|585539075|FG017|Open-Label Period|Death|0|||
162133648|NCT04955626|585539076|FG018|Open-Label Period|Death|0|||
162133649|NCT04955626|585539077|FG019|Open-Label Period|Death|0|||
162133650|NCT04955626|585539078|FG020|Open-Label Period|Death|0|||
162133651|NCT04955626|585539079|FG021|Open-Label Period|Death|0|||
162133652|NCT04955626|585539080|FG022|Open-Label Period|Death|0|||
162133653|NCT04955626|585539081|FG023|Open-Label Period|Death|0|||
162133654|NCT04955626|585539082|FG024|Open-Label Period|Death|0|||
162133655|NCT04955626|585539083|FG025|Open-Label Period|Death|0|||
162133656|NCT04955626|585539084|FG026|Open-Label Period|Death|0|||
162133657|NCT04955626|585539085|FG027|Open-Label Period|Death|0|||
162133658|NCT04955626|585539086|FG028|Open-Label Period|Death|0|||
162133659|NCT04955626|585539087|FG029|Open-Label Period|Death|0|||
162133660|NCT04955626|585539088|FG030|Open-Label Period|Death|0|||
162133661|NCT04955626|585539089|FG031|Open-Label Period|Death|0|||
162133662|NCT04955626|585539090|FG032|Open-Label Period|Death|0|||
162133663|NCT04955626|585539091|FG033|Open-Label Period|Death|0|||
162133664|NCT04955626|585539092|FG034|Open-Label Period|Death|0|||
162133665|NCT04955626|585539093|FG035|Open-Label Period|Death|0|||
162133666|NCT04955626|585539058|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
162133667|NCT04955626|585539059|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
162133668|NCT04955626|585539060|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
162133669|NCT04955626|585539061|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
162133670|NCT04955626|585539062|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
162133671|NCT04955626|585539063|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
162133672|NCT04955626|585539064|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
162133673|NCT04955626|585539065|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
162133674|NCT04955626|585539066|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
162133675|NCT04955626|585539067|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
162133676|NCT04955626|585539068|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
162133677|NCT04955626|585539069|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
162133678|NCT04955626|585539070|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
162133679|NCT04955626|585539071|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
162133680|NCT04955626|585539072|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
162133681|NCT04955626|585539073|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
162133682|NCT04955626|585539074|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
162133683|NCT04955626|585539075|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
162133684|NCT04955626|585539076|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
162133685|NCT04955626|585539077|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
162133686|NCT04955626|585539078|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
162133687|NCT04955626|585539079|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
162133688|NCT04955626|585539080|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
162133689|NCT04955626|585539081|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
162133690|NCT04955626|585539082|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
162133691|NCT04955626|585539083|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
162133692|NCT04955626|585539084|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
162133693|NCT04955626|585539085|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
162133694|NCT04955626|585539086|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
161795125|NCT04956666|584293664|FG000|Overall Study|Physician Decision|5|||
161795126|NCT01700621|584293665|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
161795127|NCT01700621|584293666|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
161795128|NCT01700621|584293665|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
162133695|NCT04955626|585539087|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
162133696|NCT04955626|585539088|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
162133697|NCT04955626|585539089|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
162133698|NCT04955626|585539090|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
162133699|NCT04955626|585539091|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
162133700|NCT04955626|585539092|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
162133701|NCT04955626|585539093|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
162133702|NCT04955626|585539058|FG000|Open-Label Period|Other|621|||
162133703|NCT04955626|585539059|FG001|Open-Label Period|Other|429|||
162133704|NCT04955626|585539060|FG002|Open-Label Period|Other|0|||
162133705|NCT04955626|585539061|FG003|Open-Label Period|Other|0|||
162133706|NCT04955626|585539062|FG004|Open-Label Period|Other|0|||
162133707|NCT04955626|585539063|FG005|Open-Label Period|Other|0|||
162133708|NCT04955626|585539064|FG006|Open-Label Period|Other|0|||
162133709|NCT04955626|585539065|FG007|Open-Label Period|Other|0|||
162133710|NCT04955626|585539066|FG008|Open-Label Period|Other|0|||
162133711|NCT04955626|585539067|FG009|Open-Label Period|Other|0|||
162133712|NCT04955626|585539068|FG010|Open-Label Period|Other|0|||
162133713|NCT04955626|585539069|FG011|Open-Label Period|Other|0|||
162133714|NCT04955626|585539070|FG012|Open-Label Period|Other|0|||
162133715|NCT04955626|585539071|FG013|Open-Label Period|Other|0|||
162133716|NCT04955626|585539072|FG014|Open-Label Period|Other|0|||
162133717|NCT04955626|585539073|FG015|Open-Label Period|Other|0|||
162133718|NCT04955626|585539074|FG016|Open-Label Period|Other|0|||
162133719|NCT04955626|585539075|FG017|Open-Label Period|Other|0|||
162133720|NCT04955626|585539076|FG018|Open-Label Period|Other|0|||
162133721|NCT04955626|585539077|FG019|Open-Label Period|Other|0|||
162133722|NCT04955626|585539078|FG020|Open-Label Period|Other|0|||
162133723|NCT04955626|585539079|FG021|Open-Label Period|Other|0|||
162133724|NCT04955626|585539080|FG022|Open-Label Period|Other|0|||
162133725|NCT04955626|585539081|FG023|Open-Label Period|Other|0|||
162133726|NCT04955626|585539082|FG024|Open-Label Period|Other|0|||
162133727|NCT04955626|585539083|FG025|Open-Label Period|Other|0|||
162133728|NCT04955626|585539084|FG026|Open-Label Period|Other|0|||
162133729|NCT04955626|585539085|FG027|Open-Label Period|Other|0|||
162133730|NCT04955626|585539086|FG028|Open-Label Period|Other|0|||
162133731|NCT04955626|585539087|FG029|Open-Label Period|Other|0|||
162133732|NCT04955626|585539088|FG030|Open-Label Period|Other|0|||
162133733|NCT04955626|585539089|FG031|Open-Label Period|Other|0|||
162133734|NCT04955626|585539090|FG032|Open-Label Period|Other|0|||
162133735|NCT04955626|585539091|FG033|Open-Label Period|Other|0|||
162133736|NCT04955626|585539092|FG034|Open-Label Period|Other|0|||
162133737|NCT04955626|585539093|FG035|Open-Label Period|Other|0|||
162133738|NCT04955626|585539058|FG000|Open-Label Period|Physician Decision|2|||
162133739|NCT04955626|585539059|FG001|Open-Label Period|Physician Decision|0|||
162133740|NCT04955626|585539060|FG002|Open-Label Period|Physician Decision|0|||
162133741|NCT04955626|585539061|FG003|Open-Label Period|Physician Decision|0|||
162133742|NCT04955626|585539062|FG004|Open-Label Period|Physician Decision|0|||
162133743|NCT04955626|585539063|FG005|Open-Label Period|Physician Decision|0|||
162133744|NCT04955626|585539064|FG006|Open-Label Period|Physician Decision|0|||
162133745|NCT04955626|585539065|FG007|Open-Label Period|Physician Decision|0|||
162133746|NCT04955626|585539066|FG008|Open-Label Period|Physician Decision|0|||
162133747|NCT04955626|585539067|FG009|Open-Label Period|Physician Decision|0|||
162133748|NCT04955626|585539068|FG010|Open-Label Period|Physician Decision|0|||
162133749|NCT04955626|585539069|FG011|Open-Label Period|Physician Decision|0|||
162133750|NCT04955626|585539070|FG012|Open-Label Period|Physician Decision|0|||
162133751|NCT04955626|585539071|FG013|Open-Label Period|Physician Decision|0|||
162133752|NCT04955626|585539072|FG014|Open-Label Period|Physician Decision|0|||
162133753|NCT04955626|585539073|FG015|Open-Label Period|Physician Decision|0|||
162133754|NCT04955626|585539074|FG016|Open-Label Period|Physician Decision|0|||
162133755|NCT04955626|585539075|FG017|Open-Label Period|Physician Decision|0|||
162133756|NCT04955626|585539076|FG018|Open-Label Period|Physician Decision|0|||
162133757|NCT04955626|585539077|FG019|Open-Label Period|Physician Decision|0|||
162133758|NCT04955626|585539078|FG020|Open-Label Period|Physician Decision|0|||
162133759|NCT04955626|585539079|FG021|Open-Label Period|Physician Decision|0|||
162133760|NCT04955626|585539080|FG022|Open-Label Period|Physician Decision|0|||
162133761|NCT04955626|585539081|FG023|Open-Label Period|Physician Decision|0|||
162133762|NCT04955626|585539082|FG024|Open-Label Period|Physician Decision|0|||
162133763|NCT04955626|585539083|FG025|Open-Label Period|Physician Decision|0|||
162133764|NCT04955626|585539084|FG026|Open-Label Period|Physician Decision|0|||
162133765|NCT04955626|585539085|FG027|Open-Label Period|Physician Decision|0|||
162133766|NCT04955626|585539086|FG028|Open-Label Period|Physician Decision|0|||
162133767|NCT04955626|585539087|FG029|Open-Label Period|Physician Decision|0|||
162133768|NCT04955626|585539088|FG030|Open-Label Period|Physician Decision|0|||
162133769|NCT04955626|585539089|FG031|Open-Label Period|Physician Decision|0|||
162133770|NCT04955626|585539090|FG032|Open-Label Period|Physician Decision|0|||
162133771|NCT04955626|585539091|FG033|Open-Label Period|Physician Decision|0|||
162133772|NCT04955626|585539092|FG034|Open-Label Period|Physician Decision|0|||
162133773|NCT04955626|585539093|FG035|Open-Label Period|Physician Decision|0|||
162133774|NCT04955626|585539058|FG000|Open-Label Period|Withdrawal by Subject|135|||
162133775|NCT04955626|585539059|FG001|Open-Label Period|Withdrawal by Subject|25|||
162133776|NCT04955626|585539060|FG002|Open-Label Period|Withdrawal by Subject|0|||
162133777|NCT04955626|585539061|FG003|Open-Label Period|Withdrawal by Subject|0|||
162133778|NCT04955626|585539062|FG004|Open-Label Period|Withdrawal by Subject|0|||
162133779|NCT04955626|585539063|FG005|Open-Label Period|Withdrawal by Subject|0|||
162133780|NCT04955626|585539064|FG006|Open-Label Period|Withdrawal by Subject|0|||
162133781|NCT04955626|585539065|FG007|Open-Label Period|Withdrawal by Subject|0|||
162133782|NCT04955626|585539066|FG008|Open-Label Period|Withdrawal by Subject|0|||
162133783|NCT04955626|585539067|FG009|Open-Label Period|Withdrawal by Subject|0|||
162133784|NCT04955626|585539068|FG010|Open-Label Period|Withdrawal by Subject|0|||
162133785|NCT04955626|585539069|FG011|Open-Label Period|Withdrawal by Subject|0|||
162133786|NCT04955626|585539070|FG012|Open-Label Period|Withdrawal by Subject|0|||
162133787|NCT04955626|585539071|FG013|Open-Label Period|Withdrawal by Subject|0|||
162133788|NCT04955626|585539072|FG014|Open-Label Period|Withdrawal by Subject|0|||
162133789|NCT04955626|585539073|FG015|Open-Label Period|Withdrawal by Subject|0|||
162133790|NCT04955626|585539074|FG016|Open-Label Period|Withdrawal by Subject|0|||
162133791|NCT04955626|585539075|FG017|Open-Label Period|Withdrawal by Subject|0|||
162133792|NCT04955626|585539076|FG018|Open-Label Period|Withdrawal by Subject|0|||
162133793|NCT04955626|585539077|FG019|Open-Label Period|Withdrawal by Subject|0|||
162133794|NCT04955626|585539078|FG020|Open-Label Period|Withdrawal by Subject|0|||
162133795|NCT04955626|585539079|FG021|Open-Label Period|Withdrawal by Subject|0|||
162133796|NCT04955626|585539080|FG022|Open-Label Period|Withdrawal by Subject|0|||
162133797|NCT04955626|585539081|FG023|Open-Label Period|Withdrawal by Subject|0|||
162133798|NCT04955626|585539082|FG024|Open-Label Period|Withdrawal by Subject|0|||
162133799|NCT04955626|585539083|FG025|Open-Label Period|Withdrawal by Subject|0|||
162133800|NCT04955626|585539084|FG026|Open-Label Period|Withdrawal by Subject|0|||
162133801|NCT04955626|585539085|FG027|Open-Label Period|Withdrawal by Subject|0|||
162133802|NCT04955626|585539086|FG028|Open-Label Period|Withdrawal by Subject|0|||
162133803|NCT04955626|585539087|FG029|Open-Label Period|Withdrawal by Subject|0|||
162133804|NCT04955626|585539088|FG030|Open-Label Period|Withdrawal by Subject|0|||
162133805|NCT04955626|585539089|FG031|Open-Label Period|Withdrawal by Subject|0|||
162133806|NCT04955626|585539090|FG032|Open-Label Period|Withdrawal by Subject|0|||
162133807|NCT04955626|585539091|FG033|Open-Label Period|Withdrawal by Subject|0|||
162133808|NCT04955626|585539092|FG034|Open-Label Period|Withdrawal by Subject|0|||
162133809|NCT04955626|585539093|FG035|Open-Label Period|Withdrawal by Subject|0|||
162133810|NCT04955626|585539058|FG000|Open-Label Period|Refused further study procedures|1|||
162133811|NCT04955626|585539059|FG001|Open-Label Period|Refused further study procedures|0|||
162133812|NCT04955626|585539060|FG002|Open-Label Period|Refused further study procedures|0|||
162133813|NCT04955626|585539061|FG003|Open-Label Period|Refused further study procedures|0|||
162133814|NCT04955626|585539062|FG004|Open-Label Period|Refused further study procedures|0|||
162133815|NCT04955626|585539063|FG005|Open-Label Period|Refused further study procedures|0|||
162133816|NCT04955626|585539064|FG006|Open-Label Period|Refused further study procedures|0|||
162133817|NCT04955626|585539065|FG007|Open-Label Period|Refused further study procedures|0|||
162133818|NCT04955626|585539066|FG008|Open-Label Period|Refused further study procedures|0|||
162133819|NCT04955626|585539067|FG009|Open-Label Period|Refused further study procedures|0|||
162133820|NCT04955626|585539068|FG010|Open-Label Period|Refused further study procedures|0|||
162133821|NCT04955626|585539069|FG011|Open-Label Period|Refused further study procedures|0|||
162133822|NCT04955626|585539070|FG012|Open-Label Period|Refused further study procedures|0|||
162133823|NCT04955626|585539071|FG013|Open-Label Period|Refused further study procedures|0|||
162133824|NCT04955626|585539072|FG014|Open-Label Period|Refused further study procedures|0|||
162133825|NCT04955626|585539073|FG015|Open-Label Period|Refused further study procedures|0|||
162133826|NCT04955626|585539074|FG016|Open-Label Period|Refused further study procedures|0|||
162133827|NCT04955626|585539075|FG017|Open-Label Period|Refused further study procedures|0|||
162133828|NCT04955626|585539076|FG018|Open-Label Period|Refused further study procedures|0|||
161795129|NCT01700621|584293666|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
161795130|NCT01700621|584293665|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
161795131|NCT01700621|584293666|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
161795132|NCT00384033|584293673|FG000|Overall Study|Adverse Event|10|||
161795133|NCT00384033|584293674|FG001|Overall Study|Adverse Event|8|||
161795134|NCT00384033|584293675|FG002|Overall Study|Adverse Event|11|||
161795135|NCT00384033|584293676|FG003|Overall Study|Adverse Event|20|||
161795136|NCT00384033|584293673|FG000|Overall Study|Failed to return|1|||
161795137|NCT00384033|584293674|FG001|Overall Study|Failed to return|3|||
161795138|NCT00384033|584293675|FG002|Overall Study|Failed to return|2|||
161795139|NCT00384033|584293676|FG003|Overall Study|Failed to return|2|||
161795140|NCT00384033|584293673|FG000|Overall Study|Physician Decision|1|||
161795141|NCT00384033|584293674|FG001|Overall Study|Physician Decision|0|||
161795142|NCT00384033|584293675|FG002|Overall Study|Physician Decision|0|||
161795143|NCT00384033|584293676|FG003|Overall Study|Physician Decision|0|||
161795144|NCT00384033|584293673|FG000|Overall Study|Lost to Follow-up|6|||
161795145|NCT00384033|584293674|FG001|Overall Study|Lost to Follow-up|12|||
161795146|NCT00384033|584293675|FG002|Overall Study|Lost to Follow-up|7|||
162133829|NCT04955626|585539077|FG019|Open-Label Period|Refused further study procedures|0|||
162133830|NCT04955626|585539078|FG020|Open-Label Period|Refused further study procedures|0|||
162133831|NCT04955626|585539079|FG021|Open-Label Period|Refused further study procedures|0|||
161900466|NCT00099632|584683037|FG000|Overall Study|Withdrawal by Subject|0|||
162133832|NCT04955626|585539080|FG022|Open-Label Period|Refused further study procedures|0|||
161900467|NCT00099632|584683038|FG001|Overall Study|Withdrawal by Subject|1|||
161900468|NCT00099632|584683039|FG002|Overall Study|Withdrawal by Subject|0|||
161900469|NCT00099632|584683040|FG003|Overall Study|Withdrawal by Subject|0|||
161900470|NCT00099632|584683041|FG004|Overall Study|Withdrawal by Subject|0|||
161900471|NCT00099632|584683042|FG005|Overall Study|Withdrawal by Subject|1|||
161900472|NCT00099632|584683037|FG000|Overall Study|Protocol Violation|0|||
161900473|NCT00099632|584683038|FG001|Overall Study|Protocol Violation|0|||
161900474|NCT00099632|584683039|FG002|Overall Study|Protocol Violation|0|||
161900475|NCT00099632|584683040|FG003|Overall Study|Protocol Violation|0|||
161900476|NCT00099632|584683041|FG004|Overall Study|Protocol Violation|0|||
161900477|NCT00099632|584683042|FG005|Overall Study|Protocol Violation|1|||
161900478|NCT02797678|584683063|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
161900479|NCT02797678|584683064|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
161900480|NCT02797678|584683065|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
161900481|NCT02797678|584683066|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
161900482|NCT02797678|584683063|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
161900483|NCT02797678|584683064|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
161900484|NCT02797678|584683065|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
161900485|NCT02797678|584683066|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
161900486|NCT02797678|584683063|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
161900487|NCT02797678|584683064|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
161900488|NCT02797678|584683065|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
161900489|NCT02797678|584683066|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
161900490|NCT03131687|584683067|FG000|Overall Study|Adverse Event|0|||
161900491|NCT03131687|584683068|FG001|Overall Study|Adverse Event|1|||
161900492|NCT03131687|584683069|FG002|Overall Study|Adverse Event|0|||
161900493|NCT03131687|584683070|FG003|Overall Study|Adverse Event|1|||
161900494|NCT03131687|584683071|FG004|Overall Study|Adverse Event|2|||
161900495|NCT03131687|584683072|FG005|Overall Study|Adverse Event|2|||
162133833|NCT04955626|585539081|FG023|Open-Label Period|Refused further study procedures|0|||
162133834|NCT04955626|585539082|FG024|Open-Label Period|Refused further study procedures|0|||
162133835|NCT04955626|585539083|FG025|Open-Label Period|Refused further study procedures|0|||
162133836|NCT04955626|585539084|FG026|Open-Label Period|Refused further study procedures|0|||
162133837|NCT04955626|585539085|FG027|Open-Label Period|Refused further study procedures|0|||
162133838|NCT04955626|585539086|FG028|Open-Label Period|Refused further study procedures|0|||
162133839|NCT04955626|585539087|FG029|Open-Label Period|Refused further study procedures|0|||
162133840|NCT04955626|585539088|FG030|Open-Label Period|Refused further study procedures|0|||
162133841|NCT04955626|585539089|FG031|Open-Label Period|Refused further study procedures|0|||
162133842|NCT04955626|585539090|FG032|Open-Label Period|Refused further study procedures|0|||
162133843|NCT04955626|585539091|FG033|Open-Label Period|Refused further study procedures|0|||
162133844|NCT04955626|585539092|FG034|Open-Label Period|Refused further study procedures|0|||
162133845|NCT04955626|585539093|FG035|Open-Label Period|Refused further study procedures|0|||
162133846|NCT04955626|585539058|FG000|Open-Label Period|Adverse Event|1|||
162133847|NCT04955626|585539059|FG001|Open-Label Period|Adverse Event|0|||
162133848|NCT04955626|585539060|FG002|Open-Label Period|Adverse Event|0|||
162133849|NCT04955626|585539061|FG003|Open-Label Period|Adverse Event|0|||
162133850|NCT04955626|585539062|FG004|Open-Label Period|Adverse Event|0|||
162133851|NCT04955626|585539063|FG005|Open-Label Period|Adverse Event|0|||
162133852|NCT04955626|585539064|FG006|Open-Label Period|Adverse Event|0|||
162133853|NCT04955626|585539065|FG007|Open-Label Period|Adverse Event|0|||
162133854|NCT04955626|585539066|FG008|Open-Label Period|Adverse Event|0|||
162133855|NCT04955626|585539067|FG009|Open-Label Period|Adverse Event|0|||
162133856|NCT04955626|585539068|FG010|Open-Label Period|Adverse Event|0|||
162133857|NCT04955626|585539069|FG011|Open-Label Period|Adverse Event|0|||
162133858|NCT04955626|585539070|FG012|Open-Label Period|Adverse Event|0|||
162133859|NCT04955626|585539071|FG013|Open-Label Period|Adverse Event|0|||
162133860|NCT04955626|585539072|FG014|Open-Label Period|Adverse Event|0|||
162133861|NCT04955626|585539073|FG015|Open-Label Period|Adverse Event|0|||
162133862|NCT04955626|585539074|FG016|Open-Label Period|Adverse Event|0|||
161900496|NCT03131687|584683067|FG000|Overall Study|Death|1|||
161900497|NCT03131687|584683068|FG001|Overall Study|Death|0|||
161900498|NCT03131687|584683069|FG002|Overall Study|Death|0|||
161900499|NCT03131687|584683070|FG003|Overall Study|Death|0|||
161900500|NCT03131687|584683071|FG004|Overall Study|Death|0|||
161900501|NCT03131687|584683072|FG005|Overall Study|Death|0|||
161900502|NCT03131687|584683067|FG000|Overall Study|Withdrawal by Subject|3|||
161900503|NCT03131687|584683068|FG001|Overall Study|Withdrawal by Subject|3|||
162133863|NCT04955626|585539075|FG017|Open-Label Period|Adverse Event|0|||
162133864|NCT04955626|585539076|FG018|Open-Label Period|Adverse Event|0|||
162133865|NCT04955626|585539077|FG019|Open-Label Period|Adverse Event|0|||
162133866|NCT04955626|585539078|FG020|Open-Label Period|Adverse Event|0|||
162133867|NCT04955626|585539079|FG021|Open-Label Period|Adverse Event|0|||
161795147|NCT00384033|584293676|FG003|Overall Study|Lost to Follow-up|7|||
161795148|NCT00384033|584293673|FG000|Overall Study|Other|2|||
161795149|NCT00384033|584293674|FG001|Overall Study|Other|0|||
161795150|NCT00384033|584293675|FG002|Overall Study|Other|0|||
161795151|NCT00384033|584293676|FG003|Overall Study|Other|0|||
161795152|NCT00384033|584293673|FG000|Overall Study|Protocol Violation|5|||
161795153|NCT00384033|584293674|FG001|Overall Study|Protocol Violation|0|||
161795154|NCT00384033|584293675|FG002|Overall Study|Protocol Violation|5|||
161795155|NCT00384033|584293676|FG003|Overall Study|Protocol Violation|6|||
161795156|NCT00384033|584293673|FG000|Overall Study|Withdrawal by Subject|6|||
161795157|NCT00384033|584293674|FG001|Overall Study|Withdrawal by Subject|2|||
161795158|NCT00384033|584293675|FG002|Overall Study|Withdrawal by Subject|5|||
161795159|NCT00384033|584293676|FG003|Overall Study|Withdrawal by Subject|2|||
161795160|NCT00384033|584293673|FG000|Overall Study|Lack of Efficacy|7|||
161795161|NCT00384033|584293674|FG001|Overall Study|Lack of Efficacy|3|||
161795162|NCT00384033|584293675|FG002|Overall Study|Lack of Efficacy|3|||
161795163|NCT00384033|584293676|FG003|Overall Study|Lack of Efficacy|1|||
161795164|NCT00384033|584293673|FG000|Overall Study|Randomized but not treated|3|||
161795165|NCT00384033|584293674|FG001|Overall Study|Randomized but not treated|7|||
161795166|NCT00384033|584293675|FG002|Overall Study|Randomized but not treated|10|||
161795167|NCT00384033|584293676|FG003|Overall Study|Randomized but not treated|2|||
161795168|NCT03349333|584293677|FG000|Overall Study|Progression of Disease|36|||
161795169|NCT03349333|584293677|FG000|Overall Study|Adverse Event|11|||
161795170|NCT03349333|584293677|FG000|Overall Study|Other|6|||
161795171|NCT03349333|584293677|FG000|Overall Study|Withdrawal by Subject|5|||
161795172|NCT03349333|584293677|FG000|Overall Study|Conditions interfere with participation|2|||
161900504|NCT03131687|584683069|FG002|Overall Study|Withdrawal by Subject|3|||
162133868|NCT04955626|585539080|FG022|Open-Label Period|Adverse Event|0|||
162133869|NCT04955626|585539081|FG023|Open-Label Period|Adverse Event|0|||
162133870|NCT04955626|585539082|FG024|Open-Label Period|Adverse Event|0|||
162133871|NCT04955626|585539083|FG025|Open-Label Period|Adverse Event|0|||
162133872|NCT04955626|585539084|FG026|Open-Label Period|Adverse Event|0|||
162133873|NCT04955626|585539085|FG027|Open-Label Period|Adverse Event|0|||
162133874|NCT04955626|585539086|FG028|Open-Label Period|Adverse Event|0|||
162133875|NCT04955626|585539087|FG029|Open-Label Period|Adverse Event|0|||
162133876|NCT04955626|585539088|FG030|Open-Label Period|Adverse Event|0|||
162133877|NCT04955626|585539089|FG031|Open-Label Period|Adverse Event|0|||
162133878|NCT04955626|585539090|FG032|Open-Label Period|Adverse Event|0|||
162133879|NCT04955626|585539091|FG033|Open-Label Period|Adverse Event|0|||
162133880|NCT04955626|585539092|FG034|Open-Label Period|Adverse Event|0|||
162133881|NCT04955626|585539093|FG035|Open-Label Period|Adverse Event|0|||
162133882|NCT04955626|585539058|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
162133883|NCT04955626|585539059|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
162133884|NCT04955626|585539060|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
162133885|NCT04955626|585539061|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
162133886|NCT04955626|585539062|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
162133887|NCT04955626|585539063|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
162133888|NCT04955626|585539064|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
162133889|NCT04955626|585539065|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
162133890|NCT04955626|585539066|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
162133891|NCT04955626|585539067|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
162133892|NCT04955626|585539068|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
162133893|NCT04955626|585539069|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
162133894|NCT04955626|585539070|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
162133895|NCT04955626|585539071|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
162133896|NCT04955626|585539072|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
162133897|NCT04955626|585539073|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
162133898|NCT04955626|585539074|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
162133899|NCT04955626|585539075|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
162133900|NCT04955626|585539076|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
162133901|NCT04955626|585539077|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
162133902|NCT04955626|585539078|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
162133903|NCT04955626|585539079|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
162133904|NCT04955626|585539080|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
161795173|NCT03349333|584293677|FG000|Overall Study|Physician Decision|2|||
161795174|NCT03349333|584293677|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
161795175|NCT03349333|584293677|FG000|Overall Study|Patients in treatment less than 24 month|8|||
161795176|NCT02985151|584293678|FG000|Original Randomization|Withdrawal by Subject|0|||
161795177|NCT02985151|584293679|FG001|Original Randomization|Withdrawal by Subject|1|||
161795178|NCT02752776|584293682|FG000|Overall Study|Adverse Event|15|||
161795179|NCT02752776|584293683|FG001|Overall Study|Adverse Event|23|||
161795180|NCT02752776|584293684|FG002|Overall Study|Adverse Event|11|||
162133905|NCT04955626|585539081|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
162133906|NCT04955626|585539082|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
161795181|NCT02752776|584293682|FG000|Overall Study|Lack of Efficacy|2|||
161795182|NCT02752776|584293683|FG001|Overall Study|Lack of Efficacy|6|||
161795183|NCT02752776|584293684|FG002|Overall Study|Lack of Efficacy|14|||
161795184|NCT02752776|584293682|FG000|Overall Study|Lost to Follow-up|11|||
161795185|NCT02752776|584293683|FG001|Overall Study|Lost to Follow-up|12|||
161795186|NCT02752776|584293684|FG002|Overall Study|Lost to Follow-up|4|||
161795187|NCT02752776|584293682|FG000|Overall Study|Non-compliance with study treatment|0|||
161795188|NCT02752776|584293683|FG001|Overall Study|Non-compliance with study treatment|0|||
161795189|NCT02752776|584293684|FG002|Overall Study|Non-compliance with study treatment|1|||
161795190|NCT02752776|584293682|FG000|Overall Study|Physician Decision|2|||
161795191|NCT02752776|584293683|FG001|Overall Study|Physician Decision|6|||
161795192|NCT02752776|584293684|FG002|Overall Study|Physician Decision|2|||
161795193|NCT02752776|584293682|FG000|Overall Study|Pregnancy|1|||
161795194|NCT02752776|584293683|FG001|Overall Study|Pregnancy|6|||
161795195|NCT02752776|584293684|FG002|Overall Study|Pregnancy|3|||
161795196|NCT02752776|584293682|FG000|Overall Study|Protocol Violation|10|||
161795197|NCT02752776|584293683|FG001|Overall Study|Protocol Violation|13|||
161795198|NCT02752776|584293684|FG002|Overall Study|Protocol Violation|6|||
161795199|NCT02752776|584293682|FG000|Overall Study|Subject/guardian decision|8|||
161795200|NCT02752776|584293683|FG001|Overall Study|Subject/guardian decision|6|||
161795201|NCT02752776|584293684|FG002|Overall Study|Subject/guardian decision|4|||
161795202|NCT02752776|584293682|FG000|Overall Study|Death|0|||
161795203|NCT02752776|584293683|FG001|Overall Study|Death|0|||
161795204|NCT02752776|584293684|FG002|Overall Study|Death|1|||
161795205|NCT02752776|584293682|FG000|Overall Study|Withdrawal by Subject|3|||
161795206|NCT02752776|584293683|FG001|Overall Study|Withdrawal by Subject|4|||
161795207|NCT02752776|584293684|FG002|Overall Study|Withdrawal by Subject|2|||
161795208|NCT01816477|584293685|FG000|Overall Study|Withdrawal by Subject|13|||
161795209|NCT01816477|584293686|FG001|Overall Study|Withdrawal by Subject|1|||
161795210|NCT01816477|584293685|FG000|Overall Study|Unable to tolerate catheter placement|3|||
161795211|NCT01816477|584293686|FG001|Overall Study|Unable to tolerate catheter placement|0|||
161795212|NCT02116803|584293687|FG000|Overall Study|Adverse Event|2|||
161795213|NCT02116803|584293688|FG001|Overall Study|Adverse Event|1|||
161795214|NCT02116803|584293687|FG000|Overall Study|Physician Decision|1|||
161795215|NCT02116803|584293688|FG001|Overall Study|Physician Decision|0|||
161795216|NCT02116803|584293687|FG000|Overall Study|Progressive disease|4|||
161795217|NCT02116803|584293688|FG001|Overall Study|Progressive disease|0|||
161795218|NCT02116803|584293687|FG000|Overall Study|Study terminated by sponsor|2|||
161795219|NCT02116803|584293688|FG001|Overall Study|Study terminated by sponsor|1|||
161795220|NCT02116803|584293687|FG000|Overall Study|Death|1|||
162133907|NCT04955626|585539083|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
162133908|NCT04955626|585539084|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
162133909|NCT04955626|585539085|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
162133910|NCT04955626|585539086|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
162133911|NCT04955626|585539087|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
162133912|NCT04955626|585539088|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
162133913|NCT04955626|585539089|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
162133914|NCT04955626|585539090|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
162133915|NCT04955626|585539091|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
162133916|NCT04955626|585539092|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
162133917|NCT04955626|585539093|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
162133918|NCT04955626|585539058|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133919|NCT04955626|585539059|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
162133920|NCT04955626|585539060|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133921|NCT04955626|585539061|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133922|NCT04955626|585539062|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133923|NCT04955626|585539063|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133924|NCT04955626|585539064|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133925|NCT04955626|585539065|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133926|NCT04955626|585539066|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133927|NCT04955626|585539067|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133928|NCT04955626|585539068|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133929|NCT04955626|585539069|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161795221|NCT02116803|584293688|FG001|Overall Study|Death|0|||
161795222|NCT00684671|584293689|FG000|Overall Study|Adverse Event|1|||
161795223|NCT00684671|584293690|FG001|Overall Study|Adverse Event|0|||
161795224|NCT00684671|584293691|FG002|Overall Study|Adverse Event|0|||
161795225|NCT00684671|584293689|FG000|Overall Study|Lost to Follow-up|1|||
161795226|NCT00684671|584293690|FG001|Overall Study|Lost to Follow-up|0|||
161795227|NCT00684671|584293691|FG002|Overall Study|Lost to Follow-up|0|||
161795228|NCT00684671|584293689|FG000|Overall Study|Alcoholic dependance|1|||
161795229|NCT00684671|584293690|FG001|Overall Study|Alcoholic dependance|0|||
161795230|NCT00684671|584293691|FG002|Overall Study|Alcoholic dependance|0|||
161795231|NCT04128007|584293692|FG000|Overall Study|Withdrawal by Subject|9|||
161795232|NCT04128007|584293693|FG001|Overall Study|Withdrawal by Subject|6|||
162133930|NCT04955626|585539070|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133931|NCT04955626|585539071|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133932|NCT04955626|585539072|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133933|NCT04955626|585539073|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133934|NCT04955626|585539074|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133935|NCT04955626|585539075|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133936|NCT04955626|585539076|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161795233|NCT04128007|584293692|FG000|Overall Study|Protocol Violation|1|||
161795234|NCT04128007|584293693|FG001|Overall Study|Protocol Violation|0|||
161795235|NCT04128007|584293692|FG000|Overall Study|Lost to Follow-up|8|||
161795236|NCT04128007|584293693|FG001|Overall Study|Lost to Follow-up|7|||
161795237|NCT04128007|584293692|FG000|Overall Study|Adverse Event|5|||
161795238|NCT04128007|584293693|FG001|Overall Study|Adverse Event|2|||
161795239|NCT04128007|584293692|FG000|Overall Study|Not reported|0|||
161795240|NCT04128007|584293693|FG001|Overall Study|Not reported|2|||
161795241|NCT00481247|584293696|FG000|Overall Study|Death|0|||
161795242|NCT00481247|584293697|FG001|Overall Study|Death|1|||
161795243|NCT00481247|584293696|FG000|Overall Study|Disease progression|18|||
161795244|NCT00481247|584293697|FG001|Overall Study|Disease progression|22|||
161795245|NCT00481247|584293696|FG000|Overall Study|Intolerance|42|||
161795246|NCT00481247|584293697|FG001|Overall Study|Intolerance|17|||
161795247|NCT00481247|584293696|FG000|Overall Study|Treatment failure|10|||
161795248|NCT00481247|584293697|FG001|Overall Study|Treatment failure|14|||
161795249|NCT00481247|584293696|FG000|Overall Study|AE unrelated to study drug|13|||
161795250|NCT00481247|584293697|FG001|Overall Study|AE unrelated to study drug|4|||
161795251|NCT00481247|584293696|FG000|Overall Study|Withdrawal by Subject|8|||
161795252|NCT00481247|584293697|FG001|Overall Study|Withdrawal by Subject|13|||
161795253|NCT00481247|584293696|FG000|Overall Study|Pregnancy|2|||
161795254|NCT00481247|584293697|FG001|Overall Study|Pregnancy|1|||
161795255|NCT00481247|584293696|FG000|Overall Study|Lost to Follow-up|1|||
161795256|NCT00481247|584293697|FG001|Overall Study|Lost to Follow-up|2|||
161795257|NCT00481247|584293696|FG000|Overall Study|Poor compliance/noncompliance|1|||
161795258|NCT00481247|584293697|FG001|Overall Study|Poor compliance/noncompliance|7|||
161795259|NCT00481247|584293696|FG000|Overall Study|Administrative reason by sponsor|157|||
161795260|NCT00481247|584293697|FG001|Overall Study|Administrative reason by sponsor|162|||
161795261|NCT00481247|584293696|FG000|Overall Study|Varied|6|||
161795262|NCT00481247|584293697|FG001|Overall Study|Varied|15|||
161795263|NCT00481247|584293696|FG000|Overall Study|Did not receive treatment|1|||
161795264|NCT00481247|584293697|FG001|Overall Study|Did not receive treatment|2|||
161795265|NCT01716754|584293698|FG000|Overall Study|Death|0|||
161795266|NCT01716754|584293699|FG001|Overall Study|Death|0|||
161795267|NCT01716754|584293700|FG002|Overall Study|Death|0|||
161795268|NCT01716754|584293701|FG003|Overall Study|Death|1|||
161795269|NCT01716754|584293698|FG000|Overall Study|Protocol deviation|0|||
161795270|NCT01716754|584293699|FG001|Overall Study|Protocol deviation|2|||
161795271|NCT01716754|584293700|FG002|Overall Study|Protocol deviation|7|||
161795272|NCT01716754|584293701|FG003|Overall Study|Protocol deviation|2|||
161795273|NCT01716754|584293698|FG000|Overall Study|Non-compliance with study treatment|0|||
161795274|NCT01716754|584293699|FG001|Overall Study|Non-compliance with study treatment|0|||
161795275|NCT01716754|584293700|FG002|Overall Study|Non-compliance with study treatment|1|||
161795276|NCT01716754|584293701|FG003|Overall Study|Non-compliance with study treatment|0|||
161795277|NCT01716754|584293698|FG000|Overall Study|Physician Decision|1|||
161795278|NCT01716754|584293699|FG001|Overall Study|Physician Decision|0|||
161795279|NCT01716754|584293700|FG002|Overall Study|Physician Decision|0|||
161795280|NCT01716754|584293701|FG003|Overall Study|Physician Decision|0|||
161795281|NCT01716754|584293698|FG000|Overall Study|Lost to Follow-up|1|||
161795282|NCT01716754|584293699|FG001|Overall Study|Lost to Follow-up|0|||
161795283|NCT01716754|584293700|FG002|Overall Study|Lost to Follow-up|0|||
161795284|NCT01716754|584293701|FG003|Overall Study|Lost to Follow-up|1|||
161795285|NCT01716754|584293698|FG000|Overall Study|Adverse Event|4|||
161795286|NCT01716754|584293699|FG001|Overall Study|Adverse Event|2|||
161795287|NCT01716754|584293700|FG002|Overall Study|Adverse Event|2|||
161795288|NCT01716754|584293701|FG003|Overall Study|Adverse Event|1|||
161795289|NCT01716754|584293698|FG000|Overall Study|Withdrawal by Subject|5|||
161795290|NCT01716754|584293699|FG001|Overall Study|Withdrawal by Subject|0|||
161795291|NCT01716754|584293700|FG002|Overall Study|Withdrawal by Subject|4|||
161795292|NCT01716754|584293701|FG003|Overall Study|Withdrawal by Subject|3|||
161795293|NCT02110706|584293719|FG000|Overall Study|Adverse Event|2|||
161795294|NCT02110706|584293720|FG001|Overall Study|Adverse Event|3|||
161795295|NCT02110706|584293719|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
161795296|NCT02110706|584293720|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
161795297|NCT04281485|584293722|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
161795298|NCT04281485|584293723|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
161795299|NCT04281485|584293722|FG000|Overall Study|Ongoing (Safety data collection)|10|||
162010751|NCT02054104|585095976|FG001|Overall Study|No evidence of immunologic response|2|||
162010752|NCT02054104|585095975|FG000|Overall Study|Disease Progression On Study|4|||
162010753|NCT02054104|585095976|FG001|Overall Study|Disease Progression On Study|5|||
162010754|NCT02054104|585095975|FG000|Overall Study|Diagnosis of lymphoma|0|||
161795300|NCT04281485|584293723|FG001|Overall Study|Ongoing (Safety data collection)|5|||
161795301|NCT04317599|584293724|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
162010755|NCT02054104|585095976|FG001|Overall Study|Diagnosis of lymphoma|1|||
162010756|NCT02054104|585095975|FG000|Overall Study|Inconclusive response|0|||
162010757|NCT02054104|585095976|FG001|Overall Study|Inconclusive response|1|||
162010758|NCT00836693|585095983|FG000|Overall Study|Adverse Event|4|||
162010759|NCT00836693|585095984|FG001|Overall Study|Adverse Event|1|||
162010760|NCT00836693|585095983|FG000|Overall Study|Sponsor Decision|0|||
162010761|NCT00836693|585095984|FG001|Overall Study|Sponsor Decision|1|||
162010762|NCT00836693|585095983|FG000|Overall Study|Physician Decision|2|||
162010763|NCT00836693|585095984|FG001|Overall Study|Physician Decision|0|||
162010764|NCT00836693|585095983|FG000|Overall Study|Withdrawal by Subject|9|||
162010765|NCT00836693|585095984|FG001|Overall Study|Withdrawal by Subject|4|||
162010766|NCT00836693|585095983|FG000|Overall Study|Protocol Violation|1|||
162010767|NCT00836693|585095984|FG001|Overall Study|Protocol Violation|0|||
162010768|NCT00836693|585095983|FG000|Overall Study|Lost to Follow-up|1|||
162010769|NCT00836693|585095984|FG001|Overall Study|Lost to Follow-up|0|||
162010770|NCT02633306|585095985|FG000|Overall Study|Withdrawal by Subject|3|||
162010771|NCT02131259|585095986|FG000|Overall Study|Progressive disease|751|||
162010772|NCT02131259|585095986|FG000|Overall Study|Adverse Event|341|||
162010773|NCT02131259|585095986|FG000|Overall Study|Lost to Follow-up|7|||
162010774|NCT02131259|585095986|FG000|Overall Study|Relocation|32|||
162010775|NCT02131259|585095986|FG000|Overall Study|Other|63|||
162010776|NCT02131259|585095986|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
162010777|NCT02131259|585095986|FG000|Overall Study|Progressive disease/relocation|1|||
162010778|NCT02131259|585095986|FG000|Overall Study|Progressive disease/other|2|||
162010779|NCT02131259|585095986|FG000|Overall Study|AE/lost to follow-up|1|||
162010780|NCT02131259|585095986|FG000|Overall Study|AE/other|1|||
162010781|NCT02131259|585095986|FG000|Overall Study|Progressive disease/AE/other|1|||
162010782|NCT02131259|585095986|FG000|Overall Study|Missing|3|||
162010783|NCT01472289|585095993|FG000|Overall Study|Death|2|||
162010784|NCT00907335|585095994|FG000|Overall Study|Withdrawal by Subject|2|||
162010785|NCT00907335|585095995|FG001|Overall Study|Withdrawal by Subject|0|||
162010786|NCT00907335|585095994|FG000|Overall Study|Adverse Event|4|||
162010787|NCT00907335|585095995|FG001|Overall Study|Adverse Event|1|||
162010788|NCT00907335|585095994|FG000|Overall Study|Lost to Follow-up|2|||
162010789|NCT00907335|585095995|FG001|Overall Study|Lost to Follow-up|0|||
162010790|NCT03879772|585095996|FG000|Overall Study|Adverse Event|2|||
162010791|NCT03879772|585095997|FG001|Overall Study|Adverse Event|2|||
162010792|NCT03879772|585095998|FG002|Overall Study|Adverse Event|3|||
162010793|NCT03879772|585095999|FG003|Overall Study|Adverse Event|4|||
162010794|NCT03879772|585096000|FG004|Overall Study|Adverse Event|3|||
162010795|NCT03879772|585095996|FG000|Overall Study|Treatment Failure|1|||
162010796|NCT03879772|585095997|FG001|Overall Study|Treatment Failure|0|||
162010797|NCT03879772|585095998|FG002|Overall Study|Treatment Failure|0|||
162010798|NCT03879772|585095999|FG003|Overall Study|Treatment Failure|2|||
162010799|NCT03879772|585096000|FG004|Overall Study|Treatment Failure|1|||
162010800|NCT03879772|585095996|FG000|Overall Study|Lost to Follow-up|0|||
162010801|NCT03879772|585095997|FG001|Overall Study|Lost to Follow-up|0|||
162010802|NCT03879772|585095998|FG002|Overall Study|Lost to Follow-up|0|||
162010803|NCT03879772|585095999|FG003|Overall Study|Lost to Follow-up|0|||
161795302|NCT04317599|584293724|FG000|Overall Study|treatment outside standard of care|4|||
161795303|NCT03933202|584293725|FG000|Overall Study|Participant withdrawn by Principal Investigator|1|||
161795304|NCT03933202|584293726|FG001|Overall Study|Participant withdrawn by Principal Investigator|0|||
161795305|NCT03933202|584293725|FG000|Overall Study|Participant transferred care|1|||
161795306|NCT03933202|584293726|FG001|Overall Study|Participant transferred care|0|||
161795307|NCT03933202|584293725|FG000|Overall Study|Site research department closing|1|||
161795308|NCT03933202|584293726|FG001|Overall Study|Site research department closing|0|||
161795309|NCT03933202|584293725|FG000|Overall Study|Site closed prematurely due to unexpected circumstances|0|||
161795310|NCT03933202|584293726|FG001|Overall Study|Site closed prematurely due to unexpected circumstances|1|||
161795311|NCT03933202|584293725|FG000|Overall Study|Participant discontinuation due to Sponsor decision to close study|0|||
162010804|NCT03879772|585096000|FG004|Overall Study|Lost to Follow-up|1|||
162010805|NCT03879772|585095996|FG000|Overall Study|Withdrawal by Subject|0|||
162010806|NCT03879772|585095997|FG001|Overall Study|Withdrawal by Subject|1|||
162010807|NCT03879772|585095998|FG002|Overall Study|Withdrawal by Subject|3|||
162010808|NCT03879772|585095999|FG003|Overall Study|Withdrawal by Subject|1|||
162010809|NCT03879772|585096000|FG004|Overall Study|Withdrawal by Subject|1|||
162010810|NCT03879772|585095996|FG000|Overall Study|Protocol Violation|0|||
162010811|NCT03879772|585095997|FG001|Overall Study|Protocol Violation|0|||
162010812|NCT03879772|585095998|FG002|Overall Study|Protocol Violation|3|||
162010813|NCT03879772|585095999|FG003|Overall Study|Protocol Violation|1|||
162010814|NCT03879772|585096000|FG004|Overall Study|Protocol Violation|2|||
161900505|NCT03131687|584683070|FG003|Overall Study|Withdrawal by Subject|1|||
161900506|NCT03131687|584683071|FG004|Overall Study|Withdrawal by Subject|2|||
161795312|NCT03933202|584293726|FG001|Overall Study|Participant discontinuation due to Sponsor decision to close study|2|||
161795313|NCT03933202|584293725|FG000|Overall Study|Participant changed primary neurology provider|1|||
161795314|NCT03933202|584293726|FG001|Overall Study|Participant changed primary neurology provider|0|||
161795315|NCT03933202|584293725|FG000|Overall Study|Participant could not be entered as a follow-up|0|||
161795316|NCT03933202|584293726|FG001|Overall Study|Participant could not be entered as a follow-up|1|||
161795317|NCT03933202|584293725|FG000|Overall Study|Participant non-compliant, therefore, has been discontinued|1|||
161795318|NCT03933202|584293726|FG001|Overall Study|Participant non-compliant, therefore, has been discontinued|0|||
161795319|NCT03933202|584293725|FG000|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|1|||
161795320|NCT03933202|584293726|FG001|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|0|||
161795321|NCT03933202|584293725|FG000|Overall Study|Missed visit|0|||
161795322|NCT03933202|584293726|FG001|Overall Study|Missed visit|1|||
161795323|NCT03933202|584293725|FG000|Overall Study|Investigator decision|4|||
161795324|NCT03933202|584293726|FG001|Overall Study|Investigator decision|0|||
161795325|NCT03933202|584293725|FG000|Overall Study|Discontinuation due to safety extension removal by Sponsor|0|||
161795326|NCT03933202|584293726|FG001|Overall Study|Discontinuation due to safety extension removal by Sponsor|1|||
161795327|NCT03933202|584293725|FG000|Overall Study|Withdrawal by Subject|10|||
161795328|NCT03933202|584293726|FG001|Overall Study|Withdrawal by Subject|8|||
161795329|NCT03933202|584293725|FG000|Overall Study|Death|2|||
161795330|NCT03933202|584293726|FG001|Overall Study|Death|0|||
161795331|NCT03933202|584293725|FG000|Overall Study|Progressive disease|0|||
161795332|NCT03933202|584293726|FG001|Overall Study|Progressive disease|3|||
161795333|NCT03933202|584293725|FG000|Overall Study|Protocol non-compliance|6|||
161795334|NCT03933202|584293726|FG001|Overall Study|Protocol non-compliance|3|||
161795335|NCT03933202|584293725|FG000|Overall Study|Lost to Follow-up|16|||
161795336|NCT03933202|584293726|FG001|Overall Study|Lost to Follow-up|8|||
161795337|NCT03933202|584293725|FG000|Overall Study|Adverse Event|3|||
161795338|NCT03933202|584293726|FG001|Overall Study|Adverse Event|0|||
161795339|NCT00947427|584293727|FG000|Overall Study|Withdrawal by Subject|1|||
161795340|NCT00947427|584293728|FG001|Overall Study|Withdrawal by Subject|3|||
161795341|NCT00947427|584293727|FG000|Overall Study|Protocol Violation|0|||
161795342|NCT00947427|584293728|FG001|Overall Study|Protocol Violation|1|||
161795343|NCT01348542|584293730|FG000|Overall Study|Withdrawal by Subject|3|||
161795344|NCT01348542|584293731|FG001|Overall Study|Withdrawal by Subject|0|||
161795345|NCT05658523|584293732|FG000|Baseline|No blood draw|1|||
161795346|NCT05658523|584293733|FG001|Baseline|No blood draw|0|||
161795347|NCT05658523|584293734|FG002|Baseline|No blood draw|0|||
161900507|NCT03131687|584683072|FG005|Overall Study|Withdrawal by Subject|1|||
161900508|NCT03131687|584683067|FG000|Overall Study|Lost to Follow-up|1|||
162133937|NCT04955626|585539077|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133938|NCT04955626|585539078|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133939|NCT04955626|585539079|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133940|NCT04955626|585539080|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133941|NCT04955626|585539081|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133942|NCT04955626|585539082|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133943|NCT04955626|585539083|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133944|NCT04955626|585539084|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133945|NCT04955626|585539085|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133946|NCT04955626|585539086|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133947|NCT04955626|585539087|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133948|NCT04955626|585539088|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133949|NCT04955626|585539089|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133950|NCT04955626|585539090|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133951|NCT04955626|585539091|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133952|NCT04955626|585539092|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133953|NCT04955626|585539093|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
162133954|NCT04951479|585539096|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
162133955|NCT04209790|585539097|FG000|Overall Study|Physician Decision|1|||
162133956|NCT03706690|585539098|FG000|Overall Study|Withdrawal by Subject|8|||
162133957|NCT03706690|585539099|FG001|Overall Study|Withdrawal by Subject|8|||
162133958|NCT03706690|585539098|FG000|Overall Study|Death|143|||
161795348|NCT05658523|584293732|FG000|28 Days|Lost to Follow-up|1|||
161795349|NCT05658523|584293733|FG001|28 Days|Lost to Follow-up|0|||
161795350|NCT05658523|584293734|FG002|28 Days|Lost to Follow-up|0|||
161795351|NCT05658523|584293732|FG000|28 Days|Withdrawal by Subject|1|||
161795352|NCT05658523|584293733|FG001|28 Days|Withdrawal by Subject|1|||
161795353|NCT05658523|584293734|FG002|28 Days|Withdrawal by Subject|0|||
161795354|NCT05658523|584293732|FG000|28 Days|Visit missed|0|||
161900509|NCT03131687|584683068|FG001|Overall Study|Lost to Follow-up|4|||
161900510|NCT03131687|584683069|FG002|Overall Study|Lost to Follow-up|0|||
162133959|NCT03706690|585539099|FG001|Overall Study|Death|75|||
162133960|NCT03706690|585539098|FG000|Overall Study|Ongoing at DCO|121|||
162133961|NCT03706690|585539099|FG001|Overall Study|Ongoing at DCO|52|||
162133962|NCT05617040|585539100|FG000|Overall Study|Adverse Event|0|||
162133963|NCT05617040|585539101|FG001|Overall Study|Adverse Event|1|||
162133964|NCT05617040|585539102|FG002|Overall Study|Adverse Event|0|||
162133965|NCT05617040|585539100|FG000|Overall Study|Death|0|||
162133966|NCT05617040|585539101|FG001|Overall Study|Death|0|||
162133967|NCT05617040|585539102|FG002|Overall Study|Death|1|||
161795355|NCT05658523|584293733|FG001|28 Days|Visit missed|4|||
161795356|NCT05658523|584293734|FG002|28 Days|Visit missed|0|||
161795357|NCT05658523|584293732|FG000|6 Months|Lost to Follow-up|1|||
161795358|NCT05658523|584293733|FG001|6 Months|Lost to Follow-up|7|||
161795359|NCT05658523|584293734|FG002|6 Months|Lost to Follow-up|2|||
161795360|NCT05658523|584293732|FG000|6 Months|Withdrawal by Subject|1|||
161795361|NCT05658523|584293733|FG001|6 Months|Withdrawal by Subject|3|||
161795362|NCT05658523|584293734|FG002|6 Months|Withdrawal by Subject|4|||
161795363|NCT05658523|584293732|FG000|6 Months|Visit missed|5|||
161795364|NCT05658523|584293733|FG001|6 Months|Visit missed|7|||
161795365|NCT05658523|584293734|FG002|6 Months|Visit missed|0|||
161795366|NCT05658523|584293732|FG000|6 Months|No blood draw|0|||
161795367|NCT05658523|584293733|FG001|6 Months|No blood draw|0|||
161795368|NCT05658523|584293734|FG002|6 Months|No blood draw|1|||
161795369|NCT05658523|584293732|FG000|12 Months|Lost to Follow-up|2|||
161795370|NCT05658523|584293733|FG001|12 Months|Lost to Follow-up|6|||
161795371|NCT05658523|584293734|FG002|12 Months|Lost to Follow-up|3|||
161795372|NCT05658523|584293732|FG000|12 Months|Withdrawal by Subject|4|||
161795373|NCT05658523|584293733|FG001|12 Months|Withdrawal by Subject|4|||
161795374|NCT05658523|584293734|FG002|12 Months|Withdrawal by Subject|2|||
161795375|NCT05658523|584293732|FG000|12 Months|Visit missed|4|||
161795376|NCT05658523|584293733|FG001|12 Months|Visit missed|8|||
161795377|NCT05658523|584293734|FG002|12 Months|Visit missed|8|||
161795378|NCT05658523|584293732|FG000|18 Months|Lost to Follow-up|5|||
161795379|NCT05658523|584293733|FG001|18 Months|Lost to Follow-up|8|||
161795380|NCT05658523|584293734|FG002|18 Months|Lost to Follow-up|2|||
161795381|NCT05658523|584293732|FG000|18 Months|Withdrawal by Subject|17|||
161795382|NCT05658523|584293733|FG001|18 Months|Withdrawal by Subject|9|||
161795383|NCT05658523|584293734|FG002|18 Months|Withdrawal by Subject|16|||
161795384|NCT05658523|584293732|FG000|18 Months|Visit missed|12|||
161795385|NCT05658523|584293733|FG001|18 Months|Visit missed|14|||
161795386|NCT05658523|584293734|FG002|18 Months|Visit missed|6|||
161795387|NCT00628212|584293737|FG000|Overall Study|Adverse Event|2|||
161795388|NCT00628212|584293738|FG001|Overall Study|Adverse Event|0|||
161795389|NCT00628212|584293739|FG002|Overall Study|Adverse Event|1|||
161795390|NCT00628212|584293740|FG003|Overall Study|Adverse Event|2|||
161795391|NCT00628212|584293737|FG000|Overall Study|Physician Decision|1|||
161795392|NCT00628212|584293738|FG001|Overall Study|Physician Decision|1|||
161795393|NCT00628212|584293739|FG002|Overall Study|Physician Decision|2|||
161795394|NCT00628212|584293740|FG003|Overall Study|Physician Decision|3|||
161795395|NCT02427607|584293741|FG000|Overall Study|Withdrawal by Subject|1|||
161795396|NCT03211416|584293742|FG000|Overall Study|Adverse Event|7|||
161795397|NCT03211416|584293742|FG000|Overall Study|Lack of Efficacy|2|||
161795398|NCT03211416|584293742|FG000|Overall Study|Physician Decision|1|||
161795399|NCT03199274|584293743|FG000|Overall Study|Withdrawal by Subject|4|||
161795400|NCT03199274|584293744|FG001|Overall Study|Withdrawal by Subject|0|||
161795401|NCT03199274|584293743|FG000|Overall Study|Lost to Follow-up|0|||
161795402|NCT03199274|584293744|FG001|Overall Study|Lost to Follow-up|1|||
161795403|NCT03199274|584293743|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
161795404|NCT03199274|584293744|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
161795405|NCT00356200|584294922|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
162133968|NCT02711826|585539103|FG000|Overall Study|Physician Decision|0|||
162133969|NCT02711826|585539104|FG001|Overall Study|Physician Decision|0|||
162133970|NCT02711826|585539105|FG002|Overall Study|Physician Decision|0|||
161795406|NCT00356200|584294923|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
161795407|NCT00356200|584294922|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
161795408|NCT00356200|584294923|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
161795409|NCT02909673|584294924|FG000|Overall Study|Did not meet inclusion criteria|129|||
161795410|NCT02909673|584294925|FG001|Overall Study|Did not meet inclusion criteria|29|||
161795411|NCT02909673|584294924|FG000|Overall Study|Surveys lost by scanner|95|||
161795412|NCT02909673|584294925|FG001|Overall Study|Surveys lost by scanner|2|||
161795413|NCT02909673|584294924|FG000|Overall Study|Tracking info missing|0|||
161795414|NCT02909673|584294925|FG001|Overall Study|Tracking info missing|5|||
161795415|NCT00783796|584294928|FG000|Overall Study|Did not receive any stent|4|||
161795416|NCT00783796|584294928|FG000|Overall Study|Received non-XIENCE V stent|1|||
161795417|NCT00783796|584294928|FG000|Overall Study|Received commercial XIENCE V stent|1|||
161795418|NCT01215942|584294929|FG000|Treatment Period|Adverse Event|15|||
161795419|NCT01215942|584294930|FG001|Treatment Period|Adverse Event|26|||
161795420|NCT01215942|584294929|FG000|Treatment Period|Death|2|||
161795421|NCT01215942|584294930|FG001|Treatment Period|Death|4|||
162133971|NCT02711826|585539106|FG003|Overall Study|Physician Decision|1|||
161900511|NCT03131687|584683070|FG003|Overall Study|Lost to Follow-up|1|||
161900512|NCT03131687|584683071|FG004|Overall Study|Lost to Follow-up|4|||
161900513|NCT03131687|584683072|FG005|Overall Study|Lost to Follow-up|2|||
161900514|NCT03131687|584683067|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
161900515|NCT03131687|584683068|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
161900516|NCT03131687|584683069|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
161900517|NCT03131687|584683070|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
161900518|NCT03131687|584683071|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
161900519|NCT03131687|584683072|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
161900520|NCT03131687|584683067|FG000|Overall Study|Principle Investigator Decision|0|||
161900521|NCT03131687|584683068|FG001|Overall Study|Principle Investigator Decision|1|||
161900522|NCT03131687|584683069|FG002|Overall Study|Principle Investigator Decision|0|||
161900523|NCT03131687|584683070|FG003|Overall Study|Principle Investigator Decision|0|||
161900524|NCT03131687|584683071|FG004|Overall Study|Principle Investigator Decision|0|||
161900525|NCT03131687|584683072|FG005|Overall Study|Principle Investigator Decision|0|||
161900526|NCT03131687|584683067|FG000|Overall Study|Inadvertent Enrollment|0|||
161900527|NCT03131687|584683068|FG001|Overall Study|Inadvertent Enrollment|0|||
161900528|NCT03131687|584683069|FG002|Overall Study|Inadvertent Enrollment|0|||
161900529|NCT03131687|584683070|FG003|Overall Study|Inadvertent Enrollment|1|||
161900530|NCT03131687|584683071|FG004|Overall Study|Inadvertent Enrollment|0|||
161900531|NCT03131687|584683072|FG005|Overall Study|Inadvertent Enrollment|0|||
161900532|NCT02137226|584683073|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
161900533|NCT02137226|584683074|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
161900534|NCT02137226|584683075|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
161900535|NCT02137226|584683076|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
161900536|NCT02137226|584683077|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
161900537|NCT02137226|584683073|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
161900538|NCT02137226|584683074|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
161900539|NCT02137226|584683075|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
162133972|NCT02711826|585539107|FG004|Overall Study|Physician Decision|0|||
162133973|NCT02711826|585539103|FG000|Overall Study|Withdrawal by Subject|0|||
162133974|NCT02711826|585539104|FG001|Overall Study|Withdrawal by Subject|1|||
162133975|NCT02711826|585539105|FG002|Overall Study|Withdrawal by Subject|0|||
162133976|NCT02711826|585539106|FG003|Overall Study|Withdrawal by Subject|4|||
162133977|NCT02711826|585539107|FG004|Overall Study|Withdrawal by Subject|0|||
162133978|NCT02711826|585539103|FG000|Overall Study|Failure to manufacture cellular product|0|||
162133979|NCT02711826|585539104|FG001|Overall Study|Failure to manufacture cellular product|0|||
162133980|NCT02711826|585539105|FG002|Overall Study|Failure to manufacture cellular product|5|||
162133981|NCT02711826|585539106|FG003|Overall Study|Failure to manufacture cellular product|0|||
162133982|NCT02711826|585539107|FG004|Overall Study|Failure to manufacture cellular product|0|||
162133983|NCT02711826|585539103|FG000|Overall Study|Infusion canceled for active infection|0|||
162133984|NCT02711826|585539104|FG001|Overall Study|Infusion canceled for active infection|1|||
162133985|NCT02711826|585539105|FG002|Overall Study|Infusion canceled for active infection|0|||
162133986|NCT02711826|585539106|FG003|Overall Study|Infusion canceled for active infection|0|||
162133987|NCT02711826|585539107|FG004|Overall Study|Infusion canceled for active infection|0|||
162133988|NCT02711826|585539103|FG000|Overall Study|Screen failures|0|||
162133989|NCT02711826|585539104|FG001|Overall Study|Screen failures|0|||
162133990|NCT02711826|585539105|FG002|Overall Study|Screen failures|0|||
162133991|NCT02711826|585539106|FG003|Overall Study|Screen failures|4|||
162133992|NCT02711826|585539107|FG004|Overall Study|Screen failures|0|||
162133993|NCT00729690|585539108|FG000|Overall Study|IT Catheter Malfunction|0|||
162133994|NCT00729690|585539109|FG001|Overall Study|IT Catheter Malfunction|2|||
162133995|NCT00729690|585539110|FG002|Overall Study|IT Catheter Malfunction|2|||
162133996|NCT02169219|585539111|FG000|Overall Study|Lack of Efficacy|6|||
162133997|NCT04482855|585539112|FG000|Overall Study|Lost to Follow-up|1|||
162133998|NCT04482855|585539113|FG001|Overall Study|Lost to Follow-up|0|||
162133999|NCT04482855|585539112|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
162134000|NCT04482855|585539113|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
162134001|NCT04482855|585539112|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
162134002|NCT04482855|585539113|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
161900540|NCT02137226|584683076|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
161900541|NCT02137226|584683077|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
161900542|NCT02137226|584683073|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
161900543|NCT02137226|584683074|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
162134003|NCT02507219|585539117|FG000|Overall Study|Physician Decision|1|||
162134004|NCT02507219|585539118|FG001|Overall Study|Physician Decision|0|||
162134005|NCT02507219|585539119|FG002|Overall Study|Physician Decision|0|||
161900544|NCT02137226|584683075|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
162134006|NCT02507219|585539120|FG003|Overall Study|Physician Decision|0|||
162010815|NCT03879772|585095996|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
162134007|NCT02507219|585539121|FG004|Overall Study|Physician Decision|0|||
162134008|NCT02507219|585539122|FG005|Overall Study|Physician Decision|0|||
162134009|NCT02507219|585539117|FG000|Overall Study|Withdrawal by Subject|0|||
162134010|NCT02507219|585539118|FG001|Overall Study|Withdrawal by Subject|0|||
162134011|NCT02507219|585539119|FG002|Overall Study|Withdrawal by Subject|0|||
162134012|NCT02507219|585539120|FG003|Overall Study|Withdrawal by Subject|0|||
162134013|NCT02507219|585539121|FG004|Overall Study|Withdrawal by Subject|1|||
162134014|NCT02507219|585539122|FG005|Overall Study|Withdrawal by Subject|0|||
162134015|NCT02886936|585539123|FG000|Overall Study|Lost to Follow-up|4|||
162134016|NCT02886936|585539124|FG001|Overall Study|Lost to Follow-up|3|||
162134017|NCT02886936|585539125|FG002|Overall Study|Lost to Follow-up|0|||
162134018|NCT04562779|585539126|FG000|Overall Study|Lost to Follow-up|7|||
162134019|NCT04562779|585539127|FG001|Overall Study|Lost to Follow-up|5|||
162134020|NCT04562779|585539128|FG002|Overall Study|Lost to Follow-up|10|||
162134021|NCT04562779|585539126|FG000|Overall Study|Protocol Violation|2|||
162134022|NCT04562779|585539127|FG001|Overall Study|Protocol Violation|2|||
162134023|NCT04562779|585539128|FG002|Overall Study|Protocol Violation|0|||
162134024|NCT02320721|585539129|FG000|Overall Study|Adverse Event|6|||
162134025|NCT02320721|585539130|FG001|Overall Study|Adverse Event|6|||
162134026|NCT02320721|585539129|FG000|Overall Study|Lack of Efficacy|2|||
162134027|NCT02320721|585539130|FG001|Overall Study|Lack of Efficacy|0|||
162134028|NCT02320721|585539129|FG000|Overall Study|Poor compliance to protocol|3|||
162134029|NCT02320721|585539130|FG001|Overall Study|Poor compliance to protocol|7|||
162134030|NCT02320721|585539129|FG000|Overall Study|Randomized but not treated|0|||
162134031|NCT02320721|585539130|FG001|Overall Study|Randomized but not treated|1|||
162134032|NCT02320721|585539129|FG000|Overall Study|Hypoglycemia|1|||
162134033|NCT02320721|585539130|FG001|Overall Study|Hypoglycemia|0|||
162134034|NCT02320721|585539129|FG000|Overall Study|Other than specified above|15|||
162134035|NCT02320721|585539130|FG001|Overall Study|Other than specified above|20|||
162134036|NCT03173248|585539131|FG000|Overall Study|Death|28|||
162134037|NCT03173248|585539132|FG001|Overall Study|Death|46|||
162134038|NCT03173248|585539131|FG000|Overall Study|Lost to Follow-up|0|||
162134039|NCT03173248|585539132|FG001|Overall Study|Lost to Follow-up|1|||
162134040|NCT03173248|585539131|FG000|Overall Study|Withdrawal by Subject|6|||
162134041|NCT03173248|585539132|FG001|Overall Study|Withdrawal by Subject|4|||
162134042|NCT03173248|585539131|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
162134043|NCT03173248|585539132|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
162134044|NCT01544582|585539133|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
162134045|NCT01544582|585539134|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
162134046|NCT01544582|585539135|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
162134047|NCT01544582|585539136|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
162134048|NCT01544582|585539133|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
162134049|NCT01544582|585539134|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
162134050|NCT01544582|585539135|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
162134051|NCT01544582|585539136|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
162134052|NCT01544582|585539133|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
162134053|NCT01544582|585539134|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
162134054|NCT01544582|585539135|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
162134055|NCT01544582|585539136|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
162134056|NCT01544582|585539133|FG000|Analysis Population|Physician Decision|0|||
162134057|NCT01544582|585539134|FG001|Analysis Population|Physician Decision|13|||
162134058|NCT01544582|585539135|FG002|Analysis Population|Physician Decision|10|||
162134059|NCT01544582|585539136|FG003|Analysis Population|Physician Decision|9|||
162134060|NCT01544582|585539133|FG000|Analysis Population|Safety Reason|0|||
162134061|NCT01544582|585539134|FG001|Analysis Population|Safety Reason|33|||
162134062|NCT01544582|585539135|FG002|Analysis Population|Safety Reason|31|||
162134063|NCT01544582|585539136|FG003|Analysis Population|Safety Reason|8|||
162134064|NCT01544582|585539133|FG000|Analysis Population|Effectiveness Reason|0|||
162134065|NCT01544582|585539134|FG001|Analysis Population|Effectiveness Reason|48|||
162134066|NCT01544582|585539135|FG002|Analysis Population|Effectiveness Reason|29|||
162134067|NCT01544582|585539136|FG003|Analysis Population|Effectiveness Reason|12|||
162134068|NCT01544582|585539133|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
162134069|NCT01544582|585539134|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
162134070|NCT01544582|585539135|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
162134071|NCT01544582|585539136|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
162134072|NCT01544582|585539133|FG000|Analysis Population|Lost to Follow-up|0|||
162134073|NCT01544582|585539134|FG001|Analysis Population|Lost to Follow-up|6|||
162134074|NCT01544582|585539135|FG002|Analysis Population|Lost to Follow-up|6|||
162134075|NCT01544582|585539136|FG003|Analysis Population|Lost to Follow-up|5|||
162134076|NCT01544582|585539133|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
162134077|NCT01544582|585539134|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
162134078|NCT01544582|585539135|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
162134079|NCT01544582|585539136|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
161795422|NCT01215942|584294929|FG000|Treatment Period|Lack of Efficacy|23|||
161795423|NCT01215942|584294930|FG001|Treatment Period|Lack of Efficacy|62|||
161795424|NCT01215942|584294929|FG000|Treatment Period|Lost to Follow-up|3|||
161795425|NCT01215942|584294930|FG001|Treatment Period|Lost to Follow-up|4|||
161795426|NCT01215942|584294929|FG000|Treatment Period|Withdrawal by Subject|17|||
161795427|NCT01215942|584294930|FG001|Treatment Period|Withdrawal by Subject|40|||
161795428|NCT01215942|584294929|FG000|Treatment Period|Physician Decision|5|||
161795429|NCT01215942|584294930|FG001|Treatment Period|Physician Decision|5|||
161795430|NCT01215942|584294929|FG000|Treatment Period|Protocol Violation|0|||
161795431|NCT01215942|584294930|FG001|Treatment Period|Protocol Violation|1|||
161795432|NCT01215942|584294929|FG000|Treatment Period|Sponsor Decision|349|||
161795433|NCT01215942|584294930|FG001|Treatment Period|Sponsor Decision|530|||
161795434|NCT01215942|584294929|FG000|Post-Treatment Follow-Up Period|Death|0|||
161795435|NCT01215942|584294930|FG001|Post-Treatment Follow-Up Period|Death|1|||
161795436|NCT01215942|584294929|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
161795437|NCT01215942|584294930|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
161795438|NCT01215942|584294929|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
161795439|NCT01215942|584294930|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
161795440|NCT01215942|584294929|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
161795441|NCT01215942|584294930|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
161795442|NCT01215942|584294929|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
161795443|NCT01215942|584294930|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
161795444|NCT03305055|584294931|FG000|Overall Study|Withdrawal by Subject|0|||
161795445|NCT03305055|584294932|FG001|Overall Study|Withdrawal by Subject|1|||
161795446|NCT03305055|584294931|FG000|Overall Study|Adverse Event|1|||
161795447|NCT03305055|584294932|FG001|Overall Study|Adverse Event|1|||
161795448|NCT02540356|584294933|FG000|Overall Study|Terminated due to disease progression|1|||
161795449|NCT02540356|584294934|FG001|Overall Study|Terminated due to disease progression|0|||
161795450|NCT01399736|584294935|FG000|Overall Study|Withdrawal by Subject|4|||
161795451|NCT01399736|584294936|FG001|Overall Study|Withdrawal by Subject|2|||
161795452|NCT01399736|584294935|FG000|Overall Study|Lost to Follow-up|0|||
161795453|NCT01399736|584294936|FG001|Overall Study|Lost to Follow-up|2|||
161795454|NCT03500484|584294937|FG000|Overall Study|Adverse Event|2|||
161795455|NCT03500484|584294938|FG001|Overall Study|Adverse Event|0|||
161795456|NCT03500484|584294937|FG000|Overall Study|Physician Decision|1|||
161795457|NCT03500484|584294938|FG001|Overall Study|Physician Decision|0|||
161795458|NCT03500484|584294937|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
161795459|NCT03500484|584294938|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
161795460|NCT02795104|584294939|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
161795461|NCT02795104|584294940|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
161795462|NCT02795104|584294941|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
161795463|NCT02795104|584294939|FG000|Overall Study|Withdrawal by Subject|0|||
161795464|NCT02795104|584294940|FG001|Overall Study|Withdrawal by Subject|2|||
161795465|NCT02795104|584294941|FG002|Overall Study|Withdrawal by Subject|0|||
161795466|NCT02795104|584294939|FG000|Overall Study|Lost to Follow-up|0|||
161795467|NCT02795104|584294940|FG001|Overall Study|Lost to Follow-up|0|||
161795468|NCT02795104|584294941|FG002|Overall Study|Lost to Follow-up|1|||
161795469|NCT03335371|584294942|FG000|Overall Study|Lost to Follow-up|0|||
161795470|NCT03335371|584294943|FG001|Overall Study|Lost to Follow-up|0|||
161795471|NCT03335371|584294944|FG002|Overall Study|Lost to Follow-up|0|||
161795472|NCT03335371|584294945|FG003|Overall Study|Lost to Follow-up|0|||
161795473|NCT03335371|584294946|FG004|Overall Study|Lost to Follow-up|1|||
161795474|NCT03335371|584294942|FG000|Overall Study|Withdrawal by Subject|0|||
161795475|NCT03335371|584294943|FG001|Overall Study|Withdrawal by Subject|0|||
162134080|NCT01544582|585539133|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
162134081|NCT01544582|585539134|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
162134082|NCT01544582|585539135|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
162134083|NCT01544582|585539136|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
162134084|NCT01544582|585539133|FG000|Analysis Population|Intolerance|0|||
162134085|NCT01544582|585539134|FG001|Analysis Population|Intolerance|1|||
162134086|NCT01544582|585539135|FG002|Analysis Population|Intolerance|0|||
162134087|NCT01544582|585539136|FG003|Analysis Population|Intolerance|0|||
162134088|NCT01544582|585539133|FG000|Analysis Population|Liver Transplantation|0|||
162134089|NCT01544582|585539134|FG001|Analysis Population|Liver Transplantation|0|||
161795476|NCT03335371|584294944|FG002|Overall Study|Withdrawal by Subject|0|||
161795477|NCT03335371|584294945|FG003|Overall Study|Withdrawal by Subject|0|||
161795478|NCT03335371|584294946|FG004|Overall Study|Withdrawal by Subject|1|||
161795479|NCT03335371|584294942|FG000|Overall Study|Randomization Error|0|||
161795480|NCT03335371|584294943|FG001|Overall Study|Randomization Error|0|||
161795481|NCT03335371|584294944|FG002|Overall Study|Randomization Error|1|||
161795482|NCT03335371|584294945|FG003|Overall Study|Randomization Error|0|||
161795483|NCT03335371|584294946|FG004|Overall Study|Randomization Error|0|||
161795484|NCT00998881|584294950|FG000|Overall Study|Adverse Event|2|||
161795485|NCT00998881|584294951|FG001|Overall Study|Adverse Event|2|||
161795486|NCT00998881|584294950|FG000|Overall Study|Lack of Efficacy|1|||
161900545|NCT02137226|584683076|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
161900546|NCT02137226|584683077|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
162134090|NCT01544582|585539135|FG002|Analysis Population|Liver Transplantation|1|||
162134091|NCT01544582|585539136|FG003|Analysis Population|Liver Transplantation|0|||
162134092|NCT01544582|585539133|FG000|Analysis Population|No Social Insurance|0|||
161900547|NCT02137226|584683073|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
161900548|NCT02137226|584683074|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
162134093|NCT01544582|585539134|FG001|Analysis Population|No Social Insurance|0|||
162134094|NCT01544582|585539135|FG002|Analysis Population|No Social Insurance|1|||
162134095|NCT01544582|585539136|FG003|Analysis Population|No Social Insurance|0|||
162134096|NCT01544582|585539133|FG000|Analysis Population|Poor Adherence|0|||
162134097|NCT01544582|585539134|FG001|Analysis Population|Poor Adherence|0|||
162134098|NCT01544582|585539135|FG002|Analysis Population|Poor Adherence|1|||
162134099|NCT01544582|585539136|FG003|Analysis Population|Poor Adherence|0|||
162134100|NCT01544582|585539133|FG000|Analysis Population|Poor Participant Compliance|0|||
162134101|NCT01544582|585539134|FG001|Analysis Population|Poor Participant Compliance|1|||
162134102|NCT01544582|585539135|FG002|Analysis Population|Poor Participant Compliance|0|||
162134103|NCT01544582|585539136|FG003|Analysis Population|Poor Participant Compliance|0|||
162134104|NCT01544582|585539133|FG000|Analysis Population|Programmed Surgery|0|||
162134105|NCT01544582|585539134|FG001|Analysis Population|Programmed Surgery|1|||
162134106|NCT01544582|585539135|FG002|Analysis Population|Programmed Surgery|0|||
162134107|NCT01544582|585539136|FG003|Analysis Population|Programmed Surgery|0|||
162134108|NCT01544582|585539133|FG000|Analysis Population|Participant in Jail|0|||
162134109|NCT01544582|585539134|FG001|Analysis Population|Participant in Jail|0|||
162134110|NCT01544582|585539135|FG002|Analysis Population|Participant in Jail|1|||
162134111|NCT01544582|585539136|FG003|Analysis Population|Participant in Jail|0|||
162134112|NCT03015740|585539139|FG000|Overall Study|Adverse Event|1|||
162134113|NCT03015740|585539140|FG001|Overall Study|Adverse Event|0|||
162134114|NCT03015740|585539141|FG002|Overall Study|Adverse Event|0|||
162134115|NCT03015740|585539139|FG000|Overall Study|Death|3|||
162134116|NCT03015740|585539140|FG001|Overall Study|Death|5|||
162134117|NCT03015740|585539141|FG002|Overall Study|Death|0|||
162134118|NCT03015740|585539139|FG000|Overall Study|Withdrawal by Subject|2|||
162134119|NCT03015740|585539140|FG001|Overall Study|Withdrawal by Subject|0|||
162134120|NCT03015740|585539141|FG002|Overall Study|Withdrawal by Subject|0|||
162134121|NCT05194735|585541213|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
162134122|NCT05194735|585541214|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
162134123|NCT05194735|585541215|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
162134124|NCT05194735|585541213|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
162134125|NCT05194735|585541214|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
162134126|NCT05194735|585541215|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
162134127|NCT05194735|585541213|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
162134128|NCT05194735|585541214|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
162134129|NCT05194735|585541215|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
162134130|NCT05194735|585541213|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
162134131|NCT05194735|585541214|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
162134132|NCT05194735|585541215|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
162134133|NCT00731042|585541216|FG000|Second Intervention|Did not meet inclusion criteria|0|||
162134134|NCT00731042|585541217|FG001|Second Intervention|Did not meet inclusion criteria|2|||
162134135|NCT01256476|585541218|FG000|Overall Study|Adverse Event|2|||
162134136|NCT01256476|585541219|FG001|Overall Study|Adverse Event|1|||
162134137|NCT01256476|585541218|FG000|Overall Study|Withdrawal by Subject|2|||
162134138|NCT01256476|585541219|FG001|Overall Study|Withdrawal by Subject|1|||
162134139|NCT01256476|585541218|FG000|Overall Study|Lost to Follow-up|1|||
162134140|NCT01256476|585541219|FG001|Overall Study|Lost to Follow-up|2|||
162134141|NCT01256476|585541218|FG000|Overall Study|Persistent ALT or AST elevation|1|||
162134142|NCT01256476|585541219|FG001|Overall Study|Persistent ALT or AST elevation|0|||
162134143|NCT01256476|585541218|FG000|Overall Study|Physician Decision|0|||
162134144|NCT01256476|585541219|FG001|Overall Study|Physician Decision|1|||
162134145|NCT01256476|585541218|FG000|Overall Study|Subject non-compliance|0|||
162134146|NCT01256476|585541219|FG001|Overall Study|Subject non-compliance|1|||
161900549|NCT02137226|584683075|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
162134147|NCT01256476|585541218|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
162134148|NCT01256476|585541219|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
161900550|NCT02137226|584683076|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
161900551|NCT02137226|584683077|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
161900552|NCT02137226|584683073|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
162010816|NCT03879772|585095997|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
162134149|NCT00231179|585541222|FG000|Overall Study|Lost to Follow-up|21|||
161900553|NCT02137226|584683074|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
161900554|NCT02137226|584683075|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
161900555|NCT02137226|584683076|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
161900556|NCT02137226|584683077|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
161900557|NCT02137226|584683073|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
161900558|NCT02137226|584683074|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
161900559|NCT02137226|584683075|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
161900560|NCT02137226|584683076|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
162134150|NCT00231179|585541223|FG001|Overall Study|Lost to Follow-up|21|||
162134151|NCT00231179|585541222|FG000|Overall Study|Withdrawal by Subject|3|||
162134152|NCT00231179|585541223|FG001|Overall Study|Withdrawal by Subject|3|||
162134153|NCT02491411|585541224|FG000|Overall Study|Physician Decision|4|||
162134154|NCT04672460|585541226|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
162134155|NCT04672460|585541227|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
162134156|NCT04672460|585541226|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
162134157|NCT04672460|585541227|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
162134158|NCT04672460|585541226|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
162134159|NCT04672460|585541227|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
162134160|NCT04672460|585541226|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
162134161|NCT04672460|585541227|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
162134162|NCT04672460|585541226|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
162134163|NCT04672460|585541227|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
162134164|NCT04672460|585541226|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
162134165|NCT04672460|585541227|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
162134166|NCT04672460|585541226|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
162134167|NCT04672460|585541227|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
162134168|NCT04672460|585541226|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
162134169|NCT04672460|585541227|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
162134170|NCT04672460|585541226|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
162134171|NCT04672460|585541227|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
162134172|NCT04672460|585541226|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
162134173|NCT04672460|585541227|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
162134174|NCT04672460|585541226|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
162134175|NCT04672460|585541227|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
162134176|NCT04672460|585541226|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
162134177|NCT04672460|585541227|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
162134178|NCT04672460|585541226|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
162134179|NCT04672460|585541227|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
162134180|NCT04672460|585541226|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
162134181|NCT04672460|585541227|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
162134182|NCT04672460|585541226|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
162134183|NCT04672460|585541227|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
162134184|NCT04672460|585541226|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
162134185|NCT04672460|585541227|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
162134186|NCT04672460|585541226|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
162134187|NCT04672460|585541227|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
162134188|NCT00940017|585541230|FG000|Overall Study|did not meet entrance criteria|3|||
162134189|NCT00940017|585541230|FG000|Overall Study|Adverse Event|1|||
162134190|NCT00569946|585541231|FG000|Overall Study|Adverse Event|16|||
162134191|NCT00569946|585541231|FG000|Overall Study|Objective Progression or Relapse|42|||
162134192|NCT00569946|585541231|FG000|Overall Study|Global Deterioration of Health Status|1|||
162134193|NCT02949271|585541234|FG000|Overall Study|Lack of Efficacy|5|||
162134194|NCT02949271|585541235|FG001|Overall Study|Lack of Efficacy|4|||
162134195|NCT02949271|585541234|FG000|Overall Study|Lost to Follow-up|3|||
162134196|NCT02949271|585541235|FG001|Overall Study|Lost to Follow-up|6|||
162134197|NCT02949271|585541234|FG000|Overall Study|Physician Decision|5|||
162134198|NCT02949271|585541235|FG001|Overall Study|Physician Decision|5|||
162134199|NCT02949271|585541234|FG000|Overall Study|Protocol Violation|6|||
162134200|NCT02949271|585541235|FG001|Overall Study|Protocol Violation|3|||
162134201|NCT02949271|585541234|FG000|Overall Study|Withdrawal by Subject|1|||
162134202|NCT02949271|585541235|FG001|Overall Study|Withdrawal by Subject|0|||
162134203|NCT02949271|585541234|FG000|Overall Study|Delivered prior to intervention|7|||
162134204|NCT02949271|585541235|FG001|Overall Study|Delivered prior to intervention|9|||
162134205|NCT02949271|585541234|FG000|Overall Study|Outside the window for cervical dilation|2|||
162134206|NCT02949271|585541235|FG001|Overall Study|Outside the window for cervical dilation|3|||
162134207|NCT05458102|585541236|FG000|Overall Study|Withdrew consent|2|||
162134208|NCT05458102|585541237|FG001|Overall Study|Withdrew consent|0|||
161900561|NCT02137226|584683077|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
161795487|NCT00998881|584294951|FG001|Overall Study|Lack of Efficacy|0|||
161795488|NCT00998881|584294950|FG000|Overall Study|Physician Decision|3|||
161795489|NCT00998881|584294951|FG001|Overall Study|Physician Decision|0|||
161795490|NCT00998881|584294950|FG000|Overall Study|Withdrawal by Subject|1|||
161795491|NCT00998881|584294951|FG001|Overall Study|Withdrawal by Subject|0|||
161795492|NCT00998881|584294950|FG000|Overall Study|Personal matter|1|||
161795493|NCT00998881|584294951|FG001|Overall Study|Personal matter|0|||
161795494|NCT02649231|584294954|FG000|Overall Study|Adverse Event|0|||
161795495|NCT02649231|584294955|FG001|Overall Study|Adverse Event|0|||
161795496|NCT02649231|584294956|FG002|Overall Study|Adverse Event|0|||
161795497|NCT02649231|584294957|FG003|Overall Study|Adverse Event|1|||
161795498|NCT02649231|584294954|FG000|Overall Study|Lost to Follow-up|2|||
161795499|NCT02649231|584294955|FG001|Overall Study|Lost to Follow-up|1|||
161795500|NCT02649231|584294956|FG002|Overall Study|Lost to Follow-up|1|||
161795501|NCT02649231|584294957|FG003|Overall Study|Lost to Follow-up|0|||
161795502|NCT02649231|584294954|FG000|Overall Study|Withdrawal by Subject|0|||
161795503|NCT02649231|584294955|FG001|Overall Study|Withdrawal by Subject|1|||
161795504|NCT02649231|584294956|FG002|Overall Study|Withdrawal by Subject|0|||
161795505|NCT02649231|584294957|FG003|Overall Study|Withdrawal by Subject|1|||
161795506|NCT02649231|584294954|FG000|Overall Study|Protocol Violation|2|||
161795507|NCT02649231|584294955|FG001|Overall Study|Protocol Violation|1|||
161795508|NCT02649231|584294956|FG002|Overall Study|Protocol Violation|1|||
161900562|NCT02137226|584683073|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
162134209|NCT05458102|585541236|FG000|Overall Study|Adverse Event|1|||
162134210|NCT05458102|585541237|FG001|Overall Study|Adverse Event|0|||
162134211|NCT05458102|585541236|FG000|Overall Study|Enrolled but never treated|1|||
162134212|NCT05458102|585541237|FG001|Overall Study|Enrolled but never treated|0|||
162134213|NCT05458102|585541236|FG000|Overall Study|Protocol Violation|1|||
162134214|NCT05458102|585541237|FG001|Overall Study|Protocol Violation|0|||
162134215|NCT00852475|585541243|FG000|Overall Study|Lost to Follow-up|3|||
162134216|NCT00852475|585541244|FG001|Overall Study|Lost to Follow-up|4|||
162134217|NCT02373813|585541245|FG000|Run-In Period|Other, Not Specified|5|||
162134218|NCT02373813|585541246|FG001|Run-In Period|Other, Not Specified|0|||
162134219|NCT02373813|585541247|FG002|Run-In Period|Other, Not Specified|0|||
162134220|NCT02373813|585541248|FG003|Run-In Period|Other, Not Specified|0|||
162134221|NCT02373813|585541245|FG000|Run-In Period|Withdrawal by Subject|16|||
162134222|NCT02373813|585541246|FG001|Run-In Period|Withdrawal by Subject|0|||
162134223|NCT02373813|585541247|FG002|Run-In Period|Withdrawal by Subject|0|||
162134224|NCT02373813|585541248|FG003|Run-In Period|Withdrawal by Subject|0|||
162134225|NCT02373813|585541245|FG000|Run-In Period|Decision by Sponsor|11|||
162134226|NCT02373813|585541246|FG001|Run-In Period|Decision by Sponsor|0|||
162134227|NCT02373813|585541247|FG002|Run-In Period|Decision by Sponsor|0|||
162134228|NCT02373813|585541248|FG003|Run-In Period|Decision by Sponsor|0|||
162134229|NCT02373813|585541245|FG000|Run-In Period|Protocol Violation|75|||
162134230|NCT02373813|585541246|FG001|Run-In Period|Protocol Violation|0|||
162134231|NCT02373813|585541247|FG002|Run-In Period|Protocol Violation|0|||
162134232|NCT02373813|585541248|FG003|Run-In Period|Protocol Violation|0|||
162134233|NCT02373813|585541245|FG000|Run-In Period|Lost to Follow-up|2|||
162134234|NCT02373813|585541246|FG001|Run-In Period|Lost to Follow-up|0|||
162134235|NCT02373813|585541247|FG002|Run-In Period|Lost to Follow-up|0|||
162134236|NCT02373813|585541248|FG003|Run-In Period|Lost to Follow-up|0|||
162134237|NCT02373813|585541245|FG000|Run-In Period|Adverse Event|3|||
162134238|NCT02373813|585541246|FG001|Run-In Period|Adverse Event|0|||
162134239|NCT02373813|585541247|FG002|Run-In Period|Adverse Event|0|||
162134240|NCT02373813|585541248|FG003|Run-In Period|Adverse Event|0|||
162134241|NCT02373813|585541245|FG000|Run-In Period|Noncompliance|1|||
162134242|NCT02373813|585541246|FG001|Run-In Period|Noncompliance|0|||
162134243|NCT02373813|585541247|FG002|Run-In Period|Noncompliance|0|||
162134244|NCT02373813|585541248|FG003|Run-In Period|Noncompliance|0|||
162134245|NCT02373813|585541245|FG000|Run-In Period|Ineligibility Determined|3|||
162134246|NCT02373813|585541246|FG001|Run-In Period|Ineligibility Determined|0|||
162134247|NCT02373813|585541247|FG002|Run-In Period|Ineligibility Determined|0|||
162134248|NCT02373813|585541248|FG003|Run-In Period|Ineligibility Determined|0|||
162134249|NCT02373813|585541245|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
162134250|NCT02373813|585541246|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
162134251|NCT02373813|585541247|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
162134252|NCT02373813|585541248|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
162134253|NCT02373813|585541245|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
162134254|NCT02373813|585541246|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
162134255|NCT02373813|585541247|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
162134256|NCT02373813|585541248|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
162134257|NCT02373813|585541245|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161795509|NCT02649231|584294957|FG003|Overall Study|Protocol Violation|0|||
161900563|NCT02137226|584683074|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
161795510|NCT02970669|584294960|FG000|Double-blind Period|Adverse Event|4|||
162134258|NCT02373813|585541246|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
161795511|NCT02970669|584294961|FG001|Double-blind Period|Adverse Event|0|||
161795512|NCT02970669|584294960|FG000|Double-blind Period|Death|1|||
162134259|NCT02373813|585541247|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
162134260|NCT02373813|585541248|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
162134261|NCT02373813|585541245|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162134262|NCT02373813|585541246|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
162134263|NCT02373813|585541247|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
162134264|NCT02373813|585541248|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
162134265|NCT01511536|585541249|FG000|Phase 1|Other|0|||
162134266|NCT01511536|585541250|FG001|Phase 1|Other|1|||
162134267|NCT01511536|585541251|FG002|Phase 1|Other|0|||
162134268|NCT01511536|585541249|FG000|Phase 2|Other|0|||
162134269|NCT01511536|585541250|FG001|Phase 2|Other|0|||
162134270|NCT01511536|585541251|FG002|Phase 2|Other|9|||
162134271|NCT01764386|585541255|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
162134272|NCT01764386|585541256|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
162134273|NCT01764386|585541255|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
162134274|NCT01764386|585541256|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
162134275|NCT01764386|585541255|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
162134276|NCT01764386|585541256|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
162134277|NCT01764386|585541255|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
162134278|NCT01764386|585541256|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
162134279|NCT01764386|585541255|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
162134280|NCT01764386|585541256|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
162134281|NCT01764386|585541255|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
162134282|NCT01764386|585541256|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
162134283|NCT01764386|585541255|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
162134284|NCT01764386|585541256|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
162134285|NCT01764386|585541255|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
162134286|NCT01764386|585541256|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
162134287|NCT02703532|585541258|FG000|Overall Study|Withdrawal by Subject|0|||
162134288|NCT02703532|585541259|FG001|Overall Study|Withdrawal by Subject|1|||
162134289|NCT02703532|585541260|FG002|Overall Study|Withdrawal by Subject|0|||
162134290|NCT02703532|585541261|FG003|Overall Study|Withdrawal by Subject|1|||
162134291|NCT02703532|585541258|FG000|Overall Study|Lost to Follow-up|2|||
162134292|NCT02703532|585541259|FG001|Overall Study|Lost to Follow-up|0|||
162134293|NCT02703532|585541260|FG002|Overall Study|Lost to Follow-up|2|||
162134294|NCT02703532|585541261|FG003|Overall Study|Lost to Follow-up|0|||
162134295|NCT03738241|585541262|FG000|Overall Study|Withdrawal by Subject|0|||
162134296|NCT03738241|585541263|FG001|Overall Study|Withdrawal by Subject|0|||
162134297|NCT03738241|585541264|FG002|Overall Study|Withdrawal by Subject|0|||
162134298|NCT03738241|585541265|FG003|Overall Study|Withdrawal by Subject|0|||
162134299|NCT03738241|585541266|FG004|Overall Study|Withdrawal by Subject|0|||
162134300|NCT03738241|585541267|FG005|Overall Study|Withdrawal by Subject|0|||
162134301|NCT03738241|585541268|FG006|Overall Study|Withdrawal by Subject|0|||
162134302|NCT03738241|585541269|FG007|Overall Study|Withdrawal by Subject|0|||
161795513|NCT02970669|584294961|FG001|Double-blind Period|Death|0|||
161795514|NCT02970669|584294960|FG000|Double-blind Period|Study terminated by sponsor|1|||
161795515|NCT02970669|584294961|FG001|Double-blind Period|Study terminated by sponsor|2|||
161795516|NCT02970669|584294960|FG000|Double-blind Period|Physician Decision|0|||
161795517|NCT02970669|584294961|FG001|Double-blind Period|Physician Decision|2|||
161795518|NCT02970669|584294960|FG000|Double-blind Period|Withdrawal by Subject|2|||
161795519|NCT02970669|584294961|FG001|Double-blind Period|Withdrawal by Subject|2|||
161795520|NCT02970669|584294960|FG000|Open-label Period|Withdrawal by Subject|2|||
161795521|NCT02970669|584294961|FG001|Open-label Period|Withdrawal by Subject|2|||
161795522|NCT02970669|584294960|FG000|Open-label Period|Adverse Event|1|||
161795523|NCT02970669|584294961|FG001|Open-label Period|Adverse Event|0|||
161795524|NCT02970669|584294960|FG000|Open-label Period|Physician Decision|1|||
161795525|NCT02970669|584294961|FG001|Open-label Period|Physician Decision|0|||
161795526|NCT00876733|584294964|FG000|Overall Study|Adverse Event|34|||
161795527|NCT00876733|584294965|FG001|Overall Study|Adverse Event|20|||
161795528|NCT00876733|584294966|FG002|Overall Study|Adverse Event|10|||
161795529|NCT00876733|584294967|FG003|Overall Study|Adverse Event|3|||
161795530|NCT00876733|584294964|FG000|Overall Study|Lack of Efficacy|17|||
162134303|NCT03738241|585541270|FG008|Overall Study|Withdrawal by Subject|0|||
162134304|NCT03738241|585541271|FG009|Overall Study|Withdrawal by Subject|1|||
162134305|NCT03738241|585541262|FG000|Overall Study|Physician Decision|0|||
161795531|NCT00876733|584294965|FG001|Overall Study|Lack of Efficacy|9|||
161795532|NCT00876733|584294966|FG002|Overall Study|Lack of Efficacy|10|||
162134306|NCT03738241|585541263|FG001|Overall Study|Physician Decision|0|||
161795533|NCT00876733|584294967|FG003|Overall Study|Lack of Efficacy|1|||
161795534|NCT00876733|584294964|FG000|Overall Study|Lost to Follow-up|26|||
161795535|NCT00876733|584294965|FG001|Overall Study|Lost to Follow-up|10|||
161795536|NCT00876733|584294966|FG002|Overall Study|Lost to Follow-up|3|||
161795537|NCT00876733|584294967|FG003|Overall Study|Lost to Follow-up|2|||
162134307|NCT03738241|585541264|FG002|Overall Study|Physician Decision|0|||
162134308|NCT03738241|585541265|FG003|Overall Study|Physician Decision|0|||
162134309|NCT03738241|585541266|FG004|Overall Study|Physician Decision|0|||
162134310|NCT03738241|585541267|FG005|Overall Study|Physician Decision|0|||
161795538|NCT00876733|584294964|FG000|Overall Study|Data not available|14|||
161795539|NCT00876733|584294965|FG001|Overall Study|Data not available|3|||
161795540|NCT00876733|584294966|FG002|Overall Study|Data not available|7|||
161795541|NCT00876733|584294967|FG003|Overall Study|Data not available|1|||
161795542|NCT02611752|584294968|FG000|Overall Study|Adverse Event|0|||
161795543|NCT02611752|584294969|FG001|Overall Study|Adverse Event|1|||
161795544|NCT03521999|584294970|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
161795545|NCT03521999|584294971|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
161795546|NCT03521999|584294970|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
161795547|NCT03521999|584294971|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
161795548|NCT03521999|584294970|FG000|Completed 3 Month Follow up|Death|0|||
161795549|NCT03521999|584294971|FG001|Completed 3 Month Follow up|Death|1|||
161795550|NCT03521999|584294970|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
161795551|NCT03521999|584294971|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
161795552|NCT03495986|584294974|FG000|Overall Study|Physician Decision|1|||
162134311|NCT03738241|585541268|FG006|Overall Study|Physician Decision|0|||
162134312|NCT03738241|585541269|FG007|Overall Study|Physician Decision|0|||
162134313|NCT03738241|585541270|FG008|Overall Study|Physician Decision|1|||
162134314|NCT03738241|585541271|FG009|Overall Study|Physician Decision|0|||
162134315|NCT03738241|585541262|FG000|Overall Study|Adverse Event|1|||
162134316|NCT03738241|585541263|FG001|Overall Study|Adverse Event|0|||
162134317|NCT03738241|585541264|FG002|Overall Study|Adverse Event|0|||
162134318|NCT03738241|585541265|FG003|Overall Study|Adverse Event|0|||
162134319|NCT03738241|585541266|FG004|Overall Study|Adverse Event|0|||
162134320|NCT03738241|585541267|FG005|Overall Study|Adverse Event|0|||
162134321|NCT03738241|585541268|FG006|Overall Study|Adverse Event|0|||
162134322|NCT03738241|585541269|FG007|Overall Study|Adverse Event|0|||
162134323|NCT03738241|585541270|FG008|Overall Study|Adverse Event|0|||
162134324|NCT03738241|585541271|FG009|Overall Study|Adverse Event|0|||
162134325|NCT03169361|585541272|FG000|Overall Study|Protocol Violation|32|||
162134326|NCT02263885|585541273|FG000|Overall Study|Withdrawal by Subject|7|||
162134327|NCT02263885|585541273|FG000|Overall Study|Alternative Treatment|3|||
162134328|NCT03929302|585541278|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
162134329|NCT03929302|585541279|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
162134330|NCT03929302|585541280|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
162134331|NCT03929302|585541278|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
162134332|NCT03929302|585541279|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
162134333|NCT03929302|585541280|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
162134334|NCT03929302|585541278|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
162134335|NCT03929302|585541279|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
162134336|NCT03929302|585541280|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
162134337|NCT04454567|585541281|FG000|Overall Study|Study Terminated by Sponsor|1|||
162134338|NCT04454567|585541282|FG001|Overall Study|Study Terminated by Sponsor|1|||
162134339|NCT00664521|585541286|FG000|Overall Study|Adverse Event|4|||
162134340|NCT00664521|585541287|FG001|Overall Study|Adverse Event|1|||
162134341|NCT00664521|585541286|FG000|Overall Study|Lost to Follow-up|1|||
162134342|NCT00664521|585541287|FG001|Overall Study|Lost to Follow-up|0|||
162134343|NCT00664521|585541286|FG000|Overall Study|Other|1|||
162134344|NCT00664521|585541287|FG001|Overall Study|Other|0|||
162134345|NCT02459964|585541288|FG000|Overall Study|Withdrawal by Subject|0|||
162134346|NCT02459964|585541289|FG001|Overall Study|Withdrawal by Subject|0|||
162134347|NCT02459964|585541290|FG002|Overall Study|Withdrawal by Subject|1|||
162134348|NCT02459964|585541288|FG000|Overall Study|Abnormal EKG changes|0|||
162134349|NCT02459964|585541289|FG001|Overall Study|Abnormal EKG changes|0|||
162134350|NCT02459964|585541290|FG002|Overall Study|Abnormal EKG changes|1|||
162134351|NCT01175707|585541291|FG000|Overall Study|Adverse Event|4|||
162134352|NCT01175707|585541292|FG001|Overall Study|Adverse Event|6|||
162134353|NCT01456780|585541293|FG000|Overall Study|Lost to Follow-up|3|||
162134354|NCT01456780|585541294|FG001|Overall Study|Lost to Follow-up|3|||
162134355|NCT01456780|585541295|FG002|Overall Study|Lost to Follow-up|0|||
162134356|NCT03239210|585541304|FG000|Overall Study|Lost to Follow-up|2|||
162134357|NCT03239210|585541305|FG001|Overall Study|Lost to Follow-up|2|||
162134358|NCT03239210|585541304|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
162134359|NCT03239210|585541305|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
161795553|NCT03495986|584294975|FG001|Overall Study|Physician Decision|0|||
161795554|NCT03495986|584294974|FG000|Overall Study|Withdrawal by Subject|1|||
161795555|NCT03495986|584294975|FG001|Overall Study|Withdrawal by Subject|1|||
161795556|NCT03495986|584294974|FG000|Overall Study|Withdrawal by Subject|1|||
162134360|NCT03239210|585541304|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
162134361|NCT03239210|585541305|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
162134362|NCT00278564|585541307|FG000|Overall Study|Lack of Efficacy|4|||
162134363|NCT00480441|585541308|FG000|Screening|Not Eligible|37|||
162134364|NCT00480441|585541309|FG001|Screening|Not Eligible|0|||
162134365|NCT00480441|585541310|FG002|Screening|Not Eligible|0|||
162134366|NCT00480441|585541308|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
162134367|NCT00480441|585541309|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
162134368|NCT00480441|585541310|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
162134369|NCT00480441|585541308|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
162134370|NCT00480441|585541309|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
162134371|NCT00480441|585541310|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
162134372|NCT00480441|585541308|FG000|Baseline Functional MRI|physical contraindication|4|||
162134373|NCT00480441|585541309|FG001|Baseline Functional MRI|physical contraindication|0|||
162134374|NCT00480441|585541310|FG002|Baseline Functional MRI|physical contraindication|0|||
162134375|NCT00480441|585541308|FG000|Randomization|Lost to Follow-up|0|||
162134376|NCT00480441|585541309|FG001|Randomization|Lost to Follow-up|7|||
162134377|NCT00480441|585541310|FG002|Randomization|Lost to Follow-up|2|||
162134378|NCT01113463|585541311|FG000|Overall Study|Physician Decision|5|||
162134379|NCT01417000|585541313|FG000|Overall Study|Death|59|||
162134380|NCT01417000|585541314|FG001|Overall Study|Death|28|||
162134381|NCT01417000|585541313|FG000|Overall Study|Lost to Follow-up|1|||
162134382|NCT01417000|585541314|FG001|Overall Study|Lost to Follow-up|0|||
162134383|NCT01417000|585541313|FG000|Overall Study|Study Terminated by Sponsor|1|||
162134384|NCT01417000|585541314|FG001|Overall Study|Study Terminated by Sponsor|1|||
161795557|NCT03495986|584294975|FG001|Overall Study|Withdrawal by Subject|0|||
161795558|NCT04182204|584294976|FG000|Safety Run-in|Lost to Follow-up|1|||
162134385|NCT01657682|585541315|FG000|Overall Study|Lost to Follow-up|1|||
162134386|NCT01657682|585541316|FG001|Overall Study|Lost to Follow-up|0|||
162134387|NCT01657682|585541317|FG002|Overall Study|Lost to Follow-up|0|||
162134388|NCT01657682|585541315|FG000|Overall Study|Withdrawal by Subject|0|||
161795559|NCT04182204|584294977|FG001|Safety Run-in|Lost to Follow-up|0|||
161795560|NCT04182204|584294978|FG002|Safety Run-in|Lost to Follow-up|0|||
161795561|NCT04182204|584294976|FG000|Safety Run-in|Withdrawal by Subject|2|||
161795562|NCT04182204|584294977|FG001|Safety Run-in|Withdrawal by Subject|0|||
161795563|NCT04182204|584294978|FG002|Safety Run-in|Withdrawal by Subject|0|||
161795564|NCT04182204|584294976|FG000|Safety Run-in|Death|7|||
161795565|NCT04182204|584294977|FG001|Safety Run-in|Death|0|||
161795566|NCT04182204|584294978|FG002|Safety Run-in|Death|0|||
161795567|NCT04182204|584294976|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
161795568|NCT04182204|584294977|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
161795569|NCT04182204|584294978|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
161795570|NCT04182204|584294976|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
161795571|NCT04182204|584294977|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
161795572|NCT04182204|584294978|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
161795573|NCT04182204|584294976|FG000|Randomized Controlled Trial|Death|0|||
161795574|NCT04182204|584294977|FG001|Randomized Controlled Trial|Death|83|||
161795575|NCT04182204|584294978|FG002|Randomized Controlled Trial|Death|66|||
161795576|NCT05476679|584294979|FG000|Overall Study|Withdrawal by Subject|0|||
161795577|NCT05476679|584294980|FG001|Overall Study|Withdrawal by Subject|0|||
161795578|NCT05476679|584294981|FG002|Overall Study|Withdrawal by Subject|0|||
161795579|NCT05476679|584294982|FG003|Overall Study|Withdrawal by Subject|1|||
161795580|NCT05476679|584294983|FG004|Overall Study|Withdrawal by Subject|0|||
161795581|NCT05476679|584294979|FG000|Overall Study|Lost to Follow-up|0|||
161795582|NCT05476679|584294980|FG001|Overall Study|Lost to Follow-up|0|||
161795583|NCT05476679|584294981|FG002|Overall Study|Lost to Follow-up|0|||
161795584|NCT05476679|584294982|FG003|Overall Study|Lost to Follow-up|1|||
161795585|NCT05476679|584294983|FG004|Overall Study|Lost to Follow-up|0|||
161795586|NCT01214330|584294984|FG000|Overall Study|Withdrawal by Subject|2|||
161795587|NCT01214330|584294984|FG000|Overall Study|Withdrawal by Subject|2|||
161795588|NCT00249821|584294985|FG000|Overall Study|Technical problem|0|||
161795589|NCT00249821|584294986|FG001|Overall Study|Technical problem|1|||
161795590|NCT00686036|584294989|FG000|Overall Study|Adverse Event|3|||
161795591|NCT00686036|584294990|FG001|Overall Study|Adverse Event|0|||
161795592|NCT00686036|584294989|FG000|Overall Study|Withdrawal by Subject|3|||
161795593|NCT00686036|584294990|FG001|Overall Study|Withdrawal by Subject|1|||
161795594|NCT00686036|584294989|FG000|Overall Study|Study terminated by AstraZeneca|2|||
161795595|NCT00686036|584294990|FG001|Overall Study|Study terminated by AstraZeneca|1|||
161795596|NCT00686036|584294989|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
161795597|NCT00686036|584294990|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
162010817|NCT03879772|585095998|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
161795598|NCT00686036|584294989|FG000|Overall Study|Other reasons not identified|0|||
161795599|NCT00686036|584294990|FG001|Overall Study|Other reasons not identified|4|||
161795600|NCT01411995|584294991|FG000|Overall Study|Failed IUD insertion|0|||
161795601|NCT01411995|584294992|FG001|Overall Study|Failed IUD insertion|1|||
162134389|NCT01657682|585541316|FG001|Overall Study|Withdrawal by Subject|1|||
162134390|NCT01657682|585541317|FG002|Overall Study|Withdrawal by Subject|1|||
162134391|NCT01657682|585541315|FG000|Overall Study|Adverse Event|0|||
162134392|NCT01657682|585541316|FG001|Overall Study|Adverse Event|1|||
162134393|NCT01657682|585541317|FG002|Overall Study|Adverse Event|0|||
161795602|NCT03212170|584294993|FG000|Overall Study|Withdrawal by Subject|1|||
162134394|NCT01318811|585541326|FG000|Overall Study|Physician Decision|1|||
162134395|NCT01318811|585541327|FG001|Overall Study|Physician Decision|1|||
162134396|NCT01318811|585541326|FG000|Overall Study|CRRT stopped for head CT|0|||
162134397|NCT01318811|585541327|FG001|Overall Study|CRRT stopped for head CT|1|||
162134398|NCT01318811|585541326|FG000|Overall Study|Death|0|||
162134399|NCT01318811|585541327|FG001|Overall Study|Death|1|||
162134400|NCT01318811|585541326|FG000|Overall Study|CRRT stopped for head MRI|0|||
162134401|NCT01318811|585541327|FG001|Overall Study|CRRT stopped for head MRI|1|||
162134402|NCT00811187|585541328|FG000|Overall Study|Unable to place device / procedure abort|3|||
162134403|NCT00811187|585541329|FG001|Overall Study|Unable to place device / procedure abort|3|||
162134404|NCT02825043|585541330|FG000|Overall Study|Lost to Follow-up|4|||
162134405|NCT00131911|585541331|FG000|Overall Study|Withdrawal by Subject|1|||
162134406|NCT00131911|585541332|FG001|Overall Study|Withdrawal by Subject|0|||
162134407|NCT00329303|585541333|FG000|Overall Study|Lack of Efficacy|1|||
162134408|NCT00329303|585541334|FG001|Overall Study|Lack of Efficacy|0|||
162134409|NCT00329303|585541333|FG000|Overall Study|Decision of the sponsor|0|||
162134410|NCT00329303|585541334|FG001|Overall Study|Decision of the sponsor|1|||
162134411|NCT00329303|585541333|FG000|Overall Study|Patient no longer available|1|||
162134412|NCT00329303|585541334|FG001|Overall Study|Patient no longer available|0|||
162134413|NCT00329303|585541333|FG000|Overall Study|Patient relocated|0|||
162134414|NCT00329303|585541334|FG001|Overall Study|Patient relocated|1|||
162134415|NCT03582137|585541340|FG000|Overall Study|Adverse Event|1|||
162134416|NCT03582137|585541341|FG001|Overall Study|Adverse Event|0|||
162134417|NCT00558753|585541342|FG000|Overall Study|Lost to Follow-up|5|||
162134418|NCT00558753|585541343|FG001|Overall Study|Lost to Follow-up|7|||
162134419|NCT03704298|585541348|FG000|Overall Study|Death|3|||
162134420|NCT03704298|585541349|FG001|Overall Study|Death|1|||
162134421|NCT03704298|585541350|FG002|Overall Study|Death|1|||
162134422|NCT03704298|585541351|FG003|Overall Study|Death|0|||
162134423|NCT03704298|585541348|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
162134424|NCT03704298|585541349|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
162134425|NCT03704298|585541350|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
162134426|NCT03704298|585541351|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
162134427|NCT03704298|585541348|FG000|Overall Study|Withdrawal by Subject|1|||
162134428|NCT03704298|585541349|FG001|Overall Study|Withdrawal by Subject|0|||
162134429|NCT03704298|585541350|FG002|Overall Study|Withdrawal by Subject|0|||
162134430|NCT03704298|585541351|FG003|Overall Study|Withdrawal by Subject|0|||
162134431|NCT03704298|585541348|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
162134432|NCT03704298|585541349|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
162134433|NCT03704298|585541350|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
162134434|NCT03704298|585541351|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
162134435|NCT00162942|585541352|FG000|Overall Study|Adverse Event|10|||
161795603|NCT01937364|584294994|FG000|Overall Study|Adverse Event|2|||
161795604|NCT01937364|584294995|FG001|Overall Study|Adverse Event|1|||
161795605|NCT00467584|584294996|FG000|Overall Study|Withdrawal by Subject|4|||
161795606|NCT00467584|584294997|FG001|Overall Study|Withdrawal by Subject|5|||
161795607|NCT00467584|584294998|FG002|Overall Study|Withdrawal by Subject|1|||
161795608|NCT02482571|584294999|FG000|Overall Study|Adverse Event|1|||
161795609|NCT02482571|584294999|FG000|Overall Study|Scanner or Respiract failure|3|||
161795610|NCT02482571|584294999|FG000|Overall Study|Withdrawal by Subject|4|||
161795611|NCT01498484|584295003|FG000|Overall Study|Death|6|||
161795612|NCT01498484|584295004|FG001|Overall Study|Death|3|||
161795613|NCT01498484|584295005|FG002|Overall Study|Death|1|||
161795614|NCT01498484|584295006|FG003|Overall Study|Death|1|||
161795615|NCT01498484|584295007|FG004|Overall Study|Death|0|||
161795616|NCT01498484|584295008|FG005|Overall Study|Death|0|||
161795617|NCT01498484|584295009|FG006|Overall Study|Death|10|||
161795618|NCT01498484|584295010|FG007|Overall Study|Death|1|||
161795619|NCT01498484|584295011|FG008|Overall Study|Death|0|||
161795620|NCT01498484|584295003|FG000|Overall Study|Physician Decision|3|||
161795621|NCT01498484|584295004|FG001|Overall Study|Physician Decision|2|||
161795622|NCT01498484|584295005|FG002|Overall Study|Physician Decision|1|||
161795623|NCT01498484|584295006|FG003|Overall Study|Physician Decision|1|||
162134436|NCT00162942|585541353|FG001|Overall Study|Adverse Event|6|||
162134437|NCT00162942|585541352|FG000|Overall Study|Death|1|||
162134438|NCT00162942|585541353|FG001|Overall Study|Death|0|||
162134439|NCT00162942|585541352|FG000|Overall Study|Withdrawal by Subject|3|||
162134440|NCT00162942|585541353|FG001|Overall Study|Withdrawal by Subject|6|||
161795624|NCT01498484|584295007|FG004|Overall Study|Physician Decision|0|||
161795625|NCT01498484|584295008|FG005|Overall Study|Physician Decision|0|||
161795626|NCT01498484|584295009|FG006|Overall Study|Physician Decision|8|||
162134441|NCT00162942|585541352|FG000|Overall Study|Physician Decision|1|||
162134442|NCT00162942|585541353|FG001|Overall Study|Physician Decision|0|||
162134443|NCT00162942|585541352|FG000|Overall Study|Enter Open-Label Study|76|||
162134444|NCT00162942|585541353|FG001|Overall Study|Enter Open-Label Study|35|||
161795627|NCT01498484|584295010|FG007|Overall Study|Physician Decision|13|||
161795628|NCT01498484|584295011|FG008|Overall Study|Physician Decision|1|||
162134445|NCT00162942|585541352|FG000|Overall Study|Alternate Therapy|6|||
162134446|NCT00162942|585541353|FG001|Overall Study|Alternate Therapy|2|||
162134447|NCT00162942|585541352|FG000|Overall Study|Lack of Efficacy|1|||
162134448|NCT00162942|585541353|FG001|Overall Study|Lack of Efficacy|0|||
162134449|NCT00162942|585541352|FG000|Overall Study|Flare During Active Treatment|7|||
162134450|NCT00162942|585541353|FG001|Overall Study|Flare During Active Treatment|3|||
162134451|NCT00162942|585541352|FG000|Overall Study|2 or more consecutive treatments missed|1|||
162134452|NCT00162942|585541353|FG001|Overall Study|2 or more consecutive treatments missed|0|||
162134453|NCT00410384|585541354|FG000|Overall Study|Withdrawal by Subject|28|||
162134454|NCT00410384|585541355|FG001|Overall Study|Withdrawal by Subject|17|||
162134455|NCT00410384|585541356|FG002|Overall Study|Withdrawal by Subject|20|||
162134456|NCT00410384|585541354|FG000|Overall Study|Adverse Event|23|||
162134457|NCT00410384|585541355|FG001|Overall Study|Adverse Event|18|||
162134458|NCT00410384|585541356|FG002|Overall Study|Adverse Event|23|||
162134459|NCT00410384|585541354|FG000|Overall Study|Lack of Efficacy|20|||
162134460|NCT00410384|585541355|FG001|Overall Study|Lack of Efficacy|12|||
162134461|NCT00410384|585541356|FG002|Overall Study|Lack of Efficacy|17|||
162134462|NCT00410384|585541354|FG000|Overall Study|Lack of Compliance|2|||
162134463|NCT00410384|585541355|FG001|Overall Study|Lack of Compliance|2|||
162134464|NCT00410384|585541356|FG002|Overall Study|Lack of Compliance|2|||
162134465|NCT00410384|585541354|FG000|Overall Study|Lost to Follow-up|4|||
162134466|NCT00410384|585541355|FG001|Overall Study|Lost to Follow-up|6|||
162134467|NCT00410384|585541356|FG002|Overall Study|Lost to Follow-up|6|||
162134468|NCT00410384|585541354|FG000|Overall Study|Protocol Violation|6|||
162134469|NCT00410384|585541355|FG001|Overall Study|Protocol Violation|6|||
162134470|NCT00410384|585541356|FG002|Overall Study|Protocol Violation|6|||
162134471|NCT00410384|585541354|FG000|Overall Study|Physician Decision|3|||
162134472|NCT00410384|585541355|FG001|Overall Study|Physician Decision|3|||
162134473|NCT00410384|585541356|FG002|Overall Study|Physician Decision|4|||
162134474|NCT00410384|585541354|FG000|Overall Study|Other|3|||
162134475|NCT00410384|585541355|FG001|Overall Study|Other|8|||
162134476|NCT00410384|585541356|FG002|Overall Study|Other|4|||
162134477|NCT01167023|585541357|FG000|Overall Study|Lost to Follow-up|0|||
162134478|NCT01167023|585541358|FG001|Overall Study|Lost to Follow-up|1|||
162134479|NCT01167023|585541359|FG002|Overall Study|Lost to Follow-up|1|||
162134480|NCT01167023|585541357|FG000|Overall Study|Screen Failure|0|||
162134481|NCT01167023|585541358|FG001|Overall Study|Screen Failure|1|||
162134482|NCT01167023|585541359|FG002|Overall Study|Screen Failure|0|||
162134483|NCT01167023|585541357|FG000|Overall Study|Sponsor Decision|0|||
162134484|NCT01167023|585541358|FG001|Overall Study|Sponsor Decision|1|||
162134485|NCT01167023|585541359|FG002|Overall Study|Sponsor Decision|0|||
162134486|NCT01167023|585541357|FG000|Overall Study|Withdrawal by Subject|0|||
162134487|NCT01167023|585541358|FG001|Overall Study|Withdrawal by Subject|0|||
162134488|NCT01167023|585541359|FG002|Overall Study|Withdrawal by Subject|1|||
162134489|NCT01192295|585541360|FG000|Overall Study|Adverse Event|3|||
162134490|NCT01192295|585541361|FG001|Overall Study|Adverse Event|7|||
162134491|NCT01192295|585541360|FG000|Overall Study|Withdrawal by Subject|3|||
161795629|NCT01498484|584295003|FG000|Overall Study|Adverse Event|0|||
161795630|NCT01498484|584295004|FG001|Overall Study|Adverse Event|0|||
161795631|NCT01498484|584295005|FG002|Overall Study|Adverse Event|0|||
161795632|NCT01498484|584295006|FG003|Overall Study|Adverse Event|0|||
161795633|NCT01498484|584295007|FG004|Overall Study|Adverse Event|0|||
161795634|NCT01498484|584295008|FG005|Overall Study|Adverse Event|1|||
161795635|NCT01498484|584295009|FG006|Overall Study|Adverse Event|0|||
161795636|NCT01498484|584295010|FG007|Overall Study|Adverse Event|0|||
161795637|NCT01498484|584295011|FG008|Overall Study|Adverse Event|0|||
161795638|NCT01498484|584295003|FG000|Overall Study|Withdrawal by Subject|0|||
161795639|NCT01498484|584295004|FG001|Overall Study|Withdrawal by Subject|0|||
161795640|NCT01498484|584295005|FG002|Overall Study|Withdrawal by Subject|0|||
161795641|NCT01498484|584295006|FG003|Overall Study|Withdrawal by Subject|1|||
161795642|NCT01498484|584295007|FG004|Overall Study|Withdrawal by Subject|0|||
161795643|NCT01498484|584295008|FG005|Overall Study|Withdrawal by Subject|0|||
161795644|NCT01498484|584295009|FG006|Overall Study|Withdrawal by Subject|1|||
162010818|NCT03879772|585095999|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
162134492|NCT01192295|585541361|FG001|Overall Study|Withdrawal by Subject|4|||
162134493|NCT01192295|585541360|FG000|Overall Study|Lost to Follow-up|0|||
162134494|NCT01192295|585541361|FG001|Overall Study|Lost to Follow-up|1|||
162134495|NCT01192295|585541360|FG000|Overall Study|Lack of Efficacy|0|||
162134496|NCT01192295|585541361|FG001|Overall Study|Lack of Efficacy|5|||
162134497|NCT01192295|585541360|FG000|Overall Study|Administrative|4|||
162134498|NCT01192295|585541361|FG001|Overall Study|Administrative|6|||
162134499|NCT00630539|585541362|FG000|Overall Study|Adverse Event|1|||
161795645|NCT01498484|584295010|FG007|Overall Study|Withdrawal by Subject|0|||
161795646|NCT01498484|584295011|FG008|Overall Study|Withdrawal by Subject|0|||
161795647|NCT01498484|584295003|FG000|Overall Study|Other|5|||
162134500|NCT00630539|585541363|FG001|Overall Study|Adverse Event|3|||
162134501|NCT00630539|585541364|FG002|Overall Study|Adverse Event|1|||
162134502|NCT00630539|585541365|FG003|Overall Study|Adverse Event|2|||
162134503|NCT00630539|585541362|FG000|Overall Study|Withdrawal by Subject|0|||
162134504|NCT00630539|585541363|FG001|Overall Study|Withdrawal by Subject|1|||
162134505|NCT00630539|585541364|FG002|Overall Study|Withdrawal by Subject|0|||
162134506|NCT00630539|585541365|FG003|Overall Study|Withdrawal by Subject|1|||
162134507|NCT03473756|585541378|FG000|Overall Study|Withdrawal by Subject|1|||
162134508|NCT03473756|585541379|FG001|Overall Study|Withdrawal by Subject|4|||
162134509|NCT03473756|585541378|FG000|Overall Study|Adverse Event|6|||
162134510|NCT03473756|585541379|FG001|Overall Study|Adverse Event|7|||
162242045|NCT02616562|585939075|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162242046|NCT02616562|585939076|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162242047|NCT02616562|585939077|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162242048|NCT02616562|585939078|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162242049|NCT02616562|585939079|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|4|||
162242050|NCT02616562|585939080|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162242051|NCT02616562|585939081|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162242052|NCT02616562|585939082|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|1|||
162242053|NCT02616562|585939083|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162242054|NCT02616562|585939084|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
162242055|NCT02616562|585939068|FG000|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242056|NCT02616562|585939069|FG001|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242057|NCT02616562|585939070|FG002|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242058|NCT02616562|585939071|FG003|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242059|NCT02616562|585939072|FG004|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242060|NCT02616562|585939073|FG005|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242061|NCT02616562|585939074|FG006|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242062|NCT02616562|585939075|FG007|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242063|NCT02616562|585939076|FG008|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242064|NCT02616562|585939077|FG009|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242065|NCT02616562|585939078|FG010|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242066|NCT02616562|585939079|FG011|Long Term Safety Extension (208 Weeks)|Protocol Violation|1|||
162242067|NCT02616562|585939080|FG012|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242068|NCT02616562|585939081|FG013|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242069|NCT02616562|585939082|FG014|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242070|NCT02616562|585939083|FG015|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242071|NCT02616562|585939084|FG016|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
162242072|NCT02616562|585939068|FG000|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242073|NCT02616562|585939069|FG001|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242074|NCT02616562|585939070|FG002|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242075|NCT02616562|585939071|FG003|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242076|NCT02616562|585939072|FG004|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242077|NCT02616562|585939073|FG005|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242078|NCT02616562|585939074|FG006|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242079|NCT02616562|585939075|FG007|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242080|NCT02616562|585939076|FG008|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242081|NCT02616562|585939077|FG009|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242082|NCT02616562|585939078|FG010|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242083|NCT02616562|585939079|FG011|Long Term Safety Extension (208 Weeks)|Adverse Event|1|||
162242084|NCT02616562|585939080|FG012|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242085|NCT02616562|585939081|FG013|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162134511|NCT03473756|585541378|FG000|Overall Study|Lack of Efficacy|3|||
162134512|NCT03473756|585541379|FG001|Overall Study|Lack of Efficacy|10|||
162134513|NCT03473756|585541378|FG000|Overall Study|Physician Decision|0|||
162134514|NCT03473756|585541379|FG001|Overall Study|Physician Decision|2|||
162134515|NCT03473756|585541378|FG000|Overall Study|End of study treatment|0|||
162134516|NCT03473756|585541379|FG001|Overall Study|End of study treatment|2|||
162134517|NCT03473756|585541378|FG000|Overall Study|Lost to Follow-up|0|||
162134518|NCT03473756|585541379|FG001|Overall Study|Lost to Follow-up|1|||
162134519|NCT03714022|585541380|FG000|Overall Study|Adverse Event|1|||
162134520|NCT03714022|585541381|FG001|Overall Study|Adverse Event|0|||
162134521|NCT03714022|585541380|FG000|Overall Study|Consent withdrawal|0|||
162134522|NCT03714022|585541381|FG001|Overall Study|Consent withdrawal|1|||
162134523|NCT03714022|585541380|FG000|Overall Study|Lost to Follow-up|3|||
162134524|NCT03714022|585541381|FG001|Overall Study|Lost to Follow-up|2|||
162134525|NCT02234310|585541385|FG000|Overall Study|Physician Decision|1|||
162134526|NCT02234310|585541385|FG000|Overall Study|Adverse Event|1|||
162134527|NCT02234310|585541385|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
162134528|NCT02234310|585541385|FG000|Overall Study|Withdrawal by Subject|2|||
162134529|NCT02487446|585541386|FG000|Period 1|Physician Decision|0|||
162134530|NCT02487446|585541387|FG001|Period 1|Physician Decision|1|||
161795648|NCT01498484|584295004|FG001|Overall Study|Other|2|||
161795649|NCT01498484|584295005|FG002|Overall Study|Other|0|||
161795650|NCT01498484|584295006|FG003|Overall Study|Other|0|||
161795651|NCT01498484|584295007|FG004|Overall Study|Other|1|||
161795652|NCT01498484|584295008|FG005|Overall Study|Other|0|||
161795653|NCT01498484|584295009|FG006|Overall Study|Other|3|||
161795654|NCT01498484|584295010|FG007|Overall Study|Other|0|||
161795655|NCT01498484|584295011|FG008|Overall Study|Other|1|||
161795656|NCT00656019|584295017|FG000|Overall Study|Not Eligible|10|||
161795657|NCT00656019|584295018|FG001|Overall Study|Not Eligible|0|||
161795658|NCT00656019|584295019|FG002|Overall Study|Not Eligible|0|||
161795659|NCT00656019|584295020|FG003|Overall Study|Not Eligible|0|||
161795660|NCT00656019|584295017|FG000|Overall Study|Withdrawal by Subject|2|||
161795661|NCT00656019|584295018|FG001|Overall Study|Withdrawal by Subject|0|||
161795662|NCT00656019|584295019|FG002|Overall Study|Withdrawal by Subject|0|||
161795663|NCT00656019|584295020|FG003|Overall Study|Withdrawal by Subject|0|||
161795664|NCT00656019|584295017|FG000|Overall Study|Lost to Follow-up|2|||
161795665|NCT00656019|584295018|FG001|Overall Study|Lost to Follow-up|1|||
161795666|NCT00656019|584295019|FG002|Overall Study|Lost to Follow-up|0|||
161795667|NCT00656019|584295020|FG003|Overall Study|Lost to Follow-up|0|||
161795668|NCT05550532|584295023|FG000|Overall Study|Withdrawal by Subject|8|||
161795669|NCT05550532|584295024|FG001|Overall Study|Withdrawal by Subject|3|||
161795670|NCT05550532|584295023|FG000|Overall Study|Adverse Event|2|||
161795671|NCT05550532|584295024|FG001|Overall Study|Adverse Event|3|||
161795672|NCT05550532|584295023|FG000|Overall Study|Lost to Follow-up|4|||
162134531|NCT02487446|585541386|FG000|Period 1|Lack of Efficacy|1|||
162134532|NCT02487446|585541387|FG001|Period 1|Lack of Efficacy|0|||
162134533|NCT02487446|585541386|FG000|Period 1|Protocol deviation|3|||
162134534|NCT02487446|585541387|FG001|Period 1|Protocol deviation|2|||
162134535|NCT02487446|585541386|FG000|Period 1|Lost to Follow-up|2|||
162134536|NCT02487446|585541387|FG001|Period 1|Lost to Follow-up|0|||
162134537|NCT02487446|585541386|FG000|Period 1|Withdrawal by Subject|2|||
162134538|NCT02487446|585541387|FG001|Period 1|Withdrawal by Subject|0|||
162134539|NCT02487446|585541386|FG000|Period 1|Adverse Event|5|||
162134540|NCT02487446|585541387|FG001|Period 1|Adverse Event|5|||
162134541|NCT02487446|585541386|FG000|Washout|Lost to Follow-up|0|||
162134542|NCT02487446|585541387|FG001|Washout|Lost to Follow-up|2|||
162134543|NCT02487446|585541386|FG000|Washout|Withdrawal by Subject|1|||
162134544|NCT02487446|585541387|FG001|Washout|Withdrawal by Subject|4|||
162134545|NCT02487446|585541386|FG000|Washout|Adverse Event|2|||
162134546|NCT02487446|585541387|FG001|Washout|Adverse Event|2|||
162134547|NCT02487446|585541386|FG000|Period 2|Protocol deviation|0|||
162134548|NCT02487446|585541387|FG001|Period 2|Protocol deviation|1|||
162134549|NCT02487446|585541386|FG000|Period 2|Lost to Follow-up|1|||
162134550|NCT02487446|585541387|FG001|Period 2|Lost to Follow-up|1|||
162134551|NCT02487446|585541386|FG000|Period 2|Withdrawal by Subject|1|||
162134552|NCT02487446|585541387|FG001|Period 2|Withdrawal by Subject|1|||
162134553|NCT02487446|585541386|FG000|Period 2|Adverse Event|6|||
162134554|NCT02487446|585541387|FG001|Period 2|Adverse Event|2|||
162134555|NCT03289455|585541388|FG000|Overall Study|Death|1|||
162134556|NCT03289455|585541389|FG001|Overall Study|Death|0|||
162134557|NCT03289455|585541390|FG002|Overall Study|Death|0|||
162134558|NCT03289455|585541388|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
162134559|NCT03289455|585541389|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
162134560|NCT03289455|585541390|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
162134561|NCT03289455|585541388|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
162134562|NCT03289455|585541389|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
162134563|NCT03289455|585541390|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
162134564|NCT03289455|585541388|FG000|Overall Study|Progressive disease|3|||
162134565|NCT03289455|585541389|FG001|Overall Study|Progressive disease|4|||
162134566|NCT03289455|585541390|FG002|Overall Study|Progressive disease|5|||
162134567|NCT02624778|585543014|FG000|Overall Study|Lost to Follow-up|0|||
162134568|NCT02624778|585543015|FG001|Overall Study|Lost to Follow-up|0|||
162134569|NCT02624778|585543016|FG002|Overall Study|Lost to Follow-up|1|||
162134570|NCT02624778|585543017|FG003|Overall Study|Lost to Follow-up|0|||
162134571|NCT02624778|585543018|FG004|Overall Study|Lost to Follow-up|0|||
162134572|NCT02624778|585543019|FG005|Overall Study|Lost to Follow-up|0|||
162134573|NCT02624778|585543020|FG006|Overall Study|Lost to Follow-up|0|||
162134574|NCT02624778|585543021|FG007|Overall Study|Lost to Follow-up|0|||
162134575|NCT02624778|585543022|FG008|Overall Study|Lost to Follow-up|0|||
162134576|NCT02624778|585543014|FG000|Overall Study|Withdrawal by Subject|0|||
162134577|NCT02624778|585543015|FG001|Overall Study|Withdrawal by Subject|1|||
162134578|NCT02624778|585543016|FG002|Overall Study|Withdrawal by Subject|0|||
161795673|NCT05550532|584295024|FG001|Overall Study|Lost to Follow-up|0|||
161795674|NCT05550532|584295023|FG000|Overall Study|Other|0|||
161795675|NCT05550532|584295024|FG001|Overall Study|Other|4|||
161795676|NCT00859469|584295025|FG000|Overall Study|Adverse Event|2|||
161795677|NCT00859469|584295025|FG000|Overall Study|Lack of Efficacy|9|||
162134579|NCT02624778|585543017|FG003|Overall Study|Withdrawal by Subject|0|||
162134580|NCT02624778|585543018|FG004|Overall Study|Withdrawal by Subject|0|||
161900564|NCT02137226|584683075|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
161900565|NCT02137226|584683076|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
161900566|NCT02137226|584683077|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
161900567|NCT02137226|584683073|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
161900568|NCT02137226|584683074|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
161900569|NCT02137226|584683075|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
161900570|NCT02137226|584683076|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
161900571|NCT02137226|584683077|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
161900572|NCT02137226|584683073|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
161900573|NCT02137226|584683074|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
161900574|NCT02137226|584683075|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
161900575|NCT02137226|584683076|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
161900576|NCT02137226|584683077|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
161900577|NCT02137226|584683073|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
161900578|NCT02137226|584683074|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
162010819|NCT03879772|585096000|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
162010820|NCT00389610|585096012|FG000|Overall Study|Disease Progression|0|||
162134581|NCT02624778|585543019|FG005|Overall Study|Withdrawal by Subject|1|||
162134582|NCT02624778|585543020|FG006|Overall Study|Withdrawal by Subject|1|||
162134583|NCT02624778|585543021|FG007|Overall Study|Withdrawal by Subject|1|||
162134584|NCT02624778|585543022|FG008|Overall Study|Withdrawal by Subject|1|||
162134585|NCT02624778|585543014|FG000|Overall Study|Adverse Event|0|||
162134586|NCT02624778|585543015|FG001|Overall Study|Adverse Event|0|||
162134587|NCT02624778|585543016|FG002|Overall Study|Adverse Event|0|||
162134588|NCT02624778|585543017|FG003|Overall Study|Adverse Event|0|||
162134589|NCT02624778|585543018|FG004|Overall Study|Adverse Event|0|||
162134590|NCT02624778|585543019|FG005|Overall Study|Adverse Event|0|||
162134591|NCT02624778|585543020|FG006|Overall Study|Adverse Event|0|||
162134592|NCT02624778|585543021|FG007|Overall Study|Adverse Event|0|||
162134593|NCT02624778|585543022|FG008|Overall Study|Adverse Event|2|||
162134594|NCT02624778|585543014|FG000|Overall Study|Death|0|||
162134595|NCT02624778|585543015|FG001|Overall Study|Death|0|||
162134596|NCT02624778|585543016|FG002|Overall Study|Death|0|||
162134597|NCT02624778|585543017|FG003|Overall Study|Death|0|||
162134598|NCT02624778|585543018|FG004|Overall Study|Death|0|||
162134599|NCT02624778|585543019|FG005|Overall Study|Death|0|||
162134600|NCT02624778|585543020|FG006|Overall Study|Death|1|||
162134601|NCT02624778|585543021|FG007|Overall Study|Death|0|||
162134602|NCT02624778|585543022|FG008|Overall Study|Death|0|||
162134603|NCT02624778|585543014|FG000|Overall Study|Physician Decision|0|||
162134604|NCT02624778|585543015|FG001|Overall Study|Physician Decision|0|||
162134605|NCT02624778|585543016|FG002|Overall Study|Physician Decision|0|||
162134606|NCT02624778|585543017|FG003|Overall Study|Physician Decision|0|||
162134607|NCT02624778|585543018|FG004|Overall Study|Physician Decision|0|||
162134608|NCT02624778|585543019|FG005|Overall Study|Physician Decision|0|||
162134609|NCT02624778|585543020|FG006|Overall Study|Physician Decision|0|||
162134610|NCT02624778|585543021|FG007|Overall Study|Physician Decision|3|||
162134611|NCT02624778|585543022|FG008|Overall Study|Physician Decision|3|||
162134612|NCT04091672|585543025|FG000|Overall Study|Death|6|||
162134613|NCT04091672|585543026|FG001|Overall Study|Death|6|||
162134614|NCT04091672|585543025|FG000|Overall Study|Lost to Follow-up|7|||
162134615|NCT04091672|585543026|FG001|Overall Study|Lost to Follow-up|7|||
162134616|NCT04091672|585543025|FG000|Overall Study|Withdrawal by Subject|3|||
162134617|NCT04091672|585543026|FG001|Overall Study|Withdrawal by Subject|3|||
162134618|NCT04091672|585543025|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
162134619|NCT04091672|585543026|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
162134620|NCT05296629|585543027|FG000|Overall Study|Withdrawal by Subject|3|||
162134621|NCT05296629|585543028|FG001|Overall Study|Withdrawal by Subject|10|||
162134622|NCT05296629|585543029|FG002|Overall Study|Withdrawal by Subject|4|||
162134623|NCT05296629|585543027|FG000|Overall Study|Lost to Follow-up|2|||
162134624|NCT05296629|585543028|FG001|Overall Study|Lost to Follow-up|7|||
162134625|NCT05296629|585543029|FG002|Overall Study|Lost to Follow-up|1|||
162134626|NCT05296629|585543027|FG000|Overall Study|Adverse Event|0|||
162134627|NCT05296629|585543028|FG001|Overall Study|Adverse Event|4|||
162134628|NCT05296629|585543029|FG002|Overall Study|Adverse Event|2|||
162134629|NCT05296629|585543027|FG000|Overall Study|Protocol Violation|0|||
162134630|NCT05296629|585543028|FG001|Overall Study|Protocol Violation|2|||
162134631|NCT05296629|585543029|FG002|Overall Study|Protocol Violation|0|||
162134632|NCT04610684|585543035|FG000|Study Treatment|Withdrawal by Subject|1|||
162134633|NCT04610684|585543035|FG000|Study Treatment|Disease Progression|2|||
162134634|NCT04610684|585543035|FG000|Follow up|Death|2|||
162134635|NCT04610684|585543035|FG000|Follow up|Withdrawal by Subject|1|||
162134636|NCT00359619|585543036|FG000|Overall Study|Adverse Event|0|||
162134637|NCT00359619|585543037|FG001|Overall Study|Adverse Event|0|||
162134638|NCT00359619|585543038|FG002|Overall Study|Adverse Event|1|||
162134639|NCT00359619|585543039|FG003|Overall Study|Adverse Event|0|||
162134640|NCT00359619|585543040|FG004|Overall Study|Adverse Event|0|||
162134641|NCT00359619|585543041|FG005|Overall Study|Adverse Event|0|||
162242086|NCT02616562|585939082|FG014|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242087|NCT02616562|585939083|FG015|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242088|NCT02616562|585939084|FG016|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
162242089|NCT02616562|585939068|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242090|NCT02616562|585939069|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242091|NCT02616562|585939070|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242092|NCT02616562|585939071|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242093|NCT02616562|585939072|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242094|NCT02616562|585939073|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242095|NCT02616562|585939074|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242096|NCT02616562|585939075|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242097|NCT02616562|585939076|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242098|NCT02616562|585939077|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242099|NCT02616562|585939078|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
162242100|NCT02616562|585939079|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242101|NCT02616562|585939080|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242102|NCT02616562|585939081|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
162242103|NCT02616562|585939082|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
162242104|NCT02616562|585939083|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242105|NCT02616562|585939084|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
162242106|NCT02616562|585939068|FG000|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242107|NCT02616562|585939069|FG001|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242108|NCT02616562|585939070|FG002|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242109|NCT02616562|585939071|FG003|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242110|NCT02616562|585939072|FG004|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242111|NCT02616562|585939073|FG005|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242112|NCT02616562|585939074|FG006|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242113|NCT02616562|585939075|FG007|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161795678|NCT00859469|584295025|FG000|Overall Study|Withdrawal by Subject|1|||
161795679|NCT00859469|584295025|FG000|Overall Study|Death|16|||
161795680|NCT04071769|584295026|FG000|Overall Study|Lost to Follow-up|3|||
161795681|NCT04071769|584295026|FG000|Overall Study|Physician Decision|2|||
161795682|NCT04071769|584295026|FG000|Overall Study|Withdrawal by Subject|8|||
161795683|NCT01890707|584295027|FG000|Overall Study|Lost to Follow-up|1|||
161795684|NCT01890707|584295028|FG001|Overall Study|Lost to Follow-up|1|||
161795685|NCT00669955|584295029|FG000|Overall Study|Adverse Event|3|||
161795686|NCT00669955|584295030|FG001|Overall Study|Adverse Event|5|||
161795687|NCT00669955|584295029|FG000|Overall Study|Death|0|||
161795688|NCT00669955|584295030|FG001|Overall Study|Death|1|||
161795689|NCT00669955|584295029|FG000|Overall Study|Withdrawal by Subject|2|||
161795690|NCT00669955|584295030|FG001|Overall Study|Withdrawal by Subject|3|||
161795691|NCT00669955|584295029|FG000|Overall Study|Lost to Follow-up|5|||
161795692|NCT00669955|584295030|FG001|Overall Study|Lost to Follow-up|7|||
161795693|NCT00669955|584295029|FG000|Overall Study|Protocol Violation|2|||
161795694|NCT00669955|584295030|FG001|Overall Study|Protocol Violation|7|||
161795695|NCT00669955|584295029|FG000|Overall Study|Investigator Sponsor Judgement|0|||
161795696|NCT00669955|584295030|FG001|Overall Study|Investigator Sponsor Judgement|1|||
161795697|NCT00669955|584295029|FG000|Overall Study|not compliant with study drug/visit|2|||
161795698|NCT00669955|584295030|FG001|Overall Study|not compliant with study drug/visit|3|||
161795699|NCT04820842|584296374|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161795700|NCT04820842|584296375|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
161795701|NCT04820842|584296376|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
161795702|NCT04820842|584296377|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161795703|NCT04820842|584296378|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161795704|NCT04820842|584296379|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161795705|NCT04820842|584296380|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161795706|NCT04820842|584296374|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
161795707|NCT04820842|584296375|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
161795708|NCT04820842|584296376|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
161795709|NCT04820842|584296377|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161831515|NCT03135899|584424798|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
161831516|NCT03135899|584424799|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
161831517|NCT03135899|584424792|FG000|Overall Study|Withdrawal by Subject|0|||
162242114|NCT02616562|585939076|FG008|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242115|NCT02616562|585939077|FG009|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242116|NCT02616562|585939078|FG010|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|1|||
162242117|NCT02616562|585939079|FG011|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242118|NCT02616562|585939080|FG012|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161795710|NCT04820842|584296378|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795711|NCT04820842|584296379|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795712|NCT04820842|584296380|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795713|NCT04820842|584296374|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161795714|NCT04820842|584296375|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
161795715|NCT04820842|584296376|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161795716|NCT04820842|584296377|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161795717|NCT04820842|584296378|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161795718|NCT04820842|584296379|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161795719|NCT04820842|584296380|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161795720|NCT04820842|584296374|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795721|NCT04820842|584296375|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795722|NCT04820842|584296376|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795723|NCT04820842|584296377|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
161795724|NCT04820842|584296378|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795725|NCT04820842|584296379|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161795726|NCT04820842|584296380|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
161795727|NCT01691508|584296381|FG000|Overall Study|Adverse Event|3|||
161795728|NCT01691508|584296382|FG001|Overall Study|Adverse Event|3|||
161795729|NCT01691508|584296381|FG000|Overall Study|Withdrawal by Subject|1|||
161795730|NCT01691508|584296382|FG001|Overall Study|Withdrawal by Subject|0|||
161795731|NCT01296932|584296383|FG000|Overall Study|Dose limiting toxicity|0|||
161795732|NCT01296932|584296384|FG001|Overall Study|Dose limiting toxicity|0|||
161795733|NCT01296932|584296385|FG002|Overall Study|Dose limiting toxicity|0|||
161795734|NCT01296932|584296386|FG003|Overall Study|Dose limiting toxicity|0|||
161795735|NCT01296932|584296387|FG004|Overall Study|Dose limiting toxicity|0|||
161795736|NCT01296932|584296388|FG005|Overall Study|Dose limiting toxicity|0|||
161795737|NCT01296932|584296389|FG006|Overall Study|Dose limiting toxicity|1|||
161795738|NCT01296932|584296390|FG007|Overall Study|Dose limiting toxicity|0|||
161795739|NCT01296932|584296391|FG008|Overall Study|Dose limiting toxicity|1|||
161795740|NCT01296932|584296383|FG000|Overall Study|Progressive disease|2|||
161795741|NCT01296932|584296384|FG001|Overall Study|Progressive disease|0|||
161795742|NCT01296932|584296385|FG002|Overall Study|Progressive disease|1|||
161795743|NCT01296932|584296386|FG003|Overall Study|Progressive disease|1|||
161795744|NCT01296932|584296387|FG004|Overall Study|Progressive disease|2|||
161795745|NCT01296932|584296388|FG005|Overall Study|Progressive disease|3|||
161795746|NCT01296932|584296389|FG006|Overall Study|Progressive disease|1|||
161795747|NCT01296932|584296390|FG007|Overall Study|Progressive disease|0|||
161795748|NCT01296932|584296391|FG008|Overall Study|Progressive disease|0|||
161795749|NCT01296932|584296383|FG000|Overall Study|Withdrawal by Subject|0|||
161795750|NCT01296932|584296384|FG001|Overall Study|Withdrawal by Subject|0|||
161795751|NCT01296932|584296385|FG002|Overall Study|Withdrawal by Subject|1|||
161795752|NCT01296932|584296386|FG003|Overall Study|Withdrawal by Subject|1|||
161795753|NCT01296932|584296387|FG004|Overall Study|Withdrawal by Subject|0|||
161795754|NCT01296932|584296388|FG005|Overall Study|Withdrawal by Subject|0|||
161795755|NCT01296932|584296389|FG006|Overall Study|Withdrawal by Subject|3|||
161795756|NCT01296932|584296390|FG007|Overall Study|Withdrawal by Subject|0|||
161795757|NCT01296932|584296391|FG008|Overall Study|Withdrawal by Subject|0|||
161795758|NCT01296932|584296383|FG000|Overall Study|Adverse Event|1|||
161795759|NCT01296932|584296384|FG001|Overall Study|Adverse Event|1|||
161795760|NCT01296932|584296385|FG002|Overall Study|Adverse Event|1|||
161795761|NCT01296932|584296386|FG003|Overall Study|Adverse Event|2|||
161795762|NCT01296932|584296387|FG004|Overall Study|Adverse Event|1|||
161795763|NCT01296932|584296388|FG005|Overall Study|Adverse Event|0|||
161795764|NCT01296932|584296389|FG006|Overall Study|Adverse Event|0|||
161795765|NCT01296932|584296390|FG007|Overall Study|Adverse Event|0|||
161795766|NCT01296932|584296391|FG008|Overall Study|Adverse Event|1|||
161795767|NCT01296932|584296383|FG000|Overall Study|Investigator decision|0|||
161795768|NCT01296932|584296384|FG001|Overall Study|Investigator decision|1|||
161795769|NCT01296932|584296385|FG002|Overall Study|Investigator decision|0|||
161795770|NCT01296932|584296386|FG003|Overall Study|Investigator decision|1|||
161795771|NCT01296932|584296387|FG004|Overall Study|Investigator decision|0|||
161795772|NCT01296932|584296388|FG005|Overall Study|Investigator decision|0|||
161795773|NCT01296932|584296389|FG006|Overall Study|Investigator decision|1|||
161795774|NCT01296932|584296390|FG007|Overall Study|Investigator decision|0|||
161795775|NCT01296932|584296391|FG008|Overall Study|Investigator decision|1|||
161795776|NCT01296932|584296383|FG000|Overall Study|No clinical benefit anymore|0|||
161795777|NCT01296932|584296384|FG001|Overall Study|No clinical benefit anymore|1|||
161795778|NCT01296932|584296385|FG002|Overall Study|No clinical benefit anymore|0|||
161795779|NCT01296932|584296386|FG003|Overall Study|No clinical benefit anymore|0|||
161795780|NCT01296932|584296387|FG004|Overall Study|No clinical benefit anymore|0|||
161795781|NCT01296932|584296388|FG005|Overall Study|No clinical benefit anymore|0|||
161795782|NCT01296932|584296389|FG006|Overall Study|No clinical benefit anymore|0|||
161795783|NCT01296932|584296390|FG007|Overall Study|No clinical benefit anymore|0|||
161795784|NCT01296932|584296391|FG008|Overall Study|No clinical benefit anymore|0|||
161795785|NCT01296932|584296383|FG000|Overall Study|Physician Decision|0|||
161795786|NCT01296932|584296384|FG001|Overall Study|Physician Decision|0|||
161795787|NCT01296932|584296385|FG002|Overall Study|Physician Decision|1|||
161795788|NCT01296932|584296386|FG003|Overall Study|Physician Decision|0|||
161795789|NCT01296932|584296387|FG004|Overall Study|Physician Decision|0|||
161795790|NCT01296932|584296388|FG005|Overall Study|Physician Decision|0|||
161795791|NCT01296932|584296389|FG006|Overall Study|Physician Decision|0|||
161795792|NCT01296932|584296390|FG007|Overall Study|Physician Decision|0|||
161795793|NCT01296932|584296391|FG008|Overall Study|Physician Decision|0|||
161795794|NCT01296932|584296383|FG000|Overall Study|IV problems, administration not possible|0|||
161795795|NCT01296932|584296384|FG001|Overall Study|IV problems, administration not possible|0|||
161795796|NCT01296932|584296385|FG002|Overall Study|IV problems, administration not possible|1|||
162134642|NCT00359619|585543042|FG006|Overall Study|Adverse Event|1|||
162134643|NCT00359619|585543036|FG000|Overall Study|Withdrawal by Subject|3|||
162134644|NCT00359619|585543037|FG001|Overall Study|Withdrawal by Subject|1|||
162134645|NCT00359619|585543038|FG002|Overall Study|Withdrawal by Subject|4|||
162134646|NCT00359619|585543039|FG003|Overall Study|Withdrawal by Subject|2|||
162134647|NCT00359619|585543040|FG004|Overall Study|Withdrawal by Subject|2|||
162134648|NCT00359619|585543041|FG005|Overall Study|Withdrawal by Subject|0|||
162134649|NCT00359619|585543042|FG006|Overall Study|Withdrawal by Subject|3|||
162134650|NCT00359619|585543036|FG000|Overall Study|Other|1|||
162134651|NCT00359619|585543037|FG001|Overall Study|Other|0|||
162134652|NCT00359619|585543038|FG002|Overall Study|Other|0|||
162134653|NCT00359619|585543039|FG003|Overall Study|Other|0|||
162134654|NCT00359619|585543040|FG004|Overall Study|Other|0|||
162134655|NCT00359619|585543041|FG005|Overall Study|Other|0|||
162134656|NCT00359619|585543042|FG006|Overall Study|Other|0|||
162134657|NCT00359619|585543036|FG000|Overall Study|Lost to Follow-up|4|||
162134658|NCT00359619|585543037|FG001|Overall Study|Lost to Follow-up|4|||
162134659|NCT00359619|585543038|FG002|Overall Study|Lost to Follow-up|2|||
162134660|NCT00359619|585543039|FG003|Overall Study|Lost to Follow-up|1|||
162134661|NCT00359619|585543040|FG004|Overall Study|Lost to Follow-up|1|||
162134662|NCT00359619|585543041|FG005|Overall Study|Lost to Follow-up|5|||
162134663|NCT00359619|585543042|FG006|Overall Study|Lost to Follow-up|0|||
162134664|NCT00049517|585543043|FG000|Induction|Disease progression|0|||
162134665|NCT00049517|585543044|FG001|Induction|Disease progression|0|||
162134666|NCT00049517|585543045|FG002|Induction|Disease progression|0|||
162134667|NCT00049517|585543046|FG003|Induction|Disease progression|0|||
162134668|NCT00049517|585543047|FG004|Induction|Disease progression|18|||
162134669|NCT00049517|585543048|FG005|Induction|Disease progression|11|||
162134670|NCT00049517|585543043|FG000|Induction|Adverse Event|0|||
162134671|NCT00049517|585543044|FG001|Induction|Adverse Event|0|||
162134672|NCT00049517|585543045|FG002|Induction|Adverse Event|0|||
162134673|NCT00049517|585543046|FG003|Induction|Adverse Event|0|||
162134674|NCT00049517|585543047|FG004|Induction|Adverse Event|5|||
162134675|NCT00049517|585543048|FG005|Induction|Adverse Event|7|||
162134676|NCT00049517|585543043|FG000|Induction|Death|0|||
162134677|NCT00049517|585543044|FG001|Induction|Death|0|||
162134678|NCT00049517|585543045|FG002|Induction|Death|0|||
162134679|NCT00049517|585543046|FG003|Induction|Death|0|||
162134680|NCT00049517|585543047|FG004|Induction|Death|9|||
162134681|NCT00049517|585543048|FG005|Induction|Death|6|||
162134682|NCT00049517|585543043|FG000|Induction|Withdrawal by Subject|0|||
162134683|NCT00049517|585543044|FG001|Induction|Withdrawal by Subject|0|||
162134684|NCT00049517|585543045|FG002|Induction|Withdrawal by Subject|0|||
162134685|NCT00049517|585543046|FG003|Induction|Withdrawal by Subject|0|||
161795797|NCT01296932|584296386|FG003|Overall Study|IV problems, administration not possible|0|||
161795798|NCT01296932|584296387|FG004|Overall Study|IV problems, administration not possible|0|||
161795799|NCT01296932|584296388|FG005|Overall Study|IV problems, administration not possible|0|||
161795800|NCT01296932|584296389|FG006|Overall Study|IV problems, administration not possible|0|||
162134686|NCT00049517|585543047|FG004|Induction|Withdrawal by Subject|1|||
162134687|NCT00049517|585543048|FG005|Induction|Withdrawal by Subject|3|||
162134688|NCT00049517|585543043|FG000|Induction|Alternative therapy|0|||
162134689|NCT00049517|585543044|FG001|Induction|Alternative therapy|0|||
162242119|NCT02616562|585939081|FG013|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242120|NCT02616562|585939082|FG014|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242121|NCT02616562|585939083|FG015|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
161900579|NCT02137226|584683075|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
161900580|NCT02137226|584683076|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
161900581|NCT02137226|584683077|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
161900582|NCT02137226|584683073|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
161900583|NCT02137226|584683074|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
161900584|NCT02137226|584683075|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
161900585|NCT02137226|584683076|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
161900586|NCT02137226|584683077|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
161900587|NCT02137226|584683073|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
161900588|NCT02137226|584683074|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
161900589|NCT02137226|584683075|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
161900590|NCT02137226|584683076|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
162134690|NCT00049517|585543045|FG002|Induction|Alternative therapy|0|||
162134691|NCT00049517|585543046|FG003|Induction|Alternative therapy|0|||
162134692|NCT00049517|585543047|FG004|Induction|Alternative therapy|2|||
162134693|NCT00049517|585543048|FG005|Induction|Alternative therapy|2|||
162134694|NCT00049517|585543043|FG000|Induction|Other complicating disease|0|||
162134695|NCT00049517|585543044|FG001|Induction|Other complicating disease|0|||
162134696|NCT00049517|585543045|FG002|Induction|Other complicating disease|0|||
162134697|NCT00049517|585543046|FG003|Induction|Other complicating disease|0|||
162134698|NCT00049517|585543047|FG004|Induction|Other complicating disease|3|||
162134699|NCT00049517|585543048|FG005|Induction|Other complicating disease|0|||
162134700|NCT00049517|585543043|FG000|Induction|Reasons not reported|0|||
162134701|NCT00049517|585543044|FG001|Induction|Reasons not reported|0|||
162134702|NCT00049517|585543045|FG002|Induction|Reasons not reported|0|||
162134703|NCT00049517|585543046|FG003|Induction|Reasons not reported|0|||
162134704|NCT00049517|585543047|FG004|Induction|Reasons not reported|22|||
162134705|NCT00049517|585543048|FG005|Induction|Reasons not reported|25|||
162134706|NCT00049517|585543043|FG000|Conditioning/Transplant|Disease progression|14|||
162134707|NCT00049517|585543044|FG001|Conditioning/Transplant|Disease progression|6|||
162134708|NCT00049517|585543045|FG002|Conditioning/Transplant|Disease progression|10|||
162134709|NCT00049517|585543046|FG003|Conditioning/Transplant|Disease progression|6|||
162134710|NCT00049517|585543047|FG004|Conditioning/Transplant|Disease progression|0|||
162134711|NCT00049517|585543048|FG005|Conditioning/Transplant|Disease progression|0|||
162134712|NCT00049517|585543043|FG000|Conditioning/Transplant|Adverse Event|2|||
162134713|NCT00049517|585543044|FG001|Conditioning/Transplant|Adverse Event|1|||
162134714|NCT00049517|585543045|FG002|Conditioning/Transplant|Adverse Event|4|||
162134715|NCT00049517|585543046|FG003|Conditioning/Transplant|Adverse Event|8|||
162134716|NCT00049517|585543047|FG004|Conditioning/Transplant|Adverse Event|0|||
162134717|NCT00049517|585543048|FG005|Conditioning/Transplant|Adverse Event|0|||
162134718|NCT00049517|585543043|FG000|Conditioning/Transplant|Death|1|||
162134719|NCT00049517|585543044|FG001|Conditioning/Transplant|Death|0|||
162134720|NCT00049517|585543045|FG002|Conditioning/Transplant|Death|0|||
162134721|NCT00049517|585543046|FG003|Conditioning/Transplant|Death|2|||
162134722|NCT00049517|585543047|FG004|Conditioning/Transplant|Death|0|||
162134723|NCT00049517|585543048|FG005|Conditioning/Transplant|Death|0|||
162134724|NCT00049517|585543043|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
162134725|NCT00049517|585543044|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
162134726|NCT00049517|585543045|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
162134727|NCT00049517|585543046|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
162134728|NCT00049517|585543047|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
162134729|NCT00049517|585543048|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
162134730|NCT00049517|585543043|FG000|Conditioning/Transplant|Alternative therapy|4|||
162134731|NCT00049517|585543044|FG001|Conditioning/Transplant|Alternative therapy|4|||
162134732|NCT00049517|585543045|FG002|Conditioning/Transplant|Alternative therapy|2|||
162134733|NCT00049517|585543046|FG003|Conditioning/Transplant|Alternative therapy|1|||
162134734|NCT00049517|585543047|FG004|Conditioning/Transplant|Alternative therapy|1|||
162134735|NCT00049517|585543048|FG005|Conditioning/Transplant|Alternative therapy|0|||
162134736|NCT00049517|585543043|FG000|Conditioning/Transplant|Other complicating disease|2|||
161900591|NCT02137226|584683077|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
162134737|NCT00049517|585543044|FG001|Conditioning/Transplant|Other complicating disease|0|||
162134738|NCT00049517|585543045|FG002|Conditioning/Transplant|Other complicating disease|0|||
162134739|NCT00049517|585543046|FG003|Conditioning/Transplant|Other complicating disease|4|||
162134740|NCT00049517|585543047|FG004|Conditioning/Transplant|Other complicating disease|0|||
162134741|NCT00049517|585543048|FG005|Conditioning/Transplant|Other complicating disease|1|||
162134742|NCT00049517|585543043|FG000|Conditioning/Transplant|Reasons not reported|25|||
162134743|NCT00049517|585543044|FG001|Conditioning/Transplant|Reasons not reported|31|||
161900592|NCT03134911|584683079|FG000|Overall Study|Screen failure|31|||
162134744|NCT00049517|585543045|FG002|Conditioning/Transplant|Reasons not reported|18|||
162242122|NCT02616562|585939084|FG016|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
162242123|NCT02616562|585939068|FG000|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242124|NCT02616562|585939069|FG001|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242125|NCT02616562|585939070|FG002|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242126|NCT02616562|585939071|FG003|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242127|NCT02616562|585939072|FG004|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242128|NCT02616562|585939073|FG005|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242129|NCT02616562|585939074|FG006|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242130|NCT02616562|585939075|FG007|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242131|NCT02616562|585939076|FG008|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242132|NCT02616562|585939077|FG009|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242133|NCT02616562|585939078|FG010|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242134|NCT02616562|585939079|FG011|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|1|||
162242135|NCT02616562|585939080|FG012|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242136|NCT02616562|585939081|FG013|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242137|NCT02616562|585939082|FG014|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242138|NCT02616562|585939083|FG015|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242139|NCT02616562|585939084|FG016|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
162242140|NCT02616562|585939068|FG000|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
161795801|NCT01296932|584296390|FG007|Overall Study|IV problems, administration not possible|0|||
161795802|NCT01296932|584296391|FG008|Overall Study|IV problems, administration not possible|0|||
161795803|NCT01296932|584296383|FG000|Overall Study|per protocol|0|||
161795804|NCT01296932|584296384|FG001|Overall Study|per protocol|0|||
162134745|NCT00049517|585543046|FG003|Conditioning/Transplant|Reasons not reported|15|||
162134746|NCT00049517|585543047|FG004|Conditioning/Transplant|Reasons not reported|5|||
162134747|NCT00049517|585543048|FG005|Conditioning/Transplant|Reasons not reported|5|||
162134748|NCT02788656|585543049|FG000|Overall Study|Withdrawal by Subject|1|||
162134749|NCT02788656|585543050|FG001|Overall Study|Withdrawal by Subject|0|||
162134750|NCT02757885|585543056|FG000|Overall Study|Screen Failures|4|||
162134751|NCT04531540|585543057|FG000|Overall Study|Adverse Event|1|||
162134752|NCT04531540|585543057|FG000|Overall Study|Protocol Violation|3|||
162134753|NCT04531540|585543057|FG000|Overall Study|Withdrawal by Subject|4|||
162134754|NCT04531540|585543057|FG000|Overall Study|Found to be Ineligible|1|||
162134755|NCT02688621|585543060|FG000|Overall Study|Pregnancy|1|||
162134756|NCT02688621|585543061|FG001|Overall Study|Pregnancy|3|||
162134757|NCT02688621|585543060|FG000|Overall Study|Lost to Follow-up|38|||
162134758|NCT02688621|585543061|FG001|Overall Study|Lost to Follow-up|15|||
162134759|NCT02688621|585543060|FG000|Overall Study|Withdrawal by Subject|1|||
162134760|NCT02688621|585543061|FG001|Overall Study|Withdrawal by Subject|0|||
162134761|NCT01575860|585543064|FG000|Overall Study|Withdrawal by Subject|1|||
162134762|NCT01575860|585543064|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
162134763|NCT05349864|585543069|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
162134764|NCT05349864|585543070|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
162134765|NCT00984282|585543071|FG000|Double Blind Treatment|Adverse Event|40|||
162134766|NCT00984282|585543072|FG001|Double Blind Treatment|Adverse Event|6|||
161795805|NCT01296932|584296385|FG002|Overall Study|per protocol|1|||
161795806|NCT01296932|584296386|FG003|Overall Study|per protocol|1|||
161795807|NCT01296932|584296387|FG004|Overall Study|per protocol|0|||
161795808|NCT01296932|584296388|FG005|Overall Study|per protocol|0|||
161795809|NCT01296932|584296389|FG006|Overall Study|per protocol|0|||
161795810|NCT01296932|584296390|FG007|Overall Study|per protocol|0|||
161795811|NCT01296932|584296391|FG008|Overall Study|per protocol|0|||
161795812|NCT01296932|584296383|FG000|Overall Study|Low benefit and too many side effects|0|||
162134767|NCT00984282|585543071|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
162134768|NCT00984282|585543072|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
162134769|NCT00984282|585543071|FG000|Double Blind Treatment|Physician Decision|1|||
162134770|NCT00984282|585543072|FG001|Double Blind Treatment|Physician Decision|2|||
162134771|NCT00984282|585543071|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
162134772|NCT00984282|585543072|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
162134773|NCT00984282|585543071|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
162134774|NCT00984282|585543072|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
162134775|NCT00984282|585543071|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
162134776|NCT00984282|585543072|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
162134777|NCT00984282|585543071|FG000|Double Blind Treatment|Lost to Follow-up|3|||
162134778|NCT00984282|585543072|FG001|Double Blind Treatment|Lost to Follow-up|0|||
161795813|NCT01296932|584296384|FG001|Overall Study|Low benefit and too many side effects|0|||
162010821|NCT00389610|585096013|FG001|Overall Study|Disease Progression|19|||
162134779|NCT00984282|585543071|FG000|Double Blind Treatment|Death|8|||
162134780|NCT00984282|585543072|FG001|Double Blind Treatment|Death|4|||
162134781|NCT00984282|585543071|FG000|Double Blind Treatment|Not treated|0|||
162134782|NCT00984282|585543072|FG001|Double Blind Treatment|Not treated|1|||
162134783|NCT00984282|585543071|FG000|Double Blind Treatment|Switched to commercial drug|6|||
162134784|NCT00984282|585543072|FG001|Double Blind Treatment|Switched to commercial drug|1|||
162134785|NCT00984282|585543071|FG000|Double Blind Treatment|protocol driven decision point|1|||
162134786|NCT00984282|585543072|FG001|Double Blind Treatment|protocol driven decision point|1|||
162134787|NCT00984282|585543071|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
162134788|NCT00984282|585543072|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
162134789|NCT00984282|585543071|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
162134790|NCT00984282|585543072|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
162134791|NCT00984282|585543071|FG000|Open-label Treatment|Adverse Event|20|||
162134792|NCT00984282|585543072|FG001|Open-label Treatment|Adverse Event|30|||
162134793|NCT00984282|585543071|FG000|Open-label Treatment|Withdrawal by Subject|6|||
162134794|NCT00984282|585543072|FG001|Open-label Treatment|Withdrawal by Subject|21|||
162134795|NCT00984282|585543071|FG000|Open-label Treatment|Death|7|||
162134796|NCT00984282|585543072|FG001|Open-label Treatment|Death|15|||
162134797|NCT00984282|585543071|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
162134798|NCT00984282|585543072|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
162134799|NCT00984282|585543071|FG000|Open-label Treatment|Lost to Follow-up|1|||
162134800|NCT00984282|585543072|FG001|Open-label Treatment|Lost to Follow-up|1|||
162134801|NCT00984282|585543071|FG000|Open-label Treatment|Patient convenience|1|||
162134802|NCT00984282|585543072|FG001|Open-label Treatment|Patient convenience|0|||
162134803|NCT00984282|585543071|FG000|Open-label Treatment|Non-compliant with study medication|1|||
162134804|NCT00984282|585543072|FG001|Open-label Treatment|Non-compliant with study medication|0|||
162134805|NCT00984282|585543071|FG000|Open-label Treatment|Target lesion removed|0|||
162134806|NCT00984282|585543072|FG001|Open-label Treatment|Target lesion removed|1|||
162134807|NCT00984282|585543071|FG000|Open-label Treatment|Protocol driven decision point|1|||
162134808|NCT00984282|585543072|FG001|Open-label Treatment|Protocol driven decision point|1|||
162134809|NCT00984282|585543071|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
162134810|NCT00984282|585543072|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
162134811|NCT00984282|585543071|FG000|Open-label Treatment|Switched to commercial drug|6|||
162134812|NCT00984282|585543072|FG001|Open-label Treatment|Switched to commercial drug|7|||
162134813|NCT00984282|585543071|FG000|Open-label Treatment|Physician Decision|1|||
162134814|NCT00984282|585543072|FG001|Open-label Treatment|Physician Decision|0|||
162134815|NCT00984282|585543071|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
162134816|NCT00984282|585543072|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
161795814|NCT01296932|584296385|FG002|Overall Study|Low benefit and too many side effects|0|||
161795815|NCT01296932|584296386|FG003|Overall Study|Low benefit and too many side effects|0|||
161795816|NCT01296932|584296387|FG004|Overall Study|Low benefit and too many side effects|0|||
161795817|NCT01296932|584296388|FG005|Overall Study|Low benefit and too many side effects|0|||
161795818|NCT01296932|584296389|FG006|Overall Study|Low benefit and too many side effects|0|||
161795819|NCT01296932|584296390|FG007|Overall Study|Low benefit and too many side effects|1|||
161795820|NCT01296932|584296391|FG008|Overall Study|Low benefit and too many side effects|0|||
161795821|NCT01296932|584296383|FG000|Overall Study|No adequate treatment response|0|||
161795822|NCT01296932|584296384|FG001|Overall Study|No adequate treatment response|0|||
161795823|NCT01296932|584296385|FG002|Overall Study|No adequate treatment response|0|||
161795824|NCT01296932|584296386|FG003|Overall Study|No adequate treatment response|0|||
161795825|NCT01296932|584296387|FG004|Overall Study|No adequate treatment response|0|||
161795826|NCT01296932|584296388|FG005|Overall Study|No adequate treatment response|0|||
161795827|NCT01296932|584296389|FG006|Overall Study|No adequate treatment response|0|||
161795828|NCT01296932|584296390|FG007|Overall Study|No adequate treatment response|1|||
161795829|NCT01296932|584296391|FG008|Overall Study|No adequate treatment response|0|||
161795830|NCT01296932|584296383|FG000|Overall Study|Dosage already reduced, AE still present|0|||
161795831|NCT01296932|584296384|FG001|Overall Study|Dosage already reduced, AE still present|0|||
161795832|NCT01296932|584296385|FG002|Overall Study|Dosage already reduced, AE still present|0|||
161795833|NCT01296932|584296386|FG003|Overall Study|Dosage already reduced, AE still present|0|||
161795834|NCT01296932|584296387|FG004|Overall Study|Dosage already reduced, AE still present|0|||
161795835|NCT01296932|584296388|FG005|Overall Study|Dosage already reduced, AE still present|0|||
161795836|NCT01296932|584296389|FG006|Overall Study|Dosage already reduced, AE still present|0|||
161795837|NCT01296932|584296390|FG007|Overall Study|Dosage already reduced, AE still present|0|||
161795838|NCT01296932|584296391|FG008|Overall Study|Dosage already reduced, AE still present|1|||
161795839|NCT02489318|584296394|FG000|Randomized|Withdrawal by Subject|0|||
161795840|NCT02489318|584296395|FG001|Randomized|Withdrawal by Subject|1|||
161795841|NCT02489318|584296394|FG000|Treated|Adverse Event|19|||
161795842|NCT02489318|584296395|FG001|Treated|Adverse Event|62|||
161795843|NCT02489318|584296394|FG000|Treated|Death|13|||
161795844|NCT02489318|584296395|FG001|Treated|Death|11|||
161795845|NCT02489318|584296394|FG000|Treated|Physician Decision|4|||
162134817|NCT00984282|585543071|FG000|Long Term Follow-up|Death|27|||
162134818|NCT00984282|585543072|FG001|Long Term Follow-up|Death|68|||
162134819|NCT00984282|585543071|FG000|Long Term Follow-up|Lost to Follow-up|3|||
162134820|NCT00984282|585543072|FG001|Long Term Follow-up|Lost to Follow-up|6|||
162134821|NCT00984282|585543071|FG000|Long Term Follow-up|Protocol driven decision point|25|||
162134822|NCT00984282|585543072|FG001|Long Term Follow-up|Protocol driven decision point|26|||
162134823|NCT00984282|585543071|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
162134824|NCT00984282|585543072|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
162134825|NCT00984282|585543071|FG000|Long Term Follow-up|Switched to commercial drug|4|||
162134826|NCT00984282|585543072|FG001|Long Term Follow-up|Switched to commercial drug|2|||
162134827|NCT00984282|585543071|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
162134828|NCT00984282|585543072|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
162134829|NCT02223793|585543073|FG000|Overall Study|Lost to Follow-up|10|||
162134830|NCT02223793|585543074|FG001|Overall Study|Lost to Follow-up|1|||
162134831|NCT02223793|585543075|FG002|Overall Study|Lost to Follow-up|2|||
162134832|NCT02223793|585543073|FG000|Overall Study|Withdrawal by Subject|3|||
162134833|NCT02223793|585543074|FG001|Overall Study|Withdrawal by Subject|2|||
162134834|NCT02223793|585543075|FG002|Overall Study|Withdrawal by Subject|3|||
162134835|NCT02223793|585543073|FG000|Overall Study|Moved/studycenter unable to participate|4|||
162134836|NCT02223793|585543074|FG001|Overall Study|Moved/studycenter unable to participate|6|||
162134837|NCT02223793|585543075|FG002|Overall Study|Moved/studycenter unable to participate|8|||
162134838|NCT02321540|585543078|FG000|Overall Study|Death|0|||
162134839|NCT02321540|585543079|FG001|Overall Study|Death|1|||
162134840|NCT02321540|585543078|FG000|Overall Study|Progression|3|||
162134841|NCT02321540|585543079|FG001|Overall Study|Progression|9|||
162134842|NCT03606460|585543080|FG000|Overall Study|Lost to Follow-up|1|||
162134843|NCT03606460|585543081|FG001|Overall Study|Lost to Follow-up|8|||
162134844|NCT00003377|585543082|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
162134845|NCT00003377|585543083|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
162134846|NCT00003377|585543084|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
162134847|NCT00003377|585543085|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
162134848|NCT00003377|585543086|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
162134849|NCT00003377|585543082|FG000|Period II|Ureteral stent complications|0|||
162134850|NCT00003377|585543083|FG001|Period II|Ureteral stent complications|0|||
162134851|NCT00003377|585543084|FG002|Period II|Ureteral stent complications|0|||
162134852|NCT00003377|585543085|FG003|Period II|Ureteral stent complications|0|||
162134853|NCT00003377|585543086|FG004|Period II|Ureteral stent complications|1|||
162134854|NCT04541186|585543090|FG000|Main Study|Adverse Event|0|||
162134855|NCT04541186|585543091|FG001|Main Study|Adverse Event|0|||
162134856|NCT04541186|585543092|FG002|Main Study|Adverse Event|4|||
162134857|NCT04541186|585543093|FG003|Main Study|Adverse Event|0|||
162134858|NCT04541186|585543094|FG004|Main Study|Adverse Event|0|||
162134859|NCT04541186|585543090|FG000|Main Study|Investigator Decision|0|||
162134860|NCT04541186|585543091|FG001|Main Study|Investigator Decision|0|||
162134861|NCT04541186|585543092|FG002|Main Study|Investigator Decision|1|||
162134862|NCT04541186|585543093|FG003|Main Study|Investigator Decision|1|||
162134863|NCT04541186|585543094|FG004|Main Study|Investigator Decision|0|||
162134864|NCT04541186|585543090|FG000|Main Study|Withdrawal by Subject|1|||
162134865|NCT04541186|585543091|FG001|Main Study|Withdrawal by Subject|1|||
162134866|NCT04541186|585543092|FG002|Main Study|Withdrawal by Subject|0|||
162134867|NCT04541186|585543093|FG003|Main Study|Withdrawal by Subject|0|||
162134868|NCT04541186|585543094|FG004|Main Study|Withdrawal by Subject|0|||
162134869|NCT04541186|585543090|FG000|Main Study|COVID-19-related Dose Interruption|0|||
162134870|NCT04541186|585543091|FG001|Main Study|COVID-19-related Dose Interruption|0|||
162134871|NCT04541186|585543092|FG002|Main Study|COVID-19-related Dose Interruption|0|||
162134872|NCT04541186|585543093|FG003|Main Study|COVID-19-related Dose Interruption|0|||
162134873|NCT04541186|585543094|FG004|Main Study|COVID-19-related Dose Interruption|1|||
162134874|NCT04541186|585543090|FG000|Main Study|Randomized in Error Not Treated|0|||
162134875|NCT04541186|585543091|FG001|Main Study|Randomized in Error Not Treated|0|||
162134876|NCT04541186|585543092|FG002|Main Study|Randomized in Error Not Treated|1|||
162134877|NCT04541186|585543093|FG003|Main Study|Randomized in Error Not Treated|0|||
162134878|NCT04541186|585543094|FG004|Main Study|Randomized in Error Not Treated|0|||
162134879|NCT04541186|585543090|FG000|Fibrate Expansion Study|Other than Specified|0|||
161795846|NCT02489318|584296395|FG001|Treated|Physician Decision|6|||
161795847|NCT02489318|584296394|FG000|Treated|Protocol Violation|1|||
161795848|NCT02489318|584296395|FG001|Treated|Protocol Violation|2|||
161795849|NCT02489318|584296394|FG000|Treated|Withdrawal by Subject|37|||
161795850|NCT02489318|584296395|FG001|Treated|Withdrawal by Subject|36|||
161795851|NCT02489318|584296394|FG000|Treated|Other: Progressive Disease|245|||
162134880|NCT04541186|585543091|FG001|Fibrate Expansion Study|Other than Specified|0|||
162134881|NCT04541186|585543092|FG002|Fibrate Expansion Study|Other than Specified|0|||
161795852|NCT02489318|584296395|FG001|Treated|Other: Progressive Disease|138|||
161795853|NCT02489318|584296394|FG000|Treated|Other|0|||
161795854|NCT02489318|584296395|FG001|Treated|Other|2|||
161795855|NCT02489318|584296394|FG000|Treated|Ongoing|0|||
161795856|NCT02489318|584296395|FG001|Treated|Ongoing|267|||
161795857|NCT02918162|584296399|FG000|Overall Study|Withdrawal by Subject|1|||
161795858|NCT02918162|584296399|FG000|Overall Study|Omental Disease|1|||
161795859|NCT00395226|584296400|FG000|Overall Study|Adverse Event|4|||
161795860|NCT00395226|584296401|FG001|Overall Study|Adverse Event|3|||
161795861|NCT00395226|584296400|FG000|Overall Study|Withdrawal by Subject|0|||
161795862|NCT00395226|584296401|FG001|Overall Study|Withdrawal by Subject|1|||
161795863|NCT00395226|584296400|FG000|Overall Study|Lost to Follow-up|0|||
161795864|NCT00395226|584296401|FG001|Overall Study|Lost to Follow-up|1|||
161795865|NCT02655237|584296404|FG000|Overall Study|Adverse Event|10|||
161795866|NCT02655237|584296405|FG001|Overall Study|Adverse Event|7|||
161795867|NCT02655237|584296404|FG000|Overall Study|Protocol Deviation|2|||
161795868|NCT02655237|584296405|FG001|Overall Study|Protocol Deviation|0|||
161795869|NCT02655237|584296404|FG000|Overall Study|Withdrawal by Participant|1|||
161795870|NCT02655237|584296405|FG001|Overall Study|Withdrawal by Participant|2|||
161900593|NCT03134911|584683079|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
162134882|NCT04541186|585543093|FG003|Fibrate Expansion Study|Other than Specified|0|||
162134883|NCT04541186|585543094|FG004|Fibrate Expansion Study|Other than Specified|1|||
162134884|NCT00303303|585543097|FG000|Overall Study|Withdrawal by Subject|0|||
162134885|NCT00303303|585543098|FG001|Overall Study|Withdrawal by Subject|0|||
162134886|NCT00303303|585543099|FG002|Overall Study|Withdrawal by Subject|1|||
162134887|NCT00058058|585543100|FG000|Overall Study|Withdrawal by Subject|4|||
162134888|NCT00058058|585543100|FG000|Overall Study|Ineligible|20|||
162134889|NCT00058058|585543100|FG000|Overall Study|Claustrophobic|5|||
162134890|NCT00058058|585543100|FG000|Overall Study|technical issues|6|||
162134891|NCT00058058|585543100|FG000|Overall Study|Poor positioning, illness,pain|3|||
162134892|NCT03085017|585543101|FG000|Overall Study|Death|0|||
162134893|NCT03085017|585543102|FG001|Overall Study|Death|3|||
162134894|NCT00582790|585543103|FG000|Overall Study|Rapid progression of disease|1|||
162134895|NCT02680756|585543108|FG000|Overall Study|Adverse Event|10|||
162134896|NCT02680756|585543109|FG001|Overall Study|Adverse Event|2|||
161795871|NCT02655237|584296404|FG000|Overall Study|Lack of Efficacy|0|||
161795872|NCT02655237|584296405|FG001|Overall Study|Lack of Efficacy|1|||
161900594|NCT00672633|584683080|FG000|Overall Study|Withdrawal by Subject|0|||
161900595|NCT00672633|584683081|FG001|Overall Study|Withdrawal by Subject|1|||
161900596|NCT02824627|584683082|FG000|Overall Study|Adverse Event|1|||
161900597|NCT02824627|584683083|FG001|Overall Study|Adverse Event|2|||
161900598|NCT02824627|584683082|FG000|Overall Study|Lost to Follow-up|2|||
161900599|NCT02824627|584683083|FG001|Overall Study|Lost to Follow-up|1|||
161900600|NCT01868165|584683084|FG000|Overall Study|Withdrawal by Subject|36|||
161900601|NCT01868165|584683084|FG000|Overall Study|Physician Decision|2|||
161900602|NCT01868165|584683084|FG000|Overall Study|Lost to Follow-up|3|||
161900603|NCT01868165|584683084|FG000|Overall Study|Death|4|||
161900604|NCT01603407|584683085|FG000|Overall Study|Adverse Event|1|||
161900605|NCT01603407|584683086|FG001|Overall Study|Adverse Event|1|||
161900606|NCT01603407|584683087|FG002|Overall Study|Adverse Event|1|||
161900607|NCT01603407|584683085|FG000|Overall Study|Protocol Violation|2|||
161900608|NCT01603407|584683086|FG001|Overall Study|Protocol Violation|2|||
161900609|NCT01603407|584683087|FG002|Overall Study|Protocol Violation|0|||
161900610|NCT01603407|584683085|FG000|Overall Study|Withdrawal by Subject|8|||
161900611|NCT01603407|584683086|FG001|Overall Study|Withdrawal by Subject|5|||
161900612|NCT01603407|584683087|FG002|Overall Study|Withdrawal by Subject|7|||
161900613|NCT01603407|584683085|FG000|Overall Study|Lost to Follow-up|0|||
161900614|NCT01603407|584683086|FG001|Overall Study|Lost to Follow-up|3|||
161900615|NCT01603407|584683087|FG002|Overall Study|Lost to Follow-up|2|||
161900616|NCT02358031|584685128|FG000|Overall Study|Death|253|||
161900617|NCT02358031|584685129|FG001|Overall Study|Death|237|||
161900618|NCT02358031|584685130|FG002|Overall Study|Death|266|||
161900619|NCT02358031|584685128|FG000|Overall Study|Lost to Follow-up|1|||
161900620|NCT02358031|584685129|FG001|Overall Study|Lost to Follow-up|1|||
161900621|NCT02358031|584685130|FG002|Overall Study|Lost to Follow-up|0|||
161900622|NCT02358031|584685128|FG000|Overall Study|Withdrawal by Subject|19|||
161900623|NCT02358031|584685129|FG001|Overall Study|Withdrawal by Subject|14|||
161900624|NCT02358031|584685130|FG002|Overall Study|Withdrawal by Subject|18|||
161900625|NCT02358031|584685128|FG000|Overall Study|Sponsor Decision|26|||
161900626|NCT02358031|584685129|FG001|Overall Study|Sponsor Decision|28|||
161900627|NCT02358031|584685130|FG002|Overall Study|Sponsor Decision|16|||
161900628|NCT00823134|584685137|FG000|Overall Study|Invalid measurement|1|||
161900629|NCT01325350|584685141|FG000|Overall Study|Adverse Event|3|||
161900630|NCT01325350|584685142|FG001|Overall Study|Adverse Event|3|||
161900631|NCT01325350|584685143|FG002|Overall Study|Adverse Event|3|||
161900632|NCT01325350|584685144|FG003|Overall Study|Adverse Event|1|||
162010822|NCT00389610|585096012|FG000|Overall Study|Death|0|||
161900633|NCT01325350|584685145|FG004|Overall Study|Adverse Event|2|||
161900634|NCT01325350|584685141|FG000|Overall Study|Pregnancy|0|||
161900635|NCT01325350|584685142|FG001|Overall Study|Pregnancy|0|||
161900636|NCT01325350|584685143|FG002|Overall Study|Pregnancy|1|||
162134897|NCT02680756|585543108|FG000|Overall Study|Lost to Follow-up|7|||
162134898|NCT02680756|585543109|FG001|Overall Study|Lost to Follow-up|6|||
162134899|NCT02680756|585543108|FG000|Overall Study|Withdrawal by Subject|5|||
162134900|NCT02680756|585543109|FG001|Overall Study|Withdrawal by Subject|5|||
162134901|NCT02680756|585543108|FG000|Overall Study|Physician Decision|4|||
162134902|NCT02680756|585543109|FG001|Overall Study|Physician Decision|1|||
162134903|NCT02680756|585543108|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
162134904|NCT02680756|585543109|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
162134905|NCT02680756|585543108|FG000|Overall Study|Blood transfusion for any reason|0|||
162134906|NCT02680756|585543109|FG001|Overall Study|Blood transfusion for any reason|1|||
162134907|NCT02680756|585543108|FG000|Overall Study|Death|1|||
162134908|NCT02680756|585543109|FG001|Overall Study|Death|0|||
162134909|NCT02680756|585543108|FG000|Overall Study|Protocol Violation|1|||
162134910|NCT02680756|585543109|FG001|Overall Study|Protocol Violation|0|||
162134911|NCT02680756|585543108|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
162134912|NCT02680756|585543109|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
162134913|NCT02680756|585543108|FG000|Overall Study|None of above or not recorded|3|||
162134914|NCT02680756|585543109|FG001|Overall Study|None of above or not recorded|2|||
162134915|NCT02374957|585543110|FG000|Overall Study|Patient did not complete forms correctly|1|||
162134916|NCT02374957|585543111|FG001|Overall Study|Patient did not complete forms correctly|0|||
162134917|NCT00748969|585543112|FG000|Overall Study|Withdrawal by Subject|1|||
162134918|NCT00748969|585543113|FG001|Overall Study|Withdrawal by Subject|0|||
162134919|NCT00748969|585543112|FG000|Overall Study|Withdrawal by Subject|0|||
162134920|NCT00748969|585543113|FG001|Overall Study|Withdrawal by Subject|1|||
162134921|NCT03532178|585543114|FG000|First Period|Withdrawal by Subject|1|||
162134922|NCT03532178|585543115|FG001|First Period|Withdrawal by Subject|3|||
162134923|NCT03532178|585543114|FG000|First Period|technical issues in data collection Technical issues|0|||
162134924|NCT03532178|585543115|FG001|First Period|technical issues in data collection Technical issues|1|||
162134925|NCT03532178|585543114|FG000|Second Period|Withdrawal by Subject|1|||
162134926|NCT03532178|585543115|FG001|Second Period|Withdrawal by Subject|1|||
162134927|NCT03532178|585543114|FG000|Second Period|Technical issues|0|||
162134928|NCT03532178|585543115|FG001|Second Period|Technical issues|1|||
162134929|NCT00372528|585543118|FG000|Overall Study|Lack of Efficacy|1|||
162134930|NCT00372528|585543118|FG000|Overall Study|Adverse Event|1|||
162134931|NCT00372528|585543118|FG000|Overall Study|Study Terminated by Sponsor|18|||
162134932|NCT00372528|585543118|FG000|Overall Study|Other|1|||
162134933|NCT00562965|585543119|FG000|Overall Study|Withdrawal by Subject|0|||
162134934|NCT00562965|585543120|FG001|Overall Study|Withdrawal by Subject|1|||
162134935|NCT00562965|585543119|FG000|Overall Study|Death|2|||
162134936|NCT00562965|585543120|FG001|Overall Study|Death|4|||
162134937|NCT00562965|585543119|FG000|Overall Study|Lost to Follow-up|1|||
162134938|NCT00562965|585543120|FG001|Overall Study|Lost to Follow-up|0|||
162134939|NCT00562965|585543119|FG000|Overall Study|Other|0|||
162134940|NCT00562965|585543120|FG001|Overall Study|Other|1|||
162134941|NCT00761774|585543121|FG000|Overall Study|Adverse Event|17|||
162134942|NCT00761774|585543121|FG000|Overall Study|Lack of Efficacy|37|||
162134943|NCT00761774|585543121|FG000|Overall Study|Lost to Follow-up|2|||
162134944|NCT00761774|585543121|FG000|Overall Study|Withdrawal by Subject|9|||
162134945|NCT00761774|585543121|FG000|Overall Study|Non-compliance|4|||
162134946|NCT00761774|585543121|FG000|Overall Study|End of study|2|||
162134947|NCT00761774|585543121|FG000|Overall Study|Reclassification of seizures|1|||
162134948|NCT00761774|585543121|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
162134949|NCT00761774|585543121|FG000|Overall Study|Sponsor decision|1|||
162134950|NCT00761774|585543121|FG000|Overall Study|Investigator clinical judgement|1|||
162134951|NCT00761774|585543121|FG000|Overall Study|Patient moved out of study area|1|||
162134952|NCT00761774|585543121|FG000|Overall Study|Coordinator leaving site|1|||
162134953|NCT00761774|585543121|FG000|Overall Study|Subject IP non-compliance|1|||
162134954|NCT00761774|585543121|FG000|Overall Study|IP stopped by hospital physician|1|||
162134955|NCT01648283|585543122|FG000|Overall Study|Withdrawal by Subject|14|||
162134956|NCT01124617|585543123|FG000|Overall Study|Adverse Event|5|||
162134957|NCT01124617|585543124|FG001|Overall Study|Adverse Event|2|||
162134958|NCT01124617|585543123|FG000|Overall Study|Lack of Efficacy|2|||
162134959|NCT01124617|585543124|FG001|Overall Study|Lack of Efficacy|1|||
162134960|NCT01124617|585543123|FG000|Overall Study|Protocol Violation|1|||
162134961|NCT01124617|585543124|FG001|Overall Study|Protocol Violation|1|||
162134962|NCT01124617|585543123|FG000|Overall Study|Withdrawal by Subject|9|||
162134963|NCT01124617|585543124|FG001|Overall Study|Withdrawal by Subject|1|||
162134964|NCT01124617|585543123|FG000|Overall Study|Other|2|||
162134965|NCT01124617|585543124|FG001|Overall Study|Other|1|||
162134966|NCT01354938|585543128|FG000|Overall Study|Lost to Follow-up|1|||
162134967|NCT01253200|585543129|FG000|Overall Study|Death|1|||
162134968|NCT01253200|585543130|FG001|Overall Study|Death|0|||
162134969|NCT01253200|585543131|FG002|Overall Study|Death|0|||
162134970|NCT01253200|585543132|FG003|Overall Study|Death|0|||
162134971|NCT01253200|585543133|FG004|Overall Study|Death|0|||
162134972|NCT01253200|585543129|FG000|Overall Study|Lost to Follow-up|1|||
162134973|NCT01253200|585543130|FG001|Overall Study|Lost to Follow-up|1|||
162134974|NCT01253200|585543131|FG002|Overall Study|Lost to Follow-up|0|||
162134975|NCT01253200|585543132|FG003|Overall Study|Lost to Follow-up|0|||
162134976|NCT01253200|585543133|FG004|Overall Study|Lost to Follow-up|0|||
162134977|NCT01253200|585543129|FG000|Overall Study|Withdrawal by Subject|2|||
162242141|NCT02616562|585939069|FG001|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242142|NCT02616562|585939070|FG002|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242143|NCT02616562|585939071|FG003|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242144|NCT02616562|585939072|FG004|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242145|NCT02616562|585939073|FG005|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242146|NCT02616562|585939074|FG006|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242147|NCT02616562|585939075|FG007|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242148|NCT02616562|585939076|FG008|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242149|NCT02616562|585939077|FG009|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242150|NCT02616562|585939078|FG010|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242151|NCT02616562|585939079|FG011|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|1|||
162242152|NCT02616562|585939080|FG012|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242153|NCT02616562|585939081|FG013|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242154|NCT02616562|585939082|FG014|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242155|NCT02616562|585939083|FG015|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242156|NCT02616562|585939084|FG016|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
162242157|NCT02616562|585939068|FG000|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242158|NCT02616562|585939069|FG001|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242159|NCT02616562|585939070|FG002|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242160|NCT02616562|585939071|FG003|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242161|NCT02616562|585939072|FG004|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242162|NCT02616562|585939073|FG005|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242163|NCT02616562|585939074|FG006|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242164|NCT02616562|585939075|FG007|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242165|NCT02616562|585939076|FG008|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242166|NCT02616562|585939077|FG009|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242167|NCT02616562|585939078|FG010|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242168|NCT02616562|585939079|FG011|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242169|NCT02616562|585939080|FG012|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
161795873|NCT02655237|584296404|FG000|Overall Study|Recovery Leading to Surgery|2|||
161795874|NCT02655237|584296405|FG001|Overall Study|Recovery Leading to Surgery|1|||
161795875|NCT02655237|584296404|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
161795876|NCT02655237|584296405|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
161795877|NCT02655237|584296404|FG000|Overall Study|Randomized but Not Treated|1|||
161795878|NCT02655237|584296405|FG001|Overall Study|Randomized but Not Treated|0|||
161795879|NCT03679741|584296406|FG000|Period 1|No longer meet eligibility criteria|1|||
161795880|NCT03679741|584296407|FG001|Period 1|No longer meet eligibility criteria|0|||
161795881|NCT03679741|584296406|FG000|Period 1|Lost to Follow-up|0|||
161795882|NCT03679741|584296407|FG001|Period 1|Lost to Follow-up|1|||
161795883|NCT03679741|584296406|FG000|Period 1|Adverse Event|1|||
161795884|NCT03679741|584296407|FG001|Period 1|Adverse Event|1|||
161795885|NCT03679741|584296406|FG000|Period 1|Withdrawal by Subject|0|||
161795886|NCT03679741|584296407|FG001|Period 1|Withdrawal by Subject|1|||
161795887|NCT03679741|584296406|FG000|Period 2|Adverse Event|2|||
161795888|NCT03679741|584296407|FG001|Period 2|Adverse Event|1|||
161795889|NCT03679741|584296406|FG000|Period 2|Withdrawal by Subject|1|||
161795890|NCT03679741|584296407|FG001|Period 2|Withdrawal by Subject|1|||
161795891|NCT02227862|584296409|FG000|Overall Study|Protocol Violation|7|||
161795892|NCT02227862|584296410|FG001|Overall Study|Protocol Violation|9|||
161795893|NCT02227862|584296409|FG000|Overall Study|Other|0|||
161795894|NCT02227862|584296410|FG001|Overall Study|Other|2|||
161795895|NCT02227862|584296409|FG000|Overall Study|Adverse Event|4|||
161795896|NCT02227862|584296410|FG001|Overall Study|Adverse Event|3|||
161795897|NCT02227862|584296409|FG000|Overall Study|Withdrawal by Subject|7|||
161795898|NCT02227862|584296410|FG001|Overall Study|Withdrawal by Subject|6|||
161795899|NCT02227862|584296409|FG000|Overall Study|Lost to Follow-up|1|||
161795900|NCT02227862|584296410|FG001|Overall Study|Lost to Follow-up|2|||
161795901|NCT05014204|584296411|FG000|Overall Study|Withdrawal by Subject|1|||
161795902|NCT05014204|584296411|FG000|Overall Study|Physician Decision|1|||
161795903|NCT02035137|584296412|FG000|Overall Study|Physician Decision|0|||
161795904|NCT02035137|584296413|FG001|Overall Study|Physician Decision|0|||
161795905|NCT02035137|584296414|FG002|Overall Study|Physician Decision|1|||
161795906|NCT02035137|584296412|FG000|Overall Study|Withdrawal by Subject|0|||
161795907|NCT02035137|584296413|FG001|Overall Study|Withdrawal by Subject|1|||
161795908|NCT02035137|584296414|FG002|Overall Study|Withdrawal by Subject|2|||
161795909|NCT02035137|584296412|FG000|Overall Study|Ineligible|0|||
161795910|NCT02035137|584296413|FG001|Overall Study|Ineligible|1|||
161795911|NCT02035137|584296414|FG002|Overall Study|Ineligible|2|||
161795912|NCT02035137|584296412|FG000|Overall Study|Disease progression prior to treatment start|2|||
161795913|NCT02035137|584296413|FG001|Overall Study|Disease progression prior to treatment start|0|||
161795914|NCT02035137|584296414|FG002|Overall Study|Disease progression prior to treatment start|0|||
161795915|NCT00819247|584296418|FG000|Overall Study|Adverse Event|0|||
161795916|NCT00819247|584296419|FG001|Overall Study|Adverse Event|5|||
161795917|NCT00819247|584296420|FG002|Overall Study|Adverse Event|3|||
161795918|NCT00819247|584296418|FG000|Overall Study|Insufficient testosterone response|5|||
161795919|NCT00819247|584296419|FG001|Overall Study|Insufficient testosterone response|8|||
161795920|NCT00819247|584296420|FG002|Overall Study|Insufficient testosterone response|10|||
161795921|NCT00819247|584296418|FG000|Overall Study|Withdrawal by Subject|1|||
161795922|NCT00819247|584296419|FG001|Overall Study|Withdrawal by Subject|0|||
161795923|NCT00819247|584296420|FG002|Overall Study|Withdrawal by Subject|0|||
161795924|NCT00819247|584296418|FG000|Overall Study|Protocol Violation|1|||
161795925|NCT00819247|584296419|FG001|Overall Study|Protocol Violation|0|||
161795926|NCT00819247|584296420|FG002|Overall Study|Protocol Violation|1|||
161795927|NCT00819247|584296418|FG000|Overall Study|Mistakenly withdrawn|0|||
161795928|NCT00819247|584296419|FG001|Overall Study|Mistakenly withdrawn|1|||
161795929|NCT00819247|584296420|FG002|Overall Study|Mistakenly withdrawn|0|||
161795930|NCT00819247|584296418|FG000|Overall Study|Bad prostate-specific antigen response|3|||
161795931|NCT00819247|584296419|FG001|Overall Study|Bad prostate-specific antigen response|2|||
161795932|NCT00819247|584296420|FG002|Overall Study|Bad prostate-specific antigen response|0|||
162134978|NCT01253200|585543130|FG001|Overall Study|Withdrawal by Subject|0|||
162134979|NCT01253200|585543131|FG002|Overall Study|Withdrawal by Subject|0|||
162134980|NCT01253200|585543132|FG003|Overall Study|Withdrawal by Subject|0|||
162134981|NCT01253200|585543133|FG004|Overall Study|Withdrawal by Subject|0|||
162134982|NCT01253200|585543129|FG000|Overall Study|Protocol Violation|1|||
162134983|NCT01253200|585543130|FG001|Overall Study|Protocol Violation|4|||
162134984|NCT01253200|585543131|FG002|Overall Study|Protocol Violation|0|||
162134985|NCT01253200|585543132|FG003|Overall Study|Protocol Violation|0|||
162134986|NCT01253200|585543133|FG004|Overall Study|Protocol Violation|5|||
162134987|NCT01253200|585543129|FG000|Overall Study|intents|10|||
162134988|NCT01253200|585543130|FG001|Overall Study|intents|10|||
162134989|NCT01253200|585543131|FG002|Overall Study|intents|1|||
162134990|NCT01253200|585543132|FG003|Overall Study|intents|3|||
162134991|NCT01253200|585543133|FG004|Overall Study|intents|0|||
162134992|NCT01253200|585543129|FG000|Overall Study|Attempts|6|||
162134993|NCT01253200|585543130|FG001|Overall Study|Attempts|4|||
162134994|NCT01253200|585543131|FG002|Overall Study|Attempts|1|||
162134995|NCT01253200|585543132|FG003|Overall Study|Attempts|2|||
162134996|NCT01253200|585543133|FG004|Overall Study|Attempts|0|||
162134997|NCT02049437|585543134|FG000|Period 1|Adverse Event|1|||
162134998|NCT02049437|585543135|FG001|Period 1|Adverse Event|1|||
162134999|NCT02049437|585543134|FG000|Period 1|Adverse Event|1|||
162135000|NCT02049437|585543135|FG001|Period 1|Adverse Event|0|||
162135001|NCT01163149|585543141|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
162135002|NCT01163149|585543142|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
162135003|NCT01163149|585543143|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
162135004|NCT01163149|585543141|FG000|Extension Treatment Period|Adverse Event|0|||
162135005|NCT01163149|585543142|FG001|Extension Treatment Period|Adverse Event|1|||
162135006|NCT01163149|585543143|FG002|Extension Treatment Period|Adverse Event|0|||
162135007|NCT01163149|585543141|FG000|Extension Treatment Period|Noncompliance|0|||
162135008|NCT01163149|585543142|FG001|Extension Treatment Period|Noncompliance|0|||
162135009|NCT01163149|585543143|FG002|Extension Treatment Period|Noncompliance|1|||
162135010|NCT01700530|585543144|FG000|Overall Study|Withdrawal by Subject|0|||
162135011|NCT01700530|585543145|FG001|Overall Study|Withdrawal by Subject|3|||
162135012|NCT01700530|585543146|FG002|Overall Study|Withdrawal by Subject|1|||
162135013|NCT00578227|585543148|FG000|Overall Study|Lost to Follow-up|0|||
162135014|NCT00578227|585543149|FG001|Overall Study|Lost to Follow-up|1|||
162135015|NCT00578227|585543150|FG002|Overall Study|Lost to Follow-up|1|||
162135016|NCT00578227|585543148|FG000|Overall Study|Withdrawal by Subject|5|||
162135017|NCT00578227|585543149|FG001|Overall Study|Withdrawal by Subject|1|||
162135018|NCT00578227|585543150|FG002|Overall Study|Withdrawal by Subject|3|||
162135019|NCT00916006|585543154|FG000|Overall Study|Adverse Event|1|||
162135020|NCT00916006|585543155|FG001|Overall Study|Adverse Event|1|||
162135021|NCT00916006|585543154|FG000|Overall Study|Withdrawal by Subject|2|||
162135022|NCT00916006|585543155|FG001|Overall Study|Withdrawal by Subject|5|||
162135023|NCT00916006|585543154|FG000|Overall Study|Protocol Violation|0|||
162135024|NCT00916006|585543155|FG001|Overall Study|Protocol Violation|1|||
162135025|NCT04824131|585543156|FG000|CAB LA Oral Phase|Adverse Event|1|||
162135026|NCT04824131|585543156|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
162135027|NCT04824131|585543156|FG000|Step 3|Withdrawal by Subject|2|||
162135028|NCT04736056|585543158|FG000|Overall Study|Death|0|||
162135029|NCT04736056|585543159|FG001|Overall Study|Death|0|||
162135030|NCT04736056|585543160|FG002|Overall Study|Death|0|||
162135031|NCT04736056|585543161|FG003|Overall Study|Death|1|||
162135032|NCT04736056|585543158|FG000|Overall Study|Lost to Follow-up|1|||
162135033|NCT04736056|585543159|FG001|Overall Study|Lost to Follow-up|0|||
162135034|NCT04736056|585543160|FG002|Overall Study|Lost to Follow-up|1|||
162135035|NCT04736056|585543161|FG003|Overall Study|Lost to Follow-up|1|||
162135036|NCT04736056|585543158|FG000|Overall Study|Withdrawal by Subject|2|||
162135037|NCT04736056|585543159|FG001|Overall Study|Withdrawal by Subject|0|||
162135038|NCT04736056|585543160|FG002|Overall Study|Withdrawal by Subject|0|||
162135039|NCT04736056|585543161|FG003|Overall Study|Withdrawal by Subject|0|||
162135040|NCT04736056|585543158|FG000|Overall Study|Physician Decision|1|||
162135041|NCT04736056|585543159|FG001|Overall Study|Physician Decision|0|||
162135042|NCT04736056|585543160|FG002|Overall Study|Physician Decision|1|||
162135043|NCT04736056|585543161|FG003|Overall Study|Physician Decision|0|||
162135044|NCT04529538|585543162|FG000|Overall Study|Lost to Follow-up|3|||
162135045|NCT04529538|585543163|FG001|Overall Study|Lost to Follow-up|2|||
162135046|NCT04529538|585543164|FG002|Overall Study|Lost to Follow-up|1|||
162135047|NCT04529538|585543165|FG003|Overall Study|Lost to Follow-up|0|||
162135048|NCT04529538|585543166|FG004|Overall Study|Lost to Follow-up|1|||
162135049|NCT04529538|585543167|FG005|Overall Study|Lost to Follow-up|1|||
162135050|NCT04529538|585543168|FG006|Overall Study|Lost to Follow-up|2|||
162242170|NCT02616562|585939081|FG013|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|1|||
162242171|NCT02616562|585939082|FG014|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242172|NCT02616562|585939083|FG015|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242173|NCT02616562|585939084|FG016|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
162242174|NCT02616562|585939068|FG000|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242175|NCT02616562|585939069|FG001|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242176|NCT02616562|585939070|FG002|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242177|NCT02616562|585939071|FG003|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242178|NCT02616562|585939072|FG004|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242179|NCT02616562|585939073|FG005|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242180|NCT02616562|585939074|FG006|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242181|NCT02616562|585939075|FG007|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242182|NCT02616562|585939076|FG008|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242183|NCT02616562|585939077|FG009|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242184|NCT02616562|585939078|FG010|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242185|NCT02616562|585939079|FG011|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242186|NCT02616562|585939080|FG012|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242187|NCT02616562|585939081|FG013|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242188|NCT02616562|585939082|FG014|Long Term Safety Extension (208 Weeks)|Adult height reached|1|||
162242189|NCT02616562|585939083|FG015|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242190|NCT02616562|585939084|FG016|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
162242191|NCT02616562|585939068|FG000|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242192|NCT02616562|585939069|FG001|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242193|NCT02616562|585939070|FG002|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242194|NCT02616562|585939071|FG003|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242195|NCT02616562|585939072|FG004|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242196|NCT02616562|585939073|FG005|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242197|NCT02616562|585939074|FG006|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242198|NCT02616562|585939075|FG007|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242199|NCT02616562|585939076|FG008|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242200|NCT02616562|585939077|FG009|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242201|NCT02616562|585939078|FG010|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242202|NCT02616562|585939079|FG011|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242203|NCT02616562|585939080|FG012|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242204|NCT02616562|585939081|FG013|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242205|NCT02616562|585939082|FG014|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
162242206|NCT02616562|585939083|FG015|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|5|||
162242207|NCT02616562|585939084|FG016|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|16|||
161795933|NCT00819247|584296418|FG000|Overall Study|Other|1|||
161795934|NCT00819247|584296419|FG001|Overall Study|Other|0|||
161795935|NCT00819247|584296420|FG002|Overall Study|Other|0|||
161795936|NCT04471935|584296421|FG000|Overall Study|Withdrawal by Subject|1|||
161795937|NCT04471935|584296421|FG000|Overall Study|Deemed ineligible to participate|1|||
161795938|NCT00948675|584296422|FG000|Overall Study|Lost to Follow-up|1|||
161795939|NCT00948675|584296423|FG001|Overall Study|Lost to Follow-up|0|||
162135051|NCT04529538|585543169|FG007|Overall Study|Lost to Follow-up|0|||
162135052|NCT04529538|585543162|FG000|Overall Study|Not eligible at enrollment|0|||
162135053|NCT04529538|585543163|FG001|Overall Study|Not eligible at enrollment|1|||
162135054|NCT04529538|585543164|FG002|Overall Study|Not eligible at enrollment|2|||
162135055|NCT04529538|585543165|FG003|Overall Study|Not eligible at enrollment|1|||
162135056|NCT04529538|585543166|FG004|Overall Study|Not eligible at enrollment|0|||
162135057|NCT04529538|585543167|FG005|Overall Study|Not eligible at enrollment|0|||
162242208|NCT04697381|585939085|FG000|Extension Period|Adverse Event|0|||
162242209|NCT04697381|585939086|FG001|Extension Period|Adverse Event|0|||
162242210|NCT04697381|585939087|FG002|Extension Period|Adverse Event|3|||
162242211|NCT04697381|585939085|FG000|Extension Period|Physician Decision|0|||
162242212|NCT04697381|585939086|FG001|Extension Period|Physician Decision|0|||
162242213|NCT04697381|585939087|FG002|Extension Period|Physician Decision|2|||
162242214|NCT04697381|585939085|FG000|Extension Period|Other|0|||
162242215|NCT04697381|585939086|FG001|Extension Period|Other|0|||
162242216|NCT04697381|585939087|FG002|Extension Period|Other|1|||
162242217|NCT04837040|585939091|FG000|RC Phase (Up to Week 36)|Withdrawal by Subject|0|||
162242218|NCT04837040|585939092|FG001|RC Phase (Up to Week 36)|Withdrawal by Subject|1|||
162242219|NCT02961218|585939094|FG000|Overall Study|Lost to Follow-up|0|||
162242220|NCT02961218|585939095|FG001|Overall Study|Lost to Follow-up|2|||
162242221|NCT02961218|585939094|FG000|Overall Study|Physician Decision|0|||
162242222|NCT02961218|585939095|FG001|Overall Study|Physician Decision|2|||
162242223|NCT02961218|585939094|FG000|Overall Study|Subject/Guardian Decision|3|||
162242224|NCT02961218|585939095|FG001|Overall Study|Subject/Guardian Decision|1|||
162242225|NCT02486718|585939098|FG000|Enrollment Phase|Death|19|||
162242226|NCT02486718|585939099|FG001|Enrollment Phase|Death|0|||
162242227|NCT02486718|585939100|FG002|Enrollment Phase|Death|0|||
162242228|NCT02486718|585939098|FG000|Enrollment Phase|Symptomatic deterioration|1|||
162242229|NCT02486718|585939099|FG001|Enrollment Phase|Symptomatic deterioration|0|||
162242230|NCT02486718|585939100|FG002|Enrollment Phase|Symptomatic deterioration|0|||
162242231|NCT02486718|585939098|FG000|Enrollment Phase|Withdrawal by Subject|86|||
162242232|NCT02486718|585939099|FG001|Enrollment Phase|Withdrawal by Subject|0|||
162242233|NCT02486718|585939100|FG002|Enrollment Phase|Withdrawal by Subject|0|||
162242234|NCT02486718|585939098|FG000|Enrollment Phase|Protocol Violation|18|||
162242235|NCT02486718|585939099|FG001|Enrollment Phase|Protocol Violation|0|||
162242236|NCT02486718|585939100|FG002|Enrollment Phase|Protocol Violation|0|||
162242237|NCT02486718|585939098|FG000|Enrollment Phase|Physician Decision|18|||
162242238|NCT02486718|585939099|FG001|Enrollment Phase|Physician Decision|0|||
162242239|NCT02486718|585939100|FG002|Enrollment Phase|Physician Decision|0|||
162242240|NCT02486718|585939098|FG000|Enrollment Phase|Reason not provided|41|||
162242241|NCT02486718|585939099|FG001|Enrollment Phase|Reason not provided|0|||
162242242|NCT02486718|585939100|FG002|Enrollment Phase|Reason not provided|0|||
162242243|NCT02486718|585939098|FG000|Enrollment Phase|Disease relapse|54|||
162242244|NCT02486718|585939099|FG001|Enrollment Phase|Disease relapse|0|||
162242245|NCT02486718|585939100|FG002|Enrollment Phase|Disease relapse|0|||
162242246|NCT02486718|585939098|FG000|Enrollment Phase|Lost to Follow-up|4|||
162242247|NCT02486718|585939099|FG001|Enrollment Phase|Lost to Follow-up|0|||
162242248|NCT02486718|585939100|FG002|Enrollment Phase|Lost to Follow-up|0|||
162242249|NCT02486718|585939098|FG000|Enrollment Phase|Adverse Event|34|||
162242250|NCT02486718|585939099|FG001|Enrollment Phase|Adverse Event|0|||
162242251|NCT02486718|585939100|FG002|Enrollment Phase|Adverse Event|0|||
162242252|NCT02486718|585939098|FG000|Randomized Phase|Withdrawal by Subject|0|||
162242253|NCT02486718|585939099|FG001|Randomized Phase|Withdrawal by Subject|44|||
162242254|NCT02486718|585939100|FG002|Randomized Phase|Withdrawal by Subject|47|||
162242255|NCT02486718|585939098|FG000|Randomized Phase|Protocol Violation|0|||
162242256|NCT02486718|585939099|FG001|Randomized Phase|Protocol Violation|2|||
162242257|NCT02486718|585939100|FG002|Randomized Phase|Protocol Violation|0|||
162242258|NCT02486718|585939098|FG000|Randomized Phase|Physician Decision|0|||
162242259|NCT02486718|585939099|FG001|Randomized Phase|Physician Decision|0|||
162242260|NCT02486718|585939100|FG002|Randomized Phase|Physician Decision|3|||
162242261|NCT02486718|585939098|FG000|Randomized Phase|Lost to Follow-up|0|||
162242262|NCT02486718|585939099|FG001|Randomized Phase|Lost to Follow-up|5|||
162242263|NCT02486718|585939100|FG002|Randomized Phase|Lost to Follow-up|11|||
162242264|NCT02486718|585939098|FG000|Randomized Phase|Disease Relapse|0|||
162242265|NCT02486718|585939099|FG001|Randomized Phase|Disease Relapse|1|||
162242266|NCT02486718|585939100|FG002|Randomized Phase|Disease Relapse|0|||
162242267|NCT02486718|585939098|FG000|Randomized Phase|Death|0|||
162242268|NCT02486718|585939099|FG001|Randomized Phase|Death|154|||
162242269|NCT02486718|585939100|FG002|Randomized Phase|Death|155|||
162242270|NCT02486718|585939098|FG000|Randomized Phase|Ongoing|0|||
162242271|NCT02486718|585939099|FG001|Randomized Phase|Ongoing|301|||
162242272|NCT02486718|585939100|FG002|Randomized Phase|Ongoing|282|||
161900637|NCT01325350|584685144|FG003|Overall Study|Pregnancy|0|||
162242273|NCT00602667|585939101|FG000|Overall Study|Still on Therapy|0|||
162242274|NCT00602667|585939102|FG001|Overall Study|Still on Therapy|2|||
162242275|NCT00602667|585939103|FG002|Overall Study|Still on Therapy|2|||
162242276|NCT00602667|585939101|FG000|Overall Study|Death|0|||
162242277|NCT00602667|585939102|FG001|Overall Study|Death|1|||
162242278|NCT00602667|585939103|FG002|Overall Study|Death|1|||
162242279|NCT00602667|585939101|FG000|Overall Study|Family request|3|||
162242280|NCT00602667|585939102|FG001|Overall Study|Family request|25|||
162242281|NCT00602667|585939103|FG002|Overall Study|Family request|6|||
162242282|NCT00602667|585939101|FG000|Overall Study|Excessive toxicity|1|||
162242283|NCT00602667|585939102|FG001|Overall Study|Excessive toxicity|1|||
162242284|NCT00602667|585939103|FG002|Overall Study|Excessive toxicity|0|||
162242285|NCT00602667|585939101|FG000|Overall Study|Second malignancy|0|||
161900638|NCT01325350|584685145|FG004|Overall Study|Pregnancy|1|||
161900639|NCT01325350|584685141|FG000|Overall Study|Lost to Follow-up|1|||
161900640|NCT01325350|584685142|FG001|Overall Study|Lost to Follow-up|0|||
161900641|NCT01325350|584685143|FG002|Overall Study|Lost to Follow-up|5|||
161900642|NCT01325350|584685144|FG003|Overall Study|Lost to Follow-up|1|||
161900643|NCT01325350|584685145|FG004|Overall Study|Lost to Follow-up|5|||
161900644|NCT01325350|584685141|FG000|Overall Study|Personal Reasons|2|||
161900645|NCT01325350|584685142|FG001|Overall Study|Personal Reasons|1|||
161900646|NCT01325350|584685143|FG002|Overall Study|Personal Reasons|6|||
161900647|NCT01325350|584685144|FG003|Overall Study|Personal Reasons|5|||
161900648|NCT01325350|584685145|FG004|Overall Study|Personal Reasons|3|||
161900649|NCT01325350|584685141|FG000|Overall Study|Protocol Violation|0|||
161900650|NCT01325350|584685142|FG001|Overall Study|Protocol Violation|0|||
161900651|NCT01325350|584685143|FG002|Overall Study|Protocol Violation|0|||
161900652|NCT01325350|584685144|FG003|Overall Study|Protocol Violation|1|||
161900653|NCT01325350|584685145|FG004|Overall Study|Protocol Violation|0|||
162135058|NCT04529538|585543168|FG006|Overall Study|Not eligible at enrollment|0|||
162135059|NCT04529538|585543169|FG007|Overall Study|Not eligible at enrollment|1|||
162135060|NCT04529538|585543162|FG000|Overall Study|Withdrawal by Subject|0|||
162135061|NCT04529538|585543163|FG001|Overall Study|Withdrawal by Subject|1|||
162135062|NCT04529538|585543164|FG002|Overall Study|Withdrawal by Subject|1|||
162135063|NCT04529538|585543165|FG003|Overall Study|Withdrawal by Subject|2|||
162135064|NCT04529538|585543166|FG004|Overall Study|Withdrawal by Subject|0|||
162135065|NCT04529538|585543167|FG005|Overall Study|Withdrawal by Subject|2|||
162135066|NCT04529538|585543168|FG006|Overall Study|Withdrawal by Subject|3|||
162135067|NCT04529538|585543169|FG007|Overall Study|Withdrawal by Subject|0|||
162135068|NCT04529538|585543162|FG000|Overall Study|Other|0|||
162135069|NCT04529538|585543163|FG001|Overall Study|Other|1|||
162135070|NCT04529538|585543164|FG002|Overall Study|Other|0|||
162135071|NCT04529538|585543165|FG003|Overall Study|Other|0|||
162135072|NCT04529538|585543166|FG004|Overall Study|Other|0|||
162135073|NCT04529538|585543167|FG005|Overall Study|Other|0|||
162135074|NCT04529538|585543168|FG006|Overall Study|Other|0|||
162135075|NCT04529538|585543169|FG007|Overall Study|Other|0|||
162135076|NCT04529538|585543162|FG000|Overall Study|Adverse Event|0|||
162135077|NCT04529538|585543163|FG001|Overall Study|Adverse Event|0|||
162135078|NCT04529538|585543164|FG002|Overall Study|Adverse Event|0|||
162135079|NCT04529538|585543165|FG003|Overall Study|Adverse Event|1|||
162135080|NCT04529538|585543166|FG004|Overall Study|Adverse Event|0|||
162135081|NCT04529538|585543167|FG005|Overall Study|Adverse Event|0|||
162135082|NCT04529538|585543168|FG006|Overall Study|Adverse Event|0|||
162135083|NCT04529538|585543169|FG007|Overall Study|Adverse Event|0|||
162135084|NCT04529538|585543162|FG000|Overall Study|Protocol Deviation|0|||
162135085|NCT04529538|585543163|FG001|Overall Study|Protocol Deviation|0|||
162135086|NCT04529538|585543164|FG002|Overall Study|Protocol Deviation|0|||
162135087|NCT04529538|585543165|FG003|Overall Study|Protocol Deviation|1|||
162135088|NCT04529538|585543166|FG004|Overall Study|Protocol Deviation|0|||
162135089|NCT04529538|585543167|FG005|Overall Study|Protocol Deviation|0|||
162135090|NCT04529538|585543168|FG006|Overall Study|Protocol Deviation|0|||
162135091|NCT04529538|585543169|FG007|Overall Study|Protocol Deviation|0|||
162135092|NCT04529538|585543162|FG000|Overall Study|Physician Decision|0|||
162135093|NCT04529538|585543163|FG001|Overall Study|Physician Decision|0|||
162135094|NCT04529538|585543164|FG002|Overall Study|Physician Decision|0|||
162135095|NCT04529538|585543165|FG003|Overall Study|Physician Decision|0|||
162135096|NCT04529538|585543166|FG004|Overall Study|Physician Decision|0|||
162135097|NCT04529538|585543167|FG005|Overall Study|Physician Decision|1|||
162135098|NCT04529538|585543168|FG006|Overall Study|Physician Decision|0|||
162135099|NCT04529538|585543169|FG007|Overall Study|Physician Decision|1|||
162135100|NCT02223182|585543171|FG000|Double-Blind Period|Adverse Event|0|||
162135101|NCT02223182|585543172|FG001|Double-Blind Period|Adverse Event|2|||
162135102|NCT02223182|585543173|FG002|Double-Blind Period|Adverse Event|1|||
162135103|NCT02223182|585543174|FG003|Double-Blind Period|Adverse Event|0|||
162135104|NCT02223182|585543171|FG000|Double-Blind Period|Withdrawal by Subject|1|||
162135105|NCT02223182|585543172|FG001|Double-Blind Period|Withdrawal by Subject|1|||
162135106|NCT02223182|585543173|FG002|Double-Blind Period|Withdrawal by Subject|1|||
162135107|NCT02223182|585543174|FG003|Double-Blind Period|Withdrawal by Subject|0|||
162135108|NCT02223182|585543171|FG000|Double-Blind Period|Lost to Follow-up|0|||
162135109|NCT02223182|585543172|FG001|Double-Blind Period|Lost to Follow-up|1|||
162135110|NCT02223182|585543173|FG002|Double-Blind Period|Lost to Follow-up|0|||
162135111|NCT02223182|585543174|FG003|Double-Blind Period|Lost to Follow-up|0|||
161900654|NCT01325350|584685141|FG000|Overall Study|Withdrawal by Subject|0|||
161900655|NCT01325350|584685142|FG001|Overall Study|Withdrawal by Subject|0|||
162135112|NCT02223182|585543171|FG000|Double-Blind Period|Non Compliance|0|||
162135113|NCT02223182|585543172|FG001|Double-Blind Period|Non Compliance|0|||
162135114|NCT02223182|585543173|FG002|Double-Blind Period|Non Compliance|0|||
162135115|NCT02223182|585543174|FG003|Double-Blind Period|Non Compliance|1|||
161900656|NCT01325350|584685143|FG002|Overall Study|Withdrawal by Subject|1|||
162135116|NCT02223182|585543171|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
162135117|NCT02223182|585543172|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
162242286|NCT00602667|585939102|FG001|Overall Study|Second malignancy|1|||
162242287|NCT00602667|585939103|FG002|Overall Study|Second malignancy|0|||
162242288|NCT00602667|585939101|FG000|Overall Study|Physician Decision|2|||
162242289|NCT00602667|585939102|FG001|Overall Study|Physician Decision|3|||
162242290|NCT00602667|585939103|FG002|Overall Study|Physician Decision|8|||
162242291|NCT00602667|585939101|FG000|Overall Study|Progressive disease|13|||
162242292|NCT00602667|585939102|FG001|Overall Study|Progressive disease|48|||
162242293|NCT00602667|585939103|FG002|Overall Study|Progressive disease|45|||
162242294|NCT00602667|585939101|FG000|Overall Study|Progressive disease prior to therapy|0|||
162242295|NCT00602667|585939102|FG001|Overall Study|Progressive disease prior to therapy|0|||
162242296|NCT00602667|585939103|FG002|Overall Study|Progressive disease prior to therapy|1|||
162242297|NCT02975700|585939107|FG000|Overall Study|Adverse Event|1|||
162242298|NCT02975700|585939107|FG000|Overall Study|Progressive disease|3|||
162242299|NCT02975700|585939107|FG000|Overall Study|Failed screening criteria|2|||
162242300|NCT05702918|585939108|FG000|Overall Study|Withdrawal by Subject|0|||
162242301|NCT05702918|585939109|FG001|Overall Study|Withdrawal by Subject|2|||
162242302|NCT05702918|585939108|FG000|Overall Study|Lost to Follow-up|0|||
162242303|NCT05702918|585939109|FG001|Overall Study|Lost to Follow-up|2|||
162242304|NCT05702918|585939108|FG000|Overall Study|Unrelated injury|2|||
162242305|NCT05702918|585939109|FG001|Overall Study|Unrelated injury|0|||
162242306|NCT05270265|585939112|FG000|Overall Study|Lost to Follow-up|0|||
162242307|NCT05270265|585939113|FG001|Overall Study|Lost to Follow-up|1|||
162242308|NCT05270265|585939114|FG002|Overall Study|Lost to Follow-up|0|||
162242309|NCT04765059|585939115|FG000|Overall Study|Failure to meet randomization criteria|1|||
162242310|NCT04765059|585939116|FG001|Overall Study|Failure to meet randomization criteria|0|||
162242311|NCT04765059|585939115|FG000|Overall Study|Withdrawal by Subject|1|||
162242312|NCT04765059|585939116|FG001|Overall Study|Withdrawal by Subject|4|||
162242313|NCT04765059|585939115|FG000|Overall Study|Lost to Follow-up|1|||
162242314|NCT04765059|585939116|FG001|Overall Study|Lost to Follow-up|1|||
162242315|NCT04765059|585939115|FG000|Overall Study|Death|25|||
162242316|NCT04765059|585939116|FG001|Overall Study|Death|28|||
162242317|NCT04765059|585939115|FG000|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|21|||
162242318|NCT04765059|585939116|FG001|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|16|||
162242319|NCT04088331|585939118|FG000|Overall Study|Lost to Follow-up|3|||
162242320|NCT04088331|585939118|FG000|Overall Study|Withdrawal by Subject|7|||
162242321|NCT04088331|585939118|FG000|Overall Study|Adverse Event|4|||
162242322|NCT03500172|585939125|FG000|Period 1: Baseline Randomization|Death|0|||
162242323|NCT03500172|585939126|FG001|Period 1: Baseline Randomization|Death|0|||
162242324|NCT03500172|585939127|FG002|Period 1: Baseline Randomization|Death|0|||
162242325|NCT03500172|585939128|FG003|Period 1: Baseline Randomization|Death|0|||
162242326|NCT03500172|585939129|FG004|Period 1: Baseline Randomization|Death|0|||
162242327|NCT03500172|585939130|FG005|Period 1: Baseline Randomization|Death|0|||
162242328|NCT03500172|585939131|FG006|Period 1: Baseline Randomization|Death|0|||
162242329|NCT03500172|585939132|FG007|Period 1: Baseline Randomization|Death|0|||
161795940|NCT01654380|584296427|FG000|Part B, Period 1|Physician Decision|0|||
161795941|NCT01654380|584296428|FG001|Part B, Period 1|Physician Decision|0|||
161795942|NCT01654380|584296429|FG002|Part B, Period 1|Physician Decision|1|||
161795943|NCT01654380|584296430|FG003|Part B, Period 1|Physician Decision|0|||
161795944|NCT06331156|584296431|FG000|Overall Study|Adverse Event|1|||
161795945|NCT06331156|584296432|FG001|Overall Study|Adverse Event|0|||
161795946|NCT06331156|584296431|FG000|Overall Study|Lost to Follow-up|1|||
161795947|NCT06331156|584296432|FG001|Overall Study|Lost to Follow-up|0|||
161795948|NCT06331156|584296431|FG000|Overall Study|Migrated / Moved from the study area|4|||
161795949|NCT06331156|584296432|FG001|Overall Study|Migrated / Moved from the study area|3|||
161795950|NCT06331156|584296431|FG000|Overall Study|Other|7|||
161795951|NCT06331156|584296432|FG001|Overall Study|Other|0|||
161795952|NCT06331156|584296431|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
161795953|NCT06331156|584296432|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
161795954|NCT05845645|584296433|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795955|NCT05845645|584296434|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795956|NCT05845645|584296435|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
161795957|NCT05845645|584296436|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795958|NCT05845645|584296437|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795959|NCT05845645|584296438|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
162242330|NCT03500172|585939133|FG008|Period 1: Baseline Randomization|Death|0|||
162242331|NCT03500172|585939134|FG009|Period 1: Baseline Randomization|Death|2|||
162242332|NCT03500172|585939135|FG010|Period 1: Baseline Randomization|Death|0|||
162242333|NCT03500172|585939125|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
162242334|NCT03500172|585939126|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
162242335|NCT03500172|585939127|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
162242336|NCT03500172|585939128|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
162242337|NCT03500172|585939129|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
162242338|NCT03500172|585939130|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
162242339|NCT03500172|585939131|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
162242340|NCT03500172|585939132|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
162242341|NCT03500172|585939133|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
162242342|NCT03500172|585939134|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
162242343|NCT03500172|585939135|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
162242344|NCT03500172|585939125|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
162242345|NCT03500172|585939126|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
162242346|NCT03500172|585939127|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
162242347|NCT03500172|585939128|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
162242348|NCT03500172|585939129|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
162242349|NCT03500172|585939130|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
162242350|NCT03500172|585939131|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
162242351|NCT03500172|585939132|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
162242352|NCT03500172|585939133|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
162242353|NCT03500172|585939134|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
162242354|NCT03500172|585939135|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
162242355|NCT03500172|585939125|FG000|Period 2: Re-Randomization|Death|0|||
162242356|NCT03500172|585939126|FG001|Period 2: Re-Randomization|Death|0|||
162242357|NCT03500172|585939127|FG002|Period 2: Re-Randomization|Death|0|||
162242358|NCT03500172|585939128|FG003|Period 2: Re-Randomization|Death|4|||
162242359|NCT03500172|585939129|FG004|Period 2: Re-Randomization|Death|2|||
162242360|NCT03500172|585939130|FG005|Period 2: Re-Randomization|Death|0|||
162242361|NCT03500172|585939131|FG006|Period 2: Re-Randomization|Death|5|||
162242362|NCT03500172|585939132|FG007|Period 2: Re-Randomization|Death|2|||
162242363|NCT03500172|585939133|FG008|Period 2: Re-Randomization|Death|0|||
162242364|NCT03500172|585939134|FG009|Period 2: Re-Randomization|Death|0|||
162242365|NCT03500172|585939135|FG010|Period 2: Re-Randomization|Death|0|||
162242366|NCT04300309|585939136|FG000|Overall Study|Lost to Follow-up|1|||
162242367|NCT04300309|585939137|FG001|Overall Study|Lost to Follow-up|0|||
162242368|NCT03171545|585939140|FG000|Baseline|Withdrawal by Subject|0|||
162242369|NCT03171545|585939141|FG001|Baseline|Withdrawal by Subject|0|||
162242370|NCT03171545|585939142|FG002|Baseline|Withdrawal by Subject|1|||
162242371|NCT03171545|585939143|FG003|Baseline|Withdrawal by Subject|2|||
162242372|NCT03171545|585939140|FG000|Baseline|Transferred out of clinic|4|||
162242373|NCT03171545|585939141|FG001|Baseline|Transferred out of clinic|0|||
162242374|NCT03171545|585939142|FG002|Baseline|Transferred out of clinic|2|||
162242375|NCT03171545|585939143|FG003|Baseline|Transferred out of clinic|0|||
162242376|NCT03171545|585939140|FG000|Baseline|Death|1|||
162242377|NCT03171545|585939141|FG001|Baseline|Death|2|||
162242378|NCT03171545|585939142|FG002|Baseline|Death|1|||
162242379|NCT03171545|585939143|FG003|Baseline|Death|5|||
162242380|NCT03171545|585939140|FG000|Baseline|Recovered renal function|0|||
162242381|NCT03171545|585939141|FG001|Baseline|Recovered renal function|0|||
162242382|NCT03171545|585939142|FG002|Baseline|Recovered renal function|1|||
162242383|NCT03171545|585939143|FG003|Baseline|Recovered renal function|0|||
162242384|NCT03171545|585939140|FG000|Baseline|Received transplant|0|||
162242385|NCT03171545|585939141|FG001|Baseline|Received transplant|0|||
162242386|NCT03171545|585939142|FG002|Baseline|Received transplant|1|||
162242387|NCT03171545|585939143|FG003|Baseline|Received transplant|0|||
162242388|NCT03171545|585939140|FG000|Baseline|No longer receiving in-center hemodialysis|0|||
162242389|NCT03171545|585939141|FG001|Baseline|No longer receiving in-center hemodialysis|2|||
162242390|NCT03171545|585939142|FG002|Baseline|No longer receiving in-center hemodialysis|3|||
162242391|NCT03171545|585939143|FG003|Baseline|No longer receiving in-center hemodialysis|0|||
162242392|NCT03171545|585939140|FG000|Intervention|Withdrawal by Subject|2|||
162242393|NCT03171545|585939141|FG001|Intervention|Withdrawal by Subject|0|||
162242394|NCT03171545|585939142|FG002|Intervention|Withdrawal by Subject|0|||
162242395|NCT03171545|585939143|FG003|Intervention|Withdrawal by Subject|4|||
162242396|NCT03171545|585939140|FG000|Intervention|Transferred out of clinic|12|||
162242397|NCT03171545|585939141|FG001|Intervention|Transferred out of clinic|9|||
162242398|NCT03171545|585939142|FG002|Intervention|Transferred out of clinic|17|||
162242399|NCT03171545|585939143|FG003|Intervention|Transferred out of clinic|9|||
162242400|NCT03171545|585939140|FG000|Intervention|Death|26|||
162242401|NCT03171545|585939141|FG001|Intervention|Death|16|||
162242402|NCT03171545|585939142|FG002|Intervention|Death|29|||
162242403|NCT03171545|585939143|FG003|Intervention|Death|14|||
162242404|NCT03171545|585939140|FG000|Intervention|Received transplant|7|||
162242405|NCT03171545|585939141|FG001|Intervention|Received transplant|5|||
162242406|NCT03171545|585939142|FG002|Intervention|Received transplant|3|||
162242407|NCT03171545|585939143|FG003|Intervention|Received transplant|6|||
162242408|NCT03171545|585939140|FG000|Intervention|No longer receiving in-center hemodialysis|7|||
162242409|NCT03171545|585939141|FG001|Intervention|No longer receiving in-center hemodialysis|4|||
162242410|NCT03171545|585939142|FG002|Intervention|No longer receiving in-center hemodialysis|4|||
162242411|NCT03171545|585939143|FG003|Intervention|No longer receiving in-center hemodialysis|6|||
162242412|NCT03171545|585939140|FG000|Intervention|Lost to Follow-up|0|||
162010823|NCT00389610|585096013|FG001|Overall Study|Death|1|||
161795960|NCT05845645|584296439|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795961|NCT05845645|584296440|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795962|NCT05845645|584296441|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795963|NCT05845645|584296442|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795964|NCT05845645|584296443|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795965|NCT05845645|584296444|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161795966|NCT05845645|584296433|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795967|NCT05845645|584296434|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795968|NCT05845645|584296435|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795969|NCT05845645|584296436|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795970|NCT05845645|584296437|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795971|NCT05845645|584296438|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795972|NCT05845645|584296439|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795973|NCT05845645|584296440|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795974|NCT05845645|584296441|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795975|NCT05845645|584296442|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
161795976|NCT05845645|584296443|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795977|NCT05845645|584296444|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
161795978|NCT01199601|584296450|FG000|Overall Study|Lost to Follow-up|47|||
161795979|NCT01199601|584296451|FG001|Overall Study|Lost to Follow-up|66|||
161795980|NCT01199601|584296450|FG000|Overall Study|Withdrawal by Subject|15|||
161795981|NCT01199601|584296451|FG001|Overall Study|Withdrawal by Subject|3|||
161795982|NCT01199601|584296450|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
161795983|NCT01199601|584296451|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
161795984|NCT00278512|584296452|FG000|Overall Study|Death|1|||
161795985|NCT00278512|584296453|FG001|Overall Study|Death|0|||
161795986|NCT01620177|584296454|FG000|Overall Study|Failure at Screening Visit|43|||
161795987|NCT01620177|584296454|FG000|Overall Study|Withdrawal by Subject|26|||
161795988|NCT01620177|584296454|FG000|Overall Study|Lost to Follow-up|7|||
161795989|NCT01620177|584296454|FG000|Overall Study|Physician Decision|2|||
161795990|NCT01620177|584296454|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
161795991|NCT00423800|584296455|FG000|Overall Study|Protocol Violation|0|||
161795992|NCT00423800|584296456|FG001|Overall Study|Protocol Violation|1|||
161795993|NCT00814320|584296457|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
161795994|NCT00814320|584296458|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
161795995|NCT00814320|584296457|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
161795996|NCT00814320|584296458|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
161795997|NCT00814320|584296457|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
161795998|NCT00814320|584296458|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
161795999|NCT00814320|584296457|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
161796000|NCT00814320|584296458|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
161796001|NCT00814320|584296457|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
161796002|NCT00814320|584296458|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
161796003|NCT00814320|584296457|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
161796004|NCT00814320|584296458|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
161796005|NCT00814320|584296457|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
161796006|NCT00814320|584296458|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
161796007|NCT00814320|584296457|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
161796008|NCT00814320|584296458|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
161796009|NCT00814320|584296457|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
161796010|NCT00814320|584296458|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
161796011|NCT00814320|584296457|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
161796012|NCT00814320|584296458|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
161796013|NCT00619385|584296459|FG000|Overall Study|Adverse Event|0|||
161796014|NCT00619385|584296460|FG001|Overall Study|Adverse Event|0|||
161796015|NCT00619385|584296461|FG002|Overall Study|Adverse Event|3|||
161796016|NCT00619385|584296459|FG000|Overall Study|Other|1|||
161796017|NCT00619385|584296460|FG001|Overall Study|Other|2|||
161796018|NCT00619385|584296461|FG002|Overall Study|Other|1|||
161796019|NCT02041702|584296466|FG000|Overall Study|Lost to Follow-up|1|||
161796020|NCT02041702|584296467|FG001|Overall Study|Lost to Follow-up|6|||
161796021|NCT02041702|584296466|FG000|Overall Study|Death|4|||
161796022|NCT02041702|584296467|FG001|Overall Study|Death|0|||
161796023|NCT02041702|584296466|FG000|Overall Study|Withdrawal by Subject|4|||
161796024|NCT02041702|584296467|FG001|Overall Study|Withdrawal by Subject|3|||
161796025|NCT02041702|584296466|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
161796026|NCT02041702|584296467|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
161796027|NCT02041702|584296466|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
161900657|NCT01325350|584685144|FG003|Overall Study|Withdrawal by Subject|1|||
161900658|NCT01325350|584685145|FG004|Overall Study|Withdrawal by Subject|0|||
162242413|NCT03171545|585939141|FG001|Intervention|Lost to Follow-up|1|||
162242414|NCT03171545|585939142|FG002|Intervention|Lost to Follow-up|0|||
162242415|NCT03171545|585939143|FG003|Intervention|Lost to Follow-up|0|||
162242416|NCT03171545|585939140|FG000|Follow up|Withdrawal by Subject|1|||
162242417|NCT03171545|585939141|FG001|Follow up|Withdrawal by Subject|1|||
162242418|NCT03171545|585939142|FG002|Follow up|Withdrawal by Subject|0|||
162242419|NCT03171545|585939143|FG003|Follow up|Withdrawal by Subject|0|||
162242420|NCT03171545|585939140|FG000|Follow up|Transferred out of clinic|4|||
162242421|NCT03171545|585939141|FG001|Follow up|Transferred out of clinic|4|||
162242422|NCT03171545|585939142|FG002|Follow up|Transferred out of clinic|12|||
162242423|NCT03171545|585939143|FG003|Follow up|Transferred out of clinic|7|||
162242424|NCT03171545|585939140|FG000|Follow up|Death|18|||
162242425|NCT03171545|585939141|FG001|Follow up|Death|12|||
162242426|NCT03171545|585939142|FG002|Follow up|Death|5|||
162242427|NCT03171545|585939143|FG003|Follow up|Death|8|||
162242428|NCT03171545|585939140|FG000|Follow up|Received transplant|4|||
162242429|NCT03171545|585939141|FG001|Follow up|Received transplant|1|||
162242430|NCT03171545|585939142|FG002|Follow up|Received transplant|0|||
162242431|NCT03171545|585939143|FG003|Follow up|Received transplant|1|||
162242432|NCT03171545|585939140|FG000|Follow up|No longer receiving in-center hemodialysis|4|||
162242433|NCT03171545|585939141|FG001|Follow up|No longer receiving in-center hemodialysis|2|||
162242434|NCT03171545|585939142|FG002|Follow up|No longer receiving in-center hemodialysis|1|||
162242435|NCT03171545|585939143|FG003|Follow up|No longer receiving in-center hemodialysis|0|||
162242436|NCT03171545|585939140|FG000|Follow up|Lost to Follow-up|1|||
162242437|NCT03171545|585939141|FG001|Follow up|Lost to Follow-up|2|||
162242438|NCT03171545|585939142|FG002|Follow up|Lost to Follow-up|3|||
162242439|NCT03171545|585939143|FG003|Follow up|Lost to Follow-up|1|||
162242440|NCT04770779|585939144|FG000|Overall Study|Randomized, never treated|0|||
162242441|NCT04770779|585939145|FG001|Overall Study|Randomized, never treated|1|||
162242442|NCT04770779|585939144|FG000|Overall Study|Adverse Event|9|||
162242443|NCT04770779|585939145|FG001|Overall Study|Adverse Event|1|||
162242444|NCT04770779|585939144|FG000|Overall Study|Withdrawal by Subject|7|||
162242445|NCT04770779|585939145|FG001|Overall Study|Withdrawal by Subject|1|||
162242446|NCT04770779|585939144|FG000|Overall Study|Pregnancy|0|||
162242447|NCT04770779|585939145|FG001|Overall Study|Pregnancy|1|||
162242448|NCT03692052|585939146|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
162242449|NCT03692052|585939146|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
162242450|NCT03692052|585939146|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
162242451|NCT03692052|585939146|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
162242452|NCT02656706|585939151|FG000|Overall Study|Insurance Denial|1|||
162242453|NCT02441686|585939154|FG000|Induction|Adverse Event|4|||
162242454|NCT02441686|585939154|FG000|Induction|Complicating disease|1|||
162242455|NCT02441686|585939154|FG000|Induction|Physician Decision|1|||
162242456|NCT02441686|585939154|FG000|Induction|Withdrawal by Subject|1|||
162242457|NCT02441686|585939154|FG000|Induction|Did not receive treatment|1|||
162242458|NCT02441686|585939154|FG000|Maintenance|Remaining on Treatment|23|||
162242459|NCT02441686|585939154|FG000|Maintenance|Physician Decision|1|||
162242460|NCT02441686|585939154|FG000|Maintenance|Adverse Event|3|||
162242461|NCT02441686|585939154|FG000|Maintenance|Progressive Disease|10|||
162242462|NCT02441686|585939154|FG000|Maintenance|Withdrawal by Subject|1|||
162242463|NCT02296684|585939155|FG000|Overall Study|Withdrawal by Subject|0|||
162242464|NCT02296684|585939156|FG001|Overall Study|Withdrawal by Subject|1|||
162242465|NCT02296684|585939157|FG002|Overall Study|Withdrawal by Subject|1|||
162242466|NCT02296684|585939155|FG000|Overall Study|Death|2|||
162242467|NCT02296684|585939156|FG001|Overall Study|Death|0|||
162242468|NCT02296684|585939157|FG002|Overall Study|Death|0|||
162242469|NCT04647526|585939158|FG000|Overall Study|Death|13|||
162242470|NCT04647526|585939159|FG001|Overall Study|Death|76|||
162242471|NCT04647526|585939160|FG002|Overall Study|Death|32|||
162242472|NCT04647526|585939161|FG003|Overall Study|Death|0|||
162242473|NCT04647526|585939158|FG000|Overall Study|Lost to Follow-up|1|||
162242474|NCT04647526|585939159|FG001|Overall Study|Lost to Follow-up|0|||
162242475|NCT04647526|585939160|FG002|Overall Study|Lost to Follow-up|1|||
162242476|NCT04647526|585939161|FG003|Overall Study|Lost to Follow-up|0|||
162242477|NCT04647526|585939158|FG000|Overall Study|Withdrawal by Subject|4|||
162242478|NCT04647526|585939159|FG001|Overall Study|Withdrawal by Subject|15|||
162242479|NCT04647526|585939160|FG002|Overall Study|Withdrawal by Subject|8|||
162242480|NCT04647526|585939161|FG003|Overall Study|Withdrawal by Subject|1|||
162242481|NCT04647526|585939158|FG000|Overall Study|Incorrect enrollment|0|||
162242482|NCT04647526|585939159|FG001|Overall Study|Incorrect enrollment|1|||
162242483|NCT04647526|585939160|FG002|Overall Study|Incorrect enrollment|1|||
162242484|NCT04647526|585939161|FG003|Overall Study|Incorrect enrollment|0|||
162242485|NCT04647526|585939158|FG000|Overall Study|Physician Decision|0|||
162242486|NCT04647526|585939159|FG001|Overall Study|Physician Decision|1|||
162242487|NCT04647526|585939160|FG002|Overall Study|Physician Decision|1|||
162242488|NCT04647526|585939161|FG003|Overall Study|Physician Decision|0|||
162242489|NCT04647526|585939158|FG000|Overall Study|Ongoing|9|||
162242490|NCT04647526|585939159|FG001|Overall Study|Ongoing|183|||
162242491|NCT04647526|585939160|FG002|Overall Study|Ongoing|93|||
162242492|NCT04647526|585939161|FG003|Overall Study|Ongoing|15|||
162242493|NCT03298451|585939162|FG000|Overall Study|Death|275|||
162242494|NCT03298451|585939163|FG001|Overall Study|Death|260|||
162242495|NCT03298451|585939164|FG002|Overall Study|Death|122|||
162242496|NCT03298451|585939165|FG003|Overall Study|Death|280|||
162242497|NCT03298451|585939162|FG000|Overall Study|Lost to Follow-up|1|||
162242498|NCT03298451|585939163|FG001|Overall Study|Lost to Follow-up|1|||
162242499|NCT03298451|585939164|FG002|Overall Study|Lost to Follow-up|0|||
162242500|NCT03298451|585939165|FG003|Overall Study|Lost to Follow-up|7|||
162242501|NCT03298451|585939162|FG000|Overall Study|Withdrawal by Subject|9|||
162242502|NCT03298451|585939163|FG001|Overall Study|Withdrawal by Subject|7|||
162242503|NCT03298451|585939164|FG002|Overall Study|Withdrawal by Subject|1|||
162242504|NCT03298451|585939165|FG003|Overall Study|Withdrawal by Subject|20|||
162242505|NCT04150029|585939166|FG000|Overall Study|Disease Relapse|0|||
162242506|NCT04150029|585939167|FG001|Overall Study|Disease Relapse|18|||
162242507|NCT04150029|585939166|FG000|Overall Study|Progressive Disease|2|||
162242508|NCT04150029|585939167|FG001|Overall Study|Progressive Disease|16|||
162242509|NCT04150029|585939166|FG000|Overall Study|Adverse Event|1|||
162242510|NCT04150029|585939167|FG001|Overall Study|Adverse Event|11|||
162242511|NCT04150029|585939166|FG000|Overall Study|Physician Decision|0|||
162242512|NCT04150029|585939167|FG001|Overall Study|Physician Decision|10|||
162242513|NCT04150029|585939166|FG000|Overall Study|Study Terminated by Sponsor|1|||
162242514|NCT04150029|585939167|FG001|Overall Study|Study Terminated by Sponsor|10|||
162242515|NCT04150029|585939166|FG000|Overall Study|Death|0|||
162242516|NCT04150029|585939167|FG001|Overall Study|Death|8|||
162242517|NCT04150029|585939166|FG000|Overall Study|Participant Decision|0|||
162242518|NCT04150029|585939167|FG001|Overall Study|Participant Decision|7|||
162242519|NCT04150029|585939166|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
162242520|NCT04150029|585939167|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
162242521|NCT05076266|585939168|FG000|Overall Study|Survey not complete - Participant refusal|2|||
162242522|NCT05076266|585939169|FG001|Overall Study|Survey not complete - Participant refusal|0|||
162242523|NCT05169567|585939174|FG000|Overall Study|On study treatment|116|||
162242524|NCT05169567|585939175|FG001|Overall Study|On study treatment|128|||
162242525|NCT05169567|585939174|FG000|Overall Study|Lost to Follow-up|1|||
162242526|NCT05169567|585939175|FG001|Overall Study|Lost to Follow-up|0|||
162242527|NCT05169567|585939174|FG000|Overall Study|Withdrawal by Subject|25|||
162242528|NCT05169567|585939175|FG001|Overall Study|Withdrawal by Subject|21|||
162242529|NCT04409457|585939178|FG000|Screening Prior to Randomization|Screening fail prior to randomization|16|||
162242530|NCT04409457|585939179|FG001|Screening Prior to Randomization|Screening fail prior to randomization|13|||
162242531|NCT04409457|585939180|FG002|Screening Prior to Randomization|Screening fail prior to randomization|0|||
162242532|NCT04409457|585939181|FG003|Screening Prior to Randomization|Screening fail prior to randomization|0|||
162242533|NCT04409457|585939182|FG004|Screening Prior to Randomization|Screening fail prior to randomization|0|||
162242534|NCT04409457|585939183|FG005|Screening Prior to Randomization|Screening fail prior to randomization|0|||
162242535|NCT04409457|585939178|FG000|Screening Prior to Randomization|Withdrawal by Subject|2|||
162242536|NCT04409457|585939179|FG001|Screening Prior to Randomization|Withdrawal by Subject|1|||
162242537|NCT04409457|585939180|FG002|Screening Prior to Randomization|Withdrawal by Subject|0|||
162242538|NCT04409457|585939181|FG003|Screening Prior to Randomization|Withdrawal by Subject|0|||
162242539|NCT04409457|585939182|FG004|Screening Prior to Randomization|Withdrawal by Subject|0|||
162242540|NCT04409457|585939183|FG005|Screening Prior to Randomization|Withdrawal by Subject|0|||
162242541|NCT04409457|585939178|FG000|Randomization|Withdrawal by Subject|0|||
162242542|NCT04409457|585939179|FG001|Randomization|Withdrawal by Subject|0|||
162242543|NCT04409457|585939180|FG002|Randomization|Withdrawal by Subject|0|||
162242544|NCT04409457|585939181|FG003|Randomization|Withdrawal by Subject|0|||
162242545|NCT04409457|585939182|FG004|Randomization|Withdrawal by Subject|1|||
162242546|NCT04409457|585939183|FG005|Randomization|Withdrawal by Subject|0|||
162242547|NCT04409457|585939178|FG000|Randomization|Incidental MRI finding at scan 1|0|||
162242548|NCT04409457|585939179|FG001|Randomization|Incidental MRI finding at scan 1|0|||
162242549|NCT04409457|585939180|FG002|Randomization|Incidental MRI finding at scan 1|0|||
162242550|NCT04409457|585939181|FG003|Randomization|Incidental MRI finding at scan 1|1|||
162242551|NCT04409457|585939182|FG004|Randomization|Incidental MRI finding at scan 1|0|||
162242552|NCT04409457|585939183|FG005|Randomization|Incidental MRI finding at scan 1|1|||
162242553|NCT04409457|585939178|FG000|Randomization|Technical/equipment error at scan 1|0|||
162242554|NCT04409457|585939179|FG001|Randomization|Technical/equipment error at scan 1|0|||
162242555|NCT04409457|585939180|FG002|Randomization|Technical/equipment error at scan 1|0|||
162242556|NCT04409457|585939181|FG003|Randomization|Technical/equipment error at scan 1|0|||
162242557|NCT04409457|585939182|FG004|Randomization|Technical/equipment error at scan 1|0|||
162242558|NCT04409457|585939183|FG005|Randomization|Technical/equipment error at scan 1|1|||
162242559|NCT04865770|585939184|FG000|Overall Study|Withdrawal by Subject|3|||
162242560|NCT04865770|585939185|FG001|Overall Study|Withdrawal by Subject|0|||
162242561|NCT04865770|585939184|FG000|Overall Study|Physician Decision|9|||
162242562|NCT04865770|585939185|FG001|Overall Study|Physician Decision|0|||
162242563|NCT04865770|585939184|FG000|Overall Study|Death|1|||
162242564|NCT04865770|585939185|FG001|Overall Study|Death|1|||
162242565|NCT05497284|585939186|FG000|Overall Study|Adverse Event|1|||
162242566|NCT05497284|585939187|FG001|Overall Study|Adverse Event|0|||
161796028|NCT02041702|584296467|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
161796029|NCT00203307|584296468|FG000|First Intervention|Adverse Event|2|||
161796030|NCT00203307|584296469|FG001|First Intervention|Adverse Event|0|||
161796031|NCT03730103|584296470|FG000|Overall Study|Did not meet inclusion criteria|0|||
161796032|NCT03730103|584296471|FG001|Overall Study|Did not meet inclusion criteria|5|||
161796033|NCT02789111|584296472|FG000|Overall Study|Withdrawal by Subject|1|||
161796034|NCT02789111|584296473|FG001|Overall Study|Withdrawal by Subject|4|||
161796035|NCT01488578|584296474|FG000|Overall Study|Protocol Violation|1836|||
161796036|NCT02308111|584296475|FG000|Overall Study|Adverse Event|31|||
161796037|NCT02308111|584296476|FG001|Overall Study|Adverse Event|19|||
161796038|NCT02308111|584296475|FG000|Overall Study|Death|9|||
161796039|NCT02308111|584296476|FG001|Overall Study|Death|6|||
161796040|NCT02308111|584296475|FG000|Overall Study|Lost to Follow-up|2|||
161796041|NCT02308111|584296476|FG001|Overall Study|Lost to Follow-up|7|||
161796042|NCT02308111|584296475|FG000|Overall Study|Physician Decision|6|||
161796043|NCT02308111|584296476|FG001|Overall Study|Physician Decision|17|||
161796044|NCT02308111|584296475|FG000|Overall Study|Protocol Violation|0|||
161796045|NCT02308111|584296476|FG001|Overall Study|Protocol Violation|1|||
161796046|NCT02308111|584296475|FG000|Overall Study|Withdrawal by Subject|28|||
161796047|NCT02308111|584296476|FG001|Overall Study|Withdrawal by Subject|38|||
161796048|NCT02308111|584296475|FG000|Overall Study|Study Terminated by Sponsor|72|||
161796049|NCT02308111|584296476|FG001|Overall Study|Study Terminated by Sponsor|61|||
161796050|NCT02308111|584296475|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
161796051|NCT02308111|584296476|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
161796052|NCT02308111|584296475|FG000|Overall Study|Site Closure|3|||
161796053|NCT02308111|584296476|FG001|Overall Study|Site Closure|3|||
161796054|NCT02308111|584296475|FG000|Overall Study|Non-compliance with Study Drug|3|||
161796055|NCT02308111|584296476|FG001|Overall Study|Non-compliance with Study Drug|1|||
161796056|NCT02308111|584296475|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
161796057|NCT02308111|584296476|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
161796058|NCT02308111|584296475|FG000|Overall Study|Liver Transplant|3|||
161796059|NCT02308111|584296476|FG001|Overall Study|Liver Transplant|3|||
161796060|NCT02308111|584296475|FG000|Overall Study|Liver Transplant Waitlist|2|||
161796061|NCT02308111|584296476|FG001|Overall Study|Liver Transplant Waitlist|2|||
161796062|NCT02308111|584296475|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
161796063|NCT02308111|584296476|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
161796064|NCT03271528|584296478|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
161796065|NCT03271528|584296479|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
161796066|NCT03271528|584296478|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
161796067|NCT03271528|584296479|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
161796068|NCT03271528|584296478|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
161796069|NCT03271528|584296479|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
161796070|NCT03271528|584296478|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
161796071|NCT03271528|584296479|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
161796072|NCT03271528|584296478|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
161796073|NCT03271528|584296479|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
161796074|NCT03271528|584296478|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
161796075|NCT03271528|584296479|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
161796076|NCT03271528|584296478|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
161796077|NCT03271528|584296479|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
161796078|NCT01896297|584296489|FG000|Overall Study|Died in post treatment phase|1|||
161796079|NCT00003782|584296492|FG000|Overall Study|No follow up data|30|||
161796080|NCT00003782|584296493|FG001|Overall Study|No follow up data|31|||
161796081|NCT00003782|584296494|FG002|Overall Study|No follow up data|26|||
161796082|NCT03626857|584296497|FG000|Overall Study|Adverse Event|9|||
161796083|NCT03626857|584296498|FG001|Overall Study|Adverse Event|7|||
161796084|NCT03626857|584296497|FG000|Overall Study|Lost to Follow-up|8|||
161796085|NCT03626857|584296498|FG001|Overall Study|Lost to Follow-up|8|||
161796086|NCT03626857|584296497|FG000|Overall Study|Withdrawal by Subject|2|||
161796087|NCT03626857|584296498|FG001|Overall Study|Withdrawal by Subject|2|||
161796088|NCT03626857|584296497|FG000|Overall Study|Protocol Violation|1|||
161796089|NCT03626857|584296498|FG001|Overall Study|Protocol Violation|3|||
161900659|NCT01325350|584685141|FG000|Overall Study|Did Not Receive Treatment|0|||
161900660|NCT01325350|584685142|FG001|Overall Study|Did Not Receive Treatment|1|||
161900661|NCT01325350|584685143|FG002|Overall Study|Did Not Receive Treatment|1|||
161900662|NCT01325350|584685144|FG003|Overall Study|Did Not Receive Treatment|0|||
161796090|NCT01301833|584296499|FG000|Overall Study|Adverse Event|7|||
161796091|NCT01301833|584296500|FG001|Overall Study|Adverse Event|5|||
161796092|NCT01301833|584296501|FG002|Overall Study|Adverse Event|5|||
161796093|NCT01301833|584296502|FG003|Overall Study|Adverse Event|5|||
161796094|NCT01301833|584296499|FG000|Overall Study|Lack of Efficacy|1|||
161900663|NCT01325350|584685145|FG004|Overall Study|Did Not Receive Treatment|1|||
162242567|NCT05497284|585939186|FG000|Overall Study|Physician Decision|0|||
162242568|NCT05497284|585939187|FG001|Overall Study|Physician Decision|1|||
162242569|NCT05497284|585939186|FG000|Overall Study|Study terminated by sponsor|7|||
162242570|NCT05497284|585939187|FG001|Overall Study|Study terminated by sponsor|4|||
162242571|NCT05497284|585939186|FG000|Overall Study|Subject Decision|0|||
162242572|NCT05497284|585939187|FG001|Overall Study|Subject Decision|1|||
162242573|NCT03816891|585939189|FG000|Double-Blind Period|Withdrawal by Subject|1|||
162242574|NCT03816891|585939190|FG001|Double-Blind Period|Withdrawal by Subject|2|||
162242575|NCT03816891|585939191|FG002|Double-Blind Period|Withdrawal by Subject|0|||
162242576|NCT03816891|585939192|FG003|Double-Blind Period|Withdrawal by Subject|2|||
162242577|NCT03816891|585939193|FG004|Double-Blind Period|Withdrawal by Subject|0|||
162242578|NCT03816891|585939194|FG005|Double-Blind Period|Withdrawal by Subject|0|||
162242579|NCT03816891|585939189|FG000|Double-Blind Period|Adverse Event|0|||
162242580|NCT03816891|585939190|FG001|Double-Blind Period|Adverse Event|0|||
162242581|NCT03816891|585939191|FG002|Double-Blind Period|Adverse Event|2|||
162242582|NCT03816891|585939192|FG003|Double-Blind Period|Adverse Event|0|||
162242583|NCT03816891|585939193|FG004|Double-Blind Period|Adverse Event|0|||
162242584|NCT03816891|585939194|FG005|Double-Blind Period|Adverse Event|0|||
162242585|NCT03816891|585939189|FG000|Double-Blind Period|Lost to Follow-up|2|||
162242586|NCT03816891|585939190|FG001|Double-Blind Period|Lost to Follow-up|0|||
162242587|NCT03816891|585939191|FG002|Double-Blind Period|Lost to Follow-up|0|||
162242588|NCT03816891|585939192|FG003|Double-Blind Period|Lost to Follow-up|0|||
162242589|NCT03816891|585939193|FG004|Double-Blind Period|Lost to Follow-up|0|||
162242590|NCT03816891|585939194|FG005|Double-Blind Period|Lost to Follow-up|1|||
162242591|NCT03816891|585939189|FG000|Double-Blind Period|Physician Decision|0|||
162242592|NCT03816891|585939190|FG001|Double-Blind Period|Physician Decision|0|||
162242593|NCT03816891|585939191|FG002|Double-Blind Period|Physician Decision|0|||
162242594|NCT03816891|585939192|FG003|Double-Blind Period|Physician Decision|1|||
162242595|NCT03816891|585939193|FG004|Double-Blind Period|Physician Decision|0|||
162242596|NCT03816891|585939194|FG005|Double-Blind Period|Physician Decision|0|||
162242597|NCT03816891|585939189|FG000|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
162242598|NCT03816891|585939190|FG001|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
162242599|NCT03816891|585939191|FG002|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
162242600|NCT03816891|585939192|FG003|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
162242601|NCT03816891|585939193|FG004|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
162242602|NCT03816891|585939194|FG005|Double-Blind Period|Coronavirus Disease (COVID-19)|1|||
162242603|NCT03816891|585939189|FG000|Double-Blind Period|Other|1|||
162242604|NCT03816891|585939190|FG001|Double-Blind Period|Other|0|||
162242605|NCT03816891|585939191|FG002|Double-Blind Period|Other|0|||
162242606|NCT03816891|585939192|FG003|Double-Blind Period|Other|0|||
162242607|NCT03816891|585939193|FG004|Double-Blind Period|Other|0|||
162242608|NCT03816891|585939194|FG005|Double-Blind Period|Other|0|||
162242609|NCT03816891|585939189|FG000|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
162242610|NCT03816891|585939190|FG001|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
162242611|NCT03816891|585939191|FG002|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|4|||
162242612|NCT03816891|585939192|FG003|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|3|||
162242613|NCT03816891|585939193|FG004|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|2|||
162242614|NCT03816891|585939194|FG005|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
162242615|NCT03816891|585939189|FG000|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
162242616|NCT03816891|585939190|FG001|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
162242617|NCT03816891|585939191|FG002|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
162242618|NCT03816891|585939192|FG003|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
162242619|NCT03816891|585939193|FG004|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
162242620|NCT03816891|585939194|FG005|Open-Label Period (Phase 2b Only)|Adverse Event|1|||
162242621|NCT03816891|585939189|FG000|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
162242622|NCT03816891|585939190|FG001|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
162242623|NCT03816891|585939191|FG002|Open-Label Period (Phase 2b Only)|Lack of Efficacy|1|||
162242624|NCT03816891|585939192|FG003|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
162242625|NCT03816891|585939193|FG004|Open-Label Period (Phase 2b Only)|Lack of Efficacy|3|||
162242626|NCT03816891|585939194|FG005|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
162242627|NCT03816891|585939189|FG000|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
162242628|NCT03816891|585939190|FG001|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
162242629|NCT03816891|585939191|FG002|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
162242630|NCT03816891|585939192|FG003|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
162242631|NCT03816891|585939193|FG004|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
162242632|NCT03816891|585939194|FG005|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
162242633|NCT03816891|585939189|FG000|Open-Label Period (Phase 2b Only)|Other|0|||
162242634|NCT03816891|585939190|FG001|Open-Label Period (Phase 2b Only)|Other|0|||
162242635|NCT03816891|585939191|FG002|Open-Label Period (Phase 2b Only)|Other|0|||
162242636|NCT03816891|585939192|FG003|Open-Label Period (Phase 2b Only)|Other|0|||
162242637|NCT03816891|585939193|FG004|Open-Label Period (Phase 2b Only)|Other|0|||
162010824|NCT00389610|585096012|FG000|Overall Study|Physician Decision|0|||
162010825|NCT00389610|585096013|FG001|Overall Study|Physician Decision|1|||
161796095|NCT01301833|584296500|FG001|Overall Study|Lack of Efficacy|1|||
161796096|NCT01301833|584296501|FG002|Overall Study|Lack of Efficacy|0|||
161796097|NCT01301833|584296502|FG003|Overall Study|Lack of Efficacy|0|||
161796098|NCT01301833|584296499|FG000|Overall Study|Physician Decision|3|||
161796099|NCT01301833|584296500|FG001|Overall Study|Physician Decision|1|||
161796100|NCT01301833|584296501|FG002|Overall Study|Physician Decision|1|||
161796101|NCT01301833|584296502|FG003|Overall Study|Physician Decision|0|||
161796102|NCT01301833|584296499|FG000|Overall Study|Withdrawal by Subject|3|||
161796103|NCT01301833|584296500|FG001|Overall Study|Withdrawal by Subject|1|||
161796104|NCT01301833|584296501|FG002|Overall Study|Withdrawal by Subject|1|||
161796105|NCT01301833|584296502|FG003|Overall Study|Withdrawal by Subject|2|||
161796106|NCT01301833|584296499|FG000|Overall Study|Personal matter|1|||
161796107|NCT01301833|584296500|FG001|Overall Study|Personal matter|0|||
161796108|NCT01301833|584296501|FG002|Overall Study|Personal matter|0|||
161796109|NCT01301833|584296502|FG003|Overall Study|Personal matter|0|||
161796110|NCT02637557|584298157|FG000|Overall Study|Adverse Event|3|||
161796111|NCT02637557|584298158|FG001|Overall Study|Adverse Event|1|||
161796112|NCT02637557|584298159|FG002|Overall Study|Adverse Event|3|||
161796113|NCT02637557|584298160|FG003|Overall Study|Adverse Event|3|||
161796114|NCT02637557|584298157|FG000|Overall Study|Lost to Follow-up|1|||
161796115|NCT02637557|584298158|FG001|Overall Study|Lost to Follow-up|1|||
161796116|NCT02637557|584298159|FG002|Overall Study|Lost to Follow-up|0|||
161796117|NCT02637557|584298160|FG003|Overall Study|Lost to Follow-up|1|||
161796118|NCT02637557|584298157|FG000|Overall Study|Physician Decision|1|||
161796119|NCT02637557|584298158|FG001|Overall Study|Physician Decision|0|||
161796120|NCT02637557|584298159|FG002|Overall Study|Physician Decision|0|||
161796121|NCT02637557|584298160|FG003|Overall Study|Physician Decision|0|||
161796122|NCT02637557|584298157|FG000|Overall Study|Protocol Violation|2|||
161796123|NCT02637557|584298158|FG001|Overall Study|Protocol Violation|0|||
161796124|NCT02637557|584298159|FG002|Overall Study|Protocol Violation|2|||
161796125|NCT02637557|584298160|FG003|Overall Study|Protocol Violation|1|||
161796126|NCT02637557|584298157|FG000|Overall Study|Withdrawal by Subject|1|||
161796127|NCT02637557|584298158|FG001|Overall Study|Withdrawal by Subject|3|||
161796128|NCT02637557|584298159|FG002|Overall Study|Withdrawal by Subject|4|||
161796129|NCT02637557|584298160|FG003|Overall Study|Withdrawal by Subject|2|||
161796130|NCT05218655|584298161|FG000|Overall Study|Adverse Event|6|||
161796131|NCT05218655|584298161|FG000|Overall Study|Sponsor's decision|85|||
161796132|NCT05218655|584298161|FG000|Overall Study|Death|1|||
161796133|NCT05218655|584298161|FG000|Overall Study|Lost to Follow-up|3|||
161796134|NCT05218655|584298161|FG000|Overall Study|Withdrawal by Subject|3|||
161796135|NCT05218655|584298161|FG000|Overall Study|Other than specified|3|||
161796136|NCT02228382|584298164|FG000|Overall Study|Death|5|||
161796137|NCT02228382|584298165|FG001|Overall Study|Death|7|||
161796138|NCT02228382|584298166|FG002|Overall Study|Death|5|||
161796139|NCT02228382|584298167|FG003|Overall Study|Death|0|||
161796140|NCT02228382|584298168|FG004|Overall Study|Death|2|||
161796141|NCT02228382|584298164|FG000|Overall Study|Participant refused further follow-up|0|||
161796142|NCT02228382|584298165|FG001|Overall Study|Participant refused further follow-up|0|||
161796143|NCT02228382|584298166|FG002|Overall Study|Participant refused further follow-up|1|||
162135118|NCT02223182|585543173|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
162135119|NCT02223182|585543174|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
162135120|NCT02223182|585543171|FG000|Open-Label 500 Period|Adverse Event|1|||
162135121|NCT02223182|585543172|FG001|Open-Label 500 Period|Adverse Event|0|||
162135122|NCT02223182|585543173|FG002|Open-Label 500 Period|Adverse Event|2|||
162135123|NCT02223182|585543174|FG003|Open-Label 500 Period|Adverse Event|1|||
162135124|NCT02223182|585543171|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
162135125|NCT02223182|585543172|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
162135126|NCT02223182|585543173|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
162135127|NCT02223182|585543174|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
162135128|NCT02223182|585543171|FG000|Open-Label 500 Period|Physician Decision|0|||
162135129|NCT02223182|585543172|FG001|Open-Label 500 Period|Physician Decision|0|||
162135130|NCT02223182|585543173|FG002|Open-Label 500 Period|Physician Decision|0|||
162135131|NCT02223182|585543174|FG003|Open-Label 500 Period|Physician Decision|1|||
162135132|NCT02223182|585543171|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
162135133|NCT02223182|585543172|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
162135134|NCT02223182|585543173|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
161796144|NCT02228382|584298167|FG003|Overall Study|Participant refused further follow-up|0|||
161796145|NCT02228382|584298168|FG004|Overall Study|Participant refused further follow-up|0|||
161796146|NCT02228382|584298164|FG000|Overall Study|Study terminated by sponsor|3|||
161796147|NCT02228382|584298165|FG001|Overall Study|Study terminated by sponsor|5|||
161796148|NCT02228382|584298166|FG002|Overall Study|Study terminated by sponsor|7|||
161796149|NCT02228382|584298167|FG003|Overall Study|Study terminated by sponsor|0|||
161796150|NCT02228382|584298168|FG004|Overall Study|Study terminated by sponsor|0|||
161796151|NCT02228382|584298164|FG000|Overall Study|Lost to Follow-up|0|||
161796152|NCT02228382|584298165|FG001|Overall Study|Lost to Follow-up|0|||
161796153|NCT02228382|584298166|FG002|Overall Study|Lost to Follow-up|3|||
162242638|NCT03816891|585939194|FG005|Open-Label Period (Phase 2b Only)|Other|1|||
162242639|NCT04576455|585939197|FG000|Overall Study|Ongoing in the Study|48|||
162242640|NCT04576455|585939198|FG001|Overall Study|Ongoing in the Study|58|||
162242641|NCT04576455|585939197|FG000|Overall Study|Death|83|||
162242642|NCT04576455|585939198|FG001|Overall Study|Death|77|||
162242643|NCT04576455|585939197|FG000|Overall Study|Lost to Follow-up|4|||
162242644|NCT04576455|585939198|FG001|Overall Study|Lost to Follow-up|5|||
162242645|NCT04576455|585939197|FG000|Overall Study|Withdrawal by Subject|16|||
162242646|NCT04576455|585939198|FG001|Overall Study|Withdrawal by Subject|12|||
162242647|NCT04449055|585939199|FG000|Overall Study|Lost to Follow-up|2|||
162242648|NCT04449055|585939200|FG001|Overall Study|Lost to Follow-up|1|||
162242649|NCT04449055|585939199|FG000|Overall Study|Missed 4 treatments--removed by PI|1|||
162242650|NCT04449055|585939200|FG001|Overall Study|Missed 4 treatments--removed by PI|1|||
162242651|NCT04449055|585939199|FG000|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|1|||
162242652|NCT04449055|585939200|FG001|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|0|||
162242653|NCT04449055|585939199|FG000|Overall Study|Incarcerated|1|||
162242654|NCT04449055|585939200|FG001|Overall Study|Incarcerated|0|||
162242655|NCT02577029|585939201|FG000|Overall Study|Adverse Event|1|||
162242656|NCT02577029|585939202|FG001|Overall Study|Adverse Event|0|||
162242657|NCT02577029|585939203|FG002|Overall Study|Adverse Event|2|||
162242658|NCT02577029|585939204|FG003|Overall Study|Adverse Event|0|||
162242659|NCT02577029|585939205|FG004|Overall Study|Adverse Event|1|||
162242660|NCT02577029|585939206|FG005|Overall Study|Adverse Event|0|||
162242661|NCT02577029|585939207|FG006|Overall Study|Adverse Event|0|||
162242662|NCT02577029|585939208|FG007|Overall Study|Adverse Event|0|||
162242663|NCT02577029|585939201|FG000|Overall Study|Withdrawal by Subject|0|||
162242664|NCT02577029|585939202|FG001|Overall Study|Withdrawal by Subject|0|||
162242665|NCT02577029|585939203|FG002|Overall Study|Withdrawal by Subject|0|||
162242666|NCT02577029|585939204|FG003|Overall Study|Withdrawal by Subject|0|||
162242667|NCT02577029|585939205|FG004|Overall Study|Withdrawal by Subject|0|||
162242668|NCT02577029|585939206|FG005|Overall Study|Withdrawal by Subject|1|||
162242669|NCT02577029|585939207|FG006|Overall Study|Withdrawal by Subject|0|||
162242670|NCT02577029|585939208|FG007|Overall Study|Withdrawal by Subject|0|||
162242671|NCT02577029|585939201|FG000|Overall Study|Sponsor Termination of the Study|9|||
162242672|NCT02577029|585939202|FG001|Overall Study|Sponsor Termination of the Study|2|||
162242673|NCT02577029|585939203|FG002|Overall Study|Sponsor Termination of the Study|5|||
162242674|NCT02577029|585939204|FG003|Overall Study|Sponsor Termination of the Study|12|||
162242675|NCT02577029|585939205|FG004|Overall Study|Sponsor Termination of the Study|10|||
162242676|NCT02577029|585939206|FG005|Overall Study|Sponsor Termination of the Study|12|||
162242677|NCT02577029|585939207|FG006|Overall Study|Sponsor Termination of the Study|12|||
162242678|NCT02577029|585939208|FG007|Overall Study|Sponsor Termination of the Study|12|||
162242679|NCT06596005|585939725|FG000|Overall Study|Withdrawal by Subject|2|||
162242680|NCT06596005|585939726|FG001|Overall Study|Withdrawal by Subject|2|||
162242681|NCT06596005|585939727|FG002|Overall Study|Withdrawal by Subject|1|||
162242682|NCT06596005|585939725|FG000|Overall Study|Other|0|||
162242683|NCT06596005|585939726|FG001|Overall Study|Other|2|||
162242684|NCT06596005|585939727|FG002|Overall Study|Other|0|||
162242685|NCT03734666|585939728|FG000|Overall Study|Other|7|||
162242686|NCT03734666|585939729|FG001|Overall Study|Other|4|||
162242687|NCT03734666|585939728|FG000|Overall Study|Lost to Follow-up|12|||
162242688|NCT03734666|585939729|FG001|Overall Study|Lost to Follow-up|12|||
162242689|NCT05866185|585939730|FG000|Overall Study|Lost to Follow-up|2|||
162242690|NCT05866185|585939731|FG001|Overall Study|Lost to Follow-up|4|||
162242691|NCT05866185|585939732|FG002|Overall Study|Lost to Follow-up|4|||
162242692|NCT05866185|585939733|FG003|Overall Study|Lost to Follow-up|6|||
162242693|NCT02445391|585939734|FG000|Overall Study|No active protocol treatment|3|||
162242694|NCT02445391|585939735|FG001|Overall Study|No active protocol treatment|0|||
162242695|NCT02445391|585939736|FG002|Overall Study|No active protocol treatment|0|||
162242696|NCT02445391|585939734|FG000|Overall Study|Adverse Event|0|||
162242697|NCT02445391|585939735|FG001|Overall Study|Adverse Event|21|||
162242698|NCT02445391|585939736|FG002|Overall Study|Adverse Event|12|||
162242699|NCT02445391|585939734|FG000|Overall Study|Alternative therapy|0|||
162242700|NCT02445391|585939735|FG001|Overall Study|Alternative therapy|0|||
162242701|NCT02445391|585939736|FG002|Overall Study|Alternative therapy|1|||
162242702|NCT02445391|585939734|FG000|Overall Study|Disease progression|0|||
162242703|NCT02445391|585939735|FG001|Overall Study|Disease progression|7|||
162242704|NCT02445391|585939736|FG002|Overall Study|Disease progression|22|||
162242705|NCT02445391|585939734|FG000|Overall Study|Complicating disease|0|||
162242706|NCT02445391|585939735|FG001|Overall Study|Complicating disease|2|||
162242707|NCT02445391|585939736|FG002|Overall Study|Complicating disease|1|||
162242708|NCT02445391|585939734|FG000|Overall Study|Withdrawal by Subject|0|||
162242709|NCT02445391|585939735|FG001|Overall Study|Withdrawal by Subject|4|||
162242710|NCT02445391|585939736|FG002|Overall Study|Withdrawal by Subject|9|||
162242711|NCT02445391|585939734|FG000|Overall Study|Financial issue|0|||
161796154|NCT02228382|584298167|FG003|Overall Study|Lost to Follow-up|1|||
162242712|NCT02445391|585939735|FG001|Overall Study|Financial issue|0|||
162242713|NCT02445391|585939736|FG002|Overall Study|Financial issue|2|||
162242714|NCT02445391|585939734|FG000|Overall Study|Still on treatment|0|||
162242715|NCT02445391|585939735|FG001|Overall Study|Still on treatment|7|||
162242716|NCT02445391|585939736|FG002|Overall Study|Still on treatment|16|||
162242717|NCT02445391|585939734|FG000|Overall Study|Not start protocol therapy|0|||
162242718|NCT02445391|585939735|FG001|Overall Study|Not start protocol therapy|12|||
162242719|NCT02445391|585939736|FG002|Overall Study|Not start protocol therapy|9|||
162242720|NCT03246529|585939738|FG000|Core Study (until 100 d post-transplant)|Adverse Event|0|||
162242721|NCT03246529|585939739|FG001|Core Study (until 100 d post-transplant)|Adverse Event|2|||
162242722|NCT03246529|585939740|FG002|Core Study (until 100 d post-transplant)|Adverse Event|0|||
162242723|NCT03246529|585939738|FG000|Core Study (until 100 d post-transplant)|Lost to Follow-up|0|||
162242724|NCT03246529|585939739|FG001|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
162242725|NCT03246529|585939740|FG002|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
162242726|NCT03246529|585939738|FG000|Core Study (until 100 d post-transplant)|Other Reasons|0|||
162242727|NCT03246529|585939739|FG001|Core Study (until 100 d post-transplant)|Other Reasons|2|||
162242728|NCT03246529|585939740|FG002|Core Study (until 100 d post-transplant)|Other Reasons|2|||
162242729|NCT03246529|585939738|FG000|Core Study (until 100 d post-transplant)|Physician Decision|0|||
162242730|NCT03246529|585939739|FG001|Core Study (until 100 d post-transplant)|Physician Decision|0|||
162242731|NCT03246529|585939740|FG002|Core Study (until 100 d post-transplant)|Physician Decision|1|||
162242732|NCT03246529|585939738|FG000|Core Study (until 100 d post-transplant)|Withdrawal by Subject|0|||
162242733|NCT03246529|585939739|FG001|Core Study (until 100 d post-transplant)|Withdrawal by Subject|1|||
162242734|NCT03246529|585939740|FG002|Core Study (until 100 d post-transplant)|Withdrawal by Subject|4|||
162242735|NCT03246529|585939738|FG000|Follow-up period at 1 year FU Completion|Disease progression|2|||
162242736|NCT03246529|585939739|FG001|Follow-up period at 1 year FU Completion|Disease progression|1|||
162242737|NCT03246529|585939740|FG002|Follow-up period at 1 year FU Completion|Disease progression|1|||
162242738|NCT03246529|585939738|FG000|Follow-up period at 1 year FU Completion|Lost to Follow-up|1|||
162242739|NCT03246529|585939739|FG001|Follow-up period at 1 year FU Completion|Lost to Follow-up|3|||
162242740|NCT03246529|585939740|FG002|Follow-up period at 1 year FU Completion|Lost to Follow-up|0|||
162242741|NCT03246529|585939738|FG000|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
162242742|NCT03246529|585939739|FG001|Follow-up period at 1 year FU Completion|Withdrawal by Subject|3|||
162242743|NCT03246529|585939740|FG002|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
162242744|NCT03246529|585939738|FG000|Follow-up period at 1 year FU Completion|Death|0|||
162242745|NCT03246529|585939739|FG001|Follow-up period at 1 year FU Completion|Death|0|||
162242746|NCT03246529|585939740|FG002|Follow-up period at 1 year FU Completion|Death|1|||
162242747|NCT04379518|585939741|FG000|Overall Study|Physician Decision|2|||
162242748|NCT04379518|585939742|FG001|Overall Study|Physician Decision|0|||
162242749|NCT04379518|585939743|FG002|Overall Study|Physician Decision|0|||
162242750|NCT04379518|585939744|FG003|Overall Study|Physician Decision|0|||
162242751|NCT04379518|585939745|FG004|Overall Study|Physician Decision|0|||
162242752|NCT04379518|585939741|FG000|Overall Study|Withdrawal by Subject|1|||
162242753|NCT04379518|585939742|FG001|Overall Study|Withdrawal by Subject|0|||
162242754|NCT04379518|585939743|FG002|Overall Study|Withdrawal by Subject|0|||
162242755|NCT04379518|585939744|FG003|Overall Study|Withdrawal by Subject|0|||
162242756|NCT04379518|585939745|FG004|Overall Study|Withdrawal by Subject|0|||
162242757|NCT05666505|585939746|FG000|Overall Study|Withdrawn due to caregiver consent obtained from non-legal guardian|1|||
162242758|NCT05135000|585940169|FG000|Overall Study|Adverse Event|2|||
162242759|NCT05135000|585940170|FG001|Overall Study|Adverse Event|0|||
162242760|NCT05135000|585940169|FG000|Overall Study|Lost to Follow-up|1|||
162242761|NCT05135000|585940170|FG001|Overall Study|Lost to Follow-up|0|||
162242762|NCT05135000|585940169|FG000|Overall Study|Study Terminated by Sponsor|6|||
162242763|NCT05135000|585940170|FG001|Overall Study|Study Terminated by Sponsor|3|||
162242764|NCT05561673|585940175|FG000|Overall Study|Lost to Follow-up|0|||
162242765|NCT05561673|585940176|FG001|Overall Study|Lost to Follow-up|1|||
162242766|NCT05561673|585940177|FG002|Overall Study|Lost to Follow-up|0|||
162242767|NCT05561673|585940178|FG003|Overall Study|Lost to Follow-up|1|||
162242768|NCT05561673|585940179|FG004|Overall Study|Lost to Follow-up|0|||
162242769|NCT05561673|585940175|FG000|Overall Study|Consent withdrawal, not due to (S)AE|0|||
162242770|NCT05561673|585940176|FG001|Overall Study|Consent withdrawal, not due to (S)AE|1|||
162242771|NCT05561673|585940177|FG002|Overall Study|Consent withdrawal, not due to (S)AE|0|||
162242772|NCT05561673|585940178|FG003|Overall Study|Consent withdrawal, not due to (S)AE|0|||
162242773|NCT05561673|585940179|FG004|Overall Study|Consent withdrawal, not due to (S)AE|0|||
162242774|NCT05561673|585940175|FG000|Overall Study|Other|1|||
162242775|NCT05561673|585940176|FG001|Overall Study|Other|0|||
162242776|NCT05561673|585940177|FG002|Overall Study|Other|1|||
162242777|NCT05561673|585940178|FG003|Overall Study|Other|0|||
162242778|NCT05561673|585940179|FG004|Overall Study|Other|0|||
162242779|NCT03961555|585940180|FG000|Overall Study|Lost to Follow-up|0|||
162010826|NCT00389610|585096012|FG000|Overall Study|Withdrawal by Subject|0|||
162010827|NCT00389610|585096013|FG001|Overall Study|Withdrawal by Subject|1|||
162242780|NCT03961555|585940181|FG001|Overall Study|Lost to Follow-up|0|||
162242781|NCT03961555|585940182|FG002|Overall Study|Lost to Follow-up|1|||
162242782|NCT03961555|585940183|FG003|Overall Study|Lost to Follow-up|0|||
162242783|NCT03961555|585940180|FG000|Overall Study|Withdrawal by Subject|0|||
162242784|NCT03961555|585940181|FG001|Overall Study|Withdrawal by Subject|0|||
162242785|NCT03961555|585940182|FG002|Overall Study|Withdrawal by Subject|2|||
162242786|NCT03961555|585940183|FG003|Overall Study|Withdrawal by Subject|4|||
162242787|NCT03961555|585940180|FG000|Overall Study|Death|0|||
162242788|NCT03961555|585940181|FG001|Overall Study|Death|1|||
162242789|NCT03961555|585940182|FG002|Overall Study|Death|0|||
162242790|NCT03961555|585940183|FG003|Overall Study|Death|0|||
162242791|NCT03961555|585940180|FG000|Overall Study|Other|0|||
162242792|NCT03961555|585940181|FG001|Overall Study|Other|0|||
162242793|NCT03961555|585940182|FG002|Overall Study|Other|2|||
162242794|NCT03961555|585940183|FG003|Overall Study|Other|2|||
162242795|NCT03961555|585940180|FG000|Overall Study|No treatment received|0|||
162242796|NCT03961555|585940181|FG001|Overall Study|No treatment received|0|||
162242797|NCT03961555|585940182|FG002|Overall Study|No treatment received|1|||
162242798|NCT03961555|585940183|FG003|Overall Study|No treatment received|0|||
162242799|NCT04522973|585940184|FG000|Overall Study|Lost to Follow-up|4|||
162242800|NCT04522973|585940184|FG000|Overall Study|Could not adhere to study schedule|1|||
162242801|NCT04007796|585940187|FG000|Overall Study|Exclusion criterion met during the trial|1|||
162242802|NCT04007796|585940188|FG001|Overall Study|Exclusion criterion met during the trial|1|||
162242803|NCT04007796|585940187|FG000|Overall Study|Withdrawal by Subject|1|||
162242804|NCT04007796|585940188|FG001|Overall Study|Withdrawal by Subject|0|||
162242805|NCT03573401|585940477|FG000|Overall Study|Withdrawal by Subject|2|||
162242806|NCT03573401|585940478|FG001|Overall Study|Withdrawal by Subject|0|||
162242807|NCT03573401|585940477|FG000|Overall Study|Subject non-compliance with study schedule|1|||
162242808|NCT03573401|585940478|FG001|Overall Study|Subject non-compliance with study schedule|0|||
162242809|NCT03573401|585940477|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
162242810|NCT03573401|585940478|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
162242811|NCT03573401|585940477|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
162242812|NCT03573401|585940478|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
162242813|NCT05579249|585940479|FG000|Overall Study|Withdrawal by Subject|1|||
162242814|NCT05579249|585940480|FG001|Overall Study|Withdrawal by Subject|3|||
162242815|NCT05579249|585940479|FG000|Overall Study|Lost to Follow-up|33|||
162242816|NCT05579249|585940480|FG001|Overall Study|Lost to Follow-up|52|||
162242817|NCT05579249|585940479|FG000|Overall Study|Physician Decision|2|||
161796155|NCT02228382|584298168|FG004|Overall Study|Lost to Follow-up|0|||
161796156|NCT02228382|584298164|FG000|Overall Study|Withdrawal by Subject|0|||
161796157|NCT02228382|584298165|FG001|Overall Study|Withdrawal by Subject|3|||
161796158|NCT02228382|584298166|FG002|Overall Study|Withdrawal by Subject|2|||
161796159|NCT02228382|584298167|FG003|Overall Study|Withdrawal by Subject|1|||
161796160|NCT02228382|584298168|FG004|Overall Study|Withdrawal by Subject|0|||
161796161|NCT02228382|584298164|FG000|Overall Study|Other|2|||
161796162|NCT02228382|584298165|FG001|Overall Study|Other|3|||
161796163|NCT02228382|584298166|FG002|Overall Study|Other|3|||
161796164|NCT02228382|584298167|FG003|Overall Study|Other|0|||
161796165|NCT02228382|584298168|FG004|Overall Study|Other|0|||
161796166|NCT02396381|584298169|FG000|Overall Study|Adverse Event|3|||
161796167|NCT02396381|584298170|FG001|Overall Study|Adverse Event|2|||
161796168|NCT02396381|584298169|FG000|Overall Study|Withdrawal by Subject|33|||
161796169|NCT02396381|584298170|FG001|Overall Study|Withdrawal by Subject|24|||
161796170|NCT02396381|584298169|FG000|Overall Study|Lost to Follow-up|49|||
161796171|NCT02396381|584298170|FG001|Overall Study|Lost to Follow-up|31|||
161796172|NCT02396381|584298169|FG000|Overall Study|Protocol Violation|1|||
161796173|NCT02396381|584298170|FG001|Overall Study|Protocol Violation|0|||
161796174|NCT02396381|584298169|FG000|Overall Study|Site terminated by sponsor|7|||
161796175|NCT02396381|584298170|FG001|Overall Study|Site terminated by sponsor|8|||
161796176|NCT02396381|584298169|FG000|Overall Study|Physician Decision|5|||
161796177|NCT02396381|584298170|FG001|Overall Study|Physician Decision|5|||
161796178|NCT02396381|584298169|FG000|Overall Study|Pregnancy|2|||
161796179|NCT02396381|584298170|FG001|Overall Study|Pregnancy|0|||
161796180|NCT02396381|584298169|FG000|Overall Study|Non-compliance with study procedures|1|||
161796181|NCT02396381|584298170|FG001|Overall Study|Non-compliance with study procedures|0|||
161796182|NCT02396381|584298169|FG000|Overall Study|Moved out of town/state|1|||
161796183|NCT02396381|584298170|FG001|Overall Study|Moved out of town/state|3|||
161796184|NCT02396381|584298169|FG000|Overall Study|Could not complete visit|1|||
161796185|NCT02396381|584298170|FG001|Overall Study|Could not complete visit|0|||
161796186|NCT02396381|584298169|FG000|Overall Study|Possible conflict of interest|1|||
161796187|NCT02396381|584298170|FG001|Overall Study|Possible conflict of interest|0|||
162242818|NCT05579249|585940480|FG001|Overall Study|Physician Decision|2|||
162242819|NCT05579249|585940479|FG000|Overall Study|Death|0|||
161796188|NCT02396381|584298169|FG000|Overall Study|Randomization/Screening Error|3|||
162242820|NCT05579249|585940480|FG001|Overall Study|Death|2|||
161796189|NCT02396381|584298170|FG001|Overall Study|Randomization/Screening Error|1|||
161796190|NCT00113490|584298171|FG000|Overall Study|Withdrawal by Subject|1|||
162242821|NCT05222555|585940481|FG000|Overall Study|Ongoing|2|||
162242822|NCT05222555|585940482|FG001|Overall Study|Ongoing|18|||
162135135|NCT02223182|585543174|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
162135136|NCT02223182|585543171|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
162135137|NCT02223182|585543172|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
162135138|NCT02223182|585543173|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
162135139|NCT02223182|585543174|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
162135140|NCT02223182|585543171|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
162135141|NCT02223182|585543172|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
162135142|NCT02223182|585543173|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
162135143|NCT02223182|585543174|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
162135144|NCT02223182|585543171|FG000|Open-Label 300 Period|Non Compliance|0|||
162135145|NCT02223182|585543172|FG001|Open-Label 300 Period|Non Compliance|2|||
162135146|NCT02223182|585543173|FG002|Open-Label 300 Period|Non Compliance|1|||
162135147|NCT02223182|585543174|FG003|Open-Label 300 Period|Non Compliance|0|||
162135148|NCT04956692|585543181|FG000|Overall Study|Death|115|||
162135149|NCT04956692|585543182|FG001|Overall Study|Death|47|||
162135150|NCT04956692|585543181|FG000|Overall Study|Lost to Follow-up|0|||
162135151|NCT04956692|585543182|FG001|Overall Study|Lost to Follow-up|1|||
162135152|NCT04956692|585543181|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
162135153|NCT04956692|585543182|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162135154|NCT04956692|585543181|FG000|Overall Study|Withdrawal by Subject|5|||
162135155|NCT04956692|585543182|FG001|Overall Study|Withdrawal by Subject|2|||
162135156|NCT04956692|585543181|FG000|Overall Study|Ongoing in Study|236|||
162135157|NCT04956692|585543182|FG001|Overall Study|Ongoing in Study|123|||
162135158|NCT02099539|585543187|FG000|Overall Study|Progressive Disease|3|||
162135159|NCT02099539|585543188|FG001|Overall Study|Progressive Disease|2|||
162135160|NCT02099539|585543189|FG002|Overall Study|Progressive Disease|2|||
162135161|NCT02099539|585543190|FG003|Overall Study|Progressive Disease|1|||
162135162|NCT02099539|585543191|FG004|Overall Study|Progressive Disease|4|||
162135163|NCT02099539|585543192|FG005|Overall Study|Progressive Disease|2|||
162135164|NCT02099539|585543193|FG006|Overall Study|Progressive Disease|0|||
162135165|NCT02099539|585543187|FG000|Overall Study|Adverse Event|0|||
162135166|NCT02099539|585543188|FG001|Overall Study|Adverse Event|0|||
162135167|NCT02099539|585543189|FG002|Overall Study|Adverse Event|1|||
162135168|NCT02099539|585543190|FG003|Overall Study|Adverse Event|1|||
162135169|NCT02099539|585543191|FG004|Overall Study|Adverse Event|0|||
162135170|NCT02099539|585543192|FG005|Overall Study|Adverse Event|0|||
162135171|NCT02099539|585543193|FG006|Overall Study|Adverse Event|0|||
162135172|NCT02099539|585543187|FG000|Overall Study|Physician Decision|0|||
162135173|NCT02099539|585543188|FG001|Overall Study|Physician Decision|0|||
162135174|NCT02099539|585543189|FG002|Overall Study|Physician Decision|0|||
162135175|NCT02099539|585543190|FG003|Overall Study|Physician Decision|0|||
162135176|NCT02099539|585543191|FG004|Overall Study|Physician Decision|0|||
162135177|NCT02099539|585543192|FG005|Overall Study|Physician Decision|1|||
162135178|NCT02099539|585543193|FG006|Overall Study|Physician Decision|0|||
162135179|NCT01449721|585543195|FG000|Overall Study|Physician Decision|0|||
162135180|NCT01449721|585543196|FG001|Overall Study|Physician Decision|1|||
162135181|NCT01449721|585543195|FG000|Overall Study|Physician Decision|0|||
162135182|NCT01449721|585543196|FG001|Overall Study|Physician Decision|1|||
162135183|NCT03212365|585543197|FG000|Overall Study|Discharged prior to Xa level|12|||
162135184|NCT03212365|585543198|FG001|Overall Study|Discharged prior to Xa level|8|||
162135185|NCT03212365|585543197|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
162135186|NCT03212365|585543198|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
162135187|NCT03212365|585543197|FG000|Overall Study|Refused study medication|3|||
162135188|NCT03212365|585543198|FG001|Overall Study|Refused study medication|0|||
162135189|NCT03212365|585543197|FG000|Overall Study|Initiated heparin infusion on floor|1|||
162135190|NCT03212365|585543198|FG001|Overall Study|Initiated heparin infusion on floor|1|||
162135191|NCT03212365|585543197|FG000|Overall Study|Unexpected return to OR|1|||
162135192|NCT03212365|585543198|FG001|Overall Study|Unexpected return to OR|1|||
162135193|NCT03212365|585543197|FG000|Overall Study|Medication distribution error|1|||
162135194|NCT03212365|585543198|FG001|Overall Study|Medication distribution error|0|||
162135195|NCT03212365|585543197|FG000|Overall Study|Required epidural placement|1|||
162135196|NCT03212365|585543198|FG001|Overall Study|Required epidural placement|0|||
162135197|NCT03212365|585543197|FG000|Overall Study|Withdrawal by Subject|0|||
162135198|NCT03212365|585543198|FG001|Overall Study|Withdrawal by Subject|1|||
162135199|NCT03212365|585543197|FG000|Overall Study|developed acute renal failure|0|||
162135200|NCT03212365|585543198|FG001|Overall Study|developed acute renal failure|1|||
162135201|NCT00333138|585543199|FG000|Core Study (6 Months)|Adverse Event|4|||
162135202|NCT00333138|585543200|FG001|Core Study (6 Months)|Adverse Event|5|||
162135203|NCT00333138|585543201|FG002|Core Study (6 Months)|Adverse Event|8|||
162135204|NCT00333138|585543199|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
162135205|NCT00333138|585543200|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
162135206|NCT00333138|585543201|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
162135207|NCT00333138|585543199|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
162135208|NCT00333138|585543200|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
162135209|NCT00333138|585543201|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
162135210|NCT00333138|585543199|FG000|Core Study (6 Months)|Protocol Violation|1|||
162135211|NCT00333138|585543200|FG001|Core Study (6 Months)|Protocol Violation|0|||
162135212|NCT00333138|585543201|FG002|Core Study (6 Months)|Protocol Violation|1|||
162135213|NCT00333138|585543199|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
162135214|NCT00333138|585543200|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
162135215|NCT00333138|585543201|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
162135216|NCT00333138|585543199|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
162135217|NCT00333138|585543200|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
162135218|NCT00333138|585543201|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
162135219|NCT00333138|585543199|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
162135220|NCT00333138|585543200|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
162135221|NCT00333138|585543201|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
162135222|NCT00333138|585543199|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
162135223|NCT00333138|585543200|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
162135224|NCT00333138|585543201|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
162135225|NCT00333138|585543199|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
162135226|NCT00333138|585543200|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
162135227|NCT00333138|585543201|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
162135228|NCT00333138|585543199|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
162135229|NCT00333138|585543200|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
162135230|NCT00333138|585543201|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
162135231|NCT00333138|585543199|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
162135232|NCT00333138|585543200|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
162135233|NCT00333138|585543201|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
162135234|NCT00333138|585543199|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
162135235|NCT00333138|585543200|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
162135236|NCT00333138|585543201|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
162135237|NCT00333138|585543199|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
162135238|NCT00333138|585543200|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
162135239|NCT00333138|585543201|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
162135240|NCT00333138|585543199|FG000|Extension Study (Month6 to End of Study)|Death|0|||
162135241|NCT00333138|585543200|FG001|Extension Study (Month6 to End of Study)|Death|1|||
162135242|NCT00333138|585543201|FG002|Extension Study (Month6 to End of Study)|Death|0|||
162135243|NCT03005288|585543202|FG000|Overall Study|Withdrawal by Subject|7|||
162135244|NCT03005288|585543203|FG001|Overall Study|Withdrawal by Subject|5|||
162135245|NCT03005288|585543202|FG000|Overall Study|Lost to Follow-up|0|||
162135246|NCT03005288|585543203|FG001|Overall Study|Lost to Follow-up|1|||
162135247|NCT03005288|585543202|FG000|Overall Study|Adverse Event|5|||
162135248|NCT03005288|585543203|FG001|Overall Study|Adverse Event|0|||
162135249|NCT03005288|585543202|FG000|Overall Study|Protocol deviation|0|||
162135250|NCT03005288|585543203|FG001|Overall Study|Protocol deviation|1|||
162135251|NCT03005288|585543202|FG000|Overall Study|Physician Decision|0|||
162135252|NCT03005288|585543203|FG001|Overall Study|Physician Decision|1|||
162135253|NCT04011033|585543204|FG000|Overall Study|Physician Decision|2|||
162135254|NCT04011033|585543205|FG001|Overall Study|Physician Decision|3|||
162135255|NCT04011033|585543204|FG000|Overall Study|Withdrawal by Subject|1|||
162135256|NCT04011033|585543205|FG001|Overall Study|Withdrawal by Subject|0|||
162135257|NCT01342887|585543206|FG000|Overall Study|Death|2|||
162135258|NCT04978363|585545396|FG000|Overall Study|Other medical issues unrelated to the study|0|||
162135259|NCT04978363|585545397|FG001|Overall Study|Other medical issues unrelated to the study|0|||
162135260|NCT04978363|585545398|FG002|Overall Study|Other medical issues unrelated to the study|0|||
162135261|NCT04978363|585545399|FG003|Overall Study|Other medical issues unrelated to the study|0|||
162135262|NCT04978363|585545400|FG004|Overall Study|Other medical issues unrelated to the study|1|||
162135263|NCT04978363|585545401|FG005|Overall Study|Other medical issues unrelated to the study|0|||
162135264|NCT04978363|585545402|FG006|Overall Study|Other medical issues unrelated to the study|0|||
162135265|NCT04978363|585545403|FG007|Overall Study|Other medical issues unrelated to the study|0|||
162135266|NCT04978363|585545404|FG008|Overall Study|Other medical issues unrelated to the study|0|||
162135267|NCT04978363|585545405|FG009|Overall Study|Other medical issues unrelated to the study|0|||
162135268|NCT04978363|585545406|FG010|Overall Study|Other medical issues unrelated to the study|0|||
162135269|NCT04978363|585545396|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
162135270|NCT04978363|585545397|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
162135271|NCT04978363|585545398|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
162135272|NCT04978363|585545399|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
162135273|NCT04978363|585545400|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
162135274|NCT04978363|585545401|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
162135275|NCT04978363|585545402|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
162135276|NCT04978363|585545403|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
162242823|NCT05222555|585940481|FG000|Overall Study|Adverse Event|1|||
162242824|NCT05222555|585940482|FG001|Overall Study|Adverse Event|1|||
162242825|NCT05222555|585940481|FG000|Overall Study|Death|0|||
162242826|NCT05222555|585940482|FG001|Overall Study|Death|6|||
162242827|NCT05222555|585940481|FG000|Overall Study|Withdrawal by Subject|0|||
162135277|NCT04978363|585545404|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
162135278|NCT04978363|585545405|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
162135279|NCT04978363|585545406|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
162135280|NCT04978363|585545396|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162135281|NCT04978363|585545397|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
162135282|NCT04978363|585545398|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162135283|NCT04978363|585545399|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162135284|NCT04978363|585545400|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162135285|NCT04978363|585545401|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162135286|NCT04978363|585545402|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162135287|NCT04978363|585545403|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162135288|NCT04978363|585545404|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162135289|NCT04978363|585545405|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162135290|NCT04978363|585545406|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
162135291|NCT01251614|585545407|FG000|Overall Study|Adverse Event|1|||
162135292|NCT01251614|585545408|FG001|Overall Study|Adverse Event|0|||
162135293|NCT01251614|585545409|FG002|Overall Study|Adverse Event|1|||
162135294|NCT01251614|585545407|FG000|Overall Study|Lack of Efficacy|1|||
162135295|NCT01251614|585545408|FG001|Overall Study|Lack of Efficacy|9|||
162135296|NCT01251614|585545409|FG002|Overall Study|Lack of Efficacy|4|||
162135297|NCT01251614|585545407|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
162135298|NCT01251614|585545408|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
162135299|NCT01251614|585545409|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
162135300|NCT01251614|585545407|FG000|Overall Study|Pregnancy|0|||
162135301|NCT01251614|585545408|FG001|Overall Study|Pregnancy|0|||
162135302|NCT01251614|585545409|FG002|Overall Study|Pregnancy|2|||
162135303|NCT01251614|585545407|FG000|Overall Study|Loss of Disease Control|0|||
162135304|NCT01251614|585545408|FG001|Overall Study|Loss of Disease Control|1|||
162135305|NCT01251614|585545409|FG002|Overall Study|Loss of Disease Control|0|||
162135306|NCT01251614|585545407|FG000|Overall Study|Withdrawal by Subject|0|||
162135307|NCT01251614|585545408|FG001|Overall Study|Withdrawal by Subject|2|||
162135308|NCT01251614|585545409|FG002|Overall Study|Withdrawal by Subject|1|||
162135309|NCT01251614|585545407|FG000|Overall Study|Lost to Follow-up|0|||
162135310|NCT01251614|585545408|FG001|Overall Study|Lost to Follow-up|1|||
162135311|NCT01251614|585545409|FG002|Overall Study|Lost to Follow-up|0|||
162135312|NCT01876043|585545410|FG000|Overall Study|Death|1|||
162135313|NCT01876043|585545410|FG000|Overall Study|Withdrawal by Subject|1|||
162135314|NCT01211665|585545412|FG000|Overall Study|Withdrawal by Subject|1|||
162135315|NCT01211665|585545413|FG001|Overall Study|Withdrawal by Subject|0|||
162135316|NCT01211665|585545412|FG000|Overall Study|Death|1|||
162135317|NCT01211665|585545413|FG001|Overall Study|Death|0|||
162135318|NCT00498186|585545416|FG000|Overall Study|Protocol Violation|10|||
162135319|NCT00498186|585545416|FG000|Overall Study|Lack of Efficacy|31|||
162135320|NCT00498186|585545416|FG000|Overall Study|Adverse Event|89|||
162135321|NCT00498186|585545416|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
162135322|NCT00498186|585545416|FG000|Overall Study|Withdrawal by Subject|18|||
162135323|NCT00498186|585545416|FG000|Overall Study|Lost to Follow-up|3|||
162135324|NCT00498186|585545416|FG000|Overall Study|Other|10|||
162135325|NCT03302156|585545417|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
162135326|NCT03302156|585545418|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
162135327|NCT03302156|585545419|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
162135328|NCT03635112|585545421|FG000|Overall Study|Adverse Event|5|||
162135329|NCT03635112|585545422|FG001|Overall Study|Adverse Event|9|||
162135330|NCT03635112|585545423|FG002|Overall Study|Adverse Event|14|||
162135331|NCT03635112|585545421|FG000|Overall Study|Lost to Follow-up|1|||
162135332|NCT03635112|585545422|FG001|Overall Study|Lost to Follow-up|0|||
162135333|NCT03635112|585545423|FG002|Overall Study|Lost to Follow-up|1|||
162135334|NCT03635112|585545421|FG000|Overall Study|Physician Decision|5|||
162135335|NCT03635112|585545422|FG001|Overall Study|Physician Decision|7|||
162135336|NCT03635112|585545423|FG002|Overall Study|Physician Decision|5|||
162135337|NCT03635112|585545421|FG000|Overall Study|Protocol Violation|0|||
162135338|NCT03635112|585545422|FG001|Overall Study|Protocol Violation|0|||
162135339|NCT03635112|585545423|FG002|Overall Study|Protocol Violation|1|||
162135340|NCT03635112|585545421|FG000|Overall Study|Study Terminated by Sponsor|11|||
162135341|NCT03635112|585545422|FG001|Overall Study|Study Terminated by Sponsor|17|||
162242828|NCT05222555|585940482|FG001|Overall Study|Withdrawal by Subject|11|||
162242829|NCT03516942|585940489|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
162135342|NCT03635112|585545423|FG002|Overall Study|Study Terminated by Sponsor|21|||
162135343|NCT03635112|585545421|FG000|Overall Study|Withdrawal by Subject|4|||
162242830|NCT03516942|585940489|FG000|Registration through baseline survey com|Death|8|||
162242831|NCT03516942|585940489|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
162242832|NCT03516942|585940489|FG000|T0: Baseline|LOST|13|||
162242833|NCT03516942|585940489|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
162242834|NCT03516942|585940489|FG000|T1: 3 Months Survey|Death|10|||
162242835|NCT03516942|585940489|FG000|T1: 3 Months Survey|Lost|163|||
162242836|NCT03516942|585940489|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
162242837|NCT03516942|585940489|FG000|T2: 6 Month Survey|Death|14|||
162242838|NCT03516942|585940489|FG000|T2: 6 Month Survey|Lost|180|||
162242839|NCT03516942|585940489|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
162242840|NCT03516942|585940489|FG000|T3: 12 Month Survey|Death|19|||
162242841|NCT03516942|585940489|FG000|T3: 12 Month Survey|Lost|209|||
162242842|NCT05028517|585940490|FG000|Overall Study|Lost to Follow-up|13|||
162242843|NCT05028517|585940491|FG001|Overall Study|Lost to Follow-up|20|||
162242844|NCT05028517|585940492|FG002|Overall Study|Lost to Follow-up|12|||
162242845|NCT05028517|585940490|FG000|Overall Study|Withdrawal by Subject|0|||
162242846|NCT05028517|585940491|FG001|Overall Study|Withdrawal by Subject|0|||
162242847|NCT05028517|585940492|FG002|Overall Study|Withdrawal by Subject|1|||
162242848|NCT05089656|585940493|FG000|Period 1 - First Intervention (52 weeks)|Physician Decision|1|||
162242849|NCT05089656|585940494|FG001|Period 1 - First Intervention (52 weeks)|Physician Decision|0|||
162242850|NCT05089656|585940493|FG000|Period 1 - First Intervention (52 weeks)|Guardian decision|1|||
162242851|NCT05089656|585940494|FG001|Period 1 - First Intervention (52 weeks)|Guardian decision|0|||
162242852|NCT05089656|585940493|FG000|Period 1 - First Intervention (52 weeks)|Adverse Event|0|||
162242853|NCT05089656|585940494|FG001|Period 1 - First Intervention (52 weeks)|Adverse Event|1|||
162242854|NCT05089656|585940493|FG000|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|6|||
162242855|NCT05089656|585940494|FG001|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|4|||
162242856|NCT02535416|585940496|FG000|Overall Study|Family bereavement overseas|1|||
162242857|NCT02535416|585940497|FG001|Overall Study|Family bereavement overseas|0|||
162242858|NCT02535416|585940498|FG002|Overall Study|Family bereavement overseas|0|||
162242859|NCT02535416|585940499|FG003|Overall Study|Family bereavement overseas|0|||
162242860|NCT02535416|585940500|FG004|Overall Study|Family bereavement overseas|0|||
162242861|NCT02535416|585940501|FG005|Overall Study|Family bereavement overseas|0|||
162242862|NCT02535416|585940502|FG006|Overall Study|Family bereavement overseas|0|||
162242863|NCT02535416|585940503|FG007|Overall Study|Family bereavement overseas|0|||
162242864|NCT02535416|585940504|FG008|Overall Study|Family bereavement overseas|0|||
162242865|NCT04514341|585940505|FG000|Step 2 (Months 19-21)|In a 3-month delay period|0|||
162242866|NCT04514341|585940506|FG001|Step 2 (Months 19-21)|In a 3-month delay period|15725|||
162242867|NCT04514341|585940505|FG000|Step 4 (Months 31-33)|In a 3-month delay period|0|||
162242868|NCT04514341|585940506|FG001|Step 4 (Months 31-33)|In a 3-month delay period|15037|||
161900664|NCT02692586|584685146|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
161900665|NCT02692586|584685146|FG000|Overall Study|Received adjunctive thrombolytics|2|||
162135344|NCT03635112|585545422|FG001|Overall Study|Withdrawal by Subject|9|||
162135345|NCT03635112|585545423|FG002|Overall Study|Withdrawal by Subject|7|||
162135346|NCT03635112|585545421|FG000|Overall Study|Miscellaneous|0|||
162135347|NCT03635112|585545422|FG001|Overall Study|Miscellaneous|0|||
162135348|NCT03635112|585545423|FG002|Overall Study|Miscellaneous|1|||
162135349|NCT03283553|585545428|FG000|Patient Participant Flow|Death|5|||
162135350|NCT03283553|585545429|FG001|Patient Participant Flow|Death|10|||
162135351|NCT03283553|585545428|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
162135352|NCT03283553|585545429|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
162135353|NCT03283553|585545428|FG000|Patient Participant Flow|Lost to Follow-up|1|||
162135354|NCT03283553|585545429|FG001|Patient Participant Flow|Lost to Follow-up|1|||
162135355|NCT03283553|585545428|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
162135356|NCT03283553|585545429|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
162135357|NCT03283553|585545428|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
162135358|NCT03283553|585545429|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
162135359|NCT03283553|585545428|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
162135360|NCT03283553|585545429|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
162135361|NCT03686683|585545430|FG000|Overall Study|Withdrawal by Subject|52|||
162135362|NCT03686683|585545431|FG001|Overall Study|Withdrawal by Subject|32|||
162135363|NCT03686683|585545430|FG000|Overall Study|Lost to Follow-up|23|||
162135364|NCT03686683|585545431|FG001|Overall Study|Lost to Follow-up|19|||
162135365|NCT03686683|585545430|FG000|Overall Study|Adverse Event|1|||
162135366|NCT03686683|585545431|FG001|Overall Study|Adverse Event|0|||
162135367|NCT03686683|585545430|FG000|Overall Study|Death|10|||
162135368|NCT03686683|585545431|FG001|Overall Study|Death|5|||
162135369|NCT03686683|585545430|FG000|Overall Study|Progressive Disease|1|||
162135370|NCT03686683|585545431|FG001|Overall Study|Progressive Disease|1|||
162135371|NCT03686683|585545430|FG000|Overall Study|Noncompliance|1|||
162135372|NCT03686683|585545431|FG001|Overall Study|Noncompliance|0|||
162135373|NCT03686683|585545430|FG000|Overall Study|Physician Decision|1|||
162135374|NCT03686683|585545431|FG001|Overall Study|Physician Decision|1|||
162135375|NCT03686683|585545430|FG000|Overall Study|Screen fail post-randomization|1|||
162135376|NCT03686683|585545431|FG001|Overall Study|Screen fail post-randomization|0|||
162135377|NCT03686683|585545430|FG000|Overall Study|Protocol Violation|3|||
162135378|NCT03686683|585545431|FG001|Overall Study|Protocol Violation|0|||
162135379|NCT03686683|585545430|FG000|Overall Study|No data available|1|||
162135380|NCT03686683|585545431|FG001|Overall Study|No data available|0|||
162135381|NCT01770860|585545432|FG000|Overall Study|Withdrawal by Subject|4|||
162135382|NCT01770860|585545432|FG000|Overall Study|Lost to Follow-up|1|||
162135383|NCT01770860|585545432|FG000|Overall Study|Administrative decision made by the PI|1|||
162135384|NCT05124899|585545433|FG000|Overall Study|Lost to Follow-up|3|||
162135385|NCT03432533|585545438|FG000|Overall Study|Lost to Follow-up|1|||
162135386|NCT03432533|585545439|FG001|Overall Study|Lost to Follow-up|2|||
162135387|NCT03432533|585545438|FG000|Overall Study|Withdrawal by Subject|14|||
162135388|NCT03432533|585545439|FG001|Overall Study|Withdrawal by Subject|9|||
162135389|NCT01605136|585545450|FG000|Study Period|Withdrawal by Subject|2|||
162135390|NCT01605136|585545451|FG001|Study Period|Withdrawal by Subject|0|||
162135391|NCT01605136|585545450|FG000|Study Period|Physician Decision|1|||
162135392|NCT01605136|585545451|FG001|Study Period|Physician Decision|1|||
162135393|NCT01605136|585545450|FG000|Study Period|Lost to Follow-up|0|||
162135394|NCT01605136|585545451|FG001|Study Period|Lost to Follow-up|2|||
162135395|NCT01605136|585545450|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
162135396|NCT01605136|585545451|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
162135397|NCT01072929|585545452|FG000|Overall Study|Adverse Event|8|||
162135398|NCT01072929|585545453|FG001|Overall Study|Adverse Event|11|||
162135399|NCT01072929|585545454|FG002|Overall Study|Adverse Event|2|||
161796191|NCT00113490|584298172|FG001|Overall Study|Withdrawal by Subject|3|||
161796192|NCT00113490|584298171|FG000|Overall Study|Lost to Follow-up|1|||
161796193|NCT00113490|584298172|FG001|Overall Study|Lost to Follow-up|0|||
161796194|NCT04652453|584298174|FG000|Overall Study|Death|8|||
161796195|NCT04652453|584298175|FG001|Overall Study|Death|2|||
161796196|NCT04652453|584298176|FG002|Overall Study|Death|0|||
161796197|NCT04652453|584298174|FG000|Overall Study|Hospice|5|||
161796198|NCT04652453|584298175|FG001|Overall Study|Hospice|5|||
162135400|NCT01072929|585545452|FG000|Overall Study|Lack of Efficacy|7|||
162135401|NCT01072929|585545453|FG001|Overall Study|Lack of Efficacy|4|||
162135402|NCT01072929|585545454|FG002|Overall Study|Lack of Efficacy|0|||
162135403|NCT01072929|585545452|FG000|Overall Study|Withdrawal by Subject|7|||
162135404|NCT01072929|585545453|FG001|Overall Study|Withdrawal by Subject|15|||
162135405|NCT01072929|585545454|FG002|Overall Study|Withdrawal by Subject|3|||
162135406|NCT01072929|585545452|FG000|Overall Study|Protocol Violation|13|||
162135407|NCT01072929|585545453|FG001|Overall Study|Protocol Violation|11|||
162135408|NCT01072929|585545454|FG002|Overall Study|Protocol Violation|2|||
162135409|NCT01072929|585545452|FG000|Overall Study|Lost to Follow-up|8|||
162135410|NCT01072929|585545453|FG001|Overall Study|Lost to Follow-up|4|||
162135411|NCT01072929|585545454|FG002|Overall Study|Lost to Follow-up|1|||
162135412|NCT01072929|585545452|FG000|Overall Study|Noncompliance with study medication|0|||
162135413|NCT01072929|585545453|FG001|Overall Study|Noncompliance with study medication|3|||
162135414|NCT01072929|585545454|FG002|Overall Study|Noncompliance with study medication|0|||
162135415|NCT01072929|585545452|FG000|Overall Study|Noncompliance with study procedures|1|||
162135416|NCT01072929|585545453|FG001|Overall Study|Noncompliance with study procedures|0|||
162135417|NCT01072929|585545454|FG002|Overall Study|Noncompliance with study procedures|1|||
162135418|NCT01072929|585545452|FG000|Overall Study|Other|0|||
162135419|NCT01072929|585545453|FG001|Overall Study|Other|3|||
162135420|NCT01072929|585545454|FG002|Overall Study|Other|0|||
162135421|NCT04833855|585545455|FG000|Overall Study|Decision by sponsor|0|||
162135422|NCT04833855|585545456|FG001|Overall Study|Decision by sponsor|1|||
162135423|NCT04833855|585545457|FG002|Overall Study|Decision by sponsor|0|||
162135424|NCT04833855|585545458|FG003|Overall Study|Decision by sponsor|0|||
162135425|NCT04833855|585545455|FG000|Overall Study|Withdrawal by Subject|4|||
162135426|NCT04833855|585545456|FG001|Overall Study|Withdrawal by Subject|1|||
162135427|NCT04833855|585545457|FG002|Overall Study|Withdrawal by Subject|3|||
162135428|NCT04833855|585545458|FG003|Overall Study|Withdrawal by Subject|1|||
162135429|NCT04833855|585545455|FG000|Overall Study|Lost to Follow-up|1|||
162135430|NCT04833855|585545456|FG001|Overall Study|Lost to Follow-up|0|||
162135431|NCT04833855|585545457|FG002|Overall Study|Lost to Follow-up|2|||
162135432|NCT04833855|585545458|FG003|Overall Study|Lost to Follow-up|2|||
162135433|NCT04833855|585545455|FG000|Overall Study|Protocol specified criteria|0|||
162135434|NCT04833855|585545456|FG001|Overall Study|Protocol specified criteria|0|||
162135435|NCT04833855|585545457|FG002|Overall Study|Protocol specified criteria|2|||
162135436|NCT04833855|585545458|FG003|Overall Study|Protocol specified criteria|1|||
162135437|NCT02806336|585545459|FG000|Overall Study|Physician Decision|1|||
162135438|NCT02806336|585545460|FG001|Overall Study|Physician Decision|0|||
162135439|NCT02806336|585545459|FG000|Overall Study|Withdrawal by Subject|2|||
162135440|NCT02806336|585545460|FG001|Overall Study|Withdrawal by Subject|4|||
162135441|NCT02806336|585545459|FG000|Overall Study|COVID-19 research shut down|3|||
162135442|NCT02806336|585545460|FG001|Overall Study|COVID-19 research shut down|4|||
162135443|NCT02806336|585545459|FG000|Overall Study|Lack of Efficacy|0|||
162135444|NCT02806336|585545460|FG001|Overall Study|Lack of Efficacy|1|||
162135445|NCT03682536|585545461|FG000|Randomization|Withdrawal by Subject|0|||
162135446|NCT03682536|585545462|FG001|Randomization|Withdrawal by Subject|2|||
162135447|NCT03682536|585545461|FG000|Treatment|Other Reasons|8|||
161796199|NCT04652453|584298176|FG002|Overall Study|Hospice|0|||
161900666|NCT03316586|584685151|FG000|Overall Study|Adverse Event|2|||
161900667|NCT03316586|584685151|FG000|Overall Study|Physician Decision|3|||
161900668|NCT03316586|584685151|FG000|Overall Study|Lack of Efficacy|10|||
161900669|NCT03316586|584685151|FG000|Overall Study|still on treatment|1|||
162135448|NCT03682536|585545462|FG001|Treatment|Other Reasons|7|||
162135449|NCT03682536|585545461|FG000|Treatment|Physician Decision|5|||
162135450|NCT03682536|585545462|FG001|Treatment|Physician Decision|5|||
162135451|NCT03682536|585545461|FG000|Treatment|Protocol Violation|1|||
162135452|NCT03682536|585545462|FG001|Treatment|Protocol Violation|0|||
162135453|NCT03682536|585545461|FG000|Treatment|Study Terminated by Sponsor|1|||
162135454|NCT03682536|585545462|FG001|Treatment|Study Terminated by Sponsor|2|||
162135455|NCT03682536|585545461|FG000|Treatment|Lost to Follow-up|0|||
162135456|NCT03682536|585545462|FG001|Treatment|Lost to Follow-up|1|||
162135457|NCT03682536|585545461|FG000|Treatment|Withdrawal by Subject|16|||
162135458|NCT03682536|585545462|FG001|Treatment|Withdrawal by Subject|18|||
162135459|NCT03682536|585545461|FG000|Treatment|Lack of Efficacy|41|||
162135460|NCT03682536|585545462|FG001|Treatment|Lack of Efficacy|68|||
162135461|NCT03682536|585545461|FG000|Treatment|Disease Progression|9|||
162135462|NCT03682536|585545462|FG001|Treatment|Disease Progression|7|||
162135463|NCT03682536|585545461|FG000|Treatment|Adverse Event|9|||
162135464|NCT03682536|585545462|FG001|Treatment|Adverse Event|5|||
162135465|NCT03682536|585545461|FG000|Treatment|Death|14|||
162135466|NCT03682536|585545462|FG001|Treatment|Death|13|||
162135467|NCT03008122|585545468|FG000|Overall Study|Physician Decision|3|||
162135468|NCT03008122|585545469|FG001|Overall Study|Physician Decision|2|||
162135469|NCT03008122|585545470|FG002|Overall Study|Physician Decision|0|||
162135470|NCT03008122|585545468|FG000|Overall Study|Withdrawal by Subject|1|||
162135471|NCT03008122|585545469|FG001|Overall Study|Withdrawal by Subject|3|||
162135472|NCT03008122|585545470|FG002|Overall Study|Withdrawal by Subject|0|||
162135473|NCT03008122|585545468|FG000|Overall Study|Lost to Follow-up|4|||
162135474|NCT03008122|585545469|FG001|Overall Study|Lost to Follow-up|8|||
162135475|NCT03008122|585545470|FG002|Overall Study|Lost to Follow-up|3|||
162135476|NCT03008122|585545468|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
162135477|NCT03008122|585545469|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
162135478|NCT03008122|585545470|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
162135479|NCT03008122|585545468|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
162135480|NCT03008122|585545469|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
162135481|NCT03008122|585545470|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
162135482|NCT03008122|585545468|FG000|Overall Study|Death|0|||
162135483|NCT03008122|585545469|FG001|Overall Study|Death|0|||
162135484|NCT03008122|585545470|FG002|Overall Study|Death|1|||
162135485|NCT04159896|585545471|FG000|Overall Study|Lack of Efficacy|7|||
162135486|NCT04159896|585545471|FG000|Overall Study|Withdrawal by Subject|1|||
162135487|NCT04159896|585545471|FG000|Overall Study|Adverse Event|1|||
162135488|NCT04159896|585545471|FG000|Overall Study|A transient ischaemic attack|1|||
162135489|NCT01222247|585545472|FG000|Overall Study|Lost to Follow-up|2|||
162135490|NCT01222247|585545473|FG001|Overall Study|Lost to Follow-up|2|||
162135491|NCT02338609|585545474|FG000|Overall Study|Physician Decision|1|||
162135492|NCT02338609|585545474|FG000|Overall Study|Death|1|||
162135493|NCT02084082|585545475|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
162135494|NCT02084082|585545476|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
162135495|NCT02084082|585545477|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
162135496|NCT02084082|585545478|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
162135497|NCT02084082|585545475|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
162135498|NCT02084082|585545476|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
162135499|NCT02084082|585545477|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
162135500|NCT02084082|585545478|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
162135501|NCT02148718|585545483|FG000|Overall Study|Protocol Violation|26|||
162135502|NCT02148718|585545483|FG000|Overall Study|Discontinued Study Prematurely|5|||
162135503|NCT01822821|585545488|FG000|Overall Study|Eligible surgery cancelled|1|||
162135504|NCT01822821|585545489|FG001|Overall Study|Eligible surgery cancelled|1|||
162135505|NCT01822821|585545488|FG000|Overall Study|Other reasons|1|||
162135506|NCT01822821|585545489|FG001|Overall Study|Other reasons|0|||
162135507|NCT00333788|585545492|FG000|Overall Study|Adverse Event|44|||
162135508|NCT00333788|585545492|FG000|Overall Study|Lack of Efficacy|80|||
162135509|NCT00333788|585545492|FG000|Overall Study|Lost to Follow-up|2|||
162135510|NCT00333788|585545492|FG000|Overall Study|Withdrawal by Subject|24|||
162135511|NCT00333788|585545492|FG000|Overall Study|Other: Non-compliance|2|||
162135512|NCT00333788|585545492|FG000|Overall Study|Other: Moved|2|||
162135513|NCT00333788|585545492|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
162135514|NCT00333788|585545492|FG000|Overall Study|Other: Investigator decision|1|||
162135515|NCT00333788|585545492|FG000|Overall Study|Other: Quality of life concern|1|||
162135516|NCT00333788|585545492|FG000|Overall Study|Other: Sponsor decision|1|||
161900670|NCT03316586|584685151|FG000|Overall Study|Patient needed radiation therapy|1|||
162135517|NCT00333788|585545492|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
162135518|NCT00333788|585545492|FG000|Overall Study|Other: Medical monitor decision|1|||
162135519|NCT00333788|585545492|FG000|Overall Study|Other: Physician decision|1|||
162135520|NCT00333788|585545492|FG000|Overall Study|Other: Signed consent for another study|1|||
161796200|NCT04652453|584298174|FG000|Overall Study|Withdrawal by Subject|2|||
161796201|NCT04652453|584298175|FG001|Overall Study|Withdrawal by Subject|0|||
161796202|NCT04652453|584298176|FG002|Overall Study|Withdrawal by Subject|0|||
161796203|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
162135521|NCT00114959|585545493|FG000|Overall Study|Lack of Efficacy|6|||
162135522|NCT00114959|585545493|FG000|Overall Study|Physician Decision|1|||
162135523|NCT00114959|585545493|FG000|Overall Study|Death|1|||
162135524|NCT02322775|585545500|FG000|Overall Study|Adverse Event|1|||
162135525|NCT02322775|585545501|FG001|Overall Study|Adverse Event|0|||
162135526|NCT02322775|585545500|FG000|Overall Study|Lost to Follow-up|0|||
162135527|NCT02322775|585545501|FG001|Overall Study|Lost to Follow-up|1|||
162135528|NCT02322775|585545500|FG000|Overall Study|Protocol Violation|1|||
162135529|NCT02322775|585545501|FG001|Overall Study|Protocol Violation|0|||
162135530|NCT02322775|585545500|FG000|Overall Study|Withdrawal by Subject|3|||
162135531|NCT02322775|585545501|FG001|Overall Study|Withdrawal by Subject|4|||
162135532|NCT02322775|585545500|FG000|Overall Study|Not willing to perform all FU visits|0|||
162135533|NCT02322775|585545501|FG001|Overall Study|Not willing to perform all FU visits|1|||
162135534|NCT04739423|585545502|FG000|Overall Study|Protocol Violation|0|||
162135535|NCT04739423|585545503|FG001|Overall Study|Protocol Violation|1|||
162135536|NCT04739423|585545504|FG002|Overall Study|Protocol Violation|0|||
162135537|NCT04739423|585545505|FG003|Overall Study|Protocol Violation|0|||
162135538|NCT04739423|585545506|FG004|Overall Study|Protocol Violation|0|||
162135539|NCT04739423|585545507|FG005|Overall Study|Protocol Violation|0|||
162135540|NCT04739423|585545502|FG000|Overall Study|Adverse Event|0|||
162135541|NCT04739423|585545503|FG001|Overall Study|Adverse Event|0|||
162135542|NCT04739423|585545504|FG002|Overall Study|Adverse Event|1|||
162135543|NCT04739423|585545505|FG003|Overall Study|Adverse Event|0|||
162135544|NCT04739423|585545506|FG004|Overall Study|Adverse Event|1|||
162135545|NCT04739423|585545507|FG005|Overall Study|Adverse Event|0|||
162135546|NCT04739423|585545502|FG000|Overall Study|Withdrawal by Subject|0|||
162135547|NCT04739423|585545503|FG001|Overall Study|Withdrawal by Subject|0|||
162135548|NCT04739423|585545504|FG002|Overall Study|Withdrawal by Subject|0|||
162135549|NCT04739423|585545505|FG003|Overall Study|Withdrawal by Subject|0|||
162135550|NCT04739423|585545506|FG004|Overall Study|Withdrawal by Subject|0|||
162135551|NCT04739423|585545507|FG005|Overall Study|Withdrawal by Subject|1|||
162135552|NCT01007552|585545511|FG000|Overall Study|Withdrawal by Subject|1|||
162135553|NCT01823341|585545527|FG000|Overall Study|Failed run-in|7|||
162135554|NCT01823341|585545527|FG000|Overall Study|Withdrawal by Subject|7|||
162135555|NCT01823341|585545527|FG000|Overall Study|Adverse Event|1|||
162135556|NCT00663962|585545528|FG000|Overall Study|somnolence|1|||
162135557|NCT00663962|585545529|FG001|Overall Study|somnolence|0|||
162135558|NCT02698436|585545541|FG000|Overall Study|Adverse Event|1|||
162135559|NCT02698436|585545542|FG001|Overall Study|Adverse Event|0|||
162135560|NCT02698436|585545541|FG000|Overall Study|Withdrawal by Subject|3|||
162135561|NCT02698436|585545542|FG001|Overall Study|Withdrawal by Subject|3|||
162135562|NCT02698436|585545541|FG000|Overall Study|Lost to Follow-up|2|||
162135563|NCT02698436|585545542|FG001|Overall Study|Lost to Follow-up|4|||
162135564|NCT02698436|585545541|FG000|Overall Study|Non-compliance with study regimen|1|||
162135565|NCT02698436|585545542|FG001|Overall Study|Non-compliance with study regimen|0|||
162135566|NCT00665561|585545547|FG000|Overall Study|Death recorded on subject summary pages|75|||
162135567|NCT00665561|585545548|FG001|Overall Study|Death recorded on subject summary pages|75|||
162135568|NCT00665561|585545547|FG000|Overall Study|Does not meet entrance criteria|19|||
162135569|NCT00665561|585545548|FG001|Overall Study|Does not meet entrance criteria|21|||
162135570|NCT00665561|585545547|FG000|Overall Study|Lost to Follow-up|203|||
162135571|NCT00665561|585545548|FG001|Overall Study|Lost to Follow-up|264|||
162135572|NCT00665561|585545547|FG000|Overall Study|Withdrawal by Subject|74|||
162135573|NCT00665561|585545548|FG001|Overall Study|Withdrawal by Subject|65|||
162135574|NCT00665561|585545547|FG000|Overall Study|Other|123|||
162135575|NCT00665561|585545548|FG001|Overall Study|Other|108|||
162135576|NCT00665561|585545547|FG000|Overall Study|Site closed|8|||
162135577|NCT00665561|585545548|FG001|Overall Study|Site closed|0|||
162135578|NCT00665561|585545547|FG000|Overall Study|Withdrawn due to pregnancy|0|||
162135579|NCT00665561|585545548|FG001|Overall Study|Withdrawn due to pregnancy|1|||
162135580|NCT01449929|585545549|FG000|Randomization Phase 96 Week|Adverse Event|5|||
162135581|NCT01449929|585545550|FG001|Randomization Phase 96 Week|Adverse Event|13|||
162135582|NCT01449929|585545551|FG002|Randomization Phase 96 Week|Adverse Event|0|||
162135583|NCT01449929|585545549|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
162135584|NCT01449929|585545550|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
162135585|NCT01449929|585545551|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
162135586|NCT01449929|585545549|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
162135587|NCT01449929|585545550|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
162135588|NCT01449929|585545551|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
162135589|NCT01449929|585545549|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
162135590|NCT01449929|585545550|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
161796204|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
161796205|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796206|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796207|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796208|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
161796209|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
161796210|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796211|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796212|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796213|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
162135591|NCT01449929|585545551|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
162135592|NCT01449929|585545549|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
162135593|NCT01449929|585545550|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
162135594|NCT01449929|585545551|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
162135595|NCT01449929|585545549|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
162135596|NCT01449929|585545550|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
162135597|NCT01449929|585545551|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
162135598|NCT01449929|585545549|FG000|Randomization Phase 96 Week|Physician Decision|2|||
162135599|NCT01449929|585545550|FG001|Randomization Phase 96 Week|Physician Decision|3|||
162135600|NCT01449929|585545551|FG002|Randomization Phase 96 Week|Physician Decision|0|||
162135601|NCT01449929|585545549|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
162135602|NCT01449929|585545550|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
162135603|NCT01449929|585545551|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
161796214|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796215|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796216|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161796217|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796218|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796219|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796220|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796221|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796222|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
161796223|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
161796224|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796225|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796226|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
162135604|NCT01449929|585545549|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
162135605|NCT01449929|585545550|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
162135606|NCT01449929|585545551|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
162135607|NCT01449929|585545549|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
162135608|NCT01449929|585545550|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
162135609|NCT01449929|585545551|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
162135610|NCT01449929|585545549|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
162135611|NCT01449929|585545550|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
162135612|NCT01449929|585545551|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
162135613|NCT03253653|585545552|FG000|Overall Study|Withdrawal by Subject|4|||
162135614|NCT03253653|585545553|FG001|Overall Study|Withdrawal by Subject|1|||
162135615|NCT03253653|585545552|FG000|Overall Study|Protocol Violation|0|||
162135616|NCT03253653|585545553|FG001|Overall Study|Protocol Violation|5|||
162135617|NCT00079937|585547305|FG000|Overall Study|Adverse Event|2|||
162135618|NCT00079937|585547306|FG001|Overall Study|Adverse Event|1|||
162135619|NCT00079937|585547305|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162135620|NCT00079937|585547306|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162135621|NCT00079937|585547305|FG000|Overall Study|Subject no longer requires study drug|3|||
162135622|NCT00079937|585547306|FG001|Overall Study|Subject no longer requires study drug|0|||
162135623|NCT00079937|585547305|FG000|Overall Study|Protocol Violation|8|||
162135624|NCT00079937|585547306|FG001|Overall Study|Protocol Violation|6|||
162135625|NCT00079937|585547305|FG000|Overall Study|Withdrawal by Subject|21|||
162135626|NCT00079937|585547306|FG001|Overall Study|Withdrawal by Subject|7|||
162135627|NCT00079937|585547305|FG000|Overall Study|Lost to Follow-up|12|||
161796227|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796228|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796229|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796230|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161796231|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
161796232|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796233|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796234|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796235|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796236|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796237|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
161796238|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796239|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796240|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796241|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796242|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796243|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796244|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161796245|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796246|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796247|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796248|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796249|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796250|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
161796251|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
161796252|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796253|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796254|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796255|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796256|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796257|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796258|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161796259|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796260|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796261|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796262|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796263|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796264|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796265|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
161796266|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161900671|NCT03316586|584685151|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
162135628|NCT00079937|585547306|FG001|Overall Study|Lost to Follow-up|5|||
162135629|NCT00079937|585547305|FG000|Overall Study|Administrative problems|22|||
162135630|NCT00079937|585547306|FG001|Overall Study|Administrative problems|11|||
162135631|NCT02857283|585547307|FG000|First Exposure|Withdrawal by Subject|1|||
161796267|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161900672|NCT00994110|584685152|FG000|Overall Study|Withdrawal by Subject|9|||
162135632|NCT02857283|585547308|FG001|First Exposure|Withdrawal by Subject|0|||
162135633|NCT00093795|585547309|FG000|Overall Study|No follow up data|20|||
162010828|NCT00887809|585096014|FG000|Overall Study|Patient Not Treated|3|||
162135634|NCT00093795|585547310|FG001|Overall Study|No follow up data|16|||
162135635|NCT00093795|585547311|FG002|Overall Study|No follow up data|17|||
162135636|NCT00613301|585547312|FG000|Overall Study|Adverse Event|49|||
162135637|NCT00613301|585547312|FG000|Overall Study|Lost to Follow-up|88|||
162135638|NCT00613301|585547312|FG000|Overall Study|Withdrawal by Subject|5|||
162135639|NCT00613301|585547312|FG000|Overall Study|Death|6|||
162135640|NCT00613301|585547312|FG000|Overall Study|Lack of Efficacy|13|||
162135641|NCT00613301|585547312|FG000|Overall Study|Physician Decision|2|||
162135642|NCT00613301|585547312|FG000|Overall Study|No data was collected|53|||
162135643|NCT00613301|585547312|FG000|Overall Study|Irregularly enrolled patients|12|||
162135644|NCT01684046|585547315|FG000|Period 1, First 30 Days|Adverse Event|0|||
162135645|NCT01684046|585547316|FG001|Period 1, First 30 Days|Adverse Event|2|||
162135646|NCT00587288|585547317|FG000|Overall Study|Adverse Event|0|||
162135647|NCT00587288|585547318|FG001|Overall Study|Adverse Event|1|||
162135648|NCT00587288|585547317|FG000|Overall Study|Lack of Efficacy|2|||
162135649|NCT00587288|585547318|FG001|Overall Study|Lack of Efficacy|8|||
162135650|NCT00587288|585547317|FG000|Overall Study|Protocol Violation|1|||
162135651|NCT00587288|585547318|FG001|Overall Study|Protocol Violation|0|||
162135652|NCT00762463|585547319|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
162135653|NCT00762463|585547320|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
162135654|NCT00762463|585547321|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
162135655|NCT00762463|585547322|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
162135656|NCT00762463|585547319|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
162135657|NCT00762463|585547320|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
162135658|NCT00762463|585547321|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
162135659|NCT00762463|585547322|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
162135660|NCT00762463|585547319|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
162135661|NCT00762463|585547320|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
162135662|NCT00762463|585547321|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
162135663|NCT00762463|585547322|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
162135664|NCT00762463|585547319|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
162135665|NCT00762463|585547320|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
162135666|NCT00762463|585547321|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
162135667|NCT00762463|585547322|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
162135668|NCT00762463|585547319|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
162135669|NCT00762463|585547320|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
162135670|NCT00762463|585547321|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
162135671|NCT00762463|585547322|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
162135672|NCT00762463|585547319|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
162135673|NCT00762463|585547320|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
162135674|NCT00762463|585547321|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
162135675|NCT00762463|585547322|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
162135676|NCT00762463|585547319|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
162135677|NCT00762463|585547320|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
162135678|NCT00762463|585547321|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
162135679|NCT00762463|585547322|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
162135680|NCT00762463|585547319|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
162135681|NCT00762463|585547320|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
162135682|NCT00762463|585547321|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
162135683|NCT00762463|585547322|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
162135684|NCT00797862|585547323|FG000|Overall Study|Adverse Event|86|||
162135685|NCT00797862|585547324|FG001|Overall Study|Adverse Event|44|||
162135686|NCT00797862|585547325|FG002|Overall Study|Adverse Event|58|||
162135687|NCT00797862|585547323|FG000|Overall Study|Abnormal Test Procedure Result|0|||
162135688|NCT00797862|585547324|FG001|Overall Study|Abnormal Test Procedure Result|1|||
162135689|NCT00797862|585547325|FG002|Overall Study|Abnormal Test Procedure Result|1|||
162135690|NCT00797862|585547323|FG000|Overall Study|Lack of Efficacy|1|||
162135691|NCT00797862|585547324|FG001|Overall Study|Lack of Efficacy|7|||
162135692|NCT00797862|585547325|FG002|Overall Study|Lack of Efficacy|6|||
162135693|NCT00797862|585547323|FG000|Overall Study|No longer required study medication|1|||
162135694|NCT00797862|585547324|FG001|Overall Study|No longer required study medication|0|||
162135695|NCT00797862|585547325|FG002|Overall Study|No longer required study medication|0|||
162135696|NCT00797862|585547323|FG000|Overall Study|Withdrawal by Subject|14|||
162135697|NCT00797862|585547324|FG001|Overall Study|Withdrawal by Subject|7|||
162135698|NCT00797862|585547325|FG002|Overall Study|Withdrawal by Subject|7|||
162135699|NCT00797862|585547323|FG000|Overall Study|Lost to Follow-up|11|||
162135700|NCT00797862|585547324|FG001|Overall Study|Lost to Follow-up|0|||
162135701|NCT00797862|585547325|FG002|Overall Study|Lost to Follow-up|5|||
162135702|NCT00797862|585547323|FG000|Overall Study|Administrative Problem|4|||
161900673|NCT00994110|584685153|FG001|Overall Study|Withdrawal by Subject|9|||
161900674|NCT00994110|584685152|FG000|Overall Study|Not Treated|4|||
161900675|NCT00994110|584685153|FG001|Overall Study|Not Treated|8|||
161900676|NCT00994110|584685152|FG000|Overall Study|Adverse Event|1|||
161900677|NCT00994110|584685153|FG001|Overall Study|Adverse Event|0|||
161900678|NCT00994110|584685152|FG000|Overall Study|Patient not resected|41|||
161900679|NCT00994110|584685153|FG001|Overall Study|Patient not resected|52|||
161900680|NCT00994110|584685152|FG000|Overall Study|Pt not eligible|10|||
161900681|NCT00994110|584685153|FG001|Overall Study|Pt not eligible|5|||
162135703|NCT00797862|585547324|FG001|Overall Study|Administrative Problem|0|||
162135704|NCT00797862|585547325|FG002|Overall Study|Administrative Problem|0|||
162135705|NCT00797862|585547323|FG000|Overall Study|Protocol Violation|4|||
162135706|NCT00797862|585547324|FG001|Overall Study|Protocol Violation|6|||
162135707|NCT00797862|585547325|FG002|Overall Study|Protocol Violation|8|||
162135708|NCT00797862|585547323|FG000|Overall Study|Mis-randomized|3|||
162135709|NCT00797862|585547324|FG001|Overall Study|Mis-randomized|3|||
162135710|NCT00797862|585547325|FG002|Overall Study|Mis-randomized|1|||
162135711|NCT00531479|585547326|FG000|Overall Study|Death|68|||
162135712|NCT00531479|585547327|FG001|Overall Study|Death|71|||
162135713|NCT00531479|585547326|FG000|Overall Study|Lost to Follow-up|0|||
162135714|NCT00531479|585547327|FG001|Overall Study|Lost to Follow-up|2|||
162135715|NCT00531479|585547326|FG000|Overall Study|Other|0|||
162135716|NCT00531479|585547327|FG001|Overall Study|Other|1|||
162135717|NCT00531479|585547326|FG000|Overall Study|Withdrawal by Subject|6|||
162135718|NCT00531479|585547327|FG001|Overall Study|Withdrawal by Subject|6|||
162135719|NCT00531479|585547326|FG000|Overall Study|Did not receive treatment|2|||
162135720|NCT00531479|585547327|FG001|Overall Study|Did not receive treatment|3|||
162135721|NCT05074498|585547332|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
162135722|NCT05074498|585547333|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
162135723|NCT05074498|585547334|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
162135724|NCT05074498|585547335|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
162135725|NCT05074498|585547336|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
162135726|NCT05074498|585547337|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
162135727|NCT05074498|585547332|FG000|Part 1 (Upto Day 104)|Other|1|||
162135728|NCT05074498|585547333|FG001|Part 1 (Upto Day 104)|Other|0|||
162135729|NCT05074498|585547334|FG002|Part 1 (Upto Day 104)|Other|0|||
162135730|NCT05074498|585547335|FG003|Part 1 (Upto Day 104)|Other|0|||
162135731|NCT05074498|585547336|FG004|Part 1 (Upto Day 104)|Other|0|||
162135732|NCT05074498|585547337|FG005|Part 1 (Upto Day 104)|Other|0|||
162135733|NCT05074498|585547332|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
162135734|NCT05074498|585547333|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
162135735|NCT05074498|585547334|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
162135736|NCT05074498|585547335|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
162135737|NCT05074498|585547336|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
162135738|NCT05074498|585547337|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
162135739|NCT05074498|585547332|FG000|Part 2 (Upto Day 104)|Death|0|||
162135740|NCT05074498|585547333|FG001|Part 2 (Upto Day 104)|Death|0|||
162135741|NCT05074498|585547334|FG002|Part 2 (Upto Day 104)|Death|0|||
162135742|NCT05074498|585547335|FG003|Part 2 (Upto Day 104)|Death|0|||
162135743|NCT05074498|585547336|FG004|Part 2 (Upto Day 104)|Death|1|||
162135744|NCT05074498|585547337|FG005|Part 2 (Upto Day 104)|Death|0|||
162135745|NCT05074498|585547332|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
162135746|NCT05074498|585547333|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
162135747|NCT05074498|585547334|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
162135748|NCT05074498|585547335|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
162135749|NCT05074498|585547336|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
162135750|NCT05074498|585547337|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
162135751|NCT05074498|585547332|FG000|Part 2 (Upto Day 104)|Other|0|||
162135752|NCT05074498|585547333|FG001|Part 2 (Upto Day 104)|Other|0|||
162135753|NCT05074498|585547334|FG002|Part 2 (Upto Day 104)|Other|0|||
162135754|NCT05074498|585547335|FG003|Part 2 (Upto Day 104)|Other|0|||
162135755|NCT05074498|585547336|FG004|Part 2 (Upto Day 104)|Other|1|||
162135756|NCT05074498|585547337|FG005|Part 2 (Upto Day 104)|Other|0|||
162135757|NCT01306331|585547339|FG000|Overall Study|Adverse Event|28|||
162135758|NCT01306331|585547340|FG001|Overall Study|Adverse Event|25|||
162135759|NCT01306331|585547339|FG000|Overall Study|Lost to Follow-up|321|||
162135760|NCT01306331|585547340|FG001|Overall Study|Lost to Follow-up|323|||
162135761|NCT01306331|585547339|FG000|Overall Study|Physician Decision|26|||
162135762|NCT01306331|585547340|FG001|Overall Study|Physician Decision|22|||
162135763|NCT01306331|585547339|FG000|Overall Study|Pregnancy|136|||
162135764|NCT01306331|585547340|FG001|Overall Study|Pregnancy|151|||
162135765|NCT01306331|585547339|FG000|Overall Study|Protocol Violation|154|||
162135766|NCT01306331|585547340|FG001|Overall Study|Protocol Violation|124|||
162135767|NCT01306331|585547339|FG000|Overall Study|Withdrawal by Subject|163|||
162135768|NCT01306331|585547340|FG001|Overall Study|Withdrawal by Subject|152|||
162135769|NCT01306331|585547339|FG000|Overall Study|Not sexually active|29|||
162135770|NCT01306331|585547340|FG001|Overall Study|Not sexually active|28|||
162135771|NCT01306331|585547339|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
162135772|NCT01306331|585547340|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
162135773|NCT01306331|585547339|FG000|Overall Study|Other|34|||
162135774|NCT01306331|585547340|FG001|Overall Study|Other|32|||
162135775|NCT00172185|585547347|FG000|Overall Study|Adverse Event|0|||
162135776|NCT00172185|585547348|FG001|Overall Study|Adverse Event|1|||
162135777|NCT00172185|585547349|FG002|Overall Study|Adverse Event|3|||
162135778|NCT00172185|585547350|FG003|Overall Study|Adverse Event|4|||
162135779|NCT00172185|585547347|FG000|Overall Study|Physician Decision|0|||
162135780|NCT00172185|585547348|FG001|Overall Study|Physician Decision|0|||
162135781|NCT00172185|585547349|FG002|Overall Study|Physician Decision|1|||
162010829|NCT00887809|585096015|FG001|Overall Study|Patient Not Treated|0|||
162010830|NCT00887809|585096014|FG000|Overall Study|Death|1|||
161796268|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162135782|NCT00172185|585547350|FG003|Overall Study|Physician Decision|0|||
162135783|NCT00172185|585547347|FG000|Overall Study|SPONSOR Decision|0|||
162135784|NCT00172185|585547348|FG001|Overall Study|SPONSOR Decision|1|||
162135785|NCT00172185|585547349|FG002|Overall Study|SPONSOR Decision|0|||
162135786|NCT00172185|585547350|FG003|Overall Study|SPONSOR Decision|0|||
162135787|NCT00172185|585547347|FG000|Overall Study|Withdrawal by Subject|0|||
162135788|NCT00172185|585547348|FG001|Overall Study|Withdrawal by Subject|0|||
162135789|NCT00172185|585547349|FG002|Overall Study|Withdrawal by Subject|1|||
162135790|NCT00172185|585547350|FG003|Overall Study|Withdrawal by Subject|0|||
162135791|NCT01677936|585547351|FG000|Overall Study|Lost to Follow-up|4|||
162135792|NCT01677936|585547352|FG001|Overall Study|Lost to Follow-up|1|||
162135793|NCT01677936|585547351|FG000|Overall Study|Protocol Violation|3|||
162135794|NCT01677936|585547352|FG001|Overall Study|Protocol Violation|0|||
162135795|NCT01677936|585547351|FG000|Overall Study|Adverse Event|1|||
162135796|NCT01677936|585547352|FG001|Overall Study|Adverse Event|0|||
162135797|NCT01677936|585547351|FG000|Overall Study|Lost to Follow-up|1|||
162135798|NCT01677936|585547352|FG001|Overall Study|Lost to Follow-up|0|||
162135799|NCT01677936|585547351|FG000|Overall Study|Protocol Violation|0|||
162135800|NCT01677936|585547352|FG001|Overall Study|Protocol Violation|4|||
162135801|NCT02790606|585547355|FG000|Overall Study|Death|27|||
162135802|NCT02790606|585547355|FG000|Overall Study|Lost to Follow-up|4|||
162135803|NCT02790606|585547355|FG000|Overall Study|Physician Decision|3|||
162135804|NCT02790606|585547355|FG000|Overall Study|Withdrawal by Subject|1|||
162135805|NCT02735915|585547356|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
162135806|NCT02735915|585547356|FG000|Overall Study|Withdrawal following SAE|2|||
162135807|NCT02735915|585547356|FG000|Overall Study|Withdrawal by Subject|1|||
162135808|NCT05328973|585547357|FG000|Overall Study|Withdrawal by Subject|0|||
162135809|NCT05328973|585547358|FG001|Overall Study|Withdrawal by Subject|1|||
162135810|NCT00409708|585547364|FG000|Treatment|Abnormal test procedure result(s)|1|||
162135811|NCT00409708|585547365|FG001|Treatment|Abnormal test procedure result(s)|0|||
162135812|NCT00409708|585547364|FG000|Treatment|Lack of Efficacy|0|||
162135813|NCT00409708|585547365|FG001|Treatment|Lack of Efficacy|1|||
162135814|NCT00409708|585547364|FG000|Treatment|Protocol Violation|6|||
162135815|NCT00409708|585547365|FG001|Treatment|Protocol Violation|2|||
162135816|NCT00409708|585547364|FG000|Treatment|Withdrawal by Subject|3|||
162135817|NCT00409708|585547365|FG001|Treatment|Withdrawal by Subject|8|||
162135818|NCT00409708|585547364|FG000|Treatment|Lost to Follow-up|0|||
162135819|NCT00409708|585547365|FG001|Treatment|Lost to Follow-up|6|||
162135820|NCT00409708|585547364|FG000|Treatment|Administrative problems|5|||
162135821|NCT00409708|585547365|FG001|Treatment|Administrative problems|0|||
162135822|NCT00409708|585547364|FG000|Washout|Lack of Efficacy|9|||
162135823|NCT00409708|585547365|FG001|Washout|Lack of Efficacy|1|||
162135824|NCT00409708|585547364|FG000|Washout|Protocol Violation|0|||
162135825|NCT00409708|585547365|FG001|Washout|Protocol Violation|1|||
162135826|NCT00409708|585547364|FG000|Washout|Withdrawal by Subject|11|||
162135827|NCT00409708|585547365|FG001|Washout|Withdrawal by Subject|5|||
162135828|NCT00409708|585547364|FG000|Washout|Lost to Follow-up|1|||
162135829|NCT00409708|585547365|FG001|Washout|Lost to Follow-up|3|||
162135830|NCT00946114|585547366|FG000|Overall Study|Death|5|||
162135831|NCT00946114|585547367|FG001|Overall Study|Death|2|||
162135832|NCT00946114|585547366|FG000|Overall Study|Other|1|||
162135833|NCT00946114|585547367|FG001|Overall Study|Other|0|||
162135834|NCT00946114|585547366|FG000|Overall Study|Withdrawal by Subject|2|||
162135835|NCT00946114|585547367|FG001|Overall Study|Withdrawal by Subject|0|||
162135836|NCT00723294|585547368|FG000|Overall Study|Lobular histology|2|||
161796269|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796270|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
162135837|NCT00723294|585547368|FG000|Overall Study|>25% intraductal component|1|||
162135838|NCT00723294|585547368|FG000|Overall Study|No MRI tumor enhancement|1|||
162135839|NCT00723294|585547368|FG000|Overall Study|1.0-Tesla MRI|1|||
162135840|NCT00723294|585547368|FG000|Overall Study|No cryoabalation|2|||
161900682|NCT02163395|584685154|FG000|Overall Study|Withdrawal by Subject|1|||
161900683|NCT02163395|584685154|FG000|Overall Study|Lost to Follow-up|3|||
161900684|NCT02163395|584685154|FG000|Overall Study|Adverse Event|1|||
161900685|NCT03150082|584685155|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
161900686|NCT03150082|584685156|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
161900687|NCT04131712|584685157|FG000|Overall Study|COVID related|0|||
161900688|NCT04131712|584685158|FG001|Overall Study|COVID related|0|||
162135841|NCT00723294|585547368|FG000|Overall Study|Did not undergo surgery|1|||
162135842|NCT00723294|585547368|FG000|Overall Study|Treated prior to registration|1|||
162135843|NCT00723294|585547368|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
162135844|NCT00723294|585547368|FG000|Overall Study|Benign lesion|1|||
162135845|NCT00723294|585547368|FG000|Overall Study|Withdrawal by Subject|1|||
162135846|NCT00723294|585547368|FG000|Overall Study|No treatment due to probe failure|1|||
162135847|NCT00088465|585547369|FG000|Overall Study|Withdrawal by Subject|290|||
162135848|NCT00088465|585547369|FG000|Overall Study|Adverse Event|77|||
162135849|NCT00088465|585547369|FG000|Overall Study|Lost to Follow-up|57|||
162135850|NCT00088465|585547369|FG000|Overall Study|Physician Decision|45|||
162135851|NCT00088465|585547369|FG000|Overall Study|Sponsor Decision|37|||
162135852|NCT00088465|585547369|FG000|Overall Study|Lack of Efficacy|27|||
161796271|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796272|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161796273|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
161796274|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
161796275|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
161796276|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162010831|NCT00887809|585096015|FG001|Overall Study|Death|0|||
162010832|NCT03131570|585096016|FG000|Overall Study|Adverse Event|1|||
162010833|NCT03131570|585096017|FG001|Overall Study|Adverse Event|0|||
162010834|NCT04596267|585096018|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
162010835|NCT04596267|585096019|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
162010836|NCT04596267|585096018|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
162010837|NCT04596267|585096019|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
162135853|NCT00088465|585547369|FG000|Overall Study|Protocol Violation|17|||
162135854|NCT00088465|585547369|FG000|Overall Study|Death|11|||
162135855|NCT04565249|585547370|FG000|Overall Study|Death|0|||
162135856|NCT04565249|585547371|FG001|Overall Study|Death|0|||
162135857|NCT04565249|585547372|FG002|Overall Study|Death|0|||
162135858|NCT04565249|585547373|FG003|Overall Study|Death|1|||
162135859|NCT03613129|585547376|FG000|Pre-treatment Assessment|Protocol Violation|2|||
162135860|NCT03613129|585547377|FG001|Pre-treatment Assessment|Protocol Violation|0|||
162135861|NCT03613129|585547378|FG002|Pre-treatment Assessment|Protocol Violation|0|||
162135862|NCT03613129|585547379|FG003|Pre-treatment Assessment|Protocol Violation|0|||
162135863|NCT03613129|585547380|FG004|Pre-treatment Assessment|Protocol Violation|0|||
162135864|NCT03613129|585547376|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
162135865|NCT03613129|585547377|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
162135866|NCT03613129|585547378|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
162135867|NCT03613129|585547379|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
162135868|NCT03613129|585547380|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
162135869|NCT02334306|585547381|FG000|Double-blind Period|Adverse Event|0|||
162135870|NCT02334306|585547382|FG001|Double-blind Period|Adverse Event|1|||
162135871|NCT02334306|585547381|FG000|Double-blind Period|Withdrawal by Subject|1|||
162135872|NCT02334306|585547382|FG001|Double-blind Period|Withdrawal by Subject|1|||
162135873|NCT01687270|585547383|FG000|Overall Study|Lack of Efficacy|11|||
162135874|NCT01687270|585547383|FG000|Overall Study|Lost to Follow-up|1|||
162135875|NCT02390557|585547384|FG000|Wave 2|Survey non-respondent|72|||
162135876|NCT02390557|585547385|FG001|Wave 2|Survey non-respondent|41|||
162135877|NCT02390557|585547386|FG002|Wave 2|Survey non-respondent|23|||
162135878|NCT00920686|585547392|FG000|Overall Study|Lost to Follow-up|2|||
162135879|NCT00920686|585547393|FG001|Overall Study|Lost to Follow-up|3|||
162135880|NCT00920686|585547394|FG002|Overall Study|Lost to Follow-up|1|||
162135881|NCT00920686|585547392|FG000|Overall Study|Study drug dosing criteria not met|17|||
162135882|NCT00920686|585547393|FG001|Overall Study|Study drug dosing criteria not met|19|||
162135883|NCT00920686|585547394|FG002|Overall Study|Study drug dosing criteria not met|12|||
162135884|NCT03006341|585547395|FG000|Overall Study|Not linked in the EMR|25069|||
162135885|NCT03006341|585547396|FG001|Overall Study|Not linked in the EMR|67505|||
162135886|NCT03006341|585547397|FG002|Overall Study|Not linked in the EMR|30993|||
162135887|NCT03006341|585547398|FG003|Overall Study|Not linked in the EMR|10685|||
162135888|NCT04337489|585547399|FG000|Overall Study|Withdrawal by Subject|1|||
162135889|NCT02950545|585547400|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
162135890|NCT02950545|585547401|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
162135891|NCT02950545|585547402|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
162135892|NCT02950545|585547403|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
162135893|NCT02950545|585547404|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
162135894|NCT02950545|585547405|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
162135895|NCT02950545|585547400|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
162135896|NCT02950545|585547401|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
162135897|NCT02950545|585547402|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
162135898|NCT02950545|585547403|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
162135899|NCT02950545|585547404|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
162135900|NCT02950545|585547405|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
162135901|NCT02950545|585547400|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
162135902|NCT02950545|585547401|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
162135903|NCT02950545|585547402|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
162135904|NCT02950545|585547403|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
162135905|NCT02950545|585547404|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
162135906|NCT02950545|585547405|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
162135907|NCT02950545|585547400|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
162135908|NCT02950545|585547401|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
162135909|NCT02950545|585547402|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
161796277|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161796278|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
162135910|NCT02950545|585547403|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
162135911|NCT02950545|585547404|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
162135912|NCT02950545|585547405|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
162135913|NCT02950545|585547400|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
162135914|NCT02950545|585547401|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
162135915|NCT02950545|585547402|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
162135916|NCT02950545|585547403|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
162135917|NCT02950545|585547404|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
162135918|NCT02950545|585547405|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
162135919|NCT04296942|585547406|FG000|Overall Study|Study closure by sponsor|1|||
162135920|NCT04296942|585547407|FG001|Overall Study|Study closure by sponsor|0|||
162135921|NCT04296942|585547408|FG002|Overall Study|Study closure by sponsor|0|||
162135922|NCT03255941|585547409|FG000|Overall Study|Not eligible or refused injection|37|||
162135923|NCT03255941|585547410|FG001|Overall Study|Not eligible or refused injection|44|||
162135924|NCT03255941|585547411|FG002|Overall Study|Not eligible or refused injection|5|||
162135925|NCT03255941|585547412|FG003|Overall Study|Not eligible or refused injection|6|||
162135926|NCT03255941|585547409|FG000|Overall Study|Did not complete exit interview|1|||
162135927|NCT03255941|585547410|FG001|Overall Study|Did not complete exit interview|2|||
162135928|NCT03255941|585547411|FG002|Overall Study|Did not complete exit interview|0|||
162135929|NCT03255941|585547412|FG003|Overall Study|Did not complete exit interview|0|||
162135930|NCT00335153|585547424|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
162135931|NCT00335153|585547424|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
162135932|NCT00335153|585547424|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
162135933|NCT00335153|585547424|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
162135934|NCT00335153|585547424|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
162135935|NCT00335153|585547424|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
162135936|NCT00335153|585547424|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
162135937|NCT00335153|585547424|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
162135938|NCT00335153|585547424|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
162135939|NCT00335153|585547424|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
162135940|NCT01528709|585547425|FG000|Overall Study|Death|2|||
162135941|NCT01528709|585547426|FG001|Overall Study|Death|0|||
162135942|NCT01528709|585547425|FG000|Overall Study|Withdrawal by Subject|10|||
162135943|NCT01528709|585547426|FG001|Overall Study|Withdrawal by Subject|15|||
162135944|NCT01528709|585547425|FG000|Overall Study|allergy|1|||
162135945|NCT01528709|585547426|FG001|Overall Study|allergy|0|||
162135946|NCT00945477|585547427|FG000|Overall Study|Adverse Event|3|||
162135947|NCT00945477|585547427|FG000|Overall Study|Lack of Efficacy|2|||
162135948|NCT00945477|585547427|FG000|Overall Study|Withdrawal by Subject|1|||
162135949|NCT00797225|585547428|FG000|Weeks 1 to 12|Adverse Event|0|||
162135950|NCT00797225|585547429|FG001|Weeks 1 to 12|Adverse Event|0|||
162135951|NCT00797225|585547430|FG002|Weeks 1 to 12|Adverse Event|1|||
162135952|NCT00797225|585547431|FG003|Weeks 1 to 12|Adverse Event|0|||
162135953|NCT00797225|585547432|FG004|Weeks 1 to 12|Adverse Event|0|||
162135954|NCT00797225|585547433|FG005|Weeks 1 to 12|Adverse Event|0|||
162135955|NCT00797225|585547434|FG006|Weeks 1 to 12|Adverse Event|0|||
162135956|NCT00797225|585547435|FG007|Weeks 1 to 12|Adverse Event|0|||
162135957|NCT00797225|585547428|FG000|Weeks 1 to 12|Non-compliance|0|||
162135958|NCT00797225|585547429|FG001|Weeks 1 to 12|Non-compliance|1|||
162135959|NCT00797225|585547430|FG002|Weeks 1 to 12|Non-compliance|0|||
162135960|NCT00797225|585547431|FG003|Weeks 1 to 12|Non-compliance|0|||
162135961|NCT00797225|585547432|FG004|Weeks 1 to 12|Non-compliance|0|||
162135962|NCT00797225|585547433|FG005|Weeks 1 to 12|Non-compliance|0|||
162135963|NCT00797225|585547434|FG006|Weeks 1 to 12|Non-compliance|0|||
162135964|NCT00797225|585547435|FG007|Weeks 1 to 12|Non-compliance|0|||
162135965|NCT00797225|585547428|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
162135966|NCT00797225|585547429|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
162135967|NCT00797225|585547430|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
162135968|NCT00797225|585547431|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
162135969|NCT00797225|585547432|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
162135970|NCT00797225|585547433|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
162135971|NCT00797225|585547434|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
162135972|NCT00797225|585547435|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
162135973|NCT00797225|585547428|FG000|Weeks 1 to 12|Sponsor Decision|1|||
162135974|NCT00797225|585547429|FG001|Weeks 1 to 12|Sponsor Decision|0|||
162135975|NCT00797225|585547430|FG002|Weeks 1 to 12|Sponsor Decision|0|||
162135976|NCT00797225|585547431|FG003|Weeks 1 to 12|Sponsor Decision|0|||
162135977|NCT00797225|585547432|FG004|Weeks 1 to 12|Sponsor Decision|0|||
162135978|NCT00797225|585547433|FG005|Weeks 1 to 12|Sponsor Decision|0|||
162135979|NCT00797225|585547434|FG006|Weeks 1 to 12|Sponsor Decision|0|||
162135980|NCT00797225|585547435|FG007|Weeks 1 to 12|Sponsor Decision|0|||
162135981|NCT00797225|585547428|FG000|Weeks 13 to 24|Non-compliance|0|||
162135982|NCT00797225|585547429|FG001|Weeks 13 to 24|Non-compliance|2|||
162135983|NCT00797225|585547430|FG002|Weeks 13 to 24|Non-compliance|0|||
161900689|NCT04131712|584685159|FG002|Overall Study|COVID related|2|||
161900690|NCT04131712|584685160|FG003|Overall Study|COVID related|0|||
161900691|NCT04131712|584685157|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
161900692|NCT04131712|584685158|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
161900693|NCT04131712|584685159|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
162135984|NCT00797225|585547431|FG003|Weeks 13 to 24|Non-compliance|0|||
162135985|NCT00797225|585547432|FG004|Weeks 13 to 24|Non-compliance|0|||
162135986|NCT00797225|585547433|FG005|Weeks 13 to 24|Non-compliance|0|||
162135987|NCT00797225|585547434|FG006|Weeks 13 to 24|Non-compliance|0|||
162135988|NCT00797225|585547435|FG007|Weeks 13 to 24|Non-compliance|0|||
162135989|NCT00797225|585547428|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
162135990|NCT00797225|585547429|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
162135991|NCT00797225|585547430|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
162135992|NCT00797225|585547431|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
162135993|NCT00797225|585547432|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
162135994|NCT00797225|585547433|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
162135995|NCT00797225|585547434|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
162135996|NCT00797225|585547435|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
162135997|NCT00797225|585547428|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
162135998|NCT00797225|585547429|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
162135999|NCT00797225|585547430|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
162136000|NCT00797225|585547431|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
162136001|NCT00797225|585547432|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
162136002|NCT00797225|585547433|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
162136003|NCT00797225|585547434|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
162136004|NCT00797225|585547435|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
162136005|NCT00797225|585547428|FG000|Weeks 13 to 24|Adverse Event|0|||
162136006|NCT00797225|585547429|FG001|Weeks 13 to 24|Adverse Event|1|||
162136007|NCT00797225|585547430|FG002|Weeks 13 to 24|Adverse Event|0|||
162136008|NCT00797225|585547431|FG003|Weeks 13 to 24|Adverse Event|0|||
162136009|NCT00797225|585547432|FG004|Weeks 13 to 24|Adverse Event|0|||
162136010|NCT00797225|585547433|FG005|Weeks 13 to 24|Adverse Event|0|||
162136011|NCT00797225|585547434|FG006|Weeks 13 to 24|Adverse Event|1|||
162136012|NCT00797225|585547435|FG007|Weeks 13 to 24|Adverse Event|0|||
162136013|NCT00797225|585547428|FG000|Weeks 13 to 24|Sponsor Decision|0|||
162136014|NCT00797225|585547429|FG001|Weeks 13 to 24|Sponsor Decision|0|||
162136015|NCT00797225|585547430|FG002|Weeks 13 to 24|Sponsor Decision|0|||
162136016|NCT00797225|585547431|FG003|Weeks 13 to 24|Sponsor Decision|0|||
162136017|NCT00797225|585547432|FG004|Weeks 13 to 24|Sponsor Decision|0|||
162136018|NCT00797225|585547433|FG005|Weeks 13 to 24|Sponsor Decision|0|||
162136019|NCT00797225|585547434|FG006|Weeks 13 to 24|Sponsor Decision|1|||
162136020|NCT00797225|585547435|FG007|Weeks 13 to 24|Sponsor Decision|0|||
162136021|NCT00097370|585547437|FG000|Stage 1|Adverse Event|3|||
162136022|NCT00097370|585547437|FG000|Stage 1|Withdrawal by Subject|1|||
162136023|NCT00097370|585547437|FG000|Stage 1|Lack of Efficacy|2|||
162136024|NCT00097370|585547437|FG000|Stage 2|Adverse Event|5|||
162136025|NCT00097370|585547437|FG000|Stage 2|Withdrawal by Subject|1|||
162136026|NCT00097370|585547437|FG000|Stage 2|Lack of Efficacy|3|||
162136027|NCT00097370|585547437|FG000|Stage 2|Pregnancy|1|||
162136028|NCT00097370|585547437|FG000|Stage 2|Sponsor Terminated Study|2|||
162136029|NCT00097370|585547437|FG000|Stage 2|Lost to Follow-up|1|||
162136030|NCT00097370|585547437|FG000|Stage 3|Adverse Event|2|||
162136031|NCT00097370|585547437|FG000|Stage 3|Withdrawal by Subject|3|||
162136032|NCT00097370|585547437|FG000|Stage 3|Lack of Efficacy|1|||
162136033|NCT00097370|585547437|FG000|Stage 3|Sponsor Terminated Study|52|||
162136034|NCT00097370|585547437|FG000|Stage 3|Lost to Follow-up|1|||
162136035|NCT02427646|585547439|FG000|Overall Study|Lack of Efficacy|2|||
162136036|NCT02427646|585547440|FG001|Overall Study|Lack of Efficacy|3|||
162136037|NCT02427646|585547439|FG000|Overall Study|Physician Decision|1|||
162136038|NCT02427646|585547440|FG001|Overall Study|Physician Decision|4|||
162136039|NCT02427646|585547439|FG000|Overall Study|Protocol Violation|3|||
162136040|NCT02427646|585547440|FG001|Overall Study|Protocol Violation|3|||
162136041|NCT02427646|585547439|FG000|Overall Study|Bothersome hand weakness|2|||
162136042|NCT02427646|585547440|FG001|Overall Study|Bothersome hand weakness|4|||
162136043|NCT00062868|585547441|FG000|Dose Level 1|Death|2|||
162136044|NCT00062868|585547442|FG001|Dose Level 1|Death|0|||
162136045|NCT00062868|585547443|FG002|Dose Level 1|Death|0|||
162136046|NCT00062868|585547444|FG003|Dose Level 1|Death|2|||
162136047|NCT00062868|585547445|FG004|Dose Level 1|Death|0|||
162136048|NCT00062868|585547446|FG005|Dose Level 1|Death|0|||
162136049|NCT00062868|585547447|FG006|Dose Level 1|Death|3|||
162136050|NCT00062868|585547448|FG007|Dose Level 1|Death|0|||
162136051|NCT00062868|585547449|FG008|Dose Level 1|Death|0|||
162136052|NCT00062868|585547450|FG009|Dose Level 1|Death|0|||
162136053|NCT00062868|585547451|FG010|Dose Level 1|Death|0|||
162136054|NCT00062868|585547452|FG011|Dose Level 1|Death|0|||
162136055|NCT00062868|585547453|FG012|Dose Level 1|Death|0|||
162136056|NCT00062868|585547454|FG013|Dose Level 1|Death|0|||
162136057|NCT00062868|585547455|FG014|Dose Level 1|Death|0|||
162136058|NCT00062868|585547456|FG015|Dose Level 1|Death|0|||
162136059|NCT00062868|585547457|FG016|Dose Level 1|Death|0|||
162136060|NCT00062868|585547458|FG017|Dose Level 1|Death|0|||
162136061|NCT00062868|585547459|FG018|Dose Level 1|Death|7|||
162136062|NCT00062868|585547460|FG019|Dose Level 1|Death|0|||
162136063|NCT00062868|585547461|FG020|Dose Level 1|Death|1|||
162136064|NCT00062868|585547441|FG000|Dose Level 1|Lost to Follow-up|0|||
162136065|NCT00062868|585547442|FG001|Dose Level 1|Lost to Follow-up|0|||
162136066|NCT00062868|585547443|FG002|Dose Level 1|Lost to Follow-up|0|||
162136067|NCT00062868|585547444|FG003|Dose Level 1|Lost to Follow-up|0|||
162136068|NCT00062868|585547445|FG004|Dose Level 1|Lost to Follow-up|0|||
162136069|NCT00062868|585547446|FG005|Dose Level 1|Lost to Follow-up|0|||
162136070|NCT00062868|585547447|FG006|Dose Level 1|Lost to Follow-up|0|||
162136071|NCT00062868|585547448|FG007|Dose Level 1|Lost to Follow-up|0|||
162136072|NCT00062868|585547449|FG008|Dose Level 1|Lost to Follow-up|0|||
162136073|NCT00062868|585547450|FG009|Dose Level 1|Lost to Follow-up|0|||
162136074|NCT00062868|585547451|FG010|Dose Level 1|Lost to Follow-up|0|||
162136075|NCT00062868|585547452|FG011|Dose Level 1|Lost to Follow-up|0|||
162136076|NCT00062868|585547453|FG012|Dose Level 1|Lost to Follow-up|1|||
162136077|NCT00062868|585547454|FG013|Dose Level 1|Lost to Follow-up|0|||
162136078|NCT00062868|585547455|FG014|Dose Level 1|Lost to Follow-up|0|||
162136079|NCT00062868|585547456|FG015|Dose Level 1|Lost to Follow-up|0|||
162136080|NCT00062868|585547457|FG016|Dose Level 1|Lost to Follow-up|0|||
162136081|NCT00062868|585547458|FG017|Dose Level 1|Lost to Follow-up|0|||
162136082|NCT00062868|585547459|FG018|Dose Level 1|Lost to Follow-up|2|||
162136083|NCT00062868|585547460|FG019|Dose Level 1|Lost to Follow-up|0|||
162136084|NCT00062868|585547461|FG020|Dose Level 1|Lost to Follow-up|1|||
162136085|NCT00062868|585547441|FG000|Dose Level 2|Death|0|||
162136086|NCT00062868|585547442|FG001|Dose Level 2|Death|3|||
162136087|NCT00062868|585547443|FG002|Dose Level 2|Death|0|||
162136088|NCT00062868|585547444|FG003|Dose Level 2|Death|0|||
162136089|NCT00062868|585547445|FG004|Dose Level 2|Death|2|||
162136090|NCT00062868|585547446|FG005|Dose Level 2|Death|0|||
162136091|NCT00062868|585547447|FG006|Dose Level 2|Death|0|||
162136092|NCT00062868|585547448|FG007|Dose Level 2|Death|0|||
162136093|NCT00062868|585547449|FG008|Dose Level 2|Death|0|||
162136094|NCT00062868|585547450|FG009|Dose Level 2|Death|0|||
162136095|NCT00062868|585547451|FG010|Dose Level 2|Death|1|||
162136096|NCT00062868|585547452|FG011|Dose Level 2|Death|0|||
162136097|NCT00062868|585547453|FG012|Dose Level 2|Death|0|||
162136098|NCT00062868|585547454|FG013|Dose Level 2|Death|0|||
162136099|NCT00062868|585547455|FG014|Dose Level 2|Death|0|||
162136100|NCT00062868|585547456|FG015|Dose Level 2|Death|0|||
162136101|NCT00062868|585547457|FG016|Dose Level 2|Death|2|||
162136102|NCT00062868|585547458|FG017|Dose Level 2|Death|0|||
162136103|NCT00062868|585547459|FG018|Dose Level 2|Death|0|||
162136104|NCT00062868|585547460|FG019|Dose Level 2|Death|0|||
162136105|NCT00062868|585547461|FG020|Dose Level 2|Death|0|||
162136106|NCT00062868|585547441|FG000|Dose Level 2|Lost to Follow-up|0|||
162136107|NCT00062868|585547442|FG001|Dose Level 2|Lost to Follow-up|0|||
162136108|NCT00062868|585547443|FG002|Dose Level 2|Lost to Follow-up|0|||
161796279|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
162136109|NCT00062868|585547444|FG003|Dose Level 2|Lost to Follow-up|0|||
162136110|NCT00062868|585547445|FG004|Dose Level 2|Lost to Follow-up|0|||
162136111|NCT00062868|585547446|FG005|Dose Level 2|Lost to Follow-up|0|||
162136112|NCT00062868|585547447|FG006|Dose Level 2|Lost to Follow-up|0|||
162136113|NCT00062868|585547448|FG007|Dose Level 2|Lost to Follow-up|0|||
162136114|NCT00062868|585547449|FG008|Dose Level 2|Lost to Follow-up|0|||
162136115|NCT00062868|585547450|FG009|Dose Level 2|Lost to Follow-up|0|||
162136116|NCT00062868|585547451|FG010|Dose Level 2|Lost to Follow-up|0|||
162136117|NCT00062868|585547452|FG011|Dose Level 2|Lost to Follow-up|0|||
162136118|NCT00062868|585547453|FG012|Dose Level 2|Lost to Follow-up|0|||
162136119|NCT00062868|585547454|FG013|Dose Level 2|Lost to Follow-up|1|||
162136120|NCT00062868|585547455|FG014|Dose Level 2|Lost to Follow-up|0|||
162136121|NCT00062868|585547456|FG015|Dose Level 2|Lost to Follow-up|0|||
162136122|NCT00062868|585547457|FG016|Dose Level 2|Lost to Follow-up|1|||
162136123|NCT00062868|585547458|FG017|Dose Level 2|Lost to Follow-up|0|||
162136124|NCT00062868|585547459|FG018|Dose Level 2|Lost to Follow-up|0|||
162136125|NCT00062868|585547460|FG019|Dose Level 2|Lost to Follow-up|0|||
162136126|NCT00062868|585547461|FG020|Dose Level 2|Lost to Follow-up|0|||
162136127|NCT00062868|585547441|FG000|Dose Level 3|Death|0|||
162136128|NCT00062868|585547442|FG001|Dose Level 3|Death|0|||
162136129|NCT00062868|585547443|FG002|Dose Level 3|Death|0|||
162136130|NCT00062868|585547444|FG003|Dose Level 3|Death|0|||
162136131|NCT00062868|585547445|FG004|Dose Level 3|Death|0|||
162136132|NCT00062868|585547446|FG005|Dose Level 3|Death|0|||
162136133|NCT00062868|585547447|FG006|Dose Level 3|Death|0|||
162136134|NCT00062868|585547448|FG007|Dose Level 3|Death|0|||
162136135|NCT00062868|585547449|FG008|Dose Level 3|Death|0|||
162136136|NCT00062868|585547450|FG009|Dose Level 3|Death|0|||
162136137|NCT00062868|585547451|FG010|Dose Level 3|Death|0|||
162136138|NCT00062868|585547452|FG011|Dose Level 3|Death|1|||
162136139|NCT00062868|585547453|FG012|Dose Level 3|Death|0|||
162136140|NCT00062868|585547454|FG013|Dose Level 3|Death|0|||
162136141|NCT00062868|585547455|FG014|Dose Level 3|Death|0|||
162136142|NCT00062868|585547456|FG015|Dose Level 3|Death|0|||
162136143|NCT00062868|585547457|FG016|Dose Level 3|Death|0|||
162136144|NCT00062868|585547458|FG017|Dose Level 3|Death|1|||
162136145|NCT00062868|585547459|FG018|Dose Level 3|Death|0|||
162136146|NCT00062868|585547460|FG019|Dose Level 3|Death|0|||
162136147|NCT00062868|585547461|FG020|Dose Level 3|Death|0|||
162136148|NCT00062868|585547441|FG000|Dose Level 3|Lost to Follow-up|0|||
162136149|NCT00062868|585547442|FG001|Dose Level 3|Lost to Follow-up|0|||
162136150|NCT00062868|585547443|FG002|Dose Level 3|Lost to Follow-up|0|||
162136151|NCT00062868|585547444|FG003|Dose Level 3|Lost to Follow-up|0|||
162136152|NCT00062868|585547445|FG004|Dose Level 3|Lost to Follow-up|0|||
162136153|NCT00062868|585547446|FG005|Dose Level 3|Lost to Follow-up|0|||
162136154|NCT00062868|585547447|FG006|Dose Level 3|Lost to Follow-up|0|||
162136155|NCT00062868|585547448|FG007|Dose Level 3|Lost to Follow-up|0|||
162136156|NCT00062868|585547449|FG008|Dose Level 3|Lost to Follow-up|0|||
162136157|NCT00062868|585547450|FG009|Dose Level 3|Lost to Follow-up|0|||
162136158|NCT00062868|585547451|FG010|Dose Level 3|Lost to Follow-up|0|||
162136159|NCT00062868|585547452|FG011|Dose Level 3|Lost to Follow-up|0|||
162136160|NCT00062868|585547453|FG012|Dose Level 3|Lost to Follow-up|0|||
162136161|NCT00062868|585547454|FG013|Dose Level 3|Lost to Follow-up|0|||
162136162|NCT00062868|585547455|FG014|Dose Level 3|Lost to Follow-up|1|||
162136163|NCT00062868|585547456|FG015|Dose Level 3|Lost to Follow-up|0|||
162136164|NCT00062868|585547457|FG016|Dose Level 3|Lost to Follow-up|0|||
162136165|NCT00062868|585547458|FG017|Dose Level 3|Lost to Follow-up|0|||
162136166|NCT00062868|585547459|FG018|Dose Level 3|Lost to Follow-up|0|||
162136167|NCT00062868|585547460|FG019|Dose Level 3|Lost to Follow-up|0|||
162136168|NCT00062868|585547461|FG020|Dose Level 3|Lost to Follow-up|0|||
162136169|NCT00062868|585547441|FG000|Dose Level 3|Withdrew|0|||
162136170|NCT00062868|585547442|FG001|Dose Level 3|Withdrew|0|||
162136171|NCT00062868|585547443|FG002|Dose Level 3|Withdrew|2|||
162136172|NCT00062868|585547444|FG003|Dose Level 3|Withdrew|0|||
162136173|NCT00062868|585547445|FG004|Dose Level 3|Withdrew|0|||
162136174|NCT00062868|585547446|FG005|Dose Level 3|Withdrew|0|||
162136175|NCT00062868|585547447|FG006|Dose Level 3|Withdrew|0|||
162136176|NCT00062868|585547448|FG007|Dose Level 3|Withdrew|0|||
162136177|NCT00062868|585547449|FG008|Dose Level 3|Withdrew|0|||
162136178|NCT00062868|585547450|FG009|Dose Level 3|Withdrew|0|||
162136179|NCT00062868|585547451|FG010|Dose Level 3|Withdrew|0|||
162136180|NCT00062868|585547452|FG011|Dose Level 3|Withdrew|0|||
162136181|NCT00062868|585547453|FG012|Dose Level 3|Withdrew|0|||
162136182|NCT00062868|585547454|FG013|Dose Level 3|Withdrew|0|||
162136183|NCT00062868|585547455|FG014|Dose Level 3|Withdrew|0|||
162136184|NCT00062868|585547456|FG015|Dose Level 3|Withdrew|0|||
162136185|NCT00062868|585547457|FG016|Dose Level 3|Withdrew|0|||
162136186|NCT00062868|585547458|FG017|Dose Level 3|Withdrew|0|||
162136187|NCT00062868|585547459|FG018|Dose Level 3|Withdrew|0|||
162136188|NCT00062868|585547460|FG019|Dose Level 3|Withdrew|0|||
162136189|NCT00062868|585547461|FG020|Dose Level 3|Withdrew|0|||
162136190|NCT01734811|585547462|FG000|Overall Study|Lost to Follow-up|2|||
162136191|NCT01734811|585547463|FG001|Overall Study|Lost to Follow-up|3|||
162136192|NCT01734811|585547462|FG000|Overall Study|Withdrawal by Subject|2|||
162136193|NCT01734811|585547463|FG001|Overall Study|Withdrawal by Subject|0|||
162136194|NCT03824236|585547464|FG000|Overall Study|Lost to Follow-up|0|||
162136195|NCT03824236|585547465|FG001|Overall Study|Lost to Follow-up|0|||
162136196|NCT03824236|585547466|FG002|Overall Study|Lost to Follow-up|1|||
162136197|NCT01641861|585547467|FG000|Overall Study|Lost to Follow-up|21|||
162136198|NCT01641861|585547468|FG001|Overall Study|Lost to Follow-up|16|||
162136199|NCT01641861|585547467|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
162136200|NCT01641861|585547468|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
162136201|NCT01641861|585547467|FG000|Overall Study|Died due to drowning|0|||
162136202|NCT01641861|585547468|FG001|Overall Study|Died due to drowning|1|||
162136203|NCT04949399|585547469|FG000|Overall Study|Lost to Follow-up|11|||
162136204|NCT04949399|585547470|FG001|Overall Study|Lost to Follow-up|6|||
162136205|NCT04949399|585547469|FG000|Overall Study|Withdrawal by Subject|2|||
162136206|NCT04949399|585547470|FG001|Overall Study|Withdrawal by Subject|3|||
162136207|NCT01515319|585547471|FG000|Overall Study|Withdrawal by Subject|0|||
162136208|NCT01515319|585547472|FG001|Overall Study|Withdrawal by Subject|0|||
162136209|NCT01515319|585547473|FG002|Overall Study|Withdrawal by Subject|0|||
162136210|NCT01515319|585547474|FG003|Overall Study|Withdrawal by Subject|0|||
162136211|NCT01515319|585547475|FG004|Overall Study|Withdrawal by Subject|0|||
162136212|NCT01515319|585547476|FG005|Overall Study|Withdrawal by Subject|0|||
162136213|NCT01515319|585547477|FG006|Overall Study|Withdrawal by Subject|1|||
162136214|NCT01515319|585547478|FG007|Overall Study|Withdrawal by Subject|0|||
162136215|NCT01515319|585547479|FG008|Overall Study|Withdrawal by Subject|0|||
162136216|NCT01515319|585547480|FG009|Overall Study|Withdrawal by Subject|0|||
162136217|NCT01515319|585547471|FG000|Overall Study|Adverse Event|0|||
162136218|NCT01515319|585547472|FG001|Overall Study|Adverse Event|0|||
162136219|NCT01515319|585547473|FG002|Overall Study|Adverse Event|0|||
162136220|NCT01515319|585547474|FG003|Overall Study|Adverse Event|0|||
162136221|NCT01515319|585547475|FG004|Overall Study|Adverse Event|0|||
162136222|NCT01515319|585547476|FG005|Overall Study|Adverse Event|0|||
162136223|NCT01515319|585547477|FG006|Overall Study|Adverse Event|0|||
162136224|NCT01515319|585547478|FG007|Overall Study|Adverse Event|0|||
162136225|NCT01515319|585547479|FG008|Overall Study|Adverse Event|3|||
162136226|NCT01515319|585547480|FG009|Overall Study|Adverse Event|0|||
162136227|NCT01515319|585547471|FG000|Overall Study|Protocol Violation|0|||
162136228|NCT01515319|585547472|FG001|Overall Study|Protocol Violation|0|||
162136229|NCT01515319|585547473|FG002|Overall Study|Protocol Violation|0|||
162136230|NCT01515319|585547474|FG003|Overall Study|Protocol Violation|0|||
162136231|NCT01515319|585547475|FG004|Overall Study|Protocol Violation|0|||
162136232|NCT01515319|585547476|FG005|Overall Study|Protocol Violation|0|||
162136233|NCT01515319|585547477|FG006|Overall Study|Protocol Violation|0|||
162136234|NCT01515319|585547478|FG007|Overall Study|Protocol Violation|0|||
162136235|NCT01515319|585547479|FG008|Overall Study|Protocol Violation|2|||
162136236|NCT01515319|585547480|FG009|Overall Study|Protocol Violation|0|||
162136237|NCT04880161|585547481|FG000|Overall Study|Withdrawal by Subject|1|||
162136238|NCT04880161|585547482|FG001|Overall Study|Withdrawal by Subject|0|||
162136239|NCT04880161|585547481|FG000|Overall Study|Lack of Compliance|1|||
162136240|NCT04880161|585547482|FG001|Overall Study|Lack of Compliance|1|||
162136241|NCT04880161|585547481|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
162136242|NCT04880161|585547482|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
162136243|NCT04880161|585547481|FG000|Overall Study|Screen Failure|0|||
162136244|NCT04880161|585547482|FG001|Overall Study|Screen Failure|1|||
162136245|NCT01354106|585547483|FG000|Overall Study|Withdrawal by Subject|2|||
162136246|NCT00901485|585547484|FG000|Overall Study|Lack of Efficacy|0|||
162136247|NCT00901485|585547485|FG001|Overall Study|Lack of Efficacy|2|||
162136248|NCT00901485|585547484|FG000|Overall Study|Withdrawal by Subject|1|||
162136249|NCT00901485|585547485|FG001|Overall Study|Withdrawal by Subject|2|||
162136250|NCT01871285|585547486|FG000|First Intervention (1 Day)|Adverse Event|1|||
162136251|NCT01871285|585547487|FG001|First Intervention (1 Day)|Adverse Event|0|||
162136252|NCT01871285|585547488|FG002|First Intervention (1 Day)|Adverse Event|0|||
162136253|NCT01871285|585547489|FG003|First Intervention (1 Day)|Adverse Event|0|||
162136254|NCT01871285|585547486|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
162136255|NCT01871285|585547487|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
162136256|NCT01871285|585547488|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
162136257|NCT01871285|585547489|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
162136258|NCT05397470|585547490|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
162136259|NCT05397470|585547491|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
162136260|NCT05397470|585547492|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
162136261|NCT05397470|585547490|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
162136262|NCT05397470|585547491|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
162136263|NCT05397470|585547492|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
162136264|NCT05397470|585547490|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
162136265|NCT05397470|585547491|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
162136266|NCT05397470|585547492|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
162136267|NCT05397470|585547490|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
162136268|NCT05397470|585547491|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
161796280|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161796281|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161796282|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161796283|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162136269|NCT05397470|585547492|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
162136270|NCT05397470|585547490|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
162136271|NCT05397470|585547491|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
162136272|NCT05397470|585547492|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
162136273|NCT05397470|585547490|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
162136274|NCT05397470|585547491|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
162136275|NCT05397470|585547492|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
162136276|NCT05397470|585547490|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
162136277|NCT05397470|585547491|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
162136278|NCT05397470|585547492|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
162136279|NCT01919619|585547493|FG000|Overall Study|Physician Decision|1|||
162136280|NCT01919619|585547494|FG001|Overall Study|Physician Decision|1|||
162136281|NCT01257503|585549397|FG000|Overall Study|Lost to Follow-up|7|||
162136282|NCT01257503|585549398|FG001|Overall Study|Lost to Follow-up|10|||
162136283|NCT01257503|585549397|FG000|Overall Study|Over 5 years old at enrollment|0|||
162136284|NCT01257503|585549398|FG001|Overall Study|Over 5 years old at enrollment|1|||
161796284|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162136285|NCT01257503|585549397|FG000|Overall Study|strep culture positive at enrollment|1|||
162136286|NCT01257503|585549398|FG001|Overall Study|strep culture positive at enrollment|0|||
162136287|NCT02333630|585549399|FG000|Overall Study|Lost to Follow-up|5|||
162136288|NCT02333630|585549400|FG001|Overall Study|Lost to Follow-up|2|||
162136289|NCT00315055|585549401|FG000|Overall Study|Protocol Violation|2|||
162136290|NCT00315055|585549402|FG001|Overall Study|Protocol Violation|4|||
162136291|NCT00315055|585549401|FG000|Overall Study|Lost to Follow-up|1|||
162136292|NCT00315055|585549402|FG001|Overall Study|Lost to Follow-up|1|||
162136293|NCT02359435|585549403|FG000|Overall Study|Lost to Follow-up|4|||
162136294|NCT02359435|585549404|FG001|Overall Study|Lost to Follow-up|4|||
162136295|NCT02347943|585549405|FG000|Overall Study|Study was cancelled|140|||
162136296|NCT02347943|585549406|FG001|Overall Study|Study was cancelled|67|||
162136297|NCT02347943|585549407|FG002|Overall Study|Study was cancelled|45|||
162136298|NCT03681691|585549413|FG000|Overall Study|COVID|1|||
162136299|NCT03681691|585549414|FG001|Overall Study|COVID|0|||
162136300|NCT03681691|585549413|FG000|Overall Study|prolonged bleeding|1|||
162136301|NCT03681691|585549414|FG001|Overall Study|prolonged bleeding|0|||
162136302|NCT03681691|585549413|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
162136303|NCT03681691|585549414|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
162136304|NCT02534896|585549415|FG000|Overall Study|Adverse Event|2|||
162136305|NCT02534896|585549416|FG001|Overall Study|Adverse Event|1|||
162136306|NCT02534896|585549417|FG002|Overall Study|Adverse Event|1|||
162136307|NCT02534896|585549415|FG000|Overall Study|Insufficient therapeutic response|2|||
162136308|NCT02534896|585549416|FG001|Overall Study|Insufficient therapeutic response|0|||
162136309|NCT02534896|585549417|FG002|Overall Study|Insufficient therapeutic response|0|||
162136310|NCT00711646|585549418|FG000|Overall Study|Adverse Event|6|||
162136311|NCT00711646|585549419|FG001|Overall Study|Adverse Event|1|||
162136312|NCT00711646|585549418|FG000|Overall Study|Withdrawal by Subject|4|||
162136313|NCT00711646|585549419|FG001|Overall Study|Withdrawal by Subject|0|||
162136314|NCT00711646|585549418|FG000|Overall Study|Protocol Violation|0|||
162136315|NCT00711646|585549419|FG001|Overall Study|Protocol Violation|1|||
162136316|NCT00711646|585549418|FG000|Overall Study|Lost to Follow-up|1|||
162136317|NCT00711646|585549419|FG001|Overall Study|Lost to Follow-up|0|||
162136318|NCT00711646|585549418|FG000|Overall Study|administrative decision|0|||
162136319|NCT00711646|585549419|FG001|Overall Study|administrative decision|1|||
162136320|NCT00711646|585549418|FG000|Overall Study|patient non-compliance|1|||
162136321|NCT00711646|585549419|FG001|Overall Study|patient non-compliance|0|||
162136322|NCT03441360|585549420|FG000|Overall Study|Radiological disease progression|5|||
162136323|NCT03441360|585549421|FG001|Overall Study|Radiological disease progression|6|||
162136324|NCT03441360|585549422|FG002|Overall Study|Radiological disease progression|4|||
162136325|NCT03441360|585549420|FG000|Overall Study|Clinical disease progression|2|||
162136326|NCT03441360|585549421|FG001|Overall Study|Clinical disease progression|2|||
162136327|NCT03441360|585549422|FG002|Overall Study|Clinical disease progression|0|||
162136328|NCT03441360|585549420|FG000|Overall Study|Adverse Event|1|||
162136329|NCT03441360|585549421|FG001|Overall Study|Adverse Event|0|||
162136330|NCT03441360|585549422|FG002|Overall Study|Adverse Event|1|||
162136331|NCT00269399|585549423|FG000|Overall Study|Lack of Efficacy|27|||
162136332|NCT00269399|585549424|FG001|Overall Study|Lack of Efficacy|10|||
162136333|NCT00269399|585549423|FG000|Overall Study|Adverse Event|10|||
162136334|NCT00269399|585549424|FG001|Overall Study|Adverse Event|4|||
162136335|NCT00269399|585549423|FG000|Overall Study|Withdrawal by Subject|2|||
161796285|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162136336|NCT00269399|585549424|FG001|Overall Study|Withdrawal by Subject|5|||
162136337|NCT00269399|585549423|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
162136338|NCT00269399|585549424|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
162136339|NCT00269399|585549423|FG000|Overall Study|Other|0|||
162136340|NCT00269399|585549424|FG001|Overall Study|Other|4|||
162136341|NCT00269399|585549423|FG000|Overall Study|Development of exclusion criteria|0|||
162136342|NCT00269399|585549424|FG001|Overall Study|Development of exclusion criteria|1|||
162136343|NCT01360840|585549425|FG000|Overall Study|Ongoing at data cut-off|10|||
162136344|NCT01360840|585549426|FG001|Overall Study|Ongoing at data cut-off|10|||
162136345|NCT01360840|585549427|FG002|Overall Study|Ongoing at data cut-off|9|||
162136346|NCT00463151|585549428|FG000|Overall Study|Adverse Event|0|||
162136347|NCT00463151|585549429|FG001|Overall Study|Adverse Event|0|||
162136348|NCT00463151|585549430|FG002|Overall Study|Adverse Event|1|||
162136349|NCT00463151|585549431|FG003|Overall Study|Adverse Event|0|||
162136350|NCT00463151|585549428|FG000|Overall Study|Lack of Efficacy|2|||
162136351|NCT00463151|585549429|FG001|Overall Study|Lack of Efficacy|5|||
162136352|NCT00463151|585549430|FG002|Overall Study|Lack of Efficacy|2|||
162136353|NCT00463151|585549431|FG003|Overall Study|Lack of Efficacy|5|||
162136354|NCT00463151|585549428|FG000|Overall Study|Protocol Violation|0|||
162136355|NCT00463151|585549429|FG001|Overall Study|Protocol Violation|0|||
162136356|NCT00463151|585549430|FG002|Overall Study|Protocol Violation|0|||
162136357|NCT00463151|585549431|FG003|Overall Study|Protocol Violation|1|||
162136358|NCT00463151|585549428|FG000|Overall Study|Withdrawal by Subject|0|||
162136359|NCT00463151|585549429|FG001|Overall Study|Withdrawal by Subject|0|||
162136360|NCT00463151|585549430|FG002|Overall Study|Withdrawal by Subject|0|||
162136361|NCT00463151|585549431|FG003|Overall Study|Withdrawal by Subject|1|||
162136362|NCT05349084|585549432|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
162136363|NCT00688688|585549433|FG000|Overall Study|Eligibility criterion not met|7|||
162136364|NCT00688688|585549434|FG001|Overall Study|Eligibility criterion not met|7|||
162136365|NCT00688688|585549435|FG002|Overall Study|Eligibility criterion not met|10|||
162136366|NCT00688688|585549433|FG000|Overall Study|Adverse Event|52|||
162136367|NCT00688688|585549434|FG001|Overall Study|Adverse Event|51|||
162136368|NCT00688688|585549435|FG002|Overall Study|Adverse Event|50|||
162136369|NCT00688688|585549433|FG000|Overall Study|Lack of Efficacy|34|||
162136370|NCT00688688|585549434|FG001|Overall Study|Lack of Efficacy|25|||
162136371|NCT00688688|585549435|FG002|Overall Study|Lack of Efficacy|45|||
162136372|NCT00688688|585549433|FG000|Overall Study|Withdrawal by Subject|66|||
162136373|NCT00688688|585549434|FG001|Overall Study|Withdrawal by Subject|75|||
162136374|NCT00688688|585549435|FG002|Overall Study|Withdrawal by Subject|65|||
162136375|NCT00688688|585549433|FG000|Overall Study|Lost to Follow-up|14|||
162136376|NCT00688688|585549434|FG001|Overall Study|Lost to Follow-up|7|||
162136377|NCT00688688|585549435|FG002|Overall Study|Lost to Follow-up|7|||
162136378|NCT00688688|585549433|FG000|Overall Study|Protocol Violation|6|||
162136379|NCT00688688|585549434|FG001|Overall Study|Protocol Violation|9|||
162136380|NCT00688688|585549435|FG002|Overall Study|Protocol Violation|11|||
162136381|NCT00688688|585549433|FG000|Overall Study|Randomized but never received study drug|1|||
162136382|NCT00688688|585549434|FG001|Overall Study|Randomized but never received study drug|0|||
162136383|NCT00688688|585549435|FG002|Overall Study|Randomized but never received study drug|0|||
162136384|NCT00688688|585549433|FG000|Overall Study|Non-compliance with study procedures|5|||
162136385|NCT00688688|585549434|FG001|Overall Study|Non-compliance with study procedures|3|||
162136386|NCT00688688|585549435|FG002|Overall Study|Non-compliance with study procedures|4|||
162136387|NCT00688688|585549433|FG000|Overall Study|Taking exclusionary medications|1|||
162136388|NCT00688688|585549434|FG001|Overall Study|Taking exclusionary medications|0|||
162136389|NCT00688688|585549435|FG002|Overall Study|Taking exclusionary medications|0|||
162136390|NCT00688688|585549433|FG000|Overall Study|Site closure|0|||
162136391|NCT00688688|585549434|FG001|Overall Study|Site closure|1|||
162136392|NCT00688688|585549435|FG002|Overall Study|Site closure|0|||
162136393|NCT00688688|585549433|FG000|Overall Study|Violation of exclusion criterion|0|||
162136394|NCT00688688|585549434|FG001|Overall Study|Violation of exclusion criterion|1|||
162136395|NCT00688688|585549435|FG002|Overall Study|Violation of exclusion criterion|0|||
162136396|NCT01579578|585549436|FG000|Overall Study|Death|4|||
162136397|NCT01579578|585549437|FG001|Overall Study|Death|1|||
162136398|NCT01579578|585549436|FG000|Overall Study|Lost to Follow-up|1|||
162136399|NCT01579578|585549437|FG001|Overall Study|Lost to Follow-up|1|||
162136400|NCT01579578|585549436|FG000|Overall Study|Withdrawal by Subject|2|||
162136401|NCT01579578|585549437|FG001|Overall Study|Withdrawal by Subject|1|||
162136402|NCT01579578|585549436|FG000|Overall Study|Eligibility criteria|3|||
162136403|NCT01579578|585549437|FG001|Overall Study|Eligibility criteria|9|||
162136404|NCT01579578|585549436|FG000|Overall Study|Ongoing|3|||
162136405|NCT01579578|585549437|FG001|Overall Study|Ongoing|0|||
162136406|NCT01004263|585549440|FG000|Overall Study|Adverse Event|15|||
162136407|NCT01004263|585549440|FG000|Overall Study|Withdrawal by Subject|58|||
162136408|NCT01004263|585549440|FG000|Overall Study|Protocol Violation|10|||
162136409|NCT01004263|585549440|FG000|Overall Study|Lost to Follow-up|64|||
162136410|NCT01004263|585549440|FG000|Overall Study|Lack of Efficacy|13|||
162136411|NCT01004263|585549440|FG000|Overall Study|Pregnancy|2|||
161900694|NCT04131712|584685160|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
161900695|NCT03334188|584685161|FG000|Overall Study|Withdrawal by Subject|0|||
161900696|NCT03334188|584685162|FG001|Overall Study|Withdrawal by Subject|1|||
162136412|NCT01004263|585549440|FG000|Overall Study|Physician Decision|15|||
162136413|NCT01004263|585549440|FG000|Overall Study|Lack of Qualifying Event|2|||
162136414|NCT01237678|585549441|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
162136415|NCT01237678|585549442|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
162136416|NCT01237678|585549443|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
162136417|NCT01237678|585549441|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
162136418|NCT01237678|585549442|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
162136419|NCT01237678|585549443|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
162136420|NCT01237678|585549441|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
162136421|NCT01237678|585549442|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
162136422|NCT01237678|585549443|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
162136423|NCT01237678|585549441|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
162136424|NCT01237678|585549442|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
162136425|NCT01237678|585549443|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
162136426|NCT01237678|585549441|FG000|Phase II|Adverse Event|0|||
162136427|NCT01237678|585549442|FG001|Phase II|Adverse Event|39|||
162136428|NCT01237678|585549443|FG002|Phase II|Adverse Event|9|||
162136429|NCT01237678|585549441|FG000|Phase II|Death|0|||
162136430|NCT01237678|585549442|FG001|Phase II|Death|0|||
162136431|NCT01237678|585549443|FG002|Phase II|Death|2|||
162136432|NCT01237678|585549441|FG000|Phase II|Lack of Efficacy|0|||
162136433|NCT01237678|585549442|FG001|Phase II|Lack of Efficacy|25|||
162136434|NCT01237678|585549443|FG002|Phase II|Lack of Efficacy|3|||
162136435|NCT01237678|585549441|FG000|Phase II|Withdrawal by Subject|0|||
162136436|NCT01237678|585549442|FG001|Phase II|Withdrawal by Subject|1|||
162136437|NCT01237678|585549443|FG002|Phase II|Withdrawal by Subject|5|||
162136438|NCT01237678|585549441|FG000|Phase II|Completed Cycles 4-6|0|||
162136439|NCT01237678|585549442|FG001|Phase II|Completed Cycles 4-6|11|||
162136440|NCT01237678|585549443|FG002|Phase II|Completed Cycles 4-6|21|||
162136441|NCT01237678|585549441|FG000|Phase II|Sponsor Decision/Study Closed|0|||
162136442|NCT01237678|585549442|FG001|Phase II|Sponsor Decision/Study Closed|18|||
162136443|NCT01237678|585549443|FG002|Phase II|Sponsor Decision/Study Closed|7|||
162136444|NCT01237678|585549441|FG000|Phase II|Randomized but were not treated|0|||
162136445|NCT01237678|585549442|FG001|Phase II|Randomized but were not treated|4|||
162136446|NCT01237678|585549443|FG002|Phase II|Randomized but were not treated|3|||
162136447|NCT03398356|585549449|FG000|Before Treatment|Lost to Follow-up|1|||
162136448|NCT03398356|585549450|FG001|Before Treatment|Lost to Follow-up|2|||
162136449|NCT03398356|585549451|FG002|Before Treatment|Lost to Follow-up|0|||
162136450|NCT03398356|585549449|FG000|Before Treatment|drug intolerance|2|||
162136451|NCT03398356|585549450|FG001|Before Treatment|drug intolerance|1|||
162136452|NCT03398356|585549451|FG002|Before Treatment|drug intolerance|0|||
162136453|NCT03398356|585549449|FG000|Before Treatment|Withdrawal by Subject|0|||
162136454|NCT03398356|585549450|FG001|Before Treatment|Withdrawal by Subject|5|||
162136455|NCT03398356|585549451|FG002|Before Treatment|Withdrawal by Subject|0|||
162136456|NCT03398356|585549449|FG000|Before Treatment|Physician Decision|0|||
162136457|NCT03398356|585549450|FG001|Before Treatment|Physician Decision|0|||
162136458|NCT03398356|585549451|FG002|Before Treatment|Physician Decision|11|||
162136459|NCT03398356|585549449|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
162136460|NCT03398356|585549450|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
162136461|NCT03398356|585549451|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
162136462|NCT01982760|585549452|FG000|Overall Study|Physician Decision|1|||
162136463|NCT01982760|585549453|FG001|Overall Study|Physician Decision|0|||
162136464|NCT00821236|585549454|FG000|Overall Study|Lost to Follow-up|3|||
162136465|NCT00530777|585549455|FG000|Overall Study|Lost to Follow-up|0|||
162136466|NCT00530777|585549456|FG001|Overall Study|Lost to Follow-up|1|||
162136467|NCT00530777|585549455|FG000|Overall Study|Death|1|||
162136468|NCT00530777|585549456|FG001|Overall Study|Death|2|||
162136469|NCT00530777|585549455|FG000|Overall Study|Physician Decision|1|||
162136470|NCT00530777|585549456|FG001|Overall Study|Physician Decision|0|||
162136471|NCT00530777|585549455|FG000|Overall Study|Withdrawal by Subject|0|||
162136472|NCT00530777|585549456|FG001|Overall Study|Withdrawal by Subject|1|||
162136473|NCT00530777|585549455|FG000|Overall Study|Unable to adhere to visit schedule|5|||
162136474|NCT00530777|585549456|FG001|Overall Study|Unable to adhere to visit schedule|1|||
162136475|NCT01582243|585549458|FG000|Overall Study|Withdrawal by Subject|1|||
161796286|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
162136476|NCT01582243|585549458|FG000|Overall Study|Adverse Event|1|||
162136477|NCT01582243|585549458|FG000|Overall Study|Lost to Follow-up|1|||
162136478|NCT02954055|585549460|FG000|Overall Study|Did not initiate therapy|6|||
162136479|NCT02954055|585549461|FG001|Overall Study|Did not initiate therapy|1|||
161796287|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162136480|NCT02096003|585549462|FG000|Overall Study|Protocol Violation|0|||
162136481|NCT02096003|585549463|FG001|Overall Study|Protocol Violation|2|||
162136482|NCT02096003|585549462|FG000|Overall Study|additional surgery|2|||
162136483|NCT02096003|585549463|FG001|Overall Study|additional surgery|1|||
162136484|NCT01763047|585549464|FG000|Period 1|Test Article Not Available|4|||
162136485|NCT01763047|585549465|FG001|Period 1|Test Article Not Available|1|||
162136486|NCT01763047|585549464|FG000|Period 1|Protocol Violation|4|||
162136487|NCT01763047|585549465|FG001|Period 1|Protocol Violation|4|||
162136488|NCT01763047|585549464|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
162136489|NCT01763047|585549465|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
162136490|NCT01763047|585549464|FG000|Period 1|Adverse Event|0|||
162136491|NCT01763047|585549465|FG001|Period 1|Adverse Event|1|||
162136492|NCT01763047|585549464|FG000|Period 1|Unsatisfactory Visual Response|0|||
162136493|NCT01763047|585549465|FG001|Period 1|Unsatisfactory Visual Response|3|||
162136494|NCT01763047|585549464|FG000|Period 1|Lens Power Not Available|0|||
162136495|NCT01763047|585549465|FG001|Period 1|Lens Power Not Available|1|||
162136496|NCT01763047|585549464|FG000|Period 1|Study Site office Closed|0|||
162136497|NCT01763047|585549465|FG001|Period 1|Study Site office Closed|1|||
162136498|NCT01763047|585549464|FG000|Period 2|Lens Discomfort|1|||
162136499|NCT01763047|585549465|FG001|Period 2|Lens Discomfort|0|||
162136500|NCT01763047|585549464|FG000|Period 2|No longer meets Eligibility Criteria|1|||
162136501|NCT01763047|585549465|FG001|Period 2|No longer meets Eligibility Criteria|0|||
162136502|NCT01763047|585549464|FG000|Period 2|Study Site office Closed|1|||
162136503|NCT01763047|585549465|FG001|Period 2|Study Site office Closed|1|||
162136504|NCT01763047|585549464|FG000|Period 2|Unsatisfactory Visual Response|1|||
162136505|NCT01763047|585549465|FG001|Period 2|Unsatisfactory Visual Response|1|||
162136506|NCT01763047|585549464|FG000|Period 2|Protocol Violation|0|||
162136507|NCT01763047|585549465|FG001|Period 2|Protocol Violation|2|||
162136508|NCT01763047|585549464|FG000|Period 2|Unsatisfactory lens Fitting|0|||
162136509|NCT01763047|585549465|FG001|Period 2|Unsatisfactory lens Fitting|1|||
162136510|NCT01008748|585549468|FG000|Overall Study|Lost to Follow-up|80|||
162136511|NCT01008748|585549468|FG000|Overall Study|Other|1|||
162136512|NCT01767909|585549469|FG000|Overall Study|Withdrawal by Subject|4|||
162136513|NCT01767909|585549470|FG001|Overall Study|Withdrawal by Subject|7|||
162136514|NCT01767909|585549469|FG000|Overall Study|Adverse Event|3|||
162136515|NCT01767909|585549470|FG001|Overall Study|Adverse Event|1|||
162136516|NCT01767909|585549469|FG000|Overall Study|Withdrawal by Study Partner|3|||
162136517|NCT01767909|585549470|FG001|Overall Study|Withdrawal by Study Partner|1|||
162136518|NCT01767909|585549469|FG000|Overall Study|Non-Compliance|2|||
162136519|NCT01767909|585549470|FG001|Overall Study|Non-Compliance|0|||
162136520|NCT01767909|585549469|FG000|Overall Study|Perceived Lack of Efficacy|1|||
162136521|NCT01767909|585549470|FG001|Overall Study|Perceived Lack of Efficacy|0|||
162136522|NCT01767909|585549469|FG000|Overall Study|Investigator Recommendation|0|||
162136523|NCT01767909|585549470|FG001|Overall Study|Investigator Recommendation|1|||
162136524|NCT01767909|585549469|FG000|Overall Study|Lost to Follow-up|0|||
162136525|NCT01767909|585549470|FG001|Overall Study|Lost to Follow-up|1|||
162136526|NCT01767909|585549469|FG000|Overall Study|LP uncessessful|0|||
162136527|NCT01767909|585549470|FG001|Overall Study|LP uncessessful|1|||
162136528|NCT03251378|585549471|FG000|Overall Study|Death|3|||
162136529|NCT03251378|585549472|FG001|Overall Study|Death|2|||
162136530|NCT03251378|585549473|FG002|Overall Study|Death|3|||
162136531|NCT03251378|585549474|FG003|Overall Study|Death|30|||
162136532|NCT03251378|585549475|FG004|Overall Study|Death|24|||
162136533|NCT03251378|585549476|FG005|Overall Study|Death|12|||
162136534|NCT03251378|585549477|FG006|Overall Study|Death|12|||
162136535|NCT03251378|585549471|FG000|Overall Study|Lost to Follow-up|0|||
162136536|NCT03251378|585549472|FG001|Overall Study|Lost to Follow-up|0|||
162136537|NCT03251378|585549473|FG002|Overall Study|Lost to Follow-up|1|||
162136538|NCT03251378|585549474|FG003|Overall Study|Lost to Follow-up|3|||
162136539|NCT03251378|585549475|FG004|Overall Study|Lost to Follow-up|0|||
162136540|NCT03251378|585549476|FG005|Overall Study|Lost to Follow-up|0|||
162136541|NCT03251378|585549477|FG006|Overall Study|Lost to Follow-up|0|||
162136542|NCT03251378|585549471|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
162136543|NCT03251378|585549472|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
162136544|NCT03251378|585549473|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
162136545|NCT03251378|585549474|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
162136546|NCT03251378|585549475|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
162136547|NCT03251378|585549476|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
162136548|NCT03251378|585549477|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
162136549|NCT03251378|585549471|FG000|Overall Study|Progressive disease|2|||
162136550|NCT03251378|585549472|FG001|Overall Study|Progressive disease|0|||
162136551|NCT03251378|585549473|FG002|Overall Study|Progressive disease|0|||
162136552|NCT03251378|585549474|FG003|Overall Study|Progressive disease|1|||
162136553|NCT03251378|585549475|FG004|Overall Study|Progressive disease|0|||
162136554|NCT03251378|585549476|FG005|Overall Study|Progressive disease|0|||
162136555|NCT03251378|585549477|FG006|Overall Study|Progressive disease|0|||
162136556|NCT03251378|585549471|FG000|Overall Study|Physician Decision|0|||
162136557|NCT03251378|585549472|FG001|Overall Study|Physician Decision|2|||
162136558|NCT03251378|585549473|FG002|Overall Study|Physician Decision|0|||
162136559|NCT03251378|585549474|FG003|Overall Study|Physician Decision|0|||
162136560|NCT03251378|585549475|FG004|Overall Study|Physician Decision|0|||
162136561|NCT03251378|585549476|FG005|Overall Study|Physician Decision|0|||
162136562|NCT03251378|585549477|FG006|Overall Study|Physician Decision|0|||
162136563|NCT03251378|585549471|FG000|Overall Study|Other|2|||
162136564|NCT03251378|585549472|FG001|Overall Study|Other|3|||
162136565|NCT03251378|585549473|FG002|Overall Study|Other|2|||
162136566|NCT03251378|585549474|FG003|Overall Study|Other|0|||
162136567|NCT03251378|585549475|FG004|Overall Study|Other|1|||
162136568|NCT03251378|585549476|FG005|Overall Study|Other|1|||
162136569|NCT03251378|585549477|FG006|Overall Study|Other|1|||
162136570|NCT03251378|585549471|FG000|Overall Study|Other|0|||
162136571|NCT03251378|585549472|FG001|Overall Study|Other|0|||
162136572|NCT03251378|585549473|FG002|Overall Study|Other|0|||
162136573|NCT03251378|585549474|FG003|Overall Study|Other|4|||
162136574|NCT03251378|585549475|FG004|Overall Study|Other|13|||
162136575|NCT03251378|585549476|FG005|Overall Study|Other|0|||
162136576|NCT03251378|585549477|FG006|Overall Study|Other|0|||
162136577|NCT05780047|585549478|FG000|Overall Study|Did not submit baseline urine test kit|226|||
162136578|NCT05780047|585549478|FG000|Overall Study|Lost to Follow-up|34|||
162136579|NCT05780047|585549478|FG000|Overall Study|Did not submit second urine test kit|124|||
162136580|NCT00764868|585549488|FG000|Overall Study|Adverse Event|18|||
162136581|NCT00764868|585549488|FG000|Overall Study|Withdrawal by Subject|31|||
162136582|NCT00764868|585549488|FG000|Overall Study|Non-compliance|16|||
162136583|NCT00764868|585549488|FG000|Overall Study|Lost to Follow-up|25|||
162136584|NCT00764868|585549488|FG000|Overall Study|Lack of Efficacy|5|||
162136585|NCT00764868|585549488|FG000|Overall Study|Subject moved|7|||
162136586|NCT00764868|585549488|FG000|Overall Study|Pregnancy|3|||
162136587|NCT00764868|585549488|FG000|Overall Study|Prohibited medication|1|||
162136588|NCT00764868|585549488|FG000|Overall Study|Out of town|1|||
162136589|NCT00764868|585549488|FG000|Overall Study|Misuse and compliance of study drug|1|||
162136590|NCT00764868|585549488|FG000|Overall Study|Subject sent to boarding school|1|||
162136591|NCT00764868|585549488|FG000|Overall Study|Met an exclusion criteria|1|||
162136592|NCT00764868|585549488|FG000|Overall Study|Positive drug screen|2|||
162136593|NCT00764868|585549488|FG000|Overall Study|Sponsor requested withdrawal|1|||
162136594|NCT00783692|585549489|FG000|Induction Phase|Adverse Event|7|||
162136595|NCT00783692|585549490|FG001|Induction Phase|Adverse Event|9|||
162136596|NCT00783692|585549491|FG002|Induction Phase|Adverse Event|24|||
162136597|NCT00783692|585549492|FG003|Induction Phase|Adverse Event|0|||
162136598|NCT00783692|585549493|FG004|Induction Phase|Adverse Event|0|||
162136599|NCT00783692|585549494|FG005|Induction Phase|Adverse Event|0|||
162136600|NCT00783692|585549495|FG006|Induction Phase|Adverse Event|0|||
162136601|NCT00783692|585549489|FG000|Induction Phase|Protocol Violation|0|||
162136602|NCT00783692|585549490|FG001|Induction Phase|Protocol Violation|0|||
162136603|NCT00783692|585549491|FG002|Induction Phase|Protocol Violation|1|||
162136604|NCT00783692|585549492|FG003|Induction Phase|Protocol Violation|0|||
162136605|NCT00783692|585549493|FG004|Induction Phase|Protocol Violation|0|||
162136606|NCT00783692|585549494|FG005|Induction Phase|Protocol Violation|0|||
162136607|NCT00783692|585549495|FG006|Induction Phase|Protocol Violation|0|||
162136608|NCT00783692|585549489|FG000|Induction Phase|Lack of Efficacy|1|||
162136609|NCT00783692|585549490|FG001|Induction Phase|Lack of Efficacy|3|||
162136610|NCT00783692|585549491|FG002|Induction Phase|Lack of Efficacy|28|||
162136611|NCT00783692|585549492|FG003|Induction Phase|Lack of Efficacy|0|||
162136612|NCT00783692|585549493|FG004|Induction Phase|Lack of Efficacy|0|||
162136613|NCT00783692|585549494|FG005|Induction Phase|Lack of Efficacy|0|||
162136614|NCT00783692|585549495|FG006|Induction Phase|Lack of Efficacy|0|||
162136615|NCT00783692|585549489|FG000|Induction Phase|Withdrawal by Subject|3|||
162136616|NCT00783692|585549490|FG001|Induction Phase|Withdrawal by Subject|9|||
162136617|NCT00783692|585549491|FG002|Induction Phase|Withdrawal by Subject|16|||
162136618|NCT00783692|585549492|FG003|Induction Phase|Withdrawal by Subject|0|||
162136619|NCT00783692|585549493|FG004|Induction Phase|Withdrawal by Subject|0|||
162136620|NCT00783692|585549494|FG005|Induction Phase|Withdrawal by Subject|0|||
162136621|NCT00783692|585549495|FG006|Induction Phase|Withdrawal by Subject|0|||
162136622|NCT00783692|585549489|FG000|Induction Phase|Lost to Follow-up|0|||
162136623|NCT00783692|585549490|FG001|Induction Phase|Lost to Follow-up|0|||
162136624|NCT00783692|585549491|FG002|Induction Phase|Lost to Follow-up|3|||
162136625|NCT00783692|585549492|FG003|Induction Phase|Lost to Follow-up|0|||
162136626|NCT00783692|585549493|FG004|Induction Phase|Lost to Follow-up|0|||
162136627|NCT00783692|585549494|FG005|Induction Phase|Lost to Follow-up|0|||
162136628|NCT00783692|585549495|FG006|Induction Phase|Lost to Follow-up|0|||
162136629|NCT00783692|585549489|FG000|Induction Phase|Other|0|||
162136630|NCT00783692|585549490|FG001|Induction Phase|Other|0|||
162136631|NCT00783692|585549491|FG002|Induction Phase|Other|2|||
162136632|NCT00783692|585549492|FG003|Induction Phase|Other|0|||
162136633|NCT00783692|585549493|FG004|Induction Phase|Other|0|||
162136634|NCT00783692|585549494|FG005|Induction Phase|Other|0|||
162136635|NCT00783692|585549495|FG006|Induction Phase|Other|0|||
162136636|NCT00783692|585549489|FG000|Maintenance Phase|Adverse Event|7|||
162136637|NCT00783692|585549490|FG001|Maintenance Phase|Adverse Event|0|||
162136638|NCT00783692|585549491|FG002|Maintenance Phase|Adverse Event|0|||
162136639|NCT00783692|585549492|FG003|Maintenance Phase|Adverse Event|15|||
162136640|NCT00783692|585549493|FG004|Maintenance Phase|Adverse Event|12|||
162136641|NCT00783692|585549494|FG005|Maintenance Phase|Adverse Event|9|||
162136642|NCT00783692|585549495|FG006|Maintenance Phase|Adverse Event|38|||
161900697|NCT03334188|584685161|FG000|Overall Study|Death|1|||
161900698|NCT03334188|584685162|FG001|Overall Study|Death|0|||
161900699|NCT03334188|584685161|FG000|Overall Study|Never had qualifying clinic visit|7|||
161900700|NCT03334188|584685162|FG001|Overall Study|Never had qualifying clinic visit|7|||
161900701|NCT00766597|584685166|FG000|Overall Study|Unexpected closure of study|4|||
161900702|NCT00766597|584685166|FG000|Overall Study|Without CCR5-tropic virus|5|||
161900703|NCT05137717|584685167|FG000|Overall Study|Death|2|||
161900704|NCT05137717|584685167|FG000|Overall Study|Withdrawal by Subject|6|||
161900705|NCT02619617|584685168|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
161900706|NCT02619617|584685169|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
161900707|NCT02619617|584685168|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
161900708|NCT02619617|584685169|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
161900709|NCT00509899|584685170|FG000|Overall Study|Progressive disease|1|||
161900710|NCT00509899|584685171|FG001|Overall Study|Progressive disease|3|||
161900711|NCT00509899|584685172|FG002|Overall Study|Progressive disease|5|||
161900712|NCT00509899|584685173|FG003|Overall Study|Progressive disease|1|||
161900713|NCT00509899|584685174|FG004|Overall Study|Progressive disease|0|||
161900714|NCT00509899|584685175|FG005|Overall Study|Progressive disease|1|||
161900715|NCT00509899|584685176|FG006|Overall Study|Progressive disease|0|||
161900716|NCT00509899|584685177|FG007|Overall Study|Progressive disease|0|||
161900717|NCT00509899|584685170|FG000|Overall Study|Unacceptable Toxicity|1|||
161900718|NCT00509899|584685171|FG001|Overall Study|Unacceptable Toxicity|0|||
161900719|NCT00509899|584685172|FG002|Overall Study|Unacceptable Toxicity|0|||
161900720|NCT00509899|584685173|FG003|Overall Study|Unacceptable Toxicity|2|||
161900721|NCT00509899|584685174|FG004|Overall Study|Unacceptable Toxicity|0|||
161900722|NCT00509899|584685175|FG005|Overall Study|Unacceptable Toxicity|0|||
161900723|NCT00509899|584685176|FG006|Overall Study|Unacceptable Toxicity|0|||
161900724|NCT00509899|584685177|FG007|Overall Study|Unacceptable Toxicity|0|||
161900725|NCT00509899|584685170|FG000|Overall Study|Withdrawal by Subject|6|||
161900726|NCT00509899|584685171|FG001|Overall Study|Withdrawal by Subject|2|||
161900727|NCT00509899|584685172|FG002|Overall Study|Withdrawal by Subject|3|||
161900728|NCT00509899|584685173|FG003|Overall Study|Withdrawal by Subject|0|||
161900729|NCT00509899|584685174|FG004|Overall Study|Withdrawal by Subject|3|||
161900730|NCT00509899|584685175|FG005|Overall Study|Withdrawal by Subject|2|||
161900731|NCT00509899|584685176|FG006|Overall Study|Withdrawal by Subject|0|||
161900732|NCT00509899|584685177|FG007|Overall Study|Withdrawal by Subject|0|||
161900733|NCT00509899|584685170|FG000|Overall Study|Physician Decision|4|||
161900734|NCT00509899|584685171|FG001|Overall Study|Physician Decision|2|||
161900735|NCT00509899|584685172|FG002|Overall Study|Physician Decision|7|||
161900736|NCT00509899|584685173|FG003|Overall Study|Physician Decision|0|||
161900737|NCT00509899|584685174|FG004|Overall Study|Physician Decision|1|||
161900738|NCT00509899|584685175|FG005|Overall Study|Physician Decision|4|||
161900739|NCT00509899|584685176|FG006|Overall Study|Physician Decision|0|||
161900740|NCT00509899|584685177|FG007|Overall Study|Physician Decision|0|||
161900741|NCT00509899|584685170|FG000|Overall Study|Intercurrent Illness|1|||
161900742|NCT00509899|584685171|FG001|Overall Study|Intercurrent Illness|0|||
161900743|NCT00509899|584685172|FG002|Overall Study|Intercurrent Illness|0|||
161900744|NCT00509899|584685173|FG003|Overall Study|Intercurrent Illness|1|||
161900745|NCT00509899|584685174|FG004|Overall Study|Intercurrent Illness|0|||
161900746|NCT00509899|584685175|FG005|Overall Study|Intercurrent Illness|1|||
161900747|NCT00509899|584685176|FG006|Overall Study|Intercurrent Illness|0|||
161900748|NCT00509899|584685177|FG007|Overall Study|Intercurrent Illness|0|||
161900749|NCT00509899|584685170|FG000|Overall Study|Death|2|||
161900750|NCT00509899|584685171|FG001|Overall Study|Death|2|||
161900751|NCT00509899|584685172|FG002|Overall Study|Death|3|||
161900752|NCT00509899|584685173|FG003|Overall Study|Death|0|||
161900753|NCT00509899|584685174|FG004|Overall Study|Death|1|||
161900754|NCT00509899|584685175|FG005|Overall Study|Death|1|||
161900755|NCT00509899|584685176|FG006|Overall Study|Death|1|||
161900756|NCT00509899|584685177|FG007|Overall Study|Death|1|||
161900757|NCT00509899|584685170|FG000|Overall Study|Lack of Efficacy|1|||
161900758|NCT00509899|584685171|FG001|Overall Study|Lack of Efficacy|0|||
161900759|NCT00509899|584685172|FG002|Overall Study|Lack of Efficacy|2|||
161900760|NCT00509899|584685173|FG003|Overall Study|Lack of Efficacy|0|||
161900761|NCT00509899|584685174|FG004|Overall Study|Lack of Efficacy|0|||
161900762|NCT00509899|584685175|FG005|Overall Study|Lack of Efficacy|1|||
161900763|NCT00509899|584685176|FG006|Overall Study|Lack of Efficacy|0|||
161900764|NCT00509899|584685177|FG007|Overall Study|Lack of Efficacy|0|||
161900765|NCT01254656|584685178|FG000|Overall Study|Discontinued due to termination of study|40|||
161900766|NCT01254656|584685179|FG001|Overall Study|Discontinued due to termination of study|39|||
161900767|NCT01254656|584685180|FG002|Overall Study|Discontinued due to termination of study|13|||
161900768|NCT01254656|584685178|FG000|Overall Study|Lack of Efficacy|3|||
161900769|NCT01254656|584685179|FG001|Overall Study|Lack of Efficacy|0|||
161900770|NCT01254656|584685180|FG002|Overall Study|Lack of Efficacy|0|||
161900771|NCT01254656|584685178|FG000|Overall Study|Lost to Follow-up|1|||
161900772|NCT01254656|584685179|FG001|Overall Study|Lost to Follow-up|0|||
161900773|NCT01254656|584685180|FG002|Overall Study|Lost to Follow-up|2|||
161900774|NCT01254656|584685178|FG000|Overall Study|Withdrawal by Subject|2|||
162136643|NCT00783692|585549489|FG000|Maintenance Phase|Protocol Violation|0|||
162136644|NCT00783692|585549490|FG001|Maintenance Phase|Protocol Violation|0|||
162136645|NCT00783692|585549491|FG002|Maintenance Phase|Protocol Violation|0|||
162136646|NCT00783692|585549492|FG003|Maintenance Phase|Protocol Violation|1|||
162136647|NCT00783692|585549493|FG004|Maintenance Phase|Protocol Violation|2|||
162136648|NCT00783692|585549494|FG005|Maintenance Phase|Protocol Violation|3|||
162136649|NCT00783692|585549495|FG006|Maintenance Phase|Protocol Violation|4|||
162136650|NCT00783692|585549489|FG000|Maintenance Phase|Lack of Efficacy|79|||
162136651|NCT00783692|585549490|FG001|Maintenance Phase|Lack of Efficacy|0|||
162136652|NCT00783692|585549491|FG002|Maintenance Phase|Lack of Efficacy|0|||
162136653|NCT00783692|585549492|FG003|Maintenance Phase|Lack of Efficacy|64|||
162136654|NCT00783692|585549493|FG004|Maintenance Phase|Lack of Efficacy|58|||
162136655|NCT00783692|585549494|FG005|Maintenance Phase|Lack of Efficacy|48|||
162136656|NCT00783692|585549495|FG006|Maintenance Phase|Lack of Efficacy|177|||
162136657|NCT00783692|585549489|FG000|Maintenance Phase|Withdrawal by Subject|7|||
162136658|NCT00783692|585549490|FG001|Maintenance Phase|Withdrawal by Subject|0|||
162136659|NCT00783692|585549491|FG002|Maintenance Phase|Withdrawal by Subject|0|||
162136660|NCT00783692|585549492|FG003|Maintenance Phase|Withdrawal by Subject|7|||
162136661|NCT00783692|585549493|FG004|Maintenance Phase|Withdrawal by Subject|6|||
162136662|NCT00783692|585549494|FG005|Maintenance Phase|Withdrawal by Subject|9|||
162136663|NCT00783692|585549495|FG006|Maintenance Phase|Withdrawal by Subject|24|||
162136664|NCT00783692|585549489|FG000|Maintenance Phase|Lost to Follow-up|2|||
162136665|NCT00783692|585549490|FG001|Maintenance Phase|Lost to Follow-up|0|||
162136666|NCT00783692|585549491|FG002|Maintenance Phase|Lost to Follow-up|0|||
162136667|NCT00783692|585549492|FG003|Maintenance Phase|Lost to Follow-up|1|||
162136668|NCT00783692|585549493|FG004|Maintenance Phase|Lost to Follow-up|3|||
162136669|NCT00783692|585549494|FG005|Maintenance Phase|Lost to Follow-up|2|||
162136670|NCT00783692|585549495|FG006|Maintenance Phase|Lost to Follow-up|5|||
162136671|NCT00783692|585549489|FG000|Maintenance Phase|Other|0|||
162136672|NCT00783692|585549490|FG001|Maintenance Phase|Other|0|||
162136673|NCT00783692|585549491|FG002|Maintenance Phase|Other|0|||
162136674|NCT00783692|585549492|FG003|Maintenance Phase|Other|1|||
162136675|NCT00783692|585549493|FG004|Maintenance Phase|Other|0|||
162136676|NCT00783692|585549494|FG005|Maintenance Phase|Other|1|||
162136677|NCT00783692|585549495|FG006|Maintenance Phase|Other|1|||
162136678|NCT04438785|585549503|FG000|Overall Study|change of weight, give up intervention|2|||
162136679|NCT04438785|585549504|FG001|Overall Study|change of weight, give up intervention|10|||
162136680|NCT04831775|585549505|FG000|Overall Study|Lost to Follow-up|11|||
162136681|NCT04831775|585549506|FG001|Overall Study|Lost to Follow-up|13|||
162136682|NCT02027935|585549507|FG000|Overall Study|Death|1|||
162136683|NCT02027935|585549507|FG000|Overall Study|Lack of Efficacy|5|||
162136684|NCT02027935|585549507|FG000|Overall Study|Study Closure|1|||
162136685|NCT03115346|585549508|FG000|Overall Study|Did not have AAA surgery|28|||
162136686|NCT03115346|585549509|FG001|Overall Study|Did not have AAA surgery|15|||
162136687|NCT03115346|585549508|FG000|Overall Study|Death|3|||
162136688|NCT03115346|585549509|FG001|Overall Study|Death|1|||
162136689|NCT03115346|585549508|FG000|Overall Study|Withdrawal by Subject|0|||
162136690|NCT03115346|585549509|FG001|Overall Study|Withdrawal by Subject|3|||
162136691|NCT03115346|585549508|FG000|Overall Study|Lost to Follow-up|0|||
162136692|NCT03115346|585549509|FG001|Overall Study|Lost to Follow-up|3|||
162136693|NCT00689104|585549510|FG000|Overall Study|Eligibility criterion not met|5|||
162136694|NCT00689104|585549511|FG001|Overall Study|Eligibility criterion not met|8|||
162136695|NCT00689104|585549512|FG002|Overall Study|Eligibility criterion not met|0|||
161900775|NCT01254656|584685179|FG001|Overall Study|Withdrawal by Subject|2|||
161900776|NCT01254656|584685180|FG002|Overall Study|Withdrawal by Subject|1|||
161900777|NCT01254656|584685178|FG000|Overall Study|Pregnancy|0|||
161900778|NCT01254656|584685179|FG001|Overall Study|Pregnancy|0|||
161900779|NCT01254656|584685180|FG002|Overall Study|Pregnancy|2|||
161900780|NCT01254656|584685178|FG000|Overall Study|Adverse Event|1|||
161900781|NCT01254656|584685179|FG001|Overall Study|Adverse Event|1|||
161900782|NCT01254656|584685180|FG002|Overall Study|Adverse Event|0|||
161900783|NCT01254656|584685178|FG000|Overall Study|Death|0|||
161900784|NCT01254656|584685179|FG001|Overall Study|Death|1|||
161900785|NCT01254656|584685180|FG002|Overall Study|Death|0|||
162136696|NCT00689104|585549513|FG003|Overall Study|Eligibility criterion not met|4|||
162136697|NCT00689104|585549510|FG000|Overall Study|Adverse Event|13|||
162136698|NCT00689104|585549511|FG001|Overall Study|Adverse Event|25|||
162136699|NCT00689104|585549512|FG002|Overall Study|Adverse Event|16|||
162136700|NCT00689104|585549513|FG003|Overall Study|Adverse Event|24|||
162136701|NCT00689104|585549510|FG000|Overall Study|Lack of Efficacy|5|||
162136702|NCT00689104|585549511|FG001|Overall Study|Lack of Efficacy|6|||
162136703|NCT00689104|585549512|FG002|Overall Study|Lack of Efficacy|2|||
162136704|NCT00689104|585549513|FG003|Overall Study|Lack of Efficacy|3|||
162136705|NCT00689104|585549510|FG000|Overall Study|Withdrawal by Subject|12|||
162136706|NCT00689104|585549511|FG001|Overall Study|Withdrawal by Subject|11|||
162136707|NCT00689104|585549512|FG002|Overall Study|Withdrawal by Subject|18|||
162136708|NCT00689104|585549513|FG003|Overall Study|Withdrawal by Subject|11|||
162136709|NCT00689104|585549510|FG000|Overall Study|Lost to Follow-up|4|||
162136710|NCT00689104|585549511|FG001|Overall Study|Lost to Follow-up|3|||
162136711|NCT00689104|585549512|FG002|Overall Study|Lost to Follow-up|2|||
162136712|NCT00689104|585549513|FG003|Overall Study|Lost to Follow-up|5|||
162136713|NCT00689104|585549510|FG000|Overall Study|Protocol Violation|2|||
162136714|NCT00689104|585549511|FG001|Overall Study|Protocol Violation|3|||
162136715|NCT00689104|585549512|FG002|Overall Study|Protocol Violation|5|||
162136716|NCT00689104|585549513|FG003|Overall Study|Protocol Violation|3|||
162136717|NCT00689104|585549510|FG000|Overall Study|Randomized but never received study drug|2|||
162136718|NCT00689104|585549511|FG001|Overall Study|Randomized but never received study drug|1|||
162136719|NCT00689104|585549512|FG002|Overall Study|Randomized but never received study drug|1|||
162136720|NCT00689104|585549513|FG003|Overall Study|Randomized but never received study drug|0|||
162136721|NCT00689104|585549510|FG000|Overall Study|Physician Decision|1|||
162136722|NCT00689104|585549511|FG001|Overall Study|Physician Decision|0|||
162136723|NCT00689104|585549512|FG002|Overall Study|Physician Decision|0|||
162136724|NCT00689104|585549513|FG003|Overall Study|Physician Decision|0|||
162136725|NCT00689104|585549510|FG000|Overall Study|Non-compliance with study procedures|0|||
162136726|NCT00689104|585549511|FG001|Overall Study|Non-compliance with study procedures|0|||
162136727|NCT00689104|585549512|FG002|Overall Study|Non-compliance with study procedures|1|||
162136728|NCT00689104|585549513|FG003|Overall Study|Non-compliance with study procedures|0|||
162136729|NCT01737268|585549514|FG000|Overall Study|Adverse Event|6|||
162136730|NCT01737268|585549514|FG000|Overall Study|Worsening of Target Disease|2|||
162136731|NCT01737268|585549514|FG000|Overall Study|In consideration of the patient's safety|1|||
162136732|NCT04873817|585549515|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
162136733|NCT04873817|585549515|FG000|Overall Study|Lost to Follow-up|4|||
162136734|NCT04873817|585549515|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
162136735|NCT04873817|585549515|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
162136736|NCT04873817|585549515|FG000|Overall Study|Other Reasons|3|||
162136737|NCT02696226|585549523|FG000|Overall Study|Study terminated - lack of enrollment|1|||
162136738|NCT02696226|585549524|FG001|Overall Study|Study terminated - lack of enrollment|0|||
162136739|NCT02696226|585549525|FG002|Overall Study|Study terminated - lack of enrollment|2|||
162136740|NCT02696226|585549526|FG003|Overall Study|Study terminated - lack of enrollment|0|||
162136741|NCT01394991|585549529|FG000|Overall Study|Adverse Event|0|||
162136742|NCT01394991|585549530|FG001|Overall Study|Adverse Event|4|||
162136743|NCT01394991|585549529|FG000|Overall Study|Lack of Efficacy|5|||
162136744|NCT01394991|585549530|FG001|Overall Study|Lack of Efficacy|7|||
162136745|NCT01394991|585549529|FG000|Overall Study|Lost to Follow-up|6|||
162136746|NCT01394991|585549530|FG001|Overall Study|Lost to Follow-up|8|||
162136747|NCT01394991|585549529|FG000|Overall Study|Physician Decision|1|||
162136748|NCT01394991|585549530|FG001|Overall Study|Physician Decision|3|||
162136749|NCT01394991|585549529|FG000|Overall Study|Protocol Violation|1|||
162136750|NCT01394991|585549530|FG001|Overall Study|Protocol Violation|1|||
162136751|NCT01394991|585549529|FG000|Overall Study|Withdrawal by Subject|20|||
162136752|NCT01394991|585549530|FG001|Overall Study|Withdrawal by Subject|17|||
162136753|NCT01394991|585549529|FG000|Overall Study|Chemotherapy Termination|10|||
162136754|NCT01394991|585549530|FG001|Overall Study|Chemotherapy Termination|15|||
162136755|NCT01394991|585549529|FG000|Overall Study|Disease Progression|7|||
162136756|NCT01394991|585549530|FG001|Overall Study|Disease Progression|7|||
162136757|NCT01394991|585549529|FG000|Overall Study|Prematurely Termination of Trial|9|||
162136758|NCT01394991|585549530|FG001|Overall Study|Prematurely Termination of Trial|10|||
162136759|NCT02337361|585549531|FG000|3-month Follow-up|Lost to Follow-up|19|||
162136760|NCT02337361|585549532|FG001|3-month Follow-up|Lost to Follow-up|14|||
162136761|NCT02337361|585549531|FG000|6-month Follow-up|Lost to Follow-up|2|||
162136762|NCT02337361|585549532|FG001|6-month Follow-up|Lost to Follow-up|4|||
162136763|NCT03073005|585549533|FG000|Overall Study|Death|6|||
162136764|NCT03073005|585549534|FG001|Overall Study|Death|0|||
162136765|NCT03073005|585549535|FG002|Overall Study|Death|7|||
162136766|NCT03073005|585549536|FG003|Overall Study|Death|0|||
162136767|NCT03073005|585549533|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
162136768|NCT03073005|585549534|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
162136769|NCT03073005|585549535|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
162136770|NCT03073005|585549536|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
162136771|NCT03073005|585549533|FG000|Overall Study|Lost to Follow-up|2|||
162136772|NCT03073005|585549534|FG001|Overall Study|Lost to Follow-up|2|||
162136773|NCT03073005|585549535|FG002|Overall Study|Lost to Follow-up|1|||
162136774|NCT03073005|585549536|FG003|Overall Study|Lost to Follow-up|2|||
162136775|NCT03073005|585549533|FG000|Overall Study|Withdrawal by Subject|0|||
162136776|NCT03073005|585549534|FG001|Overall Study|Withdrawal by Subject|4|||
161900786|NCT02948829|584685183|FG000|Overall Study|Lost to Follow-up|2|||
162136777|NCT03073005|585549535|FG002|Overall Study|Withdrawal by Subject|4|||
162136778|NCT03073005|585549536|FG003|Overall Study|Withdrawal by Subject|4|||
162136779|NCT01101542|585549546|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
161796288|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
161796289|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162136780|NCT01101542|585549546|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
162136781|NCT01101542|585549546|FG000|Year 4 Surveillance Period|Other|287|||
162136782|NCT01101542|585549546|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
162136783|NCT01101542|585549546|FG000|Year 5 Surveillance Period|Pregnancy|1|||
162136784|NCT01101542|585549546|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
162136785|NCT01101542|585549546|FG000|Year 6 Surveillance Period|Pregnancy|1|||
162136786|NCT01101542|585549546|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
162136787|NCT00701311|585549547|FG000|Overall Study|Lack of Efficacy|3|||
162136788|NCT00701311|585549547|FG000|Overall Study|Adverse Event|3|||
162136789|NCT00701311|585549547|FG000|Overall Study|Withdrawal by Subject|2|||
162136790|NCT04580407|585549548|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
162136791|NCT00814489|585549551|FG000|Overall Study|Other|2|||
162136792|NCT00814489|585549552|FG001|Overall Study|Other|0|||
162136793|NCT00814489|585549553|FG002|Overall Study|Other|1|||
162136794|NCT01712685|585549579|FG000|Overall Study|pt declined to participate before trmt|1|||
162136795|NCT02738840|585551163|FG000|Overall Study|MRI Scan not Performed|5|||
162136796|NCT02738840|585551163|FG000|Overall Study|Lost to Follow-up|1|||
162136797|NCT02738840|585551163|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
162136798|NCT02738840|585551163|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
162136799|NCT02268396|585551166|FG000|Overall Study|Adverse Event|3|||
162136800|NCT02268396|585551166|FG000|Overall Study|Administrative|2|||
161796290|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162136801|NCT02268396|585551166|FG000|Overall Study|Withdrawal by Subject|1|||
162136802|NCT02268396|585551166|FG000|Overall Study|Lost to Follow-up|2|||
161796291|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796292|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
162136803|NCT02268396|585551166|FG000|Overall Study|Protocol-Specified Criteria|2|||
162136804|NCT02268396|585551166|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
162136805|NCT01311648|585551167|FG000|Main Study|Protocol Violation|0|||
162136806|NCT01311648|585551168|FG001|Main Study|Protocol Violation|1|||
162136807|NCT01311648|585551167|FG000|Main Study|Adverse Event|0|||
162136808|NCT01311648|585551168|FG001|Main Study|Adverse Event|1|||
162136809|NCT01311648|585551167|FG000|Main Study|Inhibitor management|0|||
162136810|NCT01311648|585551168|FG001|Main Study|Inhibitor management|17|||
162136811|NCT01311648|585551167|FG000|Main Study|Withdrawal by Subject|0|||
162136812|NCT01311648|585551168|FG001|Main Study|Withdrawal by Subject|2|||
162136813|NCT01311648|585551167|FG000|Extension Study|Physician Decision|0|||
162136814|NCT01311648|585551168|FG001|Extension Study|Physician Decision|1|||
162136815|NCT01311648|585551167|FG000|Extension Study|ITI therapy with marketed product|0|||
162136816|NCT01311648|585551168|FG001|Extension Study|ITI therapy with marketed product|1|||
162136817|NCT01311648|585551167|FG000|Extension Study|Incorrect visit planning|0|||
162136818|NCT01311648|585551168|FG001|Extension Study|Incorrect visit planning|1|||
162136819|NCT01311648|585551167|FG000|Extension Study|Family's decision|0|||
162136820|NCT01311648|585551168|FG001|Extension Study|Family's decision|1|||
162136821|NCT01311648|585551167|FG000|Extension Study|Failure of ITI therapy|0|||
162136822|NCT01311648|585551168|FG001|Extension Study|Failure of ITI therapy|3|||
162136823|NCT01311648|585551167|FG000|Extension Study|Long travel|0|||
162136824|NCT01311648|585551168|FG001|Extension Study|Long travel|1|||
162136825|NCT01311648|585551167|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
162136826|NCT01311648|585551168|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
162136827|NCT01311648|585551167|FG000|Extension Study|Withdrawal by Subject|0|||
162136828|NCT01311648|585551168|FG001|Extension Study|Withdrawal by Subject|1|||
162136829|NCT01311648|585551167|FG000|Extension Study|Inhibitor management|0|||
162136830|NCT01311648|585551168|FG001|Extension Study|Inhibitor management|2|||
162136831|NCT01645111|585551169|FG000|Overall Study|Did not require Clevidipine|15|||
162136832|NCT01304706|585551175|FG000|Overall Study|Adverse Event|2|||
162136833|NCT01304706|585551175|FG000|Overall Study|Lack of Efficacy|1|||
162136834|NCT01304706|585551175|FG000|Overall Study|Death|3|||
162136835|NCT01304706|585551175|FG000|Overall Study|Withdrawal by Subject|3|||
162136836|NCT01304706|585551175|FG000|Overall Study|Lost to Follow-up|7|||
162136837|NCT01304706|585551175|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
162136838|NCT05526911|585551178|FG000|Overall Study|Adverse Event|2|||
162136839|NCT05025449|585551179|FG000|Overall Study|Withdrawal by Subject|1|||
162136840|NCT05025449|585551179|FG000|Overall Study|Patient emergently taken to operating room|1|||
162136841|NCT00256308|585551180|FG000|Overall Study|Death|2|||
162136842|NCT01419717|585551181|FG000|Overall Study|Protocol-specified Criteria|62|||
162136843|NCT01419717|585551181|FG000|Overall Study|Adverse Event|19|||
162136844|NCT01419717|585551181|FG000|Overall Study|Death|17|||
162136845|NCT01419717|585551181|FG000|Overall Study|Withdrawal by Subject|10|||
162136846|NCT01419717|585551181|FG000|Overall Study|Disease Progression|9|||
162136847|NCT01419717|585551181|FG000|Overall Study|Other|4|||
162136848|NCT01419717|585551181|FG000|Overall Study|Lost to Follow-up|2|||
161900787|NCT02948829|584685183|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
162136849|NCT01419717|585551181|FG000|Overall Study|Administrative Decision|1|||
162136850|NCT01419717|585551181|FG000|Overall Study|Noncompliance|1|||
162136851|NCT01240356|585551183|FG000|Overall Study|Withdrawal by Subject|2|||
162136852|NCT01240356|585551184|FG001|Overall Study|Withdrawal by Subject|0|||
162136853|NCT01240356|585551183|FG000|Overall Study|MRI contraindication|1|||
162136854|NCT01240356|585551184|FG001|Overall Study|MRI contraindication|0|||
162136855|NCT04048135|585551187|FG000|Overall Study|Withdrawal by Subject|1|||
162136856|NCT04048135|585551188|FG001|Overall Study|Withdrawal by Subject|1|||
162136857|NCT04048135|585551189|FG002|Overall Study|Withdrawal by Subject|1|||
162136858|NCT04048135|585551190|FG003|Overall Study|Withdrawal by Subject|2|||
162136859|NCT04048135|585551191|FG004|Overall Study|Withdrawal by Subject|0|||
162136860|NCT04048135|585551192|FG005|Overall Study|Withdrawal by Subject|0|||
162136861|NCT04048135|585551193|FG006|Overall Study|Withdrawal by Subject|1|||
162136862|NCT04048135|585551194|FG007|Overall Study|Withdrawal by Subject|1|||
162136863|NCT04048135|585551187|FG000|Overall Study|Adverse Event|0|||
162136864|NCT04048135|585551188|FG001|Overall Study|Adverse Event|0|||
162136865|NCT04048135|585551189|FG002|Overall Study|Adverse Event|0|||
162136866|NCT04048135|585551190|FG003|Overall Study|Adverse Event|1|||
162136867|NCT04048135|585551191|FG004|Overall Study|Adverse Event|1|||
162136868|NCT04048135|585551192|FG005|Overall Study|Adverse Event|0|||
162136869|NCT04048135|585551193|FG006|Overall Study|Adverse Event|0|||
162136870|NCT04048135|585551194|FG007|Overall Study|Adverse Event|0|||
162136871|NCT04048135|585551187|FG000|Overall Study|Protocol Violation|0|||
162136872|NCT04048135|585551188|FG001|Overall Study|Protocol Violation|0|||
162136873|NCT04048135|585551189|FG002|Overall Study|Protocol Violation|0|||
162136874|NCT04048135|585551190|FG003|Overall Study|Protocol Violation|0|||
162136875|NCT04048135|585551191|FG004|Overall Study|Protocol Violation|0|||
162136876|NCT04048135|585551192|FG005|Overall Study|Protocol Violation|1|||
162136877|NCT04048135|585551193|FG006|Overall Study|Protocol Violation|0|||
162136878|NCT04048135|585551194|FG007|Overall Study|Protocol Violation|0|||
162136879|NCT00448864|585551195|FG000|Overall Study|Death|1|||
162136880|NCT00448864|585551196|FG001|Overall Study|Death|0|||
162136881|NCT00448864|585551197|FG002|Overall Study|Death|0|||
162136882|NCT00448864|585551195|FG000|Overall Study|Lost to Follow-up|3|||
162136883|NCT00448864|585551196|FG001|Overall Study|Lost to Follow-up|1|||
162136884|NCT00448864|585551197|FG002|Overall Study|Lost to Follow-up|0|||
162136885|NCT00448864|585551195|FG000|Overall Study|Physician Decision|1|||
162136886|NCT00448864|585551196|FG001|Overall Study|Physician Decision|0|||
162136887|NCT00448864|585551197|FG002|Overall Study|Physician Decision|1|||
162136888|NCT00448864|585551195|FG000|Overall Study|Withdrawal by Subject|0|||
162136889|NCT00448864|585551196|FG001|Overall Study|Withdrawal by Subject|2|||
162136890|NCT00448864|585551197|FG002|Overall Study|Withdrawal by Subject|0|||
162136891|NCT00448864|585551195|FG000|Overall Study|Protocol Violation|0|||
162136892|NCT00448864|585551196|FG001|Overall Study|Protocol Violation|2|||
162136893|NCT00448864|585551197|FG002|Overall Study|Protocol Violation|0|||
162136894|NCT01474538|585551199|FG000|Treatment Period 1|Death|1|||
162136895|NCT01474538|585551200|FG001|Treatment Period 1|Death|0|||
162136896|NCT01474538|585551199|FG000|Treatment Period 1|Physician Decision|1|||
162136897|NCT01474538|585551200|FG001|Treatment Period 1|Physician Decision|0|||
162136898|NCT01474538|585551199|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162136899|NCT01474538|585551200|FG001|Treatment Period 1|Withdrawal by Subject|3|||
162136900|NCT01474538|585551199|FG000|Treatment Period 1|Protocol Violation|0|||
162136901|NCT01474538|585551200|FG001|Treatment Period 1|Protocol Violation|1|||
162136902|NCT01474538|585551199|FG000|Treatment Period 2|Death|1|||
162136903|NCT01474538|585551200|FG001|Treatment Period 2|Death|0|||
162136904|NCT01474538|585551199|FG000|Treatment Period 2|Adverse Event|1|||
162136905|NCT01474538|585551200|FG001|Treatment Period 2|Adverse Event|1|||
161900788|NCT02948829|584685183|FG000|Overall Study|Pregnancy|1|||
162136906|NCT01474538|585551199|FG000|Treatment Period 2|Withdrawal by Subject|2|||
162136907|NCT01474538|585551200|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162136908|NCT01474538|585551199|FG000|Treatment Period 2|Sponsor decision|1|||
162136909|NCT01474538|585551200|FG001|Treatment Period 2|Sponsor decision|0|||
162136910|NCT01474538|585551199|FG000|Treatment Period 2|Physician Decision|0|||
162010838|NCT00071058|585096020|FG000|Overall Study|brain tumor-removed from study|1|||
161796293|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796294|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796295|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796296|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796297|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796298|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796299|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161796300|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
162136911|NCT01474538|585551200|FG001|Treatment Period 2|Physician Decision|1|||
162136912|NCT01474538|585551199|FG000|Treatment Period 2|Protocol Violation|1|||
162136913|NCT01474538|585551200|FG001|Treatment Period 2|Protocol Violation|0|||
162136914|NCT00367237|585551201|FG000|Overall Study|Adverse Event|7|||
162136915|NCT00367237|585551202|FG001|Overall Study|Adverse Event|2|||
162136916|NCT00367237|585551201|FG000|Overall Study|Lost to Follow-up|1|||
162136917|NCT00367237|585551202|FG001|Overall Study|Lost to Follow-up|0|||
162136918|NCT00367237|585551201|FG000|Overall Study|Withdrawal by Subject|0|||
162136919|NCT00367237|585551202|FG001|Overall Study|Withdrawal by Subject|4|||
162136920|NCT00367237|585551201|FG000|Overall Study|Protocol Violation|2|||
162136921|NCT00367237|585551202|FG001|Overall Study|Protocol Violation|5|||
162136922|NCT02501629|585551203|FG000|Overall Study|Death|0|||
162136923|NCT02501629|585551204|FG001|Overall Study|Death|1|||
162136924|NCT02501629|585551203|FG000|Overall Study|Withdrawn from study by sponsor|1|||
162136925|NCT02501629|585551204|FG001|Overall Study|Withdrawn from study by sponsor|0|||
162136926|NCT02501629|585551203|FG000|Overall Study|Early termination by sponsor|1|||
162136927|NCT02501629|585551204|FG001|Overall Study|Early termination by sponsor|0|||
162136928|NCT02501629|585551203|FG000|Overall Study|Withdrawal by Subject|3|||
162136929|NCT02501629|585551204|FG001|Overall Study|Withdrawal by Subject|5|||
162136930|NCT02501629|585551203|FG000|Overall Study|Subject did not return to site|0|||
162136931|NCT02501629|585551204|FG001|Overall Study|Subject did not return to site|1|||
162136932|NCT00868231|585551205|FG000|Treatment Period 1|Adverse Event|0|||
162136933|NCT00868231|585551206|FG001|Treatment Period 1|Adverse Event|0|||
162136934|NCT00868231|585551207|FG002|Treatment Period 1|Adverse Event|0|||
162136935|NCT00868231|585551208|FG003|Treatment Period 1|Adverse Event|0|||
162136936|NCT00868231|585551209|FG004|Treatment Period 1|Adverse Event|1|||
162136937|NCT00868231|585551210|FG005|Treatment Period 1|Adverse Event|0|||
162136938|NCT00868231|585551205|FG000|Treatment Period 2|Adverse Event|1|||
162136939|NCT00868231|585551206|FG001|Treatment Period 2|Adverse Event|0|||
161900789|NCT02948829|584685183|FG000|Overall Study|Other: Reason not Specified|8|||
162136940|NCT00868231|585551207|FG002|Treatment Period 2|Adverse Event|0|||
162136941|NCT00868231|585551208|FG003|Treatment Period 2|Adverse Event|0|||
162136942|NCT00868231|585551209|FG004|Treatment Period 2|Adverse Event|0|||
162136943|NCT00868231|585551210|FG005|Treatment Period 2|Adverse Event|0|||
162136944|NCT00868231|585551205|FG000|Treatment Period 3|Adverse Event|0|||
162136945|NCT00868231|585551206|FG001|Treatment Period 3|Adverse Event|0|||
161900790|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
162010839|NCT04189952|585096028|FG000|Follow-up Period|Death|1|||
162010840|NCT04189952|585096028|FG000|Follow-up Period|Withdrawal by Subject|1|||
161796301|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
161796302|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796303|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796304|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796305|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796306|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
161796307|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796308|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796309|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796310|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796311|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796312|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796313|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796314|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161796315|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796316|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796317|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796318|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
162136946|NCT00868231|585551207|FG002|Treatment Period 3|Adverse Event|1|||
161796319|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
161796320|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796321|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796322|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
161796323|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
161796324|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796325|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796326|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796327|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796328|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161796329|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796330|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796331|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162136947|NCT00868231|585551208|FG003|Treatment Period 3|Adverse Event|0|||
162136948|NCT00868231|585551209|FG004|Treatment Period 3|Adverse Event|0|||
162136949|NCT00868231|585551210|FG005|Treatment Period 3|Adverse Event|0|||
162136950|NCT03120676|585551211|FG000|Overall Study|Not treated|1|||
162136951|NCT00886613|585551216|FG000|Overall Study|Protocol deviation (Part B)|1|||
162136952|NCT00886613|585551217|FG001|Overall Study|Protocol deviation (Part B)|0|||
162136953|NCT00886613|585551218|FG002|Overall Study|Protocol deviation (Part B)|0|||
162136954|NCT00886613|585551216|FG000|Overall Study|Lost to follow-up (Part B)|1|||
162136955|NCT00886613|585551217|FG001|Overall Study|Lost to follow-up (Part B)|0|||
162136956|NCT00886613|585551218|FG002|Overall Study|Lost to follow-up (Part B)|1|||
162136957|NCT00886613|585551216|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
162136958|NCT00886613|585551217|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
162136959|NCT00886613|585551218|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
162136960|NCT01124162|585551219|FG000|First Intervention|Adverse Event|2|||
162136961|NCT01124162|585551220|FG001|First Intervention|Adverse Event|0|||
162136962|NCT01124162|585551219|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
162136963|NCT01124162|585551220|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
162136964|NCT00465985|585551221|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
162136965|NCT00465985|585551222|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
162136966|NCT00465985|585551221|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
162136967|NCT00465985|585551222|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
162136968|NCT00465985|585551221|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
162136969|NCT00465985|585551222|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
162136970|NCT00465985|585551221|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
162136971|NCT00465985|585551222|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
162136972|NCT03439124|585551223|FG000|Overall Study|Adverse Event|2|||
162136973|NCT03439124|585551224|FG001|Overall Study|Adverse Event|0|||
162136974|NCT03439124|585551223|FG000|Overall Study|Lost to Follow-up|1|||
162136975|NCT03439124|585551224|FG001|Overall Study|Lost to Follow-up|0|||
162136976|NCT03439124|585551223|FG000|Overall Study|Other reasons|1|||
162136977|NCT03439124|585551224|FG001|Overall Study|Other reasons|0|||
162136978|NCT04353037|585551225|FG000|Overall Study|Lost to Follow-up|0|||
162136979|NCT04353037|585551226|FG001|Overall Study|Lost to Follow-up|1|||
162136980|NCT04353037|585551227|FG002|Overall Study|Lost to Follow-up|2|||
162136981|NCT04353037|585551228|FG003|Overall Study|Lost to Follow-up|3|||
162136982|NCT04353037|585551225|FG000|Overall Study|Withdrawal by Subject|0|||
162136983|NCT04353037|585551226|FG001|Overall Study|Withdrawal by Subject|2|||
162010841|NCT00870740|585096029|FG000|Overall Study|Adverse Event|2|||
161900791|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
161900792|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
161900793|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900794|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900795|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900796|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900797|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900798|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900799|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900800|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900801|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900802|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900803|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900804|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161900805|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
161900806|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
161900807|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900808|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900809|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900810|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900811|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161796332|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796333|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796334|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796335|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796336|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
161796337|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
161796338|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796339|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796340|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796341|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
162136984|NCT04353037|585551227|FG002|Overall Study|Withdrawal by Subject|3|||
162136985|NCT04353037|585551228|FG003|Overall Study|Withdrawal by Subject|5|||
162136986|NCT04353037|585551225|FG000|Overall Study|Adverse Event|0|||
162136987|NCT04353037|585551226|FG001|Overall Study|Adverse Event|0|||
162136988|NCT04353037|585551227|FG002|Overall Study|Adverse Event|2|||
162136989|NCT04353037|585551228|FG003|Overall Study|Adverse Event|0|||
162136990|NCT04353037|585551225|FG000|Overall Study|Exposure Change|0|||
162136991|NCT04353037|585551226|FG001|Overall Study|Exposure Change|0|||
162136992|NCT04353037|585551227|FG002|Overall Study|Exposure Change|0|||
162136993|NCT04353037|585551228|FG003|Overall Study|Exposure Change|2|||
162136994|NCT01941316|585551239|FG000|Overall Study|Adverse Event|0|||
162136995|NCT01941316|585551240|FG001|Overall Study|Adverse Event|1|||
162136996|NCT01941316|585551241|FG002|Overall Study|Adverse Event|0|||
162136997|NCT01941316|585551242|FG003|Overall Study|Adverse Event|7|||
162136998|NCT01941316|585551239|FG000|Overall Study|Progressive Disease|3|||
162136999|NCT01941316|585551240|FG001|Overall Study|Progressive Disease|6|||
162137000|NCT01941316|585551241|FG002|Overall Study|Progressive Disease|2|||
162137001|NCT01941316|585551242|FG003|Overall Study|Progressive Disease|29|||
162137002|NCT01941316|585551239|FG000|Overall Study|Withdrawal by Subject|0|||
162137003|NCT01941316|585551240|FG001|Overall Study|Withdrawal by Subject|2|||
162137004|NCT01941316|585551241|FG002|Overall Study|Withdrawal by Subject|1|||
162137005|NCT01941316|585551242|FG003|Overall Study|Withdrawal by Subject|8|||
162137006|NCT01941316|585551239|FG000|Overall Study|Death|0|||
162137007|NCT01941316|585551240|FG001|Overall Study|Death|0|||
162137008|NCT01941316|585551241|FG002|Overall Study|Death|0|||
162137009|NCT01941316|585551242|FG003|Overall Study|Death|3|||
162137010|NCT01941316|585551239|FG000|Overall Study|Physician Decision|0|||
162137011|NCT01941316|585551240|FG001|Overall Study|Physician Decision|0|||
162137012|NCT01941316|585551241|FG002|Overall Study|Physician Decision|0|||
162137013|NCT01941316|585551242|FG003|Overall Study|Physician Decision|3|||
161796342|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161796343|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796344|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796345|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796346|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796347|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796348|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796349|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796350|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796351|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
161796352|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796353|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796354|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796355|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796356|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161796357|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796358|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796359|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796360|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
161796361|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796362|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796363|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796364|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796365|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796366|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796367|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796368|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796369|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796370|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161796371|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796372|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796373|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796374|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
162010842|NCT00870740|585096030|FG001|Overall Study|Adverse Event|1|||
162137014|NCT01941316|585551239|FG000|Overall Study|Protocol Violation|0|||
162137015|NCT01941316|585551240|FG001|Overall Study|Protocol Violation|0|||
162137016|NCT01941316|585551241|FG002|Overall Study|Protocol Violation|0|||
162137017|NCT01941316|585551242|FG003|Overall Study|Protocol Violation|3|||
162137018|NCT01941316|585551239|FG000|Overall Study|Intercurrent illness|0|||
162137019|NCT01941316|585551240|FG001|Overall Study|Intercurrent illness|0|||
162137020|NCT01941316|585551241|FG002|Overall Study|Intercurrent illness|0|||
161796375|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796376|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796377|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796378|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
161796379|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
161796380|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796381|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796382|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796383|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796384|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161796385|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796386|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796387|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796388|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796389|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796390|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796391|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796392|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
161796393|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796394|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796395|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796396|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796397|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796398|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161796399|NCT04033445|584298178|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796400|NCT04033445|584298179|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796401|NCT04033445|584298180|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796402|NCT04033445|584298181|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796403|NCT04033445|584298182|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796404|NCT04033445|584298183|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796405|NCT04033445|584298184|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796406|NCT04033445|584298185|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
161796407|NCT04033445|584298186|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796408|NCT04033445|584298187|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796409|NCT04033445|584298188|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796410|NCT04033445|584298189|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796411|NCT04033445|584298190|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796412|NCT04033445|584298191|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161796413|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796414|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796415|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796416|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796417|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796418|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796419|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796420|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161796421|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
162137021|NCT01941316|585551242|FG003|Overall Study|Intercurrent illness|1|||
162137022|NCT01941316|585551239|FG000|Overall Study|Other, not specified|0|||
162137023|NCT01941316|585551240|FG001|Overall Study|Other, not specified|0|||
162137024|NCT01941316|585551241|FG002|Overall Study|Other, not specified|0|||
162137025|NCT01941316|585551242|FG003|Overall Study|Other, not specified|1|||
162137026|NCT02775435|585551243|FG000|Overall Study|Adverse Event|32|||
162137027|NCT02775435|585551244|FG001|Overall Study|Adverse Event|27|||
162137028|NCT02775435|585551243|FG000|Overall Study|Lost to Follow-up|2|||
162137029|NCT02775435|585551244|FG001|Overall Study|Lost to Follow-up|2|||
162137030|NCT02775435|585551243|FG000|Overall Study|Sponsor decision|44|||
162137031|NCT02775435|585551244|FG001|Overall Study|Sponsor decision|19|||
162137032|NCT02775435|585551243|FG000|Overall Study|Withdrawal by Subject|4|||
162137033|NCT02775435|585551244|FG001|Overall Study|Withdrawal by Subject|9|||
162137034|NCT02775435|585551243|FG000|Overall Study|Death|196|||
162137035|NCT02775435|585551244|FG001|Overall Study|Death|224|||
162137036|NCT00320489|585551245|FG000|Overall Study|Adverse Event|26|||
162137037|NCT00320489|585551246|FG001|Overall Study|Adverse Event|25|||
162137038|NCT00320489|585551245|FG000|Overall Study|Clinical Relapse|26|||
162137039|NCT00320489|585551246|FG001|Overall Study|Clinical Relapse|20|||
162137040|NCT00320489|585551245|FG000|Overall Study|Death|0|||
162137041|NCT00320489|585551246|FG001|Overall Study|Death|2|||
162137042|NCT00320489|585551245|FG000|Overall Study|Entry Criteria Exclusion|2|||
162137043|NCT00320489|585551246|FG001|Overall Study|Entry Criteria Exclusion|4|||
162137044|NCT00320489|585551245|FG000|Overall Study|Lack of Efficacy|16|||
162137045|NCT00320489|585551246|FG001|Overall Study|Lack of Efficacy|7|||
162137046|NCT00320489|585551245|FG000|Overall Study|Lost to Follow-up|21|||
162137047|NCT00320489|585551246|FG001|Overall Study|Lost to Follow-up|22|||
162137048|NCT00320489|585551245|FG000|Overall Study|Physician Decision|8|||
162137049|NCT00320489|585551246|FG001|Overall Study|Physician Decision|8|||
162137050|NCT00320489|585551245|FG000|Overall Study|Protocol Violation|4|||
162137051|NCT00320489|585551246|FG001|Overall Study|Protocol Violation|4|||
162137052|NCT00320489|585551245|FG000|Overall Study|Sponsor Decision|3|||
162137053|NCT00320489|585551246|FG001|Overall Study|Sponsor Decision|3|||
162137054|NCT00320489|585551245|FG000|Overall Study|Withdrawal by Subject|39|||
162137055|NCT00320489|585551246|FG001|Overall Study|Withdrawal by Subject|41|||
162137056|NCT02282527|585551247|FG000|Overall Study|Lost to Follow-up|0|||
162137057|NCT02282527|585551248|FG001|Overall Study|Lost to Follow-up|1|||
162137058|NCT02282527|585551247|FG000|Overall Study|Lack of home health aid|1|||
162137059|NCT02282527|585551248|FG001|Overall Study|Lack of home health aid|0|||
162137060|NCT00941031|585551249|FG000|Induction Period|Lack of Efficacy|2|||
162137061|NCT00941031|585551250|FG001|Induction Period|Lack of Efficacy|1|||
162137062|NCT00941031|585551251|FG002|Induction Period|Lack of Efficacy|0|||
162137063|NCT00941031|585551252|FG003|Induction Period|Lack of Efficacy|5|||
162137064|NCT00941031|585551253|FG004|Induction Period|Lack of Efficacy|0|||
162137065|NCT00941031|585551254|FG005|Induction Period|Lack of Efficacy|0|||
162137066|NCT00941031|585551255|FG006|Induction Period|Lack of Efficacy|0|||
162137067|NCT00941031|585551249|FG000|Induction Period|Withdrawal by Subject|1|||
162137068|NCT00941031|585551250|FG001|Induction Period|Withdrawal by Subject|2|||
162137069|NCT00941031|585551251|FG002|Induction Period|Withdrawal by Subject|2|||
162137070|NCT00941031|585551252|FG003|Induction Period|Withdrawal by Subject|2|||
162137071|NCT00941031|585551253|FG004|Induction Period|Withdrawal by Subject|0|||
162137072|NCT00941031|585551254|FG005|Induction Period|Withdrawal by Subject|0|||
162137073|NCT00941031|585551255|FG006|Induction Period|Withdrawal by Subject|0|||
162137074|NCT00941031|585551249|FG000|Induction Period|Adminstative Problems|1|||
162137075|NCT00941031|585551250|FG001|Induction Period|Adminstative Problems|1|||
162137076|NCT00941031|585551251|FG002|Induction Period|Adminstative Problems|1|||
162137077|NCT00941031|585551252|FG003|Induction Period|Adminstative Problems|0|||
162137078|NCT00941031|585551253|FG004|Induction Period|Adminstative Problems|0|||
162137079|NCT00941031|585551254|FG005|Induction Period|Adminstative Problems|0|||
162010843|NCT00870740|585096031|FG002|Overall Study|Adverse Event|3|||
162137080|NCT00941031|585551255|FG006|Induction Period|Adminstative Problems|0|||
162137081|NCT00941031|585551249|FG000|Induction Period|Adverse Event|1|||
162137082|NCT00941031|585551250|FG001|Induction Period|Adverse Event|0|||
162137083|NCT00941031|585551251|FG002|Induction Period|Adverse Event|3|||
162137084|NCT00941031|585551252|FG003|Induction Period|Adverse Event|2|||
162137085|NCT00941031|585551253|FG004|Induction Period|Adverse Event|0|||
162137086|NCT00941031|585551254|FG005|Induction Period|Adverse Event|0|||
162137087|NCT00941031|585551255|FG006|Induction Period|Adverse Event|0|||
162137088|NCT00941031|585551249|FG000|Maintenance Period|Withdrawal by Subject|0|||
162137089|NCT00941031|585551250|FG001|Maintenance Period|Withdrawal by Subject|0|||
162137090|NCT00941031|585551251|FG002|Maintenance Period|Withdrawal by Subject|0|||
162137091|NCT00941031|585551252|FG003|Maintenance Period|Withdrawal by Subject|0|||
162137092|NCT00941031|585551253|FG004|Maintenance Period|Withdrawal by Subject|6|||
162137093|NCT00941031|585551254|FG005|Maintenance Period|Withdrawal by Subject|2|||
162137094|NCT00941031|585551255|FG006|Maintenance Period|Withdrawal by Subject|13|||
162137095|NCT00941031|585551249|FG000|Maintenance Period|Administrative Problems|0|||
162137096|NCT00941031|585551250|FG001|Maintenance Period|Administrative Problems|0|||
162137097|NCT00941031|585551251|FG002|Maintenance Period|Administrative Problems|0|||
161900812|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900813|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900814|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
162010844|NCT00870740|585096032|FG003|Overall Study|Adverse Event|2|||
161796422|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
161796423|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
162010845|NCT00870740|585096033|FG004|Overall Study|Adverse Event|1|||
161900815|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900816|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900817|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900818|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900819|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161900820|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
161900821|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
161900822|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
162010846|NCT00870740|585096034|FG005|Overall Study|Adverse Event|6|||
162137098|NCT00941031|585551252|FG003|Maintenance Period|Administrative Problems|0|||
162137099|NCT00941031|585551253|FG004|Maintenance Period|Administrative Problems|1|||
162137100|NCT00941031|585551254|FG005|Maintenance Period|Administrative Problems|0|||
162137101|NCT00941031|585551255|FG006|Maintenance Period|Administrative Problems|1|||
162137102|NCT00941031|585551249|FG000|Maintenance Period|Protocol Violation|0|||
162137103|NCT00941031|585551250|FG001|Maintenance Period|Protocol Violation|0|||
162137104|NCT00941031|585551251|FG002|Maintenance Period|Protocol Violation|0|||
162137105|NCT00941031|585551252|FG003|Maintenance Period|Protocol Violation|0|||
162137106|NCT00941031|585551253|FG004|Maintenance Period|Protocol Violation|0|||
162137107|NCT00941031|585551254|FG005|Maintenance Period|Protocol Violation|0|||
162137108|NCT00941031|585551255|FG006|Maintenance Period|Protocol Violation|1|||
162137109|NCT00941031|585551249|FG000|Maintenance Period|Adverse Event|0|||
162137110|NCT00941031|585551250|FG001|Maintenance Period|Adverse Event|0|||
162137111|NCT00941031|585551251|FG002|Maintenance Period|Adverse Event|0|||
162137112|NCT00941031|585551252|FG003|Maintenance Period|Adverse Event|0|||
162137113|NCT00941031|585551253|FG004|Maintenance Period|Adverse Event|0|||
162137114|NCT00941031|585551254|FG005|Maintenance Period|Adverse Event|2|||
162137115|NCT00941031|585551255|FG006|Maintenance Period|Adverse Event|8|||
162137116|NCT00941031|585551249|FG000|Maintenance Period|Lost to Follow-up|0|||
162137117|NCT00941031|585551250|FG001|Maintenance Period|Lost to Follow-up|0|||
162137118|NCT00941031|585551251|FG002|Maintenance Period|Lost to Follow-up|0|||
162137119|NCT00941031|585551252|FG003|Maintenance Period|Lost to Follow-up|0|||
162137120|NCT00941031|585551253|FG004|Maintenance Period|Lost to Follow-up|2|||
162137121|NCT00941031|585551254|FG005|Maintenance Period|Lost to Follow-up|2|||
162137122|NCT00941031|585551255|FG006|Maintenance Period|Lost to Follow-up|7|||
162137123|NCT00941031|585551249|FG000|Maintenance Period|Lack of Efficacy|0|||
162137124|NCT00941031|585551250|FG001|Maintenance Period|Lack of Efficacy|0|||
162137125|NCT00941031|585551251|FG002|Maintenance Period|Lack of Efficacy|0|||
162137126|NCT00941031|585551252|FG003|Maintenance Period|Lack of Efficacy|0|||
162137127|NCT00941031|585551253|FG004|Maintenance Period|Lack of Efficacy|0|||
162137128|NCT00941031|585551254|FG005|Maintenance Period|Lack of Efficacy|0|||
162137129|NCT00941031|585551255|FG006|Maintenance Period|Lack of Efficacy|13|||
162137130|NCT01872611|585551256|FG000|Overall Study|Adverse Event|3|||
162137131|NCT01872611|585551257|FG001|Overall Study|Adverse Event|1|||
162137132|NCT01872611|585551256|FG000|Overall Study|Adverse Event, prior to treatment|0|||
162137133|NCT01872611|585551257|FG001|Overall Study|Adverse Event, prior to treatment|1|||
162137134|NCT01872611|585551256|FG000|Overall Study|Death|0|||
162137135|NCT01872611|585551257|FG001|Overall Study|Death|1|||
162137136|NCT01872611|585551256|FG000|Overall Study|Death, prior to treatment|0|||
162137137|NCT01872611|585551257|FG001|Overall Study|Death, prior to treatment|1|||
162137138|NCT01872611|585551256|FG000|Overall Study|Lost to Follow-up|8|||
162137139|NCT01872611|585551257|FG001|Overall Study|Lost to Follow-up|1|||
162137140|NCT01872611|585551256|FG000|Overall Study|Physician Decision|1|||
162137141|NCT01872611|585551257|FG001|Overall Study|Physician Decision|0|||
162137142|NCT01872611|585551256|FG000|Overall Study|Withdrawal by Subject|6|||
162137143|NCT01872611|585551257|FG001|Overall Study|Withdrawal by Subject|1|||
162137144|NCT01872611|585551256|FG000|Overall Study|Reason not provided|6|||
162137145|NCT01872611|585551257|FG001|Overall Study|Reason not provided|6|||
162137146|NCT04555044|585551260|FG000|Overall Study|Adverse Event|0|||
162137147|NCT04555044|585551261|FG001|Overall Study|Adverse Event|1|||
162137148|NCT04088188|585551264|FG000|Overall Study|Withdrawal by Subject|2|||
162137149|NCT04088188|585551265|FG001|Overall Study|Withdrawal by Subject|0|||
162137150|NCT04088188|585551264|FG000|Overall Study|Adverse Event|2|||
162137151|NCT04088188|585551265|FG001|Overall Study|Adverse Event|0|||
162137152|NCT03686384|585551266|FG000|Overall Study|Lack of Efficacy|4|||
162137153|NCT03686384|585551267|FG001|Overall Study|Lack of Efficacy|13|||
162137154|NCT03686384|585551266|FG000|Overall Study|Lost to Follow-up|3|||
162137155|NCT03686384|585551267|FG001|Overall Study|Lost to Follow-up|0|||
162137156|NCT03686384|585551266|FG000|Overall Study|Physician Decision|0|||
162137157|NCT03686384|585551267|FG001|Overall Study|Physician Decision|1|||
162137158|NCT03686384|585551266|FG000|Overall Study|Took prohibited medication|0|||
162137159|NCT03686384|585551267|FG001|Overall Study|Took prohibited medication|1|||
162137160|NCT02696785|585551277|FG000|Blinded Treatment Period|Adverse Event|0|||
162137161|NCT02696785|585551278|FG001|Blinded Treatment Period|Adverse Event|1|||
162137162|NCT02696785|585551279|FG002|Blinded Treatment Period|Adverse Event|3|||
162137163|NCT02696785|585551280|FG003|Blinded Treatment Period|Adverse Event|0|||
161900823|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161796424|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
161796425|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
161796426|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
161796427|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796428|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796429|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796430|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796431|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796432|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796433|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796434|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796435|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161796436|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
161796437|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
161796438|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
161796439|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
161796440|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
161796441|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796442|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796443|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796444|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796445|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796446|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796447|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796448|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796449|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
162137164|NCT02696785|585551277|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
162137165|NCT02696785|585551278|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
162137166|NCT02696785|585551279|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
162137167|NCT02696785|585551280|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
162137168|NCT02696785|585551277|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
162137169|NCT02696785|585551278|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
162137170|NCT02696785|585551279|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
162137171|NCT02696785|585551280|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
162137172|NCT02696785|585551277|FG000|Blinded Treatment Period|Screen Failure|1|||
162137173|NCT02696785|585551278|FG001|Blinded Treatment Period|Screen Failure|0|||
162137174|NCT02696785|585551279|FG002|Blinded Treatment Period|Screen Failure|0|||
162137175|NCT02696785|585551280|FG003|Blinded Treatment Period|Screen Failure|0|||
162137176|NCT02696785|585551277|FG000|Washout Period|Withdrawal by Subject|0|||
162137177|NCT02696785|585551278|FG001|Washout Period|Withdrawal by Subject|1|||
162137178|NCT02696785|585551279|FG002|Washout Period|Withdrawal by Subject|0|||
162137179|NCT02696785|585551280|FG003|Washout Period|Withdrawal by Subject|0|||
162137180|NCT02696785|585551277|FG000|Washout Period|Lack of Efficacy|0|||
162137181|NCT02696785|585551278|FG001|Washout Period|Lack of Efficacy|1|||
162137182|NCT02696785|585551279|FG002|Washout Period|Lack of Efficacy|0|||
162137183|NCT02696785|585551280|FG003|Washout Period|Lack of Efficacy|0|||
162137184|NCT02696785|585551277|FG000|Extended Treatment Period|Adverse Event|2|||
162137185|NCT02696785|585551278|FG001|Extended Treatment Period|Adverse Event|3|||
162137186|NCT02696785|585551279|FG002|Extended Treatment Period|Adverse Event|2|||
162137187|NCT02696785|585551280|FG003|Extended Treatment Period|Adverse Event|1|||
162137188|NCT02696785|585551277|FG000|Extended Treatment Period|Lack of Efficacy|0|||
162137189|NCT02696785|585551278|FG001|Extended Treatment Period|Lack of Efficacy|1|||
162137190|NCT02696785|585551279|FG002|Extended Treatment Period|Lack of Efficacy|0|||
162137191|NCT02696785|585551280|FG003|Extended Treatment Period|Lack of Efficacy|0|||
162137192|NCT02696785|585551277|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
162137193|NCT02696785|585551278|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
162137194|NCT02696785|585551279|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
162137195|NCT02696785|585551280|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
162137196|NCT02696785|585551277|FG000|Follow-up Period|Adverse Event|0|||
162137197|NCT02696785|585551278|FG001|Follow-up Period|Adverse Event|0|||
162137198|NCT02696785|585551279|FG002|Follow-up Period|Adverse Event|8|||
162137199|NCT02696785|585551280|FG003|Follow-up Period|Adverse Event|2|||
162137200|NCT02696785|585551277|FG000|Follow-up Period|Lost to Follow-up|0|||
162137201|NCT02696785|585551278|FG001|Follow-up Period|Lost to Follow-up|0|||
162137202|NCT02696785|585551279|FG002|Follow-up Period|Lost to Follow-up|0|||
162137203|NCT02696785|585551280|FG003|Follow-up Period|Lost to Follow-up|1|||
162137204|NCT02696785|585551277|FG000|Follow-up Period|Lack of Efficacy|0|||
161900824|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900825|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
162137205|NCT02696785|585551278|FG001|Follow-up Period|Lack of Efficacy|0|||
162137206|NCT02696785|585551279|FG002|Follow-up Period|Lack of Efficacy|0|||
161900826|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900827|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900828|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
162137207|NCT02696785|585551280|FG003|Follow-up Period|Lack of Efficacy|1|||
162137208|NCT02696785|585551277|FG000|Follow-up Period|Withdrawal by Subject|1|||
162137209|NCT02696785|585551278|FG001|Follow-up Period|Withdrawal by Subject|0|||
162137210|NCT02696785|585551279|FG002|Follow-up Period|Withdrawal by Subject|5|||
162137211|NCT02696785|585551280|FG003|Follow-up Period|Withdrawal by Subject|4|||
162137212|NCT04863898|585551284|FG000|Overall Study|Away from study clinic during intervention training period|2|||
162137213|NCT04863898|585551284|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
162137214|NCT04863898|585551284|FG000|Overall Study|Lost to Follow-up|3|||
162137215|NCT04863898|585551284|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
162137216|NCT04863898|585551284|FG000|Overall Study|No longer employed at clinic|3|||
162137217|NCT00614744|585551285|FG000|Overall Study|Lost to Follow-up|5|||
162137218|NCT00614744|585551286|FG001|Overall Study|Lost to Follow-up|4|||
162137219|NCT00614744|585551285|FG000|Overall Study|Incomplete for Behavior Issues|0|||
162137220|NCT00614744|585551286|FG001|Overall Study|Incomplete for Behavior Issues|2|||
162137221|NCT00877851|585551287|FG000|Overall Study|Lost to Follow-up|5|||
162137222|NCT00877851|585551288|FG001|Overall Study|Lost to Follow-up|5|||
162137223|NCT00877851|585551287|FG000|Overall Study|computer problem|3|||
162137224|NCT00877851|585551288|FG001|Overall Study|computer problem|0|||
162137225|NCT00877851|585551287|FG000|Overall Study|no longer interested in participating|1|||
162137226|NCT00877851|585551288|FG001|Overall Study|no longer interested in participating|0|||
162137227|NCT02431533|585551289|FG000|Overall Study|Withdrawal by Subject|1|||
162137228|NCT02431533|585551290|FG001|Overall Study|Withdrawal by Subject|3|||
162137229|NCT02431533|585551289|FG000|Overall Study|Developed Exclusionary criteria|1|||
162137230|NCT02431533|585551290|FG001|Overall Study|Developed Exclusionary criteria|0|||
162137231|NCT02320253|585551291|FG000|Overall Study|Withdrawal by Subject|3|||
162137232|NCT02320253|585551292|FG001|Overall Study|Withdrawal by Subject|0|||
162137233|NCT02320253|585551293|FG002|Overall Study|Withdrawal by Subject|0|||
162137234|NCT02320253|585551291|FG000|Overall Study|Lost to Follow-up|2|||
162137235|NCT02320253|585551292|FG001|Overall Study|Lost to Follow-up|2|||
162137236|NCT02320253|585551293|FG002|Overall Study|Lost to Follow-up|1|||
162137237|NCT02320253|585551291|FG000|Overall Study|Death|1|||
162137238|NCT02320253|585551292|FG001|Overall Study|Death|0|||
162137239|NCT02320253|585551293|FG002|Overall Study|Death|1|||
162137240|NCT01516892|585551294|FG000|Overall Study|Adverse Event|25|||
162137241|NCT01516892|585551294|FG000|Overall Study|Lack of Efficacy|35|||
162137242|NCT01516892|585551294|FG000|Overall Study|Pregnancy|5|||
162137243|NCT01516892|585551294|FG000|Overall Study|Lost to Follow-up|82|||
162137244|NCT01516892|585551294|FG000|Overall Study|Subject Withdrew Consent|92|||
162137245|NCT01516892|585551294|FG000|Overall Study|Protocol Violation|60|||
162137246|NCT01516892|585551294|FG000|Overall Study|Other Miscellaneous Reasons|43|||
162137247|NCT01516892|585551294|FG000|Overall Study|Missing|1|||
162137248|NCT02956967|585551295|FG000|Overall Study|Adverse Event|3|||
162137249|NCT02956967|585551295|FG000|Overall Study|Reason non-related to neutropenia|10|||
162137250|NCT02956967|585551295|FG000|Overall Study|Lost to Follow-up|5|||
162137251|NCT02956967|585551295|FG000|Overall Study|Missing|1|||
162137252|NCT02956967|585551295|FG000|Overall Study|Termination of Nivestim administration|29|||
162137253|NCT00819234|585551296|FG000|Overall Study|Withdrawal by Subject|8|||
162137254|NCT00819234|585551297|FG001|Overall Study|Withdrawal by Subject|13|||
162137255|NCT00819234|585551298|FG002|Overall Study|Withdrawal by Subject|6|||
162137256|NCT00819234|585551299|FG003|Overall Study|Withdrawal by Subject|3|||
162137257|NCT00819234|585551300|FG004|Overall Study|Withdrawal by Subject|0|||
162137258|NCT00819234|585551301|FG005|Overall Study|Withdrawal by Subject|4|||
162137259|NCT00819234|585551302|FG006|Overall Study|Withdrawal by Subject|4|||
162137260|NCT00819234|585551303|FG007|Overall Study|Withdrawal by Subject|8|||
162137261|NCT00819234|585551304|FG008|Overall Study|Withdrawal by Subject|5|||
162137262|NCT00819234|585551305|FG009|Overall Study|Withdrawal by Subject|3|||
162137263|NCT00819234|585551296|FG000|Overall Study|Adverse Event|0|||
162137264|NCT00819234|585551297|FG001|Overall Study|Adverse Event|0|||
162137265|NCT00819234|585551298|FG002|Overall Study|Adverse Event|1|||
162137266|NCT00819234|585551299|FG003|Overall Study|Adverse Event|0|||
162137267|NCT00819234|585551300|FG004|Overall Study|Adverse Event|0|||
162137268|NCT00819234|585551301|FG005|Overall Study|Adverse Event|2|||
161900829|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
162137269|NCT00819234|585551302|FG006|Overall Study|Adverse Event|0|||
162137270|NCT00819234|585551303|FG007|Overall Study|Adverse Event|0|||
162137271|NCT00819234|585551304|FG008|Overall Study|Adverse Event|0|||
162137272|NCT00819234|585551305|FG009|Overall Study|Adverse Event|0|||
162137273|NCT00819234|585551296|FG000|Overall Study|Physician Decision|0|||
161900830|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900831|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900832|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900833|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900834|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161900835|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
162137274|NCT00819234|585551297|FG001|Overall Study|Physician Decision|0|||
162137275|NCT00819234|585551298|FG002|Overall Study|Physician Decision|0|||
162137276|NCT00819234|585551299|FG003|Overall Study|Physician Decision|1|||
162137277|NCT00819234|585551300|FG004|Overall Study|Physician Decision|0|||
162137278|NCT00819234|585551301|FG005|Overall Study|Physician Decision|0|||
162137279|NCT00819234|585551302|FG006|Overall Study|Physician Decision|0|||
162137280|NCT00819234|585551303|FG007|Overall Study|Physician Decision|0|||
162137281|NCT00819234|585551304|FG008|Overall Study|Physician Decision|0|||
162137282|NCT00819234|585551305|FG009|Overall Study|Physician Decision|2|||
162137283|NCT00819234|585551296|FG000|Overall Study|Protocol Violation|0|||
162137284|NCT00819234|585551297|FG001|Overall Study|Protocol Violation|0|||
162137285|NCT00819234|585551298|FG002|Overall Study|Protocol Violation|1|||
162137286|NCT00819234|585551299|FG003|Overall Study|Protocol Violation|0|||
162137287|NCT00819234|585551300|FG004|Overall Study|Protocol Violation|0|||
162137288|NCT00819234|585551301|FG005|Overall Study|Protocol Violation|0|||
162137289|NCT00819234|585551302|FG006|Overall Study|Protocol Violation|0|||
162137290|NCT00819234|585551303|FG007|Overall Study|Protocol Violation|0|||
162137291|NCT00819234|585551304|FG008|Overall Study|Protocol Violation|0|||
162137292|NCT00819234|585551305|FG009|Overall Study|Protocol Violation|0|||
162137293|NCT00819234|585551296|FG000|Overall Study|Lost to Follow-up|2|||
162137294|NCT00819234|585551297|FG001|Overall Study|Lost to Follow-up|2|||
162137295|NCT00819234|585551298|FG002|Overall Study|Lost to Follow-up|0|||
162137296|NCT00819234|585551299|FG003|Overall Study|Lost to Follow-up|2|||
162137297|NCT00819234|585551300|FG004|Overall Study|Lost to Follow-up|1|||
162137298|NCT00819234|585551301|FG005|Overall Study|Lost to Follow-up|1|||
162137299|NCT00819234|585551302|FG006|Overall Study|Lost to Follow-up|1|||
162137300|NCT00819234|585551303|FG007|Overall Study|Lost to Follow-up|1|||
162137301|NCT00819234|585551304|FG008|Overall Study|Lost to Follow-up|1|||
162137302|NCT00819234|585551305|FG009|Overall Study|Lost to Follow-up|2|||
162137303|NCT01096056|585551306|FG000|Overall Study|Lost to Follow-up|0|||
162137304|NCT01096056|585551307|FG001|Overall Study|Lost to Follow-up|1|||
162137305|NCT00924560|585551308|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
162137306|NCT00924560|585551309|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
162137307|NCT00924560|585551310|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
162137308|NCT00924560|585551308|FG000|Overall Study|Non Compliance with the Protocol|20|||
162137309|NCT00924560|585551309|FG001|Overall Study|Non Compliance with the Protocol|15|||
162137310|NCT00924560|585551310|FG002|Overall Study|Non Compliance with the Protocol|4|||
162137311|NCT00924560|585551308|FG000|Overall Study|Physician Decision|2|||
162137312|NCT00924560|585551309|FG001|Overall Study|Physician Decision|3|||
162137313|NCT00924560|585551310|FG002|Overall Study|Physician Decision|4|||
162137314|NCT00924560|585551308|FG000|Overall Study|Withdrawal by Subject|50|||
162137315|NCT00924560|585551309|FG001|Overall Study|Withdrawal by Subject|44|||
162137316|NCT00924560|585551310|FG002|Overall Study|Withdrawal by Subject|18|||
162137317|NCT00924560|585551308|FG000|Overall Study|Adverse Event|39|||
162137318|NCT00924560|585551309|FG001|Overall Study|Adverse Event|33|||
161796450|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796451|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
161796452|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
161796453|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161796454|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
161796455|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796456|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796457|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796458|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796459|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796460|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796461|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796462|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796463|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161796464|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
162137319|NCT00924560|585551310|FG002|Overall Study|Adverse Event|0|||
162137320|NCT00924560|585551308|FG000|Overall Study|Pregnancy|5|||
161796465|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
161796466|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
162137321|NCT00924560|585551309|FG001|Overall Study|Pregnancy|7|||
162137322|NCT00924560|585551310|FG002|Overall Study|Pregnancy|1|||
162137323|NCT00924560|585551308|FG000|Overall Study|Lost to Follow-up|78|||
162137324|NCT00924560|585551309|FG001|Overall Study|Lost to Follow-up|94|||
162137325|NCT00924560|585551310|FG002|Overall Study|Lost to Follow-up|45|||
161796467|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
161796468|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
161796469|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796470|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796471|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796472|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796473|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796474|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796475|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796476|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796477|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161796478|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
161796479|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
161796480|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
161796481|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
161796482|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
161796483|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796484|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796485|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796486|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796487|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796488|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796489|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796490|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796491|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796492|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796493|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796494|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796495|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161796496|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
161796497|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
162010847|NCT00870740|585096029|FG000|Overall Study|Consent Withdrawn|6|||
161900836|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
162010848|NCT00870740|585096030|FG001|Overall Study|Consent Withdrawn|3|||
161796498|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796499|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796500|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796501|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796502|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796503|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796504|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796505|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
161796506|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
161796507|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
161796508|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
161796509|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
161796510|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
161796511|NCT04033445|584298178|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796512|NCT04033445|584298179|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796513|NCT04033445|584298180|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796514|NCT04033445|584298181|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796515|NCT04033445|584298182|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796516|NCT04033445|584298183|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796517|NCT04033445|584298184|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796518|NCT04033445|584298185|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796519|NCT04033445|584298186|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796520|NCT04033445|584298187|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
161796521|NCT04033445|584298188|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796522|NCT04033445|584298189|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
161796523|NCT04033445|584298190|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
161796524|NCT04033445|584298191|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161796525|NCT02985957|584298196|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161796526|NCT02985957|584298197|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161796527|NCT02985957|584298198|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161796528|NCT02985957|584298199|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161796529|NCT02985957|584298200|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161796530|NCT02985957|584298201|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161796531|NCT02985957|584298202|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161796532|NCT02985957|584298196|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
161796533|NCT02985957|584298197|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
161796534|NCT02985957|584298198|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
161796535|NCT02985957|584298199|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
161796536|NCT02985957|584298200|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
161796537|NCT02985957|584298201|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
161796538|NCT02985957|584298202|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
161796539|NCT02985957|584298196|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161796540|NCT02985957|584298197|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161796541|NCT02985957|584298198|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161796542|NCT02985957|584298199|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161796543|NCT02985957|584298200|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161796544|NCT02985957|584298201|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161796545|NCT02985957|584298202|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
161796546|NCT02985957|584298196|FG000|Treatment Period|Death|0|||
161796547|NCT02985957|584298197|FG001|Treatment Period|Death|0|||
161796548|NCT02985957|584298198|FG002|Treatment Period|Death|0|||
161796549|NCT02985957|584298199|FG003|Treatment Period|Death|0|||
161796550|NCT02985957|584298200|FG004|Treatment Period|Death|1|||
161796551|NCT02985957|584298201|FG005|Treatment Period|Death|0|||
161796552|NCT02985957|584298202|FG006|Treatment Period|Death|0|||
161796553|NCT02985957|584298196|FG000|Treatment Period|Participant withdrew consent|0|||
161796554|NCT02985957|584298197|FG001|Treatment Period|Participant withdrew consent|0|||
161796555|NCT02985957|584298198|FG002|Treatment Period|Participant withdrew consent|0|||
161796556|NCT02985957|584298199|FG003|Treatment Period|Participant withdrew consent|1|||
162137326|NCT00924560|585551308|FG000|Overall Study|Miscellaneous Reasons|13|||
162137327|NCT00924560|585551309|FG001|Overall Study|Miscellaneous Reasons|10|||
162137328|NCT00924560|585551310|FG002|Overall Study|Miscellaneous Reasons|10|||
162137329|NCT03590743|585551313|FG000|Overall Study|Withdrawal by Subject|0|||
162137330|NCT03590743|585551314|FG001|Overall Study|Withdrawal by Subject|1|||
162137331|NCT01190176|585551315|FG000|Overall Study|Withdrawal by Subject|1|||
162137332|NCT01190176|585551315|FG000|Overall Study|Lost to Follow-up|1|||
162137333|NCT01221181|585551316|FG000|Overall Study|Lost to Follow-up|1|||
162137334|NCT01290094|585551317|FG000|Overall Study|Withdrawal by Subject|1|||
162137335|NCT01290094|585551317|FG000|Overall Study|Lost to Follow-up|5|||
162137336|NCT02466516|585553401|FG000|Overall Study|Adverse Event|1|||
162137337|NCT02466516|585553402|FG001|Overall Study|Adverse Event|1|||
161796557|NCT02985957|584298200|FG004|Treatment Period|Participant withdrew consent|3|||
161796558|NCT02985957|584298201|FG005|Treatment Period|Participant withdrew consent|0|||
161796559|NCT02985957|584298202|FG006|Treatment Period|Participant withdrew consent|1|||
162137338|NCT02466516|585553403|FG002|Overall Study|Adverse Event|0|||
161796560|NCT02985957|584298196|FG000|Treatment Period|Lost to Follow-up|0|||
162137339|NCT02466516|585553404|FG003|Overall Study|Adverse Event|0|||
162137340|NCT02466516|585553405|FG004|Overall Study|Adverse Event|0|||
162137341|NCT02466516|585553401|FG000|Overall Study|Withdrew Consent|1|||
162137342|NCT02466516|585553402|FG001|Overall Study|Withdrew Consent|0|||
162137343|NCT02466516|585553403|FG002|Overall Study|Withdrew Consent|0|||
162137344|NCT02466516|585553404|FG003|Overall Study|Withdrew Consent|0|||
162137345|NCT02466516|585553405|FG004|Overall Study|Withdrew Consent|0|||
162137346|NCT02466516|585553401|FG000|Overall Study|Lost to Follow-up|2|||
162137347|NCT02466516|585553402|FG001|Overall Study|Lost to Follow-up|0|||
162137348|NCT02466516|585553403|FG002|Overall Study|Lost to Follow-up|1|||
162137349|NCT02466516|585553404|FG003|Overall Study|Lost to Follow-up|0|||
162137350|NCT02466516|585553405|FG004|Overall Study|Lost to Follow-up|0|||
162137351|NCT04358549|585553406|FG000|Overall Study|Adverse Event|0|||
162137352|NCT04358549|585553407|FG001|Overall Study|Adverse Event|1|||
162137353|NCT04358549|585553406|FG000|Overall Study|Death|1|||
162137354|NCT04358549|585553407|FG001|Overall Study|Death|0|||
162137355|NCT04358549|585553406|FG000|Overall Study|Lost to Follow-up|2|||
162137356|NCT04358549|585553407|FG001|Overall Study|Lost to Follow-up|1|||
162137357|NCT04358549|585553406|FG000|Overall Study|Withdrawal by Subject|6|||
162137358|NCT04358549|585553407|FG001|Overall Study|Withdrawal by Subject|6|||
162137359|NCT04358549|585553406|FG000|Overall Study|Start remdesivir|1|||
162137360|NCT04358549|585553407|FG001|Overall Study|Start remdesivir|0|||
162137361|NCT03712930|585553408|FG000|Overall Study|Death|7|||
162137362|NCT03712930|585553408|FG000|Overall Study|Physician Decision|1|||
162137363|NCT03712930|585553408|FG000|Overall Study|Study Terminated by Sponsor|3|||
162137364|NCT03712930|585553408|FG000|Overall Study|Progressive Disease|2|||
162137365|NCT01062126|585553412|FG000|Overall Study|Death|209|||
162137366|NCT01062126|585553412|FG000|Overall Study|All Withdrawals|324|||
162137367|NCT03837028|585553413|FG000|Overall Study|Lost to Follow-up|4|||
162137368|NCT03837028|585553414|FG001|Overall Study|Lost to Follow-up|0|||
162137369|NCT03837028|585553415|FG002|Overall Study|Lost to Follow-up|2|||
162137370|NCT03837028|585553416|FG003|Overall Study|Lost to Follow-up|0|||
162137371|NCT03837028|585553413|FG000|Overall Study|Withdrawal by Subject|12|||
162137372|NCT03837028|585553414|FG001|Overall Study|Withdrawal by Subject|11|||
162137373|NCT03837028|585553415|FG002|Overall Study|Withdrawal by Subject|11|||
162137374|NCT03837028|585553416|FG003|Overall Study|Withdrawal by Subject|7|||
162137375|NCT00646451|585553417|FG000|Overall Study|Adverse Event|3|||
162137376|NCT00646451|585553418|FG001|Overall Study|Adverse Event|0|||
162137377|NCT00646451|585553417|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
162137378|NCT00646451|585553418|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
162137379|NCT03784963|585553419|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
162137380|NCT03784963|585553420|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
162137381|NCT03784963|585553421|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
162137382|NCT03784963|585553422|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
162137383|NCT04867902|585553423|FG000|Overall Study|Lost to Follow-up|1|||
162137384|NCT04867902|585553423|FG000|Overall Study|Withdrawal by Subject|2|||
162137385|NCT04867902|585553423|FG000|Overall Study|Protocol Violation|1|||
162137386|NCT01390857|585553426|FG000|Overall Study|Protocol Violation|2|||
162137387|NCT01390857|585553426|FG000|Overall Study|Lost to Follow-up|1|||
162137388|NCT01390857|585553426|FG000|Overall Study|No Visit after the First Visit|7|||
162137389|NCT00672256|585553434|FG000|Overall Study|PI dropped, bad data|44|||
162137390|NCT02072226|585553438|FG000|Overall Study|Lost to Follow-up|11|||
162137391|NCT02072226|585553439|FG001|Overall Study|Lost to Follow-up|7|||
162137392|NCT02072226|585553438|FG000|Overall Study|Patient Non-compliance|2|||
162137393|NCT02072226|585553439|FG001|Overall Study|Patient Non-compliance|3|||
162137394|NCT02072226|585553438|FG000|Overall Study|Death|1|||
161900837|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
161900838|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900839|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900840|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900841|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900842|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900843|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900844|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900845|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900846|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900847|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900848|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900849|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161900850|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900851|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900852|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
161900853|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900854|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900855|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900856|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900857|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900858|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900859|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900860|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900861|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900862|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161796561|NCT02985957|584298197|FG001|Treatment Period|Lost to Follow-up|0|||
161796562|NCT02985957|584298198|FG002|Treatment Period|Lost to Follow-up|0|||
161796563|NCT02985957|584298199|FG003|Treatment Period|Lost to Follow-up|0|||
161796564|NCT02985957|584298200|FG004|Treatment Period|Lost to Follow-up|1|||
161796565|NCT02985957|584298201|FG005|Treatment Period|Lost to Follow-up|0|||
161796566|NCT02985957|584298202|FG006|Treatment Period|Lost to Follow-up|0|||
161796567|NCT02985957|584298196|FG000|Treatment Period|Other reasons|0|||
161900863|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900864|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161900865|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900866|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161796568|NCT02985957|584298197|FG001|Treatment Period|Other reasons|0|||
161796569|NCT02985957|584298198|FG002|Treatment Period|Other reasons|1|||
161796570|NCT02985957|584298199|FG003|Treatment Period|Other reasons|3|||
161796571|NCT02985957|584298200|FG004|Treatment Period|Other reasons|5|||
161796572|NCT02985957|584298201|FG005|Treatment Period|Other reasons|0|||
161796573|NCT02985957|584298202|FG006|Treatment Period|Other reasons|1|||
161796574|NCT02985957|584298196|FG000|Treatment Period|Not reported|0|||
161796575|NCT02985957|584298197|FG001|Treatment Period|Not reported|2|||
161796576|NCT02985957|584298198|FG002|Treatment Period|Not reported|2|||
161796577|NCT02985957|584298199|FG003|Treatment Period|Not reported|5|||
161796578|NCT02985957|584298200|FG004|Treatment Period|Not reported|0|||
161796579|NCT02985957|584298201|FG005|Treatment Period|Not reported|0|||
161900867|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
161900868|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161796580|NCT02985957|584298202|FG006|Treatment Period|Not reported|0|||
161796581|NCT02985957|584298196|FG000|Treatment Period|Maximum clinical benefit|0|||
161796582|NCT02985957|584298197|FG001|Treatment Period|Maximum clinical benefit|0|||
161796583|NCT02985957|584298198|FG002|Treatment Period|Maximum clinical benefit|1|||
161796584|NCT02985957|584298199|FG003|Treatment Period|Maximum clinical benefit|1|||
161796585|NCT02985957|584298200|FG004|Treatment Period|Maximum clinical benefit|0|||
161796586|NCT02985957|584298201|FG005|Treatment Period|Maximum clinical benefit|0|||
161796587|NCT02985957|584298202|FG006|Treatment Period|Maximum clinical benefit|2|||
161796588|NCT02985957|584298196|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
161796589|NCT02985957|584298197|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
161796590|NCT02985957|584298198|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
161796591|NCT02985957|584298199|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
161796592|NCT02985957|584298200|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
161796593|NCT02985957|584298201|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
161796594|NCT02985957|584298202|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
161796595|NCT02985957|584298196|FG000|Treatment Period|Study drug toxicity|1|||
161796596|NCT02985957|584298197|FG001|Treatment Period|Study drug toxicity|23|||
161796597|NCT02985957|584298198|FG002|Treatment Period|Study drug toxicity|20|||
161796598|NCT02985957|584298199|FG003|Treatment Period|Study drug toxicity|12|||
161796599|NCT02985957|584298200|FG004|Treatment Period|Study drug toxicity|20|||
161796600|NCT02985957|584298201|FG005|Treatment Period|Study drug toxicity|3|||
161796601|NCT02985957|584298202|FG006|Treatment Period|Study drug toxicity|5|||
161796602|NCT02985957|584298196|FG000|Treatment Period|Disease progression|0|||
161796603|NCT02985957|584298197|FG001|Treatment Period|Disease progression|16|||
161796604|NCT02985957|584298198|FG002|Treatment Period|Disease progression|20|||
161796605|NCT02985957|584298199|FG003|Treatment Period|Disease progression|40|||
161796606|NCT02985957|584298200|FG004|Treatment Period|Disease progression|29|||
161796607|NCT02985957|584298201|FG005|Treatment Period|Disease progression|11|||
161796608|NCT02985957|584298202|FG006|Treatment Period|Disease progression|28|||
161796609|NCT02985957|584298196|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
161796610|NCT02985957|584298197|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
161796611|NCT02985957|584298198|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
161796612|NCT02985957|584298199|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
161796613|NCT02985957|584298200|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
161796614|NCT02985957|584298201|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
161796615|NCT02985957|584298202|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
161796616|NCT02985957|584298196|FG000|Treatment Period|Poor/Non-Compliance|0|||
161796617|NCT02985957|584298197|FG001|Treatment Period|Poor/Non-Compliance|0|||
161796618|NCT02985957|584298198|FG002|Treatment Period|Poor/Non-Compliance|0|||
161796619|NCT02985957|584298199|FG003|Treatment Period|Poor/Non-Compliance|0|||
161796620|NCT02985957|584298200|FG004|Treatment Period|Poor/Non-Compliance|1|||
161796621|NCT02985957|584298201|FG005|Treatment Period|Poor/Non-Compliance|1|||
161796622|NCT02985957|584298202|FG006|Treatment Period|Poor/Non-Compliance|0|||
161796623|NCT02978326|584298203|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
161796624|NCT02978326|584298204|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
161796625|NCT02978326|584298205|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
161796626|NCT02978326|584298203|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
161796627|NCT02978326|584298204|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
161796628|NCT02978326|584298205|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
161796629|NCT02978326|584298203|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
161796630|NCT02978326|584298204|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
161796631|NCT02978326|584298205|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
161796632|NCT02978326|584298203|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
161796633|NCT02978326|584298204|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
161796634|NCT02978326|584298205|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
161796635|NCT03748641|584298208|FG000|Overall Study|Ongoing|155|||
161796636|NCT03748641|584298209|FG001|Overall Study|Ongoing|148|||
161796637|NCT03748641|584298210|FG002|Overall Study|Ongoing|66|||
161796638|NCT03748641|584298211|FG003|Overall Study|Ongoing|79|||
161796639|NCT03748641|584298212|FG004|Overall Study|Ongoing|84|||
161796640|NCT03748641|584298208|FG000|Overall Study|Death|54|||
162010849|NCT00870740|585096031|FG002|Overall Study|Consent Withdrawn|4|||
161796641|NCT03748641|584298209|FG001|Overall Study|Death|59|||
161796642|NCT03748641|584298210|FG002|Overall Study|Death|51|||
161796643|NCT03748641|584298211|FG003|Overall Study|Death|42|||
161796644|NCT03748641|584298212|FG004|Overall Study|Death|9|||
161796645|NCT03748641|584298208|FG000|Overall Study|Lost to Follow-up|0|||
161796646|NCT03748641|584298209|FG001|Overall Study|Lost to Follow-up|2|||
161796647|NCT03748641|584298210|FG002|Overall Study|Lost to Follow-up|1|||
161796648|NCT03748641|584298211|FG003|Overall Study|Lost to Follow-up|0|||
161796649|NCT03748641|584298212|FG004|Overall Study|Lost to Follow-up|0|||
161796650|NCT03748641|584298208|FG000|Overall Study|Withdrawal by Subject|3|||
161796651|NCT03748641|584298209|FG001|Overall Study|Withdrawal by Subject|2|||
161796652|NCT03748641|584298210|FG002|Overall Study|Withdrawal by Subject|5|||
161796653|NCT03748641|584298211|FG003|Overall Study|Withdrawal by Subject|3|||
161796654|NCT03748641|584298212|FG004|Overall Study|Withdrawal by Subject|2|||
161796655|NCT00437281|584298213|FG000|Overall Study|Adverse Event|0|||
162137395|NCT02072226|585553439|FG001|Overall Study|Death|0|||
162137396|NCT02072226|585553438|FG000|Overall Study|Patient Withdrawal of Consent|1|||
162137397|NCT02072226|585553439|FG001|Overall Study|Patient Withdrawal of Consent|0|||
162137398|NCT03255018|585553440|FG000|Overall Study|Death on study|0|||
162137399|NCT03255018|585553441|FG001|Overall Study|Death on study|5|||
162137400|NCT03255018|585553440|FG000|Overall Study|Withdrawal by Subject|0|||
162137401|NCT03255018|585553441|FG001|Overall Study|Withdrawal by Subject|2|||
162137402|NCT01720043|585553443|FG000|Overall Study|Withdrawal by Subject|1|||
162137403|NCT01688973|585553444|FG000|Overall Study|Ineligible|2|||
162137404|NCT01688973|585553445|FG001|Overall Study|Ineligible|3|||
162137405|NCT03710564|585553449|FG000|Overall Study|Study Terminated by Sponsor|104|||
162137406|NCT03710564|585553450|FG001|Overall Study|Study Terminated by Sponsor|55|||
162137407|NCT03710564|585553449|FG000|Overall Study|Withdrawal by Subject|57|||
162137408|NCT03710564|585553450|FG001|Overall Study|Withdrawal by Subject|25|||
162137409|NCT03710564|585553449|FG000|Overall Study|Death|10|||
162137410|NCT03710564|585553450|FG001|Overall Study|Death|4|||
162137411|NCT03710564|585553449|FG000|Overall Study|Lost to Follow-up|5|||
162137412|NCT03710564|585553450|FG001|Overall Study|Lost to Follow-up|4|||
162137413|NCT03710564|585553449|FG000|Overall Study|Protocol Violation|3|||
162137414|NCT03710564|585553450|FG001|Overall Study|Protocol Violation|2|||
162137415|NCT03710564|585553449|FG000|Overall Study|Adverse Event|3|||
162137416|NCT03710564|585553450|FG001|Overall Study|Adverse Event|0|||
162137417|NCT03710564|585553449|FG000|Overall Study|Physician Decision|2|||
162137418|NCT03710564|585553450|FG001|Overall Study|Physician Decision|3|||
162137419|NCT00972543|585553451|FG000|Overall Study|Adverse Event|1|||
162137420|NCT00972543|585553452|FG001|Overall Study|Adverse Event|0|||
162137421|NCT00972543|585553451|FG000|Overall Study|Early study termination by sponsor|4|||
162137422|NCT00972543|585553452|FG001|Overall Study|Early study termination by sponsor|1|||
162137423|NCT00293462|585553453|FG000|Overall Study|Withdrawal by Subject|4|||
162137424|NCT00293462|585553454|FG001|Overall Study|Withdrawal by Subject|3|||
162137425|NCT00293462|585553455|FG002|Overall Study|Withdrawal by Subject|8|||
162137426|NCT00293462|585553453|FG000|Overall Study|Death|1|||
162137427|NCT00293462|585553454|FG001|Overall Study|Death|0|||
162137428|NCT00293462|585553455|FG002|Overall Study|Death|0|||
162137429|NCT00293462|585553453|FG000|Overall Study|Lost to Follow-up|0|||
162137430|NCT00293462|585553454|FG001|Overall Study|Lost to Follow-up|1|||
162137431|NCT00293462|585553455|FG002|Overall Study|Lost to Follow-up|0|||
162137432|NCT00293462|585553453|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
162137433|NCT00293462|585553454|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
162137434|NCT00293462|585553455|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
162137435|NCT00293462|585553453|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
162137436|NCT00293462|585553454|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
162137437|NCT00293462|585553455|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
162137438|NCT00293462|585553453|FG000|Overall Study|Refuse Radiation Treatment|1|||
162137439|NCT00293462|585553454|FG001|Overall Study|Refuse Radiation Treatment|0|||
162137440|NCT00293462|585553455|FG002|Overall Study|Refuse Radiation Treatment|0|||
162137441|NCT00293462|585553453|FG000|Overall Study|No Show|0|||
162137442|NCT00293462|585553454|FG001|Overall Study|No Show|0|||
162137443|NCT00293462|585553455|FG002|Overall Study|No Show|1|||
162137444|NCT00293462|585553453|FG000|Overall Study|Went back to his home country|0|||
162137445|NCT00293462|585553454|FG001|Overall Study|Went back to his home country|0|||
162137446|NCT00293462|585553455|FG002|Overall Study|Went back to his home country|1|||
162137447|NCT00293462|585553453|FG000|Overall Study|Blood clot after chemotherapy|0|||
162137448|NCT00293462|585553454|FG001|Overall Study|Blood clot after chemotherapy|0|||
162137449|NCT00293462|585553455|FG002|Overall Study|Blood clot after chemotherapy|1|||
162137450|NCT00293462|585553453|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
162137451|NCT00293462|585553454|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
162137452|NCT00293462|585553455|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
162137453|NCT00293462|585553453|FG000|Overall Study|Possible Tracheostomy leakage|0|||
162137454|NCT00293462|585553454|FG001|Overall Study|Possible Tracheostomy leakage|1|||
162137455|NCT00293462|585553455|FG002|Overall Study|Possible Tracheostomy leakage|0|||
162137456|NCT00293462|585553453|FG000|Overall Study|Low radiation dose in oral cavity|0|||
162137457|NCT00293462|585553454|FG001|Overall Study|Low radiation dose in oral cavity|1|||
162137458|NCT00293462|585553455|FG002|Overall Study|Low radiation dose in oral cavity|0|||
162137459|NCT00293462|585553453|FG000|Overall Study|Physician Decision|0|||
162137460|NCT00293462|585553454|FG001|Overall Study|Physician Decision|1|||
162137461|NCT00293462|585553455|FG002|Overall Study|Physician Decision|0|||
162137462|NCT00372060|585553456|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
162137463|NCT00372060|585553457|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
162137464|NCT00372060|585553456|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
162137465|NCT00372060|585553457|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
162137466|NCT00372060|585553456|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
161796656|NCT00437281|584298214|FG001|Overall Study|Adverse Event|0|||
161796657|NCT00437281|584298215|FG002|Overall Study|Adverse Event|0|||
161796658|NCT00437281|584298216|FG003|Overall Study|Adverse Event|1|||
161900869|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900870|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900871|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900872|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900873|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900874|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900875|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900876|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
162137467|NCT00372060|585553457|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
162137468|NCT00372060|585553456|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
162137469|NCT00372060|585553457|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
162137470|NCT00372060|585553456|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
162137471|NCT00372060|585553457|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
162137472|NCT00372060|585553456|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
162137473|NCT00372060|585553457|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
162137474|NCT00647348|585553458|FG000|Overall Study|Lost to Follow-up|3|||
162137475|NCT00647348|585553459|FG001|Overall Study|Lost to Follow-up|6|||
162137476|NCT03382821|585553463|FG000|Overall Study|Did not receive allocated intervention.|0|||
162137477|NCT03382821|585553464|FG001|Overall Study|Did not receive allocated intervention.|3|||
162137478|NCT00282438|585553465|FG000|Overall Study|Lack of Efficacy|1|||
162137479|NCT00282438|585553466|FG001|Overall Study|Lack of Efficacy|0|||
162137480|NCT00282438|585553465|FG000|Overall Study|Death|0|||
162137481|NCT00282438|585553466|FG001|Overall Study|Death|1|||
162137482|NCT01119703|585553475|FG000|Overall Study|Adverse Event|0|||
162137483|NCT01119703|585553476|FG001|Overall Study|Adverse Event|1|||
162137484|NCT01511250|585553477|FG000|Overall Study|Withdrawal of Consent|1|||
162137485|NCT01511250|585553478|FG001|Overall Study|Withdrawal of Consent|0|||
162137486|NCT01511250|585553479|FG002|Overall Study|Withdrawal of Consent|0|||
162137487|NCT01511250|585553480|FG003|Overall Study|Withdrawal of Consent|0|||
162137488|NCT01511250|585553481|FG004|Overall Study|Withdrawal of Consent|0|||
162137489|NCT01511250|585553482|FG005|Overall Study|Withdrawal of Consent|0|||
162137490|NCT01511250|585553483|FG006|Overall Study|Withdrawal of Consent|0|||
162137491|NCT01511250|585553484|FG007|Overall Study|Withdrawal of Consent|1|||
162137492|NCT01511250|585553485|FG008|Overall Study|Withdrawal of Consent|1|||
162137493|NCT01511250|585553486|FG009|Overall Study|Withdrawal of Consent|0|||
162137494|NCT01511250|585553477|FG000|Overall Study|Sponsor/Investigator Decision|1|||
162137495|NCT01511250|585553478|FG001|Overall Study|Sponsor/Investigator Decision|0|||
162137496|NCT01511250|585553479|FG002|Overall Study|Sponsor/Investigator Decision|0|||
162137497|NCT01511250|585553480|FG003|Overall Study|Sponsor/Investigator Decision|0|||
162137498|NCT01511250|585553481|FG004|Overall Study|Sponsor/Investigator Decision|0|||
162137499|NCT01511250|585553482|FG005|Overall Study|Sponsor/Investigator Decision|0|||
162137500|NCT01511250|585553483|FG006|Overall Study|Sponsor/Investigator Decision|0|||
162137501|NCT01511250|585553484|FG007|Overall Study|Sponsor/Investigator Decision|0|||
162137502|NCT01511250|585553485|FG008|Overall Study|Sponsor/Investigator Decision|0|||
162137503|NCT01511250|585553486|FG009|Overall Study|Sponsor/Investigator Decision|0|||
162137504|NCT01511250|585553477|FG000|Overall Study|Lost to Follow-up|7|||
162137505|NCT01511250|585553478|FG001|Overall Study|Lost to Follow-up|3|||
162137506|NCT01511250|585553479|FG002|Overall Study|Lost to Follow-up|3|||
162137507|NCT01511250|585553480|FG003|Overall Study|Lost to Follow-up|3|||
162137508|NCT01511250|585553481|FG004|Overall Study|Lost to Follow-up|0|||
162137509|NCT01511250|585553482|FG005|Overall Study|Lost to Follow-up|0|||
162137510|NCT01511250|585553483|FG006|Overall Study|Lost to Follow-up|2|||
162137511|NCT01511250|585553484|FG007|Overall Study|Lost to Follow-up|3|||
162137512|NCT01511250|585553485|FG008|Overall Study|Lost to Follow-up|13|||
162137513|NCT01511250|585553486|FG009|Overall Study|Lost to Follow-up|5|||
162137514|NCT01511250|585553477|FG000|Overall Study|Protocol Violation|0|||
162137515|NCT01511250|585553478|FG001|Overall Study|Protocol Violation|2|||
162137516|NCT01511250|585553479|FG002|Overall Study|Protocol Violation|1|||
162137517|NCT01511250|585553480|FG003|Overall Study|Protocol Violation|0|||
162137518|NCT01511250|585553481|FG004|Overall Study|Protocol Violation|0|||
162137519|NCT01511250|585553482|FG005|Overall Study|Protocol Violation|0|||
162137520|NCT01511250|585553483|FG006|Overall Study|Protocol Violation|0|||
162137521|NCT01511250|585553484|FG007|Overall Study|Protocol Violation|0|||
162137522|NCT01511250|585553485|FG008|Overall Study|Protocol Violation|0|||
162137523|NCT01511250|585553486|FG009|Overall Study|Protocol Violation|0|||
162137524|NCT04668144|585553487|FG000|Overall Study|Protocol Violation|0|||
162137525|NCT04668144|585553488|FG001|Overall Study|Protocol Violation|1|||
162137526|NCT04668144|585553489|FG002|Overall Study|Protocol Violation|2|||
162137527|NCT02095158|585553490|FG000|Overall Study|Adverse Event|14|||
162137528|NCT02095158|585553490|FG000|Overall Study|Lack of Efficacy|3|||
162137529|NCT02095158|585553490|FG000|Overall Study|Pregnancy|1|||
162137530|NCT02095158|585553490|FG000|Overall Study|Lost to Follow-up|20|||
162137531|NCT02095158|585553490|FG000|Overall Study|Personal Reasons|35|||
161900877|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900878|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900879|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161900880|NCT02326272|584685184|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900881|NCT02326272|584685185|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900882|NCT02326272|584685186|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
161900883|NCT02326272|584685187|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900884|NCT02326272|584685188|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900885|NCT02326272|584685189|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900886|NCT02326272|584685190|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900887|NCT02326272|584685191|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900888|NCT02326272|584685192|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900889|NCT02326272|584685193|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900890|NCT02326272|584685194|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900891|NCT02326272|584685195|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900892|NCT02326272|584685196|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900893|NCT02326272|584685197|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900894|NCT02326272|584685198|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161900895|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161796659|NCT00437281|584298217|FG004|Overall Study|Adverse Event|0|||
161796660|NCT00437281|584298218|FG005|Overall Study|Adverse Event|1|||
161900896|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900897|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900898|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900899|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
161900900|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
161900901|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
161900902|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
161900903|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
161900904|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900905|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900906|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900907|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900908|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900909|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161900910|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900911|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900912|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900913|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900914|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900915|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
161900916|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
161900917|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162137532|NCT02095158|585553490|FG000|Overall Study|Protocol Violation|1|||
162137533|NCT02095158|585553490|FG000|Overall Study|Other Miscellaneous Reasons|1|||
162137534|NCT03441984|585553491|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161796661|NCT00437281|584298219|FG006|Overall Study|Adverse Event|0|||
161796662|NCT00437281|584298220|FG007|Overall Study|Adverse Event|0|||
161796663|NCT00437281|584298221|FG008|Overall Study|Adverse Event|0|||
161796664|NCT00437281|584298222|FG009|Overall Study|Adverse Event|1|||
161796665|NCT00437281|584298223|FG010|Overall Study|Adverse Event|0|||
161796666|NCT00437281|584298224|FG011|Overall Study|Adverse Event|0|||
161796667|NCT00437281|584298225|FG012|Overall Study|Adverse Event|0|||
161796668|NCT00437281|584298226|FG013|Overall Study|Adverse Event|1|||
161796669|NCT00437281|584298227|FG014|Overall Study|Adverse Event|1|||
161796670|NCT00437281|584298228|FG015|Overall Study|Adverse Event|0|||
161796671|NCT00437281|584298229|FG016|Overall Study|Adverse Event|0|||
161796672|NCT00437281|584298230|FG017|Overall Study|Adverse Event|0|||
161796673|NCT00437281|584298231|FG018|Overall Study|Adverse Event|1|||
161796674|NCT00437281|584298232|FG019|Overall Study|Adverse Event|0|||
161796675|NCT00437281|584298213|FG000|Overall Study|Lost to Follow-up|0|||
161796676|NCT00437281|584298214|FG001|Overall Study|Lost to Follow-up|0|||
161796677|NCT00437281|584298215|FG002|Overall Study|Lost to Follow-up|0|||
161796678|NCT00437281|584298216|FG003|Overall Study|Lost to Follow-up|0|||
161796679|NCT00437281|584298217|FG004|Overall Study|Lost to Follow-up|0|||
161796680|NCT00437281|584298218|FG005|Overall Study|Lost to Follow-up|0|||
161900918|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
161900919|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
161900920|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900921|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900922|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900923|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900924|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161900925|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900926|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900927|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900928|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900929|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900930|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
161900931|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900932|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
161900933|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900934|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900935|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900936|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900937|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900938|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900939|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161900940|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900941|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900942|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900943|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161900944|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900945|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
161900946|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161900947|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161900948|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900949|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161900950|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900951|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900952|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900953|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900954|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161900955|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900956|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900957|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900958|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900959|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900960|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900961|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900962|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
161900963|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900964|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900965|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900966|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900967|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900968|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900969|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161900970|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900971|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900972|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900973|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900974|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900975|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900976|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
161900977|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900978|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900979|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161796681|NCT00437281|584298219|FG006|Overall Study|Lost to Follow-up|0|||
161796682|NCT00437281|584298220|FG007|Overall Study|Lost to Follow-up|0|||
161796683|NCT00437281|584298221|FG008|Overall Study|Lost to Follow-up|0|||
161796684|NCT00437281|584298222|FG009|Overall Study|Lost to Follow-up|0|||
161796685|NCT00437281|584298223|FG010|Overall Study|Lost to Follow-up|0|||
161796686|NCT00437281|584298224|FG011|Overall Study|Lost to Follow-up|0|||
161796687|NCT00437281|584298225|FG012|Overall Study|Lost to Follow-up|0|||
161796688|NCT00437281|584298226|FG013|Overall Study|Lost to Follow-up|0|||
161796689|NCT00437281|584298227|FG014|Overall Study|Lost to Follow-up|0|||
161796690|NCT00437281|584298228|FG015|Overall Study|Lost to Follow-up|0|||
161796691|NCT00437281|584298229|FG016|Overall Study|Lost to Follow-up|0|||
161796692|NCT00437281|584298230|FG017|Overall Study|Lost to Follow-up|0|||
161796693|NCT00437281|584298231|FG018|Overall Study|Lost to Follow-up|0|||
161796694|NCT00437281|584298232|FG019|Overall Study|Lost to Follow-up|1|||
161796695|NCT00926289|584298233|FG000|Overall Study|Adverse Event|9|||
161796696|NCT00926289|584298234|FG001|Overall Study|Adverse Event|11|||
161796697|NCT00926289|584298233|FG000|Overall Study|Protocol Violation|8|||
161796698|NCT00926289|584298234|FG001|Overall Study|Protocol Violation|12|||
161796699|NCT00926289|584298233|FG000|Overall Study|Lost to Follow-up|3|||
161796700|NCT00926289|584298234|FG001|Overall Study|Lost to Follow-up|6|||
161796701|NCT00926289|584298233|FG000|Overall Study|Withdrawal by Subject|4|||
161796702|NCT00926289|584298234|FG001|Overall Study|Withdrawal by Subject|4|||
161796703|NCT00926289|584298233|FG000|Overall Study|Other|1|||
161796704|NCT00926289|584298234|FG001|Overall Study|Other|3|||
161796705|NCT04104646|584298235|FG000|Overall Study|Withdrawal by Subject|1|||
161796706|NCT04104646|584298236|FG001|Overall Study|Withdrawal by Subject|1|||
161796707|NCT04104646|584298235|FG000|Overall Study|Lost to Follow-up|1|||
161796708|NCT04104646|584298236|FG001|Overall Study|Lost to Follow-up|0|||
161796709|NCT04104646|584298235|FG000|Overall Study|Physician Decision|2|||
161796710|NCT04104646|584298236|FG001|Overall Study|Physician Decision|0|||
161796711|NCT00753714|584298237|FG000|Overall Study|Lack of Efficacy|21|||
161796712|NCT00753714|584298238|FG001|Overall Study|Lack of Efficacy|34|||
161796713|NCT00753714|584298237|FG000|Overall Study|Adverse Event|26|||
161796714|NCT00753714|584298238|FG001|Overall Study|Adverse Event|18|||
161796715|NCT00753714|584298237|FG000|Overall Study|Protocol Violation|1|||
161796716|NCT00753714|584298238|FG001|Overall Study|Protocol Violation|0|||
161796717|NCT00753714|584298237|FG000|Overall Study|Lost to Follow-up|0|||
161796718|NCT00753714|584298238|FG001|Overall Study|Lost to Follow-up|1|||
161796719|NCT00753714|584298237|FG000|Overall Study|Withdrawal by Subject|2|||
161796720|NCT00753714|584298238|FG001|Overall Study|Withdrawal by Subject|1|||
161796721|NCT00753714|584298237|FG000|Overall Study|Death|3|||
161796722|NCT00753714|584298238|FG001|Overall Study|Death|3|||
161796723|NCT00753714|584298237|FG000|Overall Study|Other|7|||
161796724|NCT00753714|584298238|FG001|Overall Study|Other|5|||
161796725|NCT03387098|584298239|FG000|Overall Study|progressive disease|1|||
161796726|NCT03387098|584298239|FG000|Overall Study|Withdrawal by Subject|2|||
161796727|NCT03387098|584298239|FG000|Overall Study|study terminated by sponsor|1|||
161796728|NCT02292238|584298240|FG000|Overall Study|Protocol Violation|1|||
161796729|NCT02292238|584298241|FG001|Overall Study|Protocol Violation|2|||
161796730|NCT02292238|584298240|FG000|Overall Study|Withdrawal by Subject|2|||
161796731|NCT02292238|584298241|FG001|Overall Study|Withdrawal by Subject|1|||
161796732|NCT02292238|584298240|FG000|Overall Study|Lost to Follow-up|1|||
161796733|NCT02292238|584298241|FG001|Overall Study|Lost to Follow-up|0|||
161796734|NCT02292238|584298240|FG000|Overall Study|Physician Decision|0|||
161796735|NCT02292238|584298241|FG001|Overall Study|Physician Decision|1|||
161796736|NCT04000009|584298242|FG000|Overall Study|Adverse Event|13|||
161796737|NCT04000009|584298242|FG000|Overall Study|Lack of Efficacy|7|||
161796738|NCT04000009|584298242|FG000|Overall Study|Lost to Follow-up|8|||
161796739|NCT04000009|584298242|FG000|Overall Study|Noncompliance with study drug|4|||
161796740|NCT04000009|584298242|FG000|Overall Study|Physician Decision|1|||
161796741|NCT04000009|584298242|FG000|Overall Study|Use of prohibited medication|3|||
161796742|NCT04000009|584298242|FG000|Overall Study|Pregnancy|1|||
161796743|NCT04000009|584298242|FG000|Overall Study|Withdrawal by Subject|22|||
161796744|NCT04000009|584298242|FG000|Overall Study|Study terminated by sponsor|98|||
161796745|NCT04000009|584298242|FG000|Overall Study|Not further specified|8|||
161796746|NCT01754259|584298245|FG000|Overall Study|Withdrawal by Subject|2|||
161796747|NCT01754259|584298246|FG001|Overall Study|Withdrawal by Subject|4|||
161796748|NCT01754259|584298245|FG000|Overall Study|Adverse Event|3|||
161796749|NCT01754259|584298246|FG001|Overall Study|Adverse Event|1|||
161796750|NCT01754259|584298245|FG000|Overall Study|Lost to Follow-up|0|||
161796751|NCT01754259|584298246|FG001|Overall Study|Lost to Follow-up|1|||
161796752|NCT02829918|584298247|FG000|Overall Study|Death|2|||
161796753|NCT02829918|584298247|FG000|Overall Study|Withdrawal by Subject|4|||
161796754|NCT02829918|584298247|FG000|Overall Study|Adverse Event|1|||
161796755|NCT02829918|584298247|FG000|Overall Study|Progression|1|||
161796756|NCT00491504|584298250|FG000|Overall Study|Adverse Event|0|||
161796757|NCT00491504|584298251|FG001|Overall Study|Adverse Event|1|||
161796758|NCT00491504|584298252|FG002|Overall Study|Adverse Event|0|||
161796759|NCT00491504|584298253|FG003|Overall Study|Adverse Event|0|||
161796760|NCT00491504|584298250|FG000|Overall Study|Withdrawal by Subject|0|||
161900980|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900981|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900982|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900983|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900984|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161900985|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900986|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900987|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900988|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900989|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900990|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900991|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900992|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900993|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
161900994|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900995|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900996|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900997|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900998|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161900999|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161901000|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901001|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901002|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901003|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901004|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901005|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
161901006|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
161901007|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
161901008|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
161901009|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901010|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901011|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901012|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901013|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901014|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161901015|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901016|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901017|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901018|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901019|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901020|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
161901021|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901022|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901023|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901024|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901025|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901026|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901027|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901028|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901029|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161901030|NCT02326272|584685184|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901031|NCT02326272|584685185|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901032|NCT02326272|584685186|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901033|NCT02326272|584685187|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901034|NCT02326272|584685188|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901035|NCT02326272|584685189|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
162137535|NCT03441984|585553492|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161901036|NCT02326272|584685190|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
161942198|NCT02082977|584838338|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
162137536|NCT03441984|585553493|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
162137537|NCT03441984|585553494|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161901037|NCT02326272|584685191|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901038|NCT02326272|584685192|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901039|NCT02326272|584685193|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901040|NCT02326272|584685194|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901041|NCT02326272|584685195|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901042|NCT02326272|584685196|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901043|NCT02326272|584685197|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901044|NCT02326272|584685198|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161901045|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
161901046|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
161901047|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
161901048|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
161901049|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
161901050|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
161901051|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
161901052|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
161901053|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
161901054|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
161901055|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
161901056|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
161901057|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
161901058|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
161901059|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
161901060|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901061|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901062|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901063|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901064|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901065|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901066|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901067|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901068|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901069|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901070|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
161901071|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
161901072|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
161901073|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161901074|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
161901075|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901076|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901077|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901078|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901079|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901080|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901081|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901082|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901083|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901084|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901085|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161901086|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901087|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161901088|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901089|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161901090|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901091|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901092|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901093|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901094|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901095|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901096|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901097|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901098|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901099|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901100|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901101|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
161901102|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901103|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901104|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161901105|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901106|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901107|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901108|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901109|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901110|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901111|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901112|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901113|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901114|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901115|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
161901116|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901117|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
161901118|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161901119|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
161901120|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901121|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901122|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901123|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901124|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901125|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901126|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901127|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901128|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901129|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901130|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901131|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
161901132|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901133|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161901134|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
161901135|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901136|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901137|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901138|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901139|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901140|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901141|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901142|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901143|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901144|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901145|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901146|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
161901147|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
161901148|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161901149|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
161901150|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901151|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901152|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901153|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901154|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901155|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901156|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901157|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901158|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901159|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901160|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901161|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
162010850|NCT00870740|585096032|FG003|Overall Study|Consent Withdrawn|6|||
162010851|NCT00870740|585096033|FG004|Overall Study|Consent Withdrawn|6|||
161796761|NCT00491504|584298251|FG001|Overall Study|Withdrawal by Subject|0|||
161796762|NCT00491504|584298252|FG002|Overall Study|Withdrawal by Subject|1|||
161796763|NCT00491504|584298253|FG003|Overall Study|Withdrawal by Subject|2|||
161796764|NCT00491504|584298250|FG000|Overall Study|Protocol Violation|0|||
161796765|NCT00491504|584298251|FG001|Overall Study|Protocol Violation|0|||
161796766|NCT00491504|584298252|FG002|Overall Study|Protocol Violation|3|||
161796767|NCT00491504|584298253|FG003|Overall Study|Protocol Violation|2|||
161796768|NCT00673790|584298254|FG000|Overall Study|Adverse Event|23|||
161796769|NCT00673790|584298255|FG001|Overall Study|Adverse Event|14|||
161796770|NCT00673790|584298256|FG002|Overall Study|Adverse Event|2|||
161796771|NCT00673790|584298254|FG000|Overall Study|Lack of Efficacy|2|||
161796772|NCT00673790|584298255|FG001|Overall Study|Lack of Efficacy|2|||
161796773|NCT00673790|584298256|FG002|Overall Study|Lack of Efficacy|2|||
161796774|NCT00673790|584298254|FG000|Overall Study|Protocol Violation|6|||
161796775|NCT00673790|584298255|FG001|Overall Study|Protocol Violation|9|||
161796776|NCT00673790|584298256|FG002|Overall Study|Protocol Violation|1|||
161796777|NCT00673790|584298254|FG000|Overall Study|Withdrawal by Subject|7|||
161796778|NCT00673790|584298255|FG001|Overall Study|Withdrawal by Subject|4|||
161796779|NCT00673790|584298256|FG002|Overall Study|Withdrawal by Subject|1|||
161796780|NCT00673790|584298254|FG000|Overall Study|Lost to Follow-up|6|||
161796781|NCT00673790|584298255|FG001|Overall Study|Lost to Follow-up|6|||
161796782|NCT00673790|584298256|FG002|Overall Study|Lost to Follow-up|5|||
161796783|NCT00673790|584298254|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
161796784|NCT00673790|584298255|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
161796785|NCT00673790|584298256|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
161796786|NCT00673790|584298254|FG000|Overall Study|Poor compliance|1|||
161796787|NCT00673790|584298255|FG001|Overall Study|Poor compliance|0|||
161796788|NCT00673790|584298256|FG002|Overall Study|Poor compliance|0|||
161796789|NCT00673790|584298254|FG000|Overall Study|Participated in two Nebivolol studies|0|||
161796790|NCT00673790|584298255|FG001|Overall Study|Participated in two Nebivolol studies|0|||
161796791|NCT00673790|584298256|FG002|Overall Study|Participated in two Nebivolol studies|1|||
161796792|NCT00673790|584298254|FG000|Overall Study|Unconfirmed pregnancy|0|||
161796793|NCT00673790|584298255|FG001|Overall Study|Unconfirmed pregnancy|1|||
161796794|NCT00673790|584298256|FG002|Overall Study|Unconfirmed pregnancy|0|||
161796795|NCT00673790|584298254|FG000|Overall Study|Randomization criteria not met|0|||
161796796|NCT00673790|584298255|FG001|Overall Study|Randomization criteria not met|1|||
161796797|NCT00673790|584298256|FG002|Overall Study|Randomization criteria not met|0|||
161796798|NCT00717756|584298257|FG000|Overall Study|Withdrawal by Subject|1|||
161796799|NCT01364870|584298258|FG000|Overall Study|Withdrawal by Subject|13|||
161796800|NCT01364870|584298259|FG001|Overall Study|Withdrawal by Subject|24|||
161796801|NCT01364870|584298260|FG002|Overall Study|Withdrawal by Subject|10|||
161796802|NCT01364870|584298258|FG000|Overall Study|Adverse Event|8|||
161796803|NCT01364870|584298259|FG001|Overall Study|Adverse Event|6|||
161796804|NCT01364870|584298260|FG002|Overall Study|Adverse Event|4|||
161796805|NCT01364870|584298258|FG000|Overall Study|Protocol Violation|1|||
161796806|NCT01364870|584298259|FG001|Overall Study|Protocol Violation|0|||
161796807|NCT01364870|584298260|FG002|Overall Study|Protocol Violation|0|||
161796808|NCT01873859|584298261|FG000|Overall Study|Withdrawal by Subject|0|||
161796809|NCT01873859|584298262|FG001|Overall Study|Withdrawal by Subject|4|||
161796810|NCT03977584|584298263|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
161796811|NCT03977584|584298264|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
161796812|NCT03977584|584298265|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
161796813|NCT02257736|584298269|FG000|Overall Study|Progressive disease|365|||
161796814|NCT02257736|584298270|FG001|Overall Study|Progressive disease|327|||
161796815|NCT02257736|584298269|FG000|Overall Study|Adverse Event|45|||
161796816|NCT02257736|584298270|FG001|Overall Study|Adverse Event|56|||
161796817|NCT02257736|584298269|FG000|Overall Study|Withdrawal by Subject|21|||
161796818|NCT02257736|584298270|FG001|Overall Study|Withdrawal by Subject|38|||
161796819|NCT02257736|584298269|FG000|Overall Study|Death|11|||
161796820|NCT02257736|584298270|FG001|Overall Study|Death|6|||
161796821|NCT02257736|584298269|FG000|Overall Study|Physician Decision|5|||
161796822|NCT02257736|584298270|FG001|Overall Study|Physician Decision|9|||
161796823|NCT02257736|584298269|FG000|Overall Study|Non-Compliance with study drug|1|||
161796824|NCT02257736|584298270|FG001|Overall Study|Non-Compliance with study drug|2|||
161796825|NCT02257736|584298269|FG000|Overall Study|Protocol Violation|1|||
161796826|NCT02257736|584298270|FG001|Overall Study|Protocol Violation|0|||
161796827|NCT02257736|584298269|FG000|Overall Study|Other|1|||
161796828|NCT02257736|584298270|FG001|Overall Study|Other|7|||
161796829|NCT02257736|584298269|FG000|Overall Study|Randomized, not treated|1|||
161796830|NCT02257736|584298270|FG001|Overall Study|Randomized, not treated|2|||
161796831|NCT00745251|584298278|FG000|Overall Study|Adverse Event|1|||
161796832|NCT00745251|584298279|FG001|Overall Study|Adverse Event|2|||
161796833|NCT00745251|584298278|FG000|Overall Study|Withdrawal by Subject|1|||
161796834|NCT00745251|584298279|FG001|Overall Study|Withdrawal by Subject|1|||
161796835|NCT03390504|584298280|FG000|Overall Study|Lost to Follow-up|2|||
161796836|NCT03390504|584298281|FG001|Overall Study|Lost to Follow-up|4|||
161796837|NCT03390504|584298282|FG002|Overall Study|Lost to Follow-up|0|||
161796838|NCT03390504|584298283|FG003|Overall Study|Lost to Follow-up|1|||
161796839|NCT03390504|584298280|FG000|Overall Study|Withdrawal by Subject|3|||
161796840|NCT03390504|584298281|FG001|Overall Study|Withdrawal by Subject|15|||
161796841|NCT03390504|584298282|FG002|Overall Study|Withdrawal by Subject|5|||
161796842|NCT03390504|584298283|FG003|Overall Study|Withdrawal by Subject|2|||
161796843|NCT03390504|584298280|FG000|Overall Study|Other|1|||
161796844|NCT03390504|584298281|FG001|Overall Study|Other|2|||
161796845|NCT03390504|584298282|FG002|Overall Study|Other|2|||
161796846|NCT03390504|584298283|FG003|Overall Study|Other|6|||
161796847|NCT03850509|584298284|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
161796848|NCT03850509|584298285|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
161796849|NCT02666430|584298286|FG000|Period 1|Lost to Follow-up|1|||
161796850|NCT02666430|584298287|FG001|Period 1|Lost to Follow-up|0|||
161796851|NCT02666430|584298286|FG000|Period 1|Adverse Event|0|||
161796852|NCT02666430|584298287|FG001|Period 1|Adverse Event|1|||
161796853|NCT02666430|584298286|FG000|Period 2|Withdrawal by Subject|1|||
161796854|NCT02666430|584298287|FG001|Period 2|Withdrawal by Subject|4|||
161796855|NCT02666430|584298286|FG000|Period 3|Lost to Follow-up|1|||
161796856|NCT02666430|584298287|FG001|Period 3|Lost to Follow-up|0|||
161796857|NCT03922477|584298288|FG000|Overall Study|Death|9|||
161796858|NCT03922477|584298288|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
161796859|NCT03922477|584298288|FG000|Overall Study|Physician Decision|1|||
161796860|NCT03922477|584298288|FG000|Overall Study|Withdrawal by Subject|2|||
161796861|NCT01618305|584298292|FG000|Overall Study|Death|0|||
161796862|NCT01618305|584298293|FG001|Overall Study|Death|1|||
161796863|NCT01618305|584298292|FG000|Overall Study|Lost to Follow-up|11|||
161796864|NCT01618305|584298293|FG001|Overall Study|Lost to Follow-up|7|||
161796865|NCT01618305|584298292|FG000|Overall Study|Protocol Violation|1|||
161796866|NCT01618305|584298293|FG001|Overall Study|Protocol Violation|0|||
161796867|NCT01618305|584298292|FG000|Overall Study|Withdrawal by Subject|3|||
161796868|NCT01618305|584298293|FG001|Overall Study|Withdrawal by Subject|2|||
161796869|NCT01565083|584298294|FG000|Overall Study|Withdrawal by Subject|6|||
161796870|NCT01565083|584298295|FG001|Overall Study|Withdrawal by Subject|4|||
161796871|NCT01565083|584298294|FG000|Overall Study|Lost to Follow-up|2|||
161796872|NCT01565083|584298295|FG001|Overall Study|Lost to Follow-up|7|||
161796873|NCT01565083|584298294|FG000|Overall Study|Death|22|||
161796874|NCT01565083|584298295|FG001|Overall Study|Death|23|||
161796875|NCT01565083|584298294|FG000|Overall Study|Other|3|||
161796876|NCT01565083|584298295|FG001|Overall Study|Other|5|||
161796877|NCT01960816|584298296|FG000|Overall Study|Lost to Follow-up|1|||
161796878|NCT05431686|584298297|FG000|Overall Study|unable to schedule|10|||
161796879|NCT01118728|584298312|FG000|Overall Study|Adverse Event|17|||
161796880|NCT01118728|584298312|FG000|Overall Study|Lack of Efficacy|27|||
161796881|NCT01118728|584298312|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
161796882|NCT01118728|584298312|FG000|Overall Study|Withdrawal by Subject|3|||
161796883|NCT01118728|584298312|FG000|Overall Study|Lost to Follow-up|4|||
161796884|NCT01309919|584298313|FG000|Overall Study|Did not receive a postpartum IUD|17|||
161796885|NCT01309919|584298314|FG001|Overall Study|Did not receive a postpartum IUD|48|||
161796886|NCT01736553|584298319|FG000|Overall Study|Death|12|||
161796887|NCT01736553|584298320|FG001|Overall Study|Death|0|||
161796888|NCT01736553|584298319|FG000|Overall Study|Withdrawal by Subject|5|||
161796889|NCT01736553|584298320|FG001|Overall Study|Withdrawal by Subject|2|||
161796890|NCT01736553|584298319|FG000|Overall Study|Lost to Follow-up|2|||
161796891|NCT01736553|584298320|FG001|Overall Study|Lost to Follow-up|2|||
161796892|NCT02178709|584299590|FG000|Overall Study|Adverse Event|5|||
161796893|NCT02178709|584299590|FG000|Overall Study|Death|2|||
161796894|NCT02178709|584299590|FG000|Overall Study|Withdrawal by Subject|2|||
161796895|NCT02178709|584299590|FG000|Overall Study|Physician Decision|2|||
161796896|NCT02178709|584299590|FG000|Overall Study|Disease Progression|5|||
161796897|NCT02192905|584299593|FG000|Overall Study|Lost to Follow-up|1|||
161796898|NCT01691859|584299594|FG000|Overall Study|Adverse Event|19|||
161796899|NCT01691859|584299594|FG000|Overall Study|Lack of Efficacy|11|||
161796900|NCT01691859|584299594|FG000|Overall Study|Protocol Violation|4|||
161796901|NCT01691859|584299594|FG000|Overall Study|Product commercially available|221|||
161796902|NCT01691859|584299594|FG000|Overall Study|Study closed/terminated|50|||
161796903|NCT01691859|584299594|FG000|Overall Study|Lost to Follow-up|5|||
161796904|NCT01691859|584299594|FG000|Overall Study|Physician Decision|6|||
161796905|NCT01691859|584299594|FG000|Overall Study|Withdrawal by Subject|31|||
161796906|NCT00862979|584299595|FG000|Overall Study|Adverse Event|6|||
161796907|NCT00862979|584299596|FG001|Overall Study|Adverse Event|3|||
161796908|NCT00862979|584299595|FG000|Overall Study|Protocol Violation|0|||
161796909|NCT00862979|584299596|FG001|Overall Study|Protocol Violation|1|||
161796910|NCT00862979|584299595|FG000|Overall Study|Patient withdrew consent|2|||
161796911|NCT00862979|584299596|FG001|Overall Study|Patient withdrew consent|1|||
161796912|NCT00862979|584299595|FG000|Overall Study|Administrative problems|0|||
161796913|NCT00862979|584299596|FG001|Overall Study|Administrative problems|1|||
161796914|NCT00862979|584299595|FG000|Overall Study|Death|0|||
161796915|NCT00862979|584299596|FG001|Overall Study|Death|1|||
161796916|NCT00992407|584299599|FG000|Overall Study|Protocol Violation|2|||
161796917|NCT00992407|584299600|FG001|Overall Study|Protocol Violation|1|||
161796918|NCT00992407|584299599|FG000|Overall Study|Lost to Follow-up|3|||
161796919|NCT00992407|584299600|FG001|Overall Study|Lost to Follow-up|3|||
161796920|NCT00992407|584299599|FG000|Overall Study|Adverse Event|3|||
161796921|NCT00992407|584299600|FG001|Overall Study|Adverse Event|2|||
161796922|NCT00992407|584299599|FG000|Overall Study|protocol Violation & Adverse events|2|||
161796923|NCT00992407|584299600|FG001|Overall Study|protocol Violation & Adverse events|4|||
161796924|NCT00992407|584299599|FG000|Overall Study|Other|2|||
161796925|NCT00992407|584299600|FG001|Overall Study|Other|0|||
161796926|NCT00992407|584299599|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
161796927|NCT00992407|584299600|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
161796928|NCT00992407|584299599|FG000|Overall Study|Study medication not administered|17|||
161796929|NCT00992407|584299600|FG001|Overall Study|Study medication not administered|13|||
161796930|NCT03738332|584299601|FG000|Overall Study|Withdrawal by Subject|1|||
161796931|NCT01521559|584299602|FG000|Overall Study|Adverse Event|0|||
161796932|NCT01521559|584299603|FG001|Overall Study|Adverse Event|4|||
161796933|NCT01521559|584299602|FG000|Overall Study|Death|1|||
161796934|NCT01521559|584299603|FG001|Overall Study|Death|0|||
161796935|NCT01521559|584299602|FG000|Overall Study|Withdrawal by Subject|9|||
161796936|NCT01521559|584299603|FG001|Overall Study|Withdrawal by Subject|11|||
161796937|NCT01521559|584299602|FG000|Overall Study|Lost to Follow-up|3|||
161796938|NCT01521559|584299603|FG001|Overall Study|Lost to Follow-up|1|||
161796939|NCT01521559|584299602|FG000|Overall Study|Protocol Violation|1|||
161796940|NCT01521559|584299603|FG001|Overall Study|Protocol Violation|0|||
161796941|NCT01521559|584299602|FG000|Overall Study|Other|1|||
161796942|NCT01521559|584299603|FG001|Overall Study|Other|2|||
161796943|NCT02336737|584299604|FG000|Overall Study|Withdrawal by Subject|5|||
161796944|NCT02336737|584299604|FG000|Overall Study|Physician Decision|8|||
161796945|NCT00275002|584299606|FG000|Overall Study|Death|1|||
161796946|NCT00275002|584299607|FG001|Overall Study|Death|0|||
161796947|NCT00275002|584299606|FG000|Overall Study|Disease progression|21|||
161796948|NCT00275002|584299607|FG001|Overall Study|Disease progression|15|||
161796949|NCT00275002|584299606|FG000|Overall Study|Adverse Event|0|||
161796950|NCT00275002|584299607|FG001|Overall Study|Adverse Event|1|||
161796951|NCT04543136|584299621|FG000|Overall Study|Withdrawal by Subject|0|||
161796952|NCT04543136|584299622|FG001|Overall Study|Withdrawal by Subject|1|||
161796953|NCT04543136|584299623|FG002|Overall Study|Withdrawal by Subject|0|||
161796954|NCT04543136|584299624|FG003|Overall Study|Withdrawal by Subject|1|||
161796955|NCT04543136|584299625|FG004|Overall Study|Withdrawal by Subject|0|||
161796956|NCT04543136|584299626|FG005|Overall Study|Withdrawal by Subject|0|||
161796957|NCT00638157|584299631|FG000|Overall Study|Adverse Event|0|||
161796958|NCT00638157|584299632|FG001|Overall Study|Adverse Event|1|||
161796959|NCT00638157|584299631|FG000|Overall Study|Clinical (symptomatic) failure|1|||
161796960|NCT00638157|584299632|FG001|Overall Study|Clinical (symptomatic) failure|1|||
161796961|NCT00638157|584299631|FG000|Overall Study|Microbiological failure|1|||
161796962|NCT00638157|584299632|FG001|Overall Study|Microbiological failure|0|||
161796963|NCT00638157|584299631|FG000|Overall Study|Lost to Follow-up|1|||
161796964|NCT00638157|584299632|FG001|Overall Study|Lost to Follow-up|0|||
161796965|NCT00638157|584299631|FG000|Overall Study|Physician Decision|1|||
161796966|NCT00638157|584299632|FG001|Overall Study|Physician Decision|0|||
161796967|NCT00638157|584299631|FG000|Overall Study|Other|1|||
161796968|NCT00638157|584299632|FG001|Overall Study|Other|2|||
161796969|NCT00638157|584299631|FG000|Overall Study|Randomized, not treated|2|||
161796970|NCT00638157|584299632|FG001|Overall Study|Randomized, not treated|0|||
161796971|NCT02365597|584299633|FG000|Overall Study|Lost to Follow-up|0|||
161796972|NCT02365597|584299634|FG001|Overall Study|Lost to Follow-up|1|||
161796973|NCT02365597|584299635|FG002|Overall Study|Lost to Follow-up|0|||
161796974|NCT02365597|584299636|FG003|Overall Study|Lost to Follow-up|1|||
161796975|NCT02365597|584299633|FG000|Overall Study|Withdrawal by Subject|1|||
161796976|NCT02365597|584299634|FG001|Overall Study|Withdrawal by Subject|8|||
161796977|NCT02365597|584299635|FG002|Overall Study|Withdrawal by Subject|5|||
161796978|NCT02365597|584299636|FG003|Overall Study|Withdrawal by Subject|1|||
161796979|NCT02365597|584299633|FG000|Overall Study|Sponsor's decision|1|||
161796980|NCT02365597|584299634|FG001|Overall Study|Sponsor's decision|3|||
161796981|NCT02365597|584299635|FG002|Overall Study|Sponsor's decision|13|||
161796982|NCT02365597|584299636|FG003|Overall Study|Sponsor's decision|0|||
161796983|NCT02365597|584299633|FG000|Overall Study|Other|0|||
161796984|NCT02365597|584299634|FG001|Overall Study|Other|4|||
161796985|NCT02365597|584299635|FG002|Overall Study|Other|0|||
161796986|NCT02365597|584299636|FG003|Overall Study|Other|0|||
161796987|NCT02365597|584299633|FG000|Overall Study|Enrolled but not treated|0|||
161796988|NCT02365597|584299634|FG001|Overall Study|Enrolled but not treated|1|||
161901162|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901163|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161796989|NCT02365597|584299635|FG002|Overall Study|Enrolled but not treated|1|||
161796990|NCT02365597|584299636|FG003|Overall Study|Enrolled but not treated|0|||
161796991|NCT02365597|584299633|FG000|Overall Study|Ongoing|0|||
161796992|NCT02365597|584299634|FG001|Overall Study|Ongoing|0|||
161796993|NCT02365597|584299635|FG002|Overall Study|Ongoing|0|||
161796994|NCT02365597|584299636|FG003|Overall Study|Ongoing|17|||
161796995|NCT04309474|584299637|FG000|Overall Study|Randomized but not treated|0|||
161796996|NCT04309474|584299638|FG001|Overall Study|Randomized but not treated|2|||
161796997|NCT04309474|584299637|FG000|Overall Study|Adverse Event|4|||
161796998|NCT04309474|584299638|FG001|Overall Study|Adverse Event|1|||
161796999|NCT04309474|584299637|FG000|Overall Study|Withdrawal by Subject|6|||
161797000|NCT04309474|584299638|FG001|Overall Study|Withdrawal by Subject|9|||
161797001|NCT04309474|584299637|FG000|Overall Study|Lost to Follow-up|1|||
161797002|NCT04309474|584299638|FG001|Overall Study|Lost to Follow-up|2|||
161797003|NCT04309474|584299637|FG000|Overall Study|Not disclosed|10|||
161797004|NCT04309474|584299638|FG001|Overall Study|Not disclosed|6|||
161797005|NCT04670068|584299639|FG000|Overall Study|Progressive Disease|1|||
161797006|NCT04670068|584299640|FG001|Overall Study|Progressive Disease|1|||
161797007|NCT04670068|584299639|FG000|Overall Study|Withdrawal by Subject|1|||
161797008|NCT04670068|584299640|FG001|Overall Study|Withdrawal by Subject|0|||
161797009|NCT04684524|584299641|FG000|Overall Study|Other|2|||
161797010|NCT04684524|584299642|FG001|Overall Study|Other|0|||
161797011|NCT04684524|584299641|FG000|Overall Study|Withdrawal by Subject|5|||
161797012|NCT04684524|584299642|FG001|Overall Study|Withdrawal by Subject|3|||
161797013|NCT04684524|584299641|FG000|Overall Study|Adverse Event|1|||
161797014|NCT04684524|584299642|FG001|Overall Study|Adverse Event|1|||
161797015|NCT00601354|584299646|FG000|Overall Study|Lost to Follow-up|4|||
161797016|NCT00601354|584299647|FG001|Overall Study|Lost to Follow-up|5|||
161797017|NCT03466411|584299648|FG000|Overall Study|Lost to Follow-up|0|||
161797018|NCT03466411|584299649|FG001|Overall Study|Lost to Follow-up|1|||
161797019|NCT03466411|584299650|FG002|Overall Study|Lost to Follow-up|1|||
161797020|NCT03466411|584299651|FG003|Overall Study|Lost to Follow-up|0|||
161797021|NCT03466411|584299652|FG004|Overall Study|Lost to Follow-up|0|||
161797022|NCT03466411|584299653|FG005|Overall Study|Lost to Follow-up|0|||
161797023|NCT03466411|584299654|FG006|Overall Study|Lost to Follow-up|1|||
161797024|NCT03466411|584299655|FG007|Overall Study|Lost to Follow-up|1|||
161797025|NCT03466411|584299656|FG008|Overall Study|Lost to Follow-up|0|||
161797026|NCT03466411|584299657|FG009|Overall Study|Lost to Follow-up|1|||
161797027|NCT03466411|584299658|FG010|Overall Study|Lost to Follow-up|1|||
161797028|NCT03466411|584299659|FG011|Overall Study|Lost to Follow-up|1|||
161797029|NCT03466411|584299660|FG012|Overall Study|Lost to Follow-up|0|||
161797030|NCT03466411|584299648|FG000|Overall Study|Withdrawal by Subject|14|||
161797031|NCT03466411|584299649|FG001|Overall Study|Withdrawal by Subject|7|||
161797032|NCT03466411|584299650|FG002|Overall Study|Withdrawal by Subject|8|||
161797033|NCT03466411|584299651|FG003|Overall Study|Withdrawal by Subject|4|||
161797034|NCT03466411|584299652|FG004|Overall Study|Withdrawal by Subject|6|||
161797035|NCT03466411|584299653|FG005|Overall Study|Withdrawal by Subject|3|||
161797036|NCT03466411|584299654|FG006|Overall Study|Withdrawal by Subject|6|||
161797037|NCT03466411|584299655|FG007|Overall Study|Withdrawal by Subject|9|||
161797038|NCT03466411|584299656|FG008|Overall Study|Withdrawal by Subject|6|||
161797039|NCT03466411|584299657|FG009|Overall Study|Withdrawal by Subject|11|||
161797040|NCT03466411|584299658|FG010|Overall Study|Withdrawal by Subject|14|||
161797041|NCT03466411|584299659|FG011|Overall Study|Withdrawal by Subject|12|||
161797042|NCT03466411|584299660|FG012|Overall Study|Withdrawal by Subject|7|||
161797043|NCT03466411|584299648|FG000|Overall Study|Other|1|||
161797044|NCT03466411|584299649|FG001|Overall Study|Other|1|||
161797045|NCT03466411|584299650|FG002|Overall Study|Other|0|||
161797046|NCT03466411|584299651|FG003|Overall Study|Other|1|||
161797047|NCT03466411|584299652|FG004|Overall Study|Other|2|||
161797048|NCT03466411|584299653|FG005|Overall Study|Other|0|||
161797049|NCT03466411|584299654|FG006|Overall Study|Other|0|||
161901164|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161901165|NCT02326272|584685184|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901166|NCT02326272|584685185|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901167|NCT02326272|584685186|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161797050|NCT03466411|584299655|FG007|Overall Study|Other|0|||
161797051|NCT03466411|584299656|FG008|Overall Study|Other|0|||
161797052|NCT03466411|584299657|FG009|Overall Study|Other|1|||
161901168|NCT02326272|584685187|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901169|NCT02326272|584685188|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161797053|NCT03466411|584299658|FG010|Overall Study|Other|2|||
161797054|NCT03466411|584299659|FG011|Overall Study|Other|0|||
161797055|NCT03466411|584299660|FG012|Overall Study|Other|0|||
161901170|NCT02326272|584685189|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161797056|NCT03466411|584299648|FG000|Overall Study|Randomized but not Treated|0|||
161797057|NCT03466411|584299649|FG001|Overall Study|Randomized but not Treated|0|||
161797058|NCT03466411|584299650|FG002|Overall Study|Randomized but not Treated|0|||
161797059|NCT03466411|584299651|FG003|Overall Study|Randomized but not Treated|0|||
161797060|NCT03466411|584299652|FG004|Overall Study|Randomized but not Treated|0|||
161797061|NCT03466411|584299653|FG005|Overall Study|Randomized but not Treated|0|||
161797062|NCT03466411|584299654|FG006|Overall Study|Randomized but not Treated|1|||
161797063|NCT03466411|584299655|FG007|Overall Study|Randomized but not Treated|0|||
161797064|NCT03466411|584299656|FG008|Overall Study|Randomized but not Treated|0|||
161797065|NCT03466411|584299657|FG009|Overall Study|Randomized but not Treated|0|||
161797066|NCT03466411|584299658|FG010|Overall Study|Randomized but not Treated|0|||
161797067|NCT03466411|584299659|FG011|Overall Study|Randomized but not Treated|0|||
161797068|NCT03466411|584299660|FG012|Overall Study|Randomized but not Treated|0|||
161797069|NCT00319956|584299661|FG000|Overall Study|Death|20|||
161797070|NCT00319956|584299662|FG001|Overall Study|Death|24|||
161797071|NCT02607800|584299663|FG000|Overall Study|Lost to Follow-up|7|||
161797072|NCT02607800|584299664|FG001|Overall Study|Lost to Follow-up|10|||
161797073|NCT02607800|584299663|FG000|Overall Study|Withdrew Consent|2|||
161797074|NCT02607800|584299664|FG001|Overall Study|Withdrew Consent|0|||
161797075|NCT02607800|584299663|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
161797076|NCT02607800|584299664|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
161797077|NCT01185288|584299665|FG000|Overall Study|Adverse Event|7|||
161797078|NCT01185288|584299666|FG001|Overall Study|Adverse Event|6|||
161797079|NCT01185288|584299665|FG000|Overall Study|Withdrawal by Subject|6|||
161797080|NCT01185288|584299666|FG001|Overall Study|Withdrawal by Subject|4|||
161797081|NCT01185288|584299665|FG000|Overall Study|Lost to Follow-up|2|||
161797082|NCT01185288|584299666|FG001|Overall Study|Lost to Follow-up|5|||
161797083|NCT01185288|584299665|FG000|Overall Study|Lack of Efficacy|2|||
161797084|NCT01185288|584299666|FG001|Overall Study|Lack of Efficacy|0|||
161797085|NCT01185288|584299665|FG000|Overall Study|Investigator discretion|1|||
161797086|NCT01185288|584299666|FG001|Overall Study|Investigator discretion|0|||
161797087|NCT01185288|584299665|FG000|Overall Study|Did not meet inclusion criteria|1|||
161797088|NCT01185288|584299666|FG001|Overall Study|Did not meet inclusion criteria|0|||
161797089|NCT01185288|584299665|FG000|Overall Study|Noncompliance|0|||
161797090|NCT01185288|584299666|FG001|Overall Study|Noncompliance|1|||
161797091|NCT02974153|584299667|FG000|Overall Study|Adverse Event|6|||
161797092|NCT02974153|584299668|FG001|Overall Study|Adverse Event|0|||
161797093|NCT02974153|584299669|FG002|Overall Study|Adverse Event|1|||
161797094|NCT02974153|584299667|FG000|Overall Study|Lack of Efficacy|6|||
161797095|NCT02974153|584299668|FG001|Overall Study|Lack of Efficacy|5|||
161797096|NCT02974153|584299669|FG002|Overall Study|Lack of Efficacy|10|||
161797097|NCT02974153|584299667|FG000|Overall Study|Lost to Follow-up|9|||
161797098|NCT02974153|584299668|FG001|Overall Study|Lost to Follow-up|10|||
161797099|NCT02974153|584299669|FG002|Overall Study|Lost to Follow-up|17|||
161797100|NCT02974153|584299667|FG000|Overall Study|Physician Decision|0|||
161797101|NCT02974153|584299668|FG001|Overall Study|Physician Decision|2|||
161797102|NCT02974153|584299669|FG002|Overall Study|Physician Decision|1|||
161797103|NCT02974153|584299667|FG000|Overall Study|Withdrawal by Subject|9|||
161797104|NCT02974153|584299668|FG001|Overall Study|Withdrawal by Subject|16|||
161797105|NCT02974153|584299669|FG002|Overall Study|Withdrawal by Subject|11|||
161797106|NCT02974153|584299667|FG000|Overall Study|Study Burden|8|||
161797107|NCT02974153|584299668|FG001|Overall Study|Study Burden|7|||
161797108|NCT02974153|584299669|FG002|Overall Study|Study Burden|3|||
161797109|NCT02974153|584299667|FG000|Overall Study|Other|14|||
161797110|NCT02974153|584299668|FG001|Overall Study|Other|8|||
161797111|NCT02974153|584299669|FG002|Overall Study|Other|7|||
161797112|NCT01202747|584299670|FG000|Overall Study|Withdrawal by Subject|1|||
161797113|NCT01446913|584299671|FG000|Overall Study|Significant illness|1|||
161797114|NCT01446913|584299672|FG001|Overall Study|Significant illness|1|||
161797115|NCT01446913|584299673|FG002|Overall Study|Significant illness|1|||
161797116|NCT01446913|584299671|FG000|Overall Study|Withdrawal by Subject|5|||
161797117|NCT01446913|584299672|FG001|Overall Study|Withdrawal by Subject|3|||
161797118|NCT01446913|584299673|FG002|Overall Study|Withdrawal by Subject|5|||
161797119|NCT01446913|584299671|FG000|Overall Study|Physician Decision|0|||
161797120|NCT01446913|584299672|FG001|Overall Study|Physician Decision|0|||
161797121|NCT01446913|584299673|FG002|Overall Study|Physician Decision|2|||
161797122|NCT01446913|584299671|FG000|Overall Study|Lost to Follow-up|3|||
161797123|NCT01446913|584299672|FG001|Overall Study|Lost to Follow-up|5|||
161797124|NCT01446913|584299673|FG002|Overall Study|Lost to Follow-up|3|||
161797125|NCT02521948|584299674|FG000|Overall Study|Adverse Event|2|||
161797126|NCT02521948|584299674|FG000|Overall Study|Death|4|||
161797127|NCT02521948|584299674|FG000|Overall Study|Lost to Follow-up|1|||
161797128|NCT02521948|584299674|FG000|Overall Study|Did not attend one or both follow-ups|6|||
161797129|NCT04471428|584299677|FG000|Overall Study|Withdrawal by Subject|29|||
161797130|NCT04471428|584299678|FG001|Overall Study|Withdrawal by Subject|4|||
161797131|NCT04471428|584299677|FG000|Overall Study|Physician Decision|0|||
161797132|NCT04471428|584299678|FG001|Overall Study|Physician Decision|1|||
161797133|NCT04471428|584299677|FG000|Overall Study|Reason Not Specified|0|||
161797134|NCT04471428|584299678|FG001|Overall Study|Reason Not Specified|2|||
161797135|NCT04471428|584299677|FG000|Overall Study|Death|131|||
161797136|NCT04471428|584299678|FG001|Overall Study|Death|147|||
161797137|NCT04471428|584299677|FG000|Overall Study|Lost to Follow-up|0|||
161797138|NCT04471428|584299678|FG001|Overall Study|Lost to Follow-up|3|||
161797139|NCT04471428|584299677|FG000|Overall Study|Study Terminated by Sponsor|20|||
161797140|NCT04471428|584299678|FG001|Overall Study|Study Terminated by Sponsor|29|||
161797141|NCT03504852|584299679|FG000|Overall Study|Withdrawal of informed consent|2|||
161797142|NCT03504852|584299680|FG001|Overall Study|Withdrawal of informed consent|1|||
161797143|NCT03504852|584299681|FG002|Overall Study|Withdrawal of informed consent|0|||
161797144|NCT03504852|584299679|FG000|Overall Study|Withdrawal by Subject|5|||
161797145|NCT03504852|584299680|FG001|Overall Study|Withdrawal by Subject|5|||
161797146|NCT03504852|584299681|FG002|Overall Study|Withdrawal by Subject|1|||
161797147|NCT03504852|584299679|FG000|Overall Study|Lost to Follow-up|4|||
161797148|NCT03504852|584299680|FG001|Overall Study|Lost to Follow-up|1|||
161797149|NCT03504852|584299681|FG002|Overall Study|Lost to Follow-up|0|||
161797150|NCT03504852|584299679|FG000|Overall Study|New therapy for study indication|1|||
161797151|NCT03504852|584299680|FG001|Overall Study|New therapy for study indication|0|||
161797152|NCT03504852|584299681|FG002|Overall Study|New therapy for study indication|0|||
161797153|NCT03504852|584299679|FG000|Overall Study|Lack of Efficacy|1|||
161797154|NCT03504852|584299680|FG001|Overall Study|Lack of Efficacy|2|||
161797155|NCT03504852|584299681|FG002|Overall Study|Lack of Efficacy|0|||
161797156|NCT03504852|584299679|FG000|Overall Study|Death|0|||
161797157|NCT03504852|584299680|FG001|Overall Study|Death|1|||
161797158|NCT03504852|584299681|FG002|Overall Study|Death|0|||
161797159|NCT03504852|584299679|FG000|Overall Study|Adverse Event|4|||
161797160|NCT03504852|584299680|FG001|Overall Study|Adverse Event|8|||
161797161|NCT03504852|584299681|FG002|Overall Study|Adverse Event|2|||
161797162|NCT03290079|584299682|FG000|Overall Study|Death|2|||
161797163|NCT00969332|584299683|FG000|Overall Study|Physician Decision|8|||
161797164|NCT00969332|584299683|FG000|Overall Study|Withdrawal by Subject|3|||
161797165|NCT03828461|584299684|FG000|Overall Study|Lost to Follow-up|1|||
161797166|NCT03828461|584299684|FG000|Overall Study|Withdrawal by Subject|3|||
161797167|NCT00576199|584299685|FG000|Overall Study|Adverse Event|12|||
161797168|NCT00576199|584299685|FG000|Overall Study|Insufficient Therapeutic Response|14|||
161797169|NCT00576199|584299685|FG000|Overall Study|Refused Treatment|2|||
161797170|NCT00576199|584299685|FG000|Overall Study|Reason Unspecified|2|||
161797171|NCT00663871|584299687|FG000|Overall Study|Lost to Follow-up|5|||
161797172|NCT00663871|584299688|FG001|Overall Study|Lost to Follow-up|5|||
161797173|NCT00663871|584299687|FG000|Overall Study|Withdrawal by Subject|5|||
161797174|NCT00663871|584299688|FG001|Overall Study|Withdrawal by Subject|2|||
161797175|NCT00582309|584299689|FG000|Overall Study|Protocol Violation|0|||
161797176|NCT00582309|584299690|FG001|Overall Study|Protocol Violation|0|||
161797177|NCT00582309|584299691|FG002|Overall Study|Protocol Violation|2|||
161797178|NCT03095352|584299695|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
161797179|NCT03095352|584299696|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
161797180|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
161797181|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
161797182|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
161797183|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
161797184|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
161797185|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
161797186|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
161797187|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
161797188|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
161797189|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
161797190|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
161797191|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
161797192|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
161797193|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
161797194|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
161797195|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
161797196|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
161901171|NCT02326272|584685190|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161797197|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
161797198|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
161797199|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
161797200|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
161797201|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
161797202|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
161797203|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
161797204|NCT00455533|584299697|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
161797205|NCT00455533|584299698|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
161797206|NCT00455533|584299699|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
161797207|NCT00455533|584299697|FG000|Period Two: Randomized Period|Death|0|||
161797208|NCT00455533|584299698|FG001|Period Two: Randomized Period|Death|0|||
161797209|NCT00455533|584299699|FG002|Period Two: Randomized Period|Death|3|||
161797210|NCT00455533|584299697|FG000|Period Two: Randomized Period|Disease Progression|0|||
161797211|NCT00455533|584299698|FG001|Period Two: Randomized Period|Disease Progression|1|||
161797212|NCT00455533|584299699|FG002|Period Two: Randomized Period|Disease Progression|1|||
161797213|NCT00455533|584299697|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
161797214|NCT00455533|584299698|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
161797215|NCT00455533|584299699|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
161797216|NCT00455533|584299697|FG000|Period Two: Randomized Period|Other - need reasons|0|||
161797217|NCT00455533|584299698|FG001|Period Two: Randomized Period|Other - need reasons|1|||
161797218|NCT00455533|584299699|FG002|Period Two: Randomized Period|Other - need reasons|0|||
161797219|NCT00455533|584299697|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
161797220|NCT00455533|584299698|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
161797221|NCT00455533|584299699|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
161797222|NCT00455533|584299697|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
161797223|NCT00455533|584299698|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
161797224|NCT00455533|584299699|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
161797225|NCT02415959|584299700|FG000|Overall Study|Adverse Event|0|||
161797226|NCT02415959|584299701|FG001|Overall Study|Adverse Event|1|||
161797227|NCT02415959|584299702|FG002|Overall Study|Adverse Event|0|||
161797228|NCT02415959|584299703|FG003|Overall Study|Adverse Event|0|||
161797229|NCT02415959|584299704|FG004|Overall Study|Adverse Event|0|||
161797230|NCT02415959|584299700|FG000|Overall Study|Protocol Violation|0|||
161797231|NCT02415959|584299701|FG001|Overall Study|Protocol Violation|0|||
161797232|NCT02415959|584299702|FG002|Overall Study|Protocol Violation|0|||
161797233|NCT02415959|584299703|FG003|Overall Study|Protocol Violation|1|||
161797234|NCT02415959|584299704|FG004|Overall Study|Protocol Violation|0|||
161797235|NCT01497938|584299706|FG000|Overall Study|Adverse Event|0|||
161797236|NCT01497938|584299707|FG001|Overall Study|Adverse Event|1|||
161797237|NCT01497938|584299706|FG000|Overall Study|Physician Decision|0|||
161797238|NCT01497938|584299707|FG001|Overall Study|Physician Decision|1|||
161797239|NCT01497938|584299706|FG000|Overall Study|Withdrawal by Subject|4|||
161797240|NCT01497938|584299707|FG001|Overall Study|Withdrawal by Subject|0|||
161797241|NCT01497938|584299706|FG000|Overall Study|Device Violation|1|||
161797242|NCT01497938|584299707|FG001|Overall Study|Device Violation|0|||
161797243|NCT03708211|584299708|FG000|Overall Study|Progressive Disease|10|||
161797244|NCT03708211|584299709|FG001|Overall Study|Progressive Disease|7|||
161797245|NCT03708211|584299708|FG000|Overall Study|Withdrawal by Subject|0|||
161797246|NCT03708211|584299709|FG001|Overall Study|Withdrawal by Subject|1|||
161797247|NCT03708211|584299708|FG000|Overall Study|Other|2|||
161797248|NCT03708211|584299709|FG001|Overall Study|Other|0|||
161797249|NCT00365352|584299710|FG000|Overall Study|Adverse Event|6|||
161797250|NCT00365352|584299711|FG001|Overall Study|Adverse Event|7|||
161797251|NCT00365352|584299712|FG002|Overall Study|Adverse Event|8|||
161797252|NCT00365352|584299710|FG000|Overall Study|Participant Withdrew Consent|8|||
161797253|NCT00365352|584299711|FG001|Overall Study|Participant Withdrew Consent|3|||
161797254|NCT00365352|584299712|FG002|Overall Study|Participant Withdrew Consent|4|||
161797255|NCT00365352|584299710|FG000|Overall Study|Lack of Efficacy|3|||
161797256|NCT00365352|584299711|FG001|Overall Study|Lack of Efficacy|0|||
161797257|NCT00365352|584299712|FG002|Overall Study|Lack of Efficacy|0|||
162137538|NCT03441984|585553495|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161797258|NCT00365352|584299710|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
161797259|NCT00365352|584299711|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
161797260|NCT00365352|584299712|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
161797261|NCT00365352|584299710|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
161797262|NCT00365352|584299711|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
161797263|NCT00365352|584299712|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
161797264|NCT00365352|584299710|FG000|Overall Study|Lost to Follow-up|1|||
161797265|NCT00365352|584299711|FG001|Overall Study|Lost to Follow-up|1|||
161797266|NCT00365352|584299712|FG002|Overall Study|Lost to Follow-up|0|||
162137539|NCT03441984|585553496|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161797267|NCT00365352|584299710|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
161797268|NCT00365352|584299711|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
161797269|NCT00365352|584299712|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
161797270|NCT05328375|584301046|FG000|Overall Study|Withdrawal by Subject|0|||
161797271|NCT05328375|584301047|FG001|Overall Study|Withdrawal by Subject|1|||
161797272|NCT05514119|584301052|FG000|Overall Study|Ineligible due to disease progression|1|||
161797273|NCT02946385|584301053|FG000|Overall Study|Lost to Follow-up|0|||
161797274|NCT02946385|584301054|FG001|Overall Study|Lost to Follow-up|0|||
161797275|NCT02946385|584301055|FG002|Overall Study|Lost to Follow-up|3|||
161797276|NCT02946385|584301056|FG003|Overall Study|Lost to Follow-up|0|||
161797277|NCT02946385|584301057|FG004|Overall Study|Lost to Follow-up|2|||
161797278|NCT02946385|584301058|FG005|Overall Study|Lost to Follow-up|1|||
161797279|NCT04849988|584301059|FG000|Overall Study|Lack of Efficacy|3|||
161797280|NCT04849988|584301060|FG001|Overall Study|Lack of Efficacy|4|||
161797281|NCT04849988|584301061|FG002|Overall Study|Lack of Efficacy|1|||
161797282|NCT04849988|584301062|FG003|Overall Study|Lack of Efficacy|4|||
161797283|NCT04849988|584301059|FG000|Overall Study|Other reasons|1|||
161797284|NCT04849988|584301060|FG001|Overall Study|Other reasons|2|||
161797285|NCT04849988|584301061|FG002|Overall Study|Other reasons|2|||
161797286|NCT04849988|584301062|FG003|Overall Study|Other reasons|1|||
161797287|NCT01402908|584301067|FG000|Overall Study|Withdrawal by Subject|30|||
161797288|NCT01402908|584301068|FG001|Overall Study|Withdrawal by Subject|17|||
161797289|NCT01402908|584301067|FG000|Overall Study|Lost to Follow-up|3|||
161797290|NCT01402908|584301068|FG001|Overall Study|Lost to Follow-up|1|||
161797291|NCT01402908|584301067|FG000|Overall Study|Physician Decision|1|||
161797292|NCT01402908|584301068|FG001|Overall Study|Physician Decision|0|||
161797293|NCT01739790|584301069|FG000|Overall Study|Early Trial Termination|2|||
161797294|NCT01739790|584301070|FG001|Overall Study|Early Trial Termination|4|||
161797295|NCT01893905|584301071|FG000|Overall Study|Withdrawal by Subject|1|||
161797296|NCT01893905|584301072|FG001|Overall Study|Withdrawal by Subject|0|||
161797297|NCT01893905|584301071|FG000|Overall Study|Adverse Event|9|||
161797298|NCT01893905|584301072|FG001|Overall Study|Adverse Event|3|||
161797299|NCT01893905|584301071|FG000|Overall Study|Lack of Efficacy|5|||
161797300|NCT01893905|584301072|FG001|Overall Study|Lack of Efficacy|7|||
161797301|NCT01893905|584301071|FG000|Overall Study|Lost to Follow-up|1|||
161797302|NCT01893905|584301072|FG001|Overall Study|Lost to Follow-up|0|||
161797303|NCT01893905|584301071|FG000|Overall Study|Protocol Violation|6|||
161797304|NCT01893905|584301072|FG001|Overall Study|Protocol Violation|1|||
161797305|NCT01893905|584301071|FG000|Overall Study|Lack of adherence to treatment|2|||
161797306|NCT01893905|584301072|FG001|Overall Study|Lack of adherence to treatment|0|||
161797307|NCT01893905|584301071|FG000|Overall Study|Other reason|1|||
161797308|NCT01893905|584301072|FG001|Overall Study|Other reason|3|||
161797309|NCT00278200|584301074|FG000|Overall Study|Death|1|||
161797310|NCT00278200|584301075|FG001|Overall Study|Death|3|||
161797311|NCT00278200|584301074|FG000|Overall Study|Physician Decision|0|||
161797312|NCT00278200|584301075|FG001|Overall Study|Physician Decision|1|||
161797313|NCT02688400|584301081|FG000|Overall Study|Protocol Violation|2|||
161797314|NCT02688400|584301082|FG001|Overall Study|Protocol Violation|5|||
161797315|NCT02688400|584301081|FG000|Overall Study|Lack of Efficacy|7|||
161797316|NCT02688400|584301082|FG001|Overall Study|Lack of Efficacy|7|||
161797317|NCT02688400|584301081|FG000|Overall Study|Adverse Event|21|||
161797318|NCT02688400|584301082|FG001|Overall Study|Adverse Event|12|||
161797319|NCT02688400|584301081|FG000|Overall Study|Withdrawal by Subject|15|||
161797320|NCT02688400|584301082|FG001|Overall Study|Withdrawal by Subject|13|||
161797321|NCT02688400|584301081|FG000|Overall Study|No study medication intake|1|||
161797322|NCT02688400|584301082|FG001|Overall Study|No study medication intake|4|||
161797323|NCT02688400|584301081|FG000|Overall Study|Lost to Follow-up|0|||
161797324|NCT02688400|584301082|FG001|Overall Study|Lost to Follow-up|3|||
161797325|NCT05568225|584301087|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
162010852|NCT00870740|585096034|FG005|Overall Study|Consent Withdrawn|5|||
161901172|NCT02326272|584685191|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901173|NCT02326272|584685192|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901174|NCT02326272|584685193|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901175|NCT02326272|584685194|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901176|NCT02326272|584685195|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901177|NCT02326272|584685196|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
161901178|NCT02326272|584685197|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901179|NCT02326272|584685198|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161901180|NCT01348139|584685204|FG000|Period 1|Adverse Event|1|||
161901181|NCT01348139|584685205|FG001|Period 1|Adverse Event|0|||
161901182|NCT01348139|584685206|FG002|Period 1|Adverse Event|0|||
161901183|NCT01348139|584685207|FG003|Period 1|Adverse Event|0|||
161901184|NCT01348139|584685208|FG004|Period 1|Adverse Event|0|||
161901185|NCT01348139|584685209|FG005|Period 1|Adverse Event|0|||
161901186|NCT02254772|584685210|FG000|Overall Study|Ineligible|1|||
161901187|NCT02254772|584685210|FG000|Overall Study|Withdrawal by Subject|1|||
161901188|NCT00928434|584685211|FG000|Overall Study|Adverse Event|14|||
161901189|NCT00928434|584685212|FG001|Overall Study|Adverse Event|5|||
161901190|NCT00928434|584685213|FG002|Overall Study|Adverse Event|18|||
161901191|NCT00928434|584685211|FG000|Overall Study|Protocol Violation|5|||
161901192|NCT00928434|584685212|FG001|Overall Study|Protocol Violation|0|||
161901193|NCT00928434|584685213|FG002|Overall Study|Protocol Violation|8|||
161901194|NCT00928434|584685211|FG000|Overall Study|Physician Decision|2|||
161901195|NCT00928434|584685212|FG001|Overall Study|Physician Decision|0|||
161901196|NCT00928434|584685213|FG002|Overall Study|Physician Decision|3|||
161901197|NCT00928434|584685211|FG000|Overall Study|Lost to Follow-up|1|||
161901198|NCT00928434|584685212|FG001|Overall Study|Lost to Follow-up|0|||
161901199|NCT00928434|584685213|FG002|Overall Study|Lost to Follow-up|3|||
161901200|NCT00928434|584685211|FG000|Overall Study|Withdrawal by Subject|5|||
161901201|NCT00928434|584685212|FG001|Overall Study|Withdrawal by Subject|3|||
161901202|NCT00928434|584685213|FG002|Overall Study|Withdrawal by Subject|2|||
161901203|NCT00928434|584685211|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
161901204|NCT00928434|584685212|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
161901205|NCT00928434|584685213|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
161901206|NCT00928434|584685211|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
161901207|NCT00928434|584685212|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
161901208|NCT00928434|584685213|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
161901209|NCT00928434|584685211|FG000|Overall Study|Other (not meeting above criteria)|5|||
161901210|NCT00928434|584685212|FG001|Overall Study|Other (not meeting above criteria)|1|||
161901211|NCT00928434|584685213|FG002|Overall Study|Other (not meeting above criteria)|2|||
161901212|NCT03006562|584685214|FG000|Overall Study|Lost to Follow-up|0|||
161901213|NCT03006562|584685215|FG001|Overall Study|Lost to Follow-up|1|||
161901214|NCT00716456|584685220|FG000|Overall Study|Adverse Event|0|||
161901215|NCT00716456|584685221|FG001|Overall Study|Adverse Event|2|||
161901216|NCT00716456|584685222|FG002|Overall Study|Adverse Event|0|||
161901217|NCT00447772|584685223|FG000|Overall Study|Lack of Efficacy|3|||
161901218|NCT00447772|584685223|FG000|Overall Study|Insufficient compliance|6|||
161901219|NCT00447772|584685223|FG000|Overall Study|Discontinuation of drug therapy|1|||
161901220|NCT00447772|584685223|FG000|Overall Study|Lost to Follow-up|9|||
161901221|NCT00447772|584685223|FG000|Overall Study|Withdrawal by Subject|1|||
161901222|NCT00447772|584685223|FG000|Overall Study|Unable to attend all study visits|2|||
161901223|NCT00447772|584685223|FG000|Overall Study|Adverse Event|1|||
161901224|NCT00447772|584685223|FG000|Overall Study|Patient relocated|1|||
161901225|NCT00447772|584685223|FG000|Overall Study|Incomplete documentation at visit 1|1|||
161901226|NCT00447772|584685223|FG000|Overall Study|Chemotherapy for lung cancer|1|||
161901227|NCT00447772|584685223|FG000|Overall Study|Premature re-injection required|1|||
161901228|NCT02427841|584685228|FG000|Overall Study|Lack of Efficacy|5|||
161901229|NCT02427841|584685228|FG000|Overall Study|Physician Decision|2|||
161901230|NCT02427841|584685228|FG000|Overall Study|Withdrawal by Subject|1|||
161901231|NCT01765296|584685229|FG000|Overall Study|Protocol Violation|0|||
162010853|NCT00870740|585096029|FG000|Overall Study|Investigator Decision|2|||
162010854|NCT00870740|585096030|FG001|Overall Study|Investigator Decision|0|||
161901232|NCT01765296|584685230|FG001|Overall Study|Protocol Violation|5|||
161901233|NCT01765296|584685231|FG002|Overall Study|Protocol Violation|4|||
161901234|NCT01765296|584685229|FG000|Overall Study|Withdrawal by Subject|4|||
161901235|NCT01765296|584685230|FG001|Overall Study|Withdrawal by Subject|2|||
161901236|NCT01765296|584685231|FG002|Overall Study|Withdrawal by Subject|2|||
161901237|NCT01765296|584685229|FG000|Overall Study|Adverse Event|1|||
161901238|NCT01765296|584685230|FG001|Overall Study|Adverse Event|13|||
161901239|NCT01765296|584685231|FG002|Overall Study|Adverse Event|5|||
161901240|NCT01765296|584685229|FG000|Overall Study|Lack of Efficacy|0|||
161901241|NCT01765296|584685230|FG001|Overall Study|Lack of Efficacy|0|||
161901242|NCT01765296|584685231|FG002|Overall Study|Lack of Efficacy|2|||
161901243|NCT03257436|584685232|FG000|Overall Study|Withdrawal by Subject|76|||
161901244|NCT03257436|584685232|FG000|Overall Study|Death|19|||
161901245|NCT01619852|584685233|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
161901246|NCT01619852|584685234|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
161901247|NCT01619852|584685233|FG000|3 Month Follow up|Lost to Follow-up|31|||
161901248|NCT01619852|584685234|FG001|3 Month Follow up|Lost to Follow-up|34|||
161901249|NCT00970489|584685235|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
161901250|NCT00970489|584685236|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
161901251|NCT03489343|584685240|FG000|Overall Study|Documented progressive disease|1|||
161901252|NCT03489343|584685241|FG001|Overall Study|Documented progressive disease|0|||
161901253|NCT03489343|584685242|FG002|Overall Study|Documented progressive disease|3|||
161901254|NCT03489343|584685243|FG003|Overall Study|Documented progressive disease|1|||
161901255|NCT03489343|584685244|FG004|Overall Study|Documented progressive disease|3|||
161901256|NCT03489343|584685245|FG005|Overall Study|Documented progressive disease|5|||
161901257|NCT03489343|584685246|FG006|Overall Study|Documented progressive disease|4|||
161901258|NCT03489343|584685240|FG000|Overall Study|Adverse Event|0|||
161901259|NCT03489343|584685241|FG001|Overall Study|Adverse Event|1|||
161901260|NCT03489343|584685242|FG002|Overall Study|Adverse Event|0|||
161901261|NCT03489343|584685243|FG003|Overall Study|Adverse Event|0|||
161901262|NCT03489343|584685244|FG004|Overall Study|Adverse Event|0|||
161901263|NCT03489343|584685245|FG005|Overall Study|Adverse Event|1|||
161901264|NCT03489343|584685246|FG006|Overall Study|Adverse Event|0|||
161901265|NCT03489343|584685240|FG000|Overall Study|Withdrawal by Subject|0|||
161901266|NCT03489343|584685241|FG001|Overall Study|Withdrawal by Subject|0|||
161901267|NCT03489343|584685242|FG002|Overall Study|Withdrawal by Subject|0|||
161901268|NCT03489343|584685243|FG003|Overall Study|Withdrawal by Subject|1|||
161901269|NCT03489343|584685244|FG004|Overall Study|Withdrawal by Subject|0|||
161901270|NCT03489343|584685245|FG005|Overall Study|Withdrawal by Subject|1|||
161901271|NCT03489343|584685246|FG006|Overall Study|Withdrawal by Subject|1|||
161901272|NCT03489343|584685240|FG000|Overall Study|Clinical progression|0|||
161901273|NCT03489343|584685241|FG001|Overall Study|Clinical progression|0|||
161901274|NCT03489343|584685242|FG002|Overall Study|Clinical progression|0|||
161901275|NCT03489343|584685243|FG003|Overall Study|Clinical progression|1|||
161901276|NCT03489343|584685244|FG004|Overall Study|Clinical progression|0|||
161901277|NCT03489343|584685245|FG005|Overall Study|Clinical progression|0|||
161797326|NCT05568225|584301088|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
161797327|NCT05568225|584301089|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
161797328|NCT05568225|584301087|FG000|Primary Treatment Period|Physician Decision|0|||
161797329|NCT05568225|584301088|FG001|Primary Treatment Period|Physician Decision|1|||
161797330|NCT05568225|584301089|FG002|Primary Treatment Period|Physician Decision|0|||
161797331|NCT05568225|584301087|FG000|Primary Treatment Period|Disease progression|0|||
161797332|NCT05568225|584301088|FG001|Primary Treatment Period|Disease progression|1|||
161797333|NCT05568225|584301089|FG002|Primary Treatment Period|Disease progression|0|||
161797334|NCT05568225|584301087|FG000|Primary Treatment Period|Lack of Efficacy|0|||
161797335|NCT05568225|584301088|FG001|Primary Treatment Period|Lack of Efficacy|1|||
161797336|NCT05568225|584301089|FG002|Primary Treatment Period|Lack of Efficacy|0|||
161797337|NCT05568225|584301087|FG000|Primary Treatment Period|Withdrawal of conset|1|||
161797338|NCT05568225|584301088|FG001|Primary Treatment Period|Withdrawal of conset|0|||
161797339|NCT05568225|584301089|FG002|Primary Treatment Period|Withdrawal of conset|4|||
161797340|NCT05568225|584301087|FG000|Primary Treatment Period|Adverse Event|1|||
161797341|NCT05568225|584301088|FG001|Primary Treatment Period|Adverse Event|0|||
161797342|NCT05568225|584301089|FG002|Primary Treatment Period|Adverse Event|0|||
161797343|NCT05568225|584301087|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
161797344|NCT05568225|584301088|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
161797345|NCT05568225|584301089|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
161797346|NCT05568225|584301087|FG000|Extension Treatment Period|Protocol Violation|0|||
161797347|NCT05568225|584301088|FG001|Extension Treatment Period|Protocol Violation|0|||
161797348|NCT05568225|584301089|FG002|Extension Treatment Period|Protocol Violation|1|||
161797349|NCT05568225|584301087|FG000|Extension Treatment Period|Lack of Efficacy|0|||
161797350|NCT05568225|584301088|FG001|Extension Treatment Period|Lack of Efficacy|0|||
161797351|NCT05568225|584301089|FG002|Extension Treatment Period|Lack of Efficacy|1|||
161797352|NCT01027143|584301092|FG000|Overall Study|Lost to Follow-up|9|||
161797353|NCT01027143|584301093|FG001|Overall Study|Lost to Follow-up|4|||
161797354|NCT03519256|584301102|FG000|Overall Study|Disease recurrence|4|||
161797355|NCT03519256|584301103|FG001|Overall Study|Disease recurrence|4|||
161797356|NCT03519256|584301104|FG002|Overall Study|Disease recurrence|5|||
161797357|NCT03519256|584301105|FG003|Overall Study|Disease recurrence|2|||
161797358|NCT03519256|584301102|FG000|Overall Study|Study drug toxicity|0|||
161797359|NCT03519256|584301103|FG001|Overall Study|Study drug toxicity|2|||
161797360|NCT03519256|584301104|FG002|Overall Study|Study drug toxicity|5|||
161901278|NCT03489343|584685246|FG006|Overall Study|Clinical progression|1|||
161901279|NCT00327717|584685247|FG000|Overall Study|Adverse Event|6|||
161901280|NCT00327717|584685248|FG001|Overall Study|Adverse Event|6|||
161901281|NCT00327717|584685247|FG000|Overall Study|Lack of Efficacy|0|||
161901282|NCT00327717|584685248|FG001|Overall Study|Lack of Efficacy|1|||
161901283|NCT00327717|584685247|FG000|Overall Study|Withdrawal by Subject|3|||
161797361|NCT03519256|584301105|FG003|Overall Study|Study drug toxicity|2|||
161797362|NCT03519256|584301102|FG000|Overall Study|Adverse event unrelated to study drug|0|||
161797363|NCT03519256|584301103|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161797364|NCT03519256|584301104|FG002|Overall Study|Adverse event unrelated to study drug|1|||
161797365|NCT03519256|584301105|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161797366|NCT03519256|584301102|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161797367|NCT03519256|584301103|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161797368|NCT03519256|584301104|FG002|Overall Study|Participant request to discontinue study treatment|0|||
161797369|NCT03519256|584301105|FG003|Overall Study|Participant request to discontinue study treatment|2|||
161797370|NCT03519256|584301102|FG000|Overall Study|Other reasons|0|||
161797371|NCT03519256|584301103|FG001|Overall Study|Other reasons|0|||
161797372|NCT03519256|584301104|FG002|Overall Study|Other reasons|2|||
161797373|NCT03519256|584301105|FG003|Overall Study|Other reasons|0|||
161797374|NCT03519256|584301102|FG000|Overall Study|Disease progression|6|||
161797375|NCT03519256|584301103|FG001|Overall Study|Disease progression|3|||
161797376|NCT03519256|584301104|FG002|Overall Study|Disease progression|2|||
161797377|NCT03519256|584301105|FG003|Overall Study|Disease progression|1|||
161797378|NCT03519256|584301102|FG000|Overall Study|Lost to Follow-up|0|||
161797379|NCT03519256|584301103|FG001|Overall Study|Lost to Follow-up|1|||
161797380|NCT03519256|584301104|FG002|Overall Study|Lost to Follow-up|0|||
161797381|NCT03519256|584301105|FG003|Overall Study|Lost to Follow-up|0|||
161797382|NCT02207231|584301106|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
161797383|NCT02207231|584301107|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
161797384|NCT02207231|584301108|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
161797385|NCT02207231|584301109|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
161797386|NCT02207231|584301106|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
161797387|NCT02207231|584301107|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
161797388|NCT02207231|584301108|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
161797389|NCT02207231|584301109|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
161797390|NCT02207231|584301106|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
161797391|NCT02207231|584301107|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
161797392|NCT02207231|584301108|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
161797393|NCT02207231|584301109|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
161797394|NCT02207231|584301106|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
161797395|NCT02207231|584301107|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
161797396|NCT02207231|584301108|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
161797397|NCT02207231|584301109|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
161797398|NCT02207231|584301106|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
161797399|NCT02207231|584301107|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
161797400|NCT02207231|584301108|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
161797401|NCT02207231|584301109|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
161797402|NCT02207231|584301106|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
161797403|NCT02207231|584301107|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
161797404|NCT02207231|584301108|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
161797405|NCT02207231|584301109|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
161797406|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
161797407|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
161797408|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
161797409|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
161797410|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
161797411|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
161797412|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
161797413|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
161797414|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
161797415|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
161797416|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
161797417|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
161797418|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
161797419|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
161797420|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
161797421|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
161797422|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
162137540|NCT03441984|585553497|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162137541|NCT03441984|585553498|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162137542|NCT03441984|585553499|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162137543|NCT03441984|585553500|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162137544|NCT03441984|585553501|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
161797423|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
161797424|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
161797425|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
161797426|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
161797427|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
161797428|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
161797429|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
161797430|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
161797431|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
161797432|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
161797433|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
161797434|NCT02207231|584301106|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
161797435|NCT02207231|584301107|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
161797436|NCT02207231|584301108|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
161797437|NCT02207231|584301109|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
161797438|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
161797439|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
161797440|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
161797441|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
161797442|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
161797443|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
161797444|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
161797445|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
161797446|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
161797447|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
161797448|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
161797449|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
161797450|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
161797451|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
161797452|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
161797453|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
161797454|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
161797455|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
161797456|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
161797457|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
161797458|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
161797459|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
161797460|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
161797461|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
161797462|NCT02207231|584301106|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
162137545|NCT03441984|585553502|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
162137546|NCT00631917|585553503|FG000|Overall Study|Adverse Event|34|||
162137547|NCT00631917|585553504|FG001|Overall Study|Adverse Event|45|||
162137548|NCT00631917|585553503|FG000|Overall Study|Abnormal laboratory value(s)|2|||
162137549|NCT00631917|585553504|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161797463|NCT02207231|584301107|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
161797464|NCT02207231|584301108|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
161797465|NCT02207231|584301109|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
161797466|NCT00421174|584301110|FG000|Overall Study|Withdrawal by Subject|0|||
161797467|NCT00421174|584301111|FG001|Overall Study|Withdrawal by Subject|1|||
161797468|NCT00421174|584301110|FG000|Overall Study|Ineligible due to infection|2|||
161797469|NCT00421174|584301111|FG001|Overall Study|Ineligible due to infection|0|||
161797470|NCT01290263|584301114|FG000|Overall Study|Adverse Event|0|||
161797471|NCT01290263|584301115|FG001|Overall Study|Adverse Event|0|||
162137550|NCT00631917|585553503|FG000|Overall Study|Abnormal test procedure result(s)|3|||
162137551|NCT00631917|585553504|FG001|Overall Study|Abnormal test procedure result(s)|2|||
162137552|NCT00631917|585553503|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
162137553|NCT00631917|585553504|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
162137554|NCT00631917|585553503|FG000|Overall Study|No longer required study drug|0|||
162137555|NCT00631917|585553504|FG001|Overall Study|No longer required study drug|1|||
162137556|NCT00631917|585553503|FG000|Overall Study|Protocol deviation|6|||
162137557|NCT00631917|585553504|FG001|Overall Study|Protocol deviation|5|||
162137558|NCT00631917|585553503|FG000|Overall Study|Subject withdrew consent|25|||
162137559|NCT00631917|585553504|FG001|Overall Study|Subject withdrew consent|33|||
162137560|NCT00631917|585553503|FG000|Overall Study|Lost to Follow-up|7|||
162137561|NCT00631917|585553504|FG001|Overall Study|Lost to Follow-up|7|||
161797472|NCT01290263|584301116|FG002|Overall Study|Adverse Event|0|||
161797473|NCT01290263|584301117|FG003|Overall Study|Adverse Event|1|||
162137562|NCT00631917|585553503|FG000|Overall Study|Administrative problems|2|||
161797474|NCT01290263|584301118|FG004|Overall Study|Adverse Event|1|||
161797475|NCT01290263|584301114|FG000|Overall Study|Lack of Efficacy|8|||
161797476|NCT01290263|584301115|FG001|Overall Study|Lack of Efficacy|2|||
161797477|NCT01290263|584301116|FG002|Overall Study|Lack of Efficacy|7|||
161797478|NCT01290263|584301117|FG003|Overall Study|Lack of Efficacy|24|||
161797479|NCT01290263|584301118|FG004|Overall Study|Lack of Efficacy|33|||
161901284|NCT00327717|584685248|FG001|Overall Study|Withdrawal by Subject|7|||
161901285|NCT01630135|584685250|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
161901286|NCT01630135|584685251|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
161901287|NCT02658669|584685253|FG000|Overall Study|Lost to Follow-up|7|||
161901288|NCT02658669|584685254|FG001|Overall Study|Lost to Follow-up|5|||
161901289|NCT00838097|584685263|FG000|Overall Study|Ineligibility determined|6|||
161901290|NCT00838097|584685263|FG000|Overall Study|Adverse Event|2|||
161901291|NCT00838097|584685263|FG000|Overall Study|Withdrawal by Subject|3|||
161901292|NCT00838097|584685263|FG000|Overall Study|Requirement for alternative therapy|2|||
161901293|NCT00838097|584685263|FG000|Overall Study|Physician Decision|4|||
161901294|NCT00838097|584685263|FG000|Overall Study|Lost to Follow-up|11|||
161901295|NCT00838097|584685263|FG000|Overall Study|Death|6|||
161901296|NCT00838097|584685263|FG000|Overall Study|Protocol-specified criteria|142|||
161901297|NCT03311841|584685264|FG000|14-day Wash-out|Adverse Event|0|||
161901298|NCT03311841|584685265|FG001|14-day Wash-out|Adverse Event|1|||
161901299|NCT03311841|584685266|FG002|14-day Wash-out|Adverse Event|0|||
161901300|NCT03311841|584685267|FG003|14-day Wash-out|Adverse Event|0|||
161797480|NCT01290263|584301114|FG000|Overall Study|Withdrawal by Subject|3|||
161797481|NCT01290263|584301115|FG001|Overall Study|Withdrawal by Subject|1|||
161797482|NCT01290263|584301116|FG002|Overall Study|Withdrawal by Subject|0|||
161797483|NCT01290263|584301117|FG003|Overall Study|Withdrawal by Subject|1|||
161797484|NCT01290263|584301118|FG004|Overall Study|Withdrawal by Subject|2|||
161797485|NCT01290263|584301114|FG000|Overall Study|Participant Non-Compliance|0|||
161797486|NCT01290263|584301115|FG001|Overall Study|Participant Non-Compliance|0|||
161797487|NCT01290263|584301116|FG002|Overall Study|Participant Non-Compliance|0|||
161797488|NCT01290263|584301117|FG003|Overall Study|Participant Non-Compliance|1|||
161797489|NCT01290263|584301118|FG004|Overall Study|Participant Non-Compliance|1|||
161797490|NCT00576381|584301125|FG000|Overall Study|Reoperation|3|||
161797491|NCT00576381|584301125|FG000|Overall Study|Adverse Event|4|||
161797492|NCT02518113|584301126|FG000|Overall Study|Adverse Event|1|||
161797493|NCT02518113|584301127|FG001|Overall Study|Adverse Event|0|||
161797494|NCT02518113|584301128|FG002|Overall Study|Adverse Event|1|||
161797495|NCT02518113|584301129|FG003|Overall Study|Adverse Event|0|||
161797496|NCT02518113|584301126|FG000|Overall Study|Death|1|||
161797497|NCT02518113|584301127|FG001|Overall Study|Death|2|||
161797498|NCT02518113|584301128|FG002|Overall Study|Death|0|||
161797499|NCT02518113|584301129|FG003|Overall Study|Death|0|||
161797500|NCT02518113|584301126|FG000|Overall Study|Physician Decision|0|||
161797501|NCT02518113|584301127|FG001|Overall Study|Physician Decision|1|||
161797502|NCT02518113|584301128|FG002|Overall Study|Physician Decision|0|||
161797503|NCT02518113|584301129|FG003|Overall Study|Physician Decision|0|||
161797504|NCT02518113|584301126|FG000|Overall Study|Progressive Disease|1|||
161797505|NCT02518113|584301127|FG001|Overall Study|Progressive Disease|2|||
161797506|NCT02518113|584301128|FG002|Overall Study|Progressive Disease|3|||
161797507|NCT02518113|584301129|FG003|Overall Study|Progressive Disease|0|||
161797508|NCT00797108|584301130|FG000|Overall Study|Adverse Event|1|||
161797509|NCT00797108|584301131|FG001|Overall Study|Adverse Event|0|||
161797510|NCT00797108|584301132|FG002|Overall Study|Adverse Event|3|||
161797511|NCT00797108|584301130|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
161797512|NCT00797108|584301131|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
161797513|NCT00797108|584301132|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
161797514|NCT00797108|584301130|FG000|Overall Study|Global Deterioration of Health Status|0|||
161797515|NCT00797108|584301131|FG001|Overall Study|Global Deterioration of Health Status|1|||
161797516|NCT00797108|584301132|FG002|Overall Study|Global Deterioration of Health Status|0|||
161797517|NCT00797108|584301130|FG000|Overall Study|Lack of Efficacy|1|||
161797518|NCT00797108|584301131|FG001|Overall Study|Lack of Efficacy|0|||
161797519|NCT00797108|584301132|FG002|Overall Study|Lack of Efficacy|1|||
161797520|NCT00797108|584301130|FG000|Overall Study|Other|0|||
161797521|NCT00797108|584301131|FG001|Overall Study|Other|0|||
161797522|NCT00797108|584301132|FG002|Overall Study|Other|2|||
161797523|NCT00797108|584301130|FG000|Overall Study|Randomized but not Treated|2|||
161797524|NCT00797108|584301131|FG001|Overall Study|Randomized but not Treated|0|||
161797525|NCT00797108|584301132|FG002|Overall Study|Randomized but not Treated|0|||
161797526|NCT00287118|584301133|FG000|Overall Study|Adverse Event|30|||
161797527|NCT00287118|584301133|FG000|Overall Study|Death|1|||
161797528|NCT00287118|584301133|FG000|Overall Study|Lack of Efficacy|11|||
161797529|NCT00287118|584301133|FG000|Overall Study|Lost to Follow-up|1|||
161901301|NCT03311841|584685268|FG004|14-day Wash-out|Adverse Event|0|||
161901302|NCT03311841|584685264|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
161901303|NCT03311841|584685265|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
161901304|NCT03311841|584685266|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
162010855|NCT00870740|585096031|FG002|Overall Study|Investigator Decision|1|||
162010856|NCT00870740|585096032|FG003|Overall Study|Investigator Decision|0|||
161797530|NCT00287118|584301133|FG000|Overall Study|Protocol Violation|2|||
161797531|NCT00287118|584301133|FG000|Overall Study|Other|7|||
161797532|NCT02324465|584301134|FG000|Overall Study|device failure|0|||
161797533|NCT02324465|584301135|FG001|Overall Study|device failure|1|||
161901305|NCT03311841|584685267|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
161797534|NCT01631864|584301136|FG000|Overall Study|Withdrawal by Subject|0|||
161797535|NCT01631864|584301137|FG001|Overall Study|Withdrawal by Subject|1|||
161797536|NCT01631864|584301136|FG000|Overall Study|Adverse Event|2|||
161797537|NCT01631864|584301137|FG001|Overall Study|Adverse Event|3|||
161797538|NCT01031537|584301138|FG000|Overall Study|medical reasons not related to study|3|||
161797539|NCT01031537|584301138|FG000|Overall Study|Lack of Efficacy|1|||
161797540|NCT01031537|584301138|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
161797541|NCT01031537|584301138|FG000|Overall Study|moved, met exclusion criteria|10|||
161797542|NCT01031537|584301138|FG000|Overall Study|Withdrawal by Subject|5|||
161797543|NCT01031537|584301138|FG000|Overall Study|PI removal, no longer met eligibility|12|||
161797544|NCT02187042|584301145|FG000|Overall Study|Death|1|||
161797545|NCT02187042|584301146|FG001|Overall Study|Death|1|||
161797546|NCT02187042|584301145|FG000|Overall Study|Toxicity|6|||
161797547|NCT02187042|584301146|FG001|Overall Study|Toxicity|5|||
161797548|NCT02187042|584301145|FG000|Overall Study|Participant choice|1|||
161797549|NCT02187042|584301146|FG001|Overall Study|Participant choice|0|||
161797550|NCT02187042|584301145|FG000|Overall Study|Doctor choice|1|||
161797551|NCT02187042|584301146|FG001|Overall Study|Doctor choice|0|||
161797552|NCT02187042|584301145|FG000|Overall Study|Progressive disease|4|||
161797553|NCT02187042|584301146|FG001|Overall Study|Progressive disease|8|||
161797554|NCT01766921|584301149|FG000|Overall Study|Administrative Reason|5|||
161797555|NCT01766921|584301150|FG001|Overall Study|Administrative Reason|5|||
161797556|NCT01766921|584301149|FG000|Overall Study|Death|1|||
161797557|NCT01766921|584301150|FG001|Overall Study|Death|1|||
161797558|NCT01766921|584301149|FG000|Overall Study|Lost to Follow-up|1|||
161797559|NCT01766921|584301150|FG001|Overall Study|Lost to Follow-up|3|||
161797560|NCT01766921|584301149|FG000|Overall Study|Unclassified|2|||
161797561|NCT01766921|584301150|FG001|Overall Study|Unclassified|2|||
161797562|NCT01766921|584301149|FG000|Overall Study|Protocol Violation|1|||
161797563|NCT01766921|584301150|FG001|Overall Study|Protocol Violation|1|||
161797564|NCT01766921|584301149|FG000|Overall Study|Withdrawal by Subject|14|||
161797565|NCT01766921|584301150|FG001|Overall Study|Withdrawal by Subject|5|||
161797566|NCT02549495|584301153|FG000|Overall Study|Death|2|||
161797567|NCT02549495|584301153|FG000|Overall Study|Withdrawal by Subject|5|||
161797568|NCT02549495|584301153|FG000|Overall Study|Physician Decision|22|||
161797569|NCT02549495|584301153|FG000|Overall Study|Lost to Follow-up|6|||
161797570|NCT02549495|584301153|FG000|Overall Study|Protocol Violation|6|||
161797571|NCT05876091|584301154|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
161797572|NCT03402893|584301155|FG000|Overall Study|Withdrawal by Subject|1|||
161797573|NCT03462719|584301156|FG000|Overall Study|Withdrawal by Subject|4|||
161797574|NCT03462719|584301157|FG001|Overall Study|Withdrawal by Subject|3|||
161797575|NCT03462719|584301156|FG000|Overall Study|Ongoing|87|||
161797576|NCT03462719|584301157|FG001|Overall Study|Ongoing|72|||
161797577|NCT04799158|584301158|FG000|Run-In Period|Adverse Event|6|||
161797578|NCT04799158|584301159|FG001|Run-In Period|Adverse Event|0|||
161797579|NCT04799158|584301160|FG002|Run-In Period|Adverse Event|0|||
161797580|NCT04799158|584301161|FG003|Run-In Period|Adverse Event|0|||
162137563|NCT00631917|585553504|FG001|Overall Study|Administrative problems|0|||
162137564|NCT00631917|585553503|FG000|Overall Study|Death|1|||
162137565|NCT00631917|585553504|FG001|Overall Study|Death|0|||
162137566|NCT03285711|585553505|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
162137567|NCT03285711|585553506|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
162137568|NCT03285711|585553507|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
162137569|NCT03285711|585553508|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
162137570|NCT03285711|585553505|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
162137571|NCT03285711|585553506|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
162137572|NCT03285711|585553507|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
162137573|NCT03285711|585553508|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
162137574|NCT03285711|585553505|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
162137575|NCT03285711|585553506|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
161797581|NCT04799158|584301162|FG004|Run-In Period|Adverse Event|0|||
161797582|NCT04799158|584301158|FG000|Run-In Period|Lost to Follow-up|4|||
161797583|NCT04799158|584301159|FG001|Run-In Period|Lost to Follow-up|0|||
161797584|NCT04799158|584301160|FG002|Run-In Period|Lost to Follow-up|0|||
161797585|NCT04799158|584301161|FG003|Run-In Period|Lost to Follow-up|0|||
161797586|NCT04799158|584301162|FG004|Run-In Period|Lost to Follow-up|0|||
161797587|NCT04799158|584301158|FG000|Run-In Period|Significant Protocol Deviation|1|||
161797588|NCT04799158|584301159|FG001|Run-In Period|Significant Protocol Deviation|0|||
161797589|NCT04799158|584301160|FG002|Run-In Period|Significant Protocol Deviation|0|||
161797590|NCT04799158|584301161|FG003|Run-In Period|Significant Protocol Deviation|0|||
161797591|NCT04799158|584301162|FG004|Run-In Period|Significant Protocol Deviation|0|||
161797592|NCT04799158|584301158|FG000|Run-In Period|Withdrawal by Subject|11|||
161797593|NCT04799158|584301159|FG001|Run-In Period|Withdrawal by Subject|0|||
161797594|NCT04799158|584301160|FG002|Run-In Period|Withdrawal by Subject|0|||
161797595|NCT04799158|584301161|FG003|Run-In Period|Withdrawal by Subject|0|||
161797596|NCT04799158|584301162|FG004|Run-In Period|Withdrawal by Subject|0|||
161797597|NCT04799158|584301158|FG000|Run-In Period|Miscellaneous|3|||
161797598|NCT04799158|584301159|FG001|Run-In Period|Miscellaneous|0|||
161797599|NCT04799158|584301160|FG002|Run-In Period|Miscellaneous|0|||
161797600|NCT04799158|584301161|FG003|Run-In Period|Miscellaneous|0|||
161797601|NCT04799158|584301162|FG004|Run-In Period|Miscellaneous|0|||
161797602|NCT04799158|584301158|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
161797603|NCT04799158|584301159|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
161797604|NCT04799158|584301160|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
161797605|NCT04799158|584301161|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
161797606|NCT04799158|584301162|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
161797607|NCT04799158|584301158|FG000|On-Demand Treatment Period|Adverse Event|0|||
161797608|NCT04799158|584301159|FG001|On-Demand Treatment Period|Adverse Event|1|||
161797609|NCT04799158|584301160|FG002|On-Demand Treatment Period|Adverse Event|0|||
161797610|NCT04799158|584301161|FG003|On-Demand Treatment Period|Adverse Event|0|||
161797611|NCT04799158|584301162|FG004|On-Demand Treatment Period|Adverse Event|1|||
161797612|NCT04799158|584301158|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
161797613|NCT04799158|584301159|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
161797614|NCT04799158|584301160|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
161797615|NCT04799158|584301161|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
161797616|NCT04799158|584301162|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
161797617|NCT04799158|584301158|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
161797618|NCT04799158|584301159|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
161797619|NCT04799158|584301160|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
161797620|NCT04799158|584301161|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
161797621|NCT04799158|584301162|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
161797622|NCT04799158|584301158|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
161797623|NCT04799158|584301159|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
161797624|NCT04799158|584301160|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
161797625|NCT04799158|584301161|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
161797626|NCT04799158|584301162|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
161797627|NCT04799158|584301158|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
161797628|NCT04799158|584301159|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
161797629|NCT04799158|584301160|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
161797630|NCT04799158|584301161|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
161797631|NCT04799158|584301162|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
161797632|NCT04799158|584301158|FG000|On-Demand Treatment Period|Miscellaneous|0|||
161797633|NCT04799158|584301159|FG001|On-Demand Treatment Period|Miscellaneous|0|||
161797634|NCT04799158|584301160|FG002|On-Demand Treatment Period|Miscellaneous|0|||
161797635|NCT04799158|584301161|FG003|On-Demand Treatment Period|Miscellaneous|0|||
161797636|NCT04799158|584301162|FG004|On-Demand Treatment Period|Miscellaneous|1|||
161797637|NCT00679783|584301167|FG000|Overall Study|Adverse Event|0|||
161797638|NCT00679783|584301168|FG001|Overall Study|Adverse Event|0|||
161797639|NCT00679783|584301169|FG002|Overall Study|Adverse Event|0|||
161797640|NCT00679783|584301170|FG003|Overall Study|Adverse Event|3|||
161797641|NCT00679783|584301171|FG004|Overall Study|Adverse Event|0|||
161797642|NCT00679783|584301172|FG005|Overall Study|Adverse Event|0|||
161797643|NCT00679783|584301173|FG006|Overall Study|Adverse Event|1|||
161797644|NCT00679783|584301167|FG000|Overall Study|Lack of Efficacy|0|||
161797645|NCT00679783|584301168|FG001|Overall Study|Lack of Efficacy|1|||
161797646|NCT00679783|584301169|FG002|Overall Study|Lack of Efficacy|0|||
161797647|NCT00679783|584301170|FG003|Overall Study|Lack of Efficacy|2|||
161797648|NCT00679783|584301171|FG004|Overall Study|Lack of Efficacy|0|||
161797649|NCT00679783|584301172|FG005|Overall Study|Lack of Efficacy|0|||
161797650|NCT00679783|584301173|FG006|Overall Study|Lack of Efficacy|0|||
161797651|NCT00679783|584301167|FG000|Overall Study|Withdrawal by Subject|0|||
161797652|NCT00679783|584301168|FG001|Overall Study|Withdrawal by Subject|0|||
161797653|NCT00679783|584301169|FG002|Overall Study|Withdrawal by Subject|1|||
161797654|NCT00679783|584301170|FG003|Overall Study|Withdrawal by Subject|1|||
161797655|NCT00679783|584301171|FG004|Overall Study|Withdrawal by Subject|0|||
161797656|NCT00679783|584301172|FG005|Overall Study|Withdrawal by Subject|0|||
161797657|NCT00679783|584301173|FG006|Overall Study|Withdrawal by Subject|0|||
161797658|NCT00679783|584301167|FG000|Overall Study|Not Captured|0|||
161797659|NCT00679783|584301168|FG001|Overall Study|Not Captured|0|||
161797660|NCT00679783|584301169|FG002|Overall Study|Not Captured|0|||
161797661|NCT00679783|584301170|FG003|Overall Study|Not Captured|5|||
161797662|NCT00679783|584301171|FG004|Overall Study|Not Captured|0|||
161797663|NCT00679783|584301172|FG005|Overall Study|Not Captured|0|||
161797664|NCT00679783|584301173|FG006|Overall Study|Not Captured|0|||
161797665|NCT00679783|584301167|FG000|Overall Study|Ongoing at data cut-off|2|||
161797666|NCT00679783|584301168|FG001|Overall Study|Ongoing at data cut-off|2|||
161797667|NCT00679783|584301169|FG002|Overall Study|Ongoing at data cut-off|0|||
161797668|NCT00679783|584301170|FG003|Overall Study|Ongoing at data cut-off|9|||
161797669|NCT00679783|584301171|FG004|Overall Study|Ongoing at data cut-off|1|||
161797670|NCT00679783|584301172|FG005|Overall Study|Ongoing at data cut-off|0|||
161797671|NCT00679783|584301173|FG006|Overall Study|Ongoing at data cut-off|0|||
161797672|NCT01485536|584301174|FG000|Overall Study|Withdrawal by Subject|3|||
161797673|NCT01485536|584301174|FG000|Overall Study|Adverse Event|1|||
161797674|NCT02626949|584301175|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
161797675|NCT02626949|584301176|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
161797676|NCT02626949|584301175|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
161797677|NCT02626949|584301176|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
161797678|NCT02626949|584301175|FG000|Enrolled|Lost to Follow-up|7|||
161797679|NCT02626949|584301176|FG001|Enrolled|Lost to Follow-up|6|||
161797680|NCT02626949|584301175|FG000|Enrolled|Withdrawal by Subject|3|||
161797681|NCT02626949|584301176|FG001|Enrolled|Withdrawal by Subject|2|||
161797682|NCT00601484|584301177|FG000|Overall Study|Adverse Event|0|||
161797683|NCT00601484|584301178|FG001|Overall Study|Adverse Event|1|||
161797684|NCT00601484|584301177|FG000|Overall Study|Lost to Follow-up|4|||
161797685|NCT00601484|584301178|FG001|Overall Study|Lost to Follow-up|3|||
161797686|NCT00601484|584301177|FG000|Overall Study|Lack of Efficacy|0|||
161797687|NCT00601484|584301178|FG001|Overall Study|Lack of Efficacy|2|||
161797688|NCT00601484|584301177|FG000|Overall Study|Withdrawal by Subject|1|||
161797689|NCT00601484|584301178|FG001|Overall Study|Withdrawal by Subject|1|||
161797690|NCT00601484|584301177|FG000|Overall Study|Randomized, but not treated|0|||
161797691|NCT00601484|584301178|FG001|Overall Study|Randomized, but not treated|1|||
161797692|NCT02928848|584301179|FG000|Arm 2|Withdrawal by Subject|1|||
161797693|NCT02928848|584301180|FG001|Arm 2|Withdrawal by Subject|0|||
161797694|NCT02779855|584301181|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
161797695|NCT02779855|584301182|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
161797696|NCT02779855|584301183|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
161797697|NCT00319449|584301192|FG000|Overall Study|Subject did not wish to continue|1|||
161797698|NCT00319449|584301193|FG001|Overall Study|Subject did not wish to continue|0|||
161797699|NCT00319449|584301192|FG000|Overall Study|Noncompliance with the protocol|1|||
161797700|NCT00319449|584301193|FG001|Overall Study|Noncompliance with the protocol|0|||
161797701|NCT00462982|584301200|FG000|Overall Study|Adverse Event|1|||
161797702|NCT00462982|584301200|FG000|Overall Study|Patient Not Treated|2|||
161797703|NCT03471078|584302659|FG000|Overall Study|Withdrawal by Subject|9|||
161797704|NCT03471078|584302660|FG001|Overall Study|Withdrawal by Subject|1|||
161797705|NCT03471078|584302659|FG000|Overall Study|Adverse Event|4|||
161797706|NCT03471078|584302660|FG001|Overall Study|Adverse Event|1|||
161797707|NCT03471078|584302659|FG000|Overall Study|Physician Decision|3|||
161797708|NCT03471078|584302660|FG001|Overall Study|Physician Decision|2|||
161797709|NCT03471078|584302659|FG000|Overall Study|Death|2|||
161797710|NCT03471078|584302660|FG001|Overall Study|Death|0|||
161797711|NCT03471078|584302659|FG000|Overall Study|Other|3|||
161797712|NCT03471078|584302660|FG001|Overall Study|Other|2|||
161797713|NCT02309099|584302668|FG000|Overall Study|Adverse Event|2|||
161797714|NCT02309099|584302669|FG001|Overall Study|Adverse Event|0|||
161797715|NCT01545076|584302670|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
161797716|NCT01545076|584302671|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
161797717|NCT01545076|584302672|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
161797718|NCT01545076|584302673|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
161901306|NCT03311841|584685268|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
161901307|NCT00977613|584685271|FG000|Overall Study|Lost to Follow-up|16|||
161901308|NCT05464420|584685274|FG000|Overall Study|Death|0|||
161901309|NCT05464420|584685275|FG001|Overall Study|Death|0|||
161901310|NCT05464420|584685276|FG002|Overall Study|Death|0|||
161901311|NCT05464420|584685277|FG003|Overall Study|Death|1|||
161901312|NCT05464420|584685274|FG000|Overall Study|Lost to Follow-up|16|||
161901313|NCT05464420|584685275|FG001|Overall Study|Lost to Follow-up|11|||
161901314|NCT05464420|584685276|FG002|Overall Study|Lost to Follow-up|11|||
161901315|NCT05464420|584685277|FG003|Overall Study|Lost to Follow-up|11|||
161901316|NCT05464420|584685274|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
161901317|NCT05464420|584685275|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
161901318|NCT05464420|584685276|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
161901319|NCT05464420|584685277|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
161901320|NCT05464420|584685274|FG000|Overall Study|Withdrawal by Subject|4|||
161901321|NCT05464420|584685275|FG001|Overall Study|Withdrawal by Subject|8|||
161901322|NCT05464420|584685276|FG002|Overall Study|Withdrawal by Subject|3|||
161901323|NCT05464420|584685277|FG003|Overall Study|Withdrawal by Subject|1|||
161901324|NCT05464420|584685274|FG000|Overall Study|Protocol Violation|0|||
161901325|NCT05464420|584685275|FG001|Overall Study|Protocol Violation|0|||
161901326|NCT05464420|584685276|FG002|Overall Study|Protocol Violation|1|||
161901327|NCT05464420|584685277|FG003|Overall Study|Protocol Violation|1|||
161901328|NCT05464420|584685274|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
161901329|NCT05464420|584685275|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
161901330|NCT05464420|584685276|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
161901331|NCT05464420|584685277|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
161901332|NCT01383018|584685278|FG000|Overall Study|Adverse Event|14|||
161901333|NCT01383018|584685278|FG000|Overall Study|Death|10|||
161901334|NCT01383018|584685278|FG000|Overall Study|Lost to Follow-up|5|||
161901335|NCT01383018|584685278|FG000|Overall Study|Physician Decision|5|||
161901336|NCT01383018|584685278|FG000|Overall Study|Withdrawal by Subject|9|||
161901337|NCT01383018|584685278|FG000|Overall Study|Subject not implanted|76|||
161901338|NCT01383018|584685278|FG000|Overall Study|Missed Visit|247|||
161901339|NCT01383018|584685278|FG000|Overall Study|Site closed early-not compliance related|7|||
161901340|NCT01383018|584685278|FG000|Overall Study|Patient moved away from site|1|||
161901341|NCT01383018|584685278|FG000|Overall Study|Subject Incarcerated|1|||
161901342|NCT01598610|584685283|FG000|Overall Study|Adverse Event|1|||
161901343|NCT03066830|584685289|FG000|Overall Study|At the Participant's own Request|16|||
161901344|NCT03066830|584685290|FG001|Overall Study|At the Participant's own Request|17|||
161901345|NCT03066830|584685289|FG000|Overall Study|Other|3|||
161901346|NCT03066830|584685290|FG001|Overall Study|Other|0|||
161901347|NCT03066830|584685289|FG000|Overall Study|Poor Compliance to Protocol|1|||
161901348|NCT03066830|584685290|FG001|Overall Study|Poor Compliance to Protocol|0|||
161901349|NCT03066830|584685289|FG000|Overall Study|Adverse Event|2|||
161901350|NCT03066830|584685290|FG001|Overall Study|Adverse Event|2|||
161901351|NCT03066830|584685289|FG000|Overall Study|Lost to Follow-up|11|||
161901352|NCT03066830|584685290|FG001|Overall Study|Lost to Follow-up|3|||
161901353|NCT02989402|584685291|FG000|Overall Study|Adverse event, or serious adverse event|4|||
161901354|NCT02989402|584685291|FG000|Overall Study|Death|2|||
161901355|NCT02989402|584685291|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
161901356|NCT02989402|584685291|FG000|Overall Study|Lost to Follow-up|8|||
161901357|NCT02989402|584685291|FG000|Overall Study|Patient no longer on monotherapy|1|||
161901358|NCT02989402|584685291|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
162010857|NCT00870740|585096033|FG004|Overall Study|Investigator Decision|0|||
162010858|NCT00870740|585096034|FG005|Overall Study|Investigator Decision|0|||
162010859|NCT00870740|585096029|FG000|Overall Study|Subject Non-compliance|0|||
162010860|NCT00870740|585096030|FG001|Overall Study|Subject Non-compliance|0|||
162010861|NCT00870740|585096031|FG002|Overall Study|Subject Non-compliance|0|||
162010862|NCT00870740|585096032|FG003|Overall Study|Subject Non-compliance|0|||
162010863|NCT00870740|585096033|FG004|Overall Study|Subject Non-compliance|0|||
162010864|NCT00870740|585096034|FG005|Overall Study|Subject Non-compliance|1|||
162010865|NCT00870740|585096029|FG000|Overall Study|Death|0|||
162010866|NCT00870740|585096030|FG001|Overall Study|Death|0|||
162010867|NCT00870740|585096031|FG002|Overall Study|Death|0|||
161901359|NCT02989402|584685291|FG000|Overall Study|Withdrawal by Subject|7|||
161901360|NCT02989402|584685291|FG000|Overall Study|Other|2|||
161901361|NCT02039778|584685293|FG000|Overall Study|Death|2|||
161901362|NCT02039778|584685293|FG000|Overall Study|Withdrawal by Subject|1|||
161901363|NCT02039778|584685293|FG000|Overall Study|Never started the protocol treatment|1|||
161901364|NCT00656175|584685303|FG000|Overall Study|Adverse Event|1|||
161901365|NCT00656175|584685304|FG001|Overall Study|Adverse Event|0|||
161901366|NCT00656175|584685303|FG000|Overall Study|Transportation issues|0|||
161901367|NCT00656175|584685304|FG001|Overall Study|Transportation issues|1|||
162010868|NCT00870740|585096032|FG003|Overall Study|Death|0|||
161901368|NCT02149264|584685310|FG000|Overall Study|Withdrawal by Subject|9|||
161901369|NCT02149264|584685310|FG000|Overall Study|Adverse Event|7|||
161901370|NCT02149264|584685310|FG000|Overall Study|Physician Decision|3|||
162137576|NCT03285711|585553507|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
162137577|NCT03285711|585553508|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
162137578|NCT03285711|585553505|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
162137579|NCT03285711|585553506|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
162137580|NCT03285711|585553507|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
162137581|NCT03285711|585553508|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
162137582|NCT00770211|585553511|FG000|Overall Study|Lost to Follow-up|1|||
162137583|NCT00770211|585553512|FG001|Overall Study|Lost to Follow-up|0|||
162137584|NCT00770211|585553511|FG000|Overall Study|Withdrawal by Subject|0|||
162137585|NCT00770211|585553512|FG001|Overall Study|Withdrawal by Subject|2|||
162137586|NCT00318656|585553513|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
162137587|NCT00318656|585553514|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
162137588|NCT00318656|585553513|FG000|Overall Study|Did not receive any treatment|0|||
162137589|NCT00318656|585553514|FG001|Overall Study|Did not receive any treatment|1|||
162137590|NCT01446003|585553516|FG000|Period 1|Protocol Violation|2|||
162137591|NCT01446003|585553517|FG001|Period 1|Protocol Violation|0|||
162137592|NCT01446003|585553516|FG000|Period 2|Adverse Event|1|||
162137593|NCT01446003|585553517|FG001|Period 2|Adverse Event|0|||
162137594|NCT01740557|585553518|FG000|Overall Study|Ineligible|1|||
162137595|NCT01740557|585553518|FG000|Overall Study|Screen failure|1|||
162137596|NCT00490555|585553519|FG000|Overall Study|noncompliant with drug administration|0|||
162137597|NCT00490555|585553520|FG001|Overall Study|noncompliant with drug administration|0|||
162137598|NCT00490555|585553521|FG002|Overall Study|noncompliant with drug administration|2|||
162137599|NCT00490555|585553522|FG003|Overall Study|noncompliant with drug administration|0|||
162137600|NCT01007149|585553523|FG000|Overall Study|Administrative problems|0|||
162137601|NCT01007149|585553524|FG001|Overall Study|Administrative problems|1|||
162137602|NCT03568162|585553528|FG000|Overall Study|Adverse Event|0|||
162137603|NCT03568162|585553529|FG001|Overall Study|Adverse Event|1|||
162137604|NCT03568162|585553530|FG002|Overall Study|Adverse Event|2|||
162137605|NCT03568162|585553531|FG003|Overall Study|Adverse Event|0|||
161797719|NCT01545076|584302674|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
161797720|NCT01545076|584302670|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
161797721|NCT01545076|584302671|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
161797722|NCT01545076|584302672|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
161797723|NCT01545076|584302673|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
161797724|NCT01545076|584302674|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
161797725|NCT01545076|584302670|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
161797726|NCT01545076|584302671|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
161797727|NCT01545076|584302672|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
161797728|NCT01545076|584302673|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
161797729|NCT01545076|584302674|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
161797730|NCT01545076|584302670|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
161797731|NCT01545076|584302671|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
161797732|NCT01545076|584302672|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
161797733|NCT01545076|584302673|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
161797734|NCT01545076|584302674|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
161797735|NCT01545076|584302670|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
161797736|NCT01545076|584302671|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
161797737|NCT01545076|584302672|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
161797738|NCT01545076|584302673|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
161797739|NCT01545076|584302674|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
161797740|NCT01545076|584302670|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
161797741|NCT01545076|584302671|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
161797742|NCT01545076|584302672|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
161797743|NCT01545076|584302673|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
161797744|NCT01545076|584302674|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
161797745|NCT01545076|584302670|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
161797746|NCT01545076|584302671|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
161797747|NCT01545076|584302672|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
161797748|NCT01545076|584302673|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
161797749|NCT01545076|584302674|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
161797750|NCT01545076|584302670|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
161797751|NCT01545076|584302671|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
161797752|NCT01545076|584302672|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
161797753|NCT01545076|584302673|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
161797754|NCT01545076|584302674|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
162137606|NCT03568162|585553532|FG004|Overall Study|Adverse Event|0|||
162137607|NCT03568162|585553533|FG005|Overall Study|Adverse Event|1|||
162137608|NCT03568162|585553528|FG000|Overall Study|Death|0|||
162137609|NCT03568162|585553529|FG001|Overall Study|Death|0|||
161797755|NCT01545076|584302670|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
161797756|NCT01545076|584302671|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
161797757|NCT01545076|584302672|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
161797758|NCT01545076|584302673|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
161797759|NCT01545076|584302674|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
161797760|NCT05456529|584302675|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
161797761|NCT05456529|584302675|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
161797762|NCT05456529|584302675|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
161797763|NCT05456529|584302675|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
162137610|NCT03568162|585553530|FG002|Overall Study|Death|0|||
162137611|NCT03568162|585553531|FG003|Overall Study|Death|0|||
162137612|NCT03568162|585553532|FG004|Overall Study|Death|1|||
162137613|NCT03568162|585553533|FG005|Overall Study|Death|0|||
162137614|NCT03568162|585553528|FG000|Overall Study|Lost to Follow-up|3|||
162137615|NCT03568162|585553529|FG001|Overall Study|Lost to Follow-up|2|||
162137616|NCT03568162|585553530|FG002|Overall Study|Lost to Follow-up|4|||
162137617|NCT03568162|585553531|FG003|Overall Study|Lost to Follow-up|2|||
162137618|NCT03568162|585553532|FG004|Overall Study|Lost to Follow-up|3|||
162137619|NCT03568162|585553533|FG005|Overall Study|Lost to Follow-up|2|||
162137620|NCT03568162|585553528|FG000|Overall Study|Physician Decision|0|||
162137621|NCT03568162|585553529|FG001|Overall Study|Physician Decision|1|||
162137622|NCT03568162|585553530|FG002|Overall Study|Physician Decision|1|||
162137623|NCT03568162|585553531|FG003|Overall Study|Physician Decision|0|||
162137624|NCT03568162|585553532|FG004|Overall Study|Physician Decision|1|||
162137625|NCT03568162|585553533|FG005|Overall Study|Physician Decision|0|||
162137626|NCT03568162|585553528|FG000|Overall Study|Pregnancy|0|||
162137627|NCT03568162|585553529|FG001|Overall Study|Pregnancy|0|||
162137628|NCT03568162|585553530|FG002|Overall Study|Pregnancy|0|||
162137629|NCT03568162|585553531|FG003|Overall Study|Pregnancy|1|||
162137630|NCT03568162|585553532|FG004|Overall Study|Pregnancy|0|||
162137631|NCT03568162|585553533|FG005|Overall Study|Pregnancy|0|||
162137632|NCT03568162|585553528|FG000|Overall Study|Protocol Violation|1|||
162137633|NCT03568162|585553529|FG001|Overall Study|Protocol Violation|0|||
162137634|NCT03568162|585553530|FG002|Overall Study|Protocol Violation|1|||
162137635|NCT03568162|585553531|FG003|Overall Study|Protocol Violation|1|||
162137636|NCT03568162|585553532|FG004|Overall Study|Protocol Violation|1|||
162137637|NCT03568162|585553533|FG005|Overall Study|Protocol Violation|1|||
162137638|NCT03568162|585553528|FG000|Overall Study|Withdrawal by Subject|15|||
162137639|NCT03568162|585553529|FG001|Overall Study|Withdrawal by Subject|15|||
162137640|NCT03568162|585553530|FG002|Overall Study|Withdrawal by Subject|26|||
162137641|NCT03568162|585553531|FG003|Overall Study|Withdrawal by Subject|22|||
162137642|NCT03568162|585553532|FG004|Overall Study|Withdrawal by Subject|6|||
162137643|NCT03568162|585553533|FG005|Overall Study|Withdrawal by Subject|9|||
162137644|NCT03568162|585553528|FG000|Overall Study|Others|3|||
162137645|NCT03568162|585553529|FG001|Overall Study|Others|4|||
162137646|NCT03568162|585553530|FG002|Overall Study|Others|1|||
162137647|NCT03568162|585553531|FG003|Overall Study|Others|4|||
162137648|NCT03568162|585553532|FG004|Overall Study|Others|2|||
162137649|NCT03568162|585553533|FG005|Overall Study|Others|1|||
162137650|NCT00337818|585553534|FG000|Overall Study|Lost to Follow-up|289|||
162137651|NCT00337818|585553535|FG001|Overall Study|Lost to Follow-up|91|||
162137652|NCT00337818|585553536|FG002|Overall Study|Lost to Follow-up|107|||
162137653|NCT00938340|585553538|FG000|Overall Study|Withdrawal by Subject|3|||
162137654|NCT00938340|585553538|FG000|Overall Study|Protocol Violation|1|||
162137655|NCT00938340|585553538|FG000|Overall Study|Adverse Event|1|||
162137656|NCT05174065|585553540|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
162137657|NCT05174065|585553541|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
162137658|NCT05174065|585553542|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
162137659|NCT05174065|585553540|FG000|Placebo-controlled Period|Other|0|||
162137660|NCT05174065|585553541|FG001|Placebo-controlled Period|Other|1|||
162137661|NCT05174065|585553542|FG002|Placebo-controlled Period|Other|0|||
162137662|NCT05174065|585553540|FG000|Placebo-controlled Period|Adverse Event|1|||
162137663|NCT05174065|585553541|FG001|Placebo-controlled Period|Adverse Event|1|||
162137664|NCT05174065|585553542|FG002|Placebo-controlled Period|Adverse Event|0|||
162137665|NCT05174065|585553540|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
162137666|NCT05174065|585553541|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
162137667|NCT05174065|585553542|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
162137668|NCT05174065|585553540|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
162137669|NCT05174065|585553541|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
162137670|NCT05174065|585553542|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
162137671|NCT05174065|585553540|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
162137672|NCT05174065|585553541|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
162137673|NCT05174065|585553542|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
162137674|NCT00209274|585553545|FG000|Overall Study|Missed visit|3|||
162137675|NCT00209274|585553546|FG001|Overall Study|Missed visit|2|||
162137676|NCT00209274|585553545|FG000|Overall Study|Death|32|||
161901371|NCT02149264|584685310|FG000|Overall Study|Protocol Violation|1|||
161901372|NCT01938846|584685314|FG000|Overall Study|Progressive disease|26|||
161901373|NCT01938846|584685315|FG001|Overall Study|Progressive disease|18|||
161901374|NCT01938846|584685316|FG002|Overall Study|Progressive disease|16|||
161901375|NCT01938846|584685314|FG000|Overall Study|Adverse Event|8|||
161901376|NCT01938846|584685315|FG001|Overall Study|Adverse Event|4|||
161901377|NCT01938846|584685316|FG002|Overall Study|Adverse Event|3|||
161901378|NCT01938846|584685314|FG000|Overall Study|Withdrawal by Subject|2|||
161901379|NCT01938846|584685315|FG001|Overall Study|Withdrawal by Subject|2|||
161901380|NCT01938846|584685316|FG002|Overall Study|Withdrawal by Subject|1|||
161901381|NCT01938846|584685314|FG000|Overall Study|Other than listed|5|||
161901382|NCT01938846|584685315|FG001|Overall Study|Other than listed|1|||
161901383|NCT01938846|584685316|FG002|Overall Study|Other than listed|4|||
161901384|NCT02499120|584685320|FG000|Overall Study|Death|52|||
161901385|NCT02499120|584685321|FG001|Overall Study|Death|43|||
161901386|NCT02499120|584685320|FG000|Overall Study|Lost to Follow-up|1|||
161901387|NCT02499120|584685321|FG001|Overall Study|Lost to Follow-up|2|||
161901388|NCT02499120|584685320|FG000|Overall Study|Participant refused further follow-up|1|||
161901389|NCT02499120|584685321|FG001|Overall Study|Participant refused further follow-up|0|||
161901390|NCT02499120|584685320|FG000|Overall Study|Withdrawal by Subject|2|||
161901391|NCT02499120|584685321|FG001|Overall Study|Withdrawal by Subject|5|||
161901392|NCT02499120|584685320|FG000|Overall Study|Other|9|||
161901393|NCT02499120|584685321|FG001|Overall Study|Other|10|||
161901394|NCT02282163|584685322|FG000|Overall Study|Protocol Violation|1|||
161901395|NCT01839916|584685323|FG000|Overall Study|Death|9|||
161901396|NCT01839916|584685323|FG000|Overall Study|Physician Decision|17|||
161901397|NCT01839916|584685323|FG000|Overall Study|Relapse|12|||
161901398|NCT01839916|584685323|FG000|Overall Study|GVHD|2|||
161901399|NCT01839916|584685323|FG000|Overall Study|Graft Failure|1|||
161901400|NCT03877224|584685326|FG000|Overall Study|Death|3|||
161901401|NCT03877224|584685327|FG001|Overall Study|Death|2|||
161901402|NCT03877224|584685326|FG000|Overall Study|Withdrawal by Subject|1|||
162137677|NCT00209274|585553546|FG001|Overall Study|Death|15|||
162137678|NCT00209274|585553545|FG000|Overall Study|Withdrawal by Subject|30|||
162137679|NCT00209274|585553546|FG001|Overall Study|Withdrawal by Subject|15|||
162137680|NCT00209274|585553545|FG000|Overall Study|Randomized not treated (RNT)|6|||
162137681|NCT00209274|585553546|FG001|Overall Study|Randomized not treated (RNT)|15|||
162137682|NCT02753530|585553547|FG000|Overall Study|Adverse Event|7|||
162137683|NCT02753530|585553548|FG001|Overall Study|Adverse Event|1|||
162137684|NCT02753530|585553547|FG000|Overall Study|Death|0|||
162137685|NCT02753530|585553548|FG001|Overall Study|Death|1|||
162137686|NCT02753530|585553547|FG000|Overall Study|Physician Decision|0|||
162137687|NCT02753530|585553548|FG001|Overall Study|Physician Decision|1|||
162137688|NCT02753530|585553547|FG000|Overall Study|Protocol Violation|1|||
162137689|NCT02753530|585553548|FG001|Overall Study|Protocol Violation|0|||
162137690|NCT02753530|585553547|FG000|Overall Study|Withdrawal by Subject|4|||
162137691|NCT02753530|585553548|FG001|Overall Study|Withdrawal by Subject|3|||
162137692|NCT02909101|585553550|FG000|Overall Study|Lost to Follow-up|1|||
162137693|NCT02909101|585553551|FG001|Overall Study|Lost to Follow-up|1|||
162137694|NCT01959880|585553552|FG000|Overall Study|Withdrawal by Subject|11|||
162137695|NCT01959880|585553553|FG001|Overall Study|Withdrawal by Subject|13|||
162137696|NCT01959880|585553554|FG002|Overall Study|Withdrawal by Subject|8|||
162137697|NCT01959880|585553555|FG003|Overall Study|Withdrawal by Subject|7|||
162137698|NCT01959880|585553552|FG000|Overall Study|Death|1|||
162137699|NCT01959880|585553553|FG001|Overall Study|Death|10|||
162137700|NCT01959880|585553554|FG002|Overall Study|Death|1|||
162137701|NCT01959880|585553555|FG003|Overall Study|Death|2|||
161901403|NCT03877224|584685327|FG001|Overall Study|Withdrawal by Subject|6|||
161901404|NCT03877224|584685326|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
161901405|NCT03877224|584685327|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
161901406|NCT04587336|584685328|FG000|Overall Study|Lost to Follow-up|1|||
161901407|NCT04587336|584685329|FG001|Overall Study|Lost to Follow-up|0|||
161901408|NCT00379834|584687043|FG000|Overall Study|Time constraints|2|||
161901409|NCT01519817|584687044|FG000|Overall Study|Withdrawal by Subject|1|||
161901410|NCT01519817|584687045|FG001|Overall Study|Withdrawal by Subject|0|||
161901411|NCT01519817|584687046|FG002|Overall Study|Withdrawal by Subject|0|||
161901412|NCT01519817|584687047|FG003|Overall Study|Withdrawal by Subject|0|||
161901413|NCT01519817|584687044|FG000|Overall Study|Off study due to infection|0|||
162137702|NCT01959880|585553552|FG000|Overall Study|Lost to Follow-up|95|||
162137703|NCT01959880|585553553|FG001|Overall Study|Lost to Follow-up|18|||
162137704|NCT01959880|585553554|FG002|Overall Study|Lost to Follow-up|15|||
162137705|NCT01959880|585553555|FG003|Overall Study|Lost to Follow-up|8|||
161901414|NCT01519817|584687045|FG001|Overall Study|Off study due to infection|0|||
162137706|NCT01959880|585553552|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
161797764|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
161797765|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
161797766|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Physician Decision|2|||
161797767|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
161797768|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
161797769|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
161797770|NCT05456529|584302675|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
161797771|NCT00561730|584302678|FG000|Overall Study|Adverse Event|2|||
161797772|NCT00561730|584302678|FG000|Overall Study|Handling of the drug|1|||
161797773|NCT00561730|584302678|FG000|Overall Study|Lost to Follow-up|5|||
161797774|NCT00561730|584302678|FG000|Overall Study|Not specified reasons|1|||
161797775|NCT03194464|584302681|FG000|Overall Study|data not usable|2|||
161797776|NCT02750761|584302685|FG000|Overall Study|Lost to Follow-up|0|||
161797777|NCT02750761|584302686|FG001|Overall Study|Lost to Follow-up|0|||
161797778|NCT02750761|584302687|FG002|Overall Study|Lost to Follow-up|1|||
161797779|NCT02750761|584302688|FG003|Overall Study|Lost to Follow-up|0|||
161797780|NCT02750761|584302689|FG004|Overall Study|Lost to Follow-up|0|||
161797781|NCT02750761|584302690|FG005|Overall Study|Lost to Follow-up|0|||
161797782|NCT01860976|584302691|FG000|Blinded Treatment|Adverse Event|1|||
161797783|NCT01860976|584302692|FG001|Blinded Treatment|Adverse Event|3|||
161797784|NCT01860976|584302691|FG000|Blinded Treatment|Lack of Efficacy|5|||
161797785|NCT01860976|584302692|FG001|Blinded Treatment|Lack of Efficacy|12|||
161797786|NCT01860976|584302691|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
161797787|NCT01860976|584302692|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
161797788|NCT01860976|584302691|FG000|Blinded Treatment|Withdrawal by Subject|3|||
161797789|NCT01860976|584302692|FG001|Blinded Treatment|Withdrawal by Subject|5|||
161797790|NCT01860976|584302691|FG000|Blinded Treatment|Subject no longer met criteria|1|||
161797791|NCT01860976|584302692|FG001|Blinded Treatment|Subject no longer met criteria|0|||
161797792|NCT01860976|584302691|FG000|Blinded Treatment|Entered Open-Label in error|0|||
161797793|NCT01860976|584302692|FG001|Blinded Treatment|Entered Open-Label in error|1|||
161797794|NCT01860976|584302691|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
161797795|NCT01860976|584302692|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
161797796|NCT01860976|584302691|FG000|Open-Label|Adverse Event|2|||
161797797|NCT01860976|584302692|FG001|Open-Label|Adverse Event|4|||
161797798|NCT01860976|584302691|FG000|Open-Label|Lack of Efficacy|16|||
161797799|NCT01860976|584302692|FG001|Open-Label|Lack of Efficacy|8|||
161797800|NCT01860976|584302691|FG000|Open-Label|Lost to Follow-up|1|||
161797801|NCT01860976|584302692|FG001|Open-Label|Lost to Follow-up|2|||
161797802|NCT01860976|584302691|FG000|Open-Label|Subject request discontinue treatment|4|||
161797803|NCT01860976|584302692|FG001|Open-Label|Subject request discontinue treatment|3|||
161797804|NCT01860976|584302691|FG000|Open-Label|Withdrawal by Subject|4|||
161797805|NCT01860976|584302692|FG001|Open-Label|Withdrawal by Subject|1|||
161797806|NCT01860976|584302691|FG000|Open-Label|Other Reasons|1|||
161797807|NCT01860976|584302692|FG001|Open-Label|Other Reasons|1|||
161797808|NCT01860976|584302691|FG000|Long Term Extension|Adverse Event|4|||
161797809|NCT01860976|584302692|FG001|Long Term Extension|Adverse Event|0|||
161797810|NCT01860976|584302691|FG000|Long Term Extension|Lack of Efficacy|2|||
161797811|NCT01860976|584302692|FG001|Long Term Extension|Lack of Efficacy|0|||
161797812|NCT01860976|584302691|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
161797813|NCT01860976|584302692|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
161797814|NCT01860976|584302691|FG000|Long Term Extension|Lost to Follow-up|2|||
161797815|NCT01860976|584302692|FG001|Long Term Extension|Lost to Follow-up|0|||
161797816|NCT01860976|584302691|FG000|Long Term Extension|subject withdrew consent|7|||
161797817|NCT01860976|584302692|FG001|Long Term Extension|subject withdrew consent|0|||
161797818|NCT02153398|584302693|FG000|Overall Study|Withdrawal by Subject|1|||
161797819|NCT02153398|584302694|FG001|Overall Study|Withdrawal by Subject|0|||
161797820|NCT02153398|584302695|FG002|Overall Study|Withdrawal by Subject|0|||
161797821|NCT02153398|584302696|FG003|Overall Study|Withdrawal by Subject|0|||
161797822|NCT02153398|584302697|FG004|Overall Study|Withdrawal by Subject|0|||
161797823|NCT02153398|584302693|FG000|Overall Study|Adverse Event|0|||
161797824|NCT02153398|584302694|FG001|Overall Study|Adverse Event|0|||
161797825|NCT02153398|584302695|FG002|Overall Study|Adverse Event|1|||
161797826|NCT02153398|584302696|FG003|Overall Study|Adverse Event|1|||
161797827|NCT02153398|584302697|FG004|Overall Study|Adverse Event|0|||
161797828|NCT02204371|584302698|FG000|Overall Study|Adverse Event|1|||
161797829|NCT01506947|584302699|FG000|Overall Study|Lost to Follow-up|7|||
161797830|NCT01506947|584302699|FG000|Overall Study|Adverse Event|5|||
161797831|NCT01506947|584302699|FG000|Overall Study|Death|1|||
161797832|NCT01506947|584302699|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
161797833|NCT03803943|584302702|FG000|Overall Study|Withdrawal by Subject|2|||
161797834|NCT03803943|584302703|FG001|Overall Study|Withdrawal by Subject|2|||
161797835|NCT03803943|584302704|FG002|Overall Study|Withdrawal by Subject|2|||
161797836|NCT03803943|584302705|FG003|Overall Study|Withdrawal by Subject|2|||
161797837|NCT01781286|584302708|FG000|Overall Study|Lost to Follow-up|0|||
161797838|NCT01781286|584302709|FG001|Overall Study|Lost to Follow-up|0|||
161797839|NCT01781286|584302710|FG002|Overall Study|Lost to Follow-up|0|||
161797840|NCT01781286|584302711|FG003|Overall Study|Lost to Follow-up|0|||
161797841|NCT01781286|584302712|FG004|Overall Study|Lost to Follow-up|0|||
161797842|NCT01781286|584302713|FG005|Overall Study|Lost to Follow-up|1|||
161797843|NCT01781286|584302708|FG000|Overall Study|Time Constraints|2|||
161797844|NCT01781286|584302709|FG001|Overall Study|Time Constraints|0|||
161797845|NCT01781286|584302710|FG002|Overall Study|Time Constraints|2|||
161797846|NCT01781286|584302711|FG003|Overall Study|Time Constraints|0|||
161797847|NCT01781286|584302712|FG004|Overall Study|Time Constraints|0|||
161797848|NCT01781286|584302713|FG005|Overall Study|Time Constraints|0|||
161797849|NCT01781286|584302708|FG000|Overall Study|Noncompliance|0|||
161797850|NCT01781286|584302709|FG001|Overall Study|Noncompliance|0|||
161797851|NCT01781286|584302710|FG002|Overall Study|Noncompliance|0|||
161797852|NCT01781286|584302711|FG003|Overall Study|Noncompliance|1|||
161797853|NCT01781286|584302712|FG004|Overall Study|Noncompliance|0|||
161797854|NCT01781286|584302713|FG005|Overall Study|Noncompliance|0|||
161797855|NCT00995410|584302714|FG000|Overall Study|Adverse Event|51|||
161797856|NCT00995410|584302714|FG000|Overall Study|Withdrawal by Subject|7|||
161797857|NCT00995410|584302714|FG000|Overall Study|Lost to Follow-up|2|||
161797858|NCT00995410|584302714|FG000|Overall Study|Misc|28|||
161797859|NCT03594123|584302715|FG000|Overall Study|Lost to Follow-up|0|||
161797860|NCT03594123|584302716|FG001|Overall Study|Lost to Follow-up|1|||
161797861|NCT03594123|584302715|FG000|Overall Study|Adverse Event|8|||
161797862|NCT03594123|584302716|FG001|Overall Study|Adverse Event|5|||
161797863|NCT03594123|584302715|FG000|Overall Study|Site Terminated by Sponsor|4|||
161797864|NCT03594123|584302716|FG001|Overall Study|Site Terminated by Sponsor|1|||
161797865|NCT03594123|584302715|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
161797866|NCT03594123|584302716|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
161797867|NCT03594123|584302715|FG000|Overall Study|Lack of Efficacy|1|||
161797868|NCT03594123|584302716|FG001|Overall Study|Lack of Efficacy|0|||
161797869|NCT03594123|584302715|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
161797870|NCT03594123|584302716|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
161797871|NCT03019965|584302719|FG000|Overall Study|Withdrawal by Subject|1|||
161797872|NCT03019965|584302720|FG001|Overall Study|Withdrawal by Subject|0|||
161797873|NCT03019965|584302719|FG000|Overall Study|Protocol Violation|1|||
161797874|NCT03019965|584302720|FG001|Overall Study|Protocol Violation|3|||
161797875|NCT03019965|584302719|FG000|Overall Study|viral or fungal infection|3|||
161797876|NCT03019965|584302720|FG001|Overall Study|viral or fungal infection|4|||
161797877|NCT03019965|584302719|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
161797878|NCT03019965|584302720|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
161797879|NCT03019965|584302719|FG000|Overall Study|Physician Decision|1|||
161797880|NCT03019965|584302720|FG001|Overall Study|Physician Decision|1|||
161797881|NCT01513148|584302726|FG000|Overall Study|Protocol Violation|2|||
161797882|NCT01513148|584302727|FG001|Overall Study|Protocol Violation|2|||
161797883|NCT03552757|584302728|FG000|Overall Study|Withdrawal by Subject|10|||
161797884|NCT03552757|584302729|FG001|Overall Study|Withdrawal by Subject|5|||
161797885|NCT03552757|584302730|FG002|Overall Study|Withdrawal by Subject|12|||
161797886|NCT03552757|584302728|FG000|Overall Study|Lost to Follow-up|2|||
161797887|NCT03552757|584302729|FG001|Overall Study|Lost to Follow-up|7|||
161797888|NCT03552757|584302730|FG002|Overall Study|Lost to Follow-up|7|||
161797889|NCT03552757|584302728|FG000|Overall Study|Death|1|||
161797890|NCT03552757|584302729|FG001|Overall Study|Death|1|||
161797891|NCT03552757|584302730|FG002|Overall Study|Death|1|||
161797892|NCT02192099|584302733|FG000|Overall Study|Adverse Event|1|||
161901415|NCT01519817|584687046|FG002|Overall Study|Off study due to infection|0|||
162137707|NCT01959880|585553553|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
162137708|NCT01959880|585553554|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
162137709|NCT01959880|585553555|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
162137710|NCT01959880|585553552|FG000|Overall Study|Study completed early-FDA approved|1003|||
162137711|NCT01959880|585553553|FG001|Overall Study|Study completed early-FDA approved|311|||
161797893|NCT02192099|584302733|FG000|Overall Study|Lost to Follow-up|2|||
161797894|NCT02192099|584302733|FG000|Overall Study|Physician Decision|1|||
161797895|NCT02192099|584302733|FG000|Overall Study|Pregnancy|1|||
161797896|NCT02192099|584302733|FG000|Overall Study|Protocol Violation|8|||
161797897|NCT02192099|584302733|FG000|Overall Study|Study Terminated by Sponsor|32|||
161797898|NCT02192099|584302733|FG000|Overall Study|Withdrawal by Subject|11|||
161797899|NCT02192099|584302733|FG000|Overall Study|Miscellaneous Reasons|5|||
161797900|NCT00386009|584302734|FG000|Overall Study|Adverse Event|0|||
161797901|NCT00386009|584302735|FG001|Overall Study|Adverse Event|2|||
161797902|NCT00386009|584302734|FG000|Overall Study|Death|1|||
161797903|NCT00386009|584302735|FG001|Overall Study|Death|0|||
161797904|NCT00386009|584302734|FG000|Overall Study|Entry Criteria Not Met|0|||
161797905|NCT00386009|584302735|FG001|Overall Study|Entry Criteria Not Met|2|||
161797906|NCT00386009|584302734|FG000|Overall Study|Lost to Follow-up|1|||
161797907|NCT00386009|584302735|FG001|Overall Study|Lost to Follow-up|1|||
161797908|NCT00386009|584302734|FG000|Overall Study|Protocol Violation|1|||
161797909|NCT00386009|584302735|FG001|Overall Study|Protocol Violation|0|||
161797910|NCT00386009|584302734|FG000|Overall Study|Sponsor Decision|1|||
161901416|NCT01519817|584687047|FG003|Overall Study|Off study due to infection|1|||
161901417|NCT03934216|584687050|FG000|Overall Study|Other Reasons|5|||
161901418|NCT03934216|584687051|FG001|Overall Study|Other Reasons|5|||
161901419|NCT03934216|584687050|FG000|Overall Study|Adverse Event|22|||
161901420|NCT03934216|584687051|FG001|Overall Study|Adverse Event|11|||
161901421|NCT03934216|584687050|FG000|Overall Study|Lack of Efficacy|8|||
161901422|NCT03934216|584687051|FG001|Overall Study|Lack of Efficacy|7|||
161901423|NCT03934216|584687050|FG000|Overall Study|Lost to Follow-up|2|||
161901424|NCT03934216|584687051|FG001|Overall Study|Lost to Follow-up|0|||
161901425|NCT03934216|584687050|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161901426|NCT03934216|584687051|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161901427|NCT03934216|584687050|FG000|Overall Study|Pregnancy|1|||
161901428|NCT03934216|584687051|FG001|Overall Study|Pregnancy|0|||
161901429|NCT03934216|584687050|FG000|Overall Study|Withdrawal by Subject|18|||
161901430|NCT03934216|584687051|FG001|Overall Study|Withdrawal by Subject|6|||
161901431|NCT03934216|584687050|FG000|Overall Study|Randomized but not treated|1|||
161901432|NCT03934216|584687051|FG001|Overall Study|Randomized but not treated|1|||
161901433|NCT01396083|584687056|FG000|Overall Study|Adverse Event|2|||
161901434|NCT01396083|584687057|FG001|Overall Study|Adverse Event|28|||
161901435|NCT01396083|584687056|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161901436|NCT01396083|584687057|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
162137712|NCT01959880|585553554|FG002|Overall Study|Study completed early-FDA approved|179|||
162137713|NCT01959880|585553555|FG003|Overall Study|Study completed early-FDA approved|152|||
162137714|NCT01537133|585555570|FG000|Overall Study|Withdrawal by Subject|2|||
162137715|NCT01537133|585555571|FG001|Overall Study|Withdrawal by Subject|0|||
162137716|NCT01537133|585555572|FG002|Overall Study|Withdrawal by Subject|0|||
162137717|NCT01537133|585555573|FG003|Overall Study|Withdrawal by Subject|0|||
162137718|NCT01537133|585555570|FG000|Overall Study|Lost to Follow-up|1|||
162137719|NCT01537133|585555571|FG001|Overall Study|Lost to Follow-up|0|||
162137720|NCT01537133|585555572|FG002|Overall Study|Lost to Follow-up|0|||
162137721|NCT01537133|585555573|FG003|Overall Study|Lost to Follow-up|0|||
162137722|NCT00157014|585555574|FG000|Overall Study|Death|4|||
162137723|NCT00157014|585555575|FG001|Overall Study|Death|2|||
162137724|NCT00157014|585555576|FG002|Overall Study|Death|1|||
162137725|NCT00157014|585555577|FG003|Overall Study|Death|1|||
162137726|NCT00157014|585555574|FG000|Overall Study|Physician Decision|0|||
162137727|NCT00157014|585555575|FG001|Overall Study|Physician Decision|1|||
162137728|NCT00157014|585555576|FG002|Overall Study|Physician Decision|0|||
162137729|NCT00157014|585555577|FG003|Overall Study|Physician Decision|0|||
162137730|NCT00157014|585555574|FG000|Overall Study|Medications withdrawn on family request|0|||
162137731|NCT00157014|585555575|FG001|Overall Study|Medications withdrawn on family request|1|||
161901437|NCT01396083|584687056|FG000|Overall Study|Consent withdrawn|4|||
161901438|NCT01396083|584687057|FG001|Overall Study|Consent withdrawn|5|||
161901439|NCT01396083|584687056|FG000|Overall Study|Protocol deviation(s)|0|||
161901440|NCT01396083|584687057|FG001|Overall Study|Protocol deviation(s)|1|||
162137732|NCT00157014|585555576|FG002|Overall Study|Medications withdrawn on family request|0|||
162137733|NCT00157014|585555577|FG003|Overall Study|Medications withdrawn on family request|0|||
162137734|NCT00157014|585555574|FG000|Overall Study|Patient withdrawn by investigator|1|||
161797911|NCT00386009|584302735|FG001|Overall Study|Sponsor Decision|1|||
161797912|NCT00386009|584302734|FG000|Overall Study|Withdrawal by Subject|5|||
161797913|NCT00386009|584302735|FG001|Overall Study|Withdrawal by Subject|4|||
161797914|NCT01862328|584302745|FG000|Overall Study|Progressive Disease|3|||
161797915|NCT01862328|584302746|FG001|Overall Study|Progressive Disease|11|||
161797916|NCT01862328|584302747|FG002|Overall Study|Progressive Disease|5|||
161797917|NCT01862328|584302748|FG003|Overall Study|Progressive Disease|6|||
161797918|NCT01862328|584302749|FG004|Overall Study|Progressive Disease|7|||
161797919|NCT01862328|584302750|FG005|Overall Study|Progressive Disease|4|||
161797920|NCT01862328|584302751|FG006|Overall Study|Progressive Disease|3|||
161797921|NCT01862328|584302745|FG000|Overall Study|Adverse Event|0|||
161797922|NCT01862328|584302746|FG001|Overall Study|Adverse Event|4|||
161797923|NCT01862328|584302747|FG002|Overall Study|Adverse Event|0|||
161797924|NCT01862328|584302748|FG003|Overall Study|Adverse Event|1|||
161797925|NCT01862328|584302749|FG004|Overall Study|Adverse Event|0|||
161797926|NCT01862328|584302750|FG005|Overall Study|Adverse Event|2|||
161797927|NCT01862328|584302751|FG006|Overall Study|Adverse Event|4|||
161797928|NCT01862328|584302745|FG000|Overall Study|Other|0|||
161797929|NCT01862328|584302746|FG001|Overall Study|Other|2|||
161797930|NCT01862328|584302747|FG002|Overall Study|Other|1|||
161797931|NCT01862328|584302748|FG003|Overall Study|Other|0|||
161797932|NCT01862328|584302749|FG004|Overall Study|Other|4|||
161797933|NCT01862328|584302750|FG005|Overall Study|Other|0|||
161797934|NCT01862328|584302751|FG006|Overall Study|Other|1|||
161797935|NCT01862328|584302745|FG000|Overall Study|Withdrawal by Subject|1|||
161797936|NCT01862328|584302746|FG001|Overall Study|Withdrawal by Subject|1|||
161797937|NCT01862328|584302747|FG002|Overall Study|Withdrawal by Subject|0|||
161797938|NCT01862328|584302748|FG003|Overall Study|Withdrawal by Subject|0|||
161797939|NCT01862328|584302749|FG004|Overall Study|Withdrawal by Subject|1|||
161797940|NCT01862328|584302750|FG005|Overall Study|Withdrawal by Subject|1|||
161797941|NCT01862328|584302751|FG006|Overall Study|Withdrawal by Subject|1|||
161797942|NCT01862328|584302745|FG000|Overall Study|Symptomatic Deterioration|0|||
161797943|NCT01862328|584302746|FG001|Overall Study|Symptomatic Deterioration|0|||
161797944|NCT01862328|584302747|FG002|Overall Study|Symptomatic Deterioration|0|||
161797945|NCT01862328|584302748|FG003|Overall Study|Symptomatic Deterioration|0|||
161797946|NCT01862328|584302749|FG004|Overall Study|Symptomatic Deterioration|0|||
161797947|NCT01862328|584302750|FG005|Overall Study|Symptomatic Deterioration|0|||
161797948|NCT01862328|584302751|FG006|Overall Study|Symptomatic Deterioration|1|||
161797949|NCT00936975|584302752|FG000|Overall Study|Withdrawal by Subject|1|||
161797950|NCT00936975|584302752|FG000|Overall Study|Disease progression|3|||
161797951|NCT00936975|584302752|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
161797952|NCT01656889|584302756|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
161797953|NCT01656889|584302757|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
161797954|NCT01656889|584302756|FG000|Treatment Period, 12 Weeks|Death|0|||
161797955|NCT01656889|584302757|FG001|Treatment Period, 12 Weeks|Death|1|||
161797956|NCT01656889|584302756|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
161797957|NCT01656889|584302757|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
161797958|NCT01656889|584302756|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
161797959|NCT01656889|584302757|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
161797960|NCT01656889|584302756|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
161797961|NCT01656889|584302757|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
161797962|NCT01656889|584302756|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
161797963|NCT01656889|584302757|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
161797964|NCT01656889|584302756|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
161797965|NCT01656889|584302757|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
161797966|NCT01656889|584302756|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
161797967|NCT01656889|584302757|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
161797968|NCT01656889|584302756|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
161797969|NCT01656889|584302757|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
161797970|NCT01656889|584302756|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
161797971|NCT01656889|584302757|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
161797972|NCT02486796|584302758|FG000|Overall Study|Withdrawal by Subject|1|||
161797973|NCT02486796|584302759|FG001|Overall Study|Withdrawal by Subject|1|||
161901441|NCT01396083|584687056|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161797974|NCT02486796|584302758|FG000|Overall Study|Physician Decision|1|||
161797975|NCT02486796|584302759|FG001|Overall Study|Physician Decision|0|||
162010869|NCT00870740|585096033|FG004|Overall Study|Death|1|||
161797976|NCT03276975|584302760|FG000|Overall Study|Withdrawal by Subject|1|||
161797977|NCT03276975|584302761|FG001|Overall Study|Withdrawal by Subject|0|||
161797978|NCT00306384|584302764|FG000|Overall Study|Adverse Event|103|||
161797979|NCT00306384|584302765|FG001|Overall Study|Adverse Event|87|||
161797980|NCT00306384|584302766|FG002|Overall Study|Adverse Event|40|||
161797981|NCT00306384|584302764|FG000|Overall Study|Major protocol deviation|43|||
161797982|NCT00306384|584302765|FG001|Overall Study|Major protocol deviation|51|||
161797983|NCT00306384|584302766|FG002|Overall Study|Major protocol deviation|18|||
161797984|NCT00306384|584302764|FG000|Overall Study|Lost to Follow-up|57|||
161797985|NCT00306384|584302765|FG001|Overall Study|Lost to Follow-up|41|||
161901442|NCT01396083|584687057|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161901443|NCT01396083|584687056|FG000|Overall Study|Administrative problems|1|||
161901444|NCT01396083|584687057|FG001|Overall Study|Administrative problems|0|||
161901445|NCT01396083|584687056|FG000|Overall Study|Lost to Follow-up|1|||
161901446|NCT01396083|584687057|FG001|Overall Study|Lost to Follow-up|0|||
161901447|NCT01063855|584687058|FG000|Overall Study|Adverse Event|4|||
161901448|NCT01063855|584687059|FG001|Overall Study|Adverse Event|4|||
161901449|NCT01063855|584687058|FG000|Overall Study|Death|0|||
161901450|NCT01063855|584687059|FG001|Overall Study|Death|1|||
161901451|NCT01063855|584687058|FG000|Overall Study|Lost to Follow-up|8|||
161901452|NCT01063855|584687059|FG001|Overall Study|Lost to Follow-up|4|||
161901453|NCT01063855|584687058|FG000|Overall Study|Pregnancy|1|||
161901454|NCT01063855|584687059|FG001|Overall Study|Pregnancy|0|||
161901455|NCT01063855|584687058|FG000|Overall Study|Lack of Efficacy|0|||
161901456|NCT01063855|584687059|FG001|Overall Study|Lack of Efficacy|1|||
161901457|NCT01063855|584687058|FG000|Overall Study|Withdrawal by Subject|11|||
161901458|NCT01063855|584687059|FG001|Overall Study|Withdrawal by Subject|8|||
161901459|NCT01063855|584687058|FG000|Overall Study|Reason not specified|13|||
161901460|NCT01063855|584687059|FG001|Overall Study|Reason not specified|11|||
161901461|NCT01165307|584687060|FG000|Overall Study|Lost to Follow-up|11|||
161901462|NCT01165307|584687061|FG001|Overall Study|Lost to Follow-up|3|||
161901463|NCT01165307|584687060|FG000|Overall Study|Withdrawal by Subject|2|||
161901464|NCT01165307|584687061|FG001|Overall Study|Withdrawal by Subject|0|||
161901465|NCT01165307|584687060|FG000|Overall Study|Subject not available for contact|1|||
161901466|NCT01165307|584687061|FG001|Overall Study|Subject not available for contact|0|||
161901467|NCT03234036|584687063|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
161901468|NCT03234036|584687064|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
161901469|NCT03234036|584687065|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
161901470|NCT03234036|584687066|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
161901471|NCT02683239|584687086|FG000|Overall Study|Protocol Violation|35|||
161901472|NCT02683239|584687087|FG001|Overall Study|Protocol Violation|23|||
161901473|NCT02683239|584687088|FG002|Overall Study|Protocol Violation|26|||
161901474|NCT02683239|584687089|FG003|Overall Study|Protocol Violation|4|||
161901475|NCT02683239|584687090|FG004|Overall Study|Protocol Violation|35|||
161901476|NCT02683239|584687091|FG005|Overall Study|Protocol Violation|4|||
161901477|NCT02683239|584687092|FG006|Overall Study|Protocol Violation|5|||
161901478|NCT02683239|584687086|FG000|Overall Study|Adverse Event|64|||
161901479|NCT02683239|584687087|FG001|Overall Study|Adverse Event|39|||
161901480|NCT02683239|584687088|FG002|Overall Study|Adverse Event|42|||
161901481|NCT02683239|584687089|FG003|Overall Study|Adverse Event|16|||
161901482|NCT02683239|584687090|FG004|Overall Study|Adverse Event|189|||
161901483|NCT02683239|584687091|FG005|Overall Study|Adverse Event|9|||
161901484|NCT02683239|584687092|FG006|Overall Study|Adverse Event|9|||
161901485|NCT02683239|584687086|FG000|Overall Study|Physician Decision|38|||
161901486|NCT02683239|584687087|FG001|Overall Study|Physician Decision|19|||
161901487|NCT02683239|584687088|FG002|Overall Study|Physician Decision|14|||
161901488|NCT02683239|584687089|FG003|Overall Study|Physician Decision|73|||
161901489|NCT02683239|584687090|FG004|Overall Study|Physician Decision|143|||
161901490|NCT02683239|584687091|FG005|Overall Study|Physician Decision|14|||
161901491|NCT02683239|584687092|FG006|Overall Study|Physician Decision|15|||
161901492|NCT02683239|584687086|FG000|Overall Study|Withdrawal by Subject|187|||
161901493|NCT02683239|584687087|FG001|Overall Study|Withdrawal by Subject|99|||
161901494|NCT02683239|584687088|FG002|Overall Study|Withdrawal by Subject|91|||
161901495|NCT02683239|584687089|FG003|Overall Study|Withdrawal by Subject|18|||
161901496|NCT02683239|584687090|FG004|Overall Study|Withdrawal by Subject|248|||
161901497|NCT02683239|584687091|FG005|Overall Study|Withdrawal by Subject|22|||
162137735|NCT00157014|585555575|FG001|Overall Study|Patient withdrawn by investigator|0|||
162137736|NCT00157014|585555576|FG002|Overall Study|Patient withdrawn by investigator|0|||
162137737|NCT00157014|585555577|FG003|Overall Study|Patient withdrawn by investigator|0|||
162137738|NCT00157014|585555574|FG000|Overall Study|Patient unable to return in nursing home|1|||
161901498|NCT02683239|584687092|FG006|Overall Study|Withdrawal by Subject|28|||
161901499|NCT02683239|584687086|FG000|Overall Study|Lost to Follow-up|77|||
161901500|NCT02683239|584687087|FG001|Overall Study|Lost to Follow-up|24|||
161901501|NCT02683239|584687088|FG002|Overall Study|Lost to Follow-up|25|||
161901502|NCT02683239|584687089|FG003|Overall Study|Lost to Follow-up|7|||
161901503|NCT02683239|584687090|FG004|Overall Study|Lost to Follow-up|88|||
161901504|NCT02683239|584687091|FG005|Overall Study|Lost to Follow-up|8|||
161901505|NCT02683239|584687092|FG006|Overall Study|Lost to Follow-up|11|||
161901506|NCT02683239|584687086|FG000|Overall Study|Death|9|||
161901507|NCT02683239|584687087|FG001|Overall Study|Death|5|||
161901508|NCT02683239|584687088|FG002|Overall Study|Death|8|||
161901509|NCT02683239|584687089|FG003|Overall Study|Death|0|||
161901510|NCT02683239|584687090|FG004|Overall Study|Death|12|||
161901511|NCT02683239|584687091|FG005|Overall Study|Death|1|||
161901512|NCT02683239|584687092|FG006|Overall Study|Death|0|||
161901513|NCT02683239|584687086|FG000|Overall Study|Lack of Efficacy|50|||
161901514|NCT02683239|584687087|FG001|Overall Study|Lack of Efficacy|23|||
161901515|NCT02683239|584687088|FG002|Overall Study|Lack of Efficacy|12|||
161901516|NCT02683239|584687089|FG003|Overall Study|Lack of Efficacy|2|||
161901517|NCT02683239|584687090|FG004|Overall Study|Lack of Efficacy|29|||
161901518|NCT02683239|584687091|FG005|Overall Study|Lack of Efficacy|2|||
161901519|NCT02683239|584687092|FG006|Overall Study|Lack of Efficacy|3|||
161901520|NCT02683239|584687086|FG000|Overall Study|Missing data|0|||
161901521|NCT02683239|584687087|FG001|Overall Study|Missing data|1|||
161901522|NCT02683239|584687088|FG002|Overall Study|Missing data|1|||
161901523|NCT02683239|584687089|FG003|Overall Study|Missing data|0|||
161901524|NCT02683239|584687090|FG004|Overall Study|Missing data|1|||
161901525|NCT02683239|584687091|FG005|Overall Study|Missing data|0|||
161901526|NCT02683239|584687092|FG006|Overall Study|Missing data|0|||
161901527|NCT00521365|584687095|FG000|Overall Study|Adverse Event|3|||
161901528|NCT00521365|584687095|FG000|Overall Study|Lost to Follow-up|6|||
161901529|NCT00521365|584687095|FG000|Overall Study|Protocol deviation|2|||
161901530|NCT00521365|584687095|FG000|Overall Study|Drug compliance|3|||
161901531|NCT00521365|584687095|FG000|Overall Study|Usage of not allowed drugs|6|||
161901532|NCT01718483|584687096|FG000|Overall Study|Withdrawal by Subject|14|||
161901533|NCT01718483|584687097|FG001|Overall Study|Withdrawal by Subject|12|||
161797986|NCT00306384|584302766|FG002|Overall Study|Lost to Follow-up|35|||
161797987|NCT00306384|584302764|FG000|Overall Study|Voluntary withdrawal|199|||
161797988|NCT00306384|584302765|FG001|Overall Study|Voluntary withdrawal|187|||
161797989|NCT00306384|584302766|FG002|Overall Study|Voluntary withdrawal|91|||
161797990|NCT00306384|584302764|FG000|Overall Study|Study termination|1|||
161797991|NCT00306384|584302765|FG001|Overall Study|Study termination|0|||
161797992|NCT00306384|584302766|FG002|Overall Study|Study termination|1|||
161797993|NCT00306384|584302764|FG000|Overall Study|Pregnancy|3|||
161797994|NCT00306384|584302765|FG001|Overall Study|Pregnancy|1|||
161797995|NCT00306384|584302766|FG002|Overall Study|Pregnancy|1|||
161797996|NCT00306384|584302764|FG000|Overall Study|Lack of Efficacy|26|||
161797997|NCT00306384|584302765|FG001|Overall Study|Lack of Efficacy|40|||
161797998|NCT00306384|584302766|FG002|Overall Study|Lack of Efficacy|38|||
161797999|NCT00306384|584302764|FG000|Overall Study|Investigator discretion|28|||
161798000|NCT00306384|584302765|FG001|Overall Study|Investigator discretion|31|||
161798001|NCT00306384|584302766|FG002|Overall Study|Investigator discretion|21|||
161798002|NCT00306384|584302764|FG000|Overall Study|Other|80|||
161798003|NCT00306384|584302765|FG001|Overall Study|Other|70|||
161798004|NCT00306384|584302766|FG002|Overall Study|Other|32|||
161798005|NCT00306384|584302764|FG000|Overall Study|Site closure|2|||
161798006|NCT00306384|584302765|FG001|Overall Study|Site closure|0|||
161798007|NCT00306384|584302766|FG002|Overall Study|Site closure|0|||
161798008|NCT02275364|584302767|FG000|Period 1|Withdrawal by Subject|1|||
161901534|NCT01718483|584687096|FG000|Overall Study|Adverse Event|5|||
161901535|NCT01718483|584687097|FG001|Overall Study|Adverse Event|12|||
162010870|NCT00870740|585096034|FG005|Overall Study|Death|0|||
162137739|NCT00157014|585555575|FG001|Overall Study|Patient unable to return in nursing home|0|||
162137740|NCT00157014|585555576|FG002|Overall Study|Patient unable to return in nursing home|0|||
162137741|NCT00157014|585555577|FG003|Overall Study|Patient unable to return in nursing home|0|||
162137742|NCT00157014|585555574|FG000|Overall Study|Patient would not receive transplant|0|||
162137743|NCT00157014|585555575|FG001|Overall Study|Patient would not receive transplant|1|||
162137744|NCT00157014|585555576|FG002|Overall Study|Patient would not receive transplant|0|||
162137745|NCT00157014|585555577|FG003|Overall Study|Patient would not receive transplant|0|||
162137746|NCT00157014|585555574|FG000|Overall Study|Withdrawal by Subject|1|||
162137747|NCT00157014|585555575|FG001|Overall Study|Withdrawal by Subject|0|||
162137748|NCT00157014|585555576|FG002|Overall Study|Withdrawal by Subject|0|||
162137749|NCT00157014|585555577|FG003|Overall Study|Withdrawal by Subject|0|||
162137750|NCT01362491|585555578|FG000|Overall Study|Ineligible|1|||
162137751|NCT01362491|585555579|FG001|Overall Study|Ineligible|0|||
162137752|NCT01362491|585555580|FG002|Overall Study|Ineligible|0|||
162137753|NCT05355116|585555581|FG000|Overall Study|Withdrawal by Subject|2|||
162137754|NCT00349908|585555582|FG000|Overall Study|Withdrawal by Subject|0|||
162137755|NCT00349908|585555583|FG001|Overall Study|Withdrawal by Subject|4|||
162137756|NCT01289119|585555587|FG000|Overall Study|Adverse Event|2|||
162137757|NCT01289119|585555588|FG001|Overall Study|Adverse Event|1|||
162137758|NCT01289119|585555589|FG002|Overall Study|Adverse Event|0|||
162137759|NCT01289119|585555590|FG003|Overall Study|Adverse Event|2|||
162137760|NCT01289119|585555591|FG004|Overall Study|Adverse Event|1|||
161798009|NCT02275364|584302768|FG001|Period 1|Withdrawal by Subject|0|||
161798010|NCT02275364|584302767|FG000|Period 1|Other reason|1|||
161901536|NCT01718483|584687096|FG000|Overall Study|Lost to Follow-up|8|||
162137761|NCT01289119|585555592|FG005|Overall Study|Adverse Event|0|||
162137762|NCT01289119|585555587|FG000|Overall Study|Major Protocol Deviation|2|||
162137763|NCT01289119|585555588|FG001|Overall Study|Major Protocol Deviation|1|||
162137764|NCT01289119|585555589|FG002|Overall Study|Major Protocol Deviation|3|||
161798011|NCT02275364|584302768|FG001|Period 1|Other reason|0|||
161798012|NCT01463683|584302771|FG000|Overall Study|Adverse Event|2|||
161901537|NCT01718483|584687097|FG001|Overall Study|Lost to Follow-up|3|||
161901538|NCT01718483|584687096|FG000|Overall Study|Protocol Violation|4|||
161901539|NCT01718483|584687097|FG001|Overall Study|Protocol Violation|2|||
162010871|NCT00870740|585096029|FG000|Overall Study|Other|2|||
161901540|NCT01718483|584687096|FG000|Overall Study|Other|1|||
161901541|NCT01718483|584687097|FG001|Overall Study|Other|4|||
161901542|NCT01718483|584687096|FG000|Overall Study|Pregnancy|1|||
161901543|NCT01718483|584687097|FG001|Overall Study|Pregnancy|1|||
161901544|NCT01718483|584687096|FG000|Overall Study|Lack of Efficacy|1|||
161901545|NCT01718483|584687097|FG001|Overall Study|Lack of Efficacy|0|||
161901546|NCT00130689|584687100|FG000|Overall Study|Progressive Disease|29|||
161901547|NCT00130689|584687100|FG000|Overall Study|Death|1|||
161901548|NCT00130689|584687100|FG000|Overall Study|Clinical Deterioration|4|||
161901549|NCT00130689|584687100|FG000|Overall Study|Withdrawal by Subject|3|||
161901550|NCT00130689|584687100|FG000|Overall Study|Ineligible|6|||
161901551|NCT00048035|584687101|FG000|Core Period|Early Withdrawals|4|||
161901552|NCT00048035|584687102|FG001|Core Period|Early Withdrawals|2|||
161901553|NCT00048035|584687103|FG002|Core Period|Early Withdrawals|1|||
161901554|NCT00048035|584687104|FG003|Core Period|Early Withdrawals|1|||
161901555|NCT00048035|584687105|FG004|Core Period|Early Withdrawals|1|||
161901556|NCT00048035|584687106|FG005|Core Period|Early Withdrawals|1|||
161901557|NCT00048035|584687107|FG006|Core Period|Early Withdrawals|0|||
161901558|NCT00048035|584687108|FG007|Core Period|Early Withdrawals|0|||
161901559|NCT00048035|584687101|FG000|Extension Year 1|Early Withdrawals|0|||
161901560|NCT00048035|584687102|FG001|Extension Year 1|Early Withdrawals|0|||
161901561|NCT00048035|584687103|FG002|Extension Year 1|Early Withdrawals|0|||
161901562|NCT00048035|584687104|FG003|Extension Year 1|Early Withdrawals|0|||
161901563|NCT00048035|584687105|FG004|Extension Year 1|Early Withdrawals|0|||
161901564|NCT00048035|584687106|FG005|Extension Year 1|Early Withdrawals|0|||
161901565|NCT00048035|584687107|FG006|Extension Year 1|Early Withdrawals|11|||
161901566|NCT00048035|584687108|FG007|Extension Year 1|Early Withdrawals|11|||
161901567|NCT00048035|584687101|FG000|Extension Year 2|Early Withdrawals|0|||
161901568|NCT00048035|584687102|FG001|Extension Year 2|Early Withdrawals|0|||
161901569|NCT00048035|584687103|FG002|Extension Year 2|Early Withdrawals|0|||
161901570|NCT00048035|584687104|FG003|Extension Year 2|Early Withdrawals|0|||
161901571|NCT00048035|584687105|FG004|Extension Year 2|Early Withdrawals|0|||
161901572|NCT00048035|584687106|FG005|Extension Year 2|Early Withdrawals|0|||
161901573|NCT00048035|584687107|FG006|Extension Year 2|Early Withdrawals|3|||
161901574|NCT00048035|584687108|FG007|Extension Year 2|Early Withdrawals|3|||
161901575|NCT01265394|584687123|FG000|Overall Study|Subjects withdrawn|37|||
161901576|NCT05417412|584687129|FG000|Overall Study|Lost to Follow-up|2|||
161901577|NCT01576575|584687130|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
161901578|NCT01576575|584687130|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
161901579|NCT01576575|584687130|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
161901580|NCT01723072|584687135|FG000|Overall Study|Withdrawal by Subject|7|||
161901581|NCT01723072|584687136|FG001|Overall Study|Withdrawal by Subject|13|||
161901582|NCT01723072|584687135|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
161901583|NCT01723072|584687136|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
161901584|NCT01723072|584687135|FG000|Overall Study|Other|4|||
161901585|NCT01723072|584687136|FG001|Overall Study|Other|3|||
161901586|NCT01841970|584687137|FG000|Overall Study|Withdrawal by Subject|1|||
161901587|NCT01841970|584687137|FG000|Overall Study|Physician Decision|2|||
161901588|NCT01841970|584687137|FG000|Overall Study|Lost to Follow-up|8|||
161901589|NCT01610037|584687144|FG000|All Patients|Adverse Event|27|||
161901590|NCT01610037|584687145|FG001|All Patients|Adverse Event|22|||
161901591|NCT01610037|584687146|FG002|All Patients|Adverse Event|26|||
161901592|NCT01610037|584687144|FG000|All Patients|Withdrawal by Subject|12|||
161901593|NCT01610037|584687145|FG001|All Patients|Withdrawal by Subject|10|||
161901594|NCT01610037|584687146|FG002|All Patients|Withdrawal by Subject|20|||
161901595|NCT01610037|584687144|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
161901596|NCT01610037|584687145|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
161901597|NCT01610037|584687146|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
162137765|NCT01289119|585555590|FG003|Overall Study|Major Protocol Deviation|0|||
162137766|NCT01289119|585555591|FG004|Overall Study|Major Protocol Deviation|2|||
162137767|NCT01289119|585555592|FG005|Overall Study|Major Protocol Deviation|1|||
162137768|NCT01289119|585555587|FG000|Overall Study|Lost to Follow-up|0|||
162137769|NCT01289119|585555588|FG001|Overall Study|Lost to Follow-up|3|||
162137770|NCT01289119|585555589|FG002|Overall Study|Lost to Follow-up|0|||
162137771|NCT01289119|585555590|FG003|Overall Study|Lost to Follow-up|0|||
161901598|NCT01610037|584687144|FG000|All Patients|Death|4|||
161901599|NCT01610037|584687145|FG001|All Patients|Death|2|||
161901600|NCT01610037|584687146|FG002|All Patients|Death|1|||
161901601|NCT01610037|584687144|FG000|All Patients|Protocol deviation|4|||
161901602|NCT01610037|584687145|FG001|All Patients|Protocol deviation|3|||
161901603|NCT01610037|584687146|FG002|All Patients|Protocol deviation|3|||
161901604|NCT01610037|584687144|FG000|All Patients|Abnormal laboratory value|1|||
161901605|NCT01610037|584687145|FG001|All Patients|Abnormal laboratory value|1|||
161901606|NCT01610037|584687146|FG002|All Patients|Abnormal laboratory value|0|||
161901607|NCT01610037|584687144|FG000|All Patients|Administrative problems|1|||
161901608|NCT01610037|584687145|FG001|All Patients|Administrative problems|4|||
162137772|NCT01289119|585555591|FG004|Overall Study|Lost to Follow-up|0|||
161901609|NCT01610037|584687146|FG002|All Patients|Administrative problems|4|||
161901610|NCT01610037|584687144|FG000|All Patients|Lost to Follow-up|1|||
161901611|NCT01610037|584687145|FG001|All Patients|Lost to Follow-up|0|||
161901612|NCT01610037|584687146|FG002|All Patients|Lost to Follow-up|0|||
161901613|NCT01610037|584687144|FG000|All Patients|Abnormal test procedure result(s)|0|||
161901614|NCT01610037|584687145|FG001|All Patients|Abnormal test procedure result(s)|1|||
161901615|NCT01610037|584687146|FG002|All Patients|Abnormal test procedure result(s)|3|||
161901616|NCT01610037|584687144|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
161901617|NCT01610037|584687145|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
161901618|NCT01610037|584687146|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
161901619|NCT01610037|584687144|FG000|Treatment and Follow up Period|Death|10|||
161901620|NCT01610037|584687145|FG001|Treatment and Follow up Period|Death|5|||
161901621|NCT01610037|584687146|FG002|Treatment and Follow up Period|Death|4|||
161901622|NCT01610037|584687144|FG000|Treatment and Follow up Period|Administrative problems|1|||
161901623|NCT01610037|584687145|FG001|Treatment and Follow up Period|Administrative problems|3|||
161901624|NCT01610037|584687146|FG002|Treatment and Follow up Period|Administrative problems|2|||
161901625|NCT01610037|584687144|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
161901626|NCT01610037|584687145|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
161901627|NCT01610037|584687146|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
161901628|NCT00274742|584687147|FG000|Overall Study|Adverse Event|0|||
161901629|NCT00274742|584687148|FG001|Overall Study|Adverse Event|4|||
161901630|NCT00274742|584687149|FG002|Overall Study|Adverse Event|1|||
161901631|NCT00274742|584687150|FG003|Overall Study|Adverse Event|4|||
161901632|NCT00274742|584687151|FG004|Overall Study|Adverse Event|12|||
161901633|NCT00274742|584687152|FG005|Overall Study|Adverse Event|3|||
161901634|NCT00274742|584687147|FG000|Overall Study|Lost to Follow-up|0|||
161901635|NCT00274742|584687148|FG001|Overall Study|Lost to Follow-up|0|||
161901636|NCT00274742|584687149|FG002|Overall Study|Lost to Follow-up|0|||
161901637|NCT00274742|584687150|FG003|Overall Study|Lost to Follow-up|0|||
161901638|NCT00274742|584687151|FG004|Overall Study|Lost to Follow-up|1|||
161901639|NCT00274742|584687152|FG005|Overall Study|Lost to Follow-up|0|||
161901640|NCT00274742|584687147|FG000|Overall Study|End of Study|0|||
161901641|NCT00274742|584687148|FG001|Overall Study|End of Study|0|||
161901642|NCT00274742|584687149|FG002|Overall Study|End of Study|0|||
161901643|NCT00274742|584687150|FG003|Overall Study|End of Study|1|||
161901644|NCT00274742|584687151|FG004|Overall Study|End of Study|0|||
161901645|NCT00274742|584687152|FG005|Overall Study|End of Study|0|||
161901646|NCT00274742|584687147|FG000|Overall Study|Disease Progression|0|||
161901647|NCT00274742|584687148|FG001|Overall Study|Disease Progression|1|||
161901648|NCT00274742|584687149|FG002|Overall Study|Disease Progression|1|||
161901649|NCT00274742|584687150|FG003|Overall Study|Disease Progression|0|||
161901650|NCT00274742|584687151|FG004|Overall Study|Disease Progression|1|||
161901651|NCT00274742|584687152|FG005|Overall Study|Disease Progression|0|||
161901652|NCT00274742|584687147|FG000|Overall Study|Other|0|||
161901653|NCT00274742|584687148|FG001|Overall Study|Other|3|||
161901654|NCT00274742|584687149|FG002|Overall Study|Other|0|||
161901655|NCT00274742|584687150|FG003|Overall Study|Other|0|||
161901656|NCT00274742|584687151|FG004|Overall Study|Other|2|||
161901657|NCT00274742|584687152|FG005|Overall Study|Other|0|||
161901658|NCT00069823|584687163|FG000|Overall Study|Did not have follow-up diary cards|6|||
161901659|NCT00069823|584687164|FG001|Overall Study|Did not have follow-up diary cards|3|||
161901660|NCT01801111|584687165|FG000|Overall Study|Adverse Event|12|||
161901661|NCT01801111|584687165|FG000|Overall Study|Death|8|||
161901662|NCT01801111|584687165|FG000|Overall Study|Physician Decision|5|||
161901663|NCT01801111|584687165|FG000|Overall Study|Other|1|||
161901664|NCT01801111|584687165|FG000|Overall Study|Withdrawal by Subject|4|||
161901665|NCT01801111|584687165|FG000|Overall Study|Study Terminated by Sponsor|27|||
161901666|NCT01801111|584687165|FG000|Overall Study|Progressive Disease|81|||
161901667|NCT01210482|584687166|FG000|Overall Study|Protocol Violation|1|||
161901668|NCT01210482|584687166|FG000|Overall Study|Case Report Forms were not collected|18|||
161901669|NCT01210482|584687166|FG000|Overall Study|Duplicated|2|||
161901670|NCT01210482|584687166|FG000|Overall Study|No Drug Administration|28|||
162137773|NCT01289119|585555592|FG005|Overall Study|Lost to Follow-up|1|||
162137774|NCT01289119|585555587|FG000|Overall Study|Withdrawal by Subject|4|||
162137775|NCT01289119|585555588|FG001|Overall Study|Withdrawal by Subject|2|||
161901671|NCT01223937|584687167|FG000|Overall Study|Withdrawal by Subject|3|||
161901672|NCT01223937|584687168|FG001|Overall Study|Withdrawal by Subject|2|||
161901673|NCT01223937|584687167|FG000|Overall Study|Lost to Follow-up|1|||
161901674|NCT01223937|584687168|FG001|Overall Study|Lost to Follow-up|4|||
161901675|NCT01223937|584687167|FG000|Overall Study|Adverse Event|1|||
161901676|NCT01223937|584687168|FG001|Overall Study|Adverse Event|4|||
161901677|NCT01223937|584687167|FG000|Overall Study|Protocol Violation|8|||
161901678|NCT01223937|584687168|FG001|Overall Study|Protocol Violation|7|||
161901679|NCT01223937|584687167|FG000|Overall Study|Other|4|||
161901680|NCT01223937|584687168|FG001|Overall Study|Other|1|||
161901681|NCT05176717|584687169|FG000|Overall Study|Sponsor Decision|1|||
161901682|NCT05176717|584687170|FG001|Overall Study|Sponsor Decision|2|||
162137776|NCT01289119|585555589|FG002|Overall Study|Withdrawal by Subject|4|||
161901683|NCT05176717|584687171|FG002|Overall Study|Sponsor Decision|2|||
161901684|NCT03284853|584687172|FG000|Overall Study|Adverse Event|40|||
161901685|NCT03284853|584687173|FG001|Overall Study|Adverse Event|4|||
161901686|NCT03284853|584687172|FG000|Overall Study|Withdrawal by Subject|5|||
161901687|NCT03284853|584687173|FG001|Overall Study|Withdrawal by Subject|1|||
161901688|NCT03284853|584687172|FG000|Overall Study|Lost to Follow-up|1|||
161901689|NCT03284853|584687173|FG001|Overall Study|Lost to Follow-up|0|||
161901690|NCT03284853|584687172|FG000|Overall Study|Lack of Efficacy|1|||
161901691|NCT03284853|584687173|FG001|Overall Study|Lack of Efficacy|0|||
161901692|NCT03284853|584687172|FG000|Overall Study|Disallowed Concurrent Medication|1|||
161901693|NCT03284853|584687173|FG001|Overall Study|Disallowed Concurrent Medication|1|||
161901694|NCT03284853|584687172|FG000|Overall Study|Protocol Violation|3|||
161901695|NCT03284853|584687173|FG001|Overall Study|Protocol Violation|3|||
161901696|NCT03284853|584687172|FG000|Overall Study|Death|0|||
161798013|NCT01463683|584302772|FG001|Overall Study|Adverse Event|0|||
161798014|NCT01463683|584302773|FG002|Overall Study|Adverse Event|0|||
161798015|NCT01463683|584302771|FG000|Overall Study|Lost to Follow-up|10|||
161798016|NCT01463683|584302772|FG001|Overall Study|Lost to Follow-up|9|||
161798017|NCT01463683|584302773|FG002|Overall Study|Lost to Follow-up|7|||
161798018|NCT01463683|584302771|FG000|Overall Study|Physician Decision|0|||
161798019|NCT01463683|584302772|FG001|Overall Study|Physician Decision|3|||
161798020|NCT01463683|584302773|FG002|Overall Study|Physician Decision|1|||
161798021|NCT01463683|584302771|FG000|Overall Study|Pregnancy|2|||
161798022|NCT01463683|584302772|FG001|Overall Study|Pregnancy|2|||
161798023|NCT01463683|584302773|FG002|Overall Study|Pregnancy|1|||
161798024|NCT01463683|584302771|FG000|Overall Study|Withdrawal by Subject|5|||
161798025|NCT01463683|584302772|FG001|Overall Study|Withdrawal by Subject|17|||
161798026|NCT01463683|584302773|FG002|Overall Study|Withdrawal by Subject|2|||
161798027|NCT03111147|584302774|FG000|Overall Study|Lost to Follow-up|2|||
161798028|NCT03111147|584302775|FG001|Overall Study|Lost to Follow-up|5|||
161798029|NCT03111147|584302774|FG000|Overall Study|Withdrawal by Subject|4|||
161798030|NCT03111147|584302775|FG001|Overall Study|Withdrawal by Subject|3|||
161798031|NCT03111147|584302774|FG000|Overall Study|Protocol Violation|2|||
161798032|NCT03111147|584302775|FG001|Overall Study|Protocol Violation|1|||
161798033|NCT03111147|584302774|FG000|Overall Study|Death|1|||
161798034|NCT03111147|584302775|FG001|Overall Study|Death|1|||
161798035|NCT03384745|584302778|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
161798036|NCT03384745|584302779|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
161798037|NCT03384745|584302780|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
161798038|NCT03384745|584302781|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
161798039|NCT03384745|584302782|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
161798040|NCT03384745|584302783|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
161798041|NCT03384745|584302778|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
161798042|NCT03384745|584302779|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
161798043|NCT03384745|584302780|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
161798044|NCT03384745|584302781|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
161798045|NCT03384745|584302782|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
161798046|NCT03384745|584302783|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
161798047|NCT03384745|584302778|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
161798048|NCT03384745|584302779|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
161798049|NCT03384745|584302780|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
161901697|NCT03284853|584687173|FG001|Overall Study|Death|1|||
161901698|NCT03284853|584687172|FG000|Overall Study|Other - Reason not reported in CSR|4|||
161798050|NCT03384745|584302781|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
161798051|NCT03384745|584302782|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
161798052|NCT03384745|584302783|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
161798053|NCT03384745|584302778|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
161798054|NCT03384745|584302779|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
161901699|NCT03284853|584687173|FG001|Overall Study|Other - Reason not reported in CSR|3|||
161901700|NCT00765817|584687175|FG000|Overall Study|Adverse Event|13|||
161901701|NCT00765817|584687176|FG001|Overall Study|Adverse Event|1|||
161901702|NCT00765817|584687175|FG000|Overall Study|Death|0|||
161901703|NCT00765817|584687176|FG001|Overall Study|Death|1|||
161901704|NCT00765817|584687175|FG000|Overall Study|Entry criteria not met|2|||
161901705|NCT00765817|584687176|FG001|Overall Study|Entry criteria not met|2|||
161901706|NCT00765817|584687175|FG000|Overall Study|Loss of glucose control|0|||
161901707|NCT00765817|584687176|FG001|Overall Study|Loss of glucose control|2|||
161901708|NCT00765817|584687175|FG000|Overall Study|Lost to Follow-up|1|||
161901709|NCT00765817|584687176|FG001|Overall Study|Lost to Follow-up|3|||
161901710|NCT00765817|584687175|FG000|Overall Study|Physician Decision|2|||
161901711|NCT00765817|584687176|FG001|Overall Study|Physician Decision|1|||
161901712|NCT00765817|584687175|FG000|Overall Study|Protocol Violation|1|||
161901713|NCT00765817|584687176|FG001|Overall Study|Protocol Violation|1|||
161901714|NCT00765817|584687175|FG000|Overall Study|Subject decision|7|||
161901715|NCT00765817|584687176|FG001|Overall Study|Subject decision|11|||
161901716|NCT02058589|584687177|FG000|Overall Study|Serious Adverse Event|1|||
161901717|NCT02058589|584687178|FG001|Overall Study|Serious Adverse Event|1|||
161901718|NCT02058589|584687177|FG000|Overall Study|Non-Serious Adverse Event|1|||
161901719|NCT02058589|584687178|FG001|Overall Study|Non-Serious Adverse Event|0|||
161901720|NCT02058589|584687177|FG000|Overall Study|Withdrawal by Subject|0|||
161901721|NCT02058589|584687178|FG001|Overall Study|Withdrawal by Subject|1|||
161901722|NCT02308228|584687179|FG000|Overall Study|Adverse Event|3|||
161901723|NCT02308228|584687180|FG001|Overall Study|Adverse Event|4|||
161901724|NCT02308228|584687179|FG000|Overall Study|Withdrawal by Subject|5|||
161901725|NCT02308228|584687180|FG001|Overall Study|Withdrawal by Subject|3|||
161901726|NCT02143024|584687181|FG000|Overall Study|Lost to Follow-up|1|||
161901727|NCT02143024|584687182|FG001|Overall Study|Lost to Follow-up|1|||
161901728|NCT02143024|584687181|FG000|Overall Study|Withdrawal by Subject|1|||
161901729|NCT02143024|584687182|FG001|Overall Study|Withdrawal by Subject|0|||
161901730|NCT06597084|584687183|FG000|Overall Study|Withdrawal by Subject|4|||
161901731|NCT06597084|584687184|FG001|Overall Study|Withdrawal by Subject|9|||
161901732|NCT06597084|584687183|FG000|Overall Study|Consent was not given by the patient until V2|0|||
161901733|NCT06597084|584687184|FG001|Overall Study|Consent was not given by the patient until V2|3|||
161901734|NCT06597084|584687183|FG000|Overall Study|Physician Decision|1|||
161901735|NCT06597084|584687184|FG001|Overall Study|Physician Decision|0|||
161901736|NCT06597084|584687183|FG000|Overall Study|Adverse Event|3|||
161901737|NCT06597084|584687184|FG001|Overall Study|Adverse Event|2|||
161901738|NCT06597084|584687183|FG000|Overall Study|Death|4|||
161901739|NCT06597084|584687184|FG001|Overall Study|Death|0|||
161901740|NCT06597084|584687183|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
161901741|NCT06597084|584687184|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
161901742|NCT06597084|584687183|FG000|Overall Study|Lost to Follow-up|4|||
161901743|NCT06597084|584687184|FG001|Overall Study|Lost to Follow-up|2|||
161901744|NCT06597084|584687183|FG000|Overall Study|Other. Not specified|1|||
161901745|NCT06597084|584687184|FG001|Overall Study|Other. Not specified|0|||
161901746|NCT00490971|584687189|FG000|Acute/Continuation|Adverse Event|62|||
161901747|NCT00490971|584687190|FG001|Acute/Continuation|Adverse Event|13|||
161901748|NCT00490971|584687191|FG002|Acute/Continuation|Adverse Event|0|||
161901749|NCT00490971|584687192|FG003|Acute/Continuation|Adverse Event|0|||
161901750|NCT00490971|584687193|FG004|Acute/Continuation|Adverse Event|0|||
161901751|NCT00490971|584687189|FG000|Acute/Continuation|Death|2|||
161901752|NCT00490971|584687190|FG001|Acute/Continuation|Death|0|||
161901753|NCT00490971|584687191|FG002|Acute/Continuation|Death|0|||
161901754|NCT00490971|584687192|FG003|Acute/Continuation|Death|0|||
161901755|NCT00490971|584687193|FG004|Acute/Continuation|Death|0|||
161901756|NCT00490971|584687189|FG000|Acute/Continuation|Lack of Efficacy|106|||
161901757|NCT00490971|584687190|FG001|Acute/Continuation|Lack of Efficacy|12|||
161901758|NCT00490971|584687191|FG002|Acute/Continuation|Lack of Efficacy|0|||
162137777|NCT01289119|585555590|FG003|Overall Study|Withdrawal by Subject|3|||
162137778|NCT01289119|585555591|FG004|Overall Study|Withdrawal by Subject|1|||
162137779|NCT01289119|585555592|FG005|Overall Study|Withdrawal by Subject|1|||
162137780|NCT01289119|585555587|FG000|Overall Study|Pregnancy|0|||
162137781|NCT01289119|585555588|FG001|Overall Study|Pregnancy|1|||
161901759|NCT00490971|584687192|FG003|Acute/Continuation|Lack of Efficacy|0|||
161901760|NCT00490971|584687193|FG004|Acute/Continuation|Lack of Efficacy|0|||
161901761|NCT00490971|584687189|FG000|Acute/Continuation|Lost to Follow-up|23|||
161901762|NCT00490971|584687190|FG001|Acute/Continuation|Lost to Follow-up|7|||
161901763|NCT00490971|584687191|FG002|Acute/Continuation|Lost to Follow-up|0|||
161901764|NCT00490971|584687192|FG003|Acute/Continuation|Lost to Follow-up|0|||
161901765|NCT00490971|584687193|FG004|Acute/Continuation|Lost to Follow-up|0|||
161901766|NCT00490971|584687189|FG000|Acute/Continuation|Protocol Violation|10|||
162137782|NCT01289119|585555589|FG002|Overall Study|Pregnancy|0|||
161901767|NCT00490971|584687190|FG001|Acute/Continuation|Protocol Violation|2|||
161901768|NCT00490971|584687191|FG002|Acute/Continuation|Protocol Violation|0|||
161901769|NCT00490971|584687192|FG003|Acute/Continuation|Protocol Violation|0|||
162137783|NCT01289119|585555590|FG003|Overall Study|Pregnancy|0|||
162137784|NCT01289119|585555591|FG004|Overall Study|Pregnancy|0|||
162137785|NCT01289119|585555592|FG005|Overall Study|Pregnancy|0|||
161901770|NCT00490971|584687193|FG004|Acute/Continuation|Protocol Violation|0|||
161901771|NCT00490971|584687189|FG000|Acute/Continuation|Withdrawal by Subject|92|||
161901772|NCT00490971|584687190|FG001|Acute/Continuation|Withdrawal by Subject|24|||
161901773|NCT00490971|584687191|FG002|Acute/Continuation|Withdrawal by Subject|0|||
161901774|NCT00490971|584687192|FG003|Acute/Continuation|Withdrawal by Subject|0|||
161901775|NCT00490971|584687193|FG004|Acute/Continuation|Withdrawal by Subject|0|||
161901776|NCT00490971|584687189|FG000|Acute/Continuation|Other|11|||
161901777|NCT00490971|584687190|FG001|Acute/Continuation|Other|4|||
161901778|NCT00490971|584687191|FG002|Acute/Continuation|Other|0|||
161901779|NCT00490971|584687192|FG003|Acute/Continuation|Other|0|||
161901780|NCT00490971|584687193|FG004|Acute/Continuation|Other|0|||
161901781|NCT00490971|584687189|FG000|Maintenance|Adverse Event|0|||
161901782|NCT00490971|584687190|FG001|Maintenance|Adverse Event|0|||
161901783|NCT00490971|584687191|FG002|Maintenance|Adverse Event|4|||
161901784|NCT00490971|584687192|FG003|Maintenance|Adverse Event|5|||
161901785|NCT00490971|584687193|FG004|Maintenance|Adverse Event|7|||
161901786|NCT00490971|584687189|FG000|Maintenance|Death|0|||
161901787|NCT00490971|584687190|FG001|Maintenance|Death|0|||
161901788|NCT00490971|584687191|FG002|Maintenance|Death|0|||
161901789|NCT00490971|584687192|FG003|Maintenance|Death|2|||
161901790|NCT00490971|584687193|FG004|Maintenance|Death|0|||
161901791|NCT00490971|584687189|FG000|Maintenance|Lost to Follow-up|0|||
161901792|NCT00490971|584687190|FG001|Maintenance|Lost to Follow-up|0|||
161901793|NCT00490971|584687191|FG002|Maintenance|Lost to Follow-up|5|||
161901794|NCT00490971|584687192|FG003|Maintenance|Lost to Follow-up|8|||
161901795|NCT00490971|584687193|FG004|Maintenance|Lost to Follow-up|10|||
161901796|NCT00490971|584687189|FG000|Maintenance|Pregnancy|0|||
161901797|NCT00490971|584687190|FG001|Maintenance|Pregnancy|0|||
161901798|NCT00490971|584687191|FG002|Maintenance|Pregnancy|1|||
161901799|NCT00490971|584687192|FG003|Maintenance|Pregnancy|0|||
161901800|NCT00490971|584687193|FG004|Maintenance|Pregnancy|0|||
161901801|NCT00490971|584687189|FG000|Maintenance|Protocol Violation|0|||
161901802|NCT00490971|584687190|FG001|Maintenance|Protocol Violation|0|||
161901803|NCT00490971|584687191|FG002|Maintenance|Protocol Violation|4|||
161901804|NCT00490971|584687192|FG003|Maintenance|Protocol Violation|1|||
161901805|NCT00490971|584687193|FG004|Maintenance|Protocol Violation|1|||
161901806|NCT00490971|584687189|FG000|Maintenance|Withdrawal by Subject|0|||
161901807|NCT00490971|584687190|FG001|Maintenance|Withdrawal by Subject|0|||
161901808|NCT00490971|584687191|FG002|Maintenance|Withdrawal by Subject|26|||
161901809|NCT00490971|584687192|FG003|Maintenance|Withdrawal by Subject|28|||
161901810|NCT00490971|584687193|FG004|Maintenance|Withdrawal by Subject|18|||
161901811|NCT00490971|584687189|FG000|Maintenance|Other|0|||
161901812|NCT00490971|584687190|FG001|Maintenance|Other|0|||
161901813|NCT00490971|584687191|FG002|Maintenance|Other|11|||
161901814|NCT00490971|584687192|FG003|Maintenance|Other|9|||
161901815|NCT00490971|584687193|FG004|Maintenance|Other|3|||
161901816|NCT01216332|584687200|FG000|Overall Study|Withdrawal by Subject|4|||
161901817|NCT01216332|584687201|FG001|Overall Study|Withdrawal by Subject|0|||
161901818|NCT03999749|584687202|FG000|Overall Study|Toxicity|16|||
161901819|NCT03999749|584687202|FG000|Overall Study|Withdrawal by Subject|3|||
161901820|NCT03999749|584687202|FG000|Overall Study|Disease progression|26|||
161901821|NCT03999749|584687202|FG000|Overall Study|Physician Decision|4|||
161798055|NCT03384745|584302780|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
161798056|NCT03384745|584302781|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
161798057|NCT03384745|584302782|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
161798058|NCT03384745|584302783|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
161798059|NCT03384745|584302778|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
161798060|NCT03384745|584302779|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
161798061|NCT03384745|584302780|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
161798062|NCT03384745|584302781|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
161798063|NCT03384745|584302782|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
161798064|NCT03384745|584302783|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
161798065|NCT03384745|584302778|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161901822|NCT03999749|584687202|FG000|Overall Study|Death|5|||
161901823|NCT03999749|584687202|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
161901824|NCT00255164|584687203|FG000|Overall Study|Adverse Event|10|||
162137786|NCT01289119|585555587|FG000|Overall Study|Lack of Efficacy|0|||
161901825|NCT00255164|584687204|FG001|Overall Study|Adverse Event|6|||
161901826|NCT00255164|584687205|FG002|Overall Study|Adverse Event|9|||
161798066|NCT03384745|584302779|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161798067|NCT03384745|584302780|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161798068|NCT03384745|584302781|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161901827|NCT00255164|584687203|FG000|Overall Study|Lost to Follow-up|4|||
161901828|NCT00255164|584687204|FG001|Overall Study|Lost to Follow-up|3|||
161901829|NCT00255164|584687205|FG002|Overall Study|Lost to Follow-up|4|||
161901830|NCT00255164|584687203|FG000|Overall Study|Withdrawal by Subject|18|||
161901831|NCT00255164|584687204|FG001|Overall Study|Withdrawal by Subject|17|||
161901832|NCT00255164|584687205|FG002|Overall Study|Withdrawal by Subject|8|||
161901833|NCT00255164|584687203|FG000|Overall Study|Noncompliance|0|||
161901834|NCT00255164|584687204|FG001|Overall Study|Noncompliance|1|||
161901835|NCT00255164|584687205|FG002|Overall Study|Noncompliance|2|||
161901836|NCT00255164|584687203|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
161901837|NCT00255164|584687204|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
161901838|NCT00255164|584687205|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
161901839|NCT00255164|584687203|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
161901840|NCT00255164|584687204|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
161901841|NCT00255164|584687205|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
161901842|NCT00255164|584687203|FG000|Overall Study|Possible Barrett's Esophagus|1|||
161901843|NCT00255164|584687204|FG001|Overall Study|Possible Barrett's Esophagus|3|||
161901844|NCT00255164|584687205|FG002|Overall Study|Possible Barrett's Esophagus|8|||
161901845|NCT00255164|584687203|FG000|Overall Study|Esophageal Stricture|0|||
161901846|NCT00255164|584687204|FG001|Overall Study|Esophageal Stricture|0|||
161901847|NCT00255164|584687205|FG002|Overall Study|Esophageal Stricture|1|||
161901848|NCT00255164|584687203|FG000|Overall Study|Therapeutic Failure|11|||
161901849|NCT00255164|584687204|FG001|Overall Study|Therapeutic Failure|2|||
161901850|NCT00255164|584687205|FG002|Overall Study|Therapeutic Failure|3|||
161901851|NCT03677869|584687206|FG000|Overall Study|Withdrawal by Subject|1|||
161901852|NCT05219968|584687207|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
161901853|NCT05219968|584687208|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
161901854|NCT05219968|584687209|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
161901855|NCT05219968|584687210|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
161901856|NCT05219968|584687211|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
161901857|NCT05219968|584687207|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
161901858|NCT05219968|584687208|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
161901859|NCT05219968|584687209|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
161901860|NCT05219968|584687210|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
161901861|NCT05219968|584687211|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
161901862|NCT05219968|584687207|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
161901863|NCT05219968|584687208|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
161901864|NCT05219968|584687209|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
161901865|NCT05219968|584687210|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
161901866|NCT05219968|584687211|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
161901867|NCT05219968|584687207|FG000|Week 24 Treatment Period|Adverse Event|3|||
161901868|NCT05219968|584687208|FG001|Week 24 Treatment Period|Adverse Event|0|||
161901869|NCT05219968|584687209|FG002|Week 24 Treatment Period|Adverse Event|0|||
161901870|NCT05219968|584687210|FG003|Week 24 Treatment Period|Adverse Event|0|||
161901871|NCT05219968|584687211|FG004|Week 24 Treatment Period|Adverse Event|0|||
161901872|NCT05219968|584687207|FG000|Week 24 Treatment Period|Physician Decision|0|||
161901873|NCT05219968|584687208|FG001|Week 24 Treatment Period|Physician Decision|1|||
161901874|NCT05219968|584687209|FG002|Week 24 Treatment Period|Physician Decision|0|||
161901875|NCT05219968|584687210|FG003|Week 24 Treatment Period|Physician Decision|0|||
161901876|NCT05219968|584687211|FG004|Week 24 Treatment Period|Physician Decision|0|||
161901877|NCT05219968|584687207|FG000|Week 24 Treatment Period|Other, not specified|3|||
161901878|NCT05219968|584687208|FG001|Week 24 Treatment Period|Other, not specified|0|||
161901879|NCT05219968|584687209|FG002|Week 24 Treatment Period|Other, not specified|0|||
161901880|NCT05219968|584687210|FG003|Week 24 Treatment Period|Other, not specified|0|||
161901881|NCT05219968|584687211|FG004|Week 24 Treatment Period|Other, not specified|0|||
161901882|NCT05219968|584687207|FG000|Safety Extension Period|Treatment administration failure|0|||
161901883|NCT05219968|584687208|FG001|Safety Extension Period|Treatment administration failure|0|||
161901884|NCT05219968|584687209|FG002|Safety Extension Period|Treatment administration failure|0|||
161901885|NCT05219968|584687210|FG003|Safety Extension Period|Treatment administration failure|1|||
161901886|NCT05219968|584687211|FG004|Safety Extension Period|Treatment administration failure|4|||
161901887|NCT05219968|584687207|FG000|Safety Extension Period|Bilateral dislodgement|0|||
161901888|NCT05219968|584687208|FG001|Safety Extension Period|Bilateral dislodgement|0|||
161901889|NCT05219968|584687209|FG002|Safety Extension Period|Bilateral dislodgement|4|||
161901890|NCT05219968|584687210|FG003|Safety Extension Period|Bilateral dislodgement|0|||
161901891|NCT05219968|584687211|FG004|Safety Extension Period|Bilateral dislodgement|1|||
161901892|NCT05219968|584687207|FG000|Safety Extension Period|Withdrawal by Subject|0|||
161901893|NCT05219968|584687208|FG001|Safety Extension Period|Withdrawal by Subject|0|||
161901894|NCT05219968|584687209|FG002|Safety Extension Period|Withdrawal by Subject|2|||
161901895|NCT05219968|584687210|FG003|Safety Extension Period|Withdrawal by Subject|0|||
161901896|NCT05219968|584687211|FG004|Safety Extension Period|Withdrawal by Subject|4|||
161901897|NCT05219968|584687207|FG000|Safety Extension Period|Adverse Event|0|||
161901898|NCT05219968|584687208|FG001|Safety Extension Period|Adverse Event|0|||
161901899|NCT05219968|584687209|FG002|Safety Extension Period|Adverse Event|2|||
161901900|NCT05219968|584687210|FG003|Safety Extension Period|Adverse Event|1|||
161901901|NCT05219968|584687211|FG004|Safety Extension Period|Adverse Event|1|||
161901902|NCT05219968|584687207|FG000|Safety Extension Period|Lost to Follow-up|0|||
161901903|NCT05219968|584687208|FG001|Safety Extension Period|Lost to Follow-up|0|||
162137787|NCT01289119|585555588|FG001|Overall Study|Lack of Efficacy|1|||
162137788|NCT01289119|585555589|FG002|Overall Study|Lack of Efficacy|1|||
162137789|NCT01289119|585555590|FG003|Overall Study|Lack of Efficacy|1|||
161798069|NCT03384745|584302782|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
161798070|NCT03384745|584302783|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161798071|NCT03384745|584302778|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
161798072|NCT03384745|584302779|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
161798073|NCT03384745|584302780|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
161798074|NCT03384745|584302781|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
161798075|NCT03384745|584302782|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
161798076|NCT03384745|584302783|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
161798077|NCT03384745|584302778|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
161798078|NCT03384745|584302779|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
161798079|NCT03384745|584302780|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
161798080|NCT03384745|584302781|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
161798081|NCT03384745|584302782|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
161798082|NCT03384745|584302783|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
161798083|NCT03384745|584302778|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
161798084|NCT03384745|584302779|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
161798085|NCT03384745|584302780|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
161798086|NCT03384745|584302781|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
161798087|NCT03384745|584302782|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
161798088|NCT03384745|584302783|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
161798089|NCT03384745|584302778|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161798090|NCT03384745|584302779|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161798091|NCT03384745|584302780|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161798092|NCT03384745|584302781|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
161798093|NCT03384745|584302782|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161798094|NCT03384745|584302783|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161798095|NCT03384745|584302778|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
161798096|NCT03384745|584302779|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
161798097|NCT03384745|584302780|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
161798098|NCT03384745|584302781|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
161798099|NCT03384745|584302782|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
161798100|NCT03384745|584302783|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
161798101|NCT01058421|584302784|FG000|1 Month Outcomes|Death|10|||
161798102|NCT01058421|584302785|FG001|1 Month Outcomes|Death|6|||
161798103|NCT01058421|584302784|FG000|1 Month Outcomes|Lost to Follow-up|8|||
161798104|NCT01058421|584302785|FG001|1 Month Outcomes|Lost to Follow-up|7|||
161798105|NCT01058421|584302784|FG000|1 Month Outcomes|Remained in Hospital|5|||
161798106|NCT01058421|584302785|FG001|1 Month Outcomes|Remained in Hospital|12|||
161798107|NCT01058421|584302784|FG000|1 Month Outcomes|Remained in Other Facility|16|||
161798108|NCT01058421|584302785|FG001|1 Month Outcomes|Remained in Other Facility|17|||
161798109|NCT01058421|584302784|FG000|3 Month Outcomes|Death|3|||
161798110|NCT01058421|584302785|FG001|3 Month Outcomes|Death|5|||
161798111|NCT01058421|584302784|FG000|3 Month Outcomes|Lost to Follow-up|12|||
161798112|NCT01058421|584302785|FG001|3 Month Outcomes|Lost to Follow-up|11|||
161798113|NCT01058421|584302784|FG000|3 Month Outcomes|Remained in Hospital|0|||
161798114|NCT01058421|584302785|FG001|3 Month Outcomes|Remained in Hospital|2|||
161798115|NCT01058421|584302784|FG000|3 Month Outcomes|Remained in Other Facility|5|||
161798116|NCT01058421|584302785|FG001|3 Month Outcomes|Remained in Other Facility|8|||
161798117|NCT01058421|584302784|FG000|6 Month Outcomes|Death|2|||
161798118|NCT01058421|584302785|FG001|6 Month Outcomes|Death|2|||
161798119|NCT01058421|584302784|FG000|6 Month Outcomes|Lost to Follow-up|16|||
161798120|NCT01058421|584302785|FG001|6 Month Outcomes|Lost to Follow-up|21|||
161798121|NCT01058421|584302784|FG000|6 Month Outcomes|Remained in Other Facility|1|||
161798122|NCT01058421|584302785|FG001|6 Month Outcomes|Remained in Other Facility|3|||
161798123|NCT02984683|584302786|FG000|Overall Study|Adverse Event|3|||
161798124|NCT02984683|584302787|FG001|Overall Study|Adverse Event|3|||
161798125|NCT02984683|584302786|FG000|Overall Study|Withdrawal by Subject|1|||
161798126|NCT02984683|584302787|FG001|Overall Study|Withdrawal by Subject|0|||
161798127|NCT02984683|584302786|FG000|Overall Study|Disease progression|7|||
161798128|NCT02984683|584302787|FG001|Overall Study|Disease progression|9|||
161798129|NCT03131999|584302788|FG000|Overall Study|Withdrawal by Subject|0|||
161798130|NCT03131999|584302789|FG001|Overall Study|Withdrawal by Subject|1|||
161901904|NCT05219968|584687209|FG002|Safety Extension Period|Lost to Follow-up|0|||
161901905|NCT05219968|584687210|FG003|Safety Extension Period|Lost to Follow-up|1|||
161798131|NCT02260492|584302790|FG000|Overall Study|Adverse Event|6|||
161798132|NCT02260492|584302791|FG001|Overall Study|Adverse Event|1|||
161798133|NCT02260492|584302792|FG002|Overall Study|Adverse Event|2|||
161798134|NCT02260492|584302790|FG000|Overall Study|Death|0|||
161798135|NCT02260492|584302791|FG001|Overall Study|Death|1|||
161798136|NCT02260492|584302792|FG002|Overall Study|Death|0|||
161798137|NCT02260492|584302790|FG000|Overall Study|Lost to Follow-up|12|||
161798138|NCT02260492|584302791|FG001|Overall Study|Lost to Follow-up|9|||
161901906|NCT05219968|584687211|FG004|Safety Extension Period|Lost to Follow-up|0|||
161798139|NCT02260492|584302792|FG002|Overall Study|Lost to Follow-up|0|||
161798140|NCT02260492|584302790|FG000|Overall Study|Physician Decision|2|||
161798141|NCT02260492|584302791|FG001|Overall Study|Physician Decision|0|||
161798142|NCT02260492|584302792|FG002|Overall Study|Physician Decision|1|||
161798143|NCT02260492|584302790|FG000|Overall Study|Withdrawal by Subject|3|||
161798144|NCT02260492|584302791|FG001|Overall Study|Withdrawal by Subject|2|||
161798145|NCT02260492|584302792|FG002|Overall Study|Withdrawal by Subject|2|||
161798146|NCT02683187|584302793|FG000|Overall Study|Failed IV access|3|||
161798147|NCT02683187|584302793|FG000|Overall Study|Withdrawal by Subject|5|||
161798148|NCT05665595|584304407|FG000|Overall Study|Ongoing|692|||
161798149|NCT05665595|584304408|FG001|Overall Study|Ongoing|698|||
161798150|NCT05665595|584304407|FG000|Overall Study|Withdrawal by Subject|2|||
161798151|NCT05665595|584304408|FG001|Overall Study|Withdrawal by Subject|2|||
161798152|NCT05665595|584304407|FG000|Overall Study|Lost to Follow-up|1|||
161798153|NCT05665595|584304408|FG001|Overall Study|Lost to Follow-up|0|||
161798154|NCT05665595|584304407|FG000|Overall Study|Death|6|||
161798155|NCT05665595|584304408|FG001|Overall Study|Death|1|||
161798156|NCT02581345|584304409|FG000|Part 1: up to Week 16|Adverse Event|3|||
161798157|NCT02581345|584304410|FG001|Part 1: up to Week 16|Adverse Event|8|||
161798158|NCT02581345|584304411|FG002|Part 1: up to Week 16|Adverse Event|0|||
161798159|NCT02581345|584304412|FG003|Part 1: up to Week 16|Adverse Event|0|||
161798160|NCT02581345|584304409|FG000|Part 1: up to Week 16|Physician Decision|2|||
161798161|NCT02581345|584304410|FG001|Part 1: up to Week 16|Physician Decision|4|||
161798162|NCT02581345|584304411|FG002|Part 1: up to Week 16|Physician Decision|0|||
161798163|NCT02581345|584304412|FG003|Part 1: up to Week 16|Physician Decision|0|||
161798164|NCT02581345|584304409|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
161798165|NCT02581345|584304410|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
161798166|NCT02581345|584304411|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
161798167|NCT02581345|584304412|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
161798168|NCT02581345|584304409|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
161798169|NCT02581345|584304410|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
161798170|NCT02581345|584304411|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
161798171|NCT02581345|584304412|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
161798172|NCT02581345|584304409|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
161798173|NCT02581345|584304410|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
161798174|NCT02581345|584304411|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
161798175|NCT02581345|584304412|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
161798176|NCT02581345|584304409|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
161798177|NCT02581345|584304410|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
161798178|NCT02581345|584304411|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
161798179|NCT02581345|584304412|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
161798180|NCT02581345|584304409|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
161798181|NCT02581345|584304410|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
161798182|NCT02581345|584304411|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
161798183|NCT02581345|584304412|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
161798184|NCT02581345|584304409|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
161798185|NCT02581345|584304410|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
161798186|NCT02581345|584304411|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
161798187|NCT02581345|584304412|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
161798188|NCT02581345|584304409|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
161798189|NCT02581345|584304410|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
161798190|NCT02581345|584304411|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
161798191|NCT02581345|584304412|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
161798192|NCT02581345|584304409|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
161798193|NCT02581345|584304410|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
161798194|NCT02581345|584304411|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
161798195|NCT02581345|584304412|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
161798196|NCT02581345|584304409|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
161798197|NCT02581345|584304410|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
161798198|NCT02581345|584304411|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
161798199|NCT02581345|584304412|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
162010872|NCT00870740|585096030|FG001|Overall Study|Other|5|||
161798200|NCT02581345|584304409|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
161798201|NCT02581345|584304410|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
161798202|NCT02581345|584304411|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
161798203|NCT02581345|584304412|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
161798204|NCT01768858|584304413|FG000|Overall Study|Lost to Follow-up|9|||
161798205|NCT01768858|584304413|FG000|Overall Study|Lack of Efficacy|8|||
161798206|NCT01768858|584304413|FG000|Overall Study|Serious Adverse Event|1|||
161798207|NCT01768858|584304413|FG000|Overall Study|Participant moved to Germany|1|||
161798208|NCT01768858|584304413|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
161798209|NCT01768858|584304413|FG000|Overall Study|Exanthema|1|||
161798210|NCT01768858|584304413|FG000|Overall Study|Withdrawal by Subject|1|||
161798211|NCT00502775|584304418|FG000|Overall Study|Adverse Event|1|||
161798212|NCT00502775|584304419|FG001|Overall Study|Adverse Event|2|||
161798213|NCT00502775|584304420|FG002|Overall Study|Adverse Event|1|||
161798214|NCT00502775|584304418|FG000|Overall Study|Protocol Violation|1|||
161798215|NCT00502775|584304419|FG001|Overall Study|Protocol Violation|5|||
161798216|NCT00502775|584304420|FG002|Overall Study|Protocol Violation|2|||
161798217|NCT00502775|584304418|FG000|Overall Study|Withdrawal by Subject|1|||
161798218|NCT00502775|584304419|FG001|Overall Study|Withdrawal by Subject|1|||
161798219|NCT00502775|584304420|FG002|Overall Study|Withdrawal by Subject|2|||
161798220|NCT00502775|584304418|FG000|Overall Study|Sponsor Terminated Study|1|||
161798221|NCT00502775|584304419|FG001|Overall Study|Sponsor Terminated Study|0|||
161798222|NCT00502775|584304420|FG002|Overall Study|Sponsor Terminated Study|1|||
161798223|NCT00502775|584304418|FG000|Overall Study|Non-compliance with eDiary|4|||
161798224|NCT00502775|584304419|FG001|Overall Study|Non-compliance with eDiary|1|||
161798225|NCT00502775|584304420|FG002|Overall Study|Non-compliance with eDiary|1|||
161798226|NCT00502775|584304418|FG000|Overall Study|Subject unable to swallow capsule|1|||
161798227|NCT00502775|584304419|FG001|Overall Study|Subject unable to swallow capsule|0|||
161798228|NCT00502775|584304420|FG002|Overall Study|Subject unable to swallow capsule|1|||
161798229|NCT00502775|584304418|FG000|Overall Study|Logpad compliance <80%|1|||
161798230|NCT00502775|584304419|FG001|Overall Study|Logpad compliance <80%|0|||
161798231|NCT00502775|584304420|FG002|Overall Study|Logpad compliance <80%|0|||
161798232|NCT00502775|584304418|FG000|Overall Study|Randomized in error|0|||
161798233|NCT00502775|584304419|FG001|Overall Study|Randomized in error|1|||
161798234|NCT00502775|584304420|FG002|Overall Study|Randomized in error|1|||
161798235|NCT00502775|584304418|FG000|Overall Study|Non-compliance|0|||
161798236|NCT00502775|584304419|FG001|Overall Study|Non-compliance|2|||
161798237|NCT00502775|584304420|FG002|Overall Study|Non-compliance|2|||
161798238|NCT00502775|584304418|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
161798239|NCT00502775|584304419|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
161798240|NCT00502775|584304420|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
161798241|NCT00502775|584304418|FG000|Overall Study|Declining pollen counts|0|||
161798242|NCT00502775|584304419|FG001|Overall Study|Declining pollen counts|1|||
161798243|NCT00502775|584304420|FG002|Overall Study|Declining pollen counts|1|||
161798244|NCT00502775|584304418|FG000|Overall Study|Subject in jail|0|||
161798245|NCT00502775|584304419|FG001|Overall Study|Subject in jail|1|||
161798246|NCT00502775|584304420|FG002|Overall Study|Subject in jail|0|||
161798247|NCT00502775|584304418|FG000|Overall Study|Subject took disallowed drug|0|||
161798248|NCT00502775|584304419|FG001|Overall Study|Subject took disallowed drug|0|||
161798249|NCT00502775|584304420|FG002|Overall Study|Subject took disallowed drug|1|||
161798250|NCT02819362|584304424|FG000|Overall Study|On-site MRI could not be performed|70|||
161798251|NCT02710123|584304425|FG000|Overall Study|Lost to Follow-up|3|||
161798252|NCT02710123|584304426|FG001|Overall Study|Lost to Follow-up|4|||
161798253|NCT02710123|584304425|FG000|Overall Study|Withdrawal by Subject|1|||
161798254|NCT02710123|584304426|FG001|Overall Study|Withdrawal by Subject|1|||
161798255|NCT02710123|584304425|FG000|Overall Study|Illness unrelated to study intervention|1|||
161798256|NCT02710123|584304426|FG001|Overall Study|Illness unrelated to study intervention|0|||
161798257|NCT00419926|584304427|FG000|Overall Study|Withdrawal by Subject|7|||
161798258|NCT00419926|584304428|FG001|Overall Study|Withdrawal by Subject|3|||
161798259|NCT00419926|584304427|FG000|Overall Study|Administrative Problem|4|||
161798260|NCT00419926|584304428|FG001|Overall Study|Administrative Problem|4|||
161798261|NCT00419926|584304427|FG000|Overall Study|Lost to Follow-up|1|||
161798262|NCT00419926|584304428|FG001|Overall Study|Lost to Follow-up|2|||
161798263|NCT00419926|584304427|FG000|Overall Study|Death|2|||
161798264|NCT00419926|584304428|FG001|Overall Study|Death|1|||
161798265|NCT02374918|584304430|FG000|Overall Study|Protocol Violation|2|||
161798266|NCT02374918|584304431|FG001|Overall Study|Protocol Violation|0|||
161798267|NCT02374918|584304432|FG002|Overall Study|Protocol Violation|2|||
161798268|NCT02374918|584304433|FG003|Overall Study|Protocol Violation|1|||
161798269|NCT02374918|584304430|FG000|Overall Study|Withdrawal by Subject|1|||
161798270|NCT02374918|584304431|FG001|Overall Study|Withdrawal by Subject|1|||
161798271|NCT02374918|584304432|FG002|Overall Study|Withdrawal by Subject|1|||
161798272|NCT02374918|584304433|FG003|Overall Study|Withdrawal by Subject|0|||
161798273|NCT02374918|584304430|FG000|Overall Study|Lack of Efficacy|0|||
161798274|NCT02374918|584304431|FG001|Overall Study|Lack of Efficacy|0|||
161798275|NCT02374918|584304432|FG002|Overall Study|Lack of Efficacy|1|||
161798276|NCT02374918|584304433|FG003|Overall Study|Lack of Efficacy|1|||
161798277|NCT00810368|584304435|FG000|Overall Study|Lost to Follow-up|4|||
161798278|NCT00810368|584304436|FG001|Overall Study|Lost to Follow-up|2|||
161798279|NCT00810368|584304435|FG000|Overall Study|Lack of Efficacy|2|||
161798280|NCT00810368|584304436|FG001|Overall Study|Lack of Efficacy|0|||
161798281|NCT03365375|584304437|FG000|Overall Study|Withdrawal by Subject|0|||
161901907|NCT01212094|584688722|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
161798282|NCT03365375|584304438|FG001|Overall Study|Withdrawal by Subject|1|||
161798283|NCT03365375|584304437|FG000|Overall Study|Lost to Follow-up|0|||
161798284|NCT03365375|584304438|FG001|Overall Study|Lost to Follow-up|4|||
161798285|NCT02166697|584304439|FG000|Overall Study|Protocol Violation|347|||
161798286|NCT01505530|584304440|FG000|Overall Study|Progressive Disease|19|||
161798287|NCT01505530|584304441|FG001|Overall Study|Progressive Disease|17|||
161901908|NCT01212094|584688723|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
161901909|NCT01212094|584688724|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
161901910|NCT01212094|584688722|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
161901911|NCT01212094|584688723|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
161901912|NCT01212094|584688724|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
161901913|NCT01212094|584688722|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
161901914|NCT01212094|584688723|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
161901915|NCT01212094|584688724|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
161901916|NCT01212094|584688722|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
161901917|NCT01212094|584688723|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
161901918|NCT01212094|584688724|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
161901919|NCT01212094|584688722|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
161901920|NCT01212094|584688723|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
161901921|NCT01212094|584688724|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
161901922|NCT01212094|584688722|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
161901923|NCT01212094|584688723|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
161901924|NCT01212094|584688724|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
161901925|NCT05664581|584688728|FG000|Overall Study|Withdrawal by Subject|2|||
161901926|NCT03101150|584688731|FG000|Overall Study|Lost to Follow-up|2|||
161901927|NCT03101150|584688732|FG001|Overall Study|Lost to Follow-up|4|||
161901928|NCT03101150|584688731|FG000|Overall Study|Miscarriage|3|||
161901929|NCT03101150|584688732|FG001|Overall Study|Miscarriage|6|||
161901930|NCT01317641|584688734|FG000|Overall Study|Not treated|0|||
161901931|NCT01317641|584688735|FG001|Overall Study|Not treated|0|||
161901932|NCT01317641|584688736|FG002|Overall Study|Not treated|0|||
161901933|NCT01317641|584688737|FG003|Overall Study|Not treated|0|||
161901934|NCT01317641|584688738|FG004|Overall Study|Not treated|0|||
161901935|NCT01317641|584688739|FG005|Overall Study|Not treated|0|||
161901936|NCT01317641|584688740|FG006|Overall Study|Not treated|0|||
161901937|NCT01317641|584688741|FG007|Overall Study|Not treated|1|||
161901938|NCT01317641|584688742|FG008|Overall Study|Not treated|1|||
161901939|NCT01317641|584688734|FG000|Overall Study|Adverse Event|0|||
161901940|NCT01317641|584688735|FG001|Overall Study|Adverse Event|1|||
161901941|NCT01317641|584688736|FG002|Overall Study|Adverse Event|0|||
161901942|NCT01317641|584688737|FG003|Overall Study|Adverse Event|1|||
161901943|NCT01317641|584688738|FG004|Overall Study|Adverse Event|0|||
161901944|NCT01317641|584688739|FG005|Overall Study|Adverse Event|0|||
161901945|NCT01317641|584688740|FG006|Overall Study|Adverse Event|2|||
161901946|NCT01317641|584688741|FG007|Overall Study|Adverse Event|1|||
161901947|NCT01317641|584688742|FG008|Overall Study|Adverse Event|0|||
161901948|NCT01317641|584688734|FG000|Overall Study|Protocol Violation|1|||
161901949|NCT01317641|584688735|FG001|Overall Study|Protocol Violation|0|||
161901950|NCT01317641|584688736|FG002|Overall Study|Protocol Violation|0|||
161901951|NCT01317641|584688737|FG003|Overall Study|Protocol Violation|0|||
161901952|NCT01317641|584688738|FG004|Overall Study|Protocol Violation|0|||
161901953|NCT01317641|584688739|FG005|Overall Study|Protocol Violation|0|||
161901954|NCT01317641|584688740|FG006|Overall Study|Protocol Violation|0|||
161901955|NCT01317641|584688741|FG007|Overall Study|Protocol Violation|0|||
161901956|NCT01317641|584688742|FG008|Overall Study|Protocol Violation|0|||
161901957|NCT01317641|584688734|FG000|Overall Study|Disease progression|0|||
161901958|NCT01317641|584688735|FG001|Overall Study|Disease progression|0|||
161901959|NCT01317641|584688736|FG002|Overall Study|Disease progression|0|||
161901960|NCT01317641|584688737|FG003|Overall Study|Disease progression|0|||
161901961|NCT01317641|584688738|FG004|Overall Study|Disease progression|0|||
161901962|NCT01317641|584688739|FG005|Overall Study|Disease progression|0|||
161901963|NCT01317641|584688740|FG006|Overall Study|Disease progression|0|||
161901964|NCT01317641|584688741|FG007|Overall Study|Disease progression|3|||
161901965|NCT01317641|584688742|FG008|Overall Study|Disease progression|4|||
161901966|NCT01317641|584688734|FG000|Overall Study|Withdrawal by Subject|0|||
161901967|NCT01317641|584688735|FG001|Overall Study|Withdrawal by Subject|0|||
161901968|NCT01317641|584688736|FG002|Overall Study|Withdrawal by Subject|0|||
161901969|NCT01317641|584688737|FG003|Overall Study|Withdrawal by Subject|0|||
161901970|NCT01317641|584688738|FG004|Overall Study|Withdrawal by Subject|0|||
161901971|NCT01317641|584688739|FG005|Overall Study|Withdrawal by Subject|0|||
161901972|NCT01317641|584688740|FG006|Overall Study|Withdrawal by Subject|1|||
161901973|NCT01317641|584688741|FG007|Overall Study|Withdrawal by Subject|0|||
161901974|NCT01317641|584688742|FG008|Overall Study|Withdrawal by Subject|0|||
161901975|NCT00329108|584688743|FG000|Overall Study|Adverse Event|2|||
161901976|NCT00329108|584688744|FG001|Overall Study|Adverse Event|2|||
161901977|NCT00329108|584688743|FG000|Overall Study|Lack of Efficacy|3|||
161901978|NCT00329108|584688744|FG001|Overall Study|Lack of Efficacy|3|||
161901979|NCT00329108|584688743|FG000|Overall Study|Withdrawal by Subject|0|||
161901980|NCT00329108|584688744|FG001|Overall Study|Withdrawal by Subject|2|||
161901981|NCT00329108|584688743|FG000|Overall Study|symptomatic deterioration|1|||
161901982|NCT00329108|584688744|FG001|Overall Study|symptomatic deterioration|1|||
161901983|NCT00329108|584688743|FG000|Overall Study|Subject no longer willing to participate|2|||
161901984|NCT00329108|584688744|FG001|Overall Study|Subject no longer willing to participate|2|||
161901985|NCT00329108|584688743|FG000|Overall Study|study terminated by sponsor|1|||
161798288|NCT01505530|584304442|FG002|Overall Study|Progressive Disease|18|||
161798289|NCT01505530|584304440|FG000|Overall Study|Adverse Event|1|||
161798290|NCT01505530|584304441|FG001|Overall Study|Adverse Event|1|||
161798291|NCT01505530|584304442|FG002|Overall Study|Adverse Event|0|||
161798292|NCT01505530|584304440|FG000|Overall Study|Withdrawal by Subject|7|||
161798293|NCT01505530|584304441|FG001|Overall Study|Withdrawal by Subject|8|||
161798294|NCT01505530|584304442|FG002|Overall Study|Withdrawal by Subject|6|||
161798295|NCT01505530|584304440|FG000|Overall Study|Physician Decision|6|||
161798296|NCT01505530|584304441|FG001|Overall Study|Physician Decision|2|||
161798297|NCT01505530|584304442|FG002|Overall Study|Physician Decision|5|||
161798298|NCT01505530|584304440|FG000|Overall Study|Sponsor Decision|1|||
161798299|NCT01505530|584304441|FG001|Overall Study|Sponsor Decision|8|||
161798300|NCT01505530|584304442|FG002|Overall Study|Sponsor Decision|7|||
161798301|NCT01505530|584304440|FG000|Overall Study|Death|7|||
161798302|NCT01505530|584304441|FG001|Overall Study|Death|6|||
161798303|NCT01505530|584304442|FG002|Overall Study|Death|5|||
161798304|NCT01505530|584304440|FG000|Overall Study|entry criteria not met|0|||
161798305|NCT01505530|584304441|FG001|Overall Study|entry criteria not met|1|||
161798306|NCT01505530|584304442|FG002|Overall Study|entry criteria not met|0|||
161798307|NCT01153984|584304445|FG000|Overall Study|Withdrawal by Subject|1|||
161798308|NCT01153984|584304445|FG000|Overall Study|Adverse Event|1|||
161798309|NCT00973700|584304446|FG000|Overall Study|Withdrawal by Subject|2|||
161798310|NCT00973700|584304447|FG001|Overall Study|Withdrawal by Subject|2|||
161798311|NCT00973700|584304448|FG002|Overall Study|Withdrawal by Subject|8|||
161798312|NCT00973700|584304449|FG003|Overall Study|Withdrawal by Subject|4|||
161798313|NCT00973700|584304450|FG004|Overall Study|Withdrawal by Subject|4|||
161798314|NCT00973700|584304446|FG000|Overall Study|Lost to Follow-up|5|||
161798315|NCT00973700|584304447|FG001|Overall Study|Lost to Follow-up|0|||
161798316|NCT00973700|584304448|FG002|Overall Study|Lost to Follow-up|1|||
161798317|NCT00973700|584304449|FG003|Overall Study|Lost to Follow-up|8|||
161798318|NCT00973700|584304450|FG004|Overall Study|Lost to Follow-up|5|||
161798319|NCT00973700|584304446|FG000|Overall Study|Inappropriate enrolment|0|||
161798320|NCT00973700|584304447|FG001|Overall Study|Inappropriate enrolment|0|||
161798321|NCT00973700|584304448|FG002|Overall Study|Inappropriate enrolment|0|||
161798322|NCT00973700|584304449|FG003|Overall Study|Inappropriate enrolment|4|||
161798323|NCT00973700|584304450|FG004|Overall Study|Inappropriate enrolment|0|||
161798324|NCT00973700|584304446|FG000|Overall Study|Unable to Classify|0|||
161798325|NCT00973700|584304447|FG001|Overall Study|Unable to Classify|0|||
161798326|NCT00973700|584304448|FG002|Overall Study|Unable to Classify|1|||
161798327|NCT00973700|584304449|FG003|Overall Study|Unable to Classify|2|||
161798328|NCT00973700|584304450|FG004|Overall Study|Unable to Classify|1|||
162137790|NCT01289119|585555591|FG004|Overall Study|Lack of Efficacy|1|||
162137791|NCT01289119|585555592|FG005|Overall Study|Lack of Efficacy|1|||
162137792|NCT01289119|585555587|FG000|Overall Study|Other|1|||
162137793|NCT01289119|585555588|FG001|Overall Study|Other|0|||
162137794|NCT01289119|585555589|FG002|Overall Study|Other|1|||
162137795|NCT01289119|585555590|FG003|Overall Study|Other|0|||
162137796|NCT01289119|585555591|FG004|Overall Study|Other|0|||
162137797|NCT01289119|585555592|FG005|Overall Study|Other|0|||
162137798|NCT01704846|585555593|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162137799|NCT01704846|585555594|FG001|Treatment Period 2|Withdrawal by Subject|1|||
162137800|NCT00530335|585555597|FG000|Overall Study|Adverse Event|3|||
162137801|NCT00530335|585555597|FG000|Overall Study|Protocol Violation|1|||
162137802|NCT00530335|585555597|FG000|Overall Study|Withdrawal by Subject|1|||
162137803|NCT00530335|585555597|FG000|Overall Study|Physician Decision|1|||
162137804|NCT01244984|585555599|FG000|Overall Study|Adverse Event|2|||
162137805|NCT01244984|585555600|FG001|Overall Study|Adverse Event|11|||
162137806|NCT01244984|585555601|FG002|Overall Study|Adverse Event|2|||
162137807|NCT01244984|585555599|FG000|Overall Study|Protocol Violation|1|||
162137808|NCT01244984|585555600|FG001|Overall Study|Protocol Violation|0|||
162137809|NCT01244984|585555601|FG002|Overall Study|Protocol Violation|0|||
162137810|NCT01244984|585555599|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
162137811|NCT01244984|585555600|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
162137812|NCT01244984|585555601|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
161798329|NCT00290745|584304460|FG000|Overall Study|Withdrawal by Subject|4|||
161798330|NCT00290745|584304460|FG000|Overall Study|Physician Decision|2|||
161798331|NCT00290745|584304460|FG000|Overall Study|Surgery after 3 months for progression|3|||
161798332|NCT00290745|584304460|FG000|Overall Study|Baseline MRI not available|3|||
161798333|NCT00626925|584304463|FG000|Overall Study|Lost to Follow-up|1|||
161798334|NCT00626925|584304464|FG001|Overall Study|Lost to Follow-up|2|||
162137813|NCT01244984|585555599|FG000|Overall Study|Withdrawal by Subject|1|||
162137814|NCT01244984|585555600|FG001|Overall Study|Withdrawal by Subject|2|||
161798335|NCT00626925|584304463|FG000|Overall Study|relapse|1|||
161798336|NCT00626925|584304464|FG001|Overall Study|relapse|0|||
161901986|NCT00329108|584688744|FG001|Overall Study|study terminated by sponsor|0|||
162137815|NCT01244984|585555601|FG002|Overall Study|Withdrawal by Subject|2|||
162137816|NCT04577183|585555602|FG000|Overall Study|Death|1|||
162137817|NCT04577183|585555602|FG000|Overall Study|Withdrawal by Subject|3|||
161901987|NCT00329108|584688743|FG000|Overall Study|withdrew patient after SAE resolved|1|||
161901988|NCT00329108|584688744|FG001|Overall Study|withdrew patient after SAE resolved|0|||
161901989|NCT00329108|584688743|FG000|Overall Study|Protocol Violation|0|||
161901990|NCT00329108|584688744|FG001|Overall Study|Protocol Violation|2|||
161901991|NCT01302418|584688745|FG000|Overall Study|Protocol Violation|9|||
161901992|NCT01302418|584688745|FG000|Overall Study|Non-evaluable|9|||
161901993|NCT02787304|584688750|FG000|Overall Study|Adverse Event|9|||
161901994|NCT02787304|584688751|FG001|Overall Study|Adverse Event|3|||
161901995|NCT02787304|584688752|FG002|Overall Study|Adverse Event|8|||
161901996|NCT02787304|584688753|FG003|Overall Study|Adverse Event|1|||
161901997|NCT02787304|584688750|FG000|Overall Study|Withdrawal by Subject|1|||
161901998|NCT02787304|584688751|FG001|Overall Study|Withdrawal by Subject|4|||
161901999|NCT02787304|584688752|FG002|Overall Study|Withdrawal by Subject|0|||
161902000|NCT02787304|584688753|FG003|Overall Study|Withdrawal by Subject|0|||
161902001|NCT02787304|584688750|FG000|Overall Study|Lost to Follow-up|1|||
161902002|NCT02787304|584688751|FG001|Overall Study|Lost to Follow-up|0|||
161902003|NCT02787304|584688752|FG002|Overall Study|Lost to Follow-up|0|||
161902004|NCT02787304|584688753|FG003|Overall Study|Lost to Follow-up|1|||
161902005|NCT02787304|584688750|FG000|Overall Study|Noncompliance with study drug|0|||
161902006|NCT02787304|584688751|FG001|Overall Study|Noncompliance with study drug|0|||
161902007|NCT02787304|584688752|FG002|Overall Study|Noncompliance with study drug|1|||
161902008|NCT02787304|584688753|FG003|Overall Study|Noncompliance with study drug|0|||
161902009|NCT02787304|584688750|FG000|Overall Study|Physician Decision|0|||
161902010|NCT02787304|584688751|FG001|Overall Study|Physician Decision|0|||
161902011|NCT02787304|584688752|FG002|Overall Study|Physician Decision|1|||
161902012|NCT02787304|584688753|FG003|Overall Study|Physician Decision|0|||
161902013|NCT02787304|584688750|FG000|Overall Study|Study terminated by sponsor|25|||
161902014|NCT02787304|584688751|FG001|Overall Study|Study terminated by sponsor|31|||
161902015|NCT02787304|584688752|FG002|Overall Study|Study terminated by sponsor|31|||
161902016|NCT02787304|584688753|FG003|Overall Study|Study terminated by sponsor|32|||
161902017|NCT04771013|584688756|FG000|Overall Study|Withdrawal by Subject|2|||
161902018|NCT04771013|584688757|FG001|Overall Study|Withdrawal by Subject|0|||
161902019|NCT04771013|584688756|FG000|Overall Study|Death|0|||
161902020|NCT04771013|584688757|FG001|Overall Study|Death|5|||
161902021|NCT04771013|584688756|FG000|Overall Study|Referred to another hospital before day 20|0|||
161902022|NCT04771013|584688757|FG001|Overall Study|Referred to another hospital before day 20|1|||
161902023|NCT00419757|584688760|FG000|Overall Study|Adverse Event|1|||
161902024|NCT00419757|584688761|FG001|Overall Study|Adverse Event|4|||
161902025|NCT00419757|584688760|FG000|Overall Study|Lost to Follow-up|1|||
161902026|NCT00419757|584688761|FG001|Overall Study|Lost to Follow-up|4|||
161902027|NCT00419757|584688760|FG000|Overall Study|Withdrawal by Subject|7|||
161902028|NCT00419757|584688761|FG001|Overall Study|Withdrawal by Subject|1|||
161902029|NCT00419757|584688760|FG000|Overall Study|Protocol Violation|2|||
161902030|NCT00419757|584688761|FG001|Overall Study|Protocol Violation|3|||
161902031|NCT00419757|584688760|FG000|Overall Study|Study specific discontinuation criteria|4|||
161902032|NCT00419757|584688761|FG001|Overall Study|Study specific discontinuation criteria|8|||
161902033|NCT00419757|584688760|FG000|Overall Study|Multiple reasons|3|||
161902034|NCT00419757|584688761|FG001|Overall Study|Multiple reasons|1|||
161902035|NCT01051921|584688762|FG000|Overall Study|Physician Decision|9|||
161902036|NCT01051921|584688762|FG000|Overall Study|Adverse Event|8|||
161902037|NCT01051921|584688762|FG000|Overall Study|Withdrawal by Subject|7|||
161902038|NCT01051921|584688762|FG000|Overall Study|Lost to Follow-up|4|||
161902039|NCT01051921|584688762|FG000|Overall Study|virological failure|1|||
161902040|NCT01051921|584688762|FG000|Overall Study|patient moved|1|||
161902041|NCT01716806|584688765|FG000|Overall Study|Patient withdrawal of consent|4|||
161902042|NCT01716806|584688766|FG001|Overall Study|Patient withdrawal of consent|2|||
161902043|NCT01716806|584688767|FG002|Overall Study|Patient withdrawal of consent|4|||
161902044|NCT01716806|584688768|FG003|Overall Study|Patient withdrawal of consent|3|||
161902045|NCT01716806|584688769|FG004|Overall Study|Patient withdrawal of consent|2|||
161902046|NCT01716806|584688770|FG005|Overall Study|Patient withdrawal of consent|0|||
161902047|NCT01716806|584688765|FG000|Overall Study|Lost to Follow-up|3|||
161902048|NCT01716806|584688766|FG001|Overall Study|Lost to Follow-up|3|||
161902049|NCT01716806|584688767|FG002|Overall Study|Lost to Follow-up|0|||
161902050|NCT01716806|584688768|FG003|Overall Study|Lost to Follow-up|2|||
161902051|NCT01716806|584688769|FG004|Overall Study|Lost to Follow-up|1|||
161902052|NCT01716806|584688770|FG005|Overall Study|Lost to Follow-up|0|||
161902053|NCT01716806|584688765|FG000|Overall Study|Death|13|||
161902054|NCT01716806|584688766|FG001|Overall Study|Death|9|||
161902055|NCT01716806|584688767|FG002|Overall Study|Death|12|||
161902056|NCT01716806|584688768|FG003|Overall Study|Death|4|||
161902057|NCT01716806|584688769|FG004|Overall Study|Death|10|||
161902058|NCT01716806|584688770|FG005|Overall Study|Death|5|||
161902059|NCT01716806|584688765|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
161902060|NCT01716806|584688766|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
161942199|NCT02082977|584838339|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
161902061|NCT01716806|584688767|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
161902062|NCT01716806|584688768|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
161902063|NCT01716806|584688769|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
161902064|NCT01716806|584688770|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
161902065|NCT01716806|584688765|FG000|Overall Study|PI decision|0|||
161902066|NCT01716806|584688766|FG001|Overall Study|PI decision|0|||
161902067|NCT01716806|584688767|FG002|Overall Study|PI decision|0|||
161902068|NCT01716806|584688768|FG003|Overall Study|PI decision|0|||
161902069|NCT01716806|584688769|FG004|Overall Study|PI decision|1|||
161902070|NCT01716806|584688770|FG005|Overall Study|PI decision|0|||
161902071|NCT01716806|584688765|FG000|Overall Study|Change in performance status|1|||
161902072|NCT01716806|584688766|FG001|Overall Study|Change in performance status|0|||
161902073|NCT01716806|584688767|FG002|Overall Study|Change in performance status|0|||
161902074|NCT01716806|584688768|FG003|Overall Study|Change in performance status|0|||
161902075|NCT01716806|584688769|FG004|Overall Study|Change in performance status|0|||
161902076|NCT01716806|584688770|FG005|Overall Study|Change in performance status|0|||
161902077|NCT01716806|584688765|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
161902078|NCT01716806|584688766|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
161902079|NCT01716806|584688767|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
161902080|NCT01716806|584688768|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
161902081|NCT01716806|584688769|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
161902082|NCT01716806|584688770|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
161902083|NCT01716806|584688765|FG000|Overall Study|Sponsor direction|7|||
161902084|NCT01716806|584688766|FG001|Overall Study|Sponsor direction|8|||
161902085|NCT01716806|584688767|FG002|Overall Study|Sponsor direction|5|||
161902086|NCT01716806|584688768|FG003|Overall Study|Sponsor direction|12|||
161902087|NCT01716806|584688769|FG004|Overall Study|Sponsor direction|16|||
161902088|NCT01716806|584688770|FG005|Overall Study|Sponsor direction|1|||
161902089|NCT00735709|584688775|FG000|Overall Study|Adverse Event|2|||
161902090|NCT00735709|584688776|FG001|Overall Study|Adverse Event|3|||
161902091|NCT00735709|584688777|FG002|Overall Study|Adverse Event|1|||
161902092|NCT00735709|584688778|FG003|Overall Study|Adverse Event|5|||
161902093|NCT00735709|584688775|FG000|Overall Study|Lack of Efficacy|8|||
161902094|NCT00735709|584688776|FG001|Overall Study|Lack of Efficacy|4|||
161902095|NCT00735709|584688777|FG002|Overall Study|Lack of Efficacy|2|||
161902096|NCT00735709|584688778|FG003|Overall Study|Lack of Efficacy|3|||
161902097|NCT00735709|584688775|FG000|Overall Study|Noncompliance|0|||
161902098|NCT00735709|584688776|FG001|Overall Study|Noncompliance|0|||
161902099|NCT00735709|584688777|FG002|Overall Study|Noncompliance|1|||
161902100|NCT00735709|584688778|FG003|Overall Study|Noncompliance|0|||
161902101|NCT00735709|584688775|FG000|Overall Study|Protocol deviations|1|||
161902102|NCT00735709|584688776|FG001|Overall Study|Protocol deviations|2|||
161902103|NCT00735709|584688777|FG002|Overall Study|Protocol deviations|1|||
161902104|NCT00735709|584688778|FG003|Overall Study|Protocol deviations|1|||
161902105|NCT00735709|584688775|FG000|Overall Study|Voluntary Withdrawal|1|||
161902106|NCT00735709|584688776|FG001|Overall Study|Voluntary Withdrawal|3|||
161902107|NCT00735709|584688777|FG002|Overall Study|Voluntary Withdrawal|5|||
161902108|NCT00735709|584688778|FG003|Overall Study|Voluntary Withdrawal|7|||
161902109|NCT00735709|584688775|FG000|Overall Study|Lost to Follow-up|0|||
161902110|NCT00735709|584688776|FG001|Overall Study|Lost to Follow-up|1|||
161902111|NCT00735709|584688777|FG002|Overall Study|Lost to Follow-up|1|||
161902112|NCT00735709|584688778|FG003|Overall Study|Lost to Follow-up|1|||
161902113|NCT00735709|584688775|FG000|Overall Study|Excluded medication|1|||
161902114|NCT00735709|584688776|FG001|Overall Study|Excluded medication|0|||
161902115|NCT00735709|584688777|FG002|Overall Study|Excluded medication|0|||
161902116|NCT00735709|584688778|FG003|Overall Study|Excluded medication|1|||
161902117|NCT02498678|584688781|FG000|Overall Study|interference from the surgical team|0|||
161902118|NCT02498678|584688782|FG001|Overall Study|interference from the surgical team|2|||
161902119|NCT03627832|584688784|FG000|Overall Study|Withdrawal by Subject|10|||
161902120|NCT03627832|584688785|FG001|Overall Study|Withdrawal by Subject|1|||
161902121|NCT01145482|584688789|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
161902122|NCT01145482|584688790|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
161902123|NCT04547140|584688791|FG000|Overall Study|Adverse Event|0|||
161902124|NCT04547140|584688792|FG001|Overall Study|Adverse Event|1|||
161902125|NCT04547140|584688791|FG000|Overall Study|Withdrawal by Subject|0|||
161902126|NCT04547140|584688792|FG001|Overall Study|Withdrawal by Subject|1|||
161902127|NCT04547140|584688791|FG000|Overall Study|Lost to Follow-up|3|||
161902128|NCT04547140|584688792|FG001|Overall Study|Lost to Follow-up|1|||
161902129|NCT04547140|584688791|FG000|Overall Study|Death|2|||
161902130|NCT04547140|584688792|FG001|Overall Study|Death|1|||
161902131|NCT04547140|584688791|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
161902132|NCT04547140|584688792|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
161902133|NCT04547140|584688791|FG000|Overall Study|Pregnancy|1|||
161902134|NCT04547140|584688792|FG001|Overall Study|Pregnancy|0|||
161902135|NCT04547140|584688791|FG000|Overall Study|Reason Not Specified|4|||
161902136|NCT04547140|584688792|FG001|Overall Study|Reason Not Specified|1|||
161902137|NCT02119299|584688793|FG000|Overall Study|Withdrawal by Subject|7|||
161902138|NCT02119299|584688793|FG000|Overall Study|Lack of Efficacy|1|||
161902139|NCT02119299|584688793|FG000|Overall Study|Pregnancy|1|||
161902140|NCT04613739|584688794|FG000|Overall Study|Lost to Follow-up|6|||
161902141|NCT04613739|584688795|FG001|Overall Study|Lost to Follow-up|9|||
161902142|NCT04613739|584688794|FG000|Overall Study|potentially duplicative/fraudulent|1|||
161902143|NCT04613739|584688795|FG001|Overall Study|potentially duplicative/fraudulent|3|||
161902144|NCT00483652|584688796|FG000|Double-blind Treatment Period|Protocol Violation|2|||
161902145|NCT00483652|584688797|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161902146|NCT00483652|584688796|FG000|Double-blind Treatment Period|Adverse Event|3|||
161902147|NCT00483652|584688797|FG001|Double-blind Treatment Period|Adverse Event|4|||
161902148|NCT00483652|584688796|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
161902149|NCT00483652|584688797|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
161902150|NCT00483652|584688796|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
161902151|NCT00483652|584688797|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
161902152|NCT02154139|584688798|FG000|Overall Study|Injection not administered|2|||
161902153|NCT02154139|584688798|FG000|Overall Study|Other|2|||
161902154|NCT02154139|584688798|FG000|Overall Study|Investigator transferred|3|||
161902155|NCT00891813|584688799|FG000|Overall Study|Adverse Event|3|||
161902156|NCT00891813|584688799|FG000|Overall Study|Withdrawal by Subject|1|||
161902157|NCT00891813|584688799|FG000|Overall Study|Patient Noncompliance|6|||
161902158|NCT00891813|584688799|FG000|Overall Study|Protocol Violation|2|||
161902159|NCT03075267|584688808|FG000|Overall Study|Protocol Violation|1|||
161902160|NCT03075267|584688809|FG001|Overall Study|Protocol Violation|0|||
161902161|NCT03075267|584688810|FG002|Overall Study|Protocol Violation|0|||
161902162|NCT03874013|584688811|FG000|Overall Study|Adverse Event|0|||
161902163|NCT03874013|584688812|FG001|Overall Study|Adverse Event|1|||
161902164|NCT01443858|584688819|FG000|Overall Study|Withdrawal by Subject|9|||
161902165|NCT01443858|584688820|FG001|Overall Study|Withdrawal by Subject|8|||
161902166|NCT01443858|584688821|FG002|Overall Study|Withdrawal by Subject|5|||
161902167|NCT01443858|584688819|FG000|Overall Study|Lack of Efficacy|1|||
161902168|NCT01443858|584688820|FG001|Overall Study|Lack of Efficacy|0|||
161902169|NCT01443858|584688821|FG002|Overall Study|Lack of Efficacy|0|||
162137818|NCT04577183|585555602|FG000|Overall Study|Early termination|2|||
162137819|NCT01168401|585555606|FG000|Overall Study|Lost to Follow-up|1|||
161798337|NCT00626925|584304463|FG000|Overall Study|Adverse effect|6|||
161798338|NCT00626925|584304464|FG001|Overall Study|Adverse effect|2|||
161798339|NCT00626925|584304463|FG000|Overall Study|Lack of Efficacy|1|||
161798340|NCT00626925|584304464|FG001|Overall Study|Lack of Efficacy|4|||
161798341|NCT00626925|584304463|FG000|Overall Study|Time constraints|3|||
161798342|NCT00626925|584304464|FG001|Overall Study|Time constraints|1|||
161798343|NCT00625807|584304467|FG000|Overall Study|schedule conflict|2|||
161798344|NCT00625807|584304468|FG001|Overall Study|schedule conflict|8|||
161798345|NCT01802879|584304469|FG000|Overall Study|Administrative problems|2|||
161798346|NCT01802879|584304469|FG000|Overall Study|Disease progression|6|||
161798347|NCT00266409|584304470|FG000|Overall Study|Lack of Efficacy|2|||
161798348|NCT00266409|584304471|FG001|Overall Study|Lack of Efficacy|6|||
161798349|NCT00266409|584304472|FG002|Overall Study|Lack of Efficacy|1|||
161798350|NCT00266409|584304473|FG003|Overall Study|Lack of Efficacy|2|||
161798351|NCT00266409|584304470|FG000|Overall Study|Adverse Event|7|||
161798352|NCT00266409|584304471|FG001|Overall Study|Adverse Event|2|||
161798353|NCT00266409|584304472|FG002|Overall Study|Adverse Event|1|||
161798354|NCT00266409|584304473|FG003|Overall Study|Adverse Event|1|||
161798355|NCT00266409|584304470|FG000|Overall Study|Lost to Follow-up|18|||
161798356|NCT00266409|584304471|FG001|Overall Study|Lost to Follow-up|21|||
161798357|NCT00266409|584304472|FG002|Overall Study|Lost to Follow-up|6|||
161798358|NCT00266409|584304473|FG003|Overall Study|Lost to Follow-up|8|||
161798359|NCT00266409|584304470|FG000|Overall Study|Withdrawal by Subject|6|||
161798360|NCT00266409|584304471|FG001|Overall Study|Withdrawal by Subject|10|||
161798361|NCT00266409|584304472|FG002|Overall Study|Withdrawal by Subject|3|||
161798362|NCT00266409|584304473|FG003|Overall Study|Withdrawal by Subject|9|||
161798363|NCT00266409|584304470|FG000|Overall Study|Protocol Violation|5|||
161798364|NCT00266409|584304471|FG001|Overall Study|Protocol Violation|3|||
161798365|NCT00266409|584304472|FG002|Overall Study|Protocol Violation|4|||
161798366|NCT00266409|584304473|FG003|Overall Study|Protocol Violation|2|||
161798367|NCT00266409|584304470|FG000|Overall Study|Other|7|||
161798368|NCT00266409|584304471|FG001|Overall Study|Other|4|||
161798369|NCT00266409|584304472|FG002|Overall Study|Other|2|||
161798370|NCT00266409|584304473|FG003|Overall Study|Other|0|||
161798371|NCT00108732|584304476|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
161798372|NCT00108732|584304476|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
161902170|NCT01443858|584688819|FG000|Overall Study|Lost to Follow-up|5|||
161902171|NCT01443858|584688820|FG001|Overall Study|Lost to Follow-up|5|||
161798373|NCT00108732|584304476|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
161798374|NCT00108732|584304476|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
161798375|NCT00108732|584304476|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
161798376|NCT00108732|584304476|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
161798377|NCT00108732|584304476|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
161798378|NCT01946165|584304478|FG000|Overall Study|Physician Decision|2|||
161798379|NCT01946165|584304479|FG001|Overall Study|Physician Decision|0|||
161798380|NCT01946165|584304478|FG000|Overall Study|Withdrawal by Subject|0|||
161798381|NCT01946165|584304479|FG001|Overall Study|Withdrawal by Subject|2|||
161798382|NCT01901055|584304480|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
161798383|NCT01901055|584304481|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
161798384|NCT01901055|584304480|FG000|Randomization But Not Titrated|Physician Decision|0|||
161798385|NCT01901055|584304481|FG001|Randomization But Not Titrated|Physician Decision|1|||
161798386|NCT01901055|584304480|FG000|Started Protocol to Week 6|Physician Decision|2|||
161798387|NCT01901055|584304481|FG001|Started Protocol to Week 6|Physician Decision|1|||
161798388|NCT01901055|584304480|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
161798389|NCT01901055|584304481|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
161798390|NCT01901055|584304480|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
161798391|NCT01901055|584304481|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
161798392|NCT01901055|584304480|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
161798393|NCT01901055|584304481|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
161798394|NCT01901055|584304480|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
161798395|NCT01901055|584304481|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
161798396|NCT01901055|584304480|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
161798397|NCT01901055|584304481|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
161798398|NCT01901055|584304480|FG000|Week 24|Withdrawal by Subject|13|||
161798399|NCT01901055|584304481|FG001|Week 24|Withdrawal by Subject|19|||
161798400|NCT01901055|584304480|FG000|Week 24|Physician Decision|1|||
161798401|NCT01901055|584304481|FG001|Week 24|Physician Decision|0|||
161798402|NCT01901055|584304480|FG000|Week 36|Withdrawal by Subject|0|||
161798403|NCT01901055|584304481|FG001|Week 36|Withdrawal by Subject|5|||
161798404|NCT01659567|584304482|FG000|Overall Study|Lack of Efficacy|22|||
161798405|NCT01659567|584304482|FG000|Overall Study|Switched to Pegferon|6|||
161798406|NCT01659567|584304482|FG000|Overall Study|Adverse Event|12|||
161798407|NCT01659567|584304482|FG000|Overall Study|Good result at early stage of treatment|5|||
161798408|NCT01659567|584304482|FG000|Overall Study|Withdrawal by Subject|64|||
161798409|NCT01659567|584304482|FG000|Overall Study|Progression of the main disease|1|||
161798410|NCT01659567|584304482|FG000|Overall Study|Other|13|||
161798411|NCT01179919|584304485|FG000|Overall Study|Protocol Violation|1|||
161798412|NCT01179919|584304485|FG000|Overall Study|Adverse Event|1|||
161798413|NCT01915732|584304491|FG000|Overall Study|Withdrawal by Subject|18|||
161798414|NCT01915732|584304492|FG001|Overall Study|Withdrawal by Subject|18|||
161798415|NCT01915732|584304491|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
161798416|NCT01915732|584304492|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
161798417|NCT01915732|584304491|FG000|Overall Study|Adverse Event|12|||
161798418|NCT01915732|584304492|FG001|Overall Study|Adverse Event|4|||
161798419|NCT01915732|584304491|FG000|Overall Study|Protocol Violation|5|||
161798420|NCT01915732|584304492|FG001|Overall Study|Protocol Violation|5|||
161798421|NCT01915732|584304491|FG000|Overall Study|Lack of Efficacy|6|||
161798422|NCT01915732|584304492|FG001|Overall Study|Lack of Efficacy|11|||
161798423|NCT01915732|584304491|FG000|Overall Study|Lost to Follow-up|22|||
161798424|NCT01915732|584304492|FG001|Overall Study|Lost to Follow-up|26|||
161798425|NCT01915732|584304491|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
161798426|NCT01915732|584304492|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
161798427|NCT01915732|584304491|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
161798428|NCT01915732|584304492|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
161798429|NCT01915732|584304491|FG000|Overall Study|Drug Release Error|1|||
161798430|NCT01915732|584304492|FG001|Overall Study|Drug Release Error|0|||
161798431|NCT01915732|584304491|FG000|Overall Study|Recovered|1|||
161798432|NCT01915732|584304492|FG001|Overall Study|Recovered|0|||
161798433|NCT01915732|584304491|FG000|Overall Study|Pregnancy|1|||
161798434|NCT01915732|584304492|FG001|Overall Study|Pregnancy|0|||
161798435|NCT01915732|584304491|FG000|Overall Study|Poor Perceived Efficacy|1|||
161798436|NCT01915732|584304492|FG001|Overall Study|Poor Perceived Efficacy|0|||
161798437|NCT01915732|584304491|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
161798438|NCT01915732|584304492|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
161798439|NCT01915732|584304491|FG000|Overall Study|Got Well|0|||
161798440|NCT01915732|584304492|FG001|Overall Study|Got Well|1|||
161798441|NCT01915732|584304491|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
161798442|NCT01915732|584304492|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
161798443|NCT01915732|584304491|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
161798444|NCT01915732|584304492|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
161798445|NCT01915732|584304491|FG000|Overall Study|Job Transfer|0|||
161798446|NCT01915732|584304492|FG001|Overall Study|Job Transfer|1|||
161798447|NCT01915732|584304491|FG000|Overall Study|Improper Facial Procedure|0|||
161902172|NCT01443858|584688821|FG002|Overall Study|Lost to Follow-up|2|||
161902173|NCT06060496|584688822|FG000|Overall Study|Withdrawal by Subject|2|||
161902174|NCT06060496|584688822|FG000|Overall Study|Lost to Follow-up|2|||
161902175|NCT00149396|584688825|FG000|Overall Study|Death|15|||
161902176|NCT00149396|584688825|FG000|Overall Study|Withdrawal by Subject|1|||
161902177|NCT00149396|584688825|FG000|Overall Study|Subject noncompliance|2|||
161902178|NCT00149396|584688825|FG000|Overall Study|other treatment|5|||
161902179|NCT00807885|584688826|FG000|Overall Study|Lost to Follow-up|0|||
161902180|NCT00807885|584688827|FG001|Overall Study|Lost to Follow-up|0|||
161902181|NCT00807885|584688828|FG002|Overall Study|Lost to Follow-up|0|||
161902182|NCT00807885|584688829|FG003|Overall Study|Lost to Follow-up|0|||
161902183|NCT00807885|584688830|FG004|Overall Study|Lost to Follow-up|0|||
161902184|NCT00807885|584688831|FG005|Overall Study|Lost to Follow-up|1|||
161902185|NCT00807885|584688832|FG006|Overall Study|Lost to Follow-up|0|||
161902186|NCT00807885|584688833|FG007|Overall Study|Lost to Follow-up|0|||
161902187|NCT00807885|584688834|FG008|Overall Study|Lost to Follow-up|0|||
161902188|NCT01670045|584688838|FG000|Overall Study|Withdrawal by Subject|3|||
161902189|NCT01670045|584688838|FG000|Overall Study|Adverse Event|1|||
161902190|NCT01670045|584688838|FG000|Overall Study|Death|1|||
161902191|NCT01670045|584688838|FG000|Overall Study|Lost to Follow-up|11|||
161902192|NCT03360019|584688839|FG000|Overall Study|Withdrawal by Subject|2|||
161902193|NCT03360019|584688840|FG001|Overall Study|Withdrawal by Subject|0|||
161902194|NCT03360019|584688841|FG002|Overall Study|Withdrawal by Subject|0|||
161902195|NCT03360019|584688839|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
161798448|NCT01915732|584304492|FG001|Overall Study|Improper Facial Procedure|1|||
161798449|NCT01915732|584304491|FG000|Overall Study|Poor Conscious Effect|0|||
161798450|NCT01915732|584304492|FG001|Overall Study|Poor Conscious Effect|1|||
161798451|NCT00698685|584304493|FG000|Overall Study|Sister withdrew as donor|1|||
161798452|NCT00698685|584304493|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
161798453|NCT01325207|584304494|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161798454|NCT01325207|584304495|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161798455|NCT01325207|584304496|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161798456|NCT01325207|584304497|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161798457|NCT01325207|584304498|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
161798458|NCT01325207|584304499|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161798459|NCT01325207|584304494|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
161798460|NCT01325207|584304495|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
161798461|NCT01325207|584304496|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
161798462|NCT01325207|584304497|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
161798463|NCT01325207|584304498|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
161798464|NCT01325207|584304499|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
161798465|NCT01325207|584304494|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
161798466|NCT01325207|584304495|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
161798467|NCT01325207|584304496|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
161798468|NCT01325207|584304497|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
161798469|NCT01325207|584304498|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
161798470|NCT01325207|584304499|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
161798471|NCT01325207|584304494|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161798472|NCT01325207|584304495|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
161798473|NCT01325207|584304496|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161798474|NCT01325207|584304497|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161798475|NCT01325207|584304498|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161798476|NCT01325207|584304499|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161798477|NCT01325207|584304494|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161798478|NCT01325207|584304495|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161798479|NCT01325207|584304496|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161798480|NCT01325207|584304497|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161798481|NCT01325207|584304498|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161798482|NCT01325207|584304499|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
161798483|NCT01325207|584304494|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161798484|NCT01325207|584304495|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161798485|NCT01325207|584304496|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161798486|NCT01325207|584304497|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161902196|NCT03360019|584688840|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
161902197|NCT03360019|584688841|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
161902198|NCT00753675|584688844|FG000|Overall Study|other reason|11|||
161902199|NCT00753675|584688845|FG001|Overall Study|other reason|12|||
161902200|NCT00753675|584688846|FG002|Overall Study|other reason|13|||
161902201|NCT00753675|584688844|FG000|Overall Study|Death|1|||
161902202|NCT00753675|584688845|FG001|Overall Study|Death|2|||
161902203|NCT00753675|584688846|FG002|Overall Study|Death|4|||
161902204|NCT00753675|584688844|FG000|Overall Study|Adverse Event|11|||
161902205|NCT00753675|584688845|FG001|Overall Study|Adverse Event|9|||
161902206|NCT00753675|584688846|FG002|Overall Study|Adverse Event|4|||
161902207|NCT00753675|584688844|FG000|Overall Study|Objective progression of disease|35|||
161902208|NCT00753675|584688845|FG001|Overall Study|Objective progression of disease|35|||
161902209|NCT00753675|584688846|FG002|Overall Study|Objective progression of disease|35|||
161902210|NCT00753675|584688844|FG000|Overall Study|Withdrawal by Subject|0|||
161902211|NCT00753675|584688845|FG001|Overall Study|Withdrawal by Subject|1|||
161902212|NCT00753675|584688846|FG002|Overall Study|Withdrawal by Subject|0|||
161902213|NCT00753675|584688844|FG000|Overall Study|Lost to Follow-up|1|||
161902214|NCT00753675|584688845|FG001|Overall Study|Lost to Follow-up|0|||
161902215|NCT00753675|584688846|FG002|Overall Study|Lost to Follow-up|0|||
161902216|NCT01462110|584688847|FG000|Overall Study|Adverse Event|1|||
161902217|NCT01462110|584688848|FG001|Overall Study|Adverse Event|0|||
161902218|NCT05279131|584688849|FG000|Overall Study|Lost to Follow-up|1|||
161902219|NCT05279131|584688849|FG000|Overall Study|Death|1|||
161902220|NCT05279131|584688849|FG000|Overall Study|Physician Decision|1|||
161902221|NCT04754542|584688857|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
161902222|NCT04754542|584688858|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
161902223|NCT00873730|584690490|FG000|Overall Study|Protocol Deviation|5|||
161902224|NCT00873730|584690491|FG001|Overall Study|Protocol Deviation|2|||
161902225|NCT00873730|584690490|FG000|Overall Study|Adverse Event|0|||
161902226|NCT00873730|584690491|FG001|Overall Study|Adverse Event|2|||
161902227|NCT00873730|584690490|FG000|Overall Study|Withdrawal by Subject|0|||
161902228|NCT00873730|584690491|FG001|Overall Study|Withdrawal by Subject|1|||
161902229|NCT00873730|584690490|FG000|Overall Study|Sponsor decision|1|||
161902230|NCT00873730|584690491|FG001|Overall Study|Sponsor decision|0|||
161902231|NCT04110314|584690494|FG000|Overall Study|Did not meet inclusion criteria|35255|||
161902232|NCT04110314|584690495|FG001|Overall Study|Did not meet inclusion criteria|35104|||
161902233|NCT04110314|584690496|FG002|Overall Study|Did not meet inclusion criteria|35636|||
162137820|NCT01168401|585555607|FG001|Overall Study|Lost to Follow-up|1|||
162137821|NCT01168401|585555608|FG002|Overall Study|Lost to Follow-up|2|||
162137822|NCT01168401|585555609|FG003|Overall Study|Lost to Follow-up|1|||
162137823|NCT01168401|585555610|FG004|Overall Study|Lost to Follow-up|0|||
162137824|NCT01168401|585555611|FG005|Overall Study|Lost to Follow-up|0|||
162137825|NCT01168401|585555612|FG006|Overall Study|Lost to Follow-up|0|||
162137826|NCT01168401|585555613|FG007|Overall Study|Lost to Follow-up|0|||
162137827|NCT01168401|585555614|FG008|Overall Study|Lost to Follow-up|0|||
161902234|NCT04110314|584690497|FG003|Overall Study|Did not meet inclusion criteria|35135|||
161902235|NCT04110314|584690498|FG004|Overall Study|Did not meet inclusion criteria|35247|||
161902236|NCT04110314|584690499|FG005|Overall Study|Did not meet inclusion criteria|35727|||
161902237|NCT01711983|584690507|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
161902238|NCT01711983|584690507|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
161902239|NCT01711983|584690507|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
161902240|NCT01711983|584690507|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
161902241|NCT00737100|584690508|FG000|Overall Study|Adverse Event|6|||
161902242|NCT00737100|584690509|FG001|Overall Study|Adverse Event|5|||
161902243|NCT00737100|584690510|FG002|Overall Study|Adverse Event|3|||
161902244|NCT00737100|584690508|FG000|Overall Study|Lost to Follow-up|0|||
161902245|NCT00737100|584690509|FG001|Overall Study|Lost to Follow-up|1|||
161902246|NCT00737100|584690510|FG002|Overall Study|Lost to Follow-up|0|||
162137828|NCT01168401|585555615|FG009|Overall Study|Lost to Follow-up|0|||
162137829|NCT01168401|585555616|FG010|Overall Study|Lost to Follow-up|0|||
162137830|NCT01168401|585555606|FG000|Overall Study|Withdrawal by Subject|0|||
161902247|NCT00737100|584690508|FG000|Overall Study|Withdrawal by Subject|0|||
161902248|NCT00737100|584690509|FG001|Overall Study|Withdrawal by Subject|0|||
161902249|NCT00737100|584690510|FG002|Overall Study|Withdrawal by Subject|3|||
161902250|NCT00737100|584690508|FG000|Overall Study|Reason discontinued not explained above|1|||
161902251|NCT00737100|584690509|FG001|Overall Study|Reason discontinued not explained above|1|||
161902252|NCT00737100|584690510|FG002|Overall Study|Reason discontinued not explained above|1|||
161902253|NCT00735943|584690515|FG000|Overall Study|Lost to Follow-up|1|||
161902254|NCT00735943|584690515|FG000|Overall Study|Adverse Event|1|||
162137831|NCT01168401|585555607|FG001|Overall Study|Withdrawal by Subject|0|||
161902255|NCT00115778|584690516|FG000|Overall Study|Withdrawal by Subject|0|||
161902256|NCT00115778|584690517|FG001|Overall Study|Withdrawal by Subject|1|||
161902257|NCT01607593|584690518|FG000|Overall Study|Adverse Event|15|||
162010873|NCT00870740|585096031|FG002|Overall Study|Other|2|||
162137832|NCT01168401|585555608|FG002|Overall Study|Withdrawal by Subject|0|||
162137833|NCT01168401|585555609|FG003|Overall Study|Withdrawal by Subject|1|||
161902258|NCT01607593|584690518|FG000|Overall Study|Lack of Efficacy|16|||
161902259|NCT01607593|584690518|FG000|Overall Study|Lost to Follow-up|25|||
161902260|NCT01607593|584690518|FG000|Overall Study|Continuation|33|||
162137834|NCT01168401|585555610|FG004|Overall Study|Withdrawal by Subject|0|||
162137835|NCT01168401|585555611|FG005|Overall Study|Withdrawal by Subject|0|||
161902261|NCT01607593|584690518|FG000|Overall Study|Other|4|||
161902262|NCT03713684|584690523|FG000|Overall Study|Adverse Event|1|||
161902263|NCT03713684|584690524|FG001|Overall Study|Adverse Event|3|||
161902264|NCT03713684|584690525|FG002|Overall Study|Adverse Event|1|||
161902265|NCT03713684|584690526|FG003|Overall Study|Adverse Event|0|||
161902266|NCT03713684|584690523|FG000|Overall Study|Poor compliance to protocol|2|||
161902267|NCT03713684|584690524|FG001|Overall Study|Poor compliance to protocol|1|||
161902268|NCT03713684|584690525|FG002|Overall Study|Poor compliance to protocol|0|||
161902269|NCT03713684|584690526|FG003|Overall Study|Poor compliance to protocol|1|||
161902270|NCT03713684|584690523|FG000|Overall Study|Withdrawal by Subject|14|||
161902271|NCT03713684|584690524|FG001|Overall Study|Withdrawal by Subject|6|||
161902272|NCT03713684|584690525|FG002|Overall Study|Withdrawal by Subject|14|||
161902273|NCT03713684|584690526|FG003|Overall Study|Withdrawal by Subject|16|||
161902274|NCT03713684|584690523|FG000|Overall Study|Other than specified|69|||
161902275|NCT03713684|584690524|FG001|Overall Study|Other than specified|77|||
161902276|NCT03713684|584690525|FG002|Overall Study|Other than specified|73|||
161902277|NCT03713684|584690526|FG003|Overall Study|Other than specified|70|||
161902278|NCT02515630|584690527|FG000|Overall Study|Withdrawal by Subject|5|||
161902279|NCT02515630|584690527|FG000|Overall Study|Adverse Event|4|||
161902280|NCT02515630|584690527|FG000|Overall Study|Physician Decision|4|||
161902281|NCT02515630|584690527|FG000|Overall Study|Death|2|||
161902282|NCT02515630|584690527|FG000|Overall Study|Disease Progression|1|||
161902283|NCT01064414|584690530|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
161902284|NCT01064414|584690531|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
161902285|NCT01064414|584690532|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
161902286|NCT01064414|584690530|FG000|Core Period: Baseline to Week 26|Death|0|||
161902287|NCT01064414|584690531|FG001|Core Period: Baseline to Week 26|Death|1|||
161902288|NCT01064414|584690532|FG002|Core Period: Baseline to Week 26|Death|0|||
161902289|NCT01064414|584690530|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
161902290|NCT01064414|584690531|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
161902291|NCT01064414|584690532|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
161902292|NCT01064414|584690530|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
161902293|NCT01064414|584690531|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
161902294|NCT01064414|584690532|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
161902295|NCT01064414|584690530|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161902296|NCT01064414|584690531|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161902297|NCT01064414|584690532|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161902298|NCT01064414|584690530|FG000|Core Period: Baseline to Week 26|Other|4|||
161902299|NCT01064414|584690531|FG001|Core Period: Baseline to Week 26|Other|7|||
161902300|NCT01064414|584690532|FG002|Core Period: Baseline to Week 26|Other|2|||
161902301|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
161902302|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161902303|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
161902304|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Death|0|||
161902305|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Death|1|||
161902306|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Death|0|||
162137836|NCT01168401|585555612|FG006|Overall Study|Withdrawal by Subject|0|||
162137837|NCT01168401|585555613|FG007|Overall Study|Withdrawal by Subject|0|||
162137838|NCT01168401|585555614|FG008|Overall Study|Withdrawal by Subject|0|||
162137839|NCT01168401|585555615|FG009|Overall Study|Withdrawal by Subject|0|||
162137840|NCT01168401|585555616|FG010|Overall Study|Withdrawal by Subject|0|||
162137841|NCT01801930|585555618|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
162137842|NCT01801930|585555619|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
162137843|NCT01801930|585555620|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
162137844|NCT01801930|585555621|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
162137845|NCT01801930|585555618|FG000|Overall Study|DLT occurs|0|||
162137846|NCT01801930|585555619|FG001|Overall Study|DLT occurs|1|||
162137847|NCT01801930|585555620|FG002|Overall Study|DLT occurs|0|||
162137848|NCT01801930|585555621|FG003|Overall Study|DLT occurs|0|||
162137849|NCT03396835|585555634|FG000|Overall Study|Withdrawn prior to completion|1|||
162137850|NCT03396835|585555634|FG000|Overall Study|Did not meet criteria for data analysis|1|||
162137851|NCT03467724|585555635|FG000|Overall Study|Lost to Follow-up|5|||
162137852|NCT03467724|585555635|FG000|Overall Study|Withdrawal by Subject|1|||
161902307|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
161902308|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161902309|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161902310|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
161902311|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161902312|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162137853|NCT03467724|585555635|FG000|Overall Study|Protocol Violation|1|||
162137854|NCT03467724|585555635|FG000|Overall Study|Adverse Event|1|||
162137855|NCT01451814|585555636|FG000|Overall Study|Withdrawal by Subject|1|||
161902313|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161902314|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161902315|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161902316|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
161902317|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
161902318|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
161902319|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161902320|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161902321|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161902322|NCT01064414|584690530|FG000|Extension Period: Week 26 to Week 52|Other|5|||
161902323|NCT01064414|584690531|FG001|Extension Period: Week 26 to Week 52|Other|2|||
161902324|NCT01064414|584690532|FG002|Extension Period: Week 26 to Week 52|Other|1|||
161902325|NCT00974311|584690533|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
161902326|NCT00974311|584690534|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
161902327|NCT00974311|584690533|FG000|DB Phase (up to 24 Months)|Death|561|||
161902328|NCT00974311|584690534|FG001|DB Phase (up to 24 Months)|Death|298|||
161902329|NCT00974311|584690533|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
161902330|NCT00974311|584690534|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
161902331|NCT00974311|584690533|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
161902332|NCT00974311|584690534|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
161902333|NCT00974311|584690533|FG000|DB Phase (up to 24 Months)|Other|1|||
161902334|NCT00974311|584690534|FG001|DB Phase (up to 24 Months)|Other|0|||
161902335|NCT00974311|584690533|FG000|OLE Phase (up to 77 Months)|Death|14|||
161902336|NCT00974311|584690534|FG001|OLE Phase (up to 77 Months)|Death|21|||
161902337|NCT00974311|584690533|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
161902338|NCT00974311|584690534|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
161902339|NCT00974311|584690533|FG000|OLE Phase (up to 77 Months)|Other|15|||
161902340|NCT00974311|584690534|FG001|OLE Phase (up to 77 Months)|Other|2|||
161902341|NCT00974311|584690533|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
161902342|NCT00974311|584690534|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
161902343|NCT02595502|584690535|FG000|Period 1|Adverse Event|0|||
161902344|NCT02595502|584690536|FG001|Period 1|Adverse Event|1|||
161902345|NCT02595502|584690535|FG000|Period 1|Withdrawal by Subject|1|||
161902346|NCT02595502|584690536|FG001|Period 1|Withdrawal by Subject|0|||
161902347|NCT02595502|584690535|FG000|Period 1|Lost to Follow-up|0|||
161902348|NCT02595502|584690536|FG001|Period 1|Lost to Follow-up|1|||
161902349|NCT02595502|584690535|FG000|Period 2|Adverse Event|1|||
161902350|NCT02595502|584690536|FG001|Period 2|Adverse Event|1|||
161902351|NCT02595502|584690535|FG000|Period 2|Received incorrect lens at Period 1|0|||
161902352|NCT02595502|584690536|FG001|Period 2|Received incorrect lens at Period 1|1|||
161902353|NCT02595502|584690535|FG000|Period 3|Protocol Violation|0|||
161902354|NCT02595502|584690536|FG001|Period 3|Protocol Violation|1|||
161902355|NCT02595502|584690535|FG000|Period 3|Lost to Follow-up|1|||
161902356|NCT02595502|584690536|FG001|Period 3|Lost to Follow-up|0|||
161902357|NCT02595502|584690535|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
161902358|NCT02595502|584690536|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
161902359|NCT03286218|584690537|FG000|Qualification Phase Period 1|Adverse Event|1|||
161902360|NCT03286218|584690538|FG001|Qualification Phase Period 1|Adverse Event|0|||
161902361|NCT03286218|584690539|FG002|Qualification Phase Period 1|Adverse Event|0|||
161902362|NCT03286218|584690540|FG003|Qualification Phase Period 1|Adverse Event|0|||
161902363|NCT03286218|584690541|FG004|Qualification Phase Period 1|Adverse Event|0|||
161902364|NCT03286218|584690542|FG005|Qualification Phase Period 1|Adverse Event|0|||
161798487|NCT01325207|584304498|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161798488|NCT01325207|584304499|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
161798489|NCT01325207|584304494|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161798490|NCT01325207|584304495|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161798491|NCT01325207|584304496|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161798492|NCT01325207|584304497|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161798493|NCT01325207|584304498|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
161798494|NCT01325207|584304499|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161798495|NCT00708422|584304500|FG000|Overall Study|Adverse Event|3|||
161798496|NCT00708422|584304501|FG001|Overall Study|Adverse Event|1|||
161902365|NCT03286218|584690543|FG006|Qualification Phase Period 1|Adverse Event|0|||
161902366|NCT03286218|584690544|FG007|Qualification Phase Period 1|Adverse Event|0|||
161902367|NCT03286218|584690545|FG008|Qualification Phase Period 1|Adverse Event|0|||
161902368|NCT03286218|584690546|FG009|Qualification Phase Period 1|Adverse Event|0|||
161902369|NCT03286218|584690547|FG010|Qualification Phase Period 1|Adverse Event|0|||
161902370|NCT03286218|584690548|FG011|Qualification Phase Period 1|Adverse Event|0|||
161902371|NCT03286218|584690537|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902372|NCT03286218|584690538|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
161902373|NCT03286218|584690539|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902374|NCT03286218|584690540|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902375|NCT03286218|584690541|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902376|NCT03286218|584690542|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902377|NCT03286218|584690543|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902378|NCT03286218|584690544|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902379|NCT03286218|584690545|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902380|NCT03286218|584690546|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902381|NCT03286218|584690547|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902382|NCT03286218|584690548|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
161902383|NCT03286218|584690537|FG000|Qualification Phase Period 2|Adverse Event|0|||
161902384|NCT03286218|584690538|FG001|Qualification Phase Period 2|Adverse Event|1|||
161902385|NCT03286218|584690539|FG002|Qualification Phase Period 2|Adverse Event|0|||
161902386|NCT03286218|584690540|FG003|Qualification Phase Period 2|Adverse Event|0|||
161902387|NCT03286218|584690541|FG004|Qualification Phase Period 2|Adverse Event|0|||
161902388|NCT03286218|584690542|FG005|Qualification Phase Period 2|Adverse Event|0|||
161902389|NCT03286218|584690543|FG006|Qualification Phase Period 2|Adverse Event|0|||
161902390|NCT03286218|584690544|FG007|Qualification Phase Period 2|Adverse Event|0|||
161902391|NCT03286218|584690545|FG008|Qualification Phase Period 2|Adverse Event|0|||
161902392|NCT03286218|584690546|FG009|Qualification Phase Period 2|Adverse Event|0|||
161902393|NCT03286218|584690547|FG010|Qualification Phase Period 2|Adverse Event|0|||
161902394|NCT03286218|584690548|FG011|Qualification Phase Period 2|Adverse Event|0|||
161902395|NCT03286218|584690537|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
161902396|NCT03286218|584690538|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
161902397|NCT03286218|584690539|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902398|NCT03286218|584690540|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902399|NCT03286218|584690541|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902400|NCT03286218|584690542|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
162010874|NCT00870740|585096032|FG003|Overall Study|Other|4|||
162010875|NCT00870740|585096033|FG004|Overall Study|Other|3|||
161798497|NCT00708422|584304500|FG000|Overall Study|Withdrawal by Subject|1|||
161798498|NCT00708422|584304501|FG001|Overall Study|Withdrawal by Subject|0|||
161798499|NCT01254409|584304502|FG000|Overall Study|Adverse Event|0|||
161798500|NCT01254409|584304503|FG001|Overall Study|Adverse Event|1|||
161798501|NCT01254409|584304504|FG002|Overall Study|Adverse Event|0|||
161798502|NCT01254409|584304505|FG003|Overall Study|Adverse Event|0|||
161798503|NCT00337571|584304512|FG000|Overall Study|Lack of Efficacy|3|||
161798504|NCT00337571|584304513|FG001|Overall Study|Lack of Efficacy|0|||
161798505|NCT00337571|584304514|FG002|Overall Study|Lack of Efficacy|0|||
161798506|NCT00337571|584304515|FG003|Overall Study|Lack of Efficacy|0|||
161798507|NCT00337571|584304512|FG000|Overall Study|Adverse Event|4|||
161798508|NCT00337571|584304513|FG001|Overall Study|Adverse Event|5|||
161798509|NCT00337571|584304514|FG002|Overall Study|Adverse Event|8|||
161798510|NCT00337571|584304515|FG003|Overall Study|Adverse Event|4|||
161798511|NCT00337571|584304512|FG000|Overall Study|Withdrawal by Subject|2|||
161798512|NCT00337571|584304513|FG001|Overall Study|Withdrawal by Subject|2|||
161798513|NCT00337571|584304514|FG002|Overall Study|Withdrawal by Subject|1|||
161798514|NCT00337571|584304515|FG003|Overall Study|Withdrawal by Subject|0|||
161798515|NCT00337571|584304512|FG000|Overall Study|Lost to Follow-up|3|||
162010876|NCT00870740|585096034|FG005|Overall Study|Other|5|||
161798516|NCT00337571|584304513|FG001|Overall Study|Lost to Follow-up|1|||
161798517|NCT00337571|584304514|FG002|Overall Study|Lost to Follow-up|0|||
161798518|NCT00337571|584304515|FG003|Overall Study|Lost to Follow-up|1|||
161798519|NCT00337571|584304512|FG000|Overall Study|Poor/noncompliance|1|||
161902401|NCT03286218|584690543|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902402|NCT03286218|584690544|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902403|NCT03286218|584690545|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902404|NCT03286218|584690546|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902405|NCT03286218|584690547|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902406|NCT03286218|584690548|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161902407|NCT03286218|584690537|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
161902408|NCT03286218|584690538|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
161902409|NCT03286218|584690539|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
161902410|NCT03286218|584690540|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
161902411|NCT03286218|584690541|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
161902412|NCT03286218|584690542|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
161902413|NCT03286218|584690543|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
161902414|NCT03286218|584690544|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
161902415|NCT03286218|584690545|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
161902416|NCT03286218|584690546|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
161902417|NCT03286218|584690547|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
161902418|NCT03286218|584690548|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
161902419|NCT03286218|584690537|FG000|Qualification Phase Period 2|Protocol Violation|2|||
161902420|NCT03286218|584690538|FG001|Qualification Phase Period 2|Protocol Violation|0|||
161902421|NCT03286218|584690539|FG002|Qualification Phase Period 2|Protocol Violation|0|||
161902422|NCT03286218|584690540|FG003|Qualification Phase Period 2|Protocol Violation|0|||
161902423|NCT03286218|584690541|FG004|Qualification Phase Period 2|Protocol Violation|0|||
161902424|NCT03286218|584690542|FG005|Qualification Phase Period 2|Protocol Violation|0|||
161902425|NCT03286218|584690543|FG006|Qualification Phase Period 2|Protocol Violation|0|||
161902426|NCT03286218|584690544|FG007|Qualification Phase Period 2|Protocol Violation|0|||
161902427|NCT03286218|584690545|FG008|Qualification Phase Period 2|Protocol Violation|0|||
161902428|NCT03286218|584690546|FG009|Qualification Phase Period 2|Protocol Violation|0|||
161902429|NCT03286218|584690547|FG010|Qualification Phase Period 2|Protocol Violation|0|||
161902430|NCT03286218|584690548|FG011|Qualification Phase Period 2|Protocol Violation|0|||
161902431|NCT03286218|584690537|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
161902432|NCT03286218|584690538|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
161902433|NCT03286218|584690539|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902434|NCT03286218|584690540|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902435|NCT03286218|584690541|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902436|NCT03286218|584690542|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902437|NCT03286218|584690543|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902438|NCT03286218|584690544|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902439|NCT03286218|584690545|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902440|NCT03286218|584690546|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902441|NCT03286218|584690547|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902442|NCT03286218|584690548|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
161902443|NCT03286218|584690537|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902444|NCT03286218|584690538|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902445|NCT03286218|584690539|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
161902446|NCT03286218|584690540|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
161902447|NCT03286218|584690541|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902448|NCT03286218|584690542|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
161902449|NCT03286218|584690543|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902450|NCT03286218|584690544|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902451|NCT03286218|584690545|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902452|NCT03286218|584690546|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902453|NCT03286218|584690547|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
161902454|NCT03286218|584690548|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
161902455|NCT03286218|584690537|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902456|NCT03286218|584690538|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902457|NCT03286218|584690539|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902458|NCT03286218|584690540|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902459|NCT03286218|584690541|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902460|NCT03286218|584690542|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902461|NCT03286218|584690543|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902462|NCT03286218|584690544|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902463|NCT03286218|584690545|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902464|NCT03286218|584690546|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902465|NCT03286218|584690547|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
161902466|NCT03286218|584690548|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
161902467|NCT03131167|584690551|FG000|Overall Study|Other (Unspecified)|0|||
161902468|NCT03131167|584690552|FG001|Overall Study|Other (Unspecified)|0|||
161902469|NCT03131167|584690553|FG002|Overall Study|Other (Unspecified)|0|||
161902470|NCT03131167|584690554|FG003|Overall Study|Other (Unspecified)|0|||
161902471|NCT03131167|584690555|FG004|Overall Study|Other (Unspecified)|0|||
161902472|NCT03131167|584690556|FG005|Overall Study|Other (Unspecified)|1|||
161902473|NCT03131167|584690557|FG006|Overall Study|Other (Unspecified)|0|||
161902474|NCT03131167|584690558|FG007|Overall Study|Other (Unspecified)|0|||
161902475|NCT03131167|584690559|FG008|Overall Study|Other (Unspecified)|0|||
161902476|NCT03131167|584690560|FG009|Overall Study|Other (Unspecified)|0|||
161902477|NCT03131167|584690561|FG010|Overall Study|Other (Unspecified)|0|||
161902478|NCT03131167|584690562|FG011|Overall Study|Other (Unspecified)|0|||
161902479|NCT03131167|584690563|FG012|Overall Study|Other (Unspecified)|0|||
161902480|NCT00458003|584690564|FG000|Overall Study|Non protocol spinal anesthesia|1|||
161902481|NCT00458003|584690565|FG001|Overall Study|Non protocol spinal anesthesia|1|||
161902482|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Death|20|||
161902483|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Death|26|||
161902484|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
161902485|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
161902486|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
161902487|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
161902488|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
161902489|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
161902490|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
161902491|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
161902492|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
161902493|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
161902494|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
161902495|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
161902496|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
161902497|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
161902498|NCT00643201|584690568|FG000|Randomized, Completed 6 Months of Study|Other|107|||
161902499|NCT00643201|584690569|FG001|Randomized, Completed 6 Months of Study|Other|107|||
161902500|NCT00643201|584690568|FG000|Completed Study Follow Up|Death|28|||
161902501|NCT00643201|584690569|FG001|Completed Study Follow Up|Death|34|||
161902502|NCT00643201|584690568|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
161902503|NCT00643201|584690569|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
161902504|NCT00643201|584690568|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
161902505|NCT00643201|584690569|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
161902506|NCT00643201|584690568|FG000|Completed Study Follow Up|non-specified|1|||
161902507|NCT00643201|584690569|FG001|Completed Study Follow Up|non-specified|0|||
161902508|NCT00165503|584690570|FG000|Overall Study|Death|1|||
161902509|NCT00165503|584690570|FG000|Overall Study|Lost to Follow-up|12|||
161902510|NCT00165503|584690570|FG000|Overall Study|Unresectable|3|||
161902511|NCT02346708|584690571|FG000|Overall Study|Adverse Event|2|||
161902512|NCT02346708|584690572|FG001|Overall Study|Adverse Event|0|||
161902513|NCT02346708|584690571|FG000|Overall Study|Protocol Violation|0|||
161902514|NCT02346708|584690572|FG001|Overall Study|Protocol Violation|1|||
161902515|NCT01781962|584690575|FG000|Overall Study|Other Miscellaneous Reasons|5|||
161902516|NCT00473655|584690582|FG000|Overall Study|Lost to Follow-up|9|||
161902517|NCT00473655|584690583|FG001|Overall Study|Lost to Follow-up|5|||
161902518|NCT00473655|584690584|FG002|Overall Study|Lost to Follow-up|8|||
161902519|NCT04556760|584690585|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161902520|NCT04556760|584690586|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
161902521|NCT04556760|584690587|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161902522|NCT04556760|584690588|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161902523|NCT04556760|584690589|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161902524|NCT04556760|584690590|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161942200|NCT02082977|584838340|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
161902525|NCT04556760|584690585|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161902526|NCT04556760|584690586|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161902527|NCT04556760|584690587|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161902528|NCT04556760|584690588|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
161902529|NCT04556760|584690589|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161902530|NCT04556760|584690590|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161902531|NCT02513550|584690591|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
161902532|NCT02513550|584690592|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
161902533|NCT02513550|584690593|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
161902534|NCT02513550|584690594|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
161902535|NCT02513550|584690595|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
161902536|NCT02513550|584690596|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
161902537|NCT02513550|584690591|FG000|Double Blind Treatment Period|Adverse Event|5|||
161902538|NCT02513550|584690592|FG001|Double Blind Treatment Period|Adverse Event|13|||
161902539|NCT02513550|584690593|FG002|Double Blind Treatment Period|Adverse Event|17|||
161902540|NCT02513550|584690594|FG003|Double Blind Treatment Period|Adverse Event|0|||
161902541|NCT02513550|584690595|FG004|Double Blind Treatment Period|Adverse Event|1|||
161902542|NCT02513550|584690596|FG005|Double Blind Treatment Period|Adverse Event|0|||
161902543|NCT02513550|584690591|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
161902544|NCT02513550|584690592|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
161902545|NCT02513550|584690593|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
161902546|NCT02513550|584690594|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
161902547|NCT02513550|584690595|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
161902548|NCT02513550|584690596|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
161902549|NCT02513550|584690591|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
161902550|NCT02513550|584690592|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
161902551|NCT02513550|584690593|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
161902552|NCT02513550|584690594|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
161902553|NCT02513550|584690595|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
161902554|NCT02513550|584690596|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
161902555|NCT02513550|584690591|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161902556|NCT02513550|584690592|FG001|Double Blind Treatment Period|Protocol Violation|1|||
161902557|NCT02513550|584690593|FG002|Double Blind Treatment Period|Protocol Violation|4|||
161902558|NCT02513550|584690594|FG003|Double Blind Treatment Period|Protocol Violation|0|||
161902559|NCT02513550|584690595|FG004|Double Blind Treatment Period|Protocol Violation|0|||
161902560|NCT02513550|584690596|FG005|Double Blind Treatment Period|Protocol Violation|0|||
161902561|NCT02513550|584690591|FG000|Double Blind Treatment Period|Physician Decision|2|||
161902562|NCT02513550|584690592|FG001|Double Blind Treatment Period|Physician Decision|0|||
161902563|NCT02513550|584690593|FG002|Double Blind Treatment Period|Physician Decision|4|||
161902564|NCT02513550|584690594|FG003|Double Blind Treatment Period|Physician Decision|0|||
161902565|NCT02513550|584690595|FG004|Double Blind Treatment Period|Physician Decision|0|||
161902566|NCT02513550|584690596|FG005|Double Blind Treatment Period|Physician Decision|0|||
161902567|NCT02513550|584690591|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
161902568|NCT02513550|584690592|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
161902569|NCT02513550|584690593|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
161902570|NCT02513550|584690594|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
161902571|NCT02513550|584690595|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
161902572|NCT02513550|584690596|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
161902573|NCT02513550|584690591|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161902574|NCT02513550|584690592|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161902575|NCT02513550|584690593|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
161902576|NCT02513550|584690594|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161902577|NCT02513550|584690595|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161902578|NCT02513550|584690596|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161902579|NCT02513550|584690591|FG000|Double Blind Treatment Period|Due to personal business|2|||
161902580|NCT02513550|584690592|FG001|Double Blind Treatment Period|Due to personal business|0|||
161902581|NCT02513550|584690593|FG002|Double Blind Treatment Period|Due to personal business|1|||
161902582|NCT02513550|584690594|FG003|Double Blind Treatment Period|Due to personal business|0|||
161902583|NCT02513550|584690595|FG004|Double Blind Treatment Period|Due to personal business|0|||
161902584|NCT02513550|584690596|FG005|Double Blind Treatment Period|Due to personal business|0|||
161902585|NCT02513550|584690591|FG000|Double Blind Treatment Period|Death|1|||
161902586|NCT02513550|584690592|FG001|Double Blind Treatment Period|Death|0|||
161902587|NCT02513550|584690593|FG002|Double Blind Treatment Period|Death|2|||
161902588|NCT02513550|584690594|FG003|Double Blind Treatment Period|Death|0|||
162010877|NCT00453206|585096042|FG000|Overall Study|Death|1|||
161902589|NCT02513550|584690595|FG004|Double Blind Treatment Period|Death|0|||
161902590|NCT02513550|584690596|FG005|Double Blind Treatment Period|Death|0|||
161902591|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
161902592|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
161902593|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
161902594|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161902595|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161902596|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161902597|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
161902598|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
161902599|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
161902600|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
161902601|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
161902602|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
161902603|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
161902604|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
161902605|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
161902606|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161902607|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161902608|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161902609|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
161902610|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
161902611|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
161902612|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
161902613|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
161902614|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
161902615|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
161902616|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
161902617|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
161902618|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
161902619|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
161902620|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
161902621|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Death|0|||
161902622|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Death|0|||
161902623|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Death|1|||
161902624|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Death|0|||
161902625|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Death|0|||
161902626|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Death|0|||
161902627|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
161902628|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
161902629|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
161902630|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
161902631|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
161902632|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
161902633|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161902634|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161902635|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
161902636|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161902637|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161902638|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161902639|NCT02513550|584690591|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
161902640|NCT02513550|584690592|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
161902641|NCT02513550|584690593|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
161902642|NCT02513550|584690594|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
161902643|NCT02513550|584690595|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
161902644|NCT02513550|584690596|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
161902645|NCT02849743|584690597|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
162137856|NCT01451814|585555637|FG001|Overall Study|Withdrawal by Subject|1|||
162137857|NCT01451814|585555636|FG000|Overall Study|Lost to Follow-up|5|||
162137858|NCT01451814|585555637|FG001|Overall Study|Lost to Follow-up|4|||
162137859|NCT02049866|585555638|FG000|Overall Study|Withdrawal by Subject|1|||
162137860|NCT03101592|585555641|FG000|Overall Study|participant files could not be located|111|||
162137861|NCT03101592|585555642|FG001|Overall Study|participant files could not be located|170|||
162137862|NCT03101592|585555643|FG002|Overall Study|participant files could not be located|118|||
162137863|NCT02397889|585555646|FG000|Overall Study|Physician Decision|1|||
162137864|NCT02397889|585555647|FG001|Overall Study|Physician Decision|0|||
162137865|NCT02219490|585555651|FG000|Overall Study|Adverse Event|24|||
162137866|NCT02219490|585555651|FG000|Overall Study|Withdrew consent|96|||
162137867|NCT02219490|585555651|FG000|Overall Study|Lost to Follow-up|126|||
161902646|NCT02849743|584690598|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
161902647|NCT02849743|584690597|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
161902648|NCT02849743|584690598|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
161902649|NCT02168491|584690601|FG000|Overall Study|Withdrawal by Subject|1|||
161902650|NCT00809445|584690602|FG000|1 Month Follow-up|Lost contact|1|||
161902651|NCT00809445|584690603|FG001|1 Month Follow-up|Lost contact|2|||
161902652|NCT00809445|584690604|FG002|1 Month Follow-up|Lost contact|1|||
161902653|NCT00809445|584690602|FG000|1 Month Follow-up|Withdrew consent|1|||
161902654|NCT00809445|584690603|FG001|1 Month Follow-up|Withdrew consent|1|||
161902655|NCT00809445|584690604|FG002|1 Month Follow-up|Withdrew consent|1|||
161902656|NCT00809445|584690602|FG000|1 Month Follow-up|Death|0|||
161902657|NCT00809445|584690603|FG001|1 Month Follow-up|Death|1|||
161902658|NCT00809445|584690604|FG002|1 Month Follow-up|Death|1|||
161902659|NCT00809445|584690602|FG000|1 Month Follow-up|Incarcerated|0|||
161902660|NCT00809445|584690603|FG001|1 Month Follow-up|Incarcerated|0|||
161902661|NCT00809445|584690604|FG002|1 Month Follow-up|Incarcerated|1|||
161902662|NCT00809445|584690602|FG000|6 Month Follow-up|Lost contact|16|||
161902663|NCT00809445|584690603|FG001|6 Month Follow-up|Lost contact|14|||
161902664|NCT00809445|584690604|FG002|6 Month Follow-up|Lost contact|14|||
161902665|NCT00809445|584690602|FG000|6 Month Follow-up|Death|2|||
161902666|NCT00809445|584690603|FG001|6 Month Follow-up|Death|1|||
161902667|NCT00809445|584690604|FG002|6 Month Follow-up|Death|1|||
161902668|NCT00809445|584690602|FG000|6 Month Follow-up|Incarcerated|6|||
161902669|NCT00809445|584690603|FG001|6 Month Follow-up|Incarcerated|8|||
161902670|NCT00809445|584690604|FG002|6 Month Follow-up|Incarcerated|8|||
161902671|NCT00809445|584690602|FG000|6 Month Follow-up|Withdrew consent|0|||
161902672|NCT00809445|584690603|FG001|6 Month Follow-up|Withdrew consent|0|||
161902673|NCT00809445|584690604|FG002|6 Month Follow-up|Withdrew consent|1|||
161902674|NCT04919317|584690605|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
161902675|NCT04919317|584690606|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
161902676|NCT04919317|584690605|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
161902677|NCT04919317|584690606|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
161902678|NCT01566604|584690607|FG000|Overall Study|Patient's inability to use the device|1|||
161902679|NCT01566604|584690608|FG001|Overall Study|Patient's inability to use the device|0|||
161902680|NCT01566604|584690607|FG000|Overall Study|Administrative problems|1|||
161902681|NCT01566604|584690608|FG001|Overall Study|Administrative problems|0|||
161902682|NCT01566604|584690607|FG000|Overall Study|Lack of Efficacy|1|||
161902683|NCT01566604|584690608|FG001|Overall Study|Lack of Efficacy|2|||
161902684|NCT01566604|584690607|FG000|Overall Study|Protocol deviation|2|||
161902685|NCT01566604|584690608|FG001|Overall Study|Protocol deviation|0|||
161902686|NCT01566604|584690607|FG000|Overall Study|Abnormal laboratory value|2|||
161902687|NCT01566604|584690608|FG001|Overall Study|Abnormal laboratory value|0|||
161902688|NCT01566604|584690607|FG000|Overall Study|Death|4|||
161902689|NCT01566604|584690608|FG001|Overall Study|Death|1|||
161902690|NCT01566604|584690607|FG000|Overall Study|Adverse Event|4|||
161902691|NCT01566604|584690608|FG001|Overall Study|Adverse Event|2|||
161902692|NCT01566604|584690607|FG000|Overall Study|Withdrawal by Subject|9|||
161902693|NCT01566604|584690608|FG001|Overall Study|Withdrawal by Subject|6|||
161902694|NCT00661089|584690613|FG000|Overall Study|1 subject withdrawal|0|||
161902695|NCT00661089|584690614|FG001|Overall Study|1 subject withdrawal|1|||
161902696|NCT00661089|584690613|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
161902697|NCT00661089|584690614|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
161902698|NCT00321906|584690620|FG000|Overall Study|Adverse Event|36|||
161902699|NCT00321906|584690621|FG001|Overall Study|Adverse Event|44|||
161902700|NCT00321906|584690620|FG000|Overall Study|Death|9|||
161902701|NCT00321906|584690621|FG001|Overall Study|Death|6|||
161902702|NCT00321906|584690620|FG000|Overall Study|Lost to Follow-up|1|||
161902703|NCT00321906|584690621|FG001|Overall Study|Lost to Follow-up|2|||
161902704|NCT00321906|584690620|FG000|Overall Study|Withdrawal by Subject|0|||
161902705|NCT00321906|584690621|FG001|Overall Study|Withdrawal by Subject|4|||
161902706|NCT00810069|584690622|FG000|Lead-in Period I|Adverse Event|43|||
161902707|NCT00810069|584690623|FG001|Lead-in Period I|Adverse Event|0|||
161902708|NCT00810069|584690624|FG002|Lead-in Period I|Adverse Event|0|||
161902709|NCT00810069|584690622|FG000|Lead-in Period I|Lack of Efficacy|1|||
162010878|NCT02594124|585096043|FG000|Overall Study|Adverse Event|0|||
161902710|NCT00810069|584690623|FG001|Lead-in Period I|Lack of Efficacy|0|||
161902711|NCT00810069|584690624|FG002|Lead-in Period I|Lack of Efficacy|0|||
161902712|NCT00810069|584690622|FG000|Lead-in Period I|Lost to Follow-up|19|||
161902713|NCT00810069|584690623|FG001|Lead-in Period I|Lost to Follow-up|0|||
161902714|NCT00810069|584690624|FG002|Lead-in Period I|Lost to Follow-up|0|||
161902715|NCT00810069|584690622|FG000|Lead-in Period I|Physician Decision|1|||
161902716|NCT00810069|584690623|FG001|Lead-in Period I|Physician Decision|0|||
161902717|NCT00810069|584690624|FG002|Lead-in Period I|Physician Decision|0|||
162137868|NCT02219490|585555651|FG000|Overall Study|COVID-19 infection|2|||
161902718|NCT00810069|584690622|FG000|Lead-in Period I|Protocol Violation|1|||
161902719|NCT00810069|584690623|FG001|Lead-in Period I|Protocol Violation|0|||
161902720|NCT00810069|584690624|FG002|Lead-in Period I|Protocol Violation|0|||
161902721|NCT00810069|584690622|FG000|Lead-in Period I|Withdrawal by Subject|46|||
161902722|NCT00810069|584690623|FG001|Lead-in Period I|Withdrawal by Subject|0|||
161902723|NCT00810069|584690624|FG002|Lead-in Period I|Withdrawal by Subject|0|||
161902724|NCT00810069|584690622|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
161902725|NCT00810069|584690623|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
161902726|NCT00810069|584690624|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
161902727|NCT00810069|584690622|FG000|Lead-in Period I|Randomization criteria not met|158|||
161902728|NCT00810069|584690623|FG001|Lead-in Period I|Randomization criteria not met|0|||
162010879|NCT02594124|585096044|FG001|Overall Study|Adverse Event|5|||
162010880|NCT02594124|585096045|FG002|Overall Study|Adverse Event|8|||
161798520|NCT00337571|584304513|FG001|Overall Study|Poor/noncompliance|1|||
161798521|NCT00337571|584304514|FG002|Overall Study|Poor/noncompliance|1|||
161798522|NCT00337571|584304515|FG003|Overall Study|Poor/noncompliance|1|||
161798523|NCT00337571|584304512|FG000|Overall Study|No longer met study criteria|1|||
161798524|NCT00337571|584304513|FG001|Overall Study|No longer met study criteria|0|||
161798525|NCT00337571|584304514|FG002|Overall Study|No longer met study criteria|0|||
161798526|NCT00337571|584304515|FG003|Overall Study|No longer met study criteria|0|||
161798527|NCT00337571|584304512|FG000|Overall Study|High Potassium level|0|||
161798528|NCT00337571|584304513|FG001|Overall Study|High Potassium level|0|||
161798529|NCT00337571|584304514|FG002|Overall Study|High Potassium level|0|||
161798530|NCT00337571|584304515|FG003|Overall Study|High Potassium level|1|||
161798531|NCT01890915|584304517|FG000|Overall Study|Adverse Event|1|||
161798532|NCT01890915|584304518|FG001|Overall Study|Adverse Event|0|||
161798533|NCT01890915|584304517|FG000|Overall Study|Protocol Violation|2|||
161798534|NCT01890915|584304518|FG001|Overall Study|Protocol Violation|0|||
161798535|NCT01890915|584304517|FG000|Overall Study|Equipment Malfunction|0|||
161798536|NCT01890915|584304518|FG001|Overall Study|Equipment Malfunction|1|||
161798537|NCT01974895|584304519|FG000|Overall Study|Protocol Violation|1|||
161798538|NCT01974895|584304520|FG001|Overall Study|Protocol Violation|0|||
161798539|NCT01974895|584304519|FG000|Overall Study|Lost to Follow-up|4|||
161798540|NCT01974895|584304520|FG001|Overall Study|Lost to Follow-up|6|||
161798541|NCT01974895|584304519|FG000|Overall Study|Withdrawal by Subject|0|||
161798542|NCT01974895|584304520|FG001|Overall Study|Withdrawal by Subject|1|||
161798543|NCT01974895|584304519|FG000|Overall Study|Other (Missed Visit)|1|||
161798544|NCT01974895|584304520|FG001|Overall Study|Other (Missed Visit)|0|||
161798545|NCT01974895|584304519|FG000|Overall Study|Other (Reason unknown)|9|||
161798546|NCT01974895|584304520|FG001|Overall Study|Other (Reason unknown)|8|||
161798547|NCT00635154|584304521|FG000|Overall Study|Alternative Treatment|8|||
161798548|NCT00635154|584304521|FG000|Overall Study|Other|4|||
161798549|NCT00635154|584304521|FG000|Overall Study|Still on treatment|21|||
161798550|NCT02660242|584304526|FG000|Glucose Tabs|Lost to Follow-up|1|||
161798551|NCT02660242|584304526|FG000|Glucagon Injection|Lost to Follow-up|1|||
161798552|NCT02796664|584304528|FG000|Overall Study|Withdrawal by Subject|0|||
161798553|NCT02796664|584304529|FG001|Overall Study|Withdrawal by Subject|3|||
161798554|NCT02796664|584304528|FG000|Overall Study|Noncompliance|1|||
161798555|NCT02796664|584304529|FG001|Overall Study|Noncompliance|1|||
161798556|NCT02796664|584304528|FG000|Overall Study|Death|0|||
161798557|NCT02796664|584304529|FG001|Overall Study|Death|1|||
161798558|NCT02246478|584304530|FG000|Multiple-dose Phase|Protocol Violation|1|||
161798559|NCT02246478|584304531|FG001|Multiple-dose Phase|Protocol Violation|0|||
161798560|NCT02246478|584304532|FG002|Multiple-dose Phase|Protocol Violation|0|||
161798561|NCT02246478|584304533|FG003|Multiple-dose Phase|Protocol Violation|1|||
161798562|NCT00536575|584304534|FG000|Overall Study|Withdrawal by Subject|1|||
161798563|NCT00536575|584304534|FG000|Overall Study|Death|1|||
161798564|NCT00198029|584304538|FG000|Overall Study|Withdrawal by Subject|4|||
161798565|NCT04634409|584304545|FG000|Overall Study|Death|0|||
161798566|NCT04634409|584304546|FG001|Overall Study|Death|0|||
161798567|NCT04634409|584304547|FG002|Overall Study|Death|0|||
161798568|NCT04634409|584304548|FG003|Overall Study|Death|0|||
161798569|NCT04634409|584304549|FG004|Overall Study|Death|0|||
161798570|NCT04634409|584304550|FG005|Overall Study|Death|0|||
161798571|NCT04634409|584304551|FG006|Overall Study|Death|0|||
161798572|NCT04634409|584304552|FG007|Overall Study|Death|0|||
161798573|NCT04634409|584304553|FG008|Overall Study|Death|0|||
161798574|NCT04634409|584304554|FG009|Overall Study|Death|0|||
161798575|NCT04634409|584304555|FG010|Overall Study|Death|1|||
161798576|NCT04634409|584304556|FG011|Overall Study|Death|0|||
161798577|NCT04634409|584304557|FG012|Overall Study|Death|1|||
161798578|NCT04634409|584304558|FG013|Overall Study|Death|0|||
161798579|NCT04634409|584304559|FG014|Overall Study|Death|0|||
161798580|NCT04634409|584304560|FG015|Overall Study|Death|0|||
161798581|NCT04634409|584304561|FG016|Overall Study|Death|0|||
161798582|NCT04634409|584304562|FG017|Overall Study|Death|0|||
161798583|NCT04634409|584304563|FG018|Overall Study|Death|0|||
161798584|NCT04634409|584304564|FG019|Overall Study|Death|0|||
161798585|NCT04634409|584304565|FG020|Overall Study|Death|0|||
161798586|NCT04634409|584304566|FG021|Overall Study|Death|0|||
161798587|NCT04634409|584304567|FG022|Overall Study|Death|0|||
161798588|NCT04634409|584304568|FG023|Overall Study|Death|0|||
161798589|NCT04634409|584304569|FG024|Overall Study|Death|0|||
161798590|NCT04634409|584304570|FG025|Overall Study|Death|0|||
161798591|NCT04634409|584304571|FG026|Overall Study|Death|0|||
161798592|NCT04634409|584304545|FG000|Overall Study|Adverse Event|0|||
161798593|NCT04634409|584304546|FG001|Overall Study|Adverse Event|0|||
161798594|NCT04634409|584304547|FG002|Overall Study|Adverse Event|1|||
161798595|NCT04634409|584304548|FG003|Overall Study|Adverse Event|0|||
161798596|NCT04634409|584304549|FG004|Overall Study|Adverse Event|0|||
161798597|NCT04634409|584304550|FG005|Overall Study|Adverse Event|1|||
161798598|NCT04634409|584304551|FG006|Overall Study|Adverse Event|0|||
161798599|NCT04634409|584304552|FG007|Overall Study|Adverse Event|0|||
161798600|NCT04634409|584304553|FG008|Overall Study|Adverse Event|0|||
161798601|NCT04634409|584304554|FG009|Overall Study|Adverse Event|0|||
161798602|NCT04634409|584304555|FG010|Overall Study|Adverse Event|0|||
161798603|NCT04634409|584304556|FG011|Overall Study|Adverse Event|0|||
161798604|NCT04634409|584304557|FG012|Overall Study|Adverse Event|0|||
161798605|NCT04634409|584304558|FG013|Overall Study|Adverse Event|0|||
161798606|NCT04634409|584304559|FG014|Overall Study|Adverse Event|0|||
161798607|NCT04634409|584304560|FG015|Overall Study|Adverse Event|0|||
161798608|NCT04634409|584304561|FG016|Overall Study|Adverse Event|0|||
161798609|NCT04634409|584304562|FG017|Overall Study|Adverse Event|0|||
161798610|NCT04634409|584304563|FG018|Overall Study|Adverse Event|0|||
161798611|NCT04634409|584304564|FG019|Overall Study|Adverse Event|0|||
161798612|NCT04634409|584304565|FG020|Overall Study|Adverse Event|0|||
161798613|NCT04634409|584304566|FG021|Overall Study|Adverse Event|0|||
161798614|NCT04634409|584304567|FG022|Overall Study|Adverse Event|0|||
161798615|NCT04634409|584304568|FG023|Overall Study|Adverse Event|0|||
161798616|NCT04634409|584304569|FG024|Overall Study|Adverse Event|0|||
161798617|NCT04634409|584304570|FG025|Overall Study|Adverse Event|0|||
161798618|NCT04634409|584304571|FG026|Overall Study|Adverse Event|0|||
161798619|NCT04634409|584304545|FG000|Overall Study|Lost to Follow-up|3|||
161798620|NCT04634409|584304546|FG001|Overall Study|Lost to Follow-up|1|||
161798621|NCT04634409|584304547|FG002|Overall Study|Lost to Follow-up|1|||
161798622|NCT04634409|584304548|FG003|Overall Study|Lost to Follow-up|3|||
161798623|NCT04634409|584304549|FG004|Overall Study|Lost to Follow-up|1|||
161798624|NCT04634409|584304550|FG005|Overall Study|Lost to Follow-up|1|||
161798625|NCT04634409|584304551|FG006|Overall Study|Lost to Follow-up|1|||
161798626|NCT04634409|584304552|FG007|Overall Study|Lost to Follow-up|3|||
161798627|NCT04634409|584304553|FG008|Overall Study|Lost to Follow-up|3|||
161798628|NCT04634409|584304554|FG009|Overall Study|Lost to Follow-up|11|||
161798629|NCT04634409|584304555|FG010|Overall Study|Lost to Follow-up|8|||
161798630|NCT04634409|584304556|FG011|Overall Study|Lost to Follow-up|15|||
161798631|NCT04634409|584304557|FG012|Overall Study|Lost to Follow-up|3|||
161798632|NCT04634409|584304558|FG013|Overall Study|Lost to Follow-up|2|||
161798633|NCT04634409|584304559|FG014|Overall Study|Lost to Follow-up|7|||
161798634|NCT04634409|584304560|FG015|Overall Study|Lost to Follow-up|0|||
161798635|NCT04634409|584304561|FG016|Overall Study|Lost to Follow-up|0|||
161798636|NCT04634409|584304562|FG017|Overall Study|Lost to Follow-up|0|||
161798637|NCT04634409|584304563|FG018|Overall Study|Lost to Follow-up|0|||
161798638|NCT04634409|584304564|FG019|Overall Study|Lost to Follow-up|0|||
161798639|NCT04634409|584304565|FG020|Overall Study|Lost to Follow-up|0|||
161798640|NCT04634409|584304566|FG021|Overall Study|Lost to Follow-up|0|||
161798641|NCT04634409|584304567|FG022|Overall Study|Lost to Follow-up|0|||
161798642|NCT04634409|584304568|FG023|Overall Study|Lost to Follow-up|0|||
161798643|NCT04634409|584304569|FG024|Overall Study|Lost to Follow-up|0|||
161798644|NCT04634409|584304570|FG025|Overall Study|Lost to Follow-up|0|||
161798645|NCT04634409|584304571|FG026|Overall Study|Lost to Follow-up|0|||
161798646|NCT04634409|584304545|FG000|Overall Study|Withdrawal by Subject|3|||
161798647|NCT04634409|584304546|FG001|Overall Study|Withdrawal by Subject|1|||
161798648|NCT04634409|584304547|FG002|Overall Study|Withdrawal by Subject|6|||
161798649|NCT04634409|584304548|FG003|Overall Study|Withdrawal by Subject|4|||
161798650|NCT04634409|584304549|FG004|Overall Study|Withdrawal by Subject|2|||
161798651|NCT04634409|584304550|FG005|Overall Study|Withdrawal by Subject|0|||
162137869|NCT02219490|585555651|FG000|Overall Study|COVID-19 logistical restrictions|33|||
161798652|NCT04634409|584304551|FG006|Overall Study|Withdrawal by Subject|0|||
161798653|NCT04634409|584304552|FG007|Overall Study|Withdrawal by Subject|2|||
161798654|NCT04634409|584304553|FG008|Overall Study|Withdrawal by Subject|3|||
162137870|NCT02219490|585555651|FG000|Overall Study|Other, not specified|57|||
162137871|NCT01928940|585555655|FG000|Overall Study|Adverse Event|0|||
162137872|NCT01928940|585555656|FG001|Overall Study|Adverse Event|1|||
162137873|NCT01352507|585555659|FG000|Treatment Period 1|Adverse Event|3|||
162137874|NCT01352507|585555660|FG001|Treatment Period 1|Adverse Event|0|||
161798655|NCT04634409|584304554|FG009|Overall Study|Withdrawal by Subject|2|||
161798656|NCT04634409|584304555|FG010|Overall Study|Withdrawal by Subject|3|||
161798657|NCT04634409|584304556|FG011|Overall Study|Withdrawal by Subject|2|||
161798658|NCT04634409|584304557|FG012|Overall Study|Withdrawal by Subject|2|||
161798659|NCT04634409|584304558|FG013|Overall Study|Withdrawal by Subject|1|||
161798660|NCT04634409|584304559|FG014|Overall Study|Withdrawal by Subject|5|||
161798661|NCT04634409|584304560|FG015|Overall Study|Withdrawal by Subject|0|||
161798662|NCT04634409|584304561|FG016|Overall Study|Withdrawal by Subject|0|||
161798663|NCT04634409|584304562|FG017|Overall Study|Withdrawal by Subject|1|||
161902729|NCT00810069|584690624|FG002|Lead-in Period I|Randomization criteria not met|0|||
161902730|NCT00810069|584690622|FG000|Double-Blind Period II|Adverse Event|0|||
161902731|NCT00810069|584690623|FG001|Double-Blind Period II|Adverse Event|9|||
161902732|NCT00810069|584690624|FG002|Double-Blind Period II|Adverse Event|8|||
161902733|NCT00810069|584690622|FG000|Double-Blind Period II|Lack of Efficacy|0|||
161902734|NCT00810069|584690623|FG001|Double-Blind Period II|Lack of Efficacy|7|||
161902735|NCT00810069|584690624|FG002|Double-Blind Period II|Lack of Efficacy|12|||
161902736|NCT00810069|584690622|FG000|Double-Blind Period II|Lost to Follow-up|0|||
161902737|NCT00810069|584690623|FG001|Double-Blind Period II|Lost to Follow-up|9|||
161902738|NCT00810069|584690624|FG002|Double-Blind Period II|Lost to Follow-up|9|||
161902739|NCT00810069|584690622|FG000|Double-Blind Period II|Physician Decision|0|||
161902740|NCT00810069|584690623|FG001|Double-Blind Period II|Physician Decision|0|||
161902741|NCT00810069|584690624|FG002|Double-Blind Period II|Physician Decision|1|||
161902742|NCT00810069|584690622|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
161902743|NCT00810069|584690623|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
161902744|NCT00810069|584690624|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
161902745|NCT00810069|584690622|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
161902746|NCT00810069|584690623|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
161902747|NCT00810069|584690624|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
161902748|NCT00810069|584690622|FG000|Double-Blind Period II|Clinical relapse|0|||
161902749|NCT00810069|584690623|FG001|Double-Blind Period II|Clinical relapse|3|||
161902750|NCT00810069|584690624|FG002|Double-Blind Period II|Clinical relapse|0|||
161902751|NCT00810069|584690622|FG000|Double-Blind Period II|Protocol Violation|0|||
161902752|NCT00810069|584690623|FG001|Double-Blind Period II|Protocol Violation|7|||
161902753|NCT00810069|584690624|FG002|Double-Blind Period II|Protocol Violation|6|||
161902754|NCT02899065|584690627|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
161902755|NCT02899065|584690628|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
161902756|NCT02899065|584690627|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
161902757|NCT02899065|584690628|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
161902758|NCT02899065|584690627|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
161902759|NCT02899065|584690628|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
161902760|NCT00186485|584690630|FG000|Overall Study|Lost to Follow-up|3|||
161902761|NCT01166750|584690631|FG000|Overall Study|Lost to Follow-up|1|||
161902762|NCT01166750|584690632|FG001|Overall Study|Lost to Follow-up|0|||
161902763|NCT05225389|584690633|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
161902764|NCT03113968|584690634|FG000|Overall Study|Withdrawal by Subject|31|||
161902765|NCT03113968|584690635|FG001|Overall Study|Withdrawal by Subject|4|||
161902766|NCT04805671|584690636|FG000|Overall Study|Death|2|||
161902767|NCT04805671|584690637|FG001|Overall Study|Death|7|||
161902768|NCT04805671|584690636|FG000|Overall Study|Lost to Follow-up|1|||
161902769|NCT04805671|584690637|FG001|Overall Study|Lost to Follow-up|0|||
161902770|NCT04805671|584690636|FG000|Overall Study|Withdrawal by Subject|9|||
161902771|NCT04805671|584690637|FG001|Overall Study|Withdrawal by Subject|7|||
161902772|NCT04805671|584690636|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
161902773|NCT04805671|584690637|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
161902774|NCT00901342|584690638|FG000|Overall Study|Adverse Event|1|||
161902775|NCT00901342|584690638|FG000|Overall Study|Death|4|||
161902776|NCT00901342|584690638|FG000|Overall Study|Disease progression|1|||
161902777|NCT00901342|584690638|FG000|Overall Study|Withdrawal by Subject|9|||
161902778|NCT03804268|584690639|FG000|Overall Study|Adverse Event|2|||
161902779|NCT03804268|584690640|FG001|Overall Study|Adverse Event|2|||
161902780|NCT03804268|584690639|FG000|Overall Study|Withdrawal by Subject|2|||
161902781|NCT03804268|584690640|FG001|Overall Study|Withdrawal by Subject|0|||
161902782|NCT03804268|584690639|FG000|Overall Study|Lost to Follow-up|1|||
161902783|NCT03804268|584690640|FG001|Overall Study|Lost to Follow-up|0|||
161902784|NCT03804268|584690639|FG000|Overall Study|Physician Decision|2|||
161902785|NCT03804268|584690640|FG001|Overall Study|Physician Decision|0|||
161902786|NCT02849587|584690641|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
161902787|NCT02849587|584690642|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
161902788|NCT02849587|584690643|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
161902789|NCT02849587|584690641|FG000|Overall Study|Withdrawal by Subject|0|||
161902790|NCT02849587|584690642|FG001|Overall Study|Withdrawal by Subject|1|||
161902791|NCT02849587|584690643|FG002|Overall Study|Withdrawal by Subject|0|||
161902792|NCT03380377|584690644|FG000|Overall Study|Physician Decision|1|||
161902793|NCT03380377|584690644|FG000|Overall Study|Withdrawal by Subject|1|||
161902794|NCT00385918|584690645|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
161902795|NCT00385918|584690646|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
161902796|NCT00385918|584690647|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
161902797|NCT00385918|584690645|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
162137875|NCT01352507|585555659|FG000|Treatment Period 1|Lost to Follow-up|3|||
162137876|NCT01352507|585555660|FG001|Treatment Period 1|Lost to Follow-up|4|||
162137877|NCT01352507|585555659|FG000|Treatment Period 1|Withdrawal by Subject|7|||
162137878|NCT01352507|585555660|FG001|Treatment Period 1|Withdrawal by Subject|5|||
162137879|NCT01352507|585555659|FG000|Treatment Period 1|Physician Decision|1|||
162137880|NCT01352507|585555660|FG001|Treatment Period 1|Physician Decision|0|||
162137881|NCT01352507|585555659|FG000|Washout Period|Withdrawal by Subject|0|||
162137882|NCT01352507|585555660|FG001|Washout Period|Withdrawal by Subject|1|||
162137883|NCT01352507|585555659|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
162137884|NCT01352507|585555660|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
162137885|NCT01352507|585555659|FG000|Treatment Period 2|Withdrawal by Subject|4|||
162137886|NCT01352507|585555660|FG001|Treatment Period 2|Withdrawal by Subject|3|||
162137887|NCT01352507|585555659|FG000|Treatment Period 2|Lack of Efficacy|1|||
162137888|NCT01352507|585555660|FG001|Treatment Period 2|Lack of Efficacy|0|||
162137889|NCT03178201|585555661|FG000|Overall Study|Off study|5|||
162137890|NCT04639947|585555666|FG000|Overall Study|Screen fail|1|||
162137891|NCT01018511|585555667|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
162137892|NCT01018511|585555668|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
162137893|NCT01018511|585555669|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
162137894|NCT01018511|585555670|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
162137895|NCT01018511|585555667|FG000|Overall Study|Adverse Event|5|||
162137896|NCT01018511|585555668|FG001|Overall Study|Adverse Event|9|||
162137897|NCT01018511|585555669|FG002|Overall Study|Adverse Event|13|||
162137898|NCT01018511|585555670|FG003|Overall Study|Adverse Event|10|||
162137899|NCT01018511|585555667|FG000|Overall Study|Lack of Efficacy|4|||
162137900|NCT01018511|585555668|FG001|Overall Study|Lack of Efficacy|1|||
162137901|NCT01018511|585555669|FG002|Overall Study|Lack of Efficacy|1|||
162137902|NCT01018511|585555670|FG003|Overall Study|Lack of Efficacy|2|||
162137903|NCT01018511|585555667|FG000|Overall Study|Withdrawal by Subject|6|||
162137904|NCT01018511|585555668|FG001|Overall Study|Withdrawal by Subject|5|||
162137905|NCT01018511|585555669|FG002|Overall Study|Withdrawal by Subject|11|||
162137906|NCT01018511|585555670|FG003|Overall Study|Withdrawal by Subject|9|||
162137907|NCT01018511|585555667|FG000|Overall Study|Lost to Follow-up|0|||
162137908|NCT01018511|585555668|FG001|Overall Study|Lost to Follow-up|0|||
162137909|NCT01018511|585555669|FG002|Overall Study|Lost to Follow-up|1|||
162137910|NCT01018511|585555670|FG003|Overall Study|Lost to Follow-up|0|||
162137911|NCT01018511|585555667|FG000|Overall Study|Protocol Violation|5|||
162137912|NCT01018511|585555668|FG001|Overall Study|Protocol Violation|8|||
162137913|NCT01018511|585555669|FG002|Overall Study|Protocol Violation|7|||
162137914|NCT01018511|585555670|FG003|Overall Study|Protocol Violation|9|||
162137915|NCT01018511|585555667|FG000|Overall Study|Miscellaneous|0|||
162137916|NCT01018511|585555668|FG001|Overall Study|Miscellaneous|2|||
162137917|NCT01018511|585555669|FG002|Overall Study|Miscellaneous|0|||
162137918|NCT01018511|585555670|FG003|Overall Study|Miscellaneous|0|||
162137919|NCT03424239|585555678|FG000|Overall Study|Withdrawal by Subject|2|||
162137920|NCT00604786|585555679|FG000|Overall Study|Lost to Follow-up|2|||
162137921|NCT00604786|585555680|FG001|Overall Study|Lost to Follow-up|0|||
162137922|NCT03697460|585555681|FG000|Overall Study|Withdrawal by Subject|3|||
162137923|NCT03369951|585555682|FG000|Overall Study|Withdrawal by Subject|3|||
162137924|NCT03369951|585555682|FG000|Overall Study|Death|1|||
162137925|NCT03369951|585555682|FG000|Overall Study|Lost to Follow-up|1|||
162137926|NCT03369951|585555682|FG000|Overall Study|Protocol Violation|1|||
162137927|NCT03677375|585555683|FG000|Overall Study|Incomplete procedure|8|||
161798664|NCT04634409|584304563|FG018|Overall Study|Withdrawal by Subject|0|||
161798665|NCT04634409|584304564|FG019|Overall Study|Withdrawal by Subject|0|||
161798666|NCT04634409|584304565|FG020|Overall Study|Withdrawal by Subject|0|||
161798667|NCT04634409|584304566|FG021|Overall Study|Withdrawal by Subject|0|||
161798668|NCT04634409|584304567|FG022|Overall Study|Withdrawal by Subject|0|||
161798669|NCT04634409|584304568|FG023|Overall Study|Withdrawal by Subject|1|||
161798670|NCT04634409|584304569|FG024|Overall Study|Withdrawal by Subject|0|||
161798671|NCT04634409|584304570|FG025|Overall Study|Withdrawal by Subject|0|||
161798672|NCT04634409|584304571|FG026|Overall Study|Withdrawal by Subject|0|||
161798673|NCT04634409|584304545|FG000|Overall Study|Other - As reported by Investigator|1|||
161798674|NCT04634409|584304546|FG001|Overall Study|Other - As reported by Investigator|0|||
161798675|NCT04634409|584304547|FG002|Overall Study|Other - As reported by Investigator|0|||
161798676|NCT04634409|584304548|FG003|Overall Study|Other - As reported by Investigator|0|||
161798677|NCT04634409|584304549|FG004|Overall Study|Other - As reported by Investigator|0|||
161798678|NCT04634409|584304550|FG005|Overall Study|Other - As reported by Investigator|0|||
161798679|NCT04634409|584304551|FG006|Overall Study|Other - As reported by Investigator|0|||
161798680|NCT04634409|584304552|FG007|Overall Study|Other - As reported by Investigator|6|||
161798681|NCT04634409|584304553|FG008|Overall Study|Other - As reported by Investigator|4|||
161798682|NCT04634409|584304554|FG009|Overall Study|Other - As reported by Investigator|0|||
161798683|NCT04634409|584304555|FG010|Overall Study|Other - As reported by Investigator|1|||
161798684|NCT04634409|584304556|FG011|Overall Study|Other - As reported by Investigator|2|||
161798685|NCT04634409|584304557|FG012|Overall Study|Other - As reported by Investigator|2|||
162010881|NCT02594124|585096046|FG003|Overall Study|Adverse Event|1|||
162137928|NCT03677375|585555683|FG000|Overall Study|Adverse Event|3|||
162137929|NCT03677375|585555683|FG000|Overall Study|Physician Decision|1|||
162137930|NCT00725010|585555689|FG000|Overall Study|Toxicity|9|||
162137931|NCT00725010|585555689|FG000|Overall Study|Tumor Progression|7|||
162137932|NCT00725010|585555689|FG000|Overall Study|Withdrawal by Subject|2|||
162137933|NCT00725010|585555689|FG000|Overall Study|Death|1|||
162137934|NCT00725010|585555689|FG000|Overall Study|Lost to Follow-up|1|||
162137935|NCT00725010|585555689|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
162137936|NCT00725010|585555689|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
162137937|NCT00725010|585555689|FG000|Overall Study|No further documentation|1|||
162137938|NCT00725010|585555689|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
162137939|NCT02414828|585555690|FG000|Overall Study|Lost to Follow-up|0|||
162137940|NCT02414828|585555691|FG001|Overall Study|Lost to Follow-up|1|||
162137941|NCT02414828|585555692|FG002|Overall Study|Lost to Follow-up|1|||
162137942|NCT02414828|585555693|FG003|Overall Study|Lost to Follow-up|2|||
162137943|NCT00630864|585555695|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
162137944|NCT00630864|585555695|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
162137945|NCT00430677|585555696|FG000|Short-term Period|Death|1|||
162137946|NCT00430677|585555697|FG001|Short-term Period|Death|1|||
162137947|NCT00430677|585555698|FG002|Short-term Period|Death|5|||
162137948|NCT00430677|585555696|FG000|Short-term Period|Adverse Event|15|||
162137949|NCT00430677|585555697|FG001|Short-term Period|Adverse Event|13|||
162137950|NCT00430677|585555698|FG002|Short-term Period|Adverse Event|9|||
162137951|NCT00430677|585555696|FG000|Short-term Period|Lack of Efficacy|5|||
161798686|NCT04634409|584304558|FG013|Overall Study|Other - As reported by Investigator|1|||
161798687|NCT04634409|584304559|FG014|Overall Study|Other - As reported by Investigator|0|||
161798688|NCT04634409|584304560|FG015|Overall Study|Other - As reported by Investigator|0|||
161798689|NCT04634409|584304561|FG016|Overall Study|Other - As reported by Investigator|0|||
161798690|NCT04634409|584304562|FG017|Overall Study|Other - As reported by Investigator|0|||
161798691|NCT04634409|584304563|FG018|Overall Study|Other - As reported by Investigator|0|||
161798692|NCT04634409|584304564|FG019|Overall Study|Other - As reported by Investigator|0|||
161798693|NCT04634409|584304565|FG020|Overall Study|Other - As reported by Investigator|0|||
161798694|NCT04634409|584304566|FG021|Overall Study|Other - As reported by Investigator|0|||
161798695|NCT04634409|584304567|FG022|Overall Study|Other - As reported by Investigator|0|||
161798696|NCT04634409|584304568|FG023|Overall Study|Other - As reported by Investigator|0|||
161798697|NCT04634409|584304569|FG024|Overall Study|Other - As reported by Investigator|0|||
161798698|NCT04634409|584304570|FG025|Overall Study|Other - As reported by Investigator|0|||
161798699|NCT04634409|584304571|FG026|Overall Study|Other - As reported by Investigator|0|||
161798700|NCT02785913|584307089|FG000|Overall Study|Adverse Event|5|||
161798701|NCT02785913|584307089|FG000|Overall Study|Death|2|||
161798702|NCT02785913|584307089|FG000|Overall Study|Progression|18|||
161798703|NCT02785913|584307089|FG000|Overall Study|Not protocol specified|1|||
161798704|NCT01298570|584307090|FG000|Overall Study|Disease progression, relapse during acti|64|||
161798705|NCT01298570|584307091|FG001|Overall Study|Disease progression, relapse during acti|40|||
161798706|NCT01298570|584307090|FG000|Overall Study|Adverse Event|20|||
161798707|NCT01298570|584307091|FG001|Overall Study|Adverse Event|2|||
161798708|NCT01298570|584307090|FG000|Overall Study|Withdrawal by Subject|21|||
161798709|NCT01298570|584307091|FG001|Overall Study|Withdrawal by Subject|6|||
161798710|NCT01298570|584307090|FG000|Overall Study|Treatment delay > 4 weeks|4|||
161798711|NCT01298570|584307091|FG001|Overall Study|Treatment delay > 4 weeks|5|||
161798712|NCT01298570|584307090|FG000|Overall Study|Physician Decision|4|||
161798713|NCT01298570|584307091|FG001|Overall Study|Physician Decision|2|||
161798714|NCT01298570|584307090|FG000|Overall Study|Other complicating disease|2|||
161798715|NCT01298570|584307091|FG001|Overall Study|Other complicating disease|1|||
161798716|NCT01298570|584307090|FG000|Overall Study|Surgery|2|||
161798717|NCT01298570|584307091|FG001|Overall Study|Surgery|1|||
161798718|NCT01298570|584307090|FG000|Overall Study|Symptomatic progression/deterioration|3|||
161798719|NCT01298570|584307091|FG001|Overall Study|Symptomatic progression/deterioration|2|||
161798720|NCT01298570|584307090|FG000|Overall Study|Death|0|||
161798721|NCT01298570|584307091|FG001|Overall Study|Death|1|||
161798722|NCT01298570|584307090|FG000|Overall Study|Ineligibility|0|||
161798723|NCT01298570|584307091|FG001|Overall Study|Ineligibility|1|||
161798724|NCT00076102|584307092|FG000|Overall Study|Clinical progression|1|||
161798725|NCT00076102|584307092|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
161798726|NCT00076102|584307092|FG000|Overall Study|plexiform neurofibroma surgery|1|||
161798727|NCT00076102|584307092|FG000|Overall Study|refusal of further therapy|2|||
161798728|NCT01052116|584307093|FG000|Overall Study|Lost to Follow-up|11|||
161798729|NCT01052116|584307094|FG001|Overall Study|Lost to Follow-up|17|||
161798730|NCT01052116|584307093|FG000|Overall Study|Withdrawal by Subject|3|||
161798731|NCT01052116|584307094|FG001|Overall Study|Withdrawal by Subject|6|||
161798732|NCT01052116|584307093|FG000|Overall Study|Spirometry not performed|0|||
161798733|NCT01052116|584307094|FG001|Overall Study|Spirometry not performed|4|||
161798734|NCT02180711|584307095|FG000|Overall Study|Death|0|||
161798735|NCT02180711|584307096|FG001|Overall Study|Death|1|||
161798736|NCT02180711|584307097|FG002|Overall Study|Death|0|||
162137952|NCT00430677|585555697|FG001|Short-term Period|Lack of Efficacy|6|||
161902798|NCT00385918|584690646|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
161902799|NCT00385918|584690647|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
161902800|NCT00385918|584690645|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
161902801|NCT00385918|584690646|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
161902802|NCT00385918|584690647|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
161902803|NCT00385918|584690645|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
161902804|NCT00385918|584690646|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
161902805|NCT00385918|584690647|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
161902806|NCT00385918|584690645|FG000|Intervention Phase After Randomization|Physician Decision|1|||
161902807|NCT00385918|584690646|FG001|Intervention Phase After Randomization|Physician Decision|0|||
161902808|NCT00385918|584690647|FG002|Intervention Phase After Randomization|Physician Decision|0|||
161902809|NCT00385918|584690645|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
161902810|NCT00385918|584690646|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
161902811|NCT00385918|584690647|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
161902812|NCT00128661|584690648|FG000|Overall Study|Adverse Event|14|||
161902813|NCT00128661|584690649|FG001|Overall Study|Adverse Event|11|||
161902814|NCT00128661|584690648|FG000|Overall Study|Lost to Follow-up|10|||
161902815|NCT00128661|584690649|FG001|Overall Study|Lost to Follow-up|7|||
161902816|NCT00128661|584690648|FG000|Overall Study|Withdrawal by Subject|243|||
161902817|NCT00128661|584690649|FG001|Overall Study|Withdrawal by Subject|232|||
161902818|NCT00128661|584690648|FG000|Overall Study|Other|7|||
161902819|NCT00128661|584690649|FG001|Overall Study|Other|8|||
161902820|NCT03421379|584690650|FG000|Period 1|Withdrawal by Subject|0|||
161902821|NCT03421379|584690651|FG001|Period 1|Withdrawal by Subject|1|||
161902822|NCT03421379|584690650|FG000|Period 1|Physician Decision|1|||
161902823|NCT03421379|584690651|FG001|Period 1|Physician Decision|1|||
161902824|NCT03421379|584690650|FG000|Period 1|Did not receive treatment|1|||
161902825|NCT03421379|584690651|FG001|Period 1|Did not receive treatment|2|||
161902826|NCT04010461|584690652|FG000|Overall Study|COVID based withdrawal|5|||
161902827|NCT04010461|584690652|FG000|Overall Study|Withdrawal by Subject|5|||
161902828|NCT04010461|584690652|FG000|Overall Study|Adverse Event|1|||
161902829|NCT04010461|584690652|FG000|Overall Study|No Motor Threshold obtainable|1|||
161902830|NCT04010461|584690652|FG000|Overall Study|Physician Decision|1|||
161902831|NCT03771963|584690653|FG000|Overall Study|Lost to Follow-up|22|||
161902832|NCT03771963|584690653|FG000|Overall Study|Withdrawal of Consent|10|||
161902833|NCT01026948|584690654|FG000|Overall Study|Physician Decision|8|||
161902834|NCT00102596|584690655|FG000|Part A|Screen failures|6|||
161902835|NCT00102596|584690656|FG001|Part A|Screen failures|0|||
161902836|NCT00102596|584690655|FG000|Part A|Adverse Event|1|||
161902837|NCT00102596|584690656|FG001|Part A|Adverse Event|0|||
161902838|NCT00964028|584690657|FG000|Overall Study|Withdrawal by Subject|0|||
161902839|NCT00964028|584690658|FG001|Overall Study|Withdrawal by Subject|1|||
161902840|NCT02106351|584690659|FG000|Treatment Cycle 1|Adverse Event|2|||
161902841|NCT02106351|584690660|FG001|Treatment Cycle 1|Adverse Event|0|||
161902842|NCT02106351|584690661|FG002|Treatment Cycle 1|Adverse Event|0|||
161902843|NCT02106351|584690659|FG000|Treatment Cycle 1|Consent withdrawn|1|||
161902844|NCT02106351|584690660|FG001|Treatment Cycle 1|Consent withdrawn|0|||
161902845|NCT02106351|584690661|FG002|Treatment Cycle 1|Consent withdrawn|2|||
161902846|NCT02106351|584690659|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
161902847|NCT02106351|584690660|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
161902848|NCT02106351|584690661|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
161902849|NCT02106351|584690659|FG000|Treatment Cycle 1|Other|0|||
161902850|NCT02106351|584690660|FG001|Treatment Cycle 1|Other|3|||
161902851|NCT02106351|584690661|FG002|Treatment Cycle 1|Other|1|||
161902852|NCT02106351|584690659|FG000|Treatment Cycle 1|Randomised but not treated|1|||
161902853|NCT02106351|584690660|FG001|Treatment Cycle 1|Randomised but not treated|0|||
161902854|NCT02106351|584690661|FG002|Treatment Cycle 1|Randomised but not treated|1|||
161902855|NCT02106351|584690659|FG000|Treatment Cycle 2|Adverse Event|0|||
161902856|NCT02106351|584690660|FG001|Treatment Cycle 2|Adverse Event|2|||
161902857|NCT02106351|584690661|FG002|Treatment Cycle 2|Adverse Event|0|||
161902858|NCT02106351|584690659|FG000|Treatment Cycle 2|Consent withdrawn|0|||
161902859|NCT02106351|584690660|FG001|Treatment Cycle 2|Consent withdrawn|1|||
161902860|NCT02106351|584690661|FG002|Treatment Cycle 2|Consent withdrawn|1|||
161902861|NCT02106351|584690659|FG000|Treatment Cycle 2|Other|0|||
161902862|NCT02106351|584690660|FG001|Treatment Cycle 2|Other|2|||
161902863|NCT02106351|584690661|FG002|Treatment Cycle 2|Other|2|||
161902864|NCT02106351|584690659|FG000|Treatment Cycle 3|Adverse Event|0|||
161902865|NCT02106351|584690660|FG001|Treatment Cycle 3|Adverse Event|1|||
161902866|NCT02106351|584690661|FG002|Treatment Cycle 3|Adverse Event|0|||
161902867|NCT02106351|584690659|FG000|Treatment Cycle 3|Consent withdrawn|0|||
161902868|NCT02106351|584690660|FG001|Treatment Cycle 3|Consent withdrawn|0|||
161902869|NCT02106351|584690661|FG002|Treatment Cycle 3|Consent withdrawn|2|||
161902870|NCT02106351|584690659|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
161902871|NCT02106351|584690660|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
161902872|NCT02106351|584690661|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
161902873|NCT02106351|584690659|FG000|Treatment Cycle 3|Other|0|||
161798737|NCT02180711|584307098|FG003|Overall Study|Death|0|||
161798738|NCT02180711|584307099|FG004|Overall Study|Death|7|||
161798739|NCT02180711|584307100|FG005|Overall Study|Death|0|||
161798740|NCT02180711|584307101|FG006|Overall Study|Death|1|||
161798741|NCT02180711|584307102|FG007|Overall Study|Death|3|||
161798742|NCT02180711|584307095|FG000|Overall Study|Lost to Follow-up|0|||
161798743|NCT02180711|584307096|FG001|Overall Study|Lost to Follow-up|1|||
161798744|NCT02180711|584307097|FG002|Overall Study|Lost to Follow-up|0|||
161798745|NCT02180711|584307098|FG003|Overall Study|Lost to Follow-up|0|||
161798746|NCT02180711|584307099|FG004|Overall Study|Lost to Follow-up|1|||
161798747|NCT02180711|584307100|FG005|Overall Study|Lost to Follow-up|1|||
161798748|NCT02180711|584307101|FG006|Overall Study|Lost to Follow-up|0|||
161798749|NCT02180711|584307102|FG007|Overall Study|Lost to Follow-up|3|||
161798750|NCT02180711|584307095|FG000|Overall Study|Withdrawal by Subject|2|||
161798751|NCT02180711|584307096|FG001|Overall Study|Withdrawal by Subject|1|||
161798752|NCT02180711|584307097|FG002|Overall Study|Withdrawal by Subject|0|||
161798753|NCT02180711|584307098|FG003|Overall Study|Withdrawal by Subject|4|||
161798754|NCT02180711|584307099|FG004|Overall Study|Withdrawal by Subject|3|||
161798755|NCT02180711|584307100|FG005|Overall Study|Withdrawal by Subject|0|||
161798756|NCT02180711|584307101|FG006|Overall Study|Withdrawal by Subject|3|||
161798757|NCT02180711|584307102|FG007|Overall Study|Withdrawal by Subject|2|||
161798758|NCT02180711|584307095|FG000|Overall Study|- Disease Progression|0|||
161798759|NCT02180711|584307096|FG001|Overall Study|- Disease Progression|1|||
161798760|NCT02180711|584307097|FG002|Overall Study|- Disease Progression|0|||
161798761|NCT02180711|584307098|FG003|Overall Study|- Disease Progression|0|||
161798762|NCT02180711|584307099|FG004|Overall Study|- Disease Progression|0|||
161798763|NCT02180711|584307100|FG005|Overall Study|- Disease Progression|0|||
161798764|NCT02180711|584307101|FG006|Overall Study|- Disease Progression|0|||
161798765|NCT02180711|584307102|FG007|Overall Study|- Disease Progression|0|||
161798766|NCT02180711|584307095|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
161798767|NCT02180711|584307096|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
161798768|NCT02180711|584307097|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
161798769|NCT02180711|584307098|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
161798770|NCT02180711|584307099|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
161798771|NCT02180711|584307100|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
161798772|NCT02180711|584307101|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
161798773|NCT02180711|584307102|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
161798774|NCT02180711|584307095|FG000|Overall Study|- Study Terminated by Sponsor|2|||
161798775|NCT02180711|584307096|FG001|Overall Study|- Study Terminated by Sponsor|3|||
161798776|NCT02180711|584307097|FG002|Overall Study|- Study Terminated by Sponsor|0|||
161798777|NCT02180711|584307098|FG003|Overall Study|- Study Terminated by Sponsor|5|||
161798778|NCT02180711|584307099|FG004|Overall Study|- Study Terminated by Sponsor|32|||
161798779|NCT02180711|584307100|FG005|Overall Study|- Study Terminated by Sponsor|0|||
161798780|NCT02180711|584307101|FG006|Overall Study|- Study Terminated by Sponsor|4|||
161798781|NCT02180711|584307102|FG007|Overall Study|- Study Terminated by Sponsor|13|||
161798782|NCT02180711|584307095|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
161798783|NCT02180711|584307096|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
161798784|NCT02180711|584307097|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
161798785|NCT02180711|584307098|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
161798786|NCT02180711|584307099|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
161798787|NCT02180711|584307100|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
161798788|NCT02180711|584307101|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
161798789|NCT02180711|584307102|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
161798790|NCT02180711|584307095|FG000|Overall Study|- Other|1|||
161798791|NCT02180711|584307096|FG001|Overall Study|- Other|0|||
161798792|NCT02180711|584307097|FG002|Overall Study|- Other|0|||
162137953|NCT00430677|585555698|FG002|Short-term Period|Lack of Efficacy|4|||
162137954|NCT00430677|585555696|FG000|Short-term Period|Withdrawal by Subject|1|||
162137955|NCT00430677|585555697|FG001|Short-term Period|Withdrawal by Subject|1|||
162137956|NCT00430677|585555698|FG002|Short-term Period|Withdrawal by Subject|2|||
162137957|NCT00430677|585555696|FG000|Short-term Period|Participant no longer met study criteria|1|||
162137958|NCT00430677|585555697|FG001|Short-term Period|Participant no longer met study criteria|1|||
162137959|NCT00430677|585555698|FG002|Short-term Period|Participant no longer met study criteria|2|||
162137960|NCT00430677|585555696|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
162137961|NCT00430677|585555697|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
161798793|NCT02180711|584307098|FG003|Overall Study|- Other|1|||
161798794|NCT02180711|584307099|FG004|Overall Study|- Other|0|||
161798795|NCT02180711|584307100|FG005|Overall Study|- Other|0|||
161798796|NCT02180711|584307101|FG006|Overall Study|- Other|0|||
161902874|NCT02106351|584690660|FG001|Treatment Cycle 3|Other|2|||
161902875|NCT02106351|584690661|FG002|Treatment Cycle 3|Other|3|||
161798797|NCT02180711|584307102|FG007|Overall Study|- Other|0|||
161798798|NCT00444145|584307103|FG000|Overall Study|Withdrawal by Subject|2|||
161798799|NCT00444145|584307103|FG000|Overall Study|Lost to Follow-up|1|||
161798800|NCT00444145|584307103|FG000|Overall Study|non-compliant|11|||
161798801|NCT00444145|584307103|FG000|Overall Study|Screen Failures|5|||
161798802|NCT01619800|584307104|FG000|Overall Study|study terminated|2|||
161798803|NCT01619800|584307105|FG001|Overall Study|study terminated|0|||
161798804|NCT00414466|584307107|FG000|Overall Study|Adverse Event|0|||
161798805|NCT00414466|584307108|FG001|Overall Study|Adverse Event|0|||
161798806|NCT00414466|584307109|FG002|Overall Study|Adverse Event|1|||
161798807|NCT00414466|584307110|FG003|Overall Study|Adverse Event|1|||
161798808|NCT00414466|584307107|FG000|Overall Study|Lack of Efficacy|1|||
161798809|NCT00414466|584307108|FG001|Overall Study|Lack of Efficacy|0|||
161798810|NCT00414466|584307109|FG002|Overall Study|Lack of Efficacy|0|||
161798811|NCT00414466|584307110|FG003|Overall Study|Lack of Efficacy|0|||
161798812|NCT00414466|584307107|FG000|Overall Study|Withdrawn by Sponsor|1|||
161798813|NCT00414466|584307108|FG001|Overall Study|Withdrawn by Sponsor|0|||
161798814|NCT00414466|584307109|FG002|Overall Study|Withdrawn by Sponsor|0|||
161798815|NCT00414466|584307110|FG003|Overall Study|Withdrawn by Sponsor|0|||
161798816|NCT02742090|584307111|FG000|Overall Study|Adverse Event|10|||
161798817|NCT02742090|584307111|FG000|Overall Study|Death|3|||
161798818|NCT02742090|584307111|FG000|Overall Study|Disease Progression|25|||
161798819|NCT02742090|584307111|FG000|Overall Study|Investigator's Decision|1|||
161798820|NCT02742090|584307111|FG000|Overall Study|Lost to Follow-up|1|||
161798821|NCT02742090|584307111|FG000|Overall Study|Non-compliance with Study|1|||
161798822|NCT02742090|584307111|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
161798823|NCT02742090|584307111|FG000|Overall Study|Withdrawal by Subject|4|||
161798824|NCT02742090|584307111|FG000|Overall Study|Reason Not Specified|1|||
161798825|NCT02016300|584307114|FG000|Overall Study|Lost to Follow-up|0|||
161798826|NCT02016300|584307115|FG001|Overall Study|Lost to Follow-up|3|||
161798827|NCT05301751|584307120|FG000|Overall Study|Withdrawal by Subject|0|||
161798828|NCT05301751|584307121|FG001|Overall Study|Withdrawal by Subject|0|||
161798829|NCT05301751|584307122|FG002|Overall Study|Withdrawal by Subject|1|||
161798830|NCT05301751|584307123|FG003|Overall Study|Withdrawal by Subject|0|||
161798831|NCT06165744|584307126|FG000|Overall Study|Non device-related adverse event|1|||
161798832|NCT01546987|584307127|FG000|Overall Study|Protocol Violation|3|||
161798833|NCT01546987|584307128|FG001|Overall Study|Protocol Violation|4|||
161798834|NCT02270736|584307129|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
161798835|NCT02270736|584307130|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
161798836|NCT02270736|584307131|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
161798837|NCT02270736|584307132|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
161798838|NCT02270736|584307133|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
161798839|NCT02270736|584307129|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
161798840|NCT02270736|584307130|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
161798841|NCT02270736|584307131|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
161902876|NCT02106351|584690659|FG000|Treatment Cycle 4|Consent withdrawn|0|||
161902877|NCT02106351|584690660|FG001|Treatment Cycle 4|Consent withdrawn|0|||
161902878|NCT02106351|584690661|FG002|Treatment Cycle 4|Consent withdrawn|2|||
161902879|NCT02106351|584690659|FG000|Treatment Cycle 4|Other|0|||
161798842|NCT02270736|584307132|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
161798843|NCT02270736|584307133|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
161798844|NCT02270736|584307129|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
161798845|NCT02270736|584307130|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
161798846|NCT02270736|584307131|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
161798847|NCT02270736|584307132|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
161798848|NCT02270736|584307133|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
161798849|NCT02270736|584307129|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
161798850|NCT02270736|584307130|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
161798851|NCT02270736|584307131|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
161798852|NCT02270736|584307132|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
161798853|NCT02270736|584307133|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
161798854|NCT02270736|584307129|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
161798855|NCT02270736|584307130|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
161798856|NCT02270736|584307131|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
161798857|NCT02270736|584307132|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
161798858|NCT02270736|584307133|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
161798859|NCT02270736|584307129|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
161798860|NCT02270736|584307130|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
161798861|NCT02270736|584307131|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
161798862|NCT02270736|584307132|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
161798863|NCT02270736|584307133|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
161798864|NCT02270736|584307129|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
161798865|NCT02270736|584307130|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
161798866|NCT02270736|584307131|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
161798867|NCT02270736|584307132|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
161798868|NCT02270736|584307133|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
161798869|NCT02270736|584307129|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
161798870|NCT02270736|584307130|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
161798871|NCT02270736|584307131|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
161798872|NCT02270736|584307132|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
161798873|NCT02270736|584307133|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
161798874|NCT02270736|584307129|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
161798875|NCT02270736|584307130|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
161798876|NCT02270736|584307131|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
161798877|NCT02270736|584307132|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
161798878|NCT02270736|584307133|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
161798879|NCT00262600|584307134|FG000|Overall Study|Lost to Follow-up|17|||
161798880|NCT00262600|584307135|FG001|Overall Study|Lost to Follow-up|31|||
161798881|NCT00262600|584307136|FG002|Overall Study|Lost to Follow-up|41|||
161798882|NCT00262600|584307134|FG000|Overall Study|Withdrawal by Subject|128|||
161798883|NCT00262600|584307135|FG001|Overall Study|Withdrawal by Subject|145|||
161798884|NCT00262600|584307136|FG002|Overall Study|Withdrawal by Subject|139|||
161798885|NCT00262600|584307134|FG000|Overall Study|Not Treated|32|||
161798886|NCT00262600|584307135|FG001|Overall Study|Not Treated|17|||
161798887|NCT00262600|584307136|FG002|Overall Study|Not Treated|24|||
161798888|NCT00262600|584307134|FG000|Overall Study|Other|58|||
161798889|NCT00262600|584307135|FG001|Overall Study|Other|59|||
161798890|NCT00262600|584307136|FG002|Overall Study|Other|62|||
161798891|NCT05381948|584307141|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
161798892|NCT05381948|584307142|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
161798893|NCT05381948|584307143|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
161798894|NCT05381948|584307141|FG000|Overall Study|Adverse Event: Non-ocular|0|||
161798895|NCT05381948|584307142|FG001|Overall Study|Adverse Event: Non-ocular|1|||
161798896|NCT05381948|584307143|FG002|Overall Study|Adverse Event: Non-ocular|0|||
161798897|NCT05381948|584307141|FG000|Overall Study|Lost to Follow-up|1|||
161798898|NCT05381948|584307142|FG001|Overall Study|Lost to Follow-up|0|||
161798899|NCT05381948|584307143|FG002|Overall Study|Lost to Follow-up|0|||
161798900|NCT05381948|584307141|FG000|Overall Study|Protocol Deviation|0|||
161798901|NCT05381948|584307142|FG001|Overall Study|Protocol Deviation|2|||
161798902|NCT05381948|584307143|FG002|Overall Study|Protocol Deviation|0|||
161798903|NCT05381948|584307141|FG000|Overall Study|Withdrawal by Subject|1|||
161798904|NCT05381948|584307142|FG001|Overall Study|Withdrawal by Subject|0|||
161798905|NCT05381948|584307143|FG002|Overall Study|Withdrawal by Subject|1|||
161798906|NCT05381948|584307141|FG000|Overall Study|Death|0|||
161798907|NCT05381948|584307142|FG001|Overall Study|Death|2|||
161798908|NCT05381948|584307143|FG002|Overall Study|Death|0|||
161798909|NCT05381948|584307141|FG000|Overall Study|Discontinued study without receiving study drug|0|||
161798910|NCT05381948|584307142|FG001|Overall Study|Discontinued study without receiving study drug|0|||
161798911|NCT05381948|584307143|FG002|Overall Study|Discontinued study without receiving study drug|1|||
161798912|NCT04471207|584307144|FG000|Overall Study|Lost to Follow-up|4|||
161798913|NCT04471207|584307145|FG001|Overall Study|Lost to Follow-up|1|||
161798914|NCT04471207|584307144|FG000|Overall Study|Medication Contraindication|0|||
161798915|NCT04471207|584307145|FG001|Overall Study|Medication Contraindication|1|||
161798916|NCT04471207|584307144|FG000|Overall Study|Loss of Interest|2|||
161798917|NCT04471207|584307145|FG001|Overall Study|Loss of Interest|1|||
161798918|NCT04471207|584307144|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
161798919|NCT04471207|584307145|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
161798920|NCT04471207|584307144|FG000|Overall Study|Scheduling Conflicts|3|||
161798921|NCT04471207|584307145|FG001|Overall Study|Scheduling Conflicts|1|||
161798922|NCT04471207|584307144|FG000|Overall Study|Physician Decision|1|||
161798923|NCT04471207|584307145|FG001|Overall Study|Physician Decision|0|||
161798924|NCT04471207|584307144|FG000|Overall Study|Unwilling to Use System|0|||
161798925|NCT04471207|584307145|FG001|Overall Study|Unwilling to Use System|1|||
161798926|NCT02132247|584307150|FG000|Overall Study|Protocol Violation|1|||
161798927|NCT02132247|584307151|FG001|Overall Study|Protocol Violation|0|||
161798928|NCT00520741|584307154|FG000|Overall Study|Adverse Event|16|||
161798929|NCT00520741|584307155|FG001|Overall Study|Adverse Event|56|||
161902880|NCT02106351|584690660|FG001|Treatment Cycle 4|Other|1|||
161902881|NCT02106351|584690661|FG002|Treatment Cycle 4|Other|0|||
161902882|NCT01386606|584692413|FG000|Overall Study|Adverse Event|0|||
161902883|NCT01386606|584692414|FG001|Overall Study|Adverse Event|1|||
161902884|NCT01386606|584692415|FG002|Overall Study|Adverse Event|0|||
161902885|NCT01386606|584692416|FG003|Overall Study|Adverse Event|0|||
161902886|NCT01386606|584692413|FG000|Overall Study|Withdrawal by Subject|0|||
161902887|NCT01386606|584692414|FG001|Overall Study|Withdrawal by Subject|1|||
161902888|NCT01386606|584692415|FG002|Overall Study|Withdrawal by Subject|1|||
161902889|NCT01386606|584692416|FG003|Overall Study|Withdrawal by Subject|0|||
161902890|NCT01386606|584692413|FG000|Overall Study|Protocol Violation|1|||
161902891|NCT01386606|584692414|FG001|Overall Study|Protocol Violation|0|||
161902892|NCT01386606|584692415|FG002|Overall Study|Protocol Violation|1|||
161902893|NCT01386606|584692416|FG003|Overall Study|Protocol Violation|1|||
161902894|NCT01386606|584692413|FG000|Overall Study|Lost to Follow-up|2|||
161902895|NCT01386606|584692414|FG001|Overall Study|Lost to Follow-up|0|||
161902896|NCT01386606|584692415|FG002|Overall Study|Lost to Follow-up|0|||
161902897|NCT01386606|584692416|FG003|Overall Study|Lost to Follow-up|0|||
161902898|NCT01386606|584692413|FG000|Overall Study|Subject incarcerated|0|||
162137962|NCT00430677|585555698|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
162137963|NCT00430677|585555696|FG000|Short-term Period|Pregnancy|0|||
162137964|NCT00430677|585555697|FG001|Short-term Period|Pregnancy|2|||
162137965|NCT00430677|585555698|FG002|Short-term Period|Pregnancy|0|||
162137966|NCT00430677|585555696|FG000|Long-term Extension Period|Death|1|||
162137967|NCT00430677|585555697|FG001|Long-term Extension Period|Death|0|||
162137968|NCT00430677|585555698|FG002|Long-term Extension Period|Death|0|||
162137969|NCT00430677|585555696|FG000|Long-term Extension Period|Adverse Event|3|||
162137970|NCT00430677|585555697|FG001|Long-term Extension Period|Adverse Event|2|||
162137971|NCT00430677|585555698|FG002|Long-term Extension Period|Adverse Event|5|||
162137972|NCT00430677|585555696|FG000|Long-term Extension Period|Lack of Efficacy|5|||
162137973|NCT00430677|585555697|FG001|Long-term Extension Period|Lack of Efficacy|3|||
162137974|NCT00430677|585555698|FG002|Long-term Extension Period|Lack of Efficacy|8|||
162137975|NCT00430677|585555696|FG000|Long-term Extension Period|Lost to Follow-up|1|||
162137976|NCT00430677|585555697|FG001|Long-term Extension Period|Lost to Follow-up|1|||
162137977|NCT00430677|585555698|FG002|Long-term Extension Period|Lost to Follow-up|1|||
162137978|NCT00430677|585555696|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
162137979|NCT00430677|585555697|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
162137980|NCT00430677|585555698|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
162137981|NCT00430677|585555696|FG000|Long-term Extension Period|Pregnancy|1|||
162137982|NCT00430677|585555697|FG001|Long-term Extension Period|Pregnancy|1|||
162137983|NCT00430677|585555698|FG002|Long-term Extension Period|Pregnancy|0|||
162137984|NCT00430677|585555696|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
162137985|NCT00430677|585555697|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
162137986|NCT00430677|585555698|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
162137987|NCT00430677|585555696|FG000|Long-term Extension Period|Other|2|||
162137988|NCT00430677|585555697|FG001|Long-term Extension Period|Other|1|||
162137989|NCT00430677|585555698|FG002|Long-term Extension Period|Other|1|||
162137990|NCT00430677|585555696|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
162137991|NCT00430677|585555697|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
162137992|NCT00430677|585555698|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
162137993|NCT01555762|585555699|FG000|Overall Study|No information on Bevacizumab intake|11|||
162137994|NCT01555762|585555699|FG000|Overall Study|Missing start date of infusion|8|||
162137995|NCT01555762|585555699|FG000|Overall Study|75 years old or more ticked No|1|||
162137996|NCT01555762|585555699|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
162137997|NCT01555762|585555699|FG000|Overall Study|Death linked to progression of disease|165|||
162137998|NCT01555762|585555699|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
162137999|NCT01555762|585555699|FG000|Overall Study|Investigator's decision|10|||
162138000|NCT01555762|585555699|FG000|Overall Study|Participant not wishing to continue|5|||
162138001|NCT01555762|585555699|FG000|Overall Study|Missing data|1|||
162138002|NCT01555762|585555699|FG000|Overall Study|Death linked to an adverse event|14|||
162138003|NCT00299702|585555708|FG000|Overall Study|Death|1|||
161798930|NCT00520741|584307154|FG000|Overall Study|Lack of Efficacy|11|||
161798931|NCT00520741|584307155|FG001|Overall Study|Lack of Efficacy|30|||
161798932|NCT00520741|584307154|FG000|Overall Study|Withdrawal by Subject|0|||
161902899|NCT01386606|584692414|FG001|Overall Study|Subject incarcerated|1|||
161798933|NCT00520741|584307155|FG001|Overall Study|Withdrawal by Subject|11|||
161798934|NCT00520741|584307154|FG000|Overall Study|Protocol Violation|2|||
161798935|NCT00520741|584307155|FG001|Overall Study|Protocol Violation|15|||
161798936|NCT00520741|584307154|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
161798937|NCT00520741|584307155|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
161798938|NCT00520741|584307154|FG000|Overall Study|Lost to Follow-up|4|||
161798939|NCT00520741|584307155|FG001|Overall Study|Lost to Follow-up|4|||
161798940|NCT00520741|584307154|FG000|Overall Study|Other reasons for premature termination|0|||
161798941|NCT00520741|584307155|FG001|Overall Study|Other reasons for premature termination|6|||
161798942|NCT03702621|584307156|FG000|Overall Study|Physician Decision|6|||
161798943|NCT03702621|584307157|FG001|Overall Study|Physician Decision|6|||
161798944|NCT03444038|584307158|FG000|Overall Study|Adverse Event|12|||
161798945|NCT03444038|584307158|FG000|Overall Study|Withdrawal by Subject|7|||
161798946|NCT03444038|584307158|FG000|Overall Study|Lost to Follow-up|1|||
161798947|NCT03444038|584307158|FG000|Overall Study|Physician Decision|2|||
161798948|NCT03444038|584307158|FG000|Overall Study|Lack of Efficacy|7|||
161798949|NCT02354586|584307160|FG000|Overall Study|Death|230|||
161798950|NCT02354586|584307160|FG000|Overall Study|Withdrawal by Subject|59|||
161798951|NCT02354586|584307160|FG000|Overall Study|Lost to Follow-up|11|||
161798952|NCT02354586|584307160|FG000|Overall Study|Sponsor decision|51|||
161798953|NCT02354586|584307160|FG000|Overall Study|Site closure|2|||
161798954|NCT02354586|584307160|FG000|Overall Study|Intercurrent illness|1|||
161798955|NCT02354586|584307160|FG000|Overall Study|Protocol Violation|3|||
161798956|NCT02354586|584307160|FG000|Overall Study|Physician Decision|13|||
161798957|NCT02354586|584307160|FG000|Overall Study|Lack of Efficacy|86|||
161798958|NCT02354586|584307160|FG000|Overall Study|Adverse Event|7|||
161798959|NCT01957488|584307161|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
161798960|NCT01957488|584307162|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
161798961|NCT01957488|584307163|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
161798962|NCT01957488|584307164|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
161798963|NCT01957488|584307165|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
161798964|NCT01957488|584307166|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
161798965|NCT01957488|584307161|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
161798966|NCT01957488|584307162|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
161798967|NCT01957488|584307163|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
161798968|NCT01957488|584307164|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
161798969|NCT01957488|584307165|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
161798970|NCT01957488|584307166|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
161798971|NCT01957488|584307161|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
161798972|NCT01957488|584307162|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
161798973|NCT01957488|584307163|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
161798974|NCT01957488|584307164|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
161798975|NCT01957488|584307165|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
161798976|NCT01957488|584307166|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
161798977|NCT01957488|584307161|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
161798978|NCT01957488|584307162|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
161798979|NCT01957488|584307163|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
161798980|NCT01957488|584307164|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
161798981|NCT01957488|584307165|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
161798982|NCT01957488|584307166|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
161798983|NCT01957488|584307161|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161798984|NCT01957488|584307162|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161798985|NCT01957488|584307163|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161798986|NCT01957488|584307164|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161798987|NCT01957488|584307165|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
161798988|NCT01957488|584307166|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161798989|NCT01957488|584307161|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
161798990|NCT01957488|584307162|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
161798991|NCT01957488|584307163|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
161798992|NCT01957488|584307164|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
161798993|NCT01957488|584307165|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
161798994|NCT01957488|584307166|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
161798995|NCT01957488|584307161|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
161798996|NCT01957488|584307162|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
161798997|NCT01957488|584307163|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
161798998|NCT01957488|584307164|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
161798999|NCT01957488|584307165|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
161902900|NCT01386606|584692415|FG002|Overall Study|Subject incarcerated|0|||
161902901|NCT01386606|584692416|FG003|Overall Study|Subject incarcerated|0|||
161902902|NCT01386606|584692413|FG000|Overall Study|Unable to draw PK|1|||
161799000|NCT01957488|584307166|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
161799001|NCT01957488|584307161|FG000|Test Period 2 (2 Weeks)|Other|1|||
161799002|NCT01957488|584307162|FG001|Test Period 2 (2 Weeks)|Other|0|||
161902903|NCT01386606|584692414|FG001|Overall Study|Unable to draw PK|0|||
161902904|NCT01386606|584692415|FG002|Overall Study|Unable to draw PK|0|||
161902905|NCT01386606|584692416|FG003|Overall Study|Unable to draw PK|0|||
161902906|NCT01386606|584692413|FG000|Overall Study|T levels too high|0|||
161902907|NCT01386606|584692414|FG001|Overall Study|T levels too high|1|||
161902908|NCT01386606|584692415|FG002|Overall Study|T levels too high|1|||
161902909|NCT01386606|584692416|FG003|Overall Study|T levels too high|0|||
161902910|NCT00593814|584692418|FG000|Overall Study|Death|7|||
161902911|NCT00593814|584692419|FG001|Overall Study|Death|0|||
161902912|NCT00593814|584692418|FG000|Overall Study|Withdrawal by Subject|7|||
161902913|NCT00593814|584692419|FG001|Overall Study|Withdrawal by Subject|0|||
161902914|NCT00593814|584692418|FG000|Overall Study|Lost to Follow-up|7|||
161902915|NCT00593814|584692419|FG001|Overall Study|Lost to Follow-up|0|||
161902916|NCT00593814|584692418|FG000|Overall Study|Physician Decision|3|||
161902917|NCT00593814|584692419|FG001|Overall Study|Physician Decision|0|||
161902918|NCT02723188|584692422|FG000|Overall Study|Withdrawal by Subject|1|||
161902919|NCT02723188|584692423|FG001|Overall Study|Withdrawal by Subject|0|||
161902920|NCT02723188|584692424|FG002|Overall Study|Withdrawal by Subject|0|||
161902921|NCT03110354|584692428|FG000|Overall Study|Death|1|||
161902922|NCT03110354|584692429|FG001|Overall Study|Death|0|||
161902923|NCT03110354|584692430|FG002|Overall Study|Death|0|||
161902924|NCT03110354|584692431|FG003|Overall Study|Death|1|||
161902925|NCT03110354|584692432|FG004|Overall Study|Death|0|||
161902926|NCT03110354|584692428|FG000|Overall Study|Start of new therapy|0|||
161902927|NCT03110354|584692429|FG001|Overall Study|Start of new therapy|0|||
161902928|NCT03110354|584692430|FG002|Overall Study|Start of new therapy|0|||
161902929|NCT03110354|584692431|FG003|Overall Study|Start of new therapy|0|||
161902930|NCT03110354|584692432|FG004|Overall Study|Start of new therapy|1|||
161902931|NCT03110354|584692428|FG000|Overall Study|Failure to achieve response|2|||
161902932|NCT03110354|584692429|FG001|Overall Study|Failure to achieve response|3|||
161902933|NCT03110354|584692430|FG002|Overall Study|Failure to achieve response|0|||
161902934|NCT03110354|584692431|FG003|Overall Study|Failure to achieve response|2|||
161902935|NCT03110354|584692432|FG004|Overall Study|Failure to achieve response|1|||
161902936|NCT03110354|584692428|FG000|Overall Study|Progressive disease|1|||
161902937|NCT03110354|584692429|FG001|Overall Study|Progressive disease|1|||
161902938|NCT03110354|584692430|FG002|Overall Study|Progressive disease|3|||
161902939|NCT03110354|584692431|FG003|Overall Study|Progressive disease|4|||
161902940|NCT03110354|584692432|FG004|Overall Study|Progressive disease|2|||
161902941|NCT03110354|584692428|FG000|Overall Study|Adverse Event|0|||
161902942|NCT03110354|584692429|FG001|Overall Study|Adverse Event|0|||
161902943|NCT03110354|584692430|FG002|Overall Study|Adverse Event|0|||
161902944|NCT03110354|584692431|FG003|Overall Study|Adverse Event|2|||
161902945|NCT03110354|584692432|FG004|Overall Study|Adverse Event|2|||
161902946|NCT03110354|584692428|FG000|Overall Study|Other|0|||
161902947|NCT03110354|584692429|FG001|Overall Study|Other|0|||
161902948|NCT03110354|584692430|FG002|Overall Study|Other|0|||
161902949|NCT03110354|584692431|FG003|Overall Study|Other|1|||
161902950|NCT03110354|584692432|FG004|Overall Study|Other|1|||
161902951|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
161902952|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
161902953|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
161902954|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
161902955|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
161902956|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
161902957|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
161902958|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
161902959|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
161902960|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
161902961|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
161902962|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
161902963|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
161902964|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
161902965|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
161902966|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
161902967|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
161902968|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
161902969|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
161902970|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
161902971|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
161902972|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
161902973|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
161902974|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
161902975|NCT01198002|584692439|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
161902976|NCT01198002|584692440|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
161902977|NCT01198002|584692441|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
161902978|NCT01198002|584692439|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
161902979|NCT01198002|584692440|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
161799003|NCT01957488|584307163|FG002|Test Period 2 (2 Weeks)|Other|0|||
161799004|NCT01957488|584307164|FG003|Test Period 2 (2 Weeks)|Other|0|||
161799005|NCT01957488|584307165|FG004|Test Period 2 (2 Weeks)|Other|0|||
161799006|NCT01957488|584307166|FG005|Test Period 2 (2 Weeks)|Other|0|||
161799007|NCT01957488|584307161|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161799008|NCT01957488|584307162|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
161799009|NCT01957488|584307163|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161799010|NCT01957488|584307164|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161799011|NCT01957488|584307165|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161799012|NCT01957488|584307166|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161799013|NCT01957488|584307161|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
161799014|NCT01957488|584307162|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
161799015|NCT01957488|584307163|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
161799016|NCT01957488|584307164|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
161799017|NCT01957488|584307165|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
161799018|NCT01957488|584307166|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
161799019|NCT01957488|584307161|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161799020|NCT01957488|584307162|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161799021|NCT01957488|584307163|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161799022|NCT01957488|584307164|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161799023|NCT01957488|584307165|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161799024|NCT01957488|584307166|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
161799025|NCT01957488|584307161|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
161799026|NCT01957488|584307162|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161799027|NCT01957488|584307163|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161799028|NCT01957488|584307164|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161799029|NCT01957488|584307165|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161799030|NCT01957488|584307166|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161799031|NCT01957488|584307161|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161799032|NCT01957488|584307162|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
161799033|NCT01957488|584307163|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161799034|NCT01957488|584307164|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161799035|NCT01957488|584307165|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161799036|NCT01957488|584307166|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161799037|NCT00721409|584307167|FG000|Overall Study|Global deterioration of health status|2|||
161799038|NCT00721409|584307168|FG001|Overall Study|Global deterioration of health status|6|||
161799039|NCT00721409|584307169|FG002|Overall Study|Global deterioration of health status|3|||
161799040|NCT00721409|584307167|FG000|Overall Study|Death|0|||
161799041|NCT00721409|584307168|FG001|Overall Study|Death|1|||
161799042|NCT00721409|584307169|FG002|Overall Study|Death|0|||
161799043|NCT00721409|584307167|FG000|Overall Study|Randomized not Treated|0|||
161799044|NCT00721409|584307168|FG001|Overall Study|Randomized not Treated|1|||
161799045|NCT00721409|584307169|FG002|Overall Study|Randomized not Treated|4|||
161799046|NCT00721409|584307167|FG000|Overall Study|Reason not specified|1|||
161799047|NCT00721409|584307168|FG001|Overall Study|Reason not specified|0|||
161799048|NCT00721409|584307169|FG002|Overall Study|Reason not specified|2|||
161799049|NCT00721409|584307167|FG000|Overall Study|Adverse Event|0|||
161799050|NCT00721409|584307168|FG001|Overall Study|Adverse Event|13|||
161799051|NCT00721409|584307169|FG002|Overall Study|Adverse Event|2|||
161799052|NCT00721409|584307167|FG000|Overall Study|Lost to Follow-up|0|||
161799053|NCT00721409|584307168|FG001|Overall Study|Lost to Follow-up|0|||
161799054|NCT00721409|584307169|FG002|Overall Study|Lost to Follow-up|1|||
161799055|NCT00721409|584307167|FG000|Overall Study|Withdrawal by Subject|1|||
161799056|NCT00721409|584307168|FG001|Overall Study|Withdrawal by Subject|6|||
161799057|NCT00721409|584307169|FG002|Overall Study|Withdrawal by Subject|5|||
161799058|NCT00721409|584307167|FG000|Overall Study|Objective progression or relapse|8|||
161799059|NCT00721409|584307168|FG001|Overall Study|Objective progression or relapse|55|||
161799060|NCT00721409|584307169|FG002|Overall Study|Objective progression or relapse|62|||
161799061|NCT02402166|584307170|FG000|Overall Study|Adverse Event|2|||
161799062|NCT02402166|584307170|FG000|Overall Study|Withdrawal by Subject|2|||
161799063|NCT02402166|584307170|FG000|Overall Study|Lost to Follow-up|1|||
161799064|NCT00623103|584307171|FG000|Overall Study|Adverse Event|70|||
161799065|NCT00623103|584307172|FG001|Overall Study|Adverse Event|60|||
161799066|NCT00623103|584307171|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161799067|NCT00623103|584307172|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
161799068|NCT00623103|584307171|FG000|Overall Study|Withdrawal by Subject|18|||
161799069|NCT00623103|584307172|FG001|Overall Study|Withdrawal by Subject|24|||
161799070|NCT00623103|584307171|FG000|Overall Study|Lost to Follow-up|4|||
161799071|NCT00623103|584307172|FG001|Overall Study|Lost to Follow-up|1|||
161799072|NCT00623103|584307171|FG000|Overall Study|Administrative problems|2|||
161799073|NCT00623103|584307172|FG001|Overall Study|Administrative problems|4|||
162138004|NCT00299702|585555709|FG001|Overall Study|Death|0|||
162138005|NCT00299702|585555708|FG000|Overall Study|Adverse Event|0|||
162138006|NCT00299702|585555709|FG001|Overall Study|Adverse Event|4|||
162138007|NCT00299702|585555708|FG000|Overall Study|Lost to Follow-up|18|||
162138008|NCT00299702|585555709|FG001|Overall Study|Lost to Follow-up|10|||
162138009|NCT00299702|585555708|FG000|Overall Study|Withdrawal by Subject|25|||
162138010|NCT00299702|585555709|FG001|Overall Study|Withdrawal by Subject|23|||
162138011|NCT00299702|585555708|FG000|Overall Study|Pregnancy|0|||
162138012|NCT00299702|585555709|FG001|Overall Study|Pregnancy|1|||
162138013|NCT00299702|585555708|FG000|Overall Study|Insufficient Response|4|||
162138014|NCT00299702|585555709|FG001|Overall Study|Insufficient Response|3|||
162138015|NCT00299702|585555708|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
162138016|NCT00299702|585555709|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
162138017|NCT02931396|585555710|FG000|Overall Study|Lost to Follow-up|3|||
162138018|NCT02931396|585555711|FG001|Overall Study|Lost to Follow-up|0|||
162138019|NCT02931396|585555710|FG000|Overall Study|Withdrawal by Subject|2|||
162138020|NCT02931396|585555711|FG001|Overall Study|Withdrawal by Subject|0|||
162138021|NCT00670540|585555712|FG000|Overall Study|ineligible|17|||
162138022|NCT00670540|585555712|FG000|Overall Study|not living in France|348|||
162138023|NCT00670540|585555712|FG000|Overall Study|refused to participate|189|||
162138024|NCT00670540|585555712|FG000|Overall Study|controls randomised for no follow up|2770|||
162138025|NCT00670540|585555712|FG000|Overall Study|missing information inclusion criteria|1|||
162138026|NCT01866917|585555713|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
162138027|NCT01866917|585555714|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
162138028|NCT01562743|585555719|FG000|Overall Study|Adverse Event|29|||
162138029|NCT01562743|585555719|FG000|Overall Study|Lack of Efficacy|3|||
162138030|NCT01562743|585555719|FG000|Overall Study|Withdrawal by Subject|13|||
162138031|NCT01562743|585555719|FG000|Overall Study|Protocol Violation|1|||
162138032|NCT01562743|585555719|FG000|Overall Study|Discontinuation criteria|2|||
162138033|NCT01562743|585555719|FG000|Overall Study|Lost to Follow-up|2|||
162138034|NCT01562743|585555719|FG000|Overall Study|Physician Decision|2|||
162138035|NCT00662909|585555721|FG000|Overall Study|Adverse Event|17|||
162138036|NCT00662909|585555722|FG001|Overall Study|Adverse Event|18|||
162138037|NCT00662909|585555723|FG002|Overall Study|Adverse Event|19|||
162138038|NCT00662909|585555721|FG000|Overall Study|Lack of Efficacy|9|||
162138039|NCT00662909|585555722|FG001|Overall Study|Lack of Efficacy|1|||
162138040|NCT00662909|585555723|FG002|Overall Study|Lack of Efficacy|5|||
162138041|NCT00662909|585555721|FG000|Overall Study|Withdrawal by Subject|29|||
162138042|NCT00662909|585555722|FG001|Overall Study|Withdrawal by Subject|22|||
162138043|NCT00662909|585555723|FG002|Overall Study|Withdrawal by Subject|16|||
162138044|NCT00662909|585555721|FG000|Overall Study|Lost to Follow-up|2|||
162138045|NCT00662909|585555722|FG001|Overall Study|Lost to Follow-up|9|||
162138046|NCT00662909|585555723|FG002|Overall Study|Lost to Follow-up|3|||
162138047|NCT00662909|585555721|FG000|Overall Study|Protocol Violation|7|||
162138048|NCT00662909|585555722|FG001|Overall Study|Protocol Violation|4|||
162138049|NCT00662909|585555723|FG002|Overall Study|Protocol Violation|5|||
162138050|NCT00662909|585555721|FG000|Overall Study|Randomized- never received study drug|1|||
162138051|NCT00662909|585555722|FG001|Overall Study|Randomized- never received study drug|0|||
162138052|NCT00662909|585555723|FG002|Overall Study|Randomized- never received study drug|0|||
161799074|NCT00623103|584307171|FG000|Overall Study|Death|11|||
161799075|NCT00623103|584307172|FG001|Overall Study|Death|11|||
161799076|NCT00623103|584307171|FG000|Overall Study|Protocol deviation|2|||
161799077|NCT00623103|584307172|FG001|Overall Study|Protocol deviation|1|||
161799078|NCT02433678|584307177|FG000|Overall Study|Lost to Follow-up|1|||
162138053|NCT00662909|585555721|FG000|Overall Study|Non-compliance with study procedures|3|||
162138054|NCT00662909|585555722|FG001|Overall Study|Non-compliance with study procedures|3|||
162138055|NCT00662909|585555723|FG002|Overall Study|Non-compliance with study procedures|2|||
162138056|NCT00662909|585555721|FG000|Overall Study|Physician Decision|1|||
161902980|NCT01198002|584692441|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
161902981|NCT01198002|584692439|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
161902982|NCT01198002|584692440|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
161902983|NCT01198002|584692441|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
161902984|NCT01198002|584692439|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
161902985|NCT01198002|584692440|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
161902986|NCT01198002|584692441|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
161902987|NCT01198002|584692439|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
161902988|NCT01198002|584692440|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
161902989|NCT01198002|584692441|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
161902990|NCT01198002|584692439|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
161902991|NCT01198002|584692440|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
161902992|NCT01198002|584692441|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
161902993|NCT01198002|584692439|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
161902994|NCT01198002|584692440|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
161902995|NCT01198002|584692441|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
161902996|NCT03353792|584692442|FG000|Overall Study|Lost to Follow-up|1|||
161902997|NCT03353792|584692443|FG001|Overall Study|Lost to Follow-up|0|||
161902998|NCT03353792|584692442|FG000|Overall Study|Participant Unable to Manage Device|1|||
161902999|NCT03353792|584692443|FG001|Overall Study|Participant Unable to Manage Device|0|||
161903000|NCT01965327|584692444|FG000|Overall Study|Physician Decision|2|||
161903001|NCT00528424|584692445|FG000|Overall Study|Lost to Follow-up|13|||
161903002|NCT00528424|584692445|FG000|Overall Study|Withdrew consent|2|||
161903003|NCT00528424|584692445|FG000|Overall Study|Administrative reason|2|||
161903004|NCT00528424|584692445|FG000|Overall Study|Other|12|||
161903005|NCT02185417|584692446|FG000|Overall Study|Death|448|||
161903006|NCT02185417|584692447|FG001|Overall Study|Death|446|||
161903007|NCT02185417|584692448|FG002|Overall Study|Death|0|||
161903008|NCT02185417|584692446|FG000|Overall Study|Withdrawal by Subject|7|||
161903009|NCT02185417|584692447|FG001|Overall Study|Withdrawal by Subject|12|||
161903010|NCT02185417|584692448|FG002|Overall Study|Withdrawal by Subject|0|||
161903011|NCT02976519|584692451|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161903012|NCT02976519|584692452|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
161903013|NCT02976519|584692453|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161903014|NCT02976519|584692454|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161903015|NCT02976519|584692455|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161903016|NCT02976519|584692456|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161903017|NCT02976519|584692457|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161903018|NCT02976519|584692451|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161903019|NCT02976519|584692452|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161903020|NCT02976519|584692453|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161903021|NCT02976519|584692454|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
161903022|NCT02976519|584692455|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161903023|NCT02976519|584692456|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161903024|NCT02976519|584692457|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161903025|NCT02976519|584692451|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161903026|NCT02976519|584692452|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161903027|NCT02976519|584692453|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161903028|NCT02976519|584692454|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161903029|NCT02976519|584692455|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161903030|NCT02976519|584692456|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161903031|NCT02976519|584692457|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
161903032|NCT02976519|584692451|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161903033|NCT02976519|584692452|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161903034|NCT02976519|584692453|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161903035|NCT02976519|584692454|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161903036|NCT02976519|584692455|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
162138057|NCT00662909|585555722|FG001|Overall Study|Physician Decision|1|||
162138058|NCT00662909|585555723|FG002|Overall Study|Physician Decision|2|||
162138059|NCT00662909|585555721|FG000|Overall Study|Eligibility criterion not met|0|||
162138060|NCT00662909|585555722|FG001|Overall Study|Eligibility criterion not met|1|||
162138061|NCT00662909|585555723|FG002|Overall Study|Eligibility criterion not met|1|||
162138062|NCT04176458|585557241|FG000|Overall Study|Covid 19|4|||
162138063|NCT02082158|585557242|FG000|Overall Study|Withdrawal by Subject|0|||
162138064|NCT02082158|585557243|FG001|Overall Study|Withdrawal by Subject|0|||
161903037|NCT02976519|584692456|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161903038|NCT02976519|584692457|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
161903039|NCT02976519|584692451|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161903040|NCT02976519|584692452|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161799079|NCT02433678|584307178|FG001|Overall Study|Lost to Follow-up|2|||
161799080|NCT01424722|584307182|FG000|Overall Study|Sponsor terminated investigation|2258|||
161799081|NCT02483975|584307183|FG000|Overall Study|Adverse Event|0|||
161799082|NCT02483975|584307184|FG001|Overall Study|Adverse Event|1|||
161799083|NCT02483975|584307183|FG000|Overall Study|Lost to Follow-up|0|||
161799084|NCT02483975|584307184|FG001|Overall Study|Lost to Follow-up|1|||
161799085|NCT02483975|584307183|FG000|Overall Study|Physician Decision|2|||
161799086|NCT02483975|584307184|FG001|Overall Study|Physician Decision|0|||
161799087|NCT00818883|584307185|FG000|Overall Study|Adverse Event|28|||
161799088|NCT00818883|584307186|FG001|Overall Study|Adverse Event|19|||
161799089|NCT00818883|584307185|FG000|Overall Study|Protocol Violation|2|||
161799090|NCT00818883|584307186|FG001|Overall Study|Protocol Violation|2|||
161799091|NCT00818883|584307185|FG000|Overall Study|Lost to Follow-up|3|||
161799092|NCT00818883|584307186|FG001|Overall Study|Lost to Follow-up|2|||
161799093|NCT00818883|584307185|FG000|Overall Study|Withdrawal by Subject|16|||
161799094|NCT00818883|584307186|FG001|Overall Study|Withdrawal by Subject|14|||
161799095|NCT00818883|584307185|FG000|Overall Study|Lack of Efficacy|0|||
161799096|NCT00818883|584307186|FG001|Overall Study|Lack of Efficacy|2|||
161799097|NCT00818883|584307185|FG000|Overall Study|Other|2|||
161799098|NCT00818883|584307186|FG001|Overall Study|Other|7|||
161799099|NCT02684578|584307190|FG000|Overall Study|Withdrawal by Subject|10|||
161799100|NCT02684578|584307191|FG001|Overall Study|Withdrawal by Subject|7|||
161799101|NCT02684578|584307190|FG000|Overall Study|Lost to Follow-up|0|||
161799102|NCT02684578|584307191|FG001|Overall Study|Lost to Follow-up|3|||
161799103|NCT02684578|584307190|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
161799104|NCT02684578|584307191|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
161799105|NCT02684578|584307190|FG000|Overall Study|Missing follow-up data|0|||
161799106|NCT02684578|584307191|FG001|Overall Study|Missing follow-up data|1|||
161799107|NCT01618266|584307195|FG000|Overall Study|Lost to Follow-up|9|||
161799108|NCT01618266|584307195|FG000|Overall Study|Treatment satisfaction|10|||
161799109|NCT01618266|584307195|FG000|Overall Study|Other reasons|11|||
161799110|NCT01618266|584307195|FG000|Overall Study|Lack of Efficacy|23|||
161799111|NCT01618266|584307195|FG000|Overall Study|Protocol Violation|43|||
161799112|NCT01966042|584307196|FG000|Overall Study|Death|2|||
161799113|NCT03267264|584307197|FG000|Overall Study|Withdrawal by Subject|1|||
161799114|NCT03267264|584307198|FG001|Overall Study|Withdrawal by Subject|0|||
161799115|NCT03267264|584307199|FG002|Overall Study|Withdrawal by Subject|2|||
161799116|NCT03267264|584307200|FG003|Overall Study|Withdrawal by Subject|4|||
161799117|NCT02224391|584307201|FG000|Overall Study|Lost to Follow-up|26|||
161799118|NCT02224391|584307202|FG001|Overall Study|Lost to Follow-up|19|||
161799119|NCT02224391|584307201|FG000|Overall Study|Withdrawal by Subject|6|||
161799120|NCT02224391|584307202|FG001|Overall Study|Withdrawal by Subject|5|||
161799121|NCT02492958|584307203|FG000|Overall Study|Withdrawal by Subject|0|||
161799122|NCT02492958|584307204|FG001|Overall Study|Withdrawal by Subject|0|||
161799123|NCT02492958|584307205|FG002|Overall Study|Withdrawal by Subject|1|||
161799124|NCT02492958|584307206|FG003|Overall Study|Withdrawal by Subject|0|||
161799125|NCT02492958|584307203|FG000|Overall Study|Adverse Event|1|||
161799126|NCT02492958|584307204|FG001|Overall Study|Adverse Event|0|||
161799127|NCT02492958|584307205|FG002|Overall Study|Adverse Event|1|||
161799128|NCT02492958|584307206|FG003|Overall Study|Adverse Event|0|||
161799129|NCT03522948|584307207|FG000|Overall Study|Lost to Follow-up|1|||
161799130|NCT02236130|584307212|FG000|Overall Study|Lost to Follow-up|7|||
161799131|NCT02236130|584307213|FG001|Overall Study|Lost to Follow-up|12|||
161799132|NCT02114697|584307223|FG000|Overall Study|Study terminated|5|||
161799133|NCT02114697|584307224|FG001|Overall Study|Study terminated|4|||
161799134|NCT00424489|584307225|FG000|Overall Study|Death|3|||
161799135|NCT01984242|584307226|FG000|Overall Study|Death|52|||
161903041|NCT02976519|584692453|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161903042|NCT02976519|584692454|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161903043|NCT02976519|584692455|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161903044|NCT02976519|584692456|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161903045|NCT02976519|584692457|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
161903046|NCT01278342|584692458|FG000|Overall Study|Physician Decision|0|||
161903047|NCT01278342|584692459|FG001|Overall Study|Physician Decision|1|||
161903048|NCT01278342|584692460|FG002|Overall Study|Physician Decision|0|||
161903049|NCT01278342|584692458|FG000|Overall Study|Lost to Follow-up|1|||
161903050|NCT01278342|584692459|FG001|Overall Study|Lost to Follow-up|0|||
161903051|NCT01278342|584692460|FG002|Overall Study|Lost to Follow-up|0|||
161903052|NCT01278342|584692458|FG000|Overall Study|Administrative problems|2|||
161903053|NCT01278342|584692459|FG001|Overall Study|Administrative problems|0|||
161903054|NCT01278342|584692460|FG002|Overall Study|Administrative problems|0|||
161903055|NCT01278342|584692458|FG000|Overall Study|Other|1|||
161903056|NCT01278342|584692459|FG001|Overall Study|Other|0|||
161903057|NCT01278342|584692460|FG002|Overall Study|Other|0|||
161903058|NCT00243919|584692475|FG000|Overall Study|Death|3|||
161903059|NCT00243919|584692476|FG001|Overall Study|Death|4|||
161903060|NCT00243919|584692477|FG002|Overall Study|Death|6|||
161903061|NCT00243919|584692475|FG000|Overall Study|Withdrawal by Subject|6|||
161903062|NCT00243919|584692476|FG001|Overall Study|Withdrawal by Subject|6|||
161903063|NCT00243919|584692477|FG002|Overall Study|Withdrawal by Subject|2|||
161903064|NCT00243919|584692475|FG000|Overall Study|Lost to Follow-up|6|||
161903065|NCT00243919|584692476|FG001|Overall Study|Lost to Follow-up|7|||
161903066|NCT00243919|584692477|FG002|Overall Study|Lost to Follow-up|3|||
161903067|NCT00243919|584692475|FG000|Overall Study|Administrative Error|1|||
161903068|NCT00243919|584692476|FG001|Overall Study|Administrative Error|0|||
161903069|NCT00243919|584692477|FG002|Overall Study|Administrative Error|0|||
161903070|NCT00243919|584692475|FG000|Overall Study|Physician Decision|1|||
161903071|NCT00243919|584692476|FG001|Overall Study|Physician Decision|1|||
161903072|NCT00243919|584692477|FG002|Overall Study|Physician Decision|0|||
161903073|NCT04176939|584692478|FG000|Overall Study|Withdrawal by Subject|5|||
161903074|NCT04176939|584692478|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
161903075|NCT04176939|584692478|FG000|Overall Study|Lost to Follow-up|2|||
161903076|NCT04176939|584692478|FG000|Overall Study|Unspecified reason|4|||
161903077|NCT04176939|584692478|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
161903078|NCT02221648|584692482|FG000|Overall Study|Withdrawal by Subject|3|||
161903079|NCT02221648|584692483|FG001|Overall Study|Withdrawal by Subject|3|||
161903080|NCT00905424|584692485|FG000|Overall Study|Lost to Follow-up|3|||
162138065|NCT02082158|585557244|FG002|Overall Study|Withdrawal by Subject|0|||
162138066|NCT02082158|585557245|FG003|Overall Study|Withdrawal by Subject|0|||
162138067|NCT02082158|585557246|FG004|Overall Study|Withdrawal by Subject|1|||
162138068|NCT02082158|585557247|FG005|Overall Study|Withdrawal by Subject|0|||
162138069|NCT02082158|585557242|FG000|Overall Study|Failed Fit-testing|8|||
162138070|NCT02082158|585557243|FG001|Overall Study|Failed Fit-testing|8|||
162138071|NCT02082158|585557244|FG002|Overall Study|Failed Fit-testing|14|||
162138072|NCT02082158|585557245|FG003|Overall Study|Failed Fit-testing|4|||
162138073|NCT02082158|585557246|FG004|Overall Study|Failed Fit-testing|3|||
162138074|NCT02082158|585557247|FG005|Overall Study|Failed Fit-testing|7|||
162138075|NCT01466881|585557250|FG000|Overall Study|Ineligible|5|||
162138076|NCT01466881|585557250|FG000|Overall Study|Adverse Event|6|||
162138077|NCT01466881|585557250|FG000|Overall Study|Progression/relapse|20|||
162138078|NCT01466881|585557250|FG000|Overall Study|Death|4|||
162138079|NCT01466881|585557250|FG000|Overall Study|Other reason not protocol specified|5|||
162138080|NCT00742274|585557251|FG000|Overall Study|Death|1|||
162138081|NCT00742274|585557252|FG001|Overall Study|Death|0|||
162138082|NCT00742274|585557251|FG000|Overall Study|Withdrawal by Subject|1|||
162138083|NCT00742274|585557252|FG001|Overall Study|Withdrawal by Subject|2|||
162138084|NCT00742274|585557251|FG000|Overall Study|Removed for medical reasons|1|||
162138085|NCT00742274|585557252|FG001|Overall Study|Removed for medical reasons|1|||
162138086|NCT01670019|585557257|FG000|Overall Study|Adverse Event|3|||
162138087|NCT01670019|585557258|FG001|Overall Study|Adverse Event|0|||
162138088|NCT01670019|585557257|FG000|Overall Study|Withdrawal by Subject|6|||
162138089|NCT01670019|585557258|FG001|Overall Study|Withdrawal by Subject|0|||
162138090|NCT03537651|585557259|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
162138091|NCT03537651|585557259|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
162138092|NCT03537651|585557259|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
162138093|NCT03537651|585557259|FG000|Part A (Up to 96 Weeks)|Other|1|||
162138094|NCT03537651|585557259|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
162138095|NCT03537651|585557259|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
162138096|NCT03537651|585557259|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
161903081|NCT00905424|584692486|FG001|Overall Study|Lost to Follow-up|3|||
161903082|NCT00905424|584692485|FG000|Overall Study|Withdrawal by Subject|1|||
162138097|NCT03537651|585557259|FG000|Part B (Up to 192 Weeks)|Other|1|||
162138098|NCT00197236|585557260|FG000|Overall Study|Adverse Event|1|||
162138099|NCT00197236|585557261|FG001|Overall Study|Adverse Event|0|||
162138100|NCT00197236|585557262|FG002|Overall Study|Adverse Event|1|||
162138101|NCT00197236|585557260|FG000|Overall Study|Lost to Follow-up|5|||
162138102|NCT00197236|585557261|FG001|Overall Study|Lost to Follow-up|14|||
162138103|NCT00197236|585557262|FG002|Overall Study|Lost to Follow-up|6|||
162138104|NCT00197236|585557260|FG000|Overall Study|Protocol Violation|0|||
162138105|NCT00197236|585557261|FG001|Overall Study|Protocol Violation|0|||
162138106|NCT00197236|585557262|FG002|Overall Study|Protocol Violation|1|||
162138107|NCT00197236|585557260|FG000|Overall Study|Withdrawal by Subject|7|||
162138108|NCT00197236|585557261|FG001|Overall Study|Withdrawal by Subject|3|||
162138109|NCT00197236|585557262|FG002|Overall Study|Withdrawal by Subject|11|||
162138110|NCT00197236|585557260|FG000|Overall Study|Study drug/medication expiration|1|||
162138111|NCT00197236|585557261|FG001|Overall Study|Study drug/medication expiration|0|||
162138112|NCT00197236|585557262|FG002|Overall Study|Study drug/medication expiration|3|||
162138113|NCT00197236|585557260|FG000|Overall Study|Returned out of specified time window|0|||
162138114|NCT00197236|585557261|FG001|Overall Study|Returned out of specified time window|0|||
162138115|NCT00197236|585557262|FG002|Overall Study|Returned out of specified time window|1|||
162138116|NCT02524288|585557263|FG000|Overall Study|Adverse Event|115|||
162138117|NCT02524288|585557263|FG000|Overall Study|Lost to Follow-up|216|||
162138118|NCT02524288|585557263|FG000|Overall Study|Non-Compliance With Protocol|32|||
162138119|NCT02524288|585557263|FG000|Overall Study|Non-Compliance With Study Drug|14|||
161799136|NCT01984242|584307227|FG001|Overall Study|Death|50|||
161799137|NCT01984242|584307228|FG002|Overall Study|Death|52|||
161799138|NCT01984242|584307226|FG000|Overall Study|Withdrawal by Subject|5|||
161799139|NCT01984242|584307227|FG001|Overall Study|Withdrawal by Subject|3|||
161799140|NCT01984242|584307228|FG002|Overall Study|Withdrawal by Subject|10|||
161799141|NCT01984242|584307226|FG000|Overall Study|Physician Decision|0|||
161799142|NCT01984242|584307227|FG001|Overall Study|Physician Decision|0|||
161799143|NCT01984242|584307228|FG002|Overall Study|Physician Decision|1|||
161799144|NCT01984242|584307226|FG000|Overall Study|Lost to Follow-up|4|||
161799145|NCT01984242|584307227|FG001|Overall Study|Lost to Follow-up|0|||
161799146|NCT01984242|584307228|FG002|Overall Study|Lost to Follow-up|3|||
161799147|NCT01984242|584307226|FG000|Overall Study|Sponsor Decision|1|||
161799148|NCT01984242|584307227|FG001|Overall Study|Sponsor Decision|0|||
161799149|NCT01984242|584307228|FG002|Overall Study|Sponsor Decision|0|||
161799150|NCT01984242|584307226|FG000|Overall Study|Non-Compliance|1|||
161799151|NCT01984242|584307227|FG001|Overall Study|Non-Compliance|0|||
161799152|NCT01984242|584307228|FG002|Overall Study|Non-Compliance|0|||
161799153|NCT01984242|584307226|FG000|Overall Study|Study terminated by Sponsor|38|||
161799154|NCT01984242|584307227|FG001|Overall Study|Study terminated by Sponsor|50|||
161799155|NCT01984242|584307228|FG002|Overall Study|Study terminated by Sponsor|34|||
161799156|NCT01984242|584307226|FG000|Overall Study|Disease Progression|0|||
161799157|NCT01984242|584307227|FG001|Overall Study|Disease Progression|0|||
161799158|NCT01984242|584307228|FG002|Overall Study|Disease Progression|1|||
161799159|NCT00449150|584307231|FG000|Overall Study|Adverse Event|11|||
161799160|NCT00449150|584307232|FG001|Overall Study|Adverse Event|18|||
161799161|NCT00449150|584307233|FG002|Overall Study|Adverse Event|9|||
161799162|NCT00449150|584307231|FG000|Overall Study|Lack of Efficacy|1|||
161799163|NCT00449150|584307232|FG001|Overall Study|Lack of Efficacy|2|||
161799164|NCT00449150|584307233|FG002|Overall Study|Lack of Efficacy|2|||
161799165|NCT00449150|584307231|FG000|Overall Study|Other|16|||
161799166|NCT00449150|584307232|FG001|Overall Study|Other|13|||
161799167|NCT00449150|584307233|FG002|Overall Study|Other|14|||
161799168|NCT00449150|584307231|FG000|Overall Study|Withdrawal by Subject|17|||
161799169|NCT00449150|584307232|FG001|Overall Study|Withdrawal by Subject|18|||
161799170|NCT00449150|584307233|FG002|Overall Study|Withdrawal by Subject|21|||
161799171|NCT00449150|584307231|FG000|Overall Study|Protocol Violation|1|||
161799172|NCT00449150|584307232|FG001|Overall Study|Protocol Violation|2|||
161799173|NCT00449150|584307233|FG002|Overall Study|Protocol Violation|1|||
161799174|NCT00770510|584307234|FG000|Overall Study|Lost to Follow-up|2|||
161799175|NCT00770510|584307234|FG000|Overall Study|Pregnancy|1|||
161799176|NCT00770510|584307234|FG000|Overall Study|Withdrawal by Subject|2|||
161799177|NCT04117607|584307241|FG000|Overall Study|Early Termination|0|||
161799178|NCT04117607|584307242|FG001|Overall Study|Early Termination|1|||
161799179|NCT04117607|584307243|FG002|Overall Study|Early Termination|0|||
161799180|NCT04117607|584307244|FG003|Overall Study|Early Termination|0|||
161799181|NCT04117607|584307245|FG004|Overall Study|Early Termination|0|||
161799182|NCT04117607|584307246|FG005|Overall Study|Early Termination|0|||
161799183|NCT04117607|584307247|FG006|Overall Study|Early Termination|1|||
161799184|NCT04117607|584307248|FG007|Overall Study|Early Termination|0|||
161799185|NCT04117607|584307249|FG008|Overall Study|Early Termination|0|||
161799186|NCT04117607|584307250|FG009|Overall Study|Early Termination|0|||
161799187|NCT04117607|584307251|FG010|Overall Study|Early Termination|0|||
161799188|NCT04117607|584307252|FG011|Overall Study|Early Termination|0|||
161799189|NCT04117607|584307253|FG012|Overall Study|Early Termination|0|||
161799190|NCT04117607|584307254|FG013|Overall Study|Early Termination|0|||
161799191|NCT01626079|584307255|FG000|Overall Study|Death|167|||
161799192|NCT01626079|584307256|FG001|Overall Study|Death|192|||
161903083|NCT00905424|584692486|FG001|Overall Study|Withdrawal by Subject|2|||
161903084|NCT00905424|584692485|FG000|Overall Study|Adverse Event|4|||
161903085|NCT00905424|584692486|FG001|Overall Study|Adverse Event|2|||
161903086|NCT00905424|584692485|FG000|Overall Study|Non-compliance with study medication|2|||
161903087|NCT00905424|584692486|FG001|Overall Study|Non-compliance with study medication|0|||
161903088|NCT00905424|584692485|FG000|Overall Study|Sponsor decision|1|||
161903089|NCT00905424|584692486|FG001|Overall Study|Sponsor decision|0|||
161903090|NCT00905424|584692485|FG000|Overall Study|Positive urine drug screen|0|||
161903091|NCT00905424|584692486|FG001|Overall Study|Positive urine drug screen|1|||
161903092|NCT00905424|584692485|FG000|Overall Study|Non-adherence to visit schedule|0|||
161903093|NCT00905424|584692486|FG001|Overall Study|Non-adherence to visit schedule|1|||
161903094|NCT00426764|584692487|FG000|Overall Study|Protocol Violation|1|||
161903095|NCT00426764|584692487|FG000|Overall Study|Withdrawal by Subject|4|||
161903096|NCT00426764|584692487|FG000|Overall Study|Physician Decision|6|||
161903097|NCT00426764|584692487|FG000|Overall Study|Compassionate Use|1|||
161903098|NCT00426764|584692487|FG000|Overall Study|Progressive Disease|83|||
161903099|NCT00426764|584692487|FG000|Overall Study|Adverse Event|24|||
161903100|NCT00426764|584692487|FG000|Overall Study|Other|1|||
161903101|NCT00426764|584692487|FG000|Overall Study|Death|1|||
161903102|NCT00426764|584692487|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
161903103|NCT00379899|584692488|FG000|Overall Study|Adverse Event|7|||
161903104|NCT00379899|584692489|FG001|Overall Study|Adverse Event|3|||
161903105|NCT00379899|584692488|FG000|Overall Study|Death|10|||
161903106|NCT00379899|584692489|FG001|Overall Study|Death|10|||
161903107|NCT00379899|584692488|FG000|Overall Study|Lost to Follow-up|2|||
161903108|NCT00379899|584692489|FG001|Overall Study|Lost to Follow-up|4|||
161903109|NCT00379899|584692488|FG000|Overall Study|Physician Decision|3|||
161903110|NCT00379899|584692489|FG001|Overall Study|Physician Decision|4|||
161903111|NCT00379899|584692488|FG000|Overall Study|Withdrawal by Subject|5|||
161903112|NCT00379899|584692489|FG001|Overall Study|Withdrawal by Subject|5|||
161903113|NCT00379899|584692488|FG000|Overall Study|Ineligibility determined|0|||
161903114|NCT00379899|584692489|FG001|Overall Study|Ineligibility determined|1|||
161903115|NCT00379899|584692488|FG000|Overall Study|Noncompliance|1|||
161903116|NCT00379899|584692489|FG001|Overall Study|Noncompliance|1|||
161903117|NCT00379899|584692488|FG000|Overall Study|Parathyroidectomy|0|||
161903118|NCT00379899|584692489|FG001|Overall Study|Parathyroidectomy|2|||
161903119|NCT00379899|584692488|FG000|Overall Study|Renal transplantation|5|||
161903120|NCT00379899|584692489|FG001|Overall Study|Renal transplantation|4|||
161903121|NCT00379899|584692488|FG000|Overall Study|Coronary artery bypass graft|1|||
161903122|NCT00379899|584692489|FG001|Overall Study|Coronary artery bypass graft|1|||
162138120|NCT02524288|585557263|FG000|Overall Study|Pregnancy Wish|6|||
162138121|NCT02524288|585557263|FG000|Overall Study|Protocol Violation|6|||
162138122|NCT02524288|585557263|FG000|Overall Study|Screen Failure|2|||
162138123|NCT02524288|585557263|FG000|Overall Study|Site Discontinued Study Participation|1|||
162138124|NCT02524288|585557263|FG000|Overall Study|Study Terminated By Sponsor|1417|||
162138125|NCT02524288|585557263|FG000|Overall Study|Subject Moved|32|||
162138126|NCT02524288|585557263|FG000|Overall Study|Withdrawal by Subject|76|||
162138127|NCT02524288|585557263|FG000|Overall Study|Pregnancy|22|||
162138128|NCT02524288|585557263|FG000|Overall Study|Physician Decision|2|||
162138129|NCT01835899|585557265|FG000|Overall Study|Adverse Event|0|||
162138130|NCT01835899|585557266|FG001|Overall Study|Adverse Event|0|||
162138131|NCT01835899|585557267|FG002|Overall Study|Adverse Event|1|||
162138132|NCT01835899|585557265|FG000|Overall Study|Other than stated above|0|||
162138133|NCT01835899|585557266|FG001|Overall Study|Other than stated above|1|||
162138134|NCT01835899|585557267|FG002|Overall Study|Other than stated above|0|||
162138135|NCT02616263|585557268|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
162138136|NCT02616263|585557269|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
162138137|NCT02616263|585557268|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
162138138|NCT02616263|585557269|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
162138139|NCT02616263|585557268|FG000|6 Month to 1.5 Year|Death|1|||
162138140|NCT02616263|585557269|FG001|6 Month to 1.5 Year|Death|0|||
162138141|NCT02616263|585557268|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
162138142|NCT02616263|585557269|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
161903123|NCT00379899|584692488|FG000|Overall Study|Other protocol-specified criteria|3|||
161903124|NCT00379899|584692489|FG001|Overall Study|Other protocol-specified criteria|4|||
161903125|NCT00379899|584692488|FG000|Overall Study|Other|3|||
161903126|NCT00379899|584692489|FG001|Overall Study|Other|1|||
161903127|NCT01922258|584692490|FG000|Overall Study|Lost to Follow-up|1|||
161903128|NCT01922258|584692491|FG001|Overall Study|Lost to Follow-up|1|||
161903129|NCT01922258|584692490|FG000|Overall Study|Adverse Event|9|||
161903130|NCT01922258|584692491|FG001|Overall Study|Adverse Event|2|||
161903131|NCT01922258|584692490|FG000|Overall Study|Met Withdrawal Criteria|0|||
161903132|NCT01922258|584692491|FG001|Overall Study|Met Withdrawal Criteria|4|||
161903133|NCT01922258|584692490|FG000|Overall Study|Withdrawn by the Investigator|1|||
161903134|NCT01922258|584692491|FG001|Overall Study|Withdrawn by the Investigator|4|||
162138143|NCT02616263|585557268|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
162138144|NCT02616263|585557269|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
161799193|NCT01626079|584307257|FG002|Overall Study|Death|39|||
161799194|NCT01626079|584307255|FG000|Overall Study|Withdrawal by Subject|23|||
161799195|NCT01626079|584307256|FG001|Overall Study|Withdrawal by Subject|37|||
161799196|NCT01626079|584307257|FG002|Overall Study|Withdrawal by Subject|5|||
161799197|NCT01626079|584307255|FG000|Overall Study|Lost to Follow-up|7|||
161799198|NCT01626079|584307256|FG001|Overall Study|Lost to Follow-up|4|||
161799199|NCT01626079|584307257|FG002|Overall Study|Lost to Follow-up|2|||
161799200|NCT01626079|584307255|FG000|Overall Study|Missed Visits|1|||
161799201|NCT01626079|584307256|FG001|Overall Study|Missed Visits|4|||
161799202|NCT01626079|584307257|FG002|Overall Study|Missed Visits|6|||
161799203|NCT02073643|584307260|FG000|Overall Study|Lost to Follow-up|24|||
161799204|NCT02430870|584307261|FG000|Part 2|Voluntary Withdrawal|0|||
161799205|NCT02430870|584307262|FG001|Part 2|Voluntary Withdrawal|0|||
161799206|NCT02430870|584307263|FG002|Part 2|Voluntary Withdrawal|0|||
161799207|NCT02430870|584307264|FG003|Part 2|Voluntary Withdrawal|0|||
161799208|NCT02430870|584307265|FG004|Part 2|Voluntary Withdrawal|0|||
161799209|NCT02430870|584307266|FG005|Part 2|Voluntary Withdrawal|0|||
161799210|NCT02430870|584307267|FG006|Part 2|Voluntary Withdrawal|1|||
161799211|NCT02430870|584307268|FG007|Part 2|Voluntary Withdrawal|0|||
161799212|NCT02430870|584307261|FG000|Part 2|Other Reason Not Specified|0|||
161799213|NCT02430870|584307262|FG001|Part 2|Other Reason Not Specified|0|||
161799214|NCT02430870|584307263|FG002|Part 2|Other Reason Not Specified|0|||
161799215|NCT02430870|584307264|FG003|Part 2|Other Reason Not Specified|0|||
161799216|NCT02430870|584307265|FG004|Part 2|Other Reason Not Specified|0|||
161799217|NCT02430870|584307266|FG005|Part 2|Other Reason Not Specified|0|||
161799218|NCT02430870|584307267|FG006|Part 2|Other Reason Not Specified|0|||
161799219|NCT02430870|584307268|FG007|Part 2|Other Reason Not Specified|1|||
161799220|NCT00865709|584307269|FG000|Treatment|Adverse Event|9|||
161799221|NCT00865709|584307270|FG001|Treatment|Adverse Event|6|||
161799222|NCT00865709|584307269|FG000|Treatment|Withdrawal by Subject|10|||
161799223|NCT00865709|584307270|FG001|Treatment|Withdrawal by Subject|7|||
161799224|NCT00865709|584307269|FG000|Treatment|Physician Decision|3|||
161799225|NCT00865709|584307270|FG001|Treatment|Physician Decision|2|||
161799226|NCT00865709|584307269|FG000|Treatment|Surgery|8|||
161799227|NCT00865709|584307270|FG001|Treatment|Surgery|3|||
161799228|NCT00429923|584307271|FG000|Overall Study|Adverse Event|0|||
161799229|NCT00429923|584307272|FG001|Overall Study|Adverse Event|2|||
161799230|NCT00429923|584307273|FG002|Overall Study|Adverse Event|3|||
161799231|NCT00429923|584307271|FG000|Overall Study|Lack of Efficacy|4|||
161799232|NCT00429923|584307272|FG001|Overall Study|Lack of Efficacy|1|||
161799233|NCT00429923|584307273|FG002|Overall Study|Lack of Efficacy|33|||
161799234|NCT00429923|584307271|FG000|Overall Study|Lost to Follow-up|0|||
161799235|NCT00429923|584307272|FG001|Overall Study|Lost to Follow-up|0|||
161799236|NCT00429923|584307273|FG002|Overall Study|Lost to Follow-up|2|||
161799237|NCT00429923|584307271|FG000|Overall Study|Withdrew Consent|1|||
161799238|NCT00429923|584307272|FG001|Overall Study|Withdrew Consent|0|||
161799239|NCT00429923|584307273|FG002|Overall Study|Withdrew Consent|1|||
161799240|NCT00429923|584307271|FG000|Overall Study|Early Termination|0|||
161799241|NCT00429923|584307272|FG001|Overall Study|Early Termination|1|||
162138145|NCT02616263|585557268|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
162138146|NCT02616263|585557269|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
162138147|NCT02939183|585557275|FG000|Overall Study|Death|0|||
162138148|NCT02939183|585557276|FG001|Overall Study|Death|0|||
162138149|NCT02939183|585557277|FG002|Overall Study|Death|1|||
162138150|NCT02939183|585557278|FG003|Overall Study|Death|0|||
162138151|NCT02939183|585557279|FG004|Overall Study|Death|0|||
162138152|NCT02939183|585557280|FG005|Overall Study|Death|2|||
162138153|NCT02939183|585557281|FG006|Overall Study|Death|1|||
162138154|NCT02939183|585557282|FG007|Overall Study|Death|0|||
162138155|NCT02939183|585557283|FG008|Overall Study|Death|0|||
162138156|NCT02939183|585557275|FG000|Overall Study|Sponsor decision|0|||
162138157|NCT02939183|585557276|FG001|Overall Study|Sponsor decision|1|||
162138158|NCT02939183|585557277|FG002|Overall Study|Sponsor decision|0|||
161799242|NCT00429923|584307273|FG002|Overall Study|Early Termination|0|||
161799243|NCT01265784|584307274|FG000|Overall Study|Lost to Follow-up|5|||
161799244|NCT01265784|584307275|FG001|Overall Study|Lost to Follow-up|3|||
161799245|NCT01265784|584307276|FG002|Overall Study|Lost to Follow-up|2|||
161799246|NCT01265784|584307274|FG000|Overall Study|Withdrawal by Subject|0|||
161799247|NCT01265784|584307275|FG001|Overall Study|Withdrawal by Subject|5|||
161799248|NCT01265784|584307276|FG002|Overall Study|Withdrawal by Subject|0|||
161799249|NCT01265784|584307274|FG000|Overall Study|Physician Decision|1|||
161799250|NCT01265784|584307275|FG001|Overall Study|Physician Decision|0|||
161799251|NCT01265784|584307276|FG002|Overall Study|Physician Decision|1|||
161799252|NCT01265784|584307274|FG000|Overall Study|Adverse Event|1|||
161799253|NCT01265784|584307275|FG001|Overall Study|Adverse Event|0|||
161799254|NCT01265784|584307276|FG002|Overall Study|Adverse Event|0|||
161799255|NCT01265784|584307274|FG000|Overall Study|Death|3|||
162138159|NCT02939183|585557278|FG003|Overall Study|Sponsor decision|1|||
162138160|NCT02939183|585557279|FG004|Overall Study|Sponsor decision|2|||
162138161|NCT02939183|585557280|FG005|Overall Study|Sponsor decision|0|||
162138162|NCT02939183|585557281|FG006|Overall Study|Sponsor decision|3|||
161903135|NCT01922258|584692490|FG000|Overall Study|Withdrawal by participant|5|||
161903136|NCT01922258|584692491|FG001|Overall Study|Withdrawal by participant|5|||
161903137|NCT02417753|584692492|FG000|Overall Study|Death|1|||
161903138|NCT02716779|584692495|FG000|Monotherapy|Adverse Event|0|||
161903139|NCT02716779|584692496|FG001|Monotherapy|Adverse Event|1|||
161903140|NCT02716779|584692497|FG002|Monotherapy|Adverse Event|1|||
161903141|NCT02716779|584692495|FG000|Combination Therapy|Adverse Event|0|||
161903142|NCT02716779|584692496|FG001|Combination Therapy|Adverse Event|2|||
161903143|NCT02716779|584692497|FG002|Combination Therapy|Adverse Event|1|||
161903144|NCT01261390|584692500|FG000|Overall Study|Significant Concurrent Illness|1|||
161903145|NCT01261390|584692501|FG001|Overall Study|Significant Concurrent Illness|0|||
161903146|NCT01261390|584692502|FG002|Overall Study|Significant Concurrent Illness|1|||
161903147|NCT01261390|584692503|FG003|Overall Study|Significant Concurrent Illness|0|||
161903148|NCT01261390|584692500|FG000|Overall Study|Dissatisfaction with Treatment|2|||
161903149|NCT01261390|584692501|FG001|Overall Study|Dissatisfaction with Treatment|1|||
161903150|NCT01261390|584692502|FG002|Overall Study|Dissatisfaction with Treatment|1|||
161903151|NCT01261390|584692503|FG003|Overall Study|Dissatisfaction with Treatment|2|||
161903152|NCT01261390|584692500|FG000|Overall Study|Relocation|0|||
161903153|NCT01261390|584692501|FG001|Overall Study|Relocation|1|||
161903154|NCT01261390|584692502|FG002|Overall Study|Relocation|0|||
161903155|NCT01261390|584692503|FG003|Overall Study|Relocation|0|||
161903156|NCT01261390|584692500|FG000|Overall Study|Loss of Interest in the Study|3|||
161903157|NCT01261390|584692501|FG001|Overall Study|Loss of Interest in the Study|1|||
161903158|NCT01261390|584692502|FG002|Overall Study|Loss of Interest in the Study|0|||
161903159|NCT01261390|584692503|FG003|Overall Study|Loss of Interest in the Study|0|||
161903160|NCT01261390|584692500|FG000|Overall Study|Lost to Follow-up|1|||
161903161|NCT01261390|584692501|FG001|Overall Study|Lost to Follow-up|6|||
161903162|NCT01261390|584692502|FG002|Overall Study|Lost to Follow-up|5|||
161903163|NCT01261390|584692503|FG003|Overall Study|Lost to Follow-up|6|||
161903164|NCT02782741|584692505|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
161903165|NCT02782741|584692506|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
161903166|NCT02782741|584692507|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
161903167|NCT02782741|584692505|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
161903168|NCT02782741|584692506|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
161903169|NCT02782741|584692507|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
161903170|NCT02782741|584692505|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
161903171|NCT02782741|584692506|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
161903172|NCT02782741|584692507|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
161903173|NCT02782741|584692505|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
161903174|NCT02782741|584692506|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
161903175|NCT02782741|584692507|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
161903176|NCT02782741|584692505|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
161903177|NCT02782741|584692506|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
161903178|NCT02782741|584692507|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
161903179|NCT01951417|584692509|FG000|Overall Study|Withdrawal by Subject|1|||
161903180|NCT01951417|584692509|FG000|Overall Study|Protocol Violation|2|||
161903181|NCT01951417|584692509|FG000|Overall Study|Lost to Follow-up|6|||
161903182|NCT01497067|584692511|FG000|Overall Study|Lost to Follow-up|56|||
161903183|NCT01497067|584692511|FG000|Overall Study|Adverse Event|3|||
161903184|NCT01497067|584692511|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
161903185|NCT01497067|584692511|FG000|Overall Study|Other|13|||
161903186|NCT01275144|584692512|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
161903187|NCT01275144|584692513|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
161903188|NCT05116202|584692514|FG000|Overall Study|Study Terminated by Sponsor|21|||
161903189|NCT05116202|584692515|FG001|Overall Study|Study Terminated by Sponsor|38|||
161903190|NCT05116202|584692516|FG002|Overall Study|Study Terminated by Sponsor|17|||
161903191|NCT05116202|584692517|FG003|Overall Study|Study Terminated by Sponsor|18|||
161903192|NCT05116202|584692518|FG004|Overall Study|Study Terminated by Sponsor|0|||
161903193|NCT05116202|584692514|FG000|Overall Study|Withdrawal by Subject|0|||
161903194|NCT05116202|584692515|FG001|Overall Study|Withdrawal by Subject|1|||
161903195|NCT05116202|584692516|FG002|Overall Study|Withdrawal by Subject|1|||
161903196|NCT05116202|584692517|FG003|Overall Study|Withdrawal by Subject|1|||
161903197|NCT05116202|584692518|FG004|Overall Study|Withdrawal by Subject|1|||
161903198|NCT05116202|584692514|FG000|Overall Study|Lost to Follow-up|0|||
161903199|NCT05116202|584692515|FG001|Overall Study|Lost to Follow-up|0|||
161903200|NCT05116202|584692516|FG002|Overall Study|Lost to Follow-up|0|||
161903201|NCT05116202|584692517|FG003|Overall Study|Lost to Follow-up|0|||
161903202|NCT05116202|584692518|FG004|Overall Study|Lost to Follow-up|2|||
161903203|NCT05116202|584692514|FG000|Overall Study|Death|1|||
161903204|NCT05116202|584692515|FG001|Overall Study|Death|1|||
161903205|NCT05116202|584692516|FG002|Overall Study|Death|2|||
161903206|NCT05116202|584692517|FG003|Overall Study|Death|1|||
161903207|NCT05116202|584692518|FG004|Overall Study|Death|5|||
161903208|NCT02864407|584692525|FG000|Overall Study|Protocol Violation|3|||
161903209|NCT02864407|584692525|FG000|Overall Study|Lost to Follow-up|115|||
161903210|NCT02864407|584692525|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
161903211|NCT02864407|584692525|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
161903212|NCT02864407|584692525|FG000|Overall Study|Consent prior to the contract date|1|||
161903213|NCT00096538|584692533|FG000|Overall Study|Withdrawal by Subject|1|||
161903214|NCT02686164|584692537|FG000|Overall Study|Adverse Event|1|||
161903215|NCT02686164|584692537|FG000|Overall Study|Withdrawal of consent|1|||
161903216|NCT02686164|584692537|FG000|Overall Study|Clinical progression|1|||
161903217|NCT01827592|584692542|FG000|Overall Study|Adverse Event|11|||
161903218|NCT01827592|584692543|FG001|Overall Study|Adverse Event|9|||
161903219|NCT01827592|584692544|FG002|Overall Study|Adverse Event|2|||
161903220|NCT01827592|584692542|FG000|Overall Study|Physician Decision|0|||
161903221|NCT01827592|584692543|FG001|Overall Study|Physician Decision|2|||
161903222|NCT01827592|584692544|FG002|Overall Study|Physician Decision|1|||
161903223|NCT01827592|584692542|FG000|Overall Study|Protocol Violation|2|||
161903224|NCT01827592|584692543|FG001|Overall Study|Protocol Violation|1|||
161903225|NCT01827592|584692544|FG002|Overall Study|Protocol Violation|0|||
161903226|NCT01827592|584692542|FG000|Overall Study|Lost to Follow-up|1|||
161903227|NCT01827592|584692543|FG001|Overall Study|Lost to Follow-up|2|||
161903228|NCT01827592|584692544|FG002|Overall Study|Lost to Follow-up|2|||
161903229|NCT01827592|584692542|FG000|Overall Study|Withdrawal by Subject|12|||
161903230|NCT01827592|584692543|FG001|Overall Study|Withdrawal by Subject|11|||
161903231|NCT01827592|584692544|FG002|Overall Study|Withdrawal by Subject|11|||
161903232|NCT01827592|584692542|FG000|Overall Study|Patient's substantial non-compliance|1|||
161903233|NCT01827592|584692543|FG001|Overall Study|Patient's substantial non-compliance|1|||
161903234|NCT01827592|584692544|FG002|Overall Study|Patient's substantial non-compliance|6|||
161903235|NCT01827592|584692542|FG000|Overall Study|Trial terminated by Sponsor|47|||
161903236|NCT01827592|584692543|FG001|Overall Study|Trial terminated by Sponsor|53|||
161903237|NCT01827592|584692544|FG002|Overall Study|Trial terminated by Sponsor|51|||
161903238|NCT01827592|584692542|FG000|Overall Study|Others|0|||
161903239|NCT01827592|584692543|FG001|Overall Study|Others|1|||
161903240|NCT01827592|584692544|FG002|Overall Study|Others|3|||
161903241|NCT02324361|584692545|FG000|Overall Study|Lost to Follow-up|5|||
161903242|NCT02324361|584692546|FG001|Overall Study|Lost to Follow-up|2|||
161903243|NCT00003471|584692557|FG000|Overall Study|Not evaluable|4|||
161903244|NCT00715403|584692562|FG000|Overall Study|Progressive disease|0|||
161903245|NCT00715403|584692563|FG001|Overall Study|Progressive disease|1|||
161903246|NCT00715403|584692564|FG002|Overall Study|Progressive disease|3|||
161903247|NCT00715403|584692565|FG003|Overall Study|Progressive disease|9|||
161903248|NCT00715403|584692566|FG004|Overall Study|Progressive disease|5|||
161903249|NCT00715403|584692567|FG005|Overall Study|Progressive disease|14|||
161903250|NCT00715403|584692568|FG006|Overall Study|Progressive disease|1|||
161903251|NCT00715403|584692562|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
161903252|NCT00715403|584692563|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
161903253|NCT00715403|584692564|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
161903254|NCT00715403|584692565|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
161903255|NCT00715403|584692566|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
161903256|NCT00715403|584692567|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
161903257|NCT00715403|584692568|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
161903258|NCT00715403|584692562|FG000|Overall Study|Other Adverse Event than DLT|1|||
161903259|NCT00715403|584692563|FG001|Overall Study|Other Adverse Event than DLT|0|||
161903260|NCT00715403|584692564|FG002|Overall Study|Other Adverse Event than DLT|0|||
161903261|NCT00715403|584692565|FG003|Overall Study|Other Adverse Event than DLT|0|||
161903262|NCT00715403|584692566|FG004|Overall Study|Other Adverse Event than DLT|0|||
161903263|NCT00715403|584692567|FG005|Overall Study|Other Adverse Event than DLT|2|||
161903264|NCT00715403|584692568|FG006|Overall Study|Other Adverse Event than DLT|0|||
161903265|NCT00715403|584692562|FG000|Overall Study|Protocol Violation|0|||
161903266|NCT00715403|584692563|FG001|Overall Study|Protocol Violation|0|||
161903267|NCT00715403|584692564|FG002|Overall Study|Protocol Violation|0|||
161903268|NCT00715403|584692565|FG003|Overall Study|Protocol Violation|0|||
161903269|NCT00715403|584692566|FG004|Overall Study|Protocol Violation|0|||
161903270|NCT00715403|584692567|FG005|Overall Study|Protocol Violation|1|||
162138163|NCT02939183|585557282|FG007|Overall Study|Sponsor decision|1|||
162138164|NCT02939183|585557283|FG008|Overall Study|Sponsor decision|4|||
162138165|NCT02939183|585557275|FG000|Overall Study|Withdrawal by Subject|0|||
161903271|NCT00715403|584692568|FG006|Overall Study|Protocol Violation|0|||
161903272|NCT00715403|584692562|FG000|Overall Study|Other reason not defined above|0|||
161903273|NCT00715403|584692563|FG001|Overall Study|Other reason not defined above|0|||
161903274|NCT00715403|584692564|FG002|Overall Study|Other reason not defined above|1|||
161903275|NCT00715403|584692565|FG003|Overall Study|Other reason not defined above|0|||
161903276|NCT00715403|584692566|FG004|Overall Study|Other reason not defined above|1|||
161903277|NCT00715403|584692567|FG005|Overall Study|Other reason not defined above|1|||
161903278|NCT00715403|584692568|FG006|Overall Study|Other reason not defined above|0|||
161903279|NCT00520039|584692571|FG000|Overall Study|Exclusion criteria met at first visit|7|||
161903280|NCT00520039|584692572|FG001|Overall Study|Exclusion criteria met at first visit|5|||
162138166|NCT02939183|585557276|FG001|Overall Study|Withdrawal by Subject|2|||
161799256|NCT01265784|584307275|FG001|Overall Study|Death|0|||
161799257|NCT01265784|584307276|FG002|Overall Study|Death|0|||
161799258|NCT01265784|584307274|FG000|Overall Study|Protocol Violation|2|||
161799259|NCT01265784|584307275|FG001|Overall Study|Protocol Violation|0|||
161799260|NCT01265784|584307276|FG002|Overall Study|Protocol Violation|0|||
161799261|NCT01265784|584307274|FG000|Overall Study|Incorrectly Randomized|0|||
161799262|NCT01265784|584307275|FG001|Overall Study|Incorrectly Randomized|0|||
161799263|NCT01265784|584307276|FG002|Overall Study|Incorrectly Randomized|1|||
161799264|NCT04333095|584307281|FG000|Overall Study|Protocol Violation|4|||
161799265|NCT04333095|584307282|FG001|Overall Study|Protocol Violation|0|||
161799266|NCT04333095|584307281|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
161799267|NCT04333095|584307282|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
161799268|NCT04333095|584307281|FG000|Overall Study|Mini Sternotomy|4|||
161799269|NCT04333095|584307282|FG001|Overall Study|Mini Sternotomy|5|||
161799270|NCT03740165|584307283|FG000|Overall Study|Death|232|||
161799271|NCT03740165|584307284|FG001|Overall Study|Death|242|||
161799272|NCT03740165|584307285|FG002|Overall Study|Death|229|||
161799273|NCT03740165|584307283|FG000|Overall Study|Lost to Follow-up|0|||
161799274|NCT03740165|584307284|FG001|Overall Study|Lost to Follow-up|0|||
161799275|NCT03740165|584307285|FG002|Overall Study|Lost to Follow-up|1|||
161799276|NCT03740165|584307283|FG000|Overall Study|Withdrawal by Subject|7|||
161799277|NCT03740165|584307284|FG001|Overall Study|Withdrawal by Subject|4|||
161799278|NCT03740165|584307285|FG002|Overall Study|Withdrawal by Subject|3|||
161799279|NCT03740165|584307283|FG000|Overall Study|Ongoing in Study|216|||
161799280|NCT03740165|584307284|FG001|Overall Study|Ongoing in Study|212|||
161799281|NCT03740165|584307285|FG002|Overall Study|Ongoing in Study|221|||
161799282|NCT03049618|584307286|FG000|Overall Study|Death|1|||
161799283|NCT03049618|584307287|FG001|Overall Study|Death|0|||
161799284|NCT03049618|584307286|FG000|Overall Study|Lack of Efficacy|1|||
161799285|NCT03049618|584307287|FG001|Overall Study|Lack of Efficacy|2|||
161799286|NCT03717064|584309198|FG000|Period 2|Adverse Event|1|||
161799287|NCT02841709|584309199|FG000|5th Intervention|Adverse Event|2|||
161799288|NCT02841709|584309200|FG001|5th Intervention|Adverse Event|0|||
161903281|NCT03560869|584692573|FG000|Overall Study|Withdrawal by Subject|3|||
161903282|NCT03560869|584692574|FG001|Overall Study|Withdrawal by Subject|4|||
161903283|NCT03560869|584692573|FG000|Overall Study|Screening failure|4|||
161903284|NCT03560869|584692574|FG001|Overall Study|Screening failure|4|||
161903285|NCT03560869|584692573|FG000|Overall Study|Withdrawal by PI|0|||
161903286|NCT03560869|584692574|FG001|Overall Study|Withdrawal by PI|1|||
161903287|NCT02481050|584694779|FG000|Overall Study|Adverse Event|1|||
161903288|NCT02481050|584694779|FG000|Overall Study|Disease Progression|47|||
161903289|NCT02481050|584694779|FG000|Overall Study|Withdrawal by Subject|7|||
161903290|NCT02481050|584694779|FG000|Overall Study|Other|3|||
161903291|NCT01548599|584694782|FG000|Overall Study|Lost to Follow-up|0|||
161903292|NCT01548599|584694783|FG001|Overall Study|Lost to Follow-up|1|||
161903293|NCT01548599|584694782|FG000|Overall Study|Withdrawal by Subject|4|||
161903294|NCT01548599|584694783|FG001|Overall Study|Withdrawal by Subject|0|||
161903295|NCT01548599|584694782|FG000|Overall Study|Death|2|||
161903296|NCT01548599|584694783|FG001|Overall Study|Death|1|||
161903297|NCT02188160|584694784|FG000|Overall Study|Adverse Event|1|||
161903298|NCT02188160|584694785|FG001|Overall Study|Adverse Event|0|||
161903299|NCT02188160|584694784|FG000|Overall Study|Use of an excluded medication|0|||
161903300|NCT02188160|584694785|FG001|Overall Study|Use of an excluded medication|1|||
161903301|NCT01022203|584694790|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
161903302|NCT01022203|584694791|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
161903303|NCT01022203|584694790|FG000|Post Treatment Assessment|Physician Decision|2|||
161903304|NCT01022203|584694791|FG001|Post Treatment Assessment|Physician Decision|0|||
161903305|NCT01022203|584694790|FG000|Post Treatment Assessment|Adverse Event|0|||
161903306|NCT01022203|584694791|FG001|Post Treatment Assessment|Adverse Event|2|||
161903307|NCT01022203|584694790|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
161903308|NCT01022203|584694791|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
161903309|NCT03163446|584694792|FG000|Overall Study|Unable to return for Day 180 visit|2|||
161903310|NCT03163446|584694793|FG001|Overall Study|Unable to return for Day 180 visit|0|||
161903311|NCT03163446|584694792|FG000|Overall Study|Withdrawal by Subject|2|||
161903312|NCT03163446|584694793|FG001|Overall Study|Withdrawal by Subject|6|||
161903313|NCT03163446|584694792|FG000|Overall Study|Death|16|||
161903314|NCT03163446|584694793|FG001|Overall Study|Death|5|||
161903315|NCT03163446|584694792|FG000|Overall Study|Lost to Follow-up|6|||
161903316|NCT03163446|584694793|FG001|Overall Study|Lost to Follow-up|5|||
161903317|NCT03163446|584694792|FG000|Overall Study|Physician Decision|1|||
161903318|NCT03163446|584694793|FG001|Overall Study|Physician Decision|1|||
161903319|NCT03163446|584694792|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
161903320|NCT03163446|584694793|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
161903321|NCT03638128|584694794|FG000|Overall Study|Withdrawal by Subject|1|||
161903322|NCT03638128|584694795|FG001|Overall Study|Withdrawal by Subject|7|||
161903323|NCT03638128|584694796|FG002|Overall Study|Withdrawal by Subject|6|||
161903324|NCT03638128|584694794|FG000|Overall Study|Sponsor Decision|15|||
161903325|NCT03638128|584694795|FG001|Overall Study|Sponsor Decision|12|||
161903326|NCT03638128|584694796|FG002|Overall Study|Sponsor Decision|19|||
161903327|NCT03638128|584694794|FG000|Overall Study|Lost to Follow-up|0|||
161903328|NCT03638128|584694795|FG001|Overall Study|Lost to Follow-up|0|||
161903329|NCT03638128|584694796|FG002|Overall Study|Lost to Follow-up|1|||
161903330|NCT00611806|584694797|FG000|Overall Study|Withdrawal by Subject|8|||
161903331|NCT00611806|584694798|FG001|Overall Study|Withdrawal by Subject|2|||
161903332|NCT00611806|584694797|FG000|Overall Study|Adverse Event|2|||
161903333|NCT00611806|584694798|FG001|Overall Study|Adverse Event|1|||
161903334|NCT00611806|584694797|FG000|Overall Study|Lost to Follow-up|6|||
161903335|NCT00611806|584694798|FG001|Overall Study|Lost to Follow-up|0|||
161903336|NCT00903201|584694800|FG000|Overall Study|Adverse Event|1|||
161903337|NCT00903201|584694801|FG001|Overall Study|Adverse Event|4|||
161903338|NCT00903201|584694802|FG002|Overall Study|Adverse Event|0|||
161903339|NCT00903201|584694800|FG000|Overall Study|Protocol Violation|2|||
161903340|NCT00903201|584694801|FG001|Overall Study|Protocol Violation|1|||
161903341|NCT00903201|584694802|FG002|Overall Study|Protocol Violation|0|||
161903342|NCT00903201|584694800|FG000|Overall Study|Lost to Follow-up|0|||
162138167|NCT02939183|585557277|FG002|Overall Study|Withdrawal by Subject|0|||
162138168|NCT02939183|585557278|FG003|Overall Study|Withdrawal by Subject|1|||
162138169|NCT02939183|585557279|FG004|Overall Study|Withdrawal by Subject|0|||
161903343|NCT00903201|584694801|FG001|Overall Study|Lost to Follow-up|1|||
161903344|NCT00903201|584694802|FG002|Overall Study|Lost to Follow-up|0|||
161903345|NCT00903201|584694800|FG000|Overall Study|Physician Decision|1|||
161903346|NCT00903201|584694801|FG001|Overall Study|Physician Decision|0|||
161903347|NCT00903201|584694802|FG002|Overall Study|Physician Decision|1|||
161903348|NCT00903201|584694800|FG000|Overall Study|Withdrawal by Subject|1|||
161903349|NCT00903201|584694801|FG001|Overall Study|Withdrawal by Subject|0|||
161903350|NCT00903201|584694802|FG002|Overall Study|Withdrawal by Subject|1|||
161903351|NCT00945243|584694803|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
161903352|NCT00754741|584694804|FG000|Overall Study|Died or disenrolled|57|||
161903353|NCT00754741|584694805|FG001|Overall Study|Died or disenrolled|69|||
161903354|NCT00754741|584694806|FG002|Overall Study|Died or disenrolled|54|||
161799289|NCT02841709|584309201|FG002|5th Intervention|Adverse Event|0|||
161799290|NCT02841709|584309202|FG003|5th Intervention|Adverse Event|0|||
161799291|NCT02841709|584309203|FG004|5th Intervention|Adverse Event|2|||
161799292|NCT01929109|584309204|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
161799293|NCT01929109|584309205|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
161799294|NCT01929109|584309206|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
161799295|NCT01929109|584309207|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
161799296|NCT01929109|584309208|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
161799297|NCT04526210|584309213|FG000|Overall Study|Sponsor decision|7|||
161799298|NCT04526210|584309214|FG001|Overall Study|Sponsor decision|5|||
161799299|NCT04526210|584309213|FG000|Overall Study|Withdrawal by Subject|3|||
161799300|NCT04526210|584309214|FG001|Overall Study|Withdrawal by Subject|2|||
161799301|NCT01781637|584309215|FG000|Overall Study|Adverse Event|1|||
161799302|NCT01781637|584309216|FG001|Overall Study|Adverse Event|0|||
161799303|NCT01781637|584309215|FG000|Overall Study|Lack of Efficacy|2|||
161799304|NCT01781637|584309216|FG001|Overall Study|Lack of Efficacy|6|||
161799305|NCT01781637|584309215|FG000|Overall Study|Withdrawal by Subject|1|||
161799306|NCT01781637|584309216|FG001|Overall Study|Withdrawal by Subject|0|||
161799307|NCT02637232|584309217|FG000|Overall Study|Lost to Follow-up|42|||
161799308|NCT02637232|584309217|FG000|Overall Study|Adverse Event|11|||
161799309|NCT02637232|584309217|FG000|Overall Study|patient 's decision|2|||
161799310|NCT00090857|584309218|FG000|Overall Study|Lost to Follow-up|0|||
161799311|NCT00090857|584309219|FG001|Overall Study|Lost to Follow-up|1|||
161799312|NCT00090857|584309218|FG000|Overall Study|Withdrawal by Subject|2|||
161799313|NCT00090857|584309219|FG001|Overall Study|Withdrawal by Subject|0|||
161799314|NCT00090857|584309218|FG000|Overall Study|Adverse Event|2|||
161799315|NCT00090857|584309219|FG001|Overall Study|Adverse Event|2|||
161799316|NCT05097326|584309221|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
161799317|NCT05097326|584309222|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
161799318|NCT03480425|584309224|FG000|Overall Study|Force transducer technical failure|1|||
161799319|NCT01244126|584309225|FG000|Overall Study|Protocol Violation|3|||
161799320|NCT01244126|584309226|FG001|Overall Study|Protocol Violation|3|||
161799321|NCT01244126|584309227|FG002|Overall Study|Protocol Violation|9|||
161799322|NCT04373434|584309236|FG000|Overall Study|Lost to Follow-up|37|||
161799323|NCT04373434|584309237|FG001|Overall Study|Lost to Follow-up|32|||
161799324|NCT04373434|584309236|FG000|Overall Study|Refused at 9 months|1|||
161799325|NCT04373434|584309237|FG001|Overall Study|Refused at 9 months|2|||
161942201|NCT02082977|584838341|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
161799326|NCT04373434|584309236|FG000|Overall Study|Refused at 4 months|7|||
161799327|NCT04373434|584309237|FG001|Overall Study|Refused at 4 months|3|||
161799328|NCT04373434|584309236|FG000|Overall Study|Excluded|2|||
161799329|NCT04373434|584309237|FG001|Overall Study|Excluded|0|||
161903355|NCT04152200|584694807|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
161903356|NCT04152200|584694808|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
161903357|NCT04969289|584694809|FG000|Overall Study|Lost to Follow-up|13|||
161903358|NCT04969289|584694810|FG001|Overall Study|Lost to Follow-up|9|||
161903359|NCT02699996|584694811|FG000|Overall Study|Withdrawal by Subject|5|||
161903360|NCT02699996|584694812|FG001|Overall Study|Withdrawal by Subject|2|||
161903361|NCT01921517|584694813|FG000|Overall Study|Lost to Follow-up|5|||
161903362|NCT01921517|584694814|FG001|Overall Study|Lost to Follow-up|0|||
161903363|NCT01921517|584694813|FG000|Overall Study|Newly diagnosed health concern|2|||
161903364|NCT01921517|584694814|FG001|Overall Study|Newly diagnosed health concern|0|||
161903365|NCT01921517|584694813|FG000|Overall Study|Physician Decision|0|||
161903366|NCT01921517|584694814|FG001|Overall Study|Physician Decision|2|||
161903367|NCT01921517|584694813|FG000|Overall Study|Withdrawal by Subject|7|||
161903368|NCT01921517|584694814|FG001|Overall Study|Withdrawal by Subject|3|||
161903369|NCT01921517|584694813|FG000|Overall Study|Subject missed final imaging|1|||
161903370|NCT01921517|584694814|FG001|Overall Study|Subject missed final imaging|4|||
161903371|NCT04069715|584694815|FG000|Overall Study|Lost to Follow-up|1|||
161903372|NCT04069715|584694816|FG001|Overall Study|Lost to Follow-up|1|||
161903373|NCT04069715|584694815|FG000|Overall Study|Physician Decision|1|||
161903374|NCT04069715|584694816|FG001|Overall Study|Physician Decision|1|||
161903375|NCT04069715|584694815|FG000|Overall Study|Withdrawal by Subject|3|||
161903376|NCT04069715|584694816|FG001|Overall Study|Withdrawal by Subject|3|||
161903377|NCT02486692|584694819|FG000|Overall Study|did not login for randomization|4|||
161903378|NCT02486692|584694820|FG001|Overall Study|did not login for randomization|7|||
161903379|NCT02063672|584694821|FG000|Overall Study|Ongoing Follow-up|27|||
161903380|NCT02063672|584694822|FG001|Overall Study|Ongoing Follow-up|14|||
161903381|NCT02063672|584694821|FG000|Overall Study|Death|5|||
161903382|NCT02063672|584694822|FG001|Overall Study|Death|3|||
161903383|NCT02063672|584694821|FG000|Overall Study|Lost to Follow-up|1|||
161903384|NCT02063672|584694822|FG001|Overall Study|Lost to Follow-up|3|||
161903385|NCT02063672|584694821|FG000|Overall Study|Withdrawal by Subject|2|||
161903386|NCT02063672|584694822|FG001|Overall Study|Withdrawal by Subject|2|||
161903387|NCT01307787|584694824|FG000|Overall Study|Withdrawal by Subject|2|||
161903388|NCT01307787|584694825|FG001|Overall Study|Withdrawal by Subject|0|||
161903389|NCT02452047|584694830|FG000|Overall Study|Adverse Event|0|||
161903390|NCT02452047|584694831|FG001|Overall Study|Adverse Event|1|||
161903391|NCT02452047|584694832|FG002|Overall Study|Adverse Event|1|||
161799330|NCT00527423|584309238|FG000|Overall Study|Protocol Violation|1|||
161799331|NCT00527423|584309238|FG000|Overall Study|Adverse Event|5|||
161799332|NCT00527423|584309238|FG000|Overall Study|Physician Decision|4|||
161799333|NCT00527423|584309238|FG000|Overall Study|Withdrawal by Subject|10|||
161799334|NCT00527423|584309238|FG000|Overall Study|Lost to Follow-up|4|||
161799335|NCT00527423|584309238|FG000|Overall Study|OTHER|4|||
161799336|NCT00527423|584309238|FG000|Overall Study|Death|9|||
161799337|NCT02446132|584309239|FG000|Overall Study|Adverse Event|10|||
161799338|NCT02446132|584309240|FG001|Overall Study|Adverse Event|27|||
161799339|NCT02446132|584309241|FG002|Overall Study|Adverse Event|27|||
161799340|NCT02446132|584309239|FG000|Overall Study|Death|2|||
161799341|NCT02446132|584309240|FG001|Overall Study|Death|13|||
161799342|NCT02446132|584309241|FG002|Overall Study|Death|10|||
161799343|NCT02446132|584309239|FG000|Overall Study|Lack of Efficacy|1|||
161799344|NCT02446132|584309240|FG001|Overall Study|Lack of Efficacy|10|||
161799345|NCT02446132|584309241|FG002|Overall Study|Lack of Efficacy|6|||
161799346|NCT02446132|584309239|FG000|Overall Study|Lost to Follow-up|2|||
161799347|NCT02446132|584309240|FG001|Overall Study|Lost to Follow-up|4|||
161799348|NCT02446132|584309241|FG002|Overall Study|Lost to Follow-up|5|||
161799349|NCT02446132|584309239|FG000|Overall Study|Non-compliance With Study Drug|2|||
161799350|NCT02446132|584309240|FG001|Overall Study|Non-compliance With Study Drug|2|||
161799351|NCT02446132|584309241|FG002|Overall Study|Non-compliance With Study Drug|3|||
161799352|NCT02446132|584309239|FG000|Overall Study|Physician Decision|1|||
161799353|NCT02446132|584309240|FG001|Overall Study|Physician Decision|8|||
161799354|NCT02446132|584309241|FG002|Overall Study|Physician Decision|13|||
161799355|NCT02446132|584309239|FG000|Overall Study|Protocol Deviation|0|||
161799356|NCT02446132|584309240|FG001|Overall Study|Protocol Deviation|0|||
161799357|NCT02446132|584309241|FG002|Overall Study|Protocol Deviation|1|||
161799358|NCT02446132|584309239|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
161799359|NCT02446132|584309240|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
161799360|NCT02446132|584309241|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
161799361|NCT02446132|584309239|FG000|Overall Study|Study Terminated by Sponsor|4|||
161799362|NCT02446132|584309240|FG001|Overall Study|Study Terminated by Sponsor|35|||
161799363|NCT02446132|584309241|FG002|Overall Study|Study Terminated by Sponsor|58|||
161799364|NCT02446132|584309239|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
161799365|NCT02446132|584309240|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
161799366|NCT02446132|584309241|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
161799367|NCT02446132|584309239|FG000|Overall Study|Withdrawal by Subject|11|||
161799368|NCT02446132|584309240|FG001|Overall Study|Withdrawal by Subject|29|||
161799369|NCT02446132|584309241|FG002|Overall Study|Withdrawal by Subject|25|||
161799370|NCT02446132|584309239|FG000|Overall Study|Reason not Specified|4|||
161799371|NCT02446132|584309240|FG001|Overall Study|Reason not Specified|16|||
161799372|NCT02446132|584309241|FG002|Overall Study|Reason not Specified|10|||
161799373|NCT02446132|584309239|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
161799374|NCT02446132|584309240|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
161799375|NCT02446132|584309241|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
161799376|NCT00436007|584309242|FG000|Overall Study|Withdrawal by Subject|5|||
161799377|NCT00436007|584309243|FG001|Overall Study|Withdrawal by Subject|3|||
161799378|NCT00436007|584309244|FG002|Overall Study|Withdrawal by Subject|4|||
161799379|NCT00436007|584309242|FG000|Overall Study|Lost to Follow-up|14|||
161799380|NCT00436007|584309243|FG001|Overall Study|Lost to Follow-up|10|||
161799381|NCT00436007|584309244|FG002|Overall Study|Lost to Follow-up|13|||
161799382|NCT00436007|584309242|FG000|Overall Study|Physician Decision|0|||
161799383|NCT00436007|584309243|FG001|Overall Study|Physician Decision|0|||
161799384|NCT00436007|584309244|FG002|Overall Study|Physician Decision|2|||
161799385|NCT00436007|584309242|FG000|Overall Study|Death|0|||
161799386|NCT00436007|584309243|FG001|Overall Study|Death|1|||
161799387|NCT00436007|584309244|FG002|Overall Study|Death|3|||
161799388|NCT00436007|584309242|FG000|Overall Study|Other|0|||
161799389|NCT00436007|584309243|FG001|Overall Study|Other|0|||
161799390|NCT00436007|584309244|FG002|Overall Study|Other|1|||
161799391|NCT01439165|584309245|FG000|Overall Study|Protocol Violation|3|||
161799392|NCT01439165|584309246|FG001|Overall Study|Protocol Violation|0|||
161799393|NCT01439165|584309245|FG000|Overall Study|Lost to Follow-up|11|||
161799394|NCT01439165|584309246|FG001|Overall Study|Lost to Follow-up|1|||
161903392|NCT02452047|584694830|FG000|Overall Study|Death|1|||
161903393|NCT02452047|584694831|FG001|Overall Study|Death|3|||
161903394|NCT02452047|584694832|FG002|Overall Study|Death|1|||
161903395|NCT02452047|584694830|FG000|Overall Study|Physician Decision|1|||
161799395|NCT01439165|584309245|FG000|Overall Study|Withdrawal by Subject|7|||
161799396|NCT01439165|584309246|FG001|Overall Study|Withdrawal by Subject|1|||
161799397|NCT01089647|584309247|FG000|Overall Study|Lost to Follow-up|2|||
161799398|NCT01089647|584309248|FG001|Overall Study|Lost to Follow-up|2|||
161799399|NCT01089647|584309247|FG000|Overall Study|Withdrawal by Subject|2|||
161799400|NCT01089647|584309248|FG001|Overall Study|Withdrawal by Subject|1|||
161903396|NCT02452047|584694831|FG001|Overall Study|Physician Decision|0|||
161903397|NCT02452047|584694832|FG002|Overall Study|Physician Decision|0|||
161903398|NCT02452047|584694830|FG000|Overall Study|Lost to Follow-up|1|||
161903399|NCT02452047|584694831|FG001|Overall Study|Lost to Follow-up|1|||
161903400|NCT02452047|584694832|FG002|Overall Study|Lost to Follow-up|0|||
161903401|NCT02452047|584694830|FG000|Overall Study|Withdrawal by Subject|1|||
161903402|NCT02452047|584694831|FG001|Overall Study|Withdrawal by Subject|0|||
161903403|NCT02452047|584694832|FG002|Overall Study|Withdrawal by Subject|0|||
161903404|NCT02157519|584694845|FG000|Overall Study|Death|3|||
161903405|NCT02157519|584694846|FG001|Overall Study|Death|1|||
161903406|NCT02157519|584694845|FG000|Overall Study|Withdrawal by Subject|7|||
161903407|NCT02157519|584694846|FG001|Overall Study|Withdrawal by Subject|0|||
161903408|NCT02157519|584694845|FG000|Overall Study|Lost to Follow-up|1|||
161903409|NCT02157519|584694846|FG001|Overall Study|Lost to Follow-up|0|||
161903410|NCT01656395|584694847|FG000|Overall Study|Adverse Event|1|||
161903411|NCT01656395|584694848|FG001|Overall Study|Adverse Event|14|||
161903412|NCT01656395|584694849|FG002|Overall Study|Adverse Event|5|||
161903413|NCT01656395|584694850|FG003|Overall Study|Adverse Event|4|||
161903414|NCT01656395|584694851|FG004|Overall Study|Adverse Event|5|||
161903415|NCT01656395|584694852|FG005|Overall Study|Adverse Event|7|||
161903416|NCT01656395|584694853|FG006|Overall Study|Adverse Event|0|||
161903417|NCT01656395|584694854|FG007|Overall Study|Adverse Event|0|||
161903418|NCT01656395|584694847|FG000|Overall Study|Lack of Efficacy|1|||
161903419|NCT01656395|584694848|FG001|Overall Study|Lack of Efficacy|8|||
161903420|NCT01656395|584694849|FG002|Overall Study|Lack of Efficacy|6|||
161903421|NCT01656395|584694850|FG003|Overall Study|Lack of Efficacy|1|||
161903422|NCT01656395|584694851|FG004|Overall Study|Lack of Efficacy|1|||
161903423|NCT01656395|584694852|FG005|Overall Study|Lack of Efficacy|6|||
161903424|NCT01656395|584694853|FG006|Overall Study|Lack of Efficacy|0|||
161903425|NCT01656395|584694854|FG007|Overall Study|Lack of Efficacy|0|||
161903426|NCT01656395|584694847|FG000|Overall Study|Lost to Follow-up|1|||
161903427|NCT01656395|584694848|FG001|Overall Study|Lost to Follow-up|0|||
161903428|NCT01656395|584694849|FG002|Overall Study|Lost to Follow-up|0|||
161903429|NCT01656395|584694850|FG003|Overall Study|Lost to Follow-up|0|||
161903430|NCT01656395|584694851|FG004|Overall Study|Lost to Follow-up|0|||
162138170|NCT02939183|585557280|FG005|Overall Study|Withdrawal by Subject|0|||
162138171|NCT02939183|585557281|FG006|Overall Study|Withdrawal by Subject|2|||
162138172|NCT02939183|585557282|FG007|Overall Study|Withdrawal by Subject|2|||
162138173|NCT02939183|585557283|FG008|Overall Study|Withdrawal by Subject|2|||
162138174|NCT02939183|585557275|FG000|Overall Study|Not treated due to adverse event|0|||
162138175|NCT02939183|585557276|FG001|Overall Study|Not treated due to adverse event|0|||
162138176|NCT02939183|585557277|FG002|Overall Study|Not treated due to adverse event|0|||
162138177|NCT02939183|585557278|FG003|Overall Study|Not treated due to adverse event|1|||
162138178|NCT02939183|585557279|FG004|Overall Study|Not treated due to adverse event|0|||
162138179|NCT02939183|585557280|FG005|Overall Study|Not treated due to adverse event|0|||
162138180|NCT02939183|585557281|FG006|Overall Study|Not treated due to adverse event|1|||
162138181|NCT02939183|585557282|FG007|Overall Study|Not treated due to adverse event|0|||
162138182|NCT02939183|585557283|FG008|Overall Study|Not treated due to adverse event|0|||
162138183|NCT05015478|585557284|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
162138184|NCT05015478|585557285|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
162138185|NCT05015478|585557286|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
162138186|NCT05015478|585557287|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
162138187|NCT04939428|585557288|FG000|Overall Study|Death|0|||
162138188|NCT04939428|585557289|FG001|Overall Study|Death|1|||
162138189|NCT04939428|585557290|FG002|Overall Study|Death|0|||
162138190|NCT04939428|585557288|FG000|Overall Study|Lost to Follow-up|0|||
162138191|NCT04939428|585557289|FG001|Overall Study|Lost to Follow-up|5|||
162138192|NCT04939428|585557290|FG002|Overall Study|Lost to Follow-up|0|||
162138193|NCT04939428|585557288|FG000|Overall Study|Physician Decision|1|||
162138194|NCT04939428|585557289|FG001|Overall Study|Physician Decision|0|||
162138195|NCT04939428|585557290|FG002|Overall Study|Physician Decision|0|||
162138196|NCT04939428|585557288|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
162138197|NCT04939428|585557289|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162138198|NCT04939428|585557290|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162138199|NCT04939428|585557288|FG000|Overall Study|Withdrawal by Subject|10|||
162138200|NCT04939428|585557289|FG001|Overall Study|Withdrawal by Subject|11|||
162138201|NCT04939428|585557290|FG002|Overall Study|Withdrawal by Subject|0|||
162138202|NCT04939428|585557288|FG000|Overall Study|Unkown|6|||
162138203|NCT04939428|585557289|FG001|Overall Study|Unkown|3|||
162138204|NCT04939428|585557290|FG002|Overall Study|Unkown|0|||
162138205|NCT04939428|585557288|FG000|Overall Study|Discotinued per protocol|0|||
162138206|NCT04939428|585557289|FG001|Overall Study|Discotinued per protocol|0|||
162138207|NCT04939428|585557290|FG002|Overall Study|Discotinued per protocol|902|||
162138208|NCT04319094|585557293|FG000|Baseline|Lost to Follow-up|4|||
162138209|NCT04319094|585557294|FG001|Baseline|Lost to Follow-up|5|||
162138210|NCT04319094|585557293|FG000|Baseline|Protocol Violation|0|||
162138211|NCT04319094|585557294|FG001|Baseline|Protocol Violation|3|||
162138212|NCT04319094|585557293|FG000|Baseline|Withdrawal by Subject|2|||
162138213|NCT04319094|585557294|FG001|Baseline|Withdrawal by Subject|1|||
161903431|NCT01656395|584694852|FG005|Overall Study|Lost to Follow-up|0|||
161799401|NCT01089647|584309247|FG000|Overall Study|Adverse Event|0|||
161799402|NCT01089647|584309248|FG001|Overall Study|Adverse Event|1|||
161799403|NCT01531205|584309249|FG000|Overall Study|Did not proceed to surgery|1|||
161799404|NCT02001558|584309252|FG000|Overall Study|Lost to Follow-up|8|||
161799405|NCT02001558|584309253|FG001|Overall Study|Lost to Follow-up|14|||
161799406|NCT01457053|584309255|FG000|Overall Study|Unable to undergo selected treatment|1|||
161799407|NCT01457053|584309256|FG001|Overall Study|Unable to undergo selected treatment|1|||
161799408|NCT00984295|584309258|FG000|Overall Study|Lost to Follow-up|31|||
161799409|NCT00984295|584309259|FG001|Overall Study|Lost to Follow-up|12|||
161799410|NCT00984295|584309260|FG002|Overall Study|Lost to Follow-up|13|||
161799411|NCT00984295|584309258|FG000|Overall Study|Protocol Violation|2|||
161799412|NCT00984295|584309259|FG001|Overall Study|Protocol Violation|1|||
161799413|NCT00984295|584309260|FG002|Overall Study|Protocol Violation|4|||
161799414|NCT00984295|584309258|FG000|Overall Study|Withdrawal by Subject|18|||
161799415|NCT00984295|584309259|FG001|Overall Study|Withdrawal by Subject|9|||
161799416|NCT00984295|584309260|FG002|Overall Study|Withdrawal by Subject|12|||
161799417|NCT00984295|584309258|FG000|Overall Study|CAE - discontinued test vaccine|0|||
161799418|NCT00984295|584309259|FG001|Overall Study|CAE - discontinued test vaccine|1|||
161799419|NCT00984295|584309260|FG002|Overall Study|CAE - discontinued test vaccine|3|||
161799420|NCT00984295|584309258|FG000|Overall Study|Missed one or more blood samplings|3|||
161799421|NCT00984295|584309259|FG001|Overall Study|Missed one or more blood samplings|7|||
161799422|NCT00984295|584309260|FG002|Overall Study|Missed one or more blood samplings|2|||
161799423|NCT00984295|584309258|FG000|Overall Study|Incomplete safety follow-up|11|||
161799424|NCT00984295|584309259|FG001|Overall Study|Incomplete safety follow-up|2|||
161799425|NCT00984295|584309260|FG002|Overall Study|Incomplete safety follow-up|3|||
161799426|NCT02364557|584309261|FG000|Overall Study|Protocol Violation|3|||
161799427|NCT02364557|584309262|FG001|Overall Study|Protocol Violation|1|||
161799428|NCT04347239|584309263|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
161799429|NCT04347239|584309264|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
161799430|NCT04347239|584309265|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
161799431|NCT04347239|584309263|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
161799432|NCT04347239|584309264|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
161799433|NCT04347239|584309265|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
161799434|NCT04582539|584309266|FG000|Overall Study|Death|1|||
161799435|NCT04582539|584309267|FG001|Overall Study|Death|1|||
161799436|NCT04582539|584309268|FG002|Overall Study|Death|0|||
161799437|NCT04582539|584309269|FG003|Overall Study|Death|1|||
161799438|NCT04582539|584309270|FG004|Overall Study|Death|0|||
161799439|NCT04582539|584309266|FG000|Overall Study|Lost to Follow-up|1|||
161799440|NCT04582539|584309267|FG001|Overall Study|Lost to Follow-up|0|||
161799441|NCT04582539|584309268|FG002|Overall Study|Lost to Follow-up|0|||
161799442|NCT04582539|584309269|FG003|Overall Study|Lost to Follow-up|0|||
161799443|NCT04582539|584309270|FG004|Overall Study|Lost to Follow-up|0|||
161799444|NCT04582539|584309266|FG000|Overall Study|Study Terminated by Sponsor|1|||
161799445|NCT04582539|584309267|FG001|Overall Study|Study Terminated by Sponsor|3|||
161799446|NCT04582539|584309268|FG002|Overall Study|Study Terminated by Sponsor|2|||
161799447|NCT04582539|584309269|FG003|Overall Study|Study Terminated by Sponsor|2|||
161799448|NCT04582539|584309270|FG004|Overall Study|Study Terminated by Sponsor|3|||
161799449|NCT04582539|584309266|FG000|Overall Study|Physician Decision|0|||
161903432|NCT01656395|584694853|FG006|Overall Study|Lost to Follow-up|0|||
161799450|NCT04582539|584309267|FG001|Overall Study|Physician Decision|1|||
161799451|NCT04582539|584309268|FG002|Overall Study|Physician Decision|0|||
161799452|NCT04582539|584309269|FG003|Overall Study|Physician Decision|0|||
161799453|NCT04582539|584309270|FG004|Overall Study|Physician Decision|0|||
161799454|NCT04582539|584309266|FG000|Overall Study|Withdrawal by Subject|1|||
161799455|NCT04582539|584309267|FG001|Overall Study|Withdrawal by Subject|0|||
161903433|NCT01656395|584694854|FG007|Overall Study|Lost to Follow-up|0|||
161903434|NCT01656395|584694847|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161903435|NCT01656395|584694848|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161903436|NCT01656395|584694849|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161903437|NCT01656395|584694850|FG003|Overall Study|Non-Compliance with Study Drug|0|||
161903438|NCT01656395|584694851|FG004|Overall Study|Non-Compliance with Study Drug|1|||
161903439|NCT01656395|584694852|FG005|Overall Study|Non-Compliance with Study Drug|1|||
161903440|NCT01656395|584694853|FG006|Overall Study|Non-Compliance with Study Drug|0|||
161903441|NCT01656395|584694854|FG007|Overall Study|Non-Compliance with Study Drug|0|||
161903442|NCT01656395|584694847|FG000|Overall Study|Other|0|||
161903443|NCT01656395|584694848|FG001|Overall Study|Other|0|||
161903444|NCT01656395|584694849|FG002|Overall Study|Other|1|||
161903445|NCT01656395|584694850|FG003|Overall Study|Other|0|||
161903446|NCT01656395|584694851|FG004|Overall Study|Other|0|||
161903447|NCT01656395|584694852|FG005|Overall Study|Other|1|||
161903448|NCT01656395|584694853|FG006|Overall Study|Other|0|||
161903449|NCT01656395|584694854|FG007|Overall Study|Other|0|||
161903450|NCT01656395|584694847|FG000|Overall Study|Physician Decision|2|||
161903451|NCT01656395|584694848|FG001|Overall Study|Physician Decision|3|||
161903452|NCT01656395|584694849|FG002|Overall Study|Physician Decision|3|||
161903453|NCT01656395|584694850|FG003|Overall Study|Physician Decision|2|||
161903454|NCT01656395|584694851|FG004|Overall Study|Physician Decision|3|||
161903455|NCT01656395|584694852|FG005|Overall Study|Physician Decision|3|||
161903456|NCT01656395|584694853|FG006|Overall Study|Physician Decision|0|||
161903457|NCT01656395|584694854|FG007|Overall Study|Physician Decision|0|||
161903458|NCT01656395|584694847|FG000|Overall Study|Pregnancy|0|||
161903459|NCT01656395|584694848|FG001|Overall Study|Pregnancy|0|||
161903460|NCT01656395|584694849|FG002|Overall Study|Pregnancy|1|||
161903461|NCT01656395|584694850|FG003|Overall Study|Pregnancy|0|||
161903462|NCT01656395|584694851|FG004|Overall Study|Pregnancy|0|||
161903463|NCT01656395|584694852|FG005|Overall Study|Pregnancy|0|||
161903464|NCT01656395|584694853|FG006|Overall Study|Pregnancy|0|||
162138214|NCT04319094|585557293|FG000|Post-Intervention|Death|0|||
162138215|NCT04319094|585557294|FG001|Post-Intervention|Death|1|||
162138216|NCT04319094|585557293|FG000|Post-Intervention|Lost to Follow-up|4|||
162138217|NCT04319094|585557294|FG001|Post-Intervention|Lost to Follow-up|4|||
162138218|NCT04319094|585557293|FG000|Post-Intervention|Withdrawal by Subject|8|||
162138219|NCT04319094|585557294|FG001|Post-Intervention|Withdrawal by Subject|5|||
162138220|NCT04319094|585557293|FG000|Post-Intervention|Incomplete Data Collection|1|||
162138221|NCT04319094|585557294|FG001|Post-Intervention|Incomplete Data Collection|3|||
162138222|NCT04319094|585557293|FG000|3-month|Death|1|||
162138223|NCT04319094|585557294|FG001|3-month|Death|0|||
162138224|NCT04319094|585557293|FG000|3-month|Lost to Follow-up|2|||
162138225|NCT04319094|585557294|FG001|3-month|Lost to Follow-up|2|||
162138226|NCT04319094|585557293|FG000|3-month|Withdrawal by Subject|0|||
162138227|NCT04319094|585557294|FG001|3-month|Withdrawal by Subject|3|||
162138228|NCT04319094|585557293|FG000|3-month|Incomplete data collection|9|||
162138229|NCT04319094|585557294|FG001|3-month|Incomplete data collection|7|||
162138230|NCT04319094|585557293|FG000|6-month|Lost to Follow-up|1|||
162138231|NCT04319094|585557294|FG001|6-month|Lost to Follow-up|1|||
162138232|NCT04319094|585557293|FG000|6-month|Withdrawal by Subject|0|||
162138233|NCT04319094|585557294|FG001|6-month|Withdrawal by Subject|3|||
162138234|NCT04319094|585557293|FG000|6-month|Incomplete data collection|14|||
162138235|NCT04319094|585557294|FG001|6-month|Incomplete data collection|9|||
162138236|NCT04319094|585557293|FG000|9-month|Lost to Follow-up|8|||
162138237|NCT04319094|585557294|FG001|9-month|Lost to Follow-up|4|||
162138238|NCT04319094|585557293|FG000|9-month|Withdrawal by Subject|0|||
162138239|NCT04319094|585557294|FG001|9-month|Withdrawal by Subject|1|||
162138240|NCT04319094|585557293|FG000|9-month|Incomplete data collection|8|||
162138241|NCT04319094|585557294|FG001|9-month|Incomplete data collection|5|||
162138242|NCT04319094|585557293|FG000|12-month|Lost to Follow-up|11|||
162138243|NCT04319094|585557294|FG001|12-month|Lost to Follow-up|8|||
162138244|NCT00654238|585557298|FG000|Overall Study|Screen Failures|4|||
162138245|NCT03905135|585557300|FG000|Dose Escalation|Adverse Event|1|||
162138246|NCT03905135|585557301|FG001|Dose Escalation|Adverse Event|1|||
162138247|NCT03905135|585557300|FG000|Dose Escalation|Progressive disease|3|||
162138248|NCT03905135|585557301|FG001|Dose Escalation|Progressive disease|1|||
161903465|NCT01656395|584694854|FG007|Overall Study|Pregnancy|0|||
161903466|NCT01656395|584694847|FG000|Overall Study|Progressive Disease|0|||
161903467|NCT01656395|584694848|FG001|Overall Study|Progressive Disease|0|||
161903468|NCT01656395|584694849|FG002|Overall Study|Progressive Disease|0|||
161903469|NCT01656395|584694850|FG003|Overall Study|Progressive Disease|0|||
161903470|NCT01656395|584694851|FG004|Overall Study|Progressive Disease|0|||
162138249|NCT03905135|585557300|FG000|Dose Escalation|Intercurrent illness|1|||
162138250|NCT03905135|585557301|FG001|Dose Escalation|Intercurrent illness|0|||
162138251|NCT04523181|585557302|FG000|Overall Study|Withdrawal by Subject|4|||
162138252|NCT04523181|585557303|FG001|Overall Study|Withdrawal by Subject|5|||
162138253|NCT04523181|585557302|FG000|Overall Study|Lost to Follow-up|2|||
161903471|NCT01656395|584694852|FG005|Overall Study|Progressive Disease|1|||
161903472|NCT01656395|584694853|FG006|Overall Study|Progressive Disease|0|||
161903473|NCT01656395|584694854|FG007|Overall Study|Progressive Disease|0|||
161799456|NCT04582539|584309268|FG002|Overall Study|Withdrawal by Subject|2|||
161799457|NCT04582539|584309269|FG003|Overall Study|Withdrawal by Subject|1|||
161799458|NCT04582539|584309270|FG004|Overall Study|Withdrawal by Subject|0|||
161799459|NCT04582539|584309266|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
161799460|NCT04582539|584309267|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
161799461|NCT04582539|584309268|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
161799462|NCT04582539|584309269|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
161799463|NCT04582539|584309270|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
161799464|NCT00788957|584309279|FG000|Part 1|Death|8|||
161799465|NCT00788957|584309280|FG001|Part 1|Death|0|||
161799466|NCT00788957|584309281|FG002|Part 1|Death|0|||
161799467|NCT00788957|584309282|FG003|Part 1|Death|0|||
161799468|NCT00788957|584309283|FG004|Part 1|Death|0|||
161799469|NCT00788957|584309284|FG005|Part 1|Death|0|||
161799470|NCT00788957|584309279|FG000|Part 1|Lost to Follow-up|1|||
161799471|NCT00788957|584309280|FG001|Part 1|Lost to Follow-up|0|||
161799472|NCT00788957|584309281|FG002|Part 1|Lost to Follow-up|0|||
161799473|NCT00788957|584309282|FG003|Part 1|Lost to Follow-up|0|||
161799474|NCT00788957|584309283|FG004|Part 1|Lost to Follow-up|0|||
161799475|NCT00788957|584309284|FG005|Part 1|Lost to Follow-up|0|||
161799476|NCT00788957|584309279|FG000|Part 2|Withdrawal by Subject|0|||
161799477|NCT00788957|584309280|FG001|Part 2|Withdrawal by Subject|9|||
161799478|NCT00788957|584309281|FG002|Part 2|Withdrawal by Subject|5|||
161799479|NCT00788957|584309282|FG003|Part 2|Withdrawal by Subject|3|||
161799480|NCT00788957|584309283|FG004|Part 2|Withdrawal by Subject|0|||
161799481|NCT00788957|584309284|FG005|Part 2|Withdrawal by Subject|0|||
161799482|NCT00788957|584309279|FG000|Part 2|Death|0|||
161799483|NCT00788957|584309280|FG001|Part 2|Death|32|||
161799484|NCT00788957|584309281|FG002|Part 2|Death|35|||
161799485|NCT00788957|584309282|FG003|Part 2|Death|37|||
161799486|NCT00788957|584309283|FG004|Part 2|Death|0|||
161799487|NCT00788957|584309284|FG005|Part 2|Death|0|||
161799488|NCT00788957|584309279|FG000|Part 2|Lost to Follow-up|0|||
161799489|NCT00788957|584309280|FG001|Part 2|Lost to Follow-up|0|||
161799490|NCT00788957|584309281|FG002|Part 2|Lost to Follow-up|3|||
161799491|NCT00788957|584309282|FG003|Part 2|Lost to Follow-up|0|||
161799492|NCT00788957|584309283|FG004|Part 2|Lost to Follow-up|0|||
161799493|NCT00788957|584309284|FG005|Part 2|Lost to Follow-up|0|||
161903474|NCT01656395|584694847|FG000|Overall Study|Protocol Violation|6|||
161799494|NCT00788957|584309279|FG000|Part 2|On-study at time of data cut-off|0|||
161799495|NCT00788957|584309280|FG001|Part 2|On-study at time of data cut-off|1|||
161799496|NCT00788957|584309281|FG002|Part 2|On-study at time of data cut-off|1|||
161799497|NCT00788957|584309282|FG003|Part 2|On-study at time of data cut-off|1|||
161799498|NCT00788957|584309283|FG004|Part 2|On-study at time of data cut-off|0|||
161903475|NCT01656395|584694848|FG001|Overall Study|Protocol Violation|6|||
161799499|NCT00788957|584309284|FG005|Part 2|On-study at time of data cut-off|0|||
161799500|NCT00788957|584309279|FG000|Part 3|Withdrawal by Subject|0|||
161799501|NCT00788957|584309280|FG001|Part 3|Withdrawal by Subject|0|||
161799502|NCT00788957|584309281|FG002|Part 3|Withdrawal by Subject|0|||
161799503|NCT00788957|584309282|FG003|Part 3|Withdrawal by Subject|0|||
161799504|NCT00788957|584309283|FG004|Part 3|Withdrawal by Subject|0|||
161799505|NCT00788957|584309284|FG005|Part 3|Withdrawal by Subject|2|||
161799506|NCT00788957|584309279|FG000|Part 3|Death|0|||
161799507|NCT00788957|584309280|FG001|Part 3|Death|0|||
161799508|NCT00788957|584309281|FG002|Part 3|Death|0|||
161799509|NCT00788957|584309282|FG003|Part 3|Death|0|||
161799510|NCT00788957|584309283|FG004|Part 3|Death|8|||
161799511|NCT00788957|584309284|FG005|Part 3|Death|8|||
161799512|NCT00788957|584309279|FG000|Part 3|On-study at time of data cut-off|0|||
161799513|NCT00788957|584309280|FG001|Part 3|On-study at time of data cut-off|0|||
161799514|NCT00788957|584309281|FG002|Part 3|On-study at time of data cut-off|0|||
161799515|NCT00788957|584309282|FG003|Part 3|On-study at time of data cut-off|0|||
161799516|NCT00788957|584309283|FG004|Part 3|On-study at time of data cut-off|1|||
161799517|NCT00788957|584309284|FG005|Part 3|On-study at time of data cut-off|0|||
161799518|NCT00662129|584309285|FG000|Overall Study|Protocol Violation|1|||
161799519|NCT00662129|584309285|FG000|Overall Study|Cancel prior to beginning treatment|1|||
161799520|NCT00662129|584309285|FG000|Overall Study|Ineligible|1|||
161799521|NCT00796510|584309298|FG000|Overall Study|Death|1|||
161799522|NCT00796510|584309299|FG001|Overall Study|Death|0|||
161799523|NCT00796510|584309298|FG000|Overall Study|Study Terminated|2|||
161799524|NCT00796510|584309299|FG001|Overall Study|Study Terminated|0|||
161799525|NCT05030753|584309300|FG000|9-week|Lost to Follow-up|10|||
161799526|NCT05030753|584309301|FG001|9-week|Lost to Follow-up|7|||
161799527|NCT05030753|584309300|FG000|9-week|Withdrawal by Subject|1|||
161799528|NCT05030753|584309301|FG001|9-week|Withdrawal by Subject|0|||
161799529|NCT05030753|584309300|FG000|9-week|Excluded from analysis due to missing covariates|2|||
161799530|NCT05030753|584309301|FG001|9-week|Excluded from analysis due to missing covariates|1|||
161799531|NCT05030753|584309300|FG000|6-month post intervention|Lost to Follow-up|5|||
161799532|NCT05030753|584309301|FG001|6-month post intervention|Lost to Follow-up|4|||
161799533|NCT05030753|584309300|FG000|6-month post intervention|Withdrawal by Subject|4|||
161799534|NCT05030753|584309301|FG001|6-month post intervention|Withdrawal by Subject|0|||
161799535|NCT05030753|584309300|FG000|18-month post intervention|Lost to Follow-up|3|||
161799536|NCT05030753|584309301|FG001|18-month post intervention|Lost to Follow-up|1|||
161799537|NCT03072459|584309306|FG000|Overall Study|Device revised/removed|1|||
161799538|NCT03072459|584309306|FG000|Overall Study|Subject not able to return|1|||
161799539|NCT00329602|584309307|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
161799540|NCT00329602|584309308|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
161799541|NCT00329602|584309309|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
161799542|NCT00329602|584309307|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
161799543|NCT00329602|584309308|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
161799544|NCT00329602|584309309|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
161799545|NCT00329602|584309307|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
161799546|NCT00329602|584309308|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
161799547|NCT00329602|584309309|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
161799548|NCT00329602|584309307|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
161799549|NCT00329602|584309308|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
161799550|NCT00329602|584309309|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
161799551|NCT00329602|584309307|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
161799552|NCT00329602|584309308|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
161799553|NCT00329602|584309309|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
161799554|NCT00329602|584309307|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
161799555|NCT00329602|584309308|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
161799556|NCT00329602|584309309|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
161799557|NCT02579096|584309310|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
161799558|NCT02579096|584309311|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
161799559|NCT02579096|584309310|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
161799560|NCT02579096|584309311|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
161799561|NCT02579096|584309310|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
161799562|NCT02579096|584309311|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
161799563|NCT02579096|584309310|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
161903476|NCT01656395|584694849|FG002|Overall Study|Protocol Violation|9|||
161799564|NCT02579096|584309311|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
161799565|NCT02579096|584309310|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
161799566|NCT02579096|584309311|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
161799567|NCT02579096|584309310|FG000|Phase 2, Weeks 25 - 48|Death|2|||
161799568|NCT02579096|584309311|FG001|Phase 2, Weeks 25 - 48|Death|4|||
161903477|NCT01656395|584694850|FG003|Overall Study|Protocol Violation|2|||
161799569|NCT02579096|584309310|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
161903478|NCT01656395|584694851|FG004|Overall Study|Protocol Violation|4|||
161903479|NCT01656395|584694852|FG005|Overall Study|Protocol Violation|10|||
161903480|NCT01656395|584694853|FG006|Overall Study|Protocol Violation|0|||
161903481|NCT01656395|584694854|FG007|Overall Study|Protocol Violation|0|||
161903482|NCT01656395|584694847|FG000|Overall Study|Screen Failure|2|||
161903483|NCT01656395|584694848|FG001|Overall Study|Screen Failure|1|||
161903484|NCT01656395|584694849|FG002|Overall Study|Screen Failure|7|||
161903485|NCT01656395|584694850|FG003|Overall Study|Screen Failure|1|||
161903486|NCT01656395|584694851|FG004|Overall Study|Screen Failure|0|||
161903487|NCT01656395|584694852|FG005|Overall Study|Screen Failure|8|||
161903488|NCT01656395|584694853|FG006|Overall Study|Screen Failure|0|||
161903489|NCT01656395|584694854|FG007|Overall Study|Screen Failure|0|||
161903490|NCT01656395|584694847|FG000|Overall Study|Withdrawal by Subject|3|||
161903491|NCT01656395|584694848|FG001|Overall Study|Withdrawal by Subject|1|||
161903492|NCT01656395|584694849|FG002|Overall Study|Withdrawal by Subject|4|||
161903493|NCT01656395|584694850|FG003|Overall Study|Withdrawal by Subject|2|||
161903494|NCT01656395|584694851|FG004|Overall Study|Withdrawal by Subject|0|||
161903495|NCT01656395|584694852|FG005|Overall Study|Withdrawal by Subject|3|||
161903496|NCT01656395|584694853|FG006|Overall Study|Withdrawal by Subject|0|||
161903497|NCT01656395|584694854|FG007|Overall Study|Withdrawal by Subject|0|||
161903498|NCT00230048|584694858|FG000|Overall Study|Lost to Follow-up|13|||
161903499|NCT00230048|584694859|FG001|Overall Study|Lost to Follow-up|18|||
161903500|NCT00676403|584694860|FG000|Overall Study|Adverse Event|1|||
161903501|NCT00676403|584694861|FG001|Overall Study|Adverse Event|2|||
161903502|NCT00676403|584694862|FG002|Overall Study|Adverse Event|0|||
161903503|NCT00676403|584694863|FG003|Overall Study|Adverse Event|5|||
161799570|NCT02579096|584309311|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
161799571|NCT02579096|584309310|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
161799572|NCT02579096|584309311|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
161799573|NCT02579096|584309310|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
161799574|NCT02579096|584309311|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
161799575|NCT02579096|584309310|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
161799576|NCT02579096|584309311|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
161799577|NCT02579096|584309310|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
161799578|NCT02579096|584309311|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
161799579|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Death|3|||
161799580|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Death|2|||
161799581|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
161799582|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
161799583|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
161799584|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
161799585|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
161799586|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
161799587|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
161799588|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
161799589|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
161799590|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
161799591|NCT02579096|584309310|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
161799592|NCT02579096|584309311|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
161799593|NCT02097121|584309316|FG000|Overall Study|Other, not specified|4|||
161799594|NCT02097121|584309317|FG001|Overall Study|Other, not specified|2|||
161799595|NCT02097121|584309318|FG002|Overall Study|Other, not specified|3|||
161799596|NCT02097121|584309316|FG000|Overall Study|Lack of Efficacy|2|||
161799597|NCT02097121|584309317|FG001|Overall Study|Lack of Efficacy|1|||
161799598|NCT02097121|584309318|FG002|Overall Study|Lack of Efficacy|3|||
161799599|NCT02097121|584309316|FG000|Overall Study|Withdrawal by Subject|0|||
161799600|NCT02097121|584309317|FG001|Overall Study|Withdrawal by Subject|1|||
161799601|NCT02097121|584309318|FG002|Overall Study|Withdrawal by Subject|2|||
161799602|NCT02097121|584309316|FG000|Overall Study|Adverse Event|0|||
161799603|NCT02097121|584309317|FG001|Overall Study|Adverse Event|1|||
161799604|NCT02097121|584309318|FG002|Overall Study|Adverse Event|0|||
161799605|NCT02097121|584309316|FG000|Overall Study|Lost to Follow-up|1|||
161799606|NCT02097121|584309317|FG001|Overall Study|Lost to Follow-up|1|||
161799607|NCT02097121|584309318|FG002|Overall Study|Lost to Follow-up|2|||
161903504|NCT00676403|584694864|FG004|Overall Study|Adverse Event|1|||
161903505|NCT00676403|584694865|FG005|Overall Study|Adverse Event|2|||
161903506|NCT00676403|584694860|FG000|Overall Study|Lost to Follow-up|0|||
161903507|NCT00676403|584694861|FG001|Overall Study|Lost to Follow-up|0|||
161903508|NCT00676403|584694862|FG002|Overall Study|Lost to Follow-up|0|||
161903509|NCT00676403|584694863|FG003|Overall Study|Lost to Follow-up|0|||
161799608|NCT00510510|584309319|FG000|Overall Study|Adverse Event|4|||
161799609|NCT00510510|584309320|FG001|Overall Study|Adverse Event|3|||
161799610|NCT00510510|584309321|FG002|Overall Study|Adverse Event|6|||
161799611|NCT00510510|584309319|FG000|Overall Study|Lack of Efficacy|0|||
161799612|NCT00510510|584309320|FG001|Overall Study|Lack of Efficacy|1|||
161799613|NCT00510510|584309321|FG002|Overall Study|Lack of Efficacy|1|||
161799614|NCT00510510|584309319|FG000|Overall Study|Subjects no longer requires study drug|0|||
161799615|NCT00510510|584309320|FG001|Overall Study|Subjects no longer requires study drug|0|||
161799616|NCT00510510|584309321|FG002|Overall Study|Subjects no longer requires study drug|2|||
161799617|NCT00510510|584309319|FG000|Overall Study|Withdrawal by Subject|1|||
161799618|NCT00510510|584309320|FG001|Overall Study|Withdrawal by Subject|2|||
161799619|NCT00510510|584309321|FG002|Overall Study|Withdrawal by Subject|3|||
161799620|NCT00510510|584309319|FG000|Overall Study|Lost to Follow-up|0|||
161799621|NCT00510510|584309320|FG001|Overall Study|Lost to Follow-up|0|||
161799622|NCT00510510|584309321|FG002|Overall Study|Lost to Follow-up|1|||
161799623|NCT00510510|584309319|FG000|Overall Study|Protocol Violation|0|||
161799624|NCT00510510|584309320|FG001|Overall Study|Protocol Violation|3|||
161799625|NCT00510510|584309321|FG002|Overall Study|Protocol Violation|4|||
161799626|NCT03595657|584309322|FG000|Overall Study|Adverse Event|14|||
161799627|NCT03595657|584309322|FG000|Overall Study|Death|1|||
161799628|NCT03595657|584309322|FG000|Overall Study|Lack of Efficacy|40|||
161799629|NCT03595657|584309322|FG000|Overall Study|Withdrawal by Subject|10|||
161799630|NCT03595657|584309322|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
161799631|NCT03595657|584309322|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
161799632|NCT01066052|584309323|FG000|Overall Study|Enrolled But Not Treated|3|||
161799633|NCT01066052|584309324|FG001|Overall Study|Enrolled But Not Treated|0|||
161799634|NCT01200394|584309325|FG000|Overall Study|Adverse Event|0|||
161799635|NCT01200394|584309326|FG001|Overall Study|Adverse Event|14|||
161799636|NCT01200394|584309325|FG000|Overall Study|Death|1|||
161799637|NCT01200394|584309326|FG001|Overall Study|Death|0|||
161799638|NCT01200394|584309325|FG000|Overall Study|Lost to Follow-up|0|||
161799639|NCT01200394|584309326|FG001|Overall Study|Lost to Follow-up|1|||
161799640|NCT01200394|584309325|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
161799641|NCT01200394|584309326|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
161799642|NCT01200394|584309325|FG000|Overall Study|Protocol Violation|0|||
161799643|NCT01200394|584309326|FG001|Overall Study|Protocol Violation|3|||
161799644|NCT01200394|584309325|FG000|Overall Study|Withdrawal by Subject|0|||
161799645|NCT01200394|584309326|FG001|Overall Study|Withdrawal by Subject|5|||
161799646|NCT01200394|584309325|FG000|Overall Study|Other|0|||
161799647|NCT01200394|584309326|FG001|Overall Study|Other|1|||
161799648|NCT01835145|584309329|FG000|Overall Study|Ineligible prior to treatment|1|||
161799649|NCT01835145|584309330|FG001|Overall Study|Ineligible prior to treatment|0|||
161799650|NCT02729896|584309331|FG000|Overall Study|Death|0|||
161799651|NCT02729896|584309332|FG001|Overall Study|Death|2|||
161799652|NCT02729896|584309333|FG002|Overall Study|Death|13|||
161799653|NCT02729896|584309331|FG000|Overall Study|Lost to Follow-up|0|||
161799654|NCT02729896|584309332|FG001|Overall Study|Lost to Follow-up|2|||
161799655|NCT02729896|584309333|FG002|Overall Study|Lost to Follow-up|3|||
161799656|NCT02729896|584309331|FG000|Overall Study|Other|0|||
162138254|NCT04523181|585557303|FG001|Overall Study|Lost to Follow-up|3|||
162138255|NCT04523181|585557302|FG000|Overall Study|Physician Decision|1|||
162138256|NCT04523181|585557303|FG001|Overall Study|Physician Decision|0|||
162138257|NCT04523181|585557302|FG000|Overall Study|Transferred to external facility.|1|||
162138258|NCT04523181|585557303|FG001|Overall Study|Transferred to external facility.|1|||
162138259|NCT02042443|585557306|FG000|Overall Study|Adverse Event|2|||
162138260|NCT02042443|585557307|FG001|Overall Study|Adverse Event|1|||
162138261|NCT02042443|585557306|FG000|Overall Study|Withdrawal by Subject|0|||
162138262|NCT02042443|585557307|FG001|Overall Study|Withdrawal by Subject|1|||
162138263|NCT02042443|585557306|FG000|Overall Study|Progression|21|||
162138264|NCT02042443|585557307|FG001|Overall Study|Progression|17|||
162138265|NCT02042443|585557306|FG000|Overall Study|not protocol specified|1|||
162138266|NCT02042443|585557307|FG001|Overall Study|not protocol specified|1|||
162138267|NCT02042443|585557306|FG000|Overall Study|Not eligible/not analyzable|3|||
162138268|NCT02042443|585557307|FG001|Overall Study|Not eligible/not analyzable|6|||
161799657|NCT02729896|584309332|FG001|Overall Study|Other|2|||
161799658|NCT02729896|584309333|FG002|Overall Study|Other|0|||
161799659|NCT02729896|584309331|FG000|Overall Study|Physician Decision|1|||
161799660|NCT02729896|584309332|FG001|Overall Study|Physician Decision|2|||
161799661|NCT02729896|584309333|FG002|Overall Study|Physician Decision|3|||
161799662|NCT02729896|584309331|FG000|Overall Study|Progressive Disease|0|||
161799663|NCT02729896|584309332|FG001|Overall Study|Progressive Disease|1|||
161799664|NCT02729896|584309333|FG002|Overall Study|Progressive Disease|0|||
162138269|NCT01649427|585557308|FG000|Overall Study|Adverse Event|1|||
161799665|NCT02729896|584309331|FG000|Overall Study|Withdrawal by Subject|1|||
161799666|NCT02729896|584309332|FG001|Overall Study|Withdrawal by Subject|0|||
161799667|NCT02729896|584309333|FG002|Overall Study|Withdrawal by Subject|3|||
161799668|NCT04094870|584309334|FG000|Overall Study|Lost to Follow-up|1|||
162138270|NCT01649427|585557309|FG001|Overall Study|Adverse Event|1|||
161903510|NCT00676403|584694864|FG004|Overall Study|Lost to Follow-up|0|||
161903511|NCT00676403|584694865|FG005|Overall Study|Lost to Follow-up|1|||
161903512|NCT00676403|584694860|FG000|Overall Study|Reason Unspecified|1|||
161903513|NCT00676403|584694861|FG001|Overall Study|Reason Unspecified|0|||
161903514|NCT00676403|584694862|FG002|Overall Study|Reason Unspecified|1|||
161903515|NCT00676403|584694863|FG003|Overall Study|Reason Unspecified|0|||
161903516|NCT00676403|584694864|FG004|Overall Study|Reason Unspecified|0|||
161903517|NCT00676403|584694865|FG005|Overall Study|Reason Unspecified|1|||
161903518|NCT00676403|584694860|FG000|Overall Study|Withdrawal by Subject|0|||
161903519|NCT00676403|584694861|FG001|Overall Study|Withdrawal by Subject|0|||
161903520|NCT00676403|584694862|FG002|Overall Study|Withdrawal by Subject|0|||
161903521|NCT00676403|584694863|FG003|Overall Study|Withdrawal by Subject|0|||
161903522|NCT00676403|584694864|FG004|Overall Study|Withdrawal by Subject|0|||
161903523|NCT00676403|584694865|FG005|Overall Study|Withdrawal by Subject|1|||
161903524|NCT03225170|584694866|FG000|Overall Study|Lost to Follow-up|4|||
161903525|NCT03225170|584694867|FG001|Overall Study|Lost to Follow-up|4|||
161903526|NCT03225170|584694868|FG002|Overall Study|Lost to Follow-up|0|||
161903527|NCT03225170|584694866|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
161903528|NCT03225170|584694867|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
161903529|NCT03225170|584694868|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
161903530|NCT01272908|584694869|FG000|Initial Treatment Period|Adverse Event|1|||
161903531|NCT01272908|584694869|FG000|Initial Treatment Period|Lack of Efficacy|5|||
161903532|NCT01272908|584694869|FG000|Initial Treatment Period|Protocol Violation|1|||
161903533|NCT01272908|584694869|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
161903534|NCT01272908|584694869|FG000|Re-Treatment Period|Adverse Event|2|||
161903535|NCT01272908|584694869|FG000|Re-Treatment Period|Lack of Efficacy|3|||
161903536|NCT01272908|584694869|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
161903537|NCT00971867|584694870|FG000|Overall Study|Adverse Event|4|||
161903538|NCT00971867|584694870|FG000|Overall Study|Participant Withdrew Consent|1|||
161903539|NCT00971867|584694870|FG000|Overall Study|Disease Progression|6|||
161903540|NCT04157088|584694882|FG000|Overall Study|Study terminated by sponsor|23|||
161903541|NCT04157088|584694882|FG000|Overall Study|Withdrawal by Subject|4|||
161903542|NCT04157088|584694882|FG000|Overall Study|Lost to Follow-up|2|||
161903543|NCT04157088|584694882|FG000|Overall Study|Death|1|||
161903544|NCT02421419|584694883|FG000|Overall Study|Physician Decision|0|||
161903545|NCT02421419|584694884|FG001|Overall Study|Physician Decision|0|||
161903546|NCT02421419|584694885|FG002|Overall Study|Physician Decision|1|||
161903547|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
161903548|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
161903549|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Adverse Event|57|||
161903550|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Adverse Event|49|||
161903551|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
161903552|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
161903553|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Site closure|3|||
161903554|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Site closure|2|||
161903555|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
161903556|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
161903557|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Physician Decision|48|||
161903558|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Physician Decision|38|||
161903559|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
161903560|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
161903561|NCT01705977|584694886|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
161903562|NCT01705977|584694887|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
161903563|NCT01705977|584694886|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
161903564|NCT01705977|584694887|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
161903565|NCT01705977|584694886|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
161903566|NCT01705977|584694887|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
161903567|NCT01705977|584694886|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
161903568|NCT01705977|584694887|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
161903569|NCT01705977|584694886|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
161903570|NCT01705977|584694887|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
161903571|NCT05067972|584694888|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
161903572|NCT05067972|584694889|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
161903573|NCT05067972|584694890|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
161903574|NCT05067972|584694891|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
161903575|NCT05067972|584694892|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
162010882|NCT02594124|585096047|FG004|Overall Study|Adverse Event|0|||
162138271|NCT01649427|585557308|FG000|Overall Study|Withdrawal by Subject|8|||
162138272|NCT01649427|585557309|FG001|Overall Study|Withdrawal by Subject|7|||
162138273|NCT01649427|585557308|FG000|Overall Study|Lost to Follow-up|0|||
162138274|NCT01649427|585557309|FG001|Overall Study|Lost to Follow-up|1|||
162138275|NCT01649427|585557308|FG000|Overall Study|Graft loss|0|||
162138276|NCT01649427|585557309|FG001|Overall Study|Graft loss|1|||
162138277|NCT01649427|585557308|FG000|Overall Study|Surgical problems during nephrectomy|2|||
161799669|NCT04094870|584309335|FG001|Overall Study|Lost to Follow-up|1|||
161799670|NCT02708277|584309337|FG000|Overall Study|Lost to Follow-up|7|||
161799671|NCT02708277|584309338|FG001|Overall Study|Lost to Follow-up|4|||
161799672|NCT01592370|584309341|FG000|Overall Study|Disease Progression|62|||
161799673|NCT01592370|584309342|FG001|Overall Study|Disease Progression|16|||
161799674|NCT01592370|584309343|FG002|Overall Study|Disease Progression|52|||
161799675|NCT01592370|584309344|FG003|Overall Study|Disease Progression|3|||
161799676|NCT01592370|584309345|FG004|Overall Study|Disease Progression|3|||
161799677|NCT01592370|584309346|FG005|Overall Study|Disease Progression|31|||
161799678|NCT01592370|584309347|FG006|Overall Study|Disease Progression|14|||
161799679|NCT01592370|584309341|FG000|Overall Study|Study Drug Toxicity|14|||
161799680|NCT01592370|584309342|FG001|Overall Study|Study Drug Toxicity|3|||
161799681|NCT01592370|584309343|FG002|Overall Study|Study Drug Toxicity|0|||
161799682|NCT01592370|584309344|FG003|Overall Study|Study Drug Toxicity|0|||
161799683|NCT01592370|584309345|FG004|Overall Study|Study Drug Toxicity|0|||
161799684|NCT01592370|584309346|FG005|Overall Study|Study Drug Toxicity|0|||
161799685|NCT01592370|584309347|FG006|Overall Study|Study Drug Toxicity|1|||
161799686|NCT01592370|584309341|FG000|Overall Study|AE unrelated to study drug|4|||
161799687|NCT01592370|584309342|FG001|Overall Study|AE unrelated to study drug|3|||
161799688|NCT01592370|584309343|FG002|Overall Study|AE unrelated to study drug|0|||
161799689|NCT01592370|584309344|FG003|Overall Study|AE unrelated to study drug|0|||
161799690|NCT01592370|584309345|FG004|Overall Study|AE unrelated to study drug|0|||
161799691|NCT01592370|584309346|FG005|Overall Study|AE unrelated to study drug|0|||
161799692|NCT01592370|584309347|FG006|Overall Study|AE unrelated to study drug|1|||
161799693|NCT01592370|584309341|FG000|Overall Study|Request to discontinue study treatment|5|||
161799694|NCT01592370|584309342|FG001|Overall Study|Request to discontinue study treatment|0|||
161799695|NCT01592370|584309343|FG002|Overall Study|Request to discontinue study treatment|2|||
161799696|NCT01592370|584309344|FG003|Overall Study|Request to discontinue study treatment|0|||
161799697|NCT01592370|584309345|FG004|Overall Study|Request to discontinue study treatment|1|||
161799698|NCT01592370|584309346|FG005|Overall Study|Request to discontinue study treatment|2|||
161799699|NCT01592370|584309347|FG006|Overall Study|Request to discontinue study treatment|0|||
161799700|NCT01592370|584309341|FG000|Overall Study|Withdrew consent|1|||
161799701|NCT01592370|584309342|FG001|Overall Study|Withdrew consent|2|||
161799702|NCT01592370|584309343|FG002|Overall Study|Withdrew consent|1|||
161799703|NCT01592370|584309344|FG003|Overall Study|Withdrew consent|1|||
161799704|NCT01592370|584309345|FG004|Overall Study|Withdrew consent|0|||
161799705|NCT01592370|584309346|FG005|Overall Study|Withdrew consent|0|||
161799706|NCT01592370|584309347|FG006|Overall Study|Withdrew consent|0|||
161799707|NCT01592370|584309341|FG000|Overall Study|Maximum clinical benefit|11|||
161799708|NCT01592370|584309342|FG001|Overall Study|Maximum clinical benefit|1|||
161799709|NCT01592370|584309343|FG002|Overall Study|Maximum clinical benefit|7|||
161799710|NCT01592370|584309344|FG003|Overall Study|Maximum clinical benefit|1|||
161799711|NCT01592370|584309345|FG004|Overall Study|Maximum clinical benefit|0|||
161799712|NCT01592370|584309346|FG005|Overall Study|Maximum clinical benefit|0|||
161799713|NCT01592370|584309347|FG006|Overall Study|Maximum clinical benefit|0|||
161799714|NCT01592370|584309341|FG000|Overall Study|No longer meets study criteria|1|||
161799715|NCT01592370|584309342|FG001|Overall Study|No longer meets study criteria|0|||
161799716|NCT01592370|584309343|FG002|Overall Study|No longer meets study criteria|0|||
161799717|NCT01592370|584309344|FG003|Overall Study|No longer meets study criteria|0|||
161799718|NCT01592370|584309345|FG004|Overall Study|No longer meets study criteria|0|||
161799719|NCT01592370|584309346|FG005|Overall Study|No longer meets study criteria|0|||
161799720|NCT01592370|584309347|FG006|Overall Study|No longer meets study criteria|0|||
161799721|NCT01592370|584309341|FG000|Overall Study|Other Reasons|6|||
161799722|NCT01592370|584309342|FG001|Overall Study|Other Reasons|0|||
161799723|NCT01592370|584309343|FG002|Overall Study|Other Reasons|10|||
162010883|NCT02594124|585096048|FG005|Overall Study|Adverse Event|0|||
161799724|NCT01592370|584309344|FG003|Overall Study|Other Reasons|0|||
161799725|NCT01592370|584309345|FG004|Overall Study|Other Reasons|0|||
161799726|NCT01592370|584309346|FG005|Overall Study|Other Reasons|1|||
161799727|NCT01592370|584309347|FG006|Overall Study|Other Reasons|0|||
161799728|NCT01592370|584309341|FG000|Overall Study|Not Treated|0|||
161799729|NCT01592370|584309342|FG001|Overall Study|Not Treated|0|||
161799730|NCT01592370|584309343|FG002|Overall Study|Not Treated|0|||
161799731|NCT01592370|584309344|FG003|Overall Study|Not Treated|0|||
161799732|NCT01592370|584309345|FG004|Overall Study|Not Treated|2|||
161799733|NCT01592370|584309346|FG005|Overall Study|Not Treated|2|||
161799734|NCT01592370|584309347|FG006|Overall Study|Not Treated|0|||
161799735|NCT02742181|584309348|FG000|Overall Study|Physician Decision|1|||
161903576|NCT05067972|584694893|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
161903577|NCT05067972|584694894|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
161903578|NCT05067972|584694888|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
161903579|NCT05067972|584694889|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
161903580|NCT05067972|584694890|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
161903581|NCT05067972|584694891|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
161903582|NCT05067972|584694892|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
161903583|NCT05067972|584694893|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
161903584|NCT05067972|584694894|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
161903585|NCT05067972|584694888|FG000|Part 1: Treatment|Progressive Disease|3|||
161903586|NCT05067972|584694889|FG001|Part 1: Treatment|Progressive Disease|3|||
161903587|NCT05067972|584694890|FG002|Part 1: Treatment|Progressive Disease|4|||
161903588|NCT05067972|584694891|FG003|Part 1: Treatment|Progressive Disease|2|||
161903589|NCT05067972|584694892|FG004|Part 1: Treatment|Progressive Disease|3|||
161903590|NCT05067972|584694893|FG005|Part 1: Treatment|Progressive Disease|0|||
161903591|NCT05067972|584694894|FG006|Part 1: Treatment|Progressive Disease|2|||
161903592|NCT05067972|584694888|FG000|Part 1: Treatment|Physician Decision|0|||
161903593|NCT05067972|584694889|FG001|Part 1: Treatment|Physician Decision|0|||
161903594|NCT05067972|584694890|FG002|Part 1: Treatment|Physician Decision|0|||
161903595|NCT05067972|584694891|FG003|Part 1: Treatment|Physician Decision|1|||
161903596|NCT05067972|584694892|FG004|Part 1: Treatment|Physician Decision|0|||
161903597|NCT05067972|584694893|FG005|Part 1: Treatment|Physician Decision|0|||
161903598|NCT05067972|584694894|FG006|Part 1: Treatment|Physician Decision|0|||
161903599|NCT05067972|584694888|FG000|Part 1: Treatment|Death|0|||
161903600|NCT05067972|584694889|FG001|Part 1: Treatment|Death|0|||
161903601|NCT05067972|584694890|FG002|Part 1: Treatment|Death|0|||
161903602|NCT05067972|584694891|FG003|Part 1: Treatment|Death|2|||
161903603|NCT05067972|584694892|FG004|Part 1: Treatment|Death|0|||
161903604|NCT05067972|584694893|FG005|Part 1: Treatment|Death|0|||
161903605|NCT05067972|584694894|FG006|Part 1: Treatment|Death|0|||
161903606|NCT05067972|584694888|FG000|Part 1: Treatment|Adverse Event|0|||
161903607|NCT05067972|584694889|FG001|Part 1: Treatment|Adverse Event|0|||
161903608|NCT05067972|584694890|FG002|Part 1: Treatment|Adverse Event|0|||
161903609|NCT05067972|584694891|FG003|Part 1: Treatment|Adverse Event|0|||
161903610|NCT05067972|584694892|FG004|Part 1: Treatment|Adverse Event|0|||
161903611|NCT05067972|584694893|FG005|Part 1: Treatment|Adverse Event|2|||
161903612|NCT05067972|584694894|FG006|Part 1: Treatment|Adverse Event|1|||
161903613|NCT05067972|584694888|FG000|Part 1: Follow-up|Adverse Event|0|||
161903614|NCT05067972|584694889|FG001|Part 1: Follow-up|Adverse Event|0|||
161903615|NCT05067972|584694890|FG002|Part 1: Follow-up|Adverse Event|0|||
161903616|NCT05067972|584694891|FG003|Part 1: Follow-up|Adverse Event|0|||
161903617|NCT05067972|584694892|FG004|Part 1: Follow-up|Adverse Event|0|||
161903618|NCT05067972|584694893|FG005|Part 1: Follow-up|Adverse Event|1|||
161903619|NCT05067972|584694894|FG006|Part 1: Follow-up|Adverse Event|0|||
161903620|NCT05067972|584694888|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
161903621|NCT05067972|584694889|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
161903622|NCT05067972|584694890|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
161903623|NCT05067972|584694891|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
161903624|NCT05067972|584694892|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
161903625|NCT05067972|584694893|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
161903626|NCT05067972|584694894|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
161903627|NCT05067972|584694888|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161903628|NCT05067972|584694889|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161903629|NCT05067972|584694890|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161903630|NCT05067972|584694891|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161903631|NCT05067972|584694892|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161903632|NCT05067972|584694893|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
161903633|NCT05067972|584694894|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161903634|NCT05067972|584694888|FG000|Part 1: Follow-up|Physician Decision|0|||
161903635|NCT05067972|584694889|FG001|Part 1: Follow-up|Physician Decision|0|||
161903636|NCT05067972|584694890|FG002|Part 1: Follow-up|Physician Decision|0|||
161903637|NCT05067972|584694891|FG003|Part 1: Follow-up|Physician Decision|1|||
161903638|NCT05067972|584694892|FG004|Part 1: Follow-up|Physician Decision|0|||
161903639|NCT05067972|584694893|FG005|Part 1: Follow-up|Physician Decision|0|||
161903640|NCT05067972|584694894|FG006|Part 1: Follow-up|Physician Decision|0|||
161903641|NCT05067972|584694888|FG000|Part 1: Follow-up|Death|1|||
161903642|NCT05067972|584694889|FG001|Part 1: Follow-up|Death|2|||
161903643|NCT05067972|584694890|FG002|Part 1: Follow-up|Death|1|||
161903644|NCT05067972|584694891|FG003|Part 1: Follow-up|Death|0|||
161903645|NCT05067972|584694892|FG004|Part 1: Follow-up|Death|1|||
161903646|NCT05067972|584694893|FG005|Part 1: Follow-up|Death|0|||
161903647|NCT05067972|584694894|FG006|Part 1: Follow-up|Death|1|||
161903648|NCT00810199|584694902|FG000|Overall Study|Adverse Event|24|||
161903649|NCT00810199|584694903|FG001|Overall Study|Adverse Event|26|||
161903650|NCT00810199|584694902|FG000|Overall Study|Death|4|||
161903651|NCT00810199|584694903|FG001|Overall Study|Death|6|||
161903652|NCT00810199|584694902|FG000|Overall Study|Withdrew consent|9|||
161903653|NCT00810199|584694903|FG001|Overall Study|Withdrew consent|12|||
161903654|NCT00810199|584694902|FG000|Overall Study|Insufficient therapeutic response|5|||
161903655|NCT00810199|584694903|FG001|Overall Study|Insufficient therapeutic response|14|||
161903656|NCT00810199|584694902|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
161903657|NCT00810199|584694903|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
161903658|NCT00810199|584694902|FG000|Overall Study|Administrative/Other|5|||
161903659|NCT00810199|584694903|FG001|Overall Study|Administrative/Other|6|||
161903660|NCT00810199|584694902|FG000|Overall Study|Protocol Violation|2|||
161903661|NCT00810199|584694903|FG001|Overall Study|Protocol Violation|6|||
161903662|NCT00810199|584694902|FG000|Overall Study|Failure to return|1|||
161903663|NCT00810199|584694903|FG001|Overall Study|Failure to return|4|||
161903664|NCT00810199|584694902|FG000|Overall Study|Did not receive study drug|2|||
161903665|NCT00810199|584694903|FG001|Overall Study|Did not receive study drug|1|||
161903666|NCT00101868|584694911|FG000|Overall Study|Death|10|||
161903667|NCT00101868|584694912|FG001|Overall Study|Death|10|||
161903668|NCT00101868|584694911|FG000|Overall Study|Withdrawal by Subject|8|||
161903669|NCT00101868|584694912|FG001|Overall Study|Withdrawal by Subject|9|||
161903670|NCT00101868|584694911|FG000|Overall Study|Protocol Violation|3|||
161903671|NCT00101868|584694912|FG001|Overall Study|Protocol Violation|0|||
161903672|NCT00101868|584694911|FG000|Overall Study|Lost to Follow-up|8|||
161903673|NCT00101868|584694912|FG001|Overall Study|Lost to Follow-up|13|||
161903674|NCT04001803|584694914|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
161903675|NCT04001803|584694914|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
161903676|NCT04001803|584694914|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
161903677|NCT04001803|584694914|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
161903678|NCT04001803|584694914|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
161903679|NCT04001803|584694914|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
161903680|NCT04001803|584694914|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
161903681|NCT04001803|584694914|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
161903682|NCT04001803|584694914|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
161903683|NCT04001803|584694914|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
161903684|NCT01931397|584694917|FG000|Overall Study|Physician Decision|2|||
161903685|NCT01931397|584694917|FG000|Overall Study|Withdrawal by Subject|8|||
161903686|NCT01931397|584694917|FG000|Overall Study|moved out of state|1|||
161903687|NCT02329327|584694921|FG000|Overall Study|Death|78|||
161903688|NCT02329327|584694922|FG001|Overall Study|Death|0|||
161903689|NCT02329327|584694921|FG000|Overall Study|Withdrawal by Subject|3|||
161903690|NCT02329327|584694922|FG001|Overall Study|Withdrawal by Subject|0|||
161903691|NCT02329327|584694921|FG000|Overall Study|Lost to Follow-up|4|||
161903692|NCT02329327|584694922|FG001|Overall Study|Lost to Follow-up|0|||
161903693|NCT02493517|584694923|FG000|Overall Study|Protocol Violation|1|||
161903694|NCT02493517|584694924|FG001|Overall Study|Protocol Violation|2|||
161903695|NCT02493517|584694923|FG000|Overall Study|Withdrawal by Subject|1|||
161903696|NCT02493517|584694924|FG001|Overall Study|Withdrawal by Subject|2|||
161903697|NCT02493517|584694923|FG000|Overall Study|Adverse Event|0|||
161903698|NCT02493517|584694924|FG001|Overall Study|Adverse Event|2|||
161903699|NCT02493517|584694923|FG000|Overall Study|Missed study visit|0|||
161903700|NCT02493517|584694924|FG001|Overall Study|Missed study visit|1|||
161903701|NCT01367249|584694925|FG000|Overall Study|Withdrawal by Subject|6|||
161903702|NCT01367249|584694926|FG001|Overall Study|Withdrawal by Subject|6|||
161903703|NCT01367249|584694925|FG000|Overall Study|Other|3|||
161903704|NCT01367249|584694926|FG001|Overall Study|Other|10|||
161903705|NCT03718429|584694927|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
161903706|NCT03718429|584694928|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
161903707|NCT03718429|584694929|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
161903708|NCT03718429|584694930|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
161903709|NCT05404711|584694931|FG000|Completed Study Visit|Withdrawal by Subject|1|||
161903710|NCT05404711|584694931|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
161903711|NCT05404711|584694931|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
161903712|NCT05404711|584694931|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
161903713|NCT05404711|584694931|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
161903714|NCT05404711|584694931|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
161903715|NCT00325819|584694932|FG000|Overall Study|Study product lost in mail|2|||
161903716|NCT00325819|584694933|FG001|Overall Study|Study product lost in mail|1|||
161903717|NCT00325819|584694932|FG000|Overall Study|Did not take a dose of study product|4|||
161903718|NCT00325819|584694933|FG001|Overall Study|Did not take a dose of study product|9|||
161903719|NCT00325819|584694932|FG000|Overall Study|Lost to Follow-up|3|||
161903720|NCT00325819|584694933|FG001|Overall Study|Lost to Follow-up|3|||
161903721|NCT02346877|584694934|FG000|Overall Study|Adverse Event|1|||
161903722|NCT02346877|584694935|FG001|Overall Study|Adverse Event|0|||
161903723|NCT02346877|584694934|FG000|Overall Study|Administrative Decision|1|||
161903724|NCT02346877|584694935|FG001|Overall Study|Administrative Decision|0|||
161903725|NCT02346877|584694934|FG000|Overall Study|Sponsor Decision|12|||
161903726|NCT02346877|584694935|FG001|Overall Study|Sponsor Decision|0|||
161903727|NCT02346877|584694934|FG000|Overall Study|Missing|5|||
161903728|NCT02346877|584694935|FG001|Overall Study|Missing|0|||
161903729|NCT01683604|584694942|FG000|Overall Study|Adverse Event|2|||
161903730|NCT01683604|584694942|FG000|Overall Study|Lack of Efficacy|1|||
161903731|NCT01683604|584694942|FG000|Overall Study|Other|2|||
161903732|NCT03430856|584694943|FG000|Overall Study|Adverse Event|0|||
161903733|NCT03430856|584694944|FG001|Overall Study|Adverse Event|1|||
161903734|NCT03430856|584694945|FG002|Overall Study|Adverse Event|0|||
161903735|NCT03430856|584694943|FG000|Overall Study|Rescue criteria|1|||
161903736|NCT03430856|584694944|FG001|Overall Study|Rescue criteria|1|||
161903737|NCT03430856|584694945|FG002|Overall Study|Rescue criteria|0|||
161903738|NCT03430856|584694943|FG000|Overall Study|Voluntary withdrawal of consent|1|||
161903739|NCT03430856|584694944|FG001|Overall Study|Voluntary withdrawal of consent|1|||
161903740|NCT03430856|584694945|FG002|Overall Study|Voluntary withdrawal of consent|1|||
161903741|NCT01094288|584696876|FG000|Overall Study|Adverse Event|0|||
161903742|NCT01094288|584696877|FG001|Overall Study|Adverse Event|3|||
161903743|NCT01094288|584696878|FG002|Overall Study|Adverse Event|1|||
161903744|NCT01094288|584696879|FG003|Overall Study|Adverse Event|1|||
161903745|NCT01094288|584696880|FG004|Overall Study|Adverse Event|0|||
161903746|NCT01094288|584696881|FG005|Overall Study|Adverse Event|0|||
161903747|NCT01094288|584696882|FG006|Overall Study|Adverse Event|0|||
161903748|NCT01094288|584696883|FG007|Overall Study|Adverse Event|0|||
161903749|NCT01094288|584696876|FG000|Overall Study|Withdrawal by Subject|0|||
161903750|NCT01094288|584696877|FG001|Overall Study|Withdrawal by Subject|1|||
161903751|NCT01094288|584696878|FG002|Overall Study|Withdrawal by Subject|2|||
161903752|NCT01094288|584696879|FG003|Overall Study|Withdrawal by Subject|0|||
161903753|NCT01094288|584696880|FG004|Overall Study|Withdrawal by Subject|0|||
161903754|NCT01094288|584696881|FG005|Overall Study|Withdrawal by Subject|0|||
161903755|NCT01094288|584696882|FG006|Overall Study|Withdrawal by Subject|0|||
161903756|NCT01094288|584696883|FG007|Overall Study|Withdrawal by Subject|2|||
161903757|NCT01094288|584696876|FG000|Overall Study|Initiation of Alternative Therapy|0|||
161903758|NCT01094288|584696877|FG001|Overall Study|Initiation of Alternative Therapy|0|||
161903759|NCT01094288|584696878|FG002|Overall Study|Initiation of Alternative Therapy|1|||
161903760|NCT01094288|584696879|FG003|Overall Study|Initiation of Alternative Therapy|0|||
161903761|NCT01094288|584696880|FG004|Overall Study|Initiation of Alternative Therapy|0|||
161903762|NCT01094288|584696881|FG005|Overall Study|Initiation of Alternative Therapy|0|||
161903763|NCT01094288|584696882|FG006|Overall Study|Initiation of Alternative Therapy|0|||
161903764|NCT01094288|584696883|FG007|Overall Study|Initiation of Alternative Therapy|0|||
161903765|NCT01094288|584696876|FG000|Overall Study|Reason not Specified|2|||
161903766|NCT01094288|584696877|FG001|Overall Study|Reason not Specified|3|||
161903767|NCT01094288|584696878|FG002|Overall Study|Reason not Specified|0|||
161903768|NCT01094288|584696879|FG003|Overall Study|Reason not Specified|1|||
161903769|NCT01094288|584696880|FG004|Overall Study|Reason not Specified|0|||
161903770|NCT01094288|584696881|FG005|Overall Study|Reason not Specified|0|||
161903771|NCT01094288|584696882|FG006|Overall Study|Reason not Specified|0|||
161903772|NCT01094288|584696883|FG007|Overall Study|Reason not Specified|0|||
161903773|NCT01094288|584696876|FG000|Overall Study|Ongoing Participants|0|||
161903774|NCT01094288|584696877|FG001|Overall Study|Ongoing Participants|3|||
161903775|NCT01094288|584696878|FG002|Overall Study|Ongoing Participants|0|||
161903776|NCT01094288|584696879|FG003|Overall Study|Ongoing Participants|0|||
161903777|NCT01094288|584696880|FG004|Overall Study|Ongoing Participants|0|||
161903778|NCT01094288|584696881|FG005|Overall Study|Ongoing Participants|0|||
161903779|NCT01094288|584696882|FG006|Overall Study|Ongoing Participants|0|||
161903780|NCT01094288|584696883|FG007|Overall Study|Ongoing Participants|0|||
161903781|NCT02611882|584696886|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
161903782|NCT02611882|584696887|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
161903783|NCT02611882|584696888|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
161903784|NCT01228591|584696889|FG000|Baseline|Lack of Efficacy|1|||
161903785|NCT01228591|584696890|FG001|Baseline|Lack of Efficacy|2|||
161903786|NCT01389232|584696891|FG000|Overall Study|Had scaffold removed|15|||
161903787|NCT01389232|584696891|FG000|Overall Study|Personal reasons|2|||
161903788|NCT01389232|584696891|FG000|Overall Study|Adverse Event|1|||
161903789|NCT01389232|584696891|FG000|Overall Study|Death|1|||
161903790|NCT01317940|584696892|FG000|Overall Study|Death|1|||
161799736|NCT02742181|584309349|FG001|Overall Study|Physician Decision|0|||
161799737|NCT02739984|584309350|FG000|Overall Study|Sponsor Decision|1|||
161799738|NCT02739984|584309351|FG001|Overall Study|Sponsor Decision|0|||
161799739|NCT02739984|584309350|FG000|Overall Study|Withdrawal by Subject|1|||
161799740|NCT02739984|584309351|FG001|Overall Study|Withdrawal by Subject|1|||
161799741|NCT02739984|584309350|FG000|Overall Study|Death|0|||
161799742|NCT02739984|584309351|FG001|Overall Study|Death|1|||
161799743|NCT02739984|584309350|FG000|Overall Study|Lost to Follow-up|3|||
161799744|NCT02739984|584309351|FG001|Overall Study|Lost to Follow-up|0|||
161799745|NCT01048333|584309356|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161799746|NCT01048333|584309357|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
161799747|NCT01048333|584309358|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161799748|NCT01048333|584309359|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161799749|NCT01048333|584309360|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161799750|NCT01048333|584309361|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161799751|NCT00996736|584309363|FG000|Overall Study|Death|1|||
161799752|NCT00996736|584309364|FG001|Overall Study|Death|1|||
161799753|NCT00996736|584309363|FG000|Overall Study|Lost to Follow-up|15|||
161799754|NCT00996736|584309364|FG001|Overall Study|Lost to Follow-up|14|||
161799755|NCT00996736|584309363|FG000|Overall Study|Visit not within 3-month window|5|||
161799756|NCT00996736|584309364|FG001|Overall Study|Visit not within 3-month window|3|||
161799757|NCT02346201|584309365|FG000|Overall Study|Adverse Event|3|||
161799758|NCT02346201|584309366|FG001|Overall Study|Adverse Event|2|||
161799759|NCT02346201|584309365|FG000|Overall Study|Lost to Follow-up|1|||
161799760|NCT02346201|584309366|FG001|Overall Study|Lost to Follow-up|0|||
161799761|NCT02346201|584309365|FG000|Overall Study|Withdrawal by Subject|6|||
161799762|NCT02346201|584309366|FG001|Overall Study|Withdrawal by Subject|3|||
161799763|NCT02346201|584309365|FG000|Overall Study|Unavailable for future follow-up|0|||
161799764|NCT02346201|584309366|FG001|Overall Study|Unavailable for future follow-up|1|||
161799765|NCT02346201|584309365|FG000|Overall Study|Physician Decision|0|||
161799766|NCT02346201|584309366|FG001|Overall Study|Physician Decision|1|||
161799767|NCT02346201|584309365|FG000|Overall Study|Missed final visit|0|||
161799768|NCT02346201|584309366|FG001|Overall Study|Missed final visit|2|||
161799769|NCT05200858|584309367|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
161799770|NCT05200858|584309368|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
161799771|NCT05200858|584309369|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
161799772|NCT05200858|584309370|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
161799773|NCT00409578|584309373|FG000|Overall Study|Adverse Event|27|||
161799774|NCT00409578|584309374|FG001|Overall Study|Adverse Event|37|||
161799775|NCT00409578|584309375|FG002|Overall Study|Adverse Event|25|||
161799776|NCT00409578|584309376|FG003|Overall Study|Adverse Event|33|||
161799777|NCT00409578|584309373|FG000|Overall Study|Abnormal laboratory value(s)|2|||
161799778|NCT00409578|584309374|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161799779|NCT00409578|584309375|FG002|Overall Study|Abnormal laboratory value(s)|2|||
161799780|NCT00409578|584309376|FG003|Overall Study|Abnormal laboratory value(s)|4|||
161799781|NCT00409578|584309373|FG000|Overall Study|Lack of Efficacy|0|||
161799782|NCT00409578|584309374|FG001|Overall Study|Lack of Efficacy|0|||
161799783|NCT00409578|584309375|FG002|Overall Study|Lack of Efficacy|0|||
161799784|NCT00409578|584309376|FG003|Overall Study|Lack of Efficacy|2|||
161799785|NCT00409578|584309373|FG000|Overall Study|Subject no longer requires study drug|0|||
161799786|NCT00409578|584309374|FG001|Overall Study|Subject no longer requires study drug|0|||
161799787|NCT00409578|584309375|FG002|Overall Study|Subject no longer requires study drug|0|||
161799788|NCT00409578|584309376|FG003|Overall Study|Subject no longer requires study drug|1|||
161799789|NCT00409578|584309373|FG000|Overall Study|Withdrawal by Subject|8|||
161799790|NCT00409578|584309374|FG001|Overall Study|Withdrawal by Subject|15|||
161799791|NCT00409578|584309375|FG002|Overall Study|Withdrawal by Subject|16|||
161799792|NCT00409578|584309376|FG003|Overall Study|Withdrawal by Subject|17|||
161799793|NCT00409578|584309373|FG000|Overall Study|Lost to Follow-up|2|||
161903791|NCT01317940|584696893|FG001|Overall Study|Death|0|||
161799794|NCT00409578|584309374|FG001|Overall Study|Lost to Follow-up|0|||
161799795|NCT00409578|584309375|FG002|Overall Study|Lost to Follow-up|2|||
161799796|NCT00409578|584309376|FG003|Overall Study|Lost to Follow-up|2|||
161799797|NCT00409578|584309373|FG000|Overall Study|Administrative problems|8|||
161799798|NCT00409578|584309374|FG001|Overall Study|Administrative problems|9|||
161799799|NCT00409578|584309375|FG002|Overall Study|Administrative problems|2|||
161799800|NCT00409578|584309376|FG003|Overall Study|Administrative problems|4|||
161799801|NCT00409578|584309373|FG000|Overall Study|Death|2|||
161903792|NCT01317940|584696894|FG002|Overall Study|Death|1|||
161903793|NCT01317940|584696895|FG003|Overall Study|Death|0|||
161799802|NCT00409578|584309374|FG001|Overall Study|Death|4|||
161799803|NCT00409578|584309375|FG002|Overall Study|Death|4|||
161799804|NCT00409578|584309376|FG003|Overall Study|Death|2|||
161799805|NCT00409578|584309373|FG000|Overall Study|Protocol Violation|3|||
161799806|NCT00409578|584309374|FG001|Overall Study|Protocol Violation|2|||
161799807|NCT00409578|584309375|FG002|Overall Study|Protocol Violation|3|||
161903794|NCT01317940|584696896|FG004|Overall Study|Death|0|||
161903795|NCT01317940|584696897|FG005|Overall Study|Death|0|||
161903796|NCT01317940|584696892|FG000|Overall Study|Lost to Follow-up|0|||
161903797|NCT01317940|584696893|FG001|Overall Study|Lost to Follow-up|0|||
161903798|NCT01317940|584696894|FG002|Overall Study|Lost to Follow-up|1|||
161903799|NCT01317940|584696895|FG003|Overall Study|Lost to Follow-up|1|||
161903800|NCT01317940|584696896|FG004|Overall Study|Lost to Follow-up|1|||
161903801|NCT01317940|584696897|FG005|Overall Study|Lost to Follow-up|0|||
161903802|NCT01317940|584696892|FG000|Overall Study|Change in therapy plan|0|||
161903803|NCT01317940|584696893|FG001|Overall Study|Change in therapy plan|0|||
161903804|NCT01317940|584696894|FG002|Overall Study|Change in therapy plan|3|||
161903805|NCT01317940|584696895|FG003|Overall Study|Change in therapy plan|0|||
161903806|NCT01317940|584696896|FG004|Overall Study|Change in therapy plan|0|||
161903807|NCT01317940|584696897|FG005|Overall Study|Change in therapy plan|0|||
161903808|NCT02371616|584696899|FG000|Overall Study|Protocol Violation|2|||
161903809|NCT02371616|584696900|FG001|Overall Study|Protocol Violation|1|||
161903810|NCT02371616|584696899|FG000|Overall Study|Adverse Event|0|||
161903811|NCT02371616|584696900|FG001|Overall Study|Adverse Event|1|||
161903812|NCT02371616|584696899|FG000|Overall Study|Withdrawal of Consent|1|||
161903813|NCT02371616|584696900|FG001|Overall Study|Withdrawal of Consent|0|||
161903814|NCT02371616|584696899|FG000|Overall Study|Other (Not specified)|1|||
161903815|NCT02371616|584696900|FG001|Overall Study|Other (Not specified)|5|||
161903816|NCT03205150|584696903|FG000|Overall Study|Protocol deviation|1|||
161903817|NCT03205150|584696904|FG001|Overall Study|Protocol deviation|3|||
161903818|NCT03205150|584696905|FG002|Overall Study|Protocol deviation|0|||
161903819|NCT03205150|584696903|FG000|Overall Study|Patient/guardian decision|0|||
161903820|NCT03205150|584696904|FG001|Overall Study|Patient/guardian decision|3|||
161903821|NCT03205150|584696905|FG002|Overall Study|Patient/guardian decision|0|||
161903822|NCT03205150|584696903|FG000|Overall Study|Adverse Event|1|||
161903823|NCT03205150|584696904|FG001|Overall Study|Adverse Event|1|||
161903824|NCT03205150|584696905|FG002|Overall Study|Adverse Event|1|||
161903825|NCT03205150|584696903|FG000|Overall Study|Lost to Follow-up|0|||
161903826|NCT03205150|584696904|FG001|Overall Study|Lost to Follow-up|0|||
161903827|NCT03205150|584696905|FG002|Overall Study|Lost to Follow-up|1|||
161903828|NCT01095835|584696906|FG000|Overall Study|Adverse Event|8|||
161903829|NCT01095835|584696907|FG001|Overall Study|Adverse Event|6|||
161903830|NCT01095835|584696908|FG002|Overall Study|Adverse Event|6|||
161903831|NCT01095835|584696906|FG000|Overall Study|Lack of Efficacy|0|||
161903832|NCT01095835|584696907|FG001|Overall Study|Lack of Efficacy|1|||
161903833|NCT01095835|584696908|FG002|Overall Study|Lack of Efficacy|0|||
161903834|NCT01095835|584696906|FG000|Overall Study|Physician Decision|0|||
161903835|NCT01095835|584696907|FG001|Overall Study|Physician Decision|0|||
161903836|NCT01095835|584696908|FG002|Overall Study|Physician Decision|1|||
161903837|NCT01095835|584696906|FG000|Overall Study|Withdrawal by Subject|1|||
161903838|NCT01095835|584696907|FG001|Overall Study|Withdrawal by Subject|3|||
161903839|NCT01095835|584696908|FG002|Overall Study|Withdrawal by Subject|0|||
161903840|NCT01095835|584696906|FG000|Overall Study|Non study compliance|0|||
161903841|NCT01095835|584696907|FG001|Overall Study|Non study compliance|0|||
161903842|NCT01095835|584696908|FG002|Overall Study|Non study compliance|1|||
161903843|NCT01095835|584696906|FG000|Overall Study|Protocol Violation|1|||
161903844|NCT01095835|584696907|FG001|Overall Study|Protocol Violation|2|||
161903845|NCT01095835|584696908|FG002|Overall Study|Protocol Violation|0|||
161903846|NCT03028142|584696909|FG000|Overall Study|Adverse Event|1|||
161903847|NCT03028142|584696910|FG001|Overall Study|Adverse Event|1|||
161903848|NCT03028142|584696911|FG002|Overall Study|Adverse Event|0|||
161903849|NCT03028142|584696912|FG003|Overall Study|Adverse Event|0|||
161903850|NCT03028142|584696913|FG004|Overall Study|Adverse Event|0|||
161903851|NCT03028142|584696914|FG005|Overall Study|Adverse Event|1|||
161903852|NCT03028142|584696909|FG000|Overall Study|Withdrawal by Subject|0|||
161903853|NCT03028142|584696910|FG001|Overall Study|Withdrawal by Subject|0|||
162010884|NCT02594124|585096049|FG006|Overall Study|Adverse Event|2|||
161799808|NCT00409578|584309376|FG003|Overall Study|Protocol Violation|1|||
161799809|NCT00409578|584309373|FG000|Overall Study|Missing|0|||
161799810|NCT00409578|584309374|FG001|Overall Study|Missing|1|||
161799811|NCT00409578|584309375|FG002|Overall Study|Missing|0|||
161799812|NCT00409578|584309376|FG003|Overall Study|Missing|1|||
161799813|NCT02109133|584309377|FG000|Overall Study|Lost to Follow-up|1|||
161799814|NCT02109133|584309378|FG001|Overall Study|Lost to Follow-up|0|||
161799815|NCT02448771|584309379|FG000|Overall Study|Disease Progression|30|||
161799816|NCT02448771|584309379|FG000|Overall Study|Unacceptable Toxicity|1|||
161799817|NCT02448771|584309379|FG000|Overall Study|Physician Decision|3|||
161799818|NCT02448771|584309379|FG000|Overall Study|Started new therapy|2|||
161799819|NCT00770315|584309381|FG000|Overall Study|Adverse Event|11|||
161799820|NCT00770315|584309382|FG001|Overall Study|Adverse Event|17|||
161799821|NCT00770315|584309383|FG002|Overall Study|Adverse Event|16|||
161799822|NCT00770315|584309384|FG003|Overall Study|Adverse Event|6|||
161799823|NCT00770315|584309381|FG000|Overall Study|Lost to Follow-up|9|||
161799824|NCT00770315|584309382|FG001|Overall Study|Lost to Follow-up|5|||
161903854|NCT03028142|584696911|FG002|Overall Study|Withdrawal by Subject|0|||
161903855|NCT03028142|584696912|FG003|Overall Study|Withdrawal by Subject|0|||
161799825|NCT00770315|584309383|FG002|Overall Study|Lost to Follow-up|10|||
161799826|NCT00770315|584309384|FG003|Overall Study|Lost to Follow-up|3|||
161799827|NCT00770315|584309381|FG000|Overall Study|Withdrawal by Subject|13|||
161799828|NCT00770315|584309382|FG001|Overall Study|Withdrawal by Subject|17|||
161799829|NCT00770315|584309383|FG002|Overall Study|Withdrawal by Subject|24|||
161799830|NCT00770315|584309384|FG003|Overall Study|Withdrawal by Subject|20|||
161799831|NCT00770315|584309381|FG000|Overall Study|Noncompliance with Protocol|7|||
161799832|NCT00770315|584309382|FG001|Overall Study|Noncompliance with Protocol|4|||
161799833|NCT00770315|584309383|FG002|Overall Study|Noncompliance with Protocol|7|||
161799834|NCT00770315|584309384|FG003|Overall Study|Noncompliance with Protocol|9|||
161799835|NCT01210001|584310895|FG000|Overall Study|Not treated|1|||
161799836|NCT01210001|584310896|FG001|Overall Study|Not treated|0|||
161799837|NCT01210001|584310897|FG002|Overall Study|Not treated|0|||
161799838|NCT01210001|584310895|FG000|Overall Study|Adverse Event|4|||
161799839|NCT01210001|584310896|FG001|Overall Study|Adverse Event|2|||
161799840|NCT01210001|584310897|FG002|Overall Study|Adverse Event|5|||
161799841|NCT01210001|584310895|FG000|Overall Study|Non compliant with protocol|2|||
161799842|NCT01210001|584310896|FG001|Overall Study|Non compliant with protocol|2|||
161799843|NCT01210001|584310897|FG002|Overall Study|Non compliant with protocol|3|||
161799844|NCT01210001|584310895|FG000|Overall Study|Lost to Follow-up|4|||
161799845|NCT01210001|584310896|FG001|Overall Study|Lost to Follow-up|3|||
161799846|NCT01210001|584310897|FG002|Overall Study|Lost to Follow-up|2|||
161799847|NCT01210001|584310895|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
161799848|NCT01210001|584310896|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
161799849|NCT01210001|584310897|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
161799850|NCT01210001|584310895|FG000|Overall Study|Other reason not defined above|2|||
161799851|NCT01210001|584310896|FG001|Overall Study|Other reason not defined above|2|||
161799852|NCT01210001|584310897|FG002|Overall Study|Other reason not defined above|1|||
161799853|NCT00788125|584310898|FG000|Overall Study|Death|6|||
161799854|NCT01374919|584310908|FG000|Overall Study|Withdrawal by Subject|2|||
161799855|NCT02999178|584310909|FG000|Overall Study|Adverse Event|85|||
161799856|NCT02999178|584310910|FG001|Overall Study|Adverse Event|62|||
161799857|NCT02999178|584310909|FG000|Overall Study|Protocol Violation|1|||
161799858|NCT02999178|584310910|FG001|Overall Study|Protocol Violation|2|||
161799859|NCT02999178|584310909|FG000|Overall Study|Lost to Follow-up|0|||
161799860|NCT02999178|584310910|FG001|Overall Study|Lost to Follow-up|2|||
161799861|NCT02999178|584310909|FG000|Overall Study|Withdrawal by Subject|21|||
161799862|NCT02999178|584310910|FG001|Overall Study|Withdrawal by Subject|21|||
161799863|NCT02999178|584310909|FG000|Overall Study|Other reason not defined above|7|||
161799864|NCT02999178|584310910|FG001|Overall Study|Other reason not defined above|13|||
161799865|NCT00630305|584310911|FG000|Overall Study|Withdrawal by Subject|1|||
161799866|NCT00630305|584310911|FG000|Overall Study|Inability to insert contact lens|1|||
161799867|NCT01085045|584310912|FG000|Part A|Withdrawal by Subject|4|||
161799868|NCT01085045|584310912|FG000|Part A|Adverse Event|6|||
161799869|NCT01085045|584310912|FG000|Part A|Protocol Violation|1|||
161799870|NCT01085045|584310912|FG000|Part A|Protocol Specified Criteria|7|||
161799871|NCT01085045|584310912|FG000|Part B|Withdrawal by Subject|2|||
161799872|NCT01085045|584310912|FG000|Part B|Protocol Specified Criteria|6|||
161799873|NCT01085045|584310912|FG000|Part B|Lost to Follow-up|1|||
161799874|NCT01085045|584310912|FG000|Part B|Adverse Event|6|||
161799875|NCT00863746|584310920|FG000|Treatment|Not treated|4|||
161799876|NCT00863746|584310921|FG001|Treatment|Not treated|2|||
161799877|NCT00863746|584310920|FG000|Treatment|Adverse Event|41|||
161799878|NCT00863746|584310921|FG001|Treatment|Adverse Event|16|||
161799879|NCT00863746|584310920|FG000|Treatment|non-compliant with study medication|4|||
161799880|NCT00863746|584310921|FG001|Treatment|non-compliant with study medication|0|||
161799881|NCT00863746|584310920|FG000|Treatment|Consent withdrawn|15|||
161799882|NCT00863746|584310921|FG001|Treatment|Consent withdrawn|14|||
161799883|NCT00863746|584310920|FG000|Treatment|Lost to Follow-up|1|||
161799884|NCT00863746|584310921|FG001|Treatment|Lost to Follow-up|0|||
161799885|NCT00863746|584310920|FG000|Treatment|Protocol Violation|5|||
162138278|NCT01649427|585557309|FG001|Overall Study|Surgical problems during nephrectomy|2|||
162138279|NCT02138916|585557312|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
162138280|NCT02138916|585557313|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
162138281|NCT02138916|585557314|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
162138282|NCT02138916|585557312|FG000|Overall Study|Death|14|||
162138283|NCT02138916|585557313|FG001|Overall Study|Death|11|||
162138284|NCT02138916|585557314|FG002|Overall Study|Death|12|||
162138285|NCT02138916|585557312|FG000|Overall Study|Withdrawal by Subject|27|||
162138286|NCT02138916|585557313|FG001|Overall Study|Withdrawal by Subject|31|||
162138287|NCT02138916|585557314|FG002|Overall Study|Withdrawal by Subject|32|||
162138288|NCT02138916|585557312|FG000|Overall Study|Study specific withdrawal criteria|0|||
162138289|NCT02138916|585557313|FG001|Overall Study|Study specific withdrawal criteria|0|||
162138290|NCT02138916|585557314|FG002|Overall Study|Study specific withdrawal criteria|1|||
162138291|NCT02138916|585557312|FG000|Overall Study|incorrect enrolment|1|||
162138292|NCT02138916|585557313|FG001|Overall Study|incorrect enrolment|1|||
162138293|NCT02138916|585557314|FG002|Overall Study|incorrect enrolment|0|||
162138294|NCT02138916|585557312|FG000|Overall Study|Severe non-compliance|1|||
162138295|NCT02138916|585557313|FG001|Overall Study|Severe non-compliance|2|||
162138296|NCT02138916|585557314|FG002|Overall Study|Severe non-compliance|1|||
162138297|NCT02138916|585557312|FG000|Overall Study|Lost to Follow-up|4|||
162138298|NCT02138916|585557313|FG001|Overall Study|Lost to Follow-up|2|||
162138299|NCT02138916|585557314|FG002|Overall Study|Lost to Follow-up|3|||
162138300|NCT02138916|585557312|FG000|Overall Study|Adverse Event|4|||
162138301|NCT02138916|585557313|FG001|Overall Study|Adverse Event|4|||
162138302|NCT02138916|585557314|FG002|Overall Study|Adverse Event|3|||
162138303|NCT01913340|585557315|FG000|Overall Study|Death|2|||
162138304|NCT01913340|585557316|FG001|Overall Study|Death|5|||
162138305|NCT01913340|585557315|FG000|Overall Study|Lost to Follow-up|1|||
162138306|NCT01913340|585557316|FG001|Overall Study|Lost to Follow-up|1|||
162138307|NCT05750745|585557318|FG000|Overall Study|Adverse Event|1|||
162138308|NCT05750745|585557319|FG001|Overall Study|Adverse Event|0|||
162138309|NCT05750745|585557320|FG002|Overall Study|Adverse Event|0|||
162138310|NCT05750745|585557318|FG000|Overall Study|Protocol Violation|1|||
162138311|NCT05750745|585557319|FG001|Overall Study|Protocol Violation|0|||
162138312|NCT05750745|585557320|FG002|Overall Study|Protocol Violation|0|||
161799886|NCT00863746|584310921|FG001|Treatment|Protocol Violation|3|||
162138313|NCT05750745|585557318|FG000|Overall Study|Withdrawal by Subject|0|||
162138314|NCT05750745|585557319|FG001|Overall Study|Withdrawal by Subject|1|||
162138315|NCT05750745|585557320|FG002|Overall Study|Withdrawal by Subject|0|||
162138316|NCT05096884|585557322|FG000|Overall Study|Excluded based on negative tilt table test|4|||
162138317|NCT02482233|585557323|FG000|Overall Study|Lost to Follow-up|1|||
161799887|NCT00863746|584310920|FG000|Treatment|Other|1|||
161799888|NCT00863746|584310921|FG001|Treatment|Other|0|||
161799889|NCT00863746|584310920|FG000|Survival Follow up|Death|244|||
161799890|NCT00863746|584310921|FG001|Survival Follow up|Death|271|||
162138318|NCT02482233|585557324|FG001|Overall Study|Lost to Follow-up|1|||
161799891|NCT00863746|584310920|FG000|Survival Follow up|Lost to Follow-up|2|||
161799892|NCT00863746|584310921|FG001|Survival Follow up|Lost to Follow-up|1|||
161799893|NCT00863746|584310920|FG000|Survival Follow up|Consent Withdrawn|7|||
161799894|NCT00863746|584310921|FG001|Survival Follow up|Consent Withdrawn|8|||
161903856|NCT03028142|584696913|FG004|Overall Study|Withdrawal by Subject|1|||
161903857|NCT03028142|584696914|FG005|Overall Study|Withdrawal by Subject|0|||
161903858|NCT00116688|584696918|FG000|Overall Study|Protocol deviation|1|||
161903859|NCT00116688|584696919|FG001|Overall Study|Protocol deviation|0|||
161903860|NCT00116688|584696918|FG000|Overall Study|Noncompliance|3|||
161903861|NCT00116688|584696919|FG001|Overall Study|Noncompliance|1|||
161903862|NCT00116688|584696918|FG000|Overall Study|Adverse Event|11|||
161903863|NCT00116688|584696919|FG001|Overall Study|Adverse Event|0|||
161903864|NCT00116688|584696918|FG000|Overall Study|Withdrawal by Subject|26|||
161903865|NCT00116688|584696919|FG001|Overall Study|Withdrawal by Subject|2|||
161903866|NCT00116688|584696918|FG000|Overall Study|Requirement for alternative therapy|11|||
161903867|NCT00116688|584696919|FG001|Overall Study|Requirement for alternative therapy|1|||
161903868|NCT00116688|584696918|FG000|Overall Study|Physician Decision|7|||
161903869|NCT00116688|584696919|FG001|Overall Study|Physician Decision|0|||
161903870|NCT00116688|584696918|FG000|Overall Study|Lost to Follow-up|3|||
161903871|NCT00116688|584696919|FG001|Overall Study|Lost to Follow-up|0|||
161903872|NCT00116688|584696918|FG000|Overall Study|Death|15|||
161903873|NCT00116688|584696919|FG001|Overall Study|Death|0|||
161903874|NCT00116688|584696918|FG000|Overall Study|Protocol-specified criteria|3|||
161903875|NCT00116688|584696919|FG001|Overall Study|Protocol-specified criteria|0|||
161903876|NCT00116688|584696918|FG000|Overall Study|Pregnancy|1|||
161903877|NCT00116688|584696919|FG001|Overall Study|Pregnancy|0|||
161903878|NCT00116688|584696918|FG000|Overall Study|Other|11|||
161903879|NCT00116688|584696919|FG001|Overall Study|Other|0|||
161903880|NCT01775670|584696924|FG000|Overall Study|Lost to Follow-up|1|||
161903881|NCT01775670|584696925|FG001|Overall Study|Lost to Follow-up|1|||
161903882|NCT01298700|584696927|FG000|Overall Study|Adverse Event|50|||
161903883|NCT01298700|584696928|FG001|Overall Study|Adverse Event|51|||
161903884|NCT01298700|584696927|FG000|Overall Study|Lack of Efficacy|9|||
161903885|NCT01298700|584696928|FG001|Overall Study|Lack of Efficacy|14|||
161903886|NCT01298700|584696927|FG000|Overall Study|Lost to Follow-up|5|||
161903887|NCT01298700|584696928|FG001|Overall Study|Lost to Follow-up|2|||
161903888|NCT01298700|584696927|FG000|Overall Study|Withdrawal by Subject|12|||
161903889|NCT01298700|584696928|FG001|Overall Study|Withdrawal by Subject|9|||
161903890|NCT01298700|584696927|FG000|Overall Study|Protocol Violation|6|||
161903891|NCT01298700|584696928|FG001|Overall Study|Protocol Violation|4|||
161903892|NCT01298700|584696927|FG000|Overall Study|Other Miscellaneous Reasons|16|||
161903893|NCT01298700|584696928|FG001|Overall Study|Other Miscellaneous Reasons|15|||
161903894|NCT01298700|584696927|FG000|Overall Study|Did not Receive Study Drug|3|||
161903895|NCT01298700|584696928|FG001|Overall Study|Did not Receive Study Drug|5|||
161903896|NCT04006145|584696931|FG000|Overall Study|Lost to Follow-up|0|||
161903897|NCT04006145|584696932|FG001|Overall Study|Lost to Follow-up|1|||
161903898|NCT04006145|584696931|FG000|Overall Study|Other|1|||
161903899|NCT04006145|584696932|FG001|Overall Study|Other|2|||
161903900|NCT01001429|584696933|FG000|Overall Study|surgery cancelled|0|||
161903901|NCT01001429|584696934|FG001|Overall Study|surgery cancelled|1|||
161903902|NCT00010257|584696937|FG000|Overall Study|Withdrawal by Subject|1|||
161903903|NCT00010257|584696938|FG001|Overall Study|Withdrawal by Subject|0|||
161903904|NCT02812186|584696939|FG000|Period 1|Post randomization screen failure|5|||
161903905|NCT02812186|584696940|FG001|Period 1|Post randomization screen failure|9|||
161903906|NCT02812186|584696939|FG000|Period 1|nonevaluable data sets|6|||
161903907|NCT02812186|584696940|FG001|Period 1|nonevaluable data sets|6|||
161903908|NCT00643760|584696943|FG000|Overall Study|Adverse Event|11|||
161903909|NCT00643760|584696944|FG001|Overall Study|Adverse Event|5|||
161903910|NCT00643760|584696945|FG002|Overall Study|Adverse Event|12|||
161903911|NCT00643760|584696946|FG003|Overall Study|Adverse Event|21|||
161903912|NCT00643760|584696947|FG004|Overall Study|Adverse Event|6|||
161903913|NCT00643760|584696943|FG000|Overall Study|Lack of Efficacy|3|||
161903914|NCT00643760|584696944|FG001|Overall Study|Lack of Efficacy|1|||
161903915|NCT00643760|584696945|FG002|Overall Study|Lack of Efficacy|0|||
161903916|NCT00643760|584696946|FG003|Overall Study|Lack of Efficacy|4|||
161903917|NCT00643760|584696947|FG004|Overall Study|Lack of Efficacy|3|||
161903918|NCT00643760|584696943|FG000|Overall Study|Protocol Violation|7|||
161903919|NCT00643760|584696944|FG001|Overall Study|Protocol Violation|6|||
161903920|NCT00643760|584696945|FG002|Overall Study|Protocol Violation|4|||
161903921|NCT00643760|584696946|FG003|Overall Study|Protocol Violation|4|||
161903922|NCT00643760|584696947|FG004|Overall Study|Protocol Violation|6|||
161903923|NCT00643760|584696943|FG000|Overall Study|Lost to Follow-up|6|||
161903924|NCT00643760|584696944|FG001|Overall Study|Lost to Follow-up|2|||
161903925|NCT00643760|584696945|FG002|Overall Study|Lost to Follow-up|1|||
161903926|NCT00643760|584696946|FG003|Overall Study|Lost to Follow-up|3|||
161903927|NCT00643760|584696947|FG004|Overall Study|Lost to Follow-up|3|||
161903928|NCT00643760|584696943|FG000|Overall Study|Investigator Discretion|0|||
161903929|NCT00643760|584696944|FG001|Overall Study|Investigator Discretion|0|||
161903930|NCT00643760|584696945|FG002|Overall Study|Investigator Discretion|0|||
161903931|NCT00643760|584696946|FG003|Overall Study|Investigator Discretion|2|||
161903932|NCT00643760|584696947|FG004|Overall Study|Investigator Discretion|0|||
161903933|NCT00643760|584696943|FG000|Overall Study|Withdrawal by Subject|3|||
161903934|NCT00643760|584696944|FG001|Overall Study|Withdrawal by Subject|1|||
162010885|NCT02594124|585096050|FG007|Overall Study|Adverse Event|2|||
161903935|NCT00643760|584696945|FG002|Overall Study|Withdrawal by Subject|2|||
161903936|NCT00643760|584696946|FG003|Overall Study|Withdrawal by Subject|4|||
161903937|NCT00643760|584696947|FG004|Overall Study|Withdrawal by Subject|1|||
161903938|NCT00789321|584696951|FG000|Overall Study|Adverse Event|0|||
161903939|NCT00789321|584696952|FG001|Overall Study|Adverse Event|1|||
161903940|NCT00104052|584696953|FG000|Overall Study|Adverse Event|1|||
161903941|NCT00104052|584696953|FG000|Overall Study|Lack of Efficacy|26|||
161903942|NCT00104052|584696953|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
161903943|NCT01162343|584696954|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
161903944|NCT01162343|584696954|FG000|Overall Study|Refused psychiatrist assessment|12|||
161903945|NCT01294423|584696959|FG000|Overall Study|Adverse Event|1|||
161903946|NCT01294423|584696960|FG001|Overall Study|Adverse Event|2|||
161903947|NCT01294423|584696961|FG002|Overall Study|Adverse Event|3|||
161903948|NCT01294423|584696959|FG000|Overall Study|Withdrawal by Subject|1|||
161903949|NCT01294423|584696960|FG001|Overall Study|Withdrawal by Subject|2|||
161903950|NCT01294423|584696961|FG002|Overall Study|Withdrawal by Subject|2|||
161903951|NCT01294423|584696959|FG000|Overall Study|subject no longer meets study criteria|2|||
161903952|NCT01294423|584696960|FG001|Overall Study|subject no longer meets study criteria|5|||
161903953|NCT01294423|584696961|FG002|Overall Study|subject no longer meets study criteria|2|||
161903954|NCT01294423|584696959|FG000|Overall Study|poor/non-compliance|1|||
161903955|NCT01294423|584696960|FG001|Overall Study|poor/non-compliance|0|||
161903956|NCT01294423|584696961|FG002|Overall Study|poor/non-compliance|1|||
161903957|NCT01241279|584696962|FG000|Overall Study|Lost to Follow-up|0|||
161903958|NCT01241279|584696963|FG001|Overall Study|Lost to Follow-up|1|||
161903959|NCT01484951|584696964|FG000|Overall Study|Adverse Event|3|||
161903960|NCT01484951|584696964|FG000|Overall Study|Personal Reasons|1|||
161903961|NCT01484951|584696964|FG000|Overall Study|Non-Compliance|1|||
161903962|NCT02026141|584696966|FG000|Overall Study|Protocol Violation|0|||
161903963|NCT02026141|584696967|FG001|Overall Study|Protocol Violation|1|||
161903964|NCT02169505|584696968|FG000|Overall Study|Withdrawal by Subject|1|||
161903965|NCT01248455|584696969|FG000|Overall Study|switched to alternate treatment|1|||
161903966|NCT02735980|584696970|FG000|Overall Study|Adverse Event|0|||
161903967|NCT02735980|584696971|FG001|Overall Study|Adverse Event|4|||
161903968|NCT02735980|584696972|FG002|Overall Study|Adverse Event|1|||
161903969|NCT02735980|584696970|FG000|Overall Study|Death|5|||
161903970|NCT02735980|584696971|FG001|Overall Study|Death|4|||
161903971|NCT02735980|584696972|FG002|Overall Study|Death|0|||
161903972|NCT02735980|584696970|FG000|Overall Study|Physician Decision|3|||
161903973|NCT02735980|584696971|FG001|Overall Study|Physician Decision|1|||
161799895|NCT02924038|584310922|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
161799896|NCT02924038|584310923|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
161799897|NCT02473640|584310924|FG000|Treatment Period 1|Adverse Event|1|||
161799898|NCT02395822|584310925|FG000|Overall Study|Withdrawal by Subject|1|||
161799899|NCT02395822|584310925|FG000|Overall Study|Death|1|||
161799900|NCT03292653|584310928|FG000|Overall Study|Adverse Event|0|||
161799901|NCT03292653|584310929|FG001|Overall Study|Adverse Event|0|||
161799902|NCT03292653|584310930|FG002|Overall Study|Adverse Event|1|||
161799903|NCT03292653|584310928|FG000|Overall Study|Did not Receive Treatment|1|||
161799904|NCT03292653|584310929|FG001|Overall Study|Did not Receive Treatment|0|||
161799905|NCT03292653|584310930|FG002|Overall Study|Did not Receive Treatment|0|||
161799906|NCT04720664|584310931|FG000|Overall Study|Adverse Event|2|||
161799907|NCT04720664|584310931|FG000|Overall Study|Lack of Efficacy|9|||
161799908|NCT03311646|584310938|FG000|Overall Study|Physician Decision|1|||
161799909|NCT03311646|584310938|FG000|Overall Study|Withdrawal by Subject|5|||
161799910|NCT03311646|584310938|FG000|Overall Study|Lost to Follow-up|5|||
161799911|NCT03311646|584310938|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
161799912|NCT03103100|584310941|FG000|Overall Study|Adverse Event|1|||
161799913|NCT03103100|584310942|FG001|Overall Study|Adverse Event|0|||
161799914|NCT03103100|584310943|FG002|Overall Study|Adverse Event|0|||
161799915|NCT03103100|584310941|FG000|Overall Study|Physician Decision|1|||
161799916|NCT03103100|584310942|FG001|Overall Study|Physician Decision|0|||
161799917|NCT03103100|584310943|FG002|Overall Study|Physician Decision|2|||
161799918|NCT00531206|584310944|FG000|Overall Study|Adverse Event related|5|||
161799919|NCT00531206|584310944|FG000|Overall Study|Lack of Efficacy|2|||
161799920|NCT00531206|584310944|FG000|Overall Study|Lost to Follow-up|5|||
161799921|NCT00531206|584310944|FG000|Overall Study|including non-related adverse events|8|||
161799922|NCT03331042|584310963|FG000|Overall Study|Protocol Violation|1|||
161799923|NCT03331042|584310964|FG001|Overall Study|Protocol Violation|0|||
161799924|NCT03331042|584310965|FG002|Overall Study|Protocol Violation|0|||
161799925|NCT03331042|584310966|FG003|Overall Study|Protocol Violation|0|||
161799926|NCT03331042|584310963|FG000|Overall Study|Physician Decision|0|||
161799927|NCT03331042|584310964|FG001|Overall Study|Physician Decision|0|||
161799928|NCT03331042|584310965|FG002|Overall Study|Physician Decision|1|||
161799929|NCT03331042|584310966|FG003|Overall Study|Physician Decision|0|||
161799930|NCT03331042|584310963|FG000|Overall Study|Lost to Follow-up|0|||
161799931|NCT03331042|584310964|FG001|Overall Study|Lost to Follow-up|0|||
161799932|NCT03331042|584310965|FG002|Overall Study|Lost to Follow-up|0|||
161799933|NCT03331042|584310966|FG003|Overall Study|Lost to Follow-up|1|||
161799934|NCT02720510|584310970|FG000|Overall Study|Study Terminated by the sponsor|2|||
161799935|NCT02720510|584310971|FG001|Overall Study|Study Terminated by the sponsor|0|||
161799936|NCT02720510|584310970|FG000|Overall Study|Adverse Event|0|||
161799937|NCT02720510|584310971|FG001|Overall Study|Adverse Event|1|||
161799938|NCT02720510|584310970|FG000|Overall Study|Physician Decision|1|||
161799939|NCT02720510|584310971|FG001|Overall Study|Physician Decision|2|||
161799940|NCT02460159|584310972|FG000|Overall Study|Adverse Event|4|||
161799941|NCT02460159|584310973|FG001|Overall Study|Adverse Event|1|||
161799942|NCT02460159|584310972|FG000|Overall Study|Withdrawal by Subject|2|||
161799943|NCT02460159|584310973|FG001|Overall Study|Withdrawal by Subject|0|||
161799944|NCT03499964|584310974|FG000|Overall Study|Lack of Efficacy|6|||
161799945|NCT03499964|584310975|FG001|Overall Study|Lack of Efficacy|26|||
161799946|NCT03499964|584310974|FG000|Overall Study|Adverse Event|1|||
161799947|NCT03499964|584310975|FG001|Overall Study|Adverse Event|0|||
162138319|NCT04888585|585557325|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
162138320|NCT04888585|585557326|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
162138321|NCT04888585|585557327|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
162138322|NCT04888585|585557328|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
162138323|NCT04888585|585557329|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
162138324|NCT04888585|585557330|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162138325|NCT04888585|585557331|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162138326|NCT04888585|585557332|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162138327|NCT04888585|585557333|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162138328|NCT04888585|585557334|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162138329|NCT04888585|585557335|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
162138330|NCT04888585|585557325|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
161799948|NCT03499964|584310974|FG000|Overall Study|Death|1|||
161799949|NCT03499964|584310975|FG001|Overall Study|Death|0|||
161799950|NCT03499964|584310974|FG000|Overall Study|Withdrawal by Subject|2|||
161799951|NCT03499964|584310975|FG001|Overall Study|Withdrawal by Subject|1|||
161799952|NCT03499964|584310974|FG000|Overall Study|Lost to Follow-up|1|||
161799953|NCT03499964|584310975|FG001|Overall Study|Lost to Follow-up|0|||
161799954|NCT00084084|584310976|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
161799955|NCT00084084|584310976|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
161799956|NCT01047345|584310977|FG000|Base Study|Adverse Event|3|||
161799957|NCT01047345|584310978|FG001|Base Study|Adverse Event|0|||
161799958|NCT01047345|584310979|FG002|Base Study|Adverse Event|0|||
161799959|NCT01047345|584310977|FG000|Base Study|Lost to Follow-up|4|||
161799960|NCT01047345|584310978|FG001|Base Study|Lost to Follow-up|1|||
161799961|NCT01047345|584310979|FG002|Base Study|Lost to Follow-up|0|||
161799962|NCT01047345|584310977|FG000|Base Study|Protocol Violation|3|||
161799963|NCT01047345|584310978|FG001|Base Study|Protocol Violation|1|||
161799964|NCT01047345|584310979|FG002|Base Study|Protocol Violation|0|||
161799965|NCT01047345|584310977|FG000|Base Study|Withdrawal by Subject|12|||
161799966|NCT01047345|584310978|FG001|Base Study|Withdrawal by Subject|4|||
161799967|NCT01047345|584310979|FG002|Base Study|Withdrawal by Subject|0|||
161799968|NCT01047345|584310977|FG000|Extension|Withdrawal by Subject|0|||
161799969|NCT01047345|584310978|FG001|Extension|Withdrawal by Subject|0|||
161799970|NCT01047345|584310979|FG002|Extension|Withdrawal by Subject|1|||
161799971|NCT01047345|584310977|FG000|Extension|Lost to Follow-up|0|||
161799972|NCT01047345|584310978|FG001|Extension|Lost to Follow-up|0|||
161799973|NCT01047345|584310979|FG002|Extension|Lost to Follow-up|5|||
161799974|NCT00712010|584310980|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
161799975|NCT00995553|584310984|FG000|Overall Study|Withdrawal by Subject|2|||
161799976|NCT00995553|584310985|FG001|Overall Study|Withdrawal by Subject|6|||
161799977|NCT00927810|584310986|FG000|Overall Study|Withdrawal by Subject|0|||
161799978|NCT00927810|584310987|FG001|Overall Study|Withdrawal by Subject|3|||
161799979|NCT00927810|584310988|FG002|Overall Study|Withdrawal by Subject|0|||
161799980|NCT00927810|584310989|FG003|Overall Study|Withdrawal by Subject|1|||
161799981|NCT00927810|584310986|FG000|Overall Study|Lost to Follow-up|0|||
161799982|NCT00927810|584310987|FG001|Overall Study|Lost to Follow-up|2|||
161799983|NCT00927810|584310988|FG002|Overall Study|Lost to Follow-up|1|||
161799984|NCT00927810|584310989|FG003|Overall Study|Lost to Follow-up|1|||
161799985|NCT00927810|584310986|FG000|Overall Study|Death|0|||
161799986|NCT00927810|584310987|FG001|Overall Study|Death|2|||
161799987|NCT00927810|584310988|FG002|Overall Study|Death|0|||
161799988|NCT00927810|584310989|FG003|Overall Study|Death|0|||
161799989|NCT00927810|584310986|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161799990|NCT00927810|584310987|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161799991|NCT00927810|584310988|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161799992|NCT00927810|584310989|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161799993|NCT02465567|584310990|FG000|Overall Study|Adverse Event|118|||
161799994|NCT02465567|584310991|FG001|Overall Study|Adverse Event|113|||
161799995|NCT02465567|584310992|FG002|Overall Study|Adverse Event|147|||
161903974|NCT02735980|584696972|FG002|Overall Study|Physician Decision|0|||
161903975|NCT02735980|584696970|FG000|Overall Study|Screen failure|1|||
161903976|NCT02735980|584696971|FG001|Overall Study|Screen failure|0|||
161903977|NCT02735980|584696972|FG002|Overall Study|Screen failure|0|||
161903978|NCT02735980|584696970|FG000|Overall Study|Withdrawal by Subject|1|||
161903979|NCT02735980|584696971|FG001|Overall Study|Withdrawal by Subject|2|||
161903980|NCT02735980|584696972|FG002|Overall Study|Withdrawal by Subject|0|||
161903981|NCT00917124|584696976|FG000|Overall Study|Protocol Violation|4|||
161903982|NCT00917124|584696977|FG001|Overall Study|Protocol Violation|6|||
161903983|NCT01783743|584696978|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
161903984|NCT01783743|584696979|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
161903985|NCT01783743|584696978|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
161903986|NCT01783743|584696979|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
161903987|NCT01783743|584696978|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
161903988|NCT01783743|584696979|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
161903989|NCT00126594|584696994|FG000|Overall Study|Ineligible|2|||
161903990|NCT00126594|584696995|FG001|Overall Study|Ineligible|0|||
161903991|NCT00126594|584696994|FG000|Overall Study|Withdrawal by Subject|0|||
161903992|NCT00126594|584696995|FG001|Overall Study|Withdrawal by Subject|4|||
161903993|NCT00126594|584696994|FG000|Overall Study|Physician Decision|1|||
161903994|NCT00126594|584696995|FG001|Overall Study|Physician Decision|3|||
161903995|NCT00126594|584696994|FG000|Overall Study|Adverse Event|7|||
161903996|NCT00126594|584696995|FG001|Overall Study|Adverse Event|5|||
161903997|NCT00126594|584696994|FG000|Overall Study|Non-compliance|0|||
161903998|NCT00126594|584696995|FG001|Overall Study|Non-compliance|1|||
161903999|NCT00126594|584696994|FG000|Overall Study|Disease Progression|29|||
161904000|NCT00126594|584696995|FG001|Overall Study|Disease Progression|24|||
161904001|NCT00983372|584696996|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
161904002|NCT00983372|584696996|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
161904003|NCT00983372|584696996|FG000|Diltiazem ER Alone|Adverse Event|1|||
161904004|NCT05635045|584696997|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
161904005|NCT05635045|584696998|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
161904006|NCT05635045|584696999|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
161904007|NCT05635045|584697000|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
161904008|NCT00673257|584697010|FG000|Overall Study|Withdrawal by Subject|4|||
161904009|NCT00673257|584697010|FG000|Overall Study|Unable to obtain specimen|1|||
161904010|NCT01585246|584697017|FG000|Overall Study|Lost to Follow-up|0|||
161904011|NCT01585246|584697018|FG001|Overall Study|Lost to Follow-up|0|||
161904012|NCT01585246|584697019|FG002|Overall Study|Lost to Follow-up|2|||
161904013|NCT01585246|584697020|FG003|Overall Study|Lost to Follow-up|1|||
161904014|NCT01585246|584697021|FG004|Overall Study|Lost to Follow-up|0|||
161904015|NCT01585246|584697017|FG000|Overall Study|Protocol Violation|0|||
161904016|NCT01585246|584697018|FG001|Overall Study|Protocol Violation|0|||
161904017|NCT01585246|584697019|FG002|Overall Study|Protocol Violation|0|||
161904018|NCT01585246|584697020|FG003|Overall Study|Protocol Violation|0|||
161904019|NCT01585246|584697021|FG004|Overall Study|Protocol Violation|1|||
161904020|NCT01585246|584697017|FG000|Overall Study|Withdrawal by Subject|0|||
161904021|NCT01585246|584697018|FG001|Overall Study|Withdrawal by Subject|0|||
161904022|NCT01585246|584697019|FG002|Overall Study|Withdrawal by Subject|1|||
161904023|NCT01585246|584697020|FG003|Overall Study|Withdrawal by Subject|2|||
161904024|NCT01585246|584697021|FG004|Overall Study|Withdrawal by Subject|1|||
161904025|NCT01585246|584697017|FG000|Overall Study|Other|0|||
161904026|NCT01585246|584697018|FG001|Overall Study|Other|1|||
161904027|NCT01585246|584697019|FG002|Overall Study|Other|1|||
161904028|NCT01585246|584697020|FG003|Overall Study|Other|1|||
161904029|NCT01585246|584697021|FG004|Overall Study|Other|0|||
161904030|NCT04396626|584697022|FG000|Overall Study|Premature termination of study|975|||
161904031|NCT02111174|584697023|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
161904032|NCT02111174|584697024|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
161904033|NCT02111174|584697023|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
161904034|NCT02111174|584697024|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
161904035|NCT02111174|584697023|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
161904036|NCT02111174|584697024|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
161904037|NCT02111174|584697023|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
161904038|NCT02111174|584697024|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
161904039|NCT04552132|584697025|FG000|Overall Study|Lost to Follow-up|4|||
161904040|NCT04552132|584697026|FG001|Overall Study|Lost to Follow-up|3|||
161904041|NCT04552132|584697025|FG000|Overall Study|Protocol Violation|1|||
161904042|NCT04552132|584697026|FG001|Overall Study|Protocol Violation|0|||
161904043|NCT01657162|584697027|FG000|Overall Study|Adverse Event|26|||
161904044|NCT01657162|584697028|FG001|Overall Study|Adverse Event|36|||
161904045|NCT01657162|584697027|FG000|Overall Study|Withdrawal by Subject|13|||
161904046|NCT01657162|584697028|FG001|Overall Study|Withdrawal by Subject|13|||
161904047|NCT01657162|584697027|FG000|Overall Study|Continuing Significant Deterioration|9|||
161904048|NCT01657162|584697028|FG001|Overall Study|Continuing Significant Deterioration|3|||
161904049|NCT01657162|584697027|FG000|Overall Study|Refusal of Treatment|4|||
161904050|NCT01657162|584697028|FG001|Overall Study|Refusal of Treatment|6|||
161904051|NCT01657162|584697027|FG000|Overall Study|Lost to Follow-up|3|||
161904052|NCT01657162|584697028|FG001|Overall Study|Lost to Follow-up|4|||
161904053|NCT01657162|584697027|FG000|Overall Study|Death|2|||
161904054|NCT01657162|584697028|FG001|Overall Study|Death|3|||
161904055|NCT01657162|584697027|FG000|Overall Study|Inability to Complete Study Procedures|1|||
161904056|NCT01657162|584697028|FG001|Overall Study|Inability to Complete Study Procedures|7|||
161904057|NCT01657162|584697027|FG000|Overall Study|Protocol Violation|1|||
161904058|NCT01657162|584697028|FG001|Overall Study|Protocol Violation|0|||
161904059|NCT01657162|584697027|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
161904060|NCT01657162|584697028|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
161904061|NCT01657162|584697027|FG000|Overall Study|Other than Specified|0|||
161904062|NCT01657162|584697028|FG001|Overall Study|Other than Specified|2|||
161904063|NCT02600923|584697031|FG000|Overall Study|Death|10|||
161904064|NCT02600923|584697031|FG000|Overall Study|Adverse Event|3|||
161904065|NCT02600923|584697031|FG000|Overall Study|Global deterioration of health status|2|||
161904066|NCT02600923|584697031|FG000|Overall Study|Insufficient clinical response|6|||
161904067|NCT02600923|584697031|FG000|Overall Study|Lost to Follow-up|1|||
161904068|NCT02600923|584697031|FG000|Overall Study|Withdrawal by Subject|5|||
161904069|NCT02600923|584697031|FG000|Overall Study|Objective progression or relapse|50|||
161904070|NCT02600923|584697031|FG000|Overall Study|Study terminated by Sponsor|53|||
161904071|NCT02600923|584697031|FG000|Overall Study|Not treated|1|||
161904072|NCT00792909|584697032|FG000|Overall Study|Withdrawal by Subject|0|||
161904073|NCT00792909|584697033|FG001|Overall Study|Withdrawal by Subject|1|||
161904074|NCT00792909|584697034|FG002|Overall Study|Withdrawal by Subject|0|||
161904075|NCT01747499|584697037|FG000|Overall Study|Steroid refractory aGvHD|1|||
161904076|NCT01747499|584697038|FG001|Overall Study|Steroid refractory aGvHD|0|||
161904077|NCT01747499|584697039|FG002|Overall Study|Steroid refractory aGvHD|0|||
161904078|NCT01747499|584697040|FG003|Overall Study|Steroid refractory aGvHD|1|||
161904079|NCT01747499|584697041|FG004|Overall Study|Steroid refractory aGvHD|4|||
161904080|NCT01747499|584697037|FG000|Overall Study|Physician Decision|0|||
161904081|NCT01747499|584697038|FG001|Overall Study|Physician Decision|1|||
161904082|NCT01747499|584697039|FG002|Overall Study|Physician Decision|0|||
161904083|NCT01747499|584697040|FG003|Overall Study|Physician Decision|0|||
161904084|NCT01747499|584697041|FG004|Overall Study|Physician Decision|2|||
161904085|NCT01747499|584697037|FG000|Overall Study|Death|0|||
161904086|NCT01747499|584697038|FG001|Overall Study|Death|0|||
161904087|NCT01747499|584697039|FG002|Overall Study|Death|0|||
161904088|NCT01747499|584697040|FG003|Overall Study|Death|1|||
161904089|NCT01747499|584697041|FG004|Overall Study|Death|1|||
161904090|NCT01747499|584697037|FG000|Overall Study|Withdrawal by Subject|0|||
162138331|NCT04888585|585557326|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
162138332|NCT04888585|585557327|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
162138333|NCT04888585|585557328|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
162138334|NCT04888585|585557329|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
162138335|NCT04888585|585557330|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162138336|NCT04888585|585557331|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162138337|NCT04888585|585557332|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162138338|NCT04888585|585557333|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162138339|NCT04888585|585557334|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162138340|NCT04888585|585557335|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
162138341|NCT04888585|585557325|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162138342|NCT04888585|585557326|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162138343|NCT04888585|585557327|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
162138344|NCT04888585|585557328|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162138345|NCT04888585|585557329|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
162138346|NCT04888585|585557330|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162138347|NCT04888585|585557331|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162138348|NCT04888585|585557332|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162138349|NCT04888585|585557333|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
162138350|NCT04888585|585557334|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
161904091|NCT01747499|584697038|FG001|Overall Study|Withdrawal by Subject|0|||
161904092|NCT01747499|584697039|FG002|Overall Study|Withdrawal by Subject|0|||
161904093|NCT01747499|584697040|FG003|Overall Study|Withdrawal by Subject|0|||
161904094|NCT01747499|584697041|FG004|Overall Study|Withdrawal by Subject|6|||
161904095|NCT01747499|584697037|FG000|Overall Study|Developed AML and death|0|||
161904096|NCT01747499|584697038|FG001|Overall Study|Developed AML and death|0|||
161904097|NCT01747499|584697039|FG002|Overall Study|Developed AML and death|0|||
161904098|NCT01747499|584697040|FG003|Overall Study|Developed AML and death|0|||
161904099|NCT01747499|584697041|FG004|Overall Study|Developed AML and death|1|||
161904100|NCT01747499|584697037|FG000|Overall Study|Determined not to be eligible|0|||
161799996|NCT02465567|584310993|FG003|Overall Study|Adverse Event|138|||
161799997|NCT02465567|584310990|FG000|Overall Study|Lack of Efficacy|103|||
161799998|NCT02465567|584310991|FG001|Overall Study|Lack of Efficacy|102|||
161799999|NCT02465567|584310992|FG002|Overall Study|Lack of Efficacy|171|||
161800000|NCT02465567|584310993|FG003|Overall Study|Lack of Efficacy|135|||
161800001|NCT02465567|584310990|FG000|Overall Study|Withdrawal by Subject|104|||
161800002|NCT02465567|584310991|FG001|Overall Study|Withdrawal by Subject|94|||
161800003|NCT02465567|584310992|FG002|Overall Study|Withdrawal by Subject|123|||
161800004|NCT02465567|584310993|FG003|Overall Study|Withdrawal by Subject|130|||
161800005|NCT02465567|584310990|FG000|Overall Study|Physician Decision|23|||
161800006|NCT02465567|584310991|FG001|Overall Study|Physician Decision|33|||
161800007|NCT02465567|584310992|FG002|Overall Study|Physician Decision|38|||
161800008|NCT02465567|584310993|FG003|Overall Study|Physician Decision|28|||
161800009|NCT02465567|584310990|FG000|Overall Study|Major Protocol Deviation|24|||
161800010|NCT02465567|584310991|FG001|Overall Study|Major Protocol Deviation|26|||
161800011|NCT02465567|584310992|FG002|Overall Study|Major Protocol Deviation|22|||
161800012|NCT02465567|584310993|FG003|Overall Study|Major Protocol Deviation|25|||
161800013|NCT02465567|584310990|FG000|Overall Study|Lost to Follow-up|25|||
161800014|NCT02465567|584310991|FG001|Overall Study|Lost to Follow-up|21|||
161800015|NCT02465567|584310992|FG002|Overall Study|Lost to Follow-up|19|||
161800016|NCT02465567|584310993|FG003|Overall Study|Lost to Follow-up|15|||
161800017|NCT02465567|584310990|FG000|Overall Study|Protocol Specified Criteria|20|||
161800018|NCT02465567|584310991|FG001|Overall Study|Protocol Specified Criteria|10|||
161800019|NCT02465567|584310992|FG002|Overall Study|Protocol Specified Criteria|9|||
161800020|NCT02465567|584310993|FG003|Overall Study|Protocol Specified Criteria|12|||
161800021|NCT02465567|584310990|FG000|Overall Study|Administrative Reasons|12|||
161800022|NCT02465567|584310991|FG001|Overall Study|Administrative Reasons|9|||
161800023|NCT02465567|584310992|FG002|Overall Study|Administrative Reasons|11|||
161800024|NCT02465567|584310993|FG003|Overall Study|Administrative Reasons|5|||
161800025|NCT02465567|584310990|FG000|Overall Study|Randomized but not treated|1|||
161800026|NCT02465567|584310991|FG001|Overall Study|Randomized but not treated|5|||
161800027|NCT02465567|584310992|FG002|Overall Study|Randomized but not treated|4|||
161800028|NCT02465567|584310993|FG003|Overall Study|Randomized but not treated|5|||
161800029|NCT02465567|584310990|FG000|Overall Study|enrolled in >1 studies|18|||
161800030|NCT02465567|584310991|FG001|Overall Study|enrolled in >1 studies|11|||
161800031|NCT02465567|584310992|FG002|Overall Study|enrolled in >1 studies|19|||
161800032|NCT02465567|584310993|FG003|Overall Study|enrolled in >1 studies|15|||
161800033|NCT02465567|584310990|FG000|Overall Study|missing PI Signature|1|||
161800034|NCT02465567|584310991|FG001|Overall Study|missing PI Signature|0|||
161800035|NCT02465567|584310992|FG002|Overall Study|missing PI Signature|0|||
161800036|NCT02465567|584310993|FG003|Overall Study|missing PI Signature|0|||
161800037|NCT00950807|584310997|FG000|Treatment Period 1|Lack of Efficacy|1|||
161800038|NCT00950807|584310998|FG001|Treatment Period 1|Lack of Efficacy|0|||
161800039|NCT00950807|584310999|FG002|Treatment Period 1|Lack of Efficacy|0|||
161800040|NCT00950807|584311000|FG003|Treatment Period 1|Lack of Efficacy|0|||
161800041|NCT00950807|584311001|FG004|Treatment Period 1|Lack of Efficacy|0|||
161800042|NCT00950807|584311002|FG005|Treatment Period 1|Lack of Efficacy|1|||
161800043|NCT00950807|584311003|FG006|Treatment Period 1|Lack of Efficacy|0|||
161800044|NCT00950807|584311004|FG007|Treatment Period 1|Lack of Efficacy|0|||
161800045|NCT00950807|584311005|FG008|Treatment Period 1|Lack of Efficacy|0|||
161800046|NCT00950807|584311006|FG009|Treatment Period 1|Lack of Efficacy|0|||
161800047|NCT00950807|584310997|FG000|Treatment Period 1|Protocol Violation|1|||
161800048|NCT00950807|584310998|FG001|Treatment Period 1|Protocol Violation|0|||
161800049|NCT00950807|584310999|FG002|Treatment Period 1|Protocol Violation|0|||
161800050|NCT00950807|584311000|FG003|Treatment Period 1|Protocol Violation|0|||
161800051|NCT00950807|584311001|FG004|Treatment Period 1|Protocol Violation|0|||
161800052|NCT00950807|584311002|FG005|Treatment Period 1|Protocol Violation|0|||
161800053|NCT00950807|584311003|FG006|Treatment Period 1|Protocol Violation|0|||
161800054|NCT00950807|584311004|FG007|Treatment Period 1|Protocol Violation|0|||
161800055|NCT00950807|584311005|FG008|Treatment Period 1|Protocol Violation|0|||
161800056|NCT00950807|584311006|FG009|Treatment Period 1|Protocol Violation|0|||
161800057|NCT00950807|584310997|FG000|Treatment Period 1|Lost to Follow-up|0|||
161800058|NCT00950807|584310998|FG001|Treatment Period 1|Lost to Follow-up|0|||
161800059|NCT00950807|584310999|FG002|Treatment Period 1|Lost to Follow-up|1|||
161800060|NCT00950807|584311000|FG003|Treatment Period 1|Lost to Follow-up|0|||
161800061|NCT00950807|584311001|FG004|Treatment Period 1|Lost to Follow-up|0|||
161800062|NCT00950807|584311002|FG005|Treatment Period 1|Lost to Follow-up|0|||
161800063|NCT00950807|584311003|FG006|Treatment Period 1|Lost to Follow-up|0|||
161800064|NCT00950807|584311004|FG007|Treatment Period 1|Lost to Follow-up|0|||
161800065|NCT00950807|584311005|FG008|Treatment Period 1|Lost to Follow-up|0|||
161800066|NCT00950807|584311006|FG009|Treatment Period 1|Lost to Follow-up|0|||
161800067|NCT00950807|584310997|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161800068|NCT00950807|584310998|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161800069|NCT00950807|584310999|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161800070|NCT00950807|584311000|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161800071|NCT00950807|584311001|FG004|Treatment Period 1|Withdrawal by Subject|1|||
161800072|NCT00950807|584311002|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161800073|NCT00950807|584311003|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161800074|NCT00950807|584311004|FG007|Treatment Period 1|Withdrawal by Subject|0|||
161800075|NCT00950807|584311005|FG008|Treatment Period 1|Withdrawal by Subject|1|||
161800076|NCT00950807|584311006|FG009|Treatment Period 1|Withdrawal by Subject|0|||
161800077|NCT00950807|584310997|FG000|Treatment Period 1|Adverse Event|0|||
161800078|NCT00950807|584310998|FG001|Treatment Period 1|Adverse Event|0|||
161800079|NCT00950807|584310999|FG002|Treatment Period 1|Adverse Event|0|||
161800080|NCT00950807|584311000|FG003|Treatment Period 1|Adverse Event|0|||
161800081|NCT00950807|584311001|FG004|Treatment Period 1|Adverse Event|0|||
161800082|NCT00950807|584311002|FG005|Treatment Period 1|Adverse Event|1|||
161800083|NCT00950807|584311003|FG006|Treatment Period 1|Adverse Event|0|||
161800084|NCT00950807|584311004|FG007|Treatment Period 1|Adverse Event|0|||
161800085|NCT00950807|584311005|FG008|Treatment Period 1|Adverse Event|0|||
161800086|NCT00950807|584311006|FG009|Treatment Period 1|Adverse Event|0|||
161800087|NCT00950807|584310997|FG000|Washout Period 1|Lack of Efficacy|0|||
161800088|NCT00950807|584310998|FG001|Washout Period 1|Lack of Efficacy|0|||
161800089|NCT00950807|584310999|FG002|Washout Period 1|Lack of Efficacy|0|||
161800090|NCT00950807|584311000|FG003|Washout Period 1|Lack of Efficacy|0|||
161800091|NCT00950807|584311001|FG004|Washout Period 1|Lack of Efficacy|0|||
161800092|NCT00950807|584311002|FG005|Washout Period 1|Lack of Efficacy|0|||
161800093|NCT00950807|584311003|FG006|Washout Period 1|Lack of Efficacy|1|||
161800094|NCT00950807|584311004|FG007|Washout Period 1|Lack of Efficacy|0|||
161800095|NCT00950807|584311005|FG008|Washout Period 1|Lack of Efficacy|0|||
161800096|NCT00950807|584311006|FG009|Washout Period 1|Lack of Efficacy|0|||
161800097|NCT00950807|584310997|FG000|Washout Period 1|Withdrawal by Subject|0|||
161800098|NCT00950807|584310998|FG001|Washout Period 1|Withdrawal by Subject|0|||
161800099|NCT00950807|584310999|FG002|Washout Period 1|Withdrawal by Subject|0|||
161800100|NCT00950807|584311000|FG003|Washout Period 1|Withdrawal by Subject|0|||
161800101|NCT00950807|584311001|FG004|Washout Period 1|Withdrawal by Subject|0|||
161800102|NCT00950807|584311002|FG005|Washout Period 1|Withdrawal by Subject|0|||
161800103|NCT00950807|584311003|FG006|Washout Period 1|Withdrawal by Subject|0|||
161800104|NCT00950807|584311004|FG007|Washout Period 1|Withdrawal by Subject|0|||
161800105|NCT00950807|584311005|FG008|Washout Period 1|Withdrawal by Subject|1|||
161800106|NCT00950807|584311006|FG009|Washout Period 1|Withdrawal by Subject|0|||
161800107|NCT00950807|584310997|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
161800108|NCT00950807|584310998|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800109|NCT00950807|584310999|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800110|NCT00950807|584311000|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800111|NCT00950807|584311001|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800112|NCT00950807|584311002|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800113|NCT00950807|584311003|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
161800114|NCT00950807|584311004|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
161800115|NCT00950807|584311005|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800116|NCT00950807|584311006|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161800117|NCT00950807|584310997|FG000|Washout Period 1|Adverse Event|2|||
161800118|NCT00950807|584310998|FG001|Washout Period 1|Adverse Event|0|||
161800119|NCT00950807|584310999|FG002|Washout Period 1|Adverse Event|0|||
161800120|NCT00950807|584311000|FG003|Washout Period 1|Adverse Event|1|||
161800121|NCT00950807|584311001|FG004|Washout Period 1|Adverse Event|1|||
161800122|NCT00950807|584311002|FG005|Washout Period 1|Adverse Event|0|||
161800123|NCT00950807|584311003|FG006|Washout Period 1|Adverse Event|0|||
161800124|NCT00950807|584311004|FG007|Washout Period 1|Adverse Event|0|||
161800125|NCT00950807|584311005|FG008|Washout Period 1|Adverse Event|0|||
161800126|NCT00950807|584311006|FG009|Washout Period 1|Adverse Event|0|||
161800127|NCT00950807|584310997|FG000|Treatment Period 2|Lack of Efficacy|1|||
161800128|NCT00950807|584310998|FG001|Treatment Period 2|Lack of Efficacy|0|||
161800129|NCT00950807|584310999|FG002|Treatment Period 2|Lack of Efficacy|0|||
161800130|NCT00950807|584311000|FG003|Treatment Period 2|Lack of Efficacy|0|||
161800131|NCT00950807|584311001|FG004|Treatment Period 2|Lack of Efficacy|0|||
161904101|NCT01747499|584697038|FG001|Overall Study|Determined not to be eligible|0|||
161904102|NCT01747499|584697039|FG002|Overall Study|Determined not to be eligible|0|||
161800132|NCT00950807|584311002|FG005|Treatment Period 2|Lack of Efficacy|0|||
161800133|NCT00950807|584311003|FG006|Treatment Period 2|Lack of Efficacy|0|||
161800134|NCT00950807|584311004|FG007|Treatment Period 2|Lack of Efficacy|0|||
161800135|NCT00950807|584311005|FG008|Treatment Period 2|Lack of Efficacy|0|||
161800136|NCT00950807|584311006|FG009|Treatment Period 2|Lack of Efficacy|0|||
161800137|NCT00950807|584310997|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161904103|NCT01747499|584697040|FG003|Overall Study|Determined not to be eligible|0|||
161904104|NCT01747499|584697041|FG004|Overall Study|Determined not to be eligible|1|||
161904105|NCT01676701|584697042|FG000|Overall Study|Protocol Violation|1|||
161904106|NCT01676701|584697043|FG001|Overall Study|Protocol Violation|0|||
161904107|NCT01676701|584697042|FG000|Overall Study|Sponsor Decision|3|||
161904108|NCT01676701|584697043|FG001|Overall Study|Sponsor Decision|4|||
161904109|NCT00196105|584697044|FG000|Overall Study|Lost to Follow-up|4|||
161904110|NCT00196105|584697045|FG001|Overall Study|Lost to Follow-up|5|||
161904111|NCT00196105|584697046|FG002|Overall Study|Lost to Follow-up|7|||
161904112|NCT04058028|584697050|FG000|Overall Study|Withdrawal of Consent from Study|12|||
161904113|NCT04058028|584697051|FG001|Overall Study|Withdrawal of Consent from Study|8|||
161904114|NCT04058028|584697052|FG002|Overall Study|Withdrawal of Consent from Study|6|||
161904115|NCT04058028|584697053|FG003|Overall Study|Withdrawal of Consent from Study|7|||
161904116|NCT04058028|584697050|FG000|Overall Study|Decision by Sponsor|13|||
161904117|NCT04058028|584697051|FG001|Overall Study|Decision by Sponsor|4|||
161904118|NCT04058028|584697052|FG002|Overall Study|Decision by Sponsor|1|||
161904119|NCT04058028|584697053|FG003|Overall Study|Decision by Sponsor|35|||
161904120|NCT04058028|584697050|FG000|Overall Study|Lost to Follow-up|1|||
161904121|NCT04058028|584697051|FG001|Overall Study|Lost to Follow-up|1|||
161904122|NCT04058028|584697052|FG002|Overall Study|Lost to Follow-up|1|||
161904123|NCT04058028|584697053|FG003|Overall Study|Lost to Follow-up|0|||
161904124|NCT04058028|584697050|FG000|Overall Study|Death|0|||
161904125|NCT04058028|584697051|FG001|Overall Study|Death|1|||
161904126|NCT04058028|584697052|FG002|Overall Study|Death|0|||
161904127|NCT04058028|584697053|FG003|Overall Study|Death|0|||
161904128|NCT02227784|584697054|FG000|Double-Blind Phase|Adverse Event|3|||
161904129|NCT02227784|584697055|FG001|Double-Blind Phase|Adverse Event|2|||
161904130|NCT02227784|584697056|FG002|Double-Blind Phase|Adverse Event|1|||
161904131|NCT02227784|584697057|FG003|Double-Blind Phase|Adverse Event|3|||
161904132|NCT02227784|584697058|FG004|Double-Blind Phase|Adverse Event|0|||
161904133|NCT02227784|584697054|FG000|Double-Blind Phase|Physician Decision|1|||
161904134|NCT02227784|584697055|FG001|Double-Blind Phase|Physician Decision|0|||
161904135|NCT02227784|584697056|FG002|Double-Blind Phase|Physician Decision|0|||
161904136|NCT02227784|584697057|FG003|Double-Blind Phase|Physician Decision|1|||
161904137|NCT02227784|584697058|FG004|Double-Blind Phase|Physician Decision|0|||
161904138|NCT02227784|584697054|FG000|Double-Blind Phase|Protocol Violation|0|||
161904139|NCT02227784|584697055|FG001|Double-Blind Phase|Protocol Violation|0|||
161904140|NCT02227784|584697056|FG002|Double-Blind Phase|Protocol Violation|1|||
161904141|NCT02227784|584697057|FG003|Double-Blind Phase|Protocol Violation|1|||
161904142|NCT02227784|584697058|FG004|Double-Blind Phase|Protocol Violation|0|||
161904143|NCT02227784|584697054|FG000|Double-Blind Phase|Sponsor Decision|34|||
161904144|NCT02227784|584697055|FG001|Double-Blind Phase|Sponsor Decision|15|||
161904145|NCT02227784|584697056|FG002|Double-Blind Phase|Sponsor Decision|14|||
161904146|NCT02227784|584697057|FG003|Double-Blind Phase|Sponsor Decision|32|||
161904147|NCT02227784|584697058|FG004|Double-Blind Phase|Sponsor Decision|0|||
161904148|NCT02227784|584697054|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
161904149|NCT02227784|584697055|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
161904150|NCT02227784|584697056|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
161904151|NCT02227784|584697057|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
161904152|NCT02227784|584697058|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161904153|NCT02227784|584697054|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
161904154|NCT02227784|584697055|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
161904155|NCT02227784|584697056|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
161904156|NCT02227784|584697057|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
161904157|NCT02227784|584697058|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
161904158|NCT02227784|584697054|FG000|Open-Label Extension Phase (OLE)|Death|0|||
161904159|NCT02227784|584697055|FG001|Open-Label Extension Phase (OLE)|Death|0|||
161904160|NCT02227784|584697056|FG002|Open-Label Extension Phase (OLE)|Death|0|||
161904161|NCT02227784|584697057|FG003|Open-Label Extension Phase (OLE)|Death|0|||
161904162|NCT02227784|584697058|FG004|Open-Label Extension Phase (OLE)|Death|1|||
161904163|NCT02227784|584697054|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161904164|NCT02227784|584697055|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161904165|NCT02227784|584697056|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161904166|NCT02227784|584697057|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161904167|NCT02227784|584697058|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
161904168|NCT02227784|584697054|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
161904169|NCT02227784|584697055|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
161904170|NCT02227784|584697056|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
161904171|NCT02227784|584697057|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
161904172|NCT02227784|584697058|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
161904173|NCT00248651|584697059|FG000|Overall Study|Withdrawal by Subject|28|||
161904174|NCT00248651|584697060|FG001|Overall Study|Withdrawal by Subject|40|||
161904175|NCT00248651|584697061|FG002|Overall Study|Withdrawal by Subject|32|||
161904176|NCT00828113|584697064|FG000|Overall Study|Withdrawal by Subject|27|||
161904177|NCT00828113|584697065|FG001|Overall Study|Withdrawal by Subject|26|||
161904178|NCT00828113|584697064|FG000|Overall Study|Lost to Follow-up|3|||
161904179|NCT00828113|584697065|FG001|Overall Study|Lost to Follow-up|5|||
161904180|NCT01365130|584697066|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
161904181|NCT05607576|584697068|FG000|Overall Study|immediate sensor error|2|||
161904182|NCT05607576|584697068|FG000|Overall Study|Physician Decision|2|||
161904183|NCT05616013|584697069|FG000|Overall Study|Adverse Event|6|||
161904184|NCT05616013|584697070|FG001|Overall Study|Adverse Event|12|||
161904185|NCT05616013|584697071|FG002|Overall Study|Adverse Event|8|||
161904186|NCT05616013|584697072|FG003|Overall Study|Adverse Event|4|||
161904187|NCT05616013|584697073|FG004|Overall Study|Adverse Event|6|||
161904188|NCT05616013|584697074|FG005|Overall Study|Adverse Event|8|||
161904189|NCT05616013|584697075|FG006|Overall Study|Adverse Event|3|||
161904190|NCT05616013|584697076|FG007|Overall Study|Adverse Event|6|||
161904191|NCT05616013|584697077|FG008|Overall Study|Adverse Event|1|||
161904192|NCT05616013|584697069|FG000|Overall Study|Lost to Follow-up|5|||
161904193|NCT05616013|584697070|FG001|Overall Study|Lost to Follow-up|4|||
161904194|NCT05616013|584697071|FG002|Overall Study|Lost to Follow-up|3|||
161904195|NCT05616013|584697072|FG003|Overall Study|Lost to Follow-up|2|||
161904196|NCT05616013|584697073|FG004|Overall Study|Lost to Follow-up|0|||
161904197|NCT05616013|584697074|FG005|Overall Study|Lost to Follow-up|5|||
161904198|NCT05616013|584697075|FG006|Overall Study|Lost to Follow-up|2|||
161904199|NCT05616013|584697076|FG007|Overall Study|Lost to Follow-up|1|||
161904200|NCT05616013|584697077|FG008|Overall Study|Lost to Follow-up|2|||
161904201|NCT05616013|584697069|FG000|Overall Study|Non-compliance with study requirements|2|||
161904202|NCT05616013|584697070|FG001|Overall Study|Non-compliance with study requirements|2|||
161904203|NCT05616013|584697071|FG002|Overall Study|Non-compliance with study requirements|2|||
161904204|NCT05616013|584697072|FG003|Overall Study|Non-compliance with study requirements|3|||
161904205|NCT05616013|584697073|FG004|Overall Study|Non-compliance with study requirements|0|||
161904206|NCT05616013|584697074|FG005|Overall Study|Non-compliance with study requirements|2|||
161904207|NCT05616013|584697075|FG006|Overall Study|Non-compliance with study requirements|1|||
161904208|NCT05616013|584697076|FG007|Overall Study|Non-compliance with study requirements|1|||
161904209|NCT05616013|584697077|FG008|Overall Study|Non-compliance with study requirements|4|||
161904210|NCT05616013|584697069|FG000|Overall Study|Withdrawal by Subject|11|||
161904211|NCT05616013|584697070|FG001|Overall Study|Withdrawal by Subject|9|||
161904212|NCT05616013|584697071|FG002|Overall Study|Withdrawal by Subject|8|||
161904213|NCT05616013|584697072|FG003|Overall Study|Withdrawal by Subject|6|||
161904214|NCT05616013|584697073|FG004|Overall Study|Withdrawal by Subject|3|||
161904215|NCT05616013|584697074|FG005|Overall Study|Withdrawal by Subject|4|||
161904216|NCT05616013|584697075|FG006|Overall Study|Withdrawal by Subject|6|||
161904217|NCT05616013|584697076|FG007|Overall Study|Withdrawal by Subject|5|||
161904218|NCT05616013|584697077|FG008|Overall Study|Withdrawal by Subject|4|||
161904219|NCT05616013|584697069|FG000|Overall Study|Physician Decision|0|||
162010886|NCT02594124|585096051|FG008|Overall Study|Adverse Event|0|||
161800138|NCT00950807|584310998|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161800139|NCT00950807|584310999|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161800140|NCT00950807|584311000|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161800141|NCT00950807|584311001|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161800142|NCT00950807|584311002|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161800143|NCT00950807|584311003|FG006|Treatment Period 2|Withdrawal by Subject|1|||
161800144|NCT00950807|584311004|FG007|Treatment Period 2|Withdrawal by Subject|2|||
161800145|NCT00950807|584311005|FG008|Treatment Period 2|Withdrawal by Subject|0|||
161800146|NCT00950807|584311006|FG009|Treatment Period 2|Withdrawal by Subject|0|||
161800147|NCT00950807|584310997|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
161800148|NCT00950807|584310998|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800149|NCT00950807|584310999|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800150|NCT00950807|584311000|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800151|NCT00950807|584311001|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800152|NCT00950807|584311002|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800153|NCT00950807|584311003|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800154|NCT00950807|584311004|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800155|NCT00950807|584311005|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800156|NCT00950807|584311006|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161800157|NCT00950807|584310997|FG000|Treatment Period 2|Adverse Event|0|||
161800158|NCT00950807|584310998|FG001|Treatment Period 2|Adverse Event|1|||
161800159|NCT00950807|584310999|FG002|Treatment Period 2|Adverse Event|0|||
161800160|NCT00950807|584311000|FG003|Treatment Period 2|Adverse Event|1|||
161800161|NCT00950807|584311001|FG004|Treatment Period 2|Adverse Event|0|||
161800162|NCT00950807|584311002|FG005|Treatment Period 2|Adverse Event|1|||
161800163|NCT00950807|584311003|FG006|Treatment Period 2|Adverse Event|0|||
161800164|NCT00950807|584311004|FG007|Treatment Period 2|Adverse Event|1|||
161800165|NCT00950807|584311005|FG008|Treatment Period 2|Adverse Event|0|||
161800166|NCT00950807|584311006|FG009|Treatment Period 2|Adverse Event|0|||
161800167|NCT00950807|584310997|FG000|Washout Period 2|Lack of Efficacy|1|||
161800168|NCT00950807|584310998|FG001|Washout Period 2|Lack of Efficacy|0|||
161800169|NCT00950807|584310999|FG002|Washout Period 2|Lack of Efficacy|0|||
161800170|NCT00950807|584311000|FG003|Washout Period 2|Lack of Efficacy|0|||
161800171|NCT00950807|584311001|FG004|Washout Period 2|Lack of Efficacy|0|||
161800172|NCT00950807|584311002|FG005|Washout Period 2|Lack of Efficacy|0|||
161800173|NCT00950807|584311003|FG006|Washout Period 2|Lack of Efficacy|0|||
161800174|NCT00950807|584311004|FG007|Washout Period 2|Lack of Efficacy|0|||
161800175|NCT00950807|584311005|FG008|Washout Period 2|Lack of Efficacy|0|||
161800176|NCT00950807|584311006|FG009|Washout Period 2|Lack of Efficacy|0|||
161800177|NCT00950807|584310997|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161800178|NCT00950807|584310998|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
161800179|NCT00950807|584310999|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161800180|NCT00950807|584311000|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161800181|NCT00950807|584311001|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
161800182|NCT00950807|584311002|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161800183|NCT00950807|584311003|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
161800184|NCT00950807|584311004|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
161800185|NCT00950807|584311005|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161800186|NCT00950807|584311006|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161800187|NCT00950807|584310997|FG000|Washout Period 2|Adverse Event|3|||
161800188|NCT00950807|584310998|FG001|Washout Period 2|Adverse Event|0|||
161800189|NCT00950807|584310999|FG002|Washout Period 2|Adverse Event|0|||
161800190|NCT00950807|584311000|FG003|Washout Period 2|Adverse Event|1|||
161800191|NCT00950807|584311001|FG004|Washout Period 2|Adverse Event|0|||
161800192|NCT00950807|584311002|FG005|Washout Period 2|Adverse Event|0|||
161800193|NCT00950807|584311003|FG006|Washout Period 2|Adverse Event|0|||
161800194|NCT00950807|584311004|FG007|Washout Period 2|Adverse Event|0|||
161800195|NCT00950807|584311005|FG008|Washout Period 2|Adverse Event|0|||
161800196|NCT00950807|584311006|FG009|Washout Period 2|Adverse Event|0|||
161800197|NCT00950807|584310997|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161800198|NCT00950807|584310998|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161800199|NCT00950807|584310999|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162138351|NCT04888585|585557335|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
161800200|NCT00950807|584311000|FG003|Treatment Period 3|Withdrawal by Subject|0|||
161800201|NCT00950807|584311001|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161800202|NCT00950807|584311002|FG005|Treatment Period 3|Withdrawal by Subject|0|||
161800203|NCT00950807|584311003|FG006|Treatment Period 3|Withdrawal by Subject|0|||
161800204|NCT00950807|584311004|FG007|Treatment Period 3|Withdrawal by Subject|0|||
161800205|NCT00950807|584311005|FG008|Treatment Period 3|Withdrawal by Subject|0|||
161800206|NCT00950807|584311006|FG009|Treatment Period 3|Withdrawal by Subject|1|||
161800207|NCT00950807|584310997|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
161800208|NCT00950807|584310998|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800209|NCT00950807|584310999|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800210|NCT00950807|584311000|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800211|NCT00950807|584311001|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800212|NCT00950807|584311002|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800213|NCT00950807|584311003|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800214|NCT00950807|584311004|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
161800215|NCT00950807|584311005|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800216|NCT00950807|584311006|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161800217|NCT00950807|584310997|FG000|Treatment Period 3|Adverse Event|0|||
161800218|NCT00950807|584310998|FG001|Treatment Period 3|Adverse Event|0|||
161800219|NCT00950807|584310999|FG002|Treatment Period 3|Adverse Event|0|||
161800220|NCT00950807|584311000|FG003|Treatment Period 3|Adverse Event|0|||
161800221|NCT00950807|584311001|FG004|Treatment Period 3|Adverse Event|0|||
161800222|NCT00950807|584311002|FG005|Treatment Period 3|Adverse Event|0|||
161800223|NCT00950807|584311003|FG006|Treatment Period 3|Adverse Event|1|||
161800224|NCT00950807|584311004|FG007|Treatment Period 3|Adverse Event|0|||
161800225|NCT00950807|584311005|FG008|Treatment Period 3|Adverse Event|0|||
161800226|NCT00950807|584311006|FG009|Treatment Period 3|Adverse Event|0|||
161800227|NCT00337077|584311007|FG000|Overall Study|Progressive disease|25|||
161800228|NCT00337077|584311008|FG001|Overall Study|Progressive disease|37|||
161800229|NCT00337077|584311009|FG002|Overall Study|Progressive disease|19|||
161800230|NCT00337077|584311007|FG000|Overall Study|Adverse Event|7|||
161800231|NCT00337077|584311008|FG001|Overall Study|Adverse Event|7|||
161800232|NCT00337077|584311009|FG002|Overall Study|Adverse Event|1|||
161800233|NCT00337077|584311007|FG000|Overall Study|Death|0|||
161800234|NCT00337077|584311008|FG001|Overall Study|Death|1|||
161800235|NCT00337077|584311009|FG002|Overall Study|Death|0|||
161800236|NCT00337077|584311007|FG000|Overall Study|Withdrawal by Subject|7|||
161800237|NCT00337077|584311008|FG001|Overall Study|Withdrawal by Subject|2|||
161800238|NCT00337077|584311009|FG002|Overall Study|Withdrawal by Subject|2|||
161800239|NCT00337077|584311007|FG000|Overall Study|Alternative therapy|1|||
161800240|NCT00337077|584311008|FG001|Overall Study|Alternative therapy|0|||
161800241|NCT00337077|584311009|FG002|Overall Study|Alternative therapy|0|||
161800242|NCT00337077|584311007|FG000|Overall Study|Physician Decision|1|||
161800243|NCT00337077|584311008|FG001|Overall Study|Physician Decision|4|||
161800244|NCT00337077|584311009|FG002|Overall Study|Physician Decision|2|||
161800245|NCT00337077|584311007|FG000|Overall Study|Never started treatment|1|||
161800246|NCT00337077|584311008|FG001|Overall Study|Never started treatment|1|||
161800247|NCT00337077|584311009|FG002|Overall Study|Never started treatment|0|||
161800248|NCT00337077|584311007|FG000|Overall Study|Ineligible|1|||
161800249|NCT00337077|584311008|FG001|Overall Study|Ineligible|1|||
161800250|NCT00337077|584311009|FG002|Overall Study|Ineligible|1|||
161800251|NCT01492400|584311013|FG000|Overall Study|Miscellaneous Reasons|2|||
161800252|NCT01492400|584311014|FG001|Overall Study|Miscellaneous Reasons|3|||
161800253|NCT01492400|584311013|FG000|Overall Study|Personal Reasons|0|||
161800254|NCT01492400|584311014|FG001|Overall Study|Personal Reasons|5|||
161800255|NCT01492400|584311013|FG000|Overall Study|Lost to Follow-up|3|||
161800256|NCT01492400|584311014|FG001|Overall Study|Lost to Follow-up|1|||
161800257|NCT01492400|584311013|FG000|Overall Study|Pregnancy|0|||
161800258|NCT01492400|584311014|FG001|Overall Study|Pregnancy|1|||
161800259|NCT01492400|584311013|FG000|Overall Study|Lack of Efficacy|1|||
161800260|NCT01492400|584311014|FG001|Overall Study|Lack of Efficacy|1|||
161800261|NCT01492400|584311013|FG000|Overall Study|Adverse Event|10|||
161800262|NCT01492400|584311014|FG001|Overall Study|Adverse Event|5|||
161800263|NCT00659607|584311015|FG000|Overall Study|No blood pressure recorded|147|||
161800264|NCT00659607|584311015|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
161800265|NCT00659607|584311015|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
161800266|NCT00659607|584311015|FG000|Overall Study|No recorded efficacy data|15|||
161800267|NCT00659607|584311015|FG000|Overall Study|Inconsistent BP measuring date|2|||
161800268|NCT02568384|584311021|FG000|Overall Study|Mobile devices incompatible with App|2|||
161800269|NCT03184441|584311022|FG000|Overall Study|Withdrawal by Subject|1|||
161800270|NCT00264810|584311023|FG000|Baseline|Withdrawal by Subject|10|||
161800271|NCT00264810|584311024|FG001|Baseline|Withdrawal by Subject|10|||
161800272|NCT00264810|584311023|FG000|Baseline|Physician Decision|7|||
161800273|NCT00264810|584311024|FG001|Baseline|Physician Decision|8|||
161800274|NCT00264810|584311023|FG000|Baseline|Subject Compliance Failure|3|||
161800275|NCT00264810|584311024|FG001|Baseline|Subject Compliance Failure|3|||
161800276|NCT00264810|584311023|FG000|Baseline|Insufficient Seizure Frequency|2|||
161800277|NCT00264810|584311024|FG001|Baseline|Insufficient Seizure Frequency|2|||
161800278|NCT00264810|584311023|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
161800279|NCT00264810|584311024|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
161800280|NCT00264810|584311023|FG000|Baseline|Other|0|||
161904220|NCT05616013|584697070|FG001|Overall Study|Physician Decision|0|||
161904221|NCT05616013|584697071|FG002|Overall Study|Physician Decision|1|||
161904222|NCT05616013|584697072|FG003|Overall Study|Physician Decision|0|||
161904223|NCT05616013|584697073|FG004|Overall Study|Physician Decision|0|||
161904224|NCT05616013|584697074|FG005|Overall Study|Physician Decision|1|||
161904225|NCT05616013|584697075|FG006|Overall Study|Physician Decision|3|||
161904226|NCT05616013|584697076|FG007|Overall Study|Physician Decision|0|||
161904227|NCT05616013|584697077|FG008|Overall Study|Physician Decision|0|||
161904228|NCT05616013|584697069|FG000|Overall Study|Protocol Violation|0|||
161904229|NCT05616013|584697070|FG001|Overall Study|Protocol Violation|0|||
161904230|NCT05616013|584697071|FG002|Overall Study|Protocol Violation|0|||
161904231|NCT05616013|584697072|FG003|Overall Study|Protocol Violation|0|||
161904232|NCT05616013|584697073|FG004|Overall Study|Protocol Violation|0|||
161800281|NCT00264810|584311024|FG001|Baseline|Other|1|||
161800282|NCT00264810|584311023|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
161800283|NCT00264810|584311024|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
161800284|NCT00264810|584311023|FG000|Stimulation Optimization Period|Death|0|||
161800285|NCT00264810|584311024|FG001|Stimulation Optimization Period|Death|1|||
161800286|NCT00264810|584311023|FG000|Blinded Evaluation Period|Explant due to infection|1|||
161800287|NCT00264810|584311024|FG001|Blinded Evaluation Period|Explant due to infection|1|||
161800288|NCT00264810|584311023|FG000|Open Label Evaluation Period|Explant due to infection|1|||
161800289|NCT00264810|584311024|FG001|Open Label Evaluation Period|Explant due to infection|1|||
161800290|NCT00264810|584311023|FG000|Open Label Evaluation Period|Death|3|||
161800291|NCT00264810|584311024|FG001|Open Label Evaluation Period|Death|2|||
161800292|NCT00264810|584311023|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
161800293|NCT00264810|584311024|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
161800294|NCT02994056|584311025|FG000|Overall Study|Death|8|||
161800295|NCT02994056|584311025|FG000|Overall Study|Withdrew Consent|1|||
161800296|NCT02199509|584311028|FG000|Overall Study|Suicidal Ideation|0|||
161800297|NCT02199509|584311029|FG001|Overall Study|Suicidal Ideation|1|||
161800298|NCT02199509|584311028|FG000|Overall Study|Misunderstood titration schedule|1|||
161800299|NCT02199509|584311029|FG001|Overall Study|Misunderstood titration schedule|0|||
161800300|NCT01346410|584311031|FG000|Overall Study|Death|1|||
161800301|NCT00979628|584311032|FG000|Overall Study|received regimen < 24 hours|7|||
161800302|NCT00979628|584311033|FG001|Overall Study|received regimen < 24 hours|6|||
161800303|NCT00979628|584311034|FG002|Overall Study|received regimen < 24 hours|5|||
161800304|NCT00979628|584311032|FG000|Overall Study|received steroids|1|||
161800305|NCT00979628|584311033|FG001|Overall Study|received steroids|1|||
161800306|NCT00979628|584311034|FG002|Overall Study|received steroids|0|||
161800307|NCT00979628|584311032|FG000|Overall Study|transferred to ICU|1|||
161800308|NCT00979628|584311033|FG001|Overall Study|transferred to ICU|2|||
161800309|NCT00979628|584311034|FG002|Overall Study|transferred to ICU|1|||
161800310|NCT05905783|584311035|FG000|Overall Study|Lost to Follow-up|12|||
161800311|NCT05905783|584311036|FG001|Overall Study|Lost to Follow-up|18|||
161800312|NCT05905783|584311035|FG000|Overall Study|Withdrawal by Subject|29|||
161800313|NCT05905783|584311036|FG001|Overall Study|Withdrawal by Subject|37|||
161800314|NCT05905783|584311035|FG000|Overall Study|Decision by sponsor|69|||
161800315|NCT05905783|584311036|FG001|Overall Study|Decision by sponsor|65|||
161800316|NCT00911859|584311037|FG000|Treatment Period|Adverse Event|3|||
161800317|NCT00911859|584311038|FG001|Treatment Period|Adverse Event|3|||
161800318|NCT00911859|584311039|FG002|Treatment Period|Adverse Event|7|||
161800319|NCT00911859|584311037|FG000|Treatment Period|Death|1|||
161800320|NCT00911859|584311038|FG001|Treatment Period|Death|3|||
161800321|NCT00911859|584311039|FG002|Treatment Period|Death|5|||
161800322|NCT00911859|584311037|FG000|Treatment Period|Lack of Efficacy|1|||
161800323|NCT00911859|584311038|FG001|Treatment Period|Lack of Efficacy|7|||
161800324|NCT00911859|584311039|FG002|Treatment Period|Lack of Efficacy|5|||
161800325|NCT00911859|584311037|FG000|Treatment Period|Physician Decision|3|||
161800326|NCT00911859|584311038|FG001|Treatment Period|Physician Decision|3|||
161800327|NCT00911859|584311039|FG002|Treatment Period|Physician Decision|3|||
161800328|NCT00911859|584311037|FG000|Treatment Period|Withdrawal by Subject|0|||
161800329|NCT00911859|584311038|FG001|Treatment Period|Withdrawal by Subject|4|||
161800330|NCT00911859|584311039|FG002|Treatment Period|Withdrawal by Subject|5|||
161800331|NCT00911859|584311037|FG000|Treatment Period|Did not receive study treatment|0|||
161800332|NCT00911859|584311038|FG001|Treatment Period|Did not receive study treatment|1|||
161800333|NCT00911859|584311039|FG002|Treatment Period|Did not receive study treatment|0|||
161800334|NCT00911859|584311037|FG000|Maintainance Period|Lack of Efficacy|0|||
161800335|NCT00911859|584311038|FG001|Maintainance Period|Lack of Efficacy|0|||
161800336|NCT00911859|584311039|FG002|Maintainance Period|Lack of Efficacy|9|||
161800337|NCT00911859|584311037|FG000|Maintainance Period|Physician Decision|0|||
161800338|NCT00911859|584311038|FG001|Maintainance Period|Physician Decision|0|||
161800339|NCT00911859|584311039|FG002|Maintainance Period|Physician Decision|9|||
161800340|NCT00911859|584311037|FG000|Maintainance Period|Withdrawal by Subject|0|||
161904233|NCT05616013|584697074|FG005|Overall Study|Protocol Violation|0|||
161904234|NCT05616013|584697075|FG006|Overall Study|Protocol Violation|1|||
161904235|NCT05616013|584697076|FG007|Overall Study|Protocol Violation|0|||
161904236|NCT05616013|584697077|FG008|Overall Study|Protocol Violation|2|||
161800341|NCT00911859|584311038|FG001|Maintainance Period|Withdrawal by Subject|0|||
161800342|NCT00911859|584311039|FG002|Maintainance Period|Withdrawal by Subject|3|||
161800343|NCT00911859|584311037|FG000|Follow-up Period|Death|5|||
161800344|NCT00911859|584311038|FG001|Follow-up Period|Death|8|||
161800345|NCT00911859|584311039|FG002|Follow-up Period|Death|10|||
161800346|NCT00911859|584311037|FG000|Follow-up Period|Lost to Follow-up|1|||
161800347|NCT00911859|584311038|FG001|Follow-up Period|Lost to Follow-up|1|||
161800348|NCT00911859|584311039|FG002|Follow-up Period|Lost to Follow-up|0|||
161800349|NCT00911859|584311037|FG000|Follow-up Period|Withdrawal by Subject|0|||
161800350|NCT00911859|584311038|FG001|Follow-up Period|Withdrawal by Subject|4|||
161800351|NCT00911859|584311039|FG002|Follow-up Period|Withdrawal by Subject|4|||
161800352|NCT00911859|584311037|FG000|Follow-up Period|Study terminated by sponsor|5|||
161800353|NCT00911859|584311038|FG001|Follow-up Period|Study terminated by sponsor|33|||
161800354|NCT00911859|584311039|FG002|Follow-up Period|Study terminated by sponsor|27|||
161800355|NCT03008460|584311044|FG000|Overall Study|Protocol deviation|0|||
161800356|NCT03008460|584311045|FG001|Overall Study|Protocol deviation|2|||
161800357|NCT03008460|584311044|FG000|Overall Study|Study drug not dispensed|0|||
161800358|NCT03008460|584311045|FG001|Overall Study|Study drug not dispensed|1|||
161800359|NCT03008460|584311044|FG000|Overall Study|Adverse Event|0|||
161800360|NCT03008460|584311045|FG001|Overall Study|Adverse Event|1|||
161800361|NCT03008460|584311044|FG000|Overall Study|Withdrawal by Subject|5|||
161800362|NCT03008460|584311045|FG001|Overall Study|Withdrawal by Subject|6|||
161800363|NCT03008460|584311044|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
161800364|NCT03008460|584311045|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
161800365|NCT03008460|584311044|FG000|Overall Study|End of study visit outside permitted time window|0|||
161800366|NCT03008460|584311045|FG001|Overall Study|End of study visit outside permitted time window|1|||
161800367|NCT03008460|584311044|FG000|Overall Study|Lost to Follow-up|1|||
161800368|NCT03008460|584311045|FG001|Overall Study|Lost to Follow-up|3|||
161800369|NCT00634179|584311049|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
161800370|NCT04947579|584311050|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161800371|NCT04947579|584311051|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161800372|NCT04947579|584311052|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161800373|NCT04947579|584311053|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
161800374|NCT04947579|584311054|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161800375|NCT04947579|584311055|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161800376|NCT04947579|584311050|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161800377|NCT04947579|584311051|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161800378|NCT04947579|584311052|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
161800379|NCT04947579|584311053|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161800380|NCT04947579|584311054|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161800381|NCT04947579|584311055|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161800382|NCT04947579|584311050|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
161800383|NCT04947579|584311051|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
161800384|NCT04947579|584311052|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
161800385|NCT04947579|584311053|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
161800386|NCT04947579|584311054|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
161800387|NCT04947579|584311055|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
161800388|NCT04947579|584311050|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
161800389|NCT04947579|584311051|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
161800390|NCT04947579|584311052|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
161800391|NCT04947579|584311053|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
161800392|NCT04947579|584311054|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
161800393|NCT04947579|584311055|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
161800394|NCT04947579|584311050|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
161800395|NCT04947579|584311051|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161800396|NCT04947579|584311052|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161800397|NCT04947579|584311053|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161800398|NCT04947579|584311054|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161800399|NCT04947579|584311055|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161800400|NCT04947579|584311050|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161800401|NCT04947579|584311051|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161800402|NCT04947579|584311052|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
161800403|NCT04947579|584311053|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161800404|NCT04947579|584311054|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161800405|NCT04947579|584311055|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161800406|NCT04947579|584311050|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
161800407|NCT04947579|584311051|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
161800408|NCT04947579|584311052|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
161800409|NCT04947579|584311053|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
161800410|NCT04947579|584311054|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
161800411|NCT04947579|584311055|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
161800412|NCT04947579|584311050|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161800413|NCT04947579|584311051|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161800414|NCT04947579|584311052|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
161800415|NCT04947579|584311053|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161800416|NCT04947579|584311054|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161800417|NCT04947579|584311055|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161800418|NCT04947579|584311050|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
161800419|NCT04947579|584311051|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
161800420|NCT04947579|584311052|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
161800421|NCT04947579|584311053|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
161800422|NCT04947579|584311054|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
161800423|NCT04947579|584311055|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
161800424|NCT04947579|584311050|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
161800425|NCT04947579|584311051|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
161800426|NCT04947579|584311052|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
161800427|NCT04947579|584311053|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
161800428|NCT04947579|584311054|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
161800429|NCT04947579|584311055|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
161800430|NCT04947579|584311050|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
161800431|NCT04947579|584311051|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
161800432|NCT04947579|584311052|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
161800433|NCT04947579|584311053|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
161800434|NCT04947579|584311054|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
161800435|NCT04947579|584311055|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
161800436|NCT00767325|584311056|FG000|Overall Study|Lack of Efficacy|2|||
161800437|NCT00767325|584311056|FG000|Overall Study|Adverse Event|7|||
161800438|NCT00767325|584311056|FG000|Overall Study|Lost to Follow-up|3|||
161800439|NCT00767325|584311056|FG000|Overall Study|No longer met study criteria|2|||
161800440|NCT00767325|584311056|FG000|Overall Study|Missed visit due to family reasons|1|||
161800441|NCT03538756|584311057|FG000|Long-Term Follow-up|Adverse Event|0|||
161800442|NCT03538756|584311058|FG001|Long-Term Follow-up|Adverse Event|0|||
161800443|NCT03538756|584311059|FG002|Long-Term Follow-up|Adverse Event|6|||
161800444|NCT03538756|584311057|FG000|Long-Term Follow-up|Death|0|||
161800445|NCT03538756|584311058|FG001|Long-Term Follow-up|Death|0|||
161800446|NCT03538756|584311059|FG002|Long-Term Follow-up|Death|1|||
161800447|NCT03538756|584311057|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
161800448|NCT03538756|584311058|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
161800449|NCT03538756|584311059|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
161800450|NCT03538756|584311057|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
161800451|NCT03538756|584311058|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
161800452|NCT03538756|584311059|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
161800453|NCT03538756|584311057|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
161800454|NCT03538756|584311058|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
161800455|NCT03538756|584311059|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
161800456|NCT00752856|584311060|FG000|Overall Study|randomized but did not do viral kinetics|0|||
161800457|NCT00752856|584311061|FG001|Overall Study|randomized but did not do viral kinetics|1|||
161800458|NCT02688608|584311062|FG000|Overall Study|Lost to Follow-up|1|||
161800459|NCT00454636|584312305|FG000|Overall Study|Adverse Event|10|||
161800460|NCT00454636|584312306|FG001|Overall Study|Adverse Event|6|||
161800461|NCT00454636|584312307|FG002|Overall Study|Adverse Event|9|||
161800462|NCT00454636|584312308|FG003|Overall Study|Adverse Event|15|||
161800463|NCT00454636|584312305|FG000|Overall Study|Disease Progression|11|||
161800464|NCT00454636|584312306|FG001|Overall Study|Disease Progression|12|||
161800465|NCT00454636|584312307|FG002|Overall Study|Disease Progression|4|||
161800466|NCT00454636|584312308|FG003|Overall Study|Disease Progression|11|||
161800467|NCT00454636|584312305|FG000|Overall Study|Protocol Violation|3|||
161800468|NCT00454636|584312306|FG001|Overall Study|Protocol Violation|2|||
161800469|NCT00454636|584312307|FG002|Overall Study|Protocol Violation|3|||
161800470|NCT00454636|584312308|FG003|Overall Study|Protocol Violation|3|||
161800471|NCT00454636|584312305|FG000|Overall Study|Death|6|||
161800472|NCT00454636|584312306|FG001|Overall Study|Death|1|||
161800473|NCT00454636|584312307|FG002|Overall Study|Death|1|||
161800474|NCT00454636|584312308|FG003|Overall Study|Death|1|||
161800475|NCT00454636|584312305|FG000|Overall Study|Patient refusal|1|||
161800476|NCT00454636|584312306|FG001|Overall Study|Patient refusal|1|||
161800477|NCT00454636|584312307|FG002|Overall Study|Patient refusal|3|||
161800478|NCT00454636|584312308|FG003|Overall Study|Patient refusal|2|||
161800479|NCT00454636|584312305|FG000|Overall Study|Lost to Follow-up|0|||
161800480|NCT00454636|584312306|FG001|Overall Study|Lost to Follow-up|1|||
161800481|NCT00454636|584312307|FG002|Overall Study|Lost to Follow-up|0|||
161800482|NCT00454636|584312308|FG003|Overall Study|Lost to Follow-up|0|||
161800483|NCT00806156|584312309|FG000|Overall Study|Death|35|||
161800484|NCT00806156|584312310|FG001|Overall Study|Death|95|||
161800485|NCT00806156|584312309|FG000|Overall Study|Did not meet eligibility criteria|1|||
161800486|NCT00806156|584312310|FG001|Overall Study|Did not meet eligibility criteria|0|||
161800487|NCT00806156|584312309|FG000|Overall Study|Study terminated by Sponsor|2|||
161800488|NCT00806156|584312310|FG001|Overall Study|Study terminated by Sponsor|40|||
161800489|NCT00806156|584312309|FG000|Overall Study|Consent withdrawn by subject|1|||
161800490|NCT00806156|584312310|FG001|Overall Study|Consent withdrawn by subject|3|||
161800491|NCT00806156|584312309|FG000|Overall Study|Lost to Follow-up|0|||
161800492|NCT00806156|584312310|FG001|Overall Study|Lost to Follow-up|1|||
161800493|NCT02674334|584312315|FG000|Overall Study|Lost to Follow-up|5|||
161800494|NCT02674334|584312316|FG001|Overall Study|Lost to Follow-up|3|||
161800495|NCT02674334|584312315|FG000|Overall Study|participant difficulty breathing|1|||
161800496|NCT02674334|584312316|FG001|Overall Study|participant difficulty breathing|0|||
161800497|NCT02674334|584312315|FG000|Overall Study|NIRS not recording|1|||
161800498|NCT02674334|584312316|FG001|Overall Study|NIRS not recording|0|||
161800499|NCT00860405|584312327|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
161800500|NCT00860405|584312328|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
161800501|NCT00864097|584312329|FG000|Overall Study|Death|0|||
161800502|NCT00864097|584312330|FG001|Overall Study|Death|1|||
161800503|NCT00864097|584312331|FG002|Overall Study|Death|0|||
161800504|NCT00864097|584312332|FG003|Overall Study|Death|0|||
161800505|NCT00864097|584312329|FG000|Overall Study|Adverse Event|6|||
161800506|NCT00864097|584312330|FG001|Overall Study|Adverse Event|8|||
161800507|NCT00864097|584312331|FG002|Overall Study|Adverse Event|11|||
161800508|NCT00864097|584312332|FG003|Overall Study|Adverse Event|9|||
161800509|NCT00864097|584312329|FG000|Overall Study|Lack of Efficacy|9|||
161800510|NCT00864097|584312330|FG001|Overall Study|Lack of Efficacy|3|||
161800511|NCT00864097|584312331|FG002|Overall Study|Lack of Efficacy|7|||
161800512|NCT00864097|584312332|FG003|Overall Study|Lack of Efficacy|2|||
161800513|NCT00864097|584312329|FG000|Overall Study|Lost to Follow-up|0|||
161800514|NCT00864097|584312330|FG001|Overall Study|Lost to Follow-up|1|||
161800515|NCT00864097|584312331|FG002|Overall Study|Lost to Follow-up|0|||
161800516|NCT00864097|584312332|FG003|Overall Study|Lost to Follow-up|1|||
161800517|NCT00864097|584312329|FG000|Overall Study|Withdrawal by Subject|15|||
161800518|NCT00864097|584312330|FG001|Overall Study|Withdrawal by Subject|11|||
161800519|NCT00864097|584312331|FG002|Overall Study|Withdrawal by Subject|11|||
161904237|NCT05616013|584697069|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
161800520|NCT00864097|584312332|FG003|Overall Study|Withdrawal by Subject|12|||
161800521|NCT00864097|584312329|FG000|Overall Study|Protocol Violation|2|||
161800522|NCT00864097|584312330|FG001|Overall Study|Protocol Violation|1|||
161800523|NCT00864097|584312331|FG002|Overall Study|Protocol Violation|0|||
161800524|NCT00864097|584312332|FG003|Overall Study|Protocol Violation|1|||
161800525|NCT00864097|584312329|FG000|Overall Study|Terminated by sponsor|105|||
161800526|NCT00864097|584312330|FG001|Overall Study|Terminated by sponsor|112|||
161800527|NCT00864097|584312331|FG002|Overall Study|Terminated by sponsor|102|||
161800528|NCT00864097|584312332|FG003|Overall Study|Terminated by sponsor|99|||
161800529|NCT00864097|584312329|FG000|Overall Study|Randomized but not treated|2|||
161800530|NCT00864097|584312330|FG001|Overall Study|Randomized but not treated|0|||
161800531|NCT00864097|584312331|FG002|Overall Study|Randomized but not treated|1|||
161800532|NCT00864097|584312332|FG003|Overall Study|Randomized but not treated|0|||
161800533|NCT00864097|584312329|FG000|Overall Study|Other|0|||
161800534|NCT00864097|584312330|FG001|Overall Study|Other|0|||
161800535|NCT00864097|584312331|FG002|Overall Study|Other|0|||
161800536|NCT00864097|584312332|FG003|Overall Study|Other|1|||
161800537|NCT00320112|584312335|FG000|Overall Study|Lost to Follow-up|3|||
161800538|NCT00320112|584312336|FG001|Overall Study|Lost to Follow-up|4|||
161800539|NCT00320112|584312335|FG000|Overall Study|Withdrawal by Subject|3|||
161800540|NCT00320112|584312336|FG001|Overall Study|Withdrawal by Subject|0|||
161800541|NCT00320112|584312335|FG000|Overall Study|Death|2|||
161800542|NCT00320112|584312336|FG001|Overall Study|Death|1|||
161800543|NCT02899338|584312337|FG000|Overall Study|Adverse Event|1|||
161800544|NCT02899338|584312338|FG001|Overall Study|Adverse Event|2|||
161800545|NCT02899338|584312337|FG000|Overall Study|Withdrawal by Subject|2|||
161800546|NCT02899338|584312338|FG001|Overall Study|Withdrawal by Subject|0|||
161800547|NCT06179108|584312339|FG000|Overall Study|Withdrawal by Subject|16|||
161904238|NCT05616013|584697070|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
161800548|NCT06179108|584312340|FG001|Overall Study|Withdrawal by Subject|19|||
161800549|NCT06179108|584312341|FG002|Overall Study|Withdrawal by Subject|10|||
161800550|NCT06179108|584312342|FG003|Overall Study|Withdrawal by Subject|11|||
161800551|NCT06179108|584312339|FG000|Overall Study|Lost to Follow-up|12|||
161800552|NCT06179108|584312340|FG001|Overall Study|Lost to Follow-up|4|||
161800553|NCT06179108|584312341|FG002|Overall Study|Lost to Follow-up|1|||
161800554|NCT06179108|584312342|FG003|Overall Study|Lost to Follow-up|9|||
161800555|NCT06179108|584312339|FG000|Overall Study|Adverse Event|2|||
161800556|NCT06179108|584312340|FG001|Overall Study|Adverse Event|3|||
161800557|NCT06179108|584312341|FG002|Overall Study|Adverse Event|3|||
161800558|NCT06179108|584312342|FG003|Overall Study|Adverse Event|2|||
161800559|NCT06179108|584312339|FG000|Overall Study|Protocol Violation|0|||
161800560|NCT06179108|584312340|FG001|Overall Study|Protocol Violation|1|||
161800561|NCT06179108|584312341|FG002|Overall Study|Protocol Violation|0|||
161800562|NCT06179108|584312342|FG003|Overall Study|Protocol Violation|1|||
161800563|NCT06179108|584312339|FG000|Overall Study|Physician Decision|1|||
161800564|NCT06179108|584312340|FG001|Overall Study|Physician Decision|1|||
161800565|NCT06179108|584312341|FG002|Overall Study|Physician Decision|0|||
161800566|NCT06179108|584312342|FG003|Overall Study|Physician Decision|0|||
161800567|NCT06179108|584312339|FG000|Overall Study|Lack of Efficacy|0|||
161800568|NCT06179108|584312340|FG001|Overall Study|Lack of Efficacy|0|||
161800569|NCT06179108|584312341|FG002|Overall Study|Lack of Efficacy|0|||
161800570|NCT06179108|584312342|FG003|Overall Study|Lack of Efficacy|1|||
161800571|NCT06179108|584312339|FG000|Overall Study|Death|0|||
161800572|NCT06179108|584312340|FG001|Overall Study|Death|0|||
161800573|NCT06179108|584312341|FG002|Overall Study|Death|0|||
161800574|NCT06179108|584312342|FG003|Overall Study|Death|1|||
161800575|NCT00814463|584312343|FG000|Overall Study|Lost to Follow-up|1|||
161800576|NCT02780687|584312346|FG000|Overall Study|Adverse Event|1|||
161800577|NCT02780687|584312347|FG001|Overall Study|Adverse Event|1|||
161800578|NCT02780687|584312346|FG000|Overall Study|Withdrawal by Subject|2|||
161800579|NCT02780687|584312347|FG001|Overall Study|Withdrawal by Subject|1|||
161800580|NCT02780687|584312346|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
161800581|NCT02780687|584312347|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
161800582|NCT02780687|584312346|FG000|Overall Study|progressive disease|29|||
161800583|NCT02780687|584312347|FG001|Overall Study|progressive disease|6|||
161800584|NCT00414765|584312349|FG000|Overall Study|Adverse Event|5|||
161800585|NCT00414765|584312350|FG001|Overall Study|Adverse Event|9|||
161800586|NCT00414765|584312349|FG000|Overall Study|Withdrawal by Subject|1|||
161800587|NCT00414765|584312350|FG001|Overall Study|Withdrawal by Subject|1|||
161800588|NCT00414765|584312349|FG000|Overall Study|Disease Progression|0|||
161800589|NCT00414765|584312350|FG001|Overall Study|Disease Progression|1|||
161800590|NCT05694013|584312352|FG000|Overall Study|Death|6|||
161800591|NCT05694013|584312353|FG001|Overall Study|Death|2|||
161800592|NCT05694013|584312352|FG000|Overall Study|Participant Decision|0|||
161800593|NCT05694013|584312353|FG001|Overall Study|Participant Decision|1|||
161800594|NCT05694013|584312352|FG000|Overall Study|Physician Decision|1|||
161800595|NCT05694013|584312353|FG001|Overall Study|Physician Decision|0|||
161800596|NCT05694013|584312352|FG000|Overall Study|Progressive Disease|0|||
161800597|NCT05694013|584312353|FG001|Overall Study|Progressive Disease|1|||
161800598|NCT05694013|584312352|FG000|Overall Study|Study Terminated by Sponsor|12|||
161800599|NCT05694013|584312353|FG001|Overall Study|Study Terminated by Sponsor|17|||
161800600|NCT05694013|584312352|FG000|Overall Study|Withdrawal by Subject|3|||
162138352|NCT04888585|585557325|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
162138353|NCT04888585|585557326|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
162138354|NCT04888585|585557327|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
162138355|NCT04888585|585557328|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
162138356|NCT04888585|585557329|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
162138357|NCT04888585|585557330|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
162138358|NCT04888585|585557331|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
162138359|NCT04888585|585557332|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
162138360|NCT04888585|585557333|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
162138361|NCT04888585|585557334|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
162138362|NCT04888585|585557335|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
162138363|NCT04888585|585557325|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
162138364|NCT04888585|585557326|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
162138365|NCT04888585|585557327|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
162138366|NCT04888585|585557328|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
161800601|NCT05694013|584312353|FG001|Overall Study|Withdrawal by Subject|0|||
161800602|NCT01199861|584312354|FG000|Overall Study|Administrative problems|1|||
161800603|NCT01199861|584312355|FG001|Overall Study|Administrative problems|0|||
161800604|NCT01199861|584312354|FG000|Overall Study|Adverse Event|1|||
161800605|NCT01199861|584312355|FG001|Overall Study|Adverse Event|0|||
161800606|NCT04817891|584312356|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
161800607|NCT04817891|584312356|FG000|Overall Study|Adverse Event|1|||
161800608|NCT04817891|584312356|FG000|Overall Study|Withdrawal by Subject|1|||
161800609|NCT03982433|584312357|FG000|Overall Study|Lost to Follow-up|1|||
161800610|NCT04981912|584312358|FG000|Overall Study|Physician Decision|2|||
161800611|NCT05630547|584312359|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
161800612|NCT05630547|584312360|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
161904239|NCT05616013|584697071|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904240|NCT05616013|584697072|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904241|NCT05616013|584697073|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904242|NCT05616013|584697074|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904243|NCT05616013|584697075|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904244|NCT05616013|584697076|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904245|NCT05616013|584697077|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
161904246|NCT05616013|584697069|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
161904247|NCT05616013|584697070|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904248|NCT05616013|584697071|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904249|NCT05616013|584697072|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904250|NCT05616013|584697073|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904251|NCT05616013|584697074|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904252|NCT05616013|584697075|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904253|NCT05616013|584697076|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904254|NCT05616013|584697077|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161904255|NCT05616013|584697069|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
161904256|NCT05616013|584697070|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904257|NCT05616013|584697071|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904258|NCT05616013|584697072|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904259|NCT05616013|584697073|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904260|NCT05616013|584697074|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904261|NCT05616013|584697075|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904262|NCT05616013|584697076|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904263|NCT05616013|584697077|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161904264|NCT05616013|584697069|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904265|NCT05616013|584697070|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
161904266|NCT05616013|584697071|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904267|NCT05616013|584697072|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904268|NCT05616013|584697073|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904269|NCT05616013|584697074|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904270|NCT05616013|584697075|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904271|NCT05616013|584697076|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904272|NCT05616013|584697077|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161904273|NCT05616013|584697069|FG000|Overall Study|Participant Decision, Time Constraints|0|||
161904274|NCT05616013|584697070|FG001|Overall Study|Participant Decision, Time Constraints|1|||
161904275|NCT05616013|584697071|FG002|Overall Study|Participant Decision, Time Constraints|0|||
161904276|NCT05616013|584697072|FG003|Overall Study|Participant Decision, Time Constraints|0|||
161904277|NCT05616013|584697073|FG004|Overall Study|Participant Decision, Time Constraints|0|||
161904278|NCT05616013|584697074|FG005|Overall Study|Participant Decision, Time Constraints|0|||
161904279|NCT05616013|584697075|FG006|Overall Study|Participant Decision, Time Constraints|0|||
161904280|NCT05616013|584697076|FG007|Overall Study|Participant Decision, Time Constraints|0|||
161904281|NCT05616013|584697077|FG008|Overall Study|Participant Decision, Time Constraints|0|||
161904282|NCT05616013|584697069|FG000|Overall Study|Prohibited Concomitant Medication|0|||
161904283|NCT05616013|584697070|FG001|Overall Study|Prohibited Concomitant Medication|0|||
161904284|NCT05616013|584697071|FG002|Overall Study|Prohibited Concomitant Medication|1|||
161904285|NCT05616013|584697072|FG003|Overall Study|Prohibited Concomitant Medication|0|||
161904286|NCT05616013|584697073|FG004|Overall Study|Prohibited Concomitant Medication|0|||
161904287|NCT05616013|584697074|FG005|Overall Study|Prohibited Concomitant Medication|0|||
161904288|NCT05616013|584697075|FG006|Overall Study|Prohibited Concomitant Medication|0|||
161904289|NCT05616013|584697076|FG007|Overall Study|Prohibited Concomitant Medication|0|||
161904290|NCT05616013|584697077|FG008|Overall Study|Prohibited Concomitant Medication|0|||
161904291|NCT05616013|584697069|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
161904292|NCT05616013|584697070|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
161904293|NCT05616013|584697071|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
161904294|NCT05616013|584697072|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
161904295|NCT05616013|584697073|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
161904296|NCT05616013|584697074|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
161904297|NCT05616013|584697075|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
162138367|NCT04888585|585557329|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
162138368|NCT04888585|585557330|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
161800613|NCT05630547|584312361|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
161800614|NCT05630547|584312362|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
161800615|NCT05630547|584312359|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
161800616|NCT05630547|584312360|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
161800617|NCT05630547|584312361|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
161800618|NCT05630547|584312362|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
161800619|NCT05630547|584312359|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
161800620|NCT05630547|584312360|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
161800621|NCT05630547|584312361|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
161800622|NCT05630547|584312362|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
161800623|NCT05630547|584312359|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
161800624|NCT05630547|584312360|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
161800625|NCT05630547|584312361|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
161800626|NCT05630547|584312362|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
161800627|NCT05630547|584312359|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
161800628|NCT05630547|584312360|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
161800629|NCT05630547|584312361|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
161800630|NCT05630547|584312362|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
161800631|NCT05630547|584312359|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
161800632|NCT05630547|584312360|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
161800633|NCT05630547|584312361|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
161800634|NCT05630547|584312362|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
161800635|NCT05630547|584312359|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
161800636|NCT05630547|584312360|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
161800637|NCT05630547|584312361|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
161800638|NCT05630547|584312362|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
161800639|NCT05630547|584312359|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
161800640|NCT05630547|584312360|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
161800641|NCT05630547|584312361|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
161800642|NCT05630547|584312362|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
161800643|NCT05630547|584312359|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
161800644|NCT05630547|584312360|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
161800645|NCT05630547|584312361|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
161800646|NCT05630547|584312362|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
161800647|NCT05630547|584312359|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
161800648|NCT05630547|584312360|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
161800649|NCT05630547|584312361|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
161800650|NCT05630547|584312362|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
161800651|NCT02153736|584312369|FG000|Overall Study|Lost to Follow-up|1|||
161800652|NCT02153736|584312370|FG001|Overall Study|Lost to Follow-up|0|||
161800653|NCT02153736|584312369|FG000|Overall Study|Medical status change made ineligible|1|||
161800654|NCT02153736|584312370|FG001|Overall Study|Medical status change made ineligible|0|||
161800655|NCT02153736|584312369|FG000|Overall Study|Death|0|||
161800656|NCT02153736|584312370|FG001|Overall Study|Death|1|||
161800657|NCT02153736|584312369|FG000|Overall Study|Withdrawal by Subject|0|||
161800658|NCT02153736|584312370|FG001|Overall Study|Withdrawal by Subject|1|||
161800659|NCT01734772|584312371|FG000|Overall Study|Adverse Event|1|||
161800660|NCT01734772|584312372|FG001|Overall Study|Adverse Event|2|||
161800661|NCT01734772|584312371|FG000|Overall Study|Withdrawal by Subject|0|||
161800662|NCT01734772|584312372|FG001|Overall Study|Withdrawal by Subject|1|||
161800663|NCT00720122|584312379|FG000|Overall Study|Lost to Follow-up|1|||
161800664|NCT00720122|584312379|FG000|Overall Study|Physician Decision|1|||
161800665|NCT00720122|584312379|FG000|Overall Study|Withdrawal by Subject|7|||
161800666|NCT01867242|584312380|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
161800667|NCT01867242|584312381|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
161800668|NCT01867242|584312382|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
161800669|NCT03066999|584312383|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
161800670|NCT03066999|584312384|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
161800671|NCT00661999|584312385|FG000|Overall Study|Adverse Event|11|||
161800672|NCT00661999|584312386|FG001|Overall Study|Adverse Event|5|||
161800673|NCT00661999|584312387|FG002|Overall Study|Adverse Event|8|||
161800674|NCT00661999|584312385|FG000|Overall Study|Death|8|||
161800675|NCT00661999|584312386|FG001|Overall Study|Death|6|||
161800676|NCT00661999|584312387|FG002|Overall Study|Death|3|||
161800677|NCT00661999|584312385|FG000|Overall Study|Other Reasons|5|||
161800678|NCT00661999|584312386|FG001|Overall Study|Other Reasons|12|||
161800679|NCT00661999|584312387|FG002|Overall Study|Other Reasons|23|||
161800680|NCT00661999|584312385|FG000|Overall Study|Withdrawal by Subject|30|||
161800681|NCT00661999|584312386|FG001|Overall Study|Withdrawal by Subject|23|||
161800682|NCT00661999|584312387|FG002|Overall Study|Withdrawal by Subject|14|||
161800683|NCT00661999|584312385|FG000|Overall Study|Alternative Treatment|1|||
161800684|NCT00661999|584312386|FG001|Overall Study|Alternative Treatment|0|||
161800685|NCT00661999|584312387|FG002|Overall Study|Alternative Treatment|0|||
161800686|NCT00661999|584312385|FG000|Overall Study|Other Medical Problems|4|||
161800687|NCT00661999|584312386|FG001|Overall Study|Other Medical Problems|4|||
161800688|NCT00661999|584312387|FG002|Overall Study|Other Medical Problems|9|||
161800689|NCT01139164|584312390|FG000|Overall Study|Withdrawn prior to study start|0|||
161800690|NCT01139164|584312391|FG001|Overall Study|Withdrawn prior to study start|2|||
161800691|NCT01139164|584312392|FG002|Overall Study|Withdrawn prior to study start|0|||
161800692|NCT01790568|584312393|FG000|Overall Study|Progression prior to transplant|0|||
161800693|NCT01790568|584312394|FG001|Overall Study|Progression prior to transplant|1|||
161800694|NCT01361126|584312395|FG000|Overall Study|Sponsor decision|0|||
161800695|NCT01361126|584312396|FG001|Overall Study|Sponsor decision|2|||
161800696|NCT01658943|584312399|FG000|Overall Study|Adverse Event|6|||
161800697|NCT01658943|584312400|FG001|Overall Study|Adverse Event|13|||
161800698|NCT01658943|584312399|FG000|Overall Study|Withdrawal by Subject|9|||
161800699|NCT01658943|584312400|FG001|Overall Study|Withdrawal by Subject|2|||
161800700|NCT01658943|584312399|FG000|Overall Study|Progression/Relapse|39|||
161800701|NCT01658943|584312400|FG001|Overall Study|Progression/Relapse|40|||
161800702|NCT01658943|584312399|FG000|Overall Study|Death|4|||
161800703|NCT01658943|584312400|FG001|Overall Study|Death|2|||
161800704|NCT01658943|584312399|FG000|Overall Study|not protocol specified|4|||
161800705|NCT01658943|584312400|FG001|Overall Study|not protocol specified|1|||
161800706|NCT01658943|584312399|FG000|Overall Study|Not eligible|7|||
161800707|NCT01658943|584312400|FG001|Overall Study|Not eligible|9|||
161800708|NCT01658943|584312399|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
161800709|NCT01658943|584312400|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
161800710|NCT04272801|584312403|FG000|Overall Study|Withdrawal by Subject|4|||
161800711|NCT04272801|584312403|FG000|Overall Study|Lost to Follow-up|4|||
161800712|NCT04272801|584312403|FG000|Overall Study|Ineligible|1|||
161800713|NCT02456909|584312404|FG000|Overall Study|Did not receive allocated intervention|24|||
161800714|NCT02456909|584312405|FG001|Overall Study|Did not receive allocated intervention|26|||
161800715|NCT02456909|584312404|FG000|Overall Study|Did not complete the primary outcome|0|||
161800716|NCT02456909|584312405|FG001|Overall Study|Did not complete the primary outcome|1|||
161800717|NCT02130466|584312406|FG000|Overall Study|Death|4|||
161800718|NCT02130466|584312407|FG001|Overall Study|Death|1|||
161800719|NCT02130466|584312408|FG002|Overall Study|Death|1|||
161800720|NCT02130466|584312409|FG003|Overall Study|Death|3|||
161800721|NCT02130466|584312410|FG004|Overall Study|Death|2|||
161800722|NCT02130466|584312411|FG005|Overall Study|Death|30|||
161800723|NCT02130466|584312412|FG006|Overall Study|Death|45|||
161800724|NCT02130466|584312413|FG007|Overall Study|Death|2|||
161800725|NCT02130466|584312414|FG008|Overall Study|Death|3|||
161800726|NCT02130466|584312415|FG009|Overall Study|Death|4|||
161800727|NCT02130466|584312416|FG010|Overall Study|Death|5|||
161800728|NCT02130466|584312417|FG011|Overall Study|Death|3|||
161800729|NCT02130466|584312418|FG012|Overall Study|Death|11|||
161800730|NCT02130466|584312419|FG013|Overall Study|Death|7|||
161800731|NCT02130466|584312406|FG000|Overall Study|Lost to Follow-up|1|||
161800732|NCT02130466|584312407|FG001|Overall Study|Lost to Follow-up|0|||
161800733|NCT02130466|584312408|FG002|Overall Study|Lost to Follow-up|0|||
161800734|NCT02130466|584312409|FG003|Overall Study|Lost to Follow-up|0|||
161800735|NCT02130466|584312410|FG004|Overall Study|Lost to Follow-up|0|||
161800736|NCT02130466|584312411|FG005|Overall Study|Lost to Follow-up|1|||
161800737|NCT02130466|584312412|FG006|Overall Study|Lost to Follow-up|0|||
161800738|NCT02130466|584312413|FG007|Overall Study|Lost to Follow-up|0|||
161800739|NCT02130466|584312414|FG008|Overall Study|Lost to Follow-up|0|||
161800740|NCT02130466|584312415|FG009|Overall Study|Lost to Follow-up|0|||
161800741|NCT02130466|584312416|FG010|Overall Study|Lost to Follow-up|0|||
161800742|NCT02130466|584312417|FG011|Overall Study|Lost to Follow-up|0|||
161800743|NCT02130466|584312418|FG012|Overall Study|Lost to Follow-up|1|||
161800744|NCT02130466|584312419|FG013|Overall Study|Lost to Follow-up|0|||
161800745|NCT02130466|584312406|FG000|Overall Study|Physician Decision|0|||
161800746|NCT02130466|584312407|FG001|Overall Study|Physician Decision|0|||
161800747|NCT02130466|584312408|FG002|Overall Study|Physician Decision|0|||
161800748|NCT02130466|584312409|FG003|Overall Study|Physician Decision|0|||
161800749|NCT02130466|584312410|FG004|Overall Study|Physician Decision|0|||
161800750|NCT02130466|584312411|FG005|Overall Study|Physician Decision|1|||
161800751|NCT02130466|584312412|FG006|Overall Study|Physician Decision|1|||
161800752|NCT02130466|584312413|FG007|Overall Study|Physician Decision|0|||
161800753|NCT02130466|584312414|FG008|Overall Study|Physician Decision|0|||
161800754|NCT02130466|584312415|FG009|Overall Study|Physician Decision|0|||
161800755|NCT02130466|584312416|FG010|Overall Study|Physician Decision|0|||
161800756|NCT02130466|584312417|FG011|Overall Study|Physician Decision|0|||
161800757|NCT02130466|584312418|FG012|Overall Study|Physician Decision|0|||
161800758|NCT02130466|584312419|FG013|Overall Study|Physician Decision|0|||
161800759|NCT02130466|584312406|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161800760|NCT02130466|584312407|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
161800761|NCT02130466|584312408|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161800762|NCT02130466|584312409|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
161800763|NCT02130466|584312410|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
161800764|NCT02130466|584312411|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
161800765|NCT02130466|584312412|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
161800766|NCT02130466|584312413|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161800767|NCT02130466|584312414|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
161800768|NCT02130466|584312415|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161800769|NCT02130466|584312416|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161800770|NCT02130466|584312417|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
161800771|NCT02130466|584312418|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
161800772|NCT02130466|584312419|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
161800773|NCT02130466|584312406|FG000|Overall Study|Withdrawal by Subject|1|||
161800774|NCT02130466|584312407|FG001|Overall Study|Withdrawal by Subject|0|||
161800775|NCT02130466|584312408|FG002|Overall Study|Withdrawal by Subject|0|||
161800776|NCT02130466|584312409|FG003|Overall Study|Withdrawal by Subject|0|||
161800777|NCT02130466|584312410|FG004|Overall Study|Withdrawal by Subject|0|||
161800778|NCT02130466|584312411|FG005|Overall Study|Withdrawal by Subject|1|||
161800779|NCT02130466|584312412|FG006|Overall Study|Withdrawal by Subject|0|||
161800780|NCT02130466|584312413|FG007|Overall Study|Withdrawal by Subject|0|||
161800781|NCT02130466|584312414|FG008|Overall Study|Withdrawal by Subject|1|||
161800782|NCT02130466|584312415|FG009|Overall Study|Withdrawal by Subject|0|||
161800783|NCT02130466|584312416|FG010|Overall Study|Withdrawal by Subject|0|||
161800784|NCT02130466|584312417|FG011|Overall Study|Withdrawal by Subject|0|||
161800785|NCT02130466|584312418|FG012|Overall Study|Withdrawal by Subject|0|||
162138369|NCT04888585|585557331|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
161800786|NCT02130466|584312419|FG013|Overall Study|Withdrawal by Subject|0|||
161800787|NCT04529109|584312421|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
161904298|NCT05616013|584697076|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
161800788|NCT04529109|584312422|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
161800789|NCT01508936|584312424|FG000|Overall Study|Adverse Event|11|||
161800790|NCT01508936|584312425|FG001|Overall Study|Adverse Event|32|||
161800791|NCT01508936|584312424|FG000|Overall Study|Lack of Efficacy|0|||
161800792|NCT01508936|584312425|FG001|Overall Study|Lack of Efficacy|1|||
161800793|NCT01508936|584312424|FG000|Overall Study|Withdrawal by Subject|4|||
161800794|NCT01508936|584312425|FG001|Overall Study|Withdrawal by Subject|18|||
161800795|NCT01508936|584312424|FG000|Overall Study|Protocol Violation|2|||
161904299|NCT05616013|584697077|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
161904300|NCT05616013|584697069|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904301|NCT05616013|584697070|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904302|NCT05616013|584697071|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904303|NCT05616013|584697072|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
161904304|NCT05616013|584697073|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904305|NCT05616013|584697074|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904306|NCT05616013|584697075|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904307|NCT05616013|584697076|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904308|NCT05616013|584697077|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161904309|NCT05616013|584697069|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904310|NCT05616013|584697070|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904311|NCT05616013|584697071|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904312|NCT05616013|584697072|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904313|NCT05616013|584697073|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904314|NCT05616013|584697074|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904315|NCT05616013|584697075|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
161904316|NCT05616013|584697076|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904317|NCT05616013|584697077|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161904318|NCT05616013|584697069|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904319|NCT05616013|584697070|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904320|NCT05616013|584697071|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904321|NCT05616013|584697072|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904322|NCT05616013|584697073|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904323|NCT05616013|584697074|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904324|NCT05616013|584697075|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904325|NCT05616013|584697076|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161904326|NCT05616013|584697077|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
161904327|NCT05616013|584697069|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904328|NCT05616013|584697070|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904329|NCT05616013|584697071|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904330|NCT05616013|584697072|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904331|NCT05616013|584697073|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904332|NCT05616013|584697074|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904333|NCT05616013|584697075|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904334|NCT05616013|584697076|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
161904335|NCT05616013|584697077|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
161904336|NCT02357459|584698619|FG000|Overall Study|Adverse Event|0|||
161904337|NCT02357459|584698620|FG001|Overall Study|Adverse Event|1|||
161904338|NCT02357459|584698621|FG002|Overall Study|Adverse Event|1|||
161904339|NCT02357459|584698619|FG000|Overall Study|Withdrawal by Subject|5|||
161904340|NCT02357459|584698620|FG001|Overall Study|Withdrawal by Subject|3|||
161904341|NCT02357459|584698621|FG002|Overall Study|Withdrawal by Subject|3|||
161904342|NCT02357459|584698619|FG000|Overall Study|Physician Decision|0|||
161904343|NCT02357459|584698620|FG001|Overall Study|Physician Decision|2|||
161904344|NCT02357459|584698621|FG002|Overall Study|Physician Decision|0|||
161904345|NCT02357459|584698619|FG000|Overall Study|Protocol Violation|1|||
161904346|NCT02357459|584698620|FG001|Overall Study|Protocol Violation|1|||
161904347|NCT02357459|584698621|FG002|Overall Study|Protocol Violation|0|||
161904348|NCT02357459|584698619|FG000|Overall Study|Lost to Follow-up|1|||
161904349|NCT02357459|584698620|FG001|Overall Study|Lost to Follow-up|3|||
161904350|NCT02357459|584698621|FG002|Overall Study|Lost to Follow-up|0|||
161904351|NCT02357459|584698619|FG000|Overall Study|Lack of Efficacy|7|||
161904352|NCT02357459|584698620|FG001|Overall Study|Lack of Efficacy|4|||
161904353|NCT02357459|584698621|FG002|Overall Study|Lack of Efficacy|4|||
161904354|NCT02357459|584698619|FG000|Overall Study|Patient Relocated|2|||
161904355|NCT02357459|584698620|FG001|Overall Study|Patient Relocated|0|||
161904356|NCT02357459|584698621|FG002|Overall Study|Patient Relocated|0|||
161904357|NCT02357459|584698619|FG000|Overall Study|Instruction from PCP|1|||
161904358|NCT02357459|584698620|FG001|Overall Study|Instruction from PCP|0|||
161904359|NCT02357459|584698621|FG002|Overall Study|Instruction from PCP|0|||
161904360|NCT02357459|584698619|FG000|Overall Study|Incarceration|0|||
161904361|NCT02357459|584698620|FG001|Overall Study|Incarceration|0|||
161904362|NCT02357459|584698621|FG002|Overall Study|Incarceration|1|||
161800796|NCT01508936|584312425|FG001|Overall Study|Protocol Violation|3|||
161800797|NCT01508936|584312424|FG000|Overall Study|Lost to Follow-up|2|||
161800798|NCT01508936|584312425|FG001|Overall Study|Lost to Follow-up|9|||
161800799|NCT01508936|584312424|FG000|Overall Study|Other|0|||
161800800|NCT01508936|584312425|FG001|Overall Study|Other|5|||
161800801|NCT01508936|584312424|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
161800802|NCT01508936|584312425|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
161800803|NCT00679367|584312426|FG000|Overall Study|Adverse Event|7|||
161800804|NCT00679367|584312426|FG000|Overall Study|inability to swallow oral drugs|1|||
161800805|NCT00679367|584312426|FG000|Overall Study|Lack of Efficacy|3|||
161800806|NCT00679367|584312426|FG000|Overall Study|Withdrawal by Subject|1|||
161800807|NCT00922779|584312427|FG000|Overall Study|Adverse Event|67|||
161800808|NCT00922779|584312427|FG000|Overall Study|Pregnancy|7|||
161904363|NCT02357459|584698619|FG000|Overall Study|Pre-planned Knee surgery|0|||
161904364|NCT02357459|584698620|FG001|Overall Study|Pre-planned Knee surgery|0|||
161904365|NCT02357459|584698621|FG002|Overall Study|Pre-planned Knee surgery|2|||
162138370|NCT04888585|585557332|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
162138371|NCT04888585|585557333|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
162138372|NCT04888585|585557334|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
162138373|NCT04888585|585557335|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
162138374|NCT04888585|585557325|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
162138375|NCT04888585|585557326|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
162138376|NCT04888585|585557327|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
162138377|NCT04888585|585557328|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
162138378|NCT04888585|585557329|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
162138379|NCT04888585|585557330|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
162138380|NCT04888585|585557331|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
162138381|NCT04888585|585557332|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
162138382|NCT04888585|585557333|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
162138383|NCT04888585|585557334|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
162138384|NCT04888585|585557335|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
162138385|NCT04888585|585557325|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
161800809|NCT00922779|584312427|FG000|Overall Study|Withdrawal by Subject|308|||
161800810|NCT00922779|584312427|FG000|Overall Study|Lost to Follow-up|44|||
161800811|NCT00922779|584312427|FG000|Overall Study|Other|27|||
161800812|NCT00922779|584312427|FG000|Overall Study|Missing|1874|||
161800813|NCT01611090|584312428|FG000|Randomized Period|Lost to Follow-up|8|||
161904366|NCT02357459|584698619|FG000|Overall Study|Job Commitments|0|||
161800814|NCT01611090|584312429|FG001|Randomized Period|Lost to Follow-up|3|||
161800815|NCT01611090|584312430|FG002|Randomized Period|Lost to Follow-up|0|||
161904367|NCT02357459|584698620|FG001|Overall Study|Job Commitments|0|||
161904368|NCT02357459|584698621|FG002|Overall Study|Job Commitments|1|||
162138386|NCT04888585|585557326|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
161800816|NCT01611090|584312428|FG000|Randomized Period|Withdrawal by Subject|22|||
161800817|NCT01611090|584312429|FG001|Randomized Period|Withdrawal by Subject|26|||
161800818|NCT01611090|584312430|FG002|Randomized Period|Withdrawal by Subject|0|||
161800819|NCT01611090|584312428|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
161800820|NCT01611090|584312429|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
161800821|NCT01611090|584312430|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
161800822|NCT01611090|584312428|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
161800823|NCT01611090|584312429|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
161800824|NCT01611090|584312430|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
161800825|NCT03968224|584312431|FG000|Overall Study|Lost to Follow-up|11|||
161800826|NCT03968224|584312432|FG001|Overall Study|Lost to Follow-up|18|||
161800827|NCT04256421|584312434|FG000|Overall Study|Death|171|||
161800828|NCT04256421|584312435|FG001|Overall Study|Death|180|||
161800829|NCT04256421|584312434|FG000|Overall Study|Lost to Follow-up|1|||
161800830|NCT04256421|584312435|FG001|Overall Study|Lost to Follow-up|1|||
161800831|NCT04256421|584312434|FG000|Overall Study|Withdrawal by Subject|9|||
161800832|NCT04256421|584312435|FG001|Overall Study|Withdrawal by Subject|10|||
161800833|NCT04256421|584312434|FG000|Overall Study|Ongoing in Study|66|||
161800834|NCT04256421|584312435|FG001|Overall Study|Ongoing in Study|52|||
161800835|NCT05771428|584314373|FG000|Overall Study|Adverse Event|0|||
161800836|NCT05771428|584314374|FG001|Overall Study|Adverse Event|1|||
161800837|NCT05771428|584314375|FG002|Overall Study|Adverse Event|1|||
161800838|NCT05771428|584314376|FG003|Overall Study|Adverse Event|1|||
161800839|NCT05771428|584314373|FG000|Overall Study|Withdrawal by Subject|3|||
161800840|NCT05771428|584314374|FG001|Overall Study|Withdrawal by Subject|2|||
161800841|NCT05771428|584314375|FG002|Overall Study|Withdrawal by Subject|1|||
161800842|NCT05771428|584314376|FG003|Overall Study|Withdrawal by Subject|4|||
161800843|NCT05771428|584314373|FG000|Overall Study|Other|0|||
161800844|NCT05771428|584314374|FG001|Overall Study|Other|1|||
161800845|NCT05771428|584314375|FG002|Overall Study|Other|2|||
161800846|NCT05771428|584314376|FG003|Overall Study|Other|1|||
161800847|NCT05771428|584314373|FG000|Overall Study|Randomized but Not Treated|0|||
161800848|NCT05771428|584314374|FG001|Overall Study|Randomized but Not Treated|0|||
161800849|NCT05771428|584314375|FG002|Overall Study|Randomized but Not Treated|1|||
161800850|NCT05771428|584314376|FG003|Overall Study|Randomized but Not Treated|0|||
162138387|NCT04888585|585557327|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
162138388|NCT04888585|585557328|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
162138389|NCT04888585|585557329|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
162138390|NCT04888585|585557330|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
162138391|NCT04888585|585557331|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
162138392|NCT04888585|585557332|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
162138393|NCT04888585|585557333|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
162138394|NCT04888585|585557334|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
162138395|NCT04888585|585557335|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
162138396|NCT04888585|585557325|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162138397|NCT04888585|585557326|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162138398|NCT04888585|585557327|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162138399|NCT04888585|585557328|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162138400|NCT04888585|585557329|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162138401|NCT04888585|585557330|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162138402|NCT04888585|585557331|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
162138403|NCT04888585|585557332|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
162138404|NCT04888585|585557333|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
162138405|NCT04888585|585557334|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
162138406|NCT04888585|585557335|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
162138407|NCT04927975|585557336|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
162138408|NCT04927975|585557337|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
162138409|NCT04927975|585557338|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
162138410|NCT04927975|585557339|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
162138411|NCT04927975|585557340|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
162138412|NCT04927975|585557341|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
161800851|NCT04025229|584314377|FG000|Overall Study|Adverse Event|1|||
162138413|NCT04927975|585557336|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
162138414|NCT04927975|585557337|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
162138415|NCT04927975|585557338|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
162138416|NCT04927975|585557339|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
162138417|NCT04927975|585557340|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
161800852|NCT04025229|584314378|FG001|Overall Study|Adverse Event|0|||
161800853|NCT04025229|584314377|FG000|Overall Study|Withdrawal by Subject|0|||
161800854|NCT04025229|584314378|FG001|Overall Study|Withdrawal by Subject|2|||
161800855|NCT04025229|584314377|FG000|Overall Study|Death|0|||
161800856|NCT04025229|584314378|FG001|Overall Study|Death|1|||
161800857|NCT04025229|584314377|FG000|Overall Study|Physician Decision|0|||
161800858|NCT04025229|584314378|FG001|Overall Study|Physician Decision|1|||
161800859|NCT03815942|584314379|FG000|Overall Study|Withdrawal by Subject|0|||
161800860|NCT03815942|584314380|FG001|Overall Study|Withdrawal by Subject|17|||
161800861|NCT00366899|584314381|FG000|Infant Series|Withdrawal by Subject|4|||
161800862|NCT00366899|584314382|FG001|Infant Series|Withdrawal by Subject|7|||
161800863|NCT00366899|584314381|FG000|Infant Series|Protocol Violation|2|||
161800864|NCT00366899|584314382|FG001|Infant Series|Protocol Violation|1|||
161800865|NCT00366899|584314381|FG000|Infant Series|Failed to return|1|||
161800866|NCT00366899|584314382|FG001|Infant Series|Failed to return|1|||
161800867|NCT00366899|584314381|FG000|Infant Series|Lost to Follow-up|0|||
161800868|NCT00366899|584314382|FG001|Infant Series|Lost to Follow-up|2|||
161800869|NCT00366899|584314381|FG000|Infant Series|Adverse Event|0|||
161800870|NCT00366899|584314382|FG001|Infant Series|Adverse Event|1|||
161800871|NCT00366899|584314381|FG000|Infant Series|Physician Decision|1|||
161800872|NCT00366899|584314382|FG001|Infant Series|Physician Decision|0|||
161800873|NCT00366899|584314381|FG000|Infant Series|Randomized but not consented|1|||
161800874|NCT00366899|584314382|FG001|Infant Series|Randomized but not consented|0|||
161800875|NCT00366899|584314381|FG000|After Infant Series|Lost to Follow-up|4|||
161800876|NCT00366899|584314382|FG001|After Infant Series|Lost to Follow-up|3|||
161800877|NCT00366899|584314381|FG000|After Infant Series|Withdrawal by Subject|1|||
161800878|NCT00366899|584314382|FG001|After Infant Series|Withdrawal by Subject|4|||
161800879|NCT00366899|584314381|FG000|After Infant Series|Adverse Event|1|||
161800880|NCT00366899|584314382|FG001|After Infant Series|Adverse Event|2|||
161800881|NCT00366899|584314381|FG000|After Infant Series|Protocol Violation|1|||
161800882|NCT00366899|584314382|FG001|After Infant Series|Protocol Violation|0|||
161800883|NCT00366899|584314381|FG000|Toddler Dose|Withdrawal by Subject|1|||
161800884|NCT00366899|584314382|FG001|Toddler Dose|Withdrawal by Subject|1|||
161800885|NCT00366899|584314381|FG000|Toddler Dose|Protocol Violation|1|||
161800886|NCT00366899|584314382|FG001|Toddler Dose|Protocol Violation|0|||
161800887|NCT03601637|584314383|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
161800888|NCT03601637|584314384|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
161800889|NCT03601637|584314383|FG000|Overall Study|Adverse Event|1|||
161800890|NCT03601637|584314384|FG001|Overall Study|Adverse Event|1|||
161800891|NCT03601637|584314383|FG000|Overall Study|Other|0|||
161800892|NCT03601637|584314384|FG001|Overall Study|Other|1|||
161800893|NCT02322047|584314386|FG000|Overall Study|Physician Decision|1|||
161800894|NCT02322047|584314387|FG001|Overall Study|Physician Decision|0|||
161800895|NCT02322047|584314388|FG002|Overall Study|Physician Decision|0|||
161800896|NCT02322047|584314389|FG003|Overall Study|Physician Decision|0|||
161800897|NCT02322047|584314386|FG000|Overall Study|Withdrawal by Subject|1|||
161800898|NCT02322047|584314387|FG001|Overall Study|Withdrawal by Subject|0|||
161800899|NCT02322047|584314388|FG002|Overall Study|Withdrawal by Subject|0|||
161800900|NCT02322047|584314389|FG003|Overall Study|Withdrawal by Subject|1|||
161800901|NCT02322047|584314386|FG000|Overall Study|Adverse Event|0|||
161800902|NCT02322047|584314387|FG001|Overall Study|Adverse Event|1|||
161800903|NCT02322047|584314388|FG002|Overall Study|Adverse Event|0|||
161800904|NCT02322047|584314389|FG003|Overall Study|Adverse Event|0|||
161800905|NCT02322047|584314386|FG000|Overall Study|Lost to Follow-up|0|||
161800906|NCT02322047|584314387|FG001|Overall Study|Lost to Follow-up|0|||
161800907|NCT02322047|584314388|FG002|Overall Study|Lost to Follow-up|1|||
161800908|NCT02322047|584314389|FG003|Overall Study|Lost to Follow-up|1|||
161800909|NCT00920140|584314392|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
161800910|NCT00920140|584314393|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
161800911|NCT00920140|584314394|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
161800912|NCT00920140|584314395|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
161800913|NCT00920140|584314396|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
161800914|NCT00920140|584314392|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
161800915|NCT00920140|584314393|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
161800916|NCT00920140|584314394|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
161800917|NCT00920140|584314395|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
161800918|NCT00920140|584314396|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
161800919|NCT00920140|584314392|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161800920|NCT00920140|584314393|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
161800921|NCT00920140|584314394|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161800922|NCT00920140|584314395|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161800923|NCT00920140|584314396|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161800924|NCT00920140|584314392|FG000|Phase 2|Adverse Event|0|||
161800925|NCT00920140|584314393|FG001|Phase 2|Adverse Event|0|||
161800926|NCT00920140|584314394|FG002|Phase 2|Adverse Event|14|||
161800927|NCT00920140|584314395|FG003|Phase 2|Adverse Event|2|||
161800928|NCT00920140|584314396|FG004|Phase 2|Adverse Event|3|||
161800929|NCT00920140|584314392|FG000|Phase 2|Lack of Efficacy|0|||
161800930|NCT00920140|584314393|FG001|Phase 2|Lack of Efficacy|0|||
161800931|NCT00920140|584314394|FG002|Phase 2|Lack of Efficacy|29|||
161800932|NCT00920140|584314395|FG003|Phase 2|Lack of Efficacy|14|||
161800933|NCT00920140|584314396|FG004|Phase 2|Lack of Efficacy|5|||
161800934|NCT00920140|584314392|FG000|Phase 2|Lost to Follow-up|0|||
161800935|NCT00920140|584314393|FG001|Phase 2|Lost to Follow-up|0|||
161800936|NCT00920140|584314394|FG002|Phase 2|Lost to Follow-up|0|||
161800937|NCT00920140|584314395|FG003|Phase 2|Lost to Follow-up|1|||
161800938|NCT00920140|584314396|FG004|Phase 2|Lost to Follow-up|0|||
161800939|NCT00920140|584314392|FG000|Phase 2|Physician Decision|0|||
161800940|NCT00920140|584314393|FG001|Phase 2|Physician Decision|0|||
161800941|NCT00920140|584314394|FG002|Phase 2|Physician Decision|3|||
161800942|NCT00920140|584314395|FG003|Phase 2|Physician Decision|3|||
161800943|NCT00920140|584314396|FG004|Phase 2|Physician Decision|2|||
161800944|NCT00920140|584314392|FG000|Phase 2|Withdrawal by Subject|0|||
161800945|NCT00920140|584314393|FG001|Phase 2|Withdrawal by Subject|0|||
161800946|NCT00920140|584314394|FG002|Phase 2|Withdrawal by Subject|4|||
161800947|NCT00920140|584314395|FG003|Phase 2|Withdrawal by Subject|2|||
161800948|NCT00920140|584314396|FG004|Phase 2|Withdrawal by Subject|1|||
161800949|NCT01400425|584314397|FG000|Overall Study|Withdrawal by Subject|10|||
161800950|NCT00720096|584314399|FG000|Overall Study|Withdrawal by Subject|0|||
161800951|NCT00720096|584314400|FG001|Overall Study|Withdrawal by Subject|2|||
161800952|NCT04557124|584314401|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
161800953|NCT04557124|584314402|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
161800954|NCT04557124|584314401|FG000|Mid-point (1 Month)|Missed testing|5|||
161800955|NCT04557124|584314402|FG001|Mid-point (1 Month)|Missed testing|4|||
161800956|NCT04557124|584314401|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
161800957|NCT04557124|584314402|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
161800958|NCT04557124|584314401|FG000|Post-testing (2 Months)|Missed testing|1|||
161800959|NCT04557124|584314402|FG001|Post-testing (2 Months)|Missed testing|5|||
161800960|NCT04557124|584314401|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
161800961|NCT04557124|584314402|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
161800962|NCT04557124|584314401|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
161800963|NCT04557124|584314402|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
161800964|NCT00001849|584314403|FG000|Overall Study|Death|4|||
161800965|NCT00001849|584314403|FG000|Overall Study|Lost to Follow-up|2|||
161800966|NCT00001849|584314403|FG000|Overall Study|Withdrawal by Subject|2|||
161800967|NCT00001849|584314403|FG000|Overall Study|tumor remained occult|6|||
161800968|NCT00442936|584314404|FG000|Overall Study|Protocol Violation|1|||
161800969|NCT00442936|584314405|FG001|Overall Study|Protocol Violation|0|||
161800970|NCT00442936|584314406|FG002|Overall Study|Protocol Violation|1|||
161800971|NCT00442936|584314407|FG003|Overall Study|Protocol Violation|1|||
161800972|NCT02428699|584314408|FG000|Washout Period 1|Screen Failure|1|||
161800973|NCT02428699|584314409|FG001|Washout Period 1|Screen Failure|2|||
161800974|NCT03127137|584314410|FG000|Overall Study|Requested sedation after consent|1|||
161800975|NCT03127137|584314411|FG001|Overall Study|Requested sedation after consent|0|||
161800976|NCT03127137|584314410|FG000|Overall Study|Malfunction in electronic data collection|1|||
161800977|NCT03127137|584314411|FG001|Overall Study|Malfunction in electronic data collection|0|||
161800978|NCT03127137|584314410|FG000|Overall Study|Post procedure testing could not be obtained|0|||
161800979|NCT03127137|584314411|FG001|Overall Study|Post procedure testing could not be obtained|1|||
161800980|NCT04424407|584314412|FG000|Overall Study|Withdrawal by Subject|2|||
161800981|NCT04424407|584314412|FG000|Overall Study|Lost to Follow-up|1|||
161800982|NCT00264797|584314413|FG000|Overall Study|Withdrawal by Subject|11|||
161800983|NCT00264797|584314414|FG001|Overall Study|Withdrawal by Subject|11|||
161800984|NCT00264797|584314413|FG000|Overall Study|Lost to Follow-up|9|||
161800985|NCT00264797|584314414|FG001|Overall Study|Lost to Follow-up|17|||
161800986|NCT00264797|584314413|FG000|Overall Study|Moved from area|3|||
161800987|NCT00264797|584314414|FG001|Overall Study|Moved from area|1|||
161800988|NCT00264797|584314413|FG000|Overall Study|Practical Problems|2|||
161800989|NCT00264797|584314414|FG001|Overall Study|Practical Problems|3|||
161800990|NCT00264797|584314413|FG000|Overall Study|Incarceration|4|||
161800991|NCT00264797|584314414|FG001|Overall Study|Incarceration|5|||
161800992|NCT00264797|584314413|FG000|Overall Study|Pressure/advice from Outsiders|1|||
161800993|NCT00264797|584314414|FG001|Overall Study|Pressure/advice from Outsiders|1|||
161800994|NCT00264797|584314413|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
161800995|NCT00264797|584314414|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
161800996|NCT00264797|584314413|FG000|Overall Study|Other|3|||
161800997|NCT00264797|584314414|FG001|Overall Study|Other|4|||
161904369|NCT03246347|584698622|FG000|Overall Study|On Study|23|||
161800998|NCT03992196|584314415|FG000|Enrollment|lost to follow-up prior dosing|1|||
161800999|NCT03992196|584314416|FG001|Enrollment|lost to follow-up prior dosing|0|||
162138418|NCT04927975|585557341|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
161801000|NCT03992196|584314417|FG002|Enrollment|lost to follow-up prior dosing|0|||
161801001|NCT03992196|584314415|FG000|Treatment|Protocol Violation|0|||
161801002|NCT03992196|584314416|FG001|Treatment|Protocol Violation|0|||
161801003|NCT03992196|584314417|FG002|Treatment|Protocol Violation|1|||
161801004|NCT03992196|584314415|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
161801005|NCT03992196|584314416|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
161801006|NCT03992196|584314417|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
161801007|NCT03992196|584314415|FG000|Treatment|Withdrawal due to non-compliance|0|||
161801008|NCT03992196|584314416|FG001|Treatment|Withdrawal due to non-compliance|0|||
161801009|NCT03992196|584314417|FG002|Treatment|Withdrawal due to non-compliance|1|||
161801010|NCT03992196|584314415|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
161801011|NCT03992196|584314416|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
161801012|NCT03992196|584314417|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
161801013|NCT03992196|584314415|FG000|Treatment|Withdrawal by parent/guardian|0|||
161801014|NCT03992196|584314416|FG001|Treatment|Withdrawal by parent/guardian|0|||
161801015|NCT03992196|584314417|FG002|Treatment|Withdrawal by parent/guardian|2|||
161801016|NCT00755196|584314419|FG000|Overall Study|Lost to Follow-up|1|||
161801017|NCT00755196|584314419|FG000|Overall Study|Lack of Efficiency|1|||
161801018|NCT02388763|584314420|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
161801019|NCT02388763|584314421|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
161801020|NCT02388763|584314420|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
161801021|NCT02388763|584314421|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
161801022|NCT01604850|584314422|FG000|Overall Study|Enrolled but never treated|0|||
161904370|NCT00916578|584698623|FG000|Overall Study|Physician Decision|2|||
162138419|NCT04927975|585557336|FG000|Period 1 (Baseline-Week 24)|Death|0|||
162138420|NCT04927975|585557337|FG001|Period 1 (Baseline-Week 24)|Death|0|||
162138421|NCT04927975|585557338|FG002|Period 1 (Baseline-Week 24)|Death|0|||
162138422|NCT04927975|585557339|FG003|Period 1 (Baseline-Week 24)|Death|0|||
162138423|NCT04927975|585557340|FG004|Period 1 (Baseline-Week 24)|Death|0|||
162138424|NCT04927975|585557341|FG005|Period 1 (Baseline-Week 24)|Death|1|||
162138425|NCT04927975|585557336|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
162138426|NCT04927975|585557337|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
162138427|NCT04927975|585557338|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
162138428|NCT04927975|585557339|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
162138429|NCT04927975|585557340|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
162138430|NCT04927975|585557341|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
162138431|NCT04927975|585557336|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
162138432|NCT04927975|585557337|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
162138433|NCT04927975|585557338|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
162138434|NCT04927975|585557339|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
162138435|NCT04927975|585557340|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
162138436|NCT04927975|585557341|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
162138437|NCT03822351|585557342|FG000|Overall Study|Death|27|||
162138438|NCT03822351|585557343|FG001|Overall Study|Death|23|||
162138439|NCT03822351|585557344|FG002|Overall Study|Death|24|||
162138440|NCT03822351|585557342|FG000|Overall Study|Lost to Follow-up|6|||
162138441|NCT03822351|585557343|FG001|Overall Study|Lost to Follow-up|2|||
162138442|NCT03822351|585557344|FG002|Overall Study|Lost to Follow-up|1|||
162138443|NCT03822351|585557342|FG000|Overall Study|Withdrawal by Subject|10|||
162138444|NCT03822351|585557343|FG001|Overall Study|Withdrawal by Subject|4|||
162138445|NCT03822351|585557344|FG002|Overall Study|Withdrawal by Subject|6|||
162138446|NCT03822351|585557342|FG000|Overall Study|Progressive Disease|2|||
162138447|NCT03822351|585557343|FG001|Overall Study|Progressive Disease|1|||
161904371|NCT00916578|584698623|FG000|Overall Study|Withdrawal by Subject|3|||
161904372|NCT00916578|584698623|FG000|Overall Study|Insurance Denial|2|||
162138448|NCT03822351|585557344|FG002|Overall Study|Progressive Disease|0|||
162138449|NCT03822351|585557342|FG000|Overall Study|Not Treated|1|||
162138450|NCT03822351|585557343|FG001|Overall Study|Not Treated|1|||
162138451|NCT03822351|585557344|FG002|Overall Study|Not Treated|1|||
162138452|NCT00768066|585557347|FG000|Overall Study|Did not receive study product injection.|3|||
162138453|NCT00768066|585557348|FG001|Overall Study|Did not receive study product injection.|3|||
162138454|NCT00768066|585557349|FG002|Overall Study|Did not receive study product injection.|0|||
162138455|NCT05550337|585557350|FG000|Overall Study|Lack of Efficacy|0|||
162138456|NCT05550337|585557351|FG001|Overall Study|Lack of Efficacy|0|||
162138457|NCT05550337|585557352|FG002|Overall Study|Lack of Efficacy|1|||
162138458|NCT05550337|585557350|FG000|Overall Study|Adverse Event|1|||
162138459|NCT05550337|585557351|FG001|Overall Study|Adverse Event|5|||
162138460|NCT05550337|585557352|FG002|Overall Study|Adverse Event|0|||
162138461|NCT05550337|585557350|FG000|Overall Study|Withdrawal by Subject|8|||
162138462|NCT05550337|585557351|FG001|Overall Study|Withdrawal by Subject|14|||
162138463|NCT05550337|585557352|FG002|Overall Study|Withdrawal by Subject|10|||
161904373|NCT02771275|584698630|FG000|Overall Study|Reoperation|3|||
161904374|NCT02771275|584698630|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
161904375|NCT05556148|584698631|FG000|Overall Study|Early Termination|29|||
161904376|NCT05556148|584698631|FG000|Overall Study|Baseline Tasks Expired|4|||
161904377|NCT05556148|584698631|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
161904378|NCT05556148|584698631|FG000|Overall Study|No Longer Wished to Participate|1|||
161904379|NCT05556148|584698631|FG000|Overall Study|Bacterial Conjunctivitis|1|||
161904380|NCT01171898|584698632|FG000|Overall Study|Death|0|||
161904381|NCT01171898|584698633|FG001|Overall Study|Death|0|||
161904382|NCT01171898|584698634|FG002|Overall Study|Death|2|||
161904383|NCT01171898|584698635|FG003|Overall Study|Death|0|||
161904384|NCT01171898|584698632|FG000|Overall Study|Lost to Follow-up|0|||
161904385|NCT01171898|584698633|FG001|Overall Study|Lost to Follow-up|1|||
161904386|NCT01171898|584698634|FG002|Overall Study|Lost to Follow-up|1|||
161904387|NCT01171898|584698635|FG003|Overall Study|Lost to Follow-up|1|||
161904388|NCT01171898|584698632|FG000|Overall Study|Withdrawal by Subject|1|||
161904389|NCT01171898|584698633|FG001|Overall Study|Withdrawal by Subject|4|||
161904390|NCT01171898|584698634|FG002|Overall Study|Withdrawal by Subject|6|||
161904391|NCT01171898|584698635|FG003|Overall Study|Withdrawal by Subject|3|||
161904392|NCT01171898|584698632|FG000|Overall Study|Terminated by Sponsor|1|||
161904393|NCT01171898|584698633|FG001|Overall Study|Terminated by Sponsor|0|||
161904394|NCT01171898|584698634|FG002|Overall Study|Terminated by Sponsor|0|||
161904395|NCT01171898|584698635|FG003|Overall Study|Terminated by Sponsor|0|||
161904396|NCT01171898|584698632|FG000|Overall Study|Ongoing|1|||
161904397|NCT01171898|584698633|FG001|Overall Study|Ongoing|9|||
161904398|NCT01171898|584698634|FG002|Overall Study|Ongoing|3|||
161904399|NCT01171898|584698635|FG003|Overall Study|Ongoing|0|||
161904400|NCT01171898|584698632|FG000|Overall Study|Other|1|||
161904401|NCT01171898|584698633|FG001|Overall Study|Other|5|||
161904402|NCT01171898|584698634|FG002|Overall Study|Other|0|||
161904403|NCT01171898|584698635|FG003|Overall Study|Other|2|||
161904404|NCT03191799|584698636|FG000|Overall Study|Withdrawal by Subject|4|||
161904405|NCT03191799|584698636|FG000|Overall Study|Physician Decision|2|||
161904406|NCT03191799|584698636|FG000|Overall Study|Lost to Follow-up|1|||
161904407|NCT03191799|584698636|FG000|Overall Study|Death|2|||
161904408|NCT01239797|584698637|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
161904409|NCT01239797|584698638|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
161904410|NCT01239797|584698637|FG000|Randomized Participants|Participant withdrew consent|1|||
161904411|NCT01239797|584698638|FG001|Randomized Participants|Participant withdrew consent|7|||
161904412|NCT01239797|584698637|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
161904413|NCT01239797|584698638|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
161904414|NCT01239797|584698637|FG000|Treated Participants|Disease progression|185|||
161904415|NCT01239797|584698638|FG001|Treated Participants|Disease progression|185|||
161904416|NCT01239797|584698637|FG000|Treated Participants|Study drug toxicity|39|||
161904417|NCT01239797|584698638|FG001|Treated Participants|Study drug toxicity|45|||
161904418|NCT01239797|584698637|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
161904419|NCT01239797|584698638|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
161904420|NCT01239797|584698637|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
161904421|NCT01239797|584698638|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
161904422|NCT01239797|584698637|FG000|Treated Participants|Administrative reason by sponsor|13|||
161904423|NCT01239797|584698638|FG001|Treated Participants|Administrative reason by sponsor|4|||
161904424|NCT01239797|584698637|FG000|Treated Participants|Other reasons|14|||
161904425|NCT01239797|584698638|FG001|Treated Participants|Other reasons|14|||
161904426|NCT01239797|584698637|FG000|Treated Participants|Participant withdrew consent|6|||
161904427|NCT01239797|584698638|FG001|Treated Participants|Participant withdrew consent|11|||
161904428|NCT01239797|584698637|FG000|Treated Participants|Death|1|||
161904429|NCT01239797|584698638|FG001|Treated Participants|Death|1|||
161904430|NCT01239797|584698637|FG000|Treated Participants|Participant no longer meets study criteria|1|||
161904431|NCT01239797|584698638|FG001|Treated Participants|Participant no longer meets study criteria|1|||
161904432|NCT01239797|584698637|FG000|Treated Participants|Poor/non-compliance|0|||
161904433|NCT01239797|584698638|FG001|Treated Participants|Poor/non-compliance|1|||
161904434|NCT00853762|584698641|FG000|Overall Study|Premature Termination|16|||
161904435|NCT00853762|584698642|FG001|Overall Study|Premature Termination|15|||
161904436|NCT00853762|584698643|FG002|Overall Study|Premature Termination|14|||
162138464|NCT05550337|585557350|FG000|Overall Study|Pregnancy|0|||
162138465|NCT05550337|585557351|FG001|Overall Study|Pregnancy|0|||
162138466|NCT05550337|585557352|FG002|Overall Study|Pregnancy|1|||
162138467|NCT05550337|585557350|FG000|Overall Study|Protocol Violation|1|||
162138468|NCT05550337|585557351|FG001|Overall Study|Protocol Violation|3|||
161904437|NCT00853762|584698644|FG003|Overall Study|Premature Termination|21|||
161904438|NCT00853762|584698641|FG000|Overall Study|Protocol Violation|0|||
161904439|NCT00853762|584698642|FG001|Overall Study|Protocol Violation|0|||
161904440|NCT00853762|584698643|FG002|Overall Study|Protocol Violation|0|||
162010887|NCT02594124|585096043|FG000|Overall Study|Withdrawal by Subject|2|||
162138469|NCT05550337|585557352|FG002|Overall Study|Protocol Violation|4|||
161801023|NCT01604850|584314423|FG001|Overall Study|Enrolled but never treated|1|||
161801024|NCT01604850|584314422|FG000|Overall Study|Efficacy Failure|50|||
161801025|NCT01604850|584314423|FG001|Overall Study|Efficacy Failure|29|||
161801026|NCT01604850|584314422|FG000|Overall Study|Lost to Follow-up|1|||
161801027|NCT01604850|584314423|FG001|Overall Study|Lost to Follow-up|0|||
161801028|NCT01604850|584314422|FG000|Overall Study|Subject withdrew consent|1|||
161801029|NCT01604850|584314423|FG001|Overall Study|Subject withdrew consent|0|||
161801030|NCT01703832|584314424|FG000|Overall Study|Withdrawal by Subject|1|||
161904441|NCT00853762|584698644|FG003|Overall Study|Protocol Violation|1|||
161801031|NCT01703832|584314425|FG001|Overall Study|Withdrawal by Subject|0|||
161904442|NCT00853762|584698641|FG000|Overall Study|Withdrawal by Subject|0|||
161904443|NCT00853762|584698642|FG001|Overall Study|Withdrawal by Subject|0|||
161904444|NCT00853762|584698643|FG002|Overall Study|Withdrawal by Subject|1|||
161904445|NCT00853762|584698644|FG003|Overall Study|Withdrawal by Subject|0|||
161904446|NCT00853762|584698641|FG000|Overall Study|Other|0|||
161904447|NCT00853762|584698642|FG001|Overall Study|Other|2|||
161904448|NCT00853762|584698643|FG002|Overall Study|Other|0|||
161904449|NCT00853762|584698644|FG003|Overall Study|Other|0|||
161904450|NCT00853762|584698641|FG000|Overall Study|Randomised but not Treated|0|||
161904451|NCT00853762|584698642|FG001|Overall Study|Randomised but not Treated|2|||
161904452|NCT00853762|584698643|FG002|Overall Study|Randomised but not Treated|2|||
161904453|NCT00853762|584698644|FG003|Overall Study|Randomised but not Treated|0|||
161904454|NCT02000921|584698645|FG000|Overall Study|Withdrawal by Subject|3|||
161904455|NCT02000921|584698646|FG001|Overall Study|Withdrawal by Subject|10|||
161904456|NCT02000921|584698647|FG002|Overall Study|Withdrawal by Subject|5|||
161904457|NCT02000921|584698645|FG000|Overall Study|Lost to Follow-up|2|||
161904458|NCT02000921|584698646|FG001|Overall Study|Lost to Follow-up|4|||
161904459|NCT02000921|584698647|FG002|Overall Study|Lost to Follow-up|5|||
161904460|NCT02000921|584698645|FG000|Overall Study|Physician Decision|0|||
161904461|NCT02000921|584698646|FG001|Overall Study|Physician Decision|2|||
161904462|NCT02000921|584698647|FG002|Overall Study|Physician Decision|0|||
161904463|NCT02631941|584698654|FG000|Overall Study|Physician Decision|0|||
161904464|NCT02631941|584698655|FG001|Overall Study|Physician Decision|1|||
161904465|NCT02631941|584698656|FG002|Overall Study|Physician Decision|0|||
161904466|NCT02631941|584698657|FG003|Overall Study|Physician Decision|0|||
161904467|NCT02631941|584698658|FG004|Overall Study|Physician Decision|0|||
161904468|NCT02631941|584698659|FG005|Overall Study|Physician Decision|0|||
161904469|NCT02631941|584698660|FG006|Overall Study|Physician Decision|0|||
161904470|NCT02631941|584698661|FG007|Overall Study|Physician Decision|0|||
161904471|NCT02631941|584698662|FG008|Overall Study|Physician Decision|0|||
161904472|NCT02631941|584698663|FG009|Overall Study|Physician Decision|0|||
161904473|NCT02631941|584698654|FG000|Overall Study|Adverse Event|0|||
161904474|NCT02631941|584698655|FG001|Overall Study|Adverse Event|1|||
161904475|NCT02631941|584698656|FG002|Overall Study|Adverse Event|0|||
161904476|NCT02631941|584698657|FG003|Overall Study|Adverse Event|0|||
161904477|NCT02631941|584698658|FG004|Overall Study|Adverse Event|0|||
161904478|NCT02631941|584698659|FG005|Overall Study|Adverse Event|0|||
161904479|NCT02631941|584698660|FG006|Overall Study|Adverse Event|0|||
161904480|NCT02631941|584698661|FG007|Overall Study|Adverse Event|0|||
161904481|NCT02631941|584698662|FG008|Overall Study|Adverse Event|0|||
161904482|NCT02631941|584698663|FG009|Overall Study|Adverse Event|0|||
161904483|NCT02631941|584698654|FG000|Overall Study|Withdrawal by Subject|0|||
161904484|NCT02631941|584698655|FG001|Overall Study|Withdrawal by Subject|0|||
161904485|NCT02631941|584698656|FG002|Overall Study|Withdrawal by Subject|0|||
161904486|NCT02631941|584698657|FG003|Overall Study|Withdrawal by Subject|0|||
161904487|NCT02631941|584698658|FG004|Overall Study|Withdrawal by Subject|1|||
161904488|NCT02631941|584698659|FG005|Overall Study|Withdrawal by Subject|0|||
161904489|NCT02631941|584698660|FG006|Overall Study|Withdrawal by Subject|0|||
161904490|NCT02631941|584698661|FG007|Overall Study|Withdrawal by Subject|1|||
161904491|NCT02631941|584698662|FG008|Overall Study|Withdrawal by Subject|0|||
161904492|NCT02631941|584698663|FG009|Overall Study|Withdrawal by Subject|0|||
161904493|NCT02631941|584698654|FG000|Overall Study|Lost to Follow-up|0|||
161904494|NCT02631941|584698655|FG001|Overall Study|Lost to Follow-up|0|||
161904495|NCT02631941|584698656|FG002|Overall Study|Lost to Follow-up|0|||
161904496|NCT02631941|584698657|FG003|Overall Study|Lost to Follow-up|0|||
161904497|NCT02631941|584698658|FG004|Overall Study|Lost to Follow-up|0|||
161904498|NCT02631941|584698659|FG005|Overall Study|Lost to Follow-up|0|||
161904499|NCT02631941|584698660|FG006|Overall Study|Lost to Follow-up|0|||
161904500|NCT02631941|584698661|FG007|Overall Study|Lost to Follow-up|0|||
161904501|NCT02631941|584698662|FG008|Overall Study|Lost to Follow-up|1|||
161904502|NCT02631941|584698663|FG009|Overall Study|Lost to Follow-up|0|||
161904503|NCT03933449|584698664|FG000|Overall Study|Adverse Event|6|||
161904504|NCT03933449|584698665|FG001|Overall Study|Adverse Event|4|||
161904505|NCT03933449|584698664|FG000|Overall Study|Death|55|||
161904506|NCT03933449|584698665|FG001|Overall Study|Death|57|||
161904507|NCT03933449|584698664|FG000|Overall Study|Sponsor Decision|1|||
161904508|NCT03933449|584698665|FG001|Overall Study|Sponsor Decision|0|||
161904509|NCT02087774|584698668|FG000|Overall Study|Were absent day of data collection|8|||
161904510|NCT02087774|584698669|FG001|Overall Study|Were absent day of data collection|20|||
161904511|NCT02204917|584698670|FG000|Overall Study|Protocol Violation|1|||
161904512|NCT02869789|584698671|FG000|Overall Study|Disease progression|184|||
161904513|NCT02869789|584698672|FG001|Overall Study|Disease progression|109|||
161904514|NCT02869789|584698673|FG002|Overall Study|Disease progression|260|||
161904515|NCT02869789|584698674|FG003|Overall Study|Disease progression|19|||
161904516|NCT02869789|584698671|FG000|Overall Study|Study drug toxicity|90|||
161904517|NCT02869789|584698672|FG001|Overall Study|Study drug toxicity|32|||
161904518|NCT02869789|584698673|FG002|Overall Study|Study drug toxicity|55|||
161904519|NCT02869789|584698674|FG003|Overall Study|Study drug toxicity|14|||
161904520|NCT02869789|584698671|FG000|Overall Study|Death|7|||
161904521|NCT02869789|584698672|FG001|Overall Study|Death|3|||
161904522|NCT02869789|584698673|FG002|Overall Study|Death|5|||
161904523|NCT02869789|584698674|FG003|Overall Study|Death|1|||
161904524|NCT02869789|584698671|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
161904525|NCT02869789|584698672|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
161904526|NCT02869789|584698673|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
161904527|NCT02869789|584698674|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
161904528|NCT02869789|584698671|FG000|Overall Study|Participant request to discontinue study treatment|10|||
161904529|NCT02869789|584698672|FG001|Overall Study|Participant request to discontinue study treatment|5|||
161904530|NCT02869789|584698673|FG002|Overall Study|Participant request to discontinue study treatment|5|||
161904531|NCT02869789|584698674|FG003|Overall Study|Participant request to discontinue study treatment|3|||
161904532|NCT02869789|584698671|FG000|Overall Study|Withdrawal by Subject|5|||
161904533|NCT02869789|584698672|FG001|Overall Study|Withdrawal by Subject|2|||
161904534|NCT02869789|584698673|FG002|Overall Study|Withdrawal by Subject|7|||
161904535|NCT02869789|584698674|FG003|Overall Study|Withdrawal by Subject|2|||
161904536|NCT02869789|584698671|FG000|Overall Study|Lost to Follow-up|0|||
161904537|NCT02869789|584698672|FG001|Overall Study|Lost to Follow-up|0|||
161904538|NCT02869789|584698673|FG002|Overall Study|Lost to Follow-up|2|||
161904539|NCT02869789|584698674|FG003|Overall Study|Lost to Follow-up|0|||
161904540|NCT02869789|584698671|FG000|Overall Study|Maximum clinical benefit|5|||
161904541|NCT02869789|584698672|FG001|Overall Study|Maximum clinical benefit|2|||
161904542|NCT02869789|584698673|FG002|Overall Study|Maximum clinical benefit|1|||
161904543|NCT02869789|584698674|FG003|Overall Study|Maximum clinical benefit|0|||
161904544|NCT02869789|584698671|FG000|Overall Study|Poor/Non-compliance|0|||
161904545|NCT02869789|584698672|FG001|Overall Study|Poor/Non-compliance|2|||
161904546|NCT02869789|584698673|FG002|Overall Study|Poor/Non-compliance|1|||
161904547|NCT02869789|584698674|FG003|Overall Study|Poor/Non-compliance|0|||
161904548|NCT02869789|584698671|FG000|Overall Study|Participant no longer meets study criteria|0|||
161904549|NCT02869789|584698672|FG001|Overall Study|Participant no longer meets study criteria|1|||
161904550|NCT02869789|584698673|FG002|Overall Study|Participant no longer meets study criteria|1|||
161904551|NCT02869789|584698674|FG003|Overall Study|Participant no longer meets study criteria|0|||
161904552|NCT02869789|584698671|FG000|Overall Study|Administrative reason by sponsor|0|||
161904553|NCT02869789|584698672|FG001|Overall Study|Administrative reason by sponsor|0|||
161904554|NCT02869789|584698673|FG002|Overall Study|Administrative reason by sponsor|1|||
162138470|NCT05550337|585557350|FG000|Overall Study|Physician Decision|2|||
161904555|NCT02869789|584698674|FG003|Overall Study|Administrative reason by sponsor|0|||
162138471|NCT05550337|585557351|FG001|Overall Study|Physician Decision|1|||
162138472|NCT05550337|585557352|FG002|Overall Study|Physician Decision|1|||
161904556|NCT02869789|584698671|FG000|Overall Study|Other reasons|4|||
161904557|NCT02869789|584698672|FG001|Overall Study|Other reasons|8|||
161904558|NCT02869789|584698673|FG002|Overall Study|Other reasons|6|||
161904559|NCT02869789|584698674|FG003|Overall Study|Other reasons|0|||
161904560|NCT00297648|584698676|FG000|Overall Study|Adverse Event|13|||
161904561|NCT00297648|584698676|FG000|Overall Study|Lack of Efficacy|18|||
161904562|NCT00297648|584698676|FG000|Overall Study|Lost to Follow-up|1|||
161904563|NCT00297648|584698676|FG000|Overall Study|Withdrawal by Subject|3|||
161904564|NCT00297648|584698676|FG000|Overall Study|Other: Incompliance|1|||
161904565|NCT01529606|584698680|FG000|Overall Study|Lost to Follow-up|21|||
161904566|NCT01529606|584698681|FG001|Overall Study|Lost to Follow-up|18|||
161904567|NCT01746862|584698682|FG000|Overall Study|Withdrawal by Subject|1|||
161904568|NCT01746862|584698683|FG001|Overall Study|Withdrawal by Subject|1|||
161904569|NCT01746862|584698682|FG000|Overall Study|Protocol Violation|1|||
161904570|NCT01746862|584698683|FG001|Overall Study|Protocol Violation|0|||
161904571|NCT01746862|584698682|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
161904572|NCT01746862|584698683|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
161904573|NCT01746862|584698682|FG000|Overall Study|Entered puberty during the study|1|||
161904574|NCT01746862|584698683|FG001|Overall Study|Entered puberty during the study|0|||
161904575|NCT04742673|584698684|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
161904576|NCT04742673|584698685|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
161904577|NCT00731822|584698692|FG000|Overall Study|Adverse Event|2|||
161904578|NCT00731822|584698693|FG001|Overall Study|Adverse Event|1|||
161904579|NCT00731822|584698692|FG000|Overall Study|Protocol Violation|1|||
161904580|NCT00731822|584698693|FG001|Overall Study|Protocol Violation|0|||
161904581|NCT00731822|584698692|FG000|Overall Study|Lost to Follow-up|1|||
161904582|NCT00731822|584698693|FG001|Overall Study|Lost to Follow-up|0|||
161904583|NCT05209880|584698695|FG000|1-Month Follow-up|Spoke with Doctor|5|||
161904584|NCT05209880|584698696|FG001|1-Month Follow-up|Spoke with Doctor|5|||
161904585|NCT05209880|584698695|FG000|1-Month Follow-up|Lost to Follow-up|7|||
161904586|NCT05209880|584698696|FG001|1-Month Follow-up|Lost to Follow-up|9|||
161904587|NCT05209880|584698695|FG000|1-Month Follow-up|Discontinued|0|||
161904588|NCT05209880|584698696|FG001|1-Month Follow-up|Discontinued|1|||
161904589|NCT05209880|584698695|FG000|3-Month Follow-up|Spoke with Doctor|17|||
161904590|NCT05209880|584698696|FG001|3-Month Follow-up|Spoke with Doctor|7|||
161904591|NCT05209880|584698695|FG000|3-Month Follow-up|Lost to Follow-up|8|||
161904592|NCT05209880|584698696|FG001|3-Month Follow-up|Lost to Follow-up|10|||
161904593|NCT05209880|584698695|FG000|3-Month Follow-up|Discontinued|1|||
161904594|NCT05209880|584698696|FG001|3-Month Follow-up|Discontinued|3|||
161904595|NCT05209880|584698695|FG000|6-Month Follow-up|Spoke with Doctor|25|||
161904596|NCT05209880|584698696|FG001|6-Month Follow-up|Spoke with Doctor|14|||
161904597|NCT05209880|584698695|FG000|6-Month Follow-up|Lost to Follow-up|9|||
161904598|NCT05209880|584698696|FG001|6-Month Follow-up|Lost to Follow-up|14|||
161904599|NCT05209880|584698695|FG000|6-Month Follow-up|Discontinued|1|||
161904600|NCT05209880|584698696|FG001|6-Month Follow-up|Discontinued|3|||
161904601|NCT02127658|584698697|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
161904602|NCT02127658|584698698|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
161904603|NCT02127658|584698697|FG000|Overall Study|Withdrawal by Subject|0|||
161904604|NCT02127658|584698698|FG001|Overall Study|Withdrawal by Subject|2|||
161904605|NCT02127658|584698697|FG000|Overall Study|Physician Decision|0|||
161904606|NCT02127658|584698698|FG001|Overall Study|Physician Decision|1|||
161904607|NCT03834493|584698699|FG000|Overall Study|Participants Ongoing|311|||
161904608|NCT03834493|584698700|FG001|Overall Study|Participants Ongoing|324|||
161904609|NCT03834493|584698699|FG000|Overall Study|Withdrawal by Subject|20|||
161904610|NCT03834493|584698700|FG001|Overall Study|Withdrawal by Subject|17|||
161904611|NCT03834493|584698699|FG000|Overall Study|Physician Decision|1|||
161904612|NCT03834493|584698700|FG001|Overall Study|Physician Decision|0|||
161904613|NCT03834493|584698699|FG000|Overall Study|Death|289|||
161904614|NCT03834493|584698700|FG001|Overall Study|Death|282|||
161904615|NCT04003103|584698701|FG000|Overall Study|Death|1|||
161904616|NCT04003103|584698702|FG001|Overall Study|Death|0|||
161904617|NCT04003103|584698703|FG002|Overall Study|Death|0|||
161904618|NCT04003103|584698701|FG000|Overall Study|Lost to Follow-up|4|||
161904619|NCT04003103|584698702|FG001|Overall Study|Lost to Follow-up|3|||
161904620|NCT04003103|584698703|FG002|Overall Study|Lost to Follow-up|2|||
161904621|NCT04003103|584698701|FG000|Overall Study|Withdrawal by Subject|10|||
161904622|NCT04003103|584698702|FG001|Overall Study|Withdrawal by Subject|1|||
161904623|NCT04003103|584698703|FG002|Overall Study|Withdrawal by Subject|1|||
161904624|NCT04003103|584698701|FG000|Overall Study|Status not recorded|0|||
161904625|NCT04003103|584698702|FG001|Overall Study|Status not recorded|2|||
161904626|NCT04003103|584698703|FG002|Overall Study|Status not recorded|0|||
161904627|NCT04073303|584698708|FG000|Overall Study|Adverse Event|0|||
161904628|NCT04073303|584698709|FG001|Overall Study|Adverse Event|2|||
161904629|NCT04073303|584698708|FG000|Overall Study|Withdrawal by Subject|16|||
161904630|NCT04073303|584698709|FG001|Overall Study|Withdrawal by Subject|36|||
161904631|NCT04073303|584698708|FG000|Overall Study|Lost to Follow-up|6|||
161904632|NCT04073303|584698709|FG001|Overall Study|Lost to Follow-up|1|||
161904633|NCT04073303|584698708|FG000|Overall Study|Protocol Deviation|0|||
161904634|NCT04073303|584698709|FG001|Overall Study|Protocol Deviation|4|||
161904635|NCT04073303|584698708|FG000|Overall Study|Other|1|||
161904636|NCT04073303|584698709|FG001|Overall Study|Other|1|||
161904637|NCT02277028|584698712|FG000|Overall Study|Lost to Follow-up|1|||
161904638|NCT02277028|584698713|FG001|Overall Study|Lost to Follow-up|0|||
161904639|NCT02277028|584698712|FG000|Overall Study|Withdrawal by Subject|0|||
161904640|NCT02277028|584698713|FG001|Overall Study|Withdrawal by Subject|1|||
161904641|NCT02718911|584698714|FG000|Overall Study|Adverse Event|0|||
161904642|NCT02718911|584698715|FG001|Overall Study|Adverse Event|0|||
161904643|NCT02718911|584698716|FG002|Overall Study|Adverse Event|0|||
161904644|NCT02718911|584698717|FG003|Overall Study|Adverse Event|0|||
161904645|NCT02718911|584698718|FG004|Overall Study|Adverse Event|0|||
161904646|NCT02718911|584698719|FG005|Overall Study|Adverse Event|0|||
161904647|NCT02718911|584698720|FG006|Overall Study|Adverse Event|0|||
161904648|NCT02718911|584698721|FG007|Overall Study|Adverse Event|0|||
161904649|NCT02718911|584698722|FG008|Overall Study|Adverse Event|0|||
161904650|NCT02718911|584698723|FG009|Overall Study|Adverse Event|2|||
161904651|NCT02718911|584698714|FG000|Overall Study|Death|2|||
161904652|NCT02718911|584698715|FG001|Overall Study|Death|3|||
161904653|NCT02718911|584698716|FG002|Overall Study|Death|1|||
161904654|NCT02718911|584698717|FG003|Overall Study|Death|0|||
161904655|NCT02718911|584698718|FG004|Overall Study|Death|1|||
161904656|NCT02718911|584698719|FG005|Overall Study|Death|3|||
161904657|NCT02718911|584698720|FG006|Overall Study|Death|1|||
161904658|NCT02718911|584698721|FG007|Overall Study|Death|1|||
161904659|NCT02718911|584698722|FG008|Overall Study|Death|4|||
161904660|NCT02718911|584698723|FG009|Overall Study|Death|3|||
161904661|NCT02718911|584698714|FG000|Overall Study|Lost to Follow-up|0|||
161904662|NCT02718911|584698715|FG001|Overall Study|Lost to Follow-up|0|||
161904663|NCT02718911|584698716|FG002|Overall Study|Lost to Follow-up|0|||
161904664|NCT02718911|584698717|FG003|Overall Study|Lost to Follow-up|0|||
161904665|NCT02718911|584698718|FG004|Overall Study|Lost to Follow-up|0|||
161904666|NCT02718911|584698719|FG005|Overall Study|Lost to Follow-up|0|||
161904667|NCT02718911|584698720|FG006|Overall Study|Lost to Follow-up|0|||
161904668|NCT02718911|584698721|FG007|Overall Study|Lost to Follow-up|0|||
161904669|NCT02718911|584698722|FG008|Overall Study|Lost to Follow-up|1|||
161904670|NCT02718911|584698723|FG009|Overall Study|Lost to Follow-up|0|||
161904671|NCT02718911|584698714|FG000|Overall Study|Physician Decision|2|||
161904672|NCT02718911|584698715|FG001|Overall Study|Physician Decision|0|||
161904673|NCT02718911|584698716|FG002|Overall Study|Physician Decision|1|||
161904674|NCT02718911|584698717|FG003|Overall Study|Physician Decision|1|||
161904675|NCT02718911|584698718|FG004|Overall Study|Physician Decision|0|||
161904676|NCT02718911|584698719|FG005|Overall Study|Physician Decision|0|||
161904677|NCT02718911|584698720|FG006|Overall Study|Physician Decision|0|||
161904678|NCT02718911|584698721|FG007|Overall Study|Physician Decision|1|||
161904679|NCT02718911|584698722|FG008|Overall Study|Physician Decision|2|||
161904680|NCT02718911|584698723|FG009|Overall Study|Physician Decision|1|||
161904681|NCT02718911|584698714|FG000|Overall Study|Withdrawal by Subject|0|||
161904682|NCT02718911|584698715|FG001|Overall Study|Withdrawal by Subject|0|||
161904683|NCT02718911|584698716|FG002|Overall Study|Withdrawal by Subject|0|||
161904684|NCT02718911|584698717|FG003|Overall Study|Withdrawal by Subject|0|||
161904685|NCT02718911|584698718|FG004|Overall Study|Withdrawal by Subject|1|||
161904686|NCT02718911|584698719|FG005|Overall Study|Withdrawal by Subject|0|||
161904687|NCT02718911|584698720|FG006|Overall Study|Withdrawal by Subject|0|||
161904688|NCT02718911|584698721|FG007|Overall Study|Withdrawal by Subject|0|||
161904689|NCT02718911|584698722|FG008|Overall Study|Withdrawal by Subject|1|||
161904690|NCT02718911|584698723|FG009|Overall Study|Withdrawal by Subject|4|||
161904691|NCT02718911|584698714|FG000|Overall Study|Reason Not Collected|0|||
161904692|NCT02718911|584698715|FG001|Overall Study|Reason Not Collected|0|||
161904693|NCT02718911|584698716|FG002|Overall Study|Reason Not Collected|1|||
161904694|NCT02718911|584698717|FG003|Overall Study|Reason Not Collected|0|||
161904695|NCT02718911|584698718|FG004|Overall Study|Reason Not Collected|0|||
161904696|NCT02718911|584698719|FG005|Overall Study|Reason Not Collected|0|||
161904697|NCT02718911|584698720|FG006|Overall Study|Reason Not Collected|2|||
161904698|NCT02718911|584698721|FG007|Overall Study|Reason Not Collected|1|||
161904699|NCT02718911|584698722|FG008|Overall Study|Reason Not Collected|4|||
161904700|NCT02718911|584698723|FG009|Overall Study|Reason Not Collected|9|||
161904701|NCT04817332|584698724|FG000|Overall Study|Lost to Follow-up|3|||
161904702|NCT04817332|584698725|FG001|Overall Study|Lost to Follow-up|3|||
161904703|NCT04817332|584698724|FG000|Overall Study|Protocol Violation|2|||
161904704|NCT04817332|584698725|FG001|Overall Study|Protocol Violation|0|||
161904705|NCT01867008|584698728|FG000|Overall Study|Withdrawal by Subject|1|||
161904706|NCT01158261|584698730|FG000|Overall Study|Lost to Follow-up|9|||
161904707|NCT01158261|584698730|FG000|Overall Study|Death|7|||
161904708|NCT01158261|584698730|FG000|Overall Study|Withdrawal by Subject|1|||
161904709|NCT03143101|584698731|FG000|Overall Study|Withdrawal by Subject|0|||
161904710|NCT03143101|584698732|FG001|Overall Study|Withdrawal by Subject|1|||
161904711|NCT03143101|584698733|FG002|Overall Study|Withdrawal by Subject|0|||
161904712|NCT03143101|584698731|FG000|Overall Study|Lost to Follow-up|2|||
161904713|NCT03143101|584698732|FG001|Overall Study|Lost to Follow-up|2|||
161904714|NCT03143101|584698733|FG002|Overall Study|Lost to Follow-up|0|||
161904715|NCT05227118|584698734|FG000|Overall Study|Adverse Event|0|||
161904716|NCT05227118|584698735|FG001|Overall Study|Adverse Event|0|||
161904717|NCT05227118|584698736|FG002|Overall Study|Adverse Event|1|||
161904718|NCT05227118|584698737|FG003|Overall Study|Adverse Event|0|||
161904719|NCT05227118|584698734|FG000|Overall Study|Withdrawal by Subject|0|||
161904720|NCT05227118|584698735|FG001|Overall Study|Withdrawal by Subject|0|||
161904721|NCT05227118|584698736|FG002|Overall Study|Withdrawal by Subject|2|||
161904722|NCT05227118|584698737|FG003|Overall Study|Withdrawal by Subject|0|||
161904723|NCT03727841|584698738|FG000|Overall Study|Physician Decision|3|||
161904724|NCT03727841|584698739|FG001|Overall Study|Physician Decision|1|||
161904725|NCT03126786|584698740|FG000|Overall Study|Adverse Event|3|||
161904726|NCT03126786|584698741|FG001|Overall Study|Adverse Event|0|||
161801032|NCT00243932|584314426|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
161801033|NCT00243932|584314427|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
161801034|NCT00243932|584314428|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
161801035|NCT01458405|584314431|FG000|Phase 1 (up to 12 Months)|Other|0|||
161801036|NCT01458405|584314432|FG001|Phase 1 (up to 12 Months)|Other|1|||
161801037|NCT01458405|584314433|FG002|Phase 1 (up to 12 Months)|Other|0|||
161801038|NCT01458405|584314434|FG003|Phase 1 (up to 12 Months)|Other|0|||
161801039|NCT01458405|584314431|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
161801040|NCT01458405|584314432|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
161801041|NCT01458405|584314433|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
161801042|NCT01458405|584314434|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
161801043|NCT01458405|584314431|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
161801044|NCT01458405|584314432|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
161801045|NCT01458405|584314433|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
161801046|NCT01458405|584314434|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
161801047|NCT01458405|584314431|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
161801048|NCT01458405|584314432|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
161801049|NCT01458405|584314433|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
161801050|NCT01458405|584314434|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
161801051|NCT02497781|584314438|FG000|Overall Study|Withdrawal by Subject|2|||
161801052|NCT02497781|584314439|FG001|Overall Study|Withdrawal by Subject|0|||
161801053|NCT02497781|584314438|FG000|Overall Study|Lack of Efficacy|0|||
161801054|NCT02497781|584314439|FG001|Overall Study|Lack of Efficacy|1|||
161801055|NCT02497781|584314438|FG000|Overall Study|Randomised but not treated|1|||
161801056|NCT02497781|584314439|FG001|Overall Study|Randomised but not treated|1|||
161801057|NCT02497781|584314438|FG000|Overall Study|Lost to Follow-up|1|||
161801058|NCT02497781|584314439|FG001|Overall Study|Lost to Follow-up|1|||
161801059|NCT01193608|584314440|FG000|Overall Study|Other|0|||
161801060|NCT01193608|584314441|FG001|Overall Study|Other|1|||
161801061|NCT01193608|584314442|FG002|Overall Study|Other|0|||
161801062|NCT01193608|584314443|FG003|Overall Study|Other|0|||
161801063|NCT01193608|584314444|FG004|Overall Study|Other|0|||
161801064|NCT01193608|584314445|FG005|Overall Study|Other|0|||
161801065|NCT01193608|584314440|FG000|Overall Study|Withdrawal by Subject|0|||
161801066|NCT01193608|584314441|FG001|Overall Study|Withdrawal by Subject|1|||
161801067|NCT01193608|584314442|FG002|Overall Study|Withdrawal by Subject|2|||
161801068|NCT01193608|584314443|FG003|Overall Study|Withdrawal by Subject|3|||
161801069|NCT01193608|584314444|FG004|Overall Study|Withdrawal by Subject|3|||
161801070|NCT01193608|584314445|FG005|Overall Study|Withdrawal by Subject|0|||
161801071|NCT01193608|584314440|FG000|Overall Study|Lost to Follow-up|0|||
161801072|NCT01193608|584314441|FG001|Overall Study|Lost to Follow-up|0|||
161801073|NCT01193608|584314442|FG002|Overall Study|Lost to Follow-up|0|||
161904727|NCT03126786|584698740|FG000|Overall Study|Lost to Follow-up|0|||
161904728|NCT03126786|584698741|FG001|Overall Study|Lost to Follow-up|1|||
161904729|NCT03126786|584698740|FG000|Overall Study|Withdrawal by Subject|3|||
161904730|NCT03126786|584698741|FG001|Overall Study|Withdrawal by Subject|1|||
161904731|NCT01601496|584698742|FG000|Overall Study|Physician Decision|1|||
161904732|NCT01601496|584698742|FG000|Overall Study|Withdrawal by Subject|1|||
161904733|NCT01601496|584698742|FG000|Overall Study|Lost to Follow-up|6|||
161904734|NCT01601496|584698742|FG000|Overall Study|Death|4|||
161904735|NCT01601496|584698742|FG000|Overall Study|Other: patient refusal to continue|3|||
161904736|NCT03243305|584698743|FG000|Overall Study|Lost to Follow-up|250|||
161904737|NCT03243305|584698743|FG000|Overall Study|Withdrawal by Subject|170|||
161904738|NCT03243305|584698743|FG000|Overall Study|Pregnancy|104|||
161904739|NCT03243305|584698743|FG000|Overall Study|Non-Compliance with Study Drug|38|||
161904740|NCT03243305|584698743|FG000|Overall Study|Adverse Event|23|||
161904741|NCT03243305|584698743|FG000|Overall Study|No sexually active|26|||
161904742|NCT03243305|584698743|FG000|Overall Study|Physician Decision|22|||
161904743|NCT03243305|584698743|FG000|Overall Study|Protocol Violation|22|||
161904744|NCT03243305|584698743|FG000|Overall Study|Study method no longer primary method|12|||
161904745|NCT03243305|584698743|FG000|Overall Study|Study Terminated by Sponsor|1|||
161904746|NCT03243305|584698743|FG000|Overall Study|Early terminations|267|||
161904747|NCT00227539|584698744|FG000|Overall Study|Protocol Violation|1|||
161904748|NCT02689804|584698745|FG000|Overall Study|Withdrawal by Subject|2|||
161904749|NCT02689804|584698746|FG001|Overall Study|Withdrawal by Subject|0|||
161904750|NCT00570401|584698749|FG000|Overall Study|Adverse Event|2|||
161904751|NCT04391842|584698753|FG000|Overall Study|Withdrawal by Subject|2|||
161904752|NCT00992017|584698754|FG000|Overall Study|Lost to Follow-up|2|||
161904753|NCT00992017|584698754|FG000|Overall Study|Withdrawal by Subject|2|||
161904754|NCT00992017|584698754|FG000|Overall Study|Unable to get to clinic|5|||
161904755|NCT00992017|584698754|FG000|Overall Study|Not adhere to study requirements|1|||
161904756|NCT01691378|584698755|FG000|Overall Study|Withdrawal by Subject|2|||
161904757|NCT01691378|584698756|FG001|Overall Study|Withdrawal by Subject|0|||
161904758|NCT01691378|584698755|FG000|Overall Study|Lost to Follow-up|5|||
161904759|NCT01691378|584698756|FG001|Overall Study|Lost to Follow-up|2|||
161904760|NCT01107925|584698763|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
161904761|NCT01107925|584698764|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
161904762|NCT01107925|584698765|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
161904763|NCT01107925|584698766|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
161904764|NCT01107925|584698767|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
161904765|NCT01107925|584698768|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
161904766|NCT01107925|584698763|FG000|Period 2|Withdrawal by Subject|0|||
161904767|NCT01107925|584698764|FG001|Period 2|Withdrawal by Subject|1|||
161904768|NCT01107925|584698765|FG002|Period 2|Withdrawal by Subject|0|||
161904769|NCT01107925|584698766|FG003|Period 2|Withdrawal by Subject|0|||
161904770|NCT01107925|584698767|FG004|Period 2|Withdrawal by Subject|0|||
161904771|NCT01107925|584698768|FG005|Period 2|Withdrawal by Subject|1|||
161904772|NCT04877990|584698769|FG000|Treatment|Other reasons|3|||
161904773|NCT04877990|584698770|FG001|Treatment|Other reasons|1|||
161904774|NCT04877990|584698769|FG000|Treatment|Administrative reasons by sponsor|17|||
161904775|NCT04877990|584698770|FG001|Treatment|Administrative reasons by sponsor|33|||
161904776|NCT04877990|584698769|FG000|Treatment|Withdrawal by Subject|2|||
161904777|NCT04877990|584698770|FG001|Treatment|Withdrawal by Subject|6|||
161904778|NCT04877990|584698769|FG000|Treatment|Adverse Event|2|||
161904779|NCT04877990|584698770|FG001|Treatment|Adverse Event|1|||
161904780|NCT04235504|584698771|FG000|Study Phase|Withdrawal by Subject|5|||
161904781|NCT04235504|584698772|FG001|Study Phase|Withdrawal by Subject|2|||
161904782|NCT04235504|584698773|FG002|Study Phase|Withdrawal by Subject|0|||
161904783|NCT04235504|584698774|FG003|Study Phase|Withdrawal by Subject|0|||
161904784|NCT04235504|584698771|FG000|Continuation Phase|Withdrawal by Subject|0|||
161904785|NCT04235504|584698772|FG001|Continuation Phase|Withdrawal by Subject|4|||
161904786|NCT04235504|584698773|FG002|Continuation Phase|Withdrawal by Subject|0|||
161904787|NCT04235504|584698774|FG003|Continuation Phase|Withdrawal by Subject|0|||
161904788|NCT04235504|584698771|FG000|Continuation Phase|Adverse Event|0|||
161904789|NCT04235504|584698772|FG001|Continuation Phase|Adverse Event|1|||
161904790|NCT04235504|584698773|FG002|Continuation Phase|Adverse Event|0|||
161904791|NCT04235504|584698774|FG003|Continuation Phase|Adverse Event|0|||
161904792|NCT04235504|584698771|FG000|Continuation Phase|Physician Decision|1|||
161904793|NCT04235504|584698772|FG001|Continuation Phase|Physician Decision|2|||
161904794|NCT04235504|584698773|FG002|Continuation Phase|Physician Decision|1|||
161904795|NCT04235504|584698774|FG003|Continuation Phase|Physician Decision|0|||
161904796|NCT04888494|584698777|FG000|Overall Study|Lost to Follow-up|2|||
161904797|NCT04888494|584698778|FG001|Overall Study|Lost to Follow-up|3|||
161904798|NCT04888494|584698777|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
161904799|NCT04888494|584698778|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
161904800|NCT00565604|584698780|FG000|Overall Study|Failure to treat|2|||
161904801|NCT00565604|584698780|FG000|Overall Study|Lost to Follow-up|2|||
161904802|NCT03652818|584701086|FG000|Overall Study|Adverse Event|1|||
161904803|NCT03652818|584701087|FG001|Overall Study|Adverse Event|0|||
161904804|NCT03652818|584701088|FG002|Overall Study|Adverse Event|0|||
161904805|NCT03652818|584701089|FG003|Overall Study|Adverse Event|0|||
161904806|NCT03652818|584701090|FG004|Overall Study|Adverse Event|0|||
161904807|NCT03652818|584701086|FG000|Overall Study|Physician Decision|1|||
161904808|NCT03652818|584701087|FG001|Overall Study|Physician Decision|0|||
161904809|NCT03652818|584701088|FG002|Overall Study|Physician Decision|0|||
161904810|NCT03652818|584701089|FG003|Overall Study|Physician Decision|0|||
161904811|NCT03652818|584701090|FG004|Overall Study|Physician Decision|0|||
161904812|NCT03652818|584701086|FG000|Overall Study|Lost to Follow-up|0|||
161904813|NCT03652818|584701087|FG001|Overall Study|Lost to Follow-up|1|||
161904814|NCT03652818|584701088|FG002|Overall Study|Lost to Follow-up|2|||
161904815|NCT03652818|584701089|FG003|Overall Study|Lost to Follow-up|1|||
161904816|NCT03652818|584701090|FG004|Overall Study|Lost to Follow-up|1|||
161904817|NCT01699750|584701093|FG000|Overall Study|Withdrew Consent|0|||
161904818|NCT01699750|584701094|FG001|Overall Study|Withdrew Consent|1|||
161904819|NCT01699750|584701093|FG000|Overall Study|Other|0|||
161904820|NCT01699750|584701094|FG001|Overall Study|Other|2|||
161904821|NCT01868646|584701097|FG000|Overall Study|Do not meet inclusion criteria|3|||
161904822|NCT01868646|584701098|FG001|Overall Study|Do not meet inclusion criteria|5|||
161904823|NCT01831427|584701099|FG000|Overall Study|Adverse Event|0|||
161904824|NCT01831427|584701100|FG001|Overall Study|Adverse Event|1|||
161904825|NCT01831427|584701101|FG002|Overall Study|Adverse Event|0|||
161904826|NCT01831427|584701102|FG003|Overall Study|Adverse Event|0|||
161904827|NCT01831427|584701103|FG004|Overall Study|Adverse Event|0|||
161904828|NCT01831427|584701104|FG005|Overall Study|Adverse Event|1|||
161904829|NCT01831427|584701105|FG006|Overall Study|Adverse Event|0|||
161904830|NCT01831427|584701106|FG007|Overall Study|Adverse Event|1|||
161904831|NCT01831427|584701107|FG008|Overall Study|Adverse Event|0|||
161904832|NCT01831427|584701108|FG009|Overall Study|Adverse Event|0|||
161904833|NCT01831427|584701109|FG010|Overall Study|Adverse Event|2|||
161904834|NCT01831427|584701099|FG000|Overall Study|Investigator's Discretion|0|||
161904835|NCT01831427|584701100|FG001|Overall Study|Investigator's Discretion|0|||
161904836|NCT01831427|584701101|FG002|Overall Study|Investigator's Discretion|0|||
161904837|NCT01831427|584701102|FG003|Overall Study|Investigator's Discretion|1|||
161904838|NCT01831427|584701103|FG004|Overall Study|Investigator's Discretion|0|||
161904839|NCT01831427|584701104|FG005|Overall Study|Investigator's Discretion|0|||
161904840|NCT01831427|584701105|FG006|Overall Study|Investigator's Discretion|0|||
161904841|NCT01831427|584701106|FG007|Overall Study|Investigator's Discretion|0|||
161904842|NCT01831427|584701107|FG008|Overall Study|Investigator's Discretion|0|||
161904843|NCT01831427|584701108|FG009|Overall Study|Investigator's Discretion|0|||
161904844|NCT01831427|584701109|FG010|Overall Study|Investigator's Discretion|0|||
161904845|NCT01831427|584701099|FG000|Overall Study|Withdrew Consent|0|||
161904846|NCT01831427|584701100|FG001|Overall Study|Withdrew Consent|0|||
161904847|NCT01831427|584701101|FG002|Overall Study|Withdrew Consent|0|||
161904848|NCT01831427|584701102|FG003|Overall Study|Withdrew Consent|0|||
161904849|NCT01831427|584701103|FG004|Overall Study|Withdrew Consent|0|||
161904850|NCT01831427|584701104|FG005|Overall Study|Withdrew Consent|0|||
161904851|NCT01831427|584701105|FG006|Overall Study|Withdrew Consent|2|||
161904852|NCT01831427|584701106|FG007|Overall Study|Withdrew Consent|0|||
161904853|NCT01831427|584701107|FG008|Overall Study|Withdrew Consent|0|||
161904854|NCT01831427|584701108|FG009|Overall Study|Withdrew Consent|1|||
161904855|NCT01831427|584701109|FG010|Overall Study|Withdrew Consent|1|||
161904856|NCT00536510|584701112|FG000|Overall Study|Adverse Event|27|||
161904857|NCT00536510|584701113|FG001|Overall Study|Adverse Event|4|||
161904858|NCT00536510|584701112|FG000|Overall Study|Lost to Follow-up|11|||
161904859|NCT00536510|584701113|FG001|Overall Study|Lost to Follow-up|8|||
161904860|NCT00536510|584701112|FG000|Overall Study|Protocol Violation|4|||
161904861|NCT00536510|584701113|FG001|Overall Study|Protocol Violation|5|||
161904862|NCT00536510|584701112|FG000|Overall Study|Withdrawal by Subject|16|||
161801074|NCT01193608|584314443|FG003|Overall Study|Lost to Follow-up|0|||
161801075|NCT01193608|584314444|FG004|Overall Study|Lost to Follow-up|1|||
161801076|NCT01193608|584314445|FG005|Overall Study|Lost to Follow-up|2|||
161801077|NCT01193608|584314440|FG000|Overall Study|Adverse Event|0|||
161801078|NCT01193608|584314441|FG001|Overall Study|Adverse Event|0|||
161801079|NCT01193608|584314442|FG002|Overall Study|Adverse Event|0|||
161801080|NCT01193608|584314443|FG003|Overall Study|Adverse Event|0|||
161801081|NCT01193608|584314444|FG004|Overall Study|Adverse Event|1|||
161801082|NCT01193608|584314445|FG005|Overall Study|Adverse Event|0|||
161801083|NCT01249664|584314446|FG000|Overall Study|Withdrawal by Subject|5|||
161801084|NCT01249664|584314447|FG001|Overall Study|Withdrawal by Subject|0|||
161801085|NCT01249664|584314446|FG000|Overall Study|Adverse Event|1|||
161801086|NCT01249664|584314447|FG001|Overall Study|Adverse Event|0|||
161801087|NCT01025037|584314452|FG000|Overall Study|Adverse Event|3|||
161801088|NCT01025037|584314452|FG000|Overall Study|Lost to Follow-up|7|||
161801089|NCT01025037|584314452|FG000|Overall Study|Withdrawal by Subject|1|||
161801090|NCT01370408|584314453|FG000|Overall Study|treatment failure|9|||
161801091|NCT05014412|584314457|FG000|Overall Study|Death|11|||
161801092|NCT05014412|584314458|FG001|Overall Study|Death|7|||
161801093|NCT05014412|584314459|FG002|Overall Study|Death|4|||
161801094|NCT05014412|584314460|FG003|Overall Study|Death|7|||
161801095|NCT05014412|584314457|FG000|Overall Study|Withdrawal by Subject|1|||
161801096|NCT05014412|584314458|FG001|Overall Study|Withdrawal by Subject|1|||
161801097|NCT05014412|584314459|FG002|Overall Study|Withdrawal by Subject|1|||
161801098|NCT05014412|584314460|FG003|Overall Study|Withdrawal by Subject|2|||
161801099|NCT05014412|584314457|FG000|Overall Study|Ongoing|21|||
161801100|NCT05014412|584314458|FG001|Overall Study|Ongoing|4|||
161801101|NCT05014412|584314459|FG002|Overall Study|Ongoing|6|||
161801102|NCT05014412|584314460|FG003|Overall Study|Ongoing|20|||
161801103|NCT02353169|584314461|FG000|Overall Study|QTc > 450 msec|1|||
161801104|NCT02353169|584314462|FG001|Overall Study|QTc > 450 msec|1|||
161801105|NCT02353169|584314463|FG002|Overall Study|QTc > 450 msec|1|||
161801106|NCT02353169|584314464|FG003|Overall Study|QTc > 450 msec|1|||
161801107|NCT02353169|584314461|FG000|Overall Study|OR team declined|2|||
161801108|NCT02353169|584314462|FG001|Overall Study|OR team declined|0|||
161801109|NCT02353169|584314463|FG002|Overall Study|OR team declined|0|||
161801110|NCT02353169|584314464|FG003|Overall Study|OR team declined|0|||
161801111|NCT02353169|584314461|FG000|Overall Study|Inhalational induction|0|||
161801112|NCT02353169|584314462|FG001|Overall Study|Inhalational induction|2|||
161801113|NCT02353169|584314463|FG002|Overall Study|Inhalational induction|0|||
161801114|NCT02353169|584314464|FG003|Overall Study|Inhalational induction|0|||
161801115|NCT02353169|584314461|FG000|Overall Study|ECG data error|0|||
161801116|NCT02353169|584314462|FG001|Overall Study|ECG data error|3|||
161801117|NCT02353169|584314463|FG002|Overall Study|ECG data error|2|||
161801118|NCT02353169|584314464|FG003|Overall Study|ECG data error|2|||
161801119|NCT02353169|584314461|FG000|Overall Study|Pre-op medication|0|||
161801120|NCT02353169|584314462|FG001|Overall Study|Pre-op medication|0|||
161801121|NCT02353169|584314463|FG002|Overall Study|Pre-op medication|1|||
161801122|NCT02353169|584314464|FG003|Overall Study|Pre-op medication|0|||
161801123|NCT00486837|584314465|FG000|Overall Study|Withdrawal by Subject|1|||
161801124|NCT00486837|584314466|FG001|Overall Study|Withdrawal by Subject|0|||
161801125|NCT00486837|584314465|FG000|Overall Study|Adverse Event|1|||
161801126|NCT00486837|584314466|FG001|Overall Study|Adverse Event|1|||
161801127|NCT00486837|584314465|FG000|Overall Study|Protocol Violation|4|||
161801128|NCT00486837|584314466|FG001|Overall Study|Protocol Violation|2|||
161801129|NCT00486837|584314465|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
161801130|NCT00486837|584314466|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
161801131|NCT05295953|584314467|FG000|Overall Study|Withdrawal by Subject|0|||
161801132|NCT05295953|584314468|FG001|Overall Study|Withdrawal by Subject|1|||
161801133|NCT05956665|584314472|FG000|Overall Study|Death|1|||
161801134|NCT05956665|584314472|FG000|Overall Study|Withdrawal by Subject|1|||
161801135|NCT00368277|584314475|FG000|Overall Study|Adverse Event|33|||
161801136|NCT00368277|584314476|FG001|Overall Study|Adverse Event|49|||
161801137|NCT00368277|584314475|FG000|Overall Study|Death|2|||
161801138|NCT00368277|584314476|FG001|Overall Study|Death|1|||
161904863|NCT00536510|584701113|FG001|Overall Study|Withdrawal by Subject|9|||
161801139|NCT00368277|584314475|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
161904864|NCT00536510|584701112|FG000|Overall Study|Flushing with Product|20|||
161904865|NCT00536510|584701113|FG001|Overall Study|Flushing with Product|0|||
161801140|NCT00368277|584314476|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
161801141|NCT00368277|584314475|FG000|Overall Study|Protocol deviation|7|||
161801142|NCT00368277|584314476|FG001|Overall Study|Protocol deviation|0|||
161801143|NCT00368277|584314475|FG000|Overall Study|Patient withdrew consent|32|||
161801144|NCT00368277|584314476|FG001|Overall Study|Patient withdrew consent|28|||
161801145|NCT00368277|584314475|FG000|Overall Study|Lost to Follow-up|8|||
161801146|NCT00368277|584314476|FG001|Overall Study|Lost to Follow-up|6|||
161801147|NCT00117949|584314479|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
161801148|NCT00117949|584314480|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
161801149|NCT00117949|584314481|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
161801150|NCT00117949|584314482|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
161801151|NCT00117949|584314479|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
161801152|NCT00117949|584314480|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
161801153|NCT00117949|584314481|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
161801154|NCT00117949|584314482|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
161801155|NCT00117949|584314479|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
161801156|NCT00117949|584314480|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
161801157|NCT00117949|584314481|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
161801158|NCT00117949|584314482|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
161801159|NCT00117949|584314479|FG000|Overall Study|PSA increase >=10ng/mL|0|||
161801160|NCT00117949|584314480|FG001|Overall Study|PSA increase >=10ng/mL|1|||
161801161|NCT00117949|584314481|FG002|Overall Study|PSA increase >=10ng/mL|1|||
161801162|NCT00117949|584314482|FG003|Overall Study|PSA increase >=10ng/mL|0|||
161801163|NCT00117949|584314479|FG000|Overall Study|PSA reduction <=50%|0|||
161801164|NCT00117949|584314480|FG001|Overall Study|PSA reduction <=50%|2|||
161801165|NCT00117949|584314481|FG002|Overall Study|PSA reduction <=50%|2|||
161801166|NCT00117949|584314482|FG003|Overall Study|PSA reduction <=50%|4|||
161801167|NCT00117949|584314479|FG000|Overall Study|Hepatic abnormalities|0|||
161801168|NCT00117949|584314480|FG001|Overall Study|Hepatic abnormalities|1|||
161801169|NCT00117949|584314481|FG002|Overall Study|Hepatic abnormalities|0|||
161801170|NCT00117949|584314482|FG003|Overall Study|Hepatic abnormalities|1|||
161801171|NCT05275998|584314483|FG000|Overall Study|Adverse Event|0|||
161801172|NCT05275998|584314484|FG001|Overall Study|Adverse Event|0|||
161801173|NCT05275998|584314485|FG002|Overall Study|Adverse Event|0|||
161801174|NCT05275998|584314486|FG003|Overall Study|Adverse Event|1|||
161801175|NCT05275998|584314483|FG000|Overall Study|Withdrawal by Subject|0|||
161801176|NCT05275998|584314484|FG001|Overall Study|Withdrawal by Subject|0|||
161801177|NCT05275998|584314485|FG002|Overall Study|Withdrawal by Subject|0|||
161801178|NCT05275998|584314486|FG003|Overall Study|Withdrawal by Subject|1|||
161801179|NCT05275998|584314483|FG000|Overall Study|Physician Decision|0|||
161801180|NCT05275998|584314484|FG001|Overall Study|Physician Decision|0|||
161801181|NCT05275998|584314485|FG002|Overall Study|Physician Decision|0|||
161801182|NCT05275998|584314486|FG003|Overall Study|Physician Decision|1|||
161801183|NCT05275998|584314483|FG000|Overall Study|Protocol Violation|0|||
161801184|NCT05275998|584314484|FG001|Overall Study|Protocol Violation|0|||
161801185|NCT05275998|584314485|FG002|Overall Study|Protocol Violation|1|||
161801186|NCT05275998|584314486|FG003|Overall Study|Protocol Violation|0|||
161801187|NCT01936948|584314487|FG000|Overall Study|no 30-day follow-up data|0|||
161801188|NCT01936948|584314488|FG001|Overall Study|no 30-day follow-up data|3|||
161801189|NCT01936948|584314489|FG002|Overall Study|no 30-day follow-up data|3|||
161801190|NCT01936948|584314490|FG003|Overall Study|no 30-day follow-up data|3|||
161801191|NCT01974141|584314491|FG000|Overall Study|Other Reasons|28|||
161801192|NCT01974141|584314492|FG001|Overall Study|Other Reasons|18|||
161801193|NCT01974141|584314491|FG000|Overall Study|Protocol Violation|2|||
161801194|NCT01974141|584314492|FG001|Overall Study|Protocol Violation|6|||
161801195|NCT01974141|584314491|FG000|Overall Study|Personal Reasons|21|||
161801196|NCT01974141|584314492|FG001|Overall Study|Personal Reasons|20|||
161801197|NCT01974141|584314491|FG000|Overall Study|Lost to Follow-up|38|||
161801198|NCT01974141|584314492|FG001|Overall Study|Lost to Follow-up|29|||
161801199|NCT01974141|584314491|FG000|Overall Study|Pregnancy|3|||
161801200|NCT01974141|584314492|FG001|Overall Study|Pregnancy|3|||
161801201|NCT01974141|584314491|FG000|Overall Study|Lack of Efficacy|0|||
161801202|NCT01974141|584314492|FG001|Overall Study|Lack of Efficacy|1|||
161801203|NCT01974141|584314491|FG000|Overall Study|Adverse Event|4|||
161801204|NCT01974141|584314492|FG001|Overall Study|Adverse Event|5|||
161801205|NCT00406848|584314494|FG000|Overall Study|Withdrawal by Subject|27|||
161801206|NCT00406848|584314495|FG001|Overall Study|Withdrawal by Subject|22|||
161801207|NCT00406848|584314494|FG000|Overall Study|Adverse Event|38|||
161801208|NCT00406848|584314495|FG001|Overall Study|Adverse Event|7|||
161801209|NCT00406848|584314494|FG000|Overall Study|Lack of Efficacy|9|||
161801210|NCT00406848|584314495|FG001|Overall Study|Lack of Efficacy|14|||
161801211|NCT00406848|584314494|FG000|Overall Study|Protocol Violation|10|||
161801212|NCT00406848|584314495|FG001|Overall Study|Protocol Violation|6|||
161801213|NCT00406848|584314494|FG000|Overall Study|Lost to Follow-up|6|||
161801214|NCT00406848|584314495|FG001|Overall Study|Lost to Follow-up|2|||
161801215|NCT00406848|584314494|FG000|Overall Study|Physician Decision|2|||
161801216|NCT00406848|584314495|FG001|Overall Study|Physician Decision|2|||
161801217|NCT00406848|584314494|FG000|Overall Study|Sponsor Decision|1|||
161801218|NCT00406848|584314495|FG001|Overall Study|Sponsor Decision|1|||
161801219|NCT04803357|584314496|FG000|Overall Study|Withdrawal by Subject|31|||
161904866|NCT00536510|584701112|FG000|Overall Study|Laboratory Adverse Event|2|||
161801220|NCT04803357|584314497|FG001|Overall Study|Withdrawal by Subject|5|||
161801221|NCT02879643|584314499|FG000|Overall Study|Adverse Event|0|||
161801222|NCT02879643|584314500|FG001|Overall Study|Adverse Event|0|||
161801223|NCT02879643|584314501|FG002|Overall Study|Adverse Event|1|||
161801224|NCT02879643|584314502|FG003|Overall Study|Adverse Event|1|||
161801225|NCT02879643|584314503|FG004|Overall Study|Adverse Event|0|||
161801226|NCT00182091|584314504|FG000|Overall Study|Withdrawal by Subject|1|||
161801227|NCT00182091|584314505|FG001|Overall Study|Withdrawal by Subject|0|||
161801228|NCT00182091|584314506|FG002|Overall Study|Withdrawal by Subject|0|||
161801229|NCT00182091|584314507|FG003|Overall Study|Withdrawal by Subject|0|||
161801230|NCT01046253|584314508|FG000|Second Intervention|Adverse Event|0|||
161801231|NCT01046253|584314509|FG001|Second Intervention|Adverse Event|1|||
161801232|NCT01046253|584314508|FG000|Second Intervention|Protocol Violation|0|||
161801233|NCT01046253|584314509|FG001|Second Intervention|Protocol Violation|1|||
161801234|NCT02339909|584314510|FG000|Overall Study|Became ineligible after randomisation|89|||
161801235|NCT02339909|584314511|FG001|Overall Study|Became ineligible after randomisation|63|||
161801236|NCT02339909|584314512|FG002|Overall Study|Became ineligible after randomisation|71|||
161801237|NCT00860028|584314513|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
161801238|NCT00860028|584314514|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
161801239|NCT02576990|584314515|FG000|Overall Study|Death|29|||
161801240|NCT02576990|584314516|FG001|Overall Study|Death|18|||
161801241|NCT02576990|584314515|FG000|Overall Study|Physician Decision|1|||
161801242|NCT02576990|584314516|FG001|Overall Study|Physician Decision|0|||
161801243|NCT02576990|584314515|FG000|Overall Study|Screen failure|2|||
161801244|NCT02576990|584314516|FG001|Overall Study|Screen failure|0|||
161801245|NCT02576990|584314515|FG000|Overall Study|Sponsor's decision|24|||
161801246|NCT02576990|584314516|FG001|Overall Study|Sponsor's decision|4|||
161801247|NCT02576990|584314515|FG000|Overall Study|Withdrawal by Subject|0|||
161801248|NCT02576990|584314516|FG001|Overall Study|Withdrawal by Subject|2|||
161801249|NCT00936390|584314517|FG000|Overall Study|Protocol Violation|21|||
161801250|NCT00936390|584314518|FG001|Overall Study|Protocol Violation|25|||
161801251|NCT02093689|584314519|FG000|Overall Study|Physician Decision|4|||
161801252|NCT02093689|584314520|FG001|Overall Study|Physician Decision|0|||
161801253|NCT02093689|584314521|FG002|Overall Study|Physician Decision|0|||
161801254|NCT00475020|584314522|FG000|Overall Study|Physician Decision|3|||
161801255|NCT00475020|584314522|FG000|Overall Study|Insurance Denial|1|||
161801256|NCT00475020|584314522|FG000|Overall Study|Donor not able to donate the last minute|1|||
161801257|NCT01575054|584314523|FG000|Overall Study|Other Reasons|5|||
161801258|NCT01575054|584314524|FG001|Overall Study|Other Reasons|3|||
161801259|NCT01575054|584314523|FG000|Overall Study|Protocol Violation|2|||
161801260|NCT01575054|584314524|FG001|Overall Study|Protocol Violation|1|||
161801261|NCT01575054|584314523|FG000|Overall Study|Personal Reasons|10|||
161801262|NCT01575054|584314524|FG001|Overall Study|Personal Reasons|11|||
161801263|NCT01575054|584314523|FG000|Overall Study|Lost to Follow-up|3|||
161801264|NCT01575054|584314524|FG001|Overall Study|Lost to Follow-up|3|||
161801265|NCT01575054|584314523|FG000|Overall Study|Adverse Event|9|||
161801266|NCT01575054|584314524|FG001|Overall Study|Adverse Event|8|||
161801267|NCT03481309|584314525|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
161801268|NCT03481309|584314526|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161801269|NCT03481309|584314527|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161801270|NCT03481309|584314528|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161801271|NCT03481309|584314529|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161801272|NCT03481309|584314530|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161801273|NCT03309956|584314533|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
161801274|NCT02768298|584314534|FG000|Overall Study|Adverse Event|1|||
161801275|NCT02768298|584314535|FG001|Overall Study|Adverse Event|4|||
161801276|NCT02768298|584314534|FG000|Overall Study|Death|2|||
161801277|NCT02768298|584314535|FG001|Overall Study|Death|1|||
161801278|NCT02768298|584314534|FG000|Overall Study|Non-compliance with study treatment|0|||
161801279|NCT02768298|584314535|FG001|Overall Study|Non-compliance with study treatment|1|||
161801280|NCT02768298|584314534|FG000|Overall Study|Subject/guardian decision|1|||
161801281|NCT02768298|584314535|FG001|Overall Study|Subject/guardian decision|0|||
161801282|NCT02768298|584314534|FG000|Overall Study|Withdrawal of informed consent|0|||
161801283|NCT02768298|584314535|FG001|Overall Study|Withdrawal of informed consent|1|||
161801284|NCT03365947|584314536|FG000|Overall Study|Lost to Follow-up|0|||
161801285|NCT03365947|584314537|FG001|Overall Study|Lost to Follow-up|0|||
161801286|NCT03365947|584314538|FG002|Overall Study|Lost to Follow-up|0|||
161801287|NCT03365947|584314539|FG003|Overall Study|Lost to Follow-up|0|||
161801288|NCT03365947|584314540|FG004|Overall Study|Lost to Follow-up|0|||
161801289|NCT03365947|584314541|FG005|Overall Study|Lost to Follow-up|1|||
161801290|NCT03365947|584314542|FG006|Overall Study|Lost to Follow-up|0|||
161801291|NCT03365947|584314543|FG007|Overall Study|Lost to Follow-up|0|||
161801292|NCT03365947|584314544|FG008|Overall Study|Lost to Follow-up|0|||
161801293|NCT03365947|584314545|FG009|Overall Study|Lost to Follow-up|0|||
161904867|NCT00536510|584701113|FG001|Overall Study|Laboratory Adverse Event|1|||
161904868|NCT00536510|584701112|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
161904869|NCT00536510|584701113|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
161904870|NCT01249417|584701114|FG000|Randomised Population|Study treatment not received|0|||
161904871|NCT01249417|584701115|FG001|Randomised Population|Study treatment not received|0|||
161904872|NCT01249417|584701116|FG002|Randomised Population|Study treatment not received|2|||
161904873|NCT01249417|584701114|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
161904874|NCT01249417|584701115|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
161904875|NCT01249417|584701116|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
161904876|NCT01249417|584701114|FG000|Treatment Phase - ITT Population|Other|0|||
161904877|NCT01249417|584701115|FG001|Treatment Phase - ITT Population|Other|0|||
161904878|NCT01249417|584701116|FG002|Treatment Phase - ITT Population|Other|1|||
161904879|NCT01249417|584701114|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
161904880|NCT01249417|584701115|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
161904881|NCT01249417|584701116|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
161904882|NCT01249417|584701114|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
161904883|NCT01249417|584701115|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
161904884|NCT01249417|584701116|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
161904885|NCT01249417|584701114|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
161904886|NCT01249417|584701115|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
161904887|NCT01249417|584701116|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
161904888|NCT01854697|584701117|FG000|Overall Study|Adverse Event|1|||
161904889|NCT01854697|584701118|FG001|Overall Study|Adverse Event|0|||
161904890|NCT01854697|584701119|FG002|Overall Study|Adverse Event|0|||
161904891|NCT01854697|584701120|FG003|Overall Study|Adverse Event|0|||
161904892|NCT01854697|584701121|FG004|Overall Study|Adverse Event|1|||
161904893|NCT01854697|584701117|FG000|Overall Study|Lost to Follow-up|4|||
161904894|NCT01854697|584701118|FG001|Overall Study|Lost to Follow-up|1|||
161904895|NCT01854697|584701119|FG002|Overall Study|Lost to Follow-up|1|||
161904896|NCT01854697|584701120|FG003|Overall Study|Lost to Follow-up|2|||
161904897|NCT01854697|584701121|FG004|Overall Study|Lost to Follow-up|0|||
161904898|NCT01854697|584701117|FG000|Overall Study|To enter another AbbVie study|1|||
161904899|NCT01854697|584701118|FG001|Overall Study|To enter another AbbVie study|0|||
161904900|NCT01854697|584701119|FG002|Overall Study|To enter another AbbVie study|0|||
161904901|NCT01854697|584701120|FG003|Overall Study|To enter another AbbVie study|0|||
161904902|NCT01854697|584701121|FG004|Overall Study|To enter another AbbVie study|1|||
161904903|NCT01854697|584701117|FG000|Overall Study|Withdrew Consent|0|||
161904904|NCT01854697|584701118|FG001|Overall Study|Withdrew Consent|1|||
161904905|NCT01854697|584701119|FG002|Overall Study|Withdrew Consent|0|||
161904906|NCT01854697|584701120|FG003|Overall Study|Withdrew Consent|1|||
161904907|NCT01854697|584701121|FG004|Overall Study|Withdrew Consent|0|||
161904908|NCT01854697|584701117|FG000|Overall Study|Other|0|||
161904909|NCT01854697|584701118|FG001|Overall Study|Other|1|||
161904910|NCT01854697|584701119|FG002|Overall Study|Other|1|||
161904911|NCT01854697|584701120|FG003|Overall Study|Other|0|||
161904912|NCT01854697|584701121|FG004|Overall Study|Other|0|||
161904913|NCT03074695|584701122|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
161904914|NCT03074695|584701123|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
161904915|NCT03074695|584701122|FG000|Overall Study|Research staff not available|1|||
161904916|NCT03074695|584701123|FG001|Overall Study|Research staff not available|2|||
161904917|NCT03074695|584701122|FG000|Overall Study|Did not receive neuraxial block|2|||
161904918|NCT03074695|584701123|FG001|Overall Study|Did not receive neuraxial block|2|||
161904919|NCT00902577|584701124|FG000|Overall Study|Withdrawal by Subject|6|||
161904920|NCT00902577|584701124|FG000|Overall Study|FMISO production failure|2|||
161904921|NCT01232790|584701125|FG000|Randomization|Withdrawal by Subject|2|||
161904922|NCT01232790|584701126|FG001|Randomization|Withdrawal by Subject|0|||
161904923|NCT01232790|584701125|FG000|Randomization|Protocol Violation|0|||
161904924|NCT01232790|584701126|FG001|Randomization|Protocol Violation|1|||
161904925|NCT01232790|584701125|FG000|Randomization|Physician Decision|0|||
161904926|NCT01232790|584701126|FG001|Randomization|Physician Decision|1|||
161904927|NCT01232790|584701125|FG000|Initial Assessment|Withdrawal by Subject|0|||
161904928|NCT01232790|584701126|FG001|Initial Assessment|Withdrawal by Subject|1|||
161904929|NCT01232790|584701125|FG000|First Crossover|Withdrawal by Subject|1|||
161904930|NCT01232790|584701126|FG001|First Crossover|Withdrawal by Subject|0|||
161904931|NCT01232790|584701125|FG000|Second Crossover|Withdrawal by Subject|1|||
161904932|NCT01232790|584701126|FG001|Second Crossover|Withdrawal by Subject|2|||
161904933|NCT00468585|584701127|FG000|Overall Study|Patient not treated|1|||
161801294|NCT03365947|584314546|FG010|Overall Study|Lost to Follow-up|0|||
161801295|NCT03365947|584314547|FG011|Overall Study|Lost to Follow-up|0|||
161801296|NCT03365947|584314548|FG012|Overall Study|Lost to Follow-up|0|||
161801297|NCT03365947|584314549|FG013|Overall Study|Lost to Follow-up|0|||
161801298|NCT03365947|584314550|FG014|Overall Study|Lost to Follow-up|0|||
161801299|NCT03365947|584314551|FG015|Overall Study|Lost to Follow-up|0|||
161801300|NCT03365947|584314552|FG016|Overall Study|Lost to Follow-up|0|||
161801301|NCT03365947|584314553|FG017|Overall Study|Lost to Follow-up|0|||
161801302|NCT03365947|584314554|FG018|Overall Study|Lost to Follow-up|0|||
161801303|NCT02518685|584314555|FG000|Overall Study|Adverse Event|29|||
161801304|NCT02518685|584314556|FG001|Overall Study|Adverse Event|1|||
161801305|NCT02518685|584314555|FG000|Overall Study|Withdrawal by Subject|10|||
161801306|NCT02518685|584314556|FG001|Overall Study|Withdrawal by Subject|3|||
161801307|NCT02518685|584314555|FG000|Overall Study|relocation, study fatigue|7|||
161801308|NCT02518685|584314556|FG001|Overall Study|relocation, study fatigue|2|||
161801309|NCT02518685|584314555|FG000|Overall Study|Pregnancy|1|||
161801310|NCT02518685|584314556|FG001|Overall Study|Pregnancy|0|||
161801311|NCT02518685|584314555|FG000|Overall Study|Physician Decision|1|||
161904934|NCT00468585|584701128|FG001|Overall Study|Patient not treated|0|||
161801312|NCT02518685|584314556|FG001|Overall Study|Physician Decision|0|||
161904935|NCT00468585|584701129|FG002|Overall Study|Patient not treated|1|||
161801313|NCT02518685|584314555|FG000|Overall Study|Lost to Follow-up|1|||
161801314|NCT02518685|584314556|FG001|Overall Study|Lost to Follow-up|4|||
161904936|NCT00468585|584701130|FG003|Overall Study|Patient not treated|0|||
161904937|NCT00468585|584701127|FG000|Overall Study|Patient found to be ineligible|0|||
161904938|NCT00468585|584701128|FG001|Overall Study|Patient found to be ineligible|0|||
161904939|NCT00468585|584701129|FG002|Overall Study|Patient found to be ineligible|1|||
161904940|NCT00468585|584701130|FG003|Overall Study|Patient found to be ineligible|0|||
161904941|NCT00468585|584701127|FG000|Overall Study|Adverse Event|0|||
161904942|NCT00468585|584701128|FG001|Overall Study|Adverse Event|0|||
161904943|NCT00468585|584701129|FG002|Overall Study|Adverse Event|1|||
161904944|NCT00468585|584701130|FG003|Overall Study|Adverse Event|0|||
161904945|NCT00468585|584701127|FG000|Overall Study|Withdrawal by Subject|0|||
161904946|NCT00468585|584701128|FG001|Overall Study|Withdrawal by Subject|0|||
161904947|NCT00468585|584701129|FG002|Overall Study|Withdrawal by Subject|2|||
161904948|NCT00468585|584701130|FG003|Overall Study|Withdrawal by Subject|1|||
161904949|NCT03769649|584701131|FG000|Overall Study|Lost to Follow-up|4|||
161904950|NCT03322293|584701132|FG000|Overall Study|Lost to Follow-up|0|||
161904951|NCT03322293|584701133|FG001|Overall Study|Lost to Follow-up|0|||
161904952|NCT03322293|584701134|FG002|Overall Study|Lost to Follow-up|1|||
161904953|NCT00083915|584701137|FG000|Overall Study|Death|6|||
161904954|NCT00083915|584701138|FG001|Overall Study|Death|3|||
161904955|NCT00083915|584701137|FG000|Overall Study|Physician Decision|11|||
161904956|NCT00083915|584701138|FG001|Overall Study|Physician Decision|6|||
161904957|NCT00083915|584701137|FG000|Overall Study|Withdrawal by Subject|8|||
161904958|NCT00083915|584701138|FG001|Overall Study|Withdrawal by Subject|3|||
161904959|NCT00083915|584701137|FG000|Overall Study|disease progression|18|||
161904960|NCT00083915|584701138|FG001|Overall Study|disease progression|23|||
161904961|NCT00083915|584701137|FG000|Overall Study|Failure to collect|3|||
161904962|NCT00083915|584701138|FG001|Overall Study|Failure to collect|0|||
161904963|NCT00083915|584701137|FG000|Overall Study|No response|3|||
161904964|NCT00083915|584701138|FG001|Overall Study|No response|1|||
161904965|NCT00083915|584701137|FG000|Overall Study|Insurance issues|1|||
161904966|NCT00083915|584701138|FG001|Overall Study|Insurance issues|1|||
161904967|NCT00719901|584701140|FG000|Overall Study|Adverse Event|5|||
161904968|NCT00719901|584701140|FG000|Overall Study|Withdrawal by Subject|1|||
161904969|NCT00719901|584701140|FG000|Overall Study|Alternate Treatment|1|||
161904970|NCT00719901|584701140|FG000|Overall Study|Disease Progression|3|||
161904971|NCT00719901|584701140|FG000|Overall Study|Availability of Study Drug|1|||
161904972|NCT04456686|584701143|FG000|Overall Study|Adverse Event|2|||
161904973|NCT04456686|584701144|FG001|Overall Study|Adverse Event|1|||
161904974|NCT04456686|584701143|FG000|Overall Study|Lack of Efficacy|3|||
161904975|NCT04456686|584701144|FG001|Overall Study|Lack of Efficacy|1|||
161904976|NCT04456686|584701143|FG000|Overall Study|Withdrew consent|3|||
161904977|NCT04456686|584701144|FG001|Overall Study|Withdrew consent|1|||
161904978|NCT04456686|584701143|FG000|Overall Study|Physician Decision|2|||
161904979|NCT04456686|584701144|FG001|Overall Study|Physician Decision|2|||
161904980|NCT04456686|584701143|FG000|Overall Study|Withdrawal by Subject|5|||
161904981|NCT04456686|584701144|FG001|Overall Study|Withdrawal by Subject|1|||
161904982|NCT04456686|584701143|FG000|Overall Study|Protocol Violation|0|||
161904983|NCT04456686|584701144|FG001|Overall Study|Protocol Violation|1|||
161904984|NCT02858401|584701147|FG000|Overall Study|Withdrew Consent|0|||
161904985|NCT02858401|584701148|FG001|Overall Study|Withdrew Consent|0|||
161904986|NCT02858401|584701149|FG002|Overall Study|Withdrew Consent|0|||
161904987|NCT02858401|584701150|FG003|Overall Study|Withdrew Consent|0|||
161904988|NCT02858401|584701151|FG004|Overall Study|Withdrew Consent|0|||
161904989|NCT02858401|584701152|FG005|Overall Study|Withdrew Consent|1|||
161904990|NCT02858401|584701153|FG006|Overall Study|Withdrew Consent|0|||
161904991|NCT02858401|584701147|FG000|Overall Study|Lost to Follow-up|0|||
161904992|NCT02858401|584701148|FG001|Overall Study|Lost to Follow-up|1|||
161904993|NCT02858401|584701149|FG002|Overall Study|Lost to Follow-up|0|||
161904994|NCT02858401|584701150|FG003|Overall Study|Lost to Follow-up|0|||
161904995|NCT02858401|584701151|FG004|Overall Study|Lost to Follow-up|0|||
161904996|NCT02858401|584701152|FG005|Overall Study|Lost to Follow-up|0|||
161904997|NCT02858401|584701153|FG006|Overall Study|Lost to Follow-up|0|||
161904998|NCT03722576|584701154|FG000|Overall Study|Withdrawal by Subject|3|||
161904999|NCT03722576|584701154|FG000|Overall Study|Adverse Event|2|||
161905000|NCT03722576|584701154|FG000|Overall Study|Physician Decision|1|||
161905001|NCT03722576|584701154|FG000|Overall Study|Lost to Follow-up|1|||
161905002|NCT02059239|584701158|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
161905003|NCT02059239|584701159|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
161905004|NCT02059239|584701158|FG000|Overall Study|Physician Decision|1|||
161905005|NCT02059239|584701159|FG001|Overall Study|Physician Decision|0|||
161905006|NCT01408706|584701161|FG000|Overall Study|Physician Decision|1|||
161905007|NCT01408706|584701162|FG001|Overall Study|Physician Decision|0|||
161905008|NCT01268267|584701163|FG000|Overall Study|Protocol Violation|1|||
161905009|NCT01222104|584701164|FG000|Overall Study|Lost to Follow-up|37|||
161905010|NCT01222104|584701164|FG000|Overall Study|Death|10|||
161905011|NCT00888654|584701166|FG000|Overall Study|Problems swallowing oral meds.|1|||
161905012|NCT00888654|584701166|FG000|Overall Study|Not enough oral meds before surgery|3|||
161905013|NCT00888654|584701166|FG000|Overall Study|Surgery aborted|2|||
161905014|NCT00888654|584701166|FG000|Overall Study|Withdrawal by Subject|1|||
161801315|NCT01922349|584314557|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
161801316|NCT01922349|584314558|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
161801317|NCT01922349|584314559|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
161801318|NCT01922349|584314560|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
161801319|NCT05109234|584314561|FG000|Overall Study|Adverse Event|2|||
161801320|NCT05109234|584314562|FG001|Overall Study|Adverse Event|2|||
161801321|NCT05109234|584314561|FG000|Overall Study|Lack of Efficacy|5|||
161801322|NCT05109234|584314562|FG001|Overall Study|Lack of Efficacy|0|||
161801323|NCT05109234|584314561|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
161801324|NCT05109234|584314562|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
161801325|NCT05109234|584314561|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
161801326|NCT05109234|584314562|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
161801327|NCT05109234|584314561|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
161801328|NCT05109234|584314562|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
161801329|NCT05109234|584314561|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
161801330|NCT05109234|584314562|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
161801331|NCT00336024|584314563|FG000|Overall Study|Death|2|||
161801332|NCT00336024|584314564|FG001|Overall Study|Death|1|||
161801333|NCT00336024|584314563|FG000|Overall Study|Physician Decision|4|||
161801334|NCT00336024|584314564|FG001|Overall Study|Physician Decision|1|||
161801335|NCT00336024|584314563|FG000|Overall Study|Protocol Violation|1|||
161801336|NCT00336024|584314564|FG001|Overall Study|Protocol Violation|0|||
161801337|NCT00336024|584314563|FG000|Overall Study|Withdrawal by Subject|1|||
161801338|NCT00336024|584314564|FG001|Overall Study|Withdrawal by Subject|2|||
162010888|NCT02594124|585096044|FG001|Overall Study|Withdrawal by Subject|3|||
161801339|NCT00336024|584314563|FG000|Overall Study|Failure to fulfill consolidation|1|||
162138473|NCT05550337|585557350|FG000|Overall Study|Lost to Follow-up|16|||
162138474|NCT05550337|585557351|FG001|Overall Study|Lost to Follow-up|11|||
162138475|NCT05550337|585557352|FG002|Overall Study|Lost to Follow-up|11|||
162138476|NCT02189863|585557353|FG000|First 2 Weeks|Motion Sickness|4|||
162138477|NCT02189863|585557354|FG001|First 2 Weeks|Motion Sickness|2|||
162138478|NCT02926937|585557361|FG000|Overall Study|Adverse Event|0|||
162138479|NCT02926937|585557362|FG001|Overall Study|Adverse Event|1|||
162138480|NCT02926937|585557363|FG002|Overall Study|Adverse Event|1|||
162138481|NCT02926937|585557361|FG000|Overall Study|Poor Compliance to Protocol|1|||
162138482|NCT02926937|585557362|FG001|Overall Study|Poor Compliance to Protocol|0|||
162138483|NCT02926937|585557363|FG002|Overall Study|Poor Compliance to Protocol|0|||
162138484|NCT02926937|585557361|FG000|Overall Study|Lost to Follow-up|4|||
162138485|NCT02926937|585557362|FG001|Overall Study|Lost to Follow-up|5|||
162138486|NCT02926937|585557363|FG002|Overall Study|Lost to Follow-up|0|||
162138487|NCT02926937|585557361|FG000|Overall Study|At the Participant's own Request|11|||
162138488|NCT02926937|585557362|FG001|Overall Study|At the Participant's own Request|5|||
162138489|NCT02926937|585557363|FG002|Overall Study|At the Participant's own Request|8|||
162138490|NCT02926937|585557361|FG000|Overall Study|Reason not Specified|3|||
162138491|NCT02926937|585557362|FG001|Overall Study|Reason not Specified|4|||
162138492|NCT02926937|585557363|FG002|Overall Study|Reason not Specified|2|||
162138493|NCT01559090|585557364|FG000|Stage I|Withdrawal by Subject|2|||
162138494|NCT01559090|585557365|FG001|Stage I|Withdrawal by Subject|2|||
162138495|NCT01559090|585557366|FG002|Stage I|Withdrawal by Subject|3|||
162138496|NCT01559090|585557364|FG000|Stage II|Withdrawal by Subject|1|||
162138497|NCT01559090|585557365|FG001|Stage II|Withdrawal by Subject|0|||
162138498|NCT01559090|585557366|FG002|Stage II|Withdrawal by Subject|0|||
162138499|NCT03499600|585557370|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
162138500|NCT03499600|585557371|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
162138501|NCT00561574|585557372|FG000|Overall Study|Adverse Event|21|||
162138502|NCT00561574|585557373|FG001|Overall Study|Adverse Event|24|||
162138503|NCT00561574|585557372|FG000|Overall Study|Lack of Efficacy|11|||
162138504|NCT00561574|585557373|FG001|Overall Study|Lack of Efficacy|21|||
162138505|NCT00561574|585557372|FG000|Overall Study|Withdrawal by Subject|4|||
162138506|NCT00561574|585557373|FG001|Overall Study|Withdrawal by Subject|4|||
162138507|NCT00561574|585557372|FG000|Overall Study|Reason Unrelated to Trial|6|||
162138508|NCT00561574|585557373|FG001|Overall Study|Reason Unrelated to Trial|2|||
162138509|NCT00561574|585557372|FG000|Overall Study|Lost to Follow-up|1|||
162138510|NCT00561574|585557373|FG001|Overall Study|Lost to Follow-up|0|||
162138511|NCT00561574|585557372|FG000|Overall Study|Other|5|||
162138512|NCT00561574|585557373|FG001|Overall Study|Other|7|||
162138513|NCT03971357|585557374|FG000|Overall Study|Lack of Efficacy|0|||
162138514|NCT03971357|585557375|FG001|Overall Study|Lack of Efficacy|1|||
162138515|NCT01729871|585557376|FG000|Overall Study|Adverse Event|7|||
162138516|NCT01729871|585557377|FG001|Overall Study|Adverse Event|7|||
162138517|NCT01729871|585557376|FG000|Overall Study|Death|0|||
162138518|NCT01729871|585557377|FG001|Overall Study|Death|1|||
162138519|NCT01729871|585557376|FG000|Overall Study|Lack of Efficacy|0|||
162138520|NCT01729871|585557377|FG001|Overall Study|Lack of Efficacy|1|||
162138521|NCT01729871|585557376|FG000|Overall Study|Physician Decision|0|||
162138522|NCT01729871|585557377|FG001|Overall Study|Physician Decision|2|||
162138523|NCT01729871|585557376|FG000|Overall Study|Protocol Violation|1|||
162138524|NCT01729871|585557377|FG001|Overall Study|Protocol Violation|0|||
162138525|NCT01729871|585557376|FG000|Overall Study|Withdrawal by Subject|0|||
162138526|NCT01729871|585557377|FG001|Overall Study|Withdrawal by Subject|3|||
162138527|NCT01729871|585557376|FG000|Overall Study|Other|4|||
162138528|NCT01729871|585557377|FG001|Overall Study|Other|9|||
162138529|NCT00445692|585557378|FG000|Overall Study|Adverse Event|11|||
162138530|NCT00445692|585557378|FG000|Overall Study|Lack of Efficacy|5|||
162138531|NCT01143077|585557382|FG000|Overall Study|Lack of Efficacy|0|||
162138532|NCT01143077|585557383|FG001|Overall Study|Lack of Efficacy|2|||
162138533|NCT01143077|585557384|FG002|Overall Study|Lack of Efficacy|1|||
162138534|NCT01143077|585557382|FG000|Overall Study|Adverse Event|5|||
162138535|NCT01143077|585557383|FG001|Overall Study|Adverse Event|6|||
162138536|NCT01143077|585557384|FG002|Overall Study|Adverse Event|5|||
161905015|NCT00888654|584701166|FG000|Overall Study|Inelig. due to contraindication of med|1|||
161905016|NCT00888654|584701166|FG000|Overall Study|Change in surg date|1|||
161905017|NCT00888654|584701166|FG000|Overall Study|Stopped meds due to headaches|1|||
161905018|NCT01418339|584701167|FG000|Overall Study|Adverse Event|5|||
161905019|NCT01418339|584701168|FG001|Overall Study|Adverse Event|2|||
161905020|NCT01418339|584701167|FG000|Overall Study|Subject Withdrew Consent|1|||
161905021|NCT01418339|584701168|FG001|Overall Study|Subject Withdrew Consent|2|||
161905022|NCT01418339|584701167|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
161905023|NCT01418339|584701168|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
161905024|NCT02219685|584701173|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
161905025|NCT02219685|584701174|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
161905026|NCT02219685|584701173|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
161905027|NCT02219685|584701174|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
161905028|NCT02048722|584701175|FG000|2 Cycles of Treatment|Adverse Event|2|||
161905029|NCT02048722|584701175|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
162138537|NCT01143077|585557382|FG000|Overall Study|Lost to Follow-up|2|||
162138538|NCT01143077|585557383|FG001|Overall Study|Lost to Follow-up|3|||
162138539|NCT01143077|585557384|FG002|Overall Study|Lost to Follow-up|4|||
162138540|NCT01143077|585557382|FG000|Overall Study|Protocol Violation|2|||
162138541|NCT01143077|585557383|FG001|Overall Study|Protocol Violation|0|||
162138542|NCT01143077|585557384|FG002|Overall Study|Protocol Violation|0|||
162138543|NCT01143077|585557382|FG000|Overall Study|Withdrawal by Subject|4|||
162138544|NCT01143077|585557383|FG001|Overall Study|Withdrawal by Subject|3|||
162138545|NCT01143077|585557384|FG002|Overall Study|Withdrawal by Subject|3|||
162138546|NCT01143077|585557382|FG000|Overall Study|Non-compliance with study drug|0|||
162138547|NCT01143077|585557383|FG001|Overall Study|Non-compliance with study drug|1|||
162138548|NCT01143077|585557384|FG002|Overall Study|Non-compliance with study drug|1|||
162138549|NCT01143077|585557382|FG000|Overall Study|Administrative|1|||
162138550|NCT01143077|585557383|FG001|Overall Study|Administrative|0|||
162138551|NCT01143077|585557384|FG002|Overall Study|Administrative|0|||
162138552|NCT01143077|585557382|FG000|Overall Study|Principal Investigator Decision|2|||
162138553|NCT01143077|585557383|FG001|Overall Study|Principal Investigator Decision|0|||
162138554|NCT01143077|585557384|FG002|Overall Study|Principal Investigator Decision|1|||
162138555|NCT00681811|585557392|FG000|Overall Study|Adverse Event|1|||
162138556|NCT00681811|585557393|FG001|Overall Study|Adverse Event|1|||
162138557|NCT00681811|585557392|FG000|Overall Study|Withdrawal by Subject|2|||
162138558|NCT00681811|585557393|FG001|Overall Study|Withdrawal by Subject|2|||
162138559|NCT00681811|585557392|FG000|Overall Study|Non-compliance|0|||
162138560|NCT00681811|585557393|FG001|Overall Study|Non-compliance|1|||
162138561|NCT01140347|585557400|FG000|Overall Study|Lost to Follow-up|5|||
162138562|NCT01140347|585557401|FG001|Overall Study|Lost to Follow-up|6|||
162138563|NCT01140347|585557400|FG000|Overall Study|Withdrawal by Subject|13|||
162138564|NCT01140347|585557401|FG001|Overall Study|Withdrawal by Subject|8|||
162138565|NCT00828919|585557402|FG000|Overall Study|Death|0|||
162138566|NCT00828919|585557403|FG001|Overall Study|Death|1|||
162138567|NCT00828919|585557404|FG002|Overall Study|Death|2|||
162138568|NCT00828919|585557405|FG003|Overall Study|Death|0|||
162138569|NCT00828919|585557406|FG004|Overall Study|Death|0|||
162138570|NCT00828919|585557402|FG000|Overall Study|Adverse Event|2|||
162138571|NCT00828919|585557403|FG001|Overall Study|Adverse Event|2|||
162138572|NCT00828919|585557404|FG002|Overall Study|Adverse Event|2|||
162138573|NCT00828919|585557405|FG003|Overall Study|Adverse Event|1|||
162138574|NCT00828919|585557406|FG004|Overall Study|Adverse Event|3|||
162138575|NCT00828919|585557402|FG000|Overall Study|Objective progression or relapse|4|||
162138576|NCT00828919|585557403|FG001|Overall Study|Objective progression or relapse|4|||
162138577|NCT00828919|585557404|FG002|Overall Study|Objective progression or relapse|11|||
162138578|NCT00828919|585557405|FG003|Overall Study|Objective progression or relapse|0|||
162138579|NCT00828919|585557406|FG004|Overall Study|Objective progression or relapse|5|||
162138580|NCT00828919|585557402|FG000|Overall Study|No longer willing to participate in study|0|||
162138581|NCT00828919|585557403|FG001|Overall Study|No longer willing to participate in study|0|||
162138582|NCT00828919|585557404|FG002|Overall Study|No longer willing to participate in study|2|||
162138583|NCT00828919|585557405|FG003|Overall Study|No longer willing to participate in study|0|||
162138584|NCT00828919|585557406|FG004|Overall Study|No longer willing to participate in study|0|||
162138585|NCT00828919|585557402|FG000|Overall Study|Insufficient Clinical Response|0|||
162138586|NCT00828919|585557403|FG001|Overall Study|Insufficient Clinical Response|1|||
162138587|NCT00828919|585557404|FG002|Overall Study|Insufficient Clinical Response|2|||
162138588|NCT00828919|585557405|FG003|Overall Study|Insufficient Clinical Response|0|||
162138589|NCT00828919|585557406|FG004|Overall Study|Insufficient Clinical Response|0|||
162138590|NCT00828919|585557402|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
162138591|NCT00828919|585557403|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
162138592|NCT00828919|585557404|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
161801340|NCT00336024|584314564|FG001|Overall Study|Failure to fulfill consolidation|1|||
161801341|NCT00336024|584314563|FG000|Overall Study|Progressive Disease|4|||
161801342|NCT00336024|584314564|FG001|Overall Study|Progressive Disease|7|||
161801343|NCT00336024|584314563|FG000|Overall Study|Ineligible|7|||
161801344|NCT00336024|584314564|FG001|Overall Study|Ineligible|7|||
161801345|NCT05067504|584314566|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
161801346|NCT05067504|584314567|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
161801347|NCT05067504|584314566|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
161801348|NCT05067504|584314567|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
161801349|NCT05067504|584314566|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
161801350|NCT05067504|584314567|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
161801351|NCT03805438|584316450|FG000|Overall Study|Lack of Efficacy|1|||
161801352|NCT03805438|584316450|FG000|Overall Study|Protocol Violation|1|||
161801353|NCT00419770|584316453|FG000|Overall Study|Withdrawal by Subject|5|||
161801354|NCT00419770|584316454|FG001|Overall Study|Withdrawal by Subject|1|||
161801355|NCT02424188|584316462|FG000|Overall Study|Death|2|||
161801356|NCT02424188|584316463|FG001|Overall Study|Death|2|||
161801357|NCT02424188|584316462|FG000|Overall Study|Lost to Follow-up|1|||
161801358|NCT02424188|584316463|FG001|Overall Study|Lost to Follow-up|3|||
161801359|NCT02424188|584316462|FG000|Overall Study|Incarceration|1|||
161801360|NCT02424188|584316463|FG001|Overall Study|Incarceration|0|||
161801361|NCT01494506|584316468|FG000|Overall Study|Lack of Efficacy|77|||
161801362|NCT01494506|584316469|FG001|Overall Study|Lack of Efficacy|83|||
161905030|NCT02048722|584701175|FG000|2 Cycles of Treatment|Progressive Disease|2|||
161905031|NCT02048722|584701175|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
161905032|NCT02048722|584701175|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
161905033|NCT02048722|584701175|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
161905034|NCT00705757|584701176|FG000|Overall Study|Lack of Efficacy|5|||
161905035|NCT00705757|584701177|FG001|Overall Study|Lack of Efficacy|1|||
161905036|NCT00705757|584701178|FG002|Overall Study|Lack of Efficacy|3|||
161905037|NCT00705757|584701176|FG000|Overall Study|Lost to Follow-up|7|||
161905038|NCT00705757|584701177|FG001|Overall Study|Lost to Follow-up|6|||
161905039|NCT00705757|584701178|FG002|Overall Study|Lost to Follow-up|6|||
161905040|NCT00705757|584701176|FG000|Overall Study|Withdrawal by Subject|1|||
161905041|NCT00705757|584701177|FG001|Overall Study|Withdrawal by Subject|1|||
161905042|NCT00705757|584701178|FG002|Overall Study|Withdrawal by Subject|2|||
161905043|NCT04144322|584701187|FG000|Overall Study|Lack of Efficacy|2|||
161905044|NCT04144322|584701188|FG001|Overall Study|Lack of Efficacy|2|||
161905045|NCT01435759|584701192|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
161905046|NCT01435759|584701193|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
161905047|NCT01435759|584701194|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
161905048|NCT01435759|584701195|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
161905049|NCT01435759|584701196|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
161905050|NCT01435759|584701197|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
161905051|NCT01435759|584701192|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
161905052|NCT01435759|584701193|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
161905053|NCT01435759|584701194|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
161905054|NCT01435759|584701195|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
161905055|NCT01435759|584701196|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
161905056|NCT01435759|584701197|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
161801363|NCT01494506|584316470|FG002|Overall Study|Lack of Efficacy|57|||
161801364|NCT01494506|584316468|FG000|Overall Study|Adverse Event|17|||
161801365|NCT01494506|584316469|FG001|Overall Study|Adverse Event|10|||
161801366|NCT01494506|584316470|FG002|Overall Study|Adverse Event|11|||
161801367|NCT01494506|584316468|FG000|Overall Study|Death|9|||
161801368|NCT01494506|584316469|FG001|Overall Study|Death|5|||
161801369|NCT01494506|584316470|FG002|Overall Study|Death|2|||
161801370|NCT01494506|584316468|FG000|Overall Study|Physician Decision|7|||
161801371|NCT01494506|584316469|FG001|Overall Study|Physician Decision|5|||
161801372|NCT01494506|584316470|FG002|Overall Study|Physician Decision|4|||
161801373|NCT01494506|584316468|FG000|Overall Study|Withdrawal by Subject|17|||
161801374|NCT01494506|584316469|FG001|Overall Study|Withdrawal by Subject|20|||
161801375|NCT01494506|584316470|FG002|Overall Study|Withdrawal by Subject|14|||
161801376|NCT01494506|584316468|FG000|Overall Study|Clinical Deterioration|21|||
161801377|NCT01494506|584316469|FG001|Overall Study|Clinical Deterioration|17|||
161801378|NCT01494506|584316470|FG002|Overall Study|Clinical Deterioration|13|||
161801379|NCT01494506|584316468|FG000|Overall Study|Sponsor Decision|0|||
161801380|NCT01494506|584316469|FG001|Overall Study|Sponsor Decision|0|||
161801381|NCT01494506|584316470|FG002|Overall Study|Sponsor Decision|1|||
161801382|NCT01494506|584316468|FG000|Overall Study|Other|0|||
161801383|NCT01494506|584316469|FG001|Overall Study|Other|3|||
161801384|NCT01494506|584316470|FG002|Overall Study|Other|1|||
161801385|NCT02777528|584316474|FG000|Overall Study|Still in study|24|||
161801386|NCT02777528|584316475|FG001|Overall Study|Still in study|10|||
161801387|NCT02777528|584316476|FG002|Overall Study|Still in study|1|||
161801388|NCT02777528|584316474|FG000|Overall Study|Study Device Explanted|1|||
161801389|NCT02777528|584316475|FG001|Overall Study|Study Device Explanted|0|||
161801390|NCT02777528|584316476|FG002|Overall Study|Study Device Explanted|0|||
161801391|NCT02777528|584316474|FG000|Overall Study|Death|14|||
161801392|NCT02777528|584316475|FG001|Overall Study|Death|7|||
161801393|NCT02777528|584316476|FG002|Overall Study|Death|1|||
161801394|NCT02777528|584316474|FG000|Overall Study|Withdrawal by Subject|2|||
161801395|NCT02777528|584316475|FG001|Overall Study|Withdrawal by Subject|2|||
161801396|NCT02777528|584316476|FG002|Overall Study|Withdrawal by Subject|1|||
161801397|NCT02777528|584316474|FG000|Overall Study|Physician Decision|2|||
161801398|NCT02777528|584316475|FG001|Overall Study|Physician Decision|1|||
161801399|NCT02777528|584316476|FG002|Overall Study|Physician Decision|0|||
161801400|NCT02777528|584316474|FG000|Overall Study|Lost to Follow-up|2|||
161801401|NCT02777528|584316475|FG001|Overall Study|Lost to Follow-up|0|||
161801402|NCT02777528|584316476|FG002|Overall Study|Lost to Follow-up|0|||
161801403|NCT02777528|584316474|FG000|Overall Study|Discontinued due to Other|1|||
161801404|NCT02777528|584316475|FG001|Overall Study|Discontinued due to Other|0|||
161801405|NCT02777528|584316476|FG002|Overall Study|Discontinued due to Other|0|||
161801406|NCT00453362|584316477|FG000|Overall Study|Adverse Event|5|||
161801407|NCT00453362|584316477|FG000|Overall Study|Death|7|||
161801408|NCT00453362|584316477|FG000|Overall Study|Physician Decision|2|||
161801409|NCT00453362|584316477|FG000|Overall Study|Withdrawal by Subject|3|||
161801410|NCT00453362|584316477|FG000|Overall Study|Progression of disease|56|||
161801411|NCT00453362|584316477|FG000|Overall Study|Screening Failure|14|||
161801412|NCT02127281|584316478|FG000|Overall Study|Lost to Follow-up|1|||
161801413|NCT02127281|584316479|FG001|Overall Study|Lost to Follow-up|0|||
161801414|NCT04885296|584316480|FG000|Period 1|Covid-19 Related|1|||
161905057|NCT01435759|584701192|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
161801415|NCT04885296|584316481|FG001|Period 1|Covid-19 Related|0|||
161801416|NCT04885296|584316480|FG000|Period 1|Adverse Event|0|||
161801417|NCT04885296|584316481|FG001|Period 1|Adverse Event|1|||
161801418|NCT04885296|584316480|FG000|Period 1|Withdrawal by Subject|1|||
161801419|NCT04885296|584316481|FG001|Period 1|Withdrawal by Subject|1|||
161801420|NCT04885296|584316480|FG000|Period 1|Test Article No Longer Available|1|||
161801421|NCT04885296|584316481|FG001|Period 1|Test Article No Longer Available|0|||
161801422|NCT04885296|584316480|FG000|Period 1|Dispensed Study lens in Error|1|||
161905058|NCT01435759|584701193|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161801423|NCT04885296|584316481|FG001|Period 1|Dispensed Study lens in Error|0|||
161801424|NCT04885296|584316480|FG000|Period 1|Lost to Follow-up|1|||
161801425|NCT04885296|584316481|FG001|Period 1|Lost to Follow-up|0|||
161905059|NCT01435759|584701194|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161801426|NCT04885296|584316480|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
161801427|NCT04885296|584316481|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
161801428|NCT00433147|584316483|FG000|Overall Study|Adverse Event|0|||
161801429|NCT00433147|584316484|FG001|Overall Study|Adverse Event|1|||
161801430|NCT00433147|584316485|FG002|Overall Study|Adverse Event|0|||
162138593|NCT00828919|585557405|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
162138594|NCT00828919|585557406|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
162138595|NCT00828919|585557402|FG000|Overall Study|Other|1|||
162138596|NCT00828919|585557403|FG001|Overall Study|Other|0|||
162138597|NCT00828919|585557404|FG002|Overall Study|Other|1|||
162138598|NCT00828919|585557405|FG003|Overall Study|Other|1|||
162138599|NCT00828919|585557406|FG004|Overall Study|Other|0|||
162138600|NCT00828919|585557402|FG000|Overall Study|Lost to Follow-up|0|||
162138601|NCT00828919|585557403|FG001|Overall Study|Lost to Follow-up|1|||
162138602|NCT00828919|585557404|FG002|Overall Study|Lost to Follow-up|0|||
161905060|NCT01435759|584701195|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161905061|NCT01435759|584701196|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161905062|NCT01435759|584701197|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161905063|NCT01435759|584701192|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
161905064|NCT01435759|584701193|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161905065|NCT01435759|584701194|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161905066|NCT01435759|584701195|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161905067|NCT01435759|584701196|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161905068|NCT01435759|584701197|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161905069|NCT01435759|584701192|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
161905070|NCT01435759|584701193|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905071|NCT01435759|584701194|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905072|NCT01435759|584701195|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905073|NCT01435759|584701196|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905074|NCT01435759|584701197|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905075|NCT01435759|584701192|FG000|Antidepressant Lead-in Phase|Other|119|||
161905076|NCT01435759|584701193|FG001|Antidepressant Lead-in Phase|Other|0|||
161905077|NCT01435759|584701194|FG002|Antidepressant Lead-in Phase|Other|0|||
161905078|NCT01435759|584701195|FG003|Antidepressant Lead-in Phase|Other|0|||
162138603|NCT00828919|585557405|FG003|Overall Study|Lost to Follow-up|0|||
162138604|NCT00828919|585557406|FG004|Overall Study|Lost to Follow-up|0|||
162138605|NCT05567159|585557407|FG000|Overall Study|Adverse Event|4|||
162138606|NCT05567159|585557407|FG000|Overall Study|Physician Decision|3|||
162138607|NCT05567159|585557407|FG000|Overall Study|Protocol deviation|1|||
162138608|NCT04155424|585557408|FG000|Overall Study|Other than specified|3|||
162138609|NCT04155424|585557408|FG000|Overall Study|Withdrawal by Subject|1|||
162138610|NCT04155424|585557408|FG000|Overall Study|Adverse Event|1|||
162138611|NCT01259102|585559859|FG000|Overall Study|Adverse Event|1|||
162138612|NCT01259102|585559860|FG001|Overall Study|Adverse Event|0|||
162138613|NCT01259102|585559861|FG002|Overall Study|Adverse Event|1|||
162138614|NCT01259102|585559862|FG003|Overall Study|Adverse Event|1|||
162138615|NCT01259102|585559863|FG004|Overall Study|Adverse Event|0|||
162138616|NCT01259102|585559859|FG000|Overall Study|Other|0|||
162138617|NCT01259102|585559860|FG001|Overall Study|Other|0|||
162138618|NCT01259102|585559861|FG002|Overall Study|Other|1|||
162138619|NCT01259102|585559862|FG003|Overall Study|Other|1|||
162138620|NCT01259102|585559863|FG004|Overall Study|Other|1|||
162138621|NCT00817635|585559864|FG000|Overall Study|Adverse Event|1|||
162138622|NCT00817635|585559865|FG001|Overall Study|Adverse Event|0|||
162138623|NCT00817635|585559866|FG002|Overall Study|Adverse Event|0|||
162138624|NCT00817635|585559867|FG003|Overall Study|Adverse Event|1|||
162138625|NCT00817635|585559868|FG004|Overall Study|Adverse Event|1|||
162138626|NCT00817635|585559864|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
162138627|NCT00817635|585559865|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
162138628|NCT00817635|585559866|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
162138629|NCT00817635|585559867|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
162138630|NCT00817635|585559868|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
162138631|NCT00817635|585559864|FG000|Overall Study|Withdrawal by Subject|2|||
162138632|NCT00817635|585559865|FG001|Overall Study|Withdrawal by Subject|1|||
162138633|NCT00817635|585559866|FG002|Overall Study|Withdrawal by Subject|0|||
162138634|NCT00817635|585559867|FG003|Overall Study|Withdrawal by Subject|1|||
162138635|NCT00817635|585559868|FG004|Overall Study|Withdrawal by Subject|2|||
162138636|NCT00817635|585559864|FG000|Overall Study|Lost to Follow-up|0|||
162138637|NCT00817635|585559865|FG001|Overall Study|Lost to Follow-up|1|||
162138638|NCT00817635|585559866|FG002|Overall Study|Lost to Follow-up|0|||
162138639|NCT00817635|585559867|FG003|Overall Study|Lost to Follow-up|1|||
162138640|NCT00817635|585559868|FG004|Overall Study|Lost to Follow-up|0|||
162138641|NCT00817635|585559864|FG000|Overall Study|Administrative Problems|0|||
162138642|NCT00817635|585559865|FG001|Overall Study|Administrative Problems|0|||
162138643|NCT00817635|585559866|FG002|Overall Study|Administrative Problems|0|||
162138644|NCT00817635|585559867|FG003|Overall Study|Administrative Problems|0|||
162138645|NCT00817635|585559868|FG004|Overall Study|Administrative Problems|1|||
162138646|NCT00817635|585559864|FG000|Overall Study|Protocol Violation|5|||
162138647|NCT00817635|585559865|FG001|Overall Study|Protocol Violation|1|||
162138648|NCT00817635|585559866|FG002|Overall Study|Protocol Violation|3|||
162138649|NCT00817635|585559867|FG003|Overall Study|Protocol Violation|2|||
162138650|NCT00817635|585559868|FG004|Overall Study|Protocol Violation|3|||
162138651|NCT00918957|585559870|FG000|Overall Study|Adverse Event|2|||
161801431|NCT00433147|584316486|FG003|Overall Study|Adverse Event|0|||
161801432|NCT01882647|584316487|FG000|Overall Study|Lost to Follow-up|2|||
161801433|NCT01882647|584316488|FG001|Overall Study|Lost to Follow-up|2|||
161801434|NCT01882647|584316487|FG000|Overall Study|Withdrawal by Subject|0|||
161801435|NCT01882647|584316488|FG001|Overall Study|Withdrawal by Subject|4|||
161801436|NCT01108094|584316490|FG000|Overall Study|Adverse Event|2|||
161801437|NCT01108094|584316491|FG001|Overall Study|Adverse Event|0|||
161801438|NCT01108094|584316492|FG002|Overall Study|Adverse Event|0|||
161801439|NCT01108094|584316493|FG003|Overall Study|Adverse Event|0|||
161801440|NCT01108094|584316490|FG000|Overall Study|Withdrawal by Subject|1|||
161801441|NCT01108094|584316491|FG001|Overall Study|Withdrawal by Subject|0|||
161801442|NCT01108094|584316492|FG002|Overall Study|Withdrawal by Subject|0|||
161801443|NCT01108094|584316493|FG003|Overall Study|Withdrawal by Subject|0|||
161801444|NCT05037097|584316496|FG000|Overall Study|Withdrawal by Subject|0|||
161801445|NCT05037097|584316497|FG001|Overall Study|Withdrawal by Subject|1|||
161801446|NCT05037097|584316498|FG002|Overall Study|Withdrawal by Subject|0|||
161801447|NCT05037097|584316499|FG003|Overall Study|Withdrawal by Subject|1|||
161801448|NCT05037097|584316500|FG004|Overall Study|Withdrawal by Subject|0|||
161801449|NCT05037097|584316501|FG005|Overall Study|Withdrawal by Subject|2|||
161801450|NCT05037097|584316502|FG006|Overall Study|Withdrawal by Subject|0|||
161801451|NCT05037097|584316503|FG007|Overall Study|Withdrawal by Subject|0|||
161801452|NCT05037097|584316496|FG000|Overall Study|Lost to Follow-up|0|||
162138652|NCT00918957|585559871|FG001|Overall Study|Adverse Event|0|||
161801453|NCT05037097|584316497|FG001|Overall Study|Lost to Follow-up|1|||
161801454|NCT05037097|584316498|FG002|Overall Study|Lost to Follow-up|0|||
161801455|NCT05037097|584316499|FG003|Overall Study|Lost to Follow-up|0|||
161801456|NCT05037097|584316500|FG004|Overall Study|Lost to Follow-up|1|||
162138653|NCT00918957|585559870|FG000|Overall Study|Withdrawal by Subject|1|||
162138654|NCT00918957|585559871|FG001|Overall Study|Withdrawal by Subject|0|||
162138655|NCT03107611|585559872|FG000|Overall Study|Adverse Event|1|||
162138656|NCT03107611|585559873|FG001|Overall Study|Adverse Event|0|||
162138657|NCT03107611|585559874|FG002|Overall Study|Adverse Event|2|||
161801457|NCT05037097|584316501|FG005|Overall Study|Lost to Follow-up|1|||
161801458|NCT05037097|584316502|FG006|Overall Study|Lost to Follow-up|0|||
161801459|NCT05037097|584316503|FG007|Overall Study|Lost to Follow-up|0|||
161801460|NCT02918877|584316506|FG000|Overall Study|Withdrawal by Subject|2|||
161801461|NCT02918877|584316507|FG001|Overall Study|Withdrawal by Subject|2|||
161801462|NCT02918877|584316506|FG000|Overall Study|Surgery cancelled|1|||
161801463|NCT02918877|584316507|FG001|Overall Study|Surgery cancelled|0|||
161801464|NCT02918877|584316506|FG000|Overall Study|Physician Decision|1|||
161801465|NCT02918877|584316507|FG001|Overall Study|Physician Decision|0|||
161801466|NCT02918877|584316506|FG000|Overall Study|Received intraoperative steroids|1|||
161801467|NCT02918877|584316507|FG001|Overall Study|Received intraoperative steroids|0|||
161801468|NCT02918877|584316506|FG000|Overall Study|Unable to obtain lab samples|1|||
161801469|NCT02918877|584316507|FG001|Overall Study|Unable to obtain lab samples|0|||
161801470|NCT02918877|584316506|FG000|Overall Study|Unsafe to perform BAL|0|||
161801471|NCT02918877|584316507|FG001|Overall Study|Unsafe to perform BAL|1|||
161801472|NCT04510857|584316508|FG000|Overall Study|Withdrawal by Subject|1|||
161801473|NCT04510857|584316509|FG001|Overall Study|Withdrawal by Subject|2|||
161801474|NCT05346055|584316510|FG000|Overall Study|Withdrawal by Subject|1|||
161801475|NCT05346055|584316510|FG000|Overall Study|Protocol Violation|1|||
161801476|NCT05346055|584316510|FG000|Overall Study|Therapist decision|1|||
161801477|NCT00376220|584316513|FG000|Overall Study|Lost to Follow-up|7|||
161801478|NCT00376220|584316514|FG001|Overall Study|Lost to Follow-up|10|||
161801479|NCT00376220|584316513|FG000|Overall Study|Withdrawal by Subject|3|||
161801480|NCT00376220|584316514|FG001|Overall Study|Withdrawal by Subject|2|||
161801481|NCT02564263|584316515|FG000|Overall Study|Adverse Event|31|||
161801482|NCT02564263|584316516|FG001|Overall Study|Adverse Event|29|||
161801483|NCT02564263|584316515|FG000|Overall Study|Death|270|||
161801484|NCT02564263|584316516|FG001|Overall Study|Death|262|||
161801485|NCT02564263|584316515|FG000|Overall Study|Withdrawal by Subject|4|||
161801486|NCT02564263|584316516|FG001|Overall Study|Withdrawal by Subject|19|||
161801487|NCT02564263|584316515|FG000|Overall Study|Sponsor's decision|9|||
161905079|NCT01435759|584701196|FG004|Antidepressant Lead-in Phase|Other|0|||
161905080|NCT01435759|584701197|FG005|Antidepressant Lead-in Phase|Other|0|||
161905081|NCT01435759|584701192|FG000|Double-blind Phase|Adverse Event|7|||
161905082|NCT01435759|584701193|FG001|Double-blind Phase|Adverse Event|0|||
161905083|NCT01435759|584701194|FG002|Double-blind Phase|Adverse Event|1|||
161905084|NCT01435759|584701195|FG003|Double-blind Phase|Adverse Event|1|||
161801488|NCT02564263|584316516|FG001|Overall Study|Sponsor's decision|4|||
161801489|NCT02906709|584316517|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
161801490|NCT02906709|584316518|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
161801491|NCT02906709|584316517|FG000|Phase A (Week 0 to Week 16)|Death|0|||
161905085|NCT01435759|584701196|FG004|Double-blind Phase|Adverse Event|1|||
161801492|NCT02906709|584316518|FG001|Phase A (Week 0 to Week 16)|Death|1|||
161905086|NCT01435759|584701197|FG005|Double-blind Phase|Adverse Event|3|||
161905087|NCT01435759|584701192|FG000|Double-blind Phase|Protocol Violation|2|||
161905088|NCT01435759|584701193|FG001|Double-blind Phase|Protocol Violation|0|||
161905089|NCT01435759|584701194|FG002|Double-blind Phase|Protocol Violation|1|||
161905090|NCT01435759|584701195|FG003|Double-blind Phase|Protocol Violation|2|||
161905091|NCT01435759|584701196|FG004|Double-blind Phase|Protocol Violation|0|||
161905092|NCT01435759|584701197|FG005|Double-blind Phase|Protocol Violation|1|||
161905093|NCT01435759|584701192|FG000|Double-blind Phase|Withdrawal by Subject|17|||
161905094|NCT01435759|584701193|FG001|Double-blind Phase|Withdrawal by Subject|4|||
161905095|NCT01435759|584701194|FG002|Double-blind Phase|Withdrawal by Subject|3|||
161905096|NCT01435759|584701195|FG003|Double-blind Phase|Withdrawal by Subject|4|||
161905097|NCT01435759|584701196|FG004|Double-blind Phase|Withdrawal by Subject|2|||
161905098|NCT01435759|584701197|FG005|Double-blind Phase|Withdrawal by Subject|2|||
161905099|NCT01435759|584701192|FG000|Double-blind Phase|Lost to Follow-up|31|||
161905100|NCT01435759|584701193|FG001|Double-blind Phase|Lost to Follow-up|1|||
161905101|NCT01435759|584701194|FG002|Double-blind Phase|Lost to Follow-up|2|||
161905102|NCT01435759|584701195|FG003|Double-blind Phase|Lost to Follow-up|0|||
161905103|NCT01435759|584701196|FG004|Double-blind Phase|Lost to Follow-up|3|||
162138658|NCT03107611|585559872|FG000|Overall Study|Lost to Follow-up|3|||
162138659|NCT03107611|585559873|FG001|Overall Study|Lost to Follow-up|3|||
162138660|NCT03107611|585559874|FG002|Overall Study|Lost to Follow-up|3|||
162138661|NCT03107611|585559872|FG000|Overall Study|Protocol Violation|0|||
162138662|NCT03107611|585559873|FG001|Overall Study|Protocol Violation|0|||
162138663|NCT03107611|585559874|FG002|Overall Study|Protocol Violation|1|||
162138664|NCT03107611|585559872|FG000|Overall Study|Withdrawal by Subject|1|||
162138665|NCT03107611|585559873|FG001|Overall Study|Withdrawal by Subject|0|||
162138666|NCT03107611|585559874|FG002|Overall Study|Withdrawal by Subject|1|||
162138667|NCT03107611|585559872|FG000|Overall Study|Worsening signs/symptoms|2|||
162138668|NCT03107611|585559873|FG001|Overall Study|Worsening signs/symptoms|1|||
162138669|NCT03107611|585559874|FG002|Overall Study|Worsening signs/symptoms|2|||
162138670|NCT01720446|585559875|FG000|Overall Study|Lost to Follow-up|12|||
162138671|NCT01720446|585559876|FG001|Overall Study|Lost to Follow-up|6|||
162138672|NCT01720446|585559877|FG002|Overall Study|Lost to Follow-up|16|||
162138673|NCT01720446|585559878|FG003|Overall Study|Lost to Follow-up|16|||
162138674|NCT01720446|585559875|FG000|Overall Study|Withdrawal by Subject|2|||
162138675|NCT01720446|585559876|FG001|Overall Study|Withdrawal by Subject|5|||
162138676|NCT01720446|585559877|FG002|Overall Study|Withdrawal by Subject|4|||
162138677|NCT01720446|585559878|FG003|Overall Study|Withdrawal by Subject|4|||
162138678|NCT01020838|585559881|FG000|Overall Study|Death|90|||
162138679|NCT01020838|585559881|FG000|Overall Study|Adverse Event|1|||
162138680|NCT01020838|585559881|FG000|Overall Study|Withdrawal by Subject|9|||
162138681|NCT01020838|585559881|FG000|Overall Study|Lost to Follow-up|6|||
162138682|NCT01020838|585559881|FG000|Overall Study|Most common: Study ended by sponsor|77|||
162138683|NCT00891618|585559882|FG000|Overall Study|Withdrawal by Subject|1|||
162138684|NCT02145182|585559883|FG000|Overall Study|Adverse Event|4|||
162138685|NCT02145182|585559884|FG001|Overall Study|Adverse Event|1|||
162138686|NCT02145182|585559883|FG000|Overall Study|Death|7|||
162138687|NCT02145182|585559884|FG001|Overall Study|Death|7|||
162138688|NCT02145182|585559883|FG000|Overall Study|Lost to Follow-up|2|||
162138689|NCT02145182|585559884|FG001|Overall Study|Lost to Follow-up|2|||
162138690|NCT02145182|585559883|FG000|Overall Study|Pre-transplant Withdrawal|0|||
162138691|NCT02145182|585559884|FG001|Overall Study|Pre-transplant Withdrawal|2|||
162138692|NCT02145182|585559883|FG000|Overall Study|Withdrawal by Subject|5|||
162138693|NCT02145182|585559884|FG001|Overall Study|Withdrawal by Subject|4|||
162138694|NCT03999554|585559886|FG000|Overall Study|Lost to Follow-up|4|||
162138695|NCT03999554|585559887|FG001|Overall Study|Lost to Follow-up|5|||
162138696|NCT03999554|585559888|FG002|Overall Study|Lost to Follow-up|4|||
162138697|NCT03999554|585559889|FG003|Overall Study|Lost to Follow-up|5|||
162138698|NCT03999554|585559890|FG004|Overall Study|Lost to Follow-up|8|||
162138699|NCT03999554|585559886|FG000|Overall Study|Protocol Violation|0|||
162138700|NCT03999554|585559887|FG001|Overall Study|Protocol Violation|0|||
162138701|NCT03999554|585559888|FG002|Overall Study|Protocol Violation|5|||
162138702|NCT03999554|585559889|FG003|Overall Study|Protocol Violation|0|||
162138703|NCT03999554|585559890|FG004|Overall Study|Protocol Violation|0|||
162138704|NCT03999554|585559886|FG000|Overall Study|Pregnancy|0|||
162138705|NCT03999554|585559887|FG001|Overall Study|Pregnancy|0|||
162138706|NCT03999554|585559888|FG002|Overall Study|Pregnancy|1|||
162138707|NCT03999554|585559889|FG003|Overall Study|Pregnancy|0|||
162138708|NCT03999554|585559890|FG004|Overall Study|Pregnancy|0|||
162138709|NCT03999554|585559886|FG000|Overall Study|Withdrawal by Subject|2|||
162138710|NCT03999554|585559887|FG001|Overall Study|Withdrawal by Subject|2|||
162138711|NCT03999554|585559888|FG002|Overall Study|Withdrawal by Subject|2|||
162138712|NCT03999554|585559889|FG003|Overall Study|Withdrawal by Subject|1|||
162138713|NCT03999554|585559890|FG004|Overall Study|Withdrawal by Subject|1|||
162138714|NCT03999554|585559886|FG000|Overall Study|failure to comply with protocol requirements|0|||
162138715|NCT03999554|585559887|FG001|Overall Study|failure to comply with protocol requirements|0|||
162138716|NCT03999554|585559888|FG002|Overall Study|failure to comply with protocol requirements|0|||
162138717|NCT03999554|585559889|FG003|Overall Study|failure to comply with protocol requirements|1|||
162138718|NCT03999554|585559890|FG004|Overall Study|failure to comply with protocol requirements|0|||
162138719|NCT01101165|585559891|FG000|Period 1|Adverse Event|1|||
162138720|NCT01101165|585559892|FG001|Period 1|Adverse Event|2|||
162138721|NCT01101165|585559891|FG000|Period 1|Withdrawal by Subject|0|||
161905104|NCT01435759|584701197|FG005|Double-blind Phase|Lost to Follow-up|3|||
162138722|NCT01101165|585559892|FG001|Period 1|Withdrawal by Subject|2|||
162138723|NCT01101165|585559891|FG000|Period 1|Positive Drug Screen|0|||
162138724|NCT01101165|585559892|FG001|Period 1|Positive Drug Screen|1|||
162138725|NCT01101165|585559891|FG000|Period 1|Lost to Follow-up|1|||
162138726|NCT01101165|585559892|FG001|Period 1|Lost to Follow-up|0|||
162138727|NCT01101165|585559891|FG000|Period 2|Withdrawal by Subject|3|||
162138728|NCT01101165|585559892|FG001|Period 2|Withdrawal by Subject|1|||
162138729|NCT01101165|585559891|FG000|Period 2|Adverse Event|1|||
162138730|NCT01101165|585559892|FG001|Period 2|Adverse Event|0|||
162138731|NCT00619151|585559894|FG000|Overall Study|Study terminated prior to followup|1|||
162138732|NCT00619151|585559895|FG001|Overall Study|Study terminated prior to followup|0|||
162138733|NCT03124108|585559899|FG000|Overall Study|Adverse Event|0|||
162138734|NCT03124108|585559900|FG001|Overall Study|Adverse Event|1|||
161801493|NCT02906709|584316517|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
161801494|NCT02906709|584316518|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
161801495|NCT02906709|584316517|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
161801496|NCT02906709|584316518|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
161801497|NCT01124149|584316519|FG000|Acute Phase|Withdrawal by Subject|22|||
161905105|NCT01435759|584701192|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
161905106|NCT01435759|584701193|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905107|NCT01435759|584701194|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905108|NCT01435759|584701195|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905109|NCT01435759|584701196|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
161905110|NCT01435759|584701197|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
161905111|NCT01435759|584701192|FG000|Double-blind Phase|Other|8|||
161905112|NCT01435759|584701193|FG001|Double-blind Phase|Other|2|||
161905113|NCT01435759|584701194|FG002|Double-blind Phase|Other|0|||
161905114|NCT01435759|584701195|FG003|Double-blind Phase|Other|2|||
161905115|NCT01435759|584701196|FG004|Double-blind Phase|Other|0|||
161905116|NCT01435759|584701197|FG005|Double-blind Phase|Other|0|||
161905117|NCT01710020|584701198|FG000|Period 1|Protocol Violation|1|||
161905118|NCT00427908|584701199|FG000|Primary Phase|Lost to Follow-up|4|||
161905119|NCT00427908|584701200|FG001|Primary Phase|Lost to Follow-up|0|||
161905120|NCT00427908|584701201|FG002|Primary Phase|Lost to Follow-up|2|||
161905121|NCT00427908|584701202|FG003|Primary Phase|Lost to Follow-up|0|||
161905122|NCT00427908|584701199|FG000|Primary Phase|Withdrawal by Subject|1|||
161905123|NCT00427908|584701200|FG001|Primary Phase|Withdrawal by Subject|2|||
161905124|NCT00427908|584701201|FG002|Primary Phase|Withdrawal by Subject|1|||
161905125|NCT00427908|584701202|FG003|Primary Phase|Withdrawal by Subject|0|||
161905126|NCT00427908|584701199|FG000|Primary Phase|Adverse Event|0|||
161905127|NCT00427908|584701200|FG001|Primary Phase|Adverse Event|1|||
161905128|NCT00427908|584701201|FG002|Primary Phase|Adverse Event|0|||
161905129|NCT00427908|584701202|FG003|Primary Phase|Adverse Event|0|||
161905130|NCT01764841|584701203|FG000|Overall Study|Logistical Difficulties|0|||
161905131|NCT01764841|584701204|FG001|Overall Study|Logistical Difficulties|1|||
161905132|NCT01764841|584701205|FG002|Overall Study|Logistical Difficulties|0|||
161905133|NCT01764841|584701206|FG003|Overall Study|Logistical Difficulties|0|||
161905134|NCT01764841|584701203|FG000|Overall Study|Death|3|||
162138735|NCT03124108|585559901|FG002|Overall Study|Adverse Event|0|||
162138736|NCT03586167|585559910|FG000|Overall Study|Other|1|||
162138737|NCT03586167|585559911|FG001|Overall Study|Other|0|||
162138738|NCT05487703|585559915|FG000|Overall Study|Other|19|||
162138739|NCT05487703|585559915|FG000|Overall Study|Participant not well|5|||
162138740|NCT05487703|585559915|FG000|Overall Study|Insurance Reasons|6|||
162138741|NCT05487703|585559915|FG000|Overall Study|Physician Decision|19|||
162138742|NCT05487703|585559915|FG000|Overall Study|Lack of Efficacy|60|||
162138743|NCT02403323|585559916|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
162138744|NCT02403323|585559917|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
162138745|NCT02403323|585559918|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
162138746|NCT02403323|585559916|FG000|Part 1: Open Label Extension Period|Death|3|||
162138747|NCT02403323|585559917|FG001|Part 1: Open Label Extension Period|Death|0|||
162138748|NCT02403323|585559918|FG002|Part 1: Open Label Extension Period|Death|0|||
162138749|NCT02403323|585559916|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
162138750|NCT02403323|585559917|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
162138751|NCT02403323|585559918|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
162138752|NCT02403323|585559916|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
162138753|NCT02403323|585559917|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
162138754|NCT02403323|585559918|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
162138755|NCT02403323|585559916|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
162138756|NCT02403323|585559917|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
162138757|NCT02403323|585559918|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
162138758|NCT02403323|585559916|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
162138759|NCT02403323|585559917|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
162138760|NCT02403323|585559918|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
162138761|NCT02403323|585559916|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
162138762|NCT02403323|585559917|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
162138763|NCT02403323|585559918|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
162138764|NCT02403323|585559916|FG000|Part 1: Open Label Extension Period|Other|1|||
162138765|NCT02403323|585559917|FG001|Part 1: Open Label Extension Period|Other|0|||
162138766|NCT02403323|585559918|FG002|Part 1: Open Label Extension Period|Other|0|||
162138767|NCT02403323|585559916|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
162138768|NCT02403323|585559917|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
162138769|NCT02403323|585559918|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
162138770|NCT02403323|585559916|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
162138771|NCT02403323|585559917|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
162138772|NCT02403323|585559918|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
161905135|NCT01764841|584701204|FG001|Overall Study|Death|0|||
161905136|NCT01764841|584701205|FG002|Overall Study|Death|1|||
161905137|NCT01764841|584701206|FG003|Overall Study|Death|4|||
161905138|NCT01764841|584701203|FG000|Overall Study|No Follow Up|1|||
161801498|NCT01124149|584316519|FG000|Acute Phase|Adverse Event|21|||
161801499|NCT01124149|584316519|FG000|Acute Phase|Lack of Efficacy|17|||
161801500|NCT01124149|584316519|FG000|Acute Phase|Protocol Violation|14|||
161801501|NCT01124149|584316519|FG000|Acute Phase|Lost to Follow-up|2|||
161801502|NCT01124149|584316519|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
161801503|NCT01124149|584316519|FG000|Acute Phase|Sponsor request|1|||
161801504|NCT01124149|584316519|FG000|Acute Phase|UC symptoms not ameliorated|1|||
161801505|NCT01124149|584316519|FG000|Acute Phase|Non-compliance|1|||
161801506|NCT01124149|584316519|FG000|Acute Phase|Low hemoglobin|1|||
161801507|NCT01124149|584316519|FG000|Acute Phase|Travelling to another country|1|||
161801508|NCT01124149|584316519|FG000|Acute Phase|Sponsor decision|1|||
161801509|NCT01124149|584316519|FG000|Maintenance Phase|Lack of Efficacy|40|||
161801510|NCT01124149|584316519|FG000|Maintenance Phase|Adverse Event|24|||
161801511|NCT01124149|584316519|FG000|Maintenance Phase|Lost to Follow-up|15|||
161801512|NCT01124149|584316519|FG000|Maintenance Phase|Withdrawal by Subject|10|||
161801513|NCT01124149|584316519|FG000|Maintenance Phase|Protocol Violation|5|||
161801514|NCT01124149|584316519|FG000|Maintenance Phase|Coordinator error|1|||
161801515|NCT01124149|584316519|FG000|Maintenance Phase|Non-compliance|1|||
161801516|NCT00977106|584316520|FG000|Overall Study|Adverse Event|5|||
161801517|NCT00977106|584316521|FG001|Overall Study|Adverse Event|6|||
161801518|NCT00977106|584316520|FG000|Overall Study|Withdrawal by Subject|2|||
161801519|NCT00977106|584316521|FG001|Overall Study|Withdrawal by Subject|2|||
161801520|NCT00977106|584316520|FG000|Overall Study|Lack of Efficacy|2|||
161801521|NCT00977106|584316521|FG001|Overall Study|Lack of Efficacy|2|||
161801522|NCT00977106|584316520|FG000|Overall Study|Protocol Violation|0|||
161801523|NCT00977106|584316521|FG001|Overall Study|Protocol Violation|1|||
161801524|NCT00977106|584316520|FG000|Overall Study|Other|1|||
161801525|NCT00977106|584316521|FG001|Overall Study|Other|0|||
161801526|NCT01644500|584316522|FG000|Overall Study|Adverse Event|6|||
161801527|NCT01644500|584316523|FG001|Overall Study|Adverse Event|1|||
161801528|NCT01644500|584316524|FG002|Overall Study|Adverse Event|2|||
161801529|NCT01644500|584316522|FG000|Overall Study|Death|0|||
161801530|NCT01644500|584316523|FG001|Overall Study|Death|1|||
161801531|NCT01644500|584316524|FG002|Overall Study|Death|0|||
161801532|NCT01644500|584316522|FG000|Overall Study|Lost to Follow-up|3|||
161801533|NCT01644500|584316523|FG001|Overall Study|Lost to Follow-up|8|||
161801534|NCT01644500|584316524|FG002|Overall Study|Lost to Follow-up|0|||
161801535|NCT01644500|584316522|FG000|Overall Study|Protocol Violation|1|||
161801536|NCT01644500|584316523|FG001|Overall Study|Protocol Violation|1|||
161801537|NCT01644500|584316524|FG002|Overall Study|Protocol Violation|0|||
161801538|NCT01644500|584316522|FG000|Overall Study|Withdrawal by Subject|11|||
161801539|NCT01644500|584316523|FG001|Overall Study|Withdrawal by Subject|12|||
161801540|NCT01644500|584316524|FG002|Overall Study|Withdrawal by Subject|12|||
161801541|NCT01644500|584316522|FG000|Overall Study|Physician Decision|1|||
161801542|NCT01644500|584316523|FG001|Overall Study|Physician Decision|1|||
161801543|NCT01644500|584316524|FG002|Overall Study|Physician Decision|1|||
161801544|NCT02419313|584316525|FG000|First Intervention|Lost to Follow-up|2|||
161801545|NCT02419313|584316526|FG001|First Intervention|Lost to Follow-up|0|||
161801546|NCT02419313|584316525|FG000|Second Intervention|Lost to Follow-up|1|||
161801547|NCT02419313|584316526|FG001|Second Intervention|Lost to Follow-up|0|||
161801548|NCT00322491|584316533|FG000|Overall Study|Adverse Event|1|||
161801549|NCT00322491|584316534|FG001|Overall Study|Adverse Event|0|||
161801550|NCT00322491|584316533|FG000|Overall Study|Death|1|||
161801551|NCT00322491|584316534|FG001|Overall Study|Death|2|||
161905139|NCT01764841|584701204|FG001|Overall Study|No Follow Up|0|||
162138773|NCT02403323|585559916|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
162138774|NCT02403323|585559917|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
162138775|NCT02403323|585559918|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
162138776|NCT02403323|585559916|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
162138777|NCT02403323|585559917|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
162138778|NCT02403323|585559918|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
162138779|NCT02403323|585559916|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
162138780|NCT02403323|585559917|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
161801552|NCT00688064|584316535|FG000|Overall Study|Protocol Violation|0|||
161801553|NCT00688064|584316536|FG001|Overall Study|Protocol Violation|1|||
161801554|NCT00688064|584316535|FG000|Overall Study|Adverse Event|2|||
161801555|NCT00688064|584316536|FG001|Overall Study|Adverse Event|4|||
161801556|NCT00688064|584316535|FG000|Overall Study|Withdrawal by Subject|7|||
161801557|NCT00688064|584316536|FG001|Overall Study|Withdrawal by Subject|7|||
161801558|NCT00688064|584316535|FG000|Overall Study|Lost to Follow-up|10|||
161801559|NCT00688064|584316536|FG001|Overall Study|Lost to Follow-up|10|||
161801560|NCT00688064|584316535|FG000|Overall Study|Lack of Efficacy|0|||
161801561|NCT00688064|584316536|FG001|Overall Study|Lack of Efficacy|1|||
161801562|NCT00688064|584316535|FG000|Overall Study|Pregnancy|1|||
161801563|NCT00688064|584316536|FG001|Overall Study|Pregnancy|0|||
161801564|NCT00688064|584316535|FG000|Overall Study|Any other reasons|1|||
161801565|NCT00688064|584316536|FG001|Overall Study|Any other reasons|3|||
161801566|NCT00524459|584316542|FG000|Overall Study|Withdrawal by Subject|1|||
161801567|NCT00524459|584316542|FG000|Overall Study|Other|1|||
161801568|NCT00728949|584316543|FG000|Overall Study|Adverse Event|8|||
161801569|NCT00728949|584316544|FG001|Overall Study|Adverse Event|0|||
161801570|NCT00728949|584316543|FG000|Overall Study|Withdrawal by Subject|2|||
161801571|NCT00728949|584316544|FG001|Overall Study|Withdrawal by Subject|2|||
162138781|NCT02403323|585559918|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
162138782|NCT02403323|585559916|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
162138783|NCT02403323|585559917|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
162138784|NCT02403323|585559918|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
162138785|NCT02403323|585559916|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
162138786|NCT02403323|585559917|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
162138787|NCT02403323|585559918|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
162138788|NCT02403323|585559916|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
162138789|NCT02403323|585559917|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
162138790|NCT02403323|585559918|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
162138791|NCT02403323|585559916|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
162138792|NCT02403323|585559917|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
162138793|NCT02403323|585559918|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
162138794|NCT02403323|585559916|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
162138795|NCT02403323|585559917|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
162138796|NCT02403323|585559918|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
162138797|NCT03885596|585559926|FG000|Overall Study|Withdrawal by Subject|2|||
162138798|NCT03885596|585559927|FG001|Overall Study|Withdrawal by Subject|1|||
162138799|NCT03885596|585559928|FG002|Overall Study|Withdrawal by Subject|0|||
162138800|NCT03885596|585559929|FG003|Overall Study|Withdrawal by Subject|0|||
162138801|NCT00746330|585559930|FG000|Period 1|Abnormal test procedure result|0|||
161801572|NCT00728949|584316543|FG000|Overall Study|Abnormal Lab Results|0|||
161801573|NCT00728949|584316544|FG001|Overall Study|Abnormal Lab Results|2|||
161801574|NCT00728949|584316543|FG000|Overall Study|On treatment at cutoff date|1|||
161801575|NCT00728949|584316544|FG001|Overall Study|On treatment at cutoff date|0|||
161801576|NCT02319148|584316549|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
161801577|NCT02319148|584316550|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
161801578|NCT02319148|584316551|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
161801579|NCT02319148|584316552|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
161801580|NCT02319148|584316549|FG000|Second Intervention Period|No longer willing to participate|0|||
161801581|NCT02319148|584316550|FG001|Second Intervention Period|No longer willing to participate|1|||
161801582|NCT02319148|584316551|FG002|Second Intervention Period|No longer willing to participate|0|||
161801583|NCT02319148|584316552|FG003|Second Intervention Period|No longer willing to participate|0|||
161801584|NCT02319148|584316549|FG000|Second Intervention Period|Other|0|||
161801585|NCT02319148|584316550|FG001|Second Intervention Period|Other|0|||
161801586|NCT02319148|584316551|FG002|Second Intervention Period|Other|0|||
161801587|NCT02319148|584316552|FG003|Second Intervention Period|Other|1|||
161801588|NCT01574248|584316553|FG000|Overall Study|Withdrawal by Subject|2|||
161801589|NCT01574248|584316554|FG001|Overall Study|Withdrawal by Subject|0|||
161801590|NCT01574248|584316553|FG000|Overall Study|Missing primary endpoint data|1|||
161801591|NCT01574248|584316554|FG001|Overall Study|Missing primary endpoint data|0|||
161801592|NCT00048048|584316557|FG000|Core Treatment|Withdrawal by Subject|0|||
161801593|NCT00048048|584316558|FG001|Core Treatment|Withdrawal by Subject|0|||
161801594|NCT00048048|584316559|FG002|Core Treatment|Withdrawal by Subject|1|||
162138802|NCT00746330|585559931|FG001|Period 1|Abnormal test procedure result|0|||
162138803|NCT00746330|585559932|FG002|Period 1|Abnormal test procedure result|1|||
162138804|NCT00746330|585559933|FG003|Period 1|Abnormal test procedure result|0|||
162138805|NCT01076335|585559934|FG000|Overall Study|Withdrawal by Subject|3|||
162138806|NCT01076335|585559934|FG000|Overall Study|Withdrawal without treatment|1|||
162138807|NCT00517933|585559936|FG000|Period 1|Death|2|||
162138808|NCT00517933|585559937|FG001|Period 1|Death|1|||
162138809|NCT00517933|585559936|FG000|Period 1|Adverse Event|4|||
162138810|NCT00517933|585559937|FG001|Period 1|Adverse Event|4|||
162138811|NCT00517933|585559936|FG000|Period 1|Lost to Follow-up|2|||
162138812|NCT00517933|585559937|FG001|Period 1|Lost to Follow-up|0|||
162138813|NCT00517933|585559936|FG000|Period 1|Underwent lung transplant|0|||
162138814|NCT00517933|585559937|FG001|Period 1|Underwent lung transplant|1|||
162138815|NCT00517933|585559936|FG000|Period 2|Death|2|||
162138816|NCT00517933|585559937|FG001|Period 2|Death|4|||
162138817|NCT00517933|585559936|FG000|Period 2|Adverse Event|2|||
162138818|NCT00517933|585559937|FG001|Period 2|Adverse Event|4|||
162138819|NCT00517933|585559936|FG000|Period 2|Physician Decision|1|||
162138820|NCT00517933|585559937|FG001|Period 2|Physician Decision|0|||
162138821|NCT00517933|585559936|FG000|Period 2|Withdrawal by Subject|1|||
162138822|NCT00517933|585559937|FG001|Period 2|Withdrawal by Subject|3|||
162138823|NCT00517933|585559936|FG000|Period 2|Underwent lung transplant|0|||
162138824|NCT00517933|585559937|FG001|Period 2|Underwent lung transplant|2|||
162138825|NCT00235495|585559945|FG000|Overall Study|Death|52|||
162138826|NCT00235495|585559946|FG001|Overall Study|Death|42|||
162138827|NCT00235495|585559945|FG000|Overall Study|Withdrawal by Subject|5|||
162138828|NCT00235495|585559946|FG001|Overall Study|Withdrawal by Subject|3|||
161905140|NCT01764841|584701205|FG002|Overall Study|No Follow Up|1|||
161905141|NCT01764841|584701206|FG003|Overall Study|No Follow Up|0|||
161905142|NCT01764841|584701203|FG000|Overall Study|Protocol Violation|0|||
161905143|NCT01764841|584701204|FG001|Overall Study|Protocol Violation|1|||
161905144|NCT01764841|584701205|FG002|Overall Study|Protocol Violation|0|||
161905145|NCT01764841|584701206|FG003|Overall Study|Protocol Violation|0|||
161905146|NCT01764841|584701203|FG000|Overall Study|Withdrawal by Subject|16|||
161905147|NCT01764841|584701204|FG001|Overall Study|Withdrawal by Subject|24|||
161905148|NCT01764841|584701205|FG002|Overall Study|Withdrawal by Subject|11|||
161905149|NCT01764841|584701206|FG003|Overall Study|Withdrawal by Subject|15|||
161905150|NCT01764841|584701203|FG000|Overall Study|Lost to Follow-up|3|||
161905151|NCT01764841|584701204|FG001|Overall Study|Lost to Follow-up|0|||
161905152|NCT01764841|584701205|FG002|Overall Study|Lost to Follow-up|1|||
161905153|NCT01764841|584701206|FG003|Overall Study|Lost to Follow-up|0|||
161905154|NCT02115607|584701207|FG000|Overall Study|Withdrawal by Subject|1|||
161905155|NCT04863872|584701210|FG000|Overall Study|Withdrawal by Subject|4|||
161905156|NCT04863872|584701211|FG001|Overall Study|Withdrawal by Subject|15|||
161905157|NCT04863872|584701210|FG000|Overall Study|Death|5|||
161905158|NCT04863872|584701211|FG001|Overall Study|Death|2|||
161905159|NCT04863872|584701210|FG000|Overall Study|Lost to Follow-up|2|||
161905160|NCT04863872|584701211|FG001|Overall Study|Lost to Follow-up|1|||
161905161|NCT00549549|584701212|FG000|Overall Study|Adverse Event|5|||
161905162|NCT00549549|584701213|FG001|Overall Study|Adverse Event|3|||
161905163|NCT00549549|584701214|FG002|Overall Study|Adverse Event|1|||
161905164|NCT00549549|584701215|FG003|Overall Study|Adverse Event|9|||
161905165|NCT00549549|584701212|FG000|Overall Study|Lack of Efficacy|9|||
161905166|NCT00549549|584701213|FG001|Overall Study|Lack of Efficacy|6|||
161905167|NCT00549549|584701214|FG002|Overall Study|Lack of Efficacy|4|||
161905168|NCT00549549|584701215|FG003|Overall Study|Lack of Efficacy|2|||
161801595|NCT00048048|584316560|FG003|Core Treatment|Withdrawal by Subject|0|||
161801596|NCT00048048|584316561|FG004|Core Treatment|Withdrawal by Subject|0|||
161801597|NCT00048048|584316562|FG005|Core Treatment|Withdrawal by Subject|0|||
161801598|NCT00048048|584316563|FG006|Core Treatment|Withdrawal by Subject|0|||
161801599|NCT00048048|584316564|FG007|Core Treatment|Withdrawal by Subject|0|||
162138829|NCT00235495|585559945|FG000|Overall Study|Lost to Follow-up|11|||
162138830|NCT00235495|585559946|FG001|Overall Study|Lost to Follow-up|13|||
162138831|NCT00235495|585559945|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
162138832|NCT00235495|585559946|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
162138833|NCT01268566|585559951|FG000|Overall Study|Lost to Follow-up|1|||
162138834|NCT01268566|585559951|FG000|Overall Study|Withdrawal by Subject|12|||
162138835|NCT01268566|585559951|FG000|Overall Study|Death|30|||
162138836|NCT02784704|585559958|FG000|Overall Study|Adverse Event|4|||
162138837|NCT02784704|585559959|FG001|Overall Study|Adverse Event|2|||
162138838|NCT02784704|585559958|FG000|Overall Study|Lost to Follow-up|6|||
162138839|NCT02784704|585559959|FG001|Overall Study|Lost to Follow-up|4|||
162138840|NCT02784704|585559958|FG000|Overall Study|Withdrawal by Subject|1|||
162138841|NCT02784704|585559959|FG001|Overall Study|Withdrawal by Subject|3|||
162138842|NCT02784704|585559958|FG000|Overall Study|Subject Non Compliance|2|||
162138843|NCT02784704|585559959|FG001|Overall Study|Subject Non Compliance|0|||
162138844|NCT00603538|585559960|FG000|Overall Study|Adverse Event|0|||
162138845|NCT00603538|585559961|FG001|Overall Study|Adverse Event|4|||
162138846|NCT00603538|585559962|FG002|Overall Study|Adverse Event|2|||
162138847|NCT00603538|585559960|FG000|Overall Study|Objective progression or relapse|3|||
162138848|NCT00603538|585559961|FG001|Overall Study|Objective progression or relapse|0|||
162138849|NCT00603538|585559962|FG002|Overall Study|Objective progression or relapse|0|||
162138850|NCT04794179|585559964|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
162138851|NCT04794179|585559965|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
162138852|NCT03781804|585559977|FG000|Overall Study|Adverse Event|2|||
162138853|NCT03781804|585559978|FG001|Overall Study|Adverse Event|2|||
162138854|NCT03781804|585559979|FG002|Overall Study|Adverse Event|3|||
162138855|NCT03781804|585559977|FG000|Overall Study|Lost to Follow-up|1|||
162138856|NCT03781804|585559978|FG001|Overall Study|Lost to Follow-up|1|||
162138857|NCT03781804|585559979|FG002|Overall Study|Lost to Follow-up|2|||
162138858|NCT03781804|585559977|FG000|Overall Study|Lack of Efficacy|4|||
162138859|NCT03781804|585559978|FG001|Overall Study|Lack of Efficacy|2|||
162138860|NCT03781804|585559979|FG002|Overall Study|Lack of Efficacy|9|||
162138861|NCT03781804|585559977|FG000|Overall Study|Protocol Violation|0|||
162138862|NCT03781804|585559978|FG001|Overall Study|Protocol Violation|0|||
162138863|NCT03781804|585559979|FG002|Overall Study|Protocol Violation|1|||
162138864|NCT03781804|585559977|FG000|Overall Study|Withdrawal by Subject|0|||
162138865|NCT03781804|585559978|FG001|Overall Study|Withdrawal by Subject|1|||
162138866|NCT03781804|585559979|FG002|Overall Study|Withdrawal by Subject|1|||
162138867|NCT03781804|585559977|FG000|Overall Study|Reason not provided|2|||
162138868|NCT03781804|585559978|FG001|Overall Study|Reason not provided|2|||
162138869|NCT03781804|585559979|FG002|Overall Study|Reason not provided|0|||
162138870|NCT03717194|585559980|FG000|Overall Study|Withdrawal by Subject|2|||
162138871|NCT03717194|585559981|FG001|Overall Study|Withdrawal by Subject|4|||
162138872|NCT03717194|585559980|FG000|Overall Study|Adverse Event|1|||
162138873|NCT03717194|585559981|FG001|Overall Study|Adverse Event|1|||
162138874|NCT04678830|585559982|FG000|Overall Study|Lack of Efficacy|2|||
162138875|NCT04678830|585559983|FG001|Overall Study|Lack of Efficacy|0|||
162138876|NCT04678830|585559982|FG000|Overall Study|Withdrawal by Subject|0|||
162138877|NCT04678830|585559983|FG001|Overall Study|Withdrawal by Subject|1|||
162138878|NCT01836458|585559986|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
162138879|NCT01836458|585559987|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162138880|NCT01836458|585559988|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
162138881|NCT01836458|585559989|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
162138882|NCT00429793|585559990|FG000|Overall Study|Improper pre-protocol treatment|3|||
162138883|NCT00429793|585559990|FG000|Overall Study|Required test not done|1|||
162138884|NCT00429793|585559990|FG000|Overall Study|Never treated|1|||
162138885|NCT00429793|585559990|FG000|Overall Study|Non-measurable|1|||
162138886|NCT00813488|585559991|FG000|Titration Period 1|Adverse Event|6|||
162138887|NCT00813488|585559992|FG001|Titration Period 1|Adverse Event|1|||
161801600|NCT00048048|584316565|FG008|Core Treatment|Withdrawal by Subject|0|||
161801601|NCT00048048|584316566|FG009|Core Treatment|Withdrawal by Subject|0|||
162138888|NCT00813488|585559991|FG000|Titration Period 1|Lack of Efficacy|9|||
162138889|NCT00813488|585559992|FG001|Titration Period 1|Lack of Efficacy|7|||
162138890|NCT00813488|585559991|FG000|Titration Period 1|Withdrawal by Subject|2|||
162138891|NCT00813488|585559992|FG001|Titration Period 1|Withdrawal by Subject|2|||
162138892|NCT00813488|585559991|FG000|Titration Period 1|Protocol Violation|4|||
162138893|NCT00813488|585559992|FG001|Titration Period 1|Protocol Violation|3|||
162138894|NCT00813488|585559991|FG000|Titration Period 1|Non-compliance to study medication|4|||
162138895|NCT00813488|585559992|FG001|Titration Period 1|Non-compliance to study medication|1|||
162138896|NCT00813488|585559991|FG000|Titration Period 1|Non-compliance to study procedures|2|||
162138897|NCT00813488|585559992|FG001|Titration Period 1|Non-compliance to study procedures|2|||
161801602|NCT00048048|584316567|FG010|Core Treatment|Withdrawal by Subject|0|||
161801603|NCT00048048|584316568|FG011|Core Treatment|Withdrawal by Subject|0|||
161801604|NCT00048048|584316557|FG000|Core Treatment|Adverse Event|0|||
161801605|NCT00048048|584316558|FG001|Core Treatment|Adverse Event|0|||
161801606|NCT00048048|584316559|FG002|Core Treatment|Adverse Event|0|||
161801607|NCT00048048|584316560|FG003|Core Treatment|Adverse Event|0|||
161801608|NCT00048048|584316561|FG004|Core Treatment|Adverse Event|0|||
161801609|NCT00048048|584316562|FG005|Core Treatment|Adverse Event|0|||
161801610|NCT00048048|584316563|FG006|Core Treatment|Adverse Event|0|||
161801611|NCT00048048|584316564|FG007|Core Treatment|Adverse Event|1|||
161801612|NCT00048048|584316565|FG008|Core Treatment|Adverse Event|0|||
161801613|NCT00048048|584316566|FG009|Core Treatment|Adverse Event|0|||
161801614|NCT00048048|584316567|FG010|Core Treatment|Adverse Event|0|||
161801615|NCT00048048|584316568|FG011|Core Treatment|Adverse Event|0|||
161801616|NCT00048048|584316557|FG000|Extension Year 1|Early withdrawals|0|||
161801617|NCT00048048|584316558|FG001|Extension Year 1|Early withdrawals|0|||
161801618|NCT00048048|584316559|FG002|Extension Year 1|Early withdrawals|0|||
161801619|NCT00048048|584316560|FG003|Extension Year 1|Early withdrawals|0|||
161801620|NCT00048048|584316561|FG004|Extension Year 1|Early withdrawals|0|||
161801621|NCT00048048|584316562|FG005|Extension Year 1|Early withdrawals|0|||
161801622|NCT00048048|584316563|FG006|Extension Year 1|Early withdrawals|0|||
161801623|NCT00048048|584316564|FG007|Extension Year 1|Early withdrawals|0|||
161801624|NCT00048048|584316565|FG008|Extension Year 1|Early withdrawals|0|||
161801625|NCT00048048|584316566|FG009|Extension Year 1|Early withdrawals|2|||
161801626|NCT00048048|584316567|FG010|Extension Year 1|Early withdrawals|2|||
161801627|NCT00048048|584316568|FG011|Extension Year 1|Early withdrawals|4|||
161801628|NCT00048048|584316557|FG000|Extension Year 2|Early withdrawals|0|||
161801629|NCT00048048|584316558|FG001|Extension Year 2|Early withdrawals|0|||
161801630|NCT00048048|584316559|FG002|Extension Year 2|Early withdrawals|0|||
161801631|NCT00048048|584316560|FG003|Extension Year 2|Early withdrawals|0|||
161801632|NCT00048048|584316561|FG004|Extension Year 2|Early withdrawals|0|||
161801633|NCT00048048|584316562|FG005|Extension Year 2|Early withdrawals|0|||
161801634|NCT00048048|584316563|FG006|Extension Year 2|Early withdrawals|0|||
161801635|NCT00048048|584316564|FG007|Extension Year 2|Early withdrawals|0|||
161801636|NCT00048048|584316565|FG008|Extension Year 2|Early withdrawals|0|||
161801637|NCT00048048|584316566|FG009|Extension Year 2|Early withdrawals|0|||
161801638|NCT00048048|584316567|FG010|Extension Year 2|Early withdrawals|4|||
161801639|NCT00048048|584316568|FG011|Extension Year 2|Early withdrawals|2|||
161801640|NCT05518487|584316571|FG000|Overall Study|Withdrawal by Subject|3|||
161801641|NCT00543309|584316572|FG000|Overall Study|Physician Decision|0|||
161801642|NCT00543309|584316573|FG001|Overall Study|Physician Decision|1|||
161801643|NCT00543309|584316574|FG002|Overall Study|Physician Decision|0|||
161801644|NCT02194998|584316579|FG000|On-HCV Treatment|Did not pick up study medication|0|||
161801645|NCT02194998|584316580|FG001|On-HCV Treatment|Did not pick up study medication|1|||
161801646|NCT02194998|584316581|FG002|On-HCV Treatment|Did not pick up study medication|0|||
161801647|NCT02194998|584316582|FG003|On-HCV Treatment|Did not pick up study medication|0|||
161801648|NCT02194998|584316579|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
161905169|NCT00549549|584701212|FG000|Overall Study|Lost to Follow-up|1|||
161905170|NCT00549549|584701213|FG001|Overall Study|Lost to Follow-up|0|||
161801649|NCT02194998|584316580|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
161801650|NCT02194998|584316581|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
161801651|NCT02194998|584316582|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
161905171|NCT00549549|584701214|FG002|Overall Study|Lost to Follow-up|1|||
161905172|NCT00549549|584701215|FG003|Overall Study|Lost to Follow-up|2|||
161905173|NCT00549549|584701212|FG000|Overall Study|Withdrawal by Subject|0|||
161905174|NCT00549549|584701213|FG001|Overall Study|Withdrawal by Subject|4|||
161905175|NCT00549549|584701214|FG002|Overall Study|Withdrawal by Subject|1|||
161905176|NCT00549549|584701215|FG003|Overall Study|Withdrawal by Subject|0|||
161905177|NCT00549549|584701212|FG000|Overall Study|Other|9|||
161905178|NCT00549549|584701213|FG001|Overall Study|Other|9|||
161905179|NCT00549549|584701214|FG002|Overall Study|Other|9|||
161905180|NCT00549549|584701215|FG003|Overall Study|Other|11|||
161905181|NCT00549549|584701212|FG000|Overall Study|Randomized but not treated|0|||
161905182|NCT00549549|584701213|FG001|Overall Study|Randomized but not treated|0|||
161905183|NCT00549549|584701214|FG002|Overall Study|Randomized but not treated|1|||
161905184|NCT00549549|584701215|FG003|Overall Study|Randomized but not treated|1|||
161905185|NCT02155699|584701216|FG000|Overall Study|Withdrawal by Subject|0|||
161905186|NCT02155699|584701217|FG001|Overall Study|Withdrawal by Subject|3|||
161905187|NCT02155699|584701218|FG002|Overall Study|Withdrawal by Subject|6|||
161905188|NCT02155699|584701219|FG003|Overall Study|Withdrawal by Subject|1|||
161905189|NCT02155699|584701216|FG000|Overall Study|Lost to Follow-up|0|||
161905190|NCT02155699|584701217|FG001|Overall Study|Lost to Follow-up|0|||
161905191|NCT02155699|584701218|FG002|Overall Study|Lost to Follow-up|0|||
161905192|NCT02155699|584701219|FG003|Overall Study|Lost to Follow-up|3|||
161905193|NCT02155699|584701216|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
161905194|NCT02155699|584701217|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
161905195|NCT02155699|584701218|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
161905196|NCT02155699|584701219|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
161905197|NCT05547386|584701220|FG000|Overall Study|Withdrawal by Subject|7|||
162138898|NCT00813488|585559991|FG000|Titration Period 1|Technical Difficulties|0|||
162138899|NCT00813488|585559992|FG001|Titration Period 1|Technical Difficulties|1|||
162138900|NCT00813488|585559991|FG000|Titration Period 2|Adverse Event|2|||
162138901|NCT00813488|585559992|FG001|Titration Period 2|Adverse Event|3|||
162138902|NCT00813488|585559991|FG000|Titration Period 2|Lack of Efficacy|8|||
162138903|NCT00813488|585559992|FG001|Titration Period 2|Lack of Efficacy|4|||
162138904|NCT00813488|585559991|FG000|Titration Period 2|Protocol Violation|3|||
162138905|NCT00813488|585559992|FG001|Titration Period 2|Protocol Violation|2|||
162138906|NCT00813488|585559991|FG000|Titration Period 2|Lost to Follow-up|1|||
161801652|NCT01400113|584316583|FG000|Overall Study|Withdrawal by Subject|1|||
161801653|NCT01400113|584316584|FG001|Overall Study|Withdrawal by Subject|1|||
161801654|NCT00282256|584316585|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
161801655|NCT00282256|584316585|FG000|Extension Treatment Period|Adverse Event|2|||
162138907|NCT00813488|585559992|FG001|Titration Period 2|Lost to Follow-up|0|||
162138908|NCT00813488|585559991|FG000|Titration Period 2|Non-compliance with study procedures|2|||
162138909|NCT00813488|585559992|FG001|Titration Period 2|Non-compliance with study procedures|1|||
162138910|NCT00813488|585559991|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
162138911|NCT00813488|585559992|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
162138912|NCT00813488|585559991|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
162138913|NCT00813488|585559992|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
162138914|NCT00813488|585559991|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
161801656|NCT00762086|584316586|FG000|Overall Study|Adverse Event|2|||
161801657|NCT00762086|584316587|FG001|Overall Study|Adverse Event|0|||
161801658|NCT00762086|584316586|FG000|Overall Study|Lost to Follow-up|0|||
161801659|NCT00762086|584316587|FG001|Overall Study|Lost to Follow-up|2|||
161801660|NCT00762086|584316586|FG000|Overall Study|Non compliance|1|||
161801661|NCT00762086|584316587|FG001|Overall Study|Non compliance|0|||
161801662|NCT00762086|584316586|FG000|Overall Study|Withdrawal by Subject|2|||
161801663|NCT00762086|584316587|FG001|Overall Study|Withdrawal by Subject|2|||
161801664|NCT00762086|584316586|FG000|Overall Study|Ineligible to participate in the study|1|||
162138915|NCT00813488|585559992|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
162138916|NCT00813488|585559991|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
162138917|NCT00813488|585559992|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
162138918|NCT00813488|585559991|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
162138919|NCT00813488|585559992|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
161801665|NCT00762086|584316587|FG001|Overall Study|Ineligible to participate in the study|0|||
161801666|NCT03661528|584316588|FG000|Overall Study|Death|1|||
161801667|NCT03661528|584316589|FG001|Overall Study|Death|0|||
161801668|NCT03661528|584316588|FG000|Overall Study|Physician Decision|3|||
161801669|NCT03661528|584316589|FG001|Overall Study|Physician Decision|1|||
161801670|NCT03661528|584316588|FG000|Overall Study|Other than Specified|5|||
161801671|NCT03661528|584316589|FG001|Overall Study|Other than Specified|2|||
161801672|NCT03661528|584316588|FG000|Overall Study|Withdrawal by Subject|5|||
161801673|NCT03661528|584316589|FG001|Overall Study|Withdrawal by Subject|3|||
161801674|NCT03661528|584316588|FG000|Overall Study|Disease Progression|8|||
161801675|NCT03661528|584316589|FG001|Overall Study|Disease Progression|13|||
161801676|NCT03661528|584316588|FG000|Overall Study|Adverse Event|61|||
161801677|NCT03661528|584316589|FG001|Overall Study|Adverse Event|55|||
161801678|NCT03130699|584316595|FG000|Overall Study|Lost to Follow-up|34|||
161801679|NCT03130699|584316596|FG001|Overall Study|Lost to Follow-up|37|||
161801680|NCT03130699|584316597|FG002|Overall Study|Lost to Follow-up|26|||
161801681|NCT03130699|584316595|FG000|Overall Study|Withdrawal by Subject|5|||
161801682|NCT03130699|584316596|FG001|Overall Study|Withdrawal by Subject|1|||
162138920|NCT00813488|585559991|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
162138921|NCT00813488|585559992|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
161801683|NCT03130699|584316597|FG002|Overall Study|Withdrawal by Subject|0|||
161801684|NCT03130699|584316595|FG000|Overall Study|Withdrawal by PI|1|||
161801685|NCT03130699|584316596|FG001|Overall Study|Withdrawal by PI|2|||
161801686|NCT03130699|584316597|FG002|Overall Study|Withdrawal by PI|5|||
161801687|NCT03130699|584316595|FG000|Overall Study|Death|0|||
161905198|NCT02573259|584701226|FG000|Overall Study|Death|1|||
161905199|NCT02573259|584701227|FG001|Overall Study|Death|6|||
161801688|NCT03130699|584316596|FG001|Overall Study|Death|0|||
161801689|NCT03130699|584316597|FG002|Overall Study|Death|1|||
161801690|NCT04534283|584316598|FG000|Overall Study|Physician Decision|2|||
161801691|NCT04534283|584316598|FG000|Overall Study|Withdrawal by Subject|1|||
161801692|NCT04534283|584316598|FG000|Overall Study|Disease Progression|12|||
161801693|NCT04534283|584316598|FG000|Overall Study|Adverse Event|1|||
161801694|NCT05049460|584316599|FG000|Overall Study|Withdrawal by Subject|2|||
161801695|NCT05049460|584316600|FG001|Overall Study|Withdrawal by Subject|2|||
161801696|NCT05049460|584316599|FG000|Overall Study|Lost to Follow-up|2|||
161801697|NCT05049460|584316600|FG001|Overall Study|Lost to Follow-up|2|||
161801698|NCT00977470|584316601|FG000|Overall Study|Lack of Efficacy|32|||
162010889|NCT02594124|585096045|FG002|Overall Study|Withdrawal by Subject|5|||
162010890|NCT02594124|585096046|FG003|Overall Study|Withdrawal by Subject|1|||
161801699|NCT00977470|584316602|FG001|Overall Study|Lack of Efficacy|30|||
161801700|NCT00977470|584316601|FG000|Overall Study|Physician Decision|2|||
161801701|NCT00977470|584316602|FG001|Overall Study|Physician Decision|0|||
161801702|NCT00977470|584316601|FG000|Overall Study|Adverse Event|1|||
161801703|NCT00977470|584316602|FG001|Overall Study|Adverse Event|2|||
161801704|NCT00977470|584316601|FG000|Overall Study|Protocol Violation|1|||
161801705|NCT00977470|584316602|FG001|Overall Study|Protocol Violation|0|||
161801706|NCT00977470|584316601|FG000|Overall Study|Withdrawal by Subject|0|||
161801707|NCT00977470|584316602|FG001|Overall Study|Withdrawal by Subject|2|||
161801708|NCT00977470|584316601|FG000|Overall Study|Death|0|||
161801709|NCT00977470|584316602|FG001|Overall Study|Death|2|||
161801710|NCT00977470|584316601|FG000|Overall Study|clinical decline|0|||
161801711|NCT00977470|584316602|FG001|Overall Study|clinical decline|1|||
161801712|NCT00977470|584316601|FG000|Overall Study|prolonged recovery post-surgery|0|||
161801713|NCT00977470|584316602|FG001|Overall Study|prolonged recovery post-surgery|1|||
161801714|NCT00977470|584316601|FG000|Overall Study|Still on-study|2|||
161801715|NCT00977470|584316602|FG001|Overall Study|Still on-study|0|||
161801716|NCT03257462|584316603|FG000|Cohort A|Lost to Follow-up|1|||
161801717|NCT03257462|584316604|FG001|Cohort A|Lost to Follow-up|0|||
161801718|NCT03257462|584316605|FG002|Cohort A|Lost to Follow-up|0|||
161801719|NCT03257462|584316606|FG003|Cohort A|Lost to Follow-up|0|||
161801720|NCT03257462|584316603|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
161801721|NCT03257462|584316604|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
161801722|NCT03257462|584316605|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
161801723|NCT03257462|584316606|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
161801724|NCT00796822|584316607|FG000|Overall Study|Lost to Follow-up|2|||
161801725|NCT00796822|584316608|FG001|Overall Study|Lost to Follow-up|0|||
161801726|NCT00796822|584316607|FG000|Overall Study|Adverse Event|1|||
161801727|NCT00796822|584316608|FG001|Overall Study|Adverse Event|0|||
161801728|NCT06354270|584316609|FG000|Overall Study|Withdrawal by Subject|1|||
161801729|NCT06354270|584316610|FG001|Overall Study|Withdrawal by Subject|0|||
161801730|NCT05097989|584316611|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801731|NCT05097989|584316612|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801732|NCT05097989|584316613|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801733|NCT05097989|584316614|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801734|NCT05097989|584316615|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801735|NCT05097989|584316616|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
161801736|NCT05097989|584316617|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801737|NCT05097989|584316618|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801738|NCT05097989|584316619|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161801739|NCT05097989|584316611|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
161801740|NCT05097989|584316612|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
161801741|NCT05097989|584316613|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
161801742|NCT05097989|584316614|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
161801743|NCT05097989|584316615|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
161801744|NCT05097989|584316616|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
161801745|NCT05097989|584316617|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
161801746|NCT05097989|584316618|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
161801747|NCT05097989|584316619|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
161801748|NCT05097989|584316611|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161801749|NCT05097989|584316612|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161801750|NCT05097989|584316613|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161801751|NCT05097989|584316614|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161801752|NCT05097989|584316615|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161801753|NCT05097989|584316616|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
161801754|NCT05097989|584316617|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
161801755|NCT05097989|584316618|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
161801756|NCT05097989|584316619|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161801757|NCT05097989|584316611|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161801758|NCT05097989|584316612|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161801759|NCT05097989|584316613|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
161801760|NCT05097989|584316614|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161801761|NCT05097989|584316615|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
162138922|NCT00813488|585559991|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
162138923|NCT00813488|585559992|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
162138924|NCT00813488|585559991|FG000|Double-blind Treatment Period 2|Other|1|||
162138925|NCT00813488|585559992|FG001|Double-blind Treatment Period 2|Other|0|||
162138926|NCT00813488|585559991|FG000|Open-label Extension|Adverse Event|1|||
162138927|NCT00813488|585559992|FG001|Open-label Extension|Adverse Event|2|||
162138928|NCT00813488|585559991|FG000|Open-label Extension|Lack of Efficacy|3|||
162138929|NCT00813488|585559992|FG001|Open-label Extension|Lack of Efficacy|0|||
162138930|NCT00813488|585559991|FG000|Open-label Extension|Withdrawal by Subject|0|||
162138931|NCT00813488|585559992|FG001|Open-label Extension|Withdrawal by Subject|2|||
162138932|NCT00813488|585559991|FG000|Open-label Extension|Protocol Violation|1|||
162138933|NCT00813488|585559992|FG001|Open-label Extension|Protocol Violation|2|||
162138934|NCT00813488|585559991|FG000|Open-label Extension|Non-compliance study medication|4|||
162138935|NCT00813488|585559992|FG001|Open-label Extension|Non-compliance study medication|0|||
162138936|NCT00813488|585559991|FG000|Open-label Extension|Non-compliance study procedures|2|||
162138937|NCT00813488|585559992|FG001|Open-label Extension|Non-compliance study procedures|1|||
161801762|NCT05097989|584316616|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
161801763|NCT05097989|584316617|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161801764|NCT05097989|584316618|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
161801765|NCT05097989|584316619|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161801766|NCT05097989|584316611|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801767|NCT05097989|584316612|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801768|NCT05097989|584316613|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
161801769|NCT05097989|584316614|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801770|NCT05097989|584316615|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801771|NCT05097989|584316616|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801772|NCT05097989|584316617|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801773|NCT05097989|584316618|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801774|NCT05097989|584316619|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161801775|NCT05097989|584316611|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801776|NCT05097989|584316612|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
161801777|NCT05097989|584316613|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801778|NCT05097989|584316614|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801779|NCT05097989|584316615|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801780|NCT05097989|584316616|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801781|NCT05097989|584316617|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801782|NCT05097989|584316618|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801783|NCT05097989|584316619|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161801784|NCT05097989|584316611|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801785|NCT05097989|584316612|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801786|NCT05097989|584316613|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801787|NCT05097989|584316614|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801788|NCT05097989|584316615|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161801789|NCT05097989|584316616|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801790|NCT05097989|584316617|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801791|NCT05097989|584316618|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801792|NCT05097989|584316619|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161801793|NCT05097989|584316611|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801794|NCT05097989|584316612|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801795|NCT05097989|584316613|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801796|NCT05097989|584316614|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801797|NCT05097989|584316615|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
161801798|NCT05097989|584316616|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801799|NCT05097989|584316617|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801800|NCT05097989|584316618|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801801|NCT05097989|584316619|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161801802|NCT05097989|584316611|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801803|NCT05097989|584316612|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161801804|NCT05097989|584316613|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801805|NCT05097989|584316614|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161801806|NCT05097989|584316615|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801807|NCT05097989|584316616|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801808|NCT05097989|584316617|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801809|NCT05097989|584316618|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801810|NCT05097989|584316619|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161801811|NCT05097989|584316611|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
161801812|NCT05097989|584316612|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
161801813|NCT05097989|584316613|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
161801814|NCT05097989|584316614|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
161801815|NCT05097989|584316615|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
161801816|NCT05097989|584316616|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
161801817|NCT05097989|584316617|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
161801818|NCT05097989|584316618|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
161801819|NCT05097989|584316619|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
161801820|NCT05097989|584316611|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
161801821|NCT05097989|584316612|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
161801822|NCT05097989|584316613|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
161801823|NCT05097989|584316614|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
161905200|NCT02573259|584701228|FG002|Overall Study|Death|5|||
161905201|NCT02573259|584701229|FG003|Overall Study|Death|6|||
161905202|NCT02573259|584701230|FG004|Overall Study|Death|9|||
161905203|NCT02573259|584701231|FG005|Overall Study|Death|32|||
161905204|NCT02573259|584701232|FG006|Overall Study|Death|21|||
161905205|NCT02573259|584701226|FG000|Overall Study|Lost to Follow-up|0|||
161905206|NCT02573259|584701227|FG001|Overall Study|Lost to Follow-up|0|||
161801824|NCT05097989|584316615|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
161801825|NCT05097989|584316616|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
161801826|NCT05097989|584316617|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
161801827|NCT05097989|584316618|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
161801828|NCT05097989|584316619|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
161801829|NCT05097989|584316611|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801830|NCT05097989|584316612|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801831|NCT05097989|584316613|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801832|NCT05097989|584316614|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801833|NCT05097989|584316615|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
161801834|NCT05097989|584316616|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801835|NCT05097989|584316617|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801836|NCT05097989|584316618|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801837|NCT05097989|584316619|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
161801838|NCT05097989|584316611|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
161801839|NCT05097989|584316612|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
161801840|NCT05097989|584316613|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801841|NCT05097989|584316614|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801842|NCT05097989|584316615|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801843|NCT05097989|584316616|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801844|NCT05097989|584316617|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801845|NCT05097989|584316618|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801846|NCT05097989|584316619|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161801847|NCT05097989|584316611|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
161801848|NCT05097989|584316612|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
161801849|NCT05097989|584316613|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
161801850|NCT05097989|584316614|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
161801851|NCT05097989|584316615|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
161801852|NCT05097989|584316616|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
161801853|NCT05097989|584316617|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
161801854|NCT05097989|584316618|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
161801855|NCT05097989|584316619|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
161801856|NCT00918567|584316628|FG000|Overall Study|Lack of Efficacy|3|||
161801857|NCT00918567|584316629|FG001|Overall Study|Lack of Efficacy|1|||
161801858|NCT00918567|584316628|FG000|Overall Study|Withdrawal by Subject|1|||
161801859|NCT00918567|584316629|FG001|Overall Study|Withdrawal by Subject|1|||
161801860|NCT00918567|584316628|FG000|Overall Study|Adverse Event|1|||
161801861|NCT00918567|584316629|FG001|Overall Study|Adverse Event|0|||
161801862|NCT02327130|584316635|FG000|Overall Study|Discharged in less than 5 days|5|||
161801863|NCT02327130|584316635|FG000|Overall Study|Physician Decision|2|||
161801864|NCT02327130|584316635|FG000|Overall Study|Unable to provide breath sample|1|||
161801865|NCT02327130|584316635|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
161801866|NCT02327130|584316635|FG000|Overall Study|Met exclusion criteria|3|||
161801867|NCT04028843|584316636|FG000|Overall Study|Lost to Follow-up|32|||
161801868|NCT04028843|584316637|FG001|Overall Study|Lost to Follow-up|39|||
161801869|NCT04028843|584316636|FG000|Overall Study|Adverse Event|1|||
161801870|NCT04028843|584316637|FG001|Overall Study|Adverse Event|0|||
161801871|NCT04028843|584316636|FG000|Overall Study|Non-viable Pregnancy|0|||
161801872|NCT04028843|584316637|FG001|Overall Study|Non-viable Pregnancy|1|||
161801873|NCT04028843|584316636|FG000|Overall Study|Withdrawal by Subject|4|||
161801874|NCT04028843|584316637|FG001|Overall Study|Withdrawal by Subject|2|||
161801875|NCT02684344|584318054|FG000|Overall Study|Withdrawal by Subject|0|||
161801876|NCT02684344|584318055|FG001|Overall Study|Withdrawal by Subject|1|||
161801877|NCT01451762|584318056|FG000|Overall Study|Lost to Follow-up|3|||
161801878|NCT01451762|584318057|FG001|Overall Study|Lost to Follow-up|6|||
161801879|NCT01451762|584318058|FG002|Overall Study|Lost to Follow-up|6|||
161801880|NCT00525590|584318082|FG000|Overall Study|Adverse Event|3|||
161801881|NCT00525590|584318082|FG000|Overall Study|Physician Decision|3|||
161801882|NCT00525590|584318082|FG000|Overall Study|Withdrawal by Subject|16|||
161801883|NCT00525590|584318082|FG000|Overall Study|Lost to Follow-up|1|||
161905207|NCT02573259|584701228|FG002|Overall Study|Lost to Follow-up|0|||
161905208|NCT02573259|584701229|FG003|Overall Study|Lost to Follow-up|0|||
161905209|NCT02573259|584701230|FG004|Overall Study|Lost to Follow-up|0|||
161905210|NCT02573259|584701231|FG005|Overall Study|Lost to Follow-up|2|||
161905211|NCT02573259|584701232|FG006|Overall Study|Lost to Follow-up|1|||
161905212|NCT02573259|584701226|FG000|Overall Study|Participant refused further follow-up|0|||
161905213|NCT02573259|584701227|FG001|Overall Study|Participant refused further follow-up|2|||
161905214|NCT02573259|584701228|FG002|Overall Study|Participant refused further follow-up|1|||
161905215|NCT02573259|584701229|FG003|Overall Study|Participant refused further follow-up|0|||
161905216|NCT02573259|584701230|FG004|Overall Study|Participant refused further follow-up|3|||
161905217|NCT02573259|584701231|FG005|Overall Study|Participant refused further follow-up|20|||
161905218|NCT02573259|584701232|FG006|Overall Study|Participant refused further follow-up|7|||
161905219|NCT02573259|584701226|FG000|Overall Study|Other|0|||
161905220|NCT02573259|584701227|FG001|Overall Study|Other|0|||
161905221|NCT02573259|584701228|FG002|Overall Study|Other|0|||
161905222|NCT02573259|584701229|FG003|Overall Study|Other|0|||
161905223|NCT02573259|584701230|FG004|Overall Study|Other|1|||
161905224|NCT02573259|584701231|FG005|Overall Study|Other|4|||
161905225|NCT02573259|584701232|FG006|Overall Study|Other|5|||
161905226|NCT00751140|584701236|FG000|Overall Study|benign angioma excluded from analysis|1|||
161905227|NCT00808067|584701237|FG000|Overall Study|Major/minor bleed|30|||
161905228|NCT00808067|584701238|FG001|Overall Study|Major/minor bleed|44|||
161905229|NCT00808067|584701237|FG000|Overall Study|Outcome event - other|33|||
161905230|NCT00808067|584701238|FG001|Overall Study|Outcome event - other|25|||
161905231|NCT00808067|584701237|FG000|Overall Study|Adverse Event|111|||
161905232|NCT00808067|584701238|FG001|Overall Study|Adverse Event|121|||
161905233|NCT00808067|584701237|FG000|Overall Study|Hospitalization (not including surgery)|18|||
161905234|NCT00808067|584701238|FG001|Overall Study|Hospitalization (not including surgery)|17|||
161905235|NCT00808067|584701237|FG000|Overall Study|Hospitalization due to surgery|37|||
161905236|NCT00808067|584701238|FG001|Overall Study|Hospitalization due to surgery|40|||
161905237|NCT00808067|584701237|FG000|Overall Study|Reduced creatinine clearance|53|||
161905238|NCT00808067|584701238|FG001|Overall Study|Reduced creatinine clearance|55|||
161905239|NCT00808067|584701237|FG000|Overall Study|Elevated LFT results|7|||
161905240|NCT00808067|584701238|FG001|Overall Study|Elevated LFT results|3|||
161905241|NCT00808067|584701237|FG000|Overall Study|Patient refused to take study medication|65|||
161905242|NCT00808067|584701238|FG001|Overall Study|Patient refused to take study medication|76|||
161905243|NCT00808067|584701237|FG000|Overall Study|Missing|1|||
161905244|NCT00808067|584701238|FG001|Overall Study|Missing|0|||
161905245|NCT00808067|584701237|FG000|Overall Study|Death|1|||
161905246|NCT00808067|584701238|FG001|Overall Study|Death|1|||
161905247|NCT00808067|584701237|FG000|Overall Study|Procedure|6|||
161905248|NCT00808067|584701238|FG001|Overall Study|Procedure|7|||
161905249|NCT00808067|584701237|FG000|Overall Study|Withdrawal by Subject|21|||
161905250|NCT00808067|584701238|FG001|Overall Study|Withdrawal by Subject|25|||
161905251|NCT00808067|584701237|FG000|Overall Study|Site closed|4|||
161905252|NCT00808067|584701238|FG001|Overall Study|Site closed|3|||
161905253|NCT00808067|584701237|FG000|Overall Study|Physician Decision|47|||
161905254|NCT00808067|584701238|FG001|Overall Study|Physician Decision|38|||
161905255|NCT00808067|584701237|FG000|Overall Study|Protocol Violation|3|||
161905256|NCT00808067|584701238|FG001|Overall Study|Protocol Violation|11|||
161905257|NCT00808067|584701237|FG000|Overall Study|Patient elected|7|||
161905258|NCT00808067|584701238|FG001|Overall Study|Patient elected|9|||
161905259|NCT00808067|584701237|FG000|Overall Study|Site closed for cause|19|||
161905260|NCT00808067|584701238|FG001|Overall Study|Site closed for cause|19|||
161905261|NCT00808067|584701237|FG000|Overall Study|Other reason not defined above|5|||
161905262|NCT00808067|584701238|FG001|Overall Study|Other reason not defined above|5|||
161905263|NCT00808067|584701237|FG000|Overall Study|Excluded from analysis|13|||
161905264|NCT00808067|584701238|FG001|Overall Study|Excluded from analysis|19|||
161905265|NCT01939314|584701239|FG000|Overall Study|Withdrawal by Subject|3|||
161905266|NCT01939314|584701240|FG001|Overall Study|Withdrawal by Subject|1|||
161905267|NCT01939314|584701239|FG000|Overall Study|Protocol Violation|1|||
161905268|NCT01939314|584701240|FG001|Overall Study|Protocol Violation|0|||
161905269|NCT01939314|584701239|FG000|Overall Study|Pregnancy|0|||
161905270|NCT01939314|584701240|FG001|Overall Study|Pregnancy|1|||
161905271|NCT01939314|584701239|FG000|Overall Study|Lost to Follow-up|5|||
161801884|NCT00525590|584318082|FG000|Overall Study|Death|9|||
161801885|NCT00525590|584318082|FG000|Overall Study|Other|13|||
161801886|NCT01345019|584318083|FG000|Blinded Treatment Phase|Death|147|||
161801887|NCT01345019|584318084|FG001|Blinded Treatment Phase|Death|137|||
161801888|NCT01345019|584318083|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
161801889|NCT01345019|584318084|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
161905272|NCT01939314|584701240|FG001|Overall Study|Lost to Follow-up|6|||
161905273|NCT00735007|584701241|FG000|Overall Study|Adverse Event|4|||
161905274|NCT00735007|584701241|FG000|Overall Study|Protocol Violation|1|||
161905275|NCT03311945|584701242|FG000|Overall Study|Adverse Event|2|||
161905276|NCT03311945|584701242|FG000|Overall Study|Lack of Efficacy|1|||
161801890|NCT01345019|584318083|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
161801891|NCT01345019|584318084|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
161905277|NCT03839394|584701243|FG000|Overall Study|Lost to Follow-up|6|||
161801892|NCT01345019|584318083|FG000|Blinded Treatment Phase|Disease Progression|12|||
161801893|NCT01345019|584318084|FG001|Blinded Treatment Phase|Disease Progression|10|||
161801894|NCT01345019|584318083|FG000|Blinded Treatment Phase|Adverse Event|6|||
161801895|NCT01345019|584318084|FG001|Blinded Treatment Phase|Adverse Event|13|||
161801896|NCT01345019|584318083|FG000|Blinded Treatment Phase|Administrative Decision|10|||
161801897|NCT01345019|584318084|FG001|Blinded Treatment Phase|Administrative Decision|8|||
161801898|NCT01345019|584318083|FG000|Blinded Treatment Phase|Noncompliance|5|||
161801899|NCT01345019|584318084|FG001|Blinded Treatment Phase|Noncompliance|3|||
161801900|NCT01345019|584318083|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
161801901|NCT01345019|584318084|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
161801902|NCT01345019|584318083|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
161801903|NCT01345019|584318084|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
161801904|NCT01345019|584318083|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
161801905|NCT01345019|584318084|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
161801906|NCT01345019|584318083|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
161801907|NCT01345019|584318084|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
161801908|NCT01345019|584318083|FG000|Open Label Treatment Phase|Death|49|||
161801909|NCT01345019|584318084|FG001|Open Label Treatment Phase|Death|48|||
161801910|NCT01345019|584318083|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
161801911|NCT01345019|584318084|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
161801912|NCT01345019|584318083|FG000|Open Label Treatment Phase|Adverse Event|30|||
161801913|NCT01345019|584318084|FG001|Open Label Treatment Phase|Adverse Event|51|||
161801914|NCT01345019|584318083|FG000|Open Label Treatment Phase|Administrative Decision|30|||
161801915|NCT01345019|584318084|FG001|Open Label Treatment Phase|Administrative Decision|15|||
161801916|NCT01345019|584318083|FG000|Open Label Treatment Phase|Disease Progression|17|||
161801917|NCT01345019|584318084|FG001|Open Label Treatment Phase|Disease Progression|18|||
161801918|NCT01345019|584318083|FG000|Open Label Treatment Phase|Noncompliance|5|||
161801919|NCT01345019|584318084|FG001|Open Label Treatment Phase|Noncompliance|4|||
161801920|NCT01345019|584318083|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
161801921|NCT01345019|584318084|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
161801922|NCT01345019|584318083|FG000|Open Label Treatment Phase|Pregnancy|1|||
161801923|NCT01345019|584318084|FG001|Open Label Treatment Phase|Pregnancy|0|||
161801924|NCT01345019|584318083|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
161801925|NCT01345019|584318084|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
161801926|NCT01345019|584318083|FG000|Open Label Treatment Phase|Protocol Violation|0|||
161801927|NCT01345019|584318084|FG001|Open Label Treatment Phase|Protocol Violation|1|||
161801928|NCT02636907|584318085|FG000|Autoinjector Assessment Period|Adverse Event|2|||
161801929|NCT02636907|584318085|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
161801930|NCT02636907|584318085|FG000|Extension Phase|Adverse Event|2|||
161801931|NCT02636907|584318085|FG000|Extension Phase|Withdrawal by Subject|4|||
161801932|NCT02636907|584318085|FG000|Extension Phase|Physician Decision|1|||
161801933|NCT02636907|584318085|FG000|Extension Phase|Lost to Follow-up|2|||
161801934|NCT02636907|584318085|FG000|Extension Phase|Lack of Efficacy|1|||
161801935|NCT03830164|584318090|FG000|Overall Study|Adverse Event|0|||
161801936|NCT03830164|584318091|FG001|Overall Study|Adverse Event|2|||
161801937|NCT03830164|584318092|FG002|Overall Study|Adverse Event|0|||
161801938|NCT03830164|584318090|FG000|Overall Study|Lack of Efficacy|1|||
161801939|NCT03830164|584318091|FG001|Overall Study|Lack of Efficacy|5|||
161801940|NCT03830164|584318092|FG002|Overall Study|Lack of Efficacy|0|||
161801941|NCT03830164|584318090|FG000|Overall Study|Lost to Follow-up|0|||
161801942|NCT03830164|584318091|FG001|Overall Study|Lost to Follow-up|1|||
161801943|NCT03830164|584318092|FG002|Overall Study|Lost to Follow-up|0|||
161801944|NCT03830164|584318090|FG000|Overall Study|Withdrawal by Subject|1|||
161801945|NCT03830164|584318091|FG001|Overall Study|Withdrawal by Subject|0|||
161801946|NCT03830164|584318092|FG002|Overall Study|Withdrawal by Subject|0|||
161801947|NCT04099888|584318093|FG000|Overall Study|Study terminated by sponsor|9|||
161801948|NCT04099888|584318094|FG001|Overall Study|Study terminated by sponsor|11|||
161801949|NCT04099888|584318093|FG000|Overall Study|Lost to Follow-up|1|||
161801950|NCT04099888|584318094|FG001|Overall Study|Lost to Follow-up|1|||
161801951|NCT04099888|584318093|FG000|Overall Study|Withdrawal by Subject|5|||
161801952|NCT04099888|584318094|FG001|Overall Study|Withdrawal by Subject|6|||
161801953|NCT04099888|584318093|FG000|Overall Study|Death|5|||
161801954|NCT04099888|584318094|FG001|Overall Study|Death|2|||
161801955|NCT04099888|584318093|FG000|Overall Study|Other|1|||
161801956|NCT04099888|584318094|FG001|Overall Study|Other|0|||
161905278|NCT03839394|584701244|FG001|Overall Study|Lost to Follow-up|8|||
161905279|NCT03839394|584701243|FG000|Overall Study|Withdrawal by Subject|0|||
161905280|NCT03839394|584701244|FG001|Overall Study|Withdrawal by Subject|2|||
161905281|NCT01945944|584701254|FG000|Overall Study|Adverse Event|0|||
161801957|NCT00497796|584318106|FG000|Overall Study|Adverse event (not related)|9|||
161801958|NCT00497796|584318107|FG001|Overall Study|Adverse event (not related)|9|||
161801959|NCT00497796|584318106|FG000|Overall Study|Adverse event (related)|5|||
161801960|NCT00497796|584318107|FG001|Overall Study|Adverse event (related)|4|||
161905282|NCT01945944|584701255|FG001|Overall Study|Adverse Event|2|||
161801961|NCT00497796|584318106|FG000|Overall Study|CMV infection or disease treatment|30|||
161801962|NCT00497796|584318107|FG001|Overall Study|CMV infection or disease treatment|4|||
161801963|NCT00497796|584318106|FG000|Overall Study|Consent withdrawn|10|||
161801964|NCT00497796|584318107|FG001|Overall Study|Consent withdrawn|3|||
161905283|NCT01945944|584701254|FG000|Overall Study|Physician Decision|1|||
161905284|NCT01945944|584701255|FG001|Overall Study|Physician Decision|0|||
161905285|NCT01945944|584701254|FG000|Overall Study|Withdrawal by Subject|0|||
161905286|NCT01945944|584701255|FG001|Overall Study|Withdrawal by Subject|1|||
161905287|NCT01817075|584701256|FG000|Overall Study|Adverse Event|7|||
161905288|NCT01817075|584701257|FG001|Overall Study|Adverse Event|5|||
161905289|NCT01817075|584701256|FG000|Overall Study|Physician Decision|9|||
161905290|NCT01817075|584701257|FG001|Overall Study|Physician Decision|12|||
161905291|NCT01817075|584701256|FG000|Overall Study|Withdrawal by Subject|31|||
161905292|NCT01817075|584701257|FG001|Overall Study|Withdrawal by Subject|15|||
161905293|NCT01817075|584701256|FG000|Overall Study|Received Sorafenib after enrollment|0|||
161905294|NCT01817075|584701257|FG001|Overall Study|Received Sorafenib after enrollment|1|||
162138938|NCT00813488|585559991|FG000|Open-label Extension|Other|1|||
162138939|NCT00813488|585559992|FG001|Open-label Extension|Other|0|||
162138940|NCT01333514|585559995|FG000|Overall Study|Withdrawal by Subject|1|||
162138941|NCT01333514|585559996|FG001|Overall Study|Withdrawal by Subject|0|||
161801965|NCT00497796|584318106|FG000|Overall Study|Investigator/sponsor discretion|31|||
161801966|NCT00497796|584318107|FG001|Overall Study|Investigator/sponsor discretion|34|||
161801967|NCT00497796|584318106|FG000|Overall Study|Lost to Follow-up|0|||
161801968|NCT00497796|584318107|FG001|Overall Study|Lost to Follow-up|1|||
161801969|NCT00497796|584318106|FG000|Overall Study|Not applicable (randomized not treated)|0|||
161801970|NCT00497796|584318107|FG001|Overall Study|Not applicable (randomized not treated)|4|||
161801971|NCT01074554|584318108|FG000|Overall Study|Adverse Event|3|||
161801972|NCT01074554|584318109|FG001|Overall Study|Adverse Event|3|||
161801973|NCT01074554|584318108|FG000|Overall Study|Lost to Follow-up|0|||
161801974|NCT01074554|584318109|FG001|Overall Study|Lost to Follow-up|1|||
161801975|NCT01856309|584318111|FG000|Overall Study|Death|4|||
161801976|NCT01856309|584318112|FG001|Overall Study|Death|6|||
161801977|NCT01856309|584318113|FG002|Overall Study|Death|11|||
161801978|NCT01856309|584318114|FG003|Overall Study|Death|6|||
161801979|NCT01856309|584318111|FG000|Overall Study|Lost to Follow-up|6|||
161801980|NCT01856309|584318112|FG001|Overall Study|Lost to Follow-up|2|||
161801981|NCT01856309|584318113|FG002|Overall Study|Lost to Follow-up|4|||
161801982|NCT01856309|584318114|FG003|Overall Study|Lost to Follow-up|8|||
161801983|NCT01856309|584318111|FG000|Overall Study|Withdrawal by Subject|11|||
161801984|NCT01856309|584318112|FG001|Overall Study|Withdrawal by Subject|13|||
161801985|NCT01856309|584318113|FG002|Overall Study|Withdrawal by Subject|28|||
161801986|NCT01856309|584318114|FG003|Overall Study|Withdrawal by Subject|26|||
161801987|NCT01856309|584318111|FG000|Overall Study|Other|227|||
161801988|NCT01856309|584318112|FG001|Overall Study|Other|225|||
161801989|NCT01856309|584318113|FG002|Overall Study|Other|447|||
161801990|NCT01856309|584318114|FG003|Overall Study|Other|469|||
161801991|NCT01856309|584318111|FG000|Overall Study|Lack of Efficacy|14|||
161801992|NCT01856309|584318112|FG001|Overall Study|Lack of Efficacy|9|||
161801993|NCT01856309|584318113|FG002|Overall Study|Lack of Efficacy|40|||
161801994|NCT01856309|584318114|FG003|Overall Study|Lack of Efficacy|25|||
161801995|NCT01856309|584318111|FG000|Overall Study|Adverse Event|31|||
161801996|NCT01856309|584318112|FG001|Overall Study|Adverse Event|31|||
161801997|NCT01856309|584318113|FG002|Overall Study|Adverse Event|55|||
161801998|NCT01856309|584318114|FG003|Overall Study|Adverse Event|65|||
161801999|NCT01856309|584318111|FG000|Overall Study|Pregnancy|0|||
161802000|NCT01856309|584318112|FG001|Overall Study|Pregnancy|0|||
161802001|NCT01856309|584318113|FG002|Overall Study|Pregnancy|0|||
161802002|NCT01856309|584318114|FG003|Overall Study|Pregnancy|1|||
161802003|NCT01856309|584318111|FG000|Overall Study|Physician Decision|6|||
161802004|NCT01856309|584318112|FG001|Overall Study|Physician Decision|1|||
161802005|NCT01856309|584318113|FG002|Overall Study|Physician Decision|6|||
161802006|NCT01856309|584318114|FG003|Overall Study|Physician Decision|8|||
161802007|NCT01856309|584318111|FG000|Overall Study|Noncompliance With Study Drug|0|||
161802008|NCT01856309|584318112|FG001|Overall Study|Noncompliance With Study Drug|1|||
161802009|NCT01856309|584318113|FG002|Overall Study|Noncompliance With Study Drug|4|||
161802010|NCT01856309|584318114|FG003|Overall Study|Noncompliance With Study Drug|1|||
161802011|NCT00832377|584318115|FG000|Overall Study|Protocol Violation|1|||
161802012|NCT00220337|584318116|FG000|Overall Study|Adverse Event|70|||
161802013|NCT00220337|584318116|FG000|Overall Study|Lack of Efficacy|17|||
161905295|NCT01817075|584701256|FG000|Overall Study|Ineligible|0|||
162138942|NCT00819910|585559997|FG000|Overall Study|Adverse Event|0|||
161802014|NCT00220337|584318116|FG000|Overall Study|Withdrawal by Subject|68|||
161905296|NCT01817075|584701257|FG001|Overall Study|Ineligible|2|||
161905297|NCT04376515|584701260|FG000|Overall Study|Found to have been vaccinated before study start|6|||
161802015|NCT00220337|584318116|FG000|Overall Study|Protocol Violation|2|||
161802016|NCT00220337|584318116|FG000|Overall Study|Lost to Follow-up|5|||
161802017|NCT00220337|584318116|FG000|Overall Study|Other|12|||
161905298|NCT04376515|584701261|FG001|Overall Study|Found to have been vaccinated before study start|6|||
162138943|NCT00819910|585559998|FG001|Overall Study|Adverse Event|0|||
161802018|NCT00220337|584318116|FG000|Overall Study|Unsatisfactory compliance|5|||
161802019|NCT00944697|584318117|FG000|Overall Study|Withdrawal by Subject|1|||
161802020|NCT00944697|584318118|FG001|Overall Study|Withdrawal by Subject|1|||
162138944|NCT00819910|585559999|FG002|Overall Study|Adverse Event|2|||
161905299|NCT04157517|584701262|FG000|Overall Study|Death|1|||
161905300|NCT04157517|584701263|FG001|Overall Study|Death|2|||
161905301|NCT04157517|584701264|FG002|Overall Study|Death|2|||
161905302|NCT04157517|584701265|FG003|Overall Study|Death|3|||
161905303|NCT04157517|584701266|FG004|Overall Study|Death|3|||
161905304|NCT04157517|584701267|FG005|Overall Study|Death|4|||
161905305|NCT04157517|584701268|FG006|Overall Study|Death|1|||
161905306|NCT04157517|584701269|FG007|Overall Study|Death|2|||
161905307|NCT04157517|584701270|FG008|Overall Study|Death|4|||
161905308|NCT04157517|584701271|FG009|Overall Study|Death|0|||
162138945|NCT00819910|585560000|FG003|Overall Study|Adverse Event|1|||
162138946|NCT00819910|585559997|FG000|Overall Study|Withdrawal by Subject|1|||
162138947|NCT00819910|585559998|FG001|Overall Study|Withdrawal by Subject|1|||
162138948|NCT00819910|585559999|FG002|Overall Study|Withdrawal by Subject|1|||
162138949|NCT00819910|585560000|FG003|Overall Study|Withdrawal by Subject|0|||
162138950|NCT00819910|585559997|FG000|Overall Study|Lost to Follow-up|1|||
162138951|NCT00819910|585559998|FG001|Overall Study|Lost to Follow-up|0|||
162138952|NCT00819910|585559999|FG002|Overall Study|Lost to Follow-up|0|||
162138953|NCT00819910|585560000|FG003|Overall Study|Lost to Follow-up|0|||
162138954|NCT00836810|585560001|FG000|Overall Study|New diagnosis|1|||
162138955|NCT00836810|585560002|FG001|Overall Study|New diagnosis|0|||
162138956|NCT00871429|585560004|FG000|Overall Study|Lost to Follow-up|6|||
162138957|NCT00871429|585560004|FG000|Overall Study|Withdrawal by Subject|17|||
162138958|NCT00871429|585560004|FG000|Overall Study|Questionnaire not completed|1|||
161802021|NCT00944697|584318117|FG000|Overall Study|Adverse Event|0|||
161802022|NCT00944697|584318118|FG001|Overall Study|Adverse Event|3|||
161905309|NCT04157517|584701262|FG000|Overall Study|Withdrawal by Subject|1|||
161905310|NCT04157517|584701263|FG001|Overall Study|Withdrawal by Subject|1|||
161905311|NCT04157517|584701264|FG002|Overall Study|Withdrawal by Subject|1|||
161905312|NCT04157517|584701265|FG003|Overall Study|Withdrawal by Subject|0|||
161905313|NCT04157517|584701266|FG004|Overall Study|Withdrawal by Subject|0|||
161905314|NCT04157517|584701267|FG005|Overall Study|Withdrawal by Subject|1|||
161905315|NCT04157517|584701268|FG006|Overall Study|Withdrawal by Subject|0|||
161905316|NCT04157517|584701269|FG007|Overall Study|Withdrawal by Subject|0|||
161905317|NCT04157517|584701270|FG008|Overall Study|Withdrawal by Subject|1|||
161905318|NCT04157517|584701271|FG009|Overall Study|Withdrawal by Subject|0|||
161905319|NCT04157517|584701262|FG000|Overall Study|Other|1|||
161905320|NCT04157517|584701263|FG001|Overall Study|Other|0|||
161905321|NCT04157517|584701264|FG002|Overall Study|Other|0|||
161905322|NCT04157517|584701265|FG003|Overall Study|Other|0|||
161905323|NCT04157517|584701266|FG004|Overall Study|Other|0|||
161905324|NCT04157517|584701267|FG005|Overall Study|Other|1|||
161905325|NCT04157517|584701268|FG006|Overall Study|Other|2|||
161905326|NCT04157517|584701269|FG007|Overall Study|Other|7|||
161905327|NCT04157517|584701270|FG008|Overall Study|Other|7|||
161905328|NCT04157517|584701271|FG009|Overall Study|Other|0|||
161905329|NCT03433898|584701274|FG000|Overall Study|Progressive disease|6|||
161905330|NCT03433898|584701275|FG001|Overall Study|Progressive disease|3|||
161905331|NCT03433898|584701276|FG002|Overall Study|Progressive disease|3|||
161905332|NCT03433898|584701277|FG003|Overall Study|Progressive disease|2|||
161905333|NCT03433898|584701278|FG004|Overall Study|Progressive disease|30|||
162138959|NCT03102242|585560005|FG000|Overall Study|Adverse Event|2|||
162138960|NCT00389519|585560006|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
162138961|NCT00389519|585560007|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
161802023|NCT00944697|584318117|FG000|Overall Study|Administrative|1|||
161802024|NCT00944697|584318118|FG001|Overall Study|Administrative|1|||
161802025|NCT01273181|584318119|FG000|Phase I, Dose 1|Study termination|1|||
161802026|NCT01273181|584318120|FG001|Phase I, Dose 1|Study termination|0|||
161802027|NCT01273181|584318121|FG002|Phase I, Dose 1|Study termination|0|||
161802028|NCT01273181|584318122|FG003|Phase I, Dose 1|Study termination|0|||
161802029|NCT01273181|584318119|FG000|Phase I, Dose 2|Death during treatment|0|||
161802030|NCT01273181|584318120|FG001|Phase I, Dose 2|Death during treatment|1|||
161802031|NCT01273181|584318121|FG002|Phase I, Dose 2|Death during treatment|0|||
161802032|NCT01273181|584318122|FG003|Phase I, Dose 2|Death during treatment|0|||
161802033|NCT01273181|584318119|FG000|Phase 2, Dose 1|Study termination|0|||
161802034|NCT01273181|584318120|FG001|Phase 2, Dose 1|Study termination|0|||
161802035|NCT01273181|584318121|FG002|Phase 2, Dose 1|Study termination|1|||
161905334|NCT03433898|584701279|FG005|Overall Study|Progressive disease|29|||
161905335|NCT03433898|584701280|FG006|Overall Study|Progressive disease|17|||
161905336|NCT03433898|584701281|FG007|Overall Study|Progressive disease|30|||
161905337|NCT03433898|584701274|FG000|Overall Study|Not treated|1|||
161905338|NCT03433898|584701275|FG001|Overall Study|Not treated|0|||
161905339|NCT03433898|584701276|FG002|Overall Study|Not treated|0|||
161905340|NCT03433898|584701277|FG003|Overall Study|Not treated|0|||
161905341|NCT03433898|584701278|FG004|Overall Study|Not treated|1|||
161905342|NCT03433898|584701279|FG005|Overall Study|Not treated|0|||
161905343|NCT03433898|584701280|FG006|Overall Study|Not treated|0|||
161905344|NCT03433898|584701281|FG007|Overall Study|Not treated|0|||
162138962|NCT00389519|585560008|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
162138963|NCT00389519|585560009|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
162138964|NCT00389519|585560006|FG000|Placebo Run-In|Withdrawal by Subject|19|||
161802036|NCT01273181|584318122|FG003|Phase 2, Dose 1|Study termination|0|||
161802037|NCT01273181|584318119|FG000|Phase 2, Dose 2|Death during treatment|0|||
161802038|NCT01273181|584318120|FG001|Phase 2, Dose 2|Death during treatment|0|||
161802039|NCT01273181|584318121|FG002|Phase 2, Dose 2|Death during treatment|0|||
161802040|NCT01273181|584318122|FG003|Phase 2, Dose 2|Death during treatment|1|||
161802041|NCT02458469|584318128|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161802042|NCT02458469|584318129|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161802043|NCT02458469|584318130|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
161802044|NCT02458469|584318131|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161802045|NCT02458469|584318132|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161802046|NCT02458469|584318133|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161802047|NCT02458469|584318128|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
161802048|NCT02458469|584318129|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
161802049|NCT02458469|584318130|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
161802050|NCT02458469|584318131|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
161802051|NCT02458469|584318132|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
161802052|NCT02458469|584318133|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
161802053|NCT02458469|584318128|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161802054|NCT02458469|584318129|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161802055|NCT02458469|584318130|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161802056|NCT02458469|584318131|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161802057|NCT02458469|584318132|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161802058|NCT02458469|584318133|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
161802059|NCT00661505|584318134|FG000|Overall Study|Adverse Event|3|||
161802060|NCT00661505|584318134|FG000|Overall Study|Protocol Violation|14|||
161802061|NCT00661505|584318134|FG000|Overall Study|Withdrawal by Subject|8|||
161802062|NCT00661505|584318134|FG000|Overall Study|Lost to Follow-up|3|||
161802063|NCT00661505|584318134|FG000|Overall Study|Other|2|||
161802064|NCT02603952|584318144|FG000|Overall Study|Withdrawal by Subject|1|||
161802065|NCT02603952|584318145|FG001|Overall Study|Withdrawal by Subject|0|||
161802066|NCT02603952|584318146|FG002|Overall Study|Withdrawal by Subject|0|||
161802067|NCT02603952|584318147|FG003|Overall Study|Withdrawal by Subject|0|||
161802068|NCT02603952|584318144|FG000|Overall Study|Received oseltamivir by error|0|||
161802069|NCT02603952|584318145|FG001|Overall Study|Received oseltamivir by error|0|||
161802070|NCT02603952|584318146|FG002|Overall Study|Received oseltamivir by error|0|||
161802071|NCT02603952|584318147|FG003|Overall Study|Received oseltamivir by error|1|||
161802072|NCT03283709|584318158|FG000|Overall Study|trial terminated|0|||
161802073|NCT03283709|584318159|FG001|Overall Study|trial terminated|1|||
161802074|NCT01347710|584318163|FG000|Overall Study|Withdrawal by Subject|2|||
161802075|NCT01347710|584318163|FG000|Overall Study|Adverse Event|4|||
161802076|NCT01347710|584318163|FG000|Overall Study|Angio or SPECT not completed|18|||
161802077|NCT01347710|584318163|FG000|Overall Study|issue with vitals prior to dosing|1|||
161802078|NCT01347710|584318163|FG000|Overall Study|Lost to Follow-up|1|||
161802079|NCT01347710|584318163|FG000|Overall Study|Physician Decision|2|||
161802080|NCT01347710|584318163|FG000|Overall Study|Other|3|||
161802081|NCT04591626|584318165|FG000|Overall Study|Adverse Event|4|||
161802082|NCT04591626|584318166|FG001|Overall Study|Adverse Event|0|||
161802083|NCT04591626|584318165|FG000|Overall Study|Withdrawal by Subject|5|||
161802084|NCT04591626|584318166|FG001|Overall Study|Withdrawal by Subject|3|||
161802085|NCT04591626|584318165|FG000|Overall Study|Physician Decision|0|||
161802086|NCT04591626|584318166|FG001|Overall Study|Physician Decision|1|||
161802087|NCT04591626|584318165|FG000|Overall Study|Death|0|||
161802088|NCT04591626|584318166|FG001|Overall Study|Death|1|||
161802089|NCT04591626|584318165|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161802090|NCT04591626|584318166|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161802091|NCT01004172|584318168|FG000|Overall Study|Progressive Disease in CNS Only|16|||
161802092|NCT01004172|584318168|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
161802093|NCT01004172|584318168|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
161802094|NCT01004172|584318168|FG000|Overall Study|Adverse Event|1|||
161802095|NCT01004172|584318168|FG000|Overall Study|Physician Decision|1|||
161802096|NCT01004172|584318168|FG000|Overall Study|Symptomatic Deterioration|2|||
161802097|NCT02003183|584318172|FG000|Overall Study|Lost to Follow-up|0|||
161802098|NCT02003183|584318173|FG001|Overall Study|Lost to Follow-up|2|||
161802099|NCT00841100|584318178|FG000|Phase 1 (28 Days)|Adverse Event|1|||
161802100|NCT00841100|584318178|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
162138965|NCT00389519|585560007|FG001|Placebo Run-In|Withdrawal by Subject|0|||
161802101|NCT03338972|584318179|FG000|Overall Study|Death|1|||
162138966|NCT00389519|585560008|FG002|Placebo Run-In|Withdrawal by Subject|0|||
162138967|NCT00389519|585560009|FG003|Placebo Run-In|Withdrawal by Subject|0|||
162138968|NCT00389519|585560006|FG000|Placebo Run-In|Reason not specified|40|||
162138969|NCT00389519|585560007|FG001|Placebo Run-In|Reason not specified|0|||
162138970|NCT00389519|585560008|FG002|Placebo Run-In|Reason not specified|0|||
162138971|NCT00389519|585560009|FG003|Placebo Run-In|Reason not specified|0|||
162138972|NCT00389519|585560006|FG000|Randomized|Did not receive study drug|2|||
162138973|NCT00389519|585560007|FG001|Randomized|Did not receive study drug|0|||
162138974|NCT00389519|585560008|FG002|Randomized|Did not receive study drug|0|||
162138975|NCT00389519|585560009|FG003|Randomized|Did not receive study drug|0|||
162138976|NCT00389519|585560006|FG000|Treated|Adverse Event|1|||
162138977|NCT00389519|585560007|FG001|Treated|Adverse Event|0|||
162138978|NCT00389519|585560008|FG002|Treated|Adverse Event|0|||
162138979|NCT00389519|585560009|FG003|Treated|Adverse Event|2|||
162138980|NCT00389519|585560006|FG000|Treated|Reason not specified|1|||
162138981|NCT00389519|585560007|FG001|Treated|Reason not specified|1|||
162138982|NCT00389519|585560008|FG002|Treated|Reason not specified|0|||
162138983|NCT00389519|585560009|FG003|Treated|Reason not specified|2|||
162138984|NCT03425539|585560012|FG000|Overall Study|Randomized but not treated|0|||
162138985|NCT03425539|585560013|FG001|Overall Study|Randomized but not treated|1|||
162138986|NCT03425539|585560012|FG000|Overall Study|Adverse Event|2|||
162138987|NCT03425539|585560013|FG001|Overall Study|Adverse Event|2|||
162138988|NCT03425539|585560012|FG000|Overall Study|Withdrawal by Subject|3|||
162138989|NCT03425539|585560013|FG001|Overall Study|Withdrawal by Subject|0|||
162138990|NCT03425539|585560012|FG000|Overall Study|Lost to Follow-up|0|||
162138991|NCT03425539|585560013|FG001|Overall Study|Lost to Follow-up|1|||
162138992|NCT02040844|585560014|FG000|Overall Study|Adverse Event|0|||
162138993|NCT02040844|585560015|FG001|Overall Study|Adverse Event|0|||
162138994|NCT02040844|585560016|FG002|Overall Study|Adverse Event|1|||
162138995|NCT02040844|585560014|FG000|Overall Study|Withdrawal by Subject|16|||
162138996|NCT02040844|585560015|FG001|Overall Study|Withdrawal by Subject|22|||
162138997|NCT02040844|585560016|FG002|Overall Study|Withdrawal by Subject|25|||
162138998|NCT02040844|585560014|FG000|Overall Study|Lost to Follow-up|12|||
162138999|NCT02040844|585560015|FG001|Overall Study|Lost to Follow-up|9|||
162139000|NCT02040844|585560016|FG002|Overall Study|Lost to Follow-up|13|||
162139001|NCT02040844|585560014|FG000|Overall Study|Missing|13|||
162139002|NCT02040844|585560015|FG001|Overall Study|Missing|3|||
162139003|NCT02040844|585560016|FG002|Overall Study|Missing|2|||
162139004|NCT02040844|585560014|FG000|Overall Study|Non-specified|8|||
162139005|NCT02040844|585560015|FG001|Overall Study|Non-specified|2|||
162139006|NCT02040844|585560016|FG002|Overall Study|Non-specified|5|||
162139007|NCT02040844|585560014|FG000|Overall Study|Concomitant medication|1|||
162139008|NCT02040844|585560015|FG001|Overall Study|Concomitant medication|3|||
162139009|NCT02040844|585560016|FG002|Overall Study|Concomitant medication|1|||
162139010|NCT01772719|585560017|FG000|Overall Study|Withdrawal by Subject|3|||
162139011|NCT01772719|585560017|FG000|Overall Study|Adverse Event|2|||
162139012|NCT01772719|585560017|FG000|Overall Study|Protocol Violation|1|||
162139013|NCT01772719|585560017|FG000|Overall Study|Lost to Follow-up|1|||
162139014|NCT00946192|585560018|FG000|Overall Study|Lost to Follow-up|6|||
162139015|NCT00946192|585560019|FG001|Overall Study|Lost to Follow-up|11|||
162139016|NCT00946192|585560020|FG002|Overall Study|Lost to Follow-up|9|||
162139017|NCT00946192|585560018|FG000|Overall Study|Withdrawal by Subject|10|||
161802102|NCT03338972|584318180|FG001|Overall Study|Death|1|||
161802103|NCT03338972|584318181|FG002|Overall Study|Death|0|||
161802104|NCT03338972|584318182|FG003|Overall Study|Death|0|||
161802105|NCT03338972|584318179|FG000|Overall Study|Withdrawal by Subject|1|||
161802106|NCT03338972|584318180|FG001|Overall Study|Withdrawal by Subject|0|||
161802107|NCT03338972|584318181|FG002|Overall Study|Withdrawal by Subject|0|||
161802108|NCT03338972|584318182|FG003|Overall Study|Withdrawal by Subject|0|||
162139018|NCT00946192|585560019|FG001|Overall Study|Withdrawal by Subject|7|||
162139019|NCT00946192|585560020|FG002|Overall Study|Withdrawal by Subject|3|||
162139020|NCT00946192|585560018|FG000|Overall Study|Did not start medication|2|||
162139021|NCT00946192|585560019|FG001|Overall Study|Did not start medication|0|||
162139022|NCT00946192|585560020|FG002|Overall Study|Did not start medication|0|||
162139023|NCT00477412|585560021|FG000|Overall Study|Death|0|||
161802109|NCT01355081|584318183|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
162139024|NCT00477412|585560022|FG001|Overall Study|Death|0|||
162139025|NCT00477412|585560023|FG002|Overall Study|Death|0|||
162139026|NCT00477412|585560024|FG003|Overall Study|Death|4|||
162139027|NCT00477412|585560021|FG000|Overall Study|Lost to Follow-up|0|||
161802110|NCT01355081|584318184|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
161802111|NCT01355081|584318185|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
161802112|NCT01355081|584318183|FG000|Overall Study|Major Protocol Deviation|0|||
161802113|NCT01355081|584318184|FG001|Overall Study|Major Protocol Deviation|1|||
161802114|NCT01355081|584318185|FG002|Overall Study|Major Protocol Deviation|0|||
161802115|NCT01355081|584318183|FG000|Overall Study|Lost to Follow-up|0|||
161802116|NCT01355081|584318184|FG001|Overall Study|Lost to Follow-up|0|||
161802117|NCT01355081|584318185|FG002|Overall Study|Lost to Follow-up|1|||
161802118|NCT01355081|584318183|FG000|Overall Study|Withdrawal of Consent|2|||
161802119|NCT01355081|584318184|FG001|Overall Study|Withdrawal of Consent|3|||
161802120|NCT01355081|584318185|FG002|Overall Study|Withdrawal of Consent|3|||
161802121|NCT01355081|584318183|FG000|Overall Study|Lack of Efficacy|2|||
161802122|NCT01355081|584318184|FG001|Overall Study|Lack of Efficacy|1|||
161802123|NCT01355081|584318185|FG002|Overall Study|Lack of Efficacy|1|||
161802124|NCT01355081|584318183|FG000|Overall Study|Non Compliance with Study Medication|0|||
161802125|NCT01355081|584318184|FG001|Overall Study|Non Compliance with Study Medication|1|||
161802126|NCT01355081|584318185|FG002|Overall Study|Non Compliance with Study Medication|0|||
161802127|NCT02719522|584318188|FG000|Overall Study|Implant Failure|4|||
161802128|NCT02719522|584318188|FG000|Overall Study|Death|2|||
161802129|NCT02719522|584318188|FG000|Overall Study|Lost to Follow-up|5|||
161802130|NCT06096168|584318189|FG000|Overall Study|Death|30|||
161802131|NCT06096168|584318189|FG000|Overall Study|Revision|2|||
161802132|NCT01868009|584318190|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
161802133|NCT01868009|584318191|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
161802134|NCT01868009|584318190|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
161802135|NCT01868009|584318191|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
161802136|NCT01868009|584318190|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
161802137|NCT01868009|584318191|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
161802138|NCT04603937|584318192|FG000|Overall Study|Adverse Event|9|||
161802139|NCT04603937|584318193|FG001|Overall Study|Adverse Event|10|||
161802140|NCT04603937|584318192|FG000|Overall Study|Withdrawal by Subject|7|||
161802141|NCT04603937|584318193|FG001|Overall Study|Withdrawal by Subject|6|||
161802142|NCT04603937|584318192|FG000|Overall Study|Lost to Follow-up|5|||
161802143|NCT04603937|584318193|FG001|Overall Study|Lost to Follow-up|6|||
161802144|NCT04603937|584318192|FG000|Overall Study|Physician Decision|0|||
161802145|NCT04603937|584318193|FG001|Overall Study|Physician Decision|1|||
161802146|NCT04603937|584318192|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
161802147|NCT04603937|584318193|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
161802148|NCT00993616|584318194|FG000|Overall Study|No tumor at entry|1|||
161802149|NCT00993616|584318194|FG000|Overall Study|Never treated|1|||
161802150|NCT02585258|584318195|FG000|Overall Study|Adverse Event|28|||
161802151|NCT02585258|584318196|FG001|Overall Study|Adverse Event|29|||
161802152|NCT02585258|584318195|FG000|Overall Study|Death|3|||
161802153|NCT02585258|584318196|FG001|Overall Study|Death|2|||
161802154|NCT02585258|584318195|FG000|Overall Study|Lack of Efficacy|7|||
161905345|NCT03433898|584701274|FG000|Overall Study|Death|0|||
161905346|NCT03433898|584701275|FG001|Overall Study|Death|0|||
161905347|NCT03433898|584701276|FG002|Overall Study|Death|0|||
161905348|NCT03433898|584701277|FG003|Overall Study|Death|0|||
161905349|NCT03433898|584701278|FG004|Overall Study|Death|0|||
161905350|NCT03433898|584701279|FG005|Overall Study|Death|0|||
161905351|NCT03433898|584701280|FG006|Overall Study|Death|1|||
161905352|NCT03433898|584701281|FG007|Overall Study|Death|1|||
161905353|NCT03433898|584701274|FG000|Overall Study|Withdrawal by Subject|0|||
161905354|NCT03433898|584701275|FG001|Overall Study|Withdrawal by Subject|0|||
161905355|NCT03433898|584701276|FG002|Overall Study|Withdrawal by Subject|0|||
161905356|NCT03433898|584701277|FG003|Overall Study|Withdrawal by Subject|0|||
161905357|NCT03433898|584701278|FG004|Overall Study|Withdrawal by Subject|2|||
161905358|NCT03433898|584701279|FG005|Overall Study|Withdrawal by Subject|0|||
161905359|NCT03433898|584701280|FG006|Overall Study|Withdrawal by Subject|0|||
161905360|NCT03433898|584701281|FG007|Overall Study|Withdrawal by Subject|0|||
161905361|NCT03433898|584701274|FG000|Overall Study|Adverse Event|0|||
161905362|NCT03433898|584701275|FG001|Overall Study|Adverse Event|0|||
161905363|NCT03433898|584701276|FG002|Overall Study|Adverse Event|0|||
161905364|NCT03433898|584701277|FG003|Overall Study|Adverse Event|0|||
161905365|NCT03433898|584701278|FG004|Overall Study|Adverse Event|0|||
161905366|NCT03433898|584701279|FG005|Overall Study|Adverse Event|5|||
161905367|NCT03433898|584701280|FG006|Overall Study|Adverse Event|2|||
161905368|NCT03433898|584701281|FG007|Overall Study|Adverse Event|2|||
161905369|NCT03433898|584701274|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905370|NCT03433898|584701275|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905371|NCT03433898|584701276|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905372|NCT03433898|584701277|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905373|NCT03433898|584701278|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
161905374|NCT03433898|584701279|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905375|NCT03433898|584701280|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905376|NCT03433898|584701281|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161905377|NCT01395810|584701286|FG000|Overall Study|Adverse Event|0|||
161905378|NCT01395810|584701287|FG001|Overall Study|Adverse Event|1|||
161905379|NCT01395810|584701288|FG002|Overall Study|Adverse Event|0|||
161905380|NCT01395810|584701289|FG003|Overall Study|Adverse Event|0|||
161905381|NCT01395810|584701286|FG000|Overall Study|Lack of Efficacy|0|||
161905382|NCT01395810|584701287|FG001|Overall Study|Lack of Efficacy|1|||
161905383|NCT01395810|584701288|FG002|Overall Study|Lack of Efficacy|0|||
161905384|NCT01395810|584701289|FG003|Overall Study|Lack of Efficacy|0|||
161905385|NCT01395810|584701286|FG000|Overall Study|Withdrawal criteria|0|||
161905386|NCT01395810|584701287|FG001|Overall Study|Withdrawal criteria|2|||
161905387|NCT01395810|584701288|FG002|Overall Study|Withdrawal criteria|0|||
161905388|NCT01395810|584701289|FG003|Overall Study|Withdrawal criteria|0|||
161905389|NCT01395810|584701286|FG000|Overall Study|Unclassified|2|||
161905390|NCT01395810|584701287|FG001|Overall Study|Unclassified|0|||
161905391|NCT01395810|584701288|FG002|Overall Study|Unclassified|0|||
161905392|NCT01395810|584701289|FG003|Overall Study|Unclassified|0|||
161905393|NCT04579380|584703322|FG000|Overall Study|Death|9|||
161905394|NCT04579380|584703323|FG001|Overall Study|Death|22|||
161905395|NCT04579380|584703324|FG002|Overall Study|Death|22|||
161905396|NCT04579380|584703325|FG003|Overall Study|Death|17|||
161905397|NCT04579380|584703326|FG004|Overall Study|Death|6|||
161905398|NCT04579380|584703327|FG005|Overall Study|Death|21|||
161905399|NCT04579380|584703328|FG006|Overall Study|Death|10|||
161905400|NCT04579380|584703329|FG007|Overall Study|Death|11|||
161905401|NCT04579380|584703330|FG008|Overall Study|Death|25|||
161905402|NCT04579380|584703322|FG000|Overall Study|Withdrawal by Subject|0|||
161905403|NCT04579380|584703323|FG001|Overall Study|Withdrawal by Subject|3|||
161905404|NCT04579380|584703324|FG002|Overall Study|Withdrawal by Subject|4|||
161905405|NCT04579380|584703325|FG003|Overall Study|Withdrawal by Subject|0|||
161905406|NCT04579380|584703326|FG004|Overall Study|Withdrawal by Subject|1|||
161905407|NCT04579380|584703327|FG005|Overall Study|Withdrawal by Subject|2|||
161905408|NCT04579380|584703328|FG006|Overall Study|Withdrawal by Subject|0|||
161905409|NCT04579380|584703329|FG007|Overall Study|Withdrawal by Subject|1|||
161905410|NCT04579380|584703330|FG008|Overall Study|Withdrawal by Subject|2|||
161905411|NCT04579380|584703322|FG000|Overall Study|Ongoing|2|||
161905412|NCT04579380|584703323|FG001|Overall Study|Ongoing|6|||
161905413|NCT04579380|584703324|FG002|Overall Study|Ongoing|4|||
161905414|NCT04579380|584703325|FG003|Overall Study|Ongoing|8|||
161905415|NCT04579380|584703326|FG004|Overall Study|Ongoing|5|||
161905416|NCT04579380|584703327|FG005|Overall Study|Ongoing|8|||
161905417|NCT04579380|584703328|FG006|Overall Study|Ongoing|3|||
161905418|NCT04579380|584703329|FG007|Overall Study|Ongoing|19|||
161905419|NCT04579380|584703330|FG008|Overall Study|Ongoing|6|||
161905420|NCT04113694|584703331|FG000|Overall Study|Adverse Event|2|||
161905421|NCT04113694|584703331|FG000|Overall Study|Lost to Follow-up|2|||
161905422|NCT04113694|584703331|FG000|Overall Study|Withdrawal by Subject|6|||
161905423|NCT04113694|584703331|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
161905424|NCT05630196|584703334|FG000|Overall Study|Adverse Event|2|||
161905425|NCT05630196|584703335|FG001|Overall Study|Adverse Event|1|||
161905426|NCT05630196|584703334|FG000|Overall Study|Lost to Follow-up|1|||
161905427|NCT05630196|584703335|FG001|Overall Study|Lost to Follow-up|1|||
161905428|NCT05630196|584703334|FG000|Overall Study|Protocol Violation|2|||
161905429|NCT05630196|584703335|FG001|Overall Study|Protocol Violation|3|||
161905430|NCT05630196|584703334|FG000|Overall Study|Physician Decision|1|||
161905431|NCT05630196|584703335|FG001|Overall Study|Physician Decision|0|||
161905432|NCT05630196|584703334|FG000|Overall Study|Withdrawal by Subject|3|||
161905433|NCT05630196|584703335|FG001|Overall Study|Withdrawal by Subject|4|||
161905434|NCT03973996|584703337|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161905435|NCT03973996|584703338|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161905436|NCT03973996|584703339|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161905437|NCT03973996|584703340|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
161905438|NCT04070989|584703341|FG000|Overall Study|Death|1|||
161802155|NCT02585258|584318196|FG001|Overall Study|Lack of Efficacy|9|||
161802156|NCT02585258|584318195|FG000|Overall Study|includes covid-related access problems|42|||
161802157|NCT02585258|584318196|FG001|Overall Study|includes covid-related access problems|46|||
162139028|NCT00477412|585560022|FG001|Overall Study|Lost to Follow-up|0|||
162139029|NCT00477412|585560023|FG002|Overall Study|Lost to Follow-up|0|||
162139030|NCT00477412|585560024|FG003|Overall Study|Lost to Follow-up|1|||
162139031|NCT00477412|585560021|FG000|Overall Study|Withdrawal by Subject|0|||
162139032|NCT00477412|585560022|FG001|Overall Study|Withdrawal by Subject|0|||
162139033|NCT00477412|585560023|FG002|Overall Study|Withdrawal by Subject|0|||
162139034|NCT00477412|585560024|FG003|Overall Study|Withdrawal by Subject|2|||
162139035|NCT00477412|585560021|FG000|Overall Study|Second Malignancy|0|||
162139036|NCT00477412|585560022|FG001|Overall Study|Second Malignancy|0|||
162139037|NCT00477412|585560023|FG002|Overall Study|Second Malignancy|0|||
162139038|NCT00477412|585560024|FG003|Overall Study|Second Malignancy|1|||
162139039|NCT00477412|585560021|FG000|Overall Study|Adverse Event|1|||
162139040|NCT00477412|585560022|FG001|Overall Study|Adverse Event|0|||
162139041|NCT00477412|585560023|FG002|Overall Study|Adverse Event|1|||
162139042|NCT00477412|585560024|FG003|Overall Study|Adverse Event|0|||
162139043|NCT01080131|585560025|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
162139044|NCT01080131|585560026|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
162139045|NCT01080131|585560025|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
162139046|NCT01080131|585560026|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
162139047|NCT01080131|585560025|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
162139048|NCT01080131|585560026|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
162139049|NCT01080131|585560025|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
162139050|NCT01080131|585560026|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
162139051|NCT01080131|585560025|FG000|Core Study (0- 12 Weeks)|Death|1|||
162139052|NCT01080131|585560026|FG001|Core Study (0- 12 Weeks)|Death|0|||
162139053|NCT01080131|585560025|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
162139054|NCT01080131|585560026|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
161802158|NCT02585258|584318195|FG000|Overall Study|Lost to Follow-up|5|||
161802159|NCT02585258|584318196|FG001|Overall Study|Lost to Follow-up|2|||
161802160|NCT05125952|584318197|FG000|Overall Study|Physician Decision|1|||
161802161|NCT03946449|584318198|FG000|Treatment Extension II|Rolled over to another study|0|||
161802162|NCT03946449|584318199|FG001|Treatment Extension II|Rolled over to another study|0|||
161802163|NCT03946449|584318200|FG002|Treatment Extension II|Rolled over to another study|2|||
161802164|NCT03946449|584318198|FG000|Treatment Extension II|Withdrawal by Subject|0|||
161802165|NCT03946449|584318199|FG001|Treatment Extension II|Withdrawal by Subject|0|||
161802166|NCT03946449|584318200|FG002|Treatment Extension II|Withdrawal by Subject|1|||
161802167|NCT02848326|584319603|FG000|Treatment Period|Adverse Event|5|||
161802168|NCT02848326|584319604|FG001|Treatment Period|Adverse Event|4|||
161802169|NCT02848326|584319605|FG002|Treatment Period|Adverse Event|11|||
161802170|NCT02848326|584319606|FG003|Treatment Period|Adverse Event|6|||
161802171|NCT02848326|584319607|FG004|Treatment Period|Adverse Event|5|||
161802172|NCT02848326|584319608|FG005|Treatment Period|Adverse Event|7|||
161802173|NCT02848326|584319603|FG000|Treatment Period|Withdrawal of Consent|20|||
161802174|NCT02848326|584319604|FG001|Treatment Period|Withdrawal of Consent|6|||
161802175|NCT02848326|584319605|FG002|Treatment Period|Withdrawal of Consent|9|||
161802176|NCT02848326|584319606|FG003|Treatment Period|Withdrawal of Consent|6|||
161802177|NCT02848326|584319607|FG004|Treatment Period|Withdrawal of Consent|9|||
161802178|NCT02848326|584319608|FG005|Treatment Period|Withdrawal of Consent|6|||
161802179|NCT02848326|584319603|FG000|Treatment Period|Lost to Follow-up|5|||
161802180|NCT02848326|584319604|FG001|Treatment Period|Lost to Follow-up|1|||
161802181|NCT02848326|584319605|FG002|Treatment Period|Lost to Follow-up|11|||
161802182|NCT02848326|584319606|FG003|Treatment Period|Lost to Follow-up|7|||
161802183|NCT02848326|584319607|FG004|Treatment Period|Lost to Follow-up|2|||
161802184|NCT02848326|584319608|FG005|Treatment Period|Lost to Follow-up|3|||
161802185|NCT02848326|584319603|FG000|Treatment Period|Pregnancy|0|||
161802186|NCT02848326|584319604|FG001|Treatment Period|Pregnancy|0|||
161802187|NCT02848326|584319605|FG002|Treatment Period|Pregnancy|1|||
161802188|NCT02848326|584319606|FG003|Treatment Period|Pregnancy|1|||
161802189|NCT02848326|584319607|FG004|Treatment Period|Pregnancy|0|||
161802190|NCT02848326|584319608|FG005|Treatment Period|Pregnancy|1|||
161802191|NCT02848326|584319603|FG000|Treatment Period|Protocol Violation|4|||
161802192|NCT02848326|584319604|FG001|Treatment Period|Protocol Violation|3|||
161802193|NCT02848326|584319605|FG002|Treatment Period|Protocol Violation|4|||
161802194|NCT02848326|584319606|FG003|Treatment Period|Protocol Violation|2|||
161802195|NCT02848326|584319607|FG004|Treatment Period|Protocol Violation|3|||
161802196|NCT02848326|584319608|FG005|Treatment Period|Protocol Violation|3|||
161802197|NCT02848326|584319603|FG000|Treatment Period|Non-compliance with Study Drug|4|||
161802198|NCT02848326|584319604|FG001|Treatment Period|Non-compliance with Study Drug|0|||
161802199|NCT02848326|584319605|FG002|Treatment Period|Non-compliance with Study Drug|0|||
161802200|NCT02848326|584319606|FG003|Treatment Period|Non-compliance with Study Drug|1|||
162010891|NCT02594124|585096047|FG004|Overall Study|Withdrawal by Subject|8|||
162010892|NCT02594124|585096048|FG005|Overall Study|Withdrawal by Subject|4|||
162139055|NCT01080131|585560025|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
162139056|NCT01080131|585560026|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
162139057|NCT01080131|585560025|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
161802201|NCT02848326|584319607|FG004|Treatment Period|Non-compliance with Study Drug|0|||
161802202|NCT02848326|584319608|FG005|Treatment Period|Non-compliance with Study Drug|0|||
161802203|NCT02848326|584319603|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
161802204|NCT02848326|584319604|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
161802205|NCT02848326|584319605|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
161802206|NCT02848326|584319606|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
161802207|NCT02848326|584319607|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
161802208|NCT02848326|584319608|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
161802209|NCT02848326|584319603|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
161802210|NCT02848326|584319604|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
161802211|NCT02848326|584319605|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
161802212|NCT02848326|584319606|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
161802213|NCT02848326|584319607|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
161802214|NCT02848326|584319608|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
161802215|NCT04349917|584319626|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
161802216|NCT04349917|584319627|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
161802217|NCT04349917|584319626|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
161802218|NCT04349917|584319627|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
161802219|NCT00441467|584319631|FG000|Overall Study|Adverse Event|6|||
161802220|NCT00441467|584319631|FG000|Overall Study|Withdrawal by Subject|3|||
161802221|NCT00441467|584319631|FG000|Overall Study|Progressive disease|9|||
161802222|NCT01042522|584319633|FG000|Overall Study|Adverse Event|1|||
161802223|NCT01042522|584319634|FG001|Overall Study|Adverse Event|2|||
161802224|NCT01042522|584319633|FG000|Overall Study|Disease Progression|5|||
161802225|NCT01042522|584319634|FG001|Overall Study|Disease Progression|0|||
161802226|NCT01042522|584319633|FG000|Overall Study|Death|1|||
161802227|NCT01042522|584319634|FG001|Overall Study|Death|0|||
161802228|NCT01042522|584319633|FG000|Overall Study|Patient Refused|0|||
161802229|NCT01042522|584319634|FG001|Overall Study|Patient Refused|3|||
161802230|NCT01042522|584319633|FG000|Overall Study|Withdrawal by Subject|1|||
161802231|NCT01042522|584319634|FG001|Overall Study|Withdrawal by Subject|1|||
161802232|NCT00745420|584319638|FG000|Overall Study|Ineligible|1|||
162139058|NCT01080131|585560026|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
162139059|NCT01080131|585560025|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
162139060|NCT01080131|585560026|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
162139061|NCT01080131|585560025|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
162139062|NCT01080131|585560026|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
162139063|NCT01080131|585560025|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
162139064|NCT01080131|585560026|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
162139065|NCT01080131|585560025|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
162139066|NCT01080131|585560026|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
162139067|NCT01080131|585560025|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
162139068|NCT01080131|585560026|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
162139069|NCT02014558|585560027|FG000|Overall Study|Never Received Study Drug|0|||
162139070|NCT02014558|585560028|FG001|Overall Study|Never Received Study Drug|0|||
162139071|NCT02014558|585560029|FG002|Overall Study|Never Received Study Drug|0|||
162139072|NCT02014558|585560030|FG003|Overall Study|Never Received Study Drug|0|||
162139073|NCT02014558|585560031|FG004|Overall Study|Never Received Study Drug|1|||
162139074|NCT02014558|585560032|FG005|Overall Study|Never Received Study Drug|0|||
162139075|NCT02014558|585560033|FG006|Overall Study|Never Received Study Drug|1|||
162139076|NCT02014558|585560034|FG007|Overall Study|Never Received Study Drug|0|||
162139077|NCT02014558|585560035|FG008|Overall Study|Never Received Study Drug|2|||
162139078|NCT02014558|585560036|FG009|Overall Study|Never Received Study Drug|0|||
162139079|NCT02014558|585560037|FG010|Overall Study|Never Received Study Drug|2|||
162139080|NCT02014558|585560038|FG011|Overall Study|Never Received Study Drug|2|||
162139081|NCT02014558|585560039|FG012|Overall Study|Never Received Study Drug|0|||
162139082|NCT02014558|585560027|FG000|Overall Study|Adverse Event|0|||
162139083|NCT02014558|585560028|FG001|Overall Study|Adverse Event|0|||
162139084|NCT02014558|585560029|FG002|Overall Study|Adverse Event|0|||
162139085|NCT02014558|585560030|FG003|Overall Study|Adverse Event|0|||
162139086|NCT02014558|585560031|FG004|Overall Study|Adverse Event|1|||
162139087|NCT02014558|585560032|FG005|Overall Study|Adverse Event|0|||
162139088|NCT02014558|585560033|FG006|Overall Study|Adverse Event|0|||
162139089|NCT02014558|585560034|FG007|Overall Study|Adverse Event|0|||
162139090|NCT02014558|585560035|FG008|Overall Study|Adverse Event|2|||
162139091|NCT02014558|585560036|FG009|Overall Study|Adverse Event|2|||
162139092|NCT02014558|585560037|FG010|Overall Study|Adverse Event|5|||
162139093|NCT02014558|585560038|FG011|Overall Study|Adverse Event|21|||
162139094|NCT02014558|585560039|FG012|Overall Study|Adverse Event|3|||
162139095|NCT02014558|585560027|FG000|Overall Study|Death|1|||
162139096|NCT02014558|585560028|FG001|Overall Study|Death|0|||
162139097|NCT02014558|585560029|FG002|Overall Study|Death|0|||
162139098|NCT02014558|585560030|FG003|Overall Study|Death|0|||
162139099|NCT02014558|585560031|FG004|Overall Study|Death|0|||
162139100|NCT02014558|585560032|FG005|Overall Study|Death|0|||
162139101|NCT02014558|585560033|FG006|Overall Study|Death|1|||
162139102|NCT02014558|585560034|FG007|Overall Study|Death|1|||
162139103|NCT02014558|585560035|FG008|Overall Study|Death|2|||
162139104|NCT02014558|585560036|FG009|Overall Study|Death|5|||
162139105|NCT02014558|585560037|FG010|Overall Study|Death|5|||
162139106|NCT02014558|585560038|FG011|Overall Study|Death|19|||
162139107|NCT02014558|585560039|FG012|Overall Study|Death|2|||
162139108|NCT02014558|585560027|FG000|Overall Study|Lack of Efficacy|1|||
162139109|NCT02014558|585560028|FG001|Overall Study|Lack of Efficacy|2|||
162139110|NCT02014558|585560029|FG002|Overall Study|Lack of Efficacy|1|||
162139111|NCT02014558|585560030|FG003|Overall Study|Lack of Efficacy|1|||
162139112|NCT02014558|585560031|FG004|Overall Study|Lack of Efficacy|0|||
162139113|NCT02014558|585560032|FG005|Overall Study|Lack of Efficacy|0|||
162139114|NCT02014558|585560033|FG006|Overall Study|Lack of Efficacy|1|||
162139115|NCT02014558|585560034|FG007|Overall Study|Lack of Efficacy|3|||
162139116|NCT02014558|585560035|FG008|Overall Study|Lack of Efficacy|3|||
162139117|NCT02014558|585560036|FG009|Overall Study|Lack of Efficacy|3|||
162139118|NCT02014558|585560037|FG010|Overall Study|Lack of Efficacy|16|||
161802233|NCT00088829|584319648|FG000|Overall Study|PI left institution and study was close|22|||
161802234|NCT01367275|584319649|FG000|Overall Study|Ineligible|1|||
161802235|NCT01367275|584319649|FG000|Overall Study|Disease Progression|2|||
162139119|NCT02014558|585560038|FG011|Overall Study|Lack of Efficacy|8|||
162139120|NCT02014558|585560039|FG012|Overall Study|Lack of Efficacy|5|||
162139121|NCT02014558|585560027|FG000|Overall Study|Lost to Follow-up|0|||
162139122|NCT02014558|585560028|FG001|Overall Study|Lost to Follow-up|0|||
162139123|NCT02014558|585560029|FG002|Overall Study|Lost to Follow-up|0|||
162139124|NCT02014558|585560030|FG003|Overall Study|Lost to Follow-up|0|||
162139125|NCT02014558|585560031|FG004|Overall Study|Lost to Follow-up|0|||
162139126|NCT02014558|585560032|FG005|Overall Study|Lost to Follow-up|0|||
161905439|NCT04070989|584703342|FG001|Overall Study|Death|0|||
161905440|NCT04070989|584703343|FG002|Overall Study|Death|0|||
161905441|NCT04070989|584703341|FG000|Overall Study|Study Terminated by Sponsor|7|||
161905442|NCT04070989|584703342|FG001|Overall Study|Study Terminated by Sponsor|8|||
161905443|NCT04070989|584703343|FG002|Overall Study|Study Terminated by Sponsor|23|||
161905444|NCT04070989|584703341|FG000|Overall Study|Withdrawal by Subject|0|||
161905445|NCT04070989|584703342|FG001|Overall Study|Withdrawal by Subject|1|||
161905446|NCT04070989|584703343|FG002|Overall Study|Withdrawal by Subject|0|||
161905447|NCT04070989|584703341|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
161905448|NCT04070989|584703342|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
161905449|NCT04070989|584703343|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
161905450|NCT04070989|584703341|FG000|Overall Study|Other|1|||
161905451|NCT04070989|584703342|FG001|Overall Study|Other|1|||
161905452|NCT04070989|584703343|FG002|Overall Study|Other|0|||
161802236|NCT02532764|584319650|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161802237|NCT02532764|584319651|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161802238|NCT02532764|584319652|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161802239|NCT02532764|584319653|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161802240|NCT02532764|584319654|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161802241|NCT02532764|584319655|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161905453|NCT06088784|584703344|FG000|Overall Study|Adverse Event|0|||
161802242|NCT02532764|584319656|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161802243|NCT02532764|584319657|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
161802244|NCT02532764|584319658|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
161905454|NCT06088784|584703345|FG001|Overall Study|Adverse Event|0|||
162139127|NCT02014558|585560033|FG006|Overall Study|Lost to Follow-up|0|||
162139128|NCT02014558|585560034|FG007|Overall Study|Lost to Follow-up|0|||
162139129|NCT02014558|585560035|FG008|Overall Study|Lost to Follow-up|0|||
162139130|NCT02014558|585560036|FG009|Overall Study|Lost to Follow-up|0|||
162139131|NCT02014558|585560037|FG010|Overall Study|Lost to Follow-up|1|||
162139132|NCT02014558|585560038|FG011|Overall Study|Lost to Follow-up|0|||
162139133|NCT02014558|585560039|FG012|Overall Study|Lost to Follow-up|0|||
162139134|NCT02014558|585560027|FG000|Overall Study|Progressive Disease|1|||
162139135|NCT02014558|585560028|FG001|Overall Study|Progressive Disease|0|||
162139136|NCT02014558|585560029|FG002|Overall Study|Progressive Disease|1|||
161905455|NCT06088784|584703346|FG002|Overall Study|Adverse Event|0|||
161905456|NCT06088784|584703347|FG003|Overall Study|Adverse Event|0|||
161905457|NCT06088784|584703348|FG004|Overall Study|Adverse Event|0|||
161905458|NCT06088784|584703349|FG005|Overall Study|Adverse Event|0|||
161905459|NCT06088784|584703350|FG006|Overall Study|Adverse Event|3|||
161905460|NCT06088784|584703351|FG007|Overall Study|Adverse Event|0|||
161905461|NCT06088784|584703352|FG008|Overall Study|Adverse Event|0|||
161905462|NCT06088784|584703353|FG009|Overall Study|Adverse Event|0|||
161905463|NCT06088784|584703354|FG010|Overall Study|Adverse Event|0|||
161905464|NCT06088784|584703355|FG011|Overall Study|Adverse Event|0|||
161905465|NCT06088784|584703344|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905466|NCT06088784|584703345|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905467|NCT06088784|584703346|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905468|NCT06088784|584703347|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905469|NCT06088784|584703348|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905470|NCT06088784|584703349|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905471|NCT06088784|584703350|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
161905472|NCT06088784|584703351|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905473|NCT06088784|584703352|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905474|NCT06088784|584703353|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905475|NCT06088784|584703354|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905476|NCT06088784|584703355|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161905477|NCT05556616|584703358|FG000|Overall Study|Withdrawal by Subject|1|||
161905478|NCT05556616|584703359|FG001|Overall Study|Withdrawal by Subject|0|||
161905479|NCT05556616|584703360|FG002|Overall Study|Withdrawal by Subject|0|||
162139137|NCT02014558|585560030|FG003|Overall Study|Progressive Disease|1|||
162139138|NCT02014558|585560031|FG004|Overall Study|Progressive Disease|1|||
162139139|NCT02014558|585560032|FG005|Overall Study|Progressive Disease|2|||
162139140|NCT02014558|585560033|FG006|Overall Study|Progressive Disease|1|||
162139141|NCT02014558|585560034|FG007|Overall Study|Progressive Disease|6|||
162139142|NCT02014558|585560035|FG008|Overall Study|Progressive Disease|5|||
162139143|NCT02014558|585560036|FG009|Overall Study|Progressive Disease|6|||
162139144|NCT02014558|585560037|FG010|Overall Study|Progressive Disease|22|||
162139145|NCT02014558|585560038|FG011|Overall Study|Progressive Disease|31|||
162139146|NCT02014558|585560039|FG012|Overall Study|Progressive Disease|6|||
162139147|NCT02014558|585560027|FG000|Overall Study|Withdrawal by Subject|0|||
162139148|NCT02014558|585560028|FG001|Overall Study|Withdrawal by Subject|0|||
162139149|NCT02014558|585560029|FG002|Overall Study|Withdrawal by Subject|0|||
162139150|NCT02014558|585560030|FG003|Overall Study|Withdrawal by Subject|0|||
162139151|NCT02014558|585560031|FG004|Overall Study|Withdrawal by Subject|1|||
162139152|NCT02014558|585560032|FG005|Overall Study|Withdrawal by Subject|0|||
162139153|NCT02014558|585560033|FG006|Overall Study|Withdrawal by Subject|0|||
162139154|NCT02014558|585560034|FG007|Overall Study|Withdrawal by Subject|0|||
162139155|NCT02014558|585560035|FG008|Overall Study|Withdrawal by Subject|0|||
162139156|NCT02014558|585560036|FG009|Overall Study|Withdrawal by Subject|2|||
162139157|NCT02014558|585560037|FG010|Overall Study|Withdrawal by Subject|6|||
162139158|NCT02014558|585560038|FG011|Overall Study|Withdrawal by Subject|10|||
162139159|NCT02014558|585560039|FG012|Overall Study|Withdrawal by Subject|0|||
162139160|NCT02014558|585560027|FG000|Overall Study|Miscellaneous|2|||
162139161|NCT02014558|585560028|FG001|Overall Study|Miscellaneous|1|||
162139162|NCT02014558|585560029|FG002|Overall Study|Miscellaneous|1|||
162139163|NCT02014558|585560030|FG003|Overall Study|Miscellaneous|1|||
162139164|NCT02014558|585560031|FG004|Overall Study|Miscellaneous|0|||
162139165|NCT02014558|585560032|FG005|Overall Study|Miscellaneous|1|||
162139166|NCT02014558|585560033|FG006|Overall Study|Miscellaneous|0|||
162139167|NCT02014558|585560034|FG007|Overall Study|Miscellaneous|1|||
162139168|NCT02014558|585560035|FG008|Overall Study|Miscellaneous|1|||
162139169|NCT02014558|585560036|FG009|Overall Study|Miscellaneous|3|||
162139170|NCT02014558|585560037|FG010|Overall Study|Miscellaneous|12|||
162139171|NCT02014558|585560038|FG011|Overall Study|Miscellaneous|11|||
162139172|NCT02014558|585560039|FG012|Overall Study|Miscellaneous|1|||
162139173|NCT01560949|585560040|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
162139174|NCT01560949|585560040|FG000|Surgery Phase|Physician Decision|3|||
161905480|NCT05556616|584703361|FG003|Overall Study|Withdrawal by Subject|0|||
161905481|NCT05556616|584703362|FG004|Overall Study|Withdrawal by Subject|0|||
161905482|NCT05556616|584703363|FG005|Overall Study|Withdrawal by Subject|0|||
161905483|NCT05556616|584703364|FG006|Overall Study|Withdrawal by Subject|0|||
162139175|NCT05460663|585560041|FG000|Overall Study|Withdrawal by Subject|2|||
162139176|NCT05460663|585560042|FG001|Overall Study|Withdrawal by Subject|5|||
162139177|NCT03068468|585561368|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
162139178|NCT03068468|585561369|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
162139179|NCT03068468|585561370|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
161905484|NCT05556616|584703358|FG000|Overall Study|Death|0|||
162139180|NCT03068468|585561371|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
162139181|NCT03068468|585561368|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
162139182|NCT03068468|585561369|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
162139183|NCT03068468|585561370|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
162139184|NCT03068468|585561371|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
161802245|NCT02532764|584319659|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
161802246|NCT00048568|584319661|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
161802247|NCT00048568|584319662|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
161802248|NCT00048568|584319663|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
161802249|NCT00048568|584319661|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
161802250|NCT00048568|584319662|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
161802251|NCT00048568|584319663|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
161802252|NCT00048568|584319661|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
161802253|NCT00048568|584319662|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
161802254|NCT00048568|584319663|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
161802255|NCT00048568|584319661|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
161802256|NCT00048568|584319662|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
161802257|NCT00048568|584319663|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
161802258|NCT00048568|584319661|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
161802259|NCT00048568|584319662|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
161802260|NCT00048568|584319663|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
161802261|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|Death|1|||
161802262|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|Death|1|||
161802263|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|Death|0|||
161802264|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
161802265|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
161802266|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
161802267|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
161802268|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
161802269|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
161802270|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
161802271|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
161802272|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
161802273|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
161802274|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
161802275|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
161802276|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
161802277|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
161802278|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
161802279|NCT00048568|584319661|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
161802280|NCT00048568|584319662|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
161802281|NCT00048568|584319663|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
161802282|NCT00048568|584319661|FG000|Open-Label Period|Death|0|||
161802283|NCT00048568|584319662|FG001|Open-Label Period|Death|0|||
161802284|NCT00048568|584319663|FG002|Open-Label Period|Death|13|||
161802285|NCT00048568|584319661|FG000|Open-Label Period|Adverse Event|0|||
161802286|NCT00048568|584319662|FG001|Open-Label Period|Adverse Event|0|||
161802287|NCT00048568|584319663|FG002|Open-Label Period|Adverse Event|49|||
161802288|NCT00048568|584319661|FG000|Open-Label Period|Lack of Efficacy|0|||
161802289|NCT00048568|584319662|FG001|Open-Label Period|Lack of Efficacy|0|||
161802290|NCT00048568|584319663|FG002|Open-Label Period|Lack of Efficacy|32|||
161802291|NCT00048568|584319661|FG000|Open-Label Period|Withdrawal by Subject|0|||
161802292|NCT00048568|584319662|FG001|Open-Label Period|Withdrawal by Subject|0|||
161802293|NCT00048568|584319663|FG002|Open-Label Period|Withdrawal by Subject|26|||
161802294|NCT00048568|584319661|FG000|Open-Label Period|Pregnancy|0|||
161802295|NCT00048568|584319662|FG001|Open-Label Period|Pregnancy|0|||
161802296|NCT00048568|584319663|FG002|Open-Label Period|Pregnancy|5|||
161802297|NCT00048568|584319661|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
161802298|NCT00048568|584319662|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
161905485|NCT05556616|584703359|FG001|Overall Study|Death|0|||
161905486|NCT05556616|584703360|FG002|Overall Study|Death|2|||
161905487|NCT05556616|584703361|FG003|Overall Study|Death|1|||
161802299|NCT00048568|584319663|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
161802300|NCT00048568|584319661|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
161802301|NCT00048568|584319662|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
161802302|NCT00048568|584319663|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
161802303|NCT00048568|584319661|FG000|Open-Label Period|Unknown Reasons|0|||
161802304|NCT00048568|584319662|FG001|Open-Label Period|Unknown Reasons|0|||
161802305|NCT00048568|584319663|FG002|Open-Label Period|Unknown Reasons|25|||
161802306|NCT00048568|584319661|FG000|Open-Label Period|Lost to Follow-up|0|||
161802307|NCT00048568|584319662|FG001|Open-Label Period|Lost to Follow-up|0|||
161802308|NCT00048568|584319663|FG002|Open-Label Period|Lost to Follow-up|7|||
161802309|NCT01717976|584319664|FG000|Overall Study|Protocol Violation|0|||
161802310|NCT01717976|584319665|FG001|Overall Study|Protocol Violation|1|||
161802311|NCT03831048|584319666|FG000|Overall Study|Protocol Violation|9|||
161802312|NCT03831048|584319667|FG001|Overall Study|Protocol Violation|3|||
161802313|NCT03831048|584319666|FG000|Overall Study|Death|4|||
161802314|NCT03831048|584319667|FG001|Overall Study|Death|9|||
161802315|NCT03831048|584319666|FG000|Overall Study|Re-transplant|0|||
161802316|NCT03831048|584319667|FG001|Overall Study|Re-transplant|2|||
161802317|NCT03831048|584319666|FG000|Overall Study|Protocol violation and death|1|||
161802318|NCT03831048|584319667|FG001|Overall Study|Protocol violation and death|1|||
161802319|NCT01996033|584319669|FG000|Overall Study|Death|1|||
161905488|NCT05556616|584703362|FG004|Overall Study|Death|0|||
161802320|NCT01996033|584319669|FG000|Overall Study|Physician Decision|1|||
161802321|NCT01996033|584319669|FG000|Overall Study|Withdrawal by Subject|4|||
161802322|NCT01996033|584319669|FG000|Overall Study|Lost to Follow-up|3|||
161905489|NCT05556616|584703363|FG005|Overall Study|Death|0|||
161802323|NCT02731157|584319671|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
161802324|NCT04276883|584319676|FG000|Overall Study|Withdrawal by Subject|2|||
161802325|NCT04276883|584319677|FG001|Overall Study|Withdrawal by Subject|3|||
161802326|NCT04276883|584319678|FG002|Overall Study|Withdrawal by Subject|6|||
161802327|NCT04276883|584319676|FG000|Overall Study|Lost to Follow-up|1|||
161802328|NCT04276883|584319677|FG001|Overall Study|Lost to Follow-up|3|||
161905490|NCT05556616|584703364|FG006|Overall Study|Death|0|||
161905491|NCT05556616|584703358|FG000|Overall Study|Study Terminated by Sponsor|0|||
161905492|NCT05556616|584703359|FG001|Overall Study|Study Terminated by Sponsor|3|||
161905493|NCT05556616|584703360|FG002|Overall Study|Study Terminated by Sponsor|0|||
161905494|NCT05556616|584703361|FG003|Overall Study|Study Terminated by Sponsor|0|||
161905495|NCT05556616|584703362|FG004|Overall Study|Study Terminated by Sponsor|0|||
161905496|NCT05556616|584703363|FG005|Overall Study|Study Terminated by Sponsor|0|||
161905497|NCT05556616|584703364|FG006|Overall Study|Study Terminated by Sponsor|0|||
161905498|NCT03256578|584703365|FG000|Overall Study|Excluded Post Randomization|66|||
161905499|NCT03256578|584703366|FG001|Overall Study|Excluded Post Randomization|56|||
161905500|NCT05428436|584703367|FG000|Period 1 - 2 washout|Adverse Event|1|||
161905501|NCT05428436|584703368|FG001|Period 1 - 2 washout|Adverse Event|0|||
161802329|NCT04276883|584319678|FG002|Overall Study|Lost to Follow-up|0|||
161802330|NCT04276883|584319676|FG000|Overall Study|Adverse Event|0|||
161802331|NCT04276883|584319677|FG001|Overall Study|Adverse Event|1|||
161802332|NCT04276883|584319678|FG002|Overall Study|Adverse Event|0|||
161802333|NCT04276883|584319676|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
161802334|NCT04276883|584319677|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
161802335|NCT04276883|584319678|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
161802336|NCT02732210|584319679|FG000|Overall Study|Site Closed|0|||
161905502|NCT05428436|584703369|FG002|Period 1 - 2 washout|Adverse Event|0|||
161905503|NCT03964207|584703370|FG000|First Treatment|Withdrawal by Subject|1|||
161905504|NCT03964207|584703371|FG001|First Treatment|Withdrawal by Subject|2|||
161905505|NCT03964207|584703370|FG000|First Treatment|Protocol Violation|1|||
161905506|NCT03964207|584703371|FG001|First Treatment|Protocol Violation|0|||
161905507|NCT03964207|584703370|FG000|First Treatment|Lost to Follow-up|1|||
161905508|NCT03964207|584703371|FG001|First Treatment|Lost to Follow-up|0|||
161905509|NCT03964207|584703370|FG000|Second Treatment|Lost to Follow-up|0|||
161802337|NCT02732210|584319680|FG001|Overall Study|Site Closed|11|||
161802338|NCT02732210|584319679|FG000|Overall Study|Study Ended|13|||
161802339|NCT02732210|584319680|FG001|Overall Study|Study Ended|13|||
161802340|NCT02732210|584319679|FG000|Overall Study|Withdrawal by Subject|28|||
161802341|NCT02732210|584319680|FG001|Overall Study|Withdrawal by Subject|87|||
161905510|NCT03964207|584703371|FG001|Second Treatment|Lost to Follow-up|1|||
161905511|NCT03964207|584703370|FG000|Second Treatment|Adverse Event|1|||
161905512|NCT03964207|584703371|FG001|Second Treatment|Adverse Event|2|||
161905513|NCT00830219|584703372|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161905514|NCT00830219|584703373|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161905515|NCT01130272|584703374|FG000|Overall Study|Adverse Event|2|||
161802342|NCT02732210|584319679|FG000|Overall Study|Lost to Follow-up|5|||
161905516|NCT01130272|584703375|FG001|Overall Study|Adverse Event|5|||
161905517|NCT01130272|584703376|FG002|Overall Study|Adverse Event|6|||
161905518|NCT01130272|584703377|FG003|Overall Study|Adverse Event|22|||
161905519|NCT01130272|584703378|FG004|Overall Study|Adverse Event|7|||
161905520|NCT01130272|584703374|FG000|Overall Study|IVRS-confirmed constipation|0|||
161905521|NCT01130272|584703375|FG001|Overall Study|IVRS-confirmed constipation|1|||
161905522|NCT01130272|584703376|FG002|Overall Study|IVRS-confirmed constipation|1|||
161905523|NCT01130272|584703377|FG003|Overall Study|IVRS-confirmed constipation|2|||
161905524|NCT01130272|584703378|FG004|Overall Study|IVRS-confirmed constipation|0|||
161905525|NCT01130272|584703374|FG000|Overall Study|Rescue medications due to diarrhea|3|||
161905526|NCT01130272|584703375|FG001|Overall Study|Rescue medications due to diarrhea|5|||
161905527|NCT01130272|584703376|FG002|Overall Study|Rescue medications due to diarrhea|8|||
161905528|NCT01130272|584703377|FG003|Overall Study|Rescue medications due to diarrhea|8|||
161905529|NCT01130272|584703378|FG004|Overall Study|Rescue medications due to diarrhea|6|||
161905530|NCT01130272|584703374|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
161905531|NCT01130272|584703375|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
161905532|NCT01130272|584703376|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
161905533|NCT01130272|584703377|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
161905534|NCT01130272|584703378|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
161905535|NCT01130272|584703374|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
161905536|NCT01130272|584703375|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
161905537|NCT01130272|584703376|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
161905538|NCT01130272|584703377|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
161905539|NCT01130272|584703378|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
161802343|NCT02732210|584319680|FG001|Overall Study|Lost to Follow-up|57|||
161802344|NCT02732210|584319679|FG000|Overall Study|Death|4|||
161802345|NCT02732210|584319680|FG001|Overall Study|Death|15|||
161905540|NCT01130272|584703374|FG000|Overall Study|Protocol Violation|0|||
161905541|NCT01130272|584703375|FG001|Overall Study|Protocol Violation|0|||
161905542|NCT01130272|584703376|FG002|Overall Study|Protocol Violation|3|||
161905543|NCT01130272|584703377|FG003|Overall Study|Protocol Violation|5|||
161905544|NCT01130272|584703378|FG004|Overall Study|Protocol Violation|5|||
161905545|NCT01130272|584703374|FG000|Overall Study|Lost to Follow-up|4|||
161905546|NCT01130272|584703375|FG001|Overall Study|Lost to Follow-up|3|||
161905547|NCT01130272|584703376|FG002|Overall Study|Lost to Follow-up|4|||
161905548|NCT01130272|584703377|FG003|Overall Study|Lost to Follow-up|7|||
161905549|NCT01130272|584703378|FG004|Overall Study|Lost to Follow-up|6|||
161905550|NCT01130272|584703374|FG000|Overall Study|Withdrawal by Subject|4|||
161905551|NCT01130272|584703375|FG001|Overall Study|Withdrawal by Subject|11|||
161905552|NCT01130272|584703376|FG002|Overall Study|Withdrawal by Subject|10|||
161905553|NCT01130272|584703377|FG003|Overall Study|Withdrawal by Subject|9|||
161905554|NCT01130272|584703378|FG004|Overall Study|Withdrawal by Subject|8|||
161905555|NCT01130272|584703374|FG000|Overall Study|Physician Decision|1|||
161905556|NCT01130272|584703375|FG001|Overall Study|Physician Decision|1|||
161905557|NCT01130272|584703376|FG002|Overall Study|Physician Decision|0|||
161905558|NCT01130272|584703377|FG003|Overall Study|Physician Decision|1|||
161905559|NCT01130272|584703378|FG004|Overall Study|Physician Decision|2|||
161905560|NCT01130272|584703374|FG000|Overall Study|Sponsor decision|6|||
161905561|NCT01130272|584703375|FG001|Overall Study|Sponsor decision|15|||
161905562|NCT01130272|584703376|FG002|Overall Study|Sponsor decision|16|||
161905563|NCT01130272|584703377|FG003|Overall Study|Sponsor decision|13|||
161905564|NCT01130272|584703378|FG004|Overall Study|Sponsor decision|16|||
161905565|NCT01130272|584703374|FG000|Overall Study|Study arm discontinued|38|||
161905566|NCT01130272|584703375|FG001|Overall Study|Study arm discontinued|0|||
161905567|NCT01130272|584703376|FG002|Overall Study|Study arm discontinued|0|||
161905568|NCT01130272|584703377|FG003|Overall Study|Study arm discontinued|0|||
161905569|NCT01130272|584703378|FG004|Overall Study|Study arm discontinued|0|||
161905570|NCT00641056|584703379|FG000|Overall Study|Adverse Event|12|||
161905571|NCT00641056|584703380|FG001|Overall Study|Adverse Event|2|||
161905572|NCT00641056|584703379|FG000|Overall Study|Lost to Follow-up|2|||
161905573|NCT00641056|584703380|FG001|Overall Study|Lost to Follow-up|1|||
161905574|NCT00641056|584703379|FG000|Overall Study|Physician Decision|3|||
161802346|NCT02732210|584319679|FG000|Overall Study|Other|35|||
161802347|NCT02732210|584319680|FG001|Overall Study|Other|103|||
161802348|NCT02732210|584319679|FG000|Overall Study|Missing|0|||
161802349|NCT02732210|584319680|FG001|Overall Study|Missing|8|||
161802350|NCT01876706|584319681|FG000|Overall Study|BPH Intervention|9|||
161802351|NCT01876706|584319681|FG000|Overall Study|Lost to Follow-up|7|||
161802352|NCT01876706|584319681|FG000|Overall Study|Withdrawals|6|||
161802353|NCT01876706|584319681|FG000|Overall Study|Death|3|||
161802354|NCT00604500|584319682|FG000|Overall Study|Adverse Event|2|||
161802355|NCT00604500|584319682|FG000|Overall Study|Protocol Violation|2|||
161802356|NCT00604500|584319682|FG000|Overall Study|Treatment Failure|1|||
161802357|NCT00604500|584319682|FG000|Overall Study|Withdrawal by Subject|4|||
161802358|NCT00604500|584319682|FG000|Overall Study|Administrative|1|||
161802359|NCT00604500|584319682|FG000|Overall Study|Did not meet protocol eligibility|1|||
161802360|NCT01448057|584319684|FG000|Overall Study|Protocol Violation|3|||
161802361|NCT01448057|584319685|FG001|Overall Study|Protocol Violation|2|||
161905575|NCT00641056|584703380|FG001|Overall Study|Physician Decision|1|||
161802362|NCT01448057|584319684|FG000|Overall Study|Lost to Follow-up|3|||
161802363|NCT01448057|584319685|FG001|Overall Study|Lost to Follow-up|0|||
161802364|NCT01448057|584319684|FG000|Overall Study|Adverse Event|0|||
161802365|NCT01448057|584319685|FG001|Overall Study|Adverse Event|2|||
161802366|NCT01448057|584319684|FG000|Overall Study|Withdrawal by Subject|2|||
161905576|NCT00641056|584703379|FG000|Overall Study|Protocol Violation|2|||
161802367|NCT01448057|584319685|FG001|Overall Study|Withdrawal by Subject|0|||
161802368|NCT03883906|584319686|FG000|Overall Study|Withdrawal by Subject|2|||
161802369|NCT03883906|584319686|FG000|Overall Study|Physician Decision|5|||
161802370|NCT02468778|584319690|FG000|Overall Study|Death|2|||
161802371|NCT02468778|584319691|FG001|Overall Study|Death|1|||
161802372|NCT02468778|584319692|FG002|Overall Study|Death|0|||
161802373|NCT02468778|584319690|FG000|Overall Study|Lost to Follow-up|1|||
161802374|NCT02468778|584319691|FG001|Overall Study|Lost to Follow-up|2|||
161802375|NCT02468778|584319692|FG002|Overall Study|Lost to Follow-up|2|||
161802376|NCT02468778|584319690|FG000|Overall Study|Withdrawal by Subject|0|||
161802377|NCT02468778|584319691|FG001|Overall Study|Withdrawal by Subject|1|||
161802378|NCT02468778|584319692|FG002|Overall Study|Withdrawal by Subject|1|||
161802379|NCT03912337|584319697|FG000|Overall Study|Withdrawal of Consent From Study|1|||
161905577|NCT00641056|584703380|FG001|Overall Study|Protocol Violation|0|||
162139185|NCT03068468|585561368|FG000|Placebo-Controlled Period|Adverse Event|16|||
162139186|NCT03068468|585561369|FG001|Placebo-Controlled Period|Adverse Event|21|||
162139187|NCT03068468|585561370|FG002|Placebo-Controlled Period|Adverse Event|0|||
162139188|NCT03068468|585561371|FG003|Placebo-Controlled Period|Adverse Event|0|||
162139189|NCT03068468|585561368|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
162139190|NCT03068468|585561369|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
162139191|NCT03068468|585561370|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
162139192|NCT03068468|585561371|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
162139193|NCT03068468|585561368|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
162139194|NCT03068468|585561369|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
162139195|NCT03068468|585561370|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162139196|NCT03068468|585561371|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162139197|NCT03068468|585561368|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
162139198|NCT03068468|585561369|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
162139199|NCT03068468|585561370|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
162139200|NCT03068468|585561371|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
162139201|NCT03068468|585561368|FG000|Placebo-Controlled Period|Death|0|||
162139202|NCT03068468|585561369|FG001|Placebo-Controlled Period|Death|1|||
162139203|NCT03068468|585561370|FG002|Placebo-Controlled Period|Death|0|||
162139204|NCT03068468|585561371|FG003|Placebo-Controlled Period|Death|0|||
162139205|NCT03068468|585561368|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
162139206|NCT03068468|585561369|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
162139207|NCT03068468|585561370|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
162139208|NCT03068468|585561371|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
162139209|NCT03068468|585561368|FG000|Open-Label Extension Period|Adverse Event|0|||
162139210|NCT03068468|585561369|FG001|Open-Label Extension Period|Adverse Event|0|||
162139211|NCT03068468|585561370|FG002|Open-Label Extension Period|Adverse Event|13|||
162139212|NCT03068468|585561371|FG003|Open-Label Extension Period|Adverse Event|17|||
162139213|NCT03068468|585561368|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
162139214|NCT03068468|585561369|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
162139215|NCT03068468|585561370|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
162139216|NCT03068468|585561371|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
162139217|NCT03068468|585561368|FG000|Open-Label Extension Period|Death|0|||
162139218|NCT03068468|585561369|FG001|Open-Label Extension Period|Death|0|||
162139219|NCT03068468|585561370|FG002|Open-Label Extension Period|Death|0|||
162139220|NCT03068468|585561371|FG003|Open-Label Extension Period|Death|1|||
162139221|NCT03068468|585561368|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
162139222|NCT03068468|585561369|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
162139223|NCT03068468|585561370|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
162139224|NCT03068468|585561371|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
162139225|NCT03068468|585561368|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
162139226|NCT03068468|585561369|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
162139227|NCT03068468|585561370|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
162139228|NCT03068468|585561371|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
162139229|NCT03068468|585561368|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
162139230|NCT03068468|585561369|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
162139231|NCT03068468|585561370|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
162139232|NCT03068468|585561371|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
162139233|NCT03068468|585561368|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
162139234|NCT03068468|585561369|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
161802380|NCT03912337|584319698|FG001|Overall Study|Withdrawal of Consent From Study|0|||
162139235|NCT03068468|585561370|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
162139236|NCT03068468|585561371|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
162139237|NCT03068468|585561368|FG000|Open-Label Extension Period|Reason not Specified|0|||
162139238|NCT03068468|585561369|FG001|Open-Label Extension Period|Reason not Specified|0|||
162139239|NCT03068468|585561370|FG002|Open-Label Extension Period|Reason not Specified|1|||
162139240|NCT03068468|585561371|FG003|Open-Label Extension Period|Reason not Specified|4|||
161802381|NCT03912337|584319697|FG000|Overall Study|Lost to Follow-up|1|||
161802382|NCT03912337|584319698|FG001|Overall Study|Lost to Follow-up|1|||
161802383|NCT03561883|584319702|FG000|Overall Study|Adverse Event|10|||
161802384|NCT03561883|584319703|FG001|Overall Study|Adverse Event|13|||
161802385|NCT03561883|584319702|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161802386|NCT03561883|584319703|FG001|Overall Study|Non-Compliance With Study Drug|2|||
161802387|NCT03561883|584319702|FG000|Overall Study|Protocol Violation|2|||
161802388|NCT03561883|584319703|FG001|Overall Study|Protocol Violation|3|||
161802389|NCT03561883|584319702|FG000|Overall Study|Withdrawal by Subject|14|||
161802390|NCT03561883|584319703|FG001|Overall Study|Withdrawal by Subject|6|||
161802391|NCT03561883|584319702|FG000|Overall Study|Lost to Follow-up|2|||
161802392|NCT03561883|584319703|FG001|Overall Study|Lost to Follow-up|6|||
161802393|NCT03561883|584319702|FG000|Overall Study|Study Terminated by Sponsor|12|||
161802394|NCT03561883|584319703|FG001|Overall Study|Study Terminated by Sponsor|11|||
161802395|NCT03561883|584319702|FG000|Overall Study|Physician Decision|1|||
161802396|NCT03561883|584319703|FG001|Overall Study|Physician Decision|0|||
161802397|NCT03561883|584319702|FG000|Overall Study|Randomized by Mistake|1|||
162139241|NCT03140176|585561379|FG000|Overall Study|Reason missing|23|||
162139242|NCT03140176|585561379|FG000|Overall Study|Death|33|||
162139243|NCT03140176|585561379|FG000|Overall Study|Disease progression|1|||
162139244|NCT03140176|585561379|FG000|Overall Study|Physician Decision|1|||
162139245|NCT03140176|585561379|FG000|Overall Study|Withdrawal by Subject|1|||
162139246|NCT03140176|585561379|FG000|Overall Study|Lost to Follow-up|15|||
162139247|NCT01091454|585561382|FG000|Overall Study|Ineligible|1|||
162139248|NCT01510912|585561386|FG000|Overall Study|Adverse Event|99|||
162139249|NCT01510912|585561386|FG000|Overall Study|Lack of Efficacy|12|||
162139250|NCT01510912|585561386|FG000|Overall Study|Non-compliance with trial drug|23|||
162139251|NCT01510912|585561386|FG000|Overall Study|Withdrawal by Subject|49|||
162139252|NCT01510912|585561386|FG000|Overall Study|Physician Decision|1|||
162139253|NCT01510912|585561386|FG000|Overall Study|Protocol Violation|27|||
162139254|NCT01510912|585561386|FG000|Overall Study|Lost to Follow-up|26|||
162139255|NCT01510912|585561386|FG000|Overall Study|Other, including joint replacement|5|||
162139256|NCT03179787|585561387|FG000|Overall Study|Lost to Follow-up|15|||
162139257|NCT03179787|585561387|FG000|Overall Study|Case report failures|2|||
162139258|NCT03179787|585561387|FG000|Overall Study|Treatment not administered|1|||
162139259|NCT03181958|585561388|FG000|Overall Study|Lost to Follow-up|17|||
162139260|NCT03181958|585561389|FG001|Overall Study|Lost to Follow-up|21|||
162139261|NCT03181958|585561390|FG002|Overall Study|Lost to Follow-up|15|||
162139262|NCT02030028|585561391|FG000|Overall Study|Withdrawal by Subject|4|||
162139263|NCT02030028|585561391|FG000|Overall Study|lack of transportation|1|||
162139264|NCT00661778|585561392|FG000|Overall Study|Disease Progression|23|||
162139265|NCT00661778|585561392|FG000|Overall Study|Adverse Event|18|||
162139266|NCT00661778|585561392|FG000|Overall Study|Reason not Specified|6|||
162139267|NCT00661778|585561392|FG000|Overall Study|Protocol Violation|2|||
162139268|NCT00661778|585561392|FG000|Overall Study|Withdrawal of Consent|1|||
162139269|NCT02236559|585561399|FG000|Overall Study|Met Exclusion|3|||
162139270|NCT02236559|585561400|FG001|Overall Study|Met Exclusion|6|||
162139271|NCT02236559|585561399|FG000|Overall Study|Did not Meet Inclusion|3|||
162139272|NCT02236559|585561400|FG001|Overall Study|Did not Meet Inclusion|3|||
162139273|NCT02236559|585561399|FG000|Overall Study|Subject Did Not Consent|4|||
162139274|NCT02236559|585561400|FG001|Overall Study|Subject Did Not Consent|2|||
162139275|NCT02236559|585561399|FG000|Overall Study|Physician Decision|1|||
162139276|NCT02236559|585561400|FG001|Overall Study|Physician Decision|1|||
162139277|NCT02236559|585561399|FG000|Overall Study|Withdrawal by Subject|1|||
162139278|NCT02236559|585561400|FG001|Overall Study|Withdrawal by Subject|0|||
162139279|NCT02263508|585561401|FG000|Overall Study|Withdrawal by Subject|1|||
162139280|NCT02263508|585561402|FG001|Overall Study|Withdrawal by Subject|23|||
162139281|NCT02263508|585561403|FG002|Overall Study|Withdrawal by Subject|17|||
162139282|NCT02263508|585561401|FG000|Overall Study|Sponsor Decision|12|||
162139283|NCT02263508|585561402|FG001|Overall Study|Sponsor Decision|165|||
162139284|NCT02263508|585561403|FG002|Overall Study|Sponsor Decision|182|||
162139285|NCT02263508|585561401|FG000|Overall Study|Lost to Follow-up|2|||
162139286|NCT02263508|585561402|FG001|Overall Study|Lost to Follow-up|7|||
161802398|NCT03561883|584319703|FG001|Overall Study|Randomized by Mistake|0|||
161802399|NCT03561883|584319702|FG000|Overall Study|Other, Not Specified|3|||
161802400|NCT03561883|584319703|FG001|Overall Study|Other, Not Specified|2|||
161802401|NCT03978624|584319704|FG000|Overall Study|Protocol Violation|1|||
162139287|NCT02263508|585561403|FG002|Overall Study|Lost to Follow-up|7|||
162139288|NCT02263508|585561401|FG000|Overall Study|Death|6|||
162139289|NCT02263508|585561402|FG001|Overall Study|Death|151|||
162139290|NCT02263508|585561403|FG002|Overall Study|Death|140|||
161802402|NCT03978624|584319705|FG001|Overall Study|Protocol Violation|0|||
162139291|NCT04148937|585561404|FG000|Overall Study|Withdrawal by Subject|0|||
162139292|NCT04148937|585561405|FG001|Overall Study|Withdrawal by Subject|0|||
162139293|NCT04148937|585561406|FG002|Overall Study|Withdrawal by Subject|0|||
162139294|NCT04148937|585561407|FG003|Overall Study|Withdrawal by Subject|1|||
162139295|NCT04148937|585561408|FG004|Overall Study|Withdrawal by Subject|0|||
162139296|NCT04148937|585561409|FG005|Overall Study|Withdrawal by Subject|1|||
161905578|NCT00641056|584703379|FG000|Overall Study|Entry Criteria Not Met|3|||
161802403|NCT00958243|584319710|FG000|Overall Study|Withdrawal by Subject|0|||
161802404|NCT00958243|584319711|FG001|Overall Study|Withdrawal by Subject|1|||
161802405|NCT00958243|584319712|FG002|Overall Study|Withdrawal by Subject|3|||
161802406|NCT00958243|584319713|FG003|Overall Study|Withdrawal by Subject|1|||
161802407|NCT00958243|584319714|FG004|Overall Study|Withdrawal by Subject|1|||
161802408|NCT00958243|584319715|FG005|Overall Study|Withdrawal by Subject|5|||
161802409|NCT00958243|584319710|FG000|Overall Study|Lost to Follow-up|2|||
161802410|NCT00958243|584319711|FG001|Overall Study|Lost to Follow-up|5|||
161802411|NCT00958243|584319712|FG002|Overall Study|Lost to Follow-up|11|||
161802412|NCT00958243|584319713|FG003|Overall Study|Lost to Follow-up|2|||
161802413|NCT00958243|584319714|FG004|Overall Study|Lost to Follow-up|8|||
161802414|NCT00958243|584319715|FG005|Overall Study|Lost to Follow-up|5|||
161802415|NCT04646109|584319716|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
161802416|NCT04646109|584319717|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
161802417|NCT06176768|584319718|FG000|Overall Study|Adverse Event|1|||
161802418|NCT06176768|584319719|FG001|Overall Study|Adverse Event|0|||
161905579|NCT00641056|584703380|FG001|Overall Study|Entry Criteria Not Met|0|||
161905580|NCT00641056|584703379|FG000|Overall Study|Subject Decision|6|||
161905581|NCT00641056|584703380|FG001|Overall Study|Subject Decision|19|||
161802419|NCT06176768|584319718|FG000|Overall Study|Assigned treatment by mistake|1|||
161802420|NCT06176768|584319719|FG001|Overall Study|Assigned treatment by mistake|0|||
161905582|NCT00641056|584703379|FG000|Overall Study|Sponsor Decision|1|||
161802421|NCT06176768|584319718|FG000|Overall Study|Lost to Follow-up|0|||
161802422|NCT06176768|584319719|FG001|Overall Study|Lost to Follow-up|3|||
161802423|NCT06176768|584319718|FG000|Overall Study|Physician Decision|1|||
161802424|NCT06176768|584319719|FG001|Overall Study|Physician Decision|0|||
161802425|NCT06176768|584319718|FG000|Overall Study|Protocol deviation|3|||
161802426|NCT06176768|584319719|FG001|Overall Study|Protocol deviation|1|||
161802427|NCT06176768|584319718|FG000|Overall Study|Other|1|||
161802428|NCT06176768|584319719|FG001|Overall Study|Other|0|||
161802429|NCT06176768|584319718|FG000|Overall Study|Withdrawal by Subject|6|||
161802430|NCT06176768|584319719|FG001|Overall Study|Withdrawal by Subject|9|||
161802431|NCT01606306|584319722|FG000|Overall Study|Lack of Efficacy|2|||
161802432|NCT01606306|584319723|FG001|Overall Study|Lack of Efficacy|1|||
161802433|NCT01606306|584319724|FG002|Overall Study|Lack of Efficacy|4|||
161802434|NCT01606306|584319725|FG003|Overall Study|Lack of Efficacy|4|||
161802435|NCT01606306|584319726|FG004|Overall Study|Lack of Efficacy|1|||
161802436|NCT01606306|584319727|FG005|Overall Study|Lack of Efficacy|2|||
161802437|NCT01606306|584319722|FG000|Overall Study|Adverse Event|1|||
161802438|NCT01606306|584319723|FG001|Overall Study|Adverse Event|0|||
161802439|NCT01606306|584319724|FG002|Overall Study|Adverse Event|1|||
161802440|NCT01606306|584319725|FG003|Overall Study|Adverse Event|1|||
161802441|NCT01606306|584319726|FG004|Overall Study|Adverse Event|2|||
161802442|NCT01606306|584319727|FG005|Overall Study|Adverse Event|0|||
161802443|NCT01606306|584319722|FG000|Overall Study|Lost to Follow-up|7|||
161802444|NCT01606306|584319723|FG001|Overall Study|Lost to Follow-up|4|||
161802445|NCT01606306|584319724|FG002|Overall Study|Lost to Follow-up|5|||
161802446|NCT01606306|584319725|FG003|Overall Study|Lost to Follow-up|4|||
161802447|NCT01606306|584319726|FG004|Overall Study|Lost to Follow-up|3|||
162139297|NCT04148937|585561410|FG006|Overall Study|Withdrawal by Subject|1|||
162139298|NCT04148937|585561411|FG007|Overall Study|Withdrawal by Subject|0|||
162139299|NCT04148937|585561404|FG000|Overall Study|Lost to Follow-up|0|||
162139300|NCT04148937|585561405|FG001|Overall Study|Lost to Follow-up|0|||
162139301|NCT04148937|585561406|FG002|Overall Study|Lost to Follow-up|1|||
161802448|NCT01606306|584319727|FG005|Overall Study|Lost to Follow-up|5|||
161802449|NCT01606306|584319722|FG000|Overall Study|Withdrawal by Subject|4|||
161802450|NCT01606306|584319723|FG001|Overall Study|Withdrawal by Subject|3|||
161802451|NCT01606306|584319724|FG002|Overall Study|Withdrawal by Subject|4|||
161802452|NCT01606306|584319725|FG003|Overall Study|Withdrawal by Subject|4|||
161802453|NCT01606306|584319726|FG004|Overall Study|Withdrawal by Subject|5|||
161802454|NCT01606306|584319727|FG005|Overall Study|Withdrawal by Subject|4|||
161802455|NCT01606306|584319722|FG000|Overall Study|Physician Decision|1|||
161802456|NCT01606306|584319723|FG001|Overall Study|Physician Decision|2|||
161802457|NCT01606306|584319724|FG002|Overall Study|Physician Decision|0|||
161802458|NCT01606306|584319725|FG003|Overall Study|Physician Decision|0|||
161802459|NCT01606306|584319726|FG004|Overall Study|Physician Decision|0|||
161802460|NCT01606306|584319727|FG005|Overall Study|Physician Decision|0|||
161802461|NCT00970281|584319728|FG000|Overall Study|Lack of Efficacy|1|||
161802462|NCT00970281|584319729|FG001|Overall Study|Lack of Efficacy|14|||
161802463|NCT00970281|584319728|FG000|Overall Study|Withdrawal by Subject|0|||
161802464|NCT00970281|584319729|FG001|Overall Study|Withdrawal by Subject|1|||
161802465|NCT00970281|584319728|FG000|Overall Study|Physician Decision|1|||
161802466|NCT00970281|584319729|FG001|Overall Study|Physician Decision|1|||
161802467|NCT02937701|584321354|FG000|Day 1 to Week 22|Adverse Event|11|||
161802468|NCT02937701|584321355|FG001|Day 1 to Week 22|Adverse Event|14|||
161802469|NCT02937701|584321356|FG002|Day 1 to Week 22|Adverse Event|0|||
161802470|NCT02937701|584321357|FG003|Day 1 to Week 22|Adverse Event|0|||
161802471|NCT02937701|584321358|FG004|Day 1 to Week 22|Adverse Event|0|||
162139302|NCT04148937|585561407|FG003|Overall Study|Lost to Follow-up|0|||
162139303|NCT04148937|585561408|FG004|Overall Study|Lost to Follow-up|0|||
162139304|NCT04148937|585561409|FG005|Overall Study|Lost to Follow-up|2|||
162139305|NCT04148937|585561410|FG006|Overall Study|Lost to Follow-up|0|||
162139306|NCT04148937|585561411|FG007|Overall Study|Lost to Follow-up|0|||
162139307|NCT01149681|585561412|FG000|Overall Study|Withdrawal by Subject|7|||
162139308|NCT01149681|585561412|FG000|Overall Study|Progressive disease|1|||
162139309|NCT01149681|585561412|FG000|Overall Study|Physician Decision|2|||
162139310|NCT01149681|585561412|FG000|Overall Study|adverse events nonrelated study drug|2|||
162139311|NCT00686517|585561413|FG000|Treatment|Serious Adverse Event|1|||
162139312|NCT00686517|585561414|FG001|Treatment|Serious Adverse Event|2|||
162139313|NCT00686517|585561415|FG002|Treatment|Serious Adverse Event|1|||
162139314|NCT00686517|585561413|FG000|Treatment|Adverse Event|2|||
162139315|NCT00686517|585561414|FG001|Treatment|Adverse Event|0|||
162139316|NCT00686517|585561415|FG002|Treatment|Adverse Event|0|||
162139317|NCT00686517|585561413|FG000|Treatment|Poor Protocol Compliance|1|||
162139318|NCT00686517|585561414|FG001|Treatment|Poor Protocol Compliance|0|||
162139319|NCT00686517|585561415|FG002|Treatment|Poor Protocol Compliance|0|||
162139320|NCT00686517|585561413|FG000|Treatment|Protocol Violation|2|||
162139321|NCT00686517|585561414|FG001|Treatment|Protocol Violation|1|||
162139322|NCT00686517|585561415|FG002|Treatment|Protocol Violation|0|||
162139323|NCT01803646|585561416|FG000|Overall Study|Protocol Violation|1|||
162139324|NCT01803646|585561417|FG001|Overall Study|Protocol Violation|0|||
162139325|NCT01803646|585561416|FG000|Overall Study|Adverse Event|1|||
162139326|NCT01803646|585561417|FG001|Overall Study|Adverse Event|1|||
162139327|NCT01803646|585561416|FG000|Overall Study|Withdrawal by Subject|9|||
162139328|NCT01803646|585561417|FG001|Overall Study|Withdrawal by Subject|6|||
162139329|NCT01803646|585561416|FG000|Overall Study|Randomization error|1|||
162139330|NCT01803646|585561417|FG001|Overall Study|Randomization error|2|||
162139331|NCT01803646|585561416|FG000|Overall Study|Lost to Follow-up|5|||
162139332|NCT01803646|585561417|FG001|Overall Study|Lost to Follow-up|1|||
162139333|NCT01167426|585561418|FG000|Overall Study|Lost to Follow-up|6|||
162139334|NCT01167426|585561418|FG000|Overall Study|Protocol Violation|1|||
162139335|NCT01167426|585561418|FG000|Overall Study|Withdrawal by Subject|2|||
162139336|NCT01167426|585561418|FG000|Overall Study|Sponsor Decision|1|||
162139337|NCT02993471|585561419|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
162139338|NCT02993471|585561419|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
162139339|NCT01908634|585561420|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
162139340|NCT01908634|585561420|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
161802472|NCT02937701|584321354|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
162139341|NCT01876511|585561422|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
162139342|NCT01876511|585561423|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
162139343|NCT01876511|585561424|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
162139344|NCT01876511|585561422|FG000|Overall Study|Death (unrelated)|3|||
162139345|NCT01876511|585561423|FG001|Overall Study|Death (unrelated)|0|||
162139346|NCT01876511|585561424|FG002|Overall Study|Death (unrelated)|2|||
162139347|NCT01876511|585561422|FG000|Overall Study|Drug-related Toxicity|5|||
162139348|NCT01876511|585561423|FG001|Overall Study|Drug-related Toxicity|1|||
161905583|NCT00641056|584703380|FG001|Overall Study|Sponsor Decision|2|||
161905584|NCT00239720|584703381|FG000|Overall Study|Adverse Event|1|||
161905585|NCT00239720|584703382|FG001|Overall Study|Adverse Event|0|||
161905586|NCT00239720|584703381|FG000|Overall Study|Lost to Follow-up|0|||
161905587|NCT00239720|584703382|FG001|Overall Study|Lost to Follow-up|1|||
161905588|NCT01811732|584703383|FG000|Overall Study|Lost to Follow-up|24|||
161905589|NCT01811732|584703384|FG001|Overall Study|Lost to Follow-up|30|||
161905590|NCT01811732|584703383|FG000|Overall Study|Withdrawal by Subject|16|||
161905591|NCT01811732|584703384|FG001|Overall Study|Withdrawal by Subject|10|||
161905592|NCT01811732|584703383|FG000|Overall Study|Adverse Event|3|||
161905593|NCT01811732|584703384|FG001|Overall Study|Adverse Event|9|||
162139349|NCT01876511|585561424|FG002|Overall Study|Drug-related Toxicity|6|||
162139350|NCT01876511|585561422|FG000|Overall Study|Patient Decision|3|||
162139351|NCT01876511|585561423|FG001|Overall Study|Patient Decision|0|||
162139352|NCT01876511|585561424|FG002|Overall Study|Patient Decision|6|||
162139353|NCT01876511|585561422|FG000|Overall Study|Physician Decision|1|||
162139354|NCT01876511|585561423|FG001|Overall Study|Physician Decision|0|||
162139355|NCT01876511|585561424|FG002|Overall Study|Physician Decision|1|||
162139356|NCT05790408|585561425|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
162139357|NCT04044664|585561439|FG000|Stage 1|Adverse Event|3|||
162139358|NCT04044664|585561440|FG001|Stage 1|Adverse Event|3|||
162139359|NCT04044664|585561441|FG002|Stage 1|Adverse Event|1|||
162139360|NCT04044664|585561439|FG000|Stage 1|Lost to Follow-up|3|||
162139361|NCT04044664|585561440|FG001|Stage 1|Lost to Follow-up|2|||
162139362|NCT04044664|585561441|FG002|Stage 1|Lost to Follow-up|2|||
162139363|NCT04044664|585561439|FG000|Stage 1|Withdrawal by Subject|9|||
162139364|NCT04044664|585561440|FG001|Stage 1|Withdrawal by Subject|1|||
162139365|NCT04044664|585561441|FG002|Stage 1|Withdrawal by Subject|0|||
162139366|NCT04044664|585561439|FG000|Stage 1|noncompliance, personal reason|2|||
162139367|NCT04044664|585561440|FG001|Stage 1|noncompliance, personal reason|0|||
162139368|NCT04044664|585561441|FG002|Stage 1|noncompliance, personal reason|0|||
162139369|NCT04044664|585561439|FG000|Stage 1|randomization error|0|||
162139370|NCT04044664|585561440|FG001|Stage 1|randomization error|1|||
162139371|NCT04044664|585561441|FG002|Stage 1|randomization error|0|||
162139372|NCT04044664|585561439|FG000|Stage 2|Adverse Event|2|||
162139373|NCT04044664|585561440|FG001|Stage 2|Adverse Event|0|||
162139374|NCT04044664|585561441|FG002|Stage 2|Adverse Event|0|||
162139375|NCT04044664|585561439|FG000|Stage 2|Lost to Follow-up|3|||
162139376|NCT04044664|585561440|FG001|Stage 2|Lost to Follow-up|2|||
162139377|NCT04044664|585561441|FG002|Stage 2|Lost to Follow-up|1|||
162139378|NCT04044664|585561439|FG000|Stage 2|Withdrawal by Subject|3|||
162139379|NCT04044664|585561440|FG001|Stage 2|Withdrawal by Subject|0|||
162139380|NCT04044664|585561441|FG002|Stage 2|Withdrawal by Subject|0|||
162139381|NCT04044664|585561439|FG000|Stage 2|protocol deviation|1|||
162139382|NCT04044664|585561440|FG001|Stage 2|protocol deviation|0|||
162139383|NCT04044664|585561441|FG002|Stage 2|protocol deviation|0|||
162139384|NCT00001575|585561445|FG000|Overall Study|Screening failures-Ph I portion|22|||
162139385|NCT00001575|585561445|FG000|Overall Study|Withdrawn/deaths|23|||
162139386|NCT00831792|585561448|FG000|Overall Study|Not Eligible|3|||
162139387|NCT00831792|585561448|FG000|Overall Study|Adverse Event|1|||
162139388|NCT00831792|585561448|FG000|Overall Study|Death|1|||
162139389|NCT00831792|585561448|FG000|Overall Study|Lack of Efficacy|1|||
162139390|NCT03736785|585561449|FG000|Overall Study|Adverse Event|1|||
162139391|NCT03736785|585561450|FG001|Overall Study|Adverse Event|1|||
162139392|NCT03736785|585561451|FG002|Overall Study|Adverse Event|1|||
162139393|NCT03736785|585561449|FG000|Overall Study|Death|1|||
162139394|NCT03736785|585561450|FG001|Overall Study|Death|0|||
162139395|NCT03736785|585561451|FG002|Overall Study|Death|1|||
162139396|NCT03736785|585561449|FG000|Overall Study|Lost to Follow-up|0|||
162139397|NCT03736785|585561450|FG001|Overall Study|Lost to Follow-up|2|||
162139398|NCT03736785|585561451|FG002|Overall Study|Lost to Follow-up|3|||
162139399|NCT03736785|585561449|FG000|Overall Study|Non compliance with study drug|1|||
162139400|NCT03736785|585561450|FG001|Overall Study|Non compliance with study drug|1|||
162139401|NCT03736785|585561451|FG002|Overall Study|Non compliance with study drug|0|||
162139402|NCT03736785|585561449|FG000|Overall Study|Physician Decision|0|||
162139403|NCT03736785|585561450|FG001|Overall Study|Physician Decision|1|||
162139404|NCT03736785|585561451|FG002|Overall Study|Physician Decision|1|||
162139405|NCT03736785|585561449|FG000|Overall Study|Protocol Violation|1|||
161905594|NCT01811732|584703383|FG000|Overall Study|Lack of Efficacy|3|||
162139406|NCT03736785|585561450|FG001|Overall Study|Protocol Violation|4|||
162139407|NCT03736785|585561451|FG002|Overall Study|Protocol Violation|3|||
162139408|NCT03736785|585561449|FG000|Overall Study|Sponsor Decision|1|||
162139409|NCT03736785|585561450|FG001|Overall Study|Sponsor Decision|0|||
162139410|NCT03736785|585561451|FG002|Overall Study|Sponsor Decision|0|||
162139411|NCT03736785|585561449|FG000|Overall Study|Unknown/Missing data|3|||
162139412|NCT03736785|585561450|FG001|Overall Study|Unknown/Missing data|2|||
162139413|NCT03736785|585561451|FG002|Overall Study|Unknown/Missing data|1|||
162139414|NCT03736785|585561449|FG000|Overall Study|Withdrawal by Subject|9|||
162139415|NCT03736785|585561450|FG001|Overall Study|Withdrawal by Subject|6|||
162139416|NCT03736785|585561451|FG002|Overall Study|Withdrawal by Subject|4|||
162139417|NCT02974010|585561455|FG000|Overall Study|Lost to Follow-up|3|||
162139418|NCT02974010|585561456|FG001|Overall Study|Lost to Follow-up|1|||
162139419|NCT02974010|585561457|FG002|Overall Study|Lost to Follow-up|0|||
162139420|NCT02974010|585561458|FG003|Overall Study|Lost to Follow-up|0|||
162139421|NCT02974010|585561455|FG000|Overall Study|Withdrawal by Subject|2|||
162139422|NCT02974010|585561456|FG001|Overall Study|Withdrawal by Subject|1|||
162139423|NCT02974010|585561457|FG002|Overall Study|Withdrawal by Subject|0|||
162139424|NCT02974010|585561458|FG003|Overall Study|Withdrawal by Subject|0|||
162139425|NCT02974010|585561455|FG000|Overall Study|Adverse Event|0|||
162139426|NCT02974010|585561456|FG001|Overall Study|Adverse Event|1|||
162139427|NCT02974010|585561457|FG002|Overall Study|Adverse Event|0|||
162139428|NCT02974010|585561458|FG003|Overall Study|Adverse Event|0|||
162139429|NCT02974010|585561455|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
162139430|NCT02974010|585561456|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
162139431|NCT02974010|585561457|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
162139432|NCT02974010|585561458|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
162139433|NCT02974010|585561455|FG000|Overall Study|Lack of Efficacy|0|||
162139434|NCT02974010|585561456|FG001|Overall Study|Lack of Efficacy|0|||
162139435|NCT02974010|585561457|FG002|Overall Study|Lack of Efficacy|1|||
162139436|NCT02974010|585561458|FG003|Overall Study|Lack of Efficacy|0|||
162139437|NCT03256344|585561459|FG000|Overall Study|Death|6|||
162139438|NCT03256344|585561460|FG001|Overall Study|Death|22|||
162139439|NCT03256344|585561459|FG000|Overall Study|Withdrawal by Subject|3|||
162139440|NCT03256344|585561460|FG001|Overall Study|Withdrawal by Subject|3|||
162139441|NCT03256344|585561459|FG000|Overall Study|Sponsor Decision|1|||
162139442|NCT03256344|585561460|FG001|Overall Study|Sponsor Decision|0|||
162139443|NCT00880906|585561461|FG000|Overall Study|Lost to Follow-up|0|||
162139444|NCT00880906|585561462|FG001|Overall Study|Lost to Follow-up|1|||
162139445|NCT00880906|585561461|FG000|Overall Study|Did not meet criteria following patholog|12|||
162139446|NCT00880906|585561462|FG001|Overall Study|Did not meet criteria following patholog|6|||
162139447|NCT01664104|585561463|FG000|Overall Study|Adverse Event|6|||
162139448|NCT01664104|585561463|FG000|Overall Study|Lack of Efficacy|2|||
162139449|NCT01664104|585561463|FG000|Overall Study|Withdrawal by Subject|1|||
162139450|NCT01664104|585561463|FG000|Overall Study|Lost to Follow-up|4|||
162139451|NCT01664104|585561463|FG000|Overall Study|Other|1|||
162139452|NCT01664104|585561463|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
162139453|NCT04163458|585561464|FG000|Overall Study|Protocol Deviation|7|||
162139454|NCT04163458|585561465|FG001|Overall Study|Protocol Deviation|13|||
162139455|NCT04163458|585561464|FG000|Overall Study|Adverse Event|5|||
162139456|NCT04163458|585561465|FG001|Overall Study|Adverse Event|8|||
162139457|NCT04163458|585561464|FG000|Overall Study|Due to COVID-19 pandemic|4|||
162139458|NCT04163458|585561465|FG001|Overall Study|Due to COVID-19 pandemic|2|||
162139459|NCT04163458|585561464|FG000|Overall Study|Participant withdrew consent|2|||
162139460|NCT04163458|585561465|FG001|Overall Study|Participant withdrew consent|3|||
162139461|NCT04163458|585561464|FG000|Overall Study|Randomization failure|2|||
162139462|NCT04163458|585561465|FG001|Overall Study|Randomization failure|2|||
162139463|NCT04163458|585561464|FG000|Overall Study|Other|4|||
162139464|NCT04163458|585561465|FG001|Overall Study|Other|2|||
162139465|NCT03852433|585561466|FG000|Overall Study|Withdrawal of consent|5|||
162139466|NCT03852433|585561467|FG001|Overall Study|Withdrawal of consent|8|||
162139467|NCT03852433|585561468|FG002|Overall Study|Withdrawal of consent|1|||
162139468|NCT03852433|585561469|FG003|Overall Study|Withdrawal of consent|1|||
162139469|NCT03852433|585561466|FG000|Overall Study|Adverse Event|1|||
162139470|NCT03852433|585561467|FG001|Overall Study|Adverse Event|1|||
162139471|NCT03852433|585561468|FG002|Overall Study|Adverse Event|1|||
162139472|NCT03852433|585561469|FG003|Overall Study|Adverse Event|1|||
162139473|NCT03852433|585561466|FG000|Overall Study|Lost to Follow-up|0|||
162139474|NCT03852433|585561467|FG001|Overall Study|Lost to Follow-up|1|||
162139475|NCT03852433|585561468|FG002|Overall Study|Lost to Follow-up|0|||
162139476|NCT03852433|585561469|FG003|Overall Study|Lost to Follow-up|1|||
162139477|NCT03852433|585561466|FG000|Overall Study|Pregnancy|0|||
162139478|NCT03852433|585561467|FG001|Overall Study|Pregnancy|1|||
162139479|NCT03852433|585561468|FG002|Overall Study|Pregnancy|1|||
162139480|NCT03852433|585561469|FG003|Overall Study|Pregnancy|0|||
162139481|NCT03852433|585561466|FG000|Overall Study|Protocol Violation|0|||
162139482|NCT03852433|585561467|FG001|Overall Study|Protocol Violation|0|||
162139483|NCT03852433|585561468|FG002|Overall Study|Protocol Violation|1|||
162139484|NCT03852433|585561469|FG003|Overall Study|Protocol Violation|1|||
162139485|NCT03852433|585561466|FG000|Overall Study|Death|0|||
162139486|NCT03852433|585561467|FG001|Overall Study|Death|0|||
162139487|NCT03852433|585561468|FG002|Overall Study|Death|1|||
162139488|NCT03852433|585561469|FG003|Overall Study|Death|0|||
162139489|NCT03852433|585561466|FG000|Overall Study|Lack of Efficacy|0|||
162139490|NCT03852433|585561467|FG001|Overall Study|Lack of Efficacy|1|||
162139491|NCT03852433|585561468|FG002|Overall Study|Lack of Efficacy|0|||
162139492|NCT03852433|585561469|FG003|Overall Study|Lack of Efficacy|0|||
162139493|NCT03852433|585561466|FG000|Overall Study|Non-compliance with study drug|0|||
161802473|NCT02937701|584321355|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
161802474|NCT02937701|584321356|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
161802475|NCT02937701|584321357|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
161802476|NCT02937701|584321358|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
161802477|NCT02937701|584321354|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
161802478|NCT02937701|584321355|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
161802479|NCT02937701|584321356|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
161802480|NCT02937701|584321357|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
161905595|NCT01811732|584703384|FG001|Overall Study|Lack of Efficacy|1|||
161905596|NCT01811732|584703383|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
161905597|NCT01811732|584703384|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
161905598|NCT01811732|584703383|FG000|Overall Study|Physician Decision|2|||
161905599|NCT01811732|584703384|FG001|Overall Study|Physician Decision|0|||
161905600|NCT01811732|584703383|FG000|Overall Study|Death|1|||
161905601|NCT01811732|584703384|FG001|Overall Study|Death|1|||
162139494|NCT03852433|585561467|FG001|Overall Study|Non-compliance with study drug|0|||
162139495|NCT03852433|585561468|FG002|Overall Study|Non-compliance with study drug|0|||
162139496|NCT03852433|585561469|FG003|Overall Study|Non-compliance with study drug|1|||
162139497|NCT03852433|585561466|FG000|Overall Study|Physician Decision|1|||
162139498|NCT03852433|585561467|FG001|Overall Study|Physician Decision|0|||
162139499|NCT03852433|585561468|FG002|Overall Study|Physician Decision|0|||
162139500|NCT03852433|585561469|FG003|Overall Study|Physician Decision|0|||
162139501|NCT03852433|585561466|FG000|Overall Study|Randomized but never treated|1|||
162139502|NCT03852433|585561467|FG001|Overall Study|Randomized but never treated|0|||
162139503|NCT03852433|585561468|FG002|Overall Study|Randomized but never treated|0|||
162139504|NCT03852433|585561469|FG003|Overall Study|Randomized but never treated|0|||
162139505|NCT05273801|585561477|FG000|Overall Study|Physician Decision|1|||
162139506|NCT04159506|585561478|FG000|Overall Study|Lost to Follow-up|2|||
162139507|NCT04159506|585561479|FG001|Overall Study|Lost to Follow-up|5|||
162139508|NCT02449044|585561480|FG000|Overall Study|Lost to Follow-up|2|||
162139509|NCT02449044|585561480|FG000|Overall Study|Withdrawal by Subject|13|||
162139510|NCT02449044|585561480|FG000|Overall Study|Adverse Event|30|||
162139511|NCT02449044|585561480|FG000|Overall Study|Met Withdrawal Criteria|7|||
162139512|NCT02449044|585561480|FG000|Overall Study|Physician Decision|9|||
162139513|NCT02449044|585561480|FG000|Overall Study|Sponsor Discontinued Trial|3|||
162139514|NCT04257058|585563148|FG000|Overall Study|Lost to Follow-up|31|||
162139515|NCT03227757|585563149|FG000|Overall Study|Death|25|||
162139516|NCT03227757|585563149|FG000|Overall Study|Withdrawal|10|||
162139517|NCT03227757|585563149|FG000|Overall Study|Missed visits|1|||
162139518|NCT03227757|585563149|FG000|Overall Study|Lost to Follow-up|2|||
162139519|NCT05570006|585563150|FG000|Overall Study|Lost to Follow-up|2|||
162139520|NCT05570006|585563150|FG000|Overall Study|Withdrawal by Subject|5|||
162139521|NCT05570006|585563150|FG000|Overall Study|Other than Specified|5|||
162139522|NCT01144468|585563153|FG000|Overall Study|Lost to Follow-up|4|||
162139523|NCT01144468|585563154|FG001|Overall Study|Lost to Follow-up|7|||
162139524|NCT01144468|585563153|FG000|Overall Study|Adverse Event|3|||
162139525|NCT01144468|585563154|FG001|Overall Study|Adverse Event|2|||
162139526|NCT01144468|585563153|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
162139527|NCT01144468|585563154|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
162139528|NCT02960659|585563155|FG000|Overall Study|Withdrawal by Subject|1|||
162139529|NCT02960659|585563156|FG001|Overall Study|Withdrawal by Subject|0|||
162139530|NCT02960659|585563155|FG000|Overall Study|Poor compliance|0|||
162139531|NCT02960659|585563156|FG001|Overall Study|Poor compliance|1|||
162139532|NCT04199728|585563162|FG000|Overall Study|Adverse Event|1|||
162139533|NCT04199728|585563163|FG001|Overall Study|Adverse Event|0|||
162139534|NCT04199728|585563162|FG000|Overall Study|Withdrawal by Subject|8|||
162139535|NCT04199728|585563163|FG001|Overall Study|Withdrawal by Subject|3|||
162139536|NCT04199728|585563162|FG000|Overall Study|Screen fail after consent|0|||
162139537|NCT04199728|585563163|FG001|Overall Study|Screen fail after consent|1|||
162139538|NCT04199728|585563162|FG000|Overall Study|Early withdraw criteria met|0|||
162139539|NCT04199728|585563163|FG001|Overall Study|Early withdraw criteria met|1|||
162139540|NCT04199728|585563162|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
162139541|NCT04199728|585563163|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
161802481|NCT02937701|584321358|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
161802482|NCT02937701|584321354|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
161802483|NCT02937701|584321355|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
161802484|NCT02937701|584321356|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
162139542|NCT01875250|585563164|FG000|Overall Study|Adverse Event|2|||
162139543|NCT01875250|585563165|FG001|Overall Study|Adverse Event|0|||
162139544|NCT04057196|585563166|FG000|Overall Study|Withdrawal by Subject|3|||
162139545|NCT04057196|585563166|FG000|Overall Study|Death|3|||
162139546|NCT03895034|585563168|FG000|Overall Study|Lost to Follow-up|2|||
162139547|NCT01118377|585563169|FG000|Overall Study|Did Not Receive Study Medication|1|||
161905602|NCT01811732|584703383|FG000|Overall Study|Insufficient venous access|0|||
161905603|NCT01811732|584703384|FG001|Overall Study|Insufficient venous access|1|||
161802485|NCT02937701|584321357|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
161802486|NCT02937701|584321358|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
161802487|NCT02937701|584321354|FG000|Day 1 to Week 22|Death|1|||
161802488|NCT02937701|584321355|FG001|Day 1 to Week 22|Death|1|||
161802489|NCT02937701|584321356|FG002|Day 1 to Week 22|Death|0|||
161802490|NCT02937701|584321357|FG003|Day 1 to Week 22|Death|0|||
161802491|NCT02937701|584321358|FG004|Day 1 to Week 22|Death|0|||
161802492|NCT02937701|584321354|FG000|Day 1 to Week 22|Protocol Violation|1|||
161802493|NCT02937701|584321355|FG001|Day 1 to Week 22|Protocol Violation|1|||
161802494|NCT02937701|584321356|FG002|Day 1 to Week 22|Protocol Violation|0|||
161802495|NCT02937701|584321357|FG003|Day 1 to Week 22|Protocol Violation|0|||
161802496|NCT02937701|584321358|FG004|Day 1 to Week 22|Protocol Violation|0|||
161802497|NCT02937701|584321354|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
161802498|NCT02937701|584321355|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
161802499|NCT02937701|584321356|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
161802500|NCT02937701|584321357|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
161802501|NCT02937701|584321358|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
161802502|NCT02937701|584321354|FG000|Day 1 to Week 22|Physician Decision|2|||
161802503|NCT02937701|584321355|FG001|Day 1 to Week 22|Physician Decision|0|||
161802504|NCT02937701|584321356|FG002|Day 1 to Week 22|Physician Decision|0|||
161802505|NCT02937701|584321357|FG003|Day 1 to Week 22|Physician Decision|0|||
161802506|NCT02937701|584321358|FG004|Day 1 to Week 22|Physician Decision|0|||
161802507|NCT02937701|584321354|FG000|Day 1 to Week 22|Other|1|||
161802508|NCT02937701|584321355|FG001|Day 1 to Week 22|Other|0|||
161802509|NCT02937701|584321356|FG002|Day 1 to Week 22|Other|0|||
161802510|NCT02937701|584321357|FG003|Day 1 to Week 22|Other|0|||
161802511|NCT02937701|584321358|FG004|Day 1 to Week 22|Other|0|||
161802512|NCT02937701|584321354|FG000|Week 22 to Week 50|Adverse Event|0|||
161802513|NCT02937701|584321355|FG001|Week 22 to Week 50|Adverse Event|0|||
161802514|NCT02937701|584321356|FG002|Week 22 to Week 50|Adverse Event|10|||
161802515|NCT02937701|584321357|FG003|Week 22 to Week 50|Adverse Event|3|||
161802516|NCT02937701|584321358|FG004|Week 22 to Week 50|Adverse Event|3|||
161802517|NCT02937701|584321354|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
161802518|NCT02937701|584321355|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
161802519|NCT02937701|584321356|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
161802520|NCT02937701|584321357|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
161802521|NCT02937701|584321358|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
161905604|NCT01811732|584703383|FG000|Overall Study|Protocol Violation|0|||
161905605|NCT01811732|584703384|FG001|Overall Study|Protocol Violation|1|||
161802522|NCT02937701|584321354|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
161905606|NCT01811732|584703383|FG000|Overall Study|Subject incarcerated|1|||
161905607|NCT01811732|584703384|FG001|Overall Study|Subject incarcerated|2|||
161802523|NCT02937701|584321355|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
161802524|NCT02937701|584321356|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
161802525|NCT02937701|584321357|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
161802526|NCT02937701|584321358|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
161802527|NCT02937701|584321354|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
161802528|NCT02937701|584321355|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
161802529|NCT02937701|584321356|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
161802530|NCT02937701|584321357|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
161802531|NCT02937701|584321358|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
161802532|NCT02937701|584321354|FG000|Week 22 to Week 50|Physician Decision|0|||
161802533|NCT02937701|584321355|FG001|Week 22 to Week 50|Physician Decision|0|||
161802534|NCT02937701|584321356|FG002|Week 22 to Week 50|Physician Decision|2|||
161802535|NCT02937701|584321357|FG003|Week 22 to Week 50|Physician Decision|0|||
161802536|NCT02937701|584321358|FG004|Week 22 to Week 50|Physician Decision|1|||
161802537|NCT02937701|584321354|FG000|Week 22 to Week 50|Other|0|||
161802538|NCT02937701|584321355|FG001|Week 22 to Week 50|Other|0|||
161802539|NCT02937701|584321356|FG002|Week 22 to Week 50|Other|0|||
161802540|NCT02937701|584321357|FG003|Week 22 to Week 50|Other|0|||
161802541|NCT02937701|584321358|FG004|Week 22 to Week 50|Other|1|||
161802542|NCT02289963|584321359|FG000|Overall Study|Adverse Event|1|||
161802543|NCT02289963|584321360|FG001|Overall Study|Adverse Event|2|||
161802544|NCT02289963|584321359|FG000|Overall Study|Poor compliance to protocol|1|||
161802545|NCT02289963|584321360|FG001|Overall Study|Poor compliance to protocol|0|||
161802546|NCT02289963|584321359|FG000|Overall Study|Withdrawal by Subject|1|||
161802547|NCT02289963|584321360|FG001|Overall Study|Withdrawal by Subject|0|||
161802548|NCT02289963|584321359|FG000|Overall Study|Last injection missed|2|||
161802549|NCT02289963|584321360|FG001|Overall Study|Last injection missed|2|||
161802550|NCT02289963|584321359|FG000|Overall Study|End treatment visit outside visit window|0|||
161802551|NCT02289963|584321360|FG001|Overall Study|End treatment visit outside visit window|4|||
161802552|NCT02289963|584321359|FG000|Overall Study|Other than specified above|0|||
161802553|NCT02289963|584321360|FG001|Overall Study|Other than specified above|2|||
161802554|NCT01507051|584321362|FG000|Overall Study|Withdrawal by Subject|1|||
161802555|NCT01507051|584321363|FG001|Overall Study|Withdrawal by Subject|3|||
161802556|NCT01507051|584321364|FG002|Overall Study|Withdrawal by Subject|1|||
161802557|NCT01507051|584321365|FG003|Overall Study|Withdrawal by Subject|6|||
161802558|NCT01507051|584321362|FG000|Overall Study|Physician Decision|0|||
161802559|NCT01507051|584321363|FG001|Overall Study|Physician Decision|0|||
161802560|NCT01507051|584321364|FG002|Overall Study|Physician Decision|0|||
161802561|NCT01507051|584321365|FG003|Overall Study|Physician Decision|1|||
161802562|NCT01507051|584321362|FG000|Overall Study|Adverse Event|1|||
161802563|NCT01507051|584321363|FG001|Overall Study|Adverse Event|0|||
161802564|NCT01507051|584321364|FG002|Overall Study|Adverse Event|0|||
161802565|NCT01507051|584321365|FG003|Overall Study|Adverse Event|0|||
161802566|NCT01941095|584321366|FG000|Overall Study|Insufficient therapeutic response|13|||
161802567|NCT01941095|584321366|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
161802568|NCT01941095|584321366|FG000|Overall Study|Adverse Event|11|||
162139548|NCT01118377|585563169|FG000|Overall Study|Death|38|||
162139549|NCT01118377|585563169|FG000|Overall Study|Failure to Return|3|||
162139550|NCT00739102|585563170|FG000|Overall Study|Death|5|||
162139551|NCT00739102|585563170|FG000|Overall Study|Withdrawal by Subject|10|||
162139552|NCT01331824|585563172|FG000|Overall Study|Adverse Event|2|||
162139553|NCT01331824|585563172|FG000|Overall Study|Death|1|||
162139554|NCT01331824|585563172|FG000|Overall Study|Disease Progression|9|||
162139555|NCT01331824|585563172|FG000|Overall Study|Withdrawal by Subject|1|||
162139556|NCT00149630|585563179|FG000|Overall Study|Incarceration|2|||
162139557|NCT00149630|585563180|FG001|Overall Study|Incarceration|0|||
162139558|NCT00149630|585563179|FG000|Overall Study|Treatment Programs|4|||
162139559|NCT00149630|585563180|FG001|Overall Study|Treatment Programs|5|||
162139560|NCT00149630|585563179|FG000|Overall Study|Adverse Event|2|||
162139561|NCT00149630|585563180|FG001|Overall Study|Adverse Event|0|||
162139562|NCT00991276|585563191|FG000|First Intervention Period|Adverse Event|0|||
162139563|NCT00991276|585563192|FG001|First Intervention Period|Adverse Event|1|||
162139564|NCT00991276|585563193|FG002|First Intervention Period|Adverse Event|0|||
162139565|NCT00991276|585563194|FG003|First Intervention Period|Adverse Event|1|||
162139566|NCT00991276|585563195|FG004|First Intervention Period|Adverse Event|0|||
162139567|NCT00991276|585563196|FG005|First Intervention Period|Adverse Event|0|||
162139568|NCT00991276|585563191|FG000|First Intervention Period|Protocol Violation|0|||
162139569|NCT00991276|585563192|FG001|First Intervention Period|Protocol Violation|0|||
162139570|NCT00991276|585563193|FG002|First Intervention Period|Protocol Violation|0|||
162139571|NCT00991276|585563194|FG003|First Intervention Period|Protocol Violation|0|||
162139572|NCT00991276|585563195|FG004|First Intervention Period|Protocol Violation|2|||
162139573|NCT00991276|585563196|FG005|First Intervention Period|Protocol Violation|0|||
162139574|NCT00991276|585563191|FG000|First Intervention Period|Insufficient clinical response|0|||
162139575|NCT00991276|585563192|FG001|First Intervention Period|Insufficient clinical response|0|||
162139576|NCT00991276|585563193|FG002|First Intervention Period|Insufficient clinical response|0|||
162139577|NCT00991276|585563194|FG003|First Intervention Period|Insufficient clinical response|0|||
162139578|NCT00991276|585563195|FG004|First Intervention Period|Insufficient clinical response|1|||
162139579|NCT00991276|585563196|FG005|First Intervention Period|Insufficient clinical response|0|||
162139580|NCT00991276|585563191|FG000|First Intervention Period|Other|0|||
162139581|NCT00991276|585563192|FG001|First Intervention Period|Other|0|||
162139582|NCT00991276|585563193|FG002|First Intervention Period|Other|0|||
162139583|NCT00991276|585563194|FG003|First Intervention Period|Other|1|||
162139584|NCT00991276|585563195|FG004|First Intervention Period|Other|1|||
161802569|NCT01941095|584321366|FG000|Overall Study|Physician Decision|3|||
161802570|NCT01941095|584321366|FG000|Overall Study|Withdrawal by Subject|17|||
162010893|NCT02594124|585096049|FG006|Overall Study|Withdrawal by Subject|13|||
162010894|NCT02594124|585096050|FG007|Overall Study|Withdrawal by Subject|19|||
162010895|NCT02594124|585096051|FG008|Overall Study|Withdrawal by Subject|0|||
162010896|NCT02594124|585096043|FG000|Overall Study|Physician Decision|0|||
162010897|NCT02594124|585096044|FG001|Overall Study|Physician Decision|2|||
162010898|NCT02594124|585096045|FG002|Overall Study|Physician Decision|0|||
162010899|NCT02594124|585096046|FG003|Overall Study|Physician Decision|0|||
162010900|NCT02594124|585096047|FG004|Overall Study|Physician Decision|0|||
162010901|NCT02594124|585096048|FG005|Overall Study|Physician Decision|0|||
162010902|NCT02594124|585096049|FG006|Overall Study|Physician Decision|0|||
162010903|NCT02594124|585096050|FG007|Overall Study|Physician Decision|1|||
162010904|NCT02594124|585096051|FG008|Overall Study|Physician Decision|0|||
162010905|NCT02594124|585096043|FG000|Overall Study|Commercial drug|0|||
162010906|NCT02594124|585096044|FG001|Overall Study|Commercial drug|1|||
162010907|NCT02594124|585096045|FG002|Overall Study|Commercial drug|6|||
162010908|NCT02594124|585096046|FG003|Overall Study|Commercial drug|3|||
162010909|NCT02594124|585096047|FG004|Overall Study|Commercial drug|0|||
162010910|NCT02594124|585096048|FG005|Overall Study|Commercial drug|0|||
162010911|NCT02594124|585096049|FG006|Overall Study|Commercial drug|7|||
162010912|NCT02594124|585096050|FG007|Overall Study|Commercial drug|11|||
162010913|NCT02594124|585096051|FG008|Overall Study|Commercial drug|2|||
162010914|NCT02594124|585096043|FG000|Overall Study|Reason Not Specified|1|||
162010915|NCT02594124|585096044|FG001|Overall Study|Reason Not Specified|3|||
162010916|NCT02594124|585096045|FG002|Overall Study|Reason Not Specified|4|||
162139585|NCT00991276|585563196|FG005|First Intervention Period|Other|0|||
161802571|NCT01941095|584321366|FG000|Overall Study|Lost to Follow-up|10|||
162010917|NCT02594124|585096046|FG003|Overall Study|Reason Not Specified|0|||
162010918|NCT02594124|585096047|FG004|Overall Study|Reason Not Specified|0|||
162010919|NCT02594124|585096048|FG005|Overall Study|Reason Not Specified|1|||
162010920|NCT02594124|585096049|FG006|Overall Study|Reason Not Specified|1|||
162010921|NCT02594124|585096050|FG007|Overall Study|Reason Not Specified|6|||
162010922|NCT02594124|585096051|FG008|Overall Study|Reason Not Specified|1|||
162139586|NCT00991276|585563191|FG000|First Intervention Period|Withdrawal by Subject|0|||
162139587|NCT00991276|585563192|FG001|First Intervention Period|Withdrawal by Subject|1|||
161802572|NCT03527745|584321367|FG000|Overall Study|Lost to Follow-up|3|||
161802573|NCT03527745|584321368|FG001|Overall Study|Lost to Follow-up|6|||
161802574|NCT03527745|584321369|FG002|Overall Study|Lost to Follow-up|7|||
161802575|NCT03527745|584321370|FG003|Overall Study|Lost to Follow-up|9|||
161802576|NCT03527745|584321371|FG004|Overall Study|Lost to Follow-up|0|||
161802577|NCT03527745|584321372|FG005|Overall Study|Lost to Follow-up|2|||
161802578|NCT03527745|584321373|FG006|Overall Study|Lost to Follow-up|3|||
161802579|NCT03527745|584321374|FG007|Overall Study|Lost to Follow-up|2|||
161802580|NCT03527745|584321375|FG008|Overall Study|Lost to Follow-up|3|||
161802581|NCT03527745|584321376|FG009|Overall Study|Lost to Follow-up|2|||
161802582|NCT03527745|584321377|FG010|Overall Study|Lost to Follow-up|1|||
161802583|NCT03527745|584321378|FG011|Overall Study|Lost to Follow-up|1|||
161802584|NCT03527745|584321379|FG012|Overall Study|Lost to Follow-up|0|||
161802585|NCT03527745|584321380|FG013|Overall Study|Lost to Follow-up|0|||
161802586|NCT03527745|584321381|FG014|Overall Study|Lost to Follow-up|0|||
161802587|NCT03527745|584321382|FG015|Overall Study|Lost to Follow-up|0|||
161802588|NCT03527745|584321383|FG016|Overall Study|Lost to Follow-up|1|||
162139588|NCT00991276|585563193|FG002|First Intervention Period|Withdrawal by Subject|0|||
162139589|NCT00991276|585563194|FG003|First Intervention Period|Withdrawal by Subject|1|||
162139590|NCT00991276|585563195|FG004|First Intervention Period|Withdrawal by Subject|0|||
162139591|NCT00991276|585563196|FG005|First Intervention Period|Withdrawal by Subject|1|||
162139592|NCT00991276|585563191|FG000|First Intervention Period|Lost to Follow-up|0|||
162139593|NCT00991276|585563192|FG001|First Intervention Period|Lost to Follow-up|1|||
162139594|NCT00991276|585563193|FG002|First Intervention Period|Lost to Follow-up|0|||
162139595|NCT00991276|585563194|FG003|First Intervention Period|Lost to Follow-up|1|||
162139596|NCT00991276|585563195|FG004|First Intervention Period|Lost to Follow-up|0|||
162139597|NCT00991276|585563196|FG005|First Intervention Period|Lost to Follow-up|0|||
162139598|NCT00991276|585563191|FG000|Second Intervention Period|Adverse Event|0|||
162139599|NCT00991276|585563192|FG001|Second Intervention Period|Adverse Event|2|||
162139600|NCT00991276|585563193|FG002|Second Intervention Period|Adverse Event|0|||
162139601|NCT00991276|585563194|FG003|Second Intervention Period|Adverse Event|1|||
162139602|NCT00991276|585563195|FG004|Second Intervention Period|Adverse Event|1|||
162139603|NCT00991276|585563196|FG005|Second Intervention Period|Adverse Event|0|||
162139604|NCT00991276|585563191|FG000|Second Intervention Period|Protocol Violation|1|||
162139605|NCT00991276|585563192|FG001|Second Intervention Period|Protocol Violation|0|||
162139606|NCT00991276|585563193|FG002|Second Intervention Period|Protocol Violation|0|||
162139607|NCT00991276|585563194|FG003|Second Intervention Period|Protocol Violation|0|||
162139608|NCT00991276|585563195|FG004|Second Intervention Period|Protocol Violation|0|||
162139609|NCT00991276|585563196|FG005|Second Intervention Period|Protocol Violation|0|||
162139610|NCT00991276|585563191|FG000|Second Intervention Period|Other|0|||
162139611|NCT00991276|585563192|FG001|Second Intervention Period|Other|0|||
162139612|NCT00991276|585563193|FG002|Second Intervention Period|Other|0|||
162139613|NCT00991276|585563194|FG003|Second Intervention Period|Other|1|||
162139614|NCT00991276|585563195|FG004|Second Intervention Period|Other|0|||
162139615|NCT00991276|585563196|FG005|Second Intervention Period|Other|1|||
162139616|NCT00991276|585563191|FG000|Third Intervention Period|Protocol Violation|1|||
162139617|NCT00991276|585563192|FG001|Third Intervention Period|Protocol Violation|0|||
162139618|NCT00991276|585563193|FG002|Third Intervention Period|Protocol Violation|0|||
162139619|NCT00991276|585563194|FG003|Third Intervention Period|Protocol Violation|0|||
162139620|NCT00991276|585563195|FG004|Third Intervention Period|Protocol Violation|0|||
162139621|NCT00991276|585563196|FG005|Third Intervention Period|Protocol Violation|0|||
162139622|NCT00991276|585563191|FG000|Third Intervention Period|Other|0|||
162139623|NCT00991276|585563192|FG001|Third Intervention Period|Other|0|||
162139624|NCT00991276|585563193|FG002|Third Intervention Period|Other|0|||
162139625|NCT00991276|585563194|FG003|Third Intervention Period|Other|0|||
162139626|NCT00991276|585563195|FG004|Third Intervention Period|Other|0|||
162139627|NCT00991276|585563196|FG005|Third Intervention Period|Other|1|||
162139628|NCT00991276|585563191|FG000|Third Intervention Period|Adverse Event|0|||
162139629|NCT00991276|585563192|FG001|Third Intervention Period|Adverse Event|0|||
162139630|NCT00991276|585563193|FG002|Third Intervention Period|Adverse Event|1|||
162139631|NCT00991276|585563194|FG003|Third Intervention Period|Adverse Event|0|||
162139632|NCT00991276|585563195|FG004|Third Intervention Period|Adverse Event|0|||
162139633|NCT00991276|585563196|FG005|Third Intervention Period|Adverse Event|0|||
162139634|NCT00991276|585563191|FG000|Third Intervention Period|Withdrawal by Subject|0|||
162139635|NCT00991276|585563192|FG001|Third Intervention Period|Withdrawal by Subject|0|||
162139636|NCT00991276|585563193|FG002|Third Intervention Period|Withdrawal by Subject|0|||
162139637|NCT00991276|585563194|FG003|Third Intervention Period|Withdrawal by Subject|1|||
162139638|NCT00991276|585563195|FG004|Third Intervention Period|Withdrawal by Subject|0|||
162139639|NCT00991276|585563196|FG005|Third Intervention Period|Withdrawal by Subject|0|||
162139640|NCT01268891|585563198|FG000|Overall Study|Adverse Event|3|||
162139641|NCT01268891|585563199|FG001|Overall Study|Adverse Event|7|||
162139642|NCT01268891|585563198|FG000|Overall Study|Lack of Efficacy|1|||
162139643|NCT01268891|585563199|FG001|Overall Study|Lack of Efficacy|0|||
162139644|NCT01268891|585563198|FG000|Overall Study|Withdrawal of Consent|3|||
162139645|NCT01268891|585563199|FG001|Overall Study|Withdrawal of Consent|1|||
162139646|NCT01268891|585563198|FG000|Overall Study|Administrative or other reason(s)|1|||
162139647|NCT01268891|585563199|FG001|Overall Study|Administrative or other reason(s)|0|||
162139648|NCT02001623|585563201|FG000|Overall Study|Disease Progression|2|||
162139649|NCT02001623|585563202|FG001|Overall Study|Disease Progression|2|||
162139650|NCT02001623|585563203|FG002|Overall Study|Disease Progression|3|||
162139651|NCT02001623|585563204|FG003|Overall Study|Disease Progression|2|||
161802589|NCT03527745|584321384|FG017|Overall Study|Lost to Follow-up|0|||
161802590|NCT03527745|584321385|FG018|Overall Study|Lost to Follow-up|0|||
161802591|NCT03527745|584321386|FG019|Overall Study|Lost to Follow-up|1|||
161802592|NCT03527745|584321387|FG020|Overall Study|Lost to Follow-up|1|||
162139652|NCT02001623|585563205|FG004|Overall Study|Disease Progression|3|||
162139653|NCT02001623|585563206|FG005|Overall Study|Disease Progression|2|||
162139654|NCT02001623|585563207|FG006|Overall Study|Disease Progression|3|||
162139655|NCT02001623|585563208|FG007|Overall Study|Disease Progression|3|||
162139656|NCT02001623|585563209|FG008|Overall Study|Disease Progression|7|||
162139657|NCT02001623|585563210|FG009|Overall Study|Disease Progression|40|||
162139658|NCT02001623|585563211|FG010|Overall Study|Disease Progression|5|||
162139659|NCT02001623|585563212|FG011|Overall Study|Disease Progression|9|||
162139660|NCT02001623|585563213|FG012|Overall Study|Disease Progression|9|||
162139661|NCT02001623|585563214|FG013|Overall Study|Disease Progression|20|||
162139662|NCT02001623|585563215|FG014|Overall Study|Disease Progression|9|||
162139663|NCT02001623|585563201|FG000|Overall Study|Physician Decision|0|||
162139664|NCT02001623|585563202|FG001|Overall Study|Physician Decision|0|||
162139665|NCT02001623|585563203|FG002|Overall Study|Physician Decision|0|||
162139666|NCT02001623|585563204|FG003|Overall Study|Physician Decision|0|||
162139667|NCT02001623|585563205|FG004|Overall Study|Physician Decision|0|||
162139668|NCT02001623|585563206|FG005|Overall Study|Physician Decision|0|||
162139669|NCT02001623|585563207|FG006|Overall Study|Physician Decision|0|||
162139670|NCT02001623|585563208|FG007|Overall Study|Physician Decision|0|||
162139671|NCT02001623|585563209|FG008|Overall Study|Physician Decision|3|||
162139672|NCT02001623|585563210|FG009|Overall Study|Physician Decision|2|||
162139673|NCT02001623|585563211|FG010|Overall Study|Physician Decision|3|||
162139674|NCT02001623|585563212|FG011|Overall Study|Physician Decision|3|||
162139675|NCT02001623|585563213|FG012|Overall Study|Physician Decision|1|||
162139676|NCT02001623|585563214|FG013|Overall Study|Physician Decision|2|||
162139677|NCT02001623|585563215|FG014|Overall Study|Physician Decision|1|||
162139678|NCT02001623|585563201|FG000|Overall Study|Death|0|||
162139679|NCT02001623|585563202|FG001|Overall Study|Death|1|||
162139680|NCT02001623|585563203|FG002|Overall Study|Death|0|||
162139681|NCT02001623|585563204|FG003|Overall Study|Death|0|||
162139682|NCT02001623|585563205|FG004|Overall Study|Death|0|||
162139683|NCT02001623|585563206|FG005|Overall Study|Death|0|||
162139684|NCT02001623|585563207|FG006|Overall Study|Death|0|||
162139685|NCT02001623|585563208|FG007|Overall Study|Death|0|||
162139686|NCT02001623|585563209|FG008|Overall Study|Death|0|||
162139687|NCT02001623|585563210|FG009|Overall Study|Death|0|||
162139688|NCT02001623|585563211|FG010|Overall Study|Death|0|||
162139689|NCT02001623|585563212|FG011|Overall Study|Death|0|||
162139690|NCT02001623|585563213|FG012|Overall Study|Death|0|||
162139691|NCT02001623|585563214|FG013|Overall Study|Death|0|||
162139692|NCT02001623|585563215|FG014|Overall Study|Death|0|||
162139693|NCT02001623|585563201|FG000|Overall Study|Adverse Event|0|||
162139694|NCT02001623|585563202|FG001|Overall Study|Adverse Event|0|||
162139695|NCT02001623|585563203|FG002|Overall Study|Adverse Event|0|||
162139696|NCT02001623|585563204|FG003|Overall Study|Adverse Event|0|||
162139697|NCT02001623|585563205|FG004|Overall Study|Adverse Event|0|||
162139698|NCT02001623|585563206|FG005|Overall Study|Adverse Event|1|||
162139699|NCT02001623|585563207|FG006|Overall Study|Adverse Event|0|||
162139700|NCT02001623|585563208|FG007|Overall Study|Adverse Event|3|||
162139701|NCT02001623|585563209|FG008|Overall Study|Adverse Event|4|||
162139702|NCT02001623|585563210|FG009|Overall Study|Adverse Event|6|||
162139703|NCT02001623|585563211|FG010|Overall Study|Adverse Event|4|||
162139704|NCT02001623|585563212|FG011|Overall Study|Adverse Event|0|||
162139705|NCT02001623|585563213|FG012|Overall Study|Adverse Event|3|||
162139706|NCT02001623|585563214|FG013|Overall Study|Adverse Event|5|||
162139707|NCT02001623|585563215|FG014|Overall Study|Adverse Event|6|||
162139708|NCT02001623|585563201|FG000|Overall Study|Other - Miscellaneous|0|||
162139709|NCT02001623|585563202|FG001|Overall Study|Other - Miscellaneous|0|||
162139710|NCT02001623|585563203|FG002|Overall Study|Other - Miscellaneous|0|||
162139711|NCT02001623|585563204|FG003|Overall Study|Other - Miscellaneous|0|||
162139712|NCT02001623|585563205|FG004|Overall Study|Other - Miscellaneous|0|||
162139713|NCT02001623|585563206|FG005|Overall Study|Other - Miscellaneous|0|||
162139714|NCT02001623|585563207|FG006|Overall Study|Other - Miscellaneous|0|||
162139715|NCT02001623|585563208|FG007|Overall Study|Other - Miscellaneous|0|||
162139716|NCT02001623|585563209|FG008|Overall Study|Other - Miscellaneous|0|||
162139717|NCT02001623|585563210|FG009|Overall Study|Other - Miscellaneous|1|||
162139718|NCT02001623|585563211|FG010|Overall Study|Other - Miscellaneous|0|||
162139719|NCT02001623|585563212|FG011|Overall Study|Other - Miscellaneous|0|||
162139720|NCT02001623|585563213|FG012|Overall Study|Other - Miscellaneous|0|||
162139721|NCT02001623|585563214|FG013|Overall Study|Other - Miscellaneous|1|||
162139722|NCT02001623|585563215|FG014|Overall Study|Other - Miscellaneous|0|||
162139723|NCT02001623|585563201|FG000|Overall Study|Withdrawal by Subject|1|||
162139724|NCT02001623|585563202|FG001|Overall Study|Withdrawal by Subject|0|||
162139725|NCT02001623|585563203|FG002|Overall Study|Withdrawal by Subject|0|||
162139726|NCT02001623|585563204|FG003|Overall Study|Withdrawal by Subject|0|||
162139727|NCT02001623|585563205|FG004|Overall Study|Withdrawal by Subject|0|||
162139728|NCT02001623|585563206|FG005|Overall Study|Withdrawal by Subject|0|||
162139729|NCT02001623|585563207|FG006|Overall Study|Withdrawal by Subject|0|||
162139730|NCT02001623|585563208|FG007|Overall Study|Withdrawal by Subject|0|||
162139731|NCT02001623|585563209|FG008|Overall Study|Withdrawal by Subject|1|||
162139732|NCT02001623|585563210|FG009|Overall Study|Withdrawal by Subject|3|||
162139733|NCT02001623|585563211|FG010|Overall Study|Withdrawal by Subject|2|||
162139734|NCT02001623|585563212|FG011|Overall Study|Withdrawal by Subject|2|||
162139735|NCT02001623|585563213|FG012|Overall Study|Withdrawal by Subject|1|||
162139736|NCT02001623|585563214|FG013|Overall Study|Withdrawal by Subject|5|||
162139737|NCT02001623|585563215|FG014|Overall Study|Withdrawal by Subject|2|||
162139738|NCT02001623|585563201|FG000|Overall Study|Lost to Follow-up|0|||
162139739|NCT02001623|585563202|FG001|Overall Study|Lost to Follow-up|0|||
162139740|NCT02001623|585563203|FG002|Overall Study|Lost to Follow-up|0|||
162139741|NCT02001623|585563204|FG003|Overall Study|Lost to Follow-up|0|||
162139742|NCT02001623|585563205|FG004|Overall Study|Lost to Follow-up|0|||
162139743|NCT02001623|585563206|FG005|Overall Study|Lost to Follow-up|0|||
162139744|NCT02001623|585563207|FG006|Overall Study|Lost to Follow-up|0|||
162139745|NCT02001623|585563208|FG007|Overall Study|Lost to Follow-up|0|||
162139746|NCT02001623|585563209|FG008|Overall Study|Lost to Follow-up|0|||
162139747|NCT02001623|585563210|FG009|Overall Study|Lost to Follow-up|1|||
162139748|NCT02001623|585563211|FG010|Overall Study|Lost to Follow-up|0|||
162139749|NCT02001623|585563212|FG011|Overall Study|Lost to Follow-up|0|||
162139750|NCT02001623|585563213|FG012|Overall Study|Lost to Follow-up|0|||
162139751|NCT02001623|585563214|FG013|Overall Study|Lost to Follow-up|0|||
162139752|NCT02001623|585563215|FG014|Overall Study|Lost to Follow-up|0|||
162139753|NCT02001623|585563201|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
162139754|NCT02001623|585563202|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
162139755|NCT02001623|585563203|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
162139756|NCT02001623|585563204|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
162139757|NCT02001623|585563205|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
162139758|NCT02001623|585563206|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
162139759|NCT02001623|585563207|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
162139760|NCT02001623|585563208|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
162139761|NCT02001623|585563209|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
162139762|NCT02001623|585563210|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
162139763|NCT02001623|585563211|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
162139764|NCT02001623|585563212|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
162139765|NCT02001623|585563213|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
162139766|NCT02001623|585563214|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
162139767|NCT02001623|585563215|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
162139768|NCT02001623|585563201|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
162139769|NCT02001623|585563202|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
162139770|NCT02001623|585563203|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
162139771|NCT02001623|585563204|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
162139772|NCT02001623|585563205|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
162139773|NCT02001623|585563206|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
162139774|NCT02001623|585563207|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
162139775|NCT02001623|585563208|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
162139776|NCT02001623|585563209|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
162139777|NCT02001623|585563210|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
162139778|NCT02001623|585563211|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
162139779|NCT02001623|585563212|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
162139780|NCT02001623|585563213|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
162139781|NCT02001623|585563214|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
162139782|NCT02001623|585563215|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
162139783|NCT01063036|585563218|FG000|Participants Treated With Study Drug|Adverse Event|1|||
162139784|NCT01063036|585563218|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
162139785|NCT01063036|585563218|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
162139786|NCT01063036|585563218|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
162139787|NCT01063036|585563218|FG000|Participants Treated With Study Drug|Pregnancy|1|||
162139788|NCT01063036|585563218|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
162139789|NCT01063036|585563218|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
162139790|NCT01063036|585563218|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
162139791|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
162139792|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
162139793|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
162139794|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
162139795|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Adverse Event|198|||
162139796|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Adverse Event|0|||
162139797|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Adverse Event|0|||
162139798|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Adverse Event|0|||
162139799|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Death|62|||
162139800|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Death|0|||
162139801|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Death|0|||
162139802|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Death|0|||
162139803|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
162139804|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
162139805|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
161905608|NCT01811732|584703383|FG000|Overall Study|Admitted to another facility|1|||
161905609|NCT01811732|584703384|FG001|Overall Study|Admitted to another facility|0|||
161905610|NCT01811732|584703383|FG000|Overall Study|Correct study drug not available on site|1|||
161905611|NCT01811732|584703384|FG001|Overall Study|Correct study drug not available on site|0|||
161905612|NCT01405560|584703387|FG000|Overall Study|Physician Decision|1|||
161905613|NCT00896493|584703388|FG000|Overall Study|Early disease relapse|3|||
161905614|NCT02035553|584703389|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
161905615|NCT02035553|584703390|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
161905616|NCT02035553|584703389|FG000|Overall Study|Adverse Event|10|||
161905617|NCT02035553|584703390|FG001|Overall Study|Adverse Event|6|||
161905618|NCT02035553|584703389|FG000|Overall Study|Physician Decision|3|||
161905619|NCT02035553|584703390|FG001|Overall Study|Physician Decision|2|||
161905620|NCT02035553|584703389|FG000|Overall Study|Lack of Efficacy|1|||
161905621|NCT02035553|584703390|FG001|Overall Study|Lack of Efficacy|1|||
161905622|NCT02035553|584703389|FG000|Overall Study|Withdrawal by Subject|4|||
161905623|NCT02035553|584703390|FG001|Overall Study|Withdrawal by Subject|7|||
161905624|NCT02035553|584703389|FG000|Overall Study|Non-compliance with Study Drug|0|||
161905625|NCT02035553|584703390|FG001|Overall Study|Non-compliance with Study Drug|1|||
161905626|NCT02035553|584703389|FG000|Overall Study|Lost to Follow-up|0|||
161905627|NCT02035553|584703390|FG001|Overall Study|Lost to Follow-up|1|||
161905628|NCT02035553|584703389|FG000|Overall Study|Other Reason|0|||
161905629|NCT02035553|584703390|FG001|Overall Study|Other Reason|4|||
161905630|NCT04539964|584703391|FG000|Overall Study|device malfunction|1|||
161905631|NCT04539964|584703392|FG001|Overall Study|device malfunction|0|||
161905632|NCT04539964|584703391|FG000|Overall Study|Withdrawal by Subject|1|||
161905633|NCT04539964|584703392|FG001|Overall Study|Withdrawal by Subject|2|||
161905634|NCT04539964|584703391|FG000|Overall Study|Adverse Event|0|||
161905635|NCT04539964|584703392|FG001|Overall Study|Adverse Event|2|||
162139806|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
162139807|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Complicating disease|13|||
162139808|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Complicating disease|0|||
162139809|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Complicating disease|0|||
162139810|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Complicating disease|0|||
162139811|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
162139812|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
162139813|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
162139814|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
162139815|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
162139816|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
162139817|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
162139818|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
162139819|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Non-compliance|4|||
162139820|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Non-compliance|0|||
162139821|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Non-compliance|0|||
162139822|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Non-compliance|0|||
162139823|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Pain|4|||
162139824|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Pain|0|||
162139825|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Pain|0|||
162139826|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Pain|0|||
162139827|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
162139828|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
162139829|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
162139830|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
162139831|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Hospice care|1|||
162139832|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Hospice care|0|||
162139833|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Hospice care|0|||
162139834|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Hospice care|0|||
162139835|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Physician Decision|1|||
162139836|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Physician Decision|0|||
162139837|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Physician Decision|0|||
162139838|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Physician Decision|0|||
162139839|NCT01107626|585563219|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
162139840|NCT01107626|585563220|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
162139841|NCT01107626|585563221|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
162139842|NCT01107626|585563222|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
162139843|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
162139844|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
162139845|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
162139846|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
162139847|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
162139848|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
162139849|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
162139850|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
162139851|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Death|0|||
162139852|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Death|8|||
162139853|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Death|2|||
162139854|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Death|13|||
162139855|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
162139856|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
162139857|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
162139858|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
162139859|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
162139860|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
162139861|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
162139862|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
162139863|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
162139864|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
162139865|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
162139866|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
162139867|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
162139868|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
162139869|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
162139870|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
162139871|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
162139872|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
162139873|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
162139874|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
162139875|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
162139876|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
162139877|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
162139878|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
162139879|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
162139880|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
162139881|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
162139882|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
162139883|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
162139884|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
162139885|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
162139886|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
162139887|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
162139888|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
162139889|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
162139890|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
162139891|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
162139892|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
162139893|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
162139894|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
162139895|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Pain|0|||
162139896|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Pain|0|||
162139897|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Pain|0|||
162139898|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Pain|1|||
162139899|NCT01107626|585563219|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
162139900|NCT01107626|585563220|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
162139901|NCT01107626|585563221|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
162139902|NCT01107626|585563222|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
162139903|NCT02715258|585563223|FG000|Overall Study|Withdrawal by Subject|6|||
162139904|NCT02715258|585563224|FG001|Overall Study|Withdrawal by Subject|1|||
162139905|NCT02715258|585563223|FG000|Overall Study|Lost to Follow-up|7|||
162139906|NCT02715258|585563224|FG001|Overall Study|Lost to Follow-up|1|||
162139907|NCT02715258|585563223|FG000|Overall Study|Terminated by Sponsor|0|||
162139908|NCT02715258|585563224|FG001|Overall Study|Terminated by Sponsor|1|||
162139909|NCT02715258|585563223|FG000|Overall Study|Death|0|||
162139910|NCT02715258|585563224|FG001|Overall Study|Death|1|||
162139911|NCT02715258|585563223|FG000|Overall Study|Subject non-compliant|1|||
162139912|NCT02715258|585563224|FG001|Overall Study|Subject non-compliant|1|||
162139913|NCT02715258|585563223|FG000|Overall Study|GCP violation|2|||
162139914|NCT02715258|585563224|FG001|Overall Study|GCP violation|1|||
162139915|NCT01117480|585563234|FG000|Overall Study|Protocol Violation|8|||
162139916|NCT01117480|585563234|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
162139917|NCT01280591|585563235|FG000|Overall Study|Withdrawal by Subject|0|||
162139918|NCT01280591|585563236|FG001|Overall Study|Withdrawal by Subject|0|||
162139919|NCT01280591|585563237|FG002|Overall Study|Withdrawal by Subject|0|||
162139920|NCT01280591|585563238|FG003|Overall Study|Withdrawal by Subject|2|||
162139921|NCT01280591|585563235|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
162139922|NCT01280591|585563236|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
162139923|NCT01280591|585563237|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
162139924|NCT01280591|585563238|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
162139925|NCT02955069|585563240|FG000|Overall Study|Adverse Event|7|||
162139926|NCT02955069|585563241|FG001|Overall Study|Adverse Event|2|||
162139927|NCT02955069|585563240|FG000|Overall Study|Death|7|||
162139928|NCT02955069|585563241|FG001|Overall Study|Death|3|||
162139929|NCT02955069|585563240|FG000|Overall Study|Physician Decision|10|||
162139930|NCT02955069|585563241|FG001|Overall Study|Physician Decision|2|||
162139931|NCT02955069|585563240|FG000|Overall Study|Progressive disease|64|||
162139932|NCT02955069|585563241|FG001|Overall Study|Progressive disease|13|||
162139933|NCT02955069|585563240|FG000|Overall Study|Study terminated by sponsor|4|||
162139934|NCT02955069|585563241|FG001|Overall Study|Study terminated by sponsor|0|||
162139935|NCT02955069|585563240|FG000|Overall Study|Subject/Guardian decision|3|||
162139936|NCT02955069|585563241|FG001|Overall Study|Subject/Guardian decision|1|||
162139937|NCT03721016|585563242|FG000|Overall Study|Adverse Event|0|||
162139938|NCT03721016|585563243|FG001|Overall Study|Adverse Event|1|||
162139939|NCT03721016|585563244|FG002|Overall Study|Adverse Event|1|||
162139940|NCT03721016|585563242|FG000|Overall Study|Withdrawal by Subject|8|||
162139941|NCT03721016|585563243|FG001|Overall Study|Withdrawal by Subject|16|||
162139942|NCT03721016|585563244|FG002|Overall Study|Withdrawal by Subject|13|||
162139943|NCT03721016|585563242|FG000|Overall Study|Lost to Follow-up|4|||
162139944|NCT03721016|585563243|FG001|Overall Study|Lost to Follow-up|6|||
162139945|NCT03721016|585563244|FG002|Overall Study|Lost to Follow-up|5|||
162139946|NCT03721016|585563242|FG000|Overall Study|Physician Decision|0|||
162139947|NCT03721016|585563243|FG001|Overall Study|Physician Decision|1|||
162139948|NCT03721016|585563244|FG002|Overall Study|Physician Decision|2|||
162139949|NCT03721016|585563242|FG000|Overall Study|Protocol Violation|0|||
162139950|NCT03721016|585563243|FG001|Overall Study|Protocol Violation|1|||
162139951|NCT03721016|585563244|FG002|Overall Study|Protocol Violation|0|||
162139952|NCT03721016|585563242|FG000|Overall Study|Site terminated by sponsor|3|||
162139953|NCT03721016|585563243|FG001|Overall Study|Site terminated by sponsor|7|||
162139954|NCT03721016|585563244|FG002|Overall Study|Site terminated by sponsor|6|||
162139955|NCT03721016|585563242|FG000|Overall Study|Subject exited early due to COVID-19|1|||
162139956|NCT03721016|585563243|FG001|Overall Study|Subject exited early due to COVID-19|0|||
162139957|NCT03721016|585563244|FG002|Overall Study|Subject exited early due to COVID-19|0|||
162139958|NCT03357341|585563245|FG000|Overall Study|Withdrawal by Subject|3|||
162139959|NCT03357341|585563246|FG001|Overall Study|Withdrawal by Subject|6|||
162139960|NCT03357341|585563245|FG000|Overall Study|Lost to Follow-up|4|||
162139961|NCT03357341|585563246|FG001|Overall Study|Lost to Follow-up|5|||
162139962|NCT03357341|585563245|FG000|Overall Study|Death|0|||
162139963|NCT03357341|585563246|FG001|Overall Study|Death|1|||
162139964|NCT01072357|585563249|FG000|Overall Study|Lost to Follow-up|0|||
162139965|NCT01072357|585563250|FG001|Overall Study|Lost to Follow-up|1|||
162139966|NCT02131324|585563251|FG000|Overall Study|Withdrawal by Subject|1|||
162139967|NCT02131324|585563252|FG001|Overall Study|Withdrawal by Subject|2|||
162139968|NCT02131324|585563251|FG000|Overall Study|Lost to Follow-up|1|||
162139969|NCT02131324|585563252|FG001|Overall Study|Lost to Follow-up|1|||
162139970|NCT01048788|585563253|FG000|Overall Study|Adverse Event|5|||
162139971|NCT01048788|585563254|FG001|Overall Study|Adverse Event|1|||
162139972|NCT01048788|585563255|FG002|Overall Study|Adverse Event|1|||
162139973|NCT01048788|585563253|FG000|Overall Study|Lack of Efficacy|0|||
162139974|NCT01048788|585563254|FG001|Overall Study|Lack of Efficacy|0|||
162139975|NCT01048788|585563255|FG002|Overall Study|Lack of Efficacy|1|||
162139976|NCT01048788|585563253|FG000|Overall Study|Withdrawal by Subject|0|||
162139977|NCT01048788|585563254|FG001|Overall Study|Withdrawal by Subject|1|||
162139978|NCT01048788|585563255|FG002|Overall Study|Withdrawal by Subject|0|||
162139979|NCT01233050|585563256|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
162139980|NCT01233050|585563257|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
162139981|NCT04582877|585563262|FG000|Overall Study|Did not use device measurement|5|||
162139982|NCT04582877|585563262|FG000|Overall Study|No fractional flow reserve test results|2|||
162139983|NCT04582877|585563262|FG000|Overall Study|Protocol Violation|1|||
162139984|NCT00957229|585563264|FG000|Study Start|Adverse Event|0|||
162139985|NCT00957229|585563265|FG001|Study Start|Adverse Event|3|||
162139986|NCT00957229|585563264|FG000|Study Start|Disease Progression|1|||
162139987|NCT00957229|585563265|FG001|Study Start|Disease Progression|0|||
162139988|NCT00957229|585563264|FG000|Reallocated to or Continued Vismodegib|Death|1|||
162139989|NCT00957229|585563265|FG001|Reallocated to or Continued Vismodegib|Death|1|||
162139990|NCT00957229|585563264|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
162139991|NCT00957229|585563265|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
162139992|NCT03095508|585563267|FG000|Overall Study|Adverse Event|0|||
162139993|NCT03095508|585563268|FG001|Overall Study|Adverse Event|1|||
162139994|NCT00335556|585563269|FG000|Overall Study|Death|0|||
162139995|NCT00335556|585563270|FG001|Overall Study|Death|5|||
162139996|NCT00335556|585563271|FG002|Overall Study|Death|0|||
162139997|NCT00335556|585563272|FG003|Overall Study|Death|0|||
162139998|NCT00335556|585563273|FG004|Overall Study|Death|1|||
162139999|NCT00335556|585563274|FG005|Overall Study|Death|0|||
162140000|NCT00335556|585563269|FG000|Overall Study|Lack of Efficacy|0|||
162140001|NCT00335556|585563270|FG001|Overall Study|Lack of Efficacy|19|||
162140002|NCT00335556|585563271|FG002|Overall Study|Lack of Efficacy|3|||
162140003|NCT00335556|585563272|FG003|Overall Study|Lack of Efficacy|3|||
162140004|NCT00335556|585563273|FG004|Overall Study|Lack of Efficacy|0|||
162140005|NCT00335556|585563274|FG005|Overall Study|Lack of Efficacy|1|||
162140006|NCT00335556|585563269|FG000|Overall Study|Physician Decision|0|||
162140007|NCT00335556|585563270|FG001|Overall Study|Physician Decision|6|||
162140008|NCT00335556|585563271|FG002|Overall Study|Physician Decision|2|||
162140009|NCT00335556|585563272|FG003|Overall Study|Physician Decision|1|||
162140010|NCT00335556|585563273|FG004|Overall Study|Physician Decision|0|||
162140011|NCT00335556|585563274|FG005|Overall Study|Physician Decision|0|||
162140012|NCT00335556|585563269|FG000|Overall Study|Ineligible|2|||
162140013|NCT00335556|585563270|FG001|Overall Study|Ineligible|0|||
162140014|NCT00335556|585563271|FG002|Overall Study|Ineligible|0|||
162140015|NCT00335556|585563272|FG003|Overall Study|Ineligible|0|||
162140016|NCT00335556|585563273|FG004|Overall Study|Ineligible|0|||
162140017|NCT00335556|585563274|FG005|Overall Study|Ineligible|0|||
162140018|NCT00335556|585563269|FG000|Overall Study|Refusal of further protocol therapy|0|||
162140019|NCT00335556|585563270|FG001|Overall Study|Refusal of further protocol therapy|4|||
162140020|NCT00335556|585563271|FG002|Overall Study|Refusal of further protocol therapy|0|||
162140021|NCT00335556|585563272|FG003|Overall Study|Refusal of further protocol therapy|1|||
162140022|NCT00335556|585563273|FG004|Overall Study|Refusal of further protocol therapy|0|||
162140023|NCT00335556|585563274|FG005|Overall Study|Refusal of further protocol therapy|0|||
162140024|NCT01878890|585563282|FG000|Overall Study|Protocol Violation|0|||
162140025|NCT01878890|585563283|FG001|Overall Study|Protocol Violation|1|||
162140026|NCT01878890|585563284|FG002|Overall Study|Protocol Violation|0|||
161802593|NCT03527745|584321388|FG021|Overall Study|Lost to Follow-up|5|||
161802594|NCT03527745|584321389|FG022|Overall Study|Lost to Follow-up|6|||
161802595|NCT03527745|584321390|FG023|Overall Study|Lost to Follow-up|8|||
161802596|NCT03527745|584321391|FG024|Overall Study|Lost to Follow-up|1|||
161802597|NCT03527745|584321392|FG025|Overall Study|Lost to Follow-up|3|||
161802598|NCT01475838|584321396|FG000|Randomized Phase|Randomized but Not Treated|0|||
161802599|NCT01475838|584321397|FG001|Randomized Phase|Randomized but Not Treated|5|||
161802600|NCT01475838|584321396|FG000|Randomized Phase|Adverse Event|6|||
161802601|NCT01475838|584321397|FG001|Randomized Phase|Adverse Event|1|||
161802602|NCT01475838|584321396|FG000|Randomized Phase|Pregnancy|0|||
161802603|NCT01475838|584321397|FG001|Randomized Phase|Pregnancy|1|||
161802604|NCT01475838|584321396|FG000|Randomized Phase|Investigators Discretion|1|||
161802605|NCT01475838|584321397|FG001|Randomized Phase|Investigators Discretion|2|||
161802606|NCT01475838|584321396|FG000|Randomized Phase|Withdrew Consent|10|||
161802607|NCT01475838|584321397|FG001|Randomized Phase|Withdrew Consent|14|||
161802608|NCT01475838|584321396|FG000|Randomized Phase|Lost to Follow-up|3|||
161802609|NCT01475838|584321397|FG001|Randomized Phase|Lost to Follow-up|4|||
161802610|NCT01475838|584321396|FG000|Randomized Phase|Participant Noncompliance|1|||
161802611|NCT01475838|584321397|FG001|Randomized Phase|Participant Noncompliance|5|||
161802612|NCT01475838|584321396|FG000|Randomized Phase|Protocol Violation|9|||
161802613|NCT01475838|584321397|FG001|Randomized Phase|Protocol Violation|4|||
161802614|NCT01475838|584321396|FG000|Extension Phase|Participant Noncompliance|1|||
161802615|NCT01475838|584321397|FG001|Extension Phase|Participant Noncompliance|0|||
162140027|NCT01878890|585563285|FG003|Overall Study|Protocol Violation|0|||
162140028|NCT01710514|585563290|FG000|Overall Study|Adverse Event|6|||
162140029|NCT01710514|585563291|FG001|Overall Study|Adverse Event|7|||
162140030|NCT01710514|585563290|FG000|Overall Study|Withdrawal by Subject|1|||
162140031|NCT01710514|585563291|FG001|Overall Study|Withdrawal by Subject|0|||
162140032|NCT03404843|585563292|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
162140033|NCT03404843|585563293|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
162140034|NCT00567164|585563294|FG000|Overall Study|Withdrawal by Subject|171|||
162140035|NCT00567164|585563295|FG001|Overall Study|Withdrawal by Subject|21|||
162140036|NCT00567164|585563296|FG002|Overall Study|Withdrawal by Subject|17|||
162140037|NCT00567164|585563294|FG000|Overall Study|Protocol Violation|23|||
162140038|NCT00567164|585563295|FG001|Overall Study|Protocol Violation|4|||
162140039|NCT00567164|585563296|FG002|Overall Study|Protocol Violation|2|||
162140040|NCT00567164|585563294|FG000|Overall Study|Adverse Event|92|||
161802616|NCT00560235|584321403|FG000|Phase 1|Discontinued|8|||
161802617|NCT00560235|584321404|FG001|Phase 1|Discontinued|0|||
161802618|NCT00560235|584321405|FG002|Phase 1|Discontinued|0|||
161802619|NCT00560235|584321403|FG000|Phase 1B|Discontinued|0|||
161802620|NCT00560235|584321404|FG001|Phase 1B|Discontinued|19|||
161802621|NCT00560235|584321405|FG002|Phase 1B|Discontinued|0|||
161802622|NCT00560235|584321403|FG000|Phase 2|Discontinued|0|||
161802623|NCT00560235|584321404|FG001|Phase 2|Discontinued|0|||
161802624|NCT00560235|584321405|FG002|Phase 2|Discontinued|96|||
161802625|NCT00560235|584321403|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
161802626|NCT00560235|584321404|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
161802627|NCT00560235|584321405|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
161802628|NCT04015232|584321407|FG000|Overall Study|Withdrawal by Subject|7|||
161802629|NCT04015232|584321408|FG001|Overall Study|Withdrawal by Subject|4|||
161802630|NCT04015232|584321407|FG000|Overall Study|Protocol Violation|1|||
161802631|NCT04015232|584321408|FG001|Overall Study|Protocol Violation|0|||
161802632|NCT04015232|584321407|FG000|Overall Study|Medical Grounds|3|||
161802633|NCT04015232|584321408|FG001|Overall Study|Medical Grounds|3|||
161802634|NCT00365300|584321413|FG000|Open-label Phase|Adverse Event|4|||
161802635|NCT00365300|584321414|FG001|Open-label Phase|Adverse Event|0|||
161802636|NCT00365300|584321413|FG000|Open-label Phase|Failed to Return|1|||
161802637|NCT00365300|584321414|FG001|Open-label Phase|Failed to Return|0|||
161802638|NCT00365300|584321413|FG000|Open-label Phase|Physician Decision|1|||
161802639|NCT00365300|584321414|FG001|Open-label Phase|Physician Decision|0|||
161802640|NCT00365300|584321413|FG000|Open-label Phase|Noncompliance|9|||
161802641|NCT00365300|584321414|FG001|Open-label Phase|Noncompliance|0|||
161802642|NCT00365300|584321413|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
161802643|NCT00365300|584321414|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
161802644|NCT00365300|584321413|FG000|Open-label Phase|Protocol Violation|1|||
161802645|NCT00365300|584321414|FG001|Open-label Phase|Protocol Violation|0|||
161802646|NCT00365300|584321413|FG000|Open-label Phase|Lack of Efficacy|1|||
161802647|NCT00365300|584321414|FG001|Open-label Phase|Lack of Efficacy|0|||
161802648|NCT00365300|584321413|FG000|Open-label Phase|Patient skipped open label phase|1|||
161802649|NCT00365300|584321414|FG001|Open-label Phase|Patient skipped open label phase|0|||
161802650|NCT00365300|584321413|FG000|Double-blind Phase|Failed to return|1|||
161802651|NCT00365300|584321414|FG001|Double-blind Phase|Failed to return|0|||
161802652|NCT00365300|584321413|FG000|Double-blind Phase|Noncompliance|1|||
161802653|NCT00365300|584321414|FG001|Double-blind Phase|Noncompliance|1|||
161802654|NCT00365300|584321413|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161802655|NCT00365300|584321414|FG001|Double-blind Phase|Withdrawal by Subject|1|||
161802656|NCT00365300|584321413|FG000|Double-blind Phase|Protocol Violation|3|||
161802657|NCT00365300|584321414|FG001|Double-blind Phase|Protocol Violation|1|||
161802658|NCT00365300|584321413|FG000|Double-blind Phase|Lack of Efficacy|6|||
161802659|NCT00365300|584321414|FG001|Double-blind Phase|Lack of Efficacy|6|||
161802660|NCT01991470|584321415|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
161802661|NCT01991470|584321415|FG000|Enlite 1 Period|Adverse Event|1|||
161802662|NCT01991470|584321415|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
161802663|NCT01991470|584321415|FG000|Enlite 3 Period|Lost to Follow-up|1|||
161802664|NCT01991470|584321415|FG000|Enlite 3 Period|Physician Decision|2|||
161802665|NCT01991470|584321415|FG000|Enlite 3 Period|Physician Decision|8|||
161802666|NCT01991470|584321415|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
161802667|NCT02896361|584321416|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
161802668|NCT02896361|584321417|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
161802669|NCT02896361|584321418|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
161802670|NCT02896361|584321416|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
161802671|NCT02896361|584321417|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
161802672|NCT02896361|584321418|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
161802673|NCT02143102|584321423|FG000|Overall Study|Lost to Follow-up|11|||
161802674|NCT02143102|584321424|FG001|Overall Study|Lost to Follow-up|0|||
161802675|NCT03164772|584321427|FG000|Overall Study|Death|4|||
161802676|NCT03164772|584321428|FG001|Overall Study|Death|2|||
161802677|NCT03164772|584321427|FG000|Overall Study|Adverse Event|1|||
161802678|NCT03164772|584321428|FG001|Overall Study|Adverse Event|4|||
161802679|NCT03164772|584321427|FG000|Overall Study|Progressive Disease|11|||
161802680|NCT03164772|584321428|FG001|Overall Study|Progressive Disease|21|||
161802681|NCT03164772|584321427|FG000|Overall Study|Physician Decision|2|||
161802682|NCT03164772|584321428|FG001|Overall Study|Physician Decision|0|||
161802683|NCT03164772|584321427|FG000|Overall Study|Withdrawal by Subject|0|||
161802684|NCT03164772|584321428|FG001|Overall Study|Withdrawal by Subject|4|||
161802685|NCT01029353|584321429|FG000|Overall Study|Lost to Follow-up|4|||
161802686|NCT01029353|584321430|FG001|Overall Study|Lost to Follow-up|5|||
161802687|NCT01029353|584321431|FG002|Overall Study|Lost to Follow-up|5|||
161802688|NCT01029353|584321432|FG003|Overall Study|Lost to Follow-up|4|||
161802689|NCT01029353|584321429|FG000|Overall Study|Consent Withdrawn|2|||
161802690|NCT01029353|584321430|FG001|Overall Study|Consent Withdrawn|0|||
161802691|NCT01029353|584321431|FG002|Overall Study|Consent Withdrawn|0|||
161802692|NCT01029353|584321432|FG003|Overall Study|Consent Withdrawn|0|||
161802693|NCT01029353|584321429|FG000|Overall Study|Primary Outcome Indeterminate|1|||
161905636|NCT01674725|584703393|FG000|Overall Study|Adverse Event|1|||
161905637|NCT01674725|584703394|FG001|Overall Study|Adverse Event|0|||
161905638|NCT01674725|584703393|FG000|Overall Study|Did not receive study drug|1|||
161905639|NCT01674725|584703394|FG001|Overall Study|Did not receive study drug|0|||
161905640|NCT01674725|584703393|FG000|Overall Study|Withdrawal by Subject|1|||
161905641|NCT01674725|584703394|FG001|Overall Study|Withdrawal by Subject|0|||
161905642|NCT01674725|584703393|FG000|Overall Study|Lost to Follow-up|0|||
161905643|NCT01674725|584703394|FG001|Overall Study|Lost to Follow-up|1|||
161905644|NCT03102762|584703395|FG000|Overall Study|Lost to Follow-up|1|||
161905645|NCT03102762|584703396|FG001|Overall Study|Lost to Follow-up|0|||
161905646|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
161905647|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
161905648|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
161905649|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
161905650|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
161905651|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
161905652|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
161905653|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
161905654|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
161905655|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
161905656|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
161905657|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
161905658|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
161905659|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
161905660|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
161905661|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
161905662|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
161905663|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
161905664|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
161802694|NCT01029353|584321430|FG001|Overall Study|Primary Outcome Indeterminate|3|||
161802695|NCT01029353|584321431|FG002|Overall Study|Primary Outcome Indeterminate|2|||
161802696|NCT01029353|584321432|FG003|Overall Study|Primary Outcome Indeterminate|0|||
161802697|NCT04538170|584321435|FG000|Overall Study|Withdrawal by Subject|104|||
161802698|NCT04538170|584321436|FG001|Overall Study|Withdrawal by Subject|210|||
161802699|NCT00324168|584321441|FG000|Overall Study|Lost to Follow-up|19|||
161802700|NCT00324168|584321442|FG001|Overall Study|Lost to Follow-up|18|||
161802701|NCT00324168|584321441|FG000|Overall Study|Death|3|||
161802702|NCT00324168|584321442|FG001|Overall Study|Death|3|||
161802703|NCT00324168|584321441|FG000|Overall Study|Patient did not visit in f/u window|6|||
161802704|NCT00324168|584321442|FG001|Overall Study|Patient did not visit in f/u window|9|||
161802705|NCT01203878|584321443|FG000|Overall Study|Withdrawal by Subject|0|||
161802706|NCT01203878|584321444|FG001|Overall Study|Withdrawal by Subject|0|||
161802707|NCT01203878|584321445|FG002|Overall Study|Withdrawal by Subject|1|||
161802708|NCT01203878|584321443|FG000|Overall Study|Adverse Event|0|||
161802709|NCT01203878|584321444|FG001|Overall Study|Adverse Event|0|||
161802710|NCT01203878|584321445|FG002|Overall Study|Adverse Event|2|||
161802711|NCT00274937|584321446|FG000|Overall Study|Physician Decision|10|||
161802712|NCT00274937|584321446|FG000|Overall Study|Withdrawal by Subject|6|||
161802713|NCT00274937|584321446|FG000|Overall Study|Progressive Disease|4|||
161802714|NCT01682083|584321448|FG000|Overall Study|Lost to Follow-up|11|||
161802715|NCT01682083|584321449|FG001|Overall Study|Lost to Follow-up|18|||
161802716|NCT01682083|584321448|FG000|Overall Study|Withdrawal by Subject|31|||
161802717|NCT01682083|584321449|FG001|Overall Study|Withdrawal by Subject|40|||
161802718|NCT01682083|584321448|FG000|Overall Study|Death|60|||
161802719|NCT01682083|584321449|FG001|Overall Study|Death|93|||
161802720|NCT01682083|584321448|FG000|Overall Study|Physician Decision|5|||
161802721|NCT01682083|584321449|FG001|Overall Study|Physician Decision|4|||
161802722|NCT02932878|584321450|FG000|Overall Study|Due to Lab Results|2|||
161802723|NCT02932878|584321451|FG001|Overall Study|Due to Lab Results|1|||
161802724|NCT01918397|584321452|FG000|Overall Study|Never started treatment|2|||
161802725|NCT01918397|584321453|FG001|Overall Study|Never started treatment|1|||
161802726|NCT01918397|584321454|FG002|Overall Study|Never started treatment|0|||
161905665|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
161905666|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
161905667|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
161905668|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
161905669|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
161802727|NCT01918397|584321455|FG003|Overall Study|Never started treatment|0|||
161802728|NCT01918397|584321452|FG000|Overall Study|Adverse Event|1|||
161802729|NCT01918397|584321453|FG001|Overall Study|Adverse Event|1|||
161802730|NCT01918397|584321454|FG002|Overall Study|Adverse Event|1|||
161802731|NCT01918397|584321455|FG003|Overall Study|Adverse Event|0|||
161802732|NCT01918397|584321452|FG000|Overall Study|Lack of compliance|2|||
161905670|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
161905671|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
161905672|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
161905673|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
161905674|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
161905675|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
161905676|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
161905677|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
161905678|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
161905679|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
161905680|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
161905681|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
161905682|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
161905683|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
161905684|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
161905685|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
161905686|NCT02709746|584703397|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
161905687|NCT02709746|584703398|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
161905688|NCT02709746|584703399|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
161905689|NCT02709746|584703400|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
161905690|NCT02709746|584703401|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
161905691|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
161905692|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
161905693|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
161905694|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
161905695|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
161905696|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
161905697|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
161905698|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
161905699|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
161905700|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
161905701|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
161802733|NCT01918397|584321453|FG001|Overall Study|Lack of compliance|2|||
161802734|NCT01918397|584321454|FG002|Overall Study|Lack of compliance|3|||
161802735|NCT01918397|584321455|FG003|Overall Study|Lack of compliance|0|||
161802736|NCT01918397|584321452|FG000|Overall Study|Pregnancy|0|||
161802737|NCT01918397|584321453|FG001|Overall Study|Pregnancy|1|||
161802738|NCT01918397|584321454|FG002|Overall Study|Pregnancy|0|||
161802739|NCT01918397|584321455|FG003|Overall Study|Pregnancy|0|||
161802740|NCT01918397|584321452|FG000|Overall Study|Rifampin susceptible|0|||
161802741|NCT01918397|584321453|FG001|Overall Study|Rifampin susceptible|0|||
161802742|NCT01918397|584321454|FG002|Overall Study|Rifampin susceptible|0|||
161802743|NCT01918397|584321455|FG003|Overall Study|Rifampin susceptible|2|||
161802744|NCT01918397|584321452|FG000|Overall Study|Treatment failure|0|||
161802745|NCT01918397|584321453|FG001|Overall Study|Treatment failure|0|||
161802746|NCT01918397|584321454|FG002|Overall Study|Treatment failure|0|||
161802747|NCT01918397|584321455|FG003|Overall Study|Treatment failure|1|||
161802748|NCT01918397|584321452|FG000|Overall Study|Withdrawal by Subject|3|||
161802749|NCT01918397|584321453|FG001|Overall Study|Withdrawal by Subject|2|||
161802750|NCT01918397|584321454|FG002|Overall Study|Withdrawal by Subject|1|||
161802751|NCT01918397|584321455|FG003|Overall Study|Withdrawal by Subject|1|||
161802752|NCT01918397|584321452|FG000|Overall Study|XDR at baseline|0|||
161802753|NCT01918397|584321453|FG001|Overall Study|XDR at baseline|0|||
161802754|NCT01918397|584321454|FG002|Overall Study|XDR at baseline|1|||
161802755|NCT01918397|584321455|FG003|Overall Study|XDR at baseline|0|||
161802756|NCT01918397|584321452|FG000|Overall Study|Lost to Follow-up|2|||
161802757|NCT01918397|584321453|FG001|Overall Study|Lost to Follow-up|1|||
161802758|NCT01918397|584321454|FG002|Overall Study|Lost to Follow-up|1|||
161802759|NCT01918397|584321455|FG003|Overall Study|Lost to Follow-up|1|||
161802760|NCT01918397|584321452|FG000|Overall Study|Increased QTc|1|||
161802761|NCT01918397|584321453|FG001|Overall Study|Increased QTc|0|||
161802762|NCT01918397|584321454|FG002|Overall Study|Increased QTc|0|||
161802763|NCT01918397|584321455|FG003|Overall Study|Increased QTc|1|||
161802764|NCT01918397|584321452|FG000|Overall Study|Death|0|||
161802765|NCT01918397|584321453|FG001|Overall Study|Death|0|||
161802766|NCT01918397|584321454|FG002|Overall Study|Death|1|||
161802767|NCT01918397|584321455|FG003|Overall Study|Death|0|||
161802768|NCT01918397|584321452|FG000|Overall Study|Involved in another investigative trial|0|||
161802769|NCT01918397|584321453|FG001|Overall Study|Involved in another investigative trial|0|||
161905702|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
161905703|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
161905704|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
161905705|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
161905706|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
161905707|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
161905708|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
161905709|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
161905710|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
161905711|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
161905712|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
161905713|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
161905714|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
161905715|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
161905716|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
161905717|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
161905718|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
161905719|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
161905720|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
161905721|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
161905722|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
161905723|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
161905724|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
161905725|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
161905726|NCT02709746|584703397|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
161905727|NCT02709746|584703398|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
161905728|NCT02709746|584703399|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
161905729|NCT02709746|584703400|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
161905730|NCT02709746|584703401|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
161905731|NCT01290718|584703404|FG000|Overall Study|Early termination of the study|4|||
161905732|NCT00748241|584703406|FG000|Overall Study|Implant failure|1|||
161905733|NCT00748241|584703406|FG000|Overall Study|Lost to Follow-up|5|||
161905734|NCT00748241|584703406|FG000|Overall Study|Death|2|||
161905735|NCT01240382|584703407|FG000|Overall Study|Adverse Event|2|||
161905736|NCT01240382|584703408|FG001|Overall Study|Adverse Event|1|||
161905737|NCT01240382|584703407|FG000|Overall Study|Lack of Efficacy|0|||
161905738|NCT01240382|584703408|FG001|Overall Study|Lack of Efficacy|2|||
161905739|NCT01240382|584703407|FG000|Overall Study|Fear of adverse events|0|||
161905740|NCT01240382|584703408|FG001|Overall Study|Fear of adverse events|1|||
161905741|NCT02643693|584703409|FG000|Overall Study|Physician Decision|0|||
161905742|NCT02643693|584703410|FG001|Overall Study|Physician Decision|1|||
161905743|NCT02643693|584703411|FG002|Overall Study|Physician Decision|0|||
161905744|NCT02643693|584703412|FG003|Overall Study|Physician Decision|0|||
161905745|NCT02643693|584703413|FG004|Overall Study|Physician Decision|0|||
161905746|NCT02643693|584703414|FG005|Overall Study|Physician Decision|0|||
161905747|NCT02643693|584703409|FG000|Overall Study|Withdrawal by Subject|0|||
161905748|NCT02643693|584703410|FG001|Overall Study|Withdrawal by Subject|1|||
161905749|NCT02643693|584703411|FG002|Overall Study|Withdrawal by Subject|0|||
161905750|NCT02643693|584703412|FG003|Overall Study|Withdrawal by Subject|0|||
161905751|NCT02643693|584703413|FG004|Overall Study|Withdrawal by Subject|0|||
161905752|NCT02643693|584703414|FG005|Overall Study|Withdrawal by Subject|0|||
161905753|NCT02643693|584703409|FG000|Overall Study|Protocol Adherence Issues|2|||
161905754|NCT02643693|584703410|FG001|Overall Study|Protocol Adherence Issues|0|||
161905755|NCT02643693|584703411|FG002|Overall Study|Protocol Adherence Issues|1|||
161905756|NCT02643693|584703412|FG003|Overall Study|Protocol Adherence Issues|0|||
161905757|NCT02643693|584703413|FG004|Overall Study|Protocol Adherence Issues|0|||
161905758|NCT02643693|584703414|FG005|Overall Study|Protocol Adherence Issues|1|||
161905759|NCT01319565|584703415|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
161905760|NCT01319565|584703416|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
161905761|NCT01319565|584703417|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
161905762|NCT00698815|584703419|FG000|Overall Study|Death|1|||
161905763|NCT00698815|584703420|FG001|Overall Study|Death|2|||
161905764|NCT00698815|584703421|FG002|Overall Study|Death|4|||
161905765|NCT00698815|584703419|FG000|Overall Study|Withdrawal by Subject|6|||
161905766|NCT00698815|584703420|FG001|Overall Study|Withdrawal by Subject|3|||
161905767|NCT00698815|584703421|FG002|Overall Study|Withdrawal by Subject|2|||
161905768|NCT00698815|584703419|FG000|Overall Study|MD discretion|2|||
161905769|NCT00698815|584703420|FG001|Overall Study|MD discretion|7|||
161905770|NCT00698815|584703421|FG002|Overall Study|MD discretion|2|||
161905771|NCT00698815|584703419|FG000|Overall Study|Did not receive protocol treatment|1|||
161802770|NCT01918397|584321454|FG002|Overall Study|Involved in another investigative trial|0|||
161802771|NCT01918397|584321455|FG003|Overall Study|Involved in another investigative trial|1|||
161802772|NCT03952143|584321460|FG000|Lead-In Period|Adverse Event|2|||
161802773|NCT03952143|584321461|FG001|Lead-In Period|Adverse Event|0|||
161802774|NCT03952143|584321462|FG002|Lead-In Period|Adverse Event|0|||
161802775|NCT03952143|584321460|FG000|Lead-In Period|Lack of Efficacy|2|||
161802776|NCT03952143|584321461|FG001|Lead-In Period|Lack of Efficacy|0|||
161802777|NCT03952143|584321462|FG002|Lead-In Period|Lack of Efficacy|0|||
161802778|NCT03952143|584321460|FG000|Lead-In Period|Physician Decision|5|||
161802779|NCT03952143|584321461|FG001|Lead-In Period|Physician Decision|0|||
161802780|NCT03952143|584321462|FG002|Lead-In Period|Physician Decision|0|||
161802781|NCT03952143|584321460|FG000|Lead-In Period|Protocol Violation|5|||
161802782|NCT03952143|584321461|FG001|Lead-In Period|Protocol Violation|0|||
161802783|NCT03952143|584321462|FG002|Lead-In Period|Protocol Violation|0|||
161802784|NCT03952143|584321460|FG000|Lead-In Period|Withdrawal by Subject|19|||
161802785|NCT03952143|584321461|FG001|Lead-In Period|Withdrawal by Subject|0|||
161802786|NCT03952143|584321462|FG002|Lead-In Period|Withdrawal by Subject|0|||
161802787|NCT03952143|584321460|FG000|Treatment Period|Adverse Event|0|||
161802788|NCT03952143|584321461|FG001|Treatment Period|Adverse Event|0|||
161802789|NCT03952143|584321462|FG002|Treatment Period|Adverse Event|1|||
161802790|NCT03952143|584321460|FG000|Treatment Period|Lost to Follow-up|0|||
161802791|NCT03952143|584321461|FG001|Treatment Period|Lost to Follow-up|2|||
161802792|NCT03952143|584321462|FG002|Treatment Period|Lost to Follow-up|0|||
161802793|NCT03952143|584321460|FG000|Treatment Period|Physician Decision|0|||
161802794|NCT03952143|584321461|FG001|Treatment Period|Physician Decision|0|||
161802795|NCT03952143|584321462|FG002|Treatment Period|Physician Decision|2|||
161802796|NCT03952143|584321460|FG000|Treatment Period|Protocol Violation|0|||
161802797|NCT03952143|584321461|FG001|Treatment Period|Protocol Violation|0|||
161802798|NCT03952143|584321462|FG002|Treatment Period|Protocol Violation|1|||
161802799|NCT03952143|584321460|FG000|Treatment Period|Withdrawal by Subject|0|||
161802800|NCT03952143|584321461|FG001|Treatment Period|Withdrawal by Subject|5|||
161802801|NCT03952143|584321462|FG002|Treatment Period|Withdrawal by Subject|26|||
161802802|NCT03952143|584321460|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
161802803|NCT03952143|584321461|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
161802804|NCT03952143|584321462|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
161802805|NCT03952143|584321460|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
161802806|NCT03952143|584321461|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
161802807|NCT03952143|584321462|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
161802808|NCT02152566|584321463|FG000|Overall Study|Lost to Follow-up|1|||
161802809|NCT02152566|584321463|FG000|Overall Study|Withdrawal by Subject|2|||
161802810|NCT00496964|584321464|FG000|Overall Study|Withdrawal by Subject|0|||
161802811|NCT00496964|584321465|FG001|Overall Study|Withdrawal by Subject|1|||
161802812|NCT02942264|584321466|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161802813|NCT02942264|584321467|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
161802814|NCT02942264|584321468|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161802815|NCT02942264|584321469|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161802816|NCT02942264|584321470|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161802817|NCT02942264|584321471|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161802818|NCT02942264|584321472|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
161802819|NCT02942264|584321473|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161802820|NCT02942264|584321474|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161802821|NCT02942264|584321466|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802822|NCT02942264|584321467|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802823|NCT02942264|584321468|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802824|NCT02942264|584321469|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802825|NCT02942264|584321470|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802826|NCT02942264|584321471|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802827|NCT02942264|584321472|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802828|NCT02942264|584321473|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161802829|NCT02942264|584321474|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
161802830|NCT01328093|584321475|FG000|Double-Blind Phase|Adverse Event|78|||
161802831|NCT01328093|584321476|FG001|Double-Blind Phase|Adverse Event|15|||
161802832|NCT01328093|584321475|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
161802833|NCT01328093|584321476|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
161802834|NCT01328093|584321475|FG000|Double-Blind Phase|Lost to Follow-up|39|||
161802835|NCT01328093|584321476|FG001|Double-Blind Phase|Lost to Follow-up|14|||
161802836|NCT01328093|584321475|FG000|Double-Blind Phase|Protocol Violation|30|||
161802837|NCT01328093|584321476|FG001|Double-Blind Phase|Protocol Violation|10|||
161802838|NCT01328093|584321475|FG000|Double-Blind Phase|Lack of Efficacy|55|||
161802839|NCT01328093|584321476|FG001|Double-Blind Phase|Lack of Efficacy|13|||
161802840|NCT01328093|584321475|FG000|Double-Blind Phase|Sponsor Decision|17|||
161802841|NCT01328093|584321476|FG001|Double-Blind Phase|Sponsor Decision|3|||
161802842|NCT01328093|584321475|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
161802843|NCT01328093|584321476|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
161802844|NCT01328093|584321475|FG000|Double-Blind Phase|Scheduling conflict|8|||
161802845|NCT01328093|584321476|FG001|Double-Blind Phase|Scheduling conflict|3|||
161802846|NCT01328093|584321475|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
161802847|NCT01328093|584321476|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
161802848|NCT01328093|584321475|FG000|Double-Blind Phase|Death|1|||
161802849|NCT01328093|584321476|FG001|Double-Blind Phase|Death|0|||
161802850|NCT01328093|584321475|FG000|Open-Label Phase|Sponsor Decision|98|||
161802851|NCT01328093|584321476|FG001|Open-Label Phase|Sponsor Decision|34|||
161802852|NCT01328093|584321475|FG000|Open-Label Phase|Protocol Violation|8|||
161802853|NCT01328093|584321476|FG001|Open-Label Phase|Protocol Violation|3|||
161802854|NCT01328093|584321475|FG000|Open-Label Phase|Lost to Follow-up|10|||
161802855|NCT01328093|584321476|FG001|Open-Label Phase|Lost to Follow-up|1|||
161802856|NCT01328093|584321475|FG000|Open-Label Phase|Adverse Event|10|||
161802857|NCT01328093|584321476|FG001|Open-Label Phase|Adverse Event|4|||
161802858|NCT01328093|584321475|FG000|Open-Label Phase|Lack of Efficacy|5|||
161802859|NCT01328093|584321476|FG001|Open-Label Phase|Lack of Efficacy|6|||
161802860|NCT01328093|584321475|FG000|Open-Label Phase|Withdrawal by Subject|4|||
161802861|NCT01328093|584321476|FG001|Open-Label Phase|Withdrawal by Subject|1|||
161802862|NCT01328093|584321475|FG000|Open-Label Phase|Scheduling conflict|2|||
161802863|NCT01328093|584321476|FG001|Open-Label Phase|Scheduling conflict|1|||
161802864|NCT01328093|584321475|FG000|Open-Label Phase|Subject is moving or has moved|2|||
161802865|NCT01328093|584321476|FG001|Open-Label Phase|Subject is moving or has moved|0|||
161802866|NCT01328093|584321475|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
161802867|NCT01328093|584321476|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
161802868|NCT01225146|584321479|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
161802869|NCT01225146|584321480|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
161802870|NCT03657160|584321481|FG000|Overall Study|Adverse Event|5|||
161802871|NCT03657160|584321482|FG001|Overall Study|Adverse Event|6|||
161802872|NCT03657160|584321481|FG000|Overall Study|Protocol Deviation|3|||
161802873|NCT03657160|584321482|FG001|Overall Study|Protocol Deviation|0|||
161802874|NCT03657160|584321481|FG000|Overall Study|Withdrawal by Subject|18|||
161802875|NCT03657160|584321482|FG001|Overall Study|Withdrawal by Subject|16|||
161802876|NCT03657160|584321481|FG000|Overall Study|Site Termination|1|||
161802877|NCT03657160|584321482|FG001|Overall Study|Site Termination|0|||
161802878|NCT03657160|584321481|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
161802879|NCT03657160|584321482|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
161802880|NCT03657160|584321481|FG000|Overall Study|Death|33|||
161802881|NCT03657160|584321482|FG001|Overall Study|Death|26|||
161802882|NCT03657160|584321481|FG000|Overall Study|Death (COVID-19-Related)|1|||
161802883|NCT03657160|584321482|FG001|Overall Study|Death (COVID-19-Related)|0|||
161802884|NCT03657160|584321481|FG000|Overall Study|Reason Not Specified|5|||
161802885|NCT03657160|584321482|FG001|Overall Study|Reason Not Specified|5|||
161802886|NCT03657160|584321481|FG000|Overall Study|Other (COVID-19-Related)|0|||
161802887|NCT03657160|584321482|FG001|Overall Study|Other (COVID-19-Related)|1|||
161802888|NCT00686959|584321485|FG000|Overall Study|Participants censored (no death events)|124|||
161802889|NCT00686959|584321486|FG001|Overall Study|Participants censored (no death events)|117|||
161802890|NCT02191891|584321488|FG000|Overall Study|Withdrawal by Subject|0|||
161802891|NCT02191891|584321489|FG001|Overall Study|Withdrawal by Subject|1|||
161802892|NCT02191891|584321490|FG002|Overall Study|Withdrawal by Subject|0|||
161802893|NCT02191891|584321491|FG003|Overall Study|Withdrawal by Subject|0|||
161802894|NCT02191891|584321492|FG004|Overall Study|Withdrawal by Subject|1|||
161802895|NCT02191891|584321488|FG000|Overall Study|Adverse Event|0|||
161802896|NCT02191891|584321489|FG001|Overall Study|Adverse Event|1|||
161802897|NCT02191891|584321490|FG002|Overall Study|Adverse Event|0|||
161802898|NCT02191891|584321491|FG003|Overall Study|Adverse Event|0|||
161802899|NCT02191891|584321492|FG004|Overall Study|Adverse Event|2|||
161802900|NCT02191891|584321488|FG000|Overall Study|Disease Progression|4|||
161905772|NCT00698815|584703420|FG001|Overall Study|Did not receive protocol treatment|2|||
161905773|NCT00698815|584703421|FG002|Overall Study|Did not receive protocol treatment|2|||
161905774|NCT03575702|584703423|FG000|Overall Study|Withdrawal by Subject|1|||
161905775|NCT03575702|584703424|FG001|Overall Study|Withdrawal by Subject|1|||
161905776|NCT03575702|584703423|FG000|Overall Study|Lost to Follow-up|1|||
161905777|NCT03575702|584703424|FG001|Overall Study|Lost to Follow-up|2|||
161905778|NCT03575702|584703423|FG000|Overall Study|Protocol Violation|0|||
161905779|NCT03575702|584703424|FG001|Overall Study|Protocol Violation|1|||
161905780|NCT03575702|584703423|FG000|Overall Study|Patient non compliance|4|||
161905781|NCT03575702|584703424|FG001|Overall Study|Patient non compliance|0|||
161905782|NCT00490035|584703429|FG000|Overall Study|AE, non-serious non-fatal|3|||
161905783|NCT00490035|584703430|FG001|Overall Study|AE, non-serious non-fatal|4|||
161905784|NCT00490035|584703431|FG002|Overall Study|AE, non-serious non-fatal|4|||
161905785|NCT00490035|584703432|FG003|Overall Study|AE, non-serious non-fatal|5|||
161905786|NCT00490035|584703429|FG000|Overall Study|Lost to Follow-up|2|||
161905787|NCT00490035|584703430|FG001|Overall Study|Lost to Follow-up|0|||
161905788|NCT00490035|584703431|FG002|Overall Study|Lost to Follow-up|1|||
161905789|NCT00490035|584703432|FG003|Overall Study|Lost to Follow-up|0|||
161905790|NCT00490035|584703429|FG000|Overall Study|Withdrawal by Subject|2|||
161905791|NCT00490035|584703430|FG001|Overall Study|Withdrawal by Subject|1|||
161905792|NCT00490035|584703431|FG002|Overall Study|Withdrawal by Subject|1|||
161905793|NCT00490035|584703432|FG003|Overall Study|Withdrawal by Subject|0|||
161905794|NCT00490035|584703429|FG000|Overall Study|Other reason|0|||
161905795|NCT00490035|584703430|FG001|Overall Study|Other reason|1|||
161905796|NCT00490035|584703431|FG002|Overall Study|Other reason|3|||
161905797|NCT00490035|584703432|FG003|Overall Study|Other reason|1|||
161905798|NCT00490035|584703429|FG000|Overall Study|AE, serious fatal|1|||
161905799|NCT00490035|584703430|FG001|Overall Study|AE, serious fatal|0|||
161905800|NCT00490035|584703431|FG002|Overall Study|AE, serious fatal|0|||
161905801|NCT00490035|584703432|FG003|Overall Study|AE, serious fatal|0|||
161905802|NCT00490035|584703429|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
161905803|NCT00490035|584703430|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
161905804|NCT00490035|584703431|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
161905805|NCT00490035|584703432|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
161905806|NCT00490035|584703429|FG000|Overall Study|AE of unknown type|0|||
161905807|NCT00490035|584703430|FG001|Overall Study|AE of unknown type|0|||
161905808|NCT00490035|584703431|FG002|Overall Study|AE of unknown type|2|||
161905809|NCT00490035|584703432|FG003|Overall Study|AE of unknown type|0|||
161905810|NCT05559905|584703433|FG000|Overall Study|Withdrawal by Subject|1|||
161905811|NCT05559905|584703434|FG001|Overall Study|Withdrawal by Subject|0|||
161905812|NCT05559905|584703435|FG002|Overall Study|Withdrawal by Subject|0|||
161905813|NCT05559905|584703433|FG000|Overall Study|Not Reported|1|||
161905814|NCT05559905|584703434|FG001|Overall Study|Not Reported|0|||
161905815|NCT05559905|584703435|FG002|Overall Study|Not Reported|0|||
161905816|NCT05276973|584703436|FG000|Overall Study|Treated and DLT unevaluable|1|||
161905817|NCT05276973|584703437|FG001|Overall Study|Treated and DLT unevaluable|1|||
161905818|NCT05276973|584703438|FG002|Overall Study|Treated and DLT unevaluable|0|||
161905819|NCT03180736|584703439|FG000|Overall Study|Adverse Event|3|||
161905820|NCT03180736|584703440|FG001|Overall Study|Adverse Event|4|||
161905821|NCT03180736|584703439|FG000|Overall Study|Death|10|||
161905822|NCT03180736|584703440|FG001|Overall Study|Death|7|||
161905823|NCT03180736|584703439|FG000|Overall Study|Withdrawal by Subject|5|||
161905824|NCT03180736|584703440|FG001|Overall Study|Withdrawal by Subject|12|||
161905825|NCT03180736|584703439|FG000|Overall Study|Lost to Follow-up|1|||
161905826|NCT03180736|584703440|FG001|Overall Study|Lost to Follow-up|0|||
161905827|NCT03180736|584703439|FG000|Overall Study|Lack of Efficacy|66|||
161905828|NCT03180736|584703440|FG001|Overall Study|Lack of Efficacy|87|||
161905829|NCT03180736|584703439|FG000|Overall Study|Physician Decision|4|||
161905830|NCT03180736|584703440|FG001|Overall Study|Physician Decision|7|||
161905831|NCT03180736|584703439|FG000|Overall Study|randomized but not treated|2|||
161905832|NCT03180736|584703440|FG001|Overall Study|randomized but not treated|3|||
161905833|NCT03258593|584703441|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
161905834|NCT03258593|584703442|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
161905835|NCT03258593|584703443|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
161905836|NCT03258593|584703444|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
161905837|NCT03258593|584703441|FG000|Run-In Maintenance Phase|Disease progression|3|||
161905838|NCT03258593|584703442|FG001|Run-In Maintenance Phase|Disease progression|0|||
161905839|NCT03258593|584703443|FG002|Run-In Maintenance Phase|Disease progression|0|||
161905840|NCT03258593|584703444|FG003|Run-In Maintenance Phase|Disease progression|0|||
161905841|NCT03258593|584703441|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
161905842|NCT03258593|584703442|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
161905843|NCT03258593|584703443|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
161905844|NCT03258593|584703444|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
162140041|NCT00567164|585563295|FG001|Overall Study|Adverse Event|13|||
162140042|NCT00567164|585563296|FG002|Overall Study|Adverse Event|9|||
161905845|NCT03258593|584703441|FG000|Expansion Maintenance Phase|Physician Decision|0|||
161802901|NCT02191891|584321489|FG001|Overall Study|Disease Progression|10|||
161802902|NCT02191891|584321490|FG002|Overall Study|Disease Progression|4|||
161802903|NCT02191891|584321491|FG003|Overall Study|Disease Progression|2|||
161802904|NCT02191891|584321492|FG004|Overall Study|Disease Progression|7|||
161802905|NCT01062256|584321493|FG000|Overall Study|Adverse Event|1|||
161802906|NCT01062256|584321494|FG001|Overall Study|Adverse Event|0|||
161802907|NCT01062256|584321495|FG002|Overall Study|Adverse Event|0|||
161802908|NCT01062256|584321493|FG000|Overall Study|Withdrawal by Subject|1|||
161802909|NCT01062256|584321494|FG001|Overall Study|Withdrawal by Subject|1|||
161802910|NCT01062256|584321495|FG002|Overall Study|Withdrawal by Subject|1|||
161802911|NCT01062256|584321493|FG000|Overall Study|Ineligible|1|||
161802912|NCT01062256|584321494|FG001|Overall Study|Ineligible|4|||
161802913|NCT01062256|584321495|FG002|Overall Study|Ineligible|3|||
161802914|NCT01062256|584321493|FG000|Overall Study|Administrative|0|||
161802915|NCT01062256|584321494|FG001|Overall Study|Administrative|2|||
161802916|NCT01062256|584321495|FG002|Overall Study|Administrative|0|||
161802917|NCT03099538|584321496|FG000|Overall Study|Lack of Efficacy|3|||
161802918|NCT02365207|584321508|FG000|Overall Study|Withdrawal by Subject|1|||
161802919|NCT02365207|584321508|FG000|Overall Study|Physician Decision|1|||
161802920|NCT01318499|584321511|FG000|Overall Study|Adverse Event|16|||
161802921|NCT01318499|584321512|FG001|Overall Study|Adverse Event|11|||
161802922|NCT01318499|584321513|FG002|Overall Study|Adverse Event|6|||
161802923|NCT01318499|584321511|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
161802924|NCT01318499|584321512|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
161802925|NCT01318499|584321513|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
161802926|NCT01318499|584321511|FG000|Overall Study|Noncompliance|2|||
161802927|NCT01318499|584321512|FG001|Overall Study|Noncompliance|3|||
161802928|NCT01318499|584321513|FG002|Overall Study|Noncompliance|0|||
161802929|NCT01318499|584321511|FG000|Overall Study|Treatment Failure|19|||
161802930|NCT01318499|584321512|FG001|Overall Study|Treatment Failure|19|||
161802931|NCT01318499|584321513|FG002|Overall Study|Treatment Failure|101|||
161802932|NCT01318499|584321511|FG000|Overall Study|Protocol Violation|2|||
161802933|NCT01318499|584321512|FG001|Overall Study|Protocol Violation|4|||
161802934|NCT01318499|584321513|FG002|Overall Study|Protocol Violation|2|||
161802935|NCT01318499|584321511|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
161802936|NCT01318499|584321512|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
161802937|NCT01318499|584321513|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
161802938|NCT01318499|584321511|FG000|Overall Study|Other|7|||
161802939|NCT01318499|584321512|FG001|Overall Study|Other|10|||
161802940|NCT01318499|584321513|FG002|Overall Study|Other|22|||
161802941|NCT01395030|584321514|FG000|Overall Study|Did not complete FCH PET/CT|7|||
161802942|NCT02672553|584321515|FG000|Overall Study|Death|3|||
161802943|NCT02672553|584321516|FG001|Overall Study|Death|5|||
161802944|NCT02672553|584321515|FG000|Overall Study|Valve Explant|1|||
161802945|NCT02672553|584321516|FG001|Overall Study|Valve Explant|0|||
161802946|NCT02672553|584321515|FG000|Overall Study|Conversion to Commercial Valve|3|||
161802947|NCT02672553|584321516|FG001|Overall Study|Conversion to Commercial Valve|0|||
161802948|NCT02672553|584321515|FG000|Overall Study|Withdrawal by Subject|3|||
161802949|NCT02672553|584321516|FG001|Overall Study|Withdrawal by Subject|3|||
161802950|NCT02672553|584321515|FG000|Overall Study|Intraoperative screen failure|2|||
161802951|NCT02672553|584321516|FG001|Overall Study|Intraoperative screen failure|0|||
161802952|NCT00950872|584321517|FG000|Overall Study|Withdrawal by Subject|1|||
161802953|NCT00950872|584321517|FG000|Overall Study|Did not have surgery|2|||
161802954|NCT01759290|584321518|FG000|Overall Study|Subjects withdrawn consent|5|||
161802955|NCT01759290|584321518|FG000|Overall Study|Physician Decision|2|||
161802956|NCT01759290|584321518|FG000|Overall Study|Death|17|||
161905846|NCT03258593|584703442|FG001|Expansion Maintenance Phase|Physician Decision|1|||
161905847|NCT03258593|584703443|FG002|Expansion Maintenance Phase|Physician Decision|0|||
161905848|NCT03258593|584703444|FG003|Expansion Maintenance Phase|Physician Decision|0|||
161905849|NCT05457257|584703451|FG000|Overall Study|Withdrawal by Subject|0|||
161905850|NCT05457257|584703452|FG001|Overall Study|Withdrawal by Subject|2|||
161905851|NCT05457257|584703451|FG000|Overall Study|Death|10|||
161905852|NCT05457257|584703452|FG001|Overall Study|Death|3|||
161905853|NCT05457257|584703451|FG000|Overall Study|Ongoing|19|||
161905854|NCT05457257|584703452|FG001|Overall Study|Ongoing|9|||
161905855|NCT02131064|584703455|FG000|Overall Study|Death|5|||
161905856|NCT02131064|584703456|FG001|Overall Study|Death|6|||
161905857|NCT02131064|584703455|FG000|Overall Study|Lost to Follow-up|4|||
161905858|NCT02131064|584703456|FG001|Overall Study|Lost to Follow-up|8|||
161905859|NCT02131064|584703455|FG000|Overall Study|Withdrawal by Subject|14|||
161905860|NCT02131064|584703456|FG001|Overall Study|Withdrawal by Subject|18|||
161905861|NCT02131064|584703455|FG000|Overall Study|Other|2|||
161905862|NCT02131064|584703456|FG001|Overall Study|Other|2|||
161905863|NCT00593918|584703461|FG000|Overall Study|Withdrawal by Subject|5|||
161905864|NCT00593918|584703462|FG001|Overall Study|Withdrawal by Subject|24|||
161905865|NCT00871234|584703469|FG000|Overall Study|Adverse Event|2|||
161905866|NCT00871234|584703469|FG000|Overall Study|Lost to Follow-up|3|||
161905867|NCT04344301|584703471|FG000|Overall Study|Withdrawal by Subject|1|||
161905868|NCT04344301|584703472|FG001|Overall Study|Withdrawal by Subject|0|||
161905869|NCT04344301|584703471|FG000|Overall Study|Death|0|||
161905870|NCT04344301|584703472|FG001|Overall Study|Death|1|||
161905871|NCT00072410|584703473|FG000|Overall Study|Progressive disease|0|||
161905872|NCT00072410|584703474|FG001|Overall Study|Progressive disease|3|||
161905873|NCT03160716|584703475|FG000|Overall Study|Lost to Follow-up|1|||
161905874|NCT01628848|584703476|FG000|Overall Study|Adverse Event|9|||
161905875|NCT01628848|584703477|FG001|Overall Study|Adverse Event|7|||
161905876|NCT01628848|584703476|FG000|Overall Study|Lack of Efficacy|0|||
161905877|NCT01628848|584703477|FG001|Overall Study|Lack of Efficacy|4|||
161905878|NCT01628848|584703476|FG000|Overall Study|Withdrawal by Subject|0|||
161905879|NCT01628848|584703477|FG001|Overall Study|Withdrawal by Subject|2|||
161905880|NCT01628848|584703476|FG000|Overall Study|Physician Decision|3|||
161905881|NCT01628848|584703477|FG001|Overall Study|Physician Decision|1|||
161905882|NCT00689338|584703479|FG000|Overall Study|Death|65|||
161905883|NCT00689338|584703479|FG000|Overall Study|Adverse Event|13|||
161905884|NCT00689338|584703479|FG000|Overall Study|Insufficient Clinical Response|1|||
161905885|NCT00689338|584703479|FG000|Overall Study|Lack of Efficacy|6|||
161905886|NCT00689338|584703479|FG000|Overall Study|Other|8|||
161905887|NCT00689338|584703479|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
161905888|NCT00689338|584703479|FG000|Overall Study|Lost to Follow-up|5|||
161905889|NCT00689338|584703479|FG000|Overall Study|Withdrawal by Subject|3|||
161905890|NCT00689338|584703479|FG000|Overall Study|Protocol Violation|15|||
161905891|NCT02104895|584703482|FG000|Overall Study|Withdrawal by Subject|0|||
161905892|NCT02104895|584703483|FG001|Overall Study|Withdrawal by Subject|14|||
161905893|NCT00969228|584703484|FG000|Overall Study|Adverse Event|1|||
161905894|NCT00969228|584703485|FG001|Overall Study|Adverse Event|0|||
161905895|NCT00969228|584703484|FG000|Overall Study|Withdrawal by Subject|4|||
161905896|NCT00969228|584703485|FG001|Overall Study|Withdrawal by Subject|0|||
161905897|NCT00969228|584703484|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
161905898|NCT00969228|584703485|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
161905899|NCT02895295|584703487|FG000|Overall Study|Survey Non-response|71|||
161905900|NCT02895295|584703488|FG001|Overall Study|Survey Non-response|94|||
161905901|NCT02895295|584703489|FG002|Overall Study|Survey Non-response|92|||
161905902|NCT02532283|584703490|FG000|Overall Study|Adverse Event|0|||
161905903|NCT02532283|584703491|FG001|Overall Study|Adverse Event|1|||
161905904|NCT02532283|584703490|FG000|Overall Study|Death|1|||
161905905|NCT02532283|584703491|FG001|Overall Study|Death|0|||
161905906|NCT02532283|584703490|FG000|Overall Study|Lost to Follow-up|0|||
161905907|NCT02532283|584703491|FG001|Overall Study|Lost to Follow-up|1|||
161905908|NCT02532283|584703490|FG000|Overall Study|Withdrawal by Subject|8|||
161905909|NCT02532283|584703491|FG001|Overall Study|Withdrawal by Subject|3|||
161905910|NCT03811821|584703492|FG000|Overall Study|Adverse Event|1|||
161905911|NCT03811821|584703493|FG001|Overall Study|Adverse Event|1|||
161905912|NCT03811821|584703492|FG000|Overall Study|Withdrawal by Subject|5|||
161905913|NCT03811821|584703493|FG001|Overall Study|Withdrawal by Subject|4|||
161905914|NCT03811821|584703492|FG000|Overall Study|Lost to Follow-up|2|||
161905915|NCT03811821|584703493|FG001|Overall Study|Lost to Follow-up|2|||
161905916|NCT03811821|584703492|FG000|Overall Study|Contraindication for treatment|0|||
161905917|NCT03811821|584703493|FG001|Overall Study|Contraindication for treatment|1|||
161905918|NCT03811821|584703492|FG000|Overall Study|Tolerability|0|||
161905919|NCT03811821|584703493|FG001|Overall Study|Tolerability|3|||
161905920|NCT03811821|584703492|FG000|Overall Study|Comorbidities|0|||
161905921|NCT03811821|584703493|FG001|Overall Study|Comorbidities|2|||
161802957|NCT01759290|584321518|FG000|Overall Study|Lost to Follow-up|53|||
161802958|NCT01759290|584321518|FG000|Overall Study|Unknown reason|4|||
161802959|NCT01766778|584321522|FG000|Overall Study|Adverse Event|4|||
161802960|NCT01766778|584321523|FG001|Overall Study|Adverse Event|4|||
161802961|NCT01766778|584321522|FG000|Overall Study|Withdrawal by Subject|1|||
161802962|NCT01766778|584321523|FG001|Overall Study|Withdrawal by Subject|0|||
161802963|NCT01054599|584321524|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
161802964|NCT01054599|584321525|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
161802965|NCT01054599|584321524|FG000|Overall Study|Protocol Violation|1|||
161802966|NCT01054599|584321525|FG001|Overall Study|Protocol Violation|0|||
161802967|NCT01054599|584321524|FG000|Overall Study|Spells/seizure-like episodes|1|||
161802968|NCT01054599|584321525|FG001|Overall Study|Spells/seizure-like episodes|1|||
161802969|NCT01054599|584321524|FG000|Overall Study|Timing/scheduling difficulties|1|||
161802970|NCT01054599|584321525|FG001|Overall Study|Timing/scheduling difficulties|1|||
161802971|NCT01054599|584321524|FG000|Overall Study|Visual impairment, WTAR <80|0|||
161802972|NCT01054599|584321525|FG001|Overall Study|Visual impairment, WTAR <80|1|||
161802973|NCT01054599|584321524|FG000|Overall Study|Lost to Follow-up|0|||
161802974|NCT01054599|584321525|FG001|Overall Study|Lost to Follow-up|2|||
161802975|NCT01054599|584321524|FG000|Overall Study|Adverse Event|0|||
161802976|NCT01054599|584321525|FG001|Overall Study|Adverse Event|1|||
161802977|NCT01054599|584321524|FG000|Overall Study|Withdrawal by Subject|0|||
161802978|NCT01054599|584321525|FG001|Overall Study|Withdrawal by Subject|1|||
161802979|NCT01104662|584321526|FG000|Overall Study|Adverse Event|2|||
161802980|NCT01104662|584321527|FG001|Overall Study|Adverse Event|2|||
161802981|NCT01104662|584321528|FG002|Overall Study|Adverse Event|0|||
161802982|NCT01104662|584321529|FG003|Overall Study|Adverse Event|1|||
161802983|NCT01104662|584321530|FG004|Overall Study|Adverse Event|1|||
161802984|NCT01104662|584321531|FG005|Overall Study|Adverse Event|1|||
161802985|NCT01104662|584321532|FG006|Overall Study|Adverse Event|0|||
161905922|NCT01496976|584704745|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
161905923|NCT00870727|584704746|FG000|Overall Study|Lost to Follow-up|0|||
161905924|NCT00870727|584704747|FG001|Overall Study|Lost to Follow-up|1|||
161905925|NCT00870727|584704746|FG000|Overall Study|Lack of Efficacy|1|||
161905926|NCT00870727|584704747|FG001|Overall Study|Lack of Efficacy|3|||
161905927|NCT00870727|584704746|FG000|Overall Study|Adverse Event|0|||
161905928|NCT00870727|584704747|FG001|Overall Study|Adverse Event|1|||
161905929|NCT01774981|584704761|FG000|Overall Study|Adverse Event|0|||
161905930|NCT01774981|584704762|FG001|Overall Study|Adverse Event|0|||
161905931|NCT01774981|584704763|FG002|Overall Study|Adverse Event|0|||
161905932|NCT01774981|584704764|FG003|Overall Study|Adverse Event|0|||
161905933|NCT01774981|584704765|FG004|Overall Study|Adverse Event|0|||
161905934|NCT01774981|584704766|FG005|Overall Study|Adverse Event|1|||
161905935|NCT01774981|584704767|FG006|Overall Study|Adverse Event|0|||
161905936|NCT01774981|584704768|FG007|Overall Study|Adverse Event|0|||
161905937|NCT01774981|584704761|FG000|Overall Study|Withdrawal by Subject|0|||
161905938|NCT01774981|584704762|FG001|Overall Study|Withdrawal by Subject|0|||
161905939|NCT01774981|584704763|FG002|Overall Study|Withdrawal by Subject|0|||
161905940|NCT01774981|584704764|FG003|Overall Study|Withdrawal by Subject|0|||
161905941|NCT01774981|584704765|FG004|Overall Study|Withdrawal by Subject|0|||
161905942|NCT01774981|584704766|FG005|Overall Study|Withdrawal by Subject|0|||
161905943|NCT01774981|584704767|FG006|Overall Study|Withdrawal by Subject|0|||
161905944|NCT01774981|584704768|FG007|Overall Study|Withdrawal by Subject|1|||
161905945|NCT01774981|584704761|FG000|Overall Study|Death|0|||
161905946|NCT01774981|584704762|FG001|Overall Study|Death|0|||
161905947|NCT01774981|584704763|FG002|Overall Study|Death|0|||
161905948|NCT01774981|584704764|FG003|Overall Study|Death|0|||
161905949|NCT01774981|584704765|FG004|Overall Study|Death|1|||
161905950|NCT01774981|584704766|FG005|Overall Study|Death|0|||
161905951|NCT01774981|584704767|FG006|Overall Study|Death|0|||
161905952|NCT01774981|584704768|FG007|Overall Study|Death|0|||
161905953|NCT00001566|584704771|FG000|Overall Study|patients' choice to discontinue protocol|3|||
161905954|NCT00001566|584704771|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
161905955|NCT00001566|584704771|FG000|Overall Study|Death|13|||
161905956|NCT00001566|584704771|FG000|Overall Study|Lost to Follow-up|1|||
161905957|NCT00001566|584704771|FG000|Overall Study|unable to complete initial apheresis|1|||
161905958|NCT02915835|584704772|FG000|Overall Study|Physician Decision|1|||
161905959|NCT02915835|584704773|FG001|Overall Study|Physician Decision|0|||
161905960|NCT02915835|584704772|FG000|Overall Study|Withdrawal by Subject|0|||
162140043|NCT00567164|585563294|FG000|Overall Study|Death|0|||
161802986|NCT01104662|584321533|FG007|Overall Study|Adverse Event|0|||
161802987|NCT01104662|584321526|FG000|Overall Study|Clinical Failure|1|||
161905961|NCT02915835|584704773|FG001|Overall Study|Withdrawal by Subject|1|||
162140044|NCT00567164|585563295|FG001|Overall Study|Death|0|||
161802988|NCT01104662|584321527|FG001|Overall Study|Clinical Failure|0|||
161905962|NCT00433836|584704774|FG000|Overall Study|Adverse Event|7|||
161905963|NCT00433836|584704775|FG001|Overall Study|Adverse Event|0|||
161905964|NCT00433836|584704774|FG000|Overall Study|Lost to Follow-up|3|||
161905965|NCT00433836|584704775|FG001|Overall Study|Lost to Follow-up|0|||
161905966|NCT00433836|584704774|FG000|Overall Study|Withdrawal by Subject|2|||
162140045|NCT00567164|585563296|FG002|Overall Study|Death|1|||
162140046|NCT00567164|585563294|FG000|Overall Study|Lost to Follow-up|202|||
162140047|NCT00567164|585563295|FG001|Overall Study|Lost to Follow-up|23|||
162140048|NCT00567164|585563296|FG002|Overall Study|Lost to Follow-up|21|||
162140049|NCT00567164|585563294|FG000|Overall Study|Pregnancy|20|||
162140050|NCT00567164|585563295|FG001|Overall Study|Pregnancy|4|||
162140051|NCT00567164|585563296|FG002|Overall Study|Pregnancy|6|||
162140052|NCT00567164|585563294|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
162140053|NCT00567164|585563295|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
162140054|NCT00567164|585563296|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
162140055|NCT00567164|585563294|FG000|Overall Study|Missing|1|||
162140056|NCT00567164|585563295|FG001|Overall Study|Missing|0|||
162140057|NCT00567164|585563296|FG002|Overall Study|Missing|0|||
162140058|NCT03381274|585563303|FG000|Overall Study|Death|2|||
162140059|NCT03381274|585563304|FG001|Overall Study|Death|9|||
162140060|NCT03381274|585563305|FG002|Overall Study|Death|3|||
162140061|NCT03381274|585563306|FG003|Overall Study|Death|2|||
162140062|NCT03381274|585563307|FG004|Overall Study|Death|3|||
161802989|NCT01104662|584321528|FG002|Overall Study|Clinical Failure|0|||
161802990|NCT01104662|584321529|FG003|Overall Study|Clinical Failure|0|||
161802991|NCT01104662|584321530|FG004|Overall Study|Clinical Failure|0|||
161802992|NCT01104662|584321531|FG005|Overall Study|Clinical Failure|1|||
161802993|NCT01104662|584321532|FG006|Overall Study|Clinical Failure|0|||
161802994|NCT01104662|584321533|FG007|Overall Study|Clinical Failure|0|||
161802995|NCT01104662|584321526|FG000|Overall Study|Participant left investigator's care|1|||
161802996|NCT01104662|584321527|FG001|Overall Study|Participant left investigator's care|1|||
161802997|NCT01104662|584321528|FG002|Overall Study|Participant left investigator's care|0|||
161802998|NCT01104662|584321529|FG003|Overall Study|Participant left investigator's care|0|||
161802999|NCT01104662|584321530|FG004|Overall Study|Participant left investigator's care|0|||
161803000|NCT01104662|584321531|FG005|Overall Study|Participant left investigator's care|0|||
161803001|NCT01104662|584321532|FG006|Overall Study|Participant left investigator's care|0|||
161803002|NCT01104662|584321533|FG007|Overall Study|Participant left investigator's care|0|||
161803003|NCT01104662|584321526|FG000|Overall Study|Reason not specified|3|||
161803004|NCT01104662|584321527|FG001|Overall Study|Reason not specified|3|||
161803005|NCT01104662|584321528|FG002|Overall Study|Reason not specified|0|||
161803006|NCT01104662|584321529|FG003|Overall Study|Reason not specified|0|||
161803007|NCT01104662|584321530|FG004|Overall Study|Reason not specified|0|||
161803008|NCT01104662|584321531|FG005|Overall Study|Reason not specified|1|||
161803009|NCT01104662|584321532|FG006|Overall Study|Reason not specified|0|||
161803010|NCT01104662|584321533|FG007|Overall Study|Reason not specified|0|||
161803011|NCT01104662|584321526|FG000|Overall Study|Randomized but not treated|3|||
161803012|NCT01104662|584321527|FG001|Overall Study|Randomized but not treated|4|||
161803013|NCT01104662|584321528|FG002|Overall Study|Randomized but not treated|1|||
161803014|NCT01104662|584321529|FG003|Overall Study|Randomized but not treated|0|||
161803015|NCT01104662|584321530|FG004|Overall Study|Randomized but not treated|0|||
161803016|NCT01104662|584321531|FG005|Overall Study|Randomized but not treated|1|||
161803017|NCT01104662|584321532|FG006|Overall Study|Randomized but not treated|0|||
161803018|NCT01104662|584321533|FG007|Overall Study|Randomized but not treated|0|||
161803019|NCT01478620|584321534|FG000|Overall Study|Lost to Follow-up|6|||
161803020|NCT02888171|584321540|FG000|Overall Study|Lost to Follow-up|2|||
161803021|NCT02888171|584321541|FG001|Overall Study|Lost to Follow-up|1|||
161803022|NCT02888171|584321540|FG000|Overall Study|Withdrawal by Subject|3|||
161803023|NCT02888171|584321541|FG001|Overall Study|Withdrawal by Subject|2|||
161803024|NCT02888171|584321540|FG000|Overall Study|Adverse Event|0|||
161803025|NCT02888171|584321541|FG001|Overall Study|Adverse Event|1|||
161803026|NCT04188106|584323323|FG000|Overall Study|Lost to Follow-up|5|||
161803027|NCT04188106|584323323|FG000|Overall Study|Non-Compliance|1|||
161803028|NCT01101022|584323324|FG000|Overall Study|Adverse Event|6|||
161803029|NCT01101022|584323325|FG001|Overall Study|Adverse Event|2|||
161803030|NCT01101022|584323324|FG000|Overall Study|Protocol Violation|4|||
161803031|NCT01101022|584323325|FG001|Overall Study|Protocol Violation|3|||
161803032|NCT01101022|584323324|FG000|Overall Study|Withdrawal by Subject|3|||
161803033|NCT01101022|584323325|FG001|Overall Study|Withdrawal by Subject|8|||
161803034|NCT01101022|584323324|FG000|Overall Study|Lost to Follow-up|1|||
161803035|NCT01101022|584323325|FG001|Overall Study|Lost to Follow-up|4|||
161803036|NCT01101022|584323324|FG000|Overall Study|Lack of Efficacy|0|||
161803037|NCT01101022|584323325|FG001|Overall Study|Lack of Efficacy|7|||
161803038|NCT01101022|584323324|FG000|Overall Study|Sponsor decision|1|||
161803039|NCT01101022|584323325|FG001|Overall Study|Sponsor decision|1|||
161803040|NCT01101022|584323324|FG000|Overall Study|Non-compliance|1|||
162140063|NCT03381274|585563303|FG000|Overall Study|Lost to Follow-up|0|||
162140064|NCT03381274|585563304|FG001|Overall Study|Lost to Follow-up|0|||
162140065|NCT03381274|585563305|FG002|Overall Study|Lost to Follow-up|0|||
161803041|NCT01101022|584323325|FG001|Overall Study|Non-compliance|0|||
161803042|NCT01101022|584323324|FG000|Overall Study|Work schedule|1|||
161803043|NCT01101022|584323325|FG001|Overall Study|Work schedule|1|||
162140066|NCT03381274|585563306|FG003|Overall Study|Lost to Follow-up|1|||
161803044|NCT01101022|584323324|FG000|Overall Study|Vacation|0|||
161803045|NCT01101022|584323325|FG001|Overall Study|Vacation|1|||
161803046|NCT03075761|584323326|FG000|Overall Study|Lost to Follow-up|1|||
161803047|NCT03075761|584323327|FG001|Overall Study|Lost to Follow-up|6|||
161803048|NCT01139047|584323328|FG000|Overall Study|Withdrawal by Subject|1|||
161803049|NCT00420303|584323333|FG000|Overall Study|Serious Adverse Event|1|||
161803050|NCT00420303|584323334|FG001|Overall Study|Serious Adverse Event|0|||
161803051|NCT00420303|584323333|FG000|Overall Study|Lack of Efficacy|0|||
161803052|NCT00420303|584323334|FG001|Overall Study|Lack of Efficacy|3|||
161803053|NCT00420303|584323333|FG000|Overall Study|Physician Decision|0|||
161803054|NCT00420303|584323334|FG001|Overall Study|Physician Decision|1|||
161803055|NCT04455633|584323336|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
161803056|NCT04455633|584323337|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
161803057|NCT04455633|584323338|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
161803058|NCT04455633|584323336|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
161803059|NCT04455633|584323337|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
161803060|NCT04455633|584323338|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
161803061|NCT04455633|584323336|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
161803062|NCT04455633|584323337|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
161803063|NCT04455633|584323338|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
161803064|NCT04455633|584323336|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
161803065|NCT04455633|584323337|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
161803066|NCT04455633|584323338|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
161803067|NCT01648166|584323339|FG000|Overall Study|inadequate toenail samples|53|||
161803068|NCT01648166|584323340|FG001|Overall Study|inadequate toenail samples|100|||
161803069|NCT00883090|584323341|FG000|Overall Study|Sponsor's decision|1|||
161803070|NCT00883090|584323341|FG000|Overall Study|Withdrawal by Subject|1|||
161803071|NCT01087970|584323344|FG000|Overall Study|Protocol Violation|2|||
161803072|NCT00849901|584323352|FG000|Acute Treatment Phase|Adverse Event|9|||
161803073|NCT00849901|584323353|FG001|Acute Treatment Phase|Adverse Event|1|||
161803074|NCT00849901|584323354|FG002|Acute Treatment Phase|Adverse Event|3|||
161803075|NCT00849901|584323352|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
161803076|NCT00849901|584323353|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
161803077|NCT00849901|584323354|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
161803078|NCT00849901|584323352|FG000|Acute Treatment Phase|Protocol Violation|0|||
161803079|NCT00849901|584323353|FG001|Acute Treatment Phase|Protocol Violation|2|||
161803080|NCT00849901|584323354|FG002|Acute Treatment Phase|Protocol Violation|1|||
161803081|NCT00849901|584323352|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
161803082|NCT00849901|584323353|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
161803083|NCT00849901|584323354|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
161803084|NCT00849901|584323352|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
161803085|NCT00849901|584323353|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
161803086|NCT00849901|584323354|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
161803087|NCT00849901|584323352|FG000|Acute Treatment Phase|Physician Decision|1|||
161803088|NCT00849901|584323353|FG001|Acute Treatment Phase|Physician Decision|1|||
161803089|NCT00849901|584323354|FG002|Acute Treatment Phase|Physician Decision|1|||
161803090|NCT00849901|584323352|FG000|Acute Treatment Phase|Sponsor Decision|1|||
161803091|NCT00849901|584323353|FG001|Acute Treatment Phase|Sponsor Decision|0|||
161803092|NCT00849901|584323354|FG002|Acute Treatment Phase|Sponsor Decision|0|||
161803093|NCT00849901|584323352|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
161803094|NCT00849901|584323353|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
161803095|NCT00849901|584323354|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
161803096|NCT00849901|584323352|FG000|Extension Phase|Adverse Event|2|||
161803097|NCT00849901|584323353|FG001|Extension Phase|Adverse Event|8|||
161803098|NCT00849901|584323354|FG002|Extension Phase|Adverse Event|4|||
161803099|NCT00849901|584323352|FG000|Extension Phase|Lost to Follow-up|3|||
161803100|NCT00849901|584323353|FG001|Extension Phase|Lost to Follow-up|0|||
161803101|NCT00849901|584323354|FG002|Extension Phase|Lost to Follow-up|1|||
161803102|NCT00849901|584323352|FG000|Extension Phase|Protocol Violation|2|||
161803103|NCT00849901|584323353|FG001|Extension Phase|Protocol Violation|2|||
161905967|NCT00433836|584704775|FG001|Overall Study|Withdrawal by Subject|1|||
161905968|NCT00433836|584704774|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161905969|NCT00433836|584704775|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161905970|NCT00433836|584704774|FG000|Overall Study|Protocol Violation|0|||
161905971|NCT00433836|584704775|FG001|Overall Study|Protocol Violation|2|||
161905972|NCT00433836|584704774|FG000|Overall Study|Condition no longer requires study drug|0|||
161905973|NCT00433836|584704775|FG001|Overall Study|Condition no longer requires study drug|1|||
161905974|NCT00433836|584704774|FG000|Overall Study|Abnormal laboratory values|0|||
161905975|NCT00433836|584704775|FG001|Overall Study|Abnormal laboratory values|1|||
161905976|NCT00113607|584704776|FG000|Overall Study|Adverse Event|40|||
161905977|NCT00113607|584704777|FG001|Overall Study|Adverse Event|71|||
161803104|NCT00849901|584323354|FG002|Extension Phase|Protocol Violation|4|||
161803105|NCT00849901|584323352|FG000|Extension Phase|Withdrawal by Subject|7|||
161905978|NCT00113607|584704776|FG000|Overall Study|Death|8|||
161905979|NCT00113607|584704777|FG001|Overall Study|Death|8|||
161905980|NCT00113607|584704776|FG000|Overall Study|Withdrawal by Subject|50|||
161905981|NCT00113607|584704777|FG001|Overall Study|Withdrawal by Subject|58|||
161905982|NCT00113607|584704776|FG000|Overall Study|Lost to Follow-up|0|||
161905983|NCT00113607|584704777|FG001|Overall Study|Lost to Follow-up|2|||
161905984|NCT00113607|584704776|FG000|Overall Study|Disease Progression|180|||
161905985|NCT00113607|584704777|FG001|Overall Study|Disease Progression|142|||
161905986|NCT00113607|584704776|FG000|Overall Study|Complete Response (Confirmed)|14|||
161905987|NCT00113607|584704777|FG001|Overall Study|Complete Response (Confirmed)|24|||
161905988|NCT00113607|584704776|FG000|Overall Study|Other|43|||
161905989|NCT00113607|584704777|FG001|Overall Study|Other|32|||
161905990|NCT03669549|584704778|FG000|Overall Study|Adverse Event|4|||
161905991|NCT03669549|584704778|FG000|Overall Study|Withdrawal by Subject|1|||
161905992|NCT03669549|584704778|FG000|Overall Study|Study terminated by the Sponsor|1|||
161905993|NCT00909844|584704779|FG000|Overall Study|Adverse Event|1|||
161905994|NCT00909844|584704779|FG000|Overall Study|Withdrawal by Subject|1|||
161905995|NCT00909844|584704779|FG000|Overall Study|Lost to Follow-up|2|||
161905996|NCT00706004|584704780|FG000|Overall Study|Did not meet eligibility criteria|2|||
161905997|NCT02674516|584704781|FG000|Overall Study|Lost to Follow-up|3|||
161905998|NCT02674516|584704782|FG001|Overall Study|Lost to Follow-up|0|||
161905999|NCT02674516|584704781|FG000|Overall Study|Protocol Violation|0|||
161906000|NCT02674516|584704782|FG001|Overall Study|Protocol Violation|4|||
161906001|NCT02674516|584704781|FG000|Overall Study|Knowledge of study hypothesis|1|||
161906002|NCT02674516|584704782|FG001|Overall Study|Knowledge of study hypothesis|0|||
161906003|NCT01064479|584704783|FG000|Overall Study|Death|10|||
161906004|NCT01064479|584704784|FG001|Overall Study|Death|11|||
161906005|NCT01064479|584704783|FG000|Overall Study|Withdrawal by Subject|2|||
161906006|NCT01064479|584704784|FG001|Overall Study|Withdrawal by Subject|2|||
161906007|NCT01064479|584704783|FG000|Overall Study|Disease progression|1|||
161906008|NCT01064479|584704784|FG001|Overall Study|Disease progression|1|||
161906009|NCT01064479|584704783|FG000|Overall Study|Toxicity|1|||
161906010|NCT01064479|584704784|FG001|Overall Study|Toxicity|1|||
161906011|NCT01064479|584704783|FG000|Overall Study|Other|1|||
161906012|NCT01064479|584704784|FG001|Overall Study|Other|2|||
161906013|NCT05696392|584704790|FG000|Overall Study|Lost to Follow-up|3|||
161906014|NCT05696392|584704790|FG000|Overall Study|Protocol Violation|1|||
161906015|NCT05696392|584704790|FG000|Overall Study|Withdrawal by Subject|1|||
161906016|NCT04464707|584704794|FG000|Overall Study|Adverse Event|1|||
161906017|NCT04464707|584704795|FG001|Overall Study|Adverse Event|0|||
161906018|NCT04464707|584704796|FG002|Overall Study|Adverse Event|0|||
161906019|NCT04464707|584704794|FG000|Overall Study|Withdrawal by Subject|0|||
161906020|NCT04464707|584704795|FG001|Overall Study|Withdrawal by Subject|0|||
161906021|NCT04464707|584704796|FG002|Overall Study|Withdrawal by Subject|2|||
161906022|NCT04464707|584704794|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161906023|NCT04464707|584704795|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161906024|NCT04464707|584704796|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161906025|NCT04464707|584704794|FG000|Overall Study|Protocol Deviation|1|||
161906026|NCT04464707|584704795|FG001|Overall Study|Protocol Deviation|0|||
161906027|NCT04464707|584704796|FG002|Overall Study|Protocol Deviation|0|||
161906028|NCT04464707|584704794|FG000|Overall Study|Lost to Follow-up|2|||
161906029|NCT04464707|584704795|FG001|Overall Study|Lost to Follow-up|0|||
161906030|NCT04464707|584704796|FG002|Overall Study|Lost to Follow-up|1|||
161906031|NCT04831138|584704797|FG000|Overall Study|Lost to Follow-up|2|||
161906032|NCT04831138|584704798|FG001|Overall Study|Lost to Follow-up|0|||
161906033|NCT04202497|584704806|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
161906034|NCT04202497|584704807|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
161906035|NCT04202497|584704808|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
161906036|NCT04202497|584704809|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
161906037|NCT05590377|584704812|FG000|Overall Study|Death|1|||
161906038|NCT05590377|584704813|FG001|Overall Study|Death|1|||
161906039|NCT05590377|584704814|FG002|Overall Study|Death|2|||
161906040|NCT05590377|584704815|FG003|Overall Study|Death|0|||
161906041|NCT05590377|584704816|FG004|Overall Study|Death|0|||
161906042|NCT05590377|584704812|FG000|Overall Study|Study Terminated by Sponsor|1|||
161906043|NCT05590377|584704813|FG001|Overall Study|Study Terminated by Sponsor|5|||
161906044|NCT05590377|584704814|FG002|Overall Study|Study Terminated by Sponsor|4|||
161906045|NCT05590377|584704815|FG003|Overall Study|Study Terminated by Sponsor|0|||
161906046|NCT05590377|584704816|FG004|Overall Study|Study Terminated by Sponsor|0|||
161906047|NCT05590377|584704812|FG000|Overall Study|Withdrawal by Subject|1|||
161906048|NCT05590377|584704813|FG001|Overall Study|Withdrawal by Subject|0|||
161906049|NCT05590377|584704814|FG002|Overall Study|Withdrawal by Subject|0|||
161906050|NCT05590377|584704815|FG003|Overall Study|Withdrawal by Subject|0|||
161906051|NCT05590377|584704816|FG004|Overall Study|Withdrawal by Subject|0|||
161906052|NCT03389620|584704817|FG000|Overall Study|Lost to Follow-up|5|||
161906053|NCT03389620|584704818|FG001|Overall Study|Lost to Follow-up|1|||
161906054|NCT04782180|584704825|FG000|Overall Study|Withdrawal by Subject|2|||
161906055|NCT04782180|584704825|FG000|Overall Study|Lost to Follow-up|2|||
161906056|NCT05852353|584704826|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
161906057|NCT05852353|584704826|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
161906058|NCT05852353|584704826|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
161906059|NCT05852353|584704826|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
161906060|NCT01005745|584704827|FG000|Overall Study|No TIL growth|1|||
161906061|NCT01005745|584704827|FG000|Overall Study|Disease progressed during TIL growth|3|||
161906062|NCT01005745|584704827|FG000|Overall Study|Death prior to treatment|1|||
161906063|NCT01005745|584704827|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
161906064|NCT06077773|584704828|FG000|Overall Study|Withdrawal by Subject|1|||
161906065|NCT06077773|584704829|FG001|Overall Study|Withdrawal by Subject|0|||
161906066|NCT06077773|584704830|FG002|Overall Study|Withdrawal by Subject|1|||
161906067|NCT06077773|584704828|FG000|Overall Study|Lost to Follow-up|0|||
161906068|NCT06077773|584704829|FG001|Overall Study|Lost to Follow-up|1|||
161906069|NCT06077773|584704830|FG002|Overall Study|Lost to Follow-up|0|||
161803106|NCT00849901|584323353|FG001|Extension Phase|Withdrawal by Subject|6|||
161803107|NCT00849901|584323354|FG002|Extension Phase|Withdrawal by Subject|3|||
161803108|NCT00849901|584323352|FG000|Extension Phase|Parent or Caregiver Decision|10|||
161803109|NCT00849901|584323353|FG001|Extension Phase|Parent or Caregiver Decision|4|||
161803110|NCT00849901|584323354|FG002|Extension Phase|Parent or Caregiver Decision|4|||
161803111|NCT00849901|584323352|FG000|Extension Phase|Physician Decision|1|||
161803112|NCT00849901|584323353|FG001|Extension Phase|Physician Decision|2|||
161803113|NCT00849901|584323354|FG002|Extension Phase|Physician Decision|0|||
161803114|NCT00849901|584323352|FG000|Extension Phase|Lack of Efficacy|2|||
161803115|NCT00849901|584323353|FG001|Extension Phase|Lack of Efficacy|4|||
161803116|NCT00849901|584323354|FG002|Extension Phase|Lack of Efficacy|1|||
161803117|NCT00262223|584323355|FG000|Treatment Phase|Withdrawal by Subject|3|||
161803118|NCT00262223|584323356|FG001|Treatment Phase|Withdrawal by Subject|6|||
161803119|NCT00262223|584323355|FG000|Treatment Phase|Adverse Event|1|||
161803120|NCT00262223|584323356|FG001|Treatment Phase|Adverse Event|2|||
161803121|NCT00262223|584323355|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
161803122|NCT00262223|584323356|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
161803123|NCT00262223|584323355|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
161803124|NCT00262223|584323356|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
161803125|NCT00262223|584323355|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
161803126|NCT00262223|584323356|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
161803127|NCT00437658|584323357|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
161803128|NCT00437658|584323358|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
161803129|NCT00437658|584323359|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
161803130|NCT00437658|584323357|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
161803131|NCT00437658|584323358|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
161803132|NCT00437658|584323359|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
161803133|NCT00437658|584323357|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
161803134|NCT00437658|584323358|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
161803135|NCT00437658|584323359|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
161803136|NCT00437658|584323357|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
161803137|NCT00437658|584323358|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
161803138|NCT00437658|584323359|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
161803139|NCT00437658|584323357|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
161803140|NCT00437658|584323358|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
161803141|NCT00437658|584323359|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
161803142|NCT00437658|584323357|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
161803143|NCT00437658|584323358|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
161803144|NCT00437658|584323359|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
161803145|NCT00437658|584323357|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
161803146|NCT00437658|584323358|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
161803147|NCT00437658|584323359|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
161803148|NCT00437658|584323357|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
161803149|NCT00437658|584323358|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
161803150|NCT00437658|584323359|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
161803151|NCT00437658|584323357|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
161803152|NCT00437658|584323358|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
161803153|NCT00437658|584323359|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
161803154|NCT00437658|584323357|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
161803155|NCT00437658|584323358|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
161803156|NCT00437658|584323359|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
161803157|NCT00437658|584323357|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
161803158|NCT00437658|584323358|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
161803159|NCT00437658|584323359|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
161803160|NCT00437658|584323357|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
161803161|NCT00437658|584323358|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
161906070|NCT06077773|584704828|FG000|Overall Study|Adverse Event|0|||
161906071|NCT06077773|584704829|FG001|Overall Study|Adverse Event|0|||
161906072|NCT06077773|584704830|FG002|Overall Study|Adverse Event|2|||
161906073|NCT03834506|584704831|FG000|Overall Study|Death|336|||
161906074|NCT03834506|584704832|FG001|Overall Study|Death|326|||
161906075|NCT03834506|584704831|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161906076|NCT03834506|584704832|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161906077|NCT03834506|584704831|FG000|Overall Study|Withdrawal by Subject|10|||
161906078|NCT03834506|584704832|FG001|Overall Study|Withdrawal by Subject|8|||
161906079|NCT03834506|584704831|FG000|Overall Study|Sponsor decision|165|||
161906080|NCT03834506|584704832|FG001|Overall Study|Sponsor decision|178|||
161906081|NCT03834506|584704831|FG000|Overall Study|Physician Decision|3|||
161906082|NCT03834506|584704832|FG001|Overall Study|Physician Decision|1|||
161906083|NCT03834506|584704831|FG000|Overall Study|Lost to Follow-up|0|||
161906084|NCT03834506|584704832|FG001|Overall Study|Lost to Follow-up|1|||
161906085|NCT04577794|584704833|FG000|Overall Study|Adverse Event|1|||
161906086|NCT04577794|584704834|FG001|Overall Study|Adverse Event|1|||
161906087|NCT01619878|584704837|FG000|6 Week Follow-up Phase|Adverse Event|1|||
161906088|NCT01619878|584704837|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
161906089|NCT01619878|584704837|FG000|Follow-up at 12 Months of Age|Death|2|||
161906090|NCT01883895|584704838|FG000|Overall Study|Lost to Follow-up|2|||
161906091|NCT04414787|584704839|FG000|Overall Study|Patient Death|18|||
161906092|NCT04414787|584704840|FG001|Overall Study|Patient Death|18|||
161906093|NCT04414787|584704841|FG002|Overall Study|Patient Death|15|||
161906094|NCT04414787|584704842|FG003|Overall Study|Patient Death|15|||
161906095|NCT04414787|584704839|FG000|Overall Study|Patient Hospitalization|1|||
161906096|NCT04414787|584704840|FG001|Overall Study|Patient Hospitalization|1|||
161906097|NCT04414787|584704841|FG002|Overall Study|Patient Hospitalization|2|||
161906098|NCT04414787|584704842|FG003|Overall Study|Patient Hospitalization|2|||
161906099|NCT04414787|584704839|FG000|Overall Study|Lost to Follow-up|7|||
161803162|NCT00437658|584323359|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
161906100|NCT04414787|584704840|FG001|Overall Study|Lost to Follow-up|7|||
161906101|NCT04414787|584704841|FG002|Overall Study|Lost to Follow-up|5|||
161906102|NCT04414787|584704842|FG003|Overall Study|Lost to Follow-up|5|||
161906103|NCT04414787|584704839|FG000|Overall Study|Residence in post-acute care facility|3|||
161906104|NCT04414787|584704840|FG001|Overall Study|Residence in post-acute care facility|3|||
161906105|NCT04414787|584704841|FG002|Overall Study|Residence in post-acute care facility|5|||
161906106|NCT04414787|584704842|FG003|Overall Study|Residence in post-acute care facility|5|||
161906107|NCT05093933|584704843|FG000|Overall Study|Death|372|||
161906108|NCT05093933|584704844|FG001|Overall Study|Death|434|||
161906109|NCT05093933|584704843|FG000|Overall Study|Lost to Follow-up|13|||
161906110|NCT05093933|584704844|FG001|Overall Study|Lost to Follow-up|16|||
161906111|NCT05093933|584704843|FG000|Overall Study|Physician Decision|0|||
161906112|NCT05093933|584704844|FG001|Overall Study|Physician Decision|2|||
161803163|NCT01866319|584323360|FG000|Overall Study|Adverse Event|12|||
161803164|NCT01866319|584323361|FG001|Overall Study|Adverse Event|5|||
161803165|NCT01866319|584323362|FG002|Overall Study|Adverse Event|9|||
161803166|NCT01866319|584323360|FG000|Overall Study|Clinical progression|3|||
161803167|NCT01866319|584323361|FG001|Overall Study|Clinical progression|2|||
161803168|NCT01866319|584323362|FG002|Overall Study|Clinical progression|2|||
161803169|NCT01866319|584323360|FG000|Overall Study|Death|153|||
161803170|NCT01866319|584323361|FG001|Overall Study|Death|154|||
161803171|NCT01866319|584323362|FG002|Overall Study|Death|147|||
161803172|NCT01866319|584323360|FG000|Overall Study|Lost to Follow-up|6|||
161803173|NCT01866319|584323361|FG001|Overall Study|Lost to Follow-up|3|||
161803174|NCT01866319|584323362|FG002|Overall Study|Lost to Follow-up|8|||
161803175|NCT01866319|584323360|FG000|Overall Study|Physician Decision|1|||
161803176|NCT01866319|584323361|FG001|Overall Study|Physician Decision|0|||
161803177|NCT01866319|584323362|FG002|Overall Study|Physician Decision|1|||
161803178|NCT01866319|584323360|FG000|Overall Study|Protocol Violation|0|||
161803179|NCT01866319|584323361|FG001|Overall Study|Protocol Violation|0|||
161803180|NCT01866319|584323362|FG002|Overall Study|Protocol Violation|1|||
161803181|NCT01866319|584323360|FG000|Overall Study|Withdrawal by Subject|32|||
161803182|NCT01866319|584323361|FG001|Overall Study|Withdrawal by Subject|14|||
161803183|NCT01866319|584323362|FG002|Overall Study|Withdrawal by Subject|12|||
161803184|NCT03980483|584323363|FG000|Overall Study|Adverse Event|13|||
161803185|NCT03980483|584323364|FG001|Overall Study|Adverse Event|29|||
161803186|NCT03980483|584323365|FG002|Overall Study|Adverse Event|11|||
161803187|NCT03980483|584323366|FG003|Overall Study|Adverse Event|2|||
161803188|NCT03980483|584323367|FG004|Overall Study|Adverse Event|2|||
161803189|NCT03980483|584323368|FG005|Overall Study|Adverse Event|2|||
161803190|NCT03980483|584323363|FG000|Overall Study|Lack of Efficacy|7|||
161803191|NCT03980483|584323364|FG001|Overall Study|Lack of Efficacy|6|||
161906113|NCT05093933|584704843|FG000|Overall Study|Sponsor Decision|1|||
161906114|NCT05093933|584704844|FG001|Overall Study|Sponsor Decision|3|||
161906115|NCT05093933|584704843|FG000|Overall Study|Withdrawal by Guardian|1|||
161906116|NCT05093933|584704844|FG001|Overall Study|Withdrawal by Guardian|1|||
161906117|NCT05093933|584704843|FG000|Overall Study|Withdrawal by Subject|18|||
161906118|NCT05093933|584704844|FG001|Overall Study|Withdrawal by Subject|25|||
161906119|NCT05069259|584704848|FG000|Overall Study|Withdrawal by Subject|1|||
161906120|NCT05069259|584704848|FG000|Overall Study|Sponsor decision|1|||
161906121|NCT00922636|584706241|FG000|Overall Study|Adverse Event|3|||
161906122|NCT00922636|584706242|FG001|Overall Study|Adverse Event|3|||
161906123|NCT00922636|584706243|FG002|Overall Study|Adverse Event|2|||
161906124|NCT00922636|584706244|FG003|Overall Study|Adverse Event|3|||
161906125|NCT00922636|584706245|FG004|Overall Study|Adverse Event|2|||
161906126|NCT00922636|584706241|FG000|Overall Study|Lack of Efficacy|1|||
161906127|NCT00922636|584706242|FG001|Overall Study|Lack of Efficacy|7|||
161906128|NCT00922636|584706243|FG002|Overall Study|Lack of Efficacy|3|||
161906129|NCT00922636|584706244|FG003|Overall Study|Lack of Efficacy|2|||
161906130|NCT00922636|584706245|FG004|Overall Study|Lack of Efficacy|4|||
161906131|NCT00922636|584706241|FG000|Overall Study|Sponsor Decision|0|||
161906132|NCT00922636|584706242|FG001|Overall Study|Sponsor Decision|0|||
161906133|NCT00922636|584706243|FG002|Overall Study|Sponsor Decision|2|||
161906134|NCT00922636|584706244|FG003|Overall Study|Sponsor Decision|0|||
161906135|NCT00922636|584706245|FG004|Overall Study|Sponsor Decision|0|||
161906136|NCT00922636|584706241|FG000|Overall Study|Withdrawal by Subject|0|||
161906137|NCT00922636|584706242|FG001|Overall Study|Withdrawal by Subject|0|||
161906138|NCT00922636|584706243|FG002|Overall Study|Withdrawal by Subject|5|||
161906139|NCT00922636|584706244|FG003|Overall Study|Withdrawal by Subject|2|||
161906140|NCT00922636|584706245|FG004|Overall Study|Withdrawal by Subject|4|||
161906141|NCT00922636|584706241|FG000|Overall Study|Protocol Violation|0|||
161906142|NCT00922636|584706242|FG001|Overall Study|Protocol Violation|0|||
161906143|NCT00922636|584706243|FG002|Overall Study|Protocol Violation|2|||
161906144|NCT00922636|584706244|FG003|Overall Study|Protocol Violation|2|||
161906145|NCT00922636|584706245|FG004|Overall Study|Protocol Violation|0|||
161906146|NCT00922636|584706241|FG000|Overall Study|Entry Criteria Not Met|0|||
161906147|NCT00922636|584706242|FG001|Overall Study|Entry Criteria Not Met|0|||
161906148|NCT00922636|584706243|FG002|Overall Study|Entry Criteria Not Met|1|||
161906149|NCT00922636|584706244|FG003|Overall Study|Entry Criteria Not Met|1|||
161906150|NCT00922636|584706245|FG004|Overall Study|Entry Criteria Not Met|0|||
161906151|NCT00922636|584706241|FG000|Overall Study|Parent/Caregiver Decision|2|||
161906152|NCT00922636|584706242|FG001|Overall Study|Parent/Caregiver Decision|4|||
161906153|NCT00922636|584706243|FG002|Overall Study|Parent/Caregiver Decision|3|||
161906154|NCT00922636|584706244|FG003|Overall Study|Parent/Caregiver Decision|5|||
161906155|NCT00922636|584706245|FG004|Overall Study|Parent/Caregiver Decision|2|||
161906156|NCT00922636|584706241|FG000|Overall Study|Lost to Follow-up|1|||
161906157|NCT00922636|584706242|FG001|Overall Study|Lost to Follow-up|2|||
161906158|NCT00922636|584706243|FG002|Overall Study|Lost to Follow-up|2|||
161906159|NCT00922636|584706244|FG003|Overall Study|Lost to Follow-up|2|||
161906160|NCT00922636|584706245|FG004|Overall Study|Lost to Follow-up|4|||
161906161|NCT01117870|584706246|FG000|Overall Study|Inability to place needle|1|||
161906162|NCT01117870|584706247|FG001|Overall Study|Inability to place needle|0|||
161906163|NCT01309386|584706248|FG000|Overall Study|Other|2|||
161906164|NCT01309386|584706249|FG001|Overall Study|Other|0|||
161906165|NCT01309386|584706248|FG000|Overall Study|Withdrawal by Subject|2|||
161906166|NCT01309386|584706249|FG001|Overall Study|Withdrawal by Subject|0|||
161906167|NCT01309386|584706248|FG000|Overall Study|Progressive disease|9|||
161906168|NCT01309386|584706249|FG001|Overall Study|Progressive disease|11|||
161906169|NCT01309386|584706248|FG000|Overall Study|Physician Decision|1|||
161906170|NCT01309386|584706249|FG001|Overall Study|Physician Decision|1|||
161906171|NCT01309386|584706248|FG000|Overall Study|Lack of Efficacy|3|||
161906172|NCT01309386|584706249|FG001|Overall Study|Lack of Efficacy|1|||
161906173|NCT01309386|584706248|FG000|Overall Study|Adverse Event|5|||
161906174|NCT01309386|584706249|FG001|Overall Study|Adverse Event|8|||
161906175|NCT02456727|584706250|FG000|Overall Study|Lost to Follow-up|63|||
161906176|NCT02456727|584706251|FG001|Overall Study|Lost to Follow-up|65|||
161906177|NCT02456727|584706250|FG000|Overall Study|Death|2|||
161906178|NCT02456727|584706251|FG001|Overall Study|Death|1|||
161906179|NCT02456727|584706250|FG000|Overall Study|Withdrawal by Subject|1|||
161906180|NCT02456727|584706251|FG001|Overall Study|Withdrawal by Subject|10|||
161906181|NCT02456727|584706250|FG000|Overall Study|Never Initiated Treatment|43|||
161906182|NCT02456727|584706251|FG001|Overall Study|Never Initiated Treatment|30|||
161906183|NCT03885908|584706252|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
161906184|NCT03885908|584706253|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
161906185|NCT03885908|584706252|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
161906186|NCT03885908|584706253|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
161906187|NCT03885908|584706252|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
161906188|NCT03885908|584706253|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
161906189|NCT03885908|584706252|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
161906190|NCT03885908|584706253|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
161906191|NCT02974868|584706254|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
161906192|NCT02974868|584706255|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
161906193|NCT02974868|584706256|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
161906194|NCT02974868|584706257|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
161906195|NCT02974868|584706254|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
161906196|NCT02974868|584706255|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
161906197|NCT02974868|584706256|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
161906198|NCT02974868|584706257|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
161906199|NCT02974868|584706254|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
161906200|NCT02974868|584706255|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
161906201|NCT02974868|584706256|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
161906202|NCT02974868|584706257|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
161906203|NCT02974868|584706254|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
161906204|NCT02974868|584706255|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
161906205|NCT02974868|584706256|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
161906206|NCT02974868|584706257|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
161906207|NCT00749398|584706258|FG000|Overall Study|Lack of Efficacy|7|||
161906208|NCT00749398|584706258|FG000|Overall Study|Adverse Event|4|||
161906209|NCT00749398|584706258|FG000|Overall Study|Serious adverse event|11|||
161906210|NCT00749398|584706258|FG000|Overall Study|Withdrawal by Subject|17|||
161906211|NCT00749398|584706258|FG000|Overall Study|Lost to Follow-up|11|||
161906212|NCT00749398|584706258|FG000|Overall Study|Reason not specified|2|||
161906213|NCT00749398|584706258|FG000|Overall Study|Unknown reason|1|||
161906214|NCT01663402|584706259|FG000|Overall Study|Randomized but not treated|19|||
161906215|NCT01663402|584706260|FG001|Overall Study|Randomized but not treated|11|||
161906216|NCT01663402|584706259|FG000|Overall Study|Adverse Event|347|||
161906217|NCT01663402|584706260|FG001|Overall Study|Adverse Event|362|||
161906218|NCT01663402|584706259|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
161906219|NCT01663402|584706260|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
161906220|NCT01663402|584706259|FG000|Overall Study|Poor compliance to protocol|529|||
161906221|NCT01663402|584706260|FG001|Overall Study|Poor compliance to protocol|454|||
161906222|NCT01663402|584706259|FG000|Overall Study|Physician Decision|77|||
161906223|NCT01663402|584706260|FG001|Overall Study|Physician Decision|62|||
161906224|NCT01663402|584706259|FG000|Overall Study|Site terminated by sponsor|1|||
161906225|NCT01663402|584706260|FG001|Overall Study|Site terminated by sponsor|3|||
161906226|NCT01663402|584706259|FG000|Overall Study|Participant moved|139|||
161906227|NCT01663402|584706260|FG001|Overall Study|Participant moved|104|||
161906228|NCT01663402|584706259|FG000|Overall Study|Withdrawal by Subject|118|||
161906229|NCT01663402|584706260|FG001|Overall Study|Withdrawal by Subject|91|||
161906230|NCT01663402|584706259|FG000|Overall Study|Related to study drug administration|96|||
161906231|NCT01663402|584706260|FG001|Overall Study|Related to study drug administration|105|||
161906232|NCT01663402|584706259|FG000|Overall Study|Lost to Follow-up|17|||
161906233|NCT01663402|584706260|FG001|Overall Study|Lost to Follow-up|15|||
161906234|NCT01663402|584706259|FG000|Overall Study|Other than specified above|172|||
161906235|NCT01663402|584706260|FG001|Overall Study|Other than specified above|147|||
161906236|NCT05953363|584706263|FG000|Overall Study|Screen Failure|2|||
161906237|NCT05953363|584706263|FG000|Overall Study|Withdrawal by Subject|3|||
161906238|NCT05953363|584706263|FG000|Overall Study|Surgery cancelled|2|||
161906239|NCT05953363|584706263|FG000|Overall Study|Adverse Event|1|||
161906240|NCT01701674|584706264|FG000|Overall Study|Unable to safely complete treatment|1|||
161906241|NCT04613518|584706269|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
161906242|NCT04613518|584706270|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
161906243|NCT04613518|584706271|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
161906244|NCT04613518|584706269|FG000|Double-Blind Treatment Period|Adverse Event|2|||
161906245|NCT04613518|584706270|FG001|Double-Blind Treatment Period|Adverse Event|0|||
161906246|NCT04613518|584706271|FG002|Double-Blind Treatment Period|Adverse Event|1|||
161906247|NCT04613518|584706269|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
161906248|NCT04613518|584706270|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
161906249|NCT04613518|584706271|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
161906250|NCT04613518|584706269|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
161906251|NCT04613518|584706270|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
161906252|NCT04613518|584706271|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
161906253|NCT04613518|584706269|FG000|Double-Blind Treatment Period|Other Reasons|2|||
161906254|NCT04613518|584706270|FG001|Double-Blind Treatment Period|Other Reasons|0|||
161906255|NCT04613518|584706271|FG002|Double-Blind Treatment Period|Other Reasons|0|||
161906256|NCT04613518|584706269|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
161906257|NCT04613518|584706270|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
161906258|NCT04613518|584706271|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
161906259|NCT04613518|584706269|FG000|Open-Label Treatment Period|Adverse Event|1|||
161906260|NCT04613518|584706270|FG001|Open-Label Treatment Period|Adverse Event|0|||
161906261|NCT04613518|584706271|FG002|Open-Label Treatment Period|Adverse Event|3|||
161906262|NCT04613518|584706269|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
161906263|NCT04613518|584706270|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
161906264|NCT04613518|584706271|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
161906265|NCT04613518|584706269|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
161906266|NCT04613518|584706270|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
161906267|NCT04613518|584706271|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
161906268|NCT04613518|584706269|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
161906269|NCT04613518|584706270|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
161906270|NCT04613518|584706271|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
161906271|NCT04613518|584706269|FG000|Open-Label Treatment Period|Other reasons|1|||
161906272|NCT04613518|584706270|FG001|Open-Label Treatment Period|Other reasons|0|||
161906273|NCT04613518|584706271|FG002|Open-Label Treatment Period|Other reasons|0|||
161906274|NCT03509467|584706272|FG000|Overall Study|Withdrawal by Subject|5|||
161906275|NCT03509467|584706273|FG001|Overall Study|Withdrawal by Subject|1|||
161906276|NCT03509467|584706274|FG002|Overall Study|Withdrawal by Subject|6|||
161906277|NCT03509467|584706275|FG003|Overall Study|Withdrawal by Subject|7|||
161906278|NCT03509467|584706276|FG004|Overall Study|Withdrawal by Subject|10|||
161906279|NCT03509467|584706277|FG005|Overall Study|Withdrawal by Subject|10|||
161906280|NCT03509467|584706278|FG006|Overall Study|Withdrawal by Subject|10|||
161906281|NCT03509467|584706279|FG007|Overall Study|Withdrawal by Subject|10|||
161906282|NCT03509467|584706272|FG000|Overall Study|Death|0|||
161906283|NCT03509467|584706273|FG001|Overall Study|Death|0|||
161803192|NCT03980483|584323365|FG002|Overall Study|Lack of Efficacy|0|||
161803193|NCT03980483|584323366|FG003|Overall Study|Lack of Efficacy|3|||
161803194|NCT03980483|584323367|FG004|Overall Study|Lack of Efficacy|1|||
161803195|NCT03980483|584323368|FG005|Overall Study|Lack of Efficacy|1|||
161803196|NCT03980483|584323363|FG000|Overall Study|Lost to Follow-up|2|||
161803197|NCT03980483|584323364|FG001|Overall Study|Lost to Follow-up|4|||
161803198|NCT03980483|584323365|FG002|Overall Study|Lost to Follow-up|2|||
161803199|NCT03980483|584323366|FG003|Overall Study|Lost to Follow-up|1|||
161803200|NCT03980483|584323367|FG004|Overall Study|Lost to Follow-up|2|||
161803201|NCT03980483|584323368|FG005|Overall Study|Lost to Follow-up|0|||
161803202|NCT03980483|584323363|FG000|Overall Study|Protocol Violation|4|||
161803203|NCT03980483|584323364|FG001|Overall Study|Protocol Violation|2|||
161803204|NCT03980483|584323365|FG002|Overall Study|Protocol Violation|1|||
161803205|NCT03980483|584323366|FG003|Overall Study|Protocol Violation|1|||
161803206|NCT03980483|584323367|FG004|Overall Study|Protocol Violation|0|||
161803207|NCT03980483|584323368|FG005|Overall Study|Protocol Violation|0|||
161803208|NCT03980483|584323363|FG000|Overall Study|Physician Decision|14|||
161803209|NCT03980483|584323364|FG001|Overall Study|Physician Decision|10|||
161803210|NCT03980483|584323365|FG002|Overall Study|Physician Decision|7|||
161803211|NCT03980483|584323366|FG003|Overall Study|Physician Decision|4|||
161803212|NCT03980483|584323367|FG004|Overall Study|Physician Decision|4|||
161803213|NCT03980483|584323368|FG005|Overall Study|Physician Decision|2|||
161803214|NCT03980483|584323363|FG000|Overall Study|Withdrawal by Subject|38|||
161803215|NCT03980483|584323364|FG001|Overall Study|Withdrawal by Subject|21|||
161803216|NCT03980483|584323365|FG002|Overall Study|Withdrawal by Subject|15|||
161803217|NCT03980483|584323366|FG003|Overall Study|Withdrawal by Subject|5|||
161803218|NCT03980483|584323367|FG004|Overall Study|Withdrawal by Subject|3|||
161803219|NCT03980483|584323368|FG005|Overall Study|Withdrawal by Subject|4|||
161803220|NCT03980483|584323363|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
161906284|NCT03509467|584706274|FG002|Overall Study|Death|2|||
161906285|NCT03509467|584706275|FG003|Overall Study|Death|2|||
161906286|NCT03509467|584706276|FG004|Overall Study|Death|1|||
161906287|NCT03509467|584706277|FG005|Overall Study|Death|0|||
161906288|NCT03509467|584706278|FG006|Overall Study|Death|1|||
161906289|NCT03509467|584706279|FG007|Overall Study|Death|0|||
161906290|NCT03509467|584706272|FG000|Overall Study|Proxy Withdrawal|0|||
161906291|NCT03509467|584706273|FG001|Overall Study|Proxy Withdrawal|0|||
161906292|NCT03509467|584706274|FG002|Overall Study|Proxy Withdrawal|0|||
161906293|NCT03509467|584706275|FG003|Overall Study|Proxy Withdrawal|0|||
161906294|NCT03509467|584706276|FG004|Overall Study|Proxy Withdrawal|0|||
161906295|NCT03509467|584706277|FG005|Overall Study|Proxy Withdrawal|0|||
161906296|NCT03509467|584706278|FG006|Overall Study|Proxy Withdrawal|0|||
161906297|NCT03509467|584706279|FG007|Overall Study|Proxy Withdrawal|1|||
161906298|NCT04275973|584706282|FG000|Overall Study|Withdrawal by Subject|2|||
161906299|NCT04275973|584706283|FG001|Overall Study|Withdrawal by Subject|1|||
161906300|NCT06110754|584706284|FG000|Overall Study|Withdrawal by Subject|0|||
161906301|NCT06110754|584706285|FG001|Overall Study|Withdrawal by Subject|0|||
161906302|NCT06110754|584706286|FG002|Overall Study|Withdrawal by Subject|1|||
161803221|NCT03980483|584323364|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161803222|NCT03980483|584323365|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161803223|NCT03980483|584323366|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161803224|NCT03980483|584323367|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161906303|NCT06110754|584706287|FG003|Overall Study|Withdrawal by Subject|0|||
161906304|NCT02499146|584706290|FG000|Overall Study|Global deterioration of health status|1|||
161906305|NCT02499146|584706290|FG000|Overall Study|Objective progression or relapse|20|||
161906306|NCT02499146|584706290|FG000|Overall Study|Other|2|||
161906307|NCT02499146|584706290|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
161906308|NCT04325828|584706291|FG000|Overall Study|Ongoing|26|||
161906309|NCT05115630|584706292|FG000|Overall Study|Due to COVID19|1|||
161906310|NCT05115630|584706292|FG000|Overall Study|Due to Bacteremia|1|||
161906311|NCT05115630|584706292|FG000|Overall Study|Due to viral infection|1|||
161906312|NCT02287038|584706295|FG000|Overall Study|Stopped attending appointments|3|||
161906313|NCT02287038|584706296|FG001|Overall Study|Stopped attending appointments|2|||
161906314|NCT02287038|584706295|FG000|Overall Study|Anxiety after starting medication|0|||
161906315|NCT02287038|584706296|FG001|Overall Study|Anxiety after starting medication|1|||
161906316|NCT02287038|584706295|FG000|Overall Study|Nausea after starting medication|1|||
161906317|NCT02287038|584706296|FG001|Overall Study|Nausea after starting medication|0|||
161906318|NCT02287038|584706295|FG000|Overall Study|Abnormal ECG after starting medication|1|||
161906319|NCT02287038|584706296|FG001|Overall Study|Abnormal ECG after starting medication|0|||
161906320|NCT05502302|584706304|FG000|Overall Study|Lost to Follow-up|6|||
161906321|NCT05502302|584706304|FG000|Overall Study|Death|2|||
161906322|NCT02998151|584706308|FG000|Overall Study|Withdrawal by Subject|3|||
161906323|NCT02998151|584706308|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
161906324|NCT02998151|584706308|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
161906325|NCT02667301|584706311|FG000|Overall Study|Adverse Event|1|||
161906326|NCT02667301|584706311|FG000|Overall Study|Lack of Efficacy|1|||
161906327|NCT00846586|584706313|FG000|Overall Study|Adverse Event|20|||
161906328|NCT00846586|584706314|FG001|Overall Study|Adverse Event|10|||
161906329|NCT00846586|584706313|FG000|Overall Study|Subject withdrew consent|8|||
161906330|NCT00846586|584706314|FG001|Overall Study|Subject withdrew consent|10|||
161906331|NCT00846586|584706313|FG000|Overall Study|Administrative problems|5|||
161906332|NCT00846586|584706314|FG001|Overall Study|Administrative problems|4|||
161906333|NCT00846586|584706313|FG000|Overall Study|Death|2|||
161906334|NCT00846586|584706314|FG001|Overall Study|Death|0|||
161906335|NCT00846586|584706313|FG000|Overall Study|Protocol deviation|2|||
161906336|NCT00846586|584706314|FG001|Overall Study|Protocol deviation|6|||
161906337|NCT00846586|584706313|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161906338|NCT00846586|584706314|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161906339|NCT00846586|584706313|FG000|Overall Study|Lost to Follow-up|1|||
161906340|NCT00846586|584706314|FG001|Overall Study|Lost to Follow-up|4|||
161906341|NCT00846586|584706313|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161906342|NCT00846586|584706314|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161906343|NCT04037358|584706317|FG000|Overall Study|Patient withdrew before intervention|1|||
161906344|NCT04037358|584706318|FG001|Overall Study|Patient withdrew before intervention|0|||
161906345|NCT05027815|584706321|FG000|Overall Study|Death|2|||
161906346|NCT05027815|584706322|FG001|Overall Study|Death|1|||
161906347|NCT04802161|584706324|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
161906348|NCT04802161|584706325|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
161906349|NCT04802161|584706326|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
161906350|NCT04802161|584706327|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
161906351|NCT04802161|584706324|FG000|Overall Study|Clinical Instability|0|||
161906352|NCT04802161|584706325|FG001|Overall Study|Clinical Instability|0|||
161906353|NCT04802161|584706326|FG002|Overall Study|Clinical Instability|1|||
161906354|NCT04802161|584706327|FG003|Overall Study|Clinical Instability|0|||
161906355|NCT04802161|584706324|FG000|Overall Study|Adverse Event|0|||
161906356|NCT04802161|584706325|FG001|Overall Study|Adverse Event|0|||
161906357|NCT04802161|584706326|FG002|Overall Study|Adverse Event|1|||
161906358|NCT04802161|584706327|FG003|Overall Study|Adverse Event|0|||
161906359|NCT04802161|584706324|FG000|Overall Study|Death|0|||
161906360|NCT04802161|584706325|FG001|Overall Study|Death|0|||
162140067|NCT03381274|585563307|FG004|Overall Study|Lost to Follow-up|0|||
162140068|NCT03381274|585563303|FG000|Overall Study|Withdrawal by Subject|2|||
161906361|NCT04802161|584706326|FG002|Overall Study|Death|1|||
162140069|NCT03381274|585563304|FG001|Overall Study|Withdrawal by Subject|1|||
162140070|NCT03381274|585563305|FG002|Overall Study|Withdrawal by Subject|3|||
162140071|NCT03381274|585563306|FG003|Overall Study|Withdrawal by Subject|1|||
161906362|NCT04802161|584706327|FG003|Overall Study|Death|0|||
161906363|NCT00447902|584706333|FG000|Overall Study|Adverse Event|0|||
161906364|NCT00447902|584706334|FG001|Overall Study|Adverse Event|3|||
161906365|NCT00447902|584706333|FG000|Overall Study|Protocol Violation|1|||
161906366|NCT00447902|584706334|FG001|Overall Study|Protocol Violation|0|||
161906367|NCT00447902|584706333|FG000|Overall Study|Withdrawal by Subject|0|||
161906368|NCT00447902|584706334|FG001|Overall Study|Withdrawal by Subject|1|||
161906369|NCT00447902|584706333|FG000|Overall Study|included patients who discontinued|1|||
161906370|NCT00447902|584706334|FG001|Overall Study|included patients who discontinued|1|||
162140072|NCT03381274|585563307|FG004|Overall Study|Withdrawal by Subject|0|||
161906371|NCT00447902|584706333|FG000|Overall Study|Lack of Efficacy|2|||
161803225|NCT03980483|584323368|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161803226|NCT03980483|584323363|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161803227|NCT03980483|584323364|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
161803228|NCT03980483|584323365|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161803229|NCT03980483|584323366|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161803230|NCT03980483|584323367|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161803231|NCT03980483|584323368|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161803232|NCT03980483|584323363|FG000|Overall Study|Other|0|||
161803233|NCT03980483|584323364|FG001|Overall Study|Other|1|||
161803234|NCT03980483|584323365|FG002|Overall Study|Other|0|||
161803235|NCT03980483|584323366|FG003|Overall Study|Other|0|||
161803236|NCT03980483|584323367|FG004|Overall Study|Other|0|||
161803237|NCT03980483|584323368|FG005|Overall Study|Other|0|||
161803238|NCT05150964|584323369|FG000|Overall Study|Lost to Follow-up|2|||
161803239|NCT00623779|584323370|FG000|Overall Study|Adverse Event|1|||
161803240|NCT00623779|584323371|FG001|Overall Study|Adverse Event|3|||
161803241|NCT00623779|584323372|FG002|Overall Study|Adverse Event|0|||
161803242|NCT00623779|584323370|FG000|Overall Study|Criteria from CSR|2|||
161803243|NCT00623779|584323371|FG001|Overall Study|Criteria from CSR|0|||
161803244|NCT00623779|584323372|FG002|Overall Study|Criteria from CSR|1|||
161803245|NCT01629381|584323380|FG000|Overall Study|Withdrawal by Subject|2|||
161803246|NCT01629381|584323381|FG001|Overall Study|Withdrawal by Subject|5|||
161803247|NCT00906347|584323384|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
161803248|NCT00906347|584323385|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
161803249|NCT00906347|584323384|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
161803250|NCT00906347|584323385|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
161803251|NCT00906347|584323384|FG000|Received Study Drug|Refused study drug|1|||
161803252|NCT00906347|584323385|FG001|Received Study Drug|Refused study drug|0|||
161803253|NCT00906347|584323384|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
161803254|NCT00906347|584323385|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
161803255|NCT00680121|584323391|FG000|Overall Study|Lost to Follow-up|27|||
161803256|NCT00680121|584323392|FG001|Overall Study|Lost to Follow-up|23|||
161803257|NCT02849652|584323395|FG000|Overall Study|Lost to Follow-up|104|||
161803258|NCT02849652|584323396|FG001|Overall Study|Lost to Follow-up|35|||
161803259|NCT02849652|584323397|FG002|Overall Study|Lost to Follow-up|116|||
161803260|NCT02849652|584323398|FG003|Overall Study|Lost to Follow-up|22|||
161803261|NCT02849652|584323395|FG000|Overall Study|Withdrawal by Subject|10|||
161803262|NCT02849652|584323396|FG001|Overall Study|Withdrawal by Subject|2|||
161803263|NCT02849652|584323397|FG002|Overall Study|Withdrawal by Subject|8|||
161803264|NCT02849652|584323398|FG003|Overall Study|Withdrawal by Subject|4|||
162140073|NCT03381274|585563303|FG000|Overall Study|Other|1|||
162140074|NCT03381274|585563304|FG001|Overall Study|Other|11|||
161803265|NCT02545998|584323399|FG000|Overall Study|Lost to Follow-up|12|||
161803266|NCT02545998|584323400|FG001|Overall Study|Lost to Follow-up|3|||
161803267|NCT02545998|584323399|FG000|Overall Study|Withdrawal by Subject|3|||
161803268|NCT02545998|584323400|FG001|Overall Study|Withdrawal by Subject|2|||
161803269|NCT00472290|584323401|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
161803270|NCT00472290|584323401|FG000|Overall Study|Protocol Specified Criteria|7|||
161803271|NCT00472290|584323401|FG000|Overall Study|Administrative Decision|37|||
161803272|NCT00472290|584323401|FG000|Overall Study|Death|3|||
161803273|NCT00472290|584323401|FG000|Overall Study|Lost to Follow-up|1|||
161803274|NCT00472290|584323401|FG000|Overall Study|Lack of Efficacy|1|||
161803275|NCT00472290|584323401|FG000|Overall Study|Disease Progression|4|||
161803276|NCT00472290|584323401|FG000|Overall Study|Withdrawal by Subject|5|||
161906372|NCT00447902|584706334|FG001|Overall Study|Lack of Efficacy|1|||
162140075|NCT03381274|585563305|FG002|Overall Study|Other|0|||
162140076|NCT03381274|585563306|FG003|Overall Study|Other|2|||
162140077|NCT03381274|585563307|FG004|Overall Study|Other|2|||
162140078|NCT00751036|585563308|FG000|Overall Study|Disease Progression|28|||
162140079|NCT00751036|585563309|FG001|Overall Study|Disease Progression|29|||
162140080|NCT00751036|585563308|FG000|Overall Study|Adverse Event|6|||
162140081|NCT00751036|585563309|FG001|Overall Study|Adverse Event|4|||
162140082|NCT00751036|585563308|FG000|Overall Study|Administrative Problems|3|||
162140083|NCT00751036|585563309|FG001|Overall Study|Administrative Problems|4|||
162140084|NCT00751036|585563308|FG000|Overall Study|Withdrawal by Subject|5|||
162140085|NCT00751036|585563309|FG001|Overall Study|Withdrawal by Subject|2|||
162140086|NCT00751036|585563308|FG000|Overall Study|Death|3|||
162140087|NCT00751036|585563309|FG001|Overall Study|Death|3|||
162140088|NCT00751036|585563308|FG000|Overall Study|Lost to Follow-up|0|||
162140089|NCT00751036|585563309|FG001|Overall Study|Lost to Follow-up|1|||
162140090|NCT00751036|585563308|FG000|Overall Study|Protocol Violation|1|||
162140091|NCT00751036|585563309|FG001|Overall Study|Protocol Violation|0|||
162140092|NCT00751036|585563308|FG000|Overall Study|Missing end of Treatment Page|2|||
162140093|NCT00751036|585563309|FG001|Overall Study|Missing end of Treatment Page|3|||
162140094|NCT05298111|585565520|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
162140095|NCT05298111|585565521|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
162140096|NCT00109967|585565526|FG000|Overall Study|Cancel Prior to Treatment|2|||
162140097|NCT00109967|585565527|FG001|Overall Study|Cancel Prior to Treatment|0|||
162140098|NCT00109967|585565526|FG000|Overall Study|Adverse Event|12|||
162140099|NCT00109967|585565527|FG001|Overall Study|Adverse Event|1|||
162140100|NCT00109967|585565526|FG000|Overall Study|Withdrawal by Subject|5|||
162140101|NCT00109967|585565527|FG001|Overall Study|Withdrawal by Subject|0|||
162140102|NCT00109967|585565526|FG000|Overall Study|Physician Decision|1|||
162140103|NCT00109967|585565527|FG001|Overall Study|Physician Decision|3|||
162140104|NCT00109967|585565526|FG000|Overall Study|Death|0|||
162140105|NCT00109967|585565527|FG001|Overall Study|Death|2|||
162140106|NCT01977612|585565534|FG000|Overall Study|Lost to Follow-up|1|||
162140107|NCT01977612|585565535|FG001|Overall Study|Lost to Follow-up|1|||
162140108|NCT04381494|585565536|FG000|Overall Study|Early termination of trial|19|||
162140109|NCT04381494|585565536|FG000|Overall Study|Investigator's discretion|1|||
162140110|NCT04381494|585565536|FG000|Overall Study|Withdrawal by Subject|9|||
162140111|NCT04381494|585565536|FG000|Overall Study|NSCLC disease progression|4|||
162140112|NCT04381494|585565536|FG000|Overall Study|Device-Related Adverse Event|2|||
162140113|NCT04310579|585565538|FG000|Overall Study|Adverse Event|0|||
162140114|NCT04310579|585565539|FG001|Overall Study|Adverse Event|0|||
162140115|NCT04310579|585565540|FG002|Overall Study|Adverse Event|0|||
162140116|NCT04310579|585565541|FG003|Overall Study|Adverse Event|0|||
162140117|NCT04310579|585565542|FG004|Overall Study|Adverse Event|0|||
162140118|NCT04310579|585565543|FG005|Overall Study|Adverse Event|0|||
161803277|NCT00472290|584323401|FG000|Overall Study|Adverse Event|6|||
161803278|NCT00472290|584323401|FG000|Overall Study|Requirement for alternative therapy|7|||
161803279|NCT00777829|584323403|FG000|Overall Study|Withdrawal by Subject|0|||
161803280|NCT00777829|584323404|FG001|Overall Study|Withdrawal by Subject|2|||
161803281|NCT00745095|584323406|FG000|Overall Study|Declined to participate|1|||
161803282|NCT00745095|584323407|FG001|Overall Study|Declined to participate|0|||
161803283|NCT00745095|584323408|FG002|Overall Study|Declined to participate|0|||
161803284|NCT00745095|584323409|FG003|Overall Study|Declined to participate|0|||
161803285|NCT00745095|584323410|FG004|Overall Study|Declined to participate|92|||
161803286|NCT00745095|584323411|FG005|Overall Study|Declined to participate|95|||
161803287|NCT00745095|584323406|FG000|Overall Study|Ineligible due to GFR criteria|0|||
161803288|NCT00745095|584323407|FG001|Overall Study|Ineligible due to GFR criteria|2|||
161803289|NCT00745095|584323408|FG002|Overall Study|Ineligible due to GFR criteria|3|||
161803290|NCT00745095|584323409|FG003|Overall Study|Ineligible due to GFR criteria|3|||
161803291|NCT00745095|584323410|FG004|Overall Study|Ineligible due to GFR criteria|30|||
161803292|NCT00745095|584323411|FG005|Overall Study|Ineligible due to GFR criteria|28|||
161803293|NCT01226797|584323416|FG000|Overall Study|Adverse Event|1|||
161803294|NCT01226797|584323417|FG001|Overall Study|Adverse Event|0|||
161803295|NCT01226797|584323416|FG000|Overall Study|No longer willing to participate|1|||
161803296|NCT01226797|584323417|FG001|Overall Study|No longer willing to participate|0|||
161803297|NCT01226797|584323416|FG000|Overall Study|Protocol Violation|0|||
161803298|NCT01226797|584323417|FG001|Overall Study|Protocol Violation|1|||
161803299|NCT00577460|584323418|FG000|Overall Study|Adverse Event|11|||
161803300|NCT00577460|584323419|FG001|Overall Study|Adverse Event|7|||
161803301|NCT00577460|584323420|FG002|Overall Study|Adverse Event|14|||
161803302|NCT00577460|584323418|FG000|Overall Study|Protocol Violation|0|||
161803303|NCT00577460|584323419|FG001|Overall Study|Protocol Violation|1|||
161803304|NCT00577460|584323420|FG002|Overall Study|Protocol Violation|1|||
161803305|NCT00577460|584323418|FG000|Overall Study|Lost to Follow-up|0|||
161803306|NCT00577460|584323419|FG001|Overall Study|Lost to Follow-up|3|||
161803307|NCT00577460|584323420|FG002|Overall Study|Lost to Follow-up|4|||
161803308|NCT00577460|584323418|FG000|Overall Study|Withdrawal by Subject|5|||
161803309|NCT00577460|584323419|FG001|Overall Study|Withdrawal by Subject|5|||
161803310|NCT00577460|584323420|FG002|Overall Study|Withdrawal by Subject|6|||
161803311|NCT00577460|584323418|FG000|Overall Study|Other|0|||
161803312|NCT00577460|584323419|FG001|Overall Study|Other|3|||
161803313|NCT00577460|584323420|FG002|Overall Study|Other|2|||
161803314|NCT00162123|584323421|FG000|Overall Study|Disease progression|27|||
161803315|NCT00162123|584323422|FG001|Overall Study|Disease progression|19|||
161803316|NCT00162123|584323423|FG002|Overall Study|Disease progression|10|||
161803317|NCT00162123|584323424|FG003|Overall Study|Disease progression|4|||
161803318|NCT00162123|584323425|FG004|Overall Study|Disease progression|8|||
161803319|NCT00162123|584323426|FG005|Overall Study|Disease progression|3|||
161803320|NCT00162123|584323427|FG006|Overall Study|Disease progression|1|||
161803321|NCT00162123|584323428|FG007|Overall Study|Disease progression|0|||
161803322|NCT00162123|584323421|FG000|Overall Study|Study drug toxicity|6|||
161803323|NCT00162123|584323422|FG001|Overall Study|Study drug toxicity|1|||
161803324|NCT00162123|584323423|FG002|Overall Study|Study drug toxicity|5|||
161803325|NCT00162123|584323424|FG003|Overall Study|Study drug toxicity|0|||
161803326|NCT00162123|584323425|FG004|Overall Study|Study drug toxicity|4|||
161803327|NCT00162123|584323426|FG005|Overall Study|Study drug toxicity|1|||
161803328|NCT00162123|584323427|FG006|Overall Study|Study drug toxicity|1|||
161803329|NCT00162123|584323428|FG007|Overall Study|Study drug toxicity|0|||
161803330|NCT00162123|584323421|FG000|Overall Study|Death|3|||
161803331|NCT00162123|584323422|FG001|Overall Study|Death|3|||
161803332|NCT00162123|584323423|FG002|Overall Study|Death|1|||
161803333|NCT00162123|584323424|FG003|Overall Study|Death|1|||
162140119|NCT04310579|585565544|FG006|Overall Study|Adverse Event|2|||
161803334|NCT00162123|584323425|FG004|Overall Study|Death|1|||
161803335|NCT00162123|584323426|FG005|Overall Study|Death|1|||
162140120|NCT04310579|585565545|FG007|Overall Study|Adverse Event|0|||
162140121|NCT04310579|585565546|FG008|Overall Study|Adverse Event|1|||
162140122|NCT04310579|585565547|FG009|Overall Study|Adverse Event|1|||
162140123|NCT04310579|585565548|FG010|Overall Study|Adverse Event|0|||
162140124|NCT04310579|585565538|FG000|Overall Study|Withdrawal by Subject|0|||
162140125|NCT04310579|585565539|FG001|Overall Study|Withdrawal by Subject|0|||
162140126|NCT04310579|585565540|FG002|Overall Study|Withdrawal by Subject|0|||
162140127|NCT04310579|585565541|FG003|Overall Study|Withdrawal by Subject|0|||
162140128|NCT04310579|585565542|FG004|Overall Study|Withdrawal by Subject|0|||
162140129|NCT04310579|585565543|FG005|Overall Study|Withdrawal by Subject|1|||
161906373|NCT01655901|584708731|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
162140130|NCT04310579|585565544|FG006|Overall Study|Withdrawal by Subject|0|||
161906374|NCT01655901|584708732|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
161803336|NCT00162123|584323427|FG006|Overall Study|Death|0|||
161906375|NCT01655901|584708733|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
161906376|NCT01655901|584708734|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
161906377|NCT01655901|584708735|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
161906378|NCT01655901|584708736|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
161906379|NCT00352118|584708737|FG000|Overall Study|Physician Decision|4|||
161906380|NCT02997163|584708738|FG000|Overall Study|Adverse Event|1|||
161906381|NCT02997163|584708739|FG001|Overall Study|Adverse Event|0|||
161906382|NCT02997163|584708740|FG002|Overall Study|Adverse Event|0|||
161906383|NCT02997163|584708741|FG003|Overall Study|Adverse Event|1|||
161906384|NCT00557466|584708745|FG000|Overall Study|Adverse Event|3|||
161906385|NCT00557466|584708746|FG001|Overall Study|Adverse Event|1|||
161906386|NCT00557466|584708747|FG002|Overall Study|Adverse Event|4|||
161906387|NCT00557466|584708748|FG003|Overall Study|Adverse Event|1|||
161906388|NCT00557466|584708749|FG004|Overall Study|Adverse Event|2|||
161906389|NCT00557466|584708750|FG005|Overall Study|Adverse Event|4|||
161906390|NCT00557466|584708745|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162140131|NCT04310579|585565545|FG007|Overall Study|Withdrawal by Subject|0|||
162140132|NCT04310579|585565546|FG008|Overall Study|Withdrawal by Subject|0|||
162140133|NCT04310579|585565547|FG009|Overall Study|Withdrawal by Subject|0|||
162140134|NCT04310579|585565548|FG010|Overall Study|Withdrawal by Subject|0|||
162140135|NCT04310579|585565538|FG000|Overall Study|Positive COVID-19 test|0|||
162140136|NCT04310579|585565539|FG001|Overall Study|Positive COVID-19 test|0|||
162140137|NCT04310579|585565540|FG002|Overall Study|Positive COVID-19 test|0|||
162140138|NCT04310579|585565541|FG003|Overall Study|Positive COVID-19 test|0|||
162140139|NCT04310579|585565542|FG004|Overall Study|Positive COVID-19 test|0|||
162140140|NCT04310579|585565543|FG005|Overall Study|Positive COVID-19 test|0|||
162140141|NCT04310579|585565544|FG006|Overall Study|Positive COVID-19 test|0|||
162140142|NCT04310579|585565545|FG007|Overall Study|Positive COVID-19 test|0|||
162140143|NCT04310579|585565546|FG008|Overall Study|Positive COVID-19 test|0|||
162140144|NCT04310579|585565547|FG009|Overall Study|Positive COVID-19 test|0|||
162140145|NCT04310579|585565548|FG010|Overall Study|Positive COVID-19 test|1|||
162140146|NCT04083976|585565549|FG000|Overall Study|Lost to Follow-up|3|||
162140147|NCT04083976|585565550|FG001|Overall Study|Lost to Follow-up|0|||
162140148|NCT04083976|585565551|FG002|Overall Study|Lost to Follow-up|0|||
162140149|NCT04083976|585565552|FG003|Overall Study|Lost to Follow-up|1|||
162140150|NCT04083976|585565549|FG000|Overall Study|Withdrawal by Subject|16|||
162140151|NCT04083976|585565550|FG001|Overall Study|Withdrawal by Subject|1|||
162140152|NCT04083976|585565551|FG002|Overall Study|Withdrawal by Subject|9|||
162140153|NCT04083976|585565552|FG003|Overall Study|Withdrawal by Subject|0|||
162140154|NCT04083976|585565549|FG000|Overall Study|Sponsor Decision|14|||
162140155|NCT04083976|585565550|FG001|Overall Study|Sponsor Decision|0|||
162140156|NCT04083976|585565551|FG002|Overall Study|Sponsor Decision|0|||
162140157|NCT04083976|585565552|FG003|Overall Study|Sponsor Decision|7|||
162140158|NCT04083976|585565549|FG000|Overall Study|Other|1|||
162140159|NCT04083976|585565550|FG001|Overall Study|Other|0|||
162140160|NCT04083976|585565551|FG002|Overall Study|Other|1|||
162140161|NCT04083976|585565552|FG003|Overall Study|Other|0|||
162140162|NCT00943605|585565553|FG000|Overall Study|Study termination|30|||
162140163|NCT00943605|585565554|FG001|Overall Study|Study termination|30|||
162140164|NCT02232178|585565556|FG000|Overall Study|Lost to Follow-up|0|||
162140165|NCT02232178|585565557|FG001|Overall Study|Lost to Follow-up|1|||
162140166|NCT02232178|585565558|FG002|Overall Study|Lost to Follow-up|0|||
162140167|NCT02232178|585565556|FG000|Overall Study|ineligibility|0|||
162140168|NCT02232178|585565557|FG001|Overall Study|ineligibility|0|||
162140169|NCT02232178|585565558|FG002|Overall Study|ineligibility|1|||
162140170|NCT02232178|585565556|FG000|Overall Study|surgical complication|1|||
162140171|NCT02232178|585565557|FG001|Overall Study|surgical complication|0|||
162140172|NCT02232178|585565558|FG002|Overall Study|surgical complication|0|||
162140173|NCT01956669|585565561|FG000|Overall Study|Disease Progression|12|||
162140174|NCT01956669|585565562|FG001|Overall Study|Disease Progression|7|||
161906391|NCT00557466|584708746|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161906392|NCT00557466|584708747|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161906393|NCT00557466|584708748|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161906394|NCT00557466|584708749|FG004|Overall Study|Abnormal laboratory value(s)|0|||
161906395|NCT00557466|584708750|FG005|Overall Study|Abnormal laboratory value(s)|0|||
161906396|NCT00557466|584708745|FG000|Overall Study|Protocol deviation|0|||
161906397|NCT00557466|584708746|FG001|Overall Study|Protocol deviation|1|||
162140175|NCT01956669|585565563|FG002|Overall Study|Disease Progression|7|||
162140176|NCT01956669|585565564|FG003|Overall Study|Disease Progression|8|||
162140177|NCT01956669|585565565|FG004|Overall Study|Disease Progression|4|||
162140178|NCT01956669|585565566|FG005|Overall Study|Disease Progression|3|||
162140179|NCT01956669|585565567|FG006|Overall Study|Disease Progression|5|||
162140180|NCT01956669|585565561|FG000|Overall Study|Adverse Event|0|||
162140181|NCT01956669|585565562|FG001|Overall Study|Adverse Event|2|||
162140182|NCT01956669|585565563|FG002|Overall Study|Adverse Event|2|||
161803337|NCT00162123|584323428|FG007|Overall Study|Death|0|||
161803338|NCT00162123|584323421|FG000|Overall Study|Withdrawal by Subject|2|||
161803339|NCT00162123|584323422|FG001|Overall Study|Withdrawal by Subject|0|||
161803340|NCT00162123|584323423|FG002|Overall Study|Withdrawal by Subject|2|||
161803341|NCT00162123|584323424|FG003|Overall Study|Withdrawal by Subject|1|||
161803342|NCT00162123|584323425|FG004|Overall Study|Withdrawal by Subject|1|||
161803343|NCT00162123|584323426|FG005|Overall Study|Withdrawal by Subject|2|||
161803344|NCT00162123|584323427|FG006|Overall Study|Withdrawal by Subject|1|||
161803345|NCT00162123|584323428|FG007|Overall Study|Withdrawal by Subject|0|||
161803346|NCT00162123|584323421|FG000|Overall Study|Deterioration without progression|2|||
161803347|NCT00162123|584323422|FG001|Overall Study|Deterioration without progression|2|||
161803348|NCT00162123|584323423|FG002|Overall Study|Deterioration without progression|3|||
161803349|NCT00162123|584323424|FG003|Overall Study|Deterioration without progression|0|||
161803350|NCT00162123|584323425|FG004|Overall Study|Deterioration without progression|1|||
161803351|NCT00162123|584323426|FG005|Overall Study|Deterioration without progression|0|||
161803352|NCT00162123|584323427|FG006|Overall Study|Deterioration without progression|0|||
161803353|NCT00162123|584323428|FG007|Overall Study|Deterioration without progression|0|||
161803354|NCT00162123|584323421|FG000|Overall Study|Adverse Event|1|||
161803355|NCT00162123|584323422|FG001|Overall Study|Adverse Event|2|||
161803356|NCT00162123|584323423|FG002|Overall Study|Adverse Event|0|||
161803357|NCT00162123|584323424|FG003|Overall Study|Adverse Event|2|||
161803358|NCT00162123|584323425|FG004|Overall Study|Adverse Event|1|||
161803359|NCT00162123|584323426|FG005|Overall Study|Adverse Event|0|||
161803360|NCT00162123|584323427|FG006|Overall Study|Adverse Event|0|||
161803361|NCT00162123|584323428|FG007|Overall Study|Adverse Event|0|||
161803362|NCT00162123|584323421|FG000|Overall Study|Not specified (before treatment)|2|||
161803363|NCT00162123|584323422|FG001|Overall Study|Not specified (before treatment)|0|||
161803364|NCT00162123|584323423|FG002|Overall Study|Not specified (before treatment)|0|||
161803365|NCT00162123|584323424|FG003|Overall Study|Not specified (before treatment)|0|||
161803366|NCT00162123|584323425|FG004|Overall Study|Not specified (before treatment)|12|||
161803367|NCT00162123|584323426|FG005|Overall Study|Not specified (before treatment)|1|||
161803368|NCT00162123|584323427|FG006|Overall Study|Not specified (before treatment)|0|||
161803369|NCT00162123|584323428|FG007|Overall Study|Not specified (before treatment)|0|||
161803370|NCT00162123|584323421|FG000|Overall Study|Not specified (after start of treatment)|0|||
161803371|NCT00162123|584323422|FG001|Overall Study|Not specified (after start of treatment)|0|||
161803372|NCT00162123|584323423|FG002|Overall Study|Not specified (after start of treatment)|0|||
161803373|NCT00162123|584323424|FG003|Overall Study|Not specified (after start of treatment)|0|||
161803374|NCT00162123|584323425|FG004|Overall Study|Not specified (after start of treatment)|3|||
161803375|NCT00162123|584323426|FG005|Overall Study|Not specified (after start of treatment)|0|||
161803376|NCT00162123|584323427|FG006|Overall Study|Not specified (after start of treatment)|0|||
161803377|NCT00162123|584323428|FG007|Overall Study|Not specified (after start of treatment)|0|||
161803378|NCT00162123|584323421|FG000|Overall Study|Physician Decision|1|||
161803379|NCT00162123|584323422|FG001|Overall Study|Physician Decision|2|||
161803380|NCT00162123|584323423|FG002|Overall Study|Physician Decision|0|||
161803381|NCT00162123|584323424|FG003|Overall Study|Physician Decision|0|||
161803382|NCT00162123|584323425|FG004|Overall Study|Physician Decision|0|||
161803383|NCT00162123|584323426|FG005|Overall Study|Physician Decision|1|||
161803384|NCT00162123|584323427|FG006|Overall Study|Physician Decision|1|||
161803385|NCT00162123|584323428|FG007|Overall Study|Physician Decision|0|||
161803386|NCT00162123|584323421|FG000|Overall Study|Tumor assessment only (not treated)|0|||
161803387|NCT00162123|584323422|FG001|Overall Study|Tumor assessment only (not treated)|0|||
161803388|NCT00162123|584323423|FG002|Overall Study|Tumor assessment only (not treated)|0|||
161803389|NCT00162123|584323424|FG003|Overall Study|Tumor assessment only (not treated)|0|||
161803390|NCT00162123|584323425|FG004|Overall Study|Tumor assessment only (not treated)|0|||
161803391|NCT00162123|584323426|FG005|Overall Study|Tumor assessment only (not treated)|0|||
161803392|NCT00162123|584323427|FG006|Overall Study|Tumor assessment only (not treated)|0|||
161803393|NCT00162123|584323428|FG007|Overall Study|Tumor assessment only (not treated)|1|||
161803394|NCT00162123|584323421|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
161803395|NCT00162123|584323422|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
161803396|NCT00162123|584323423|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
161803397|NCT00162123|584323424|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
161803398|NCT00162123|584323425|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
161803399|NCT00162123|584323426|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
161803400|NCT00162123|584323427|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
161803401|NCT00162123|584323428|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
161803402|NCT02016170|584323429|FG000|Overall Study|Adverse Event|1|||
161803403|NCT02016170|584323430|FG001|Overall Study|Adverse Event|1|||
161803404|NCT02016170|584323431|FG002|Overall Study|Adverse Event|0|||
161803405|NCT02016170|584323429|FG000|Overall Study|Protocol Violation|1|||
161803406|NCT02016170|584323430|FG001|Overall Study|Protocol Violation|0|||
161803407|NCT02016170|584323431|FG002|Overall Study|Protocol Violation|0|||
161803408|NCT05214560|584323436|FG000|Overall Study|Screening Failure|1|||
161803409|NCT05214560|584323436|FG000|Overall Study|Physician Decision|4|||
161803410|NCT05214560|584323436|FG000|Overall Study|Withdrawal by Subject|1|||
161803411|NCT05214560|584323436|FG000|Overall Study|Lost to Follow-up|2|||
161803412|NCT05214560|584323436|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
161803413|NCT05214560|584323436|FG000|Overall Study|Study physician not available for the anesthesia|3|||
161803414|NCT05214560|584323436|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
161803415|NCT05214560|584323436|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
161803416|NCT05214560|584323436|FG000|Overall Study|Surgery not performed|3|||
161803417|NCT00408902|584323440|FG000|Overall Study|Lack of Efficacy|7|||
161803418|NCT00408902|584323440|FG000|Overall Study|Adverse Event|3|||
161803419|NCT00878995|584323441|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
161803420|NCT00878995|584323442|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
161803421|NCT03629249|584323443|FG000|Overall Study|Study terminated by sponsor|197|||
161803422|NCT03629249|584323444|FG001|Overall Study|Study terminated by sponsor|197|||
161803423|NCT03629249|584323445|FG002|Overall Study|Study terminated by sponsor|194|||
161803424|NCT03629249|584323443|FG000|Overall Study|Protocol deviation|0|||
161803425|NCT03629249|584323444|FG001|Overall Study|Protocol deviation|2|||
161803426|NCT03629249|584323445|FG002|Overall Study|Protocol deviation|5|||
161803427|NCT03629249|584323443|FG000|Overall Study|Subject decision|1|||
161803428|NCT03629249|584323444|FG001|Overall Study|Subject decision|1|||
161803429|NCT03629249|584323445|FG002|Overall Study|Subject decision|3|||
161803430|NCT03629249|584323443|FG000|Overall Study|Adverse Event|1|||
161803431|NCT03629249|584323444|FG001|Overall Study|Adverse Event|1|||
161803432|NCT03629249|584323445|FG002|Overall Study|Adverse Event|0|||
161803433|NCT03629249|584323443|FG000|Overall Study|Death|1|||
161803434|NCT03629249|584323444|FG001|Overall Study|Death|0|||
161803435|NCT03629249|584323445|FG002|Overall Study|Death|0|||
161803436|NCT03629249|584323443|FG000|Overall Study|Physician Decision|1|||
161803437|NCT03629249|584323444|FG001|Overall Study|Physician Decision|0|||
161803438|NCT03629249|584323445|FG002|Overall Study|Physician Decision|0|||
161803439|NCT00352690|584323446|FG000|Overall Study|Determined to be ineligible|2|||
161803440|NCT00352690|584323447|FG001|Overall Study|Determined to be ineligible|0|||
161803441|NCT03633721|584323450|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
161803442|NCT03633721|584323451|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
161803443|NCT03633721|584323452|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
161803444|NCT03633721|584323453|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
161803445|NCT01475474|584323457|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
161803446|NCT01475474|584323457|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
161803447|NCT02343120|584323458|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
161803448|NCT02343120|584323459|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
161803449|NCT02343120|584323460|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
161803450|NCT02343120|584323461|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
161803451|NCT02343120|584323462|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
161803452|NCT02343120|584323458|FG000|Part 1: Dose Escalation|Death|1|||
161803453|NCT02343120|584323459|FG001|Part 1: Dose Escalation|Death|2|||
161803454|NCT02343120|584323460|FG002|Part 1: Dose Escalation|Death|2|||
161803455|NCT02343120|584323461|FG003|Part 1: Dose Escalation|Death|2|||
161803456|NCT02343120|584323462|FG004|Part 1: Dose Escalation|Death|1|||
161803457|NCT02343120|584323458|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
161803458|NCT02343120|584323459|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
161803459|NCT02343120|584323460|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
161803460|NCT02343120|584323461|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
161803461|NCT02343120|584323462|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
161803462|NCT02343120|584323458|FG000|Part 2: Expansion|Sponsor decision|0|||
161803463|NCT02343120|584323459|FG001|Part 2: Expansion|Sponsor decision|0|||
161803464|NCT02343120|584323460|FG002|Part 2: Expansion|Sponsor decision|0|||
161803465|NCT02343120|584323461|FG003|Part 2: Expansion|Sponsor decision|165|||
161803466|NCT02343120|584323462|FG004|Part 2: Expansion|Sponsor decision|67|||
161803467|NCT02343120|584323458|FG000|Part 2: Expansion|Death|0|||
161803468|NCT02343120|584323459|FG001|Part 2: Expansion|Death|0|||
161803469|NCT02343120|584323460|FG002|Part 2: Expansion|Death|0|||
161803470|NCT02343120|584323461|FG003|Part 2: Expansion|Death|74|||
161803471|NCT02343120|584323462|FG004|Part 2: Expansion|Death|17|||
161803472|NCT02343120|584323458|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
161803473|NCT02343120|584323459|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
161803474|NCT02343120|584323460|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
161803475|NCT02343120|584323461|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
161803476|NCT02343120|584323462|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
161803477|NCT02343120|584323458|FG000|Part 2: Expansion|Lost to Follow-up|0|||
161803478|NCT02343120|584323459|FG001|Part 2: Expansion|Lost to Follow-up|0|||
161803479|NCT02343120|584323460|FG002|Part 2: Expansion|Lost to Follow-up|0|||
161803480|NCT02343120|584323461|FG003|Part 2: Expansion|Lost to Follow-up|5|||
161803481|NCT02343120|584323462|FG004|Part 2: Expansion|Lost to Follow-up|2|||
161803482|NCT02343120|584323458|FG000|Part 2: Expansion|Other|0|||
161803483|NCT02343120|584323459|FG001|Part 2: Expansion|Other|0|||
161803484|NCT02343120|584323460|FG002|Part 2: Expansion|Other|0|||
161803485|NCT02343120|584323461|FG003|Part 2: Expansion|Other|1|||
161906398|NCT00557466|584708747|FG002|Overall Study|Protocol deviation|0|||
161906399|NCT00557466|584708748|FG003|Overall Study|Protocol deviation|2|||
161906400|NCT00557466|584708749|FG004|Overall Study|Protocol deviation|0|||
161906401|NCT00557466|584708750|FG005|Overall Study|Protocol deviation|0|||
161906402|NCT00557466|584708745|FG000|Overall Study|Subject withdrew consent|0|||
161906403|NCT00557466|584708746|FG001|Overall Study|Subject withdrew consent|0|||
161906404|NCT00557466|584708747|FG002|Overall Study|Subject withdrew consent|0|||
161906405|NCT00557466|584708748|FG003|Overall Study|Subject withdrew consent|0|||
161906406|NCT00557466|584708749|FG004|Overall Study|Subject withdrew consent|1|||
161906407|NCT00557466|584708750|FG005|Overall Study|Subject withdrew consent|2|||
161906408|NCT00557466|584708745|FG000|Overall Study|Administrative problems|0|||
161906409|NCT00557466|584708746|FG001|Overall Study|Administrative problems|1|||
161906410|NCT00557466|584708747|FG002|Overall Study|Administrative problems|1|||
161906411|NCT00557466|584708748|FG003|Overall Study|Administrative problems|0|||
161906412|NCT00557466|584708749|FG004|Overall Study|Administrative problems|0|||
161906413|NCT00557466|584708750|FG005|Overall Study|Administrative problems|0|||
161906414|NCT00557466|584708745|FG000|Overall Study|Abnormal test procedure results|0|||
161906415|NCT00557466|584708746|FG001|Overall Study|Abnormal test procedure results|0|||
161906416|NCT00557466|584708747|FG002|Overall Study|Abnormal test procedure results|1|||
161906417|NCT00557466|584708748|FG003|Overall Study|Abnormal test procedure results|0|||
161906418|NCT00557466|584708749|FG004|Overall Study|Abnormal test procedure results|0|||
161906419|NCT00557466|584708750|FG005|Overall Study|Abnormal test procedure results|0|||
161906420|NCT00557466|584708745|FG000|Overall Study|Lost to Follow-up|0|||
161906421|NCT00557466|584708746|FG001|Overall Study|Lost to Follow-up|0|||
161906422|NCT00557466|584708747|FG002|Overall Study|Lost to Follow-up|0|||
161906423|NCT00557466|584708748|FG003|Overall Study|Lost to Follow-up|1|||
161906424|NCT00557466|584708749|FG004|Overall Study|Lost to Follow-up|0|||
161906425|NCT00557466|584708750|FG005|Overall Study|Lost to Follow-up|0|||
161906426|NCT01712516|584708751|FG000|Overall Study|Technical problems|0|||
161906427|NCT01712516|584708752|FG001|Overall Study|Technical problems|0|||
161906428|NCT01712516|584708753|FG002|Overall Study|Technical problems|0|||
161906429|NCT01712516|584708754|FG003|Overall Study|Technical problems|2|||
161906430|NCT01712516|584708751|FG000|Overall Study|Lost to Follow-up|0|||
161906431|NCT01712516|584708752|FG001|Overall Study|Lost to Follow-up|0|||
161906432|NCT01712516|584708753|FG002|Overall Study|Lost to Follow-up|2|||
161906433|NCT01712516|584708754|FG003|Overall Study|Lost to Follow-up|1|||
161906434|NCT01712516|584708751|FG000|Overall Study|Death|0|||
161906435|NCT01712516|584708752|FG001|Overall Study|Death|1|||
161906436|NCT01712516|584708753|FG002|Overall Study|Death|0|||
161906437|NCT01712516|584708754|FG003|Overall Study|Death|0|||
161906438|NCT01712516|584708751|FG000|Overall Study|Protocol deviation|1|||
161906439|NCT01712516|584708752|FG001|Overall Study|Protocol deviation|0|||
161906440|NCT01712516|584708753|FG002|Overall Study|Protocol deviation|1|||
161906441|NCT01712516|584708754|FG003|Overall Study|Protocol deviation|0|||
161906442|NCT01712516|584708751|FG000|Overall Study|Physician Decision|2|||
161906443|NCT01712516|584708752|FG001|Overall Study|Physician Decision|0|||
161906444|NCT01712516|584708753|FG002|Overall Study|Physician Decision|0|||
161906445|NCT01712516|584708754|FG003|Overall Study|Physician Decision|1|||
161906446|NCT01712516|584708751|FG000|Overall Study|Withdrawal by Subject|3|||
161906447|NCT01712516|584708752|FG001|Overall Study|Withdrawal by Subject|9|||
161906448|NCT01712516|584708753|FG002|Overall Study|Withdrawal by Subject|3|||
161906449|NCT01712516|584708754|FG003|Overall Study|Withdrawal by Subject|9|||
161906450|NCT01251952|584708759|FG000|Overall Study|Adverse Event|1|||
161906451|NCT00496769|584708760|FG000|Double Blind|>=1 reason assigned per patient|558|||
161803486|NCT02343120|584323462|FG004|Part 2: Expansion|Other|5|||
161803487|NCT02343120|584323458|FG000|Part 2: Expansion|Adverse Event|0|||
161803488|NCT02343120|584323459|FG001|Part 2: Expansion|Adverse Event|0|||
161803489|NCT02343120|584323460|FG002|Part 2: Expansion|Adverse Event|0|||
161803490|NCT02343120|584323461|FG003|Part 2: Expansion|Adverse Event|1|||
161803491|NCT02343120|584323462|FG004|Part 2: Expansion|Adverse Event|1|||
161803492|NCT02534493|584323468|FG000|Overall Study|Lost to Follow-up|1|||
161803493|NCT02534493|584323468|FG000|Overall Study|Withdrawal by Subject|1|||
161906452|NCT00496769|584708761|FG001|Double Blind|>=1 reason assigned per patient|649|||
161906453|NCT00496769|584708762|FG002|Double Blind|>=1 reason assigned per patient|0|||
161906454|NCT00496769|584708760|FG000|Open Label|>=1 reason assigned per patient|0|||
161906455|NCT00496769|584708761|FG001|Open Label|>=1 reason assigned per patient|0|||
161906456|NCT00496769|584708762|FG002|Open Label|>=1 reason assigned per patient|1011|||
161906457|NCT02308046|584708763|FG000|Overall Study|Negative yeast culture at Baseline|32|||
161906458|NCT02308046|584708764|FG001|Overall Study|Negative yeast culture at Baseline|33|||
161906459|NCT02308046|584708763|FG000|Overall Study|Positive for STD at Baseline|1|||
161906460|NCT02308046|584708764|FG001|Overall Study|Positive for STD at Baseline|2|||
161906461|NCT02308046|584708763|FG000|Overall Study|Lost to Follow-up|1|||
162140183|NCT01956669|585565564|FG003|Overall Study|Adverse Event|1|||
161803494|NCT02514174|584323470|FG000|Overall Study|Patient refused to continue medication|1|||
161803495|NCT02514174|584323470|FG000|Overall Study|Adverse Event|2|||
161803496|NCT02514174|584323470|FG000|Overall Study|Study closed by sponsor|9|||
161803497|NCT02514174|584323470|FG000|Overall Study|Progressive disease|11|||
161906462|NCT02308046|584708764|FG001|Overall Study|Lost to Follow-up|3|||
161906463|NCT02224625|584708770|FG000|Irritation|Adverse Event|6|||
161906464|NCT02224625|584708770|FG000|Sensitization|Adverse Event|55|||
161906465|NCT01181167|584708771|FG000|Overall Study|Adverse Event|11|||
161906466|NCT01181167|584708772|FG001|Overall Study|Adverse Event|21|||
161906467|NCT01181167|584708771|FG000|Overall Study|Lost to Follow-up|1|||
161906468|NCT01181167|584708772|FG001|Overall Study|Lost to Follow-up|0|||
161906469|NCT01181167|584708771|FG000|Overall Study|Physician Decision|2|||
161906470|NCT01181167|584708772|FG001|Overall Study|Physician Decision|3|||
161906471|NCT01181167|584708771|FG000|Overall Study|Protocol Violation|3|||
161906472|NCT01181167|584708772|FG001|Overall Study|Protocol Violation|0|||
161906473|NCT01181167|584708771|FG000|Overall Study|Withdrawal by Subject|6|||
161906474|NCT01181167|584708772|FG001|Overall Study|Withdrawal by Subject|8|||
161906475|NCT01573000|584708773|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
161906476|NCT01573000|584708774|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
161906477|NCT01573000|584708773|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
161906478|NCT01573000|584708774|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
161906479|NCT01573000|584708773|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
161906480|NCT01573000|584708774|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
161906481|NCT01573000|584708773|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
161906482|NCT01573000|584708774|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
161906483|NCT01573000|584708773|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
161906484|NCT01573000|584708774|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
161906485|NCT01573000|584708773|FG000|Crossover Phase|Lack of Efficacy|0|||
161906486|NCT01573000|584708774|FG001|Crossover Phase|Lack of Efficacy|13|||
161906487|NCT01573000|584708773|FG000|Crossover Phase|Lost to Follow-up|0|||
161906488|NCT01573000|584708774|FG001|Crossover Phase|Lost to Follow-up|2|||
161906489|NCT01573000|584708773|FG000|Crossover Phase|Death|0|||
161906490|NCT01573000|584708774|FG001|Crossover Phase|Death|3|||
161906491|NCT01573000|584708773|FG000|Long-Term Follow-Up|Death|3|||
161906492|NCT01573000|584708774|FG001|Long-Term Follow-Up|Death|0|||
161906493|NCT01573000|584708773|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
161906494|NCT01573000|584708774|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
161906495|NCT03342001|584708780|FG000|Overall Study|Adverse Event|1|||
161906496|NCT03342001|584708780|FG000|Overall Study|Lost to Follow-up|1|||
161906497|NCT01433159|584708781|FG000|Overall Study|Adverse Event|1|||
161906498|NCT01433159|584708782|FG001|Overall Study|Adverse Event|0|||
161906499|NCT01433159|584708781|FG000|Overall Study|Physician Decision|1|||
161906500|NCT01433159|584708782|FG001|Overall Study|Physician Decision|0|||
161906501|NCT01433159|584708781|FG000|Overall Study|Protocol Violation|0|||
161906502|NCT01433159|584708782|FG001|Overall Study|Protocol Violation|1|||
161906503|NCT01100853|584708783|FG000|Overall Study|Lost to Follow-up|11|||
161906504|NCT01100853|584708784|FG001|Overall Study|Lost to Follow-up|6|||
161906505|NCT01100853|584708783|FG000|Overall Study|Received <4 study injections|10|||
161906506|NCT01100853|584708784|FG001|Overall Study|Received <4 study injections|13|||
161906507|NCT01100853|584708783|FG000|Overall Study|Withdrawal by Subject|6|||
161906508|NCT01100853|584708784|FG001|Overall Study|Withdrawal by Subject|4|||
161803498|NCT02514174|584323470|FG000|Overall Study|Treatment change|1|||
161803499|NCT02514174|584323470|FG000|Overall Study|Treated off study with Afatinib.|1|||
161803500|NCT01691248|584323471|FG000|Overall Study|Protocol Violation|43|||
161803501|NCT01691248|584323472|FG001|Overall Study|Protocol Violation|27|||
161803502|NCT01691248|584323471|FG000|Overall Study|Adverse Event|24|||
161803503|NCT01691248|584323472|FG001|Overall Study|Adverse Event|22|||
161803504|NCT01691248|584323471|FG000|Overall Study|Withdrawal by Subject|20|||
161803505|NCT01691248|584323472|FG001|Overall Study|Withdrawal by Subject|18|||
161803506|NCT01691248|584323471|FG000|Overall Study|Confirmed CDAD|14|||
161803507|NCT01691248|584323472|FG001|Overall Study|Confirmed CDAD|31|||
161803508|NCT01691248|584323471|FG000|Overall Study|Lost to Follow-up|2|||
161803509|NCT01691248|584323472|FG001|Overall Study|Lost to Follow-up|5|||
161803510|NCT01691248|584323471|FG000|Overall Study|Reason not provided|4|||
161803511|NCT01691248|584323472|FG001|Overall Study|Reason not provided|4|||
161803512|NCT01691248|584323471|FG000|Overall Study|Not Treated|4|||
161803513|NCT01691248|584323472|FG001|Overall Study|Not Treated|7|||
161803514|NCT02817841|584325095|FG000|Overall Study|Lost to Follow-up|287|||
161803515|NCT02817841|584325095|FG000|Overall Study|Withdrawal by Subject|183|||
161803516|NCT02817841|584325095|FG000|Overall Study|Adverse event not related to bleeding|131|||
161803517|NCT02817841|584325095|FG000|Overall Study|Adverse event related to bleeding|51|||
161803518|NCT02817841|584325095|FG000|Overall Study|Pregnancy|32|||
161906509|NCT01384877|584708785|FG000|Treatment 2|Lost to Follow-up|2|||
161906510|NCT01384877|584708786|FG001|Treatment 2|Lost to Follow-up|2|||
161906511|NCT01930539|584708799|FG000|Overall Study|Withdrawal by Subject|2|||
161906512|NCT01930539|584708800|FG001|Overall Study|Withdrawal by Subject|2|||
161906513|NCT01548404|584708801|FG000|Overall Study|Adverse Event|3|||
161906514|NCT01548404|584708802|FG001|Overall Study|Adverse Event|1|||
161803519|NCT02817841|584325095|FG000|Overall Study|Pregnancy wish|17|||
161803520|NCT02817841|584325095|FG000|Overall Study|Other reasons|53|||
161803521|NCT02817841|584325095|FG000|Overall Study|Protocol Violation|94|||
161906515|NCT01548404|584708801|FG000|Overall Study|Physician Decision|2|||
161906516|NCT01548404|584708802|FG001|Overall Study|Physician Decision|1|||
161906517|NCT01548404|584708801|FG000|Overall Study|Inadequate response to study treatment|23|||
161906518|NCT01548404|584708802|FG001|Overall Study|Inadequate response to study treatment|7|||
161906519|NCT01548404|584708801|FG000|Overall Study|Lost to Follow-up|2|||
161906520|NCT01548404|584708802|FG001|Overall Study|Lost to Follow-up|0|||
161906521|NCT01548404|584708801|FG000|Overall Study|Withdrawal by Subject|0|||
161906522|NCT01548404|584708802|FG001|Overall Study|Withdrawal by Subject|3|||
161906523|NCT01548404|584708801|FG000|Overall Study|Other than specified above|0|||
161906524|NCT01548404|584708802|FG001|Overall Study|Other than specified above|2|||
161906525|NCT00883181|584708803|FG000|Overall Study|Hematological Adverse Event|26|||
161906526|NCT00883181|584708803|FG000|Overall Study|Non-hematological Adverse Event|55|||
161906527|NCT00883181|584708803|FG000|Overall Study|Disease Progression|94|||
161906528|NCT00883181|584708803|FG000|Overall Study|Administrative Reason|24|||
161906529|NCT00883181|584708803|FG000|Overall Study|Withdrawal by Subject|4|||
161906530|NCT00883181|584708803|FG000|Overall Study|Death|31|||
161906531|NCT00883181|584708803|FG000|Overall Study|Other|38|||
161906532|NCT00883181|584708803|FG000|Overall Study|Protocol Deviation|3|||
161906533|NCT00883181|584708803|FG000|Overall Study|Noncompliance|3|||
161906534|NCT04040439|584708804|FG000|Overall Study|Invalid registration|11|||
161906535|NCT04040439|584708804|FG000|Overall Study|No IC* on publication of study results|2|||
161906536|NCT00426270|584708805|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
161906537|NCT00426270|584708805|FG000|Overall Study|Adverse Event|5|||
161906538|NCT01450813|584708806|FG000|Overall Study|Physician Decision|1|||
161906539|NCT01450813|584708807|FG001|Overall Study|Physician Decision|1|||
161906540|NCT01450813|584708808|FG002|Overall Study|Physician Decision|0|||
161906541|NCT01450813|584708809|FG003|Overall Study|Physician Decision|3|||
161906542|NCT02062437|584708812|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
161906543|NCT02062437|584708812|FG000|Overall Study|Patient not available for the 2y visit|18|||
161906544|NCT02062437|584708812|FG000|Overall Study|Death|2|||
161906545|NCT02062437|584708812|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
161906546|NCT00752089|584708813|FG000|Overall Study|Adverse Event|1|||
161906547|NCT00752089|584708813|FG000|Overall Study|Protocol Deviation|2|||
161906548|NCT00752089|584708813|FG000|Overall Study|Could not attend visit 9|1|||
161906549|NCT00752089|584708813|FG000|Overall Study|Not capable of wearing partial denture|1|||
161803522|NCT00705536|584325096|FG000|Start Period 1|Withdrawal by Subject|0|||
161803523|NCT00705536|584325097|FG001|Start Period 1|Withdrawal by Subject|0|||
161803524|NCT00705536|584325098|FG002|Start Period 1|Withdrawal by Subject|0|||
161803525|NCT00705536|584325099|FG003|Start Period 1|Withdrawal by Subject|1|||
161803526|NCT01746017|584325102|FG000|Period 1|Withdrawal by Subject|0|||
161803527|NCT01746017|584325103|FG001|Period 1|Withdrawal by Subject|0|||
161803528|NCT01746017|584325104|FG002|Period 1|Withdrawal by Subject|0|||
161803529|NCT01746017|584325105|FG003|Period 1|Withdrawal by Subject|0|||
161803530|NCT01746017|584325106|FG004|Period 1|Withdrawal by Subject|0|||
161803531|NCT01746017|584325107|FG005|Period 1|Withdrawal by Subject|0|||
161803532|NCT01746017|584325108|FG006|Period 1|Withdrawal by Subject|1|||
161803533|NCT01746017|584325109|FG007|Period 1|Withdrawal by Subject|0|||
161803534|NCT01746017|584325110|FG008|Period 1|Withdrawal by Subject|0|||
161803535|NCT01746017|584325111|FG009|Period 1|Withdrawal by Subject|0|||
161803536|NCT01746017|584325112|FG010|Period 1|Withdrawal by Subject|0|||
161803537|NCT01746017|584325102|FG000|Period 3|Withdrawal by Subject|0|||
161803538|NCT01746017|584325103|FG001|Period 3|Withdrawal by Subject|0|||
161803539|NCT01746017|584325104|FG002|Period 3|Withdrawal by Subject|0|||
161803540|NCT01746017|584325105|FG003|Period 3|Withdrawal by Subject|0|||
161803541|NCT01746017|584325106|FG004|Period 3|Withdrawal by Subject|0|||
161803542|NCT01746017|584325107|FG005|Period 3|Withdrawal by Subject|1|||
161803543|NCT01746017|584325108|FG006|Period 3|Withdrawal by Subject|0|||
161803544|NCT01746017|584325109|FG007|Period 3|Withdrawal by Subject|0|||
161803545|NCT01746017|584325110|FG008|Period 3|Withdrawal by Subject|0|||
161803546|NCT01746017|584325111|FG009|Period 3|Withdrawal by Subject|0|||
161803547|NCT01746017|584325112|FG010|Period 3|Withdrawal by Subject|0|||
161803548|NCT02424097|584325115|FG000|Overall Study|Lost to Follow-up|1|||
161803549|NCT02424097|584325116|FG001|Overall Study|Lost to Follow-up|2|||
161803550|NCT01675622|584325117|FG000|Overall Study|Withdrawal by Subject|2|||
161906550|NCT00752089|584708813|FG000|Overall Study|Cannot continue the study|1|||
161906551|NCT00960193|584708814|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
161906552|NCT01324102|584708815|FG000|Overall Study|illness|1|||
161906553|NCT01324102|584708816|FG001|Overall Study|illness|6|||
161906554|NCT00728494|584708819|FG000|Overall Study|Adverse Event|7|||
161803551|NCT01675622|584325118|FG001|Overall Study|Withdrawal by Subject|2|||
161803552|NCT01675622|584325117|FG000|Overall Study|Adverse Event|12|||
161803553|NCT01675622|584325118|FG001|Overall Study|Adverse Event|10|||
161803554|NCT01675622|584325117|FG000|Overall Study|Protocol Violation|4|||
161803555|NCT01675622|584325118|FG001|Overall Study|Protocol Violation|1|||
161803556|NCT01675622|584325117|FG000|Overall Study|Lack of Efficacy|2|||
161803557|NCT01675622|584325118|FG001|Overall Study|Lack of Efficacy|4|||
161803558|NCT01675622|584325117|FG000|Overall Study|Lost to Follow-up|1|||
161803559|NCT01675622|584325118|FG001|Overall Study|Lost to Follow-up|3|||
161906555|NCT00728494|584708820|FG001|Overall Study|Adverse Event|0|||
161906556|NCT00728494|584708819|FG000|Overall Study|Withdrawal by Subject|0|||
161906557|NCT00728494|584708820|FG001|Overall Study|Withdrawal by Subject|2|||
161906558|NCT00728494|584708819|FG000|Overall Study|Lack of Efficacy|2|||
161906559|NCT00728494|584708820|FG001|Overall Study|Lack of Efficacy|4|||
161906560|NCT00728494|584708819|FG000|Overall Study|No data available|0|||
161906561|NCT00728494|584708820|FG001|Overall Study|No data available|1|||
161906562|NCT00386334|584708821|FG000|Double Blind Period|Adverse Event|9|||
161906563|NCT00386334|584708822|FG001|Double Blind Period|Adverse Event|14|||
161906564|NCT00386334|584708821|FG000|Double Blind Period|Protocol Violation|1|||
161906565|NCT00386334|584708822|FG001|Double Blind Period|Protocol Violation|1|||
161906566|NCT00386334|584708821|FG000|Double Blind Period|Withdrawal by Subject|9|||
161906567|NCT00386334|584708822|FG001|Double Blind Period|Withdrawal by Subject|13|||
161906568|NCT00386334|584708821|FG000|Double Blind Period|Lack of Efficacy|20|||
161906569|NCT00386334|584708822|FG001|Double Blind Period|Lack of Efficacy|11|||
161906570|NCT00386334|584708821|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
161906571|NCT00386334|584708822|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
161906572|NCT00386334|584708821|FG000|Double Blind Period|Other|3|||
161906573|NCT00386334|584708822|FG001|Double Blind Period|Other|3|||
161906574|NCT00386334|584708821|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
161906575|NCT00386334|584708822|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
161906576|NCT03238417|584708823|FG000|Overall|non-response|955|||
161906577|NCT03238417|584708824|FG001|Overall|non-response|1920|||
161906578|NCT03238417|584708823|FG000|Overall|partial completion|48|||
161906579|NCT03238417|584708824|FG001|Overall|partial completion|68|||
161906580|NCT03238417|584708823|FG000|Baseline|Partial completion|17|||
161906581|NCT03238417|584708824|FG001|Baseline|Partial completion|48|||
161906582|NCT03238417|584708823|FG000|Baseline|non-response|372|||
161906583|NCT03238417|584708824|FG001|Baseline|non-response|669|||
161906584|NCT03238417|584708823|FG000|12-month|non-response|296|||
161906585|NCT03238417|584708824|FG001|12-month|non-response|669|||
161906586|NCT03238417|584708823|FG000|12-month|partial completion|23|||
161906587|NCT03238417|584708824|FG001|12-month|partial completion|37|||
161906588|NCT03238417|584708823|FG000|24-month|non-response|287|||
161906589|NCT03238417|584708824|FG001|24-month|non-response|594|||
161906590|NCT03238417|584708823|FG000|24-month|partial completion|8|||
161906591|NCT03238417|584708824|FG001|24-month|partial completion|31|||
161906592|NCT02089347|584708825|FG000|Overall Study|Protocol Violation|1|||
161906593|NCT02089347|584708826|FG001|Overall Study|Protocol Violation|0|||
161906594|NCT00975416|584708827|FG000|Overall Study|early discharge from tx|3|||
161906595|NCT00975416|584708828|FG001|Overall Study|early discharge from tx|5|||
161906596|NCT01249131|584708829|FG000|Washout Period of 10 Days|Adverse Event|0|||
161906597|NCT01249131|584708830|FG001|Washout Period of 10 Days|Adverse Event|0|||
161906598|NCT01249131|584708831|FG002|Washout Period of 10 Days|Adverse Event|0|||
161906599|NCT01249131|584708832|FG003|Washout Period of 10 Days|Adverse Event|0|||
161906600|NCT01249131|584708833|FG004|Washout Period of 10 Days|Adverse Event|1|||
161906601|NCT01249131|584708834|FG005|Washout Period of 10 Days|Adverse Event|0|||
161906602|NCT01225549|584708835|FG000|Period 4 - Washout|Disallowed medication|0|||
161906603|NCT01225549|584708836|FG001|Period 4 - Washout|Disallowed medication|1|||
161906604|NCT01225549|584708837|FG002|Period 4 - Washout|Disallowed medication|0|||
161906605|NCT01225549|584708838|FG003|Period 4 - Washout|Disallowed medication|0|||
161906606|NCT01225549|584708839|FG004|Period 4 - Washout|Disallowed medication|0|||
161906607|NCT01225549|584708840|FG005|Period 4 - Washout|Disallowed medication|0|||
161906608|NCT01225549|584708841|FG006|Period 4 - Washout|Disallowed medication|0|||
161906609|NCT01225549|584708842|FG007|Period 4 - Washout|Disallowed medication|0|||
161906610|NCT01225549|584708843|FG008|Period 4 - Washout|Disallowed medication|0|||
161906611|NCT01225549|584708844|FG009|Period 4 - Washout|Disallowed medication|0|||
161906612|NCT01225549|584708835|FG000|Period 6 - Washout|Disallowed medication|0|||
161906613|NCT01225549|584708836|FG001|Period 6 - Washout|Disallowed medication|0|||
161906614|NCT01225549|584708837|FG002|Period 6 - Washout|Disallowed medication|0|||
161906615|NCT01225549|584708838|FG003|Period 6 - Washout|Disallowed medication|1|||
161906616|NCT01225549|584708839|FG004|Period 6 - Washout|Disallowed medication|0|||
161906617|NCT01225549|584708840|FG005|Period 6 - Washout|Disallowed medication|0|||
161906618|NCT01225549|584708841|FG006|Period 6 - Washout|Disallowed medication|0|||
161906619|NCT01225549|584708842|FG007|Period 6 - Washout|Disallowed medication|0|||
161906620|NCT01225549|584708843|FG008|Period 6 - Washout|Disallowed medication|0|||
161906621|NCT01225549|584708844|FG009|Period 6 - Washout|Disallowed medication|0|||
161906622|NCT01184872|584708845|FG000|Overall Study|Adverse Event|3|||
161906623|NCT01184872|584708846|FG001|Overall Study|Adverse Event|4|||
161906624|NCT01184872|584708845|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
161906625|NCT01184872|584708846|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161906626|NCT01184872|584708845|FG000|Overall Study|Withdrawal by Subject|2|||
161906627|NCT01184872|584708846|FG001|Overall Study|Withdrawal by Subject|0|||
161906628|NCT01184872|584708845|FG000|Overall Study|Lost to Follow-up|0|||
161906629|NCT01184872|584708846|FG001|Overall Study|Lost to Follow-up|1|||
161906630|NCT01184872|584708845|FG000|Overall Study|Administrative problems|1|||
161906631|NCT01184872|584708846|FG001|Overall Study|Administrative problems|1|||
161803560|NCT01675622|584325117|FG000|Overall Study|Other|5|||
161803561|NCT01675622|584325118|FG001|Overall Study|Other|4|||
161803562|NCT04032977|584325119|FG000|Overall Study|Withdrawal by Subject|6|||
161803563|NCT04032977|584325120|FG001|Overall Study|Withdrawal by Subject|1|||
161803564|NCT04032977|584325119|FG000|Overall Study|Lost to Follow-up|2|||
161803565|NCT04032977|584325120|FG001|Overall Study|Lost to Follow-up|7|||
161803566|NCT04032977|584325119|FG000|Overall Study|Pregnancy|1|||
161803567|NCT04032977|584325120|FG001|Overall Study|Pregnancy|0|||
161803568|NCT01519661|584325122|FG000|Overall Study|Protocol deviation|6|||
161803569|NCT01519661|584325122|FG000|Overall Study|Lost to Follow-up|3|||
161803570|NCT01519661|584325122|FG000|Overall Study|Withdrawal by Subject|17|||
161803571|NCT01519661|584325122|FG000|Overall Study|Lack of Efficacy|6|||
161803572|NCT01519661|584325122|FG000|Overall Study|Adverse Event|29|||
161803573|NCT00840632|584325124|FG000|First Intervention|Withdrawal by Subject|0|||
161803574|NCT00840632|584325125|FG001|First Intervention|Withdrawal by Subject|1|||
161803575|NCT00840632|584325124|FG000|Washout|Withdrawal by Subject|1|||
161803576|NCT00840632|584325125|FG001|Washout|Withdrawal by Subject|1|||
161803577|NCT05017480|584325126|FG000|Stage 1 Study|Withdrawal by Subject|8|||
161803578|NCT05017480|584325127|FG001|Stage 1 Study|Withdrawal by Subject|6|||
161803579|NCT05017480|584325128|FG002|Stage 1 Study|Withdrawal by Subject|0|||
161803580|NCT05017480|584325129|FG003|Stage 1 Study|Withdrawal by Subject|0|||
161803581|NCT05017480|584325130|FG004|Stage 1 Study|Withdrawal by Subject|0|||
161803582|NCT05017480|584325126|FG000|Stage 1 Study|Adverse Event|1|||
161803583|NCT05017480|584325127|FG001|Stage 1 Study|Adverse Event|1|||
161803584|NCT05017480|584325128|FG002|Stage 1 Study|Adverse Event|0|||
161803585|NCT05017480|584325129|FG003|Stage 1 Study|Adverse Event|0|||
161803586|NCT05017480|584325130|FG004|Stage 1 Study|Adverse Event|0|||
161803587|NCT05017480|584325126|FG000|Stage 1 Study|Poor Compliance|1|||
161803588|NCT05017480|584325127|FG001|Stage 1 Study|Poor Compliance|1|||
161803589|NCT05017480|584325128|FG002|Stage 1 Study|Poor Compliance|0|||
161803590|NCT05017480|584325129|FG003|Stage 1 Study|Poor Compliance|0|||
161803591|NCT05017480|584325130|FG004|Stage 1 Study|Poor Compliance|0|||
161803592|NCT05017480|584325126|FG000|Stage 1 Study|Physician Decision|0|||
161803593|NCT05017480|584325127|FG001|Stage 1 Study|Physician Decision|1|||
161803594|NCT05017480|584325128|FG002|Stage 1 Study|Physician Decision|0|||
161803595|NCT05017480|584325129|FG003|Stage 1 Study|Physician Decision|0|||
161803596|NCT05017480|584325130|FG004|Stage 1 Study|Physician Decision|0|||
161803597|NCT05017480|584325126|FG000|Stage 2 Study|Withdrawal by Subject|0|||
161803598|NCT05017480|584325127|FG001|Stage 2 Study|Withdrawal by Subject|0|||
161803599|NCT05017480|584325128|FG002|Stage 2 Study|Withdrawal by Subject|6|||
161803600|NCT05017480|584325129|FG003|Stage 2 Study|Withdrawal by Subject|9|||
161803601|NCT05017480|584325130|FG004|Stage 2 Study|Withdrawal by Subject|11|||
161803602|NCT05017480|584325126|FG000|Stage 2 Study|Lost to Follow-up|0|||
161803603|NCT05017480|584325127|FG001|Stage 2 Study|Lost to Follow-up|0|||
161803604|NCT05017480|584325128|FG002|Stage 2 Study|Lost to Follow-up|0|||
161803605|NCT05017480|584325129|FG003|Stage 2 Study|Lost to Follow-up|2|||
161803606|NCT05017480|584325130|FG004|Stage 2 Study|Lost to Follow-up|1|||
161803607|NCT05017480|584325126|FG000|Stage 2 Study|Adverse Event|0|||
161803608|NCT05017480|584325127|FG001|Stage 2 Study|Adverse Event|0|||
161803609|NCT05017480|584325128|FG002|Stage 2 Study|Adverse Event|0|||
161803610|NCT05017480|584325129|FG003|Stage 2 Study|Adverse Event|1|||
161803611|NCT05017480|584325130|FG004|Stage 2 Study|Adverse Event|0|||
161803612|NCT05017480|584325126|FG000|Stage 2 Study|COVID-19|0|||
161803613|NCT05017480|584325127|FG001|Stage 2 Study|COVID-19|0|||
161803614|NCT05017480|584325128|FG002|Stage 2 Study|COVID-19|0|||
161803615|NCT05017480|584325129|FG003|Stage 2 Study|COVID-19|1|||
161803616|NCT05017480|584325130|FG004|Stage 2 Study|COVID-19|0|||
161803617|NCT05017480|584325126|FG000|Stage 2 Study|Pregnancy|0|||
161803618|NCT05017480|584325127|FG001|Stage 2 Study|Pregnancy|0|||
161803619|NCT05017480|584325128|FG002|Stage 2 Study|Pregnancy|0|||
161803620|NCT05017480|584325129|FG003|Stage 2 Study|Pregnancy|0|||
161803621|NCT05017480|584325130|FG004|Stage 2 Study|Pregnancy|1|||
161803622|NCT02311361|584325131|FG000|Overall Study|Did not receive treatment|0|||
161803623|NCT02311361|584325132|FG001|Overall Study|Did not receive treatment|1|||
161803624|NCT02311361|584325133|FG002|Overall Study|Did not receive treatment|0|||
161803625|NCT02311361|584325134|FG003|Overall Study|Did not receive treatment|1|||
161803626|NCT05628675|584325139|FG000|Overall Study|Lost to Follow-up|2|||
161803627|NCT05628675|584325139|FG000|Overall Study|Withdrawal by Subject|1|||
161803628|NCT00633594|584325142|FG000|Overall Study|Adverse Event|0|||
161803629|NCT00633594|584325143|FG001|Overall Study|Adverse Event|4|||
161803630|NCT00633594|584325144|FG002|Overall Study|Adverse Event|7|||
161803631|NCT00633594|584325142|FG000|Overall Study|Death|0|||
161803632|NCT00633594|584325143|FG001|Overall Study|Death|1|||
161803633|NCT00633594|584325144|FG002|Overall Study|Death|2|||
161803634|NCT00633594|584325142|FG000|Overall Study|Disease Progression|0|||
161803635|NCT00633594|584325143|FG001|Overall Study|Disease Progression|0|||
161803636|NCT00633594|584325144|FG002|Overall Study|Disease Progression|1|||
161803637|NCT02028715|584325145|FG000|Overall Study|Adverse Event|2|||
161803638|NCT02028715|584325146|FG001|Overall Study|Adverse Event|2|||
161803639|NCT02028715|584325145|FG000|Overall Study|Physician Decision|1|||
161906632|NCT01184872|584708845|FG000|Overall Study|Protocol deviation|1|||
161906633|NCT01184872|584708846|FG001|Overall Study|Protocol deviation|0|||
161906634|NCT03426345|584708847|FG000|Overall Study|Adverse Event|4|||
161906635|NCT03426345|584708848|FG001|Overall Study|Adverse Event|4|||
161906636|NCT03426345|584708847|FG000|Overall Study|Lack of Efficacy|1|||
161906637|NCT03426345|584708848|FG001|Overall Study|Lack of Efficacy|0|||
161906638|NCT03426345|584708847|FG000|Overall Study|Withdrawal by Subject|5|||
161906639|NCT03426345|584708848|FG001|Overall Study|Withdrawal by Subject|6|||
161906640|NCT03426345|584708847|FG000|Overall Study|Lost to Follow-up|3|||
161906641|NCT03426345|584708848|FG001|Overall Study|Lost to Follow-up|1|||
161906642|NCT03426345|584708847|FG000|Overall Study|Protocol Deviation|3|||
161906643|NCT03426345|584708848|FG001|Overall Study|Protocol Deviation|4|||
161906644|NCT03426345|584708847|FG000|Overall Study|Reason Not Specified|1|||
161906645|NCT03426345|584708848|FG001|Overall Study|Reason Not Specified|2|||
161906646|NCT03426345|584708847|FG000|Overall Study|Missing Completion Status|1|||
161906647|NCT03426345|584708848|FG001|Overall Study|Missing Completion Status|0|||
161906648|NCT00192114|584708855|FG000|Overall Study|Objective Tumor Progression|19|||
161906649|NCT00192114|584708855|FG000|Overall Study|Adverse Event|2|||
161906650|NCT00192114|584708855|FG000|Overall Study|Clinical Progression|2|||
161906651|NCT00192114|584708855|FG000|Overall Study|Death|1|||
161906652|NCT00492297|584708856|FG000|Treatment|Death|2|||
161906653|NCT00492297|584708856|FG000|Treatment|Study terminated by sponsor|3|||
161906654|NCT00492297|584708856|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
161906655|NCT00492297|584708856|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
161906656|NCT00492297|584708856|FG000|Survival Only Follow-up|Death|46|||
161906657|NCT00492297|584708856|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
161906658|NCT00492297|584708856|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
161906659|NCT01900444|584708866|FG000|Overall Study|Protocol Violation|2|||
161906660|NCT01900444|584708866|FG000|Overall Study|Lost to Follow-up|1|||
161906661|NCT00072384|584708867|FG000|Overall Study|Physician Decision|1|||
161906662|NCT00072384|584708867|FG000|Overall Study|Ineligible|8|||
161906663|NCT01825200|584708868|FG000|Overall Study|Lost to Follow-up|5|||
161906664|NCT01825200|584708869|FG001|Overall Study|Lost to Follow-up|6|||
161906665|NCT01825200|584708868|FG000|Overall Study|Withdrawal by Subject|0|||
161906666|NCT01825200|584708869|FG001|Overall Study|Withdrawal by Subject|1|||
161906667|NCT04219189|584708871|FG000|Overall Study|Withdrawal by Subject|1|||
161906668|NCT04219189|584708872|FG001|Overall Study|Withdrawal by Subject|2|||
161906669|NCT04219189|584708871|FG000|Overall Study|Protocol Violation|0|||
161906670|NCT04219189|584708872|FG001|Overall Study|Protocol Violation|1|||
161906671|NCT04219189|584708871|FG000|Overall Study|Lost to Follow-up|0|||
161906672|NCT04219189|584708872|FG001|Overall Study|Lost to Follow-up|1|||
161906673|NCT04219189|584708871|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
161906674|NCT04219189|584708872|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
161906675|NCT06058390|584708873|FG000|Overall Study|Lost to Follow-up|0|||
161906676|NCT06058390|584708874|FG001|Overall Study|Lost to Follow-up|0|||
161906677|NCT06058390|584708875|FG002|Overall Study|Lost to Follow-up|2|||
161906678|NCT06058390|584708876|FG003|Overall Study|Lost to Follow-up|1|||
161906679|NCT06058390|584708873|FG000|Overall Study|Physician Decision|0|||
161906680|NCT06058390|584708874|FG001|Overall Study|Physician Decision|0|||
161906681|NCT06058390|584708875|FG002|Overall Study|Physician Decision|0|||
161906682|NCT06058390|584708876|FG003|Overall Study|Physician Decision|1|||
161906683|NCT06058390|584708873|FG000|Overall Study|Participants did not receive any study intervention|0|||
161906684|NCT06058390|584708874|FG001|Overall Study|Participants did not receive any study intervention|0|||
161906685|NCT06058390|584708875|FG002|Overall Study|Participants did not receive any study intervention|0|||
161906686|NCT06058390|584708876|FG003|Overall Study|Participants did not receive any study intervention|1|||
161906687|NCT03585270|584708877|FG000|Overall Study|Withdrawal by Subject|2|||
161906688|NCT03585270|584708878|FG001|Overall Study|Withdrawal by Subject|6|||
161906689|NCT03585270|584708877|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
161906690|NCT03585270|584708878|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
161906691|NCT03585270|584708877|FG000|Overall Study|Adverse Event|5|||
161906692|NCT03585270|584708878|FG001|Overall Study|Adverse Event|2|||
161906693|NCT03585270|584708877|FG000|Overall Study|Lost to Follow-up|1|||
161906694|NCT03585270|584708878|FG001|Overall Study|Lost to Follow-up|4|||
161906695|NCT03585270|584708877|FG000|Overall Study|Death|5|||
161906696|NCT03585270|584708878|FG001|Overall Study|Death|3|||
161906697|NCT03585270|584708877|FG000|Overall Study|Other reasons|2|||
161906698|NCT03585270|584708878|FG001|Overall Study|Other reasons|2|||
161906699|NCT03292016|584708879|FG000|Second Washout|Adverse Event|0|||
161906700|NCT03292016|584708880|FG001|Second Washout|Adverse Event|1|||
161906701|NCT03292016|584708881|FG002|Second Washout|Adverse Event|0|||
161906702|NCT03292016|584708882|FG003|Second Washout|Adverse Event|0|||
161906703|NCT03292016|584708883|FG004|Second Washout|Adverse Event|0|||
161906704|NCT03292016|584708884|FG005|Second Washout|Adverse Event|0|||
161906705|NCT03904693|584708885|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161906706|NCT03904693|584708886|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
162140184|NCT01956669|585565565|FG004|Overall Study|Adverse Event|0|||
162140185|NCT01956669|585565566|FG005|Overall Study|Adverse Event|0|||
162140186|NCT01956669|585565567|FG006|Overall Study|Adverse Event|0|||
162140187|NCT01956669|585565561|FG000|Overall Study|Physician Decision|0|||
162140188|NCT01956669|585565562|FG001|Overall Study|Physician Decision|2|||
162140189|NCT01956669|585565563|FG002|Overall Study|Physician Decision|0|||
161803640|NCT02028715|584325146|FG001|Overall Study|Physician Decision|0|||
161803641|NCT02028715|584325145|FG000|Overall Study|Did not complete satisfaction surveys|2|||
161803642|NCT02028715|584325146|FG001|Overall Study|Did not complete satisfaction surveys|2|||
161803643|NCT01492361|584325147|FG000|Overall Study|Withdrawal by Subject|281|||
161803644|NCT01492361|584325148|FG001|Overall Study|Withdrawal by Subject|297|||
161803645|NCT01492361|584325147|FG000|Overall Study|Physician Decision|12|||
161803646|NCT01492361|584325148|FG001|Overall Study|Physician Decision|12|||
161803647|NCT01492361|584325147|FG000|Overall Study|Lost to Follow-up|6|||
161803648|NCT01492361|584325148|FG001|Overall Study|Lost to Follow-up|13|||
161803649|NCT01492361|584325147|FG000|Overall Study|Other than specified above|106|||
161803650|NCT01492361|584325148|FG001|Overall Study|Other than specified above|138|||
161803651|NCT01315249|584325154|FG000|Overall Study|Adverse Event|22|||
161803652|NCT01315249|584325155|FG001|Overall Study|Adverse Event|26|||
161803653|NCT01315249|584325154|FG000|Overall Study|Withdrawal by Subject|11|||
161803654|NCT01315249|584325155|FG001|Overall Study|Withdrawal by Subject|10|||
161803655|NCT01315249|584325154|FG000|Overall Study|Protocol Violation|8|||
161803656|NCT01315249|584325155|FG001|Overall Study|Protocol Violation|5|||
161803657|NCT01315249|584325154|FG000|Overall Study|Abnormal test results|1|||
161803658|NCT01315249|584325155|FG001|Overall Study|Abnormal test results|2|||
161803659|NCT01315249|584325154|FG000|Overall Study|Administrative problems|1|||
161803660|NCT01315249|584325155|FG001|Overall Study|Administrative problems|0|||
161803661|NCT01315249|584325154|FG000|Overall Study|inability to use device|1|||
161803662|NCT01315249|584325155|FG001|Overall Study|inability to use device|0|||
161803663|NCT01315249|584325154|FG000|Overall Study|Lack of Efficacy|0|||
161803664|NCT01315249|584325155|FG001|Overall Study|Lack of Efficacy|1|||
161803665|NCT01315249|584325154|FG000|Overall Study|Lost to Follow-up|0|||
161803666|NCT01315249|584325155|FG001|Overall Study|Lost to Follow-up|2|||
161803667|NCT01315249|584325154|FG000|Overall Study|Death|0|||
161803668|NCT01315249|584325155|FG001|Overall Study|Death|1|||
161803669|NCT03655106|584325156|FG000|Overall Study|Withdrawal by Subject|3|||
161803670|NCT03655106|584325157|FG001|Overall Study|Withdrawal by Subject|2|||
161803671|NCT03655106|584325156|FG000|Overall Study|Lost to Follow-up|2|||
161803672|NCT03655106|584325157|FG001|Overall Study|Lost to Follow-up|1|||
161803673|NCT03655106|584325156|FG000|Overall Study|Duplicate Enrollment|1|||
161803674|NCT03655106|584325157|FG001|Overall Study|Duplicate Enrollment|1|||
161803675|NCT03655106|584325156|FG000|Overall Study|Protocol Violation|3|||
161803676|NCT03655106|584325157|FG001|Overall Study|Protocol Violation|0|||
161803677|NCT03227445|584325158|FG000|Period 1 (28 Days)|Adverse Event|1|||
161803678|NCT03227445|584325159|FG001|Period 1 (28 Days)|Adverse Event|2|||
161803679|NCT03227445|584325160|FG002|Period 1 (28 Days)|Adverse Event|0|||
161803680|NCT03227445|584325161|FG003|Period 1 (28 Days)|Adverse Event|1|||
161803681|NCT03227445|584325158|FG000|Period 1 (28 Days)|Protocol Violation|1|||
161803682|NCT03227445|584325159|FG001|Period 1 (28 Days)|Protocol Violation|0|||
161803683|NCT03227445|584325160|FG002|Period 1 (28 Days)|Protocol Violation|0|||
161803684|NCT03227445|584325161|FG003|Period 1 (28 Days)|Protocol Violation|0|||
161803685|NCT03227445|584325158|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
161803686|NCT03227445|584325159|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
161803687|NCT03227445|584325160|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
161803688|NCT03227445|584325161|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
161803689|NCT03227445|584325158|FG000|Period 2 (28 Days)|Adverse Event|1|||
161803690|NCT03227445|584325159|FG001|Period 2 (28 Days)|Adverse Event|0|||
161803691|NCT03227445|584325160|FG002|Period 2 (28 Days)|Adverse Event|2|||
161803692|NCT03227445|584325161|FG003|Period 2 (28 Days)|Adverse Event|1|||
161803693|NCT03227445|584325158|FG000|Period 2 (28 Days)|Protocol Violation|0|||
161803694|NCT03227445|584325159|FG001|Period 2 (28 Days)|Protocol Violation|0|||
161803695|NCT03227445|584325160|FG002|Period 2 (28 Days)|Protocol Violation|0|||
161803696|NCT03227445|584325161|FG003|Period 2 (28 Days)|Protocol Violation|1|||
161803697|NCT03227445|584325158|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
161803698|NCT03227445|584325159|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
161803699|NCT03227445|584325160|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
161803700|NCT03227445|584325161|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
161803701|NCT01287013|584325166|FG000|Overall Study|Non-evaluable|3|||
161906707|NCT03904693|584708887|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
161803702|NCT01287013|584325167|FG001|Overall Study|Non-evaluable|5|||
161803703|NCT01287013|584325168|FG002|Overall Study|Non-evaluable|21|||
161803704|NCT00051025|584325169|FG000|Overall Study|Progressive Disease|1|||
161803705|NCT00051025|584325170|FG001|Overall Study|Progressive Disease|1|||
161803706|NCT00051025|584325169|FG000|Overall Study|Adverse Event|1|||
161803707|NCT00051025|584325170|FG001|Overall Study|Adverse Event|1|||
161803708|NCT00051025|584325169|FG000|Overall Study|Withdrawal by Subject|0|||
161803709|NCT00051025|584325170|FG001|Overall Study|Withdrawal by Subject|1|||
161803710|NCT00051025|584325169|FG000|Overall Study|Death|0|||
162140190|NCT01956669|585565564|FG003|Overall Study|Physician Decision|0|||
161906708|NCT03904693|584708888|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161906709|NCT03904693|584708889|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161906710|NCT03904693|584708890|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161906711|NCT03904693|584708885|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161906712|NCT03904693|584708886|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161906713|NCT03904693|584708887|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
161906714|NCT03904693|584708888|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161906715|NCT03904693|584708889|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161906716|NCT03904693|584708890|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161906717|NCT03904693|584708885|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161906718|NCT03904693|584708886|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
161906719|NCT03904693|584708887|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
161906720|NCT03904693|584708888|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161906721|NCT03904693|584708889|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161906722|NCT03904693|584708890|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161906723|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
161906724|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
161906725|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
161906726|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
161906727|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
161906728|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
161906729|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
161906730|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
161906731|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
161906732|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
161906733|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
161906734|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
161906735|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161906736|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161906737|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161906738|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
161906739|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161906740|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161906741|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161906742|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161906743|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161906744|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
161906745|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161906746|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161803711|NCT00051025|584325170|FG001|Overall Study|Death|1|||
161803712|NCT01179048|584325171|FG000|Overall Study|Withdrawn - does not allow contact|4|||
161803713|NCT01179048|584325172|FG001|Overall Study|Withdrawn - does not allow contact|8|||
161803714|NCT01179048|584325171|FG000|Overall Study|Lost to Follow-up|8|||
161803715|NCT01179048|584325172|FG001|Overall Study|Lost to Follow-up|9|||
161803716|NCT01179048|584325171|FG000|Overall Study|Alive|127|||
161803717|NCT01179048|584325172|FG001|Overall Study|Alive|142|||
161803718|NCT01900730|584325173|FG000|Overall Study|Withdrawal by Subject|1|||
161803719|NCT01900730|584325174|FG001|Overall Study|Withdrawal by Subject|0|||
161803720|NCT01900730|584325173|FG000|Overall Study|Screen Failure|1|||
161803721|NCT01900730|584325174|FG001|Overall Study|Screen Failure|0|||
161803722|NCT02109042|584325175|FG000|Overall Study|Sponsor Decision|15|||
161803723|NCT03203447|584325180|FG000|Overall Study|Withdrawal by Subject|2|||
161803724|NCT03203447|584325181|FG001|Overall Study|Withdrawal by Subject|1|||
161803725|NCT03203447|584325180|FG000|Overall Study|Lost to Follow-up|1|||
161803726|NCT03203447|584325181|FG001|Overall Study|Lost to Follow-up|10|||
161803727|NCT03203447|584325180|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
161803728|NCT03203447|584325181|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
161803729|NCT02189941|584325182|FG000|Overall Study|Non-compliance|0|||
161803730|NCT02189941|584325183|FG001|Overall Study|Non-compliance|0|||
161906747|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161906748|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161803731|NCT02189941|584325184|FG002|Overall Study|Non-compliance|1|||
161803732|NCT00445003|584325185|FG000|Overall Study|Death|1|||
161803733|NCT00445003|584325186|FG001|Overall Study|Death|2|||
161803734|NCT00445003|584325187|FG002|Overall Study|Death|1|||
161803735|NCT00445003|584325185|FG000|Overall Study|Missed Visit|3|||
161906749|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161906750|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161906751|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161906752|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
161906753|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161906754|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161906755|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161906756|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161906757|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
161906758|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161906759|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161906760|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161906761|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161906762|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161906763|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161906764|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
161906765|NCT03904693|584708885|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161803736|NCT00445003|584325186|FG001|Overall Study|Missed Visit|5|||
161803737|NCT00445003|584325187|FG002|Overall Study|Missed Visit|1|||
161803738|NCT00445003|584325185|FG000|Overall Study|Dropped|1|||
161803739|NCT00445003|584325186|FG001|Overall Study|Dropped|3|||
161803740|NCT00445003|584325187|FG002|Overall Study|Dropped|2|||
161803741|NCT01471093|584325190|FG000|Overall Study|Adverse Event|1|||
161803742|NCT01471093|584325191|FG001|Overall Study|Adverse Event|0|||
161803743|NCT01471093|584325192|FG002|Overall Study|Adverse Event|0|||
161803744|NCT01471093|584325193|FG003|Overall Study|Adverse Event|0|||
161803745|NCT00528606|584325194|FG000|Overall Study|Withdrew consent|4|||
161803746|NCT00528606|584325195|FG001|Overall Study|Withdrew consent|3|||
161803747|NCT00528606|584325194|FG000|Overall Study|Lost to Follow-up|4|||
161803748|NCT00528606|584325195|FG001|Overall Study|Lost to Follow-up|1|||
161803749|NCT00528606|584325194|FG000|Overall Study|Adverse Event|3|||
161803750|NCT00528606|584325195|FG001|Overall Study|Adverse Event|0|||
161803751|NCT00528606|584325194|FG000|Overall Study|Other|2|||
161803752|NCT00528606|584325195|FG001|Overall Study|Other|0|||
161803753|NCT02475954|584325196|FG000|Overall Study|Withdrawal by Subject|2|||
161803754|NCT02475954|584325197|FG001|Overall Study|Withdrawal by Subject|2|||
161803755|NCT02475954|584325196|FG000|Overall Study|Lost to Follow-up|11|||
161803756|NCT02475954|584325197|FG001|Overall Study|Lost to Follow-up|9|||
161803757|NCT02475954|584325196|FG000|Overall Study|Death|1|||
161803758|NCT02475954|584325197|FG001|Overall Study|Death|1|||
161803759|NCT00880568|584325199|FG000|Overall Study|Disease progression|3|||
161803760|NCT00880568|584325200|FG001|Overall Study|Disease progression|3|||
161803761|NCT00880568|584325201|FG002|Overall Study|Disease progression|3|||
161803762|NCT00880568|584325202|FG003|Overall Study|Disease progression|1|||
161803763|NCT00880568|584325203|FG004|Overall Study|Disease progression|3|||
161803764|NCT00880568|584325204|FG005|Overall Study|Disease progression|3|||
161803765|NCT00880568|584325205|FG006|Overall Study|Disease progression|5|||
161803766|NCT00880568|584325206|FG007|Overall Study|Disease progression|0|||
161803767|NCT00880568|584325207|FG008|Overall Study|Disease progression|3|||
161906766|NCT03904693|584708886|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161906767|NCT03904693|584708887|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161906768|NCT03904693|584708888|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161906769|NCT03904693|584708889|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161906770|NCT03904693|584708890|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
161906771|NCT01172873|584708891|FG000|Overall Study|Withdrawal by Subject|3|||
161906772|NCT01172873|584708892|FG001|Overall Study|Withdrawal by Subject|2|||
161906773|NCT05518539|584708893|FG000|Overall Study|Lost to Follow-up|6|||
161906774|NCT03589807|584708894|FG000|Overall Study|Lost to Follow-up|0|||
161906775|NCT03589807|584708895|FG001|Overall Study|Lost to Follow-up|2|||
161906776|NCT03589807|584708896|FG002|Overall Study|Lost to Follow-up|2|||
161803768|NCT00880568|584325199|FG000|Overall Study|Adverse Event|0|||
161803769|NCT00880568|584325200|FG001|Overall Study|Adverse Event|0|||
161803770|NCT00880568|584325201|FG002|Overall Study|Adverse Event|0|||
161803771|NCT00880568|584325202|FG003|Overall Study|Adverse Event|0|||
161803772|NCT00880568|584325203|FG004|Overall Study|Adverse Event|0|||
161803773|NCT00880568|584325204|FG005|Overall Study|Adverse Event|0|||
161803774|NCT00880568|584325205|FG006|Overall Study|Adverse Event|1|||
161803775|NCT00880568|584325206|FG007|Overall Study|Adverse Event|1|||
161803776|NCT00880568|584325207|FG008|Overall Study|Adverse Event|0|||
161803777|NCT00880568|584325199|FG000|Overall Study|Withdrawal by Subject|0|||
161803778|NCT00880568|584325200|FG001|Overall Study|Withdrawal by Subject|0|||
161803779|NCT00880568|584325201|FG002|Overall Study|Withdrawal by Subject|0|||
161803780|NCT00880568|584325202|FG003|Overall Study|Withdrawal by Subject|0|||
161803781|NCT00880568|584325203|FG004|Overall Study|Withdrawal by Subject|0|||
161906777|NCT03589807|584708897|FG003|Overall Study|Lost to Follow-up|3|||
161906778|NCT03589807|584708898|FG004|Overall Study|Lost to Follow-up|1|||
161906779|NCT03589807|584708899|FG005|Overall Study|Lost to Follow-up|1|||
161906780|NCT03589807|584708894|FG000|Overall Study|Withdrawal by Subject|0|||
161906781|NCT03589807|584708895|FG001|Overall Study|Withdrawal by Subject|5|||
161906782|NCT03589807|584708896|FG002|Overall Study|Withdrawal by Subject|0|||
161906783|NCT03589807|584708897|FG003|Overall Study|Withdrawal by Subject|0|||
161906784|NCT03589807|584708898|FG004|Overall Study|Withdrawal by Subject|0|||
161906785|NCT03589807|584708899|FG005|Overall Study|Withdrawal by Subject|0|||
161906786|NCT03589807|584708894|FG000|Overall Study|Protocol Violation|0|||
161906787|NCT03589807|584708895|FG001|Overall Study|Protocol Violation|0|||
161906788|NCT03589807|584708896|FG002|Overall Study|Protocol Violation|0|||
161906789|NCT03589807|584708897|FG003|Overall Study|Protocol Violation|1|||
161906790|NCT03589807|584708898|FG004|Overall Study|Protocol Violation|0|||
161906791|NCT03589807|584708899|FG005|Overall Study|Protocol Violation|0|||
161906792|NCT03589807|584708894|FG000|Overall Study|Enrolled but treatment not administered|0|||
161906793|NCT03589807|584708895|FG001|Overall Study|Enrolled but treatment not administered|0|||
161906794|NCT03589807|584708896|FG002|Overall Study|Enrolled but treatment not administered|0|||
161906795|NCT03589807|584708897|FG003|Overall Study|Enrolled but treatment not administered|0|||
161906796|NCT03589807|584708898|FG004|Overall Study|Enrolled but treatment not administered|1|||
161906797|NCT03589807|584708899|FG005|Overall Study|Enrolled but treatment not administered|0|||
161906798|NCT01211145|584708900|FG000|Overall Study|Reason not specified|3|||
161906799|NCT01211145|584708901|FG001|Overall Study|Reason not specified|2|||
161906800|NCT01211145|584708902|FG002|Overall Study|Reason not specified|2|||
161906801|NCT01211145|584708903|FG003|Overall Study|Reason not specified|1|||
161906802|NCT01211145|584708900|FG000|Overall Study|Lost to Follow-up|3|||
161906803|NCT01211145|584708901|FG001|Overall Study|Lost to Follow-up|2|||
161906804|NCT01211145|584708902|FG002|Overall Study|Lost to Follow-up|1|||
161906805|NCT01211145|584708903|FG003|Overall Study|Lost to Follow-up|2|||
161906806|NCT01211145|584708900|FG000|Overall Study|Study-specific withdrawal criteria|1|||
161906807|NCT01211145|584708901|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161906808|NCT01211145|584708902|FG002|Overall Study|Study-specific withdrawal criteria|0|||
161906809|NCT01211145|584708903|FG003|Overall Study|Study-specific withdrawal criteria|0|||
161906810|NCT01211145|584708900|FG000|Overall Study|Severe noncompliance to protocol|1|||
161906811|NCT01211145|584708901|FG001|Overall Study|Severe noncompliance to protocol|0|||
161906812|NCT01211145|584708902|FG002|Overall Study|Severe noncompliance to protocol|0|||
161906813|NCT01211145|584708903|FG003|Overall Study|Severe noncompliance to protocol|0|||
161906814|NCT01211145|584708900|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
161906815|NCT01211145|584708901|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
161803782|NCT00880568|584325204|FG005|Overall Study|Withdrawal by Subject|0|||
161803783|NCT00880568|584325205|FG006|Overall Study|Withdrawal by Subject|0|||
161803784|NCT00880568|584325206|FG007|Overall Study|Withdrawal by Subject|1|||
161803785|NCT00880568|584325207|FG008|Overall Study|Withdrawal by Subject|0|||
161803786|NCT00620022|584325208|FG000|Treatment Period 1|Adverse Event|4|||
161803787|NCT00620022|584325209|FG001|Treatment Period 1|Adverse Event|6|||
161803788|NCT00620022|584325208|FG000|Treatment Period 1|Subject withdrew consent|1|||
161803789|NCT00620022|584325209|FG001|Treatment Period 1|Subject withdrew consent|0|||
161803790|NCT00620022|584325208|FG000|Treatment Period 2|Adverse Event|2|||
161803791|NCT00620022|584325209|FG001|Treatment Period 2|Adverse Event|2|||
161803792|NCT00760266|584325211|FG000|Overall Study|Adverse Event|13|||
161803793|NCT00760266|584325212|FG001|Overall Study|Adverse Event|7|||
161803794|NCT00760266|584325211|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161803795|NCT00760266|584325212|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161803796|NCT00760266|584325211|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161803797|NCT00760266|584325212|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161803798|NCT00760266|584325211|FG000|Overall Study|Lack of Efficacy|2|||
161803799|NCT00760266|584325212|FG001|Overall Study|Lack of Efficacy|2|||
161803800|NCT00760266|584325211|FG000|Overall Study|Protocol deviation|2|||
161803801|NCT00760266|584325212|FG001|Overall Study|Protocol deviation|4|||
161803802|NCT00760266|584325211|FG000|Overall Study|Patient withdrew consent|3|||
161803803|NCT00760266|584325212|FG001|Overall Study|Patient withdrew consent|3|||
161803804|NCT00760266|584325211|FG000|Overall Study|Lost to Follow-up|2|||
161803805|NCT00760266|584325212|FG001|Overall Study|Lost to Follow-up|1|||
161803806|NCT00760266|584325211|FG000|Overall Study|Administrative Problems|0|||
161803807|NCT00760266|584325212|FG001|Overall Study|Administrative Problems|1|||
161803808|NCT01239121|584325213|FG000|Overall Study|Withdrawal by Subject|2|||
161906816|NCT01211145|584708902|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
161803809|NCT01239121|584325214|FG001|Overall Study|Withdrawal by Subject|4|||
161906817|NCT01211145|584708903|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
161906818|NCT01211145|584708900|FG000|Overall Study|Patient decision|2|||
161906819|NCT01211145|584708901|FG001|Overall Study|Patient decision|1|||
161803810|NCT01239121|584325215|FG002|Overall Study|Withdrawal by Subject|0|||
161803811|NCT04006171|584325218|FG000|Overall Study|Withdrawal by Subject|8|||
161803812|NCT04006171|584325219|FG001|Overall Study|Withdrawal by Subject|7|||
161906820|NCT01211145|584708902|FG002|Overall Study|Patient decision|0|||
161906821|NCT01211145|584708903|FG003|Overall Study|Patient decision|2|||
161906822|NCT00249834|584708906|FG000|Overall Study|Ovarian stimulation failed|1|||
161906823|NCT00249834|584708907|FG001|Overall Study|Ovarian stimulation failed|0|||
161906824|NCT00249834|584708908|FG002|Overall Study|Ovarian stimulation failed|0|||
161906825|NCT00249834|584708909|FG003|Overall Study|Ovarian stimulation failed|0|||
161906826|NCT00249834|584708910|FG004|Overall Study|Ovarian stimulation failed|0|||
161906827|NCT00249834|584708911|FG005|Overall Study|Ovarian stimulation failed|0|||
161906828|NCT00249834|584708912|FG006|Overall Study|Ovarian stimulation failed|0|||
161906829|NCT00249834|584708913|FG007|Overall Study|Ovarian stimulation failed|0|||
161906830|NCT00249834|584708906|FG000|Overall Study|Failure of down-regulation|0|||
161906831|NCT00249834|584708907|FG001|Overall Study|Failure of down-regulation|0|||
161906832|NCT00249834|584708908|FG002|Overall Study|Failure of down-regulation|0|||
161906833|NCT00249834|584708909|FG003|Overall Study|Failure of down-regulation|0|||
161906834|NCT00249834|584708910|FG004|Overall Study|Failure of down-regulation|0|||
161906835|NCT00249834|584708911|FG005|Overall Study|Failure of down-regulation|0|||
161906836|NCT00249834|584708912|FG006|Overall Study|Failure of down-regulation|1|||
161906837|NCT00249834|584708913|FG007|Overall Study|Failure of down-regulation|0|||
161906838|NCT00249834|584708906|FG000|Overall Study|Protocol Violation|0|||
161906839|NCT00249834|584708907|FG001|Overall Study|Protocol Violation|19|||
161906840|NCT00249834|584708908|FG002|Overall Study|Protocol Violation|14|||
161906841|NCT00249834|584708909|FG003|Overall Study|Protocol Violation|8|||
161906842|NCT00249834|584708910|FG004|Overall Study|Protocol Violation|5|||
161803813|NCT04006171|584325218|FG000|Overall Study|missing serum samples|2|||
161803814|NCT04006171|584325219|FG001|Overall Study|missing serum samples|2|||
161803815|NCT04006171|584325218|FG000|Overall Study|insufficient sample volume|2|||
161803816|NCT04006171|584325219|FG001|Overall Study|insufficient sample volume|3|||
161803817|NCT03049488|584325220|FG000|Overall Study|Lost to Follow-up|1|||
161803818|NCT03049488|584325221|FG001|Overall Study|Lost to Follow-up|1|||
161803819|NCT03049488|584325222|FG002|Overall Study|Lost to Follow-up|0|||
161803820|NCT03049488|584325223|FG003|Overall Study|Lost to Follow-up|0|||
161803821|NCT03049488|584325224|FG004|Overall Study|Lost to Follow-up|0|||
161803822|NCT03049488|584325225|FG005|Overall Study|Lost to Follow-up|0|||
161803823|NCT03049488|584325220|FG000|Overall Study|Moved from Area|1|||
161803824|NCT03049488|584325221|FG001|Overall Study|Moved from Area|0|||
161803825|NCT03049488|584325222|FG002|Overall Study|Moved from Area|0|||
161803826|NCT03049488|584325223|FG003|Overall Study|Moved from Area|1|||
161803827|NCT03049488|584325224|FG004|Overall Study|Moved from Area|1|||
161803828|NCT03049488|584325225|FG005|Overall Study|Moved from Area|0|||
161803829|NCT03049488|584325220|FG000|Overall Study|Physician Decision|0|||
161803830|NCT03049488|584325221|FG001|Overall Study|Physician Decision|1|||
161803831|NCT03049488|584325222|FG002|Overall Study|Physician Decision|0|||
161803832|NCT03049488|584325223|FG003|Overall Study|Physician Decision|0|||
161803833|NCT03049488|584325224|FG004|Overall Study|Physician Decision|0|||
161803834|NCT03049488|584325225|FG005|Overall Study|Physician Decision|0|||
161803835|NCT03049488|584325220|FG000|Overall Study|Withdrawal by Subject|0|||
161803836|NCT03049488|584325221|FG001|Overall Study|Withdrawal by Subject|0|||
161803837|NCT03049488|584325222|FG002|Overall Study|Withdrawal by Subject|0|||
161803838|NCT03049488|584325223|FG003|Overall Study|Withdrawal by Subject|1|||
161803839|NCT03049488|584325224|FG004|Overall Study|Withdrawal by Subject|1|||
161803840|NCT03049488|584325225|FG005|Overall Study|Withdrawal by Subject|0|||
161803841|NCT00440557|584325226|FG000|Overall Study|Withdrawal by Subject|10|||
161803842|NCT00440557|584325227|FG001|Overall Study|Withdrawal by Subject|5|||
161803843|NCT00440557|584325228|FG002|Overall Study|Withdrawal by Subject|11|||
161803844|NCT00440557|584325226|FG000|Overall Study|Lost to Follow-up|1|||
161803845|NCT00440557|584325227|FG001|Overall Study|Lost to Follow-up|2|||
161803846|NCT00440557|584325228|FG002|Overall Study|Lost to Follow-up|6|||
161803847|NCT00440557|584325226|FG000|Overall Study|Adverse Event|3|||
161803848|NCT00440557|584325227|FG001|Overall Study|Adverse Event|3|||
161906843|NCT00249834|584708911|FG005|Overall Study|Protocol Violation|2|||
161906844|NCT00249834|584708912|FG006|Overall Study|Protocol Violation|0|||
161906845|NCT00249834|584708913|FG007|Overall Study|Protocol Violation|0|||
161906846|NCT02688933|584708916|FG000|Overall Study|Adverse Event|3|||
161906847|NCT02688933|584708917|FG001|Overall Study|Adverse Event|1|||
161906848|NCT02688933|584708916|FG000|Overall Study|Lack of Efficacy|2|||
161803849|NCT00440557|584325228|FG002|Overall Study|Adverse Event|5|||
161803850|NCT00440557|584325226|FG000|Overall Study|Death|2|||
161803851|NCT00440557|584325227|FG001|Overall Study|Death|6|||
161906849|NCT02688933|584708917|FG001|Overall Study|Lack of Efficacy|2|||
161906850|NCT02688933|584708916|FG000|Overall Study|Poor compliance to protocol|7|||
161906851|NCT02688933|584708917|FG001|Overall Study|Poor compliance to protocol|4|||
161803852|NCT00440557|584325228|FG002|Overall Study|Death|3|||
161803853|NCT00440557|584325226|FG000|Overall Study|Began Dialysis|4|||
161803854|NCT00440557|584325227|FG001|Overall Study|Began Dialysis|1|||
161803855|NCT00440557|584325228|FG002|Overall Study|Began Dialysis|4|||
161803856|NCT00440557|584325226|FG000|Overall Study|Principal Investigator decision|0|||
161803857|NCT00440557|584325227|FG001|Overall Study|Principal Investigator decision|3|||
161803858|NCT00440557|584325228|FG002|Overall Study|Principal Investigator decision|1|||
161906852|NCT02688933|584708916|FG000|Overall Study|Hypoglycemia|2|||
161906853|NCT02688933|584708917|FG001|Overall Study|Hypoglycemia|0|||
161906854|NCT02688933|584708916|FG000|Overall Study|Other than Specified|14|||
161906855|NCT02688933|584708917|FG001|Overall Study|Other than Specified|25|||
161906856|NCT02688933|584708916|FG000|Overall Study|Lost to Follow-up|1|||
161906857|NCT02688933|584708917|FG001|Overall Study|Lost to Follow-up|5|||
161906858|NCT01949142|584708931|FG000|Overall Study|Withdrawal of consent|1|||
161906859|NCT01949142|584708932|FG001|Overall Study|Withdrawal of consent|0|||
161906860|NCT01949142|584708931|FG000|Overall Study|Lost to Follow-up|1|||
161906861|NCT01949142|584708932|FG001|Overall Study|Lost to Follow-up|1|||
161906862|NCT01949142|584708931|FG000|Overall Study|Parent changed their mind|1|||
161906863|NCT01949142|584708932|FG001|Overall Study|Parent changed their mind|0|||
161906864|NCT02873689|584710445|FG000|Overall Study|Lack of Efficacy|1|||
161906865|NCT02873689|584710446|FG001|Overall Study|Lack of Efficacy|0|||
161906866|NCT02873689|584710445|FG000|Overall Study|Withdrawal by Subject|2|||
161906867|NCT02873689|584710446|FG001|Overall Study|Withdrawal by Subject|2|||
161906868|NCT02873689|584710445|FG000|Overall Study|Protocol Violation|1|||
161906869|NCT02873689|584710446|FG001|Overall Study|Protocol Violation|0|||
161906870|NCT02873689|584710445|FG000|Overall Study|Adverse Event|2|||
161906871|NCT02873689|584710446|FG001|Overall Study|Adverse Event|2|||
161906872|NCT02873689|584710445|FG000|Overall Study|Randomized but not Treated|1|||
161906873|NCT02873689|584710446|FG001|Overall Study|Randomized but not Treated|1|||
161906874|NCT00434252|584710450|FG000|Overall Study|Lack of Efficacy|50|||
161906875|NCT00434252|584710451|FG001|Overall Study|Lack of Efficacy|100|||
161906876|NCT00434252|584710450|FG000|Overall Study|Adverse Event|6|||
161906877|NCT00434252|584710451|FG001|Overall Study|Adverse Event|13|||
161906878|NCT00434252|584710450|FG000|Overall Study|Death|1|||
161906879|NCT00434252|584710451|FG001|Overall Study|Death|2|||
161906880|NCT00434252|584710450|FG000|Overall Study|Lost to Follow-up|0|||
161906881|NCT00434252|584710451|FG001|Overall Study|Lost to Follow-up|1|||
161906882|NCT00434252|584710450|FG000|Overall Study|Physician Decision|4|||
161906883|NCT00434252|584710451|FG001|Overall Study|Physician Decision|8|||
161906884|NCT00434252|584710450|FG000|Overall Study|Withdrawal by Subject|3|||
161906885|NCT00434252|584710451|FG001|Overall Study|Withdrawal by Subject|7|||
161906886|NCT02337764|584710452|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
161906887|NCT02337764|584710452|FG000|Overall Study|Voluntary Withdrawal|12|||
161906888|NCT02337764|584710452|FG000|Overall Study|Lack of Efficacy|2|||
161906889|NCT02990000|584710453|FG000|Overall Study|Failed to provide data beyond baseline|36|||
161906890|NCT02990000|584710454|FG001|Overall Study|Failed to provide data beyond baseline|34|||
161906891|NCT02810418|584710461|FG000|Arm A Dose Escalation|Adverse Event|2|||
161906892|NCT02810418|584710462|FG001|Arm A Dose Escalation|Adverse Event|1|||
161906893|NCT02810418|584710463|FG002|Arm A Dose Escalation|Adverse Event|0|||
161906894|NCT02810418|584710464|FG003|Arm A Dose Escalation|Adverse Event|0|||
161906895|NCT02810418|584710465|FG004|Arm A Dose Escalation|Adverse Event|0|||
161906896|NCT02810418|584710466|FG005|Arm A Dose Escalation|Adverse Event|0|||
161906897|NCT02810418|584710467|FG006|Arm A Dose Escalation|Adverse Event|0|||
161906898|NCT02810418|584710461|FG000|Dose Expansion|Adverse Event|0|||
161906899|NCT02810418|584710462|FG001|Dose Expansion|Adverse Event|1|||
161906900|NCT02810418|584710463|FG002|Dose Expansion|Adverse Event|1|||
161906901|NCT02810418|584710464|FG003|Dose Expansion|Adverse Event|0|||
161906902|NCT02810418|584710465|FG004|Dose Expansion|Adverse Event|0|||
161906903|NCT02810418|584710466|FG005|Dose Expansion|Adverse Event|0|||
161906904|NCT02810418|584710467|FG006|Dose Expansion|Adverse Event|0|||
161906905|NCT02810418|584710461|FG000|Dose Expansion|Physician Decision|0|||
161906906|NCT02810418|584710462|FG001|Dose Expansion|Physician Decision|0|||
161906907|NCT02810418|584710463|FG002|Dose Expansion|Physician Decision|2|||
161906908|NCT02810418|584710464|FG003|Dose Expansion|Physician Decision|0|||
161906909|NCT02810418|584710465|FG004|Dose Expansion|Physician Decision|0|||
161906910|NCT02810418|584710466|FG005|Dose Expansion|Physician Decision|0|||
162140191|NCT01956669|585565565|FG004|Overall Study|Physician Decision|0|||
162140192|NCT01956669|585565566|FG005|Overall Study|Physician Decision|1|||
162140193|NCT01956669|585565567|FG006|Overall Study|Physician Decision|0|||
162140194|NCT01956669|585565561|FG000|Overall Study|Withdrawal by Subject|0|||
162140195|NCT01956669|585565562|FG001|Overall Study|Withdrawal by Subject|0|||
161906911|NCT02810418|584710467|FG006|Dose Expansion|Physician Decision|0|||
161906912|NCT02810418|584710461|FG000|Arm B Dose Escalation|Adverse Event|0|||
161906913|NCT02810418|584710462|FG001|Arm B Dose Escalation|Adverse Event|0|||
161906914|NCT02810418|584710463|FG002|Arm B Dose Escalation|Adverse Event|0|||
161906915|NCT02810418|584710464|FG003|Arm B Dose Escalation|Adverse Event|0|||
161906916|NCT02810418|584710465|FG004|Arm B Dose Escalation|Adverse Event|1|||
161906917|NCT02810418|584710466|FG005|Arm B Dose Escalation|Adverse Event|2|||
161906918|NCT02810418|584710467|FG006|Arm B Dose Escalation|Adverse Event|0|||
161906919|NCT03103503|584710468|FG000|Overall Study|Death|64|||
161906920|NCT03103503|584710468|FG000|Overall Study|Physician Decision|57|||
161906921|NCT03103503|584710468|FG000|Overall Study|Withdrawal by Subject|10|||
161906922|NCT03103503|584710468|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
162140196|NCT01956669|585565563|FG002|Overall Study|Withdrawal by Subject|1|||
162140197|NCT01956669|585565564|FG003|Overall Study|Withdrawal by Subject|1|||
161906923|NCT03103503|584710468|FG000|Overall Study|Lost to Follow-up|3|||
161906924|NCT03103503|584710468|FG000|Overall Study|Study Closure|757|||
161906925|NCT04161391|584710475|FG000|Overall Study|Adverse Event|0|||
161906926|NCT04161391|584710476|FG001|Overall Study|Adverse Event|1|||
161906927|NCT04161391|584710477|FG002|Overall Study|Adverse Event|0|||
161906928|NCT04161391|584710478|FG003|Overall Study|Adverse Event|1|||
161906929|NCT04161391|584710479|FG004|Overall Study|Adverse Event|0|||
161906930|NCT04161391|584710480|FG005|Overall Study|Adverse Event|0|||
161906931|NCT04161391|584710481|FG006|Overall Study|Adverse Event|0|||
161906932|NCT04161391|584710482|FG007|Overall Study|Adverse Event|3|||
161906933|NCT04161391|584710483|FG008|Overall Study|Adverse Event|0|||
161906934|NCT04161391|584710475|FG000|Overall Study|Death|0|||
161906935|NCT04161391|584710476|FG001|Overall Study|Death|0|||
161906936|NCT04161391|584710477|FG002|Overall Study|Death|0|||
161906937|NCT04161391|584710478|FG003|Overall Study|Death|0|||
161906938|NCT04161391|584710479|FG004|Overall Study|Death|0|||
161906939|NCT04161391|584710480|FG005|Overall Study|Death|0|||
161906940|NCT04161391|584710481|FG006|Overall Study|Death|0|||
161906941|NCT04161391|584710482|FG007|Overall Study|Death|1|||
161906942|NCT04161391|584710483|FG008|Overall Study|Death|0|||
161906943|NCT04161391|584710475|FG000|Overall Study|Physician Decision|0|||
161906944|NCT04161391|584710476|FG001|Overall Study|Physician Decision|0|||
161906945|NCT04161391|584710477|FG002|Overall Study|Physician Decision|1|||
161906946|NCT04161391|584710478|FG003|Overall Study|Physician Decision|2|||
161906947|NCT04161391|584710479|FG004|Overall Study|Physician Decision|0|||
161906948|NCT04161391|584710480|FG005|Overall Study|Physician Decision|0|||
161906949|NCT04161391|584710481|FG006|Overall Study|Physician Decision|2|||
161906950|NCT04161391|584710482|FG007|Overall Study|Physician Decision|0|||
161906951|NCT04161391|584710483|FG008|Overall Study|Physician Decision|0|||
161906952|NCT04161391|584710475|FG000|Overall Study|Progressive Disease|4|||
161906953|NCT04161391|584710476|FG001|Overall Study|Progressive Disease|3|||
161906954|NCT04161391|584710477|FG002|Overall Study|Progressive Disease|3|||
161906955|NCT04161391|584710478|FG003|Overall Study|Progressive Disease|5|||
161906956|NCT04161391|584710479|FG004|Overall Study|Progressive Disease|3|||
161906957|NCT04161391|584710480|FG005|Overall Study|Progressive Disease|3|||
161906958|NCT04161391|584710481|FG006|Overall Study|Progressive Disease|5|||
161906959|NCT04161391|584710482|FG007|Overall Study|Progressive Disease|2|||
161906960|NCT04161391|584710483|FG008|Overall Study|Progressive Disease|2|||
161906961|NCT02579629|584710489|FG000|Overall Study|Withdrawal by Subject|0|||
161906962|NCT02579629|584710490|FG001|Overall Study|Withdrawal by Subject|1|||
161906963|NCT02579629|584710491|FG002|Overall Study|Withdrawal by Subject|0|||
161906964|NCT02579629|584710489|FG000|Overall Study|Screen Failure|2|||
161906965|NCT02579629|584710490|FG001|Overall Study|Screen Failure|0|||
161906966|NCT02579629|584710491|FG002|Overall Study|Screen Failure|2|||
161906967|NCT00737048|584710492|FG000|Overall Study|Physician Decision|0|||
161906968|NCT00737048|584710493|FG001|Overall Study|Physician Decision|0|||
161906969|NCT00737048|584710494|FG002|Overall Study|Physician Decision|1|||
161906970|NCT00737048|584710492|FG000|Overall Study|Adverse Event|0|||
161906971|NCT00737048|584710493|FG001|Overall Study|Adverse Event|1|||
161906972|NCT00737048|584710494|FG002|Overall Study|Adverse Event|0|||
161906973|NCT00737048|584710492|FG000|Overall Study|Worsening of the symptoms|3|||
161906974|NCT00737048|584710493|FG001|Overall Study|Worsening of the symptoms|5|||
161906975|NCT00737048|584710494|FG002|Overall Study|Worsening of the symptoms|3|||
162140198|NCT01956669|585565565|FG004|Overall Study|Withdrawal by Subject|0|||
162140199|NCT01956669|585565566|FG005|Overall Study|Withdrawal by Subject|0|||
161906976|NCT01739335|584710495|FG000|Overall Study|Lost to Follow-up|7|||
161906977|NCT01739335|584710496|FG001|Overall Study|Lost to Follow-up|4|||
161906978|NCT01739335|584710495|FG000|Overall Study|Ineligible patient randomized|0|||
161906979|NCT01739335|584710496|FG001|Overall Study|Ineligible patient randomized|1|||
162140200|NCT01956669|585565567|FG006|Overall Study|Withdrawal by Subject|1|||
162140201|NCT01570751|585565568|FG000|Period A (16 Weeks)|Protocol Violation|1|||
162140202|NCT01570751|585565569|FG001|Period A (16 Weeks)|Protocol Violation|1|||
162140203|NCT01570751|585565568|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
162140204|NCT01570751|585565569|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
162140205|NCT01570751|585565568|FG000|Period A (16 Weeks)|Unclassified|2|||
162140206|NCT01570751|585565569|FG001|Period A (16 Weeks)|Unclassified|3|||
161906980|NCT01863771|584710498|FG000|Induction Phase|Adverse Event|9|||
161906981|NCT01863771|584710499|FG001|Induction Phase|Adverse Event|0|||
161906982|NCT01863771|584710500|FG002|Induction Phase|Adverse Event|0|||
161906983|NCT01863771|584710501|FG003|Induction Phase|Adverse Event|0|||
161906984|NCT01863771|584710498|FG000|Induction Phase|Lack of Efficacy|10|||
161906985|NCT01863771|584710499|FG001|Induction Phase|Lack of Efficacy|0|||
161906986|NCT01863771|584710500|FG002|Induction Phase|Lack of Efficacy|0|||
161906987|NCT01863771|584710501|FG003|Induction Phase|Lack of Efficacy|0|||
161906988|NCT01863771|584710498|FG000|Induction Phase|Withdrawal by Subject|2|||
161906989|NCT01863771|584710499|FG001|Induction Phase|Withdrawal by Subject|0|||
161906990|NCT01863771|584710500|FG002|Induction Phase|Withdrawal by Subject|0|||
161906991|NCT01863771|584710501|FG003|Induction Phase|Withdrawal by Subject|0|||
161906992|NCT01863771|584710498|FG000|Maintenance Phase|Adverse Event|0|||
161906993|NCT01863771|584710499|FG001|Maintenance Phase|Adverse Event|0|||
161906994|NCT01863771|584710500|FG002|Maintenance Phase|Adverse Event|1|||
161906995|NCT01863771|584710501|FG003|Maintenance Phase|Adverse Event|1|||
161906996|NCT01863771|584710498|FG000|Maintenance Phase|Lack of Efficacy|0|||
161906997|NCT01863771|584710499|FG001|Maintenance Phase|Lack of Efficacy|3|||
161906998|NCT01863771|584710500|FG002|Maintenance Phase|Lack of Efficacy|7|||
161906999|NCT01863771|584710501|FG003|Maintenance Phase|Lack of Efficacy|38|||
161907000|NCT01863771|584710498|FG000|Maintenance Phase|Physician Decision|0|||
161907001|NCT01863771|584710499|FG001|Maintenance Phase|Physician Decision|0|||
161907002|NCT01863771|584710500|FG002|Maintenance Phase|Physician Decision|2|||
161907003|NCT01863771|584710501|FG003|Maintenance Phase|Physician Decision|1|||
161907004|NCT01863771|584710498|FG000|Maintenance Phase|Pregnancy|0|||
161907005|NCT01863771|584710499|FG001|Maintenance Phase|Pregnancy|1|||
161907006|NCT01863771|584710500|FG002|Maintenance Phase|Pregnancy|0|||
161907007|NCT01863771|584710501|FG003|Maintenance Phase|Pregnancy|0|||
161907008|NCT01863771|584710498|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161907009|NCT01863771|584710499|FG001|Maintenance Phase|Withdrawal by Subject|1|||
161907010|NCT01863771|584710500|FG002|Maintenance Phase|Withdrawal by Subject|2|||
161907011|NCT01863771|584710501|FG003|Maintenance Phase|Withdrawal by Subject|3|||
161907012|NCT02914834|584710507|FG000|Overall Study|Study halted due to COVID|1|||
161907013|NCT02914834|584710508|FG001|Overall Study|Study halted due to COVID|1|||
161907014|NCT02914834|584710507|FG000|Overall Study|1 subject withdrew|0|||
161907015|NCT02914834|584710508|FG001|Overall Study|1 subject withdrew|1|||
161907016|NCT01245101|584710515|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
161907017|NCT01245101|584710516|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
161907018|NCT01245101|584710515|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
161907019|NCT01245101|584710516|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
161907020|NCT01245101|584710515|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
161907021|NCT01245101|584710516|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
161907022|NCT00473083|584710519|FG000|Overall Study|Adverse Event|1|||
161907023|NCT00473083|584710520|FG001|Overall Study|Adverse Event|0|||
161907024|NCT00473083|584710521|FG002|Overall Study|Adverse Event|0|||
161907025|NCT02446691|584710522|FG000|Overall Study|Withdrawal by Subject|2|||
161907026|NCT02446691|584710522|FG000|Overall Study|Lost to Follow-up|8|||
161907027|NCT02446691|584710522|FG000|Overall Study|Protocol Violation|1|||
161907028|NCT03903172|584710525|FG000|Overall Study|screen fail|4|||
161907029|NCT03903172|584710526|FG001|Overall Study|screen fail|1|||
161907030|NCT01545388|584710527|FG000|Overall Study|Adverse Event|2|||
161907031|NCT01545388|584710528|FG001|Overall Study|Adverse Event|4|||
161907032|NCT01545388|584710529|FG002|Overall Study|Adverse Event|1|||
161907033|NCT01545388|584710527|FG000|Overall Study|Lack of Efficacy|3|||
161907034|NCT01545388|584710528|FG001|Overall Study|Lack of Efficacy|2|||
161907035|NCT01545388|584710529|FG002|Overall Study|Lack of Efficacy|5|||
161907036|NCT01545388|584710527|FG000|Overall Study|Participant moved or relocated|1|||
161907037|NCT01545388|584710528|FG001|Overall Study|Participant moved or relocated|0|||
161907038|NCT01545388|584710529|FG002|Overall Study|Participant moved or relocated|0|||
161907039|NCT01545388|584710527|FG000|Overall Study|Withdrawal by Subject|1|||
161907040|NCT01545388|584710528|FG001|Overall Study|Withdrawal by Subject|4|||
161907041|NCT01545388|584710529|FG002|Overall Study|Withdrawal by Subject|2|||
161907042|NCT01545388|584710527|FG000|Overall Study|Other|1|||
161907043|NCT01545388|584710528|FG001|Overall Study|Other|1|||
161907044|NCT01545388|584710529|FG002|Overall Study|Other|0|||
161907045|NCT01474486|584710532|FG000|Overall Study|Death|2|||
161907046|NCT01474486|584710532|FG000|Overall Study|Withdrawal by Subject|4|||
161907047|NCT01474486|584710532|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
161907048|NCT01255163|584710533|FG000|Overall Study|Withdrawal by Subject|1|||
161907049|NCT01255163|584710534|FG001|Overall Study|Withdrawal by Subject|0|||
161907050|NCT01255163|584710533|FG000|Overall Study|Lost to Follow-up|2|||
161907051|NCT01255163|584710534|FG001|Overall Study|Lost to Follow-up|0|||
161907052|NCT01255163|584710533|FG000|Overall Study|Adverse Event|0|||
161907053|NCT01255163|584710534|FG001|Overall Study|Adverse Event|2|||
161907054|NCT01255163|584710533|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
161907055|NCT01255163|584710534|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
161907056|NCT02495389|584710535|FG000|Overall Study|Withdrawal by Subject|40|||
161907057|NCT01924533|584710536|FG000|Overall Study|Death|181|||
161907058|NCT01924533|584710537|FG001|Overall Study|Death|200|||
161907059|NCT01924533|584710536|FG000|Overall Study|Lost to Follow-up|0|||
161907060|NCT01924533|584710537|FG001|Overall Study|Lost to Follow-up|1|||
161907061|NCT01924533|584710536|FG000|Overall Study|Withdrawal by Subject|7|||
161907062|NCT01924533|584710537|FG001|Overall Study|Withdrawal by Subject|3|||
161907063|NCT01924533|584710536|FG000|Overall Study|Other Eligibility criteria|1|||
161907064|NCT01924533|584710537|FG001|Overall Study|Other Eligibility criteria|1|||
161907065|NCT05817669|584710538|FG000|Overall Study|Prohibited medication used|1|||
161907066|NCT05817669|584710539|FG001|Overall Study|Prohibited medication used|2|||
161907067|NCT05817669|584710538|FG000|Overall Study|Adverse Event|1|||
161907068|NCT05817669|584710539|FG001|Overall Study|Adverse Event|0|||
161907069|NCT05817669|584710538|FG000|Overall Study|Withdrawal by Subject|1|||
161907070|NCT05817669|584710539|FG001|Overall Study|Withdrawal by Subject|2|||
161907071|NCT04233879|584710540|FG000|Overall Study|Death|2|||
161907072|NCT04233879|584710541|FG001|Overall Study|Death|0|||
161907073|NCT04233879|584710540|FG000|Overall Study|Lost to Follow-up|3|||
161907074|NCT04233879|584710541|FG001|Overall Study|Lost to Follow-up|8|||
161907075|NCT04233879|584710540|FG000|Overall Study|Physician Decision|4|||
161907076|NCT04233879|584710541|FG001|Overall Study|Physician Decision|4|||
161907077|NCT04233879|584710540|FG000|Overall Study|Withdrawal by Subject|7|||
161907078|NCT04233879|584710541|FG001|Overall Study|Withdrawal by Subject|10|||
161907079|NCT04233879|584710540|FG000|Overall Study|Other|281|||
161907080|NCT04233879|584710541|FG001|Overall Study|Other|279|||
161907081|NCT01802385|584710545|FG000|Overall Study|Death|106|||
161907082|NCT01802385|584710546|FG001|Overall Study|Death|120|||
161907083|NCT03810183|584710547|FG000|Overall Study|Study terminated by Sponsor|2|||
161907084|NCT03810183|584710548|FG001|Overall Study|Study terminated by Sponsor|1|||
161907085|NCT00323063|584710550|FG000|Overall Study|Adverse Event|1|||
161907086|NCT00323063|584710551|FG001|Overall Study|Adverse Event|0|||
161907087|NCT00323063|584710550|FG000|Overall Study|brain mets discovered prior to treatment|1|||
161907088|NCT00323063|584710551|FG001|Overall Study|brain mets discovered prior to treatment|0|||
161907089|NCT05002972|584710553|FG000|Overall Study|Withdrawal by Subject|2|||
161907090|NCT01664091|584710554|FG000|Overall Study|Death|1|||
161907091|NCT01664091|584710554|FG000|Overall Study|Disease Progression|2|||
161907092|NCT01664091|584710554|FG000|Overall Study|Lost to Follow-up|2|||
161907093|NCT01664091|584710554|FG000|Overall Study|Withdrawal by Subject|1|||
161907094|NCT02053493|584710557|FG000|Overall Study|Withdrawal by Subject|1|||
161907095|NCT02053493|584710558|FG001|Overall Study|Withdrawal by Subject|1|||
161907096|NCT01076543|584710561|FG000|Overall Study|Withdrawal by Subject|2|||
161907097|NCT01076543|584710562|FG001|Overall Study|Withdrawal by Subject|0|||
161907098|NCT01076543|584710563|FG002|Overall Study|Withdrawal by Subject|0|||
161907099|NCT01076543|584710564|FG003|Overall Study|Withdrawal by Subject|0|||
161907100|NCT01076543|584710565|FG004|Overall Study|Withdrawal by Subject|0|||
161907101|NCT01076543|584710566|FG005|Overall Study|Withdrawal by Subject|0|||
161907102|NCT00338741|584710567|FG000|Overall Study|Lost to Follow-up|2|||
161907103|NCT00338741|584710568|FG001|Overall Study|Lost to Follow-up|0|||
161907104|NCT01534273|584710569|FG000|Period 1|Physician Decision|0|||
161907105|NCT01534273|584710570|FG001|Period 1|Physician Decision|0|||
161907106|NCT01534273|584710571|FG002|Period 1|Physician Decision|0|||
161907107|NCT01534273|584710572|FG003|Period 1|Physician Decision|1|||
161907108|NCT01534273|584710573|FG004|Period 1|Physician Decision|0|||
161907109|NCT01534273|584710574|FG005|Period 1|Physician Decision|0|||
161907110|NCT01534273|584710575|FG006|Period 1|Physician Decision|0|||
161907111|NCT01619865|584710576|FG000|Overall Study|Adverse Event|1|||
161907112|NCT01619865|584710576|FG000|Overall Study|Death|2|||
161907113|NCT01619865|584710576|FG000|Overall Study|subject not able to comply|1|||
161907114|NCT03586050|584710577|FG000|Overall Study|Death|3|||
161907115|NCT03586050|584710577|FG000|Overall Study|Withdrawal by Subject|2|||
161907116|NCT01494818|584710578|FG000|Overall Study|Relocation|1|||
161907117|NCT01494818|584710579|FG001|Overall Study|Relocation|2|||
161907118|NCT01494818|584710578|FG000|Overall Study|Lost to Follow-up|1|||
161907119|NCT01494818|584710579|FG001|Overall Study|Lost to Follow-up|0|||
161907120|NCT00791999|584710580|FG000|Overall Study|Protocol planed withdrawal|14|||
161907121|NCT00791999|584710581|FG001|Overall Study|Protocol planed withdrawal|11|||
161907122|NCT00791999|584710582|FG002|Overall Study|Protocol planed withdrawal|11|||
161907123|NCT00791999|584710583|FG003|Overall Study|Protocol planed withdrawal|45|||
161907124|NCT00791999|584710580|FG000|Overall Study|Withdrawal by Subject|0|||
162140207|NCT01570751|585565568|FG000|Period B (16 Weeks)|Adverse Event|1|||
162140208|NCT01570751|585565569|FG001|Period B (16 Weeks)|Adverse Event|0|||
162140209|NCT01570751|585565568|FG000|Period B (16 Weeks)|Protocol Violation|0|||
162140210|NCT01570751|585565569|FG001|Period B (16 Weeks)|Protocol Violation|1|||
162140211|NCT01131494|585565574|FG000|Overall Study|Withdrawal by Subject|2|||
162140212|NCT01196988|585565575|FG000|Overall Study|Adverse Event|1|||
162140213|NCT01196988|585565576|FG001|Overall Study|Adverse Event|2|||
162140214|NCT01196988|585565577|FG002|Overall Study|Adverse Event|0|||
162140215|NCT01196988|585565578|FG003|Overall Study|Adverse Event|0|||
161907125|NCT00791999|584710581|FG001|Overall Study|Withdrawal by Subject|1|||
161907126|NCT00791999|584710582|FG002|Overall Study|Withdrawal by Subject|0|||
161907127|NCT00791999|584710583|FG003|Overall Study|Withdrawal by Subject|2|||
161907128|NCT00791999|584710580|FG000|Overall Study|Protocol Violation|3|||
161907129|NCT00791999|584710581|FG001|Overall Study|Protocol Violation|0|||
161907130|NCT00791999|584710582|FG002|Overall Study|Protocol Violation|1|||
161907131|NCT00791999|584710583|FG003|Overall Study|Protocol Violation|0|||
162140216|NCT01196988|585565575|FG000|Overall Study|Withdrawal by Subject|5|||
161907132|NCT00791999|584710580|FG000|Overall Study|Adverse Event|3|||
161907133|NCT00791999|584710581|FG001|Overall Study|Adverse Event|3|||
162140217|NCT01196988|585565576|FG001|Overall Study|Withdrawal by Subject|1|||
161907134|NCT00791999|584710582|FG002|Overall Study|Adverse Event|7|||
161907135|NCT00791999|584710583|FG003|Overall Study|Adverse Event|3|||
162140218|NCT01196988|585565577|FG002|Overall Study|Withdrawal by Subject|4|||
161907136|NCT00791999|584710580|FG000|Overall Study|Lack of Efficacy|0|||
161907137|NCT00791999|584710581|FG001|Overall Study|Lack of Efficacy|1|||
161907138|NCT00791999|584710582|FG002|Overall Study|Lack of Efficacy|0|||
161907139|NCT00791999|584710583|FG003|Overall Study|Lack of Efficacy|2|||
161907140|NCT00791999|584710580|FG000|Overall Study|Reason other than those above|1|||
161907141|NCT00791999|584710581|FG001|Overall Study|Reason other than those above|0|||
161907142|NCT00791999|584710582|FG002|Overall Study|Reason other than those above|1|||
161907143|NCT00791999|584710583|FG003|Overall Study|Reason other than those above|0|||
161907144|NCT00617357|584710586|FG000|Overall Study|Lost to Follow-up|7|||
161907145|NCT00617357|584710586|FG000|Overall Study|Death|5|||
161907146|NCT00617357|584710586|FG000|Overall Study|insurance concerns|2|||
161907147|NCT00617357|584710586|FG000|Overall Study|Withdrawal by Subject|1|||
161907148|NCT00617357|584710586|FG000|Overall Study|Physician Decision|1|||
161907149|NCT02153918|584710591|FG000|Overall Study|Refused further treatment|1|||
161907150|NCT03327324|584710592|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907151|NCT03327324|584710593|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
161907152|NCT03327324|584710594|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161803859|NCT00440557|584325226|FG000|Overall Study|Patient moved|1|||
161803860|NCT00440557|584325227|FG001|Overall Study|Patient moved|2|||
161803861|NCT00440557|584325228|FG002|Overall Study|Patient moved|1|||
161803862|NCT00440557|584325226|FG000|Overall Study|Principal Investigator's office closed|3|||
161803863|NCT00440557|584325227|FG001|Overall Study|Principal Investigator's office closed|6|||
161803864|NCT00440557|584325228|FG002|Overall Study|Principal Investigator's office closed|4|||
161803865|NCT00440557|584325226|FG000|Overall Study|Patient transferred to nursing home|0|||
161803866|NCT00440557|584325227|FG001|Overall Study|Patient transferred to nursing home|1|||
161803867|NCT00440557|584325228|FG002|Overall Study|Patient transferred to nursing home|0|||
161803868|NCT00440557|584325226|FG000|Overall Study|Patient had surgery|1|||
161803869|NCT00440557|584325227|FG001|Overall Study|Patient had surgery|0|||
161803870|NCT00440557|584325228|FG002|Overall Study|Patient had surgery|0|||
161803871|NCT01939197|584325229|FG000|Overall Study|Withdrawal by Subject|1|||
161803872|NCT01939197|584325230|FG001|Overall Study|Withdrawal by Subject|0|||
161803873|NCT01939197|584325231|FG002|Overall Study|Withdrawal by Subject|0|||
161803874|NCT01939197|584325232|FG003|Overall Study|Withdrawal by Subject|0|||
161803875|NCT01939197|584325233|FG004|Overall Study|Withdrawal by Subject|1|||
161803876|NCT01939197|584325234|FG005|Overall Study|Withdrawal by Subject|0|||
161803877|NCT01939197|584325235|FG006|Overall Study|Withdrawal by Subject|0|||
161803878|NCT01939197|584325229|FG000|Overall Study|Lost to Follow-up|0|||
161803879|NCT01939197|584325230|FG001|Overall Study|Lost to Follow-up|1|||
161803880|NCT01939197|584325231|FG002|Overall Study|Lost to Follow-up|0|||
161803881|NCT01939197|584325232|FG003|Overall Study|Lost to Follow-up|1|||
161803882|NCT01939197|584325233|FG004|Overall Study|Lost to Follow-up|3|||
161803883|NCT01939197|584325234|FG005|Overall Study|Lost to Follow-up|1|||
161803884|NCT01939197|584325235|FG006|Overall Study|Lost to Follow-up|2|||
161803885|NCT04977336|584325236|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
161803886|NCT04977336|584325237|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161803887|NCT04977336|584325238|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161803888|NCT04977336|584325239|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
161803889|NCT04977336|584325240|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
161803890|NCT04977336|584325236|FG000|Overall Study|Lost to Follow-up|0|||
161803891|NCT04977336|584325237|FG001|Overall Study|Lost to Follow-up|0|||
161803892|NCT04977336|584325238|FG002|Overall Study|Lost to Follow-up|1|||
161803893|NCT04977336|584325239|FG003|Overall Study|Lost to Follow-up|0|||
161803894|NCT04977336|584325240|FG004|Overall Study|Lost to Follow-up|0|||
161803895|NCT02480764|584325242|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
161803896|NCT02480764|584325243|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
161803897|NCT02480764|584325244|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
161803898|NCT02480764|584325242|FG000|Overall Study|Major Protocol Deviation|1|||
161803899|NCT02480764|584325243|FG001|Overall Study|Major Protocol Deviation|4|||
161803900|NCT02480764|584325244|FG002|Overall Study|Major Protocol Deviation|3|||
161803901|NCT02480764|584325242|FG000|Overall Study|Lost to Follow-up|0|||
161803902|NCT02480764|584325243|FG001|Overall Study|Lost to Follow-up|1|||
161803903|NCT02480764|584325244|FG002|Overall Study|Lost to Follow-up|2|||
161803904|NCT02480764|584325242|FG000|Overall Study|Voluntary Withdrawal|6|||
161803905|NCT02480764|584325243|FG001|Overall Study|Voluntary Withdrawal|5|||
161803906|NCT02480764|584325244|FG002|Overall Study|Voluntary Withdrawal|10|||
161803907|NCT02480764|584325242|FG000|Overall Study|Lack of Efficacy|0|||
161803908|NCT02480764|584325243|FG001|Overall Study|Lack of Efficacy|3|||
161907153|NCT03327324|584710595|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
161803909|NCT02480764|584325244|FG002|Overall Study|Lack of Efficacy|3|||
161803910|NCT02480764|584325242|FG000|Overall Study|Reason not Specified|0|||
161803911|NCT02480764|584325243|FG001|Overall Study|Reason not Specified|1|||
161803912|NCT02480764|584325244|FG002|Overall Study|Reason not Specified|0|||
161803913|NCT01030965|584325247|FG000|Overall Study|Lack of Efficacy|3|||
162140219|NCT01196988|585565578|FG003|Overall Study|Withdrawal by Subject|0|||
162140220|NCT01196988|585565575|FG000|Overall Study|Lost to Follow-up|16|||
162140221|NCT01196988|585565576|FG001|Overall Study|Lost to Follow-up|29|||
162140222|NCT01196988|585565577|FG002|Overall Study|Lost to Follow-up|21|||
162140223|NCT01196988|585565578|FG003|Overall Study|Lost to Follow-up|1|||
162140224|NCT01196988|585565575|FG000|Overall Study|Other|2|||
161803914|NCT01030965|584325248|FG001|Overall Study|Lack of Efficacy|2|||
161803915|NCT01030965|584325249|FG002|Overall Study|Lack of Efficacy|0|||
161803916|NCT01030965|584325250|FG003|Overall Study|Lack of Efficacy|3|||
161803917|NCT01030965|584325247|FG000|Overall Study|Protocol Violation|1|||
161803918|NCT01030965|584325248|FG001|Overall Study|Protocol Violation|1|||
161803919|NCT01030965|584325249|FG002|Overall Study|Protocol Violation|1|||
161803920|NCT01030965|584325250|FG003|Overall Study|Protocol Violation|1|||
161803921|NCT01030965|584325247|FG000|Overall Study|Adverse Event|0|||
161803922|NCT01030965|584325248|FG001|Overall Study|Adverse Event|1|||
161803923|NCT01030965|584325249|FG002|Overall Study|Adverse Event|2|||
161803924|NCT01030965|584325250|FG003|Overall Study|Adverse Event|1|||
161803925|NCT01030965|584325247|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
161803926|NCT01030965|584325248|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
161803927|NCT01030965|584325249|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
161803928|NCT01030965|584325250|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
161803929|NCT01030965|584325247|FG000|Overall Study|Withdrawal by Subject|0|||
161803930|NCT01030965|584325248|FG001|Overall Study|Withdrawal by Subject|1|||
161803931|NCT01030965|584325249|FG002|Overall Study|Withdrawal by Subject|0|||
161803932|NCT01030965|584325250|FG003|Overall Study|Withdrawal by Subject|2|||
161803933|NCT02097290|584325251|FG000|Overall Study|Death|6|||
161803934|NCT02097290|584325251|FG000|Overall Study|Total Withdrawals|3|||
161803935|NCT02097290|584325251|FG000|Overall Study|Attempt|8|||
161803936|NCT03991494|584325252|FG000|Overall Study|Progressive Disease|4|||
161803937|NCT05277389|584325253|FG000|Overall Study|Lost to Follow-up|1|||
161803938|NCT05277389|584325254|FG001|Overall Study|Lost to Follow-up|4|||
161803939|NCT00591630|584325262|FG000|Overall Study|Death|0|||
161803940|NCT00591630|584325263|FG001|Overall Study|Death|0|||
161803941|NCT00591630|584325264|FG002|Overall Study|Death|1|||
161803942|NCT00591630|584325265|FG003|Overall Study|Death|0|||
161803943|NCT01432171|584325266|FG000|Overall Study|Death|1|||
161803944|NCT01432171|584325267|FG001|Overall Study|Death|2|||
161803945|NCT01432171|584325266|FG000|Overall Study|Lost to Follow-up|6|||
161803946|NCT01432171|584325267|FG001|Overall Study|Lost to Follow-up|5|||
161803947|NCT01432171|584325266|FG000|Overall Study|Withdrawal by Subject|3|||
161803948|NCT01432171|584325267|FG001|Overall Study|Withdrawal by Subject|1|||
161803949|NCT01432171|584325266|FG000|Overall Study|Noncompliance|2|||
161803950|NCT01432171|584325267|FG001|Overall Study|Noncompliance|3|||
161803951|NCT01432171|584325266|FG000|Overall Study|Insurance denial trial coverage|1|||
161803952|NCT01432171|584325267|FG001|Overall Study|Insurance denial trial coverage|0|||
161803953|NCT01432171|584325266|FG000|Overall Study|Patient moved to palliative care|1|||
161803954|NCT01432171|584325267|FG001|Overall Study|Patient moved to palliative care|0|||
161803955|NCT02863575|584325268|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
161803956|NCT02863575|584325269|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
162140225|NCT01196988|585565576|FG001|Overall Study|Other|0|||
162140226|NCT01196988|585565577|FG002|Overall Study|Other|0|||
162140227|NCT01196988|585565578|FG003|Overall Study|Other|0|||
162140228|NCT05419557|585565580|FG000|Overall Study|Lost to Follow-up|11|||
162140229|NCT05419557|585565581|FG001|Overall Study|Lost to Follow-up|4|||
162140230|NCT02281318|585565583|FG000|Overall Study|Adverse Event|2|||
162140231|NCT02281318|585565584|FG001|Overall Study|Adverse Event|2|||
162140232|NCT02281318|585565583|FG000|Overall Study|Lack of Efficacy|2|||
162140233|NCT02281318|585565584|FG001|Overall Study|Lack of Efficacy|0|||
161803957|NCT02863575|584325270|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
161803958|NCT02863575|584325268|FG000|Overall Study|Withdrawal by Subject|0|||
161803959|NCT02863575|584325269|FG001|Overall Study|Withdrawal by Subject|1|||
161803960|NCT02863575|584325270|FG002|Overall Study|Withdrawal by Subject|1|||
161803961|NCT02863575|584325268|FG000|Overall Study|Adverse Event|0|||
161803962|NCT02863575|584325269|FG001|Overall Study|Adverse Event|1|||
161803963|NCT02863575|584325270|FG002|Overall Study|Adverse Event|0|||
161803964|NCT01248247|584326613|FG000|Overall Study|Adverse Event|2|||
161803965|NCT01248247|584326614|FG001|Overall Study|Adverse Event|4|||
161803966|NCT01248247|584326615|FG002|Overall Study|Adverse Event|4|||
161803967|NCT01248247|584326616|FG003|Overall Study|Adverse Event|2|||
161803968|NCT01248247|584326613|FG000|Overall Study|Death|0|||
161803969|NCT01248247|584326614|FG001|Overall Study|Death|1|||
161803970|NCT01248247|584326615|FG002|Overall Study|Death|4|||
161803971|NCT01248247|584326616|FG003|Overall Study|Death|7|||
161803972|NCT01248247|584326613|FG000|Overall Study|Lost to Follow-up|0|||
161803973|NCT01248247|584326614|FG001|Overall Study|Lost to Follow-up|1|||
161803974|NCT01248247|584326615|FG002|Overall Study|Lost to Follow-up|1|||
161803975|NCT01248247|584326616|FG003|Overall Study|Lost to Follow-up|0|||
161803976|NCT01248247|584326613|FG000|Overall Study|Alternative treatment|0|||
161803977|NCT01248247|584326614|FG001|Overall Study|Alternative treatment|1|||
162140234|NCT02281318|585565583|FG000|Overall Study|Lost to Follow-up|2|||
161803978|NCT01248247|584326615|FG002|Overall Study|Alternative treatment|0|||
161803979|NCT01248247|584326616|FG003|Overall Study|Alternative treatment|0|||
161803980|NCT01248247|584326613|FG000|Overall Study|Other|2|||
161803981|NCT01248247|584326614|FG001|Overall Study|Other|8|||
161803982|NCT01248247|584326615|FG002|Overall Study|Other|8|||
161803983|NCT01248247|584326616|FG003|Overall Study|Other|5|||
161803984|NCT01248247|584326613|FG000|Overall Study|Progression|18|||
161803985|NCT01248247|584326614|FG001|Overall Study|Progression|27|||
161803986|NCT01248247|584326615|FG002|Overall Study|Progression|56|||
161803987|NCT01248247|584326616|FG003|Overall Study|Progression|44|||
161803988|NCT01248247|584326613|FG000|Overall Study|Refuse further treatment|0|||
161803989|NCT01248247|584326614|FG001|Overall Study|Refuse further treatment|0|||
161803990|NCT01248247|584326615|FG002|Overall Study|Refuse further treatment|1|||
161803991|NCT01248247|584326616|FG003|Overall Study|Refuse further treatment|2|||
161803992|NCT01248247|584326613|FG000|Overall Study|Complicating disease|0|||
161803993|NCT01248247|584326614|FG001|Overall Study|Complicating disease|0|||
161803994|NCT01248247|584326615|FG002|Overall Study|Complicating disease|1|||
161803995|NCT01248247|584326616|FG003|Overall Study|Complicating disease|1|||
161803996|NCT00549718|584326617|FG000|Overall Study|Insufficient clinical response|20|||
161803997|NCT00549718|584326618|FG001|Overall Study|Insufficient clinical response|7|||
161803998|NCT00549718|584326619|FG002|Overall Study|Insufficient clinical response|18|||
161803999|NCT00549718|584326620|FG003|Overall Study|Insufficient clinical response|32|||
161804000|NCT00549718|584326617|FG000|Overall Study|Adverse Event|6|||
161804001|NCT00549718|584326618|FG001|Overall Study|Adverse Event|8|||
161804002|NCT00549718|584326619|FG002|Overall Study|Adverse Event|7|||
161804003|NCT00549718|584326620|FG003|Overall Study|Adverse Event|3|||
161804004|NCT00549718|584326617|FG000|Overall Study|Lost to Follow-up|4|||
161804005|NCT00549718|584326618|FG001|Overall Study|Lost to Follow-up|2|||
161804006|NCT00549718|584326619|FG002|Overall Study|Lost to Follow-up|0|||
161804007|NCT00549718|584326620|FG003|Overall Study|Lost to Follow-up|6|||
161804008|NCT00549718|584326617|FG000|Overall Study|Withdrawal by Subject|9|||
161804009|NCT00549718|584326618|FG001|Overall Study|Withdrawal by Subject|18|||
161804010|NCT00549718|584326619|FG002|Overall Study|Withdrawal by Subject|12|||
161804011|NCT00549718|584326620|FG003|Overall Study|Withdrawal by Subject|13|||
161804012|NCT00549718|584326617|FG000|Overall Study|Administrative|2|||
161804013|NCT00549718|584326618|FG001|Overall Study|Administrative|2|||
161804014|NCT00549718|584326619|FG002|Overall Study|Administrative|2|||
161804015|NCT00549718|584326620|FG003|Overall Study|Administrative|1|||
161804016|NCT00397488|584326621|FG000|Overall Study|Withdrawal by Subject|3|||
161804017|NCT00397488|584326621|FG000|Overall Study|Adverse Event|3|||
161804018|NCT00397488|584326621|FG000|Overall Study|Death|1|||
161804019|NCT02880761|584326625|FG000|Overall Study|Death|6|||
161804020|NCT02880761|584326626|FG001|Overall Study|Death|8|||
161804021|NCT02880761|584326625|FG000|Overall Study|Withdrawal by Subject|3|||
161804022|NCT02880761|584326626|FG001|Overall Study|Withdrawal by Subject|6|||
161804023|NCT02880761|584326625|FG000|Overall Study|Protocol Violation|4|||
161804024|NCT02880761|584326626|FG001|Overall Study|Protocol Violation|3|||
161804025|NCT02880761|584326625|FG000|Overall Study|Lost to Follow-up|3|||
161804026|NCT02880761|584326626|FG001|Overall Study|Lost to Follow-up|4|||
161804027|NCT02943447|584326627|FG000|Blinded Study Phase|Withdrew Consent|1|||
161804028|NCT02943447|584326628|FG001|Blinded Study Phase|Withdrew Consent|2|||
161804029|NCT02943447|584326629|FG002|Blinded Study Phase|Withdrew Consent|1|||
161804030|NCT02943447|584326627|FG000|Blinded Study Phase|Adverse Event|3|||
161804031|NCT02943447|584326628|FG001|Blinded Study Phase|Adverse Event|0|||
161804032|NCT02943447|584326629|FG002|Blinded Study Phase|Adverse Event|0|||
161804033|NCT02943447|584326627|FG000|Blinded Study Phase|Investigator's discretion|1|||
161804034|NCT02943447|584326628|FG001|Blinded Study Phase|Investigator's discretion|0|||
161804035|NCT02943447|584326629|FG002|Blinded Study Phase|Investigator's discretion|0|||
161804036|NCT02943447|584326627|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
161804037|NCT02943447|584326628|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
161804038|NCT02943447|584326629|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
161804039|NCT02943447|584326627|FG000|Open-Label Extension Phase|Adverse Event|4|||
161804040|NCT02943447|584326628|FG001|Open-Label Extension Phase|Adverse Event|7|||
161804041|NCT02943447|584326629|FG002|Open-Label Extension Phase|Adverse Event|3|||
161804042|NCT02943447|584326627|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
161804043|NCT02943447|584326628|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
161804044|NCT02943447|584326629|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
161804045|NCT02943447|584326627|FG000|Open-Label Extension Phase|Withdrew consent|1|||
161804046|NCT02943447|584326628|FG001|Open-Label Extension Phase|Withdrew consent|1|||
161804047|NCT02943447|584326629|FG002|Open-Label Extension Phase|Withdrew consent|1|||
161804048|NCT02943447|584326627|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
161804049|NCT02943447|584326628|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
161804050|NCT02943447|584326629|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
161804051|NCT02106156|584326630|FG000|Overall Study|Patient Died|19|||
161804052|NCT02106156|584326631|FG001|Overall Study|Patient Died|0|||
161804053|NCT02106156|584326632|FG002|Overall Study|Patient Died|0|||
161907154|NCT03327324|584710596|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907155|NCT03327324|584710597|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
161907156|NCT03327324|584710592|FG000|Baseline (Month 0-Month 3)|Refused|0|||
161907157|NCT03327324|584710593|FG001|Baseline (Month 0-Month 3)|Refused|0|||
161907158|NCT03327324|584710594|FG002|Baseline (Month 0-Month 3)|Refused|0|||
161907159|NCT03327324|584710595|FG003|Baseline (Month 0-Month 3)|Refused|0|||
161907160|NCT03327324|584710596|FG004|Baseline (Month 0-Month 3)|Refused|1|||
161907161|NCT03327324|584710597|FG005|Baseline (Month 0-Month 3)|Refused|0|||
161907162|NCT03327324|584710592|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161907163|NCT03327324|584710593|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
161907164|NCT03327324|584710594|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161907165|NCT03327324|584710595|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161907166|NCT03327324|584710596|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161907167|NCT03327324|584710597|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161907168|NCT03327324|584710592|FG000|Baseline (Month 0-Month 3)|Death|0|||
161907169|NCT03327324|584710593|FG001|Baseline (Month 0-Month 3)|Death|0|||
161907170|NCT03327324|584710594|FG002|Baseline (Month 0-Month 3)|Death|0|||
161907171|NCT03327324|584710595|FG003|Baseline (Month 0-Month 3)|Death|0|||
161907172|NCT03327324|584710596|FG004|Baseline (Month 0-Month 3)|Death|1|||
161907173|NCT03327324|584710597|FG005|Baseline (Month 0-Month 3)|Death|0|||
161907174|NCT03327324|584710592|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907175|NCT03327324|584710593|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907176|NCT03327324|584710594|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907177|NCT03327324|584710595|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907178|NCT03327324|584710596|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907179|NCT03327324|584710597|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
161907180|NCT03327324|584710592|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907181|NCT03327324|584710593|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907182|NCT03327324|584710594|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
161907183|NCT03327324|584710595|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907184|NCT03327324|584710596|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907185|NCT03327324|584710597|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907186|NCT03327324|584710592|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
161907187|NCT03327324|584710593|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
161907188|NCT03327324|584710594|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
161907189|NCT03327324|584710595|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
161907190|NCT03327324|584710596|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
161907191|NCT03327324|584710597|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
161907192|NCT03327324|584710592|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
161907193|NCT03327324|584710593|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161907194|NCT03327324|584710594|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161907195|NCT03327324|584710595|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161907196|NCT03327324|584710596|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161907197|NCT03327324|584710597|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161907198|NCT03327324|584710592|FG000|Intervention (Month 3-Month 6)|Death|1|||
161907199|NCT03327324|584710593|FG001|Intervention (Month 3-Month 6)|Death|0|||
161907200|NCT03327324|584710594|FG002|Intervention (Month 3-Month 6)|Death|1|||
161907201|NCT03327324|584710595|FG003|Intervention (Month 3-Month 6)|Death|1|||
161907202|NCT03327324|584710596|FG004|Intervention (Month 3-Month 6)|Death|1|||
161907203|NCT03327324|584710597|FG005|Intervention (Month 3-Month 6)|Death|0|||
161907204|NCT03327324|584710592|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907205|NCT03327324|584710593|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907206|NCT03327324|584710594|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907207|NCT03327324|584710595|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907208|NCT03327324|584710596|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907209|NCT03327324|584710597|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
161907210|NCT03327324|584710592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
161942202|NCT02082977|584838342|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
161907211|NCT03327324|584710593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907212|NCT03327324|584710594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907213|NCT03327324|584710595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907214|NCT03327324|584710596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907215|NCT03327324|584710597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161907216|NCT03327324|584710592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
161907217|NCT03327324|584710593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
161907218|NCT03327324|584710594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
161907219|NCT03327324|584710595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
161907220|NCT03327324|584710596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
161907221|NCT03327324|584710597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
161907222|NCT03327324|584710592|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
161907223|NCT03327324|584710593|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
161907224|NCT03327324|584710594|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
161907225|NCT03327324|584710595|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
161907226|NCT03327324|584710596|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
161907227|NCT03327324|584710597|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
161907228|NCT03327324|584710592|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907229|NCT03327324|584710593|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907230|NCT03327324|584710594|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907231|NCT03327324|584710595|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
161907232|NCT03327324|584710596|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
161907233|NCT03327324|584710597|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161907234|NCT03327324|584710592|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
161907235|NCT03327324|584710593|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161907236|NCT03327324|584710594|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161907237|NCT03327324|584710595|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161907238|NCT03327324|584710596|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161907239|NCT03327324|584710597|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161907240|NCT03327324|584710592|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
161907241|NCT03327324|584710593|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161907242|NCT03327324|584710594|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161907243|NCT03327324|584710595|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161907244|NCT03327324|584710596|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161907245|NCT03327324|584710597|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161907246|NCT01791985|584710598|FG000|Overall Study|Adverse Event|7|||
161907247|NCT01791985|584710598|FG000|Overall Study|Withdrawal by Subject|1|||
161907248|NCT01103323|584710599|FG000|Without/Before Drug Switch|Adverse Event|50|||
161907249|NCT01103323|584710600|FG001|Without/Before Drug Switch|Adverse Event|7|||
161907250|NCT01103323|584710599|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
161907251|NCT01103323|584710600|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
161907252|NCT01103323|584710599|FG000|Without/Before Drug Switch|Protocol Violation|2|||
161907253|NCT01103323|584710600|FG001|Without/Before Drug Switch|Protocol Violation|0|||
161907254|NCT01103323|584710599|FG000|Without/Before Drug Switch|Physician Decision|2|||
161907255|NCT01103323|584710600|FG001|Without/Before Drug Switch|Physician Decision|0|||
161907256|NCT01103323|584710599|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
161907257|NCT01103323|584710600|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
161907258|NCT01103323|584710599|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
161907259|NCT01103323|584710600|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
161907260|NCT01103323|584710599|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
161907261|NCT01103323|584710600|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
161907262|NCT01946204|584710606|FG000|Overall Study|Death|38|||
161907263|NCT01946204|584710607|FG001|Overall Study|Death|59|||
161907264|NCT01946204|584710606|FG000|Overall Study|Withdrawal by Subject|37|||
161907265|NCT01946204|584710607|FG001|Overall Study|Withdrawal by Subject|50|||
161907266|NCT01946204|584710606|FG000|Overall Study|Lost to Follow-up|3|||
161907267|NCT01946204|584710607|FG001|Overall Study|Lost to Follow-up|7|||
161907268|NCT01946204|584710606|FG000|Overall Study|Ongoing|316|||
161907269|NCT01946204|584710607|FG001|Overall Study|Ongoing|687|||
161907270|NCT01946204|584710606|FG000|Overall Study|Other|7|||
161907271|NCT01946204|584710607|FG001|Overall Study|Other|3|||
161907272|NCT03797898|584710608|FG000|Overall Study|Lost to Follow-up|60|||
161907273|NCT03797898|584710609|FG001|Overall Study|Lost to Follow-up|69|||
161804054|NCT02106156|584326630|FG000|Overall Study|Lack of Tolerability|305|||
161804055|NCT02106156|584326631|FG001|Overall Study|Lack of Tolerability|3|||
161804056|NCT02106156|584326632|FG002|Overall Study|Lack of Tolerability|0|||
161804057|NCT02106156|584326630|FG000|Overall Study|Lack of Virological Response|1044|||
161804058|NCT02106156|584326631|FG001|Overall Study|Lack of Virological Response|8|||
161804059|NCT02106156|584326632|FG002|Overall Study|Lack of Virological Response|0|||
161804060|NCT02106156|584326630|FG000|Overall Study|Concomitant Disease|74|||
161804061|NCT02106156|584326631|FG001|Overall Study|Concomitant Disease|2|||
161804062|NCT02106156|584326632|FG002|Overall Study|Concomitant Disease|0|||
161804063|NCT02106156|584326630|FG000|Overall Study|Lack of Compliance|211|||
161804064|NCT02106156|584326631|FG001|Overall Study|Lack of Compliance|7|||
161804065|NCT02106156|584326632|FG002|Overall Study|Lack of Compliance|0|||
161804066|NCT02106156|584326630|FG000|Overall Study|Patients Request|307|||
161804067|NCT02106156|584326631|FG001|Overall Study|Patients Request|9|||
161804068|NCT02106156|584326632|FG002|Overall Study|Patients Request|0|||
161804069|NCT02106156|584326630|FG000|Overall Study|Lost to Follow-up|451|||
161804070|NCT02106156|584326631|FG001|Overall Study|Lost to Follow-up|8|||
161804071|NCT02106156|584326632|FG002|Overall Study|Lost to Follow-up|0|||
161804072|NCT02106156|584326630|FG000|Overall Study|Unplanned Event|82|||
161804073|NCT02106156|584326631|FG001|Overall Study|Unplanned Event|2|||
161804074|NCT02106156|584326632|FG002|Overall Study|Unplanned Event|0|||
161804075|NCT02106156|584326630|FG000|Overall Study|Change of Laboratory Parameter|10|||
161804076|NCT02106156|584326631|FG001|Overall Study|Change of Laboratory Parameter|0|||
161804077|NCT02106156|584326632|FG002|Overall Study|Change of Laboratory Parameter|0|||
161804078|NCT02106156|584326630|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
161804079|NCT02106156|584326631|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
161804080|NCT02106156|584326632|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
161804081|NCT02106156|584326630|FG000|Overall Study|Relocation/Change of Physician|40|||
161804082|NCT02106156|584326631|FG001|Overall Study|Relocation/Change of Physician|1|||
161804083|NCT02106156|584326632|FG002|Overall Study|Relocation/Change of Physician|0|||
161804084|NCT01136382|584326635|FG000|Overall Study|Other|8|||
161804085|NCT01136382|584326636|FG001|Overall Study|Other|3|||
161804086|NCT01136382|584326635|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
161804087|NCT01136382|584326636|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
161804088|NCT01136382|584326635|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
161804089|NCT01136382|584326636|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
161804090|NCT01136382|584326635|FG000|Overall Study|Withdrawal by Subject|4|||
161804091|NCT01136382|584326636|FG001|Overall Study|Withdrawal by Subject|1|||
161804092|NCT00358449|584326640|FG000|Overall Study|Adverse Event|1|||
161804093|NCT00358449|584326641|FG001|Overall Study|Adverse Event|0|||
161804094|NCT00358449|584326642|FG002|Overall Study|Adverse Event|1|||
161804095|NCT00358449|584326640|FG000|Overall Study|Lost to Follow-up|1|||
161804096|NCT00358449|584326641|FG001|Overall Study|Lost to Follow-up|0|||
161804097|NCT00358449|584326642|FG002|Overall Study|Lost to Follow-up|0|||
161804098|NCT00358449|584326640|FG000|Overall Study|Withdrawal by Subject|2|||
161804099|NCT00358449|584326641|FG001|Overall Study|Withdrawal by Subject|0|||
161804100|NCT00358449|584326642|FG002|Overall Study|Withdrawal by Subject|0|||
161804101|NCT00358449|584326640|FG000|Overall Study|Lack of Efficacy|0|||
161804102|NCT00358449|584326641|FG001|Overall Study|Lack of Efficacy|1|||
161804103|NCT00358449|584326642|FG002|Overall Study|Lack of Efficacy|0|||
161804104|NCT00358449|584326640|FG000|Overall Study|Steriod Inhaler was Increased|0|||
161804105|NCT00358449|584326641|FG001|Overall Study|Steriod Inhaler was Increased|0|||
161804106|NCT00358449|584326642|FG002|Overall Study|Steriod Inhaler was Increased|1|||
161804107|NCT01804270|584326643|FG000|Overall Study|Withdrawal by Subject|1|||
161804108|NCT01804270|584326644|FG001|Overall Study|Withdrawal by Subject|1|||
161804109|NCT02334722|584326646|FG000|Overall Study|Lost to Follow-up|4|||
161804110|NCT02334722|584326647|FG001|Overall Study|Lost to Follow-up|0|||
161804111|NCT02334722|584326646|FG000|Overall Study|6 week questionnaire not completed|2|||
161804112|NCT02334722|584326647|FG001|Overall Study|6 week questionnaire not completed|0|||
161804113|NCT02334722|584326646|FG000|Overall Study|Unable to obtain medication|1|||
161804114|NCT02334722|584326647|FG001|Overall Study|Unable to obtain medication|1|||
161804115|NCT02334722|584326646|FG000|Overall Study|Withdrawal by Subject|0|||
161804116|NCT02334722|584326647|FG001|Overall Study|Withdrawal by Subject|3|||
161804117|NCT02334722|584326646|FG000|Overall Study|Adverse Event|0|||
161804118|NCT02334722|584326647|FG001|Overall Study|Adverse Event|2|||
161804119|NCT02334722|584326646|FG000|Overall Study|Physician Decision|0|||
161804120|NCT02334722|584326647|FG001|Overall Study|Physician Decision|1|||
161804121|NCT03988803|584326648|FG000|Period 2|Prematurely discontinued from medication|2|||
161804122|NCT03988803|584326648|FG000|Period 2|Adverse Event|1|||
161804123|NCT01617668|584326649|FG000|Overall Study|Adverse Event|7|||
161804124|NCT01617668|584326650|FG001|Overall Study|Adverse Event|0|||
161804125|NCT01617668|584326651|FG002|Overall Study|Adverse Event|12|||
161804126|NCT01617668|584326652|FG003|Overall Study|Adverse Event|5|||
161804127|NCT01617668|584326649|FG000|Overall Study|Physician Decision|1|||
161804128|NCT01617668|584326650|FG001|Overall Study|Physician Decision|2|||
161804129|NCT01617668|584326651|FG002|Overall Study|Physician Decision|3|||
161804130|NCT01617668|584326652|FG003|Overall Study|Physician Decision|0|||
161907274|NCT03797898|584710608|FG000|Overall Study|Withdrawal by Subject|9|||
161907275|NCT03797898|584710609|FG001|Overall Study|Withdrawal by Subject|7|||
161907276|NCT03797898|584710608|FG000|Overall Study|Became ineligible|5|||
161907277|NCT03797898|584710609|FG001|Overall Study|Became ineligible|2|||
161907278|NCT00485069|584710610|FG000|Overall Study|Adverse Event|10|||
161907279|NCT00485069|584710611|FG001|Overall Study|Adverse Event|4|||
161907280|NCT00485069|584710610|FG000|Overall Study|Lack of Efficacy|2|||
161907281|NCT00485069|584710611|FG001|Overall Study|Lack of Efficacy|1|||
161907282|NCT00485069|584710610|FG000|Overall Study|Protocol Violation|0|||
161907283|NCT00485069|584710611|FG001|Overall Study|Protocol Violation|1|||
161907284|NCT00485069|584710610|FG000|Overall Study|Withdrawal by Subject|6|||
161907285|NCT00485069|584710611|FG001|Overall Study|Withdrawal by Subject|6|||
161907286|NCT03217591|584710612|FG000|Overall Study|Adverse Event|1|||
161907287|NCT03217591|584710613|FG001|Overall Study|Adverse Event|2|||
161907288|NCT03217591|584710614|FG002|Overall Study|Adverse Event|6|||
161804131|NCT01617668|584326649|FG000|Overall Study|Progressive Disease|4|||
161907289|NCT03217591|584710612|FG000|Overall Study|Withdrawal by Subject|0|||
161907290|NCT03217591|584710613|FG001|Overall Study|Withdrawal by Subject|1|||
161907291|NCT03217591|584710614|FG002|Overall Study|Withdrawal by Subject|3|||
161907292|NCT03217591|584710612|FG000|Overall Study|Lost to Follow-up|1|||
161804132|NCT01617668|584326650|FG001|Overall Study|Progressive Disease|4|||
161804133|NCT01617668|584326651|FG002|Overall Study|Progressive Disease|6|||
161804134|NCT01617668|584326652|FG003|Overall Study|Progressive Disease|9|||
161804135|NCT01617668|584326649|FG000|Overall Study|Subject/guardian decision|1|||
161804136|NCT01617668|584326650|FG001|Overall Study|Subject/guardian decision|3|||
161804137|NCT01617668|584326651|FG002|Overall Study|Subject/guardian decision|2|||
161804138|NCT01617668|584326652|FG003|Overall Study|Subject/guardian decision|1|||
161804139|NCT00925769|584326653|FG000|Overall Study|Major toxicity|1|||
161804140|NCT00925769|584326654|FG001|Overall Study|Major toxicity|0|||
161804141|NCT00925769|584326655|FG002|Overall Study|Major toxicity|1|||
161804142|NCT00925769|584326656|FG003|Overall Study|Major toxicity|1|||
161804143|NCT00925769|584326657|FG004|Overall Study|Major toxicity|0|||
161804144|NCT00925769|584326658|FG005|Overall Study|Major toxicity|0|||
161804145|NCT00925769|584326653|FG000|Overall Study|Disease progression|4|||
161804146|NCT00925769|584326654|FG001|Overall Study|Disease progression|5|||
161804147|NCT00925769|584326655|FG002|Overall Study|Disease progression|3|||
161804148|NCT00925769|584326656|FG003|Overall Study|Disease progression|4|||
161804149|NCT00925769|584326657|FG004|Overall Study|Disease progression|2|||
161804150|NCT00925769|584326658|FG005|Overall Study|Disease progression|3|||
161804151|NCT00925769|584326653|FG000|Overall Study|Death|0|||
161804152|NCT00925769|584326654|FG001|Overall Study|Death|0|||
161804153|NCT00925769|584326655|FG002|Overall Study|Death|1|||
161804154|NCT00925769|584326656|FG003|Overall Study|Death|0|||
161804155|NCT00925769|584326657|FG004|Overall Study|Death|0|||
161804156|NCT00925769|584326658|FG005|Overall Study|Death|0|||
161804157|NCT00925769|584326653|FG000|Overall Study|Physician Decision|1|||
161804158|NCT00925769|584326654|FG001|Overall Study|Physician Decision|0|||
161804159|NCT00925769|584326655|FG002|Overall Study|Physician Decision|0|||
161804160|NCT00925769|584326656|FG003|Overall Study|Physician Decision|0|||
161804161|NCT00925769|584326657|FG004|Overall Study|Physician Decision|0|||
161804162|NCT00925769|584326658|FG005|Overall Study|Physician Decision|0|||
161804163|NCT00925769|584326653|FG000|Overall Study|Missing documentation|0|||
161804164|NCT00925769|584326654|FG001|Overall Study|Missing documentation|1|||
162140235|NCT02281318|585565584|FG001|Overall Study|Lost to Follow-up|1|||
161907293|NCT03217591|584710613|FG001|Overall Study|Lost to Follow-up|0|||
161907294|NCT03217591|584710614|FG002|Overall Study|Lost to Follow-up|0|||
161907295|NCT03217591|584710612|FG000|Overall Study|Protocol Violation|1|||
161907296|NCT03217591|584710613|FG001|Overall Study|Protocol Violation|0|||
161907297|NCT03217591|584710614|FG002|Overall Study|Protocol Violation|1|||
162140236|NCT02281318|585565583|FG000|Overall Study|Physician Decision|2|||
162140237|NCT02281318|585565584|FG001|Overall Study|Physician Decision|0|||
162140238|NCT02281318|585565583|FG000|Overall Study|Withdrawal by Subject|6|||
162140239|NCT02281318|585565584|FG001|Overall Study|Withdrawal by Subject|2|||
162140240|NCT05257798|585565585|FG000|Follow-up Phase|Lost to Follow-up|1|||
162140241|NCT05257798|585565586|FG001|Follow-up Phase|Lost to Follow-up|0|||
161804165|NCT00925769|584326655|FG002|Overall Study|Missing documentation|0|||
161804166|NCT00925769|584326656|FG003|Overall Study|Missing documentation|0|||
161804167|NCT00925769|584326657|FG004|Overall Study|Missing documentation|0|||
161804168|NCT00925769|584326658|FG005|Overall Study|Missing documentation|0|||
161804169|NCT00925769|584326653|FG000|Overall Study|End of study visit not done|0|||
161804170|NCT00925769|584326654|FG001|Overall Study|End of study visit not done|0|||
161804171|NCT00925769|584326655|FG002|Overall Study|End of study visit not done|1|||
161804172|NCT00925769|584326656|FG003|Overall Study|End of study visit not done|0|||
161907298|NCT00086190|584710615|FG000|Overall Study|Adverse Event|6|||
161907299|NCT00086190|584710616|FG001|Overall Study|Adverse Event|2|||
161804173|NCT00925769|584326657|FG004|Overall Study|End of study visit not done|0|||
161804174|NCT00925769|584326658|FG005|Overall Study|End of study visit not done|0|||
161804175|NCT00925769|584326653|FG000|Overall Study|Participant is unable to swallow drug|0|||
161804176|NCT00925769|584326654|FG001|Overall Study|Participant is unable to swallow drug|0|||
161907300|NCT00086190|584710617|FG002|Overall Study|Adverse Event|2|||
161907301|NCT00086190|584710615|FG000|Overall Study|Withdrawal by Subject|0|||
161907302|NCT00086190|584710616|FG001|Overall Study|Withdrawal by Subject|2|||
161907303|NCT00086190|584710617|FG002|Overall Study|Withdrawal by Subject|2|||
161907304|NCT00086190|584710615|FG000|Overall Study|Protocol Violation|1|||
161907305|NCT00086190|584710616|FG001|Overall Study|Protocol Violation|0|||
161907306|NCT00086190|584710617|FG002|Overall Study|Protocol Violation|0|||
161907307|NCT00086190|584710615|FG000|Overall Study|Moved|1|||
161907308|NCT00086190|584710616|FG001|Overall Study|Moved|0|||
161907309|NCT00086190|584710617|FG002|Overall Study|Moved|0|||
161907310|NCT00086190|584710615|FG000|Overall Study|Worsening depression|0|||
161907311|NCT00086190|584710616|FG001|Overall Study|Worsening depression|0|||
161907312|NCT00086190|584710617|FG002|Overall Study|Worsening depression|2|||
162140242|NCT00703911|585565587|FG000|Overall Study|Death|1|||
161804177|NCT00925769|584326655|FG002|Overall Study|Participant is unable to swallow drug|0|||
161804178|NCT00925769|584326656|FG003|Overall Study|Participant is unable to swallow drug|1|||
161804179|NCT00925769|584326657|FG004|Overall Study|Participant is unable to swallow drug|0|||
161804180|NCT00925769|584326658|FG005|Overall Study|Participant is unable to swallow drug|0|||
161804181|NCT00925769|584326653|FG000|Overall Study|Adverse Event|0|||
161804182|NCT00925769|584326654|FG001|Overall Study|Adverse Event|0|||
161804183|NCT00925769|584326655|FG002|Overall Study|Adverse Event|0|||
161804184|NCT00925769|584326656|FG003|Overall Study|Adverse Event|0|||
161804185|NCT00925769|584326657|FG004|Overall Study|Adverse Event|1|||
161804186|NCT00925769|584326658|FG005|Overall Study|Adverse Event|0|||
161804187|NCT01666730|584326661|FG000|Overall Study|Adverse Event|16|||
161804188|NCT01666730|584326661|FG000|Overall Study|Death|2|||
161804189|NCT01666730|584326661|FG000|Overall Study|Physician Decision|5|||
161804190|NCT01666730|584326661|FG000|Overall Study|Withdrawal by Subject|9|||
161804191|NCT01666730|584326661|FG000|Overall Study|Disease progression/relapse|18|||
161804192|NCT01434693|584326662|FG000|Overall Study|Adverse Event|1|||
161804193|NCT01434693|584326663|FG001|Overall Study|Adverse Event|0|||
161804194|NCT01434693|584326664|FG002|Overall Study|Adverse Event|0|||
161804195|NCT01434693|584326665|FG003|Overall Study|Adverse Event|0|||
161804196|NCT01434693|584326662|FG000|Overall Study|Withdrawal by Subject|1|||
161804197|NCT01434693|584326663|FG001|Overall Study|Withdrawal by Subject|0|||
161804198|NCT01434693|584326664|FG002|Overall Study|Withdrawal by Subject|1|||
161804199|NCT01434693|584326665|FG003|Overall Study|Withdrawal by Subject|1|||
161804200|NCT01434693|584326662|FG000|Overall Study|Lost to Follow-up|1|||
161804201|NCT01434693|584326663|FG001|Overall Study|Lost to Follow-up|0|||
161804202|NCT01434693|584326664|FG002|Overall Study|Lost to Follow-up|0|||
161804203|NCT01434693|584326665|FG003|Overall Study|Lost to Follow-up|0|||
161804204|NCT00912288|584326666|FG000|Overall Study|Death|0|||
161804205|NCT00912288|584326667|FG001|Overall Study|Death|1|||
161804206|NCT00912288|584326666|FG000|Overall Study|Adverse Event|1|||
161804207|NCT00912288|584326667|FG001|Overall Study|Adverse Event|1|||
161804208|NCT00912288|584326666|FG000|Overall Study|Lost to Follow-up|1|||
161804209|NCT00912288|584326667|FG001|Overall Study|Lost to Follow-up|0|||
161804210|NCT00912288|584326666|FG000|Overall Study|Protocol Violation|1|||
161804211|NCT00912288|584326667|FG001|Overall Study|Protocol Violation|0|||
161804212|NCT00912288|584326666|FG000|Overall Study|Withdrawal by Subject|3|||
161804213|NCT00912288|584326667|FG001|Overall Study|Withdrawal by Subject|3|||
161804214|NCT00912288|584326666|FG000|Overall Study|Study terminated by sponsor|34|||
161804215|NCT00912288|584326667|FG001|Overall Study|Study terminated by sponsor|35|||
161804216|NCT00912288|584326666|FG000|Overall Study|Other|1|||
161804217|NCT00912288|584326667|FG001|Overall Study|Other|0|||
161804218|NCT02087904|584326669|FG000|Overall Study|Did Not Receive Study Drug|0|||
161804219|NCT02087904|584326670|FG001|Overall Study|Did Not Receive Study Drug|0|||
161804220|NCT02087904|584326671|FG002|Overall Study|Did Not Receive Study Drug|2|||
161804221|NCT02087904|584326672|FG003|Overall Study|Did Not Receive Study Drug|1|||
161907313|NCT03902613|584710622|FG000|Overall Study|Physician Decision|1|||
161907314|NCT00350545|584712125|FG000|Overall Study|Withdrawal by Subject|2|||
161907315|NCT01190891|584712126|FG000|Overall Study|Protocol Violation|1|||
161907316|NCT01190891|584712127|FG001|Overall Study|Protocol Violation|0|||
161907317|NCT01190891|584712126|FG000|Overall Study|Withdrawal by Subject|5|||
161804222|NCT02087904|584326669|FG000|Overall Study|Adverse Event|8|||
161804223|NCT02087904|584326670|FG001|Overall Study|Adverse Event|4|||
161804224|NCT02087904|584326671|FG002|Overall Study|Adverse Event|4|||
161804225|NCT02087904|584326672|FG003|Overall Study|Adverse Event|12|||
161804226|NCT02087904|584326669|FG000|Overall Study|Lack of Efficacy|3|||
161804227|NCT02087904|584326670|FG001|Overall Study|Lack of Efficacy|6|||
161804228|NCT02087904|584326671|FG002|Overall Study|Lack of Efficacy|3|||
161804229|NCT02087904|584326672|FG003|Overall Study|Lack of Efficacy|2|||
161804230|NCT02087904|584326669|FG000|Overall Study|Other|6|||
161804231|NCT02087904|584326670|FG001|Overall Study|Other|2|||
161804232|NCT02087904|584326671|FG002|Overall Study|Other|4|||
161804233|NCT02087904|584326672|FG003|Overall Study|Other|4|||
161804234|NCT02087904|584326669|FG000|Overall Study|Withdrawal by Subject|8|||
161804235|NCT02087904|584326670|FG001|Overall Study|Withdrawal by Subject|3|||
161804236|NCT02087904|584326671|FG002|Overall Study|Withdrawal by Subject|7|||
161907318|NCT01190891|584712127|FG001|Overall Study|Withdrawal by Subject|0|||
161907319|NCT00301834|584712128|FG000|Overall Study|Death|1|||
161907320|NCT02737358|584712129|FG000|Overall Study|Withdrawal by Subject|7|||
161907321|NCT02737358|584712130|FG001|Overall Study|Withdrawal by Subject|12|||
161907322|NCT02737358|584712129|FG000|Overall Study|Lost to Follow-up|2|||
161907323|NCT02737358|584712130|FG001|Overall Study|Lost to Follow-up|3|||
161907324|NCT00744939|584712131|FG000|Overall Study|Withdrawal by Subject|9|||
161907325|NCT00744939|584712131|FG000|Overall Study|Protocol Violation|13|||
161907326|NCT00744939|584712131|FG000|Overall Study|Death|24|||
161907327|NCT00744939|584712131|FG000|Overall Study|distance|4|||
161907328|NCT00744939|584712131|FG000|Overall Study|Lost to Follow-up|12|||
161907329|NCT00744939|584712131|FG000|Overall Study|Medical history exclusionary|1|||
161907330|NCT00744939|584712131|FG000|Overall Study|Did not receive Magnevist|7|||
161907331|NCT00744939|584712131|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
161907332|NCT00744939|584712131|FG000|Overall Study|coma|1|||
161907333|NCT00744939|584712131|FG000|Overall Study|incorrect race|1|||
161907334|NCT00183430|584712132|FG000|Overall Study|Adverse Event|1|||
161907335|NCT00183430|584712133|FG001|Overall Study|Adverse Event|0|||
161907336|NCT00183430|584712132|FG000|Overall Study|Lost to Follow-up|3|||
161907337|NCT00183430|584712133|FG001|Overall Study|Lost to Follow-up|0|||
161907338|NCT00183430|584712132|FG000|Overall Study|did not meet inclusion criteria|1|||
161907339|NCT00183430|584712133|FG001|Overall Study|did not meet inclusion criteria|0|||
161907340|NCT00183430|584712132|FG000|Overall Study|Withdrawal by Subject|1|||
161907341|NCT00183430|584712133|FG001|Overall Study|Withdrawal by Subject|0|||
161907342|NCT03636256|584712142|FG000|Overall Study|Lost to Follow-up|3|||
161907343|NCT03636256|584712143|FG001|Overall Study|Lost to Follow-up|0|||
161907344|NCT03636256|584712144|FG002|Overall Study|Lost to Follow-up|2|||
161907345|NCT03636256|584712145|FG003|Overall Study|Lost to Follow-up|1|||
161907346|NCT03636256|584712146|FG004|Overall Study|Lost to Follow-up|0|||
161907347|NCT03636256|584712147|FG005|Overall Study|Lost to Follow-up|4|||
161907348|NCT03636256|584712148|FG006|Overall Study|Lost to Follow-up|2|||
161907349|NCT03636256|584712149|FG007|Overall Study|Lost to Follow-up|0|||
161907350|NCT03636256|584712150|FG008|Overall Study|Lost to Follow-up|4|||
161907351|NCT03636256|584712142|FG000|Overall Study|Withdrawal by Subject|0|||
161907352|NCT03636256|584712143|FG001|Overall Study|Withdrawal by Subject|0|||
161907353|NCT03636256|584712144|FG002|Overall Study|Withdrawal by Subject|0|||
161907354|NCT03636256|584712145|FG003|Overall Study|Withdrawal by Subject|0|||
161907355|NCT03636256|584712146|FG004|Overall Study|Withdrawal by Subject|0|||
161907356|NCT03636256|584712147|FG005|Overall Study|Withdrawal by Subject|0|||
161907357|NCT03636256|584712148|FG006|Overall Study|Withdrawal by Subject|0|||
161907358|NCT03636256|584712149|FG007|Overall Study|Withdrawal by Subject|0|||
161907359|NCT03636256|584712150|FG008|Overall Study|Withdrawal by Subject|1|||
161907360|NCT01218308|584712151|FG000|Overall Study|Adverse Event|1|||
161907361|NCT01218308|584712152|FG001|Overall Study|Adverse Event|2|||
161907362|NCT01218308|584712151|FG000|Overall Study|Protocol Violation|0|||
161907363|NCT01218308|584712152|FG001|Overall Study|Protocol Violation|2|||
161907364|NCT01218308|584712151|FG000|Overall Study|Withdrawal by Subject|61|||
161907365|NCT01218308|584712152|FG001|Overall Study|Withdrawal by Subject|64|||
161907366|NCT01218308|584712151|FG000|Overall Study|Lost to Follow-up|27|||
161907367|NCT01218308|584712152|FG001|Overall Study|Lost to Follow-up|31|||
161907368|NCT01218308|584712151|FG000|Overall Study|Other|14|||
161907369|NCT01218308|584712152|FG001|Overall Study|Other|21|||
161907370|NCT02666222|584712160|FG000|Overall Study|Death|2|||
161907371|NCT03504917|584712164|FG000|Blinded Treatment Period|Protocol Violation|1|||
161907372|NCT03504917|584712165|FG001|Blinded Treatment Period|Protocol Violation|0|||
161907373|NCT03504917|584712164|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
161907374|NCT03504917|584712165|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
161907375|NCT03504917|584712164|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
161907376|NCT03504917|584712165|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
161907377|NCT03504917|584712164|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
161907378|NCT03504917|584712165|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
161907379|NCT03504917|584712164|FG000|Blinded Treatment Period|Adverse Event|4|||
161907380|NCT03504917|584712165|FG001|Blinded Treatment Period|Adverse Event|4|||
161907381|NCT03504917|584712164|FG000|Blinded Treatment Period|Physician Decision|1|||
161907382|NCT03504917|584712165|FG001|Blinded Treatment Period|Physician Decision|0|||
161907383|NCT03504917|584712164|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
161907384|NCT03504917|584712165|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
161907385|NCT03504917|584712164|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
161907386|NCT03504917|584712165|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
161907387|NCT03504917|584712164|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
162140243|NCT00703911|585565587|FG000|Overall Study|Physician Decision|6|||
161907388|NCT03504917|584712165|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
161907389|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
161907390|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
162140244|NCT00703911|585565587|FG000|Overall Study|Lost to Follow-up|1|||
161804237|NCT02087904|584326672|FG003|Overall Study|Withdrawal by Subject|4|||
161804238|NCT02087904|584326669|FG000|Overall Study|Lost to Follow-up|0|||
161804239|NCT02087904|584326670|FG001|Overall Study|Lost to Follow-up|4|||
161804240|NCT02087904|584326671|FG002|Overall Study|Lost to Follow-up|2|||
161804241|NCT02087904|584326672|FG003|Overall Study|Lost to Follow-up|2|||
161804242|NCT01735630|584326673|FG000|Overall Study|Adverse Event|8|||
161804243|NCT01735630|584326674|FG001|Overall Study|Adverse Event|7|||
161804244|NCT01735630|584326673|FG000|Overall Study|Lost to Follow-up|1|||
161804245|NCT01735630|584326674|FG001|Overall Study|Lost to Follow-up|0|||
161804246|NCT01735630|584326673|FG000|Overall Study|Physician Decision|0|||
161804247|NCT01735630|584326674|FG001|Overall Study|Physician Decision|1|||
161804248|NCT01735630|584326673|FG000|Overall Study|Sponsor Decision|2|||
161804249|NCT01735630|584326674|FG001|Overall Study|Sponsor Decision|1|||
161804250|NCT01735630|584326673|FG000|Overall Study|Withdrawal by Subject|7|||
161804251|NCT01735630|584326674|FG001|Overall Study|Withdrawal by Subject|9|||
161804252|NCT00891293|584326676|FG000|Overall Study|Adverse Event|2|||
161804253|NCT00891293|584326676|FG000|Overall Study|Protocol Violation|2|||
161804254|NCT00891293|584326676|FG000|Overall Study|Laboratory abnormality|4|||
161804255|NCT00891293|584326676|FG000|Overall Study|Lost to Follow-up|7|||
161804256|NCT00891293|584326676|FG000|Overall Study|Subject withdrew consent|7|||
161804257|NCT00891293|584326676|FG000|Overall Study|Sponsor termination|62|||
161804258|NCT02178722|584326677|FG000|Overall Study|Withdrawal by Subject|0|||
161804259|NCT02178722|584326678|FG001|Overall Study|Withdrawal by Subject|0|||
161804260|NCT02178722|584326679|FG002|Overall Study|Withdrawal by Subject|0|||
161804261|NCT02178722|584326680|FG003|Overall Study|Withdrawal by Subject|2|||
161804262|NCT02178722|584326681|FG004|Overall Study|Withdrawal by Subject|33|||
161804263|NCT02178722|584326677|FG000|Overall Study|Death|2|||
161804264|NCT02178722|584326678|FG001|Overall Study|Death|13|||
161804265|NCT02178722|584326679|FG002|Overall Study|Death|12|||
161804266|NCT02178722|584326680|FG003|Overall Study|Death|12|||
161804267|NCT02178722|584326681|FG004|Overall Study|Death|205|||
161804268|NCT02178722|584326677|FG000|Overall Study|Lost to Follow-up|0|||
161804269|NCT02178722|584326678|FG001|Overall Study|Lost to Follow-up|0|||
161804270|NCT02178722|584326679|FG002|Overall Study|Lost to Follow-up|0|||
161804271|NCT02178722|584326680|FG003|Overall Study|Lost to Follow-up|2|||
161804272|NCT02178722|584326681|FG004|Overall Study|Lost to Follow-up|11|||
161804273|NCT02178722|584326677|FG000|Overall Study|Study terminated by Sponsor|2|||
161804274|NCT02178722|584326678|FG001|Overall Study|Study terminated by Sponsor|7|||
161804275|NCT02178722|584326679|FG002|Overall Study|Study terminated by Sponsor|6|||
161804276|NCT02178722|584326680|FG003|Overall Study|Study terminated by Sponsor|4|||
161804277|NCT02178722|584326681|FG004|Overall Study|Study terminated by Sponsor|128|||
161804278|NCT02178722|584326677|FG000|Overall Study|Physician Decision|0|||
161907391|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
161907392|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
161907393|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
161907394|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
161907395|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
161907396|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
161804279|NCT02178722|584326678|FG001|Overall Study|Physician Decision|0|||
161804280|NCT02178722|584326679|FG002|Overall Study|Physician Decision|0|||
161804281|NCT02178722|584326680|FG003|Overall Study|Physician Decision|0|||
161804282|NCT02178722|584326681|FG004|Overall Study|Physician Decision|3|||
161804283|NCT02178722|584326677|FG000|Overall Study|Other|0|||
161804284|NCT02178722|584326678|FG001|Overall Study|Other|0|||
161907397|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
161907398|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
161907399|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
161804285|NCT02178722|584326679|FG002|Overall Study|Other|0|||
161804286|NCT02178722|584326680|FG003|Overall Study|Other|0|||
161804287|NCT02178722|584326681|FG004|Overall Study|Other|2|||
161804288|NCT01572948|584326682|FG000|Overall Study|Lost to Follow-up|1|||
161804289|NCT01572948|584326683|FG001|Overall Study|Lost to Follow-up|0|||
161804290|NCT01572948|584326682|FG000|Overall Study|unable to contact|0|||
161804291|NCT01572948|584326683|FG001|Overall Study|unable to contact|1|||
161804292|NCT02107092|584326690|FG000|Overall Study|Miscellaneous|3|||
161804293|NCT02107092|584326690|FG000|Overall Study|Subject compliance|3|||
161804294|NCT02107092|584326690|FG000|Overall Study|Hypo-or hyperkalemia|2|||
161804295|NCT02107092|584326690|FG000|Overall Study|Met ECG withdrawal criteria|3|||
161804296|NCT02107092|584326690|FG000|Overall Study|Physician Decision|3|||
161804297|NCT02107092|584326690|FG000|Overall Study|Lost to Follow-up|2|||
161804298|NCT02107092|584326690|FG000|Overall Study|Withdrawal by Subject|9|||
161804299|NCT02107092|584326690|FG000|Overall Study|Adverse Event|7|||
161804300|NCT02107092|584326690|FG000|Overall Study|Expected progression of CKD|12|||
161804301|NCT00537030|584326691|FG000|Overall Study|Physician Decision|2|||
161804302|NCT00537030|584326691|FG000|Overall Study|Withdrawal by Subject|2|||
161804303|NCT00537030|584326691|FG000|Overall Study|≥ Grade 2 allergy|7|||
161804304|NCT00537030|584326691|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
161804305|NCT00537030|584326691|FG000|Overall Study|Ineligible|2|||
161907400|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
161907401|NCT03504917|584712164|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
161907402|NCT03504917|584712165|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
161907403|NCT03863353|584712166|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
161907404|NCT03863353|584712167|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
161907405|NCT04079790|584712171|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
161907406|NCT04079790|584712172|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
161907407|NCT04079790|584712173|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
161907408|NCT04079790|584712174|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
161907409|NCT04079790|584712171|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
161907410|NCT04079790|584712172|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
161907411|NCT04079790|584712173|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
161907412|NCT04079790|584712174|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
161907413|NCT04079790|584712171|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
161907414|NCT04079790|584712172|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
161907415|NCT04079790|584712173|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
161907416|NCT04079790|584712174|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
161907417|NCT04275336|584712178|FG000|Overall Study|First venipuncture failed|4|||
161907418|NCT04275336|584712179|FG001|Overall Study|First venipuncture failed|6|||
161907419|NCT04275336|584712180|FG002|Overall Study|First venipuncture failed|5|||
161907420|NCT04275336|584712178|FG000|Overall Study|Unscheduled venipuncture|9|||
161907421|NCT04275336|584712179|FG001|Overall Study|Unscheduled venipuncture|13|||
161907422|NCT04275336|584712180|FG002|Overall Study|Unscheduled venipuncture|7|||
161907423|NCT04275336|584712178|FG000|Overall Study|Failed specimen of saliva|4|||
161907424|NCT04275336|584712179|FG001|Overall Study|Failed specimen of saliva|3|||
161907425|NCT04275336|584712180|FG002|Overall Study|Failed specimen of saliva|4|||
161907426|NCT03055936|584712181|FG000|Overall Study|Adverse Event|0|||
161907427|NCT03055936|584712182|FG001|Overall Study|Adverse Event|1|||
161907428|NCT03055936|584712183|FG002|Overall Study|Adverse Event|1|||
161907429|NCT03055936|584712184|FG003|Overall Study|Adverse Event|1|||
161907430|NCT03055936|584712181|FG000|Overall Study|Personal reason|2|||
161907431|NCT03055936|584712182|FG001|Overall Study|Personal reason|0|||
161907432|NCT03055936|584712183|FG002|Overall Study|Personal reason|1|||
161907433|NCT03055936|584712184|FG003|Overall Study|Personal reason|0|||
161907434|NCT01909804|584712191|FG000|Overall Study|Randomized but Never Treated|0|||
161907435|NCT01909804|584712192|FG001|Overall Study|Randomized but Never Treated|0|||
161907436|NCT01909804|584712193|FG002|Overall Study|Randomized but Never Treated|0|||
161907437|NCT01909804|584712194|FG003|Overall Study|Randomized but Never Treated|0|||
161907438|NCT01909804|584712195|FG004|Overall Study|Randomized but Never Treated|0|||
161907439|NCT01909804|584712196|FG005|Overall Study|Randomized but Never Treated|0|||
161907440|NCT01909804|584712197|FG006|Overall Study|Randomized but Never Treated|1|||
161907441|NCT01909804|584712198|FG007|Overall Study|Randomized but Never Treated|0|||
161907442|NCT01909804|584712199|FG008|Overall Study|Randomized but Never Treated|0|||
161907443|NCT01909804|584712200|FG009|Overall Study|Randomized but Never Treated|0|||
161907444|NCT01909804|584712201|FG010|Overall Study|Randomized but Never Treated|0|||
161907445|NCT01909804|584712202|FG011|Overall Study|Randomized but Never Treated|1|||
161907446|NCT01909804|584712191|FG000|Overall Study|Death|0|||
161907447|NCT01909804|584712192|FG001|Overall Study|Death|0|||
161907448|NCT01909804|584712193|FG002|Overall Study|Death|0|||
161907449|NCT01909804|584712194|FG003|Overall Study|Death|0|||
161907450|NCT01909804|584712195|FG004|Overall Study|Death|0|||
161907451|NCT01909804|584712196|FG005|Overall Study|Death|0|||
161907452|NCT01909804|584712197|FG006|Overall Study|Death|0|||
161907453|NCT01909804|584712198|FG007|Overall Study|Death|0|||
161907454|NCT01909804|584712199|FG008|Overall Study|Death|0|||
161907455|NCT01909804|584712200|FG009|Overall Study|Death|0|||
161907456|NCT01909804|584712201|FG010|Overall Study|Death|1|||
161907457|NCT01909804|584712202|FG011|Overall Study|Death|0|||
161907458|NCT01909804|584712191|FG000|Overall Study|Lack of Efficacy|4|||
161907459|NCT01909804|584712192|FG001|Overall Study|Lack of Efficacy|1|||
161907460|NCT01909804|584712193|FG002|Overall Study|Lack of Efficacy|0|||
161907461|NCT01909804|584712194|FG003|Overall Study|Lack of Efficacy|0|||
161907462|NCT01909804|584712195|FG004|Overall Study|Lack of Efficacy|7|||
161907463|NCT01909804|584712196|FG005|Overall Study|Lack of Efficacy|3|||
161907464|NCT01909804|584712197|FG006|Overall Study|Lack of Efficacy|1|||
161907465|NCT01909804|584712198|FG007|Overall Study|Lack of Efficacy|1|||
161907466|NCT01909804|584712199|FG008|Overall Study|Lack of Efficacy|0|||
161907467|NCT01909804|584712200|FG009|Overall Study|Lack of Efficacy|1|||
161907468|NCT01909804|584712201|FG010|Overall Study|Lack of Efficacy|0|||
161907469|NCT01909804|584712202|FG011|Overall Study|Lack of Efficacy|1|||
161907470|NCT01909804|584712191|FG000|Overall Study|Withdrew Consent|0|||
161907471|NCT01909804|584712192|FG001|Overall Study|Withdrew Consent|0|||
161907472|NCT01909804|584712193|FG002|Overall Study|Withdrew Consent|0|||
161804306|NCT00537030|584326691|FG000|Overall Study|Inevaluable|2|||
161804307|NCT04213326|584326693|FG000|Overall Study|Consent withdrawn|51|||
161804308|NCT04213326|584326694|FG001|Overall Study|Consent withdrawn|241|||
161804309|NCT04213326|584326693|FG000|Overall Study|Lost to Follow-up|50|||
161804310|NCT04213326|584326694|FG001|Overall Study|Lost to Follow-up|902|||
161804311|NCT04213326|584326693|FG000|Overall Study|Protocol Violation|3|||
161804312|NCT04213326|584326694|FG001|Overall Study|Protocol Violation|25|||
161804313|NCT04213326|584326693|FG000|Overall Study|Participant eligibility changed|106|||
161804314|NCT04213326|584326694|FG001|Overall Study|Participant eligibility changed|19|||
161804315|NCT04213326|584326693|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
161804316|NCT04213326|584326694|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
161804317|NCT04213326|584326693|FG000|Overall Study|Incomplete study visit|0|||
161804318|NCT04213326|584326694|FG001|Overall Study|Incomplete study visit|367|||
161804319|NCT01496183|584326695|FG000|Overall Study|Physician Decision|3|||
161804320|NCT01496183|584326696|FG001|Overall Study|Physician Decision|1|||
161804321|NCT01496183|584326695|FG000|Overall Study|Withdrawal by Subject|0|||
161804322|NCT01496183|584326696|FG001|Overall Study|Withdrawal by Subject|1|||
161804323|NCT01173692|584326699|FG000|Overall Study|Adverse Event|1|||
161804324|NCT01173692|584326700|FG001|Overall Study|Adverse Event|2|||
161804325|NCT01173692|584326699|FG000|Overall Study|Withdrawal by Subject|1|||
161804326|NCT01173692|584326700|FG001|Overall Study|Withdrawal by Subject|3|||
161804327|NCT00669864|584326703|FG000|Overall Study|Lost to Follow-up|2|||
161804328|NCT00669864|584326703|FG000|Overall Study|Protocol Violation|2|||
161804329|NCT00669864|584326703|FG000|Overall Study|Withdrawal by Subject|3|||
161804330|NCT00669864|584326703|FG000|Overall Study|Other|2|||
161804331|NCT02457832|584326714|FG000|Training|Lost to Follow-up|10|||
161804332|NCT02457832|584326715|FG001|Training|Lost to Follow-up|6|||
161804333|NCT02457832|584326716|FG002|Training|Lost to Follow-up|3|||
161804334|NCT02457832|584326714|FG000|One Month Washout|Lost to Follow-up|0|||
161804335|NCT02457832|584326715|FG001|One Month Washout|Lost to Follow-up|1|||
161804336|NCT02457832|584326716|FG002|One Month Washout|Lost to Follow-up|1|||
161804337|NCT01044732|584326717|FG000|Overall Study|Lost to Follow-up|2|||
161804338|NCT01044732|584326718|FG001|Overall Study|Lost to Follow-up|1|||
161804339|NCT01044732|584326717|FG000|Overall Study|Physician Decision|5|||
161804340|NCT01044732|584326718|FG001|Overall Study|Physician Decision|3|||
161804341|NCT01044732|584326717|FG000|Overall Study|Protocol Violation|11|||
161804342|NCT01044732|584326718|FG001|Overall Study|Protocol Violation|12|||
161804343|NCT01044732|584326717|FG000|Overall Study|Withdrawal by Subject|0|||
161804344|NCT01044732|584326718|FG001|Overall Study|Withdrawal by Subject|1|||
161804345|NCT01044732|584326717|FG000|Overall Study|Inadequate bowel preparation|11|||
161804346|NCT01044732|584326718|FG001|Overall Study|Inadequate bowel preparation|17|||
161804347|NCT01044732|584326717|FG000|Overall Study|Inability to reach cecum|5|||
161804348|NCT01044732|584326718|FG001|Overall Study|Inability to reach cecum|2|||
161804349|NCT01044732|584326717|FG000|Overall Study|Technical error or malfunction|15|||
161804350|NCT01044732|584326718|FG001|Overall Study|Technical error or malfunction|14|||
161804351|NCT03069937|584326723|FG000|Overall Study|Second primary malignancy noted|1|||
161804352|NCT03144687|584326724|FG000|Overall Study|Death|0|||
161804353|NCT03144687|584326725|FG001|Overall Study|Death|2|||
161804354|NCT03144687|584326724|FG000|Overall Study|Lost to Follow-up|0|||
161804355|NCT03144687|584326725|FG001|Overall Study|Lost to Follow-up|1|||
161804356|NCT03144687|584326724|FG000|Overall Study|Physician Decision|0|||
161804357|NCT03144687|584326725|FG001|Overall Study|Physician Decision|1|||
161804358|NCT03144687|584326724|FG000|Overall Study|Withdrawal by Subject|1|||
161804359|NCT03144687|584326725|FG001|Overall Study|Withdrawal by Subject|3|||
161804360|NCT03144687|584326724|FG000|Overall Study|Not Reported|2|||
161804361|NCT03144687|584326725|FG001|Overall Study|Not Reported|0|||
161804362|NCT00824265|584326728|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
161907473|NCT01909804|584712194|FG003|Overall Study|Withdrew Consent|0|||
161804363|NCT00824265|584326729|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
161804364|NCT00824265|584326728|FG000|Treatment Phase|Protocol Violation|1|||
161804365|NCT00824265|584326729|FG001|Treatment Phase|Protocol Violation|0|||
161804366|NCT00824265|584326728|FG000|Treatment Phase|Lost to Follow-up|1|||
161804367|NCT00824265|584326729|FG001|Treatment Phase|Lost to Follow-up|1|||
161804368|NCT00824265|584326728|FG000|Treatment Phase|Physician Decision|6|||
161804369|NCT00824265|584326729|FG001|Treatment Phase|Physician Decision|12|||
161804370|NCT00824265|584326728|FG000|Treatment Phase|Withdrawal by Subject|6|||
161804371|NCT00824265|584326729|FG001|Treatment Phase|Withdrawal by Subject|15|||
161804372|NCT00824265|584326728|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
161804373|NCT00824265|584326729|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
161804374|NCT00824265|584326728|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
161804375|NCT00824265|584326729|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
161804376|NCT01411332|584326732|FG000|Enrollment|Protocol Violation|0|||
161804377|NCT01411332|584326733|FG001|Enrollment|Protocol Violation|1|||
161804378|NCT01411332|584326732|FG000|Enrollment|Withdrawal by Subject|0|||
161804379|NCT01411332|584326733|FG001|Enrollment|Withdrawal by Subject|1|||
161804380|NCT01411332|584326732|FG000|Treatment|Lost to Follow-up|1|||
161804381|NCT01411332|584326733|FG001|Treatment|Lost to Follow-up|0|||
161804382|NCT02170688|584326734|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
161804383|NCT02170688|584326735|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
161804384|NCT02170688|584326736|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
161804385|NCT02170688|584326737|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
161804386|NCT02170688|584326738|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
161804387|NCT02170688|584326734|FG000|Overall Study|Full dose not received|0|||
161804388|NCT02170688|584326735|FG001|Overall Study|Full dose not received|1|||
161804389|NCT02170688|584326736|FG002|Overall Study|Full dose not received|0|||
161804390|NCT02170688|584326737|FG003|Overall Study|Full dose not received|0|||
161804391|NCT02170688|584326738|FG004|Overall Study|Full dose not received|0|||
161804392|NCT02170688|584326734|FG000|Overall Study|Physician Decision|0|||
161804393|NCT02170688|584326735|FG001|Overall Study|Physician Decision|0|||
161804394|NCT02170688|584326736|FG002|Overall Study|Physician Decision|1|||
161804395|NCT02170688|584326737|FG003|Overall Study|Physician Decision|0|||
161804396|NCT02170688|584326738|FG004|Overall Study|Physician Decision|0|||
161804397|NCT02079532|584326741|FG000|Overall Study|Adverse Event|7|||
161804398|NCT02079532|584326741|FG000|Overall Study|Additional or changed therapy|2|||
161804399|NCT02079532|584326741|FG000|Overall Study|Lack of Efficacy|9|||
161804400|NCT02079532|584326741|FG000|Overall Study|Protocol Violation|3|||
161804401|NCT02079532|584326741|FG000|Overall Study|Withdrawal by Subject|1|||
161804402|NCT02079532|584326741|FG000|Overall Study|Administrative problems|1|||
161804403|NCT02079532|584326741|FG000|Overall Study|Inclusion into ReFIRST|3|||
161804404|NCT02079532|584326741|FG000|Overall Study|Other|3|||
161804405|NCT02920996|584326742|FG000|Overall Study|Adverse Event|8|||
161804406|NCT02920996|584326743|FG001|Overall Study|Adverse Event|0|||
161804407|NCT02920996|584326742|FG000|Overall Study|Physician Decision|1|||
161804408|NCT02920996|584326743|FG001|Overall Study|Physician Decision|0|||
161804409|NCT02920996|584326742|FG000|Overall Study|Death|1|||
161804410|NCT02920996|584326743|FG001|Overall Study|Death|0|||
161804411|NCT02920996|584326742|FG000|Overall Study|Missing|1|||
161804412|NCT02920996|584326743|FG001|Overall Study|Missing|0|||
161804413|NCT02920996|584326742|FG000|Overall Study|Subject Non-Compliance|1|||
161804414|NCT02920996|584326743|FG001|Overall Study|Subject Non-Compliance|0|||
161804415|NCT01402947|584326744|FG000|First Intervention|Adverse Event|0|||
161804416|NCT01402947|584326745|FG001|First Intervention|Adverse Event|1|||
161804417|NCT01471522|584326749|FG000|Overall Study|Withdrawal by Subject|28|||
161804418|NCT01471522|584326750|FG001|Overall Study|Withdrawal by Subject|22|||
161804419|NCT01471522|584326749|FG000|Overall Study|Lost to Follow-up|36|||
161804420|NCT01471522|584326750|FG001|Overall Study|Lost to Follow-up|26|||
161804421|NCT01706926|584326752|FG000|Overall Study|Lost to Follow-up|0|||
161804422|NCT01706926|584326753|FG001|Overall Study|Lost to Follow-up|0|||
161804423|NCT01706926|584326754|FG002|Overall Study|Lost to Follow-up|1|||
161804424|NCT01706926|584326755|FG003|Overall Study|Lost to Follow-up|0|||
161804425|NCT01706926|584326752|FG000|Overall Study|Withdrawal by Subject|2|||
161804426|NCT01706926|584326753|FG001|Overall Study|Withdrawal by Subject|0|||
161804427|NCT01706926|584326754|FG002|Overall Study|Withdrawal by Subject|1|||
161804428|NCT01706926|584326755|FG003|Overall Study|Withdrawal by Subject|2|||
161804429|NCT01706926|584326752|FG000|Overall Study|Other|4|||
161804430|NCT01706926|584326753|FG001|Overall Study|Other|4|||
161804431|NCT01706926|584326754|FG002|Overall Study|Other|4|||
161804432|NCT01706926|584326755|FG003|Overall Study|Other|3|||
161804433|NCT03597256|584327962|FG000|Overall Study|Lost to Follow-up|3|||
161804434|NCT03597256|584327963|FG001|Overall Study|Lost to Follow-up|1|||
161804435|NCT03597256|584327962|FG000|Overall Study|Withdrawal by Subject|0|||
161804436|NCT03597256|584327963|FG001|Overall Study|Withdrawal by Subject|1|||
161804437|NCT03597256|584327962|FG000|Overall Study|Could not return for treatment|0|||
161804438|NCT03597256|584327963|FG001|Overall Study|Could not return for treatment|1|||
161804439|NCT03597256|584327962|FG000|Overall Study|Moved from location|0|||
161804440|NCT03597256|584327963|FG001|Overall Study|Moved from location|1|||
161804441|NCT03597256|584327962|FG000|Overall Study|Not accepted the treatment|0|||
161804442|NCT03597256|584327963|FG001|Overall Study|Not accepted the treatment|1|||
161804443|NCT01725529|584327972|FG000|Overall Study|Adverse Event|1|||
161804444|NCT01725529|584327973|FG001|Overall Study|Adverse Event|0|||
161804445|NCT01725529|584327974|FG002|Overall Study|Adverse Event|0|||
161804446|NCT01725529|584327972|FG000|Overall Study|Lost to Follow-up|2|||
161804447|NCT01725529|584327973|FG001|Overall Study|Lost to Follow-up|1|||
161804448|NCT01725529|584327974|FG002|Overall Study|Lost to Follow-up|1|||
161804449|NCT01725529|584327972|FG000|Overall Study|Protocol Violation|0|||
161804450|NCT01725529|584327973|FG001|Overall Study|Protocol Violation|1|||
161804451|NCT01725529|584327974|FG002|Overall Study|Protocol Violation|1|||
161804452|NCT01725529|584327972|FG000|Overall Study|Withdrawal by Subject|12|||
161804453|NCT01725529|584327973|FG001|Overall Study|Withdrawal by Subject|14|||
161804454|NCT01725529|584327974|FG002|Overall Study|Withdrawal by Subject|8|||
161804455|NCT02653664|584327976|FG000|Post-Treatment|Withdrawal by Subject|6|||
161804456|NCT02653664|584327977|FG001|Post-Treatment|Withdrawal by Subject|5|||
161804457|NCT02653664|584327978|FG002|Post-Treatment|Withdrawal by Subject|7|||
161804458|NCT02653664|584327976|FG000|Post-Treatment|Lost to Follow-up|8|||
161804459|NCT02653664|584327977|FG001|Post-Treatment|Lost to Follow-up|1|||
161804460|NCT02653664|584327978|FG002|Post-Treatment|Lost to Follow-up|7|||
161804461|NCT02653664|584327976|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
161804462|NCT02653664|584327977|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
161804463|NCT02653664|584327978|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
161804464|NCT02653664|584327976|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
161804465|NCT02653664|584327977|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
161804466|NCT02653664|584327978|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
161804467|NCT02653664|584327976|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
161804468|NCT02653664|584327977|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
161804469|NCT02653664|584327978|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
161804470|NCT02653664|584327976|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
161804471|NCT02653664|584327977|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
161804472|NCT02653664|584327978|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
161804473|NCT02653664|584327976|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
161804474|NCT02653664|584327977|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
161804475|NCT02653664|584327978|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
161804476|NCT02653664|584327976|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
161804477|NCT02653664|584327977|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
161804478|NCT02653664|584327978|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
161804479|NCT02653664|584327976|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
161804480|NCT02653664|584327977|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
161804481|NCT02653664|584327978|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
161804482|NCT02653664|584327976|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
161804483|NCT02653664|584327977|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
161804484|NCT02653664|584327978|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
161804485|NCT04657770|584327979|FG000|Overall Study|Withdrawal by Subject|3|||
161804486|NCT04657770|584327979|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
161804487|NCT00485472|584327980|FG000|Overall Study|Adverse Event|8|||
161804488|NCT00485472|584327981|FG001|Overall Study|Adverse Event|5|||
161804489|NCT00485472|584327980|FG000|Overall Study|Lack of Efficacy|5|||
161804490|NCT00485472|584327981|FG001|Overall Study|Lack of Efficacy|4|||
161804491|NCT00485472|584327980|FG000|Overall Study|Withdrawal by Subject|1|||
161804492|NCT00485472|584327981|FG001|Overall Study|Withdrawal by Subject|0|||
161804493|NCT00485472|584327980|FG000|Overall Study|Protocol Violation|0|||
161804494|NCT00485472|584327981|FG001|Overall Study|Protocol Violation|1|||
161804495|NCT00485472|584327980|FG000|Overall Study|Other|2|||
161804496|NCT00485472|584327981|FG001|Overall Study|Other|1|||
161804497|NCT00485472|584327980|FG000|Overall Study|Lost to Follow-up|0|||
161804498|NCT00485472|584327981|FG001|Overall Study|Lost to Follow-up|1|||
161804499|NCT00746798|584327982|FG000|Overall Study|Protocol Violation|0|||
161804500|NCT00746798|584327983|FG001|Overall Study|Protocol Violation|1|||
161804501|NCT00746798|584327984|FG002|Overall Study|Protocol Violation|0|||
161907474|NCT01909804|584712195|FG004|Overall Study|Withdrew Consent|1|||
161907475|NCT01909804|584712196|FG005|Overall Study|Withdrew Consent|1|||
161907476|NCT01909804|584712197|FG006|Overall Study|Withdrew Consent|0|||
161907477|NCT01909804|584712198|FG007|Overall Study|Withdrew Consent|0|||
161907478|NCT01909804|584712199|FG008|Overall Study|Withdrew Consent|0|||
161907479|NCT01909804|584712200|FG009|Overall Study|Withdrew Consent|0|||
161804502|NCT00746798|584327985|FG003|Overall Study|Protocol Violation|0|||
161804503|NCT00746798|584327982|FG000|Overall Study|Withdrawal by Subject|0|||
161804504|NCT00746798|584327983|FG001|Overall Study|Withdrawal by Subject|1|||
161804505|NCT00746798|584327984|FG002|Overall Study|Withdrawal by Subject|1|||
161804506|NCT00746798|584327985|FG003|Overall Study|Withdrawal by Subject|0|||
161907480|NCT01909804|584712201|FG010|Overall Study|Withdrew Consent|0|||
161907481|NCT01909804|584712202|FG011|Overall Study|Withdrew Consent|0|||
161907482|NCT01909804|584712191|FG000|Overall Study|Protocol Violation|0|||
161907483|NCT01909804|584712192|FG001|Overall Study|Protocol Violation|0|||
161907484|NCT01909804|584712193|FG002|Overall Study|Protocol Violation|0|||
161907485|NCT01909804|584712194|FG003|Overall Study|Protocol Violation|0|||
161907486|NCT01909804|584712195|FG004|Overall Study|Protocol Violation|0|||
161907487|NCT01909804|584712196|FG005|Overall Study|Protocol Violation|0|||
162140245|NCT00703911|585565587|FG000|Overall Study|Withdrawal by Subject|2|||
162140246|NCT01064817|585565588|FG000|Study Completion|Physician Decision|1|||
162140247|NCT01064817|585565589|FG001|Study Completion|Physician Decision|0|||
162140248|NCT01064817|585565588|FG000|Study Completion|Withdrawal by Subject|1|||
162140249|NCT01064817|585565589|FG001|Study Completion|Withdrawal by Subject|0|||
161804507|NCT00746798|584327982|FG000|Overall Study|Death|0|||
161804508|NCT00746798|584327983|FG001|Overall Study|Death|0|||
161907488|NCT01909804|584712197|FG006|Overall Study|Protocol Violation|0|||
161907489|NCT01909804|584712198|FG007|Overall Study|Protocol Violation|0|||
161907490|NCT01909804|584712199|FG008|Overall Study|Protocol Violation|0|||
161907491|NCT01909804|584712200|FG009|Overall Study|Protocol Violation|0|||
161907492|NCT01909804|584712201|FG010|Overall Study|Protocol Violation|0|||
161907493|NCT01909804|584712202|FG011|Overall Study|Protocol Violation|1|||
161907494|NCT05222880|584712204|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
161907495|NCT05222880|584712204|FG000|Overall Study|Withdrew Consent during Study|1|||
161907496|NCT05222880|584712204|FG000|Overall Study|COVID-19 Related|1|||
161907497|NCT05401565|584712205|FG000|Overall Study|Lost to Follow-up|1|||
161907498|NCT05401565|584712206|FG001|Overall Study|Lost to Follow-up|0|||
161907499|NCT05401565|584712205|FG000|Overall Study|Adverse Event|2|||
161907500|NCT05401565|584712206|FG001|Overall Study|Adverse Event|0|||
161907501|NCT01077323|584712209|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
161907502|NCT01077323|584712210|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
161907503|NCT01077323|584712211|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
161907504|NCT01077323|584712209|FG000|Overall Study|Dispensing of drug in baseline period|0|||
161907505|NCT01077323|584712210|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
161907506|NCT01077323|584712211|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
161907507|NCT01077323|584712209|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
161907508|NCT01077323|584712210|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
161907509|NCT01077323|584712211|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
161907510|NCT01091246|584712212|FG000|Overall Study|Lost to Follow-up|23|||
161907511|NCT01091246|584712213|FG001|Overall Study|Lost to Follow-up|11|||
161907512|NCT01091246|584712214|FG002|Overall Study|Lost to Follow-up|7|||
161907513|NCT01091246|584712212|FG000|Overall Study|Adverse Event|1|||
161907514|NCT01091246|584712213|FG001|Overall Study|Adverse Event|0|||
161907515|NCT01091246|584712214|FG002|Overall Study|Adverse Event|1|||
161907516|NCT01091246|584712212|FG000|Overall Study|Withdrawal by Subject|9|||
161907517|NCT01091246|584712213|FG001|Overall Study|Withdrawal by Subject|5|||
161907518|NCT01091246|584712214|FG002|Overall Study|Withdrawal by Subject|4|||
161907519|NCT01091246|584712212|FG000|Overall Study|Subject not dosed|2|||
161907520|NCT01091246|584712213|FG001|Overall Study|Subject not dosed|0|||
161907521|NCT01091246|584712214|FG002|Overall Study|Subject not dosed|1|||
161907522|NCT01676012|584712215|FG000|Overall Study|Adverse Event|2|||
161907523|NCT01676012|584712215|FG000|Overall Study|incomplete set of videos|1|||
161907524|NCT02155985|584712220|FG000|Overall Study|Withdrawal by Subject|0|||
161907525|NCT02155985|584712221|FG001|Overall Study|Withdrawal by Subject|0|||
161907526|NCT02155985|584712222|FG002|Overall Study|Withdrawal by Subject|1|||
161907527|NCT02155985|584712220|FG000|Overall Study|Lost to Follow-up|1|||
161907528|NCT02155985|584712221|FG001|Overall Study|Lost to Follow-up|0|||
161907529|NCT02155985|584712222|FG002|Overall Study|Lost to Follow-up|0|||
161907530|NCT04460326|584712227|FG000|Completed at Least 4 Meals|Early discharge|5|||
161907531|NCT04460326|584712228|FG001|Completed at Least 4 Meals|Early discharge|5|||
161907532|NCT04460326|584712227|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
161907533|NCT04460326|584712228|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
161907534|NCT04460326|584712227|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
161907535|NCT04460326|584712228|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
161907536|NCT04460326|584712227|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
161907537|NCT04460326|584712228|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
161907538|NCT04460326|584712227|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
161907539|NCT04460326|584712228|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
161907540|NCT04460326|584712227|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
161907541|NCT04460326|584712228|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
161907542|NCT03372798|584712229|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
161907543|NCT03372798|584712230|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
161907544|NCT03372798|584712229|FG000|Overall Study|Failure of imaging probe|0|||
161907545|NCT03372798|584712230|FG001|Overall Study|Failure of imaging probe|1|||
161907546|NCT04794751|584712231|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
161907547|NCT04794751|584712232|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
161907548|NCT04794751|584712231|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
161907549|NCT04794751|584712232|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
161907550|NCT04794751|584712231|FG000|Period 1|Protocol Violation|0|||
161907551|NCT04794751|584712232|FG001|Period 1|Protocol Violation|2|||
161907552|NCT04794751|584712231|FG000|Period 1|Withdrawal by Subject|0|||
161907553|NCT04794751|584712232|FG001|Period 1|Withdrawal by Subject|1|||
161907554|NCT04794751|584712231|FG000|Period 2|Withdrawal by Subject|0|||
161907555|NCT04794751|584712232|FG001|Period 2|Withdrawal by Subject|1|||
161907556|NCT04794751|584712231|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
161907557|NCT04794751|584712232|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
161907558|NCT04794751|584712231|FG000|Period 2|Protocol Violation|1|||
161907559|NCT04794751|584712232|FG001|Period 2|Protocol Violation|0|||
161907560|NCT01405898|584712233|FG000|Overall Study|Withdrawal by Subject|2|||
161907561|NCT01405898|584712234|FG001|Overall Study|Withdrawal by Subject|2|||
161907562|NCT01687218|584712235|FG000|Overall Study|Withdrawal by Subject|2|||
161907563|NCT01687218|584712236|FG001|Overall Study|Withdrawal by Subject|3|||
161907564|NCT01687218|584712237|FG002|Overall Study|Withdrawal by Subject|0|||
161907565|NCT01687218|584712238|FG003|Overall Study|Withdrawal by Subject|1|||
161907566|NCT01687218|584712239|FG004|Overall Study|Withdrawal by Subject|1|||
161907567|NCT01687218|584712240|FG005|Overall Study|Withdrawal by Subject|0|||
161907568|NCT01687218|584712235|FG000|Overall Study|Relocated, no follow-up planned|1|||
161907569|NCT01687218|584712236|FG001|Overall Study|Relocated, no follow-up planned|0|||
161907570|NCT01687218|584712237|FG002|Overall Study|Relocated, no follow-up planned|1|||
161907571|NCT01687218|584712238|FG003|Overall Study|Relocated, no follow-up planned|1|||
161907572|NCT01687218|584712239|FG004|Overall Study|Relocated, no follow-up planned|0|||
161907573|NCT01687218|584712240|FG005|Overall Study|Relocated, no follow-up planned|0|||
161907574|NCT03528551|584712245|FG000|Overall Study|Lost to Follow-up|0|||
161907575|NCT03528551|584712246|FG001|Overall Study|Lost to Follow-up|1|||
161907576|NCT03528551|584712247|FG002|Overall Study|Lost to Follow-up|0|||
161907577|NCT03528551|584712245|FG000|Overall Study|Transferred to other arm/group|2|||
161907578|NCT03528551|584712246|FG001|Overall Study|Transferred to other arm/group|3|||
161907579|NCT03528551|584712247|FG002|Overall Study|Transferred to other arm/group|0|||
161907580|NCT03528551|584712245|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161907581|NCT03528551|584712246|FG001|Overall Study|Withdrawal by parent/guardian|5|||
161804509|NCT00746798|584327984|FG002|Overall Study|Death|2|||
161804510|NCT00746798|584327985|FG003|Overall Study|Death|0|||
161804511|NCT00746798|584327982|FG000|Overall Study|Participant unable to return for visit|1|||
161804512|NCT00746798|584327983|FG001|Overall Study|Participant unable to return for visit|0|||
161804513|NCT00746798|584327984|FG002|Overall Study|Participant unable to return for visit|0|||
161804514|NCT00746798|584327985|FG003|Overall Study|Participant unable to return for visit|0|||
161804515|NCT04915755|584327988|FG000|Overall Study|Physician Decision|3|||
161804516|NCT04915755|584327989|FG001|Overall Study|Physician Decision|2|||
161804517|NCT04915755|584327988|FG000|Overall Study|Withdrawal by Subject|1|||
161804518|NCT04915755|584327989|FG001|Overall Study|Withdrawal by Subject|1|||
161804519|NCT04915755|584327988|FG000|Overall Study|Ongoing for PACT|3|||
161804520|NCT04915755|584327989|FG001|Overall Study|Ongoing for PACT|2|||
161804521|NCT04915755|584327988|FG000|Overall Study|Other|7|||
161804522|NCT04915755|584327989|FG001|Overall Study|Other|11|||
161804523|NCT02495857|584327998|FG000|Overall Study|Adverse Event|5|||
161804524|NCT02495857|584327999|FG001|Overall Study|Adverse Event|0|||
161804525|NCT02495857|584328000|FG002|Overall Study|Adverse Event|1|||
161804526|NCT02495857|584327998|FG000|Overall Study|Withdrawal by Subject|9|||
161804527|NCT02495857|584327999|FG001|Overall Study|Withdrawal by Subject|6|||
161804528|NCT02495857|584328000|FG002|Overall Study|Withdrawal by Subject|10|||
161804529|NCT02495857|584327998|FG000|Overall Study|Physician Decision|0|||
161804530|NCT02495857|584327999|FG001|Overall Study|Physician Decision|1|||
161804531|NCT02495857|584328000|FG002|Overall Study|Physician Decision|0|||
161804532|NCT02495857|584327998|FG000|Overall Study|Protocol Violation|1|||
161804533|NCT02495857|584327999|FG001|Overall Study|Protocol Violation|1|||
161804534|NCT02495857|584328000|FG002|Overall Study|Protocol Violation|2|||
161804535|NCT02495857|584327998|FG000|Overall Study|Lost to Follow-up|4|||
161804536|NCT02495857|584327999|FG001|Overall Study|Lost to Follow-up|5|||
161804537|NCT02495857|584328000|FG002|Overall Study|Lost to Follow-up|3|||
161804538|NCT02495857|584327998|FG000|Overall Study|Other|3|||
161804539|NCT02495857|584327999|FG001|Overall Study|Other|3|||
161804540|NCT02495857|584328000|FG002|Overall Study|Other|2|||
161804541|NCT01367457|584328001|FG000|Overall Study|Death|2|||
161804542|NCT01367457|584328002|FG001|Overall Study|Death|0|||
161804543|NCT01367457|584328003|FG002|Overall Study|Death|0|||
161804544|NCT01367457|584328001|FG000|Overall Study|Investigator's decision|2|||
161804545|NCT01367457|584328002|FG001|Overall Study|Investigator's decision|0|||
161804546|NCT01367457|584328003|FG002|Overall Study|Investigator's decision|0|||
161804547|NCT01367457|584328001|FG000|Overall Study|Clinical decline (CD)|2|||
161804548|NCT01367457|584328002|FG001|Overall Study|Clinical decline (CD)|0|||
161804549|NCT01367457|584328003|FG002|Overall Study|Clinical decline (CD)|0|||
161804550|NCT01367457|584328001|FG000|Overall Study|Progression and death|8|||
161804551|NCT01367457|584328002|FG001|Overall Study|Progression and death|0|||
161804552|NCT01367457|584328003|FG002|Overall Study|Progression and death|0|||
161907582|NCT03528551|584712247|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161907583|NCT03528551|584712245|FG000|Overall Study|Protocol Violation|0|||
161907584|NCT03528551|584712246|FG001|Overall Study|Protocol Violation|3|||
162140250|NCT03102710|585565590|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
161804553|NCT01367457|584328001|FG000|Overall Study|Toxicity|16|||
161804554|NCT01367457|584328002|FG001|Overall Study|Toxicity|0|||
161804555|NCT01367457|584328003|FG002|Overall Study|Toxicity|0|||
161804556|NCT01367457|584328001|FG000|Overall Study|Progression|137|||
161907585|NCT03528551|584712247|FG002|Overall Study|Protocol Violation|0|||
161907586|NCT03528551|584712245|FG000|Overall Study|Withdrawal by Subject|0|||
161804557|NCT01367457|584328002|FG001|Overall Study|Progression|0|||
161804558|NCT01367457|584328003|FG002|Overall Study|Progression|0|||
161804559|NCT01367457|584328001|FG000|Overall Study|Patient asks for rest + slow progression|1|||
161804560|NCT01367457|584328002|FG001|Overall Study|Patient asks for rest + slow progression|0|||
161907587|NCT03528551|584712246|FG001|Overall Study|Withdrawal by Subject|7|||
161907588|NCT03528551|584712247|FG002|Overall Study|Withdrawal by Subject|0|||
161907589|NCT01789047|584712250|FG000|Overall Study|Adverse Event|3|||
161907590|NCT01789047|584712251|FG001|Overall Study|Adverse Event|2|||
161907591|NCT01789047|584712250|FG000|Overall Study|Withdrawal by Subject|1|||
161907592|NCT01789047|584712251|FG001|Overall Study|Withdrawal by Subject|2|||
161907593|NCT03644017|584712252|FG000|Overall Study|Access Abandonment|5|||
161907594|NCT03644017|584712252|FG000|Overall Study|Kidney Transplant|2|||
161907595|NCT01204671|584712253|FG000|Overall Study|Adverse Event|4|||
161907596|NCT01204671|584712254|FG001|Overall Study|Adverse Event|3|||
161907597|NCT01204671|584712255|FG002|Overall Study|Adverse Event|3|||
161907598|NCT01204671|584712256|FG003|Overall Study|Adverse Event|3|||
161907599|NCT01204671|584712257|FG004|Overall Study|Adverse Event|1|||
161907600|NCT01204671|584712253|FG000|Overall Study|Withdrawal by Subject|2|||
161907601|NCT01204671|584712254|FG001|Overall Study|Withdrawal by Subject|3|||
161907602|NCT01204671|584712255|FG002|Overall Study|Withdrawal by Subject|4|||
161907603|NCT01204671|584712256|FG003|Overall Study|Withdrawal by Subject|5|||
161907604|NCT01204671|584712257|FG004|Overall Study|Withdrawal by Subject|3|||
161907605|NCT01204671|584712253|FG000|Overall Study|Lost to Follow-up|7|||
161907606|NCT01204671|584712254|FG001|Overall Study|Lost to Follow-up|8|||
161907607|NCT01204671|584712255|FG002|Overall Study|Lost to Follow-up|6|||
162140251|NCT03102710|585565591|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
161804561|NCT01367457|584328003|FG002|Overall Study|Patient asks for rest + slow progression|0|||
161804562|NCT01367457|584328001|FG000|Overall Study|Investigator's opinion, stable disease|1|||
161804563|NCT01367457|584328002|FG001|Overall Study|Investigator's opinion, stable disease|0|||
161804564|NCT01367457|584328003|FG002|Overall Study|Investigator's opinion, stable disease|0|||
161804565|NCT01367457|584328001|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
161804566|NCT01367457|584328002|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
161804567|NCT01367457|584328003|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
161804568|NCT01367457|584328001|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
161804569|NCT01367457|584328002|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
161804570|NCT01367457|584328003|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
161804571|NCT01367457|584328001|FG000|Overall Study|low grade toxicities + stable disease|1|||
161804572|NCT01367457|584328002|FG001|Overall Study|low grade toxicities + stable disease|0|||
161804573|NCT01367457|584328003|FG002|Overall Study|low grade toxicities + stable disease|0|||
161804574|NCT01367457|584328001|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
161804575|NCT01367457|584328002|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
161804576|NCT01367457|584328003|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
161804577|NCT01367457|584328001|FG000|Overall Study|Withdrawal by Subject|1|||
161804578|NCT01367457|584328002|FG001|Overall Study|Withdrawal by Subject|0|||
161804579|NCT01367457|584328003|FG002|Overall Study|Withdrawal by Subject|0|||
161804580|NCT01367457|584328001|FG000|Overall Study|CD, associated leukaemia|1|||
161804581|NCT01367457|584328002|FG001|Overall Study|CD, associated leukaemia|0|||
161804582|NCT01367457|584328003|FG002|Overall Study|CD, associated leukaemia|0|||
161804583|NCT01367457|584328001|FG000|Overall Study|Uncontrolled pain|1|||
161804584|NCT01367457|584328002|FG001|Overall Study|Uncontrolled pain|0|||
161804585|NCT01367457|584328003|FG002|Overall Study|Uncontrolled pain|0|||
161804586|NCT01367457|584328001|FG000|Overall Study|Overall status worsens to grade 4|1|||
161804587|NCT01367457|584328002|FG001|Overall Study|Overall status worsens to grade 4|0|||
161804588|NCT01367457|584328003|FG002|Overall Study|Overall status worsens to grade 4|0|||
161804589|NCT01367457|584328001|FG000|Overall Study|Stabilisation + frequent infections|1|||
161804590|NCT01367457|584328002|FG001|Overall Study|Stabilisation + frequent infections|0|||
161804591|NCT01367457|584328003|FG002|Overall Study|Stabilisation + frequent infections|0|||
161804592|NCT01367457|584328001|FG000|Overall Study|No clinical benefit|1|||
161804593|NCT01367457|584328002|FG001|Overall Study|No clinical benefit|0|||
161804594|NCT01367457|584328003|FG002|Overall Study|No clinical benefit|0|||
161804595|NCT01367457|584328001|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
161804596|NCT01367457|584328002|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
161804597|NCT01367457|584328003|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
161804598|NCT01367457|584328001|FG000|Overall Study|Overall decline|1|||
161804599|NCT01367457|584328002|FG001|Overall Study|Overall decline|0|||
161804600|NCT01367457|584328003|FG002|Overall Study|Overall decline|0|||
161804601|NCT01367457|584328001|FG000|Overall Study|Rejection of treatment|1|||
161804602|NCT01367457|584328002|FG001|Overall Study|Rejection of treatment|0|||
161804603|NCT01367457|584328003|FG002|Overall Study|Rejection of treatment|0|||
161804604|NCT01367457|584328001|FG000|Overall Study|Lost to Follow-up|1|||
161804605|NCT01367457|584328002|FG001|Overall Study|Lost to Follow-up|0|||
161804606|NCT01367457|584328003|FG002|Overall Study|Lost to Follow-up|0|||
161804607|NCT01367457|584328001|FG000|Overall Study|Death from septic shock|1|||
161804608|NCT01367457|584328002|FG001|Overall Study|Death from septic shock|0|||
161804609|NCT01367457|584328003|FG002|Overall Study|Death from septic shock|0|||
161907608|NCT01204671|584712256|FG003|Overall Study|Lost to Follow-up|4|||
161907609|NCT01204671|584712257|FG004|Overall Study|Lost to Follow-up|0|||
161907610|NCT01204671|584712253|FG000|Overall Study|Unknown Completion Status|1|||
161804610|NCT01367457|584328001|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
161804611|NCT01367457|584328002|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
161804612|NCT01367457|584328003|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
161804613|NCT01367457|584328001|FG000|Overall Study|Patient's Wish|1|||
161804614|NCT01367457|584328002|FG001|Overall Study|Patient's Wish|0|||
161804615|NCT01367457|584328003|FG002|Overall Study|Patient's Wish|0|||
161804616|NCT01367457|584328001|FG000|Overall Study|Palliative. Overall decline|1|||
161804617|NCT01367457|584328002|FG001|Overall Study|Palliative. Overall decline|0|||
161804618|NCT01367457|584328003|FG002|Overall Study|Palliative. Overall decline|0|||
161804619|NCT01367457|584328001|FG000|Overall Study|Suspected DP/suspected active infection|1|||
161804620|NCT01367457|584328002|FG001|Overall Study|Suspected DP/suspected active infection|0|||
161804621|NCT01367457|584328003|FG002|Overall Study|Suspected DP/suspected active infection|0|||
161804622|NCT04407806|584328008|FG000|Overall Study|Withdrawal by Subject|1|||
161804623|NCT04407806|584328009|FG001|Overall Study|Withdrawal by Subject|2|||
161804624|NCT03447262|584328012|FG000|Overall Study|Adverse Event|7|||
161804625|NCT03447262|584328012|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
161804626|NCT03447262|584328012|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
161804627|NCT03447262|584328012|FG000|Overall Study|Death|2|||
161804628|NCT03447262|584328012|FG000|Overall Study|Study Termination by Sponsor|455|||
161804629|NCT03447262|584328012|FG000|Overall Study|Other|4|||
161804630|NCT02058498|584328016|FG000|Overall Study|Withdrawal by Subject|4|||
161804631|NCT03478397|584328017|FG000|Overall Study|Refused to participate|31|||
161804632|NCT03478397|584328018|FG001|Overall Study|Refused to participate|7|||
161804633|NCT04605094|584328019|FG000|Overall Study|Adverse Event|2|||
161804634|NCT04605094|584328020|FG001|Overall Study|Adverse Event|2|||
161804635|NCT04605094|584328019|FG000|Overall Study|Lost to Follow-up|1|||
161804636|NCT04605094|584328020|FG001|Overall Study|Lost to Follow-up|4|||
161804637|NCT04605094|584328019|FG000|Overall Study|Physician Decision|2|||
161804638|NCT04605094|584328020|FG001|Overall Study|Physician Decision|2|||
161804639|NCT04605094|584328019|FG000|Overall Study|Study terminated by Sponsor|31|||
161804640|NCT04605094|584328020|FG001|Overall Study|Study terminated by Sponsor|33|||
161804641|NCT04605094|584328019|FG000|Overall Study|Withdrawal by Subject|22|||
161804642|NCT04605094|584328020|FG001|Overall Study|Withdrawal by Subject|19|||
161804643|NCT04605094|584328019|FG000|Overall Study|Other|1|||
161804644|NCT04605094|584328020|FG001|Overall Study|Other|1|||
161804645|NCT04206332|584328023|FG000|Part A|Lost to Follow-up|0|||
161804646|NCT04206332|584328024|FG001|Part A|Lost to Follow-up|1|||
161804647|NCT04206332|584328025|FG002|Part A|Lost to Follow-up|0|||
161804648|NCT04206332|584328026|FG003|Part A|Lost to Follow-up|0|||
161804649|NCT04206332|584328027|FG004|Part A|Lost to Follow-up|0|||
161804650|NCT04206332|584328028|FG005|Part A|Lost to Follow-up|0|||
161804651|NCT04206332|584328029|FG006|Part A|Lost to Follow-up|0|||
161804652|NCT04206332|584328030|FG007|Part A|Lost to Follow-up|0|||
161804653|NCT04206332|584328031|FG008|Part A|Lost to Follow-up|0|||
161804654|NCT04206332|584328032|FG009|Part A|Lost to Follow-up|0|||
161804655|NCT04206332|584328033|FG010|Part A|Lost to Follow-up|0|||
161804656|NCT04206332|584328034|FG011|Part A|Lost to Follow-up|0|||
161804657|NCT04206332|584328035|FG012|Part A|Lost to Follow-up|0|||
161804658|NCT04206332|584328036|FG013|Part A|Lost to Follow-up|0|||
161804659|NCT04206332|584328037|FG014|Part A|Lost to Follow-up|0|||
161804660|NCT04206332|584328038|FG015|Part A|Lost to Follow-up|0|||
161804661|NCT04206332|584328039|FG016|Part A|Lost to Follow-up|0|||
161804662|NCT04206332|584328023|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804663|NCT04206332|584328024|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804664|NCT04206332|584328025|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804665|NCT04206332|584328026|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804666|NCT04206332|584328027|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804667|NCT04206332|584328028|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
161804668|NCT04206332|584328029|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804669|NCT04206332|584328030|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804670|NCT04206332|584328031|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804671|NCT04206332|584328032|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804672|NCT04206332|584328033|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804673|NCT04206332|584328034|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804674|NCT04206332|584328035|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804675|NCT04206332|584328036|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804676|NCT04206332|584328037|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804677|NCT04206332|584328038|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804678|NCT04206332|584328039|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161804679|NCT04206332|584328023|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804680|NCT04206332|584328024|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804681|NCT04206332|584328025|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804682|NCT04206332|584328026|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804683|NCT04206332|584328027|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804684|NCT04206332|584328028|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804685|NCT04206332|584328029|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804686|NCT04206332|584328030|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
161804687|NCT04206332|584328031|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804688|NCT04206332|584328032|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804689|NCT04206332|584328033|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
161804690|NCT04206332|584328034|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804691|NCT04206332|584328035|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804692|NCT04206332|584328036|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804693|NCT04206332|584328037|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804694|NCT04206332|584328038|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804695|NCT04206332|584328039|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804696|NCT04206332|584328023|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804697|NCT04206332|584328024|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804698|NCT04206332|584328025|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804699|NCT04206332|584328026|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804700|NCT04206332|584328027|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804701|NCT04206332|584328028|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804702|NCT04206332|584328029|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804703|NCT04206332|584328030|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804704|NCT04206332|584328031|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804705|NCT04206332|584328032|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804706|NCT04206332|584328033|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804707|NCT04206332|584328034|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804708|NCT04206332|584328035|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804709|NCT04206332|584328036|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804710|NCT04206332|584328037|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804711|NCT04206332|584328038|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161804712|NCT04206332|584328039|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
161804713|NCT04206332|584328023|FG000|Part C|Withdrawal by Subject|0|||
161804714|NCT04206332|584328024|FG001|Part C|Withdrawal by Subject|0|||
161804715|NCT04206332|584328025|FG002|Part C|Withdrawal by Subject|0|||
161804716|NCT04206332|584328026|FG003|Part C|Withdrawal by Subject|0|||
161804717|NCT04206332|584328027|FG004|Part C|Withdrawal by Subject|0|||
161804718|NCT04206332|584328028|FG005|Part C|Withdrawal by Subject|0|||
161804719|NCT04206332|584328029|FG006|Part C|Withdrawal by Subject|0|||
161804720|NCT04206332|584328030|FG007|Part C|Withdrawal by Subject|0|||
161804721|NCT04206332|584328031|FG008|Part C|Withdrawal by Subject|0|||
161804722|NCT04206332|584328032|FG009|Part C|Withdrawal by Subject|0|||
161804723|NCT04206332|584328033|FG010|Part C|Withdrawal by Subject|0|||
161804724|NCT04206332|584328034|FG011|Part C|Withdrawal by Subject|0|||
161804725|NCT04206332|584328035|FG012|Part C|Withdrawal by Subject|0|||
161804726|NCT04206332|584328036|FG013|Part C|Withdrawal by Subject|0|||
161804727|NCT04206332|584328037|FG014|Part C|Withdrawal by Subject|2|||
161907611|NCT01204671|584712254|FG001|Overall Study|Unknown Completion Status|1|||
161907612|NCT01204671|584712255|FG002|Overall Study|Unknown Completion Status|0|||
161907613|NCT01204671|584712256|FG003|Overall Study|Unknown Completion Status|0|||
161907614|NCT01204671|584712257|FG004|Overall Study|Unknown Completion Status|0|||
161907615|NCT01204671|584712253|FG000|Overall Study|Physician Decision|0|||
161907616|NCT01204671|584712254|FG001|Overall Study|Physician Decision|0|||
161907617|NCT01204671|584712255|FG002|Overall Study|Physician Decision|0|||
161907618|NCT01204671|584712256|FG003|Overall Study|Physician Decision|1|||
161907619|NCT01204671|584712257|FG004|Overall Study|Physician Decision|0|||
161804728|NCT04206332|584328038|FG015|Part C|Withdrawal by Subject|0|||
161804729|NCT04206332|584328039|FG016|Part C|Withdrawal by Subject|0|||
161804730|NCT01449630|584328044|FG000|Period 1|Physician Decision|1|||
161804731|NCT01449630|584328045|FG001|Period 1|Physician Decision|0|||
161804732|NCT01449630|584328046|FG002|Period 1|Physician Decision|0|||
161804733|NCT01449630|584328047|FG003|Period 1|Physician Decision|1|||
161804734|NCT01449630|584328048|FG004|Period 1|Physician Decision|0|||
161804735|NCT01449630|584328049|FG005|Period 1|Physician Decision|0|||
161804736|NCT01449630|584328050|FG006|Period 1|Physician Decision|0|||
161804737|NCT01449630|584328051|FG007|Period 1|Physician Decision|0|||
161804738|NCT01449630|584328052|FG008|Period 1|Physician Decision|0|||
161804739|NCT01449630|584328044|FG000|Period 1|Sponsor Decision|0|||
161804740|NCT01449630|584328045|FG001|Period 1|Sponsor Decision|0|||
161804741|NCT01449630|584328046|FG002|Period 1|Sponsor Decision|0|||
161804742|NCT01449630|584328047|FG003|Period 1|Sponsor Decision|0|||
161804743|NCT01449630|584328048|FG004|Period 1|Sponsor Decision|0|||
161804744|NCT01449630|584328049|FG005|Period 1|Sponsor Decision|1|||
161804745|NCT01449630|584328050|FG006|Period 1|Sponsor Decision|0|||
161804746|NCT01449630|584328051|FG007|Period 1|Sponsor Decision|0|||
161804747|NCT01449630|584328052|FG008|Period 1|Sponsor Decision|0|||
161804748|NCT01449630|584328044|FG000|Period 2|Sponsor Decision|0|||
161804749|NCT01449630|584328045|FG001|Period 2|Sponsor Decision|0|||
161804750|NCT01449630|584328046|FG002|Period 2|Sponsor Decision|0|||
161804751|NCT01449630|584328047|FG003|Period 2|Sponsor Decision|0|||
161804752|NCT01449630|584328048|FG004|Period 2|Sponsor Decision|0|||
161804753|NCT01449630|584328049|FG005|Period 2|Sponsor Decision|0|||
161804754|NCT01449630|584328050|FG006|Period 2|Sponsor Decision|1|||
161804755|NCT01449630|584328051|FG007|Period 2|Sponsor Decision|0|||
161804756|NCT01449630|584328052|FG008|Period 2|Sponsor Decision|0|||
161804757|NCT00874237|584328053|FG000|Overall Study|Physician Decision|0|||
161804758|NCT00874237|584328054|FG001|Overall Study|Physician Decision|1|||
161804759|NCT00874237|584328055|FG002|Overall Study|Physician Decision|0|||
161804760|NCT00874237|584328056|FG003|Overall Study|Physician Decision|0|||
161804761|NCT00874237|584328057|FG004|Overall Study|Physician Decision|0|||
161804762|NCT00874237|584328058|FG005|Overall Study|Physician Decision|0|||
161804763|NCT00874237|584328053|FG000|Overall Study|Withdrawal by Subject|0|||
161804764|NCT00874237|584328054|FG001|Overall Study|Withdrawal by Subject|0|||
161804765|NCT00874237|584328055|FG002|Overall Study|Withdrawal by Subject|1|||
161804766|NCT00874237|584328056|FG003|Overall Study|Withdrawal by Subject|0|||
161804767|NCT00874237|584328057|FG004|Overall Study|Withdrawal by Subject|0|||
161804768|NCT00874237|584328058|FG005|Overall Study|Withdrawal by Subject|0|||
161804769|NCT00877032|584328061|FG000|Overall Study|Did not meet entrance criteria|0|||
161804770|NCT00877032|584328062|FG001|Overall Study|Did not meet entrance criteria|0|||
161804771|NCT00877032|584328063|FG002|Overall Study|Did not meet entrance criteria|0|||
161804772|NCT00877032|584328064|FG003|Overall Study|Did not meet entrance criteria|1|||
161804773|NCT00877032|584328065|FG004|Overall Study|Did not meet entrance criteria|0|||
161804774|NCT00877032|584328066|FG005|Overall Study|Did not meet entrance criteria|0|||
161804775|NCT00877032|584328067|FG006|Overall Study|Did not meet entrance criteria|2|||
161804776|NCT01941030|584328070|FG000|Overall Study|Death|3|||
161804777|NCT01941030|584328071|FG001|Overall Study|Death|2|||
161804778|NCT01941030|584328070|FG000|Overall Study|Lost to Follow-up|6|||
161804779|NCT01941030|584328071|FG001|Overall Study|Lost to Follow-up|5|||
161804780|NCT01941030|584328070|FG000|Overall Study|Withdrawal by Subject|4|||
161804781|NCT01941030|584328071|FG001|Overall Study|Withdrawal by Subject|6|||
161804782|NCT05067647|584328072|FG000|Overall Study|Lost to Follow-up|1|||
161804783|NCT02781727|584328073|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
161804784|NCT02781727|584328074|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
161804785|NCT02781727|584328073|FG000|Treatment Period|Withdrawal by Subject|1|||
161804786|NCT02781727|584328074|FG001|Treatment Period|Withdrawal by Subject|0|||
161804787|NCT02781727|584328073|FG000|Treatment Period|Lost to Follow-up|0|||
161804788|NCT02781727|584328074|FG001|Treatment Period|Lost to Follow-up|1|||
161804789|NCT01569152|584328078|FG000|Phase IIa, Period 1|Early Escape|5|||
161804790|NCT01569152|584328079|FG001|Phase IIa, Period 1|Early Escape|22|||
161804791|NCT01569152|584328080|FG002|Phase IIa, Period 1|Early Escape|0|||
161804792|NCT01569152|584328078|FG000|Phase IIa, Period 1|Adverse Event|4|||
161804793|NCT01569152|584328079|FG001|Phase IIa, Period 1|Adverse Event|0|||
161804794|NCT01569152|584328080|FG002|Phase IIa, Period 1|Adverse Event|0|||
161804795|NCT01569152|584328078|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
161804796|NCT01569152|584328079|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
161804797|NCT01569152|584328080|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
161804798|NCT01569152|584328078|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
161804799|NCT01569152|584328079|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
161804800|NCT01569152|584328080|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
161804801|NCT01569152|584328078|FG000|Phase IIa, Period 1|Protocol Violation|0|||
161804802|NCT01569152|584328079|FG001|Phase IIa, Period 1|Protocol Violation|1|||
161804803|NCT01569152|584328080|FG002|Phase IIa, Period 1|Protocol Violation|0|||
161804804|NCT01569152|584328078|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
161804805|NCT01569152|584328079|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
161907620|NCT02700048|584712258|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
161907621|NCT02700048|584712259|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
161907622|NCT02175225|584712260|FG000|Overall Study|Withdrawal by Subject|1|||
161907623|NCT02175225|584712261|FG001|Overall Study|Withdrawal by Subject|2|||
161907624|NCT02175225|584712260|FG000|Overall Study|Lost to Follow-up|6|||
161907625|NCT02175225|584712261|FG001|Overall Study|Lost to Follow-up|7|||
161907626|NCT02175225|584712260|FG000|Overall Study|Study drug not administered|1|||
161907627|NCT02175225|584712261|FG001|Overall Study|Study drug not administered|2|||
161907628|NCT02340000|584712262|FG000|Time Period 1|Withdrawal by Subject|6|||
161907629|NCT02340000|584712263|FG001|Time Period 1|Withdrawal by Subject|8|||
161907630|NCT02340000|584712262|FG000|Time Period 1|Lost to Follow-up|6|||
161907631|NCT02340000|584712263|FG001|Time Period 1|Lost to Follow-up|7|||
161907632|NCT02340000|584712262|FG000|Time Period 2|Withdrawal by Subject|9|||
161907633|NCT02340000|584712263|FG001|Time Period 2|Withdrawal by Subject|7|||
161907634|NCT02340000|584712262|FG000|Time Period 2|Lost to Follow-up|10|||
161907635|NCT02340000|584712263|FG001|Time Period 2|Lost to Follow-up|8|||
161907636|NCT02668640|584712264|FG000|Overall Study|Lost to Follow-up|13|||
161907637|NCT02668640|584712264|FG000|Overall Study|Other, not specified|1|||
161907638|NCT00919633|584712274|FG000|Overall Study|Adverse Event|1|||
161907639|NCT00919633|584712275|FG001|Overall Study|Adverse Event|9|||
161907640|NCT00919633|584712276|FG002|Overall Study|Adverse Event|12|||
161907641|NCT00919633|584712277|FG003|Overall Study|Adverse Event|10|||
161907642|NCT00919633|584712274|FG000|Overall Study|Death|0|||
161907643|NCT00919633|584712275|FG001|Overall Study|Death|0|||
161907644|NCT00919633|584712276|FG002|Overall Study|Death|2|||
161907645|NCT00919633|584712277|FG003|Overall Study|Death|0|||
161907646|NCT00919633|584712274|FG000|Overall Study|Lack of Efficacy|17|||
161907647|NCT00919633|584712275|FG001|Overall Study|Lack of Efficacy|3|||
161907648|NCT00919633|584712276|FG002|Overall Study|Lack of Efficacy|2|||
161907649|NCT00919633|584712277|FG003|Overall Study|Lack of Efficacy|3|||
161907650|NCT00919633|584712274|FG000|Overall Study|Withdrawal by Subject|1|||
161907651|NCT00919633|584712275|FG001|Overall Study|Withdrawal by Subject|2|||
161907652|NCT00919633|584712276|FG002|Overall Study|Withdrawal by Subject|4|||
161907653|NCT00919633|584712277|FG003|Overall Study|Withdrawal by Subject|3|||
161907654|NCT00919633|584712274|FG000|Overall Study|Lost to Follow-up|3|||
161907655|NCT00919633|584712275|FG001|Overall Study|Lost to Follow-up|1|||
161907656|NCT00919633|584712276|FG002|Overall Study|Lost to Follow-up|0|||
161907657|NCT00919633|584712277|FG003|Overall Study|Lost to Follow-up|2|||
161907658|NCT00919633|584712274|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
161907659|NCT00919633|584712275|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
161907660|NCT00919633|584712276|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
161907661|NCT00919633|584712277|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
161907662|NCT00919633|584712274|FG000|Overall Study|Protocol Violation|0|||
161907663|NCT00919633|584712275|FG001|Overall Study|Protocol Violation|0|||
161907664|NCT00919633|584712276|FG002|Overall Study|Protocol Violation|0|||
161907665|NCT00919633|584712277|FG003|Overall Study|Protocol Violation|1|||
161907666|NCT00919633|584712274|FG000|Overall Study|Physician Decision|0|||
161907667|NCT00919633|584712275|FG001|Overall Study|Physician Decision|0|||
161907668|NCT00919633|584712276|FG002|Overall Study|Physician Decision|0|||
161907669|NCT00919633|584712277|FG003|Overall Study|Physician Decision|1|||
161907670|NCT00919633|584712274|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
161907671|NCT00919633|584712275|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
161907672|NCT00919633|584712276|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
161907673|NCT00919633|584712277|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
161907674|NCT00919633|584712274|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
161907675|NCT00919633|584712275|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
161907676|NCT00919633|584712276|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
161907677|NCT00919633|584712277|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
161907678|NCT01526785|584712278|FG000|Overall Study|Study Terminated by Sponsor|8|||
161907679|NCT01526785|584712278|FG000|Overall Study|Death|2|||
161907680|NCT01526785|584712278|FG000|Overall Study|Physician Decision|1|||
161907681|NCT01526785|584712278|FG000|Overall Study|Withdrawal by Subject|2|||
161907682|NCT01121263|584712281|FG000|Overall Study|Death|3|||
161907683|NCT01121263|584712282|FG001|Overall Study|Death|2|||
161907684|NCT01121263|584712281|FG000|Overall Study|Lost to Follow-up|22|||
161907685|NCT01121263|584712282|FG001|Overall Study|Lost to Follow-up|12|||
161907686|NCT01121263|584712281|FG000|Overall Study|Withdrawal by Subject|0|||
161907687|NCT01121263|584712282|FG001|Overall Study|Withdrawal by Subject|1|||
161907688|NCT00723229|584713989|FG000|First Intervention|Lost to Follow-up|7|||
161907689|NCT00723229|584713990|FG001|First Intervention|Lost to Follow-up|3|||
161907690|NCT02337491|584713991|FG000|Overall Study|Death|1|||
161907691|NCT02337491|584713992|FG001|Overall Study|Death|1|||
161907692|NCT02337491|584713991|FG000|Overall Study|Adverse Event|0|||
161907693|NCT02337491|584713992|FG001|Overall Study|Adverse Event|1|||
161907694|NCT02337491|584713991|FG000|Overall Study|Withdrawal by Subject|3|||
161907695|NCT02337491|584713992|FG001|Overall Study|Withdrawal by Subject|0|||
161907696|NCT02337491|584713991|FG000|Overall Study|Progressive Disease|44|||
161907697|NCT02337491|584713992|FG001|Overall Study|Progressive Disease|28|||
161907698|NCT02337491|584713991|FG000|Overall Study|On Treatment|2|||
161907699|NCT02337491|584713992|FG001|Overall Study|On Treatment|0|||
161907700|NCT01432951|584713993|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
161907701|NCT02900352|584713994|FG000|Overall Study|Lost to Follow-up|28|||
161907702|NCT02900352|584713995|FG001|Overall Study|Lost to Follow-up|17|||
161907703|NCT00785356|584713997|FG000|Overall Study|Study prematurely terminated|8|||
161907704|NCT03712280|584714003|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
161907705|NCT03712280|584714004|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
161907706|NCT03712280|584714005|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
161907707|NCT03712280|584714006|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
161907708|NCT03712280|584714003|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
161907709|NCT03712280|584714004|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
161907710|NCT03712280|584714005|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
161907711|NCT03712280|584714006|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
161907712|NCT03712280|584714003|FG000|Overall Study|Adverse Event|0|||
161907713|NCT03712280|584714004|FG001|Overall Study|Adverse Event|0|||
161907714|NCT03712280|584714005|FG002|Overall Study|Adverse Event|1|||
161907715|NCT03712280|584714006|FG003|Overall Study|Adverse Event|0|||
161907716|NCT00106002|584714007|FG000|Overall Study|Did not take any study drug|1|||
161907717|NCT00106002|584714007|FG000|Overall Study|Ineligible after Registration|1|||
161907718|NCT01122173|584714012|FG000|Overall Study|Lost to Follow-up|3|||
161907719|NCT01122173|584714012|FG000|Overall Study|Withdrawal by Subject|3|||
161907720|NCT01122173|584714012|FG000|Overall Study|Left study for other reasons|3|||
161907721|NCT02265510|584714013|FG000|Overall Study|Withdrawal by Subject|1|||
161907722|NCT02265510|584714014|FG001|Overall Study|Withdrawal by Subject|1|||
161907723|NCT02265510|584714015|FG002|Overall Study|Withdrawal by Subject|2|||
161907724|NCT02265510|584714016|FG003|Overall Study|Withdrawal by Subject|1|||
161907725|NCT02265510|584714017|FG004|Overall Study|Withdrawal by Subject|0|||
161907726|NCT02265510|584714018|FG005|Overall Study|Withdrawal by Subject|2|||
161907727|NCT02265510|584714019|FG006|Overall Study|Withdrawal by Subject|0|||
161907728|NCT02265510|584714020|FG007|Overall Study|Withdrawal by Subject|2|||
161907729|NCT02265510|584714021|FG008|Overall Study|Withdrawal by Subject|0|||
161907730|NCT02265510|584714022|FG009|Overall Study|Withdrawal by Subject|0|||
161907731|NCT02265510|584714023|FG010|Overall Study|Withdrawal by Subject|0|||
161907732|NCT02265510|584714024|FG011|Overall Study|Withdrawal by Subject|0|||
161907733|NCT02265510|584714025|FG012|Overall Study|Withdrawal by Subject|1|||
161907734|NCT02265510|584714026|FG013|Overall Study|Withdrawal by Subject|0|||
161907735|NCT02265510|584714013|FG000|Overall Study|Disease Progression|0|||
161907736|NCT02265510|584714014|FG001|Overall Study|Disease Progression|1|||
161907737|NCT02265510|584714015|FG002|Overall Study|Disease Progression|2|||
161907738|NCT02265510|584714016|FG003|Overall Study|Disease Progression|1|||
161907739|NCT02265510|584714017|FG004|Overall Study|Disease Progression|1|||
161907740|NCT02265510|584714018|FG005|Overall Study|Disease Progression|0|||
161907741|NCT02265510|584714019|FG006|Overall Study|Disease Progression|0|||
161907742|NCT02265510|584714020|FG007|Overall Study|Disease Progression|0|||
161907743|NCT02265510|584714021|FG008|Overall Study|Disease Progression|0|||
161907744|NCT02265510|584714022|FG009|Overall Study|Disease Progression|0|||
161907745|NCT02265510|584714023|FG010|Overall Study|Disease Progression|0|||
161907746|NCT02265510|584714024|FG011|Overall Study|Disease Progression|0|||
161907747|NCT02265510|584714025|FG012|Overall Study|Disease Progression|0|||
161907748|NCT02265510|584714026|FG013|Overall Study|Disease Progression|0|||
161907749|NCT02265510|584714013|FG000|Overall Study|Death|2|||
161907750|NCT02265510|584714014|FG001|Overall Study|Death|0|||
161907751|NCT02265510|584714015|FG002|Overall Study|Death|2|||
161907752|NCT02265510|584714016|FG003|Overall Study|Death|2|||
161907753|NCT02265510|584714017|FG004|Overall Study|Death|1|||
161907754|NCT02265510|584714018|FG005|Overall Study|Death|3|||
161907755|NCT02265510|584714019|FG006|Overall Study|Death|2|||
161907756|NCT02265510|584714020|FG007|Overall Study|Death|1|||
161907757|NCT02265510|584714021|FG008|Overall Study|Death|3|||
161907758|NCT02265510|584714022|FG009|Overall Study|Death|3|||
161907759|NCT02265510|584714023|FG010|Overall Study|Death|4|||
161907760|NCT02265510|584714024|FG011|Overall Study|Death|12|||
161907761|NCT02265510|584714025|FG012|Overall Study|Death|7|||
161907762|NCT02265510|584714026|FG013|Overall Study|Death|6|||
161907763|NCT02265510|584714013|FG000|Overall Study|Lost to Follow-up|0|||
161907764|NCT02265510|584714014|FG001|Overall Study|Lost to Follow-up|0|||
161907765|NCT02265510|584714015|FG002|Overall Study|Lost to Follow-up|0|||
161907766|NCT02265510|584714016|FG003|Overall Study|Lost to Follow-up|0|||
161907767|NCT02265510|584714017|FG004|Overall Study|Lost to Follow-up|1|||
161907768|NCT02265510|584714018|FG005|Overall Study|Lost to Follow-up|0|||
161907769|NCT02265510|584714019|FG006|Overall Study|Lost to Follow-up|0|||
161907770|NCT02265510|584714020|FG007|Overall Study|Lost to Follow-up|0|||
161907771|NCT02265510|584714021|FG008|Overall Study|Lost to Follow-up|0|||
161907772|NCT02265510|584714022|FG009|Overall Study|Lost to Follow-up|2|||
161907773|NCT02265510|584714023|FG010|Overall Study|Lost to Follow-up|0|||
161907774|NCT02265510|584714024|FG011|Overall Study|Lost to Follow-up|0|||
161907775|NCT02265510|584714025|FG012|Overall Study|Lost to Follow-up|0|||
161907776|NCT02265510|584714026|FG013|Overall Study|Lost to Follow-up|2|||
161907777|NCT02265510|584714013|FG000|Overall Study|Other|0|||
161907778|NCT02265510|584714014|FG001|Overall Study|Other|1|||
161907779|NCT02265510|584714015|FG002|Overall Study|Other|0|||
161907780|NCT02265510|584714016|FG003|Overall Study|Other|0|||
161907781|NCT02265510|584714017|FG004|Overall Study|Other|0|||
161907782|NCT02265510|584714018|FG005|Overall Study|Other|0|||
161907783|NCT02265510|584714019|FG006|Overall Study|Other|0|||
161907784|NCT02265510|584714020|FG007|Overall Study|Other|0|||
161907785|NCT02265510|584714021|FG008|Overall Study|Other|0|||
161907786|NCT02265510|584714022|FG009|Overall Study|Other|0|||
161907787|NCT02265510|584714023|FG010|Overall Study|Other|0|||
161907788|NCT02265510|584714024|FG011|Overall Study|Other|0|||
161907789|NCT02265510|584714025|FG012|Overall Study|Other|0|||
161907790|NCT02265510|584714026|FG013|Overall Study|Other|0|||
161907791|NCT02265510|584714013|FG000|Overall Study|Study Terminated by Sponsor|0|||
161907792|NCT02265510|584714014|FG001|Overall Study|Study Terminated by Sponsor|0|||
161907793|NCT02265510|584714015|FG002|Overall Study|Study Terminated by Sponsor|0|||
161907794|NCT02265510|584714016|FG003|Overall Study|Study Terminated by Sponsor|0|||
161907795|NCT02265510|584714017|FG004|Overall Study|Study Terminated by Sponsor|0|||
161907796|NCT02265510|584714018|FG005|Overall Study|Study Terminated by Sponsor|1|||
161907797|NCT02265510|584714019|FG006|Overall Study|Study Terminated by Sponsor|1|||
161907798|NCT02265510|584714020|FG007|Overall Study|Study Terminated by Sponsor|1|||
161907799|NCT02265510|584714021|FG008|Overall Study|Study Terminated by Sponsor|1|||
161907800|NCT02265510|584714022|FG009|Overall Study|Study Terminated by Sponsor|2|||
161907801|NCT02265510|584714023|FG010|Overall Study|Study Terminated by Sponsor|1|||
161907802|NCT02265510|584714024|FG011|Overall Study|Study Terminated by Sponsor|4|||
161907803|NCT02265510|584714025|FG012|Overall Study|Study Terminated by Sponsor|1|||
161907804|NCT02265510|584714026|FG013|Overall Study|Study Terminated by Sponsor|2|||
161907805|NCT02530385|584714027|FG000|Overall Study|Withdrawal by Subject|0|||
161907806|NCT02530385|584714028|FG001|Overall Study|Withdrawal by Subject|1|||
161907807|NCT00116142|584714029|FG000|Overall Study|Adverse Event|8|||
161907808|NCT00116142|584714030|FG001|Overall Study|Adverse Event|7|||
161907809|NCT00116142|584714029|FG000|Overall Study|Protocol Violation|2|||
161907810|NCT00116142|584714030|FG001|Overall Study|Protocol Violation|1|||
161907811|NCT00116142|584714029|FG000|Overall Study|Withdrawal by Subject|5|||
161907812|NCT00116142|584714030|FG001|Overall Study|Withdrawal by Subject|5|||
161907813|NCT00116142|584714029|FG000|Overall Study|Physician Decision|3|||
161907814|NCT00116142|584714030|FG001|Overall Study|Physician Decision|1|||
161907815|NCT00116142|584714029|FG000|Overall Study|Delayed Radiation Therapy|1|||
161907816|NCT00116142|584714030|FG001|Overall Study|Delayed Radiation Therapy|0|||
161907817|NCT00116142|584714029|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
161907818|NCT00116142|584714030|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
161907819|NCT00116142|584714029|FG000|Overall Study|Patient stopped due to depression|0|||
161907820|NCT00116142|584714030|FG001|Overall Study|Patient stopped due to depression|1|||
161907821|NCT00116142|584714029|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
161907822|NCT00116142|584714030|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
161907823|NCT00116142|584714029|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
161907824|NCT00116142|584714030|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
161907825|NCT00116142|584714029|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
161804806|NCT01569152|584328080|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
161804807|NCT01569152|584328078|FG000|Safety Extension, Period 3|Adverse Event|0|||
161804808|NCT01569152|584328079|FG001|Safety Extension, Period 3|Adverse Event|0|||
161804809|NCT01569152|584328080|FG002|Safety Extension, Period 3|Adverse Event|4|||
161804810|NCT01569152|584328078|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
161804811|NCT01569152|584328079|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
161804812|NCT01569152|584328080|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
161804813|NCT01569152|584328078|FG000|Safety Extension, Period 3|Physician Decision|0|||
161804814|NCT01569152|584328079|FG001|Safety Extension, Period 3|Physician Decision|0|||
161804815|NCT01569152|584328080|FG002|Safety Extension, Period 3|Physician Decision|2|||
161804816|NCT01569152|584328078|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
161804817|NCT01569152|584328079|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
161804818|NCT01569152|584328080|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
161804819|NCT00683293|584328085|FG000|Overall Study|Withdrawal by Subject|2|||
161804820|NCT00683293|584328086|FG001|Overall Study|Withdrawal by Subject|3|||
161804821|NCT00743197|584328089|FG000|Overall Study|Study terminated due to departure of PI.|1|||
161804822|NCT00743197|584328090|FG001|Overall Study|Study terminated due to departure of PI.|2|||
161804823|NCT02507375|584328091|FG000|Overall Study|Progressive Disease|4|||
161804824|NCT02507375|584328092|FG001|Overall Study|Progressive Disease|5|||
161907826|NCT00116142|584714030|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
161907827|NCT03093181|584714032|FG000|Overall Study|Withdrawal by Subject|2|||
161907828|NCT03093181|584714033|FG001|Overall Study|Withdrawal by Subject|1|||
161907829|NCT03093181|584714034|FG002|Overall Study|Withdrawal by Subject|2|||
161907830|NCT03093181|584714032|FG000|Overall Study|Other (Not specified)|1|||
161907831|NCT03093181|584714033|FG001|Overall Study|Other (Not specified)|0|||
161907832|NCT03093181|584714034|FG002|Overall Study|Other (Not specified)|0|||
161907833|NCT03093181|584714032|FG000|Overall Study|Adverse Event|0|||
161907834|NCT03093181|584714033|FG001|Overall Study|Adverse Event|1|||
161907835|NCT03093181|584714034|FG002|Overall Study|Adverse Event|0|||
161907836|NCT03093181|584714032|FG000|Overall Study|Other (Protocol violation)|0|||
161907837|NCT03093181|584714033|FG001|Overall Study|Other (Protocol violation)|0|||
161907838|NCT03093181|584714034|FG002|Overall Study|Other (Protocol violation)|1|||
161907839|NCT04076917|584714035|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
161907840|NCT04076917|584714035|FG000|Overall Study|Study closure|13|||
161907841|NCT04076917|584714035|FG000|Overall Study|Physician Decision|3|||
161907842|NCT04076917|584714035|FG000|Overall Study|Death|1|||
161907843|NCT04076917|584714035|FG000|Overall Study|Lost to Follow-up|1|||
161907844|NCT04076917|584714035|FG000|Overall Study|Withdrawal by Subject|1|||
161907845|NCT04076917|584714035|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
161907846|NCT04210986|584714036|FG000|Overall Study|Lost to Follow-up|5|||
161907847|NCT04210986|584714037|FG001|Overall Study|Lost to Follow-up|2|||
161907848|NCT04210986|584714036|FG000|Overall Study|Withdrawal by Subject|3|||
161907849|NCT04210986|584714037|FG001|Overall Study|Withdrawal by Subject|1|||
161907850|NCT04210986|584714036|FG000|Overall Study|Protocol Violation|1|||
161907851|NCT04210986|584714037|FG001|Overall Study|Protocol Violation|1|||
161907852|NCT04210986|584714036|FG000|Overall Study|Physician Decision|0|||
161907853|NCT04210986|584714037|FG001|Overall Study|Physician Decision|1|||
161907854|NCT02378662|584714038|FG000|Overall Study|Early Discontinuation|2|||
161907855|NCT02378662|584714039|FG001|Overall Study|Early Discontinuation|0|||
161907856|NCT01774591|584714040|FG000|Overall Study|Physician Decision|1|||
161907857|NCT01774591|584714041|FG001|Overall Study|Physician Decision|1|||
161907858|NCT01774591|584714040|FG000|Overall Study|Withdrawal by Subject|0|||
161907859|NCT01774591|584714041|FG001|Overall Study|Withdrawal by Subject|1|||
161907860|NCT01774591|584714040|FG000|Overall Study|Adverse Event|0|||
161907861|NCT01774591|584714041|FG001|Overall Study|Adverse Event|2|||
161907862|NCT01159574|584714042|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
161907863|NCT01159574|584714042|FG000|Treatment Phase|Adverse Event|3|||
161907864|NCT01159574|584714042|FG000|Treatment Phase|Death|6|||
161907865|NCT01159574|584714042|FG000|Treatment Phase|Physician Decision|2|||
161907866|NCT01159574|584714042|FG000|Treatment Phase|Withdrawal by Subject|7|||
161907867|NCT01159574|584714042|FG000|Treatment Phase|still on treatment|2|||
161907868|NCT01159574|584714042|FG000|Follow Up Phase|Lost to Follow-up|2|||
161907869|NCT01159574|584714042|FG000|Follow Up Phase|still being followed for overall surviva|18|||
161907870|NCT02984982|584714043|FG000|Overall Study|Adverse Event|2|||
161907871|NCT02984982|584714044|FG001|Overall Study|Adverse Event|5|||
161907872|NCT02984982|584714043|FG000|Overall Study|Poor Compliance to Protocol|4|||
161907873|NCT02984982|584714044|FG001|Overall Study|Poor Compliance to Protocol|4|||
161907874|NCT02984982|584714043|FG000|Overall Study|Withdrawal by Subject|2|||
161907875|NCT02984982|584714044|FG001|Overall Study|Withdrawal by Subject|0|||
161907876|NCT02984982|584714043|FG000|Overall Study|Randomized but not treated|0|||
161907877|NCT02984982|584714044|FG001|Overall Study|Randomized but not treated|1|||
161907878|NCT02144701|584714045|FG000|Overall Study|development of relapse, GVHD or death|9|||
161907879|NCT02144701|584714046|FG001|Overall Study|development of relapse, GVHD or death|3|||
161907880|NCT04622969|584714057|FG000|Overall Study|Withdrawal by Subject|2|||
161907881|NCT04622969|584714058|FG001|Overall Study|Withdrawal by Subject|3|||
161907882|NCT04467515|584714059|FG000|Overall Study|Lost to Follow-up|1|||
161907883|NCT04467515|584714060|FG001|Overall Study|Lost to Follow-up|0|||
161907884|NCT04467515|584714061|FG002|Overall Study|Lost to Follow-up|0|||
161907885|NCT04467515|584714059|FG000|Overall Study|Withdrawal by Subject|1|||
161907886|NCT04467515|584714060|FG001|Overall Study|Withdrawal by Subject|0|||
161907887|NCT04467515|584714061|FG002|Overall Study|Withdrawal by Subject|1|||
161907888|NCT04467515|584714059|FG000|Overall Study|Progressive Disease|0|||
161907889|NCT04467515|584714060|FG001|Overall Study|Progressive Disease|1|||
161907890|NCT04467515|584714061|FG002|Overall Study|Progressive Disease|3|||
161907891|NCT04467515|584714059|FG000|Overall Study|Death|0|||
161907892|NCT04467515|584714060|FG001|Overall Study|Death|1|||
161907893|NCT04467515|584714061|FG002|Overall Study|Death|0|||
161907894|NCT04249427|584714064|FG000|Overall Study|Adverse Event|3|||
161907895|NCT04249427|584714065|FG001|Overall Study|Adverse Event|1|||
161907896|NCT04249427|584714064|FG000|Overall Study|Lack of Efficacy|0|||
161907897|NCT04249427|584714065|FG001|Overall Study|Lack of Efficacy|1|||
161907898|NCT04249427|584714064|FG000|Overall Study|Withdrawal by Subject|1|||
161907899|NCT04249427|584714065|FG001|Overall Study|Withdrawal by Subject|2|||
161907900|NCT03886272|584714066|FG000|Period 1|Withdrawal by Subject|0|||
161907901|NCT03886272|584714067|FG001|Period 1|Withdrawal by Subject|0|||
161907902|NCT03886272|584714068|FG002|Period 1|Withdrawal by Subject|0|||
161907903|NCT03886272|584714069|FG003|Period 1|Withdrawal by Subject|0|||
161907904|NCT03886272|584714070|FG004|Period 1|Withdrawal by Subject|0|||
161907905|NCT03886272|584714071|FG005|Period 1|Withdrawal by Subject|1|||
161907906|NCT03886272|584714072|FG006|Period 1|Withdrawal by Subject|0|||
161907907|NCT02848664|584714078|FG000|Overall Study|Withdrawal by Subject|2|||
161907908|NCT02848664|584714078|FG000|Overall Study|Adverse Event|1|||
161907909|NCT02848664|584714078|FG000|Overall Study|no assistance for device training|1|||
161907910|NCT02849080|584714081|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
161907911|NCT02849080|584714082|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
161907912|NCT02849080|584714083|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
161907913|NCT02849080|584714084|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
161907914|NCT02849080|584714081|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
161907915|NCT02849080|584714082|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
161907916|NCT02849080|584714083|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
161907917|NCT02849080|584714084|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
161907918|NCT02849080|584714081|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
161907919|NCT02849080|584714082|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
161907920|NCT02849080|584714083|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
161907921|NCT02849080|584714084|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
161907922|NCT02849080|584714081|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
161907923|NCT02849080|584714082|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
161907924|NCT02849080|584714083|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
161907925|NCT02849080|584714084|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
161907926|NCT02849080|584714081|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
161907927|NCT02849080|584714082|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
161907928|NCT02849080|584714083|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
161907929|NCT02849080|584714084|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
161907930|NCT02849080|584714081|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
161907931|NCT02849080|584714082|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
161907932|NCT02849080|584714083|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
161907933|NCT02849080|584714084|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
161907934|NCT01819727|584714087|FG000|Overall Study|Adverse Event|8|||
161907935|NCT01819727|584714088|FG001|Overall Study|Adverse Event|9|||
161907936|NCT01819727|584714087|FG000|Overall Study|Death|1|||
161907937|NCT01819727|584714088|FG001|Overall Study|Death|0|||
161907938|NCT01819727|584714087|FG000|Overall Study|Lost to Follow-up|1|||
161907939|NCT01819727|584714088|FG001|Overall Study|Lost to Follow-up|1|||
161907940|NCT01819727|584714087|FG000|Overall Study|Physician Decision|3|||
161907941|NCT01819727|584714088|FG001|Overall Study|Physician Decision|2|||
161907942|NCT01819727|584714087|FG000|Overall Study|Pregnancy|1|||
161907943|NCT01819727|584714088|FG001|Overall Study|Pregnancy|0|||
161907944|NCT01819727|584714087|FG000|Overall Study|Protocol Violation|0|||
161907945|NCT01819727|584714088|FG001|Overall Study|Protocol Violation|2|||
161907946|NCT01819727|584714087|FG000|Overall Study|Study Terminated by Sponsor|0|||
161907947|NCT01819727|584714088|FG001|Overall Study|Study Terminated by Sponsor|1|||
161907948|NCT01819727|584714087|FG000|Overall Study|Withdrawal by Subject|6|||
161907949|NCT01819727|584714088|FG001|Overall Study|Withdrawal by Subject|11|||
161907950|NCT01819727|584714087|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
161907951|NCT01819727|584714088|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
161907952|NCT01819727|584714087|FG000|Overall Study|Quit due to lack of health benifits|0|||
161907953|NCT01819727|584714088|FG001|Overall Study|Quit due to lack of health benifits|1|||
161907954|NCT00732069|584714091|FG000|Washout After First Study Drug|Adverse Event|1|||
161907955|NCT00732069|584714092|FG001|Washout After First Study Drug|Adverse Event|0|||
161907956|NCT00732069|584714093|FG002|Washout After First Study Drug|Adverse Event|0|||
161907957|NCT00732069|584714094|FG003|Washout After First Study Drug|Adverse Event|0|||
161907958|NCT00732069|584714095|FG004|Washout After First Study Drug|Adverse Event|0|||
161907959|NCT00732069|584714096|FG005|Washout After First Study Drug|Adverse Event|0|||
161907960|NCT00402727|584714097|FG000|Overall Study|Adverse Event|10|||
161907961|NCT00402727|584714098|FG001|Overall Study|Adverse Event|6|||
161907962|NCT00402727|584714097|FG000|Overall Study|Death|1|||
161907963|NCT00402727|584714098|FG001|Overall Study|Death|0|||
161907964|NCT00402727|584714097|FG000|Overall Study|Lack of Efficacy|1|||
161907965|NCT00402727|584714098|FG001|Overall Study|Lack of Efficacy|3|||
161907966|NCT00402727|584714097|FG000|Overall Study|Lost to Follow-up|24|||
161907967|NCT00402727|584714098|FG001|Overall Study|Lost to Follow-up|11|||
161907968|NCT00402727|584714097|FG000|Overall Study|Physician Decision|1|||
161907969|NCT00402727|584714098|FG001|Overall Study|Physician Decision|1|||
161907970|NCT00402727|584714097|FG000|Overall Study|Protocol Violation|0|||
161907971|NCT00402727|584714098|FG001|Overall Study|Protocol Violation|4|||
161907972|NCT00402727|584714097|FG000|Overall Study|Withdrawal by Subject|3|||
161907973|NCT00402727|584714098|FG001|Overall Study|Withdrawal by Subject|7|||
161907974|NCT00402727|584714097|FG000|Overall Study|supply problems|2|||
161907975|NCT00402727|584714098|FG001|Overall Study|supply problems|1|||
161907976|NCT00402727|584714097|FG000|Overall Study|non-compliance|0|||
161907977|NCT00402727|584714098|FG001|Overall Study|non-compliance|1|||
161907978|NCT00577317|584714099|FG000|Overall Study|Study Terminated|0|||
161907979|NCT00577317|584714100|FG001|Overall Study|Study Terminated|2|||
161907980|NCT02283658|584714104|FG000|Overall Study|Withdrawal by Subject|1|||
161907981|NCT03608826|584714106|FG000|Overall Study|Death|3|||
161804825|NCT02507375|584328091|FG000|Overall Study|Death|0|||
161804826|NCT02507375|584328092|FG001|Overall Study|Death|1|||
161804827|NCT02507375|584328091|FG000|Overall Study|Refused treatment|0|||
161804828|NCT02507375|584328092|FG001|Overall Study|Refused treatment|1|||
161804829|NCT02507375|584328091|FG000|Overall Study|Adverse Event|0|||
161804830|NCT02507375|584328092|FG001|Overall Study|Adverse Event|1|||
161804831|NCT02158936|584328093|FG000|Overall Study|Study closed/ terminated|57|||
161804832|NCT02158936|584328094|FG001|Overall Study|Study closed/ terminated|77|||
161804833|NCT02158936|584328093|FG000|Overall Study|Azacitidine tx discontinued|53|||
161804834|NCT02158936|584328094|FG001|Overall Study|Azacitidine tx discontinued|46|||
161804835|NCT02158936|584328093|FG000|Overall Study|Adverse Event|39|||
161804836|NCT02158936|584328094|FG001|Overall Study|Adverse Event|24|||
161804837|NCT02158936|584328093|FG000|Overall Study|Withdrawal by Subject|15|||
161804838|NCT02158936|584328094|FG001|Overall Study|Withdrawal by Subject|16|||
161804839|NCT02158936|584328093|FG000|Overall Study|Physician Decision|15|||
161804840|NCT02158936|584328094|FG001|Overall Study|Physician Decision|13|||
161804841|NCT02158936|584328093|FG000|Overall Study|Lost to Follow-up|0|||
161804842|NCT02158936|584328094|FG001|Overall Study|Lost to Follow-up|1|||
161804843|NCT00522457|584328095|FG000|Overall Study|Due to disease progression|16|||
161804844|NCT00522457|584328095|FG000|Overall Study|Adverse Event|2|||
161804845|NCT01215981|584329776|FG000|Overall Study|Physician Decision|0|||
161804846|NCT01215981|584329777|FG001|Overall Study|Physician Decision|1|||
161804847|NCT01215981|584329776|FG000|Overall Study|Protocol Violation|1|||
161804848|NCT01215981|584329777|FG001|Overall Study|Protocol Violation|0|||
161804849|NCT01215981|584329776|FG000|Overall Study|Withdrawal by Subject|1|||
161804850|NCT01215981|584329777|FG001|Overall Study|Withdrawal by Subject|0|||
161804851|NCT00727571|584329783|FG000|Overall Study|Ineligibility determined|1|||
161804852|NCT00727571|584329784|FG001|Overall Study|Ineligibility determined|1|||
161804853|NCT00727571|584329785|FG002|Overall Study|Ineligibility determined|1|||
161804854|NCT00727571|584329786|FG003|Overall Study|Ineligibility determined|0|||
161804855|NCT00727571|584329783|FG000|Overall Study|Death|0|||
161804856|NCT00727571|584329784|FG001|Overall Study|Death|19|||
161804857|NCT00727571|584329785|FG002|Overall Study|Death|5|||
161804858|NCT00727571|584329786|FG003|Overall Study|Death|1|||
161804859|NCT00727571|584329783|FG000|Overall Study|Physician Decision|0|||
161804860|NCT00727571|584329784|FG001|Overall Study|Physician Decision|5|||
161804861|NCT00727571|584329785|FG002|Overall Study|Physician Decision|0|||
161804862|NCT00727571|584329786|FG003|Overall Study|Physician Decision|0|||
161804863|NCT00727571|584329783|FG000|Overall Study|Withdrawal by Subject|0|||
161804864|NCT00727571|584329784|FG001|Overall Study|Withdrawal by Subject|10|||
161804865|NCT00727571|584329785|FG002|Overall Study|Withdrawal by Subject|11|||
161804866|NCT00727571|584329786|FG003|Overall Study|Withdrawal by Subject|0|||
161804867|NCT00727571|584329783|FG000|Overall Study|Subject Non Compliance|0|||
161804868|NCT00727571|584329784|FG001|Overall Study|Subject Non Compliance|6|||
161804869|NCT00727571|584329785|FG002|Overall Study|Subject Non Compliance|0|||
161804870|NCT00727571|584329786|FG003|Overall Study|Subject Non Compliance|4|||
161804871|NCT00727571|584329783|FG000|Overall Study|Dismissed from nursing home|0|||
161804872|NCT00727571|584329784|FG001|Overall Study|Dismissed from nursing home|9|||
161804873|NCT00727571|584329785|FG002|Overall Study|Dismissed from nursing home|5|||
161804874|NCT00727571|584329786|FG003|Overall Study|Dismissed from nursing home|0|||
161804875|NCT00727571|584329783|FG000|Overall Study|Hospitalization|0|||
161804876|NCT00727571|584329784|FG001|Overall Study|Hospitalization|1|||
161804877|NCT00727571|584329785|FG002|Overall Study|Hospitalization|0|||
161804878|NCT00727571|584329786|FG003|Overall Study|Hospitalization|1|||
161804879|NCT00727571|584329783|FG000|Overall Study|AE not leading to hospitalization|0|||
161804880|NCT00727571|584329784|FG001|Overall Study|AE not leading to hospitalization|0|||
161804881|NCT00727571|584329785|FG002|Overall Study|AE not leading to hospitalization|2|||
161804882|NCT00727571|584329786|FG003|Overall Study|AE not leading to hospitalization|0|||
161804883|NCT00727571|584329783|FG000|Overall Study|Other|0|||
161804884|NCT00727571|584329784|FG001|Overall Study|Other|4|||
161804885|NCT00727571|584329785|FG002|Overall Study|Other|6|||
161804886|NCT00727571|584329786|FG003|Overall Study|Other|0|||
162140252|NCT03102710|585565592|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
161804887|NCT03247556|584329787|FG000|Overall Study|Adverse Event|1|||
161804888|NCT03247556|584329788|FG001|Overall Study|Adverse Event|4|||
161804889|NCT03247556|584329789|FG002|Overall Study|Adverse Event|5|||
161804890|NCT03247556|584329787|FG000|Overall Study|Lost to Follow-up|5|||
161804891|NCT03247556|584329788|FG001|Overall Study|Lost to Follow-up|5|||
161804892|NCT03247556|584329789|FG002|Overall Study|Lost to Follow-up|4|||
161804893|NCT03247556|584329787|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
161804894|NCT03247556|584329788|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
162140253|NCT03102710|585565590|FG000|Overall Study|Technical issues during final MRI scan|0|||
161804895|NCT03247556|584329789|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
161804896|NCT03247556|584329787|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
161804897|NCT03247556|584329788|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
161804898|NCT03247556|584329789|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
161804899|NCT03247556|584329787|FG000|Overall Study|Protocol Violation|2|||
161804900|NCT03247556|584329788|FG001|Overall Study|Protocol Violation|0|||
161907982|NCT03608826|584714106|FG000|Overall Study|Heart Transplant|3|||
161907983|NCT03608826|584714106|FG000|Overall Study|Physician Decision|4|||
161907984|NCT00875810|584714123|FG000|Overall Study|Withdrawal by Subject|1|||
161907985|NCT00875810|584714123|FG000|Overall Study|Physician Decision|3|||
161907986|NCT00875810|584714123|FG000|Overall Study|Lost to Follow-up|39|||
161907987|NCT00875810|584714123|FG000|Overall Study|Patient enroled but not implanted|2|||
161907988|NCT00875810|584714123|FG000|Overall Study|Device explanted|1|||
161907989|NCT00887484|584714127|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
161907990|NCT00887484|584714127|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
161907991|NCT00887484|584714127|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
161907992|NCT01061606|584714128|FG000|Overall Study|Adverse Event|1|||
161907993|NCT01061606|584714128|FG000|Overall Study|Death|1|||
161907994|NCT01061606|584714128|FG000|Overall Study|Disease Progression|4|||
161907995|NCT01061606|584714128|FG000|Overall Study|alternative therapy|2|||
161907996|NCT01316224|584714129|FG000|Overall Study|Protocol Violation|3|||
161907997|NCT01316224|584714129|FG000|Overall Study|Adverse Event|3|||
161907998|NCT01316224|584714129|FG000|Overall Study|Lack of Efficacy|1|||
161907999|NCT01316224|584714129|FG000|Overall Study|Withdrawal by Subject|1|||
161908000|NCT01316224|584714129|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
161908001|NCT01316224|584714129|FG000|Overall Study|Other|1|||
161908002|NCT03106077|584714134|FG000|Overall Study|Screen Failure|94|||
161908003|NCT03106077|584714135|FG001|Overall Study|Screen Failure|0|||
161804901|NCT03247556|584329789|FG002|Overall Study|Protocol Violation|1|||
161804902|NCT03247556|584329787|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
161804903|NCT03247556|584329788|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
161804904|NCT03247556|584329789|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
161804905|NCT01710657|584329791|FG000|Overall Study|Lost to Follow-up|2|||
161804906|NCT01710657|584329792|FG001|Overall Study|Lost to Follow-up|0|||
161804907|NCT01710657|584329793|FG002|Overall Study|Lost to Follow-up|1|||
161804908|NCT01710657|584329791|FG000|Overall Study|Protocol Violation|2|||
161804909|NCT01710657|584329792|FG001|Overall Study|Protocol Violation|2|||
161804910|NCT01710657|584329793|FG002|Overall Study|Protocol Violation|0|||
161804911|NCT01710657|584329791|FG000|Overall Study|Adverse Event|14|||
161804912|NCT01710657|584329792|FG001|Overall Study|Adverse Event|8|||
161804913|NCT01710657|584329793|FG002|Overall Study|Adverse Event|28|||
161804914|NCT01710657|584329791|FG000|Overall Study|Withdrawal by Subject|0|||
161804915|NCT01710657|584329792|FG001|Overall Study|Withdrawal by Subject|1|||
161804916|NCT01710657|584329793|FG002|Overall Study|Withdrawal by Subject|2|||
161804917|NCT01710657|584329791|FG000|Overall Study|Lack of Efficacy|0|||
161804918|NCT01710657|584329792|FG001|Overall Study|Lack of Efficacy|1|||
161804919|NCT01710657|584329793|FG002|Overall Study|Lack of Efficacy|1|||
161804920|NCT02724462|584329795|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
161804921|NCT02724462|584329796|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
161804922|NCT02724462|584329795|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
161804923|NCT02724462|584329796|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
161804924|NCT02724462|584329795|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
161804925|NCT02724462|584329796|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
161804926|NCT02724462|584329795|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
161804927|NCT02724462|584329796|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
161804928|NCT02724462|584329795|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
161804929|NCT02724462|584329796|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
161804930|NCT02724462|584329795|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
161804931|NCT02724462|584329796|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
161804932|NCT00469417|584329797|FG000|Overall Study|Treatment failure all lesions|18|||
161804933|NCT00469417|584329798|FG001|Overall Study|Treatment failure all lesions|11|||
161804934|NCT00469417|584329797|FG000|Overall Study|Consent withdrawn|1|||
161804935|NCT00469417|584329798|FG001|Overall Study|Consent withdrawn|1|||
161804936|NCT00469417|584329797|FG000|Overall Study|Adverse Event|8|||
161804937|NCT00469417|584329798|FG001|Overall Study|Adverse Event|2|||
161804938|NCT00469417|584329797|FG000|Overall Study|Lost to Follow-up|1|||
161804939|NCT00469417|584329798|FG001|Overall Study|Lost to Follow-up|2|||
161804940|NCT00469417|584329797|FG000|Overall Study|Intercurrent disease|0|||
161804941|NCT00469417|584329798|FG001|Overall Study|Intercurrent disease|1|||
161804942|NCT00469417|584329797|FG000|Overall Study|Randomized but not treated|2|||
161804943|NCT00469417|584329798|FG001|Overall Study|Randomized but not treated|0|||
161804944|NCT05327491|584329801|FG000|Periods 1 & 2|Miscellaneous|0|||
161804945|NCT05327491|584329802|FG001|Periods 1 & 2|Miscellaneous|1|||
161804946|NCT05327491|584329803|FG002|Periods 1 & 2|Miscellaneous|0|||
161804947|NCT05327491|584329804|FG003|Periods 1 & 2|Miscellaneous|0|||
161804948|NCT05327491|584329801|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
161804949|NCT05327491|584329802|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
161804950|NCT05327491|584329803|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
161804951|NCT05327491|584329804|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
161804952|NCT02188303|584329805|FG000|Overall Study|Adverse Event|0|||
161804953|NCT02188303|584329806|FG001|Overall Study|Adverse Event|0|||
161908004|NCT01274533|584714136|FG000|Overall Study|Withdrawal by Subject|1|||
161908005|NCT01274533|584714136|FG000|Overall Study|Non-compliance|1|||
161908006|NCT01274533|584714136|FG000|Overall Study|Disease progression|2|||
161908007|NCT02563899|584714137|FG000|Overall Study|Protocol Violation|1|||
161908008|NCT02563899|584714138|FG001|Overall Study|Protocol Violation|0|||
161908009|NCT02563899|584714139|FG002|Overall Study|Protocol Violation|0|||
161908010|NCT02563899|584714140|FG003|Overall Study|Protocol Violation|0|||
161908011|NCT02563899|584714137|FG000|Overall Study|Withdrawal by Subject|0|||
161908012|NCT02563899|584714138|FG001|Overall Study|Withdrawal by Subject|0|||
161908013|NCT02563899|584714139|FG002|Overall Study|Withdrawal by Subject|1|||
161908014|NCT02563899|584714140|FG003|Overall Study|Withdrawal by Subject|0|||
161908015|NCT02008526|584714141|FG000|Overall Study|Death|0|||
161908016|NCT02008526|584714142|FG001|Overall Study|Death|2|||
161908017|NCT02008526|584714143|FG002|Overall Study|Death|1|||
161908018|NCT02008526|584714141|FG000|Overall Study|Withdrawal by Subject|3|||
161908019|NCT02008526|584714142|FG001|Overall Study|Withdrawal by Subject|3|||
161908020|NCT02008526|584714143|FG002|Overall Study|Withdrawal by Subject|2|||
161908021|NCT02008526|584714141|FG000|Overall Study|Lost to Follow-up|5|||
161908022|NCT02008526|584714142|FG001|Overall Study|Lost to Follow-up|9|||
161908023|NCT02008526|584714143|FG002|Overall Study|Lost to Follow-up|6|||
161908024|NCT01305564|584714150|FG000|Overall Study|Death|21|||
161908025|NCT01305564|584714150|FG000|Overall Study|Lost to Follow-up|12|||
161908026|NCT01305564|584714150|FG000|Overall Study|Withdrawal by Subject|1|||
161908027|NCT01305564|584714150|FG000|Overall Study|Physician Decision|3|||
161908028|NCT02322749|584714151|FG000|Period 2|Adverse Event|0|||
161908029|NCT02322749|584714152|FG001|Period 2|Adverse Event|0|||
161908030|NCT02322749|584714153|FG002|Period 2|Adverse Event|0|||
161908031|NCT02322749|584714154|FG003|Period 2|Adverse Event|1|||
161908032|NCT02322749|584714155|FG004|Period 2|Adverse Event|0|||
161908033|NCT02322749|584714156|FG005|Period 2|Adverse Event|0|||
161908034|NCT02322749|584714151|FG000|Period 2|Withdrawal by Subject|0|||
161908035|NCT02322749|584714152|FG001|Period 2|Withdrawal by Subject|0|||
161908036|NCT02322749|584714153|FG002|Period 2|Withdrawal by Subject|0|||
161908037|NCT02322749|584714154|FG003|Period 2|Withdrawal by Subject|1|||
161908038|NCT02322749|584714155|FG004|Period 2|Withdrawal by Subject|0|||
161908039|NCT02322749|584714156|FG005|Period 2|Withdrawal by Subject|0|||
161908040|NCT02322749|584714151|FG000|Period 3|Withdrawal by Subject|0|||
161908041|NCT02322749|584714152|FG001|Period 3|Withdrawal by Subject|0|||
161908042|NCT02322749|584714153|FG002|Period 3|Withdrawal by Subject|1|||
161908043|NCT02322749|584714154|FG003|Period 3|Withdrawal by Subject|0|||
161908044|NCT02322749|584714155|FG004|Period 3|Withdrawal by Subject|0|||
161908045|NCT02322749|584714156|FG005|Period 3|Withdrawal by Subject|0|||
161908046|NCT01190813|584714161|FG000|Overall Study|Lost to Follow-up|1|||
161908047|NCT01190813|584714162|FG001|Overall Study|Lost to Follow-up|2|||
161908048|NCT01190813|584714161|FG000|Overall Study|Withdrawal by Subject|2|||
161908049|NCT01190813|584714162|FG001|Overall Study|Withdrawal by Subject|1|||
161908050|NCT01190813|584714161|FG000|Overall Study|Refused study treatment after randomized|1|||
161908051|NCT01190813|584714162|FG001|Overall Study|Refused study treatment after randomized|0|||
161908052|NCT01190813|584714161|FG000|Overall Study|Adverse Event|0|||
161908053|NCT01190813|584714162|FG001|Overall Study|Adverse Event|1|||
161908054|NCT03810456|584714164|FG000|Treatment|Urgent Family Matters|3|||
161908055|NCT03810456|584714165|FG001|Treatment|Urgent Family Matters|0|||
161908056|NCT03810456|584714166|FG002|Treatment|Urgent Family Matters|0|||
161908057|NCT03810456|584714164|FG000|Treatment|Scheduling Conflicts|0|||
161908058|NCT03810456|584714165|FG001|Treatment|Scheduling Conflicts|11|||
161908059|NCT03810456|584714166|FG002|Treatment|Scheduling Conflicts|0|||
161908060|NCT03810456|584714164|FG000|Treatment|No Longer Interested|0|||
161908061|NCT03810456|584714165|FG001|Treatment|No Longer Interested|12|||
161908062|NCT03810456|584714166|FG002|Treatment|No Longer Interested|0|||
161908063|NCT03810456|584714164|FG000|Treatment|Transportation Issues|0|||
161908064|NCT03810456|584714165|FG001|Treatment|Transportation Issues|1|||
161908065|NCT03810456|584714166|FG002|Treatment|Transportation Issues|0|||
161908066|NCT03810456|584714164|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
161908067|NCT03810456|584714165|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
161908068|NCT03810456|584714166|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
161908069|NCT03810456|584714164|FG000|1 Month Follow-Up|Relocated to Different State|1|||
161908070|NCT03810456|584714165|FG001|1 Month Follow-Up|Relocated to Different State|0|||
161908071|NCT03810456|584714166|FG002|1 Month Follow-Up|Relocated to Different State|1|||
161908072|NCT03810456|584714164|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
161908073|NCT03810456|584714165|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
161908074|NCT03810456|584714166|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
161908075|NCT03810456|584714164|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
161908076|NCT03810456|584714165|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
161908077|NCT03810456|584714166|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
161908078|NCT03810456|584714164|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
161908079|NCT03810456|584714165|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
161908080|NCT03810456|584714166|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
161908081|NCT03810456|584714164|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
161908082|NCT03810456|584714165|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
161908083|NCT03810456|584714166|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
161908084|NCT03810456|584714164|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
161908085|NCT03810456|584714165|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
161908086|NCT03810456|584714166|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
161908087|NCT04265261|584714171|FG000|Overall Study|Adverse Event|2|||
161908088|NCT04265261|584714172|FG001|Overall Study|Adverse Event|0|||
161908089|NCT04265261|584714173|FG002|Overall Study|Adverse Event|0|||
161908090|NCT04265261|584714171|FG000|Overall Study|Death|1|||
161908091|NCT04265261|584714172|FG001|Overall Study|Death|0|||
161908092|NCT04265261|584714173|FG002|Overall Study|Death|0|||
161908093|NCT04265261|584714171|FG000|Overall Study|Lost to Follow-up|4|||
161908094|NCT04265261|584714172|FG001|Overall Study|Lost to Follow-up|1|||
161908095|NCT04265261|584714173|FG002|Overall Study|Lost to Follow-up|3|||
161908096|NCT04265261|584714171|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161908097|NCT04265261|584714172|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161908098|NCT04265261|584714173|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161908099|NCT04265261|584714171|FG000|Overall Study|Physician Decision|0|||
161908100|NCT04265261|584714172|FG001|Overall Study|Physician Decision|0|||
161908101|NCT04265261|584714173|FG002|Overall Study|Physician Decision|1|||
161908102|NCT04265261|584714171|FG000|Overall Study|Protocol Deviation|0|||
161908103|NCT04265261|584714172|FG001|Overall Study|Protocol Deviation|2|||
161908104|NCT04265261|584714173|FG002|Overall Study|Protocol Deviation|0|||
161908105|NCT04265261|584714171|FG000|Overall Study|Withdrawal by Subject|2|||
161908106|NCT04265261|584714172|FG001|Overall Study|Withdrawal by Subject|1|||
161908107|NCT04265261|584714173|FG002|Overall Study|Withdrawal by Subject|4|||
161908108|NCT07116759|584714174|FG000|Overall Study|Incompatibility with the RHMC device|2|||
161908109|NCT03408899|584715765|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
161908110|NCT00606008|584715766|FG000|Overall Study|Adverse Event|1|||
161908111|NCT00606008|584715766|FG000|Overall Study|Withdrawal by Subject|4|||
161908112|NCT04745351|584715767|FG000|Overall Study|Death|51|||
161908113|NCT04745351|584715768|FG001|Overall Study|Death|25|||
161908114|NCT04745351|584715767|FG000|Overall Study|Lost to Follow-up|9|||
161908115|NCT04745351|584715768|FG001|Overall Study|Lost to Follow-up|3|||
161908116|NCT04745351|584715767|FG000|Overall Study|Randomized but Never Treated|3|||
161908117|NCT04745351|584715768|FG001|Overall Study|Randomized but Never Treated|3|||
161908118|NCT04745351|584715767|FG000|Overall Study|Adverse Event|4|||
161908119|NCT04745351|584715768|FG001|Overall Study|Adverse Event|0|||
161908120|NCT04745351|584715767|FG000|Overall Study|Withdrew Consent|1|||
161908121|NCT04745351|584715768|FG001|Overall Study|Withdrew Consent|2|||
161908122|NCT04745351|584715767|FG000|Overall Study|Investigator's Discretion|2|||
161908123|NCT04745351|584715768|FG001|Overall Study|Investigator's Discretion|0|||
161908124|NCT04745351|584715767|FG000|Overall Study|Protocol Violation|1|||
161908125|NCT04745351|584715768|FG001|Overall Study|Protocol Violation|0|||
161908126|NCT02014272|584715772|FG000|Intervention Period 1|Withdrawal by Subject|1|||
161908127|NCT02014272|584715773|FG001|Intervention Period 1|Withdrawal by Subject|0|||
161908128|NCT02014272|584715772|FG000|Intervention Period 1|Adverse Event|0|||
161908129|NCT02014272|584715773|FG001|Intervention Period 1|Adverse Event|1|||
161908130|NCT03499795|584715774|FG000|Overall Study|Adverse Event|1|||
161908131|NCT03499795|584715774|FG000|Overall Study|Lost to Follow-up|1|||
161908132|NCT00630916|584715775|FG000|Overall Study|Death|110|||
161908133|NCT00630916|584715775|FG000|Overall Study|Explant|8|||
161908134|NCT00630916|584715775|FG000|Overall Study|Lost to Follow-up|5|||
161908135|NCT00630916|584715775|FG000|Overall Study|Withdrawal by Subject|30|||
161908136|NCT00630916|584715775|FG000|Overall Study|Protocol Violation|7|||
161908137|NCT00630916|584715775|FG000|Overall Study|Physician Decision|47|||
161908138|NCT00630916|584715775|FG000|Overall Study|Lack of Efficacy|3|||
161908139|NCT00324155|584715776|FG000|Enrolled and Randomized|No longer met study criteria|3|||
161908140|NCT00324155|584715777|FG001|Enrolled and Randomized|No longer met study criteria|0|||
161908141|NCT00324155|584715776|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
161908142|NCT00324155|584715777|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
161908143|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
161908144|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
161908145|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
162010923|NCT05523089|585096052|FG000|Overall Study|Withdrawal by Subject|1|||
162010924|NCT05523089|585096053|FG001|Overall Study|Withdrawal by Subject|0|||
161908146|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
161908147|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Death|8|||
161908148|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Death|15|||
161908149|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
161908150|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
161908151|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
161908152|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
161908153|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
161908154|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
162010925|NCT05523089|585096054|FG002|Overall Study|Withdrawal by Subject|0|||
161908155|NCT00324155|584715776|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
161908156|NCT00324155|584715777|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
161908157|NCT00324155|584715776|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
161908158|NCT00324155|584715777|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
161908159|NCT00324155|584715776|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
161908160|NCT00324155|584715777|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
161908161|NCT00324155|584715776|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
161908162|NCT00324155|584715777|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
161908163|NCT00324155|584715776|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
161908164|NCT00324155|584715777|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
161908165|NCT00324155|584715776|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
161908166|NCT00324155|584715777|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
161908167|NCT00324155|584715776|FG000|Follow-up Phase|On-going participants still on drug|11|||
161908168|NCT00324155|584715777|FG001|Follow-up Phase|On-going participants still on drug|6|||
161908169|NCT00390689|584715778|FG000|Overall Study|Adverse Event|2|||
161908170|NCT00390689|584715779|FG001|Overall Study|Adverse Event|5|||
161908171|NCT00390689|584715780|FG002|Overall Study|Adverse Event|2|||
161908172|NCT00390689|584715778|FG000|Overall Study|Lack of Efficacy|0|||
161908173|NCT00390689|584715779|FG001|Overall Study|Lack of Efficacy|0|||
161908174|NCT00390689|584715780|FG002|Overall Study|Lack of Efficacy|1|||
161908175|NCT00390689|584715778|FG000|Overall Study|Protocol Violation|1|||
161908176|NCT00390689|584715779|FG001|Overall Study|Protocol Violation|0|||
161908177|NCT00390689|584715780|FG002|Overall Study|Protocol Violation|0|||
161908178|NCT00390689|584715778|FG000|Overall Study|Investigator's judgement|2|||
161908179|NCT00390689|584715779|FG001|Overall Study|Investigator's judgement|0|||
161908180|NCT00390689|584715780|FG002|Overall Study|Investigator's judgement|0|||
161908181|NCT01253161|584715781|FG000|Overall Study|Adverse Event|1|||
161908182|NCT03101020|584715783|FG000|Overall Study|Lack of time to participate|1|||
161908183|NCT03101020|584715784|FG001|Overall Study|Lack of time to participate|0|||
161908184|NCT03101020|584715783|FG000|Overall Study|Ran over by a car|0|||
161908185|NCT03101020|584715784|FG001|Overall Study|Ran over by a car|1|||
161908186|NCT03101020|584715783|FG000|Overall Study|Withdrawal by Subject|0|||
161908187|NCT03101020|584715784|FG001|Overall Study|Withdrawal by Subject|2|||
161908188|NCT05412134|584715785|FG000|Overall Study|Lost to Follow-up|2|||
161908189|NCT05412134|584715786|FG001|Overall Study|Lost to Follow-up|0|||
161908190|NCT03167242|584715788|FG000|Overall Study|Patient/Guardian Decision|0|||
161908191|NCT03167242|584715789|FG001|Overall Study|Patient/Guardian Decision|1|||
161908192|NCT03167242|584715790|FG002|Overall Study|Patient/Guardian Decision|2|||
161908193|NCT03167242|584715791|FG003|Overall Study|Patient/Guardian Decision|1|||
161908194|NCT03167242|584715792|FG004|Overall Study|Patient/Guardian Decision|1|||
161908195|NCT03167242|584715793|FG005|Overall Study|Patient/Guardian Decision|1|||
161908196|NCT03167242|584715794|FG006|Overall Study|Patient/Guardian Decision|0|||
161908197|NCT03167242|584715795|FG007|Overall Study|Patient/Guardian Decision|0|||
161908198|NCT03167242|584715796|FG008|Overall Study|Patient/Guardian Decision|0|||
161908199|NCT03167242|584715797|FG009|Overall Study|Patient/Guardian Decision|0|||
161908200|NCT03167242|584715798|FG010|Overall Study|Patient/Guardian Decision|1|||
161908201|NCT03167242|584715799|FG011|Overall Study|Patient/Guardian Decision|0|||
161908202|NCT03167242|584715788|FG000|Overall Study|Lost to Follow-up|0|||
161908203|NCT03167242|584715789|FG001|Overall Study|Lost to Follow-up|0|||
161908204|NCT03167242|584715790|FG002|Overall Study|Lost to Follow-up|1|||
161908205|NCT03167242|584715791|FG003|Overall Study|Lost to Follow-up|0|||
161908206|NCT03167242|584715792|FG004|Overall Study|Lost to Follow-up|0|||
161908207|NCT03167242|584715793|FG005|Overall Study|Lost to Follow-up|1|||
161908208|NCT03167242|584715794|FG006|Overall Study|Lost to Follow-up|2|||
161908209|NCT03167242|584715795|FG007|Overall Study|Lost to Follow-up|1|||
161908210|NCT03167242|584715796|FG008|Overall Study|Lost to Follow-up|0|||
161908211|NCT03167242|584715797|FG009|Overall Study|Lost to Follow-up|0|||
161908212|NCT03167242|584715798|FG010|Overall Study|Lost to Follow-up|1|||
161908213|NCT03167242|584715799|FG011|Overall Study|Lost to Follow-up|1|||
161908214|NCT03167242|584715788|FG000|Overall Study|Reason not provided|0|||
161908215|NCT03167242|584715789|FG001|Overall Study|Reason not provided|0|||
161908216|NCT03167242|584715790|FG002|Overall Study|Reason not provided|0|||
161908217|NCT03167242|584715791|FG003|Overall Study|Reason not provided|0|||
161908218|NCT03167242|584715792|FG004|Overall Study|Reason not provided|0|||
161908219|NCT03167242|584715793|FG005|Overall Study|Reason not provided|0|||
161908220|NCT03167242|584715794|FG006|Overall Study|Reason not provided|0|||
161908221|NCT03167242|584715795|FG007|Overall Study|Reason not provided|0|||
161908222|NCT03167242|584715796|FG008|Overall Study|Reason not provided|1|||
161908223|NCT03167242|584715797|FG009|Overall Study|Reason not provided|0|||
161908224|NCT03167242|584715798|FG010|Overall Study|Reason not provided|0|||
161908225|NCT03167242|584715799|FG011|Overall Study|Reason not provided|0|||
161908226|NCT03444584|584715801|FG000|Overall Study|Withdrawal by Subject|0|||
161908227|NCT03444584|584715802|FG001|Overall Study|Withdrawal by Subject|1|||
161908228|NCT03444584|584715801|FG000|Overall Study|Other|0|||
161908229|NCT03444584|584715802|FG001|Overall Study|Other|1|||
161908230|NCT03786380|584715803|FG000|Overall Study|Adverse Event|1|||
161908231|NCT03786380|584715804|FG001|Overall Study|Adverse Event|0|||
161908232|NCT03786380|584715805|FG002|Overall Study|Adverse Event|0|||
161908233|NCT03786380|584715806|FG003|Overall Study|Adverse Event|3|||
161908234|NCT03786380|584715807|FG004|Overall Study|Adverse Event|1|||
161908235|NCT03786380|584715803|FG000|Overall Study|Lack of Efficacy|0|||
161908236|NCT03786380|584715804|FG001|Overall Study|Lack of Efficacy|0|||
161908237|NCT03786380|584715805|FG002|Overall Study|Lack of Efficacy|0|||
161908238|NCT03786380|584715806|FG003|Overall Study|Lack of Efficacy|0|||
161908239|NCT03786380|584715807|FG004|Overall Study|Lack of Efficacy|1|||
161908240|NCT03786380|584715803|FG000|Overall Study|Withdrawal by Subject|1|||
161908241|NCT03786380|584715804|FG001|Overall Study|Withdrawal by Subject|2|||
161908242|NCT03786380|584715805|FG002|Overall Study|Withdrawal by Subject|2|||
161908243|NCT03786380|584715806|FG003|Overall Study|Withdrawal by Subject|1|||
161908244|NCT03786380|584715807|FG004|Overall Study|Withdrawal by Subject|2|||
161908245|NCT03786380|584715803|FG000|Overall Study|Lost to Follow-up|3|||
161908246|NCT03786380|584715804|FG001|Overall Study|Lost to Follow-up|0|||
161908247|NCT03786380|584715805|FG002|Overall Study|Lost to Follow-up|1|||
161908248|NCT03786380|584715806|FG003|Overall Study|Lost to Follow-up|2|||
161908249|NCT03786380|584715807|FG004|Overall Study|Lost to Follow-up|0|||
161908250|NCT03786380|584715803|FG000|Overall Study|Physician Decision|0|||
161908251|NCT03786380|584715804|FG001|Overall Study|Physician Decision|0|||
161908252|NCT03786380|584715805|FG002|Overall Study|Physician Decision|1|||
161908253|NCT03786380|584715806|FG003|Overall Study|Physician Decision|0|||
161908254|NCT03786380|584715807|FG004|Overall Study|Physician Decision|0|||
161908255|NCT03786380|584715803|FG000|Overall Study|Study Terminated by the Sponsor|30|||
161908256|NCT03786380|584715804|FG001|Overall Study|Study Terminated by the Sponsor|20|||
161908257|NCT03786380|584715805|FG002|Overall Study|Study Terminated by the Sponsor|50|||
161908258|NCT03786380|584715806|FG003|Overall Study|Study Terminated by the Sponsor|57|||
161908259|NCT03786380|584715807|FG004|Overall Study|Study Terminated by the Sponsor|23|||
161908260|NCT03786380|584715803|FG000|Overall Study|Reason Not Specified|0|||
161908261|NCT03786380|584715804|FG001|Overall Study|Reason Not Specified|0|||
161908262|NCT03786380|584715805|FG002|Overall Study|Reason Not Specified|0|||
161908263|NCT03786380|584715806|FG003|Overall Study|Reason Not Specified|0|||
161908264|NCT03786380|584715807|FG004|Overall Study|Reason Not Specified|1|||
161908265|NCT01038687|584715810|FG000|Overall Study|Adverse Event|0|||
161908266|NCT01038687|584715811|FG001|Overall Study|Adverse Event|2|||
161908267|NCT01038687|584715812|FG002|Overall Study|Adverse Event|1|||
161908268|NCT02783911|584715813|FG000|Overall Study|Lost to Follow-up|3|||
161908269|NCT02783911|584715814|FG001|Overall Study|Lost to Follow-up|32|||
161908270|NCT02616783|584715815|FG000|Overall Study|Randomized but Not Treated|1|||
161908271|NCT02616783|584715816|FG001|Overall Study|Randomized but Not Treated|0|||
161908272|NCT02616783|584715815|FG000|Overall Study|Adverse Event|1|||
161908273|NCT02616783|584715816|FG001|Overall Study|Adverse Event|0|||
161908274|NCT02616783|584715815|FG000|Overall Study|Death|1|||
161908275|NCT02616783|584715816|FG001|Overall Study|Death|0|||
161908276|NCT02616783|584715815|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161908277|NCT02616783|584715816|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161908278|NCT02616783|584715815|FG000|Overall Study|Protocol Violation|1|||
161908279|NCT02616783|584715816|FG001|Overall Study|Protocol Violation|1|||
161908280|NCT02616783|584715815|FG000|Overall Study|Withdrew Consent|1|||
161908281|NCT02616783|584715816|FG001|Overall Study|Withdrew Consent|1|||
161908282|NCT00467519|584715817|FG000|Overall Study|Protocol Violation|8|||
161908283|NCT00467519|584715818|FG001|Overall Study|Protocol Violation|4|||
161908284|NCT00467519|584715817|FG000|Overall Study|Lost to Follow-up|2|||
161908285|NCT00467519|584715818|FG001|Overall Study|Lost to Follow-up|9|||
161908286|NCT00467519|584715817|FG000|Overall Study|Withdrawal by Subject|4|||
161908287|NCT00467519|584715818|FG001|Overall Study|Withdrawal by Subject|10|||
161908288|NCT00372424|584715819|FG000|Overall Study|Adverse Event|2|||
161908289|NCT00372424|584715819|FG000|Overall Study|Withdrawal by Subject|1|||
161908290|NCT00372424|584715819|FG000|Overall Study|Death|1|||
161908291|NCT00372424|584715819|FG000|Overall Study|Objective Progression or Relapse|14|||
161908292|NCT00372424|584715819|FG000|Overall Study|Other|7|||
161908293|NCT00372424|584715819|FG000|Overall Study|Enrolled, Not Treated|1|||
161908294|NCT02314728|584715830|FG000|Overall Study|Protocol Violation|1|||
161908295|NCT02314728|584715831|FG001|Overall Study|Protocol Violation|0|||
161908296|NCT02314728|584715830|FG000|Overall Study|Lost to Follow-up|0|||
161908297|NCT02314728|584715831|FG001|Overall Study|Lost to Follow-up|1|||
161908298|NCT03118934|584715833|FG000|Overall Study|Adverse Event|0|||
161908299|NCT03118934|584715834|FG001|Overall Study|Adverse Event|0|||
161908300|NCT03118934|584715835|FG002|Overall Study|Adverse Event|0|||
161908301|NCT03118934|584715836|FG003|Overall Study|Adverse Event|0|||
162140254|NCT03102710|585565591|FG001|Overall Study|Technical issues during final MRI scan|1|||
161908302|NCT03118934|584715837|FG004|Overall Study|Adverse Event|0|||
161908303|NCT03118934|584715838|FG005|Overall Study|Adverse Event|1|||
161908304|NCT03118934|584715833|FG000|Overall Study|Physician Decision|0|||
161908305|NCT03118934|584715834|FG001|Overall Study|Physician Decision|0|||
161908306|NCT03118934|584715835|FG002|Overall Study|Physician Decision|0|||
161908307|NCT03118934|584715836|FG003|Overall Study|Physician Decision|0|||
161804954|NCT02188303|584329807|FG002|Overall Study|Adverse Event|0|||
161804955|NCT02188303|584329808|FG003|Overall Study|Adverse Event|0|||
161804956|NCT02188303|584329809|FG004|Overall Study|Adverse Event|0|||
161804957|NCT02188303|584329810|FG005|Overall Study|Adverse Event|2|||
161804958|NCT02188303|584329811|FG006|Overall Study|Adverse Event|0|||
161804959|NCT02188303|584329812|FG007|Overall Study|Adverse Event|2|||
161804960|NCT02188303|584329805|FG000|Overall Study|Dose Termination Criteria Met|0|||
161804961|NCT02188303|584329806|FG001|Overall Study|Dose Termination Criteria Met|0|||
161804962|NCT02188303|584329807|FG002|Overall Study|Dose Termination Criteria Met|0|||
161804963|NCT02188303|584329808|FG003|Overall Study|Dose Termination Criteria Met|0|||
161804964|NCT02188303|584329809|FG004|Overall Study|Dose Termination Criteria Met|0|||
161804965|NCT02188303|584329810|FG005|Overall Study|Dose Termination Criteria Met|0|||
161804966|NCT02188303|584329811|FG006|Overall Study|Dose Termination Criteria Met|2|||
161804967|NCT02188303|584329812|FG007|Overall Study|Dose Termination Criteria Met|4|||
161804968|NCT05612724|584329815|FG000|Overall Study|Lost to Follow-up|4|||
161804969|NCT04000815|584329822|FG000|Overall Study|Lost to Follow-up|9|||
161804970|NCT04000815|584329823|FG001|Overall Study|Lost to Follow-up|2|||
161804971|NCT04000815|584329824|FG002|Overall Study|Lost to Follow-up|3|||
161804972|NCT04000815|584329822|FG000|Overall Study|Withdrawal by Subject|4|||
161804973|NCT04000815|584329823|FG001|Overall Study|Withdrawal by Subject|3|||
161804974|NCT04000815|584329824|FG002|Overall Study|Withdrawal by Subject|2|||
161804975|NCT04000815|584329822|FG000|Overall Study|Right ovarian cyst occured|1|||
161804976|NCT04000815|584329823|FG001|Overall Study|Right ovarian cyst occured|0|||
161804977|NCT04000815|584329824|FG002|Overall Study|Right ovarian cyst occured|0|||
161804978|NCT04000815|584329822|FG000|Overall Study|Hypertension occured on follow up|0|||
161804979|NCT04000815|584329823|FG001|Overall Study|Hypertension occured on follow up|0|||
161804980|NCT04000815|584329824|FG002|Overall Study|Hypertension occured on follow up|2|||
161804981|NCT00239577|584329825|FG000|Primary Phase|Adverse Event|0|||
161804982|NCT00239577|584329826|FG001|Primary Phase|Adverse Event|0|||
161804983|NCT00239577|584329827|FG002|Primary Phase|Adverse Event|1|||
161804984|NCT00239577|584329828|FG003|Primary Phase|Adverse Event|0|||
161804985|NCT00239577|584329825|FG000|Primary Phase|Other|5|||
161804986|NCT00239577|584329826|FG001|Primary Phase|Other|3|||
161804987|NCT00239577|584329827|FG002|Primary Phase|Other|2|||
161804988|NCT00239577|584329828|FG003|Primary Phase|Other|0|||
161804989|NCT01034358|584329831|FG000|Overall Study|Withdrawal by Subject|1|||
161804990|NCT01034358|584329831|FG000|Overall Study|Protocol Violation|1|||
161804991|NCT00377260|584329834|FG000|Overall Study|Lost to Follow-up|0|||
161804992|NCT00377260|584329835|FG001|Overall Study|Lost to Follow-up|1|||
161804993|NCT00377260|584329834|FG000|Overall Study|Withdrawal by Subject|2|||
161804994|NCT00377260|584329835|FG001|Overall Study|Withdrawal by Subject|4|||
161804995|NCT02017964|584329836|FG000|Overall Study|Patient deemed ineligible|1|||
161804996|NCT02300103|584329837|FG000|Overall Study|Lack of Efficacy|3|||
161804997|NCT02300103|584329837|FG000|Overall Study|Protocol Violation|1|||
161804998|NCT02300103|584329837|FG000|Overall Study|Withdrew Consent|2|||
161804999|NCT04091971|584329838|FG000|Overall Study|Withdrawal by Subject|1|||
161805000|NCT04091971|584329838|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
161805001|NCT04091971|584329838|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
161805002|NCT01391793|584329839|FG000|Overall Study|Ineligible|3|||
161805003|NCT01391793|584329840|FG001|Overall Study|Ineligible|0|||
161805004|NCT01391793|584329839|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
161805005|NCT01391793|584329840|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
161805006|NCT01391793|584329839|FG000|Overall Study|No DMSA|73|||
161805007|NCT01391793|584329840|FG001|Overall Study|No DMSA|57|||
161805008|NCT01015625|584329841|FG000|Overall Study|Lost to Follow-up|3|||
161805009|NCT01015625|584329842|FG001|Overall Study|Lost to Follow-up|1|||
161805010|NCT01015625|584329841|FG000|Overall Study|Withdrawal by Subject|2|||
161805011|NCT01015625|584329842|FG001|Overall Study|Withdrawal by Subject|3|||
161805012|NCT01015625|584329841|FG000|Overall Study|Physician Decision|2|||
161805013|NCT01015625|584329842|FG001|Overall Study|Physician Decision|0|||
161805014|NCT01015625|584329841|FG000|Overall Study|Death|30|||
161805015|NCT01015625|584329842|FG001|Overall Study|Death|22|||
161805016|NCT00150462|584329845|FG000|Overall Study|Disease Progression or Relapse|3|||
161805017|NCT00150462|584329846|FG001|Overall Study|Disease Progression or Relapse|1|||
161805018|NCT00150462|584329847|FG002|Overall Study|Disease Progression or Relapse|2|||
161805019|NCT00150462|584329848|FG003|Overall Study|Disease Progression or Relapse|1|||
161805020|NCT00150462|584329849|FG004|Overall Study|Disease Progression or Relapse|2|||
161805021|NCT00150462|584329850|FG005|Overall Study|Disease Progression or Relapse|2|||
161805022|NCT00150462|584329851|FG006|Overall Study|Disease Progression or Relapse|3|||
161805023|NCT00150462|584329852|FG007|Overall Study|Disease Progression or Relapse|5|||
161805024|NCT00150462|584329853|FG008|Overall Study|Disease Progression or Relapse|5|||
161805025|NCT00150462|584329854|FG009|Overall Study|Disease Progression or Relapse|3|||
161805026|NCT00150462|584329855|FG010|Overall Study|Disease Progression or Relapse|2|||
161805027|NCT00150462|584329845|FG000|Overall Study|Withdrawal by Subject|0|||
161805028|NCT00150462|584329846|FG001|Overall Study|Withdrawal by Subject|1|||
161805029|NCT00150462|584329847|FG002|Overall Study|Withdrawal by Subject|1|||
161805030|NCT00150462|584329848|FG003|Overall Study|Withdrawal by Subject|0|||
161805031|NCT00150462|584329849|FG004|Overall Study|Withdrawal by Subject|1|||
161805032|NCT00150462|584329850|FG005|Overall Study|Withdrawal by Subject|2|||
161805033|NCT00150462|584329851|FG006|Overall Study|Withdrawal by Subject|0|||
161805034|NCT00150462|584329852|FG007|Overall Study|Withdrawal by Subject|1|||
161805035|NCT00150462|584329853|FG008|Overall Study|Withdrawal by Subject|0|||
161805036|NCT00150462|584329854|FG009|Overall Study|Withdrawal by Subject|1|||
161805037|NCT00150462|584329855|FG010|Overall Study|Withdrawal by Subject|0|||
161805038|NCT00150462|584329845|FG000|Overall Study|Death|0|||
161805039|NCT00150462|584329846|FG001|Overall Study|Death|1|||
161805040|NCT00150462|584329847|FG002|Overall Study|Death|0|||
161805041|NCT00150462|584329848|FG003|Overall Study|Death|0|||
161805042|NCT00150462|584329849|FG004|Overall Study|Death|0|||
161805043|NCT00150462|584329850|FG005|Overall Study|Death|0|||
161805044|NCT00150462|584329851|FG006|Overall Study|Death|0|||
161805045|NCT00150462|584329852|FG007|Overall Study|Death|0|||
161805046|NCT00150462|584329853|FG008|Overall Study|Death|1|||
161805047|NCT00150462|584329854|FG009|Overall Study|Death|0|||
161805048|NCT00150462|584329855|FG010|Overall Study|Death|0|||
161805049|NCT00150462|584329845|FG000|Overall Study|Adverse Event|0|||
161805050|NCT00150462|584329846|FG001|Overall Study|Adverse Event|0|||
161805051|NCT00150462|584329847|FG002|Overall Study|Adverse Event|0|||
161805052|NCT00150462|584329848|FG003|Overall Study|Adverse Event|1|||
161805053|NCT00150462|584329849|FG004|Overall Study|Adverse Event|0|||
161805054|NCT00150462|584329850|FG005|Overall Study|Adverse Event|0|||
161805055|NCT00150462|584329851|FG006|Overall Study|Adverse Event|0|||
161805056|NCT00150462|584329852|FG007|Overall Study|Adverse Event|2|||
161805057|NCT00150462|584329853|FG008|Overall Study|Adverse Event|0|||
161805058|NCT00150462|584329854|FG009|Overall Study|Adverse Event|1|||
161805059|NCT00150462|584329855|FG010|Overall Study|Adverse Event|0|||
161805060|NCT00150462|584329845|FG000|Overall Study|Physician Decision|0|||
161805061|NCT00150462|584329846|FG001|Overall Study|Physician Decision|0|||
161805062|NCT00150462|584329847|FG002|Overall Study|Physician Decision|1|||
161805063|NCT00150462|584329848|FG003|Overall Study|Physician Decision|1|||
161805064|NCT00150462|584329849|FG004|Overall Study|Physician Decision|0|||
161805065|NCT00150462|584329850|FG005|Overall Study|Physician Decision|0|||
161805066|NCT00150462|584329851|FG006|Overall Study|Physician Decision|0|||
161805067|NCT00150462|584329852|FG007|Overall Study|Physician Decision|0|||
161805068|NCT00150462|584329853|FG008|Overall Study|Physician Decision|0|||
161805069|NCT00150462|584329854|FG009|Overall Study|Physician Decision|0|||
161805070|NCT00150462|584329855|FG010|Overall Study|Physician Decision|0|||
161805071|NCT00150462|584329845|FG000|Overall Study|Other|0|||
161805072|NCT00150462|584329846|FG001|Overall Study|Other|0|||
161805073|NCT00150462|584329847|FG002|Overall Study|Other|0|||
161805074|NCT00150462|584329848|FG003|Overall Study|Other|0|||
161805075|NCT00150462|584329849|FG004|Overall Study|Other|0|||
161908308|NCT03118934|584715837|FG004|Overall Study|Physician Decision|0|||
161908309|NCT03118934|584715838|FG005|Overall Study|Physician Decision|1|||
161908310|NCT03118934|584715833|FG000|Overall Study|Discontinued prior to exposure|0|||
161908311|NCT03118934|584715834|FG001|Overall Study|Discontinued prior to exposure|1|||
161908312|NCT03118934|584715835|FG002|Overall Study|Discontinued prior to exposure|1|||
161908313|NCT03118934|584715836|FG003|Overall Study|Discontinued prior to exposure|1|||
161908314|NCT03118934|584715837|FG004|Overall Study|Discontinued prior to exposure|2|||
161908315|NCT03118934|584715838|FG005|Overall Study|Discontinued prior to exposure|0|||
161908316|NCT00069264|584715841|FG000|Overall Study|Adverse Event|3|||
161908317|NCT00069264|584715841|FG000|Overall Study|Progressive Disease|23|||
161908318|NCT00069264|584715841|FG000|Overall Study|Withdrawal by Subject|3|||
161908319|NCT00069264|584715841|FG000|Overall Study|Discon Therapy|3|||
161908320|NCT03014206|584715842|FG000|Overall Study|Registration Violation|12|||
161908321|NCT02895347|584715845|FG000|Overall Study|Withdrawal by Subject|3|||
161908322|NCT02895347|584715846|FG001|Overall Study|Withdrawal by Subject|1|||
161908323|NCT01673178|584715847|FG000|Overall Study|Lost to Follow-up|0|||
161805076|NCT00150462|584329850|FG005|Overall Study|Other|0|||
161805077|NCT00150462|584329851|FG006|Overall Study|Other|0|||
161805078|NCT00150462|584329852|FG007|Overall Study|Other|0|||
161805079|NCT00150462|584329853|FG008|Overall Study|Other|0|||
161805080|NCT00150462|584329854|FG009|Overall Study|Other|1|||
161805081|NCT00150462|584329855|FG010|Overall Study|Other|1|||
161805082|NCT00569374|584329856|FG000|Overall Study|Withdrawal by Subject|4|||
161805083|NCT03107091|584329857|FG000|Overall Study|Physician Decision|1|||
161805084|NCT00105196|584329860|FG000|Overall Study|Lack of Efficacy|2|||
161805085|NCT00105196|584329861|FG001|Overall Study|Lack of Efficacy|3|||
161805086|NCT00105196|584329860|FG000|Overall Study|Adverse Event|11|||
161805087|NCT00105196|584329861|FG001|Overall Study|Adverse Event|3|||
161805088|NCT00105196|584329860|FG000|Overall Study|Withdrawal by Subject|6|||
161805089|NCT00105196|584329861|FG001|Overall Study|Withdrawal by Subject|6|||
161805090|NCT00105196|584329860|FG000|Overall Study|Lost to Follow-up|3|||
161908324|NCT01673178|584715848|FG001|Overall Study|Lost to Follow-up|1|||
161805091|NCT00105196|584329861|FG001|Overall Study|Lost to Follow-up|2|||
161805092|NCT00105196|584329860|FG000|Overall Study|Poor/noncompliance|3|||
161805093|NCT00105196|584329861|FG001|Overall Study|Poor/noncompliance|4|||
161805094|NCT00105196|584329860|FG000|Overall Study|Protocol Violation|5|||
161805095|NCT00105196|584329861|FG001|Overall Study|Protocol Violation|2|||
161805096|NCT00105196|584329860|FG000|Overall Study|pending surgery|0|||
161805097|NCT00105196|584329861|FG001|Overall Study|pending surgery|1|||
161805098|NCT00105196|584329860|FG000|Overall Study|marijuana use|0|||
161805099|NCT00105196|584329861|FG001|Overall Study|marijuana use|1|||
161805100|NCT00105196|584329860|FG000|Overall Study|Subject became unblinded|0|||
161805101|NCT00105196|584329861|FG001|Overall Study|Subject became unblinded|1|||
161805102|NCT03340727|584329862|FG000|Overall Study|Death|1|||
161805103|NCT03340727|584329863|FG001|Overall Study|Death|0|||
161805104|NCT03340727|584329862|FG000|Overall Study|Lost to Follow-up|31|||
161805105|NCT03340727|584329863|FG001|Overall Study|Lost to Follow-up|35|||
161805106|NCT03340727|584329862|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
161805107|NCT03340727|584329863|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
161805108|NCT03340727|584329862|FG000|Overall Study|Transferred to another facility|10|||
161805109|NCT03340727|584329863|FG001|Overall Study|Transferred to another facility|7|||
161805110|NCT03340727|584329862|FG000|Overall Study|Withdrawal by Subject|28|||
161805111|NCT03340727|584329863|FG001|Overall Study|Withdrawal by Subject|17|||
161805112|NCT01126736|584329864|FG000|Overall Study|Death|2|||
161805113|NCT01126736|584329865|FG001|Overall Study|Death|2|||
161805114|NCT01126736|584329866|FG002|Overall Study|Death|1|||
161805115|NCT01126736|584329867|FG003|Overall Study|Death|19|||
161805116|NCT01126736|584329868|FG004|Overall Study|Death|19|||
161805117|NCT01126736|584329864|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
161805118|NCT01126736|584329865|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
161805119|NCT01126736|584329866|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
161805120|NCT01126736|584329867|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
161805121|NCT01126736|584329868|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
161805122|NCT01126736|584329864|FG000|Overall Study|Lost to Follow-up|0|||
161805123|NCT01126736|584329865|FG001|Overall Study|Lost to Follow-up|0|||
161805124|NCT01126736|584329866|FG002|Overall Study|Lost to Follow-up|0|||
161805125|NCT01126736|584329867|FG003|Overall Study|Lost to Follow-up|1|||
161805126|NCT01126736|584329868|FG004|Overall Study|Lost to Follow-up|1|||
161805127|NCT01126736|584329864|FG000|Overall Study|Administrative reasons|0|||
161805128|NCT01126736|584329865|FG001|Overall Study|Administrative reasons|0|||
161805129|NCT01126736|584329866|FG002|Overall Study|Administrative reasons|0|||
161805130|NCT01126736|584329867|FG003|Overall Study|Administrative reasons|0|||
161805131|NCT01126736|584329868|FG004|Overall Study|Administrative reasons|1|||
161805132|NCT01126736|584329864|FG000|Overall Study|Progressive disease|0|||
161805133|NCT01126736|584329865|FG001|Overall Study|Progressive disease|0|||
161805134|NCT01126736|584329866|FG002|Overall Study|Progressive disease|0|||
161805135|NCT01126736|584329867|FG003|Overall Study|Progressive disease|2|||
161805136|NCT01126736|584329868|FG004|Overall Study|Progressive disease|1|||
161805137|NCT01126736|584329864|FG000|Overall Study|Withdrawal by Subject|0|||
161805138|NCT01126736|584329865|FG001|Overall Study|Withdrawal by Subject|0|||
161805139|NCT01126736|584329866|FG002|Overall Study|Withdrawal by Subject|0|||
161805140|NCT01126736|584329867|FG003|Overall Study|Withdrawal by Subject|1|||
161805141|NCT01126736|584329868|FG004|Overall Study|Withdrawal by Subject|1|||
161805142|NCT01126736|584329864|FG000|Overall Study|Other|2|||
161805143|NCT01126736|584329865|FG001|Overall Study|Other|4|||
161805144|NCT01126736|584329866|FG002|Overall Study|Other|4|||
161805145|NCT01126736|584329867|FG003|Overall Study|Other|16|||
161805146|NCT01126736|584329868|FG004|Overall Study|Other|15|||
161805147|NCT00813293|584329871|FG000|Overall Study|Intercurrent illness|1|||
161805148|NCT00813293|584329872|FG001|Overall Study|Intercurrent illness|0|||
161805149|NCT00813293|584329871|FG000|Overall Study|Adverse Event|0|||
161805150|NCT00813293|584329872|FG001|Overall Study|Adverse Event|1|||
161805151|NCT02794974|584329873|FG000|Overall Study|Physician Decision|0|||
161805152|NCT02794974|584329874|FG001|Overall Study|Physician Decision|1|||
161805153|NCT00533273|584329877|FG000|Double-blind|Withdrew consent|0|||
161805154|NCT00533273|584329878|FG001|Double-blind|Withdrew consent|2|||
161805155|NCT00533273|584329877|FG000|Open-label|Withdrawal by Subject|6|||
161805156|NCT00533273|584329878|FG001|Open-label|Withdrawal by Subject|0|||
161805157|NCT01873586|584329880|FG000|Overall Study|Lost to Follow-up|3|||
161908325|NCT01673178|584715849|FG002|Overall Study|Lost to Follow-up|0|||
161805158|NCT02202850|584329881|FG000|Overall Study|Other|2|||
161805159|NCT02202850|584329882|FG001|Overall Study|Other|2|||
161805160|NCT02202850|584329881|FG000|Overall Study|Enbrel treatment discontinued|15|||
161805161|NCT02202850|584329882|FG001|Overall Study|Enbrel treatment discontinued|3|||
161805162|NCT02202850|584329881|FG000|Overall Study|Lost to Follow-up|7|||
161805163|NCT02202850|584329882|FG001|Overall Study|Lost to Follow-up|1|||
161805164|NCT00615069|584329883|FG000|Overall Study|Death|10|||
161805165|NCT00615069|584329883|FG000|Overall Study|Physician Decision|2|||
161805166|NCT00615069|584329883|FG000|Overall Study|Withdrawal by Subject|4|||
161805167|NCT00669942|584329884|FG000|Parts 2 and 3|Adverse Event|0|||
161805168|NCT00669942|584329885|FG001|Parts 2 and 3|Adverse Event|0|||
161805169|NCT00669942|584329886|FG002|Parts 2 and 3|Adverse Event|0|||
161805170|NCT00669942|584329887|FG003|Parts 2 and 3|Adverse Event|0|||
161805171|NCT00669942|584329888|FG004|Parts 2 and 3|Adverse Event|0|||
161805172|NCT00669942|584329889|FG005|Parts 2 and 3|Adverse Event|0|||
161805173|NCT00669942|584329890|FG006|Parts 2 and 3|Adverse Event|0|||
161805174|NCT00669942|584329891|FG007|Parts 2 and 3|Adverse Event|2|||
161805175|NCT00669942|584329892|FG008|Parts 2 and 3|Adverse Event|1|||
161805176|NCT00669942|584329893|FG009|Parts 2 and 3|Adverse Event|0|||
161805177|NCT00669942|584329894|FG010|Parts 2 and 3|Adverse Event|0|||
161805178|NCT00669942|584329895|FG011|Parts 2 and 3|Adverse Event|0|||
161805179|NCT00669942|584329884|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
161805180|NCT00669942|584329885|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
161805181|NCT00669942|584329886|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
161805182|NCT00669942|584329887|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
161805183|NCT00669942|584329888|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
161805184|NCT00669942|584329889|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
161805185|NCT00669942|584329890|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
161805186|NCT00669942|584329891|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
161805187|NCT00669942|584329892|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
161805188|NCT00669942|584329893|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
161805189|NCT00669942|584329894|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
161805190|NCT00669942|584329895|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
161805191|NCT00669942|584329884|FG000|Parts 2 and 3|Protocol Violation|0|||
161805192|NCT00669942|584329885|FG001|Parts 2 and 3|Protocol Violation|0|||
161805193|NCT00669942|584329886|FG002|Parts 2 and 3|Protocol Violation|0|||
161805194|NCT00669942|584329887|FG003|Parts 2 and 3|Protocol Violation|0|||
161805195|NCT00669942|584329888|FG004|Parts 2 and 3|Protocol Violation|0|||
161805196|NCT00669942|584329889|FG005|Parts 2 and 3|Protocol Violation|1|||
161805197|NCT00669942|584329890|FG006|Parts 2 and 3|Protocol Violation|0|||
161805198|NCT00669942|584329891|FG007|Parts 2 and 3|Protocol Violation|0|||
161805199|NCT00669942|584329892|FG008|Parts 2 and 3|Protocol Violation|0|||
161805200|NCT00669942|584329893|FG009|Parts 2 and 3|Protocol Violation|0|||
161805201|NCT00669942|584329894|FG010|Parts 2 and 3|Protocol Violation|0|||
161805202|NCT00669942|584329895|FG011|Parts 2 and 3|Protocol Violation|0|||
161805203|NCT03752528|584329896|FG000|Part A|Lost to Follow-up|1|||
161805204|NCT03752528|584329896|FG000|Part A|Protocol Violation|1|||
161805205|NCT03752528|584329896|FG000|Part B|Protocol Violation|1|||
161805206|NCT03752528|584329896|FG000|Part B|Study terminated by sponsor|3|||
161805207|NCT01981720|584329897|FG000|Overall Study|Adverse Event|1|||
161805208|NCT01981720|584329897|FG000|Overall Study|Withdrawal by Subject|3|||
161805209|NCT01981720|584329897|FG000|Overall Study|Pregnancy|1|||
161805210|NCT00282048|584329898|FG000|Overall Study|Lack of Efficacy|30|||
161805211|NCT00282048|584329898|FG000|Overall Study|Adverse Event|22|||
161805212|NCT00282048|584329898|FG000|Overall Study|Withdrawal by Subject|1|||
161805213|NCT00282048|584329898|FG000|Overall Study|Other|8|||
161805214|NCT00282048|584329898|FG000|Overall Study|Ongoing|1|||
161805215|NCT00259012|584329901|FG000|Overall Study|Adverse Event|0|||
161805216|NCT00259012|584329902|FG001|Overall Study|Adverse Event|1|||
161805217|NCT00259012|584329901|FG000|Overall Study|Withdrawal by Subject|1|||
161805218|NCT00259012|584329902|FG001|Overall Study|Withdrawal by Subject|0|||
161805219|NCT00259012|584329901|FG000|Overall Study|Physician Decision|0|||
161805220|NCT00259012|584329902|FG001|Overall Study|Physician Decision|1|||
161805221|NCT00259012|584329901|FG000|Overall Study|Lost to Follow-up|0|||
161805222|NCT00259012|584329902|FG001|Overall Study|Lost to Follow-up|1|||
161805223|NCT00259012|584329901|FG000|Overall Study|Protocol Violation|1|||
161805224|NCT00259012|584329902|FG001|Overall Study|Protocol Violation|1|||
161805225|NCT03522675|584329903|FG000|Overall Study|Screen fail|1|||
161805226|NCT03522675|584329903|FG000|Overall Study|Non-reactive to histamine|1|||
161805227|NCT00707161|584329904|FG000|Overall Study|Physician Decision|6|||
161805228|NCT02674477|584329905|FG000|Overall Study|Protocol Violation|8|||
161908326|NCT01673178|584715850|FG003|Overall Study|Lost to Follow-up|0|||
161805229|NCT02674477|584329906|FG001|Overall Study|Protocol Violation|2|||
161805230|NCT02336165|584329911|FG000|Overall Study|Death|3|||
161805231|NCT02336165|584329912|FG001|Overall Study|Death|0|||
161805232|NCT02336165|584329913|FG002|Overall Study|Death|0|||
161805233|NCT02336165|584329914|FG003|Overall Study|Death|0|||
161805234|NCT02336165|584329915|FG004|Overall Study|Death|1|||
161805235|NCT02336165|584329911|FG000|Overall Study|Physician Decision|2|||
161805236|NCT02336165|584329912|FG001|Overall Study|Physician Decision|2|||
161805237|NCT02336165|584329913|FG002|Overall Study|Physician Decision|1|||
161805238|NCT02336165|584329914|FG003|Overall Study|Physician Decision|1|||
161805239|NCT02336165|584329915|FG004|Overall Study|Physician Decision|0|||
161805240|NCT02336165|584329911|FG000|Overall Study|Withdrawal by Subject|0|||
161805241|NCT02336165|584329912|FG001|Overall Study|Withdrawal by Subject|0|||
161805242|NCT02336165|584329913|FG002|Overall Study|Withdrawal by Subject|1|||
161805243|NCT02336165|584329914|FG003|Overall Study|Withdrawal by Subject|0|||
161805244|NCT02336165|584329915|FG004|Overall Study|Withdrawal by Subject|1|||
161805245|NCT02336165|584329911|FG000|Overall Study|Adverse Event|4|||
161805246|NCT02336165|584329912|FG001|Overall Study|Adverse Event|1|||
161908327|NCT01673178|584715851|FG004|Overall Study|Lost to Follow-up|0|||
161908328|NCT01673178|584715847|FG000|Overall Study|Withdrawal by Subject|0|||
161908329|NCT01673178|584715848|FG001|Overall Study|Withdrawal by Subject|0|||
161908330|NCT01673178|584715849|FG002|Overall Study|Withdrawal by Subject|1|||
161908331|NCT01673178|584715850|FG003|Overall Study|Withdrawal by Subject|4|||
161908332|NCT01673178|584715851|FG004|Overall Study|Withdrawal by Subject|2|||
161908333|NCT01673178|584715847|FG000|Overall Study|Protocol Violation|1|||
161908334|NCT01673178|584715848|FG001|Overall Study|Protocol Violation|1|||
161908335|NCT01673178|584715849|FG002|Overall Study|Protocol Violation|0|||
161908336|NCT01673178|584715850|FG003|Overall Study|Protocol Violation|1|||
161908337|NCT01673178|584715851|FG004|Overall Study|Protocol Violation|0|||
161908338|NCT01673178|584715847|FG000|Overall Study|Adverse Event|1|||
161908339|NCT01673178|584715848|FG001|Overall Study|Adverse Event|0|||
161908340|NCT01673178|584715849|FG002|Overall Study|Adverse Event|0|||
161908341|NCT01673178|584715850|FG003|Overall Study|Adverse Event|2|||
161908342|NCT01673178|584715851|FG004|Overall Study|Adverse Event|0|||
161908343|NCT01673178|584715847|FG000|Overall Study|Other|1|||
161908344|NCT01673178|584715848|FG001|Overall Study|Other|0|||
161908345|NCT01673178|584715849|FG002|Overall Study|Other|2|||
161908346|NCT01673178|584715850|FG003|Overall Study|Other|1|||
161908347|NCT01673178|584715851|FG004|Overall Study|Other|0|||
161908348|NCT03177148|584715852|FG000|Overall Study|Lost to Follow-up|50|||
161908349|NCT03177148|584715853|FG001|Overall Study|Lost to Follow-up|1|||
161908350|NCT03177148|584715852|FG000|Overall Study|Death|1|||
161908351|NCT03177148|584715853|FG001|Overall Study|Death|0|||
161908352|NCT02557399|584715854|FG000|Overall Study|Adverse Event|6|||
161908353|NCT02557399|584715855|FG001|Overall Study|Adverse Event|5|||
161908354|NCT02557399|584715854|FG000|Overall Study|Protocol Violation|0|||
161908355|NCT02557399|584715855|FG001|Overall Study|Protocol Violation|1|||
161908356|NCT02557399|584715854|FG000|Overall Study|Protocol-defined stopping criteria|0|||
161908357|NCT02557399|584715855|FG001|Overall Study|Protocol-defined stopping criteria|1|||
161908358|NCT02557399|584715854|FG000|Overall Study|Withdrawal by Subject|1|||
161908359|NCT02557399|584715855|FG001|Overall Study|Withdrawal by Subject|1|||
161908360|NCT03139552|584715859|FG000|Overall Study|unable to attend tasting due to schedule|3|||
161908361|NCT00780975|584715866|FG000|Overall Study|Progressive disease|3|||
161908362|NCT00780975|584715866|FG000|Overall Study|Toxicity|5|||
161908363|NCT03122171|584715867|FG000|Overall Study|Withdrawal by Subject|1|||
161908364|NCT03044314|584715868|FG000|Overall Study|Physician Decision|2|||
161908365|NCT03044314|584715868|FG000|Overall Study|Withdrawal by Subject|1|||
161908366|NCT03044314|584715868|FG000|Overall Study|Connector tubing not available|1|||
161908367|NCT00264147|584715869|FG000|Treatment I Period|Adverse Event|3|||
161908368|NCT00264147|584715870|FG001|Treatment I Period|Adverse Event|6|||
161908369|NCT00264147|584715871|FG002|Treatment I Period|Adverse Event|3|||
161908370|NCT00264147|584715872|FG003|Treatment I Period|Adverse Event|5|||
161908371|NCT00264147|584715873|FG004|Treatment I Period|Adverse Event|7|||
161908372|NCT00264147|584715874|FG005|Treatment I Period|Adverse Event|0|||
161908373|NCT00264147|584715869|FG000|Treatment I Period|Laboratory Adverse Event|0|||
161908374|NCT00264147|584715870|FG001|Treatment I Period|Laboratory Adverse Event|0|||
161908375|NCT00264147|584715871|FG002|Treatment I Period|Laboratory Adverse Event|0|||
161908376|NCT00264147|584715872|FG003|Treatment I Period|Laboratory Adverse Event|1|||
161908377|NCT00264147|584715873|FG004|Treatment I Period|Laboratory Adverse Event|0|||
161908378|NCT00264147|584715874|FG005|Treatment I Period|Laboratory Adverse Event|0|||
161908379|NCT00264147|584715869|FG000|Treatment I Period|Lack of Efficacy|6|||
161908380|NCT00264147|584715870|FG001|Treatment I Period|Lack of Efficacy|2|||
161908381|NCT00264147|584715871|FG002|Treatment I Period|Lack of Efficacy|8|||
161908382|NCT00264147|584715872|FG003|Treatment I Period|Lack of Efficacy|0|||
161908383|NCT00264147|584715873|FG004|Treatment I Period|Lack of Efficacy|1|||
161908384|NCT00264147|584715874|FG005|Treatment I Period|Lack of Efficacy|0|||
161908385|NCT00264147|584715869|FG000|Treatment I Period|Lost to Follow-up|1|||
161908386|NCT00264147|584715870|FG001|Treatment I Period|Lost to Follow-up|0|||
161908387|NCT00264147|584715871|FG002|Treatment I Period|Lost to Follow-up|0|||
161908388|NCT00264147|584715872|FG003|Treatment I Period|Lost to Follow-up|1|||
161908389|NCT00264147|584715873|FG004|Treatment I Period|Lost to Follow-up|1|||
161908390|NCT00264147|584715874|FG005|Treatment I Period|Lost to Follow-up|0|||
161908391|NCT00264147|584715869|FG000|Treatment I Period|Protocol Violation|2|||
161908392|NCT00264147|584715870|FG001|Treatment I Period|Protocol Violation|2|||
161908393|NCT00264147|584715871|FG002|Treatment I Period|Protocol Violation|0|||
161908394|NCT00264147|584715872|FG003|Treatment I Period|Protocol Violation|0|||
161908395|NCT00264147|584715873|FG004|Treatment I Period|Protocol Violation|0|||
161908396|NCT00264147|584715874|FG005|Treatment I Period|Protocol Violation|0|||
161908397|NCT00264147|584715869|FG000|Treatment I Period|Withdrawal by Subject|2|||
161908398|NCT00264147|584715870|FG001|Treatment I Period|Withdrawal by Subject|0|||
161908399|NCT00264147|584715871|FG002|Treatment I Period|Withdrawal by Subject|0|||
161908400|NCT00264147|584715872|FG003|Treatment I Period|Withdrawal by Subject|2|||
161908401|NCT00264147|584715873|FG004|Treatment I Period|Withdrawal by Subject|2|||
161908402|NCT00264147|584715874|FG005|Treatment I Period|Withdrawal by Subject|0|||
161908403|NCT00264147|584715869|FG000|Treatment I Period|Patient out of town for an extended time|0|||
161908404|NCT00264147|584715870|FG001|Treatment I Period|Patient out of town for an extended time|1|||
161908405|NCT00264147|584715871|FG002|Treatment I Period|Patient out of town for an extended time|0|||
161908406|NCT00264147|584715872|FG003|Treatment I Period|Patient out of town for an extended time|0|||
161908407|NCT00264147|584715873|FG004|Treatment I Period|Patient out of town for an extended time|0|||
161908408|NCT00264147|584715874|FG005|Treatment I Period|Patient out of town for an extended time|0|||
161908409|NCT00264147|584715869|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161908410|NCT00264147|584715870|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161908411|NCT00264147|584715871|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
161908412|NCT00264147|584715872|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161908413|NCT00264147|584715873|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161908414|NCT00264147|584715874|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161908415|NCT00264147|584715869|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
161908416|NCT00264147|584715870|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
161908417|NCT00264147|584715871|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
161908418|NCT00264147|584715872|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
161908419|NCT00264147|584715873|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
161908420|NCT00264147|584715874|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
161908421|NCT00264147|584715869|FG000|Treatment II Period|Adverse Event|0|||
161908422|NCT00264147|584715870|FG001|Treatment II Period|Adverse Event|0|||
161908423|NCT00264147|584715871|FG002|Treatment II Period|Adverse Event|0|||
161908424|NCT00264147|584715872|FG003|Treatment II Period|Adverse Event|0|||
161908425|NCT00264147|584715873|FG004|Treatment II Period|Adverse Event|9|||
161908426|NCT00264147|584715874|FG005|Treatment II Period|Adverse Event|9|||
161908427|NCT00264147|584715869|FG000|Treatment II Period|Laboratory Adverse Event|0|||
161908428|NCT00264147|584715870|FG001|Treatment II Period|Laboratory Adverse Event|0|||
161908429|NCT00264147|584715871|FG002|Treatment II Period|Laboratory Adverse Event|0|||
161908430|NCT00264147|584715872|FG003|Treatment II Period|Laboratory Adverse Event|0|||
161908431|NCT00264147|584715873|FG004|Treatment II Period|Laboratory Adverse Event|0|||
161908432|NCT00264147|584715874|FG005|Treatment II Period|Laboratory Adverse Event|1|||
161908433|NCT00264147|584715869|FG000|Treatment II Period|Lack of Efficacy|0|||
161908434|NCT00264147|584715870|FG001|Treatment II Period|Lack of Efficacy|0|||
161908435|NCT00264147|584715871|FG002|Treatment II Period|Lack of Efficacy|0|||
161908436|NCT00264147|584715872|FG003|Treatment II Period|Lack of Efficacy|0|||
161908437|NCT00264147|584715873|FG004|Treatment II Period|Lack of Efficacy|20|||
161908438|NCT00264147|584715874|FG005|Treatment II Period|Lack of Efficacy|19|||
161908439|NCT00264147|584715869|FG000|Treatment II Period|Lost to Follow-up|0|||
161908440|NCT00264147|584715870|FG001|Treatment II Period|Lost to Follow-up|0|||
161908441|NCT00264147|584715871|FG002|Treatment II Period|Lost to Follow-up|0|||
161908442|NCT00264147|584715872|FG003|Treatment II Period|Lost to Follow-up|0|||
161908443|NCT00264147|584715873|FG004|Treatment II Period|Lost to Follow-up|1|||
161908444|NCT00264147|584715874|FG005|Treatment II Period|Lost to Follow-up|1|||
161908445|NCT00264147|584715869|FG000|Treatment II Period|Withdrawal by Subject|0|||
161908446|NCT00264147|584715870|FG001|Treatment II Period|Withdrawal by Subject|0|||
161908447|NCT00264147|584715871|FG002|Treatment II Period|Withdrawal by Subject|0|||
161908448|NCT00264147|584715872|FG003|Treatment II Period|Withdrawal by Subject|0|||
161908449|NCT00264147|584715873|FG004|Treatment II Period|Withdrawal by Subject|3|||
161908450|NCT00264147|584715874|FG005|Treatment II Period|Withdrawal by Subject|2|||
161908451|NCT00264147|584715869|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
161908452|NCT00264147|584715870|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
161908453|NCT00264147|584715871|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
161908454|NCT00264147|584715872|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
161908455|NCT00264147|584715873|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
161908456|NCT00264147|584715874|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
161908457|NCT03234465|584715875|FG000|Overall Study|Adverse Event|4|||
161908458|NCT03234465|584715876|FG001|Overall Study|Adverse Event|2|||
161908459|NCT03234465|584715875|FG000|Overall Study|Death|0|||
161908460|NCT03234465|584715876|FG001|Overall Study|Death|1|||
161908461|NCT03234465|584715875|FG000|Overall Study|Lost to Follow-up|1|||
161908462|NCT03234465|584715876|FG001|Overall Study|Lost to Follow-up|1|||
161908463|NCT03234465|584715875|FG000|Overall Study|Withdrawal by Subject|12|||
161908464|NCT03234465|584715876|FG001|Overall Study|Withdrawal by Subject|27|||
161908465|NCT03234465|584715875|FG000|Overall Study|Symptomatic deterioration|0|||
161908466|NCT03234465|584715876|FG001|Overall Study|Symptomatic deterioration|1|||
161908467|NCT03234465|584715875|FG000|Overall Study|Non-compliance|2|||
161908468|NCT03234465|584715876|FG001|Overall Study|Non-compliance|0|||
161908469|NCT03234465|584715875|FG000|Overall Study|Other|14|||
161908470|NCT03234465|584715876|FG001|Overall Study|Other|8|||
161908471|NCT00449163|584715877|FG000|Overall Study|Physician Decision|3|||
161908472|NCT00606307|584715880|FG000|Overall Study|Adverse Event|2|||
161908473|NCT00606307|584715880|FG000|Overall Study|Withdrawal by Subject|2|||
161908474|NCT00606307|584715880|FG000|Overall Study|Disease progression|6|||
161908475|NCT00606307|584715880|FG000|Overall Study|QTc prolongation|1|||
161908476|NCT03368807|584715881|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
161908477|NCT03368807|584715881|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
161908478|NCT03368807|584715881|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
161908479|NCT03368807|584715881|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
161908480|NCT03669588|584715895|FG000|Overall Study|Adverse Event|1|||
161908481|NCT03669588|584715896|FG001|Overall Study|Adverse Event|0|||
161908482|NCT03669588|584715895|FG000|Overall Study|Physician Decision|0|||
161908483|NCT03669588|584715896|FG001|Overall Study|Physician Decision|1|||
161908484|NCT03669588|584715895|FG000|Overall Study|Protocol Violation|1|||
161908485|NCT03669588|584715896|FG001|Overall Study|Protocol Violation|0|||
161908486|NCT03669588|584715895|FG000|Overall Study|Sponsor Decision|1|||
161908487|NCT03669588|584715896|FG001|Overall Study|Sponsor Decision|1|||
161908488|NCT03669588|584715895|FG000|Overall Study|Withdrawal by Subject|1|||
161908489|NCT03669588|584715896|FG001|Overall Study|Withdrawal by Subject|4|||
161908490|NCT03669588|584715895|FG000|Overall Study|Rescue Therapy Needed|0|||
161908491|NCT03669588|584715896|FG001|Overall Study|Rescue Therapy Needed|1|||
161908492|NCT00369343|584715906|FG000|Double-blind Phase|Adverse Event|19|||
161908493|NCT00369343|584715907|FG001|Double-blind Phase|Adverse Event|4|||
161908494|NCT00369343|584715906|FG000|Double-blind Phase|Failed to return|2|||
161908495|NCT00369343|584715907|FG001|Double-blind Phase|Failed to return|0|||
161908496|NCT00369343|584715906|FG000|Double-blind Phase|Lost to Follow-up|9|||
161908497|NCT00369343|584715907|FG001|Double-blind Phase|Lost to Follow-up|2|||
161908498|NCT00369343|584715906|FG000|Double-blind Phase|Protocol Violation|2|||
161908499|NCT00369343|584715907|FG001|Double-blind Phase|Protocol Violation|0|||
161908500|NCT00369343|584715906|FG000|Double-blind Phase|Withdrawal by Subject|8|||
161908501|NCT00369343|584715907|FG001|Double-blind Phase|Withdrawal by Subject|6|||
161805247|NCT02336165|584329913|FG002|Overall Study|Adverse Event|2|||
161805248|NCT02336165|584329914|FG003|Overall Study|Adverse Event|4|||
161805249|NCT02336165|584329915|FG004|Overall Study|Adverse Event|1|||
161805250|NCT02336165|584329911|FG000|Overall Study|Progressive disease|23|||
161805251|NCT02336165|584329912|FG001|Overall Study|Progressive disease|22|||
161805252|NCT02336165|584329913|FG002|Overall Study|Progressive disease|27|||
161805253|NCT02336165|584329914|FG003|Overall Study|Progressive disease|24|||
161805254|NCT02336165|584329915|FG004|Overall Study|Progressive disease|19|||
161805255|NCT02336165|584329911|FG000|Overall Study|Non-compliance|1|||
161805256|NCT02336165|584329912|FG001|Overall Study|Non-compliance|0|||
161805257|NCT02336165|584329913|FG002|Overall Study|Non-compliance|0|||
161805258|NCT02336165|584329914|FG003|Overall Study|Non-compliance|1|||
161805259|NCT02336165|584329915|FG004|Overall Study|Non-compliance|0|||
161805260|NCT02336165|584329911|FG000|Overall Study|Other|1|||
161805261|NCT02336165|584329912|FG001|Overall Study|Other|0|||
161805262|NCT02336165|584329913|FG002|Overall Study|Other|0|||
161805263|NCT02336165|584329914|FG003|Overall Study|Other|1|||
161805264|NCT02336165|584329915|FG004|Overall Study|Other|0|||
161805265|NCT00450190|584329916|FG000|Overall Study|Withdrawal by Subject|2|||
161805266|NCT03002077|584329919|FG000|Overall Study|Non-compliance with Study Drug|4|||
161805267|NCT03002077|584329919|FG000|Overall Study|Non-compliance w/Background ADT|1|||
161805268|NCT03002077|584329919|FG000|Overall Study|Study Terminated by Sponsor|257|||
161805269|NCT03002077|584329919|FG000|Overall Study|Site Terminated by Sponsor|5|||
161805270|NCT03002077|584329919|FG000|Overall Study|Miscellaneous Reasons|10|||
161805271|NCT03002077|584329919|FG000|Overall Study|Adverse Event|23|||
161805272|NCT03002077|584329919|FG000|Overall Study|Lack of Efficacy|20|||
161805273|NCT03002077|584329919|FG000|Overall Study|Withdrawal by Subject|72|||
161805274|NCT03002077|584329919|FG000|Overall Study|Lost to Follow-up|21|||
161805275|NCT03002077|584329919|FG000|Overall Study|Pregnancy|4|||
161805276|NCT03002077|584329919|FG000|Overall Study|Protocol Violation|21|||
161805277|NCT00834756|584329922|FG000|First Intervention|Adverse Event|1|||
161805278|NCT00834756|584329923|FG001|First Intervention|Adverse Event|0|||
161805279|NCT00834756|584329922|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
161805280|NCT00834756|584329923|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
161805281|NCT04625114|584329935|FG000|Overall Study|Adverse Event|3|||
161805282|NCT04625114|584329936|FG001|Overall Study|Adverse Event|1|||
161805283|NCT04625114|584329935|FG000|Overall Study|Withdrawal by Subject|2|||
161908502|NCT00369343|584715906|FG000|Double-blind Phase|Lack of Efficacy|0|||
161908503|NCT00369343|584715907|FG001|Double-blind Phase|Lack of Efficacy|4|||
161805284|NCT04625114|584329936|FG001|Overall Study|Withdrawal by Subject|0|||
161908504|NCT00369343|584715906|FG000|Double-blind Phase|Protocol deviation|4|||
161805285|NCT00986245|584329937|FG000|First Intervention|Poor compliance|8|||
161805286|NCT00986245|584329938|FG001|First Intervention|Poor compliance|4|||
161908505|NCT00369343|584715907|FG001|Double-blind Phase|Protocol deviation|0|||
161908506|NCT00369343|584715906|FG000|Open-label Phase|Adverse Event|19|||
161908507|NCT00369343|584715907|FG001|Open-label Phase|Adverse Event|7|||
161805287|NCT00986245|584329937|FG000|First Intervention|Lack of Efficacy|1|||
161805288|NCT00986245|584329938|FG001|First Intervention|Lack of Efficacy|2|||
161805289|NCT00986245|584329937|FG000|First Intervention|Withdrawal by Subject|0|||
161805290|NCT00986245|584329938|FG001|First Intervention|Withdrawal by Subject|1|||
161908508|NCT00369343|584715906|FG000|Open-label Phase|Failed to return|4|||
161805291|NCT00986245|584329937|FG000|First Intervention|Protocol Violation|0|||
161805292|NCT00986245|584329938|FG001|First Intervention|Protocol Violation|1|||
161805293|NCT00986245|584329937|FG000|First Intervention|Out of indication|1|||
161805294|NCT00986245|584329938|FG001|First Intervention|Out of indication|0|||
161805295|NCT00986245|584329937|FG000|Second Intervention|Poor compliance|1|||
161805296|NCT00986245|584329938|FG001|Second Intervention|Poor compliance|0|||
161805297|NCT00986245|584329937|FG000|Second Intervention|Lost to Follow-up|1|||
161805298|NCT00986245|584329938|FG001|Second Intervention|Lost to Follow-up|0|||
161805299|NCT00986245|584329937|FG000|Second Intervention|Protocol Violation|0|||
161805300|NCT00986245|584329938|FG001|Second Intervention|Protocol Violation|1|||
161805301|NCT00854308|584329942|FG000|Overall Study|Disease progression|42|||
161805302|NCT00854308|584329943|FG001|Overall Study|Disease progression|50|||
161805303|NCT00854308|584329942|FG000|Overall Study|Adverse Event|8|||
161805304|NCT00854308|584329943|FG001|Overall Study|Adverse Event|3|||
161805305|NCT00854308|584329942|FG000|Overall Study|Death|2|||
161805306|NCT00854308|584329943|FG001|Overall Study|Death|5|||
161805307|NCT00854308|584329942|FG000|Overall Study|Physician Decision|6|||
161805308|NCT00854308|584329943|FG001|Overall Study|Physician Decision|6|||
161805309|NCT00854308|584329942|FG000|Overall Study|Withdrawal by Subject|4|||
161805310|NCT00854308|584329943|FG001|Overall Study|Withdrawal by Subject|2|||
161805311|NCT00854308|584329942|FG000|Overall Study|Sponsor's decision to terminate study|0|||
161805312|NCT00854308|584329943|FG001|Overall Study|Sponsor's decision to terminate study|1|||
161805313|NCT01390844|584329944|FG000|Treatment Phase|Adverse Event|12|||
161805314|NCT01390844|584329945|FG001|Treatment Phase|Adverse Event|2|||
161805315|NCT01390844|584329946|FG002|Treatment Phase|Adverse Event|3|||
161805316|NCT01390844|584329947|FG003|Treatment Phase|Adverse Event|2|||
161805317|NCT01390844|584329944|FG000|Treatment Phase|Treatment Failure|23|||
161805318|NCT01390844|584329945|FG001|Treatment Phase|Treatment Failure|25|||
161805319|NCT01390844|584329946|FG002|Treatment Phase|Treatment Failure|10|||
161805320|NCT01390844|584329947|FG003|Treatment Phase|Treatment Failure|13|||
161805321|NCT01390844|584329944|FG000|Treatment Phase|Non-Medical Reasons|5|||
161805322|NCT01390844|584329945|FG001|Treatment Phase|Non-Medical Reasons|1|||
161805323|NCT01390844|584329946|FG002|Treatment Phase|Non-Medical Reasons|8|||
161805324|NCT01390844|584329947|FG003|Treatment Phase|Non-Medical Reasons|1|||
161805325|NCT01390844|584329944|FG000|Treatment Phase|Non-GCP Compliant|0|||
161805326|NCT01390844|584329945|FG001|Treatment Phase|Non-GCP Compliant|0|||
161805327|NCT01390844|584329946|FG002|Treatment Phase|Non-GCP Compliant|10|||
161805328|NCT01390844|584329947|FG003|Treatment Phase|Non-GCP Compliant|3|||
161805329|NCT01390844|584329944|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
161805330|NCT01390844|584329945|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
161805331|NCT01390844|584329946|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
161805332|NCT01390844|584329947|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
161805333|NCT03048500|584329950|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
161805334|NCT03048500|584329950|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
161805335|NCT03048500|584329950|FG000|Reached 1st Response/Continued Treatment|Death|1|||
161805336|NCT03048500|584329950|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
161805337|NCT03048500|584329950|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
161805338|NCT03048500|584329950|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
161805339|NCT03048500|584329950|FG000|Follow up for 3 Years|Death|12|||
161805340|NCT01479439|584329951|FG000|Overall Study|Adverse Event|1|||
161805341|NCT01479439|584329952|FG001|Overall Study|Adverse Event|0|||
161805342|NCT01479439|584329953|FG002|Overall Study|Adverse Event|0|||
161805343|NCT01479439|584329951|FG000|Overall Study|Lost to Follow-up|0|||
161805344|NCT01479439|584329952|FG001|Overall Study|Lost to Follow-up|1|||
161805345|NCT01479439|584329953|FG002|Overall Study|Lost to Follow-up|0|||
161805346|NCT01479439|584329951|FG000|Overall Study|Protocol Violation|0|||
161805347|NCT01479439|584329952|FG001|Overall Study|Protocol Violation|0|||
161805348|NCT01479439|584329953|FG002|Overall Study|Protocol Violation|2|||
161805349|NCT02079766|584329956|FG000|Overall Study|Physician Decision|1|||
161805350|NCT02079766|584329957|FG001|Overall Study|Physician Decision|0|||
161805351|NCT02079766|584329956|FG000|Overall Study|Withdrawal by Subject|1|||
161805352|NCT02079766|584329957|FG001|Overall Study|Withdrawal by Subject|0|||
161805353|NCT03018249|584329964|FG000|Overall Study|Withdrawal by Subject|2|||
161805354|NCT03018249|584329965|FG001|Overall Study|Withdrawal by Subject|2|||
161805355|NCT03544138|584329966|FG000|Overall Study|Lost to Follow-up|29|||
161805356|NCT00096447|584331657|FG000|Overall Study|Never treated|1|||
161805357|NCT01838941|584331658|FG000|Overall Study|Adverse Event|1|||
161805358|NCT01838941|584331658|FG000|Overall Study|Withdrawal by Subject|1|||
161805359|NCT00829530|584331664|FG000|First Intervention|Adverse Event|0|||
161805360|NCT00829530|584331665|FG001|First Intervention|Adverse Event|1|||
161908509|NCT00369343|584715907|FG001|Open-label Phase|Failed to return|0|||
161805361|NCT00829530|584331664|FG000|First Intervention|Intolerance to Venopuncture|0|||
161805362|NCT00829530|584331665|FG001|First Intervention|Intolerance to Venopuncture|1|||
161805363|NCT00829530|584331664|FG000|Second Intervention|Intolerance to Venopuncture|1|||
161805364|NCT00829530|584331665|FG001|Second Intervention|Intolerance to Venopuncture|0|||
161805365|NCT04466111|584331666|FG000|Prior to Trial Phase|Physician Decision|1|||
161805366|NCT03553823|584331675|FG000|Overall Study|Physician Decision|0|||
161805367|NCT03553823|584331676|FG001|Overall Study|Physician Decision|1|||
161908510|NCT00369343|584715906|FG000|Open-label Phase|Physician Decision|2|||
161805368|NCT00893464|584331677|FG000|Overall Study|Did not complete therapy/experience PD|0|||
161805369|NCT00893464|584331678|FG001|Overall Study|Did not complete therapy/experience PD|0|||
161908511|NCT00369343|584715907|FG001|Open-label Phase|Physician Decision|0|||
161908512|NCT00369343|584715906|FG000|Open-label Phase|Lost to Follow-up|5|||
161908513|NCT00369343|584715907|FG001|Open-label Phase|Lost to Follow-up|3|||
161908514|NCT00369343|584715906|FG000|Open-label Phase|inadvertently reported study completers|3|||
161908515|NCT00369343|584715907|FG001|Open-label Phase|inadvertently reported study completers|2|||
161908516|NCT00369343|584715906|FG000|Open-label Phase|Protocol Violation|1|||
161908517|NCT00369343|584715907|FG001|Open-label Phase|Protocol Violation|3|||
161908518|NCT00369343|584715906|FG000|Open-label Phase|Withdrawal by Subject|15|||
161908519|NCT00369343|584715907|FG001|Open-label Phase|Withdrawal by Subject|6|||
161908520|NCT00369343|584715906|FG000|Open-label Phase|Lack of Efficacy|4|||
161908521|NCT00369343|584715907|FG001|Open-label Phase|Lack of Efficacy|3|||
161908522|NCT00369343|584715906|FG000|Open-label Phase|Lack of continuance tolerability|3|||
161908523|NCT00369343|584715907|FG001|Open-label Phase|Lack of continuance tolerability|4|||
161908524|NCT00369343|584715906|FG000|Open-label Phase|did not take study drug|1|||
161908525|NCT00369343|584715907|FG001|Open-label Phase|did not take study drug|2|||
161908526|NCT00073918|584715908|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
161908527|NCT00073918|584715908|FG000|Overall Study|Rapid disease progression|2|||
161908528|NCT00073918|584715908|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
161908529|NCT02033759|584715911|FG000|Overall Study|Withdrawal by Subject|2|||
161908530|NCT02033759|584715912|FG001|Overall Study|Withdrawal by Subject|1|||
161908531|NCT02033759|584715911|FG000|Overall Study|Protocol Violation|1|||
161908532|NCT02033759|584715912|FG001|Overall Study|Protocol Violation|1|||
161908533|NCT04821830|584715918|FG000|Overall Study|Withdrawal by Subject|1|||
161908534|NCT04821830|584715919|FG001|Overall Study|Withdrawal by Subject|0|||
161908535|NCT00490919|584715920|FG000|Open-label Run-in Period|Adverse Event|239|||
161908536|NCT00490919|584715921|FG001|Open-label Run-in Period|Adverse Event|0|||
161805370|NCT00893464|584331679|FG002|Overall Study|Did not complete therapy/experience PD|0|||
161805371|NCT00893464|584331680|FG003|Overall Study|Did not complete therapy/experience PD|0|||
161805372|NCT00893464|584331681|FG004|Overall Study|Did not complete therapy/experience PD|0|||
161805373|NCT00893464|584331682|FG005|Overall Study|Did not complete therapy/experience PD|0|||
161805374|NCT00893464|584331683|FG006|Overall Study|Did not complete therapy/experience PD|2|||
161805375|NCT00893464|584331684|FG007|Overall Study|Did not complete therapy/experience PD|2|||
161805376|NCT03450070|584331685|FG000|Overall Study|Withdrawal by Subject|8|||
161805377|NCT02910037|584331688|FG000|Overall Study|Withdrawal by Subject|4|||
161805378|NCT02910037|584331688|FG000|Overall Study|Lost to Follow-up|6|||
161805379|NCT01035060|584331689|FG000|Overall Study|Lost to Follow-up|0|||
161805380|NCT01035060|584331690|FG001|Overall Study|Lost to Follow-up|7|||
161805381|NCT01035060|584331689|FG000|Overall Study|Did not quality after 2nd screening|14|||
161805382|NCT01035060|584331690|FG001|Overall Study|Did not quality after 2nd screening|1|||
161805383|NCT01035060|584331689|FG000|Overall Study|Withdrawal by Subject|8|||
161805384|NCT01035060|584331690|FG001|Overall Study|Withdrawal by Subject|6|||
161805385|NCT01035060|584331689|FG000|Overall Study|Physician Decision|2|||
161805386|NCT01035060|584331690|FG001|Overall Study|Physician Decision|0|||
161805387|NCT00454909|584331691|FG000|Overall Study|Withdrawal by Subject|1|||
161805388|NCT00454909|584331692|FG001|Overall Study|Withdrawal by Subject|0|||
161805389|NCT00454909|584331693|FG002|Overall Study|Withdrawal by Subject|0|||
161805390|NCT00454909|584331691|FG000|Overall Study|Migrated/moved from study area|0|||
161805391|NCT00454909|584331692|FG001|Overall Study|Migrated/moved from study area|0|||
161805392|NCT00454909|584331693|FG002|Overall Study|Migrated/moved from study area|1|||
161805393|NCT00454909|584331691|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
161805394|NCT00454909|584331692|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
161805395|NCT00454909|584331693|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
161805396|NCT00454909|584331691|FG000|Overall Study|Others|1|||
161805397|NCT00454909|584331692|FG001|Overall Study|Others|0|||
161805398|NCT00454909|584331693|FG002|Overall Study|Others|0|||
161805399|NCT02549092|584331694|FG000|Treatment Period|Adverse Event|2|||
161805400|NCT02549092|584331695|FG001|Treatment Period|Adverse Event|2|||
161805401|NCT02549092|584331694|FG000|Treatment Period|Withdrawal by Subject|1|||
161805402|NCT02549092|584331695|FG001|Treatment Period|Withdrawal by Subject|3|||
161805403|NCT02549092|584331694|FG000|Treatment Period|Lack of Efficacy|0|||
161805404|NCT02549092|584331695|FG001|Treatment Period|Lack of Efficacy|2|||
161805405|NCT02549092|584331694|FG000|Extension/Transition Period|Adverse Event|1|||
161805406|NCT02549092|584331695|FG001|Extension/Transition Period|Adverse Event|1|||
161805407|NCT02549092|584331694|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
161908537|NCT00490919|584715922|FG002|Open-label Run-in Period|Adverse Event|0|||
161805408|NCT02549092|584331695|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
161908538|NCT00490919|584715920|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
161908539|NCT00490919|584715921|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
161908540|NCT00490919|584715922|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
161908541|NCT00490919|584715920|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
161908542|NCT00490919|584715921|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
161908543|NCT00490919|584715922|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
161908544|NCT00490919|584715920|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
161908545|NCT00490919|584715921|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
161908546|NCT00490919|584715922|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
161908547|NCT00490919|584715920|FG000|Open-label Run-in Period|Administrative|40|||
161908548|NCT00490919|584715921|FG001|Open-label Run-in Period|Administrative|0|||
161908549|NCT00490919|584715922|FG002|Open-label Run-in Period|Administrative|0|||
161908550|NCT00490919|584715920|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
161908551|NCT00490919|584715921|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
161908552|NCT00490919|584715922|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
161908553|NCT00490919|584715920|FG000|Double-blind Phase|Adverse Event|0|||
161908554|NCT00490919|584715921|FG001|Double-blind Phase|Adverse Event|40|||
161908555|NCT00490919|584715922|FG002|Double-blind Phase|Adverse Event|20|||
161908556|NCT00490919|584715920|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161908557|NCT00490919|584715921|FG001|Double-blind Phase|Withdrawal by Subject|10|||
161908558|NCT00490919|584715922|FG002|Double-blind Phase|Withdrawal by Subject|11|||
161908559|NCT00490919|584715920|FG000|Double-blind Phase|Lost to Follow-up|0|||
161908560|NCT00490919|584715921|FG001|Double-blind Phase|Lost to Follow-up|8|||
161908561|NCT00490919|584715922|FG002|Double-blind Phase|Lost to Follow-up|11|||
161908562|NCT00490919|584715920|FG000|Double-blind Phase|Lack of Efficacy|0|||
161908563|NCT00490919|584715921|FG001|Double-blind Phase|Lack of Efficacy|22|||
161908564|NCT00490919|584715922|FG002|Double-blind Phase|Lack of Efficacy|36|||
161908565|NCT00490919|584715920|FG000|Double-blind Phase|Administrative|0|||
161908566|NCT00490919|584715921|FG001|Double-blind Phase|Administrative|6|||
161908567|NCT00490919|584715922|FG002|Double-blind Phase|Administrative|6|||
161908568|NCT04350827|584715923|FG000|Overall Study|Lost to Follow-up|1|||
161908569|NCT04350827|584715924|FG001|Overall Study|Lost to Follow-up|2|||
161908570|NCT02034006|584717724|FG000|Overall Study|Withdrawal by Subject|7|||
161908571|NCT02034006|584717724|FG000|Overall Study|Lost to Follow-up|5|||
161908572|NCT02034006|584717724|FG000|Overall Study|Death|1|||
161908573|NCT02034006|584717724|FG000|Overall Study|Pregnancy|1|||
161908574|NCT00161213|584717727|FG000|Overall Study|Withdrawal by Subject|1|||
161908575|NCT00161213|584717727|FG000|Overall Study|Evaluable for toxicity but not response|1|||
161908576|NCT01926028|584717728|FG000|Overall Study|Lost to Follow-up|7|||
161908577|NCT01926028|584717729|FG001|Overall Study|Lost to Follow-up|6|||
161908578|NCT01926028|584717730|FG002|Overall Study|Lost to Follow-up|0|||
161908579|NCT01926028|584717728|FG000|Overall Study|Physician Decision|1|||
161908580|NCT01926028|584717729|FG001|Overall Study|Physician Decision|5|||
161908581|NCT01926028|584717730|FG002|Overall Study|Physician Decision|0|||
161805409|NCT02549092|584331694|FG000|Extension/Transition Period|Other, Not Specified|4|||
161805410|NCT02549092|584331695|FG001|Extension/Transition Period|Other, Not Specified|2|||
161908582|NCT01926028|584717728|FG000|Overall Study|Withdrawal by Subject|9|||
161908583|NCT01926028|584717729|FG001|Overall Study|Withdrawal by Subject|9|||
161908584|NCT01926028|584717730|FG002|Overall Study|Withdrawal by Subject|2|||
161805411|NCT00910663|584331698|FG000|Period 1|Withdrawal by Subject|0|||
161805412|NCT00910663|584331699|FG001|Period 1|Withdrawal by Subject|1|||
161805413|NCT01772537|584331700|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
161805414|NCT01772537|584331701|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
161805415|NCT01772537|584331702|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
161805416|NCT01536574|584331706|FG000|Overall Study|Adverse Event|4|||
161805417|NCT01536574|584331707|FG001|Overall Study|Adverse Event|5|||
161805418|NCT01536574|584331706|FG000|Overall Study|Withdrawal by Subject|1|||
161805419|NCT01536574|584331707|FG001|Overall Study|Withdrawal by Subject|2|||
161805420|NCT01536574|584331706|FG000|Overall Study|Lack of Efficacy|1|||
161805421|NCT01536574|584331707|FG001|Overall Study|Lack of Efficacy|0|||
161805422|NCT01376167|584331708|FG000|Overall Study|Lost to Follow-up|2|||
161805423|NCT01376167|584331709|FG001|Overall Study|Lost to Follow-up|4|||
161805424|NCT01376167|584331710|FG002|Overall Study|Lost to Follow-up|2|||
161805425|NCT01376167|584331708|FG000|Overall Study|Physician Decision|1|||
161805426|NCT01376167|584331709|FG001|Overall Study|Physician Decision|1|||
161805427|NCT01376167|584331710|FG002|Overall Study|Physician Decision|0|||
161805428|NCT01376167|584331708|FG000|Overall Study|Withdrawal by Subject|1|||
161805429|NCT01376167|584331709|FG001|Overall Study|Withdrawal by Subject|5|||
161908585|NCT01926028|584717728|FG000|Overall Study|Non compliance or other reasons|4|||
161908586|NCT01926028|584717729|FG001|Overall Study|Non compliance or other reasons|2|||
161805430|NCT01376167|584331710|FG002|Overall Study|Withdrawal by Subject|4|||
161805431|NCT02193165|584331713|FG000|4 Week Product Use|Lost to Follow-up|1|||
161805432|NCT02193165|584331714|FG001|4 Week Product Use|Lost to Follow-up|1|||
161805433|NCT02193165|584331715|FG002|4 Week Product Use|Lost to Follow-up|1|||
161908587|NCT01926028|584717730|FG002|Overall Study|Non compliance or other reasons|0|||
161908588|NCT02351934|584717731|FG000|Allocation|POD weight<pre-op weight|3|||
161908589|NCT02351934|584717732|FG001|Allocation|POD weight<pre-op weight|0|||
161908590|NCT02351934|584717731|FG000|Allocation|Hypotension preventing administration|2|||
161908591|NCT02351934|584717732|FG001|Allocation|Hypotension preventing administration|0|||
161908592|NCT02351934|584717731|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
161805434|NCT02193165|584331713|FG000|6 Week Product Use|Lost to Follow-up|0|||
161805435|NCT02193165|584331714|FG001|6 Week Product Use|Lost to Follow-up|1|||
161805436|NCT02193165|584331715|FG002|6 Week Product Use|Lost to Follow-up|0|||
161805437|NCT01546545|584331717|FG000|Overall Study|Withdrawal by Subject|1|||
161805438|NCT01214850|584331718|FG000|Overall Study|Withdrawal by Subject|38|||
161805439|NCT01214850|584331719|FG001|Overall Study|Withdrawal by Subject|31|||
161805440|NCT01214850|584331720|FG002|Overall Study|Withdrawal by Subject|28|||
161805441|NCT01214850|584331718|FG000|Overall Study|Lost to Follow-up|124|||
161805442|NCT01214850|584331719|FG001|Overall Study|Lost to Follow-up|98|||
161805443|NCT01214850|584331720|FG002|Overall Study|Lost to Follow-up|123|||
161805444|NCT01214850|584331718|FG000|Overall Study|Protocol Violation|5|||
161805445|NCT01214850|584331719|FG001|Overall Study|Protocol Violation|5|||
161805446|NCT01214850|584331720|FG002|Overall Study|Protocol Violation|6|||
161805447|NCT01214850|584331718|FG000|Overall Study|Adverse event or death|11|||
161805448|NCT01214850|584331719|FG001|Overall Study|Adverse event or death|8|||
161805449|NCT01214850|584331720|FG002|Overall Study|Adverse event or death|3|||
161805450|NCT01214850|584331718|FG000|Overall Study|Inappropriate enrollment|2|||
161805451|NCT01214850|584331719|FG001|Overall Study|Inappropriate enrollment|1|||
161805452|NCT01214850|584331720|FG002|Overall Study|Inappropriate enrollment|0|||
161805453|NCT01214850|584331718|FG000|Overall Study|Administrative reason|1|||
161805454|NCT01214850|584331719|FG001|Overall Study|Administrative reason|0|||
161805455|NCT01214850|584331720|FG002|Overall Study|Administrative reason|0|||
161805456|NCT01214850|584331718|FG000|Overall Study|Unable to classify|2|||
161805457|NCT01214850|584331719|FG001|Overall Study|Unable to classify|1|||
161805458|NCT01214850|584331720|FG002|Overall Study|Unable to classify|1|||
161805459|NCT00610363|584331725|FG000|Overall Study|Non-compliance with protocol|0|||
161805460|NCT00610363|584331726|FG001|Overall Study|Non-compliance with protocol|1|||
161805461|NCT00610363|584331725|FG000|Overall Study|Adverse Event|3|||
161805462|NCT00610363|584331726|FG001|Overall Study|Adverse Event|1|||
161805463|NCT00610363|584331725|FG000|Overall Study|Lack of Efficacy|2|||
161805464|NCT00610363|584331726|FG001|Overall Study|Lack of Efficacy|0|||
161805465|NCT00610363|584331725|FG000|Overall Study|Lost to Follow-up|4|||
161805466|NCT00610363|584331726|FG001|Overall Study|Lost to Follow-up|0|||
161805467|NCT00610363|584331725|FG000|Overall Study|Withdrawal by Subject|1|||
161805468|NCT00610363|584331726|FG001|Overall Study|Withdrawal by Subject|0|||
161805469|NCT00610363|584331725|FG000|Overall Study|Other than specified above|1|||
161805470|NCT00610363|584331726|FG001|Overall Study|Other than specified above|1|||
161805471|NCT03361228|584331736|FG000|Overall Study|Other|1|||
161805472|NCT03361228|584331737|FG001|Overall Study|Other|1|||
161805473|NCT03361228|584331736|FG000|Overall Study|Death|3|||
161805474|NCT03361228|584331737|FG001|Overall Study|Death|0|||
161805475|NCT01722877|584331739|FG000|Overall Study|Death|1|||
161805476|NCT01722877|584331739|FG000|Overall Study|Lost to Follow-up|1|||
161805477|NCT03693430|584331740|FG000|Overall Study|Lost to Follow-up|3|||
161805478|NCT03693430|584331741|FG001|Overall Study|Lost to Follow-up|14|||
161805479|NCT03693430|584331740|FG000|Overall Study|Death|1|||
161805480|NCT03693430|584331741|FG001|Overall Study|Death|0|||
161805481|NCT03693430|584331740|FG000|Overall Study|Withdrawal by Subject|0|||
161805482|NCT03693430|584331741|FG001|Overall Study|Withdrawal by Subject|4|||
161805483|NCT00585689|584331743|FG000|Overall Study|Received different ABI-007 schedule|3|||
161805484|NCT00585689|584331743|FG000|Overall Study|Adverse Event|1|||
161805485|NCT00585689|584331743|FG000|Overall Study|Patient Declined Surgery|1|||
161805486|NCT00585689|584331743|FG000|Overall Study|Patient had unresectable disease|1|||
161805487|NCT00585689|584331743|FG000|Overall Study|Death|1|||
161805488|NCT02930005|584331744|FG000|Overall Study|Lost to Follow-up|1|||
161805489|NCT02930005|584331745|FG001|Overall Study|Lost to Follow-up|5|||
161805490|NCT02373098|584331746|FG000|Overall Study|Lost to Follow-up|1|||
161805491|NCT02373098|584331747|FG001|Overall Study|Lost to Follow-up|0|||
161805492|NCT02373098|584331746|FG000|Overall Study|Protocol Violation|3|||
161805493|NCT02373098|584331747|FG001|Overall Study|Protocol Violation|0|||
161805494|NCT02373098|584331746|FG000|Overall Study|Withdrawal by Subject|5|||
161805495|NCT02373098|584331747|FG001|Overall Study|Withdrawal by Subject|0|||
161805496|NCT02373098|584331746|FG000|Overall Study|Adverse Event|3|||
161805497|NCT02373098|584331747|FG001|Overall Study|Adverse Event|0|||
161805498|NCT00304083|584331755|FG000|Overall Study|Withdrawal by Subject|4|||
161805499|NCT00304083|584331756|FG001|Overall Study|Withdrawal by Subject|2|||
161805500|NCT00304083|584331755|FG000|Overall Study|Physician Decision|8|||
161908593|NCT02351934|584717732|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
161805501|NCT00304083|584331756|FG001|Overall Study|Physician Decision|3|||
161908594|NCT02351934|584717731|FG000|Follow-Up|POD weight<pre-op weight|3|||
161908595|NCT02351934|584717732|FG001|Follow-Up|POD weight<pre-op weight|0|||
161805502|NCT00304083|584331755|FG000|Overall Study|Disease Progression|5|||
161805503|NCT00304083|584331756|FG001|Overall Study|Disease Progression|1|||
161805504|NCT00304083|584331755|FG000|Overall Study|Other|5|||
161805505|NCT00304083|584331756|FG001|Overall Study|Other|2|||
161805506|NCT03966365|584331757|FG000|Overall Study|Protocol Violation|1|||
161805507|NCT03966365|584331758|FG001|Overall Study|Protocol Violation|0|||
161805508|NCT01378975|584331759|FG000|Overall Study|Death|77|||
161805509|NCT01378975|584331760|FG001|Overall Study|Death|46|||
161908596|NCT02351934|584717731|FG000|Follow-Up|Acute Kidney Injury|1|||
161908597|NCT02351934|584717732|FG001|Follow-Up|Acute Kidney Injury|0|||
161908598|NCT02351934|584717731|FG000|Follow-Up|Early dismissal|3|||
161908599|NCT02351934|584717732|FG001|Follow-Up|Early dismissal|0|||
161908600|NCT02351934|584717731|FG000|Follow-Up|Hypotension|3|||
161908601|NCT02351934|584717732|FG001|Follow-Up|Hypotension|0|||
161908602|NCT02351934|584717731|FG000|Follow-Up|No documentation|2|||
161908603|NCT02351934|584717732|FG001|Follow-Up|No documentation|0|||
161908604|NCT02351934|584717731|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
161908605|NCT02351934|584717732|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
161908606|NCT02351934|584717731|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
161908607|NCT02351934|584717732|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
161908608|NCT04635839|584717733|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
161908609|NCT04635839|584717734|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
161908610|NCT02870868|584717735|FG000|Overall Study|Withdrawal by Subject|2|||
161908611|NCT02870868|584717736|FG001|Overall Study|Withdrawal by Subject|1|||
161908612|NCT00499122|584717737|FG000|Overall Study|Withdrawal by Subject|2|||
161908613|NCT00288912|584717738|FG000|Overall Study|Developed exclusion criterion|4|||
161908614|NCT00288912|584717739|FG001|Overall Study|Developed exclusion criterion|6|||
161908615|NCT00288912|584717740|FG002|Overall Study|Developed exclusion criterion|7|||
161908616|NCT00288912|584717738|FG000|Overall Study|Lost to Follow-up|9|||
161908617|NCT00288912|584717739|FG001|Overall Study|Lost to Follow-up|6|||
161908618|NCT00288912|584717740|FG002|Overall Study|Lost to Follow-up|9|||
161908619|NCT00288912|584717738|FG000|Overall Study|Withdrawal by Subject|4|||
161908620|NCT00288912|584717739|FG001|Overall Study|Withdrawal by Subject|5|||
161908621|NCT00288912|584717740|FG002|Overall Study|Withdrawal by Subject|12|||
161908622|NCT03312738|584717741|FG000|Overall Study|Progressive disease|58|||
161908623|NCT03312738|584717742|FG001|Overall Study|Progressive disease|67|||
161908624|NCT03312738|584717741|FG000|Overall Study|Patient/guardian decision|13|||
161908625|NCT03312738|584717742|FG001|Overall Study|Patient/guardian decision|5|||
161908626|NCT03312738|584717741|FG000|Overall Study|Adverse Event|5|||
161908627|NCT03312738|584717742|FG001|Overall Study|Adverse Event|3|||
161908628|NCT03312738|584717741|FG000|Overall Study|Protocol deviation|2|||
161908629|NCT03312738|584717742|FG001|Overall Study|Protocol deviation|0|||
161908630|NCT03312738|584717741|FG000|Overall Study|Technical problems|0|||
161908631|NCT03312738|584717742|FG001|Overall Study|Technical problems|1|||
161908632|NCT03312738|584717741|FG000|Overall Study|Physician Decision|2|||
162140255|NCT03102710|585565592|FG002|Overall Study|Technical issues during final MRI scan|0|||
162140256|NCT03102710|585565590|FG000|Overall Study|Nausea during MRI scan|0|||
162140257|NCT03102710|585565591|FG001|Overall Study|Nausea during MRI scan|1|||
162140258|NCT03102710|585565592|FG002|Overall Study|Nausea during MRI scan|0|||
162140259|NCT03102710|585565590|FG000|Overall Study|Subject unable to attend final session|0|||
162140260|NCT03102710|585565591|FG001|Overall Study|Subject unable to attend final session|1|||
162140261|NCT03102710|585565592|FG002|Overall Study|Subject unable to attend final session|0|||
162140262|NCT01368406|585565593|FG000|Overall Study|Lost to Follow-up|8|||
161908633|NCT03312738|584717742|FG001|Overall Study|Physician Decision|3|||
161908634|NCT02466399|584717751|FG000|Overall Study|Adverse Event|1|||
161908635|NCT02466399|584717752|FG001|Overall Study|Adverse Event|0|||
161908636|NCT02466399|584717751|FG000|Overall Study|Early exit due to family emergency|1|||
161908637|NCT02466399|584717752|FG001|Overall Study|Early exit due to family emergency|0|||
161908638|NCT04539275|584717753|FG000|Overall Study|Death|2|||
161908639|NCT04539275|584717754|FG001|Overall Study|Death|4|||
161908640|NCT04539275|584717753|FG000|Overall Study|Lost to Follow-up|1|||
161908641|NCT04539275|584717754|FG001|Overall Study|Lost to Follow-up|1|||
161908642|NCT04539275|584717753|FG000|Overall Study|Withdrawal by Subject|3|||
161908643|NCT04539275|584717754|FG001|Overall Study|Withdrawal by Subject|0|||
161908644|NCT00607893|584717759|FG000|Overall Study|Lost to Follow-up|4|||
161908645|NCT00607893|584717760|FG001|Overall Study|Lost to Follow-up|0|||
161908646|NCT00607893|584717759|FG000|Overall Study|withdrew due to loss of interest|0|||
161908647|NCT00607893|584717760|FG001|Overall Study|withdrew due to loss of interest|1|||
161908648|NCT00607893|584717759|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
161908649|NCT00607893|584717760|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
161908650|NCT00607893|584717759|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
161908651|NCT00607893|584717760|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
161908652|NCT00607893|584717759|FG000|Overall Study|Declined to be treated|1|||
161908653|NCT00607893|584717760|FG001|Overall Study|Declined to be treated|0|||
161908654|NCT00607893|584717759|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
161908655|NCT00607893|584717760|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
161908656|NCT02669849|584717761|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161908657|NCT02669849|584717762|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161908658|NCT02669849|584717763|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
161908659|NCT02669849|584717761|FG000|Overall Study|Lost to Follow-up|1|||
161908660|NCT02669849|584717762|FG001|Overall Study|Lost to Follow-up|0|||
161908661|NCT02669849|584717763|FG002|Overall Study|Lost to Follow-up|3|||
161908662|NCT02669849|584717761|FG000|Overall Study|Death|1|||
161908663|NCT02669849|584717762|FG001|Overall Study|Death|1|||
161908664|NCT02669849|584717763|FG002|Overall Study|Death|2|||
161908665|NCT02669849|584717761|FG000|Overall Study|Study terminated by sponsor|16|||
161908666|NCT02669849|584717762|FG001|Overall Study|Study terminated by sponsor|1|||
161908667|NCT02669849|584717763|FG002|Overall Study|Study terminated by sponsor|14|||
161908668|NCT02669849|584717761|FG000|Overall Study|Other|0|||
161908669|NCT02669849|584717762|FG001|Overall Study|Other|0|||
161908670|NCT02669849|584717763|FG002|Overall Study|Other|2|||
161908671|NCT01799941|584717764|FG000|Overall Study|Adverse Event|34|||
161908672|NCT01799941|584717764|FG000|Overall Study|Withdrawal by Subject|21|||
161908673|NCT01799941|584717764|FG000|Overall Study|Death|2|||
161908674|NCT01799941|584717764|FG000|Overall Study|Investigator Decision|4|||
161908675|NCT01799941|584717764|FG000|Overall Study|Lack of Efficacy|3|||
161908676|NCT01799941|584717764|FG000|Overall Study|Lost to Follow-up|17|||
161908677|NCT01799941|584717764|FG000|Overall Study|Other|15|||
161908678|NCT00547339|584717765|FG000|Overall Study|Physician Decision|0|||
161908679|NCT00547339|584717766|FG001|Overall Study|Physician Decision|0|||
161908680|NCT00547339|584717767|FG002|Overall Study|Physician Decision|1|||
161908681|NCT00547339|584717768|FG003|Overall Study|Physician Decision|0|||
161908682|NCT02426684|584717769|FG000|Overall Study|Physician Decision|1|||
162140263|NCT01368406|585565594|FG001|Overall Study|Lost to Follow-up|4|||
162140264|NCT01368406|585565593|FG000|Overall Study|Withdrawal by Subject|8|||
162140265|NCT01368406|585565594|FG001|Overall Study|Withdrawal by Subject|4|||
162140266|NCT01368406|585565593|FG000|Overall Study|relapse of the disease|3|||
162140267|NCT01368406|585565594|FG001|Overall Study|relapse of the disease|2|||
162140268|NCT01368406|585565593|FG000|Overall Study|started working|2|||
162140269|NCT01368406|585565594|FG001|Overall Study|started working|3|||
162140270|NCT04304534|585565595|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
162140271|NCT04304534|585565596|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
162140272|NCT04304534|585565597|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
162140273|NCT04304534|585565598|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
162140274|NCT04304534|585565595|FG000|Overall Study|Non-Compliance with study drug|0|||
162140275|NCT04304534|585565596|FG001|Overall Study|Non-Compliance with study drug|1|||
162140276|NCT04304534|585565597|FG002|Overall Study|Non-Compliance with study drug|1|||
162140277|NCT04304534|585565598|FG003|Overall Study|Non-Compliance with study drug|1|||
162140278|NCT04304534|585565595|FG000|Overall Study|Lost to Follow-up|0|||
162140279|NCT04304534|585565596|FG001|Overall Study|Lost to Follow-up|1|||
162140280|NCT04304534|585565597|FG002|Overall Study|Lost to Follow-up|2|||
162140281|NCT04304534|585565598|FG003|Overall Study|Lost to Follow-up|3|||
162140282|NCT04304534|585565595|FG000|Overall Study|Unspecific|4|||
162140283|NCT04304534|585565596|FG001|Overall Study|Unspecific|2|||
162140284|NCT04304534|585565597|FG002|Overall Study|Unspecific|2|||
162140285|NCT04304534|585565598|FG003|Overall Study|Unspecific|2|||
162140286|NCT04304534|585565595|FG000|Overall Study|Technical Problems|2|||
162140287|NCT04304534|585565596|FG001|Overall Study|Technical Problems|2|||
162140288|NCT04304534|585565597|FG002|Overall Study|Technical Problems|3|||
162140289|NCT04304534|585565598|FG003|Overall Study|Technical Problems|4|||
161908683|NCT03736967|584717770|FG000|Overall Study|Withdrawal by Subject|26|||
161908684|NCT03736967|584717771|FG001|Overall Study|Withdrawal by Subject|25|||
161908685|NCT03736967|584717772|FG002|Overall Study|Withdrawal by Subject|23|||
161908686|NCT03736967|584717773|FG003|Overall Study|Withdrawal by Subject|26|||
161908687|NCT03736967|584717770|FG000|Overall Study|Lost to Follow-up|3|||
161908688|NCT03736967|584717771|FG001|Overall Study|Lost to Follow-up|2|||
161908689|NCT03736967|584717772|FG002|Overall Study|Lost to Follow-up|1|||
161908690|NCT03736967|584717773|FG003|Overall Study|Lost to Follow-up|1|||
161908691|NCT03736967|584717770|FG000|Overall Study|Physician Decision|1|||
161908692|NCT03736967|584717771|FG001|Overall Study|Physician Decision|0|||
161908693|NCT03736967|584717772|FG002|Overall Study|Physician Decision|0|||
161908694|NCT03736967|584717773|FG003|Overall Study|Physician Decision|1|||
161908695|NCT03736967|584717770|FG000|Overall Study|Adverse Event|0|||
161908696|NCT03736967|584717771|FG001|Overall Study|Adverse Event|1|||
161908697|NCT03736967|584717772|FG002|Overall Study|Adverse Event|0|||
161908698|NCT03736967|584717773|FG003|Overall Study|Adverse Event|1|||
161908699|NCT03736967|584717770|FG000|Overall Study|Death|0|||
161908700|NCT03736967|584717771|FG001|Overall Study|Death|0|||
161908701|NCT03736967|584717772|FG002|Overall Study|Death|0|||
161908702|NCT03736967|584717773|FG003|Overall Study|Death|1|||
161908703|NCT03736967|584717770|FG000|Overall Study|Randomized but never treated|1|||
161908704|NCT03736967|584717771|FG001|Overall Study|Randomized but never treated|0|||
161908705|NCT03736967|584717772|FG002|Overall Study|Randomized but never treated|0|||
161908706|NCT03736967|584717773|FG003|Overall Study|Randomized but never treated|0|||
161908707|NCT02369653|584717774|FG000|Overall Study|Lost to Follow-up|0|||
161908708|NCT02369653|584717775|FG001|Overall Study|Lost to Follow-up|1|||
161908709|NCT02369653|584717774|FG000|Overall Study|Administrative reason by sponsor|0|||
161908710|NCT02369653|584717775|FG001|Overall Study|Administrative reason by sponsor|1|||
161908711|NCT02369653|584717774|FG000|Overall Study|Death|1|||
161908712|NCT02369653|584717775|FG001|Overall Study|Death|2|||
161908713|NCT02369653|584717774|FG000|Overall Study|Participant withdrew consent|13|||
161908714|NCT02369653|584717775|FG001|Overall Study|Participant withdrew consent|3|||
161908715|NCT03587636|584717776|FG000|Overall Study|Lost to Follow-up|2|||
161908716|NCT03587636|584717777|FG001|Overall Study|Lost to Follow-up|5|||
161908717|NCT01587885|584717778|FG000|Treatment Period 1|Failure to Return|0|||
161908718|NCT01587885|584717779|FG001|Treatment Period 1|Failure to Return|1|||
161908719|NCT01587885|584717778|FG000|Treatment Period 1|Protocol Violation|0|||
161908720|NCT01587885|584717779|FG001|Treatment Period 1|Protocol Violation|2|||
161908721|NCT01458587|584717780|FG000|Overall Study|Withdrawal by Subject|1|||
161908722|NCT01458587|584717781|FG001|Overall Study|Withdrawal by Subject|0|||
161908723|NCT01603602|584717782|FG000|Overall Study|Adverse Event|1|||
161908724|NCT01603602|584717783|FG001|Overall Study|Adverse Event|0|||
161908725|NCT01603602|584717784|FG002|Overall Study|Adverse Event|0|||
161908726|NCT01603602|584717782|FG000|Overall Study|Personal Reasons|1|||
161908727|NCT01603602|584717783|FG001|Overall Study|Personal Reasons|0|||
161908728|NCT01603602|584717784|FG002|Overall Study|Personal Reasons|1|||
161908729|NCT04748718|584717788|FG000|Overall Study|Lost to Follow-up|50|||
161908730|NCT00316004|584717789|FG000|Overall Study|Subject was not given study fluid.|14|||
161908731|NCT00316004|584717790|FG001|Overall Study|Subject was not given study fluid.|14|||
161908732|NCT00316004|584717791|FG002|Overall Study|Subject was not given study fluid.|21|||
161908733|NCT01118299|584717792|FG000|Overall Study|Death|7|||
161908734|NCT01118299|584717793|FG001|Overall Study|Death|5|||
161908735|NCT01118299|584717792|FG000|Overall Study|Withdrawal by Subject|8|||
161908736|NCT01118299|584717793|FG001|Overall Study|Withdrawal by Subject|8|||
161908737|NCT01118299|584717792|FG000|Overall Study|Lost to Follow-up|2|||
161908738|NCT01118299|584717793|FG001|Overall Study|Lost to Follow-up|1|||
161908739|NCT01118299|584717792|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
161908740|NCT01118299|584717793|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
161908741|NCT01935089|584717795|FG000|Overall Study|Adverse Event|2|||
161908742|NCT01935089|584717795|FG000|Overall Study|Withdrawal by Subject|1|||
161908743|NCT02932943|584717796|FG000|Overall Study|Lost to Follow-up|0|||
161908744|NCT02932943|584717797|FG001|Overall Study|Lost to Follow-up|2|||
161908745|NCT02932943|584717796|FG000|Overall Study|Adverse Event|2|||
161908746|NCT02932943|584717797|FG001|Overall Study|Adverse Event|2|||
161908747|NCT02932943|584717796|FG000|Overall Study|Withdrawal by Subject|3|||
161908748|NCT02932943|584717797|FG001|Overall Study|Withdrawal by Subject|3|||
161908749|NCT02665117|584717800|FG000|Overall Study|Physician Decision|1|||
161908750|NCT02665117|584717801|FG001|Overall Study|Physician Decision|0|||
161908751|NCT00977197|584717802|FG000|Overall Study|Withdrawal by Subject|3|||
161908752|NCT00977197|584717803|FG001|Overall Study|Withdrawal by Subject|4|||
161908753|NCT00977197|584717802|FG000|Overall Study|Adverse Event|3|||
161908754|NCT00977197|584717803|FG001|Overall Study|Adverse Event|1|||
162140290|NCT04304534|585565595|FG000|Overall Study|Death|7|||
162140291|NCT04304534|585565596|FG001|Overall Study|Death|2|||
161908755|NCT00977197|584717802|FG000|Overall Study|Lack of Efficacy|1|||
161908756|NCT00977197|584717803|FG001|Overall Study|Lack of Efficacy|0|||
161908757|NCT00977197|584717802|FG000|Overall Study|Lost to Follow-up|1|||
161908758|NCT00977197|584717803|FG001|Overall Study|Lost to Follow-up|3|||
161908759|NCT00977197|584717802|FG000|Overall Study|Nonadherence|1|||
161908760|NCT00977197|584717803|FG001|Overall Study|Nonadherence|1|||
161908761|NCT05379920|584717804|FG000|Overall Study|Lost to Follow-up|0|||
161908762|NCT05379920|584717805|FG001|Overall Study|Lost to Follow-up|5|||
161908763|NCT05379920|584717806|FG002|Overall Study|Lost to Follow-up|0|||
161908764|NCT05379920|584717807|FG003|Overall Study|Lost to Follow-up|0|||
161908765|NCT03530293|584717810|FG000|Pre-randomization|Adverse Event|12|||
161908766|NCT03530293|584717811|FG001|Pre-randomization|Adverse Event|0|||
161908767|NCT03530293|584717812|FG002|Pre-randomization|Adverse Event|0|||
161908768|NCT03530293|584717810|FG000|Pre-randomization|Protocol Violation|2|||
161908769|NCT03530293|584717811|FG001|Pre-randomization|Protocol Violation|0|||
162140292|NCT04304534|585565597|FG002|Overall Study|Death|4|||
161805510|NCT01378975|584331759|FG000|Overall Study|Investigator Request|1|||
161805511|NCT01378975|584331760|FG001|Overall Study|Investigator Request|0|||
161805512|NCT01378975|584331759|FG000|Overall Study|Lost to Follow-up|4|||
161805513|NCT01378975|584331760|FG001|Overall Study|Lost to Follow-up|1|||
161805514|NCT01378975|584331759|FG000|Overall Study|Withdrew Consent|4|||
161805515|NCT01378975|584331760|FG001|Overall Study|Withdrew Consent|3|||
161805516|NCT03929393|584331763|FG000|Overall Study|Death|1|||
161805517|NCT03929393|584331764|FG001|Overall Study|Death|0|||
161805518|NCT03929393|584331763|FG000|Overall Study|Time Commitment|2|||
161805519|NCT03929393|584331764|FG001|Overall Study|Time Commitment|5|||
161805520|NCT03929393|584331763|FG000|Overall Study|Motor Vehicle Accident|0|||
161805521|NCT03929393|584331764|FG001|Overall Study|Motor Vehicle Accident|1|||
161805522|NCT03929393|584331763|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
161805523|NCT03929393|584331764|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
161805524|NCT03929393|584331763|FG000|Overall Study|Other|1|||
161805525|NCT03929393|584331764|FG001|Overall Study|Other|3|||
161805526|NCT00694551|584331777|FG000|Overall Study|Disease Progression|1|||
161805527|NCT00694551|584331778|FG001|Overall Study|Disease Progression|0|||
161805528|NCT00694551|584331779|FG002|Overall Study|Disease Progression|1|||
161805529|NCT01937390|584331783|FG000|Overall Study|Death|2|||
161805530|NCT01937390|584331783|FG000|Overall Study|Lost to Follow-up|7|||
161805531|NCT01937390|584331783|FG000|Overall Study|Withdrawal by Subject|5|||
161805532|NCT01937390|584331783|FG000|Overall Study|Fail to return|21|||
161805533|NCT02216071|584331784|FG000|Overall Study|Withdrawal by Subject|7|||
161805534|NCT02216071|584331785|FG001|Overall Study|Withdrawal by Subject|2|||
161805535|NCT02216071|584331784|FG000|Overall Study|Lost to Follow-up|3|||
161805536|NCT02216071|584331785|FG001|Overall Study|Lost to Follow-up|3|||
161805537|NCT02216071|584331784|FG000|Overall Study|Protocol Violation|3|||
161805538|NCT02216071|584331785|FG001|Overall Study|Protocol Violation|5|||
161805539|NCT02216071|584331784|FG000|Overall Study|Other|2|||
161805540|NCT02216071|584331785|FG001|Overall Study|Other|2|||
161805541|NCT01706536|584331786|FG000|Overall Study|Withdrawal by Subject|1|||
161805542|NCT01706536|584331787|FG001|Overall Study|Withdrawal by Subject|0|||
161805543|NCT01706536|584331788|FG002|Overall Study|Withdrawal by Subject|1|||
161805544|NCT01706536|584331789|FG003|Overall Study|Withdrawal by Subject|0|||
161805545|NCT01706536|584331790|FG004|Overall Study|Withdrawal by Subject|0|||
161805546|NCT01706536|584331786|FG000|Overall Study|Adverse Event|2|||
161805547|NCT01706536|584331787|FG001|Overall Study|Adverse Event|3|||
161805548|NCT01706536|584331788|FG002|Overall Study|Adverse Event|4|||
161805549|NCT01706536|584331789|FG003|Overall Study|Adverse Event|3|||
161805550|NCT01706536|584331790|FG004|Overall Study|Adverse Event|2|||
161805551|NCT01706536|584331786|FG000|Overall Study|Lack of Efficacy|1|||
161805552|NCT01706536|584331787|FG001|Overall Study|Lack of Efficacy|0|||
161805553|NCT01706536|584331788|FG002|Overall Study|Lack of Efficacy|0|||
161805554|NCT01706536|584331789|FG003|Overall Study|Lack of Efficacy|1|||
161805555|NCT01706536|584331790|FG004|Overall Study|Lack of Efficacy|0|||
161805556|NCT01706536|584331786|FG000|Overall Study|non compliance|0|||
161805557|NCT01706536|584331787|FG001|Overall Study|non compliance|1|||
161805558|NCT01706536|584331788|FG002|Overall Study|non compliance|0|||
161805559|NCT01706536|584331789|FG003|Overall Study|non compliance|0|||
161805560|NCT01706536|584331790|FG004|Overall Study|non compliance|0|||
161805561|NCT04753437|584331791|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161805562|NCT04753437|584331792|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
161805563|NCT04753437|584331791|FG000|Overall Study|Liver Function Test Abnormalities|2|||
161805564|NCT04753437|584331792|FG001|Overall Study|Liver Function Test Abnormalities|4|||
161805565|NCT00385684|584331795|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
161805566|NCT00385684|584331796|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
161805567|NCT00385684|584331795|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
161805568|NCT00385684|584331796|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
161805569|NCT00385684|584331795|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
161805570|NCT00385684|584331796|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
161805571|NCT00463606|584331797|FG000|Overall Study|Adverse Event|21|||
161805572|NCT00463606|584331798|FG001|Overall Study|Adverse Event|18|||
161805573|NCT00463606|584331799|FG002|Overall Study|Adverse Event|11|||
161805574|NCT00463606|584331797|FG000|Overall Study|Withdrawal by Subject|11|||
161805575|NCT00463606|584331798|FG001|Overall Study|Withdrawal by Subject|11|||
161805576|NCT00463606|584331799|FG002|Overall Study|Withdrawal by Subject|5|||
161805577|NCT00463606|584331797|FG000|Overall Study|Lost to Follow-up|2|||
161805578|NCT00463606|584331798|FG001|Overall Study|Lost to Follow-up|2|||
161805579|NCT00463606|584331799|FG002|Overall Study|Lost to Follow-up|3|||
161805580|NCT00463606|584331797|FG000|Overall Study|Subject noncompliance|1|||
161805581|NCT00463606|584331798|FG001|Overall Study|Subject noncompliance|1|||
161805582|NCT00463606|584331799|FG002|Overall Study|Subject noncompliance|0|||
161805583|NCT00463606|584331797|FG000|Overall Study|Subject moved out of town|1|||
161805584|NCT00463606|584331798|FG001|Overall Study|Subject moved out of town|0|||
161805585|NCT00463606|584331799|FG002|Overall Study|Subject moved out of town|0|||
161805586|NCT00463606|584331797|FG000|Overall Study|Physician Decision|0|||
161805587|NCT00463606|584331798|FG001|Overall Study|Physician Decision|1|||
161908770|NCT03530293|584717812|FG002|Pre-randomization|Protocol Violation|0|||
161908771|NCT03530293|584717810|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
161908772|NCT03530293|584717811|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
161908773|NCT03530293|584717812|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
161908774|NCT03530293|584717810|FG000|Pre-randomization|Withdrawal by Subject|5|||
161908775|NCT03530293|584717811|FG001|Pre-randomization|Withdrawal by Subject|0|||
161908776|NCT03530293|584717812|FG002|Pre-randomization|Withdrawal by Subject|0|||
161908777|NCT03530293|584717810|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
161908778|NCT03530293|584717811|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
161908779|NCT03530293|584717812|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
161908780|NCT03530293|584717810|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
161908781|NCT03530293|584717811|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
161908782|NCT03530293|584717812|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
161908783|NCT03530293|584717810|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
161908784|NCT03530293|584717811|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
161908785|NCT03530293|584717812|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
161908786|NCT03530293|584717810|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
161908787|NCT03530293|584717811|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
161908788|NCT03530293|584717812|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
161908789|NCT03530293|584717810|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
161908790|NCT03530293|584717811|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
161908791|NCT03530293|584717812|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
161908792|NCT03482024|584717814|FG000|Overall Study|Physician Decision|1|||
161908793|NCT03482024|584717815|FG001|Overall Study|Physician Decision|0|||
161908794|NCT03482024|584717816|FG002|Overall Study|Physician Decision|0|||
161908795|NCT03482024|584717817|FG003|Overall Study|Physician Decision|0|||
161908796|NCT03482024|584717818|FG004|Overall Study|Physician Decision|0|||
161908797|NCT02295644|584717819|FG000|Overall Study|Did not meet inclusion criterion|0|||
161908798|NCT02295644|584717820|FG001|Overall Study|Did not meet inclusion criterion|0|||
161908799|NCT02295644|584717821|FG002|Overall Study|Did not meet inclusion criterion|1|||
161908800|NCT02295644|584717822|FG003|Overall Study|Did not meet inclusion criterion|2|||
161908801|NCT02147626|584717823|FG000|Overall Study|Lost to Follow-up|4|||
161908802|NCT02147626|584717824|FG001|Overall Study|Lost to Follow-up|4|||
161908803|NCT02147626|584717823|FG000|Overall Study|Pregnancy|1|||
161908804|NCT02147626|584717824|FG001|Overall Study|Pregnancy|2|||
161908805|NCT02147626|584717823|FG000|Overall Study|Withdrawal by Subject|0|||
161908806|NCT02147626|584717824|FG001|Overall Study|Withdrawal by Subject|1|||
161908807|NCT00423046|584717825|FG000|Overall Study|Other|340|||
161908808|NCT00423046|584717826|FG001|Overall Study|Other|345|||
161908809|NCT05214118|584717827|FG000|Overall Study|Lost to Follow-up|0|||
161908810|NCT05214118|584717828|FG001|Overall Study|Lost to Follow-up|2|||
161908811|NCT05214118|584717827|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
161908812|NCT05214118|584717828|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
161908813|NCT05214118|584717827|FG000|Overall Study|moved|1|||
161908814|NCT05214118|584717828|FG001|Overall Study|moved|0|||
161908815|NCT03080935|584717829|FG000|Overall Study|Death|34|||
161908816|NCT03080935|584717830|FG001|Overall Study|Death|50|||
161908817|NCT03080935|584717829|FG000|Overall Study|Lost to Follow-up|5|||
161908818|NCT03080935|584717830|FG001|Overall Study|Lost to Follow-up|4|||
161908819|NCT03080935|584717829|FG000|Overall Study|Withdrawal by Subject|11|||
161908820|NCT03080935|584717830|FG001|Overall Study|Withdrawal by Subject|15|||
161908821|NCT01614470|584717831|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
161908822|NCT01614470|584717832|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161908823|NCT01614470|584717833|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161908824|NCT01614470|584717831|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
161908825|NCT01614470|584717832|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
161908826|NCT01614470|584717833|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
161908827|NCT02175121|584717834|FG000|Overall Study|Lack of Efficacy|1|||
161908828|NCT02175121|584717835|FG001|Overall Study|Lack of Efficacy|0|||
161908829|NCT02175121|584717836|FG002|Overall Study|Lack of Efficacy|0|||
161908830|NCT02175121|584717837|FG003|Overall Study|Lack of Efficacy|0|||
161908831|NCT02175121|584717838|FG004|Overall Study|Lack of Efficacy|0|||
161908832|NCT02175121|584717834|FG000|Overall Study|Lost to Follow-up|0|||
161908833|NCT02175121|584717835|FG001|Overall Study|Lost to Follow-up|1|||
161908834|NCT02175121|584717836|FG002|Overall Study|Lost to Follow-up|0|||
161908835|NCT02175121|584717837|FG003|Overall Study|Lost to Follow-up|1|||
161908836|NCT02175121|584717838|FG004|Overall Study|Lost to Follow-up|0|||
161908837|NCT02175121|584717834|FG000|Overall Study|Personal emergency|0|||
161908838|NCT02175121|584717835|FG001|Overall Study|Personal emergency|0|||
161908839|NCT02175121|584717836|FG002|Overall Study|Personal emergency|0|||
161908840|NCT02175121|584717837|FG003|Overall Study|Personal emergency|0|||
161908841|NCT02175121|584717838|FG004|Overall Study|Personal emergency|1|||
161908842|NCT02175121|584717834|FG000|Overall Study|Schedule conflict|0|||
161908843|NCT02175121|584717835|FG001|Overall Study|Schedule conflict|0|||
161908844|NCT02175121|584717836|FG002|Overall Study|Schedule conflict|1|||
161908845|NCT02175121|584717837|FG003|Overall Study|Schedule conflict|0|||
161908846|NCT02175121|584717838|FG004|Overall Study|Schedule conflict|0|||
161908847|NCT02175121|584717834|FG000|Overall Study|Time issues|0|||
161908848|NCT02175121|584717835|FG001|Overall Study|Time issues|0|||
161908849|NCT02175121|584717836|FG002|Overall Study|Time issues|1|||
161908850|NCT02175121|584717837|FG003|Overall Study|Time issues|0|||
161908851|NCT02175121|584717838|FG004|Overall Study|Time issues|0|||
161908852|NCT02949947|584717844|FG000|Overall Study|Non Compliance|0|||
161908853|NCT02949947|584717845|FG001|Overall Study|Non Compliance|1|||
161908854|NCT02949947|584717844|FG000|Overall Study|Insurance change|1|||
161908855|NCT02949947|584717845|FG001|Overall Study|Insurance change|0|||
161908856|NCT00794664|584717846|FG000|Treatment Period|Withdrawal by Subject|0|||
161908857|NCT00794664|584717847|FG001|Treatment Period|Withdrawal by Subject|2|||
161908858|NCT00794664|584717846|FG000|Treatment Period|Protocol non-compliance|0|||
161908859|NCT00794664|584717847|FG001|Treatment Period|Protocol non-compliance|1|||
161908860|NCT00794664|584717846|FG000|Treatment Period|Other|0|||
161908861|NCT00794664|584717847|FG001|Treatment Period|Other|1|||
161908862|NCT00794664|584717846|FG000|Treatment Period|Adverse Event|1|||
161908863|NCT00794664|584717847|FG001|Treatment Period|Adverse Event|8|||
161908864|NCT00794664|584717846|FG000|Follow-up Period|Other|1|||
161908865|NCT00794664|584717847|FG001|Follow-up Period|Other|2|||
161908866|NCT00794664|584717846|FG000|Follow-up Period|Withdrawal by Subject|0|||
161908867|NCT00794664|584717847|FG001|Follow-up Period|Withdrawal by Subject|2|||
161908868|NCT00794664|584717846|FG000|Follow-up Period|Protocol non-compliance|0|||
161908869|NCT00794664|584717847|FG001|Follow-up Period|Protocol non-compliance|1|||
161908870|NCT01973218|584717848|FG000|Overall Study|Adverse Event|1|||
161908871|NCT01973218|584717849|FG001|Overall Study|Adverse Event|0|||
161908872|NCT01973218|584717848|FG000|Overall Study|Withdrawal by Subject|1|||
161908873|NCT01973218|584717849|FG001|Overall Study|Withdrawal by Subject|0|||
161908874|NCT00720499|584717850|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
161908875|NCT00720499|584717851|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
161908876|NCT00720499|584717850|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
161908877|NCT00720499|584717851|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
161908878|NCT00720499|584717850|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
161908879|NCT00720499|584717851|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
161908880|NCT02247466|584717852|FG000|Overall Study|Procedure changed to open surgery|0|||
161908881|NCT02247466|584717853|FG001|Overall Study|Procedure changed to open surgery|3|||
161908882|NCT00492726|584717854|FG000|Overall Study|Adverse Event|10|||
161908883|NCT00492726|584717855|FG001|Overall Study|Adverse Event|6|||
161908884|NCT00492726|584717854|FG000|Overall Study|Death|7|||
161908885|NCT00492726|584717855|FG001|Overall Study|Death|2|||
161908886|NCT00492726|584717854|FG000|Overall Study|Lack of Efficacy|0|||
161908887|NCT00492726|584717855|FG001|Overall Study|Lack of Efficacy|2|||
161908888|NCT00492726|584717854|FG000|Overall Study|Lost to Follow-up|27|||
161908889|NCT00492726|584717855|FG001|Overall Study|Lost to Follow-up|19|||
161908890|NCT00492726|584717854|FG000|Overall Study|Physician Decision|0|||
161908891|NCT00492726|584717855|FG001|Overall Study|Physician Decision|1|||
161908892|NCT00492726|584717854|FG000|Overall Study|Withdrawal by Subject|6|||
161908893|NCT00492726|584717855|FG001|Overall Study|Withdrawal by Subject|3|||
161908894|NCT00492726|584717854|FG000|Overall Study|Non compliant with study medication|0|||
161908895|NCT00492726|584717855|FG001|Overall Study|Non compliant with study medication|3|||
161908896|NCT04386902|584717856|FG000|Overall Study|Withdrawal by Subject|5|||
161908897|NCT04386902|584717856|FG000|Overall Study|Technical problems in the recording|5|||
161908898|NCT01100502|584717857|FG000|Overall Study|Withdrawal by Subject|18|||
161908899|NCT01100502|584717858|FG001|Overall Study|Withdrawal by Subject|25|||
161908900|NCT01100502|584717857|FG000|Overall Study|Lost to Follow-up|13|||
161908901|NCT01100502|584717858|FG001|Overall Study|Lost to Follow-up|28|||
161908902|NCT01100502|584717857|FG000|Overall Study|Site request to end participation in study|0|||
161908903|NCT01100502|584717858|FG001|Overall Study|Site request to end participation in study|1|||
161908904|NCT01100502|584717857|FG000|Overall Study|Death|45|||
161908905|NCT01100502|584717858|FG001|Overall Study|Death|40|||
161908906|NCT04356937|584717866|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
161908907|NCT04356937|584717867|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
161908908|NCT00807365|584717868|FG000|Overall Study|Study Terminated|5|||
161908909|NCT00960804|584717869|FG000|Overall Study|Adverse Event|1|||
161908910|NCT00960804|584717870|FG001|Overall Study|Adverse Event|0|||
161908911|NCT00960804|584717871|FG002|Overall Study|Adverse Event|0|||
161908912|NCT00960804|584717869|FG000|Overall Study|Withdrawal by Subject|1|||
161908913|NCT00960804|584717870|FG001|Overall Study|Withdrawal by Subject|0|||
161908914|NCT00960804|584717871|FG002|Overall Study|Withdrawal by Subject|0|||
161908915|NCT00960804|584717869|FG000|Overall Study|Study terminated by the sponsor|5|||
161908916|NCT00960804|584717870|FG001|Overall Study|Study terminated by the sponsor|4|||
161908917|NCT00960804|584717871|FG002|Overall Study|Study terminated by the sponsor|10|||
161908918|NCT02007720|584717873|FG000|Overall Study|Withdrawal by Subject|9|||
161908919|NCT02007720|584717874|FG001|Overall Study|Withdrawal by Subject|11|||
161908920|NCT02007720|584717873|FG000|Overall Study|study terminated by sponsor|58|||
161908921|NCT02007720|584717874|FG001|Overall Study|study terminated by sponsor|54|||
161908922|NCT02007720|584717873|FG000|Overall Study|technical problem|4|||
161908923|NCT02007720|584717874|FG001|Overall Study|technical problem|2|||
161908924|NCT02007720|584717873|FG000|Overall Study|patient followd less than 165 days|11|||
161908925|NCT02007720|584717874|FG001|Overall Study|patient followd less than 165 days|5|||
161908926|NCT02100124|584717877|FG000|Overall Study|Lost to Follow-up|5|||
161908927|NCT02100124|584717878|FG001|Overall Study|Lost to Follow-up|11|||
161908928|NCT02100124|584717879|FG002|Overall Study|Lost to Follow-up|3|||
161908929|NCT02100124|584717877|FG000|Overall Study|Withdrawal by Subject|1|||
161908930|NCT02100124|584717878|FG001|Overall Study|Withdrawal by Subject|0|||
161908931|NCT02100124|584717879|FG002|Overall Study|Withdrawal by Subject|0|||
161908932|NCT00750269|584719206|FG000|Overall Study|Protocol Violation|0|||
161908933|NCT00750269|584719207|FG001|Overall Study|Protocol Violation|1|||
161908934|NCT00750269|584719208|FG002|Overall Study|Protocol Violation|1|||
161908935|NCT00750269|584719209|FG003|Overall Study|Protocol Violation|2|||
161908936|NCT00750269|584719210|FG004|Overall Study|Protocol Violation|4|||
161908937|NCT00750269|584719206|FG000|Overall Study|Withdrawal by Subject|0|||
161908938|NCT00750269|584719207|FG001|Overall Study|Withdrawal by Subject|0|||
161908939|NCT00750269|584719208|FG002|Overall Study|Withdrawal by Subject|2|||
161908940|NCT00750269|584719209|FG003|Overall Study|Withdrawal by Subject|2|||
161908941|NCT00750269|584719210|FG004|Overall Study|Withdrawal by Subject|2|||
161908942|NCT00750269|584719206|FG000|Overall Study|Physician Decision|0|||
161908943|NCT00750269|584719207|FG001|Overall Study|Physician Decision|0|||
161908944|NCT00750269|584719208|FG002|Overall Study|Physician Decision|0|||
161908945|NCT00750269|584719209|FG003|Overall Study|Physician Decision|0|||
161908946|NCT00750269|584719210|FG004|Overall Study|Physician Decision|2|||
161908947|NCT00750269|584719206|FG000|Overall Study|Patient too large for positioning|0|||
161908948|NCT00750269|584719207|FG001|Overall Study|Patient too large for positioning|0|||
161908949|NCT00750269|584719208|FG002|Overall Study|Patient too large for positioning|1|||
161908950|NCT00750269|584719209|FG003|Overall Study|Patient too large for positioning|0|||
161908951|NCT00750269|584719210|FG004|Overall Study|Patient too large for positioning|0|||
161908952|NCT00750269|584719206|FG000|Overall Study|Site error|0|||
161908953|NCT00750269|584719207|FG001|Overall Study|Site error|0|||
161908954|NCT00750269|584719208|FG002|Overall Study|Site error|0|||
161908955|NCT00750269|584719209|FG003|Overall Study|Site error|1|||
161908956|NCT00750269|584719210|FG004|Overall Study|Site error|0|||
161908957|NCT00750269|584719206|FG000|Overall Study|SBRT plan could not be drawn|0|||
161908958|NCT00750269|584719207|FG001|Overall Study|SBRT plan could not be drawn|0|||
161908959|NCT00750269|584719208|FG002|Overall Study|SBRT plan could not be drawn|0|||
161908960|NCT00750269|584719209|FG003|Overall Study|SBRT plan could not be drawn|0|||
161908961|NCT00750269|584719210|FG004|Overall Study|SBRT plan could not be drawn|1|||
161908962|NCT00750269|584719206|FG000|Overall Study|Fiducials could not be placed|0|||
161908963|NCT00750269|584719207|FG001|Overall Study|Fiducials could not be placed|0|||
161908964|NCT00750269|584719208|FG002|Overall Study|Fiducials could not be placed|0|||
161908965|NCT00750269|584719209|FG003|Overall Study|Fiducials could not be placed|0|||
161908966|NCT00750269|584719210|FG004|Overall Study|Fiducials could not be placed|1|||
161908967|NCT01898078|584719211|FG000|Overall Study|Progressive Disease|1|||
161908968|NCT01898078|584719212|FG001|Overall Study|Progressive Disease|5|||
161908969|NCT01898078|584719211|FG000|Overall Study|Adverse Event|2|||
161908970|NCT01898078|584719212|FG001|Overall Study|Adverse Event|1|||
161908971|NCT01898078|584719211|FG000|Overall Study|Withdrawal by Subject|1|||
161908972|NCT01898078|584719212|FG001|Overall Study|Withdrawal by Subject|1|||
161908973|NCT01898078|584719211|FG000|Overall Study|Symptomatic Deterioration|2|||
161908974|NCT01898078|584719212|FG001|Overall Study|Symptomatic Deterioration|0|||
161908975|NCT01898078|584719211|FG000|Overall Study|Reason not Specified|0|||
161908976|NCT01898078|584719212|FG001|Overall Study|Reason not Specified|1|||
161908977|NCT03630393|584719219|FG000|Overall Study|Death|1|||
161908978|NCT03630393|584719220|FG001|Overall Study|Death|0|||
161908979|NCT00900562|584719229|FG000|Overall Study|Progressive disease|9|||
161908980|NCT00900562|584719230|FG001|Overall Study|Progressive disease|5|||
161908981|NCT00900562|584719229|FG000|Overall Study|Toxicity|1|||
161908982|NCT00900562|584719230|FG001|Overall Study|Toxicity|0|||
161908983|NCT00900562|584719229|FG000|Overall Study|Death|1|||
161908984|NCT00900562|584719230|FG001|Overall Study|Death|1|||
161908985|NCT00900562|584719229|FG000|Overall Study|Withdrawal by Subject|0|||
161908986|NCT00900562|584719230|FG001|Overall Study|Withdrawal by Subject|1|||
161908987|NCT00900562|584719229|FG000|Overall Study|Unrelated adverse event|1|||
161908988|NCT00900562|584719230|FG001|Overall Study|Unrelated adverse event|0|||
161908989|NCT01483118|584719242|FG000|Overall Study|Lost to Follow-up|12|||
161908990|NCT01483118|584719243|FG001|Overall Study|Lost to Follow-up|16|||
161908991|NCT01079780|584719245|FG000|Overall Study|Disease progression|43|||
161908992|NCT01079780|584719246|FG001|Overall Study|Disease progression|7|||
161908993|NCT01079780|584719247|FG002|Overall Study|Disease progression|31|||
161908994|NCT01079780|584719245|FG000|Overall Study|Adverse Event|13|||
161908995|NCT01079780|584719246|FG001|Overall Study|Adverse Event|5|||
161908996|NCT01079780|584719247|FG002|Overall Study|Adverse Event|7|||
161908997|NCT01079780|584719245|FG000|Overall Study|Death|2|||
161908998|NCT01079780|584719246|FG001|Overall Study|Death|0|||
161908999|NCT01079780|584719247|FG002|Overall Study|Death|2|||
161909000|NCT01079780|584719245|FG000|Overall Study|Withdrawal by Subject|6|||
161909001|NCT01079780|584719246|FG001|Overall Study|Withdrawal by Subject|4|||
161909002|NCT01079780|584719247|FG002|Overall Study|Withdrawal by Subject|4|||
161909003|NCT01079780|584719245|FG000|Overall Study|Alternative therapy|2|||
161909004|NCT01079780|584719246|FG001|Overall Study|Alternative therapy|0|||
161909005|NCT01079780|584719247|FG002|Overall Study|Alternative therapy|2|||
161909006|NCT01079780|584719245|FG000|Overall Study|Physician Decision|1|||
161909007|NCT01079780|584719246|FG001|Overall Study|Physician Decision|0|||
161909008|NCT01079780|584719247|FG002|Overall Study|Physician Decision|1|||
161909009|NCT01079780|584719245|FG000|Overall Study|Error made in lesion measurement|1|||
161909010|NCT01079780|584719246|FG001|Overall Study|Error made in lesion measurement|0|||
161909011|NCT01079780|584719247|FG002|Overall Study|Error made in lesion measurement|0|||
161909012|NCT01079780|584719245|FG000|Overall Study|Patient had surgery|1|||
161909013|NCT01079780|584719246|FG001|Overall Study|Patient had surgery|0|||
161909014|NCT01079780|584719247|FG002|Overall Study|Patient had surgery|0|||
161909015|NCT01079780|584719245|FG000|Overall Study|Treatment cycle delay|0|||
161909016|NCT01079780|584719246|FG001|Overall Study|Treatment cycle delay|0|||
161909017|NCT01079780|584719247|FG002|Overall Study|Treatment cycle delay|1|||
161909018|NCT01079780|584719245|FG000|Overall Study|Never started treatment|1|||
161909019|NCT01079780|584719246|FG001|Overall Study|Never started treatment|0|||
161909020|NCT01079780|584719247|FG002|Overall Study|Never started treatment|2|||
161909021|NCT01178294|584719248|FG000|Overall Study|Adverse Event|4|||
161909022|NCT01178294|584719248|FG000|Overall Study|Lost to Follow-up|2|||
161909023|NCT01178294|584719248|FG000|Overall Study|Lack of Efficacy|1|||
161909024|NCT01178294|584719248|FG000|Overall Study|Death|1|||
161909025|NCT01178294|584719248|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
161909026|NCT01178294|584719248|FG000|Overall Study|Subject status is terminal|1|||
161909027|NCT01178294|584719248|FG000|Overall Study|Completion status could not be verified|1|||
161909028|NCT02783066|584719249|FG000|Overall Study|Withdrawal by Subject|13|||
161909029|NCT00551369|584719250|FG000|Overall Study|Protocol Violation|5|||
161909030|NCT00551369|584719250|FG000|Overall Study|Withdrawal by Subject|1|||
161909031|NCT00551369|584719250|FG000|Overall Study|Not treated per protocol and re|1|||
161909032|NCT01663623|584719253|FG000|Overall Study|Adverse Event|3|||
161909033|NCT01663623|584719254|FG001|Overall Study|Adverse Event|7|||
161909034|NCT01663623|584719253|FG000|Overall Study|Lack of Efficacy|5|||
161909035|NCT01663623|584719254|FG001|Overall Study|Lack of Efficacy|6|||
161909036|NCT01663623|584719253|FG000|Overall Study|Protocol Violation|0|||
161909037|NCT01663623|584719254|FG001|Overall Study|Protocol Violation|1|||
161909038|NCT01663623|584719253|FG000|Overall Study|Other-Study closed/terminated|1|||
161909039|NCT01663623|584719254|FG001|Overall Study|Other-Study closed/terminated|1|||
161909040|NCT01663623|584719253|FG000|Overall Study|Physician Decision|1|||
161909041|NCT01663623|584719254|FG001|Overall Study|Physician Decision|4|||
161909042|NCT01663623|584719253|FG000|Overall Study|Withdrawal by Subject|2|||
161909043|NCT01663623|584719254|FG001|Overall Study|Withdrawal by Subject|1|||
161909044|NCT02251275|584719255|FG000|Overall Study|Adverse Event|23|||
161909045|NCT02251275|584719256|FG001|Overall Study|Adverse Event|60|||
161909046|NCT02251275|584719257|FG002|Overall Study|Adverse Event|28|||
161909047|NCT02251275|584719258|FG003|Overall Study|Adverse Event|0|||
161909048|NCT02251275|584719259|FG004|Overall Study|Adverse Event|0|||
161909049|NCT02251275|584719255|FG000|Overall Study|Lost to Follow-up|5|||
161909050|NCT02251275|584719256|FG001|Overall Study|Lost to Follow-up|6|||
161909051|NCT02251275|584719257|FG002|Overall Study|Lost to Follow-up|4|||
161909052|NCT02251275|584719258|FG003|Overall Study|Lost to Follow-up|0|||
161909053|NCT02251275|584719259|FG004|Overall Study|Lost to Follow-up|0|||
161909054|NCT02251275|584719255|FG000|Overall Study|Physician Decision|19|||
161909055|NCT02251275|584719256|FG001|Overall Study|Physician Decision|30|||
161909056|NCT02251275|584719257|FG002|Overall Study|Physician Decision|26|||
161909057|NCT02251275|584719258|FG003|Overall Study|Physician Decision|0|||
161909058|NCT02251275|584719259|FG004|Overall Study|Physician Decision|1|||
161909059|NCT02251275|584719255|FG000|Overall Study|Protocol Deviation|0|||
161909060|NCT02251275|584719256|FG001|Overall Study|Protocol Deviation|0|||
161909061|NCT02251275|584719257|FG002|Overall Study|Protocol Deviation|1|||
161909062|NCT02251275|584719258|FG003|Overall Study|Protocol Deviation|0|||
161909063|NCT02251275|584719259|FG004|Overall Study|Protocol Deviation|0|||
161909064|NCT02251275|584719255|FG000|Overall Study|Withdrawal by Subject|25|||
161909065|NCT02251275|584719256|FG001|Overall Study|Withdrawal by Subject|51|||
161909066|NCT02251275|584719257|FG002|Overall Study|Withdrawal by Subject|35|||
161909067|NCT02251275|584719258|FG003|Overall Study|Withdrawal by Subject|1|||
161909068|NCT02251275|584719259|FG004|Overall Study|Withdrawal by Subject|0|||
161909069|NCT01004614|584719263|FG000|Washout|Withdrawal by Subject|0|||
161909070|NCT01004614|584719264|FG001|Washout|Withdrawal by Subject|1|||
161909071|NCT01004614|584719265|FG002|Washout|Withdrawal by Subject|0|||
161909072|NCT01004614|584719266|FG003|Washout|Withdrawal by Subject|0|||
161909073|NCT01569022|584719268|FG000|First Intervention|Lost to Follow-up|2|||
161909074|NCT01569022|584719269|FG001|First Intervention|Lost to Follow-up|1|||
161909075|NCT01569022|584719268|FG000|Second Intervention|Lost to Follow-up|2|||
161909076|NCT01569022|584719269|FG001|Second Intervention|Lost to Follow-up|2|||
161909077|NCT02111083|584719274|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
161909078|NCT02111083|584719275|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
161909079|NCT00644059|584719276|FG000|Overall Study|Lost to Follow-up|37|||
161909080|NCT00644059|584719277|FG001|Overall Study|Lost to Follow-up|34|||
161909081|NCT00644059|584719278|FG002|Overall Study|Lost to Follow-up|16|||
161909082|NCT00644059|584719276|FG000|Overall Study|Withdrawal by Subject|52|||
161909083|NCT00644059|584719277|FG001|Overall Study|Withdrawal by Subject|60|||
161909084|NCT00644059|584719278|FG002|Overall Study|Withdrawal by Subject|30|||
161909085|NCT00644059|584719276|FG000|Overall Study|Adverse Event|8|||
161909086|NCT00644059|584719277|FG001|Overall Study|Adverse Event|5|||
161909087|NCT00644059|584719278|FG002|Overall Study|Adverse Event|1|||
161909088|NCT00644059|584719276|FG000|Overall Study|Inappropriate Enrollment|1|||
161909089|NCT00644059|584719277|FG001|Overall Study|Inappropriate Enrollment|3|||
161909090|NCT00644059|584719278|FG002|Overall Study|Inappropriate Enrollment|0|||
161909091|NCT00644059|584719276|FG000|Overall Study|Protocol Deviation/violation|20|||
161909092|NCT00644059|584719277|FG001|Overall Study|Protocol Deviation/violation|19|||
161909093|NCT00644059|584719278|FG002|Overall Study|Protocol Deviation/violation|15|||
161909094|NCT00644059|584719276|FG000|Overall Study|Unable to classify|6|||
161909095|NCT00644059|584719277|FG001|Overall Study|Unable to classify|2|||
161909096|NCT00644059|584719278|FG002|Overall Study|Unable to classify|3|||
161909097|NCT01302899|584719279|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
161909098|NCT01302899|584719280|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
161909099|NCT01302899|584719279|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
161909100|NCT01302899|584719280|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
161909101|NCT02834975|584719281|FG000|Overall Study|Physician Decision|2|||
161909102|NCT02834975|584719281|FG000|Overall Study|Adverse Event|1|||
161909103|NCT02834975|584719281|FG000|Overall Study|Withdrawal by Subject|1|||
161909104|NCT02834975|584719281|FG000|Overall Study|Lack of Efficacy|1|||
161909105|NCT02497469|584719283|FG000|Overall Study|Randomized but not Treated|0|||
161909106|NCT02497469|584719284|FG001|Overall Study|Randomized but not Treated|2|||
161909107|NCT02497469|584719283|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
161909108|NCT02497469|584719284|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
161909109|NCT02497469|584719283|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
161909110|NCT02497469|584719284|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
161909111|NCT02497469|584719283|FG000|Overall Study|Significant Protocol Deviation|4|||
161909112|NCT02497469|584719284|FG001|Overall Study|Significant Protocol Deviation|5|||
161909113|NCT02497469|584719283|FG000|Overall Study|Lost to Follow-up|14|||
161909114|NCT02497469|584719284|FG001|Overall Study|Lost to Follow-up|4|||
161909115|NCT02497469|584719283|FG000|Overall Study|Voluntary Withdrawal|39|||
161909116|NCT02497469|584719284|FG001|Overall Study|Voluntary Withdrawal|41|||
161909117|NCT02497469|584719283|FG000|Overall Study|Pregnancy|1|||
161909118|NCT02497469|584719284|FG001|Overall Study|Pregnancy|1|||
161909119|NCT02497469|584719283|FG000|Overall Study|Lack of Efficacy|86|||
161909120|NCT02497469|584719284|FG001|Overall Study|Lack of Efficacy|40|||
161909121|NCT02497469|584719283|FG000|Overall Study|Reason not Specified|6|||
161909122|NCT02497469|584719284|FG001|Overall Study|Reason not Specified|6|||
161909123|NCT03558516|584719285|FG000|Overall Study|Protocol Violation|2|||
161909124|NCT03558516|584719286|FG001|Overall Study|Protocol Violation|2|||
161909125|NCT02714153|584719287|FG000|Overall Study|Death|1|||
161909126|NCT02737722|584719290|FG000|Overall Study|Physician Decision|0|||
161909127|NCT02737722|584719291|FG001|Overall Study|Physician Decision|0|||
161909128|NCT02737722|584719292|FG002|Overall Study|Physician Decision|1|||
161909129|NCT02737722|584719293|FG003|Overall Study|Physician Decision|0|||
161909130|NCT01603277|584719294|FG000|Overall Study|Adverse Event|1|||
161909131|NCT01603277|584719295|FG001|Overall Study|Adverse Event|2|||
161909132|NCT01603277|584719294|FG000|Overall Study|Physician Decision|0|||
161909133|NCT01603277|584719295|FG001|Overall Study|Physician Decision|1|||
161909134|NCT01603277|584719294|FG000|Overall Study|Protocol Violation|6|||
161909135|NCT01603277|584719295|FG001|Overall Study|Protocol Violation|10|||
161909136|NCT01603277|584719294|FG000|Overall Study|Withdrawal by Subject|5|||
161909137|NCT01603277|584719295|FG001|Overall Study|Withdrawal by Subject|4|||
161909138|NCT01603277|584719294|FG000|Overall Study|Non-Compliance|2|||
161909139|NCT01603277|584719295|FG001|Overall Study|Non-Compliance|1|||
161909140|NCT02785939|584719301|FG000|Overall Study|Progression|25|||
161909141|NCT02785939|584719302|FG001|Overall Study|Progression|8|||
161909142|NCT02785939|584719301|FG000|Overall Study|Adverse Event|3|||
161909143|NCT02785939|584719302|FG001|Overall Study|Adverse Event|1|||
162140293|NCT04304534|585565598|FG003|Overall Study|Death|3|||
161909144|NCT02785939|584719301|FG000|Overall Study|Death|1|||
161909145|NCT02785939|584719302|FG001|Overall Study|Death|0|||
161909146|NCT02785939|584719301|FG000|Overall Study|Refusal|1|||
161909147|NCT02785939|584719302|FG001|Overall Study|Refusal|0|||
161909148|NCT02785939|584719301|FG000|Overall Study|Deteriorating health|1|||
161909149|NCT02785939|584719302|FG001|Overall Study|Deteriorating health|0|||
161909150|NCT02785939|584719301|FG000|Overall Study|Not protocol specified|0|||
161909151|NCT02785939|584719302|FG001|Overall Study|Not protocol specified|1|||
161909152|NCT04465422|584719303|FG000|Overall Study|Lost to Follow-up|0|||
161805588|NCT00463606|584331799|FG002|Overall Study|Physician Decision|0|||
161805589|NCT00463606|584331797|FG000|Overall Study|Sponsor request|0|||
161805590|NCT00463606|584331798|FG001|Overall Study|Sponsor request|1|||
161805591|NCT00463606|584331799|FG002|Overall Study|Sponsor request|0|||
161805592|NCT00463606|584331797|FG000|Overall Study|Exclusion criteria violation|2|||
161805593|NCT00463606|584331798|FG001|Overall Study|Exclusion criteria violation|0|||
161805594|NCT00463606|584331799|FG002|Overall Study|Exclusion criteria violation|0|||
161805595|NCT00463606|584331797|FG000|Overall Study|Coordinator error|1|||
161805596|NCT00463606|584331798|FG001|Overall Study|Coordinator error|0|||
161805597|NCT00463606|584331799|FG002|Overall Study|Coordinator error|0|||
161805598|NCT00463606|584331797|FG000|Overall Study|Patient randomized in error|1|||
161805599|NCT00463606|584331798|FG001|Overall Study|Patient randomized in error|0|||
161805600|NCT00463606|584331799|FG002|Overall Study|Patient randomized in error|0|||
161805601|NCT00463606|584331797|FG000|Overall Study|Participation in another ABT-335 trial|1|||
161805602|NCT00463606|584331798|FG001|Overall Study|Participation in another ABT-335 trial|0|||
161805603|NCT00463606|584331799|FG002|Overall Study|Participation in another ABT-335 trial|0|||
161805604|NCT00463606|584331797|FG000|Overall Study|Protocol Violation|0|||
161805605|NCT00463606|584331798|FG001|Overall Study|Protocol Violation|0|||
161805606|NCT00463606|584331799|FG002|Overall Study|Protocol Violation|1|||
161805607|NCT02682602|584331801|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
161805608|NCT02682602|584331802|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
161805609|NCT02682602|584331801|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
161805610|NCT02682602|584331802|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
161805611|NCT03567174|584331803|FG000|Overall Study|Death|24|||
161805612|NCT03567174|584331804|FG001|Overall Study|Death|31|||
161805613|NCT03567174|584331803|FG000|Overall Study|Lost to Follow-up|165|||
161805614|NCT03567174|584331804|FG001|Overall Study|Lost to Follow-up|174|||
161805615|NCT02140060|584331805|FG000|Overall Study|Adverse Event|0|||
161805616|NCT02140060|584331806|FG001|Overall Study|Adverse Event|0|||
161805617|NCT02140060|584331807|FG002|Overall Study|Adverse Event|0|||
161805618|NCT02140060|584331808|FG003|Overall Study|Adverse Event|1|||
161805619|NCT02140060|584331809|FG004|Overall Study|Adverse Event|1|||
161805620|NCT02140060|584331810|FG005|Overall Study|Adverse Event|1|||
161805621|NCT02140060|584331805|FG000|Overall Study|Lack of Efficacy|0|||
161805622|NCT02140060|584331806|FG001|Overall Study|Lack of Efficacy|0|||
161805623|NCT02140060|584331807|FG002|Overall Study|Lack of Efficacy|0|||
161805624|NCT02140060|584331808|FG003|Overall Study|Lack of Efficacy|1|||
161805625|NCT02140060|584331809|FG004|Overall Study|Lack of Efficacy|0|||
161805626|NCT02140060|584331810|FG005|Overall Study|Lack of Efficacy|0|||
161805627|NCT01066143|584333804|FG000|Overall Study|ineligible for the study|8|||
161805628|NCT05376319|584333805|FG000|Overall Study|Funding termination|2|||
161805629|NCT05376319|584333806|FG001|Overall Study|Funding termination|4|||
161805630|NCT01340495|584333807|FG000|Overall Study|Withdrawal by Subject|1|||
161805631|NCT03497897|584333808|FG000|Overall Study|Adverse Event|1|||
161805632|NCT03497897|584333809|FG001|Overall Study|Adverse Event|1|||
161805633|NCT03497897|584333810|FG002|Overall Study|Adverse Event|1|||
161805634|NCT03497897|584333808|FG000|Overall Study|Lost to Follow-up|2|||
161805635|NCT03497897|584333809|FG001|Overall Study|Lost to Follow-up|0|||
161805636|NCT03497897|584333810|FG002|Overall Study|Lost to Follow-up|2|||
161805637|NCT03497897|584333808|FG000|Overall Study|Physician Decision|1|||
161805638|NCT03497897|584333809|FG001|Overall Study|Physician Decision|0|||
161805639|NCT03497897|584333810|FG002|Overall Study|Physician Decision|0|||
161805640|NCT03497897|584333808|FG000|Overall Study|Subject/Guardian Decision|2|||
161805641|NCT03497897|584333809|FG001|Overall Study|Subject/Guardian Decision|1|||
161805642|NCT03497897|584333810|FG002|Overall Study|Subject/Guardian Decision|3|||
161805643|NCT00723528|584333811|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
161805644|NCT00723528|584333812|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
161805645|NCT00723528|584333813|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
161805646|NCT00723528|584333814|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
161805647|NCT00723528|584333815|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
161805648|NCT00723528|584333816|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
161805649|NCT00723528|584333817|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
161805650|NCT00723528|584333811|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
161805651|NCT00723528|584333812|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161805652|NCT00723528|584333813|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161805653|NCT00723528|584333814|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161805654|NCT00723528|584333815|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161805655|NCT00723528|584333816|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161909153|NCT04465422|584719304|FG001|Overall Study|Lost to Follow-up|2|||
161909154|NCT01787552|584719305|FG000|Overall Study|Withdrawal by Subject|2|||
161909155|NCT01787552|584719306|FG001|Overall Study|Withdrawal by Subject|0|||
161909156|NCT01787552|584719307|FG002|Overall Study|Withdrawal by Subject|0|||
161909157|NCT01787552|584719308|FG003|Overall Study|Withdrawal by Subject|4|||
161909158|NCT01787552|584719305|FG000|Overall Study|Physician Decision|2|||
161909159|NCT01787552|584719306|FG001|Overall Study|Physician Decision|2|||
161909160|NCT01787552|584719307|FG002|Overall Study|Physician Decision|1|||
161909161|NCT01787552|584719308|FG003|Overall Study|Physician Decision|2|||
161909162|NCT01787552|584719305|FG000|Overall Study|Death|0|||
161909163|NCT01787552|584719306|FG001|Overall Study|Death|0|||
161909164|NCT01787552|584719307|FG002|Overall Study|Death|0|||
161909165|NCT01787552|584719308|FG003|Overall Study|Death|1|||
161909166|NCT01787552|584719305|FG000|Overall Study|Adverse Event|2|||
161909167|NCT01787552|584719306|FG001|Overall Study|Adverse Event|5|||
161909168|NCT01787552|584719307|FG002|Overall Study|Adverse Event|2|||
161909169|NCT01787552|584719308|FG003|Overall Study|Adverse Event|16|||
161909170|NCT01787552|584719305|FG000|Overall Study|Study terminated by Sponsor|0|||
161909171|NCT01787552|584719306|FG001|Overall Study|Study terminated by Sponsor|0|||
161909172|NCT01787552|584719307|FG002|Overall Study|Study terminated by Sponsor|1|||
161909173|NCT01787552|584719308|FG003|Overall Study|Study terminated by Sponsor|3|||
161909174|NCT01787552|584719305|FG000|Overall Study|Progressive Disease|2|||
161909175|NCT01787552|584719306|FG001|Overall Study|Progressive Disease|2|||
161909176|NCT01787552|584719307|FG002|Overall Study|Progressive Disease|1|||
161909177|NCT01787552|584719308|FG003|Overall Study|Progressive Disease|1|||
161909178|NCT01604785|584719313|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
161909179|NCT01604785|584719314|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
161909180|NCT00931632|584719317|FG000|Overall Study|Withdrawal by Subject|2|||
161909181|NCT00931632|584719318|FG001|Overall Study|Withdrawal by Subject|3|||
161909182|NCT00931632|584719317|FG000|Overall Study|Adverse Event|19|||
161909183|NCT00931632|584719318|FG001|Overall Study|Adverse Event|15|||
161909184|NCT01419314|584719319|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
161909185|NCT01419314|584719320|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
161909186|NCT01419314|584719319|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
161909187|NCT01419314|584719320|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
161909188|NCT01419314|584719319|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
161909189|NCT01419314|584719320|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
161909190|NCT01118052|584719325|FG000|Overall Study|Never treated|2|||
161909191|NCT00843492|584719326|FG000|Overall Study|Adverse Event|0|||
161909192|NCT00843492|584719327|FG001|Overall Study|Adverse Event|3|||
161909193|NCT00843492|584719326|FG000|Overall Study|Lost to Follow-up|4|||
161909194|NCT00843492|584719327|FG001|Overall Study|Lost to Follow-up|4|||
161909195|NCT00843492|584719326|FG000|Overall Study|Withdrawal by Subject|0|||
161909196|NCT00843492|584719327|FG001|Overall Study|Withdrawal by Subject|4|||
161909197|NCT00843492|584719326|FG000|Overall Study|Immobilization Stopped|1|||
161909198|NCT00843492|584719327|FG001|Overall Study|Immobilization Stopped|0|||
161909199|NCT00843492|584719326|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
161909200|NCT00843492|584719327|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
161909201|NCT00843492|584719326|FG000|Overall Study|Orthopedic Surgery|0|||
161909202|NCT00843492|584719327|FG001|Overall Study|Orthopedic Surgery|2|||
161909203|NCT00843492|584719326|FG000|Overall Study|Visit Not Performed|1|||
161909204|NCT00843492|584719327|FG001|Overall Study|Visit Not Performed|0|||
161909205|NCT00843492|584719326|FG000|Overall Study|Deep-vein Thrombosis|1|||
161909206|NCT00843492|584719327|FG001|Overall Study|Deep-vein Thrombosis|0|||
161909207|NCT01677741|584719328|FG000|Overall Study|Death|0|||
161909208|NCT01677741|584719329|FG001|Overall Study|Death|0|||
161909209|NCT01677741|584719330|FG002|Overall Study|Death|0|||
161909210|NCT01677741|584719331|FG003|Overall Study|Death|1|||
161909211|NCT01677741|584719332|FG004|Overall Study|Death|0|||
162140294|NCT04304534|585565595|FG000|Overall Study|Withdrawal by Subject|7|||
162140295|NCT04304534|585565596|FG001|Overall Study|Withdrawal by Subject|2|||
162140296|NCT04304534|585565597|FG002|Overall Study|Withdrawal by Subject|7|||
162140297|NCT04304534|585565598|FG003|Overall Study|Withdrawal by Subject|4|||
162140298|NCT04304534|585565595|FG000|Overall Study|Physician Decision|4|||
162140299|NCT04304534|585565596|FG001|Overall Study|Physician Decision|9|||
162140300|NCT04304534|585565597|FG002|Overall Study|Physician Decision|9|||
162140301|NCT04304534|585565598|FG003|Overall Study|Physician Decision|5|||
162140302|NCT04304534|585565595|FG000|Overall Study|Subject Decision|34|||
162140303|NCT04304534|585565596|FG001|Overall Study|Subject Decision|25|||
162140304|NCT04304534|585565597|FG002|Overall Study|Subject Decision|25|||
161909212|NCT01677741|584719333|FG005|Overall Study|Death|1|||
161909213|NCT01677741|584719334|FG006|Overall Study|Death|0|||
161909214|NCT01677741|584719335|FG007|Overall Study|Death|0|||
161909215|NCT01677741|584719328|FG000|Overall Study|Withdrawal by Subject|2|||
161909216|NCT01677741|584719329|FG001|Overall Study|Withdrawal by Subject|7|||
161909217|NCT01677741|584719330|FG002|Overall Study|Withdrawal by Subject|5|||
161909218|NCT01677741|584719331|FG003|Overall Study|Withdrawal by Subject|4|||
161909219|NCT01677741|584719332|FG004|Overall Study|Withdrawal by Subject|11|||
161909220|NCT01677741|584719333|FG005|Overall Study|Withdrawal by Subject|20|||
161909221|NCT01677741|584719334|FG006|Overall Study|Withdrawal by Subject|4|||
161909222|NCT01677741|584719335|FG007|Overall Study|Withdrawal by Subject|2|||
161909223|NCT01677741|584719328|FG000|Overall Study|Enrolled in a rollover study|0|||
161909224|NCT01677741|584719329|FG001|Overall Study|Enrolled in a rollover study|3|||
161909225|NCT01677741|584719330|FG002|Overall Study|Enrolled in a rollover study|2|||
161909226|NCT01677741|584719331|FG003|Overall Study|Enrolled in a rollover study|1|||
161909227|NCT01677741|584719332|FG004|Overall Study|Enrolled in a rollover study|6|||
161909228|NCT01677741|584719333|FG005|Overall Study|Enrolled in a rollover study|6|||
161909229|NCT01677741|584719334|FG006|Overall Study|Enrolled in a rollover study|7|||
161909230|NCT01677741|584719335|FG007|Overall Study|Enrolled in a rollover study|0|||
161909231|NCT01677741|584719328|FG000|Overall Study|Progressive disease|1|||
161909232|NCT01677741|584719329|FG001|Overall Study|Progressive disease|0|||
161909233|NCT01677741|584719330|FG002|Overall Study|Progressive disease|1|||
161909234|NCT01677741|584719331|FG003|Overall Study|Progressive disease|0|||
161909235|NCT01677741|584719332|FG004|Overall Study|Progressive disease|0|||
161909236|NCT01677741|584719333|FG005|Overall Study|Progressive disease|1|||
161909237|NCT01677741|584719334|FG006|Overall Study|Progressive disease|0|||
161909238|NCT01677741|584719335|FG007|Overall Study|Progressive disease|0|||
161909239|NCT00721799|584719338|FG000|Overall Study|Withdrawal by Subject|7|||
161909240|NCT00721799|584719338|FG000|Overall Study|withdraw by subject after scan 1|1|||
161909241|NCT01441973|584719339|FG000|Overall Study|Disease progression|8|||
161909242|NCT01441973|584719340|FG001|Overall Study|Disease progression|6|||
161909243|NCT01441973|584719339|FG000|Overall Study|Adverse event unrelated to study drug|3|||
161909244|NCT01441973|584719340|FG001|Overall Study|Adverse event unrelated to study drug|2|||
161909245|NCT01441973|584719339|FG000|Overall Study|Participant request to discontinue|1|||
161909246|NCT01441973|584719340|FG001|Overall Study|Participant request to discontinue|1|||
161909247|NCT01441973|584719339|FG000|Overall Study|Poor compliance/noncompliance|0|||
161909248|NCT01441973|584719340|FG001|Overall Study|Poor compliance/noncompliance|1|||
161909249|NCT01441973|584719339|FG000|Overall Study|Administrative reason by sponsor|3|||
161909250|NCT01441973|584719340|FG001|Overall Study|Administrative reason by sponsor|5|||
161909251|NCT01441973|584719339|FG000|Overall Study|Participant withdrew consent|0|||
161909252|NCT01441973|584719340|FG001|Overall Study|Participant withdrew consent|1|||
161909253|NCT00941928|584721346|FG000|Overall Study|Withdrawal by Subject|1|||
161909254|NCT00941928|584721346|FG000|Overall Study|Disease Progression|1|||
161909255|NCT02300610|584721347|FG000|Overall Study|Withdrawal by Subject|1|||
161909256|NCT02300610|584721348|FG001|Overall Study|Withdrawal by Subject|0|||
161909257|NCT02300610|584721349|FG002|Overall Study|Withdrawal by Subject|1|||
161909258|NCT00095979|584721350|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
161909259|NCT02051296|584721357|FG000|Overall Study|Lost to Follow-up|1|||
161909260|NCT02051296|584721358|FG001|Overall Study|Lost to Follow-up|2|||
161909261|NCT02051296|584721357|FG000|Overall Study|withdraw prior to treatment|7|||
161909262|NCT02051296|584721358|FG001|Overall Study|withdraw prior to treatment|7|||
161909263|NCT02133508|584721359|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
161909264|NCT02133508|584721359|FG000|Overall Study|Death|12|||
161909265|NCT02133508|584721359|FG000|Overall Study|Lost to Follow-up|2|||
161909266|NCT02152007|584721360|FG000|Overall Study|Withdrawal by Subject|1|||
161909267|NCT03363906|584721369|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
161909268|NCT03363906|584721370|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
161909269|NCT03363906|584721369|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
161909270|NCT03363906|584721370|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
161909271|NCT03363906|584721369|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
161909272|NCT03363906|584721370|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
161909273|NCT03363906|584721369|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
161909274|NCT03363906|584721370|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
161909275|NCT00676143|584721371|FG000|Overall Study|Adverse Event|34|||
161909276|NCT00676143|584721372|FG001|Overall Study|Adverse Event|60|||
161909277|NCT00676143|584721371|FG000|Overall Study|Death|4|||
161909278|NCT00676143|584721372|FG001|Overall Study|Death|4|||
161909279|NCT00676143|584721371|FG000|Overall Study|Lack of Efficacy|0|||
161909280|NCT00676143|584721372|FG001|Overall Study|Lack of Efficacy|6|||
161909281|NCT00676143|584721371|FG000|Overall Study|Lost to Follow-up|0|||
161909282|NCT00676143|584721372|FG001|Overall Study|Lost to Follow-up|13|||
161909283|NCT00676143|584721371|FG000|Overall Study|Physician Decision|5|||
161909284|NCT00676143|584721372|FG001|Overall Study|Physician Decision|8|||
161909285|NCT00676143|584721371|FG000|Overall Study|Protocol Violation|4|||
161909286|NCT00676143|584721372|FG001|Overall Study|Protocol Violation|8|||
161909287|NCT00676143|584721371|FG000|Overall Study|Withdrawal by Subject|24|||
161909288|NCT00676143|584721372|FG001|Overall Study|Withdrawal by Subject|42|||
161909289|NCT00676143|584721371|FG000|Overall Study|Discontinuation of study by sponsor|65|||
161909290|NCT00676143|584721372|FG001|Overall Study|Discontinuation of study by sponsor|88|||
161909291|NCT00676143|584721371|FG000|Overall Study|Failed to return|2|||
161909292|NCT00676143|584721372|FG001|Overall Study|Failed to return|1|||
161909293|NCT00676143|584721371|FG000|Overall Study|Loss of caregiver|5|||
162140305|NCT04304534|585565598|FG003|Overall Study|Subject Decision|26|||
161909294|NCT00676143|584721372|FG001|Overall Study|Loss of caregiver|3|||
161909295|NCT00676143|584721371|FG000|Overall Study|Other|11|||
161909296|NCT00676143|584721372|FG001|Overall Study|Other|20|||
161909297|NCT00676143|584721371|FG000|Overall Study|Participant participation unknown|1|||
161909298|NCT00676143|584721372|FG001|Overall Study|Participant participation unknown|4|||
161909299|NCT00676143|584721371|FG000|Overall Study|Vasogenic edema recurrence|1|||
161909300|NCT00676143|584721372|FG001|Overall Study|Vasogenic edema recurrence|3|||
161909301|NCT00929669|584721373|FG000|Overall Study|elevated glucose levels|1|||
161909302|NCT00472420|584721374|FG000|Induction Treatment Period|Physician Decision|9|||
161909303|NCT00472420|584721374|FG000|Induction Treatment Period|Adverse Event|3|||
161909304|NCT00472420|584721374|FG000|Induction Treatment Period|Non-compliance|1|||
161909305|NCT00472420|584721374|FG000|Induction Treatment Period|Death|3|||
161909306|NCT00472420|584721374|FG000|Follow-up Period|Death|5|||
161909307|NCT00472420|584721374|FG000|Follow-up Period|Physician Decision|9|||
161909308|NCT00472420|584721374|FG000|Follow-up Period|Lost to Follow-up|2|||
161909309|NCT00472420|584721374|FG000|Follow-up Period|Protocol Violation|1|||
161909310|NCT00686972|584721376|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
161909311|NCT01901185|584721377|FG000|Overall Study|Withdrawal by Subject|2|||
161909312|NCT02065557|584721380|FG000|Induction Period|Withdrawal by Subject|2|||
161909313|NCT02065557|584721381|FG001|Induction Period|Withdrawal by Subject|1|||
161909314|NCT02065557|584721382|FG002|Induction Period|Withdrawal by Subject|0|||
161909315|NCT02065557|584721383|FG003|Induction Period|Withdrawal by Subject|0|||
161909316|NCT02065557|584721384|FG004|Induction Period|Withdrawal by Subject|0|||
161909317|NCT02065557|584721385|FG005|Induction Period|Withdrawal by Subject|0|||
161909318|NCT02065557|584721380|FG000|Induction Period|Lack of Efficacy|2|||
161909319|NCT02065557|584721381|FG001|Induction Period|Lack of Efficacy|1|||
161909320|NCT02065557|584721382|FG002|Induction Period|Lack of Efficacy|1|||
161909321|NCT02065557|584721383|FG003|Induction Period|Lack of Efficacy|0|||
161909322|NCT02065557|584721384|FG004|Induction Period|Lack of Efficacy|0|||
161909323|NCT02065557|584721385|FG005|Induction Period|Lack of Efficacy|0|||
161909324|NCT02065557|584721380|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
161909325|NCT02065557|584721381|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
161909326|NCT02065557|584721382|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
161909327|NCT02065557|584721383|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
161909328|NCT02065557|584721384|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
161909329|NCT02065557|584721385|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
161909330|NCT02065557|584721380|FG000|Induction Period|Non-Responder at Week 8|4|||
161909331|NCT02065557|584721381|FG001|Induction Period|Non-Responder at Week 8|4|||
161909332|NCT02065557|584721382|FG002|Induction Period|Non-Responder at Week 8|0|||
161909333|NCT02065557|584721383|FG003|Induction Period|Non-Responder at Week 8|0|||
161909334|NCT02065557|584721384|FG004|Induction Period|Non-Responder at Week 8|0|||
161909335|NCT02065557|584721385|FG005|Induction Period|Non-Responder at Week 8|0|||
161909336|NCT02065557|584721380|FG000|Induction Period|Adverse Event|1|||
161909337|NCT02065557|584721381|FG001|Induction Period|Adverse Event|1|||
161909338|NCT02065557|584721382|FG002|Induction Period|Adverse Event|0|||
161909339|NCT02065557|584721383|FG003|Induction Period|Adverse Event|0|||
161909340|NCT02065557|584721384|FG004|Induction Period|Adverse Event|0|||
161909341|NCT02065557|584721385|FG005|Induction Period|Adverse Event|0|||
161909342|NCT02065557|584721380|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
161909343|NCT02065557|584721381|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
161909344|NCT02065557|584721382|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
161909345|NCT02065557|584721383|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
161909346|NCT02065557|584721384|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
161909347|NCT02065557|584721385|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
161909348|NCT02065557|584721380|FG000|Maintenance Period|Withdrawal by Subject|0|||
161909349|NCT02065557|584721381|FG001|Maintenance Period|Withdrawal by Subject|0|||
161909350|NCT02065557|584721382|FG002|Maintenance Period|Withdrawal by Subject|0|||
161909351|NCT02065557|584721383|FG003|Maintenance Period|Withdrawal by Subject|0|||
161909352|NCT02065557|584721384|FG004|Maintenance Period|Withdrawal by Subject|2|||
161909353|NCT02065557|584721385|FG005|Maintenance Period|Withdrawal by Subject|1|||
161909354|NCT02065557|584721380|FG000|Maintenance Period|Lack of Efficacy|0|||
161909355|NCT02065557|584721381|FG001|Maintenance Period|Lack of Efficacy|0|||
161909356|NCT02065557|584721382|FG002|Maintenance Period|Lack of Efficacy|0|||
161909357|NCT02065557|584721383|FG003|Maintenance Period|Lack of Efficacy|0|||
161909358|NCT02065557|584721384|FG004|Maintenance Period|Lack of Efficacy|5|||
161909359|NCT02065557|584721385|FG005|Maintenance Period|Lack of Efficacy|2|||
161909360|NCT02065557|584721380|FG000|Maintenance Period|Subject Non-Compliance|0|||
161805656|NCT00723528|584333817|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161805657|NCT00723528|584333811|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
161805658|NCT00723528|584333812|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
161805659|NCT00723528|584333813|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
161805660|NCT00723528|584333814|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
161805661|NCT00723528|584333815|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
161805662|NCT00723528|584333816|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
161805663|NCT00723528|584333817|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
161805664|NCT00723528|584333811|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161805665|NCT00723528|584333812|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161805666|NCT00723528|584333813|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
161805667|NCT00723528|584333814|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161805668|NCT00723528|584333815|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161805669|NCT00723528|584333816|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161805670|NCT00723528|584333817|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161805671|NCT00723528|584333811|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
161805672|NCT00723528|584333812|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161805673|NCT00723528|584333813|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
161805674|NCT00723528|584333814|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161805675|NCT00723528|584333815|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161805676|NCT00723528|584333816|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161805677|NCT00723528|584333817|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161805678|NCT00723528|584333811|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
161805679|NCT00723528|584333812|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
161805680|NCT00723528|584333813|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
161805681|NCT00723528|584333814|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
161805682|NCT00723528|584333815|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
161805683|NCT00723528|584333816|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
161805684|NCT00723528|584333817|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
161805685|NCT00723528|584333811|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161805686|NCT00723528|584333812|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161805687|NCT00723528|584333813|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161805688|NCT00723528|584333814|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161805689|NCT00723528|584333815|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161805690|NCT00723528|584333816|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
161805691|NCT00723528|584333817|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161805692|NCT00723528|584333811|FG000|Period 2: After Controlled Period|Other|0|||
161805693|NCT00723528|584333812|FG001|Period 2: After Controlled Period|Other|0|||
161805694|NCT00723528|584333813|FG002|Period 2: After Controlled Period|Other|0|||
161805695|NCT00723528|584333814|FG003|Period 2: After Controlled Period|Other|0|||
161805696|NCT00723528|584333815|FG004|Period 2: After Controlled Period|Other|1|||
161805697|NCT00723528|584333816|FG005|Period 2: After Controlled Period|Other|4|||
161805698|NCT00723528|584333817|FG006|Period 2: After Controlled Period|Other|0|||
161805699|NCT00723528|584333811|FG000|Period 2: After Controlled Period|Adverse Event|0|||
161805700|NCT00723528|584333812|FG001|Period 2: After Controlled Period|Adverse Event|0|||
161805701|NCT00723528|584333813|FG002|Period 2: After Controlled Period|Adverse Event|0|||
161805702|NCT00723528|584333814|FG003|Period 2: After Controlled Period|Adverse Event|0|||
161805703|NCT00723528|584333815|FG004|Period 2: After Controlled Period|Adverse Event|1|||
161805704|NCT00723528|584333816|FG005|Period 2: After Controlled Period|Adverse Event|0|||
161805705|NCT00723528|584333817|FG006|Period 2: After Controlled Period|Adverse Event|1|||
161805706|NCT00723528|584333811|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161805707|NCT00723528|584333812|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161805708|NCT00723528|584333813|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161805709|NCT00723528|584333814|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161805710|NCT00723528|584333815|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161805711|NCT00723528|584333816|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161805712|NCT00723528|584333817|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
161805713|NCT00723528|584333811|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161805714|NCT00723528|584333812|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161805715|NCT00723528|584333813|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161805716|NCT00723528|584333814|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161805717|NCT00723528|584333815|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161805718|NCT00723528|584333816|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161805719|NCT00723528|584333817|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
161805720|NCT00667862|584333819|FG000|Overall Study|Adverse Event|9|||
161805721|NCT00667862|584333819|FG000|Overall Study|Death|1|||
161805722|NCT00667862|584333819|FG000|Overall Study|Disease Progression|22|||
161805723|NCT00667862|584333819|FG000|Overall Study|Withdrawal by Subject|3|||
162140306|NCT04304534|585565595|FG000|Overall Study|Adverse Event|35|||
162140307|NCT04304534|585565596|FG001|Overall Study|Adverse Event|40|||
162140308|NCT04304534|585565597|FG002|Overall Study|Adverse Event|39|||
162140309|NCT04304534|585565598|FG003|Overall Study|Adverse Event|44|||
162140310|NCT04012853|585565599|FG000|Overall Study|Withdrawal by Subject|1|||
162140311|NCT04012853|585565600|FG001|Overall Study|Withdrawal by Subject|1|||
161805724|NCT00667095|584333823|FG000|Overall Study|Withdrawal by Subject|0|||
161805725|NCT00667095|584333824|FG001|Overall Study|Withdrawal by Subject|1|||
161805726|NCT01520909|584333825|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
161805727|NCT01520909|584333826|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
161805728|NCT01520909|584333827|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
161805729|NCT01520909|584333825|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
161805730|NCT01520909|584333826|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
161805731|NCT01520909|584333827|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
161805732|NCT01520909|584333825|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
161805733|NCT01520909|584333826|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
161805734|NCT01520909|584333827|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
161805735|NCT01520909|584333825|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
161805736|NCT01520909|584333826|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
161805737|NCT01520909|584333827|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
161805738|NCT01435265|584333829|FG000|Overall Study|Lost to Follow-up|0|||
161805739|NCT01435265|584333830|FG001|Overall Study|Lost to Follow-up|1|||
161805740|NCT01149473|584333831|FG000|First Intervention|Adverse Event|1|||
161805741|NCT01149473|584333832|FG001|First Intervention|Adverse Event|1|||
161805742|NCT01149473|584333831|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161805743|NCT01149473|584333832|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161805744|NCT02128997|584333833|FG000|Overall Study|Lost to Follow-up|6|||
161805745|NCT02128997|584333834|FG001|Overall Study|Lost to Follow-up|11|||
161805746|NCT00856388|584333844|FG000|Overall Study|Other|1|||
161805747|NCT05038293|584333845|FG000|Overall Study|device was not operating properly for one subject.|1|||
161805748|NCT05038293|584333846|FG001|Overall Study|device was not operating properly for one subject.|0|||
161805749|NCT05038293|584333845|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
161805750|NCT05038293|584333846|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
161805751|NCT01171989|584333848|FG000|Overall Study|Lost to Follow-up|0|||
161805752|NCT01171989|584333849|FG001|Overall Study|Lost to Follow-up|0|||
161805753|NCT01171989|584333850|FG002|Overall Study|Lost to Follow-up|1|||
161805754|NCT00418184|584333851|FG000|Double-blind Phase|Withdrawal by Subject|22|||
161805755|NCT00418184|584333852|FG001|Double-blind Phase|Withdrawal by Subject|9|||
161805756|NCT00418184|584333851|FG000|Double-blind Phase|Adverse Event|2|||
161805757|NCT00418184|584333852|FG001|Double-blind Phase|Adverse Event|1|||
161805758|NCT00418184|584333851|FG000|Double-blind Phase|Poor compliance|3|||
161805759|NCT00418184|584333852|FG001|Double-blind Phase|Poor compliance|1|||
161805760|NCT00620074|584333854|FG000|Overall Study|Adverse Event|1|||
161805761|NCT01247701|584333856|FG000|Overall Study|Death|2|||
161805762|NCT01247701|584333856|FG000|Overall Study|Relapsed|8|||
161805763|NCT04166630|584333857|FG000|Overall Study|Withdrawal by Subject|0|||
161805764|NCT04166630|584333858|FG001|Overall Study|Withdrawal by Subject|1|||
161805765|NCT02822235|584333859|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
161805766|NCT02822235|584333860|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
161805767|NCT02822235|584333859|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
161805768|NCT02822235|584333860|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
161805769|NCT02822235|584333859|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
161805770|NCT02822235|584333860|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
161805771|NCT02822235|584333859|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
161805772|NCT02822235|584333860|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
161805773|NCT02822235|584333859|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
161805774|NCT02822235|584333860|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
162140312|NCT04012853|585565599|FG000|Overall Study|Protocol Violation|1|||
162140313|NCT04012853|585565600|FG001|Overall Study|Protocol Violation|0|||
161805775|NCT02822235|584333859|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
161805776|NCT02822235|584333860|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
162140314|NCT04012853|585565599|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
161805777|NCT01038856|584333863|FG000|Overall Study|Adverse Event|2|||
161805778|NCT04638153|584333864|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162010926|NCT05523089|585096052|FG000|Overall Study|Lost to Follow-up|1|||
161805779|NCT04638153|584333865|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161805780|NCT04638153|584333866|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161805781|NCT04638153|584333864|FG000|Overall Study|Study terminated by sponsor|4|||
161805782|NCT04638153|584333865|FG001|Overall Study|Study terminated by sponsor|2|||
161805783|NCT04638153|584333866|FG002|Overall Study|Study terminated by sponsor|14|||
161805784|NCT01440283|584333867|FG000|Overall Study|Death|3|||
161805785|NCT01440283|584333867|FG000|Overall Study|Withdrawal by Subject|4|||
161805786|NCT01440283|584333867|FG000|Overall Study|Physician Decision|3|||
161805787|NCT01196052|584333868|FG000|Overall Study|Adverse Event|9|||
161805788|NCT01196052|584333868|FG000|Overall Study|Lost to Follow-up|1|||
161805789|NCT01196052|584333868|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
161805790|NCT01196052|584333868|FG000|Overall Study|Reason not Specified|5|||
161805791|NCT01196052|584333868|FG000|Overall Study|Withdrawal by Subject|6|||
161805792|NCT01389102|584333869|FG000|Overall Study|Adverse Event|1|||
161805793|NCT01389102|584333870|FG001|Overall Study|Adverse Event|3|||
161805794|NCT01389102|584333871|FG002|Overall Study|Adverse Event|2|||
161805795|NCT01389102|584333872|FG003|Overall Study|Adverse Event|2|||
161805796|NCT01389102|584333873|FG004|Overall Study|Adverse Event|2|||
161805797|NCT01389102|584333874|FG005|Overall Study|Adverse Event|2|||
161805798|NCT01389102|584333869|FG000|Overall Study|Hurricane Katrina|4|||
161805799|NCT01389102|584333870|FG001|Overall Study|Hurricane Katrina|2|||
161805800|NCT01389102|584333871|FG002|Overall Study|Hurricane Katrina|3|||
161805801|NCT01389102|584333872|FG003|Overall Study|Hurricane Katrina|0|||
161805802|NCT01389102|584333873|FG004|Overall Study|Hurricane Katrina|3|||
161805803|NCT01389102|584333874|FG005|Overall Study|Hurricane Katrina|1|||
161805804|NCT01389102|584333869|FG000|Overall Study|Lost to Follow-up|4|||
161805805|NCT01389102|584333870|FG001|Overall Study|Lost to Follow-up|1|||
161805806|NCT01389102|584333871|FG002|Overall Study|Lost to Follow-up|1|||
161805807|NCT01389102|584333872|FG003|Overall Study|Lost to Follow-up|2|||
161805808|NCT01389102|584333873|FG004|Overall Study|Lost to Follow-up|4|||
161805809|NCT01389102|584333874|FG005|Overall Study|Lost to Follow-up|1|||
161805810|NCT01389102|584333869|FG000|Overall Study|Protocol Violation|0|||
161805811|NCT01389102|584333870|FG001|Overall Study|Protocol Violation|0|||
161805812|NCT01389102|584333871|FG002|Overall Study|Protocol Violation|3|||
161805813|NCT01389102|584333872|FG003|Overall Study|Protocol Violation|0|||
161805814|NCT01389102|584333873|FG004|Overall Study|Protocol Violation|1|||
161805815|NCT01389102|584333874|FG005|Overall Study|Protocol Violation|1|||
161805816|NCT01389102|584333869|FG000|Overall Study|Withdrawal by Subject|7|||
161805817|NCT01389102|584333870|FG001|Overall Study|Withdrawal by Subject|4|||
161805818|NCT01389102|584333871|FG002|Overall Study|Withdrawal by Subject|9|||
161805819|NCT01389102|584333872|FG003|Overall Study|Withdrawal by Subject|2|||
161805820|NCT01389102|584333873|FG004|Overall Study|Withdrawal by Subject|3|||
161805821|NCT01389102|584333874|FG005|Overall Study|Withdrawal by Subject|3|||
161805822|NCT01389102|584333869|FG000|Overall Study|Subject Traveling Out of Country|0|||
161805823|NCT01389102|584333870|FG001|Overall Study|Subject Traveling Out of Country|0|||
161805824|NCT01389102|584333871|FG002|Overall Study|Subject Traveling Out of Country|0|||
161805825|NCT01389102|584333872|FG003|Overall Study|Subject Traveling Out of Country|1|||
161805826|NCT01389102|584333873|FG004|Overall Study|Subject Traveling Out of Country|0|||
161805827|NCT01389102|584333874|FG005|Overall Study|Subject Traveling Out of Country|0|||
161805828|NCT01389102|584333869|FG000|Overall Study|Subject Moved|2|||
161805829|NCT01389102|584333870|FG001|Overall Study|Subject Moved|0|||
161805830|NCT01389102|584333871|FG002|Overall Study|Subject Moved|1|||
161805831|NCT01389102|584333872|FG003|Overall Study|Subject Moved|0|||
161805832|NCT01389102|584333873|FG004|Overall Study|Subject Moved|0|||
161805833|NCT01389102|584333874|FG005|Overall Study|Subject Moved|0|||
161805834|NCT01389102|584333869|FG000|Overall Study|Unavailable due to husband's illness|0|||
161805835|NCT01389102|584333870|FG001|Overall Study|Unavailable due to husband's illness|1|||
161805836|NCT01389102|584333871|FG002|Overall Study|Unavailable due to husband's illness|0|||
161805837|NCT01389102|584333872|FG003|Overall Study|Unavailable due to husband's illness|0|||
161805838|NCT01389102|584333873|FG004|Overall Study|Unavailable due to husband's illness|0|||
161805839|NCT01389102|584333874|FG005|Overall Study|Unavailable due to husband's illness|0|||
161805840|NCT01389102|584333869|FG000|Overall Study|Investigator Judgement|0|||
161805841|NCT01389102|584333870|FG001|Overall Study|Investigator Judgement|1|||
161805842|NCT01389102|584333871|FG002|Overall Study|Investigator Judgement|0|||
161805843|NCT01389102|584333872|FG003|Overall Study|Investigator Judgement|0|||
161805844|NCT01389102|584333873|FG004|Overall Study|Investigator Judgement|0|||
161805845|NCT01389102|584333874|FG005|Overall Study|Investigator Judgement|0|||
161805846|NCT00050778|584333875|FG000|Overall Study|Adverse Event|13|||
161805847|NCT00050778|584333876|FG001|Overall Study|Adverse Event|3|||
161805848|NCT00050778|584333877|FG002|Overall Study|Adverse Event|2|||
161805849|NCT00050778|584333875|FG000|Overall Study|Death|0|||
161805850|NCT00050778|584333876|FG001|Overall Study|Death|1|||
161805851|NCT00050778|584333877|FG002|Overall Study|Death|1|||
161805852|NCT00050778|584333875|FG000|Overall Study|Lack of Efficacy|16|||
161805853|NCT00050778|584333876|FG001|Overall Study|Lack of Efficacy|2|||
161805854|NCT00050778|584333877|FG002|Overall Study|Lack of Efficacy|2|||
161805855|NCT00050778|584333875|FG000|Overall Study|Lost to Follow-up|0|||
161909361|NCT02065557|584721381|FG001|Maintenance Period|Subject Non-Compliance|0|||
161909362|NCT02065557|584721382|FG002|Maintenance Period|Subject Non-Compliance|0|||
161909363|NCT02065557|584721383|FG003|Maintenance Period|Subject Non-Compliance|0|||
161909364|NCT02065557|584721384|FG004|Maintenance Period|Subject Non-Compliance|0|||
161909365|NCT02065557|584721385|FG005|Maintenance Period|Subject Non-Compliance|1|||
161909366|NCT01462942|584721389|FG000|Overall Study|Adverse Event|7|||
161805856|NCT00050778|584333876|FG001|Overall Study|Lost to Follow-up|2|||
161909367|NCT01462942|584721390|FG001|Overall Study|Adverse Event|12|||
161909368|NCT01462942|584721391|FG002|Overall Study|Adverse Event|10|||
161909369|NCT01462942|584721392|FG003|Overall Study|Adverse Event|11|||
161909370|NCT01462942|584721393|FG004|Overall Study|Adverse Event|11|||
161909371|NCT01462942|584721389|FG000|Overall Study|Other, including COPD exacerbation|3|||
161909372|NCT01462942|584721390|FG001|Overall Study|Other, including COPD exacerbation|5|||
161909373|NCT01462942|584721391|FG002|Overall Study|Other, including COPD exacerbation|2|||
161909374|NCT01462942|584721392|FG003|Overall Study|Other, including COPD exacerbation|8|||
161909375|NCT01462942|584721393|FG004|Overall Study|Other, including COPD exacerbation|5|||
161909376|NCT01462942|584721389|FG000|Overall Study|Withdrawal by Subject|14|||
161909377|NCT01462942|584721390|FG001|Overall Study|Withdrawal by Subject|10|||
161805857|NCT00050778|584333877|FG002|Overall Study|Lost to Follow-up|4|||
161805858|NCT00050778|584333875|FG000|Overall Study|Physician Decision|3|||
161805859|NCT00050778|584333876|FG001|Overall Study|Physician Decision|0|||
161805860|NCT00050778|584333877|FG002|Overall Study|Physician Decision|2|||
161805861|NCT00050778|584333875|FG000|Overall Study|Protocol Violation|2|||
161805862|NCT00050778|584333876|FG001|Overall Study|Protocol Violation|0|||
161805863|NCT00050778|584333877|FG002|Overall Study|Protocol Violation|1|||
161805864|NCT00050778|584333875|FG000|Overall Study|Withdrawal by Subject|6|||
161805865|NCT00050778|584333876|FG001|Overall Study|Withdrawal by Subject|8|||
161805866|NCT00050778|584333877|FG002|Overall Study|Withdrawal by Subject|4|||
161805867|NCT00050778|584333875|FG000|Overall Study|Randomized but not treated|4|||
161805868|NCT00050778|584333876|FG001|Overall Study|Randomized but not treated|5|||
161805869|NCT00050778|584333877|FG002|Overall Study|Randomized but not treated|2|||
161805870|NCT00050778|584333875|FG000|Overall Study|Familial and personal reasons|1|||
161805871|NCT00050778|584333876|FG001|Overall Study|Familial and personal reasons|0|||
161805872|NCT00050778|584333877|FG002|Overall Study|Familial and personal reasons|0|||
161805873|NCT01661686|584333879|FG000|Overall Study|Lost to Follow-up|2|||
161805874|NCT01661686|584333880|FG001|Overall Study|Lost to Follow-up|1|||
161805875|NCT01661686|584333879|FG000|Overall Study|did not receive allocated intervention|0|||
161805876|NCT01661686|584333880|FG001|Overall Study|did not receive allocated intervention|1|||
161805877|NCT01720264|584333885|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
161805878|NCT01720264|584333885|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
161805879|NCT01720264|584333885|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
161805880|NCT04869787|584333886|FG000|Screening|Physician Decision|1|||
161805881|NCT04869787|584333886|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
161805882|NCT02914600|584333887|FG000|Overall Study|Adverse Event|298|||
161805883|NCT02914600|584333888|FG001|Overall Study|Adverse Event|35|||
161805884|NCT02914600|584333889|FG002|Overall Study|Adverse Event|25|||
161805885|NCT02914600|584333887|FG000|Overall Study|Sponsors decision|287|||
161805886|NCT02914600|584333888|FG001|Overall Study|Sponsors decision|41|||
161805887|NCT02914600|584333889|FG002|Overall Study|Sponsors decision|12|||
161805888|NCT02914600|584333887|FG000|Overall Study|Withdrawal by Subject|158|||
161805889|NCT02914600|584333888|FG001|Overall Study|Withdrawal by Subject|20|||
161805890|NCT02914600|584333889|FG002|Overall Study|Withdrawal by Subject|18|||
161805891|NCT02914600|584333887|FG000|Overall Study|Investigators discretion|169|||
161805892|NCT02914600|584333888|FG001|Overall Study|Investigators discretion|14|||
161805893|NCT02914600|584333889|FG002|Overall Study|Investigators discretion|13|||
161805894|NCT02914600|584333887|FG000|Overall Study|Lost to Follow-up|10|||
161805895|NCT02914600|584333888|FG001|Overall Study|Lost to Follow-up|4|||
161805896|NCT02914600|584333889|FG002|Overall Study|Lost to Follow-up|0|||
161805897|NCT02914600|584333887|FG000|Overall Study|Pregnancy|8|||
161805898|NCT02914600|584333888|FG001|Overall Study|Pregnancy|0|||
161805899|NCT02914600|584333889|FG002|Overall Study|Pregnancy|0|||
161805900|NCT02914600|584333887|FG000|Overall Study|Protocol Violation|5|||
161805901|NCT02914600|584333888|FG001|Overall Study|Protocol Violation|3|||
161805902|NCT02914600|584333889|FG002|Overall Study|Protocol Violation|0|||
161805903|NCT02914600|584333887|FG000|Overall Study|Non-compliance with study drug|6|||
161805904|NCT02914600|584333888|FG001|Overall Study|Non-compliance with study drug|1|||
161909378|NCT01462942|584721391|FG002|Overall Study|Withdrawal by Subject|14|||
161909379|NCT01462942|584721392|FG003|Overall Study|Withdrawal by Subject|16|||
162010927|NCT05523089|585096053|FG001|Overall Study|Lost to Follow-up|0|||
162010928|NCT05523089|585096054|FG002|Overall Study|Lost to Follow-up|0|||
161909380|NCT01462942|584721393|FG004|Overall Study|Withdrawal by Subject|19|||
162010929|NCT05530252|585096055|FG000|Overall Study|Lost to Follow-up|1|||
161805905|NCT02914600|584333889|FG002|Overall Study|Non-compliance with study drug|0|||
161805906|NCT02914600|584333887|FG000|Overall Study|Death|3|||
161805907|NCT02914600|584333888|FG001|Overall Study|Death|1|||
161805908|NCT02914600|584333889|FG002|Overall Study|Death|1|||
161909381|NCT01462942|584721389|FG000|Overall Study|Lack of Efficacy|6|||
161909382|NCT01462942|584721390|FG001|Overall Study|Lack of Efficacy|0|||
161909383|NCT01462942|584721391|FG002|Overall Study|Lack of Efficacy|4|||
161909384|NCT01462942|584721392|FG003|Overall Study|Lack of Efficacy|5|||
161909385|NCT01462942|584721393|FG004|Overall Study|Lack of Efficacy|3|||
161909386|NCT01462942|584721389|FG000|Overall Study|Lost to Follow-up|0|||
161909387|NCT01462942|584721390|FG001|Overall Study|Lost to Follow-up|1|||
161909388|NCT01462942|584721391|FG002|Overall Study|Lost to Follow-up|1|||
161909389|NCT01462942|584721392|FG003|Overall Study|Lost to Follow-up|1|||
161909390|NCT01462942|584721393|FG004|Overall Study|Lost to Follow-up|1|||
161909391|NCT01462942|584721389|FG000|Overall Study|Protocol Violation|4|||
161909392|NCT01462942|584721390|FG001|Overall Study|Protocol Violation|6|||
161909393|NCT01462942|584721391|FG002|Overall Study|Protocol Violation|9|||
161909394|NCT01462942|584721392|FG003|Overall Study|Protocol Violation|9|||
161909395|NCT01462942|584721393|FG004|Overall Study|Protocol Violation|6|||
161909396|NCT01026493|584721394|FG000|Overall Study|Protocol Violation|0|||
161909397|NCT01026493|584721395|FG001|Overall Study|Protocol Violation|1|||
161909398|NCT01026493|584721396|FG002|Overall Study|Protocol Violation|0|||
161909399|NCT01026493|584721397|FG003|Overall Study|Protocol Violation|0|||
161909400|NCT01026493|584721398|FG004|Overall Study|Protocol Violation|2|||
161909401|NCT01026493|584721399|FG005|Overall Study|Protocol Violation|3|||
161909402|NCT01026493|584721400|FG006|Overall Study|Protocol Violation|4|||
161909403|NCT01026493|584721401|FG007|Overall Study|Protocol Violation|1|||
161909404|NCT02662569|584721402|FG000|Overall Study|Withdrawal by Subject|6|||
161909405|NCT02662569|584721403|FG001|Overall Study|Withdrawal by Subject|1|||
161909406|NCT02662569|584721404|FG002|Overall Study|Withdrawal by Subject|6|||
161909407|NCT02662569|584721405|FG003|Overall Study|Withdrawal by Subject|4|||
161909408|NCT02662569|584721402|FG000|Overall Study|Lost to Follow-up|1|||
161909409|NCT02662569|584721403|FG001|Overall Study|Lost to Follow-up|0|||
161909410|NCT02662569|584721404|FG002|Overall Study|Lost to Follow-up|0|||
161909411|NCT02662569|584721405|FG003|Overall Study|Lost to Follow-up|0|||
161909412|NCT03154086|584721406|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909413|NCT03154086|584721407|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909414|NCT03154086|584721408|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909415|NCT03154086|584721409|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
161909416|NCT03154086|584721410|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909417|NCT03154086|584721411|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909418|NCT03154086|584721412|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909419|NCT03154086|584721413|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909420|NCT03154086|584721414|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909421|NCT03154086|584721415|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909422|NCT03154086|584721416|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909423|NCT03154086|584721417|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909424|NCT03154086|584721418|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909425|NCT03154086|584721419|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909426|NCT03154086|584721420|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161909427|NCT03154086|584721406|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909428|NCT03154086|584721407|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
161909429|NCT03154086|584721408|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909430|NCT03154086|584721409|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909431|NCT03154086|584721410|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909432|NCT03154086|584721411|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909433|NCT03154086|584721412|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909434|NCT03154086|584721413|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909435|NCT03154086|584721414|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909436|NCT03154086|584721415|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909437|NCT03154086|584721416|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909438|NCT03154086|584721417|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909439|NCT03154086|584721418|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909440|NCT03154086|584721419|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909441|NCT03154086|584721420|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161909442|NCT03154086|584721406|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909443|NCT03154086|584721407|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
162010930|NCT05530252|585096056|FG001|Overall Study|Lost to Follow-up|1|||
161909444|NCT03154086|584721408|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
161909445|NCT03154086|584721409|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909446|NCT03154086|584721410|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909447|NCT03154086|584721411|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161805909|NCT02914600|584333887|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
161805910|NCT02914600|584333888|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
161805911|NCT02914600|584333889|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
161805912|NCT02914600|584333887|FG000|Overall Study|Enrolled but not treated|1|||
161805913|NCT02914600|584333888|FG001|Overall Study|Enrolled but not treated|0|||
161805914|NCT02914600|584333889|FG002|Overall Study|Enrolled but not treated|0|||
161805915|NCT02996682|584333890|FG000|Overall Study|Death|0|||
161805916|NCT02996682|584333891|FG001|Overall Study|Death|3|||
161805917|NCT02457520|584333892|FG000|Active Treatment Phase|Adverse Event|10|||
161805918|NCT02457520|584333892|FG000|Active Treatment Phase|Lost to Follow-up|8|||
161805919|NCT02457520|584333892|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
161805920|NCT02457520|584333892|FG000|Active Treatment Phase|other|4|||
161805921|NCT02457520|584333892|FG000|Active Treatment Phase|Physician Decision|1|||
161805922|NCT02457520|584333892|FG000|Active Treatment Phase|Protocol Violation|1|||
161805923|NCT02457520|584333892|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
161805924|NCT02457520|584333892|FG000|Post-treatment Period|Other: Retreatment Required|7|||
161805925|NCT02457520|584333892|FG000|Post-treatment Period|Lost to Follow-up|23|||
161805926|NCT02457520|584333892|FG000|Post-treatment Period|Other|3|||
161805927|NCT02457520|584333892|FG000|Post-treatment Period|Physician Decision|1|||
161805928|NCT02457520|584333892|FG000|Post-treatment Period|Withdrawal by Subject|14|||
161805929|NCT02511782|584333895|FG000|Overall Study|Withdrawal by Subject|1|||
161805930|NCT02511782|584333896|FG001|Overall Study|Withdrawal by Subject|0|||
161805931|NCT02511782|584333897|FG002|Overall Study|Withdrawal by Subject|0|||
161805932|NCT00579670|584333898|FG000|Overall Study|Death|1|||
161805933|NCT00579670|584333899|FG001|Overall Study|Death|0|||
161805934|NCT00579670|584333900|FG002|Overall Study|Death|0|||
161805935|NCT00579670|584333901|FG003|Overall Study|Death|0|||
161805936|NCT00579670|584333902|FG004|Overall Study|Death|0|||
161805937|NCT00579670|584333898|FG000|Overall Study|Adverse Event|1|||
161805938|NCT00579670|584333899|FG001|Overall Study|Adverse Event|0|||
161805939|NCT00579670|584333900|FG002|Overall Study|Adverse Event|1|||
161805940|NCT00579670|584333901|FG003|Overall Study|Adverse Event|2|||
161805941|NCT00579670|584333902|FG004|Overall Study|Adverse Event|0|||
161805942|NCT00579670|584333898|FG000|Overall Study|Lack of Efficacy|0|||
161805943|NCT00579670|584333899|FG001|Overall Study|Lack of Efficacy|0|||
161805944|NCT00579670|584333900|FG002|Overall Study|Lack of Efficacy|1|||
161805945|NCT00579670|584333901|FG003|Overall Study|Lack of Efficacy|14|||
161805946|NCT00579670|584333902|FG004|Overall Study|Lack of Efficacy|0|||
161805947|NCT00579670|584333898|FG000|Overall Study|Lost to Follow-up|0|||
161805948|NCT00579670|584333899|FG001|Overall Study|Lost to Follow-up|1|||
161805949|NCT00579670|584333900|FG002|Overall Study|Lost to Follow-up|0|||
161805950|NCT00579670|584333901|FG003|Overall Study|Lost to Follow-up|4|||
161805951|NCT00579670|584333902|FG004|Overall Study|Lost to Follow-up|0|||
161805952|NCT00579670|584333898|FG000|Overall Study|Other|0|||
161805953|NCT00579670|584333899|FG001|Overall Study|Other|0|||
161805954|NCT00579670|584333900|FG002|Overall Study|Other|1|||
161805955|NCT00579670|584333901|FG003|Overall Study|Other|2|||
161805956|NCT00579670|584333902|FG004|Overall Study|Other|0|||
161805957|NCT00579670|584333898|FG000|Overall Study|Withdrawal by Subject|0|||
161805958|NCT00579670|584333899|FG001|Overall Study|Withdrawal by Subject|0|||
161805959|NCT00579670|584333900|FG002|Overall Study|Withdrawal by Subject|1|||
161805960|NCT00579670|584333901|FG003|Overall Study|Withdrawal by Subject|0|||
161805961|NCT00579670|584333902|FG004|Overall Study|Withdrawal by Subject|0|||
161805962|NCT00112463|584333903|FG000|Overall Study|Physician Decision|1|||
161805963|NCT00112463|584333903|FG000|Overall Study|Progression|30|||
161805964|NCT00112463|584333903|FG000|Overall Study|Second Primary|1|||
161805965|NCT00112463|584333903|FG000|Overall Study|Toxicity|3|||
161805966|NCT00112463|584333903|FG000|Overall Study|Withdrawal by Subject|2|||
161805967|NCT00112463|584333903|FG000|Overall Study|Never started treatment|2|||
161909448|NCT03154086|584721412|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161805968|NCT00678639|584333904|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
161805969|NCT00678639|584333905|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
161805970|NCT00870870|584333909|FG000|Overall Study|Withdrawal by Subject|0|||
161805971|NCT00870870|584333910|FG001|Overall Study|Withdrawal by Subject|1|||
161909449|NCT03154086|584721413|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909450|NCT03154086|584721414|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909451|NCT03154086|584721415|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909452|NCT03154086|584721416|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909453|NCT03154086|584721417|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909454|NCT03154086|584721418|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909455|NCT03154086|584721419|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909456|NCT03154086|584721420|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161909457|NCT03154086|584721406|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
161909458|NCT03154086|584721407|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909459|NCT03154086|584721408|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909460|NCT03154086|584721409|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909461|NCT03154086|584721410|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909462|NCT03154086|584721411|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909463|NCT03154086|584721412|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909464|NCT03154086|584721413|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909465|NCT03154086|584721414|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909466|NCT03154086|584721415|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909467|NCT03154086|584721416|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909468|NCT03154086|584721417|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909469|NCT03154086|584721418|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909470|NCT03154086|584721419|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909471|NCT03154086|584721420|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161909472|NCT03154086|584721406|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909473|NCT03154086|584721407|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909474|NCT03154086|584721408|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909475|NCT03154086|584721409|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909476|NCT03154086|584721410|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909477|NCT03154086|584721411|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909478|NCT03154086|584721412|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909479|NCT03154086|584721413|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909480|NCT03154086|584721414|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
161909481|NCT03154086|584721415|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909482|NCT03154086|584721416|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909483|NCT03154086|584721417|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909484|NCT03154086|584721418|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909485|NCT03154086|584721419|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909486|NCT03154086|584721420|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161909487|NCT03154086|584721406|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909488|NCT03154086|584721407|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909489|NCT03154086|584721408|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909490|NCT03154086|584721409|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909491|NCT03154086|584721410|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909492|NCT03154086|584721411|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909493|NCT03154086|584721412|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909494|NCT03154086|584721413|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
161909495|NCT03154086|584721414|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909496|NCT03154086|584721415|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909497|NCT03154086|584721416|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909498|NCT03154086|584721417|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909499|NCT03154086|584721418|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909500|NCT03154086|584721419|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909501|NCT03154086|584721420|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161909502|NCT03154086|584721406|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
161909503|NCT03154086|584721407|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
161909504|NCT03154086|584721408|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
161909505|NCT03154086|584721409|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
161909506|NCT03154086|584721410|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
161909507|NCT03154086|584721411|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
161909508|NCT03154086|584721412|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
161909509|NCT03154086|584721413|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
161909510|NCT03154086|584721414|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
161909511|NCT03154086|584721415|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
161909512|NCT03154086|584721416|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
161909513|NCT03154086|584721417|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
162140315|NCT04012853|585565600|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
161909514|NCT03154086|584721418|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
161909515|NCT03154086|584721419|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
161909516|NCT03154086|584721420|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
161909517|NCT01701245|584721425|FG000|Overall Study|Protocol Violation|1|||
161909518|NCT01701245|584721426|FG001|Overall Study|Protocol Violation|3|||
161909519|NCT01701245|584721425|FG000|Overall Study|Did not complete the open label period|11|||
161909520|NCT01701245|584721426|FG001|Overall Study|Did not complete the open label period|12|||
161909521|NCT01299584|584721451|FG000|Overall Study|Protocol Violation|9|||
161909522|NCT00572832|584721452|FG000|Overall Study|Lost to Follow-up|0|||
161909523|NCT00572832|584721453|FG001|Overall Study|Lost to Follow-up|11|||
161909524|NCT00572832|584721452|FG000|Overall Study|Pregnancy|0|||
161909525|NCT00572832|584721453|FG001|Overall Study|Pregnancy|1|||
161909526|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
161909527|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161909528|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161909529|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161909530|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161909531|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161909532|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161909533|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
161909534|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161909535|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161909536|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161909537|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161909538|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161909539|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161909540|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161909541|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
161909542|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161909543|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161909544|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
162140316|NCT01313182|585565601|FG000|Overall Study|Protocol Violation|66|||
161805972|NCT00870870|584333911|FG002|Overall Study|Withdrawal by Subject|1|||
161805973|NCT00870870|584333912|FG003|Overall Study|Withdrawal by Subject|3|||
162140317|NCT01313182|585565602|FG001|Overall Study|Protocol Violation|92|||
161805974|NCT00870870|584333909|FG000|Overall Study|Adverse Event|0|||
161805975|NCT00870870|584333910|FG001|Overall Study|Adverse Event|0|||
161805976|NCT00870870|584333911|FG002|Overall Study|Adverse Event|2|||
161805977|NCT00870870|584333912|FG003|Overall Study|Adverse Event|2|||
161805978|NCT03639311|584333916|FG000|Maintenance Phase|Lost to Follow-up|1|||
161805979|NCT03639311|584333917|FG001|Maintenance Phase|Lost to Follow-up|0|||
161805980|NCT03639311|584333918|FG002|Maintenance Phase|Lost to Follow-up|0|||
161805981|NCT03639311|584333916|FG000|Maintenance Phase|Adverse Event|1|||
161805982|NCT03639311|584333917|FG001|Maintenance Phase|Adverse Event|0|||
161805983|NCT03639311|584333918|FG002|Maintenance Phase|Adverse Event|0|||
161805984|NCT03639311|584333916|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
161805985|NCT03639311|584333917|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
161805986|NCT03639311|584333918|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
161805987|NCT03639311|584333916|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
161805988|NCT03639311|584333917|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
161805989|NCT03639311|584333918|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
161805990|NCT03639311|584333916|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
161805991|NCT03639311|584333917|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
161805992|NCT03639311|584333918|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
161805993|NCT03639311|584333916|FG000|Maintenance Phase|Lack of Efficacy|1|||
161805994|NCT03639311|584333917|FG001|Maintenance Phase|Lack of Efficacy|0|||
161805995|NCT03639311|584333918|FG002|Maintenance Phase|Lack of Efficacy|0|||
161805996|NCT00822926|584333919|FG000|Second Injection Visit|Lost to Follow-up|1|||
161805997|NCT00822926|584333920|FG001|Second Injection Visit|Lost to Follow-up|0|||
161805998|NCT00822926|584333919|FG000|Second Injection Visit|Withdrawal by Subject|0|||
161805999|NCT00822926|584333920|FG001|Second Injection Visit|Withdrawal by Subject|1|||
161806000|NCT00855738|584333921|FG000|Overall Study|Lost to Follow-up|2|||
161806001|NCT00855738|584333921|FG000|Overall Study|Adverse Event|1|||
161909545|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161909546|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161909547|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
162010931|NCT05530252|585096057|FG002|Overall Study|Lost to Follow-up|1|||
161806002|NCT00855738|584333921|FG000|Overall Study|Subject Defaulted|1|||
161806003|NCT00855738|584333921|FG000|Overall Study|Death|1|||
161806004|NCT03135834|584333922|FG000|Stage 1|Adverse Event|1|||
161806005|NCT03135834|584333923|FG001|Stage 1|Adverse Event|2|||
161806006|NCT03135834|584333924|FG002|Stage 1|Adverse Event|2|||
161806007|NCT03135834|584333925|FG003|Stage 1|Adverse Event|1|||
161806008|NCT03135834|584333922|FG000|Stage 1|Death|1|||
161806009|NCT03135834|584333923|FG001|Stage 1|Death|0|||
161806010|NCT03135834|584333924|FG002|Stage 1|Death|0|||
161806011|NCT03135834|584333925|FG003|Stage 1|Death|0|||
161806012|NCT03135834|584333922|FG000|Stage 1|Lost to Follow-up|17|||
161806013|NCT03135834|584333923|FG001|Stage 1|Lost to Follow-up|24|||
161806014|NCT03135834|584333924|FG002|Stage 1|Lost to Follow-up|21|||
161806015|NCT03135834|584333925|FG003|Stage 1|Lost to Follow-up|38|||
161806016|NCT03135834|584333922|FG000|Stage 1|No longer met eligibility criteria|1|||
161806017|NCT03135834|584333923|FG001|Stage 1|No longer met eligibility criteria|6|||
161806018|NCT03135834|584333924|FG002|Stage 1|No longer met eligibility criteria|2|||
161806019|NCT03135834|584333925|FG003|Stage 1|No longer met eligibility criteria|5|||
161806020|NCT03135834|584333922|FG000|Stage 1|Other|0|||
161806021|NCT03135834|584333923|FG001|Stage 1|Other|2|||
161806022|NCT03135834|584333924|FG002|Stage 1|Other|1|||
161806023|NCT03135834|584333925|FG003|Stage 1|Other|0|||
161806024|NCT03135834|584333922|FG000|Stage 1|Physician Decision|0|||
161806025|NCT03135834|584333923|FG001|Stage 1|Physician Decision|1|||
161806026|NCT03135834|584333924|FG002|Stage 1|Physician Decision|0|||
161806027|NCT03135834|584333925|FG003|Stage 1|Physician Decision|0|||
161806028|NCT03135834|584333922|FG000|Stage 1|Pregnancy|0|||
161806029|NCT03135834|584333923|FG001|Stage 1|Pregnancy|4|||
161806030|NCT03135834|584333924|FG002|Stage 1|Pregnancy|2|||
161806031|NCT03135834|584333925|FG003|Stage 1|Pregnancy|4|||
161806032|NCT03135834|584333922|FG000|Stage 1|Protocol Violation|1|||
161806033|NCT03135834|584333923|FG001|Stage 1|Protocol Violation|1|||
161806034|NCT03135834|584333924|FG002|Stage 1|Protocol Violation|2|||
161806035|NCT03135834|584333925|FG003|Stage 1|Protocol Violation|1|||
161806036|NCT03135834|584333922|FG000|Stage 1|Withdrawal by parent/guardian|2|||
161806037|NCT03135834|584333923|FG001|Stage 1|Withdrawal by parent/guardian|10|||
161806038|NCT03135834|584333924|FG002|Stage 1|Withdrawal by parent/guardian|2|||
161806039|NCT03135834|584333925|FG003|Stage 1|Withdrawal by parent/guardian|1|||
161806040|NCT03135834|584333922|FG000|Stage 1|Withdrawal by Subject|16|||
161806041|NCT03135834|584333923|FG001|Stage 1|Withdrawal by Subject|22|||
161806042|NCT03135834|584333924|FG002|Stage 1|Withdrawal by Subject|7|||
161806043|NCT03135834|584333925|FG003|Stage 1|Withdrawal by Subject|10|||
161806044|NCT03135834|584333922|FG000|Stage 1|Randomized but not Vaccinated|0|||
161806045|NCT03135834|584333923|FG001|Stage 1|Randomized but not Vaccinated|3|||
161806046|NCT03135834|584333924|FG002|Stage 1|Randomized but not Vaccinated|1|||
161806047|NCT03135834|584333925|FG003|Stage 1|Randomized but not Vaccinated|6|||
161806048|NCT03135834|584333922|FG000|Stage 2|Lost to Follow-up|0|||
161806049|NCT03135834|584333923|FG001|Stage 2|Lost to Follow-up|1|||
161806050|NCT03135834|584333924|FG002|Stage 2|Lost to Follow-up|0|||
161806051|NCT03135834|584333925|FG003|Stage 2|Lost to Follow-up|0|||
161806052|NCT03135834|584333922|FG000|Stage 2|Withdrawal by Subject|0|||
161806053|NCT03135834|584333923|FG001|Stage 2|Withdrawal by Subject|1|||
161806054|NCT03135834|584333924|FG002|Stage 2|Withdrawal by Subject|0|||
161806055|NCT03135834|584333925|FG003|Stage 2|Withdrawal by Subject|0|||
161806056|NCT03135834|584333922|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
161806057|NCT03135834|584333923|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
161806058|NCT03135834|584333924|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
161806059|NCT03135834|584333925|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
161806060|NCT03135834|584333922|FG000|Stage 2|Did not receive Booster Vaccination|1|||
161806061|NCT03135834|584333923|FG001|Stage 2|Did not receive Booster Vaccination|1|||
161806062|NCT03135834|584333924|FG002|Stage 2|Did not receive Booster Vaccination|0|||
161806063|NCT03135834|584333925|FG003|Stage 2|Did not receive Booster Vaccination|0|||
161806064|NCT00319735|584333926|FG000|Overall Study|Death|2|||
161806065|NCT02421952|584333935|FG000|Overall Study|Diary Not Returned|93|||
161806066|NCT02421952|584333935|FG000|Overall Study|Failed seriation task|13|||
161806067|NCT02421952|584333935|FG000|Overall Study|Subject uncooperative for baseline test|2|||
161806068|NCT02421952|584333935|FG000|Overall Study|Surgery cancelled|1|||
161806069|NCT03262012|584333946|FG000|Overall Study|Withdrawal by Subject|15|||
161806070|NCT03262012|584333947|FG001|Overall Study|Withdrawal by Subject|13|||
161806071|NCT03262012|584333948|FG002|Overall Study|Withdrawal by Subject|8|||
161806072|NCT03262012|584333949|FG003|Overall Study|Withdrawal by Subject|7|||
161806073|NCT03262012|584333946|FG000|Overall Study|Adverse Event|10|||
161806074|NCT03262012|584333947|FG001|Overall Study|Adverse Event|12|||
161806075|NCT03262012|584333948|FG002|Overall Study|Adverse Event|4|||
161806076|NCT03262012|584333949|FG003|Overall Study|Adverse Event|6|||
161806077|NCT03262012|584333946|FG000|Overall Study|Physician Decision|2|||
161806078|NCT03262012|584333947|FG001|Overall Study|Physician Decision|5|||
162010932|NCT01350999|585096058|FG000|Overall Study|Adverse Event|4|||
161806079|NCT03262012|584333948|FG002|Overall Study|Physician Decision|1|||
161806080|NCT03262012|584333949|FG003|Overall Study|Physician Decision|0|||
161806081|NCT03262012|584333946|FG000|Overall Study|Lack of Efficacy|0|||
161806082|NCT03262012|584333947|FG001|Overall Study|Lack of Efficacy|5|||
161806083|NCT03262012|584333948|FG002|Overall Study|Lack of Efficacy|1|||
161806084|NCT03262012|584333949|FG003|Overall Study|Lack of Efficacy|2|||
161806085|NCT03262012|584333946|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
161909548|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161806086|NCT03262012|584333947|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
161806087|NCT03262012|584333948|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
161806088|NCT03262012|584333949|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
161806089|NCT00154102|584333952|FG000|Overall Study|investigational study phase ongoing|7|||
161806090|NCT00154102|584333953|FG001|Overall Study|investigational study phase ongoing|2|||
161806091|NCT02865122|584333954|FG000|Overall Study|Adverse Event|1|||
161806092|NCT02865122|584333955|FG001|Overall Study|Adverse Event|0|||
161806093|NCT02865122|584333956|FG002|Overall Study|Adverse Event|0|||
161806094|NCT02422264|584335831|FG000|Overall Study|Serious Adverse Event|1|||
161806095|NCT02422264|584335832|FG001|Overall Study|Serious Adverse Event|0|||
161806096|NCT02422264|584335831|FG000|Overall Study|Withdrawal by Subject|1|||
161806097|NCT02422264|584335832|FG001|Overall Study|Withdrawal by Subject|2|||
161806098|NCT02422264|584335831|FG000|Overall Study|Migrated/moved from study area|3|||
161806099|NCT02422264|584335832|FG001|Overall Study|Migrated/moved from study area|1|||
161806100|NCT02422264|584335831|FG000|Overall Study|Subject vaccinated outside of the study|0|||
161806101|NCT02422264|584335832|FG001|Overall Study|Subject vaccinated outside of the study|1|||
161806102|NCT03021018|584335833|FG000|Overall Study|Adverse Event|1|||
161806103|NCT03021018|584335834|FG001|Overall Study|Adverse Event|0|||
161806104|NCT03021018|584335835|FG002|Overall Study|Adverse Event|0|||
161806105|NCT03021018|584335833|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
161806106|NCT03021018|584335834|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
161806107|NCT03021018|584335835|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
161806108|NCT04123548|584335838|FG000|Overall Study|Withdrawal by Subject|1|||
161806109|NCT04123548|584335838|FG000|Overall Study|Lost to Follow-up|8|||
161806110|NCT04123548|584335838|FG000|Overall Study|Death|4|||
161806111|NCT04123548|584335838|FG000|Overall Study|Reason Not Specified|1|||
161806112|NCT04112823|584335841|FG000|Overall Study|Lost to Follow-up|2|||
161806113|NCT04112823|584335842|FG001|Overall Study|Lost to Follow-up|3|||
161806114|NCT03603314|584335845|FG000|Overall Study|Lost to Follow-up|0|||
161806115|NCT03603314|584335846|FG001|Overall Study|Lost to Follow-up|3|||
161806116|NCT03603314|584335847|FG002|Overall Study|Lost to Follow-up|0|||
161806117|NCT03603314|584335845|FG000|Overall Study|Protocol Violation|0|||
161806118|NCT03603314|584335846|FG001|Overall Study|Protocol Violation|1|||
161806119|NCT03603314|584335847|FG002|Overall Study|Protocol Violation|0|||
161806120|NCT03603314|584335845|FG000|Overall Study|Adverse Event|2|||
161806121|NCT03603314|584335846|FG001|Overall Study|Adverse Event|0|||
161806122|NCT03603314|584335847|FG002|Overall Study|Adverse Event|0|||
161806123|NCT03603314|584335845|FG000|Overall Study|Physician Decision|1|||
161806124|NCT03603314|584335846|FG001|Overall Study|Physician Decision|1|||
161806125|NCT03603314|584335847|FG002|Overall Study|Physician Decision|0|||
161806126|NCT03603314|584335845|FG000|Overall Study|Withdrawal by Subject|4|||
161806127|NCT03603314|584335846|FG001|Overall Study|Withdrawal by Subject|5|||
161806128|NCT03603314|584335847|FG002|Overall Study|Withdrawal by Subject|3|||
161806129|NCT03603314|584335845|FG000|Overall Study|Other|0|||
161806130|NCT03603314|584335846|FG001|Overall Study|Other|1|||
161806131|NCT03603314|584335847|FG002|Overall Study|Other|0|||
161806132|NCT00436553|584335848|FG000|Overall Study|Adverse Event|4|||
161806133|NCT00436553|584335849|FG001|Overall Study|Adverse Event|3|||
161806134|NCT00436553|584335850|FG002|Overall Study|Adverse Event|4|||
161806135|NCT00436553|584335848|FG000|Overall Study|Death|3|||
161806136|NCT00436553|584335849|FG001|Overall Study|Death|1|||
161806137|NCT00436553|584335850|FG002|Overall Study|Death|3|||
161806138|NCT00436553|584335848|FG000|Overall Study|Lost to Follow-up|0|||
161806139|NCT00436553|584335849|FG001|Overall Study|Lost to Follow-up|2|||
161806140|NCT00436553|584335850|FG002|Overall Study|Lost to Follow-up|0|||
161806141|NCT00436553|584335848|FG000|Overall Study|Protocol Violation|1|||
161806142|NCT00436553|584335849|FG001|Overall Study|Protocol Violation|0|||
161806143|NCT00436553|584335850|FG002|Overall Study|Protocol Violation|0|||
161806144|NCT00436553|584335848|FG000|Overall Study|Withdrawal by Subject|5|||
161806145|NCT00436553|584335849|FG001|Overall Study|Withdrawal by Subject|6|||
161806146|NCT00436553|584335850|FG002|Overall Study|Withdrawal by Subject|3|||
161806147|NCT00625443|584335859|FG000|Overall Study|Adverse Event|1|||
161909549|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
161909550|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161806148|NCT00625443|584335860|FG001|Overall Study|Adverse Event|4|||
161806149|NCT00625443|584335861|FG002|Overall Study|Adverse Event|0|||
161806150|NCT00625443|584335859|FG000|Overall Study|Non-compliance with protocol|0|||
161806151|NCT00625443|584335860|FG001|Overall Study|Non-compliance with protocol|1|||
161806152|NCT00625443|584335861|FG002|Overall Study|Non-compliance with protocol|0|||
161806153|NCT00625443|584335859|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
161806154|NCT00625443|584335860|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
161806155|NCT00625443|584335861|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
161806156|NCT00625443|584335859|FG000|Overall Study|Withdrawal by Subject|0|||
161806157|NCT00625443|584335860|FG001|Overall Study|Withdrawal by Subject|1|||
161806158|NCT00625443|584335861|FG002|Overall Study|Withdrawal by Subject|2|||
161806159|NCT00625443|584335859|FG000|Overall Study|Physician Decision|0|||
161806160|NCT00625443|584335860|FG001|Overall Study|Physician Decision|4|||
161806161|NCT00625443|584335861|FG002|Overall Study|Physician Decision|2|||
161806162|NCT00625443|584335859|FG000|Overall Study|Other|0|||
161806163|NCT00625443|584335860|FG001|Overall Study|Other|1|||
161806164|NCT00625443|584335861|FG002|Overall Study|Other|1|||
161806165|NCT02015390|584335862|FG000|Overall Study|Lost to Follow-up|1|||
161806166|NCT02015390|584335863|FG001|Overall Study|Lost to Follow-up|0|||
161806167|NCT02015390|584335862|FG000|Overall Study|Adverse Event|0|||
161806168|NCT02015390|584335863|FG001|Overall Study|Adverse Event|3|||
161806169|NCT02015390|584335862|FG000|Overall Study|Physician Decision|0|||
161806170|NCT02015390|584335863|FG001|Overall Study|Physician Decision|1|||
161806171|NCT00064753|584335866|FG000|Overall Study|Death|251|||
161806172|NCT00064753|584335867|FG001|Overall Study|Death|242|||
161806173|NCT00064753|584335866|FG000|Overall Study|Withdrawal by Subject|198|||
161806174|NCT00064753|584335867|FG001|Overall Study|Withdrawal by Subject|171|||
161806175|NCT00064753|584335866|FG000|Overall Study|Lost to Follow-up|225|||
161806176|NCT00064753|584335867|FG001|Overall Study|Lost to Follow-up|235|||
161806177|NCT02193880|584335868|FG000|Overall Study|patients did not collect enough HPC|3|||
161806178|NCT03136380|584335869|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161806179|NCT03136380|584335870|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
161806180|NCT03136380|584335871|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161806181|NCT03136380|584335872|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161806182|NCT03136380|584335873|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161806183|NCT02728102|584335877|FG000|Overall Study|Death|3|||
161806184|NCT02728102|584335878|FG001|Overall Study|Death|0|||
161806185|NCT02728102|584335879|FG002|Overall Study|Death|1|||
161806186|NCT02728102|584335877|FG000|Overall Study|Withdrawal by Subject|0|||
161806187|NCT02728102|584335878|FG001|Overall Study|Withdrawal by Subject|2|||
161806188|NCT02728102|584335879|FG002|Overall Study|Withdrawal by Subject|3|||
161806189|NCT02728102|584335877|FG000|Overall Study|Physician Decision|1|||
161806190|NCT02728102|584335878|FG001|Overall Study|Physician Decision|1|||
161806191|NCT02728102|584335879|FG002|Overall Study|Physician Decision|0|||
161806192|NCT02728102|584335877|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
161806193|NCT02728102|584335878|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
161806194|NCT02728102|584335879|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
161806195|NCT02728102|584335877|FG000|Overall Study|Covid|0|||
161806196|NCT02728102|584335878|FG001|Overall Study|Covid|0|||
161806197|NCT02728102|584335879|FG002|Overall Study|Covid|1|||
161806198|NCT02419937|584335884|FG000|Overall Study|Lost to Follow-up|1|||
161806199|NCT02419937|584335885|FG001|Overall Study|Lost to Follow-up|0|||
161806200|NCT00553280|584335886|FG000|Overall Study|Adverse Event|19|||
161806201|NCT00553280|584335886|FG000|Overall Study|Lack of Efficacy|3|||
161806202|NCT00553280|584335886|FG000|Overall Study|Withdrawal by Subject|3|||
161806203|NCT00553280|584335886|FG000|Overall Study|Physician Decision|1|||
161806204|NCT01182415|584335887|FG000|Overall Study|Lost to Follow-up|1|||
161806205|NCT01544127|584335888|FG000|Overall Study|Lost to Follow-up|4|||
161806206|NCT01544127|584335889|FG001|Overall Study|Lost to Follow-up|2|||
161806207|NCT01544127|584335890|FG002|Overall Study|Lost to Follow-up|9|||
161806208|NCT01544127|584335888|FG000|Overall Study|Withdrawal by Subject|2|||
161806209|NCT01544127|584335889|FG001|Overall Study|Withdrawal by Subject|2|||
161806210|NCT01544127|584335890|FG002|Overall Study|Withdrawal by Subject|1|||
161806211|NCT01544127|584335888|FG000|Overall Study|Discharged out of catchment area|1|||
161806212|NCT01544127|584335889|FG001|Overall Study|Discharged out of catchment area|1|||
161806213|NCT01544127|584335890|FG002|Overall Study|Discharged out of catchment area|1|||
161806214|NCT01544127|584335888|FG000|Overall Study|Death|1|||
161806215|NCT01544127|584335889|FG001|Overall Study|Death|0|||
161806216|NCT01544127|584335890|FG002|Overall Study|Death|0|||
161806217|NCT01544127|584335888|FG000|Overall Study|Jail or Prison|1|||
161806218|NCT01544127|584335889|FG001|Overall Study|Jail or Prison|1|||
161806219|NCT01544127|584335890|FG002|Overall Study|Jail or Prison|2|||
162010933|NCT01350999|585096059|FG001|Overall Study|Adverse Event|9|||
161806220|NCT01544127|584335888|FG000|Overall Study|Became Psychotic|1|||
161806221|NCT01544127|584335889|FG001|Overall Study|Became Psychotic|0|||
161806222|NCT01544127|584335890|FG002|Overall Study|Became Psychotic|0|||
161806223|NCT01544127|584335888|FG000|Overall Study|Researcher withdrew|1|||
161806224|NCT01544127|584335889|FG001|Overall Study|Researcher withdrew|0|||
161806225|NCT01544127|584335890|FG002|Overall Study|Researcher withdrew|0|||
161806226|NCT01544127|584335888|FG000|Overall Study|Went active duty|0|||
161806227|NCT01544127|584335889|FG001|Overall Study|Went active duty|0|||
161806228|NCT01544127|584335890|FG002|Overall Study|Went active duty|1|||
161806229|NCT01256684|584335893|FG000|Overall Study|Adverse Event|1|||
161806230|NCT01256684|584335894|FG001|Overall Study|Adverse Event|4|||
161806231|NCT01256684|584335895|FG002|Overall Study|Adverse Event|2|||
161806232|NCT01256684|584335893|FG000|Overall Study|Withdrawal by Subject|4|||
161806233|NCT01256684|584335894|FG001|Overall Study|Withdrawal by Subject|0|||
161806234|NCT01256684|584335895|FG002|Overall Study|Withdrawal by Subject|2|||
161806235|NCT01256684|584335893|FG000|Overall Study|Physician Decision|0|||
161806236|NCT01256684|584335894|FG001|Overall Study|Physician Decision|1|||
161806237|NCT01256684|584335895|FG002|Overall Study|Physician Decision|0|||
161806238|NCT01256684|584335893|FG000|Overall Study|Lack of Efficacy|0|||
161806239|NCT01256684|584335894|FG001|Overall Study|Lack of Efficacy|1|||
161806240|NCT01256684|584335895|FG002|Overall Study|Lack of Efficacy|1|||
161806241|NCT01256684|584335893|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
161806242|NCT01256684|584335894|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
161806243|NCT01256684|584335895|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
161806244|NCT02587962|584335899|FG000|Overall Study|Adverse Event|0|||
161806245|NCT02587962|584335900|FG001|Overall Study|Adverse Event|0|||
161806246|NCT02587962|584335901|FG002|Overall Study|Adverse Event|1|||
161806247|NCT02587962|584335902|FG003|Overall Study|Adverse Event|0|||
161806248|NCT02587962|584335903|FG004|Overall Study|Adverse Event|0|||
161806249|NCT02587962|584335899|FG000|Overall Study|Withdrawal by Subject|0|||
161806250|NCT02587962|584335900|FG001|Overall Study|Withdrawal by Subject|0|||
161806251|NCT02587962|584335901|FG002|Overall Study|Withdrawal by Subject|1|||
161806252|NCT02587962|584335902|FG003|Overall Study|Withdrawal by Subject|1|||
161806253|NCT02587962|584335903|FG004|Overall Study|Withdrawal by Subject|4|||
161806254|NCT02587962|584335899|FG000|Overall Study|Radiological progression|2|||
161806255|NCT02587962|584335900|FG001|Overall Study|Radiological progression|2|||
161806256|NCT02587962|584335901|FG002|Overall Study|Radiological progression|2|||
161806257|NCT02587962|584335902|FG003|Overall Study|Radiological progression|5|||
161806258|NCT02587962|584335903|FG004|Overall Study|Radiological progression|10|||
161806259|NCT02587962|584335899|FG000|Overall Study|Clinical progression|0|||
161806260|NCT02587962|584335900|FG001|Overall Study|Clinical progression|1|||
161806261|NCT02587962|584335901|FG002|Overall Study|Clinical progression|2|||
161806262|NCT02587962|584335902|FG003|Overall Study|Clinical progression|0|||
161806263|NCT02587962|584335903|FG004|Overall Study|Clinical progression|1|||
161806264|NCT00184600|584335904|FG000|Overall Study|Adverse Event|9|||
161806265|NCT00184600|584335905|FG001|Overall Study|Adverse Event|0|||
161806266|NCT00184600|584335906|FG002|Overall Study|Adverse Event|5|||
161806267|NCT00184600|584335904|FG000|Overall Study|Death|3|||
161806268|NCT00184600|584335905|FG001|Overall Study|Death|9|||
161806269|NCT00184600|584335906|FG002|Overall Study|Death|7|||
161806270|NCT00184600|584335904|FG000|Overall Study|Lack of Efficacy|3|||
161806271|NCT00184600|584335905|FG001|Overall Study|Lack of Efficacy|1|||
161806272|NCT00184600|584335906|FG002|Overall Study|Lack of Efficacy|3|||
161806273|NCT00184600|584335904|FG000|Overall Study|Lost to Follow-up|4|||
161806274|NCT00184600|584335905|FG001|Overall Study|Lost to Follow-up|6|||
161806275|NCT00184600|584335906|FG002|Overall Study|Lost to Follow-up|1|||
161806276|NCT00184600|584335904|FG000|Overall Study|Protocol Violation|2|||
161806277|NCT00184600|584335905|FG001|Overall Study|Protocol Violation|2|||
161806278|NCT00184600|584335906|FG002|Overall Study|Protocol Violation|3|||
161806279|NCT00184600|584335904|FG000|Overall Study|Withdrawal by Subject|20|||
161806280|NCT00184600|584335905|FG001|Overall Study|Withdrawal by Subject|28|||
161806281|NCT00184600|584335906|FG002|Overall Study|Withdrawal by Subject|12|||
161806282|NCT00184600|584335904|FG000|Overall Study|Unclassified|4|||
161806283|NCT00184600|584335905|FG001|Overall Study|Unclassified|5|||
161806284|NCT00184600|584335906|FG002|Overall Study|Unclassified|3|||
161806285|NCT00696020|584335909|FG000|Overall Study|Adverse Event|3|||
161806286|NCT00696020|584335910|FG001|Overall Study|Adverse Event|1|||
162010934|NCT01350999|585096060|FG002|Overall Study|Adverse Event|10|||
161806287|NCT00696020|584335911|FG002|Overall Study|Adverse Event|2|||
161806288|NCT00696020|584335912|FG003|Overall Study|Adverse Event|1|||
161806289|NCT00696020|584335909|FG000|Overall Study|Lack of Efficacy|1|||
161806290|NCT00696020|584335910|FG001|Overall Study|Lack of Efficacy|0|||
161806291|NCT00696020|584335911|FG002|Overall Study|Lack of Efficacy|0|||
161806292|NCT00696020|584335912|FG003|Overall Study|Lack of Efficacy|0|||
161909551|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161909552|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161909553|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161909554|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161909555|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161909556|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
161909557|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161909558|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161909559|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161909560|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161909561|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161909562|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161909563|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
161909564|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161909565|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161909566|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161909567|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161909568|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161909569|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161909570|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161909571|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
161909572|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161909573|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161909574|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161909575|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161909576|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161909577|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161909578|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
161909579|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161909580|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161909581|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161909582|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161909583|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161909584|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161909585|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161909586|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
161909587|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161909588|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161909589|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161909590|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161909591|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161909592|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161909593|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
161909594|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161909595|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161909596|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161909597|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161909598|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161909599|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161909600|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
161909601|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161909602|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161909603|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161909604|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161909605|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161909606|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161909607|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
161806293|NCT00696020|584335909|FG000|Overall Study|Protocol Violation|0|||
161909608|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161909609|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161909610|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161909611|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161909612|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161909613|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161909614|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161909615|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
161909616|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161909617|NCT01791595|584721465|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161909618|NCT01791595|584721466|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161909619|NCT01791595|584721467|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161909620|NCT01791595|584721468|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161909621|NCT01791595|584721469|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161909622|NCT01791595|584721470|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
161909623|NCT01791595|584721471|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161909624|NCT01791595|584721465|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161909625|NCT01791595|584721466|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161806294|NCT00696020|584335910|FG001|Overall Study|Protocol Violation|0|||
161806295|NCT00696020|584335911|FG002|Overall Study|Protocol Violation|0|||
161806296|NCT00696020|584335912|FG003|Overall Study|Protocol Violation|1|||
161806297|NCT00696020|584335909|FG000|Overall Study|Withdrawal by Subject|0|||
161806298|NCT00696020|584335910|FG001|Overall Study|Withdrawal by Subject|1|||
161806299|NCT00696020|584335911|FG002|Overall Study|Withdrawal by Subject|0|||
161806300|NCT00696020|584335912|FG003|Overall Study|Withdrawal by Subject|1|||
161806301|NCT00696020|584335909|FG000|Overall Study|Other not stated above|0|||
161806302|NCT00696020|584335910|FG001|Overall Study|Other not stated above|0|||
161806303|NCT00696020|584335911|FG002|Overall Study|Other not stated above|1|||
161806304|NCT00696020|584335912|FG003|Overall Study|Other not stated above|1|||
161806305|NCT00624065|584335913|FG000|Overall Study|Adverse Event|5|||
161806306|NCT00624065|584335914|FG001|Overall Study|Adverse Event|6|||
161806307|NCT00624065|584335913|FG000|Overall Study|Lost to Follow-up|4|||
161806308|NCT00624065|584335914|FG001|Overall Study|Lost to Follow-up|1|||
161806309|NCT00624065|584335913|FG000|Overall Study|Consent withdrawn|6|||
161806310|NCT00624065|584335914|FG001|Overall Study|Consent withdrawn|5|||
161806311|NCT00624065|584335913|FG000|Overall Study|Lack of Efficacy|0|||
161806312|NCT00624065|584335914|FG001|Overall Study|Lack of Efficacy|3|||
161806313|NCT00624065|584335913|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
161806314|NCT00624065|584335914|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
161806315|NCT01387022|584335915|FG000|Overall Study|Death|1|||
161806316|NCT01387022|584335916|FG001|Overall Study|Death|1|||
161806317|NCT01387022|584335915|FG000|Overall Study|Lost to Follow-up|0|||
161806318|NCT01387022|584335916|FG001|Overall Study|Lost to Follow-up|3|||
161806319|NCT02076022|584335917|FG000|Overall Study|Withdrawal by Subject|2|||
161806320|NCT02076022|584335918|FG001|Overall Study|Withdrawal by Subject|0|||
161806321|NCT01536405|584335921|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
161806322|NCT01536405|584335922|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
161806323|NCT01536405|584335921|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
161806324|NCT01536405|584335922|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
161806325|NCT01536405|584335921|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
161806326|NCT01536405|584335922|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
161806327|NCT01536405|584335921|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
161806328|NCT01536405|584335922|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
161806329|NCT01536405|584335921|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
161806330|NCT01536405|584335922|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
161806331|NCT01536405|584335921|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
161806332|NCT01536405|584335922|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
161909626|NCT01791595|584721467|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161909627|NCT01791595|584721468|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161909628|NCT01791595|584721469|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161806333|NCT01536405|584335921|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
161806334|NCT01536405|584335922|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
161806335|NCT01536405|584335921|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
161806336|NCT01536405|584335922|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
161806337|NCT01536405|584335921|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
161806338|NCT01536405|584335922|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
161806339|NCT01536405|584335921|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
161806340|NCT01536405|584335922|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
161806341|NCT01536405|584335921|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
161806342|NCT01536405|584335922|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
161806343|NCT01536405|584335921|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
161806344|NCT01536405|584335922|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
161806345|NCT01536405|584335921|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
161806346|NCT01536405|584335922|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
161806347|NCT03687736|584335926|FG000|Overall Study|Lost to Follow-up|7|||
161806348|NCT03687736|584335926|FG000|Overall Study|Withdrawal by Subject|3|||
161806349|NCT01844375|584335927|FG000|Overall Study|Protocol Violation|1|||
161806350|NCT01844375|584335928|FG001|Overall Study|Protocol Violation|1|||
161806351|NCT03627091|584335929|FG000|Overall Study|Adverse Event|0|||
161806352|NCT03627091|584335930|FG001|Overall Study|Adverse Event|0|||
161806353|NCT03627091|584335931|FG002|Overall Study|Adverse Event|2|||
161806354|NCT03627091|584335929|FG000|Overall Study|Withdrawal by Subject|2|||
161806355|NCT03627091|584335930|FG001|Overall Study|Withdrawal by Subject|0|||
161806356|NCT03627091|584335931|FG002|Overall Study|Withdrawal by Subject|2|||
161806357|NCT03627091|584335929|FG000|Overall Study|Physician Decision|2|||
161806358|NCT03627091|584335930|FG001|Overall Study|Physician Decision|0|||
161806359|NCT03627091|584335931|FG002|Overall Study|Physician Decision|0|||
161806360|NCT03627091|584335929|FG000|Overall Study|Site terminated by sponsor|0|||
161806361|NCT03627091|584335930|FG001|Overall Study|Site terminated by sponsor|1|||
161806362|NCT03627091|584335931|FG002|Overall Study|Site terminated by sponsor|0|||
161806363|NCT03627091|584335929|FG000|Overall Study|Disease relapse|7|||
161806364|NCT03627091|584335930|FG001|Overall Study|Disease relapse|5|||
161806365|NCT03627091|584335931|FG002|Overall Study|Disease relapse|1|||
161806366|NCT03627091|584335929|FG000|Overall Study|Other|1|||
161806367|NCT03627091|584335930|FG001|Overall Study|Other|0|||
161806368|NCT03627091|584335931|FG002|Overall Study|Other|0|||
161806369|NCT02514122|584335932|FG000|Overall Study|Withdrawal by Subject|2|||
161806370|NCT02514122|584335933|FG001|Overall Study|Withdrawal by Subject|0|||
161806371|NCT01472341|584335937|FG000|Overall Study|Started insulin therapy|55|||
161806372|NCT01472341|584335937|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
161806373|NCT01472341|584335937|FG000|Overall Study|Withdrawal by Subject|39|||
161806374|NCT01472341|584335937|FG000|Overall Study|Lost to Follow-up|52|||
161806375|NCT01472341|584335937|FG000|Overall Study|Laboratory parameters unavailable|25|||
161806376|NCT01472341|584335937|FG000|Overall Study|Death|9|||
161806377|NCT00296647|584335941|FG000|Overall Study|Death|4|||
161806378|NCT00296647|584335942|FG001|Overall Study|Death|1|||
161806379|NCT00296647|584335943|FG002|Overall Study|Death|2|||
161806380|NCT00296647|584335944|FG003|Overall Study|Death|1|||
161806381|NCT00296647|584335945|FG004|Overall Study|Death|1|||
161806382|NCT00296647|584335941|FG000|Overall Study|Withdrawal by Subject|28|||
161806383|NCT00296647|584335942|FG001|Overall Study|Withdrawal by Subject|27|||
161806384|NCT00296647|584335943|FG002|Overall Study|Withdrawal by Subject|32|||
161806385|NCT00296647|584335944|FG003|Overall Study|Withdrawal by Subject|16|||
161806386|NCT00296647|584335945|FG004|Overall Study|Withdrawal by Subject|19|||
161806387|NCT05615935|584335948|FG000|Overall Study|Lost to Follow-up|1|||
161806388|NCT05615935|584335949|FG001|Overall Study|Lost to Follow-up|1|||
161806389|NCT01863745|584335950|FG000|Overall Study|Disease Progression|9|||
161806390|NCT01863745|584335950|FG000|Overall Study|Adverse Event|2|||
161806391|NCT01863745|584335950|FG000|Overall Study|Death|1|||
161806392|NCT01863745|584335950|FG000|Overall Study|Withdrawal by Subject|1|||
161806393|NCT00735904|584335951|FG000|Overall Study|Adverse Event|3|||
161806394|NCT00735904|584335951|FG000|Overall Study|Death|20|||
161806395|NCT00735904|584335951|FG000|Overall Study|Protocol Violation|1|||
161806396|NCT00735904|584335951|FG000|Overall Study|Withdrawal by Subject|1|||
161806397|NCT00735904|584335951|FG000|Overall Study|Study Terminated by Sponsor|5|||
161806398|NCT00735904|584335951|FG000|Overall Study|Other|8|||
161806399|NCT01171963|584335954|FG000|Overall Study|Adverse Event|10|||
161806400|NCT01171963|584335955|FG001|Overall Study|Adverse Event|15|||
161806401|NCT01171963|584335954|FG000|Overall Study|Lost to Follow-up|23|||
161806402|NCT01171963|584335955|FG001|Overall Study|Lost to Follow-up|24|||
161806403|NCT01171963|584335954|FG000|Overall Study|Other - diarrhoea|1|||
161806404|NCT01171963|584335955|FG001|Overall Study|Other - diarrhoea|0|||
161806405|NCT01171963|584335954|FG000|Overall Study|Withdrawal by Subject|114|||
161806406|NCT01171963|584335955|FG001|Overall Study|Withdrawal by Subject|129|||
161806407|NCT05093205|584335956|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
161806408|NCT05093205|584335957|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
161806409|NCT05093205|584335958|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
161806410|NCT05093205|584335959|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
161806411|NCT05093205|584335960|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
161806412|NCT05093205|584335961|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
161806413|NCT05093205|584335962|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
161806414|NCT05093205|584335963|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
161806415|NCT05093205|584335964|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
161806416|NCT05093205|584335965|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
161806417|NCT05093205|584335966|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
161806418|NCT05093205|584335967|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
161806419|NCT05093205|584335968|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
161806420|NCT05093205|584335956|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806421|NCT05093205|584335957|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806422|NCT05093205|584335958|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
161806423|NCT05093205|584335959|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806424|NCT05093205|584335960|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806425|NCT05093205|584335961|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806426|NCT05093205|584335962|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806427|NCT05093205|584335963|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806428|NCT05093205|584335964|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806429|NCT05093205|584335965|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806430|NCT05093205|584335966|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806431|NCT05093205|584335967|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806432|NCT05093205|584335968|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161806433|NCT05093205|584335956|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
161806434|NCT05093205|584335957|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
161806435|NCT05093205|584335958|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
161806436|NCT05093205|584335959|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
161806437|NCT05093205|584335960|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
161806438|NCT05093205|584335961|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
161806439|NCT05093205|584335962|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
161806440|NCT05093205|584335963|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
161806441|NCT05093205|584335964|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
161806442|NCT05093205|584335965|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
161806443|NCT05093205|584335966|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
161806444|NCT05093205|584335967|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
161806445|NCT05093205|584335968|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
161806446|NCT05093205|584335956|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
161806447|NCT05093205|584335957|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
161806448|NCT05093205|584335958|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
161806449|NCT05093205|584335959|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
161806450|NCT05093205|584335960|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
161806451|NCT05093205|584335961|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
161806452|NCT05093205|584335962|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
161806453|NCT05093205|584335963|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
161806454|NCT05093205|584335964|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
161806455|NCT05093205|584335965|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
161806456|NCT05093205|584335966|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
161806457|NCT05093205|584335967|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
161806458|NCT05093205|584335968|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
161806459|NCT05093205|584335956|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
161806460|NCT05093205|584335957|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
161806461|NCT05093205|584335958|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
161806462|NCT05093205|584335959|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
161806463|NCT05093205|584335960|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
161806464|NCT05093205|584335961|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
161806465|NCT05093205|584335962|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
161806466|NCT05093205|584335963|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
161806467|NCT05093205|584335964|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
161806468|NCT05093205|584335965|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
161806469|NCT05093205|584335966|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
161909629|NCT01791595|584721470|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161909630|NCT01791595|584721471|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
161909631|NCT01791595|584721465|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161909632|NCT01791595|584721466|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161909633|NCT01791595|584721467|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161909634|NCT01791595|584721468|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161909635|NCT01791595|584721469|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161909636|NCT01791595|584721470|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161909637|NCT01791595|584721471|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
161909638|NCT01791595|584721465|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161909639|NCT01791595|584721466|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161909640|NCT01791595|584721467|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161806470|NCT05093205|584335967|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
161806471|NCT05093205|584335968|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
161806472|NCT05093205|584335956|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
161806473|NCT05093205|584335957|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
161806474|NCT05093205|584335958|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
161806475|NCT05093205|584335959|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
161806476|NCT05093205|584335960|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
161806477|NCT05093205|584335961|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
161806478|NCT05093205|584335962|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
161806479|NCT05093205|584335963|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
161806480|NCT05093205|584335964|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
161806481|NCT05093205|584335965|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
161806482|NCT05093205|584335966|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
161806483|NCT05093205|584335967|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
161806484|NCT05093205|584335968|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
161806485|NCT05093205|584335956|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
161806486|NCT05093205|584335957|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
161806487|NCT05093205|584335958|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
161806488|NCT05093205|584335959|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
161806489|NCT05093205|584335960|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
161806490|NCT05093205|584335961|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
161806491|NCT05093205|584335962|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
161806492|NCT05093205|584335963|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
161806493|NCT05093205|584335964|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
161806494|NCT05093205|584335965|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
161806495|NCT05093205|584335966|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
161806496|NCT05093205|584335967|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
161806497|NCT05093205|584335968|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
161806498|NCT05093205|584335956|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
161806499|NCT05093205|584335957|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
161806500|NCT05093205|584335958|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
161806501|NCT05093205|584335959|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
161806502|NCT05093205|584335960|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
161806503|NCT05093205|584335961|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
161806504|NCT05093205|584335962|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
161806505|NCT05093205|584335963|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
161806506|NCT05093205|584335964|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
161806507|NCT05093205|584335965|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
161806508|NCT05093205|584335966|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
161806509|NCT05093205|584335967|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
161806510|NCT05093205|584335968|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
161806511|NCT05093205|584335956|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806512|NCT05093205|584335957|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806513|NCT05093205|584335958|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806514|NCT05093205|584335959|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806515|NCT05093205|584335960|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806516|NCT05093205|584335961|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806517|NCT05093205|584335962|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806518|NCT05093205|584335963|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806519|NCT05093205|584335964|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806520|NCT05093205|584335965|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
161806521|NCT05093205|584335966|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806522|NCT05093205|584335967|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806523|NCT05093205|584335968|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161806524|NCT05093205|584335956|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
161806525|NCT05093205|584335957|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
161806526|NCT05093205|584335958|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
161806527|NCT05093205|584335959|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
161909641|NCT01791595|584721468|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161909642|NCT01791595|584721469|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161909643|NCT01791595|584721470|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161909644|NCT01791595|584721471|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
161909645|NCT01791595|584721465|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161909646|NCT01791595|584721466|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161909647|NCT01791595|584721467|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161909648|NCT01791595|584721468|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161909649|NCT01791595|584721469|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161909650|NCT01791595|584721470|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161909651|NCT01791595|584721471|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
161909652|NCT01776554|584721472|FG000|Overall Study|Adverse Event|1|||
161909653|NCT01776554|584721473|FG001|Overall Study|Adverse Event|0|||
161909654|NCT01776554|584721472|FG000|Overall Study|Withdrawal by Subject|3|||
161909655|NCT01776554|584721473|FG001|Overall Study|Withdrawal by Subject|8|||
161909656|NCT01776554|584721472|FG000|Overall Study|Lost to Follow-up|6|||
161909657|NCT01776554|584721473|FG001|Overall Study|Lost to Follow-up|9|||
161909658|NCT01776554|584721472|FG000|Overall Study|Administrative Reason|2|||
161909659|NCT01776554|584721473|FG001|Overall Study|Administrative Reason|5|||
161909660|NCT01776554|584721472|FG000|Overall Study|Protocol Violation|1|||
161909661|NCT01776554|584721473|FG001|Overall Study|Protocol Violation|0|||
161909662|NCT01776554|584721472|FG000|Overall Study|Unclassified|4|||
161909663|NCT01776554|584721473|FG001|Overall Study|Unclassified|1|||
161909664|NCT01041859|584721474|FG000|Open-Label Titration|Adverse Event|69|||
161909665|NCT01041859|584721475|FG001|Open-Label Titration|Adverse Event|0|||
161909666|NCT01041859|584721476|FG002|Open-Label Titration|Adverse Event|0|||
161909667|NCT01041859|584721474|FG000|Open-Label Titration|Lack of Efficacy|3|||
161909668|NCT01041859|584721475|FG001|Open-Label Titration|Lack of Efficacy|0|||
161909669|NCT01041859|584721476|FG002|Open-Label Titration|Lack of Efficacy|0|||
161909670|NCT01041859|584721474|FG000|Open-Label Titration|Lost to Follow-up|1|||
161909671|NCT01041859|584721475|FG001|Open-Label Titration|Lost to Follow-up|0|||
161909672|NCT01041859|584721476|FG002|Open-Label Titration|Lost to Follow-up|0|||
161909673|NCT01041859|584721474|FG000|Open-Label Titration|Physician Decision|1|||
161909674|NCT01041859|584721475|FG001|Open-Label Titration|Physician Decision|0|||
161909675|NCT01041859|584721476|FG002|Open-Label Titration|Physician Decision|0|||
161909676|NCT01041859|584721474|FG000|Open-Label Titration|Protocol Violation|1|||
161909677|NCT01041859|584721475|FG001|Open-Label Titration|Protocol Violation|0|||
161909678|NCT01041859|584721476|FG002|Open-Label Titration|Protocol Violation|0|||
161909679|NCT01041859|584721474|FG000|Open-Label Titration|Other|7|||
161909680|NCT01041859|584721475|FG001|Open-Label Titration|Other|0|||
161909681|NCT01041859|584721476|FG002|Open-Label Titration|Other|0|||
161909682|NCT01041859|584721474|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
161909683|NCT01041859|584721475|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
161909684|NCT01041859|584721476|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
161909685|NCT01041859|584721474|FG000|Open-Label Titration|Withdrawal by Subject|11|||
161909686|NCT01041859|584721475|FG001|Open-Label Titration|Withdrawal by Subject|0|||
161909687|NCT01041859|584721476|FG002|Open-Label Titration|Withdrawal by Subject|0|||
161909688|NCT01041859|584721474|FG000|Double-Blind Maintenance|Adverse Event|0|||
161909689|NCT01041859|584721475|FG001|Double-Blind Maintenance|Adverse Event|23|||
161909690|NCT01041859|584721476|FG002|Double-Blind Maintenance|Adverse Event|13|||
161909691|NCT01041859|584721474|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
161909692|NCT01041859|584721475|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
161909693|NCT01041859|584721476|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
161909694|NCT01041859|584721474|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
161909695|NCT01041859|584721475|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
161909696|NCT01041859|584721476|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
161909697|NCT01041859|584721474|FG000|Double-Blind Maintenance|Physician Decision|0|||
161806528|NCT05093205|584335960|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
161806529|NCT05093205|584335961|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
161806530|NCT05093205|584335962|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
161806531|NCT05093205|584335963|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
161806532|NCT05093205|584335964|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
161806533|NCT05093205|584335965|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
161806534|NCT05093205|584335966|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
161806535|NCT05093205|584335967|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
161806536|NCT05093205|584335968|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
161806537|NCT05093205|584335956|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806538|NCT05093205|584335957|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806539|NCT05093205|584335958|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806540|NCT05093205|584335959|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806541|NCT05093205|584335960|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806542|NCT05093205|584335961|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161909698|NCT01041859|584721475|FG001|Double-Blind Maintenance|Physician Decision|2|||
161909699|NCT01041859|584721476|FG002|Double-Blind Maintenance|Physician Decision|1|||
161909700|NCT01041859|584721474|FG000|Double-Blind Maintenance|Protocol Violation|0|||
161909701|NCT01041859|584721475|FG001|Double-Blind Maintenance|Protocol Violation|1|||
161909702|NCT01041859|584721476|FG002|Double-Blind Maintenance|Protocol Violation|3|||
161909703|NCT01041859|584721474|FG000|Double-Blind Maintenance|Other|0|||
161909704|NCT01041859|584721475|FG001|Double-Blind Maintenance|Other|6|||
161909705|NCT01041859|584721476|FG002|Double-Blind Maintenance|Other|2|||
161909706|NCT01041859|584721474|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
161909707|NCT01041859|584721475|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
161909708|NCT01041859|584721476|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
161909709|NCT01041859|584721474|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
161909710|NCT01041859|584721475|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
161909711|NCT01041859|584721476|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
161909712|NCT02027025|584721477|FG000|Overall Study|Adverse Event|0|||
161909713|NCT02027025|584721478|FG001|Overall Study|Adverse Event|1|||
161909714|NCT02027025|584721479|FG002|Overall Study|Adverse Event|1|||
161909715|NCT02027025|584721477|FG000|Overall Study|Protocol Violation|1|||
161909716|NCT02027025|584721478|FG001|Overall Study|Protocol Violation|0|||
161909717|NCT02027025|584721479|FG002|Overall Study|Protocol Violation|0|||
161909718|NCT02027025|584721477|FG000|Overall Study|Lost to Follow-up|0|||
161909719|NCT02027025|584721478|FG001|Overall Study|Lost to Follow-up|2|||
161909720|NCT02027025|584721479|FG002|Overall Study|Lost to Follow-up|0|||
161909721|NCT02027025|584721477|FG000|Overall Study|Withdrawal by Subject|0|||
161909722|NCT02027025|584721478|FG001|Overall Study|Withdrawal by Subject|1|||
161909723|NCT02027025|584721479|FG002|Overall Study|Withdrawal by Subject|0|||
162010935|NCT01350999|585096058|FG000|Overall Study|Voluntary withdrawal|3|||
162010936|NCT01350999|585096059|FG001|Overall Study|Voluntary withdrawal|4|||
162010937|NCT01350999|585096060|FG002|Overall Study|Voluntary withdrawal|6|||
162010938|NCT01350999|585096058|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
162010939|NCT01350999|585096059|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
162010940|NCT01350999|585096060|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
162010941|NCT00554216|585097678|FG000|Overall Study|Lost to Follow-up|92|||
162010942|NCT00554216|585097679|FG001|Overall Study|Lost to Follow-up|31|||
162010943|NCT00554216|585097680|FG002|Overall Study|Lost to Follow-up|63|||
162010944|NCT00554216|585097678|FG000|Overall Study|Adverse Event|16|||
162010945|NCT00554216|585097679|FG001|Overall Study|Adverse Event|16|||
162010946|NCT00554216|585097680|FG002|Overall Study|Adverse Event|36|||
162010947|NCT00554216|585097678|FG000|Overall Study|Withdrawal by Subject|92|||
162010948|NCT00554216|585097679|FG001|Overall Study|Withdrawal by Subject|31|||
162010949|NCT00554216|585097680|FG002|Overall Study|Withdrawal by Subject|43|||
162010950|NCT00554216|585097678|FG000|Overall Study|Non compliance|10|||
162010951|NCT00554216|585097679|FG001|Overall Study|Non compliance|4|||
162010952|NCT00554216|585097680|FG002|Overall Study|Non compliance|5|||
162010953|NCT00554216|585097678|FG000|Overall Study|Pregnancy|2|||
162010954|NCT00554216|585097679|FG001|Overall Study|Pregnancy|1|||
162010955|NCT00554216|585097680|FG002|Overall Study|Pregnancy|14|||
162010956|NCT00554216|585097678|FG000|Overall Study|Restricted med|3|||
162010957|NCT00554216|585097679|FG001|Overall Study|Restricted med|1|||
162010958|NCT00554216|585097680|FG002|Overall Study|Restricted med|1|||
162010959|NCT00554216|585097678|FG000|Overall Study|Other|12|||
162010960|NCT00554216|585097679|FG001|Overall Study|Other|7|||
162010961|NCT00554216|585097680|FG002|Overall Study|Other|10|||
162010962|NCT00554216|585097678|FG000|Overall Study|Lack of Efficacy|15|||
162010963|NCT00554216|585097679|FG001|Overall Study|Lack of Efficacy|3|||
162010964|NCT00554216|585097680|FG002|Overall Study|Lack of Efficacy|0|||
162010965|NCT05291520|585097681|FG000|Overall Study|Lost to Follow-up|0|||
162010966|NCT05291520|585097682|FG001|Overall Study|Lost to Follow-up|0|||
162010967|NCT05291520|585097683|FG002|Overall Study|Lost to Follow-up|1|||
162010968|NCT01347112|585097684|FG000|Overall Study|Withdrawal by Subject|1|||
162010969|NCT01347112|585097685|FG001|Overall Study|Withdrawal by Subject|7|||
162010970|NCT01347112|585097684|FG000|Overall Study|Lost to Follow-up|3|||
162010971|NCT01347112|585097685|FG001|Overall Study|Lost to Follow-up|5|||
162010972|NCT05462756|585097688|FG000|Treatment Period|Adverse Event|3|||
162010973|NCT05462756|585097689|FG001|Treatment Period|Adverse Event|0|||
162010974|NCT05462756|585097688|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
162010975|NCT05462756|585097689|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
162010976|NCT05462756|585097688|FG000|Treatment Period|Death|0|||
161909724|NCT02027025|584721477|FG000|Overall Study|Sponsor's decision|0|||
162010977|NCT05462756|585097689|FG001|Treatment Period|Death|1|||
162010978|NCT05462756|585097688|FG000|Treatment Period|Lost to Follow-up|2|||
162010979|NCT05462756|585097689|FG001|Treatment Period|Lost to Follow-up|1|||
162010980|NCT05462756|585097688|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
162010981|NCT05462756|585097689|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
162010982|NCT05462756|585097688|FG000|Treatment Period|Physician Decision|2|||
162010983|NCT05462756|585097689|FG001|Treatment Period|Physician Decision|0|||
162010984|NCT05462756|585097688|FG000|Treatment Period|Protocol Violation|0|||
161909725|NCT02027025|584721478|FG001|Overall Study|Sponsor's decision|1|||
161909726|NCT02027025|584721479|FG002|Overall Study|Sponsor's decision|0|||
161909727|NCT04798027|584721480|FG000|Overall Study|Protocol Violation|0|||
161909728|NCT04798027|584721481|FG001|Overall Study|Protocol Violation|0|||
161909729|NCT04798027|584721482|FG002|Overall Study|Protocol Violation|0|||
161909730|NCT04798027|584721483|FG003|Overall Study|Protocol Violation|0|||
161909731|NCT04798027|584721484|FG004|Overall Study|Protocol Violation|1|||
161909732|NCT04798027|584721485|FG005|Overall Study|Protocol Violation|0|||
161909733|NCT04798027|584721486|FG006|Overall Study|Protocol Violation|0|||
161909734|NCT04798027|584721487|FG007|Overall Study|Protocol Violation|1|||
161909735|NCT04798027|584721488|FG008|Overall Study|Protocol Violation|0|||
161909736|NCT04798027|584721480|FG000|Overall Study|Withdrawal by Subject|1|||
161909737|NCT04798027|584721481|FG001|Overall Study|Withdrawal by Subject|0|||
161909738|NCT04798027|584721482|FG002|Overall Study|Withdrawal by Subject|1|||
161909739|NCT04798027|584721483|FG003|Overall Study|Withdrawal by Subject|1|||
161909740|NCT04798027|584721484|FG004|Overall Study|Withdrawal by Subject|1|||
161909741|NCT04798027|584721485|FG005|Overall Study|Withdrawal by Subject|1|||
161909742|NCT04798027|584721486|FG006|Overall Study|Withdrawal by Subject|3|||
161909743|NCT04798027|584721487|FG007|Overall Study|Withdrawal by Subject|2|||
161909744|NCT04798027|584721488|FG008|Overall Study|Withdrawal by Subject|2|||
161909745|NCT04798027|584721480|FG000|Overall Study|Lost to Follow-up|1|||
161909746|NCT04798027|584721481|FG001|Overall Study|Lost to Follow-up|3|||
161909747|NCT04798027|584721482|FG002|Overall Study|Lost to Follow-up|0|||
161909748|NCT04798027|584721483|FG003|Overall Study|Lost to Follow-up|0|||
161909749|NCT04798027|584721484|FG004|Overall Study|Lost to Follow-up|0|||
161909750|NCT04798027|584721485|FG005|Overall Study|Lost to Follow-up|1|||
161909751|NCT04798027|584721486|FG006|Overall Study|Lost to Follow-up|0|||
161909752|NCT04798027|584721487|FG007|Overall Study|Lost to Follow-up|0|||
161909753|NCT04798027|584721488|FG008|Overall Study|Lost to Follow-up|1|||
161909754|NCT04798027|584721480|FG000|Overall Study|Withdrawal by Sponsor|8|||
161909755|NCT04798027|584721481|FG001|Overall Study|Withdrawal by Sponsor|22|||
161909756|NCT04798027|584721482|FG002|Overall Study|Withdrawal by Sponsor|9|||
161909757|NCT04798027|584721483|FG003|Overall Study|Withdrawal by Sponsor|26|||
161909758|NCT04798027|584721484|FG004|Overall Study|Withdrawal by Sponsor|24|||
161909759|NCT04798027|584721485|FG005|Overall Study|Withdrawal by Sponsor|11|||
161909760|NCT04798027|584721486|FG006|Overall Study|Withdrawal by Sponsor|25|||
161909761|NCT04798027|584721487|FG007|Overall Study|Withdrawal by Sponsor|26|||
161909762|NCT04798027|584721488|FG008|Overall Study|Withdrawal by Sponsor|11|||
161909763|NCT00828711|584721491|FG000|Overall Study|Lost to Follow-up|1|||
161909764|NCT00828711|584721492|FG001|Overall Study|Lost to Follow-up|0|||
161909765|NCT00828711|584721493|FG002|Overall Study|Lost to Follow-up|0|||
161909766|NCT01618968|584721494|FG000|Overall Study|Adverse Event|1|||
161909767|NCT01618968|584721495|FG001|Overall Study|Adverse Event|0|||
161909768|NCT01618968|584721496|FG002|Overall Study|Adverse Event|0|||
161909769|NCT01618968|584721497|FG003|Overall Study|Adverse Event|0|||
161909770|NCT01618968|584721494|FG000|Overall Study|Death|0|||
161909771|NCT01618968|584721495|FG001|Overall Study|Death|0|||
161909772|NCT01618968|584721496|FG002|Overall Study|Death|0|||
161909773|NCT01618968|584721497|FG003|Overall Study|Death|1|||
161909774|NCT02230891|584721500|FG000|Baseline|Did not meet inclusion|0|||
161909775|NCT02230891|584721501|FG001|Baseline|Did not meet inclusion|1|||
161909776|NCT02230891|584721502|FG002|Baseline|Did not meet inclusion|1|||
161909777|NCT02230891|584721500|FG000|2 Week|Withdrawal by Subject|2|||
161909778|NCT02230891|584721501|FG001|2 Week|Withdrawal by Subject|2|||
161909779|NCT02230891|584721502|FG002|2 Week|Withdrawal by Subject|0|||
161909780|NCT02230891|584721500|FG000|2 Week|Consent withdrawn|1|||
161909781|NCT02230891|584721501|FG001|2 Week|Consent withdrawn|0|||
161909782|NCT02230891|584721502|FG002|2 Week|Consent withdrawn|0|||
161909783|NCT02230891|584721500|FG000|6 Month|Withdrawal by Subject|1|||
161909784|NCT02230891|584721501|FG001|6 Month|Withdrawal by Subject|1|||
161909785|NCT02230891|584721502|FG002|6 Month|Withdrawal by Subject|1|||
161909786|NCT02230891|584721500|FG000|6 Month|Physician Decision|0|||
161909787|NCT02230891|584721501|FG001|6 Month|Physician Decision|2|||
161909788|NCT02230891|584721502|FG002|6 Month|Physician Decision|0|||
161909789|NCT02230891|584721500|FG000|12 Month|Death|1|||
161909790|NCT02230891|584721501|FG001|12 Month|Death|0|||
161909791|NCT02230891|584721502|FG002|12 Month|Death|0|||
161909792|NCT02230891|584721500|FG000|12 Month|Lost to Follow-up|0|||
161909793|NCT02230891|584721501|FG001|12 Month|Lost to Follow-up|1|||
161909794|NCT02230891|584721502|FG002|12 Month|Lost to Follow-up|0|||
161909795|NCT02230891|584721500|FG000|12 Month|Withdrawal by Subject|0|||
161909796|NCT02230891|584721501|FG001|12 Month|Withdrawal by Subject|2|||
161909797|NCT02230891|584721502|FG002|12 Month|Withdrawal by Subject|0|||
161909798|NCT02230891|584721500|FG000|18 Month End of Study|Death|0|||
161909799|NCT02230891|584721501|FG001|18 Month End of Study|Death|0|||
161909800|NCT02230891|584721502|FG002|18 Month End of Study|Death|1|||
161909801|NCT02230891|584721500|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
161909802|NCT02230891|584721501|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
161909803|NCT02230891|584721502|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
161909804|NCT03087058|584721504|FG000|Overall Study|Withdrawal by Subject|2|||
161909805|NCT03087058|584721505|FG001|Overall Study|Withdrawal by Subject|0|||
161909806|NCT03087058|584721506|FG002|Overall Study|Withdrawal by Subject|0|||
161909807|NCT05158140|584721510|FG000|Overall Study|Death|0|||
161909808|NCT05158140|584721511|FG001|Overall Study|Death|0|||
161909809|NCT05158140|584721512|FG002|Overall Study|Death|0|||
161909810|NCT05158140|584721513|FG003|Overall Study|Death|1|||
161909811|NCT05158140|584721510|FG000|Overall Study|Lost to Follow-up|3|||
161909812|NCT05158140|584721511|FG001|Overall Study|Lost to Follow-up|6|||
161909813|NCT05158140|584721512|FG002|Overall Study|Lost to Follow-up|4|||
161909814|NCT05158140|584721513|FG003|Overall Study|Lost to Follow-up|3|||
161909815|NCT05158140|584721510|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161909816|NCT05158140|584721511|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161909817|NCT05158140|584721512|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
161909818|NCT05158140|584721513|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161909819|NCT05158140|584721510|FG000|Overall Study|Withdrawal by Subject|3|||
161909820|NCT05158140|584721511|FG001|Overall Study|Withdrawal by Subject|7|||
161909821|NCT05158140|584721512|FG002|Overall Study|Withdrawal by Subject|3|||
161909822|NCT05158140|584721513|FG003|Overall Study|Withdrawal by Subject|7|||
161909823|NCT00617279|584721514|FG000|Overall Study|Study terminated by Sponsor|10|||
161909824|NCT00617279|584721515|FG001|Overall Study|Study terminated by Sponsor|15|||
161909825|NCT00617279|584721514|FG000|Overall Study|Graft abandonment|2|||
161909826|NCT00617279|584721515|FG001|Overall Study|Graft abandonment|0|||
161909827|NCT00617279|584721514|FG000|Overall Study|Lost to Follow-up|1|||
161909828|NCT00617279|584721515|FG001|Overall Study|Lost to Follow-up|0|||
161909829|NCT00617279|584721514|FG000|Overall Study|Death|1|||
161909830|NCT00617279|584721515|FG001|Overall Study|Death|2|||
161909831|NCT01814007|584721517|FG000|Overall Study|Withdrawal by Subject|1|||
161909832|NCT01324947|584721519|FG000|Overall Study|Adverse Event|7|||
161909833|NCT01324947|584721519|FG000|Overall Study|Death|10|||
161909834|NCT01324947|584721519|FG000|Overall Study|Other|3|||
161909835|NCT01324947|584721519|FG000|Overall Study|Progressive Disease|50|||
161909836|NCT01324947|584721519|FG000|Overall Study|Withdrawal by Subject|3|||
161909837|NCT01324947|584721519|FG000|Overall Study|1 discontinued before starting drug|1|||
161909838|NCT01274351|584721520|FG000|Overall Study|Lost to Follow-up|1|||
161909839|NCT01274351|584721520|FG000|Overall Study|patient not compliant with the protocol|1|||
161909840|NCT01274351|584721520|FG000|Overall Study|Pregnancy|1|||
161909841|NCT01274351|584721520|FG000|Overall Study|Death|2|||
161909842|NCT01274351|584721520|FG000|Overall Study|Withdrawal by Subject|3|||
161909843|NCT01274351|584721520|FG000|Overall Study|Adverse Event|8|||
161909844|NCT01274351|584721520|FG000|Overall Study|progression of disease|3|||
161909845|NCT01274351|584721520|FG000|Overall Study|hospitalization|1|||
161909846|NCT01296412|584721521|FG000|Overall Study|Adverse Event|8|||
161909847|NCT01296412|584721522|FG001|Overall Study|Adverse Event|29|||
161909848|NCT01296412|584721521|FG000|Overall Study|Lack of Efficacy|1|||
161909849|NCT01296412|584721522|FG001|Overall Study|Lack of Efficacy|0|||
161909850|NCT01296412|584721521|FG000|Overall Study|Lost to Follow-up|10|||
161909851|NCT01296412|584721522|FG001|Overall Study|Lost to Follow-up|7|||
161909852|NCT01296412|584721521|FG000|Overall Study|Non-compliance with study drug|1|||
161909853|NCT01296412|584721522|FG001|Overall Study|Non-compliance with study drug|2|||
161909854|NCT01296412|584721521|FG000|Overall Study|Other reason not specified|20|||
161909855|NCT01296412|584721522|FG001|Overall Study|Other reason not specified|15|||
161909856|NCT01296412|584721521|FG000|Overall Study|Physician Decision|1|||
161909857|NCT01296412|584721522|FG001|Overall Study|Physician Decision|3|||
161909858|NCT01296412|584721521|FG000|Overall Study|Pregnancy|0|||
161909859|NCT01296412|584721522|FG001|Overall Study|Pregnancy|1|||
161909860|NCT01296412|584721521|FG000|Overall Study|Withdrawal by Subject|10|||
161909861|NCT01296412|584721522|FG001|Overall Study|Withdrawal by Subject|13|||
161909862|NCT02160626|584721523|FG000|Overall Study|Adverse Event|1|||
161909863|NCT02160626|584721524|FG001|Overall Study|Adverse Event|0|||
161909864|NCT02160626|584721525|FG002|Overall Study|Adverse Event|0|||
161909865|NCT02160626|584721523|FG000|Overall Study|Schedule not conducive to study visits|0|||
161909866|NCT02160626|584721524|FG001|Overall Study|Schedule not conducive to study visits|0|||
161909867|NCT02160626|584721525|FG002|Overall Study|Schedule not conducive to study visits|1|||
161909868|NCT02160626|584721523|FG000|Overall Study|Withdrawal by Subject|0|||
161909869|NCT02160626|584721524|FG001|Overall Study|Withdrawal by Subject|1|||
161909870|NCT02160626|584721525|FG002|Overall Study|Withdrawal by Subject|0|||
161909871|NCT03861039|584723410|FG000|Overall Study|Adverse Event|2|||
161909872|NCT03861039|584723411|FG001|Overall Study|Adverse Event|5|||
161909873|NCT03861039|584723412|FG002|Overall Study|Adverse Event|11|||
161909874|NCT03861039|584723410|FG000|Overall Study|Withdrawal by Subject|1|||
161909875|NCT03861039|584723411|FG001|Overall Study|Withdrawal by Subject|3|||
161909876|NCT03861039|584723412|FG002|Overall Study|Withdrawal by Subject|4|||
161909877|NCT01113749|584723413|FG000|Overall Study|Lost to Follow-up|1|||
161909878|NCT01113749|584723414|FG001|Overall Study|Lost to Follow-up|2|||
161909879|NCT03427892|584723415|FG000|Overall Study|Lost to Follow-up|2|||
161909880|NCT03255187|584723416|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
161909881|NCT03255187|584723417|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
161909882|NCT03255187|584723416|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
161909883|NCT03255187|584723417|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
161909884|NCT02934178|584723418|FG000|Received Vaccination 2|Death|0|||
161909885|NCT02934178|584723419|FG001|Received Vaccination 2|Death|1|||
161909886|NCT02934178|584723418|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
161909887|NCT02934178|584723419|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
161909888|NCT00720278|584723423|FG000|Overall Study|Adverse Event|5|||
161909889|NCT00720278|584723424|FG001|Overall Study|Adverse Event|3|||
161909890|NCT00720278|584723425|FG002|Overall Study|Adverse Event|4|||
161909891|NCT00720278|584723423|FG000|Overall Study|Withdrawal by Subject|0|||
161909892|NCT00720278|584723424|FG001|Overall Study|Withdrawal by Subject|1|||
161909893|NCT00720278|584723425|FG002|Overall Study|Withdrawal by Subject|0|||
161909894|NCT00720278|584723423|FG000|Overall Study|Lost to Follow-up|0|||
161909895|NCT00720278|584723424|FG001|Overall Study|Lost to Follow-up|0|||
161909896|NCT00720278|584723425|FG002|Overall Study|Lost to Follow-up|1|||
161909897|NCT00720278|584723423|FG000|Overall Study|Non-compliance|1|||
161909898|NCT00720278|584723424|FG001|Overall Study|Non-compliance|0|||
161909899|NCT00720278|584723425|FG002|Overall Study|Non-compliance|0|||
161909900|NCT00720278|584723423|FG000|Overall Study|eligibility criteria violation|1|||
161909901|NCT00720278|584723424|FG001|Overall Study|eligibility criteria violation|0|||
161909902|NCT00720278|584723425|FG002|Overall Study|eligibility criteria violation|1|||
161909903|NCT01075048|584723427|FG000|Overall Study|Death|4|||
161909904|NCT01075048|584723428|FG001|Overall Study|Death|17|||
161909905|NCT01075048|584723429|FG002|Overall Study|Death|12|||
161909906|NCT01075048|584723427|FG000|Overall Study|Start of other or new therapy|4|||
161909907|NCT01075048|584723428|FG001|Overall Study|Start of other or new therapy|36|||
161909908|NCT01075048|584723429|FG002|Overall Study|Start of other or new therapy|46|||
161909909|NCT01075048|584723427|FG000|Overall Study|Withdrawal by Subject|1|||
161909910|NCT01075048|584723428|FG001|Overall Study|Withdrawal by Subject|6|||
161909911|NCT01075048|584723429|FG002|Overall Study|Withdrawal by Subject|3|||
161909912|NCT01075048|584723427|FG000|Overall Study|Lost to Follow-up|0|||
161909913|NCT01075048|584723428|FG001|Overall Study|Lost to Follow-up|1|||
161909914|NCT01075048|584723429|FG002|Overall Study|Lost to Follow-up|1|||
161909915|NCT03944616|584723430|FG000|Overall Study|Lost to Follow-up|0|||
161909916|NCT03944616|584723431|FG001|Overall Study|Lost to Follow-up|2|||
161909917|NCT00408499|584723433|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
161909918|NCT00408499|584723434|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
161909919|NCT00408499|584723435|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
161909920|NCT00408499|584723436|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
161909921|NCT00408499|584723437|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
161909922|NCT00408499|584723433|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
161909923|NCT00408499|584723434|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
161909924|NCT00408499|584723435|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
161909925|NCT00408499|584723436|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
161909926|NCT00408499|584723437|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
161909927|NCT00408499|584723433|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
161909928|NCT00408499|584723434|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
161909929|NCT00408499|584723435|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
161909930|NCT00408499|584723436|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
161909931|NCT00408499|584723437|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
161909932|NCT00408499|584723433|FG000|Phase II- MTD Expansion|Adverse Event|0|||
161909933|NCT00408499|584723434|FG001|Phase II- MTD Expansion|Adverse Event|0|||
161909934|NCT00408499|584723435|FG002|Phase II- MTD Expansion|Adverse Event|0|||
161909935|NCT00408499|584723436|FG003|Phase II- MTD Expansion|Adverse Event|0|||
161909936|NCT00408499|584723437|FG004|Phase II- MTD Expansion|Adverse Event|9|||
161909937|NCT00408499|584723433|FG000|Phase II- MTD Expansion|Death|0|||
161909938|NCT00408499|584723434|FG001|Phase II- MTD Expansion|Death|0|||
161909939|NCT00408499|584723435|FG002|Phase II- MTD Expansion|Death|0|||
161909940|NCT00408499|584723436|FG003|Phase II- MTD Expansion|Death|0|||
161909941|NCT00408499|584723437|FG004|Phase II- MTD Expansion|Death|2|||
161909942|NCT00408499|584723433|FG000|Phase II- MTD Expansion|Physician Decision|0|||
161909943|NCT00408499|584723434|FG001|Phase II- MTD Expansion|Physician Decision|0|||
161909944|NCT00408499|584723435|FG002|Phase II- MTD Expansion|Physician Decision|0|||
161909945|NCT00408499|584723436|FG003|Phase II- MTD Expansion|Physician Decision|0|||
161909946|NCT00408499|584723437|FG004|Phase II- MTD Expansion|Physician Decision|1|||
161909947|NCT00408499|584723433|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
161909948|NCT00408499|584723434|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
161909949|NCT00408499|584723435|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
161909950|NCT00408499|584723436|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
161909951|NCT00408499|584723437|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
161909952|NCT00408499|584723433|FG000|Phase II- MTD Expansion|treatment delay|0|||
161909953|NCT00408499|584723434|FG001|Phase II- MTD Expansion|treatment delay|0|||
161909954|NCT00408499|584723435|FG002|Phase II- MTD Expansion|treatment delay|0|||
161909955|NCT00408499|584723436|FG003|Phase II- MTD Expansion|treatment delay|0|||
161909956|NCT00408499|584723437|FG004|Phase II- MTD Expansion|treatment delay|3|||
161909957|NCT00997334|584723440|FG000|Overall Study|still on therapy|12|||
161909958|NCT00997334|584723440|FG000|Overall Study|Adverse Event|3|||
161909959|NCT00997334|584723440|FG000|Overall Study|Patient non-compliance|1|||
161909960|NCT00997334|584723440|FG000|Overall Study|Withdrawal by Subject|3|||
161909961|NCT00997334|584723440|FG000|Overall Study|Death|2|||
161909962|NCT00997334|584723440|FG000|Overall Study|Urgent Palliative Care|2|||
161909963|NCT00997334|584723440|FG000|Overall Study|No lesion amenable|1|||
161909964|NCT00997334|584723440|FG000|Overall Study|Ineligible|1|||
161909965|NCT01586195|584723444|FG000|Overall Study|Death|11|||
161909966|NCT01586195|584723444|FG000|Overall Study|Withdrawal of Consent|5|||
161909967|NCT01586195|584723444|FG000|Overall Study|Started new anti-melanoma therapy|1|||
161909968|NCT01586195|584723444|FG000|Overall Study|Reason not specified|9|||
161909969|NCT01855958|584723445|FG000|Overall Study|Withdrawal by Subject|1|||
161909970|NCT01855958|584723446|FG001|Overall Study|Withdrawal by Subject|0|||
161909971|NCT01287936|584723447|FG000|Overall Study|Lost to Follow-up|0|||
161909972|NCT01287936|584723448|FG001|Overall Study|Lost to Follow-up|1|||
161909973|NCT01287936|584723449|FG002|Overall Study|Lost to Follow-up|1|||
161909974|NCT00296244|584723450|FG000|Overall Study|Underwent retransplant|0|||
161909975|NCT00296244|584723451|FG001|Overall Study|Underwent retransplant|1|||
161909976|NCT00266708|584723457|FG000|Overall Study|No renal function|1|||
161909977|NCT00266708|584723458|FG001|Overall Study|No renal function|1|||
161909978|NCT00266708|584723457|FG000|Overall Study|Refused biopsy|3|||
161909979|NCT00266708|584723458|FG001|Overall Study|Refused biopsy|6|||
161909980|NCT00266708|584723457|FG000|Overall Study|Asthma|0|||
161909981|NCT00266708|584723458|FG001|Overall Study|Asthma|2|||
161909982|NCT00703534|584723459|FG000|Overall Study|Adverse Event|14|||
161909983|NCT00703534|584723460|FG001|Overall Study|Adverse Event|3|||
161909984|NCT00703534|584723459|FG000|Overall Study|Withdrawal by Subject|8|||
161909985|NCT00703534|584723460|FG001|Overall Study|Withdrawal by Subject|7|||
161909986|NCT00703534|584723459|FG000|Overall Study|Incorrect Enrollment|6|||
161909987|NCT00703534|584723460|FG001|Overall Study|Incorrect Enrollment|6|||
161909988|NCT00703534|584723459|FG000|Overall Study|Lost to Follow-up|1|||
161909989|NCT00703534|584723460|FG001|Overall Study|Lost to Follow-up|4|||
161909990|NCT00703534|584723459|FG000|Overall Study|Severe Non Compliance|1|||
161909991|NCT00703534|584723460|FG001|Overall Study|Severe Non Compliance|5|||
161909992|NCT02791269|584723461|FG000|Overall Study|Lost to Follow-up|0|||
161909993|NCT02791269|584723462|FG001|Overall Study|Lost to Follow-up|1|||
161909994|NCT00427934|584723463|FG000|Overall Study|Adverse Event|1|||
161909995|NCT00427934|584723464|FG001|Overall Study|Adverse Event|0|||
161909996|NCT00427934|584723465|FG002|Overall Study|Adverse Event|5|||
161909997|NCT00427934|584723466|FG003|Overall Study|Adverse Event|4|||
161909998|NCT00427934|584723463|FG000|Overall Study|Lack of Efficacy|0|||
161909999|NCT00427934|584723464|FG001|Overall Study|Lack of Efficacy|0|||
161910000|NCT00427934|584723465|FG002|Overall Study|Lack of Efficacy|5|||
161910001|NCT00427934|584723466|FG003|Overall Study|Lack of Efficacy|2|||
161910002|NCT00427934|584723463|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
161910003|NCT00427934|584723464|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
161910004|NCT00427934|584723465|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
161910005|NCT00427934|584723466|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
161910006|NCT00427934|584723463|FG000|Overall Study|Other|0|||
161910007|NCT00427934|584723464|FG001|Overall Study|Other|0|||
161910008|NCT00427934|584723465|FG002|Overall Study|Other|11|||
161910009|NCT00427934|584723466|FG003|Overall Study|Other|5|||
161910010|NCT00427934|584723463|FG000|Overall Study|Withdrawal by Subject|0|||
161910011|NCT00427934|584723464|FG001|Overall Study|Withdrawal by Subject|0|||
161910012|NCT00427934|584723465|FG002|Overall Study|Withdrawal by Subject|1|||
161910013|NCT00427934|584723466|FG003|Overall Study|Withdrawal by Subject|3|||
161910014|NCT02683109|584723467|FG000|Overall Study|Adverse Event|1|||
162140318|NCT01695317|585565603|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
162140319|NCT01695317|585565604|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
162140320|NCT01695317|585565603|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
162140321|NCT01695317|585565604|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
162140322|NCT00003656|585565605|FG000|Overall Study|Adverse Event|0|||
162140323|NCT00003656|585565606|FG001|Overall Study|Adverse Event|1|||
162140324|NCT00464672|585565607|FG000|Overall Study|withdrawal of consent|0|||
162140325|NCT00464672|585565608|FG001|Overall Study|withdrawal of consent|0|||
162140326|NCT00464672|585565609|FG002|Overall Study|withdrawal of consent|0|||
162140327|NCT00464672|585565610|FG003|Overall Study|withdrawal of consent|1|||
162140328|NCT00464672|585565611|FG004|Overall Study|withdrawal of consent|9|||
161910015|NCT02683109|584723468|FG001|Overall Study|Adverse Event|0|||
161910016|NCT00368251|584723469|FG000|Overall Study|SAE, non-fatal|1|||
161910017|NCT00368251|584723470|FG001|Overall Study|SAE, non-fatal|0|||
161910018|NCT00368251|584723471|FG002|Overall Study|SAE, non-fatal|0|||
161910019|NCT00368251|584723469|FG000|Overall Study|AE, non-serious non-fatal|0|||
161910020|NCT00368251|584723470|FG001|Overall Study|AE, non-serious non-fatal|0|||
162010985|NCT05462756|585097689|FG001|Treatment Period|Protocol Violation|1|||
161910021|NCT00368251|584723471|FG002|Overall Study|AE, non-serious non-fatal|1|||
161910022|NCT03617588|584723472|FG000|Overall Study|Withdrawal by Subject|1|||
161910023|NCT03617588|584723473|FG001|Overall Study|Withdrawal by Subject|0|||
161910024|NCT03098979|584723478|FG000|Overall Study|Adverse Event|1|||
161910025|NCT03098979|584723479|FG001|Overall Study|Adverse Event|0|||
161910026|NCT03098979|584723480|FG002|Overall Study|Adverse Event|1|||
161910027|NCT03098979|584723481|FG003|Overall Study|Adverse Event|4|||
161910028|NCT03098979|584723482|FG004|Overall Study|Adverse Event|6|||
161910029|NCT03098979|584723483|FG005|Overall Study|Adverse Event|1|||
161910030|NCT03098979|584723478|FG000|Overall Study|Withdrawal by Subject|2|||
161910031|NCT03098979|584723479|FG001|Overall Study|Withdrawal by Subject|1|||
161910032|NCT03098979|584723480|FG002|Overall Study|Withdrawal by Subject|1|||
161910033|NCT03098979|584723481|FG003|Overall Study|Withdrawal by Subject|1|||
161910034|NCT03098979|584723482|FG004|Overall Study|Withdrawal by Subject|2|||
161910035|NCT03098979|584723483|FG005|Overall Study|Withdrawal by Subject|1|||
161910036|NCT03098979|584723478|FG000|Overall Study|Death|1|||
161910037|NCT03098979|584723479|FG001|Overall Study|Death|0|||
161910038|NCT03098979|584723480|FG002|Overall Study|Death|2|||
161910039|NCT03098979|584723481|FG003|Overall Study|Death|0|||
161910040|NCT03098979|584723482|FG004|Overall Study|Death|1|||
161910041|NCT03098979|584723483|FG005|Overall Study|Death|0|||
161910042|NCT03098979|584723478|FG000|Overall Study|Physician Decision|2|||
161910043|NCT03098979|584723479|FG001|Overall Study|Physician Decision|1|||
161910044|NCT03098979|584723480|FG002|Overall Study|Physician Decision|0|||
161910045|NCT03098979|584723481|FG003|Overall Study|Physician Decision|0|||
161910046|NCT03098979|584723482|FG004|Overall Study|Physician Decision|0|||
161910047|NCT03098979|584723483|FG005|Overall Study|Physician Decision|0|||
161910048|NCT03098979|584723478|FG000|Overall Study|Non-compliance|0|||
161910049|NCT03098979|584723479|FG001|Overall Study|Non-compliance|0|||
161910050|NCT03098979|584723480|FG002|Overall Study|Non-compliance|0|||
161910051|NCT03098979|584723481|FG003|Overall Study|Non-compliance|0|||
161910052|NCT03098979|584723482|FG004|Overall Study|Non-compliance|0|||
161910053|NCT03098979|584723483|FG005|Overall Study|Non-compliance|1|||
161910054|NCT03098979|584723478|FG000|Overall Study|Protocol Violation|0|||
161910055|NCT03098979|584723479|FG001|Overall Study|Protocol Violation|0|||
161910056|NCT03098979|584723480|FG002|Overall Study|Protocol Violation|0|||
161910057|NCT03098979|584723481|FG003|Overall Study|Protocol Violation|0|||
161910058|NCT03098979|584723482|FG004|Overall Study|Protocol Violation|0|||
161910059|NCT03098979|584723483|FG005|Overall Study|Protocol Violation|1|||
161910060|NCT04459338|584723486|FG000|Overall Study|Loss of IV during study|1|||
161910061|NCT04459338|584723487|FG001|Overall Study|Loss of IV during study|0|||
161910062|NCT03157089|584723488|FG000|Overall Study|Treated only with pembrolizumab|1|||
161910063|NCT03157089|584723489|FG001|Overall Study|Treated only with pembrolizumab|0|||
161910064|NCT03157089|584723488|FG000|Overall Study|Adverse Event|5|||
161910065|NCT03157089|584723489|FG001|Overall Study|Adverse Event|4|||
161910066|NCT03157089|584723488|FG000|Overall Study|Progressive disease|6|||
161910067|NCT03157089|584723489|FG001|Overall Study|Progressive disease|8|||
161910068|NCT00784875|584723490|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
161910069|NCT00784875|584723491|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
161910070|NCT00784875|584723492|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
161910071|NCT00784875|584723493|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
161910072|NCT00784875|584723490|FG000|Period A - Baseline|Adverse Event|0|||
161910073|NCT00784875|584723491|FG001|Period A - Baseline|Adverse Event|0|||
161910074|NCT00784875|584723492|FG002|Period A - Baseline|Adverse Event|0|||
161910075|NCT00784875|584723493|FG003|Period A - Baseline|Adverse Event|8|||
161910076|NCT00784875|584723490|FG000|Period A - Baseline|Protocol Violation|0|||
161910077|NCT00784875|584723491|FG001|Period A - Baseline|Protocol Violation|0|||
161910078|NCT00784875|584723492|FG002|Period A - Baseline|Protocol Violation|0|||
161910079|NCT00784875|584723493|FG003|Period A - Baseline|Protocol Violation|25|||
161910080|NCT00784875|584723490|FG000|Period A - Baseline|Withdrawal by Subject|0|||
161910081|NCT00784875|584723491|FG001|Period A - Baseline|Withdrawal by Subject|0|||
161910082|NCT00784875|584723492|FG002|Period A - Baseline|Withdrawal by Subject|0|||
162010986|NCT05462756|585097688|FG000|Treatment Period|Withdrawal by Subject|5|||
162010987|NCT05462756|585097689|FG001|Treatment Period|Withdrawal by Subject|12|||
162140329|NCT00464672|585565612|FG005|Overall Study|withdrawal of consent|4|||
162140330|NCT00464672|585565607|FG000|Overall Study|Lost to Follow-up|25|||
161910083|NCT00784875|584723493|FG003|Period A - Baseline|Withdrawal by Subject|27|||
161910084|NCT00784875|584723490|FG000|Period A - Baseline|Physician Decision|0|||
161910085|NCT00784875|584723491|FG001|Period A - Baseline|Physician Decision|0|||
161910086|NCT00784875|584723492|FG002|Period A - Baseline|Physician Decision|0|||
161910087|NCT00784875|584723493|FG003|Period A - Baseline|Physician Decision|2|||
161910088|NCT00784875|584723490|FG000|Period A - Baseline|Sponsor Decision|0|||
161910089|NCT00784875|584723491|FG001|Period A - Baseline|Sponsor Decision|0|||
161910090|NCT00784875|584723492|FG002|Period A - Baseline|Sponsor Decision|0|||
161910091|NCT00784875|584723493|FG003|Period A - Baseline|Sponsor Decision|113|||
161910092|NCT00784875|584723490|FG000|Period A - Baseline|Lost to Follow-up|0|||
161910093|NCT00784875|584723491|FG001|Period A - Baseline|Lost to Follow-up|0|||
161910094|NCT00784875|584723492|FG002|Period A - Baseline|Lost to Follow-up|0|||
161910095|NCT00784875|584723493|FG003|Period A - Baseline|Lost to Follow-up|2|||
161910096|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
161806543|NCT05093205|584335962|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806544|NCT05093205|584335963|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806545|NCT05093205|584335964|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806546|NCT05093205|584335965|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806547|NCT05093205|584335966|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
161806548|NCT05093205|584335967|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806549|NCT05093205|584335968|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161806550|NCT05093205|584335956|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806551|NCT05093205|584335957|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806552|NCT05093205|584335958|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806553|NCT05093205|584335959|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806554|NCT05093205|584335960|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806555|NCT05093205|584335961|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806556|NCT05093205|584335962|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806557|NCT05093205|584335963|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806558|NCT05093205|584335964|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806559|NCT05093205|584335965|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806560|NCT05093205|584335966|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806561|NCT05093205|584335967|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
161806562|NCT05093205|584335968|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161806563|NCT05093205|584335956|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
161806564|NCT05093205|584335957|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
161806565|NCT05093205|584335958|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
161806566|NCT05093205|584335959|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
161806567|NCT05093205|584335960|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
161806568|NCT05093205|584335961|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
161806569|NCT05093205|584335962|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
161806570|NCT05093205|584335963|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
161806571|NCT05093205|584335964|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
161806572|NCT05093205|584335965|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
161806573|NCT05093205|584335966|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
161806574|NCT05093205|584335967|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
161806575|NCT05093205|584335968|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
161806576|NCT05093205|584335956|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806577|NCT05093205|584335957|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806578|NCT05093205|584335958|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806579|NCT05093205|584335959|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806580|NCT05093205|584335960|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806581|NCT05093205|584335961|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806582|NCT05093205|584335962|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806583|NCT05093205|584335963|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806584|NCT05093205|584335964|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806585|NCT05093205|584335965|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806586|NCT05093205|584335966|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806587|NCT05093205|584335967|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
161806588|NCT05093205|584335968|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161806589|NCT00268905|584335978|FG000|Overall Study|Adverse Event|3|||
161806590|NCT00268905|584335979|FG001|Overall Study|Adverse Event|0|||
161806591|NCT00268905|584335980|FG002|Overall Study|Adverse Event|4|||
161806592|NCT00268905|584335978|FG000|Overall Study|Lost to Follow-up|0|||
161806593|NCT00268905|584335979|FG001|Overall Study|Lost to Follow-up|1|||
161806594|NCT00268905|584335980|FG002|Overall Study|Lost to Follow-up|0|||
161806595|NCT00268905|584335978|FG000|Overall Study|Withdrawal by Subject|0|||
161806596|NCT00268905|584335979|FG001|Overall Study|Withdrawal by Subject|0|||
161806597|NCT00268905|584335980|FG002|Overall Study|Withdrawal by Subject|3|||
161806598|NCT00268905|584335978|FG000|Overall Study|Progressive Disease|28|||
161806599|NCT00268905|584335979|FG001|Overall Study|Progressive Disease|4|||
161910097|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
161910098|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
161910099|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
161910100|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
161910101|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
161910102|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
161910103|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
161910104|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
161910105|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
161910106|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
161910107|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
161910108|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
161910109|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
161910110|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
161910111|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
161910112|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
161910113|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
161910114|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
161910115|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
161910116|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
161910117|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
161910118|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
161910119|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
161910120|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
161910121|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
161910122|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
161910123|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
161910124|NCT00784875|584723490|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
161910125|NCT00784875|584723491|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
161910126|NCT00784875|584723492|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
161910127|NCT00784875|584723493|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
161910128|NCT00784875|584723490|FG000|Period C|Adverse Event|1|||
161910129|NCT00784875|584723491|FG001|Period C|Adverse Event|0|||
161910130|NCT00784875|584723492|FG002|Period C|Adverse Event|4|||
161910131|NCT00784875|584723493|FG003|Period C|Adverse Event|2|||
161910132|NCT00784875|584723490|FG000|Period C|Protocol Violation|0|||
161910133|NCT00784875|584723491|FG001|Period C|Protocol Violation|0|||
161910134|NCT00784875|584723492|FG002|Period C|Protocol Violation|1|||
161910135|NCT00784875|584723493|FG003|Period C|Protocol Violation|2|||
161910136|NCT00784875|584723490|FG000|Period C|Lack of Efficacy|0|||
161910137|NCT00784875|584723491|FG001|Period C|Lack of Efficacy|0|||
161910138|NCT00784875|584723492|FG002|Period C|Lack of Efficacy|1|||
161910139|NCT00784875|584723493|FG003|Period C|Lack of Efficacy|0|||
161910140|NCT00784875|584723490|FG000|Period C|Withdrawal by Subject|1|||
161910141|NCT00784875|584723491|FG001|Period C|Withdrawal by Subject|1|||
161910142|NCT00784875|584723492|FG002|Period C|Withdrawal by Subject|2|||
161910143|NCT00784875|584723493|FG003|Period C|Withdrawal by Subject|0|||
161910144|NCT00784875|584723490|FG000|Period C|Physician Decision|0|||
161910145|NCT00784875|584723491|FG001|Period C|Physician Decision|0|||
162140331|NCT00464672|585565608|FG001|Overall Study|Lost to Follow-up|10|||
162140332|NCT00464672|585565609|FG002|Overall Study|Lost to Follow-up|0|||
162140333|NCT00464672|585565610|FG003|Overall Study|Lost to Follow-up|0|||
162140334|NCT00464672|585565611|FG004|Overall Study|Lost to Follow-up|1|||
162140335|NCT00464672|585565612|FG005|Overall Study|Lost to Follow-up|0|||
162140336|NCT03055767|585565613|FG000|Open-Label Period|Lost to Follow-up|0|||
162140337|NCT03055767|585565614|FG001|Open-Label Period|Lost to Follow-up|0|||
162140338|NCT03055767|585565615|FG002|Open-Label Period|Lost to Follow-up|2|||
162140339|NCT03055767|585565616|FG003|Open-Label Period|Lost to Follow-up|0|||
162140340|NCT03055767|585565613|FG000|Open-Label Period|Withdrawal by Subject|0|||
162140341|NCT03055767|585565614|FG001|Open-Label Period|Withdrawal by Subject|0|||
162140342|NCT03055767|585565615|FG002|Open-Label Period|Withdrawal by Subject|0|||
162140343|NCT03055767|585565616|FG003|Open-Label Period|Withdrawal by Subject|1|||
162140344|NCT02759731|585565619|FG000|Overall Study|Did not complete treatment.|8|||
162140345|NCT00763282|585565624|FG000|Overall Study|Withdrawal by Subject|6|||
162140346|NCT00763282|585565625|FG001|Overall Study|Withdrawal by Subject|5|||
162140347|NCT00763282|585565624|FG000|Overall Study|Death|4|||
162140348|NCT00763282|585565625|FG001|Overall Study|Death|3|||
162140349|NCT00763282|585565624|FG000|Overall Study|Lost to Follow-up|22|||
162140350|NCT00763282|585565625|FG001|Overall Study|Lost to Follow-up|26|||
162140351|NCT00606580|585565626|FG000|Overall Study|Lost to Follow-up|1|||
162140352|NCT00606580|585565627|FG001|Overall Study|Lost to Follow-up|1|||
162140353|NCT00606580|585565628|FG002|Overall Study|Lost to Follow-up|4|||
162140354|NCT00606580|585565626|FG000|Overall Study|Clinical failures|1|||
162140355|NCT00606580|585565627|FG001|Overall Study|Clinical failures|0|||
162140356|NCT00606580|585565628|FG002|Overall Study|Clinical failures|12|||
162140357|NCT00606580|585565626|FG000|Overall Study|Withdrawal by investigator|0|||
162140358|NCT00606580|585565627|FG001|Overall Study|Withdrawal by investigator|1|||
162140359|NCT00606580|585565628|FG002|Overall Study|Withdrawal by investigator|6|||
162140360|NCT00606580|585565626|FG000|Overall Study|Withdrawal by Subject|0|||
162140361|NCT00606580|585565627|FG001|Overall Study|Withdrawal by Subject|1|||
162140362|NCT00606580|585565628|FG002|Overall Study|Withdrawal by Subject|0|||
162140363|NCT04580303|585565629|FG000|Overall Study|Adverse Event|0|||
162140364|NCT04580303|585565630|FG001|Overall Study|Adverse Event|1|||
162140365|NCT04580303|585565631|FG002|Overall Study|Adverse Event|0|||
162140366|NCT04580303|585565632|FG003|Overall Study|Adverse Event|0|||
162140367|NCT04580303|585565629|FG000|Overall Study|Withdrawal by Subject|0|||
162140368|NCT04580303|585565630|FG001|Overall Study|Withdrawal by Subject|0|||
162140369|NCT04580303|585565631|FG002|Overall Study|Withdrawal by Subject|1|||
162140370|NCT04580303|585565632|FG003|Overall Study|Withdrawal by Subject|0|||
162140371|NCT01833065|585565633|FG000|Overall Study|Adverse Event|6|||
162140372|NCT01833065|585565634|FG001|Overall Study|Adverse Event|1|||
162140373|NCT01833065|585565635|FG002|Overall Study|Adverse Event|0|||
162140374|NCT01833065|585565636|FG003|Overall Study|Adverse Event|2|||
162140375|NCT01833065|585565637|FG004|Overall Study|Adverse Event|3|||
162140376|NCT01833065|585565633|FG000|Overall Study|Protocol Violation|1|||
162140377|NCT01833065|585565634|FG001|Overall Study|Protocol Violation|0|||
162140378|NCT01833065|585565635|FG002|Overall Study|Protocol Violation|0|||
162140379|NCT01833065|585565636|FG003|Overall Study|Protocol Violation|0|||
162140380|NCT01833065|585565637|FG004|Overall Study|Protocol Violation|2|||
162140381|NCT01833065|585565633|FG000|Overall Study|Lost to Follow-up|1|||
162140382|NCT01833065|585565634|FG001|Overall Study|Lost to Follow-up|0|||
162140383|NCT01833065|585565635|FG002|Overall Study|Lost to Follow-up|0|||
162140384|NCT01833065|585565636|FG003|Overall Study|Lost to Follow-up|0|||
162140385|NCT01833065|585565637|FG004|Overall Study|Lost to Follow-up|3|||
162140386|NCT01833065|585565633|FG000|Overall Study|Withdrawal by Subject|6|||
162140387|NCT01833065|585565634|FG001|Overall Study|Withdrawal by Subject|2|||
162140388|NCT01833065|585565635|FG002|Overall Study|Withdrawal by Subject|4|||
162140389|NCT01833065|585565636|FG003|Overall Study|Withdrawal by Subject|3|||
162140390|NCT01833065|585565637|FG004|Overall Study|Withdrawal by Subject|11|||
162140391|NCT01833065|585565633|FG000|Overall Study|Subject's substantial non-compliance|0|||
162140392|NCT01833065|585565634|FG001|Overall Study|Subject's substantial non-compliance|1|||
162140393|NCT01833065|585565635|FG002|Overall Study|Subject's substantial non-compliance|0|||
162140394|NCT01833065|585565636|FG003|Overall Study|Subject's substantial non-compliance|0|||
162140395|NCT01833065|585565637|FG004|Overall Study|Subject's substantial non-compliance|0|||
162140396|NCT01833065|585565633|FG000|Overall Study|Trial terminated by sponsor|8|||
162140397|NCT01833065|585565634|FG001|Overall Study|Trial terminated by sponsor|8|||
162140398|NCT01833065|585565635|FG002|Overall Study|Trial terminated by sponsor|7|||
162140399|NCT01833065|585565636|FG003|Overall Study|Trial terminated by sponsor|3|||
162140400|NCT01833065|585565637|FG004|Overall Study|Trial terminated by sponsor|13|||
162140401|NCT01833065|585565633|FG000|Overall Study|Others|2|||
162140402|NCT01833065|585565634|FG001|Overall Study|Others|1|||
162140403|NCT01833065|585565635|FG002|Overall Study|Others|1|||
162140404|NCT01833065|585565636|FG003|Overall Study|Others|1|||
162140405|NCT01833065|585565637|FG004|Overall Study|Others|4|||
162140406|NCT00601640|585565639|FG000|Overall Study|Withdrawal by Subject|3|||
162140407|NCT00601640|585565640|FG001|Overall Study|Withdrawal by Subject|0|||
162140408|NCT00601640|585565641|FG002|Overall Study|Withdrawal by Subject|7|||
162140409|NCT00601640|585565639|FG000|Overall Study|Death|1|||
162140410|NCT00601640|585565640|FG001|Overall Study|Death|0|||
162140411|NCT00601640|585565641|FG002|Overall Study|Death|0|||
162140412|NCT00601640|585565639|FG000|Overall Study|Adverse Event|0|||
162140413|NCT00601640|585565640|FG001|Overall Study|Adverse Event|4|||
162140414|NCT00601640|585565641|FG002|Overall Study|Adverse Event|2|||
162140415|NCT00601640|585565639|FG000|Overall Study|intercurrent illness|1|||
162140416|NCT00601640|585565640|FG001|Overall Study|intercurrent illness|0|||
162140417|NCT00601640|585565641|FG002|Overall Study|intercurrent illness|0|||
162140418|NCT00601640|585565639|FG000|Overall Study|change in eligibility status|0|||
162140419|NCT00601640|585565640|FG001|Overall Study|change in eligibility status|1|||
162140420|NCT00601640|585565641|FG002|Overall Study|change in eligibility status|1|||
162140421|NCT00015457|585565644|FG000|First Intervention|Adverse Event|0|||
162140422|NCT00015457|585565645|FG001|First Intervention|Adverse Event|2|||
162140423|NCT00015457|585565644|FG000|First Intervention|Lack of Efficacy|0|||
162140424|NCT00015457|585565645|FG001|First Intervention|Lack of Efficacy|1|||
162140425|NCT00015457|585565644|FG000|Second Intervention|Withdrawal by Subject|1|||
162140426|NCT00015457|585565645|FG001|Second Intervention|Withdrawal by Subject|0|||
162140427|NCT01456936|585565646|FG000|Overall Study|Other reason|41|||
162140428|NCT01456936|585565647|FG001|Overall Study|Other reason|30|||
162140429|NCT01456936|585565648|FG002|Overall Study|Other reason|36|||
162140430|NCT01456936|585565649|FG003|Overall Study|Other reason|33|||
162140431|NCT01456936|585565646|FG000|Overall Study|No longer meets eligibility criteria|4|||
162140432|NCT01456936|585565647|FG001|Overall Study|No longer meets eligibility criteria|8|||
162140433|NCT01456936|585565648|FG002|Overall Study|No longer meets eligibility criteria|6|||
162140434|NCT01456936|585565649|FG003|Overall Study|No longer meets eligibility criteria|5|||
162140435|NCT01456936|585565646|FG000|Overall Study|Protocol Violation|4|||
162140436|NCT01456936|585565647|FG001|Overall Study|Protocol Violation|2|||
162140437|NCT01456936|585565648|FG002|Overall Study|Protocol Violation|5|||
162140438|NCT01456936|585565649|FG003|Overall Study|Protocol Violation|5|||
162140439|NCT01456936|585565646|FG000|Overall Study|Pregnancy|1|||
162140440|NCT01456936|585565647|FG001|Overall Study|Pregnancy|0|||
162140441|NCT01456936|585565648|FG002|Overall Study|Pregnancy|0|||
162140442|NCT01456936|585565649|FG003|Overall Study|Pregnancy|1|||
162140443|NCT01456936|585565646|FG000|Overall Study|Insufficient clinical response|4|||
162140444|NCT01456936|585565647|FG001|Overall Study|Insufficient clinical response|4|||
162140445|NCT01456936|585565648|FG002|Overall Study|Insufficient clinical response|14|||
162140446|NCT01456936|585565649|FG003|Overall Study|Insufficient clinical response|13|||
162140447|NCT01456936|585565646|FG000|Overall Study|No longer willing to participate|195|||
162140448|NCT01456936|585565647|FG001|Overall Study|No longer willing to participate|218|||
162140449|NCT01456936|585565648|FG002|Overall Study|No longer willing to participate|224|||
162140450|NCT01456936|585565649|FG003|Overall Study|No longer willing to participate|248|||
162140451|NCT01456936|585565646|FG000|Overall Study|Lost to Follow-up|135|||
162140452|NCT01456936|585565647|FG001|Overall Study|Lost to Follow-up|126|||
162140453|NCT01456936|585565648|FG002|Overall Study|Lost to Follow-up|144|||
162140454|NCT01456936|585565649|FG003|Overall Study|Lost to Follow-up|127|||
162140455|NCT01456936|585565646|FG000|Overall Study|Medication error|0|||
162140456|NCT01456936|585565647|FG001|Overall Study|Medication error|1|||
162140457|NCT01456936|585565648|FG002|Overall Study|Medication error|0|||
162140458|NCT01456936|585565649|FG003|Overall Study|Medication error|1|||
162140459|NCT01456936|585565646|FG000|Overall Study|Adverse event (study drug)|25|||
162140460|NCT01456936|585565647|FG001|Overall Study|Adverse event (study drug)|21|||
162140461|NCT01456936|585565648|FG002|Overall Study|Adverse event (study drug)|26|||
162140462|NCT01456936|585565649|FG003|Overall Study|Adverse event (study drug)|17|||
162140463|NCT01456936|585565646|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
162140464|NCT01456936|585565647|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
162140465|NCT01456936|585565648|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
162140466|NCT01456936|585565649|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
162140467|NCT01456936|585565646|FG000|Overall Study|Death|0|||
162140468|NCT01456936|585565647|FG001|Overall Study|Death|3|||
162140469|NCT01456936|585565648|FG002|Overall Study|Death|1|||
162140470|NCT01456936|585565649|FG003|Overall Study|Death|3|||
162140471|NCT01456936|585565646|FG000|Overall Study|Randomized but not treated|21|||
162140472|NCT01456936|585565647|FG001|Overall Study|Randomized but not treated|28|||
162140473|NCT01456936|585565648|FG002|Overall Study|Randomized but not treated|16|||
162140474|NCT01456936|585565649|FG003|Overall Study|Randomized but not treated|21|||
162140475|NCT00543725|585565650|FG000|Overall Study|Adverse Event|18|||
162140476|NCT00543725|585565651|FG001|Overall Study|Adverse Event|27|||
162140477|NCT00543725|585565650|FG000|Overall Study|Sponsor's Decision|0|||
162140478|NCT00543725|585565651|FG001|Overall Study|Sponsor's Decision|1|||
162140479|NCT00543725|585565650|FG000|Overall Study|Subject Non-Compliant|4|||
162140480|NCT00543725|585565651|FG001|Overall Study|Subject Non-Compliant|4|||
162140481|NCT00543725|585565650|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
162140482|NCT00543725|585565651|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
162140483|NCT00543725|585565650|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
162140484|NCT00543725|585565651|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
162140485|NCT00543725|585565650|FG000|Overall Study|Protocol Violation|0|||
162140486|NCT00543725|585565651|FG001|Overall Study|Protocol Violation|1|||
162140487|NCT00543725|585565650|FG000|Overall Study|Withdrawal by Subject|4|||
162140488|NCT00543725|585565651|FG001|Overall Study|Withdrawal by Subject|13|||
162140489|NCT00543725|585565650|FG000|Overall Study|Lost to Follow-up|15|||
162140490|NCT00543725|585565651|FG001|Overall Study|Lost to Follow-up|11|||
162140491|NCT00543725|585565650|FG000|Overall Study|Other|3|||
162140492|NCT00543725|585565651|FG001|Overall Study|Other|3|||
162140493|NCT00906698|585565652|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
162140494|NCT00906698|585565653|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
162140495|NCT00906698|585565654|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
162140496|NCT00906698|585565655|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
162140497|NCT00906698|585565656|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
162140498|NCT00906698|585565657|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
162140499|NCT00906698|585565652|FG000|Overall Study|Adverse Event|0|||
162140500|NCT00906698|585565653|FG001|Overall Study|Adverse Event|0|||
162140501|NCT00906698|585565654|FG002|Overall Study|Adverse Event|2|||
162140502|NCT00906698|585565655|FG003|Overall Study|Adverse Event|0|||
162140503|NCT00906698|585565656|FG004|Overall Study|Adverse Event|4|||
162140504|NCT00906698|585565657|FG005|Overall Study|Adverse Event|1|||
162140505|NCT00906698|585565652|FG000|Overall Study|Disease progression|3|||
162140506|NCT00906698|585565653|FG001|Overall Study|Disease progression|12|||
162140507|NCT00906698|585565654|FG002|Overall Study|Disease progression|4|||
162140508|NCT00906698|585565655|FG003|Overall Study|Disease progression|4|||
162140509|NCT00906698|585565656|FG004|Overall Study|Disease progression|12|||
162140510|NCT00906698|585565657|FG005|Overall Study|Disease progression|4|||
162140511|NCT00906698|585565652|FG000|Overall Study|Withdrawal by Subject|0|||
162140512|NCT00906698|585565653|FG001|Overall Study|Withdrawal by Subject|0|||
162140513|NCT00906698|585565654|FG002|Overall Study|Withdrawal by Subject|0|||
162140514|NCT00906698|585565655|FG003|Overall Study|Withdrawal by Subject|0|||
162140515|NCT00906698|585565656|FG004|Overall Study|Withdrawal by Subject|1|||
162140516|NCT00906698|585565657|FG005|Overall Study|Withdrawal by Subject|0|||
162140517|NCT00906698|585565652|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
162140518|NCT00906698|585565653|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
162140519|NCT00906698|585565654|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
162140520|NCT00906698|585565655|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
162140521|NCT00906698|585565656|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
162140522|NCT00906698|585565657|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
162140523|NCT01250002|585565658|FG000|Overall Study|Change to open surgical procedure|4|||
162140524|NCT01250002|585565659|FG001|Overall Study|Change to open surgical procedure|3|||
162140525|NCT02317705|585565660|FG000|Overall Study|Withdrawal by Subject|3|||
162140526|NCT02317705|585565660|FG000|Overall Study|Physician Decision|1|||
162140527|NCT02317705|585565660|FG000|Overall Study|Drug not usable|1|||
162140528|NCT01674569|585565661|FG000|Overall Study|Adverse Event|0|||
162140529|NCT01674569|585565662|FG001|Overall Study|Adverse Event|2|||
162140530|NCT01674569|585565663|FG002|Overall Study|Adverse Event|0|||
162140531|NCT01674569|585565664|FG003|Overall Study|Adverse Event|1|||
162140532|NCT01674569|585565665|FG004|Overall Study|Adverse Event|2|||
162140533|NCT01674569|585565666|FG005|Overall Study|Adverse Event|2|||
162140534|NCT01674569|585565661|FG000|Overall Study|Protocol Violation|0|||
162140535|NCT01674569|585565662|FG001|Overall Study|Protocol Violation|1|||
162140536|NCT01674569|585565663|FG002|Overall Study|Protocol Violation|1|||
162140537|NCT01674569|585565664|FG003|Overall Study|Protocol Violation|0|||
162140538|NCT01674569|585565665|FG004|Overall Study|Protocol Violation|0|||
162140539|NCT01674569|585565666|FG005|Overall Study|Protocol Violation|0|||
162140540|NCT01674569|585565661|FG000|Overall Study|Withdrawal by Subject|0|||
162140541|NCT01674569|585565662|FG001|Overall Study|Withdrawal by Subject|0|||
162140542|NCT01674569|585565663|FG002|Overall Study|Withdrawal by Subject|1|||
162140543|NCT01674569|585565664|FG003|Overall Study|Withdrawal by Subject|0|||
162140544|NCT01674569|585565665|FG004|Overall Study|Withdrawal by Subject|0|||
162140545|NCT01674569|585565666|FG005|Overall Study|Withdrawal by Subject|0|||
162140546|NCT01599325|585565667|FG000|Primary Parent Phase|Adverse Event|5|||
162140547|NCT01599325|585565667|FG000|Primary Parent Phase|Disease Progression|7|||
162140548|NCT01599325|585565667|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
162140549|NCT01599325|585565667|FG000|Primary Parent Phase|Death|13|||
162140550|NCT01599325|585565667|FG000|Primary Parent Phase|Protocol Violation|1|||
162140551|NCT01599325|585565667|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
162140552|NCT01599325|585565667|FG000|Primary Parent Phase|Other|2|||
162140553|NCT01599325|585565667|FG000|Extension Phase|Study Closure|1|||
162140554|NCT01599325|585565667|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
162140555|NCT01599325|585565667|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
162140556|NCT01599325|585565667|FG000|Extension Phase|Disease Progression|1|||
162140557|NCT01599325|585565667|FG000|Extension Phase|Withdrawal by Subject|8|||
162140558|NCT02365298|585565670|FG000|Period 2|incorrect Rx dispensed|1|||
162140559|NCT02365298|585565671|FG001|Period 2|incorrect Rx dispensed|0|||
162140560|NCT02365298|585565670|FG000|Period 2|Discontinued at request of Sponsor|1|||
161910146|NCT00784875|584723492|FG002|Period C|Physician Decision|1|||
161910147|NCT00784875|584723493|FG003|Period C|Physician Decision|1|||
161910148|NCT00784875|584723490|FG000|Period C|Sponsor Decision|5|||
161910149|NCT00784875|584723491|FG001|Period C|Sponsor Decision|5|||
161910150|NCT00784875|584723492|FG002|Period C|Sponsor Decision|4|||
161910151|NCT00784875|584723493|FG003|Period C|Sponsor Decision|2|||
161910152|NCT00784875|584723490|FG000|Period D|Adverse Event|0|||
161910153|NCT00784875|584723491|FG001|Period D|Adverse Event|2|||
161910154|NCT00784875|584723492|FG002|Period D|Adverse Event|2|||
161910155|NCT00784875|584723493|FG003|Period D|Adverse Event|0|||
161910156|NCT00784875|584723490|FG000|Period D|Protocol Violation|1|||
161910157|NCT00784875|584723491|FG001|Period D|Protocol Violation|0|||
161910158|NCT00784875|584723492|FG002|Period D|Protocol Violation|0|||
161910159|NCT00784875|584723493|FG003|Period D|Protocol Violation|0|||
161910160|NCT00784875|584723490|FG000|Period D|Withdrawal by Subject|2|||
161910161|NCT00784875|584723491|FG001|Period D|Withdrawal by Subject|0|||
161910162|NCT00784875|584723492|FG002|Period D|Withdrawal by Subject|2|||
161910163|NCT00784875|584723493|FG003|Period D|Withdrawal by Subject|0|||
161910164|NCT00784875|584723490|FG000|Period D|Physician Decision|0|||
161910165|NCT00784875|584723491|FG001|Period D|Physician Decision|1|||
161910166|NCT00784875|584723492|FG002|Period D|Physician Decision|0|||
161910167|NCT00784875|584723493|FG003|Period D|Physician Decision|0|||
161910168|NCT00784875|584723490|FG000|Period D|Sponsor Decision|1|||
161910169|NCT00784875|584723491|FG001|Period D|Sponsor Decision|1|||
161910170|NCT00784875|584723492|FG002|Period D|Sponsor Decision|1|||
161910171|NCT00784875|584723493|FG003|Period D|Sponsor Decision|0|||
161910172|NCT00784875|584723490|FG000|Period D|Lost to Follow-up|1|||
161910173|NCT00784875|584723491|FG001|Period D|Lost to Follow-up|0|||
161910174|NCT00784875|584723492|FG002|Period D|Lost to Follow-up|1|||
161910175|NCT00784875|584723493|FG003|Period D|Lost to Follow-up|1|||
161910176|NCT00958074|584723494|FG000|Overall Study|Withdrawal by Subject|0|||
161910177|NCT00958074|584723495|FG001|Overall Study|Withdrawal by Subject|1|||
161910178|NCT01829347|584723500|FG000|VTI-210|Death|5|||
161910179|NCT01829347|584723501|FG001|VTI-210|Death|3|||
161910180|NCT01829347|584723500|FG000|VTI-210|Withdrawal by Subject|1|||
161910181|NCT01829347|584723501|FG001|VTI-210|Withdrawal by Subject|0|||
161910182|NCT01829347|584723500|FG000|VTI-210E|Death|2|||
161910183|NCT01829347|584723501|FG001|VTI-210E|Death|1|||
161910184|NCT01829347|584723500|FG000|VTI-210E|Study terminated prematurely|1|||
161910185|NCT01829347|584723501|FG001|VTI-210E|Study terminated prematurely|5|||
161910186|NCT02515227|584723502|FG000|Overall Study|Adverse Event|0|||
161910187|NCT02515227|584723503|FG001|Overall Study|Adverse Event|2|||
161910188|NCT02515227|584723502|FG000|Overall Study|Progressive disease|2|||
161910189|NCT02515227|584723503|FG001|Overall Study|Progressive disease|9|||
161910190|NCT03451071|584723510|FG000|First Vaccine|Withdrawal by Subject|1|||
161910191|NCT03451071|584723510|FG000|Second Vaccine|Lost to Follow-up|19|||
161910192|NCT03451071|584723510|FG000|Third Vaccine|Lost to Follow-up|22|||
161910193|NCT03451071|584723510|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
161910194|NCT00250588|584723511|FG000|Overall Study|Withdrawal by Subject|3|||
161806600|NCT00268905|584335980|FG002|Overall Study|Progressive Disease|3|||
161806601|NCT00268905|584335978|FG000|Overall Study|Physician Decision|3|||
161806602|NCT00268905|584335979|FG001|Overall Study|Physician Decision|0|||
161806603|NCT00268905|584335980|FG002|Overall Study|Physician Decision|1|||
161806604|NCT00268905|584335978|FG000|Overall Study|Clinical Progression|9|||
161806605|NCT00268905|584335979|FG001|Overall Study|Clinical Progression|4|||
161806606|NCT00268905|584335980|FG002|Overall Study|Clinical Progression|1|||
161806607|NCT04510285|584335981|FG000|Overall Study|Death|1|||
161806608|NCT00048581|584335982|FG000|Double-Blind Period|Adverse Event|9|||
161806609|NCT00048581|584335983|FG001|Double-Blind Period|Adverse Event|5|||
161910195|NCT00250588|584723512|FG001|Overall Study|Withdrawal by Subject|6|||
161910196|NCT00250588|584723513|FG002|Overall Study|Withdrawal by Subject|0|||
161910197|NCT00250588|584723511|FG000|Overall Study|Lost to Follow-up|6|||
161910198|NCT00250588|584723512|FG001|Overall Study|Lost to Follow-up|13|||
161910199|NCT00250588|584723513|FG002|Overall Study|Lost to Follow-up|13|||
161910200|NCT00706797|584723514|FG000|Overall Study|Lack of Efficacy|3|||
161910201|NCT00706797|584723515|FG001|Overall Study|Lack of Efficacy|0|||
161910202|NCT00706797|584723514|FG000|Overall Study|Adverse Event|0|||
161910203|NCT00706797|584723515|FG001|Overall Study|Adverse Event|3|||
161910204|NCT00706797|584723514|FG000|Overall Study|Withdrawal by Subject|8|||
161910205|NCT00706797|584723515|FG001|Overall Study|Withdrawal by Subject|1|||
161910206|NCT00706797|584723514|FG000|Overall Study|Death|1|||
161910207|NCT00706797|584723515|FG001|Overall Study|Death|0|||
161910208|NCT00706797|584723514|FG000|Overall Study|Discontinuation of study by sponsor|52|||
161910209|NCT00706797|584723515|FG001|Overall Study|Discontinuation of study by sponsor|63|||
161910210|NCT00706797|584723514|FG000|Overall Study|Protocol Violation|3|||
161806610|NCT00048581|584335984|FG002|Double-Blind Period|Adverse Event|0|||
161910211|NCT00706797|584723515|FG001|Overall Study|Protocol Violation|2|||
161910212|NCT00706797|584723514|FG000|Overall Study|Lost to Follow-up|1|||
161910213|NCT00706797|584723515|FG001|Overall Study|Lost to Follow-up|2|||
161910214|NCT00706797|584723514|FG000|Overall Study|Other|1|||
161910215|NCT00706797|584723515|FG001|Overall Study|Other|0|||
161910216|NCT01670292|584723518|FG000|Overall Study|Lost to Follow-up|14|||
161910217|NCT03555149|584723522|FG000|Overall Study|Death|18|||
161910218|NCT03555149|584723523|FG001|Overall Study|Death|15|||
161910219|NCT03555149|584723524|FG002|Overall Study|Death|15|||
161910220|NCT03555149|584723525|FG003|Overall Study|Death|4|||
161910221|NCT03555149|584723526|FG004|Overall Study|Death|4|||
161910222|NCT03555149|584723527|FG005|Overall Study|Death|11|||
161910223|NCT03555149|584723528|FG006|Overall Study|Death|12|||
161910224|NCT03555149|584723529|FG007|Overall Study|Death|1|||
161910225|NCT03555149|584723522|FG000|Overall Study|Lost to Follow-up|1|||
161910226|NCT03555149|584723523|FG001|Overall Study|Lost to Follow-up|0|||
161910227|NCT03555149|584723524|FG002|Overall Study|Lost to Follow-up|0|||
161910228|NCT03555149|584723525|FG003|Overall Study|Lost to Follow-up|0|||
161910229|NCT03555149|584723526|FG004|Overall Study|Lost to Follow-up|0|||
161910230|NCT03555149|584723527|FG005|Overall Study|Lost to Follow-up|1|||
161910231|NCT03555149|584723528|FG006|Overall Study|Lost to Follow-up|0|||
161910232|NCT03555149|584723529|FG007|Overall Study|Lost to Follow-up|0|||
161910233|NCT03555149|584723522|FG000|Overall Study|Physician Decision|1|||
161910234|NCT03555149|584723523|FG001|Overall Study|Physician Decision|0|||
161910235|NCT03555149|584723524|FG002|Overall Study|Physician Decision|0|||
161910236|NCT03555149|584723525|FG003|Overall Study|Physician Decision|0|||
161910237|NCT03555149|584723526|FG004|Overall Study|Physician Decision|0|||
161910238|NCT03555149|584723527|FG005|Overall Study|Physician Decision|0|||
161910239|NCT03555149|584723528|FG006|Overall Study|Physician Decision|0|||
161910240|NCT03555149|584723529|FG007|Overall Study|Physician Decision|0|||
161910241|NCT03555149|584723522|FG000|Overall Study|Study Terminated By Sponsor|1|||
161910242|NCT03555149|584723523|FG001|Overall Study|Study Terminated By Sponsor|0|||
161910243|NCT03555149|584723524|FG002|Overall Study|Study Terminated By Sponsor|0|||
161910244|NCT03555149|584723525|FG003|Overall Study|Study Terminated By Sponsor|0|||
161910245|NCT03555149|584723526|FG004|Overall Study|Study Terminated By Sponsor|0|||
161910246|NCT03555149|584723527|FG005|Overall Study|Study Terminated By Sponsor|2|||
161910247|NCT03555149|584723528|FG006|Overall Study|Study Terminated By Sponsor|3|||
161910248|NCT03555149|584723529|FG007|Overall Study|Study Terminated By Sponsor|1|||
161910249|NCT03555149|584723522|FG000|Overall Study|Withdrawal by Subject|3|||
161910250|NCT03555149|584723523|FG001|Overall Study|Withdrawal by Subject|0|||
161910251|NCT03555149|584723524|FG002|Overall Study|Withdrawal by Subject|0|||
161910252|NCT03555149|584723525|FG003|Overall Study|Withdrawal by Subject|2|||
161910253|NCT03555149|584723526|FG004|Overall Study|Withdrawal by Subject|0|||
161910254|NCT03555149|584723527|FG005|Overall Study|Withdrawal by Subject|1|||
161910255|NCT03555149|584723528|FG006|Overall Study|Withdrawal by Subject|0|||
161910256|NCT03555149|584723529|FG007|Overall Study|Withdrawal by Subject|0|||
161910257|NCT01692119|584723535|FG000|Overall Study|Protocol Violation|3|||
161910258|NCT01692119|584723536|FG001|Overall Study|Protocol Violation|1|||
161910259|NCT01692119|584723535|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
161910260|NCT01692119|584723536|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
161910261|NCT04656652|584723537|FG000|Overall Study|Lost to Follow-up|2|||
161910262|NCT04656652|584723538|FG001|Overall Study|Lost to Follow-up|2|||
161910263|NCT04656652|584723537|FG000|Overall Study|Death|213|||
161910264|NCT04656652|584723538|FG001|Overall Study|Death|212|||
161910265|NCT04656652|584723537|FG000|Overall Study|Other|1|||
161910266|NCT04656652|584723538|FG001|Overall Study|Other|0|||
161910267|NCT04656652|584723537|FG000|Overall Study|Withdrawal by Subject|15|||
161910268|NCT04656652|584723538|FG001|Overall Study|Withdrawal by Subject|29|||
161910269|NCT02722967|584723539|FG000|Overall Study|Adverse Event|1|||
161910270|NCT02722967|584723540|FG001|Overall Study|Adverse Event|0|||
161910271|NCT02722967|584723541|FG002|Overall Study|Adverse Event|0|||
161910272|NCT02722967|584723539|FG000|Overall Study|Lost to Follow-up|0|||
161910273|NCT02722967|584723540|FG001|Overall Study|Lost to Follow-up|1|||
161910274|NCT02722967|584723541|FG002|Overall Study|Lost to Follow-up|0|||
161910275|NCT02722967|584723539|FG000|Overall Study|Non-compliance with patch wearing|2|||
161910276|NCT02722967|584723540|FG001|Overall Study|Non-compliance with patch wearing|1|||
161910277|NCT02722967|584723541|FG002|Overall Study|Non-compliance with patch wearing|1|||
162010988|NCT05462756|585097688|FG000|Follow-Up Period|Adverse Event|1|||
161806611|NCT00048581|584335982|FG000|Double-Blind Period|Lack of Efficacy|14|||
161806612|NCT00048581|584335983|FG001|Double-Blind Period|Lack of Efficacy|27|||
161806613|NCT00048581|584335984|FG002|Double-Blind Period|Lack of Efficacy|0|||
161806614|NCT00048581|584335982|FG000|Double-Blind Period|Lost to Follow-up|5|||
161806615|NCT00048581|584335983|FG001|Double-Blind Period|Lost to Follow-up|0|||
161806616|NCT00048581|584335984|FG002|Double-Blind Period|Lost to Follow-up|0|||
161806617|NCT00048581|584335982|FG000|Double-Blind Period|Withdrawal by Subject|5|||
161806618|NCT00048581|584335983|FG001|Double-Blind Period|Withdrawal by Subject|2|||
161806619|NCT00048581|584335984|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161806620|NCT00048581|584335982|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
161806621|NCT00048581|584335983|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
161806622|NCT00048581|584335984|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
161806623|NCT00048581|584335982|FG000|Double-Blind Period|Investigator Decision|1|||
161806624|NCT00048581|584335983|FG001|Double-Blind Period|Investigator Decision|0|||
161806625|NCT00048581|584335984|FG002|Double-Blind Period|Investigator Decision|0|||
161806626|NCT00048581|584335982|FG000|Open-Label Period|Death|0|||
161806627|NCT00048581|584335983|FG001|Open-Label Period|Death|0|||
161806628|NCT00048581|584335984|FG002|Open-Label Period|Death|4|||
161806629|NCT00048581|584335982|FG000|Open-Label Period|Adverse Event|0|||
161806630|NCT00048581|584335983|FG001|Open-Label Period|Adverse Event|0|||
161806631|NCT00048581|584335984|FG002|Open-Label Period|Adverse Event|37|||
161806632|NCT00048581|584335982|FG000|Open-Label Period|Lack of Efficacy|0|||
161806633|NCT00048581|584335983|FG001|Open-Label Period|Lack of Efficacy|0|||
161806634|NCT00048581|584335984|FG002|Open-Label Period|Lack of Efficacy|69|||
161806635|NCT00048581|584335982|FG000|Open-Label Period|Lost to Follow-up|0|||
161806636|NCT00048581|584335983|FG001|Open-Label Period|Lost to Follow-up|0|||
161806637|NCT00048581|584335984|FG002|Open-Label Period|Lost to Follow-up|14|||
161806638|NCT00048581|584335982|FG000|Open-Label Period|Withdrawal by Subject|0|||
161806639|NCT00048581|584335983|FG001|Open-Label Period|Withdrawal by Subject|0|||
161806640|NCT00048581|584335984|FG002|Open-Label Period|Withdrawal by Subject|20|||
161806641|NCT00048581|584335982|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
161806642|NCT00048581|584335983|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
161806643|NCT00048581|584335984|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
161806644|NCT00048581|584335982|FG000|Open-Label Period|Poor/Non-compliance|0|||
161806645|NCT00048581|584335983|FG001|Open-Label Period|Poor/Non-compliance|0|||
161806646|NCT00048581|584335984|FG002|Open-Label Period|Poor/Non-compliance|5|||
161806647|NCT00048581|584335982|FG000|Open-Label Period|Pregnancy|0|||
161806648|NCT00048581|584335983|FG001|Open-Label Period|Pregnancy|0|||
161806649|NCT00048581|584335984|FG002|Open-Label Period|Pregnancy|7|||
161806650|NCT00048581|584335982|FG000|Open-Label Period|Study Site Closure|0|||
161806651|NCT00048581|584335983|FG001|Open-Label Period|Study Site Closure|0|||
161806652|NCT00048581|584335984|FG002|Open-Label Period|Study Site Closure|2|||
161806653|NCT00048581|584335982|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
161806654|NCT00048581|584335983|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
161806655|NCT00048581|584335984|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
161806656|NCT00048581|584335982|FG000|Open-Label Period|Problem With Transportation To Site|0|||
161806657|NCT00048581|584335983|FG001|Open-Label Period|Problem With Transportation To Site|0|||
161806658|NCT00048581|584335984|FG002|Open-Label Period|Problem With Transportation To Site|1|||
161806659|NCT00048581|584335982|FG000|Open-Label Period|Primary Investigator Retired|0|||
161806660|NCT00048581|584335983|FG001|Open-Label Period|Primary Investigator Retired|0|||
161806661|NCT00048581|584335984|FG002|Open-Label Period|Primary Investigator Retired|2|||
161806662|NCT00048581|584335982|FG000|Open-Label Period|Study Ended By Sponsor|0|||
161806663|NCT00048581|584335983|FG001|Open-Label Period|Study Ended By Sponsor|0|||
161806664|NCT00048581|584335984|FG002|Open-Label Period|Study Ended By Sponsor|1|||
161806665|NCT01406795|584335985|FG000|Overall Study|Withdrawal by Subject|1|||
161806666|NCT03897088|584335988|FG000|Overall Study|Withdrawal by Subject|12|||
161806667|NCT03897088|584335989|FG001|Overall Study|Withdrawal by Subject|12|||
161806668|NCT03897088|584335988|FG000|Overall Study|Lost to Follow-up|7|||
161806669|NCT03897088|584335989|FG001|Overall Study|Lost to Follow-up|15|||
161806670|NCT03897088|584335988|FG000|Overall Study|Sponsor Decision|1|||
161806671|NCT03897088|584335989|FG001|Overall Study|Sponsor Decision|2|||
161806672|NCT03897088|584335988|FG000|Overall Study|COVID-19|2|||
161806673|NCT03897088|584335989|FG001|Overall Study|COVID-19|0|||
161806674|NCT03897088|584335988|FG000|Overall Study|Other|3|||
161806675|NCT03897088|584335989|FG001|Overall Study|Other|0|||
161806676|NCT03897088|584335988|FG000|Overall Study|Non-compliance with Study Drug|1|||
162010989|NCT05462756|585097689|FG001|Follow-Up Period|Adverse Event|0|||
162010990|NCT05462756|585097688|FG000|Follow-Up Period|Death|1|||
162010991|NCT05462756|585097689|FG001|Follow-Up Period|Death|0|||
162010992|NCT05462756|585097688|FG000|Follow-Up Period|Lost to Follow-up|3|||
162010993|NCT05462756|585097689|FG001|Follow-Up Period|Lost to Follow-up|1|||
162010994|NCT05462756|585097688|FG000|Follow-Up Period|Withdrawal by Subject|0|||
162010995|NCT05462756|585097689|FG001|Follow-Up Period|Withdrawal by Subject|4|||
162010996|NCT02144610|585097692|FG000|Overall Study|Physician Decision|1|||
162010997|NCT02144610|585097693|FG001|Overall Study|Physician Decision|0|||
162010998|NCT02144610|585097692|FG000|Overall Study|Withdrawal by Subject|1|||
162010999|NCT02144610|585097693|FG001|Overall Study|Withdrawal by Subject|5|||
162011000|NCT02144610|585097692|FG000|Overall Study|Death|2|||
162011001|NCT02144610|585097693|FG001|Overall Study|Death|2|||
162011002|NCT02144610|585097692|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
162011003|NCT02144610|585097693|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
162011004|NCT02144610|585097692|FG000|Overall Study|Other|0|||
162011005|NCT02144610|585097693|FG001|Overall Study|Other|1|||
162011006|NCT01354899|585097698|FG000|Overall Study|discharge from the hospital|2|||
162011007|NCT01354899|585097698|FG000|Overall Study|Protocol Violation|1|||
162011008|NCT01432730|585097701|FG000|Period 1|Adverse Event|2|||
162011009|NCT01432730|585097702|FG001|Period 1|Adverse Event|0|||
162011010|NCT01432730|585097701|FG000|Period 2|Adverse Event|0|||
162011011|NCT01432730|585097702|FG001|Period 2|Adverse Event|4|||
162011012|NCT00641667|585097705|FG000|Overall Study|Withdrawal by Subject|1|||
162011013|NCT00641667|585097705|FG000|Overall Study|Adverse Event|1|||
162011014|NCT00641667|585097705|FG000|Overall Study|Physician Decision|1|||
162011015|NCT00641667|585097705|FG000|Overall Study|Worsening of underlying disease|3|||
162011016|NCT01235741|585097706|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
162011017|NCT01235741|585097707|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
162011018|NCT01235741|585097708|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
162011019|NCT01235741|585097706|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
162011020|NCT01235741|585097707|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
162011021|NCT01235741|585097708|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
162011022|NCT01235741|585097706|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
162011023|NCT01235741|585097707|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
162011024|NCT01235741|585097708|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
162011025|NCT01235741|585097706|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
162011026|NCT01235741|585097707|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
162011027|NCT01235741|585097708|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
162011028|NCT01235741|585097706|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
162011029|NCT01235741|585097707|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
162011030|NCT01235741|585097708|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
162011031|NCT01235741|585097706|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
162011032|NCT01235741|585097707|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
162011033|NCT01235741|585097708|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
162011034|NCT01235741|585097706|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
162011035|NCT01235741|585097707|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
162011036|NCT01235741|585097708|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
162011037|NCT01235741|585097706|FG000|Randomized to Treatment|Adverse Event|0|||
162011038|NCT01235741|585097707|FG001|Randomized to Treatment|Adverse Event|1|||
162011039|NCT01235741|585097708|FG002|Randomized to Treatment|Adverse Event|1|||
162011040|NCT01235741|585097706|FG000|Randomized to Treatment|Sponsor terminated study|0|||
162011041|NCT01235741|585097707|FG001|Randomized to Treatment|Sponsor terminated study|35|||
162011042|NCT01235741|585097708|FG002|Randomized to Treatment|Sponsor terminated study|34|||
162011043|NCT01235741|585097706|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
162011044|NCT01235741|585097707|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
162011045|NCT01235741|585097708|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
162011046|NCT01235741|585097706|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
162011047|NCT01235741|585097707|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
162011048|NCT01235741|585097708|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
162011049|NCT01235741|585097706|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
162011050|NCT01235741|585097707|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
162011051|NCT01235741|585097708|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
162011052|NCT01421719|585097709|FG000|Overall Study|Withdrawal by Subject|4|||
161910278|NCT02722967|584723539|FG000|Overall Study|Withdrawal by Subject|1|||
161910279|NCT02722967|584723540|FG001|Overall Study|Withdrawal by Subject|0|||
161910280|NCT02722967|584723541|FG002|Overall Study|Withdrawal by Subject|1|||
161910281|NCT02722967|584723539|FG000|Overall Study|Physician Decision|1|||
161910282|NCT02722967|584723540|FG001|Overall Study|Physician Decision|0|||
161910283|NCT02722967|584723541|FG002|Overall Study|Physician Decision|0|||
161910284|NCT02722967|584723539|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
161910285|NCT02722967|584723540|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
161910286|NCT02722967|584723541|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
161910287|NCT04142242|584723542|FG000|Stage I|Non-compliance with the protocol|1|||
161910288|NCT04142242|584723543|FG001|Stage I|Non-compliance with the protocol|0|||
161910289|NCT04142242|584723544|FG002|Stage I|Non-compliance with the protocol|0|||
161910290|NCT04142242|584723545|FG003|Stage I|Non-compliance with the protocol|0|||
161910291|NCT04142242|584723546|FG004|Stage I|Non-compliance with the protocol|0|||
161910292|NCT04142242|584723547|FG005|Stage I|Non-compliance with the protocol|1|||
161910293|NCT04142242|584723542|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161910294|NCT04142242|584723543|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
161910295|NCT04142242|584723544|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
162011053|NCT01124006|585097710|FG000|Overall Study|Withdrawal by Subject|2|||
162011054|NCT01124006|585097711|FG001|Overall Study|Withdrawal by Subject|2|||
161910296|NCT04142242|584723545|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161910297|NCT04142242|584723546|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161910298|NCT04142242|584723547|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161910299|NCT04142242|584723542|FG000|Stage II|Non-compliance with the protocol|0|||
161910300|NCT04142242|584723543|FG001|Stage II|Non-compliance with the protocol|0|||
161910301|NCT04142242|584723544|FG002|Stage II|Non-compliance with the protocol|0|||
161910302|NCT04142242|584723545|FG003|Stage II|Non-compliance with the protocol|2|||
161910303|NCT04142242|584723546|FG004|Stage II|Non-compliance with the protocol|0|||
161910304|NCT04142242|584723547|FG005|Stage II|Non-compliance with the protocol|0|||
161910305|NCT04142242|584723542|FG000|Stage II|Lost to Follow-up|0|||
161910306|NCT04142242|584723543|FG001|Stage II|Lost to Follow-up|0|||
161910307|NCT04142242|584723544|FG002|Stage II|Lost to Follow-up|1|||
161910308|NCT04142242|584723545|FG003|Stage II|Lost to Follow-up|2|||
161910309|NCT04142242|584723546|FG004|Stage II|Lost to Follow-up|0|||
161910310|NCT04142242|584723547|FG005|Stage II|Lost to Follow-up|0|||
161910311|NCT04142242|584723542|FG000|Stage II|Withdrawal by Subject|0|||
161910312|NCT04142242|584723543|FG001|Stage II|Withdrawal by Subject|0|||
161910313|NCT04142242|584723544|FG002|Stage II|Withdrawal by Subject|5|||
161910314|NCT04142242|584723545|FG003|Stage II|Withdrawal by Subject|9|||
161910315|NCT04142242|584723546|FG004|Stage II|Withdrawal by Subject|0|||
161910316|NCT04142242|584723547|FG005|Stage II|Withdrawal by Subject|0|||
161910317|NCT00846053|584723550|FG000|Overall Study|Physician Decision|3|||
161910318|NCT00846053|584723551|FG001|Overall Study|Physician Decision|0|||
161910319|NCT03883386|584723559|FG000|First Assignment|Lost to Follow-up|1|||
161910320|NCT03883386|584723560|FG001|First Assignment|Lost to Follow-up|0|||
161910321|NCT03883386|584723559|FG000|First Assignment|Withdrawal by Subject|1|||
161910322|NCT03883386|584723560|FG001|First Assignment|Withdrawal by Subject|1|||
161910323|NCT01326871|584723561|FG000|Overall Study|Major surgery|0|||
161910324|NCT01326871|584723562|FG001|Overall Study|Major surgery|1|||
161910325|NCT01326871|584723563|FG002|Overall Study|Major surgery|0|||
161910326|NCT01326871|584723561|FG000|Overall Study|SAE and death|0|||
161910327|NCT01326871|584723562|FG001|Overall Study|SAE and death|2|||
161910328|NCT01326871|584723563|FG002|Overall Study|SAE and death|0|||
162011055|NCT01124006|585097712|FG002|Overall Study|Withdrawal by Subject|0|||
161910329|NCT01326871|584723561|FG000|Overall Study|Physician decision and decreased performance status|0|||
161910330|NCT01326871|584723562|FG001|Overall Study|Physician decision and decreased performance status|1|||
161910331|NCT01326871|584723563|FG002|Overall Study|Physician decision and decreased performance status|0|||
161910332|NCT01326871|584723561|FG000|Overall Study|Disease progression|0|||
161910333|NCT01326871|584723562|FG001|Overall Study|Disease progression|11|||
161910334|NCT01326871|584723563|FG002|Overall Study|Disease progression|5|||
161910335|NCT01326871|584723561|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
161910336|NCT01326871|584723562|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
161910337|NCT01326871|584723563|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
161910338|NCT01326871|584723561|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
161910339|NCT01326871|584723562|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
161910340|NCT01326871|584723563|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
161910341|NCT01326871|584723561|FG000|Overall Study|Withdrawal by Subject|0|||
161910342|NCT01326871|584723562|FG001|Overall Study|Withdrawal by Subject|1|||
161910343|NCT01326871|584723563|FG002|Overall Study|Withdrawal by Subject|0|||
161910344|NCT01326871|584723561|FG000|Overall Study|DLT|0|||
161910345|NCT01326871|584723562|FG001|Overall Study|DLT|2|||
161910346|NCT01326871|584723563|FG002|Overall Study|DLT|0|||
161910347|NCT01326871|584723561|FG000|Overall Study|SAE, disease progression and subject decision|0|||
161910348|NCT01326871|584723562|FG001|Overall Study|SAE, disease progression and subject decision|1|||
161910349|NCT01326871|584723563|FG002|Overall Study|SAE, disease progression and subject decision|0|||
161910350|NCT01326871|584723561|FG000|Overall Study|Death|0|||
161910351|NCT01326871|584723562|FG001|Overall Study|Death|1|||
161910352|NCT01326871|584723563|FG002|Overall Study|Death|0|||
161910353|NCT01326871|584723561|FG000|Overall Study|Other|0|||
161910354|NCT01326871|584723562|FG001|Overall Study|Other|3|||
161910355|NCT01326871|584723563|FG002|Overall Study|Other|0|||
161910356|NCT01326871|584723561|FG000|Overall Study|SAE and disease progression|0|||
161910357|NCT01326871|584723562|FG001|Overall Study|SAE and disease progression|0|||
161910358|NCT01326871|584723563|FG002|Overall Study|SAE and disease progression|1|||
161806677|NCT03897088|584335989|FG001|Overall Study|Non-compliance with Study Drug|1|||
161806678|NCT03897088|584335988|FG000|Overall Study|Pregnancy|0|||
161806679|NCT03897088|584335989|FG001|Overall Study|Pregnancy|1|||
161806680|NCT04320849|584336000|FG000|Overall Study|Withdrawal by Subject|4|||
161806681|NCT04320849|584336000|FG000|Overall Study|Imaging data unavailable|2|||
161806682|NCT04320849|584336000|FG000|Overall Study|Incomplete imaging|2|||
161806683|NCT00119379|584336003|FG000|Overall Study|Adverse Event|4|||
161806684|NCT00119379|584336004|FG001|Overall Study|Adverse Event|1|||
161806685|NCT01469546|584336005|FG000|Received 5 mg Dose|Adverse Event|13|||
161806686|NCT01469546|584336005|FG000|Received 5 mg Dose|Death|2|||
161806687|NCT01469546|584336005|FG000|Received 5 mg Dose|Protocol Violation|2|||
161806688|NCT01469546|584336005|FG000|Received 5 mg Dose|Progressive Disease|3|||
161806689|NCT01469546|584336005|FG000|Received 5 mg Dose|Physician Decision|3|||
161806690|NCT02801877|584336006|FG000|Overall Study|Lost to Follow-up|1|||
161806691|NCT02801877|584336007|FG001|Overall Study|Lost to Follow-up|1|||
161806692|NCT02801877|584336008|FG002|Overall Study|Lost to Follow-up|2|||
161806693|NCT02801877|584336009|FG003|Overall Study|Lost to Follow-up|0|||
161806694|NCT02801877|584336006|FG000|Overall Study|Never Started Treatment|2|||
161806695|NCT02801877|584336007|FG001|Overall Study|Never Started Treatment|0|||
161806696|NCT02801877|584336008|FG002|Overall Study|Never Started Treatment|4|||
161806697|NCT02801877|584336009|FG003|Overall Study|Never Started Treatment|0|||
161806698|NCT04934722|584337680|FG000|Overall Study|Death|4|||
161806699|NCT04934722|584337681|FG001|Overall Study|Death|3|||
161806700|NCT04934722|584337680|FG000|Overall Study|Participants Ongoing|88|||
161806701|NCT04934722|584337681|FG001|Overall Study|Participants Ongoing|91|||
161806702|NCT06358820|584337682|FG000|Overall Study|Adverse Event|11|||
161806703|NCT06358820|584337682|FG000|Overall Study|kidney transplantation|3|||
161806704|NCT06358820|584337682|FG000|Overall Study|patient voluntary withdrawal|6|||
161806705|NCT06358820|584337682|FG000|Overall Study|Physician Decision|1|||
161806706|NCT01294787|584337683|FG000|Period 1|Adverse Event|0|||
161806707|NCT01294787|584337684|FG001|Period 1|Adverse Event|0|||
161806708|NCT01294787|584337685|FG002|Period 1|Adverse Event|0|||
161806709|NCT01294787|584337686|FG003|Period 1|Adverse Event|0|||
161806710|NCT01294787|584337687|FG004|Period 1|Adverse Event|1|||
161806711|NCT01294787|584337688|FG005|Period 1|Adverse Event|0|||
161806712|NCT01294787|584337683|FG000|Period 1|Withdrawal by Subject|0|||
161806713|NCT01294787|584337684|FG001|Period 1|Withdrawal by Subject|0|||
161806714|NCT01294787|584337685|FG002|Period 1|Withdrawal by Subject|0|||
161806715|NCT01294787|584337686|FG003|Period 1|Withdrawal by Subject|1|||
161806716|NCT01294787|584337687|FG004|Period 1|Withdrawal by Subject|1|||
161806717|NCT01294787|584337688|FG005|Period 1|Withdrawal by Subject|1|||
161806718|NCT01294787|584337683|FG000|Period 1|Administrative problem|0|||
161806719|NCT01294787|584337684|FG001|Period 1|Administrative problem|0|||
161806720|NCT01294787|584337685|FG002|Period 1|Administrative problem|1|||
161806721|NCT01294787|584337686|FG003|Period 1|Administrative problem|0|||
161806722|NCT01294787|584337687|FG004|Period 1|Administrative problem|0|||
161806723|NCT01294787|584337688|FG005|Period 1|Administrative problem|1|||
161806724|NCT01294787|584337683|FG000|Period 2|Adverse Event|0|||
161806725|NCT01294787|584337684|FG001|Period 2|Adverse Event|3|||
161806726|NCT01294787|584337685|FG002|Period 2|Adverse Event|0|||
161806727|NCT01294787|584337686|FG003|Period 2|Adverse Event|1|||
161806728|NCT01294787|584337687|FG004|Period 2|Adverse Event|0|||
161806729|NCT01294787|584337688|FG005|Period 2|Adverse Event|0|||
161806730|NCT01294787|584337683|FG000|Period 2|No longer needs study drug|0|||
161806731|NCT01294787|584337684|FG001|Period 2|No longer needs study drug|0|||
161806732|NCT01294787|584337685|FG002|Period 2|No longer needs study drug|0|||
161806733|NCT01294787|584337686|FG003|Period 2|No longer needs study drug|1|||
161806734|NCT01294787|584337687|FG004|Period 2|No longer needs study drug|0|||
161806735|NCT01294787|584337688|FG005|Period 2|No longer needs study drug|0|||
161806736|NCT01294787|584337683|FG000|Period 3|Adverse Event|0|||
161806737|NCT01294787|584337684|FG001|Period 3|Adverse Event|0|||
161806738|NCT01294787|584337685|FG002|Period 3|Adverse Event|0|||
161806739|NCT01294787|584337686|FG003|Period 3|Adverse Event|0|||
161806740|NCT01294787|584337687|FG004|Period 3|Adverse Event|1|||
161806741|NCT01294787|584337688|FG005|Period 3|Adverse Event|0|||
161806742|NCT01124175|584337689|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
161806743|NCT01124175|584337690|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
161806744|NCT00942968|584337691|FG000|Overall Study|Adverse Event|60|||
161806745|NCT00942968|584337691|FG000|Overall Study|Death|76|||
161806746|NCT00942968|584337691|FG000|Overall Study|Protocol Violation|9|||
161910359|NCT01326871|584723561|FG000|Overall Study|SAE and physician decision|0|||
161910360|NCT01326871|584723562|FG001|Overall Study|SAE and physician decision|0|||
161910361|NCT01326871|584723563|FG002|Overall Study|SAE and physician decision|1|||
161910362|NCT01326871|584723561|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
161910363|NCT01326871|584723562|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
162140561|NCT02365298|585565671|FG001|Period 2|Discontinued at request of Sponsor|0|||
162140562|NCT02365298|585565670|FG000|Period 2|Test Article longer available|0|||
162140563|NCT02365298|585565671|FG001|Period 2|Test Article longer available|1|||
162140564|NCT02365298|585565670|FG000|Period 2|Protocol Violation|0|||
162140565|NCT02365298|585565671|FG001|Period 2|Protocol Violation|1|||
162140566|NCT02846415|585565672|FG000|Overall Study|Lost to Follow-up|2|||
162140567|NCT02846415|585565673|FG001|Overall Study|Lost to Follow-up|0|||
162140568|NCT02846415|585565672|FG000|Overall Study|Withdrawal by Subject|1|||
161910364|NCT01326871|584723563|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
162011056|NCT01124006|585097710|FG000|Overall Study|Lost to Follow-up|1|||
162140569|NCT02846415|585565673|FG001|Overall Study|Withdrawal by Subject|1|||
162140570|NCT02595398|585565674|FG000|Overall Study|Non-compliance|1|||
162140571|NCT02595398|585565675|FG001|Overall Study|Non-compliance|0|||
162140572|NCT02595398|585565674|FG000|Overall Study|Withdrawal by Subject|2|||
162140573|NCT02595398|585565675|FG001|Overall Study|Withdrawal by Subject|1|||
162140574|NCT02595398|585565674|FG000|Overall Study|Lost to Follow-up|1|||
161806747|NCT00942968|584337691|FG000|Overall Study|Lost to Follow-up|4|||
161806748|NCT00942968|584337691|FG000|Overall Study|Withdrawal by Subject|44|||
162140575|NCT02595398|585565675|FG001|Overall Study|Lost to Follow-up|0|||
162140576|NCT00502593|585565676|FG000|Overall Study|Withdrawn unspecified reason|1|||
162140577|NCT00502593|585565677|FG001|Overall Study|Withdrawn unspecified reason|1|||
162140578|NCT00502593|585565678|FG002|Overall Study|Withdrawn unspecified reason|3|||
162140579|NCT00502593|585565679|FG003|Overall Study|Withdrawn unspecified reason|1|||
161806749|NCT00942968|584337691|FG000|Overall Study|Sponsor request|5|||
161806750|NCT00942968|584337691|FG000|Overall Study|Physician Decision|11|||
161806751|NCT00942968|584337691|FG000|Overall Study|Progression of disease|12|||
161806752|NCT00942968|584337691|FG000|Overall Study|Inferior vena cava filter placement|4|||
161806753|NCT00942968|584337691|FG000|Overall Study|Pulmonary embolism (PE)|1|||
161910365|NCT01326871|584723561|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
162140580|NCT00502593|585565680|FG004|Overall Study|Withdrawn unspecified reason|2|||
162140581|NCT00502593|585565681|FG005|Overall Study|Withdrawn unspecified reason|0|||
162140582|NCT00502593|585565682|FG006|Overall Study|Withdrawn unspecified reason|2|||
162140583|NCT00502593|585565683|FG007|Overall Study|Withdrawn unspecified reason|0|||
162140584|NCT00502593|585565684|FG008|Overall Study|Withdrawn unspecified reason|0|||
162140585|NCT00502593|585565685|FG009|Overall Study|Withdrawn unspecified reason|0|||
162140586|NCT00502593|585565686|FG010|Overall Study|Withdrawn unspecified reason|0|||
162140587|NCT00502593|585565687|FG011|Overall Study|Withdrawn unspecified reason|0|||
162140588|NCT00502593|585565676|FG000|Overall Study|Withdrawal by Subject|0|||
162140589|NCT00502593|585565677|FG001|Overall Study|Withdrawal by Subject|0|||
162140590|NCT00502593|585565678|FG002|Overall Study|Withdrawal by Subject|6|||
162140591|NCT00502593|585565679|FG003|Overall Study|Withdrawal by Subject|2|||
162140592|NCT00502593|585565680|FG004|Overall Study|Withdrawal by Subject|2|||
162140593|NCT00502593|585565681|FG005|Overall Study|Withdrawal by Subject|0|||
162140594|NCT00502593|585565682|FG006|Overall Study|Withdrawal by Subject|3|||
162140595|NCT00502593|585565683|FG007|Overall Study|Withdrawal by Subject|0|||
162140596|NCT00502593|585565684|FG008|Overall Study|Withdrawal by Subject|3|||
162140597|NCT00502593|585565685|FG009|Overall Study|Withdrawal by Subject|0|||
162140598|NCT00502593|585565686|FG010|Overall Study|Withdrawal by Subject|1|||
162140599|NCT00502593|585565687|FG011|Overall Study|Withdrawal by Subject|0|||
162140600|NCT00502593|585565676|FG000|Overall Study|Lost to Follow-up|2|||
162140601|NCT00502593|585565677|FG001|Overall Study|Lost to Follow-up|1|||
162140602|NCT00502593|585565678|FG002|Overall Study|Lost to Follow-up|1|||
162140603|NCT00502593|585565679|FG003|Overall Study|Lost to Follow-up|1|||
162140604|NCT00502593|585565680|FG004|Overall Study|Lost to Follow-up|0|||
162140605|NCT00502593|585565681|FG005|Overall Study|Lost to Follow-up|0|||
162140606|NCT00502593|585565682|FG006|Overall Study|Lost to Follow-up|0|||
162140607|NCT00502593|585565683|FG007|Overall Study|Lost to Follow-up|0|||
162140608|NCT00502593|585565684|FG008|Overall Study|Lost to Follow-up|3|||
162140609|NCT00502593|585565685|FG009|Overall Study|Lost to Follow-up|0|||
162140610|NCT00502593|585565686|FG010|Overall Study|Lost to Follow-up|1|||
162140611|NCT00502593|585565687|FG011|Overall Study|Lost to Follow-up|0|||
162140612|NCT00544440|585565688|FG000|Overall Study|Other|1|||
162140613|NCT00544440|585565688|FG000|Overall Study|Adverse Event|1|||
162140614|NCT00544440|585565688|FG000|Overall Study|Withdrawal by Subject|2|||
162140615|NCT00544440|585565688|FG000|Overall Study|Subject Non-compliance|1|||
162140616|NCT00544440|585565688|FG000|Overall Study|Progressive Disease|47|||
162140617|NCT00544440|585565688|FG000|Overall Study|Other|5|||
162140618|NCT03601507|585565689|FG000|Overall Study|Adverse Event|1|||
162140619|NCT00591838|585565692|FG000|Overall Study|Withdrawal by Subject|0|||
162140620|NCT00591838|585565693|FG001|Overall Study|Withdrawal by Subject|0|||
162140621|NCT00591838|585565694|FG002|Overall Study|Withdrawal by Subject|0|||
162140622|NCT00591838|585565695|FG003|Overall Study|Withdrawal by Subject|1|||
162140623|NCT00591838|585565696|FG004|Overall Study|Withdrawal by Subject|0|||
162140624|NCT00586339|585565697|FG000|Overall Study|Withdrawal by Subject|1|||
162140625|NCT00586339|585565698|FG001|Overall Study|Withdrawal by Subject|3|||
162140626|NCT00586339|585565699|FG002|Overall Study|Withdrawal by Subject|1|||
162140627|NCT00586339|585565697|FG000|Overall Study|Migrated/moved from study area|3|||
162140628|NCT00586339|585565698|FG001|Overall Study|Migrated/moved from study area|2|||
162140629|NCT00586339|585565699|FG002|Overall Study|Migrated/moved from study area|4|||
162140630|NCT00586339|585565697|FG000|Overall Study|Lost to Follow-up|3|||
162140631|NCT00586339|585565698|FG001|Overall Study|Lost to Follow-up|2|||
162140632|NCT00586339|585565699|FG002|Overall Study|Lost to Follow-up|1|||
162140633|NCT00559949|585565700|FG000|Overall Study|Progressive Disease during cycle 1|1|||
162140634|NCT00559949|585565700|FG000|Overall Study|Adverse Event|1|||
162140635|NCT00559949|585565700|FG000|Overall Study|Withdrawal by Subject|4|||
162140636|NCT00559949|585565700|FG000|Overall Study|No disease evaluation per protocol|1|||
161806754|NCT00942968|584337691|FG000|Overall Study|Participant required pancreatic biopsy|1|||
161910366|NCT01326871|584723562|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
161910367|NCT01326871|584723563|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
161910368|NCT01326871|584723561|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
161910369|NCT01326871|584723562|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
161910370|NCT01326871|584723563|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
161910371|NCT01326871|584723561|FG000|Overall Study|Physician Decision|0|||
161910372|NCT01326871|584723562|FG001|Overall Study|Physician Decision|0|||
161910373|NCT01326871|584723563|FG002|Overall Study|Physician Decision|1|||
161910374|NCT01326871|584723561|FG000|Overall Study|SAE|0|||
161910375|NCT01326871|584723562|FG001|Overall Study|SAE|0|||
161910376|NCT01326871|584723563|FG002|Overall Study|SAE|1|||
161910377|NCT01326871|584723561|FG000|Overall Study|Disease progression and death|0|||
161910378|NCT01326871|584723562|FG001|Overall Study|Disease progression and death|0|||
161910379|NCT01326871|584723563|FG002|Overall Study|Disease progression and death|1|||
161910380|NCT01326871|584723561|FG000|Overall Study|Subject decision|0|||
161910381|NCT01326871|584723562|FG001|Overall Study|Subject decision|0|||
161910382|NCT01326871|584723563|FG002|Overall Study|Subject decision|1|||
161910383|NCT00251758|584723564|FG000|Overall Study|Adverse Event|7|||
161910384|NCT00251758|584723565|FG001|Overall Study|Adverse Event|9|||
161910385|NCT00251758|584723566|FG002|Overall Study|Adverse Event|11|||
161910386|NCT00251758|584723564|FG000|Overall Study|Lost to Follow-up|4|||
161910387|NCT00251758|584723565|FG001|Overall Study|Lost to Follow-up|2|||
161910388|NCT00251758|584723566|FG002|Overall Study|Lost to Follow-up|5|||
161910389|NCT00251758|584723564|FG000|Overall Study|Withdrawal by Subject|13|||
161910390|NCT00251758|584723565|FG001|Overall Study|Withdrawal by Subject|7|||
161910391|NCT00251758|584723566|FG002|Overall Study|Withdrawal by Subject|3|||
161910392|NCT00251758|584723564|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
161910393|NCT00251758|584723565|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
161910394|NCT00251758|584723566|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
161910395|NCT00251758|584723564|FG000|Overall Study|Lack of Efficacy|3|||
161910396|NCT00251758|584723565|FG001|Overall Study|Lack of Efficacy|0|||
161910397|NCT00251758|584723566|FG002|Overall Study|Lack of Efficacy|0|||
161910398|NCT00251758|584723564|FG000|Overall Study|Noncompliant|0|||
161910399|NCT00251758|584723565|FG001|Overall Study|Noncompliant|2|||
161910400|NCT00251758|584723566|FG002|Overall Study|Noncompliant|2|||
161910401|NCT00251758|584723564|FG000|Overall Study|Pregnancy|0|||
161910402|NCT00251758|584723565|FG001|Overall Study|Pregnancy|1|||
161910403|NCT00251758|584723566|FG002|Overall Study|Pregnancy|0|||
161910404|NCT00251758|584723564|FG000|Overall Study|Per Subject Request|0|||
161910405|NCT00251758|584723565|FG001|Overall Study|Per Subject Request|0|||
161910406|NCT00251758|584723566|FG002|Overall Study|Per Subject Request|1|||
161910407|NCT00251758|584723564|FG000|Overall Study|Per Investigator Request|1|||
161910408|NCT00251758|584723565|FG001|Overall Study|Per Investigator Request|0|||
161910409|NCT00251758|584723566|FG002|Overall Study|Per Investigator Request|0|||
161910410|NCT01387269|584723568|FG000|Overall Study|Death|38|||
161910411|NCT01387269|584723569|FG001|Overall Study|Death|20|||
161910412|NCT01387269|584723568|FG000|Overall Study|Other|8|||
161910413|NCT01387269|584723569|FG001|Overall Study|Other|7|||
161910414|NCT01387269|584723568|FG000|Overall Study|Unrelated AE|12|||
161910415|NCT01387269|584723569|FG001|Overall Study|Unrelated AE|3|||
161910416|NCT01387269|584723568|FG000|Overall Study|Withdrawal by patient|32|||
161910417|NCT01387269|584723569|FG001|Overall Study|Withdrawal by patient|10|||
161910418|NCT01387269|584723568|FG000|Overall Study|Study drug-related AE|1|||
161910419|NCT01387269|584723569|FG001|Overall Study|Study drug-related AE|0|||
161910420|NCT01387269|584723568|FG000|Overall Study|Lost to Follow-up|1|||
161910421|NCT01387269|584723569|FG001|Overall Study|Lost to Follow-up|0|||
161910422|NCT01200329|584723572|FG000|Overall Study|Lack of financial coverage|2|||
161910423|NCT01200329|584723572|FG000|Overall Study|Progressive disease|1|||
161910424|NCT03642990|584723577|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
161910425|NCT03642990|584723577|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
161910426|NCT01265498|584723582|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
161910427|NCT01265498|584723583|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
161910428|NCT04158219|584723589|FG000|Overall Study|Lost to Follow-up|1|||
161910429|NCT04239924|584723596|FG000|Overall Study|Lost to Follow-up|2|||
161910430|NCT04194814|584723597|FG000|Overall Study|Physician Decision|3|||
161910431|NCT04194814|584723598|FG001|Overall Study|Physician Decision|0|||
161910432|NCT04194814|584723597|FG000|Overall Study|Withdrawal by Subject|0|||
161910433|NCT04194814|584723598|FG001|Overall Study|Withdrawal by Subject|2|||
161910434|NCT00959751|584725543|FG000|Overall Study|Lost to Follow-up|2|||
161910435|NCT00959751|584725544|FG001|Overall Study|Lost to Follow-up|3|||
161910436|NCT00959751|584725543|FG000|Overall Study|Consent Withdrawn|0|||
161910437|NCT00959751|584725544|FG001|Overall Study|Consent Withdrawn|1|||
161910438|NCT00959751|584725543|FG000|Overall Study|Non-compliance to Study Procedures|0|||
161910439|NCT00959751|584725544|FG001|Overall Study|Non-compliance to Study Procedures|1|||
161910440|NCT00959751|584725543|FG000|Overall Study|No migraine headache without aura|7|||
161910441|NCT00959751|584725544|FG001|Overall Study|No migraine headache without aura|7|||
161910442|NCT03737994|584725545|FG000|Overall Study|Withdrawal by Subject|0|||
161910443|NCT03737994|584725546|FG001|Overall Study|Withdrawal by Subject|0|||
161910444|NCT03737994|584725547|FG002|Overall Study|Withdrawal by Subject|0|||
161910445|NCT03737994|584725548|FG003|Overall Study|Withdrawal by Subject|0|||
161910446|NCT03737994|584725549|FG004|Overall Study|Withdrawal by Subject|0|||
161910447|NCT03737994|584725550|FG005|Overall Study|Withdrawal by Subject|0|||
161910448|NCT03737994|584725551|FG006|Overall Study|Withdrawal by Subject|1|||
161806755|NCT00942968|584337691|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
161806756|NCT01948258|584337692|FG000|Overall Study|Pregnancy|41|||
161806757|NCT01948258|584337692|FG000|Overall Study|Did not complete by cut-off date|35|||
161806758|NCT01948258|584337692|FG000|Overall Study|Lost to Follow-up|27|||
161806759|NCT01948258|584337692|FG000|Overall Study|Withdrawal by SPD|8|||
161806760|NCT01948258|584337692|FG000|Overall Study|Withdrawal by Subject|6|||
161806761|NCT01948258|584337692|FG000|Overall Study|Health Care Professional|43|||
161806762|NCT01948258|584337692|FG000|Overall Study|Removed from statistical analysis|2|||
161806763|NCT00520130|584337699|FG000|Overall Study|Disease progression on study|4|||
161806764|NCT00520130|584337700|FG001|Overall Study|Disease progression on study|0|||
161806765|NCT00520130|584337699|FG000|Overall Study|Physician Decision|1|||
161806766|NCT00520130|584337700|FG001|Overall Study|Physician Decision|1|||
161806767|NCT01045096|584337703|FG000|Overall Study|Withdrawal by Subject|2|||
161806768|NCT01045096|584337704|FG001|Overall Study|Withdrawal by Subject|0|||
161806769|NCT01045096|584337705|FG002|Overall Study|Withdrawal by Subject|0|||
161806770|NCT01045096|584337703|FG000|Overall Study|Other|1|||
161806771|NCT01045096|584337704|FG001|Overall Study|Other|0|||
161806772|NCT01045096|584337705|FG002|Overall Study|Other|0|||
161806773|NCT01900691|584337706|FG000|Overall Study|Death|7|||
161806774|NCT01900691|584337706|FG000|Overall Study|Lost to Follow-up|4|||
161806775|NCT01900691|584337706|FG000|Overall Study|Study Device Not Placed|3|||
161806776|NCT01900691|584337706|FG000|Overall Study|Non study stent placed|2|||
161806777|NCT01900691|584337706|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
161806778|NCT01900691|584337706|FG000|Overall Study|Complete stent migration through digestive tract|1|||
161806779|NCT01954394|584337707|FG000|Overall Study|Enrolled but not treated|1|||
161806780|NCT01954394|584337708|FG001|Overall Study|Enrolled but not treated|0|||
161806781|NCT01954394|584337707|FG000|Overall Study|Adverse Event|10|||
161806782|NCT01954394|584337708|FG001|Overall Study|Adverse Event|23|||
161806783|NCT01954394|584337707|FG000|Overall Study|Poor compliance to protocol|7|||
161806784|NCT01954394|584337708|FG001|Overall Study|Poor compliance to protocol|7|||
161806785|NCT01954394|584337707|FG000|Overall Study|Participant Moved|0|||
161806786|NCT01954394|584337708|FG001|Overall Study|Participant Moved|4|||
161806787|NCT01954394|584337707|FG000|Overall Study|Related to Study Drug administration|2|||
161806788|NCT01954394|584337708|FG001|Overall Study|Related to Study Drug administration|2|||
161806789|NCT01954394|584337707|FG000|Overall Study|Other than specified above|10|||
161806790|NCT01954394|584337708|FG001|Overall Study|Other than specified above|21|||
161806791|NCT00909610|584337709|FG000|Period: First Intervention|Adverse Event|0|||
161910449|NCT00761319|584725552|FG000|Overall Study|Protocol Violation|21|||
161910450|NCT00761319|584725553|FG001|Overall Study|Protocol Violation|14|||
161910451|NCT00761319|584725552|FG000|Overall Study|Adverse Event|11|||
161910452|NCT00761319|584725553|FG001|Overall Study|Adverse Event|7|||
161910453|NCT00761319|584725552|FG000|Overall Study|Withdrawal by Subject|8|||
161910454|NCT00761319|584725553|FG001|Overall Study|Withdrawal by Subject|7|||
161806792|NCT00909610|584337710|FG001|Period: First Intervention|Adverse Event|1|||
161806793|NCT00909610|584337709|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
161806794|NCT00909610|584337710|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
161806795|NCT00909610|584337709|FG000|Period: Second Intervention|Adverse Event|1|||
162140637|NCT02081391|585565701|FG000|12-hour Treatment|Withdrawal by Subject|3|||
161910455|NCT00761319|584725552|FG000|Overall Study|Noncompliance|4|||
161910456|NCT00761319|584725553|FG001|Overall Study|Noncompliance|3|||
161910457|NCT00761319|584725552|FG000|Overall Study|Lost to Follow-up|1|||
161910458|NCT00761319|584725553|FG001|Overall Study|Lost to Follow-up|1|||
161910459|NCT00761319|584725552|FG000|Overall Study|Nonspecified|2|||
161910460|NCT00761319|584725553|FG001|Overall Study|Nonspecified|2|||
161910461|NCT00761319|584725552|FG000|Overall Study|Missing|1|||
161910462|NCT00761319|584725553|FG001|Overall Study|Missing|0|||
161910463|NCT01373164|584725554|FG000|Overall Study|Lost to Follow-up|0|||
161910464|NCT01373164|584725555|FG001|Overall Study|Lost to Follow-up|0|||
161910465|NCT01373164|584725556|FG002|Overall Study|Lost to Follow-up|1|||
161910466|NCT01373164|584725557|FG003|Overall Study|Lost to Follow-up|2|||
161910467|NCT01373164|584725558|FG004|Overall Study|Lost to Follow-up|0|||
161910468|NCT01373164|584725554|FG000|Overall Study|Withdrawal by Subject|0|||
161910469|NCT01373164|584725555|FG001|Overall Study|Withdrawal by Subject|1|||
161910470|NCT01373164|584725556|FG002|Overall Study|Withdrawal by Subject|0|||
161910471|NCT01373164|584725557|FG003|Overall Study|Withdrawal by Subject|10|||
161910472|NCT01373164|584725558|FG004|Overall Study|Withdrawal by Subject|2|||
162140638|NCT02081391|585565702|FG001|12-hour Treatment|Withdrawal by Subject|2|||
162140639|NCT02081391|585565703|FG002|12-hour Treatment|Withdrawal by Subject|0|||
162140640|NCT02081391|585565704|FG003|12-hour Treatment|Withdrawal by Subject|0|||
162140641|NCT02081391|585565701|FG000|12-hour Treatment|Physician Decision|4|||
162140642|NCT02081391|585565702|FG001|12-hour Treatment|Physician Decision|1|||
162140643|NCT02081391|585565703|FG002|12-hour Treatment|Physician Decision|0|||
162140644|NCT02081391|585565704|FG003|12-hour Treatment|Physician Decision|0|||
162140645|NCT02081391|585565701|FG000|12-hour Treatment|Lack of Efficacy|3|||
162140646|NCT02081391|585565702|FG001|12-hour Treatment|Lack of Efficacy|0|||
162140647|NCT02081391|585565703|FG002|12-hour Treatment|Lack of Efficacy|0|||
162140648|NCT02081391|585565704|FG003|12-hour Treatment|Lack of Efficacy|0|||
162140649|NCT02081391|585565701|FG000|12-hour Treatment|Adverse Event|4|||
162140650|NCT02081391|585565702|FG001|12-hour Treatment|Adverse Event|2|||
162140651|NCT02081391|585565703|FG002|12-hour Treatment|Adverse Event|0|||
162140652|NCT02081391|585565704|FG003|12-hour Treatment|Adverse Event|0|||
162140653|NCT02081391|585565701|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
162140654|NCT02081391|585565702|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
162140655|NCT02081391|585565703|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
162140656|NCT02081391|585565704|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
162140657|NCT02081391|585565701|FG000|12-hour Treatment|Further reasons|2|||
162140658|NCT02081391|585565702|FG001|12-hour Treatment|Further reasons|1|||
162140659|NCT02081391|585565703|FG002|12-hour Treatment|Further reasons|0|||
162140660|NCT02081391|585565704|FG003|12-hour Treatment|Further reasons|0|||
162140661|NCT02081391|585565701|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
162140662|NCT02081391|585565702|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
162140663|NCT02081391|585565703|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
162140664|NCT02081391|585565704|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
161910473|NCT01125930|584725563|FG000|Overall Study|Adverse Event|0|||
161910474|NCT01125930|584725564|FG001|Overall Study|Adverse Event|1|||
161910475|NCT01125930|584725563|FG000|Overall Study|Withdrawal by Subject|1|||
161910476|NCT01125930|584725564|FG001|Overall Study|Withdrawal by Subject|6|||
162140665|NCT02081391|585565701|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
162140666|NCT02081391|585565702|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
162140667|NCT02081391|585565703|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
162140668|NCT02081391|585565704|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
161910477|NCT01125930|584725563|FG000|Overall Study|Protocol Violation|0|||
161910478|NCT01125930|584725564|FG001|Overall Study|Protocol Violation|1|||
161910479|NCT01125930|584725563|FG000|Overall Study|Lost to Follow-up|0|||
161910480|NCT01125930|584725564|FG001|Overall Study|Lost to Follow-up|2|||
161910481|NCT01715831|584725569|FG000|Overall Study|Adverse Event|1|||
161910482|NCT03261401|584725570|FG000|Overall Study|Withdrawal by Subject|0|||
161910483|NCT03261401|584725571|FG001|Overall Study|Withdrawal by Subject|0|||
161910484|NCT03261401|584725572|FG002|Overall Study|Withdrawal by Subject|0|||
161910485|NCT03261401|584725573|FG003|Overall Study|Withdrawal by Subject|0|||
161910486|NCT03261401|584725574|FG004|Overall Study|Withdrawal by Subject|0|||
161910487|NCT03261401|584725575|FG005|Overall Study|Withdrawal by Subject|1|||
161910488|NCT03261401|584725576|FG006|Overall Study|Withdrawal by Subject|0|||
161910489|NCT03261401|584725577|FG007|Overall Study|Withdrawal by Subject|0|||
161910490|NCT03261401|584725578|FG008|Overall Study|Withdrawal by Subject|0|||
161910491|NCT03261401|584725579|FG009|Overall Study|Withdrawal by Subject|0|||
161910492|NCT03261401|584725580|FG010|Overall Study|Withdrawal by Subject|0|||
161910493|NCT03261401|584725581|FG011|Overall Study|Withdrawal by Subject|0|||
161910494|NCT03261401|584725582|FG012|Overall Study|Withdrawal by Subject|0|||
161910495|NCT03261401|584725570|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
161910496|NCT03261401|584725571|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
161910497|NCT03261401|584725572|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
161910498|NCT03261401|584725573|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
161910499|NCT03261401|584725574|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
161910500|NCT03261401|584725575|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
161910501|NCT03261401|584725576|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
161910502|NCT03261401|584725577|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
161910503|NCT03261401|584725578|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
161910504|NCT03261401|584725579|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
161910505|NCT03261401|584725580|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
161910506|NCT03261401|584725581|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
162140669|NCT02081391|585565701|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
162140670|NCT02081391|585565702|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
162140671|NCT02081391|585565703|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
162140672|NCT02081391|585565704|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
162140673|NCT02081391|585565701|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
162140674|NCT02081391|585565702|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
162140675|NCT02081391|585565703|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
162140676|NCT02081391|585565704|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
162140677|NCT02081391|585565701|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
162140678|NCT02081391|585565702|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
162140679|NCT02081391|585565703|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
162140680|NCT02081391|585565704|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
162140681|NCT02081391|585565701|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
162140682|NCT02081391|585565702|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
162140683|NCT02081391|585565703|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
162140684|NCT02081391|585565704|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
162140685|NCT01458275|585565705|FG000|Overall Study|Adverse Event|3|||
162140686|NCT01458275|585565706|FG001|Overall Study|Adverse Event|4|||
162140687|NCT01458275|585565707|FG002|Overall Study|Adverse Event|1|||
162140688|NCT01458275|585565705|FG000|Overall Study|Lost to Follow-up|3|||
162140689|NCT01458275|585565706|FG001|Overall Study|Lost to Follow-up|2|||
162140690|NCT01458275|585565707|FG002|Overall Study|Lost to Follow-up|5|||
162140691|NCT01458275|585565705|FG000|Overall Study|Protocol Violation|5|||
162140692|NCT01458275|585565706|FG001|Overall Study|Protocol Violation|5|||
162140693|NCT01458275|585565707|FG002|Overall Study|Protocol Violation|2|||
162140694|NCT01458275|585565705|FG000|Overall Study|Withdrawal by Subject|3|||
162140695|NCT01458275|585565706|FG001|Overall Study|Withdrawal by Subject|2|||
162140696|NCT01458275|585565707|FG002|Overall Study|Withdrawal by Subject|1|||
162140697|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
162140698|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
162140699|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
162140700|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
162140701|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
162140702|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
162140703|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
161910507|NCT03261401|584725582|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
162011057|NCT01124006|585097711|FG001|Overall Study|Lost to Follow-up|0|||
162140704|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
162140705|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
161910508|NCT01516216|584725583|FG000|Overall Study|Adverse Event|2|||
162140706|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
162140707|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
161910509|NCT01516216|584725584|FG001|Overall Study|Adverse Event|4|||
161910510|NCT01516216|584725583|FG000|Overall Study|Disease Progression|38|||
161910511|NCT01516216|584725584|FG001|Overall Study|Disease Progression|34|||
161910512|NCT01516216|584725583|FG000|Overall Study|Withdrawal by Subject|9|||
161910513|NCT01516216|584725584|FG001|Overall Study|Withdrawal by Subject|11|||
161910514|NCT01516216|584725583|FG000|Overall Study|Potentially Curative Resection|6|||
161910515|NCT01516216|584725584|FG001|Overall Study|Potentially Curative Resection|12|||
161910516|NCT01516216|584725583|FG000|Overall Study|Nonadherence|2|||
161910517|NCT01516216|584725584|FG001|Overall Study|Nonadherence|3|||
161910518|NCT01516216|584725583|FG000|Overall Study|Physician Decision|6|||
161910519|NCT01516216|584725584|FG001|Overall Study|Physician Decision|3|||
161910520|NCT01516216|584725583|FG000|Overall Study|Prolonged Treatment Delay|5|||
161910521|NCT01516216|584725584|FG001|Overall Study|Prolonged Treatment Delay|1|||
161910522|NCT01516216|584725583|FG000|Overall Study|Intercurrent Illness|1|||
161910523|NCT01516216|584725584|FG001|Overall Study|Intercurrent Illness|0|||
161910524|NCT01516216|584725583|FG000|Overall Study|Death|1|||
161910525|NCT01516216|584725584|FG001|Overall Study|Death|1|||
161910526|NCT01715298|584725585|FG000|Overall Study|Lost to Follow-up|0|||
161910527|NCT01715298|584725586|FG001|Overall Study|Lost to Follow-up|2|||
161910528|NCT01715298|584725585|FG000|Overall Study|Patient/guardian decision|7|||
161910529|NCT01715298|584725586|FG001|Overall Study|Patient/guardian decision|9|||
161910530|NCT02419807|584725587|FG000|Overall Study|Withdrawal by Subject|4|||
161910531|NCT02419807|584725587|FG000|Overall Study|Physician Decision|1|||
161910532|NCT02419807|584725587|FG000|Overall Study|Protocol Violation|5|||
161910533|NCT01006629|584725590|FG000|Overall Study|Adverse Event|1|||
161910534|NCT01006629|584725590|FG000|Overall Study|Parent refused to continue participation|1|||
161910535|NCT01006629|584725590|FG000|Overall Study|Parent unable to perform site visit|4|||
161910536|NCT01499511|584725591|FG000|Overall Study|Death|1|||
161910537|NCT01499511|584725592|FG001|Overall Study|Death|0|||
161910538|NCT00998946|584725594|FG000|Overall Study|Lost to Follow-up|1|||
161910539|NCT00998946|584725594|FG000|Overall Study|Withdrawal by Subject|1|||
161910540|NCT00998946|584725594|FG000|Overall Study|Death|2|||
161910541|NCT00998946|584725594|FG000|Overall Study|Reason Unspecified|3|||
161910542|NCT00998946|584725594|FG000|Overall Study|Enrolled but not Dosed|2|||
161910543|NCT01065818|584725596|FG000|Overall Study|Withdrawal by Subject|1|||
161910544|NCT01065818|584725596|FG000|Overall Study|Not a candidate for surgery|1|||
161910545|NCT00853385|584725597|FG000|Overall Study|Death|0|||
161910546|NCT00853385|584725598|FG001|Overall Study|Death|0|||
161910547|NCT00853385|584725599|FG002|Overall Study|Death|0|||
161910548|NCT00853385|584725600|FG003|Overall Study|Death|0|||
161910549|NCT00853385|584725601|FG004|Overall Study|Death|1|||
161910550|NCT00853385|584725597|FG000|Overall Study|Adverse Event|24|||
161910551|NCT00853385|584725598|FG001|Overall Study|Adverse Event|24|||
161910552|NCT00853385|584725599|FG002|Overall Study|Adverse Event|2|||
161910553|NCT00853385|584725600|FG003|Overall Study|Adverse Event|5|||
161910554|NCT00853385|584725601|FG004|Overall Study|Adverse Event|22|||
161910555|NCT00853385|584725597|FG000|Overall Study|Lack of Efficacy|6|||
161910556|NCT00853385|584725598|FG001|Overall Study|Lack of Efficacy|7|||
161910557|NCT00853385|584725599|FG002|Overall Study|Lack of Efficacy|3|||
161910558|NCT00853385|584725600|FG003|Overall Study|Lack of Efficacy|3|||
161910559|NCT00853385|584725601|FG004|Overall Study|Lack of Efficacy|6|||
161910560|NCT00853385|584725597|FG000|Overall Study|Lost to Follow-up|2|||
161910561|NCT00853385|584725598|FG001|Overall Study|Lost to Follow-up|1|||
161910562|NCT00853385|584725599|FG002|Overall Study|Lost to Follow-up|0|||
162011058|NCT01124006|585097712|FG002|Overall Study|Lost to Follow-up|1|||
161910563|NCT00853385|584725600|FG003|Overall Study|Lost to Follow-up|0|||
161910564|NCT00853385|584725601|FG004|Overall Study|Lost to Follow-up|0|||
161910565|NCT00853385|584725597|FG000|Overall Study|Withdrawal by Subject|4|||
161910566|NCT00853385|584725598|FG001|Overall Study|Withdrawal by Subject|2|||
161910567|NCT00853385|584725599|FG002|Overall Study|Withdrawal by Subject|0|||
161910568|NCT00853385|584725600|FG003|Overall Study|Withdrawal by Subject|1|||
161910569|NCT00853385|584725601|FG004|Overall Study|Withdrawal by Subject|1|||
161910570|NCT00853385|584725597|FG000|Overall Study|Other|18|||
161910571|NCT00853385|584725598|FG001|Overall Study|Other|9|||
161910572|NCT00853385|584725599|FG002|Overall Study|Other|4|||
161910573|NCT00853385|584725600|FG003|Overall Study|Other|4|||
161806796|NCT00909610|584337710|FG001|Period: Second Intervention|Adverse Event|0|||
161806797|NCT00328926|584337714|FG000|Overall Study|Pregnancy|2|||
161806798|NCT00328926|584337715|FG001|Overall Study|Pregnancy|1|||
161806799|NCT00328926|584337716|FG002|Overall Study|Pregnancy|0|||
161806800|NCT00328926|584337714|FG000|Overall Study|Lost to Follow-up|0|||
161806801|NCT00328926|584337715|FG001|Overall Study|Lost to Follow-up|1|||
161806802|NCT00328926|584337716|FG002|Overall Study|Lost to Follow-up|0|||
161806803|NCT00328926|584337714|FG000|Overall Study|Death|0|||
161806804|NCT00328926|584337715|FG001|Overall Study|Death|0|||
161806805|NCT00328926|584337716|FG002|Overall Study|Death|1|||
161806806|NCT00328926|584337714|FG000|Overall Study|In vitro fertilization treatment|0|||
161806807|NCT00328926|584337715|FG001|Overall Study|In vitro fertilization treatment|0|||
161806808|NCT00328926|584337716|FG002|Overall Study|In vitro fertilization treatment|1|||
161806809|NCT00328926|584337714|FG000|Overall Study|Lack of ovarian response|0|||
161806810|NCT00328926|584337715|FG001|Overall Study|Lack of ovarian response|1|||
161806811|NCT00328926|584337716|FG002|Overall Study|Lack of ovarian response|0|||
161806812|NCT02269657|584337719|FG000|Overall Study|Protocol Violation|3|||
161806813|NCT00834249|584337724|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161806814|NCT00834249|584337725|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
161806815|NCT00834249|584337724|FG000|Second Intervention|Adverse Event|1|||
161806816|NCT00834249|584337725|FG001|Second Intervention|Adverse Event|0|||
161806817|NCT00851877|584337726|FG000|Phase I-1|Death|1|||
161806818|NCT00851877|584337727|FG001|Phase I-1|Death|0|||
161806819|NCT00851877|584337728|FG002|Phase I-1|Death|0|||
161806820|NCT00851877|584337726|FG000|Phase II|Withdrawal by Subject|0|||
161910574|NCT00853385|584725601|FG004|Overall Study|Other|12|||
162140708|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
161806821|NCT00851877|584337727|FG001|Phase II|Withdrawal by Subject|0|||
161806822|NCT00851877|584337728|FG002|Phase II|Withdrawal by Subject|3|||
161806823|NCT00834743|584337729|FG000|Second Intervention|Withdrawal by Subject|1|||
161806824|NCT00834743|584337730|FG001|Second Intervention|Withdrawal by Subject|0|||
161806825|NCT00627016|584337731|FG000|Overall Study|Adverse Event|1|||
161806826|NCT00627016|584337732|FG001|Overall Study|Adverse Event|1|||
161806827|NCT00627016|584337731|FG000|Overall Study|Protocol Violation|0|||
161806828|NCT00627016|584337732|FG001|Overall Study|Protocol Violation|2|||
161806829|NCT00627016|584337731|FG000|Overall Study|Lost to Follow-up|0|||
161806830|NCT00627016|584337732|FG001|Overall Study|Lost to Follow-up|1|||
161806831|NCT00627016|584337731|FG000|Overall Study|Withdrawal by Subject|2|||
161806832|NCT00627016|584337732|FG001|Overall Study|Withdrawal by Subject|1|||
161806833|NCT00627016|584337731|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
161806834|NCT00627016|584337732|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
161806835|NCT00627016|584337731|FG000|Overall Study|Lack of Efficacy|1|||
161806836|NCT00627016|584337732|FG001|Overall Study|Lack of Efficacy|0|||
161806837|NCT00627016|584337731|FG000|Overall Study|Placed on Excluded Drugs|1|||
161806838|NCT00627016|584337732|FG001|Overall Study|Placed on Excluded Drugs|0|||
161806839|NCT00627016|584337731|FG000|Overall Study|Pregnancy|1|||
161806840|NCT00627016|584337732|FG001|Overall Study|Pregnancy|0|||
161806841|NCT01534663|584337733|FG000|Overall Study|Lost to Follow-up|0|||
161910575|NCT00915525|584725602|FG000|Overall Study|Protocol Violation|9|||
162140709|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
162140710|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
162140711|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
162140712|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
162140713|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
162140714|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
162140715|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
162140716|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
162140717|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
162140718|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
162140719|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
162140720|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
162140721|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
162140722|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
162140723|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
162140724|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
162140725|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
162140726|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
162140727|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
161806842|NCT01534663|584337734|FG001|Overall Study|Lost to Follow-up|2|||
161806843|NCT01534663|584337733|FG000|Overall Study|Adverse Event|2|||
161806844|NCT01534663|584337734|FG001|Overall Study|Adverse Event|1|||
161806845|NCT01693523|584337735|FG000|Overall Study|Adverse Event|2|||
161806846|NCT01693523|584337736|FG001|Overall Study|Adverse Event|1|||
161806847|NCT01693523|584337737|FG002|Overall Study|Adverse Event|0|||
161910576|NCT00915525|584725603|FG001|Overall Study|Protocol Violation|4|||
161910577|NCT00915525|584725602|FG000|Overall Study|Withdrawal by Subject|59|||
161910578|NCT00915525|584725603|FG001|Overall Study|Withdrawal by Subject|21|||
161910579|NCT00915525|584725602|FG000|Overall Study|Lost to Follow-up|27|||
161806848|NCT01693523|584337735|FG000|Overall Study|Death|0|||
161806849|NCT01693523|584337736|FG001|Overall Study|Death|1|||
161806850|NCT01693523|584337737|FG002|Overall Study|Death|1|||
161806851|NCT01693523|584337735|FG000|Overall Study|Lost to Follow-up|0|||
161806852|NCT01693523|584337736|FG001|Overall Study|Lost to Follow-up|0|||
161806853|NCT01693523|584337737|FG002|Overall Study|Lost to Follow-up|4|||
161806854|NCT01693523|584337735|FG000|Overall Study|Physician Decision|0|||
161806855|NCT01693523|584337736|FG001|Overall Study|Physician Decision|0|||
161806856|NCT01693523|584337737|FG002|Overall Study|Physician Decision|1|||
161806857|NCT01693523|584337735|FG000|Overall Study|Withdrawal by Subject|1|||
161806858|NCT01693523|584337736|FG001|Overall Study|Withdrawal by Subject|2|||
161806859|NCT01693523|584337737|FG002|Overall Study|Withdrawal by Subject|2|||
161806860|NCT01693523|584337735|FG000|Overall Study|Lack of compliance study medication|1|||
161806861|NCT01693523|584337736|FG001|Overall Study|Lack of compliance study medication|2|||
161806862|NCT01693523|584337737|FG002|Overall Study|Lack of compliance study medication|0|||
161806863|NCT01693523|584337735|FG000|Overall Study|Chemotherapy was held|1|||
161806864|NCT01693523|584337736|FG001|Overall Study|Chemotherapy was held|2|||
161806865|NCT01693523|584337737|FG002|Overall Study|Chemotherapy was held|0|||
161806866|NCT03025880|584337738|FG000|Overall Study|Adverse Event|1|||
161806867|NCT03025880|584337739|FG001|Overall Study|Adverse Event|0|||
161806868|NCT03025880|584337738|FG000|Overall Study|Death|1|||
161806869|NCT03025880|584337739|FG001|Overall Study|Death|1|||
161806870|NCT03025880|584337738|FG000|Overall Study|Withdrawal by Subject|0|||
161806871|NCT03025880|584337739|FG001|Overall Study|Withdrawal by Subject|1|||
161806872|NCT03025880|584337738|FG000|Overall Study|Physician Decision|0|||
161806873|NCT03025880|584337739|FG001|Overall Study|Physician Decision|1|||
161806874|NCT03025880|584337738|FG000|Overall Study|Progressive Disease|12|||
161806875|NCT03025880|584337739|FG001|Overall Study|Progressive Disease|19|||
161806876|NCT00086996|584337741|FG000|Overall Study|Adverse Event|29|||
161806877|NCT00086996|584337741|FG000|Overall Study|Death|4|||
161910580|NCT00915525|584725603|FG001|Overall Study|Lost to Follow-up|16|||
161806878|NCT00086996|584337741|FG000|Overall Study|progression/relapse|7|||
161806879|NCT00086996|584337741|FG000|Overall Study|Withdrawal by Subject|13|||
161806880|NCT00086996|584337741|FG000|Overall Study|Other|6|||
161806881|NCT00086996|584337741|FG000|Overall Study|not eligible|5|||
161910581|NCT00915525|584725602|FG000|Overall Study|Pregnancy|2|||
162140728|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
162140729|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
162140730|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
162140731|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
162140732|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
162140733|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
162140734|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
162140735|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
162140736|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
162140737|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
162140738|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
161806882|NCT01422538|584337742|FG000|Overall Study|Lost to Follow-up|0|||
161910582|NCT00915525|584725603|FG001|Overall Study|Pregnancy|0|||
161910583|NCT00915525|584725602|FG000|Overall Study|Lack of Efficacy|15|||
162140739|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
162140740|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
162140741|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
162140742|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
162140743|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162140744|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162140745|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162140746|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162140747|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162140748|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162140749|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162140750|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
162140751|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140752|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
162140753|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140754|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140755|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140756|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140757|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140758|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140759|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140760|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162140761|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
161910584|NCT00915525|584725603|FG001|Overall Study|Lack of Efficacy|32|||
161910585|NCT00915525|584725602|FG000|Overall Study|Adverse Event|29|||
161910586|NCT00915525|584725603|FG001|Overall Study|Adverse Event|13|||
161910587|NCT00915525|584725602|FG000|Overall Study|Missing|12|||
161910588|NCT00915525|584725603|FG001|Overall Study|Missing|1|||
161910589|NCT00915525|584725602|FG000|Overall Study|Other Reason|35|||
161910590|NCT00915525|584725603|FG001|Overall Study|Other Reason|12|||
161910591|NCT00915525|584725602|FG000|Overall Study|Site Closed|27|||
161910592|NCT00915525|584725603|FG001|Overall Study|Site Closed|9|||
161910593|NCT00915525|584725602|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
161910594|NCT00915525|584725603|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
161910595|NCT00915525|584725602|FG000|Overall Study|Study Burden|28|||
161910596|NCT00915525|584725603|FG001|Overall Study|Study Burden|12|||
161910597|NCT00915525|584725602|FG000|Overall Study|Non-Compliance|3|||
161910598|NCT00915525|584725603|FG001|Overall Study|Non-Compliance|1|||
161910599|NCT00915525|584725602|FG000|Overall Study|Patient Moved|15|||
161910600|NCT00915525|584725603|FG001|Overall Study|Patient Moved|9|||
161910601|NCT00577408|584725604|FG000|Overall Study|Stopped attending study visits|9|||
161910602|NCT00577408|584725605|FG001|Overall Study|Stopped attending study visits|11|||
161910603|NCT00577408|584725604|FG000|Overall Study|Continued opioid use|3|||
161910604|NCT00577408|584725605|FG001|Overall Study|Continued opioid use|2|||
161910605|NCT00577408|584725604|FG000|Overall Study|Non-compliance with study meds|0|||
161910606|NCT00577408|584725605|FG001|Overall Study|Non-compliance with study meds|3|||
161910607|NCT00577408|584725604|FG000|Overall Study|Refused Oral Naltrexone|0|||
161910608|NCT00577408|584725605|FG001|Overall Study|Refused Oral Naltrexone|1|||
161910609|NCT00577408|584725604|FG000|Overall Study|Moved out of state|0|||
161910610|NCT00577408|584725605|FG001|Overall Study|Moved out of state|1|||
161910611|NCT00577408|584725604|FG000|Overall Study|Scheduling Issues|0|||
161910612|NCT00577408|584725605|FG001|Overall Study|Scheduling Issues|3|||
161910613|NCT00577408|584725604|FG000|Overall Study|Death|0|||
161910614|NCT00577408|584725605|FG001|Overall Study|Death|1|||
161910615|NCT00577408|584725604|FG000|Overall Study|Psychiatric hospitalization|0|||
161910616|NCT00577408|584725605|FG001|Overall Study|Psychiatric hospitalization|1|||
161910617|NCT03435055|584725606|FG000|Screening|Physician Decision|2|||
161910618|NCT03435055|584725606|FG000|Received Intervention|Did not complete nitrous administration|3|||
161910619|NCT02732639|584725612|FG000|Overall Study|Lost to Follow-up|1|||
161910620|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
161910621|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
161910622|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
161910623|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
161910624|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
161910625|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
161910626|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
162140762|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
162140763|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162140764|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162140765|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162140766|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162140767|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162140768|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
162140769|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
162140770|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162140771|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162140772|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162140773|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162140774|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162140775|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162140776|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162140777|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
162140778|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
162140779|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162140780|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162140781|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
161910627|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
161910628|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
161910629|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
161910630|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
161910631|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
161910632|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
161910633|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
161806883|NCT01422538|584337743|FG001|Overall Study|Lost to Follow-up|1|||
161806884|NCT01422538|584337744|FG002|Overall Study|Lost to Follow-up|1|||
161806885|NCT01422538|584337742|FG000|Overall Study|Missed visit|0|||
161806886|NCT01422538|584337743|FG001|Overall Study|Missed visit|1|||
161806887|NCT01422538|584337744|FG002|Overall Study|Missed visit|1|||
161806888|NCT00312663|584337745|FG000|Immunization Phase|Adverse Event|0|||
161806889|NCT00312663|584337746|FG001|Immunization Phase|Adverse Event|1|||
161806890|NCT00312663|584337747|FG002|Immunization Phase|Adverse Event|0|||
161806891|NCT00286754|584337748|FG000|Overall Study|Adverse Event|2|||
161806892|NCT00286754|584337749|FG001|Overall Study|Adverse Event|2|||
161806893|NCT00286754|584337750|FG002|Overall Study|Adverse Event|3|||
161806894|NCT00286754|584337748|FG000|Overall Study|Withdrawal by Subject|6|||
161806895|NCT00286754|584337749|FG001|Overall Study|Withdrawal by Subject|2|||
161806896|NCT00286754|584337750|FG002|Overall Study|Withdrawal by Subject|0|||
161806897|NCT00286754|584337748|FG000|Overall Study|Lost to Follow-up|12|||
161806898|NCT00286754|584337749|FG001|Overall Study|Lost to Follow-up|14|||
161806899|NCT00286754|584337750|FG002|Overall Study|Lost to Follow-up|6|||
161806900|NCT00286754|584337748|FG000|Overall Study|Moved out of state|0|||
161806901|NCT00286754|584337749|FG001|Overall Study|Moved out of state|0|||
161806902|NCT00286754|584337750|FG002|Overall Study|Moved out of state|1|||
161806903|NCT02661295|584337751|FG000|Overall Study|Death|1|||
161806904|NCT02661295|584337751|FG000|Overall Study|Transferred Out|1|||
161806905|NCT02661295|584337751|FG000|Overall Study|Kidney Transplant|1|||
161806906|NCT02661295|584337751|FG000|Overall Study|Withdrawn due to side effects|8|||
161806907|NCT02661295|584337751|FG000|Overall Study|Withdrawn due to access type|1|||
161806908|NCT02661295|584337751|FG000|Overall Study|Withdrawn due to allergies|1|||
161806909|NCT02661295|584337751|FG000|Overall Study|Withdrawn due to non-compliance|1|||
161806910|NCT02661295|584337751|FG000|Overall Study|Withdrawal by Subject|3|||
161806911|NCT02661295|584337751|FG000|Overall Study|Failed screening|2|||
161806912|NCT00301366|584337752|FG000|Overall Study|Adverse Event|1|||
161806913|NCT01313273|584337753|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
161806914|NCT01313273|584337754|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
161806915|NCT01313273|584337753|FG000|Overall Study|Withdrawal by Subject|1|||
161806916|NCT01313273|584337754|FG001|Overall Study|Withdrawal by Subject|0|||
161806917|NCT01313273|584337753|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
161806918|NCT01313273|584337754|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
161806919|NCT02726581|584337755|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
161806920|NCT02726581|584337756|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
161806921|NCT02726581|584337757|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
161806922|NCT02726581|584337755|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
161806923|NCT02726581|584337756|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
161806924|NCT02726581|584337757|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
161806925|NCT02726581|584337755|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161806926|NCT02726581|584337756|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161806927|NCT02726581|584337757|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161806928|NCT02726581|584337755|FG000|Treatment Period|Disease progression|47|||
161806929|NCT02726581|584337756|FG001|Treatment Period|Disease progression|50|||
161806930|NCT02726581|584337757|FG002|Treatment Period|Disease progression|16|||
161806931|NCT02726581|584337755|FG000|Treatment Period|Other reasons|9|||
161806932|NCT02726581|584337756|FG001|Treatment Period|Other reasons|8|||
161806933|NCT02726581|584337757|FG002|Treatment Period|Other reasons|2|||
161806934|NCT02726581|584337755|FG000|Treatment Period|Study drug toxicity|6|||
161806935|NCT02726581|584337756|FG001|Treatment Period|Study drug toxicity|3|||
161806936|NCT02726581|584337757|FG002|Treatment Period|Study drug toxicity|2|||
161910634|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
162140782|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162140783|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162140784|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
161910635|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
162140785|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162140786|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
162140787|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
162140788|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162140789|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162140790|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162140791|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162140792|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162140793|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162140794|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162140795|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
162140796|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140797|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
162140798|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
162140799|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140800|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
161910636|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
161910637|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
161910638|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
161910639|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
161910640|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
161910641|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
161910642|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
161910643|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
161910644|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
161910645|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
161910646|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
161910647|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
161910648|NCT01668797|584725613|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
161910649|NCT01668797|584725614|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
161910650|NCT01668797|584725615|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
161910651|NCT01668797|584725616|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
161910652|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
161910653|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
161910654|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
161910655|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
161910656|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
161910657|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
161910658|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
161910659|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
161910660|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
161910661|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
161910662|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
161910663|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
161910664|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
161910665|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
161910666|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
161910667|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
161910668|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
161910669|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
161910670|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
161910671|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
161910672|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
161910673|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
161910674|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
161910675|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
161910676|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
162140801|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140802|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140803|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140804|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
162140805|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
162140806|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
162140807|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
161806937|NCT02726581|584337755|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
161806938|NCT02726581|584337756|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
161806939|NCT02726581|584337757|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
161806940|NCT02726581|584337755|FG000|Treatment Period|Participant withdrew consent|3|||
161806941|NCT02726581|584337756|FG001|Treatment Period|Participant withdrew consent|1|||
161806942|NCT02726581|584337757|FG002|Treatment Period|Participant withdrew consent|1|||
161806943|NCT02726581|584337755|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
161910677|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
162140808|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162140809|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162140810|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162140811|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162140812|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162140813|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
162140814|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162140815|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
162140816|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162140817|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162140818|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162140819|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162140820|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162140821|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162140822|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
162140823|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162140824|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
162140825|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162140826|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162140827|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162140828|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162140829|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162140830|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162140831|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
162140832|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162140833|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162140834|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
162140835|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162140836|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162140837|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162140838|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162140839|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162140840|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
162140841|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162140842|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162140843|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
162140844|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162140845|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162140846|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162140847|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162140848|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162140849|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
162140850|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162140851|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162140852|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
162140853|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162140854|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162140855|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162140856|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162140857|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162140858|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
162140859|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162140860|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162140861|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162140862|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162140863|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162140864|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162140865|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
161806944|NCT02726581|584337756|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
161806945|NCT02726581|584337757|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
161806946|NCT02726581|584337755|FG000|Treatment Period|Maximum clinical benefit|0|||
161806947|NCT02726581|584337756|FG001|Treatment Period|Maximum clinical benefit|2|||
161806948|NCT02726581|584337757|FG002|Treatment Period|Maximum clinical benefit|0|||
161806949|NCT02726581|584337755|FG000|Treatment Period|Death|1|||
161806950|NCT02726581|584337756|FG001|Treatment Period|Death|0|||
161806951|NCT02726581|584337757|FG002|Treatment Period|Death|0|||
161806952|NCT02726581|584337755|FG000|Treatment Period|Poor/non-compliance|1|||
161806953|NCT02726581|584337756|FG001|Treatment Period|Poor/non-compliance|0|||
161806954|NCT02726581|584337757|FG002|Treatment Period|Poor/non-compliance|0|||
161806955|NCT02726581|584337755|FG000|Treatment Period|Participant no longer meets study criteria|0|||
161806956|NCT02726581|584337756|FG001|Treatment Period|Participant no longer meets study criteria|1|||
161806957|NCT02726581|584337757|FG002|Treatment Period|Participant no longer meets study criteria|0|||
161806958|NCT03496623|584337759|FG000|Run-In Period (2 Weeks)|Death|1|||
161806959|NCT03496623|584337760|FG001|Run-In Period (2 Weeks)|Death|0|||
161806960|NCT03496623|584337761|FG002|Run-In Period (2 Weeks)|Death|0|||
161806961|NCT03496623|584337762|FG003|Run-In Period (2 Weeks)|Death|0|||
161806962|NCT03496623|584337763|FG004|Run-In Period (2 Weeks)|Death|0|||
161806963|NCT03496623|584337759|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
161806964|NCT03496623|584337760|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
161806965|NCT03496623|584337761|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
161806966|NCT03496623|584337762|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
161806967|NCT03496623|584337763|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
161806968|NCT03496623|584337759|FG000|Period 1 (12 Weeks)|Death|0|||
161806969|NCT03496623|584337760|FG001|Period 1 (12 Weeks)|Death|3|||
161806970|NCT03496623|584337761|FG002|Period 1 (12 Weeks)|Death|0|||
161806971|NCT03496623|584337762|FG003|Period 1 (12 Weeks)|Death|0|||
161806972|NCT03496623|584337763|FG004|Period 1 (12 Weeks)|Death|0|||
161806973|NCT03496623|584337759|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
161910678|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
161910679|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
161910680|NCT01668797|584725613|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
161910681|NCT01668797|584725614|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
161910682|NCT01668797|584725615|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
161910683|NCT01668797|584725616|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
161910684|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
161910685|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
161910686|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
161910687|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
162011059|NCT01124006|585097710|FG000|Overall Study|Other|0|||
162011060|NCT01124006|585097711|FG001|Overall Study|Other|0|||
161806974|NCT03496623|584337760|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
161806975|NCT03496623|584337761|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
161806976|NCT03496623|584337762|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
161806977|NCT03496623|584337763|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
161806978|NCT03496623|584337759|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161806979|NCT03496623|584337760|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
161806980|NCT03496623|584337761|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
161910688|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
161910689|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
161910690|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
161806981|NCT03496623|584337762|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161806982|NCT03496623|584337763|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161806983|NCT03496623|584337759|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
161806984|NCT03496623|584337760|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
161806985|NCT03496623|584337761|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
161806986|NCT03496623|584337762|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
161806987|NCT03496623|584337763|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
161806988|NCT03496623|584337759|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161806989|NCT03496623|584337760|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161806990|NCT03496623|584337761|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
161806991|NCT03496623|584337762|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161806992|NCT03496623|584337763|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162140866|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162140867|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
162140868|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
162140869|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
162140870|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162140871|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162140872|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162140873|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162140874|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162140875|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162140876|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
162140877|NCT03598790|585566959|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162140878|NCT03598790|585566960|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162140879|NCT03598790|585566961|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
162140880|NCT03598790|585566962|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162140881|NCT03598790|585566963|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162140882|NCT03598790|585566964|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162140883|NCT03598790|585566965|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162140884|NCT03598790|585566966|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162140885|NCT03598790|585566967|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
162140886|NCT03598790|585566959|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162140887|NCT03598790|585566960|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162140888|NCT03598790|585566961|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162140889|NCT03598790|585566962|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
162140890|NCT03598790|585566963|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
162140891|NCT03598790|585566964|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
162140892|NCT03598790|585566965|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162140893|NCT03598790|585566966|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162140894|NCT03598790|585566967|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162140895|NCT03598790|585566959|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162140896|NCT03598790|585566960|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162140897|NCT03598790|585566961|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162140898|NCT03598790|585566962|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
162140899|NCT03598790|585566963|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162140900|NCT03598790|585566964|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162140901|NCT03598790|585566965|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162140902|NCT03598790|585566966|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162140903|NCT03598790|585566967|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
162140904|NCT03598790|585566959|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162140905|NCT03598790|585566960|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162140906|NCT03598790|585566961|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162140907|NCT03598790|585566962|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
162140908|NCT03598790|585566963|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162140909|NCT03598790|585566964|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162140910|NCT03598790|585566965|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162140911|NCT03598790|585566966|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162140912|NCT03598790|585566967|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162140913|NCT03598790|585566959|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162140914|NCT03598790|585566960|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162140915|NCT03598790|585566961|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162140916|NCT03598790|585566962|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
162140917|NCT03598790|585566963|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
162140918|NCT03598790|585566964|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
161806993|NCT03496623|584337759|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
161806994|NCT03496623|584337760|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
161806995|NCT03496623|584337761|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
161806996|NCT03496623|584337762|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
161806997|NCT03496623|584337763|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
161806998|NCT03496623|584337759|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161806999|NCT03496623|584337760|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
161807000|NCT03496623|584337761|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161807001|NCT03496623|584337762|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161807002|NCT03496623|584337763|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161807003|NCT02543203|584337764|FG000|Overall Study|Unpalatable Fragrance|2|||
161807004|NCT02543203|584337765|FG001|Overall Study|Unpalatable Fragrance|2|||
161807005|NCT02543203|584337764|FG000|Overall Study|Lost to Follow-up|1|||
161807006|NCT02543203|584337765|FG001|Overall Study|Lost to Follow-up|0|||
161807007|NCT02543203|584337764|FG000|Overall Study|Increased Irritability|1|||
161807008|NCT02543203|584337765|FG001|Overall Study|Increased Irritability|0|||
161807009|NCT02543203|584337764|FG000|Overall Study|Family|1|||
161807010|NCT02543203|584337765|FG001|Overall Study|Family|2|||
161807011|NCT02543203|584337764|FG000|Overall Study|Negative Behavior|1|||
161807012|NCT02543203|584337765|FG001|Overall Study|Negative Behavior|0|||
161807013|NCT02543203|584337764|FG000|Overall Study|Withdrawal by Subject|0|||
161807014|NCT02543203|584337765|FG001|Overall Study|Withdrawal by Subject|1|||
161807015|NCT04786184|584337766|FG000|Overall Study|Adverse Event|4|||
161807016|NCT04786184|584337767|FG001|Overall Study|Adverse Event|0|||
161807017|NCT04786184|584337766|FG000|Overall Study|Withdrawal by Subject|3|||
161807018|NCT04786184|584337767|FG001|Overall Study|Withdrawal by Subject|1|||
161807019|NCT04786184|584337766|FG000|Overall Study|Lost to Follow-up|4|||
161807020|NCT04786184|584337767|FG001|Overall Study|Lost to Follow-up|2|||
161807021|NCT00565448|584337768|FG000|Overall Study|Adverse Event|1|||
161807022|NCT00565448|584337769|FG001|Overall Study|Adverse Event|2|||
161807023|NCT00565448|584337768|FG000|Overall Study|Disease progression|1|||
161807024|NCT00565448|584337769|FG001|Overall Study|Disease progression|0|||
161807025|NCT00565448|584337768|FG000|Overall Study|Withdrawal by Subject|1|||
161807026|NCT00565448|584337769|FG001|Overall Study|Withdrawal by Subject|0|||
161807027|NCT00193609|584337770|FG000|Overall Study|Lack of Efficacy|2|||
161807028|NCT00193609|584337770|FG000|Overall Study|Adverse Event|2|||
161807029|NCT00302952|584337771|FG000|Overall Study|Physician Decision|1|||
161807030|NCT00302952|584337772|FG001|Overall Study|Physician Decision|1|||
161807031|NCT00302952|584337771|FG000|Overall Study|Withdrawal by Subject|2|||
161807032|NCT00302952|584337772|FG001|Overall Study|Withdrawal by Subject|3|||
161807033|NCT00302952|584337771|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
161807034|NCT00302952|584337772|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
161807035|NCT02979353|584337773|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
161807036|NCT02979353|584337774|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
161807037|NCT02979353|584337773|FG000|Overall Study|Withdrawal by Subject|16|||
161807038|NCT02979353|584337774|FG001|Overall Study|Withdrawal by Subject|12|||
161807039|NCT02979353|584337773|FG000|Overall Study|Death|10|||
161807040|NCT02979353|584337774|FG001|Overall Study|Death|11|||
161807041|NCT02979353|584337773|FG000|Overall Study|Transfer to Hospice Care|19|||
161807042|NCT02979353|584337774|FG001|Overall Study|Transfer to Hospice Care|14|||
161807043|NCT02979353|584337773|FG000|Overall Study|Lost to Follow-up|1|||
161807044|NCT02979353|584337774|FG001|Overall Study|Lost to Follow-up|5|||
161807045|NCT00857623|584337775|FG000|Overall Study|Adverse Event|5|||
161807046|NCT00857623|584337776|FG001|Overall Study|Adverse Event|2|||
161807047|NCT00857623|584337775|FG000|Overall Study|Study-specific discontinuation criteria|5|||
161807048|NCT00857623|584337776|FG001|Overall Study|Study-specific discontinuation criteria|3|||
161807049|NCT00857623|584337775|FG000|Overall Study|Withdrawal by Subject|2|||
161807050|NCT00857623|584337776|FG001|Overall Study|Withdrawal by Subject|1|||
161807051|NCT00857623|584337775|FG000|Overall Study|Lack of Efficacy|1|||
161807052|NCT00857623|584337776|FG001|Overall Study|Lack of Efficacy|1|||
161807053|NCT00857623|584337775|FG000|Overall Study|Severe non-compliance to protocol|1|||
161807054|NCT00857623|584337776|FG001|Overall Study|Severe non-compliance to protocol|1|||
161807055|NCT00857623|584337775|FG000|Overall Study|Intake of prohibited medication|0|||
161807056|NCT00857623|584337776|FG001|Overall Study|Intake of prohibited medication|1|||
161807057|NCT00857623|584337775|FG000|Overall Study|Positive for HEP C|0|||
161807058|NCT00857623|584337776|FG001|Overall Study|Positive for HEP C|1|||
161807059|NCT04185909|584337777|FG000|Overall Study|Lost to Follow-up|1|||
161807060|NCT02193178|584337778|FG000|Overall Study|Lost to Follow-up|1|||
161807061|NCT02193178|584337778|FG000|Overall Study|Dry eyes|1|||
161807062|NCT03435081|584337779|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
161807063|NCT03435081|584337780|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
161807064|NCT03435081|584337781|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
161807065|NCT03435081|584337779|FG000|Week 0 to Week 16|Adverse Event|2|||
161807066|NCT03435081|584337780|FG001|Week 0 to Week 16|Adverse Event|2|||
161807067|NCT03435081|584337781|FG002|Week 0 to Week 16|Adverse Event|2|||
161807068|NCT03435081|584337779|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
161807069|NCT03435081|584337780|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
161807070|NCT03435081|584337781|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
161807071|NCT03435081|584337779|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
161807072|NCT03435081|584337780|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
161807073|NCT03435081|584337781|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
161807074|NCT03435081|584337779|FG000|Week 0 to Week 16|Pregnancy|1|||
161807075|NCT03435081|584337780|FG001|Week 0 to Week 16|Pregnancy|0|||
161807076|NCT03435081|584337781|FG002|Week 0 to Week 16|Pregnancy|0|||
161807077|NCT03435081|584337779|FG000|Week 0 to Week 16|Non-compliance|1|||
161807078|NCT03435081|584337780|FG001|Week 0 to Week 16|Non-compliance|0|||
161807079|NCT03435081|584337781|FG002|Week 0 to Week 16|Non-compliance|2|||
161807080|NCT03435081|584337779|FG000|Week 0 to Week 16|Inadequate Response|0|||
161807081|NCT03435081|584337780|FG001|Week 0 to Week 16|Inadequate Response|1|||
161807082|NCT03435081|584337781|FG002|Week 0 to Week 16|Inadequate Response|0|||
161807083|NCT03435081|584337779|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
161807084|NCT03435081|584337780|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
161807085|NCT03435081|584337781|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
161807086|NCT03435081|584337779|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
161807087|NCT03435081|584337780|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
161807088|NCT03435081|584337781|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
161807089|NCT03435081|584337779|FG000|Week 16 to Week 104|Adverse Event|1|||
161807090|NCT03435081|584337780|FG001|Week 16 to Week 104|Adverse Event|0|||
161807091|NCT03435081|584337781|FG002|Week 16 to Week 104|Adverse Event|2|||
161807092|NCT03435081|584337779|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
161807093|NCT03435081|584337780|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
161807094|NCT03435081|584337781|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
161807095|NCT03435081|584337779|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
161807096|NCT03435081|584337780|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
161807097|NCT03435081|584337781|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
161807098|NCT03435081|584337779|FG000|Week 16 to Week 104|Non--Compliance|0|||
161807099|NCT03435081|584337780|FG001|Week 16 to Week 104|Non--Compliance|0|||
161807100|NCT03435081|584337781|FG002|Week 16 to Week 104|Non--Compliance|1|||
161807101|NCT02601560|584337782|FG000|Overall Study|Other|0|||
161807102|NCT02601560|584337783|FG001|Overall Study|Other|0|||
161807103|NCT02601560|584337784|FG002|Overall Study|Other|0|||
161807104|NCT02601560|584337785|FG003|Overall Study|Other|0|||
161807105|NCT02601560|584337786|FG004|Overall Study|Other|0|||
161807106|NCT02601560|584337787|FG005|Overall Study|Other|0|||
161807107|NCT02601560|584337788|FG006|Overall Study|Other|1|||
161807108|NCT02601560|584337789|FG007|Overall Study|Other|0|||
161807109|NCT00420238|584337790|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
161807110|NCT00420238|584337791|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
161807111|NCT00420238|584337790|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
161807112|NCT00420238|584337791|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
161807113|NCT00420238|584337790|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
161807114|NCT00420238|584337791|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
161807115|NCT00420238|584337790|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
161807116|NCT00420238|584337791|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
161807117|NCT00420238|584337790|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
161807118|NCT00420238|584337791|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
162140919|NCT03598790|585566965|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162140920|NCT03598790|585566966|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162140921|NCT03598790|585566967|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
162140922|NCT03598790|585566959|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162140923|NCT03598790|585566960|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162140924|NCT03598790|585566961|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162140925|NCT03598790|585566962|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
162140926|NCT03598790|585566963|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162140927|NCT03598790|585566964|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162140928|NCT03598790|585566965|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162140929|NCT03598790|585566966|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162140930|NCT03598790|585566967|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
162140931|NCT03410992|585566969|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162140932|NCT03410992|585566970|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
162140933|NCT03410992|585566971|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162140934|NCT03410992|585566972|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162140935|NCT03410992|585566973|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162140936|NCT03410992|585566974|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162140937|NCT03410992|585566975|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162140938|NCT03410992|585566976|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162140939|NCT03410992|585566977|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162140940|NCT03410992|585566978|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
161807119|NCT00420238|584337790|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
161807120|NCT00420238|584337791|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
161807121|NCT00626548|584337792|FG000|Overall Study|Adverse Event|164|||
161807122|NCT00626548|584337793|FG001|Overall Study|Adverse Event|44|||
161807123|NCT00626548|584337792|FG000|Overall Study|Withdrawal by Subject|42|||
161807124|NCT00626548|584337793|FG001|Overall Study|Withdrawal by Subject|46|||
161807125|NCT00626548|584337792|FG000|Overall Study|Protocol Violation|4|||
161807126|NCT00626548|584337793|FG001|Overall Study|Protocol Violation|11|||
161807127|NCT00626548|584337792|FG000|Overall Study|Lost to Follow-up|2|||
161807128|NCT00626548|584337793|FG001|Overall Study|Lost to Follow-up|2|||
161807129|NCT00626548|584337792|FG000|Overall Study|Other termination reason|493|||
161807130|NCT00626548|584337793|FG001|Overall Study|Other termination reason|613|||
161807131|NCT03555305|584337794|FG000|Period 1|Physician Decision|0|||
161807132|NCT03555305|584337795|FG001|Period 1|Physician Decision|1|||
161807133|NCT03555305|584337794|FG000|Period 1|Adverse Event|0|||
161807134|NCT03555305|584337795|FG001|Period 1|Adverse Event|1|||
161807135|NCT03125200|584337796|FG000|Overall Study|Study Termination|0|||
161807136|NCT03125200|584337797|FG001|Overall Study|Study Termination|0|||
161807137|NCT03125200|584337798|FG002|Overall Study|Study Termination|0|||
161807138|NCT03125200|584337799|FG003|Overall Study|Study Termination|1|||
162140941|NCT03410992|585566979|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
162140942|NCT03410992|585566969|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
162140943|NCT03410992|585566970|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
162140944|NCT03410992|585566971|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162140945|NCT03410992|585566972|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162140946|NCT03410992|585566973|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162140947|NCT03410992|585566974|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162140948|NCT03410992|585566975|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162140949|NCT03410992|585566976|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162140950|NCT03410992|585566977|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162140951|NCT03410992|585566978|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162140952|NCT03410992|585566979|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
162140953|NCT03410992|585566969|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
161807139|NCT03125200|584337800|FG004|Overall Study|Study Termination|1|||
161807140|NCT03125200|584337801|FG005|Overall Study|Study Termination|2|||
161807141|NCT03125200|584337802|FG006|Overall Study|Study Termination|1|||
161807142|NCT03125200|584337796|FG000|Overall Study|Clinical Progression|0|||
162140954|NCT03410992|585566970|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
162140955|NCT03410992|585566971|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162140956|NCT03410992|585566972|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162140957|NCT03410992|585566973|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162140958|NCT03410992|585566974|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162140959|NCT03410992|585566975|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162140960|NCT03410992|585566976|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162140961|NCT03410992|585566977|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162140962|NCT03410992|585566978|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
161807143|NCT03125200|584337797|FG001|Overall Study|Clinical Progression|0|||
161807144|NCT03125200|584337798|FG002|Overall Study|Clinical Progression|0|||
161807145|NCT03125200|584337799|FG003|Overall Study|Clinical Progression|1|||
161807146|NCT03125200|584337800|FG004|Overall Study|Clinical Progression|0|||
161807147|NCT03125200|584337801|FG005|Overall Study|Clinical Progression|1|||
161807148|NCT03125200|584337802|FG006|Overall Study|Clinical Progression|0|||
161807149|NCT03125200|584337796|FG000|Overall Study|Progressive Disease|2|||
161807150|NCT03125200|584337797|FG001|Overall Study|Progressive Disease|1|||
161807151|NCT03125200|584337798|FG002|Overall Study|Progressive Disease|2|||
161807152|NCT03125200|584337799|FG003|Overall Study|Progressive Disease|1|||
161910691|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
161910692|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
161910693|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
161910694|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
162140963|NCT03410992|585566979|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
162140964|NCT03410992|585566969|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
162140965|NCT03410992|585566970|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
161807153|NCT03125200|584337800|FG004|Overall Study|Progressive Disease|2|||
161807154|NCT03125200|584337801|FG005|Overall Study|Progressive Disease|0|||
161807155|NCT03125200|584337802|FG006|Overall Study|Progressive Disease|1|||
161807156|NCT03125200|584337796|FG000|Overall Study|Lack of Efficacy|0|||
161807157|NCT03125200|584337797|FG001|Overall Study|Lack of Efficacy|0|||
161807158|NCT03125200|584337798|FG002|Overall Study|Lack of Efficacy|0|||
161807159|NCT03125200|584337799|FG003|Overall Study|Lack of Efficacy|1|||
161807160|NCT03125200|584337800|FG004|Overall Study|Lack of Efficacy|0|||
161807161|NCT03125200|584337801|FG005|Overall Study|Lack of Efficacy|0|||
161807162|NCT03125200|584337802|FG006|Overall Study|Lack of Efficacy|0|||
161807163|NCT03125200|584337796|FG000|Overall Study|Toxicity|0|||
161807164|NCT03125200|584337797|FG001|Overall Study|Toxicity|0|||
161807165|NCT03125200|584337798|FG002|Overall Study|Toxicity|0|||
161807166|NCT03125200|584337799|FG003|Overall Study|Toxicity|1|||
161807167|NCT03125200|584337800|FG004|Overall Study|Toxicity|0|||
161807168|NCT03125200|584337801|FG005|Overall Study|Toxicity|0|||
161807169|NCT03125200|584337802|FG006|Overall Study|Toxicity|0|||
161807170|NCT03125200|584337796|FG000|Overall Study|Consent Withdrawn by Subject|0|||
161807171|NCT03125200|584337797|FG001|Overall Study|Consent Withdrawn by Subject|1|||
161807172|NCT03125200|584337798|FG002|Overall Study|Consent Withdrawn by Subject|0|||
161807173|NCT03125200|584337799|FG003|Overall Study|Consent Withdrawn by Subject|0|||
161807174|NCT03125200|584337800|FG004|Overall Study|Consent Withdrawn by Subject|1|||
161807175|NCT03125200|584337801|FG005|Overall Study|Consent Withdrawn by Subject|0|||
161807176|NCT03125200|584337802|FG006|Overall Study|Consent Withdrawn by Subject|1|||
161807177|NCT01811953|584339650|FG000|Overall Study|Adverse Event|0|||
161807178|NCT01811953|584339651|FG001|Overall Study|Adverse Event|0|||
161807179|NCT01811953|584339652|FG002|Overall Study|Adverse Event|0|||
161807180|NCT01811953|584339653|FG003|Overall Study|Adverse Event|1|||
162140966|NCT03410992|585566971|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162140967|NCT03410992|585566972|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162140968|NCT03410992|585566973|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162140969|NCT03410992|585566974|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162140970|NCT03410992|585566975|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162140971|NCT03410992|585566976|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162140972|NCT03410992|585566977|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162140973|NCT03410992|585566978|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162140974|NCT03410992|585566979|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
162140975|NCT03410992|585566969|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
162140976|NCT03410992|585566970|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
162140977|NCT03410992|585566971|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162140978|NCT03410992|585566972|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162140979|NCT03410992|585566973|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
161807181|NCT01811953|584339654|FG004|Overall Study|Adverse Event|0|||
161807182|NCT01811953|584339655|FG005|Overall Study|Adverse Event|1|||
161807183|NCT01811953|584339650|FG000|Overall Study|Protocol Violation|0|||
161807184|NCT01811953|584339651|FG001|Overall Study|Protocol Violation|0|||
161807185|NCT01811953|584339652|FG002|Overall Study|Protocol Violation|0|||
161807186|NCT01811953|584339653|FG003|Overall Study|Protocol Violation|0|||
161807187|NCT01811953|584339654|FG004|Overall Study|Protocol Violation|1|||
161807188|NCT01811953|584339655|FG005|Overall Study|Protocol Violation|0|||
161807189|NCT03785548|584339656|FG000|Overall Study|age > 80|1|||
161807190|NCT03785548|584339657|FG001|Overall Study|age > 80|0|||
161807191|NCT03785548|584339656|FG000|Overall Study|no Postop queries|1|||
161807192|NCT03785548|584339657|FG001|Overall Study|no Postop queries|0|||
161807193|NCT00396279|584339660|FG000|Overall Study|Ongoing in study|26|||
161807194|NCT00396279|584339660|FG000|Overall Study|Disease progression|2|||
161807195|NCT00396279|584339660|FG000|Overall Study|Withdrawal by Subject|1|||
161807196|NCT00396279|584339660|FG000|Overall Study|Physician Decision|1|||
161807197|NCT01882257|584339669|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
161807198|NCT01882257|584339670|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
161807199|NCT01882257|584339671|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
162011061|NCT01124006|585097712|FG002|Overall Study|Other|1|||
161807200|NCT01882257|584339669|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
162140980|NCT03410992|585566974|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162140981|NCT03410992|585566975|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162140982|NCT03410992|585566976|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162140983|NCT03410992|585566977|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162140984|NCT03410992|585566978|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162140985|NCT03410992|585566979|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
162140986|NCT03410992|585566969|FG000|Week 16 Assessment|Incorrect escapers|0|||
162140987|NCT03410992|585566970|FG001|Week 16 Assessment|Incorrect escapers|6|||
162140988|NCT03410992|585566971|FG002|Week 16 Assessment|Incorrect escapers|0|||
162140989|NCT03410992|585566972|FG003|Week 16 Assessment|Incorrect escapers|0|||
162140990|NCT03410992|585566973|FG004|Week 16 Assessment|Incorrect escapers|0|||
162140991|NCT03410992|585566974|FG005|Week 16 Assessment|Incorrect escapers|0|||
162140992|NCT03410992|585566975|FG006|Week 16 Assessment|Incorrect escapers|0|||
162140993|NCT03410992|585566976|FG007|Week 16 Assessment|Incorrect escapers|0|||
162140994|NCT03410992|585566977|FG008|Week 16 Assessment|Incorrect escapers|0|||
162140995|NCT03410992|585566978|FG009|Week 16 Assessment|Incorrect escapers|0|||
162140996|NCT03410992|585566979|FG010|Week 16 Assessment|Incorrect escapers|0|||
162140997|NCT03410992|585566969|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162140998|NCT03410992|585566970|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162140999|NCT03410992|585566971|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162141000|NCT03410992|585566972|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
162141001|NCT03410992|585566973|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
162141002|NCT03410992|585566974|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162141003|NCT03410992|585566975|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162141004|NCT03410992|585566976|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162141005|NCT03410992|585566977|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162141006|NCT03410992|585566978|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162141007|NCT03410992|585566979|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
162141008|NCT03410992|585566969|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162141009|NCT03410992|585566970|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162141010|NCT03410992|585566971|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162141011|NCT03410992|585566972|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
162141012|NCT03410992|585566973|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
162141013|NCT03410992|585566974|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
162141014|NCT03410992|585566975|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162141015|NCT03410992|585566976|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162141016|NCT03410992|585566977|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162141017|NCT03410992|585566978|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162141018|NCT03410992|585566979|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
162141019|NCT03410992|585566969|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162141020|NCT03410992|585566970|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162141021|NCT03410992|585566971|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162141022|NCT03410992|585566972|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162141023|NCT03410992|585566973|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162141024|NCT03410992|585566974|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
162141025|NCT03410992|585566975|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162141026|NCT03410992|585566976|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162141027|NCT03410992|585566977|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162141028|NCT03410992|585566978|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162141029|NCT03410992|585566979|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
162141030|NCT03410992|585566969|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162141031|NCT03410992|585566970|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162141032|NCT03410992|585566971|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162141033|NCT03410992|585566972|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
162141034|NCT03410992|585566973|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
162141035|NCT03410992|585566974|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
162141036|NCT03410992|585566975|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162141037|NCT03410992|585566976|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162141038|NCT03410992|585566977|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162141039|NCT03410992|585566978|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162141040|NCT03410992|585566979|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
162141041|NCT03410992|585566969|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
162141042|NCT03410992|585566970|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
162141043|NCT03410992|585566971|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
162141044|NCT03410992|585566972|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
162141045|NCT03410992|585566973|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
162141046|NCT03410992|585566974|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
162141047|NCT03410992|585566975|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
162141048|NCT03410992|585566976|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
162141049|NCT03410992|585566977|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
162141050|NCT03410992|585566978|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
162141051|NCT03410992|585566979|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
162141052|NCT03410992|585566969|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162141053|NCT03410992|585566970|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162141054|NCT03410992|585566971|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162141055|NCT03410992|585566972|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162141056|NCT03410992|585566973|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162141057|NCT03410992|585566974|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162141058|NCT03410992|585566975|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162141059|NCT03410992|585566976|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162141060|NCT03410992|585566977|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
162141061|NCT03410992|585566978|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162141062|NCT03410992|585566979|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
162141063|NCT04988295|585566985|FG000|Overall Study|Withdrawal by Subject|9|||
162141064|NCT04988295|585566986|FG001|Overall Study|Withdrawal by Subject|29|||
162141065|NCT04988295|585566987|FG002|Overall Study|Withdrawal by Subject|6|||
162141066|NCT04988295|585566988|FG003|Overall Study|Withdrawal by Subject|0|||
162141067|NCT04988295|585566985|FG000|Overall Study|Lost to Follow-up|1|||
162141068|NCT04988295|585566986|FG001|Overall Study|Lost to Follow-up|0|||
162141069|NCT04988295|585566987|FG002|Overall Study|Lost to Follow-up|0|||
162141070|NCT04988295|585566988|FG003|Overall Study|Lost to Follow-up|0|||
162141071|NCT04988295|585566985|FG000|Overall Study|Study participation ongoing|186|||
162141072|NCT04988295|585566986|FG001|Overall Study|Study participation ongoing|169|||
162141073|NCT04988295|585566987|FG002|Overall Study|Study participation ongoing|99|||
162141074|NCT04988295|585566988|FG003|Overall Study|Study participation ongoing|119|||
162141075|NCT00930813|585566993|FG000|Overall Study|Death|4|||
162141076|NCT00930813|585566994|FG001|Overall Study|Death|5|||
162141077|NCT00930813|585566993|FG000|Overall Study|Withdrawal by Subject|2|||
162141078|NCT00930813|585566994|FG001|Overall Study|Withdrawal by Subject|5|||
162141079|NCT00930813|585566993|FG000|Overall Study|Lost to Follow-up|2|||
162141080|NCT00930813|585566994|FG001|Overall Study|Lost to Follow-up|4|||
162141081|NCT01693614|585566995|FG000|Overall Study|Adverse Event|7|||
162141082|NCT01693614|585566996|FG001|Overall Study|Adverse Event|11|||
162141083|NCT01693614|585566997|FG002|Overall Study|Adverse Event|5|||
162141084|NCT01693614|585566995|FG000|Overall Study|Disease progression|11|||
162141085|NCT01693614|585566996|FG001|Overall Study|Disease progression|8|||
162141086|NCT01693614|585566997|FG002|Overall Study|Disease progression|7|||
162141087|NCT01693614|585566995|FG000|Overall Study|Protocol Violation|5|||
162141088|NCT01693614|585566996|FG001|Overall Study|Protocol Violation|2|||
162141089|NCT01693614|585566997|FG002|Overall Study|Protocol Violation|1|||
162141090|NCT01693614|585566995|FG000|Overall Study|Death|1|||
162141091|NCT01693614|585566996|FG001|Overall Study|Death|0|||
162141092|NCT01693614|585566997|FG002|Overall Study|Death|0|||
162141093|NCT01693614|585566995|FG000|Overall Study|Physician Decision|1|||
162141094|NCT01693614|585566996|FG001|Overall Study|Physician Decision|1|||
162141095|NCT01693614|585566997|FG002|Overall Study|Physician Decision|4|||
162141096|NCT01693614|585566995|FG000|Overall Study|Withdrawal by subject/guardian|0|||
162141097|NCT01693614|585566996|FG001|Overall Study|Withdrawal by subject/guardian|0|||
162141098|NCT01693614|585566997|FG002|Overall Study|Withdrawal by subject/guardian|2|||
162141099|NCT01693614|585566995|FG000|Overall Study|Withdrawal by Subject|1|||
162141100|NCT01693614|585566996|FG001|Overall Study|Withdrawal by Subject|0|||
162141101|NCT01693614|585566997|FG002|Overall Study|Withdrawal by Subject|5|||
162141102|NCT04618471|585566998|FG000|Overall Study|Screen Failure|62|||
162141103|NCT04618471|585566998|FG000|Overall Study|Withdrawal by Subject|6|||
162141104|NCT04618471|585566998|FG000|Overall Study|Physician Decision|2|||
162141105|NCT04618471|585566998|FG000|Overall Study|Lost to Follow-up|1|||
162141106|NCT04618471|585566998|FG000|Overall Study|Various other reasons|2|||
162141107|NCT04618471|585566998|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
162141108|NCT00588666|585566999|FG000|Overall Study|Adverse Event|4|||
162141109|NCT00927823|585567002|FG000|Continuous Dosing Period|Death|0|||
162141110|NCT00927823|585567003|FG001|Continuous Dosing Period|Death|0|||
162141111|NCT00927823|585567004|FG002|Continuous Dosing Period|Death|6|||
162141112|NCT00927823|585567005|FG003|Continuous Dosing Period|Death|0|||
162141113|NCT00927823|585567002|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
162141114|NCT00927823|585567003|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
162141115|NCT00927823|585567004|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
162141116|NCT00927823|585567005|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
161807201|NCT01882257|584339670|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
162141117|NCT00927823|585567002|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
162141118|NCT00927823|585567003|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
161807202|NCT01882257|584339671|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
161807203|NCT00830206|584339672|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
161807204|NCT00830206|584339673|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
161807205|NCT00905346|584339675|FG000|Period 1|Withdrawal by Subject|1|||
161807206|NCT00905346|584339676|FG001|Period 1|Withdrawal by Subject|0|||
161807207|NCT03351335|584339677|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
161807208|NCT03351335|584339678|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
161807209|NCT03351335|584339679|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
161807210|NCT04089735|584339684|FG000|Overall Study|Adverse Event|1|||
161807211|NCT04089735|584339685|FG001|Overall Study|Adverse Event|0|||
161807212|NCT04089735|584339686|FG002|Overall Study|Adverse Event|1|||
161807213|NCT04089735|584339687|FG003|Overall Study|Adverse Event|1|||
161910695|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
161910696|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
161807214|NCT04089735|584339688|FG004|Overall Study|Adverse Event|0|||
161807215|NCT04089735|584339689|FG005|Overall Study|Adverse Event|0|||
161807216|NCT04089735|584339684|FG000|Overall Study|Physician Decision|0|||
161807217|NCT04089735|584339685|FG001|Overall Study|Physician Decision|3|||
162141119|NCT00927823|585567004|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
162141120|NCT00927823|585567005|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
162141121|NCT00927823|585567002|FG000|Continuous Dosing Period|Other|1|||
162141122|NCT00927823|585567003|FG001|Continuous Dosing Period|Other|2|||
162141123|NCT00927823|585567004|FG002|Continuous Dosing Period|Other|9|||
162141124|NCT00927823|585567005|FG003|Continuous Dosing Period|Other|3|||
162141125|NCT02299635|585567006|FG000|Overall Study|Adverse Event|2|||
162141126|NCT02299635|585567006|FG000|Overall Study|Death|1|||
162141127|NCT02299635|585567006|FG000|Overall Study|Global deterioration of health status|1|||
162141128|NCT02299635|585567006|FG000|Overall Study|Objective progression or relapse|10|||
162141129|NCT02299635|585567006|FG000|Overall Study|Withdrawal by Subject|2|||
162141130|NCT02299635|585567006|FG000|Overall Study|Other|3|||
162141131|NCT00828672|585567007|FG000|Study Treatment|Lost to Follow-up|1|||
162141132|NCT00828672|585567008|FG001|Study Treatment|Lost to Follow-up|0|||
162141133|NCT00828672|585567007|FG000|Study Treatment|Adverse Event|0|||
162141134|NCT00828672|585567008|FG001|Study Treatment|Adverse Event|1|||
162141135|NCT00828672|585567007|FG000|Study Treatment|Complete response, no surgery|1|||
162141136|NCT00828672|585567008|FG001|Study Treatment|Complete response, no surgery|1|||
162141137|NCT00828672|585567007|FG000|Post-surgery (<30 Days)|No central review materials|0|||
162141138|NCT00828672|585567008|FG001|Post-surgery (<30 Days)|No central review materials|1|||
162141139|NCT04889118|585567009|FG000|Overall Study|Death|49|||
162141140|NCT04889118|585567010|FG001|Overall Study|Death|47|||
162141141|NCT04889118|585567009|FG000|Overall Study|Sponsor Decision|15|||
162141142|NCT04889118|585567010|FG001|Overall Study|Sponsor Decision|20|||
162141143|NCT01744691|585567011|FG000|Overall Study|Progressive Disease|18|||
162141144|NCT01744691|585567011|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
162141145|NCT01744691|585567011|FG000|Overall Study|Withdrawal of consent for treatment|3|||
162141146|NCT01744691|585567011|FG000|Overall Study|Physician Decision|4|||
162141147|NCT02701361|585567012|FG000|Overall Study|Lost to Follow-up|5|||
162141148|NCT02701361|585567013|FG001|Overall Study|Lost to Follow-up|2|||
162141149|NCT02701361|585567014|FG002|Overall Study|Lost to Follow-up|1|||
162141150|NCT02701361|585567012|FG000|Overall Study|Withdrawal by Subject|4|||
162141151|NCT02701361|585567013|FG001|Overall Study|Withdrawal by Subject|0|||
162141152|NCT02701361|585567014|FG002|Overall Study|Withdrawal by Subject|0|||
162141153|NCT02701361|585567012|FG000|Overall Study|timed out in rehab center|0|||
162141154|NCT02701361|585567013|FG001|Overall Study|timed out in rehab center|1|||
162141155|NCT02701361|585567014|FG002|Overall Study|timed out in rehab center|0|||
162141156|NCT02701361|585567012|FG000|Overall Study|incarceration|0|||
162141157|NCT02701361|585567013|FG001|Overall Study|incarceration|0|||
162141158|NCT02701361|585567014|FG002|Overall Study|incarceration|1|||
162141159|NCT00404079|585567021|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
162141160|NCT00404079|585567022|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
162141161|NCT00853827|585567023|FG000|Single Blind Period (1 Week)|Other|4|||
162141162|NCT00853827|585567024|FG001|Single Blind Period (1 Week)|Other|0|||
162141163|NCT00853827|585567023|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
162141164|NCT00853827|585567024|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
162141165|NCT00853827|585567023|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
162141166|NCT00853827|585567024|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
162141167|NCT00853827|585567023|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
162141168|NCT00853827|585567024|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
162141169|NCT00853827|585567023|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
162141170|NCT00853827|585567024|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
162141171|NCT00853827|585567023|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
162141172|NCT00853827|585567024|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
162141173|NCT00853827|585567023|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
162141174|NCT00853827|585567024|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
162141175|NCT00853827|585567023|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
162141176|NCT00853827|585567024|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
162141177|NCT00853827|585567023|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
162141178|NCT00853827|585567024|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
162141179|NCT00853827|585567023|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
162141180|NCT00853827|585567024|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
162141181|NCT00853827|585567023|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
162141182|NCT00853827|585567024|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
162141183|NCT00853827|585567023|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
162141184|NCT00853827|585567024|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
162141185|NCT00853827|585567023|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
162141186|NCT00853827|585567024|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
162141187|NCT00853827|585567023|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
162141188|NCT00853827|585567024|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
162141189|NCT00853827|585567023|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
162141190|NCT00853827|585567024|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
161807218|NCT04089735|584339686|FG002|Overall Study|Physician Decision|0|||
161807219|NCT04089735|584339687|FG003|Overall Study|Physician Decision|0|||
161807220|NCT04089735|584339688|FG004|Overall Study|Physician Decision|0|||
161807221|NCT04089735|584339689|FG005|Overall Study|Physician Decision|0|||
161807222|NCT04089735|584339684|FG000|Overall Study|Withdrawal by Subject|0|||
161807223|NCT04089735|584339685|FG001|Overall Study|Withdrawal by Subject|0|||
161807224|NCT04089735|584339686|FG002|Overall Study|Withdrawal by Subject|1|||
161807225|NCT04089735|584339687|FG003|Overall Study|Withdrawal by Subject|0|||
161807226|NCT04089735|584339688|FG004|Overall Study|Withdrawal by Subject|0|||
161807227|NCT04089735|584339689|FG005|Overall Study|Withdrawal by Subject|0|||
161807228|NCT04089735|584339684|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
161807229|NCT04089735|584339685|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
161807230|NCT04089735|584339686|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
161807231|NCT04089735|584339687|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
161807232|NCT04089735|584339688|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
161910697|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
161807233|NCT04089735|584339689|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
161807234|NCT02736721|584339694|FG000|Overall Study|Adverse Event|8|||
161807235|NCT02736721|584339694|FG000|Overall Study|Lost to Follow-up|3|||
161807236|NCT02736721|584339694|FG000|Overall Study|Other|5|||
161807237|NCT02956460|584339695|FG000|Lens 1|Lost to Follow-up|1|||
161807238|NCT02956460|584339696|FG001|Lens 1|Lost to Follow-up|0|||
161807239|NCT00829673|584339697|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161807240|NCT00829673|584339698|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161807241|NCT00272779|584339699|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
161807242|NCT00272779|584339700|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
161807243|NCT00272779|584339699|FG000|Baseline Through Week 48|Death before Week 48|4|||
161807244|NCT00272779|584339700|FG001|Baseline Through Week 48|Death before Week 48|4|||
161807245|NCT00272779|584339699|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
161807246|NCT00272779|584339700|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
161807247|NCT00272779|584339699|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
161807248|NCT00272779|584339700|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
161807249|NCT00272779|584339699|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
161807250|NCT00272779|584339700|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
161807251|NCT00272779|584339699|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
161807252|NCT00272779|584339700|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
161807253|NCT00272779|584339699|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
161807254|NCT00272779|584339700|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
161807255|NCT00272779|584339699|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
161807256|NCT00272779|584339700|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
161807257|NCT00272779|584339699|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
161807258|NCT00272779|584339700|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
161807259|NCT00272779|584339699|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
161807260|NCT00272779|584339700|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
161807261|NCT00272779|584339699|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
161807262|NCT00272779|584339700|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
161807263|NCT00272779|584339699|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
161807264|NCT00272779|584339700|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
161807265|NCT00272779|584339699|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
161807266|NCT00272779|584339700|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
161807267|NCT00272779|584339699|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
161807268|NCT00272779|584339700|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
161807269|NCT00272779|584339699|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
161807270|NCT00272779|584339700|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
161807271|NCT00272779|584339699|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
161807272|NCT00272779|584339700|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
161807273|NCT00272779|584339699|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
161807274|NCT00272779|584339700|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
161807275|NCT00272779|584339699|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
161807276|NCT00272779|584339700|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
161807277|NCT00272779|584339699|FG000|Baseline Through Week 48|Continuing treatment|385|||
161807278|NCT00272779|584339700|FG001|Baseline Through Week 48|Continuing treatment|368|||
161807279|NCT00272779|584339699|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
161807280|NCT00272779|584339700|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
161807281|NCT00272779|584339699|FG000|Baseline Through Week 48|Never treated|2|||
161807282|NCT00272779|584339700|FG001|Baseline Through Week 48|Never treated|3|||
161807283|NCT00272779|584339699|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
161807284|NCT00272779|584339700|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
161807285|NCT00272779|584339699|FG000|Baseline Through Week 96|Death before Week 96|6|||
161807286|NCT00272779|584339700|FG001|Baseline Through Week 96|Death before Week 96|5|||
161807287|NCT00272779|584339699|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
161807288|NCT00272779|584339700|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
161807289|NCT00272779|584339699|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
161807290|NCT00272779|584339700|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
161807291|NCT00272779|584339699|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
161910698|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
161910699|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
161807292|NCT00272779|584339700|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
161807293|NCT00272779|584339699|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
161807294|NCT00272779|584339700|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
161807295|NCT00272779|584339699|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
161807296|NCT00272779|584339700|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
162141191|NCT00853827|585567023|FG000|Double Blind Period (103 Weeks)|Death|1|||
162141192|NCT00853827|585567024|FG001|Double Blind Period (103 Weeks)|Death|6|||
162141193|NCT00580801|585567035|FG000|Overall Study|Physician Decision|1|||
162141194|NCT00580801|585567036|FG001|Overall Study|Physician Decision|0|||
162141195|NCT00580801|585567037|FG002|Overall Study|Physician Decision|0|||
162141196|NCT00580801|585567035|FG000|Overall Study|Adverse Event|2|||
162141197|NCT00580801|585567036|FG001|Overall Study|Adverse Event|0|||
162141198|NCT00580801|585567037|FG002|Overall Study|Adverse Event|0|||
162141199|NCT00580801|585567035|FG000|Overall Study|Lost to Follow-up|2|||
162141200|NCT00580801|585567036|FG001|Overall Study|Lost to Follow-up|0|||
162141201|NCT00580801|585567037|FG002|Overall Study|Lost to Follow-up|0|||
162141202|NCT00580801|585567035|FG000|Overall Study|Reached a virologic endpoint|0|||
162141203|NCT00580801|585567036|FG001|Overall Study|Reached a virologic endpoint|1|||
162141204|NCT00580801|585567037|FG002|Overall Study|Reached a virologic endpoint|2|||
162141205|NCT00580801|585567035|FG000|Overall Study|Participant non-compliant|0|||
162141206|NCT00580801|585567036|FG001|Overall Study|Participant non-compliant|0|||
162141207|NCT00580801|585567037|FG002|Overall Study|Participant non-compliant|1|||
162141208|NCT00580801|585567035|FG000|Overall Study|Travel|1|||
162141209|NCT00580801|585567036|FG001|Overall Study|Travel|0|||
162141210|NCT00580801|585567037|FG002|Overall Study|Travel|0|||
162141211|NCT05576051|585567038|FG000|Overall Study|Lack of Efficacy|543|||
162141212|NCT05576051|585567039|FG001|Overall Study|Lack of Efficacy|343|||
162141213|NCT05576051|585567040|FG002|Overall Study|Lack of Efficacy|108|||
162141214|NCT05576051|585567041|FG003|Overall Study|Lack of Efficacy|72|||
162141215|NCT05576051|585567042|FG004|Overall Study|Lack of Efficacy|28|||
162141216|NCT05576051|585567043|FG005|Overall Study|Lack of Efficacy|50|||
162141217|NCT05576051|585567038|FG000|Overall Study|Safety|78|||
162141218|NCT05576051|585567039|FG001|Overall Study|Safety|74|||
162141219|NCT05576051|585567040|FG002|Overall Study|Safety|16|||
162141220|NCT05576051|585567041|FG003|Overall Study|Safety|14|||
162141221|NCT05576051|585567042|FG004|Overall Study|Safety|4|||
162141222|NCT05576051|585567043|FG005|Overall Study|Safety|5|||
162141223|NCT05576051|585567038|FG000|Overall Study|Efficacy + Safety|10|||
162141224|NCT05576051|585567039|FG001|Overall Study|Efficacy + Safety|7|||
162141225|NCT05576051|585567040|FG002|Overall Study|Efficacy + Safety|3|||
162141226|NCT05576051|585567041|FG003|Overall Study|Efficacy + Safety|0|||
162141227|NCT05576051|585567042|FG004|Overall Study|Efficacy + Safety|0|||
162141228|NCT05576051|585567043|FG005|Overall Study|Efficacy + Safety|0|||
162141229|NCT05576051|585567038|FG000|Overall Study|Other|231|||
162141230|NCT05576051|585567039|FG001|Overall Study|Other|127|||
162141231|NCT05576051|585567040|FG002|Overall Study|Other|35|||
162141232|NCT05576051|585567041|FG003|Overall Study|Other|14|||
162141233|NCT05576051|585567042|FG004|Overall Study|Other|6|||
162141234|NCT05576051|585567043|FG005|Overall Study|Other|0|||
162141235|NCT04154943|585567044|FG000|Overall Study|Study Ongoing|68|||
162141236|NCT04154943|585567044|FG000|Overall Study|Lost to Follow-up|1|||
162141237|NCT04154943|585567044|FG000|Overall Study|Decision by the Investigator|1|||
162141238|NCT04154943|585567044|FG000|Overall Study|Death|5|||
162141239|NCT04154943|585567044|FG000|Overall Study|Withdrawal by Subject|4|||
162141240|NCT02107014|585567045|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
162141241|NCT02512042|585567046|FG000|Overall Study|Adverse Event|0|||
162141242|NCT02512042|585567047|FG001|Overall Study|Adverse Event|4|||
162141243|NCT02512042|585567046|FG000|Overall Study|Withdrawal by Subject|6|||
162141244|NCT02512042|585567047|FG001|Overall Study|Withdrawal by Subject|6|||
162141245|NCT02512042|585567046|FG000|Overall Study|Non-compliance with study drug|1|||
162141246|NCT02512042|585567047|FG001|Overall Study|Non-compliance with study drug|2|||
162141247|NCT02512042|585567046|FG000|Overall Study|Lost to Follow-up|5|||
162141248|NCT02512042|585567047|FG001|Overall Study|Lost to Follow-up|2|||
162141249|NCT02512042|585567046|FG000|Overall Study|Other|11|||
162141250|NCT02512042|585567047|FG001|Overall Study|Other|11|||
162141251|NCT01467700|585567049|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
162141252|NCT01467700|585567050|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
162141253|NCT01467700|585567051|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
162141254|NCT01467700|585567052|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
162141255|NCT01467700|585567049|FG000|Overall Study|Major Protocol Deviation|3|||
162141256|NCT01467700|585567050|FG001|Overall Study|Major Protocol Deviation|3|||
162141257|NCT01467700|585567051|FG002|Overall Study|Major Protocol Deviation|2|||
162141258|NCT01467700|585567052|FG003|Overall Study|Major Protocol Deviation|3|||
162141259|NCT01467700|585567049|FG000|Overall Study|Lost to Follow-up|6|||
162141260|NCT01467700|585567050|FG001|Overall Study|Lost to Follow-up|5|||
162141261|NCT01467700|585567051|FG002|Overall Study|Lost to Follow-up|2|||
162141262|NCT01467700|585567052|FG003|Overall Study|Lost to Follow-up|3|||
162141263|NCT01467700|585567049|FG000|Overall Study|Voluntary Withdrawal|5|||
162141264|NCT01467700|585567050|FG001|Overall Study|Voluntary Withdrawal|7|||
162141265|NCT01467700|585567051|FG002|Overall Study|Voluntary Withdrawal|6|||
162141266|NCT01467700|585567052|FG003|Overall Study|Voluntary Withdrawal|2|||
161910700|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
161910701|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
161910702|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
161910703|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
162141267|NCT01467700|585567049|FG000|Overall Study|Study Termination|6|||
162141268|NCT01467700|585567050|FG001|Overall Study|Study Termination|5|||
162141269|NCT01467700|585567051|FG002|Overall Study|Study Termination|10|||
162141270|NCT01467700|585567052|FG003|Overall Study|Study Termination|7|||
162141271|NCT01467700|585567049|FG000|Overall Study|Pregnancy|0|||
162141272|NCT01467700|585567050|FG001|Overall Study|Pregnancy|1|||
162141273|NCT01467700|585567051|FG002|Overall Study|Pregnancy|1|||
162141274|NCT01467700|585567052|FG003|Overall Study|Pregnancy|0|||
162141275|NCT01467700|585567049|FG000|Overall Study|Lack of Efficacy|2|||
162141276|NCT01467700|585567050|FG001|Overall Study|Lack of Efficacy|0|||
162141277|NCT01467700|585567051|FG002|Overall Study|Lack of Efficacy|2|||
162141278|NCT01467700|585567052|FG003|Overall Study|Lack of Efficacy|1|||
162141279|NCT01467700|585567049|FG000|Overall Study|Reason not Specified|1|||
162141280|NCT01467700|585567050|FG001|Overall Study|Reason not Specified|3|||
162141281|NCT01467700|585567051|FG002|Overall Study|Reason not Specified|2|||
162141282|NCT01467700|585567052|FG003|Overall Study|Reason not Specified|8|||
162141283|NCT00121199|585567053|FG000|Overall Study|Adverse Event|11|||
162141284|NCT00121199|585567053|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
162141285|NCT00121199|585567053|FG000|Overall Study|Progression/Relapse|1|||
162141286|NCT00121199|585567053|FG000|Overall Study|Death|3|||
162141287|NCT00121199|585567053|FG000|Overall Study|Other - Not Protocol Specified|3|||
162141288|NCT00121199|585567053|FG000|Overall Study|Ineligible|9|||
162141289|NCT03168438|585567054|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
162141290|NCT03168438|585567055|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
162141291|NCT04109118|585567058|FG000|Overall Study|Lost to Follow-up|3|||
162141292|NCT03235349|585567061|FG000|Overall Study|Adverse Event|1|||
162141293|NCT03235349|585567061|FG000|Overall Study|Other|1|||
162141294|NCT03394027|585567062|FG000|Overall Study|Ineligible|3|||
162141295|NCT03394027|585567063|FG001|Overall Study|Ineligible|1|||
162141296|NCT03394027|585567064|FG002|Overall Study|Ineligible|3|||
162141297|NCT03394027|585567062|FG000|Overall Study|Participant declined to participate before treatment started|0|||
162141298|NCT03394027|585567063|FG001|Overall Study|Participant declined to participate before treatment started|0|||
162141299|NCT03394027|585567064|FG002|Overall Study|Participant declined to participate before treatment started|1|||
162141300|NCT02824432|585567069|FG000|Overall Study|Major Protocol Deviation|1|||
162141301|NCT02824432|585567070|FG001|Overall Study|Major Protocol Deviation|0|||
162141302|NCT01348087|585567071|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
162141303|NCT01348087|585567071|FG000|Overall Study|Administrative problems|79|||
162141304|NCT01348087|585567071|FG000|Overall Study|protocol deviation|1|||
162141305|NCT01348087|585567071|FG000|Overall Study|Lost to Follow-up|1|||
162141306|NCT01348087|585567071|FG000|Overall Study|Subject withdrew consent|7|||
162141307|NCT01348087|585567071|FG000|Overall Study|Adverse Event|25|||
162141308|NCT00124982|585567074|FG000|Short-term Period|Death|1|||
162141309|NCT00124982|585567075|FG001|Short-term Period|Death|1|||
162141310|NCT00124982|585567076|FG002|Short-term Period|Death|0|||
162141311|NCT00124982|585567074|FG000|Short-term Period|Adverse Event|17|||
162141312|NCT00124982|585567075|FG001|Short-term Period|Adverse Event|22|||
162141313|NCT00124982|585567076|FG002|Short-term Period|Adverse Event|0|||
162141314|NCT00124982|585567074|FG000|Short-term Period|Lack of Efficacy|32|||
162141315|NCT00124982|585567075|FG001|Short-term Period|Lack of Efficacy|73|||
162141316|NCT00124982|585567076|FG002|Short-term Period|Lack of Efficacy|0|||
162141317|NCT00124982|585567074|FG000|Short-term Period|Lost to Follow-up|8|||
162141318|NCT00124982|585567075|FG001|Short-term Period|Lost to Follow-up|5|||
162141319|NCT00124982|585567076|FG002|Short-term Period|Lost to Follow-up|0|||
162141320|NCT00124982|585567074|FG000|Short-term Period|Withdrawal of Consent|7|||
162141321|NCT00124982|585567075|FG001|Short-term Period|Withdrawal of Consent|9|||
162141322|NCT00124982|585567076|FG002|Short-term Period|Withdrawal of Consent|0|||
162141323|NCT00124982|585567074|FG000|Short-term Period|Poor/Non-compliance|3|||
162141324|NCT00124982|585567075|FG001|Short-term Period|Poor/Non-compliance|1|||
162141325|NCT00124982|585567076|FG002|Short-term Period|Poor/Non-compliance|0|||
162141326|NCT00124982|585567074|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
162141327|NCT00124982|585567075|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
162141328|NCT00124982|585567076|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
162141329|NCT00124982|585567074|FG000|Short-term Period|Participant Decision|1|||
162141330|NCT00124982|585567075|FG001|Short-term Period|Participant Decision|0|||
162141331|NCT00124982|585567076|FG002|Short-term Period|Participant Decision|0|||
162141332|NCT00124982|585567074|FG000|Short-term Period|Participant Chose Own Doctor|0|||
162141333|NCT00124982|585567075|FG001|Short-term Period|Participant Chose Own Doctor|1|||
162141334|NCT00124982|585567076|FG002|Short-term Period|Participant Chose Own Doctor|0|||
162141335|NCT00124982|585567074|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
162141336|NCT00124982|585567075|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
162141337|NCT00124982|585567076|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
161807297|NCT00272779|584339699|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
161807298|NCT00272779|584339700|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
161807299|NCT00272779|584339699|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
161807300|NCT00272779|584339700|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
161807301|NCT00272779|584339699|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
161807302|NCT00272779|584339700|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
161807303|NCT00272779|584339699|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
161807304|NCT00272779|584339700|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
161807305|NCT00272779|584339699|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
161807306|NCT00272779|584339700|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
161807307|NCT00272779|584339699|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
161807308|NCT00272779|584339700|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
161807309|NCT00272779|584339699|FG000|Baseline Through Week 96|Never treated|2|||
162141338|NCT00124982|585567074|FG000|Short-term Period|Participant Had Lymphopenia|1|||
162141339|NCT00124982|585567075|FG001|Short-term Period|Participant Had Lymphopenia|0|||
162141340|NCT00124982|585567076|FG002|Short-term Period|Participant Had Lymphopenia|0|||
162141341|NCT00124982|585567074|FG000|Long-term Period|Death|0|||
162141342|NCT00124982|585567075|FG001|Long-term Period|Death|0|||
162141343|NCT00124982|585567076|FG002|Long-term Period|Death|1|||
162141344|NCT00124982|585567074|FG000|Long-term Period|Adverse Event|0|||
162141345|NCT00124982|585567075|FG001|Long-term Period|Adverse Event|0|||
162141346|NCT00124982|585567076|FG002|Long-term Period|Adverse Event|17|||
162141347|NCT00124982|585567074|FG000|Long-term Period|Lack of Efficacy|0|||
162141348|NCT00124982|585567075|FG001|Long-term Period|Lack of Efficacy|0|||
162141349|NCT00124982|585567076|FG002|Long-term Period|Lack of Efficacy|46|||
162141350|NCT00124982|585567074|FG000|Long-term Period|Lost to Follow-up|0|||
162141351|NCT00124982|585567075|FG001|Long-term Period|Lost to Follow-up|0|||
162141352|NCT00124982|585567076|FG002|Long-term Period|Lost to Follow-up|4|||
162141353|NCT00124982|585567074|FG000|Long-term Period|Withdrawal by Subject|0|||
162141354|NCT00124982|585567075|FG001|Long-term Period|Withdrawal by Subject|0|||
162141355|NCT00124982|585567076|FG002|Long-term Period|Withdrawal by Subject|16|||
162141356|NCT00124982|585567074|FG000|Long-term Period|Pregnancy|0|||
162141357|NCT00124982|585567075|FG001|Long-term Period|Pregnancy|0|||
162141358|NCT00124982|585567076|FG002|Long-term Period|Pregnancy|1|||
162141359|NCT00124982|585567074|FG000|Long-term Period|Poor/Non-compliance|0|||
162141360|NCT00124982|585567075|FG001|Long-term Period|Poor/Non-compliance|0|||
162141361|NCT00124982|585567076|FG002|Long-term Period|Poor/Non-compliance|2|||
162141362|NCT00124982|585567074|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
162141363|NCT00124982|585567075|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
162141364|NCT00124982|585567076|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
162141365|NCT00124982|585567074|FG000|Long-term Period|Neurologist Recommendation|0|||
162141366|NCT00124982|585567075|FG001|Long-term Period|Neurologist Recommendation|0|||
162141367|NCT00124982|585567076|FG002|Long-term Period|Neurologist Recommendation|1|||
162141368|NCT00980538|585567077|FG000|Overall Study|Lost to Follow-up|20|||
162141369|NCT00980538|585567077|FG000|Overall Study|Sponsor's Decision|4|||
162141370|NCT00980538|585567077|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
162141371|NCT00980538|585567077|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
162141372|NCT00980538|585567077|FG000|Overall Study|Switch to Commercially Available Medication|25|||
162141373|NCT00980538|585567077|FG000|Overall Study|Participant Non-Compliant|9|||
162141374|NCT00980538|585567077|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
162141375|NCT00980538|585567077|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
162141376|NCT00980538|585567077|FG000|Overall Study|Other|60|||
162141377|NCT00980538|585567077|FG000|Overall Study|Other|1|||
162141378|NCT05663866|585567078|FG000|Overall Study|Adverse Event|0|||
162141379|NCT05663866|585567079|FG001|Overall Study|Adverse Event|0|||
162141380|NCT05663866|585567080|FG002|Overall Study|Adverse Event|1|||
162141381|NCT05663866|585567081|FG003|Overall Study|Adverse Event|0|||
162141382|NCT05663866|585567078|FG000|Overall Study|Physician Decision|0|||
162141383|NCT05663866|585567079|FG001|Overall Study|Physician Decision|0|||
162141384|NCT05663866|585567080|FG002|Overall Study|Physician Decision|0|||
162141385|NCT05663866|585567081|FG003|Overall Study|Physician Decision|1|||
162141386|NCT05663866|585567078|FG000|Overall Study|Withdrawal by Subject|0|||
162141387|NCT05663866|585567079|FG001|Overall Study|Withdrawal by Subject|2|||
162141388|NCT05663866|585567080|FG002|Overall Study|Withdrawal by Subject|1|||
162141389|NCT05663866|585567081|FG003|Overall Study|Withdrawal by Subject|2|||
162141390|NCT05663866|585567078|FG000|Overall Study|Progressive disease|4|||
162141391|NCT05663866|585567079|FG001|Overall Study|Progressive disease|8|||
162141392|NCT05663866|585567080|FG002|Overall Study|Progressive disease|5|||
162141393|NCT05663866|585567081|FG003|Overall Study|Progressive disease|2|||
162141394|NCT05663866|585567078|FG000|Overall Study|Other|1|||
162141395|NCT05663866|585567079|FG001|Overall Study|Other|0|||
162141396|NCT05663866|585567080|FG002|Overall Study|Other|0|||
162141397|NCT05663866|585567081|FG003|Overall Study|Other|0|||
162141398|NCT05663866|585567078|FG000|Overall Study|Ongoing|1|||
162141399|NCT05663866|585567079|FG001|Overall Study|Ongoing|27|||
161910704|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
161910705|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
162141400|NCT05663866|585567080|FG002|Overall Study|Ongoing|6|||
162141401|NCT05663866|585567081|FG003|Overall Study|Ongoing|1|||
162141402|NCT05803720|585567082|FG000|Overall Study|Lost to Follow-up|3|||
162141403|NCT05803720|585567083|FG001|Overall Study|Lost to Follow-up|4|||
162141404|NCT05803720|585567082|FG000|Overall Study|Family leave/emergency|1|||
162141405|NCT05803720|585567083|FG001|Overall Study|Family leave/emergency|1|||
162141406|NCT03370133|585567084|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
162141407|NCT03370133|585567085|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
162141408|NCT03370133|585567086|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
162141409|NCT03370133|585567087|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
162141410|NCT03370133|585567088|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
162141411|NCT03370133|585567089|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
162141412|NCT03370133|585567084|FG000|Initial Treatment Period (WK 16)|Death|1|||
162141413|NCT03370133|585567085|FG001|Initial Treatment Period (WK 16)|Death|1|||
162141414|NCT03370133|585567086|FG002|Initial Treatment Period (WK 16)|Death|1|||
162141415|NCT03370133|585567087|FG003|Initial Treatment Period (WK 16)|Death|0|||
162141416|NCT03370133|585567088|FG004|Initial Treatment Period (WK 16)|Death|0|||
162141417|NCT03370133|585567089|FG005|Initial Treatment Period (WK 16)|Death|0|||
162141418|NCT03370133|585567084|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
162141419|NCT03370133|585567085|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
162141420|NCT03370133|585567086|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
162141421|NCT03370133|585567087|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
162141422|NCT03370133|585567088|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
162141423|NCT03370133|585567089|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
162141424|NCT03370133|585567084|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
162141425|NCT03370133|585567085|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
162141426|NCT03370133|585567086|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
162141427|NCT03370133|585567087|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
162141428|NCT03370133|585567088|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
162141429|NCT03370133|585567089|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
162141430|NCT03370133|585567084|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
162141431|NCT03370133|585567085|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
162141432|NCT03370133|585567086|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
162141433|NCT03370133|585567087|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
162141434|NCT03370133|585567088|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
162141435|NCT03370133|585567089|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
162141436|NCT03370133|585567084|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
162141437|NCT03370133|585567085|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
162141438|NCT03370133|585567086|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
162141439|NCT03370133|585567087|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
162141440|NCT03370133|585567088|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
162141441|NCT03370133|585567089|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
162141442|NCT03370133|585567084|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
162141443|NCT03370133|585567085|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
162141444|NCT03370133|585567086|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
162141445|NCT03370133|585567087|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
162141446|NCT03370133|585567088|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
162141447|NCT03370133|585567089|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
162141448|NCT03370133|585567084|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
162141449|NCT03370133|585567085|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
162141450|NCT03370133|585567086|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
162141451|NCT03370133|585567087|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
162141452|NCT03370133|585567088|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
162141453|NCT03370133|585567089|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
162141454|NCT03370133|585567084|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
162141455|NCT03370133|585567085|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
162141456|NCT03370133|585567086|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
162141457|NCT03370133|585567087|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
162141458|NCT03370133|585567088|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
162141459|NCT03370133|585567089|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
162141460|NCT03370133|585567084|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
162141461|NCT03370133|585567085|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
162141462|NCT03370133|585567086|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
162141463|NCT03370133|585567087|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
162141464|NCT03370133|585567088|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
162141465|NCT03370133|585567089|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
161910706|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
161807310|NCT00272779|584339700|FG001|Baseline Through Week 96|Never treated|3|||
161807311|NCT00272779|584339699|FG000|Baseline Through Week 96|Continuing on treatment|61|||
161807312|NCT00272779|584339700|FG001|Baseline Through Week 96|Continuing on treatment|38|||
162141466|NCT03370133|585567084|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
162141467|NCT03370133|585567085|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
162141468|NCT03370133|585567086|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
162141469|NCT03370133|585567087|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
162141470|NCT03370133|585567088|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
162141471|NCT03370133|585567089|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
162141472|NCT03370133|585567084|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
162141473|NCT03370133|585567085|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
162141474|NCT03370133|585567086|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
162141475|NCT03370133|585567087|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
162141476|NCT03370133|585567088|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
162141477|NCT03370133|585567089|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
162141478|NCT03370133|585567084|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
162141479|NCT03370133|585567085|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
162141480|NCT03370133|585567086|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
162141481|NCT03370133|585567087|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
162141482|NCT03370133|585567088|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
162141483|NCT03370133|585567089|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
162141484|NCT03370133|585567084|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
162141485|NCT03370133|585567085|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
162141486|NCT03370133|585567086|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
162141487|NCT03370133|585567087|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
162141488|NCT03370133|585567088|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
162141489|NCT03370133|585567089|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
162141490|NCT03370133|585567084|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
162141491|NCT03370133|585567085|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
162141492|NCT03370133|585567086|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
162141493|NCT03370133|585567087|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
162141494|NCT03370133|585567088|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
162141495|NCT03370133|585567089|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
162141496|NCT06688370|585567090|FG000|Overall Study|Discontinued the treatment|1|||
162141497|NCT06688370|585567090|FG000|Overall Study|Prohibited treatment taken|4|||
162141498|NCT04018066|585568615|FG000|Overall Study|participants started taking medications during the study period|3|||
162141499|NCT04018066|585568615|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
162141500|NCT03568318|585568616|FG000|Overall Study|Adverse Event|3|||
162141501|NCT03568318|585568617|FG001|Overall Study|Adverse Event|1|||
162141502|NCT03568318|585568618|FG002|Overall Study|Adverse Event|1|||
162141503|NCT03568318|585568619|FG003|Overall Study|Adverse Event|0|||
162141504|NCT03568318|585568620|FG004|Overall Study|Adverse Event|1|||
162141505|NCT03568318|585568621|FG005|Overall Study|Adverse Event|0|||
162141506|NCT03568318|585568616|FG000|Overall Study|Withdrawal by Subject|6|||
162141507|NCT03568318|585568617|FG001|Overall Study|Withdrawal by Subject|5|||
162141508|NCT03568318|585568618|FG002|Overall Study|Withdrawal by Subject|2|||
162141509|NCT03568318|585568619|FG003|Overall Study|Withdrawal by Subject|1|||
162141510|NCT03568318|585568620|FG004|Overall Study|Withdrawal by Subject|0|||
162141511|NCT03568318|585568621|FG005|Overall Study|Withdrawal by Subject|0|||
162141512|NCT03568318|585568616|FG000|Overall Study|Lost to Follow-up|3|||
162141513|NCT03568318|585568617|FG001|Overall Study|Lost to Follow-up|2|||
162141514|NCT03568318|585568618|FG002|Overall Study|Lost to Follow-up|2|||
162141515|NCT03568318|585568619|FG003|Overall Study|Lost to Follow-up|2|||
162141516|NCT03568318|585568620|FG004|Overall Study|Lost to Follow-up|1|||
162141517|NCT03568318|585568621|FG005|Overall Study|Lost to Follow-up|0|||
162141518|NCT03568318|585568616|FG000|Overall Study|Other|3|||
162141519|NCT03568318|585568617|FG001|Overall Study|Other|1|||
162141520|NCT03568318|585568618|FG002|Overall Study|Other|3|||
162141521|NCT03568318|585568619|FG003|Overall Study|Other|0|||
162141522|NCT03568318|585568620|FG004|Overall Study|Other|0|||
162141523|NCT03568318|585568621|FG005|Overall Study|Other|0|||
162141524|NCT03568318|585568616|FG000|Overall Study|Ongoing at Time of Analysis|5|||
162141525|NCT03568318|585568617|FG001|Overall Study|Ongoing at Time of Analysis|3|||
162141526|NCT03568318|585568618|FG002|Overall Study|Ongoing at Time of Analysis|2|||
162141527|NCT03568318|585568619|FG003|Overall Study|Ongoing at Time of Analysis|1|||
162141528|NCT03568318|585568620|FG004|Overall Study|Ongoing at Time of Analysis|0|||
161807313|NCT02440711|584339701|FG000|Second Intervention|Lost to Follow-up|1|||
162141529|NCT03568318|585568621|FG005|Overall Study|Ongoing at Time of Analysis|0|||
162141530|NCT01249092|585568623|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
162141531|NCT01249092|585568623|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
161807314|NCT02440711|584339702|FG001|Second Intervention|Lost to Follow-up|0|||
161807315|NCT04129346|584339703|FG000|Overall Study|Death|1|||
161807316|NCT04129346|584339704|FG001|Overall Study|Death|0|||
161807317|NCT05755282|584339705|FG000|Overall Study|Protocol Violation|0|||
161807318|NCT05755282|584339706|FG001|Overall Study|Protocol Violation|1|||
161807319|NCT00573066|584339707|FG000|Overall Study|Exclusion criteria|18|||
161807320|NCT00573066|584339707|FG000|Overall Study|IV malfunction|1|||
161807321|NCT00573066|584339707|FG000|Overall Study|Postoperative bleeding|1|||
161807322|NCT04088760|584339709|FG000|Overall Study|Physician Decision|1|||
161807323|NCT01185548|584339710|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
161807324|NCT02770820|584339712|FG000|Overall Study|Death|1|||
161807325|NCT02770820|584339712|FG000|Overall Study|Physician Decision|2|||
161807326|NCT00376623|584339713|FG000|Overall Study|Progressive disease|35|||
161807327|NCT00376623|584339714|FG001|Overall Study|Progressive disease|22|||
161807328|NCT00376623|584339715|FG002|Overall Study|Progressive disease|17|||
161807329|NCT00376623|584339713|FG000|Overall Study|Lost to Follow-up|0|||
161807330|NCT00376623|584339714|FG001|Overall Study|Lost to Follow-up|1|||
161807331|NCT00376623|584339715|FG002|Overall Study|Lost to Follow-up|0|||
161807332|NCT00376623|584339713|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
161807333|NCT00376623|584339714|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
161807334|NCT00376623|584339715|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
161910707|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
161910708|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
161910709|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
161910710|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
161910711|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
161910712|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
161910713|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
161910714|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
161910715|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
161910716|NCT01668797|584725613|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
161910717|NCT01668797|584725614|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
161910718|NCT01668797|584725615|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
161910719|NCT01668797|584725616|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
161910720|NCT00827567|584725617|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
161910721|NCT01200355|584725621|FG000|Overall Study|Death|7|||
161910722|NCT01200355|584725622|FG001|Overall Study|Death|2|||
161910723|NCT03502798|584725623|FG000|Overall Study|equipment failure|0|||
161910724|NCT03502798|584725624|FG001|Overall Study|equipment failure|7|||
161910725|NCT00485303|584725625|FG000|Overall Study|Adverse Event|5|||
161910726|NCT00485303|584725625|FG000|Overall Study|Progressive Disease|44|||
161910727|NCT00485303|584725625|FG000|Overall Study|Other|3|||
161910728|NCT00485303|584725625|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
161910729|NCT00485303|584725625|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
161910730|NCT00296335|584725632|FG000|Overall Study|Recurrence|3|||
161910731|NCT00296335|584725633|FG001|Overall Study|Recurrence|51|||
161910732|NCT00296335|584725632|FG000|Overall Study|Adverse Event|17|||
161910733|NCT00296335|584725633|FG001|Overall Study|Adverse Event|27|||
161910734|NCT00296335|584725632|FG000|Overall Study|Lost to Follow-up|7|||
161910735|NCT00296335|584725633|FG001|Overall Study|Lost to Follow-up|33|||
161910736|NCT00296335|584725632|FG000|Overall Study|Physician Decision|3|||
162026104|NCT00369629|585152886|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
161910737|NCT00296335|584725633|FG001|Overall Study|Physician Decision|11|||
161910738|NCT01027845|584725634|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
161910739|NCT01027845|584725635|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
161910740|NCT01027845|584725636|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
161910741|NCT01027845|584725637|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
161910742|NCT01027845|584725634|FG000|Primary Vaccination Phase|Adverse Event|1|||
161910743|NCT01027845|584725635|FG001|Primary Vaccination Phase|Adverse Event|0|||
161910744|NCT01027845|584725636|FG002|Primary Vaccination Phase|Adverse Event|0|||
161910745|NCT01027845|584725637|FG003|Primary Vaccination Phase|Adverse Event|0|||
161910746|NCT01027845|584725634|FG000|Primary Vaccination Phase|Protocol Violation|1|||
161910747|NCT01027845|584725635|FG001|Primary Vaccination Phase|Protocol Violation|0|||
161910748|NCT01027845|584725636|FG002|Primary Vaccination Phase|Protocol Violation|0|||
161910749|NCT01027845|584725637|FG003|Primary Vaccination Phase|Protocol Violation|0|||
161910750|NCT01027845|584725634|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
161910751|NCT01027845|584725635|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
161910752|NCT01027845|584725636|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
161910753|NCT01027845|584725637|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
161910754|NCT01027845|584725634|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
161910755|NCT01027845|584725635|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
161910756|NCT01027845|584725636|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
161910757|NCT01027845|584725637|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
161910758|NCT01027845|584725634|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
161910759|NCT01027845|584725635|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
161910760|NCT01027845|584725636|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
161910761|NCT01027845|584725637|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
161910762|NCT00368550|584725638|FG000|Overall Study|Adverse Event|7|||
161910763|NCT00368550|584725639|FG001|Overall Study|Adverse Event|4|||
161910764|NCT00368550|584725638|FG000|Overall Study|Lack of Efficacy|4|||
161910765|NCT00368550|584725639|FG001|Overall Study|Lack of Efficacy|9|||
161910766|NCT00368550|584725638|FG000|Overall Study|Withdrawal by Subject|17|||
161910767|NCT00368550|584725639|FG001|Overall Study|Withdrawal by Subject|10|||
161910768|NCT00087178|584725640|FG000|Overall Study|No follow up data|5|||
161910769|NCT00087178|584725641|FG001|Overall Study|No follow up data|15|||
161910770|NCT00087178|584725640|FG000|Overall Study|No clinical assessment|1|||
161910771|NCT00087178|584725641|FG001|Overall Study|No clinical assessment|2|||
161910772|NCT00087178|584725640|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
161910773|NCT00087178|584725641|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
161910774|NCT03895086|584725642|FG000|Overall Study|Early termination study|1|||
161910775|NCT03895086|584725643|FG001|Overall Study|Early termination study|0|||
161910776|NCT00062166|584725644|FG000|Overall Study|Withdrawal by Subject|6|||
161910777|NCT06494761|584725648|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
161910778|NCT06494761|584725648|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
161910779|NCT04865289|584725649|FG000|Overall Study|Death|34|||
161910780|NCT04865289|584725650|FG001|Overall Study|Death|25|||
161910781|NCT04865289|584725649|FG000|Overall Study|Physician Decision|27|||
161910782|NCT04865289|584725650|FG001|Overall Study|Physician Decision|27|||
161910783|NCT04865289|584725649|FG000|Overall Study|Sponsor Decision|11|||
161910784|NCT04865289|584725650|FG001|Overall Study|Sponsor Decision|1|||
161910785|NCT04865289|584725649|FG000|Overall Study|Withdrawal by Subject|2|||
161910786|NCT04865289|584725650|FG001|Overall Study|Withdrawal by Subject|3|||
161910787|NCT03104374|584725651|FG000|Period 1|Adverse Event|7|||
161910788|NCT03104374|584725652|FG001|Period 1|Adverse Event|7|||
161910789|NCT03104374|584725653|FG002|Period 1|Adverse Event|12|||
161910790|NCT03104374|584725654|FG003|Period 1|Adverse Event|14|||
161910791|NCT03104374|584725651|FG000|Period 1|Withdrawal by Subject|18|||
161807335|NCT00376623|584339713|FG000|Overall Study|Not treated with BI 2536|1|||
161807336|NCT00376623|584339714|FG001|Overall Study|Not treated with BI 2536|0|||
161807337|NCT00376623|584339715|FG002|Overall Study|Not treated with BI 2536|0|||
161807338|NCT00376623|584339713|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
161807339|NCT00376623|584339714|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
161807340|NCT00376623|584339715|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
161807341|NCT00376623|584339713|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
161807342|NCT00376623|584339714|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
161807343|NCT00376623|584339715|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
161807344|NCT00376623|584339713|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
161807345|NCT00376623|584339714|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
161910792|NCT03104374|584725652|FG001|Period 1|Withdrawal by Subject|9|||
161910793|NCT03104374|584725653|FG002|Period 1|Withdrawal by Subject|10|||
161910794|NCT03104374|584725654|FG003|Period 1|Withdrawal by Subject|17|||
161910795|NCT03104374|584725651|FG000|Period 1|Lost to Follow-up|4|||
161910796|NCT03104374|584725652|FG001|Period 1|Lost to Follow-up|4|||
161910797|NCT03104374|584725653|FG002|Period 1|Lost to Follow-up|6|||
161910798|NCT03104374|584725654|FG003|Period 1|Lost to Follow-up|8|||
161910799|NCT03104374|584725651|FG000|Period 1|Lack of Efficacy|6|||
161910800|NCT03104374|584725652|FG001|Period 1|Lack of Efficacy|7|||
161910801|NCT03104374|584725653|FG002|Period 1|Lack of Efficacy|12|||
161910802|NCT03104374|584725654|FG003|Period 1|Lack of Efficacy|6|||
161910803|NCT03104374|584725651|FG000|Period 1|Other|2|||
161910804|NCT03104374|584725652|FG001|Period 1|Other|2|||
161910805|NCT03104374|584725653|FG002|Period 1|Other|4|||
161910806|NCT03104374|584725654|FG003|Period 1|Other|7|||
161910807|NCT03104374|584725651|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
162141532|NCT03518112|585568624|FG000|Overall Study|Withdrawal by Subject|1|||
162141533|NCT05197049|585568630|FG000|Overall Study|Death|0|||
162141534|NCT05197049|585568631|FG001|Overall Study|Death|1|||
162141535|NCT05197049|585568632|FG002|Overall Study|Death|0|||
162141536|NCT05197049|585568630|FG000|Overall Study|Lost to Follow-up|3|||
162141537|NCT05197049|585568631|FG001|Overall Study|Lost to Follow-up|1|||
162141538|NCT05197049|585568632|FG002|Overall Study|Lost to Follow-up|0|||
162141539|NCT05197049|585568630|FG000|Overall Study|Withdrawal by Subject|15|||
162141540|NCT05197049|585568631|FG001|Overall Study|Withdrawal by Subject|3|||
162141541|NCT05197049|585568632|FG002|Overall Study|Withdrawal by Subject|1|||
162141542|NCT05197049|585568630|FG000|Overall Study|GCP non-compliance|1|||
162141543|NCT05197049|585568631|FG001|Overall Study|GCP non-compliance|2|||
162141544|NCT05197049|585568632|FG002|Overall Study|GCP non-compliance|0|||
162141545|NCT05650333|585568634|FG000|Treatment Period (7 Days)|Adverse Event|1|||
162141546|NCT01460342|585568635|FG000|Overall Study|Adverse Event|5|||
162141547|NCT01460342|585568636|FG001|Overall Study|Adverse Event|4|||
162141548|NCT01460342|585568635|FG000|Overall Study|Lost to Follow-up|1|||
162141549|NCT01460342|585568636|FG001|Overall Study|Lost to Follow-up|2|||
162141550|NCT01460342|585568635|FG000|Overall Study|Protocol Violation|0|||
162141551|NCT01460342|585568636|FG001|Overall Study|Protocol Violation|1|||
162141552|NCT01460342|585568635|FG000|Overall Study|Withdrawal by Subject|3|||
162141553|NCT01460342|585568636|FG001|Overall Study|Withdrawal by Subject|4|||
162141554|NCT01460342|585568635|FG000|Overall Study|Physician Decision|1|||
162141555|NCT01460342|585568636|FG001|Overall Study|Physician Decision|3|||
162141556|NCT01460342|585568635|FG000|Overall Study|Lack of Efficacy|1|||
162141557|NCT01460342|585568636|FG001|Overall Study|Lack of Efficacy|0|||
162141558|NCT03761784|585568637|FG000|Overall Study|Adverse Event|4|||
162141559|NCT03761784|585568638|FG001|Overall Study|Adverse Event|0|||
162141560|NCT03761784|585568637|FG000|Overall Study|Lost to Follow-up|10|||
162141561|NCT03761784|585568638|FG001|Overall Study|Lost to Follow-up|7|||
162141562|NCT03761784|585568637|FG000|Overall Study|Pregnancy|1|||
162141563|NCT03761784|585568638|FG001|Overall Study|Pregnancy|0|||
162141564|NCT03761784|585568637|FG000|Overall Study|Protocol Violation|2|||
162141565|NCT03761784|585568638|FG001|Overall Study|Protocol Violation|0|||
162141566|NCT03761784|585568637|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
162141567|NCT03761784|585568638|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
162141568|NCT03761784|585568637|FG000|Overall Study|Withdrawal by Subject|9|||
162141569|NCT03761784|585568638|FG001|Overall Study|Withdrawal by Subject|4|||
162141570|NCT03761784|585568637|FG000|Overall Study|Physician Decision|1|||
162141571|NCT03761784|585568638|FG001|Overall Study|Physician Decision|0|||
162141572|NCT03761784|585568637|FG000|Overall Study|Other Than Specified|1|||
162141573|NCT03761784|585568638|FG001|Overall Study|Other Than Specified|0|||
162141574|NCT01549652|585568639|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
162141575|NCT01549652|585568640|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
162141576|NCT01549652|585568641|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
162141577|NCT01549652|585568642|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
162141578|NCT01549652|585568639|FG000|Overall Study|Study Drug Titration Failure|5|||
162141579|NCT01549652|585568640|FG001|Overall Study|Study Drug Titration Failure|6|||
162141580|NCT01549652|585568641|FG002|Overall Study|Study Drug Titration Failure|0|||
162141581|NCT01549652|585568642|FG003|Overall Study|Study Drug Titration Failure|0|||
162141582|NCT01549652|585568639|FG000|Overall Study|Withdrawal Effect|0|||
162141583|NCT01549652|585568640|FG001|Overall Study|Withdrawal Effect|2|||
162141584|NCT01549652|585568641|FG002|Overall Study|Withdrawal Effect|0|||
162141585|NCT01549652|585568642|FG003|Overall Study|Withdrawal Effect|0|||
162141586|NCT01549652|585568639|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
162141587|NCT01549652|585568640|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
161910808|NCT03104374|584725652|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
161910809|NCT03104374|584725653|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
161942203|NCT02082977|584838333|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
162141588|NCT01549652|585568641|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
162141589|NCT01549652|585568642|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
162141590|NCT01549652|585568639|FG000|Overall Study|Problem with Infusion|1|||
162141591|NCT01549652|585568640|FG001|Overall Study|Problem with Infusion|0|||
162141592|NCT01549652|585568641|FG002|Overall Study|Problem with Infusion|0|||
162011062|NCT03847896|585097726|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
161910810|NCT03104374|584725654|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
161910811|NCT03104374|584725651|FG000|Period 2|Adverse Event|4|||
161910812|NCT03104374|584725652|FG001|Period 2|Adverse Event|7|||
161910813|NCT03104374|584725653|FG002|Period 2|Adverse Event|10|||
161910814|NCT03104374|584725654|FG003|Period 2|Adverse Event|10|||
161910815|NCT03104374|584725651|FG000|Period 2|Withdrawal by Subject|3|||
161910816|NCT03104374|584725652|FG001|Period 2|Withdrawal by Subject|7|||
161910817|NCT03104374|584725653|FG002|Period 2|Withdrawal by Subject|13|||
161910818|NCT03104374|584725654|FG003|Period 2|Withdrawal by Subject|16|||
161910819|NCT03104374|584725651|FG000|Period 2|Lost to Follow-up|2|||
161910820|NCT03104374|584725652|FG001|Period 2|Lost to Follow-up|2|||
161910821|NCT03104374|584725653|FG002|Period 2|Lost to Follow-up|3|||
161910822|NCT03104374|584725654|FG003|Period 2|Lost to Follow-up|5|||
161910823|NCT03104374|584725651|FG000|Period 2|Lack of Efficacy|2|||
161910824|NCT03104374|584725652|FG001|Period 2|Lack of Efficacy|4|||
161910825|NCT03104374|584725653|FG002|Period 2|Lack of Efficacy|7|||
161910826|NCT03104374|584725654|FG003|Period 2|Lack of Efficacy|4|||
161910827|NCT03104374|584725651|FG000|Period 2|COVID-19 Infection|0|||
161910828|NCT03104374|584725652|FG001|Period 2|COVID-19 Infection|0|||
161910829|NCT03104374|584725653|FG002|Period 2|COVID-19 Infection|1|||
161910830|NCT03104374|584725654|FG003|Period 2|COVID-19 Infection|0|||
161910831|NCT03104374|584725651|FG000|Period 2|Other|3|||
161910832|NCT03104374|584725652|FG001|Period 2|Other|2|||
161910833|NCT03104374|584725653|FG002|Period 2|Other|2|||
161910834|NCT03104374|584725654|FG003|Period 2|Other|4|||
161910835|NCT03210714|584725655|FG000|Overall Study|Adverse Event|6|||
161910836|NCT03210714|584725655|FG000|Overall Study|Physician Decision|1|||
161910837|NCT03210714|584725655|FG000|Overall Study|Progressive disease|11|||
161910838|NCT03210714|584725655|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
161910839|NCT00803179|584725656|FG000|Overall Study|Lost to Follow-up|3|||
161910840|NCT04158648|584725657|FG000|Overall Study|Ongoing in the Study|69|||
161910841|NCT04158648|584725657|FG000|Overall Study|Withdrawal by Subject|4|||
161910842|NCT04609514|584725658|FG000|Overall Study|Lost to Follow-up|5|||
161910843|NCT04609514|584725659|FG001|Overall Study|Lost to Follow-up|4|||
161910844|NCT04609514|584725658|FG000|Overall Study|Withdrawal by PI|0|||
161910845|NCT04609514|584725659|FG001|Overall Study|Withdrawal by PI|2|||
161910846|NCT00885118|584725660|FG000|Overall Study|Adverse Event|1|||
161910847|NCT00885118|584725661|FG001|Overall Study|Adverse Event|0|||
161910848|NCT00885118|584725662|FG002|Overall Study|Adverse Event|0|||
161910849|NCT00885118|584725663|FG003|Overall Study|Adverse Event|0|||
161910850|NCT00885118|584725664|FG004|Overall Study|Adverse Event|0|||
161910851|NCT00885118|584725660|FG000|Overall Study|Withdrawal by Subject|0|||
161910852|NCT00885118|584725661|FG001|Overall Study|Withdrawal by Subject|0|||
161910853|NCT00885118|584725662|FG002|Overall Study|Withdrawal by Subject|0|||
161910854|NCT00885118|584725663|FG003|Overall Study|Withdrawal by Subject|0|||
161910855|NCT00885118|584725664|FG004|Overall Study|Withdrawal by Subject|1|||
161910856|NCT00885118|584725660|FG000|Overall Study|Other reason not defined above|0|||
161910857|NCT00885118|584725661|FG001|Overall Study|Other reason not defined above|0|||
161910858|NCT00885118|584725662|FG002|Overall Study|Other reason not defined above|1|||
161910859|NCT00885118|584725663|FG003|Overall Study|Other reason not defined above|0|||
161910860|NCT00885118|584725664|FG004|Overall Study|Other reason not defined above|0|||
161910861|NCT00921024|584725679|FG000|Overall Study|Lost to Follow-up|2|||
161910862|NCT00921024|584725680|FG001|Overall Study|Lost to Follow-up|0|||
161910863|NCT00921024|584725679|FG000|Overall Study|Received concomittant therapy|2|||
161910864|NCT00921024|584725680|FG001|Overall Study|Received concomittant therapy|0|||
161910865|NCT00921024|584725679|FG000|Overall Study|Withdrawal by Subject|0|||
161910866|NCT00921024|584725680|FG001|Overall Study|Withdrawal by Subject|3|||
161910867|NCT02097823|584725681|FG000|Overall Study|Withdrawal by Subject|1|||
161910868|NCT02097823|584725682|FG001|Overall Study|Withdrawal by Subject|1|||
161910869|NCT05399680|584727086|FG000|Overall Study|Lost to Follow-up|1|||
161910870|NCT05399680|584727087|FG001|Overall Study|Lost to Follow-up|0|||
161910871|NCT05399680|584727086|FG000|Overall Study|Death|0|||
161807346|NCT00376623|584339715|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
161807347|NCT00376623|584339713|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
161807348|NCT00376623|584339714|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
161807349|NCT00376623|584339715|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
161807350|NCT00376623|584339713|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
161910872|NCT05399680|584727087|FG001|Overall Study|Death|1|||
161807351|NCT00376623|584339714|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
161807352|NCT00376623|584339715|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
161807353|NCT00376623|584339713|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
161807354|NCT00376623|584339714|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
161807355|NCT00376623|584339715|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
161807356|NCT00376623|584339713|FG000|Overall Study|Increase of tumour markers|0|||
161807357|NCT00376623|584339714|FG001|Overall Study|Increase of tumour markers|1|||
161807358|NCT00376623|584339715|FG002|Overall Study|Increase of tumour markers|0|||
161807359|NCT00376623|584339713|FG000|Overall Study|Bone metastasis|1|||
161807360|NCT00376623|584339714|FG001|Overall Study|Bone metastasis|0|||
161807361|NCT00376623|584339715|FG002|Overall Study|Bone metastasis|0|||
161807362|NCT02331394|584339718|FG000|Overall Study|Disease progression|1|||
161807363|NCT02098876|584339726|FG000|Overall Study|Withdrawal by Subject|5|||
161807364|NCT02098876|584339727|FG001|Overall Study|Withdrawal by Subject|5|||
161807365|NCT03195491|584339728|FG000|Overall Study|Study drug toxicity|25|||
161807366|NCT03195491|584339729|FG001|Overall Study|Study drug toxicity|3|||
161807367|NCT03195491|584339728|FG000|Overall Study|Maximum clinical benefit|5|||
161807368|NCT03195491|584339729|FG001|Overall Study|Maximum clinical benefit|0|||
161807369|NCT03195491|584339728|FG000|Overall Study|Lost to Follow-up|1|||
161807370|NCT03195491|584339729|FG001|Overall Study|Lost to Follow-up|0|||
161807371|NCT03195491|584339728|FG000|Overall Study|Death|3|||
161807372|NCT03195491|584339729|FG001|Overall Study|Death|0|||
161807373|NCT03195491|584339728|FG000|Overall Study|Adverse event unrelated to study drug|19|||
161807374|NCT03195491|584339729|FG001|Overall Study|Adverse event unrelated to study drug|2|||
161807375|NCT03195491|584339728|FG000|Overall Study|Disease progression|266|||
161807376|NCT03195491|584339729|FG001|Overall Study|Disease progression|8|||
161807377|NCT03195491|584339728|FG000|Overall Study|Other reasons|10|||
161807378|NCT03195491|584339729|FG001|Overall Study|Other reasons|0|||
161807379|NCT03195491|584339728|FG000|Overall Study|Participant withdrew consent|8|||
161807380|NCT03195491|584339729|FG001|Overall Study|Participant withdrew consent|1|||
161807381|NCT03195491|584339728|FG000|Overall Study|Participant no longer meets study criteria|0|||
161807382|NCT03195491|584339729|FG001|Overall Study|Participant no longer meets study criteria|1|||
161807383|NCT03195491|584339728|FG000|Overall Study|Participant request to discontinue study treatment|10|||
161807384|NCT03195491|584339729|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161807385|NCT01061866|584339732|FG000|Overall Study|Adverse Event|2|||
161807386|NCT01270503|584339733|FG000|Overall Study|Lost to Follow-up|1|||
161807387|NCT02459951|584339734|FG000|Overall Study|Unable to meet holding requirement|1|||
161807388|NCT02255097|584339735|FG000|Overall Study|Death|151|||
161807389|NCT02255097|584339735|FG000|Overall Study|Lost to Follow-up|5|||
161807390|NCT02255097|584339735|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
161910873|NCT02659865|584727088|FG000|Period 1|Withdrawal by Subject|1|||
161807391|NCT02255097|584339735|FG000|Overall Study|Withdrawal by Subject|7|||
161807392|NCT02255097|584339735|FG000|Overall Study|Allocated but not treated|1|||
161807393|NCT04239872|584339736|FG000|Overall Study|Lost to Follow-up|0|||
161807394|NCT04239872|584339737|FG001|Overall Study|Lost to Follow-up|1|||
161807395|NCT03956862|584339742|FG000|Overall Study|Lost to Follow-up|1|||
161807396|NCT03956862|584339743|FG001|Overall Study|Lost to Follow-up|1|||
161807397|NCT03956862|584339742|FG000|Overall Study|Withdrawal by Subject|1|||
161807398|NCT03956862|584339743|FG001|Overall Study|Withdrawal by Subject|1|||
161807399|NCT01498120|584339744|FG000|Overall Study|Lost to Follow-up|1|||
161807400|NCT01498120|584339744|FG000|Overall Study|Withdrawal by Subject|5|||
161807401|NCT01498120|584339744|FG000|Overall Study|AE, non-serious non-fatal|3|||
161807402|NCT01498120|584339744|FG000|Overall Study|Other|4|||
161910874|NCT02659865|584727089|FG001|Period 1|Withdrawal by Subject|0|||
161910875|NCT02659865|584727090|FG002|Period 1|Withdrawal by Subject|0|||
161910876|NCT02659865|584727091|FG003|Period 1|Withdrawal by Subject|0|||
161910877|NCT02659865|584727092|FG004|Period 1|Withdrawal by Subject|0|||
161910878|NCT02659865|584727088|FG000|Period 1|Adverse Event|0|||
161910879|NCT02659865|584727089|FG001|Period 1|Adverse Event|0|||
161910880|NCT02659865|584727090|FG002|Period 1|Adverse Event|0|||
161910881|NCT02659865|584727091|FG003|Period 1|Adverse Event|0|||
161910882|NCT02659865|584727092|FG004|Period 1|Adverse Event|1|||
161910883|NCT02325414|584727093|FG000|Overall Study|Withdrawal by Subject|3|||
161910884|NCT02325414|584727094|FG001|Overall Study|Withdrawal by Subject|1|||
161910885|NCT02325414|584727093|FG000|Overall Study|Lost to Follow-up|5|||
161910886|NCT02325414|584727094|FG001|Overall Study|Lost to Follow-up|5|||
161910887|NCT02775851|584727095|FG000|Overall Study|Adverse Event|1|||
161910888|NCT02775851|584727096|FG001|Overall Study|Adverse Event|10|||
161910889|NCT02775851|584727095|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
161910890|NCT02775851|584727096|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
161910891|NCT02775851|584727095|FG000|Overall Study|Progression/Relapse|0|||
161910892|NCT02775851|584727096|FG001|Overall Study|Progression/Relapse|4|||
161910893|NCT02775851|584727095|FG000|Overall Study|Other - Not Protocol Specified|0|||
161910894|NCT02775851|584727096|FG001|Overall Study|Other - Not Protocol Specified|7|||
161910895|NCT02775851|584727095|FG000|Overall Study|Withdrawal by Subject|1|||
161910896|NCT02775851|584727096|FG001|Overall Study|Withdrawal by Subject|0|||
161910897|NCT03055013|584727097|FG000|Overall Study|Adverse Event|78|||
161910898|NCT03055013|584727098|FG001|Overall Study|Adverse Event|0|||
161910899|NCT03055013|584727097|FG000|Overall Study|Death|6|||
161910900|NCT03055013|584727098|FG001|Overall Study|Death|0|||
161910901|NCT03055013|584727097|FG000|Overall Study|Disease relapse|33|||
161910902|NCT03055013|584727098|FG001|Overall Study|Disease relapse|0|||
161910903|NCT03055013|584727097|FG000|Overall Study|Withdrawal by Subject|28|||
161910904|NCT03055013|584727098|FG001|Overall Study|Withdrawal by Subject|0|||
161910905|NCT03055013|584727097|FG000|Overall Study|Other complicating disease|5|||
161910906|NCT03055013|584727098|FG001|Overall Study|Other complicating disease|0|||
161910907|NCT03055013|584727097|FG000|Overall Study|Physician Decision|1|||
161910908|NCT03055013|584727098|FG001|Overall Study|Physician Decision|0|||
161910909|NCT03055013|584727097|FG000|Overall Study|Benign mass/non-RCC|4|||
161910910|NCT03055013|584727098|FG001|Overall Study|Benign mass/non-RCC|0|||
161910911|NCT03055013|584727097|FG000|Overall Study|Enrolled in another trial|1|||
161910912|NCT03055013|584727098|FG001|Overall Study|Enrolled in another trial|0|||
161910913|NCT03055013|584727097|FG000|Overall Study|Non-protocol therapy|1|||
161910914|NCT03055013|584727098|FG001|Overall Study|Non-protocol therapy|0|||
161910915|NCT03055013|584727097|FG000|Overall Study|Incompliance|1|||
162141593|NCT01549652|585568642|FG003|Overall Study|Problem with Infusion|0|||
162141594|NCT01549652|585568639|FG000|Overall Study|Titration Non-Compliance|1|||
162141595|NCT01549652|585568640|FG001|Overall Study|Titration Non-Compliance|3|||
162141596|NCT01549652|585568641|FG002|Overall Study|Titration Non-Compliance|4|||
162141597|NCT01549652|585568642|FG003|Overall Study|Titration Non-Compliance|5|||
162141598|NCT01549652|585568639|FG000|Overall Study|Titration Side Effects|0|||
162141599|NCT01549652|585568640|FG001|Overall Study|Titration Side Effects|0|||
162141600|NCT01549652|585568641|FG002|Overall Study|Titration Side Effects|6|||
162141601|NCT01549652|585568642|FG003|Overall Study|Titration Side Effects|3|||
162141602|NCT01549652|585568639|FG000|Overall Study|Withdrawal by Subject|0|||
162141603|NCT01549652|585568640|FG001|Overall Study|Withdrawal by Subject|0|||
162141604|NCT01549652|585568641|FG002|Overall Study|Withdrawal by Subject|5|||
162141605|NCT01549652|585568642|FG003|Overall Study|Withdrawal by Subject|3|||
162141606|NCT01194258|585568645|FG000|Titration Period|Withdrawal by Subject|6|||
162141607|NCT01194258|585568646|FG001|Titration Period|Withdrawal by Subject|0|||
162141608|NCT01194258|585568647|FG002|Titration Period|Withdrawal by Subject|0|||
162141609|NCT01194258|585568648|FG003|Titration Period|Withdrawal by Subject|0|||
162141610|NCT01194258|585568649|FG004|Titration Period|Withdrawal by Subject|0|||
162141611|NCT01194258|585568645|FG000|Titration Period|Lost to Follow-up|2|||
162141612|NCT01194258|585568646|FG001|Titration Period|Lost to Follow-up|0|||
162141613|NCT01194258|585568647|FG002|Titration Period|Lost to Follow-up|0|||
162141614|NCT01194258|585568648|FG003|Titration Period|Lost to Follow-up|0|||
162141615|NCT01194258|585568649|FG004|Titration Period|Lost to Follow-up|0|||
161910916|NCT03055013|584727098|FG001|Overall Study|Incompliance|0|||
161910917|NCT03055013|584727097|FG000|Overall Study|Insurance issues|1|||
162141616|NCT01194258|585568645|FG000|Titration Period|Titration failure|3|||
162141617|NCT01194258|585568646|FG001|Titration Period|Titration failure|0|||
162141618|NCT01194258|585568647|FG002|Titration Period|Titration failure|0|||
161910918|NCT03055013|584727098|FG001|Overall Study|Insurance issues|0|||
161910919|NCT03055013|584727097|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
162141619|NCT01194258|585568648|FG003|Titration Period|Titration failure|0|||
161910920|NCT03055013|584727098|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
161910921|NCT03055013|584727097|FG000|Overall Study|Did not receive nivolumab|10|||
161910922|NCT03055013|584727098|FG001|Overall Study|Did not receive nivolumab|0|||
161910923|NCT03055013|584727097|FG000|Overall Study|Did not receive surgery|0|||
162141620|NCT01194258|585568649|FG004|Titration Period|Titration failure|0|||
161910924|NCT03055013|584727098|FG001|Overall Study|Did not receive surgery|28|||
161910925|NCT03817528|584727105|FG000|Overall Study|Withdrawal by Subject|1|||
161910926|NCT03817528|584727105|FG000|Overall Study|Adverse Event|2|||
161910927|NCT02765035|584727110|FG000|First Intervention (90 Days)|Adverse Event|1|||
161910928|NCT02765035|584727111|FG001|First Intervention (90 Days)|Adverse Event|1|||
161910929|NCT02765035|584727110|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
161910930|NCT02765035|584727111|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
161910931|NCT00671749|584727113|FG000|Overall Study|Adverse Event|2|||
161910932|NCT00671749|584727113|FG000|Overall Study|Withdrawal by Subject|4|||
161910933|NCT00671749|584727113|FG000|Overall Study|Protocol Violation|1|||
161910934|NCT00671749|584727113|FG000|Overall Study|Lost to Follow-up|1|||
161910935|NCT01259245|584727119|FG000|Overall Study|Withdrawal by Subject|27|||
161910936|NCT01259245|584727120|FG001|Overall Study|Withdrawal by Subject|24|||
161910937|NCT01259245|584727119|FG000|Overall Study|Death|1|||
161910938|NCT01259245|584727120|FG001|Overall Study|Death|2|||
161910939|NCT03937778|584727121|FG000|Overall Study|Withdrawal by Subject|1|||
161910940|NCT03937778|584727121|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
161807403|NCT02294604|584339745|FG000|Overall Study|Did not provide samples for culture|0|||
161807404|NCT02294604|584339746|FG001|Overall Study|Did not provide samples for culture|1|||
161807405|NCT02294604|584339747|FG002|Overall Study|Did not provide samples for culture|0|||
161807406|NCT02294604|584339745|FG000|Overall Study|Culture contamination|1|||
161807407|NCT02294604|584339746|FG001|Overall Study|Culture contamination|2|||
161807408|NCT02294604|584339747|FG002|Overall Study|Culture contamination|0|||
161807409|NCT01118312|584339748|FG000|Overall Study|Lost to Follow-up|33|||
161807410|NCT01118312|584339749|FG001|Overall Study|Lost to Follow-up|32|||
161807411|NCT01118312|584339748|FG000|Overall Study|Withdrawal by Subject|1|||
161807412|NCT01118312|584339749|FG001|Overall Study|Withdrawal by Subject|3|||
161807413|NCT03965091|584339750|FG000|Overall Study|Adverse Event|0|||
161807414|NCT03965091|584339751|FG001|Overall Study|Adverse Event|2|||
161807415|NCT03965091|584339752|FG002|Overall Study|Adverse Event|3|||
161807416|NCT03965091|584339750|FG000|Overall Study|Withdrawal by Subject|11|||
161807417|NCT03965091|584339751|FG001|Overall Study|Withdrawal by Subject|3|||
161807418|NCT03965091|584339752|FG002|Overall Study|Withdrawal by Subject|5|||
161807419|NCT03965091|584339750|FG000|Overall Study|Non-compliance with study drug|0|||
161807420|NCT03965091|584339751|FG001|Overall Study|Non-compliance with study drug|0|||
161807421|NCT03965091|584339752|FG002|Overall Study|Non-compliance with study drug|1|||
161807422|NCT03965091|584339750|FG000|Overall Study|Lost to Follow-up|1|||
161807423|NCT03965091|584339751|FG001|Overall Study|Lost to Follow-up|1|||
161807424|NCT03965091|584339752|FG002|Overall Study|Lost to Follow-up|1|||
161807425|NCT03965091|584339750|FG000|Overall Study|Lack of Efficacy|2|||
161807426|NCT03965091|584339751|FG001|Overall Study|Lack of Efficacy|0|||
161807427|NCT03965091|584339752|FG002|Overall Study|Lack of Efficacy|0|||
161807428|NCT03965091|584339750|FG000|Overall Study|Other than specified|9|||
161807429|NCT03965091|584339751|FG001|Overall Study|Other than specified|11|||
161807430|NCT03965091|584339752|FG002|Overall Study|Other than specified|8|||
161807431|NCT04060147|584339754|FG000|Overall Study|Withdrew consent|1|||
161807432|NCT01534520|584339755|FG000|Overall Study|Adverse Event|0|||
161807433|NCT01534520|584339756|FG001|Overall Study|Adverse Event|1|||
161807434|NCT03204539|584339759|FG000|Overall Study|Loss of funding|0|||
161807435|NCT03204539|584339760|FG001|Overall Study|Loss of funding|1|||
161807436|NCT00550537|584339763|FG000|Overall Study|Death|18|||
161807437|NCT00550537|584339763|FG000|Overall Study|Adverse Event|20|||
161807438|NCT00550537|584339763|FG000|Overall Study|Disease progression before|46|||
161807439|NCT00550537|584339763|FG000|Overall Study|Withdrawal by Subject|7|||
161910941|NCT01281306|584727123|FG000|Overall Study|Lack of Efficacy|0|||
161910942|NCT01281306|584727124|FG001|Overall Study|Lack of Efficacy|1|||
161910943|NCT01281306|584727125|FG002|Overall Study|Lack of Efficacy|3|||
161910944|NCT01281306|584727126|FG003|Overall Study|Lack of Efficacy|0|||
161910945|NCT01281306|584727127|FG004|Overall Study|Lack of Efficacy|2|||
161910946|NCT01281306|584727128|FG005|Overall Study|Lack of Efficacy|0|||
161910947|NCT01281306|584727129|FG006|Overall Study|Lack of Efficacy|1|||
161910948|NCT01281306|584727123|FG000|Overall Study|Withdrawal by Subject|1|||
161910949|NCT01281306|584727124|FG001|Overall Study|Withdrawal by Subject|0|||
161910950|NCT01281306|584727125|FG002|Overall Study|Withdrawal by Subject|2|||
161910951|NCT01281306|584727126|FG003|Overall Study|Withdrawal by Subject|4|||
161910952|NCT01281306|584727127|FG004|Overall Study|Withdrawal by Subject|1|||
161910953|NCT01281306|584727128|FG005|Overall Study|Withdrawal by Subject|3|||
161910954|NCT01281306|584727129|FG006|Overall Study|Withdrawal by Subject|1|||
161910955|NCT01281306|584727123|FG000|Overall Study|Protocol deviation|0|||
161910956|NCT01281306|584727124|FG001|Overall Study|Protocol deviation|1|||
161910957|NCT01281306|584727125|FG002|Overall Study|Protocol deviation|1|||
161910958|NCT01281306|584727126|FG003|Overall Study|Protocol deviation|1|||
161910959|NCT01281306|584727127|FG004|Overall Study|Protocol deviation|1|||
161910960|NCT01281306|584727128|FG005|Overall Study|Protocol deviation|0|||
161910961|NCT01281306|584727129|FG006|Overall Study|Protocol deviation|0|||
161910962|NCT01281306|584727123|FG000|Overall Study|Condition no longer requires study drug|1|||
161910963|NCT01281306|584727124|FG001|Overall Study|Condition no longer requires study drug|0|||
161910964|NCT01281306|584727125|FG002|Overall Study|Condition no longer requires study drug|0|||
161910965|NCT01281306|584727126|FG003|Overall Study|Condition no longer requires study drug|0|||
161910966|NCT01281306|584727127|FG004|Overall Study|Condition no longer requires study drug|0|||
161910967|NCT01281306|584727128|FG005|Overall Study|Condition no longer requires study drug|1|||
161910968|NCT01281306|584727129|FG006|Overall Study|Condition no longer requires study drug|1|||
161910969|NCT01281306|584727123|FG000|Overall Study|Lost to Follow-up|1|||
161910970|NCT01281306|584727124|FG001|Overall Study|Lost to Follow-up|0|||
161910971|NCT01281306|584727125|FG002|Overall Study|Lost to Follow-up|0|||
161910972|NCT01281306|584727126|FG003|Overall Study|Lost to Follow-up|2|||
161910973|NCT01281306|584727127|FG004|Overall Study|Lost to Follow-up|0|||
161910974|NCT01281306|584727128|FG005|Overall Study|Lost to Follow-up|0|||
161910975|NCT01281306|584727129|FG006|Overall Study|Lost to Follow-up|1|||
161910976|NCT01281306|584727123|FG000|Overall Study|Death|1|||
161910977|NCT01281306|584727124|FG001|Overall Study|Death|0|||
161910978|NCT01281306|584727125|FG002|Overall Study|Death|0|||
161910979|NCT01281306|584727126|FG003|Overall Study|Death|0|||
161910980|NCT01281306|584727127|FG004|Overall Study|Death|0|||
161910981|NCT01281306|584727128|FG005|Overall Study|Death|0|||
161910982|NCT01281306|584727129|FG006|Overall Study|Death|0|||
161910983|NCT01281306|584727123|FG000|Overall Study|Adverse Event|3|||
161910984|NCT01281306|584727124|FG001|Overall Study|Adverse Event|2|||
161910985|NCT01281306|584727125|FG002|Overall Study|Adverse Event|2|||
161910986|NCT01281306|584727126|FG003|Overall Study|Adverse Event|3|||
161910987|NCT01281306|584727127|FG004|Overall Study|Adverse Event|5|||
161910988|NCT01281306|584727128|FG005|Overall Study|Adverse Event|3|||
161910989|NCT01281306|584727129|FG006|Overall Study|Adverse Event|3|||
161910990|NCT01281306|584727123|FG000|Overall Study|Randomized in error|1|||
161910991|NCT01281306|584727124|FG001|Overall Study|Randomized in error|0|||
161910992|NCT01281306|584727125|FG002|Overall Study|Randomized in error|0|||
161910993|NCT01281306|584727126|FG003|Overall Study|Randomized in error|1|||
161910994|NCT01281306|584727127|FG004|Overall Study|Randomized in error|0|||
161910995|NCT01281306|584727128|FG005|Overall Study|Randomized in error|0|||
161910996|NCT01281306|584727129|FG006|Overall Study|Randomized in error|0|||
161910997|NCT01401322|584727130|FG000|Overall Study|Withdrawal by Subject|1|||
161910998|NCT01401322|584727130|FG000|Overall Study|Physician Decision|1|||
161910999|NCT03466346|584727133|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
161911000|NCT03466346|584727134|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
161911001|NCT03466346|584727135|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
161911002|NCT03466346|584727136|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
161911003|NCT03466346|584727137|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
161911004|NCT03466346|584727133|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
161911005|NCT03466346|584727134|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
162141621|NCT01194258|585568645|FG000|Period 1 (12 Weeks)|Death|0|||
162141622|NCT01194258|585568646|FG001|Period 1 (12 Weeks)|Death|0|||
162141623|NCT01194258|585568647|FG002|Period 1 (12 Weeks)|Death|0|||
162141624|NCT01194258|585568648|FG003|Period 1 (12 Weeks)|Death|0|||
162141625|NCT01194258|585568649|FG004|Period 1 (12 Weeks)|Death|1|||
162141626|NCT01194258|585568645|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162141627|NCT01194258|585568646|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162141628|NCT01194258|585568647|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162141629|NCT01194258|585568648|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
162141630|NCT01194258|585568649|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
162141631|NCT01194258|585568645|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
162141632|NCT01194258|585568646|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
162141633|NCT01194258|585568647|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
162141634|NCT01194258|585568648|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
162141635|NCT01194258|585568649|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
162141636|NCT01194258|585568645|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162141637|NCT01194258|585568646|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162141638|NCT01194258|585568647|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162141639|NCT01194258|585568648|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162141640|NCT01194258|585568649|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162141641|NCT02873754|585568651|FG000|Overall Study|Lost to Follow-up|5|||
162141642|NCT02873754|585568651|FG000|Overall Study|Couldn't complete study procedures|1|||
162141643|NCT01981850|585568652|FG000|Main Phase Stage 1|Death|2|||
162141644|NCT01981850|585568653|FG001|Main Phase Stage 1|Death|0|||
162141645|NCT01981850|585568654|FG002|Main Phase Stage 1|Death|0|||
162141646|NCT01981850|585568655|FG003|Main Phase Stage 1|Death|0|||
162141647|NCT01981850|585568656|FG004|Main Phase Stage 1|Death|0|||
162141648|NCT01981850|585568657|FG005|Main Phase Stage 1|Death|0|||
162141649|NCT01981850|585568658|FG006|Main Phase Stage 1|Death|0|||
162141650|NCT01981850|585568659|FG007|Main Phase Stage 1|Death|0|||
162141651|NCT01981850|585568660|FG008|Main Phase Stage 1|Death|0|||
162141652|NCT01981850|585568661|FG009|Main Phase Stage 1|Death|0|||
162141653|NCT01981850|585568652|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
162141654|NCT01981850|585568653|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162141655|NCT01981850|585568654|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162141656|NCT01981850|585568655|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162141657|NCT01981850|585568656|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162141658|NCT01981850|585568657|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162141659|NCT01981850|585568658|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162141660|NCT01981850|585568659|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162141661|NCT01981850|585568660|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162141662|NCT01981850|585568661|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
162141663|NCT01981850|585568652|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
162141664|NCT01981850|585568653|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
162141665|NCT01981850|585568654|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
162141666|NCT01981850|585568655|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
162141667|NCT01981850|585568656|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
162141668|NCT01981850|585568657|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
162141669|NCT01981850|585568658|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
162141670|NCT01981850|585568659|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
162141671|NCT01981850|585568660|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
162141672|NCT01981850|585568661|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
162141673|NCT01981850|585568652|FG000|Main Phase Stage 1|Various reasons|0|||
162141674|NCT01981850|585568653|FG001|Main Phase Stage 1|Various reasons|0|||
162141675|NCT01981850|585568654|FG002|Main Phase Stage 1|Various reasons|2|||
162141676|NCT01981850|585568655|FG003|Main Phase Stage 1|Various reasons|0|||
162141677|NCT01981850|585568656|FG004|Main Phase Stage 1|Various reasons|0|||
162141678|NCT01981850|585568657|FG005|Main Phase Stage 1|Various reasons|0|||
162141679|NCT01981850|585568658|FG006|Main Phase Stage 1|Various reasons|0|||
162141680|NCT01981850|585568659|FG007|Main Phase Stage 1|Various reasons|0|||
162141681|NCT01981850|585568660|FG008|Main Phase Stage 1|Various reasons|0|||
162141682|NCT01981850|585568661|FG009|Main Phase Stage 1|Various reasons|0|||
162141683|NCT01981850|585568652|FG000|Main Phase Stage 2|Adverse Event|0|||
161911006|NCT03466346|584727135|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
162141684|NCT01981850|585568653|FG001|Main Phase Stage 2|Adverse Event|0|||
162141685|NCT01981850|585568654|FG002|Main Phase Stage 2|Adverse Event|0|||
162141686|NCT01981850|585568655|FG003|Main Phase Stage 2|Adverse Event|0|||
162141687|NCT01981850|585568656|FG004|Main Phase Stage 2|Adverse Event|6|||
161911007|NCT03466346|584727136|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
161911008|NCT03466346|584727137|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
161911009|NCT03466346|584727133|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
161911010|NCT03466346|584727134|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
161911011|NCT03466346|584727135|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
161911012|NCT03466346|584727136|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
161911013|NCT03466346|584727137|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
161911014|NCT03466346|584727133|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
161911015|NCT03466346|584727134|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
161911016|NCT03466346|584727135|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
161911017|NCT03466346|584727136|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
161911018|NCT03466346|584727137|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
161911019|NCT03466346|584727133|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
161911020|NCT03466346|584727134|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
161911021|NCT03466346|584727135|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
161911022|NCT03466346|584727136|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
161911023|NCT03466346|584727137|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
161911024|NCT03466346|584727133|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
161911025|NCT03466346|584727134|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
161911026|NCT03466346|584727135|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
161911027|NCT03466346|584727136|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
161911028|NCT03466346|584727137|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
161911029|NCT03466346|584727133|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
161911030|NCT03466346|584727134|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
161911031|NCT03466346|584727135|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
161911032|NCT03466346|584727136|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
161911033|NCT03466346|584727137|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
161911034|NCT02410629|584727139|FG000|Overall Study|Family cannot commit to the study|2|||
161911035|NCT02410629|584727140|FG001|Overall Study|Family cannot commit to the study|1|||
161911036|NCT02410629|584727139|FG000|Overall Study|Subject returned to work|1|||
161911037|NCT02410629|584727140|FG001|Overall Study|Subject returned to work|0|||
161911038|NCT02410629|584727139|FG000|Overall Study|Subject moved back to home country|0|||
161911039|NCT02410629|584727140|FG001|Overall Study|Subject moved back to home country|1|||
161911040|NCT02410629|584727139|FG000|Overall Study|Subject underwent heart surgery|0|||
161911041|NCT02410629|584727140|FG001|Overall Study|Subject underwent heart surgery|1|||
161911042|NCT01192815|584727141|FG000|Overall Study|Withdrawal by Subject|1|||
161911043|NCT01192815|584727141|FG000|Overall Study|Lack of Efficacy|1|||
161911044|NCT03451045|584727142|FG000|Overall Study|Lack of Efficacy|3|||
161911045|NCT03451045|584727143|FG001|Overall Study|Lack of Efficacy|2|||
161911046|NCT03451045|584727144|FG002|Overall Study|Lack of Efficacy|2|||
161911047|NCT03451045|584727142|FG000|Overall Study|Physician Decision|1|||
161911048|NCT03451045|584727143|FG001|Overall Study|Physician Decision|1|||
161911049|NCT03451045|584727144|FG002|Overall Study|Physician Decision|1|||
161911050|NCT03451045|584727142|FG000|Overall Study|Withdrawal by Subject|4|||
161911051|NCT03451045|584727143|FG001|Overall Study|Withdrawal by Subject|0|||
161911052|NCT03451045|584727144|FG002|Overall Study|Withdrawal by Subject|5|||
161911053|NCT03451045|584727142|FG000|Overall Study|Pregnancy|0|||
161911054|NCT03451045|584727143|FG001|Overall Study|Pregnancy|0|||
161911055|NCT03451045|584727144|FG002|Overall Study|Pregnancy|2|||
161911056|NCT03451045|584727142|FG000|Overall Study|Adverse Event|7|||
161911057|NCT03451045|584727143|FG001|Overall Study|Adverse Event|1|||
162011063|NCT03847896|585097727|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
161911058|NCT03451045|584727144|FG002|Overall Study|Adverse Event|3|||
161911059|NCT03451045|584727142|FG000|Overall Study|Non-compliance with study|2|||
161911060|NCT03451045|584727143|FG001|Overall Study|Non-compliance with study|0|||
161911061|NCT03451045|584727144|FG002|Overall Study|Non-compliance with study|1|||
161911062|NCT03451045|584727142|FG000|Overall Study|any other reason|10|||
161911063|NCT03451045|584727143|FG001|Overall Study|any other reason|2|||
161911064|NCT03451045|584727144|FG002|Overall Study|any other reason|13|||
161911065|NCT00863707|584727145|FG000|Overall Study|Randomized, but drug not received|4|||
161807440|NCT00550537|584339763|FG000|Overall Study|Change in treatment plan|4|||
161807441|NCT00550537|584339763|FG000|Overall Study|Other complicating ilness|3|||
161807442|NCT00550537|584339763|FG000|Overall Study|Declining performance status|2|||
161807443|NCT00550537|584339763|FG000|Overall Study|Treated closer to home|4|||
161807444|NCT02008565|584339764|FG000|Overall Study|Protocol Violation|1|||
161807445|NCT02008565|584339765|FG001|Overall Study|Protocol Violation|1|||
161807446|NCT02008565|584339766|FG002|Overall Study|Protocol Violation|2|||
161807447|NCT02008565|584339767|FG003|Overall Study|Protocol Violation|0|||
161807448|NCT00617305|584339768|FG000|Overall Study|Adverse Event|4|||
161807449|NCT00617305|584339769|FG001|Overall Study|Adverse Event|0|||
161807450|NCT00617305|584339770|FG002|Overall Study|Adverse Event|0|||
161807451|NCT00617305|584339768|FG000|Overall Study|Death|1|||
161807452|NCT00617305|584339769|FG001|Overall Study|Death|0|||
161807453|NCT00617305|584339770|FG002|Overall Study|Death|0|||
161807454|NCT00617305|584339768|FG000|Overall Study|Physician Decision|1|||
161807455|NCT00617305|584339769|FG001|Overall Study|Physician Decision|0|||
161807456|NCT00617305|584339770|FG002|Overall Study|Physician Decision|0|||
161807457|NCT00617305|584339768|FG000|Overall Study|Protocol Violation|1|||
161807458|NCT00617305|584339769|FG001|Overall Study|Protocol Violation|0|||
161807459|NCT00617305|584339770|FG002|Overall Study|Protocol Violation|1|||
161807460|NCT00617305|584339768|FG000|Overall Study|Withdrawal by Subject|1|||
161807461|NCT00617305|584339769|FG001|Overall Study|Withdrawal by Subject|0|||
161807462|NCT00617305|584339770|FG002|Overall Study|Withdrawal by Subject|0|||
161807463|NCT00537979|584339772|FG000|Overall Study|Adverse Event|2|||
161807464|NCT00537979|584339773|FG001|Overall Study|Adverse Event|2|||
161807465|NCT00537979|584339772|FG000|Overall Study|Withdrawal by Subject|1|||
161807466|NCT00537979|584339773|FG001|Overall Study|Withdrawal by Subject|4|||
161807467|NCT00537979|584339772|FG000|Overall Study|Lost to Follow-up|1|||
161807468|NCT00537979|584339773|FG001|Overall Study|Lost to Follow-up|4|||
161911066|NCT00863707|584727146|FG001|Overall Study|Randomized, but drug not received|3|||
161911067|NCT01142336|584727147|FG000|Overall Study|Adverse Event|1|||
161911068|NCT01142336|584727148|FG001|Overall Study|Adverse Event|1|||
161911069|NCT01142336|584727147|FG000|Overall Study|Lost to Follow-up|0|||
161911070|NCT01142336|584727148|FG001|Overall Study|Lost to Follow-up|1|||
161911071|NCT00830128|584727149|FG000|Overall Study|Adverse Event|5|||
161911072|NCT00830128|584727149|FG000|Overall Study|Lack of Efficacy|7|||
161911073|NCT00830128|584727149|FG000|Overall Study|Protocol Violation|1|||
161911074|NCT00830128|584727149|FG000|Overall Study|Withdrawal by Subject|2|||
161911075|NCT00830128|584727149|FG000|Overall Study|Family obligation|1|||
161911076|NCT00830128|584727149|FG000|Overall Study|Relocation|1|||
161911077|NCT00830128|584727149|FG000|Overall Study|Work obligation|1|||
161911078|NCT00830128|584727149|FG000|Overall Study|Operating a vehicle|1|||
161911079|NCT03040726|584727150|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
161911080|NCT03040726|584727151|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
161911081|NCT03040726|584727150|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
161911082|NCT03040726|584727151|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
161911083|NCT03040726|584727150|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
161911084|NCT03040726|584727151|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
161911085|NCT03040726|584727150|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
161911086|NCT03040726|584727151|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
161911087|NCT03040726|584727150|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
161911088|NCT03040726|584727151|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
161911089|NCT03025035|584727152|FG000|Overall Study|Death|2|||
161807469|NCT00537979|584339772|FG000|Overall Study|Lack of Efficacy|0|||
161807470|NCT00537979|584339773|FG001|Overall Study|Lack of Efficacy|1|||
161807471|NCT00537979|584339772|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
161807472|NCT00537979|584339773|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
161807473|NCT00537979|584339772|FG000|Overall Study|Death|0|||
161807474|NCT00537979|584339773|FG001|Overall Study|Death|3|||
161807475|NCT00537979|584339772|FG000|Overall Study|Kidney transplant|0|||
161807476|NCT00537979|584339773|FG001|Overall Study|Kidney transplant|3|||
161807477|NCT00537979|584339772|FG000|Overall Study|Heart failure|0|||
161807478|NCT00537979|584339773|FG001|Overall Study|Heart failure|1|||
161807479|NCT04384978|584339777|FG000|Overall Study|Withdrawal by Subject|4|||
161807480|NCT04384978|584339778|FG001|Overall Study|Withdrawal by Subject|0|||
161807481|NCT00385593|584339779|FG000|Overall Study|Adverse Event|3|||
161807482|NCT00385593|584339780|FG001|Overall Study|Adverse Event|2|||
161807483|NCT00385593|584339779|FG000|Overall Study|Withdrawal by Subject|17|||
161807484|NCT00385593|584339780|FG001|Overall Study|Withdrawal by Subject|7|||
161807485|NCT00385593|584339779|FG000|Overall Study|Lost to Follow-up|12|||
161807486|NCT00385593|584339780|FG001|Overall Study|Lost to Follow-up|8|||
161807487|NCT00385593|584339779|FG000|Overall Study|Protocol Violation|7|||
161807488|NCT00385593|584339780|FG001|Overall Study|Protocol Violation|4|||
161807489|NCT00385593|584339779|FG000|Overall Study|Several reasons|17|||
161807490|NCT00385593|584339780|FG001|Overall Study|Several reasons|15|||
161807491|NCT00385593|584339779|FG000|Overall Study|Incorrect inclusion|2|||
161807492|NCT00385593|584339780|FG001|Overall Study|Incorrect inclusion|0|||
161807493|NCT00385593|584339779|FG000|Overall Study|Incorrect randomization|0|||
161807494|NCT00385593|584339780|FG001|Overall Study|Incorrect randomization|1|||
161807495|NCT01223365|584339801|FG000|Open-label Titration Period|Enrolled but not treated|1|||
161807496|NCT01223365|584339801|FG000|Open-label Titration Period|Adverse Event|23|||
161807497|NCT01223365|584339801|FG000|Open-label Titration Period|Lack of Efficacy|3|||
161807498|NCT01223365|584339801|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
161807499|NCT01223365|584339801|FG000|Open-label Titration Period|Protocol Violation|1|||
161807500|NCT01223365|584339801|FG000|Open-label Titration Period|Lost to Follow-up|2|||
161807501|NCT01223365|584339801|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
161807502|NCT01223365|584339801|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
161807503|NCT01223365|584339801|FG000|Open-label Titration Period|Starting physical therapy|1|||
161807504|NCT01223365|584339801|FG000|Open-label Treatment Period|Adverse Event|39|||
161807505|NCT01223365|584339801|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
161807506|NCT01223365|584339801|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
161807507|NCT01223365|584339801|FG000|Open-label Treatment Period|Protocol Violation|15|||
161807508|NCT01223365|584339801|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
161807509|NCT01223365|584339801|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
161807510|NCT01223365|584339801|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
161807511|NCT01223365|584339801|FG000|Open-label Treatment Period|Moved out of area|2|||
161807512|NCT01223365|584339801|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
161807513|NCT01223365|584339801|FG000|Open-label Treatment Period|"Out of window"|1|||
161807514|NCT01223365|584339801|FG000|Open-label Treatment Period|Starting physical therapy|1|||
161807515|NCT01223365|584339801|FG000|Open-label Treatment Period|Physician Decision|2|||
161807516|NCT03041025|584339802|FG000|Overall Study|Adverse Event|0|||
161807517|NCT03041025|584339803|FG001|Overall Study|Adverse Event|0|||
161807518|NCT03041025|584339804|FG002|Overall Study|Adverse Event|1|||
161807519|NCT03041025|584339802|FG000|Overall Study|Lost to Follow-up|1|||
161807520|NCT03041025|584339803|FG001|Overall Study|Lost to Follow-up|0|||
161807521|NCT03041025|584339804|FG002|Overall Study|Lost to Follow-up|0|||
161807522|NCT03041025|584339802|FG000|Overall Study|Withdrawal by Subject|0|||
161807523|NCT03041025|584339803|FG001|Overall Study|Withdrawal by Subject|0|||
161807524|NCT03041025|584339804|FG002|Overall Study|Withdrawal by Subject|1|||
161807525|NCT02963259|584339805|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
161807526|NCT02963259|584339805|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
161807527|NCT02963259|584339805|FG000|Overall Study|Death|1|||
161807528|NCT02963259|584339805|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
161807529|NCT02131129|584339806|FG000|Overall Study|Withdrawal by Subject|1|||
161807530|NCT02131129|584339807|FG001|Overall Study|Withdrawal by Subject|0|||
161807531|NCT03880266|584339808|FG000|Overall Study|Withdrawal by Subject|0|||
161807532|NCT03880266|584339809|FG001|Overall Study|Withdrawal by Subject|1|||
161807533|NCT03880266|584339810|FG002|Overall Study|Withdrawal by Subject|1|||
161807534|NCT03880266|584339811|FG003|Overall Study|Withdrawal by Subject|0|||
161807535|NCT03880266|584339812|FG004|Overall Study|Withdrawal by Subject|0|||
161807536|NCT03880266|584339813|FG005|Overall Study|Withdrawal by Subject|0|||
161807537|NCT03880266|584339814|FG006|Overall Study|Withdrawal by Subject|0|||
161807538|NCT03880266|584339815|FG007|Overall Study|Withdrawal by Subject|0|||
161807539|NCT01511939|584341133|FG000|Overall Study|Withdrawal by Subject|2|||
161807540|NCT01511939|584341134|FG001|Overall Study|Withdrawal by Subject|1|||
161807541|NCT01511939|584341135|FG002|Overall Study|Withdrawal by Subject|0|||
161807542|NCT01993030|584341138|FG000|Overall Study|Adverse Event|0|||
161807543|NCT01993030|584341139|FG001|Overall Study|Adverse Event|4|||
161807544|NCT00829790|584341145|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
161942204|NCT02082977|584838334|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161911090|NCT03025035|584727152|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
161911091|NCT01123655|584727155|FG000|Overall Study|Medication for RA had to be changed|1|||
161911092|NCT01123655|584727156|FG001|Overall Study|Medication for RA had to be changed|0|||
161911093|NCT01123655|584727157|FG002|Overall Study|Medication for RA had to be changed|0|||
161911094|NCT01123655|584727155|FG000|Overall Study|new illness|0|||
161911095|NCT01123655|584727156|FG001|Overall Study|new illness|1|||
161911096|NCT01123655|584727157|FG002|Overall Study|new illness|0|||
161911097|NCT01123655|584727155|FG000|Overall Study|began prohibitive drug|0|||
161911098|NCT01123655|584727156|FG001|Overall Study|began prohibitive drug|0|||
161911099|NCT01123655|584727157|FG002|Overall Study|began prohibitive drug|1|||
161911100|NCT05063448|584727162|FG000|Overall Study|Withdrawal by Subject|1|||
161911101|NCT02475369|584727166|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
161911102|NCT02475369|584727167|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
161911103|NCT03329885|584727173|FG000|Overall Study|Sponsor discontinued the study early|0|||
161911104|NCT03329885|584727174|FG001|Overall Study|Sponsor discontinued the study early|0|||
161911105|NCT03329885|584727175|FG002|Overall Study|Sponsor discontinued the study early|0|||
161911106|NCT03329885|584727176|FG003|Overall Study|Sponsor discontinued the study early|0|||
161911107|NCT03329885|584727177|FG004|Overall Study|Sponsor discontinued the study early|0|||
161911108|NCT03329885|584727178|FG005|Overall Study|Sponsor discontinued the study early|0|||
161911109|NCT03329885|584727179|FG006|Overall Study|Sponsor discontinued the study early|1|||
161911110|NCT03329885|584727180|FG007|Overall Study|Sponsor discontinued the study early|1|||
161911111|NCT03329885|584727181|FG008|Overall Study|Sponsor discontinued the study early|0|||
161911112|NCT01991795|584727182|FG000|Overall Study|Lost to Follow-up|6|||
161911113|NCT01991795|584727183|FG001|Overall Study|Lost to Follow-up|4|||
161911114|NCT01991795|584727182|FG000|Overall Study|Withdrawal by Subject|117|||
161911115|NCT01991795|584727183|FG001|Overall Study|Withdrawal by Subject|94|||
161911116|NCT01991795|584727182|FG000|Overall Study|Site prematurely closed by sponsor|26|||
161911117|NCT01991795|584727183|FG001|Overall Study|Site prematurely closed by sponsor|25|||
161911118|NCT01981616|584727185|FG000|Overall Study|Adverse Event|0|||
161911119|NCT01981616|584727186|FG001|Overall Study|Adverse Event|1|||
161911120|NCT01981616|584727185|FG000|Overall Study|Protocol Violation|1|||
161911121|NCT01981616|584727186|FG001|Overall Study|Protocol Violation|0|||
161911122|NCT03641508|584727187|FG000|First Injection|Lost to Follow-up|2|||
161911123|NCT03641508|584727188|FG001|First Injection|Lost to Follow-up|0|||
161911124|NCT02404545|584727189|FG000|Overall Study|Sponsor Termination|6|||
161807545|NCT00829790|584341146|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
161807546|NCT04247282|584341150|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
161807547|NCT04247282|584341151|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
161807548|NCT04247282|584341152|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
161807549|NCT04247282|584341153|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
161807550|NCT04247282|584341150|FG000|Overall Study|Refused further treatment|0|||
161911125|NCT02404545|584727190|FG001|Overall Study|Sponsor Termination|6|||
161807551|NCT04247282|584341151|FG001|Overall Study|Refused further treatment|1|||
161807552|NCT04247282|584341152|FG002|Overall Study|Refused further treatment|0|||
161807553|NCT04247282|584341153|FG003|Overall Study|Refused further treatment|0|||
161911126|NCT00094445|584727191|FG000|Overall Study|Withdrawal by Subject|3|||
161911127|NCT00094445|584727191|FG000|Overall Study|Lost to Follow-up|1|||
161911128|NCT00094445|584727191|FG000|Overall Study|Progressive Disease|2|||
161911129|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
161911130|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
161911131|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
161911132|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
161911133|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
161911134|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
161911135|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
161911136|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
161911137|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
161911138|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
161911139|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
161911140|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
161911141|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
161911142|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
161911143|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
161911144|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
161911145|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
161911146|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
161911147|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
161911148|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
161911149|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
161911150|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
161911151|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
161911152|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
161911153|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
161911154|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
161911155|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
161911156|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
161911157|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
161911158|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
161911159|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
161911160|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
161911161|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
161911162|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
161911163|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
161911164|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
161911165|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
162141688|NCT01981850|585568657|FG005|Main Phase Stage 2|Adverse Event|5|||
162141689|NCT01981850|585568658|FG006|Main Phase Stage 2|Adverse Event|7|||
162141690|NCT01981850|585568659|FG007|Main Phase Stage 2|Adverse Event|0|||
162141691|NCT01981850|585568660|FG008|Main Phase Stage 2|Adverse Event|0|||
162141692|NCT01981850|585568661|FG009|Main Phase Stage 2|Adverse Event|0|||
162141693|NCT01981850|585568652|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162141694|NCT01981850|585568653|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162141695|NCT01981850|585568654|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162141696|NCT01981850|585568655|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162141697|NCT01981850|585568656|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
162141698|NCT01981850|585568657|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
162141699|NCT01981850|585568658|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
162141700|NCT01981850|585568659|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162141701|NCT01981850|585568660|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162141702|NCT01981850|585568661|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
162141703|NCT01981850|585568652|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
162141704|NCT01981850|585568653|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
162141705|NCT01981850|585568654|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
162141706|NCT01981850|585568655|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
162141707|NCT01981850|585568656|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
162141708|NCT01981850|585568657|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
162141709|NCT01981850|585568658|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
162141710|NCT01981850|585568659|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
162141711|NCT01981850|585568660|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
162141712|NCT01981850|585568661|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
162141713|NCT01981850|585568652|FG000|Main Phase Stage 2|Various reasons|0|||
162141714|NCT01981850|585568653|FG001|Main Phase Stage 2|Various reasons|0|||
162141715|NCT01981850|585568654|FG002|Main Phase Stage 2|Various reasons|0|||
162141716|NCT01981850|585568655|FG003|Main Phase Stage 2|Various reasons|0|||
162141717|NCT01981850|585568656|FG004|Main Phase Stage 2|Various reasons|2|||
162141718|NCT01981850|585568657|FG005|Main Phase Stage 2|Various reasons|0|||
161911166|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
161911167|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
161911168|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
161911169|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
161911170|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
161911171|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
162141719|NCT01981850|585568658|FG006|Main Phase Stage 2|Various reasons|1|||
162141720|NCT01981850|585568659|FG007|Main Phase Stage 2|Various reasons|0|||
162141721|NCT01981850|585568660|FG008|Main Phase Stage 2|Various reasons|0|||
162141722|NCT01981850|585568661|FG009|Main Phase Stage 2|Various reasons|0|||
162141723|NCT01981850|585568652|FG000|Main Phase Stage 2|Progressive Disease|0|||
162141724|NCT01981850|585568653|FG001|Main Phase Stage 2|Progressive Disease|0|||
162141725|NCT01981850|585568654|FG002|Main Phase Stage 2|Progressive Disease|0|||
162141726|NCT01981850|585568655|FG003|Main Phase Stage 2|Progressive Disease|0|||
162141727|NCT01981850|585568656|FG004|Main Phase Stage 2|Progressive Disease|0|||
162141728|NCT01981850|585568657|FG005|Main Phase Stage 2|Progressive Disease|6|||
162141729|NCT01981850|585568658|FG006|Main Phase Stage 2|Progressive Disease|6|||
162141730|NCT01981850|585568659|FG007|Main Phase Stage 2|Progressive Disease|0|||
162141731|NCT01981850|585568660|FG008|Main Phase Stage 2|Progressive Disease|0|||
162141732|NCT01981850|585568661|FG009|Main Phase Stage 2|Progressive Disease|0|||
162141733|NCT01981850|585568652|FG000|Open Label Extension (OLE)|Adverse Event|0|||
162141734|NCT01981850|585568653|FG001|Open Label Extension (OLE)|Adverse Event|0|||
162141735|NCT01981850|585568654|FG002|Open Label Extension (OLE)|Adverse Event|0|||
162141736|NCT01981850|585568655|FG003|Open Label Extension (OLE)|Adverse Event|0|||
162141737|NCT01981850|585568656|FG004|Open Label Extension (OLE)|Adverse Event|0|||
162011064|NCT03847896|585097728|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
162141738|NCT01981850|585568657|FG005|Open Label Extension (OLE)|Adverse Event|0|||
162141739|NCT01981850|585568658|FG006|Open Label Extension (OLE)|Adverse Event|0|||
162141740|NCT01981850|585568659|FG007|Open Label Extension (OLE)|Adverse Event|2|||
162141741|NCT01981850|585568660|FG008|Open Label Extension (OLE)|Adverse Event|1|||
162141742|NCT01981850|585568661|FG009|Open Label Extension (OLE)|Adverse Event|8|||
162141743|NCT01981850|585568652|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
162141744|NCT01981850|585568653|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
162141745|NCT01981850|585568654|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
162141746|NCT01981850|585568655|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
162141747|NCT01981850|585568656|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
162141748|NCT01981850|585568657|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
162141749|NCT01981850|585568658|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
162141750|NCT01981850|585568659|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
162141751|NCT01981850|585568660|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
162141752|NCT01981850|585568661|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
162141753|NCT01981850|585568652|FG000|Open Label Extension (OLE)|Various reasons|0|||
162141754|NCT01981850|585568653|FG001|Open Label Extension (OLE)|Various reasons|0|||
162141755|NCT01981850|585568654|FG002|Open Label Extension (OLE)|Various reasons|0|||
162141756|NCT01981850|585568655|FG003|Open Label Extension (OLE)|Various reasons|0|||
162141757|NCT01981850|585568656|FG004|Open Label Extension (OLE)|Various reasons|0|||
162141758|NCT01981850|585568657|FG005|Open Label Extension (OLE)|Various reasons|0|||
162141759|NCT01981850|585568658|FG006|Open Label Extension (OLE)|Various reasons|0|||
162141760|NCT01981850|585568659|FG007|Open Label Extension (OLE)|Various reasons|3|||
162141761|NCT01981850|585568660|FG008|Open Label Extension (OLE)|Various reasons|1|||
162141762|NCT01981850|585568661|FG009|Open Label Extension (OLE)|Various reasons|3|||
162141763|NCT01981850|585568652|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
162141764|NCT01981850|585568653|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
162141765|NCT01981850|585568654|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
162141766|NCT01981850|585568655|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
162141767|NCT01981850|585568656|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
162141768|NCT01981850|585568657|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
162141769|NCT01981850|585568658|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
162141770|NCT01981850|585568659|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
162141771|NCT01981850|585568660|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
162141772|NCT01981850|585568661|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
162141773|NCT01981850|585568652|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162141774|NCT01981850|585568653|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162141775|NCT01981850|585568654|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162141776|NCT01981850|585568655|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162141777|NCT01981850|585568656|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162141778|NCT01981850|585568657|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162141779|NCT01981850|585568658|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162141780|NCT01981850|585568659|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162141781|NCT01981850|585568660|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
162141782|NCT01981850|585568661|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
162141783|NCT01981850|585568652|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
162141784|NCT01981850|585568653|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
162141785|NCT01981850|585568654|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
162141786|NCT01981850|585568655|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
162141787|NCT01981850|585568656|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
162011065|NCT03847896|585097729|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
162011066|NCT03847896|585097730|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
162011067|NCT03847896|585097726|FG000|Overall Study|Withdrawal by Subject|2|||
162011068|NCT03847896|585097727|FG001|Overall Study|Withdrawal by Subject|10|||
162011069|NCT03847896|585097728|FG002|Overall Study|Withdrawal by Subject|5|||
162011070|NCT03847896|585097729|FG003|Overall Study|Withdrawal by Subject|9|||
162011071|NCT03847896|585097730|FG004|Overall Study|Withdrawal by Subject|8|||
162011072|NCT03847896|585097726|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162011073|NCT03847896|585097727|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162011074|NCT03847896|585097728|FG002|Overall Study|Withdrawal by parent/guardian|1|||
162011075|NCT03847896|585097729|FG003|Overall Study|Withdrawal by parent/guardian|0|||
162011076|NCT03847896|585097730|FG004|Overall Study|Withdrawal by parent/guardian|0|||
162011077|NCT03847896|585097726|FG000|Overall Study|Adverse Event|2|||
162011078|NCT03847896|585097727|FG001|Overall Study|Adverse Event|1|||
162011079|NCT03847896|585097728|FG002|Overall Study|Adverse Event|3|||
162011080|NCT03847896|585097729|FG003|Overall Study|Adverse Event|2|||
162011081|NCT03847896|585097730|FG004|Overall Study|Adverse Event|4|||
162141788|NCT01981850|585568657|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
162141789|NCT01981850|585568658|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
161807554|NCT01263704|584341154|FG000|Overall Study|Progressive disease|18|||
161807555|NCT01263704|584341154|FG000|Overall Study|Adverse Event|3|||
161807556|NCT01263704|584341154|FG000|Overall Study|Death|2|||
161807557|NCT01263704|584341154|FG000|Overall Study|Patient withdrew consent|2|||
161807558|NCT01263704|584341154|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
161807559|NCT01263704|584341154|FG000|Overall Study|Lost to Follow-up|1|||
161807560|NCT01263704|584341154|FG000|Overall Study|Colon metastases|1|||
161807561|NCT01263704|584341154|FG000|Overall Study|Principal Investigator (PI) decision|1|||
161807562|NCT00102440|584341155|FG000|Overall Study|Lost to Follow-up|25|||
161807563|NCT00102440|584341156|FG001|Overall Study|Lost to Follow-up|18|||
161807564|NCT00102440|584341157|FG002|Overall Study|Lost to Follow-up|21|||
161807565|NCT00102440|584341155|FG000|Overall Study|Adverse Event|16|||
161807566|NCT00102440|584341156|FG001|Overall Study|Adverse Event|23|||
161807567|NCT00102440|584341157|FG002|Overall Study|Adverse Event|8|||
161807568|NCT00102440|584341155|FG000|Overall Study|Gout Flare|10|||
161807569|NCT00102440|584341156|FG001|Overall Study|Gout Flare|28|||
161807570|NCT00102440|584341157|FG002|Overall Study|Gout Flare|9|||
161807571|NCT00102440|584341155|FG000|Overall Study|Personal Reason(s)|19|||
161807572|NCT00102440|584341156|FG001|Overall Study|Personal Reason(s)|13|||
161807573|NCT00102440|584341157|FG002|Overall Study|Personal Reason(s)|13|||
161807574|NCT00102440|584341155|FG000|Overall Study|Other|11|||
161807575|NCT00102440|584341156|FG001|Overall Study|Other|14|||
161807576|NCT00102440|584341157|FG002|Overall Study|Other|14|||
161807577|NCT00102440|584341155|FG000|Overall Study|Protocol Violation|7|||
161807578|NCT00102440|584341156|FG001|Overall Study|Protocol Violation|2|||
161807579|NCT00102440|584341157|FG002|Overall Study|Protocol Violation|1|||
161807580|NCT01792635|584341159|FG000|Part B|Adverse Event|0|||
161807581|NCT01792635|584341160|FG001|Part B|Adverse Event|0|||
161807582|NCT01792635|584341161|FG002|Part B|Adverse Event|1|||
161807583|NCT01792635|584341159|FG000|Part B|Study terminated|0|||
161807584|NCT01792635|584341160|FG001|Part B|Study terminated|4|||
161807585|NCT01792635|584341161|FG002|Part B|Study terminated|3|||
161807586|NCT01010542|584341162|FG000|Overall Study|Adverse Event|0|||
161807587|NCT01010542|584341163|FG001|Overall Study|Adverse Event|1|||
161807588|NCT01010542|584341164|FG002|Overall Study|Adverse Event|0|||
161911172|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
161911173|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
161911174|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
161911175|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
161911176|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
161911177|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
161911178|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
161911179|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
161911180|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
161911181|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
161911182|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
161911183|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
161911184|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
161911185|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
161911186|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
161911187|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
161911188|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
161911189|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
161911190|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
161911191|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
161911192|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
161911193|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
161911194|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
161911195|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
161911196|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
161911197|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
161911198|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
161911199|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
161911200|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
161911201|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
161911202|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
161911203|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
161911204|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
161911205|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
161911206|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
161911207|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
161911208|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
161911209|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
161911210|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
161911211|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
161911212|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
161911213|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
161911214|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
161911215|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
161911216|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
161911217|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
161911218|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
161911219|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
161911220|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
161807589|NCT01010542|584341162|FG000|Overall Study|Lost to Follow-up|0|||
161807590|NCT01010542|584341163|FG001|Overall Study|Lost to Follow-up|1|||
161807591|NCT01010542|584341164|FG002|Overall Study|Lost to Follow-up|0|||
161807592|NCT01010542|584341162|FG000|Overall Study|Withdrawal by Subject|0|||
161807593|NCT01010542|584341163|FG001|Overall Study|Withdrawal by Subject|3|||
161807594|NCT01010542|584341164|FG002|Overall Study|Withdrawal by Subject|2|||
161807595|NCT01401647|584341176|FG000|Overall Study|Withdrawal by Subject|1|||
161807596|NCT01401647|584341177|FG001|Overall Study|Withdrawal by Subject|5|||
161807597|NCT01401647|584341178|FG002|Overall Study|Withdrawal by Subject|2|||
161807598|NCT01401647|584341176|FG000|Overall Study|Lost to Follow-up|3|||
161807599|NCT01401647|584341177|FG001|Overall Study|Lost to Follow-up|3|||
161807600|NCT01401647|584341178|FG002|Overall Study|Lost to Follow-up|1|||
161807601|NCT00473330|584341182|FG000|Core Study|Adverse Event|4|||
161807602|NCT00473330|584341183|FG001|Core Study|Adverse Event|4|||
161807603|NCT00473330|584341184|FG002|Core Study|Adverse Event|1|||
161807604|NCT00473330|584341182|FG000|Core Study|Death|6|||
161807605|NCT00473330|584341183|FG001|Core Study|Death|4|||
161807606|NCT00473330|584341184|FG002|Core Study|Death|4|||
161807607|NCT00473330|584341182|FG000|Core Study|Lost to Follow-up|5|||
161807608|NCT00473330|584341183|FG001|Core Study|Lost to Follow-up|5|||
161807609|NCT00473330|584341184|FG002|Core Study|Lost to Follow-up|10|||
161807610|NCT00473330|584341182|FG000|Core Study|Physician Decision|2|||
161807611|NCT00473330|584341183|FG001|Core Study|Physician Decision|1|||
161807612|NCT00473330|584341184|FG002|Core Study|Physician Decision|3|||
161807613|NCT00473330|584341182|FG000|Core Study|Subject Non-compliance|1|||
161807614|NCT00473330|584341183|FG001|Core Study|Subject Non-compliance|2|||
161807615|NCT00473330|584341184|FG002|Core Study|Subject Non-compliance|1|||
161807616|NCT00473330|584341182|FG000|Core Study|Subject Required Other Therapy|0|||
161807617|NCT00473330|584341183|FG001|Core Study|Subject Required Other Therapy|1|||
161807618|NCT00473330|584341184|FG002|Core Study|Subject Required Other Therapy|3|||
161807619|NCT00473330|584341182|FG000|Core Study|Subject's Decision|9|||
161807620|NCT00473330|584341183|FG001|Core Study|Subject's Decision|8|||
161807621|NCT00473330|584341184|FG002|Core Study|Subject's Decision|19|||
161807622|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
161807623|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
161807624|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
161807625|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Death|2|||
161807626|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Death|0|||
161807627|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Death|0|||
161807628|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
161807629|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
161807630|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
161807631|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
161807632|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
161807633|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
161807634|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
161807635|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
161807636|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
161807637|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
161807638|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
161807639|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
161807640|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
161807641|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
161807642|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
161807643|NCT00473330|584341182|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
161807644|NCT00473330|584341183|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
161807645|NCT00473330|584341184|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
161807646|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
161807647|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
161807648|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
162141790|NCT01981850|585568659|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
162141791|NCT01981850|585568660|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
162141792|NCT01981850|585568661|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
162141793|NCT02059980|585568666|FG000|Overall Study|Lost to Follow-up|2|||
162141794|NCT02059980|585568667|FG001|Overall Study|Lost to Follow-up|1|||
162141795|NCT01321606|585568668|FG000|Overall Study|Lost to Follow-up|0|||
162141796|NCT01321606|585568669|FG001|Overall Study|Lost to Follow-up|0|||
162141797|NCT01321606|585568670|FG002|Overall Study|Lost to Follow-up|0|||
162141798|NCT01321606|585568671|FG003|Overall Study|Lost to Follow-up|1|||
162141799|NCT03412747|585568672|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
162141800|NCT03412747|585568673|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
162141801|NCT03412747|585568674|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
162141802|NCT03412747|585568672|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
162141803|NCT03412747|585568673|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
162141804|NCT03412747|585568674|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
162141805|NCT03412747|585568672|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
162141806|NCT03412747|585568673|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
162141807|NCT03412747|585568674|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
162141808|NCT03412747|585568672|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
162141809|NCT03412747|585568673|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
162141810|NCT03412747|585568674|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
162141811|NCT03412747|585568672|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
162141812|NCT03412747|585568673|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
162141813|NCT03412747|585568674|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
162141814|NCT03412747|585568672|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
161911221|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
161911222|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
162141815|NCT03412747|585568673|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
162141816|NCT03412747|585568674|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
161807649|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Death|2|||
161807650|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Death|2|||
161807651|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Death|1|||
161807652|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
161807653|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
161807654|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
161807655|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
161807656|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
161807657|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
161807658|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
161807659|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
161807660|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
161807661|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
161807662|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
161807663|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
161807664|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
161807665|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
161807666|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
161807667|NCT00473330|584341182|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
161807668|NCT00473330|584341183|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
161807669|NCT00473330|584341184|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
161807670|NCT01975948|584341186|FG000|Overall Study|Withdrawal by Subject|17|||
161807671|NCT01975948|584341187|FG001|Overall Study|Withdrawal by Subject|21|||
161807672|NCT01975948|584341188|FG002|Overall Study|Withdrawal by Subject|7|||
161807673|NCT01975948|584341189|FG003|Overall Study|Withdrawal by Subject|6|||
161807674|NCT01675765|584341190|FG000|Overall Study|Progressive disease|4|||
161807675|NCT01675765|584341191|FG001|Overall Study|Progressive disease|4|||
161807676|NCT01675765|584341190|FG000|Overall Study|Adverse Event|1|||
161807677|NCT01675765|584341191|FG001|Overall Study|Adverse Event|2|||
161807678|NCT01675765|584341190|FG000|Overall Study|Withdrawal by Subject|2|||
161807679|NCT01675765|584341191|FG001|Overall Study|Withdrawal by Subject|0|||
161807680|NCT01675765|584341190|FG000|Overall Study|Death|1|||
161807681|NCT01675765|584341191|FG001|Overall Study|Death|0|||
161807682|NCT01675765|584341190|FG000|Overall Study|Clinical progression|3|||
161807683|NCT01675765|584341191|FG001|Overall Study|Clinical progression|2|||
161807684|NCT00336479|584341193|FG000|Overall Study|Adverse Event|8|||
161807685|NCT00336479|584341194|FG001|Overall Study|Adverse Event|11|||
161807686|NCT00336479|584341195|FG002|Overall Study|Adverse Event|18|||
161807687|NCT00336479|584341196|FG003|Overall Study|Adverse Event|4|||
161807688|NCT00336479|584341193|FG000|Overall Study|Noncompliant|1|||
161807689|NCT00336479|584341194|FG001|Overall Study|Noncompliant|7|||
161807690|NCT00336479|584341195|FG002|Overall Study|Noncompliant|3|||
161807691|NCT00336479|584341196|FG003|Overall Study|Noncompliant|0|||
161807692|NCT00336479|584341193|FG000|Overall Study|Physician Decision|2|||
161807693|NCT00336479|584341194|FG001|Overall Study|Physician Decision|3|||
161807694|NCT00336479|584341195|FG002|Overall Study|Physician Decision|1|||
161807695|NCT00336479|584341196|FG003|Overall Study|Physician Decision|0|||
161807696|NCT00336479|584341193|FG000|Overall Study|Lost to Follow-up|3|||
161807697|NCT00336479|584341194|FG001|Overall Study|Lost to Follow-up|2|||
161807698|NCT00336479|584341195|FG002|Overall Study|Lost to Follow-up|0|||
161807699|NCT00336479|584341196|FG003|Overall Study|Lost to Follow-up|0|||
161807700|NCT00336479|584341193|FG000|Overall Study|Withdrawal by Subject|3|||
161807701|NCT00336479|584341194|FG001|Overall Study|Withdrawal by Subject|2|||
161807702|NCT00336479|584341195|FG002|Overall Study|Withdrawal by Subject|3|||
161807703|NCT00336479|584341196|FG003|Overall Study|Withdrawal by Subject|0|||
161807704|NCT00336479|584341193|FG000|Overall Study|Other|0|||
161807705|NCT00336479|584341194|FG001|Overall Study|Other|0|||
161911223|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
161911224|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
161911225|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
161911226|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
161911227|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
161911228|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
161911229|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
161911230|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
161911231|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
161911232|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
161911233|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
161911234|NCT02717195|584727192|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
161911235|NCT02717195|584727193|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
161911236|NCT02717195|584727194|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
161911237|NCT02717195|584727195|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
161911238|NCT02717195|584727196|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
161911239|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
161911240|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
161911241|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
161911242|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
161911243|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
161911244|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
161911245|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
161911246|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
161911247|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
161911248|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
161911249|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
161911250|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
161911251|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
161911252|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
161911253|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
161911254|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
161911255|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
161911256|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
161911257|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
161911258|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
161911259|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161911260|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161911261|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
161911262|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
161911263|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
161911264|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
161911265|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
161911266|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
161911267|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
161911268|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
161911269|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
161911270|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
161911271|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
161911272|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
161911273|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
161911274|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
161911275|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
161807706|NCT00336479|584341195|FG002|Overall Study|Other|1|||
161807707|NCT00336479|584341196|FG003|Overall Study|Other|0|||
161807708|NCT00336479|584341193|FG000|Overall Study|Virologic Stopping Rule|20|||
161807709|NCT00336479|584341194|FG001|Overall Study|Virologic Stopping Rule|0|||
161807710|NCT00336479|584341195|FG002|Overall Study|Virologic Stopping Rule|0|||
161807711|NCT00336479|584341196|FG003|Overall Study|Virologic Stopping Rule|0|||
161807712|NCT00846495|584341197|FG000|Overall Study|Lost to Follow-up|1|||
161807713|NCT00846495|584341198|FG001|Overall Study|Lost to Follow-up|0|||
161911276|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
161911277|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
161807714|NCT00846495|584341197|FG000|Overall Study|Adverse Event|5|||
161807715|NCT00846495|584341198|FG001|Overall Study|Adverse Event|1|||
161807716|NCT00846495|584341197|FG000|Overall Study|Lack of Efficacy|1|||
161911278|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
161911279|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
161911280|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
161911281|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
161911282|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
161911283|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
161911284|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
161911285|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
161911286|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
161911287|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
161911288|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
161911289|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
161911290|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
161911291|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
161911292|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
161911293|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
161911294|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
161911295|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
161911296|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
161911297|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
161911298|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
161911299|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
161911300|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
161911301|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
161911302|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
161911303|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
161911304|NCT02717195|584727192|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
161911305|NCT02717195|584727193|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
161911306|NCT02717195|584727194|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
161911307|NCT02717195|584727195|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
161911308|NCT02717195|584727196|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
161911309|NCT02078817|584727197|FG000|Overall Study|Withdrawal by Subject|1|||
161911310|NCT00855218|584727198|FG000|Overall Study|Adverse Event|43|||
161911311|NCT00855218|584727199|FG001|Overall Study|Adverse Event|27|||
161911312|NCT00855218|584727198|FG000|Overall Study|Withdrawal by Subject|10|||
161911313|NCT00855218|584727199|FG001|Overall Study|Withdrawal by Subject|6|||
161911314|NCT00855218|584727198|FG000|Overall Study|Physician Decision|18|||
161911315|NCT00855218|584727199|FG001|Overall Study|Physician Decision|11|||
161911316|NCT00855218|584727198|FG000|Overall Study|Lost to Follow-up|0|||
161911317|NCT00855218|584727199|FG001|Overall Study|Lost to Follow-up|1|||
161911318|NCT00855218|584727198|FG000|Overall Study|Protocol Violation|5|||
161911319|NCT00855218|584727199|FG001|Overall Study|Protocol Violation|9|||
161911320|NCT00855218|584727198|FG000|Overall Study|non-compliant with study drug|3|||
161911321|NCT00855218|584727199|FG001|Overall Study|non-compliant with study drug|1|||
161911322|NCT00855218|584727198|FG000|Overall Study|patient convenience|2|||
161911323|NCT00855218|584727199|FG001|Overall Study|patient convenience|0|||
161911324|NCT00855218|584727198|FG000|Overall Study|technical problems|2|||
161911325|NCT00855218|584727199|FG001|Overall Study|technical problems|1|||
161911326|NCT00855218|584727198|FG000|Overall Study|Still treated with study medication|0|||
161911327|NCT00855218|584727199|FG001|Overall Study|Still treated with study medication|1|||
161911328|NCT00855218|584727198|FG000|Overall Study|Untreatable disease progression|54|||
161911329|NCT00855218|584727199|FG001|Overall Study|Untreatable disease progression|67|||
161911330|NCT00855218|584727198|FG000|Overall Study|Second malignancy|0|||
161911331|NCT00855218|584727199|FG001|Overall Study|Second malignancy|1|||
161911332|NCT00855218|584727198|FG000|Overall Study|Progression measurement proven|7|||
161911333|NCT00855218|584727199|FG001|Overall Study|Progression measurement proven|15|||
161911334|NCT00855218|584727198|FG000|Overall Study|Clinical endpoint reached|10|||
162141817|NCT03412747|585568672|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
162141818|NCT03412747|585568673|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
162141819|NCT03412747|585568674|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
162141820|NCT03412747|585568672|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
162141821|NCT03412747|585568673|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
162141822|NCT03412747|585568674|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
162141823|NCT03412747|585568672|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
162141824|NCT03412747|585568673|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
162141825|NCT03412747|585568674|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
162141826|NCT03412747|585568672|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
161911335|NCT00855218|584727199|FG001|Overall Study|Clinical endpoint reached|13|||
161911336|NCT00769561|584727201|FG000|Overall Study|Withdrawal by Subject|2|||
162141827|NCT03412747|585568673|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
162141828|NCT03412747|585568674|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
162141829|NCT03412747|585568672|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
162141830|NCT03412747|585568673|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
161911337|NCT00769561|584727202|FG001|Overall Study|Withdrawal by Subject|2|||
161911338|NCT00769561|584727201|FG000|Overall Study|Lost to Follow-up|1|||
161911339|NCT00769561|584727202|FG001|Overall Study|Lost to Follow-up|3|||
161911340|NCT03824561|584727205|FG000|Overall Study|Protocol Violation|19|||
161911341|NCT01773928|584727206|FG000|Overall Study|Adverse Event|0|||
161911342|NCT01773928|584727207|FG001|Overall Study|Adverse Event|0|||
161911343|NCT01773928|584727208|FG002|Overall Study|Adverse Event|0|||
161911344|NCT01773928|584727209|FG003|Overall Study|Adverse Event|0|||
161911345|NCT01773928|584727210|FG004|Overall Study|Adverse Event|0|||
161911346|NCT01773928|584727211|FG005|Overall Study|Adverse Event|0|||
161911347|NCT01773928|584727212|FG006|Overall Study|Adverse Event|0|||
161911348|NCT01773928|584727213|FG007|Overall Study|Adverse Event|1|||
161911349|NCT01773928|584727214|FG008|Overall Study|Adverse Event|0|||
161911350|NCT01773928|584727206|FG000|Overall Study|Physician Decision|0|||
161911351|NCT01773928|584727207|FG001|Overall Study|Physician Decision|0|||
161911352|NCT01773928|584727208|FG002|Overall Study|Physician Decision|0|||
161911353|NCT01773928|584727209|FG003|Overall Study|Physician Decision|1|||
161911354|NCT01773928|584727210|FG004|Overall Study|Physician Decision|0|||
161911355|NCT01773928|584727211|FG005|Overall Study|Physician Decision|0|||
161911356|NCT01773928|584727212|FG006|Overall Study|Physician Decision|0|||
161911357|NCT01773928|584727213|FG007|Overall Study|Physician Decision|0|||
161911358|NCT01773928|584727214|FG008|Overall Study|Physician Decision|0|||
161911359|NCT01773928|584727206|FG000|Overall Study|Withdrawal by Subject|5|||
161911360|NCT01773928|584727207|FG001|Overall Study|Withdrawal by Subject|4|||
161911361|NCT01773928|584727208|FG002|Overall Study|Withdrawal by Subject|4|||
161911362|NCT01773928|584727209|FG003|Overall Study|Withdrawal by Subject|4|||
161911363|NCT01773928|584727210|FG004|Overall Study|Withdrawal by Subject|7|||
161911364|NCT01773928|584727211|FG005|Overall Study|Withdrawal by Subject|1|||
161911365|NCT01773928|584727212|FG006|Overall Study|Withdrawal by Subject|0|||
161911366|NCT01773928|584727213|FG007|Overall Study|Withdrawal by Subject|0|||
161911367|NCT01773928|584727214|FG008|Overall Study|Withdrawal by Subject|1|||
161911368|NCT01773928|584727206|FG000|Overall Study|Lost to Follow-up|0|||
161911369|NCT01773928|584727207|FG001|Overall Study|Lost to Follow-up|0|||
161911370|NCT01773928|584727208|FG002|Overall Study|Lost to Follow-up|0|||
161911371|NCT01773928|584727209|FG003|Overall Study|Lost to Follow-up|0|||
161911372|NCT01773928|584727210|FG004|Overall Study|Lost to Follow-up|0|||
161911373|NCT01773928|584727211|FG005|Overall Study|Lost to Follow-up|1|||
161911374|NCT01773928|584727212|FG006|Overall Study|Lost to Follow-up|0|||
161911375|NCT01773928|584727213|FG007|Overall Study|Lost to Follow-up|0|||
162141831|NCT03412747|585568674|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
162141832|NCT03412747|585568672|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
162141833|NCT03412747|585568673|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
162141834|NCT03412747|585568674|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
162141835|NCT03412747|585568672|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
162141836|NCT03412747|585568673|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
162141837|NCT03412747|585568674|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
162141838|NCT03412747|585568672|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
162141839|NCT03412747|585568673|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
162141840|NCT03412747|585568674|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
162141841|NCT03412747|585568672|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
162141842|NCT03412747|585568673|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
162141843|NCT03412747|585568674|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
162141844|NCT03412747|585568672|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
162141845|NCT03412747|585568673|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
162141846|NCT03412747|585568674|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
162141847|NCT01582945|585568675|FG000|Overall Study|Intolerable side-effects|1|||
162141848|NCT01582945|585568675|FG000|Overall Study|Scheduling conflicts|1|||
162141849|NCT01726023|585568676|FG000|Overall Study|Death|1|||
162141850|NCT01726023|585568677|FG001|Overall Study|Death|1|||
161911376|NCT01773928|584727214|FG008|Overall Study|Lost to Follow-up|0|||
161911377|NCT01773928|584727206|FG000|Overall Study|Subject misrepresented age|0|||
161911378|NCT01773928|584727207|FG001|Overall Study|Subject misrepresented age|1|||
161911379|NCT01773928|584727208|FG002|Overall Study|Subject misrepresented age|0|||
161911380|NCT01773928|584727209|FG003|Overall Study|Subject misrepresented age|0|||
161911381|NCT01773928|584727210|FG004|Overall Study|Subject misrepresented age|0|||
161911382|NCT01773928|584727211|FG005|Overall Study|Subject misrepresented age|0|||
161911383|NCT01773928|584727212|FG006|Overall Study|Subject misrepresented age|0|||
161911384|NCT01773928|584727213|FG007|Overall Study|Subject misrepresented age|0|||
161911385|NCT01773928|584727214|FG008|Overall Study|Subject misrepresented age|0|||
161911386|NCT01773928|584727206|FG000|Overall Study|Subject met exclusion criteria|0|||
161911387|NCT01773928|584727207|FG001|Overall Study|Subject met exclusion criteria|0|||
161911388|NCT01773928|584727208|FG002|Overall Study|Subject met exclusion criteria|0|||
161911389|NCT01773928|584727209|FG003|Overall Study|Subject met exclusion criteria|0|||
161911390|NCT01773928|584727210|FG004|Overall Study|Subject met exclusion criteria|0|||
161911391|NCT01773928|584727211|FG005|Overall Study|Subject met exclusion criteria|0|||
161911392|NCT01773928|584727212|FG006|Overall Study|Subject met exclusion criteria|0|||
161911393|NCT01773928|584727213|FG007|Overall Study|Subject met exclusion criteria|0|||
161911394|NCT01773928|584727214|FG008|Overall Study|Subject met exclusion criteria|1|||
161911395|NCT01773928|584727206|FG000|Overall Study|Randomized, had to leave, never returned|0|||
161911396|NCT01773928|584727207|FG001|Overall Study|Randomized, had to leave, never returned|0|||
161911397|NCT01773928|584727208|FG002|Overall Study|Randomized, had to leave, never returned|0|||
161911398|NCT01773928|584727209|FG003|Overall Study|Randomized, had to leave, never returned|1|||
161911399|NCT01773928|584727210|FG004|Overall Study|Randomized, had to leave, never returned|0|||
161911400|NCT01773928|584727211|FG005|Overall Study|Randomized, had to leave, never returned|0|||
161911401|NCT01773928|584727212|FG006|Overall Study|Randomized, had to leave, never returned|0|||
161911402|NCT01773928|584727213|FG007|Overall Study|Randomized, had to leave, never returned|0|||
161911403|NCT01773928|584727214|FG008|Overall Study|Randomized, had to leave, never returned|0|||
161911404|NCT01773928|584727206|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
161911405|NCT01773928|584727207|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
161911406|NCT01773928|584727208|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
161911407|NCT01773928|584727209|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
161911408|NCT01773928|584727210|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
161911409|NCT01773928|584727211|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
161911410|NCT01773928|584727212|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
161911411|NCT01773928|584727213|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
161911412|NCT01773928|584727214|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
161911413|NCT02370511|584727215|FG000|Overall Study|Death|10|||
161911414|NCT02370511|584727216|FG001|Overall Study|Death|7|||
161911415|NCT02370511|584727217|FG002|Overall Study|Death|1|||
161911416|NCT02370511|584727215|FG000|Overall Study|Withdrawal by Subject|2|||
161911417|NCT02370511|584727216|FG001|Overall Study|Withdrawal by Subject|0|||
161911418|NCT02370511|584727217|FG002|Overall Study|Withdrawal by Subject|0|||
161911419|NCT02370511|584727215|FG000|Overall Study|Lost to Follow-up|0|||
161911420|NCT02370511|584727216|FG001|Overall Study|Lost to Follow-up|4|||
161911421|NCT02370511|584727217|FG002|Overall Study|Lost to Follow-up|0|||
161911422|NCT01149655|584727218|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
161911423|NCT01149655|584727219|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
161911424|NCT01149655|584727220|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
161911425|NCT01149655|584727221|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
161911426|NCT01149655|584727218|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
161911427|NCT01149655|584727219|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
161911428|NCT01149655|584727220|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
162141851|NCT01726023|585568676|FG000|Overall Study|Lost to Follow-up|5|||
162141852|NCT01726023|585568677|FG001|Overall Study|Lost to Follow-up|10|||
162141853|NCT01726023|585568676|FG000|Overall Study|Other Eligibility criteria|7|||
162141854|NCT01726023|585568677|FG001|Overall Study|Other Eligibility criteria|7|||
162141855|NCT01726023|585568676|FG000|Overall Study|Withdrawal by Subject|16|||
162141856|NCT01726023|585568677|FG001|Overall Study|Withdrawal by Subject|8|||
162141857|NCT04982575|585568684|FG000|Overall Study|Withdrawal by Subject|2|||
162141858|NCT04982575|585568685|FG001|Overall Study|Withdrawal by Subject|0|||
162141859|NCT04982575|585568686|FG002|Overall Study|Withdrawal by Subject|2|||
162141860|NCT03038022|585568689|FG000|Overall Study|Withdrawal by Subject|2|||
162141861|NCT03038022|585568690|FG001|Overall Study|Withdrawal by Subject|0|||
162141862|NCT03038022|585568689|FG000|Overall Study|Adverse Event|4|||
162141863|NCT03038022|585568690|FG001|Overall Study|Adverse Event|2|||
162141864|NCT01467427|585568691|FG000|Overall Study|Withdrawal by Subject|1|||
162141865|NCT01467427|585568692|FG001|Overall Study|Withdrawal by Subject|0|||
162141866|NCT01467427|585568691|FG000|Overall Study|Not continuing in extension phase|0|||
161911429|NCT01149655|584727221|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
161911430|NCT01149655|584727218|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
161911431|NCT01149655|584727219|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
161911432|NCT01149655|584727220|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
161911433|NCT01149655|584727221|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
161911434|NCT01149655|584727218|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
161911435|NCT01149655|584727219|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
161911436|NCT01149655|584727220|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
161911437|NCT01149655|584727221|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
161911438|NCT01149655|584727218|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
161911439|NCT01149655|584727219|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
161911440|NCT01149655|584727220|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
161911441|NCT01149655|584727221|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
161911442|NCT01149655|584727218|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
161911443|NCT01149655|584727219|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
161911444|NCT01149655|584727220|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
161911445|NCT01149655|584727221|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
161911446|NCT01149655|584727218|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
161911447|NCT01149655|584727219|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
162141867|NCT01467427|585568692|FG001|Overall Study|Not continuing in extension phase|2|||
162141868|NCT01467427|585568691|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
162141869|NCT01467427|585568692|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
162141870|NCT01467427|585568691|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
162141871|NCT01467427|585568692|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
162141872|NCT01467427|585568691|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
162141873|NCT01467427|585568692|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
162141874|NCT01467427|585568691|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
162141875|NCT01467427|585568692|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
162141876|NCT04269200|585568693|FG000|Global Cohort|Death|72|||
162141877|NCT04269200|585568694|FG001|Global Cohort|Death|54|||
162141878|NCT04269200|585568695|FG002|Global Cohort|Death|49|||
162141879|NCT04269200|585568693|FG000|Global Cohort|Lost to Follow-up|0|||
162141880|NCT04269200|585568694|FG001|Global Cohort|Lost to Follow-up|0|||
162141881|NCT04269200|585568695|FG002|Global Cohort|Lost to Follow-up|2|||
162141882|NCT04269200|585568693|FG000|Global Cohort|Withdrawal by Subject|22|||
162141883|NCT04269200|585568694|FG001|Global Cohort|Withdrawal by Subject|25|||
162141884|NCT04269200|585568695|FG002|Global Cohort|Withdrawal by Subject|18|||
162141885|NCT04269200|585568693|FG000|China Cohort|Death|12|||
162141886|NCT04269200|585568694|FG001|China Cohort|Death|11|||
162141887|NCT04269200|585568695|FG002|China Cohort|Death|13|||
162141888|NCT04269200|585568693|FG000|China Cohort|Lost to Follow-up|0|||
162141889|NCT04269200|585568694|FG001|China Cohort|Lost to Follow-up|1|||
162141890|NCT04269200|585568695|FG002|China Cohort|Lost to Follow-up|1|||
162141891|NCT04269200|585568693|FG000|China Cohort|Withdrawal by Subject|2|||
162141892|NCT04269200|585568694|FG001|China Cohort|Withdrawal by Subject|2|||
162141893|NCT04269200|585568695|FG002|China Cohort|Withdrawal by Subject|4|||
162141894|NCT04181827|585568696|FG000|Overall Study|Ongoing|124|||
162141895|NCT04181827|585568697|FG001|Overall Study|Ongoing|157|||
162141896|NCT04181827|585568696|FG000|Overall Study|Death|82|||
162141897|NCT04181827|585568697|FG001|Overall Study|Death|50|||
162141898|NCT04181827|585568696|FG000|Overall Study|Lost to Follow-up|0|||
162141899|NCT04181827|585568697|FG001|Overall Study|Lost to Follow-up|1|||
162141900|NCT04181827|585568696|FG000|Overall Study|Withdrawal by Subject|5|||
162141901|NCT04181827|585568697|FG001|Overall Study|Withdrawal by Subject|0|||
162141902|NCT03887936|585568698|FG000|Overall Study|Relocation|2|||
162141903|NCT03887936|585568699|FG001|Overall Study|Relocation|2|||
162141904|NCT03887936|585568698|FG000|Overall Study|Physician Decision|0|||
162141905|NCT03887936|585568699|FG001|Overall Study|Physician Decision|1|||
162141906|NCT03887936|585568698|FG000|Overall Study|Withdrawal by Subject|0|||
162141907|NCT03887936|585568699|FG001|Overall Study|Withdrawal by Subject|1|||
162141908|NCT00539591|585568700|FG000|Overall Study|Toxicity|3|||
162141909|NCT00539591|585568701|FG001|Overall Study|Toxicity|0|||
162141910|NCT00539591|585568702|FG002|Overall Study|Toxicity|0|||
162141911|NCT00539591|585568700|FG000|Overall Study|Disease progression|2|||
162141912|NCT00539591|585568701|FG001|Overall Study|Disease progression|2|||
162141913|NCT00539591|585568702|FG002|Overall Study|Disease progression|3|||
162141914|NCT06269367|585568703|FG000|Phase I|Unable to perform study procedures|0|||
162141915|NCT06269367|585568704|FG001|Phase I|Unable to perform study procedures|1|||
162141916|NCT06269367|585568703|FG000|Phase I|Could not continue study for personal reasons.|1|||
162141917|NCT06269367|585568704|FG001|Phase I|Could not continue study for personal reasons.|0|||
162141918|NCT04305912|585568708|FG000|First Intervention|COVID-19 Suspension|2|||
162141919|NCT04305912|585568709|FG001|First Intervention|COVID-19 Suspension|0|||
162141920|NCT04305912|585568708|FG000|First Intervention|Withdrawal by Subject|0|||
162141921|NCT04305912|585568709|FG001|First Intervention|Withdrawal by Subject|1|||
161807717|NCT00846495|584341198|FG001|Overall Study|Lack of Efficacy|2|||
161807718|NCT00846495|584341197|FG000|Overall Study|Physician Decision|1|||
161807719|NCT00846495|584341198|FG001|Overall Study|Physician Decision|0|||
161807720|NCT01079988|584341199|FG000|Overall Study|Lost to Follow-up|0|||
161807721|NCT01079988|584341200|FG001|Overall Study|Lost to Follow-up|0|||
161807722|NCT01079988|584341201|FG002|Overall Study|Lost to Follow-up|0|||
161911448|NCT01149655|584727220|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
161911449|NCT01149655|584727221|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
161911450|NCT01149655|584727218|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
162141922|NCT04305912|585568708|FG000|Second Intervention|Adverse Event|0|||
162141923|NCT04305912|585568709|FG001|Second Intervention|Adverse Event|1|||
162141924|NCT00117988|585568714|FG000|Overall Study|Death|3|||
162141925|NCT00117988|585568714|FG000|Overall Study|Adverse Event|1|||
162141926|NCT05824351|585568715|FG000|Overall Study|Adverse Event|6|||
162141927|NCT02137850|585568716|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
162141928|NCT02137850|585568717|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
162141929|NCT02137850|585568718|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
162141930|NCT02137850|585568716|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
162141931|NCT02137850|585568717|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
162141932|NCT02137850|585568718|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
162141933|NCT02137850|585568716|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
162141934|NCT02137850|585568717|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
162141935|NCT02137850|585568718|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
162141936|NCT02137850|585568716|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
162141937|NCT02137850|585568717|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
162141938|NCT02137850|585568718|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
162141939|NCT02137850|585568716|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
162141940|NCT02137850|585568717|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
162141941|NCT02137850|585568718|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
162141942|NCT02137850|585568716|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
162141943|NCT02137850|585568717|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
162141944|NCT02137850|585568718|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
162141945|NCT02137850|585568716|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
162141946|NCT02137850|585568717|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
162141947|NCT02137850|585568718|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
162141948|NCT02137850|585568716|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
162141949|NCT02137850|585568717|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
162141950|NCT02137850|585568718|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
162141951|NCT02137850|585568716|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
162141952|NCT02137850|585568717|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
162141953|NCT02137850|585568718|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
162141954|NCT02137850|585568716|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
162141955|NCT02137850|585568717|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
162141956|NCT02137850|585568718|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
162141957|NCT02137850|585568716|FG000|Main Phase: Prophylaxis|Other|0|||
162141958|NCT02137850|585568717|FG001|Main Phase: Prophylaxis|Other|1|||
162141959|NCT02137850|585568718|FG002|Main Phase: Prophylaxis|Other|0|||
162141960|NCT02137850|585568716|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
162141961|NCT02137850|585568717|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
162141962|NCT02137850|585568718|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
162141963|NCT02137850|585568716|FG000|Main Phase: Prophylaxis|Early site closure|0|||
162141964|NCT02137850|585568717|FG001|Main Phase: Prophylaxis|Early site closure|2|||
162141965|NCT02137850|585568718|FG002|Main Phase: Prophylaxis|Early site closure|0|||
162141966|NCT02137850|585568716|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
162141967|NCT02137850|585568717|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
162141968|NCT02137850|585568718|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
162141969|NCT02137850|585568716|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
162141970|NCT02137850|585568717|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
162141971|NCT02137850|585568718|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
162141972|NCT02137850|585568716|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
162141973|NCT02137850|585568717|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
162141974|NCT02137850|585568718|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
162141975|NCT02137850|585568716|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
162141976|NCT02137850|585568717|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
162141977|NCT02137850|585568718|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
162141978|NCT02137850|585568716|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
162141979|NCT02137850|585568717|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
162141980|NCT02137850|585568718|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
162141981|NCT02137850|585568716|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
162141982|NCT02137850|585568717|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
162141983|NCT02137850|585568718|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
162141984|NCT02137850|585568716|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
162141985|NCT02137850|585568717|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
162141986|NCT02137850|585568718|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
162141987|NCT02137850|585568716|FG000|Extension Phase: Prophylaxis|Other|0|||
161911451|NCT01149655|584727219|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
161911452|NCT01149655|584727220|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
161911453|NCT01149655|584727221|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
161911454|NCT01149655|584727218|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
161911455|NCT01149655|584727219|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
161911456|NCT01149655|584727220|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
161911457|NCT01149655|584727221|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
161911458|NCT01149655|584727218|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
161911459|NCT01149655|584727219|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
161911460|NCT01149655|584727220|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
161911461|NCT01149655|584727221|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
161911462|NCT01149655|584727218|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
161911463|NCT01149655|584727219|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
161911464|NCT01149655|584727220|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
161911465|NCT01149655|584727221|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
161911466|NCT01149655|584727218|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
161911467|NCT01149655|584727219|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
162011082|NCT03847896|585097726|FG000|Overall Study|A severe exacerbation event|0|||
161807723|NCT01079988|584341202|FG003|Overall Study|Lost to Follow-up|1|||
161807724|NCT01079988|584341203|FG004|Overall Study|Lost to Follow-up|0|||
161807725|NCT01079988|584341199|FG000|Overall Study|Lack of Efficacy|1|||
161807726|NCT01079988|584341200|FG001|Overall Study|Lack of Efficacy|0|||
161807727|NCT01079988|584341201|FG002|Overall Study|Lack of Efficacy|0|||
161807728|NCT01079988|584341202|FG003|Overall Study|Lack of Efficacy|0|||
161807729|NCT01079988|584341203|FG004|Overall Study|Lack of Efficacy|0|||
161807730|NCT01079988|584341199|FG000|Overall Study|Other|0|||
161807731|NCT01079988|584341200|FG001|Overall Study|Other|0|||
161807732|NCT01079988|584341201|FG002|Overall Study|Other|0|||
161807733|NCT01079988|584341202|FG003|Overall Study|Other|2|||
161807734|NCT01079988|584341203|FG004|Overall Study|Other|1|||
161807735|NCT01265056|584341204|FG000|Initial Study Period|Withdrawal by Subject|1|||
161807736|NCT01265056|584341205|FG001|Initial Study Period|Withdrawal by Subject|1|||
161807737|NCT01265056|584341204|FG000|Initial Study Period|Withdrawal by Subject|1|||
161807738|NCT01265056|584341205|FG001|Initial Study Period|Withdrawal by Subject|1|||
161807739|NCT01265056|584341204|FG000|Follow up|Lost to Follow-up|7|||
161807740|NCT01265056|584341205|FG001|Follow up|Lost to Follow-up|3|||
161807741|NCT02711852|584341210|FG000|Overall Study|Death|5|||
161807742|NCT02711852|584341210|FG000|Overall Study|Lost to Follow-up|1|||
161807743|NCT02711852|584341210|FG000|Overall Study|Completed follow-up|3|||
161807744|NCT02711852|584341210|FG000|Overall Study|Withdrawal by Subject|1|||
161807745|NCT01417078|584341214|FG000|Overall Study|Withdrawal by Subject|1|||
161807746|NCT01059903|584341215|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
161807747|NCT01059903|584341216|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
161911468|NCT01149655|584727220|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
161911469|NCT01149655|584727221|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
161911470|NCT01149655|584727218|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
161911471|NCT01149655|584727219|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
161911472|NCT01149655|584727220|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
161911473|NCT01149655|584727221|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
161911474|NCT01149655|584727218|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
161911475|NCT01149655|584727219|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
162141988|NCT02137850|585568717|FG001|Extension Phase: Prophylaxis|Other|1|||
161911476|NCT01149655|584727220|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
161911477|NCT01149655|584727221|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
161911478|NCT01149655|584727218|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
161911479|NCT01149655|584727219|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
161911480|NCT01149655|584727220|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
161911481|NCT01149655|584727221|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
161911482|NCT01149655|584727218|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
161807748|NCT00858845|584341217|FG000|Overall Study|Patient underwent heart transplant.|0|||
161807749|NCT00858845|584341218|FG001|Overall Study|Patient underwent heart transplant.|1|||
161807750|NCT03031847|584341219|FG000|Overall Study|Death|1|||
161807751|NCT03031847|584341220|FG001|Overall Study|Death|1|||
161807752|NCT03031847|584341221|FG002|Overall Study|Death|2|||
161807753|NCT03031847|584341222|FG003|Overall Study|Death|3|||
161807754|NCT03031847|584341219|FG000|Overall Study|Lost to Follow-up|1|||
161807755|NCT03031847|584341220|FG001|Overall Study|Lost to Follow-up|1|||
161807756|NCT03031847|584341221|FG002|Overall Study|Lost to Follow-up|2|||
161807757|NCT03031847|584341222|FG003|Overall Study|Lost to Follow-up|3|||
161911483|NCT01149655|584727219|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
162011083|NCT03847896|585097727|FG001|Overall Study|A severe exacerbation event|0|||
162141989|NCT02137850|585568718|FG002|Extension Phase: Prophylaxis|Other|0|||
162141990|NCT02137850|585568716|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
162141991|NCT02137850|585568717|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
162141992|NCT02137850|585568718|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
162141993|NCT02912260|585568719|FG000|Main Study|Lost to Follow-up|5|||
162141994|NCT02912260|585568720|FG001|Main Study|Lost to Follow-up|4|||
162141995|NCT02912260|585568719|FG000|Main Study|Withdrawal by Subject|2|||
162141996|NCT02912260|585568720|FG001|Main Study|Withdrawal by Subject|2|||
162141997|NCT02912260|585568719|FG000|Main Study|Adverse Event|3|||
162141998|NCT02912260|585568720|FG001|Main Study|Adverse Event|0|||
162141999|NCT02912260|585568719|FG000|Main Study|Physician Decision|0|||
162142000|NCT02912260|585568720|FG001|Main Study|Physician Decision|1|||
162142001|NCT02912260|585568719|FG000|Extension Study|Withdrawal by Subject|1|||
162142002|NCT02912260|585568720|FG001|Extension Study|Withdrawal by Subject|1|||
162142003|NCT03563053|585568722|FG000|Overall Study|Withdrawal by Subject|17|||
162142004|NCT03563053|585568722|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
162142005|NCT03563053|585568722|FG000|Overall Study|Adverse Event|3|||
162142006|NCT03563053|585568722|FG000|Overall Study|Physician Decision|1|||
162142007|NCT03563053|585568722|FG000|Overall Study|study terminated by sponsor|71|||
162142008|NCT01137292|585568723|FG000|Overall Study|Death|30|||
162142009|NCT01137292|585568723|FG000|Overall Study|Adverse Event|3|||
162142010|NCT01137292|585568723|FG000|Overall Study|Lack of Efficacy|13|||
162142011|NCT01137292|585568723|FG000|Overall Study|Lost to Follow-up|1|||
162142012|NCT01137292|585568723|FG000|Overall Study|Other|7|||
162142013|NCT01311713|585568726|FG000|Overall Study|Death|0|||
162142014|NCT01311713|585568727|FG001|Overall Study|Death|0|||
162142015|NCT01311713|585568728|FG002|Overall Study|Death|1|||
162142016|NCT01311713|585568729|FG003|Overall Study|Death|1|||
162142017|NCT01311713|585568730|FG004|Overall Study|Death|0|||
162142018|NCT01311713|585568731|FG005|Overall Study|Death|1|||
162142019|NCT01311713|585568732|FG006|Overall Study|Death|0|||
161807758|NCT02100228|584341225|FG000|Overall Study|Other|19|||
161807759|NCT02100228|584341226|FG001|Overall Study|Other|19|||
161807760|NCT02100228|584341225|FG000|Overall Study|Administrative reason|0|||
161807761|NCT02100228|584341226|FG001|Overall Study|Administrative reason|1|||
162142020|NCT01311713|585568726|FG000|Overall Study|Adverse Event|0|||
162142021|NCT01311713|585568727|FG001|Overall Study|Adverse Event|1|||
162142022|NCT01311713|585568728|FG002|Overall Study|Adverse Event|0|||
161911484|NCT01149655|584727220|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
161911485|NCT01149655|584727221|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
161911486|NCT03092752|584727222|FG000|Overall Study|Aged <40 years|14209|||
161911487|NCT03092752|584727222|FG000|Overall Study|At least one claim with T2DM|61299|||
161911488|NCT03092752|584727222|FG000|Overall Study|Having no claim of study drugs|29282|||
161911489|NCT03092752|584727222|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
161911490|NCT03092752|584727222|FG000|Overall Study|<6 month history|245900|||
161911491|NCT03882918|584727224|FG000|Overall Study|Study terminated by sponsor|98|||
161911492|NCT03882918|584727224|FG000|Overall Study|Protocol Violation|1|||
161911493|NCT03882918|584727224|FG000|Overall Study|Other|9|||
161911494|NCT03882918|584727224|FG000|Overall Study|Lack of Efficacy|14|||
161911495|NCT03882918|584727224|FG000|Overall Study|Adverse Event|13|||
161911496|NCT03882918|584727224|FG000|Overall Study|Withdrawal by Subject|5|||
161911497|NCT06996301|584727225|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
161911498|NCT06996301|584727226|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
161911499|NCT06996301|584727225|FG000|Overall Study|Patients with discordant diagnostic results|107|||
161911500|NCT06996301|584727226|FG001|Overall Study|Patients with discordant diagnostic results|90|||
161911501|NCT06996301|584727225|FG000|Overall Study|Lost to Follow-up|31|||
161911502|NCT06996301|584727226|FG001|Overall Study|Lost to Follow-up|56|||
161911503|NCT06996301|584727225|FG000|Overall Study|Withdrawal by Subject|12|||
162011084|NCT03847896|585097728|FG002|Overall Study|A severe exacerbation event|0|||
161911504|NCT06996301|584727226|FG001|Overall Study|Withdrawal by Subject|7|||
161911505|NCT04030598|584727227|FG000|Overall Study|Voluntary Withdrawal|0|||
161911506|NCT04030598|584727228|FG001|Overall Study|Voluntary Withdrawal|1|||
161911507|NCT04030598|584727229|FG002|Overall Study|Voluntary Withdrawal|0|||
162011085|NCT03847896|585097729|FG003|Overall Study|A severe exacerbation event|0|||
162011086|NCT03847896|585097730|FG004|Overall Study|A severe exacerbation event|3|||
162011087|NCT03847896|585097726|FG000|Overall Study|Protocol Violation|0|||
162011088|NCT03847896|585097727|FG001|Overall Study|Protocol Violation|2|||
162011089|NCT03847896|585097728|FG002|Overall Study|Protocol Violation|1|||
162011090|NCT03847896|585097729|FG003|Overall Study|Protocol Violation|0|||
162011091|NCT03847896|585097730|FG004|Overall Study|Protocol Violation|2|||
162011092|NCT03847896|585097726|FG000|Overall Study|Lost to Follow-up|0|||
162011093|NCT03847896|585097727|FG001|Overall Study|Lost to Follow-up|0|||
162011094|NCT03847896|585097728|FG002|Overall Study|Lost to Follow-up|0|||
162011095|NCT03847896|585097729|FG003|Overall Study|Lost to Follow-up|1|||
162142023|NCT01311713|585568729|FG003|Overall Study|Adverse Event|2|||
162142024|NCT01311713|585568730|FG004|Overall Study|Adverse Event|0|||
162142025|NCT01311713|585568731|FG005|Overall Study|Adverse Event|0|||
162142026|NCT01311713|585568732|FG006|Overall Study|Adverse Event|2|||
162142027|NCT01311713|585568726|FG000|Overall Study|Withdrawal by Subject|0|||
162142028|NCT01311713|585568727|FG001|Overall Study|Withdrawal by Subject|1|||
162142029|NCT01311713|585568728|FG002|Overall Study|Withdrawal by Subject|1|||
162142030|NCT01311713|585568729|FG003|Overall Study|Withdrawal by Subject|0|||
162142031|NCT01311713|585568730|FG004|Overall Study|Withdrawal by Subject|0|||
162142032|NCT01311713|585568731|FG005|Overall Study|Withdrawal by Subject|1|||
162142033|NCT01311713|585568732|FG006|Overall Study|Withdrawal by Subject|2|||
162142034|NCT01311713|585568726|FG000|Overall Study|Disease progression|3|||
162142035|NCT01311713|585568727|FG001|Overall Study|Disease progression|4|||
162142036|NCT01311713|585568728|FG002|Overall Study|Disease progression|3|||
162142037|NCT01311713|585568729|FG003|Overall Study|Disease progression|2|||
162142038|NCT01311713|585568730|FG004|Overall Study|Disease progression|4|||
162142039|NCT01311713|585568731|FG005|Overall Study|Disease progression|4|||
161807762|NCT02100228|584341225|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
161807763|NCT02100228|584341226|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
161807764|NCT02100228|584341225|FG000|Overall Study|Non-compliance|0|||
161807765|NCT02100228|584341226|FG001|Overall Study|Non-compliance|3|||
161807766|NCT02100228|584341225|FG000|Overall Study|Lost to Follow-up|0|||
161807767|NCT02100228|584341226|FG001|Overall Study|Lost to Follow-up|1|||
161807768|NCT02100228|584341225|FG000|Overall Study|Withdrawal by Subject|27|||
161807769|NCT02100228|584341226|FG001|Overall Study|Withdrawal by Subject|37|||
161807770|NCT02100228|584341225|FG000|Overall Study|Adverse Event|16|||
161807771|NCT02100228|584341226|FG001|Overall Study|Adverse Event|12|||
161807772|NCT02100228|584341225|FG000|Overall Study|Death|1|||
161911508|NCT01419535|584727230|FG000|Overall Study|could not maintain iv line|1|||
162142040|NCT01311713|585568732|FG006|Overall Study|Disease progression|5|||
161807773|NCT02100228|584341226|FG001|Overall Study|Death|1|||
161911509|NCT01419535|584727231|FG001|Overall Study|could not maintain iv line|1|||
161911510|NCT01419535|584727230|FG000|Overall Study|Withdrawal by Subject|0|||
161911511|NCT01419535|584727231|FG001|Overall Study|Withdrawal by Subject|1|||
161911512|NCT03675308|584728604|FG000|Overall Study|Adverse Event|3|||
161911513|NCT03675308|584728605|FG001|Overall Study|Adverse Event|2|||
161911514|NCT03675308|584728604|FG000|Overall Study|Withdrawal by Subject|6|||
161911515|NCT03675308|584728605|FG001|Overall Study|Withdrawal by Subject|4|||
161911516|NCT03675308|584728604|FG000|Overall Study|Lost to Follow-up|3|||
161911517|NCT03675308|584728605|FG001|Overall Study|Lost to Follow-up|0|||
161911518|NCT03675308|584728604|FG000|Overall Study|Lack of Efficacy|1|||
161911519|NCT03675308|584728605|FG001|Overall Study|Lack of Efficacy|1|||
161911520|NCT03675308|584728604|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
161911521|NCT03675308|584728605|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
161911522|NCT03675308|584728604|FG000|Overall Study|Other|0|||
161911523|NCT03675308|584728605|FG001|Overall Study|Other|1|||
161911524|NCT05722522|584728606|FG000|Overall Study|Adverse Event|0|||
161911525|NCT05722522|584728607|FG001|Overall Study|Adverse Event|1|||
161911526|NCT06125964|584728610|FG000|Overall Study|Lost to Follow-up|0|||
161911527|NCT06125964|584728611|FG001|Overall Study|Lost to Follow-up|1|||
161911528|NCT06125964|584728612|FG002|Overall Study|Lost to Follow-up|0|||
161911529|NCT06125964|584728613|FG003|Overall Study|Lost to Follow-up|0|||
161911530|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
161911531|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
161911532|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
161911533|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Death|1|||
161911534|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Death|1|||
161911535|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Death|0|||
161911536|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
161911537|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
161911538|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
161911539|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
161911540|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
161911541|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
161911542|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
162011096|NCT03847896|585097730|FG004|Overall Study|Lost to Follow-up|0|||
161911543|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
161911544|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
161911545|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
161911546|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
161911547|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
161911548|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
161911549|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
161911550|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
162142041|NCT01311713|585568726|FG000|Overall Study|Lost to Follow-up|0|||
162142042|NCT01311713|585568727|FG001|Overall Study|Lost to Follow-up|0|||
162142043|NCT01311713|585568728|FG002|Overall Study|Lost to Follow-up|1|||
162142044|NCT01311713|585568729|FG003|Overall Study|Lost to Follow-up|0|||
162142045|NCT01311713|585568730|FG004|Overall Study|Lost to Follow-up|0|||
162142046|NCT01311713|585568731|FG005|Overall Study|Lost to Follow-up|0|||
162142047|NCT01311713|585568732|FG006|Overall Study|Lost to Follow-up|0|||
162142048|NCT01311713|585568726|FG000|Overall Study|Stopped taking study medication|0|||
162142049|NCT01311713|585568727|FG001|Overall Study|Stopped taking study medication|0|||
162142050|NCT01311713|585568728|FG002|Overall Study|Stopped taking study medication|0|||
162142051|NCT01311713|585568729|FG003|Overall Study|Stopped taking study medication|1|||
162142052|NCT01311713|585568730|FG004|Overall Study|Stopped taking study medication|1|||
162142053|NCT01311713|585568731|FG005|Overall Study|Stopped taking study medication|0|||
162142054|NCT01311713|585568732|FG006|Overall Study|Stopped taking study medication|0|||
162142055|NCT01311713|585568726|FG000|Overall Study|Enrolled but not treated|0|||
162142056|NCT01311713|585568727|FG001|Overall Study|Enrolled but not treated|0|||
162142057|NCT01311713|585568728|FG002|Overall Study|Enrolled but not treated|1|||
162142058|NCT01311713|585568729|FG003|Overall Study|Enrolled but not treated|0|||
162142059|NCT01311713|585568730|FG004|Overall Study|Enrolled but not treated|0|||
162142060|NCT01311713|585568731|FG005|Overall Study|Enrolled but not treated|0|||
162142061|NCT01311713|585568732|FG006|Overall Study|Enrolled but not treated|0|||
162142062|NCT01311713|585568726|FG000|Overall Study|Other than specified|0|||
162142063|NCT01311713|585568727|FG001|Overall Study|Other than specified|1|||
162142064|NCT01311713|585568728|FG002|Overall Study|Other than specified|2|||
162142065|NCT01311713|585568729|FG003|Overall Study|Other than specified|0|||
162142066|NCT01311713|585568730|FG004|Overall Study|Other than specified|0|||
162142067|NCT01311713|585568731|FG005|Overall Study|Other than specified|0|||
162142068|NCT01311713|585568732|FG006|Overall Study|Other than specified|0|||
162142069|NCT03878446|585568733|FG000|Overall Study|Withdrawn by parent or guardian|1|||
162142070|NCT03878446|585568734|FG001|Overall Study|Withdrawn by parent or guardian|0|||
162142071|NCT03878446|585568735|FG002|Overall Study|Withdrawn by parent or guardian|0|||
162142072|NCT03878446|585568736|FG003|Overall Study|Withdrawn by parent or guardian|0|||
162142073|NCT03878446|585568737|FG004|Overall Study|Withdrawn by parent or guardian|0|||
162142074|NCT02501811|585568738|FG000|Overall Study|Death|1|||
162142075|NCT02501811|585568739|FG001|Overall Study|Death|3|||
162142076|NCT02501811|585568740|FG002|Overall Study|Death|2|||
162142077|NCT02501811|585568741|FG003|Overall Study|Death|3|||
162142078|NCT02501811|585568738|FG000|Overall Study|Withdrawal by Subject|3|||
162142079|NCT02501811|585568739|FG001|Overall Study|Withdrawal by Subject|3|||
162142080|NCT02501811|585568740|FG002|Overall Study|Withdrawal by Subject|2|||
161911551|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
161911552|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
161911553|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
161911554|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
162142081|NCT02501811|585568741|FG003|Overall Study|Withdrawal by Subject|3|||
162142082|NCT02501811|585568738|FG000|Overall Study|Lost to Follow-up|0|||
162142083|NCT02501811|585568739|FG001|Overall Study|Lost to Follow-up|0|||
162142084|NCT02501811|585568740|FG002|Overall Study|Lost to Follow-up|2|||
162142085|NCT02501811|585568741|FG003|Overall Study|Lost to Follow-up|1|||
162142086|NCT04804605|585570288|FG000|Overall Study|Withdrawal by Subject|46|||
162142087|NCT04804605|585570289|FG001|Overall Study|Withdrawal by Subject|26|||
162142088|NCT04804605|585570290|FG002|Overall Study|Withdrawal by Subject|37|||
162142089|NCT04804605|585570291|FG003|Overall Study|Withdrawal by Subject|21|||
162142090|NCT04804605|585570288|FG000|Overall Study|Lost to Follow-up|47|||
162142091|NCT04804605|585570289|FG001|Overall Study|Lost to Follow-up|21|||
162142092|NCT04804605|585570290|FG002|Overall Study|Lost to Follow-up|30|||
162142093|NCT04804605|585570291|FG003|Overall Study|Lost to Follow-up|17|||
162142094|NCT04804605|585570288|FG000|Overall Study|Lack of Efficacy|28|||
162142095|NCT04804605|585570289|FG001|Overall Study|Lack of Efficacy|11|||
162142096|NCT04804605|585570290|FG002|Overall Study|Lack of Efficacy|37|||
162142097|NCT04804605|585570291|FG003|Overall Study|Lack of Efficacy|8|||
162142098|NCT04804605|585570288|FG000|Overall Study|Adverse Event|10|||
162142099|NCT04804605|585570289|FG001|Overall Study|Adverse Event|10|||
162142100|NCT04804605|585570290|FG002|Overall Study|Adverse Event|10|||
162142101|NCT04804605|585570291|FG003|Overall Study|Adverse Event|7|||
162142102|NCT04804605|585570288|FG000|Overall Study|Non-compliance|8|||
162142103|NCT04804605|585570289|FG001|Overall Study|Non-compliance|3|||
162142104|NCT04804605|585570290|FG002|Overall Study|Non-compliance|5|||
162142105|NCT04804605|585570291|FG003|Overall Study|Non-compliance|1|||
162142106|NCT04804605|585570288|FG000|Overall Study|Physician Decision|3|||
162142107|NCT04804605|585570289|FG001|Overall Study|Physician Decision|0|||
162142108|NCT04804605|585570290|FG002|Overall Study|Physician Decision|5|||
162142109|NCT04804605|585570291|FG003|Overall Study|Physician Decision|0|||
162142110|NCT04804605|585570288|FG000|Overall Study|Protocol Violation|1|||
162142111|NCT04804605|585570289|FG001|Overall Study|Protocol Violation|0|||
162142112|NCT04804605|585570290|FG002|Overall Study|Protocol Violation|0|||
162142113|NCT04804605|585570291|FG003|Overall Study|Protocol Violation|1|||
162142114|NCT04804605|585570288|FG000|Overall Study|Miscellaneous|7|||
162142115|NCT04804605|585570289|FG001|Overall Study|Miscellaneous|3|||
162142116|NCT04804605|585570290|FG002|Overall Study|Miscellaneous|4|||
162142117|NCT04804605|585570291|FG003|Overall Study|Miscellaneous|2|||
162142118|NCT00567879|585570294|FG000|Overall Study|Adverse Event|2|||
162142119|NCT00567879|585570295|FG001|Overall Study|Adverse Event|0|||
162142120|NCT00567879|585570296|FG002|Overall Study|Adverse Event|1|||
162142121|NCT00567879|585570297|FG003|Overall Study|Adverse Event|0|||
162142122|NCT00567879|585570298|FG004|Overall Study|Adverse Event|1|||
162142123|NCT00567879|585570299|FG005|Overall Study|Adverse Event|0|||
161807774|NCT00214422|584341227|FG000|Overall Study|Physician Decision|2|||
161807775|NCT00214422|584341228|FG001|Overall Study|Physician Decision|0|||
161807776|NCT00214422|584341229|FG002|Overall Study|Physician Decision|0|||
161807777|NCT00214422|584341227|FG000|Overall Study|Developed esophageal ca|1|||
161807778|NCT00214422|584341228|FG001|Overall Study|Developed esophageal ca|0|||
161807779|NCT00214422|584341229|FG002|Overall Study|Developed esophageal ca|0|||
161807780|NCT00214422|584341227|FG000|Overall Study|Pt taken off study|1|||
161807781|NCT00214422|584341228|FG001|Overall Study|Pt taken off study|1|||
161807782|NCT00214422|584341229|FG002|Overall Study|Pt taken off study|0|||
161807783|NCT00214422|584341227|FG000|Overall Study|Disease progression on study|1|||
161807784|NCT00214422|584341228|FG001|Overall Study|Disease progression on study|0|||
161807785|NCT00214422|584341229|FG002|Overall Study|Disease progression on study|0|||
161807786|NCT00214422|584341227|FG000|Overall Study|Unable to make a radiation treatment|0|||
161807787|NCT00214422|584341228|FG001|Overall Study|Unable to make a radiation treatment|0|||
161807788|NCT00214422|584341229|FG002|Overall Study|Unable to make a radiation treatment|1|||
161807789|NCT02612337|584341230|FG000|Overall Study|Lack of Efficacy|1|||
161807790|NCT02612337|584341231|FG001|Overall Study|Lack of Efficacy|0|||
161807791|NCT02612337|584341230|FG000|Overall Study|Withdrawal by Subject|2|||
161807792|NCT02612337|584341231|FG001|Overall Study|Withdrawal by Subject|2|||
161807793|NCT02612337|584341230|FG000|Overall Study|Did not receive study drug|0|||
161807794|NCT02612337|584341231|FG001|Overall Study|Did not receive study drug|1|||
161807795|NCT00854100|584341238|FG000|Overall Study|Inability to complete the study visits|0|||
161807796|NCT00854100|584341239|FG001|Overall Study|Inability to complete the study visits|0|||
162142124|NCT00567879|585570294|FG000|Overall Study|Abnormal test procedure(s)|0|||
162142125|NCT00567879|585570295|FG001|Overall Study|Abnormal test procedure(s)|0|||
162142126|NCT00567879|585570296|FG002|Overall Study|Abnormal test procedure(s)|1|||
162142127|NCT00567879|585570297|FG003|Overall Study|Abnormal test procedure(s)|0|||
162142128|NCT00567879|585570298|FG004|Overall Study|Abnormal test procedure(s)|0|||
162142129|NCT00567879|585570299|FG005|Overall Study|Abnormal test procedure(s)|0|||
162142130|NCT00567879|585570294|FG000|Overall Study|Withdrawal by Subject|0|||
162142131|NCT00567879|585570295|FG001|Overall Study|Withdrawal by Subject|0|||
162142132|NCT00567879|585570296|FG002|Overall Study|Withdrawal by Subject|3|||
162142133|NCT00567879|585570297|FG003|Overall Study|Withdrawal by Subject|1|||
162142134|NCT00567879|585570298|FG004|Overall Study|Withdrawal by Subject|0|||
162142135|NCT00567879|585570299|FG005|Overall Study|Withdrawal by Subject|0|||
162142136|NCT00567879|585570294|FG000|Overall Study|New cancer therapy|0|||
162142137|NCT00567879|585570295|FG001|Overall Study|New cancer therapy|0|||
162142138|NCT00567879|585570296|FG002|Overall Study|New cancer therapy|1|||
162142139|NCT00567879|585570297|FG003|Overall Study|New cancer therapy|0|||
162142140|NCT00567879|585570298|FG004|Overall Study|New cancer therapy|0|||
162142141|NCT00567879|585570299|FG005|Overall Study|New cancer therapy|0|||
162142142|NCT00567879|585570294|FG000|Overall Study|Disease progression|5|||
162142143|NCT00567879|585570295|FG001|Overall Study|Disease progression|7|||
162142144|NCT00567879|585570296|FG002|Overall Study|Disease progression|15|||
162142145|NCT00567879|585570297|FG003|Overall Study|Disease progression|5|||
162142146|NCT00567879|585570298|FG004|Overall Study|Disease progression|11|||
162142147|NCT00567879|585570299|FG005|Overall Study|Disease progression|3|||
162142148|NCT00151996|585570302|FG000|Overall Study|Adverse Event|3|||
162142149|NCT00151996|585570303|FG001|Overall Study|Adverse Event|2|||
162142150|NCT00151996|585570302|FG000|Overall Study|Withdrawal by Subject|1|||
162142151|NCT00151996|585570303|FG001|Overall Study|Withdrawal by Subject|1|||
162142152|NCT00151996|585570302|FG000|Overall Study|Protocol Violation|1|||
162142153|NCT00151996|585570303|FG001|Overall Study|Protocol Violation|2|||
162142154|NCT00151996|585570302|FG000|Overall Study|Sponsor's decision|0|||
162142155|NCT00151996|585570303|FG001|Overall Study|Sponsor's decision|2|||
162142156|NCT01546155|585570304|FG000|Overall Study|could not tolerate long scan duration|3|||
162142157|NCT02930343|585570305|FG000|Overall Study|Lost to Follow-up|9|||
162142158|NCT02930343|585570306|FG001|Overall Study|Lost to Follow-up|7|||
162142159|NCT00420316|585570312|FG000|Overall Study|Withdrawal by Subject|0|||
162142160|NCT00420316|585570313|FG001|Overall Study|Withdrawal by Subject|1|||
162142161|NCT00420316|585570312|FG000|Overall Study|Lost to Follow-up|12|||
162142162|NCT00420316|585570313|FG001|Overall Study|Lost to Follow-up|8|||
162142163|NCT03546907|585570314|FG000|Overall Study|Lack of Efficacy|1|||
162142164|NCT03546907|585570315|FG001|Overall Study|Lack of Efficacy|1|||
162142165|NCT03546907|585570314|FG000|Overall Study|Withdrawal by Subject|8|||
162142166|NCT03546907|585570315|FG001|Overall Study|Withdrawal by Subject|9|||
162142167|NCT03546907|585570314|FG000|Overall Study|Adverse events (AEs)|7|||
162142168|NCT03546907|585570315|FG001|Overall Study|Adverse events (AEs)|10|||
162142169|NCT03546907|585570314|FG000|Overall Study|Other-unspecified|1|||
162142170|NCT03546907|585570315|FG001|Overall Study|Other-unspecified|1|||
162142171|NCT03720210|585570316|FG000|Overall Study|Lost to Follow-up|1|||
162142172|NCT04033432|585570317|FG000|Overall Study|Progressive Disease|8|||
162142173|NCT04033432|585570317|FG000|Overall Study|Adverse Event|4|||
162142174|NCT04033432|585570317|FG000|Overall Study|Death|1|||
162142175|NCT02274493|585570323|FG000|Overall Study|Withdrawal by Subject|1|||
162142176|NCT04936035|585570328|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162142177|NCT04936035|585570329|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
162142178|NCT04936035|585570330|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162142179|NCT04936035|585570331|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162142180|NCT04936035|585570332|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162142181|NCT04936035|585570333|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162142182|NCT04936035|585570334|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162142183|NCT04936035|585570335|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162142184|NCT04936035|585570336|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162142185|NCT04936035|585570337|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162142186|NCT04936035|585570338|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162142187|NCT04936035|585570339|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162142188|NCT04936035|585570340|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
162142189|NCT04936035|585570328|FG000|6-Month Placebo-controlled DB Period|Death|0|||
162142190|NCT04936035|585570329|FG001|6-Month Placebo-controlled DB Period|Death|0|||
162142191|NCT04936035|585570330|FG002|6-Month Placebo-controlled DB Period|Death|0|||
161911555|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
162142192|NCT04936035|585570331|FG003|6-Month Placebo-controlled DB Period|Death|1|||
162142193|NCT04936035|585570332|FG004|6-Month Placebo-controlled DB Period|Death|0|||
162142194|NCT04936035|585570333|FG005|6-Month Placebo-controlled DB Period|Death|0|||
162142195|NCT04936035|585570334|FG006|6-Month Placebo-controlled DB Period|Death|0|||
162142196|NCT04936035|585570335|FG007|6-Month Placebo-controlled DB Period|Death|0|||
162142197|NCT04936035|585570336|FG008|6-Month Placebo-controlled DB Period|Death|0|||
162142198|NCT04936035|585570337|FG009|6-Month Placebo-controlled DB Period|Death|0|||
162142199|NCT04936035|585570338|FG010|6-Month Placebo-controlled DB Period|Death|0|||
162142200|NCT04936035|585570339|FG011|6-Month Placebo-controlled DB Period|Death|0|||
162142201|NCT04936035|585570340|FG012|6-Month Placebo-controlled DB Period|Death|0|||
161911556|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
161911557|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
161911558|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
161911559|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
161911560|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Other|10|||
161911561|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Other|4|||
161911562|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Other|0|||
161911563|NCT04006457|584728614|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
162142202|NCT04936035|585570328|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162142203|NCT04936035|585570329|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
162142204|NCT04936035|585570330|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
162142205|NCT04936035|585570331|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
162142206|NCT04936035|585570332|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
162142207|NCT04936035|585570333|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162142208|NCT04936035|585570334|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162142209|NCT04936035|585570335|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162142210|NCT04936035|585570336|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162142211|NCT04936035|585570337|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162142212|NCT04936035|585570338|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162142213|NCT04936035|585570339|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162142214|NCT04936035|585570340|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
162142215|NCT04936035|585570328|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162142216|NCT04936035|585570329|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
162142217|NCT04936035|585570330|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162142218|NCT04936035|585570331|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162142219|NCT04936035|585570332|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162142220|NCT04936035|585570333|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162142221|NCT04936035|585570334|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162142222|NCT04936035|585570335|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162142223|NCT04936035|585570336|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162142224|NCT04936035|585570337|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162142225|NCT04936035|585570338|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162142226|NCT04936035|585570339|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162142227|NCT04936035|585570340|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
162142228|NCT04936035|585570328|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162142229|NCT04936035|585570329|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162142230|NCT04936035|585570330|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
162142231|NCT04936035|585570331|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162142232|NCT04936035|585570332|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162142233|NCT04936035|585570333|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162142234|NCT04936035|585570334|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162142235|NCT04936035|585570335|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162142236|NCT04936035|585570336|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162142237|NCT04936035|585570337|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162142238|NCT04936035|585570338|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162142239|NCT04936035|585570339|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162142240|NCT04936035|585570340|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
162142241|NCT04936035|585570328|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
162142242|NCT04936035|585570329|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
162142243|NCT04936035|585570330|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
162142244|NCT04936035|585570331|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
162142245|NCT04936035|585570332|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
162142246|NCT04936035|585570333|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162142247|NCT04936035|585570334|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162142248|NCT04936035|585570335|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162142249|NCT04936035|585570336|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162142250|NCT04936035|585570337|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162142251|NCT04936035|585570338|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162142252|NCT04936035|585570339|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162142253|NCT04936035|585570340|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
162142254|NCT04936035|585570328|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162142255|NCT04936035|585570329|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162142256|NCT04936035|585570330|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162142257|NCT04936035|585570331|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162142258|NCT04936035|585570332|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
162142259|NCT04936035|585570333|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162142260|NCT04936035|585570334|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161911564|NCT04006457|584728615|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
162142261|NCT04936035|585570335|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162142262|NCT04936035|585570336|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162142263|NCT04936035|585570337|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162142264|NCT04936035|585570338|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162142265|NCT04936035|585570339|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162142266|NCT04936035|585570340|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
162142267|NCT04936035|585570328|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
162142268|NCT04936035|585570329|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162142269|NCT04936035|585570330|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162142270|NCT04936035|585570331|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162142271|NCT04936035|585570332|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162142272|NCT04936035|585570333|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162142273|NCT04936035|585570334|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162142274|NCT04936035|585570335|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162142275|NCT04936035|585570336|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162142276|NCT04936035|585570337|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162142277|NCT04936035|585570338|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162142278|NCT04936035|585570339|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162142279|NCT04936035|585570340|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
162142280|NCT04936035|585570328|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162142281|NCT04936035|585570329|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162142282|NCT04936035|585570330|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162142283|NCT04936035|585570331|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162142284|NCT04936035|585570332|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162142285|NCT04936035|585570333|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
162142286|NCT04936035|585570334|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
162142287|NCT04936035|585570335|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162142288|NCT04936035|585570336|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
162142289|NCT04936035|585570337|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
162142290|NCT04936035|585570338|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
162142291|NCT04936035|585570339|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
162142292|NCT04936035|585570340|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
161807797|NCT00854100|584341240|FG002|Overall Study|Inability to complete the study visits|1|||
161807798|NCT00854100|584341238|FG000|Overall Study|Lost to Follow-up|2|||
161807799|NCT00854100|584341239|FG001|Overall Study|Lost to Follow-up|0|||
161807800|NCT00854100|584341240|FG002|Overall Study|Lost to Follow-up|3|||
161807801|NCT00854100|584341238|FG000|Overall Study|Withdrawal by Subject|3|||
161807802|NCT00854100|584341239|FG001|Overall Study|Withdrawal by Subject|1|||
161807803|NCT00854100|584341240|FG002|Overall Study|Withdrawal by Subject|2|||
161807804|NCT00854100|584341238|FG000|Overall Study|Protocol Violation|2|||
161807805|NCT00854100|584341239|FG001|Overall Study|Protocol Violation|4|||
161807806|NCT00854100|584341240|FG002|Overall Study|Protocol Violation|3|||
161807807|NCT00854100|584341238|FG000|Overall Study|Adverse Event|2|||
161807808|NCT00854100|584341239|FG001|Overall Study|Adverse Event|1|||
161807809|NCT00854100|584341240|FG002|Overall Study|Adverse Event|2|||
161807810|NCT02242201|584341244|FG000|Overall Study|preoperative identified neuropathy|2|||
161807811|NCT02242201|584341245|FG001|Overall Study|preoperative identified neuropathy|0|||
161807812|NCT02242201|584341246|FG002|Overall Study|preoperative identified neuropathy|0|||
161807813|NCT02242201|584341244|FG000|Overall Study|planned post-op anticoagulation|1|||
161911565|NCT04006457|584728616|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
161911566|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
161807814|NCT02242201|584341245|FG001|Overall Study|planned post-op anticoagulation|0|||
161807815|NCT02242201|584341246|FG002|Overall Study|planned post-op anticoagulation|0|||
161807816|NCT02242201|584341244|FG000|Overall Study|changed surgical procedure|1|||
161807817|NCT02242201|584341245|FG001|Overall Study|changed surgical procedure|0|||
161807818|NCT02242201|584341246|FG002|Overall Study|changed surgical procedure|0|||
161807819|NCT02242201|584341244|FG000|Overall Study|postponed surgery|0|||
161807820|NCT02242201|584341245|FG001|Overall Study|postponed surgery|0|||
161807821|NCT02242201|584341246|FG002|Overall Study|postponed surgery|1|||
161807822|NCT02242201|584341244|FG000|Overall Study|preoperative opioid consumption|0|||
161807823|NCT02242201|584341245|FG001|Overall Study|preoperative opioid consumption|1|||
161807824|NCT02242201|584341246|FG002|Overall Study|preoperative opioid consumption|0|||
161807825|NCT00389064|584341247|FG000|Overall Study|Adverse Event|11|||
161807826|NCT00389064|584341248|FG001|Overall Study|Adverse Event|3|||
161807827|NCT00389064|584341247|FG000|Overall Study|Lack of Efficacy|3|||
161807828|NCT00389064|584341248|FG001|Overall Study|Lack of Efficacy|14|||
161807829|NCT00389064|584341247|FG000|Overall Study|Withdrawal by Subject|17|||
161807830|NCT00389064|584341248|FG001|Overall Study|Withdrawal by Subject|27|||
161807831|NCT00389064|584341247|FG000|Overall Study|Physician Decision|2|||
161807832|NCT00389064|584341248|FG001|Overall Study|Physician Decision|2|||
161807833|NCT00389064|584341247|FG000|Overall Study|Lost to Follow-up|1|||
161807834|NCT00389064|584341248|FG001|Overall Study|Lost to Follow-up|2|||
161807835|NCT00389064|584341247|FG000|Overall Study|Protocol Violation|2|||
161807836|NCT00389064|584341248|FG001|Overall Study|Protocol Violation|0|||
161807837|NCT00389064|584341247|FG000|Overall Study|Multiple Reasons|9|||
161807838|NCT00389064|584341248|FG001|Overall Study|Multiple Reasons|11|||
161807839|NCT01697696|584341251|FG000|Overall Study|Study terminated by sponsor|0|||
161807840|NCT01697696|584341252|FG001|Overall Study|Study terminated by sponsor|3|||
161807841|NCT01697696|584341251|FG000|Overall Study|Protocol deviation|1|||
161807842|NCT01697696|584341252|FG001|Overall Study|Protocol deviation|0|||
161807843|NCT01697696|584341251|FG000|Overall Study|Physician Decision|1|||
161807844|NCT01697696|584341252|FG001|Overall Study|Physician Decision|0|||
161807845|NCT01697696|584341251|FG000|Overall Study|Death|4|||
161807846|NCT01697696|584341252|FG001|Overall Study|Death|2|||
161807847|NCT01697696|584341251|FG000|Overall Study|Lost to Follow-up|10|||
161807848|NCT01697696|584341252|FG001|Overall Study|Lost to Follow-up|7|||
161807849|NCT01697696|584341251|FG000|Overall Study|Subject/guardian decision|31|||
161807850|NCT01697696|584341252|FG001|Overall Study|Subject/guardian decision|35|||
161807851|NCT03616106|584341253|FG000|Overall Study|Removed by PI|6|||
161807852|NCT03616106|584341254|FG001|Overall Study|Removed by PI|0|||
161807853|NCT03616106|584341253|FG000|Overall Study|Withdrawal by Subject|1|||
161807854|NCT03616106|584341254|FG001|Overall Study|Withdrawal by Subject|1|||
161807855|NCT03616106|584341253|FG000|Overall Study|Lost to Follow-up|7|||
161807856|NCT03616106|584341254|FG001|Overall Study|Lost to Follow-up|0|||
161807857|NCT01880593|584341255|FG000|Overall Study|Adverse Event|1|||
161807858|NCT01880593|584341256|FG001|Overall Study|Adverse Event|0|||
161807859|NCT01880593|584341255|FG000|Overall Study|Lack of Efficacy|1|||
161807860|NCT01880593|584341256|FG001|Overall Study|Lack of Efficacy|5|||
161807861|NCT01880593|584341255|FG000|Overall Study|Withdrawal by Subject|6|||
161807862|NCT01880593|584341256|FG001|Overall Study|Withdrawal by Subject|1|||
161807863|NCT05275205|584341261|FG000|Overall Study|Adverse Event|1|||
161807864|NCT05275205|584341262|FG001|Overall Study|Adverse Event|2|||
161807865|NCT05275205|584341261|FG000|Overall Study|Physician Decision|1|||
161807866|NCT05275205|584341262|FG001|Overall Study|Physician Decision|1|||
161807867|NCT05275205|584341261|FG000|Overall Study|Withdrawal by Subject|2|||
161807868|NCT05275205|584341262|FG001|Overall Study|Withdrawal by Subject|3|||
161807869|NCT05275205|584341261|FG000|Overall Study|Death|1|||
161807870|NCT05275205|584341262|FG001|Overall Study|Death|0|||
161807871|NCT05275205|584341261|FG000|Overall Study|Patient unable to attend visits|1|||
161807872|NCT05275205|584341262|FG001|Overall Study|Patient unable to attend visits|0|||
161807873|NCT03243630|584341264|FG000|Overall Study|Protocol Violation|1|||
161807874|NCT03243630|584341264|FG000|Overall Study|Physician Decision|1|||
161807875|NCT00939003|584341265|FG000|Double-blind Treatment Period|Adverse Event|1|||
161807876|NCT00939003|584341266|FG001|Double-blind Treatment Period|Adverse Event|1|||
161807877|NCT00939003|584341265|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161807878|NCT00939003|584341266|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
161807879|NCT00939003|584341265|FG000|Double-blind Treatment Period|Pregnancy|0|||
161807880|NCT00939003|584341266|FG001|Double-blind Treatment Period|Pregnancy|1|||
162011097|NCT03847896|585097726|FG000|Overall Study|Condition under investigation worsened|0|||
162011098|NCT03847896|585097727|FG001|Overall Study|Condition under investigation worsened|0|||
161807881|NCT00939003|584341265|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
161807882|NCT00939003|584341266|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
161807883|NCT00939003|584341265|FG000|Open-label Treatment Period|Adverse Event|4|||
161807884|NCT00939003|584341266|FG001|Open-label Treatment Period|Adverse Event|8|||
161807885|NCT00939003|584341265|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
161807886|NCT00939003|584341266|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
161807887|NCT00939003|584341265|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
161807888|NCT00939003|584341266|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
161807889|NCT00939003|584341265|FG000|Open-label Treatment Period|Pregnancy|1|||
162142293|NCT04936035|585570328|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162142294|NCT04936035|585570329|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162142295|NCT04936035|585570330|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162142296|NCT04936035|585570331|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162142297|NCT04936035|585570332|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162142298|NCT04936035|585570333|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
162142299|NCT04936035|585570334|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
162142300|NCT04936035|585570335|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162142301|NCT04936035|585570336|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
162142302|NCT04936035|585570337|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
162142303|NCT04936035|585570338|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
162142304|NCT04936035|585570339|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
162142305|NCT04936035|585570340|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
162142306|NCT04936035|585570328|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
162142307|NCT04936035|585570329|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
162142308|NCT04936035|585570330|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
162142309|NCT04936035|585570331|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
162142310|NCT04936035|585570332|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
162142311|NCT04936035|585570333|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
162142312|NCT04936035|585570334|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
162142313|NCT04936035|585570335|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
162142314|NCT04936035|585570336|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
162142315|NCT04936035|585570337|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
162142316|NCT04936035|585570338|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
162142317|NCT04936035|585570339|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
162142318|NCT04936035|585570340|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
162142319|NCT04936035|585570328|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
162142320|NCT04936035|585570329|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
162142321|NCT04936035|585570330|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
162142322|NCT04936035|585570331|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
162142323|NCT04936035|585570332|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
162142324|NCT04936035|585570333|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
162142325|NCT04936035|585570334|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
162142326|NCT04936035|585570335|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
162142327|NCT04936035|585570336|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
162142328|NCT04936035|585570337|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
162142329|NCT04936035|585570338|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
162142330|NCT04936035|585570339|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
162142331|NCT04936035|585570340|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
162142332|NCT04936035|585570328|FG000|Post-6-Month DB Period (30months)|Death|0|||
162142333|NCT04936035|585570329|FG001|Post-6-Month DB Period (30months)|Death|0|||
162142334|NCT04936035|585570330|FG002|Post-6-Month DB Period (30months)|Death|0|||
162142335|NCT04936035|585570331|FG003|Post-6-Month DB Period (30months)|Death|0|||
162142336|NCT04936035|585570332|FG004|Post-6-Month DB Period (30months)|Death|0|||
162142337|NCT04936035|585570333|FG005|Post-6-Month DB Period (30months)|Death|0|||
162142338|NCT04936035|585570334|FG006|Post-6-Month DB Period (30months)|Death|0|||
161807890|NCT00939003|584341266|FG001|Open-label Treatment Period|Pregnancy|1|||
161807891|NCT00939003|584341265|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
161807892|NCT00939003|584341266|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
161807893|NCT00939003|584341265|FG000|Open-label Treatment Period|Site Closure|3|||
161807894|NCT00939003|584341266|FG001|Open-label Treatment Period|Site Closure|4|||
161807895|NCT02186821|584341268|FG000|Overall Study|Adverse Event|9|||
161807896|NCT02186821|584341268|FG000|Overall Study|Death|2|||
161807897|NCT02186821|584341268|FG000|Overall Study|Disease progression|32|||
161807898|NCT02186821|584341268|FG000|Overall Study|Protocol Violation|1|||
161807899|NCT02186821|584341268|FG000|Overall Study|Physician Decision|1|||
161807900|NCT02186821|584341268|FG000|Overall Study|Study terminated by sponsor|2|||
162142339|NCT04936035|585570335|FG007|Post-6-Month DB Period (30months)|Death|0|||
162142340|NCT04936035|585570336|FG008|Post-6-Month DB Period (30months)|Death|0|||
162142341|NCT04936035|585570337|FG009|Post-6-Month DB Period (30months)|Death|1|||
162142342|NCT04936035|585570338|FG010|Post-6-Month DB Period (30months)|Death|0|||
161911567|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
161911568|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
161911569|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
161911570|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
161911571|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
161911572|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
161911573|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
161911574|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
161911575|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
161911576|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
161911577|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
161911578|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
162142343|NCT04936035|585570339|FG011|Post-6-Month DB Period (30months)|Death|0|||
162142344|NCT04936035|585570340|FG012|Post-6-Month DB Period (30months)|Death|0|||
162142345|NCT04936035|585570328|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162142346|NCT04936035|585570329|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162142347|NCT04936035|585570330|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162142348|NCT04936035|585570331|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162142349|NCT04936035|585570332|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162142350|NCT04936035|585570333|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
162142351|NCT04936035|585570334|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162142352|NCT04936035|585570335|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162142353|NCT04936035|585570336|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162142354|NCT04936035|585570337|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
162142355|NCT04936035|585570338|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
162142356|NCT04936035|585570339|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162142357|NCT04936035|585570340|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
162142358|NCT05827926|585570343|FG000|Overall Study|Lost to Follow-up|1|||
162142359|NCT05827926|585570344|FG001|Overall Study|Lost to Follow-up|0|||
162142360|NCT05827926|585570345|FG002|Overall Study|Lost to Follow-up|0|||
162142361|NCT05827926|585570346|FG003|Overall Study|Lost to Follow-up|0|||
162142362|NCT05827926|585570347|FG004|Overall Study|Lost to Follow-up|0|||
162142363|NCT05827926|585570348|FG005|Overall Study|Lost to Follow-up|1|||
162142364|NCT05827926|585570349|FG006|Overall Study|Lost to Follow-up|0|||
162142365|NCT05827926|585570350|FG007|Overall Study|Lost to Follow-up|0|||
162142366|NCT05827926|585570351|FG008|Overall Study|Lost to Follow-up|0|||
162142367|NCT05827926|585570352|FG009|Overall Study|Lost to Follow-up|0|||
162142368|NCT05827926|585570353|FG010|Overall Study|Lost to Follow-up|0|||
162142369|NCT05827926|585570354|FG011|Overall Study|Lost to Follow-up|0|||
162142370|NCT05827926|585570355|FG012|Overall Study|Lost to Follow-up|1|||
162142371|NCT05827926|585570356|FG013|Overall Study|Lost to Follow-up|1|||
162142372|NCT05827926|585570357|FG014|Overall Study|Lost to Follow-up|0|||
162142373|NCT05827926|585570358|FG015|Overall Study|Lost to Follow-up|1|||
162142374|NCT05827926|585570359|FG016|Overall Study|Lost to Follow-up|2|||
162142375|NCT05827926|585570360|FG017|Overall Study|Lost to Follow-up|0|||
162142376|NCT05827926|585570361|FG018|Overall Study|Lost to Follow-up|0|||
162142377|NCT05827926|585570362|FG019|Overall Study|Lost to Follow-up|0|||
162142378|NCT05827926|585570363|FG020|Overall Study|Lost to Follow-up|1|||
162142379|NCT05827926|585570364|FG021|Overall Study|Lost to Follow-up|2|||
162142380|NCT05827926|585570365|FG022|Overall Study|Lost to Follow-up|1|||
162142381|NCT05827926|585570366|FG023|Overall Study|Lost to Follow-up|1|||
162142382|NCT05827926|585570367|FG024|Overall Study|Lost to Follow-up|2|||
162142383|NCT05827926|585570368|FG025|Overall Study|Lost to Follow-up|1|||
162142384|NCT05827926|585570369|FG026|Overall Study|Lost to Follow-up|4|||
162142385|NCT05827926|585570370|FG027|Overall Study|Lost to Follow-up|1|||
162142386|NCT05827926|585570371|FG028|Overall Study|Lost to Follow-up|2|||
162142387|NCT05827926|585570372|FG029|Overall Study|Lost to Follow-up|1|||
162142388|NCT05827926|585570373|FG030|Overall Study|Lost to Follow-up|5|||
162142389|NCT05827926|585570374|FG031|Overall Study|Lost to Follow-up|0|||
162142390|NCT05827926|585570375|FG032|Overall Study|Lost to Follow-up|3|||
162142391|NCT05827926|585570376|FG033|Overall Study|Lost to Follow-up|2|||
161911579|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
161911580|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
161911581|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Other|2|||
162142392|NCT05827926|585570377|FG034|Overall Study|Lost to Follow-up|1|||
162142393|NCT05827926|585570378|FG035|Overall Study|Lost to Follow-up|3|||
162142394|NCT05827926|585570379|FG036|Overall Study|Lost to Follow-up|4|||
162142395|NCT05827926|585570343|FG000|Overall Study|Withdrawal by Subject|1|||
162142396|NCT05827926|585570344|FG001|Overall Study|Withdrawal by Subject|0|||
162142397|NCT05827926|585570345|FG002|Overall Study|Withdrawal by Subject|1|||
162142398|NCT05827926|585570346|FG003|Overall Study|Withdrawal by Subject|1|||
162142399|NCT05827926|585570347|FG004|Overall Study|Withdrawal by Subject|0|||
162142400|NCT05827926|585570348|FG005|Overall Study|Withdrawal by Subject|0|||
162142401|NCT05827926|585570349|FG006|Overall Study|Withdrawal by Subject|0|||
162142402|NCT05827926|585570350|FG007|Overall Study|Withdrawal by Subject|0|||
162142403|NCT05827926|585570351|FG008|Overall Study|Withdrawal by Subject|0|||
162142404|NCT05827926|585570352|FG009|Overall Study|Withdrawal by Subject|0|||
162142405|NCT05827926|585570353|FG010|Overall Study|Withdrawal by Subject|0|||
162142406|NCT05827926|585570354|FG011|Overall Study|Withdrawal by Subject|0|||
162142407|NCT05827926|585570355|FG012|Overall Study|Withdrawal by Subject|1|||
162142408|NCT05827926|585570356|FG013|Overall Study|Withdrawal by Subject|1|||
162142409|NCT05827926|585570357|FG014|Overall Study|Withdrawal by Subject|1|||
162142410|NCT05827926|585570358|FG015|Overall Study|Withdrawal by Subject|2|||
162142411|NCT05827926|585570359|FG016|Overall Study|Withdrawal by Subject|1|||
162142412|NCT05827926|585570360|FG017|Overall Study|Withdrawal by Subject|1|||
162142413|NCT05827926|585570361|FG018|Overall Study|Withdrawal by Subject|0|||
162142414|NCT05827926|585570362|FG019|Overall Study|Withdrawal by Subject|0|||
162142415|NCT05827926|585570363|FG020|Overall Study|Withdrawal by Subject|1|||
162142416|NCT05827926|585570364|FG021|Overall Study|Withdrawal by Subject|0|||
162142417|NCT05827926|585570365|FG022|Overall Study|Withdrawal by Subject|0|||
162142418|NCT05827926|585570366|FG023|Overall Study|Withdrawal by Subject|2|||
162142419|NCT05827926|585570367|FG024|Overall Study|Withdrawal by Subject|1|||
162142420|NCT05827926|585570368|FG025|Overall Study|Withdrawal by Subject|0|||
162142421|NCT05827926|585570369|FG026|Overall Study|Withdrawal by Subject|0|||
162142422|NCT05827926|585570370|FG027|Overall Study|Withdrawal by Subject|1|||
162142423|NCT05827926|585570371|FG028|Overall Study|Withdrawal by Subject|0|||
162142424|NCT05827926|585570372|FG029|Overall Study|Withdrawal by Subject|0|||
162142425|NCT05827926|585570373|FG030|Overall Study|Withdrawal by Subject|0|||
162142426|NCT05827926|585570374|FG031|Overall Study|Withdrawal by Subject|2|||
162142427|NCT05827926|585570375|FG032|Overall Study|Withdrawal by Subject|0|||
162142428|NCT05827926|585570376|FG033|Overall Study|Withdrawal by Subject|0|||
162142429|NCT05827926|585570377|FG034|Overall Study|Withdrawal by Subject|0|||
162142430|NCT05827926|585570378|FG035|Overall Study|Withdrawal by Subject|0|||
162142431|NCT05827926|585570379|FG036|Overall Study|Withdrawal by Subject|1|||
162142432|NCT05827926|585570343|FG000|Overall Study|Other Than Specified|0|||
162142433|NCT05827926|585570344|FG001|Overall Study|Other Than Specified|0|||
162142434|NCT05827926|585570345|FG002|Overall Study|Other Than Specified|0|||
162142435|NCT05827926|585570346|FG003|Overall Study|Other Than Specified|1|||
162142436|NCT05827926|585570347|FG004|Overall Study|Other Than Specified|0|||
162142437|NCT05827926|585570348|FG005|Overall Study|Other Than Specified|0|||
162142438|NCT05827926|585570349|FG006|Overall Study|Other Than Specified|1|||
162142439|NCT05827926|585570350|FG007|Overall Study|Other Than Specified|0|||
162142440|NCT05827926|585570351|FG008|Overall Study|Other Than Specified|0|||
162142441|NCT05827926|585570352|FG009|Overall Study|Other Than Specified|0|||
162142442|NCT05827926|585570353|FG010|Overall Study|Other Than Specified|0|||
162142443|NCT05827926|585570354|FG011|Overall Study|Other Than Specified|0|||
162142444|NCT05827926|585570355|FG012|Overall Study|Other Than Specified|0|||
162142445|NCT05827926|585570356|FG013|Overall Study|Other Than Specified|1|||
162142446|NCT05827926|585570357|FG014|Overall Study|Other Than Specified|0|||
162142447|NCT05827926|585570358|FG015|Overall Study|Other Than Specified|1|||
162142448|NCT05827926|585570359|FG016|Overall Study|Other Than Specified|0|||
162142449|NCT05827926|585570360|FG017|Overall Study|Other Than Specified|0|||
162142450|NCT05827926|585570361|FG018|Overall Study|Other Than Specified|0|||
162142451|NCT05827926|585570362|FG019|Overall Study|Other Than Specified|0|||
162142452|NCT05827926|585570363|FG020|Overall Study|Other Than Specified|0|||
162142453|NCT05827926|585570364|FG021|Overall Study|Other Than Specified|1|||
162142454|NCT05827926|585570365|FG022|Overall Study|Other Than Specified|1|||
162142455|NCT05827926|585570366|FG023|Overall Study|Other Than Specified|0|||
162142456|NCT05827926|585570367|FG024|Overall Study|Other Than Specified|0|||
162142457|NCT05827926|585570368|FG025|Overall Study|Other Than Specified|1|||
162142458|NCT05827926|585570369|FG026|Overall Study|Other Than Specified|0|||
162142459|NCT05827926|585570370|FG027|Overall Study|Other Than Specified|0|||
162142460|NCT05827926|585570371|FG028|Overall Study|Other Than Specified|0|||
162142461|NCT05827926|585570372|FG029|Overall Study|Other Than Specified|0|||
162142462|NCT05827926|585570373|FG030|Overall Study|Other Than Specified|0|||
162142463|NCT05827926|585570374|FG031|Overall Study|Other Than Specified|1|||
162142464|NCT05827926|585570375|FG032|Overall Study|Other Than Specified|0|||
162142465|NCT05827926|585570376|FG033|Overall Study|Other Than Specified|0|||
162142466|NCT05827926|585570377|FG034|Overall Study|Other Than Specified|0|||
162142467|NCT05827926|585570378|FG035|Overall Study|Other Than Specified|0|||
162142468|NCT05827926|585570379|FG036|Overall Study|Other Than Specified|0|||
162142469|NCT05827926|585570343|FG000|Overall Study|Physician Decision|0|||
162142470|NCT05827926|585570344|FG001|Overall Study|Physician Decision|0|||
162142471|NCT05827926|585570345|FG002|Overall Study|Physician Decision|0|||
162142472|NCT05827926|585570346|FG003|Overall Study|Physician Decision|0|||
162142473|NCT05827926|585570347|FG004|Overall Study|Physician Decision|0|||
162142474|NCT05827926|585570348|FG005|Overall Study|Physician Decision|0|||
162142475|NCT05827926|585570349|FG006|Overall Study|Physician Decision|0|||
162142476|NCT05827926|585570350|FG007|Overall Study|Physician Decision|0|||
162142477|NCT05827926|585570351|FG008|Overall Study|Physician Decision|0|||
162142478|NCT05827926|585570352|FG009|Overall Study|Physician Decision|0|||
162142479|NCT05827926|585570353|FG010|Overall Study|Physician Decision|0|||
162142480|NCT05827926|585570354|FG011|Overall Study|Physician Decision|0|||
162142481|NCT05827926|585570355|FG012|Overall Study|Physician Decision|0|||
162142482|NCT05827926|585570356|FG013|Overall Study|Physician Decision|0|||
162142483|NCT05827926|585570357|FG014|Overall Study|Physician Decision|0|||
162142484|NCT05827926|585570358|FG015|Overall Study|Physician Decision|0|||
162142485|NCT05827926|585570359|FG016|Overall Study|Physician Decision|0|||
162142486|NCT05827926|585570360|FG017|Overall Study|Physician Decision|0|||
162142487|NCT05827926|585570361|FG018|Overall Study|Physician Decision|1|||
162142488|NCT05827926|585570362|FG019|Overall Study|Physician Decision|0|||
162142489|NCT05827926|585570363|FG020|Overall Study|Physician Decision|0|||
162142490|NCT05827926|585570364|FG021|Overall Study|Physician Decision|0|||
162142491|NCT05827926|585570365|FG022|Overall Study|Physician Decision|0|||
162142492|NCT05827926|585570366|FG023|Overall Study|Physician Decision|0|||
162142493|NCT05827926|585570367|FG024|Overall Study|Physician Decision|0|||
162142494|NCT05827926|585570368|FG025|Overall Study|Physician Decision|0|||
162142495|NCT05827926|585570369|FG026|Overall Study|Physician Decision|0|||
162142496|NCT05827926|585570370|FG027|Overall Study|Physician Decision|0|||
162142497|NCT05827926|585570371|FG028|Overall Study|Physician Decision|0|||
162142498|NCT05827926|585570372|FG029|Overall Study|Physician Decision|0|||
162142499|NCT05827926|585570373|FG030|Overall Study|Physician Decision|0|||
162142500|NCT05827926|585570374|FG031|Overall Study|Physician Decision|0|||
162142501|NCT05827926|585570375|FG032|Overall Study|Physician Decision|0|||
162142502|NCT05827926|585570376|FG033|Overall Study|Physician Decision|0|||
162142503|NCT05827926|585570377|FG034|Overall Study|Physician Decision|0|||
162142504|NCT05827926|585570378|FG035|Overall Study|Physician Decision|0|||
162142505|NCT05827926|585570379|FG036|Overall Study|Physician Decision|0|||
162142506|NCT04588480|585570387|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
162142507|NCT04588480|585570388|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
161807901|NCT05472038|584342689|FG000|Overall Study|Adverse Event|0|||
161807902|NCT05472038|584342690|FG001|Overall Study|Adverse Event|0|||
162142508|NCT04588480|585570389|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
162142509|NCT04588480|585570387|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
162142510|NCT04588480|585570388|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
162142511|NCT04588480|585570389|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
162142512|NCT01242085|585570390|FG000|Overall Study|Withdrawal by Subject|4|||
162142513|NCT01242085|585570391|FG001|Overall Study|Withdrawal by Subject|2|||
162142514|NCT01242085|585570392|FG002|Overall Study|Withdrawal by Subject|0|||
162142515|NCT01242085|585570390|FG000|Overall Study|medically unable to have surgery|4|||
162142516|NCT01242085|585570391|FG001|Overall Study|medically unable to have surgery|5|||
162142517|NCT01242085|585570392|FG002|Overall Study|medically unable to have surgery|0|||
162142518|NCT01178762|585570393|FG000|Overall Study|Lost to Follow-up|15|||
162142519|NCT02322216|585570396|FG000|Overall Study|Adverse Event|1|||
162142520|NCT02322216|585570397|FG001|Overall Study|Adverse Event|0|||
162142521|NCT02322216|585570396|FG000|Overall Study|Withdrawal by Subject|1|||
162142522|NCT02322216|585570397|FG001|Overall Study|Withdrawal by Subject|4|||
162142523|NCT02430532|585570399|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
162142524|NCT02430532|585570400|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
162142525|NCT02430532|585570399|FG000|Overall Study|Consent Withdrawn|0|||
162142526|NCT02430532|585570400|FG001|Overall Study|Consent Withdrawn|2|||
162142527|NCT02430532|585570399|FG000|Overall Study|Adverse Event|0|||
162142528|NCT02430532|585570400|FG001|Overall Study|Adverse Event|1|||
162142529|NCT01190150|585570401|FG000|First Treatment|Withdrawal by Subject|1|||
161807903|NCT05472038|584342691|FG002|Overall Study|Adverse Event|1|||
161807904|NCT05472038|584342692|FG003|Overall Study|Adverse Event|0|||
161807905|NCT05472038|584342693|FG004|Overall Study|Adverse Event|0|||
161807906|NCT05472038|584342694|FG005|Overall Study|Adverse Event|0|||
161807907|NCT05472038|584342695|FG006|Overall Study|Adverse Event|0|||
161807908|NCT05472038|584342696|FG007|Overall Study|Adverse Event|0|||
161807909|NCT05472038|584342697|FG008|Overall Study|Adverse Event|0|||
161807910|NCT05472038|584342698|FG009|Overall Study|Adverse Event|0|||
161807911|NCT05472038|584342699|FG010|Overall Study|Adverse Event|0|||
161807912|NCT05472038|584342700|FG011|Overall Study|Adverse Event|0|||
161807913|NCT05472038|584342689|FG000|Overall Study|Death|0|||
161807914|NCT05472038|584342690|FG001|Overall Study|Death|0|||
161807915|NCT05472038|584342691|FG002|Overall Study|Death|0|||
161807916|NCT05472038|584342692|FG003|Overall Study|Death|0|||
161807917|NCT05472038|584342693|FG004|Overall Study|Death|0|||
161807918|NCT05472038|584342694|FG005|Overall Study|Death|1|||
161807919|NCT05472038|584342695|FG006|Overall Study|Death|0|||
161807920|NCT05472038|584342696|FG007|Overall Study|Death|0|||
161807921|NCT05472038|584342697|FG008|Overall Study|Death|0|||
161807922|NCT05472038|584342698|FG009|Overall Study|Death|0|||
161807923|NCT05472038|584342699|FG010|Overall Study|Death|0|||
161807924|NCT05472038|584342700|FG011|Overall Study|Death|0|||
161807925|NCT05472038|584342689|FG000|Overall Study|Lost to Follow-up|1|||
161807926|NCT05472038|584342690|FG001|Overall Study|Lost to Follow-up|3|||
161807927|NCT05472038|584342691|FG002|Overall Study|Lost to Follow-up|3|||
161807928|NCT05472038|584342692|FG003|Overall Study|Lost to Follow-up|9|||
161807929|NCT05472038|584342693|FG004|Overall Study|Lost to Follow-up|2|||
161807930|NCT05472038|584342694|FG005|Overall Study|Lost to Follow-up|2|||
161807931|NCT05472038|584342695|FG006|Overall Study|Lost to Follow-up|1|||
161807932|NCT05472038|584342696|FG007|Overall Study|Lost to Follow-up|0|||
161807933|NCT05472038|584342697|FG008|Overall Study|Lost to Follow-up|1|||
161807934|NCT05472038|584342698|FG009|Overall Study|Lost to Follow-up|0|||
161807935|NCT05472038|584342699|FG010|Overall Study|Lost to Follow-up|2|||
161807936|NCT05472038|584342700|FG011|Overall Study|Lost to Follow-up|1|||
161807937|NCT05472038|584342689|FG000|Overall Study|Physician Decision|0|||
161807938|NCT05472038|584342690|FG001|Overall Study|Physician Decision|0|||
161807939|NCT05472038|584342691|FG002|Overall Study|Physician Decision|0|||
161807940|NCT05472038|584342692|FG003|Overall Study|Physician Decision|0|||
161807941|NCT05472038|584342693|FG004|Overall Study|Physician Decision|1|||
162142530|NCT01190150|585570402|FG001|First Treatment|Withdrawal by Subject|0|||
162142531|NCT01190150|585570401|FG000|Washout|Withdrawal by Subject|0|||
162142532|NCT01190150|585570402|FG001|Washout|Withdrawal by Subject|1|||
162142533|NCT01190150|585570401|FG000|Washout|Difficulty in adherence|0|||
162142534|NCT01190150|585570402|FG001|Washout|Difficulty in adherence|1|||
161807942|NCT05472038|584342694|FG005|Overall Study|Physician Decision|0|||
161807943|NCT05472038|584342695|FG006|Overall Study|Physician Decision|0|||
161807944|NCT05472038|584342696|FG007|Overall Study|Physician Decision|0|||
161807945|NCT05472038|584342697|FG008|Overall Study|Physician Decision|0|||
161807946|NCT05472038|584342698|FG009|Overall Study|Physician Decision|0|||
161807947|NCT05472038|584342699|FG010|Overall Study|Physician Decision|0|||
161807948|NCT05472038|584342700|FG011|Overall Study|Physician Decision|0|||
161807949|NCT05472038|584342689|FG000|Overall Study|Withdrawal by Subject|1|||
161807950|NCT05472038|584342690|FG001|Overall Study|Withdrawal by Subject|3|||
162142535|NCT00608907|585570404|FG000|Overall Study|Adverse Event|6|||
162142536|NCT00608907|585570405|FG001|Overall Study|Adverse Event|0|||
162142537|NCT00608907|585570406|FG002|Overall Study|Adverse Event|1|||
162142538|NCT00608907|585570404|FG000|Overall Study|Death|1|||
162142539|NCT00608907|585570405|FG001|Overall Study|Death|0|||
162142540|NCT00608907|585570406|FG002|Overall Study|Death|0|||
162142541|NCT00608907|585570404|FG000|Overall Study|Withdrawal by Subject|4|||
162142542|NCT00608907|585570405|FG001|Overall Study|Withdrawal by Subject|0|||
162142543|NCT00608907|585570406|FG002|Overall Study|Withdrawal by Subject|0|||
162142544|NCT00608907|585570404|FG000|Overall Study|Progressive Disease|1|||
162142545|NCT00608907|585570405|FG001|Overall Study|Progressive Disease|0|||
162142546|NCT00608907|585570406|FG002|Overall Study|Progressive Disease|0|||
162142547|NCT02982213|585570409|FG000|Overall Study|Did not complete follow up questionnaire|5|||
162142548|NCT02982213|585570410|FG001|Overall Study|Did not complete follow up questionnaire|1|||
162142549|NCT03247543|585570411|FG000|Overall Study|Adverse Event|3|||
162142550|NCT03247543|585570412|FG001|Overall Study|Adverse Event|6|||
162142551|NCT03247543|585570413|FG002|Overall Study|Adverse Event|4|||
162142552|NCT03247543|585570411|FG000|Overall Study|Lost to Follow-up|10|||
162142553|NCT03247543|585570412|FG001|Overall Study|Lost to Follow-up|7|||
162142554|NCT03247543|585570413|FG002|Overall Study|Lost to Follow-up|8|||
162142555|NCT03247543|585570411|FG000|Overall Study|Consent withdrawn by caregiver|2|||
162142556|NCT03247543|585570412|FG001|Overall Study|Consent withdrawn by caregiver|2|||
162142557|NCT03247543|585570413|FG002|Overall Study|Consent withdrawn by caregiver|9|||
162142558|NCT03247543|585570411|FG000|Overall Study|Withdrawal by Subject|0|||
162142559|NCT03247543|585570412|FG001|Overall Study|Withdrawal by Subject|0|||
162142560|NCT03247543|585570413|FG002|Overall Study|Withdrawal by Subject|1|||
162142561|NCT03247543|585570411|FG000|Overall Study|Failure to Follow study procedures|1|||
162142562|NCT03247543|585570412|FG001|Overall Study|Failure to Follow study procedures|3|||
162142563|NCT03247543|585570413|FG002|Overall Study|Failure to Follow study procedures|1|||
162142564|NCT03247543|585570411|FG000|Overall Study|Lack of Efficacy|1|||
162142565|NCT03247543|585570412|FG001|Overall Study|Lack of Efficacy|0|||
162142566|NCT03247543|585570413|FG002|Overall Study|Lack of Efficacy|0|||
162142567|NCT03247543|585570411|FG000|Overall Study|Non-compliance with study visits|0|||
162142568|NCT03247543|585570412|FG001|Overall Study|Non-compliance with study visits|1|||
162142569|NCT03247543|585570413|FG002|Overall Study|Non-compliance with study visits|0|||
162142570|NCT01253226|585570419|FG000|Overall Study|Adverse Event|0|||
162142571|NCT01253226|585570420|FG001|Overall Study|Adverse Event|0|||
162142572|NCT01253226|585570421|FG002|Overall Study|Adverse Event|1|||
162142573|NCT01253226|585570422|FG003|Overall Study|Adverse Event|0|||
162142574|NCT01253226|585570423|FG004|Overall Study|Adverse Event|0|||
162142575|NCT01253226|585570419|FG000|Overall Study|Death|0|||
162142576|NCT01253226|585570420|FG001|Overall Study|Death|1|||
162142577|NCT01253226|585570421|FG002|Overall Study|Death|0|||
162142578|NCT01253226|585570422|FG003|Overall Study|Death|0|||
162142579|NCT01253226|585570423|FG004|Overall Study|Death|0|||
162142580|NCT01253226|585570419|FG000|Overall Study|Physician Decision|0|||
162142581|NCT01253226|585570420|FG001|Overall Study|Physician Decision|0|||
162142582|NCT01253226|585570421|FG002|Overall Study|Physician Decision|0|||
162142583|NCT01253226|585570422|FG003|Overall Study|Physician Decision|0|||
162142584|NCT01253226|585570423|FG004|Overall Study|Physician Decision|2|||
162142585|NCT01253226|585570419|FG000|Overall Study|Withdrawal by Subject|0|||
162142586|NCT01253226|585570420|FG001|Overall Study|Withdrawal by Subject|0|||
162142587|NCT01253226|585570421|FG002|Overall Study|Withdrawal by Subject|0|||
162142588|NCT01253226|585570422|FG003|Overall Study|Withdrawal by Subject|1|||
162142589|NCT01253226|585570423|FG004|Overall Study|Withdrawal by Subject|0|||
161807951|NCT05472038|584342691|FG002|Overall Study|Withdrawal by Subject|1|||
161807952|NCT05472038|584342692|FG003|Overall Study|Withdrawal by Subject|6|||
161807953|NCT05472038|584342693|FG004|Overall Study|Withdrawal by Subject|1|||
161807954|NCT05472038|584342694|FG005|Overall Study|Withdrawal by Subject|3|||
161807955|NCT05472038|584342695|FG006|Overall Study|Withdrawal by Subject|0|||
161807956|NCT05472038|584342696|FG007|Overall Study|Withdrawal by Subject|2|||
161807957|NCT05472038|584342697|FG008|Overall Study|Withdrawal by Subject|3|||
161807958|NCT05472038|584342698|FG009|Overall Study|Withdrawal by Subject|1|||
161807959|NCT05472038|584342699|FG010|Overall Study|Withdrawal by Subject|2|||
161807960|NCT05472038|584342700|FG011|Overall Study|Withdrawal by Subject|2|||
162142590|NCT04075266|585570425|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
162142591|NCT04075266|585570426|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
162142592|NCT04075266|585570425|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
162142593|NCT04075266|585570426|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
162142594|NCT03643211|585570427|FG000|Overall Study|Contract violation/deficiency|12|||
162142595|NCT03643211|585570427|FG000|Overall Study|Invalid registration|3|||
162142596|NCT03643211|585570427|FG000|Overall Study|No treatment information|2|||
162142597|NCT03643211|585570427|FG000|Overall Study|No adverse event information - No revisit|4|||
162142598|NCT04858425|585570428|FG000|Overall Study|Adverse Event|2|||
161807961|NCT05472038|584342689|FG000|Overall Study|Protocol Violation|0|||
162142599|NCT04858425|585570429|FG001|Overall Study|Adverse Event|2|||
162142600|NCT04858425|585570428|FG000|Overall Study|Withdrawal by Subject|3|||
162142601|NCT04858425|585570429|FG001|Overall Study|Withdrawal by Subject|1|||
162142602|NCT04858425|585570428|FG000|Overall Study|Lost to Follow-up|4|||
162142603|NCT04858425|585570429|FG001|Overall Study|Lost to Follow-up|2|||
162142604|NCT04858425|585570428|FG000|Overall Study|Lost to Follow-up|1|||
162142605|NCT04858425|585570429|FG001|Overall Study|Lost to Follow-up|0|||
162142606|NCT03473743|585570430|FG000|Overall Study|Withdrawal by Subject|0|||
162142607|NCT03473743|585570431|FG001|Overall Study|Withdrawal by Subject|0|||
162142608|NCT03473743|585570432|FG002|Overall Study|Withdrawal by Subject|0|||
161911582|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Other|3|||
161911583|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Other|0|||
161911584|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
161911585|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
161911586|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
162142609|NCT03473743|585570433|FG003|Overall Study|Withdrawal by Subject|0|||
162142610|NCT03473743|585570434|FG004|Overall Study|Withdrawal by Subject|0|||
162142611|NCT03473743|585570435|FG005|Overall Study|Withdrawal by Subject|0|||
162142612|NCT03473743|585570436|FG006|Overall Study|Withdrawal by Subject|0|||
162142613|NCT03473743|585570437|FG007|Overall Study|Withdrawal by Subject|3|||
162142614|NCT03473743|585570430|FG000|Overall Study|Other|0|||
162142615|NCT03473743|585570431|FG001|Overall Study|Other|0|||
162142616|NCT03473743|585570432|FG002|Overall Study|Other|0|||
162142617|NCT03473743|585570433|FG003|Overall Study|Other|1|||
162142618|NCT03473743|585570434|FG004|Overall Study|Other|0|||
162142619|NCT03473743|585570435|FG005|Overall Study|Other|0|||
162142620|NCT03473743|585570436|FG006|Overall Study|Other|0|||
162142621|NCT03473743|585570437|FG007|Overall Study|Other|0|||
162142622|NCT03473743|585570430|FG000|Overall Study|Ongoing|0|||
162142623|NCT03473743|585570431|FG001|Overall Study|Ongoing|0|||
162142624|NCT03473743|585570432|FG002|Overall Study|Ongoing|6|||
162142625|NCT03473743|585570433|FG003|Overall Study|Ongoing|8|||
162142626|NCT03473743|585570434|FG004|Overall Study|Ongoing|1|||
162142627|NCT03473743|585570435|FG005|Overall Study|Ongoing|1|||
162142628|NCT03473743|585570436|FG006|Overall Study|Ongoing|22|||
162142629|NCT03473743|585570437|FG007|Overall Study|Ongoing|24|||
162142630|NCT03473743|585570430|FG000|Overall Study|Randomized but not treated|0|||
162142631|NCT03473743|585570431|FG001|Overall Study|Randomized but not treated|0|||
162142632|NCT03473743|585570432|FG002|Overall Study|Randomized but not treated|0|||
162142633|NCT03473743|585570433|FG003|Overall Study|Randomized but not treated|0|||
162142634|NCT03473743|585570434|FG004|Overall Study|Randomized but not treated|0|||
162142635|NCT03473743|585570435|FG005|Overall Study|Randomized but not treated|0|||
162142636|NCT03473743|585570436|FG006|Overall Study|Randomized but not treated|1|||
162142637|NCT03473743|585570437|FG007|Overall Study|Randomized but not treated|1|||
162142638|NCT02864992|585570438|FG000|Overall Study|still on treatment|15|||
162142639|NCT02864992|585570439|FG001|Overall Study|still on treatment|1|||
162142640|NCT02864992|585570440|FG002|Overall Study|still on treatment|33|||
162142641|NCT04536077|585570442|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
162142642|NCT04536077|585570443|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
162142643|NCT04536077|585570442|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
162142644|NCT04536077|585570443|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
162142645|NCT04948333|585570444|FG000|Overall Study|Adverse Event|6|||
162142646|NCT04948333|585570445|FG001|Overall Study|Adverse Event|4|||
162142647|NCT04948333|585570446|FG002|Overall Study|Adverse Event|0|||
162142648|NCT04948333|585570447|FG003|Overall Study|Adverse Event|2|||
162142649|NCT04948333|585570444|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
162142650|NCT04948333|585570445|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
162142651|NCT04948333|585570446|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162142652|NCT04948333|585570447|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162142653|NCT04948333|585570444|FG000|Overall Study|Progressive Disease|1|||
162142654|NCT04948333|585570445|FG001|Overall Study|Progressive Disease|5|||
162142655|NCT04948333|585570446|FG002|Overall Study|Progressive Disease|0|||
162142656|NCT04948333|585570447|FG003|Overall Study|Progressive Disease|0|||
162142657|NCT04948333|585570444|FG000|Overall Study|Physician Decision|2|||
162142658|NCT04948333|585570445|FG001|Overall Study|Physician Decision|2|||
162142659|NCT04948333|585570446|FG002|Overall Study|Physician Decision|0|||
162142660|NCT04948333|585570447|FG003|Overall Study|Physician Decision|0|||
162142661|NCT04948333|585570444|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
162142662|NCT04948333|585570445|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
162142663|NCT04948333|585570446|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
162142664|NCT04948333|585570447|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
162142665|NCT04948333|585570444|FG000|Overall Study|Withdrawal by Subject|2|||
162142666|NCT04948333|585570445|FG001|Overall Study|Withdrawal by Subject|0|||
162142667|NCT04948333|585570446|FG002|Overall Study|Withdrawal by Subject|0|||
162142668|NCT04948333|585570447|FG003|Overall Study|Withdrawal by Subject|1|||
162142669|NCT04948333|585570444|FG000|Overall Study|Protocol Violation|0|||
162142670|NCT04948333|585570445|FG001|Overall Study|Protocol Violation|1|||
161807962|NCT05472038|584342690|FG001|Overall Study|Protocol Violation|0|||
161807963|NCT05472038|584342691|FG002|Overall Study|Protocol Violation|0|||
161807964|NCT05472038|584342692|FG003|Overall Study|Protocol Violation|0|||
161807965|NCT05472038|584342693|FG004|Overall Study|Protocol Violation|0|||
161807966|NCT05472038|584342694|FG005|Overall Study|Protocol Violation|0|||
161807967|NCT05472038|584342695|FG006|Overall Study|Protocol Violation|0|||
161807968|NCT05472038|584342696|FG007|Overall Study|Protocol Violation|1|||
161807969|NCT05472038|584342697|FG008|Overall Study|Protocol Violation|1|||
161807970|NCT05472038|584342698|FG009|Overall Study|Protocol Violation|1|||
161807971|NCT05472038|584342699|FG010|Overall Study|Protocol Violation|1|||
161807972|NCT05472038|584342700|FG011|Overall Study|Protocol Violation|1|||
161807973|NCT05472038|584342689|FG000|Overall Study|Not vaccinated|0|||
161807974|NCT05472038|584342690|FG001|Overall Study|Not vaccinated|0|||
161807975|NCT05472038|584342691|FG002|Overall Study|Not vaccinated|0|||
161807976|NCT05472038|584342692|FG003|Overall Study|Not vaccinated|1|||
161807977|NCT05472038|584342693|FG004|Overall Study|Not vaccinated|0|||
161807978|NCT05472038|584342694|FG005|Overall Study|Not vaccinated|0|||
161807979|NCT05472038|584342695|FG006|Overall Study|Not vaccinated|0|||
161807980|NCT05472038|584342696|FG007|Overall Study|Not vaccinated|0|||
161807981|NCT05472038|584342697|FG008|Overall Study|Not vaccinated|0|||
161807982|NCT05472038|584342698|FG009|Overall Study|Not vaccinated|0|||
161807983|NCT05472038|584342699|FG010|Overall Study|Not vaccinated|0|||
161807984|NCT05472038|584342700|FG011|Overall Study|Not vaccinated|0|||
161807985|NCT03235739|584342701|FG000|Overall Study|Withdrawal by Subject|2|||
161807986|NCT03235739|584342702|FG001|Overall Study|Withdrawal by Subject|2|||
161807987|NCT03235739|584342701|FG000|Overall Study|Physician Decision|0|||
161807988|NCT03235739|584342702|FG001|Overall Study|Physician Decision|1|||
161807989|NCT00070291|584342705|FG000|Step 1|Withdrawal by Subject|1|||
161807990|NCT00070291|584342705|FG000|Step 1|Adverse Event|1|||
161807991|NCT00070291|584342705|FG000|Step 2|Adverse Event|1|||
161807992|NCT02096211|584342706|FG000|Overall Study|Death|2|||
161807993|NCT02096211|584342706|FG000|Overall Study|Withdrawal by Subject|8|||
161807994|NCT02096211|584342706|FG000|Overall Study|Revision of implant|7|||
161807995|NCT02096211|584342706|FG000|Overall Study|Lost to Follow-up|43|||
161807996|NCT01591785|584342710|FG000|Overall Study|worsening condition|1|||
161807997|NCT01591785|584342711|FG001|Overall Study|worsening condition|2|||
161807998|NCT01591785|584342710|FG000|Overall Study|Protocol Violation|2|||
161807999|NCT01591785|584342711|FG001|Overall Study|Protocol Violation|0|||
161808000|NCT01591785|584342710|FG000|Overall Study|Lost to Follow-up|1|||
161808001|NCT01591785|584342711|FG001|Overall Study|Lost to Follow-up|0|||
161808002|NCT01049334|584342712|FG000|Overall Study|Withdrawal by Subject|5|||
161808003|NCT01049334|584342713|FG001|Overall Study|Withdrawal by Subject|3|||
161808004|NCT01049334|584342712|FG000|Overall Study|Adverse Event|2|||
161808005|NCT01049334|584342713|FG001|Overall Study|Adverse Event|3|||
161808006|NCT01049334|584342712|FG000|Overall Study|Physician Decision|2|||
161808007|NCT01049334|584342713|FG001|Overall Study|Physician Decision|0|||
161808008|NCT01049334|584342712|FG000|Overall Study|Protocol Violation|0|||
161808009|NCT01049334|584342713|FG001|Overall Study|Protocol Violation|1|||
161808010|NCT02883452|584342714|FG000|Overall Study|Withdrawal by Subject|1|||
161808011|NCT02883452|584342715|FG001|Overall Study|Withdrawal by Subject|1|||
161808012|NCT02883452|584342716|FG002|Overall Study|Withdrawal by Subject|3|||
161808013|NCT02883452|584342717|FG003|Overall Study|Withdrawal by Subject|0|||
161808014|NCT02883452|584342718|FG004|Overall Study|Withdrawal by Subject|2|||
161808015|NCT02883452|584342719|FG005|Overall Study|Withdrawal by Subject|5|||
161808016|NCT02883452|584342714|FG000|Overall Study|Disease progression|1|||
161808017|NCT02883452|584342715|FG001|Overall Study|Disease progression|0|||
161808018|NCT02883452|584342716|FG002|Overall Study|Disease progression|0|||
161808019|NCT02883452|584342717|FG003|Overall Study|Disease progression|1|||
161808020|NCT02883452|584342718|FG004|Overall Study|Disease progression|4|||
161808021|NCT02883452|584342719|FG005|Overall Study|Disease progression|5|||
161808022|NCT02883452|584342714|FG000|Overall Study|Adverse Event|2|||
162142671|NCT04948333|585570446|FG002|Overall Study|Protocol Violation|0|||
162142672|NCT04948333|585570447|FG003|Overall Study|Protocol Violation|0|||
162142673|NCT04948333|585570444|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
162142674|NCT04948333|585570445|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
162142675|NCT04948333|585570446|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
162142676|NCT04948333|585570447|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
162142677|NCT03805295|585570451|FG000|Overall Study|Lost to Follow-up|17|||
162142678|NCT03805295|585570452|FG001|Overall Study|Lost to Follow-up|43|||
162142679|NCT04925752|585570453|FG000|Overall Study|Still on Study|1826|||
162142680|NCT04925752|585570454|FG001|Overall Study|Still on Study|926|||
162142681|NCT04925752|585570453|FG000|Overall Study|Withdrew Consent|128|||
162142682|NCT04925752|585570454|FG001|Overall Study|Withdrew Consent|59|||
162142683|NCT04925752|585570453|FG000|Overall Study|Lost to Follow-up|73|||
162142684|NCT04925752|585570454|FG001|Overall Study|Lost to Follow-up|47|||
162142685|NCT04925752|585570453|FG000|Overall Study|Randomized but Never Treated|12|||
162142686|NCT04925752|585570454|FG001|Overall Study|Randomized but Never Treated|9|||
162142687|NCT04925752|585570453|FG000|Overall Study|Hiv-1 Infection|6|||
162142688|NCT04925752|585570454|FG001|Overall Study|Hiv-1 Infection|7|||
162142689|NCT04925752|585570453|FG000|Overall Study|Investigator's discretion|8|||
162142690|NCT04925752|585570454|FG001|Overall Study|Investigator's discretion|5|||
162142691|NCT04925752|585570453|FG000|Overall Study|Non-compliance with Study Drug|8|||
162142692|NCT04925752|585570454|FG001|Overall Study|Non-compliance with Study Drug|5|||
162142693|NCT04925752|585570453|FG000|Overall Study|Adverse Event|5|||
162142694|NCT04925752|585570454|FG001|Overall Study|Adverse Event|2|||
162142695|NCT04925752|585570453|FG000|Overall Study|Death|4|||
162142696|NCT04925752|585570454|FG001|Overall Study|Death|2|||
162142697|NCT04925752|585570453|FG000|Overall Study|Protocol Violation|1|||
162142698|NCT04925752|585570454|FG001|Overall Study|Protocol Violation|3|||
161808023|NCT02883452|584342715|FG001|Overall Study|Adverse Event|1|||
161808024|NCT02883452|584342716|FG002|Overall Study|Adverse Event|1|||
161808025|NCT02883452|584342717|FG003|Overall Study|Adverse Event|1|||
161808026|NCT02883452|584342718|FG004|Overall Study|Adverse Event|1|||
161808027|NCT02883452|584342719|FG005|Overall Study|Adverse Event|3|||
161808028|NCT02883452|584342714|FG000|Overall Study|Physician Decision|0|||
161808029|NCT02883452|584342715|FG001|Overall Study|Physician Decision|0|||
161808030|NCT02883452|584342716|FG002|Overall Study|Physician Decision|0|||
161808031|NCT02883452|584342717|FG003|Overall Study|Physician Decision|0|||
161808032|NCT02883452|584342718|FG004|Overall Study|Physician Decision|4|||
161808033|NCT02883452|584342719|FG005|Overall Study|Physician Decision|1|||
161808034|NCT02883452|584342714|FG000|Overall Study|Death|1|||
161808035|NCT02883452|584342715|FG001|Overall Study|Death|0|||
161808036|NCT02883452|584342716|FG002|Overall Study|Death|1|||
161808037|NCT02883452|584342717|FG003|Overall Study|Death|0|||
161808038|NCT02883452|584342718|FG004|Overall Study|Death|0|||
161808039|NCT02883452|584342719|FG005|Overall Study|Death|0|||
161808040|NCT02883452|584342714|FG000|Overall Study|Other|0|||
162142699|NCT04925752|585570453|FG000|Overall Study|Withdrew Assent|1|||
162142700|NCT04925752|585570454|FG001|Overall Study|Withdrew Assent|0|||
162142701|NCT03331250|585570455|FG000|Overall Study|Withdrawal by Subject|1|||
162142702|NCT01155869|585570461|FG000|Overall Study|Lost to Follow-up|3|||
162142703|NCT01155869|585570462|FG001|Overall Study|Lost to Follow-up|1|||
162142704|NCT04540835|585570465|FG000|Week 1|Lost to Follow-up|1|||
162142705|NCT04540835|585570465|FG000|Week 6|Pregnancy|1|||
162142706|NCT04540835|585570465|FG000|Week 6|Lack of Efficacy|1|||
161808041|NCT02883452|584342715|FG001|Overall Study|Other|0|||
161808042|NCT02883452|584342716|FG002|Overall Study|Other|0|||
161808043|NCT02883452|584342717|FG003|Overall Study|Other|0|||
161808044|NCT02883452|584342718|FG004|Overall Study|Other|0|||
161808045|NCT02883452|584342719|FG005|Overall Study|Other|1|||
161808046|NCT01439880|584342729|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
161808047|NCT01439880|584342730|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
161808048|NCT01439880|584342729|FG000|SOC-controlled Period (Year 1)|Death|2|||
161808049|NCT01439880|584342730|FG001|SOC-controlled Period (Year 1)|Death|1|||
161808050|NCT01439880|584342729|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
161808051|NCT01439880|584342730|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
161808052|NCT01439880|584342729|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
161808053|NCT01439880|584342730|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
161808054|NCT01439880|584342729|FG000|SOC-controlled Period (Year 1)|Other|8|||
161808055|NCT01439880|584342730|FG001|SOC-controlled Period (Year 1)|Other|13|||
161808056|NCT01439880|584342729|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
161911587|NCT04006457|584728614|FG000|Main Study: Treatment Period 2|Ongoing|86|||
161911588|NCT04006457|584728615|FG001|Main Study: Treatment Period 2|Ongoing|96|||
161911589|NCT04006457|584728616|FG002|Main Study: Treatment Period 2|Ongoing|0|||
161911590|NCT04006457|584728614|FG000|Main Study Observation Period|Adverse Event|1|||
161911591|NCT04006457|584728615|FG001|Main Study Observation Period|Adverse Event|1|||
161911592|NCT04006457|584728616|FG002|Main Study Observation Period|Adverse Event|0|||
161911593|NCT04006457|584728614|FG000|Main Study Observation Period|Lost to Follow-up|0|||
161911594|NCT04006457|584728615|FG001|Main Study Observation Period|Lost to Follow-up|1|||
161911595|NCT04006457|584728616|FG002|Main Study Observation Period|Lost to Follow-up|0|||
161911596|NCT04006457|584728614|FG000|Main Study Observation Period|Pregnancy|1|||
161911597|NCT04006457|584728615|FG001|Main Study Observation Period|Pregnancy|0|||
161911598|NCT04006457|584728616|FG002|Main Study Observation Period|Pregnancy|0|||
161911599|NCT04006457|584728614|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
161911600|NCT04006457|584728615|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
161911601|NCT04006457|584728616|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
162142707|NCT01838200|585570466|FG000|Overall Study|Adverse Event|0|||
162142708|NCT01838200|585570467|FG001|Overall Study|Adverse Event|2|||
162142709|NCT01838200|585570466|FG000|Overall Study|Progressive disease|3|||
162142710|NCT01838200|585570467|FG001|Overall Study|Progressive disease|0|||
162142711|NCT03105336|585570468|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
162142712|NCT03105336|585570469|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
162142713|NCT03105336|585570468|FG000|Overall Study|Death|40|||
162142714|NCT03105336|585570469|FG001|Overall Study|Death|8|||
162142715|NCT03105336|585570468|FG000|Overall Study|Lost to Follow-up|13|||
162142716|NCT03105336|585570469|FG001|Overall Study|Lost to Follow-up|2|||
162142717|NCT03105336|585570468|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
162142718|NCT03105336|585570469|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
162142719|NCT03105336|585570468|FG000|Overall Study|Reason Not Specified|3|||
162142720|NCT03105336|585570469|FG001|Overall Study|Reason Not Specified|3|||
162142721|NCT03105336|585570468|FG000|Overall Study|Investigator Decision|3|||
162142722|NCT03105336|585570469|FG001|Overall Study|Investigator Decision|0|||
162142723|NCT03451851|585570470|FG000|PCP: Week 0 -16|Adverse Event|1|||
162142724|NCT03451851|585570471|FG001|PCP: Week 0 -16|Adverse Event|0|||
162142725|NCT03451851|585570472|FG002|PCP: Week 0 -16|Adverse Event|0|||
162142726|NCT03451851|585570473|FG003|PCP: Week 0 -16|Adverse Event|0|||
162142727|NCT03451851|585570474|FG004|PCP: Week 0 -16|Adverse Event|0|||
162142728|NCT03451851|585570475|FG005|PCP: Week 0 -16|Adverse Event|0|||
162142729|NCT03451851|585570476|FG006|PCP: Week 0 -16|Adverse Event|1|||
162142730|NCT03451851|585570477|FG007|PCP: Week 0 -16|Adverse Event|0|||
162142731|NCT03451851|585570470|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
162142732|NCT03451851|585570471|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
162142733|NCT03451851|585570472|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
162142734|NCT03451851|585570473|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
162142735|NCT03451851|585570474|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
162142736|NCT03451851|585570475|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
162142737|NCT03451851|585570476|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
162142738|NCT03451851|585570477|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
162142739|NCT03451851|585570470|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162142740|NCT03451851|585570471|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162142741|NCT03451851|585570472|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
162142742|NCT03451851|585570473|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162142743|NCT03451851|585570474|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162142744|NCT03451851|585570475|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162142745|NCT03451851|585570476|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162142746|NCT03451851|585570477|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
162142747|NCT03451851|585570470|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
162142748|NCT03451851|585570471|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
162142749|NCT03451851|585570472|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
162142750|NCT03451851|585570473|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
162142751|NCT03451851|585570474|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
161808057|NCT01439880|584342730|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
161808058|NCT01439880|584342729|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
162142752|NCT03451851|585570475|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
162142753|NCT03451851|585570476|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
162142754|NCT03451851|585570477|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
162142755|NCT03451851|585570470|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162142756|NCT03451851|585570471|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162142757|NCT03451851|585570472|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162142758|NCT03451851|585570473|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162142759|NCT03451851|585570474|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
162142760|NCT03451851|585570475|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162142761|NCT03451851|585570476|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162142762|NCT03451851|585570477|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
162142763|NCT03451851|585570470|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162142764|NCT03451851|585570471|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162142765|NCT03451851|585570472|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162142766|NCT03451851|585570473|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162142767|NCT03451851|585570474|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
162142768|NCT03451851|585570475|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162142769|NCT03451851|585570476|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162142770|NCT03451851|585570477|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
162142771|NCT00777556|585571564|FG000|Overall Study|Inappropriate self-selection|34|||
162142772|NCT00777556|585571564|FG000|Overall Study|Dispensed but did not use product|12|||
162142773|NCT00777556|585571564|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
162142774|NCT02380742|585571565|FG000|Overall Study|Withdrawal by Subject|1|||
162142775|NCT02380742|585571566|FG001|Overall Study|Withdrawal by Subject|0|||
162142776|NCT01227278|585571569|FG000|Overall Study|Withdrawal by Subject|4|||
162142777|NCT01227278|585571570|FG001|Overall Study|Withdrawal by Subject|4|||
162142778|NCT01227278|585571569|FG000|Overall Study|Death|0|||
162142779|NCT01227278|585571570|FG001|Overall Study|Death|2|||
162142780|NCT01227278|585571569|FG000|Overall Study|Other|1|||
162142781|NCT01227278|585571570|FG001|Overall Study|Other|2|||
162142782|NCT01281813|585571579|FG000|Overall Study|Adverse Event|0|||
162142783|NCT01281813|585571580|FG001|Overall Study|Adverse Event|0|||
162142784|NCT01281813|585571581|FG002|Overall Study|Adverse Event|10|||
162142785|NCT01281813|585571579|FG000|Overall Study|Lost to Follow-up|0|||
162142786|NCT01281813|585571580|FG001|Overall Study|Lost to Follow-up|0|||
162142787|NCT01281813|585571581|FG002|Overall Study|Lost to Follow-up|31|||
162142788|NCT01281813|585571579|FG000|Overall Study|Withdrawal by Subject|0|||
162142789|NCT01281813|585571580|FG001|Overall Study|Withdrawal by Subject|0|||
162142790|NCT01281813|585571581|FG002|Overall Study|Withdrawal by Subject|13|||
162142791|NCT01281813|585571579|FG000|Overall Study|Subject Non-Compliant|0|||
162142792|NCT01281813|585571580|FG001|Overall Study|Subject Non-Compliant|0|||
162142793|NCT01281813|585571581|FG002|Overall Study|Subject Non-Compliant|6|||
162142794|NCT01281813|585571579|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
162142795|NCT01281813|585571580|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
162142796|NCT01281813|585571581|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
162142797|NCT01281813|585571579|FG000|Overall Study|Sponsor's Decision|4|||
162142798|NCT01281813|585571580|FG001|Overall Study|Sponsor's Decision|3|||
161911602|NCT04006457|584728614|FG000|Main Study Observation Period|Other|8|||
161911603|NCT04006457|584728615|FG001|Main Study Observation Period|Other|16|||
161911604|NCT04006457|584728616|FG002|Main Study Observation Period|Other|0|||
161911605|NCT04006457|584728614|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
161911606|NCT04006457|584728615|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
161911607|NCT04006457|584728616|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
161911608|NCT04006457|584728614|FG000|Main Study Observation Period|Ongoing|2|||
161911609|NCT04006457|584728615|FG001|Main Study Observation Period|Ongoing|1|||
161911610|NCT04006457|584728616|FG002|Main Study Observation Period|Ongoing|0|||
161808059|NCT01439880|584342730|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
161911611|NCT04006457|584728614|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
161911612|NCT04006457|584728615|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
161911613|NCT04006457|584728616|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
161911614|NCT03370172|584728617|FG000|Overall Study|Withdrawal by Subject|0|||
161808060|NCT01439880|584342729|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
161808061|NCT01439880|584342730|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
161808062|NCT01439880|584342729|FG000|All-IP Period (Years 2 to 5)|Death|3|||
161808063|NCT01439880|584342730|FG001|All-IP Period (Years 2 to 5)|Death|13|||
161808064|NCT01439880|584342729|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
161808065|NCT01439880|584342730|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
161808066|NCT01439880|584342729|FG000|All-IP Period (Years 2 to 5)|Other|14|||
161808067|NCT01439880|584342730|FG001|All-IP Period (Years 2 to 5)|Other|31|||
161808068|NCT01439880|584342729|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
161808069|NCT01439880|584342730|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
161808070|NCT02378935|584342733|FG000|Overall Study|Lack of Efficacy|10|||
161808071|NCT02378935|584342734|FG001|Overall Study|Lack of Efficacy|0|||
161808072|NCT02378935|584342735|FG002|Overall Study|Lack of Efficacy|2|||
161808073|NCT02378935|584342736|FG003|Overall Study|Lack of Efficacy|6|||
161808074|NCT02378935|584342737|FG004|Overall Study|Lack of Efficacy|0|||
161808075|NCT02378935|584342738|FG005|Overall Study|Lack of Efficacy|0|||
161808076|NCT02378935|584342739|FG006|Overall Study|Lack of Efficacy|0|||
161808077|NCT02378935|584342733|FG000|Overall Study|Death|0|||
161808078|NCT02378935|584342734|FG001|Overall Study|Death|0|||
161808079|NCT02378935|584342735|FG002|Overall Study|Death|1|||
161808080|NCT02378935|584342736|FG003|Overall Study|Death|0|||
161808081|NCT02378935|584342737|FG004|Overall Study|Death|0|||
161808082|NCT02378935|584342738|FG005|Overall Study|Death|0|||
161808083|NCT02378935|584342739|FG006|Overall Study|Death|0|||
161808084|NCT03450057|584342744|FG000|Overall Study|Death|17|||
161808085|NCT03450057|584342744|FG000|Overall Study|ICF withdrawal|4|||
161808086|NCT03450057|584342744|FG000|Overall Study|Lost to Follow-up|2|||
161808087|NCT03214952|584342747|FG000|Overall Study|Protocol Deviation|45|||
161808088|NCT03214952|584342747|FG000|Overall Study|Case Report Forms Uncollected|13|||
161808089|NCT03935880|584342748|FG000|Overall Study|Lost to Follow-up|0|||
161808090|NCT03935880|584342749|FG001|Overall Study|Lost to Follow-up|1|||
161808091|NCT02476994|584342750|FG000|Overall Study|Based on feedback from FDA|1|||
161808092|NCT02476994|584342751|FG001|Overall Study|Based on feedback from FDA|0|||
161808093|NCT02246166|584342752|FG000|Overall Study|Protocol Violation|1|||
161808094|NCT02246166|584342753|FG001|Overall Study|Protocol Violation|0|||
161808095|NCT03769896|584342754|FG000|Open-label Phase|Lack of Efficacy|5|||
161808096|NCT03769896|584342755|FG001|Open-label Phase|Lack of Efficacy|0|||
161808097|NCT03769896|584342754|FG000|Open-label Phase|Adverse Event|3|||
161808098|NCT03769896|584342755|FG001|Open-label Phase|Adverse Event|0|||
161808099|NCT03769896|584342754|FG000|Open-label Phase|Withdrawal by Subject|1|||
161808100|NCT03769896|584342755|FG001|Open-label Phase|Withdrawal by Subject|0|||
161808101|NCT01015703|584342756|FG000|Overall Study|Withdrawal by Subject|0|||
161808102|NCT01015703|584342757|FG001|Overall Study|Withdrawal by Subject|1|||
161808103|NCT01015703|584342758|FG002|Overall Study|Withdrawal by Subject|0|||
161808104|NCT01015703|584342759|FG003|Overall Study|Withdrawal by Subject|0|||
161808105|NCT01015703|584342760|FG004|Overall Study|Withdrawal by Subject|0|||
162142799|NCT01281813|585571581|FG002|Overall Study|Sponsor's Decision|7|||
162142800|NCT01281813|585571579|FG000|Overall Study|Switched to Commercially Available Medication|0|||
161808106|NCT01015703|584342756|FG000|Overall Study|Adverse Event|1|||
161808107|NCT01015703|584342757|FG001|Overall Study|Adverse Event|0|||
161808108|NCT01015703|584342758|FG002|Overall Study|Adverse Event|0|||
161808109|NCT01015703|584342759|FG003|Overall Study|Adverse Event|0|||
161808110|NCT01015703|584342760|FG004|Overall Study|Adverse Event|0|||
161808111|NCT01015703|584342756|FG000|Overall Study|Protocol Violation|1|||
161808112|NCT01015703|584342757|FG001|Overall Study|Protocol Violation|0|||
162142801|NCT01281813|585571580|FG001|Overall Study|Switched to Commercially Available Medication|0|||
162142802|NCT01281813|585571581|FG002|Overall Study|Switched to Commercially Available Medication|26|||
162142803|NCT01281813|585571579|FG000|Overall Study|Other|0|||
162142804|NCT01281813|585571580|FG001|Overall Study|Other|1|||
162142805|NCT01281813|585571581|FG002|Overall Study|Other|39|||
162142806|NCT00558363|585571588|FG000|Overall Study|Physician Decision|18|||
162142807|NCT00558363|585571589|FG001|Overall Study|Physician Decision|4|||
162011099|NCT03847896|585097728|FG002|Overall Study|Condition under investigation worsened|0|||
162142808|NCT00558363|585571588|FG000|Overall Study|Withdrawal by Subject|11|||
162142809|NCT00558363|585571589|FG001|Overall Study|Withdrawal by Subject|4|||
162142810|NCT00558363|585571588|FG000|Overall Study|Adverse Event|5|||
162142811|NCT00558363|585571589|FG001|Overall Study|Adverse Event|5|||
162142812|NCT00558363|585571588|FG000|Overall Study|Lack of Efficacy|2|||
162142813|NCT00558363|585571589|FG001|Overall Study|Lack of Efficacy|2|||
162142814|NCT00558363|585571588|FG000|Overall Study|Protocol Violation|2|||
162142815|NCT00558363|585571589|FG001|Overall Study|Protocol Violation|1|||
162142816|NCT00558363|585571588|FG000|Overall Study|Lost to Follow-up|0|||
162142817|NCT00558363|585571589|FG001|Overall Study|Lost to Follow-up|1|||
162142818|NCT00558363|585571588|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
162142819|NCT00558363|585571589|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
162142820|NCT00558363|585571588|FG000|Overall Study|Randomized in Error|1|||
162142821|NCT00558363|585571589|FG001|Overall Study|Randomized in Error|2|||
162142822|NCT00558363|585571588|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
162142823|NCT00558363|585571589|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
162142824|NCT00868192|585571590|FG000|Overall Study|Ineligible|4|||
161911615|NCT03370172|584728618|FG001|Overall Study|Withdrawal by Subject|1|||
161911616|NCT05918055|584728619|FG000|Phase I - Dose Level 1|Ineligible|0|||
161911617|NCT05918055|584728620|FG001|Phase I - Dose Level 1|Ineligible|0|||
161911618|NCT05918055|584728621|FG002|Phase I - Dose Level 1|Ineligible|1|||
161911619|NCT05918055|584728619|FG000|Phase I - Dose Level -1|Physician Decision|1|||
161911620|NCT05918055|584728620|FG001|Phase I - Dose Level -1|Physician Decision|0|||
161911621|NCT05918055|584728621|FG002|Phase I - Dose Level -1|Physician Decision|0|||
161911622|NCT02194465|584728622|FG000|Overall Study|Adverse Event|6|||
161911623|NCT02194465|584728623|FG001|Overall Study|Adverse Event|1|||
161911624|NCT02194465|584728624|FG002|Overall Study|Adverse Event|4|||
161911625|NCT02194465|584728625|FG003|Overall Study|Adverse Event|4|||
161911626|NCT02194465|584728626|FG004|Overall Study|Adverse Event|4|||
161911627|NCT02194465|584728627|FG005|Overall Study|Adverse Event|2|||
161911628|NCT02194465|584728628|FG006|Overall Study|Adverse Event|0|||
161911629|NCT02194465|584728622|FG000|Overall Study|Lost to Follow-up|0|||
161808113|NCT01015703|584342758|FG002|Overall Study|Protocol Violation|0|||
161808114|NCT01015703|584342759|FG003|Overall Study|Protocol Violation|0|||
161808115|NCT01015703|584342760|FG004|Overall Study|Protocol Violation|0|||
161808116|NCT03122535|584342761|FG000|Overall Study|Lost to Follow-up|68|||
161808117|NCT03122535|584342762|FG001|Overall Study|Lost to Follow-up|68|||
161808118|NCT03122535|584342761|FG000|Overall Study|Physician Decision|3|||
161808119|NCT03122535|584342762|FG001|Overall Study|Physician Decision|3|||
161808120|NCT03122535|584342761|FG000|Overall Study|Withdrawal by Subject|2|||
161808121|NCT03122535|584342762|FG001|Overall Study|Withdrawal by Subject|2|||
161808122|NCT00857454|584342765|FG000|Overall Study|Withdrawal by Subject|2|||
161808123|NCT00857454|584342765|FG000|Overall Study|Lost to Follow-up|1|||
161808124|NCT00857454|584342765|FG000|Overall Study|Adverse Event|2|||
161808125|NCT00857454|584342765|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
161911630|NCT02194465|584728623|FG001|Overall Study|Lost to Follow-up|0|||
161911631|NCT02194465|584728624|FG002|Overall Study|Lost to Follow-up|0|||
161911632|NCT02194465|584728625|FG003|Overall Study|Lost to Follow-up|1|||
162142825|NCT02174562|585571592|FG000|Overall Study|Withdrawal by Subject|7|||
162142826|NCT02174562|585571593|FG001|Overall Study|Withdrawal by Subject|2|||
162142827|NCT02174562|585571592|FG000|Overall Study|Death|2|||
161911633|NCT02194465|584728626|FG004|Overall Study|Lost to Follow-up|0|||
161911634|NCT02194465|584728627|FG005|Overall Study|Lost to Follow-up|1|||
162142828|NCT02174562|585571593|FG001|Overall Study|Death|0|||
162142829|NCT02174562|585571592|FG000|Overall Study|Lost to Follow-up|0|||
162142830|NCT02174562|585571593|FG001|Overall Study|Lost to Follow-up|3|||
162142831|NCT00798096|585571595|FG000|Overall Study|Ongoing|2|||
162142832|NCT00843193|585571596|FG000|Overall Study|Adverse Event|2|||
162142833|NCT00843193|585571597|FG001|Overall Study|Adverse Event|4|||
162142834|NCT00843193|585571596|FG000|Overall Study|Lack of Efficacy|1|||
162142835|NCT00843193|585571597|FG001|Overall Study|Lack of Efficacy|1|||
162142836|NCT00843193|585571596|FG000|Overall Study|Protocol Violation|1|||
162142837|NCT00843193|585571597|FG001|Overall Study|Protocol Violation|2|||
162142838|NCT00843193|585571596|FG000|Overall Study|Lost to Follow-up|1|||
162142839|NCT00843193|585571597|FG001|Overall Study|Lost to Follow-up|0|||
162142840|NCT00843193|585571596|FG000|Overall Study|Physician Decision|0|||
162142841|NCT00843193|585571597|FG001|Overall Study|Physician Decision|1|||
162142842|NCT00843193|585571596|FG000|Overall Study|Withdrawal by Subject|3|||
162142843|NCT00843193|585571597|FG001|Overall Study|Withdrawal by Subject|3|||
162142844|NCT04511650|585571598|FG000|Overall Study|Lost to Follow-up|1|||
162142845|NCT04511650|585571599|FG001|Overall Study|Lost to Follow-up|0|||
162142846|NCT04511650|585571600|FG002|Overall Study|Lost to Follow-up|0|||
162142847|NCT04511650|585571598|FG000|Overall Study|Withdrawal by Subject|1|||
162142848|NCT04511650|585571599|FG001|Overall Study|Withdrawal by Subject|0|||
162142849|NCT04511650|585571600|FG002|Overall Study|Withdrawal by Subject|0|||
162142850|NCT04511650|585571598|FG000|Overall Study|reason not provided|0|||
162142851|NCT04511650|585571599|FG001|Overall Study|reason not provided|0|||
162142852|NCT04511650|585571600|FG002|Overall Study|reason not provided|1|||
162142853|NCT04511650|585571598|FG000|Overall Study|Death|1|||
162142854|NCT04511650|585571599|FG001|Overall Study|Death|1|||
162142855|NCT04511650|585571600|FG002|Overall Study|Death|1|||
162142856|NCT03523962|585571606|FG000|Closed Fractures|Death|86|||
162142857|NCT03523962|585571607|FG001|Closed Fractures|Death|71|||
162142858|NCT03523962|585571608|FG002|Closed Fractures|Death|0|||
162142859|NCT03523962|585571609|FG003|Closed Fractures|Death|0|||
162142860|NCT03523962|585571606|FG000|Closed Fractures|Lost to Follow-up|62|||
162142861|NCT03523962|585571607|FG001|Closed Fractures|Lost to Follow-up|36|||
162142862|NCT03523962|585571608|FG002|Closed Fractures|Lost to Follow-up|0|||
162142863|NCT03523962|585571609|FG003|Closed Fractures|Lost to Follow-up|0|||
162142864|NCT03523962|585571606|FG000|Closed Fractures|Withdrawal by Subject|19|||
162142865|NCT03523962|585571607|FG001|Closed Fractures|Withdrawal by Subject|29|||
162142866|NCT03523962|585571608|FG002|Closed Fractures|Withdrawal by Subject|0|||
162142867|NCT03523962|585571609|FG003|Closed Fractures|Withdrawal by Subject|0|||
162142868|NCT03523962|585571606|FG000|Closed Fractures|Incarceration|1|||
162142869|NCT03523962|585571607|FG001|Closed Fractures|Incarceration|4|||
162142870|NCT03523962|585571608|FG002|Closed Fractures|Incarceration|0|||
162142871|NCT03523962|585571609|FG003|Closed Fractures|Incarceration|0|||
162142872|NCT03523962|585571606|FG000|Open Fractures|Death|0|||
162142873|NCT03523962|585571607|FG001|Open Fractures|Death|0|||
162142874|NCT03523962|585571608|FG002|Open Fractures|Death|11|||
162142875|NCT03523962|585571609|FG003|Open Fractures|Death|6|||
162142876|NCT03523962|585571606|FG000|Open Fractures|Lost to Follow-up|0|||
162142877|NCT03523962|585571607|FG001|Open Fractures|Lost to Follow-up|0|||
162142878|NCT03523962|585571608|FG002|Open Fractures|Lost to Follow-up|15|||
162142879|NCT03523962|585571609|FG003|Open Fractures|Lost to Follow-up|8|||
162142880|NCT03523962|585571606|FG000|Open Fractures|Withdrawal by Subject|0|||
162142881|NCT03523962|585571607|FG001|Open Fractures|Withdrawal by Subject|0|||
162142882|NCT03523962|585571608|FG002|Open Fractures|Withdrawal by Subject|6|||
162142883|NCT03523962|585571609|FG003|Open Fractures|Withdrawal by Subject|2|||
162142884|NCT03523962|585571606|FG000|Open Fractures|Incarceration|0|||
162142885|NCT03523962|585571607|FG001|Open Fractures|Incarceration|0|||
162142886|NCT03523962|585571608|FG002|Open Fractures|Incarceration|1|||
162142887|NCT03523962|585571609|FG003|Open Fractures|Incarceration|0|||
162142888|NCT00835380|585571610|FG000|Overall Study|Withdrawal by Subject|2|||
162142889|NCT01081145|585571611|FG000|Open-Label Phase|Lack of Efficacy|56|||
162142890|NCT01081145|585571612|FG001|Open-Label Phase|Lack of Efficacy|0|||
162142891|NCT01081145|585571611|FG000|Open-Label Phase|Response criteria not met|46|||
162142892|NCT01081145|585571612|FG001|Open-Label Phase|Response criteria not met|0|||
162142893|NCT01081145|585571611|FG000|Open-Label Phase|Adverse Event|42|||
162142894|NCT01081145|585571612|FG001|Open-Label Phase|Adverse Event|0|||
162142895|NCT01081145|585571611|FG000|Open-Label Phase|Withdrawal by Subject|41|||
162142896|NCT01081145|585571612|FG001|Open-Label Phase|Withdrawal by Subject|0|||
162142897|NCT01081145|585571611|FG000|Open-Label Phase|Other|12|||
162142898|NCT01081145|585571612|FG001|Open-Label Phase|Other|0|||
162142899|NCT01081145|585571611|FG000|Open-Label Phase|Lost to Follow-up|11|||
162142900|NCT01081145|585571612|FG001|Open-Label Phase|Lost to Follow-up|0|||
162142901|NCT01081145|585571611|FG000|Open-Label Phase|Protocol Violation|4|||
162142902|NCT01081145|585571612|FG001|Open-Label Phase|Protocol Violation|0|||
162142903|NCT01081145|585571611|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
162142904|NCT01081145|585571612|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
162142905|NCT01081145|585571611|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
162142906|NCT01081145|585571612|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
162142907|NCT01081145|585571611|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
162142908|NCT01081145|585571612|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
162142909|NCT01081145|585571611|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
162142910|NCT01081145|585571612|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
162142911|NCT01081145|585571611|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
162142912|NCT01081145|585571612|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
162142913|NCT01081145|585571611|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
162142914|NCT01081145|585571612|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
162142915|NCT01081145|585571611|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
162142916|NCT01081145|585571612|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
162142917|NCT03593070|585571613|FG000|Overall Study|administrative withdrawal|1|||
162142918|NCT03593070|585571614|FG001|Overall Study|administrative withdrawal|1|||
162142919|NCT00881335|585571615|FG000|Overall Study|Lost to Follow-up|3|||
162142920|NCT00881335|585571616|FG001|Overall Study|Lost to Follow-up|2|||
162142921|NCT04538664|585571617|FG000|Overall Study|Withdrawal by Subject|5|||
162142922|NCT04538664|585571618|FG001|Overall Study|Withdrawal by Subject|9|||
162142923|NCT04538664|585571617|FG000|Overall Study|Lost to Follow-up|2|||
162142924|NCT04538664|585571618|FG001|Overall Study|Lost to Follow-up|1|||
162142925|NCT04538664|585571617|FG000|Overall Study|Ongoing|106|||
162142926|NCT04538664|585571618|FG001|Overall Study|Ongoing|115|||
162142927|NCT03681678|585571621|FG000|Overall Study|Lost to Follow-up|20|||
162142928|NCT00828945|585571624|FG000|Overall Study|Death|4|||
162142929|NCT00828945|585571624|FG000|Overall Study|Participant was missing|1|||
162142930|NCT00828945|585571624|FG000|Overall Study|Other|36|||
162142931|NCT03431350|585571627|FG000|Overall Study|ONGOING|0|||
162142932|NCT03431350|585571628|FG001|Overall Study|ONGOING|0|||
162142933|NCT03431350|585571629|FG002|Overall Study|ONGOING|2|||
162142934|NCT03431350|585571630|FG003|Overall Study|ONGOING|0|||
162142935|NCT03431350|585571631|FG004|Overall Study|ONGOING|1|||
161808126|NCT00857454|584342765|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
161808127|NCT00857454|584342765|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
161808128|NCT00984022|584342766|FG000|Overall Study|Lost to Follow-up|10|||
161808129|NCT00984022|584342767|FG001|Overall Study|Lost to Follow-up|14|||
162142936|NCT03431350|585571632|FG005|Overall Study|ONGOING|3|||
162142937|NCT03431350|585571633|FG006|Overall Study|ONGOING|0|||
162142938|NCT03431350|585571634|FG007|Overall Study|ONGOING|1|||
162142939|NCT03431350|585571635|FG008|Overall Study|ONGOING|3|||
162142940|NCT03431350|585571636|FG009|Overall Study|ONGOING|4|||
162142941|NCT03431350|585571637|FG010|Overall Study|ONGOING|2|||
162142942|NCT03431350|585571638|FG011|Overall Study|ONGOING|1|||
161808130|NCT00573443|584342768|FG000|Double-Blind Phase|Lost to Follow-up|1|||
161808131|NCT00573443|584342769|FG001|Double-Blind Phase|Lost to Follow-up|3|||
161808132|NCT00573443|584342770|FG002|Double-Blind Phase|Lost to Follow-up|2|||
161808133|NCT00573443|584342768|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
161808134|NCT00573443|584342769|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
161808135|NCT00573443|584342770|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
161808136|NCT00573443|584342768|FG000|Double-Blind Phase|Adverse Event|1|||
161808137|NCT00573443|584342769|FG001|Double-Blind Phase|Adverse Event|5|||
161808138|NCT00573443|584342770|FG002|Double-Blind Phase|Adverse Event|0|||
161808139|NCT00573443|584342768|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
161808140|NCT00573443|584342769|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
162142943|NCT03431350|585571627|FG000|Overall Study|Death|6|||
162142944|NCT03431350|585571628|FG001|Overall Study|Death|5|||
162142945|NCT03431350|585571629|FG002|Overall Study|Death|18|||
162142946|NCT03431350|585571630|FG003|Overall Study|Death|7|||
162142947|NCT03431350|585571631|FG004|Overall Study|Death|4|||
162142948|NCT03431350|585571632|FG005|Overall Study|Death|3|||
162142949|NCT03431350|585571633|FG006|Overall Study|Death|2|||
162142950|NCT03431350|585571634|FG007|Overall Study|Death|0|||
162142951|NCT03431350|585571635|FG008|Overall Study|Death|0|||
162142952|NCT03431350|585571636|FG009|Overall Study|Death|0|||
162142953|NCT03431350|585571637|FG010|Overall Study|Death|4|||
162142954|NCT03431350|585571638|FG011|Overall Study|Death|0|||
162142955|NCT03431350|585571627|FG000|Overall Study|Lost to Follow-up|0|||
162142956|NCT03431350|585571628|FG001|Overall Study|Lost to Follow-up|1|||
162142957|NCT03431350|585571629|FG002|Overall Study|Lost to Follow-up|0|||
162142958|NCT03431350|585571630|FG003|Overall Study|Lost to Follow-up|0|||
162142959|NCT03431350|585571631|FG004|Overall Study|Lost to Follow-up|0|||
162142960|NCT03431350|585571632|FG005|Overall Study|Lost to Follow-up|0|||
162142961|NCT03431350|585571633|FG006|Overall Study|Lost to Follow-up|0|||
162142962|NCT03431350|585571634|FG007|Overall Study|Lost to Follow-up|0|||
162142963|NCT03431350|585571635|FG008|Overall Study|Lost to Follow-up|0|||
162142964|NCT03431350|585571636|FG009|Overall Study|Lost to Follow-up|0|||
162142965|NCT03431350|585571637|FG010|Overall Study|Lost to Follow-up|0|||
162142966|NCT03431350|585571638|FG011|Overall Study|Lost to Follow-up|0|||
161808141|NCT00573443|584342770|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
162142967|NCT03431350|585571627|FG000|Overall Study|Withdrawal by Subject|0|||
162142968|NCT03431350|585571628|FG001|Overall Study|Withdrawal by Subject|0|||
162142969|NCT03431350|585571629|FG002|Overall Study|Withdrawal by Subject|0|||
162142970|NCT03431350|585571630|FG003|Overall Study|Withdrawal by Subject|1|||
162142971|NCT03431350|585571631|FG004|Overall Study|Withdrawal by Subject|1|||
162142972|NCT03431350|585571632|FG005|Overall Study|Withdrawal by Subject|1|||
162142973|NCT03431350|585571633|FG006|Overall Study|Withdrawal by Subject|0|||
162142974|NCT03431350|585571634|FG007|Overall Study|Withdrawal by Subject|0|||
162142975|NCT03431350|585571635|FG008|Overall Study|Withdrawal by Subject|0|||
162142976|NCT03431350|585571636|FG009|Overall Study|Withdrawal by Subject|2|||
162142977|NCT03431350|585571637|FG010|Overall Study|Withdrawal by Subject|0|||
162142978|NCT03431350|585571638|FG011|Overall Study|Withdrawal by Subject|1|||
162142979|NCT03431350|585571627|FG000|Overall Study|Other|0|||
162142980|NCT03431350|585571628|FG001|Overall Study|Other|0|||
162142981|NCT03431350|585571629|FG002|Overall Study|Other|1|||
162142982|NCT03431350|585571630|FG003|Overall Study|Other|3|||
162142983|NCT03431350|585571631|FG004|Overall Study|Other|2|||
162142984|NCT03431350|585571632|FG005|Overall Study|Other|2|||
162142985|NCT03431350|585571633|FG006|Overall Study|Other|4|||
162142986|NCT03431350|585571634|FG007|Overall Study|Other|0|||
162142987|NCT03431350|585571635|FG008|Overall Study|Other|14|||
162142988|NCT03431350|585571636|FG009|Overall Study|Other|11|||
162142989|NCT03431350|585571637|FG010|Overall Study|Other|11|||
162142990|NCT03431350|585571638|FG011|Overall Study|Other|15|||
162142991|NCT02141074|585571641|FG000|Pre-prophylaxis|Adverse Event|3|||
162142992|NCT02141074|585571642|FG001|Pre-prophylaxis|Adverse Event|0|||
162142993|NCT02141074|585571641|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
162142994|NCT02141074|585571642|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
162142995|NCT02141074|585571641|FG000|Prophylaxis|Adverse Event|0|||
162142996|NCT02141074|585571642|FG001|Prophylaxis|Adverse Event|4|||
162142997|NCT02141074|585571641|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
162142998|NCT02141074|585571642|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
162142999|NCT02141074|585571641|FG000|Prophylaxis|Withdrawal by Subject|0|||
162143000|NCT02141074|585571642|FG001|Prophylaxis|Withdrawal by Subject|1|||
162143001|NCT03536884|585571643|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
162143002|NCT03536884|585571644|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
162143003|NCT03536884|585571645|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162143004|NCT03536884|585571646|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162143005|NCT03536884|585571647|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162143006|NCT03536884|585571648|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162143007|NCT03536884|585571649|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162143008|NCT03536884|585571650|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162143009|NCT03536884|585571651|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162143010|NCT03536884|585571652|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162143011|NCT03536884|585571653|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162143012|NCT03536884|585571654|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
162143013|NCT03536884|585571643|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162143014|NCT03536884|585571644|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
162143015|NCT03536884|585571645|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162143016|NCT03536884|585571646|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162143017|NCT03536884|585571647|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162143018|NCT03536884|585571648|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162143019|NCT03536884|585571649|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162143020|NCT03536884|585571650|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162143021|NCT03536884|585571651|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162143022|NCT03536884|585571652|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162143023|NCT03536884|585571653|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162143024|NCT03536884|585571654|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
162143025|NCT03536884|585571643|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
162143026|NCT03536884|585571644|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
162143027|NCT03536884|585571645|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162143028|NCT03536884|585571646|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162143029|NCT03536884|585571647|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162143030|NCT03536884|585571648|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162143031|NCT03536884|585571649|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162143032|NCT03536884|585571650|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162143033|NCT03536884|585571651|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162143034|NCT03536884|585571652|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162143035|NCT03536884|585571653|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162143036|NCT03536884|585571654|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
162143037|NCT03536884|585571643|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162143038|NCT03536884|585571644|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
162143039|NCT03536884|585571645|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162143040|NCT03536884|585571646|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162143041|NCT03536884|585571647|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162143042|NCT03536884|585571648|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162143043|NCT03536884|585571649|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162143044|NCT03536884|585571650|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162143045|NCT03536884|585571651|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162143046|NCT03536884|585571652|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
161808142|NCT00573443|584342768|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
161808143|NCT00573443|584342769|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
161808144|NCT00573443|584342770|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
161808145|NCT00573443|584342768|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
161808146|NCT00573443|584342769|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
161808147|NCT00573443|584342770|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
161808148|NCT00573443|584342768|FG000|Double-Blind Phase|Protocol Violation|0|||
161808149|NCT00573443|584342769|FG001|Double-Blind Phase|Protocol Violation|2|||
162143047|NCT03536884|585571653|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162143048|NCT03536884|585571654|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
162143049|NCT03536884|585571643|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162143050|NCT03536884|585571644|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
161808150|NCT00573443|584342770|FG002|Double-Blind Phase|Protocol Violation|1|||
161808151|NCT00573443|584342768|FG000|Double-Blind Phase|Other|0|||
161808152|NCT00573443|584342769|FG001|Double-Blind Phase|Other|2|||
161808153|NCT00573443|584342770|FG002|Double-Blind Phase|Other|3|||
161808154|NCT00573443|584342768|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
162143051|NCT03536884|585571645|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162143052|NCT03536884|585571646|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162143053|NCT03536884|585571647|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162143054|NCT03536884|585571648|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162143055|NCT03536884|585571649|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162143056|NCT03536884|585571650|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162143057|NCT03536884|585571651|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162143058|NCT03536884|585571652|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162143059|NCT03536884|585571653|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162143060|NCT03536884|585571654|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
162143061|NCT03536884|585571643|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162143062|NCT03536884|585571644|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
162143063|NCT03536884|585571645|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162143064|NCT03536884|585571646|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162143065|NCT03536884|585571647|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162143066|NCT03536884|585571648|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162143067|NCT03536884|585571649|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162143068|NCT03536884|585571650|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162143069|NCT03536884|585571651|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162143070|NCT03536884|585571652|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162143071|NCT03536884|585571653|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162143072|NCT03536884|585571654|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
162143073|NCT03536884|585571643|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
162143074|NCT03536884|585571644|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
162143075|NCT03536884|585571645|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
162143076|NCT03536884|585571646|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
162143077|NCT03536884|585571647|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
162143078|NCT03536884|585571648|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
162143079|NCT03536884|585571649|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
162143080|NCT03536884|585571650|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
162143081|NCT03536884|585571651|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
162143082|NCT03536884|585571652|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
162143083|NCT03536884|585571653|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
162143084|NCT03536884|585571654|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
162143085|NCT03536884|585571643|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162143086|NCT03536884|585571644|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162143087|NCT03536884|585571645|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
161808155|NCT00573443|584342769|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
161808156|NCT00573443|584342770|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
161808157|NCT00573443|584342768|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
161808158|NCT00573443|584342769|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
161808159|NCT00573443|584342770|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
161808160|NCT00573443|584342768|FG000|Open-Label Extension Phase|Adverse Event|3|||
161808161|NCT00573443|584342769|FG001|Open-Label Extension Phase|Adverse Event|0|||
161808162|NCT00573443|584342770|FG002|Open-Label Extension Phase|Adverse Event|0|||
161808163|NCT00573443|584342768|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
161808164|NCT00573443|584342769|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
161808165|NCT00573443|584342770|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
161808166|NCT00573443|584342768|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
161808167|NCT00573443|584342769|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
161808168|NCT00573443|584342770|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
161808169|NCT00573443|584342768|FG000|Open-Label Extension Phase|Protocol Violation|2|||
161808170|NCT00573443|584342769|FG001|Open-Label Extension Phase|Protocol Violation|0|||
161808171|NCT00573443|584342770|FG002|Open-Label Extension Phase|Protocol Violation|0|||
161808172|NCT00573443|584342768|FG000|Open-Label Extension Phase|Other|2|||
161808173|NCT00573443|584342769|FG001|Open-Label Extension Phase|Other|0|||
161808174|NCT00573443|584342770|FG002|Open-Label Extension Phase|Other|0|||
161808175|NCT04567186|584342774|FG000|Period 1|COVID-19 related|1|||
161808176|NCT04567186|584342775|FG001|Period 1|COVID-19 related|0|||
161808177|NCT04567186|584342774|FG000|Period 1|Protocol Violation|0|||
161808178|NCT04567186|584342775|FG001|Period 1|Protocol Violation|1|||
161808179|NCT04567186|584342774|FG000|Period 1|Adverse Event|0|||
161808180|NCT04567186|584342775|FG001|Period 1|Adverse Event|2|||
161808181|NCT04567186|584342774|FG000|Period 2|COVID-19 Related|0|||
161808182|NCT04567186|584342775|FG001|Period 2|COVID-19 Related|1|||
161808183|NCT04567186|584342774|FG000|Period 2|Protocol Violation|0|||
161808184|NCT04567186|584342775|FG001|Period 2|Protocol Violation|1|||
161808185|NCT04567186|584342774|FG000|Period 2|Lost to Follow-up|0|||
161808186|NCT04567186|584342775|FG001|Period 2|Lost to Follow-up|1|||
161808187|NCT04567186|584342774|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
161808188|NCT04567186|584342775|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
161808189|NCT02924883|584342776|FG000|Overall Study|Death|39|||
161808190|NCT02924883|584342777|FG001|Overall Study|Death|20|||
161808191|NCT02924883|584342776|FG000|Overall Study|Lost to Follow-up|1|||
161808192|NCT02924883|584342777|FG001|Overall Study|Lost to Follow-up|0|||
161808193|NCT02924883|584342776|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
161808194|NCT02924883|584342777|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
161808195|NCT02924883|584342776|FG000|Overall Study|Protocol Violation|1|||
161808196|NCT02924883|584342777|FG001|Overall Study|Protocol Violation|0|||
161808197|NCT02924883|584342776|FG000|Overall Study|Withdrawal by Subject|22|||
161808198|NCT02924883|584342777|FG001|Overall Study|Withdrawal by Subject|16|||
161808199|NCT02924883|584342776|FG000|Overall Study|Progressive Disease|1|||
161808200|NCT02924883|584342777|FG001|Overall Study|Progressive Disease|0|||
161808201|NCT02924883|584342776|FG000|Overall Study|Study Terminated by Sponsor|69|||
161808202|NCT02924883|584342777|FG001|Overall Study|Study Terminated by Sponsor|32|||
161808203|NCT00004562|584342778|FG000|Overall Study|Lost to Follow-up|102|||
161808204|NCT00004562|584342779|FG001|Overall Study|Lost to Follow-up|91|||
161911635|NCT02194465|584728628|FG006|Overall Study|Lost to Follow-up|0|||
161911636|NCT02194465|584728622|FG000|Overall Study|Physician Decision|1|||
161808205|NCT02865850|584342780|FG000|Overall Study|Death|15|||
161808206|NCT02865850|584342781|FG001|Overall Study|Death|19|||
161808207|NCT02865850|584342780|FG000|Overall Study|Withdrawal by Subject|3|||
161808208|NCT02865850|584342781|FG001|Overall Study|Withdrawal by Subject|2|||
161808209|NCT02865850|584342780|FG000|Overall Study|Lost to Follow-up|3|||
161808210|NCT02865850|584342781|FG001|Overall Study|Lost to Follow-up|2|||
162143088|NCT03536884|585571646|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
162143089|NCT03536884|585571647|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
162143090|NCT03536884|585571648|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162143091|NCT03536884|585571649|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162143092|NCT03536884|585571650|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162143093|NCT03536884|585571651|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162143094|NCT03536884|585571652|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162143095|NCT03536884|585571653|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162143096|NCT03536884|585571654|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
162143097|NCT03536884|585571643|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162143098|NCT03536884|585571644|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162143099|NCT03536884|585571645|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162143100|NCT03536884|585571646|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
162143101|NCT03536884|585571647|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
162143102|NCT03536884|585571648|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162143103|NCT03536884|585571649|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
161808211|NCT00552669|584342782|FG000|Overall Study|Death|3|||
161808212|NCT00552669|584342783|FG001|Overall Study|Death|7|||
161808213|NCT00252720|584342787|FG000|Overall Study|Withdrawal by Subject|95|||
161808214|NCT00252720|584342788|FG001|Overall Study|Withdrawal by Subject|97|||
162143104|NCT03536884|585571650|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162143105|NCT03536884|585571651|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162143106|NCT03536884|585571652|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162143107|NCT03536884|585571653|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162143108|NCT03536884|585571654|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
162143109|NCT03536884|585571643|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162143110|NCT03536884|585571644|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162143111|NCT03536884|585571645|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
162143112|NCT03536884|585571646|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
162143113|NCT03536884|585571647|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
162143114|NCT03536884|585571648|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162143115|NCT03536884|585571649|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162143116|NCT03536884|585571650|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162143117|NCT03536884|585571651|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162143118|NCT03536884|585571652|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162143119|NCT03536884|585571653|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162143120|NCT03536884|585571654|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
162143121|NCT03536884|585571643|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162143122|NCT03536884|585571644|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162143123|NCT03536884|585571645|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
162143124|NCT03536884|585571646|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
162143125|NCT03536884|585571647|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
161808215|NCT00252720|584342787|FG000|Overall Study|Death|7|||
161808216|NCT00252720|584342788|FG001|Overall Study|Death|8|||
161808217|NCT00252720|584342787|FG000|Overall Study|Moving|23|||
161808218|NCT00252720|584342788|FG001|Overall Study|Moving|42|||
161808219|NCT00252720|584342787|FG000|Overall Study|Mainly patients lost to follow-up|7|||
161808220|NCT00252720|584342788|FG001|Overall Study|Mainly patients lost to follow-up|18|||
161808221|NCT02481830|584342791|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
161808222|NCT02481830|584342792|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
161808223|NCT02481830|584342791|FG000|Pre-treatment|Withdrawal by Subject|0|||
161808224|NCT02481830|584342792|FG001|Pre-treatment|Withdrawal by Subject|10|||
161808225|NCT02481830|584342791|FG000|Pre-treatment|Disease Progression|1|||
161808226|NCT02481830|584342792|FG001|Pre-treatment|Disease Progression|1|||
161808227|NCT02481830|584342791|FG000|Pre-treatment|Other reasons|0|||
161808228|NCT02481830|584342792|FG001|Pre-treatment|Other reasons|1|||
161808229|NCT02481830|584342791|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
161808230|NCT02481830|584342792|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
161808231|NCT02481830|584342791|FG000|Treatment|Disease Progression|233|||
161808232|NCT02481830|584342792|FG001|Treatment|Disease Progression|171|||
161808233|NCT02481830|584342791|FG000|Treatment|Study drug toxicity|18|||
161808234|NCT02481830|584342792|FG001|Treatment|Study drug toxicity|38|||
161808235|NCT02481830|584342791|FG000|Treatment|Death|1|||
161808236|NCT02481830|584342792|FG001|Treatment|Death|1|||
161808237|NCT02481830|584342791|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
161808238|NCT02481830|584342792|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
161808239|NCT02481830|584342791|FG000|Treatment|Participants request to discontinue Study treatment|6|||
161808240|NCT02481830|584342792|FG001|Treatment|Participants request to discontinue Study treatment|34|||
161808241|NCT02481830|584342791|FG000|Treatment|Withdrawal by Subject|2|||
161808242|NCT02481830|584342792|FG001|Treatment|Withdrawal by Subject|3|||
161808243|NCT02481830|584342791|FG000|Treatment|Lost to Follow-up|1|||
161808244|NCT02481830|584342792|FG001|Treatment|Lost to Follow-up|0|||
161808245|NCT02481830|584342791|FG000|Treatment|Maximum Clinical Benefit|0|||
161808246|NCT02481830|584342792|FG001|Treatment|Maximum Clinical Benefit|5|||
161808247|NCT02481830|584342791|FG000|Treatment|Administrative reason by sponsor|1|||
161808248|NCT02481830|584342792|FG001|Treatment|Administrative reason by sponsor|1|||
161808249|NCT02481830|584342791|FG000|Treatment|Other reasons|6|||
161808250|NCT02481830|584342792|FG001|Treatment|Other reasons|1|||
161808251|NCT00772941|584342793|FG000|Overall Study|CRFs not available|195|||
161808252|NCT00772941|584342793|FG000|Overall Study|Study not completed|16|||
161808253|NCT00772941|584342793|FG000|Overall Study|Missed Visits|374|||
161808254|NCT00772941|584342793|FG000|Overall Study|Poor Compliance|7|||
161808255|NCT00772941|584342793|FG000|Overall Study|GPSP Violation|90|||
161808256|NCT04627038|584342794|FG000|Overall Study|Adverse Event|36|||
161808257|NCT04627038|584342795|FG001|Overall Study|Adverse Event|8|||
161808258|NCT04627038|584342794|FG000|Overall Study|Lost to Follow-up|1|||
161808259|NCT04627038|584342795|FG001|Overall Study|Lost to Follow-up|0|||
161808260|NCT04627038|584342794|FG000|Overall Study|Physician Decision|0|||
161808261|NCT04627038|584342795|FG001|Overall Study|Physician Decision|1|||
161808262|NCT04627038|584342794|FG000|Overall Study|Protocol Violation|3|||
161808263|NCT04627038|584342795|FG001|Overall Study|Protocol Violation|1|||
161808264|NCT04627038|584342794|FG000|Overall Study|Withdrawal by Subject|13|||
161808265|NCT04627038|584342795|FG001|Overall Study|Withdrawal by Subject|3|||
161808266|NCT04627038|584342794|FG000|Overall Study|Non-compliance with study drug|0|||
161808267|NCT04627038|584342795|FG001|Overall Study|Non-compliance with study drug|1|||
161808268|NCT04627038|584342794|FG000|Overall Study|Prohibited Concomitant Medication|1|||
161808269|NCT04627038|584342795|FG001|Overall Study|Prohibited Concomitant Medication|0|||
161808270|NCT02714062|584342801|FG000|Overall Study|Adverse Event|0|||
161808271|NCT02714062|584342802|FG001|Overall Study|Adverse Event|0|||
161808272|NCT02714062|584342803|FG002|Overall Study|Adverse Event|2|||
161808273|NCT02714062|584342801|FG000|Overall Study|Withdrawal by Subject|1|||
161808274|NCT02714062|584342802|FG001|Overall Study|Withdrawal by Subject|0|||
161911637|NCT02194465|584728623|FG001|Overall Study|Physician Decision|0|||
161808275|NCT02714062|584342803|FG002|Overall Study|Withdrawal by Subject|1|||
161808276|NCT02714062|584342801|FG000|Overall Study|Protocol Violation|0|||
161808277|NCT02714062|584342802|FG001|Overall Study|Protocol Violation|1|||
161911638|NCT02194465|584728624|FG002|Overall Study|Physician Decision|0|||
161911639|NCT02194465|584728625|FG003|Overall Study|Physician Decision|0|||
161911640|NCT02194465|584728626|FG004|Overall Study|Physician Decision|0|||
161911641|NCT02194465|584728627|FG005|Overall Study|Physician Decision|0|||
162143126|NCT03536884|585571648|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162143127|NCT03536884|585571649|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162143128|NCT03536884|585571650|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162143129|NCT03536884|585571651|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162143130|NCT03536884|585571652|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162143131|NCT03536884|585571653|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162143132|NCT03536884|585571654|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
162143133|NCT03536884|585571643|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
162143134|NCT03536884|585571644|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
162143135|NCT03536884|585571645|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
162143136|NCT03536884|585571646|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
162143137|NCT03536884|585571647|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
162143138|NCT03536884|585571648|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
162143139|NCT03536884|585571649|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
162143140|NCT03536884|585571650|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
162143141|NCT03536884|585571651|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
162143142|NCT03536884|585571652|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
162143143|NCT03536884|585571653|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
162143144|NCT03536884|585571654|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
162143145|NCT03536884|585571643|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162143146|NCT03536884|585571644|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162143147|NCT03536884|585571645|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
161808278|NCT02714062|584342803|FG002|Overall Study|Protocol Violation|0|||
161808279|NCT02682784|584342804|FG000|Overall Study|Withdrawal by Subject|0|||
161808280|NCT02682784|584342805|FG001|Overall Study|Withdrawal by Subject|2|||
161808281|NCT02682784|584342806|FG002|Overall Study|Withdrawal by Subject|1|||
161808282|NCT02682784|584342807|FG003|Overall Study|Withdrawal by Subject|2|||
161808283|NCT02682784|584342804|FG000|Overall Study|Physician Decision|1|||
161808284|NCT02682784|584342805|FG001|Overall Study|Physician Decision|0|||
161808285|NCT02682784|584342806|FG002|Overall Study|Physician Decision|1|||
161808286|NCT02682784|584342807|FG003|Overall Study|Physician Decision|1|||
161808287|NCT01702987|584342808|FG000|Overall Study|Withdrawal by Subject|1|||
161808288|NCT01702987|584342809|FG001|Overall Study|Withdrawal by Subject|0|||
161808289|NCT00467363|584342810|FG000|Overall Study|Lost to Follow-up|80|||
161808290|NCT00467363|584342811|FG001|Overall Study|Lost to Follow-up|70|||
161808291|NCT03181594|584342812|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
161808292|NCT03181594|584342812|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
161808293|NCT03181594|584342812|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
161808294|NCT03181594|584342812|FG000|Initial Study Protocol (12-month FU)|Death|1|||
161808295|NCT03181594|584342812|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
161808296|NCT03181594|584342812|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
161808297|NCT02017223|584342813|FG000|Overall Study|Algorithm problems|2|||
161808298|NCT00365846|584342815|FG000|Overall Study|Lost to Follow-up|1|||
161808299|NCT00904215|584342816|FG000|Overall Study|Adverse Event|25|||
161808300|NCT00904215|584342816|FG000|Overall Study|Protocol Violation|10|||
161808301|NCT00904215|584342816|FG000|Overall Study|Lost to Follow-up|63|||
161808302|NCT00904215|584342816|FG000|Overall Study|Withdrawal by Subject|9|||
161808303|NCT00904215|584342816|FG000|Overall Study|Other|28|||
161808304|NCT01185821|584342822|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161808305|NCT01185821|584342823|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161808306|NCT01185821|584342824|FG002|Overall Study|Abnormal laboratory value(s)|1|||
161808307|NCT01185821|584342825|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161808308|NCT01185821|584342826|FG004|Overall Study|Abnormal laboratory value(s)|0|||
161808309|NCT01185821|584342822|FG000|Overall Study|Protocol Violation|0|||
161808310|NCT01185821|584342823|FG001|Overall Study|Protocol Violation|0|||
161808311|NCT01185821|584342824|FG002|Overall Study|Protocol Violation|0|||
161808312|NCT01185821|584342825|FG003|Overall Study|Protocol Violation|1|||
161808313|NCT01185821|584342826|FG004|Overall Study|Protocol Violation|1|||
161808314|NCT01185821|584342822|FG000|Overall Study|Abnormal test procedure result|0|||
161808315|NCT01185821|584342823|FG001|Overall Study|Abnormal test procedure result|0|||
161808316|NCT01185821|584342824|FG002|Overall Study|Abnormal test procedure result|0|||
161808317|NCT01185821|584342825|FG003|Overall Study|Abnormal test procedure result|0|||
161808318|NCT01185821|584342826|FG004|Overall Study|Abnormal test procedure result|1|||
161808319|NCT01185821|584342822|FG000|Overall Study|Death|0|||
161808320|NCT01185821|584342823|FG001|Overall Study|Death|1|||
161808321|NCT01185821|584342824|FG002|Overall Study|Death|0|||
161808322|NCT01185821|584342825|FG003|Overall Study|Death|0|||
161808323|NCT01185821|584342826|FG004|Overall Study|Death|0|||
161808324|NCT01185821|584342822|FG000|Overall Study|Condition no longer required study drug|0|||
161808325|NCT01185821|584342823|FG001|Overall Study|Condition no longer required study drug|0|||
162143148|NCT03536884|585571646|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162143149|NCT03536884|585571647|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162143150|NCT03536884|585571648|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
162143151|NCT03536884|585571649|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
162143152|NCT03536884|585571650|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
162143153|NCT03536884|585571651|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
162143154|NCT03536884|585571652|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162143155|NCT03536884|585571653|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162143156|NCT03536884|585571654|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
162143157|NCT03536884|585571643|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162143158|NCT03536884|585571644|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162143159|NCT03536884|585571645|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162143160|NCT03536884|585571646|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
161808326|NCT01185821|584342824|FG002|Overall Study|Condition no longer required study drug|0|||
161808327|NCT01185821|584342825|FG003|Overall Study|Condition no longer required study drug|0|||
161808328|NCT01185821|584342826|FG004|Overall Study|Condition no longer required study drug|1|||
161808329|NCT01185821|584342822|FG000|Overall Study|Adverse Event|2|||
161808330|NCT01185821|584342823|FG001|Overall Study|Adverse Event|3|||
161808331|NCT01185821|584342824|FG002|Overall Study|Adverse Event|1|||
161808332|NCT01185821|584342825|FG003|Overall Study|Adverse Event|2|||
161808333|NCT01185821|584342826|FG004|Overall Study|Adverse Event|5|||
161808334|NCT01185821|584342822|FG000|Overall Study|Lack of Efficacy|0|||
161808335|NCT01185821|584342823|FG001|Overall Study|Lack of Efficacy|0|||
161808336|NCT01185821|584342824|FG002|Overall Study|Lack of Efficacy|3|||
161808337|NCT01185821|584342825|FG003|Overall Study|Lack of Efficacy|0|||
161808338|NCT01185821|584342826|FG004|Overall Study|Lack of Efficacy|9|||
161808339|NCT01185821|584342822|FG000|Overall Study|Withdrawal by Subject|3|||
161808340|NCT01185821|584342823|FG001|Overall Study|Withdrawal by Subject|2|||
161808341|NCT01185821|584342824|FG002|Overall Study|Withdrawal by Subject|2|||
161808342|NCT01185821|584342825|FG003|Overall Study|Withdrawal by Subject|1|||
161808343|NCT01185821|584342826|FG004|Overall Study|Withdrawal by Subject|3|||
161808344|NCT01185821|584342822|FG000|Overall Study|Lost to Follow-up|1|||
161808345|NCT01185821|584342823|FG001|Overall Study|Lost to Follow-up|1|||
161808346|NCT01185821|584342824|FG002|Overall Study|Lost to Follow-up|2|||
161808347|NCT01185821|584342825|FG003|Overall Study|Lost to Follow-up|1|||
161808348|NCT01185821|584342826|FG004|Overall Study|Lost to Follow-up|2|||
161808349|NCT01185821|584342822|FG000|Overall Study|Administrative problems|0|||
161808350|NCT01185821|584342823|FG001|Overall Study|Administrative problems|0|||
161808351|NCT01185821|584342824|FG002|Overall Study|Administrative problems|1|||
161808352|NCT01185821|584342825|FG003|Overall Study|Administrative problems|1|||
161808353|NCT01185821|584342826|FG004|Overall Study|Administrative problems|2|||
161808354|NCT03707912|584342829|FG000|Overall Study|Violation of inclusion criteria|1|||
161808355|NCT03707912|584342830|FG001|Overall Study|Violation of inclusion criteria|0|||
161808356|NCT01313780|584342838|FG000|Overall Study|Lack of Efficacy|4|||
161808357|NCT01313780|584342839|FG001|Overall Study|Lack of Efficacy|2|||
161808358|NCT01313780|584342838|FG000|Overall Study|Adverse Event|6|||
161808359|NCT01313780|584342839|FG001|Overall Study|Adverse Event|11|||
161808360|NCT01313780|584342838|FG000|Overall Study|Withdrawal by Subject|2|||
161808361|NCT01313780|584342839|FG001|Overall Study|Withdrawal by Subject|8|||
161808362|NCT01313780|584342838|FG000|Overall Study|Protocol Violation|10|||
161808363|NCT01313780|584342839|FG001|Overall Study|Protocol Violation|4|||
161808364|NCT01313780|584342838|FG000|Overall Study|missing data|3|||
162011100|NCT03847896|585097729|FG003|Overall Study|Condition under investigation worsened|1|||
162011101|NCT03847896|585097730|FG004|Overall Study|Condition under investigation worsened|1|||
162011102|NCT03847896|585097726|FG000|Overall Study|Lack of Efficacy|0|||
162011103|NCT03847896|585097727|FG001|Overall Study|Lack of Efficacy|0|||
162011104|NCT03847896|585097728|FG002|Overall Study|Lack of Efficacy|0|||
162011105|NCT03847896|585097729|FG003|Overall Study|Lack of Efficacy|2|||
162011106|NCT03847896|585097730|FG004|Overall Study|Lack of Efficacy|2|||
162011107|NCT03847896|585097726|FG000|Overall Study|Other reasons|3|||
162011108|NCT03847896|585097727|FG001|Overall Study|Other reasons|3|||
162011109|NCT03847896|585097728|FG002|Overall Study|Other reasons|1|||
162011110|NCT03847896|585097729|FG003|Overall Study|Other reasons|2|||
162011111|NCT03847896|585097730|FG004|Overall Study|Other reasons|1|||
162011112|NCT02395471|585097731|FG000|Overall Study|Lost to Follow-up|2|||
162011113|NCT02395471|585097732|FG001|Overall Study|Lost to Follow-up|0|||
162143161|NCT03536884|585571647|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162143162|NCT03536884|585571648|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
161808365|NCT01313780|584342839|FG001|Overall Study|missing data|3|||
162143163|NCT03536884|585571649|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162143164|NCT03536884|585571650|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
161808366|NCT00467896|584344173|FG000|Overall Study|Consent Withdrawal|18|||
161808367|NCT00467896|584344173|FG000|Overall Study|Adverse Event|7|||
161808368|NCT00467896|584344173|FG000|Overall Study|Serious Adverse Event|13|||
161808369|NCT00467896|584344173|FG000|Overall Study|Non-compliance|3|||
161808370|NCT00467896|584344173|FG000|Overall Study|Changed therapy|2|||
161808371|NCT00467896|584344173|FG000|Overall Study|Patient received transplant|2|||
161808372|NCT00467896|584344173|FG000|Overall Study|Patient had atrial septostomy|1|||
161808373|NCT00467896|584344173|FG000|Overall Study|Patient weaned off iloprost|1|||
161808374|NCT00467896|584344173|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
161808375|NCT00467896|584344173|FG000|Overall Study|Started intravenous prostacyclin|1|||
161808376|NCT00467896|584344173|FG000|Overall Study|Started inhaled Remodulin|1|||
161808377|NCT00467896|584344173|FG000|Overall Study|Patient had no improvement|1|||
161808378|NCT02847650|584344174|FG000|Overall Study|Adverse Event|2|||
161808379|NCT02847650|584344175|FG001|Overall Study|Adverse Event|4|||
161911642|NCT02194465|584728628|FG006|Overall Study|Physician Decision|0|||
161808380|NCT02847650|584344174|FG000|Overall Study|Lost to Follow-up|1|||
161808381|NCT02847650|584344175|FG001|Overall Study|Lost to Follow-up|0|||
161911643|NCT02194465|584728622|FG000|Overall Study|Protocol Violation|1|||
161911644|NCT02194465|584728623|FG001|Overall Study|Protocol Violation|1|||
161911645|NCT02194465|584728624|FG002|Overall Study|Protocol Violation|2|||
161911646|NCT02194465|584728625|FG003|Overall Study|Protocol Violation|1|||
161911647|NCT02194465|584728626|FG004|Overall Study|Protocol Violation|1|||
161911648|NCT02194465|584728627|FG005|Overall Study|Protocol Violation|0|||
161911649|NCT02194465|584728628|FG006|Overall Study|Protocol Violation|0|||
161911650|NCT02194465|584728622|FG000|Overall Study|Withdrawal by Subject|1|||
161911651|NCT02194465|584728623|FG001|Overall Study|Withdrawal by Subject|3|||
161911652|NCT02194465|584728624|FG002|Overall Study|Withdrawal by Subject|1|||
161808382|NCT02847650|584344174|FG000|Overall Study|Protocol Violation|0|||
161808383|NCT02847650|584344175|FG001|Overall Study|Protocol Violation|1|||
161808384|NCT02847650|584344174|FG000|Overall Study|Withdrawal by Subject|1|||
161808385|NCT02847650|584344175|FG001|Overall Study|Withdrawal by Subject|1|||
161808386|NCT03818581|584344178|FG000|Overall Study|Adverse Event|1|||
161808387|NCT03818581|584344179|FG001|Overall Study|Adverse Event|0|||
161808388|NCT03818581|584344180|FG002|Overall Study|Adverse Event|0|||
161808389|NCT03818581|584344181|FG003|Overall Study|Adverse Event|0|||
161808390|NCT03818581|584344182|FG004|Overall Study|Adverse Event|0|||
161808391|NCT03818581|584344178|FG000|Overall Study|Covid-19|2|||
161808392|NCT03818581|584344179|FG001|Overall Study|Covid-19|0|||
161808393|NCT03818581|584344180|FG002|Overall Study|Covid-19|0|||
161808394|NCT03818581|584344181|FG003|Overall Study|Covid-19|0|||
161808395|NCT03818581|584344182|FG004|Overall Study|Covid-19|1|||
161808396|NCT03818581|584344178|FG000|Overall Study|Withdrawal by Subject|0|||
161808397|NCT03818581|584344179|FG001|Overall Study|Withdrawal by Subject|0|||
161808398|NCT03818581|584344180|FG002|Overall Study|Withdrawal by Subject|0|||
161808399|NCT03818581|584344181|FG003|Overall Study|Withdrawal by Subject|0|||
161808400|NCT03818581|584344182|FG004|Overall Study|Withdrawal by Subject|1|||
161808401|NCT03818581|584344178|FG000|Overall Study|No longer met study criteria|0|||
161808402|NCT03818581|584344179|FG001|Overall Study|No longer met study criteria|0|||
161808403|NCT03818581|584344180|FG002|Overall Study|No longer met study criteria|0|||
161808404|NCT03818581|584344181|FG003|Overall Study|No longer met study criteria|0|||
161808405|NCT03818581|584344182|FG004|Overall Study|No longer met study criteria|1|||
161808406|NCT01466166|584344186|FG000|Overall Study|Death|1|||
161808407|NCT01466166|584344186|FG000|Overall Study|Lost to Follow-up|7|||
161808408|NCT01466166|584344186|FG000|Overall Study|Infusion Reaction (IR)|27|||
161808409|NCT01466166|584344186|FG000|Overall Study|Adverse Event (Other than IR)|11|||
161808410|NCT01466166|584344186|FG000|Overall Study|Elevated Serum Uric Acid|78|||
161808411|NCT01466166|584344186|FG000|Overall Study|Withdrawal by Subject|13|||
161808412|NCT01466166|584344186|FG000|Overall Study|Sponsor Decision|4|||
161808413|NCT01466166|584344186|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
161808414|NCT01466166|584344186|FG000|Overall Study|Other|20|||
161808415|NCT02262377|584344187|FG000|Overall Study|Lost to Follow-up|5|||
161808416|NCT02262377|584344188|FG001|Overall Study|Lost to Follow-up|6|||
161808417|NCT02262377|584344187|FG000|Overall Study|Found ineligible after enrollment|3|||
161808418|NCT02262377|584344188|FG001|Overall Study|Found ineligible after enrollment|0|||
161808419|NCT02262377|584344187|FG000|Overall Study|Withdrawal by Subject|4|||
161808420|NCT02262377|584344188|FG001|Overall Study|Withdrawal by Subject|0|||
161808421|NCT00371839|584344189|FG000|Overall Study|Death|4|||
161808422|NCT00371839|584344190|FG001|Overall Study|Death|0|||
161808423|NCT00371839|584344191|FG002|Overall Study|Death|0|||
161808424|NCT00371839|584344189|FG000|Overall Study|Withdrawal by Subject|7|||
161808425|NCT00371839|584344190|FG001|Overall Study|Withdrawal by Subject|4|||
161808426|NCT00371839|584344191|FG002|Overall Study|Withdrawal by Subject|0|||
161808427|NCT00371839|584344189|FG000|Overall Study|Lost to Follow-up|6|||
161808428|NCT00371839|584344190|FG001|Overall Study|Lost to Follow-up|3|||
161808429|NCT00371839|584344191|FG002|Overall Study|Lost to Follow-up|2|||
161808430|NCT02533258|584344193|FG000|Overall Study|Adverse Event|1|||
161808431|NCT02533258|584344193|FG000|Overall Study|Death|2|||
161808432|NCT02533258|584344193|FG000|Overall Study|Other|1|||
161808433|NCT02533258|584344193|FG000|Overall Study|Economic factor|1|||
161808434|NCT02533258|584344193|FG000|Overall Study|Progression of pleural effusion|1|||
161808435|NCT02533258|584344193|FG000|Overall Study|Lack of Efficacy|2|||
161808436|NCT02563561|584344194|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
161808437|NCT02563561|584344195|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
161808438|NCT02563561|584344196|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
161808439|NCT02563561|584344194|FG000|Overall Study|Withdrew of Consent|1|||
161808440|NCT02563561|584344195|FG001|Overall Study|Withdrew of Consent|1|||
162011114|NCT02395471|585097731|FG000|Overall Study|Withdrawal by Subject|2|||
161808441|NCT02563561|584344196|FG002|Overall Study|Withdrew of Consent|2|||
161808442|NCT02563561|584344194|FG000|Overall Study|Lost to Follow-up|1|||
161808443|NCT02563561|584344195|FG001|Overall Study|Lost to Follow-up|1|||
161808444|NCT02563561|584344196|FG002|Overall Study|Lost to Follow-up|0|||
162011115|NCT02395471|585097732|FG001|Overall Study|Withdrawal by Subject|1|||
161808445|NCT02563561|584344194|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
161808446|NCT02563561|584344195|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
161808447|NCT02563561|584344196|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
161808448|NCT02563561|584344194|FG000|Overall Study|Investigator Decision|3|||
161808449|NCT02563561|584344195|FG001|Overall Study|Investigator Decision|4|||
161808450|NCT02563561|584344196|FG002|Overall Study|Investigator Decision|2|||
161808451|NCT02563561|584344194|FG000|Overall Study|Sponsor Decision|5|||
161808452|NCT02563561|584344195|FG001|Overall Study|Sponsor Decision|2|||
161808453|NCT02563561|584344196|FG002|Overall Study|Sponsor Decision|4|||
161808454|NCT02563561|584344194|FG000|Overall Study|Other|1|||
161808455|NCT02563561|584344195|FG001|Overall Study|Other|5|||
161808456|NCT02563561|584344196|FG002|Overall Study|Other|2|||
161808457|NCT02646124|584344197|FG000|Overall Study|Lost to Follow-up|0|||
161808458|NCT02646124|584344198|FG001|Overall Study|Lost to Follow-up|2|||
161808459|NCT03154047|584344199|FG000|Overall Study|Death|1|||
161808460|NCT03154047|584344199|FG000|Overall Study|Study terminated by sponsor|76|||
161808461|NCT03154047|584344199|FG000|Overall Study|Withdrawal by Subject|3|||
161808462|NCT00365365|584344200|FG000|Overall Study|Randomized but not treated|0|||
161808463|NCT00365365|584344201|FG001|Overall Study|Randomized but not treated|2|||
161808464|NCT00365365|584344202|FG002|Overall Study|Randomized but not treated|0|||
161808465|NCT00365365|584344200|FG000|Overall Study|Poor compliance to protocol|0|||
161808466|NCT00365365|584344201|FG001|Overall Study|Poor compliance to protocol|1|||
161808467|NCT00365365|584344202|FG002|Overall Study|Poor compliance to protocol|0|||
161808468|NCT00365365|584344200|FG000|Overall Study|Lost to Follow-up|3|||
161808469|NCT00365365|584344201|FG001|Overall Study|Lost to Follow-up|3|||
161808470|NCT00365365|584344202|FG002|Overall Study|Lost to Follow-up|3|||
161808471|NCT00365365|584344200|FG000|Overall Study|Death|1|||
161808472|NCT00365365|584344201|FG001|Overall Study|Death|3|||
161808473|NCT00365365|584344202|FG002|Overall Study|Death|0|||
161808474|NCT00365365|584344200|FG000|Overall Study|Subject's request|11|||
161808475|NCT00365365|584344201|FG001|Overall Study|Subject's request|13|||
161808476|NCT00365365|584344202|FG002|Overall Study|Subject's request|1|||
161808477|NCT00365365|584344200|FG000|Overall Study|Disease progression/relapse|9|||
161808478|NCT00365365|584344201|FG001|Overall Study|Disease progression/relapse|6|||
161808479|NCT00365365|584344202|FG002|Overall Study|Disease progression/relapse|7|||
161808480|NCT00365365|584344200|FG000|Overall Study|Adverse Event|6|||
161808481|NCT00365365|584344201|FG001|Overall Study|Adverse Event|6|||
161808482|NCT00365365|584344202|FG002|Overall Study|Adverse Event|3|||
161808483|NCT00365365|584344200|FG000|Overall Study|Moved|2|||
161808484|NCT00365365|584344201|FG001|Overall Study|Moved|0|||
161808485|NCT00365365|584344202|FG002|Overall Study|Moved|0|||
161808486|NCT00365365|584344200|FG000|Overall Study|New cancer|1|||
161808487|NCT00365365|584344201|FG001|Overall Study|New cancer|0|||
161808488|NCT00365365|584344202|FG002|Overall Study|New cancer|0|||
161808489|NCT00365365|584344200|FG000|Overall Study|Withdrew consent|1|||
161808490|NCT00365365|584344201|FG001|Overall Study|Withdrew consent|1|||
161808491|NCT00365365|584344202|FG002|Overall Study|Withdrew consent|0|||
161808492|NCT00365365|584344200|FG000|Overall Study|Second malignancy|0|||
161808493|NCT00365365|584344201|FG001|Overall Study|Second malignancy|1|||
161808494|NCT00365365|584344202|FG002|Overall Study|Second malignancy|0|||
161808495|NCT00365365|584344200|FG000|Overall Study|Patient/physician decision|0|||
161808496|NCT00365365|584344201|FG001|Overall Study|Patient/physician decision|0|||
161808497|NCT00365365|584344202|FG002|Overall Study|Patient/physician decision|1|||
161808498|NCT00838630|584344203|FG000|First Intervention|Adverse Event|1|||
161808499|NCT00838630|584344204|FG001|First Intervention|Adverse Event|0|||
161808500|NCT00838630|584344203|FG000|Washout: 7 Days|Protocol Violation|1|||
161808501|NCT00838630|584344204|FG001|Washout: 7 Days|Protocol Violation|0|||
161808502|NCT04263649|584344211|FG000|Overall Study|Adverse Event|53|||
161808503|NCT04263649|584344211|FG000|Overall Study|Lost to Follow-up|3|||
161808504|NCT04263649|584344211|FG000|Overall Study|Death|29|||
161808505|NCT04263649|584344211|FG000|Overall Study|Device deficiency|19|||
161808506|NCT04263649|584344211|FG000|Overall Study|other reasons|11|||
161808507|NCT02057458|584344212|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
161808508|NCT02057458|584344213|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
161808509|NCT02057458|584344214|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
161808510|NCT02057458|584344212|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
161808511|NCT02057458|584344213|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
161808512|NCT02057458|584344214|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
161808513|NCT02057458|584344212|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
161808514|NCT02057458|584344213|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
161808515|NCT02057458|584344214|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
161808516|NCT05169710|584344215|FG000|Overall Study|Adverse Event|1|||
161808517|NCT05169710|584344216|FG001|Overall Study|Adverse Event|2|||
161808518|NCT05169710|584344217|FG002|Overall Study|Adverse Event|2|||
161808519|NCT05169710|584344215|FG000|Overall Study|Lost to Follow-up|0|||
161808520|NCT05169710|584344216|FG001|Overall Study|Lost to Follow-up|0|||
161808521|NCT05169710|584344217|FG002|Overall Study|Lost to Follow-up|1|||
161808522|NCT05169710|584344215|FG000|Overall Study|Withdrawal by Subject|2|||
161808523|NCT05169710|584344216|FG001|Overall Study|Withdrawal by Subject|1|||
161808524|NCT05169710|584344217|FG002|Overall Study|Withdrawal by Subject|0|||
161808525|NCT05169710|584344215|FG000|Overall Study|Other Study Discontinuation Reason|0|||
161808526|NCT05169710|584344216|FG001|Overall Study|Other Study Discontinuation Reason|2|||
161808527|NCT05169710|584344217|FG002|Overall Study|Other Study Discontinuation Reason|0|||
161808528|NCT00723710|584344225|FG000|Overall Study|Disease progression|48|||
161808529|NCT00723710|584344225|FG000|Overall Study|Adverse Event|88|||
161808530|NCT00723710|584344225|FG000|Overall Study|Withdrawal by Subject|36|||
161808531|NCT00723710|584344225|FG000|Overall Study|Physician Decision|2|||
161911653|NCT02194465|584728625|FG003|Overall Study|Withdrawal by Subject|2|||
161808532|NCT00468286|584344226|FG000|Overall Study|Adverse Event|1|||
161808533|NCT00468286|584344227|FG001|Overall Study|Adverse Event|6|||
161808534|NCT00468286|584344226|FG000|Overall Study|Protocol Violation|2|||
161808535|NCT00468286|584344227|FG001|Overall Study|Protocol Violation|2|||
161808536|NCT00468286|584344226|FG000|Overall Study|Withdrawal by Subject|4|||
161808537|NCT00468286|584344227|FG001|Overall Study|Withdrawal by Subject|3|||
161808538|NCT00468286|584344226|FG000|Overall Study|Physician Decision|0|||
161808539|NCT00468286|584344227|FG001|Overall Study|Physician Decision|1|||
161808540|NCT02196675|584344229|FG000|Overall Study|Withdrawal by Subject|1|||
161808541|NCT02196675|584344230|FG001|Overall Study|Withdrawal by Subject|0|||
161808542|NCT02196675|584344231|FG002|Overall Study|Withdrawal by Subject|0|||
161808543|NCT02196675|584344229|FG000|Overall Study|Intra-operative surgical exclusion|1|||
161808544|NCT02196675|584344230|FG001|Overall Study|Intra-operative surgical exclusion|1|||
161808545|NCT02196675|584344231|FG002|Overall Study|Intra-operative surgical exclusion|0|||
161808546|NCT02196675|584344229|FG000|Overall Study|Protocol Violation|0|||
161808547|NCT02196675|584344230|FG001|Overall Study|Protocol Violation|1|||
161808548|NCT02196675|584344231|FG002|Overall Study|Protocol Violation|0|||
161808549|NCT02196675|584344229|FG000|Overall Study|Death|0|||
161808550|NCT02196675|584344230|FG001|Overall Study|Death|0|||
161808551|NCT02196675|584344231|FG002|Overall Study|Death|1|||
161808552|NCT03459807|584344232|FG000|Overall Study|Withdrawal due to transplant|0|||
161808553|NCT03459807|584344233|FG001|Overall Study|Withdrawal due to transplant|1|||
161808554|NCT02392000|584344238|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
162011116|NCT02395471|585097731|FG000|Overall Study|Physician Decision|1|||
162011117|NCT02395471|585097732|FG001|Overall Study|Physician Decision|0|||
161911654|NCT02194465|584728626|FG004|Overall Study|Withdrawal by Subject|2|||
161911655|NCT02194465|584728627|FG005|Overall Study|Withdrawal by Subject|1|||
161911656|NCT02194465|584728628|FG006|Overall Study|Withdrawal by Subject|2|||
161911657|NCT02194465|584728622|FG000|Overall Study|Discontinued follow-up period|0|||
161911658|NCT02194465|584728623|FG001|Overall Study|Discontinued follow-up period|2|||
161911659|NCT02194465|584728624|FG002|Overall Study|Discontinued follow-up period|1|||
161911660|NCT02194465|584728625|FG003|Overall Study|Discontinued follow-up period|0|||
161911661|NCT02194465|584728626|FG004|Overall Study|Discontinued follow-up period|2|||
161911662|NCT02194465|584728627|FG005|Overall Study|Discontinued follow-up period|0|||
161911663|NCT02194465|584728628|FG006|Overall Study|Discontinued follow-up period|0|||
161911664|NCT00420745|584728629|FG000|Overall Study|Adverse Event|2|||
161911665|NCT00420745|584728630|FG001|Overall Study|Adverse Event|2|||
161911666|NCT00420745|584728629|FG000|Overall Study|Lost to Follow-up|10|||
161911667|NCT00420745|584728630|FG001|Overall Study|Lost to Follow-up|2|||
161911668|NCT00420745|584728629|FG000|Overall Study|Protocol Violation|1|||
161911669|NCT00420745|584728630|FG001|Overall Study|Protocol Violation|0|||
161911670|NCT00420745|584728629|FG000|Overall Study|Physician Decision|1|||
161911671|NCT00420745|584728630|FG001|Overall Study|Physician Decision|1|||
161911672|NCT00420745|584728629|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
161911673|NCT00420745|584728630|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
161911674|NCT00420745|584728629|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
161911675|NCT00420745|584728630|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
161911676|NCT02058095|584728632|FG000|Overall Study|Adverse Event|1|||
161911677|NCT02058095|584728633|FG001|Overall Study|Adverse Event|0|||
161911678|NCT00726453|584728634|FG000|Primary Enrollment Group|Death|18|||
161911679|NCT00726453|584728635|FG001|Primary Enrollment Group|Death|0|||
161911680|NCT00726453|584728634|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
161911681|NCT00726453|584728635|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
161911682|NCT00726453|584728634|FG000|38 mm Length Group|Death|0|||
161911683|NCT00726453|584728635|FG001|38 mm Length Group|Death|3|||
161911684|NCT01588509|584728639|FG000|Overall Study|Lost to Follow-up|1|||
161911685|NCT01588509|584728640|FG001|Overall Study|Lost to Follow-up|0|||
161911686|NCT01983930|584728641|FG000|Overall Study|Withdrawal by Subject|9|||
161911687|NCT01983930|584728642|FG001|Overall Study|Withdrawal by Subject|8|||
161911688|NCT01983930|584728641|FG000|Overall Study|Adverse Event|0|||
161911689|NCT01983930|584728642|FG001|Overall Study|Adverse Event|1|||
161911690|NCT01454284|584728643|FG000|Overall Study|Adverse Event|20|||
161911691|NCT01454284|584728644|FG001|Overall Study|Adverse Event|7|||
161911692|NCT01454284|584728643|FG000|Overall Study|Death|0|||
161911693|NCT01454284|584728644|FG001|Overall Study|Death|3|||
161911694|NCT01454284|584728643|FG000|Overall Study|Lost to Follow-up|13|||
161911695|NCT01454284|584728644|FG001|Overall Study|Lost to Follow-up|8|||
161911696|NCT01454284|584728643|FG000|Overall Study|Protocol Violation|9|||
161911697|NCT01454284|584728644|FG001|Overall Study|Protocol Violation|6|||
161911698|NCT01454284|584728643|FG000|Overall Study|Withdrawal by Subject|58|||
161911699|NCT01454284|584728644|FG001|Overall Study|Withdrawal by Subject|36|||
161911700|NCT01454284|584728643|FG000|Overall Study|Physician Decision|16|||
161911701|NCT01454284|584728644|FG001|Overall Study|Physician Decision|11|||
161911702|NCT01454284|584728643|FG000|Overall Study|Sponsor Decision|0|||
161911703|NCT01454284|584728644|FG001|Overall Study|Sponsor Decision|2|||
161911704|NCT02842866|584728647|FG000|Overall Study|Serious Adverse Event|0|||
161911705|NCT02842866|584728648|FG001|Overall Study|Serious Adverse Event|1|||
161911706|NCT02842866|584728647|FG000|Overall Study|Protocol Violation|4|||
161911707|NCT02842866|584728648|FG001|Overall Study|Protocol Violation|2|||
161911708|NCT02842866|584728647|FG000|Overall Study|Lost to Follow-up|2|||
161911709|NCT02842866|584728648|FG001|Overall Study|Lost to Follow-up|0|||
161911710|NCT02842866|584728647|FG000|Overall Study|Withdrawal by Subject|1|||
161911711|NCT02842866|584728648|FG001|Overall Study|Withdrawal by Subject|0|||
161911712|NCT01432327|584728649|FG000|Posttest 3 Months|depression|3|||
161911713|NCT01432327|584728650|FG001|Posttest 3 Months|depression|0|||
161911714|NCT01432327|584728651|FG002|Posttest 3 Months|depression|0|||
161911715|NCT01432327|584728652|FG003|Posttest 3 Months|depression|0|||
161911716|NCT01432327|584728649|FG000|Posttest 3 Months|Lost to Follow-up|1|||
161911717|NCT01432327|584728650|FG001|Posttest 3 Months|Lost to Follow-up|0|||
161911718|NCT01432327|584728651|FG002|Posttest 3 Months|Lost to Follow-up|2|||
161911719|NCT01432327|584728652|FG003|Posttest 3 Months|Lost to Follow-up|1|||
161911720|NCT01432327|584728649|FG000|Posttest 3 Months|Allergic reaction|0|||
161911721|NCT01432327|584728650|FG001|Posttest 3 Months|Allergic reaction|2|||
161911722|NCT01432327|584728651|FG002|Posttest 3 Months|Allergic reaction|0|||
161911723|NCT01432327|584728652|FG003|Posttest 3 Months|Allergic reaction|0|||
161911724|NCT01432327|584728649|FG000|Posttest 6 Months|Lost to Follow-up|0|||
161911725|NCT01432327|584728650|FG001|Posttest 6 Months|Lost to Follow-up|0|||
161911726|NCT01432327|584728651|FG002|Posttest 6 Months|Lost to Follow-up|3|||
161911727|NCT01432327|584728652|FG003|Posttest 6 Months|Lost to Follow-up|2|||
161911728|NCT01432327|584728649|FG000|Posttest 6 Months|Allergic reaction|0|||
161911729|NCT01432327|584728650|FG001|Posttest 6 Months|Allergic reaction|0|||
161911730|NCT01432327|584728651|FG002|Posttest 6 Months|Allergic reaction|1|||
161911731|NCT01432327|584728652|FG003|Posttest 6 Months|Allergic reaction|0|||
161911732|NCT01432327|584728649|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
161911733|NCT01432327|584728650|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
161911734|NCT01432327|584728651|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
161911735|NCT01432327|584728652|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
161911736|NCT01432327|584728649|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
161911737|NCT01432327|584728650|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
161911738|NCT01432327|584728651|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
161911739|NCT01432327|584728652|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
161911740|NCT01432327|584728649|FG000|Posttest 1 Year|Lost to Follow-up|0|||
161911741|NCT01432327|584728650|FG001|Posttest 1 Year|Lost to Follow-up|0|||
161911742|NCT01432327|584728651|FG002|Posttest 1 Year|Lost to Follow-up|4|||
161911743|NCT01432327|584728652|FG003|Posttest 1 Year|Lost to Follow-up|2|||
161911744|NCT01432327|584728649|FG000|Posttest 1 Year|Allergic reaction|0|||
161911745|NCT01432327|584728650|FG001|Posttest 1 Year|Allergic reaction|0|||
161911746|NCT01432327|584728651|FG002|Posttest 1 Year|Allergic reaction|1|||
161911747|NCT01432327|584728652|FG003|Posttest 1 Year|Allergic reaction|1|||
161911748|NCT03248037|584728653|FG000|Overall Study|Withdrawal by Subject|6|||
161911749|NCT03248037|584728654|FG001|Overall Study|Withdrawal by Subject|9|||
161808555|NCT02392000|584344238|FG000|Overall Study|Withdrawal by Subject|1|||
161808556|NCT02392000|584344238|FG000|Overall Study|Lost to Follow-up|8|||
161808557|NCT00833937|584344239|FG000|Washout|Withdrawal by Subject|1|||
161808558|NCT00833937|584344240|FG001|Washout|Withdrawal by Subject|0|||
161808559|NCT00576056|584344243|FG000|Overall Study|Adverse Event|1|||
161808560|NCT00576056|584344243|FG000|Overall Study|Death|1|||
161808561|NCT00576056|584344243|FG000|Overall Study|Lack of Efficacy|1|||
161911750|NCT03248037|584728653|FG000|Overall Study|Adverse Event|15|||
161808562|NCT00576056|584344243|FG000|Overall Study|Withdrawal by Subject|2|||
161808563|NCT00576056|584344243|FG000|Overall Study|did not meet eligibility criteria|8|||
161911751|NCT03248037|584728654|FG001|Overall Study|Adverse Event|0|||
161808564|NCT00576056|584344243|FG000|Overall Study|Physician Decision|1|||
161911752|NCT02897349|584728658|FG000|Overall Study|Lost to Follow-up|2|||
161911753|NCT02897349|584728659|FG001|Overall Study|Lost to Follow-up|2|||
161911754|NCT02897349|584728658|FG000|Overall Study|Adverse Event|3|||
161911755|NCT02897349|584728659|FG001|Overall Study|Adverse Event|3|||
161911756|NCT02897349|584728658|FG000|Overall Study|Other than listed above|0|||
161911757|NCT02897349|584728659|FG001|Overall Study|Other than listed above|1|||
161911758|NCT01218802|584728686|FG000|Overall Study|Lost to Follow-up|5|||
161911759|NCT01218802|584728687|FG001|Overall Study|Lost to Follow-up|6|||
161911760|NCT01218802|584728686|FG000|Overall Study|Withdrawal by Subject|3|||
161911761|NCT01218802|584728687|FG001|Overall Study|Withdrawal by Subject|10|||
161911762|NCT01218802|584728686|FG000|Overall Study|Adverse Event|0|||
161911763|NCT01218802|584728687|FG001|Overall Study|Adverse Event|2|||
161911764|NCT01218802|584728686|FG000|Overall Study|Incarcerated|2|||
161911765|NCT01218802|584728687|FG001|Overall Study|Incarcerated|0|||
161911766|NCT00471497|584728689|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
161911767|NCT00471497|584728690|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
161911768|NCT00471497|584728691|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
161911769|NCT00471497|584728689|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
161911770|NCT00471497|584728690|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
161911771|NCT00471497|584728691|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
161911772|NCT00471497|584728689|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
161911773|NCT00471497|584728690|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
161911774|NCT00471497|584728691|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
161911775|NCT00471497|584728689|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
161911776|NCT00471497|584728690|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
161911777|NCT00471497|584728691|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
161911778|NCT00471497|584728689|FG000|Core Treatment Phase|Lost to Follow-up|6|||
161911779|NCT00471497|584728690|FG001|Core Treatment Phase|Lost to Follow-up|6|||
161911780|NCT00471497|584728691|FG002|Core Treatment Phase|Lost to Follow-up|3|||
161911781|NCT00471497|584728689|FG000|Core Treatment Phase|Death|3|||
161911782|NCT00471497|584728690|FG001|Core Treatment Phase|Death|9|||
161911783|NCT00471497|584728691|FG002|Core Treatment Phase|Death|3|||
161911784|NCT00471497|584728689|FG000|Core Treatment Phase|Disease Progression|10|||
161911785|NCT00471497|584728690|FG001|Core Treatment Phase|Disease Progression|2|||
161911786|NCT00471497|584728691|FG002|Core Treatment Phase|Disease Progression|4|||
161911787|NCT00471497|584728689|FG000|Core Treatment Phase|Protocol Violation|6|||
161911788|NCT00471497|584728690|FG001|Core Treatment Phase|Protocol Violation|15|||
161911789|NCT00471497|584728691|FG002|Core Treatment Phase|Protocol Violation|11|||
161911790|NCT00471497|584728689|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
161911791|NCT00471497|584728690|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
161911792|NCT00471497|584728691|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
161911793|NCT00471497|584728689|FG000|Core Treatment Phase|Administrative problems|14|||
161911794|NCT00471497|584728690|FG001|Core Treatment Phase|Administrative problems|14|||
161911795|NCT00471497|584728691|FG002|Core Treatment Phase|Administrative problems|12|||
161911796|NCT00471497|584728689|FG000|Core Treatment Phase|Adverse Event|43|||
161911797|NCT00471497|584728690|FG001|Core Treatment Phase|Adverse Event|53|||
161911798|NCT00471497|584728691|FG002|Core Treatment Phase|Adverse Event|89|||
161911799|NCT00471497|584728689|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
161911800|NCT00471497|584728690|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
161911801|NCT00471497|584728691|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
161911802|NCT00471497|584728689|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
161911803|NCT00471497|584728690|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
161911804|NCT00471497|584728691|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
161911805|NCT00471497|584728689|FG000|Extension Phase|Adverse Event|9|||
161911806|NCT00471497|584728690|FG001|Extension Phase|Adverse Event|5|||
161911807|NCT00471497|584728691|FG002|Extension Phase|Adverse Event|1|||
161911808|NCT00471497|584728689|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
161911809|NCT00471497|584728690|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
161911810|NCT00471497|584728691|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
161911811|NCT00471497|584728689|FG000|Extension Phase|Withdrawal by Subject|3|||
161911812|NCT00471497|584728690|FG001|Extension Phase|Withdrawal by Subject|1|||
161911813|NCT00471497|584728691|FG002|Extension Phase|Withdrawal by Subject|0|||
161911814|NCT00471497|584728689|FG000|Extension Phase|Lost to Follow-up|2|||
161911815|NCT00471497|584728690|FG001|Extension Phase|Lost to Follow-up|0|||
161911816|NCT00471497|584728691|FG002|Extension Phase|Lost to Follow-up|0|||
161911817|NCT00471497|584728689|FG000|Extension Phase|Death|1|||
161911818|NCT00471497|584728690|FG001|Extension Phase|Death|0|||
161911819|NCT00471497|584728691|FG002|Extension Phase|Death|0|||
161911820|NCT00471497|584728689|FG000|Extension Phase|Disease progression|2|||
161911821|NCT00471497|584728690|FG001|Extension Phase|Disease progression|0|||
161808565|NCT03197883|584344244|FG000|Overall Study|Adverse Event|1|||
161808566|NCT03197883|584344245|FG001|Overall Study|Adverse Event|1|||
161808567|NCT03197883|584344244|FG000|Overall Study|Lost to Follow-up|1|||
161808568|NCT03197883|584344245|FG001|Overall Study|Lost to Follow-up|0|||
161808569|NCT03197883|584344244|FG000|Overall Study|Protocol Violation|1|||
161808570|NCT03197883|584344245|FG001|Overall Study|Protocol Violation|0|||
161808571|NCT03197883|584344244|FG000|Overall Study|Other (Not Specified)|0|||
161808572|NCT03197883|584344245|FG001|Overall Study|Other (Not Specified)|5|||
161808573|NCT01353664|584344246|FG000|Overall Study|Other|3|||
161808574|NCT01353664|584344246|FG000|Overall Study|Disease Progression|16|||
161808575|NCT03273153|584344247|FG000|Overall Study|Adverse Event|1|||
161808576|NCT03273153|584344248|FG001|Overall Study|Adverse Event|2|||
161808577|NCT03273153|584344247|FG000|Overall Study|Missing|0|||
161808578|NCT03273153|584344248|FG001|Overall Study|Missing|2|||
161808579|NCT03273153|584344247|FG000|Overall Study|Other|3|||
161808580|NCT03273153|584344248|FG001|Overall Study|Other|2|||
161808581|NCT03273153|584344247|FG000|Overall Study|Symptomatic Deterioration|0|||
161808582|NCT03273153|584344248|FG001|Overall Study|Symptomatic Deterioration|1|||
161808583|NCT03273153|584344247|FG000|Overall Study|Progressive Disease|6|||
161808584|NCT03273153|584344248|FG001|Overall Study|Progressive Disease|5|||
161808585|NCT03273153|584344247|FG000|Overall Study|Physician Decision|1|||
161808586|NCT03273153|584344248|FG001|Overall Study|Physician Decision|3|||
161808587|NCT03273153|584344247|FG000|Overall Study|Study Terminated by Sponsor|112|||
161808588|NCT03273153|584344248|FG001|Overall Study|Study Terminated by Sponsor|102|||
161808589|NCT03273153|584344247|FG000|Overall Study|Withdrawal by Subject|26|||
161808590|NCT03273153|584344248|FG001|Overall Study|Withdrawal by Subject|25|||
161808591|NCT03273153|584344247|FG000|Overall Study|Protocol Deviation|3|||
161808592|NCT03273153|584344248|FG001|Overall Study|Protocol Deviation|0|||
161808593|NCT03273153|584344247|FG000|Overall Study|Lost to Follow-up|6|||
161808594|NCT03273153|584344248|FG001|Overall Study|Lost to Follow-up|11|||
161808595|NCT03273153|584344247|FG000|Overall Study|Death|66|||
161808596|NCT03273153|584344248|FG001|Overall Study|Death|69|||
161808597|NCT00838539|584344249|FG000|Overall Study|Disease Progression|2|||
161808598|NCT00838539|584344250|FG001|Overall Study|Disease Progression|4|||
161808599|NCT00838539|584344251|FG002|Overall Study|Disease Progression|3|||
161808600|NCT00838539|584344252|FG003|Overall Study|Disease Progression|2|||
161808601|NCT00838539|584344253|FG004|Overall Study|Disease Progression|4|||
161911822|NCT00471497|584728691|FG002|Extension Phase|Disease progression|0|||
161808602|NCT00838539|584344254|FG005|Overall Study|Disease Progression|2|||
161808603|NCT00838539|584344255|FG006|Overall Study|Disease Progression|3|||
161808604|NCT00838539|584344256|FG007|Overall Study|Disease Progression|4|||
161911823|NCT00471497|584728689|FG000|Extension Phase|Protocol Violation|2|||
161911824|NCT00471497|584728690|FG001|Extension Phase|Protocol Violation|2|||
161808605|NCT00838539|584344257|FG008|Overall Study|Disease Progression|4|||
161911825|NCT00471497|584728691|FG002|Extension Phase|Protocol Violation|0|||
161911826|NCT04004000|584728692|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
161911827|NCT02121210|584728693|FG000|Overall Study|Adverse Event|5|||
161911828|NCT02121210|584728694|FG001|Overall Study|Adverse Event|7|||
161911829|NCT02121210|584728693|FG000|Overall Study|Lack of Efficacy|2|||
161911830|NCT02121210|584728694|FG001|Overall Study|Lack of Efficacy|0|||
161911831|NCT02121210|584728693|FG000|Overall Study|Other than specified above|0|||
161911832|NCT02121210|584728694|FG001|Overall Study|Other than specified above|2|||
161911833|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
161911834|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
161911835|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911836|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911837|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911838|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911839|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911840|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911841|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911842|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161911843|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
161911844|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
161911845|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911846|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911847|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911848|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911849|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911850|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911851|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911852|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161911853|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
161911854|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911855|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911856|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911857|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911858|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911859|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911860|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911861|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911862|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161911863|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
161911864|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
161911865|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911866|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911867|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911868|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911869|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911870|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911871|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911872|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161911873|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
161911874|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
161911875|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911876|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911877|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911878|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911879|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911880|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911881|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911882|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161911883|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
161911884|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
161911885|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161808606|NCT00838539|584344258|FG009|Overall Study|Disease Progression|5|||
161808607|NCT00838539|584344259|FG010|Overall Study|Disease Progression|1|||
161808608|NCT00838539|584344260|FG011|Overall Study|Disease Progression|4|||
161808609|NCT00838539|584344249|FG000|Overall Study|Adverse Event|1|||
161808610|NCT00838539|584344250|FG001|Overall Study|Adverse Event|1|||
161808611|NCT00838539|584344251|FG002|Overall Study|Adverse Event|1|||
161808612|NCT00838539|584344252|FG003|Overall Study|Adverse Event|1|||
161808613|NCT00838539|584344253|FG004|Overall Study|Adverse Event|2|||
161808614|NCT00838539|584344254|FG005|Overall Study|Adverse Event|1|||
161808615|NCT00838539|584344255|FG006|Overall Study|Adverse Event|0|||
161808616|NCT00838539|584344256|FG007|Overall Study|Adverse Event|2|||
161808617|NCT00838539|584344257|FG008|Overall Study|Adverse Event|0|||
161808618|NCT00838539|584344258|FG009|Overall Study|Adverse Event|1|||
161808619|NCT00838539|584344259|FG010|Overall Study|Adverse Event|2|||
161808620|NCT00838539|584344260|FG011|Overall Study|Adverse Event|0|||
161808621|NCT00838539|584344249|FG000|Overall Study|Withdrawal by Subject|0|||
161808622|NCT00838539|584344250|FG001|Overall Study|Withdrawal by Subject|1|||
161808623|NCT00838539|584344251|FG002|Overall Study|Withdrawal by Subject|0|||
161808624|NCT00838539|584344252|FG003|Overall Study|Withdrawal by Subject|0|||
161808625|NCT00838539|584344253|FG004|Overall Study|Withdrawal by Subject|0|||
161808626|NCT00838539|584344254|FG005|Overall Study|Withdrawal by Subject|0|||
161808627|NCT00838539|584344255|FG006|Overall Study|Withdrawal by Subject|0|||
161808628|NCT00838539|584344256|FG007|Overall Study|Withdrawal by Subject|0|||
161808629|NCT00838539|584344257|FG008|Overall Study|Withdrawal by Subject|0|||
161808630|NCT00838539|584344258|FG009|Overall Study|Withdrawal by Subject|1|||
161808631|NCT00838539|584344259|FG010|Overall Study|Withdrawal by Subject|2|||
161808632|NCT00838539|584344260|FG011|Overall Study|Withdrawal by Subject|0|||
161911886|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
162143165|NCT03536884|585571651|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162143166|NCT03536884|585571652|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162143167|NCT03536884|585571653|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162143168|NCT03536884|585571654|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
162143169|NCT03536884|585571643|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162143170|NCT03536884|585571644|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162143171|NCT03536884|585571645|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162143172|NCT03536884|585571646|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162143173|NCT03536884|585571647|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162143174|NCT03536884|585571648|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
162143175|NCT03536884|585571649|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162143176|NCT03536884|585571650|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
162143177|NCT03536884|585571651|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
162143178|NCT03536884|585571652|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162143179|NCT03536884|585571653|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162143180|NCT03536884|585571654|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
162143181|NCT03536884|585571643|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162143182|NCT03536884|585571644|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162143183|NCT03536884|585571645|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162143184|NCT03536884|585571646|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162143185|NCT03536884|585571647|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162143186|NCT03536884|585571648|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
162143187|NCT03536884|585571649|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
162143188|NCT03536884|585571650|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
162143189|NCT03536884|585571651|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
162143190|NCT03536884|585571652|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162143191|NCT03536884|585571653|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162143192|NCT03536884|585571654|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
162143193|NCT03536884|585571643|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162143194|NCT03536884|585571644|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162143195|NCT03536884|585571645|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162143196|NCT03536884|585571646|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162143197|NCT03536884|585571647|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162143198|NCT03536884|585571648|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
162143199|NCT03536884|585571649|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162143200|NCT03536884|585571650|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162143201|NCT03536884|585571651|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162143202|NCT03536884|585571652|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162143203|NCT03536884|585571653|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162143204|NCT03536884|585571654|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
162143205|NCT03536884|585571643|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162143206|NCT03536884|585571644|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161911887|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
162143207|NCT03536884|585571645|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
161808633|NCT00838539|584344249|FG000|Overall Study|Death|0|||
161808634|NCT00838539|584344250|FG001|Overall Study|Death|0|||
161808635|NCT00838539|584344251|FG002|Overall Study|Death|0|||
161808636|NCT00838539|584344252|FG003|Overall Study|Death|0|||
161808637|NCT00838539|584344253|FG004|Overall Study|Death|0|||
161808638|NCT00838539|584344254|FG005|Overall Study|Death|0|||
161808639|NCT00838539|584344255|FG006|Overall Study|Death|1|||
161808640|NCT00838539|584344256|FG007|Overall Study|Death|0|||
161808641|NCT00838539|584344257|FG008|Overall Study|Death|0|||
161808642|NCT00838539|584344258|FG009|Overall Study|Death|0|||
161808643|NCT00838539|584344259|FG010|Overall Study|Death|0|||
161808644|NCT00838539|584344260|FG011|Overall Study|Death|0|||
161808645|NCT00838539|584344249|FG000|Overall Study|Physician Decision|0|||
161808646|NCT00838539|584344250|FG001|Overall Study|Physician Decision|0|||
161808647|NCT00838539|584344251|FG002|Overall Study|Physician Decision|0|||
161808648|NCT00838539|584344252|FG003|Overall Study|Physician Decision|0|||
161808649|NCT00838539|584344253|FG004|Overall Study|Physician Decision|0|||
161808650|NCT00838539|584344254|FG005|Overall Study|Physician Decision|0|||
161808651|NCT00838539|584344255|FG006|Overall Study|Physician Decision|0|||
161808652|NCT00838539|584344256|FG007|Overall Study|Physician Decision|0|||
161808653|NCT00838539|584344257|FG008|Overall Study|Physician Decision|1|||
161808654|NCT00838539|584344258|FG009|Overall Study|Physician Decision|0|||
161808655|NCT00838539|584344259|FG010|Overall Study|Physician Decision|0|||
161808656|NCT00838539|584344260|FG011|Overall Study|Physician Decision|0|||
161808657|NCT00838539|584344249|FG000|Overall Study|Clinical Progression|0|||
161808658|NCT00838539|584344250|FG001|Overall Study|Clinical Progression|0|||
161808659|NCT00838539|584344251|FG002|Overall Study|Clinical Progression|0|||
161808660|NCT00838539|584344252|FG003|Overall Study|Clinical Progression|0|||
161808661|NCT00838539|584344253|FG004|Overall Study|Clinical Progression|0|||
161808662|NCT00838539|584344254|FG005|Overall Study|Clinical Progression|0|||
161808663|NCT00838539|584344255|FG006|Overall Study|Clinical Progression|1|||
161808664|NCT00838539|584344256|FG007|Overall Study|Clinical Progression|0|||
161808665|NCT00838539|584344257|FG008|Overall Study|Clinical Progression|0|||
161808666|NCT00838539|584344258|FG009|Overall Study|Clinical Progression|0|||
161808667|NCT00838539|584344259|FG010|Overall Study|Clinical Progression|0|||
161808668|NCT00838539|584344260|FG011|Overall Study|Clinical Progression|0|||
161808669|NCT00838539|584344249|FG000|Overall Study|Symptomatic Deterioration|0|||
161808670|NCT00838539|584344250|FG001|Overall Study|Symptomatic Deterioration|0|||
161808671|NCT00838539|584344251|FG002|Overall Study|Symptomatic Deterioration|1|||
161808672|NCT00838539|584344252|FG003|Overall Study|Symptomatic Deterioration|1|||
161808673|NCT00838539|584344253|FG004|Overall Study|Symptomatic Deterioration|0|||
161808674|NCT00838539|584344254|FG005|Overall Study|Symptomatic Deterioration|1|||
161808675|NCT00838539|584344255|FG006|Overall Study|Symptomatic Deterioration|0|||
161808676|NCT00838539|584344256|FG007|Overall Study|Symptomatic Deterioration|0|||
161808677|NCT00838539|584344257|FG008|Overall Study|Symptomatic Deterioration|0|||
161808678|NCT00838539|584344258|FG009|Overall Study|Symptomatic Deterioration|1|||
162143208|NCT03536884|585571646|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162143209|NCT03536884|585571647|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162143210|NCT03536884|585571648|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162143211|NCT03536884|585571649|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
162143212|NCT03536884|585571650|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162143213|NCT03536884|585571651|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162143214|NCT03536884|585571652|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162143215|NCT03536884|585571653|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162143216|NCT03536884|585571654|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
162143217|NCT03536884|585571643|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162143218|NCT03536884|585571644|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162143219|NCT03536884|585571645|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162143220|NCT03536884|585571646|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162143221|NCT03536884|585571647|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162143222|NCT03536884|585571648|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161808679|NCT00838539|584344259|FG010|Overall Study|Symptomatic Deterioration|0|||
161808680|NCT00838539|584344260|FG011|Overall Study|Symptomatic Deterioration|0|||
161808681|NCT01908205|584344261|FG000|Overall Study|Lost to Follow-up|2|||
161808682|NCT01908205|584344262|FG001|Overall Study|Lost to Follow-up|0|||
161808683|NCT01908205|584344261|FG000|Overall Study|Withdrawal by Subject|3|||
161808684|NCT01908205|584344262|FG001|Overall Study|Withdrawal by Subject|1|||
161808685|NCT05323396|584344263|FG000|Overall Study|Lost to Follow-up|1|||
161808686|NCT05323396|584344264|FG001|Overall Study|Lost to Follow-up|35|||
161808687|NCT05323396|584344263|FG000|Overall Study|Pregnancy|1|||
161808688|NCT05323396|584344264|FG001|Overall Study|Pregnancy|0|||
161808689|NCT03420300|584344266|FG000|Overall Study|Death|2|||
161911888|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161911889|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161911890|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161911891|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161911892|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161911893|NCT01232283|584728697|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
161911894|NCT01232283|584728698|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
161911895|NCT01232283|584728699|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911896|NCT01232283|584728700|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911897|NCT01232283|584728701|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911898|NCT01232283|584728702|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911899|NCT01232283|584728703|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911900|NCT01232283|584728704|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911901|NCT01232283|584728705|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911902|NCT01232283|584728706|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161911903|NCT01232283|584728697|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911904|NCT01232283|584728698|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911905|NCT01232283|584728699|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
161911906|NCT01232283|584728700|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
161911907|NCT01232283|584728701|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911908|NCT01232283|584728702|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911909|NCT01232283|584728703|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911910|NCT01232283|584728704|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911911|NCT01232283|584728705|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911912|NCT01232283|584728706|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161911913|NCT01232283|584728697|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911914|NCT01232283|584728698|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911915|NCT01232283|584728699|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
161911916|NCT01232283|584728700|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
161911917|NCT01232283|584728701|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911918|NCT01232283|584728702|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911919|NCT01232283|584728703|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911920|NCT01232283|584728704|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911921|NCT01232283|584728705|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911922|NCT01232283|584728706|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161911923|NCT01232283|584728697|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911924|NCT01232283|584728698|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911925|NCT01232283|584728699|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
161911926|NCT01232283|584728700|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911927|NCT01232283|584728701|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911928|NCT01232283|584728702|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911929|NCT01232283|584728703|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911930|NCT01232283|584728704|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911931|NCT01232283|584728705|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911932|NCT01232283|584728706|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161911933|NCT01232283|584728697|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911934|NCT01232283|584728698|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911935|NCT01232283|584728699|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
161911936|NCT01232283|584728700|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
161911937|NCT01232283|584728701|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911938|NCT01232283|584728702|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911939|NCT01232283|584728703|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911940|NCT01232283|584728704|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911941|NCT01232283|584728705|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911942|NCT01232283|584728706|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161911943|NCT01232283|584728697|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911944|NCT01232283|584728698|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911945|NCT01232283|584728699|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
161911946|NCT01232283|584728700|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
161911947|NCT01232283|584728701|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911948|NCT01232283|584728702|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911949|NCT01232283|584728703|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911950|NCT01232283|584728704|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911951|NCT01232283|584728705|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911952|NCT01232283|584728706|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161911953|NCT01232283|584728697|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
161911954|NCT01232283|584728698|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
161911955|NCT01232283|584728699|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
161911956|NCT01232283|584728700|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
161911957|NCT01232283|584728701|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
161911958|NCT01232283|584728702|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
161911959|NCT01232283|584728703|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
161911960|NCT01232283|584728704|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
161911961|NCT01232283|584728705|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
161911962|NCT01232283|584728706|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
161911963|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911964|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911965|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911966|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911967|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
161911968|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
161911969|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911970|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
161911971|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911972|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161911973|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161911974|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161911975|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161808690|NCT04149964|584344274|FG000|Overall Study|Lost to Follow-up|19|||
161808691|NCT04149964|584344275|FG001|Overall Study|Lost to Follow-up|18|||
161808692|NCT01424644|584344276|FG000|Overall Study|Adverse Event|2|||
161808693|NCT01424644|584344277|FG001|Overall Study|Adverse Event|0|||
161808694|NCT01424644|584344276|FG000|Overall Study|Withdrawal by Subject|9|||
161808695|NCT01424644|584344277|FG001|Overall Study|Withdrawal by Subject|12|||
161808696|NCT01424644|584344276|FG000|Overall Study|Lost to Follow-up|16|||
161808697|NCT01424644|584344277|FG001|Overall Study|Lost to Follow-up|12|||
161808698|NCT01424644|584344276|FG000|Overall Study|Protocol Violation|4|||
161808699|NCT01424644|584344277|FG001|Overall Study|Protocol Violation|3|||
161808700|NCT01424644|584344276|FG000|Overall Study|Administrative Reason|1|||
161808701|NCT01424644|584344277|FG001|Overall Study|Administrative Reason|0|||
161808702|NCT01424644|584344276|FG000|Overall Study|Unable to Classify|1|||
161808703|NCT01424644|584344277|FG001|Overall Study|Unable to Classify|0|||
161808704|NCT05593965|584344278|FG000|1st Intervention (1 Day)|Technical error|1|||
161808705|NCT05593965|584344279|FG001|1st Intervention (1 Day)|Technical error|0|||
161808706|NCT02066922|584344282|FG000|Overall Study|Adverse Event|1|||
161808707|NCT00440297|584344283|FG000|Overall Study|Adverse Event|8|||
161808708|NCT00440297|584344284|FG001|Overall Study|Adverse Event|5|||
161808709|NCT00440297|584344283|FG000|Overall Study|Lost to Follow-up|1|||
161808710|NCT00440297|584344284|FG001|Overall Study|Lost to Follow-up|0|||
161808711|NCT00440297|584344283|FG000|Overall Study|Physician Decision|1|||
161808712|NCT00440297|584344284|FG001|Overall Study|Physician Decision|0|||
161808713|NCT00440297|584344283|FG000|Overall Study|Protocol Violation|11|||
161808714|NCT00440297|584344284|FG001|Overall Study|Protocol Violation|7|||
161808715|NCT00440297|584344283|FG000|Overall Study|Withdrawal by Subject|1|||
161808716|NCT00440297|584344284|FG001|Overall Study|Withdrawal by Subject|6|||
161808717|NCT00440297|584344283|FG000|Overall Study|Randomized by mistake|1|||
161808718|NCT00440297|584344284|FG001|Overall Study|Randomized by mistake|0|||
161808719|NCT02445339|584344285|FG000|Overall Study|Physician Decision|1|||
161808720|NCT02445339|584344286|FG001|Overall Study|Physician Decision|0|||
161808721|NCT02445339|584344285|FG000|Overall Study|Lost to Follow-up|11|||
161808722|NCT02445339|584344286|FG001|Overall Study|Lost to Follow-up|15|||
161808723|NCT02024932|584344287|FG000|Overall Study|Adverse Event|2|||
161808724|NCT02024932|584344288|FG001|Overall Study|Adverse Event|3|||
161808725|NCT02024932|584344289|FG002|Overall Study|Adverse Event|0|||
161808726|NCT02024932|584344290|FG003|Overall Study|Adverse Event|0|||
161808727|NCT02024932|584344291|FG004|Overall Study|Adverse Event|2|||
161808728|NCT02024932|584344292|FG005|Overall Study|Adverse Event|0|||
161808729|NCT02024932|584344287|FG000|Overall Study|Abnormal laboratory value|0|||
161808730|NCT02024932|584344288|FG001|Overall Study|Abnormal laboratory value|0|||
161808731|NCT02024932|584344289|FG002|Overall Study|Abnormal laboratory value|0|||
161808732|NCT02024932|584344290|FG003|Overall Study|Abnormal laboratory value|2|||
161808733|NCT02024932|584344291|FG004|Overall Study|Abnormal laboratory value|0|||
161808734|NCT02024932|584344292|FG005|Overall Study|Abnormal laboratory value|0|||
161808735|NCT03206177|584344293|FG000|Overall Study|Withdrawal by Subject|1|||
161808736|NCT03020641|584344294|FG000|Overall Study|Lost to Follow-up|0|||
161808737|NCT03020641|584344295|FG001|Overall Study|Lost to Follow-up|1|||
161808738|NCT03020641|584344294|FG000|Overall Study|Converted to open surgery|2|||
161808739|NCT03020641|584344295|FG001|Overall Study|Converted to open surgery|1|||
161808740|NCT03020641|584344294|FG000|Overall Study|for surgery not performed|0|||
161808741|NCT03020641|584344295|FG001|Overall Study|for surgery not performed|1|||
161808742|NCT00727961|584344296|FG000|Overall Study|Lost to Follow-up|1|||
161808743|NCT00727961|584344296|FG000|Overall Study|Adverse Event|4|||
161808744|NCT00727961|584344296|FG000|Overall Study|Patient's refusal|2|||
161808745|NCT00727961|584344296|FG000|Overall Study|Progression|30|||
161808746|NCT03238781|584344297|FG000|Overall Study|Adverse Event|1|||
161808747|NCT03238781|584344298|FG001|Overall Study|Adverse Event|1|||
161808748|NCT03238781|584344299|FG002|Overall Study|Adverse Event|2|||
161808749|NCT03238781|584344297|FG000|Overall Study|Lost to Follow-up|2|||
161808750|NCT03238781|584344298|FG001|Overall Study|Lost to Follow-up|1|||
161808751|NCT03238781|584344299|FG002|Overall Study|Lost to Follow-up|2|||
161808752|NCT03238781|584344297|FG000|Overall Study|Withdrawal by Subject|23|||
161808753|NCT03238781|584344298|FG001|Overall Study|Withdrawal by Subject|14|||
161808754|NCT03238781|584344299|FG002|Overall Study|Withdrawal by Subject|16|||
161808755|NCT03238781|584344297|FG000|Overall Study|Decision by sponsor|0|||
161808756|NCT03238781|584344298|FG001|Overall Study|Decision by sponsor|1|||
161808757|NCT03238781|584344299|FG002|Overall Study|Decision by sponsor|0|||
161808758|NCT03161405|584344300|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
161808759|NCT01577381|584344301|FG000|Overall Study|Discontinued|2|||
161808760|NCT01577381|584344302|FG001|Overall Study|Discontinued|1|||
161808761|NCT01577381|584344303|FG002|Overall Study|Discontinued|2|||
161808762|NCT01577381|584344304|FG003|Overall Study|Discontinued|2|||
161808763|NCT01577381|584344301|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
161808764|NCT01577381|584344302|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
161808765|NCT01577381|584344303|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
161808766|NCT01577381|584344304|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
161808767|NCT01421277|584344305|FG000|Overall Study|Lack of qualifying event|0|||
161808768|NCT01421277|584344306|FG001|Overall Study|Lack of qualifying event|61|||
161808769|NCT01421277|584344305|FG000|Overall Study|Incomplete baseline data|0|||
161808770|NCT01421277|584344306|FG001|Overall Study|Incomplete baseline data|31|||
161808771|NCT02039908|584344307|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
161808772|NCT02039908|584344308|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
161808773|NCT02039908|584344309|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
161808774|NCT02039908|584344310|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
161808775|NCT02039908|584344307|FG000|Phase 1-Summer|Protocol Violation|6|||
161808776|NCT02039908|584344308|FG001|Phase 1-Summer|Protocol Violation|0|||
161808777|NCT02039908|584344309|FG002|Phase 1-Summer|Protocol Violation|0|||
161911976|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161808778|NCT02039908|584344310|FG003|Phase 1-Summer|Protocol Violation|0|||
161808779|NCT02039908|584344307|FG000|Phase 2-School Year|Lost to Follow-up|0|||
161808780|NCT02039908|584344308|FG001|Phase 2-School Year|Lost to Follow-up|0|||
161808781|NCT02039908|584344309|FG002|Phase 2-School Year|Lost to Follow-up|1|||
161808782|NCT02039908|584344310|FG003|Phase 2-School Year|Lost to Follow-up|3|||
161808783|NCT02039908|584344307|FG000|Phase 2-School Year|Protocol Violation|0|||
161808784|NCT02039908|584344308|FG001|Phase 2-School Year|Protocol Violation|0|||
161808785|NCT02039908|584344309|FG002|Phase 2-School Year|Protocol Violation|3|||
161808786|NCT02039908|584344310|FG003|Phase 2-School Year|Protocol Violation|0|||
161808787|NCT02039908|584344307|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
161808788|NCT02039908|584344308|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
161808789|NCT02039908|584344309|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
161808790|NCT02039908|584344310|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
161808791|NCT01597245|584344311|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
161808792|NCT01597245|584344312|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
161808793|NCT01597245|584344313|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
161808794|NCT01597245|584344314|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
161808795|NCT01597245|584344315|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808796|NCT01597245|584344316|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808797|NCT01597245|584344317|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808798|NCT01597245|584344318|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808799|NCT01597245|584344319|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808800|NCT01597245|584344320|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808801|NCT01597245|584344321|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808802|NCT01597245|584344322|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808803|NCT01597245|584344323|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808804|NCT01597245|584344324|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808805|NCT01597245|584344325|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808806|NCT01597245|584344326|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808807|NCT01597245|584344327|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808808|NCT01597245|584344328|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808809|NCT01597245|584344329|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808810|NCT01597245|584344330|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808811|NCT01597245|584344331|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161808812|NCT01597245|584344311|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
161808813|NCT01597245|584344312|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
161808814|NCT01597245|584344313|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
161808815|NCT01597245|584344314|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
161808816|NCT01597245|584344315|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808817|NCT01597245|584344316|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808818|NCT01597245|584344317|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808819|NCT01597245|584344318|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808820|NCT01597245|584344319|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808821|NCT01597245|584344320|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808822|NCT01597245|584344321|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808823|NCT01597245|584344322|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808824|NCT01597245|584344323|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808825|NCT01597245|584344324|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808826|NCT01597245|584344325|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808827|NCT01597245|584344326|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808828|NCT01597245|584344327|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808829|NCT01597245|584344328|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808830|NCT01597245|584344329|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808831|NCT01597245|584344330|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808832|NCT01597245|584344331|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161808833|NCT01597245|584344311|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
161808834|NCT01597245|584344312|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
161808835|NCT01597245|584344313|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
161808836|NCT01597245|584344314|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
161911977|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
161911978|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161808837|NCT01597245|584344315|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808838|NCT01597245|584344316|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161911979|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
162011118|NCT02395471|585097731|FG000|Overall Study|Protocol Violation|0|||
161911980|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
161911981|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161911982|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161911983|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161911984|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161911985|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161911986|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161911987|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
161911988|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
161911989|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
161911990|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
161911991|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161911992|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161911993|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161911994|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161911995|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161911996|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161911997|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
161911998|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161911999|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161912000|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161912001|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161912002|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161912003|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912004|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912005|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912006|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912007|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
161912008|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912009|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
161912010|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
161912011|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912012|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161912013|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912014|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912015|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912016|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912017|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912018|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912019|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912020|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
161912021|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912022|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161912023|NCT01232283|584728697|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912024|NCT01232283|584728698|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912025|NCT01232283|584728699|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912026|NCT01232283|584728700|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912027|NCT01232283|584728701|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912028|NCT01232283|584728702|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
161912029|NCT01232283|584728703|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912030|NCT01232283|584728704|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912031|NCT01232283|584728705|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912032|NCT01232283|584728706|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161912033|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912034|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912035|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912036|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912037|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912038|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912039|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
162011119|NCT02395471|585097732|FG001|Overall Study|Protocol Violation|1|||
161912040|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161912041|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
161912042|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
161912043|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912044|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912045|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912046|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912047|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912048|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912049|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912050|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161912051|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
161912052|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
161912053|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912054|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912055|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912056|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912057|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912058|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912059|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912060|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161912061|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
161912062|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
161912063|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912064|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912065|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912066|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912067|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912068|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912069|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912070|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161912071|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
161912072|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
161912073|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912074|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912075|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912076|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912077|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912078|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912079|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912080|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161912081|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
161912082|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
161912083|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912084|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912085|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912086|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912087|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912088|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912089|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912090|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912091|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
161912092|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161912093|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912094|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912095|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912096|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912097|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912098|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912099|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912100|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912101|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
161912102|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161912103|NCT01232283|584728697|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
162143223|NCT03536884|585571649|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
162143224|NCT03536884|585571650|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162143225|NCT03536884|585571651|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162143226|NCT03536884|585571652|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162143227|NCT03536884|585571653|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162143228|NCT03536884|585571654|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
162143229|NCT03536884|585571643|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
162143230|NCT03536884|585571644|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
162143231|NCT03536884|585571645|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
162143232|NCT03536884|585571646|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
162143233|NCT03536884|585571647|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
162143234|NCT03536884|585571648|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
162143235|NCT03536884|585571649|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
161912104|NCT01232283|584728698|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912105|NCT01232283|584728699|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912106|NCT01232283|584728700|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912107|NCT01232283|584728701|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912108|NCT01232283|584728702|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912109|NCT01232283|584728703|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912110|NCT01232283|584728704|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161912111|NCT01232283|584728705|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
161912112|NCT01232283|584728706|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
161912113|NCT05117060|584728719|FG000|Overall Study|Adverse Event|3|||
161912114|NCT05117060|584728720|FG001|Overall Study|Adverse Event|5|||
161912115|NCT05117060|584728721|FG002|Overall Study|Adverse Event|6|||
161912116|NCT05117060|584728722|FG003|Overall Study|Adverse Event|1|||
161912117|NCT05117060|584728719|FG000|Overall Study|Lost to Follow-up|0|||
161912118|NCT05117060|584728720|FG001|Overall Study|Lost to Follow-up|0|||
161912119|NCT05117060|584728721|FG002|Overall Study|Lost to Follow-up|0|||
161912120|NCT05117060|584728722|FG003|Overall Study|Lost to Follow-up|1|||
161912121|NCT05117060|584728719|FG000|Overall Study|Lack of Efficacy|4|||
161912122|NCT05117060|584728720|FG001|Overall Study|Lack of Efficacy|5|||
161912123|NCT05117060|584728721|FG002|Overall Study|Lack of Efficacy|2|||
161912124|NCT05117060|584728722|FG003|Overall Study|Lack of Efficacy|6|||
161912125|NCT05117060|584728719|FG000|Overall Study|Withdrawal by Subject|8|||
161912126|NCT05117060|584728720|FG001|Overall Study|Withdrawal by Subject|5|||
161912127|NCT05117060|584728721|FG002|Overall Study|Withdrawal by Subject|5|||
161912128|NCT05117060|584728722|FG003|Overall Study|Withdrawal by Subject|6|||
161912129|NCT05117060|584728719|FG000|Overall Study|Other|2|||
161912130|NCT05117060|584728720|FG001|Overall Study|Other|1|||
161912131|NCT05117060|584728721|FG002|Overall Study|Other|3|||
161912132|NCT05117060|584728722|FG003|Overall Study|Other|1|||
161912133|NCT03141359|584728723|FG000|Overall Study|Death|32|||
161912134|NCT03141359|584728723|FG000|Overall Study|Still On Study (in follow up)|29|||
161912135|NCT05079321|584728724|FG000|Overall Study|Withdrawal by Subject|2|||
161912136|NCT05079321|584728725|FG001|Overall Study|Withdrawal by Subject|2|||
161912137|NCT05079321|584728724|FG000|Overall Study|Lost to Follow-up|0|||
161912138|NCT05079321|584728725|FG001|Overall Study|Lost to Follow-up|1|||
161912139|NCT01081626|584728726|FG000|Overall Study|Dosing error|1|||
161912140|NCT01081626|584728727|FG001|Overall Study|Dosing error|1|||
161912141|NCT01081626|584728726|FG000|Overall Study|Missing Estradiol|25|||
161912142|NCT01081626|584728727|FG001|Overall Study|Missing Estradiol|28|||
161912143|NCT01081626|584728726|FG000|Overall Study|Low antral follicle count|1|||
161912144|NCT01081626|584728727|FG001|Overall Study|Low antral follicle count|0|||
161912145|NCT01081626|584728726|FG000|Overall Study|Overstimulation|0|||
161912146|NCT01081626|584728727|FG001|Overall Study|Overstimulation|1|||
161912147|NCT01081626|584728726|FG000|Overall Study|Lost to Follow-up|0|||
161912148|NCT01081626|584728727|FG001|Overall Study|Lost to Follow-up|1|||
161912149|NCT01081626|584728726|FG000|Overall Study|Other|33|||
161912150|NCT01081626|584728727|FG001|Overall Study|Other|30|||
161912151|NCT02003144|584728728|FG000|Open Label Maintenance Phase|Other than specified|2|||
161912152|NCT02003144|584728729|FG001|Open Label Maintenance Phase|Other than specified|4|||
161912153|NCT02003144|584728728|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
161912154|NCT02003144|584728729|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
161912155|NCT02003144|584728728|FG000|Open Label Maintenance Phase|Pregnancy|0|||
161912156|NCT02003144|584728729|FG001|Open Label Maintenance Phase|Pregnancy|2|||
161912157|NCT02003144|584728728|FG000|Open Label Maintenance Phase|Physician Decision|1|||
161912158|NCT02003144|584728729|FG001|Open Label Maintenance Phase|Physician Decision|1|||
161912159|NCT02003144|584728728|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
161912160|NCT02003144|584728729|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
161912161|NCT02003144|584728728|FG000|Open Label Maintenance Phase|Adverse Event|2|||
161912162|NCT02003144|584728729|FG001|Open Label Maintenance Phase|Adverse Event|1|||
161912163|NCT05965752|584728733|FG000|Overall Study|Adverse Event|0|||
161912164|NCT05965752|584728734|FG001|Overall Study|Adverse Event|1|||
161912165|NCT05965752|584728735|FG002|Overall Study|Adverse Event|0|||
161912166|NCT05965752|584728736|FG003|Overall Study|Adverse Event|1|||
161912167|NCT05965752|584728737|FG004|Overall Study|Adverse Event|3|||
161912168|NCT05965752|584728733|FG000|Overall Study|Lost to Follow-up|2|||
161912169|NCT05965752|584728734|FG001|Overall Study|Lost to Follow-up|0|||
161912170|NCT05965752|584728735|FG002|Overall Study|Lost to Follow-up|1|||
161912171|NCT05965752|584728736|FG003|Overall Study|Lost to Follow-up|1|||
161912172|NCT05965752|584728737|FG004|Overall Study|Lost to Follow-up|1|||
161912173|NCT05965752|584728733|FG000|Overall Study|Withdrawal by Subject|2|||
161912174|NCT05965752|584728734|FG001|Overall Study|Withdrawal by Subject|2|||
161912175|NCT05965752|584728735|FG002|Overall Study|Withdrawal by Subject|1|||
161912176|NCT05965752|584728736|FG003|Overall Study|Withdrawal by Subject|5|||
161912177|NCT05965752|584728737|FG004|Overall Study|Withdrawal by Subject|0|||
162143236|NCT03536884|585571650|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
162143237|NCT03536884|585571651|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
162143238|NCT03536884|585571652|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
161808839|NCT01597245|584344317|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808840|NCT01597245|584344318|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808841|NCT01597245|584344319|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808842|NCT01597245|584344320|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808843|NCT01597245|584344321|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808844|NCT01597245|584344322|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808845|NCT01597245|584344323|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808846|NCT01597245|584344324|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808847|NCT01597245|584344325|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808848|NCT01597245|584344326|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808849|NCT01597245|584344327|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808850|NCT01597245|584344328|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808851|NCT01597245|584344329|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808852|NCT01597245|584344330|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808853|NCT01597245|584344331|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161808854|NCT01597245|584344311|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
161808855|NCT01597245|584344312|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
161808856|NCT01597245|584344313|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
161808857|NCT01597245|584344314|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808858|NCT01597245|584344315|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808859|NCT01597245|584344316|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
162143239|NCT03536884|585571653|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
162143240|NCT03536884|585571654|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
162143241|NCT03536884|585571643|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162143242|NCT03536884|585571644|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162143243|NCT03536884|585571645|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162143244|NCT03536884|585571646|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162143245|NCT03536884|585571647|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162143246|NCT03536884|585571648|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162143247|NCT03536884|585571649|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162143248|NCT03536884|585571650|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162143249|NCT03536884|585571651|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
162143250|NCT03536884|585571652|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162143251|NCT03536884|585571653|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162143252|NCT03536884|585571654|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
162143253|NCT03536884|585571643|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162143254|NCT03536884|585571644|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162143255|NCT03536884|585571645|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162143256|NCT03536884|585571646|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162143257|NCT03536884|585571647|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162143258|NCT03536884|585571648|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162143259|NCT03536884|585571649|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162143260|NCT03536884|585571650|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162143261|NCT03536884|585571651|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
162143262|NCT03536884|585571652|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
162143263|NCT03536884|585571653|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
162143264|NCT03536884|585571654|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
162143265|NCT03536884|585571643|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162143266|NCT03536884|585571644|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162143267|NCT03536884|585571645|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162143268|NCT03536884|585571646|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162143269|NCT03536884|585571647|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162143270|NCT03536884|585571648|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162143271|NCT03536884|585571649|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162143272|NCT03536884|585571650|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162143273|NCT03536884|585571651|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
162143274|NCT03536884|585571652|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
162143275|NCT03536884|585571653|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
162143276|NCT03536884|585571654|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
162143277|NCT03536884|585571643|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162143278|NCT03536884|585571644|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162143279|NCT03536884|585571645|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162143280|NCT03536884|585571646|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161912178|NCT05965752|584728733|FG000|Overall Study|Disease Relapse|1|||
161912179|NCT05965752|584728734|FG001|Overall Study|Disease Relapse|0|||
162143281|NCT03536884|585571647|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
161912180|NCT05965752|584728735|FG002|Overall Study|Disease Relapse|1|||
162143282|NCT03536884|585571648|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162143283|NCT03536884|585571649|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162143284|NCT03536884|585571650|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162143285|NCT03536884|585571651|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162143286|NCT03536884|585571652|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162143287|NCT03536884|585571653|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
162143288|NCT03536884|585571654|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
162143289|NCT03536884|585571643|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162143290|NCT03536884|585571644|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162143291|NCT03536884|585571645|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162143292|NCT03536884|585571646|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162143293|NCT03536884|585571647|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162143294|NCT03536884|585571648|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162143295|NCT03536884|585571649|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162143296|NCT03536884|585571650|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162143297|NCT03536884|585571651|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162143298|NCT03536884|585571652|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162143299|NCT03536884|585571653|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
162143300|NCT03536884|585571654|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
162143301|NCT03536884|585571643|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162143302|NCT03536884|585571644|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162143303|NCT03536884|585571645|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162143304|NCT03536884|585571646|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162143305|NCT03536884|585571647|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162143306|NCT03536884|585571648|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162143307|NCT03536884|585571649|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162143308|NCT03536884|585571650|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162143309|NCT03536884|585571651|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162143310|NCT03536884|585571652|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162143311|NCT03536884|585571653|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
162143312|NCT03536884|585571654|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
162143313|NCT03722446|585571655|FG000|Overall Study|Protocol Violation|15|||
162143314|NCT03722446|585571656|FG001|Overall Study|Protocol Violation|2|||
162143315|NCT04487080|585571663|FG000|Overall Study|Withdrawal by Subject|19|||
162143316|NCT04487080|585571664|FG001|Overall Study|Withdrawal by Subject|18|||
162143317|NCT04487080|585571665|FG002|Overall Study|Withdrawal by Subject|13|||
162143318|NCT04487080|585571663|FG000|Overall Study|Lost to Follow-up|3|||
162143319|NCT04487080|585571664|FG001|Overall Study|Lost to Follow-up|1|||
162143320|NCT04487080|585571665|FG002|Overall Study|Lost to Follow-up|0|||
162143321|NCT04487080|585571663|FG000|Overall Study|Ongoing|313|||
162143322|NCT04487080|585571664|FG001|Overall Study|Ongoing|297|||
162143323|NCT04487080|585571665|FG002|Overall Study|Ongoing|149|||
162143324|NCT03425643|585571666|FG000|Overall Study|Withdrawal by Subject|10|||
162143325|NCT03425643|585571667|FG001|Overall Study|Withdrawal by Subject|12|||
162143326|NCT03425643|585571666|FG000|Overall Study|Lost to Follow-up|2|||
162143327|NCT03425643|585571667|FG001|Overall Study|Lost to Follow-up|0|||
162143328|NCT03425643|585571666|FG000|Overall Study|Death|109|||
162143329|NCT03425643|585571667|FG001|Overall Study|Death|141|||
162143330|NCT03425643|585571666|FG000|Overall Study|Ongoing in study|276|||
162143331|NCT03425643|585571667|FG001|Overall Study|Ongoing in study|247|||
162143332|NCT04133363|585571668|FG000|Overall Study|Lost to Follow-up|2|||
162143333|NCT04133363|585571669|FG001|Overall Study|Lost to Follow-up|1|||
162143334|NCT04133363|585571670|FG002|Overall Study|Lost to Follow-up|4|||
162143335|NCT03354390|585571674|FG000|Level 1|Death|2|||
162143336|NCT03354390|585571675|FG001|Level 1|Death|0|||
162143337|NCT03354390|585571676|FG002|Level 1|Death|0|||
162143338|NCT03354390|585571677|FG003|Level 1|Death|0|||
162143339|NCT03354390|585571674|FG000|Level 1|Physician Decision|1|||
162143340|NCT03354390|585571675|FG001|Level 1|Physician Decision|0|||
162143341|NCT03354390|585571676|FG002|Level 1|Physician Decision|0|||
162143342|NCT03354390|585571677|FG003|Level 1|Physician Decision|0|||
162143343|NCT03354390|585571674|FG000|Level 2|Physician Decision|0|||
162143344|NCT03354390|585571675|FG001|Level 2|Physician Decision|2|||
162143345|NCT03354390|585571676|FG002|Level 2|Physician Decision|0|||
161912181|NCT05965752|584728736|FG003|Overall Study|Disease Relapse|0|||
161912182|NCT05965752|584728737|FG004|Overall Study|Disease Relapse|0|||
161912183|NCT05965752|584728733|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
162143346|NCT03354390|585571677|FG003|Level 2|Physician Decision|0|||
162143347|NCT03354390|585571674|FG000|Level 2|Lack of Efficacy|0|||
162143348|NCT03354390|585571675|FG001|Level 2|Lack of Efficacy|1|||
162143349|NCT03354390|585571676|FG002|Level 2|Lack of Efficacy|0|||
162143350|NCT03354390|585571677|FG003|Level 2|Lack of Efficacy|0|||
162143351|NCT03354390|585571674|FG000|Level 2|Lost to Follow-up|0|||
162143352|NCT03354390|585571675|FG001|Level 2|Lost to Follow-up|1|||
162143353|NCT03354390|585571676|FG002|Level 2|Lost to Follow-up|0|||
162143354|NCT03354390|585571677|FG003|Level 2|Lost to Follow-up|0|||
162143355|NCT03354390|585571674|FG000|Level 3|Death|0|||
162143356|NCT03354390|585571675|FG001|Level 3|Death|0|||
162143357|NCT03354390|585571676|FG002|Level 3|Death|1|||
162143358|NCT03354390|585571677|FG003|Level 3|Death|0|||
162143359|NCT03354390|585571674|FG000|Level 3|Physician Decision|0|||
162143360|NCT03354390|585571675|FG001|Level 3|Physician Decision|0|||
162143361|NCT03354390|585571676|FG002|Level 3|Physician Decision|2|||
162143362|NCT03354390|585571677|FG003|Level 3|Physician Decision|0|||
162143363|NCT03354390|585571674|FG000|Level 4|Death|0|||
162143364|NCT03354390|585571675|FG001|Level 4|Death|0|||
162143365|NCT03354390|585571676|FG002|Level 4|Death|0|||
162143366|NCT03354390|585571677|FG003|Level 4|Death|3|||
162143367|NCT03944512|585571681|FG000|Overall Study|Death|0|||
162143368|NCT03944512|585571682|FG001|Overall Study|Death|0|||
162143369|NCT03944512|585571683|FG002|Overall Study|Death|1|||
162143370|NCT03944512|585571684|FG003|Overall Study|Death|2|||
162143371|NCT03944512|585571681|FG000|Overall Study|Lost to Follow-up|0|||
162143372|NCT03944512|585571682|FG001|Overall Study|Lost to Follow-up|0|||
162143373|NCT03944512|585571683|FG002|Overall Study|Lost to Follow-up|4|||
162143374|NCT03944512|585571684|FG003|Overall Study|Lost to Follow-up|4|||
162143375|NCT03944512|585571681|FG000|Overall Study|refused follow-up|0|||
162143376|NCT03944512|585571682|FG001|Overall Study|refused follow-up|0|||
162143377|NCT03944512|585571683|FG002|Overall Study|refused follow-up|2|||
162143378|NCT03944512|585571684|FG003|Overall Study|refused follow-up|2|||
162143379|NCT01090024|585573125|FG000|Period 1|Met exclusion criteria|0|||
162143380|NCT01090024|585573126|FG001|Period 1|Met exclusion criteria|0|||
162143381|NCT01090024|585573127|FG002|Period 1|Met exclusion criteria|0|||
162143382|NCT01090024|585573128|FG003|Period 1|Met exclusion criteria|0|||
162143383|NCT01090024|585573129|FG004|Period 1|Met exclusion criteria|0|||
162143384|NCT01090024|585573130|FG005|Period 1|Met exclusion criteria|0|||
162143385|NCT01090024|585573131|FG006|Period 1|Met exclusion criteria|0|||
162143386|NCT01090024|585573132|FG007|Period 1|Met exclusion criteria|0|||
162143387|NCT01090024|585573133|FG008|Period 1|Met exclusion criteria|0|||
162143388|NCT01090024|585573134|FG009|Period 1|Met exclusion criteria|0|||
162143389|NCT01090024|585573135|FG010|Period 1|Met exclusion criteria|0|||
162143390|NCT01090024|585573136|FG011|Period 1|Met exclusion criteria|0|||
162143391|NCT01090024|585573137|FG012|Period 1|Met exclusion criteria|0|||
162143392|NCT01090024|585573138|FG013|Period 1|Met exclusion criteria|0|||
162143393|NCT01090024|585573139|FG014|Period 1|Met exclusion criteria|1|||
162143394|NCT01090024|585573140|FG015|Period 1|Met exclusion criteria|0|||
162143395|NCT01090024|585573141|FG016|Period 1|Met exclusion criteria|0|||
162143396|NCT01090024|585573142|FG017|Period 1|Met exclusion criteria|0|||
162143397|NCT01090024|585573125|FG000|Period 1|Adverse Event|0|||
162143398|NCT01090024|585573126|FG001|Period 1|Adverse Event|0|||
162143399|NCT01090024|585573127|FG002|Period 1|Adverse Event|0|||
162143400|NCT01090024|585573128|FG003|Period 1|Adverse Event|0|||
162143401|NCT01090024|585573129|FG004|Period 1|Adverse Event|0|||
162143402|NCT01090024|585573130|FG005|Period 1|Adverse Event|0|||
162143403|NCT01090024|585573131|FG006|Period 1|Adverse Event|0|||
162143404|NCT01090024|585573132|FG007|Period 1|Adverse Event|0|||
162143405|NCT01090024|585573133|FG008|Period 1|Adverse Event|0|||
162143406|NCT01090024|585573134|FG009|Period 1|Adverse Event|1|||
162143407|NCT01090024|585573135|FG010|Period 1|Adverse Event|0|||
162143408|NCT01090024|585573136|FG011|Period 1|Adverse Event|1|||
162143409|NCT01090024|585573137|FG012|Period 1|Adverse Event|0|||
162143410|NCT01090024|585573138|FG013|Period 1|Adverse Event|0|||
162143411|NCT01090024|585573139|FG014|Period 1|Adverse Event|0|||
162143412|NCT01090024|585573140|FG015|Period 1|Adverse Event|0|||
162143413|NCT01090024|585573141|FG016|Period 1|Adverse Event|0|||
162143414|NCT01090024|585573142|FG017|Period 1|Adverse Event|1|||
162143415|NCT01090024|585573125|FG000|Period 1|Withdrawal by Subject|0|||
162143416|NCT01090024|585573126|FG001|Period 1|Withdrawal by Subject|0|||
162143417|NCT01090024|585573127|FG002|Period 1|Withdrawal by Subject|0|||
162143418|NCT01090024|585573128|FG003|Period 1|Withdrawal by Subject|1|||
162143419|NCT01090024|585573129|FG004|Period 1|Withdrawal by Subject|0|||
162143420|NCT01090024|585573130|FG005|Period 1|Withdrawal by Subject|0|||
162143421|NCT01090024|585573131|FG006|Period 1|Withdrawal by Subject|0|||
162143422|NCT01090024|585573132|FG007|Period 1|Withdrawal by Subject|0|||
162143423|NCT01090024|585573133|FG008|Period 1|Withdrawal by Subject|0|||
162143424|NCT01090024|585573134|FG009|Period 1|Withdrawal by Subject|0|||
162143425|NCT01090024|585573135|FG010|Period 1|Withdrawal by Subject|0|||
162143426|NCT01090024|585573136|FG011|Period 1|Withdrawal by Subject|0|||
162143427|NCT01090024|585573137|FG012|Period 1|Withdrawal by Subject|0|||
162143428|NCT01090024|585573138|FG013|Period 1|Withdrawal by Subject|0|||
162143429|NCT01090024|585573139|FG014|Period 1|Withdrawal by Subject|0|||
162143430|NCT01090024|585573140|FG015|Period 1|Withdrawal by Subject|0|||
161808860|NCT01597245|584344317|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808861|NCT01597245|584344318|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808862|NCT01597245|584344319|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808863|NCT01597245|584344320|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808864|NCT01597245|584344321|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808865|NCT01597245|584344322|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808866|NCT01597245|584344323|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808867|NCT01597245|584344324|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161912184|NCT05965752|584728734|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
161912185|NCT05965752|584728735|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
161912186|NCT05965752|584728736|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
161912187|NCT05965752|584728737|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
161912188|NCT05965752|584728733|FG000|Overall Study|Unable to Return for Study Visits|0|||
161808868|NCT01597245|584344325|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808869|NCT01597245|584344326|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808870|NCT01597245|584344327|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808871|NCT01597245|584344328|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808872|NCT01597245|584344329|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808873|NCT01597245|584344330|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808874|NCT01597245|584344331|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161808875|NCT01597245|584344311|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
161808876|NCT01597245|584344312|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808877|NCT01597245|584344313|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808878|NCT01597245|584344314|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
161808879|NCT01597245|584344315|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162143431|NCT01090024|585573141|FG016|Period 1|Withdrawal by Subject|0|||
162143432|NCT01090024|585573142|FG017|Period 1|Withdrawal by Subject|0|||
162143433|NCT01090024|585573125|FG000|Period 1|Lost to Follow-up|0|||
162143434|NCT01090024|585573126|FG001|Period 1|Lost to Follow-up|1|||
162143435|NCT01090024|585573127|FG002|Period 1|Lost to Follow-up|0|||
162143436|NCT01090024|585573128|FG003|Period 1|Lost to Follow-up|0|||
162143437|NCT01090024|585573129|FG004|Period 1|Lost to Follow-up|0|||
162143438|NCT01090024|585573130|FG005|Period 1|Lost to Follow-up|0|||
162143439|NCT01090024|585573131|FG006|Period 1|Lost to Follow-up|0|||
162143440|NCT01090024|585573132|FG007|Period 1|Lost to Follow-up|0|||
162143441|NCT01090024|585573133|FG008|Period 1|Lost to Follow-up|0|||
162143442|NCT01090024|585573134|FG009|Period 1|Lost to Follow-up|0|||
162143443|NCT01090024|585573135|FG010|Period 1|Lost to Follow-up|0|||
162143444|NCT01090024|585573136|FG011|Period 1|Lost to Follow-up|0|||
162143445|NCT01090024|585573137|FG012|Period 1|Lost to Follow-up|0|||
162143446|NCT01090024|585573138|FG013|Period 1|Lost to Follow-up|0|||
162143447|NCT01090024|585573139|FG014|Period 1|Lost to Follow-up|0|||
162143448|NCT01090024|585573140|FG015|Period 1|Lost to Follow-up|0|||
162143449|NCT01090024|585573141|FG016|Period 1|Lost to Follow-up|0|||
162143450|NCT01090024|585573142|FG017|Period 1|Lost to Follow-up|0|||
162143451|NCT01090024|585573125|FG000|Period 2|Lost to Follow-up|0|||
162143452|NCT01090024|585573126|FG001|Period 2|Lost to Follow-up|0|||
162143453|NCT01090024|585573127|FG002|Period 2|Lost to Follow-up|0|||
162143454|NCT01090024|585573128|FG003|Period 2|Lost to Follow-up|1|||
162143455|NCT01090024|585573129|FG004|Period 2|Lost to Follow-up|0|||
162143456|NCT01090024|585573130|FG005|Period 2|Lost to Follow-up|0|||
162143457|NCT01090024|585573131|FG006|Period 2|Lost to Follow-up|0|||
162143458|NCT01090024|585573132|FG007|Period 2|Lost to Follow-up|0|||
162143459|NCT01090024|585573133|FG008|Period 2|Lost to Follow-up|0|||
162143460|NCT01090024|585573134|FG009|Period 2|Lost to Follow-up|0|||
161808880|NCT01597245|584344316|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808881|NCT01597245|584344317|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808882|NCT01597245|584344318|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808883|NCT01597245|584344319|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808884|NCT01597245|584344320|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
162143461|NCT01090024|585573135|FG010|Period 2|Lost to Follow-up|0|||
162143462|NCT01090024|585573136|FG011|Period 2|Lost to Follow-up|0|||
162143463|NCT01090024|585573137|FG012|Period 2|Lost to Follow-up|0|||
162143464|NCT01090024|585573138|FG013|Period 2|Lost to Follow-up|0|||
162143465|NCT01090024|585573139|FG014|Period 2|Lost to Follow-up|0|||
162143466|NCT01090024|585573140|FG015|Period 2|Lost to Follow-up|0|||
162143467|NCT01090024|585573141|FG016|Period 2|Lost to Follow-up|0|||
162143468|NCT01090024|585573142|FG017|Period 2|Lost to Follow-up|0|||
162143469|NCT01090024|585573125|FG000|Period 2|Adverse Event|1|||
162143470|NCT01090024|585573126|FG001|Period 2|Adverse Event|0|||
162143471|NCT01090024|585573127|FG002|Period 2|Adverse Event|0|||
162143472|NCT01090024|585573128|FG003|Period 2|Adverse Event|0|||
162143473|NCT01090024|585573129|FG004|Period 2|Adverse Event|0|||
162143474|NCT01090024|585573130|FG005|Period 2|Adverse Event|0|||
162143475|NCT01090024|585573131|FG006|Period 2|Adverse Event|0|||
162143476|NCT01090024|585573132|FG007|Period 2|Adverse Event|0|||
162143477|NCT01090024|585573133|FG008|Period 2|Adverse Event|0|||
162143478|NCT01090024|585573134|FG009|Period 2|Adverse Event|0|||
162143479|NCT01090024|585573135|FG010|Period 2|Adverse Event|0|||
162143480|NCT01090024|585573136|FG011|Period 2|Adverse Event|0|||
162143481|NCT01090024|585573137|FG012|Period 2|Adverse Event|0|||
162143482|NCT01090024|585573138|FG013|Period 2|Adverse Event|0|||
162143483|NCT01090024|585573139|FG014|Period 2|Adverse Event|0|||
162143484|NCT01090024|585573140|FG015|Period 2|Adverse Event|0|||
162143485|NCT01090024|585573141|FG016|Period 2|Adverse Event|0|||
162143486|NCT01090024|585573142|FG017|Period 2|Adverse Event|0|||
162143487|NCT01090024|585573125|FG000|Period 3|Withdrawal by Subject|0|||
162143488|NCT01090024|585573126|FG001|Period 3|Withdrawal by Subject|0|||
162143489|NCT01090024|585573127|FG002|Period 3|Withdrawal by Subject|0|||
162143490|NCT01090024|585573128|FG003|Period 3|Withdrawal by Subject|0|||
162143491|NCT01090024|585573129|FG004|Period 3|Withdrawal by Subject|0|||
162143492|NCT01090024|585573130|FG005|Period 3|Withdrawal by Subject|0|||
162143493|NCT01090024|585573131|FG006|Period 3|Withdrawal by Subject|0|||
162143494|NCT01090024|585573132|FG007|Period 3|Withdrawal by Subject|0|||
162143495|NCT01090024|585573133|FG008|Period 3|Withdrawal by Subject|0|||
162143496|NCT01090024|585573134|FG009|Period 3|Withdrawal by Subject|0|||
162143497|NCT01090024|585573135|FG010|Period 3|Withdrawal by Subject|0|||
162143498|NCT01090024|585573136|FG011|Period 3|Withdrawal by Subject|0|||
162143499|NCT01090024|585573137|FG012|Period 3|Withdrawal by Subject|0|||
162143500|NCT01090024|585573138|FG013|Period 3|Withdrawal by Subject|0|||
162143501|NCT01090024|585573139|FG014|Period 3|Withdrawal by Subject|0|||
162143502|NCT01090024|585573140|FG015|Period 3|Withdrawal by Subject|1|||
162143503|NCT01090024|585573141|FG016|Period 3|Withdrawal by Subject|0|||
162143504|NCT01090024|585573142|FG017|Period 3|Withdrawal by Subject|0|||
162143505|NCT01090024|585573125|FG000|Period 3|Protocol Violation|0|||
162143506|NCT01090024|585573126|FG001|Period 3|Protocol Violation|0|||
162143507|NCT01090024|585573127|FG002|Period 3|Protocol Violation|0|||
162143508|NCT01090024|585573128|FG003|Period 3|Protocol Violation|0|||
162143509|NCT01090024|585573129|FG004|Period 3|Protocol Violation|0|||
162143510|NCT01090024|585573130|FG005|Period 3|Protocol Violation|0|||
162143511|NCT01090024|585573131|FG006|Period 3|Protocol Violation|0|||
162143512|NCT01090024|585573132|FG007|Period 3|Protocol Violation|0|||
162143513|NCT01090024|585573133|FG008|Period 3|Protocol Violation|1|||
162143514|NCT01090024|585573134|FG009|Period 3|Protocol Violation|0|||
162143515|NCT01090024|585573135|FG010|Period 3|Protocol Violation|0|||
162143516|NCT01090024|585573136|FG011|Period 3|Protocol Violation|0|||
162143517|NCT01090024|585573137|FG012|Period 3|Protocol Violation|0|||
162143518|NCT01090024|585573138|FG013|Period 3|Protocol Violation|0|||
162143519|NCT01090024|585573139|FG014|Period 3|Protocol Violation|0|||
162143520|NCT01090024|585573140|FG015|Period 3|Protocol Violation|0|||
162143521|NCT01090024|585573141|FG016|Period 3|Protocol Violation|0|||
162143522|NCT01090024|585573142|FG017|Period 3|Protocol Violation|0|||
162143523|NCT01090024|585573125|FG000|Period 3|Adverse Event|0|||
162143524|NCT01090024|585573126|FG001|Period 3|Adverse Event|0|||
162143525|NCT01090024|585573127|FG002|Period 3|Adverse Event|0|||
162143526|NCT01090024|585573128|FG003|Period 3|Adverse Event|0|||
162143527|NCT01090024|585573129|FG004|Period 3|Adverse Event|0|||
162143528|NCT01090024|585573130|FG005|Period 3|Adverse Event|1|||
162143529|NCT01090024|585573131|FG006|Period 3|Adverse Event|0|||
161912189|NCT05965752|584728734|FG001|Overall Study|Unable to Return for Study Visits|1|||
161808885|NCT01597245|584344321|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808886|NCT01597245|584344322|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808887|NCT01597245|584344323|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808888|NCT01597245|584344324|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808889|NCT01597245|584344325|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808890|NCT01597245|584344326|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808891|NCT01597245|584344327|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808892|NCT01597245|584344328|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808893|NCT01597245|584344329|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808894|NCT01597245|584344330|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808895|NCT01597245|584344331|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161808896|NCT01597245|584344311|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
161808897|NCT01597245|584344312|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
161808898|NCT01597245|584344313|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
161808899|NCT01597245|584344314|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808900|NCT01597245|584344315|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808901|NCT01597245|584344316|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808902|NCT01597245|584344317|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808903|NCT01597245|584344318|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808904|NCT01597245|584344319|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808905|NCT01597245|584344320|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808906|NCT01597245|584344321|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808907|NCT01597245|584344322|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808908|NCT01597245|584344323|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808909|NCT01597245|584344324|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808910|NCT01597245|584344325|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808911|NCT01597245|584344326|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808912|NCT01597245|584344327|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808913|NCT01597245|584344328|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808914|NCT01597245|584344329|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808915|NCT01597245|584344330|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808916|NCT01597245|584344331|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161808917|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808918|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808919|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808920|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808921|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808922|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
161808923|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
161808924|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808925|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808926|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808927|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808928|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808929|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808930|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808931|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808932|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808933|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808934|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808935|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808936|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808937|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161808938|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808939|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161912190|NCT05965752|584728735|FG002|Overall Study|Unable to Return for Study Visits|0|||
161912191|NCT05965752|584728736|FG003|Overall Study|Unable to Return for Study Visits|3|||
161912192|NCT05965752|584728737|FG004|Overall Study|Unable to Return for Study Visits|1|||
161912193|NCT05965752|584728733|FG000|Overall Study|Early Termination|0|||
161912194|NCT05965752|584728734|FG001|Overall Study|Early Termination|0|||
161912195|NCT05965752|584728735|FG002|Overall Study|Early Termination|1|||
161912196|NCT05965752|584728736|FG003|Overall Study|Early Termination|0|||
161912197|NCT05965752|584728737|FG004|Overall Study|Early Termination|0|||
161912198|NCT05965752|584728733|FG000|Overall Study|Reported Unwanted Symptoms|0|||
161912199|NCT05965752|584728734|FG001|Overall Study|Reported Unwanted Symptoms|0|||
161912200|NCT05965752|584728735|FG002|Overall Study|Reported Unwanted Symptoms|0|||
161912201|NCT05965752|584728736|FG003|Overall Study|Reported Unwanted Symptoms|0|||
161912202|NCT05965752|584728737|FG004|Overall Study|Reported Unwanted Symptoms|1|||
161912203|NCT05965752|584728733|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
161912204|NCT05965752|584728734|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
161912205|NCT05965752|584728735|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
161912206|NCT05965752|584728736|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
161912207|NCT05965752|584728737|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
161912208|NCT02074514|584728739|FG000|Overall Study|Lack of Efficacy|3|||
161912209|NCT02074514|584728740|FG001|Overall Study|Lack of Efficacy|2|||
161912210|NCT02074514|584728739|FG000|Overall Study|Lost to Follow-up|0|||
161912211|NCT02074514|584728740|FG001|Overall Study|Lost to Follow-up|1|||
161912212|NCT02074514|584728739|FG000|Overall Study|Withdrew Consent|0|||
161912213|NCT02074514|584728740|FG001|Overall Study|Withdrew Consent|1|||
161912214|NCT00666237|584728743|FG000|Overall Study|Death|5|||
161912215|NCT00666237|584728744|FG001|Overall Study|Death|5|||
161912216|NCT00666237|584728743|FG000|Overall Study|Lost to Follow-up|29|||
161912217|NCT00666237|584728744|FG001|Overall Study|Lost to Follow-up|25|||
161912218|NCT02839707|584728746|FG000|Phase I|Not eligible for analysis|9|||
161912219|NCT02839707|584728747|FG001|Phase I|Not eligible for analysis|0|||
161912220|NCT02839707|584728748|FG002|Phase I|Not eligible for analysis|0|||
161912221|NCT02839707|584728746|FG000|Phase II|Not treated according to protocol|4|||
161912222|NCT02839707|584728747|FG001|Phase II|Not treated according to protocol|0|||
161912223|NCT02839707|584728748|FG002|Phase II|Not treated according to protocol|2|||
161912224|NCT02839707|584728746|FG000|Phase III|Not treated according to protocol|0|||
161912225|NCT02839707|584728747|FG001|Phase III|Not treated according to protocol|0|||
161912226|NCT02839707|584728748|FG002|Phase III|Not treated according to protocol|4|||
161912227|NCT00109343|584730049|FG000|Overall Study|Adverse Event|1|||
161912228|NCT00109343|584730050|FG001|Overall Study|Adverse Event|0|||
161912229|NCT00109343|584730051|FG002|Overall Study|Adverse Event|2|||
161912230|NCT00109343|584730049|FG000|Overall Study|Lack of Efficacy|1|||
161912231|NCT00109343|584730050|FG001|Overall Study|Lack of Efficacy|0|||
161912232|NCT00109343|584730051|FG002|Overall Study|Lack of Efficacy|0|||
161912233|NCT00109343|584730049|FG000|Overall Study|Lost to Follow-up|35|||
161912234|NCT00109343|584730050|FG001|Overall Study|Lost to Follow-up|20|||
161912235|NCT00109343|584730051|FG002|Overall Study|Lost to Follow-up|14|||
161912236|NCT00109343|584730049|FG000|Overall Study|Protocol Violation|1|||
161912237|NCT00109343|584730050|FG001|Overall Study|Protocol Violation|2|||
161912238|NCT00109343|584730051|FG002|Overall Study|Protocol Violation|2|||
161912239|NCT00109343|584730049|FG000|Overall Study|Withdrawal by Subject|15|||
161912240|NCT00109343|584730050|FG001|Overall Study|Withdrawal by Subject|11|||
161912241|NCT00109343|584730051|FG002|Overall Study|Withdrawal by Subject|10|||
161912242|NCT00109343|584730049|FG000|Overall Study|Subject Moved|6|||
161912243|NCT00109343|584730050|FG001|Overall Study|Subject Moved|2|||
161912244|NCT00109343|584730051|FG002|Overall Study|Subject Moved|1|||
161912245|NCT00109343|584730049|FG000|Overall Study|Other|5|||
161912246|NCT00109343|584730050|FG001|Overall Study|Other|2|||
161912247|NCT00109343|584730051|FG002|Overall Study|Other|1|||
161912248|NCT01721798|584730054|FG000|Overall Study|Death|0|||
161912249|NCT01721798|584730055|FG001|Overall Study|Death|0|||
161912250|NCT01721798|584730056|FG002|Overall Study|Death|1|||
161912251|NCT01721798|584730057|FG003|Overall Study|Death|1|||
161912252|NCT01721798|584730054|FG000|Overall Study|Lost to Follow-up|2|||
162143530|NCT01090024|585573132|FG007|Period 3|Adverse Event|0|||
162143531|NCT01090024|585573133|FG008|Period 3|Adverse Event|0|||
162143532|NCT01090024|585573134|FG009|Period 3|Adverse Event|0|||
162143533|NCT01090024|585573135|FG010|Period 3|Adverse Event|0|||
162143534|NCT01090024|585573136|FG011|Period 3|Adverse Event|0|||
162143535|NCT01090024|585573137|FG012|Period 3|Adverse Event|0|||
162143536|NCT01090024|585573138|FG013|Period 3|Adverse Event|0|||
162143537|NCT01090024|585573139|FG014|Period 3|Adverse Event|0|||
162143538|NCT01090024|585573140|FG015|Period 3|Adverse Event|0|||
162143539|NCT01090024|585573141|FG016|Period 3|Adverse Event|0|||
162143540|NCT01090024|585573142|FG017|Period 3|Adverse Event|0|||
162143541|NCT00470626|585573144|FG000|Overall Study|Lost to Follow-up|10|||
162143542|NCT00470626|585573144|FG000|Overall Study|Withdrawal by Subject|7|||
162143543|NCT02689349|585573145|FG000|Overall Study|Not implanted|4|||
162143544|NCT02689349|585573146|FG001|Overall Study|Not implanted|0|||
162143545|NCT02689349|585573145|FG000|Overall Study|Withdrawal by Subject|9|||
162143546|NCT02689349|585573146|FG001|Overall Study|Withdrawal by Subject|0|||
162143547|NCT01185522|585573147|FG000|Overall Study|Lack of Efficacy|28|||
162143548|NCT01185522|585573147|FG000|Overall Study|Lost to Follow-up|19|||
162143549|NCT01185522|585573147|FG000|Overall Study|Withdrawal by Subject|10|||
162143550|NCT01185522|585573147|FG000|Overall Study|Poor tolerance|39|||
162143551|NCT01185522|585573147|FG000|Overall Study|Other reasons|12|||
162143552|NCT01729819|585573148|FG000|Overall Study|Adverse Event|2|||
162143553|NCT01729819|585573149|FG001|Overall Study|Adverse Event|4|||
162143554|NCT01729819|585573148|FG000|Overall Study|Lack of Efficacy|1|||
162143555|NCT01729819|585573149|FG001|Overall Study|Lack of Efficacy|0|||
162143556|NCT01729819|585573148|FG000|Overall Study|Lost to Follow-up|2|||
162143557|NCT01729819|585573149|FG001|Overall Study|Lost to Follow-up|0|||
162143558|NCT01729819|585573148|FG000|Overall Study|Other reason|1|||
162143559|NCT01729819|585573149|FG001|Overall Study|Other reason|0|||
162143560|NCT01729819|585573148|FG000|Overall Study|Protocol Violation|0|||
162143561|NCT01729819|585573149|FG001|Overall Study|Protocol Violation|1|||
162143562|NCT01729819|585573148|FG000|Overall Study|Withdrawal by Subject|0|||
162143563|NCT01729819|585573149|FG001|Overall Study|Withdrawal by Subject|2|||
162143564|NCT01025843|585573150|FG000|Washout 4|Withdrawal by Subject|0|||
162143565|NCT01025843|585573151|FG001|Washout 4|Withdrawal by Subject|0|||
162143566|NCT01025843|585573152|FG002|Washout 4|Withdrawal by Subject|1|||
162143567|NCT01025843|585573153|FG003|Washout 4|Withdrawal by Subject|1|||
162143568|NCT01025843|585573154|FG004|Washout 4|Withdrawal by Subject|0|||
162143569|NCT01025843|585573155|FG005|Washout 4|Withdrawal by Subject|0|||
162143570|NCT01025843|585573156|FG006|Washout 4|Withdrawal by Subject|0|||
162143571|NCT01025843|585573157|FG007|Washout 4|Withdrawal by Subject|0|||
162143572|NCT01025843|585573158|FG008|Washout 4|Withdrawal by Subject|0|||
162143573|NCT01025843|585573159|FG009|Washout 4|Withdrawal by Subject|0|||
162143574|NCT01649791|585573160|FG000|Overall Study|Disease Progression|2|||
162143575|NCT01649791|585573160|FG000|Overall Study|Adverse Event|1|||
162143576|NCT02987543|585573161|FG000|Overall Study|Ongoing study at data cut off|49|||
162143577|NCT02987543|585573162|FG001|Overall Study|Ongoing study at data cut off|21|||
162143578|NCT02987543|585573163|FG002|Overall Study|Ongoing study at data cut off|19|||
162143579|NCT02987543|585573164|FG003|Overall Study|Ongoing study at data cut off|12|||
162143580|NCT02987543|585573161|FG000|Overall Study|Death|88|||
162143581|NCT02987543|585573162|FG001|Overall Study|Death|54|||
162143582|NCT02987543|585573163|FG002|Overall Study|Death|67|||
162143583|NCT02987543|585573164|FG003|Overall Study|Death|28|||
162143584|NCT02987543|585573161|FG000|Overall Study|Lost to Follow-up|3|||
162143585|NCT02987543|585573162|FG001|Overall Study|Lost to Follow-up|0|||
162143586|NCT02987543|585573163|FG002|Overall Study|Lost to Follow-up|1|||
162143587|NCT02987543|585573164|FG003|Overall Study|Lost to Follow-up|0|||
162143588|NCT02987543|585573161|FG000|Overall Study|Screen failure|0|||
162143589|NCT02987543|585573162|FG001|Overall Study|Screen failure|0|||
162143590|NCT02987543|585573163|FG002|Overall Study|Screen failure|0|||
162143591|NCT02987543|585573164|FG003|Overall Study|Screen failure|1|||
162143592|NCT02987543|585573161|FG000|Overall Study|Withdrawal by Subject|21|||
162143593|NCT02987543|585573162|FG001|Overall Study|Withdrawal by Subject|7|||
162143594|NCT02987543|585573163|FG002|Overall Study|Withdrawal by Subject|7|||
162143595|NCT02987543|585573164|FG003|Overall Study|Withdrawal by Subject|6|||
162143596|NCT02987543|585573161|FG000|Overall Study|Study terminated by sponsor|1|||
162143597|NCT02987543|585573162|FG001|Overall Study|Study terminated by sponsor|0|||
162143598|NCT02987543|585573163|FG002|Overall Study|Study terminated by sponsor|0|||
162143599|NCT02987543|585573164|FG003|Overall Study|Study terminated by sponsor|0|||
162143600|NCT02987543|585573161|FG000|Overall Study|Investigator decision|0|||
162143601|NCT02987543|585573162|FG001|Overall Study|Investigator decision|1|||
162143602|NCT02987543|585573163|FG002|Overall Study|Investigator decision|0|||
162143603|NCT02987543|585573164|FG003|Overall Study|Investigator decision|0|||
162143604|NCT02987543|585573161|FG000|Overall Study|Disease progression|0|||
162143605|NCT02987543|585573162|FG001|Overall Study|Disease progression|0|||
162143606|NCT02987543|585573163|FG002|Overall Study|Disease progression|0|||
162143607|NCT02987543|585573164|FG003|Overall Study|Disease progression|1|||
162143608|NCT03646669|585573167|FG000|Overall Study|Withdrawal by Subject|5|||
162143609|NCT03646669|585573168|FG001|Overall Study|Withdrawal by Subject|0|||
162143610|NCT00309452|585573169|FG000|Overall Study|Withdrawal by Subject|3|||
162143611|NCT00309452|585573170|FG001|Overall Study|Withdrawal by Subject|0|||
162143612|NCT02962674|585573172|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
162143613|NCT00771667|585573173|FG000|Induction Phase|Adverse Event|5|||
162143614|NCT00771667|585573174|FG001|Induction Phase|Adverse Event|2|||
162143615|NCT00771667|585573175|FG002|Induction Phase|Adverse Event|4|||
162143616|NCT00771667|585573176|FG003|Induction Phase|Adverse Event|1|||
162143617|NCT00771667|585573177|FG004|Induction Phase|Adverse Event|0|||
162143618|NCT00771667|585573178|FG005|Induction Phase|Adverse Event|0|||
162143619|NCT00771667|585573179|FG006|Induction Phase|Adverse Event|0|||
162143620|NCT00771667|585573180|FG007|Induction Phase|Adverse Event|0|||
162143621|NCT00771667|585573181|FG008|Induction Phase|Adverse Event|0|||
162143622|NCT00771667|585573182|FG009|Induction Phase|Adverse Event|0|||
162143623|NCT00771667|585573173|FG000|Induction Phase|Lack of Efficacy|9|||
162143624|NCT00771667|585573174|FG001|Induction Phase|Lack of Efficacy|2|||
162143625|NCT00771667|585573175|FG002|Induction Phase|Lack of Efficacy|4|||
162143626|NCT00771667|585573176|FG003|Induction Phase|Lack of Efficacy|3|||
162143627|NCT00771667|585573177|FG004|Induction Phase|Lack of Efficacy|0|||
162143628|NCT00771667|585573178|FG005|Induction Phase|Lack of Efficacy|0|||
162143629|NCT00771667|585573179|FG006|Induction Phase|Lack of Efficacy|0|||
162143630|NCT00771667|585573180|FG007|Induction Phase|Lack of Efficacy|0|||
162143631|NCT00771667|585573181|FG008|Induction Phase|Lack of Efficacy|0|||
162143632|NCT00771667|585573182|FG009|Induction Phase|Lack of Efficacy|0|||
162143633|NCT00771667|585573173|FG000|Induction Phase|Lost to Follow-up|1|||
162143634|NCT00771667|585573174|FG001|Induction Phase|Lost to Follow-up|0|||
162143635|NCT00771667|585573175|FG002|Induction Phase|Lost to Follow-up|1|||
162143636|NCT00771667|585573176|FG003|Induction Phase|Lost to Follow-up|0|||
162143637|NCT00771667|585573177|FG004|Induction Phase|Lost to Follow-up|0|||
162143638|NCT00771667|585573178|FG005|Induction Phase|Lost to Follow-up|0|||
162143639|NCT00771667|585573179|FG006|Induction Phase|Lost to Follow-up|0|||
162143640|NCT00771667|585573180|FG007|Induction Phase|Lost to Follow-up|0|||
162143641|NCT00771667|585573181|FG008|Induction Phase|Lost to Follow-up|0|||
162143642|NCT00771667|585573182|FG009|Induction Phase|Lost to Follow-up|0|||
162143643|NCT00771667|585573173|FG000|Induction Phase|Other|4|||
162143644|NCT00771667|585573174|FG001|Induction Phase|Other|6|||
162143645|NCT00771667|585573175|FG002|Induction Phase|Other|3|||
162143646|NCT00771667|585573176|FG003|Induction Phase|Other|4|||
162143647|NCT00771667|585573177|FG004|Induction Phase|Other|0|||
162143648|NCT00771667|585573178|FG005|Induction Phase|Other|0|||
162143649|NCT00771667|585573179|FG006|Induction Phase|Other|0|||
162143650|NCT00771667|585573180|FG007|Induction Phase|Other|0|||
162143651|NCT00771667|585573181|FG008|Induction Phase|Other|0|||
162143652|NCT00771667|585573182|FG009|Induction Phase|Other|0|||
162143653|NCT00771667|585573173|FG000|Maintenance Phase|Adverse Event|0|||
162143654|NCT00771667|585573174|FG001|Maintenance Phase|Adverse Event|0|||
162143655|NCT00771667|585573175|FG002|Maintenance Phase|Adverse Event|0|||
162143656|NCT00771667|585573176|FG003|Maintenance Phase|Adverse Event|0|||
162143657|NCT00771667|585573177|FG004|Maintenance Phase|Adverse Event|1|||
162143658|NCT00771667|585573178|FG005|Maintenance Phase|Adverse Event|3|||
162143659|NCT00771667|585573179|FG006|Maintenance Phase|Adverse Event|5|||
162143660|NCT00771667|585573180|FG007|Maintenance Phase|Adverse Event|1|||
162143661|NCT00771667|585573181|FG008|Maintenance Phase|Adverse Event|8|||
162143662|NCT00771667|585573182|FG009|Maintenance Phase|Adverse Event|7|||
162143663|NCT00771667|585573173|FG000|Maintenance Phase|Lack of Efficacy|0|||
162143664|NCT00771667|585573174|FG001|Maintenance Phase|Lack of Efficacy|0|||
162143665|NCT00771667|585573175|FG002|Maintenance Phase|Lack of Efficacy|0|||
162143666|NCT00771667|585573176|FG003|Maintenance Phase|Lack of Efficacy|0|||
162143667|NCT00771667|585573177|FG004|Maintenance Phase|Lack of Efficacy|1|||
162143668|NCT00771667|585573178|FG005|Maintenance Phase|Lack of Efficacy|3|||
162143669|NCT00771667|585573179|FG006|Maintenance Phase|Lack of Efficacy|3|||
162143670|NCT00771667|585573180|FG007|Maintenance Phase|Lack of Efficacy|2|||
162143671|NCT00771667|585573181|FG008|Maintenance Phase|Lack of Efficacy|11|||
162143672|NCT00771667|585573182|FG009|Maintenance Phase|Lack of Efficacy|7|||
162143673|NCT00771667|585573173|FG000|Maintenance Phase|Other|0|||
162143674|NCT00771667|585573174|FG001|Maintenance Phase|Other|0|||
162143675|NCT00771667|585573175|FG002|Maintenance Phase|Other|0|||
162143676|NCT00771667|585573176|FG003|Maintenance Phase|Other|0|||
162143677|NCT00771667|585573177|FG004|Maintenance Phase|Other|0|||
162143678|NCT00771667|585573178|FG005|Maintenance Phase|Other|1|||
162143679|NCT00771667|585573179|FG006|Maintenance Phase|Other|2|||
162143680|NCT00771667|585573180|FG007|Maintenance Phase|Other|2|||
162143681|NCT00771667|585573181|FG008|Maintenance Phase|Other|3|||
162143682|NCT00771667|585573182|FG009|Maintenance Phase|Other|3|||
162143683|NCT00364286|585573183|FG000|Overall Study|Withdrawal by Subject|1|||
162143684|NCT00364286|585573183|FG000|Overall Study|Adverse Event|2|||
162143685|NCT01897233|585573184|FG000|Part B (24 Weeks)|Adverse Event|1|||
162143686|NCT01897233|585573184|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
162143687|NCT01897233|585573184|FG000|Part B (24 Weeks)|Physician Decision|1|||
162143688|NCT00628862|585573189|FG000|Overall Study|Adverse Event|6|||
162143689|NCT00628862|585573190|FG001|Overall Study|Adverse Event|8|||
162143690|NCT00628862|585573191|FG002|Overall Study|Adverse Event|10|||
162143691|NCT00628862|585573189|FG000|Overall Study|Withdrawal by Subject|4|||
162143692|NCT00628862|585573190|FG001|Overall Study|Withdrawal by Subject|6|||
162143693|NCT00628862|585573191|FG002|Overall Study|Withdrawal by Subject|11|||
162143694|NCT00628862|585573189|FG000|Overall Study|Lost to Follow-up|0|||
162143695|NCT00628862|585573190|FG001|Overall Study|Lost to Follow-up|2|||
162143696|NCT00628862|585573191|FG002|Overall Study|Lost to Follow-up|1|||
162143697|NCT00628862|585573189|FG000|Overall Study|Protocol Violation|1|||
162143698|NCT00628862|585573190|FG001|Overall Study|Protocol Violation|0|||
162143699|NCT00628862|585573191|FG002|Overall Study|Protocol Violation|0|||
162143700|NCT00628862|585573189|FG000|Overall Study|COPD Exacerbation|0|||
162143701|NCT00628862|585573190|FG001|Overall Study|COPD Exacerbation|1|||
162143702|NCT00628862|585573191|FG002|Overall Study|COPD Exacerbation|0|||
162143703|NCT02814643|585573192|FG000|Overall Study|Lost to Follow-up|0|||
162143704|NCT02814643|585573193|FG001|Overall Study|Lost to Follow-up|1|||
162143705|NCT02814643|585573192|FG000|Overall Study|Withdrawal by Subject|1|||
162143706|NCT02814643|585573193|FG001|Overall Study|Withdrawal by Subject|2|||
162143707|NCT03673124|585573195|FG000|Overall Study|Eligible with no protocol therapy|2|||
162143708|NCT00975806|585573196|FG000|Overall Study|Adverse Event|2|||
162143709|NCT00975806|585573197|FG001|Overall Study|Adverse Event|1|||
162143710|NCT00975806|585573198|FG002|Overall Study|Adverse Event|2|||
162143711|NCT00975806|585573196|FG000|Overall Study|Disease Progression|1|||
162143712|NCT00975806|585573197|FG001|Overall Study|Disease Progression|5|||
162143713|NCT00975806|585573198|FG002|Overall Study|Disease Progression|1|||
162143714|NCT00975806|585573196|FG000|Overall Study|Withdrawal by Subject|1|||
162143715|NCT00975806|585573197|FG001|Overall Study|Withdrawal by Subject|0|||
162143716|NCT00975806|585573198|FG002|Overall Study|Withdrawal by Subject|0|||
162143717|NCT00975806|585573196|FG000|Overall Study|Death|0|||
162143718|NCT00975806|585573197|FG001|Overall Study|Death|1|||
162143719|NCT00975806|585573198|FG002|Overall Study|Death|0|||
162143720|NCT00975806|585573196|FG000|Overall Study|Physician decision and disease related|1|||
162143721|NCT00975806|585573197|FG001|Overall Study|Physician decision and disease related|0|||
162143722|NCT00975806|585573198|FG002|Overall Study|Physician decision and disease related|1|||
162143723|NCT02377362|585573199|FG000|Part A Second Treatment|Protocol Violation|0|||
162143724|NCT02377362|585573200|FG001|Part A Second Treatment|Protocol Violation|0|||
162143725|NCT02377362|585573201|FG002|Part A Second Treatment|Protocol Violation|0|||
162143726|NCT02377362|585573202|FG003|Part A Second Treatment|Protocol Violation|0|||
162143727|NCT02377362|585573203|FG004|Part A Second Treatment|Protocol Violation|1|||
162143728|NCT02377362|585573204|FG005|Part A Second Treatment|Protocol Violation|0|||
162143729|NCT02377362|585573205|FG006|Part A Second Treatment|Protocol Violation|0|||
162143730|NCT02377362|585573206|FG007|Part A Second Treatment|Protocol Violation|0|||
162143731|NCT02377362|585573207|FG008|Part A Second Treatment|Protocol Violation|0|||
162143732|NCT02377362|585573208|FG009|Part A Second Treatment|Protocol Violation|0|||
162143733|NCT02377362|585573209|FG010|Part A Second Treatment|Protocol Violation|0|||
162143734|NCT02377362|585573210|FG011|Part A Second Treatment|Protocol Violation|0|||
162143735|NCT02377362|585573211|FG012|Part A Second Treatment|Protocol Violation|0|||
161808940|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808941|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808942|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
161808943|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
161808944|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
161808945|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
162011120|NCT02395471|585097731|FG000|Overall Study|Failure to swollow sponge twice|1|||
162011121|NCT02395471|585097732|FG001|Overall Study|Failure to swollow sponge twice|0|||
162011122|NCT02395471|585097731|FG000|Overall Study|Patient did not return for procedure|0|||
162011123|NCT02395471|585097732|FG001|Overall Study|Patient did not return for procedure|1|||
162011124|NCT02395471|585097731|FG000|Overall Study|Subject not eligible|1|||
162011125|NCT02395471|585097732|FG001|Overall Study|Subject not eligible|0|||
162011126|NCT02035267|585097733|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
162011127|NCT02035267|585097734|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
162011128|NCT02035267|585097735|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
162011129|NCT02035267|585097736|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
162011130|NCT02035267|585097733|FG000|Overall Study|Adverse Event|0|||
162011131|NCT02035267|585097734|FG001|Overall Study|Adverse Event|0|||
162011132|NCT02035267|585097735|FG002|Overall Study|Adverse Event|1|||
162011133|NCT02035267|585097736|FG003|Overall Study|Adverse Event|0|||
162011134|NCT02035267|585097733|FG000|Overall Study|Lost to Follow-up|0|||
162011135|NCT02035267|585097734|FG001|Overall Study|Lost to Follow-up|0|||
162011136|NCT02035267|585097735|FG002|Overall Study|Lost to Follow-up|0|||
162011137|NCT02035267|585097736|FG003|Overall Study|Lost to Follow-up|1|||
162011138|NCT02035267|585097733|FG000|Overall Study|Other unspecified|0|||
162011139|NCT02035267|585097734|FG001|Overall Study|Other unspecified|1|||
162011140|NCT02035267|585097735|FG002|Overall Study|Other unspecified|0|||
162011141|NCT02035267|585097736|FG003|Overall Study|Other unspecified|0|||
162011142|NCT03038880|585097742|FG000|Overall Study|Death|1|||
162011143|NCT03038880|585097743|FG001|Overall Study|Death|2|||
162011144|NCT03038880|585097744|FG002|Overall Study|Death|0|||
162011145|NCT03038880|585097742|FG000|Overall Study|Physician Decision|2|||
162011146|NCT03038880|585097743|FG001|Overall Study|Physician Decision|1|||
162011147|NCT03038880|585097744|FG002|Overall Study|Physician Decision|0|||
162011148|NCT03926611|585097749|FG000|Overall Study|Adverse Event|0|||
162011149|NCT03926611|585097750|FG001|Overall Study|Adverse Event|0|||
162011150|NCT03926611|585097751|FG002|Overall Study|Adverse Event|0|||
162011151|NCT03926611|585097752|FG003|Overall Study|Adverse Event|3|||
162011152|NCT03926611|585097753|FG004|Overall Study|Adverse Event|1|||
162011153|NCT03926611|585097754|FG005|Overall Study|Adverse Event|3|||
162011154|NCT03926611|585097755|FG006|Overall Study|Adverse Event|0|||
162011155|NCT03926611|585097749|FG000|Overall Study|Lack of Efficacy|1|||
162011156|NCT03926611|585097750|FG001|Overall Study|Lack of Efficacy|2|||
162011157|NCT03926611|585097751|FG002|Overall Study|Lack of Efficacy|0|||
162011158|NCT03926611|585097752|FG003|Overall Study|Lack of Efficacy|0|||
162011159|NCT03926611|585097753|FG004|Overall Study|Lack of Efficacy|1|||
162011160|NCT03926611|585097754|FG005|Overall Study|Lack of Efficacy|0|||
162011161|NCT03926611|585097755|FG006|Overall Study|Lack of Efficacy|1|||
162011162|NCT03926611|585097749|FG000|Overall Study|Physician Decision|0|||
162011163|NCT03926611|585097750|FG001|Overall Study|Physician Decision|0|||
162011164|NCT03926611|585097751|FG002|Overall Study|Physician Decision|0|||
162011165|NCT03926611|585097752|FG003|Overall Study|Physician Decision|0|||
162011166|NCT03926611|585097753|FG004|Overall Study|Physician Decision|0|||
162011167|NCT03926611|585097754|FG005|Overall Study|Physician Decision|1|||
162011168|NCT03926611|585097755|FG006|Overall Study|Physician Decision|0|||
162011169|NCT03926611|585097749|FG000|Overall Study|Protocol Violation|1|||
162011170|NCT03926611|585097750|FG001|Overall Study|Protocol Violation|0|||
162011171|NCT03926611|585097751|FG002|Overall Study|Protocol Violation|0|||
162011172|NCT03926611|585097752|FG003|Overall Study|Protocol Violation|1|||
162011173|NCT03926611|585097753|FG004|Overall Study|Protocol Violation|1|||
162011174|NCT03926611|585097754|FG005|Overall Study|Protocol Violation|1|||
162143736|NCT02377362|585573199|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
162143737|NCT02377362|585573200|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
162143738|NCT02377362|585573201|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
162143739|NCT02377362|585573202|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
162143740|NCT02377362|585573203|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
162143741|NCT02377362|585573204|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
162143742|NCT02377362|585573205|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
162143743|NCT02377362|585573206|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
162143744|NCT02377362|585573207|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
162143745|NCT02377362|585573208|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
162143746|NCT02377362|585573209|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
162143747|NCT02377362|585573210|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
162143748|NCT02377362|585573211|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
162143749|NCT02377362|585573199|FG000|Part B Overall|Protocol Violation|0|||
162143750|NCT02377362|585573200|FG001|Part B Overall|Protocol Violation|0|||
162143751|NCT02377362|585573201|FG002|Part B Overall|Protocol Violation|0|||
162143752|NCT02377362|585573202|FG003|Part B Overall|Protocol Violation|0|||
162143753|NCT02377362|585573203|FG004|Part B Overall|Protocol Violation|0|||
162143754|NCT02377362|585573204|FG005|Part B Overall|Protocol Violation|0|||
162143755|NCT02377362|585573205|FG006|Part B Overall|Protocol Violation|0|||
162143756|NCT02377362|585573206|FG007|Part B Overall|Protocol Violation|0|||
162143757|NCT02377362|585573207|FG008|Part B Overall|Protocol Violation|0|||
162143758|NCT02377362|585573208|FG009|Part B Overall|Protocol Violation|1|||
162143759|NCT02377362|585573209|FG010|Part B Overall|Protocol Violation|0|||
162143760|NCT02377362|585573210|FG011|Part B Overall|Protocol Violation|0|||
162143761|NCT02377362|585573211|FG012|Part B Overall|Protocol Violation|0|||
162143762|NCT02377362|585573199|FG000|Part B Overall|Adverse Event|0|||
162143763|NCT02377362|585573200|FG001|Part B Overall|Adverse Event|0|||
162143764|NCT02377362|585573201|FG002|Part B Overall|Adverse Event|0|||
162143765|NCT02377362|585573202|FG003|Part B Overall|Adverse Event|0|||
162143766|NCT02377362|585573203|FG004|Part B Overall|Adverse Event|0|||
162143767|NCT02377362|585573204|FG005|Part B Overall|Adverse Event|0|||
162143768|NCT02377362|585573205|FG006|Part B Overall|Adverse Event|1|||
162143769|NCT02377362|585573206|FG007|Part B Overall|Adverse Event|1|||
162143770|NCT02377362|585573207|FG008|Part B Overall|Adverse Event|0|||
162143771|NCT02377362|585573208|FG009|Part B Overall|Adverse Event|0|||
162143772|NCT02377362|585573209|FG010|Part B Overall|Adverse Event|0|||
162143773|NCT02377362|585573210|FG011|Part B Overall|Adverse Event|0|||
162143774|NCT02377362|585573211|FG012|Part B Overall|Adverse Event|0|||
162143775|NCT02377362|585573199|FG000|Part B Overall|Withdrawal by Subject|0|||
162143776|NCT02377362|585573200|FG001|Part B Overall|Withdrawal by Subject|0|||
162143777|NCT02377362|585573201|FG002|Part B Overall|Withdrawal by Subject|0|||
162143778|NCT02377362|585573202|FG003|Part B Overall|Withdrawal by Subject|0|||
162143779|NCT02377362|585573203|FG004|Part B Overall|Withdrawal by Subject|0|||
162143780|NCT02377362|585573204|FG005|Part B Overall|Withdrawal by Subject|0|||
162143781|NCT02377362|585573205|FG006|Part B Overall|Withdrawal by Subject|1|||
162143782|NCT02377362|585573206|FG007|Part B Overall|Withdrawal by Subject|0|||
162143783|NCT02377362|585573207|FG008|Part B Overall|Withdrawal by Subject|0|||
162143784|NCT02377362|585573208|FG009|Part B Overall|Withdrawal by Subject|0|||
162143785|NCT02377362|585573209|FG010|Part B Overall|Withdrawal by Subject|0|||
162143786|NCT02377362|585573210|FG011|Part B Overall|Withdrawal by Subject|1|||
162143787|NCT02377362|585573211|FG012|Part B Overall|Withdrawal by Subject|0|||
162143788|NCT01651949|585573215|FG000|Overall Study|Unknown status|4|||
162143789|NCT01651949|585573216|FG001|Overall Study|Unknown status|4|||
162143790|NCT01651949|585573217|FG002|Overall Study|Unknown status|0|||
162143791|NCT01651949|585573215|FG000|Overall Study|Lost to Follow-up|30|||
162143792|NCT01651949|585573216|FG001|Overall Study|Lost to Follow-up|56|||
162143793|NCT01651949|585573217|FG002|Overall Study|Lost to Follow-up|20|||
162143794|NCT01651949|585573215|FG000|Overall Study|Protocol Violation|0|||
162143795|NCT01651949|585573216|FG001|Overall Study|Protocol Violation|2|||
162143796|NCT01651949|585573217|FG002|Overall Study|Protocol Violation|1|||
162143797|NCT01651949|585573215|FG000|Overall Study|Physician Decision|0|||
162143798|NCT01651949|585573216|FG001|Overall Study|Physician Decision|2|||
162143799|NCT01651949|585573217|FG002|Overall Study|Physician Decision|0|||
162143800|NCT01651949|585573215|FG000|Overall Study|Adverse Event|0|||
162143801|NCT01651949|585573216|FG001|Overall Study|Adverse Event|2|||
162143802|NCT01651949|585573217|FG002|Overall Study|Adverse Event|1|||
162143803|NCT01651949|585573215|FG000|Overall Study|Screen failure|2|||
162143804|NCT01651949|585573216|FG001|Overall Study|Screen failure|2|||
162143805|NCT01651949|585573217|FG002|Overall Study|Screen failure|0|||
162143806|NCT01651949|585573215|FG000|Overall Study|Withdrawal by Subject|17|||
162143807|NCT01651949|585573216|FG001|Overall Study|Withdrawal by Subject|18|||
162143808|NCT01651949|585573217|FG002|Overall Study|Withdrawal by Subject|9|||
162143809|NCT02155829|585573220|FG000|Overall Study|Adverse Event|1|||
162143810|NCT02155829|585573221|FG001|Overall Study|Adverse Event|0|||
162143811|NCT02155829|585573220|FG000|Overall Study|Withdrawal by Subject|3|||
162143812|NCT02155829|585573221|FG001|Overall Study|Withdrawal by Subject|3|||
162011175|NCT03926611|585097755|FG006|Overall Study|Protocol Violation|1|||
162011176|NCT03926611|585097749|FG000|Overall Study|Technical problems|0|||
162011177|NCT03926611|585097750|FG001|Overall Study|Technical problems|0|||
162011178|NCT03926611|585097751|FG002|Overall Study|Technical problems|0|||
162011179|NCT03926611|585097752|FG003|Overall Study|Technical problems|0|||
162011180|NCT03926611|585097753|FG004|Overall Study|Technical problems|0|||
162011181|NCT03926611|585097754|FG005|Overall Study|Technical problems|1|||
162011182|NCT03926611|585097755|FG006|Overall Study|Technical problems|0|||
162011183|NCT03926611|585097749|FG000|Overall Study|Withdrawal by Subject|1|||
162011184|NCT03926611|585097750|FG001|Overall Study|Withdrawal by Subject|1|||
162011185|NCT03926611|585097751|FG002|Overall Study|Withdrawal by Subject|1|||
162011186|NCT03926611|585097752|FG003|Overall Study|Withdrawal by Subject|0|||
162011187|NCT03926611|585097753|FG004|Overall Study|Withdrawal by Subject|0|||
162011188|NCT03926611|585097754|FG005|Overall Study|Withdrawal by Subject|1|||
162011189|NCT03926611|585097755|FG006|Overall Study|Withdrawal by Subject|3|||
162011190|NCT03926611|585097749|FG000|Overall Study|Covid-19 pandemic|0|||
162011191|NCT03926611|585097750|FG001|Overall Study|Covid-19 pandemic|0|||
162011192|NCT03926611|585097751|FG002|Overall Study|Covid-19 pandemic|1|||
162011193|NCT03926611|585097752|FG003|Overall Study|Covid-19 pandemic|0|||
162011194|NCT03926611|585097753|FG004|Overall Study|Covid-19 pandemic|1|||
162011195|NCT03926611|585097754|FG005|Overall Study|Covid-19 pandemic|2|||
162011196|NCT03926611|585097755|FG006|Overall Study|Covid-19 pandemic|0|||
162011197|NCT02612779|585097756|FG000|Overall Study|Administrative reason by sponsor|4|||
162143813|NCT02155829|585573220|FG000|Overall Study|Protocol Violation|2|||
162143814|NCT02155829|585573221|FG001|Overall Study|Protocol Violation|0|||
162143815|NCT01585038|585573222|FG000|Overall Study|Adverse Event|2|||
162143816|NCT01585038|585573223|FG001|Overall Study|Adverse Event|2|||
162143817|NCT00678795|585573224|FG000|Overall Study|Adverse Event|7|||
162143818|NCT00678795|585573225|FG001|Overall Study|Adverse Event|3|||
162143819|NCT00678795|585573224|FG000|Overall Study|Withdrawal by Subject|3|||
162143820|NCT00678795|585573225|FG001|Overall Study|Withdrawal by Subject|0|||
162143821|NCT00678795|585573224|FG000|Overall Study|Protocol Violation|0|||
162143822|NCT00678795|585573225|FG001|Overall Study|Protocol Violation|1|||
162143823|NCT00678795|585573224|FG000|Overall Study|Lost to Follow-up|0|||
162143824|NCT00678795|585573225|FG001|Overall Study|Lost to Follow-up|1|||
162143825|NCT00678795|585573224|FG000|Overall Study|Lack of Efficacy|1|||
162143826|NCT00678795|585573225|FG001|Overall Study|Lack of Efficacy|1|||
162143827|NCT02750709|585573228|FG000|Treatment Period 1|Adverse Event|0|||
162143828|NCT02750709|585573229|FG001|Treatment Period 1|Adverse Event|0|||
162143829|NCT02750709|585573230|FG002|Treatment Period 1|Adverse Event|0|||
162143830|NCT02750709|585573231|FG003|Treatment Period 1|Adverse Event|0|||
162143831|NCT02750709|585573232|FG004|Treatment Period 1|Adverse Event|0|||
162143832|NCT02750709|585573233|FG005|Treatment Period 1|Adverse Event|1|||
162143833|NCT00771849|585573235|FG000|Overall Study|Lost to Follow-up|1|||
162143834|NCT00771849|585573236|FG001|Overall Study|Lost to Follow-up|2|||
162143835|NCT00771849|585573235|FG000|Overall Study|Withdrawal by Subject|1|||
162143836|NCT00771849|585573236|FG001|Overall Study|Withdrawal by Subject|1|||
162143837|NCT00771849|585573235|FG000|Overall Study|Not vaccinated|0|||
162143838|NCT00771849|585573236|FG001|Overall Study|Not vaccinated|1|||
162143839|NCT00290732|585573237|FG000|Overall Study|Inability to instill drug intraductally.|0|||
162143840|NCT00290732|585573238|FG001|Overall Study|Inability to instill drug intraductally.|1|||
162143841|NCT00290732|585573239|FG002|Overall Study|Inability to instill drug intraductally.|1|||
162143842|NCT00290732|585573240|FG003|Overall Study|Inability to instill drug intraductally.|0|||
162143843|NCT00290732|585573241|FG004|Overall Study|Inability to instill drug intraductally.|0|||
162143844|NCT02736799|585573245|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
162143845|NCT02736799|585573246|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
162143846|NCT02736799|585573247|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
162143847|NCT02736799|585573248|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
162143848|NCT01833832|585573249|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
162143849|NCT00197015|585573250|FG000|Overall Study|Adverse Event|3|||
162143850|NCT00197015|585573251|FG001|Overall Study|Adverse Event|0|||
162143851|NCT00197015|585573252|FG002|Overall Study|Adverse Event|1|||
162143852|NCT00197015|585573250|FG000|Overall Study|Protocol Violation|0|||
162143853|NCT00197015|585573251|FG001|Overall Study|Protocol Violation|3|||
162143854|NCT00197015|585573252|FG002|Overall Study|Protocol Violation|3|||
162143855|NCT00197015|585573250|FG000|Overall Study|Withdrawal by Subject|17|||
162143856|NCT00197015|585573251|FG001|Overall Study|Withdrawal by Subject|37|||
162143857|NCT00197015|585573252|FG002|Overall Study|Withdrawal by Subject|34|||
162143858|NCT00197015|585573250|FG000|Overall Study|Lost to Follow-up|28|||
162011198|NCT02612779|585097757|FG001|Overall Study|Administrative reason by sponsor|1|||
162011199|NCT02612779|585097756|FG000|Overall Study|No longer meet study criteria|0|||
162011200|NCT02612779|585097757|FG001|Overall Study|No longer meet study criteria|1|||
162143859|NCT00197015|585573251|FG001|Overall Study|Lost to Follow-up|46|||
162143860|NCT00197015|585573252|FG002|Overall Study|Lost to Follow-up|37|||
162143861|NCT00197015|585573250|FG000|Overall Study|Other|2|||
162143862|NCT00197015|585573251|FG001|Overall Study|Other|3|||
161912253|NCT01721798|584730055|FG001|Overall Study|Lost to Follow-up|2|||
161912254|NCT01721798|584730056|FG002|Overall Study|Lost to Follow-up|9|||
161912255|NCT01721798|584730057|FG003|Overall Study|Lost to Follow-up|9|||
161912256|NCT01721798|584730054|FG000|Overall Study|Pregnancy|0|||
161912257|NCT01721798|584730055|FG001|Overall Study|Pregnancy|0|||
161912258|NCT01721798|584730056|FG002|Overall Study|Pregnancy|1|||
161912259|NCT01721798|584730057|FG003|Overall Study|Pregnancy|1|||
162143863|NCT00197015|585573252|FG002|Overall Study|Other|2|||
162143864|NCT02596035|585573253|FG000|Overall Study|Disease Progression|64|||
162143865|NCT02596035|585573254|FG001|Overall Study|Disease Progression|32|||
162143866|NCT02596035|585573255|FG002|Overall Study|Disease Progression|1|||
162143867|NCT02596035|585573253|FG000|Overall Study|study drug toxicity|12|||
161808946|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808947|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
161808948|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808949|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808950|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
162143868|NCT02596035|585573254|FG001|Overall Study|study drug toxicity|3|||
162143869|NCT02596035|585573255|FG002|Overall Study|study drug toxicity|0|||
162143870|NCT02596035|585573253|FG000|Overall Study|AE unrelated to study drug|5|||
162143871|NCT02596035|585573254|FG001|Overall Study|AE unrelated to study drug|2|||
162143872|NCT02596035|585573255|FG002|Overall Study|AE unrelated to study drug|0|||
162143873|NCT02596035|585573253|FG000|Overall Study|participant request to discontinue study treatment|2|||
162143874|NCT02596035|585573254|FG001|Overall Study|participant request to discontinue study treatment|0|||
162143875|NCT02596035|585573255|FG002|Overall Study|participant request to discontinue study treatment|0|||
162143876|NCT02596035|585573253|FG000|Overall Study|participant withdrew consent|2|||
162143877|NCT02596035|585573254|FG001|Overall Study|participant withdrew consent|2|||
162143878|NCT02596035|585573255|FG002|Overall Study|participant withdrew consent|0|||
162143879|NCT02596035|585573253|FG000|Overall Study|Poor/Non Comlpiance|0|||
162143880|NCT02596035|585573254|FG001|Overall Study|Poor/Non Comlpiance|1|||
162143881|NCT02596035|585573255|FG002|Overall Study|Poor/Non Comlpiance|0|||
161808951|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808952|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808953|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808954|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808955|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808956|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808957|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808958|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161808959|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808960|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808961|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808962|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
162143882|NCT02596035|585573253|FG000|Overall Study|participant no longer meets study criteria|1|||
162143883|NCT02596035|585573254|FG001|Overall Study|participant no longer meets study criteria|0|||
161912260|NCT01721798|584730054|FG000|Overall Study|Withdrawal by Subject|1|||
161912261|NCT01721798|584730055|FG001|Overall Study|Withdrawal by Subject|0|||
161912262|NCT01721798|584730056|FG002|Overall Study|Withdrawal by Subject|2|||
161912263|NCT01721798|584730057|FG003|Overall Study|Withdrawal by Subject|1|||
161912264|NCT01721798|584730054|FG000|Overall Study|Not eligible for 24 month visit|1|||
161912265|NCT01721798|584730055|FG001|Overall Study|Not eligible for 24 month visit|0|||
161912266|NCT01721798|584730056|FG002|Overall Study|Not eligible for 24 month visit|8|||
161912267|NCT01721798|584730057|FG003|Overall Study|Not eligible for 24 month visit|7|||
161912268|NCT00961064|584730058|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
161912269|NCT00961064|584730058|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
161912270|NCT00961064|584730058|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
161912271|NCT00961064|584730058|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
161912272|NCT00961064|584730058|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
161912273|NCT00961064|584730058|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
161912274|NCT00961064|584730058|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
161912275|NCT00961064|584730058|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
161912276|NCT01408641|584730059|FG000|Overall Study|Physician Decision|1|||
161912277|NCT01408641|584730060|FG001|Overall Study|Physician Decision|0|||
161912278|NCT01316614|584730061|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
161912279|NCT01316614|584730061|FG000|Overall Study|Cytology slides not available for review|4|||
161912280|NCT01316614|584730061|FG000|Overall Study|Cystic lesion|5|||
161912281|NCT01316614|584730061|FG000|Overall Study|Inadequate number of passes|2|||
161912282|NCT01316614|584730061|FG000|Overall Study|Medically unstable|1|||
161912283|NCT00076570|584730062|FG000|Overall Study|Drug intolerance|8|||
161912284|NCT00076570|584730063|FG001|Overall Study|Drug intolerance|8|||
161912285|NCT03979313|584730064|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
161912286|NCT03979313|584730065|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
161912287|NCT03979313|584730064|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
161912288|NCT03979313|584730065|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
161912289|NCT03979313|584730064|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
161912290|NCT03979313|584730065|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
161912291|NCT03979313|584730064|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
161912292|NCT03979313|584730065|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
161912293|NCT03979313|584730064|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
161912294|NCT03979313|584730065|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
161912295|NCT03979313|584730064|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
161912296|NCT03979313|584730065|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
161912297|NCT03979313|584730064|FG000|All Subjects|Any Other Reason|16|||
161912298|NCT03979313|584730065|FG001|All Subjects|Any Other Reason|23|||
161912299|NCT03979313|584730064|FG000|All Subjects|Covid-19|1|||
161912300|NCT03979313|584730065|FG001|All Subjects|Covid-19|3|||
161912301|NCT03979313|584730064|FG000|All Subjects|Withdrawal by Subject|35|||
161912302|NCT03979313|584730065|FG001|All Subjects|Withdrawal by Subject|44|||
161912303|NCT03979313|584730064|FG000|All Subjects|Death|0|||
161912304|NCT03979313|584730065|FG001|All Subjects|Death|5|||
161912305|NCT03979313|584730064|FG000|All Subjects|Lost to Follow-up|28|||
161912306|NCT03979313|584730065|FG001|All Subjects|Lost to Follow-up|61|||
161912307|NCT00089648|584730066|FG000|Overall Study|Adverse Event|7|||
161912308|NCT00089648|584730066|FG000|Overall Study|Withdrawal by Subject|1|||
161912309|NCT00089648|584730066|FG000|Overall Study|Lack of Efficacy|33|||
161912310|NCT00423605|584730067|FG000|Overall Study|Adverse Event|129|||
161912311|NCT00423605|584730067|FG000|Overall Study|Withdrawal by Subject|36|||
161912312|NCT00423605|584730067|FG000|Overall Study|Lost to Follow-up|15|||
161912313|NCT00423605|584730067|FG000|Overall Study|Lack of Efficacy|38|||
161912314|NCT00423605|584730067|FG000|Overall Study|Sponsor Decision|3|||
161912315|NCT00423605|584730067|FG000|Overall Study|Physician Decision|8|||
161808963|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808964|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
161808965|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808966|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808967|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
161808968|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808969|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
161808970|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
161808971|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
161808972|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808973|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161912316|NCT00423605|584730067|FG000|Overall Study|Protocol Violation|7|||
161912317|NCT00423605|584730067|FG000|Overall Study|Not one of the pre-specified options|5|||
161912318|NCT03183908|584730068|FG000|Overall Study|Missing Symptom Diary Data|0|||
161912319|NCT03183908|584730069|FG001|Overall Study|Missing Symptom Diary Data|2|||
161912320|NCT00393367|584730070|FG000|Overall Study|Protocol Violation|2|||
161912321|NCT00393367|584730071|FG001|Overall Study|Protocol Violation|5|||
161912322|NCT00393367|584730070|FG000|Overall Study|Withdrawal by Subject|0|||
161912323|NCT00393367|584730071|FG001|Overall Study|Withdrawal by Subject|2|||
161912324|NCT01712178|584730072|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
161912325|NCT01712178|584730073|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
161912326|NCT01712178|584730072|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
161912327|NCT01712178|584730073|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
161912328|NCT01712178|584730072|FG000|Overall Study|Lost to Follow-up|0|||
161912329|NCT01712178|584730073|FG001|Overall Study|Lost to Follow-up|1|||
161912330|NCT00856180|584730074|FG000|Overall Study|Adverse Event|4|||
161912331|NCT00856180|584730074|FG000|Overall Study|Progressive Disease|16|||
161912332|NCT05001620|584730077|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
161912333|NCT05001620|584730078|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
161912334|NCT00819039|584730079|FG000|Overall Study|Physician Decision|1|||
161912335|NCT00819039|584730080|FG001|Overall Study|Physician Decision|0|||
161912336|NCT00819039|584730081|FG002|Overall Study|Physician Decision|1|||
161912337|NCT00819039|584730079|FG000|Overall Study|Protocol Violation|1|||
161912338|NCT00819039|584730080|FG001|Overall Study|Protocol Violation|0|||
161912339|NCT00819039|584730081|FG002|Overall Study|Protocol Violation|0|||
161912340|NCT04796415|584730082|FG000|Overall Study|not interested|12|||
161912341|NCT04796415|584730082|FG000|Overall Study|health issue|8|||
161912342|NCT04796415|584730082|FG000|Overall Study|Other|4|||
161912343|NCT04796415|584730082|FG000|Overall Study|discharged from home health service|3|||
161912344|NCT04796415|584730082|FG000|Overall Study|re-hospitalization|2|||
161912345|NCT04796415|584730082|FG000|Overall Study|moving to nursing home|1|||
161912346|NCT04796415|584730082|FG000|Overall Study|lost contact|1|||
161912347|NCT00486044|584730086|FG000|Overall Study|Withdrawal by Subject|2|||
161912348|NCT00486044|584730087|FG001|Overall Study|Withdrawal by Subject|1|||
161912349|NCT00486044|584730086|FG000|Overall Study|Adverse Event|0|||
161912350|NCT00486044|584730087|FG001|Overall Study|Adverse Event|1|||
161912351|NCT00486044|584730086|FG000|Overall Study|Lost to Follow-up|0|||
161912352|NCT00486044|584730087|FG001|Overall Study|Lost to Follow-up|1|||
161912353|NCT02701634|584730088|FG000|Overall Study|Adverse Event|2|||
161912354|NCT02701634|584730089|FG001|Overall Study|Adverse Event|3|||
161912355|NCT02701634|584730088|FG000|Overall Study|Death|1|||
161912356|NCT02701634|584730089|FG001|Overall Study|Death|0|||
161912357|NCT02701634|584730088|FG000|Overall Study|Investigator's Discretion|7|||
161912358|NCT02701634|584730089|FG001|Overall Study|Investigator's Discretion|4|||
161912359|NCT02701634|584730088|FG000|Overall Study|Study terminated by Sponsor|15|||
161912360|NCT02701634|584730089|FG001|Overall Study|Study terminated by Sponsor|17|||
161912361|NCT02701634|584730088|FG000|Overall Study|Withdrew Consent|6|||
161912362|NCT02701634|584730089|FG001|Overall Study|Withdrew Consent|7|||
161912363|NCT02701634|584730088|FG000|Overall Study|Randomized but not treated|1|||
161912364|NCT02701634|584730089|FG001|Overall Study|Randomized but not treated|0|||
161912365|NCT01206764|584730090|FG000|Overall Study|Adverse Event|20|||
161912366|NCT01206764|584730090|FG000|Overall Study|Abnormal laboratory value|2|||
161912367|NCT01206764|584730090|FG000|Overall Study|Abnormal test procedure result|1|||
161912368|NCT01206764|584730090|FG000|Overall Study|Patient withdrew consent|5|||
161912369|NCT01206764|584730090|FG000|Overall Study|Lost to Follow-up|6|||
161912370|NCT01206764|584730090|FG000|Overall Study|Death|11|||
161912371|NCT01206764|584730090|FG000|Overall Study|New cancer therapy|2|||
161912372|NCT01206764|584730090|FG000|Overall Study|Disease progression|88|||
161912373|NCT01206764|584730090|FG000|Overall Study|Protocol deviation|3|||
161912374|NCT04494646|584730091|FG000|Overall Study|Adverse Event|0|||
161912375|NCT04494646|584730092|FG001|Overall Study|Adverse Event|1|||
161912376|NCT04494646|584730091|FG000|Overall Study|Withdrawal by Subject|0|||
161912377|NCT04494646|584730092|FG001|Overall Study|Withdrawal by Subject|1|||
161912378|NCT00537277|584730095|FG000|Overall Study|Adverse Event|1|||
161912379|NCT00537277|584730095|FG000|Overall Study|Lack of Efficacy|2|||
161912380|NCT00537277|584730095|FG000|Overall Study|Lost to Follow-up|12|||
161912381|NCT00537277|584730095|FG000|Overall Study|Protocol Violation|11|||
161912382|NCT00537277|584730095|FG000|Overall Study|Unclassified|4|||
161912383|NCT00537277|584730095|FG000|Overall Study|Inability to tolerate trial medication|4|||
161912384|NCT00537277|584730095|FG000|Overall Study|Non-compliance with trial procedures|15|||
161912385|NCT05282823|584730096|FG000|Overall Study|Withdrawal by Subject|9|||
161912386|NCT05282823|584730096|FG000|Overall Study|Adverse Event|1|||
161912387|NCT05282823|584730096|FG000|Overall Study|did not meet protocol criteria|2|||
161912388|NCT05282823|584730096|FG000|Overall Study|Withdrawal by Subject|7|||
161912389|NCT00997893|584730097|FG000|Overall Study|Adverse Event|1|||
161912390|NCT00997893|584730098|FG001|Overall Study|Adverse Event|0|||
161912391|NCT00997893|584730099|FG002|Overall Study|Adverse Event|0|||
161912392|NCT00997893|584730097|FG000|Overall Study|Unable to meet study timelines|1|||
161912393|NCT00997893|584730098|FG001|Overall Study|Unable to meet study timelines|0|||
161912394|NCT00997893|584730099|FG002|Overall Study|Unable to meet study timelines|0|||
161912395|NCT00997893|584730097|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
161912396|NCT00997893|584730098|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
162011201|NCT02612779|585097756|FG000|Overall Study|Disease progression|29|||
161912397|NCT00997893|584730099|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
161912398|NCT03620162|584730100|FG000|Overall Study|Physician Decision|4|||
161912399|NCT03620162|584730101|FG001|Overall Study|Physician Decision|0|||
161912400|NCT03620162|584730102|FG002|Overall Study|Physician Decision|1|||
161912401|NCT03620162|584730103|FG003|Overall Study|Physician Decision|0|||
161912402|NCT03620162|584730104|FG004|Overall Study|Physician Decision|2|||
161912403|NCT03620162|584730100|FG000|Overall Study|Lost to Follow-up|2|||
161912404|NCT03620162|584730101|FG001|Overall Study|Lost to Follow-up|6|||
161912405|NCT03620162|584730102|FG002|Overall Study|Lost to Follow-up|7|||
161912406|NCT03620162|584730103|FG003|Overall Study|Lost to Follow-up|3|||
161912407|NCT03620162|584730104|FG004|Overall Study|Lost to Follow-up|2|||
161912408|NCT03620162|584730100|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
161912409|NCT03620162|584730101|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
161912410|NCT03620162|584730102|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
161912411|NCT03620162|584730103|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
161912412|NCT03620162|584730104|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
161912413|NCT04009837|584730107|FG000|Overall Study|Withdrawal by Subject|5|||
161912414|NCT04009837|584730108|FG001|Overall Study|Withdrawal by Subject|4|||
161912415|NCT04009837|584730107|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
161912416|NCT04009837|584730108|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
161912417|NCT05569174|584730109|FG000|Overall Study|Adverse Event|0|||
161912418|NCT05569174|584730110|FG001|Overall Study|Adverse Event|1|||
161912419|NCT05569174|584730109|FG000|Overall Study|Lack of compliance|0|||
161912420|NCT05569174|584730110|FG001|Overall Study|Lack of compliance|1|||
161912421|NCT05569174|584730109|FG000|Overall Study|Withdrawal of consent|0|||
161912422|NCT05569174|584730110|FG001|Overall Study|Withdrawal of consent|1|||
161912423|NCT05569174|584730109|FG000|Overall Study|Participant wish|0|||
161912424|NCT05569174|584730110|FG001|Overall Study|Participant wish|1|||
161912425|NCT05569174|584730109|FG000|Overall Study|Lost to Follow-up|0|||
161912426|NCT05569174|584730110|FG001|Overall Study|Lost to Follow-up|1|||
161912427|NCT00112957|584730111|FG000|Overall Study|Progressive disease|18|||
161912428|NCT00112957|584730111|FG000|Overall Study|Physician Decision|1|||
161912429|NCT05352815|584730114|FG000|Overall Study|Withdrawal by Subject|28|||
161912430|NCT05352815|584730115|FG001|Overall Study|Withdrawal by Subject|24|||
161912431|NCT05352815|584730114|FG000|Overall Study|Lost to Follow-up|4|||
161912432|NCT05352815|584730115|FG001|Overall Study|Lost to Follow-up|7|||
161912433|NCT05352815|584730114|FG000|Overall Study|Death|2|||
161912434|NCT05352815|584730115|FG001|Overall Study|Death|3|||
161912435|NCT05352815|584730114|FG000|Overall Study|Site closure|1|||
161912436|NCT05352815|584730115|FG001|Overall Study|Site closure|0|||
161912437|NCT00961415|584730118|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
161912438|NCT00961415|584730119|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
161912439|NCT00961415|584730120|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
161912440|NCT00961415|584730118|FG000|Induction Treatment Phase|Death|77|||
161912441|NCT00961415|584730119|FG001|Induction Treatment Phase|Death|0|||
161912442|NCT00961415|584730120|FG002|Induction Treatment Phase|Death|0|||
161912443|NCT00961415|584730118|FG000|Induction Treatment Phase|Protocol Violation|1|||
161912444|NCT00961415|584730119|FG001|Induction Treatment Phase|Protocol Violation|0|||
161912445|NCT00961415|584730120|FG002|Induction Treatment Phase|Protocol Violation|0|||
161912446|NCT00961415|584730118|FG000|Induction Treatment Phase|Physician Decision|2|||
161912447|NCT00961415|584730119|FG001|Induction Treatment Phase|Physician Decision|0|||
161912448|NCT00961415|584730120|FG002|Induction Treatment Phase|Physician Decision|0|||
161912449|NCT00961415|584730118|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
161912450|NCT00961415|584730119|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
161912451|NCT00961415|584730120|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
161912452|NCT00961415|584730118|FG000|Induction Treatment Phase|Other Reason|5|||
161912453|NCT00961415|584730119|FG001|Induction Treatment Phase|Other Reason|0|||
161912454|NCT00961415|584730120|FG002|Induction Treatment Phase|Other Reason|0|||
161912455|NCT00961415|584730118|FG000|Maintenance Treatment Phase|Death|0|||
161912456|NCT00961415|584730119|FG001|Maintenance Treatment Phase|Death|42|||
161912457|NCT00961415|584730120|FG002|Maintenance Treatment Phase|Death|34|||
161912458|NCT00961415|584730118|FG000|Maintenance Treatment Phase|Investigators decision|0|||
161912459|NCT00961415|584730119|FG001|Maintenance Treatment Phase|Investigators decision|2|||
161912460|NCT00961415|584730120|FG002|Maintenance Treatment Phase|Investigators decision|0|||
161912461|NCT00961415|584730118|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161912462|NCT00961415|584730119|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
161912463|NCT00961415|584730120|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
161912464|NCT00961415|584730118|FG000|Maintenance Treatment Phase|Other reason|0|||
161912465|NCT00961415|584730119|FG001|Maintenance Treatment Phase|Other reason|1|||
161912466|NCT00961415|584730120|FG002|Maintenance Treatment Phase|Other reason|3|||
161912467|NCT00226655|584730121|FG000|Overall Study|Death|13|||
161912468|NCT00226655|584730121|FG000|Overall Study|Withdrawal by Subject|15|||
161912469|NCT00226655|584730121|FG000|Overall Study|Adverse Event|35|||
161912470|NCT00226655|584730121|FG000|Overall Study|Physician Decision|6|||
162011202|NCT02612779|585097757|FG001|Overall Study|Disease progression|2|||
161912471|NCT00226655|584730121|FG000|Overall Study|Clinical deterioration|10|||
161912472|NCT02309359|584730122|FG000|Overall Study|Adverse Event|4|||
161912473|NCT02309359|584730123|FG001|Overall Study|Adverse Event|5|||
161912474|NCT02309359|584730124|FG002|Overall Study|Adverse Event|5|||
161912475|NCT02309359|584730125|FG003|Overall Study|Adverse Event|4|||
161912476|NCT02309359|584730126|FG004|Overall Study|Adverse Event|4|||
161912477|NCT02309359|584730122|FG000|Overall Study|Death|1|||
161912478|NCT02309359|584730123|FG001|Overall Study|Death|0|||
161912479|NCT02309359|584730124|FG002|Overall Study|Death|0|||
161912480|NCT02309359|584730125|FG003|Overall Study|Death|0|||
161912481|NCT02309359|584730126|FG004|Overall Study|Death|0|||
161912482|NCT02309359|584730122|FG000|Overall Study|Withdrawal by Subject|2|||
161912483|NCT02309359|584730123|FG001|Overall Study|Withdrawal by Subject|2|||
161912484|NCT02309359|584730124|FG002|Overall Study|Withdrawal by Subject|4|||
161912485|NCT02309359|584730125|FG003|Overall Study|Withdrawal by Subject|4|||
161912486|NCT02309359|584730126|FG004|Overall Study|Withdrawal by Subject|0|||
161912487|NCT02309359|584730122|FG000|Overall Study|Lack of Efficacy|3|||
161912488|NCT02309359|584730123|FG001|Overall Study|Lack of Efficacy|1|||
161912489|NCT02309359|584730124|FG002|Overall Study|Lack of Efficacy|0|||
161912490|NCT02309359|584730125|FG003|Overall Study|Lack of Efficacy|0|||
161912491|NCT02309359|584730126|FG004|Overall Study|Lack of Efficacy|3|||
161912492|NCT02309359|584730122|FG000|Overall Study|Lost to Follow-up|0|||
161912493|NCT02309359|584730123|FG001|Overall Study|Lost to Follow-up|0|||
161912494|NCT02309359|584730124|FG002|Overall Study|Lost to Follow-up|0|||
161912495|NCT02309359|584730125|FG003|Overall Study|Lost to Follow-up|1|||
161912496|NCT02309359|584730126|FG004|Overall Study|Lost to Follow-up|0|||
161912497|NCT02309359|584730122|FG000|Overall Study|Other|2|||
161912498|NCT02309359|584730123|FG001|Overall Study|Other|0|||
161912499|NCT02309359|584730124|FG002|Overall Study|Other|2|||
161912500|NCT02309359|584730125|FG003|Overall Study|Other|3|||
161912501|NCT02309359|584730126|FG004|Overall Study|Other|2|||
161912502|NCT05144945|584730128|FG000|Overall Study|Withdrawal by Subject|1|||
161912503|NCT05144945|584730129|FG001|Overall Study|Withdrawal by Subject|0|||
161912504|NCT06129149|584730131|FG000|Overall Study|Death|1|||
161912505|NCT04649359|584730132|FG000|Overall Study|Withdrawal by Subject|7|||
161912506|NCT04649359|584730133|FG001|Overall Study|Withdrawal by Subject|7|||
161912507|NCT04649359|584730132|FG000|Overall Study|Death|41|||
161912508|NCT04649359|584730133|FG001|Overall Study|Death|26|||
161912509|NCT04649359|584730132|FG000|Overall Study|Ongoing in the study|75|||
161912510|NCT04649359|584730133|FG001|Overall Study|Ongoing in the study|31|||
161912511|NCT03307174|584730134|FG000|Overall Study|Unplanned ICU Administrion|5|||
161912512|NCT03307174|584730135|FG001|Overall Study|Unplanned ICU Administrion|3|||
161912513|NCT03307174|584730134|FG000|Overall Study|Aborted Surgery|1|||
161912514|NCT03307174|584730135|FG001|Overall Study|Aborted Surgery|2|||
161912515|NCT03307174|584730134|FG000|Overall Study|Hypotension|6|||
161912516|NCT03307174|584730135|FG001|Overall Study|Hypotension|0|||
161912517|NCT03307174|584730134|FG000|Overall Study|Nonfunctional epidural|1|||
161912518|NCT03307174|584730135|FG001|Overall Study|Nonfunctional epidural|1|||
161912519|NCT03307174|584730134|FG000|Overall Study|Planned epidural removal|1|||
161912520|NCT03307174|584730135|FG001|Overall Study|Planned epidural removal|0|||
161912521|NCT03307174|584730134|FG000|Overall Study|Intrathecal catheter placement|0|||
161912522|NCT03307174|584730135|FG001|Overall Study|Intrathecal catheter placement|1|||
161912523|NCT05911841|584730136|FG000|Induction Period|Study Terminated by Sponsor|2|||
161912524|NCT05911841|584730137|FG001|Induction Period|Study Terminated by Sponsor|0|||
161912525|NCT05911841|584730138|FG002|Induction Period|Study Terminated by Sponsor|14|||
161912526|NCT05911841|584730139|FG003|Induction Period|Study Terminated by Sponsor|6|||
161912527|NCT05911841|584730140|FG004|Induction Period|Study Terminated by Sponsor|0|||
161912528|NCT05911841|584730141|FG005|Induction Period|Study Terminated by Sponsor|0|||
161912529|NCT05911841|584730142|FG006|Induction Period|Study Terminated by Sponsor|0|||
161912530|NCT05911841|584730143|FG007|Induction Period|Study Terminated by Sponsor|0|||
161912531|NCT05911841|584730144|FG008|Induction Period|Study Terminated by Sponsor|0|||
161912532|NCT05911841|584730145|FG009|Induction Period|Study Terminated by Sponsor|0|||
161912533|NCT05911841|584730136|FG000|Induction Period|Withdrawal by Subject|4|||
161912534|NCT05911841|584730137|FG001|Induction Period|Withdrawal by Subject|3|||
161912535|NCT05911841|584730138|FG002|Induction Period|Withdrawal by Subject|4|||
161912536|NCT05911841|584730139|FG003|Induction Period|Withdrawal by Subject|6|||
161912537|NCT05911841|584730140|FG004|Induction Period|Withdrawal by Subject|0|||
161912538|NCT05911841|584730141|FG005|Induction Period|Withdrawal by Subject|0|||
161912539|NCT05911841|584730142|FG006|Induction Period|Withdrawal by Subject|0|||
161912540|NCT05911841|584730143|FG007|Induction Period|Withdrawal by Subject|0|||
161912541|NCT05911841|584730144|FG008|Induction Period|Withdrawal by Subject|0|||
161912542|NCT05911841|584730145|FG009|Induction Period|Withdrawal by Subject|0|||
161912543|NCT05911841|584730136|FG000|Induction Period|Lack of Efficacy|3|||
161912544|NCT05911841|584730137|FG001|Induction Period|Lack of Efficacy|0|||
161912545|NCT05911841|584730138|FG002|Induction Period|Lack of Efficacy|3|||
161912546|NCT05911841|584730139|FG003|Induction Period|Lack of Efficacy|3|||
161912547|NCT05911841|584730140|FG004|Induction Period|Lack of Efficacy|0|||
161912548|NCT05911841|584730141|FG005|Induction Period|Lack of Efficacy|0|||
161912549|NCT05911841|584730142|FG006|Induction Period|Lack of Efficacy|0|||
161912550|NCT05911841|584730143|FG007|Induction Period|Lack of Efficacy|0|||
161912551|NCT05911841|584730144|FG008|Induction Period|Lack of Efficacy|0|||
161912552|NCT05911841|584730145|FG009|Induction Period|Lack of Efficacy|0|||
161912553|NCT05911841|584730136|FG000|Induction Period|Adverse Event|3|||
161912554|NCT05911841|584730137|FG001|Induction Period|Adverse Event|1|||
161912555|NCT05911841|584730138|FG002|Induction Period|Adverse Event|2|||
161912556|NCT05911841|584730139|FG003|Induction Period|Adverse Event|0|||
161912557|NCT05911841|584730140|FG004|Induction Period|Adverse Event|0|||
161912558|NCT05911841|584730141|FG005|Induction Period|Adverse Event|0|||
161912559|NCT05911841|584730142|FG006|Induction Period|Adverse Event|0|||
161912560|NCT05911841|584730143|FG007|Induction Period|Adverse Event|0|||
161912561|NCT05911841|584730144|FG008|Induction Period|Adverse Event|0|||
161912562|NCT05911841|584730145|FG009|Induction Period|Adverse Event|0|||
161912563|NCT05911841|584730136|FG000|Induction Period|Assigned Treatment by Mistake|0|||
161912564|NCT05911841|584730137|FG001|Induction Period|Assigned Treatment by Mistake|1|||
161912565|NCT05911841|584730138|FG002|Induction Period|Assigned Treatment by Mistake|0|||
161912566|NCT05911841|584730139|FG003|Induction Period|Assigned Treatment by Mistake|1|||
161912567|NCT05911841|584730140|FG004|Induction Period|Assigned Treatment by Mistake|0|||
161912568|NCT05911841|584730141|FG005|Induction Period|Assigned Treatment by Mistake|0|||
161912569|NCT05911841|584730142|FG006|Induction Period|Assigned Treatment by Mistake|0|||
161912570|NCT05911841|584730143|FG007|Induction Period|Assigned Treatment by Mistake|0|||
161912571|NCT05911841|584730144|FG008|Induction Period|Assigned Treatment by Mistake|0|||
161912572|NCT05911841|584730145|FG009|Induction Period|Assigned Treatment by Mistake|0|||
161912573|NCT05911841|584730136|FG000|Induction Period|Lost to Follow-up|0|||
161912574|NCT05911841|584730137|FG001|Induction Period|Lost to Follow-up|0|||
161912575|NCT05911841|584730138|FG002|Induction Period|Lost to Follow-up|1|||
161912576|NCT05911841|584730139|FG003|Induction Period|Lost to Follow-up|1|||
161912577|NCT05911841|584730140|FG004|Induction Period|Lost to Follow-up|0|||
161912578|NCT05911841|584730141|FG005|Induction Period|Lost to Follow-up|0|||
161912579|NCT05911841|584730142|FG006|Induction Period|Lost to Follow-up|0|||
161912580|NCT05911841|584730143|FG007|Induction Period|Lost to Follow-up|0|||
161912581|NCT05911841|584730144|FG008|Induction Period|Lost to Follow-up|0|||
161912582|NCT05911841|584730145|FG009|Induction Period|Lost to Follow-up|0|||
161912583|NCT05911841|584730136|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
161912584|NCT05911841|584730137|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
161912585|NCT05911841|584730138|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
161912586|NCT05911841|584730139|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
161912587|NCT05911841|584730140|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
161912588|NCT05911841|584730141|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
161912589|NCT05911841|584730142|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
161912590|NCT05911841|584730143|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
161912591|NCT05911841|584730144|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
161912592|NCT05911841|584730145|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
161912593|NCT05911841|584730136|FG000|Maintenance Period|Lack of Efficacy|0|||
161912594|NCT05911841|584730137|FG001|Maintenance Period|Lack of Efficacy|0|||
161912595|NCT05911841|584730138|FG002|Maintenance Period|Lack of Efficacy|0|||
161912596|NCT05911841|584730139|FG003|Maintenance Period|Lack of Efficacy|0|||
161912597|NCT05911841|584730140|FG004|Maintenance Period|Lack of Efficacy|1|||
161912598|NCT05911841|584730141|FG005|Maintenance Period|Lack of Efficacy|0|||
161912599|NCT05911841|584730142|FG006|Maintenance Period|Lack of Efficacy|1|||
161912600|NCT05911841|584730143|FG007|Maintenance Period|Lack of Efficacy|0|||
161912601|NCT05911841|584730144|FG008|Maintenance Period|Lack of Efficacy|0|||
161912602|NCT05911841|584730145|FG009|Maintenance Period|Lack of Efficacy|0|||
161912603|NCT05911841|584730136|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
161912604|NCT05911841|584730137|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
161912605|NCT05911841|584730138|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
162011203|NCT02612779|585097756|FG000|Overall Study|Study drug toxicity|10|||
161912606|NCT05911841|584730139|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
161912607|NCT05911841|584730140|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
161912608|NCT05911841|584730141|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
161912609|NCT05911841|584730142|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
161912610|NCT05911841|584730143|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
161912611|NCT05911841|584730144|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
161912612|NCT05911841|584730145|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
161912613|NCT05911841|584730136|FG000|Maintenance Period|Withdrawal by Subject|0|||
161912614|NCT05911841|584730137|FG001|Maintenance Period|Withdrawal by Subject|0|||
161912615|NCT05911841|584730138|FG002|Maintenance Period|Withdrawal by Subject|0|||
161912616|NCT05911841|584730139|FG003|Maintenance Period|Withdrawal by Subject|0|||
161912617|NCT05911841|584730140|FG004|Maintenance Period|Withdrawal by Subject|0|||
161912618|NCT05911841|584730141|FG005|Maintenance Period|Withdrawal by Subject|1|||
161912619|NCT05911841|584730142|FG006|Maintenance Period|Withdrawal by Subject|0|||
161912620|NCT05911841|584730143|FG007|Maintenance Period|Withdrawal by Subject|1|||
161912621|NCT05911841|584730144|FG008|Maintenance Period|Withdrawal by Subject|0|||
161912622|NCT05911841|584730145|FG009|Maintenance Period|Withdrawal by Subject|0|||
161912623|NCT05911841|584730136|FG000|Maintenance Period|Adverse Event|0|||
161912624|NCT05911841|584730137|FG001|Maintenance Period|Adverse Event|0|||
161912625|NCT05911841|584730138|FG002|Maintenance Period|Adverse Event|0|||
161912626|NCT05911841|584730139|FG003|Maintenance Period|Adverse Event|0|||
161912627|NCT05911841|584730140|FG004|Maintenance Period|Adverse Event|0|||
161912628|NCT05911841|584730141|FG005|Maintenance Period|Adverse Event|0|||
161912629|NCT05911841|584730142|FG006|Maintenance Period|Adverse Event|0|||
161912630|NCT05911841|584730143|FG007|Maintenance Period|Adverse Event|1|||
161912631|NCT05911841|584730144|FG008|Maintenance Period|Adverse Event|0|||
161912632|NCT05911841|584730145|FG009|Maintenance Period|Adverse Event|0|||
161912633|NCT05911841|584730136|FG000|Escape Period|Adverse Event|0|||
161912634|NCT05911841|584730137|FG001|Escape Period|Adverse Event|0|||
161912635|NCT05911841|584730138|FG002|Escape Period|Adverse Event|0|||
161912636|NCT05911841|584730139|FG003|Escape Period|Adverse Event|0|||
161912637|NCT05911841|584730140|FG004|Escape Period|Adverse Event|0|||
161912638|NCT05911841|584730141|FG005|Escape Period|Adverse Event|0|||
161912639|NCT05911841|584730142|FG006|Escape Period|Adverse Event|0|||
161912640|NCT05911841|584730143|FG007|Escape Period|Adverse Event|0|||
161912641|NCT05911841|584730144|FG008|Escape Period|Adverse Event|0|||
161912642|NCT05911841|584730145|FG009|Escape Period|Adverse Event|1|||
161912643|NCT05911841|584730136|FG000|Escape Period|Lack of Efficacy|0|||
161912644|NCT05911841|584730137|FG001|Escape Period|Lack of Efficacy|0|||
161912645|NCT05911841|584730138|FG002|Escape Period|Lack of Efficacy|0|||
161912646|NCT05911841|584730139|FG003|Escape Period|Lack of Efficacy|0|||
161912647|NCT05911841|584730140|FG004|Escape Period|Lack of Efficacy|0|||
161912648|NCT05911841|584730141|FG005|Escape Period|Lack of Efficacy|0|||
161912649|NCT05911841|584730142|FG006|Escape Period|Lack of Efficacy|0|||
161912650|NCT05911841|584730143|FG007|Escape Period|Lack of Efficacy|0|||
161912651|NCT05911841|584730144|FG008|Escape Period|Lack of Efficacy|0|||
161912652|NCT05911841|584730145|FG009|Escape Period|Lack of Efficacy|31|||
161912653|NCT05911841|584730136|FG000|Escape Period|Lost to Follow-up|0|||
161912654|NCT05911841|584730137|FG001|Escape Period|Lost to Follow-up|0|||
161912655|NCT05911841|584730138|FG002|Escape Period|Lost to Follow-up|0|||
161912656|NCT05911841|584730139|FG003|Escape Period|Lost to Follow-up|0|||
161912657|NCT05911841|584730140|FG004|Escape Period|Lost to Follow-up|0|||
161912658|NCT05911841|584730141|FG005|Escape Period|Lost to Follow-up|0|||
161912659|NCT05911841|584730142|FG006|Escape Period|Lost to Follow-up|0|||
161912660|NCT05911841|584730143|FG007|Escape Period|Lost to Follow-up|0|||
161912661|NCT05911841|584730144|FG008|Escape Period|Lost to Follow-up|0|||
161912662|NCT05911841|584730145|FG009|Escape Period|Lost to Follow-up|1|||
161912663|NCT05911841|584730136|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912664|NCT05911841|584730137|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912665|NCT05911841|584730138|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912666|NCT05911841|584730139|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912667|NCT05911841|584730140|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912668|NCT05911841|584730141|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912669|NCT05911841|584730142|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912670|NCT05911841|584730143|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912671|NCT05911841|584730144|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161912672|NCT05911841|584730145|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
161912673|NCT05911841|584730136|FG000|Escape Period|Site Terminated by Sponsor|0|||
161912674|NCT05911841|584730137|FG001|Escape Period|Site Terminated by Sponsor|0|||
161912675|NCT05911841|584730138|FG002|Escape Period|Site Terminated by Sponsor|0|||
161912676|NCT05911841|584730139|FG003|Escape Period|Site Terminated by Sponsor|0|||
161912677|NCT05911841|584730140|FG004|Escape Period|Site Terminated by Sponsor|0|||
161912678|NCT05911841|584730141|FG005|Escape Period|Site Terminated by Sponsor|0|||
161912679|NCT05911841|584730142|FG006|Escape Period|Site Terminated by Sponsor|0|||
161912680|NCT05911841|584730143|FG007|Escape Period|Site Terminated by Sponsor|0|||
161912681|NCT05911841|584730144|FG008|Escape Period|Site Terminated by Sponsor|0|||
161912682|NCT05911841|584730145|FG009|Escape Period|Site Terminated by Sponsor|1|||
161912683|NCT05911841|584730136|FG000|Escape Period|Study Terminated by Sponsor|0|||
161912684|NCT05911841|584730137|FG001|Escape Period|Study Terminated by Sponsor|0|||
161912685|NCT05911841|584730138|FG002|Escape Period|Study Terminated by Sponsor|0|||
161912686|NCT05911841|584730139|FG003|Escape Period|Study Terminated by Sponsor|0|||
162011204|NCT02612779|585097757|FG001|Overall Study|Study drug toxicity|1|||
161912687|NCT05911841|584730140|FG004|Escape Period|Study Terminated by Sponsor|0|||
161912688|NCT05911841|584730141|FG005|Escape Period|Study Terminated by Sponsor|0|||
161912689|NCT05911841|584730142|FG006|Escape Period|Study Terminated by Sponsor|0|||
161912690|NCT05911841|584730143|FG007|Escape Period|Study Terminated by Sponsor|0|||
161912691|NCT05911841|584730144|FG008|Escape Period|Study Terminated by Sponsor|0|||
161912692|NCT05911841|584730145|FG009|Escape Period|Study Terminated by Sponsor|34|||
161912693|NCT05911841|584730136|FG000|Escape Period|Withdrawal by Subject|0|||
161912694|NCT05911841|584730137|FG001|Escape Period|Withdrawal by Subject|0|||
161912695|NCT05911841|584730138|FG002|Escape Period|Withdrawal by Subject|0|||
161912696|NCT05911841|584730139|FG003|Escape Period|Withdrawal by Subject|0|||
161912697|NCT05911841|584730140|FG004|Escape Period|Withdrawal by Subject|0|||
161912698|NCT05911841|584730141|FG005|Escape Period|Withdrawal by Subject|0|||
161912699|NCT05911841|584730142|FG006|Escape Period|Withdrawal by Subject|0|||
161912700|NCT05911841|584730143|FG007|Escape Period|Withdrawal by Subject|0|||
161912701|NCT05911841|584730144|FG008|Escape Period|Withdrawal by Subject|0|||
161912702|NCT05911841|584730145|FG009|Escape Period|Withdrawal by Subject|10|||
161912703|NCT05595369|584730146|FG000|Overall Study|Adverse Event|2|||
161912704|NCT05595369|584730147|FG001|Overall Study|Adverse Event|0|||
161912705|NCT05595369|584730148|FG002|Overall Study|Adverse Event|0|||
161912706|NCT05595369|584730146|FG000|Overall Study|Lost to Follow-up|11|||
161912707|NCT05595369|584730147|FG001|Overall Study|Lost to Follow-up|10|||
161912708|NCT05595369|584730148|FG002|Overall Study|Lost to Follow-up|10|||
161912709|NCT05595369|584730146|FG000|Overall Study|Physician Decision|1|||
161912710|NCT05595369|584730147|FG001|Overall Study|Physician Decision|0|||
161912711|NCT05595369|584730148|FG002|Overall Study|Physician Decision|0|||
161912712|NCT05595369|584730146|FG000|Overall Study|Withdrawal by Subject|5|||
161912713|NCT05595369|584730147|FG001|Overall Study|Withdrawal by Subject|7|||
161912714|NCT05595369|584730148|FG002|Overall Study|Withdrawal by Subject|6|||
161912715|NCT05595369|584730146|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
161912716|NCT05595369|584730147|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
161912717|NCT05595369|584730148|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
161912718|NCT05595369|584730146|FG000|Overall Study|Study Drug Non-compliance|0|||
161912719|NCT05595369|584730147|FG001|Overall Study|Study Drug Non-compliance|1|||
161912720|NCT05595369|584730148|FG002|Overall Study|Study Drug Non-compliance|0|||
161912721|NCT05595369|584730146|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
161912722|NCT05595369|584730147|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
161912723|NCT05595369|584730148|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
161912724|NCT02391337|584730149|FG000|6 Months Follow-up|Death|5|||
161912725|NCT02391337|584730150|FG001|6 Months Follow-up|Death|4|||
161912726|NCT02391337|584730149|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
161912727|NCT02391337|584730150|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
161912728|NCT02391337|584730149|FG000|12 Months Follow-up|Death|2|||
161912729|NCT02391337|584730150|FG001|12 Months Follow-up|Death|0|||
161912730|NCT02391337|584730149|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
161912731|NCT02391337|584730150|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
161912732|NCT02391337|584730149|FG000|12 Months Follow-up|Lost to Follow-up|0|||
161912733|NCT02391337|584730150|FG001|12 Months Follow-up|Lost to Follow-up|2|||
161912734|NCT00465517|584730152|FG000|Overall Study|Adverse Event|7|||
161912735|NCT00465517|584730153|FG001|Overall Study|Adverse Event|3|||
161912736|NCT00465517|584730152|FG000|Overall Study|Lost to Follow-up|1|||
161912737|NCT00465517|584730153|FG001|Overall Study|Lost to Follow-up|0|||
161912738|NCT00465517|584730152|FG000|Overall Study|Withdrawal by Subject|4|||
161912739|NCT00465517|584730153|FG001|Overall Study|Withdrawal by Subject|1|||
161912740|NCT03191552|584730156|FG000|Overall Study|Lost to Follow-up|1|||
161912741|NCT03191552|584730157|FG001|Overall Study|Lost to Follow-up|0|||
161912742|NCT03191552|584730158|FG002|Overall Study|Lost to Follow-up|0|||
161912743|NCT03191552|584730156|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
161912744|NCT03191552|584730157|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
161912745|NCT03191552|584730158|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
161912746|NCT01499810|584730159|FG000|Overall Study|Lost to Follow-up|10|||
161912747|NCT01499810|584730159|FG000|Overall Study|Protocol Violation|1|||
161912748|NCT01499810|584730159|FG000|Overall Study|Withdrawal by Subject|1|||
161912749|NCT01884597|584730160|FG000|Overall Study|Adverse Event|0|||
161912750|NCT01884597|584730161|FG001|Overall Study|Adverse Event|0|||
161912751|NCT01884597|584730162|FG002|Overall Study|Adverse Event|1|||
161912752|NCT01884597|584730160|FG000|Overall Study|Lack of Efficacy|1|||
161912753|NCT01884597|584730161|FG001|Overall Study|Lack of Efficacy|0|||
161912754|NCT01884597|584730162|FG002|Overall Study|Lack of Efficacy|0|||
161912755|NCT01884597|584730160|FG000|Overall Study|Death|0|||
161912756|NCT01884597|584730161|FG001|Overall Study|Death|1|||
161912757|NCT01884597|584730162|FG002|Overall Study|Death|0|||
161912758|NCT02634710|584730163|FG000|Overall Study|Death|4|||
161912759|NCT04530630|584731813|FG000|Overall Study|Physician Decision|1|||
161912760|NCT03834961|584731816|FG000|Overall Study|Lack of Efficacy|1|||
161912761|NCT03834961|584731817|FG001|Overall Study|Lack of Efficacy|1|||
161912762|NCT03834961|584731818|FG002|Overall Study|Lack of Efficacy|0|||
161912763|NCT03834961|584731816|FG000|Overall Study|Physician Decision|0|||
161912764|NCT03834961|584731817|FG001|Overall Study|Physician Decision|1|||
161912765|NCT03834961|584731818|FG002|Overall Study|Physician Decision|0|||
162143884|NCT02596035|585573255|FG002|Overall Study|participant no longer meets study criteria|0|||
162143885|NCT02596035|585573253|FG000|Overall Study|other reasons|11|||
162143886|NCT02596035|585573254|FG001|Overall Study|other reasons|4|||
162143887|NCT02596035|585573255|FG002|Overall Study|other reasons|0|||
162143888|NCT03395353|585573257|FG000|Overall Study|Adverse Event|20|||
162143889|NCT03395353|585573257|FG000|Overall Study|Protocol Violation|1|||
162143890|NCT03395353|585573257|FG000|Overall Study|Lack of Efficacy|3|||
162143891|NCT03395353|585573257|FG000|Overall Study|Withdrawal by Subject|24|||
162143892|NCT03395353|585573257|FG000|Overall Study|Discontinued visit|1|||
162143893|NCT03395353|585573257|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
162143894|NCT03395353|585573257|FG000|Overall Study|Physician Decision|4|||
162143895|NCT03395353|585573257|FG000|Overall Study|Early termination of overall study|33|||
162143896|NCT03301220|585573258|FG000|Overall Study|Death|26|||
162143897|NCT03301220|585573259|FG001|Overall Study|Death|15|||
162143898|NCT03301220|585573258|FG000|Overall Study|Withdrawal by Subject|23|||
162143899|NCT03301220|585573259|FG001|Overall Study|Withdrawal by Subject|12|||
162143900|NCT03301220|585573258|FG000|Overall Study|Lost to Follow-up|1|||
162143901|NCT03301220|585573259|FG001|Overall Study|Lost to Follow-up|1|||
162143902|NCT03301220|585573258|FG000|Overall Study|Randomized in error|1|||
162143903|NCT03301220|585573259|FG001|Overall Study|Randomized in error|1|||
161912766|NCT05507437|584731821|FG000|Overall Study|Withdrawal by Subject|1|||
161912767|NCT05507437|584731822|FG001|Overall Study|Withdrawal by Subject|1|||
161912768|NCT05507437|584731821|FG000|Overall Study|Death|3|||
161912769|NCT05507437|584731822|FG001|Overall Study|Death|0|||
161912770|NCT06583096|584731823|FG000|Overall Study|Lost to Follow-up|4|||
161912771|NCT06583096|584731824|FG001|Overall Study|Lost to Follow-up|10|||
161912772|NCT06583096|584731823|FG000|Overall Study|Withdrawal by Subject|0|||
161912773|NCT06583096|584731824|FG001|Overall Study|Withdrawal by Subject|2|||
161912774|NCT05172609|584731825|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
161912775|NCT05172609|584731826|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
161912776|NCT05172609|584731825|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
161912777|NCT05172609|584731826|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
161912778|NCT05172609|584731825|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
161912779|NCT05172609|584731826|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
161912780|NCT05610605|584731829|FG000|6-month Assessment|Death|1|||
161912781|NCT05610605|584731830|FG001|6-month Assessment|Death|1|||
161912782|NCT05610605|584731829|FG000|6-month Assessment|Lost to Follow-up|20|||
161912783|NCT05610605|584731830|FG001|6-month Assessment|Lost to Follow-up|0|||
161912784|NCT05610605|584731829|FG000|6-month Assessment|Institutionalized|1|||
161912785|NCT05610605|584731830|FG001|6-month Assessment|Institutionalized|2|||
161912786|NCT05610605|584731829|FG000|12-month Assessment|Death|2|||
161912787|NCT05610605|584731830|FG001|12-month Assessment|Death|1|||
161912788|NCT05610605|584731829|FG000|12-month Assessment|Lost to Follow-up|1|||
161912789|NCT05610605|584731830|FG001|12-month Assessment|Lost to Follow-up|4|||
161912790|NCT05610605|584731829|FG000|12-month Assessment|Institutionalized|2|||
161912791|NCT05610605|584731830|FG001|12-month Assessment|Institutionalized|1|||
161912792|NCT00753519|584731831|FG000|Overall Study|Withdrawal by Subject|0|||
161912793|NCT00753519|584731832|FG001|Overall Study|Withdrawal by Subject|2|||
161912794|NCT00042289|584731833|FG000|Overall Study|Lost to Follow-up|3|||
161912795|NCT00042289|584731834|FG001|Overall Study|Lost to Follow-up|0|||
161912796|NCT00042289|584731835|FG002|Overall Study|Lost to Follow-up|0|||
161912797|NCT00042289|584731836|FG003|Overall Study|Lost to Follow-up|1|||
161912798|NCT00042289|584731837|FG004|Overall Study|Lost to Follow-up|3|||
161912799|NCT00042289|584731838|FG005|Overall Study|Lost to Follow-up|3|||
161912800|NCT00042289|584731839|FG006|Overall Study|Lost to Follow-up|6|||
161912801|NCT00042289|584731840|FG007|Overall Study|Lost to Follow-up|1|||
161912802|NCT00042289|584731841|FG008|Overall Study|Lost to Follow-up|1|||
161912803|NCT00042289|584731842|FG009|Overall Study|Lost to Follow-up|0|||
161912804|NCT00042289|584731843|FG010|Overall Study|Lost to Follow-up|0|||
161912805|NCT00042289|584731844|FG011|Overall Study|Lost to Follow-up|0|||
162143904|NCT03301220|585573258|FG000|Overall Study|Randomized but not treated|0|||
162143905|NCT03301220|585573259|FG001|Overall Study|Randomized but not treated|1|||
161912806|NCT00042289|584731845|FG012|Overall Study|Lost to Follow-up|0|||
161912807|NCT00042289|584731846|FG013|Overall Study|Lost to Follow-up|0|||
161912808|NCT00042289|584731847|FG014|Overall Study|Lost to Follow-up|0|||
161912809|NCT00042289|584731848|FG015|Overall Study|Lost to Follow-up|1|||
161912810|NCT00042289|584731849|FG016|Overall Study|Lost to Follow-up|1|||
161912811|NCT00042289|584731850|FG017|Overall Study|Lost to Follow-up|0|||
161912812|NCT00042289|584731851|FG018|Overall Study|Lost to Follow-up|3|||
161912813|NCT00042289|584731852|FG019|Overall Study|Lost to Follow-up|2|||
161912814|NCT00042289|584731853|FG020|Overall Study|Lost to Follow-up|0|||
161912815|NCT00042289|584731854|FG021|Overall Study|Lost to Follow-up|0|||
161912816|NCT00042289|584731855|FG022|Overall Study|Lost to Follow-up|0|||
161912817|NCT00042289|584731856|FG023|Overall Study|Lost to Follow-up|0|||
162143906|NCT03301220|585573258|FG000|Overall Study|Ongoing followup|145|||
162143907|NCT03301220|585573259|FG001|Overall Study|Ongoing followup|163|||
162143908|NCT03301220|585573258|FG000|Overall Study|Principal Investigator and participant decision|0|||
161912818|NCT00042289|584731857|FG024|Overall Study|Lost to Follow-up|0|||
161912819|NCT00042289|584731858|FG025|Overall Study|Lost to Follow-up|0|||
161912820|NCT00042289|584731859|FG026|Overall Study|Lost to Follow-up|2|||
161912821|NCT00042289|584731860|FG027|Overall Study|Lost to Follow-up|2|||
161912822|NCT00042289|584731861|FG028|Overall Study|Lost to Follow-up|2|||
161912823|NCT00042289|584731862|FG029|Overall Study|Lost to Follow-up|0|||
161912824|NCT00042289|584731863|FG030|Overall Study|Lost to Follow-up|0|||
161912825|NCT00042289|584731864|FG031|Overall Study|Lost to Follow-up|2|||
161912826|NCT00042289|584731865|FG032|Overall Study|Lost to Follow-up|1|||
161912827|NCT00042289|584731866|FG033|Overall Study|Lost to Follow-up|1|||
161912828|NCT00042289|584731867|FG034|Overall Study|Lost to Follow-up|1|||
161912829|NCT00042289|584731868|FG035|Overall Study|Lost to Follow-up|2|||
161912830|NCT00042289|584731869|FG036|Overall Study|Lost to Follow-up|1|||
161912831|NCT00042289|584731870|FG037|Overall Study|Lost to Follow-up|1|||
161912832|NCT00042289|584731871|FG038|Overall Study|Lost to Follow-up|0|||
161912833|NCT00042289|584731872|FG039|Overall Study|Lost to Follow-up|5|||
161912834|NCT00042289|584731873|FG040|Overall Study|Lost to Follow-up|0|||
161912835|NCT00042289|584731874|FG041|Overall Study|Lost to Follow-up|2|||
161912836|NCT00042289|584731875|FG042|Overall Study|Lost to Follow-up|2|||
161912837|NCT00042289|584731876|FG043|Overall Study|Lost to Follow-up|0|||
161912838|NCT00042289|584731877|FG044|Overall Study|Lost to Follow-up|0|||
161912839|NCT00042289|584731878|FG045|Overall Study|Lost to Follow-up|1|||
161912840|NCT00042289|584731879|FG046|Overall Study|Lost to Follow-up|0|||
161912841|NCT00042289|584731833|FG000|Overall Study|Other reason|0|||
161912842|NCT00042289|584731834|FG001|Overall Study|Other reason|0|||
161912843|NCT00042289|584731835|FG002|Overall Study|Other reason|0|||
161912844|NCT00042289|584731836|FG003|Overall Study|Other reason|2|||
161912845|NCT00042289|584731837|FG004|Overall Study|Other reason|0|||
161912846|NCT00042289|584731838|FG005|Overall Study|Other reason|0|||
161912847|NCT00042289|584731839|FG006|Overall Study|Other reason|0|||
161912848|NCT00042289|584731840|FG007|Overall Study|Other reason|0|||
161912849|NCT00042289|584731841|FG008|Overall Study|Other reason|0|||
161912850|NCT00042289|584731842|FG009|Overall Study|Other reason|0|||
161912851|NCT00042289|584731843|FG010|Overall Study|Other reason|0|||
161912852|NCT00042289|584731844|FG011|Overall Study|Other reason|0|||
161912853|NCT00042289|584731845|FG012|Overall Study|Other reason|0|||
161912854|NCT00042289|584731846|FG013|Overall Study|Other reason|0|||
161912855|NCT00042289|584731847|FG014|Overall Study|Other reason|0|||
161912856|NCT00042289|584731848|FG015|Overall Study|Other reason|0|||
161912857|NCT00042289|584731849|FG016|Overall Study|Other reason|0|||
161912858|NCT00042289|584731850|FG017|Overall Study|Other reason|0|||
161912859|NCT00042289|584731851|FG018|Overall Study|Other reason|1|||
161912860|NCT00042289|584731852|FG019|Overall Study|Other reason|0|||
161912861|NCT00042289|584731853|FG020|Overall Study|Other reason|0|||
161912862|NCT00042289|584731854|FG021|Overall Study|Other reason|0|||
161912863|NCT00042289|584731855|FG022|Overall Study|Other reason|0|||
161912864|NCT00042289|584731856|FG023|Overall Study|Other reason|1|||
161912865|NCT00042289|584731857|FG024|Overall Study|Other reason|0|||
161912866|NCT00042289|584731858|FG025|Overall Study|Other reason|0|||
161912867|NCT00042289|584731859|FG026|Overall Study|Other reason|1|||
161912868|NCT00042289|584731860|FG027|Overall Study|Other reason|0|||
161912869|NCT00042289|584731861|FG028|Overall Study|Other reason|3|||
161912870|NCT00042289|584731862|FG029|Overall Study|Other reason|0|||
161912871|NCT00042289|584731863|FG030|Overall Study|Other reason|0|||
161912872|NCT00042289|584731864|FG031|Overall Study|Other reason|1|||
161912873|NCT00042289|584731865|FG032|Overall Study|Other reason|0|||
161912874|NCT00042289|584731866|FG033|Overall Study|Other reason|1|||
161912875|NCT00042289|584731867|FG034|Overall Study|Other reason|0|||
161912876|NCT00042289|584731868|FG035|Overall Study|Other reason|2|||
161912877|NCT00042289|584731869|FG036|Overall Study|Other reason|0|||
161912878|NCT00042289|584731870|FG037|Overall Study|Other reason|0|||
162011205|NCT02612779|585097756|FG000|Overall Study|Death|1|||
162011206|NCT02612779|585097757|FG001|Overall Study|Death|0|||
162011207|NCT02612779|585097756|FG000|Overall Study|Adverse event unrelated to study drug|5|||
162011208|NCT02612779|585097757|FG001|Overall Study|Adverse event unrelated to study drug|0|||
162011209|NCT02612779|585097756|FG000|Overall Study|Participant withdrew consent|4|||
161912879|NCT00042289|584731871|FG038|Overall Study|Other reason|0|||
161912880|NCT00042289|584731872|FG039|Overall Study|Other reason|0|||
161912881|NCT00042289|584731873|FG040|Overall Study|Other reason|0|||
161912882|NCT00042289|584731874|FG041|Overall Study|Other reason|0|||
161912883|NCT00042289|584731875|FG042|Overall Study|Other reason|0|||
162011210|NCT02612779|585097757|FG001|Overall Study|Participant withdrew consent|0|||
161912884|NCT00042289|584731876|FG043|Overall Study|Other reason|1|||
161912885|NCT00042289|584731877|FG044|Overall Study|Other reason|0|||
161912886|NCT00042289|584731878|FG045|Overall Study|Other reason|0|||
161912887|NCT00042289|584731879|FG046|Overall Study|Other reason|0|||
161912888|NCT00042289|584731833|FG000|Overall Study|Severe debilitation, unable to continue|0|||
161912889|NCT00042289|584731834|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161912890|NCT00042289|584731835|FG002|Overall Study|Severe debilitation, unable to continue|0|||
161912891|NCT00042289|584731836|FG003|Overall Study|Severe debilitation, unable to continue|0|||
161912892|NCT00042289|584731837|FG004|Overall Study|Severe debilitation, unable to continue|0|||
161912893|NCT00042289|584731838|FG005|Overall Study|Severe debilitation, unable to continue|0|||
162143909|NCT03301220|585573259|FG001|Overall Study|Principal Investigator and participant decision|1|||
162143910|NCT02685033|585573260|FG000|Overall Study|Withdrawal of Consent|0|||
162143911|NCT02685033|585573261|FG001|Overall Study|Withdrawal of Consent|1|||
162143912|NCT02685033|585573260|FG000|Overall Study|Lost to Follow-up|2|||
162143913|NCT02685033|585573261|FG001|Overall Study|Lost to Follow-up|1|||
162143914|NCT02685033|585573260|FG000|Overall Study|Adverse Event|1|||
162143915|NCT02685033|585573261|FG001|Overall Study|Adverse Event|0|||
162143916|NCT04845620|585573266|FG000|Overall Study|Withdrawal by Subject|11|||
162143917|NCT04845620|585573267|FG001|Overall Study|Withdrawal by Subject|10|||
162143918|NCT04845620|585573266|FG000|Overall Study|Adverse Event|5|||
161912894|NCT00042289|584731839|FG006|Overall Study|Severe debilitation, unable to continue|0|||
161912895|NCT00042289|584731840|FG007|Overall Study|Severe debilitation, unable to continue|0|||
161912896|NCT00042289|584731841|FG008|Overall Study|Severe debilitation, unable to continue|0|||
161912897|NCT00042289|584731842|FG009|Overall Study|Severe debilitation, unable to continue|0|||
161912898|NCT00042289|584731843|FG010|Overall Study|Severe debilitation, unable to continue|0|||
161912899|NCT00042289|584731844|FG011|Overall Study|Severe debilitation, unable to continue|0|||
161912900|NCT00042289|584731845|FG012|Overall Study|Severe debilitation, unable to continue|0|||
161912901|NCT00042289|584731846|FG013|Overall Study|Severe debilitation, unable to continue|0|||
161912902|NCT00042289|584731847|FG014|Overall Study|Severe debilitation, unable to continue|0|||
161912903|NCT00042289|584731848|FG015|Overall Study|Severe debilitation, unable to continue|0|||
161912904|NCT00042289|584731849|FG016|Overall Study|Severe debilitation, unable to continue|0|||
161912905|NCT00042289|584731850|FG017|Overall Study|Severe debilitation, unable to continue|0|||
161912906|NCT00042289|584731851|FG018|Overall Study|Severe debilitation, unable to continue|0|||
161912907|NCT00042289|584731852|FG019|Overall Study|Severe debilitation, unable to continue|0|||
161912908|NCT00042289|584731853|FG020|Overall Study|Severe debilitation, unable to continue|0|||
161912909|NCT00042289|584731854|FG021|Overall Study|Severe debilitation, unable to continue|1|||
161912910|NCT00042289|584731855|FG022|Overall Study|Severe debilitation, unable to continue|0|||
161912911|NCT00042289|584731856|FG023|Overall Study|Severe debilitation, unable to continue|1|||
161912912|NCT00042289|584731857|FG024|Overall Study|Severe debilitation, unable to continue|0|||
161912913|NCT00042289|584731858|FG025|Overall Study|Severe debilitation, unable to continue|0|||
161912914|NCT00042289|584731859|FG026|Overall Study|Severe debilitation, unable to continue|0|||
161912915|NCT00042289|584731860|FG027|Overall Study|Severe debilitation, unable to continue|1|||
161912916|NCT00042289|584731861|FG028|Overall Study|Severe debilitation, unable to continue|0|||
161912917|NCT00042289|584731862|FG029|Overall Study|Severe debilitation, unable to continue|0|||
161912918|NCT00042289|584731863|FG030|Overall Study|Severe debilitation, unable to continue|0|||
161912919|NCT00042289|584731864|FG031|Overall Study|Severe debilitation, unable to continue|1|||
161912920|NCT00042289|584731865|FG032|Overall Study|Severe debilitation, unable to continue|1|||
161912921|NCT00042289|584731866|FG033|Overall Study|Severe debilitation, unable to continue|0|||
161912922|NCT00042289|584731867|FG034|Overall Study|Severe debilitation, unable to continue|0|||
161912923|NCT00042289|584731868|FG035|Overall Study|Severe debilitation, unable to continue|0|||
161912924|NCT00042289|584731869|FG036|Overall Study|Severe debilitation, unable to continue|0|||
161912925|NCT00042289|584731870|FG037|Overall Study|Severe debilitation, unable to continue|0|||
161912926|NCT00042289|584731871|FG038|Overall Study|Severe debilitation, unable to continue|0|||
161912927|NCT00042289|584731872|FG039|Overall Study|Severe debilitation, unable to continue|0|||
161912928|NCT00042289|584731873|FG040|Overall Study|Severe debilitation, unable to continue|0|||
161912929|NCT00042289|584731874|FG041|Overall Study|Severe debilitation, unable to continue|0|||
161912930|NCT00042289|584731875|FG042|Overall Study|Severe debilitation, unable to continue|0|||
161912931|NCT00042289|584731876|FG043|Overall Study|Severe debilitation, unable to continue|0|||
161912932|NCT00042289|584731877|FG044|Overall Study|Severe debilitation, unable to continue|0|||
161912933|NCT00042289|584731878|FG045|Overall Study|Severe debilitation, unable to continue|0|||
161912934|NCT00042289|584731879|FG046|Overall Study|Severe debilitation, unable to continue|0|||
161912935|NCT00042289|584731833|FG000|Overall Study|Site closed|0|||
161912936|NCT00042289|584731834|FG001|Overall Study|Site closed|0|||
161912937|NCT00042289|584731835|FG002|Overall Study|Site closed|0|||
161912938|NCT00042289|584731836|FG003|Overall Study|Site closed|0|||
161912939|NCT00042289|584731837|FG004|Overall Study|Site closed|0|||
161912940|NCT00042289|584731838|FG005|Overall Study|Site closed|0|||
161912941|NCT00042289|584731839|FG006|Overall Study|Site closed|0|||
161912942|NCT00042289|584731840|FG007|Overall Study|Site closed|0|||
161912943|NCT00042289|584731841|FG008|Overall Study|Site closed|0|||
161912944|NCT00042289|584731842|FG009|Overall Study|Site closed|0|||
161912945|NCT00042289|584731843|FG010|Overall Study|Site closed|0|||
161912946|NCT00042289|584731844|FG011|Overall Study|Site closed|0|||
161912947|NCT00042289|584731845|FG012|Overall Study|Site closed|0|||
161912948|NCT00042289|584731846|FG013|Overall Study|Site closed|0|||
161912949|NCT00042289|584731847|FG014|Overall Study|Site closed|0|||
162143919|NCT04845620|585573267|FG001|Overall Study|Adverse Event|4|||
162011211|NCT02612779|585097756|FG000|Overall Study|Lost to Follow-up|1|||
162011212|NCT02612779|585097757|FG001|Overall Study|Lost to Follow-up|0|||
162011213|NCT02612779|585097756|FG000|Overall Study|Maximum clinical benefit|10|||
162011214|NCT02612779|585097757|FG001|Overall Study|Maximum clinical benefit|1|||
162011215|NCT02612779|585097756|FG000|Overall Study|Other reasons|4|||
162011216|NCT02612779|585097757|FG001|Overall Study|Other reasons|0|||
162011217|NCT01657019|585097760|FG000|Overall Study|Withdrawal by Subject|65|||
162011218|NCT01657019|585097760|FG000|Overall Study|Adverse Event|55|||
162011219|NCT01657019|585097760|FG000|Overall Study|Lost to Follow-up|48|||
162011220|NCT01657019|585097760|FG000|Overall Study|Protocol Violation|6|||
162011221|NCT01657019|585097760|FG000|Overall Study|Lack of Efficacy|3|||
162011222|NCT01657019|585097760|FG000|Overall Study|Other|58|||
162011223|NCT00129402|585097777|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
162011224|NCT00129402|585097778|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
162011225|NCT00129402|585097779|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
162011226|NCT00129402|585097780|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
162011227|NCT00129402|585097781|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
162011228|NCT00129402|585097782|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
162011229|NCT00129402|585097783|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
162011230|NCT00129402|585097777|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
162011231|NCT00129402|585097778|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
162011232|NCT00129402|585097779|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
162011233|NCT00129402|585097780|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
162011234|NCT00129402|585097781|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
162011235|NCT00129402|585097782|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
162011236|NCT00129402|585097783|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
162011237|NCT00129402|585097777|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
162011238|NCT00129402|585097778|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
162011239|NCT00129402|585097779|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
162011240|NCT00129402|585097780|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
162143920|NCT04845620|585573266|FG000|Overall Study|Lost to Follow-up|5|||
161808974|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808975|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808976|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808977|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808978|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808979|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161808980|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808981|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808982|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808983|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808984|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
161808985|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
161912950|NCT00042289|584731848|FG015|Overall Study|Site closed|0|||
161912951|NCT00042289|584731849|FG016|Overall Study|Site closed|0|||
161912952|NCT00042289|584731850|FG017|Overall Study|Site closed|0|||
161912953|NCT00042289|584731851|FG018|Overall Study|Site closed|0|||
161912954|NCT00042289|584731852|FG019|Overall Study|Site closed|0|||
161912955|NCT00042289|584731853|FG020|Overall Study|Site closed|0|||
161912956|NCT00042289|584731854|FG021|Overall Study|Site closed|0|||
161912957|NCT00042289|584731855|FG022|Overall Study|Site closed|0|||
161912958|NCT00042289|584731856|FG023|Overall Study|Site closed|0|||
161912959|NCT00042289|584731857|FG024|Overall Study|Site closed|0|||
161912960|NCT00042289|584731858|FG025|Overall Study|Site closed|0|||
161912961|NCT00042289|584731859|FG026|Overall Study|Site closed|0|||
161912962|NCT00042289|584731860|FG027|Overall Study|Site closed|0|||
161912963|NCT00042289|584731861|FG028|Overall Study|Site closed|0|||
161912964|NCT00042289|584731862|FG029|Overall Study|Site closed|0|||
161912965|NCT00042289|584731863|FG030|Overall Study|Site closed|0|||
161912966|NCT00042289|584731864|FG031|Overall Study|Site closed|3|||
161912967|NCT00042289|584731865|FG032|Overall Study|Site closed|0|||
161912968|NCT00042289|584731866|FG033|Overall Study|Site closed|0|||
161912969|NCT00042289|584731867|FG034|Overall Study|Site closed|0|||
161912970|NCT00042289|584731868|FG035|Overall Study|Site closed|0|||
161912971|NCT00042289|584731869|FG036|Overall Study|Site closed|1|||
161912972|NCT00042289|584731870|FG037|Overall Study|Site closed|0|||
161912973|NCT00042289|584731871|FG038|Overall Study|Site closed|0|||
161912974|NCT00042289|584731872|FG039|Overall Study|Site closed|0|||
161912975|NCT00042289|584731873|FG040|Overall Study|Site closed|0|||
161912976|NCT00042289|584731874|FG041|Overall Study|Site closed|0|||
161912977|NCT00042289|584731875|FG042|Overall Study|Site closed|1|||
161912978|NCT00042289|584731876|FG043|Overall Study|Site closed|0|||
161912979|NCT00042289|584731877|FG044|Overall Study|Site closed|0|||
161912980|NCT00042289|584731878|FG045|Overall Study|Site closed|0|||
161912981|NCT00042289|584731879|FG046|Overall Study|Site closed|0|||
161912982|NCT00042289|584731833|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
162143921|NCT04845620|585573267|FG001|Overall Study|Lost to Follow-up|4|||
162143922|NCT04845620|585573266|FG000|Overall Study|Lack of Efficacy|4|||
162143923|NCT04845620|585573267|FG001|Overall Study|Lack of Efficacy|4|||
162143924|NCT04845620|585573266|FG000|Overall Study|Physician Decision|2|||
162143925|NCT04845620|585573267|FG001|Overall Study|Physician Decision|1|||
162143926|NCT00708097|585573268|FG000|Period 1|Protocol Violation|0|||
162143927|NCT00708097|585573269|FG001|Period 1|Protocol Violation|1|||
162143928|NCT00708097|585573270|FG002|Period 1|Protocol Violation|0|||
162143929|NCT00708097|585573271|FG003|Period 1|Protocol Violation|2|||
162143930|NCT00708097|585573272|FG004|Period 1|Protocol Violation|0|||
162143931|NCT00708097|585573268|FG000|Period 1|Other Reason|0|||
162143932|NCT00708097|585573269|FG001|Period 1|Other Reason|0|||
162143933|NCT00708097|585573270|FG002|Period 1|Other Reason|0|||
162143934|NCT00708097|585573271|FG003|Period 1|Other Reason|0|||
162143935|NCT00708097|585573272|FG004|Period 1|Other Reason|1|||
162143936|NCT00708097|585573268|FG000|Period 2|Protocol Violation|0|||
162143937|NCT00708097|585573269|FG001|Period 2|Protocol Violation|1|||
162143938|NCT00708097|585573270|FG002|Period 2|Protocol Violation|1|||
162143939|NCT00708097|585573271|FG003|Period 2|Protocol Violation|1|||
162143940|NCT00708097|585573272|FG004|Period 2|Protocol Violation|0|||
162143941|NCT00603447|585573273|FG000|Overall Study|Adverse Event|0|||
162143942|NCT00603447|585573274|FG001|Overall Study|Adverse Event|1|||
162143943|NCT00603447|585573275|FG002|Overall Study|Adverse Event|1|||
162143944|NCT00603447|585573276|FG003|Overall Study|Adverse Event|2|||
162143945|NCT00603447|585573277|FG004|Overall Study|Adverse Event|1|||
162143946|NCT00603447|585573278|FG005|Overall Study|Adverse Event|2|||
162143947|NCT00603447|585573279|FG006|Overall Study|Adverse Event|10|||
162143948|NCT00603447|585573273|FG000|Overall Study|Other|0|||
162143949|NCT00603447|585573274|FG001|Overall Study|Other|0|||
162143950|NCT00603447|585573275|FG002|Overall Study|Other|1|||
162143951|NCT00603447|585573276|FG003|Overall Study|Other|0|||
162143952|NCT00603447|585573277|FG004|Overall Study|Other|3|||
162143953|NCT00603447|585573278|FG005|Overall Study|Other|0|||
162143954|NCT00603447|585573279|FG006|Overall Study|Other|13|||
162143955|NCT00603447|585573273|FG000|Overall Study|Withdrew Consent|0|||
162143956|NCT00603447|585573274|FG001|Overall Study|Withdrew Consent|2|||
162143957|NCT00603447|585573275|FG002|Overall Study|Withdrew Consent|0|||
162143958|NCT00603447|585573276|FG003|Overall Study|Withdrew Consent|0|||
162143959|NCT00603447|585573277|FG004|Overall Study|Withdrew Consent|1|||
162143960|NCT00603447|585573278|FG005|Overall Study|Withdrew Consent|0|||
162143961|NCT00603447|585573279|FG006|Overall Study|Withdrew Consent|1|||
162143962|NCT07214922|585573280|FG000|Overall Study|Adverse Event|0|||
161912983|NCT00042289|584731834|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
161912984|NCT00042289|584731835|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
161912985|NCT00042289|584731836|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
161912986|NCT00042289|584731837|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
161912987|NCT00042289|584731838|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
161912988|NCT00042289|584731839|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
161912989|NCT00042289|584731840|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
161912990|NCT00042289|584731841|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
161912991|NCT00042289|584731842|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
161912992|NCT00042289|584731843|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
161912993|NCT00042289|584731844|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
161912994|NCT00042289|584731845|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
161912995|NCT00042289|584731846|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
161912996|NCT00042289|584731847|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
161912997|NCT00042289|584731848|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
161912998|NCT00042289|584731849|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
161912999|NCT00042289|584731850|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
161913000|NCT00042289|584731851|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
161913001|NCT00042289|584731852|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
161913002|NCT00042289|584731853|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
161913003|NCT00042289|584731854|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
161913004|NCT00042289|584731855|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
161913005|NCT00042289|584731856|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
161913006|NCT00042289|584731857|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
162143963|NCT07214922|585573281|FG001|Overall Study|Adverse Event|0|||
162143964|NCT07214922|585573282|FG002|Overall Study|Adverse Event|1|||
162143965|NCT07214922|585573283|FG003|Overall Study|Adverse Event|0|||
162143966|NCT07214922|585573280|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
162143967|NCT07214922|585573281|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
162143968|NCT07214922|585573282|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
162143969|NCT07214922|585573283|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
162143970|NCT00726596|585574778|FG000|Overall Study|Adverse Event|2|||
161808986|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
161808987|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
161808988|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
161808989|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
161808990|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
161808991|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
161808992|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
161808993|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808994|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808995|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808996|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808997|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808998|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161808999|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161809000|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161809001|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809002|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809003|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809004|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809005|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
161809006|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
161809007|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
161809008|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809009|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
161809010|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
161809011|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
161809012|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
161809013|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
161809014|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809015|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809016|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809017|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161809018|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161913007|NCT00042289|584731858|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
161809019|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161913008|NCT00042289|584731859|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
162011241|NCT00129402|585097781|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
161809020|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162011242|NCT00129402|585097782|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
162011243|NCT00129402|585097783|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
162011244|NCT00129402|585097777|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
162011245|NCT00129402|585097778|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
162143971|NCT00726596|585574779|FG001|Overall Study|Adverse Event|1|||
162143972|NCT00726596|585574778|FG000|Overall Study|Withdrawal by Subject|3|||
162143973|NCT00726596|585574779|FG001|Overall Study|Withdrawal by Subject|3|||
162143974|NCT00482729|585574780|FG000|Overall Study|Adverse Event|29|||
162143975|NCT00482729|585574781|FG001|Overall Study|Adverse Event|33|||
162143976|NCT00482729|585574780|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
162143977|NCT00482729|585574781|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
162143978|NCT00482729|585574780|FG000|Overall Study|Hyperglycemia Criteria|7|||
162143979|NCT00482729|585574781|FG001|Overall Study|Hyperglycemia Criteria|5|||
162143980|NCT00482729|585574780|FG000|Overall Study|Lack of Efficacy|4|||
162143981|NCT00482729|585574781|FG001|Overall Study|Lack of Efficacy|16|||
162143982|NCT00482729|585574780|FG000|Overall Study|Lost to Follow-up|86|||
162143983|NCT00482729|585574781|FG001|Overall Study|Lost to Follow-up|66|||
162143984|NCT00482729|585574780|FG000|Overall Study|Physician Decision|10|||
162143985|NCT00482729|585574781|FG001|Overall Study|Physician Decision|7|||
162143986|NCT00482729|585574780|FG000|Overall Study|Pregnancy|4|||
162143987|NCT00482729|585574781|FG001|Overall Study|Pregnancy|2|||
162143988|NCT00482729|585574780|FG000|Overall Study|Protocol Violation|10|||
162143989|NCT00482729|585574781|FG001|Overall Study|Protocol Violation|18|||
162143990|NCT00482729|585574780|FG000|Overall Study|Withdrawal by Subject|67|||
162143991|NCT00482729|585574781|FG001|Overall Study|Withdrawal by Subject|69|||
162143992|NCT00954707|585574794|FG000|Overall Study|Death|34|||
162143993|NCT00954707|585574794|FG000|Overall Study|Withdrawal by Subject|100|||
162143994|NCT00954707|585574794|FG000|Overall Study|Lost to Follow-up|33|||
162143995|NCT00486759|585574795|FG000|Treatment|Adverse event/intercurrent illness|86|||
162143996|NCT00486759|585574796|FG001|Treatment|Adverse event/intercurrent illness|39|||
162143997|NCT00486759|585574795|FG000|Treatment|Insufficient therapeutic response|37|||
162143998|NCT00486759|585574796|FG001|Treatment|Insufficient therapeutic response|39|||
162143999|NCT00486759|585574795|FG000|Treatment|Death|17|||
162144000|NCT00486759|585574796|FG001|Treatment|Death|10|||
162144001|NCT00486759|585574795|FG000|Treatment|Withdrew consent|15|||
162144002|NCT00486759|585574796|FG001|Treatment|Withdrew consent|12|||
162144003|NCT00486759|585574795|FG000|Treatment|Administrative/reason not specified|17|||
162144004|NCT00486759|585574796|FG001|Treatment|Administrative/reason not specified|21|||
162144005|NCT00486759|585574795|FG000|Treatment|Refused treatment|10|||
162144006|NCT00486759|585574796|FG001|Treatment|Refused treatment|7|||
162144007|NCT00486759|585574795|FG000|Treatment|Violation of selection criteria at entry|3|||
162144008|NCT00486759|585574796|FG001|Treatment|Violation of selection criteria at entry|3|||
162144009|NCT00486759|585574795|FG000|Treatment|Other protocol violation|1|||
162144010|NCT00486759|585574796|FG001|Treatment|Other protocol violation|5|||
162144011|NCT00486759|585574795|FG000|Treatment|Failure to return|1|||
162144012|NCT00486759|585574796|FG001|Treatment|Failure to return|1|||
162144013|NCT00486759|585574795|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
162144014|NCT00486759|585574796|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
162144015|NCT00486759|585574795|FG000|Safety Follow-up|Death|40|||
162144016|NCT00486759|585574796|FG001|Safety Follow-up|Death|29|||
162144017|NCT00486759|585574795|FG000|Safety Follow-up|Withdrew consent|32|||
162144018|NCT00486759|585574796|FG001|Safety Follow-up|Withdrew consent|23|||
162144019|NCT00486759|585574795|FG000|Safety Follow-up|Failure to return|9|||
162144020|NCT00486759|585574796|FG001|Safety Follow-up|Failure to return|6|||
162144021|NCT00486759|585574795|FG000|Safety Follow-up|Administrative/not specified|8|||
162144022|NCT00486759|585574796|FG001|Safety Follow-up|Administrative/not specified|6|||
162144023|NCT00486759|585574795|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
162144024|NCT00486759|585574796|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
162144025|NCT00486759|585574795|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
162144026|NCT00486759|585574796|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
162144027|NCT00377455|585574797|FG000|Overall Study|Withdrawal by Subject|1|||
162144028|NCT01883492|585574800|FG000|Overall Study|Lost to Follow-up|3|||
162144029|NCT01883492|585574801|FG001|Overall Study|Lost to Follow-up|4|||
162144030|NCT01883492|585574800|FG000|Overall Study|Surgery on contra-lateral hip|0|||
162144031|NCT01883492|585574801|FG001|Overall Study|Surgery on contra-lateral hip|1|||
162144032|NCT01883492|585574800|FG000|Overall Study|Poor X-ray quality|7|||
162144033|NCT01883492|585574801|FG001|Overall Study|Poor X-ray quality|4|||
162144034|NCT01883492|585574800|FG000|Overall Study|Withdrawal by Subject|1|||
162144035|NCT01883492|585574801|FG001|Overall Study|Withdrawal by Subject|0|||
162144036|NCT01883492|585574800|FG000|Overall Study|inappropriate implant used|1|||
162144037|NCT01883492|585574801|FG001|Overall Study|inappropriate implant used|1|||
162144038|NCT01883492|585574800|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
161809021|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
162011246|NCT00129402|585097779|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
162011247|NCT00129402|585097780|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
161809022|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162144039|NCT01883492|585574801|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
162011248|NCT00129402|585097781|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
162011249|NCT00129402|585097782|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
162144040|NCT03265210|585574802|FG000|Overall Study|Withdrawal by Subject|7|||
162144041|NCT03265210|585574803|FG001|Overall Study|Withdrawal by Subject|9|||
162144042|NCT03265210|585574802|FG000|Overall Study|Lost to Follow-up|2|||
162144043|NCT03265210|585574803|FG001|Overall Study|Lost to Follow-up|0|||
162144044|NCT03265210|585574802|FG000|Overall Study|Physician Decision|2|||
162144045|NCT03265210|585574803|FG001|Overall Study|Physician Decision|0|||
162144046|NCT03265210|585574802|FG000|Overall Study|Adverse Event|1|||
162144047|NCT03265210|585574803|FG001|Overall Study|Adverse Event|0|||
162144048|NCT02488980|585574809|FG000|Overall Study|Protocol Violation|2|||
162144049|NCT02488980|585574810|FG001|Overall Study|Protocol Violation|2|||
162144050|NCT02488980|585574811|FG002|Overall Study|Protocol Violation|2|||
162144051|NCT02614560|585574815|FG000|Overall Study|Death|6|||
162144052|NCT02614560|585574816|FG001|Overall Study|Death|2|||
162144053|NCT02192606|585574817|FG000|Overall Study|surgery type was changed|1|||
162144054|NCT02192606|585574818|FG001|Overall Study|surgery type was changed|1|||
162144055|NCT02192606|585574817|FG000|Overall Study|Physician Decision|1|||
162144056|NCT02192606|585574818|FG001|Overall Study|Physician Decision|2|||
162144057|NCT02192606|585574817|FG000|Overall Study|3D equipment rep unable to join|0|||
162144058|NCT02192606|585574818|FG001|Overall Study|3D equipment rep unable to join|1|||
162144059|NCT00738699|585574819|FG000|Overall Study|Withdrawal by Subject|5|||
162144060|NCT00738699|585574820|FG001|Overall Study|Withdrawal by Subject|0|||
162144061|NCT00738699|585574819|FG000|Overall Study|Lost to Follow-up|1|||
162144062|NCT00738699|585574820|FG001|Overall Study|Lost to Follow-up|0|||
162144063|NCT00738699|585574819|FG000|Overall Study|Death|144|||
162144064|NCT00738699|585574820|FG001|Overall Study|Death|68|||
162144065|NCT00738699|585574819|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
162144066|NCT00738699|585574820|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
162011250|NCT00129402|585097783|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
162011251|NCT00129402|585097777|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
162011252|NCT00129402|585097778|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
161809023|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809024|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162011253|NCT00129402|585097779|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
162011254|NCT00129402|585097780|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
162011255|NCT00129402|585097781|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
162011256|NCT00129402|585097782|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
162011257|NCT00129402|585097783|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
162011258|NCT00129402|585097777|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
162011259|NCT00129402|585097778|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
162144067|NCT00738699|585574819|FG000|Overall Study|Other|2|||
162144068|NCT00738699|585574820|FG001|Overall Study|Other|0|||
162144069|NCT00549848|585574821|FG000|Overall Study|Death|1|||
162144070|NCT00549848|585574822|FG001|Overall Study|Death|4|||
162144071|NCT00549848|585574823|FG002|Overall Study|Death|13|||
162144072|NCT00549848|585574821|FG000|Overall Study|Physician Decision|0|||
162144073|NCT00549848|585574822|FG001|Overall Study|Physician Decision|0|||
162144074|NCT00549848|585574823|FG002|Overall Study|Physician Decision|4|||
162144075|NCT00549848|585574821|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
162144076|NCT00549848|585574822|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
162144077|NCT00549848|585574823|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
162144078|NCT00549848|585574821|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
162144079|NCT00549848|585574822|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
162144080|NCT00549848|585574823|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
162144081|NCT00549848|585574821|FG000|Overall Study|Participant/Family Withdraw|2|||
162144082|NCT00549848|585574822|FG001|Overall Study|Participant/Family Withdraw|3|||
162144083|NCT00549848|585574823|FG002|Overall Study|Participant/Family Withdraw|5|||
162144084|NCT00549848|585574821|FG000|Overall Study|Second Malignancy|1|||
162144085|NCT00549848|585574822|FG001|Overall Study|Second Malignancy|0|||
162144086|NCT00549848|585574823|FG002|Overall Study|Second Malignancy|0|||
162144087|NCT00549848|585574821|FG000|Overall Study|Transplant|3|||
162144088|NCT00549848|585574822|FG001|Overall Study|Transplant|3|||
162144089|NCT00549848|585574823|FG002|Overall Study|Transplant|18|||
162144090|NCT00549848|585574821|FG000|Overall Study|Unacceptable Toxicity|1|||
162144091|NCT00549848|585574822|FG001|Overall Study|Unacceptable Toxicity|6|||
162144092|NCT00549848|585574823|FG002|Overall Study|Unacceptable Toxicity|6|||
162144093|NCT05193318|585574824|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
162144094|NCT05193318|585574824|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
162144095|NCT03670602|585574825|FG000|Overall Study|Lost to Follow-up|1|||
162144096|NCT03670602|585574826|FG001|Overall Study|Lost to Follow-up|0|||
162144097|NCT03670602|585574825|FG000|Overall Study|Withdrawal by Subject|0|||
162144098|NCT03670602|585574826|FG001|Overall Study|Withdrawal by Subject|3|||
162144099|NCT03201809|585574827|FG000|Overall Study|Lost to Follow-up|2|||
162144100|NCT03201809|585574828|FG001|Overall Study|Lost to Follow-up|0|||
162144101|NCT00957658|585574829|FG000|Overall Study|Death|1|||
162011260|NCT00129402|585097779|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
162011261|NCT00129402|585097780|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
162011262|NCT00129402|585097781|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
162144102|NCT00957658|585574829|FG000|Overall Study|Lost to Follow-up|4|||
162144103|NCT00957658|585574829|FG000|Overall Study|Withdrawal by Subject|12|||
161809025|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
162011263|NCT00129402|585097782|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
162011264|NCT00129402|585097783|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
162011265|NCT00129402|585097777|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
161809026|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
162011266|NCT00129402|585097778|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
162011267|NCT00129402|585097779|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
162011268|NCT00129402|585097780|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
162011269|NCT00129402|585097781|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
162011270|NCT00129402|585097782|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
162011271|NCT00129402|585097783|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
162011272|NCT00129402|585097777|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
162011273|NCT00129402|585097778|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
162011274|NCT00129402|585097779|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
162011275|NCT00129402|585097780|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
162011276|NCT00129402|585097781|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
162011277|NCT00129402|585097782|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
162011278|NCT00129402|585097783|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
162011279|NCT00129402|585097777|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
162011280|NCT00129402|585097778|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
162011281|NCT00129402|585097779|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
161809027|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809028|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809029|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809030|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
162144104|NCT00957658|585574829|FG000|Overall Study|Revision|1|||
162144105|NCT00957658|585574829|FG000|Overall Study|Incomplete 2 yr data|28|||
162144106|NCT00957658|585574829|FG000|Overall Study|Site termination|10|||
162144107|NCT00957658|585574829|FG000|Overall Study|unwilling/unable to return|2|||
162144108|NCT00957658|585574829|FG000|Overall Study|surgery cancelled|2|||
162144109|NCT00957658|585574829|FG000|Overall Study|Protocol Violation|5|||
162144110|NCT03383887|585574830|FG000|Overall Study|Lost to Follow-up|0|||
162144111|NCT03383887|585574831|FG001|Overall Study|Lost to Follow-up|1|||
162144112|NCT00246012|585574838|FG000|Overall Study|Adverse Event|0|||
162144113|NCT00246012|585574839|FG001|Overall Study|Adverse Event|0|||
162144114|NCT00246012|585574840|FG002|Overall Study|Adverse Event|0|||
162144115|NCT00246012|585574841|FG003|Overall Study|Adverse Event|0|||
162144116|NCT00246012|585574842|FG004|Overall Study|Adverse Event|0|||
162144117|NCT00246012|585574843|FG005|Overall Study|Adverse Event|1|||
162144118|NCT00246012|585574844|FG006|Overall Study|Adverse Event|0|||
162144119|NCT00246012|585574845|FG007|Overall Study|Adverse Event|0|||
162144120|NCT00246012|585574846|FG008|Overall Study|Adverse Event|2|||
162144121|NCT00246012|585574838|FG000|Overall Study|Withdrawal by Subject|0|||
162144122|NCT00246012|585574839|FG001|Overall Study|Withdrawal by Subject|0|||
162144123|NCT00246012|585574840|FG002|Overall Study|Withdrawal by Subject|0|||
162144124|NCT00246012|585574841|FG003|Overall Study|Withdrawal by Subject|0|||
162144125|NCT00246012|585574842|FG004|Overall Study|Withdrawal by Subject|0|||
162144126|NCT00246012|585574843|FG005|Overall Study|Withdrawal by Subject|1|||
162144127|NCT00246012|585574844|FG006|Overall Study|Withdrawal by Subject|0|||
162144128|NCT00246012|585574845|FG007|Overall Study|Withdrawal by Subject|0|||
162144129|NCT00246012|585574846|FG008|Overall Study|Withdrawal by Subject|0|||
162144130|NCT00246012|585574838|FG000|Overall Study|Disease progression|3|||
162144131|NCT00246012|585574839|FG001|Overall Study|Disease progression|1|||
162144132|NCT00246012|585574840|FG002|Overall Study|Disease progression|2|||
162144133|NCT00246012|585574841|FG003|Overall Study|Disease progression|3|||
162144134|NCT00246012|585574842|FG004|Overall Study|Disease progression|3|||
162144135|NCT00246012|585574843|FG005|Overall Study|Disease progression|25|||
162144136|NCT00246012|585574844|FG006|Overall Study|Disease progression|30|||
162144137|NCT00246012|585574845|FG007|Overall Study|Disease progression|27|||
162144138|NCT00246012|585574846|FG008|Overall Study|Disease progression|26|||
162144139|NCT00246012|585574838|FG000|Overall Study|Other|0|||
162144140|NCT00246012|585574839|FG001|Overall Study|Other|0|||
162144141|NCT00246012|585574840|FG002|Overall Study|Other|0|||
162144142|NCT00246012|585574841|FG003|Overall Study|Other|0|||
162144143|NCT00246012|585574842|FG004|Overall Study|Other|0|||
162144144|NCT00246012|585574843|FG005|Overall Study|Other|0|||
162144145|NCT00246012|585574844|FG006|Overall Study|Other|0|||
162144146|NCT00246012|585574845|FG007|Overall Study|Other|1|||
162144147|NCT00246012|585574846|FG008|Overall Study|Other|0|||
162144148|NCT00246012|585574838|FG000|Overall Study|Randomly assigned but not treated|0|||
162144149|NCT00246012|585574839|FG001|Overall Study|Randomly assigned but not treated|0|||
162144150|NCT00246012|585574840|FG002|Overall Study|Randomly assigned but not treated|0|||
162144151|NCT00246012|585574841|FG003|Overall Study|Randomly assigned but not treated|0|||
162144152|NCT00246012|585574842|FG004|Overall Study|Randomly assigned but not treated|0|||
162144153|NCT00246012|585574843|FG005|Overall Study|Randomly assigned but not treated|1|||
162144154|NCT00246012|585574844|FG006|Overall Study|Randomly assigned but not treated|1|||
162144155|NCT00246012|585574845|FG007|Overall Study|Randomly assigned but not treated|0|||
162144156|NCT00246012|585574846|FG008|Overall Study|Randomly assigned but not treated|0|||
162144157|NCT01806714|585574847|FG000|Overall Study|No functioning phone number|200|||
162144158|NCT01806714|585574848|FG001|Overall Study|No functioning phone number|170|||
162144159|NCT04107805|585574849|FG000|Overall Study|Adverse Event|0|||
162144160|NCT04107805|585574850|FG001|Overall Study|Adverse Event|0|||
162144161|NCT04107805|585574851|FG002|Overall Study|Adverse Event|0|||
162144162|NCT04107805|585574852|FG003|Overall Study|Adverse Event|1|||
162144163|NCT04107805|585574853|FG004|Overall Study|Adverse Event|0|||
162144164|NCT04107805|585574854|FG005|Overall Study|Adverse Event|1|||
162144165|NCT04107805|585574855|FG006|Overall Study|Adverse Event|0|||
162144166|NCT04107805|585574856|FG007|Overall Study|Adverse Event|0|||
162144167|NCT04107805|585574857|FG008|Overall Study|Adverse Event|1|||
162144168|NCT01120275|585574859|FG000|Overall Study|Adverse Event|3|||
162144169|NCT01120275|585574859|FG000|Overall Study|Progression|27|||
162144170|NCT01120275|585574859|FG000|Overall Study|Ineligible|3|||
162144171|NCT01120275|585574859|FG000|Overall Study|Withdrawal by Subject|1|||
162144172|NCT01120275|585574859|FG000|Overall Study|Refusal|1|||
162144173|NCT01120275|585574859|FG000|Overall Study|Not specific|1|||
162144174|NCT01191086|585574861|FG000|Overall Study|Adverse Event|20|||
162144175|NCT01191086|585574861|FG000|Overall Study|Lack of Efficacy|10|||
162144176|NCT01191086|585574861|FG000|Overall Study|Lost to Follow-up|4|||
162144177|NCT01191086|585574861|FG000|Overall Study|Physician Decision|2|||
162144178|NCT01191086|585574861|FG000|Overall Study|Withdrawal by Subject|24|||
161809031|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
161809032|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
161809033|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809034|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
161809035|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809036|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809037|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809038|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809039|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809040|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809041|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809042|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161809043|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809044|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809045|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809046|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809047|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
161809048|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
161809049|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
161809050|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809051|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
161809052|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
161809053|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
161809054|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
161809055|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
161809056|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809057|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809058|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809059|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809060|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809061|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809062|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161809063|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161913009|NCT00042289|584731860|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
161809064|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809065|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809066|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809067|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162144179|NCT01191086|585574861|FG000|Overall Study|Discontinuation criterion met|1|||
162144180|NCT01191086|585574861|FG000|Overall Study|Other|1|||
162144181|NCT01156116|585574862|FG000|Overall Study|Withdrawal by Subject|3|||
162144182|NCT01156116|585574863|FG001|Overall Study|Withdrawal by Subject|1|||
162144183|NCT01156116|585574862|FG000|Overall Study|CPAP intolerance|2|||
162144184|NCT01156116|585574863|FG001|Overall Study|CPAP intolerance|0|||
162144185|NCT02057718|585574864|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
162144186|NCT02057718|585574865|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
162144187|NCT02057718|585574864|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
162144188|NCT02057718|585574865|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
162144189|NCT02057718|585574864|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
162144190|NCT02057718|585574865|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
162144191|NCT02057718|585574864|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
162144192|NCT02057718|585574865|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
162144193|NCT02057718|585574864|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
162144194|NCT02057718|585574865|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
162144195|NCT02057718|585574864|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
162144196|NCT02057718|585574865|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
162144197|NCT02057718|585574864|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
162144198|NCT02057718|585574865|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
162144199|NCT02057718|585574864|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
162144200|NCT02057718|585574865|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
162144201|NCT02057718|585574864|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
162144202|NCT02057718|585574865|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
162144203|NCT02057718|585574864|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
162144204|NCT02057718|585574865|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
162144205|NCT02057718|585574864|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
162144206|NCT02057718|585574865|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
162144207|NCT00906035|585574874|FG000|Overall Study|Withdrawal by Subject|2|||
162144208|NCT00906035|585574875|FG001|Overall Study|Withdrawal by Subject|3|||
162144209|NCT00906035|585574876|FG002|Overall Study|Withdrawal by Subject|0|||
162144210|NCT00130637|585574877|FG000|Overall Study|Adverse Event|2|||
162144211|NCT00130637|585574877|FG000|Overall Study|Withdrawal by Subject|1|||
162144212|NCT00139737|585574878|FG000|Overall Study|Withdrawal by Subject|190|||
162144213|NCT00139737|585574878|FG000|Overall Study|Adverse Event|58|||
162144214|NCT00139737|585574878|FG000|Overall Study|Lack of Efficacy|40|||
162144215|NCT00139737|585574878|FG000|Overall Study|Lost to Follow-up|8|||
162144216|NCT00139737|585574878|FG000|Overall Study|Death|3|||
162144217|NCT00139737|585574878|FG000|Overall Study|Laboratory Abnormality|2|||
162144218|NCT00139737|585574878|FG000|Overall Study|Protocol Violation|18|||
162144219|NCT00139737|585574878|FG000|Overall Study|Withdrew During Screening Phase|8|||
162144220|NCT00139737|585574878|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
162144221|NCT00139737|585574878|FG000|Overall Study|Screened, Not Treated|13|||
162144222|NCT00217672|585574880|FG000|Allocation|Ineligible|2|||
162144223|NCT00217672|585574881|FG001|Allocation|Ineligible|0|||
162144224|NCT00217672|585574880|FG000|Treatment|disease progression|33|||
162144225|NCT00217672|585574881|FG001|Treatment|disease progression|4|||
162144226|NCT00217672|585574880|FG000|Treatment|Adverse Event|18|||
162144227|NCT00217672|585574881|FG001|Treatment|Adverse Event|2|||
162144228|NCT00217672|585574880|FG000|Treatment|reqd treatment not permitted by protocol|6|||
162144229|NCT00217672|585574881|FG001|Treatment|reqd treatment not permitted by protocol|0|||
162144230|NCT00217672|585574880|FG000|Treatment|Physician Decision|6|||
162144231|NCT00217672|585574881|FG001|Treatment|Physician Decision|0|||
162144232|NCT00217672|585574880|FG000|Treatment|insurance issues|1|||
162144233|NCT00217672|585574881|FG001|Treatment|insurance issues|1|||
162144234|NCT00217672|585574880|FG000|Treatment|Death|2|||
162144235|NCT00217672|585574881|FG001|Treatment|Death|0|||
162144236|NCT00217672|585574880|FG000|Treatment|secondary malignancy|1|||
162144237|NCT00217672|585574881|FG001|Treatment|secondary malignancy|0|||
162144238|NCT00217672|585574880|FG000|Follow-up|Withdrawal by Subject|4|||
162144239|NCT00217672|585574881|FG001|Follow-up|Withdrawal by Subject|0|||
162144240|NCT00217672|585574880|FG000|Follow-up|Lost to Follow-up|1|||
162144241|NCT00217672|585574881|FG001|Follow-up|Lost to Follow-up|0|||
162144242|NCT01972152|585574885|FG000|First Treatment Visit|Lost to Follow-up|0|||
162144243|NCT01972152|585574886|FG001|First Treatment Visit|Lost to Follow-up|1|||
162144244|NCT01972152|585574887|FG002|First Treatment Visit|Lost to Follow-up|0|||
162144245|NCT01972152|585574888|FG003|First Treatment Visit|Lost to Follow-up|0|||
162144246|NCT01972152|585574889|FG004|First Treatment Visit|Lost to Follow-up|0|||
162144247|NCT01972152|585574890|FG005|First Treatment Visit|Lost to Follow-up|0|||
162144248|NCT01972152|585574885|FG000|Second Treatment Visit|Protocol Violation|0|||
162144249|NCT01972152|585574886|FG001|Second Treatment Visit|Protocol Violation|1|||
162144250|NCT01972152|585574887|FG002|Second Treatment Visit|Protocol Violation|0|||
162144251|NCT01972152|585574888|FG003|Second Treatment Visit|Protocol Violation|0|||
161809068|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809069|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161809070|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
162144252|NCT01972152|585574889|FG004|Second Treatment Visit|Protocol Violation|0|||
161809071|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809072|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161809073|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161809074|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161809075|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161809076|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809077|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809078|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809079|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809080|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809081|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809082|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809083|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809084|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161809085|NCT01597245|584344311|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809086|NCT01597245|584344312|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809087|NCT01597245|584344313|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809088|NCT01597245|584344314|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809089|NCT01597245|584344315|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809090|NCT01597245|584344316|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809091|NCT01597245|584344317|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809092|NCT01597245|584344318|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809093|NCT01597245|584344319|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809094|NCT01597245|584344320|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809095|NCT01597245|584344321|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
161809096|NCT01597245|584344322|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809097|NCT01597245|584344323|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809098|NCT01597245|584344324|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809099|NCT01597245|584344325|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809100|NCT01597245|584344326|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809101|NCT01597245|584344327|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809102|NCT01597245|584344328|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809103|NCT01597245|584344329|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809104|NCT01597245|584344330|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809105|NCT01597245|584344331|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161809106|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162011282|NCT00129402|585097780|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
162011283|NCT00129402|585097781|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
162011284|NCT00129402|585097782|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
162011285|NCT00129402|585097783|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
162144253|NCT01972152|585574890|FG005|Second Treatment Visit|Protocol Violation|0|||
162144254|NCT04379713|585574893|FG000|Overall Study|Adverse Event|2|||
162144255|NCT04379713|585574894|FG001|Overall Study|Adverse Event|0|||
162144256|NCT04379713|585574893|FG000|Overall Study|Physician Decision|2|||
162144257|NCT04379713|585574894|FG001|Overall Study|Physician Decision|1|||
162144258|NCT04379713|585574893|FG000|Overall Study|Protocol Violation|11|||
162144259|NCT04379713|585574894|FG001|Overall Study|Protocol Violation|6|||
162144260|NCT04379713|585574893|FG000|Overall Study|No longer met eligibility criteria|14|||
162144261|NCT04379713|585574894|FG001|Overall Study|No longer met eligibility criteria|11|||
162144262|NCT04379713|585574893|FG000|Overall Study|Withdrawal by parent/guardian|36|||
162144263|NCT04379713|585574894|FG001|Overall Study|Withdrawal by parent/guardian|15|||
162144264|NCT04379713|585574893|FG000|Overall Study|Lost to Follow-up|31|||
162144265|NCT04379713|585574894|FG001|Overall Study|Lost to Follow-up|21|||
162144266|NCT04567888|585574895|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
162144267|NCT04567888|585574896|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
162144268|NCT04567888|585574895|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
162144269|NCT04567888|585574896|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
162144270|NCT04567888|585574895|FG000|Overall Study|Reported Unusual Birth Year|2|||
162144271|NCT04567888|585574896|FG001|Overall Study|Reported Unusual Birth Year|3|||
162144272|NCT04567888|585574895|FG000|Overall Study|Duplicate Responses|0|||
162144273|NCT04567888|585574896|FG001|Overall Study|Duplicate Responses|1|||
162144274|NCT01157182|585574897|FG000|Washout of 28 Days|Adverse Event|2|||
162144275|NCT01157182|585574898|FG001|Washout of 28 Days|Adverse Event|0|||
162144276|NCT00878722|585574899|FG000|Overall Study|Progressive disease|3|||
162144277|NCT00878722|585574900|FG001|Overall Study|Progressive disease|3|||
162144278|NCT00878722|585574901|FG002|Overall Study|Progressive disease|3|||
162144279|NCT00878722|585574902|FG003|Overall Study|Progressive disease|7|||
162144280|NCT00878722|585574903|FG004|Overall Study|Progressive disease|7|||
162144281|NCT00878722|585574904|FG005|Overall Study|Progressive disease|1|||
162144282|NCT00878722|585574905|FG006|Overall Study|Progressive disease|4|||
162144283|NCT00878722|585574906|FG007|Overall Study|Progressive disease|3|||
162144284|NCT00878722|585574899|FG000|Overall Study|Death|0|||
162144285|NCT00878722|585574900|FG001|Overall Study|Death|0|||
162144286|NCT00878722|585574901|FG002|Overall Study|Death|0|||
162144287|NCT00878722|585574902|FG003|Overall Study|Death|1|||
162144288|NCT00878722|585574903|FG004|Overall Study|Death|0|||
162144289|NCT00878722|585574904|FG005|Overall Study|Death|1|||
162144290|NCT00878722|585574905|FG006|Overall Study|Death|0|||
162144291|NCT00878722|585574906|FG007|Overall Study|Death|2|||
162144292|NCT00878722|585574899|FG000|Overall Study|Adverse Event|0|||
162144293|NCT00878722|585574900|FG001|Overall Study|Adverse Event|0|||
162144294|NCT00878722|585574901|FG002|Overall Study|Adverse Event|0|||
162144295|NCT00878722|585574902|FG003|Overall Study|Adverse Event|0|||
162144296|NCT00878722|585574903|FG004|Overall Study|Adverse Event|0|||
162144297|NCT00878722|585574904|FG005|Overall Study|Adverse Event|0|||
162144298|NCT00878722|585574905|FG006|Overall Study|Adverse Event|2|||
162144299|NCT00878722|585574906|FG007|Overall Study|Adverse Event|0|||
162144300|NCT00878722|585574899|FG000|Overall Study|Withdrawal by Subject|0|||
162144301|NCT00878722|585574900|FG001|Overall Study|Withdrawal by Subject|0|||
162144302|NCT00878722|585574901|FG002|Overall Study|Withdrawal by Subject|0|||
162144303|NCT00878722|585574902|FG003|Overall Study|Withdrawal by Subject|0|||
162144304|NCT00878722|585574903|FG004|Overall Study|Withdrawal by Subject|0|||
162144305|NCT00878722|585574904|FG005|Overall Study|Withdrawal by Subject|0|||
162144306|NCT00878722|585574905|FG006|Overall Study|Withdrawal by Subject|0|||
162144307|NCT00878722|585574906|FG007|Overall Study|Withdrawal by Subject|2|||
162144308|NCT00878722|585574899|FG000|Overall Study|Relapse|0|||
162144309|NCT00878722|585574900|FG001|Overall Study|Relapse|0|||
162144310|NCT00878722|585574901|FG002|Overall Study|Relapse|0|||
162144311|NCT00878722|585574902|FG003|Overall Study|Relapse|1|||
162144312|NCT00878722|585574903|FG004|Overall Study|Relapse|0|||
162144313|NCT00878722|585574904|FG005|Overall Study|Relapse|0|||
162144314|NCT00878722|585574905|FG006|Overall Study|Relapse|0|||
162144315|NCT00878722|585574906|FG007|Overall Study|Relapse|0|||
162144316|NCT00383188|585574907|FG000|Overall Study|Adverse Event|4|||
162144317|NCT00383188|585574908|FG001|Overall Study|Adverse Event|7|||
162144318|NCT00383188|585574909|FG002|Overall Study|Adverse Event|9|||
162144319|NCT00383188|585574910|FG003|Overall Study|Adverse Event|8|||
162144320|NCT00383188|585574911|FG004|Overall Study|Adverse Event|8|||
162144321|NCT00383188|585574907|FG000|Overall Study|Lack of Efficacy|9|||
162144322|NCT00383188|585574908|FG001|Overall Study|Lack of Efficacy|3|||
162144323|NCT00383188|585574909|FG002|Overall Study|Lack of Efficacy|3|||
162144324|NCT00383188|585574910|FG003|Overall Study|Lack of Efficacy|2|||
162144325|NCT00383188|585574911|FG004|Overall Study|Lack of Efficacy|6|||
162144326|NCT00383188|585574907|FG000|Overall Study|Other|3|||
162144327|NCT00383188|585574908|FG001|Overall Study|Other|1|||
162144328|NCT00383188|585574909|FG002|Overall Study|Other|0|||
162144329|NCT00383188|585574910|FG003|Overall Study|Other|2|||
162144330|NCT00383188|585574911|FG004|Overall Study|Other|6|||
162144331|NCT00383188|585574907|FG000|Overall Study|No longer willing to participate|1|||
162144332|NCT00383188|585574908|FG001|Overall Study|No longer willing to participate|0|||
162144333|NCT00383188|585574909|FG002|Overall Study|No longer willing to participate|1|||
162144334|NCT00383188|585574910|FG003|Overall Study|No longer willing to participate|0|||
162144335|NCT00383188|585574911|FG004|Overall Study|No longer willing to participate|2|||
162144336|NCT00383188|585574907|FG000|Overall Study|Lost to Follow-up|0|||
162144337|NCT00383188|585574908|FG001|Overall Study|Lost to Follow-up|0|||
162144338|NCT00383188|585574909|FG002|Overall Study|Lost to Follow-up|0|||
162144339|NCT00383188|585574910|FG003|Overall Study|Lost to Follow-up|0|||
162144340|NCT00383188|585574911|FG004|Overall Study|Lost to Follow-up|1|||
162144341|NCT00554801|585574921|FG000|Overall Study|left area before completion|5|||
162144342|NCT00554801|585574922|FG001|Overall Study|left area before completion|0|||
162144343|NCT00554801|585574921|FG000|Overall Study|Withdrawal by Subject|14|||
162144344|NCT00554801|585574922|FG001|Overall Study|Withdrawal by Subject|0|||
162144345|NCT02104765|585574923|FG000|Overall Study|Lost to Follow-up|0|||
162144346|NCT02104765|585574924|FG001|Overall Study|Lost to Follow-up|0|||
162144347|NCT02104765|585574925|FG002|Overall Study|Lost to Follow-up|1|||
162144348|NCT02104765|585574926|FG003|Overall Study|Lost to Follow-up|0|||
162144349|NCT02104765|585574927|FG004|Overall Study|Lost to Follow-up|0|||
162144350|NCT02104765|585574928|FG005|Overall Study|Lost to Follow-up|0|||
162144351|NCT02104765|585574929|FG006|Overall Study|Lost to Follow-up|0|||
162144352|NCT02104765|585574923|FG000|Overall Study|Withdrawal by Subject|0|||
162144353|NCT02104765|585574924|FG001|Overall Study|Withdrawal by Subject|0|||
162144354|NCT02104765|585574925|FG002|Overall Study|Withdrawal by Subject|0|||
162144355|NCT02104765|585574926|FG003|Overall Study|Withdrawal by Subject|1|||
162144356|NCT02104765|585574927|FG004|Overall Study|Withdrawal by Subject|1|||
162011286|NCT00129402|585097777|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
162011287|NCT00129402|585097778|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
162011288|NCT00129402|585097779|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
162011289|NCT00129402|585097780|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
162011290|NCT00129402|585097781|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
162011291|NCT00129402|585097782|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
162011292|NCT00129402|585097783|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
162011293|NCT00129402|585097777|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
162011294|NCT00129402|585097778|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
162011295|NCT00129402|585097779|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
162011296|NCT00129402|585097780|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
162011297|NCT00129402|585097781|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
162011298|NCT00129402|585097782|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
162011299|NCT00129402|585097783|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
162011300|NCT00129402|585097777|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
162011301|NCT00129402|585097778|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
162011302|NCT00129402|585097779|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
162011303|NCT00129402|585097780|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
162011304|NCT00129402|585097781|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
162011305|NCT00129402|585097782|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
162011306|NCT00129402|585097783|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
162011307|NCT00129402|585097777|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
162011308|NCT00129402|585097778|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
162011309|NCT00129402|585097779|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
162011310|NCT00129402|585097780|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
162011311|NCT00129402|585097781|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
162011312|NCT00129402|585097782|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
162011313|NCT00129402|585097783|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
162011314|NCT00763035|585097784|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
162011315|NCT00763035|585097785|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
162011316|NCT00763035|585097784|FG000|First Intervention|Adverse Event|0|||
162011317|NCT00763035|585097785|FG001|First Intervention|Adverse Event|1|||
162011318|NCT00763035|585097784|FG000|Second Intervention|Adverse Event|1|||
162011319|NCT00763035|585097785|FG001|Second Intervention|Adverse Event|0|||
162011320|NCT00763035|585097784|FG000|Second Intervention|Physician Decision|2|||
162011321|NCT00763035|585097785|FG001|Second Intervention|Physician Decision|0|||
162011322|NCT00702221|585097786|FG000|Overall Study|Adverse Event|4|||
162011323|NCT00702221|585097787|FG001|Overall Study|Adverse Event|3|||
162011324|NCT02900378|585097788|FG000|Randomization (Visit 2)|Adverse Event|14|||
162011325|NCT02900378|585097789|FG001|Randomization (Visit 2)|Adverse Event|11|||
162011326|NCT02900378|585097788|FG000|Randomization (Visit 2)|Death|1|||
162011327|NCT02900378|585097789|FG001|Randomization (Visit 2)|Death|4|||
162011328|NCT02900378|585097788|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
162011329|NCT02900378|585097789|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
162011330|NCT02900378|585097788|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
162011331|NCT02900378|585097789|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
162011332|NCT02900378|585097788|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
162011333|NCT02900378|585097789|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
162011334|NCT02900378|585097788|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
162011335|NCT02900378|585097789|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
162011336|NCT02900378|585097788|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
162011337|NCT02900378|585097789|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
162011338|NCT01134055|585097792|FG000|Overall Study|Adverse Event|5|||
162011339|NCT01134055|585097793|FG001|Overall Study|Adverse Event|2|||
162011340|NCT01134055|585097794|FG002|Overall Study|Adverse Event|2|||
162011341|NCT01134055|585097795|FG003|Overall Study|Adverse Event|2|||
162011342|NCT01134055|585097796|FG004|Overall Study|Adverse Event|5|||
162011343|NCT01134055|585097797|FG005|Overall Study|Adverse Event|7|||
162011344|NCT01134055|585097798|FG006|Overall Study|Adverse Event|2|||
162011345|NCT01134055|585097792|FG000|Overall Study|Lost to Follow-up|0|||
162011346|NCT01134055|585097793|FG001|Overall Study|Lost to Follow-up|1|||
162011347|NCT01134055|585097794|FG002|Overall Study|Lost to Follow-up|0|||
162144357|NCT02104765|585574928|FG005|Overall Study|Withdrawal by Subject|0|||
162144358|NCT02104765|585574929|FG006|Overall Study|Withdrawal by Subject|1|||
162144359|NCT00604721|585574930|FG000|Overall Study|Physician Decision|1|||
162144360|NCT00604721|585574930|FG000|Overall Study|Withdrawal by Subject|1|||
162144361|NCT00038103|585574931|FG000|Overall Study|Adverse Event|5|||
162144362|NCT00038103|585574932|FG001|Overall Study|Adverse Event|6|||
162144363|NCT00038103|585574931|FG000|Overall Study|Lack of Efficacy|48|||
162144364|NCT00038103|585574932|FG001|Overall Study|Lack of Efficacy|41|||
162144365|NCT00038103|585574931|FG000|Overall Study|Withdrawal by Subject|0|||
162144366|NCT00038103|585574932|FG001|Overall Study|Withdrawal by Subject|3|||
162144367|NCT00038103|585574931|FG000|Overall Study|Lost to Follow-up|0|||
162144368|NCT00038103|585574932|FG001|Overall Study|Lost to Follow-up|3|||
162144369|NCT00038103|585574931|FG000|Overall Study|Protocol Violation|0|||
162144370|NCT00038103|585574932|FG001|Overall Study|Protocol Violation|2|||
162144371|NCT00038103|585574931|FG000|Overall Study|Sponsor Decision|0|||
162144372|NCT00038103|585574932|FG001|Overall Study|Sponsor Decision|1|||
162144373|NCT00038103|585574931|FG000|Overall Study|Randomized/never treated|2|||
162144374|NCT00038103|585574932|FG001|Overall Study|Randomized/never treated|0|||
162144375|NCT01144182|585574933|FG000|Overall Study|Death|5|||
162144376|NCT01144182|585574934|FG001|Overall Study|Death|6|||
162144377|NCT01144182|585574933|FG000|Overall Study|Withdrawal by Subject|3|||
162144378|NCT01144182|585574934|FG001|Overall Study|Withdrawal by Subject|6|||
162144379|NCT01144182|585574933|FG000|Overall Study|Lost to Follow-up|9|||
162144380|NCT01144182|585574934|FG001|Overall Study|Lost to Follow-up|9|||
162144381|NCT01751724|585574942|FG000|Overall Study|extubated bef.start assigned treatment|1|||
162144382|NCT01751724|585574943|FG001|Overall Study|extubated bef.start assigned treatment|0|||
162144383|NCT01751724|585574942|FG000|Overall Study|withdrawn by parent|0|||
162144384|NCT01751724|585574943|FG001|Overall Study|withdrawn by parent|2|||
162144385|NCT00798265|585574946|FG000|Overall Study|Lost to Follow-up|1|||
162144386|NCT00798265|585574947|FG001|Overall Study|Lost to Follow-up|10|||
162144387|NCT00798265|585574946|FG000|Overall Study|Study closing|7|||
162144388|NCT00798265|585574947|FG001|Overall Study|Study closing|6|||
162144389|NCT00798265|585574946|FG000|Overall Study|Withdrawal by Subject|0|||
162144390|NCT00798265|585574947|FG001|Overall Study|Withdrawal by Subject|1|||
162144391|NCT00798265|585574946|FG000|Overall Study|Screen failure|0|||
162144392|NCT00798265|585574947|FG001|Overall Study|Screen failure|1|||
162144393|NCT00589667|585576280|FG000|Overall Study|Adverse Event|2|||
162144394|NCT00589667|585576280|FG000|Overall Study|Withdrawal by Subject|1|||
162144395|NCT03538041|585576283|FG000|12-Week Treatment Period|Adverse Event|1|||
162144396|NCT03538041|585576284|FG001|12-Week Treatment Period|Adverse Event|1|||
162144397|NCT03538041|585576283|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
162144398|NCT03538041|585576284|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
162144399|NCT03538041|585576283|FG000|Treatment Extension Period|Adverse Event|4|||
162144400|NCT03538041|585576284|FG001|Treatment Extension Period|Adverse Event|1|||
162144401|NCT03538041|585576283|FG000|Treatment Extension Period|Physician Decision|1|||
162144402|NCT03538041|585576284|FG001|Treatment Extension Period|Physician Decision|1|||
162011348|NCT01134055|585097795|FG003|Overall Study|Lost to Follow-up|1|||
162144403|NCT03538041|585576283|FG000|Treatment Extension Period|Lack of Efficacy|1|||
162144404|NCT03538041|585576284|FG001|Treatment Extension Period|Lack of Efficacy|4|||
162144405|NCT03538041|585576283|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
162144406|NCT03538041|585576284|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
162144407|NCT03538041|585576283|FG000|Treatment Extension Period|Death|0|||
162144408|NCT03538041|585576284|FG001|Treatment Extension Period|Death|1|||
162144409|NCT00094809|585576285|FG000|Overall Study|Protocol deviation|2|||
162144410|NCT00094809|585576286|FG001|Overall Study|Protocol deviation|2|||
162144411|NCT00094809|585576285|FG000|Overall Study|Noncompliance|1|||
162144412|NCT00094809|585576286|FG001|Overall Study|Noncompliance|0|||
162144413|NCT00094809|585576285|FG000|Overall Study|Adverse Event|3|||
162144414|NCT00094809|585576286|FG001|Overall Study|Adverse Event|1|||
162144415|NCT00094809|585576285|FG000|Overall Study|Withdrawal by Subject|8|||
162144416|NCT00094809|585576286|FG001|Overall Study|Withdrawal by Subject|9|||
161913010|NCT00042289|584731861|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
161913011|NCT00042289|584731862|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
161913012|NCT00042289|584731863|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
161913013|NCT00042289|584731864|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
161913014|NCT00042289|584731865|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
161913015|NCT00042289|584731866|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
161913016|NCT00042289|584731867|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
161913017|NCT00042289|584731868|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
161913018|NCT00042289|584731869|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
161913019|NCT00042289|584731870|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
161913020|NCT00042289|584731871|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
161913021|NCT00042289|584731872|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
161913022|NCT00042289|584731873|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
161913023|NCT00042289|584731874|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
161913024|NCT00042289|584731875|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
161913025|NCT00042289|584731876|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
161913026|NCT00042289|584731877|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
161913027|NCT00042289|584731878|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
161913028|NCT00042289|584731879|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
161913029|NCT00042289|584731833|FG000|Overall Study|Protocol Violation|0|||
161913030|NCT00042289|584731834|FG001|Overall Study|Protocol Violation|0|||
161913031|NCT00042289|584731835|FG002|Overall Study|Protocol Violation|0|||
161913032|NCT00042289|584731836|FG003|Overall Study|Protocol Violation|0|||
161913033|NCT00042289|584731837|FG004|Overall Study|Protocol Violation|0|||
161913034|NCT00042289|584731838|FG005|Overall Study|Protocol Violation|1|||
161913035|NCT00042289|584731839|FG006|Overall Study|Protocol Violation|0|||
161913036|NCT00042289|584731840|FG007|Overall Study|Protocol Violation|1|||
161913037|NCT00042289|584731841|FG008|Overall Study|Protocol Violation|0|||
161913038|NCT00042289|584731842|FG009|Overall Study|Protocol Violation|0|||
161913039|NCT00042289|584731843|FG010|Overall Study|Protocol Violation|0|||
161913040|NCT00042289|584731844|FG011|Overall Study|Protocol Violation|0|||
161913041|NCT00042289|584731845|FG012|Overall Study|Protocol Violation|0|||
161913042|NCT00042289|584731846|FG013|Overall Study|Protocol Violation|0|||
161913043|NCT00042289|584731847|FG014|Overall Study|Protocol Violation|0|||
161913044|NCT00042289|584731848|FG015|Overall Study|Protocol Violation|0|||
161913045|NCT00042289|584731849|FG016|Overall Study|Protocol Violation|0|||
161913046|NCT00042289|584731850|FG017|Overall Study|Protocol Violation|0|||
161913047|NCT00042289|584731851|FG018|Overall Study|Protocol Violation|0|||
161913048|NCT00042289|584731852|FG019|Overall Study|Protocol Violation|0|||
161913049|NCT00042289|584731853|FG020|Overall Study|Protocol Violation|0|||
161913050|NCT00042289|584731854|FG021|Overall Study|Protocol Violation|0|||
161913051|NCT00042289|584731855|FG022|Overall Study|Protocol Violation|0|||
161913052|NCT00042289|584731856|FG023|Overall Study|Protocol Violation|1|||
161913053|NCT00042289|584731857|FG024|Overall Study|Protocol Violation|1|||
162144417|NCT00094809|585576285|FG000|Overall Study|Disease progression|3|||
162144418|NCT00094809|585576286|FG001|Overall Study|Disease progression|3|||
162144419|NCT00094809|585576285|FG000|Overall Study|Physician Decision|3|||
162144420|NCT00094809|585576286|FG001|Overall Study|Physician Decision|5|||
162144421|NCT00094809|585576285|FG000|Overall Study|Lost to Follow-up|6|||
162144422|NCT00094809|585576286|FG001|Overall Study|Lost to Follow-up|6|||
162144423|NCT00094809|585576285|FG000|Overall Study|Death|19|||
162144424|NCT00094809|585576286|FG001|Overall Study|Death|25|||
162144425|NCT00094809|585576285|FG000|Overall Study|Protocol-specified criteria|1|||
162144426|NCT00094809|585576286|FG001|Overall Study|Protocol-specified criteria|1|||
162144427|NCT00094809|585576285|FG000|Overall Study|Other|2|||
162144428|NCT00094809|585576286|FG001|Overall Study|Other|4|||
162144429|NCT00094809|585576285|FG000|Overall Study|Informed consent signed after treatment|1|||
162144430|NCT00094809|585576286|FG001|Overall Study|Informed consent signed after treatment|0|||
162144431|NCT00094809|585576285|FG000|Overall Study|Study drug not received|2|||
162144432|NCT00094809|585576286|FG001|Overall Study|Study drug not received|8|||
162011349|NCT01134055|585097796|FG004|Overall Study|Lost to Follow-up|0|||
162011350|NCT01134055|585097797|FG005|Overall Study|Lost to Follow-up|0|||
162011351|NCT01134055|585097798|FG006|Overall Study|Lost to Follow-up|0|||
162011352|NCT01134055|585097792|FG000|Overall Study|Withdrawal by Subject|3|||
162011353|NCT01134055|585097793|FG001|Overall Study|Withdrawal by Subject|3|||
162011354|NCT01134055|585097794|FG002|Overall Study|Withdrawal by Subject|1|||
162011355|NCT01134055|585097795|FG003|Overall Study|Withdrawal by Subject|2|||
162011356|NCT01134055|585097796|FG004|Overall Study|Withdrawal by Subject|0|||
162011357|NCT01134055|585097797|FG005|Overall Study|Withdrawal by Subject|0|||
162011358|NCT01134055|585097798|FG006|Overall Study|Withdrawal by Subject|8|||
162011359|NCT01134055|585097792|FG000|Overall Study|Protocol Violation|0|||
162011360|NCT01134055|585097793|FG001|Overall Study|Protocol Violation|0|||
162011361|NCT01134055|585097794|FG002|Overall Study|Protocol Violation|0|||
162011362|NCT01134055|585097795|FG003|Overall Study|Protocol Violation|1|||
162011363|NCT01134055|585097796|FG004|Overall Study|Protocol Violation|1|||
162011364|NCT01134055|585097797|FG005|Overall Study|Protocol Violation|0|||
162011365|NCT01134055|585097798|FG006|Overall Study|Protocol Violation|0|||
162011366|NCT01134055|585097792|FG000|Overall Study|Physician Decision|0|||
162011367|NCT01134055|585097793|FG001|Overall Study|Physician Decision|0|||
162011368|NCT01134055|585097794|FG002|Overall Study|Physician Decision|0|||
162011369|NCT01134055|585097795|FG003|Overall Study|Physician Decision|0|||
162011370|NCT01134055|585097796|FG004|Overall Study|Physician Decision|0|||
162011371|NCT01134055|585097797|FG005|Overall Study|Physician Decision|0|||
162011372|NCT01134055|585097798|FG006|Overall Study|Physician Decision|1|||
162011373|NCT03345784|585097801|FG000|Overall Study|Withdrawal by Subject|2|||
162011374|NCT03345784|585097802|FG001|Overall Study|Withdrawal by Subject|1|||
161913054|NCT00042289|584731858|FG025|Overall Study|Protocol Violation|0|||
161913055|NCT00042289|584731859|FG026|Overall Study|Protocol Violation|2|||
161913056|NCT00042289|584731860|FG027|Overall Study|Protocol Violation|0|||
161913057|NCT00042289|584731861|FG028|Overall Study|Protocol Violation|0|||
161913058|NCT00042289|584731862|FG029|Overall Study|Protocol Violation|0|||
161913059|NCT00042289|584731863|FG030|Overall Study|Protocol Violation|1|||
161913060|NCT00042289|584731864|FG031|Overall Study|Protocol Violation|0|||
161913061|NCT00042289|584731865|FG032|Overall Study|Protocol Violation|0|||
161913062|NCT00042289|584731866|FG033|Overall Study|Protocol Violation|0|||
161913063|NCT00042289|584731867|FG034|Overall Study|Protocol Violation|0|||
161913064|NCT00042289|584731868|FG035|Overall Study|Protocol Violation|0|||
161913065|NCT00042289|584731869|FG036|Overall Study|Protocol Violation|0|||
161913066|NCT00042289|584731870|FG037|Overall Study|Protocol Violation|0|||
161913067|NCT00042289|584731871|FG038|Overall Study|Protocol Violation|0|||
161913068|NCT00042289|584731872|FG039|Overall Study|Protocol Violation|0|||
161913069|NCT00042289|584731873|FG040|Overall Study|Protocol Violation|0|||
161913070|NCT00042289|584731874|FG041|Overall Study|Protocol Violation|1|||
161913071|NCT00042289|584731875|FG042|Overall Study|Protocol Violation|1|||
161913072|NCT00042289|584731876|FG043|Overall Study|Protocol Violation|1|||
161913073|NCT00042289|584731877|FG044|Overall Study|Protocol Violation|0|||
161913074|NCT00042289|584731878|FG045|Overall Study|Protocol Violation|0|||
161913075|NCT00042289|584731879|FG046|Overall Study|Protocol Violation|0|||
161913076|NCT00042289|584731833|FG000|Overall Study|Withdrawal by Subject|4|||
161913077|NCT00042289|584731834|FG001|Overall Study|Withdrawal by Subject|1|||
161913078|NCT00042289|584731835|FG002|Overall Study|Withdrawal by Subject|0|||
161913079|NCT00042289|584731836|FG003|Overall Study|Withdrawal by Subject|2|||
161913080|NCT00042289|584731837|FG004|Overall Study|Withdrawal by Subject|0|||
161913081|NCT00042289|584731838|FG005|Overall Study|Withdrawal by Subject|2|||
161913082|NCT00042289|584731839|FG006|Overall Study|Withdrawal by Subject|0|||
161913083|NCT00042289|584731840|FG007|Overall Study|Withdrawal by Subject|0|||
161913084|NCT00042289|584731841|FG008|Overall Study|Withdrawal by Subject|0|||
161913085|NCT00042289|584731842|FG009|Overall Study|Withdrawal by Subject|1|||
161913086|NCT00042289|584731843|FG010|Overall Study|Withdrawal by Subject|0|||
161913087|NCT00042289|584731844|FG011|Overall Study|Withdrawal by Subject|0|||
161913088|NCT00042289|584731845|FG012|Overall Study|Withdrawal by Subject|2|||
161913089|NCT00042289|584731846|FG013|Overall Study|Withdrawal by Subject|0|||
161913090|NCT00042289|584731847|FG014|Overall Study|Withdrawal by Subject|0|||
161913091|NCT00042289|584731848|FG015|Overall Study|Withdrawal by Subject|0|||
161913092|NCT00042289|584731849|FG016|Overall Study|Withdrawal by Subject|0|||
161913093|NCT00042289|584731850|FG017|Overall Study|Withdrawal by Subject|0|||
161913094|NCT00042289|584731851|FG018|Overall Study|Withdrawal by Subject|0|||
161913095|NCT00042289|584731852|FG019|Overall Study|Withdrawal by Subject|0|||
161913096|NCT00042289|584731853|FG020|Overall Study|Withdrawal by Subject|0|||
161913097|NCT00042289|584731854|FG021|Overall Study|Withdrawal by Subject|1|||
161913098|NCT00042289|584731855|FG022|Overall Study|Withdrawal by Subject|1|||
161913099|NCT00042289|584731856|FG023|Overall Study|Withdrawal by Subject|1|||
161913100|NCT00042289|584731857|FG024|Overall Study|Withdrawal by Subject|0|||
161913101|NCT00042289|584731858|FG025|Overall Study|Withdrawal by Subject|0|||
161913102|NCT00042289|584731859|FG026|Overall Study|Withdrawal by Subject|1|||
161913103|NCT00042289|584731860|FG027|Overall Study|Withdrawal by Subject|0|||
161913104|NCT00042289|584731861|FG028|Overall Study|Withdrawal by Subject|2|||
161913105|NCT00042289|584731862|FG029|Overall Study|Withdrawal by Subject|0|||
161913106|NCT00042289|584731863|FG030|Overall Study|Withdrawal by Subject|0|||
161913107|NCT00042289|584731864|FG031|Overall Study|Withdrawal by Subject|1|||
161913108|NCT00042289|584731865|FG032|Overall Study|Withdrawal by Subject|2|||
161913109|NCT00042289|584731866|FG033|Overall Study|Withdrawal by Subject|1|||
161913110|NCT00042289|584731867|FG034|Overall Study|Withdrawal by Subject|0|||
161913111|NCT00042289|584731868|FG035|Overall Study|Withdrawal by Subject|0|||
161913112|NCT00042289|584731869|FG036|Overall Study|Withdrawal by Subject|0|||
161913113|NCT00042289|584731870|FG037|Overall Study|Withdrawal by Subject|1|||
161913114|NCT00042289|584731871|FG038|Overall Study|Withdrawal by Subject|0|||
161913115|NCT00042289|584731872|FG039|Overall Study|Withdrawal by Subject|0|||
161913116|NCT00042289|584731873|FG040|Overall Study|Withdrawal by Subject|0|||
161913117|NCT00042289|584731874|FG041|Overall Study|Withdrawal by Subject|0|||
162144433|NCT00094809|585576285|FG000|Overall Study|Other|1|||
162144434|NCT00094809|585576286|FG001|Overall Study|Other|1|||
162144435|NCT04889664|585576287|FG000|Screen|Lost to Follow-up|1|||
162144436|NCT04889664|585576287|FG000|Screen|Failed to meet screening criteria|1|||
162144437|NCT04889664|585576287|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
162144438|NCT02469064|585576293|FG000|Overall Study|Request not to receive intervention.|1|||
162144439|NCT02469064|585576294|FG001|Overall Study|Request not to receive intervention.|3|||
162144440|NCT00964366|585576307|FG000|Overall Study|Did not qualify at Day 1|1|||
162144441|NCT00964366|585576308|FG001|Overall Study|Did not qualify at Day 1|0|||
162144442|NCT00964366|585576307|FG000|Overall Study|Withdrawal by Subject|0|||
162144443|NCT00964366|585576308|FG001|Overall Study|Withdrawal by Subject|1|||
161913118|NCT00042289|584731875|FG042|Overall Study|Withdrawal by Subject|1|||
162011375|NCT04798196|585097804|FG000|Overall Study|Lost to Follow-up|3|||
162011376|NCT04798196|585097805|FG001|Overall Study|Lost to Follow-up|1|||
162011377|NCT04798196|585097806|FG002|Overall Study|Lost to Follow-up|3|||
162011378|NCT00001959|585097814|FG000|Overall Study|newly diagnosed colon cancer|1|||
162011379|NCT00001959|585097814|FG000|Overall Study|disabling sedation|1|||
162011380|NCT00001959|585097814|FG000|Overall Study|non-compliance|1|||
162011381|NCT04298697|585097815|FG000|Overall Study|Lost to Follow-up|5|||
162011382|NCT04298697|585097816|FG001|Overall Study|Lost to Follow-up|5|||
162011383|NCT04298697|585097817|FG002|Overall Study|Lost to Follow-up|1|||
162011384|NCT04298697|585097818|FG003|Overall Study|Lost to Follow-up|0|||
162011385|NCT04298697|585097815|FG000|Overall Study|Withdrawal by Subject|0|||
162011386|NCT04298697|585097816|FG001|Overall Study|Withdrawal by Subject|3|||
162011387|NCT04298697|585097817|FG002|Overall Study|Withdrawal by Subject|2|||
162011388|NCT04298697|585097818|FG003|Overall Study|Withdrawal by Subject|3|||
162011389|NCT03995368|585097819|FG000|Overall Study|Lost to Follow-up|1|||
162011390|NCT03995368|585097820|FG001|Overall Study|Lost to Follow-up|4|||
162011391|NCT03995368|585097821|FG002|Overall Study|Lost to Follow-up|1|||
162011392|NCT03995368|585097819|FG000|Overall Study|Did not meet inclusion criteria|1|||
162011393|NCT03995368|585097820|FG001|Overall Study|Did not meet inclusion criteria|6|||
162011394|NCT03995368|585097821|FG002|Overall Study|Did not meet inclusion criteria|3|||
162011395|NCT03995368|585097819|FG000|Overall Study|Withdrawal by Subject|0|||
161809107|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809108|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809109|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
162011396|NCT03995368|585097820|FG001|Overall Study|Withdrawal by Subject|1|||
162011397|NCT03995368|585097821|FG002|Overall Study|Withdrawal by Subject|1|||
162011398|NCT03592186|585097822|FG000|Overall Study|Withdrawal by Subject|1|||
162011399|NCT03592186|585097823|FG001|Overall Study|Withdrawal by Subject|0|||
162011400|NCT03592186|585097822|FG000|Overall Study|Lost to Follow-up|16|||
162011401|NCT03592186|585097823|FG001|Overall Study|Lost to Follow-up|11|||
162011402|NCT03755934|585097824|FG000|Overall Study|Adverse Event|4|||
162011403|NCT03755934|585097825|FG001|Overall Study|Adverse Event|1|||
162011404|NCT03755934|585097826|FG002|Overall Study|Adverse Event|1|||
162011405|NCT03755934|585097827|FG003|Overall Study|Adverse Event|3|||
162011406|NCT03755934|585097824|FG000|Overall Study|Physician Decision|2|||
161913119|NCT00042289|584731876|FG043|Overall Study|Withdrawal by Subject|0|||
161913120|NCT00042289|584731877|FG044|Overall Study|Withdrawal by Subject|0|||
161913121|NCT00042289|584731878|FG045|Overall Study|Withdrawal by Subject|0|||
161913122|NCT00042289|584731879|FG046|Overall Study|Withdrawal by Subject|0|||
161913123|NCT00548327|584731884|FG000|Overall Study|Adverse Event|0|||
161913124|NCT00548327|584731885|FG001|Overall Study|Adverse Event|1|||
161913125|NCT01673386|584731886|FG000|Overall Study|Study terminated by sponsor|16|||
161913126|NCT01673386|584731887|FG001|Overall Study|Study terminated by sponsor|22|||
161913127|NCT01673386|584731886|FG000|Overall Study|Adverse Event|5|||
161913128|NCT01673386|584731887|FG001|Overall Study|Adverse Event|2|||
161913129|NCT01673386|584731886|FG000|Overall Study|Progressive disease|4|||
161913130|NCT01673386|584731887|FG001|Overall Study|Progressive disease|1|||
161913131|NCT01673386|584731886|FG000|Overall Study|Withdrawal by Subject|0|||
161913132|NCT01673386|584731887|FG001|Overall Study|Withdrawal by Subject|2|||
161913133|NCT00274456|584731888|FG000|Overall Study|Still on treatment|2|||
161913134|NCT00274456|584731889|FG001|Overall Study|Still on treatment|3|||
161913135|NCT00274456|584731890|FG002|Overall Study|Still on treatment|5|||
161913136|NCT00274456|584731891|FG003|Overall Study|Still on treatment|1|||
161913137|NCT00274456|584731888|FG000|Overall Study|Unacceptable toxicity|10|||
161913138|NCT00274456|584731889|FG001|Overall Study|Unacceptable toxicity|5|||
161913139|NCT00274456|584731890|FG002|Overall Study|Unacceptable toxicity|12|||
161913140|NCT00274456|584731891|FG003|Overall Study|Unacceptable toxicity|16|||
161913141|NCT00274456|584731888|FG000|Overall Study|Adverse Event|0|||
161913142|NCT00274456|584731889|FG001|Overall Study|Adverse Event|1|||
161913143|NCT00274456|584731890|FG002|Overall Study|Adverse Event|2|||
161913144|NCT00274456|584731891|FG003|Overall Study|Adverse Event|2|||
161913145|NCT00274456|584731888|FG000|Overall Study|Physician Decision|7|||
161913146|NCT00274456|584731889|FG001|Overall Study|Physician Decision|5|||
162011407|NCT03755934|585097825|FG001|Overall Study|Physician Decision|0|||
162011408|NCT03755934|585097826|FG002|Overall Study|Physician Decision|0|||
162011409|NCT03755934|585097827|FG003|Overall Study|Physician Decision|1|||
162011410|NCT03755934|585097824|FG000|Overall Study|Withdrawal by Subject|5|||
162011411|NCT03755934|585097825|FG001|Overall Study|Withdrawal by Subject|0|||
162011412|NCT03755934|585097826|FG002|Overall Study|Withdrawal by Subject|0|||
162011413|NCT03755934|585097827|FG003|Overall Study|Withdrawal by Subject|1|||
162011414|NCT03755934|585097824|FG000|Overall Study|Other|3|||
162011415|NCT03755934|585097825|FG001|Overall Study|Other|1|||
162011416|NCT03755934|585097826|FG002|Overall Study|Other|3|||
162011417|NCT03755934|585097827|FG003|Overall Study|Other|1|||
162011418|NCT01498068|585097828|FG000|Overall Study|Withdrawal by Subject|1|||
162011419|NCT01498068|585097829|FG001|Overall Study|Withdrawal by Subject|1|||
162011420|NCT00361296|585097832|FG000|Overall Study|Physician Decision|1|||
162011421|NCT00361296|585097832|FG000|Overall Study|Lack of Efficacy|2|||
162011422|NCT00904982|585097834|FG000|Overall Study|Withdrawal by Subject|2|||
162011423|NCT00904982|585097835|FG001|Overall Study|Withdrawal by Subject|0|||
162011424|NCT00904982|585097836|FG002|Overall Study|Withdrawal by Subject|0|||
162011425|NCT00904982|585097837|FG003|Overall Study|Withdrawal by Subject|0|||
162011426|NCT01353898|585097840|FG000|Overall Study|Study site terminated|0|||
162011427|NCT01353898|585097841|FG001|Overall Study|Study site terminated|0|||
162011428|NCT01353898|585097842|FG002|Overall Study|Study site terminated|0|||
162011429|NCT01353898|585097843|FG003|Overall Study|Study site terminated|0|||
162011430|NCT01353898|585097844|FG004|Overall Study|Study site terminated|0|||
162011431|NCT01353898|585097845|FG005|Overall Study|Study site terminated|1|||
162011432|NCT02072668|585097846|FG000|Second Intervention|Lost to Follow-up|1|||
162011433|NCT02072668|585097847|FG001|Second Intervention|Lost to Follow-up|0|||
162011434|NCT02668653|585097848|FG000|Overall Study|Refractory disease|41|||
162011435|NCT02668653|585097849|FG001|Overall Study|Refractory disease|70|||
162011436|NCT02668653|585097848|FG000|Overall Study|Relapse|44|||
162011437|NCT02668653|585097849|FG001|Overall Study|Relapse|65|||
162011438|NCT02668653|585097848|FG000|Overall Study|Adverse Event|58|||
162011439|NCT02668653|585097849|FG001|Overall Study|Adverse Event|23|||
162011440|NCT02668653|585097848|FG000|Overall Study|Subject decision to stop study drug|25|||
162011441|NCT02668653|585097849|FG001|Overall Study|Subject decision to stop study drug|23|||
162011442|NCT02668653|585097848|FG000|Overall Study|Other reasons not specified|16|||
162011443|NCT02668653|585097849|FG001|Overall Study|Other reasons not specified|11|||
162011444|NCT02668653|585097848|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
162011445|NCT02668653|585097849|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
162011446|NCT02668653|585097848|FG000|Overall Study|Investigator decision|10|||
162011447|NCT02668653|585097849|FG001|Overall Study|Investigator decision|7|||
162011448|NCT02668653|585097848|FG000|Overall Study|Failure to meet continuation criteria|5|||
162011449|NCT02668653|585097849|FG001|Overall Study|Failure to meet continuation criteria|12|||
162011450|NCT02668653|585097848|FG000|Overall Study|Lost to Follow-up|1|||
162011451|NCT02668653|585097849|FG001|Overall Study|Lost to Follow-up|0|||
162011452|NCT02668653|585097848|FG000|Overall Study|Pregnancy|0|||
162011453|NCT02668653|585097849|FG001|Overall Study|Pregnancy|1|||
161809110|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809111|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809112|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161913147|NCT00274456|584731890|FG002|Overall Study|Physician Decision|6|||
161913148|NCT00274456|584731891|FG003|Overall Study|Physician Decision|13|||
161913149|NCT00274456|584731888|FG000|Overall Study|Lost to Follow-up|0|||
161913150|NCT00274456|584731889|FG001|Overall Study|Lost to Follow-up|0|||
161913151|NCT00274456|584731890|FG002|Overall Study|Lost to Follow-up|1|||
161913152|NCT00274456|584731891|FG003|Overall Study|Lost to Follow-up|0|||
161913153|NCT00274456|584731888|FG000|Overall Study|Withdrawal by Subject|18|||
161913154|NCT00274456|584731889|FG001|Overall Study|Withdrawal by Subject|13|||
161913155|NCT00274456|584731890|FG002|Overall Study|Withdrawal by Subject|9|||
161913156|NCT00274456|584731891|FG003|Overall Study|Withdrawal by Subject|13|||
161913157|NCT04460885|584731896|FG000|Overall Study|Withdrawal by Subject|6|||
161913158|NCT04460885|584731897|FG001|Overall Study|Withdrawal by Subject|8|||
161913159|NCT04460885|584731896|FG000|Overall Study|Site closure|1|||
161913160|NCT04460885|584731897|FG001|Overall Study|Site closure|0|||
161913161|NCT04460885|584731896|FG000|Overall Study|Death|5|||
161913162|NCT04460885|584731897|FG001|Overall Study|Death|4|||
161913163|NCT04460885|584731896|FG000|Overall Study|Physician Decision|2|||
161913164|NCT04460885|584731897|FG001|Overall Study|Physician Decision|1|||
161809113|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809114|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809115|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809116|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809117|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809118|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809119|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
161809120|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
161809121|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
161809122|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809123|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809124|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809125|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809126|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161809127|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809128|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809129|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809130|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809131|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809132|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161913165|NCT04460885|584731896|FG000|Overall Study|Lost to Follow-up|4|||
162144444|NCT02046616|585576310|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
162144445|NCT02046616|585576310|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
162144446|NCT02046616|585576310|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
162144447|NCT02046616|585576310|FG000|24-Week Treatment Period|Physician Decision|3|||
162144448|NCT02046616|585576310|FG000|24-Week Treatment Period|Other|1|||
162144449|NCT02046616|585576310|FG000|8-Week FU Period|Lost to Follow-up|1|||
162144450|NCT02957539|585576313|FG000|Baseline to Week 16|Lost to Follow-up|8|||
162144451|NCT02957539|585576314|FG001|Baseline to Week 16|Lost to Follow-up|10|||
162144452|NCT02957539|585576315|FG002|Baseline to Week 16|Lost to Follow-up|16|||
162144453|NCT02957539|585576313|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
162144454|NCT02957539|585576314|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
162144455|NCT02957539|585576315|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
162144456|NCT02957539|585576313|FG000|Week 16 to 32|Withdrawal by Subject|3|||
162144457|NCT02957539|585576314|FG001|Week 16 to 32|Withdrawal by Subject|3|||
162144458|NCT02957539|585576315|FG002|Week 16 to 32|Withdrawal by Subject|1|||
162144459|NCT02957539|585576313|FG000|Week 16 to 32|Lost to Follow-up|8|||
162144460|NCT02957539|585576314|FG001|Week 16 to 32|Lost to Follow-up|7|||
162144461|NCT02957539|585576315|FG002|Week 16 to 32|Lost to Follow-up|5|||
162144462|NCT02957539|585576313|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
162144463|NCT02957539|585576314|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
162144464|NCT02957539|585576315|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
162144465|NCT02957539|585576313|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
162144466|NCT02957539|585576314|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
162144467|NCT02957539|585576315|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
162144468|NCT03058991|585576325|FG000|Overall Study|Lost to Follow-up|17|||
162144469|NCT03058991|585576326|FG001|Overall Study|Lost to Follow-up|12|||
162144470|NCT03058991|585576327|FG002|Overall Study|Lost to Follow-up|12|||
162144471|NCT03058991|585576325|FG000|Overall Study|Withdrawal by Subject|1|||
162144472|NCT03058991|585576326|FG001|Overall Study|Withdrawal by Subject|0|||
162144473|NCT03058991|585576327|FG002|Overall Study|Withdrawal by Subject|0|||
162144474|NCT01689519|585576330|FG000|Intent to Treat|Death|157|||
162144475|NCT01689519|585576331|FG001|Intent to Treat|Death|167|||
162144476|NCT01689519|585576330|FG000|Intent to Treat|Lost to Follow-up|4|||
162144477|NCT01689519|585576331|FG001|Intent to Treat|Lost to Follow-up|8|||
162144478|NCT01689519|585576330|FG000|Intent to Treat|Other|2|||
162144479|NCT01689519|585576331|FG001|Intent to Treat|Other|4|||
162144480|NCT01689519|585576330|FG000|Intent to Treat|Physician Decision|4|||
162144481|NCT01689519|585576331|FG001|Intent to Treat|Physician Decision|1|||
162144482|NCT01689519|585576330|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
162144483|NCT01689519|585576331|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
162144484|NCT01689519|585576330|FG000|Intent to Treat|Withdrawal by Subject|21|||
162144485|NCT01689519|585576331|FG001|Intent to Treat|Withdrawal by Subject|20|||
162144486|NCT01689519|585576330|FG000|Safety Population|Death|158|||
162144487|NCT01689519|585576331|FG001|Safety Population|Death|165|||
162144488|NCT01689519|585576330|FG000|Safety Population|Lost to Follow-up|4|||
162144489|NCT01689519|585576331|FG001|Safety Population|Lost to Follow-up|8|||
162144490|NCT01689519|585576330|FG000|Safety Population|Other|2|||
162144491|NCT01689519|585576331|FG001|Safety Population|Other|4|||
162144492|NCT01689519|585576330|FG000|Safety Population|Physician Decision|4|||
162144493|NCT01689519|585576331|FG001|Safety Population|Physician Decision|1|||
162144494|NCT01689519|585576330|FG000|Safety Population|Study Terminated By Sponsor|60|||
162144495|NCT01689519|585576331|FG001|Safety Population|Study Terminated By Sponsor|47|||
162144496|NCT01689519|585576330|FG000|Safety Population|Withdrawal by Subject|20|||
162144497|NCT01689519|585576331|FG001|Safety Population|Withdrawal by Subject|20|||
162144498|NCT03525119|585576332|FG000|Overall Study|Adverse Event|0|||
162144499|NCT03525119|585576333|FG001|Overall Study|Adverse Event|1|||
162144500|NCT03525119|585576334|FG002|Overall Study|Adverse Event|0|||
162144501|NCT03525119|585576332|FG000|Overall Study|Lost to Follow-up|32|||
162144502|NCT03525119|585576333|FG001|Overall Study|Lost to Follow-up|33|||
162144503|NCT03525119|585576334|FG002|Overall Study|Lost to Follow-up|37|||
162144504|NCT03525119|585576332|FG000|Overall Study|Withdrawal by Subject|5|||
162144505|NCT03525119|585576333|FG001|Overall Study|Withdrawal by Subject|4|||
162144506|NCT03525119|585576334|FG002|Overall Study|Withdrawal by Subject|2|||
162144507|NCT03525119|585576332|FG000|Overall Study|Reason not Specified|2|||
162144508|NCT03525119|585576333|FG001|Overall Study|Reason not Specified|1|||
162144509|NCT03525119|585576334|FG002|Overall Study|Reason not Specified|2|||
162144510|NCT03525119|585576332|FG000|Overall Study|Randomized but not Vaccinated|1|||
162144511|NCT03525119|585576333|FG001|Overall Study|Randomized but not Vaccinated|0|||
162144512|NCT03525119|585576334|FG002|Overall Study|Randomized but not Vaccinated|2|||
162144513|NCT03781336|585576335|FG000|Overall Study|Withdrawal by Subject|2|||
162144514|NCT03781336|585576336|FG001|Overall Study|Withdrawal by Subject|2|||
162144515|NCT01959412|585576337|FG000|Overall Study|Protocol deviation|1|||
162144516|NCT01959412|585576338|FG001|Overall Study|Protocol deviation|1|||
162144517|NCT01959412|585576339|FG002|Overall Study|Protocol deviation|0|||
162144518|NCT01959412|585576340|FG003|Overall Study|Protocol deviation|1|||
162144519|NCT01959412|585576341|FG004|Overall Study|Protocol deviation|3|||
161913166|NCT04460885|584731897|FG001|Overall Study|Lost to Follow-up|4|||
161913167|NCT02592824|584731902|FG000|Overall Study|Protocol Violation|5|||
161809133|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809134|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809135|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809136|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161913168|NCT02592824|584731903|FG001|Overall Study|Protocol Violation|3|||
161913169|NCT02592824|584731902|FG000|Overall Study|Lost to Follow-up|2|||
161913170|NCT02592824|584731903|FG001|Overall Study|Lost to Follow-up|1|||
161913171|NCT01704261|584731904|FG000|Overall Study|Withdrawal by Subject|12|||
161913172|NCT01704261|584731905|FG001|Overall Study|Withdrawal by Subject|15|||
161913173|NCT01704261|584731904|FG000|Overall Study|Lost to Follow-up|1|||
161913174|NCT01704261|584731905|FG001|Overall Study|Lost to Follow-up|0|||
161913175|NCT02855268|584731906|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
161913176|NCT02855268|584731907|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
161913177|NCT02855268|584731906|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
161913178|NCT02855268|584731907|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
161913179|NCT02855268|584731906|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
161913180|NCT02855268|584731907|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
161913181|NCT02855268|584731906|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
161913182|NCT02855268|584731907|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
161913183|NCT02855268|584731906|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
161913184|NCT02855268|584731907|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
161913185|NCT02855268|584731906|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
161913186|NCT02855268|584731907|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
161913187|NCT03704064|584731910|FG000|Overall Study|Lost to Follow-up|8|||
161913188|NCT03704064|584731911|FG001|Overall Study|Lost to Follow-up|4|||
161913189|NCT03704064|584731910|FG000|Overall Study|Withdrawal by Subject|1|||
161913190|NCT03704064|584731911|FG001|Overall Study|Withdrawal by Subject|1|||
161913191|NCT03704064|584731910|FG000|Overall Study|No longer available for study visits|0|||
161913192|NCT03704064|584731911|FG001|Overall Study|No longer available for study visits|1|||
161913193|NCT03704064|584731910|FG000|Overall Study|Censoring event|1|||
162011454|NCT02668653|585097848|FG000|Overall Study|Death|0|||
162011455|NCT02668653|585097849|FG001|Overall Study|Death|1|||
161913194|NCT03704064|584731911|FG001|Overall Study|Censoring event|0|||
161913195|NCT01286129|584731912|FG000|Overall Study|Withdrawal by Subject|4|||
161913196|NCT01286129|584731913|FG001|Overall Study|Withdrawal by Subject|1|||
162011456|NCT01352793|585097855|FG000|Overall Study|Lost to Follow-up|289|||
161809137|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809138|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809139|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809140|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
162144520|NCT01959412|585576342|FG005|Overall Study|Protocol deviation|0|||
162144521|NCT01959412|585576337|FG000|Overall Study|Adverse Event|0|||
162144522|NCT01959412|585576338|FG001|Overall Study|Adverse Event|0|||
162144523|NCT01959412|585576339|FG002|Overall Study|Adverse Event|0|||
162144524|NCT01959412|585576340|FG003|Overall Study|Adverse Event|1|||
162144525|NCT01959412|585576341|FG004|Overall Study|Adverse Event|0|||
162144526|NCT01959412|585576342|FG005|Overall Study|Adverse Event|0|||
162144527|NCT00158054|585576344|FG000|Overall Study|Refused to continue|3|||
162144528|NCT00158054|585576345|FG001|Overall Study|Refused to continue|0|||
162144529|NCT00158054|585576344|FG000|Overall Study|Unavailable for follow up|7|||
162144530|NCT00158054|585576345|FG001|Overall Study|Unavailable for follow up|3|||
162144531|NCT00770965|585576346|FG000|Safety Set|Withdrawal by Subject|0|||
161809141|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
161809142|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
161809143|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809144|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162144532|NCT00770965|585576347|FG001|Safety Set|Withdrawal by Subject|0|||
162144533|NCT00770965|585576348|FG002|Safety Set|Withdrawal by Subject|0|||
162144534|NCT00770965|585576349|FG003|Safety Set|Withdrawal by Subject|1|||
162144535|NCT00770965|585576346|FG000|Safety Set|Protocol deviation|0|||
162144536|NCT00770965|585576347|FG001|Safety Set|Protocol deviation|0|||
161809145|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
162144537|NCT00770965|585576348|FG002|Safety Set|Protocol deviation|1|||
162144538|NCT00770965|585576349|FG003|Safety Set|Protocol deviation|0|||
162144539|NCT00770965|585576346|FG000|Excluded Set|Administrative problems|14|||
162144540|NCT00770965|585576347|FG001|Excluded Set|Administrative problems|12|||
162144541|NCT00770965|585576348|FG002|Excluded Set|Administrative problems|12|||
162144542|NCT00770965|585576349|FG003|Excluded Set|Administrative problems|10|||
162144543|NCT00770965|585576346|FG000|Excluded Set|Withdrawal by Subject|1|||
162144544|NCT00770965|585576347|FG001|Excluded Set|Withdrawal by Subject|1|||
162144545|NCT00770965|585576348|FG002|Excluded Set|Withdrawal by Subject|2|||
162144546|NCT00770965|585576349|FG003|Excluded Set|Withdrawal by Subject|3|||
162144547|NCT00509769|585576350|FG000|Overall Study|Progressive disease|77|||
162144548|NCT00509769|585576350|FG000|Overall Study|Adverse Event|4|||
162144549|NCT00509769|585576350|FG000|Overall Study|Patient's decision|1|||
162144550|NCT00509769|585576350|FG000|Overall Study|Physician Decision|8|||
162144551|NCT00509769|585576350|FG000|Overall Study|Use of prohibited therapies during study|1|||
162144552|NCT00414648|585576351|FG000|Overall Study|Adverse Event|5|||
162144553|NCT00414648|585576352|FG001|Overall Study|Adverse Event|5|||
162144554|NCT00414648|585576351|FG000|Overall Study|Death|0|||
162144555|NCT00414648|585576352|FG001|Overall Study|Death|1|||
162144556|NCT00414648|585576351|FG000|Overall Study|Lack of Efficacy|0|||
162144557|NCT00414648|585576352|FG001|Overall Study|Lack of Efficacy|2|||
162144558|NCT00414648|585576351|FG000|Overall Study|Withdrawal by Subject|0|||
162144559|NCT00414648|585576352|FG001|Overall Study|Withdrawal by Subject|1|||
162144560|NCT00972504|585576353|FG000|Overall Study|Adverse Event|2|||
162144561|NCT00972504|585576353|FG000|Overall Study|Investigator discretion|1|||
162144562|NCT00410124|585576354|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
162144563|NCT00410124|585576355|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
162144564|NCT00410124|585576354|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
162144565|NCT00410124|585576355|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
162144566|NCT00410124|585576354|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
162144567|NCT00410124|585576355|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
162144568|NCT00410124|585576354|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
162144569|NCT00410124|585576355|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
162144570|NCT00410124|585576354|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
162144571|NCT00410124|585576355|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
162144572|NCT00410124|585576354|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
162144573|NCT00410124|585576355|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
162144574|NCT00410124|585576354|FG000|Core Phase Double Blind (15 Months)|Death|7|||
162144575|NCT00410124|585576355|FG001|Core Phase Double Blind (15 Months)|Death|4|||
162144576|NCT00410124|585576354|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
162144577|NCT00410124|585576355|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
162144578|NCT00410124|585576354|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
162144579|NCT00410124|585576355|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
162144580|NCT00410124|585576354|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
162144581|NCT00410124|585576355|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
162144582|NCT00410124|585576354|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
162144583|NCT00410124|585576355|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
162144584|NCT00410124|585576354|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
162144585|NCT00410124|585576355|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
162144586|NCT00410124|585576354|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
162144587|NCT00410124|585576355|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
162144588|NCT00410124|585576354|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
162144589|NCT00410124|585576355|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
162144590|NCT00410124|585576354|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
162144591|NCT00410124|585576355|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
162144592|NCT00410124|585576354|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
162144593|NCT00410124|585576355|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
162144594|NCT00319436|585576356|FG000|Overall Study|Withdrawal by Subject|6|||
162144595|NCT00319436|585576357|FG001|Overall Study|Withdrawal by Subject|7|||
162144596|NCT01839877|585576360|FG000|Overall Study|Protocol Violation|1|||
162144597|NCT02781584|585576362|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
162144598|NCT02781584|585576363|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
162144599|NCT02781584|585576364|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
162144600|NCT02781584|585576365|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
162011457|NCT01352793|585097856|FG001|Overall Study|Lost to Follow-up|125|||
161913197|NCT01286129|584731912|FG000|Overall Study|Could not comply with study requirements|4|||
161913198|NCT01286129|584731913|FG001|Overall Study|Could not comply with study requirements|4|||
161913199|NCT00111761|584731914|FG000|Part 1|Physician Decision|0|||
161809146|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161809147|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161913200|NCT00111761|584731915|FG001|Part 1|Physician Decision|1|||
162144601|NCT02781584|585576366|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
162144602|NCT02781584|585576367|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
162144603|NCT02781584|585576368|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
162144604|NCT02781584|585576369|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
162144605|NCT02781584|585576370|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
162144606|NCT02781584|585576371|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
162144607|NCT02781584|585576372|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
162144608|NCT02781584|585576373|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
162144609|NCT02781584|585576374|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
162144610|NCT02781584|585576362|FG000|Pre-treatment Phase|Adverse Event|0|||
162144611|NCT02781584|585576363|FG001|Pre-treatment Phase|Adverse Event|0|||
162144612|NCT02781584|585576364|FG002|Pre-treatment Phase|Adverse Event|0|||
162144613|NCT02781584|585576365|FG003|Pre-treatment Phase|Adverse Event|0|||
162144614|NCT02781584|585576366|FG004|Pre-treatment Phase|Adverse Event|0|||
162144615|NCT02781584|585576367|FG005|Pre-treatment Phase|Adverse Event|0|||
162144616|NCT02781584|585576368|FG006|Pre-treatment Phase|Adverse Event|0|||
162144617|NCT02781584|585576369|FG007|Pre-treatment Phase|Adverse Event|0|||
162144618|NCT02781584|585576370|FG008|Pre-treatment Phase|Adverse Event|0|||
162144619|NCT02781584|585576371|FG009|Pre-treatment Phase|Adverse Event|0|||
162144620|NCT02781584|585576372|FG010|Pre-treatment Phase|Adverse Event|0|||
162144621|NCT02781584|585576373|FG011|Pre-treatment Phase|Adverse Event|1|||
162144622|NCT02781584|585576374|FG012|Pre-treatment Phase|Adverse Event|0|||
162144623|NCT02781584|585576362|FG000|Treatment Phase|Withdrew Consent|0|||
162144624|NCT02781584|585576363|FG001|Treatment Phase|Withdrew Consent|0|||
162144625|NCT02781584|585576364|FG002|Treatment Phase|Withdrew Consent|0|||
162144626|NCT02781584|585576365|FG003|Treatment Phase|Withdrew Consent|0|||
162144627|NCT02781584|585576366|FG004|Treatment Phase|Withdrew Consent|0|||
162144628|NCT02781584|585576367|FG005|Treatment Phase|Withdrew Consent|1|||
162144629|NCT02781584|585576368|FG006|Treatment Phase|Withdrew Consent|0|||
162144630|NCT02781584|585576369|FG007|Treatment Phase|Withdrew Consent|0|||
162144631|NCT02781584|585576370|FG008|Treatment Phase|Withdrew Consent|0|||
162144632|NCT02781584|585576371|FG009|Treatment Phase|Withdrew Consent|0|||
162144633|NCT02781584|585576372|FG010|Treatment Phase|Withdrew Consent|1|||
162144634|NCT02781584|585576373|FG011|Treatment Phase|Withdrew Consent|2|||
162144635|NCT02781584|585576374|FG012|Treatment Phase|Withdrew Consent|0|||
162144636|NCT02781584|585576362|FG000|Treatment Phase|Adverse Event|0|||
162144637|NCT02781584|585576363|FG001|Treatment Phase|Adverse Event|0|||
162144638|NCT02781584|585576364|FG002|Treatment Phase|Adverse Event|0|||
162144639|NCT02781584|585576365|FG003|Treatment Phase|Adverse Event|0|||
162144640|NCT02781584|585576366|FG004|Treatment Phase|Adverse Event|0|||
162144641|NCT02781584|585576367|FG005|Treatment Phase|Adverse Event|0|||
162144642|NCT02781584|585576368|FG006|Treatment Phase|Adverse Event|0|||
162144643|NCT02781584|585576369|FG007|Treatment Phase|Adverse Event|1|||
162144644|NCT02781584|585576370|FG008|Treatment Phase|Adverse Event|0|||
162144645|NCT02781584|585576371|FG009|Treatment Phase|Adverse Event|0|||
162144646|NCT02781584|585576372|FG010|Treatment Phase|Adverse Event|0|||
162144647|NCT02781584|585576373|FG011|Treatment Phase|Adverse Event|0|||
162144648|NCT02781584|585576374|FG012|Treatment Phase|Adverse Event|0|||
162144649|NCT00768651|585576381|FG000|Overall Study|Withdrawal by Subject|1|||
162144650|NCT04771273|585576382|FG000|Dose Escalation Period|Not treated with trial medication|0|||
162144651|NCT04771273|585576383|FG001|Dose Escalation Period|Not treated with trial medication|1|||
162144652|NCT04771273|585576384|FG002|Dose Escalation Period|Not treated with trial medication|1|||
162144653|NCT04771273|585576385|FG003|Dose Escalation Period|Not treated with trial medication|0|||
162144654|NCT04771273|585576382|FG000|Dose Escalation Period|Other reasons than listed|2|||
162144655|NCT04771273|585576383|FG001|Dose Escalation Period|Other reasons than listed|0|||
162144656|NCT04771273|585576384|FG002|Dose Escalation Period|Other reasons than listed|2|||
162144657|NCT04771273|585576385|FG003|Dose Escalation Period|Other reasons than listed|1|||
162144658|NCT04771273|585576382|FG000|Dose Escalation Period|Protocol Violation|0|||
162144659|NCT04771273|585576383|FG001|Dose Escalation Period|Protocol Violation|0|||
162144660|NCT04771273|585576384|FG002|Dose Escalation Period|Protocol Violation|3|||
162144661|NCT04771273|585576385|FG003|Dose Escalation Period|Protocol Violation|1|||
162144662|NCT04771273|585576382|FG000|Dose Escalation Period|Burden of study procedures|1|||
162144663|NCT04771273|585576383|FG001|Dose Escalation Period|Burden of study procedures|0|||
162144664|NCT04771273|585576384|FG002|Dose Escalation Period|Burden of study procedures|0|||
162144665|NCT04771273|585576385|FG003|Dose Escalation Period|Burden of study procedures|0|||
162144666|NCT04771273|585576382|FG000|Dose Escalation Period|Change of residence|0|||
162144667|NCT04771273|585576383|FG001|Dose Escalation Period|Change of residence|0|||
162144668|NCT04771273|585576384|FG002|Dose Escalation Period|Change of residence|0|||
162144669|NCT04771273|585576385|FG003|Dose Escalation Period|Change of residence|1|||
162144670|NCT04771273|585576382|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
162144671|NCT04771273|585576383|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
162144672|NCT04771273|585576384|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
162144673|NCT04771273|585576385|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
162144674|NCT04771273|585576382|FG000|Dose Escalation Period|Adverse Event|8|||
162144675|NCT04771273|585576383|FG001|Dose Escalation Period|Adverse Event|9|||
162144676|NCT04771273|585576384|FG002|Dose Escalation Period|Adverse Event|12|||
162144677|NCT04771273|585576385|FG003|Dose Escalation Period|Adverse Event|2|||
162144678|NCT04771273|585576382|FG000|Maintenance Period|Other than listed|4|||
162144679|NCT04771273|585576383|FG001|Maintenance Period|Other than listed|2|||
162144680|NCT04771273|585576384|FG002|Maintenance Period|Other than listed|0|||
162144681|NCT04771273|585576385|FG003|Maintenance Period|Other than listed|3|||
162144682|NCT04771273|585576382|FG000|Maintenance Period|Burden of study procedures|1|||
162144683|NCT04771273|585576383|FG001|Maintenance Period|Burden of study procedures|0|||
162144684|NCT04771273|585576384|FG002|Maintenance Period|Burden of study procedures|0|||
162144685|NCT04771273|585576385|FG003|Maintenance Period|Burden of study procedures|0|||
162144686|NCT04771273|585576382|FG000|Maintenance Period|Change of residence|0|||
162144687|NCT04771273|585576383|FG001|Maintenance Period|Change of residence|1|||
162144688|NCT04771273|585576384|FG002|Maintenance Period|Change of residence|3|||
162144689|NCT04771273|585576385|FG003|Maintenance Period|Change of residence|0|||
162144690|NCT04771273|585576382|FG000|Maintenance Period|Perceived lack of efficacy|0|||
162144691|NCT04771273|585576383|FG001|Maintenance Period|Perceived lack of efficacy|0|||
162144692|NCT04771273|585576384|FG002|Maintenance Period|Perceived lack of efficacy|0|||
162144693|NCT04771273|585576385|FG003|Maintenance Period|Perceived lack of efficacy|1|||
162144694|NCT04771273|585576382|FG000|Maintenance Period|Adverse Event|4|||
162144695|NCT04771273|585576383|FG001|Maintenance Period|Adverse Event|5|||
162144696|NCT04771273|585576384|FG002|Maintenance Period|Adverse Event|5|||
162144697|NCT04771273|585576385|FG003|Maintenance Period|Adverse Event|0|||
162144698|NCT05196737|585576386|FG000|Non-intervention Week|Lost to Follow-up|2|||
162144699|NCT05196737|585576386|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
162144700|NCT02357784|585576387|FG000|Overall Study|Withdrawal by Subject|1|||
162144701|NCT00462943|585576388|FG000|Overall Study|Failure to achieve a response|5|||
162144702|NCT00462943|585576389|FG001|Overall Study|Failure to achieve a response|5|||
162144703|NCT00462943|585576390|FG002|Overall Study|Failure to achieve a response|1|||
162144704|NCT00462943|585576388|FG000|Overall Study|Adverse Event|6|||
162144705|NCT00462943|585576389|FG001|Overall Study|Adverse Event|4|||
162144706|NCT00462943|585576390|FG002|Overall Study|Adverse Event|1|||
162144707|NCT00462943|585576388|FG000|Overall Study|Protocol Violation|1|||
162144708|NCT00462943|585576389|FG001|Overall Study|Protocol Violation|0|||
162144709|NCT00462943|585576390|FG002|Overall Study|Protocol Violation|0|||
162144710|NCT00462943|585576388|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
162144711|NCT00462943|585576389|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
162144712|NCT00462943|585576390|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
162144713|NCT00462943|585576388|FG000|Overall Study|Disease Progression|15|||
162144714|NCT00462943|585576389|FG001|Overall Study|Disease Progression|15|||
162144715|NCT00462943|585576390|FG002|Overall Study|Disease Progression|9|||
162144716|NCT00462943|585576388|FG000|Overall Study|Death|5|||
162144717|NCT00462943|585576389|FG001|Overall Study|Death|2|||
162144718|NCT00462943|585576390|FG002|Overall Study|Death|7|||
162144719|NCT00462943|585576388|FG000|Overall Study|Stem Cell Transplant|1|||
162144720|NCT00462943|585576389|FG001|Overall Study|Stem Cell Transplant|1|||
162144721|NCT00462943|585576390|FG002|Overall Study|Stem Cell Transplant|0|||
162144722|NCT00462943|585576388|FG000|Overall Study|Bone Marrow Transplant|1|||
162144723|NCT00462943|585576389|FG001|Overall Study|Bone Marrow Transplant|0|||
162144724|NCT00462943|585576390|FG002|Overall Study|Bone Marrow Transplant|0|||
162144725|NCT00462943|585576388|FG000|Overall Study|Required Lymphocyte Infusion|1|||
162144726|NCT00462943|585576389|FG001|Overall Study|Required Lymphocyte Infusion|0|||
162144727|NCT00462943|585576390|FG002|Overall Study|Required Lymphocyte Infusion|0|||
162144728|NCT00462943|585576388|FG000|Overall Study|Transplant - not specified|1|||
162144729|NCT00462943|585576389|FG001|Overall Study|Transplant - not specified|0|||
162144730|NCT00462943|585576390|FG002|Overall Study|Transplant - not specified|1|||
162144731|NCT00462943|585576388|FG000|Overall Study|Physician Decision|1|||
162144732|NCT00462943|585576389|FG001|Overall Study|Physician Decision|0|||
162144733|NCT00462943|585576390|FG002|Overall Study|Physician Decision|0|||
162144734|NCT00462943|585576388|FG000|Overall Study|Withdrawal by Subject|0|||
162144735|NCT00462943|585576389|FG001|Overall Study|Withdrawal by Subject|1|||
162144736|NCT00462943|585576390|FG002|Overall Study|Withdrawal by Subject|0|||
162144737|NCT00995709|585576391|FG000|Overall Study|Adverse Event|4|||
162144738|NCT00995709|585576392|FG001|Overall Study|Adverse Event|2|||
162144739|NCT00995709|585576393|FG002|Overall Study|Adverse Event|0|||
162144740|NCT00995709|585576391|FG000|Overall Study|Lack of Efficacy|0|||
162144741|NCT00995709|585576392|FG001|Overall Study|Lack of Efficacy|1|||
162144742|NCT00995709|585576393|FG002|Overall Study|Lack of Efficacy|4|||
162144743|NCT00995709|585576391|FG000|Overall Study|Withdrawal by Subject|0|||
162144744|NCT00995709|585576392|FG001|Overall Study|Withdrawal by Subject|4|||
162144745|NCT00995709|585576393|FG002|Overall Study|Withdrawal by Subject|1|||
162144746|NCT00995709|585576391|FG000|Overall Study|Lost to Follow-up|1|||
162144747|NCT00995709|585576392|FG001|Overall Study|Lost to Follow-up|0|||
162144748|NCT00995709|585576393|FG002|Overall Study|Lost to Follow-up|0|||
162144749|NCT00995709|585576391|FG000|Overall Study|Death|0|||
162144750|NCT00995709|585576392|FG001|Overall Study|Death|1|||
162144751|NCT00995709|585576393|FG002|Overall Study|Death|0|||
162144752|NCT00995709|585576391|FG000|Overall Study|Protocol Violation|2|||
161809148|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
162144753|NCT00995709|585576392|FG001|Overall Study|Protocol Violation|1|||
162144754|NCT00995709|585576393|FG002|Overall Study|Protocol Violation|0|||
162144755|NCT02698241|585576395|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
162144756|NCT02698241|585576395|FG000|Overall Study|Screening not met|7|||
162144757|NCT02698241|585576395|FG000|Overall Study|Withdrawal by Subject|7|||
162144758|NCT02698241|585576395|FG000|Overall Study|Physician Decision|2|||
162144759|NCT02698241|585576395|FG000|Overall Study|Subject underwent system modification|2|||
162144760|NCT02698241|585576395|FG000|Overall Study|Lost to Follow-up|3|||
162144761|NCT02698241|585576395|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
162144762|NCT02698241|585576395|FG000|Overall Study|geographic and licensing issue|1|||
162144763|NCT02698241|585576395|FG000|Overall Study|Death|2|||
162144764|NCT01543685|585576398|FG000|Overall Study|Lack of Efficacy|1|||
162144765|NCT01543685|585576399|FG001|Overall Study|Lack of Efficacy|2|||
162144766|NCT01543685|585576400|FG002|Overall Study|Lack of Efficacy|2|||
162144767|NCT01543685|585576401|FG003|Overall Study|Lack of Efficacy|0|||
162144768|NCT01543685|585576402|FG004|Overall Study|Lack of Efficacy|2|||
162144769|NCT01543685|585576398|FG000|Overall Study|Adverse Event|2|||
162144770|NCT01543685|585576399|FG001|Overall Study|Adverse Event|1|||
162144771|NCT01543685|585576400|FG002|Overall Study|Adverse Event|0|||
162144772|NCT01543685|585576401|FG003|Overall Study|Adverse Event|0|||
162144773|NCT01543685|585576402|FG004|Overall Study|Adverse Event|2|||
162144774|NCT04776213|585576405|FG000|Overall Study|Other|1|||
162144775|NCT04776213|585576405|FG000|Overall Study|Withdrawal by Subject|7|||
162144776|NCT04776213|585576405|FG000|Overall Study|Protocol Violation|1|||
162144777|NCT04776213|585576405|FG000|Overall Study|Lost to Follow-up|2|||
162144778|NCT01838551|585576407|FG000|Overall Study|Adverse Event|16|||
162144779|NCT01838551|585576407|FG000|Overall Study|Death|1|||
162144780|NCT01838551|585576407|FG000|Overall Study|Lack of Efficacy|10|||
162144781|NCT01838551|585576407|FG000|Overall Study|Physician Decision|4|||
162144782|NCT01838551|585576407|FG000|Overall Study|Withdrawal by Subject|10|||
162144783|NCT01838551|585576407|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
162144784|NCT00906282|585576408|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
162144785|NCT00906282|585576408|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
162144786|NCT00906282|585576408|FG000|Preoperative Chemotherapy|Progressive disease|6|||
162144787|NCT00906282|585576408|FG000|Preoperative Chemotherapy|Toxicity|1|||
162144788|NCT03254394|585576413|FG000|Overall Study|Withdrawal by Subject|0|||
162144789|NCT03254394|585576414|FG001|Overall Study|Withdrawal by Subject|2|||
162144790|NCT02163915|585576415|FG000|Overall Study|Withdrawal by Subject|2|||
162144791|NCT02163915|585576416|FG001|Overall Study|Withdrawal by Subject|0|||
162144792|NCT02163915|585576417|FG002|Overall Study|Withdrawal by Subject|2|||
162144793|NCT02163915|585576418|FG003|Overall Study|Withdrawal by Subject|2|||
162144794|NCT02163915|585576419|FG004|Overall Study|Withdrawal by Subject|2|||
162144795|NCT02163915|585576415|FG000|Overall Study|Study termination|1|||
162144796|NCT02163915|585576416|FG001|Overall Study|Study termination|0|||
162144797|NCT02163915|585576417|FG002|Overall Study|Study termination|0|||
162144798|NCT02163915|585576418|FG003|Overall Study|Study termination|0|||
162144799|NCT02163915|585576419|FG004|Overall Study|Study termination|2|||
162144800|NCT02163915|585576415|FG000|Overall Study|Physician Decision|0|||
162144801|NCT02163915|585576416|FG001|Overall Study|Physician Decision|0|||
162144802|NCT02163915|585576417|FG002|Overall Study|Physician Decision|0|||
162144803|NCT02163915|585576418|FG003|Overall Study|Physician Decision|1|||
162144804|NCT02163915|585576419|FG004|Overall Study|Physician Decision|0|||
162144805|NCT02299336|585576424|FG000|Overall Study|Withdrawal by Subject|11|||
162144806|NCT02299336|585576424|FG000|Overall Study|Adverse Event|1|||
162144807|NCT02299336|585576424|FG000|Overall Study|Death|1|||
162144808|NCT02299336|585576424|FG000|Overall Study|Lost to Follow-up|1|||
162144809|NCT02013037|585576426|FG000|Overall Study|Death|6|||
162144810|NCT02013037|585576426|FG000|Overall Study|Withdrawal by Subject|1|||
162144811|NCT02013037|585576426|FG000|Overall Study|Awaiting Transplantation|7|||
162144812|NCT02013037|585576426|FG000|Overall Study|Transplanted without DSA|2|||
162144813|NCT02465359|585576427|FG000|Overall Study|Lack of Efficacy|1|||
162144814|NCT02465359|585576427|FG000|Overall Study|Withdrawal by Subject|1|||
162144815|NCT02465359|585576427|FG000|Overall Study|Adverse Event|1|||
162144816|NCT01304147|585576428|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
162144817|NCT01304147|585576429|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
162144818|NCT02812966|585576432|FG000|Overall Study|Death|1|||
162144819|NCT02812966|585576433|FG001|Overall Study|Death|0|||
162144820|NCT01066923|585576434|FG000|Overall Study|Withdrawal by Subject|3|||
162144821|NCT01066923|585576435|FG001|Overall Study|Withdrawal by Subject|3|||
162144822|NCT01066923|585576436|FG002|Overall Study|Withdrawal by Subject|8|||
162144823|NCT01066923|585576437|FG003|Overall Study|Withdrawal by Subject|8|||
162144824|NCT01049503|585578659|FG000|Overall Study|Lost to Follow-up|11|||
162144825|NCT01049503|585578660|FG001|Overall Study|Lost to Follow-up|12|||
162144826|NCT01049503|585578661|FG002|Overall Study|Lost to Follow-up|24|||
162144827|NCT01049503|585578662|FG003|Overall Study|Lost to Follow-up|26|||
162144828|NCT01049503|585578663|FG004|Overall Study|Lost to Follow-up|27|||
162144829|NCT01049503|585578664|FG005|Overall Study|Lost to Follow-up|8|||
162144830|NCT02577523|585578667|FG000|Overall Study|Adverse Event|1|||
161809149|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809150|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809151|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809152|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161913201|NCT00111761|584731914|FG000|Part 1|Death|0|||
162144831|NCT02577523|585578668|FG001|Overall Study|Adverse Event|1|||
162144832|NCT02577523|585578667|FG000|Overall Study|Lack of Efficacy|1|||
162144833|NCT02577523|585578668|FG001|Overall Study|Lack of Efficacy|1|||
162144834|NCT02577523|585578667|FG000|Overall Study|Withdrawal by Subject|1|||
162144835|NCT02577523|585578668|FG001|Overall Study|Withdrawal by Subject|0|||
162144836|NCT00970307|585578669|FG000|Overall Study|Serious Adverse Event|1|||
162144837|NCT00970307|585578670|FG001|Overall Study|Serious Adverse Event|0|||
162144838|NCT00970307|585578671|FG002|Overall Study|Serious Adverse Event|0|||
162144839|NCT00970307|585578669|FG000|Overall Study|Withdrawal by Subject|2|||
162144840|NCT00970307|585578670|FG001|Overall Study|Withdrawal by Subject|3|||
162144841|NCT00970307|585578671|FG002|Overall Study|Withdrawal by Subject|2|||
162144842|NCT05174013|585578680|FG000|Overall Study|Lost to Follow-up|0|||
162144843|NCT05174013|585578681|FG001|Overall Study|Lost to Follow-up|0|||
162144844|NCT05174013|585578682|FG002|Overall Study|Lost to Follow-up|0|||
162144845|NCT05174013|585578683|FG003|Overall Study|Lost to Follow-up|1|||
162144846|NCT05174013|585578684|FG004|Overall Study|Lost to Follow-up|0|||
162144847|NCT05174013|585578685|FG005|Overall Study|Lost to Follow-up|0|||
162144848|NCT05174013|585578680|FG000|Overall Study|Withdrawal by Subject|0|||
162144849|NCT05174013|585578681|FG001|Overall Study|Withdrawal by Subject|0|||
162144850|NCT05174013|585578682|FG002|Overall Study|Withdrawal by Subject|1|||
162144851|NCT05174013|585578683|FG003|Overall Study|Withdrawal by Subject|0|||
162144852|NCT05174013|585578684|FG004|Overall Study|Withdrawal by Subject|0|||
162144853|NCT05174013|585578685|FG005|Overall Study|Withdrawal by Subject|0|||
162144854|NCT00241644|585578689|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
162144855|NCT00241644|585578690|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
162144856|NCT00241644|585578691|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
162144857|NCT00241644|585578692|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
162144858|NCT00241644|585578689|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
162144859|NCT00241644|585578690|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
162144860|NCT00241644|585578691|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
162144861|NCT00241644|585578692|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
162144862|NCT00241644|585578689|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
162144863|NCT00241644|585578690|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
162144864|NCT00241644|585578691|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
162144865|NCT00241644|585578692|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
162144866|NCT00241644|585578689|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
162144867|NCT00241644|585578690|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
162144868|NCT00241644|585578691|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
162144869|NCT00241644|585578692|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
162144870|NCT00241644|585578689|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
162144871|NCT00241644|585578690|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
162144872|NCT00241644|585578691|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
162144873|NCT00241644|585578692|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
162144874|NCT00241644|585578689|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
162144875|NCT00241644|585578690|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
162144876|NCT00241644|585578691|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
162144877|NCT00241644|585578692|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
162144878|NCT00241644|585578689|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
162144879|NCT00241644|585578690|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
162144880|NCT00241644|585578691|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
162144881|NCT00241644|585578692|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
162144882|NCT00241644|585578689|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
162144883|NCT00241644|585578690|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
162144884|NCT00241644|585578691|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
162144885|NCT00241644|585578692|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
162144886|NCT00241644|585578689|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
162144887|NCT00241644|585578690|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
162144888|NCT00241644|585578691|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
162144889|NCT00241644|585578692|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
162144890|NCT00241644|585578689|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
162144891|NCT00241644|585578690|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
162144892|NCT00241644|585578691|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
162144893|NCT00241644|585578692|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
162144894|NCT00241644|585578689|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
162144895|NCT00241644|585578690|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
162144896|NCT00241644|585578691|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
162144897|NCT00241644|585578692|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
162144898|NCT00241644|585578689|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
161913202|NCT00111761|584731915|FG001|Part 1|Death|2|||
161913203|NCT00111761|584731914|FG000|Part 1|Other|0|||
161913204|NCT00111761|584731915|FG001|Part 1|Other|1|||
161913205|NCT00111761|584731914|FG000|Part 1|Withdrawal by Subject|0|||
161913206|NCT00111761|584731915|FG001|Part 1|Withdrawal by Subject|1|||
161913207|NCT00111761|584731914|FG000|Part 2|Adverse Event|1|||
161913208|NCT00111761|584731915|FG001|Part 2|Adverse Event|0|||
161913209|NCT00111761|584731914|FG000|Part 2|Physician Decision|1|||
161913210|NCT00111761|584731915|FG001|Part 2|Physician Decision|0|||
161913211|NCT00111761|584731914|FG000|Part 2|Death|1|||
161913212|NCT00111761|584731915|FG001|Part 2|Death|0|||
161913213|NCT00111761|584731914|FG000|Part 2|Disease progression|3|||
161913214|NCT00111761|584731915|FG001|Part 2|Disease progression|0|||
161913215|NCT00111761|584731914|FG000|Part 2|Protocol-specified criteria|1|||
161913216|NCT00111761|584731915|FG001|Part 2|Protocol-specified criteria|0|||
161913217|NCT00111761|584731914|FG000|Part 2|Other|1|||
161913218|NCT00111761|584731915|FG001|Part 2|Other|0|||
161913219|NCT00726609|584731918|FG000|Overall Study|Adverse Event|10|||
161913220|NCT00726609|584731918|FG000|Overall Study|Withdrawal by Subject|2|||
161913221|NCT00726609|584731918|FG000|Overall Study|Lack of Efficacy|25|||
161913222|NCT00726609|584731918|FG000|Overall Study|Other|16|||
161913223|NCT00726609|584731918|FG000|Overall Study|Missing|42|||
161913224|NCT00726609|584731918|FG000|Overall Study|Other|3|||
161913225|NCT02029417|584731921|FG000|Overall Study|Death|1|||
161913226|NCT02029417|584731921|FG000|Overall Study|Adverse Event|1|||
161913227|NCT00071981|584731922|FG000|Overall Study|Lack of Efficacy|37|||
161913228|NCT00071981|584731923|FG001|Overall Study|Lack of Efficacy|29|||
161913229|NCT00071981|584731924|FG002|Overall Study|Lack of Efficacy|30|||
161913230|NCT00071981|584731925|FG003|Overall Study|Lack of Efficacy|43|||
161913231|NCT00071981|584731922|FG000|Overall Study|Adverse Event|4|||
161913232|NCT00071981|584731923|FG001|Overall Study|Adverse Event|4|||
161913233|NCT00071981|584731924|FG002|Overall Study|Adverse Event|3|||
161913234|NCT00071981|584731925|FG003|Overall Study|Adverse Event|1|||
161913235|NCT00071981|584731922|FG000|Overall Study|Death|0|||
161913236|NCT00071981|584731923|FG001|Overall Study|Death|0|||
161913237|NCT00071981|584731924|FG002|Overall Study|Death|1|||
161913238|NCT00071981|584731925|FG003|Overall Study|Death|1|||
161913239|NCT00071981|584731922|FG000|Overall Study|Withdrawal by Subject|3|||
161913240|NCT00071981|584731923|FG001|Overall Study|Withdrawal by Subject|1|||
161913241|NCT00071981|584731924|FG002|Overall Study|Withdrawal by Subject|0|||
161913242|NCT00071981|584731925|FG003|Overall Study|Withdrawal by Subject|0|||
161913243|NCT00071981|584731922|FG000|Overall Study|No protocol therapy|2|||
161913244|NCT00071981|584731923|FG001|Overall Study|No protocol therapy|5|||
161913245|NCT00071981|584731924|FG002|Overall Study|No protocol therapy|1|||
161913246|NCT00071981|584731925|FG003|Overall Study|No protocol therapy|0|||
161913247|NCT00071981|584731922|FG000|Overall Study|others (not specified in the study)|0|||
161913248|NCT00071981|584731923|FG001|Overall Study|others (not specified in the study)|2|||
161913249|NCT00071981|584731924|FG002|Overall Study|others (not specified in the study)|2|||
161913250|NCT00071981|584731925|FG003|Overall Study|others (not specified in the study)|0|||
161913251|NCT04458922|584731926|FG000|Overall Study|Withdrawal by Subject|1|||
161913252|NCT04458922|584731927|FG001|Overall Study|Withdrawal by Subject|0|||
161913253|NCT04458922|584731928|FG002|Overall Study|Withdrawal by Subject|2|||
161913254|NCT04458922|584731926|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
161913255|NCT04458922|584731927|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
161913256|NCT04458922|584731928|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
161913257|NCT04458922|584731926|FG000|Overall Study|Adverse Event|1|||
161913258|NCT04458922|584731927|FG001|Overall Study|Adverse Event|0|||
161913259|NCT04458922|584731928|FG002|Overall Study|Adverse Event|0|||
161913260|NCT04458922|584731926|FG000|Overall Study|Started new study|0|||
161913261|NCT04458922|584731927|FG001|Overall Study|Started new study|0|||
161913262|NCT04458922|584731928|FG002|Overall Study|Started new study|1|||
161913263|NCT04458922|584731926|FG000|Overall Study|Progressive disease|6|||
161913264|NCT04458922|584731927|FG001|Overall Study|Progressive disease|8|||
161913265|NCT04458922|584731928|FG002|Overall Study|Progressive disease|2|||
161913266|NCT04458922|584731926|FG000|Overall Study|Death|1|||
161913267|NCT04458922|584731927|FG001|Overall Study|Death|0|||
161913268|NCT04458922|584731928|FG002|Overall Study|Death|2|||
161913269|NCT04458922|584731926|FG000|Overall Study|Participant started chemotherapy|0|||
161913270|NCT04458922|584731927|FG001|Overall Study|Participant started chemotherapy|1|||
161913271|NCT04458922|584731928|FG002|Overall Study|Participant started chemotherapy|0|||
161913272|NCT00465179|584731931|FG000|Overall Study|Adverse Event|4|||
161913273|NCT00465179|584731931|FG000|Overall Study|Withdrawal by Subject|2|||
161913274|NCT00465179|584731931|FG000|Overall Study|Progression of Disease|47|||
161913275|NCT00833755|584731934|FG000|Overall Study|Physician Decision|4|||
161913276|NCT00833755|584731935|FG001|Overall Study|Physician Decision|4|||
161913277|NCT00833755|584731936|FG002|Overall Study|Physician Decision|2|||
161913278|NCT00833755|584731937|FG003|Overall Study|Physician Decision|6|||
161913279|NCT00833755|584731934|FG000|Overall Study|Subject had scheduling issues|0|||
161913280|NCT00833755|584731935|FG001|Overall Study|Subject had scheduling issues|1|||
161913281|NCT00833755|584731936|FG002|Overall Study|Subject had scheduling issues|0|||
161913282|NCT00833755|584731937|FG003|Overall Study|Subject had scheduling issues|0|||
161913283|NCT04108468|584731938|FG000|Overall Study|Physician Decision|0|||
161913284|NCT04108468|584731939|FG001|Overall Study|Physician Decision|1|||
161913285|NCT04108468|584731938|FG000|Overall Study|Lost to Follow-up|0|||
161913286|NCT04108468|584731939|FG001|Overall Study|Lost to Follow-up|1|||
161913287|NCT04108468|584731938|FG000|Overall Study|Non-compliance|1|||
161913288|NCT04108468|584731939|FG001|Overall Study|Non-compliance|1|||
161913289|NCT04108468|584731938|FG000|Overall Study|Unable to attend final visit|2|||
161913290|NCT04108468|584731939|FG001|Overall Study|Unable to attend final visit|0|||
161913291|NCT04108468|584731938|FG000|Overall Study|Missed study medication|0|||
161913292|NCT04108468|584731939|FG001|Overall Study|Missed study medication|1|||
161913293|NCT06121609|584731941|FG000|Overall Study|Lack of Efficacy|0|||
161913294|NCT06121609|584731942|FG001|Overall Study|Lack of Efficacy|0|||
161913295|NCT06121609|584731943|FG002|Overall Study|Lack of Efficacy|45|||
161913296|NCT02867592|584731945|FG000|Overall Study|Adverse Event|3|||
161913297|NCT02867592|584731946|FG001|Overall Study|Adverse Event|0|||
161913298|NCT02867592|584731947|FG002|Overall Study|Adverse Event|2|||
161809153|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161913299|NCT02867592|584731948|FG003|Overall Study|Adverse Event|1|||
161809154|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809155|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809156|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809157|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809158|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809159|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809160|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809161|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809162|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
161809163|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
161809164|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809165|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809166|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809167|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809168|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161809169|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809170|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809171|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809172|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809173|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809174|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809175|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809176|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809177|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809178|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161913300|NCT02867592|584731949|FG004|Overall Study|Adverse Event|1|||
161913301|NCT02867592|584731950|FG005|Overall Study|Adverse Event|5|||
161913302|NCT02867592|584731945|FG000|Overall Study|Death|0|||
161809179|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809180|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809181|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809182|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809183|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
161809184|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
161809185|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809186|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809187|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809188|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809189|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161809190|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809191|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809192|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809193|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809194|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809195|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809196|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809197|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809198|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809199|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809200|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809201|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809202|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809203|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
161809204|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
161809205|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
161809206|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809207|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809208|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809209|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809210|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161809211|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809212|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809213|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809214|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809215|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809216|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809217|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809218|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809219|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809220|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809221|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809222|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809223|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809224|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809225|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
161809226|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
161809227|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809228|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809229|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809230|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809231|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
161809232|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809233|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809234|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809235|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809236|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809237|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809238|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809239|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809240|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809241|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161913303|NCT02867592|584731946|FG001|Overall Study|Death|0|||
161913304|NCT02867592|584731947|FG002|Overall Study|Death|0|||
162144899|NCT00241644|585578690|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
162144900|NCT00241644|585578691|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
162144901|NCT00241644|585578692|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
162144902|NCT00241644|585578689|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
162144903|NCT00241644|585578690|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
162144904|NCT00241644|585578691|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
162144905|NCT00241644|585578692|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
162144906|NCT00864682|585578694|FG000|Overall Study|Protocol Violation|2|||
162144907|NCT00864682|585578695|FG001|Overall Study|Protocol Violation|1|||
162144908|NCT00864682|585578696|FG002|Overall Study|Protocol Violation|2|||
162144909|NCT02506257|585578700|FG000|Overall Study|Adverse Event|0|||
162144910|NCT02506257|585578701|FG001|Overall Study|Adverse Event|2|||
162144911|NCT02506257|585578702|FG002|Overall Study|Adverse Event|3|||
162144912|NCT02506257|585578703|FG003|Overall Study|Adverse Event|0|||
162144913|NCT02506257|585578700|FG000|Overall Study|Protocol Violation|0|||
161809242|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809243|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809244|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809245|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161913305|NCT02867592|584731948|FG003|Overall Study|Death|1|||
162144914|NCT02506257|585578701|FG001|Overall Study|Protocol Violation|0|||
162144915|NCT02506257|585578702|FG002|Overall Study|Protocol Violation|1|||
162144916|NCT02506257|585578703|FG003|Overall Study|Protocol Violation|0|||
162144917|NCT01563354|585578705|FG000|Core Phase|Adverse Event|5|||
162144918|NCT01563354|585578706|FG001|Core Phase|Adverse Event|15|||
162144919|NCT01563354|585578707|FG002|Core Phase|Adverse Event|13|||
161809246|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
162011458|NCT01352793|585097855|FG000|Overall Study|Withdrawal by Subject|120|||
162011459|NCT01352793|585097856|FG001|Overall Study|Withdrawal by Subject|55|||
162011460|NCT01352793|585097855|FG000|Overall Study|Protocol Violation|44|||
162011461|NCT01352793|585097856|FG001|Overall Study|Protocol Violation|23|||
162144920|NCT01563354|585578705|FG000|Core Phase|Withdrawal by Subject|1|||
162144921|NCT01563354|585578706|FG001|Core Phase|Withdrawal by Subject|0|||
162144922|NCT01563354|585578707|FG002|Core Phase|Withdrawal by Subject|3|||
162144923|NCT01563354|585578705|FG000|Core Phase|Lost to Follow-up|1|||
162144924|NCT01563354|585578706|FG001|Core Phase|Lost to Follow-up|0|||
162144925|NCT01563354|585578707|FG002|Core Phase|Lost to Follow-up|0|||
162144926|NCT01563354|585578705|FG000|Core Phase|Death|1|||
162144927|NCT01563354|585578706|FG001|Core Phase|Death|5|||
162144928|NCT01563354|585578707|FG002|Core Phase|Death|2|||
162144929|NCT01563354|585578705|FG000|Core Phase|Diseasse progression|18|||
162144930|NCT01563354|585578706|FG001|Core Phase|Diseasse progression|7|||
162144931|NCT01563354|585578707|FG002|Core Phase|Diseasse progression|8|||
162144932|NCT01563354|585578705|FG000|Core Phase|Protocol deviation|2|||
162144933|NCT01563354|585578706|FG001|Core Phase|Protocol deviation|0|||
162144934|NCT01563354|585578707|FG002|Core Phase|Protocol deviation|0|||
162144935|NCT01563354|585578705|FG000|Core Phase|PI decision - did not enter extension|0|||
162144936|NCT01563354|585578706|FG001|Core Phase|PI decision - did not enter extension|1|||
162144937|NCT01563354|585578707|FG002|Core Phase|PI decision - did not enter extension|0|||
162144938|NCT01563354|585578705|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
162144939|NCT01563354|585578706|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
162144940|NCT01563354|585578707|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
162144941|NCT01563354|585578705|FG000|Extension Phase|Adverse Event|0|||
162144942|NCT01563354|585578706|FG001|Extension Phase|Adverse Event|3|||
162144943|NCT01563354|585578707|FG002|Extension Phase|Adverse Event|2|||
162144944|NCT01563354|585578705|FG000|Extension Phase|Withdrawal by Subject|0|||
162144945|NCT01563354|585578706|FG001|Extension Phase|Withdrawal by Subject|1|||
162144946|NCT01563354|585578707|FG002|Extension Phase|Withdrawal by Subject|0|||
162144947|NCT01563354|585578705|FG000|Extension Phase|Administration problems|3|||
162144948|NCT01563354|585578706|FG001|Extension Phase|Administration problems|2|||
162144949|NCT01563354|585578707|FG002|Extension Phase|Administration problems|3|||
162144950|NCT01563354|585578705|FG000|Extension Phase|Disease progression|9|||
162144951|NCT01563354|585578706|FG001|Extension Phase|Disease progression|8|||
162144952|NCT01563354|585578707|FG002|Extension Phase|Disease progression|10|||
162144953|NCT01050569|585578713|FG000|Overall Study|Lost to Follow-up|20|||
162144954|NCT01050569|585578714|FG001|Overall Study|Lost to Follow-up|14|||
162144955|NCT01050569|585578715|FG002|Overall Study|Lost to Follow-up|16|||
162144956|NCT01050569|585578713|FG000|Overall Study|Withdrawal by Subject|9|||
162144957|NCT01050569|585578714|FG001|Overall Study|Withdrawal by Subject|3|||
162144958|NCT01050569|585578715|FG002|Overall Study|Withdrawal by Subject|11|||
162144959|NCT01050569|585578713|FG000|Overall Study|Lack of Efficacy|5|||
162144960|NCT01050569|585578714|FG001|Overall Study|Lack of Efficacy|4|||
162144961|NCT01050569|585578715|FG002|Overall Study|Lack of Efficacy|3|||
162144962|NCT01050569|585578713|FG000|Overall Study|Adverse Event|1|||
162144963|NCT01050569|585578714|FG001|Overall Study|Adverse Event|0|||
162144964|NCT01050569|585578715|FG002|Overall Study|Adverse Event|0|||
162144965|NCT01050569|585578713|FG000|Overall Study|Physician Decision|3|||
162144966|NCT01050569|585578714|FG001|Overall Study|Physician Decision|3|||
162144967|NCT01050569|585578715|FG002|Overall Study|Physician Decision|3|||
162144968|NCT05046132|585578716|FG000|Overall Study|Adverse Event|4|||
162144969|NCT05046132|585578717|FG001|Overall Study|Adverse Event|0|||
162144970|NCT05046132|585578718|FG002|Overall Study|Adverse Event|0|||
162144971|NCT05046132|585578716|FG000|Overall Study|Withdrawal by Subject|3|||
162144972|NCT05046132|585578717|FG001|Overall Study|Withdrawal by Subject|0|||
162144973|NCT05046132|585578718|FG002|Overall Study|Withdrawal by Subject|0|||
162011462|NCT01352793|585097855|FG000|Overall Study|Adverse Event|44|||
162144974|NCT05046132|585578716|FG000|Overall Study|Positive Covid19 Result.|0|||
162144975|NCT05046132|585578717|FG001|Overall Study|Positive Covid19 Result.|1|||
162144976|NCT05046132|585578718|FG002|Overall Study|Positive Covid19 Result.|0|||
162144977|NCT01186848|585578719|FG000|Overall Study|Lost to Follow-up|4|||
162144978|NCT01186848|585578719|FG000|Overall Study|Withdrawal by Subject|2|||
162144979|NCT01186848|585578719|FG000|Overall Study|Adverse Event|2|||
162144980|NCT02371746|585578729|FG000|Overall Study|Consent withdrawn|0|||
162144981|NCT02371746|585578730|FG001|Overall Study|Consent withdrawn|0|||
162144982|NCT02371746|585578731|FG002|Overall Study|Consent withdrawn|0|||
162011463|NCT01352793|585097856|FG001|Overall Study|Adverse Event|10|||
162144983|NCT02371746|585578732|FG003|Overall Study|Consent withdrawn|0|||
162144984|NCT02371746|585578733|FG004|Overall Study|Consent withdrawn|0|||
162144985|NCT02371746|585578734|FG005|Overall Study|Consent withdrawn|0|||
162144986|NCT02371746|585578735|FG006|Overall Study|Consent withdrawn|1|||
162144987|NCT00612586|585578736|FG000|Overall Study|Adverse Event|6|||
162011464|NCT01352793|585097855|FG000|Overall Study|Physician Decision|1|||
161809247|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
161809248|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809249|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809250|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809251|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809252|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161809253|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809254|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809255|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809256|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809257|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809258|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809259|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809260|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809261|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809262|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809263|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809264|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809265|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809266|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809267|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
161809268|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
161809269|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809270|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809271|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809272|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809273|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161809274|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809275|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809276|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809277|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809278|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809279|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809280|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809281|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809282|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809283|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809284|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809285|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809286|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809287|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809288|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
161809289|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
161809290|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809291|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809292|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809293|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809294|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161809295|NCT01597245|584344311|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809296|NCT01597245|584344312|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809297|NCT01597245|584344313|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809298|NCT01597245|584344314|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809299|NCT01597245|584344315|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809300|NCT01597245|584344316|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809301|NCT01597245|584344317|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809302|NCT01597245|584344318|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809303|NCT01597245|584344319|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809304|NCT01597245|584344320|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809305|NCT01597245|584344321|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809306|NCT01597245|584344322|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809307|NCT01597245|584344323|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809308|NCT01597245|584344324|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
161809309|NCT01597245|584344325|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809310|NCT01597245|584344326|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809311|NCT01597245|584344327|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809312|NCT01597245|584344328|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809313|NCT01597245|584344329|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809314|NCT01597245|584344330|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809315|NCT01597245|584344331|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161809316|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809317|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809318|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809319|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
162144988|NCT00612586|585578737|FG001|Overall Study|Adverse Event|2|||
162144989|NCT00612586|585578736|FG000|Overall Study|Death|1|||
162144990|NCT00612586|585578737|FG001|Overall Study|Death|0|||
162144991|NCT00612586|585578736|FG000|Overall Study|Entry Criteria Not Met|0|||
162144992|NCT00612586|585578737|FG001|Overall Study|Entry Criteria Not Met|2|||
162144993|NCT00612586|585578736|FG000|Overall Study|Withdrawal by Subject|7|||
162144994|NCT00612586|585578737|FG001|Overall Study|Withdrawal by Subject|9|||
162144995|NCT00612586|585578736|FG000|Overall Study|Physician Decision|1|||
162144996|NCT00612586|585578737|FG001|Overall Study|Physician Decision|2|||
162144997|NCT00612586|585578736|FG000|Overall Study|Sponsor Decision|1|||
162144998|NCT00612586|585578737|FG001|Overall Study|Sponsor Decision|1|||
162144999|NCT00612586|585578736|FG000|Overall Study|Progressive Disease|26|||
162145000|NCT00612586|585578737|FG001|Overall Study|Progressive Disease|24|||
162145001|NCT00612586|585578736|FG000|Overall Study|Randomized and Not Treated|1|||
162145002|NCT00612586|585578737|FG001|Overall Study|Randomized and Not Treated|1|||
162145003|NCT02613364|585578738|FG000|Overall Study|Other|19|||
162145004|NCT02613364|585578739|FG001|Overall Study|Other|29|||
162145005|NCT02613364|585578740|FG002|Overall Study|Other|17|||
162145006|NCT02613364|585578738|FG000|Overall Study|Too time consuming|21|||
162145007|NCT02613364|585578739|FG001|Overall Study|Too time consuming|26|||
162145008|NCT02613364|585578740|FG002|Overall Study|Too time consuming|26|||
162145009|NCT02613364|585578738|FG000|Overall Study|Withdrawal by Subject|13|||
162145010|NCT02613364|585578739|FG001|Overall Study|Withdrawal by Subject|18|||
162145011|NCT02613364|585578740|FG002|Overall Study|Withdrawal by Subject|17|||
162145012|NCT02613364|585578738|FG000|Overall Study|Medical|12|||
162145013|NCT02613364|585578739|FG001|Overall Study|Medical|13|||
162145014|NCT02613364|585578740|FG002|Overall Study|Medical|9|||
162145015|NCT02613364|585578738|FG000|Overall Study|Disliked Study Procedure|1|||
162145016|NCT02613364|585578739|FG001|Overall Study|Disliked Study Procedure|1|||
162145017|NCT02613364|585578740|FG002|Overall Study|Disliked Study Procedure|4|||
162145018|NCT02613364|585578738|FG000|Overall Study|Disliked Intervention|0|||
162145019|NCT02613364|585578739|FG001|Overall Study|Disliked Intervention|3|||
162145020|NCT02613364|585578740|FG002|Overall Study|Disliked Intervention|3|||
162145021|NCT01909336|585578741|FG000|Overall Study|Lost to Follow-up|4|||
162145022|NCT01909336|585578742|FG001|Overall Study|Lost to Follow-up|2|||
162145023|NCT01909336|585578743|FG002|Overall Study|Lost to Follow-up|2|||
162145024|NCT01909336|585578741|FG000|Overall Study|Physician Decision|0|||
162145025|NCT01909336|585578742|FG001|Overall Study|Physician Decision|1|||
162145026|NCT01909336|585578743|FG002|Overall Study|Physician Decision|1|||
162145027|NCT01235949|585578744|FG000|Primary Phase|Migrated/moved from study area|1|||
162145028|NCT01235949|585578745|FG001|Primary Phase|Migrated/moved from study area|1|||
162145029|NCT01235949|585578746|FG002|Primary Phase|Migrated/moved from study area|0|||
162145030|NCT01235949|585578747|FG003|Primary Phase|Migrated/moved from study area|0|||
161913306|NCT02867592|584731949|FG004|Overall Study|Death|0|||
161913307|NCT02867592|584731950|FG005|Overall Study|Death|1|||
161913308|NCT02867592|584731945|FG000|Overall Study|Lack of Efficacy|8|||
161913309|NCT02867592|584731946|FG001|Overall Study|Lack of Efficacy|10|||
161913310|NCT02867592|584731947|FG002|Overall Study|Lack of Efficacy|8|||
161913311|NCT02867592|584731948|FG003|Overall Study|Lack of Efficacy|8|||
161913312|NCT02867592|584731949|FG004|Overall Study|Lack of Efficacy|12|||
161913313|NCT02867592|584731950|FG005|Overall Study|Lack of Efficacy|17|||
161913314|NCT02867592|584731945|FG000|Overall Study|Physician Decision|1|||
161913315|NCT02867592|584731946|FG001|Overall Study|Physician Decision|2|||
161913316|NCT02867592|584731947|FG002|Overall Study|Physician Decision|2|||
161913317|NCT02867592|584731948|FG003|Overall Study|Physician Decision|0|||
161913318|NCT02867592|584731949|FG004|Overall Study|Physician Decision|5|||
161913319|NCT02867592|584731950|FG005|Overall Study|Physician Decision|1|||
161913320|NCT02867592|584731945|FG000|Overall Study|Protocol Violation|0|||
161913321|NCT02867592|584731946|FG001|Overall Study|Protocol Violation|0|||
161913322|NCT02867592|584731947|FG002|Overall Study|Protocol Violation|0|||
161913323|NCT02867592|584731948|FG003|Overall Study|Protocol Violation|0|||
161913324|NCT02867592|584731949|FG004|Overall Study|Protocol Violation|1|||
161913325|NCT02867592|584731950|FG005|Overall Study|Protocol Violation|1|||
161913326|NCT02867592|584731945|FG000|Overall Study|Withdrawal by Subject|0|||
161913327|NCT02867592|584731946|FG001|Overall Study|Withdrawal by Subject|1|||
161913328|NCT02867592|584731947|FG002|Overall Study|Withdrawal by Subject|0|||
162145031|NCT01235949|585578748|FG004|Primary Phase|Migrated/moved from study area|1|||
162145032|NCT01235949|585578749|FG005|Primary Phase|Migrated/moved from study area|2|||
162145033|NCT01235949|585578750|FG006|Primary Phase|Migrated/moved from study area|0|||
162145034|NCT01235949|585578751|FG007|Primary Phase|Migrated/moved from study area|0|||
162145035|NCT01235949|585578752|FG008|Primary Phase|Migrated/moved from study area|0|||
162145036|NCT01235949|585578753|FG009|Primary Phase|Migrated/moved from study area|0|||
162145037|NCT01235949|585578754|FG010|Primary Phase|Migrated/moved from study area|0|||
161913329|NCT02867592|584731948|FG003|Overall Study|Withdrawal by Subject|1|||
161913330|NCT02867592|584731949|FG004|Overall Study|Withdrawal by Subject|3|||
162145038|NCT01235949|585578755|FG011|Primary Phase|Migrated/moved from study area|0|||
162145039|NCT01235949|585578756|FG012|Primary Phase|Migrated/moved from study area|0|||
162145040|NCT01235949|585578757|FG013|Primary Phase|Migrated/moved from study area|0|||
162145041|NCT01235949|585578758|FG014|Primary Phase|Migrated/moved from study area|0|||
162145042|NCT01235949|585578759|FG015|Primary Phase|Migrated/moved from study area|0|||
162145043|NCT01235949|585578760|FG016|Primary Phase|Migrated/moved from study area|0|||
162145044|NCT01235949|585578761|FG017|Primary Phase|Migrated/moved from study area|0|||
162145045|NCT01235949|585578744|FG000|Primary Phase|Adverse Event|0|||
162145046|NCT01235949|585578745|FG001|Primary Phase|Adverse Event|0|||
162145047|NCT01235949|585578746|FG002|Primary Phase|Adverse Event|0|||
162145048|NCT01235949|585578747|FG003|Primary Phase|Adverse Event|1|||
162145049|NCT01235949|585578748|FG004|Primary Phase|Adverse Event|0|||
162145050|NCT01235949|585578749|FG005|Primary Phase|Adverse Event|0|||
162145051|NCT01235949|585578750|FG006|Primary Phase|Adverse Event|0|||
162145052|NCT01235949|585578751|FG007|Primary Phase|Adverse Event|0|||
162145053|NCT01235949|585578752|FG008|Primary Phase|Adverse Event|0|||
162145054|NCT01235949|585578753|FG009|Primary Phase|Adverse Event|0|||
162145055|NCT01235949|585578754|FG010|Primary Phase|Adverse Event|0|||
162145056|NCT01235949|585578755|FG011|Primary Phase|Adverse Event|0|||
162145057|NCT01235949|585578756|FG012|Primary Phase|Adverse Event|0|||
162145058|NCT01235949|585578757|FG013|Primary Phase|Adverse Event|0|||
162145059|NCT01235949|585578758|FG014|Primary Phase|Adverse Event|0|||
162145060|NCT01235949|585578759|FG015|Primary Phase|Adverse Event|0|||
162145061|NCT01235949|585578760|FG016|Primary Phase|Adverse Event|0|||
162145062|NCT01235949|585578761|FG017|Primary Phase|Adverse Event|0|||
162145063|NCT01235949|585578744|FG000|Primary Phase|Withdrawal by Subject|3|||
162145064|NCT01235949|585578745|FG001|Primary Phase|Withdrawal by Subject|2|||
162145065|NCT01235949|585578746|FG002|Primary Phase|Withdrawal by Subject|2|||
162145066|NCT01235949|585578747|FG003|Primary Phase|Withdrawal by Subject|0|||
162145067|NCT01235949|585578748|FG004|Primary Phase|Withdrawal by Subject|0|||
162145068|NCT01235949|585578749|FG005|Primary Phase|Withdrawal by Subject|3|||
162145069|NCT01235949|585578750|FG006|Primary Phase|Withdrawal by Subject|0|||
162145070|NCT01235949|585578751|FG007|Primary Phase|Withdrawal by Subject|0|||
162145071|NCT01235949|585578752|FG008|Primary Phase|Withdrawal by Subject|0|||
162145072|NCT01235949|585578753|FG009|Primary Phase|Withdrawal by Subject|0|||
162145073|NCT01235949|585578754|FG010|Primary Phase|Withdrawal by Subject|0|||
162145074|NCT01235949|585578755|FG011|Primary Phase|Withdrawal by Subject|0|||
161809320|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809321|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809322|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809323|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809324|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809325|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809326|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809327|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809328|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809329|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809330|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809331|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161809332|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
161809333|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
161809334|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
161809335|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
161809336|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
161809337|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809338|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809339|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809340|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809341|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809342|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809343|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809344|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809345|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161913331|NCT02867592|584731950|FG005|Overall Study|Withdrawal by Subject|3|||
161913332|NCT02867592|584731945|FG000|Overall Study|Ineligible|1|||
161913333|NCT02867592|584731946|FG001|Overall Study|Ineligible|1|||
161913334|NCT02867592|584731947|FG002|Overall Study|Ineligible|0|||
162145075|NCT01235949|585578756|FG012|Primary Phase|Withdrawal by Subject|0|||
162145076|NCT01235949|585578757|FG013|Primary Phase|Withdrawal by Subject|0|||
162145077|NCT01235949|585578758|FG014|Primary Phase|Withdrawal by Subject|0|||
162145078|NCT01235949|585578759|FG015|Primary Phase|Withdrawal by Subject|0|||
162145079|NCT01235949|585578760|FG016|Primary Phase|Withdrawal by Subject|0|||
161913335|NCT02867592|584731948|FG003|Overall Study|Ineligible|0|||
161913336|NCT02867592|584731949|FG004|Overall Study|Ineligible|2|||
161913337|NCT02867592|584731950|FG005|Overall Study|Ineligible|0|||
161913338|NCT02867592|584731945|FG000|Overall Study|No Treatment|1|||
161913339|NCT02867592|584731946|FG001|Overall Study|No Treatment|0|||
161913340|NCT02867592|584731947|FG002|Overall Study|No Treatment|0|||
161913341|NCT02867592|584731948|FG003|Overall Study|No Treatment|0|||
161913342|NCT02867592|584731949|FG004|Overall Study|No Treatment|0|||
161913343|NCT02867592|584731950|FG005|Overall Study|No Treatment|0|||
161913344|NCT02867592|584731945|FG000|Overall Study|Still on Therapy|0|||
161913345|NCT02867592|584731946|FG001|Overall Study|Still on Therapy|0|||
161913346|NCT02867592|584731947|FG002|Overall Study|Still on Therapy|0|||
161913347|NCT02867592|584731948|FG003|Overall Study|Still on Therapy|0|||
161913348|NCT02867592|584731949|FG004|Overall Study|Still on Therapy|1|||
161913349|NCT02867592|584731950|FG005|Overall Study|Still on Therapy|0|||
161913350|NCT02867592|584731945|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161913351|NCT02867592|584731946|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161913352|NCT02867592|584731947|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161913353|NCT02867592|584731948|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161913354|NCT02867592|584731949|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161913355|NCT02867592|584731950|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
161913356|NCT02867592|584731945|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
161913357|NCT02867592|584731946|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
161913358|NCT02867592|584731947|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
161913359|NCT02867592|584731948|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
161913360|NCT02867592|584731949|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
161913361|NCT02867592|584731950|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
161913362|NCT00909870|584731951|FG000|Overall Study|Adverse Event|13|||
161913363|NCT00909870|584731952|FG001|Overall Study|Adverse Event|7|||
161913364|NCT00909870|584731951|FG000|Overall Study|Protocol Violation|1|||
161913365|NCT00909870|584731952|FG001|Overall Study|Protocol Violation|2|||
161913366|NCT00909870|584731951|FG000|Overall Study|Withdrawal by Subject|5|||
161913367|NCT00909870|584731952|FG001|Overall Study|Withdrawal by Subject|8|||
161913368|NCT00909870|584731951|FG000|Overall Study|Lost to Follow-up|3|||
161913369|NCT00909870|584731952|FG001|Overall Study|Lost to Follow-up|3|||
161913370|NCT00909870|584731951|FG000|Overall Study|Physician Decision|0|||
161913371|NCT00909870|584731952|FG001|Overall Study|Physician Decision|2|||
161913372|NCT00909870|584731951|FG000|Overall Study|Other|1|||
161913373|NCT00909870|584731952|FG001|Overall Study|Other|5|||
161913374|NCT00848497|584731953|FG000|Overall Study|Screen failure|2|||
161913375|NCT00848497|584731954|FG001|Overall Study|Screen failure|0|||
161913376|NCT00848497|584731953|FG000|Overall Study|Withdrawal by Subject|0|||
161913377|NCT00848497|584731954|FG001|Overall Study|Withdrawal by Subject|1|||
161913378|NCT01420536|584731963|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
161913379|NCT01420536|584731964|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
161913380|NCT04711005|584731967|FG000|Overall Study|Withdrawal by Subject|0|||
161913381|NCT04711005|584731968|FG001|Overall Study|Withdrawal by Subject|0|||
161913382|NCT04711005|584731969|FG002|Overall Study|Withdrawal by Subject|0|||
161913383|NCT04711005|584731970|FG003|Overall Study|Withdrawal by Subject|0|||
161913384|NCT04711005|584731971|FG004|Overall Study|Withdrawal by Subject|0|||
161913385|NCT04711005|584731972|FG005|Overall Study|Withdrawal by Subject|0|||
161913386|NCT04711005|584731973|FG006|Overall Study|Withdrawal by Subject|0|||
161913387|NCT04711005|584731974|FG007|Overall Study|Withdrawal by Subject|1|||
161913388|NCT04711005|584731975|FG008|Overall Study|Withdrawal by Subject|0|||
161913389|NCT04711005|584731976|FG009|Overall Study|Withdrawal by Subject|0|||
161913390|NCT04711005|584731967|FG000|Overall Study|Physician Decision|0|||
161913391|NCT04711005|584731968|FG001|Overall Study|Physician Decision|0|||
161913392|NCT04711005|584731969|FG002|Overall Study|Physician Decision|0|||
161913393|NCT04711005|584731970|FG003|Overall Study|Physician Decision|0|||
161913394|NCT04711005|584731971|FG004|Overall Study|Physician Decision|0|||
161913395|NCT04711005|584731972|FG005|Overall Study|Physician Decision|0|||
161913396|NCT04711005|584731973|FG006|Overall Study|Physician Decision|0|||
161913397|NCT04711005|584731974|FG007|Overall Study|Physician Decision|2|||
162145080|NCT01235949|585578761|FG017|Primary Phase|Withdrawal by Subject|0|||
162145081|NCT01235949|585578744|FG000|Primary Phase|Lost to Follow-up|0|||
162145082|NCT01235949|585578745|FG001|Primary Phase|Lost to Follow-up|0|||
162145083|NCT01235949|585578746|FG002|Primary Phase|Lost to Follow-up|1|||
162145084|NCT01235949|585578747|FG003|Primary Phase|Lost to Follow-up|1|||
162145085|NCT01235949|585578748|FG004|Primary Phase|Lost to Follow-up|0|||
161913398|NCT04711005|584731975|FG008|Overall Study|Physician Decision|1|||
161913399|NCT04711005|584731976|FG009|Overall Study|Physician Decision|0|||
161913400|NCT00764790|584731977|FG000|Overall Study|Protocol Violation|0|||
162145086|NCT01235949|585578749|FG005|Primary Phase|Lost to Follow-up|2|||
161913401|NCT00764790|584731978|FG001|Overall Study|Protocol Violation|0|||
161913402|NCT00764790|584731979|FG002|Overall Study|Protocol Violation|1|||
161913403|NCT00764790|584731977|FG000|Overall Study|Withdrawal by Subject|10|||
161913404|NCT00764790|584731978|FG001|Overall Study|Withdrawal by Subject|12|||
161913405|NCT00764790|584731979|FG002|Overall Study|Withdrawal by Subject|6|||
161913406|NCT00764790|584731977|FG000|Overall Study|Lost to Follow-up|28|||
161913407|NCT00764790|584731978|FG001|Overall Study|Lost to Follow-up|29|||
162145087|NCT01235949|585578750|FG006|Primary Phase|Lost to Follow-up|0|||
162145088|NCT01235949|585578751|FG007|Primary Phase|Lost to Follow-up|0|||
162145089|NCT01235949|585578752|FG008|Primary Phase|Lost to Follow-up|0|||
162145090|NCT01235949|585578753|FG009|Primary Phase|Lost to Follow-up|0|||
162145091|NCT01235949|585578754|FG010|Primary Phase|Lost to Follow-up|0|||
162145092|NCT01235949|585578755|FG011|Primary Phase|Lost to Follow-up|0|||
162145093|NCT01235949|585578756|FG012|Primary Phase|Lost to Follow-up|0|||
162145094|NCT01235949|585578757|FG013|Primary Phase|Lost to Follow-up|0|||
162145095|NCT01235949|585578758|FG014|Primary Phase|Lost to Follow-up|0|||
162145096|NCT01235949|585578759|FG015|Primary Phase|Lost to Follow-up|0|||
162145097|NCT01235949|585578760|FG016|Primary Phase|Lost to Follow-up|0|||
162145098|NCT01235949|585578761|FG017|Primary Phase|Lost to Follow-up|0|||
162145099|NCT01235949|585578744|FG000|Booster Phase|Migrated/moved from study area|0|||
162145100|NCT01235949|585578745|FG001|Booster Phase|Migrated/moved from study area|0|||
162145101|NCT01235949|585578746|FG002|Booster Phase|Migrated/moved from study area|0|||
162145102|NCT01235949|585578747|FG003|Booster Phase|Migrated/moved from study area|0|||
162145103|NCT01235949|585578748|FG004|Booster Phase|Migrated/moved from study area|0|||
162145104|NCT01235949|585578749|FG005|Booster Phase|Migrated/moved from study area|0|||
162145105|NCT01235949|585578750|FG006|Booster Phase|Migrated/moved from study area|0|||
162145106|NCT01235949|585578751|FG007|Booster Phase|Migrated/moved from study area|0|||
162145107|NCT01235949|585578752|FG008|Booster Phase|Migrated/moved from study area|0|||
162145108|NCT01235949|585578753|FG009|Booster Phase|Migrated/moved from study area|0|||
162145109|NCT01235949|585578754|FG010|Booster Phase|Migrated/moved from study area|0|||
162145110|NCT01235949|585578755|FG011|Booster Phase|Migrated/moved from study area|1|||
162145111|NCT01235949|585578756|FG012|Booster Phase|Migrated/moved from study area|1|||
162145112|NCT01235949|585578757|FG013|Booster Phase|Migrated/moved from study area|0|||
162145113|NCT01235949|585578758|FG014|Booster Phase|Migrated/moved from study area|0|||
162145114|NCT01235949|585578759|FG015|Booster Phase|Migrated/moved from study area|0|||
162145115|NCT01235949|585578760|FG016|Booster Phase|Migrated/moved from study area|0|||
162145116|NCT01235949|585578761|FG017|Booster Phase|Migrated/moved from study area|1|||
162145117|NCT01235949|585578744|FG000|Booster Phase|Adverse Event|0|||
162145118|NCT01235949|585578745|FG001|Booster Phase|Adverse Event|0|||
162145119|NCT01235949|585578746|FG002|Booster Phase|Adverse Event|0|||
162145120|NCT01235949|585578747|FG003|Booster Phase|Adverse Event|0|||
162145121|NCT01235949|585578748|FG004|Booster Phase|Adverse Event|0|||
162145122|NCT01235949|585578749|FG005|Booster Phase|Adverse Event|0|||
162145123|NCT01235949|585578750|FG006|Booster Phase|Adverse Event|0|||
162145124|NCT01235949|585578751|FG007|Booster Phase|Adverse Event|0|||
162145125|NCT01235949|585578752|FG008|Booster Phase|Adverse Event|0|||
162145126|NCT01235949|585578753|FG009|Booster Phase|Adverse Event|0|||
162145127|NCT01235949|585578754|FG010|Booster Phase|Adverse Event|0|||
162145128|NCT01235949|585578755|FG011|Booster Phase|Adverse Event|0|||
162145129|NCT01235949|585578756|FG012|Booster Phase|Adverse Event|0|||
162145130|NCT01235949|585578757|FG013|Booster Phase|Adverse Event|0|||
162145131|NCT01235949|585578758|FG014|Booster Phase|Adverse Event|0|||
162145132|NCT01235949|585578759|FG015|Booster Phase|Adverse Event|1|||
162145133|NCT01235949|585578760|FG016|Booster Phase|Adverse Event|0|||
162145134|NCT01235949|585578761|FG017|Booster Phase|Adverse Event|0|||
162145135|NCT01235949|585578744|FG000|Booster Phase|Withdrawal by Subject|0|||
162145136|NCT01235949|585578745|FG001|Booster Phase|Withdrawal by Subject|0|||
162145137|NCT01235949|585578746|FG002|Booster Phase|Withdrawal by Subject|0|||
162145138|NCT01235949|585578747|FG003|Booster Phase|Withdrawal by Subject|0|||
162145139|NCT01235949|585578748|FG004|Booster Phase|Withdrawal by Subject|0|||
162145140|NCT01235949|585578749|FG005|Booster Phase|Withdrawal by Subject|0|||
162145141|NCT01235949|585578750|FG006|Booster Phase|Withdrawal by Subject|0|||
162145142|NCT01235949|585578751|FG007|Booster Phase|Withdrawal by Subject|1|||
162145143|NCT01235949|585578752|FG008|Booster Phase|Withdrawal by Subject|1|||
162145144|NCT01235949|585578753|FG009|Booster Phase|Withdrawal by Subject|0|||
162145145|NCT01235949|585578754|FG010|Booster Phase|Withdrawal by Subject|1|||
162145146|NCT01235949|585578755|FG011|Booster Phase|Withdrawal by Subject|1|||
162145147|NCT01235949|585578756|FG012|Booster Phase|Withdrawal by Subject|2|||
162145148|NCT01235949|585578757|FG013|Booster Phase|Withdrawal by Subject|0|||
162145149|NCT01235949|585578758|FG014|Booster Phase|Withdrawal by Subject|2|||
162145150|NCT01235949|585578759|FG015|Booster Phase|Withdrawal by Subject|0|||
162145151|NCT01235949|585578760|FG016|Booster Phase|Withdrawal by Subject|0|||
162145152|NCT01235949|585578761|FG017|Booster Phase|Withdrawal by Subject|0|||
162145153|NCT01235949|585578744|FG000|Booster Phase|Lost to Follow-up|0|||
161913408|NCT00764790|584731979|FG002|Overall Study|Lost to Follow-up|23|||
162145154|NCT01235949|585578745|FG001|Booster Phase|Lost to Follow-up|0|||
162145155|NCT01235949|585578746|FG002|Booster Phase|Lost to Follow-up|0|||
162145156|NCT01235949|585578747|FG003|Booster Phase|Lost to Follow-up|0|||
162145157|NCT01235949|585578748|FG004|Booster Phase|Lost to Follow-up|0|||
161809346|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809347|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809348|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809349|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809350|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809351|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809352|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809353|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161809354|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
161809355|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
161809356|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
161809357|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
161809358|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809359|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809360|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809361|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809362|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809363|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809364|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809365|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809366|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809367|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809368|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809369|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809370|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809371|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809372|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809373|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809374|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
161809375|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809376|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161809377|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
161809378|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
161809379|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809380|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809381|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809382|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809383|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809384|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809385|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809386|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809387|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809388|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809389|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809390|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809391|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809392|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809393|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809394|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809395|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809396|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161809397|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
161809398|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
161809399|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
162145158|NCT01235949|585578749|FG005|Booster Phase|Lost to Follow-up|0|||
162145159|NCT01235949|585578750|FG006|Booster Phase|Lost to Follow-up|0|||
162145160|NCT01235949|585578751|FG007|Booster Phase|Lost to Follow-up|0|||
162145161|NCT01235949|585578752|FG008|Booster Phase|Lost to Follow-up|1|||
162145162|NCT01235949|585578753|FG009|Booster Phase|Lost to Follow-up|1|||
162145163|NCT01235949|585578754|FG010|Booster Phase|Lost to Follow-up|1|||
162145164|NCT01235949|585578755|FG011|Booster Phase|Lost to Follow-up|1|||
162145165|NCT01235949|585578756|FG012|Booster Phase|Lost to Follow-up|0|||
162145166|NCT01235949|585578757|FG013|Booster Phase|Lost to Follow-up|0|||
162145167|NCT01235949|585578758|FG014|Booster Phase|Lost to Follow-up|0|||
162145168|NCT01235949|585578759|FG015|Booster Phase|Lost to Follow-up|0|||
162145169|NCT01235949|585578760|FG016|Booster Phase|Lost to Follow-up|0|||
161913409|NCT04935879|584731980|FG000|Overall Study|Adverse Event|2|||
161913410|NCT04935879|584731981|FG001|Overall Study|Adverse Event|1|||
161913411|NCT04935879|584731980|FG000|Overall Study|Lost to Follow-up|1|||
161913412|NCT04935879|584731981|FG001|Overall Study|Lost to Follow-up|1|||
161913413|NCT04935879|584731980|FG000|Overall Study|Pregnancy|2|||
161913414|NCT04935879|584731981|FG001|Overall Study|Pregnancy|3|||
161913415|NCT04935879|584731980|FG000|Overall Study|Withdrawal by Subject|8|||
161913416|NCT04935879|584731981|FG001|Overall Study|Withdrawal by Subject|6|||
161913417|NCT04935879|584731980|FG000|Overall Study|Other|3|||
161913418|NCT04935879|584731981|FG001|Overall Study|Other|3|||
161913419|NCT03054428|584731982|FG000|Overall Study|Physician Decision|0|||
161913420|NCT03054428|584731983|FG001|Overall Study|Physician Decision|1|||
162011465|NCT01352793|585097856|FG001|Overall Study|Physician Decision|0|||
162011466|NCT01352793|585097855|FG000|Overall Study|Pregnancy|26|||
162011467|NCT01352793|585097856|FG001|Overall Study|Pregnancy|8|||
162011468|NCT01352793|585097855|FG000|Overall Study|Other|25|||
162011469|NCT01352793|585097856|FG001|Overall Study|Other|7|||
161913421|NCT03054428|584731984|FG002|Overall Study|Physician Decision|1|||
161913422|NCT03054428|584731982|FG000|Overall Study|Lack of Efficacy|3|||
161913423|NCT03054428|584731983|FG001|Overall Study|Lack of Efficacy|1|||
161913424|NCT03054428|584731984|FG002|Overall Study|Lack of Efficacy|0|||
161913425|NCT03054428|584731982|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
161913426|NCT03054428|584731983|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
161913427|NCT03054428|584731984|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
161913428|NCT03054428|584731982|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
161913429|NCT03054428|584731983|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
161913430|NCT03054428|584731984|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
161913431|NCT03054428|584731982|FG000|Overall Study|Transitioned to OLE study|76|||
161913432|NCT03054428|584731983|FG001|Overall Study|Transitioned to OLE study|76|||
161913433|NCT03054428|584731984|FG002|Overall Study|Transitioned to OLE study|73|||
161913434|NCT03054428|584731982|FG000|Overall Study|Withdrawal by Subject|3|||
161913435|NCT03054428|584731983|FG001|Overall Study|Withdrawal by Subject|2|||
161913436|NCT03054428|584731984|FG002|Overall Study|Withdrawal by Subject|3|||
161913437|NCT03054428|584731982|FG000|Overall Study|Lost to Follow-up|0|||
161913438|NCT03054428|584731983|FG001|Overall Study|Lost to Follow-up|0|||
161913439|NCT03054428|584731984|FG002|Overall Study|Lost to Follow-up|1|||
161913440|NCT01652690|584731985|FG000|Overall Study|Withdrawal by Subject|16|||
161913441|NCT01652690|584731986|FG001|Overall Study|Withdrawal by Subject|4|||
161913442|NCT01652690|584731985|FG000|Overall Study|Other|8|||
161809400|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809401|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809402|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809403|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809404|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809405|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809406|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809407|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809408|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809409|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809410|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809411|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809412|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809413|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809414|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809415|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809416|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
161809417|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809418|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161809419|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
161809420|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
161913443|NCT01652690|584731986|FG001|Overall Study|Other|9|||
162145170|NCT01235949|585578761|FG017|Booster Phase|Lost to Follow-up|1|||
161913444|NCT01652690|584731985|FG000|Overall Study|Lost to Follow-up|6|||
161913445|NCT01652690|584731986|FG001|Overall Study|Lost to Follow-up|6|||
161913446|NCT01652690|584731985|FG000|Overall Study|Death|5|||
161913447|NCT01652690|584731986|FG001|Overall Study|Death|2|||
161913448|NCT03225287|584731989|FG000|Overall Study|Adverse Event|0|||
162011470|NCT01352793|585097855|FG000|Overall Study|Medication error|2|||
162011471|NCT01352793|585097856|FG001|Overall Study|Medication error|2|||
162011472|NCT01352793|585097855|FG000|Overall Study|Death|1|||
161809421|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809422|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809423|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809424|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809425|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809426|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809427|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809428|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809429|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809430|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809431|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809432|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809433|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809434|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809435|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809436|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809437|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
161809438|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809439|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161809440|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
161809441|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
161809442|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809443|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809444|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809445|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809446|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809447|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809448|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809449|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809450|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809451|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809452|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809453|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809454|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809455|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809456|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809457|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809458|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
161809459|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809460|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809461|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
161809462|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161809463|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809464|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809465|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809466|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809467|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809468|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809469|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809470|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809471|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809472|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809473|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809474|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809475|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809476|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809477|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809478|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809479|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
162011473|NCT01352793|585097856|FG001|Overall Study|Death|0|||
161809480|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809481|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809482|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
161809483|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161809484|NCT01597245|584344311|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809485|NCT01597245|584344312|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809486|NCT01597245|584344313|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809487|NCT01597245|584344314|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809488|NCT01597245|584344315|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809489|NCT01597245|584344316|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809490|NCT01597245|584344317|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809491|NCT01597245|584344318|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809492|NCT01597245|584344319|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809493|NCT01597245|584344320|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809494|NCT01597245|584344321|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809495|NCT01597245|584344322|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809496|NCT01597245|584344323|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809497|NCT01597245|584344324|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809498|NCT01597245|584344325|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809499|NCT01597245|584344326|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809500|NCT01597245|584344327|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809501|NCT01597245|584344328|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809502|NCT01597245|584344329|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809503|NCT01597245|584344330|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
161809504|NCT01597245|584344331|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161809505|NCT00731783|584344332|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
161809506|NCT00731783|584344333|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
161809507|NCT00731783|584344332|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
161809508|NCT00731783|584344333|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
161809509|NCT00731783|584344332|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
161809510|NCT00731783|584344333|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
161809511|NCT00731783|584344332|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
161809512|NCT00731783|584344333|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
161809513|NCT04115293|584345684|FG000|Overall Study|Adverse Event|0|||
161809514|NCT04115293|584345685|FG001|Overall Study|Adverse Event|2|||
161809515|NCT04115293|584345684|FG000|Overall Study|Withdrawal by Subject|2|||
161809516|NCT04115293|584345685|FG001|Overall Study|Withdrawal by Subject|1|||
161809517|NCT04115293|584345684|FG000|Overall Study|Physician Decision|1|||
161809518|NCT04115293|584345685|FG001|Overall Study|Physician Decision|0|||
161809519|NCT04115293|584345684|FG000|Overall Study|Death|1|||
161809520|NCT04115293|584345685|FG001|Overall Study|Death|1|||
161809521|NCT02674152|584345686|FG000|Overall Study|Personal Reasons|1|||
161809522|NCT02674152|584345687|FG001|Overall Study|Personal Reasons|0|||
161809523|NCT02674152|584345688|FG002|Overall Study|Personal Reasons|0|||
161809524|NCT02674152|584345689|FG003|Overall Study|Personal Reasons|1|||
161809525|NCT02674152|584345690|FG004|Overall Study|Personal Reasons|1|||
161809526|NCT02674152|584345686|FG000|Overall Study|Other adverse event or clinical progression|0|||
161913449|NCT03225287|584731990|FG001|Overall Study|Adverse Event|0|||
161913450|NCT03225287|584731991|FG002|Overall Study|Adverse Event|1|||
161913451|NCT03225287|584731989|FG000|Overall Study|Protocol non-compliance|0|||
162145171|NCT00754936|585578762|FG000|Overall Study|Lost to Follow-up|3|||
162145172|NCT00754936|585578762|FG000|Overall Study|Physician Decision|1|||
162145173|NCT00754936|585578762|FG000|Overall Study|Withdrawal by Subject|2|||
162145174|NCT00754936|585578762|FG000|Overall Study|Side Effects|3|||
162145175|NCT00754936|585578762|FG000|Overall Study|Inter-current medical events|3|||
162145176|NCT00619645|585578763|FG000|Overall Study|Adverse Event|1|||
162145177|NCT00436644|585578764|FG000|Overall Study|Adverse Event|2|||
162145178|NCT00436644|585578764|FG000|Overall Study|Death|1|||
162145179|NCT04364269|585578769|FG000|Overall Study|Adverse Event|1|||
162145180|NCT04364269|585578770|FG001|Overall Study|Adverse Event|0|||
162145181|NCT04364269|585578771|FG002|Overall Study|Adverse Event|0|||
162145182|NCT04364269|585578769|FG000|Overall Study|Withdrawal by Subject|0|||
162145183|NCT04364269|585578770|FG001|Overall Study|Withdrawal by Subject|1|||
162145184|NCT04364269|585578771|FG002|Overall Study|Withdrawal by Subject|0|||
162145185|NCT01490580|585578772|FG000|Overall Study|Parents withdrew consent|0|||
162145186|NCT01490580|585578773|FG001|Overall Study|Parents withdrew consent|2|||
162145187|NCT02026258|585578774|FG000|Randomized|Did not start treatment|2|||
162145188|NCT02026258|585578775|FG001|Randomized|Did not start treatment|1|||
162145189|NCT02026258|585578774|FG000|Randomized|Change in treatment plan|1|||
162145190|NCT02026258|585578775|FG001|Randomized|Change in treatment plan|0|||
162145191|NCT02026258|585578774|FG000|Randomized|Presence of periodontal disease|1|||
162145192|NCT02026258|585578775|FG001|Randomized|Presence of periodontal disease|1|||
162145193|NCT02026258|585578774|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
162145194|NCT02026258|585578775|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
162145195|NCT02026258|585578774|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
162145196|NCT02026258|585578775|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
162145197|NCT02534350|585578778|FG000|Overall Study|Randomized But Not Treated|1|||
162145198|NCT02534350|585578779|FG001|Overall Study|Randomized But Not Treated|0|||
162145199|NCT02534350|585578778|FG000|Overall Study|Protocol Violation|1|||
162145200|NCT02534350|585578779|FG001|Overall Study|Protocol Violation|0|||
162145201|NCT02534350|585578778|FG000|Overall Study|Withdrew Consent|2|||
162145202|NCT02534350|585578779|FG001|Overall Study|Withdrew Consent|0|||
162145203|NCT00716144|585578780|FG000|Overall Study|Withdrawal by Subject|4|||
162145204|NCT00716144|585578781|FG001|Overall Study|Withdrawal by Subject|2|||
162145205|NCT00716144|585578782|FG002|Overall Study|Withdrawal by Subject|6|||
162145206|NCT00716144|585578783|FG003|Overall Study|Withdrawal by Subject|6|||
162145207|NCT00716144|585578780|FG000|Overall Study|Lost to Follow-up|2|||
162145208|NCT00716144|585578781|FG001|Overall Study|Lost to Follow-up|2|||
162145209|NCT00716144|585578782|FG002|Overall Study|Lost to Follow-up|1|||
162145210|NCT00716144|585578783|FG003|Overall Study|Lost to Follow-up|2|||
162145211|NCT00716144|585578780|FG000|Overall Study|Adverse Event|0|||
162145212|NCT00716144|585578781|FG001|Overall Study|Adverse Event|0|||
162145213|NCT00716144|585578782|FG002|Overall Study|Adverse Event|0|||
162145214|NCT00716144|585578783|FG003|Overall Study|Adverse Event|2|||
162145215|NCT00716144|585578780|FG000|Overall Study|Non-compliance|1|||
162145216|NCT00716144|585578781|FG001|Overall Study|Non-compliance|0|||
162145217|NCT00716144|585578782|FG002|Overall Study|Non-compliance|0|||
162145218|NCT00716144|585578783|FG003|Overall Study|Non-compliance|0|||
162145219|NCT00716144|585578780|FG000|Overall Study|Protocol Violation|2|||
162145220|NCT00716144|585578781|FG001|Overall Study|Protocol Violation|0|||
162145221|NCT00716144|585578782|FG002|Overall Study|Protocol Violation|1|||
161809527|NCT02674152|584345687|FG001|Overall Study|Other adverse event or clinical progression|1|||
161809528|NCT02674152|584345688|FG002|Overall Study|Other adverse event or clinical progression|0|||
161809529|NCT02674152|584345689|FG003|Overall Study|Other adverse event or clinical progression|3|||
161809530|NCT02674152|584345690|FG004|Overall Study|Other adverse event or clinical progression|0|||
161809531|NCT02674152|584345686|FG000|Overall Study|Dose-limiting toxicity|0|||
161809532|NCT02674152|584345687|FG001|Overall Study|Dose-limiting toxicity|0|||
162145222|NCT00716144|585578783|FG003|Overall Study|Protocol Violation|0|||
162145223|NCT00716144|585578780|FG000|Overall Study|Physician Decision|0|||
162145224|NCT00716144|585578781|FG001|Overall Study|Physician Decision|1|||
162145225|NCT00716144|585578782|FG002|Overall Study|Physician Decision|2|||
162145226|NCT00716144|585578783|FG003|Overall Study|Physician Decision|2|||
162145227|NCT00716144|585578780|FG000|Overall Study|Intercurrent illness|0|||
162145228|NCT00716144|585578781|FG001|Overall Study|Intercurrent illness|0|||
162145229|NCT00716144|585578782|FG002|Overall Study|Intercurrent illness|1|||
161809533|NCT02674152|584345688|FG002|Overall Study|Dose-limiting toxicity|0|||
162145230|NCT00716144|585578783|FG003|Overall Study|Intercurrent illness|0|||
162145231|NCT00716144|585578780|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
162145232|NCT00716144|585578781|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
162145233|NCT00716144|585578782|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
162145234|NCT00716144|585578783|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
162145235|NCT00716144|585578780|FG000|Overall Study|Adverse event: left foot pain|0|||
162145236|NCT00716144|585578781|FG001|Overall Study|Adverse event: left foot pain|1|||
162145237|NCT00716144|585578782|FG002|Overall Study|Adverse event: left foot pain|0|||
162145238|NCT00716144|585578783|FG003|Overall Study|Adverse event: left foot pain|0|||
162145239|NCT00716144|585578780|FG000|Overall Study|Clinical Depression|0|||
162145240|NCT00716144|585578781|FG001|Overall Study|Clinical Depression|1|||
162145241|NCT00716144|585578782|FG002|Overall Study|Clinical Depression|0|||
162145242|NCT00716144|585578783|FG003|Overall Study|Clinical Depression|0|||
162145243|NCT00880048|585578784|FG000|Overall Study|Adverse Event|2|||
162145244|NCT00880048|585578785|FG001|Overall Study|Adverse Event|3|||
162145245|NCT00880048|585578786|FG002|Overall Study|Adverse Event|5|||
162145246|NCT00880048|585578784|FG000|Overall Study|Lack of Efficacy|1|||
162145247|NCT00880048|585578785|FG001|Overall Study|Lack of Efficacy|2|||
162145248|NCT00880048|585578786|FG002|Overall Study|Lack of Efficacy|2|||
162145249|NCT00880048|585578784|FG000|Overall Study|Protocol Violation|4|||
162145250|NCT00880048|585578785|FG001|Overall Study|Protocol Violation|6|||
162145251|NCT00880048|585578786|FG002|Overall Study|Protocol Violation|5|||
162145252|NCT00880048|585578784|FG000|Overall Study|Lost to Follow-up|6|||
162145253|NCT00880048|585578785|FG001|Overall Study|Lost to Follow-up|6|||
162145254|NCT00880048|585578786|FG002|Overall Study|Lost to Follow-up|5|||
162145255|NCT00880048|585578784|FG000|Overall Study|Physician Decision|1|||
162145256|NCT00880048|585578785|FG001|Overall Study|Physician Decision|1|||
162145257|NCT00880048|585578786|FG002|Overall Study|Physician Decision|7|||
162145258|NCT00880048|585578784|FG000|Overall Study|Withdrawal by Subject|5|||
162145259|NCT00880048|585578785|FG001|Overall Study|Withdrawal by Subject|8|||
162145260|NCT00880048|585578786|FG002|Overall Study|Withdrawal by Subject|5|||
162145261|NCT00880048|585578784|FG000|Overall Study|Study closed/terminated|9|||
162145262|NCT00880048|585578785|FG001|Overall Study|Study closed/terminated|7|||
162145263|NCT00880048|585578786|FG002|Overall Study|Study closed/terminated|6|||
162145264|NCT01104415|585578792|FG000|Core Phase|Consent withdrawn by subjects|1|||
162145265|NCT01104415|585578793|FG001|Core Phase|Consent withdrawn by subjects|0|||
162145266|NCT01104415|585578792|FG000|Extension Period|Progressive disease|0|||
162145267|NCT01104415|585578793|FG001|Extension Period|Progressive disease|4|||
162145268|NCT01104415|585578792|FG000|Extension Period|Death|0|||
162145269|NCT01104415|585578793|FG001|Extension Period|Death|1|||
162145270|NCT01104415|585578792|FG000|Extension Period|Physician Decision|0|||
162145271|NCT01104415|585578793|FG001|Extension Period|Physician Decision|1|||
162145272|NCT01104415|585578792|FG000|Extension Period|Transition to Study LX1606.302|0|||
162145273|NCT01104415|585578793|FG001|Extension Period|Transition to Study LX1606.302|4|||
162145274|NCT01104415|585578792|FG000|Extension Period|Heart surgery/feeling miserable|0|||
162145275|NCT01104415|585578793|FG001|Extension Period|Heart surgery/feeling miserable|1|||
162145276|NCT02914522|585578798|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
162145277|NCT02914522|585578799|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
162145278|NCT02914522|585578800|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
162145279|NCT02914522|585578801|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
162145280|NCT02914522|585578802|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
162145281|NCT02914522|585578803|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
162145282|NCT02914522|585578804|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
162145283|NCT02914522|585578805|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
162145284|NCT02914522|585578806|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
162145285|NCT02914522|585578807|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
162145286|NCT02914522|585578808|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
162145287|NCT02914522|585578798|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
162145288|NCT02914522|585578799|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
162145289|NCT02914522|585578800|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
162145290|NCT02914522|585578801|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
162145291|NCT02914522|585578802|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
162145292|NCT02914522|585578803|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
162145293|NCT02914522|585578804|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
162145294|NCT02914522|585578805|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
162145295|NCT02914522|585578806|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
162145296|NCT02914522|585578807|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
162145297|NCT02914522|585578808|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
162145298|NCT02914522|585578798|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
162145299|NCT02914522|585578799|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
162145300|NCT02914522|585578800|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
162145301|NCT02914522|585578801|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
162145302|NCT02914522|585578802|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
162145303|NCT02914522|585578803|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
162145304|NCT02914522|585578804|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
162145305|NCT02914522|585578805|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
162145306|NCT02914522|585578806|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
162145307|NCT02914522|585578807|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
162145308|NCT02914522|585578808|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
162145309|NCT02914522|585578798|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162145310|NCT02914522|585578799|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
162145311|NCT02914522|585578800|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
162145312|NCT02914522|585578801|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
162145313|NCT02914522|585578802|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162145314|NCT02914522|585578803|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162145315|NCT02914522|585578804|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162145316|NCT02914522|585578805|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162145317|NCT02914522|585578806|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162145318|NCT02914522|585578807|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162145319|NCT02914522|585578808|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
162145320|NCT02914522|585578798|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162145321|NCT02914522|585578799|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162145322|NCT02914522|585578800|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162145323|NCT02914522|585578801|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162145324|NCT02914522|585578802|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
162145325|NCT02914522|585578803|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162145326|NCT02914522|585578804|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162145327|NCT02914522|585578805|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162145328|NCT02914522|585578806|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162145329|NCT02914522|585578807|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162145330|NCT02914522|585578808|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
162145331|NCT02914522|585578798|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
162145332|NCT02914522|585578799|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162145333|NCT02914522|585578800|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162145334|NCT02914522|585578801|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162145335|NCT02914522|585578802|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162145336|NCT02914522|585578803|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162145337|NCT02914522|585578804|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162145338|NCT02914522|585578805|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162145339|NCT02914522|585578806|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162145340|NCT02914522|585578807|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162145341|NCT02914522|585578808|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
162145342|NCT02914522|585578798|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
162145343|NCT02914522|585578799|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
162145344|NCT02914522|585578800|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
162145345|NCT02914522|585578801|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
162145346|NCT02914522|585578802|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
162145347|NCT02914522|585578803|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
162145348|NCT02914522|585578804|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
162145349|NCT02914522|585578805|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
162145350|NCT02914522|585578806|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
162145351|NCT02914522|585578807|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
162145352|NCT02914522|585578808|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
162145353|NCT02914522|585578798|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
162145354|NCT02914522|585578799|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
162145355|NCT02914522|585578800|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
161913452|NCT03225287|584731990|FG001|Overall Study|Protocol non-compliance|0|||
161913453|NCT03225287|584731991|FG002|Overall Study|Protocol non-compliance|1|||
161913454|NCT03225287|584731989|FG000|Overall Study|Subject withdraws consent|3|||
161913455|NCT03225287|584731990|FG001|Overall Study|Subject withdraws consent|0|||
161913456|NCT03225287|584731991|FG002|Overall Study|Subject withdraws consent|0|||
161913457|NCT03225287|584731989|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
161913458|NCT03225287|584731990|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
161913459|NCT03225287|584731991|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
161913460|NCT03225287|584731989|FG000|Overall Study|Trial drug not effective|0|||
161913461|NCT03225287|584731990|FG001|Overall Study|Trial drug not effective|1|||
161913462|NCT03225287|584731991|FG002|Overall Study|Trial drug not effective|0|||
161913463|NCT03225287|584731989|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
162145356|NCT02914522|585578801|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
162145357|NCT02914522|585578802|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
162145358|NCT02914522|585578803|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
162145359|NCT02914522|585578804|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
162145360|NCT02914522|585578805|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
162145361|NCT02914522|585578806|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
162145362|NCT02914522|585578807|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
162145363|NCT02914522|585578808|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
162145364|NCT02914522|585578798|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162145365|NCT02914522|585578799|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162145366|NCT02914522|585578800|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162145367|NCT02914522|585578801|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162145368|NCT02914522|585578802|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162145369|NCT02914522|585578803|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
162145370|NCT02914522|585578804|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
162145371|NCT02914522|585578805|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
162145372|NCT02914522|585578806|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
162145373|NCT02914522|585578807|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
162145374|NCT02914522|585578808|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
162145375|NCT02914522|585578798|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
162145376|NCT02914522|585578799|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
162145377|NCT02914522|585578800|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
162145378|NCT02914522|585578801|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
162145379|NCT02914522|585578802|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
162145380|NCT02914522|585578803|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
162145381|NCT02914522|585578804|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
162145382|NCT02914522|585578805|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
162145383|NCT02914522|585578806|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
162145384|NCT02914522|585578807|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
162145385|NCT02914522|585578808|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
162145386|NCT02914522|585578798|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
162145387|NCT02914522|585578799|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
162145388|NCT02914522|585578800|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
162145389|NCT02914522|585578801|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
162145390|NCT02914522|585578802|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
162145391|NCT02914522|585578803|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
162145392|NCT02914522|585578804|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
162145393|NCT02914522|585578805|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
162145394|NCT02914522|585578806|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
162145395|NCT02914522|585578807|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
162145396|NCT02914522|585578808|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
162145397|NCT02914522|585578798|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
162145398|NCT02914522|585578799|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
162145399|NCT02914522|585578800|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
162145400|NCT02914522|585578801|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
162145401|NCT02914522|585578802|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
162145402|NCT02914522|585578803|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
162145403|NCT02914522|585578804|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
162145404|NCT02914522|585578805|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
161809534|NCT02674152|584345689|FG003|Overall Study|Dose-limiting toxicity|0|||
161809535|NCT02674152|584345690|FG004|Overall Study|Dose-limiting toxicity|1|||
161809536|NCT02674152|584345686|FG000|Overall Study|Progressive Disease|2|||
161809537|NCT02674152|584345687|FG001|Overall Study|Progressive Disease|1|||
161809538|NCT02674152|584345688|FG002|Overall Study|Progressive Disease|1|||
161809539|NCT02674152|584345689|FG003|Overall Study|Progressive Disease|13|||
161809540|NCT02674152|584345690|FG004|Overall Study|Progressive Disease|2|||
161809541|NCT02674152|584345686|FG000|Overall Study|Adverse Event|0|||
161809542|NCT02674152|584345687|FG001|Overall Study|Adverse Event|0|||
161809543|NCT02674152|584345688|FG002|Overall Study|Adverse Event|1|||
161809544|NCT02674152|584345689|FG003|Overall Study|Adverse Event|0|||
161809545|NCT02674152|584345690|FG004|Overall Study|Adverse Event|1|||
161809546|NCT02571907|584345691|FG000|Overall Study|Death|4|||
161809547|NCT02571907|584345691|FG000|Overall Study|Lost to Follow-up|3|||
161809548|NCT02571907|584345691|FG000|Overall Study|Withdrawal by Subject|3|||
161809549|NCT03772522|584345692|FG000|Pre-intervention|Withdrawal by Subject|3|||
161809550|NCT03772522|584345693|FG001|Pre-intervention|Withdrawal by Subject|4|||
162145405|NCT02914522|585578806|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
162145406|NCT02914522|585578807|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
162145407|NCT02914522|585578808|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
162145408|NCT02914522|585578798|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
162145409|NCT02914522|585578799|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
162145410|NCT02914522|585578800|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
162145411|NCT02914522|585578801|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
162145412|NCT02914522|585578802|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
162145413|NCT02914522|585578803|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
162145414|NCT02914522|585578804|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
162145415|NCT02914522|585578805|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
162145416|NCT02914522|585578806|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
162145417|NCT02914522|585578807|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
162145418|NCT02914522|585578808|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
162145419|NCT02914522|585578798|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162145420|NCT02914522|585578799|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162145421|NCT02914522|585578800|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162145422|NCT02914522|585578801|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162145423|NCT02914522|585578802|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162145424|NCT02914522|585578803|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162145425|NCT02914522|585578804|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162145426|NCT02914522|585578805|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
162145427|NCT02914522|585578806|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
162145428|NCT02914522|585578807|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162145429|NCT02914522|585578808|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
162145430|NCT02914522|585578798|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162145431|NCT02914522|585578799|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162145432|NCT02914522|585578800|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162145433|NCT02914522|585578801|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162145434|NCT02914522|585578802|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162145435|NCT02914522|585578803|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162145436|NCT02914522|585578804|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162145437|NCT02914522|585578805|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162145438|NCT02914522|585578806|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
162145439|NCT02914522|585578807|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
162145440|NCT02914522|585578808|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
162145441|NCT02914522|585578798|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162145442|NCT02914522|585578799|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162145443|NCT02914522|585578800|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162145444|NCT02914522|585578801|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162145445|NCT02914522|585578802|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162145446|NCT02914522|585578803|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162145447|NCT02914522|585578804|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162145448|NCT02914522|585578805|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162145449|NCT02914522|585578806|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162145450|NCT02914522|585578807|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
162145451|NCT02914522|585578808|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
162145452|NCT00639002|585578809|FG000|Overall Study|Death|1|||
162145453|NCT00639002|585578809|FG000|Overall Study|Adverse Event|1|||
162145454|NCT00639002|585578809|FG000|Overall Study|Protocol Violation|1|||
162145455|NCT00639002|585578809|FG000|Overall Study|Disease progression|3|||
162145456|NCT00639002|585578809|FG000|Overall Study|Physician Decision|6|||
162145457|NCT00639002|585578809|FG000|Overall Study|Lack of Efficacy|1|||
162145458|NCT00597519|585578813|FG000|Overall Study|Death|1|||
162145459|NCT03098030|585578814|FG000|Overall Study|Death|10|||
162145460|NCT03098030|585578815|FG001|Overall Study|Death|156|||
162145461|NCT03098030|585578816|FG002|Overall Study|Death|156|||
162145462|NCT03098030|585578817|FG003|Overall Study|Death|82|||
162145463|NCT03098030|585578814|FG000|Overall Study|Withdrawal by Subject|0|||
162145464|NCT03098030|585578815|FG001|Overall Study|Withdrawal by Subject|7|||
162145465|NCT03098030|585578816|FG002|Overall Study|Withdrawal by Subject|8|||
162145466|NCT03098030|585578817|FG003|Overall Study|Withdrawal by Subject|2|||
162145467|NCT03098030|585578814|FG000|Overall Study|Lost to Follow-up|0|||
162145468|NCT03098030|585578815|FG001|Overall Study|Lost to Follow-up|0|||
162145469|NCT03098030|585578816|FG002|Overall Study|Lost to Follow-up|2|||
162145470|NCT03098030|585578817|FG003|Overall Study|Lost to Follow-up|1|||
161913464|NCT03225287|584731990|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
161913465|NCT03225287|584731991|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
162145471|NCT03368001|585578818|FG000|Allocation|Lost to Pretest|16|||
162011474|NCT01352793|585097855|FG000|Overall Study|Randomized but not vaccinated|8|||
162011475|NCT01352793|585097856|FG001|Overall Study|Randomized but not vaccinated|0|||
162011476|NCT01352793|585097855|FG000|Overall Study|No longer meets eligibility criteria|25|||
162011477|NCT01352793|585097856|FG001|Overall Study|No longer meets eligibility criteria|15|||
162011478|NCT04322526|585097859|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
162011479|NCT04322526|585097860|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
162011480|NCT04322526|585097859|FG000|Washout (1 Week)|Lost to Follow-up|1|||
162011481|NCT04322526|585097860|FG001|Washout (1 Week)|Lost to Follow-up|2|||
162011482|NCT03205423|585097861|FG000|Overall Study|Personal|1|||
162011483|NCT03205423|585097862|FG001|Overall Study|Personal|1|||
162011484|NCT03205423|585097861|FG000|Overall Study|Physician Decision|0|||
162011485|NCT03205423|585097862|FG001|Overall Study|Physician Decision|2|||
162011486|NCT01987453|585099852|FG000|Overall Study|Death|0|||
162011487|NCT01987453|585099853|FG001|Overall Study|Death|0|||
162011488|NCT01987453|585099854|FG002|Overall Study|Death|1|||
162011489|NCT01987453|585099852|FG000|Overall Study|Lack of Efficacy|1|||
162011490|NCT01987453|585099853|FG001|Overall Study|Lack of Efficacy|12|||
162011491|NCT01987453|585099854|FG002|Overall Study|Lack of Efficacy|0|||
162011492|NCT04040933|585099860|FG000|Overall Study|Protocol Violation|1|||
162011493|NCT04040933|585099860|FG000|Overall Study|Withdrawal by Subject|2|||
162011494|NCT02066181|585099861|FG000|Overall Study|Withdrawal by Subject|1|||
162011495|NCT02066181|585099862|FG001|Overall Study|Withdrawal by Subject|1|||
162011496|NCT00775190|585099867|FG000|Overall Study|Lost to Follow-up|2|||
162011497|NCT00775190|585099868|FG001|Overall Study|Lost to Follow-up|3|||
162011498|NCT00775190|585099867|FG000|Overall Study|Withdrawal by Subject|1|||
162011499|NCT00775190|585099868|FG001|Overall Study|Withdrawal by Subject|2|||
162011500|NCT00775190|585099867|FG000|Overall Study|Protocol Violation|1|||
162011501|NCT00775190|585099868|FG001|Overall Study|Protocol Violation|0|||
162011502|NCT02141295|585099869|FG000|Overall Study|Adverse Event|1|||
162011503|NCT02141295|585099870|FG001|Overall Study|Adverse Event|18|||
162011504|NCT02141295|585099871|FG002|Overall Study|Adverse Event|11|||
162011505|NCT02141295|585099869|FG000|Overall Study|Physician Decision|2|||
162011506|NCT02141295|585099870|FG001|Overall Study|Physician Decision|19|||
162011507|NCT02141295|585099871|FG002|Overall Study|Physician Decision|14|||
162011508|NCT02141295|585099869|FG000|Overall Study|Study terminated by sponsor|0|||
162011509|NCT02141295|585099870|FG001|Overall Study|Study terminated by sponsor|6|||
162011510|NCT02141295|585099871|FG002|Overall Study|Study terminated by sponsor|6|||
162011511|NCT02141295|585099869|FG000|Overall Study|Non-compliance|0|||
162011512|NCT02141295|585099870|FG001|Overall Study|Non-compliance|1|||
162011513|NCT02141295|585099871|FG002|Overall Study|Non-compliance|0|||
162011514|NCT02141295|585099869|FG000|Overall Study|Progressive disease|3|||
162011515|NCT02141295|585099870|FG001|Overall Study|Progressive disease|32|||
162011516|NCT02141295|585099871|FG002|Overall Study|Progressive disease|50|||
162011517|NCT02141295|585099869|FG000|Overall Study|Reason not specified|0|||
162011518|NCT02141295|585099870|FG001|Overall Study|Reason not specified|9|||
162011519|NCT02141295|585099871|FG002|Overall Study|Reason not specified|10|||
162011520|NCT02141295|585099869|FG000|Overall Study|Withdrawal by Subject|0|||
162011521|NCT02141295|585099870|FG001|Overall Study|Withdrawal by Subject|9|||
162011522|NCT02141295|585099871|FG002|Overall Study|Withdrawal by Subject|4|||
162011523|NCT01710501|585099872|FG000|Overall Study|Lost to Follow-up|2|||
162011524|NCT01710501|585099873|FG001|Overall Study|Lost to Follow-up|0|||
162011525|NCT01710501|585099874|FG002|Overall Study|Lost to Follow-up|0|||
162011526|NCT02536976|585099875|FG000|Overall Study|Physician Decision|0|||
162011527|NCT02536976|585099876|FG001|Overall Study|Physician Decision|1|||
162011528|NCT01671319|585099879|FG000|Overall Study|Withdrawal by Subject|1|||
162011529|NCT01376804|585099880|FG000|Treatment Period|Withdrawal by Subject|1|||
162011530|NCT01376804|585099880|FG000|Treatment Period|Adverse Event|6|||
162011531|NCT01376804|585099880|FG000|Treatment Period|Patient did not receive study drug|1|||
162011532|NCT02904954|585099885|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
162011533|NCT02904954|585099886|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
162011534|NCT02904954|585099885|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
162011535|NCT02904954|585099886|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
162011536|NCT02904954|585099885|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
162011537|NCT02904954|585099886|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
162011538|NCT02904954|585099885|FG000|Adjuvant Durvalumab|Recurrence|2|||
162011539|NCT02904954|585099886|FG001|Adjuvant Durvalumab|Recurrence|0|||
162145472|NCT03368001|585578819|FG001|Allocation|Lost to Pretest|25|||
162145473|NCT03368001|585578818|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
162145474|NCT03368001|585578819|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
162011540|NCT02904954|585099885|FG000|Adjuvant Durvalumab|Adverse Event|2|||
162011541|NCT02904954|585099886|FG001|Adjuvant Durvalumab|Adverse Event|6|||
162011542|NCT02904954|585099885|FG000|Adjuvant Durvalumab|Participant wishes|12|||
162011543|NCT02904954|585099886|FG001|Adjuvant Durvalumab|Participant wishes|7|||
162011544|NCT02904954|585099885|FG000|Adjuvant Durvalumab|Physician Decision|2|||
162011545|NCT02904954|585099886|FG001|Adjuvant Durvalumab|Physician Decision|1|||
162011546|NCT02904954|585099885|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
162145475|NCT03368001|585578818|FG000|Posttest|Lost to Posttest|7|||
162145476|NCT03368001|585578819|FG001|Posttest|Lost to Posttest|11|||
162145477|NCT03368001|585578818|FG000|Posttest|Discontinued Intervention|6|||
162145478|NCT03368001|585578819|FG001|Posttest|Discontinued Intervention|19|||
162145479|NCT03368001|585578818|FG000|Follow-up|Lost to Follow-up|6|||
162145480|NCT03368001|585578819|FG001|Follow-up|Lost to Follow-up|3|||
162145481|NCT03612804|585578820|FG000|Overall Study|Death|0|||
162145482|NCT03612804|585578821|FG001|Overall Study|Death|7|||
162145483|NCT03612804|585578822|FG002|Overall Study|Death|0|||
162145484|NCT03612804|585578823|FG003|Overall Study|Death|8|||
162145485|NCT03612804|585578820|FG000|Overall Study|Medication copay coverage issues|0|||
162145486|NCT03612804|585578821|FG001|Overall Study|Medication copay coverage issues|0|||
162145487|NCT03612804|585578822|FG002|Overall Study|Medication copay coverage issues|0|||
162145488|NCT03612804|585578823|FG003|Overall Study|Medication copay coverage issues|17|||
162145489|NCT03612804|585578820|FG000|Overall Study|Not current smoker at time of screening|0|||
162145490|NCT03612804|585578821|FG001|Overall Study|Not current smoker at time of screening|1|||
162145491|NCT03612804|585578822|FG002|Overall Study|Not current smoker at time of screening|0|||
162145492|NCT03612804|585578823|FG003|Overall Study|Not current smoker at time of screening|3|||
162145493|NCT03612804|585578820|FG000|Overall Study|Non-veteran status|0|||
162145494|NCT03612804|585578821|FG001|Overall Study|Non-veteran status|1|||
162145495|NCT03612804|585578822|FG002|Overall Study|Non-veteran status|0|||
162145496|NCT03612804|585578823|FG003|Overall Study|Non-veteran status|0|||
162145497|NCT03612804|585578820|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
162145498|NCT03612804|585578821|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
162145499|NCT03612804|585578822|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
162145500|NCT03612804|585578823|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
162145501|NCT03612804|585578820|FG000|Overall Study|Provider retired from VA|0|||
162145502|NCT03612804|585578821|FG001|Overall Study|Provider retired from VA|0|||
162145503|NCT03612804|585578822|FG002|Overall Study|Provider retired from VA|2|||
162145504|NCT03612804|585578823|FG003|Overall Study|Provider retired from VA|0|||
162145505|NCT03612804|585578820|FG000|Overall Study|Withdrawal by Subject|0|||
162145506|NCT03612804|585578821|FG001|Overall Study|Withdrawal by Subject|0|||
162145507|NCT03612804|585578822|FG002|Overall Study|Withdrawal by Subject|7|||
162145508|NCT03612804|585578823|FG003|Overall Study|Withdrawal by Subject|0|||
162145509|NCT03612804|585578820|FG000|Overall Study|Provider involved with study activities|1|||
162145510|NCT03612804|585578821|FG001|Overall Study|Provider involved with study activities|0|||
162145511|NCT03612804|585578822|FG002|Overall Study|Provider involved with study activities|0|||
162145512|NCT03612804|585578823|FG003|Overall Study|Provider involved with study activities|0|||
162145513|NCT05484726|585578824|FG000|Overall Study|Protocol Violation|3|||
162145514|NCT05484726|585578825|FG001|Overall Study|Protocol Violation|3|||
162145515|NCT05484726|585578824|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
162145516|NCT05484726|585578825|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
162145517|NCT05484726|585578824|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
162145518|NCT05484726|585578825|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
162145519|NCT05484726|585578824|FG000|Overall Study|continued need of mechanical ventilation|2|||
162145520|NCT05484726|585578825|FG001|Overall Study|continued need of mechanical ventilation|3|||
162145521|NCT05484726|585578824|FG000|Overall Study|Withdrawal by Subject|2|||
162145522|NCT05484726|585578825|FG001|Overall Study|Withdrawal by Subject|3|||
162145523|NCT05484726|585578824|FG000|Overall Study|IVH (G III & IV)|2|||
162145524|NCT05484726|585578825|FG001|Overall Study|IVH (G III & IV)|1|||
162145525|NCT05484726|585578824|FG000|Overall Study|NEC (stage II & III)|2|||
162145526|NCT05484726|585578825|FG001|Overall Study|NEC (stage II & III)|3|||
162145527|NCT04550039|585578833|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
162145528|NCT04550039|585578834|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
162145529|NCT04550039|585578833|FG000|Overall Study|patient self-withdrew from study|0|||
161809551|NCT03772522|584345692|FG000|Intervention|Withdrawal by Subject|1|||
161809552|NCT03772522|584345693|FG001|Intervention|Withdrawal by Subject|0|||
161809553|NCT03772522|584345692|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
161809554|NCT03772522|584345693|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
161809555|NCT00218257|584345694|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
161809556|NCT00218257|584345695|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
161809557|NCT00579345|584345696|FG000|Overall Study|Withdrawal by Subject|2|||
161809558|NCT00579345|584345697|FG001|Overall Study|Withdrawal by Subject|0|||
161809559|NCT00579345|584345698|FG002|Overall Study|Withdrawal by Subject|0|||
161809560|NCT00579345|584345699|FG003|Overall Study|Withdrawal by Subject|0|||
161809561|NCT00579345|584345700|FG004|Overall Study|Withdrawal by Subject|0|||
161809562|NCT00579345|584345701|FG005|Overall Study|Withdrawal by Subject|0|||
161809563|NCT00579345|584345702|FG006|Overall Study|Withdrawal by Subject|0|||
161809564|NCT00579345|584345703|FG007|Overall Study|Withdrawal by Subject|1|||
161809565|NCT00579345|584345696|FG000|Overall Study|Lost to Follow-up|1|||
162145530|NCT04550039|585578834|FG001|Overall Study|patient self-withdrew from study|1|||
162145531|NCT04391309|585578835|FG000|Overall Study|Death|1|||
162145532|NCT04391309|585578836|FG001|Overall Study|Death|1|||
162011547|NCT02904954|585099886|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
162011548|NCT02904954|585099885|FG000|Adjuvant Durvalumab|Death|0|||
162011549|NCT02904954|585099886|FG001|Adjuvant Durvalumab|Death|1|||
162011550|NCT02904954|585099885|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
162011551|NCT02904954|585099886|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
162011552|NCT01281124|585099887|FG000|Overall Study|Death|1|||
162011553|NCT01198795|585099888|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
162011554|NCT01198795|585099888|FG000|Overall Study|Withdrawal by Subject|17|||
162011555|NCT01198795|585099888|FG000|Overall Study|Lost to Follow-up|15|||
162011556|NCT01198795|585099888|FG000|Overall Study|Adverse Event|9|||
162011557|NCT01198795|585099888|FG000|Overall Study|Lack of Efficacy|5|||
162011558|NCT01198795|585099888|FG000|Overall Study|Protocol Violation|2|||
162011559|NCT01198795|585099888|FG000|Overall Study|Other Reason|4|||
162011560|NCT00706238|585099889|FG000|Overall Study|Disease progression|4|||
162011561|NCT00706238|585099889|FG000|Overall Study|Other|1|||
162011562|NCT00753506|585099890|FG000|Overall Study|Withdrawal by Subject|4|||
162011563|NCT00753506|585099891|FG001|Overall Study|Withdrawal by Subject|1|||
162011564|NCT00753506|585099890|FG000|Overall Study|Lost to Follow-up|2|||
162011565|NCT00753506|585099891|FG001|Overall Study|Lost to Follow-up|0|||
162011566|NCT00753506|585099890|FG000|Overall Study|Other reason|1|||
162011567|NCT00753506|585099891|FG001|Overall Study|Other reason|1|||
162011568|NCT03819114|585099892|FG000|Overall Study|Protocol Violation|0|||
162011569|NCT03819114|585099893|FG001|Overall Study|Protocol Violation|1|||
162011570|NCT03819114|585099894|FG002|Overall Study|Protocol Violation|1|||
162011571|NCT03819114|585099895|FG003|Overall Study|Protocol Violation|0|||
162011572|NCT03819114|585099892|FG000|Overall Study|Lost to Follow-up|0|||
162011573|NCT03819114|585099893|FG001|Overall Study|Lost to Follow-up|0|||
162011574|NCT03819114|585099894|FG002|Overall Study|Lost to Follow-up|1|||
162011575|NCT03819114|585099895|FG003|Overall Study|Lost to Follow-up|0|||
162011576|NCT04226742|585099896|FG000|Overall Study|Lost to Follow-up|16|||
162011577|NCT04226742|585099897|FG001|Overall Study|Lost to Follow-up|13|||
162011578|NCT04226742|585099896|FG000|Overall Study|Withdrawal by Subject|5|||
162011579|NCT04226742|585099897|FG001|Overall Study|Withdrawal by Subject|3|||
162011580|NCT05097963|585099900|FG000|Overall Study|Protocol Violation|13|||
162011581|NCT05097963|585099900|FG000|Overall Study|Withdrawal by Subject|21|||
162011582|NCT02492763|585099901|FG000|Overall Study|Withdrawal by Subject|0|||
162011583|NCT02492763|585099902|FG001|Overall Study|Withdrawal by Subject|2|||
162011584|NCT02492763|585099903|FG002|Overall Study|Withdrawal by Subject|1|||
162011585|NCT02492763|585099904|FG003|Overall Study|Withdrawal by Subject|0|||
162011586|NCT02492763|585099901|FG000|Overall Study|Adverse Event|3|||
162011587|NCT02492763|585099902|FG001|Overall Study|Adverse Event|1|||
162011588|NCT02492763|585099903|FG002|Overall Study|Adverse Event|1|||
162011589|NCT02492763|585099904|FG003|Overall Study|Adverse Event|2|||
162011590|NCT02492763|585099901|FG000|Overall Study|Death|0|||
162011591|NCT02492763|585099902|FG001|Overall Study|Death|0|||
162011592|NCT02492763|585099903|FG002|Overall Study|Death|1|||
162011593|NCT02492763|585099904|FG003|Overall Study|Death|0|||
162011594|NCT02492763|585099901|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
162011595|NCT02492763|585099902|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
162011596|NCT02492763|585099903|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
162011597|NCT02492763|585099904|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
162011598|NCT02492763|585099901|FG000|Overall Study|Lost to Follow-up|0|||
162011599|NCT02492763|585099902|FG001|Overall Study|Lost to Follow-up|0|||
162011600|NCT02492763|585099903|FG002|Overall Study|Lost to Follow-up|1|||
162011601|NCT02492763|585099904|FG003|Overall Study|Lost to Follow-up|0|||
162011602|NCT02492763|585099901|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162011603|NCT02492763|585099902|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162011604|NCT02492763|585099903|FG002|Overall Study|Non-Compliance With Study Drug|0|||
162011605|NCT02492763|585099904|FG003|Overall Study|Non-Compliance With Study Drug|0|||
162011606|NCT02492763|585099901|FG000|Overall Study|Screen Failure|0|||
162011607|NCT02492763|585099902|FG001|Overall Study|Screen Failure|0|||
162011608|NCT02492763|585099903|FG002|Overall Study|Screen Failure|0|||
162011609|NCT02492763|585099904|FG003|Overall Study|Screen Failure|1|||
162011610|NCT02492763|585099901|FG000|Overall Study|Study Terminated by Sponsor|13|||
162145533|NCT04391309|585578835|FG000|Overall Study|Lost to Follow-up|3|||
162011611|NCT02492763|585099902|FG001|Overall Study|Study Terminated by Sponsor|10|||
162011612|NCT02492763|585099903|FG002|Overall Study|Study Terminated by Sponsor|6|||
162011613|NCT02492763|585099904|FG003|Overall Study|Study Terminated by Sponsor|10|||
162011614|NCT01193244|585099905|FG000|Overall Study|Withdrawal by Subject|79|||
162011615|NCT01193244|585099906|FG001|Overall Study|Withdrawal by Subject|97|||
162011616|NCT01193244|585099905|FG000|Overall Study|Other|303|||
162011617|NCT01193244|585099906|FG001|Overall Study|Other|278|||
162011618|NCT01193244|585099905|FG000|Overall Study|Lost to Follow-up|6|||
162011619|NCT01193244|585099906|FG001|Overall Study|Lost to Follow-up|15|||
162011620|NCT03848832|585099907|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
162011621|NCT03848832|585099908|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
162011622|NCT03848832|585099909|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
162011623|NCT03848832|585099907|FG000|Overall Study|Withdrawal by Subject|0|||
162145534|NCT04391309|585578836|FG001|Overall Study|Lost to Follow-up|2|||
162145535|NCT04391309|585578835|FG000|Overall Study|Withdrawal by Subject|2|||
162145536|NCT04391309|585578836|FG001|Overall Study|Withdrawal by Subject|2|||
162145537|NCT05826431|585578837|FG000|Overall Study|Withdrawal by Subject|1|||
162145538|NCT01697319|585578840|FG000|Primary Phase|Withdrawal by Subject|1|||
162145539|NCT01697319|585578840|FG000|Extension Phase|Terminated by Sponsor|15|||
162145540|NCT04222959|585578843|FG000|Overall Study|Lost to Follow-up|76|||
162145541|NCT04222959|585578844|FG001|Overall Study|Lost to Follow-up|28|||
162145542|NCT01981356|585578851|FG000|Overall Study|Lost to Follow-up|4|||
162145543|NCT01981356|585578852|FG001|Overall Study|Lost to Follow-up|1|||
162145544|NCT01981356|585578851|FG000|Overall Study|Withdrawal by Subject|1|||
162145545|NCT01981356|585578852|FG001|Overall Study|Withdrawal by Subject|1|||
162145546|NCT01981356|585578851|FG000|Overall Study|Protocol Violation|2|||
162145547|NCT01981356|585578852|FG001|Overall Study|Protocol Violation|0|||
162145548|NCT04248829|585578853|FG000|Overall Study|Disease progression|44|||
162145549|NCT04248829|585578854|FG001|Overall Study|Disease progression|109|||
162145550|NCT04248829|585578853|FG000|Overall Study|Adverse Event|19|||
162145551|NCT04248829|585578854|FG001|Overall Study|Adverse Event|18|||
162145552|NCT04248829|585578853|FG000|Overall Study|Withdrawal by Subject|11|||
162145553|NCT04248829|585578854|FG001|Overall Study|Withdrawal by Subject|2|||
162145554|NCT04248829|585578853|FG000|Overall Study|Lost to Follow-up|0|||
162145555|NCT04248829|585578854|FG001|Overall Study|Lost to Follow-up|1|||
162145556|NCT04248829|585578853|FG000|Overall Study|Death|12|||
162145557|NCT04248829|585578854|FG001|Overall Study|Death|14|||
162145558|NCT04248829|585578853|FG000|Overall Study|Physician Decision|2|||
162145559|NCT04248829|585578854|FG001|Overall Study|Physician Decision|4|||
162145560|NCT04248829|585578853|FG000|Overall Study|Any reason not specifically recorded|0|||
162145561|NCT04248829|585578854|FG001|Overall Study|Any reason not specifically recorded|2|||
162145562|NCT05233085|585578855|FG000|Overall Study|Adverse Event|1|||
162145563|NCT05233085|585578856|FG001|Overall Study|Adverse Event|0|||
162145564|NCT05233085|585578857|FG002|Overall Study|Adverse Event|0|||
162145565|NCT05233085|585578858|FG003|Overall Study|Adverse Event|0|||
162145566|NCT01212757|585578859|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
162145567|NCT01212757|585578860|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
162145568|NCT01212757|585578861|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
162145569|NCT01212757|585578862|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162145570|NCT01212757|585578863|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162145571|NCT01212757|585578864|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162145572|NCT01212757|585578865|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162145573|NCT01212757|585578866|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162145574|NCT01212757|585578867|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162145575|NCT01212757|585578859|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
162145576|NCT01212757|585578860|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
162145577|NCT01212757|585578861|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
162145578|NCT01212757|585578862|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162145579|NCT01212757|585578863|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162145580|NCT01212757|585578864|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162145581|NCT01212757|585578865|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162145582|NCT01212757|585578866|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162145583|NCT01212757|585578867|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162145584|NCT01212757|585578859|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
162145585|NCT01212757|585578860|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
162145586|NCT01212757|585578861|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
162145587|NCT01212757|585578862|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161913466|NCT03225287|584731989|FG000|Overall Study|Stem cell transplantation|0|||
161913467|NCT03225287|584731990|FG001|Overall Study|Stem cell transplantation|1|||
161913468|NCT03225287|584731991|FG002|Overall Study|Stem cell transplantation|0|||
161913469|NCT06070610|584731994|FG000|Washout period|Adverse Event|1|||
162145588|NCT01212757|585578863|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162145589|NCT01212757|585578864|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162145590|NCT01212757|585578865|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162145591|NCT01212757|585578866|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162145592|NCT01212757|585578867|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162145593|NCT01212757|585578859|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
162145594|NCT01212757|585578860|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162145595|NCT01212757|585578861|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
162145596|NCT01212757|585578862|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162145597|NCT01212757|585578863|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161913470|NCT06070610|584731994|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
161913471|NCT00834041|584731995|FG000|Overall Study|Withdrawal by Subject|1|||
162145598|NCT01212757|585578864|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162145599|NCT01212757|585578865|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162145600|NCT01212757|585578866|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162145601|NCT01212757|585578867|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
162145602|NCT01212757|585578859|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
162145603|NCT01212757|585578860|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
162145604|NCT01212757|585578861|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
162145605|NCT01212757|585578862|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162011624|NCT03848832|585099908|FG001|Overall Study|Withdrawal by Subject|0|||
162011625|NCT03848832|585099909|FG002|Overall Study|Withdrawal by Subject|1|||
162011626|NCT03848832|585099907|FG000|Overall Study|Withdrawal (Covid-19)|0|||
162011627|NCT03848832|585099908|FG001|Overall Study|Withdrawal (Covid-19)|2|||
162011628|NCT03848832|585099909|FG002|Overall Study|Withdrawal (Covid-19)|0|||
162011629|NCT03848832|585099907|FG000|Overall Study|Physician Decision|2|||
162011630|NCT03848832|585099908|FG001|Overall Study|Physician Decision|1|||
162011631|NCT03848832|585099909|FG002|Overall Study|Physician Decision|3|||
162011632|NCT03848832|585099907|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
162011633|NCT03848832|585099908|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
162011634|NCT03848832|585099909|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
162011635|NCT03848832|585099907|FG000|Overall Study|Adverse Event|1|||
162011636|NCT03848832|585099908|FG001|Overall Study|Adverse Event|0|||
162011637|NCT03848832|585099909|FG002|Overall Study|Adverse Event|0|||
162011638|NCT00865566|585099910|FG000|Overall Study|Death|1|||
162011639|NCT00865566|585099911|FG001|Overall Study|Death|11|||
162011640|NCT00865566|585099910|FG000|Overall Study|Lost to Follow-up|314|||
162011641|NCT00865566|585099911|FG001|Overall Study|Lost to Follow-up|315|||
162011642|NCT00865566|585099910|FG000|Overall Study|Withdrawal by Subject|45|||
162011643|NCT00865566|585099911|FG001|Overall Study|Withdrawal by Subject|65|||
162011644|NCT00865566|585099910|FG000|Overall Study|Physician Decision|0|||
162011645|NCT00865566|585099911|FG001|Overall Study|Physician Decision|1|||
162011646|NCT00865566|585099910|FG000|Overall Study|Participant relocated|78|||
162011647|NCT00865566|585099911|FG001|Overall Study|Participant relocated|107|||
162011648|NCT00865566|585099910|FG000|Overall Study|Participant unable to adhere|27|||
162011649|NCT00865566|585099911|FG001|Overall Study|Participant unable to adhere|42|||
162011650|NCT00865566|585099910|FG000|Overall Study|Other; N=245 due to early study closure|154|||
162011651|NCT00865566|585099911|FG001|Overall Study|Other; N=245 due to early study closure|139|||
162011652|NCT00865566|585099910|FG000|Overall Study|HIV infection|5|||
162011653|NCT00865566|585099911|FG001|Overall Study|HIV infection|7|||
162011654|NCT01039376|585099912|FG000|Overall Study|Lost to Follow-up|5|||
162011655|NCT01039376|585099913|FG001|Overall Study|Lost to Follow-up|12|||
162011656|NCT01039376|585099912|FG000|Overall Study|Physician Decision|15|||
162011657|NCT01039376|585099913|FG001|Overall Study|Physician Decision|10|||
162011658|NCT01039376|585099912|FG000|Overall Study|Withdrawal by Subject|20|||
162011659|NCT01039376|585099913|FG001|Overall Study|Withdrawal by Subject|32|||
162011660|NCT01039376|585099912|FG000|Overall Study|Study terminated by Sponsor|90|||
162011661|NCT01039376|585099913|FG001|Overall Study|Study terminated by Sponsor|72|||
162011662|NCT00785785|585099914|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
162011663|NCT00785785|585099915|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
162011664|NCT00785785|585099914|FG000|Core Phase up to 36 Months|Adverse Event|31|||
162011665|NCT00785785|585099915|FG001|Core Phase up to 36 Months|Adverse Event|21|||
162145606|NCT01212757|585578863|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162145607|NCT01212757|585578864|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161809566|NCT00579345|584345697|FG001|Overall Study|Lost to Follow-up|0|||
162011666|NCT00785785|585099914|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
162011667|NCT00785785|585099915|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
162011668|NCT00785785|585099914|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
162011669|NCT00785785|585099915|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
162011670|NCT00785785|585099914|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
162011671|NCT00785785|585099915|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
162011672|NCT00785785|585099914|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
162011673|NCT00785785|585099915|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
162011674|NCT00785785|585099914|FG000|Core Phase up to 36 Months|Administrative problems|3|||
162011675|NCT00785785|585099915|FG001|Core Phase up to 36 Months|Administrative problems|3|||
162011676|NCT00785785|585099914|FG000|Core Phase up to 36 Months|Death|5|||
162011677|NCT00785785|585099915|FG001|Core Phase up to 36 Months|Death|8|||
162011678|NCT00785785|585099914|FG000|Core Phase up to 36 Months|Disease progression|139|||
162011679|NCT00785785|585099915|FG001|Core Phase up to 36 Months|Disease progression|119|||
162011680|NCT00785785|585099914|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
161809567|NCT00579345|584345698|FG002|Overall Study|Lost to Follow-up|0|||
161809568|NCT00579345|584345699|FG003|Overall Study|Lost to Follow-up|0|||
161809569|NCT00579345|584345700|FG004|Overall Study|Lost to Follow-up|0|||
161809570|NCT00579345|584345701|FG005|Overall Study|Lost to Follow-up|0|||
161809571|NCT00579345|584345702|FG006|Overall Study|Lost to Follow-up|0|||
161809572|NCT00579345|584345703|FG007|Overall Study|Lost to Follow-up|0|||
161809573|NCT00579345|584345696|FG000|Overall Study|Adverse Event|0|||
161809574|NCT00579345|584345697|FG001|Overall Study|Adverse Event|0|||
161913472|NCT00834041|584731996|FG001|Overall Study|Withdrawal by Subject|0|||
161913473|NCT00834041|584731995|FG000|Overall Study|Lost to Follow-up|0|||
161913474|NCT00834041|584731996|FG001|Overall Study|Lost to Follow-up|1|||
161809575|NCT00579345|584345698|FG002|Overall Study|Adverse Event|1|||
161913475|NCT01288430|584733559|FG000|Part 1|Progressive disease|2|||
161913476|NCT01288430|584733560|FG001|Part 1|Progressive disease|1|||
161913477|NCT01288430|584733561|FG002|Part 1|Progressive disease|1|||
161913478|NCT01288430|584733562|FG003|Part 1|Progressive disease|6|||
161913479|NCT01288430|584733563|FG004|Part 1|Progressive disease|2|||
161913480|NCT01288430|584733564|FG005|Part 1|Progressive disease|4|||
161913481|NCT01288430|584733565|FG006|Part 1|Progressive disease|2|||
161913482|NCT01288430|584733566|FG007|Part 1|Progressive disease|0|||
161913483|NCT01288430|584733567|FG008|Part 1|Progressive disease|0|||
161913484|NCT01288430|584733568|FG009|Part 1|Progressive disease|0|||
161913485|NCT01288430|584733559|FG000|Part 1|Clinical disease progression|0|||
161913486|NCT01288430|584733560|FG001|Part 1|Clinical disease progression|0|||
161913487|NCT01288430|584733561|FG002|Part 1|Clinical disease progression|1|||
161913488|NCT01288430|584733562|FG003|Part 1|Clinical disease progression|0|||
161913489|NCT01288430|584733563|FG004|Part 1|Clinical disease progression|0|||
161913490|NCT01288430|584733564|FG005|Part 1|Clinical disease progression|2|||
161913491|NCT01288430|584733565|FG006|Part 1|Clinical disease progression|2|||
161913492|NCT01288430|584733566|FG007|Part 1|Clinical disease progression|0|||
161913493|NCT01288430|584733567|FG008|Part 1|Clinical disease progression|0|||
161913494|NCT01288430|584733568|FG009|Part 1|Clinical disease progression|0|||
161913495|NCT01288430|584733559|FG000|Part 1|Death due to disease progression|0|||
161913496|NCT01288430|584733560|FG001|Part 1|Death due to disease progression|0|||
161913497|NCT01288430|584733561|FG002|Part 1|Death due to disease progression|0|||
161913498|NCT01288430|584733562|FG003|Part 1|Death due to disease progression|0|||
161913499|NCT01288430|584733563|FG004|Part 1|Death due to disease progression|1|||
161913500|NCT01288430|584733564|FG005|Part 1|Death due to disease progression|0|||
161913501|NCT01288430|584733565|FG006|Part 1|Death due to disease progression|0|||
161913502|NCT01288430|584733566|FG007|Part 1|Death due to disease progression|0|||
161913503|NCT01288430|584733567|FG008|Part 1|Death due to disease progression|0|||
161913504|NCT01288430|584733568|FG009|Part 1|Death due to disease progression|0|||
161913505|NCT01288430|584733559|FG000|Part 1|Adverse Event|0|||
161913506|NCT01288430|584733560|FG001|Part 1|Adverse Event|0|||
161913507|NCT01288430|584733561|FG002|Part 1|Adverse Event|3|||
161913508|NCT01288430|584733562|FG003|Part 1|Adverse Event|1|||
161913509|NCT01288430|584733563|FG004|Part 1|Adverse Event|0|||
161913510|NCT01288430|584733564|FG005|Part 1|Adverse Event|0|||
161913511|NCT01288430|584733565|FG006|Part 1|Adverse Event|2|||
161913512|NCT01288430|584733566|FG007|Part 1|Adverse Event|0|||
161913513|NCT01288430|584733567|FG008|Part 1|Adverse Event|0|||
161913514|NCT01288430|584733568|FG009|Part 1|Adverse Event|0|||
162145608|NCT01212757|585578865|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162145609|NCT01212757|585578866|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162145610|NCT01212757|585578867|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162145611|NCT01212757|585578859|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162145612|NCT01212757|585578860|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
162145613|NCT01212757|585578861|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
162145614|NCT01212757|585578862|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162145615|NCT01212757|585578863|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162145616|NCT01212757|585578864|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162145617|NCT01212757|585578865|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162145618|NCT01212757|585578866|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162145619|NCT01212757|585578867|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162145620|NCT01212757|585578859|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
162145621|NCT01212757|585578860|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
162145622|NCT01212757|585578861|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162145623|NCT01212757|585578862|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162145624|NCT01212757|585578863|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162145625|NCT01212757|585578864|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162145626|NCT01212757|585578865|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162145627|NCT01212757|585578866|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162145628|NCT01212757|585578867|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
162145629|NCT01212757|585578859|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
161913515|NCT01288430|584733559|FG000|Part 1|Other|0|||
161913516|NCT01288430|584733560|FG001|Part 1|Other|2|||
161913517|NCT01288430|584733561|FG002|Part 1|Other|0|||
161913518|NCT01288430|584733562|FG003|Part 1|Other|0|||
161913519|NCT01288430|584733563|FG004|Part 1|Other|0|||
161913520|NCT01288430|584733564|FG005|Part 1|Other|0|||
161913521|NCT01288430|584733565|FG006|Part 1|Other|1|||
161913522|NCT01288430|584733566|FG007|Part 1|Other|0|||
161913523|NCT01288430|584733567|FG008|Part 1|Other|0|||
161913524|NCT01288430|584733568|FG009|Part 1|Other|0|||
161913525|NCT01288430|584733559|FG000|Part 2|Progressive disease|0|||
162145630|NCT01212757|585578860|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
162145631|NCT01212757|585578861|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
162145632|NCT01212757|585578862|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
162145633|NCT01212757|585578863|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
162145634|NCT01212757|585578864|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
162145635|NCT01212757|585578865|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
162145636|NCT01212757|585578866|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
162145637|NCT01212757|585578867|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
162145638|NCT01212757|585578859|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
162145639|NCT01212757|585578860|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
162145640|NCT01212757|585578861|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
162145641|NCT01212757|585578862|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
162145642|NCT01212757|585578863|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
162145643|NCT01212757|585578864|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
162145644|NCT01212757|585578865|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
162145645|NCT01212757|585578866|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
162145646|NCT01212757|585578867|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
162145647|NCT01212757|585578859|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162145648|NCT01212757|585578860|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162145649|NCT01212757|585578861|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
162145650|NCT01212757|585578862|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162145651|NCT01212757|585578863|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162145652|NCT01212757|585578864|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162145653|NCT01212757|585578865|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162145654|NCT01212757|585578866|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162145655|NCT01212757|585578867|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
162145656|NCT01212757|585578859|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
162145657|NCT01212757|585578860|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
162145658|NCT01212757|585578861|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
162145659|NCT01212757|585578862|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
162145660|NCT01212757|585578863|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
162145661|NCT01212757|585578864|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
162145662|NCT01212757|585578865|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
162145663|NCT01212757|585578866|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
162145664|NCT01212757|585578867|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
162145665|NCT01212757|585578859|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162145666|NCT01212757|585578860|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
162145667|NCT01212757|585578861|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162145668|NCT01212757|585578862|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162145669|NCT01212757|585578863|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
162145670|NCT01212757|585578864|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162145671|NCT01212757|585578865|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162145672|NCT01212757|585578866|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162145673|NCT01212757|585578867|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
162145674|NCT01212757|585578859|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162145675|NCT01212757|585578860|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
162145676|NCT01212757|585578861|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
162145677|NCT01212757|585578862|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162145678|NCT01212757|585578863|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162145679|NCT01212757|585578864|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162145680|NCT01212757|585578865|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162145681|NCT01212757|585578866|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162145682|NCT01212757|585578867|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
162145683|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162145684|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162145685|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162145686|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162145687|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162145688|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162145689|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162145690|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
162145691|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
162145692|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
162145693|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
162145694|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
162145695|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
162145696|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
162145697|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
162145698|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
162145699|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
162145700|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
162145701|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
162145702|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
162145703|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
162145704|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
162145705|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
162145706|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
162145707|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
162145708|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
162145709|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
162145710|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162145711|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
162145712|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
162145713|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162145714|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162145715|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162145716|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162145717|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
162145718|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
162145719|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162145720|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162145721|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
162145722|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162145723|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162145724|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162145725|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162145726|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162145727|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
162145728|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
162145729|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
162145730|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
162145731|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
162145732|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
162145733|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
162145734|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
162145735|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
162145736|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
162145737|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
162145738|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
162145739|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
162145740|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
162145741|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
162145742|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
162145743|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
162145744|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
162145745|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
162145746|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162145747|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162145748|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
162145749|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162145750|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162145751|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162145752|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162145753|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162145754|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
162145755|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162145756|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
162145757|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
162145758|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162145759|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162145760|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162145761|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162145762|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
162145763|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
162145764|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162145765|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162145766|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162145767|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162145768|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162145769|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162145770|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162145771|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
162145772|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
162145773|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162145774|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
162145775|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162145776|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162145777|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162145778|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162145779|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162145780|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162145781|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
162145782|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162145783|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162145784|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
162145785|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162145786|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162145787|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162145788|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162145789|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
162145790|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
162145791|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162145792|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
162145793|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162145794|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162145795|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162145796|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162145797|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162145798|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
162145799|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
162145800|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
161809576|NCT00579345|584345699|FG003|Overall Study|Adverse Event|0|||
161809577|NCT00579345|584345700|FG004|Overall Study|Adverse Event|0|||
161809578|NCT00579345|584345701|FG005|Overall Study|Adverse Event|0|||
161809579|NCT00579345|584345702|FG006|Overall Study|Adverse Event|0|||
161809580|NCT00579345|584345703|FG007|Overall Study|Adverse Event|0|||
161809581|NCT00579345|584345696|FG000|Overall Study|Protocol Violation|1|||
161809582|NCT00579345|584345697|FG001|Overall Study|Protocol Violation|0|||
161809583|NCT00579345|584345698|FG002|Overall Study|Protocol Violation|0|||
161809584|NCT00579345|584345699|FG003|Overall Study|Protocol Violation|0|||
161809585|NCT00579345|584345700|FG004|Overall Study|Protocol Violation|0|||
161809586|NCT00579345|584345701|FG005|Overall Study|Protocol Violation|0|||
161809587|NCT00579345|584345702|FG006|Overall Study|Protocol Violation|0|||
161809588|NCT00579345|584345703|FG007|Overall Study|Protocol Violation|1|||
161809589|NCT00579345|584345696|FG000|Overall Study|Death|1|||
161809590|NCT00579345|584345697|FG001|Overall Study|Death|1|||
161809591|NCT00579345|584345698|FG002|Overall Study|Death|1|||
161809592|NCT00579345|584345699|FG003|Overall Study|Death|1|||
161809593|NCT00579345|584345700|FG004|Overall Study|Death|0|||
161809594|NCT00579345|584345701|FG005|Overall Study|Death|0|||
161913526|NCT01288430|584733560|FG001|Part 2|Progressive disease|0|||
161809595|NCT00579345|584345702|FG006|Overall Study|Death|0|||
161809596|NCT00579345|584345703|FG007|Overall Study|Death|0|||
161809597|NCT03255733|584345707|FG000|Overall Study|Lost to Follow-up|4|||
161809598|NCT00905840|584345716|FG000|Overall Study|Lost to Follow-up|11|||
161809599|NCT00905840|584345716|FG000|Overall Study|Death|3|||
161809600|NCT00905840|584345716|FG000|Overall Study|Withdrawal by Subject|1|||
161809601|NCT00905840|584345716|FG000|Overall Study|Adverse Event|1|||
162145801|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
162145802|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
162145803|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
162145804|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
162145805|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
162145806|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
162145807|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
162145808|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
162145809|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
162145810|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
162145811|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
162145812|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
162145813|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
162145814|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
162145815|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
162145816|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
162145817|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
162145818|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162145819|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
162145820|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
162145821|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162145822|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162145823|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162145824|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162145825|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
162145826|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
162145827|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
162145828|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
162145829|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
162145830|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
162145831|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
162145832|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
162145833|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
162145834|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
162145835|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
162145836|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162145837|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162145838|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162145839|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162145840|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162145841|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162145842|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162145843|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
162145844|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
162145845|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162145846|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
162145847|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
162145848|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162145849|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162145850|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162145851|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162145852|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
162145853|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
162145854|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162145855|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
162145856|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
162145857|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162145858|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162145859|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162145860|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162145861|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
162145862|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
162145863|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
162145864|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
162145865|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
162145866|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
162145867|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
162145868|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
162145869|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
162145870|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
162145871|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
162145872|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162145873|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
162145874|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162145875|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162145876|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162145877|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162145878|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162145879|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162145880|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
162145881|NCT01212757|585578859|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162145882|NCT01212757|585578860|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
162145883|NCT01212757|585578861|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
162145884|NCT01212757|585578862|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162145885|NCT01212757|585578863|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162145886|NCT01212757|585578864|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162145887|NCT01212757|585578865|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162145888|NCT01212757|585578866|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162145889|NCT01212757|585578867|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
162145890|NCT03141788|585578868|FG000|Overall Study|Lost to Follow-up|1|||
162145891|NCT03141788|585578868|FG000|Overall Study|Protocol Violation|3|||
162145892|NCT03141788|585578868|FG000|Overall Study|Withdrawal by Subject|4|||
162145893|NCT00487578|585581090|FG000|Overall Study|Adverse Event|1|||
162145894|NCT00487578|585581091|FG001|Overall Study|Adverse Event|2|||
162145895|NCT00487578|585581090|FG000|Overall Study|Lack of Efficacy|0|||
162145896|NCT00487578|585581091|FG001|Overall Study|Lack of Efficacy|1|||
162145897|NCT00487578|585581090|FG000|Overall Study|Lost to Follow-up|0|||
162011681|NCT00785785|585099915|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
162011682|NCT00785785|585099914|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
162011683|NCT00785785|585099915|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
162011684|NCT00785785|585099914|FG000|Optional Extension Phase|Adverse Event|4|||
162011685|NCT00785785|585099915|FG001|Optional Extension Phase|Adverse Event|5|||
162011686|NCT00785785|585099914|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
162011687|NCT00785785|585099915|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
162011688|NCT00785785|585099914|FG000|Optional Extension Phase|Lost to Follow-up|1|||
162011689|NCT00785785|585099915|FG001|Optional Extension Phase|Lost to Follow-up|0|||
162011690|NCT00785785|585099914|FG000|Optional Extension Phase|Administrative problems|2|||
162011691|NCT00785785|585099915|FG001|Optional Extension Phase|Administrative problems|0|||
162011692|NCT00785785|585099914|FG000|Optional Extension Phase|Death|1|||
162011693|NCT00785785|585099915|FG001|Optional Extension Phase|Death|5|||
162011694|NCT00785785|585099914|FG000|Optional Extension Phase|Disease progression|22|||
162011695|NCT00785785|585099915|FG001|Optional Extension Phase|Disease progression|70|||
162011696|NCT00785785|585099914|FG000|Optional Extension Phase|Protocol deviation|0|||
162011697|NCT00785785|585099915|FG001|Optional Extension Phase|Protocol deviation|2|||
162011698|NCT00785785|585099914|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
162011699|NCT00785785|585099915|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
162011700|NCT03252925|585099916|FG000|Overall Study|Withdrawal by Subject|1|||
162011701|NCT03252925|585099917|FG001|Overall Study|Withdrawal by Subject|0|||
162011702|NCT03252925|585099916|FG000|Overall Study|Protocol Violation|6|||
162011703|NCT03252925|585099917|FG001|Overall Study|Protocol Violation|0|||
162011704|NCT03252925|585099916|FG000|Overall Study|Adverse Event|1|||
162011705|NCT03252925|585099917|FG001|Overall Study|Adverse Event|0|||
162011706|NCT03252925|585099916|FG000|Overall Study|Lost to Follow-up|6|||
162011707|NCT03252925|585099917|FG001|Overall Study|Lost to Follow-up|6|||
162011708|NCT01244893|585099918|FG000|Baseline|Protocol Violation|0|||
162145898|NCT00487578|585581091|FG001|Overall Study|Lost to Follow-up|1|||
162145899|NCT02525796|585581092|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
162145900|NCT02525796|585581093|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
162145901|NCT02525796|585581094|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
162011709|NCT01244893|585099919|FG001|Baseline|Protocol Violation|1|||
162011710|NCT01244893|585099918|FG000|1-Week Follow Up|Lost to Follow-up|1|||
162011711|NCT01244893|585099919|FG001|1-Week Follow Up|Lost to Follow-up|0|||
162011712|NCT00357552|585099920|FG000|Screening|Did not meet eligibility criteria|84|||
162011713|NCT00357552|585099920|FG000|Weeks 0 to 24|Death|1|||
162011714|NCT00357552|585099920|FG000|Weeks 24 to 104|Death|3|||
162011715|NCT00357552|585099920|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
162145902|NCT02525796|585581092|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
162145903|NCT02525796|585581093|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
162011716|NCT00521404|585099923|FG000|Overall Study|Adverse Event|13|||
162011717|NCT00521404|585099923|FG000|Overall Study|Disease Progression|33|||
162145904|NCT02525796|585581094|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
162145905|NCT02525796|585581092|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
162145906|NCT02525796|585581093|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
162145907|NCT02525796|585581094|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
162145908|NCT02525796|585581092|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
162145909|NCT02525796|585581093|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
162145910|NCT02525796|585581094|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
162145911|NCT02525796|585581092|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
162145912|NCT02525796|585581093|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
162145913|NCT02525796|585581094|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
162145914|NCT00726999|585581097|FG000|Overall Study|Physician Decision|0|||
162145915|NCT00726999|585581098|FG001|Overall Study|Physician Decision|1|||
162145916|NCT00726999|585581097|FG000|Overall Study|Withdrawal by Subject|2|||
162145917|NCT00726999|585581098|FG001|Overall Study|Withdrawal by Subject|0|||
162145918|NCT00726999|585581097|FG000|Overall Study|Protocol Violation|1|||
162145919|NCT00726999|585581098|FG001|Overall Study|Protocol Violation|0|||
162145920|NCT01198275|585581099|FG000|Overall Study|Adverse Event|2|||
162145921|NCT01198275|585581100|FG001|Overall Study|Adverse Event|3|||
162145922|NCT01198275|585581099|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
162145923|NCT01198275|585581100|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
162145924|NCT00391846|585581101|FG000|Overall Study|Adverse Event|4|||
162145925|NCT00391846|585581102|FG001|Overall Study|Adverse Event|1|||
162145926|NCT00391846|585581101|FG000|Overall Study|Did not meet the required elig. crit|2|||
162145927|NCT00391846|585581102|FG001|Overall Study|Did not meet the required elig. crit|2|||
162145928|NCT00391846|585581101|FG000|Overall Study|Withdrawal by Subject|2|||
162145929|NCT00391846|585581102|FG001|Overall Study|Withdrawal by Subject|3|||
162145930|NCT00391846|585581101|FG000|Overall Study|Developed study specific DC criteria|0|||
162145931|NCT00391846|585581102|FG001|Overall Study|Developed study specific DC criteria|1|||
162145932|NCT02477670|585581106|FG000|Stage 1|Adverse Event|2|||
162145933|NCT02477670|585581107|FG001|Stage 1|Adverse Event|7|||
162145934|NCT02477670|585581108|FG002|Stage 1|Adverse Event|0|||
162145935|NCT02477670|585581109|FG003|Stage 1|Adverse Event|0|||
162145936|NCT02477670|585581110|FG004|Stage 1|Adverse Event|0|||
162145937|NCT02477670|585581111|FG005|Stage 1|Adverse Event|0|||
162145938|NCT02477670|585581112|FG006|Stage 1|Adverse Event|0|||
162145939|NCT02477670|585581106|FG000|Stage 1|Lost to Follow-up|0|||
162145940|NCT02477670|585581107|FG001|Stage 1|Lost to Follow-up|2|||
162145941|NCT02477670|585581108|FG002|Stage 1|Lost to Follow-up|0|||
162145942|NCT02477670|585581109|FG003|Stage 1|Lost to Follow-up|0|||
162145943|NCT02477670|585581110|FG004|Stage 1|Lost to Follow-up|0|||
162145944|NCT02477670|585581111|FG005|Stage 1|Lost to Follow-up|0|||
162145945|NCT02477670|585581112|FG006|Stage 1|Lost to Follow-up|0|||
162145946|NCT02477670|585581106|FG000|Stage 1|Withdrawal by Subject|1|||
162145947|NCT02477670|585581107|FG001|Stage 1|Withdrawal by Subject|2|||
162145948|NCT02477670|585581108|FG002|Stage 1|Withdrawal by Subject|0|||
162145949|NCT02477670|585581109|FG003|Stage 1|Withdrawal by Subject|0|||
162145950|NCT02477670|585581110|FG004|Stage 1|Withdrawal by Subject|0|||
162145951|NCT02477670|585581111|FG005|Stage 1|Withdrawal by Subject|0|||
162145952|NCT02477670|585581112|FG006|Stage 1|Withdrawal by Subject|0|||
162145953|NCT02477670|585581106|FG000|Stage 1|Non-compliance with Study Drug|1|||
162145954|NCT02477670|585581107|FG001|Stage 1|Non-compliance with Study Drug|2|||
162145955|NCT02477670|585581108|FG002|Stage 1|Non-compliance with Study Drug|0|||
162145956|NCT02477670|585581109|FG003|Stage 1|Non-compliance with Study Drug|0|||
161809602|NCT00448019|584345717|FG000|Overall Study|Withdrawal by Subject|3|||
161809603|NCT00448019|584345717|FG000|Overall Study|Disease progression|1|||
161809604|NCT00448019|584345717|FG000|Overall Study|Death|2|||
161809605|NCT00448019|584345717|FG000|Overall Study|Insurance Issues|1|||
161809606|NCT03020615|584345718|FG000|Overall Study|Physician Decision|3|||
161809607|NCT03020615|584345719|FG001|Overall Study|Physician Decision|1|||
161809608|NCT03020615|584345720|FG002|Overall Study|Physician Decision|2|||
161809609|NCT03020615|584345718|FG000|Overall Study|Parent/guardian/patient choice|3|||
161809610|NCT03020615|584345719|FG001|Overall Study|Parent/guardian/patient choice|0|||
161809611|NCT03020615|584345720|FG002|Overall Study|Parent/guardian/patient choice|4|||
161809612|NCT03020615|584345718|FG000|Overall Study|Screen failure|0|||
161809613|NCT03020615|584345719|FG001|Overall Study|Screen failure|0|||
161809614|NCT03020615|584345720|FG002|Overall Study|Screen failure|1|||
161809615|NCT03020615|584345718|FG000|Overall Study|Death|1|||
162145957|NCT02477670|585581110|FG004|Stage 1|Non-compliance with Study Drug|0|||
162145958|NCT02477670|585581111|FG005|Stage 1|Non-compliance with Study Drug|0|||
162145959|NCT02477670|585581112|FG006|Stage 1|Non-compliance with Study Drug|0|||
162145960|NCT02477670|585581106|FG000|Stage 2|Adverse Event|0|||
162145961|NCT02477670|585581107|FG001|Stage 2|Adverse Event|0|||
162145962|NCT02477670|585581108|FG002|Stage 2|Adverse Event|1|||
161809616|NCT03020615|584345719|FG001|Overall Study|Death|0|||
161809617|NCT03020615|584345720|FG002|Overall Study|Death|0|||
162145963|NCT02477670|585581109|FG003|Stage 2|Adverse Event|0|||
162145964|NCT02477670|585581110|FG004|Stage 2|Adverse Event|0|||
161809618|NCT03020615|584345718|FG000|Overall Study|Lost to Follow-up|0|||
162145965|NCT02477670|585581111|FG005|Stage 2|Adverse Event|0|||
162145966|NCT02477670|585581112|FG006|Stage 2|Adverse Event|0|||
161809619|NCT03020615|584345719|FG001|Overall Study|Lost to Follow-up|1|||
161809620|NCT03020615|584345720|FG002|Overall Study|Lost to Follow-up|0|||
162011718|NCT00521404|585099923|FG000|Overall Study|Investigator decision|5|||
162011719|NCT00521404|585099923|FG000|Overall Study|Withdrawal of consent|3|||
162011720|NCT00521404|585099923|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
162011721|NCT00521404|585099923|FG000|Overall Study|Other|7|||
162011722|NCT04555616|585099926|FG000|Overall Study|Death|1|||
162011723|NCT04555616|585099927|FG001|Overall Study|Death|0|||
162011724|NCT04555616|585099928|FG002|Overall Study|Death|1|||
162011725|NCT04555616|585099926|FG000|Overall Study|Withdrawal by Subject|2|||
162011726|NCT04555616|585099927|FG001|Overall Study|Withdrawal by Subject|1|||
162011727|NCT04555616|585099928|FG002|Overall Study|Withdrawal by Subject|0|||
162011728|NCT00882557|585099929|FG000|Overall Study|Withdrawal by Subject|1|||
162011729|NCT00882557|585099930|FG001|Overall Study|Withdrawal by Subject|0|||
162011730|NCT00882557|585099929|FG000|Overall Study|Trouble with Vein Access|1|||
162011731|NCT00882557|585099930|FG001|Overall Study|Trouble with Vein Access|0|||
162011732|NCT00882557|585099929|FG000|Overall Study|Randomized Not Treated|0|||
162011733|NCT00882557|585099930|FG001|Overall Study|Randomized Not Treated|1|||
162011734|NCT02282605|585099931|FG000|Overall Study|negative SA result on Day -1|3|||
162011735|NCT02282605|585099932|FG001|Overall Study|negative SA result on Day -1|0|||
162011736|NCT02282605|585099933|FG002|Overall Study|negative SA result on Day -1|0|||
162011737|NCT00711191|585099934|FG000|Overall Study|Adverse Event|1|||
162011738|NCT00711191|585099935|FG001|Overall Study|Adverse Event|1|||
162011739|NCT00711191|585099936|FG002|Overall Study|Adverse Event|2|||
162011740|NCT00711191|585099934|FG000|Overall Study|Objective progression or relapse|2|||
162011741|NCT00711191|585099935|FG001|Overall Study|Objective progression or relapse|3|||
162011742|NCT00711191|585099936|FG002|Overall Study|Objective progression or relapse|7|||
162011743|NCT00711191|585099934|FG000|Overall Study|Withdrawal by Subject|0|||
162011744|NCT00711191|585099935|FG001|Overall Study|Withdrawal by Subject|1|||
162011745|NCT00711191|585099936|FG002|Overall Study|Withdrawal by Subject|3|||
162011746|NCT02404025|585099937|FG000|Overall Study|Adverse Event|1|||
162011747|NCT02404025|585099937|FG000|Overall Study|Lack of Efficacy|3|||
162011748|NCT01744977|585099939|FG000|Overall Study|Withdrawal by Subject|1|||
162011749|NCT01744977|585099940|FG001|Overall Study|Withdrawal by Subject|2|||
162011750|NCT01744977|585099939|FG000|Overall Study|Death|2|||
162011751|NCT01744977|585099940|FG001|Overall Study|Death|3|||
162011752|NCT01744977|585099939|FG000|Overall Study|Lost to Follow-up|2|||
162011753|NCT01744977|585099940|FG001|Overall Study|Lost to Follow-up|0|||
162011754|NCT01744977|585099939|FG000|Overall Study|No longer meets inclusion|6|||
162011755|NCT01744977|585099940|FG001|Overall Study|No longer meets inclusion|0|||
162011756|NCT01750229|585099943|FG000|Randomized Crossover Phase|Adverse Event|1|||
162145967|NCT02477670|585581106|FG000|Stage 2|Antipsychotic Medication Changed|0|||
162145968|NCT02477670|585581107|FG001|Stage 2|Antipsychotic Medication Changed|0|||
162145969|NCT02477670|585581108|FG002|Stage 2|Antipsychotic Medication Changed|1|||
162145970|NCT02477670|585581109|FG003|Stage 2|Antipsychotic Medication Changed|0|||
161809621|NCT02760368|584345721|FG000|Overall Study|Withdrawal by Subject|8|||
161809622|NCT02760368|584345722|FG001|Overall Study|Withdrawal by Subject|12|||
161809623|NCT02760368|584345723|FG002|Overall Study|Withdrawal by Subject|9|||
161809624|NCT02760368|584345721|FG000|Overall Study|Screen Failure|0|||
161809625|NCT02760368|584345722|FG001|Overall Study|Screen Failure|0|||
161809626|NCT02760368|584345723|FG002|Overall Study|Screen Failure|1|||
161809627|NCT02760368|584345721|FG000|Overall Study|Death|0|||
161809628|NCT02760368|584345722|FG001|Overall Study|Death|1|||
161809629|NCT02760368|584345723|FG002|Overall Study|Death|0|||
161809630|NCT02760368|584345721|FG000|Overall Study|Withdrawal by Sponsor|0|||
161809631|NCT02760368|584345722|FG001|Overall Study|Withdrawal by Sponsor|0|||
161809632|NCT02760368|584345723|FG002|Overall Study|Withdrawal by Sponsor|1|||
161809633|NCT00794963|584345724|FG000|Overall Study|Withdrawal by Subject|1|||
161809634|NCT00794963|584345725|FG001|Overall Study|Withdrawal by Subject|4|||
161809635|NCT01037114|584345726|FG000|Year 20|Others|1|||
161809636|NCT01602419|584345727|FG000|Overall Study|Not treated with Wilate|9|||
161809637|NCT01602419|584345727|FG000|Overall Study|Adverse Drug Reaction|4|||
161809638|NCT01602419|584345727|FG000|Overall Study|Insurance issues|3|||
161809639|NCT01602419|584345727|FG000|Overall Study|Changed treatment centre|1|||
161809640|NCT01602419|584345727|FG000|Overall Study|Treatment centre closed|1|||
161809641|NCT01602419|584345727|FG000|Overall Study|Withdrawal by Subject|5|||
161809642|NCT01602419|584345727|FG000|Overall Study|Lost to Follow-up|6|||
161809643|NCT03620747|584345733|FG000|Overall Study|Participant decision|7|||
161809644|NCT03620747|584345733|FG000|Overall Study|Adverse Event|6|||
161809645|NCT03620747|584345733|FG000|Overall Study|Lack of Efficacy|1|||
161809646|NCT03620747|584345733|FG000|Overall Study|Poor compliance to protocol|2|||
162011757|NCT01750229|585099943|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
162011758|NCT01750229|585099943|FG000|Long-term Follow-up Phase|Adverse Event|2|||
162011759|NCT01750229|585099943|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
162011760|NCT03774576|585099944|FG000|Period 2|Adverse Event|1|||
162011761|NCT01746901|585099945|FG000|Naloxone Challenge Phase|Adverse Event|2|||
162145971|NCT02477670|585581110|FG004|Stage 2|Antipsychotic Medication Changed|0|||
162145972|NCT02477670|585581111|FG005|Stage 2|Antipsychotic Medication Changed|0|||
162145973|NCT02477670|585581112|FG006|Stage 2|Antipsychotic Medication Changed|0|||
162145974|NCT02477670|585581106|FG000|Stage 2|Withdrawal by Subject|0|||
162145975|NCT02477670|585581107|FG001|Stage 2|Withdrawal by Subject|0|||
162145976|NCT02477670|585581108|FG002|Stage 2|Withdrawal by Subject|0|||
162145977|NCT02477670|585581109|FG003|Stage 2|Withdrawal by Subject|1|||
162145978|NCT02477670|585581110|FG004|Stage 2|Withdrawal by Subject|0|||
162145979|NCT02477670|585581111|FG005|Stage 2|Withdrawal by Subject|0|||
162145980|NCT02477670|585581112|FG006|Stage 2|Withdrawal by Subject|0|||
162145981|NCT02810080|585581113|FG000|Overall Study|Adverse Event|3|||
162145982|NCT02810080|585581114|FG001|Overall Study|Adverse Event|0|||
162145983|NCT02810080|585581113|FG000|Overall Study|Death|0|||
162145984|NCT02810080|585581114|FG001|Overall Study|Death|2|||
162145985|NCT02810080|585581113|FG000|Overall Study|Physician Decision|4|||
162145986|NCT02810080|585581114|FG001|Overall Study|Physician Decision|0|||
162145987|NCT02810080|585581113|FG000|Overall Study|Withdrawal by Subject|0|||
162145988|NCT02810080|585581114|FG001|Overall Study|Withdrawal by Subject|2|||
162145989|NCT01759264|585581115|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
162145990|NCT01759264|585581115|FG000|Overall Study|Adverse Event|1|||
162145991|NCT01759264|585581115|FG000|Overall Study|Other|2|||
162145992|NCT01759264|585581115|FG000|Overall Study|Lost to Follow-up|2|||
162145993|NCT01759264|585581115|FG000|Overall Study|Withdrawal by Subject|3|||
162145994|NCT01759264|585581115|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
162145995|NCT02034916|585581120|FG000|Overall Study|Death|39|||
162145996|NCT02034916|585581121|FG001|Overall Study|Death|28|||
162145997|NCT02034916|585581120|FG000|Overall Study|Withdrawal by Subject|2|||
162145998|NCT02034916|585581121|FG001|Overall Study|Withdrawal by Subject|1|||
162145999|NCT02034916|585581120|FG000|Overall Study|Lost to Follow-up|4|||
162146000|NCT02034916|585581121|FG001|Overall Study|Lost to Follow-up|1|||
162146001|NCT02034916|585581120|FG000|Overall Study|Study terminated by sponsor|4|||
162146002|NCT02034916|585581121|FG001|Overall Study|Study terminated by sponsor|5|||
162146003|NCT00753012|585581122|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
162146004|NCT00753012|585581123|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
162146005|NCT00753012|585581122|FG000|Overall Study|Adverse Event|2|||
162146006|NCT00753012|585581123|FG001|Overall Study|Adverse Event|0|||
162146007|NCT00753012|585581122|FG000|Overall Study|Withdrawal by Subject|0|||
162146008|NCT00753012|585581123|FG001|Overall Study|Withdrawal by Subject|1|||
162146009|NCT00753012|585581122|FG000|Overall Study|Lost to Follow-up|4|||
162146010|NCT00753012|585581123|FG001|Overall Study|Lost to Follow-up|0|||
162146011|NCT00753012|585581122|FG000|Overall Study|Confounded endpoint data|1|||
162146012|NCT00753012|585581123|FG001|Overall Study|Confounded endpoint data|0|||
162146013|NCT01930045|585581124|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
162146014|NCT01930045|585581125|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
162146015|NCT01930045|585581126|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
162146016|NCT01930045|585581127|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
162146017|NCT01930045|585581128|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
162146018|NCT01930045|585581129|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
162146019|NCT01930045|585581124|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
162146020|NCT01930045|585581125|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
162146021|NCT01930045|585581126|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
162146022|NCT01930045|585581127|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
161809647|NCT03620747|584345733|FG000|Overall Study|Other-unspecified|3|||
161809648|NCT01745120|584345736|FG000|Overall Study|Investigator decision|1|||
161809649|NCT01745120|584345737|FG001|Overall Study|Investigator decision|0|||
161809650|NCT00850174|584345745|FG000|Washout: One Week|Withdrawal by Subject|0|||
161809651|NCT00850174|584345746|FG001|Washout: One Week|Withdrawal by Subject|2|||
161809652|NCT00850174|584345745|FG000|Second Intervention|Withdrawal by Subject|1|||
161809653|NCT00850174|584345746|FG001|Second Intervention|Withdrawal by Subject|0|||
161809654|NCT00635492|584345747|FG000|Overall Study|Death|12|||
161809655|NCT00635492|584345748|FG001|Overall Study|Death|40|||
161809656|NCT00635492|584345747|FG000|Overall Study|Lost to Follow-up|151|||
162146023|NCT01930045|585581128|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
162146024|NCT01930045|585581129|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
162146025|NCT01370694|585581132|FG000|Overall Study|Switched to rituximab|4|||
162146026|NCT01370694|585581132|FG000|Overall Study|Progressive disease|2|||
162146027|NCT04842604|585581137|FG000|Overall Study|Death|1|||
162146028|NCT04842604|585581138|FG001|Overall Study|Death|0|||
162146029|NCT04842604|585581137|FG000|Overall Study|Other|4|||
162146030|NCT04842604|585581138|FG001|Overall Study|Other|4|||
162146031|NCT04842604|585581137|FG000|Overall Study|Randomized but not treated|1|||
162146032|NCT04842604|585581138|FG001|Overall Study|Randomized but not treated|0|||
162146033|NCT01193153|585581139|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
162146034|NCT01193153|585581140|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
162146035|NCT01193153|585581139|FG000|Open-label Lead in Period|Pregnancy|1|||
162146036|NCT01193153|585581140|FG001|Open-label Lead in Period|Pregnancy|0|||
162146037|NCT01193153|585581139|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
162146038|NCT01193153|585581140|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
162146039|NCT01193153|585581139|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
162146040|NCT01193153|585581140|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
162146041|NCT01193153|585581139|FG000|Open-label Lead in Period|Other|14|||
162146042|NCT01193153|585581140|FG001|Open-label Lead in Period|Other|0|||
162146043|NCT01193153|585581139|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
162146044|NCT01193153|585581140|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
162146045|NCT01193153|585581139|FG000|Open-label Lead in Period|Adverse Event|41|||
162146046|NCT01193153|585581140|FG001|Open-label Lead in Period|Adverse Event|0|||
162146047|NCT01193153|585581139|FG000|Open-label Lead in Period|Death|1|||
162146048|NCT01193153|585581140|FG001|Open-label Lead in Period|Death|0|||
162146049|NCT01193153|585581139|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
162146050|NCT01193153|585581140|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
162146051|NCT01193153|585581139|FG000|Open-label Stabilization Period|Adverse Event|9|||
162146052|NCT01193153|585581140|FG001|Open-label Stabilization Period|Adverse Event|0|||
162146053|NCT01193153|585581139|FG000|Open-label Stabilization Period|Death|2|||
162146054|NCT01193153|585581140|FG001|Open-label Stabilization Period|Death|0|||
162146055|NCT01193153|585581139|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
162146056|NCT01193153|585581140|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
162146057|NCT01193153|585581139|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
162146058|NCT01193153|585581140|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
162146059|NCT01193153|585581139|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
162146060|NCT01193153|585581140|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
162146061|NCT01193153|585581139|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
162146062|NCT01193153|585581140|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
162146063|NCT01193153|585581139|FG000|Open-label Stabilization Period|Other|8|||
162146064|NCT01193153|585581140|FG001|Open-label Stabilization Period|Other|0|||
162146065|NCT01193153|585581139|FG000|Double Blind Relapse Prevention Period|Other|2|||
162146066|NCT01193153|585581140|FG001|Double Blind Relapse Prevention Period|Other|3|||
162011762|NCT01746901|585099946|FG001|Naloxone Challenge Phase|Adverse Event|0|||
162011763|NCT01746901|585099947|FG002|Naloxone Challenge Phase|Adverse Event|0|||
162011764|NCT01746901|585099948|FG003|Naloxone Challenge Phase|Adverse Event|0|||
162011765|NCT01746901|585099949|FG004|Naloxone Challenge Phase|Adverse Event|0|||
162011766|NCT01746901|585099950|FG005|Naloxone Challenge Phase|Adverse Event|0|||
162011767|NCT01746901|585099951|FG006|Naloxone Challenge Phase|Adverse Event|0|||
162011768|NCT01746901|585099952|FG007|Naloxone Challenge Phase|Adverse Event|0|||
162011769|NCT01746901|585099953|FG008|Naloxone Challenge Phase|Adverse Event|0|||
162011770|NCT01746901|585099945|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
162011771|NCT01746901|585099946|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
162011772|NCT01746901|585099947|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
162011773|NCT01746901|585099948|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
162011774|NCT01746901|585099949|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
162011775|NCT01746901|585099950|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
162011776|NCT01746901|585099951|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
162011777|NCT01746901|585099952|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
162011778|NCT01746901|585099953|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
162011779|NCT01746901|585099945|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162011780|NCT01746901|585099946|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
162011781|NCT01746901|585099947|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162011782|NCT01746901|585099948|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162011783|NCT01746901|585099949|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162011784|NCT01746901|585099950|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162011785|NCT01746901|585099951|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162011786|NCT01746901|585099952|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162011787|NCT01746901|585099953|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
162011788|NCT01746901|585099945|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
162011789|NCT01746901|585099946|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
162011790|NCT01746901|585099947|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
162011791|NCT01746901|585099948|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
162146067|NCT01193153|585581139|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
162146068|NCT01193153|585581140|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
162011792|NCT01746901|585099949|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
162011793|NCT01746901|585099950|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
162011794|NCT01746901|585099951|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
162146069|NCT01193153|585581139|FG000|Double Blind Relapse Prevention Period|Death|2|||
162146070|NCT01193153|585581140|FG001|Double Blind Relapse Prevention Period|Death|0|||
162146071|NCT01193153|585581139|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
162146072|NCT01193153|585581140|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
162146073|NCT01193153|585581139|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
162146074|NCT01193153|585581140|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
162146075|NCT01193153|585581139|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
162146076|NCT01193153|585581140|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
162146077|NCT01193153|585581139|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
162146078|NCT01193153|585581140|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
162146079|NCT01193153|585581139|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
162146080|NCT01193153|585581140|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
162146081|NCT00344019|585581141|FG000|Overall Study|did not meet final inclusion criteria|0|||
162146082|NCT00344019|585581142|FG001|Overall Study|did not meet final inclusion criteria|0|||
162146083|NCT00344019|585581143|FG002|Overall Study|did not meet final inclusion criteria|74|||
162146084|NCT02503202|585581146|FG000|Base Study: Up to Month 6|Death|1|||
162146085|NCT02503202|585581147|FG001|Base Study: Up to Month 6|Death|1|||
162146086|NCT02503202|585581148|FG002|Base Study: Up to Month 6|Death|0|||
162146087|NCT02503202|585581149|FG003|Base Study: Up to Month 6|Death|0|||
162146088|NCT02503202|585581150|FG004|Base Study: Up to Month 6|Death|0|||
162146089|NCT02503202|585581146|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
162146090|NCT02503202|585581147|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
162146091|NCT02503202|585581148|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
162146092|NCT02503202|585581149|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
162146093|NCT02503202|585581150|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
162146094|NCT02503202|585581146|FG000|Base Study: Up to Month 6|Physician Decision|0|||
162146095|NCT02503202|585581147|FG001|Base Study: Up to Month 6|Physician Decision|0|||
162146096|NCT02503202|585581148|FG002|Base Study: Up to Month 6|Physician Decision|0|||
162146097|NCT02503202|585581149|FG003|Base Study: Up to Month 6|Physician Decision|0|||
162146098|NCT02503202|585581150|FG004|Base Study: Up to Month 6|Physician Decision|1|||
162146099|NCT02503202|585581146|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
162146100|NCT02503202|585581147|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
162146101|NCT02503202|585581148|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
162146102|NCT02503202|585581149|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
162146103|NCT02503202|585581150|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
162146104|NCT02503202|585581146|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
162146105|NCT02503202|585581147|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
162146106|NCT02503202|585581148|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
162146107|NCT02503202|585581149|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
162146108|NCT02503202|585581150|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
162146109|NCT02503202|585581146|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
162146110|NCT02503202|585581147|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
162146111|NCT02503202|585581148|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
162146112|NCT02503202|585581149|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
162146113|NCT02503202|585581150|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
162146114|NCT02503202|585581146|FG000|Extension: Month 6 to 24|Death|1|||
162146115|NCT02503202|585581147|FG001|Extension: Month 6 to 24|Death|0|||
161809657|NCT00635492|584345748|FG001|Overall Study|Lost to Follow-up|172|||
161809658|NCT00635492|584345747|FG000|Overall Study|Physician Decision|32|||
161809659|NCT00635492|584345748|FG001|Overall Study|Physician Decision|22|||
161809660|NCT00635492|584345747|FG000|Overall Study|Sponsor decision|2|||
161809661|NCT00635492|584345748|FG001|Overall Study|Sponsor decision|3|||
161809662|NCT00635492|584345747|FG000|Overall Study|Withdrawal by Subject|82|||
161809663|NCT00635492|584345748|FG001|Overall Study|Withdrawal by Subject|45|||
161809664|NCT04533594|584345753|FG000|Overall Study|Death|26|||
161809665|NCT01200810|584345756|FG000|Overall Study|Physician Decision|1|||
161809666|NCT01200810|584345757|FG001|Overall Study|Physician Decision|0|||
161809667|NCT01200810|584345756|FG000|Overall Study|Withdrawal by Subject|1|||
161809668|NCT01200810|584345757|FG001|Overall Study|Withdrawal by Subject|2|||
161809669|NCT01200810|584345756|FG000|Overall Study|Sponsor stopped making study drug|3|||
161809670|NCT01200810|584345757|FG001|Overall Study|Sponsor stopped making study drug|3|||
161809671|NCT03500341|584345761|FG000|Overall Study|Withdrawn prior to Completion|2|||
161809672|NCT00640562|584345764|FG000|Overall Study|Adverse Event|8|||
161809673|NCT00640562|584345765|FG001|Overall Study|Adverse Event|5|||
161809674|NCT00640562|584345764|FG000|Overall Study|Lack of Efficacy|1|||
161809675|NCT00640562|584345765|FG001|Overall Study|Lack of Efficacy|4|||
161809676|NCT00640562|584345764|FG000|Overall Study|Protocol Violation|2|||
161809677|NCT00640562|584345765|FG001|Overall Study|Protocol Violation|4|||
161809678|NCT00640562|584345764|FG000|Overall Study|Withdrawal by Subject|6|||
161809679|NCT00640562|584345765|FG001|Overall Study|Withdrawal by Subject|10|||
161809680|NCT00640562|584345764|FG000|Overall Study|Known risperidone intolerance|0|||
161809681|NCT00640562|584345765|FG001|Overall Study|Known risperidone intolerance|1|||
162011795|NCT01746901|585099952|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
162011796|NCT01746901|585099953|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
162011797|NCT01746901|585099945|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
162011798|NCT01746901|585099946|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
162011799|NCT01746901|585099947|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
162011800|NCT01746901|585099948|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
162011801|NCT01746901|585099949|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
162011802|NCT01746901|585099950|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
162011803|NCT01746901|585099951|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
162011804|NCT01746901|585099952|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
162011805|NCT01746901|585099953|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
162011806|NCT01746901|585099945|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162011807|NCT01746901|585099946|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
162011808|NCT01746901|585099947|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
162011809|NCT01746901|585099948|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162011810|NCT01746901|585099949|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162011811|NCT01746901|585099950|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162011812|NCT01746901|585099951|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162011813|NCT01746901|585099952|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162011814|NCT01746901|585099953|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
162011815|NCT01746901|585099945|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
162011816|NCT01746901|585099946|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
162011817|NCT01746901|585099947|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
162011818|NCT01746901|585099948|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
162011819|NCT01746901|585099949|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
162011820|NCT01746901|585099950|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
162011821|NCT01746901|585099951|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
162011822|NCT01746901|585099952|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
162011823|NCT01746901|585099953|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
162011824|NCT01746901|585099945|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
162011825|NCT01746901|585099946|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
162011826|NCT01746901|585099947|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
162011827|NCT01746901|585099948|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
162011828|NCT01746901|585099949|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
162011829|NCT01746901|585099950|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
162011830|NCT01746901|585099951|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
162011831|NCT01746901|585099952|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
162011832|NCT01746901|585099953|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
162011833|NCT01746901|585099945|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
162011834|NCT01746901|585099946|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
162011835|NCT01746901|585099947|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
162011836|NCT01746901|585099948|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
162011837|NCT01746901|585099949|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
162011838|NCT01746901|585099950|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
162011839|NCT01746901|585099951|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
162011840|NCT01746901|585099952|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
162011841|NCT01746901|585099953|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
162011842|NCT01746901|585099945|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
162011843|NCT01746901|585099946|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
162011844|NCT01746901|585099947|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
162011845|NCT01746901|585099948|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
162011846|NCT01746901|585099949|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
162146116|NCT02503202|585581148|FG002|Extension: Month 6 to 24|Death|0|||
162146117|NCT02503202|585581149|FG003|Extension: Month 6 to 24|Death|0|||
162146118|NCT02503202|585581150|FG004|Extension: Month 6 to 24|Death|0|||
162146119|NCT02503202|585581146|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
162146120|NCT02503202|585581147|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
162146121|NCT02503202|585581148|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
162146122|NCT02503202|585581149|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
162146123|NCT02503202|585581150|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
162146124|NCT02503202|585581146|FG000|Extension: Month 6 to 24|Physician Decision|1|||
162146125|NCT02503202|585581147|FG001|Extension: Month 6 to 24|Physician Decision|0|||
162146126|NCT02503202|585581148|FG002|Extension: Month 6 to 24|Physician Decision|1|||
162011847|NCT01746901|585099950|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
162011848|NCT01746901|585099951|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
162146127|NCT02503202|585581149|FG003|Extension: Month 6 to 24|Physician Decision|3|||
162146128|NCT02503202|585581150|FG004|Extension: Month 6 to 24|Physician Decision|0|||
162146129|NCT02503202|585581146|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
162146130|NCT02503202|585581147|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
162146131|NCT02503202|585581148|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
162146132|NCT02503202|585581149|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
162146133|NCT02503202|585581150|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
162146134|NCT01119950|585581151|FG000|Overall Study|Adverse Event|25|||
162146135|NCT01119950|585581151|FG000|Overall Study|Withdrawal by Subject|9|||
162146136|NCT01119950|585581151|FG000|Overall Study|Protocol Violation|5|||
162146137|NCT01119950|585581151|FG000|Overall Study|Lost to Follow-up|4|||
162146138|NCT01119950|585581151|FG000|Overall Study|Administrative|2|||
162146139|NCT01119950|585581151|FG000|Overall Study|Abnormal lab value|1|||
161913527|NCT01288430|584733561|FG002|Part 2|Progressive disease|0|||
161913528|NCT01288430|584733562|FG003|Part 2|Progressive disease|0|||
161913529|NCT01288430|584733563|FG004|Part 2|Progressive disease|0|||
161913530|NCT01288430|584733564|FG005|Part 2|Progressive disease|0|||
161913531|NCT01288430|584733565|FG006|Part 2|Progressive disease|0|||
161913532|NCT01288430|584733566|FG007|Part 2|Progressive disease|8|||
161913533|NCT01288430|584733567|FG008|Part 2|Progressive disease|7|||
161913534|NCT01288430|584733568|FG009|Part 2|Progressive disease|2|||
161913535|NCT01288430|584733559|FG000|Part 2|Clinical disease progression|0|||
161913536|NCT01288430|584733560|FG001|Part 2|Clinical disease progression|0|||
161913537|NCT01288430|584733561|FG002|Part 2|Clinical disease progression|0|||
161913538|NCT01288430|584733562|FG003|Part 2|Clinical disease progression|0|||
161913539|NCT01288430|584733563|FG004|Part 2|Clinical disease progression|0|||
161913540|NCT01288430|584733564|FG005|Part 2|Clinical disease progression|0|||
161913541|NCT01288430|584733565|FG006|Part 2|Clinical disease progression|0|||
161913542|NCT01288430|584733566|FG007|Part 2|Clinical disease progression|2|||
161913543|NCT01288430|584733567|FG008|Part 2|Clinical disease progression|0|||
161913544|NCT01288430|584733568|FG009|Part 2|Clinical disease progression|0|||
161913545|NCT01288430|584733559|FG000|Part 2|Withdrawal by Subject|0|||
161913546|NCT01288430|584733560|FG001|Part 2|Withdrawal by Subject|0|||
161913547|NCT01288430|584733561|FG002|Part 2|Withdrawal by Subject|0|||
161913548|NCT01288430|584733562|FG003|Part 2|Withdrawal by Subject|0|||
161913549|NCT01288430|584733563|FG004|Part 2|Withdrawal by Subject|0|||
161913550|NCT01288430|584733564|FG005|Part 2|Withdrawal by Subject|0|||
161913551|NCT01288430|584733565|FG006|Part 2|Withdrawal by Subject|0|||
161913552|NCT01288430|584733566|FG007|Part 2|Withdrawal by Subject|1|||
161913553|NCT01288430|584733567|FG008|Part 2|Withdrawal by Subject|4|||
161913554|NCT01288430|584733568|FG009|Part 2|Withdrawal by Subject|0|||
161913555|NCT01288430|584733559|FG000|Part 2|Adverse Event|0|||
161913556|NCT01288430|584733560|FG001|Part 2|Adverse Event|0|||
161913557|NCT01288430|584733561|FG002|Part 2|Adverse Event|0|||
161913558|NCT01288430|584733562|FG003|Part 2|Adverse Event|0|||
161913559|NCT01288430|584733563|FG004|Part 2|Adverse Event|0|||
161913560|NCT01288430|584733564|FG005|Part 2|Adverse Event|0|||
161913561|NCT01288430|584733565|FG006|Part 2|Adverse Event|0|||
161913562|NCT01288430|584733566|FG007|Part 2|Adverse Event|1|||
161913563|NCT01288430|584733567|FG008|Part 2|Adverse Event|1|||
161913564|NCT01288430|584733568|FG009|Part 2|Adverse Event|0|||
161913565|NCT01288430|584733559|FG000|Part 2|Other|0|||
161913566|NCT01288430|584733560|FG001|Part 2|Other|0|||
161913567|NCT01288430|584733561|FG002|Part 2|Other|0|||
161913568|NCT01288430|584733562|FG003|Part 2|Other|0|||
161913569|NCT01288430|584733563|FG004|Part 2|Other|0|||
162146140|NCT01119950|585581151|FG000|Overall Study|Death|1|||
162146141|NCT01988233|585581154|FG000|Overall Study|Lost to Follow-up|64|||
161913570|NCT01288430|584733564|FG005|Part 2|Other|0|||
161913571|NCT01288430|584733565|FG006|Part 2|Other|0|||
161913572|NCT01288430|584733566|FG007|Part 2|Other|0|||
161913573|NCT01288430|584733567|FG008|Part 2|Other|0|||
161913574|NCT01288430|584733568|FG009|Part 2|Other|1|||
162011849|NCT01746901|585099952|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
162011850|NCT01746901|585099953|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
162011851|NCT01746901|585099945|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
162146142|NCT01988233|585581155|FG001|Overall Study|Lost to Follow-up|51|||
162011852|NCT01746901|585099946|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
162011853|NCT01746901|585099947|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
162011854|NCT01746901|585099948|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
162011855|NCT01746901|585099949|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
162011856|NCT01746901|585099950|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
162146143|NCT01591616|585581158|FG000|Overall Study|Withdrawal by Subject|1|||
161913585|NCT00788671|584733573|FG000|Overall Study|Death|2|||
161913586|NCT00788671|584733573|FG000|Overall Study|Unable to biopsy|1|||
161913587|NCT00788671|584733573|FG000|Overall Study|Withdrawal by Subject|4|||
161913588|NCT00788671|584733573|FG000|Overall Study|IUD expulsed|1|||
161913589|NCT00788671|584733573|FG000|Overall Study|Lost to follow up|2|||
161913590|NCT04780659|584733574|FG000|Overall Study|Adverse event, serious fatal|3|||
161913591|NCT04780659|584733575|FG001|Overall Study|Adverse event, serious fatal|0|||
162146144|NCT00758602|585581159|FG000|Overall Study|Adverse Event|11|||
162146145|NCT00758602|585581160|FG001|Overall Study|Adverse Event|10|||
162146146|NCT00758602|585581159|FG000|Overall Study|Lost to Follow-up|4|||
162146147|NCT00758602|585581160|FG001|Overall Study|Lost to Follow-up|3|||
162146148|NCT00758602|585581159|FG000|Overall Study|Withdrawal by Subject|1|||
162146149|NCT00758602|585581160|FG001|Overall Study|Withdrawal by Subject|3|||
162146150|NCT00758602|585581159|FG000|Overall Study|Protocol Violation|0|||
162146151|NCT00758602|585581160|FG001|Overall Study|Protocol Violation|2|||
162146152|NCT00758602|585581159|FG000|Overall Study|Death|0|||
162146153|NCT00758602|585581160|FG001|Overall Study|Death|1|||
162146154|NCT00758602|585581159|FG000|Overall Study|Reason not specified|3|||
162146155|NCT00758602|585581160|FG001|Overall Study|Reason not specified|3|||
162146156|NCT02148133|585581173|FG000|Overall Study|Investigator discretion|1|||
162146157|NCT02148133|585581173|FG000|Overall Study|Lack of Efficacy|1|||
162146158|NCT02148133|585581173|FG000|Overall Study|Protocol deviation|1|||
162146159|NCT02148133|585581173|FG000|Overall Study|Protocol-defined stopping criteria|2|||
162146160|NCT03808883|585581174|FG000|Overall Study|Withdrawal by Subject|2|||
162146161|NCT03808883|585581175|FG001|Overall Study|Withdrawal by Subject|0|||
162146162|NCT03808883|585581174|FG000|Overall Study|Did not complete pre test or post test survey|4|||
162146163|NCT03808883|585581175|FG001|Overall Study|Did not complete pre test or post test survey|3|||
162146164|NCT00855465|585581177|FG000|Treatment Period|Adverse Event|4|||
162146165|NCT00855465|585581178|FG001|Treatment Period|Adverse Event|2|||
162146166|NCT00855465|585581177|FG000|Treatment Period|Death|2|||
162146167|NCT00855465|585581178|FG001|Treatment Period|Death|2|||
162146168|NCT00855465|585581177|FG000|Treatment Period|Lack of Efficacy|2|||
162146169|NCT00855465|585581178|FG001|Treatment Period|Lack of Efficacy|1|||
162146170|NCT00855465|585581177|FG000|Treatment Period|Non-compliance|1|||
162146171|NCT00855465|585581178|FG001|Treatment Period|Non-compliance|0|||
162146172|NCT00855465|585581177|FG000|Treatment Period|Protocol Violation|2|||
162146173|NCT00855465|585581178|FG001|Treatment Period|Protocol Violation|0|||
162146174|NCT00855465|585581177|FG000|Treatment Period|Withdrawal by Subject|2|||
162146175|NCT00855465|585581178|FG001|Treatment Period|Withdrawal by Subject|0|||
162146176|NCT00855465|585581177|FG000|Treatment Period|Not treated|1|||
162146177|NCT00855465|585581178|FG001|Treatment Period|Not treated|0|||
162146178|NCT00855465|585581177|FG000|Follow-up Period (FUP)|Adverse Event|0|||
162146179|NCT00855465|585581178|FG001|Follow-up Period (FUP)|Adverse Event|1|||
162146180|NCT00855465|585581177|FG000|Follow-up Period (FUP)|Death|0|||
162146181|NCT00855465|585581178|FG001|Follow-up Period (FUP)|Death|1|||
162146182|NCT00855465|585581177|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
162146183|NCT00855465|585581178|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
162146184|NCT00855465|585581177|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
162146185|NCT00855465|585581178|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
162146186|NCT00855465|585581177|FG000|Follow-up Period (FUP)|Missing|1|||
162146187|NCT00855465|585581178|FG001|Follow-up Period (FUP)|Missing|0|||
162146188|NCT03743246|585581189|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
162146189|NCT03743246|585581190|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
162146190|NCT03743246|585581191|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
162146191|NCT03743246|585581192|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
162146192|NCT03743246|585581189|FG000|Pre-Treatment Period|Death|0|||
162146193|NCT03743246|585581190|FG001|Pre-Treatment Period|Death|1|||
162146194|NCT03743246|585581191|FG002|Pre-Treatment Period|Death|0|||
162146195|NCT03743246|585581192|FG003|Pre-Treatment Period|Death|1|||
162146196|NCT03743246|585581189|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
162146197|NCT03743246|585581190|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
162146198|NCT03743246|585581191|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
162146199|NCT03743246|585581192|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
162146200|NCT03743246|585581189|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
162146201|NCT03743246|585581190|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
161809682|NCT00640562|584345764|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
162146202|NCT03743246|585581191|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
161809683|NCT00640562|584345765|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
161809684|NCT00640562|584345764|FG000|Overall Study|Low study drug dose|0|||
161809685|NCT00640562|584345765|FG001|Overall Study|Low study drug dose|1|||
162146203|NCT03743246|585581192|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
162146204|NCT03743246|585581189|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
162146205|NCT03743246|585581190|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
162146206|NCT03743246|585581191|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
162146207|NCT03743246|585581192|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
161809686|NCT00640562|584345764|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
162146208|NCT03743246|585581189|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
162146209|NCT03743246|585581190|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
162146210|NCT03743246|585581191|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
162146211|NCT03743246|585581192|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
161809687|NCT00640562|584345765|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
162146212|NCT03743246|585581189|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
162146213|NCT03743246|585581190|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
162146214|NCT03743246|585581191|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
162146215|NCT03743246|585581192|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
162146216|NCT03743246|585581189|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
162146217|NCT03743246|585581190|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
162146218|NCT03743246|585581191|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
162146219|NCT03743246|585581192|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
162146220|NCT03743246|585581189|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
162146221|NCT03743246|585581190|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
162146222|NCT03743246|585581191|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
162146223|NCT03743246|585581192|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
162146224|NCT04173572|585581193|FG000|Overall Study|Withdrawal by Subject|1|||
162146225|NCT04173572|585581194|FG001|Overall Study|Withdrawal by Subject|5|||
162146226|NCT04173572|585581193|FG000|Overall Study|Lost to Follow-up|3|||
162146227|NCT04173572|585581194|FG001|Overall Study|Lost to Follow-up|1|||
162011857|NCT01746901|585099951|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
162011858|NCT01746901|585099952|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
162011859|NCT01746901|585099953|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
162011860|NCT01746901|585099945|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
162011861|NCT01746901|585099946|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
162011862|NCT01746901|585099947|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
162011863|NCT01746901|585099948|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
162011864|NCT01746901|585099949|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
162011865|NCT01746901|585099950|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
162011866|NCT01746901|585099951|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
162011867|NCT01746901|585099952|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
162011868|NCT01746901|585099953|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
162011869|NCT03594110|585099954|FG000|Interventional Part|Participant concerned about study treatment|23|||
162011870|NCT03594110|585099955|FG001|Interventional Part|Participant concerned about study treatment|28|||
162011871|NCT03594110|585099954|FG000|Interventional Part|Doctor advice|38|||
162011872|NCT03594110|585099955|FG001|Interventional Part|Doctor advice|40|||
162011873|NCT03594110|585099954|FG000|Interventional Part|Participants' wish|89|||
162011874|NCT03594110|585099955|FG001|Interventional Part|Participants' wish|68|||
162011875|NCT03594110|585099954|FG000|Interventional Part|Adverse event-non-fatal events|119|||
162011876|NCT03594110|585099955|FG001|Interventional Part|Adverse event-non-fatal events|116|||
162011877|NCT03594110|585099954|FG000|Interventional Part|Study drug stopped, reason missing|336|||
162011878|NCT03594110|585099955|FG001|Interventional Part|Study drug stopped, reason missing|294|||
162011879|NCT03594110|585099954|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
162011880|NCT03594110|585099955|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
162011881|NCT03594110|585099954|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
162011882|NCT03594110|585099955|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
162011883|NCT03594110|585099954|FG000|Interventional Part|Contraindicated drug started|32|||
162011884|NCT03594110|585099955|FG001|Interventional Part|Contraindicated drug started|18|||
162011885|NCT03594110|585099954|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
162011886|NCT03594110|585099955|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
162011887|NCT03594110|585099954|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
162011888|NCT03594110|585099955|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
162011889|NCT03594110|585099954|FG000|Non-interventional Part|Withdrawal by Subject|3|||
162011890|NCT03594110|585099955|FG001|Non-interventional Part|Withdrawal by Subject|4|||
162011891|NCT03594110|585099954|FG000|Non-interventional Part|Lost to Follow-up|45|||
162011892|NCT03594110|585099955|FG001|Non-interventional Part|Lost to Follow-up|41|||
162011893|NCT03041038|585099956|FG000|Overall Study|Withdrawal by Subject|4|||
162011894|NCT03041038|585099957|FG001|Overall Study|Withdrawal by Subject|0|||
162011895|NCT03041038|585099956|FG000|Overall Study|Lost to Follow-up|1|||
162146228|NCT00395018|585581195|FG000|On-Treatment|Death|4|||
162146229|NCT00395018|585581195|FG000|On-Treatment|Other Reason|2|||
162146230|NCT00395018|585581195|FG000|On-Treatment|Poor/non-compliance|2|||
162146231|NCT00395018|585581195|FG000|On-Treatment|Subject no longer meets study criteria|2|||
162146232|NCT00395018|585581195|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
162146233|NCT00395018|585581195|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
162146234|NCT00395018|585581195|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
161809688|NCT02699866|584345766|FG000|Overall Study|Withdrawal by Subject|3|||
162011896|NCT03041038|585099957|FG001|Overall Study|Lost to Follow-up|1|||
162146235|NCT03478696|585581211|FG000|Overall Study|Adverse Event|1|||
162146236|NCT03478696|585581212|FG001|Overall Study|Adverse Event|5|||
162146237|NCT03478696|585581211|FG000|Overall Study|Lost to Follow-up|1|||
162146238|NCT03478696|585581212|FG001|Overall Study|Lost to Follow-up|0|||
162146239|NCT03478696|585581211|FG000|Overall Study|Physician Decision|6|||
162146240|NCT03478696|585581212|FG001|Overall Study|Physician Decision|3|||
161809689|NCT02699866|584345766|FG000|Overall Study|Physician Decision|2|||
161809690|NCT02699866|584345766|FG000|Overall Study|Adverse Event|3|||
161809691|NCT02937870|584345767|FG000|Overall Study|Adverse Event|1|||
161809692|NCT02937870|584345767|FG000|Overall Study|Protocol Deviation|2|||
161809693|NCT00244764|584345768|FG000|Overall Study|Adverse Event|37|||
161809694|NCT00244764|584345768|FG000|Overall Study|Lost to Follow-up|23|||
161809695|NCT00244764|584345768|FG000|Overall Study|Withdrawal by Subject|12|||
162146241|NCT03478696|585581211|FG000|Overall Study|Withdrawal by Subject|9|||
162146242|NCT03478696|585581212|FG001|Overall Study|Withdrawal by Subject|4|||
162146243|NCT02341625|585581221|FG000|Overall Study|Disease Progression|2|||
162146244|NCT02341625|585581222|FG001|Overall Study|Disease Progression|2|||
161809696|NCT00244764|584345768|FG000|Overall Study|Disease Progression|13|||
161913592|NCT04780659|584733574|FG000|Overall Study|Withdrawal by Subject|3|||
161809697|NCT00244764|584345768|FG000|Overall Study|Protocol Violation|2|||
161809698|NCT00244764|584345768|FG000|Overall Study|Death|1|||
162146245|NCT02341625|585581223|FG002|Overall Study|Disease Progression|3|||
162146246|NCT02341625|585581224|FG003|Overall Study|Disease Progression|6|||
162146247|NCT02341625|585581225|FG004|Overall Study|Disease Progression|7|||
161809699|NCT00244764|584345768|FG000|Overall Study|Off Study Medication for >21 Days|1|||
162011897|NCT03041038|585099956|FG000|Overall Study|Protocol Violation|1|||
162146248|NCT02341625|585581226|FG005|Overall Study|Disease Progression|7|||
162146249|NCT02341625|585581227|FG006|Overall Study|Disease Progression|28|||
162146250|NCT02341625|585581228|FG007|Overall Study|Disease Progression|5|||
162146251|NCT02341625|585581229|FG008|Overall Study|Disease Progression|4|||
162146252|NCT02341625|585581230|FG009|Overall Study|Disease Progression|19|||
162146253|NCT02341625|585581221|FG000|Overall Study|Study Drug Toxicity|0|||
162146254|NCT02341625|585581222|FG001|Overall Study|Study Drug Toxicity|0|||
162146255|NCT02341625|585581223|FG002|Overall Study|Study Drug Toxicity|0|||
162146256|NCT02341625|585581224|FG003|Overall Study|Study Drug Toxicity|1|||
162146257|NCT02341625|585581225|FG004|Overall Study|Study Drug Toxicity|0|||
162146258|NCT02341625|585581226|FG005|Overall Study|Study Drug Toxicity|3|||
162146259|NCT02341625|585581227|FG006|Overall Study|Study Drug Toxicity|10|||
162146260|NCT02341625|585581228|FG007|Overall Study|Study Drug Toxicity|0|||
162146261|NCT02341625|585581229|FG008|Overall Study|Study Drug Toxicity|0|||
162146262|NCT02341625|585581230|FG009|Overall Study|Study Drug Toxicity|3|||
162146263|NCT02341625|585581221|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162146264|NCT02341625|585581222|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162146265|NCT02341625|585581223|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162146266|NCT02341625|585581224|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162146267|NCT02341625|585581225|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162146268|NCT02341625|585581226|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162146269|NCT02341625|585581227|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
162146270|NCT02341625|585581228|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
162146271|NCT02341625|585581229|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
162146272|NCT02341625|585581230|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
162146273|NCT02341625|585581221|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162146274|NCT02341625|585581222|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162146275|NCT02341625|585581223|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162146276|NCT02341625|585581224|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162146277|NCT02341625|585581225|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162146278|NCT02341625|585581226|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162146279|NCT02341625|585581227|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
162146280|NCT02341625|585581228|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
162146281|NCT02341625|585581229|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162146282|NCT02341625|585581230|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
162146283|NCT02341625|585581221|FG000|Overall Study|Participant Withdrew Consent|0|||
162146284|NCT02341625|585581222|FG001|Overall Study|Participant Withdrew Consent|0|||
162146285|NCT02341625|585581223|FG002|Overall Study|Participant Withdrew Consent|0|||
162146286|NCT02341625|585581224|FG003|Overall Study|Participant Withdrew Consent|1|||
162146287|NCT02341625|585581225|FG004|Overall Study|Participant Withdrew Consent|0|||
162146288|NCT02341625|585581226|FG005|Overall Study|Participant Withdrew Consent|0|||
162146289|NCT02341625|585581227|FG006|Overall Study|Participant Withdrew Consent|0|||
162146290|NCT02341625|585581228|FG007|Overall Study|Participant Withdrew Consent|0|||
162146291|NCT02341625|585581229|FG008|Overall Study|Participant Withdrew Consent|0|||
162146292|NCT02341625|585581230|FG009|Overall Study|Participant Withdrew Consent|0|||
162146293|NCT02341625|585581221|FG000|Overall Study|Completed Treatment as per Protocol|0|||
162146294|NCT02341625|585581222|FG001|Overall Study|Completed Treatment as per Protocol|0|||
162146295|NCT02341625|585581223|FG002|Overall Study|Completed Treatment as per Protocol|0|||
162146296|NCT02341625|585581224|FG003|Overall Study|Completed Treatment as per Protocol|0|||
162146297|NCT02341625|585581225|FG004|Overall Study|Completed Treatment as per Protocol|0|||
162146298|NCT02341625|585581226|FG005|Overall Study|Completed Treatment as per Protocol|0|||
162146299|NCT02341625|585581227|FG006|Overall Study|Completed Treatment as per Protocol|0|||
162146300|NCT02341625|585581228|FG007|Overall Study|Completed Treatment as per Protocol|0|||
162146301|NCT02341625|585581229|FG008|Overall Study|Completed Treatment as per Protocol|0|||
162146302|NCT02341625|585581230|FG009|Overall Study|Completed Treatment as per Protocol|1|||
162146303|NCT02341625|585581221|FG000|Overall Study|Other Reasons|0|||
162146304|NCT02341625|585581222|FG001|Overall Study|Other Reasons|0|||
162146305|NCT02341625|585581223|FG002|Overall Study|Other Reasons|0|||
162146306|NCT02341625|585581224|FG003|Overall Study|Other Reasons|0|||
162146307|NCT02341625|585581225|FG004|Overall Study|Other Reasons|1|||
162146308|NCT02341625|585581226|FG005|Overall Study|Other Reasons|0|||
162146309|NCT02341625|585581227|FG006|Overall Study|Other Reasons|5|||
162146310|NCT02341625|585581228|FG007|Overall Study|Other Reasons|0|||
162146311|NCT02341625|585581229|FG008|Overall Study|Other Reasons|0|||
162146312|NCT02341625|585581230|FG009|Overall Study|Other Reasons|2|||
162146313|NCT02341625|585581221|FG000|Overall Study|Not Reported|0|||
162146314|NCT02341625|585581222|FG001|Overall Study|Not Reported|0|||
162146315|NCT02341625|585581223|FG002|Overall Study|Not Reported|0|||
162146316|NCT02341625|585581224|FG003|Overall Study|Not Reported|0|||
162146317|NCT02341625|585581225|FG004|Overall Study|Not Reported|0|||
162146318|NCT02341625|585581226|FG005|Overall Study|Not Reported|0|||
162146319|NCT02341625|585581227|FG006|Overall Study|Not Reported|0|||
162146320|NCT02341625|585581228|FG007|Overall Study|Not Reported|0|||
162146321|NCT02341625|585581229|FG008|Overall Study|Not Reported|0|||
162146322|NCT02341625|585581230|FG009|Overall Study|Not Reported|3|||
162146323|NCT03396913|585581231|FG000|Overall Study|Lost to Follow-up|0|||
162146324|NCT03396913|585581232|FG001|Overall Study|Lost to Follow-up|6|||
161913593|NCT04780659|584733575|FG001|Overall Study|Withdrawal by Subject|0|||
161913594|NCT04780659|584733574|FG000|Overall Study|Physician Decision|1|||
162146325|NCT01867580|585581241|FG000|Overall Study|Withdrawal by Subject|2|||
162146326|NCT01867580|585581242|FG001|Overall Study|Withdrawal by Subject|3|||
162146327|NCT01867580|585581241|FG000|Overall Study|Physician Decision|17|||
162146328|NCT01867580|585581242|FG001|Overall Study|Physician Decision|12|||
162146329|NCT01867580|585581241|FG000|Overall Study|Lost to Follow-up|3|||
162146330|NCT01867580|585581242|FG001|Overall Study|Lost to Follow-up|5|||
162146331|NCT01867580|585581241|FG000|Overall Study|Sponsor terminated study|1|||
162146332|NCT01867580|585581242|FG001|Overall Study|Sponsor terminated study|0|||
162146333|NCT01867580|585581241|FG000|Overall Study|Missed follow-up assessment|2|||
162146334|NCT01867580|585581242|FG001|Overall Study|Missed follow-up assessment|1|||
162146335|NCT01867580|585581241|FG000|Overall Study|Interruption to therapy|3|||
162146336|NCT01867580|585581242|FG001|Overall Study|Interruption to therapy|0|||
162146337|NCT01867580|585581241|FG000|Overall Study|Osteomyelitis|0|||
162146338|NCT01867580|585581242|FG001|Overall Study|Osteomyelitis|1|||
162146339|NCT01867580|585581241|FG000|Overall Study|Continuation of therapy|0|||
162146340|NCT01867580|585581242|FG001|Overall Study|Continuation of therapy|1|||
162146341|NCT01867580|585581241|FG000|Overall Study|Wound recurrence|0|||
162146342|NCT01867580|585581242|FG001|Overall Study|Wound recurrence|1|||
162146343|NCT01278862|585581243|FG000|Overall Study|Lost to Follow-up|1|||
162146344|NCT01278862|585581244|FG001|Overall Study|Lost to Follow-up|1|||
161913595|NCT04780659|584733575|FG001|Overall Study|Physician Decision|0|||
161913596|NCT04780659|584733574|FG000|Overall Study|Died in original disease|2|||
161913597|NCT04780659|584733575|FG001|Overall Study|Died in original disease|0|||
162146345|NCT02952261|585581246|FG000|Overall Study|Withdrawal by Subject|4|||
162146346|NCT02952261|585581247|FG001|Overall Study|Withdrawal by Subject|5|||
162146347|NCT02952261|585581246|FG000|Overall Study|Protocol Violation|1|||
162146348|NCT02952261|585581247|FG001|Overall Study|Protocol Violation|0|||
162146349|NCT03284957|585583054|FG000|Overall Study|Adverse Event|0|||
162146350|NCT03284957|585583055|FG001|Overall Study|Adverse Event|0|||
162146351|NCT03284957|585583056|FG002|Overall Study|Adverse Event|0|||
162146352|NCT03284957|585583057|FG003|Overall Study|Adverse Event|0|||
162146353|NCT03284957|585583058|FG004|Overall Study|Adverse Event|0|||
162146354|NCT03284957|585583059|FG005|Overall Study|Adverse Event|1|||
162146355|NCT03284957|585583060|FG006|Overall Study|Adverse Event|1|||
162146356|NCT03284957|585583061|FG007|Overall Study|Adverse Event|1|||
162146357|NCT03284957|585583062|FG008|Overall Study|Adverse Event|0|||
162146358|NCT03284957|585583063|FG009|Overall Study|Adverse Event|4|||
162146359|NCT03284957|585583064|FG010|Overall Study|Adverse Event|1|||
162146360|NCT03284957|585583065|FG011|Overall Study|Adverse Event|1|||
162146361|NCT03284957|585583066|FG012|Overall Study|Adverse Event|0|||
161913598|NCT04780659|584733574|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
162146362|NCT03284957|585583067|FG013|Overall Study|Adverse Event|0|||
162146363|NCT03284957|585583068|FG014|Overall Study|Adverse Event|0|||
162146364|NCT03284957|585583069|FG015|Overall Study|Adverse Event|0|||
162146365|NCT03284957|585583054|FG000|Overall Study|Progressive Disease|3|||
162146366|NCT03284957|585583055|FG001|Overall Study|Progressive Disease|3|||
162146367|NCT03284957|585583056|FG002|Overall Study|Progressive Disease|4|||
162146368|NCT03284957|585583057|FG003|Overall Study|Progressive Disease|3|||
162146369|NCT03284957|585583058|FG004|Overall Study|Progressive Disease|3|||
162146370|NCT03284957|585583059|FG005|Overall Study|Progressive Disease|5|||
162146371|NCT03284957|585583060|FG006|Overall Study|Progressive Disease|45|||
162146372|NCT03284957|585583061|FG007|Overall Study|Progressive Disease|8|||
162146373|NCT03284957|585583062|FG008|Overall Study|Progressive Disease|5|||
162146374|NCT03284957|585583063|FG009|Overall Study|Progressive Disease|18|||
162146375|NCT03284957|585583064|FG010|Overall Study|Progressive Disease|7|||
162146376|NCT03284957|585583065|FG011|Overall Study|Progressive Disease|2|||
162146377|NCT03284957|585583066|FG012|Overall Study|Progressive Disease|3|||
162146378|NCT03284957|585583067|FG013|Overall Study|Progressive Disease|1|||
162146379|NCT03284957|585583068|FG014|Overall Study|Progressive Disease|1|||
162146380|NCT03284957|585583069|FG015|Overall Study|Progressive Disease|2|||
162146381|NCT03284957|585583054|FG000|Overall Study|Withdrawal by Subject|0|||
162146382|NCT03284957|585583055|FG001|Overall Study|Withdrawal by Subject|0|||
162146383|NCT03284957|585583056|FG002|Overall Study|Withdrawal by Subject|0|||
162146384|NCT03284957|585583057|FG003|Overall Study|Withdrawal by Subject|0|||
162146385|NCT03284957|585583058|FG004|Overall Study|Withdrawal by Subject|0|||
162146386|NCT03284957|585583059|FG005|Overall Study|Withdrawal by Subject|0|||
162146387|NCT03284957|585583060|FG006|Overall Study|Withdrawal by Subject|0|||
162146388|NCT03284957|585583061|FG007|Overall Study|Withdrawal by Subject|0|||
162146389|NCT03284957|585583062|FG008|Overall Study|Withdrawal by Subject|0|||
162146390|NCT03284957|585583063|FG009|Overall Study|Withdrawal by Subject|2|||
162146391|NCT03284957|585583064|FG010|Overall Study|Withdrawal by Subject|0|||
162146392|NCT03284957|585583065|FG011|Overall Study|Withdrawal by Subject|0|||
162146393|NCT03284957|585583066|FG012|Overall Study|Withdrawal by Subject|0|||
162146394|NCT03284957|585583067|FG013|Overall Study|Withdrawal by Subject|0|||
162146395|NCT03284957|585583068|FG014|Overall Study|Withdrawal by Subject|0|||
162146396|NCT03284957|585583069|FG015|Overall Study|Withdrawal by Subject|0|||
162146397|NCT03284957|585583054|FG000|Overall Study|Other|0|||
162146398|NCT03284957|585583055|FG001|Overall Study|Other|0|||
162146399|NCT03284957|585583056|FG002|Overall Study|Other|0|||
162146400|NCT03284957|585583057|FG003|Overall Study|Other|0|||
162146401|NCT03284957|585583058|FG004|Overall Study|Other|0|||
162146402|NCT03284957|585583059|FG005|Overall Study|Other|0|||
162146403|NCT03284957|585583060|FG006|Overall Study|Other|3|||
162146404|NCT03284957|585583061|FG007|Overall Study|Other|0|||
162146405|NCT03284957|585583062|FG008|Overall Study|Other|1|||
162146406|NCT03284957|585583063|FG009|Overall Study|Other|6|||
162146407|NCT03284957|585583064|FG010|Overall Study|Other|0|||
162146408|NCT03284957|585583065|FG011|Overall Study|Other|0|||
162146409|NCT03284957|585583066|FG012|Overall Study|Other|0|||
162146410|NCT03284957|585583067|FG013|Overall Study|Other|0|||
162146411|NCT03284957|585583068|FG014|Overall Study|Other|2|||
162146412|NCT03284957|585583069|FG015|Overall Study|Other|0|||
162146413|NCT03086369|585583075|FG000|Overall Study|Lost to Follow-up|1|||
162146414|NCT03086369|585583076|FG001|Overall Study|Lost to Follow-up|0|||
162146415|NCT03086369|585583077|FG002|Overall Study|Lost to Follow-up|0|||
162146416|NCT03086369|585583078|FG003|Overall Study|Lost to Follow-up|2|||
162146417|NCT03086369|585583079|FG004|Overall Study|Lost to Follow-up|1|||
162146418|NCT03086369|585583075|FG000|Overall Study|Physician Decision|0|||
162146419|NCT03086369|585583076|FG001|Overall Study|Physician Decision|0|||
162146420|NCT03086369|585583077|FG002|Overall Study|Physician Decision|0|||
162146421|NCT03086369|585583078|FG003|Overall Study|Physician Decision|1|||
162146422|NCT03086369|585583079|FG004|Overall Study|Physician Decision|2|||
161809700|NCT00244764|584345768|FG000|Overall Study|Declining Performance Status|1|||
161809701|NCT00244764|584345768|FG000|Overall Study|Participant was Hospitalized until Death|1|||
161809702|NCT00244764|584345768|FG000|Overall Study|Primary Investigator Discretion|2|||
161809703|NCT00244764|584345768|FG000|Overall Study|Sponsor Terminated Study|2|||
161809704|NCT00244764|584345768|FG000|Overall Study|Developed Secondary Malignancy|1|||
161809705|NCT01294917|584345769|FG000|Overall Study|Relocation|5|||
161809706|NCT01294917|584345769|FG000|Overall Study|Inconvenience|1|||
162146423|NCT03086369|585583075|FG000|Overall Study|Withdrawal by Subject|0|||
162146424|NCT03086369|585583076|FG001|Overall Study|Withdrawal by Subject|0|||
162146425|NCT03086369|585583077|FG002|Overall Study|Withdrawal by Subject|0|||
162146426|NCT03086369|585583078|FG003|Overall Study|Withdrawal by Subject|5|||
162146427|NCT03086369|585583079|FG004|Overall Study|Withdrawal by Subject|3|||
162146428|NCT03086369|585583075|FG000|Overall Study|Progressive Disease|0|||
162146429|NCT03086369|585583076|FG001|Overall Study|Progressive Disease|0|||
162146430|NCT03086369|585583077|FG002|Overall Study|Progressive Disease|0|||
162146431|NCT03086369|585583078|FG003|Overall Study|Progressive Disease|1|||
162146432|NCT03086369|585583079|FG004|Overall Study|Progressive Disease|1|||
162146433|NCT03169244|585583080|FG000|Overall Study|Lost to Follow-up|1|||
162146434|NCT03169244|585583081|FG001|Overall Study|Lost to Follow-up|2|||
162146435|NCT03169244|585583080|FG000|Overall Study|Adverse Event|1|||
162146436|NCT03169244|585583081|FG001|Overall Study|Adverse Event|0|||
162146437|NCT03169244|585583080|FG000|Overall Study|Withdrawal by Subject|2|||
162146438|NCT03169244|585583081|FG001|Overall Study|Withdrawal by Subject|2|||
162146439|NCT03169244|585583080|FG000|Overall Study|Physician Decision|1|||
162146440|NCT03169244|585583081|FG001|Overall Study|Physician Decision|0|||
161809707|NCT03017885|584345770|FG000|Overall Study|Adverse Event|2|||
161809708|NCT03017885|584345771|FG001|Overall Study|Adverse Event|0|||
161809709|NCT03017885|584345772|FG002|Overall Study|Adverse Event|0|||
161809710|NCT03017885|584345773|FG003|Overall Study|Adverse Event|0|||
161809711|NCT03017885|584345774|FG004|Overall Study|Adverse Event|0|||
161809712|NCT03017885|584345775|FG005|Overall Study|Adverse Event|0|||
161809713|NCT03017885|584345770|FG000|Overall Study|Progression of disease|4|||
161809714|NCT03017885|584345771|FG001|Overall Study|Progression of disease|3|||
161913599|NCT04780659|584733575|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
161913600|NCT03729362|584733576|FG000|Overall Study|Withdrawal by Subject|2|||
161913601|NCT03729362|584733577|FG001|Overall Study|Withdrawal by Subject|0|||
161913602|NCT03729362|584733576|FG000|Overall Study|Physician Decision|1|||
161913603|NCT03729362|584733577|FG001|Overall Study|Physician Decision|0|||
161913604|NCT03729362|584733576|FG000|Overall Study|COVID-19 Pandemic|1|||
161913605|NCT03729362|584733577|FG001|Overall Study|COVID-19 Pandemic|0|||
161913606|NCT03729362|584733576|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
161913607|NCT03729362|584733577|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
161913608|NCT03729362|584733576|FG000|Overall Study|Adverse Event|0|||
161913609|NCT03729362|584733577|FG001|Overall Study|Adverse Event|1|||
161913610|NCT03729362|584733576|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
161913611|NCT03729362|584733577|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
161913612|NCT03405870|584733578|FG000|Overall Study|Withdrawal|1|||
161913613|NCT03405870|584733579|FG001|Overall Study|Withdrawal|0|||
161913614|NCT03405870|584733580|FG002|Overall Study|Withdrawal|1|||
161913615|NCT03405870|584733581|FG003|Overall Study|Withdrawal|0|||
161913616|NCT03405870|584733582|FG004|Overall Study|Withdrawal|0|||
161913617|NCT03405870|584733583|FG005|Overall Study|Withdrawal|0|||
161913618|NCT03405870|584733584|FG006|Overall Study|Withdrawal|1|||
161913619|NCT03405870|584733585|FG007|Overall Study|Withdrawal|0|||
161913620|NCT02807259|584733588|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
161913621|NCT02807259|584733589|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
161913622|NCT02807259|584733588|FG000|Midline (3 Months)|migration, refusal, not available|30|||
161913623|NCT02807259|584733589|FG001|Midline (3 Months)|migration, refusal, not available|34|||
161913624|NCT02807259|584733588|FG000|Endline (3 Months)|migration, refusal, not available|35|||
161913625|NCT02807259|584733589|FG001|Endline (3 Months)|migration, refusal, not available|87|||
161913626|NCT01171534|584733590|FG000|Overall Study|Lost to Follow-up|0|||
161913627|NCT01171534|584733591|FG001|Overall Study|Lost to Follow-up|2|||
161913628|NCT01171534|584733590|FG000|Overall Study|screen failure|0|||
161913629|NCT01171534|584733591|FG001|Overall Study|screen failure|1|||
161913630|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
161913631|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
161913632|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
161913633|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
161913634|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
161913635|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
161913636|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
161913637|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
161913638|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
161913639|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
161913640|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
161913641|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
161913642|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
161913643|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
161913644|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
161913645|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
161913646|NCT00849056|584733592|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
161913647|NCT00849056|584733593|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
161913648|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
161913649|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
161913650|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
161913651|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
161913652|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
161913653|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
161913654|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
161913655|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
161809715|NCT03017885|584345772|FG002|Overall Study|Progression of disease|4|||
161809716|NCT03017885|584345773|FG003|Overall Study|Progression of disease|0|||
162146441|NCT01070888|585583082|FG000|First Intervention (14 Days)|Adverse Event|0|||
162146442|NCT01070888|585583083|FG001|First Intervention (14 Days)|Adverse Event|1|||
162146443|NCT01070888|585583082|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
162146444|NCT01070888|585583083|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
162146445|NCT01070888|585583082|FG000|Washout (14 Days)|Physician Decision|1|||
162146446|NCT01070888|585583083|FG001|Washout (14 Days)|Physician Decision|0|||
162146447|NCT00178399|585583084|FG000|Overall Study|Physician Decision|4|||
162146448|NCT00178399|585583084|FG000|Overall Study|Withdrawal by Subject|8|||
162146449|NCT00178399|585583084|FG000|Overall Study|Lost to Follow-up|1|||
162146450|NCT02631148|585583085|FG000|Overall Study|8 were ineligible|8|||
162146451|NCT02631148|585583086|FG001|Overall Study|8 were ineligible|0|||
162146452|NCT02631148|585583085|FG000|Overall Study|Withdrawal by Subject|1|||
162146453|NCT02631148|585583086|FG001|Overall Study|Withdrawal by Subject|0|||
162146454|NCT02631148|585583085|FG000|Overall Study|PAH not available to study participant|1|||
162146455|NCT02631148|585583086|FG001|Overall Study|PAH not available to study participant|0|||
162146456|NCT00357396|585583087|FG000|Overall Study|Adverse Event|1|||
162146457|NCT00357396|585583088|FG001|Overall Study|Adverse Event|0|||
162146458|NCT00955825|585583089|FG000|Overall Study|Adverse Event|15|||
162146459|NCT00955825|585583090|FG001|Overall Study|Adverse Event|2|||
162146460|NCT00955825|585583089|FG000|Overall Study|Withdrawal by Subject|4|||
162146461|NCT00955825|585583090|FG001|Overall Study|Withdrawal by Subject|6|||
162146462|NCT00955825|585583089|FG000|Overall Study|Any other reason not above-mentioned|7|||
162146463|NCT00955825|585583090|FG001|Overall Study|Any other reason not above-mentioned|9|||
162146464|NCT00708032|585583091|FG000|Overall Study|Adverse Event|0|||
162146465|NCT00708032|585583092|FG001|Overall Study|Adverse Event|2|||
162146466|NCT00708032|585583091|FG000|Overall Study|Lost to Follow-up|1|||
162146467|NCT00708032|585583092|FG001|Overall Study|Lost to Follow-up|2|||
162146468|NCT00708032|585583091|FG000|Overall Study|Pregnancy|0|||
162146469|NCT00708032|585583092|FG001|Overall Study|Pregnancy|1|||
162146470|NCT00708032|585583091|FG000|Overall Study|Poor vision|0|||
162146471|NCT00708032|585583092|FG001|Overall Study|Poor vision|6|||
162146472|NCT00708032|585583091|FG000|Overall Study|Visit out of range at month 12|4|||
162146473|NCT00708032|585583092|FG001|Overall Study|Visit out of range at month 12|1|||
162146474|NCT00708032|585583091|FG000|Overall Study|Did not meet protocol criteria|1|||
162146475|NCT00708032|585583092|FG001|Overall Study|Did not meet protocol criteria|2|||
162146476|NCT00708032|585583091|FG000|Overall Study|Protocol Violation|4|||
162146477|NCT00708032|585583092|FG001|Overall Study|Protocol Violation|1|||
162146478|NCT00708032|585583091|FG000|Overall Study|Withdrawal by Subject|0|||
162146479|NCT00708032|585583092|FG001|Overall Study|Withdrawal by Subject|1|||
162146480|NCT00150176|585583093|FG000|Overall Study|Adverse Event|16|||
162146481|NCT00150176|585583094|FG001|Overall Study|Adverse Event|53|||
162146482|NCT00150176|585583093|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
162146483|NCT00150176|585583094|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
162146484|NCT00150176|585583093|FG000|Overall Study|Withdrawal by Subject|19|||
162146485|NCT00150176|585583094|FG001|Overall Study|Withdrawal by Subject|12|||
162146486|NCT00150176|585583093|FG000|Overall Study|Lost to Follow-up|3|||
162146487|NCT00150176|585583094|FG001|Overall Study|Lost to Follow-up|3|||
162146488|NCT00150176|585583093|FG000|Overall Study|OTHER|11|||
162146489|NCT00150176|585583094|FG001|Overall Study|OTHER|13|||
162146490|NCT04035668|585583098|FG000|Overall Study|Adverse Event|3|||
162146491|NCT04035668|585583099|FG001|Overall Study|Adverse Event|4|||
162146492|NCT04035668|585583100|FG002|Overall Study|Adverse Event|2|||
162146493|NCT04035668|585583098|FG000|Overall Study|Lost to Follow-up|0|||
162146494|NCT04035668|585583099|FG001|Overall Study|Lost to Follow-up|1|||
162146495|NCT04035668|585583100|FG002|Overall Study|Lost to Follow-up|0|||
162146496|NCT04035668|585583098|FG000|Overall Study|Physician Decision|2|||
162146497|NCT04035668|585583099|FG001|Overall Study|Physician Decision|1|||
162146498|NCT04035668|585583100|FG002|Overall Study|Physician Decision|1|||
162146499|NCT04035668|585583098|FG000|Overall Study|Subject Decision|2|||
162146500|NCT04035668|585583099|FG001|Overall Study|Subject Decision|2|||
162146501|NCT04035668|585583100|FG002|Overall Study|Subject Decision|0|||
162146502|NCT02385669|585583102|FG000|Overall Study|Adverse Event|2|||
162146503|NCT00004124|585583103|FG000|Overall Study|Received no protocol therapy|12|||
162146504|NCT00004124|585583104|FG001|Overall Study|Received no protocol therapy|20|||
162146505|NCT02937831|585583105|FG000|Overall Study|Protocol Violation|4|||
162146506|NCT00114244|585583108|FG000|Overall Study|Adverse Event|2|||
162146507|NCT00114244|585583109|FG001|Overall Study|Adverse Event|5|||
162146508|NCT00114244|585583108|FG000|Overall Study|Withdrawal by Subject|0|||
162146509|NCT00114244|585583109|FG001|Overall Study|Withdrawal by Subject|2|||
162146510|NCT03262935|585583116|FG000|Overall Study|Withdrawal by Subject|6|||
162146511|NCT03262935|585583117|FG001|Overall Study|Withdrawal by Subject|7|||
162146512|NCT03262935|585583116|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
162146513|NCT03262935|585583117|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
162146514|NCT03262935|585583116|FG000|Overall Study|Death|181|||
162146515|NCT03262935|585583117|FG001|Overall Study|Death|94|||
162146516|NCT03262935|585583116|FG000|Overall Study|Lost to Follow-up|9|||
162146517|NCT03262935|585583117|FG001|Overall Study|Lost to Follow-up|4|||
162146518|NCT03262935|585583116|FG000|Overall Study|Other reason|5|||
161913656|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
161913657|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
161913658|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
161913659|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
161913660|NCT00849056|584733592|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
161913661|NCT00849056|584733593|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
161913662|NCT04588259|584733594|FG000|Run-in period|Run-in failure|0|||
161913663|NCT04588259|584733595|FG001|Run-in period|Run-in failure|23|||
161913664|NCT04588259|584733594|FG000|Run-in period|Withdrawn before randomisation|0|||
161913665|NCT04588259|584733595|FG001|Run-in period|Withdrawn before randomisation|8|||
162011898|NCT03041038|585099957|FG001|Overall Study|Protocol Violation|1|||
162011899|NCT02796170|585099958|FG000|Overall Study|Lost to Follow-up|3|||
162011900|NCT02796170|585099959|FG001|Overall Study|Lost to Follow-up|0|||
162011901|NCT01527370|585099960|FG000|Overall Study|Withdrawal by Subject|4|||
162011902|NCT01527370|585099960|FG000|Overall Study|Physician Decision|1|||
162011903|NCT01527370|585099960|FG000|Overall Study|Death|1|||
162011904|NCT02177032|585099961|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
162011905|NCT02177032|585099962|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
162011906|NCT02177032|585099963|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
162011907|NCT02177032|585099964|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
162011908|NCT02177032|585099961|FG000|Overall Study|Lost to Follow-up|0|||
162011909|NCT02177032|585099962|FG001|Overall Study|Lost to Follow-up|2|||
162011910|NCT02177032|585099963|FG002|Overall Study|Lost to Follow-up|0|||
162011911|NCT02177032|585099964|FG003|Overall Study|Lost to Follow-up|0|||
162011912|NCT02177032|585099961|FG000|Overall Study|OTHER|2|||
162011913|NCT02177032|585099962|FG001|Overall Study|OTHER|0|||
161913666|NCT04588259|584733594|FG000|Treatment period|Withdrawal by Subject|6|||
161913667|NCT04588259|584733595|FG001|Treatment period|Withdrawal by Subject|6|||
161913668|NCT02100631|584733602|FG000|Overall Study|Withdrawal by Subject|1|||
161913669|NCT02100631|584733603|FG001|Overall Study|Withdrawal by Subject|0|||
161913670|NCT02100631|584733604|FG002|Overall Study|Withdrawal by Subject|0|||
161913671|NCT02100631|584733602|FG000|Overall Study|Lost to Follow-up|3|||
161913672|NCT02100631|584733603|FG001|Overall Study|Lost to Follow-up|4|||
161913673|NCT02100631|584733604|FG002|Overall Study|Lost to Follow-up|0|||
161913674|NCT02100631|584733602|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
161913675|NCT02100631|584733603|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
161913676|NCT02100631|584733604|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
161913677|NCT04476043|584733605|FG000|Overall Study|Withdrawal by Subject|1|||
161913678|NCT04476043|584733606|FG001|Overall Study|Withdrawal by Subject|3|||
161913679|NCT04476043|584733607|FG002|Overall Study|Withdrawal by Subject|4|||
161913680|NCT04476043|584733608|FG003|Overall Study|Withdrawal by Subject|1|||
161913681|NCT04476043|584733605|FG000|Overall Study|Lost to Follow-up|1|||
161913682|NCT04476043|584733606|FG001|Overall Study|Lost to Follow-up|1|||
161913683|NCT04476043|584733607|FG002|Overall Study|Lost to Follow-up|2|||
161913684|NCT04476043|584733608|FG003|Overall Study|Lost to Follow-up|1|||
161913685|NCT04476043|584733605|FG000|Overall Study|Adverse Event|2|||
161913686|NCT04476043|584733606|FG001|Overall Study|Adverse Event|0|||
161913687|NCT04476043|584733607|FG002|Overall Study|Adverse Event|1|||
161913688|NCT04476043|584733608|FG003|Overall Study|Adverse Event|0|||
161913689|NCT04476043|584733605|FG000|Overall Study|Protocol Violation|0|||
161913690|NCT04476043|584733606|FG001|Overall Study|Protocol Violation|1|||
161913691|NCT04476043|584733607|FG002|Overall Study|Protocol Violation|0|||
161809717|NCT03017885|584345774|FG004|Overall Study|Progression of disease|0|||
161809718|NCT03017885|584345775|FG005|Overall Study|Progression of disease|0|||
161809719|NCT03017885|584345770|FG000|Overall Study|Other than listed|1|||
161809720|NCT03017885|584345771|FG001|Overall Study|Other than listed|2|||
161809721|NCT03017885|584345772|FG002|Overall Study|Other than listed|1|||
161809722|NCT03017885|584345773|FG003|Overall Study|Other than listed|0|||
161809723|NCT03017885|584345774|FG004|Overall Study|Other than listed|0|||
161809724|NCT03017885|584345775|FG005|Overall Study|Other than listed|0|||
161809725|NCT03017885|584345770|FG000|Overall Study|Lost to Follow-up|2|||
161809726|NCT03017885|584345771|FG001|Overall Study|Lost to Follow-up|0|||
161809727|NCT03017885|584345772|FG002|Overall Study|Lost to Follow-up|3|||
161809728|NCT03017885|584345773|FG003|Overall Study|Lost to Follow-up|0|||
161809729|NCT03017885|584345774|FG004|Overall Study|Lost to Follow-up|0|||
161809730|NCT03017885|584345775|FG005|Overall Study|Lost to Follow-up|0|||
161809731|NCT03017885|584345770|FG000|Overall Study|Change to other anti-cancer therapy|0|||
161809732|NCT03017885|584345771|FG001|Overall Study|Change to other anti-cancer therapy|0|||
161809733|NCT03017885|584345772|FG002|Overall Study|Change to other anti-cancer therapy|1|||
161809734|NCT03017885|584345773|FG003|Overall Study|Change to other anti-cancer therapy|0|||
161809735|NCT03017885|584345774|FG004|Overall Study|Change to other anti-cancer therapy|0|||
161809736|NCT03017885|584345775|FG005|Overall Study|Change to other anti-cancer therapy|0|||
161809737|NCT01208337|584345783|FG000|Overall Study|Death|3|||
161809738|NCT00836056|584345789|FG000|First Intervention|Adverse Event|1|||
161809739|NCT00836056|584345790|FG001|First Intervention|Adverse Event|0|||
161809740|NCT01001208|584345794|FG000|Overall Study|Adverse Event|10|||
161809741|NCT01001208|584345795|FG001|Overall Study|Adverse Event|5|||
161809742|NCT01001208|584345794|FG000|Overall Study|Lost to Follow-up|5|||
161809743|NCT01001208|584345795|FG001|Overall Study|Lost to Follow-up|9|||
161809744|NCT01001208|584345794|FG000|Overall Study|Physician Decision|1|||
161809745|NCT01001208|584345795|FG001|Overall Study|Physician Decision|0|||
161809746|NCT01001208|584345794|FG000|Overall Study|Withdrawal by Subject|4|||
161809747|NCT01001208|584345795|FG001|Overall Study|Withdrawal by Subject|5|||
161809748|NCT01001208|584345794|FG000|Overall Study|Ineligibility Determined|4|||
161809749|NCT01001208|584345795|FG001|Overall Study|Ineligibility Determined|2|||
161809750|NCT01001208|584345794|FG000|Overall Study|Noncompliance|4|||
161809751|NCT01001208|584345795|FG001|Overall Study|Noncompliance|7|||
161913692|NCT04476043|584733608|FG003|Overall Study|Protocol Violation|0|||
161913693|NCT00336544|584733609|FG000|Overall Study|Lack of Efficacy|8|||
161809752|NCT01001208|584345794|FG000|Overall Study|Disease Progression|0|||
161809753|NCT01001208|584345795|FG001|Overall Study|Disease Progression|3|||
161809754|NCT01001208|584345794|FG000|Overall Study|Other|0|||
161809755|NCT01001208|584345795|FG001|Overall Study|Other|2|||
161809756|NCT01864174|584345796|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
161809757|NCT01864174|584345797|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
162146519|NCT03262935|585583117|FG001|Overall Study|Other reason|0|||
162146520|NCT03557008|585583118|FG000|Overall Study|Withdrawal by Subject|2|||
162146521|NCT03557008|585583119|FG001|Overall Study|Withdrawal by Subject|2|||
162146522|NCT03557008|585583118|FG000|Overall Study|Early termination from study|3|||
162146523|NCT03557008|585583119|FG001|Overall Study|Early termination from study|1|||
162146524|NCT01811706|585583120|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
162146525|NCT01811706|585583121|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
162146526|NCT02224924|585583124|FG000|Overall Study|Withdrawal by Subject|7|||
162146527|NCT02224924|585583125|FG001|Overall Study|Withdrawal by Subject|6|||
162146528|NCT02224924|585583124|FG000|Overall Study|Biopsy cancelled|20|||
162146529|NCT02224924|585583125|FG001|Overall Study|Biopsy cancelled|14|||
162146530|NCT02224924|585583124|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
162146531|NCT02224924|585583125|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
162146532|NCT02224924|585583124|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
162146533|NCT02224924|585583125|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
162146534|NCT00943735|585583128|FG000|Overall Study|Adverse Event|12|||
162146535|NCT00943735|585583128|FG000|Overall Study|Withdrawal by Subject|8|||
162146536|NCT00943735|585583128|FG000|Overall Study|Death|1|||
162146537|NCT00943735|585583128|FG000|Overall Study|Other|8|||
162146538|NCT00943735|585583128|FG000|Overall Study|Other|3|||
162146539|NCT00545844|585583129|FG000|Overall Study|Lost to Follow-up|9|||
162146540|NCT00545844|585583129|FG000|Overall Study|Protocol Violation|1|||
162146541|NCT00545844|585583129|FG000|Overall Study|Withdrawal by Subject|2|||
162146542|NCT01329328|585583130|FG000|Overall Study|Withdrawal by Subject|2|||
162146543|NCT01329328|585583131|FG001|Overall Study|Withdrawal by Subject|4|||
162146544|NCT01329328|585583132|FG002|Overall Study|Withdrawal by Subject|3|||
162146545|NCT04439799|585583133|FG000|Overall Study|Lost to Follow-up|6|||
162146546|NCT04439799|585583134|FG001|Overall Study|Lost to Follow-up|6|||
162146547|NCT04439799|585583133|FG000|Overall Study|Withdrawal by Subject|2|||
162146548|NCT04439799|585583134|FG001|Overall Study|Withdrawal by Subject|6|||
162146549|NCT04439799|585583133|FG000|Overall Study|Adverse Event|2|||
162146550|NCT04439799|585583134|FG001|Overall Study|Adverse Event|5|||
162146551|NCT00371566|585583135|FG000|Treatment Phase|Withdrawal by Subject|0|||
162146552|NCT00371566|585583136|FG001|Treatment Phase|Withdrawal by Subject|1|||
162146553|NCT00371566|585583135|FG000|Treatment Phase|Adverse Event|0|||
162146554|NCT00371566|585583136|FG001|Treatment Phase|Adverse Event|1|||
162146555|NCT00371566|585583135|FG000|Treatment Phase|Protocol Violation|0|||
162146556|NCT00371566|585583136|FG001|Treatment Phase|Protocol Violation|1|||
162146557|NCT00371566|585583135|FG000|Chemoradiation Phase|Physician Decision|2|||
162146558|NCT00371566|585583136|FG001|Chemoradiation Phase|Physician Decision|0|||
162146559|NCT00371566|585583135|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
162146560|NCT00371566|585583136|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
162146561|NCT00371566|585583135|FG000|Chemoradiation Phase|Non compliant|0|||
162146562|NCT00371566|585583136|FG001|Chemoradiation Phase|Non compliant|1|||
162146563|NCT00371566|585583135|FG000|Chemoradiation Phase|Progressive Disease|1|||
162146564|NCT00371566|585583136|FG001|Chemoradiation Phase|Progressive Disease|1|||
162146565|NCT00371566|585583135|FG000|Chemoradiation Phase|Death|2|||
162146566|NCT00371566|585583136|FG001|Chemoradiation Phase|Death|0|||
162146567|NCT00371566|585583135|FG000|Follow Up Phase|Death|0|||
162146568|NCT00371566|585583136|FG001|Follow Up Phase|Death|5|||
162146569|NCT00371566|585583135|FG000|Follow Up Phase|Disease progression|1|||
162146570|NCT00371566|585583136|FG001|Follow Up Phase|Disease progression|0|||
162146571|NCT00371566|585583135|FG000|Follow Up Phase|Withdrawal by Subject|0|||
162146572|NCT00371566|585583136|FG001|Follow Up Phase|Withdrawal by Subject|1|||
162146573|NCT00371566|585583135|FG000|Follow Up Phase|Physician Decision|1|||
162146574|NCT00371566|585583136|FG001|Follow Up Phase|Physician Decision|1|||
162146575|NCT00371566|585583135|FG000|Follow Up Phase|Lost to Follow-up|1|||
162146576|NCT00371566|585583136|FG001|Follow Up Phase|Lost to Follow-up|0|||
162146577|NCT00530842|585583141|FG000|Overall Study|Adverse Event|10|||
162146578|NCT00530842|585583142|FG001|Overall Study|Adverse Event|6|||
161809758|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
161809759|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
161809760|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
161809761|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
161809762|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
161809763|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
161809764|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Death|1|||
161809765|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Death|0|||
162146579|NCT00530842|585583141|FG000|Overall Study|Lack of Efficacy|2|||
162146580|NCT00530842|585583142|FG001|Overall Study|Lack of Efficacy|1|||
162146581|NCT00530842|585583141|FG000|Overall Study|Lost to Follow-up|0|||
162146582|NCT00530842|585583142|FG001|Overall Study|Lost to Follow-up|4|||
162146583|NCT00530842|585583141|FG000|Overall Study|Protocol Violation|3|||
162146584|NCT00530842|585583142|FG001|Overall Study|Protocol Violation|2|||
162146585|NCT00530842|585583141|FG000|Overall Study|Withdrawal by Subject|4|||
162146586|NCT00530842|585583142|FG001|Overall Study|Withdrawal by Subject|5|||
162146587|NCT00530842|585583141|FG000|Overall Study|Individual different reasons|4|||
162146588|NCT00530842|585583142|FG001|Overall Study|Individual different reasons|3|||
162146589|NCT00530842|585583141|FG000|Period 1|Adverse Event|7|||
162146590|NCT00530842|585583142|FG001|Period 1|Adverse Event|3|||
162146591|NCT00530842|585583141|FG000|Period 1|Lack of Efficacy|1|||
162146592|NCT00530842|585583142|FG001|Period 1|Lack of Efficacy|1|||
162146593|NCT00530842|585583141|FG000|Period 1|Protocol Violation|2|||
162146594|NCT00530842|585583142|FG001|Period 1|Protocol Violation|1|||
162146595|NCT00530842|585583141|FG000|Period 1|Withdrawal by Subject|2|||
162146596|NCT00530842|585583142|FG001|Period 1|Withdrawal by Subject|3|||
162146597|NCT00530842|585583141|FG000|Period 1|Individual different reasons|2|||
162146598|NCT00530842|585583142|FG001|Period 1|Individual different reasons|3|||
162146599|NCT00530842|585583141|FG000|Period 2|Adverse Event|3|||
162146600|NCT00530842|585583142|FG001|Period 2|Adverse Event|3|||
162146601|NCT00530842|585583141|FG000|Period 2|Lack of Efficacy|1|||
162146602|NCT00530842|585583142|FG001|Period 2|Lack of Efficacy|0|||
162146603|NCT00530842|585583141|FG000|Period 2|Lost to Follow-up|0|||
162146604|NCT00530842|585583142|FG001|Period 2|Lost to Follow-up|4|||
162146605|NCT00530842|585583141|FG000|Period 2|Protocol Violation|1|||
162146606|NCT00530842|585583142|FG001|Period 2|Protocol Violation|0|||
162146607|NCT00530842|585583141|FG000|Period 2|Withdrawal by Subject|1|||
162146608|NCT00530842|585583142|FG001|Period 2|Withdrawal by Subject|2|||
162146609|NCT00530842|585583141|FG000|Period 2|Individual different reasons|2|||
162146610|NCT00530842|585583142|FG001|Period 2|Individual different reasons|0|||
162146611|NCT00082810|585583144|FG000|Overall Study|Adverse Event|3|||
162146612|NCT00082810|585583144|FG000|Overall Study|Progressive disease|24|||
162146613|NCT00082810|585583144|FG000|Overall Study|Withdrawal by Subject|4|||
162146614|NCT00177216|585583145|FG000|Overall Study|Withdrawal by Subject|6|||
162146615|NCT00177216|585583146|FG001|Overall Study|Withdrawal by Subject|3|||
162146616|NCT00177216|585583147|FG002|Overall Study|Withdrawal by Subject|1|||
162146617|NCT01161498|585583150|FG000|Overall Study|Disease Progression|0|||
162146618|NCT01161498|585583151|FG001|Overall Study|Disease Progression|1|||
162146619|NCT00988637|585583152|FG000|Overall Study|Lost to Follow-up|2|||
162146620|NCT00988637|585583153|FG001|Overall Study|Lost to Follow-up|1|||
162146621|NCT00988637|585583152|FG000|Overall Study|Withdrawal by Subject|1|||
162146622|NCT00988637|585583153|FG001|Overall Study|Withdrawal by Subject|1|||
162146623|NCT00988637|585583152|FG000|Overall Study|non-compliance with study drug|0|||
162146624|NCT00988637|585583153|FG001|Overall Study|non-compliance with study drug|1|||
162146625|NCT03310983|585583159|FG000|Overall Study|Lost to Follow-up|15|||
162146626|NCT03310983|585583160|FG001|Overall Study|Lost to Follow-up|17|||
162146627|NCT01656304|585583161|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
162146628|NCT00823979|585583164|FG000|Overall Study|Lack of Efficacy|13|||
162146629|NCT00823979|585583165|FG001|Overall Study|Lack of Efficacy|16|||
162146630|NCT00823979|585583166|FG002|Overall Study|Lack of Efficacy|9|||
162146631|NCT00823979|585583164|FG000|Overall Study|Lost to Follow-up|2|||
162146632|NCT00823979|585583165|FG001|Overall Study|Lost to Follow-up|1|||
162146633|NCT00823979|585583166|FG002|Overall Study|Lost to Follow-up|0|||
162146634|NCT00823979|585583164|FG000|Overall Study|Withdrawal by Subject|2|||
162146635|NCT00823979|585583165|FG001|Overall Study|Withdrawal by Subject|3|||
162146636|NCT00823979|585583166|FG002|Overall Study|Withdrawal by Subject|2|||
162146637|NCT00823979|585583164|FG000|Overall Study|Protocol Violation|1|||
162146638|NCT00823979|585583165|FG001|Overall Study|Protocol Violation|1|||
162146639|NCT00823979|585583166|FG002|Overall Study|Protocol Violation|0|||
162146640|NCT00823979|585583164|FG000|Overall Study|Pregnancy|0|||
162146641|NCT00823979|585583165|FG001|Overall Study|Pregnancy|1|||
162146642|NCT00823979|585583166|FG002|Overall Study|Pregnancy|0|||
162146643|NCT00823979|585583164|FG000|Overall Study|Adverse Event|0|||
162146644|NCT00823979|585583165|FG001|Overall Study|Adverse Event|2|||
162146645|NCT00823979|585583166|FG002|Overall Study|Adverse Event|4|||
162146646|NCT00823979|585583164|FG000|Overall Study|Other|2|||
161809766|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
161809767|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
162146647|NCT00823979|585583165|FG001|Overall Study|Other|0|||
162146648|NCT00823979|585583166|FG002|Overall Study|Other|1|||
162146649|NCT00823979|585583164|FG000|Overall Study|Randomized but not Treated|4|||
162146650|NCT00823979|585583165|FG001|Overall Study|Randomized but not Treated|3|||
162146651|NCT00823979|585583166|FG002|Overall Study|Randomized but not Treated|1|||
162146652|NCT00823979|585583164|FG000|Overall Study|Study Terminated by Sponsor|5|||
162146653|NCT00823979|585583165|FG001|Overall Study|Study Terminated by Sponsor|5|||
162146654|NCT00823979|585583166|FG002|Overall Study|Study Terminated by Sponsor|7|||
161809768|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
162146655|NCT03523091|585583167|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
161809769|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
162146656|NCT03523091|585583168|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
162146657|NCT03523091|585583167|FG000|Overall Study|Withdrawal by Subject|0|||
162146658|NCT03523091|585583168|FG001|Overall Study|Withdrawal by Subject|3|||
162146659|NCT03523091|585583167|FG000|Overall Study|Increase Botox dose|0|||
162146660|NCT03523091|585583168|FG001|Overall Study|Increase Botox dose|1|||
162146661|NCT01093534|585583169|FG000|Overall Study|Adverse Event|2|||
162146662|NCT01093534|585583170|FG001|Overall Study|Adverse Event|5|||
162146663|NCT01093534|585583171|FG002|Overall Study|Adverse Event|2|||
162146664|NCT01093534|585583169|FG000|Overall Study|Lack of Efficacy|2|||
162146665|NCT01093534|585583170|FG001|Overall Study|Lack of Efficacy|1|||
162146666|NCT01093534|585583171|FG002|Overall Study|Lack of Efficacy|1|||
162146667|NCT01093534|585583169|FG000|Overall Study|Withdrawal by Subject|5|||
162146668|NCT01093534|585583170|FG001|Overall Study|Withdrawal by Subject|7|||
162146669|NCT01093534|585583171|FG002|Overall Study|Withdrawal by Subject|2|||
162146670|NCT01093534|585583169|FG000|Overall Study|Other|1|||
162146671|NCT01093534|585583170|FG001|Overall Study|Other|3|||
162146672|NCT01093534|585583171|FG002|Overall Study|Other|4|||
162146673|NCT00741988|585583172|FG000|Overall Study|Adverse Event|2|||
162146674|NCT00741988|585583173|FG001|Overall Study|Adverse Event|4|||
162146675|NCT00741988|585583172|FG000|Overall Study|Lack of Efficacy|2|||
162146676|NCT00741988|585583173|FG001|Overall Study|Lack of Efficacy|0|||
162146677|NCT03863834|585583183|FG000|Overall Study|Lost to Follow-up|3|||
162146678|NCT02685488|585583184|FG000|Overall Study|Withdrawal by Subject|0|||
162146679|NCT02685488|585583185|FG001|Overall Study|Withdrawal by Subject|1|||
162146680|NCT04436120|585583186|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
162146681|NCT04436120|585583187|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
162146682|NCT04436120|585583188|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
162146683|NCT04436120|585583189|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
162146684|NCT04436120|585583190|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
162146685|NCT04436120|585583191|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
162146686|NCT04436120|585583192|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
162146687|NCT02020616|585583193|FG000|Overall Study|Adverse Event|0|||
162146688|NCT02020616|585583194|FG001|Overall Study|Adverse Event|0|||
162146689|NCT02020616|585583195|FG002|Overall Study|Adverse Event|0|||
162146690|NCT02020616|585583196|FG003|Overall Study|Adverse Event|0|||
162146691|NCT02020616|585583197|FG004|Overall Study|Adverse Event|0|||
162146692|NCT02020616|585583198|FG005|Overall Study|Adverse Event|1|||
162146693|NCT02020616|585583199|FG006|Overall Study|Adverse Event|1|||
162146694|NCT02020616|585583193|FG000|Overall Study|Physician Decision|0|||
162146695|NCT02020616|585583194|FG001|Overall Study|Physician Decision|0|||
162146696|NCT02020616|585583195|FG002|Overall Study|Physician Decision|0|||
162146697|NCT02020616|585583196|FG003|Overall Study|Physician Decision|0|||
162146698|NCT02020616|585583197|FG004|Overall Study|Physician Decision|0|||
162146699|NCT02020616|585583198|FG005|Overall Study|Physician Decision|1|||
162146700|NCT02020616|585583199|FG006|Overall Study|Physician Decision|2|||
162146701|NCT02020616|585583193|FG000|Overall Study|Withdrawal by Subject|0|||
162146702|NCT02020616|585583194|FG001|Overall Study|Withdrawal by Subject|0|||
162146703|NCT02020616|585583195|FG002|Overall Study|Withdrawal by Subject|1|||
162146704|NCT02020616|585583196|FG003|Overall Study|Withdrawal by Subject|0|||
162146705|NCT02020616|585583197|FG004|Overall Study|Withdrawal by Subject|0|||
162146706|NCT02020616|585583198|FG005|Overall Study|Withdrawal by Subject|1|||
162146707|NCT02020616|585583199|FG006|Overall Study|Withdrawal by Subject|1|||
162146708|NCT02020616|585583193|FG000|Overall Study|Lost to Follow-up|0|||
162146709|NCT02020616|585583194|FG001|Overall Study|Lost to Follow-up|1|||
162146710|NCT02020616|585583195|FG002|Overall Study|Lost to Follow-up|0|||
162146711|NCT02020616|585583196|FG003|Overall Study|Lost to Follow-up|1|||
162146712|NCT02020616|585583197|FG004|Overall Study|Lost to Follow-up|1|||
162146713|NCT02020616|585583198|FG005|Overall Study|Lost to Follow-up|1|||
162146714|NCT02020616|585583199|FG006|Overall Study|Lost to Follow-up|0|||
162146715|NCT02020616|585583193|FG000|Overall Study|Early Termination Criteria Met|0|||
162146716|NCT02020616|585583194|FG001|Overall Study|Early Termination Criteria Met|0|||
162146717|NCT02020616|585583195|FG002|Overall Study|Early Termination Criteria Met|1|||
162146718|NCT02020616|585583196|FG003|Overall Study|Early Termination Criteria Met|0|||
162146719|NCT02020616|585583197|FG004|Overall Study|Early Termination Criteria Met|0|||
161809770|NCT01864174|584345796|FG000|Double Blind - Compliant Randomized|Other|6|||
161809771|NCT01864174|584345797|FG001|Double Blind - Compliant Randomized|Other|10|||
162146720|NCT02020616|585583198|FG005|Overall Study|Early Termination Criteria Met|1|||
162146721|NCT02020616|585583199|FG006|Overall Study|Early Termination Criteria Met|0|||
162146722|NCT02020616|585583193|FG000|Overall Study|Randomized in Error|0|||
162146723|NCT02020616|585583194|FG001|Overall Study|Randomized in Error|0|||
162146724|NCT02020616|585583195|FG002|Overall Study|Randomized in Error|0|||
162146725|NCT02020616|585583196|FG003|Overall Study|Randomized in Error|1|||
162146726|NCT02020616|585583197|FG004|Overall Study|Randomized in Error|0|||
162146727|NCT02020616|585583198|FG005|Overall Study|Randomized in Error|0|||
162146728|NCT02020616|585583199|FG006|Overall Study|Randomized in Error|0|||
162146729|NCT02020616|585583193|FG000|Overall Study|Lack of Efficacy|0|||
162146730|NCT02020616|585583194|FG001|Overall Study|Lack of Efficacy|0|||
162146731|NCT02020616|585583195|FG002|Overall Study|Lack of Efficacy|0|||
162146732|NCT02020616|585583196|FG003|Overall Study|Lack of Efficacy|0|||
162146733|NCT02020616|585583197|FG004|Overall Study|Lack of Efficacy|1|||
162146734|NCT02020616|585583198|FG005|Overall Study|Lack of Efficacy|0|||
162146735|NCT02020616|585583199|FG006|Overall Study|Lack of Efficacy|0|||
162146736|NCT05019729|585583202|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
162146737|NCT05019729|585583203|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
162146738|NCT05019729|585583204|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
162146739|NCT05019729|585583205|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
162146740|NCT05019729|585583206|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
162146741|NCT05019729|585583207|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
162146742|NCT03008915|585583212|FG000|Treatment 1|Withdrawal by Subject|0|||
162146743|NCT03008915|585583213|FG001|Treatment 1|Withdrawal by Subject|1|||
162146744|NCT00712166|585583216|FG000|Overall Study|Noncompliance|0|||
162146745|NCT00712166|585583217|FG001|Overall Study|Noncompliance|1|||
162146746|NCT01773122|585583218|FG000|Overall Study|Due to amended age eligibility criteria|3|||
162146747|NCT01773122|585583219|FG001|Overall Study|Due to amended age eligibility criteria|1|||
162146748|NCT01773122|585583220|FG002|Overall Study|Due to amended age eligibility criteria|0|||
162146749|NCT01773122|585583221|FG003|Overall Study|Due to amended age eligibility criteria|1|||
162146750|NCT00849147|585583224|FG000|Overall Study|Withdrawal by Subject|1|||
162146751|NCT00849147|585583224|FG000|Overall Study|Protocol Violation|2|||
162146752|NCT00849147|585583224|FG000|Overall Study|Disease Relapse/Progression|2|||
162146753|NCT05147233|585585078|FG000|Overall Study|Adverse Event|0|||
162146754|NCT05147233|585585079|FG001|Overall Study|Adverse Event|1|||
162146755|NCT05147233|585585078|FG000|Overall Study|Lost to Follow-up|1|||
162146756|NCT05147233|585585079|FG001|Overall Study|Lost to Follow-up|1|||
162146757|NCT05147233|585585078|FG000|Overall Study|Protocol Violation|0|||
162146758|NCT05147233|585585079|FG001|Overall Study|Protocol Violation|1|||
162146759|NCT05147233|585585078|FG000|Overall Study|Withdrawal by Subject|2|||
162146760|NCT05147233|585585079|FG001|Overall Study|Withdrawal by Subject|1|||
162146761|NCT04513522|585585080|FG000|Overall Study|Other reasons|1|||
162146762|NCT04513522|585585080|FG000|Overall Study|Adverse event unrelated to study drug|9|||
162146763|NCT04513522|585585080|FG000|Overall Study|Study drug toxicity|14|||
162146764|NCT04513522|585585080|FG000|Overall Study|Disease progression|39|||
162146765|NCT04513522|585585080|FG000|Overall Study|Participants withdrew consent|2|||
162146766|NCT04517864|585585083|FG000|Placebo-Controlled Phase|Adverse Event|1|||
162146767|NCT04517864|585585084|FG001|Placebo-Controlled Phase|Adverse Event|0|||
162146768|NCT04517864|585585085|FG002|Placebo-Controlled Phase|Adverse Event|0|||
162146769|NCT04517864|585585083|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
162146770|NCT04517864|585585084|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
162146771|NCT04517864|585585085|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
162146772|NCT04517864|585585083|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
162146773|NCT04517864|585585084|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
162146774|NCT04517864|585585085|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
162146775|NCT04517864|585585083|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
162146776|NCT04517864|585585084|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
162146777|NCT04517864|585585085|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
162146778|NCT04517864|585585083|FG000|Active Therapy Extension Phase|Adverse Event|1|||
162146779|NCT04517864|585585084|FG001|Active Therapy Extension Phase|Adverse Event|0|||
162146780|NCT04517864|585585085|FG002|Active Therapy Extension Phase|Adverse Event|0|||
162146781|NCT04517864|585585083|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
162011914|NCT02177032|585099963|FG002|Overall Study|OTHER|1|||
162011915|NCT02177032|585099964|FG003|Overall Study|OTHER|0|||
162011916|NCT02177032|585099961|FG000|Overall Study|Withdrawal by Subject|1|||
162011917|NCT02177032|585099962|FG001|Overall Study|Withdrawal by Subject|0|||
162011918|NCT02177032|585099963|FG002|Overall Study|Withdrawal by Subject|1|||
162146782|NCT04517864|585585084|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
162146783|NCT04517864|585585085|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
162146784|NCT04517864|585585083|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
162146785|NCT04517864|585585084|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
162146786|NCT04517864|585585085|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
162146787|NCT04517864|585585083|FG000|Active Therapy Extension Phase|Physician Decision|1|||
162146788|NCT04517864|585585084|FG001|Active Therapy Extension Phase|Physician Decision|0|||
162011919|NCT02177032|585099964|FG003|Overall Study|Withdrawal by Subject|0|||
162146789|NCT04517864|585585085|FG002|Active Therapy Extension Phase|Physician Decision|0|||
162146790|NCT04517864|585585083|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
162146791|NCT04517864|585585084|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
162146792|NCT04517864|585585085|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
162146793|NCT04517864|585585083|FG000|Extension Phase|Adverse Event|0|||
162146794|NCT04517864|585585084|FG001|Extension Phase|Adverse Event|0|||
162146795|NCT04517864|585585085|FG002|Extension Phase|Adverse Event|1|||
162146796|NCT04517864|585585083|FG000|Extension Phase|Lack of Efficacy|0|||
162146797|NCT04517864|585585084|FG001|Extension Phase|Lack of Efficacy|0|||
162146798|NCT04517864|585585085|FG002|Extension Phase|Lack of Efficacy|2|||
162146799|NCT04517864|585585083|FG000|Extension Phase|Study Terminated By Sponsor|0|||
162146800|NCT04517864|585585084|FG001|Extension Phase|Study Terminated By Sponsor|0|||
162146801|NCT04517864|585585085|FG002|Extension Phase|Study Terminated By Sponsor|32|||
162146802|NCT04517864|585585083|FG000|Extension Phase|Withdrawal by Subject|0|||
162146803|NCT04517864|585585084|FG001|Extension Phase|Withdrawal by Subject|0|||
162146804|NCT04517864|585585085|FG002|Extension Phase|Withdrawal by Subject|3|||
162146805|NCT04517864|585585083|FG000|Extension Phase|Approved Drug Available for Indication|0|||
162146806|NCT04517864|585585084|FG001|Extension Phase|Approved Drug Available for Indication|0|||
162146807|NCT04517864|585585085|FG002|Extension Phase|Approved Drug Available for Indication|7|||
162146808|NCT04722003|585585088|FG000|Overall Study|Lost to Follow-up|2|||
162146809|NCT04722003|585585089|FG001|Overall Study|Lost to Follow-up|0|||
162146810|NCT04722003|585585088|FG000|Overall Study|Physician Decision|1|||
162146811|NCT04722003|585585089|FG001|Overall Study|Physician Decision|0|||
162146812|NCT03351075|585585090|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
162146813|NCT03351075|585585091|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
162146814|NCT03351075|585585090|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
162146815|NCT03351075|585585091|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
162146816|NCT03351075|585585090|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
162146817|NCT03351075|585585091|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
162146818|NCT03351075|585585090|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
162146819|NCT03351075|585585091|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
162146820|NCT05219253|585585092|FG000|Overall Study|Withdrawal by Subject|1|||
162146821|NCT05219253|585585093|FG001|Overall Study|Withdrawal by Subject|2|||
162146822|NCT03544515|585585094|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
162146823|NCT03544515|585585095|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
162146824|NCT03544515|585585094|FG000|Overall Study|Lost to Follow-up|2|||
162146825|NCT03544515|585585095|FG001|Overall Study|Lost to Follow-up|0|||
162146826|NCT00393848|585585098|FG000|Overall Study|Surgical schedule|0|||
162146827|NCT00393848|585585099|FG001|Overall Study|Surgical schedule|0|||
162146828|NCT00393848|585585100|FG002|Overall Study|Surgical schedule|0|||
162146829|NCT00393848|585585101|FG003|Overall Study|Surgical schedule|1|||
162146830|NCT00393848|585585098|FG000|Overall Study|Personal reasons|0|||
162146831|NCT00393848|585585099|FG001|Overall Study|Personal reasons|0|||
162146832|NCT00393848|585585100|FG002|Overall Study|Personal reasons|2|||
162146833|NCT00393848|585585101|FG003|Overall Study|Personal reasons|0|||
162011920|NCT00930046|585099965|FG000|Overall Study|Wound catheter malfunctioned|1|||
162011921|NCT00930046|585099966|FG001|Overall Study|Wound catheter malfunctioned|2|||
162146834|NCT01376089|585585102|FG000|Overall Study|Patient received no contrast media|3|||
162146835|NCT01376089|585585103|FG001|Overall Study|Patient received no contrast media|4|||
162146836|NCT01458210|585585104|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
162146837|NCT01458210|585585104|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
162146838|NCT01458210|585585104|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
162146839|NCT01458210|585585104|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
162146840|NCT03020745|585585105|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
162146841|NCT03020745|585585106|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
162146842|NCT03020745|585585107|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
162146843|NCT03020745|585585108|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
162146844|NCT03020745|585585109|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
162146845|NCT03020745|585585110|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
162146846|NCT03020745|585585111|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
162146847|NCT03020745|585585112|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
162146848|NCT03020745|585585113|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
162146849|NCT03020745|585585114|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
162146850|NCT03020745|585585105|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162146851|NCT03020745|585585106|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162146852|NCT03020745|585585107|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162146853|NCT03020745|585585108|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162146854|NCT03020745|585585109|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162146855|NCT03020745|585585110|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162146856|NCT03020745|585585111|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162146857|NCT03020745|585585112|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
162146858|NCT03020745|585585113|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162146859|NCT03020745|585585114|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
162146860|NCT03020745|585585105|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162146861|NCT03020745|585585106|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162146862|NCT03020745|585585107|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162146863|NCT03020745|585585108|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162146864|NCT03020745|585585109|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162146865|NCT03020745|585585110|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
162146866|NCT03020745|585585111|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162146867|NCT03020745|585585112|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162146868|NCT03020745|585585113|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
162146869|NCT03020745|585585114|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
162146870|NCT03020745|585585105|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162146871|NCT03020745|585585106|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162146872|NCT03020745|585585107|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162146873|NCT03020745|585585108|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162146874|NCT03020745|585585109|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162146875|NCT03020745|585585110|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162146876|NCT03020745|585585111|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162146877|NCT03020745|585585112|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162146878|NCT03020745|585585113|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
162146879|NCT03020745|585585114|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
162146880|NCT01867216|585585115|FG000|Overall Study|Withdrawal by Subject|2|||
162146881|NCT01867216|585585116|FG001|Overall Study|Withdrawal by Subject|0|||
162146882|NCT01867216|585585117|FG002|Overall Study|Withdrawal by Subject|0|||
162146883|NCT01867216|585585118|FG003|Overall Study|Withdrawal by Subject|0|||
162146884|NCT01867216|585585119|FG004|Overall Study|Withdrawal by Subject|1|||
162146885|NCT01867216|585585120|FG005|Overall Study|Withdrawal by Subject|0|||
162146886|NCT01867216|585585121|FG006|Overall Study|Withdrawal by Subject|1|||
162146887|NCT01867216|585585115|FG000|Overall Study|Physician Decision|1|||
162146888|NCT01867216|585585116|FG001|Overall Study|Physician Decision|0|||
162146889|NCT01867216|585585117|FG002|Overall Study|Physician Decision|0|||
162146890|NCT01867216|585585118|FG003|Overall Study|Physician Decision|0|||
162146891|NCT01867216|585585119|FG004|Overall Study|Physician Decision|0|||
162146892|NCT01867216|585585120|FG005|Overall Study|Physician Decision|0|||
162146893|NCT01867216|585585121|FG006|Overall Study|Physician Decision|0|||
162146894|NCT01867216|585585115|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
162146895|NCT01867216|585585116|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
162146896|NCT01867216|585585117|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
162146897|NCT01867216|585585118|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
162146898|NCT01867216|585585119|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
162146899|NCT01867216|585585120|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
162146900|NCT01867216|585585121|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
162146901|NCT00186186|585585122|FG000|Overall Study|Lack of Efficacy|3|||
161913694|NCT00336544|584733610|FG001|Overall Study|Lack of Efficacy|5|||
162146902|NCT00186186|585585122|FG000|Overall Study|Withdrawal by Subject|3|||
162146903|NCT00186186|585585122|FG000|Overall Study|Not reported as to reason|2|||
162146904|NCT02567656|585585126|FG000|Overall Study|Premature discontinuation due to PD|1|||
162146905|NCT02567656|585585127|FG001|Overall Study|Premature discontinuation due to PD|1|||
162146906|NCT02567656|585585128|FG002|Overall Study|Premature discontinuation due to PD|2|||
162146907|NCT02567656|585585129|FG003|Overall Study|Premature discontinuation due to PD|0|||
161913695|NCT00336544|584733609|FG000|Overall Study|Adverse Event|4|||
161913696|NCT00336544|584733610|FG001|Overall Study|Adverse Event|9|||
162146908|NCT02567656|585585130|FG004|Overall Study|Premature discontinuation due to PD|0|||
162146909|NCT02567656|585585131|FG005|Overall Study|Premature discontinuation due to PD|0|||
162146910|NCT01616654|585585132|FG000|Overall Study|Lack of Efficacy|1|||
162146911|NCT01616654|585585133|FG001|Overall Study|Lack of Efficacy|0|||
162146912|NCT01616654|585585134|FG002|Overall Study|Lack of Efficacy|0|||
162146913|NCT01616654|585585135|FG003|Overall Study|Lack of Efficacy|0|||
162146914|NCT01616654|585585136|FG004|Overall Study|Lack of Efficacy|1|||
162146915|NCT01616654|585585132|FG000|Overall Study|Adverse Event|0|||
162146916|NCT01616654|585585133|FG001|Overall Study|Adverse Event|1|||
162146917|NCT01616654|585585134|FG002|Overall Study|Adverse Event|2|||
162146918|NCT01616654|585585135|FG003|Overall Study|Adverse Event|1|||
162146919|NCT01616654|585585136|FG004|Overall Study|Adverse Event|0|||
162146920|NCT01616654|585585132|FG000|Overall Study|Withdrawal by Subject|2|||
162146921|NCT01616654|585585133|FG001|Overall Study|Withdrawal by Subject|2|||
162146922|NCT01616654|585585134|FG002|Overall Study|Withdrawal by Subject|3|||
162146923|NCT01616654|585585135|FG003|Overall Study|Withdrawal by Subject|1|||
162146924|NCT01616654|585585136|FG004|Overall Study|Withdrawal by Subject|5|||
162146925|NCT01616654|585585132|FG000|Overall Study|Protocol Violation|0|||
162146926|NCT01616654|585585133|FG001|Overall Study|Protocol Violation|5|||
162146927|NCT01616654|585585134|FG002|Overall Study|Protocol Violation|2|||
162146928|NCT01616654|585585135|FG003|Overall Study|Protocol Violation|4|||
162146929|NCT01616654|585585136|FG004|Overall Study|Protocol Violation|4|||
162146930|NCT01616654|585585132|FG000|Overall Study|Lost to Follow-up|1|||
162146931|NCT01616654|585585133|FG001|Overall Study|Lost to Follow-up|0|||
162146932|NCT01616654|585585134|FG002|Overall Study|Lost to Follow-up|3|||
162146933|NCT01616654|585585135|FG003|Overall Study|Lost to Follow-up|2|||
162146934|NCT01616654|585585136|FG004|Overall Study|Lost to Follow-up|1|||
162146935|NCT01616654|585585132|FG000|Overall Study|Pregnancy|1|||
162146936|NCT01616654|585585133|FG001|Overall Study|Pregnancy|0|||
162146937|NCT01616654|585585134|FG002|Overall Study|Pregnancy|0|||
162146938|NCT01616654|585585135|FG003|Overall Study|Pregnancy|0|||
162146939|NCT01616654|585585136|FG004|Overall Study|Pregnancy|1|||
162146940|NCT02057692|585585137|FG000|Overall Study|Adverse Event|1|||
162146941|NCT02057692|585585138|FG001|Overall Study|Adverse Event|0|||
162146942|NCT02057692|585585139|FG002|Overall Study|Adverse Event|0|||
161809772|NCT01864174|584345796|FG000|Off Treatment Follow-Up|Other|2|||
161809773|NCT01864174|584345797|FG001|Off Treatment Follow-Up|Other|0|||
161809774|NCT01864174|584345796|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
161809775|NCT01864174|584345797|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
161809776|NCT02648347|584345798|FG000|Overall Study|Death|174|||
161809777|NCT02648347|584345799|FG001|Overall Study|Death|167|||
161809778|NCT02648347|584345798|FG000|Overall Study|Withdrawal by Subject|16|||
162146943|NCT02057692|585585140|FG003|Overall Study|Adverse Event|0|||
162146944|NCT02057692|585585137|FG000|Overall Study|Lost to Follow-up|0|||
162146945|NCT02057692|585585138|FG001|Overall Study|Lost to Follow-up|0|||
161809779|NCT02648347|584345799|FG001|Overall Study|Withdrawal by Subject|9|||
162146946|NCT02057692|585585139|FG002|Overall Study|Lost to Follow-up|0|||
162146947|NCT02057692|585585140|FG003|Overall Study|Lost to Follow-up|1|||
162146948|NCT03923491|585585141|FG000|Overall Study|Lost to Follow-up|5|||
162146949|NCT03923491|585585142|FG001|Overall Study|Lost to Follow-up|8|||
162146950|NCT03923491|585585141|FG000|Overall Study|Withdrawal by Subject|4|||
162146951|NCT03923491|585585142|FG001|Overall Study|Withdrawal by Subject|6|||
162146952|NCT03622580|585585147|FG000|Overall Study|Death|16|||
162146953|NCT03622580|585585148|FG001|Overall Study|Death|21|||
162146954|NCT03622580|585585149|FG002|Overall Study|Death|13|||
162146955|NCT03622580|585585147|FG000|Overall Study|Adverse Event|6|||
162146956|NCT03622580|585585148|FG001|Overall Study|Adverse Event|6|||
162146957|NCT03622580|585585149|FG002|Overall Study|Adverse Event|5|||
162146958|NCT03622580|585585147|FG000|Overall Study|Withdrawal by Subject|12|||
162146959|NCT03622580|585585148|FG001|Overall Study|Withdrawal by Subject|7|||
162146960|NCT03622580|585585149|FG002|Overall Study|Withdrawal by Subject|19|||
162146961|NCT03622580|585585147|FG000|Overall Study|Lost to Follow-up|12|||
162146962|NCT03622580|585585148|FG001|Overall Study|Lost to Follow-up|9|||
162146963|NCT03622580|585585149|FG002|Overall Study|Lost to Follow-up|9|||
162146964|NCT03622580|585585147|FG000|Overall Study|Protocol Violation|1|||
162146965|NCT03622580|585585148|FG001|Overall Study|Protocol Violation|0|||
162146966|NCT03622580|585585149|FG002|Overall Study|Protocol Violation|1|||
162146967|NCT03622580|585585147|FG000|Overall Study|Physician Decision|3|||
162146968|NCT03622580|585585148|FG001|Overall Study|Physician Decision|0|||
162146969|NCT03622580|585585149|FG002|Overall Study|Physician Decision|1|||
162146970|NCT03622580|585585147|FG000|Overall Study|Pregnancy|0|||
162146971|NCT03622580|585585148|FG001|Overall Study|Pregnancy|1|||
162146972|NCT03622580|585585149|FG002|Overall Study|Pregnancy|0|||
162146973|NCT03622580|585585147|FG000|Overall Study|Lack of Efficacy|0|||
162146974|NCT03622580|585585148|FG001|Overall Study|Lack of Efficacy|0|||
162146975|NCT03622580|585585149|FG002|Overall Study|Lack of Efficacy|1|||
162146976|NCT03622580|585585147|FG000|Overall Study|Other|2|||
162146977|NCT03622580|585585148|FG001|Overall Study|Other|0|||
162146978|NCT03622580|585585149|FG002|Overall Study|Other|3|||
162146979|NCT03959241|585585152|FG000|Overall Study|Withdrawal by Subject|7|||
162146980|NCT03959241|585585153|FG001|Overall Study|Withdrawal by Subject|8|||
162146981|NCT03959241|585585152|FG000|Overall Study|Lost to Follow-up|1|||
162146982|NCT03959241|585585153|FG001|Overall Study|Lost to Follow-up|0|||
162146983|NCT03959241|585585152|FG000|Overall Study|Move to Hospice Care|1|||
162146984|NCT03959241|585585153|FG001|Overall Study|Move to Hospice Care|0|||
162146985|NCT03959241|585585152|FG000|Overall Study|Screen Failure|1|||
162146986|NCT03959241|585585153|FG001|Overall Study|Screen Failure|0|||
162146987|NCT03959241|585585152|FG000|Overall Study|Disease Relapse|0|||
162146988|NCT03959241|585585153|FG001|Overall Study|Disease Relapse|1|||
162146989|NCT03959241|585585152|FG000|Overall Study|Off Study|1|||
162146990|NCT03959241|585585153|FG001|Overall Study|Off Study|0|||
162146991|NCT01565928|585585154|FG000|Overall Study|Adverse Event|3|||
162146992|NCT01565928|585585154|FG000|Overall Study|Other|3|||
162146993|NCT01565928|585585154|FG000|Overall Study|Progressive Disease|13|||
162146994|NCT01565928|585585154|FG000|Overall Study|Withdrawal by Subject|1|||
162146995|NCT01565928|585585154|FG000|Overall Study|Death|2|||
162146996|NCT02969863|585585155|FG000|Overall Study|Physician Decision|1|||
162146997|NCT02969863|585585156|FG001|Overall Study|Physician Decision|0|||
162146998|NCT02969863|585585157|FG002|Overall Study|Physician Decision|0|||
162146999|NCT02969863|585585158|FG003|Overall Study|Physician Decision|0|||
162147000|NCT02969863|585585159|FG004|Overall Study|Physician Decision|0|||
162147001|NCT02969863|585585160|FG005|Overall Study|Physician Decision|0|||
162147002|NCT02194933|585585162|FG000|Overall Study|Lost to Follow-up|1|||
162147003|NCT02194933|585585163|FG001|Overall Study|Lost to Follow-up|2|||
162147004|NCT02194933|585585162|FG000|Overall Study|Participant met withdrawal criteria|1|||
162147005|NCT02194933|585585163|FG001|Overall Study|Participant met withdrawal criteria|3|||
162147006|NCT02194933|585585162|FG000|Overall Study|Withdrawal by Subject|0|||
162147007|NCT02194933|585585163|FG001|Overall Study|Withdrawal by Subject|2|||
162147008|NCT02194933|585585162|FG000|Overall Study|Lack of Efficacy|1|||
162147009|NCT02194933|585585163|FG001|Overall Study|Lack of Efficacy|2|||
162147010|NCT00756730|585585166|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
162147011|NCT00756730|585585167|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
162147012|NCT00756730|585585166|FG000|Overall Study|persistent low-level viremmia|0|||
161809780|NCT02648347|584345798|FG000|Overall Study|Lost to Follow-up|18|||
161809781|NCT02648347|584345799|FG001|Overall Study|Lost to Follow-up|21|||
162147013|NCT00756730|585585167|FG001|Overall Study|persistent low-level viremmia|1|||
162011922|NCT01598532|585099967|FG000|Overall Study|Lost to Follow-up|3|||
162147014|NCT05382104|585585171|FG000|Period 2 (2 Days)|Adverse Event|0|||
162147015|NCT05382104|585585172|FG001|Period 2 (2 Days)|Adverse Event|1|||
162147016|NCT05382104|585585173|FG002|Period 2 (2 Days)|Adverse Event|0|||
162147017|NCT05382104|585585174|FG003|Period 2 (2 Days)|Adverse Event|0|||
162147018|NCT05382104|585585175|FG004|Period 2 (2 Days)|Adverse Event|0|||
162147019|NCT05382104|585585176|FG005|Period 2 (2 Days)|Adverse Event|0|||
162147020|NCT02807493|585585178|FG000|Overall Study|Adverse Event|5|||
162147021|NCT02807493|585585179|FG001|Overall Study|Adverse Event|2|||
162147022|NCT02807493|585585178|FG000|Overall Study|Lost to Follow-up|6|||
162147023|NCT02807493|585585179|FG001|Overall Study|Lost to Follow-up|0|||
162147024|NCT02807493|585585178|FG000|Overall Study|Physician Decision|4|||
162147025|NCT02807493|585585179|FG001|Overall Study|Physician Decision|1|||
162147026|NCT02807493|585585178|FG000|Overall Study|Protocol Violation|7|||
162147027|NCT02807493|585585179|FG001|Overall Study|Protocol Violation|0|||
162147028|NCT02807493|585585178|FG000|Overall Study|Withdrawal by Subject|17|||
162147029|NCT02807493|585585179|FG001|Overall Study|Withdrawal by Subject|10|||
162147030|NCT02807493|585585178|FG000|Overall Study|Other withdrawal|17|||
162147031|NCT02807493|585585179|FG001|Overall Study|Other withdrawal|0|||
162147032|NCT02807493|585585178|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
162147033|NCT02807493|585585179|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
162147034|NCT05190419|585585180|FG000|Overall Study|Lack of Efficacy|8|||
162147035|NCT05190419|585585181|FG001|Overall Study|Lack of Efficacy|0|||
162147036|NCT05190419|585585182|FG002|Overall Study|Lack of Efficacy|1|||
162147037|NCT05190419|585585183|FG003|Overall Study|Lack of Efficacy|0|||
162147038|NCT05190419|585585180|FG000|Overall Study|Withdrawal by Subject|7|||
162147039|NCT05190419|585585181|FG001|Overall Study|Withdrawal by Subject|1|||
162147040|NCT05190419|585585182|FG002|Overall Study|Withdrawal by Subject|2|||
162147041|NCT05190419|585585183|FG003|Overall Study|Withdrawal by Subject|2|||
162147042|NCT05190419|585585180|FG000|Overall Study|Adverse Event|2|||
162147043|NCT05190419|585585181|FG001|Overall Study|Adverse Event|10|||
162147044|NCT05190419|585585182|FG002|Overall Study|Adverse Event|11|||
162147045|NCT05190419|585585183|FG003|Overall Study|Adverse Event|21|||
161809782|NCT02648347|584345798|FG000|Overall Study|Missing|1|||
162147046|NCT05190419|585585180|FG000|Overall Study|Lost to Follow-up|1|||
162147047|NCT05190419|585585181|FG001|Overall Study|Lost to Follow-up|2|||
161809783|NCT02648347|584345799|FG001|Overall Study|Missing|0|||
161809784|NCT03546842|584345801|FG000|Overall Study|Protocol Violation|1|||
161809785|NCT03546842|584345801|FG000|Overall Study|Withdrawal by Subject|2|||
161809786|NCT01723397|584345802|FG000|Study Period 1|Protocol Violation|0|||
161809787|NCT01723397|584345803|FG001|Study Period 1|Protocol Violation|1|||
162147048|NCT05190419|585585182|FG002|Overall Study|Lost to Follow-up|3|||
162147049|NCT05190419|585585183|FG003|Overall Study|Lost to Follow-up|1|||
162147050|NCT05190419|585585180|FG000|Overall Study|Other|1|||
162147051|NCT05190419|585585181|FG001|Overall Study|Other|1|||
161809788|NCT01723397|584345802|FG000|Study Period 2|Protocol Violation|0|||
162147052|NCT05190419|585585182|FG002|Overall Study|Other|0|||
162147053|NCT05190419|585585183|FG003|Overall Study|Other|3|||
162147054|NCT02289560|585585186|FG000|Overall Study|Lost to Follow-up|6|||
162147055|NCT02289560|585585186|FG000|Overall Study|Alternative Treatment|4|||
162147056|NCT02289560|585585186|FG000|Overall Study|Inadequate Treatment|2|||
162147057|NCT02289560|585585186|FG000|Overall Study|Withdrawal by Subject|23|||
162147058|NCT02540213|585585187|FG000|Overall Study|Death/adverse event|18|||
162147059|NCT02540213|585585187|FG000|Overall Study|Administrative reasons|3|||
162147060|NCT02540213|585585187|FG000|Overall Study|Kidney transplant|3|||
162147061|NCT02540213|585585187|FG000|Overall Study|Lack of Efficacy|6|||
162147062|NCT02540213|585585187|FG000|Overall Study|Consent withdrawn|7|||
162147063|NCT02540213|585585187|FG000|Overall Study|Enrolled but not treated|2|||
162147064|NCT02908464|585585188|FG000|Overall Study|Withdrawal by Subject|2|||
162147065|NCT02908464|585585189|FG001|Overall Study|Withdrawal by Subject|1|||
162147066|NCT02908464|585585188|FG000|Overall Study|Found ineligible after randomization|0|||
162147067|NCT02908464|585585189|FG001|Overall Study|Found ineligible after randomization|2|||
162147068|NCT01264718|585585190|FG000|Overall Study|Lost to Follow-up|3|||
162147069|NCT01264718|585585191|FG001|Overall Study|Lost to Follow-up|2|||
162147070|NCT01264718|585585190|FG000|Overall Study|Withdrawal by Subject|9|||
162147071|NCT01264718|585585191|FG001|Overall Study|Withdrawal by Subject|15|||
162147072|NCT01264718|585585190|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
162147073|NCT01264718|585585191|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
162147074|NCT01769391|585585194|FG000|Overall Study|Death|10|||
162147075|NCT01769391|585585195|FG001|Overall Study|Death|1|||
162147076|NCT01769391|585585194|FG000|Overall Study|Adverse Event|0|||
162147077|NCT01769391|585585195|FG001|Overall Study|Adverse Event|3|||
162147078|NCT01769391|585585194|FG000|Overall Study|Progressive Disease|1|||
162147079|NCT01769391|585585195|FG001|Overall Study|Progressive Disease|2|||
162147080|NCT01769391|585585194|FG000|Overall Study|Withdrawal by Subject|4|||
162147081|NCT01769391|585585195|FG001|Overall Study|Withdrawal by Subject|3|||
162147082|NCT01769391|585585194|FG000|Overall Study|Investigator Decision|2|||
162147083|NCT01769391|585585195|FG001|Overall Study|Investigator Decision|0|||
162147084|NCT03386929|585585196|FG000|Overall Study|Death|0|||
162147085|NCT03386929|585585197|FG001|Overall Study|Death|0|||
162147086|NCT03386929|585585198|FG002|Overall Study|Death|1|||
162147087|NCT03386929|585585196|FG000|Overall Study|Withdrawal by Subject|0|||
162147088|NCT03386929|585585197|FG001|Overall Study|Withdrawal by Subject|1|||
162147089|NCT03386929|585585198|FG002|Overall Study|Withdrawal by Subject|0|||
162147090|NCT03386929|585585196|FG000|Overall Study|Physician Decision|0|||
162147091|NCT03386929|585585197|FG001|Overall Study|Physician Decision|0|||
162147092|NCT03386929|585585198|FG002|Overall Study|Physician Decision|1|||
162147093|NCT03386929|585585196|FG000|Overall Study|Progression|4|||
162147094|NCT03386929|585585197|FG001|Overall Study|Progression|4|||
161809789|NCT01723397|584345803|FG001|Study Period 2|Protocol Violation|1|||
161809790|NCT02739997|584345804|FG000|Overall Study|Death|1|||
161809791|NCT02739997|584345804|FG000|Overall Study|Withdrawal by Subject|1|||
162147095|NCT03386929|585585198|FG002|Overall Study|Progression|0|||
162147096|NCT03386929|585585196|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
161809792|NCT02158663|584345809|FG000|Overall Study|Withdrawal by Subject|5|||
162147097|NCT03386929|585585197|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
162147098|NCT03386929|585585198|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
162147099|NCT03386929|585585196|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
162147100|NCT03386929|585585197|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
162147101|NCT03386929|585585198|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
162147102|NCT03538054|585585199|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
162147103|NCT03538054|585585199|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
162147104|NCT03538054|585585199|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
162147105|NCT02351180|585585202|FG000|Overall Study|Withdrawal by Subject|1|||
162147106|NCT02351180|585585203|FG001|Overall Study|Withdrawal by Subject|0|||
162147107|NCT00208767|585585204|FG000|Overall Study|Adverse Event|9|||
162147108|NCT00208767|585585205|FG001|Overall Study|Adverse Event|1|||
162147109|NCT00208767|585585204|FG000|Overall Study|Withdrawal by Subject|14|||
162147110|NCT00208767|585585205|FG001|Overall Study|Withdrawal by Subject|3|||
162147111|NCT00208767|585585204|FG000|Overall Study|Death|1|||
162147112|NCT00208767|585585205|FG001|Overall Study|Death|0|||
162147113|NCT00208767|585585204|FG000|Overall Study|Lost to Follow-up|3|||
162147114|NCT00208767|585585205|FG001|Overall Study|Lost to Follow-up|3|||
162147115|NCT02317016|585585206|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
162147116|NCT02317016|585585206|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
162147117|NCT02317016|585585206|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
162147118|NCT02317016|585585206|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
162147119|NCT02317016|585585206|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
162147120|NCT02317016|585585206|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
162147121|NCT02317016|585585206|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
162147122|NCT00536380|585585207|FG000|Overall Study|Adverse Event|0|||
162147123|NCT00536380|585585208|FG001|Overall Study|Adverse Event|2|||
162147124|NCT00536380|585585209|FG002|Overall Study|Adverse Event|2|||
162147125|NCT00536380|585585207|FG000|Overall Study|Lost to Follow-up|0|||
162147126|NCT00536380|585585208|FG001|Overall Study|Lost to Follow-up|0|||
162147127|NCT00536380|585585209|FG002|Overall Study|Lost to Follow-up|1|||
162147128|NCT00536380|585585207|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
162147129|NCT00536380|585585208|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
162147130|NCT00536380|585585209|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
162147131|NCT00536380|585585207|FG000|Overall Study|Withdrawal related to study drug|7|||
162147132|NCT00536380|585585208|FG001|Overall Study|Withdrawal related to study drug|5|||
162147133|NCT00536380|585585209|FG002|Overall Study|Withdrawal related to study drug|2|||
162147134|NCT00536380|585585207|FG000|Overall Study|Noncompliance with protocol|3|||
162147135|NCT00536380|585585208|FG001|Overall Study|Noncompliance with protocol|2|||
162147136|NCT00536380|585585209|FG002|Overall Study|Noncompliance with protocol|2|||
162147137|NCT00536380|585585207|FG000|Overall Study|Did not meet protocol eligibility|0|||
162147138|NCT00536380|585585208|FG001|Overall Study|Did not meet protocol eligibility|0|||
161809793|NCT02158663|584345810|FG001|Overall Study|Withdrawal by Subject|4|||
161809794|NCT01302548|584345811|FG000|Overall Study|Lost to Follow-up|2|||
162147139|NCT00536380|585585209|FG002|Overall Study|Did not meet protocol eligibility|1|||
162147140|NCT00536380|585585207|FG000|Overall Study|Administrative|0|||
162147141|NCT00536380|585585208|FG001|Overall Study|Administrative|0|||
162147142|NCT00536380|585585209|FG002|Overall Study|Administrative|1|||
162147143|NCT00387465|585585210|FG000|Overall Study|Withdrawal by Subject|0|||
161809795|NCT01302548|584345812|FG001|Overall Study|Lost to Follow-up|1|||
161809796|NCT02409355|584345813|FG000|Overall Study|Withdrawal by Subject|1|||
161809797|NCT02409355|584345814|FG001|Overall Study|Withdrawal by Subject|0|||
161809798|NCT02409355|584345813|FG000|Overall Study|Death|1|||
161809799|NCT02409355|584345814|FG001|Overall Study|Death|1|||
161809800|NCT02409355|584345813|FG000|Overall Study|Study terminated by Sponsor|2|||
161809801|NCT02409355|584345814|FG001|Overall Study|Study terminated by Sponsor|3|||
161809802|NCT01237054|584345815|FG000|Overall Study|imaging 10C0096|1|||
161809803|NCT02089997|584345829|FG000|Overall Study|Case report forms uncollected|99|||
161809804|NCT02089997|584345829|FG000|Overall Study|Protocol Violation|147|||
161809805|NCT00095212|584345830|FG000|Overall Study|Withdrawal by Subject|1|||
161809806|NCT00095212|584345831|FG001|Overall Study|Withdrawal by Subject|3|||
161809807|NCT03681470|584345832|FG000|Overall Study|Lack of Efficacy|3|||
161809808|NCT03681470|584345832|FG000|Overall Study|Lost to Follow-up|1|||
161809809|NCT03681470|584345832|FG000|Overall Study|Protocol Violation|3|||
161809810|NCT03681470|584345832|FG000|Overall Study|Withdrawal by Subject|1|||
161809811|NCT03500692|584345837|FG000|Overall Study|Death|163|||
162147144|NCT00387465|585585211|FG001|Overall Study|Withdrawal by Subject|1|||
162147145|NCT00387465|585585212|FG002|Overall Study|Withdrawal by Subject|0|||
162147146|NCT03545984|585585213|FG000|Overall Study|CSF cases not present during rotation|11|||
162147147|NCT03545984|585585214|FG001|Overall Study|CSF cases not present during rotation|9|||
162147148|NCT03418324|585585215|FG000|Overall Study|Death|0|||
161809812|NCT03500692|584345837|FG000|Overall Study|Lost to Follow-up|75|||
161809813|NCT03500692|584345837|FG000|Overall Study|Termination Reasons|3|||
161809814|NCT02305758|584345838|FG000|Overall Study|Death|27|||
161913697|NCT00336544|584733609|FG000|Overall Study|Withdrawal by Subject|4|||
161913698|NCT00336544|584733610|FG001|Overall Study|Withdrawal by Subject|3|||
161913699|NCT00336544|584733609|FG000|Overall Study|Other|3|||
161913700|NCT00336544|584733610|FG001|Overall Study|Other|5|||
161913701|NCT00715208|584733611|FG000|Overall Study|Withdrawal by Subject|1|||
161913702|NCT00715208|584733612|FG001|Overall Study|Withdrawal by Subject|1|||
161913703|NCT00715208|584733611|FG000|Overall Study|Adverse Event|0|||
161913704|NCT00715208|584733612|FG001|Overall Study|Adverse Event|6|||
161913705|NCT00715208|584733611|FG000|Overall Study|Lack of Efficacy|0|||
161913706|NCT00715208|584733612|FG001|Overall Study|Lack of Efficacy|2|||
161913707|NCT00576758|584733613|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
161913708|NCT00576758|584733614|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
161913709|NCT00576758|584733613|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
161913710|NCT00576758|584733614|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
161913711|NCT00576758|584733613|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
161913712|NCT00576758|584733614|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
161913713|NCT00576758|584733613|FG000|Induction Treatment Period|Death|1|||
161913714|NCT00576758|584733614|FG001|Induction Treatment Period|Death|0|||
161913715|NCT00576758|584733613|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
161913716|NCT00576758|584733614|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
161913717|NCT00576758|584733613|FG000|Induction Treatment Period|Withdrew consent|1|||
161913718|NCT00576758|584733614|FG001|Induction Treatment Period|Withdrew consent|0|||
161913719|NCT00576758|584733613|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
161913720|NCT00576758|584733614|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
161913721|NCT00576758|584733613|FG000|Extension Treatment Period|Death|1|||
161913722|NCT00576758|584733614|FG001|Extension Treatment Period|Death|1|||
161913723|NCT00576758|584733613|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
161913724|NCT00576758|584733614|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
161913725|NCT00576758|584733613|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
161913726|NCT00576758|584733614|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
162011923|NCT01598532|585099967|FG000|Overall Study|Did not meet inclusion criteria|8|||
162011924|NCT00912808|585099968|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
161809815|NCT02305758|584345839|FG001|Overall Study|Death|27|||
162011925|NCT00912808|585099969|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
162011926|NCT00912808|585099968|FG000|Washout|Withdrawal by Subject|0|||
162011927|NCT00912808|585099969|FG001|Washout|Withdrawal by Subject|1|||
162011928|NCT00912808|585099968|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
162011929|NCT00912808|585099969|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
162011930|NCT00912808|585099968|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
162011931|NCT00912808|585099969|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
162011932|NCT01249261|585099970|FG000|Overall Study|Withdrawal by Subject|1|||
162011933|NCT01249261|585099971|FG001|Overall Study|Withdrawal by Subject|0|||
162011934|NCT01967940|585099978|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
162011935|NCT01967940|585099979|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
162011936|NCT01967940|585099980|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
162011937|NCT01967940|585099981|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
162011938|NCT01967940|585099978|FG000|Part 2|Adverse Event|0|||
162011939|NCT01967940|585099979|FG001|Part 2|Adverse Event|0|||
162011940|NCT01967940|585099980|FG002|Part 2|Adverse Event|0|||
162011941|NCT01967940|585099981|FG003|Part 2|Adverse Event|1|||
162011942|NCT01967940|585099978|FG000|Part 2|Unknown Reason|0|||
162011943|NCT01967940|585099979|FG001|Part 2|Unknown Reason|0|||
162011944|NCT01967940|585099980|FG002|Part 2|Unknown Reason|0|||
162011945|NCT01967940|585099981|FG003|Part 2|Unknown Reason|1|||
162011946|NCT01550003|585099982|FG000|Overall Study|Adverse Event|0|||
162011947|NCT01550003|585099983|FG001|Overall Study|Adverse Event|9|||
162011948|NCT01550003|585099984|FG002|Overall Study|Adverse Event|15|||
162011949|NCT01550003|585099982|FG000|Overall Study|Lack of Efficacy|4|||
162011950|NCT01550003|585099983|FG001|Overall Study|Lack of Efficacy|11|||
162011951|NCT01550003|585099984|FG002|Overall Study|Lack of Efficacy|15|||
162011952|NCT01550003|585099982|FG000|Overall Study|Protocol Violation|0|||
162011953|NCT01550003|585099983|FG001|Overall Study|Protocol Violation|3|||
162011954|NCT01550003|585099984|FG002|Overall Study|Protocol Violation|2|||
162011955|NCT01550003|585099982|FG000|Overall Study|Lost to Follow-up|1|||
162011956|NCT01550003|585099983|FG001|Overall Study|Lost to Follow-up|4|||
162011957|NCT01550003|585099984|FG002|Overall Study|Lost to Follow-up|8|||
162011958|NCT01550003|585099982|FG000|Overall Study|Consent withdrawn|2|||
162011959|NCT01550003|585099983|FG001|Overall Study|Consent withdrawn|11|||
162011960|NCT01550003|585099984|FG002|Overall Study|Consent withdrawn|23|||
162011961|NCT01550003|585099982|FG000|Overall Study|Missing|1|||
162011962|NCT01550003|585099983|FG001|Overall Study|Missing|0|||
162011963|NCT01550003|585099984|FG002|Overall Study|Missing|2|||
162011964|NCT01550003|585099982|FG000|Overall Study|Study closure as announced by sponsor|7|||
162011965|NCT01550003|585099983|FG001|Overall Study|Study closure as announced by sponsor|6|||
162011966|NCT01550003|585099984|FG002|Overall Study|Study closure as announced by sponsor|24|||
162011967|NCT01550003|585099982|FG000|Overall Study|Protocol Noncompliance|1|||
162011968|NCT01550003|585099983|FG001|Overall Study|Protocol Noncompliance|0|||
162011969|NCT01550003|585099984|FG002|Overall Study|Protocol Noncompliance|0|||
162011970|NCT01550003|585099982|FG000|Overall Study|Study closure|0|||
162011971|NCT01550003|585099983|FG001|Overall Study|Study closure|1|||
162011972|NCT01550003|585099984|FG002|Overall Study|Study closure|1|||
162011973|NCT01550003|585099982|FG000|Overall Study|Patient reached adulthood|0|||
162011974|NCT01550003|585099983|FG001|Overall Study|Patient reached adulthood|1|||
162011975|NCT01550003|585099984|FG002|Overall Study|Patient reached adulthood|0|||
162011976|NCT01550003|585099982|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
162011977|NCT01550003|585099983|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
162011978|NCT01550003|585099984|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
162011979|NCT01550003|585099982|FG000|Overall Study|Sponsor's order|0|||
162011980|NCT01550003|585099983|FG001|Overall Study|Sponsor's order|3|||
162011981|NCT01550003|585099984|FG002|Overall Study|Sponsor's order|3|||
162011982|NCT01550003|585099982|FG000|Overall Study|Sponsor's decision|1|||
162011983|NCT01550003|585099983|FG001|Overall Study|Sponsor's decision|5|||
162011984|NCT01550003|585099984|FG002|Overall Study|Sponsor's decision|4|||
162011985|NCT01550003|585099982|FG000|Overall Study|Subject mother passed away|0|||
162011986|NCT01550003|585099983|FG001|Overall Study|Subject mother passed away|1|||
162011987|NCT01550003|585099984|FG002|Overall Study|Subject mother passed away|0|||
162011988|NCT01550003|585099982|FG000|Overall Study|Discontinuation|0|||
162011989|NCT01550003|585099983|FG001|Overall Study|Discontinuation|1|||
162011990|NCT01550003|585099984|FG002|Overall Study|Discontinuation|0|||
162011991|NCT01550003|585099982|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
161913727|NCT00576758|584733613|FG000|Extension Treatment Period|Administrative/Other|3|||
161913728|NCT00576758|584733614|FG001|Extension Treatment Period|Administrative/Other|1|||
161913729|NCT00576758|584733613|FG000|Follow-up Period|Administrative/Other|6|||
161913730|NCT00576758|584733614|FG001|Follow-up Period|Administrative/Other|8|||
161913731|NCT00576758|584733613|FG000|Follow-up Period|Death|3|||
161913732|NCT00576758|584733614|FG001|Follow-up Period|Death|3|||
161913733|NCT00576758|584733613|FG000|Follow-up Period|Insufficient therapeutic response|16|||
161913734|NCT00576758|584733614|FG001|Follow-up Period|Insufficient therapeutic response|5|||
161913735|NCT00576758|584733613|FG000|Follow-up Period|Withdrew consent|2|||
161913736|NCT00576758|584733614|FG001|Follow-up Period|Withdrew consent|1|||
161913737|NCT03427411|584733615|FG000|Overall Study|Screen failure - platelets too low|0|||
161913738|NCT03427411|584733616|FG001|Overall Study|Screen failure - platelets too low|1|||
161913739|NCT00903968|584733617|FG000|Overall Study|Adverse Event|0|||
161913740|NCT00903968|584733618|FG001|Overall Study|Adverse Event|0|||
161913741|NCT00903968|584733619|FG002|Overall Study|Adverse Event|0|||
161913742|NCT00903968|584733620|FG003|Overall Study|Adverse Event|0|||
161913743|NCT00903968|584733621|FG004|Overall Study|Adverse Event|0|||
161913744|NCT00903968|584733622|FG005|Overall Study|Adverse Event|0|||
161913745|NCT00903968|584733623|FG006|Overall Study|Adverse Event|1|||
161913746|NCT00903968|584733624|FG007|Overall Study|Adverse Event|8|||
161913747|NCT00903968|584733617|FG000|Overall Study|DLT|0|||
161913748|NCT00903968|584733618|FG001|Overall Study|DLT|0|||
161913749|NCT00903968|584733619|FG002|Overall Study|DLT|0|||
161913750|NCT00903968|584733620|FG003|Overall Study|DLT|0|||
161913751|NCT00903968|584733621|FG004|Overall Study|DLT|0|||
161913752|NCT00903968|584733622|FG005|Overall Study|DLT|0|||
161913753|NCT00903968|584733623|FG006|Overall Study|DLT|2|||
161913754|NCT00903968|584733624|FG007|Overall Study|DLT|0|||
161913755|NCT00903968|584733617|FG000|Overall Study|Withdrawal by Subject|1|||
161913756|NCT00903968|584733618|FG001|Overall Study|Withdrawal by Subject|0|||
161913757|NCT00903968|584733619|FG002|Overall Study|Withdrawal by Subject|1|||
161913758|NCT00903968|584733620|FG003|Overall Study|Withdrawal by Subject|0|||
161913759|NCT00903968|584733621|FG004|Overall Study|Withdrawal by Subject|1|||
161913760|NCT00903968|584733622|FG005|Overall Study|Withdrawal by Subject|1|||
161913761|NCT00903968|584733623|FG006|Overall Study|Withdrawal by Subject|0|||
161913762|NCT00903968|584733624|FG007|Overall Study|Withdrawal by Subject|4|||
161913763|NCT00903968|584733617|FG000|Overall Study|Non-Compliance|0|||
161913764|NCT00903968|584733618|FG001|Overall Study|Non-Compliance|0|||
161913765|NCT00903968|584733619|FG002|Overall Study|Non-Compliance|0|||
161913766|NCT00903968|584733620|FG003|Overall Study|Non-Compliance|0|||
161913767|NCT00903968|584733621|FG004|Overall Study|Non-Compliance|0|||
161913768|NCT00903968|584733622|FG005|Overall Study|Non-Compliance|1|||
161913769|NCT00903968|584733623|FG006|Overall Study|Non-Compliance|0|||
161913770|NCT00903968|584733624|FG007|Overall Study|Non-Compliance|0|||
161913771|NCT00903968|584733617|FG000|Overall Study|Physician Decision|0|||
161913772|NCT00903968|584733618|FG001|Overall Study|Physician Decision|0|||
161913773|NCT00903968|584733619|FG002|Overall Study|Physician Decision|0|||
161913774|NCT00903968|584733620|FG003|Overall Study|Physician Decision|0|||
161913775|NCT00903968|584733621|FG004|Overall Study|Physician Decision|0|||
161913776|NCT00903968|584733622|FG005|Overall Study|Physician Decision|1|||
161913777|NCT00903968|584733623|FG006|Overall Study|Physician Decision|0|||
161913778|NCT00903968|584733624|FG007|Overall Study|Physician Decision|0|||
161913779|NCT00903968|584733617|FG000|Overall Study|Progressive Disease|2|||
161913780|NCT00903968|584733618|FG001|Overall Study|Progressive Disease|3|||
161913781|NCT00903968|584733619|FG002|Overall Study|Progressive Disease|2|||
161913782|NCT00903968|584733620|FG003|Overall Study|Progressive Disease|3|||
161913783|NCT00903968|584733621|FG004|Overall Study|Progressive Disease|3|||
161913784|NCT00903968|584733622|FG005|Overall Study|Progressive Disease|3|||
161913785|NCT00903968|584733623|FG006|Overall Study|Progressive Disease|0|||
161913786|NCT00903968|584733624|FG007|Overall Study|Progressive Disease|18|||
161913787|NCT00903968|584733617|FG000|Overall Study|Lack of Efficacy|0|||
161913788|NCT00903968|584733618|FG001|Overall Study|Lack of Efficacy|0|||
161913789|NCT00903968|584733619|FG002|Overall Study|Lack of Efficacy|0|||
161913790|NCT00903968|584733620|FG003|Overall Study|Lack of Efficacy|0|||
161913791|NCT00903968|584733621|FG004|Overall Study|Lack of Efficacy|0|||
161913792|NCT00903968|584733622|FG005|Overall Study|Lack of Efficacy|0|||
161913793|NCT00903968|584733623|FG006|Overall Study|Lack of Efficacy|0|||
161913794|NCT00903968|584733624|FG007|Overall Study|Lack of Efficacy|3|||
161913795|NCT01294046|584733625|FG000|Overall Study|Infection and surgical explant|1|||
161913796|NCT01294046|584733625|FG000|Overall Study|Eligibility criteria expanded|1|||
161913797|NCT01294046|584733625|FG000|Overall Study|Stimulation response inadqequate|1|||
161913798|NCT03738696|584733631|FG000|Overall Study|Withdrawal by Subject|0|||
161913799|NCT03738696|584733632|FG001|Overall Study|Withdrawal by Subject|1|||
161913800|NCT03738696|584733631|FG000|Overall Study|Lost to Follow-up|8|||
161913801|NCT03738696|584733632|FG001|Overall Study|Lost to Follow-up|14|||
161913802|NCT02690727|584733635|FG000|Overall Study|Adverse Event|2|||
161913803|NCT02690727|584733636|FG001|Overall Study|Adverse Event|2|||
161913804|NCT04757636|584733637|FG000|Overall Study|Adverse Event|25|||
161913805|NCT04757636|584733638|FG001|Overall Study|Adverse Event|8|||
161913806|NCT04757636|584733639|FG002|Overall Study|Adverse Event|11|||
161913807|NCT04757636|584733637|FG000|Overall Study|Death|9|||
161913808|NCT04757636|584733638|FG001|Overall Study|Death|12|||
161913809|NCT04757636|584733639|FG002|Overall Study|Death|6|||
161913810|NCT04757636|584733637|FG000|Overall Study|Lack of Efficacy|2|||
161913811|NCT04757636|584733638|FG001|Overall Study|Lack of Efficacy|0|||
161913812|NCT04757636|584733639|FG002|Overall Study|Lack of Efficacy|0|||
161913813|NCT04757636|584733637|FG000|Overall Study|Lost to Follow-up|1|||
161913814|NCT04757636|584733638|FG001|Overall Study|Lost to Follow-up|6|||
161913815|NCT04757636|584733639|FG002|Overall Study|Lost to Follow-up|7|||
161913816|NCT04757636|584733637|FG000|Overall Study|Physician Decision|1|||
161913817|NCT04757636|584733638|FG001|Overall Study|Physician Decision|3|||
161913818|NCT04757636|584733639|FG002|Overall Study|Physician Decision|4|||
161913819|NCT04757636|584733637|FG000|Overall Study|Withdrawal by Subject|20|||
161913820|NCT04757636|584733638|FG001|Overall Study|Withdrawal by Subject|23|||
162011992|NCT01550003|585099983|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
162011993|NCT01550003|585099984|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
162011994|NCT01550003|585099982|FG000|Overall Study|Site closure|0|||
162011995|NCT01550003|585099983|FG001|Overall Study|Site closure|2|||
162011996|NCT01550003|585099984|FG002|Overall Study|Site closure|0|||
162011997|NCT01550003|585099982|FG000|Overall Study|Pregnancy|0|||
162011998|NCT01550003|585099983|FG001|Overall Study|Pregnancy|1|||
162011999|NCT01550003|585099984|FG002|Overall Study|Pregnancy|0|||
162012000|NCT01550003|585099982|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
162012001|NCT01550003|585099983|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
162012002|NCT01550003|585099984|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
162012003|NCT01550003|585099982|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
162012004|NCT01550003|585099983|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
162012005|NCT01550003|585099984|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
162012006|NCT01550003|585099982|FG000|Overall Study|Switching to adult rheumatologist|0|||
162012007|NCT01550003|585099983|FG001|Overall Study|Switching to adult rheumatologist|0|||
162012008|NCT01550003|585099984|FG002|Overall Study|Switching to adult rheumatologist|1|||
162012009|NCT01550003|585099982|FG000|Overall Study|Patient transition to adult care|0|||
162012010|NCT01550003|585099983|FG001|Overall Study|Patient transition to adult care|0|||
162012011|NCT01550003|585099984|FG002|Overall Study|Patient transition to adult care|1|||
162012012|NCT01550003|585099982|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
162012013|NCT01550003|585099983|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
162012014|NCT01550003|585099984|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
162012015|NCT01550003|585099982|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
162012016|NCT01550003|585099983|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
162012017|NCT01550003|585099984|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
162012018|NCT01550003|585099982|FG000|Overall Study|Per Sponsor request|1|||
162012019|NCT01550003|585099983|FG001|Overall Study|Per Sponsor request|0|||
162012020|NCT01550003|585099984|FG002|Overall Study|Per Sponsor request|1|||
162012021|NCT01550003|585099982|FG000|Overall Study|Patient not compliance|0|||
162012022|NCT01550003|585099983|FG001|Overall Study|Patient not compliance|0|||
162012023|NCT01550003|585099984|FG002|Overall Study|Patient not compliance|1|||
162012024|NCT01550003|585099982|FG000|Overall Study|Non-compliance|0|||
162012025|NCT01550003|585099983|FG001|Overall Study|Non-compliance|0|||
162012026|NCT01550003|585099984|FG002|Overall Study|Non-compliance|1|||
162012027|NCT01550003|585099982|FG000|Overall Study|Study closed|0|||
162012028|NCT01550003|585099983|FG001|Overall Study|Study closed|1|||
162012029|NCT01550003|585099984|FG002|Overall Study|Study closed|0|||
162012030|NCT01550003|585099982|FG000|Overall Study|Transitioned to adult rheumatology|0|||
162012031|NCT01550003|585099983|FG001|Overall Study|Transitioned to adult rheumatology|0|||
162012032|NCT01550003|585099984|FG002|Overall Study|Transitioned to adult rheumatology|1|||
162012033|NCT05567783|585099985|FG000|Overall Study|Death|2|||
162012034|NCT05567783|585099986|FG001|Overall Study|Death|3|||
162012035|NCT05567783|585099987|FG002|Overall Study|Death|0|||
161913821|NCT04757636|584733639|FG002|Overall Study|Withdrawal by Subject|18|||
161913822|NCT04757636|584733637|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
161913823|NCT04757636|584733638|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
161913824|NCT04757636|584733639|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
161913825|NCT04757636|584733637|FG000|Overall Study|Study Terminated by Sponsor|103|||
161913826|NCT04757636|584733638|FG001|Overall Study|Study Terminated by Sponsor|104|||
162012036|NCT05567783|585099985|FG000|Overall Study|Lost to Follow-up|25|||
162012037|NCT05567783|585099986|FG001|Overall Study|Lost to Follow-up|19|||
162012038|NCT05567783|585099987|FG002|Overall Study|Lost to Follow-up|17|||
162012039|NCT05567783|585099985|FG000|Overall Study|Physician Decision|10|||
162012040|NCT05567783|585099986|FG001|Overall Study|Physician Decision|7|||
162012041|NCT05567783|585099987|FG002|Overall Study|Physician Decision|9|||
161809816|NCT02305758|584345838|FG000|Overall Study|Withdrew consent|9|||
161809817|NCT02305758|584345839|FG001|Overall Study|Withdrew consent|2|||
161809818|NCT02305758|584345838|FG000|Overall Study|Lost to Follow-up|6|||
161809819|NCT02305758|584345839|FG001|Overall Study|Lost to Follow-up|1|||
161913827|NCT04757636|584733639|FG002|Overall Study|Study Terminated by Sponsor|114|||
161913828|NCT04757636|584733637|FG000|Overall Study|Sponsor Decision|0|||
161913829|NCT04757636|584733638|FG001|Overall Study|Sponsor Decision|0|||
161913830|NCT04757636|584733639|FG002|Overall Study|Sponsor Decision|1|||
161913831|NCT04757636|584733637|FG000|Overall Study|Randomized in Error|0|||
161913832|NCT04757636|584733638|FG001|Overall Study|Randomized in Error|0|||
161913833|NCT04757636|584733639|FG002|Overall Study|Randomized in Error|2|||
161913834|NCT00091819|584733640|FG000|Overall Study|Adverse Event|1|||
161913835|NCT00091819|584733641|FG001|Overall Study|Adverse Event|1|||
161913836|NCT00091819|584733640|FG000|Overall Study|Death|4|||
161913837|NCT00091819|584733641|FG001|Overall Study|Death|5|||
161913838|NCT00091819|584733640|FG000|Overall Study|Lost to Follow-up|26|||
161913839|NCT00091819|584733641|FG001|Overall Study|Lost to Follow-up|23|||
161913840|NCT00091819|584733640|FG000|Overall Study|Withdrawal by Subject|5|||
161913841|NCT00091819|584733641|FG001|Overall Study|Withdrawal by Subject|8|||
161913842|NCT00091819|584733640|FG000|Overall Study|Protocol Violation|1|||
161913843|NCT00091819|584733641|FG001|Overall Study|Protocol Violation|2|||
161913844|NCT00091819|584733640|FG000|Overall Study|Other|2|||
161913845|NCT00091819|584733641|FG001|Overall Study|Other|3|||
161913846|NCT00091819|584733640|FG000|Overall Study|Never received study treatment|3|||
161913847|NCT00091819|584733641|FG001|Overall Study|Never received study treatment|4|||
161913848|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
161913849|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
161913850|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
161913851|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
161913852|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
161913853|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
161913854|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
161913855|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
161913856|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
161913857|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
161913858|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Death|3|||
161913859|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Death|1|||
161913860|NCT01056276|584733642|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
161913861|NCT01056276|584733643|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
161913862|NCT01056276|584733642|FG000|Maintenance Therapy|Toxicity|0|||
161913863|NCT01056276|584733643|FG001|Maintenance Therapy|Toxicity|2|||
161913864|NCT01056276|584733642|FG000|Maintenance Therapy|Progressive Disease|0|||
161913865|NCT01056276|584733643|FG001|Maintenance Therapy|Progressive Disease|9|||
161913866|NCT01056276|584733642|FG000|Maintenance Therapy|Physician Decision|0|||
161913867|NCT01056276|584733643|FG001|Maintenance Therapy|Physician Decision|1|||
161913868|NCT01056276|584733642|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
161913869|NCT01056276|584733643|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
161913870|NCT01056276|584733642|FG000|Maintenance Therapy|Intercurrent Illness|0|||
161913871|NCT01056276|584733643|FG001|Maintenance Therapy|Intercurrent Illness|1|||
161913872|NCT01056276|584733642|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
161913873|NCT01056276|584733643|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
161913874|NCT01859741|584733644|FG000|Overall Study|Death|3|||
161913875|NCT01859741|584733645|FG001|Overall Study|Death|2|||
161913876|NCT01859741|584733646|FG002|Overall Study|Death|4|||
161913877|NCT01859741|584733647|FG003|Overall Study|Death|3|||
161913878|NCT01859741|584733648|FG004|Overall Study|Death|5|||
161913879|NCT01859741|584733649|FG005|Overall Study|Death|4|||
161913880|NCT01859741|584733650|FG006|Overall Study|Death|51|||
161913881|NCT01859741|584733651|FG007|Overall Study|Death|51|||
161913882|NCT01859741|584733644|FG000|Overall Study|Lost to Follow-up|0|||
161913883|NCT01859741|584733645|FG001|Overall Study|Lost to Follow-up|0|||
161913884|NCT01859741|584733646|FG002|Overall Study|Lost to Follow-up|0|||
161913885|NCT01859741|584733647|FG003|Overall Study|Lost to Follow-up|0|||
161913886|NCT01859741|584733648|FG004|Overall Study|Lost to Follow-up|0|||
162012042|NCT05567783|585099985|FG000|Overall Study|Study Terminated by Sponsor|924|||
162012043|NCT05567783|585099986|FG001|Overall Study|Study Terminated by Sponsor|937|||
162012044|NCT05567783|585099987|FG002|Overall Study|Study Terminated by Sponsor|941|||
162147149|NCT03418324|585585216|FG001|Overall Study|Death|1|||
161913887|NCT01859741|584733649|FG005|Overall Study|Lost to Follow-up|1|||
161913888|NCT01859741|584733650|FG006|Overall Study|Lost to Follow-up|0|||
161913889|NCT01859741|584733651|FG007|Overall Study|Lost to Follow-up|4|||
161913890|NCT01859741|584733644|FG000|Overall Study|Withdrawal by Subject|0|||
161913891|NCT01859741|584733645|FG001|Overall Study|Withdrawal by Subject|1|||
161913892|NCT01859741|584733646|FG002|Overall Study|Withdrawal by Subject|2|||
161913893|NCT01859741|584733647|FG003|Overall Study|Withdrawal by Subject|0|||
161913894|NCT01859741|584733648|FG004|Overall Study|Withdrawal by Subject|0|||
161913895|NCT01859741|584733649|FG005|Overall Study|Withdrawal by Subject|1|||
161913896|NCT01859741|584733650|FG006|Overall Study|Withdrawal by Subject|1|||
161913897|NCT01859741|584733651|FG007|Overall Study|Withdrawal by Subject|1|||
161913898|NCT01859741|584733644|FG000|Overall Study|Study Terminated by Sponsor|0|||
161913899|NCT01859741|584733645|FG001|Overall Study|Study Terminated by Sponsor|0|||
161913900|NCT01859741|584733646|FG002|Overall Study|Study Terminated by Sponsor|0|||
161913901|NCT01859741|584733647|FG003|Overall Study|Study Terminated by Sponsor|0|||
161913902|NCT01859741|584733648|FG004|Overall Study|Study Terminated by Sponsor|1|||
161913903|NCT01859741|584733649|FG005|Overall Study|Study Terminated by Sponsor|0|||
161913904|NCT01859741|584733650|FG006|Overall Study|Study Terminated by Sponsor|16|||
161913905|NCT01859741|584733651|FG007|Overall Study|Study Terminated by Sponsor|14|||
161913906|NCT01859741|584733644|FG000|Overall Study|Other|0|||
161913907|NCT01859741|584733645|FG001|Overall Study|Other|0|||
161913908|NCT01859741|584733646|FG002|Overall Study|Other|0|||
161913909|NCT01859741|584733647|FG003|Overall Study|Other|0|||
161913910|NCT01859741|584733648|FG004|Overall Study|Other|0|||
161913911|NCT01859741|584733649|FG005|Overall Study|Other|0|||
161913912|NCT01859741|584733650|FG006|Overall Study|Other|2|||
161913913|NCT01859741|584733651|FG007|Overall Study|Other|0|||
162147150|NCT03418324|585585215|FG000|Overall Study|Physician Decision|1|||
162147151|NCT03418324|585585216|FG001|Overall Study|Physician Decision|1|||
162147152|NCT01768676|585585217|FG000|Overall Study|Adverse Event|3|||
162147153|NCT01768676|585585218|FG001|Overall Study|Adverse Event|3|||
162147154|NCT01768676|585585217|FG000|Overall Study|Lost to Follow-up|13|||
162147155|NCT01768676|585585218|FG001|Overall Study|Lost to Follow-up|16|||
162147156|NCT01768676|585585217|FG000|Overall Study|Protocol Violation|1|||
162147157|NCT01768676|585585218|FG001|Overall Study|Protocol Violation|1|||
162147158|NCT01768676|585585217|FG000|Overall Study|Physician Decision|4|||
162147159|NCT01768676|585585218|FG001|Overall Study|Physician Decision|1|||
162147160|NCT01768676|585585217|FG000|Overall Study|Withdrawal by Subject|3|||
162147161|NCT01768676|585585218|FG001|Overall Study|Withdrawal by Subject|10|||
162147162|NCT00605033|585585219|FG000|Overall Study|Adverse Event|2|||
162147163|NCT00605033|585585220|FG001|Overall Study|Adverse Event|2|||
162147164|NCT00605033|585585219|FG000|Overall Study|Lost to Follow-up|1|||
162147165|NCT00605033|585585220|FG001|Overall Study|Lost to Follow-up|1|||
162147166|NCT00605033|585585219|FG000|Overall Study|Withdrawal by Subject|3|||
162147167|NCT00605033|585585220|FG001|Overall Study|Withdrawal by Subject|4|||
162147168|NCT00605033|585585219|FG000|Overall Study|Protocol Violation|1|||
162147169|NCT00605033|585585220|FG001|Overall Study|Protocol Violation|1|||
162147170|NCT03121950|585585223|FG000|Overall Study|Withdrawal by Subject|11|||
162147171|NCT03121950|585585224|FG001|Overall Study|Withdrawal by Subject|2|||
162147172|NCT02754479|585585228|FG000|Overall Study|Lost to Follow-up|1|||
162147173|NCT03183518|585585229|FG000|Overall Study|Other (Not specified)|2|||
162147174|NCT03183518|585585229|FG000|Overall Study|Other (Withdrawal of consent)|1|||
162147175|NCT02132702|585585230|FG000|Overall Study|Protocol Violation|2|||
162147176|NCT02132702|585585230|FG000|Overall Study|Adverse Event|3|||
162147177|NCT02132702|585585230|FG000|Overall Study|Withdrawal by Subject|3|||
162147178|NCT01244828|585585233|FG000|Overall Study|Adverse Event|37|||
162147179|NCT01244828|585585233|FG000|Overall Study|Withdrawal by Subject|31|||
162147180|NCT01244828|585585233|FG000|Overall Study|Lack of Efficacy|7|||
162147181|NCT01244828|585585233|FG000|Overall Study|Lost to Follow-up|2|||
162147182|NCT01244828|585585233|FG000|Overall Study|Other reason (not specified)|1|||
162147183|NCT00573833|585585234|FG000|Overall Study|Not Treated|2|||
162147184|NCT05052983|585585235|FG000|Overall Study|Lack of Efficacy|3|||
162147185|NCT05052983|585585236|FG001|Overall Study|Lack of Efficacy|12|||
162147186|NCT05052983|585585235|FG000|Overall Study|Adverse Event|1|||
162147187|NCT05052983|585585236|FG001|Overall Study|Adverse Event|0|||
162147188|NCT04493242|585585237|FG000|Overall Study|Death|10|||
162147189|NCT04493242|585585238|FG001|Overall Study|Death|14|||
162147190|NCT04493242|585585239|FG002|Overall Study|Death|16|||
162147191|NCT04493242|585585237|FG000|Overall Study|Lost to Follow-up|1|||
162147192|NCT04493242|585585238|FG001|Overall Study|Lost to Follow-up|1|||
162147193|NCT04493242|585585239|FG002|Overall Study|Lost to Follow-up|0|||
162147194|NCT04493242|585585237|FG000|Overall Study|Withdrawal by Subject|1|||
162147195|NCT04493242|585585238|FG001|Overall Study|Withdrawal by Subject|0|||
162147196|NCT04493242|585585239|FG002|Overall Study|Withdrawal by Subject|0|||
162147197|NCT04493242|585585237|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
162147198|NCT04493242|585585238|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
162147199|NCT04493242|585585239|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
162147200|NCT04493242|585585237|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
162147201|NCT04493242|585585238|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
162147202|NCT04493242|585585239|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
162147203|NCT03175172|585587011|FG000|Overall Study|Death|3|||
162147204|NCT03175172|585587011|FG000|Overall Study|Withdrawal by Subject|3|||
162147205|NCT03175172|585587011|FG000|Overall Study|Lost to Follow-up|1|||
162147206|NCT03175172|585587011|FG000|Overall Study|Study Terminated by Sponsor|3|||
162147207|NCT00446550|585587016|FG000|Overall Study|Adverse Event|1|||
162147208|NCT00446550|585587017|FG001|Overall Study|Adverse Event|0|||
162147209|NCT02983617|585587018|FG000|Overall Study|Adverse Event|0|||
162147210|NCT02983617|585587019|FG001|Overall Study|Adverse Event|7|||
162147211|NCT02983617|585587018|FG000|Overall Study|Death|0|||
162147212|NCT02983617|585587019|FG001|Overall Study|Death|1|||
161913914|NCT02606253|584733652|FG000|Overall Study|Adverse Event|2|||
161913915|NCT02606253|584733653|FG001|Overall Study|Adverse Event|0|||
161809820|NCT02305758|584345838|FG000|Overall Study|Study Terminated by Sponsor|21|||
161809821|NCT02305758|584345839|FG001|Overall Study|Study Terminated by Sponsor|34|||
161809822|NCT02305758|584345838|FG000|Overall Study|Other, not specified|2|||
161809823|NCT02305758|584345839|FG001|Overall Study|Other, not specified|1|||
161809824|NCT02032888|584345841|FG000|Treatment Period|Poor compliance/noncompliance|1|||
161809825|NCT02032888|584345842|FG001|Treatment Period|Poor compliance/noncompliance|1|||
161809826|NCT02032888|584345843|FG002|Treatment Period|Poor compliance/noncompliance|0|||
162012045|NCT05567783|585099985|FG000|Overall Study|Withdrawal by Subject|23|||
162012046|NCT05567783|585099986|FG001|Overall Study|Withdrawal by Subject|27|||
162012047|NCT05567783|585099987|FG002|Overall Study|Withdrawal by Subject|24|||
162012048|NCT05567783|585099985|FG000|Overall Study|Incarcerated|1|||
162012049|NCT05567783|585099986|FG001|Overall Study|Incarcerated|0|||
162012050|NCT05567783|585099987|FG002|Overall Study|Incarcerated|0|||
162012051|NCT05567783|585099985|FG000|Overall Study|Participant randomized in error|4|||
162012052|NCT05567783|585099986|FG001|Overall Study|Participant randomized in error|2|||
162012053|NCT05567783|585099987|FG002|Overall Study|Participant randomized in error|2|||
162012054|NCT03675126|585099990|FG000|Overall Study|Study Terminated by Sponsor|9|||
162012055|NCT03675126|585099990|FG000|Overall Study|Death|2|||
162012056|NCT03675126|585099990|FG000|Overall Study|Withdrawal by Subject|4|||
162012057|NCT00686712|585099994|FG000|Overall Study|Protocol Violation|8|||
162012058|NCT00686712|585099995|FG001|Overall Study|Protocol Violation|8|||
162012059|NCT00686712|585099996|FG002|Overall Study|Protocol Violation|10|||
162012060|NCT00686712|585099994|FG000|Overall Study|Lost to Follow-up|1|||
162012061|NCT00686712|585099995|FG001|Overall Study|Lost to Follow-up|2|||
162012062|NCT00686712|585099996|FG002|Overall Study|Lost to Follow-up|3|||
162012063|NCT00686712|585099994|FG000|Overall Study|Adverse Event|1|||
162012064|NCT00686712|585099995|FG001|Overall Study|Adverse Event|1|||
162012065|NCT00686712|585099996|FG002|Overall Study|Adverse Event|0|||
162012066|NCT01929317|585099997|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
162012067|NCT01929317|585099998|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
162012068|NCT01929317|585099997|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
162012069|NCT01929317|585099998|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
162012070|NCT01929317|585099997|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
162012071|NCT01929317|585099998|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
162012072|NCT01929317|585099997|FG000|Long-term Phase|Adverse Event|5|||
162012073|NCT01929317|585099998|FG001|Long-term Phase|Adverse Event|1|||
162012074|NCT01929317|585099997|FG000|Long-term Phase|Physician Decision|3|||
162012075|NCT01929317|585099998|FG001|Long-term Phase|Physician Decision|0|||
162012076|NCT01929317|585099997|FG000|Long-term Phase|Withdrawal by Subject|4|||
162012077|NCT01929317|585099998|FG001|Long-term Phase|Withdrawal by Subject|0|||
162012078|NCT01929317|585099997|FG000|Long-term Phase|Protocol Violation|1|||
162012079|NCT01929317|585099998|FG001|Long-term Phase|Protocol Violation|0|||
162012080|NCT01929317|585099997|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
162012081|NCT01929317|585099998|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
162012082|NCT01929317|585099997|FG000|Long-term Phase|Study Closed/Terminated|5|||
162012083|NCT01929317|585099998|FG001|Long-term Phase|Study Closed/Terminated|3|||
162012084|NCT03815929|585100002|FG000|Overall Study|Lost to Follow-up|2|||
162012085|NCT03815929|585100003|FG001|Overall Study|Lost to Follow-up|1|||
162012086|NCT03815929|585100004|FG002|Overall Study|Lost to Follow-up|0|||
162012087|NCT03815929|585100002|FG000|Overall Study|Physician Decision|2|||
162012088|NCT03815929|585100003|FG001|Overall Study|Physician Decision|2|||
162012089|NCT03815929|585100004|FG002|Overall Study|Physician Decision|0|||
162012090|NCT03815929|585100002|FG000|Overall Study|Withdrawal by Subject|0|||
162012091|NCT03815929|585100003|FG001|Overall Study|Withdrawal by Subject|0|||
162012092|NCT03815929|585100004|FG002|Overall Study|Withdrawal by Subject|1|||
162012093|NCT02205736|585100005|FG000|Overall Study|Lost to Follow-up|106|||
162012094|NCT02638220|585100013|FG000|Overall Study|Lost to Follow-up|6|||
162012095|NCT02638220|585100013|FG000|Overall Study|Withdrawal by Subject|3|||
162012096|NCT02638220|585100013|FG000|Overall Study|Physician Decision|1|||
162012097|NCT02638220|585100013|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
162012098|NCT04323124|585100014|FG000|Overall Study|Adverse Event|0|||
162012099|NCT04323124|585100015|FG001|Overall Study|Adverse Event|0|||
162012100|NCT04323124|585100016|FG002|Overall Study|Adverse Event|0|||
162012101|NCT04323124|585100017|FG003|Overall Study|Adverse Event|0|||
162012102|NCT04323124|585100018|FG004|Overall Study|Adverse Event|0|||
162012103|NCT04323124|585100019|FG005|Overall Study|Adverse Event|1|||
162012104|NCT04323124|585100020|FG006|Overall Study|Adverse Event|0|||
162012105|NCT04323124|585100021|FG007|Overall Study|Adverse Event|1|||
162012106|NCT04323124|585100022|FG008|Overall Study|Adverse Event|1|||
162012107|NCT04323124|585100023|FG009|Overall Study|Adverse Event|0|||
162012108|NCT04323124|585100024|FG010|Overall Study|Adverse Event|0|||
162012109|NCT04323124|585100025|FG011|Overall Study|Adverse Event|0|||
162012110|NCT04323124|585100026|FG012|Overall Study|Adverse Event|0|||
162012111|NCT04323124|585100027|FG013|Overall Study|Adverse Event|0|||
162012112|NCT04323124|585100028|FG014|Overall Study|Adverse Event|0|||
162012113|NCT04323124|585100014|FG000|Overall Study|Other|0|||
162147213|NCT02983617|585587018|FG000|Overall Study|Investigator's Discretion|0|||
162147214|NCT02983617|585587019|FG001|Overall Study|Investigator's Discretion|1|||
162147215|NCT02027558|585587022|FG000|Overall Study|Death|0|||
162147216|NCT02027558|585587023|FG001|Overall Study|Death|1|||
162147217|NCT02027558|585587022|FG000|Overall Study|Withdrawal by Subject|2|||
162147218|NCT02027558|585587023|FG001|Overall Study|Withdrawal by Subject|0|||
162147219|NCT02027558|585587022|FG000|Overall Study|Lost to Follow-up|4|||
162147220|NCT02027558|585587023|FG001|Overall Study|Lost to Follow-up|1|||
162147221|NCT02027558|585587022|FG000|Overall Study|Refused assessment|3|||
162147222|NCT02027558|585587023|FG001|Overall Study|Refused assessment|0|||
162147223|NCT02698891|585587024|FG000|Overall Study|Withdrawal by Subject|2|||
162147224|NCT02698891|585587024|FG000|Overall Study|deemed ineligible|1|||
162147225|NCT02698891|585587024|FG000|Overall Study|Adverse Event|9|||
162147226|NCT04218110|585587025|FG000|Overall Study|Withdrawal by Subject|0|||
162147227|NCT04218110|585587026|FG001|Overall Study|Withdrawal by Subject|0|||
162147228|NCT04218110|585587027|FG002|Overall Study|Withdrawal by Subject|0|||
162147229|NCT04218110|585587028|FG003|Overall Study|Withdrawal by Subject|1|||
162147230|NCT00516386|585587029|FG000|Overall Study|not interested in the study|4|||
162147231|NCT00516386|585587029|FG000|Overall Study|Lost to Follow-up|2|||
162147232|NCT00002842|585587030|FG000|Overall Study|ineligible for surgical resection|27|||
162147233|NCT02694978|585587033|FG000|Overall Study|Adverse Event|10|||
162147234|NCT02694978|585587034|FG001|Overall Study|Adverse Event|9|||
162147235|NCT02694978|585587033|FG000|Overall Study|Withdrawal by Subject|22|||
162147236|NCT02694978|585587034|FG001|Overall Study|Withdrawal by Subject|19|||
162147237|NCT02694978|585587033|FG000|Overall Study|Lost to Follow-up|14|||
162147238|NCT02694978|585587034|FG001|Overall Study|Lost to Follow-up|17|||
162147239|NCT02694978|585587033|FG000|Overall Study|Death|4|||
162147240|NCT02694978|585587034|FG001|Overall Study|Death|1|||
162147241|NCT02694978|585587033|FG000|Overall Study|Other-Decision of Participant|6|||
162147242|NCT02694978|585587034|FG001|Overall Study|Other-Decision of Participant|1|||
162147243|NCT02694978|585587033|FG000|Overall Study|Other-Investigator's decision|1|||
162147244|NCT02694978|585587034|FG001|Overall Study|Other-Investigator's decision|0|||
162147245|NCT02694978|585587033|FG000|Overall Study|Other-Unable to be reached|0|||
162147246|NCT02694978|585587034|FG001|Overall Study|Other-Unable to be reached|1|||
162147247|NCT02694978|585587033|FG000|Overall Study|Other-Protocol noncompliant|2|||
162147248|NCT02694978|585587034|FG001|Overall Study|Other-Protocol noncompliant|1|||
162147249|NCT02694978|585587033|FG000|Overall Study|Other-Personal reasons|3|||
162147250|NCT02694978|585587034|FG001|Overall Study|Other-Personal reasons|3|||
162147251|NCT02694978|585587033|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
162147252|NCT02694978|585587034|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
162147253|NCT00807144|585587037|FG000|Overall Study|Lost to Follow-up|0|||
162147254|NCT00807144|585587038|FG001|Overall Study|Lost to Follow-up|1|||
162147255|NCT03823300|585587041|FG000|Overall Study|Withdrawal by Subject|16|||
162147256|NCT03823300|585587042|FG001|Overall Study|Withdrawal by Subject|22|||
162147257|NCT03823300|585587041|FG000|Overall Study|Death|10|||
162147258|NCT03823300|585587042|FG001|Overall Study|Death|14|||
162147259|NCT03823300|585587041|FG000|Overall Study|Adverse Event|3|||
162147260|NCT03823300|585587042|FG001|Overall Study|Adverse Event|5|||
161809827|NCT02032888|584345841|FG000|Treatment Period|Other|1|||
161809828|NCT02032888|584345842|FG001|Treatment Period|Other|1|||
161809829|NCT02032888|584345843|FG002|Treatment Period|Other|0|||
161809830|NCT02032888|584345841|FG000|Follow-up Period|Lost to Follow-up|1|||
161809831|NCT02032888|584345842|FG001|Follow-up Period|Lost to Follow-up|1|||
161809832|NCT02032888|584345843|FG002|Follow-up Period|Lost to Follow-up|0|||
161809833|NCT02032888|584345841|FG000|Follow-up Period|Death|1|||
161809834|NCT02032888|584345842|FG001|Follow-up Period|Death|1|||
161809835|NCT02032888|584345843|FG002|Follow-up Period|Death|0|||
161809836|NCT02032888|584345841|FG000|Follow-up Period|Other|1|||
161809837|NCT02032888|584345842|FG001|Follow-up Period|Other|0|||
161809838|NCT02032888|584345843|FG002|Follow-up Period|Other|0|||
161809839|NCT02272777|584345844|FG000|Overall Study|Adverse Event|0|||
161809840|NCT02272777|584345845|FG001|Overall Study|Adverse Event|1|||
161809841|NCT02272777|584345844|FG000|Overall Study|Withdrawal by Subject|0|||
161809842|NCT02272777|584345845|FG001|Overall Study|Withdrawal by Subject|3|||
161809843|NCT02272777|584345844|FG000|Overall Study|Lost to Follow-up|2|||
161809844|NCT02272777|584345845|FG001|Overall Study|Lost to Follow-up|0|||
161809845|NCT02272777|584345844|FG000|Overall Study|Other|2|||
161809846|NCT02272777|584345845|FG001|Overall Study|Other|0|||
161809847|NCT00837486|584345846|FG000|Blinded-treatment Phase|Physician Decision|1|||
161809848|NCT00837486|584345847|FG001|Blinded-treatment Phase|Physician Decision|0|||
161809849|NCT00837486|584345846|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
161809850|NCT00837486|584345847|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
161809851|NCT00837486|584345846|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
161809852|NCT00837486|584345847|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
161809853|NCT00837486|584345846|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
161809854|NCT00837486|584345847|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
161809855|NCT03071575|584347660|FG000|Overall Study|Death|0|||
162147261|NCT03823300|585587041|FG000|Overall Study|Physician Decision|1|||
162147262|NCT03823300|585587042|FG001|Overall Study|Physician Decision|7|||
162147263|NCT03823300|585587041|FG000|Overall Study|Lost to Follow-up|1|||
162147264|NCT03823300|585587042|FG001|Overall Study|Lost to Follow-up|3|||
162147265|NCT03823300|585587041|FG000|Overall Study|Protocol Violation|1|||
162147266|NCT03823300|585587042|FG001|Overall Study|Protocol Violation|1|||
161809856|NCT03071575|584347661|FG001|Overall Study|Death|1|||
161809857|NCT03071575|584347660|FG000|Overall Study|Lost to Follow-up|5|||
161809858|NCT03071575|584347661|FG001|Overall Study|Lost to Follow-up|11|||
161809859|NCT03071575|584347660|FG000|Overall Study|Withdrawal by Subject|4|||
161809860|NCT03071575|584347661|FG001|Overall Study|Withdrawal by Subject|2|||
161809861|NCT02267187|584347671|FG000|Overall Study|Physician Decision|2|||
161809862|NCT02267187|584347671|FG000|Overall Study|Screen fail|3|||
161809863|NCT00712959|584347676|FG000|Overall Study|Protocol Violation|3|||
161809864|NCT00712959|584347677|FG001|Overall Study|Protocol Violation|1|||
161809865|NCT00712959|584347676|FG000|Overall Study|Lost to Follow-up|13|||
161809866|NCT00712959|584347677|FG001|Overall Study|Lost to Follow-up|2|||
161809867|NCT00712959|584347676|FG000|Overall Study|Withdrawal by Subject|3|||
161809868|NCT00712959|584347677|FG001|Overall Study|Withdrawal by Subject|0|||
161809869|NCT00834067|584347678|FG000|Washout of 21 Days|Protocol Violation|0|||
161809870|NCT00834067|584347679|FG001|Washout of 21 Days|Protocol Violation|1|||
161809871|NCT01796171|584347680|FG000|Enrolled|Death|0|||
161809872|NCT01796171|584347681|FG001|Enrolled|Death|0|||
161809873|NCT01796171|584347682|FG002|Enrolled|Death|0|||
161809874|NCT01796171|584347683|FG003|Enrolled|Death|0|||
161809875|NCT01796171|584347684|FG004|Enrolled|Death|0|||
161809876|NCT01796171|584347685|FG005|Enrolled|Death|0|||
161809877|NCT01796171|584347686|FG006|Enrolled|Death|0|||
161809878|NCT01796171|584347687|FG007|Enrolled|Death|0|||
161809879|NCT01796171|584347688|FG008|Enrolled|Death|0|||
161809880|NCT01796171|584347689|FG009|Enrolled|Death|0|||
161809881|NCT01796171|584347690|FG010|Enrolled|Death|0|||
161809882|NCT01796171|584347691|FG011|Enrolled|Death|0|||
161809883|NCT01796171|584347692|FG012|Enrolled|Death|0|||
161809884|NCT01796171|584347693|FG013|Enrolled|Death|0|||
161809885|NCT01796171|584347694|FG014|Enrolled|Death|1|||
161809886|NCT01796171|584347680|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
161809887|NCT01796171|584347681|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
161809888|NCT01796171|584347682|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
161809889|NCT01796171|584347683|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
161809890|NCT01796171|584347684|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
161809891|NCT01796171|584347685|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
161809892|NCT01796171|584347686|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
161809893|NCT01796171|584347687|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
161809894|NCT01796171|584347688|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
161809895|NCT01796171|584347689|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
161809896|NCT01796171|584347690|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
161809897|NCT01796171|584347691|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
161809898|NCT01796171|584347692|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
161809899|NCT01796171|584347693|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
161809900|NCT01796171|584347694|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
161809901|NCT01796171|584347680|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809902|NCT01796171|584347681|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809903|NCT01796171|584347682|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809904|NCT01796171|584347683|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809905|NCT01796171|584347684|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162147267|NCT03823300|585587041|FG000|Overall Study|Lack of Efficacy|1|||
162147268|NCT03823300|585587042|FG001|Overall Study|Lack of Efficacy|1|||
162147269|NCT03823300|585587041|FG000|Overall Study|Not Eligible|0|||
162147270|NCT03823300|585587042|FG001|Overall Study|Not Eligible|1|||
162147271|NCT03823300|585587041|FG000|Overall Study|Other|1|||
162147272|NCT03823300|585587042|FG001|Overall Study|Other|0|||
162147273|NCT00831415|585587043|FG000|Overall Study|Adverse Event|14|||
162147274|NCT00831415|585587043|FG000|Overall Study|Failed to return|3|||
162147275|NCT00831415|585587043|FG000|Overall Study|Physician Decision|6|||
162147276|NCT00831415|585587043|FG000|Overall Study|Lost to Follow-up|9|||
162147277|NCT00831415|585587043|FG000|Overall Study|Protocol Violation|3|||
162147278|NCT00831415|585587043|FG000|Overall Study|Withdrawal by Subject|35|||
162147279|NCT00831415|585587043|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
162147280|NCT00831415|585587043|FG000|Overall Study|Death|1|||
162147281|NCT01290224|585587044|FG000|Overall Study|Adverse Event|1|||
162147282|NCT01290224|585587044|FG000|Overall Study|Refused Further Treatment|4|||
162147283|NCT01027286|585587045|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
161809906|NCT01796171|584347685|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809907|NCT01796171|584347686|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809908|NCT01796171|584347687|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809909|NCT01796171|584347688|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809910|NCT01796171|584347689|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
162147284|NCT01027286|585587046|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
162147285|NCT01027286|585587045|FG000|Overall Study|Lost to Follow-up|0|||
161913916|NCT02606253|584733654|FG002|Overall Study|Adverse Event|0|||
161913917|NCT02606253|584733652|FG000|Overall Study|Protocol Violation|2|||
161913918|NCT02606253|584733653|FG001|Overall Study|Protocol Violation|1|||
161913919|NCT02606253|584733654|FG002|Overall Study|Protocol Violation|0|||
161913920|NCT02606253|584733652|FG000|Overall Study|Physician Decision|1|||
161913921|NCT02606253|584733653|FG001|Overall Study|Physician Decision|1|||
161913922|NCT02606253|584733654|FG002|Overall Study|Physician Decision|0|||
161913923|NCT00701363|584733655|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
161913924|NCT00701363|584733656|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
161913925|NCT00701363|584733657|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
161913926|NCT00701363|584733658|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
161913927|NCT00701363|584733655|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
162012114|NCT04323124|585100015|FG001|Overall Study|Other|0|||
162012115|NCT04323124|585100016|FG002|Overall Study|Other|0|||
162012116|NCT04323124|585100017|FG003|Overall Study|Other|0|||
162147286|NCT01027286|585587046|FG001|Overall Study|Lost to Follow-up|1|||
161913928|NCT00701363|584733656|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
161913929|NCT00701363|584733657|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
161913930|NCT00701363|584733658|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
161913931|NCT00701363|584733655|FG000|Treatment Phase 1|Adverse Event|7|||
161913932|NCT00701363|584733656|FG001|Treatment Phase 1|Adverse Event|0|||
161913933|NCT00701363|584733657|FG002|Treatment Phase 1|Adverse Event|0|||
161913934|NCT00701363|584733658|FG003|Treatment Phase 1|Adverse Event|0|||
161913935|NCT00701363|584733655|FG000|Treatment Phase 1|Protocol Violation|1|||
161913936|NCT00701363|584733656|FG001|Treatment Phase 1|Protocol Violation|0|||
161913937|NCT00701363|584733657|FG002|Treatment Phase 1|Protocol Violation|0|||
161913938|NCT00701363|584733658|FG003|Treatment Phase 1|Protocol Violation|0|||
161913939|NCT00701363|584733655|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
161913940|NCT00701363|584733656|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
161913941|NCT00701363|584733657|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
161913942|NCT00701363|584733658|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
161913943|NCT00701363|584733655|FG000|Treatment Phase 1|Lack of Efficacy|1|||
161913944|NCT00701363|584733656|FG001|Treatment Phase 1|Lack of Efficacy|0|||
161913945|NCT00701363|584733657|FG002|Treatment Phase 1|Lack of Efficacy|0|||
161913946|NCT00701363|584733658|FG003|Treatment Phase 1|Lack of Efficacy|0|||
161913947|NCT00701363|584733655|FG000|Treatment Phase 2|Adverse Event|0|||
161913948|NCT00701363|584733656|FG001|Treatment Phase 2|Adverse Event|0|||
161913949|NCT00701363|584733657|FG002|Treatment Phase 2|Adverse Event|1|||
161913950|NCT00701363|584733658|FG003|Treatment Phase 2|Adverse Event|0|||
161913951|NCT00701363|584733655|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
161913952|NCT00701363|584733656|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
161913953|NCT00701363|584733657|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
161913954|NCT00701363|584733658|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
161913955|NCT03426878|584733659|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
161913956|NCT03426878|584733659|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
161913957|NCT03426878|584733659|FG000|Overall Study|Declined to receive results|3|||
161913958|NCT03426878|584733659|FG000|Overall Study|Received negative results by mailed letter|65|||
161913959|NCT03426878|584733659|FG000|Overall Study|Lost to Follow-up|177|||
161913960|NCT00746551|584733666|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
161913961|NCT00746551|584733667|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
161913962|NCT00746551|584733666|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
161913963|NCT00746551|584733667|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
161913964|NCT00746551|584733666|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
161913965|NCT00746551|584733667|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
161913966|NCT00262925|584733670|FG000|Overall Study|Lack of Efficacy|3|||
161913967|NCT00262925|584733670|FG000|Overall Study|Adverse Event|4|||
161913968|NCT00262925|584733670|FG000|Overall Study|Death|2|||
161913969|NCT00262925|584733670|FG000|Overall Study|alternative therapy|1|||
161913970|NCT00262925|584733670|FG000|Overall Study|Other|1|||
161913971|NCT04682301|584733672|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
161913972|NCT04682301|584733672|FG000|Overall Study|Death|2|||
161913973|NCT00560404|584733673|FG000|Overall Study|Adverse Event|2|||
161913974|NCT00560404|584733674|FG001|Overall Study|Adverse Event|3|||
161913975|NCT00560404|584733673|FG000|Overall Study|Death|3|||
161913976|NCT00560404|584733674|FG001|Overall Study|Death|3|||
161913977|NCT00560404|584733673|FG000|Overall Study|Protocol Violation|12|||
161913978|NCT00560404|584733674|FG001|Overall Study|Protocol Violation|7|||
162147287|NCT03804918|585587047|FG000|Overall Study|Participant did not use the app|1|||
162147288|NCT05694065|585587048|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
162147289|NCT05694065|585587048|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
162147290|NCT05694065|585587048|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
162147291|NCT00813904|585587049|FG000|Overall Study|Death|1|||
162147292|NCT01087762|585587050|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
162012117|NCT04323124|585100018|FG004|Overall Study|Other|1|||
162012118|NCT04323124|585100019|FG005|Overall Study|Other|0|||
162012119|NCT04323124|585100020|FG006|Overall Study|Other|0|||
162012120|NCT04323124|585100021|FG007|Overall Study|Other|0|||
162012121|NCT04323124|585100022|FG008|Overall Study|Other|1|||
162012122|NCT04323124|585100023|FG009|Overall Study|Other|0|||
162012123|NCT04323124|585100024|FG010|Overall Study|Other|0|||
162012124|NCT04323124|585100025|FG011|Overall Study|Other|0|||
162012125|NCT04323124|585100026|FG012|Overall Study|Other|0|||
162012126|NCT04323124|585100027|FG013|Overall Study|Other|0|||
162012127|NCT04323124|585100028|FG014|Overall Study|Other|0|||
162012128|NCT04323124|585100014|FG000|Overall Study|Coming from a red zone (COVID)|0|||
162012129|NCT04323124|585100015|FG001|Overall Study|Coming from a red zone (COVID)|0|||
162012130|NCT04323124|585100016|FG002|Overall Study|Coming from a red zone (COVID)|0|||
162012131|NCT04323124|585100017|FG003|Overall Study|Coming from a red zone (COVID)|0|||
162012132|NCT04323124|585100018|FG004|Overall Study|Coming from a red zone (COVID)|1|||
162012133|NCT04323124|585100019|FG005|Overall Study|Coming from a red zone (COVID)|1|||
162012134|NCT04323124|585100020|FG006|Overall Study|Coming from a red zone (COVID)|0|||
162012135|NCT04323124|585100021|FG007|Overall Study|Coming from a red zone (COVID)|0|||
162012136|NCT04323124|585100022|FG008|Overall Study|Coming from a red zone (COVID)|0|||
162012137|NCT04323124|585100023|FG009|Overall Study|Coming from a red zone (COVID)|0|||
162012138|NCT04323124|585100024|FG010|Overall Study|Coming from a red zone (COVID)|0|||
162012139|NCT04323124|585100025|FG011|Overall Study|Coming from a red zone (COVID)|0|||
162012140|NCT04323124|585100026|FG012|Overall Study|Coming from a red zone (COVID)|0|||
162012141|NCT04323124|585100027|FG013|Overall Study|Coming from a red zone (COVID)|0|||
162012142|NCT04323124|585100028|FG014|Overall Study|Coming from a red zone (COVID)|0|||
162012143|NCT04323124|585100014|FG000|Overall Study|No longer meets eligibility criteria|0|||
162012144|NCT04323124|585100015|FG001|Overall Study|No longer meets eligibility criteria|0|||
162012145|NCT04323124|585100016|FG002|Overall Study|No longer meets eligibility criteria|0|||
162012146|NCT04323124|585100017|FG003|Overall Study|No longer meets eligibility criteria|0|||
162012147|NCT04323124|585100018|FG004|Overall Study|No longer meets eligibility criteria|0|||
162012148|NCT04323124|585100019|FG005|Overall Study|No longer meets eligibility criteria|0|||
162012149|NCT04323124|585100020|FG006|Overall Study|No longer meets eligibility criteria|0|||
162012150|NCT04323124|585100021|FG007|Overall Study|No longer meets eligibility criteria|1|||
162012151|NCT04323124|585100022|FG008|Overall Study|No longer meets eligibility criteria|0|||
162012152|NCT04323124|585100023|FG009|Overall Study|No longer meets eligibility criteria|0|||
162012153|NCT04323124|585100024|FG010|Overall Study|No longer meets eligibility criteria|0|||
162012154|NCT04323124|585100025|FG011|Overall Study|No longer meets eligibility criteria|0|||
162012155|NCT04323124|585100026|FG012|Overall Study|No longer meets eligibility criteria|0|||
162012156|NCT04323124|585100027|FG013|Overall Study|No longer meets eligibility criteria|1|||
162012157|NCT04323124|585100028|FG014|Overall Study|No longer meets eligibility criteria|1|||
162012158|NCT04323124|585100014|FG000|Overall Study|Study terminated by sponsor|0|||
162012159|NCT04323124|585100015|FG001|Overall Study|Study terminated by sponsor|0|||
162012160|NCT04323124|585100016|FG002|Overall Study|Study terminated by sponsor|0|||
162012161|NCT04323124|585100017|FG003|Overall Study|Study terminated by sponsor|0|||
162012162|NCT04323124|585100018|FG004|Overall Study|Study terminated by sponsor|0|||
162012163|NCT04323124|585100019|FG005|Overall Study|Study terminated by sponsor|0|||
162012164|NCT04323124|585100020|FG006|Overall Study|Study terminated by sponsor|0|||
162012165|NCT04323124|585100021|FG007|Overall Study|Study terminated by sponsor|0|||
162012166|NCT04323124|585100022|FG008|Overall Study|Study terminated by sponsor|0|||
162012167|NCT04323124|585100023|FG009|Overall Study|Study terminated by sponsor|0|||
162012168|NCT04323124|585100024|FG010|Overall Study|Study terminated by sponsor|0|||
162012169|NCT04323124|585100025|FG011|Overall Study|Study terminated by sponsor|2|||
162012170|NCT04323124|585100026|FG012|Overall Study|Study terminated by sponsor|1|||
162012171|NCT04323124|585100027|FG013|Overall Study|Study terminated by sponsor|0|||
162012172|NCT04323124|585100028|FG014|Overall Study|Study terminated by sponsor|0|||
162012173|NCT02083354|585101714|FG000|Overall Study|Withdrawal by Subject|9|||
162012174|NCT02083354|585101714|FG000|Overall Study|Lost to Follow-up|1|||
162012175|NCT02083354|585101714|FG000|Overall Study|Adverse Event|3|||
162012176|NCT02083354|585101714|FG000|Overall Study|Disease progression|46|||
162012177|NCT02083354|585101714|FG000|Overall Study|Study closed/terminated|5|||
162012178|NCT00628108|585101715|FG000|Overall Study|Adverse Event|0|||
162012179|NCT00628108|585101716|FG001|Overall Study|Adverse Event|3|||
162012180|NCT00628108|585101715|FG000|Overall Study|Withdrawal by Subject|1|||
162012181|NCT00628108|585101716|FG001|Overall Study|Withdrawal by Subject|0|||
162012182|NCT02453321|585101717|FG000|Overall Study|Weakness|1|||
162012183|NCT02453321|585101718|FG001|Overall Study|Weakness|1|||
162012184|NCT02453321|585101719|FG002|Overall Study|Weakness|2|||
162012185|NCT02453321|585101717|FG000|Overall Study|Deep Venous Thrombosis|0|||
162012186|NCT02453321|585101718|FG001|Overall Study|Deep Venous Thrombosis|1|||
162012187|NCT02453321|585101719|FG002|Overall Study|Deep Venous Thrombosis|0|||
162012188|NCT00098813|585101720|FG000|Overall Study|Death|8|||
162012189|NCT00098813|585101720|FG000|Overall Study|Protocol Violation|1|||
162012190|NCT00098813|585101720|FG000|Overall Study|Withdrawal by Subject|7|||
161809911|NCT01796171|584347690|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809912|NCT01796171|584347691|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809913|NCT01796171|584347692|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809914|NCT01796171|584347693|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
161809915|NCT01796171|584347694|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161809916|NCT01796171|584347680|FG000|Treatment Period With Betalutin|Progressive disease|0|||
161809917|NCT01796171|584347681|FG001|Treatment Period With Betalutin|Progressive disease|1|||
161809918|NCT01796171|584347682|FG002|Treatment Period With Betalutin|Progressive disease|0|||
161809919|NCT01796171|584347683|FG003|Treatment Period With Betalutin|Progressive disease|0|||
161809920|NCT01796171|584347684|FG004|Treatment Period With Betalutin|Progressive disease|0|||
161809921|NCT01796171|584347685|FG005|Treatment Period With Betalutin|Progressive disease|0|||
161809922|NCT01796171|584347686|FG006|Treatment Period With Betalutin|Progressive disease|0|||
161809923|NCT01796171|584347687|FG007|Treatment Period With Betalutin|Progressive disease|0|||
161809924|NCT01796171|584347688|FG008|Treatment Period With Betalutin|Progressive disease|0|||
161809925|NCT01796171|584347689|FG009|Treatment Period With Betalutin|Progressive disease|0|||
161809926|NCT01796171|584347690|FG010|Treatment Period With Betalutin|Progressive disease|0|||
161809927|NCT01796171|584347691|FG011|Treatment Period With Betalutin|Progressive disease|0|||
161809928|NCT01796171|584347692|FG012|Treatment Period With Betalutin|Progressive disease|0|||
161809929|NCT01796171|584347693|FG013|Treatment Period With Betalutin|Progressive disease|0|||
161809930|NCT01796171|584347694|FG014|Treatment Period With Betalutin|Progressive disease|0|||
161809931|NCT01796171|584347680|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809932|NCT01796171|584347681|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809933|NCT01796171|584347682|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809934|NCT01796171|584347683|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809935|NCT01796171|584347684|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162147293|NCT01087762|585587051|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
161809936|NCT01796171|584347685|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809937|NCT01796171|584347686|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809938|NCT01796171|584347687|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809939|NCT01796171|584347688|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
161809940|NCT01796171|584347689|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809941|NCT01796171|584347690|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
162147294|NCT01087762|585587052|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
162147295|NCT01087762|585587053|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
162147296|NCT01087762|585587054|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
162147297|NCT01087762|585587050|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
162147298|NCT01087762|585587051|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
162147299|NCT01087762|585587052|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
162147300|NCT01087762|585587053|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
162147301|NCT01087762|585587054|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
162147302|NCT01087762|585587050|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
162147303|NCT01087762|585587051|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
162147304|NCT01087762|585587052|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
162147305|NCT01087762|585587053|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
162147306|NCT01087762|585587054|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
162147307|NCT01087762|585587050|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
162147308|NCT01087762|585587051|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
162147309|NCT01087762|585587052|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
162147310|NCT01087762|585587053|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
162147311|NCT01087762|585587054|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
162147312|NCT01087762|585587050|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
162147313|NCT01087762|585587051|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
162147314|NCT01087762|585587052|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
162147315|NCT01087762|585587053|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
162147316|NCT01087762|585587054|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
162147317|NCT01087762|585587050|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
162147318|NCT01087762|585587051|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
162147319|NCT01087762|585587052|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
162147320|NCT01087762|585587053|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
162147321|NCT01087762|585587054|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
162147322|NCT01087762|585587050|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
162147323|NCT01087762|585587051|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
162147324|NCT01087762|585587052|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
162147325|NCT01087762|585587053|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
162147326|NCT01087762|585587054|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
162147327|NCT01087762|585587050|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
162147328|NCT01087762|585587051|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
162147329|NCT01087762|585587052|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
162147330|NCT01087762|585587053|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
162147331|NCT01087762|585587054|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
162147332|NCT01087762|585587050|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
162147333|NCT01087762|585587051|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
162147334|NCT01087762|585587052|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
162147335|NCT01087762|585587053|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
162147336|NCT01087762|585587054|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
162147337|NCT01087762|585587050|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
162147338|NCT01087762|585587051|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
162147339|NCT01087762|585587052|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
162147340|NCT01087762|585587053|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
162147341|NCT01087762|585587054|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
162147342|NCT01087762|585587050|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
162147343|NCT01087762|585587051|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
162147344|NCT01087762|585587052|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
162147345|NCT01087762|585587053|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
162147346|NCT01087762|585587054|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
162147347|NCT01087762|585587050|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
162147348|NCT01087762|585587051|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
162147349|NCT01087762|585587052|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
162147350|NCT01087762|585587053|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
162147351|NCT01087762|585587054|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
162147352|NCT01087762|585587050|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
162147353|NCT01087762|585587051|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
162147354|NCT01087762|585587052|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
162147355|NCT01087762|585587053|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
162147356|NCT01087762|585587054|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
162147357|NCT01405924|585587057|FG000|Overall Study|Protocol Violation|8|||
162147358|NCT01405924|585587057|FG000|Overall Study|Missing/Incomplete Data|2|||
162147359|NCT02393716|585587058|FG000|Overall Study|Death|29|||
162147360|NCT02393716|585587058|FG000|Overall Study|Withdrawal by Subject|8|||
162147361|NCT02393716|585587058|FG000|Overall Study|Device Explanted|8|||
162147362|NCT02393716|585587058|FG000|Overall Study|Missed visit|16|||
162147363|NCT01924767|585587059|FG000|Overall Study|Adverse Event|1|||
162147364|NCT01924767|585587060|FG001|Overall Study|Adverse Event|0|||
162147365|NCT01924767|585587061|FG002|Overall Study|Adverse Event|1|||
162147366|NCT01924767|585587062|FG003|Overall Study|Adverse Event|0|||
162147367|NCT01924767|585587063|FG004|Overall Study|Adverse Event|0|||
162147368|NCT01648140|585587064|FG000|Overall Study|Physician Decision|1|||
162147369|NCT01648140|585587065|FG001|Overall Study|Physician Decision|0|||
162147370|NCT01648140|585587066|FG002|Overall Study|Physician Decision|0|||
162147371|NCT01648140|585587067|FG003|Overall Study|Physician Decision|0|||
162147372|NCT01648140|585587064|FG000|Overall Study|Lack of Efficacy|4|||
162147373|NCT01648140|585587065|FG001|Overall Study|Lack of Efficacy|7|||
162147374|NCT01648140|585587066|FG002|Overall Study|Lack of Efficacy|1|||
162147375|NCT01648140|585587067|FG003|Overall Study|Lack of Efficacy|0|||
162147376|NCT01648140|585587064|FG000|Overall Study|Adverse Event|3|||
162147377|NCT01648140|585587065|FG001|Overall Study|Adverse Event|1|||
161913979|NCT00560404|584733673|FG000|Overall Study|Administrative Reasons|1|||
162147378|NCT01648140|585587066|FG002|Overall Study|Adverse Event|2|||
162147379|NCT01648140|585587067|FG003|Overall Study|Adverse Event|0|||
162147380|NCT01648140|585587064|FG000|Overall Study|Withdrawal by Subject|2|||
162147381|NCT01648140|585587065|FG001|Overall Study|Withdrawal by Subject|3|||
162147382|NCT01648140|585587066|FG002|Overall Study|Withdrawal by Subject|3|||
162147383|NCT01648140|585587067|FG003|Overall Study|Withdrawal by Subject|2|||
162147384|NCT01648140|585587064|FG000|Overall Study|Lost to Follow-up|2|||
162147385|NCT01648140|585587065|FG001|Overall Study|Lost to Follow-up|1|||
162147386|NCT01648140|585587066|FG002|Overall Study|Lost to Follow-up|2|||
162147387|NCT01648140|585587067|FG003|Overall Study|Lost to Follow-up|0|||
162147388|NCT01191788|585587074|FG000|Overall Study|Lost to Follow-up|21|||
162147389|NCT01191788|585587075|FG001|Overall Study|Lost to Follow-up|22|||
162147390|NCT03621761|585587076|FG000|Overall Study|Lost to Follow-up|1|||
162147391|NCT03621761|585587077|FG001|Overall Study|Lost to Follow-up|1|||
162147392|NCT03621761|585587078|FG002|Overall Study|Lost to Follow-up|2|||
162147393|NCT03621761|585587076|FG000|Overall Study|Withdrawal by Subject|2|||
162147394|NCT03621761|585587077|FG001|Overall Study|Withdrawal by Subject|1|||
162147395|NCT03621761|585587078|FG002|Overall Study|Withdrawal by Subject|1|||
162147396|NCT03621761|585587076|FG000|Overall Study|Became Ineligible|0|||
162147397|NCT03621761|585587077|FG001|Overall Study|Became Ineligible|2|||
162147398|NCT03621761|585587078|FG002|Overall Study|Became Ineligible|0|||
162147399|NCT01713530|585587081|FG000|Overall Study|Adverse Event|0|||
162147400|NCT01713530|585587082|FG001|Overall Study|Adverse Event|5|||
162147401|NCT01713530|585587081|FG000|Overall Study|Withdrawal criteria|21|||
162147402|NCT01713530|585587082|FG001|Overall Study|Withdrawal criteria|12|||
162147403|NCT01713530|585587081|FG000|Overall Study|Unclassified|4|||
162147404|NCT01713530|585587082|FG001|Overall Study|Unclassified|2|||
162147405|NCT03939819|585587083|FG000|Overall Study|Death|2|||
162147406|NCT03939819|585587084|FG001|Overall Study|Death|0|||
162147407|NCT03987451|585587085|FG000|Overall Study|Lost to Follow-up|1|||
162147408|NCT03987451|585587086|FG001|Overall Study|Lost to Follow-up|0|||
162147409|NCT03987451|585587085|FG000|Overall Study|Withdrawal by Subject|1|||
162147410|NCT03987451|585587086|FG001|Overall Study|Withdrawal by Subject|1|||
162147411|NCT02441036|585587087|FG000|Overall Study|No tissue resected|0|||
162147412|NCT02441036|585587088|FG001|Overall Study|No tissue resected|1|||
162147413|NCT02441036|585587089|FG002|Overall Study|No tissue resected|0|||
162147414|NCT02441036|585587090|FG003|Overall Study|No tissue resected|1|||
162147415|NCT02441036|585587091|FG004|Overall Study|No tissue resected|0|||
162147416|NCT01183780|585587092|FG000|Overall Study|Withdrawal by Subject|25|||
162147417|NCT01183780|585587093|FG001|Overall Study|Withdrawal by Subject|14|||
162147418|NCT01183780|585587092|FG000|Overall Study|Lost to Follow-up|6|||
162147419|NCT01183780|585587093|FG001|Overall Study|Lost to Follow-up|11|||
162147420|NCT00079183|585587096|FG000|Overall Study|Withdrawal by Subject|4|||
162147421|NCT00079183|585587096|FG000|Overall Study|Study medication non-compliance|2|||
162147422|NCT00079183|585587096|FG000|Overall Study|Specimen collection non-compliance|1|||
162147423|NCT00762606|585587097|FG000|Overall Study|Lost to Follow-up|18|||
162147424|NCT00762606|585587098|FG001|Overall Study|Lost to Follow-up|13|||
162147425|NCT01505881|585587099|FG000|Overall Study|Adverse Event|0|||
162147426|NCT01505881|585587100|FG001|Overall Study|Adverse Event|1|||
162147427|NCT01505881|585587099|FG000|Overall Study|Lost to Follow-up|2|||
162147428|NCT01505881|585587100|FG001|Overall Study|Lost to Follow-up|0|||
162147429|NCT01505881|585587099|FG000|Overall Study|Withdrawal by Subject|2|||
162147430|NCT01505881|585587100|FG001|Overall Study|Withdrawal by Subject|0|||
162147431|NCT01147341|585587101|FG000|Double Blind Period|Lack of Efficacy|1|||
162147432|NCT01147341|585587102|FG001|Double Blind Period|Lack of Efficacy|1|||
162147433|NCT01147341|585587101|FG000|Double Blind Period|Withdrawal by Subject|0|||
162147434|NCT01147341|585587102|FG001|Double Blind Period|Withdrawal by Subject|1|||
162147435|NCT01147341|585587101|FG000|Open Label Period|Lack of Efficacy|3|||
162147436|NCT01147341|585587102|FG001|Open Label Period|Lack of Efficacy|0|||
162147437|NCT01147341|585587101|FG000|Open Label Period|Subject moved|1|||
162147438|NCT01147341|585587102|FG001|Open Label Period|Subject moved|0|||
162147439|NCT01596504|585587103|FG000|Overall Study|Participant's Private Reason|0|||
162147440|NCT01596504|585587104|FG001|Overall Study|Participant's Private Reason|1|||
162147441|NCT01596504|585587105|FG002|Overall Study|Participant's Private Reason|0|||
162147442|NCT01596504|585587103|FG000|Overall Study|Adverse Event|1|||
162147443|NCT01596504|585587104|FG001|Overall Study|Adverse Event|2|||
162147444|NCT01596504|585587105|FG002|Overall Study|Adverse Event|1|||
162147445|NCT01596504|585587103|FG000|Overall Study|Withdrawal by Subject|1|||
162147446|NCT01596504|585587104|FG001|Overall Study|Withdrawal by Subject|0|||
162147447|NCT01596504|585587105|FG002|Overall Study|Withdrawal by Subject|0|||
162147448|NCT00949975|585587106|FG000|Overall Study|Voluntary discontinuation|6|||
162147449|NCT00949975|585587107|FG001|Overall Study|Voluntary discontinuation|5|||
162147450|NCT00949975|585587108|FG002|Overall Study|Voluntary discontinuation|3|||
162147451|NCT00949975|585587109|FG003|Overall Study|Voluntary discontinuation|6|||
162147452|NCT00949975|585587106|FG000|Overall Study|Adverse Event|11|||
162147453|NCT00949975|585587107|FG001|Overall Study|Adverse Event|11|||
162147454|NCT00949975|585587108|FG002|Overall Study|Adverse Event|10|||
162147455|NCT00949975|585587109|FG003|Overall Study|Adverse Event|10|||
162147456|NCT00949975|585587106|FG000|Overall Study|Safety reason|0|||
162147457|NCT00949975|585587107|FG001|Overall Study|Safety reason|1|||
162147458|NCT00949975|585587108|FG002|Overall Study|Safety reason|0|||
162147459|NCT00949975|585587109|FG003|Overall Study|Safety reason|0|||
162147460|NCT00949975|585587106|FG000|Overall Study|Study-specific criteria|0|||
162147461|NCT00949975|585587107|FG001|Overall Study|Study-specific criteria|1|||
162147462|NCT00949975|585587108|FG002|Overall Study|Study-specific criteria|1|||
162147463|NCT00949975|585587109|FG003|Overall Study|Study-specific criteria|0|||
162147464|NCT00949975|585587106|FG000|Overall Study|Incorrect enrolment|5|||
162147465|NCT00949975|585587107|FG001|Overall Study|Incorrect enrolment|10|||
162147466|NCT00949975|585587108|FG002|Overall Study|Incorrect enrolment|4|||
162147467|NCT00949975|585587109|FG003|Overall Study|Incorrect enrolment|7|||
162147468|NCT00949975|585587106|FG000|Overall Study|Severe non-compliance|3|||
162147469|NCT00949975|585587107|FG001|Overall Study|Severe non-compliance|1|||
162147470|NCT00949975|585587108|FG002|Overall Study|Severe non-compliance|0|||
162147471|NCT00949975|585587109|FG003|Overall Study|Severe non-compliance|2|||
162147472|NCT00949975|585587106|FG000|Overall Study|Lost to Follow-up|1|||
162147473|NCT00949975|585587107|FG001|Overall Study|Lost to Follow-up|0|||
162147474|NCT00949975|585587108|FG002|Overall Study|Lost to Follow-up|1|||
162147475|NCT00949975|585587109|FG003|Overall Study|Lost to Follow-up|3|||
162147476|NCT00949975|585587106|FG000|Overall Study|Other|1|||
162147477|NCT00949975|585587107|FG001|Overall Study|Other|0|||
162147478|NCT00949975|585587108|FG002|Overall Study|Other|0|||
162147479|NCT00949975|585587109|FG003|Overall Study|Other|0|||
162147480|NCT03257813|585587110|FG000|Overall Study|Protocol Violation|6|||
162147481|NCT03257813|585587111|FG001|Overall Study|Protocol Violation|3|||
162147482|NCT04246762|585587112|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
162147483|NCT02878330|585587113|FG000|Overall Study|Death|3|||
162147484|NCT02878330|585587114|FG001|Overall Study|Death|2|||
162147485|NCT02878330|585587113|FG000|Overall Study|Lost to Follow-up|11|||
161913980|NCT00560404|584733674|FG001|Overall Study|Administrative Reasons|1|||
161913981|NCT00560404|584733673|FG000|Overall Study|Withdrew Consent|4|||
161913982|NCT00560404|584733674|FG001|Overall Study|Withdrew Consent|0|||
162147486|NCT02878330|585587114|FG001|Overall Study|Lost to Follow-up|26|||
162147487|NCT02878330|585587113|FG000|Overall Study|Withdrawal by Subject|11|||
162147488|NCT02878330|585587114|FG001|Overall Study|Withdrawal by Subject|21|||
162147489|NCT02878330|585587113|FG000|Overall Study|Other|4|||
162147490|NCT02878330|585587114|FG001|Overall Study|Other|7|||
161913983|NCT00560404|584733673|FG000|Overall Study|Failure to return|1|||
162147491|NCT03615924|585587115|FG000|Overall Study|Withdrawal by Subject|2|||
162147492|NCT03615924|585587116|FG001|Overall Study|Withdrawal by Subject|5|||
162147493|NCT03615924|585587115|FG000|Overall Study|Death|3|||
162147494|NCT03615924|585587116|FG001|Overall Study|Death|1|||
161913984|NCT00560404|584733674|FG001|Overall Study|Failure to return|2|||
162147495|NCT03615924|585587115|FG000|Overall Study|Lost to Follow-up|1|||
162147496|NCT03615924|585587116|FG001|Overall Study|Lost to Follow-up|0|||
162147497|NCT03615924|585587115|FG000|Overall Study|Randomized in error|1|||
162147498|NCT03615924|585587116|FG001|Overall Study|Randomized in error|0|||
162147499|NCT03615924|585587115|FG000|Overall Study|Study termination by Sponsor|94|||
162147500|NCT03615924|585587116|FG001|Overall Study|Study termination by Sponsor|86|||
162147501|NCT02954848|585587119|FG000|Overall Study|Randomized but Not Treated|0|||
162147502|NCT02954848|585587120|FG001|Overall Study|Randomized but Not Treated|1|||
162147503|NCT02954848|585587119|FG000|Overall Study|Adverse Event|2|||
162147504|NCT02954848|585587120|FG001|Overall Study|Adverse Event|3|||
162147505|NCT02954848|585587119|FG000|Overall Study|Withdrawal by Participant|0|||
162147506|NCT02954848|585587120|FG001|Overall Study|Withdrawal by Participant|1|||
162147507|NCT01069341|585587121|FG000|Overall Study|Lost to Follow-up|1|||
162147508|NCT00922207|585587122|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
162147509|NCT00922207|585587123|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
162147510|NCT00922207|585587124|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
162147511|NCT00922207|585587122|FG000|Overall Study|Insufficient Therapeutic Response|0|||
162147512|NCT00922207|585587123|FG001|Overall Study|Insufficient Therapeutic Response|0|||
162147513|NCT00922207|585587124|FG002|Overall Study|Insufficient Therapeutic Response|1|||
162147514|NCT00922207|585587122|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
162147515|NCT00922207|585587123|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
162147516|NCT00922207|585587124|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
162147517|NCT00922207|585587122|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
162147518|NCT00922207|585587123|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
162147519|NCT00922207|585587124|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
162147520|NCT00922207|585587122|FG000|Overall Study|Withdrew Consent|2|||
162147521|NCT00922207|585587123|FG001|Overall Study|Withdrew Consent|5|||
162147522|NCT00922207|585587124|FG002|Overall Study|Withdrew Consent|2|||
162147523|NCT00922207|585587122|FG000|Overall Study|Abnormality of Laboratory Test|0|||
162147524|NCT00922207|585587123|FG001|Overall Study|Abnormality of Laboratory Test|1|||
162147525|NCT00922207|585587124|FG002|Overall Study|Abnormality of Laboratory Test|1|||
162147526|NCT01802632|585587125|FG000|Overall Study|Death|28|||
162147527|NCT01802632|585587126|FG001|Overall Study|Death|1|||
162147528|NCT01802632|585587127|FG002|Overall Study|Death|38|||
162147529|NCT01802632|585587128|FG003|Overall Study|Death|0|||
162147530|NCT01802632|585587129|FG004|Overall Study|Death|2|||
162147531|NCT01802632|585587130|FG005|Overall Study|Death|0|||
162147532|NCT01802632|585587125|FG000|Overall Study|Withdrawal by Subject|4|||
162147533|NCT01802632|585587126|FG001|Overall Study|Withdrawal by Subject|2|||
162147534|NCT01802632|585587127|FG002|Overall Study|Withdrawal by Subject|7|||
162147535|NCT01802632|585587128|FG003|Overall Study|Withdrawal by Subject|3|||
162147536|NCT01802632|585587129|FG004|Overall Study|Withdrawal by Subject|0|||
162147537|NCT01802632|585587130|FG005|Overall Study|Withdrawal by Subject|1|||
162147538|NCT01802632|585587125|FG000|Overall Study|Objective Disease Progression|1|||
162147539|NCT01802632|585587126|FG001|Overall Study|Objective Disease Progression|12|||
162147540|NCT01802632|585587127|FG002|Overall Study|Objective Disease Progression|104|||
162147541|NCT01802632|585587128|FG003|Overall Study|Objective Disease Progression|6|||
162147542|NCT01802632|585587129|FG004|Overall Study|Objective Disease Progression|4|||
162147543|NCT01802632|585587130|FG005|Overall Study|Objective Disease Progression|4|||
162147544|NCT01802632|585587125|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
162147545|NCT01802632|585587126|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
162147546|NCT01802632|585587127|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
162147547|NCT01802632|585587128|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
162147548|NCT01802632|585587129|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
162147549|NCT01802632|585587130|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
162147550|NCT01802632|585587125|FG000|Overall Study|Other (not specified)|0|||
162147551|NCT01802632|585587126|FG001|Overall Study|Other (not specified)|0|||
162147552|NCT01802632|585587127|FG002|Overall Study|Other (not specified)|7|||
162147553|NCT01802632|585587128|FG003|Overall Study|Other (not specified)|1|||
162147554|NCT01802632|585587129|FG004|Overall Study|Other (not specified)|0|||
162147555|NCT01802632|585587130|FG005|Overall Study|Other (not specified)|1|||
162147556|NCT03299816|585587135|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
162147557|NCT03299816|585587136|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
162147558|NCT03299816|585587135|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
162147559|NCT03299816|585587136|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
162147560|NCT03299816|585587135|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
162147561|NCT03299816|585587136|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
162147562|NCT00367991|585587137|FG000|Overall Study|Withdrawal by Subject|1|||
162147563|NCT00367991|585587138|FG001|Overall Study|Withdrawal by Subject|1|||
162147564|NCT00367991|585587137|FG000|Overall Study|Adverse Event|1|||
162147565|NCT00367991|585587138|FG001|Overall Study|Adverse Event|1|||
162147566|NCT01184508|585587142|FG000|Overall Study|Adverse Event|4|||
162147567|NCT01184508|585587143|FG001|Overall Study|Adverse Event|6|||
162147568|NCT01184508|585587142|FG000|Overall Study|Lack of Efficacy|1|||
162147569|NCT01184508|585587143|FG001|Overall Study|Lack of Efficacy|1|||
162147570|NCT01184508|585587142|FG000|Overall Study|Lost to Follow-up|1|||
162147571|NCT01184508|585587143|FG001|Overall Study|Lost to Follow-up|1|||
162147572|NCT01184508|585587142|FG000|Overall Study|Physician Decision|1|||
162012191|NCT00098813|585101720|FG000|Overall Study|Progression of Disease|1|||
162147573|NCT01184508|585587143|FG001|Overall Study|Physician Decision|0|||
162147574|NCT01184508|585587142|FG000|Overall Study|Protocol Violation|3|||
162147575|NCT01184508|585587143|FG001|Overall Study|Protocol Violation|1|||
162147576|NCT01184508|585587142|FG000|Overall Study|Sponsor Decision|5|||
162147577|NCT01184508|585587143|FG001|Overall Study|Sponsor Decision|2|||
162147578|NCT01184508|585587142|FG000|Overall Study|Withdrawal by Subject|1|||
162147579|NCT01184508|585587143|FG001|Overall Study|Withdrawal by Subject|3|||
162147580|NCT01184508|585587142|FG000|Overall Study|Randomized, Not Treated|0|||
162147581|NCT01184508|585587143|FG001|Overall Study|Randomized, Not Treated|1|||
162147582|NCT00790790|585587151|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
162147583|NCT00790790|585587152|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
162147584|NCT00790790|585587153|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
162147585|NCT00790790|585587151|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
162147586|NCT00790790|585587152|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
162147587|NCT00790790|585587153|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
162147588|NCT00790790|585587151|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
162147589|NCT00790790|585587152|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
162147590|NCT00790790|585587153|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
162147591|NCT00790790|585587151|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
162147592|NCT00790790|585587152|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
162147593|NCT00790790|585587153|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
162147594|NCT00790790|585587151|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
162147595|NCT00790790|585587152|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
162147596|NCT00790790|585587153|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
162147597|NCT01493778|585587154|FG000|Overall Study|Withdrawal by Subject|8|||
162147598|NCT01227707|585587155|FG000|Overall Study|Adverse Event|10|||
162147599|NCT01227707|585587155|FG000|Overall Study|Progression of disease|3|||
162147600|NCT01227707|585587155|FG000|Overall Study|Withdrawal by Subject|1|||
162147601|NCT01227707|585587155|FG000|Overall Study|Patient non-compliance|3|||
162147602|NCT01227707|585587155|FG000|Overall Study|Medical decision|6|||
162147603|NCT01227707|585587155|FG000|Overall Study|Death|1|||
162147604|NCT03210402|585587156|FG000|Overall Study|Withdrawal by Subject|0|||
162147605|NCT03210402|585587157|FG001|Overall Study|Withdrawal by Subject|1|||
162147606|NCT00811057|585587158|FG000|Overall Study|Protocol Violation|5|||
162147607|NCT00811057|585587159|FG001|Overall Study|Protocol Violation|10|||
162147608|NCT00811057|585587160|FG002|Overall Study|Protocol Violation|10|||
162147609|NCT03215927|585588719|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
162147610|NCT03215927|585588720|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
162147611|NCT03215927|585588719|FG000|Open Label Extension|Adverse Event|1|||
162147612|NCT03215927|585588720|FG001|Open Label Extension|Adverse Event|0|||
162147613|NCT03215927|585588719|FG000|Open Label Extension|Lack of Efficacy|1|||
162147614|NCT03215927|585588720|FG001|Open Label Extension|Lack of Efficacy|0|||
162147615|NCT03215927|585588719|FG000|Open Label Extension|Death|0|||
162147616|NCT03215927|585588720|FG001|Open Label Extension|Death|1|||
162147617|NCT03779048|585588721|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
162147618|NCT03779048|585588722|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
162147619|NCT03779048|585588723|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
162147620|NCT03779048|585588721|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
162147621|NCT03779048|585588722|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
162147622|NCT03779048|585588723|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
162147623|NCT03779048|585588721|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
162147624|NCT03779048|585588722|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
162147625|NCT03779048|585588723|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
162147626|NCT05328297|585588724|FG000|Overall Study|Adverse Event|5|||
162147627|NCT05328297|585588725|FG001|Overall Study|Adverse Event|7|||
162147628|NCT05328297|585588724|FG000|Overall Study|Withdrawal by Subject|4|||
162147629|NCT05328297|585588725|FG001|Overall Study|Withdrawal by Subject|3|||
162147630|NCT05328297|585588724|FG000|Overall Study|Lack of Efficacy|1|||
162147631|NCT05328297|585588725|FG001|Overall Study|Lack of Efficacy|0|||
162147632|NCT05328297|585588724|FG000|Overall Study|Lost to Follow-up|1|||
162147633|NCT05328297|585588725|FG001|Overall Study|Lost to Follow-up|0|||
162147634|NCT05328297|585588724|FG000|Overall Study|Protocol Violation|1|||
162147635|NCT05328297|585588725|FG001|Overall Study|Protocol Violation|0|||
162147636|NCT05328297|585588724|FG000|Overall Study|Randomized but not treated|1|||
162147637|NCT05328297|585588725|FG001|Overall Study|Randomized but not treated|1|||
162147638|NCT01286272|585588726|FG000|Overall Study|Ineligible after beginning treatment|1|||
162147639|NCT01286272|585588727|FG001|Overall Study|Ineligible after beginning treatment|3|||
162147640|NCT03979365|585588730|FG000|Overall Study|Death|1|||
162147641|NCT03979365|585588731|FG001|Overall Study|Death|3|||
162147642|NCT03979365|585588730|FG000|Overall Study|Withdrawal by Subject|0|||
162147643|NCT03979365|585588731|FG001|Overall Study|Withdrawal by Subject|1|||
162012192|NCT00098813|585101720|FG000|Overall Study|Other complicating disease|1|||
162147644|NCT03979365|585588730|FG000|Overall Study|Drug Conversion|0|||
162147645|NCT03979365|585588731|FG001|Overall Study|Drug Conversion|3|||
162147646|NCT04496960|585588732|FG000|Overall Study|Physician Decision|0|||
162147647|NCT04496960|585588733|FG001|Overall Study|Physician Decision|1|||
162147648|NCT00028769|585588736|FG000|Overall Study|Adverse Event|2|||
162147649|NCT00028769|585588736|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
162147650|NCT00028769|585588736|FG000|Overall Study|Progression or Death|31|||
162147651|NCT00028769|585588736|FG000|Overall Study|Other - Not Protocol Specified|1|||
162147652|NCT00028769|585588736|FG000|Overall Study|Ineligible|5|||
162147653|NCT00028769|585588736|FG000|Overall Study|Not Analyzable|1|||
162147654|NCT02496702|585588739|FG000|Overall Study|Lost to Follow-up|8|||
162147655|NCT02496702|585588740|FG001|Overall Study|Lost to Follow-up|6|||
162147656|NCT02496702|585588739|FG000|Overall Study|Only partially tested|0|||
162147657|NCT02496702|585588740|FG001|Overall Study|Only partially tested|2|||
162147658|NCT00941655|585588741|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
162147659|NCT00941655|585588742|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
162147660|NCT00941655|585588741|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
162147661|NCT00941655|585588742|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
162147662|NCT00941655|585588741|FG000|Overall Study|progressed while on chemo|0|||
162147663|NCT00941655|585588742|FG001|Overall Study|progressed while on chemo|2|||
162147664|NCT00941655|585588741|FG000|Overall Study|refused further treatment|0|||
162147665|NCT00941655|585588742|FG001|Overall Study|refused further treatment|1|||
162147666|NCT00941655|585588741|FG000|Overall Study|withdrew consent|0|||
162147667|NCT00941655|585588742|FG001|Overall Study|withdrew consent|1|||
162147668|NCT00941655|585588741|FG000|Overall Study|non-compliant|0|||
162147669|NCT00941655|585588742|FG001|Overall Study|non-compliant|1|||
162147670|NCT05855655|585588747|FG000|Overall Study|Withdrawal by Subject|0|||
162147671|NCT05855655|585588748|FG001|Overall Study|Withdrawal by Subject|1|||
162147672|NCT05855655|585588747|FG000|Overall Study|Lost to Follow-up|4|||
162147673|NCT05855655|585588748|FG001|Overall Study|Lost to Follow-up|0|||
162147674|NCT01613716|585588751|FG000|Overall Study|screen failures|3|||
162147675|NCT01613716|585588751|FG000|Overall Study|Lost to Follow-up|4|||
162147676|NCT01426269|585588752|FG000|Period 1: 12 Weeks|Adverse Event|5|||
162147677|NCT01426269|585588753|FG001|Period 1: 12 Weeks|Adverse Event|0|||
162147678|NCT01426269|585588754|FG002|Period 1: 12 Weeks|Adverse Event|0|||
162147679|NCT01426269|585588752|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
162147680|NCT01426269|585588753|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
162147681|NCT01426269|585588754|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
162147682|NCT01426269|585588752|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
162147683|NCT01426269|585588753|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
162147684|NCT01426269|585588754|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
162147685|NCT01426269|585588752|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
162147686|NCT01426269|585588753|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
162147687|NCT01426269|585588754|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
162147688|NCT01426269|585588752|FG000|Period 1: 12 Weeks|Pregnancy|1|||
162147689|NCT01426269|585588753|FG001|Period 1: 12 Weeks|Pregnancy|0|||
162147690|NCT01426269|585588754|FG002|Period 1: 12 Weeks|Pregnancy|0|||
162147691|NCT01426269|585588752|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
162147692|NCT01426269|585588753|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
162147693|NCT01426269|585588754|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
162147694|NCT01426269|585588752|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
162147695|NCT01426269|585588753|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
162147696|NCT01426269|585588754|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
162147697|NCT01426269|585588752|FG000|Period 2: 40 Weeks|Adverse Event|0|||
162147698|NCT01426269|585588753|FG001|Period 2: 40 Weeks|Adverse Event|1|||
162147699|NCT01426269|585588754|FG002|Period 2: 40 Weeks|Adverse Event|2|||
162147700|NCT01426269|585588752|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
162147701|NCT01426269|585588753|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
162147702|NCT01426269|585588754|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
162147703|NCT01426269|585588752|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
162147704|NCT01426269|585588753|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
162147705|NCT01426269|585588754|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
162147706|NCT01426269|585588752|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
162147707|NCT01426269|585588753|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
162147708|NCT01426269|585588754|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
162147709|NCT01426269|585588752|FG000|Period 2: 40 Weeks|Site closed|0|||
161809942|NCT01796171|584347691|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
162012193|NCT00098813|585101720|FG000|Overall Study|Reversal of RAI resistance|1|||
162012194|NCT02230670|585101721|FG000|Overall Study|Adverse Event|1|||
162147710|NCT01426269|585588753|FG001|Period 2: 40 Weeks|Site closed|6|||
162147711|NCT01426269|585588754|FG002|Period 2: 40 Weeks|Site closed|5|||
162147712|NCT01426269|585588752|FG000|Period 2: 40 Weeks|Relapsed|0|||
162147713|NCT01426269|585588753|FG001|Period 2: 40 Weeks|Relapsed|9|||
162147714|NCT01426269|585588754|FG002|Period 2: 40 Weeks|Relapsed|18|||
162147715|NCT00419094|585588756|FG000|Overall Study|Adverse Event|3|||
162147716|NCT00419094|585588757|FG001|Overall Study|Adverse Event|7|||
162147717|NCT00419094|585588756|FG000|Overall Study|Lack of Efficacy|1|||
162147718|NCT00419094|585588757|FG001|Overall Study|Lack of Efficacy|0|||
162147719|NCT00419094|585588756|FG000|Overall Study|Lost to Follow-up|0|||
162147720|NCT00419094|585588757|FG001|Overall Study|Lost to Follow-up|2|||
162147721|NCT00419094|585588756|FG000|Overall Study|Protocol Violation|1|||
162147722|NCT00419094|585588757|FG001|Overall Study|Protocol Violation|14|||
162147723|NCT00419094|585588756|FG000|Overall Study|Withdrawal of consent|1|||
162147724|NCT00419094|585588757|FG001|Overall Study|Withdrawal of consent|5|||
162147725|NCT00419094|585588756|FG000|Overall Study|Other: Error determining exit criteria|1|||
162147726|NCT00419094|585588757|FG001|Overall Study|Other: Error determining exit criteria|0|||
162147727|NCT00419094|585588756|FG000|Overall Study|Other: Patient non-compliant|0|||
162147728|NCT00419094|585588757|FG001|Overall Study|Other: Patient non-compliant|1|||
162147729|NCT00419094|585588756|FG000|Overall Study|Other: No contact for extended period|0|||
162147730|NCT00419094|585588757|FG001|Overall Study|Other: No contact for extended period|1|||
162147731|NCT02296424|585588758|FG000|Part 1|New therapy for study indication|0|||
162147732|NCT02296424|585588759|FG001|Part 1|New therapy for study indication|1|||
162147733|NCT02296424|585588760|FG002|Part 1|New therapy for study indication|0|||
162147734|NCT02296424|585588761|FG003|Part 1|New therapy for study indication|0|||
162147735|NCT02296424|585588758|FG000|Part 1|Protocol Violation|0|||
162147736|NCT02296424|585588759|FG001|Part 1|Protocol Violation|1|||
162147737|NCT02296424|585588760|FG002|Part 1|Protocol Violation|0|||
162147738|NCT02296424|585588761|FG003|Part 1|Protocol Violation|0|||
162147739|NCT02296424|585588758|FG000|Part 1|Withdrawal by Subject|0|||
162147740|NCT02296424|585588759|FG001|Part 1|Withdrawal by Subject|2|||
162147741|NCT02296424|585588760|FG002|Part 1|Withdrawal by Subject|0|||
162147742|NCT02296424|585588761|FG003|Part 1|Withdrawal by Subject|0|||
162147743|NCT02296424|585588758|FG000|Part 1|Study terminated by sponsor|0|||
162147744|NCT02296424|585588759|FG001|Part 1|Study terminated by sponsor|1|||
162147745|NCT02296424|585588760|FG002|Part 1|Study terminated by sponsor|0|||
162147746|NCT02296424|585588761|FG003|Part 1|Study terminated by sponsor|0|||
162147747|NCT02296424|585588758|FG000|Part 1|Adverse Event|2|||
162147748|NCT02296424|585588759|FG001|Part 1|Adverse Event|11|||
162147749|NCT02296424|585588760|FG002|Part 1|Adverse Event|0|||
162147750|NCT02296424|585588761|FG003|Part 1|Adverse Event|0|||
162147751|NCT02296424|585588758|FG000|Part 1|Lack of Efficacy|5|||
162147752|NCT02296424|585588759|FG001|Part 1|Lack of Efficacy|17|||
162147753|NCT02296424|585588760|FG002|Part 1|Lack of Efficacy|0|||
162147754|NCT02296424|585588761|FG003|Part 1|Lack of Efficacy|0|||
162147755|NCT02296424|585588758|FG000|Part 1|16 directly started part II|16|||
162147756|NCT02296424|585588759|FG001|Part 1|16 directly started part II|0|||
162147757|NCT02296424|585588760|FG002|Part 1|16 directly started part II|0|||
162147758|NCT02296424|585588761|FG003|Part 1|16 directly started part II|0|||
162147759|NCT02296424|585588758|FG000|Part 2|Lack of Efficacy|0|||
162147760|NCT02296424|585588759|FG001|Part 2|Lack of Efficacy|0|||
162147761|NCT02296424|585588760|FG002|Part 2|Lack of Efficacy|1|||
162147762|NCT02296424|585588761|FG003|Part 2|Lack of Efficacy|0|||
162147763|NCT02296424|585588758|FG000|Part 2|Adverse Event|0|||
162147764|NCT02296424|585588759|FG001|Part 2|Adverse Event|0|||
162147765|NCT02296424|585588760|FG002|Part 2|Adverse Event|1|||
162147766|NCT02296424|585588761|FG003|Part 2|Adverse Event|0|||
162147767|NCT02296424|585588758|FG000|Part 2|Lost to Follow-up|0|||
162147768|NCT02296424|585588759|FG001|Part 2|Lost to Follow-up|0|||
162147769|NCT02296424|585588760|FG002|Part 2|Lost to Follow-up|1|||
162147770|NCT02296424|585588761|FG003|Part 2|Lost to Follow-up|0|||
162147771|NCT00743444|585588762|FG000|First Intervention|Catheter placement problems|0|||
162147772|NCT00743444|585588763|FG001|First Intervention|Catheter placement problems|1|||
162147773|NCT00743444|585588762|FG000|Washout Period|Adverse Event|0|||
162147774|NCT00743444|585588763|FG001|Washout Period|Adverse Event|1|||
162147775|NCT01337635|585588772|FG000|Overall Study|Lost to Follow-up|0|||
162147776|NCT01337635|585588773|FG001|Overall Study|Lost to Follow-up|1|||
162147777|NCT03287622|585588777|FG000|Overall Study|Withdrawal by Subject|1|||
162147778|NCT03287622|585588778|FG001|Overall Study|Withdrawal by Subject|0|||
162147779|NCT03287622|585588777|FG000|Overall Study|Lost to Follow-up|27|||
162147780|NCT03287622|585588778|FG001|Overall Study|Lost to Follow-up|15|||
162147781|NCT03287622|585588777|FG000|Overall Study|No prescripion after surgery|28|||
162147782|NCT03287622|585588778|FG001|Overall Study|No prescripion after surgery|31|||
162147783|NCT03287622|585588777|FG000|Overall Study|prolonged Length of stay|2|||
162147784|NCT03287622|585588778|FG001|Overall Study|prolonged Length of stay|0|||
162147785|NCT03287622|585588777|FG000|Overall Study|surgery related|0|||
162147786|NCT03287622|585588778|FG001|Overall Study|surgery related|2|||
162147787|NCT00486330|585588787|FG000|Overall Study|Adverse Event|2|||
162147788|NCT04347954|585588793|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
162147789|NCT04347954|585588794|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
162147790|NCT04347954|585588795|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
162147791|NCT04347954|585588793|FG000|Overall Study|Lost to Follow-up|0|||
162147792|NCT04347954|585588794|FG001|Overall Study|Lost to Follow-up|1|||
162147793|NCT04347954|585588795|FG002|Overall Study|Lost to Follow-up|0|||
162147794|NCT05641311|585588796|FG000|Dosing Period 1|Adverse Event|1|||
162147795|NCT05641311|585588797|FG001|Dosing Period 1|Adverse Event|0|||
162147796|NCT00909363|585588798|FG000|Overall Study|Withdrawal by Subject|1|||
162147797|NCT00909363|585588799|FG001|Overall Study|Withdrawal by Subject|0|||
162147798|NCT00909363|585588800|FG002|Overall Study|Withdrawal by Subject|0|||
162147799|NCT00909363|585588798|FG000|Overall Study|Lack of Efficacy|1|||
162147800|NCT00909363|585588799|FG001|Overall Study|Lack of Efficacy|0|||
162147801|NCT00909363|585588800|FG002|Overall Study|Lack of Efficacy|0|||
162147802|NCT03515304|585588807|FG000|Overall Study|Lost to Follow-up|0|||
162147803|NCT03515304|585588808|FG001|Overall Study|Lost to Follow-up|3|||
162147804|NCT02705586|585588811|FG000|Overall Study|Health Issues|2|||
162147805|NCT02705586|585588811|FG000|Overall Study|Transportation Difficulties|5|||
162147806|NCT02705586|585588811|FG000|Overall Study|Vacation/Planned Absence|1|||
162147807|NCT02808338|585588812|FG000|Screening|Screen Failure|10|||
162147808|NCT02808338|585588812|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
162147809|NCT02808338|585588812|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
162147810|NCT02045836|585588813|FG000|Overall Study|Adverse Event|4|||
162147811|NCT02045836|585588814|FG001|Overall Study|Adverse Event|4|||
162147812|NCT02045836|585588813|FG000|Overall Study|Withdrawal by Subject|1|||
162147813|NCT02045836|585588814|FG001|Overall Study|Withdrawal by Subject|1|||
162147814|NCT02045836|585588813|FG000|Overall Study|Lost to Follow-up|4|||
162147815|NCT02045836|585588814|FG001|Overall Study|Lost to Follow-up|7|||
162147816|NCT02045836|585588813|FG000|Overall Study|Migrated from study area|0|||
162147817|NCT02045836|585588814|FG001|Overall Study|Migrated from study area|2|||
162147818|NCT00057837|585588815|FG000|Overall Study|Progression/relapse|12|||
162147819|NCT00057837|585588816|FG001|Overall Study|Progression/relapse|14|||
162147820|NCT00057837|585588815|FG000|Overall Study|Adverse Event|2|||
162147821|NCT00057837|585588816|FG001|Overall Study|Adverse Event|12|||
162147822|NCT00057837|585588815|FG000|Overall Study|Death|5|||
162147823|NCT00057837|585588816|FG001|Overall Study|Death|4|||
162147824|NCT00057837|585588815|FG000|Overall Study|Withdrawal by Subject|5|||
162147825|NCT00057837|585588816|FG001|Overall Study|Withdrawal by Subject|3|||
162147826|NCT00057837|585588815|FG000|Overall Study|Alternative therapy|0|||
162147827|NCT00057837|585588816|FG001|Overall Study|Alternative therapy|1|||
162147828|NCT00057837|585588815|FG000|Overall Study|Other complicating disease|2|||
162147829|NCT00057837|585588816|FG001|Overall Study|Other complicating disease|1|||
162147830|NCT00057837|585588815|FG000|Overall Study|Physician Decision|1|||
162147831|NCT00057837|585588816|FG001|Overall Study|Physician Decision|0|||
162147832|NCT00057837|585588815|FG000|Overall Study|Ineligible|3|||
162147833|NCT00057837|585588816|FG001|Overall Study|Ineligible|3|||
162147834|NCT00057837|585588815|FG000|Overall Study|Never started treatment|1|||
162147835|NCT00057837|585588816|FG001|Overall Study|Never started treatment|1|||
162147836|NCT02000817|585588817|FG000|Overall Study|Withdrawal by Subject|2|||
162147837|NCT02000817|585588818|FG001|Overall Study|Withdrawal by Subject|0|||
162147838|NCT02000817|585588819|FG002|Overall Study|Withdrawal by Subject|0|||
162147839|NCT02000817|585588820|FG003|Overall Study|Withdrawal by Subject|0|||
162147840|NCT02000817|585588817|FG000|Overall Study|Adverse Event|0|||
162147841|NCT02000817|585588818|FG001|Overall Study|Adverse Event|1|||
162147842|NCT02000817|585588819|FG002|Overall Study|Adverse Event|0|||
162147843|NCT02000817|585588820|FG003|Overall Study|Adverse Event|0|||
162147844|NCT02000817|585588817|FG000|Overall Study|Lost to Follow-up|0|||
162147845|NCT02000817|585588818|FG001|Overall Study|Lost to Follow-up|0|||
162147846|NCT02000817|585588819|FG002|Overall Study|Lost to Follow-up|1|||
162147847|NCT02000817|585588820|FG003|Overall Study|Lost to Follow-up|0|||
162147848|NCT01317420|585588821|FG000|Overall Study|Progressive disease according to RECIST|2|||
162147849|NCT01317420|585588822|FG001|Overall Study|Progressive disease according to RECIST|3|||
162147850|NCT01317420|585588823|FG002|Overall Study|Progressive disease according to RECIST|3|||
162147851|NCT01317420|585588824|FG003|Overall Study|Progressive disease according to RECIST|3|||
162147852|NCT01317420|585588825|FG004|Overall Study|Progressive disease according to RECIST|3|||
162147853|NCT01317420|585588826|FG005|Overall Study|Progressive disease according to RECIST|3|||
162147854|NCT01317420|585588827|FG006|Overall Study|Progressive disease according to RECIST|3|||
162147855|NCT01317420|585588828|FG007|Overall Study|Progressive disease according to RECIST|3|||
162147856|NCT01317420|585588829|FG008|Overall Study|Progressive disease according to RECIST|3|||
162147857|NCT01317420|585588830|FG009|Overall Study|Progressive disease according to RECIST|2|||
162147858|NCT01317420|585588831|FG010|Overall Study|Progressive disease according to RECIST|3|||
162147859|NCT01317420|585588832|FG011|Overall Study|Progressive disease according to RECIST|11|||
162147860|NCT01317420|585588833|FG012|Overall Study|Progressive disease according to RECIST|16|||
162147861|NCT01317420|585588821|FG000|Overall Study|Other adverse event|1|||
162147862|NCT01317420|585588822|FG001|Overall Study|Other adverse event|0|||
162147863|NCT01317420|585588823|FG002|Overall Study|Other adverse event|0|||
162147864|NCT01317420|585588824|FG003|Overall Study|Other adverse event|0|||
162147865|NCT01317420|585588825|FG004|Overall Study|Other adverse event|0|||
162147866|NCT01317420|585588826|FG005|Overall Study|Other adverse event|0|||
162147867|NCT01317420|585588827|FG006|Overall Study|Other adverse event|0|||
162147868|NCT01317420|585588828|FG007|Overall Study|Other adverse event|0|||
162147869|NCT01317420|585588829|FG008|Overall Study|Other adverse event|0|||
162147870|NCT01317420|585588830|FG009|Overall Study|Other adverse event|0|||
162147871|NCT01317420|585588831|FG010|Overall Study|Other adverse event|0|||
162147872|NCT01317420|585588832|FG011|Overall Study|Other adverse event|0|||
162147873|NCT01317420|585588833|FG012|Overall Study|Other adverse event|2|||
162147874|NCT01317420|585588821|FG000|Overall Study|Non-compliant with protocol|0|||
162147875|NCT01317420|585588822|FG001|Overall Study|Non-compliant with protocol|0|||
162147876|NCT01317420|585588823|FG002|Overall Study|Non-compliant with protocol|0|||
162147877|NCT01317420|585588824|FG003|Overall Study|Non-compliant with protocol|0|||
162147878|NCT01317420|585588825|FG004|Overall Study|Non-compliant with protocol|0|||
162147879|NCT01317420|585588826|FG005|Overall Study|Non-compliant with protocol|0|||
162147880|NCT01317420|585588827|FG006|Overall Study|Non-compliant with protocol|0|||
162147881|NCT01317420|585588828|FG007|Overall Study|Non-compliant with protocol|0|||
162147882|NCT01317420|585588829|FG008|Overall Study|Non-compliant with protocol|0|||
162147883|NCT01317420|585588830|FG009|Overall Study|Non-compliant with protocol|0|||
162147884|NCT01317420|585588831|FG010|Overall Study|Non-compliant with protocol|0|||
162147885|NCT01317420|585588832|FG011|Overall Study|Non-compliant with protocol|0|||
162147886|NCT01317420|585588833|FG012|Overall Study|Non-compliant with protocol|1|||
162147887|NCT01317420|585588821|FG000|Overall Study|Refused to cont. taking trial medication|0|||
162147888|NCT01317420|585588822|FG001|Overall Study|Refused to cont. taking trial medication|0|||
162147889|NCT01317420|585588823|FG002|Overall Study|Refused to cont. taking trial medication|0|||
162147890|NCT01317420|585588824|FG003|Overall Study|Refused to cont. taking trial medication|0|||
162147891|NCT01317420|585588825|FG004|Overall Study|Refused to cont. taking trial medication|0|||
162147892|NCT01317420|585588826|FG005|Overall Study|Refused to cont. taking trial medication|0|||
162147893|NCT01317420|585588827|FG006|Overall Study|Refused to cont. taking trial medication|0|||
162147894|NCT01317420|585588828|FG007|Overall Study|Refused to cont. taking trial medication|0|||
162147895|NCT01317420|585588829|FG008|Overall Study|Refused to cont. taking trial medication|0|||
162147896|NCT01317420|585588830|FG009|Overall Study|Refused to cont. taking trial medication|0|||
162147897|NCT01317420|585588831|FG010|Overall Study|Refused to cont. taking trial medication|0|||
162147898|NCT01317420|585588832|FG011|Overall Study|Refused to cont. taking trial medication|0|||
162147899|NCT01317420|585588833|FG012|Overall Study|Refused to cont. taking trial medication|1|||
162147900|NCT01317420|585588821|FG000|Overall Study|Reason other than those specified|0|||
162147901|NCT01317420|585588822|FG001|Overall Study|Reason other than those specified|0|||
162147902|NCT01317420|585588823|FG002|Overall Study|Reason other than those specified|0|||
162147903|NCT01317420|585588824|FG003|Overall Study|Reason other than those specified|0|||
162147904|NCT01317420|585588825|FG004|Overall Study|Reason other than those specified|0|||
162147905|NCT01317420|585588826|FG005|Overall Study|Reason other than those specified|0|||
162147906|NCT01317420|585588827|FG006|Overall Study|Reason other than those specified|0|||
162147907|NCT01317420|585588828|FG007|Overall Study|Reason other than those specified|0|||
162147908|NCT01317420|585588829|FG008|Overall Study|Reason other than those specified|0|||
162147909|NCT01317420|585588830|FG009|Overall Study|Reason other than those specified|1|||
162147910|NCT01317420|585588831|FG010|Overall Study|Reason other than those specified|0|||
162147911|NCT01317420|585588832|FG011|Overall Study|Reason other than those specified|0|||
162147912|NCT01317420|585588833|FG012|Overall Study|Reason other than those specified|0|||
162147913|NCT05686421|585588834|FG000|Overall Study|Screen failure|22|||
162147914|NCT05686421|585588835|FG001|Overall Study|Screen failure|0|||
162147915|NCT05686421|585588836|FG002|Overall Study|Screen failure|0|||
162147916|NCT05686421|585588837|FG003|Overall Study|Screen failure|0|||
162147917|NCT04210180|585588838|FG000|Overall Study|Withdrawal by Subject|2|||
162147918|NCT00367055|585588839|FG000|Overall Study|Adverse Event|6|||
162147919|NCT00367055|585588840|FG001|Overall Study|Adverse Event|3|||
162147920|NCT00367055|585588839|FG000|Overall Study|Patient's Willing|3|||
162147921|NCT00367055|585588840|FG001|Overall Study|Patient's Willing|2|||
162147922|NCT00367055|585588839|FG000|Overall Study|Lack of Efficacy|1|||
162147923|NCT00367055|585588840|FG001|Overall Study|Lack of Efficacy|2|||
162147924|NCT00367055|585588839|FG000|Overall Study|Lost to Follow-up|1|||
162147925|NCT00367055|585588840|FG001|Overall Study|Lost to Follow-up|1|||
162147926|NCT00367055|585588839|FG000|Overall Study|Protocol Violation|0|||
162147927|NCT00367055|585588840|FG001|Overall Study|Protocol Violation|1|||
162147928|NCT00367055|585588839|FG000|Overall Study|Stopping Criterion Met|0|||
162147929|NCT00367055|585588840|FG001|Overall Study|Stopping Criterion Met|1|||
162147930|NCT00367055|585588839|FG000|Overall Study|Participant Living too Far from Hospital|0|||
162147931|NCT00367055|585588840|FG001|Overall Study|Participant Living too Far from Hospital|1|||
162147932|NCT00324038|585588854|FG000|Overall Study|Adverse Event|38|||
162147933|NCT00324038|585588855|FG001|Overall Study|Adverse Event|23|||
162147934|NCT00324038|585588854|FG000|Overall Study|Lack of Efficacy|5|||
162147935|NCT00324038|585588855|FG001|Overall Study|Lack of Efficacy|13|||
161809943|NCT01796171|584347692|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162147936|NCT00324038|585588854|FG000|Overall Study|Lost to Follow-up|0|||
162147937|NCT00324038|585588855|FG001|Overall Study|Lost to Follow-up|2|||
162147938|NCT00324038|585588854|FG000|Overall Study|Other|6|||
162147939|NCT00324038|585588855|FG001|Overall Study|Other|13|||
162147940|NCT00961636|585588858|FG000|Overall Study|Adverse Event|35|||
162147941|NCT00961636|585588859|FG001|Overall Study|Adverse Event|54|||
162147942|NCT00961636|585588860|FG002|Overall Study|Adverse Event|13|||
162147943|NCT00961636|585588858|FG000|Overall Study|Flushing Symptoms|29|||
162147944|NCT00961636|585588859|FG001|Overall Study|Flushing Symptoms|46|||
162147945|NCT00961636|585588860|FG002|Overall Study|Flushing Symptoms|3|||
162147946|NCT00961636|585588858|FG000|Overall Study|Lost to Follow-up|2|||
162147947|NCT00961636|585588859|FG001|Overall Study|Lost to Follow-up|3|||
162147948|NCT00961636|585588860|FG002|Overall Study|Lost to Follow-up|1|||
162147949|NCT00961636|585588858|FG000|Overall Study|Physician Decision|3|||
162147950|NCT00961636|585588859|FG001|Overall Study|Physician Decision|1|||
162147951|NCT00961636|585588860|FG002|Overall Study|Physician Decision|1|||
162147952|NCT00961636|585588858|FG000|Overall Study|Protocol Violation|9|||
162147953|NCT00961636|585588859|FG001|Overall Study|Protocol Violation|5|||
162147954|NCT00961636|585588860|FG002|Overall Study|Protocol Violation|1|||
162147955|NCT00961636|585588858|FG000|Overall Study|Withdrawal by Subject|29|||
162147956|NCT00961636|585588859|FG001|Overall Study|Withdrawal by Subject|22|||
162147957|NCT00961636|585588860|FG002|Overall Study|Withdrawal by Subject|13|||
162147958|NCT00290706|585588861|FG000|Overall Study|Withdrawal by Subject|2|||
162147959|NCT00290706|585588862|FG001|Overall Study|Withdrawal by Subject|0|||
162147960|NCT00290706|585588863|FG002|Overall Study|Withdrawal by Subject|0|||
162147961|NCT00290706|585588864|FG003|Overall Study|Withdrawal by Subject|0|||
162147962|NCT00290706|585588861|FG000|Overall Study|Progressive Disease|3|||
162147963|NCT00290706|585588862|FG001|Overall Study|Progressive Disease|5|||
162147964|NCT00290706|585588863|FG002|Overall Study|Progressive Disease|4|||
162147965|NCT00290706|585588864|FG003|Overall Study|Progressive Disease|10|||
162147966|NCT00290706|585588861|FG000|Overall Study|Adverse Event|0|||
162147967|NCT00290706|585588862|FG001|Overall Study|Adverse Event|1|||
162147968|NCT00290706|585588863|FG002|Overall Study|Adverse Event|2|||
162147969|NCT00290706|585588864|FG003|Overall Study|Adverse Event|0|||
162147970|NCT00290706|585588861|FG000|Overall Study|Receive auto transplant or radiation|0|||
162147971|NCT00290706|585588862|FG001|Overall Study|Receive auto transplant or radiation|0|||
162147972|NCT00290706|585588863|FG002|Overall Study|Receive auto transplant or radiation|0|||
162147973|NCT00290706|585588864|FG003|Overall Study|Receive auto transplant or radiation|1|||
162147974|NCT00290706|585588861|FG000|Overall Study|Physician Decision|0|||
162147975|NCT00290706|585588862|FG001|Overall Study|Physician Decision|0|||
162147976|NCT00290706|585588863|FG002|Overall Study|Physician Decision|0|||
162147977|NCT00290706|585588864|FG003|Overall Study|Physician Decision|1|||
162147978|NCT01196429|585588866|FG000|Overall Study|Ineligible - inadequate pathology|1|||
162147979|NCT01196429|585588867|FG001|Overall Study|Ineligible - inadequate pathology|0|||
162147980|NCT01196429|585588866|FG000|Overall Study|Ineligible - wrong cell type|1|||
162147981|NCT01196429|585588867|FG001|Overall Study|Ineligible - wrong cell type|0|||
162147982|NCT01196429|585588866|FG000|Overall Study|Refused - Never Treated|1|||
162147983|NCT01196429|585588867|FG001|Overall Study|Refused - Never Treated|0|||
162147984|NCT00688519|585588868|FG000|Overall Study|Adverse Event|2|||
162147985|NCT00688519|585588869|FG001|Overall Study|Adverse Event|3|||
162147986|NCT00688519|585588868|FG000|Overall Study|Lost to Follow-up|3|||
162147987|NCT00688519|585588869|FG001|Overall Study|Lost to Follow-up|3|||
162147988|NCT00688519|585588868|FG000|Overall Study|Lack of Efficacy|3|||
162147989|NCT00688519|585588869|FG001|Overall Study|Lack of Efficacy|1|||
162147990|NCT00688519|585588868|FG000|Overall Study|Withdrawal by Subject|7|||
162147991|NCT00688519|585588869|FG001|Overall Study|Withdrawal by Subject|6|||
162147992|NCT00688519|585588868|FG000|Overall Study|Prohibited medication|1|||
162147993|NCT00688519|585588869|FG001|Overall Study|Prohibited medication|0|||
162147994|NCT00688519|585588868|FG000|Overall Study|Non-compliance|0|||
162147995|NCT00688519|585588869|FG001|Overall Study|Non-compliance|1|||
162147996|NCT00688519|585588868|FG000|Overall Study|Subject moved out of state|1|||
162147997|NCT00688519|585588869|FG001|Overall Study|Subject moved out of state|0|||
162147998|NCT00688519|585588868|FG000|Overall Study|Investigator decision|1|||
162147999|NCT00688519|585588869|FG001|Overall Study|Investigator decision|0|||
162148000|NCT00688519|585588868|FG000|Overall Study|Subject moved out of area|1|||
162148001|NCT00688519|585588869|FG001|Overall Study|Subject moved out of area|0|||
162148002|NCT00688519|585588868|FG000|Overall Study|Pregnancy|0|||
162148003|NCT00688519|585588869|FG001|Overall Study|Pregnancy|1|||
162148004|NCT02551055|585588870|FG000|Overall Study|Death|2|||
162148005|NCT02551055|585588871|FG001|Overall Study|Death|4|||
162148006|NCT02551055|585588872|FG002|Overall Study|Death|2|||
162148007|NCT02551055|585588873|FG003|Overall Study|Death|2|||
162148008|NCT02551055|585588874|FG004|Overall Study|Death|2|||
162148009|NCT02551055|585588875|FG005|Overall Study|Death|1|||
162148010|NCT02551055|585588876|FG006|Overall Study|Death|2|||
162148011|NCT02551055|585588877|FG007|Overall Study|Death|0|||
161809944|NCT01796171|584347693|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
162148012|NCT02551055|585588870|FG000|Overall Study|Study Terminated by Sponsor|1|||
162148013|NCT02551055|585588871|FG001|Overall Study|Study Terminated by Sponsor|1|||
162148014|NCT02551055|585588872|FG002|Overall Study|Study Terminated by Sponsor|0|||
162148015|NCT02551055|585588873|FG003|Overall Study|Study Terminated by Sponsor|2|||
162148016|NCT02551055|585588874|FG004|Overall Study|Study Terminated by Sponsor|2|||
162148017|NCT02551055|585588875|FG005|Overall Study|Study Terminated by Sponsor|0|||
162148018|NCT02551055|585588876|FG006|Overall Study|Study Terminated by Sponsor|0|||
162148019|NCT02551055|585588877|FG007|Overall Study|Study Terminated by Sponsor|0|||
162148020|NCT02551055|585588870|FG000|Overall Study|Withdrawal by Subject|1|||
162148021|NCT02551055|585588871|FG001|Overall Study|Withdrawal by Subject|1|||
162148022|NCT02551055|585588872|FG002|Overall Study|Withdrawal by Subject|0|||
162148023|NCT02551055|585588873|FG003|Overall Study|Withdrawal by Subject|1|||
162148024|NCT02551055|585588874|FG004|Overall Study|Withdrawal by Subject|2|||
162148025|NCT02551055|585588875|FG005|Overall Study|Withdrawal by Subject|0|||
162148026|NCT02551055|585588876|FG006|Overall Study|Withdrawal by Subject|0|||
162148027|NCT02551055|585588877|FG007|Overall Study|Withdrawal by Subject|0|||
162148028|NCT02551055|585588870|FG000|Overall Study|Reason not specified|0|||
162148029|NCT02551055|585588871|FG001|Overall Study|Reason not specified|0|||
162148030|NCT02551055|585588872|FG002|Overall Study|Reason not specified|0|||
162148031|NCT02551055|585588873|FG003|Overall Study|Reason not specified|0|||
162148032|NCT02551055|585588874|FG004|Overall Study|Reason not specified|1|||
162148033|NCT02551055|585588875|FG005|Overall Study|Reason not specified|0|||
162148034|NCT02551055|585588876|FG006|Overall Study|Reason not specified|1|||
162148035|NCT02551055|585588877|FG007|Overall Study|Reason not specified|0|||
162148036|NCT00430300|585588878|FG000|Overall Study|Adverse Event|0|||
162148037|NCT00430300|585588879|FG001|Overall Study|Adverse Event|2|||
162148038|NCT00430300|585588880|FG002|Overall Study|Adverse Event|1|||
162148039|NCT00430300|585588881|FG003|Overall Study|Adverse Event|1|||
162148040|NCT00430300|585588878|FG000|Overall Study|Withdrawal by Subject|1|||
162148041|NCT00430300|585588879|FG001|Overall Study|Withdrawal by Subject|0|||
162148042|NCT00430300|585588880|FG002|Overall Study|Withdrawal by Subject|5|||
162148043|NCT00430300|585588881|FG003|Overall Study|Withdrawal by Subject|0|||
162148044|NCT00430300|585588878|FG000|Overall Study|Laboratory abnormality|1|||
162148045|NCT00430300|585588879|FG001|Overall Study|Laboratory abnormality|0|||
162148046|NCT00430300|585588880|FG002|Overall Study|Laboratory abnormality|0|||
162148047|NCT00430300|585588881|FG003|Overall Study|Laboratory abnormality|0|||
162148048|NCT00430300|585588878|FG000|Overall Study|Other|0|||
162148049|NCT00430300|585588879|FG001|Overall Study|Other|0|||
162148050|NCT00430300|585588880|FG002|Overall Study|Other|0|||
162148051|NCT00430300|585588881|FG003|Overall Study|Other|1|||
162148052|NCT02041104|585588886|FG000|Overall Study|Lost to Follow-up|1|||
162148053|NCT02041104|585588887|FG001|Overall Study|Lost to Follow-up|4|||
162148054|NCT02041104|585588886|FG000|Overall Study|discomfort during OGTT|0|||
162148055|NCT02041104|585588887|FG001|Overall Study|discomfort during OGTT|3|||
162148056|NCT01063517|585588888|FG000|Overall Study|Consent withdrawal|1|||
162148057|NCT01063517|585588889|FG001|Overall Study|Consent withdrawal|0|||
162148058|NCT01063517|585588888|FG000|Overall Study|Study reached data cut-off|19|||
162148059|NCT01063517|585588889|FG001|Overall Study|Study reached data cut-off|7|||
162148060|NCT01063517|585588888|FG000|Overall Study|Lost to Follow-up|4|||
162148061|NCT01063517|585588889|FG001|Overall Study|Lost to Follow-up|3|||
162148062|NCT01063517|585588888|FG000|Overall Study|Withdrawal by Subject|1|||
162148063|NCT01063517|585588889|FG001|Overall Study|Withdrawal by Subject|2|||
162148064|NCT01063517|585588888|FG000|Overall Study|Death|33|||
162148065|NCT01063517|585588889|FG001|Overall Study|Death|48|||
162148066|NCT02974634|585590597|FG000|Overall Study|Advanced disease|12|||
162148067|NCT02974634|585590598|FG001|Overall Study|Advanced disease|3|||
162148068|NCT02974634|585590597|FG000|Overall Study|Noncompliance|3|||
162148069|NCT02974634|585590598|FG001|Overall Study|Noncompliance|7|||
162148070|NCT02974634|585590597|FG000|Overall Study|intervention technology related issues|5|||
162148071|NCT02974634|585590598|FG001|Overall Study|intervention technology related issues|0|||
162148072|NCT02974634|585590597|FG000|Overall Study|Death|8|||
162148073|NCT02974634|585590598|FG001|Overall Study|Death|11|||
162148074|NCT05011396|585590599|FG000|Overall Study|Lost to Follow-up|3|||
162148075|NCT05011396|585590600|FG001|Overall Study|Lost to Follow-up|1|||
162148076|NCT05011396|585590599|FG000|Overall Study|Withdrawal by Subject|0|||
162148077|NCT05011396|585590600|FG001|Overall Study|Withdrawal by Subject|1|||
162148078|NCT05011396|585590599|FG000|Overall Study|Positive Drug Screen|0|||
162148079|NCT05011396|585590600|FG001|Overall Study|Positive Drug Screen|1|||
162148080|NCT04668339|585590601|FG000|Overall Study|Physician Decision|1|||
162148081|NCT04668339|585590602|FG001|Overall Study|Physician Decision|0|||
162148082|NCT04668339|585590603|FG002|Overall Study|Physician Decision|1|||
162148083|NCT04668339|585590604|FG003|Overall Study|Physician Decision|1|||
162148084|NCT04668339|585590601|FG000|Overall Study|Lost to Follow-up|14|||
162148085|NCT04668339|585590602|FG001|Overall Study|Lost to Follow-up|12|||
162148086|NCT04668339|585590603|FG002|Overall Study|Lost to Follow-up|8|||
162148087|NCT04668339|585590604|FG003|Overall Study|Lost to Follow-up|5|||
162148088|NCT04668339|585590601|FG000|Overall Study|Adverse Event|0|||
162148089|NCT04668339|585590602|FG001|Overall Study|Adverse Event|0|||
162148090|NCT04668339|585590603|FG002|Overall Study|Adverse Event|1|||
162148091|NCT04668339|585590604|FG003|Overall Study|Adverse Event|0|||
162148092|NCT04668339|585590601|FG000|Overall Study|Other than specified|3|||
162148093|NCT04668339|585590602|FG001|Overall Study|Other than specified|0|||
162148094|NCT04668339|585590603|FG002|Overall Study|Other than specified|1|||
162148095|NCT04668339|585590604|FG003|Overall Study|Other than specified|0|||
162148096|NCT04668339|585590601|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
162012195|NCT02230670|585101722|FG001|Overall Study|Adverse Event|2|||
162148097|NCT04668339|585590602|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
162148098|NCT04668339|585590603|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
162148099|NCT04668339|585590604|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
162148100|NCT04668339|585590601|FG000|Overall Study|Vaccine not Administered|0|||
162148101|NCT04668339|585590602|FG001|Overall Study|Vaccine not Administered|0|||
162148102|NCT04668339|585590603|FG002|Overall Study|Vaccine not Administered|1|||
162148103|NCT04668339|585590604|FG003|Overall Study|Vaccine not Administered|0|||
162148104|NCT04668339|585590601|FG000|Overall Study|Protocol Violation|18|||
162148105|NCT04668339|585590602|FG001|Overall Study|Protocol Violation|23|||
162148106|NCT04668339|585590603|FG002|Overall Study|Protocol Violation|12|||
162148107|NCT04668339|585590604|FG003|Overall Study|Protocol Violation|20|||
162148108|NCT04668339|585590601|FG000|Overall Study|Withdrawal by Subject|45|||
162148109|NCT04668339|585590602|FG001|Overall Study|Withdrawal by Subject|46|||
162148110|NCT04668339|585590603|FG002|Overall Study|Withdrawal by Subject|46|||
162148111|NCT04668339|585590604|FG003|Overall Study|Withdrawal by Subject|27|||
162148112|NCT04668339|585590601|FG000|Overall Study|Study Terminated by Sponsor|59|||
162148113|NCT04668339|585590602|FG001|Overall Study|Study Terminated by Sponsor|59|||
162148114|NCT04668339|585590603|FG002|Overall Study|Study Terminated by Sponsor|71|||
162148115|NCT04668339|585590604|FG003|Overall Study|Study Terminated by Sponsor|1|||
162148116|NCT03253848|585590608|FG000|Overall Study|Adverse Event|7|||
162148117|NCT03253848|585590608|FG000|Overall Study|Death|5|||
162148118|NCT03253848|585590608|FG000|Overall Study|initiation of other treatments|3|||
162148119|NCT03253848|585590608|FG000|Overall Study|Other complicating disease|1|||
162148120|NCT03253848|585590608|FG000|Overall Study|Withdrawal by Subject|1|||
162148121|NCT03253848|585590608|FG000|Overall Study|Declining health|1|||
162148122|NCT05758415|585590610|FG000|Overall Study|Subject Decision|2|||
162148123|NCT05758415|585590611|FG001|Overall Study|Subject Decision|5|||
162148124|NCT05758415|585590610|FG000|Overall Study|Lost to Follow-up|0|||
162148125|NCT05758415|585590611|FG001|Overall Study|Lost to Follow-up|1|||
162148126|NCT03622593|585590612|FG000|Overall Study|Withdrawal by Subject|11|||
162148127|NCT03622593|585590613|FG001|Overall Study|Withdrawal by Subject|9|||
162148128|NCT03622593|585590614|FG002|Overall Study|Withdrawal by Subject|13|||
162148129|NCT03622593|585590612|FG000|Overall Study|Death|12|||
162148130|NCT03622593|585590613|FG001|Overall Study|Death|9|||
162148131|NCT03622593|585590614|FG002|Overall Study|Death|10|||
162148132|NCT03622593|585590612|FG000|Overall Study|Lost to Follow-up|11|||
162148133|NCT03622593|585590613|FG001|Overall Study|Lost to Follow-up|5|||
162148134|NCT03622593|585590614|FG002|Overall Study|Lost to Follow-up|8|||
162148135|NCT03622593|585590612|FG000|Overall Study|Adverse Event|4|||
162148136|NCT03622593|585590613|FG001|Overall Study|Adverse Event|5|||
162148137|NCT03622593|585590614|FG002|Overall Study|Adverse Event|6|||
162148138|NCT03622593|585590612|FG000|Overall Study|Physician Decision|2|||
162148139|NCT03622593|585590613|FG001|Overall Study|Physician Decision|1|||
162148140|NCT03622593|585590614|FG002|Overall Study|Physician Decision|6|||
162148141|NCT03622593|585590612|FG000|Overall Study|Other|2|||
162148142|NCT03622593|585590613|FG001|Overall Study|Other|2|||
162148143|NCT03622593|585590614|FG002|Overall Study|Other|3|||
162148144|NCT03622593|585590612|FG000|Overall Study|Protocol Violation|0|||
162148145|NCT03622593|585590613|FG001|Overall Study|Protocol Violation|0|||
162148146|NCT03622593|585590614|FG002|Overall Study|Protocol Violation|1|||
162148147|NCT03622593|585590612|FG000|Overall Study|Pregnancy|0|||
162148148|NCT03622593|585590613|FG001|Overall Study|Pregnancy|0|||
162148149|NCT03622593|585590614|FG002|Overall Study|Pregnancy|1|||
162148150|NCT01393119|585590617|FG000|Overall Study|Adverse Event|1|||
162148151|NCT01393119|585590618|FG001|Overall Study|Adverse Event|1|||
162148152|NCT01393119|585590619|FG002|Overall Study|Adverse Event|0|||
162148153|NCT01393119|585590620|FG003|Overall Study|Adverse Event|1|||
162148154|NCT01393119|585590617|FG000|Overall Study|Withdrawal by Subject|0|||
162148155|NCT01393119|585590618|FG001|Overall Study|Withdrawal by Subject|1|||
162148156|NCT01393119|585590619|FG002|Overall Study|Withdrawal by Subject|1|||
162148157|NCT01393119|585590620|FG003|Overall Study|Withdrawal by Subject|0|||
162148158|NCT01393119|585590617|FG000|Overall Study|Lack of Efficacy|1|||
162148159|NCT01393119|585590618|FG001|Overall Study|Lack of Efficacy|0|||
162148160|NCT01393119|585590619|FG002|Overall Study|Lack of Efficacy|2|||
162148161|NCT01393119|585590620|FG003|Overall Study|Lack of Efficacy|1|||
162148162|NCT01393119|585590617|FG000|Overall Study|Protocol Violation|0|||
162148163|NCT01393119|585590618|FG001|Overall Study|Protocol Violation|0|||
162148164|NCT01393119|585590619|FG002|Overall Study|Protocol Violation|1|||
162148165|NCT01393119|585590620|FG003|Overall Study|Protocol Violation|0|||
162148166|NCT01393119|585590617|FG000|Overall Study|Death|0|||
162148167|NCT01393119|585590618|FG001|Overall Study|Death|0|||
162148168|NCT01393119|585590619|FG002|Overall Study|Death|0|||
162148169|NCT01393119|585590620|FG003|Overall Study|Death|1|||
162148170|NCT01393119|585590617|FG000|Overall Study|Randomized but Not treated|1|||
161809945|NCT01796171|584347694|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161809946|NCT01796171|584347680|FG000|Treatment Period With Betalutin|Physician Decision|0|||
161809947|NCT01796171|584347681|FG001|Treatment Period With Betalutin|Physician Decision|0|||
161809948|NCT01796171|584347682|FG002|Treatment Period With Betalutin|Physician Decision|0|||
162148171|NCT01393119|585590618|FG001|Overall Study|Randomized but Not treated|0|||
162148172|NCT01393119|585590619|FG002|Overall Study|Randomized but Not treated|1|||
162148173|NCT01393119|585590620|FG003|Overall Study|Randomized but Not treated|1|||
162148174|NCT01393119|585590617|FG000|Overall Study|Sponsor Termination of Study|11|||
162148175|NCT01393119|585590618|FG001|Overall Study|Sponsor Termination of Study|12|||
162148176|NCT01393119|585590619|FG002|Overall Study|Sponsor Termination of Study|9|||
162148177|NCT01393119|585590620|FG003|Overall Study|Sponsor Termination of Study|12|||
162148178|NCT04860258|585590621|FG000|Overall Study|Withdrawal by Subject|0|||
162148179|NCT04860258|585590622|FG001|Overall Study|Withdrawal by Subject|0|||
162148180|NCT04860258|585590623|FG002|Overall Study|Withdrawal by Subject|4|||
162148181|NCT04860258|585590624|FG003|Overall Study|Withdrawal by Subject|1|||
162148182|NCT04860258|585590625|FG004|Overall Study|Withdrawal by Subject|4|||
162148183|NCT04860258|585590626|FG005|Overall Study|Withdrawal by Subject|1|||
162148184|NCT04860258|585590627|FG006|Overall Study|Withdrawal by Subject|0|||
162148185|NCT01266265|585590628|FG000|Overall Study|Death|95|||
162148186|NCT01266265|585590629|FG001|Overall Study|Death|73|||
162148187|NCT01266265|585590628|FG000|Overall Study|Lost to Follow-up|23|||
162148188|NCT01266265|585590629|FG001|Overall Study|Lost to Follow-up|28|||
162148189|NCT01266265|585590628|FG000|Overall Study|Withdrawal by Subject|13|||
162148190|NCT01266265|585590629|FG001|Overall Study|Withdrawal by Subject|11|||
162148191|NCT01266265|585590628|FG000|Overall Study|Respiratory-related adverse event|2|||
162148192|NCT01266265|585590629|FG001|Overall Study|Respiratory-related adverse event|1|||
162148193|NCT01266265|585590628|FG000|Overall Study|Transferred care to another provider|22|||
162148194|NCT01266265|585590629|FG001|Overall Study|Transferred care to another provider|28|||
162148195|NCT01266265|585590628|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
162148196|NCT01266265|585590629|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
162148197|NCT01266265|585590628|FG000|Overall Study|Enrolled in another clinical study|15|||
162148198|NCT01266265|585590629|FG001|Overall Study|Enrolled in another clinical study|26|||
162148199|NCT01266265|585590628|FG000|Overall Study|Non-compliance|8|||
162148200|NCT01266265|585590629|FG001|Overall Study|Non-compliance|5|||
162148201|NCT01266265|585590628|FG000|Overall Study|Lung transplant|6|||
162148202|NCT01266265|585590629|FG001|Overall Study|Lung transplant|5|||
162148203|NCT01266265|585590628|FG000|Overall Study|Site closed early|4|||
162148204|NCT01266265|585590629|FG001|Overall Study|Site closed early|3|||
162148205|NCT01266265|585590628|FG000|Overall Study|Clinical worsening|1|||
162148206|NCT01266265|585590629|FG001|Overall Study|Clinical worsening|1|||
162148207|NCT01580293|585590630|FG000|Part A_Main Trial|Adverse Event|0|||
162148208|NCT01580293|585590631|FG001|Part A_Main Trial|Adverse Event|2|||
162148209|NCT01580293|585590632|FG002|Part A_Main Trial|Adverse Event|0|||
162148210|NCT01580293|585590630|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
162148211|NCT01580293|585590631|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
162148212|NCT01580293|585590632|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
162148213|NCT01580293|585590630|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
162148214|NCT01580293|585590631|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
162148215|NCT01580293|585590632|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
162148216|NCT01580293|585590630|FG000|Part A_Extension|Adverse Event|0|||
162148217|NCT01580293|585590631|FG001|Part A_Extension|Adverse Event|2|||
162148218|NCT01580293|585590632|FG002|Part A_Extension|Adverse Event|0|||
162148219|NCT01580293|585590630|FG000|Part A_Extension|Withdrawal by Subject|0|||
162148220|NCT01580293|585590631|FG001|Part A_Extension|Withdrawal by Subject|3|||
162148221|NCT01580293|585590632|FG002|Part A_Extension|Withdrawal by Subject|0|||
162148222|NCT01580293|585590630|FG000|Part A_Extension|Lost to Follow-up|0|||
162148223|NCT01580293|585590631|FG001|Part A_Extension|Lost to Follow-up|1|||
162148224|NCT01580293|585590632|FG002|Part A_Extension|Lost to Follow-up|0|||
162148225|NCT01580293|585590630|FG000|Part A_Extension|Other Reason|0|||
162148226|NCT01580293|585590631|FG001|Part A_Extension|Other Reason|1|||
162148227|NCT01580293|585590632|FG002|Part A_Extension|Other Reason|0|||
162148228|NCT01580293|585590630|FG000|Part A_Extension|Completed Japan only|0|||
162148229|NCT01580293|585590631|FG001|Part A_Extension|Completed Japan only|5|||
162148230|NCT01580293|585590632|FG002|Part A_Extension|Completed Japan only|0|||
162148231|NCT01580293|585590630|FG000|Part B|Withdrawal by Subject|0|||
162148232|NCT01580293|585590631|FG001|Part B|Withdrawal by Subject|0|||
162148233|NCT01580293|585590632|FG002|Part B|Withdrawal by Subject|1|||
162148234|NCT01580293|585590630|FG000|Part B|Other reason|0|||
162148235|NCT01580293|585590631|FG001|Part B|Other reason|0|||
162148236|NCT01580293|585590632|FG002|Part B|Other reason|1|||
162148237|NCT01134562|585590633|FG000|Overall Study|Adverse Event|0|||
162148238|NCT01134562|585590634|FG001|Overall Study|Adverse Event|1|||
162148239|NCT01134562|585590635|FG002|Overall Study|Adverse Event|0|||
162148240|NCT01134562|585590636|FG003|Overall Study|Adverse Event|0|||
162148241|NCT01134562|585590637|FG004|Overall Study|Adverse Event|0|||
162148242|NCT01499134|585590640|FG000|Overall Study|Withdrawal by Subject|0|||
162148243|NCT01499134|585590641|FG001|Overall Study|Withdrawal by Subject|1|||
162148244|NCT01400776|585590642|FG000|Overall Study|Adverse Event|7|||
162148245|NCT01400776|585590643|FG001|Overall Study|Adverse Event|2|||
162148246|NCT01400776|585590644|FG002|Overall Study|Adverse Event|9|||
162148247|NCT01400776|585590645|FG003|Overall Study|Adverse Event|2|||
162148248|NCT01400776|585590642|FG000|Overall Study|Lost to Follow-up|1|||
162148249|NCT01400776|585590643|FG001|Overall Study|Lost to Follow-up|0|||
162148250|NCT01400776|585590644|FG002|Overall Study|Lost to Follow-up|4|||
162148251|NCT01400776|585590645|FG003|Overall Study|Lost to Follow-up|1|||
162148252|NCT01400776|585590642|FG000|Overall Study|Withdrew Consent|4|||
162148253|NCT01400776|585590643|FG001|Overall Study|Withdrew Consent|2|||
162148254|NCT01400776|585590644|FG002|Overall Study|Withdrew Consent|6|||
162148255|NCT01400776|585590645|FG003|Overall Study|Withdrew Consent|1|||
162148256|NCT01400776|585590642|FG000|Overall Study|Protocol Deviation|6|||
162148257|NCT01400776|585590643|FG001|Overall Study|Protocol Deviation|1|||
162148258|NCT01400776|585590644|FG002|Overall Study|Protocol Deviation|5|||
162148259|NCT01400776|585590645|FG003|Overall Study|Protocol Deviation|2|||
162148260|NCT01400776|585590642|FG000|Overall Study|Reason not Specified|3|||
162148261|NCT01400776|585590643|FG001|Overall Study|Reason not Specified|0|||
162148262|NCT01400776|585590644|FG002|Overall Study|Reason not Specified|4|||
162148263|NCT01400776|585590645|FG003|Overall Study|Reason not Specified|3|||
162148264|NCT04956575|585590657|FG000|Overall Study|Death|1|||
162148265|NCT04956575|585590658|FG001|Overall Study|Death|0|||
162148266|NCT04956575|585590659|FG002|Overall Study|Death|0|||
162148267|NCT04956575|585590660|FG003|Overall Study|Death|0|||
162148268|NCT04956575|585590661|FG004|Overall Study|Death|0|||
162148269|NCT04956575|585590662|FG005|Overall Study|Death|0|||
162148270|NCT04956575|585590663|FG006|Overall Study|Death|0|||
162148271|NCT04956575|585590664|FG007|Overall Study|Death|1|||
162148272|NCT04956575|585590665|FG008|Overall Study|Death|0|||
162148273|NCT04956575|585590666|FG009|Overall Study|Death|1|||
162148274|NCT04956575|585590667|FG010|Overall Study|Death|0|||
162148275|NCT04956575|585590668|FG011|Overall Study|Death|0|||
162148276|NCT04956575|585590657|FG000|Overall Study|Lost to Follow-up|3|||
162148277|NCT04956575|585590658|FG001|Overall Study|Lost to Follow-up|4|||
162148278|NCT04956575|585590659|FG002|Overall Study|Lost to Follow-up|2|||
162148279|NCT04956575|585590660|FG003|Overall Study|Lost to Follow-up|3|||
162148280|NCT04956575|585590661|FG004|Overall Study|Lost to Follow-up|1|||
162148281|NCT04956575|585590662|FG005|Overall Study|Lost to Follow-up|10|||
162148282|NCT04956575|585590663|FG006|Overall Study|Lost to Follow-up|11|||
162148283|NCT04956575|585590664|FG007|Overall Study|Lost to Follow-up|7|||
162148284|NCT04956575|585590665|FG008|Overall Study|Lost to Follow-up|4|||
162148285|NCT04956575|585590666|FG009|Overall Study|Lost to Follow-up|2|||
162148286|NCT04956575|585590667|FG010|Overall Study|Lost to Follow-up|3|||
162148287|NCT04956575|585590668|FG011|Overall Study|Lost to Follow-up|8|||
162148288|NCT04956575|585590657|FG000|Overall Study|Withdrawal by Subject|1|||
162148289|NCT04956575|585590658|FG001|Overall Study|Withdrawal by Subject|2|||
162148290|NCT04956575|585590659|FG002|Overall Study|Withdrawal by Subject|1|||
162148291|NCT04956575|585590660|FG003|Overall Study|Withdrawal by Subject|4|||
162148292|NCT04956575|585590661|FG004|Overall Study|Withdrawal by Subject|2|||
162148293|NCT04956575|585590662|FG005|Overall Study|Withdrawal by Subject|8|||
162148294|NCT04956575|585590663|FG006|Overall Study|Withdrawal by Subject|5|||
162148295|NCT04956575|585590664|FG007|Overall Study|Withdrawal by Subject|1|||
162148296|NCT04956575|585590665|FG008|Overall Study|Withdrawal by Subject|1|||
162148297|NCT04956575|585590666|FG009|Overall Study|Withdrawal by Subject|0|||
162148298|NCT04956575|585590667|FG010|Overall Study|Withdrawal by Subject|3|||
162148299|NCT04956575|585590668|FG011|Overall Study|Withdrawal by Subject|1|||
162148300|NCT03192046|585590671|FG000|Overall Study|Withdrawal by Subject|1|||
162148301|NCT03192046|585590672|FG001|Overall Study|Withdrawal by Subject|1|||
162148302|NCT01194154|585590675|FG000|Overall Study|Adverse Event|12|||
162148303|NCT01194154|585590676|FG001|Overall Study|Adverse Event|7|||
162148304|NCT01194154|585590675|FG000|Overall Study|Lost to Follow-up|2|||
162148305|NCT01194154|585590676|FG001|Overall Study|Lost to Follow-up|3|||
162148306|NCT01194154|585590675|FG000|Overall Study|Protocol Violation|0|||
162148307|NCT01194154|585590676|FG001|Overall Study|Protocol Violation|1|||
162148308|NCT01194154|585590675|FG000|Overall Study|Withdrawal by Subject|5|||
162148309|NCT01194154|585590676|FG001|Overall Study|Withdrawal by Subject|6|||
162148310|NCT01194154|585590675|FG000|Overall Study|Blood pressure increase|5|||
162148311|NCT01194154|585590676|FG001|Overall Study|Blood pressure increase|3|||
162148312|NCT01194154|585590675|FG000|Overall Study|Hemoglobin decrease|0|||
162148313|NCT01194154|585590676|FG001|Overall Study|Hemoglobin decrease|1|||
162148314|NCT01194154|585590675|FG000|Overall Study|Hemoglobin increase|12|||
162148315|NCT01194154|585590676|FG001|Overall Study|Hemoglobin increase|3|||
162148316|NCT01194154|585590675|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
162148317|NCT01194154|585590676|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
162148318|NCT01194154|585590675|FG000|Overall Study|Treatment with prohibited medication|4|||
162148319|NCT01194154|585590676|FG001|Overall Study|Treatment with prohibited medication|5|||
162148320|NCT01194154|585590675|FG000|Overall Study|Other|4|||
162148321|NCT01194154|585590676|FG001|Overall Study|Other|0|||
162148322|NCT01194154|585590675|FG000|Overall Study|Did not receive study medication|2|||
162148323|NCT01194154|585590676|FG001|Overall Study|Did not receive study medication|4|||
162148324|NCT00842257|585590677|FG000|Overall Study|Adverse Event|1|||
162148325|NCT01901276|585590678|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
162148326|NCT01901276|585590679|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
162148327|NCT02314117|585590680|FG000|Overall Study|Lost to Follow-up|9|||
162148328|NCT02314117|585590681|FG001|Overall Study|Lost to Follow-up|14|||
162148329|NCT02314117|585590680|FG000|Overall Study|Withdrawal by Subject|3|||
162148330|NCT02314117|585590681|FG001|Overall Study|Withdrawal by Subject|2|||
162148331|NCT03383146|585590682|FG000|Overall Study|Screen Failure|1|||
162148332|NCT03383146|585590683|FG001|Overall Study|Screen Failure|0|||
162148333|NCT03383146|585590682|FG000|Overall Study|Adverse Event|6|||
162148334|NCT03383146|585590683|FG001|Overall Study|Adverse Event|18|||
162148335|NCT03383146|585590682|FG000|Overall Study|Lack of Efficacy|0|||
161809949|NCT01796171|584347683|FG003|Treatment Period With Betalutin|Physician Decision|0|||
161809950|NCT01796171|584347684|FG004|Treatment Period With Betalutin|Physician Decision|0|||
162148336|NCT03383146|585590683|FG001|Overall Study|Lack of Efficacy|3|||
162148337|NCT03383146|585590682|FG000|Overall Study|Withdrawal by Subject|20|||
162148338|NCT03383146|585590683|FG001|Overall Study|Withdrawal by Subject|36|||
162148339|NCT03383146|585590682|FG000|Overall Study|Lost to Follow-up|5|||
162148340|NCT03383146|585590683|FG001|Overall Study|Lost to Follow-up|15|||
162148341|NCT03383146|585590682|FG000|Overall Study|Death|0|||
162148342|NCT03383146|585590683|FG001|Overall Study|Death|2|||
162148343|NCT03383146|585590682|FG000|Overall Study|Physician Decision|0|||
162148344|NCT03383146|585590683|FG001|Overall Study|Physician Decision|1|||
162148345|NCT03383146|585590682|FG000|Overall Study|Protocol Deviation|1|||
162148346|NCT03383146|585590683|FG001|Overall Study|Protocol Deviation|8|||
162148347|NCT03383146|585590682|FG000|Overall Study|Study Terminated by the Sponsor|48|||
162148348|NCT03383146|585590683|FG001|Overall Study|Study Terminated by the Sponsor|95|||
162148349|NCT03383146|585590682|FG000|Overall Study|Reason not Specified|4|||
162148350|NCT03383146|585590683|FG001|Overall Study|Reason not Specified|6|||
162148351|NCT03586544|585590684|FG000|First Intervention|Adverse Event|0|||
162148352|NCT03586544|585590685|FG001|First Intervention|Adverse Event|1|||
162148353|NCT03586544|585590684|FG000|Second Intervention|Withdrawal by Subject|0|||
162148354|NCT03586544|585590685|FG001|Second Intervention|Withdrawal by Subject|1|||
162148355|NCT00539292|585590686|FG000|Overall Study|Physician Decision|1|||
162148356|NCT00539292|585590687|FG001|Overall Study|Physician Decision|0|||
162148357|NCT00361283|585590700|FG000|Overall Study|Lost to Follow-up|27|||
162148358|NCT01837641|585590701|FG000|Overall Study|Sponsor decision|1|||
162148359|NCT01837641|585590702|FG001|Overall Study|Sponsor decision|0|||
162148360|NCT01837641|585590703|FG002|Overall Study|Sponsor decision|0|||
162148361|NCT01837641|585590704|FG003|Overall Study|Sponsor decision|0|||
162148362|NCT01837641|585590705|FG004|Overall Study|Sponsor decision|0|||
162148363|NCT01837641|585590706|FG005|Overall Study|Sponsor decision|1|||
162148364|NCT01837641|585590707|FG006|Overall Study|Sponsor decision|0|||
162148365|NCT01837641|585590708|FG007|Overall Study|Sponsor decision|0|||
162148366|NCT01837641|585590701|FG000|Overall Study|Adverse Event|0|||
162148367|NCT01837641|585590702|FG001|Overall Study|Adverse Event|0|||
162148368|NCT01837641|585590703|FG002|Overall Study|Adverse Event|0|||
162148369|NCT01837641|585590704|FG003|Overall Study|Adverse Event|0|||
162148370|NCT01837641|585590705|FG004|Overall Study|Adverse Event|0|||
162148371|NCT01837641|585590706|FG005|Overall Study|Adverse Event|1|||
162148372|NCT01837641|585590707|FG006|Overall Study|Adverse Event|0|||
161809951|NCT01796171|584347685|FG005|Treatment Period With Betalutin|Physician Decision|0|||
161809952|NCT01796171|584347686|FG006|Treatment Period With Betalutin|Physician Decision|0|||
161809953|NCT01796171|584347687|FG007|Treatment Period With Betalutin|Physician Decision|0|||
161809954|NCT01796171|584347688|FG008|Treatment Period With Betalutin|Physician Decision|0|||
162148373|NCT01837641|585590708|FG007|Overall Study|Adverse Event|0|||
162148374|NCT01837641|585590701|FG000|Overall Study|Withdrawal by Subject|0|||
162148375|NCT01837641|585590702|FG001|Overall Study|Withdrawal by Subject|0|||
162148376|NCT01837641|585590703|FG002|Overall Study|Withdrawal by Subject|0|||
162148377|NCT01837641|585590704|FG003|Overall Study|Withdrawal by Subject|0|||
162148378|NCT01837641|585590705|FG004|Overall Study|Withdrawal by Subject|1|||
162148379|NCT01837641|585590706|FG005|Overall Study|Withdrawal by Subject|0|||
162148380|NCT01837641|585590707|FG006|Overall Study|Withdrawal by Subject|1|||
162148381|NCT01837641|585590708|FG007|Overall Study|Withdrawal by Subject|0|||
162148382|NCT01579916|585590709|FG000|Overall Study|Lost to Follow-up|6|||
162148383|NCT01579916|585590710|FG001|Overall Study|Lost to Follow-up|1|||
162148384|NCT01579916|585590709|FG000|Overall Study|Withdrawal by Subject|1|||
162148385|NCT01579916|585590710|FG001|Overall Study|Withdrawal by Subject|1|||
162148386|NCT01579916|585590709|FG000|Overall Study|Death|1|||
162148387|NCT01579916|585590710|FG001|Overall Study|Death|0|||
161809955|NCT01796171|584347689|FG009|Treatment Period With Betalutin|Physician Decision|0|||
161809956|NCT01796171|584347690|FG010|Treatment Period With Betalutin|Physician Decision|5|||
162148388|NCT03264456|585590711|FG000|Overall Study|Withdrawal by Subject|3|||
162148389|NCT03264456|585590711|FG000|Overall Study|Lost to Follow-up|1|||
162148390|NCT01123083|585590720|FG000|Overall Study|Investigator recommendation|1|||
162148391|NCT01123083|585590721|FG001|Overall Study|Investigator recommendation|1|||
162148392|NCT01123083|585590720|FG000|Overall Study|Administrative reasons|0|||
162148393|NCT01123083|585590721|FG001|Overall Study|Administrative reasons|4|||
162148394|NCT01123083|585590720|FG000|Overall Study|Lost to Follow-up|2|||
162148395|NCT01123083|585590721|FG001|Overall Study|Lost to Follow-up|6|||
162012196|NCT02230670|585101721|FG000|Overall Study|Withdrawal by Subject|2|||
162012197|NCT02230670|585101722|FG001|Overall Study|Withdrawal by Subject|2|||
162012198|NCT02230670|585101721|FG000|Overall Study|Physician Decision|0|||
162012199|NCT02230670|585101722|FG001|Overall Study|Physician Decision|1|||
162012200|NCT02230670|585101721|FG000|Overall Study|Protocol Violation|0|||
162012201|NCT02230670|585101722|FG001|Overall Study|Protocol Violation|1|||
162012202|NCT02230670|585101721|FG000|Overall Study|Progression to Child-Pugh C|1|||
162012203|NCT02230670|585101722|FG001|Overall Study|Progression to Child-Pugh C|2|||
162012204|NCT01907854|585101727|FG000|Overall Study|Protocol Violation|1|||
162012205|NCT01907854|585101728|FG001|Overall Study|Protocol Violation|1|||
162012206|NCT01907854|585101727|FG000|Overall Study|Withdrawal by Subject|9|||
162012207|NCT01907854|585101728|FG001|Overall Study|Withdrawal by Subject|7|||
162012208|NCT01907854|585101727|FG000|Overall Study|Lost to Follow-up|2|||
162012209|NCT01907854|585101728|FG001|Overall Study|Lost to Follow-up|2|||
162012210|NCT01907854|585101727|FG000|Overall Study|Unclassified|4|||
162012211|NCT01907854|585101728|FG001|Overall Study|Unclassified|3|||
162012212|NCT02215252|585101729|FG000|Overall Study|Adverse Event|1|||
162012213|NCT02215252|585101730|FG001|Overall Study|Adverse Event|5|||
162012214|NCT02215252|585101731|FG002|Overall Study|Adverse Event|2|||
162012215|NCT02215252|585101729|FG000|Overall Study|Lost to Follow-up|0|||
161809957|NCT01796171|584347691|FG011|Treatment Period With Betalutin|Physician Decision|1|||
161809958|NCT01796171|584347692|FG012|Treatment Period With Betalutin|Physician Decision|1|||
161809959|NCT01796171|584347693|FG013|Treatment Period With Betalutin|Physician Decision|0|||
161809960|NCT01796171|584347694|FG014|Treatment Period With Betalutin|Physician Decision|0|||
161809961|NCT01796171|584347680|FG000|Treatment Period With Betalutin|Death|0|||
161809962|NCT01796171|584347681|FG001|Treatment Period With Betalutin|Death|0|||
161809963|NCT01796171|584347682|FG002|Treatment Period With Betalutin|Death|0|||
161809964|NCT01796171|584347683|FG003|Treatment Period With Betalutin|Death|0|||
161809965|NCT01796171|584347684|FG004|Treatment Period With Betalutin|Death|0|||
162148396|NCT01123083|585590720|FG000|Overall Study|Adverse Event|1|||
162148397|NCT01123083|585590721|FG001|Overall Study|Adverse Event|0|||
162148398|NCT01123083|585590720|FG000|Overall Study|Withdrew for another reason not covered|0|||
162148399|NCT01123083|585590721|FG001|Overall Study|Withdrew for another reason not covered|1|||
162148400|NCT01123083|585590720|FG000|Overall Study|Participant/legal representative request|7|||
162148401|NCT01123083|585590721|FG001|Overall Study|Participant/legal representative request|3|||
162148402|NCT03768206|585590724|FG000|Overall Study|Lost to Follow-up|2|||
162148403|NCT03768206|585590725|FG001|Overall Study|Lost to Follow-up|1|||
162148404|NCT03768206|585590724|FG000|Overall Study|Withdrawal by Subject|0|||
162148405|NCT03768206|585590725|FG001|Overall Study|Withdrawal by Subject|1|||
162148406|NCT02106442|585590728|FG000|Overall Study|Case Report Forms Uncollected|7|||
162148407|NCT02106442|585590728|FG000|Overall Study|Protocol Deviation|30|||
162148408|NCT06269640|585592814|FG000|Overall Study|Death|1|||
162148409|NCT00423098|585592817|FG000|Overall Study|Adverse Event|1|||
162148410|NCT00423098|585592818|FG001|Overall Study|Adverse Event|2|||
162148411|NCT00423098|585592817|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162148412|NCT00423098|585592818|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162148413|NCT00423098|585592817|FG000|Overall Study|Administrative problems|0|||
162148414|NCT00423098|585592818|FG001|Overall Study|Administrative problems|1|||
162148415|NCT00423098|585592817|FG000|Overall Study|Death|2|||
162148416|NCT00423098|585592818|FG001|Overall Study|Death|0|||
162148417|NCT00711958|585592822|FG000|Overall Study|Withdrawal by Subject|6|||
162148418|NCT00711958|585592823|FG001|Overall Study|Withdrawal by Subject|8|||
162148419|NCT00711958|585592822|FG000|Overall Study|Lack of Efficacy|3|||
162148420|NCT00711958|585592823|FG001|Overall Study|Lack of Efficacy|1|||
162148421|NCT00711958|585592822|FG000|Overall Study|Clinical deterioration|1|||
162148422|NCT00711958|585592823|FG001|Overall Study|Clinical deterioration|0|||
162148423|NCT00711958|585592822|FG000|Overall Study|Adverse Event|9|||
162148424|NCT00711958|585592823|FG001|Overall Study|Adverse Event|7|||
162148425|NCT00711958|585592822|FG000|Overall Study|Protocol Violation|1|||
162148426|NCT00711958|585592823|FG001|Overall Study|Protocol Violation|0|||
162148427|NCT00711958|585592822|FG000|Overall Study|Lost to Follow-up|2|||
162148428|NCT00711958|585592823|FG001|Overall Study|Lost to Follow-up|2|||
162148429|NCT00711958|585592822|FG000|Overall Study|Death|10|||
162148430|NCT00711958|585592823|FG001|Overall Study|Death|5|||
162148431|NCT00711958|585592822|FG000|Overall Study|Progression of disease|1|||
162148432|NCT00711958|585592823|FG001|Overall Study|Progression of disease|0|||
162148433|NCT02383472|585592824|FG000|Overall Study|Withdrawal by Subject|1|||
162148434|NCT02383472|585592825|FG001|Overall Study|Withdrawal by Subject|1|||
162148435|NCT01111526|585592826|FG000|Overall Study|GVHD Disease Progression|0|||
162148436|NCT01111526|585592827|FG001|Overall Study|GVHD Disease Progression|1|||
162148437|NCT01111526|585592828|FG002|Overall Study|GVHD Disease Progression|2|||
162148438|NCT02013830|585592829|FG000|Overall Study|Adverse Event|3|||
162148439|NCT02013830|585592829|FG000|Overall Study|Death|1|||
162148440|NCT02013830|585592829|FG000|Overall Study|Insufficient therapeutic response|25|||
162148441|NCT02013830|585592829|FG000|Overall Study|Refused treatment|1|||
162148442|NCT04424641|585592830|FG000|Overall Study|Death|1|||
162148443|NCT04424641|585592831|FG001|Overall Study|Death|2|||
162148444|NCT04424641|585592832|FG002|Overall Study|Death|3|||
162148445|NCT04424641|585592833|FG003|Overall Study|Death|0|||
162148446|NCT04424641|585592834|FG004|Overall Study|Death|3|||
162148447|NCT04424641|585592835|FG005|Overall Study|Death|0|||
162148448|NCT04424641|585592836|FG006|Overall Study|Death|1|||
162148449|NCT04424641|585592837|FG007|Overall Study|Death|2|||
162148450|NCT04424641|585592830|FG000|Overall Study|Sponsor decision|0|||
162148451|NCT04424641|585592831|FG001|Overall Study|Sponsor decision|2|||
162148452|NCT04424641|585592832|FG002|Overall Study|Sponsor decision|3|||
161809966|NCT01796171|584347685|FG005|Treatment Period With Betalutin|Death|0|||
162012216|NCT02215252|585101730|FG001|Overall Study|Lost to Follow-up|0|||
162148453|NCT04424641|585592833|FG003|Overall Study|Sponsor decision|7|||
162148454|NCT04424641|585592834|FG004|Overall Study|Sponsor decision|2|||
162148455|NCT04424641|585592835|FG005|Overall Study|Sponsor decision|2|||
162148456|NCT04424641|585592836|FG006|Overall Study|Sponsor decision|3|||
162148457|NCT04424641|585592837|FG007|Overall Study|Sponsor decision|4|||
162148458|NCT04424641|585592830|FG000|Overall Study|Withdrawal by Subject|0|||
162148459|NCT04424641|585592831|FG001|Overall Study|Withdrawal by Subject|0|||
162148460|NCT04424641|585592832|FG002|Overall Study|Withdrawal by Subject|0|||
162148461|NCT04424641|585592833|FG003|Overall Study|Withdrawal by Subject|0|||
162148462|NCT04424641|585592834|FG004|Overall Study|Withdrawal by Subject|1|||
162148463|NCT04424641|585592835|FG005|Overall Study|Withdrawal by Subject|0|||
162148464|NCT04424641|585592836|FG006|Overall Study|Withdrawal by Subject|0|||
162148465|NCT04424641|585592837|FG007|Overall Study|Withdrawal by Subject|0|||
162148466|NCT04424641|585592830|FG000|Overall Study|Other|0|||
162148467|NCT04424641|585592831|FG001|Overall Study|Other|0|||
162148468|NCT04424641|585592832|FG002|Overall Study|Other|1|||
162148469|NCT04424641|585592833|FG003|Overall Study|Other|0|||
162148470|NCT04424641|585592834|FG004|Overall Study|Other|0|||
162148471|NCT04424641|585592835|FG005|Overall Study|Other|0|||
162148472|NCT04424641|585592836|FG006|Overall Study|Other|0|||
162148473|NCT04424641|585592837|FG007|Overall Study|Other|0|||
162148474|NCT02015546|585592838|FG000|Overall Study|Withdrawal by Subject|1|||
162148475|NCT02015546|585592839|FG001|Overall Study|Withdrawal by Subject|1|||
162148476|NCT02015546|585592840|FG002|Overall Study|Withdrawal by Subject|1|||
162148477|NCT02015546|585592838|FG000|Overall Study|Screem Failure|2|||
162148478|NCT02015546|585592839|FG001|Overall Study|Screem Failure|1|||
162148479|NCT02015546|585592840|FG002|Overall Study|Screem Failure|3|||
162148480|NCT01171625|585592841|FG000|Overall Study|On-Protocol|67|||
162148481|NCT01171625|585592841|FG000|Overall Study|Death|38|||
162148482|NCT01171625|585592841|FG000|Overall Study|Withdrawal by Subject|31|||
162148483|NCT01171625|585592841|FG000|Overall Study|Explanted|10|||
162148484|NCT01171625|585592841|FG000|Overall Study|Lost to Follow-up|5|||
162148485|NCT01171625|585592841|FG000|Overall Study|Patient received valve-in-valve|3|||
162148486|NCT01171625|585592841|FG000|Overall Study|Other|1|||
162012217|NCT02215252|585101731|FG002|Overall Study|Lost to Follow-up|1|||
162012218|NCT02215252|585101729|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
162012219|NCT02215252|585101730|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
162012220|NCT02215252|585101731|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
162012221|NCT02215252|585101729|FG000|Overall Study|Protocol Violation|0|||
162012222|NCT02215252|585101730|FG001|Overall Study|Protocol Violation|1|||
162012223|NCT02215252|585101731|FG002|Overall Study|Protocol Violation|0|||
162012224|NCT02215252|585101729|FG000|Overall Study|Withdrawal by Subject|1|||
162012225|NCT02215252|585101730|FG001|Overall Study|Withdrawal by Subject|0|||
162012226|NCT02215252|585101731|FG002|Overall Study|Withdrawal by Subject|0|||
162012227|NCT02215252|585101729|FG000|Overall Study|Other|0|||
162012228|NCT02215252|585101730|FG001|Overall Study|Other|1|||
162012229|NCT02215252|585101731|FG002|Overall Study|Other|1|||
162012230|NCT00892099|585101733|FG000|Overall Study|Death|1|||
162012231|NCT00892099|585101734|FG001|Overall Study|Death|0|||
162012232|NCT00892099|585101735|FG002|Overall Study|Death|1|||
162012233|NCT00892099|585101733|FG000|Overall Study|Adverse Event|1|||
162012234|NCT00892099|585101734|FG001|Overall Study|Adverse Event|0|||
162012235|NCT00892099|585101735|FG002|Overall Study|Adverse Event|0|||
162012236|NCT00892099|585101733|FG000|Overall Study|replocated|1|||
162012237|NCT00892099|585101734|FG001|Overall Study|replocated|0|||
162012238|NCT00892099|585101735|FG002|Overall Study|replocated|2|||
162012239|NCT00892099|585101733|FG000|Overall Study|Prolonged hospitalization|1|||
162012240|NCT00892099|585101734|FG001|Overall Study|Prolonged hospitalization|0|||
162012241|NCT00892099|585101735|FG002|Overall Study|Prolonged hospitalization|1|||
162012242|NCT00892099|585101733|FG000|Overall Study|no further details|1|||
162012243|NCT00892099|585101734|FG001|Overall Study|no further details|0|||
162012244|NCT00892099|585101735|FG002|Overall Study|no further details|1|||
162012245|NCT00892099|585101733|FG000|Overall Study|kidney function recovered|0|||
162012246|NCT00892099|585101734|FG001|Overall Study|kidney function recovered|1|||
162012247|NCT00892099|585101735|FG002|Overall Study|kidney function recovered|0|||
162012248|NCT00892099|585101733|FG000|Overall Study|investigator decision|0|||
162012249|NCT00892099|585101734|FG001|Overall Study|investigator decision|0|||
162012250|NCT00892099|585101735|FG002|Overall Study|investigator decision|1|||
162012251|NCT00892099|585101733|FG000|Overall Study|Lost to Follow-up|0|||
162012252|NCT00892099|585101734|FG001|Overall Study|Lost to Follow-up|0|||
162012253|NCT00892099|585101735|FG002|Overall Study|Lost to Follow-up|1|||
162148487|NCT01171625|585592841|FG000|Overall Study|Consented but did not receive device|25|||
162148488|NCT00799396|585592842|FG000|Clopidogrel Treatment|Adverse Event|6|||
162148489|NCT00799396|585592842|FG000|Clopidogrel Treatment|Physician Decision|5|||
162148490|NCT00799396|585592842|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
162012254|NCT04455815|585101736|FG000|Randomisation Phase|Adverse Event|1|||
162012255|NCT04455815|585101737|FG001|Randomisation Phase|Adverse Event|0|||
162012256|NCT04455815|585101736|FG000|Treatment Phase|Adverse Event|0|||
162012257|NCT04455815|585101737|FG001|Treatment Phase|Adverse Event|1|||
162012258|NCT04455815|585101736|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
162012259|NCT04455815|585101737|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
162012260|NCT04455815|585101736|FG000|Treatment Phase|Withdrawal by Subject|1|||
162012261|NCT04455815|585101737|FG001|Treatment Phase|Withdrawal by Subject|1|||
162148491|NCT00799396|585592842|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
162148492|NCT00799396|585592842|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
162148493|NCT01113931|585592843|FG000|Overall Study|Adverse Event|2|||
162012262|NCT02106390|585101738|FG000|Overall Study|Withdrawal by Subject|15|||
162012263|NCT02106390|585101739|FG001|Overall Study|Withdrawal by Subject|16|||
162148494|NCT01113931|585592844|FG001|Overall Study|Adverse Event|2|||
162148495|NCT01113931|585592843|FG000|Overall Study|Physician Decision|0|||
162148496|NCT01113931|585592844|FG001|Overall Study|Physician Decision|2|||
161809967|NCT01796171|584347686|FG006|Treatment Period With Betalutin|Death|0|||
161809968|NCT01796171|584347687|FG007|Treatment Period With Betalutin|Death|0|||
162148497|NCT01113931|585592843|FG000|Overall Study|Lost to Follow-up|12|||
162148498|NCT01113931|585592844|FG001|Overall Study|Lost to Follow-up|9|||
162148499|NCT01113931|585592843|FG000|Overall Study|Various|2|||
162148500|NCT01113931|585592844|FG001|Overall Study|Various|4|||
162148501|NCT01113931|585592843|FG000|Overall Study|Withdrawal by Subject|3|||
162148502|NCT01113931|585592844|FG001|Overall Study|Withdrawal by Subject|0|||
162148503|NCT01307267|585592845|FG000|Overall Study|Death|4|||
162148504|NCT01307267|585592846|FG001|Overall Study|Death|3|||
162148505|NCT01307267|585592847|FG002|Overall Study|Death|5|||
162148506|NCT01307267|585592848|FG003|Overall Study|Death|3|||
162148507|NCT01307267|585592849|FG004|Overall Study|Death|1|||
162148508|NCT01307267|585592850|FG005|Overall Study|Death|26|||
162148509|NCT01307267|585592851|FG006|Overall Study|Death|2|||
162148510|NCT01307267|585592852|FG007|Overall Study|Death|2|||
162148511|NCT01307267|585592853|FG008|Overall Study|Death|21|||
162148512|NCT01307267|585592854|FG009|Overall Study|Death|2|||
162148513|NCT01307267|585592855|FG010|Overall Study|Death|3|||
162148514|NCT01307267|585592856|FG011|Overall Study|Death|9|||
162148515|NCT01307267|585592857|FG012|Overall Study|Death|0|||
162148516|NCT01307267|585592858|FG013|Overall Study|Death|0|||
162148517|NCT01307267|585592859|FG014|Overall Study|Death|0|||
162148518|NCT01307267|585592860|FG015|Overall Study|Death|0|||
162148519|NCT01307267|585592861|FG016|Overall Study|Death|1|||
162148520|NCT01307267|585592862|FG017|Overall Study|Death|1|||
162148521|NCT01307267|585592863|FG018|Overall Study|Death|2|||
162148522|NCT01307267|585592864|FG019|Overall Study|Death|8|||
162012264|NCT02106390|585101740|FG002|Overall Study|Withdrawal by Subject|15|||
162012265|NCT02106390|585101738|FG000|Overall Study|Lost to Follow-up|25|||
162148523|NCT01307267|585592865|FG020|Overall Study|Death|1|||
162148524|NCT01307267|585592866|FG021|Overall Study|Death|2|||
162148525|NCT01307267|585592867|FG022|Overall Study|Death|2|||
162148526|NCT01307267|585592845|FG000|Overall Study|Lost to Follow-up|0|||
162148527|NCT01307267|585592846|FG001|Overall Study|Lost to Follow-up|0|||
162148528|NCT01307267|585592847|FG002|Overall Study|Lost to Follow-up|0|||
162148529|NCT01307267|585592848|FG003|Overall Study|Lost to Follow-up|0|||
162148530|NCT01307267|585592849|FG004|Overall Study|Lost to Follow-up|0|||
162148531|NCT01307267|585592850|FG005|Overall Study|Lost to Follow-up|7|||
162148532|NCT01307267|585592851|FG006|Overall Study|Lost to Follow-up|0|||
162148533|NCT01307267|585592852|FG007|Overall Study|Lost to Follow-up|0|||
162148534|NCT01307267|585592853|FG008|Overall Study|Lost to Follow-up|1|||
162012266|NCT02106390|585101739|FG001|Overall Study|Lost to Follow-up|20|||
162012267|NCT02106390|585101740|FG002|Overall Study|Lost to Follow-up|13|||
162012268|NCT02106390|585101738|FG000|Overall Study|Other: Administrative Reason|8|||
162012269|NCT02106390|585101739|FG001|Overall Study|Other: Administrative Reason|5|||
162012270|NCT02106390|585101740|FG002|Overall Study|Other: Administrative Reason|12|||
162012271|NCT02106390|585101738|FG000|Overall Study|Other: Unspecified|1|||
162012272|NCT02106390|585101739|FG001|Overall Study|Other: Unspecified|4|||
162012273|NCT02106390|585101740|FG002|Overall Study|Other: Unspecified|2|||
162012274|NCT02106390|585101738|FG000|Overall Study|Adverse Event|0|||
162012275|NCT02106390|585101739|FG001|Overall Study|Adverse Event|2|||
162012276|NCT02106390|585101740|FG002|Overall Study|Adverse Event|1|||
162012277|NCT02106390|585101738|FG000|Overall Study|Protocol Violation|0|||
162012278|NCT02106390|585101739|FG001|Overall Study|Protocol Violation|1|||
162012279|NCT02106390|585101740|FG002|Overall Study|Protocol Violation|0|||
162012280|NCT02968004|585101741|FG000|Main Study Phase|Adverse Event|1|||
162012281|NCT02968004|585101742|FG001|Main Study Phase|Adverse Event|0|||
162012282|NCT02968004|585101741|FG000|Main Study Phase|Withdrawal by Subject|0|||
162012283|NCT02968004|585101742|FG001|Main Study Phase|Withdrawal by Subject|1|||
162012284|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
162012285|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
162012286|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
162012287|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
162012288|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
162012289|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
162012290|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
162012291|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
162012292|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
162012293|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
162012294|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
162012295|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
162012296|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
162012297|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
162012298|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
162012299|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
162012300|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
162012301|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
162012302|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
162012303|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
162012304|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
162012305|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
162012306|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
162012307|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
162012308|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
162012309|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
162012310|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
162012311|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
162012312|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
162012313|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
162012314|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
162012315|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
162012316|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
162148535|NCT01307267|585592854|FG009|Overall Study|Lost to Follow-up|2|||
162148536|NCT01307267|585592855|FG010|Overall Study|Lost to Follow-up|1|||
162148537|NCT01307267|585592856|FG011|Overall Study|Lost to Follow-up|0|||
162148538|NCT01307267|585592857|FG012|Overall Study|Lost to Follow-up|0|||
162148539|NCT01307267|585592858|FG013|Overall Study|Lost to Follow-up|0|||
162148540|NCT01307267|585592859|FG014|Overall Study|Lost to Follow-up|0|||
162148541|NCT01307267|585592860|FG015|Overall Study|Lost to Follow-up|0|||
162148542|NCT01307267|585592861|FG016|Overall Study|Lost to Follow-up|0|||
162148543|NCT01307267|585592862|FG017|Overall Study|Lost to Follow-up|0|||
162148544|NCT01307267|585592863|FG018|Overall Study|Lost to Follow-up|0|||
162148545|NCT01307267|585592864|FG019|Overall Study|Lost to Follow-up|2|||
162148546|NCT01307267|585592865|FG020|Overall Study|Lost to Follow-up|0|||
162148547|NCT01307267|585592866|FG021|Overall Study|Lost to Follow-up|0|||
162148548|NCT01307267|585592867|FG022|Overall Study|Lost to Follow-up|0|||
162148549|NCT01307267|585592845|FG000|Overall Study|Withdrawal by Subject|0|||
162148550|NCT01307267|585592846|FG001|Overall Study|Withdrawal by Subject|0|||
162148551|NCT01307267|585592847|FG002|Overall Study|Withdrawal by Subject|0|||
162148552|NCT01307267|585592848|FG003|Overall Study|Withdrawal by Subject|0|||
162148553|NCT01307267|585592849|FG004|Overall Study|Withdrawal by Subject|0|||
162148554|NCT01307267|585592850|FG005|Overall Study|Withdrawal by Subject|1|||
162148555|NCT01307267|585592851|FG006|Overall Study|Withdrawal by Subject|0|||
162148556|NCT01307267|585592852|FG007|Overall Study|Withdrawal by Subject|1|||
162148557|NCT01307267|585592853|FG008|Overall Study|Withdrawal by Subject|5|||
162148558|NCT01307267|585592854|FG009|Overall Study|Withdrawal by Subject|1|||
162148559|NCT01307267|585592855|FG010|Overall Study|Withdrawal by Subject|1|||
162148560|NCT01307267|585592856|FG011|Overall Study|Withdrawal by Subject|1|||
162148561|NCT01307267|585592857|FG012|Overall Study|Withdrawal by Subject|0|||
162148562|NCT01307267|585592858|FG013|Overall Study|Withdrawal by Subject|0|||
162148563|NCT01307267|585592859|FG014|Overall Study|Withdrawal by Subject|0|||
162148564|NCT01307267|585592860|FG015|Overall Study|Withdrawal by Subject|0|||
162148565|NCT01307267|585592861|FG016|Overall Study|Withdrawal by Subject|0|||
162148566|NCT01307267|585592862|FG017|Overall Study|Withdrawal by Subject|0|||
162148567|NCT01307267|585592863|FG018|Overall Study|Withdrawal by Subject|0|||
162148568|NCT01307267|585592864|FG019|Overall Study|Withdrawal by Subject|3|||
162148569|NCT01307267|585592865|FG020|Overall Study|Withdrawal by Subject|0|||
162148570|NCT01307267|585592866|FG021|Overall Study|Withdrawal by Subject|0|||
162148571|NCT01307267|585592867|FG022|Overall Study|Withdrawal by Subject|0|||
162148572|NCT01307267|585592845|FG000|Overall Study|Other|0|||
162148573|NCT01307267|585592846|FG001|Overall Study|Other|0|||
162148574|NCT01307267|585592847|FG002|Overall Study|Other|0|||
162148575|NCT01307267|585592848|FG003|Overall Study|Other|0|||
162148576|NCT01307267|585592849|FG004|Overall Study|Other|0|||
162148577|NCT01307267|585592850|FG005|Overall Study|Other|7|||
162148578|NCT01307267|585592851|FG006|Overall Study|Other|0|||
162148579|NCT01307267|585592852|FG007|Overall Study|Other|1|||
162148580|NCT01307267|585592853|FG008|Overall Study|Other|3|||
162148581|NCT01307267|585592854|FG009|Overall Study|Other|0|||
162148582|NCT01307267|585592855|FG010|Overall Study|Other|1|||
162148583|NCT01307267|585592856|FG011|Overall Study|Other|1|||
162148584|NCT01307267|585592857|FG012|Overall Study|Other|1|||
162148585|NCT01307267|585592858|FG013|Overall Study|Other|0|||
162148586|NCT01307267|585592859|FG014|Overall Study|Other|2|||
162148587|NCT01307267|585592860|FG015|Overall Study|Other|1|||
162148588|NCT01307267|585592861|FG016|Overall Study|Other|0|||
162148589|NCT01307267|585592862|FG017|Overall Study|Other|0|||
162148590|NCT01307267|585592863|FG018|Overall Study|Other|0|||
162148591|NCT01307267|585592864|FG019|Overall Study|Other|19|||
162148592|NCT01307267|585592865|FG020|Overall Study|Other|2|||
162148593|NCT01307267|585592866|FG021|Overall Study|Other|3|||
162148594|NCT01307267|585592867|FG022|Overall Study|Other|2|||
162148595|NCT00854906|585592872|FG000|Overall Study|One person had no ocular history|1|||
162148596|NCT05526248|585592873|FG000|Overall Study|Lost to Follow-up|1|||
162148597|NCT05526248|585592873|FG000|Overall Study|Adverse Event|2|||
162148598|NCT05526248|585592873|FG000|Overall Study|Withdrawal by Subject|1|||
162148599|NCT01135511|585592881|FG000|Overall Study|Adverse Event|0|||
162148600|NCT01135511|585592882|FG001|Overall Study|Adverse Event|1|||
162148601|NCT01135511|585592883|FG002|Overall Study|Adverse Event|2|||
162148602|NCT01135511|585592884|FG003|Overall Study|Adverse Event|0|||
162148603|NCT01135511|585592885|FG004|Overall Study|Adverse Event|0|||
162148604|NCT01135511|585592886|FG005|Overall Study|Adverse Event|1|||
162148605|NCT01135511|585592887|FG006|Overall Study|Adverse Event|0|||
162148606|NCT01135511|585592888|FG007|Overall Study|Adverse Event|1|||
162148607|NCT01135511|585592889|FG008|Overall Study|Adverse Event|0|||
162148608|NCT01135511|585592881|FG000|Overall Study|Lack of Efficacy|0|||
162148609|NCT01135511|585592882|FG001|Overall Study|Lack of Efficacy|1|||
162148610|NCT01135511|585592883|FG002|Overall Study|Lack of Efficacy|1|||
162148611|NCT01135511|585592884|FG003|Overall Study|Lack of Efficacy|2|||
162148612|NCT01135511|585592885|FG004|Overall Study|Lack of Efficacy|0|||
162148613|NCT01135511|585592886|FG005|Overall Study|Lack of Efficacy|0|||
162148614|NCT01135511|585592887|FG006|Overall Study|Lack of Efficacy|0|||
162148615|NCT01135511|585592888|FG007|Overall Study|Lack of Efficacy|0|||
162148616|NCT01135511|585592889|FG008|Overall Study|Lack of Efficacy|0|||
162148617|NCT01135511|585592881|FG000|Overall Study|Protocol Violation|0|||
162148618|NCT01135511|585592882|FG001|Overall Study|Protocol Violation|0|||
162148619|NCT01135511|585592883|FG002|Overall Study|Protocol Violation|3|||
162148620|NCT01135511|585592884|FG003|Overall Study|Protocol Violation|0|||
162148621|NCT01135511|585592885|FG004|Overall Study|Protocol Violation|0|||
162148622|NCT01135511|585592886|FG005|Overall Study|Protocol Violation|0|||
162148623|NCT01135511|585592887|FG006|Overall Study|Protocol Violation|0|||
162148624|NCT01135511|585592888|FG007|Overall Study|Protocol Violation|0|||
162148625|NCT01135511|585592889|FG008|Overall Study|Protocol Violation|0|||
162148626|NCT01135511|585592881|FG000|Overall Study|Pregnancy|0|||
162148627|NCT01135511|585592882|FG001|Overall Study|Pregnancy|0|||
162148628|NCT01135511|585592883|FG002|Overall Study|Pregnancy|0|||
162148629|NCT01135511|585592884|FG003|Overall Study|Pregnancy|1|||
162148630|NCT01135511|585592885|FG004|Overall Study|Pregnancy|0|||
162148631|NCT01135511|585592886|FG005|Overall Study|Pregnancy|0|||
162148632|NCT01135511|585592887|FG006|Overall Study|Pregnancy|0|||
162148633|NCT01135511|585592888|FG007|Overall Study|Pregnancy|0|||
162148634|NCT01135511|585592889|FG008|Overall Study|Pregnancy|0|||
162148635|NCT01135511|585592881|FG000|Overall Study|could not visit the clinic|0|||
162148636|NCT01135511|585592882|FG001|Overall Study|could not visit the clinic|1|||
162148637|NCT01135511|585592883|FG002|Overall Study|could not visit the clinic|2|||
162148638|NCT01135511|585592884|FG003|Overall Study|could not visit the clinic|0|||
162148639|NCT01135511|585592885|FG004|Overall Study|could not visit the clinic|0|||
162148640|NCT01135511|585592886|FG005|Overall Study|could not visit the clinic|0|||
162148641|NCT01135511|585592887|FG006|Overall Study|could not visit the clinic|0|||
162148642|NCT01135511|585592888|FG007|Overall Study|could not visit the clinic|0|||
162148643|NCT01135511|585592889|FG008|Overall Study|could not visit the clinic|0|||
162148644|NCT01135511|585592881|FG000|Overall Study|noncompliance with study drug taken|0|||
162148645|NCT01135511|585592882|FG001|Overall Study|noncompliance with study drug taken|0|||
162148646|NCT01135511|585592883|FG002|Overall Study|noncompliance with study drug taken|0|||
162148647|NCT01135511|585592884|FG003|Overall Study|noncompliance with study drug taken|0|||
162148648|NCT01135511|585592885|FG004|Overall Study|noncompliance with study drug taken|1|||
162148649|NCT01135511|585592886|FG005|Overall Study|noncompliance with study drug taken|0|||
162148650|NCT01135511|585592887|FG006|Overall Study|noncompliance with study drug taken|0|||
162148651|NCT01135511|585592888|FG007|Overall Study|noncompliance with study drug taken|0|||
162148652|NCT01135511|585592889|FG008|Overall Study|noncompliance with study drug taken|0|||
162148653|NCT01135511|585592881|FG000|Overall Study|Withdrawal by Subject|0|||
162148654|NCT01135511|585592882|FG001|Overall Study|Withdrawal by Subject|0|||
162148655|NCT01135511|585592883|FG002|Overall Study|Withdrawal by Subject|0|||
162148656|NCT01135511|585592884|FG003|Overall Study|Withdrawal by Subject|0|||
162148657|NCT01135511|585592885|FG004|Overall Study|Withdrawal by Subject|0|||
162148658|NCT01135511|585592886|FG005|Overall Study|Withdrawal by Subject|0|||
162148659|NCT01135511|585592887|FG006|Overall Study|Withdrawal by Subject|1|||
162148660|NCT01135511|585592888|FG007|Overall Study|Withdrawal by Subject|0|||
162148661|NCT01135511|585592889|FG008|Overall Study|Withdrawal by Subject|1|||
162148662|NCT02425111|585592895|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
162148663|NCT02425111|585592895|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
162148664|NCT02425111|585592895|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
162148665|NCT02425111|585592895|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
162148666|NCT02425111|585592895|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
162148667|NCT02425111|585592895|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
162148668|NCT03482011|585592899|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
162148669|NCT03482011|585592900|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
162148670|NCT03482011|585592901|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
162148671|NCT03482011|585592902|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
162148672|NCT03482011|585592903|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
162148673|NCT03482011|585592904|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
161809969|NCT01796171|584347688|FG008|Treatment Period With Betalutin|Death|0|||
161809970|NCT01796171|584347689|FG009|Treatment Period With Betalutin|Death|0|||
161809971|NCT01796171|584347690|FG010|Treatment Period With Betalutin|Death|2|||
161809972|NCT01796171|584347691|FG011|Treatment Period With Betalutin|Death|0|||
161809973|NCT01796171|584347692|FG012|Treatment Period With Betalutin|Death|0|||
162148674|NCT03482011|585592905|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
162148675|NCT03482011|585592906|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
162148676|NCT03482011|585592899|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
162148677|NCT03482011|585592900|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
162148678|NCT03482011|585592901|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
162148679|NCT03482011|585592902|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
162148680|NCT03482011|585592903|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
162148681|NCT03482011|585592904|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
162148682|NCT03482011|585592905|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
162148683|NCT03482011|585592906|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
162148684|NCT03482011|585592899|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162148685|NCT03482011|585592900|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
162148686|NCT03482011|585592901|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162148687|NCT03482011|585592902|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162148688|NCT03482011|585592903|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162148689|NCT03482011|585592904|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162148690|NCT03482011|585592905|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162148691|NCT03482011|585592906|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
162148692|NCT03482011|585592899|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
162148693|NCT03482011|585592900|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
162148694|NCT03482011|585592901|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
162148695|NCT03482011|585592902|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
162148696|NCT03482011|585592903|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
162148697|NCT03482011|585592904|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
162148698|NCT03482011|585592905|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
162148699|NCT03482011|585592906|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
162148700|NCT03482011|585592899|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
162148701|NCT03482011|585592900|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
162148702|NCT03482011|585592901|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162148703|NCT03482011|585592902|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162148704|NCT03482011|585592903|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162148705|NCT03482011|585592904|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162148706|NCT03482011|585592905|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162148707|NCT03482011|585592906|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162148708|NCT03482011|585592899|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
162148709|NCT03482011|585592900|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
162148710|NCT03482011|585592901|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
162148711|NCT03482011|585592902|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
162148712|NCT03482011|585592903|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
162148713|NCT03482011|585592904|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
162148714|NCT03482011|585592905|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
162148715|NCT03482011|585592906|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
162148716|NCT03482011|585592899|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
162148717|NCT03482011|585592900|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
162148718|NCT03482011|585592901|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
162148719|NCT03482011|585592902|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
162148720|NCT03482011|585592903|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
162148721|NCT03482011|585592904|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
162148722|NCT03482011|585592905|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
162148723|NCT03482011|585592906|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
162148724|NCT03482011|585592899|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
162148725|NCT03482011|585592900|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
162148726|NCT03482011|585592901|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
162148727|NCT03482011|585592902|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
162148728|NCT03482011|585592903|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
162148729|NCT03482011|585592904|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
162148730|NCT03482011|585592905|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
162148731|NCT03482011|585592906|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
162148732|NCT03482011|585592899|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
162148733|NCT03482011|585592900|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
162148734|NCT03482011|585592901|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
162148735|NCT03482011|585592902|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
162148736|NCT03482011|585592903|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
161809974|NCT01796171|584347693|FG013|Treatment Period With Betalutin|Death|0|||
161809975|NCT01796171|584347694|FG014|Treatment Period With Betalutin|Death|0|||
161809976|NCT01796171|584347680|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
162012317|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
162012318|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
162012319|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
162012320|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
162012321|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
162012322|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
162012323|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
162012324|NCT02968004|585101741|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
162012325|NCT02968004|585101742|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
162012326|NCT00803569|585101744|FG000|Overall Study|Progressive Disease|3|||
162012327|NCT00803569|585101744|FG000|Overall Study|Noncompliance|1|||
162012328|NCT02504151|585101745|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
162012329|NCT02504151|585101746|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
162012330|NCT02504151|585101745|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
162148737|NCT03482011|585592904|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
162148738|NCT03482011|585592905|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
162148739|NCT03482011|585592906|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
162148740|NCT03482011|585592899|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
162148741|NCT03482011|585592900|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
162148742|NCT03482011|585592901|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
162148743|NCT03482011|585592902|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
162148744|NCT03482011|585592903|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
162148745|NCT03482011|585592904|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
162148746|NCT03482011|585592905|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
162148747|NCT03482011|585592906|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
162148748|NCT03482011|585592899|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162148749|NCT03482011|585592900|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162148750|NCT03482011|585592901|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162148751|NCT03482011|585592902|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
162148752|NCT03482011|585592903|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
162148753|NCT03482011|585592904|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
162148754|NCT03482011|585592905|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
162148755|NCT03482011|585592906|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
162148756|NCT03482011|585592899|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
162148757|NCT03482011|585592900|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
162148758|NCT03482011|585592901|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
162148759|NCT03482011|585592902|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
162148760|NCT03482011|585592903|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
162148761|NCT03482011|585592904|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
162148762|NCT03482011|585592905|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
162148763|NCT03482011|585592906|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
162148764|NCT03482011|585592899|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
162148765|NCT03482011|585592900|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
162148766|NCT03482011|585592901|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
162148767|NCT03482011|585592902|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
162148768|NCT03482011|585592903|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
162148769|NCT03482011|585592904|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
162148770|NCT03482011|585592905|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
162148771|NCT03482011|585592906|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
162148772|NCT03482011|585592899|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
162148773|NCT03482011|585592900|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
162148774|NCT03482011|585592901|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
162148775|NCT03482011|585592902|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
162148776|NCT03482011|585592903|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
162148777|NCT03482011|585592904|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
162148778|NCT03482011|585592905|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
162148779|NCT03482011|585592906|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
162148780|NCT03482011|585592899|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162148781|NCT03482011|585592900|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162148782|NCT03482011|585592901|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162148783|NCT03482011|585592902|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162148784|NCT03482011|585592903|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162148785|NCT03482011|585592904|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162148786|NCT03482011|585592905|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162148787|NCT03482011|585592906|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
162148788|NCT00468052|585592907|FG000|Overall Study|Protocol Violation|7|||
162148789|NCT00468052|585592908|FG001|Overall Study|Protocol Violation|8|||
162148790|NCT04707313|585592910|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
162148791|NCT04707313|585592911|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
162148792|NCT04707313|585592912|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
162148793|NCT04707313|585592913|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
162148794|NCT04707313|585592914|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
162148795|NCT04707313|585592915|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
162148796|NCT04707313|585592916|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
162148797|NCT04707313|585592917|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
162148798|NCT04707313|585592918|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
162148799|NCT04707313|585592919|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
162148800|NCT04707313|585592920|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
162148801|NCT04707313|585592921|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
162148802|NCT04707313|585592922|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
162148803|NCT04707313|585592910|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
162148804|NCT04707313|585592911|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
162148805|NCT04707313|585592912|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162148806|NCT04707313|585592913|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161913985|NCT00560404|584733673|FG000|Overall Study|Other withdrawal reason|13|||
161913986|NCT00560404|584733674|FG001|Overall Study|Other withdrawal reason|5|||
161913987|NCT02642042|584733681|FG000|Overall Study|Adverse Event|22|||
161913988|NCT02642042|584733681|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
161913989|NCT02642042|584733681|FG000|Overall Study|Progression/Relapse|28|||
161913990|NCT02642042|584733681|FG000|Overall Study|Death|1|||
161913991|NCT02642042|584733681|FG000|Overall Study|Not Protocol Specified|2|||
161913992|NCT03260023|584733682|FG000|Overall Study|Adverse Event|0|||
161913993|NCT03260023|584733683|FG001|Overall Study|Adverse Event|0|||
161913994|NCT03260023|584733684|FG002|Overall Study|Adverse Event|4|||
161913995|NCT03260023|584733685|FG003|Overall Study|Adverse Event|4|||
161913996|NCT03260023|584733686|FG004|Overall Study|Adverse Event|4|||
161913997|NCT03260023|584733687|FG005|Overall Study|Adverse Event|1|||
161913998|NCT03260023|584733688|FG006|Overall Study|Adverse Event|2|||
161913999|NCT03260023|584733682|FG000|Overall Study|Clinical Progression|0|||
161914000|NCT03260023|584733683|FG001|Overall Study|Clinical Progression|1|||
161914001|NCT03260023|584733684|FG002|Overall Study|Clinical Progression|3|||
161914002|NCT03260023|584733685|FG003|Overall Study|Clinical Progression|1|||
161914003|NCT03260023|584733686|FG004|Overall Study|Clinical Progression|0|||
161914004|NCT03260023|584733687|FG005|Overall Study|Clinical Progression|0|||
161914005|NCT03260023|584733688|FG006|Overall Study|Clinical Progression|0|||
161914006|NCT03260023|584733682|FG000|Overall Study|Physician Decision|0|||
161914007|NCT03260023|584733683|FG001|Overall Study|Physician Decision|0|||
161914008|NCT03260023|584733684|FG002|Overall Study|Physician Decision|0|||
161914009|NCT03260023|584733685|FG003|Overall Study|Physician Decision|1|||
161914010|NCT03260023|584733686|FG004|Overall Study|Physician Decision|1|||
161914011|NCT03260023|584733687|FG005|Overall Study|Physician Decision|0|||
161914012|NCT03260023|584733688|FG006|Overall Study|Physician Decision|0|||
161914013|NCT03260023|584733682|FG000|Overall Study|Withdrawal by Subject|0|||
161914014|NCT03260023|584733683|FG001|Overall Study|Withdrawal by Subject|0|||
161914015|NCT03260023|584733684|FG002|Overall Study|Withdrawal by Subject|0|||
161914016|NCT03260023|584733685|FG003|Overall Study|Withdrawal by Subject|0|||
161914017|NCT03260023|584733686|FG004|Overall Study|Withdrawal by Subject|3|||
161914018|NCT03260023|584733687|FG005|Overall Study|Withdrawal by Subject|0|||
161914019|NCT03260023|584733688|FG006|Overall Study|Withdrawal by Subject|0|||
161914020|NCT03260023|584733682|FG000|Overall Study|Under trial intervention|0|||
161914021|NCT03260023|584733683|FG001|Overall Study|Under trial intervention|0|||
161914022|NCT03260023|584733684|FG002|Overall Study|Under trial intervention|2|||
161914023|NCT03260023|584733685|FG003|Overall Study|Under trial intervention|5|||
161914024|NCT03260023|584733686|FG004|Overall Study|Under trial intervention|3|||
161914025|NCT03260023|584733687|FG005|Overall Study|Under trial intervention|0|||
161914026|NCT03260023|584733688|FG006|Overall Study|Under trial intervention|0|||
161914027|NCT05035407|584733691|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
161914028|NCT05035407|584733692|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161914029|NCT05035407|584733693|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161914030|NCT05035407|584733694|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161914031|NCT05035407|584733695|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161914032|NCT05035407|584733696|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161914033|NCT04220021|584733697|FG000|Overall Study|Withdrawal by Subject|11|||
161914034|NCT04220021|584733697|FG000|Overall Study|Physician Decision|2|||
161914035|NCT04220021|584733697|FG000|Overall Study|Non-study related illness|5|||
161914036|NCT04513366|584733698|FG000|Treatment Phase|Withdrawal by Subject|6|||
161914037|NCT04513366|584733699|FG001|Treatment Phase|Withdrawal by Subject|8|||
161914038|NCT04513366|584733700|FG002|Treatment Phase|Withdrawal by Subject|3|||
161914039|NCT04513366|584733698|FG000|Treatment Phase|Lost to Follow-up|1|||
161914040|NCT04513366|584733699|FG001|Treatment Phase|Lost to Follow-up|2|||
161914041|NCT04513366|584733700|FG002|Treatment Phase|Lost to Follow-up|5|||
161914042|NCT04513366|584733698|FG000|Treatment Phase|Other than Specified|1|||
161914043|NCT04513366|584733699|FG001|Treatment Phase|Other than Specified|0|||
161914044|NCT04513366|584733700|FG002|Treatment Phase|Other than Specified|2|||
161914045|NCT04513366|584733698|FG000|Treatment Phase|Physician Decision|2|||
161914046|NCT04513366|584733699|FG001|Treatment Phase|Physician Decision|0|||
161914047|NCT04513366|584733700|FG002|Treatment Phase|Physician Decision|0|||
161914048|NCT04513366|584733698|FG000|Treatment Phase|Adverse Event|0|||
161914049|NCT04513366|584733699|FG001|Treatment Phase|Adverse Event|1|||
161914050|NCT04513366|584733700|FG002|Treatment Phase|Adverse Event|1|||
161914051|NCT04513366|584733698|FG000|Extension Phase|Withdrawal by Subject|3|||
161914052|NCT04513366|584733699|FG001|Extension Phase|Withdrawal by Subject|1|||
161914053|NCT04513366|584733700|FG002|Extension Phase|Withdrawal by Subject|1|||
161914054|NCT04513366|584733698|FG000|Extension Phase|Other than Specified|4|||
162148807|NCT04707313|585592914|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
161914055|NCT04513366|584733699|FG001|Extension Phase|Other than Specified|0|||
161914056|NCT04513366|584733700|FG002|Extension Phase|Other than Specified|1|||
162148808|NCT04707313|585592915|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162148809|NCT04707313|585592916|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162148810|NCT04707313|585592917|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162148811|NCT04707313|585592918|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162148812|NCT04707313|585592919|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162148813|NCT04707313|585592920|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162148814|NCT04707313|585592921|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162148815|NCT04707313|585592922|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
162148816|NCT04707313|585592910|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
162148817|NCT04707313|585592911|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
162148818|NCT04707313|585592912|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
162148819|NCT04707313|585592913|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
162148820|NCT04707313|585592914|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
162148821|NCT04707313|585592915|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
162148822|NCT04707313|585592916|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
162148823|NCT04707313|585592917|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
162148824|NCT04707313|585592918|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
162148825|NCT04707313|585592919|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
162148826|NCT04707313|585592920|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
162148827|NCT04707313|585592921|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
162148828|NCT04707313|585592922|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
162148829|NCT04707313|585592910|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162148830|NCT04707313|585592911|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
162148831|NCT04707313|585592912|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
162148832|NCT04707313|585592913|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162148833|NCT04707313|585592914|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
162148834|NCT04707313|585592915|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162148835|NCT04707313|585592916|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162148836|NCT04707313|585592917|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162148837|NCT04707313|585592918|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162148838|NCT04707313|585592919|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162148839|NCT04707313|585592920|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162148840|NCT04707313|585592921|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162148841|NCT04707313|585592922|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
162148842|NCT04707313|585592910|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
162148843|NCT04707313|585592911|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
162148844|NCT04707313|585592912|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
162148845|NCT04707313|585592913|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
162148846|NCT04707313|585592914|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
162148847|NCT04707313|585592915|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
162148848|NCT04707313|585592916|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
162148849|NCT04707313|585592917|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
162148850|NCT04707313|585592918|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
162148851|NCT04707313|585592919|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
162148852|NCT04707313|585592920|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
162148853|NCT04707313|585592921|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
162148854|NCT04707313|585592922|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
162148855|NCT04707313|585592910|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
162148856|NCT04707313|585592911|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162148857|NCT04707313|585592912|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162148858|NCT04707313|585592913|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162148859|NCT04707313|585592914|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162148860|NCT04707313|585592915|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
162148861|NCT04707313|585592916|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
162148862|NCT04707313|585592917|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
162148863|NCT04707313|585592918|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162148864|NCT04707313|585592919|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162148865|NCT04707313|585592920|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162148866|NCT04707313|585592921|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162148867|NCT04707313|585592922|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
162148868|NCT04707313|585592910|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
162148869|NCT04707313|585592911|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
162148870|NCT04707313|585592912|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
162148871|NCT04707313|585592913|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
162148872|NCT04707313|585592914|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
162148873|NCT04707313|585592915|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
162148874|NCT04707313|585592916|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
161809977|NCT01796171|584347681|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
161809978|NCT01796171|584347682|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
161809979|NCT01796171|584347683|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
161809980|NCT01796171|584347684|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
162148875|NCT04707313|585592917|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
162148876|NCT04707313|585592918|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
162148877|NCT04707313|585592919|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
162148878|NCT04707313|585592920|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
162148879|NCT04707313|585592921|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
162148880|NCT04707313|585592922|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
162148881|NCT04707313|585592910|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162148882|NCT04707313|585592911|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162148883|NCT04707313|585592912|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
162148884|NCT04707313|585592913|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162148885|NCT04707313|585592914|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162148886|NCT04707313|585592915|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162148887|NCT04707313|585592916|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162148888|NCT04707313|585592917|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
162148889|NCT04707313|585592918|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162148890|NCT04707313|585592919|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162148891|NCT04707313|585592920|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162148892|NCT04707313|585592921|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162148893|NCT04707313|585592922|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
162148894|NCT04707313|585592910|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162148895|NCT04707313|585592911|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162148896|NCT04707313|585592912|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162148897|NCT04707313|585592913|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162148898|NCT04707313|585592914|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162148899|NCT04707313|585592915|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162148900|NCT04707313|585592916|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162148901|NCT04707313|585592917|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162148902|NCT04707313|585592918|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162148903|NCT04707313|585592919|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
162148904|NCT04707313|585592920|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
162148905|NCT04707313|585592921|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
162148906|NCT04707313|585592922|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
162148907|NCT04707313|585592910|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162148908|NCT04707313|585592911|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162148909|NCT04707313|585592912|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162148910|NCT04707313|585592913|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162148911|NCT04707313|585592914|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162148912|NCT04707313|585592915|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162148913|NCT04707313|585592916|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162148914|NCT04707313|585592917|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162148915|NCT04707313|585592918|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162148916|NCT04707313|585592919|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
162148917|NCT04707313|585592920|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
162148918|NCT04707313|585592921|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
162148919|NCT04707313|585592922|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
162148920|NCT04707313|585592910|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162148921|NCT04707313|585592911|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162148922|NCT04707313|585592912|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162148923|NCT04707313|585592913|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162148924|NCT04707313|585592914|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162148925|NCT04707313|585592915|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162148926|NCT04707313|585592916|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162148927|NCT04707313|585592917|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161809981|NCT01796171|584347685|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
161809982|NCT01796171|584347686|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
161809983|NCT01796171|584347687|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
161809984|NCT01796171|584347688|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
161809985|NCT01796171|584347689|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
161809986|NCT01796171|584347690|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
161809987|NCT01796171|584347691|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
161809988|NCT01796171|584347692|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
161809989|NCT01796171|584347693|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
161809990|NCT01796171|584347694|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
161809991|NCT01796171|584347680|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161809992|NCT01796171|584347681|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161809993|NCT01796171|584347682|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161809994|NCT01796171|584347683|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161809995|NCT01796171|584347684|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161809996|NCT01796171|584347685|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161809997|NCT01796171|584347686|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162148928|NCT04707313|585592918|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
162148929|NCT04707313|585592919|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
162148930|NCT04707313|585592920|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
162148931|NCT04707313|585592921|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
162148932|NCT04707313|585592922|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
162148933|NCT04707313|585592910|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
162148934|NCT04707313|585592911|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
162148935|NCT04707313|585592912|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
162148936|NCT04707313|585592913|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
162148937|NCT04707313|585592914|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
162148938|NCT04707313|585592915|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
162148939|NCT04707313|585592916|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
162148940|NCT04707313|585592917|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
162148941|NCT04707313|585592918|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
162148942|NCT04707313|585592919|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
162148943|NCT04707313|585592920|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
162148944|NCT04707313|585592921|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
162148945|NCT04707313|585592922|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
162148946|NCT04707313|585592910|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162148947|NCT04707313|585592911|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162148948|NCT04707313|585592912|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162148949|NCT04707313|585592913|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162148950|NCT04707313|585592914|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162148951|NCT04707313|585592915|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162148952|NCT04707313|585592916|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162148953|NCT04707313|585592917|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162148954|NCT04707313|585592918|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162148955|NCT04707313|585592919|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
162148956|NCT04707313|585592920|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
162148957|NCT04707313|585592921|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162148958|NCT04707313|585592922|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
162148959|NCT04707313|585592910|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162148960|NCT04707313|585592911|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162148961|NCT04707313|585592912|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162148962|NCT04707313|585592913|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162148963|NCT04707313|585592914|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162148964|NCT04707313|585592915|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162148965|NCT04707313|585592916|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162148966|NCT04707313|585592917|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162148967|NCT04707313|585592918|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
162148968|NCT04707313|585592919|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
162148969|NCT04707313|585592920|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
162148970|NCT04707313|585592921|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
162148971|NCT04707313|585592922|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
162148972|NCT02459899|585592923|FG000|Overall Study|Adverse Event|1|||
162148973|NCT02459899|585592924|FG001|Overall Study|Adverse Event|1|||
162148974|NCT02459899|585592925|FG002|Overall Study|Adverse Event|0|||
162148975|NCT02459899|585592926|FG003|Overall Study|Adverse Event|0|||
162148976|NCT02459899|585592923|FG000|Overall Study|Lost to Follow-up|1|||
162148977|NCT02459899|585592924|FG001|Overall Study|Lost to Follow-up|2|||
162148978|NCT02459899|585592925|FG002|Overall Study|Lost to Follow-up|0|||
162148979|NCT02459899|585592926|FG003|Overall Study|Lost to Follow-up|1|||
161914057|NCT04513366|584733698|FG000|Extension Phase|Lost to Follow-up|1|||
161914058|NCT04513366|584733699|FG001|Extension Phase|Lost to Follow-up|1|||
162148980|NCT02459899|585592923|FG000|Overall Study|Non-compliance with the treatment|0|||
162148981|NCT02459899|585592924|FG001|Overall Study|Non-compliance with the treatment|0|||
162148982|NCT02459899|585592925|FG002|Overall Study|Non-compliance with the treatment|0|||
162148983|NCT02459899|585592926|FG003|Overall Study|Non-compliance with the treatment|1|||
162148984|NCT02459899|585592923|FG000|Overall Study|Withdrawal by Subject|1|||
162148985|NCT02459899|585592924|FG001|Overall Study|Withdrawal by Subject|3|||
162148986|NCT02459899|585592925|FG002|Overall Study|Withdrawal by Subject|0|||
162148987|NCT02459899|585592926|FG003|Overall Study|Withdrawal by Subject|0|||
161914059|NCT04513366|584733700|FG002|Extension Phase|Lost to Follow-up|1|||
161914060|NCT04513366|584733698|FG000|Extension Phase|Sponsor Decision|0|||
161914061|NCT04513366|584733699|FG001|Extension Phase|Sponsor Decision|1|||
161914062|NCT04513366|584733700|FG002|Extension Phase|Sponsor Decision|0|||
161914063|NCT04513366|584733698|FG000|Extension Phase|Death|0|||
162148988|NCT02739035|585592927|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
162148989|NCT02739035|585592928|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
162148990|NCT02739035|585592927|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
162148991|NCT02739035|585592928|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
162148992|NCT02739035|585592927|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
162148993|NCT02739035|585592928|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
162148994|NCT02739035|585592927|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
162148995|NCT02739035|585592928|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
162148996|NCT00940992|585592931|FG000|Overall Study|Adverse Event|2|||
162148997|NCT00940992|585592932|FG001|Overall Study|Adverse Event|0|||
162148998|NCT00940992|585592933|FG002|Overall Study|Adverse Event|1|||
162148999|NCT00940992|585592931|FG000|Overall Study|subject request|2|||
162149000|NCT00940992|585592932|FG001|Overall Study|subject request|1|||
162149001|NCT00940992|585592933|FG002|Overall Study|subject request|0|||
162149002|NCT00940992|585592931|FG000|Overall Study|Lost to Follow-up|0|||
162149003|NCT00940992|585592932|FG001|Overall Study|Lost to Follow-up|1|||
162149004|NCT00940992|585592933|FG002|Overall Study|Lost to Follow-up|1|||
162149005|NCT04446117|585592934|FG000|Overall Study|No Study Treatment Given|4|||
162149006|NCT04446117|585592935|FG001|Overall Study|No Study Treatment Given|3|||
162149007|NCT04446117|585592934|FG000|Overall Study|Radiographic Disease Progression|132|||
161914064|NCT04513366|584733699|FG001|Extension Phase|Death|1|||
161914065|NCT04513366|584733700|FG002|Extension Phase|Death|0|||
161914066|NCT04513366|584733698|FG000|Extension Phase|Adverse Event|0|||
162149008|NCT04446117|585592935|FG001|Overall Study|Radiographic Disease Progression|158|||
162149009|NCT04446117|585592934|FG000|Overall Study|Adverse Event|79|||
162149010|NCT04446117|585592935|FG001|Overall Study|Adverse Event|43|||
162149011|NCT04446117|585592934|FG000|Overall Study|Lack of Clinical Benefit|1|||
162149012|NCT04446117|585592935|FG001|Overall Study|Lack of Clinical Benefit|1|||
162149013|NCT04446117|585592934|FG000|Overall Study|Withdrawal by Subject|24|||
162149014|NCT04446117|585592935|FG001|Overall Study|Withdrawal by Subject|22|||
162149015|NCT04446117|585592934|FG000|Overall Study|Lost to Follow-up|0|||
162149016|NCT04446117|585592935|FG001|Overall Study|Lost to Follow-up|3|||
162149017|NCT04446117|585592934|FG000|Overall Study|Miscellaneous|26|||
162149018|NCT04446117|585592935|FG001|Overall Study|Miscellaneous|36|||
162149019|NCT04446117|585592934|FG000|Overall Study|Missing Data/Data not yet Received|1|||
162149020|NCT04446117|585592935|FG001|Overall Study|Missing Data/Data not yet Received|0|||
162149021|NCT04221438|585592939|FG000|Overall Study|Adverse Event|1|||
162149022|NCT04221438|585592939|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
162149023|NCT02517307|585592944|FG000|Overall Study|Withdrawal by Subject|1|||
162149024|NCT02517307|585592945|FG001|Overall Study|Withdrawal by Subject|0|||
162149025|NCT02517307|585592946|FG002|Overall Study|Withdrawal by Subject|1|||
162149026|NCT02517307|585592947|FG003|Overall Study|Withdrawal by Subject|0|||
162149027|NCT02517307|585592944|FG000|Overall Study|Protocol Violation|0|||
162149028|NCT02517307|585592945|FG001|Overall Study|Protocol Violation|0|||
162149029|NCT02517307|585592946|FG002|Overall Study|Protocol Violation|1|||
162149030|NCT02517307|585592947|FG003|Overall Study|Protocol Violation|1|||
162149031|NCT00843882|585592948|FG000|Step 1|Lack of Efficacy|14|||
162149032|NCT00843882|585592949|FG001|Step 1|Lack of Efficacy|10|||
162149033|NCT00843882|585592950|FG002|Step 1|Lack of Efficacy|21|||
162149034|NCT00843882|585592948|FG000|Step 1|Adverse Event|8|||
162149035|NCT00843882|585592949|FG001|Step 1|Adverse Event|17|||
162149036|NCT00843882|585592950|FG002|Step 1|Adverse Event|20|||
162149037|NCT00843882|585592948|FG000|Step 1|Death|1|||
162149038|NCT00843882|585592949|FG001|Step 1|Death|2|||
162149039|NCT00843882|585592950|FG002|Step 1|Death|4|||
162149040|NCT00843882|585592948|FG000|Step 1|Withdrawal by Subject|6|||
162149041|NCT00843882|585592949|FG001|Step 1|Withdrawal by Subject|12|||
162149042|NCT00843882|585592950|FG002|Step 1|Withdrawal by Subject|9|||
162149043|NCT00843882|585592948|FG000|Step 1|Physician Decision|0|||
162149044|NCT00843882|585592949|FG001|Step 1|Physician Decision|5|||
162149045|NCT00843882|585592950|FG002|Step 1|Physician Decision|1|||
162149046|NCT00843882|585592948|FG000|Step 1|Patient and physician's decision|0|||
162149047|NCT00843882|585592949|FG001|Step 1|Patient and physician's decision|0|||
162149048|NCT00843882|585592950|FG002|Step 1|Patient and physician's decision|1|||
162149049|NCT00843882|585592948|FG000|Step 1|Other complicating disease|1|||
162149050|NCT00843882|585592949|FG001|Step 1|Other complicating disease|3|||
162149051|NCT00843882|585592950|FG002|Step 1|Other complicating disease|4|||
162149052|NCT00843882|585592948|FG000|Step 1|Alternative therapy|0|||
162149053|NCT00843882|585592949|FG001|Step 1|Alternative therapy|1|||
162149054|NCT00843882|585592950|FG002|Step 1|Alternative therapy|1|||
162149055|NCT00843882|585592948|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
162149056|NCT00843882|585592949|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
162149057|NCT00843882|585592950|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
162149058|NCT00843882|585592948|FG000|Step 1|Off treatment reason unknown|0|||
162149059|NCT00843882|585592949|FG001|Step 1|Off treatment reason unknown|1|||
162149060|NCT00843882|585592950|FG002|Step 1|Off treatment reason unknown|4|||
162149061|NCT00843882|585592948|FG000|Step 1|Never started treatment|2|||
162149062|NCT00843882|585592949|FG001|Step 1|Never started treatment|0|||
162149063|NCT00843882|585592950|FG002|Step 1|Never started treatment|0|||
162149064|NCT00843882|585592948|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
162149065|NCT00843882|585592949|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
162149066|NCT00843882|585592950|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
162149067|NCT00843882|585592948|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
162149068|NCT00843882|585592949|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
162149069|NCT00843882|585592950|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
162149070|NCT00843882|585592948|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
162149071|NCT00843882|585592949|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
162149072|NCT00843882|585592950|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
162149073|NCT00843882|585592948|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
162149074|NCT00843882|585592949|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
162149075|NCT00843882|585592950|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
162149076|NCT00843882|585592948|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
162149077|NCT00843882|585592949|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
162149078|NCT00843882|585592950|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
162149079|NCT00843882|585592948|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
162149080|NCT00843882|585592949|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
162149081|NCT00843882|585592950|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
162149082|NCT00843882|585592948|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
162149083|NCT00843882|585592949|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
162149084|NCT00843882|585592950|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
162149085|NCT00630786|585592951|FG000|Overall Study|Physician Decision|0|||
162149086|NCT00630786|585592952|FG001|Overall Study|Physician Decision|0|||
162149087|NCT00630786|585592953|FG002|Overall Study|Physician Decision|1|||
162149088|NCT00630786|585592951|FG000|Overall Study|Withdrawal by Subject|0|||
162149089|NCT00630786|585592952|FG001|Overall Study|Withdrawal by Subject|1|||
162149090|NCT00630786|585592953|FG002|Overall Study|Withdrawal by Subject|1|||
162149091|NCT00630786|585592951|FG000|Overall Study|Lost to Follow-up|0|||
162149092|NCT00630786|585592952|FG001|Overall Study|Lost to Follow-up|1|||
162149093|NCT00630786|585592953|FG002|Overall Study|Lost to Follow-up|0|||
162149094|NCT00630786|585592951|FG000|Overall Study|Other|1|||
162149095|NCT00630786|585592952|FG001|Overall Study|Other|0|||
162149096|NCT00630786|585592953|FG002|Overall Study|Other|0|||
162149097|NCT01582269|585592954|FG000|Overall Study|Withdrawal by Subject|1|||
162149098|NCT01582269|585592955|FG001|Overall Study|Withdrawal by Subject|0|||
162149099|NCT01582269|585592956|FG002|Overall Study|Withdrawal by Subject|0|||
162149100|NCT02770248|585592957|FG000|Overall Study|Adverse Event|0|||
162149101|NCT02770248|585592958|FG001|Overall Study|Adverse Event|1|||
162149102|NCT02770248|585592957|FG000|Overall Study|Randomized in error, prior to treatment|0|||
162149103|NCT02770248|585592958|FG001|Overall Study|Randomized in error, prior to treatment|1|||
162149104|NCT02486588|585592961|FG000|Overall Study|Randomized in error- ineligible|738|||
162149105|NCT02486588|585592962|FG001|Overall Study|Randomized in error- ineligible|750|||
162149106|NCT02486588|585592963|FG002|Overall Study|Randomized in error- ineligible|755|||
162149107|NCT02486588|585592964|FG003|Overall Study|Randomized in error- ineligible|738|||
162149108|NCT02486588|585592965|FG004|Overall Study|Randomized in error- ineligible|746|||
162149109|NCT02486588|585592966|FG005|Overall Study|Randomized in error- ineligible|746|||
162149110|NCT00546871|585592967|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
162149111|NCT00546871|585592968|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
162149112|NCT00546871|585592967|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
162149113|NCT00546871|585592968|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
162149114|NCT00546871|585592967|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
162149115|NCT00546871|585592968|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
162149116|NCT00546871|585592967|FG000|Study Extension Period|Protocol Violation|1|||
162149117|NCT00546871|585592968|FG001|Study Extension Period|Protocol Violation|0|||
162149118|NCT00546871|585592967|FG000|Study Extension Period|Withdrawal by Subject|0|||
162149119|NCT00546871|585592968|FG001|Study Extension Period|Withdrawal by Subject|1|||
162149120|NCT06119113|585593700|FG000|Overall Study|Lost to Follow-up|15|||
162149121|NCT06119113|585593701|FG001|Overall Study|Lost to Follow-up|13|||
162149122|NCT06119113|585593702|FG002|Overall Study|Lost to Follow-up|21|||
162149123|NCT05136443|585593705|FG000|Overall Study|Lost to Follow-up|2|||
162149124|NCT05136443|585593705|FG000|Overall Study|Adverse Event|2|||
162149125|NCT01786564|585593712|FG000|Overall Study|Lost to Follow-up|47|||
162149126|NCT01786564|585593712|FG000|Overall Study|Ineligible|17|||
162149127|NCT00424762|585593715|FG000|Overall Study|Withdrawal by Subject|18|||
162149128|NCT00424762|585593716|FG001|Overall Study|Withdrawal by Subject|19|||
162149129|NCT00424762|585593715|FG000|Overall Study|Lost to Follow-up|2|||
162149130|NCT00424762|585593716|FG001|Overall Study|Lost to Follow-up|3|||
162149131|NCT01145885|585593717|FG000|Overall Study|Progressive Disease|7|||
162149132|NCT05299606|585593718|FG000|Overall Study|Death|1|||
162149133|NCT03460756|585593720|FG000|Overall Study|Adverse Event|0|||
162149134|NCT03460756|585593721|FG001|Overall Study|Adverse Event|0|||
162149135|NCT03460756|585593722|FG002|Overall Study|Adverse Event|0|||
162149136|NCT03460756|585593723|FG003|Overall Study|Adverse Event|1|||
162149137|NCT03460756|585593720|FG000|Overall Study|Lack of Efficacy|0|||
161809998|NCT01796171|584347687|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162149138|NCT03460756|585593721|FG001|Overall Study|Lack of Efficacy|0|||
162149139|NCT03460756|585593722|FG002|Overall Study|Lack of Efficacy|0|||
161914067|NCT04513366|584733699|FG001|Extension Phase|Adverse Event|0|||
162149140|NCT03460756|585593723|FG003|Overall Study|Lack of Efficacy|2|||
162149141|NCT03460756|585593720|FG000|Overall Study|Lost to Follow-up|0|||
162149142|NCT03460756|585593721|FG001|Overall Study|Lost to Follow-up|1|||
162149143|NCT03460756|585593722|FG002|Overall Study|Lost to Follow-up|2|||
162149144|NCT03460756|585593723|FG003|Overall Study|Lost to Follow-up|1|||
162149145|NCT03460756|585593720|FG000|Overall Study|Pregnancy|0|||
162149146|NCT03460756|585593721|FG001|Overall Study|Pregnancy|0|||
162149147|NCT03460756|585593722|FG002|Overall Study|Pregnancy|0|||
162149148|NCT03460756|585593723|FG003|Overall Study|Pregnancy|1|||
162149149|NCT03460756|585593720|FG000|Overall Study|Protocol Violation|0|||
162149150|NCT03460756|585593721|FG001|Overall Study|Protocol Violation|0|||
162149151|NCT03460756|585593722|FG002|Overall Study|Protocol Violation|0|||
162149152|NCT03460756|585593723|FG003|Overall Study|Protocol Violation|1|||
162149153|NCT03460756|585593720|FG000|Overall Study|Withdrawal by Subject|0|||
162149154|NCT03460756|585593721|FG001|Overall Study|Withdrawal by Subject|4|||
162149155|NCT03460756|585593722|FG002|Overall Study|Withdrawal by Subject|7|||
162149156|NCT03460756|585593723|FG003|Overall Study|Withdrawal by Subject|3|||
162149157|NCT00723450|585593725|FG000|Open-Label Phase|Adverse Event|26|||
162149158|NCT00723450|585593726|FG001|Open-Label Phase|Adverse Event|0|||
162149159|NCT00723450|585593727|FG002|Open-Label Phase|Adverse Event|0|||
162149160|NCT00723450|585593725|FG000|Open-Label Phase|Lack of Efficacy|18|||
162149161|NCT00723450|585593726|FG001|Open-Label Phase|Lack of Efficacy|0|||
162149162|NCT00723450|585593727|FG002|Open-Label Phase|Lack of Efficacy|0|||
162149163|NCT00723450|585593725|FG000|Open-Label Phase|Protocol Violation|35|||
162149164|NCT00723450|585593726|FG001|Open-Label Phase|Protocol Violation|0|||
162149165|NCT00723450|585593727|FG002|Open-Label Phase|Protocol Violation|0|||
162149166|NCT00723450|585593725|FG000|Open-Label Phase|Lost to Follow-up|7|||
162149167|NCT00723450|585593726|FG001|Open-Label Phase|Lost to Follow-up|0|||
162149168|NCT00723450|585593727|FG002|Open-Label Phase|Lost to Follow-up|0|||
162149169|NCT00723450|585593725|FG000|Open-Label Phase|Physician Decision|2|||
162149170|NCT00723450|585593726|FG001|Open-Label Phase|Physician Decision|0|||
162149171|NCT00723450|585593727|FG002|Open-Label Phase|Physician Decision|0|||
162149172|NCT00723450|585593725|FG000|Open-Label Phase|Withdrawal by Subject|37|||
162149173|NCT00723450|585593726|FG001|Open-Label Phase|Withdrawal by Subject|0|||
162149174|NCT00723450|585593727|FG002|Open-Label Phase|Withdrawal by Subject|0|||
162149175|NCT00723450|585593725|FG000|Randomized Phase|Adverse Event|0|||
162149176|NCT00723450|585593726|FG001|Randomized Phase|Adverse Event|26|||
162149177|NCT00723450|585593727|FG002|Randomized Phase|Adverse Event|17|||
162149178|NCT00723450|585593725|FG000|Randomized Phase|Lack of Efficacy|0|||
162149179|NCT00723450|585593726|FG001|Randomized Phase|Lack of Efficacy|11|||
162149180|NCT00723450|585593727|FG002|Randomized Phase|Lack of Efficacy|11|||
162149181|NCT00723450|585593725|FG000|Randomized Phase|Protocol Violation|0|||
162149182|NCT00723450|585593726|FG001|Randomized Phase|Protocol Violation|9|||
162149183|NCT00723450|585593727|FG002|Randomized Phase|Protocol Violation|13|||
162149184|NCT00723450|585593725|FG000|Randomized Phase|Lost to Follow-up|0|||
162149185|NCT00723450|585593726|FG001|Randomized Phase|Lost to Follow-up|2|||
162149186|NCT00723450|585593727|FG002|Randomized Phase|Lost to Follow-up|3|||
162149187|NCT00723450|585593725|FG000|Randomized Phase|Physician Decision|0|||
162149188|NCT00723450|585593726|FG001|Randomized Phase|Physician Decision|3|||
162149189|NCT00723450|585593727|FG002|Randomized Phase|Physician Decision|1|||
162149190|NCT00723450|585593725|FG000|Randomized Phase|Withdrawal by Subject|0|||
162149191|NCT00723450|585593726|FG001|Randomized Phase|Withdrawal by Subject|14|||
162149192|NCT00723450|585593727|FG002|Randomized Phase|Withdrawal by Subject|22|||
162149193|NCT02950558|585593731|FG000|Overall Study|Lost to Follow-up|2|||
162149194|NCT02950558|585593732|FG001|Overall Study|Lost to Follow-up|0|||
162149195|NCT02537522|585593738|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
162149196|NCT02537522|585593739|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
162149197|NCT02537522|585593740|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
162149198|NCT02537522|585593741|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
162149199|NCT02537522|585593738|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
162149200|NCT02537522|585593739|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
162149201|NCT02537522|585593740|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
162149202|NCT02537522|585593741|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
162149203|NCT02537522|585593738|FG000|Phase I - Contralateral|incorrect randomization|0|||
162149204|NCT02537522|585593739|FG001|Phase I - Contralateral|incorrect randomization|1|||
162149205|NCT02537522|585593740|FG002|Phase I - Contralateral|incorrect randomization|0|||
162149206|NCT02537522|585593741|FG003|Phase I - Contralateral|incorrect randomization|0|||
162149207|NCT02537522|585593738|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
162149208|NCT02537522|585593739|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
162149209|NCT02537522|585593740|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
161914068|NCT04513366|584733700|FG002|Extension Phase|Adverse Event|1|||
162149210|NCT02537522|585593741|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
162149211|NCT02537522|585593738|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
161914069|NCT03344757|584733701|FG000|Overall Study|Withdrawal by Subject|18|||
161914070|NCT03344757|584733702|FG001|Overall Study|Withdrawal by Subject|16|||
162149212|NCT02537522|585593739|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
162149213|NCT02537522|585593740|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
162149214|NCT02537522|585593741|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
162149215|NCT03920215|585593743|FG000|Overall Study|Lost to Follow-up|1|||
162149216|NCT03920215|585593744|FG001|Overall Study|Lost to Follow-up|2|||
162149217|NCT03920215|585593745|FG002|Overall Study|Lost to Follow-up|0|||
162149218|NCT03920215|585593746|FG003|Overall Study|Lost to Follow-up|0|||
162149219|NCT03920215|585593743|FG000|Overall Study|Death|0|||
162149220|NCT03920215|585593744|FG001|Overall Study|Death|0|||
162149221|NCT03920215|585593745|FG002|Overall Study|Death|0|||
162149222|NCT03920215|585593746|FG003|Overall Study|Death|1|||
162149223|NCT00585533|585593747|FG000|Overall Study|objective or symptomatic progression|9|||
162149224|NCT02547922|585593748|FG000|Overall Study|Withdrawal by Subject|9|||
162149225|NCT02547922|585593749|FG001|Overall Study|Withdrawal by Subject|6|||
162149226|NCT02547922|585593750|FG002|Overall Study|Withdrawal by Subject|10|||
162149227|NCT02547922|585593748|FG000|Overall Study|Adverse Event|3|||
162149228|NCT02547922|585593749|FG001|Overall Study|Adverse Event|1|||
162149229|NCT02547922|585593750|FG002|Overall Study|Adverse Event|2|||
162149230|NCT02547922|585593748|FG000|Overall Study|Lost to Follow-up|1|||
162149231|NCT02547922|585593749|FG001|Overall Study|Lost to Follow-up|0|||
162149232|NCT02547922|585593750|FG002|Overall Study|Lost to Follow-up|0|||
162149233|NCT02547922|585593748|FG000|Overall Study|Lack of Efficacy|5|||
162149234|NCT02547922|585593749|FG001|Overall Study|Lack of Efficacy|7|||
162149235|NCT02547922|585593750|FG002|Overall Study|Lack of Efficacy|4|||
162149236|NCT02547922|585593748|FG000|Overall Study|Death|1|||
162149237|NCT02547922|585593749|FG001|Overall Study|Death|0|||
162149238|NCT02547922|585593750|FG002|Overall Study|Death|0|||
162149239|NCT02547922|585593748|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
162149240|NCT02547922|585593749|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
162149241|NCT02547922|585593750|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
162149242|NCT02547922|585593748|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
162149243|NCT02547922|585593749|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
162149244|NCT02547922|585593750|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
162149245|NCT02547922|585593748|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
162149246|NCT02547922|585593749|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
162149247|NCT02547922|585593750|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
162149248|NCT02547922|585593748|FG000|Overall Study|Physician Decision|2|||
162149249|NCT02547922|585593749|FG001|Overall Study|Physician Decision|1|||
162149250|NCT02547922|585593750|FG002|Overall Study|Physician Decision|2|||
162149251|NCT02547922|585593748|FG000|Overall Study|Patients did not receive IP|1|||
162149252|NCT02547922|585593749|FG001|Overall Study|Patients did not receive IP|1|||
162149253|NCT02547922|585593750|FG002|Overall Study|Patients did not receive IP|0|||
162149254|NCT02709655|585593751|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
162149255|NCT02709655|585593752|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
162149256|NCT02709655|585593753|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
162149257|NCT02709655|585593754|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
162149258|NCT02709655|585593755|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
162149259|NCT02709655|585593751|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
162149260|NCT02709655|585593752|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
162149261|NCT02709655|585593753|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
162149262|NCT02709655|585593754|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
162149263|NCT02709655|585593755|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
162149264|NCT02709655|585593751|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
162149265|NCT02709655|585593752|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
162149266|NCT02709655|585593753|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
162149267|NCT02709655|585593754|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
162149268|NCT02709655|585593755|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
162149269|NCT02709655|585593751|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
162149270|NCT02709655|585593752|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
162149271|NCT02709655|585593753|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
162149272|NCT02709655|585593754|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
162149273|NCT02709655|585593755|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
162149274|NCT02709655|585593751|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
162149275|NCT02709655|585593752|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
162149276|NCT02709655|585593753|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
162149277|NCT02709655|585593754|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
162149278|NCT02709655|585593755|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
162149279|NCT02709655|585593751|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
162149280|NCT02709655|585593752|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
162149281|NCT02709655|585593753|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
162149282|NCT02709655|585593754|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
162149283|NCT02709655|585593755|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
162149284|NCT02709655|585593751|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
162149285|NCT02709655|585593752|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
162149286|NCT02709655|585593753|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
162149287|NCT02709655|585593754|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
162149288|NCT02709655|585593755|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
162149289|NCT02709655|585593751|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
162149290|NCT02709655|585593752|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
162149291|NCT02709655|585593753|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
162149292|NCT02709655|585593754|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
162149293|NCT02709655|585593755|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
162149294|NCT02709655|585593751|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
162149295|NCT02709655|585593752|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
162149296|NCT02709655|585593753|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
162149297|NCT02709655|585593754|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
162149298|NCT02709655|585593755|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
162149299|NCT02709655|585593751|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
162149300|NCT02709655|585593752|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
162149301|NCT02709655|585593753|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
162149302|NCT02709655|585593754|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
162149303|NCT02709655|585593755|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
162149304|NCT02709655|585593751|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
162149305|NCT02709655|585593752|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
162149306|NCT02709655|585593753|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
162149307|NCT02709655|585593754|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
162149308|NCT02709655|585593755|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
162149309|NCT02709655|585593751|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
162149310|NCT02709655|585593752|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
162149311|NCT02709655|585593753|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
162149312|NCT02709655|585593754|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
162149313|NCT02709655|585593755|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
162149314|NCT02709655|585593751|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
162149315|NCT02709655|585593752|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
162149316|NCT02709655|585593753|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
162149317|NCT02709655|585593754|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
162149318|NCT02709655|585593755|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
162149319|NCT02709655|585593751|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
162149320|NCT02709655|585593752|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
162149321|NCT02709655|585593753|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
162149322|NCT02709655|585593754|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
162149323|NCT02709655|585593755|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
162149324|NCT02709655|585593751|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
162149325|NCT02709655|585593752|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
162149326|NCT02709655|585593753|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
162149327|NCT02709655|585593754|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
162149328|NCT02709655|585593755|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
162149329|NCT02709655|585593751|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
162149330|NCT02709655|585593752|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
162149331|NCT02709655|585593753|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
162149332|NCT02709655|585593754|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
162149333|NCT02709655|585593755|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
162149334|NCT00102063|585593756|FG000|Overall Study|Lack of Efficacy|5|||
162149335|NCT00102063|585593757|FG001|Overall Study|Lack of Efficacy|1|||
162149336|NCT00102063|585593758|FG002|Overall Study|Lack of Efficacy|1|||
162149337|NCT00102063|585593756|FG000|Overall Study|Adverse Event|7|||
162149338|NCT00102063|585593757|FG001|Overall Study|Adverse Event|4|||
162149339|NCT00102063|585593758|FG002|Overall Study|Adverse Event|2|||
162149340|NCT00102063|585593756|FG000|Overall Study|Withdrawal by Subject|4|||
161914071|NCT03344757|584733701|FG000|Overall Study|Lost to Follow-up|0|||
161914072|NCT03344757|584733702|FG001|Overall Study|Lost to Follow-up|2|||
161914073|NCT00269152|584733703|FG000|Overall Study|Adverse Event|9|||
162149341|NCT00102063|585593757|FG001|Overall Study|Withdrawal by Subject|12|||
162149342|NCT00102063|585593758|FG002|Overall Study|Withdrawal by Subject|5|||
162149343|NCT00102063|585593756|FG000|Overall Study|Lost to Follow-up|0|||
162149344|NCT00102063|585593757|FG001|Overall Study|Lost to Follow-up|0|||
162149345|NCT00102063|585593758|FG002|Overall Study|Lost to Follow-up|1|||
162149346|NCT00102063|585593756|FG000|Overall Study|Protocol Violation|0|||
162149347|NCT00102063|585593757|FG001|Overall Study|Protocol Violation|1|||
162149348|NCT00102063|585593758|FG002|Overall Study|Protocol Violation|1|||
161914074|NCT00269152|584733704|FG001|Overall Study|Adverse Event|3|||
161914075|NCT00269152|584733703|FG000|Overall Study|Withdrawal by Subject|7|||
162149349|NCT00857649|585593759|FG000|Overall Study|Adverse Event|15|||
162149350|NCT00857649|585593760|FG001|Overall Study|Adverse Event|10|||
162149351|NCT00857649|585593759|FG000|Overall Study|Non-compliance|1|||
162149352|NCT00857649|585593760|FG001|Overall Study|Non-compliance|1|||
162149353|NCT00857649|585593759|FG000|Overall Study|Protocol Violation|2|||
162149354|NCT00857649|585593760|FG001|Overall Study|Protocol Violation|2|||
162149355|NCT00857649|585593759|FG000|Overall Study|Withdrawal of Consent|10|||
162149356|NCT00857649|585593760|FG001|Overall Study|Withdrawal of Consent|7|||
162149357|NCT00857649|585593759|FG000|Overall Study|Nursing Home Placement|2|||
162149358|NCT00857649|585593760|FG001|Overall Study|Nursing Home Placement|9|||
162149359|NCT00857649|585593759|FG000|Overall Study|Other Reasons|1|||
162149360|NCT00857649|585593760|FG001|Overall Study|Other Reasons|3|||
162149361|NCT02248480|585593763|FG000|Overall Study|Lack of Efficacy|4|||
162149362|NCT02248480|585593764|FG001|Overall Study|Lack of Efficacy|6|||
162149363|NCT02248480|585593763|FG000|Overall Study|Adverse Event|11|||
162149364|NCT02248480|585593764|FG001|Overall Study|Adverse Event|2|||
162149365|NCT02248480|585593763|FG000|Overall Study|Withdrawal by Subject|2|||
162149366|NCT02248480|585593764|FG001|Overall Study|Withdrawal by Subject|4|||
162149367|NCT02248480|585593763|FG000|Overall Study|Entry Criteria Not Met|0|||
162149368|NCT02248480|585593764|FG001|Overall Study|Entry Criteria Not Met|1|||
162149369|NCT02248480|585593763|FG000|Overall Study|Other:Physician Decision|0|||
162149370|NCT02248480|585593764|FG001|Overall Study|Other:Physician Decision|1|||
162149371|NCT06001177|585594711|FG000|Treatment Phase|Adverse Event|1|||
162149372|NCT06001177|585594712|FG001|Treatment Phase|Adverse Event|0|||
162149373|NCT06001177|585594711|FG000|Treatment Phase|Withdrawal by Subject|1|||
162149374|NCT06001177|585594712|FG001|Treatment Phase|Withdrawal by Subject|0|||
162149375|NCT06001177|585594711|FG000|Observation Phase|Adverse Event|1|||
162149376|NCT06001177|585594712|FG001|Observation Phase|Adverse Event|1|||
162149377|NCT06001177|585594711|FG000|Observation Phase|Withdrawal by Subject|0|||
162149378|NCT06001177|585594712|FG001|Observation Phase|Withdrawal by Subject|1|||
162149379|NCT03593876|585594713|FG000|Overall Study|Withdrawal by Subject|1|||
162149380|NCT03593876|585594713|FG000|Overall Study|Discharged home before intervention completion|2|||
162149381|NCT05309668|585594714|FG000|Overall Study|Ongoing at data cut-off|14|||
162149382|NCT05309668|585594715|FG001|Overall Study|Ongoing at data cut-off|17|||
162149383|NCT05309668|585594716|FG002|Overall Study|Ongoing at data cut-off|4|||
162149384|NCT02696707|585594717|FG000|Per Protocol Population|Physician Decision|2|||
162149385|NCT02696707|585594718|FG001|Per Protocol Population|Physician Decision|1|||
162149386|NCT02696707|585594717|FG000|Per Protocol Population|Participant Decision|0|||
162149387|NCT02696707|585594718|FG001|Per Protocol Population|Participant Decision|2|||
162149388|NCT02696707|585594717|FG000|Completed Study as Planned|Reason = LVEF|2|||
162149389|NCT02696707|585594718|FG001|Completed Study as Planned|Reason = LVEF|2|||
162149390|NCT02696707|585594717|FG000|Completed Study as Planned|Protocol Violation|2|||
162149391|NCT02696707|585594718|FG001|Completed Study as Planned|Protocol Violation|6|||
162149392|NCT02696707|585594717|FG000|Completed Study as Planned|Metastatic disease|3|||
162149393|NCT02696707|585594718|FG001|Completed Study as Planned|Metastatic disease|0|||
162149394|NCT02696707|585594717|FG000|Completed Study as Planned|Location|1|||
162149395|NCT02696707|585594718|FG001|Completed Study as Planned|Location|1|||
162149396|NCT00071799|585594719|FG000|Overall Study|Adverse Event|19|||
162149397|NCT00071799|585594720|FG001|Overall Study|Adverse Event|10|||
162149398|NCT00071799|585594719|FG000|Overall Study|Protocol Violation|1|||
162149399|NCT00071799|585594720|FG001|Overall Study|Protocol Violation|7|||
162149400|NCT00071799|585594719|FG000|Overall Study|Lost to Follow-up|1|||
162149401|NCT00071799|585594720|FG001|Overall Study|Lost to Follow-up|1|||
162149402|NCT00071799|585594719|FG000|Overall Study|Withdrawal by Subject|15|||
162149403|NCT00071799|585594720|FG001|Overall Study|Withdrawal by Subject|37|||
162149404|NCT00071799|585594719|FG000|Overall Study|Physician Decision|0|||
162149405|NCT00071799|585594720|FG001|Overall Study|Physician Decision|2|||
161914076|NCT00269152|584733704|FG001|Overall Study|Withdrawal by Subject|3|||
161914077|NCT00269152|584733703|FG000|Overall Study|Physician Decision|2|||
162149406|NCT00071799|585594719|FG000|Overall Study|Lack of Efficacy|11|||
162149407|NCT00071799|585594720|FG001|Overall Study|Lack of Efficacy|18|||
162149408|NCT00071799|585594719|FG000|Overall Study|Disease Progression|23|||
162149409|NCT00071799|585594720|FG001|Overall Study|Disease Progression|20|||
162149410|NCT00071799|585594719|FG000|Overall Study|Different Central+Local Pathology Review|0|||
162149411|NCT00071799|585594720|FG001|Overall Study|Different Central+Local Pathology Review|1|||
162149412|NCT00071799|585594719|FG000|Overall Study|Not Documented|0|||
162149413|NCT00071799|585594720|FG001|Overall Study|Not Documented|2|||
162149414|NCT00814346|585594721|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
162149415|NCT00814346|585594722|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
162149416|NCT00814346|585594721|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
162149417|NCT00814346|585594722|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
162149418|NCT00814346|585594721|FG000|Open Phase (17 Months)|Adverse Event|5|||
162149419|NCT00814346|585594722|FG001|Open Phase (17 Months)|Adverse Event|0|||
162149420|NCT00814346|585594721|FG000|Open Phase (17 Months)|Consent|2|||
162149421|NCT00814346|585594722|FG001|Open Phase (17 Months)|Consent|0|||
162149422|NCT00814346|585594721|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
162149423|NCT00814346|585594722|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
162149424|NCT00814346|585594721|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
162149425|NCT00814346|585594722|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
162149426|NCT03034915|585594730|FG000|Overall Study|Adverse Event|29|||
162149427|NCT03034915|585594731|FG001|Overall Study|Adverse Event|32|||
162149428|NCT03034915|585594732|FG002|Overall Study|Adverse Event|22|||
162149429|NCT03034915|585594730|FG000|Overall Study|Lost to Follow-up|5|||
162149430|NCT03034915|585594731|FG001|Overall Study|Lost to Follow-up|13|||
162149431|NCT03034915|585594732|FG002|Overall Study|Lost to Follow-up|3|||
162149432|NCT03034915|585594730|FG000|Overall Study|Withdrawal by Subject|29|||
162149433|NCT03034915|585594731|FG001|Overall Study|Withdrawal by Subject|46|||
162149434|NCT03034915|585594732|FG002|Overall Study|Withdrawal by Subject|41|||
162149435|NCT03034915|585594730|FG000|Overall Study|Protocol Deviation|2|||
162149436|NCT03034915|585594731|FG001|Overall Study|Protocol Deviation|14|||
162149437|NCT03034915|585594732|FG002|Overall Study|Protocol Deviation|7|||
162149438|NCT03034915|585594730|FG000|Overall Study|Lack of Efficacy|8|||
162149439|NCT03034915|585594731|FG001|Overall Study|Lack of Efficacy|16|||
162149440|NCT03034915|585594732|FG002|Overall Study|Lack of Efficacy|18|||
162149441|NCT03034915|585594730|FG000|Overall Study|Site closed|2|||
162149442|NCT03034915|585594731|FG001|Overall Study|Site closed|2|||
162149443|NCT03034915|585594732|FG002|Overall Study|Site closed|4|||
161914078|NCT00269152|584733704|FG001|Overall Study|Physician Decision|3|||
161914079|NCT00269152|584733703|FG000|Overall Study|Protocol Violation|0|||
161914080|NCT00269152|584733704|FG001|Overall Study|Protocol Violation|1|||
161914081|NCT01832766|584733707|FG000|Washout|Lost to Follow-up|0|||
161914082|NCT01832766|584733708|FG001|Washout|Lost to Follow-up|1|||
161914083|NCT03533751|584733711|FG000|Overall Study|Withdrawal by Subject|12|||
161914084|NCT03533751|584733712|FG001|Overall Study|Withdrawal by Subject|6|||
161914085|NCT03533751|584733713|FG002|Overall Study|Withdrawal by Subject|11|||
161914086|NCT03533751|584733714|FG003|Overall Study|Withdrawal by Subject|9|||
161914087|NCT03533751|584733715|FG004|Overall Study|Withdrawal by Subject|10|||
161914088|NCT03533751|584733711|FG000|Overall Study|Adverse Event|4|||
162149444|NCT03034915|585594730|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
162149445|NCT03034915|585594731|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
162149446|NCT03034915|585594732|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
162149447|NCT03034915|585594730|FG000|Overall Study|Physician Decision|1|||
162149448|NCT03034915|585594731|FG001|Overall Study|Physician Decision|5|||
162149449|NCT03034915|585594732|FG002|Overall Study|Physician Decision|2|||
161914089|NCT03533751|584733712|FG001|Overall Study|Adverse Event|7|||
161914090|NCT03533751|584733713|FG002|Overall Study|Adverse Event|2|||
161914091|NCT03533751|584733714|FG003|Overall Study|Adverse Event|4|||
161914092|NCT03533751|584733715|FG004|Overall Study|Adverse Event|5|||
161914093|NCT03533751|584733711|FG000|Overall Study|Physician Decision|0|||
161914094|NCT03533751|584733712|FG001|Overall Study|Physician Decision|2|||
161914095|NCT03533751|584733713|FG002|Overall Study|Physician Decision|1|||
161914096|NCT03533751|584733714|FG003|Overall Study|Physician Decision|2|||
161914097|NCT03533751|584733715|FG004|Overall Study|Physician Decision|1|||
161914098|NCT03533751|584733711|FG000|Overall Study|Sponsor Decision|0|||
161914099|NCT03533751|584733712|FG001|Overall Study|Sponsor Decision|0|||
161914100|NCT03533751|584733713|FG002|Overall Study|Sponsor Decision|1|||
161914101|NCT03533751|584733714|FG003|Overall Study|Sponsor Decision|1|||
161914102|NCT03533751|584733715|FG004|Overall Study|Sponsor Decision|0|||
161914103|NCT03533751|584733711|FG000|Overall Study|Lost to Follow-up|3|||
161914104|NCT03533751|584733712|FG001|Overall Study|Lost to Follow-up|7|||
161914105|NCT03533751|584733713|FG002|Overall Study|Lost to Follow-up|6|||
162149450|NCT03861767|585594733|FG000|Overall Study|Withdrawal by Subject|2|||
162149451|NCT03861767|585594734|FG001|Overall Study|Withdrawal by Subject|1|||
162149452|NCT03861767|585594735|FG002|Overall Study|Withdrawal by Subject|0|||
162149453|NCT03861767|585594736|FG003|Overall Study|Withdrawal by Subject|5|||
162149454|NCT03861767|585594737|FG004|Overall Study|Withdrawal by Subject|2|||
162149455|NCT03861767|585594738|FG005|Overall Study|Withdrawal by Subject|1|||
162149456|NCT03861767|585594739|FG006|Overall Study|Withdrawal by Subject|3|||
162149457|NCT03861767|585594740|FG007|Overall Study|Withdrawal by Subject|1|||
162149458|NCT03861767|585594741|FG008|Overall Study|Withdrawal by Subject|0|||
161914106|NCT03533751|584733714|FG003|Overall Study|Lost to Follow-up|4|||
161914107|NCT03533751|584733715|FG004|Overall Study|Lost to Follow-up|3|||
161914108|NCT03533751|584733711|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
161914109|NCT03533751|584733712|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
162149459|NCT03861767|585594742|FG009|Overall Study|Withdrawal by Subject|5|||
162149460|NCT00346333|585594743|FG000|Overall Study|Death|1|||
162149461|NCT00346333|585594744|FG001|Overall Study|Death|0|||
162149462|NCT00346333|585594743|FG000|Overall Study|unwilling or unable to continue|4|||
161914110|NCT03533751|584733713|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
161914111|NCT03533751|584733714|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
162149463|NCT00346333|585594744|FG001|Overall Study|unwilling or unable to continue|8|||
162149464|NCT00117286|585594750|FG000|Overall Study|Adverse Event|12|||
162149465|NCT00117286|585594751|FG001|Overall Study|Adverse Event|6|||
162149466|NCT00117286|585594750|FG000|Overall Study|Lost to Follow-up|2|||
162149467|NCT00117286|585594751|FG001|Overall Study|Lost to Follow-up|0|||
162149468|NCT00117286|585594750|FG000|Overall Study|Protocol Violation|3|||
162149469|NCT00117286|585594751|FG001|Overall Study|Protocol Violation|3|||
162149470|NCT00117286|585594750|FG000|Overall Study|Withdrawal by Subject|6|||
162149471|NCT00117286|585594751|FG001|Overall Study|Withdrawal by Subject|2|||
162149472|NCT00117286|585594750|FG000|Overall Study|Physician Decision|3|||
162149473|NCT00117286|585594751|FG001|Overall Study|Physician Decision|7|||
162149474|NCT00117286|585594750|FG000|Overall Study|Lack of Efficacy|2|||
162149475|NCT00117286|585594751|FG001|Overall Study|Lack of Efficacy|1|||
162149476|NCT00117286|585594750|FG000|Overall Study|Research site closing|0|||
162149477|NCT00117286|585594751|FG001|Overall Study|Research site closing|2|||
162149478|NCT00189202|585594752|FG000|Overall Study|Physician Decision|5|||
162149479|NCT02798835|585594757|FG000|Overall Study|Protocol Violation|0|||
162149480|NCT02798835|585594758|FG001|Overall Study|Protocol Violation|0|||
162149481|NCT02798835|585594759|FG002|Overall Study|Protocol Violation|3|||
162149482|NCT03024606|585594764|FG000|Overall Study|Withdrawal by Subject|9|||
162149483|NCT03024606|585594765|FG001|Overall Study|Withdrawal by Subject|10|||
162149484|NCT01595061|585594776|FG000|Overall Study|Never Treated|3|||
162149485|NCT01595061|585594776|FG000|Overall Study|Inadequate Pathology|1|||
162149486|NCT04697628|585594784|FG000|Overall Study|Withdrawal by Subject|17|||
162149487|NCT04697628|585594785|FG001|Overall Study|Withdrawal by Subject|23|||
162149488|NCT04697628|585594784|FG000|Overall Study|Lost to Follow-up|0|||
162149489|NCT04697628|585594785|FG001|Overall Study|Lost to Follow-up|4|||
162149490|NCT04697628|585594784|FG000|Overall Study|On-going in study|122|||
162149491|NCT04697628|585594785|FG001|Overall Study|On-going in study|91|||
162149492|NCT03388632|585594786|FG000|Triplet C|Clinical progression|0|||
162149493|NCT03388632|585594787|FG001|Triplet C|Clinical progression|0|||
162149494|NCT03388632|585594788|FG002|Triplet C|Clinical progression|0|||
162149495|NCT03388632|585594789|FG003|Triplet C|Clinical progression|0|||
162149496|NCT03388632|585594790|FG004|Triplet C|Clinical progression|1|||
162149497|NCT03388632|585594791|FG005|Triplet C|Clinical progression|0|||
162149498|NCT03388632|585594792|FG006|Triplet C|Clinical progression|0|||
162149499|NCT03388632|585594793|FG007|Triplet C|Clinical progression|0|||
162149500|NCT03388632|585594794|FG008|Triplet C|Clinical progression|0|||
162149501|NCT03388632|585594786|FG000|Triplet C|42-day lapse in tx|0|||
162149502|NCT03388632|585594787|FG001|Triplet C|42-day lapse in tx|0|||
162149503|NCT03388632|585594788|FG002|Triplet C|42-day lapse in tx|0|||
162149504|NCT03388632|585594789|FG003|Triplet C|42-day lapse in tx|0|||
162149505|NCT03388632|585594790|FG004|Triplet C|42-day lapse in tx|1|||
162149506|NCT03388632|585594791|FG005|Triplet C|42-day lapse in tx|0|||
162149507|NCT03388632|585594792|FG006|Triplet C|42-day lapse in tx|0|||
162149508|NCT03388632|585594793|FG007|Triplet C|42-day lapse in tx|0|||
162149509|NCT03388632|585594794|FG008|Triplet C|42-day lapse in tx|0|||
162149510|NCT03388632|585594786|FG000|Triplet C|Adverse Event|0|||
162149511|NCT03388632|585594787|FG001|Triplet C|Adverse Event|0|||
162149512|NCT03388632|585594788|FG002|Triplet C|Adverse Event|0|||
162149513|NCT03388632|585594789|FG003|Triplet C|Adverse Event|0|||
162149514|NCT03388632|585594790|FG004|Triplet C|Adverse Event|0|||
162149515|NCT03388632|585594791|FG005|Triplet C|Adverse Event|0|||
162149516|NCT03388632|585594792|FG006|Triplet C|Adverse Event|0|||
162149517|NCT03388632|585594793|FG007|Triplet C|Adverse Event|0|||
162149518|NCT03388632|585594794|FG008|Triplet C|Adverse Event|1|||
162149519|NCT03388632|585594786|FG000|Triplet C|Switched to alternative treatment|0|||
162149520|NCT03388632|585594787|FG001|Triplet C|Switched to alternative treatment|0|||
162149521|NCT03388632|585594788|FG002|Triplet C|Switched to alternative treatment|0|||
162149522|NCT03388632|585594789|FG003|Triplet C|Switched to alternative treatment|0|||
162149523|NCT03388632|585594790|FG004|Triplet C|Switched to alternative treatment|0|||
162149524|NCT03388632|585594791|FG005|Triplet C|Switched to alternative treatment|0|||
162149525|NCT03388632|585594792|FG006|Triplet C|Switched to alternative treatment|0|||
162149526|NCT03388632|585594793|FG007|Triplet C|Switched to alternative treatment|1|||
162149527|NCT03388632|585594794|FG008|Triplet C|Switched to alternative treatment|0|||
162149528|NCT03388632|585594786|FG000|Triplet C|Participant choice|0|||
162149529|NCT03388632|585594787|FG001|Triplet C|Participant choice|0|||
162149530|NCT03388632|585594788|FG002|Triplet C|Participant choice|0|||
162149531|NCT03388632|585594789|FG003|Triplet C|Participant choice|0|||
162149532|NCT03388632|585594790|FG004|Triplet C|Participant choice|0|||
162149533|NCT03388632|585594791|FG005|Triplet C|Participant choice|1|||
162149534|NCT03388632|585594792|FG006|Triplet C|Participant choice|0|||
162149535|NCT03388632|585594793|FG007|Triplet C|Participant choice|0|||
162149536|NCT03388632|585594794|FG008|Triplet C|Participant choice|0|||
162149537|NCT02115282|585594795|FG000|Overall Study|Disease progression during treatment|216|||
162149538|NCT02115282|585594796|FG001|Overall Study|Disease progression during treatment|229|||
162149539|NCT02115282|585594795|FG000|Overall Study|Adverse Event|49|||
162149540|NCT02115282|585594796|FG001|Overall Study|Adverse Event|23|||
162149541|NCT02115282|585594795|FG000|Overall Study|Death|1|||
162149542|NCT02115282|585594796|FG001|Overall Study|Death|3|||
162149543|NCT02115282|585594795|FG000|Overall Study|Alternative therapy|1|||
162149544|NCT02115282|585594796|FG001|Overall Study|Alternative therapy|1|||
162149545|NCT02115282|585594795|FG000|Overall Study|Complicating disease|0|||
162149546|NCT02115282|585594796|FG001|Overall Study|Complicating disease|3|||
162149547|NCT02115282|585594795|FG000|Overall Study|Withdrawal by Subject|12|||
162149548|NCT02115282|585594796|FG001|Overall Study|Withdrawal by Subject|10|||
162149549|NCT02115282|585594795|FG000|Overall Study|Symptomatic progression/deterioration|7|||
162149550|NCT02115282|585594796|FG001|Overall Study|Symptomatic progression/deterioration|18|||
162149551|NCT02115282|585594795|FG000|Overall Study|Non-compliance|5|||
162149552|NCT02115282|585594796|FG001|Overall Study|Non-compliance|1|||
162149553|NCT02115282|585594795|FG000|Overall Study|Protocol Violation|2|||
162149554|NCT02115282|585594796|FG001|Overall Study|Protocol Violation|2|||
162149555|NCT02115282|585594795|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
162149556|NCT02115282|585594796|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
162149557|NCT02115282|585594795|FG000|Overall Study|Not start protocol therapy|9|||
162149558|NCT02115282|585594796|FG001|Overall Study|Not start protocol therapy|10|||
162149559|NCT06218251|585594799|FG000|Overall Study|Lost to Follow-up|4|||
162149560|NCT00997386|585594802|FG000|Overall Study|Death|7|||
162149561|NCT03492177|585594803|FG000|Overall Study|Adverse Event|1|||
162149562|NCT03492177|585594804|FG001|Overall Study|Adverse Event|0|||
162149563|NCT03492177|585594805|FG002|Overall Study|Adverse Event|0|||
162149564|NCT03492177|585594803|FG000|Overall Study|Death|3|||
162149565|NCT03492177|585594804|FG001|Overall Study|Death|0|||
162149566|NCT03492177|585594805|FG002|Overall Study|Death|3|||
162149567|NCT03492177|585594803|FG000|Overall Study|Lack of Efficacy|1|||
162149568|NCT03492177|585594804|FG001|Overall Study|Lack of Efficacy|2|||
162149569|NCT03492177|585594805|FG002|Overall Study|Lack of Efficacy|0|||
162149570|NCT03492177|585594803|FG000|Overall Study|Other|1|||
162149571|NCT03492177|585594804|FG001|Overall Study|Other|0|||
162149572|NCT03492177|585594805|FG002|Overall Study|Other|0|||
162149573|NCT03492177|585594803|FG000|Overall Study|Ongoing|16|||
162149574|NCT03492177|585594804|FG001|Overall Study|Ongoing|19|||
162149575|NCT03492177|585594805|FG002|Overall Study|Ongoing|17|||
162149576|NCT01713946|585594806|FG000|Overall Study|Death|0|||
162149577|NCT01713946|585594807|FG001|Overall Study|Death|2|||
162149578|NCT01713946|585594808|FG002|Overall Study|Death|2|||
162149579|NCT01713946|585594806|FG000|Overall Study|Adverse Event|19|||
162149580|NCT01713946|585594807|FG001|Overall Study|Adverse Event|14|||
162149581|NCT01713946|585594808|FG002|Overall Study|Adverse Event|13|||
162149582|NCT01713946|585594806|FG000|Overall Study|Withdrawal by Subject|12|||
162149583|NCT01713946|585594807|FG001|Overall Study|Withdrawal by Subject|12|||
162149584|NCT01713946|585594808|FG002|Overall Study|Withdrawal by Subject|8|||
162149585|NCT01713946|585594806|FG000|Overall Study|Lack of Efficacy|8|||
162149586|NCT01713946|585594807|FG001|Overall Study|Lack of Efficacy|8|||
162149587|NCT01713946|585594808|FG002|Overall Study|Lack of Efficacy|14|||
162149588|NCT01713946|585594806|FG000|Overall Study|Protocol Violation|2|||
162149589|NCT01713946|585594807|FG001|Overall Study|Protocol Violation|4|||
162149590|NCT01713946|585594808|FG002|Overall Study|Protocol Violation|1|||
162149591|NCT01713946|585594806|FG000|Overall Study|Lost to Follow-up|0|||
162149592|NCT01713946|585594807|FG001|Overall Study|Lost to Follow-up|0|||
162149593|NCT01713946|585594808|FG002|Overall Study|Lost to Follow-up|1|||
162149594|NCT01713946|585594806|FG000|Overall Study|Administrative problems|1|||
162149595|NCT01713946|585594807|FG001|Overall Study|Administrative problems|0|||
162149596|NCT01713946|585594808|FG002|Overall Study|Administrative problems|0|||
162149597|NCT01713946|585594806|FG000|Overall Study|Did not continue in Ext|0|||
162149598|NCT01713946|585594807|FG001|Overall Study|Did not continue in Ext|3|||
162149599|NCT01713946|585594808|FG002|Overall Study|Did not continue in Ext|0|||
162149600|NCT01713946|585594806|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
162149601|NCT01713946|585594807|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
162149602|NCT01713946|585594808|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
162149603|NCT01713946|585594806|FG000|Overall Study|Patients never switched to everolimus|0|||
162149604|NCT01713946|585594807|FG001|Overall Study|Patients never switched to everolimus|0|||
162149605|NCT01713946|585594808|FG002|Overall Study|Patients never switched to everolimus|5|||
162149606|NCT05644444|585596128|FG000|Tolerance Phase|Adverse Event|0|||
162149607|NCT05644444|585596129|FG001|Tolerance Phase|Adverse Event|2|||
162149608|NCT05644444|585596128|FG000|Treatment Phase|Adverse Event|0|||
162149609|NCT05644444|585596129|FG001|Treatment Phase|Adverse Event|2|||
162149610|NCT03723616|585596131|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
162149611|NCT03723616|585596132|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
162149612|NCT03723616|585596133|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
162149613|NCT03723616|585596134|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
162149614|NCT03723616|585596135|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
162149615|NCT03723616|585596136|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
162149616|NCT00493649|585596139|FG000|Overall Study|Adverse Event|44|||
162149617|NCT00493649|585596139|FG000|Overall Study|Patient Request|21|||
162149618|NCT00493649|585596139|FG000|Overall Study|Investigator Request|2|||
162149619|NCT00493649|585596139|FG000|Overall Study|Disease Progression|1|||
162149620|NCT00493649|585596139|FG000|Overall Study|Lost to Follow-up|1|||
162149621|NCT00493649|585596139|FG000|Overall Study|Other|13|||
162149622|NCT00925899|585596142|FG000|Part 1|Death|1|||
162149623|NCT00925899|585596143|FG001|Part 1|Death|2|||
162149624|NCT00925899|585596142|FG000|Part 1|Withdrawal by Subject|10|||
162149625|NCT00925899|585596143|FG001|Part 1|Withdrawal by Subject|9|||
162149626|NCT00683696|585596144|FG000|Overall Study|Withdrawn due to study closure|337|||
162149627|NCT00683696|585596145|FG001|Overall Study|Withdrawn due to study closure|338|||
162149628|NCT00683696|585596144|FG000|Overall Study|Withdrawn prior to study closure|13|||
162149629|NCT00683696|585596145|FG001|Overall Study|Withdrawn prior to study closure|28|||
162149630|NCT00683696|585596144|FG000|Overall Study|Lost to Follow-up|5|||
162149631|NCT00683696|585596145|FG001|Overall Study|Lost to Follow-up|6|||
161914112|NCT03533751|584733715|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
161914113|NCT03533751|584733711|FG000|Overall Study|Other|0|||
161914114|NCT03533751|584733712|FG001|Overall Study|Other|2|||
161914115|NCT03533751|584733713|FG002|Overall Study|Other|1|||
161914116|NCT03533751|584733714|FG003|Overall Study|Other|0|||
161914117|NCT03533751|584733715|FG004|Overall Study|Other|3|||
162149632|NCT00683696|585596144|FG000|Overall Study|Vital status follow-up only|3|||
162149633|NCT00683696|585596145|FG001|Overall Study|Vital status follow-up only|3|||
162149634|NCT00683696|585596144|FG000|Overall Study|Death|46|||
162149635|NCT00683696|585596145|FG001|Overall Study|Death|30|||
162149636|NCT03648762|585596148|FG000|Overall Study|Lost to Follow-up|1|||
162149637|NCT03648762|585596149|FG001|Overall Study|Lost to Follow-up|2|||
162149638|NCT03648762|585596150|FG002|Overall Study|Lost to Follow-up|0|||
162149639|NCT03648762|585596148|FG000|Overall Study|Withdrawal by Subject|5|||
162149640|NCT03648762|585596149|FG001|Overall Study|Withdrawal by Subject|2|||
162149641|NCT03648762|585596150|FG002|Overall Study|Withdrawal by Subject|1|||
162149642|NCT01662336|585596160|FG000|Overall Study|Adverse Event|1|||
162149643|NCT01662336|585596160|FG000|Overall Study|No longer on LPV/r|30|||
162149644|NCT01662336|585596160|FG000|Overall Study|Other|29|||
162149645|NCT01662336|585596160|FG000|Overall Study|Withdrawal by Subject|6|||
162149646|NCT02189252|585596161|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
162149647|NCT02189252|585596162|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
162149648|NCT02189252|585596163|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
162149649|NCT02189252|585596164|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
162149650|NCT02189252|585596161|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
162149651|NCT02189252|585596162|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
162149652|NCT02189252|585596163|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
162149653|NCT02189252|585596164|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
162149654|NCT03454529|585596167|FG000|Overall Study|Did not receive treatment|6|||
162149655|NCT03454529|585596167|FG000|Overall Study|Received < 80% doses|1|||
162149656|NCT01040689|585596169|FG000|Overall Study|Adverse Event|0|||
162149657|NCT01040689|585596170|FG001|Overall Study|Adverse Event|0|||
162149658|NCT01040689|585596171|FG002|Overall Study|Adverse Event|2|||
162149659|NCT01040689|585596172|FG003|Overall Study|Adverse Event|4|||
162149660|NCT01040689|585596169|FG000|Overall Study|Lack of Efficacy|0|||
162149661|NCT01040689|585596170|FG001|Overall Study|Lack of Efficacy|0|||
162149662|NCT01040689|585596171|FG002|Overall Study|Lack of Efficacy|1|||
162149663|NCT01040689|585596172|FG003|Overall Study|Lack of Efficacy|0|||
162149664|NCT01040689|585596169|FG000|Overall Study|Lost to Follow-up|1|||
162149665|NCT01040689|585596170|FG001|Overall Study|Lost to Follow-up|0|||
162149666|NCT01040689|585596171|FG002|Overall Study|Lost to Follow-up|0|||
162149667|NCT01040689|585596172|FG003|Overall Study|Lost to Follow-up|0|||
162149668|NCT01040689|585596169|FG000|Overall Study|Withdrawal by Subject|2|||
162149669|NCT01040689|585596170|FG001|Overall Study|Withdrawal by Subject|1|||
162149670|NCT01040689|585596171|FG002|Overall Study|Withdrawal by Subject|1|||
162149671|NCT01040689|585596172|FG003|Overall Study|Withdrawal by Subject|0|||
162149672|NCT01040689|585596169|FG000|Overall Study|Other reasons not listed above|0|||
162149673|NCT01040689|585596170|FG001|Overall Study|Other reasons not listed above|1|||
162149674|NCT01040689|585596171|FG002|Overall Study|Other reasons not listed above|0|||
162149675|NCT01040689|585596172|FG003|Overall Study|Other reasons not listed above|0|||
162149676|NCT05764161|585596175|FG000|12-week DBVC Period|Lack of Efficacy|2|||
162149677|NCT05764161|585596176|FG001|12-week DBVC Period|Lack of Efficacy|1|||
162149678|NCT05764161|585596175|FG000|12-week DBVC Period|Lost to Follow-up|0|||
162149679|NCT05764161|585596176|FG001|12-week DBVC Period|Lost to Follow-up|2|||
162149680|NCT05764161|585596175|FG000|12-week DBVC Period|Protocol Violation|2|||
162149681|NCT05764161|585596176|FG001|12-week DBVC Period|Protocol Violation|4|||
162149682|NCT05764161|585596175|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
162149683|NCT05764161|585596176|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
162149684|NCT05764161|585596175|FG000|40-week OLE Period|Lack of Efficacy|0|||
162149685|NCT05764161|585596176|FG001|40-week OLE Period|Lack of Efficacy|1|||
161914118|NCT01648764|584735507|FG000|Overall Study|Progressive Disease|0|||
161914119|NCT01648764|584735508|FG001|Overall Study|Progressive Disease|1|||
161914120|NCT01648764|584735509|FG002|Overall Study|Progressive Disease|0|||
162149686|NCT05764161|585596175|FG000|40-week OLE Period|Lost to Follow-up|1|||
162149687|NCT05764161|585596176|FG001|40-week OLE Period|Lost to Follow-up|4|||
162149688|NCT05764161|585596175|FG000|40-week OLE Period|Withdrawal by Subject|2|||
162149689|NCT05764161|585596176|FG001|40-week OLE Period|Withdrawal by Subject|7|||
162149690|NCT05764161|585596175|FG000|40-week OLE Period|Extended Travel|0|||
162149691|NCT05764161|585596176|FG001|40-week OLE Period|Extended Travel|1|||
162149692|NCT05764161|585596175|FG000|40-week OLE Period|Ongoing|66|||
162149693|NCT05764161|585596176|FG001|40-week OLE Period|Ongoing|59|||
162149694|NCT00507689|585596177|FG000|Pre-Randomization Period|Adverse Event|1|||
162149695|NCT00507689|585596178|FG001|Pre-Randomization Period|Adverse Event|0|||
162149696|NCT00507689|585596177|FG000|Pre-Randomization Period|Physician Decision|1|||
162149697|NCT00507689|585596178|FG001|Pre-Randomization Period|Physician Decision|0|||
162149698|NCT00507689|585596177|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
162149699|NCT00507689|585596178|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
161914121|NCT01648764|584735510|FG003|Overall Study|Progressive Disease|0|||
161914122|NCT01648764|584735511|FG004|Overall Study|Progressive Disease|0|||
161914123|NCT01648764|584735512|FG005|Overall Study|Progressive Disease|1|||
161914124|NCT01648764|584735513|FG006|Overall Study|Progressive Disease|1|||
161914125|NCT01648764|584735514|FG007|Overall Study|Progressive Disease|0|||
161914126|NCT01648764|584735515|FG008|Overall Study|Progressive Disease|0|||
161914127|NCT01648764|584735516|FG009|Overall Study|Progressive Disease|2|||
161914128|NCT01648764|584735517|FG010|Overall Study|Progressive Disease|0|||
161914129|NCT01648764|584735518|FG011|Overall Study|Progressive Disease|1|||
161914130|NCT01648764|584735519|FG012|Overall Study|Progressive Disease|2|||
161914131|NCT01648764|584735520|FG013|Overall Study|Progressive Disease|1|||
161914132|NCT01648764|584735507|FG000|Overall Study|Adverse Event|0|||
161914133|NCT01648764|584735508|FG001|Overall Study|Adverse Event|0|||
161914134|NCT01648764|584735509|FG002|Overall Study|Adverse Event|0|||
161914135|NCT01648764|584735510|FG003|Overall Study|Adverse Event|0|||
161914136|NCT01648764|584735511|FG004|Overall Study|Adverse Event|0|||
161914137|NCT01648764|584735512|FG005|Overall Study|Adverse Event|1|||
161914138|NCT01648764|584735513|FG006|Overall Study|Adverse Event|0|||
161914139|NCT01648764|584735514|FG007|Overall Study|Adverse Event|0|||
161914140|NCT01648764|584735515|FG008|Overall Study|Adverse Event|0|||
161914141|NCT01648764|584735516|FG009|Overall Study|Adverse Event|1|||
161914142|NCT01648764|584735517|FG010|Overall Study|Adverse Event|0|||
161914143|NCT01648764|584735518|FG011|Overall Study|Adverse Event|3|||
161914144|NCT01648764|584735519|FG012|Overall Study|Adverse Event|1|||
161914145|NCT01648764|584735520|FG013|Overall Study|Adverse Event|1|||
161914146|NCT01648764|584735507|FG000|Overall Study|Death|0|||
161914147|NCT01648764|584735508|FG001|Overall Study|Death|0|||
161914148|NCT01648764|584735509|FG002|Overall Study|Death|0|||
161914149|NCT01648764|584735510|FG003|Overall Study|Death|0|||
161914150|NCT01648764|584735511|FG004|Overall Study|Death|0|||
161914151|NCT01648764|584735512|FG005|Overall Study|Death|0|||
161914152|NCT01648764|584735513|FG006|Overall Study|Death|1|||
161914153|NCT01648764|584735514|FG007|Overall Study|Death|0|||
161914154|NCT01648764|584735515|FG008|Overall Study|Death|0|||
162149700|NCT00507689|585596177|FG000|Randomized Period|Adverse Event|1|||
162149701|NCT00507689|585596178|FG001|Randomized Period|Adverse Event|1|||
162149702|NCT00507689|585596177|FG000|Randomized Period|Withdrawal by Subject|0|||
162149703|NCT00507689|585596178|FG001|Randomized Period|Withdrawal by Subject|1|||
162149704|NCT01241292|585596179|FG000|Overall Study|Administrative Reason by Sponsor|1|||
162149705|NCT01241292|585596180|FG001|Overall Study|Administrative Reason by Sponsor|0|||
162149706|NCT01241292|585596179|FG000|Overall Study|Disease Progression|2|||
162149707|NCT01241292|585596180|FG001|Overall Study|Disease Progression|0|||
161914155|NCT01648764|584735516|FG009|Overall Study|Death|0|||
162012331|NCT02504151|585101746|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
162149708|NCT01241292|585596179|FG000|Overall Study|Study Drug Toxicity|0|||
162149709|NCT01241292|585596180|FG001|Overall Study|Study Drug Toxicity|1|||
162149710|NCT01241292|585596179|FG000|Overall Study|Participant Discontinued Treatment|0|||
162149711|NCT01241292|585596180|FG001|Overall Study|Participant Discontinued Treatment|2|||
162149712|NCT03194958|585596181|FG000|Overall Study|Death|0|||
162149713|NCT03194958|585596182|FG001|Overall Study|Death|1|||
162149714|NCT03194958|585596183|FG002|Overall Study|Death|1|||
162149715|NCT03194958|585596184|FG003|Overall Study|Death|1|||
162149716|NCT03194958|585596181|FG000|Overall Study|Withdrawal by Subject|24|||
162149717|NCT03194958|585596182|FG001|Overall Study|Withdrawal by Subject|27|||
161914156|NCT01648764|584735517|FG010|Overall Study|Death|0|||
161914157|NCT01648764|584735518|FG011|Overall Study|Death|0|||
161914158|NCT01648764|584735519|FG012|Overall Study|Death|0|||
161914159|NCT01648764|584735520|FG013|Overall Study|Death|1|||
161914160|NCT01648764|584735507|FG000|Overall Study|Withdrawal by Subject|0|||
161914161|NCT01648764|584735508|FG001|Overall Study|Withdrawal by Subject|0|||
162149718|NCT03194958|585596183|FG002|Overall Study|Withdrawal by Subject|7|||
162149719|NCT03194958|585596184|FG003|Overall Study|Withdrawal by Subject|22|||
161914162|NCT01648764|584735509|FG002|Overall Study|Withdrawal by Subject|0|||
161914163|NCT01648764|584735510|FG003|Overall Study|Withdrawal by Subject|0|||
161914164|NCT01648764|584735511|FG004|Overall Study|Withdrawal by Subject|0|||
162149720|NCT03194958|585596181|FG000|Overall Study|Lost to Follow-up|168|||
162149721|NCT03194958|585596182|FG001|Overall Study|Lost to Follow-up|196|||
162149722|NCT03194958|585596183|FG002|Overall Study|Lost to Follow-up|174|||
162149723|NCT03194958|585596184|FG003|Overall Study|Lost to Follow-up|186|||
162149724|NCT00356265|585596185|FG000|Overall Study|Withdrawal by Subject|0|||
162149725|NCT00356265|585596186|FG001|Overall Study|Withdrawal by Subject|0|||
162149726|NCT00356265|585596187|FG002|Overall Study|Withdrawal by Subject|1|||
162149727|NCT00588770|585596190|FG000|Overall Study|Disease progression|85|||
162149728|NCT00588770|585596191|FG001|Overall Study|Disease progression|68|||
162149729|NCT00588770|585596190|FG000|Overall Study|Adverse Event|29|||
162149730|NCT00588770|585596191|FG001|Overall Study|Adverse Event|58|||
162149731|NCT00588770|585596190|FG000|Overall Study|Death|13|||
162149732|NCT00588770|585596191|FG001|Overall Study|Death|22|||
162149733|NCT00588770|585596190|FG000|Overall Study|Withdrawal by Subject|15|||
162149734|NCT00588770|585596191|FG001|Overall Study|Withdrawal by Subject|25|||
162149735|NCT00588770|585596190|FG000|Overall Study|Alternative therapy|2|||
162149736|NCT00588770|585596191|FG001|Overall Study|Alternative therapy|4|||
162149737|NCT00588770|585596190|FG000|Overall Study|Other complicating disease|3|||
162149738|NCT00588770|585596191|FG001|Overall Study|Other complicating disease|2|||
162149739|NCT00588770|585596190|FG000|Overall Study|Not start protocol therapy|0|||
162149740|NCT00588770|585596191|FG001|Overall Study|Not start protocol therapy|9|||
162149741|NCT00588770|585596190|FG000|Overall Study|Lack of Efficacy|8|||
162149742|NCT00588770|585596191|FG001|Overall Study|Lack of Efficacy|10|||
162149743|NCT00588770|585596190|FG000|Overall Study|Physician discretion|2|||
162149744|NCT00588770|585596191|FG001|Overall Study|Physician discretion|0|||
162149745|NCT00588770|585596190|FG000|Overall Study|Patient non-compliance|2|||
162149746|NCT00588770|585596191|FG001|Overall Study|Patient non-compliance|2|||
162149747|NCT04177394|585596192|FG000|Overall Study|Death|16|||
162149748|NCT04177394|585596192|FG000|Overall Study|Withdrawal by Subject|19|||
162149749|NCT04177394|585596192|FG000|Overall Study|Missed visits|61|||
162149750|NCT04177394|585596192|FG000|Overall Study|Expected Visits|15|||
162149751|NCT00256243|585596193|FG000|Overall Study|Lost to Follow-up|2|||
162149752|NCT00256243|585596193|FG000|Overall Study|Death|7|||
162149753|NCT00256243|585596193|FG000|Overall Study|Not treated|1|||
162149754|NCT06129045|585596194|FG000|Overall Study|Lost to Follow-up|1|||
162149755|NCT06129045|585596195|FG001|Overall Study|Lost to Follow-up|1|||
162149756|NCT06129045|585596196|FG002|Overall Study|Lost to Follow-up|4|||
162149757|NCT02031471|585596197|FG000|24 Week Treatment Period|Adverse Event|6|||
162149758|NCT02031471|585596197|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
162149759|NCT02031471|585596197|FG000|24 Week Treatment Period|Protocol Violation|1|||
162149760|NCT02031471|585596197|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
162149761|NCT02031471|585596197|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
162149762|NCT02031471|585596197|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
162149763|NCT02031471|585596197|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
162149764|NCT05797155|585596204|FG000|Overall Study|Lost to Follow-up|33|||
162149765|NCT05797155|585596205|FG001|Overall Study|Lost to Follow-up|12|||
162149766|NCT00617201|585596211|FG000|Overall Study|Lost to Follow-up|9|||
162149767|NCT00617201|585596212|FG001|Overall Study|Lost to Follow-up|13|||
162149768|NCT01350804|585596213|FG000|Core Study|Withdrawal by Subject|11|||
162149769|NCT01350804|585596214|FG001|Core Study|Withdrawal by Subject|17|||
162149770|NCT01350804|585596215|FG002|Core Study|Withdrawal by Subject|16|||
162149771|NCT01350804|585596216|FG003|Core Study|Withdrawal by Subject|7|||
162149772|NCT01350804|585596213|FG000|Core Study|Study terminated by Sponsor|0|||
162149773|NCT01350804|585596214|FG001|Core Study|Study terminated by Sponsor|0|||
162149774|NCT01350804|585596215|FG002|Core Study|Study terminated by Sponsor|0|||
162149775|NCT01350804|585596216|FG003|Core Study|Study terminated by Sponsor|2|||
162149776|NCT01350804|585596213|FG000|Core Study|Protocol deviation|1|||
162149777|NCT01350804|585596214|FG001|Core Study|Protocol deviation|0|||
162149778|NCT01350804|585596215|FG002|Core Study|Protocol deviation|1|||
162149779|NCT01350804|585596216|FG003|Core Study|Protocol deviation|0|||
162149780|NCT01350804|585596213|FG000|Core Study|Physician Decision|1|||
162149781|NCT01350804|585596214|FG001|Core Study|Physician Decision|0|||
162149782|NCT01350804|585596215|FG002|Core Study|Physician Decision|1|||
162149783|NCT01350804|585596216|FG003|Core Study|Physician Decision|3|||
162149784|NCT01350804|585596213|FG000|Core Study|Lost to Follow-up|3|||
162149785|NCT01350804|585596214|FG001|Core Study|Lost to Follow-up|0|||
162149786|NCT01350804|585596215|FG002|Core Study|Lost to Follow-up|2|||
162149787|NCT01350804|585596216|FG003|Core Study|Lost to Follow-up|1|||
162149788|NCT01350804|585596213|FG000|Core Study|Lack of Efficacy|16|||
162149789|NCT01350804|585596214|FG001|Core Study|Lack of Efficacy|19|||
162149790|NCT01350804|585596215|FG002|Core Study|Lack of Efficacy|18|||
162149791|NCT01350804|585596216|FG003|Core Study|Lack of Efficacy|5|||
162149792|NCT01350804|585596213|FG000|Core Study|Death|1|||
162149793|NCT01350804|585596214|FG001|Core Study|Death|1|||
162149794|NCT01350804|585596215|FG002|Core Study|Death|1|||
162149795|NCT01350804|585596216|FG003|Core Study|Death|0|||
162149796|NCT01350804|585596213|FG000|Core Study|Adverse Event|8|||
162149797|NCT01350804|585596214|FG001|Core Study|Adverse Event|10|||
162149798|NCT01350804|585596215|FG002|Core Study|Adverse Event|8|||
162149799|NCT01350804|585596216|FG003|Core Study|Adverse Event|8|||
162149800|NCT01350804|585596213|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
162149801|NCT01350804|585596214|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
162149802|NCT01350804|585596215|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
162149803|NCT01350804|585596216|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
162149804|NCT01350804|585596213|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
162149805|NCT01350804|585596214|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
162149806|NCT01350804|585596215|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
162149807|NCT01350804|585596216|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
162149808|NCT01350804|585596213|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
162149809|NCT01350804|585596214|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
162149810|NCT01350804|585596215|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
162149811|NCT01350804|585596216|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
162149812|NCT01350804|585596213|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
162149813|NCT01350804|585596214|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
162149814|NCT01350804|585596215|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
162149815|NCT01350804|585596216|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
162149816|NCT01350804|585596213|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
162149817|NCT01350804|585596214|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
162149818|NCT01350804|585596215|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
162149819|NCT01350804|585596216|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
162149820|NCT01350804|585596213|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
162149821|NCT01350804|585596214|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
162149822|NCT01350804|585596215|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
162149823|NCT01350804|585596216|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
162149824|NCT05850520|585596220|FG000|Overall Study|Withdrawal by Subject|8|||
162149825|NCT05850520|585596221|FG001|Overall Study|Withdrawal by Subject|8|||
162149826|NCT05850520|585596222|FG002|Overall Study|Withdrawal by Subject|16|||
161809999|NCT01796171|584347688|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161810000|NCT01796171|584347689|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161810001|NCT01796171|584347690|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
161810002|NCT01796171|584347691|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
161810003|NCT01796171|584347692|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161810004|NCT01796171|584347693|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161810005|NCT01796171|584347694|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
162149827|NCT05850520|585596220|FG000|Overall Study|Lost to Follow-up|2|||
162149828|NCT05850520|585596221|FG001|Overall Study|Lost to Follow-up|2|||
162149829|NCT05850520|585596222|FG002|Overall Study|Lost to Follow-up|2|||
162149830|NCT05850520|585596220|FG000|Overall Study|Death|2|||
162149831|NCT05850520|585596221|FG001|Overall Study|Death|2|||
162149832|NCT05850520|585596222|FG002|Overall Study|Death|3|||
162149833|NCT05850520|585596220|FG000|Overall Study|Adverse Event|2|||
162149834|NCT05850520|585596221|FG001|Overall Study|Adverse Event|0|||
162149835|NCT05850520|585596222|FG002|Overall Study|Adverse Event|1|||
162149836|NCT05850520|585596220|FG000|Overall Study|Physician Decision|0|||
162149837|NCT05850520|585596221|FG001|Overall Study|Physician Decision|1|||
162149838|NCT05850520|585596222|FG002|Overall Study|Physician Decision|0|||
162149839|NCT05850520|585596220|FG000|Overall Study|Protocol deviation|0|||
162149840|NCT05850520|585596221|FG001|Overall Study|Protocol deviation|0|||
162149841|NCT05850520|585596222|FG002|Overall Study|Protocol deviation|1|||
162149842|NCT05850520|585596220|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
162149843|NCT05850520|585596221|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
162149844|NCT05850520|585596222|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
162149845|NCT01170026|585597137|FG000|Overall Study|Lost to Follow-up|4|||
162149846|NCT01170026|585597138|FG001|Overall Study|Lost to Follow-up|2|||
162149847|NCT03889925|585597139|FG000|Overall Study|Lost to Follow-up|11|||
162149848|NCT03889925|585597140|FG001|Overall Study|Lost to Follow-up|10|||
162149849|NCT05777785|585597141|FG000|Overall Study|Withdrawal by Subject|5|||
162149850|NCT05777785|585597141|FG000|Overall Study|Lost to Follow-up|1|||
162149851|NCT00304031|585597142|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
162149852|NCT00304031|585597143|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
162149853|NCT00304031|585597144|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
162149854|NCT00304031|585597142|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
162149855|NCT00304031|585597143|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
162149856|NCT00304031|585597144|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
162149857|NCT00304031|585597142|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
162149858|NCT00304031|585597143|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
162149859|NCT00304031|585597144|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
162149860|NCT00304031|585597142|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
162149861|NCT00304031|585597143|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
162149862|NCT00304031|585597144|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
162149863|NCT00304031|585597142|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
162149864|NCT00304031|585597143|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
162149865|NCT00304031|585597144|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
162149866|NCT00304031|585597142|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
162149867|NCT00304031|585597143|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
162149868|NCT00304031|585597144|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
162149869|NCT00304031|585597142|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
162149870|NCT00304031|585597143|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
162149871|NCT00304031|585597144|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
162149872|NCT00304031|585597142|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
162149873|NCT00304031|585597143|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
162149874|NCT00304031|585597144|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
162149875|NCT00304031|585597142|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
162149876|NCT00304031|585597143|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
161810006|NCT01796171|584347680|FG000|Follow-up Period|Start of further anticancer therapy|4|||
161810007|NCT01796171|584347681|FG001|Follow-up Period|Start of further anticancer therapy|25|||
161810008|NCT01796171|584347682|FG002|Follow-up Period|Start of further anticancer therapy|2|||
161810009|NCT01796171|584347683|FG003|Follow-up Period|Start of further anticancer therapy|1|||
162149877|NCT00304031|585597144|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
162149878|NCT01188655|585597145|FG000|Overall Study|Lack of Efficacy|1|||
162149879|NCT01188655|585597145|FG000|Overall Study|Lost to Follow-up|1|||
162149880|NCT01188655|585597145|FG000|Overall Study|Other|11|||
162149881|NCT00089544|585597146|FG000|Overall Study|Ineligible|1|||
162149882|NCT00089544|585597147|FG001|Overall Study|Ineligible|0|||
162149883|NCT02396316|585597148|FG000|Overall Study|Physician Decision|1|||
162149884|NCT02396316|585597149|FG001|Overall Study|Physician Decision|0|||
162149885|NCT02396316|585597148|FG000|Overall Study|Progressive disease|6|||
162149886|NCT02396316|585597149|FG001|Overall Study|Progressive disease|3|||
162149887|NCT02396316|585597148|FG000|Overall Study|Protocol Violation|0|||
162149888|NCT02396316|585597149|FG001|Overall Study|Protocol Violation|1|||
162149889|NCT02396316|585597148|FG000|Overall Study|Treatment unblinded|0|||
162149890|NCT02396316|585597149|FG001|Overall Study|Treatment unblinded|1|||
162149891|NCT01823536|585597150|FG000|Overall Study|Lost to Follow-up|1|||
162149892|NCT01823536|585597151|FG001|Overall Study|Lost to Follow-up|0|||
162149893|NCT01823536|585597152|FG002|Overall Study|Lost to Follow-up|0|||
162149894|NCT01823536|585597153|FG003|Overall Study|Lost to Follow-up|1|||
162149895|NCT01823536|585597154|FG004|Overall Study|Lost to Follow-up|1|||
162149896|NCT01823536|585597155|FG005|Overall Study|Lost to Follow-up|0|||
162149897|NCT01823536|585597150|FG000|Overall Study|Protocol Violation|0|||
162149898|NCT01823536|585597151|FG001|Overall Study|Protocol Violation|1|||
162149899|NCT01823536|585597152|FG002|Overall Study|Protocol Violation|0|||
162149900|NCT01823536|585597153|FG003|Overall Study|Protocol Violation|0|||
162149901|NCT01823536|585597154|FG004|Overall Study|Protocol Violation|0|||
162149902|NCT01823536|585597155|FG005|Overall Study|Protocol Violation|0|||
162149903|NCT01823536|585597150|FG000|Overall Study|Withdrawal by Subject|1|||
162149904|NCT01823536|585597151|FG001|Overall Study|Withdrawal by Subject|1|||
162149905|NCT01823536|585597152|FG002|Overall Study|Withdrawal by Subject|0|||
162149906|NCT01823536|585597153|FG003|Overall Study|Withdrawal by Subject|0|||
162149907|NCT01823536|585597154|FG004|Overall Study|Withdrawal by Subject|0|||
162149908|NCT01823536|585597155|FG005|Overall Study|Withdrawal by Subject|0|||
162149909|NCT01823536|585597150|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
162149910|NCT01823536|585597151|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
162149911|NCT01823536|585597152|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
162149912|NCT01823536|585597153|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
162149913|NCT01823536|585597154|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
162149914|NCT01823536|585597155|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
162149915|NCT01823536|585597150|FG000|Overall Study|Met exclusion criterion No 6|0|||
162149916|NCT01823536|585597151|FG001|Overall Study|Met exclusion criterion No 6|0|||
162149917|NCT01823536|585597152|FG002|Overall Study|Met exclusion criterion No 6|0|||
162149918|NCT01823536|585597153|FG003|Overall Study|Met exclusion criterion No 6|1|||
162149919|NCT01823536|585597154|FG004|Overall Study|Met exclusion criterion No 6|0|||
162149920|NCT01823536|585597155|FG005|Overall Study|Met exclusion criterion No 6|0|||
162149921|NCT01823536|585597150|FG000|Overall Study|Subject moved out of the state|0|||
162149922|NCT01823536|585597151|FG001|Overall Study|Subject moved out of the state|0|||
162149923|NCT01823536|585597152|FG002|Overall Study|Subject moved out of the state|0|||
162149924|NCT01823536|585597153|FG003|Overall Study|Subject moved out of the state|0|||
162149925|NCT01823536|585597154|FG004|Overall Study|Subject moved out of the state|1|||
162149926|NCT01823536|585597155|FG005|Overall Study|Subject moved out of the state|0|||
162149927|NCT00566735|585597159|FG000|Overall Study|Withdrawal by Subject|0|||
162149928|NCT00566735|585597160|FG001|Overall Study|Withdrawal by Subject|1|||
162149929|NCT00566735|585597159|FG000|Overall Study|Refused neuropsychological testing|2|||
162149930|NCT00566735|585597160|FG001|Overall Study|Refused neuropsychological testing|5|||
162149931|NCT00566735|585597159|FG000|Overall Study|Switched into a manic episode|0|||
162149932|NCT00566735|585597160|FG001|Overall Study|Switched into a manic episode|1|||
162149933|NCT04603924|585597161|FG000|Overall Study|Not Dosed|2|||
162149934|NCT04603924|585597162|FG001|Overall Study|Not Dosed|1|||
162149935|NCT04603924|585597161|FG000|Overall Study|Withdrawal by Subject|6|||
162149936|NCT04603924|585597162|FG001|Overall Study|Withdrawal by Subject|6|||
162149937|NCT04603924|585597161|FG000|Overall Study|Adverse Event|2|||
162149938|NCT04603924|585597162|FG001|Overall Study|Adverse Event|2|||
162149939|NCT03762668|585597165|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
162149940|NCT03762668|585597166|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
162149941|NCT00768664|585597170|FG000|Overall Study|Death|57|||
162149942|NCT00768664|585597170|FG000|Overall Study|Lost to Follow-up|2|||
162149943|NCT00768664|585597170|FG000|Overall Study|Other|9|||
162149944|NCT00768664|585597170|FG000|Overall Study|Participant refused|1|||
162149945|NCT02544152|585597171|FG000|Overall Study|Adverse Event|0|||
162149946|NCT02544152|585597172|FG001|Overall Study|Adverse Event|4|||
162149947|NCT02544152|585597171|FG000|Overall Study|Withdrawal by Subject|0|||
162149948|NCT02544152|585597172|FG001|Overall Study|Withdrawal by Subject|3|||
162149949|NCT02544152|585597171|FG000|Overall Study|Other|1|||
162149950|NCT02544152|585597172|FG001|Overall Study|Other|0|||
162149951|NCT00686855|585597173|FG000|Overall Study|Lost to Follow-up|1|||
162149952|NCT00686855|585597174|FG001|Overall Study|Lost to Follow-up|0|||
162149953|NCT00686855|585597173|FG000|Overall Study|Progressive GVHD|0|||
162149954|NCT00686855|585597174|FG001|Overall Study|Progressive GVHD|1|||
162149955|NCT02731755|585597177|FG000|First Intervention|Withdrawal by Subject|0|||
162149956|NCT02731755|585597178|FG001|First Intervention|Withdrawal by Subject|2|||
162149957|NCT02320123|585597179|FG000|Overall Study|Lost to Follow-up|4|||
162149958|NCT02320123|585597180|FG001|Overall Study|Lost to Follow-up|6|||
162149959|NCT02320123|585597179|FG000|Overall Study|Death|6|||
162149960|NCT02320123|585597180|FG001|Overall Study|Death|5|||
162149961|NCT04480827|585597181|FG000|Overall Study|Adverse Event|0|||
162149962|NCT04480827|585597182|FG001|Overall Study|Adverse Event|0|||
162149963|NCT04480827|585597183|FG002|Overall Study|Adverse Event|0|||
162149964|NCT04480827|585597184|FG003|Overall Study|Adverse Event|0|||
162149965|NCT04480827|585597185|FG004|Overall Study|Adverse Event|0|||
162149966|NCT04480827|585597186|FG005|Overall Study|Adverse Event|1|||
162149967|NCT04480827|585597187|FG006|Overall Study|Adverse Event|0|||
162149968|NCT00465816|585597188|FG000|Overall Study|Lost to Follow-up|0|||
162149969|NCT00465816|585597189|FG001|Overall Study|Lost to Follow-up|0|||
162149970|NCT00465816|585597190|FG002|Overall Study|Lost to Follow-up|2|||
162149971|NCT02139046|585597191|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
162149972|NCT02139046|585597192|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
162149973|NCT02139046|585597193|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
162149974|NCT02139046|585597194|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
162149975|NCT02139046|585597195|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
162149976|NCT02139046|585597191|FG000|Overall Study|Major Protocol Deviation|9|||
162149977|NCT02139046|585597192|FG001|Overall Study|Major Protocol Deviation|10|||
162149978|NCT02139046|585597193|FG002|Overall Study|Major Protocol Deviation|16|||
162149979|NCT02139046|585597194|FG003|Overall Study|Major Protocol Deviation|12|||
162149980|NCT02139046|585597195|FG004|Overall Study|Major Protocol Deviation|6|||
162149981|NCT02139046|585597191|FG000|Overall Study|Lost to Follow-up|13|||
161810010|NCT01796171|584347684|FG004|Follow-up Period|Start of further anticancer therapy|2|||
161810011|NCT01796171|584347685|FG005|Follow-up Period|Start of further anticancer therapy|2|||
161810012|NCT01796171|584347686|FG006|Follow-up Period|Start of further anticancer therapy|1|||
162149982|NCT02139046|585597192|FG001|Overall Study|Lost to Follow-up|16|||
162149983|NCT02139046|585597193|FG002|Overall Study|Lost to Follow-up|16|||
162149984|NCT02139046|585597194|FG003|Overall Study|Lost to Follow-up|18|||
162149985|NCT02139046|585597195|FG004|Overall Study|Lost to Follow-up|13|||
162149986|NCT02139046|585597191|FG000|Overall Study|Voluntary Withdrawal|20|||
162149987|NCT02139046|585597192|FG001|Overall Study|Voluntary Withdrawal|8|||
162149988|NCT02139046|585597193|FG002|Overall Study|Voluntary Withdrawal|10|||
162149989|NCT02139046|585597194|FG003|Overall Study|Voluntary Withdrawal|15|||
161914165|NCT01648764|584735512|FG005|Overall Study|Withdrawal by Subject|0|||
161914166|NCT01648764|584735513|FG006|Overall Study|Withdrawal by Subject|2|||
162149990|NCT02139046|585597195|FG004|Overall Study|Voluntary Withdrawal|16|||
162149991|NCT02139046|585597191|FG000|Overall Study|Lack of Efficacy|0|||
162149992|NCT02139046|585597192|FG001|Overall Study|Lack of Efficacy|1|||
162149993|NCT02139046|585597193|FG002|Overall Study|Lack of Efficacy|2|||
162149994|NCT02139046|585597194|FG003|Overall Study|Lack of Efficacy|1|||
162149995|NCT02139046|585597195|FG004|Overall Study|Lack of Efficacy|2|||
162149996|NCT02139046|585597191|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
162149997|NCT02139046|585597192|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
162149998|NCT02139046|585597193|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
162149999|NCT02139046|585597194|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
162150000|NCT02139046|585597195|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
162150001|NCT02139046|585597191|FG000|Overall Study|Other Miscellaneous Reasons|10|||
162150002|NCT02139046|585597192|FG001|Overall Study|Other Miscellaneous Reasons|9|||
162150003|NCT02139046|585597193|FG002|Overall Study|Other Miscellaneous Reasons|4|||
162150004|NCT02139046|585597194|FG003|Overall Study|Other Miscellaneous Reasons|9|||
162150005|NCT02139046|585597195|FG004|Overall Study|Other Miscellaneous Reasons|12|||
162150006|NCT00818454|585597198|FG000|Treatment Period 1|Adverse Event|0|||
162150007|NCT00818454|585597199|FG001|Treatment Period 1|Adverse Event|1|||
162150008|NCT00818454|585597200|FG002|Treatment Period 1|Adverse Event|0|||
162150009|NCT00818454|585597201|FG003|Treatment Period 1|Adverse Event|0|||
162150010|NCT00818454|585597198|FG000|Treatment Period 1|Other|3|||
162150011|NCT00818454|585597199|FG001|Treatment Period 1|Other|0|||
162150012|NCT00818454|585597200|FG002|Treatment Period 1|Other|0|||
162150013|NCT00818454|585597201|FG003|Treatment Period 1|Other|0|||
162150014|NCT00818454|585597198|FG000|Washout Period of 1 Week|Adverse Event|1|||
162150015|NCT00818454|585597199|FG001|Washout Period of 1 Week|Adverse Event|1|||
162150016|NCT00818454|585597200|FG002|Washout Period of 1 Week|Adverse Event|0|||
162150017|NCT00818454|585597201|FG003|Washout Period of 1 Week|Adverse Event|0|||
162150018|NCT00818454|585597198|FG000|Washout Period of 1 Week|Protocol Violation|2|||
162150019|NCT00818454|585597199|FG001|Washout Period of 1 Week|Protocol Violation|0|||
161810013|NCT01796171|584347687|FG007|Follow-up Period|Start of further anticancer therapy|15|||
161810014|NCT01796171|584347688|FG008|Follow-up Period|Start of further anticancer therapy|2|||
161810015|NCT01796171|584347689|FG009|Follow-up Period|Start of further anticancer therapy|0|||
161810016|NCT01796171|584347690|FG010|Follow-up Period|Start of further anticancer therapy|0|||
161810017|NCT01796171|584347691|FG011|Follow-up Period|Start of further anticancer therapy|0|||
161810018|NCT01796171|584347692|FG012|Follow-up Period|Start of further anticancer therapy|0|||
161810019|NCT01796171|584347693|FG013|Follow-up Period|Start of further anticancer therapy|0|||
161810020|NCT01796171|584347694|FG014|Follow-up Period|Start of further anticancer therapy|0|||
161810021|NCT01796171|584347680|FG000|Follow-up Period|Progressive disease|0|||
161810022|NCT01796171|584347681|FG001|Follow-up Period|Progressive disease|1|||
161810023|NCT01796171|584347682|FG002|Follow-up Period|Progressive disease|0|||
161810024|NCT01796171|584347683|FG003|Follow-up Period|Progressive disease|0|||
161810025|NCT01796171|584347684|FG004|Follow-up Period|Progressive disease|0|||
161810026|NCT01796171|584347685|FG005|Follow-up Period|Progressive disease|0|||
161810027|NCT01796171|584347686|FG006|Follow-up Period|Progressive disease|0|||
161810028|NCT01796171|584347687|FG007|Follow-up Period|Progressive disease|3|||
161810029|NCT01796171|584347688|FG008|Follow-up Period|Progressive disease|0|||
161810030|NCT01796171|584347689|FG009|Follow-up Period|Progressive disease|0|||
161810031|NCT01796171|584347690|FG010|Follow-up Period|Progressive disease|0|||
161810032|NCT01796171|584347691|FG011|Follow-up Period|Progressive disease|0|||
161810033|NCT01796171|584347692|FG012|Follow-up Period|Progressive disease|0|||
161810034|NCT01796171|584347693|FG013|Follow-up Period|Progressive disease|0|||
161810035|NCT01796171|584347694|FG014|Follow-up Period|Progressive disease|0|||
161810036|NCT01796171|584347680|FG000|Follow-up Period|Physician Decision|0|||
161810037|NCT01796171|584347681|FG001|Follow-up Period|Physician Decision|2|||
161810038|NCT01796171|584347682|FG002|Follow-up Period|Physician Decision|0|||
161810039|NCT01796171|584347683|FG003|Follow-up Period|Physician Decision|0|||
161810040|NCT01796171|584347684|FG004|Follow-up Period|Physician Decision|0|||
161810041|NCT01796171|584347685|FG005|Follow-up Period|Physician Decision|0|||
161810042|NCT01796171|584347686|FG006|Follow-up Period|Physician Decision|0|||
161810043|NCT01796171|584347687|FG007|Follow-up Period|Physician Decision|0|||
161810044|NCT01796171|584347688|FG008|Follow-up Period|Physician Decision|0|||
162150020|NCT00818454|585597200|FG002|Washout Period of 1 Week|Protocol Violation|0|||
162150021|NCT00818454|585597201|FG003|Washout Period of 1 Week|Protocol Violation|0|||
162150022|NCT00818454|585597198|FG000|Washout Period of 1 Week|Other|1|||
162150023|NCT00818454|585597199|FG001|Washout Period of 1 Week|Other|2|||
162150024|NCT00818454|585597200|FG002|Washout Period of 1 Week|Other|0|||
162150025|NCT00818454|585597201|FG003|Washout Period of 1 Week|Other|0|||
162150026|NCT00818454|585597198|FG000|Treatment Period 2|Other|2|||
162150027|NCT00818454|585597199|FG001|Treatment Period 2|Other|1|||
162150028|NCT00818454|585597200|FG002|Treatment Period 2|Other|0|||
162150029|NCT00818454|585597201|FG003|Treatment Period 2|Other|0|||
162150030|NCT00818454|585597198|FG000|Treatment Period 3|Adverse Event|0|||
162150031|NCT00818454|585597199|FG001|Treatment Period 3|Adverse Event|0|||
162150032|NCT00818454|585597200|FG002|Treatment Period 3|Adverse Event|0|||
162150033|NCT00818454|585597201|FG003|Treatment Period 3|Adverse Event|1|||
162150034|NCT01765543|585597208|FG000|Overall Study|Death|1|||
162150035|NCT01765543|585597208|FG000|Overall Study|Withdrawal by Subject|2|||
162150036|NCT05876949|585597214|FG000|Overall Study|Withdrawal by Subject|1|||
162150037|NCT05876949|585597215|FG001|Overall Study|Withdrawal by Subject|3|||
162150038|NCT05876949|585597214|FG000|Overall Study|Physician Decision|0|||
162150039|NCT05876949|585597215|FG001|Overall Study|Physician Decision|2|||
162150040|NCT05876949|585597214|FG000|Overall Study|Death|0|||
162150041|NCT05876949|585597215|FG001|Overall Study|Death|1|||
162150042|NCT02755805|585597216|FG000|Overall Study|Lost to Follow-up|1|||
162150043|NCT02755805|585597217|FG001|Overall Study|Lost to Follow-up|2|||
162150044|NCT02755805|585597216|FG000|Overall Study|Refused assessments|1|||
162150045|NCT02755805|585597217|FG001|Overall Study|Refused assessments|0|||
162150046|NCT02755805|585597216|FG000|Overall Study|Withdrawal by Subject|0|||
162150047|NCT02755805|585597217|FG001|Overall Study|Withdrawal by Subject|2|||
162150048|NCT03593213|585597224|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
162150049|NCT03593213|585597225|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
162150050|NCT03593213|585597226|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
162150051|NCT03593213|585597227|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
162150052|NCT03593213|585597224|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
162150053|NCT03593213|585597225|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
162150054|NCT03593213|585597226|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
162150055|NCT03593213|585597227|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
162150056|NCT03593213|585597224|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
162150057|NCT03593213|585597225|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
162150058|NCT03593213|585597226|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
162150059|NCT03593213|585597227|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
162150060|NCT03593213|585597224|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
162150061|NCT03593213|585597225|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
162150062|NCT03593213|585597226|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
162150063|NCT03593213|585597227|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
162150064|NCT03593213|585597224|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
162150065|NCT03593213|585597225|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
162150066|NCT03593213|585597226|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
162150067|NCT03593213|585597227|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
162150068|NCT03593213|585597224|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
162150069|NCT03593213|585597225|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
162150070|NCT03593213|585597226|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
162150071|NCT03593213|585597227|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
162150072|NCT03593213|585597224|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
162150073|NCT03593213|585597225|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
162150074|NCT03593213|585597226|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
162150075|NCT03593213|585597227|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
162150076|NCT03593213|585597224|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
162150077|NCT03593213|585597225|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
162150078|NCT03593213|585597226|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
162150079|NCT03593213|585597227|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
162150080|NCT03593213|585597224|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
162150081|NCT03593213|585597225|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
162150082|NCT03593213|585597226|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
162150083|NCT03593213|585597227|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
162150084|NCT03593213|585597224|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
162150085|NCT03593213|585597225|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
162150086|NCT03593213|585597226|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
162150087|NCT03593213|585597227|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
162150088|NCT03593213|585597224|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
162150089|NCT03593213|585597225|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
162150090|NCT03593213|585597226|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
161810045|NCT01796171|584347689|FG009|Follow-up Period|Physician Decision|0|||
161810046|NCT01796171|584347690|FG010|Follow-up Period|Physician Decision|5|||
161810047|NCT01796171|584347691|FG011|Follow-up Period|Physician Decision|0|||
162150091|NCT03593213|585597227|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
162150092|NCT03593213|585597224|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
162150093|NCT03593213|585597225|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
162150094|NCT03593213|585597226|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
162150095|NCT03593213|585597227|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
162150096|NCT03593213|585597224|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
162150097|NCT03593213|585597225|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
162150098|NCT03593213|585597226|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
162150099|NCT03593213|585597227|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
162150100|NCT03593213|585597224|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
162150101|NCT03593213|585597225|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
162150102|NCT03593213|585597226|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
162150103|NCT03593213|585597227|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
162150104|NCT03593213|585597224|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
162150105|NCT03593213|585597225|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
162150106|NCT03593213|585597226|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
162150107|NCT03593213|585597227|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
162150108|NCT03593213|585597224|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
162150109|NCT03593213|585597225|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
162150110|NCT03593213|585597226|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
162150111|NCT03593213|585597227|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
162150112|NCT03593213|585597224|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
162150113|NCT03593213|585597225|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
162150114|NCT03593213|585597226|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
162150115|NCT03593213|585597227|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
162150116|NCT03593213|585597224|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
162150117|NCT03593213|585597225|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
162150118|NCT03593213|585597226|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
162150119|NCT03593213|585597227|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
162150120|NCT03593213|585597224|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
162150121|NCT03593213|585597225|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
162150122|NCT03593213|585597226|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
162150123|NCT03593213|585597227|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
162150124|NCT03184558|585597228|FG000|Overall Study|Withdrawal by Subject|2|||
162150125|NCT03184558|585597228|FG000|Overall Study|Death|16|||
162150126|NCT03184558|585597228|FG000|Overall Study|Lost to Follow-up|2|||
162150127|NCT03184558|585597228|FG000|Overall Study|Other|9|||
162150128|NCT01831791|585597229|FG000|Overall Study|Withdrawal by Subject|10|||
162150129|NCT01190007|585597230|FG000|Overall Study|Withdrawal by Subject|4|||
162150130|NCT01190007|585597230|FG000|Overall Study|Adverse Event|8|||
162150131|NCT01190007|585597230|FG000|Overall Study|Difficulty of visit for complications|1|||
162150132|NCT01190007|585597230|FG000|Overall Study|Participant was arrested|1|||
162150133|NCT01179334|585597236|FG000|Treatment Period|Adverse Event|1|||
162150134|NCT01179334|585597237|FG001|Treatment Period|Adverse Event|0|||
162150135|NCT01179334|585597236|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
162150136|NCT01179334|585597237|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
162150137|NCT01179334|585597236|FG000|Long-term Extension (LTE) Period|Death|3|||
162150138|NCT01179334|585597237|FG001|Long-term Extension (LTE) Period|Death|0|||
162150139|NCT01179334|585597236|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
162150140|NCT01179334|585597237|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
162150141|NCT03654768|585597238|FG000|Overall Study|Adverse Event|1|||
162150142|NCT03654768|585597239|FG001|Overall Study|Adverse Event|6|||
162150143|NCT03654768|585597238|FG000|Overall Study|Loss of response|2|||
162150144|NCT03654768|585597239|FG001|Overall Study|Loss of response|2|||
162150145|NCT03654768|585597238|FG000|Overall Study|Non-compliance|0|||
162150146|NCT03654768|585597239|FG001|Overall Study|Non-compliance|1|||
162150147|NCT03654768|585597238|FG000|Overall Study|Refusal not related to toxicity|1|||
162150148|NCT03654768|585597239|FG001|Overall Study|Refusal not related to toxicity|5|||
162150149|NCT03654768|585597238|FG000|Overall Study|Did not receive protocol therapy|1|||
162150150|NCT03654768|585597239|FG001|Overall Study|Did not receive protocol therapy|1|||
162150151|NCT01152190|585597242|FG000|Overall Study|Adverse Event|2|||
161810048|NCT01796171|584347692|FG012|Follow-up Period|Physician Decision|0|||
162150152|NCT01152190|585597243|FG001|Overall Study|Adverse Event|4|||
162150153|NCT01152190|585597242|FG000|Overall Study|Death|1|||
162150154|NCT01152190|585597243|FG001|Overall Study|Death|0|||
162150155|NCT01152190|585597242|FG000|Overall Study|Protocol Violation|1|||
162150156|NCT01152190|585597243|FG001|Overall Study|Protocol Violation|1|||
162150157|NCT01152190|585597242|FG000|Overall Study|Withdrawal by Subject|1|||
162150158|NCT01152190|585597243|FG001|Overall Study|Withdrawal by Subject|3|||
162150159|NCT03070483|585597244|FG000|Overall Study|Lost to Follow-up|2|||
162150160|NCT01390402|585597247|FG000|Overall Study|Death|1|||
162150161|NCT01390402|585597247|FG000|Overall Study|Disease Progression|4|||
162150162|NCT00026312|585597250|FG000|Overall Study|Adverse Event|0|||
162150163|NCT00026312|585597251|FG001|Overall Study|Adverse Event|32|||
162150164|NCT00026312|585597250|FG000|Overall Study|Death|1|||
162150165|NCT00026312|585597251|FG001|Overall Study|Death|7|||
162150166|NCT00026312|585597250|FG000|Overall Study|Lack of Efficacy|19|||
162150167|NCT00026312|585597251|FG001|Overall Study|Lack of Efficacy|114|||
162150168|NCT00026312|585597250|FG000|Overall Study|Lost to Follow-up|0|||
162150169|NCT00026312|585597251|FG001|Overall Study|Lost to Follow-up|5|||
162150170|NCT00026312|585597250|FG000|Overall Study|Physician Decision|1|||
162150171|NCT00026312|585597251|FG001|Overall Study|Physician Decision|37|||
162150172|NCT00026312|585597250|FG000|Overall Study|Protocol Violation|0|||
162150173|NCT00026312|585597251|FG001|Overall Study|Protocol Violation|3|||
162150174|NCT00026312|585597250|FG000|Overall Study|Withdrawal by Subject|1|||
162150175|NCT00026312|585597251|FG001|Overall Study|Withdrawal by Subject|6|||
162150176|NCT00026312|585597250|FG000|Overall Study|Ineligible|4|||
162150177|NCT00026312|585597251|FG001|Overall Study|Ineligible|5|||
162150178|NCT00026312|585597250|FG000|Overall Study|Entry onto another COG study|0|||
162150179|NCT00026312|585597251|FG001|Overall Study|Entry onto another COG study|1|||
162150180|NCT00026312|585597250|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
162150181|NCT00026312|585597251|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
162150182|NCT02611037|585597252|FG000|Overall Study|Withdrawal prior to treatment|2|||
162150183|NCT02611037|585597253|FG001|Overall Study|Withdrawal prior to treatment|0|||
162150184|NCT03785782|585598364|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
162150185|NCT03785782|585598365|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
162150186|NCT03785782|585598364|FG000|Overall Study|Withdrawal by Subject|1|||
162150187|NCT03785782|585598365|FG001|Overall Study|Withdrawal by Subject|1|||
162150188|NCT03785782|585598364|FG000|Overall Study|insufficient image quality.|3|||
162150189|NCT03785782|585598365|FG001|Overall Study|insufficient image quality.|0|||
162150190|NCT04817670|585598366|FG000|Overall Study|Withdrawal by Subject|1|||
162150191|NCT04817670|585598367|FG001|Overall Study|Withdrawal by Subject|0|||
162150192|NCT04817670|585598368|FG002|Overall Study|Withdrawal by Subject|0|||
162150193|NCT04817670|585598369|FG003|Overall Study|Withdrawal by Subject|0|||
162150194|NCT04817670|585598370|FG004|Overall Study|Withdrawal by Subject|0|||
162150195|NCT04817670|585598366|FG000|Overall Study|Lost to Follow-up|0|||
162150196|NCT04817670|585598367|FG001|Overall Study|Lost to Follow-up|0|||
162150197|NCT04817670|585598368|FG002|Overall Study|Lost to Follow-up|1|||
162150198|NCT04817670|585598369|FG003|Overall Study|Lost to Follow-up|0|||
162150199|NCT04817670|585598370|FG004|Overall Study|Lost to Follow-up|0|||
162150200|NCT01185561|585598376|FG000|Overall Study|Lost to Follow-up|0|||
162150201|NCT01185561|585598377|FG001|Overall Study|Lost to Follow-up|4|||
162150202|NCT01185561|585598376|FG000|Overall Study|Withdrawal by Subject|2|||
162150203|NCT01185561|585598377|FG001|Overall Study|Withdrawal by Subject|8|||
162150204|NCT03718767|585598381|FG000|Overall Study|Declined to participate (before treatment started)|0|||
162150205|NCT03718767|585598382|FG001|Overall Study|Declined to participate (before treatment started)|0|||
162150206|NCT03718767|585598383|FG002|Overall Study|Declined to participate (before treatment started)|7|||
162150207|NCT03718767|585598381|FG000|Overall Study|Ineligible|0|||
162150208|NCT03718767|585598382|FG001|Overall Study|Ineligible|0|||
162150209|NCT03718767|585598383|FG002|Overall Study|Ineligible|17|||
162150210|NCT00494442|585598384|FG000|Overall Study|Death|1|||
162150211|NCT00494442|585598385|FG001|Overall Study|Death|1|||
162150212|NCT00494442|585598384|FG000|Overall Study|Lack of Efficacy|16|||
162150213|NCT00494442|585598385|FG001|Overall Study|Lack of Efficacy|10|||
162150214|NCT00494442|585598384|FG000|Overall Study|Adverse Event|0|||
162150215|NCT00494442|585598385|FG001|Overall Study|Adverse Event|2|||
162150216|NCT00494442|585598384|FG000|Overall Study|Physician Decision|0|||
162150217|NCT00494442|585598385|FG001|Overall Study|Physician Decision|1|||
162150218|NCT00494442|585598384|FG000|Overall Study|Non-compliance|0|||
162150219|NCT00494442|585598385|FG001|Overall Study|Non-compliance|1|||
162150220|NCT00494442|585598384|FG000|Overall Study|Intercurrent illness|0|||
162150221|NCT00494442|585598385|FG001|Overall Study|Intercurrent illness|1|||
162150222|NCT03691428|585598390|FG000|Overall Study|Withdrawal by Subject|6|||
162150223|NCT03691428|585598391|FG001|Overall Study|Withdrawal by Subject|8|||
162150224|NCT01460290|585598392|FG000|Overall Study|Adverse Event|3|||
162150225|NCT01460290|585598392|FG000|Overall Study|Elevated liver function|1|||
162150226|NCT01254019|585598397|FG000|Overall Study|Adverse Event|0|||
162150227|NCT01254019|585598398|FG001|Overall Study|Adverse Event|2|||
162150228|NCT01254019|585598397|FG000|Overall Study|Protocol Violation|1|||
162150229|NCT01254019|585598398|FG001|Overall Study|Protocol Violation|0|||
162150230|NCT01254019|585598397|FG000|Overall Study|Withdrawal by Subject|0|||
162150231|NCT01254019|585598398|FG001|Overall Study|Withdrawal by Subject|2|||
162150232|NCT03061474|585598399|FG000|Overall Study|Adverse Event|2|||
162150233|NCT03061474|585598400|FG001|Overall Study|Adverse Event|0|||
162150234|NCT03061474|585598399|FG000|Overall Study|Safety Risk|0|||
162150235|NCT03061474|585598400|FG001|Overall Study|Safety Risk|1|||
162150236|NCT03061474|585598399|FG000|Overall Study|Participant unwilling or unable to participate|0|||
162150237|NCT03061474|585598400|FG001|Overall Study|Participant unwilling or unable to participate|2|||
162150238|NCT03061474|585598399|FG000|Overall Study|Lost to Follow-up|0|||
162150239|NCT03061474|585598400|FG001|Overall Study|Lost to Follow-up|1|||
162150240|NCT00845832|585598403|FG000|Treatment Period|Adverse Event|0|||
162150241|NCT00845832|585598404|FG001|Treatment Period|Adverse Event|2|||
162150242|NCT00845832|585598405|FG002|Treatment Period|Adverse Event|0|||
162150243|NCT00845832|585598403|FG000|Treatment Period|Protocol Violation|1|||
162150244|NCT00845832|585598404|FG001|Treatment Period|Protocol Violation|1|||
162150245|NCT00845832|585598405|FG002|Treatment Period|Protocol Violation|0|||
162150246|NCT00845832|585598403|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
162150247|NCT00845832|585598404|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
162150248|NCT00845832|585598405|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
162150249|NCT00845832|585598403|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
162150250|NCT00845832|585598404|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
162150251|NCT00845832|585598405|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
162150252|NCT01391130|585598406|FG000|Overall Study|Withdrawal by Subject|3|||
162150253|NCT01391130|585598407|FG001|Overall Study|Withdrawal by Subject|2|||
162150254|NCT01391130|585598406|FG000|Overall Study|Physician Decision|2|||
162150255|NCT01391130|585598407|FG001|Overall Study|Physician Decision|3|||
162150256|NCT01391130|585598406|FG000|Overall Study|Did not Receive Drug|1|||
162150257|NCT01391130|585598407|FG001|Overall Study|Did not Receive Drug|1|||
162150258|NCT03520413|585598414|FG000|Overall Study|Lost to Follow-up|1|||
162150259|NCT03520413|585598415|FG001|Overall Study|Lost to Follow-up|1|||
162150260|NCT03520413|585598414|FG000|Overall Study|Withdrawal by Subject|1|||
162150261|NCT03520413|585598415|FG001|Overall Study|Withdrawal by Subject|2|||
162150262|NCT03520413|585598414|FG000|Overall Study|Death|0|||
162150263|NCT03520413|585598415|FG001|Overall Study|Death|1|||
162150264|NCT03520413|585598414|FG000|Overall Study|Physician Decision|3|||
162150265|NCT03520413|585598415|FG001|Overall Study|Physician Decision|3|||
162150266|NCT03520413|585598414|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
162150267|NCT03520413|585598415|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
162150268|NCT00869323|585598416|FG000|Maintenance Therapy|concurrent illness|1|||
162150269|NCT02880241|585598417|FG000|Overall Study|Lack of Efficacy|1|||
162150270|NCT02880241|585598418|FG001|Overall Study|Lack of Efficacy|0|||
162150271|NCT02880241|585598419|FG002|Overall Study|Lack of Efficacy|0|||
162150272|NCT02880241|585598420|FG003|Overall Study|Lack of Efficacy|0|||
162150273|NCT02880241|585598421|FG004|Overall Study|Lack of Efficacy|0|||
162150274|NCT02880241|585598422|FG005|Overall Study|Lack of Efficacy|0|||
162150275|NCT00638963|585598423|FG000|Overall Study|Withdrawal by Subject|1|||
162150276|NCT00638963|585598424|FG001|Overall Study|Withdrawal by Subject|0|||
162150277|NCT00566527|585598427|FG000|Overall Study|Reason not provided|3|||
162150278|NCT00566527|585598428|FG001|Overall Study|Reason not provided|11|||
162150279|NCT00566527|585598429|FG002|Overall Study|Reason not provided|10|||
162150280|NCT00566527|585598427|FG000|Overall Study|Adverse Event|2|||
162150281|NCT00566527|585598428|FG001|Overall Study|Adverse Event|0|||
162150282|NCT00566527|585598429|FG002|Overall Study|Adverse Event|1|||
162150283|NCT00566527|585598427|FG000|Overall Study|Physician Decision|3|||
162150284|NCT00566527|585598428|FG001|Overall Study|Physician Decision|8|||
162150285|NCT00566527|585598429|FG002|Overall Study|Physician Decision|20|||
162150286|NCT00566527|585598427|FG000|Overall Study|Lost to Follow-up|3|||
162150287|NCT00566527|585598428|FG001|Overall Study|Lost to Follow-up|4|||
162150288|NCT00566527|585598429|FG002|Overall Study|Lost to Follow-up|4|||
162150289|NCT00566527|585598427|FG000|Overall Study|Withdrawal by Subject|6|||
162150290|NCT00566527|585598428|FG001|Overall Study|Withdrawal by Subject|43|||
162150291|NCT00566527|585598429|FG002|Overall Study|Withdrawal by Subject|43|||
162150292|NCT04975308|585598430|FG000|Overall Study|Withdrawal by Subject|6|||
162150293|NCT04975308|585598431|FG001|Overall Study|Withdrawal by Subject|16|||
162150294|NCT04975308|585598432|FG002|Overall Study|Withdrawal by Subject|6|||
162150295|NCT04975308|585598430|FG000|Overall Study|Physician Decision|0|||
162150296|NCT04975308|585598431|FG001|Overall Study|Physician Decision|3|||
162150297|NCT04975308|585598432|FG002|Overall Study|Physician Decision|1|||
162150298|NCT04975308|585598430|FG000|Overall Study|Adverse Event|10|||
162150299|NCT04975308|585598431|FG001|Overall Study|Adverse Event|1|||
162150300|NCT04975308|585598432|FG002|Overall Study|Adverse Event|12|||
162150301|NCT04975308|585598430|FG000|Overall Study|On study treatment (Ongoing)|65|||
162150302|NCT04975308|585598431|FG001|Overall Study|On study treatment (Ongoing)|43|||
162150303|NCT04975308|585598432|FG002|Overall Study|On study treatment (Ongoing)|75|||
162150304|NCT04975308|585598430|FG000|Overall Study|Protocol Deviation|4|||
162150305|NCT04975308|585598431|FG001|Overall Study|Protocol Deviation|3|||
162150306|NCT04975308|585598432|FG002|Overall Study|Protocol Deviation|2|||
162150307|NCT00547118|585598438|FG000|Overall Study|Did not qualify prior to starting drug|1|||
162150308|NCT00547118|585598439|FG001|Overall Study|Did not qualify prior to starting drug|1|||
162150309|NCT00547118|585598438|FG000|Overall Study|Study suspended|7|||
162150310|NCT00547118|585598439|FG001|Overall Study|Study suspended|8|||
162150311|NCT00373529|585598441|FG000|Overall Study|Physician Decision|19|||
162150312|NCT00373529|585598441|FG000|Overall Study|Withdrawal by Subject|7|||
162150313|NCT00373529|585598441|FG000|Overall Study|Adverse Event|7|||
162150314|NCT00373529|585598441|FG000|Overall Study|Treatment failure|36|||
162150315|NCT00373529|585598441|FG000|Overall Study|Disease recurrence|10|||
162150316|NCT00373529|585598441|FG000|Overall Study|Death|16|||
162150317|NCT00373529|585598441|FG000|Overall Study|Need for treatment prohibited by study|1|||
162150318|NCT00373529|585598441|FG000|Overall Study|Other|8|||
162150319|NCT00373529|585598441|FG000|Overall Study|Failed independent confirmation of AML|3|||
162150320|NCT00373529|585598441|FG000|Overall Study|Consent violation|1|||
162150321|NCT04795752|585598442|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
162150322|NCT04795752|585598443|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
162150323|NCT04795752|585598442|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
162150324|NCT04795752|585598443|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
162150325|NCT04795752|585598442|FG000|Primary Endpoint Phase|Physician Decision|2|||
162150326|NCT04795752|585598443|FG001|Primary Endpoint Phase|Physician Decision|0|||
162150327|NCT04795752|585598442|FG000|Primary Endpoint Phase|Other|4|||
162150328|NCT04795752|585598443|FG001|Primary Endpoint Phase|Other|1|||
162150329|NCT04795752|585598442|FG000|Primary Endpoint Phase|Protocol Violation|1|||
162150330|NCT04795752|585598443|FG001|Primary Endpoint Phase|Protocol Violation|0|||
162150331|NCT04795752|585598442|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
162150332|NCT04795752|585598443|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
162150333|NCT04795752|585598442|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
162150334|NCT04795752|585598443|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
162150335|NCT04795752|585598442|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
162150336|NCT04795752|585598443|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
162150337|NCT04795752|585598442|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
162150338|NCT04795752|585598443|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
162150339|NCT04795752|585598442|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
162150340|NCT04795752|585598443|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
162150341|NCT00792948|585598444|FG000|Overall Study|Adverse Event|6|||
162150342|NCT00792948|585598444|FG000|Overall Study|Death|4|||
162150343|NCT00792948|585598444|FG000|Overall Study|Withdrawal by Subject|3|||
162150344|NCT00792948|585598444|FG000|Overall Study|Ineligible|2|||
162150345|NCT00792948|585598444|FG000|Overall Study|Insurance denial - not treated|1|||
162150346|NCT00792948|585598444|FG000|Overall Study|Physician Decision|11|||
162150347|NCT00792948|585598444|FG000|Overall Study|Protocol Violation|1|||
162150348|NCT01585558|585598451|FG000|Overall Study|Withdrawal by Subject|4|||
162150349|NCT01585558|585598452|FG001|Overall Study|Withdrawal by Subject|5|||
162150350|NCT01585558|585598453|FG002|Overall Study|Withdrawal by Subject|8|||
162150351|NCT01585558|585598451|FG000|Overall Study|Lost to Follow-up|2|||
162150352|NCT01585558|585598452|FG001|Overall Study|Lost to Follow-up|0|||
162150353|NCT01585558|585598453|FG002|Overall Study|Lost to Follow-up|3|||
162150354|NCT01585558|585598451|FG000|Overall Study|Adverse Event|3|||
162150355|NCT01585558|585598452|FG001|Overall Study|Adverse Event|4|||
162150356|NCT01585558|585598453|FG002|Overall Study|Adverse Event|1|||
162150357|NCT01585558|585598451|FG000|Overall Study|Protocol Violation|4|||
162150358|NCT01585558|585598452|FG001|Overall Study|Protocol Violation|3|||
162150359|NCT01585558|585598453|FG002|Overall Study|Protocol Violation|2|||
162150360|NCT01585558|585598451|FG000|Overall Study|Lack of Efficacy|0|||
162150361|NCT01585558|585598452|FG001|Overall Study|Lack of Efficacy|0|||
162150362|NCT01585558|585598453|FG002|Overall Study|Lack of Efficacy|1|||
162150363|NCT00357097|585598454|FG000|Overall Study|Did not meet inclusion criteria|5|||
162150364|NCT00357097|585598455|FG001|Overall Study|Did not meet inclusion criteria|3|||
162150365|NCT00357097|585598454|FG000|Overall Study|Adverse Event|34|||
162150366|NCT00357097|585598455|FG001|Overall Study|Adverse Event|6|||
162150367|NCT00357097|585598454|FG000|Overall Study|Withdrawal by Subject|8|||
162150368|NCT00357097|585598455|FG001|Overall Study|Withdrawal by Subject|7|||
162150369|NCT00357097|585598454|FG000|Overall Study|Non-compliance|1|||
162150370|NCT00357097|585598455|FG001|Overall Study|Non-compliance|2|||
162150371|NCT00357097|585598454|FG000|Overall Study|Lack of Efficacy|2|||
162150372|NCT00357097|585598455|FG001|Overall Study|Lack of Efficacy|8|||
162150373|NCT00357097|585598454|FG000|Overall Study|Met Exclusion Criteria|3|||
162150374|NCT00357097|585598455|FG001|Overall Study|Met Exclusion Criteria|1|||
162150375|NCT00357097|585598454|FG000|Overall Study|Other|1|||
162150376|NCT00357097|585598455|FG001|Overall Study|Other|1|||
162150377|NCT00357097|585598454|FG000|Overall Study|Increase of RLS Symptoms|0|||
162150378|NCT00357097|585598455|FG001|Overall Study|Increase of RLS Symptoms|1|||
162150379|NCT00658996|585598456|FG000|First Intervention|Positive slit lamp finding|1|||
162150380|NCT00658996|585598457|FG001|First Intervention|Positive slit lamp finding|0|||
162150381|NCT00658996|585598456|FG000|First Intervention|Lack of lenses|0|||
162150382|NCT00658996|585598457|FG001|First Intervention|Lack of lenses|1|||
162150383|NCT00658996|585598456|FG000|Crossover Period|Physician Decision|1|||
162150384|NCT00658996|585598457|FG001|Crossover Period|Physician Decision|0|||
162150385|NCT00658996|585598456|FG000|Crossover Period|Ineligible|1|||
162150386|NCT00658996|585598457|FG001|Crossover Period|Ineligible|1|||
162150387|NCT00658996|585598456|FG000|Second Intervention|Developed a stye on upper lid|1|||
162150388|NCT00658996|585598457|FG001|Second Intervention|Developed a stye on upper lid|0|||
162150389|NCT00658996|585598456|FG000|Second Intervention|Positive slit lamp finding|0|||
162150390|NCT00658996|585598457|FG001|Second Intervention|Positive slit lamp finding|1|||
162150391|NCT02994654|585598460|FG000|Overall Study|Lost to Follow-up|1|||
162150392|NCT03603717|585598469|FG000|Overall Study|Lost to Follow-up|20|||
162150393|NCT03603717|585598470|FG001|Overall Study|Lost to Follow-up|20|||
162150394|NCT03603717|585598469|FG000|Overall Study|Withdrawal by Subject|16|||
162150395|NCT03603717|585598470|FG001|Overall Study|Withdrawal by Subject|10|||
162150396|NCT00732381|585598471|FG000|Overall Study|Adverse Event|1|||
162150397|NCT00732381|585598472|FG001|Overall Study|Adverse Event|0|||
162150398|NCT00732381|585598471|FG000|Overall Study|Treatment Failure|1|||
162150399|NCT00732381|585598472|FG001|Overall Study|Treatment Failure|1|||
162150400|NCT01810263|585598475|FG000|Overall Study|Lost to Follow-up|8|||
162150401|NCT01810263|585598476|FG001|Overall Study|Lost to Follow-up|7|||
162150402|NCT02613871|585599451|FG000|Overall Study|Death|2|||
162150403|NCT02613871|585599451|FG000|Overall Study|Withdrew Consent|1|||
162150404|NCT02448446|585599453|FG000|Overall Study|Withdrawal by Subject|1|||
162150405|NCT02448446|585599454|FG001|Overall Study|Withdrawal by Subject|0|||
162150406|NCT03260140|585599455|FG000|Overall Study|Death|4|||
162150407|NCT03260140|585599456|FG001|Overall Study|Death|1|||
162150408|NCT03260140|585599455|FG000|Overall Study|Withdrawal by Subject|1|||
162150409|NCT03260140|585599456|FG001|Overall Study|Withdrawal by Subject|4|||
162150410|NCT00463788|585599457|FG000|Overall Study|Progressive Disease|86|||
162150411|NCT00463788|585599458|FG001|Overall Study|Progressive Disease|42|||
162150412|NCT00463788|585599457|FG000|Overall Study|Adverse Event|6|||
162150413|NCT00463788|585599458|FG001|Overall Study|Adverse Event|2|||
162150414|NCT00463788|585599457|FG000|Overall Study|Withdrawal by Subject|6|||
162150415|NCT00463788|585599458|FG001|Overall Study|Withdrawal by Subject|2|||
162150416|NCT00463788|585599457|FG000|Overall Study|Death|4|||
162150417|NCT00463788|585599458|FG001|Overall Study|Death|3|||
162150418|NCT00463788|585599457|FG000|Overall Study|Symptomatic Deterioration|2|||
162150419|NCT00463788|585599458|FG001|Overall Study|Symptomatic Deterioration|3|||
162150420|NCT00463788|585599457|FG000|Overall Study|Lost to Follow-up|1|||
162150421|NCT00463788|585599458|FG001|Overall Study|Lost to Follow-up|0|||
161914167|NCT01648764|584735514|FG007|Overall Study|Withdrawal by Subject|0|||
161914168|NCT01648764|584735515|FG008|Overall Study|Withdrawal by Subject|0|||
161914169|NCT01648764|584735516|FG009|Overall Study|Withdrawal by Subject|0|||
162150422|NCT00463788|585599457|FG000|Overall Study|Protocol Violation|0|||
162150423|NCT00463788|585599458|FG001|Overall Study|Protocol Violation|1|||
162150424|NCT00463788|585599457|FG000|Overall Study|Other|3|||
162150425|NCT00463788|585599458|FG001|Overall Study|Other|0|||
162150426|NCT00463788|585599457|FG000|Overall Study|Randomized but not treated|1|||
162150427|NCT00463788|585599458|FG001|Overall Study|Randomized but not treated|1|||
162150428|NCT00360698|585599459|FG000|Run-In|Physician Decision|0|||
162150429|NCT00360698|585599460|FG001|Run-In|Physician Decision|1|||
162150430|NCT00360698|585599459|FG000|Run-In|Withdrawal by Subject|0|||
162150431|NCT00360698|585599460|FG001|Run-In|Withdrawal by Subject|2|||
162150432|NCT00360698|585599459|FG000|Run-In|Non compliance with treatment procedure|0|||
161810049|NCT01796171|584347693|FG013|Follow-up Period|Physician Decision|0|||
161810050|NCT01796171|584347694|FG014|Follow-up Period|Physician Decision|0|||
161810051|NCT01796171|584347680|FG000|Follow-up Period|Withdrawal by Subject|0|||
161810052|NCT01796171|584347681|FG001|Follow-up Period|Withdrawal by Subject|1|||
161810053|NCT01796171|584347682|FG002|Follow-up Period|Withdrawal by Subject|0|||
161810054|NCT01796171|584347683|FG003|Follow-up Period|Withdrawal by Subject|0|||
161810055|NCT01796171|584347684|FG004|Follow-up Period|Withdrawal by Subject|0|||
161810056|NCT01796171|584347685|FG005|Follow-up Period|Withdrawal by Subject|1|||
161810057|NCT01796171|584347686|FG006|Follow-up Period|Withdrawal by Subject|0|||
161810058|NCT01796171|584347687|FG007|Follow-up Period|Withdrawal by Subject|0|||
161810059|NCT01796171|584347688|FG008|Follow-up Period|Withdrawal by Subject|0|||
161810060|NCT01796171|584347689|FG009|Follow-up Period|Withdrawal by Subject|0|||
161810061|NCT01796171|584347690|FG010|Follow-up Period|Withdrawal by Subject|3|||
161810062|NCT01796171|584347691|FG011|Follow-up Period|Withdrawal by Subject|1|||
161810063|NCT01796171|584347692|FG012|Follow-up Period|Withdrawal by Subject|0|||
161810064|NCT01796171|584347693|FG013|Follow-up Period|Withdrawal by Subject|0|||
161810065|NCT01796171|584347694|FG014|Follow-up Period|Withdrawal by Subject|0|||
161914170|NCT01648764|584735517|FG010|Overall Study|Withdrawal by Subject|0|||
161914171|NCT01648764|584735518|FG011|Overall Study|Withdrawal by Subject|0|||
161914172|NCT01648764|584735519|FG012|Overall Study|Withdrawal by Subject|1|||
161914173|NCT01648764|584735520|FG013|Overall Study|Withdrawal by Subject|0|||
161810066|NCT01796171|584347680|FG000|Follow-up Period|Death|0|||
161810067|NCT01796171|584347681|FG001|Follow-up Period|Death|0|||
161810068|NCT01796171|584347682|FG002|Follow-up Period|Death|0|||
161810069|NCT01796171|584347683|FG003|Follow-up Period|Death|0|||
161810070|NCT01796171|584347684|FG004|Follow-up Period|Death|0|||
161914174|NCT01648764|584735507|FG000|Overall Study|Investigator Decision|0|||
161914175|NCT01648764|584735508|FG001|Overall Study|Investigator Decision|0|||
161914176|NCT01648764|584735509|FG002|Overall Study|Investigator Decision|0|||
161914177|NCT01648764|584735510|FG003|Overall Study|Investigator Decision|0|||
161914178|NCT01648764|584735511|FG004|Overall Study|Investigator Decision|0|||
161914179|NCT01648764|584735512|FG005|Overall Study|Investigator Decision|0|||
161914180|NCT01648764|584735513|FG006|Overall Study|Investigator Decision|1|||
161914181|NCT01648764|584735514|FG007|Overall Study|Investigator Decision|0|||
161914182|NCT01648764|584735515|FG008|Overall Study|Investigator Decision|0|||
161914183|NCT01648764|584735516|FG009|Overall Study|Investigator Decision|0|||
161914184|NCT01648764|584735517|FG010|Overall Study|Investigator Decision|0|||
161914185|NCT01648764|584735518|FG011|Overall Study|Investigator Decision|1|||
161914186|NCT01648764|584735519|FG012|Overall Study|Investigator Decision|0|||
161914187|NCT01648764|584735520|FG013|Overall Study|Investigator Decision|0|||
161914188|NCT03801252|584735521|FG000|Overall Study|Protocol Violation|1|||
161914189|NCT03801252|584735522|FG001|Overall Study|Protocol Violation|2|||
161914190|NCT01732692|584735526|FG000|Overall Study|Adverse Event|0|||
161914191|NCT01732692|584735527|FG001|Overall Study|Adverse Event|1|||
161914192|NCT01027949|584735528|FG000|Overall Study|Death|174|||
161914193|NCT01027949|584735528|FG000|Overall Study|Progressive Disease|163|||
161914194|NCT01027949|584735528|FG000|Overall Study|Adverse Event|172|||
161914195|NCT01027949|584735528|FG000|Overall Study|Withdrawal by Subject|113|||
161914196|NCT01027949|584735528|FG000|Overall Study|Lost to Follow-up|17|||
161914197|NCT01027949|584735528|FG000|Overall Study|Protocol Violation|13|||
161914198|NCT01027949|584735528|FG000|Overall Study|PI Decision|8|||
161914199|NCT01027949|584735528|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
161914200|NCT01027949|584735528|FG000|Overall Study|Non-compliance with Study Procedures|7|||
161914201|NCT01027949|584735528|FG000|Overall Study|Lung Transplant|5|||
161914202|NCT01027949|584735528|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
161914203|NCT01027949|584735528|FG000|Overall Study|Use of Excluded Medication|2|||
161914204|NCT01027949|584735528|FG000|Overall Study|Patient Self-discontinuation|1|||
161914205|NCT01027949|584735528|FG000|Overall Study|Pregnancy|1|||
161914206|NCT01027949|584735528|FG000|Overall Study|Surgery|1|||
161914207|NCT00656617|584735529|FG000|Overall Study|Adverse Event|1|||
161914208|NCT00656617|584735529|FG000|Overall Study|Death|2|||
161914209|NCT00656617|584735529|FG000|Overall Study|Insurance Issues|2|||
161914210|NCT00656617|584735529|FG000|Overall Study|Move to different clinical trial|2|||
161810071|NCT01796171|584347685|FG005|Follow-up Period|Death|0|||
161810072|NCT01796171|584347686|FG006|Follow-up Period|Death|1|||
161810073|NCT01796171|584347687|FG007|Follow-up Period|Death|0|||
161810074|NCT01796171|584347688|FG008|Follow-up Period|Death|0|||
161810075|NCT01796171|584347689|FG009|Follow-up Period|Death|0|||
161810076|NCT01796171|584347690|FG010|Follow-up Period|Death|17|||
161810077|NCT01796171|584347691|FG011|Follow-up Period|Death|9|||
161810078|NCT01796171|584347692|FG012|Follow-up Period|Death|1|||
161810079|NCT01796171|584347693|FG013|Follow-up Period|Death|0|||
161810080|NCT01796171|584347694|FG014|Follow-up Period|Death|0|||
161914211|NCT02030600|584735532|FG000|Treatment Period 1|Adverse Event|5|||
161914212|NCT02030600|584735533|FG001|Treatment Period 1|Adverse Event|7|||
161914213|NCT02030600|584735532|FG000|Treatment Period 1|Lack of Efficacy|0|||
161914214|NCT02030600|584735533|FG001|Treatment Period 1|Lack of Efficacy|1|||
161810081|NCT01796171|584347680|FG000|Follow-up Period|Patient transferred to other hospital|0|||
162150433|NCT00360698|585599460|FG001|Run-In|Non compliance with treatment procedure|1|||
162150434|NCT00360698|585599459|FG000|Run-In|Sponsor request|0|||
162150435|NCT00360698|585599460|FG001|Run-In|Sponsor request|2|||
162150436|NCT00360698|585599459|FG000|Run-In|Patient did not meet inclusion criteria|0|||
162150437|NCT00360698|585599460|FG001|Run-In|Patient did not meet inclusion criteria|1|||
162150438|NCT00360698|585599459|FG000|Run-In|Patient personal reasons|0|||
162150439|NCT00360698|585599460|FG001|Run-In|Patient personal reasons|2|||
162150440|NCT00360698|585599459|FG000|Run-In|Need of insulin with meals|0|||
162150441|NCT00360698|585599460|FG001|Run-In|Need of insulin with meals|1|||
162150442|NCT00360698|585599459|FG000|Treatment Period|Non compliance with treatment procedure|1|||
162150443|NCT00360698|585599460|FG001|Treatment Period|Non compliance with treatment procedure|0|||
162150444|NCT00360698|585599459|FG000|Treatment Period|Early termination by error|0|||
162150445|NCT00360698|585599460|FG001|Treatment Period|Early termination by error|1|||
162150446|NCT02200770|585599461|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
162150447|NCT02200770|585599462|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
162150448|NCT02200770|585599461|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
162150449|NCT02200770|585599462|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
162150450|NCT02200770|585599461|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
162150451|NCT02200770|585599462|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
162150452|NCT02200770|585599461|FG000|Randomized-controlled Period (RCP)|Other|1|||
161914215|NCT02030600|584735532|FG000|Treatment Period 1|Lost to Follow-up|11|||
161914216|NCT02030600|584735533|FG001|Treatment Period 1|Lost to Follow-up|3|||
161914217|NCT02030600|584735532|FG000|Treatment Period 1|Protocol Violation|22|||
161914218|NCT02030600|584735533|FG001|Treatment Period 1|Protocol Violation|17|||
161914219|NCT02030600|584735532|FG000|Treatment Period 1|Withdrawal by Subject|13|||
161914220|NCT02030600|584735533|FG001|Treatment Period 1|Withdrawal by Subject|17|||
161914221|NCT02030600|584735532|FG000|Treatment Period 1|Casebook Unsigned|1|||
161914222|NCT02030600|584735533|FG001|Treatment Period 1|Casebook Unsigned|0|||
161914223|NCT02030600|584735532|FG000|Treatment Period 1|Unclassified|1|||
161914224|NCT02030600|584735533|FG001|Treatment Period 1|Unclassified|0|||
161914225|NCT02030600|584735532|FG000|Treatment Period 2|Adverse Event|4|||
161914226|NCT02030600|584735533|FG001|Treatment Period 2|Adverse Event|4|||
161914227|NCT02030600|584735532|FG000|Treatment Period 2|Lack of Efficacy|2|||
161914228|NCT02030600|584735533|FG001|Treatment Period 2|Lack of Efficacy|1|||
161914229|NCT02030600|584735532|FG000|Treatment Period 2|Lost to Follow-up|4|||
161914230|NCT02030600|584735533|FG001|Treatment Period 2|Lost to Follow-up|2|||
161914231|NCT02030600|584735532|FG000|Treatment Period 2|Protocol Violation|1|||
161914232|NCT02030600|584735533|FG001|Treatment Period 2|Protocol Violation|2|||
161914233|NCT02030600|584735532|FG000|Treatment Period 2|Withdrawal by Subject|13|||
161914234|NCT02030600|584735533|FG001|Treatment Period 2|Withdrawal by Subject|9|||
161914235|NCT02030600|584735532|FG000|Treatment Period 2|Unclassified|1|||
161914236|NCT02030600|584735533|FG001|Treatment Period 2|Unclassified|0|||
161914237|NCT01155323|584735540|FG000|First Intervention|exclusion criteria|1|||
161914238|NCT01155323|584735541|FG001|First Intervention|exclusion criteria|1|||
161914239|NCT01155323|584735540|FG000|Second Intervention|Lost to Follow-up|1|||
161914240|NCT01155323|584735541|FG001|Second Intervention|Lost to Follow-up|1|||
161914241|NCT01208051|584735544|FG000|Total Enrollment|Withdrawal by Subject|0|||
161914242|NCT01208051|584735545|FG001|Total Enrollment|Withdrawal by Subject|1|||
161914243|NCT01208051|584735546|FG002|Total Enrollment|Withdrawal by Subject|0|||
161914244|NCT01208051|584735547|FG003|Total Enrollment|Withdrawal by Subject|0|||
161914245|NCT01208051|584735548|FG004|Total Enrollment|Withdrawal by Subject|2|||
161914246|NCT01208051|584735544|FG000|Total Enrollment|Brain metastases|0|||
161914247|NCT01208051|584735545|FG001|Total Enrollment|Brain metastases|0|||
161914248|NCT01208051|584735546|FG002|Total Enrollment|Brain metastases|1|||
162150453|NCT02200770|585599462|FG001|Randomized-controlled Period (RCP)|Other|2|||
162150454|NCT02200770|585599461|FG000|Open-label Period (OLP)|Adverse Event|1|||
161914249|NCT01208051|584735547|FG003|Total Enrollment|Brain metastases|0|||
161914250|NCT01208051|584735548|FG004|Total Enrollment|Brain metastases|0|||
161914251|NCT02349386|584735549|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
161914252|NCT02349386|584735550|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
161914253|NCT02349386|584735551|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
161914254|NCT02349386|584735552|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
161914255|NCT02349386|584735549|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
161914256|NCT02349386|584735550|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
161914257|NCT02349386|584735551|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
161914258|NCT02349386|584735552|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
161914259|NCT02349386|584735549|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
161914260|NCT02349386|584735550|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
161914261|NCT02349386|584735551|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
161914262|NCT02349386|584735552|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
162150455|NCT02200770|585599462|FG001|Open-label Period (OLP)|Adverse Event|2|||
162150456|NCT02200770|585599461|FG000|Open-label Period (OLP)|Death|1|||
162150457|NCT02200770|585599462|FG001|Open-label Period (OLP)|Death|2|||
162150458|NCT02200770|585599461|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
162150459|NCT02200770|585599462|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
162150460|NCT02200770|585599461|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
162150461|NCT02200770|585599462|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
162150462|NCT02200770|585599461|FG000|Open-label Period (OLP)|Other|6|||
162150463|NCT02200770|585599462|FG001|Open-label Period (OLP)|Other|15|||
162150464|NCT05283395|585599466|FG000|Overall Study|Adverse Event|4|||
162150465|NCT05283395|585599467|FG001|Overall Study|Adverse Event|4|||
162150466|NCT05283395|585599468|FG002|Overall Study|Adverse Event|0|||
162150467|NCT05283395|585599466|FG000|Overall Study|Patient Lost to Follow-Up|0|||
162150468|NCT05283395|585599467|FG001|Overall Study|Patient Lost to Follow-Up|0|||
162150469|NCT05283395|585599468|FG002|Overall Study|Patient Lost to Follow-Up|1|||
162150470|NCT05283395|585599466|FG000|Overall Study|Patient Withdrawal|2|||
162150471|NCT05283395|585599467|FG001|Overall Study|Patient Withdrawal|4|||
162150472|NCT05283395|585599468|FG002|Overall Study|Patient Withdrawal|2|||
162150473|NCT05283395|585599466|FG000|Overall Study|Investigator Decision|1|||
162150474|NCT05283395|585599467|FG001|Overall Study|Investigator Decision|0|||
162150475|NCT05283395|585599468|FG002|Overall Study|Investigator Decision|1|||
161810082|NCT01796171|584347681|FG001|Follow-up Period|Patient transferred to other hospital|1|||
162150476|NCT05283395|585599466|FG000|Overall Study|Enrolled in error|0|||
162150477|NCT05283395|585599467|FG001|Overall Study|Enrolled in error|0|||
161810083|NCT01796171|584347682|FG002|Follow-up Period|Patient transferred to other hospital|0|||
161810084|NCT01796171|584347683|FG003|Follow-up Period|Patient transferred to other hospital|0|||
161810085|NCT01796171|584347684|FG004|Follow-up Period|Patient transferred to other hospital|0|||
161810086|NCT01796171|584347685|FG005|Follow-up Period|Patient transferred to other hospital|0|||
161810087|NCT01796171|584347686|FG006|Follow-up Period|Patient transferred to other hospital|0|||
161810088|NCT01796171|584347687|FG007|Follow-up Period|Patient transferred to other hospital|0|||
161810089|NCT01796171|584347688|FG008|Follow-up Period|Patient transferred to other hospital|0|||
161810090|NCT01796171|584347689|FG009|Follow-up Period|Patient transferred to other hospital|0|||
161810091|NCT01796171|584347690|FG010|Follow-up Period|Patient transferred to other hospital|0|||
161810092|NCT01796171|584347691|FG011|Follow-up Period|Patient transferred to other hospital|0|||
161810093|NCT01796171|584347692|FG012|Follow-up Period|Patient transferred to other hospital|0|||
161810094|NCT01796171|584347693|FG013|Follow-up Period|Patient transferred to other hospital|0|||
161810095|NCT01796171|584347694|FG014|Follow-up Period|Patient transferred to other hospital|0|||
161810096|NCT01796171|584347680|FG000|Follow-up Period|Sponsor Decision|0|||
161810097|NCT01796171|584347681|FG001|Follow-up Period|Sponsor Decision|0|||
161810098|NCT01796171|584347682|FG002|Follow-up Period|Sponsor Decision|0|||
161810099|NCT01796171|584347683|FG003|Follow-up Period|Sponsor Decision|0|||
162150478|NCT05283395|585599468|FG002|Overall Study|Enrolled in error|1|||
162150479|NCT00712335|585599469|FG000|Overall Study|Withdrawal by Subject|0|||
162150480|NCT00712335|585599470|FG001|Overall Study|Withdrawal by Subject|7|||
162150481|NCT00712335|585599471|FG002|Overall Study|Withdrawal by Subject|2|||
162150482|NCT00712335|585599472|FG003|Overall Study|Withdrawal by Subject|3|||
162150483|NCT00712335|585599473|FG004|Overall Study|Withdrawal by Subject|0|||
162150484|NCT00712335|585599469|FG000|Overall Study|Lost to Follow-up|2|||
162150485|NCT00712335|585599470|FG001|Overall Study|Lost to Follow-up|5|||
162150486|NCT00712335|585599471|FG002|Overall Study|Lost to Follow-up|0|||
162150487|NCT00712335|585599472|FG003|Overall Study|Lost to Follow-up|1|||
162150488|NCT00712335|585599473|FG004|Overall Study|Lost to Follow-up|0|||
162150489|NCT00712335|585599469|FG000|Overall Study|Protocol Violation|1|||
162150490|NCT00712335|585599470|FG001|Overall Study|Protocol Violation|2|||
162150491|NCT00712335|585599471|FG002|Overall Study|Protocol Violation|1|||
162150492|NCT00712335|585599472|FG003|Overall Study|Protocol Violation|0|||
162150493|NCT00712335|585599473|FG004|Overall Study|Protocol Violation|0|||
162150494|NCT00712335|585599469|FG000|Overall Study|Lack of Efficacy|0|||
162150495|NCT00712335|585599470|FG001|Overall Study|Lack of Efficacy|0|||
162150496|NCT00712335|585599471|FG002|Overall Study|Lack of Efficacy|1|||
162150497|NCT00712335|585599472|FG003|Overall Study|Lack of Efficacy|1|||
162150498|NCT00712335|585599473|FG004|Overall Study|Lack of Efficacy|0|||
162150499|NCT00712335|585599469|FG000|Overall Study|Other Reason|0|||
162150500|NCT00712335|585599470|FG001|Overall Study|Other Reason|3|||
162150501|NCT00712335|585599471|FG002|Overall Study|Other Reason|1|||
162150502|NCT00712335|585599472|FG003|Overall Study|Other Reason|0|||
162150503|NCT00712335|585599473|FG004|Overall Study|Other Reason|0|||
161810100|NCT01796171|584347684|FG004|Follow-up Period|Sponsor Decision|0|||
161810101|NCT01796171|584347685|FG005|Follow-up Period|Sponsor Decision|0|||
161810102|NCT01796171|584347686|FG006|Follow-up Period|Sponsor Decision|0|||
161810103|NCT01796171|584347687|FG007|Follow-up Period|Sponsor Decision|0|||
161810104|NCT01796171|584347688|FG008|Follow-up Period|Sponsor Decision|0|||
161810105|NCT01796171|584347689|FG009|Follow-up Period|Sponsor Decision|0|||
161810106|NCT01796171|584347690|FG010|Follow-up Period|Sponsor Decision|40|||
162150504|NCT03401112|585599474|FG000|Overall Study|Adverse Event|1|||
162150505|NCT03401112|585599475|FG001|Overall Study|Adverse Event|2|||
162150506|NCT03401112|585599476|FG002|Overall Study|Adverse Event|3|||
162150507|NCT03401112|585599477|FG003|Overall Study|Adverse Event|2|||
162150508|NCT03401112|585599478|FG004|Overall Study|Adverse Event|0|||
162150509|NCT03401112|585599474|FG000|Overall Study|Lost to Follow-up|1|||
162150510|NCT03401112|585599475|FG001|Overall Study|Lost to Follow-up|0|||
162150511|NCT03401112|585599476|FG002|Overall Study|Lost to Follow-up|0|||
162150512|NCT03401112|585599477|FG003|Overall Study|Lost to Follow-up|0|||
162150513|NCT03401112|585599478|FG004|Overall Study|Lost to Follow-up|0|||
162150514|NCT03401112|585599474|FG000|Overall Study|Noncompliance|1|||
162150515|NCT03401112|585599475|FG001|Overall Study|Noncompliance|2|||
162150516|NCT03401112|585599476|FG002|Overall Study|Noncompliance|3|||
162150517|NCT03401112|585599477|FG003|Overall Study|Noncompliance|0|||
162150518|NCT03401112|585599478|FG004|Overall Study|Noncompliance|0|||
162150519|NCT03401112|585599474|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
162150520|NCT03401112|585599475|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
162150521|NCT03401112|585599476|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
161914263|NCT02349386|584735549|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
161914264|NCT02349386|584735550|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
161914265|NCT02349386|584735551|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
161914266|NCT02349386|584735552|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
161914267|NCT02349386|584735549|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
161914268|NCT02349386|584735550|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
161914269|NCT02349386|584735551|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
161914270|NCT02349386|584735552|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
161914271|NCT02349386|584735549|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
161914272|NCT02349386|584735550|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
161914273|NCT02349386|584735551|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
161914274|NCT02349386|584735552|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
161914275|NCT00973973|584735553|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
161914276|NCT00973973|584735554|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
161914277|NCT00973973|584735553|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
161914278|NCT00973973|584735554|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
161914279|NCT00973973|584735553|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
161914280|NCT00973973|584735554|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
161914281|NCT00973973|584735553|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
161914282|NCT00973973|584735554|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
161914283|NCT00973973|584735553|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
161914284|NCT00973973|584735554|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
161914285|NCT00973973|584735553|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
161914286|NCT00973973|584735554|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
161914287|NCT00973973|584735553|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
161914288|NCT00973973|584735554|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
161914289|NCT00973973|584735553|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
161914290|NCT00973973|584735554|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
161914291|NCT00973973|584735553|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
161914292|NCT00973973|584735554|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
161914293|NCT00973973|584735553|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
161914294|NCT00973973|584735554|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
161914295|NCT00973973|584735553|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
161914296|NCT00973973|584735554|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
161914297|NCT00973973|584735553|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
161914298|NCT00973973|584735554|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
161914299|NCT02471339|584735555|FG000|Overall Study|Did not provide follow-up data|2|||
161914300|NCT02471339|584735556|FG001|Overall Study|Did not provide follow-up data|0|||
161914301|NCT06057064|584735557|FG000|Overall Study|Death|2|||
161914302|NCT06057064|584735558|FG001|Overall Study|Death|0|||
162150522|NCT03401112|585599477|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
161914303|NCT06057064|584735557|FG000|Overall Study|Physician Decision|1|||
161914304|NCT06057064|584735558|FG001|Overall Study|Physician Decision|0|||
161914305|NCT06057064|584735557|FG000|Overall Study|Withdrawal by Subject|1|||
161914306|NCT06057064|584735558|FG001|Overall Study|Withdrawal by Subject|1|||
162012332|NCT02504151|585101745|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
162150523|NCT03401112|585599478|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
162150524|NCT03401112|585599474|FG000|Overall Study|Withdrawal by Subject|0|||
162150525|NCT03401112|585599475|FG001|Overall Study|Withdrawal by Subject|3|||
162150526|NCT03401112|585599476|FG002|Overall Study|Withdrawal by Subject|2|||
162150527|NCT03401112|585599477|FG003|Overall Study|Withdrawal by Subject|1|||
162150528|NCT03401112|585599478|FG004|Overall Study|Withdrawal by Subject|0|||
162150529|NCT03401112|585599474|FG000|Overall Study|Physician Decision|0|||
162150530|NCT03401112|585599475|FG001|Overall Study|Physician Decision|0|||
162150531|NCT03401112|585599476|FG002|Overall Study|Physician Decision|0|||
162150532|NCT03401112|585599477|FG003|Overall Study|Physician Decision|2|||
162150533|NCT03401112|585599478|FG004|Overall Study|Physician Decision|0|||
162150534|NCT03401112|585599474|FG000|Overall Study|Study was Terminated by Sponsor|0|||
162150535|NCT03401112|585599475|FG001|Overall Study|Study was Terminated by Sponsor|0|||
162150536|NCT03401112|585599476|FG002|Overall Study|Study was Terminated by Sponsor|0|||
162150537|NCT03401112|585599477|FG003|Overall Study|Study was Terminated by Sponsor|1|||
162150538|NCT03401112|585599478|FG004|Overall Study|Study was Terminated by Sponsor|0|||
162150539|NCT03401112|585599474|FG000|Overall Study|Day 1 Assessment not Done|1|||
162150540|NCT03401112|585599475|FG001|Overall Study|Day 1 Assessment not Done|0|||
162150541|NCT03401112|585599476|FG002|Overall Study|Day 1 Assessment not Done|0|||
162150542|NCT03401112|585599477|FG003|Overall Study|Day 1 Assessment not Done|0|||
162150543|NCT03401112|585599478|FG004|Overall Study|Day 1 Assessment not Done|0|||
162150544|NCT03401112|585599474|FG000|Overall Study|Not Dosed|0|||
162150545|NCT03401112|585599475|FG001|Overall Study|Not Dosed|0|||
162150546|NCT03401112|585599476|FG002|Overall Study|Not Dosed|1|||
162150547|NCT03401112|585599477|FG003|Overall Study|Not Dosed|0|||
162150548|NCT03401112|585599478|FG004|Overall Study|Not Dosed|0|||
162150549|NCT03401112|585599474|FG000|Overall Study|Missed Clinical Visit|0|||
162150550|NCT03401112|585599475|FG001|Overall Study|Missed Clinical Visit|0|||
162150551|NCT03401112|585599476|FG002|Overall Study|Missed Clinical Visit|1|||
162150552|NCT03401112|585599477|FG003|Overall Study|Missed Clinical Visit|0|||
162150553|NCT03401112|585599478|FG004|Overall Study|Missed Clinical Visit|0|||
162150554|NCT03401112|585599474|FG000|Overall Study|Missed Doses|0|||
162150555|NCT03401112|585599475|FG001|Overall Study|Missed Doses|0|||
162150556|NCT03401112|585599476|FG002|Overall Study|Missed Doses|1|||
162150557|NCT03401112|585599477|FG003|Overall Study|Missed Doses|0|||
162150558|NCT03401112|585599478|FG004|Overall Study|Missed Doses|0|||
162150559|NCT01264679|585599479|FG000|Overall Study|Participation in Another Clinical Trial|1|||
162150560|NCT01264679|585599479|FG000|Overall Study|Physician Decision|1|||
162150561|NCT01264679|585599479|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
162150562|NCT01264679|585599479|FG000|Overall Study|Withdrawal by Subject|1|||
162150563|NCT03475316|585599480|FG000|6 Month Intervention|Adverse Event|2|||
162150564|NCT03475316|585599481|FG001|6 Month Intervention|Adverse Event|1|||
162150565|NCT03475316|585599480|FG000|6 Month Intervention|Withdrawal by Subject|2|||
162150566|NCT03475316|585599481|FG001|6 Month Intervention|Withdrawal by Subject|0|||
161810107|NCT01796171|584347691|FG011|Follow-up Period|Sponsor Decision|15|||
161810108|NCT01796171|584347692|FG012|Follow-up Period|Sponsor Decision|7|||
161810109|NCT01796171|584347693|FG013|Follow-up Period|Sponsor Decision|0|||
161810110|NCT01796171|584347694|FG014|Follow-up Period|Sponsor Decision|0|||
161810111|NCT00418561|584347695|FG000|Overall Study|Participant's (guardian's) decision|0|||
161810112|NCT00418561|584347696|FG001|Overall Study|Participant's (guardian's) decision|1|||
161810113|NCT00418561|584347697|FG002|Overall Study|Participant's (guardian's) decision|0|||
161810114|NCT00829309|584347698|FG000|Washout: 7 Days|Protocol Violation|1|||
161810115|NCT00829309|584347699|FG001|Washout: 7 Days|Protocol Violation|0|||
161810116|NCT01083693|584347700|FG000|Overall Study|Adverse Event|1|||
161810117|NCT01083693|584347701|FG001|Overall Study|Adverse Event|1|||
161810118|NCT01083693|584347702|FG002|Overall Study|Adverse Event|0|||
161810119|NCT01083693|584347700|FG000|Overall Study|Lost to Follow-up|2|||
161810120|NCT01083693|584347701|FG001|Overall Study|Lost to Follow-up|0|||
161810121|NCT01083693|584347702|FG002|Overall Study|Lost to Follow-up|2|||
161810122|NCT01083693|584347700|FG000|Overall Study|Lack of effectiveness|13|||
161810123|NCT01083693|584347701|FG001|Overall Study|Lack of effectiveness|2|||
161810124|NCT01083693|584347702|FG002|Overall Study|Lack of effectiveness|2|||
161810125|NCT01083693|584347700|FG000|Overall Study|Patient Moved|0|||
161810126|NCT01083693|584347701|FG001|Overall Study|Patient Moved|1|||
161810127|NCT01083693|584347702|FG002|Overall Study|Patient Moved|0|||
161810128|NCT01083693|584347700|FG000|Overall Study|Complete remission|0|||
161810129|NCT01083693|584347701|FG001|Overall Study|Complete remission|1|||
161810130|NCT01083693|584347702|FG002|Overall Study|Complete remission|0|||
161810131|NCT01083693|584347700|FG000|Overall Study|Other medical condition/surgery|1|||
162150567|NCT03475316|585599480|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
162150568|NCT03475316|585599481|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
162150569|NCT03475316|585599480|FG000|9 Months|Study stopped due to COVID pandemic|3|||
162150570|NCT03475316|585599481|FG001|9 Months|Study stopped due to COVID pandemic|4|||
161810132|NCT01083693|584347701|FG001|Overall Study|Other medical condition/surgery|1|||
162150571|NCT00424645|585599486|FG000|Overall Study|Death|1|||
162150572|NCT00424645|585599487|FG001|Overall Study|Death|0|||
162150573|NCT02555215|585599488|FG000|Overall Study|Other|1|||
162150574|NCT02555215|585599488|FG000|Overall Study|Investigator Decision|2|||
162150575|NCT00529789|585599489|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
162150576|NCT00529789|585599489|FG000|Study Period II/III|Adverse Event|3|||
162150577|NCT00529789|585599489|FG000|Study Period II/III|Lack of Efficacy|2|||
162150578|NCT00529789|585599489|FG000|Study Period II/III|Withdrawal by Subject|1|||
162150579|NCT00529789|585599489|FG000|Study Period II/III|Protocol Violation|3|||
162150580|NCT00529789|585599489|FG000|Study Period II/III|Physician Decision|3|||
162150581|NCT00529789|585599489|FG000|Study Period II/III|Lost to Follow-up|3|||
162150582|NCT00529789|585599489|FG000|Study Period IV|Parent/Caregiver Decision|1|||
162150583|NCT00529789|585599489|FG000|Study Period IV|Adverse Event|1|||
162150584|NCT00529789|585599489|FG000|Study Period IV|Lack of Efficacy|1|||
162150585|NCT00529789|585599489|FG000|Study Period IV|Lost to Follow-up|3|||
162150586|NCT02204982|585599490|FG000|Overall Study|Patient ineligible-medical monitor|1|||
162150587|NCT02204982|585599491|FG001|Overall Study|Patient ineligible-medical monitor|0|||
162150588|NCT02204982|585599490|FG000|Overall Study|Withdrawal by Subject|1|||
162150589|NCT02204982|585599491|FG001|Overall Study|Withdrawal by Subject|0|||
162150590|NCT02204982|585599490|FG000|Overall Study|Adverse Event|1|||
162150591|NCT02204982|585599491|FG001|Overall Study|Adverse Event|0|||
162150592|NCT02204982|585599490|FG000|Overall Study|Adverse Event and Investigator decision|1|||
162150593|NCT02204982|585599491|FG001|Overall Study|Adverse Event and Investigator decision|0|||
162150594|NCT02204982|585599490|FG000|Overall Study|Physician Decision|0|||
162150595|NCT02204982|585599491|FG001|Overall Study|Physician Decision|2|||
162150596|NCT02204982|585599490|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
162150597|NCT02204982|585599491|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
162150598|NCT02204982|585599490|FG000|Overall Study|Termination of Study bySponsor|0|||
162150599|NCT02204982|585599491|FG001|Overall Study|Termination of Study bySponsor|1|||
162150600|NCT01968226|585599492|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
162150601|NCT00959946|585599495|FG000|Overall Study|Adverse Event|0|||
162150602|NCT00959946|585599496|FG001|Overall Study|Adverse Event|0|||
162150603|NCT00959946|585599497|FG002|Overall Study|Adverse Event|2|||
162150604|NCT00959946|585599498|FG003|Overall Study|Adverse Event|1|||
162150605|NCT00959946|585599499|FG004|Overall Study|Adverse Event|0|||
162150606|NCT00959946|585599500|FG005|Overall Study|Adverse Event|1|||
162150607|NCT00959946|585599501|FG006|Overall Study|Adverse Event|0|||
162150608|NCT00959946|585599502|FG007|Overall Study|Adverse Event|0|||
162150609|NCT00959946|585599495|FG000|Overall Study|Death|0|||
162150610|NCT00959946|585599496|FG001|Overall Study|Death|0|||
162150611|NCT00959946|585599497|FG002|Overall Study|Death|0|||
162150612|NCT00959946|585599498|FG003|Overall Study|Death|0|||
162150613|NCT00959946|585599499|FG004|Overall Study|Death|0|||
162150614|NCT00959946|585599500|FG005|Overall Study|Death|1|||
162150615|NCT00959946|585599501|FG006|Overall Study|Death|0|||
162150616|NCT00959946|585599502|FG007|Overall Study|Death|0|||
162150617|NCT00959946|585599495|FG000|Overall Study|Disease Progression|2|||
162150618|NCT00959946|585599496|FG001|Overall Study|Disease Progression|4|||
162150619|NCT00959946|585599497|FG002|Overall Study|Disease Progression|2|||
162150620|NCT00959946|585599498|FG003|Overall Study|Disease Progression|4|||
162150621|NCT00959946|585599499|FG004|Overall Study|Disease Progression|4|||
162150622|NCT00959946|585599500|FG005|Overall Study|Disease Progression|6|||
162150623|NCT00959946|585599501|FG006|Overall Study|Disease Progression|2|||
162150624|NCT00959946|585599502|FG007|Overall Study|Disease Progression|2|||
162150625|NCT00959946|585599495|FG000|Overall Study|Withdrawal by Subject|0|||
162150626|NCT00959946|585599496|FG001|Overall Study|Withdrawal by Subject|0|||
162150627|NCT00959946|585599497|FG002|Overall Study|Withdrawal by Subject|0|||
162150628|NCT00959946|585599498|FG003|Overall Study|Withdrawal by Subject|0|||
162150629|NCT00959946|585599499|FG004|Overall Study|Withdrawal by Subject|0|||
162150630|NCT00959946|585599500|FG005|Overall Study|Withdrawal by Subject|1|||
162150631|NCT00959946|585599501|FG006|Overall Study|Withdrawal by Subject|0|||
162150632|NCT00959946|585599502|FG007|Overall Study|Withdrawal by Subject|0|||
162150633|NCT00457743|585599503|FG000|Overall Study|Adverse Event|0|||
162150634|NCT00457743|585599504|FG001|Overall Study|Adverse Event|4|||
162150635|NCT00457743|585599505|FG002|Overall Study|Adverse Event|0|||
162150636|NCT00457743|585599503|FG000|Overall Study|Lack of Efficacy|3|||
162150637|NCT00457743|585599504|FG001|Overall Study|Lack of Efficacy|23|||
161810133|NCT01083693|584347702|FG002|Overall Study|Other medical condition/surgery|0|||
161810134|NCT01083693|584347700|FG000|Overall Study|Withdrawal by Subject|3|||
162150638|NCT00457743|585599505|FG002|Overall Study|Lack of Efficacy|3|||
162150639|NCT01837966|585599507|FG000|Overall Study|Withdrawal by Subject|2|||
162150640|NCT01837966|585599508|FG001|Overall Study|Withdrawal by Subject|1|||
162150641|NCT00468910|585599512|FG000|Overall Study|Lost to Follow-up|2|||
162150642|NCT00468910|585599513|FG001|Overall Study|Lost to Follow-up|1|||
162150643|NCT00468910|585599512|FG000|Overall Study|Withdrawal by Subject|2|||
162150644|NCT00468910|585599513|FG001|Overall Study|Withdrawal by Subject|1|||
162150645|NCT00468910|585599512|FG000|Overall Study|Medical Contraindication|0|||
162150646|NCT00468910|585599513|FG001|Overall Study|Medical Contraindication|1|||
162150647|NCT01909778|585599514|FG000|Overall Study|failed screening|1|||
162150648|NCT01943916|585599515|FG000|Overall Study|Technically invalid images|10|||
162150649|NCT01943916|585599515|FG000|Overall Study|Enrollment Failure|23|||
162150650|NCT01943916|585599515|FG000|Overall Study|Pilot Phase exclusion|100|||
162150651|NCT01943916|585599515|FG000|Overall Study|Quality Assurance Reader Fail|130|||
162150652|NCT01943916|585599515|FG000|Overall Study|Technical Failure|39|||
162150653|NCT01943916|585599515|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
162150654|NCT01943916|585599515|FG000|Overall Study|No Truth Panel Review|38|||
162150655|NCT01943916|585599515|FG000|Overall Study|Protocol Deviation|1|||
162150656|NCT00919763|585599516|FG000|Overall Study|Adverse Event|7|||
162150657|NCT00919763|585599517|FG001|Overall Study|Adverse Event|1|||
162150658|NCT00919763|585599516|FG000|Overall Study|Lost to Follow-up|1|||
162150659|NCT00919763|585599517|FG001|Overall Study|Lost to Follow-up|0|||
162150660|NCT00919763|585599516|FG000|Overall Study|Protocol Violation|1|||
162150661|NCT00919763|585599517|FG001|Overall Study|Protocol Violation|1|||
162150662|NCT00919763|585599516|FG000|Overall Study|Withdrawal by Subject|3|||
162150663|NCT00919763|585599517|FG001|Overall Study|Withdrawal by Subject|1|||
162150664|NCT00919763|585599516|FG000|Overall Study|Non-compliance|0|||
162150665|NCT00919763|585599517|FG001|Overall Study|Non-compliance|1|||
162150666|NCT05323734|585599518|FG000|Overall Study|Adverse Event|5|||
162150667|NCT05323734|585599519|FG001|Overall Study|Adverse Event|2|||
162150668|NCT05323734|585599518|FG000|Overall Study|Physician Decision|1|||
162150669|NCT05323734|585599519|FG001|Overall Study|Physician Decision|0|||
162150670|NCT05323734|585599518|FG000|Overall Study|Lack of Efficacy|1|||
162150671|NCT05323734|585599519|FG001|Overall Study|Lack of Efficacy|2|||
162150672|NCT05323734|585599518|FG000|Overall Study|Withdrawal by Subject|2|||
162150673|NCT05323734|585599519|FG001|Overall Study|Withdrawal by Subject|0|||
162150674|NCT05323734|585599518|FG000|Overall Study|Participant Withdrawn Due|0|||
162150675|NCT05323734|585599519|FG001|Overall Study|Participant Withdrawn Due|1|||
162150676|NCT01595321|585599520|FG000|Overall Study|Adverse Event|1|||
162150677|NCT01595321|585599521|FG001|Overall Study|Adverse Event|1|||
162150678|NCT01595321|585599522|FG002|Overall Study|Adverse Event|1|||
162150679|NCT01595321|585599520|FG000|Overall Study|Lack of Efficacy|0|||
162150680|NCT01595321|585599521|FG001|Overall Study|Lack of Efficacy|0|||
162150681|NCT01595321|585599522|FG002|Overall Study|Lack of Efficacy|4|||
162150682|NCT00834834|585599523|FG000|Overall Study|Withdrawal by Subject|4|||
162150683|NCT00834834|585599524|FG001|Overall Study|Withdrawal by Subject|3|||
162150684|NCT00841035|585599529|FG000|Phase 1 Overall Study|Physician Decision|13|||
162150685|NCT00433199|585599534|FG000|Double-Blind Period|Adverse Event|0|||
162150686|NCT00433199|585599535|FG001|Double-Blind Period|Adverse Event|25|||
162150687|NCT00433199|585599534|FG000|Double-Blind Period|Lack of Efficacy|0|||
162150688|NCT00433199|585599535|FG001|Double-Blind Period|Lack of Efficacy|2|||
162150689|NCT00433199|585599534|FG000|Double-Blind Period|Lost to Follow-up|2|||
162150690|NCT00433199|585599535|FG001|Double-Blind Period|Lost to Follow-up|5|||
162150691|NCT00433199|585599534|FG000|Double-Blind Period|Withdrawal by Subject|8|||
162150692|NCT00433199|585599535|FG001|Double-Blind Period|Withdrawal by Subject|19|||
162150693|NCT00433199|585599534|FG000|Double-Blind Period|Protocol Violation|1|||
162150694|NCT00433199|585599535|FG001|Double-Blind Period|Protocol Violation|10|||
162150695|NCT00433199|585599534|FG000|Double-Blind Period|Administrative|1|||
162150696|NCT00433199|585599535|FG001|Double-Blind Period|Administrative|5|||
162150697|NCT00433199|585599534|FG000|Open-Label Period|Adverse Event|0|||
162150698|NCT00433199|585599535|FG001|Open-Label Period|Adverse Event|19|||
162150699|NCT00433199|585599534|FG000|Open-Label Period|Lack of Efficacy|0|||
162150700|NCT00433199|585599535|FG001|Open-Label Period|Lack of Efficacy|2|||
162150701|NCT00433199|585599534|FG000|Open-Label Period|Lost to Follow-up|0|||
162150702|NCT00433199|585599535|FG001|Open-Label Period|Lost to Follow-up|3|||
162150703|NCT00433199|585599534|FG000|Open-Label Period|Withdrawal by Subject|0|||
162150704|NCT00433199|585599535|FG001|Open-Label Period|Withdrawal by Subject|7|||
162150705|NCT00433199|585599534|FG000|Open-Label Period|Protocol Violation|0|||
162150706|NCT00433199|585599535|FG001|Open-Label Period|Protocol Violation|2|||
162150707|NCT00433199|585599534|FG000|Open-Label Period|Administrative|0|||
162150708|NCT00433199|585599535|FG001|Open-Label Period|Administrative|1|||
162150709|NCT00457691|585599538|FG000|Overall Study|Adverse Event|4|||
162150710|NCT00457691|585599539|FG001|Overall Study|Adverse Event|1|||
162150711|NCT00457691|585599538|FG000|Overall Study|Death|163|||
162150712|NCT00457691|585599539|FG001|Overall Study|Death|148|||
162150713|NCT00457691|585599538|FG000|Overall Study|Protocol Violation|1|||
162150714|NCT00457691|585599539|FG001|Overall Study|Protocol Violation|3|||
162150715|NCT00457691|585599538|FG000|Overall Study|Lost to Follow-up|23|||
162150716|NCT00457691|585599539|FG001|Overall Study|Lost to Follow-up|14|||
162150717|NCT00457691|585599538|FG000|Overall Study|Study terminated by Sponsor|1|||
162150718|NCT00457691|585599539|FG001|Overall Study|Study terminated by Sponsor|1|||
162150719|NCT00457691|585599538|FG000|Overall Study|Subject refused (reason other than AE)|14|||
162150720|NCT00457691|585599539|FG001|Overall Study|Subject refused (reason other than AE)|19|||
162150721|NCT00457691|585599538|FG000|Overall Study|Disease progression, study terminated|180|||
162150722|NCT00457691|585599539|FG001|Overall Study|Disease progression, study terminated|196|||
162150723|NCT01460446|585600742|FG000|Overall Study|Non-compliance|2|||
162150724|NCT01460446|585600743|FG001|Overall Study|Non-compliance|9|||
162150725|NCT01460446|585600742|FG000|Overall Study|Consent Withdrawn|0|||
162150726|NCT01460446|585600743|FG001|Overall Study|Consent Withdrawn|4|||
162150727|NCT01460446|585600742|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
161810135|NCT01083693|584347701|FG001|Overall Study|Withdrawal by Subject|0|||
161810136|NCT01083693|584347702|FG002|Overall Study|Withdrawal by Subject|2|||
161810137|NCT01083693|584347700|FG000|Overall Study|Reason unknown|0|||
161810138|NCT01083693|584347701|FG001|Overall Study|Reason unknown|0|||
161810139|NCT01083693|584347702|FG002|Overall Study|Reason unknown|1|||
161914307|NCT00851591|584735560|FG000|Overall Study|Withdrawal by Subject|2|||
161914308|NCT00851591|584735561|FG001|Overall Study|Withdrawal by Subject|0|||
161914309|NCT02736617|584735562|FG000|Treatment|Adverse Event|1|||
161914310|NCT02736617|584735562|FG000|Treatment|Lack of Efficacy|1|||
161914311|NCT02736617|584735562|FG000|Treatment|Withdrawal by Subject|1|||
161914312|NCT02736617|584735562|FG000|Maintenance|Lack of Efficacy|4|||
161914313|NCT02736617|584735562|FG000|Maintenance|Physician Decision|1|||
161914314|NCT00481676|584735565|FG000|Overall Study|Adverse Event|0|||
161914315|NCT00481676|584735566|FG001|Overall Study|Adverse Event|1|||
161914316|NCT00481676|584735565|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161914317|NCT00481676|584735566|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
161914318|NCT00481676|584735565|FG000|Overall Study|Administrative problem|1|||
161914319|NCT00481676|584735566|FG001|Overall Study|Administrative problem|0|||
161914320|NCT02911116|584735567|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161914321|NCT02911116|584735568|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161914322|NCT02911116|584735567|FG000|Overall Study|Lost to Follow-up|0|||
161914323|NCT02911116|584735568|FG001|Overall Study|Lost to Follow-up|1|||
161914324|NCT01513590|584735569|FG000|Overall Study|Adverse Event|2|||
161914325|NCT01513590|584735570|FG001|Overall Study|Adverse Event|3|||
161914326|NCT01513590|584735569|FG000|Overall Study|Withdrawal Criteria|3|||
161914327|NCT01513590|584735570|FG001|Overall Study|Withdrawal Criteria|0|||
161914328|NCT01513590|584735569|FG000|Overall Study|Unclassified|5|||
161914329|NCT01513590|584735570|FG001|Overall Study|Unclassified|10|||
161914330|NCT01240694|584735571|FG000|Overall Study|Adverse Event|9|||
161914331|NCT01240694|584735571|FG000|Overall Study|Lack of Efficacy|6|||
161914332|NCT01240694|584735571|FG000|Overall Study|Withdrawal by Subject|6|||
161914333|NCT01240694|584735571|FG000|Overall Study|Protocol Violation|2|||
161914334|NCT01240694|584735571|FG000|Overall Study|Lost to Follow-up|2|||
161914335|NCT01240694|584735571|FG000|Overall Study|Other than specified|3|||
161914336|NCT01240694|584735571|FG000|Overall Study|Withdrawn due to early study termination|107|||
161914337|NCT02110693|584735572|FG000|Overall Study|Withdrawal by Subject|6|||
161914338|NCT02110693|584735573|FG001|Overall Study|Withdrawal by Subject|7|||
161914339|NCT02110693|584735572|FG000|Overall Study|skipped assessment|15|||
161914340|NCT02110693|584735573|FG001|Overall Study|skipped assessment|18|||
161914341|NCT02110693|584735572|FG000|Overall Study|technical difficulties|6|||
161914342|NCT02110693|584735573|FG001|Overall Study|technical difficulties|4|||
161914343|NCT02110693|584735572|FG000|Overall Study|Other|1|||
161914344|NCT02110693|584735573|FG001|Overall Study|Other|0|||
161914345|NCT01881425|584735574|FG000|Overall Study|Death|5|||
161914346|NCT01881425|584735575|FG001|Overall Study|Death|1|||
161914347|NCT01881425|584735574|FG000|Overall Study|Withdrawal by Subject|8|||
161914348|NCT01881425|584735575|FG001|Overall Study|Withdrawal by Subject|3|||
161914349|NCT01881425|584735574|FG000|Overall Study|Physician Decision|2|||
161914350|NCT01881425|584735575|FG001|Overall Study|Physician Decision|1|||
161810140|NCT00455312|584347703|FG000|Overall Study|Death|0|||
161810141|NCT00455312|584347704|FG001|Overall Study|Death|1|||
161810142|NCT00777023|584347706|FG000|Overall Study|Adverse Event|15|||
161914351|NCT01881425|584735574|FG000|Overall Study|Adverse Event|3|||
161914352|NCT01881425|584735575|FG001|Overall Study|Adverse Event|0|||
161914353|NCT01881425|584735574|FG000|Overall Study|General Anesthesia panic attack|0|||
161914354|NCT01881425|584735575|FG001|Overall Study|General Anesthesia panic attack|1|||
161914355|NCT01881425|584735574|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
161914356|NCT01881425|584735575|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
161914357|NCT01881425|584735574|FG000|Overall Study|Lost to Follow-up|7|||
161914358|NCT01881425|584735575|FG001|Overall Study|Lost to Follow-up|2|||
161914359|NCT04154956|584735580|FG000|Overall Study|Death|109|||
161914360|NCT04154956|584735581|FG001|Overall Study|Death|110|||
161914361|NCT04154956|584735580|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
161914362|NCT04154956|584735581|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
161914363|NCT04154956|584735580|FG000|Overall Study|Withdrawal by Subject|1|||
161914364|NCT04154956|584735581|FG001|Overall Study|Withdrawal by Subject|7|||
161810143|NCT00777023|584347707|FG001|Overall Study|Adverse Event|21|||
161810144|NCT00777023|584347708|FG002|Overall Study|Adverse Event|8|||
161914365|NCT04154956|584735580|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
161914366|NCT04154956|584735581|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
161914367|NCT04424901|584735582|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
161914368|NCT04424901|584735583|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
161914369|NCT00147238|584735584|FG000|Overall Study|Inevaluable|8|||
161914370|NCT04810962|584735585|FG000|Overall Study|Adverse Event|0|||
161914371|NCT04810962|584735586|FG001|Overall Study|Adverse Event|1|||
161914372|NCT04810962|584735585|FG000|Overall Study|Lost to Follow-up|2|||
161914373|NCT04810962|584735586|FG001|Overall Study|Lost to Follow-up|1|||
161914374|NCT04810962|584735585|FG000|Overall Study|Physician Decision|1|||
161914375|NCT04810962|584735586|FG001|Overall Study|Physician Decision|0|||
161914376|NCT04810962|584735585|FG000|Overall Study|Withdrawal by Subject|1|||
161914377|NCT04810962|584735586|FG001|Overall Study|Withdrawal by Subject|3|||
161914378|NCT04810962|584735585|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
161914379|NCT04810962|584735586|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
161914380|NCT01348269|584735587|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
161914381|NCT01348269|584735588|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
161914382|NCT01348269|584735587|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
161914383|NCT01348269|584735588|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
161914384|NCT01348269|584735587|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
161914385|NCT01348269|584735588|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
162150728|NCT01460446|585600743|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
162150729|NCT01460446|585600742|FG000|Overall Study|Surgery/Illness|1|||
162150730|NCT01460446|585600743|FG001|Overall Study|Surgery/Illness|1|||
162150731|NCT01460446|585600742|FG000|Overall Study|Pregnancy|1|||
162150732|NCT01460446|585600743|FG001|Overall Study|Pregnancy|0|||
162150733|NCT01460446|585600742|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
162150734|NCT01460446|585600743|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
162150735|NCT00516321|585600744|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
162150736|NCT00516321|585600745|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
162150737|NCT00516321|585600746|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
162150738|NCT00516321|585600744|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
162150739|NCT00516321|585600745|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
162150740|NCT00516321|585600746|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
162150741|NCT00516321|585600744|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
162150742|NCT00516321|585600745|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
162150743|NCT00516321|585600746|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
162150744|NCT00516321|585600744|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
162150745|NCT00516321|585600745|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
162150746|NCT00516321|585600746|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
162150747|NCT00516321|585600744|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
162150748|NCT00516321|585600745|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
162150749|NCT00516321|585600746|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
162150750|NCT00516321|585600744|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
162150751|NCT00516321|585600745|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
162150752|NCT00516321|585600746|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
162150753|NCT00516321|585600744|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
162150754|NCT00516321|585600745|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
162150755|NCT00516321|585600746|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
162150756|NCT00516321|585600744|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
162150757|NCT00516321|585600745|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
162150758|NCT00516321|585600746|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
162150759|NCT00516321|585600744|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
162150760|NCT00516321|585600745|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
162150761|NCT00516321|585600746|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
162150762|NCT00516321|585600744|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
162150763|NCT00516321|585600745|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
162150764|NCT00516321|585600746|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
162150765|NCT00516321|585600744|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
162150766|NCT00516321|585600745|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
162150767|NCT00516321|585600746|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
162150768|NCT00414544|585600747|FG000|Overall Study|Lost to Follow-up|14|||
162150769|NCT01318382|585600751|FG000|Overall Study|Physician Decision|2|||
162150770|NCT01318382|585600751|FG000|Overall Study|Device Malfunction|10|||
162150771|NCT01318382|585600751|FG000|Overall Study|Protocol Violation|1|||
161914386|NCT00805532|584735589|FG000|Overall Study|invalid data|0|||
161914387|NCT00805532|584735590|FG001|Overall Study|invalid data|1|||
161914388|NCT02412657|584735591|FG000|Overall Study|Lost to Follow-up|1|||
161914389|NCT02412657|584735592|FG001|Overall Study|Lost to Follow-up|0|||
161914390|NCT02412657|584735593|FG002|Overall Study|Lost to Follow-up|0|||
161914391|NCT02412657|584735591|FG000|Overall Study|Protocol Violation|0|||
161914392|NCT02412657|584735592|FG001|Overall Study|Protocol Violation|2|||
162150772|NCT01599104|585600752|FG000|Overall Study|Withdrawal by Subject|1|||
162150773|NCT01599104|585600753|FG001|Overall Study|Withdrawal by Subject|1|||
162150774|NCT01599104|585600754|FG002|Overall Study|Withdrawal by Subject|2|||
162150775|NCT01599104|585600752|FG000|Overall Study|Technical Problems|1|||
162150776|NCT01599104|585600753|FG001|Overall Study|Technical Problems|0|||
161810145|NCT00777023|584347706|FG000|Overall Study|Lack of Efficacy|1|||
161810146|NCT00777023|584347707|FG001|Overall Study|Lack of Efficacy|0|||
161810147|NCT00777023|584347708|FG002|Overall Study|Lack of Efficacy|14|||
161810148|NCT00777023|584347706|FG000|Overall Study|Protocol Violation|2|||
161810149|NCT00777023|584347707|FG001|Overall Study|Protocol Violation|1|||
161810150|NCT00777023|584347708|FG002|Overall Study|Protocol Violation|1|||
162150777|NCT01599104|585600754|FG002|Overall Study|Technical Problems|0|||
162150778|NCT01599104|585600752|FG000|Overall Study|Physician Decision|3|||
162150779|NCT01599104|585600753|FG001|Overall Study|Physician Decision|2|||
162150780|NCT01599104|585600754|FG002|Overall Study|Physician Decision|2|||
162150781|NCT01599104|585600752|FG000|Overall Study|Non-compliance with study treatment|0|||
162150782|NCT01599104|585600753|FG001|Overall Study|Non-compliance with study treatment|1|||
162150783|NCT01599104|585600754|FG002|Overall Study|Non-compliance with study treatment|0|||
162150784|NCT01599104|585600752|FG000|Overall Study|Lack of Efficacy|4|||
162150785|NCT01599104|585600753|FG001|Overall Study|Lack of Efficacy|4|||
162150786|NCT01599104|585600754|FG002|Overall Study|Lack of Efficacy|10|||
162150787|NCT01599104|585600752|FG000|Overall Study|Adverse Event|7|||
162150788|NCT01599104|585600753|FG001|Overall Study|Adverse Event|6|||
161810151|NCT00777023|584347706|FG000|Overall Study|Lost to Follow-up|2|||
161810152|NCT00777023|584347707|FG001|Overall Study|Lost to Follow-up|3|||
161810153|NCT00777023|584347708|FG002|Overall Study|Lost to Follow-up|3|||
161810154|NCT00777023|584347706|FG000|Overall Study|Death|0|||
161810155|NCT00777023|584347707|FG001|Overall Study|Death|1|||
161810156|NCT00777023|584347708|FG002|Overall Study|Death|0|||
161810157|NCT00777023|584347706|FG000|Overall Study|Withdrawal by Subject|7|||
161810158|NCT00777023|584347707|FG001|Overall Study|Withdrawal by Subject|7|||
161810159|NCT00777023|584347708|FG002|Overall Study|Withdrawal by Subject|8|||
161810160|NCT00777023|584347706|FG000|Overall Study|Missing data|1|||
161810161|NCT00777023|584347707|FG001|Overall Study|Missing data|1|||
161810162|NCT00777023|584347708|FG002|Overall Study|Missing data|0|||
161810163|NCT00777023|584347706|FG000|Overall Study|Reasons not specified|4|||
161810164|NCT00777023|584347707|FG001|Overall Study|Reasons not specified|4|||
161810165|NCT00777023|584347708|FG002|Overall Study|Reasons not specified|2|||
161810166|NCT00777023|584347706|FG000|Overall Study|Last dose date unknown|3|||
161810167|NCT00777023|584347707|FG001|Overall Study|Last dose date unknown|3|||
161810168|NCT00777023|584347708|FG002|Overall Study|Last dose date unknown|1|||
161810169|NCT02472366|584347711|FG000|Overall Study|Lost to Follow-up|1|||
161810170|NCT02472366|584347712|FG001|Overall Study|Lost to Follow-up|0|||
161810171|NCT03699020|584347713|FG000|Overall Study|Withdrawal by Subject|3|||
161810172|NCT03699020|584347714|FG001|Overall Study|Withdrawal by Subject|2|||
161810173|NCT04274686|584347715|FG000|Overall Study|Physician Decision|1|||
161810174|NCT04274686|584347716|FG001|Overall Study|Physician Decision|0|||
161810175|NCT00089661|584347719|FG000|Overall Study|Adverse Event|0|||
161810176|NCT00089661|584347720|FG001|Overall Study|Adverse Event|2|||
161810177|NCT00089661|584347719|FG000|Overall Study|Death|1|||
161810178|NCT00089661|584347720|FG001|Overall Study|Death|0|||
161810179|NCT00089661|584347719|FG000|Overall Study|Lost to Follow-up|0|||
161810180|NCT00089661|584347720|FG001|Overall Study|Lost to Follow-up|3|||
161810181|NCT00089661|584347719|FG000|Overall Study|Withdrawal by Subject|11|||
161810182|NCT00089661|584347720|FG001|Overall Study|Withdrawal by Subject|9|||
162150789|NCT01599104|585600754|FG002|Overall Study|Adverse Event|12|||
162150790|NCT00714714|585600757|FG000|Overall Study|Adverse Event|1|||
161810183|NCT00089661|584347719|FG000|Overall Study|Disease progression|1|||
161810184|NCT00089661|584347720|FG001|Overall Study|Disease progression|3|||
162150791|NCT01308567|585600760|FG000|Overall Study|Lost to Follow-up|2|||
162150792|NCT01308567|585600761|FG001|Overall Study|Lost to Follow-up|4|||
162150793|NCT01308567|585600762|FG002|Overall Study|Lost to Follow-up|4|||
162150794|NCT01078116|585600767|FG000|Overall Study|Lost to Follow-up|17|||
162150795|NCT01078116|585600767|FG000|Overall Study|Adverse Event|5|||
162150796|NCT01078116|585600767|FG000|Overall Study|Withdrawal by Subject|8|||
162150797|NCT01078116|585600767|FG000|Overall Study|Lack of effectiveness|15|||
162150798|NCT01078116|585600767|FG000|Overall Study|Case report form not completed|3|||
162150799|NCT00585052|585600768|FG000|Overall Study|Withdrawal by Subject|1|||
162150800|NCT02616900|585600769|FG000|Overall Study|Lack of Efficacy|7|||
162150801|NCT02616900|585600769|FG000|Overall Study|Lost to Follow-up|2|||
162150802|NCT02616900|585600769|FG000|Overall Study|Protocol Violation|5|||
162150803|NCT02616900|585600769|FG000|Overall Study|Withdrawal by Subject|3|||
162150804|NCT02616900|585600769|FG000|Overall Study|Incomplete data|6|||
162150805|NCT04425863|585600770|FG000|Overall Study|Death|0|||
162150806|NCT04425863|585600771|FG001|Overall Study|Death|0|||
162150807|NCT04425863|585600772|FG002|Overall Study|Death|1|||
162150808|NCT02527148|585600774|FG000|Overall Study|Did not receive study intervention|1|||
162150809|NCT02527148|585600775|FG001|Overall Study|Did not receive study intervention|0|||
162150810|NCT02918279|585600776|FG000|Overall Study|Lost to Follow-up|3|||
162150811|NCT02918279|585600777|FG001|Overall Study|Lost to Follow-up|6|||
162150812|NCT02918279|585600776|FG000|Overall Study|Withdrawal by Subject|5|||
162150813|NCT02918279|585600777|FG001|Overall Study|Withdrawal by Subject|15|||
162150814|NCT02918279|585600776|FG000|Overall Study|Withdrawal by parent/guardian|2|||
162150815|NCT02918279|585600777|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162150816|NCT02918279|585600776|FG000|Overall Study|Other|3|||
162150817|NCT02918279|585600777|FG001|Overall Study|Other|1|||
162150818|NCT00309907|585600778|FG000|Overall Study|Death|4|||
162150819|NCT00309907|585600778|FG000|Overall Study|Physician Decision|1|||
162150820|NCT00309907|585600778|FG000|Overall Study|Ineligible|11|||
162150821|NCT00309907|585600778|FG000|Overall Study|Major infectious event|4|||
162150822|NCT00494780|585600779|FG000|Overall Study|Adverse Event|1|||
162150823|NCT00494780|585600780|FG001|Overall Study|Adverse Event|0|||
162150824|NCT00494780|585600779|FG000|Overall Study|Withdrew before Dosed|0|||
162150825|NCT00494780|585600780|FG001|Overall Study|Withdrew before Dosed|1|||
162150826|NCT00494780|585600779|FG000|Overall Study|Progression of Study Disease|7|||
162150827|NCT00494780|585600780|FG001|Overall Study|Progression of Study Disease|8|||
162150828|NCT00494780|585600779|FG000|Overall Study|New Treatment|2|||
162150829|NCT00494780|585600780|FG001|Overall Study|New Treatment|2|||
162150830|NCT00494780|585600779|FG000|Overall Study|Non-compliance|1|||
162150831|NCT00494780|585600780|FG001|Overall Study|Non-compliance|0|||
162150832|NCT00494780|585600779|FG000|Overall Study|Residual Tumour Mass|0|||
162150833|NCT00494780|585600780|FG001|Overall Study|Residual Tumour Mass|1|||
161914393|NCT02412657|584735593|FG002|Overall Study|Protocol Violation|3|||
162150834|NCT00494780|585600779|FG000|Overall Study|Insurance Issues|0|||
162150835|NCT00494780|585600780|FG001|Overall Study|Insurance Issues|1|||
162150836|NCT00869258|585600781|FG000|Overall Study|Physician Decision|1|||
162150837|NCT01641198|585600782|FG000|After 12 Months of Function|Lost to Follow-up|3|||
162150838|NCT01641198|585600783|FG001|After 12 Months of Function|Lost to Follow-up|2|||
162150839|NCT01641198|585600784|FG002|After 12 Months of Function|Lost to Follow-up|2|||
162150840|NCT01641198|585600782|FG000|After 12 Months of Function|Protocol Violation|1|||
162150841|NCT01641198|585600783|FG001|After 12 Months of Function|Protocol Violation|0|||
162150842|NCT01641198|585600784|FG002|After 12 Months of Function|Protocol Violation|0|||
162150843|NCT01641198|585600782|FG000|After 12 Months of Function|Adverse Event|0|||
162150844|NCT01641198|585600783|FG001|After 12 Months of Function|Adverse Event|1|||
162150845|NCT01641198|585600784|FG002|After 12 Months of Function|Adverse Event|0|||
162150846|NCT01641198|585600782|FG000|After 24 Months of Function|Lost to Follow-up|4|||
161914394|NCT00920816|584735597|FG000|Overall Study|Death|116|||
162150847|NCT01641198|585600783|FG001|After 24 Months of Function|Lost to Follow-up|9|||
162150848|NCT01641198|585600784|FG002|After 24 Months of Function|Lost to Follow-up|6|||
162150849|NCT01641198|585600782|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
162150850|NCT01641198|585600783|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
162150851|NCT01641198|585600784|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
162150852|NCT01641198|585600782|FG000|At 15-20 Years of Function|Death|1|||
162150853|NCT01641198|585600783|FG001|At 15-20 Years of Function|Death|0|||
162150854|NCT01641198|585600784|FG002|At 15-20 Years of Function|Death|1|||
162150855|NCT00980330|585600786|FG000|Overall Study|Adverse Event|0|||
162150856|NCT00980330|585600787|FG001|Overall Study|Adverse Event|0|||
162150857|NCT00980330|585600788|FG002|Overall Study|Adverse Event|0|||
162150858|NCT00980330|585600789|FG003|Overall Study|Adverse Event|1|||
162150859|NCT00980330|585600790|FG004|Overall Study|Adverse Event|0|||
162150860|NCT00980330|585600791|FG005|Overall Study|Adverse Event|0|||
162150861|NCT00980330|585600792|FG006|Overall Study|Adverse Event|0|||
162150862|NCT00980330|585600786|FG000|Overall Study|Lost to Follow-up|1|||
162150863|NCT00980330|585600787|FG001|Overall Study|Lost to Follow-up|1|||
162150864|NCT00980330|585600788|FG002|Overall Study|Lost to Follow-up|4|||
162150865|NCT00980330|585600789|FG003|Overall Study|Lost to Follow-up|2|||
162150866|NCT00980330|585600790|FG004|Overall Study|Lost to Follow-up|1|||
162150867|NCT00980330|585600791|FG005|Overall Study|Lost to Follow-up|1|||
162150868|NCT00980330|585600792|FG006|Overall Study|Lost to Follow-up|2|||
162150869|NCT00980330|585600786|FG000|Overall Study|Withdrawal by Subject|2|||
162150870|NCT00980330|585600787|FG001|Overall Study|Withdrawal by Subject|4|||
162150871|NCT00980330|585600788|FG002|Overall Study|Withdrawal by Subject|4|||
162150872|NCT00980330|585600789|FG003|Overall Study|Withdrawal by Subject|1|||
162150873|NCT00980330|585600790|FG004|Overall Study|Withdrawal by Subject|3|||
162150874|NCT00980330|585600791|FG005|Overall Study|Withdrawal by Subject|2|||
162150875|NCT00980330|585600792|FG006|Overall Study|Withdrawal by Subject|5|||
162150876|NCT00980330|585600786|FG000|Overall Study|(not specified)|2|||
162150877|NCT00980330|585600787|FG001|Overall Study|(not specified)|0|||
162150878|NCT00980330|585600788|FG002|Overall Study|(not specified)|0|||
162150879|NCT00980330|585600789|FG003|Overall Study|(not specified)|1|||
162150880|NCT00980330|585600790|FG004|Overall Study|(not specified)|1|||
162150881|NCT00980330|585600791|FG005|Overall Study|(not specified)|1|||
162150882|NCT00980330|585600792|FG006|Overall Study|(not specified)|0|||
162150883|NCT00346151|585600793|FG000|Overall Study|Withdrawal by Subject|3|||
162150884|NCT01075217|585600794|FG000|Overall Study|Adverse Event|1|||
162150885|NCT01075217|585600795|FG001|Overall Study|Adverse Event|1|||
162150886|NCT01075217|585600794|FG000|Overall Study|Physician Decision|1|||
162150887|NCT01075217|585600795|FG001|Overall Study|Physician Decision|0|||
162150888|NCT01692938|585600805|FG000|Overall Study|Protocol Deviation|1|||
162150889|NCT01692938|585600806|FG001|Overall Study|Protocol Deviation|1|||
162150890|NCT01692938|585600805|FG000|Overall Study|Study completed prior to site completion|3|||
162150891|NCT01692938|585600806|FG001|Overall Study|Study completed prior to site completion|3|||
162150892|NCT01444417|585600811|FG000|Overall Study|Ineligibility Determined|0|||
162150893|NCT01444417|585600812|FG001|Overall Study|Ineligibility Determined|1|||
162150894|NCT01444417|585600811|FG000|Overall Study|Withdrawal by Subject|2|||
162150895|NCT01444417|585600812|FG001|Overall Study|Withdrawal by Subject|0|||
162150896|NCT02423291|585600813|FG000|Overall Study|Lack of Efficacy|14|||
162150897|NCT02423291|585600813|FG000|Overall Study|Adverse Event|1|||
162150898|NCT02214160|585600816|FG000|Overall Study|Withdrawal by Subject|1|||
162150899|NCT02214160|585600817|FG001|Overall Study|Withdrawal by Subject|0|||
162150900|NCT02214160|585600818|FG002|Overall Study|Withdrawal by Subject|6|||
162150901|NCT02214160|585600816|FG000|Overall Study|Death|2|||
162150902|NCT02214160|585600817|FG001|Overall Study|Death|2|||
162150903|NCT02214160|585600818|FG002|Overall Study|Death|1|||
162150904|NCT02214160|585600816|FG000|Overall Study|Subject Non-Compliance|0|||
162150905|NCT02214160|585600817|FG001|Overall Study|Subject Non-Compliance|3|||
162150906|NCT02214160|585600818|FG002|Overall Study|Subject Non-Compliance|1|||
162150907|NCT02214160|585600816|FG000|Overall Study|Adverse Event|0|||
162012333|NCT02504151|585101746|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
162150908|NCT02214160|585600817|FG001|Overall Study|Adverse Event|1|||
162150909|NCT02214160|585600818|FG002|Overall Study|Adverse Event|1|||
162150910|NCT02214160|585600816|FG000|Overall Study|Sponsor Decision|0|||
162150911|NCT02214160|585600817|FG001|Overall Study|Sponsor Decision|2|||
162150912|NCT02214160|585600818|FG002|Overall Study|Sponsor Decision|0|||
162150913|NCT02214160|585600816|FG000|Overall Study|Protocol Violation|1|||
162150914|NCT02214160|585600817|FG001|Overall Study|Protocol Violation|0|||
162150915|NCT02214160|585600818|FG002|Overall Study|Protocol Violation|0|||
162150916|NCT02214160|585600816|FG000|Overall Study|Physician Decision|0|||
162150917|NCT02214160|585600817|FG001|Overall Study|Physician Decision|0|||
162150918|NCT02214160|585600818|FG002|Overall Study|Physician Decision|1|||
162150919|NCT01063972|585600819|FG000|Overall Study|Death|12|||
162150920|NCT01063972|585600820|FG001|Overall Study|Death|11|||
162150921|NCT01063972|585600819|FG000|Overall Study|Incarcerated|2|||
162150922|NCT01063972|585600820|FG001|Overall Study|Incarcerated|1|||
162150923|NCT01510717|585600822|FG000|Overall Study|Adverse Event|1|||
162150924|NCT01510717|585600823|FG001|Overall Study|Adverse Event|2|||
162150925|NCT01510717|585600822|FG000|Overall Study|Death|1|||
162150926|NCT01510717|585600823|FG001|Overall Study|Death|0|||
162150927|NCT01510717|585600822|FG000|Overall Study|Lost to Follow-up|0|||
162150928|NCT01510717|585600823|FG001|Overall Study|Lost to Follow-up|1|||
162150929|NCT01510717|585600822|FG000|Overall Study|Withdrawal by Subject|0|||
162150930|NCT01510717|585600823|FG001|Overall Study|Withdrawal by Subject|2|||
162150931|NCT01430611|585600825|FG000|Overall Study|Adverse Event|0|||
162150932|NCT01430611|585600826|FG001|Overall Study|Adverse Event|1|||
162150933|NCT01430611|585600825|FG000|Overall Study|Protocol Violation|1|||
162150934|NCT01430611|585600826|FG001|Overall Study|Protocol Violation|0|||
162150935|NCT01430611|585600825|FG000|Overall Study|Lost to Follow-up|1|||
162150936|NCT01430611|585600826|FG001|Overall Study|Lost to Follow-up|0|||
162150937|NCT01430611|585600825|FG000|Overall Study|Withdrawal by Subject|15|||
162150938|NCT01430611|585600826|FG001|Overall Study|Withdrawal by Subject|14|||
162150939|NCT02115139|585600827|FG000|Overall Study|Protocol Violation|1|||
162150940|NCT02115139|585600827|FG000|Overall Study|treatment discontinuation|6|||
162150941|NCT04740164|585600828|FG000|Overall Study|Lack of Efficacy|4|||
162150942|NCT04740164|585600829|FG001|Overall Study|Lack of Efficacy|0|||
162150943|NCT04740164|585600828|FG000|Overall Study|Physician Decision|3|||
162150944|NCT04740164|585600829|FG001|Overall Study|Physician Decision|3|||
162150945|NCT00258895|585600835|FG000|Overall Study|Lost to Follow-up|3|||
162150946|NCT00258895|585600836|FG001|Overall Study|Lost to Follow-up|1|||
161914395|NCT00920816|584735598|FG001|Overall Study|Death|63|||
161914396|NCT00920816|584735599|FG002|Overall Study|Death|8|||
161914397|NCT00920816|584735600|FG003|Overall Study|Death|3|||
161914398|NCT00920816|584735597|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
161914399|NCT00920816|584735598|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
161914400|NCT00920816|584735599|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
161914401|NCT00920816|584735600|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
161914402|NCT00920816|584735597|FG000|Overall Study|Global deterioration of health status|2|||
161914403|NCT00920816|584735598|FG001|Overall Study|Global deterioration of health status|0|||
161914404|NCT00920816|584735599|FG002|Overall Study|Global deterioration of health status|0|||
161914405|NCT00920816|584735600|FG003|Overall Study|Global deterioration of health status|0|||
161914406|NCT00920816|584735597|FG000|Overall Study|Objective progression or relapse|6|||
161914407|NCT00920816|584735598|FG001|Overall Study|Objective progression or relapse|2|||
161914408|NCT00920816|584735599|FG002|Overall Study|Objective progression or relapse|0|||
161914409|NCT00920816|584735600|FG003|Overall Study|Objective progression or relapse|0|||
161914410|NCT00920816|584735597|FG000|Overall Study|Other|26|||
162150947|NCT00258895|585600835|FG000|Overall Study|Protocol Violation|6|||
162150948|NCT00258895|585600836|FG001|Overall Study|Protocol Violation|2|||
162150949|NCT00258895|585600835|FG000|Overall Study|Withdrawal by Subject|1|||
162150950|NCT00258895|585600836|FG001|Overall Study|Withdrawal by Subject|0|||
162150951|NCT00442117|585600837|FG000|Overall Study|Adverse Event|3|||
162150952|NCT00442117|585600838|FG001|Overall Study|Adverse Event|2|||
162150953|NCT00442117|585600837|FG000|Overall Study|Lack of Efficacy|2|||
162150954|NCT00442117|585600838|FG001|Overall Study|Lack of Efficacy|6|||
162150955|NCT00442117|585600837|FG000|Overall Study|Lost to Follow-up|1|||
162150956|NCT00442117|585600838|FG001|Overall Study|Lost to Follow-up|2|||
162150957|NCT00442117|585600837|FG000|Overall Study|Withdrawal by Subject|2|||
162150958|NCT00442117|585600838|FG001|Overall Study|Withdrawal by Subject|2|||
162150959|NCT00442117|585600837|FG000|Overall Study|Major Deviation|25|||
162150960|NCT00442117|585600838|FG001|Overall Study|Major Deviation|20|||
161914411|NCT00920816|584735598|FG001|Overall Study|Other|15|||
161914412|NCT00920816|584735599|FG002|Overall Study|Other|1|||
161914413|NCT00920816|584735600|FG003|Overall Study|Other|2|||
162150961|NCT00442117|585600837|FG000|Overall Study|Non compliance with protocol|3|||
162150962|NCT00442117|585600838|FG001|Overall Study|Non compliance with protocol|5|||
162150963|NCT00442117|585600837|FG000|Overall Study|Met Withdrawal Criteria|2|||
161914414|NCT00920816|584735597|FG000|Overall Study|Lost to Follow-up|11|||
161914415|NCT00920816|584735598|FG001|Overall Study|Lost to Follow-up|2|||
161914416|NCT00920816|584735599|FG002|Overall Study|Lost to Follow-up|0|||
161914417|NCT00920816|584735600|FG003|Overall Study|Lost to Follow-up|0|||
162150964|NCT00442117|585600838|FG001|Overall Study|Met Withdrawal Criteria|1|||
162150965|NCT01121549|585600847|FG000|Overall Study|Adverse Event|10|||
162150966|NCT01121549|585600847|FG000|Overall Study|Lack of Efficacy|11|||
162150967|NCT01121549|585600847|FG000|Overall Study|Lost to Follow-up|12|||
162150968|NCT01121549|585600847|FG000|Overall Study|Did not meet entrance criteria|9|||
162150969|NCT01121549|585600847|FG000|Overall Study|Study terminated by sponsor|197|||
162150970|NCT01121549|585600847|FG000|Overall Study|Pregnancy|1|||
162150971|NCT01121549|585600847|FG000|Overall Study|Protocol Violation|33|||
162150972|NCT01121549|585600847|FG000|Overall Study|Withdrawal by Subject|16|||
162150973|NCT01121549|585600847|FG000|Overall Study|Other|58|||
162150974|NCT03073941|585602834|FG000|Overall Study|Received non-study device intraoperatively|0|||
162150975|NCT03073941|585602835|FG001|Overall Study|Received non-study device intraoperatively|2|||
161914418|NCT00920816|584735597|FG000|Overall Study|Adverse Event|1|||
161914419|NCT00920816|584735598|FG001|Overall Study|Adverse Event|1|||
161914420|NCT00920816|584735599|FG002|Overall Study|Adverse Event|1|||
162150976|NCT03073941|585602834|FG000|Overall Study|Death|1|||
162150977|NCT03073941|585602835|FG001|Overall Study|Death|0|||
162150978|NCT03073941|585602834|FG000|Overall Study|Withdrawal by Subject|1|||
162150979|NCT03073941|585602835|FG001|Overall Study|Withdrawal by Subject|3|||
162150980|NCT03073941|585602834|FG000|Overall Study|Lost to Follow-up|5|||
162150981|NCT03073941|585602835|FG001|Overall Study|Lost to Follow-up|4|||
162150982|NCT03073941|585602834|FG000|Overall Study|Adverse Event|4|||
162150983|NCT03073941|585602835|FG001|Overall Study|Adverse Event|2|||
162150984|NCT03073941|585602834|FG000|Overall Study|Met an exclusion criterion|0|||
162150985|NCT03073941|585602835|FG001|Overall Study|Met an exclusion criterion|1|||
162150986|NCT04250883|585602836|FG000|Overall Study|Lost to Follow-up|1|||
162150987|NCT04250883|585602837|FG001|Overall Study|Lost to Follow-up|0|||
162150988|NCT02763319|585602838|FG000|Overall Study|Adverse Event|12|||
162150989|NCT02763319|585602839|FG001|Overall Study|Adverse Event|3|||
162150990|NCT02763319|585602838|FG000|Overall Study|Death|123|||
162150991|NCT02763319|585602839|FG001|Overall Study|Death|123|||
161914421|NCT00920816|584735600|FG003|Overall Study|Adverse Event|0|||
161914422|NCT00920816|584735597|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
161914423|NCT00920816|584735598|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
161914424|NCT00920816|584735599|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
161914425|NCT00920816|584735600|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
161914426|NCT00920816|584735597|FG000|Overall Study|Randomized but not treated|3|||
161914427|NCT00920816|584735598|FG001|Overall Study|Randomized but not treated|0|||
161914428|NCT00920816|584735599|FG002|Overall Study|Randomized but not treated|0|||
161914429|NCT00920816|584735600|FG003|Overall Study|Randomized but not treated|0|||
161914430|NCT03185208|584735601|FG000|Overall Study|Did not start study medication|0|||
161914431|NCT03185208|584735602|FG001|Overall Study|Did not start study medication|3|||
161914432|NCT03834350|584735603|FG000|Overall Study|Withdrawal by Subject|1|||
161914433|NCT02765165|584735608|FG000|Treatment Period|Progressive disease|3|||
161914434|NCT02765165|584735609|FG001|Treatment Period|Progressive disease|2|||
161914435|NCT02765165|584735610|FG002|Treatment Period|Progressive disease|3|||
161914436|NCT02765165|584735611|FG003|Treatment Period|Progressive disease|3|||
161914437|NCT02765165|584735612|FG004|Treatment Period|Progressive disease|4|||
161914438|NCT02765165|584735613|FG005|Treatment Period|Progressive disease|2|||
161914439|NCT02765165|584735614|FG006|Treatment Period|Progressive disease|2|||
161914440|NCT02765165|584735608|FG000|Treatment Period|Physician Decision|0|||
161914441|NCT02765165|584735609|FG001|Treatment Period|Physician Decision|1|||
161914442|NCT02765165|584735610|FG002|Treatment Period|Physician Decision|0|||
161914443|NCT02765165|584735611|FG003|Treatment Period|Physician Decision|0|||
161914444|NCT02765165|584735612|FG004|Treatment Period|Physician Decision|0|||
161914445|NCT02765165|584735613|FG005|Treatment Period|Physician Decision|0|||
161914446|NCT02765165|584735614|FG006|Treatment Period|Physician Decision|0|||
161914447|NCT02765165|584735608|FG000|Treatment Period|Adverse Event|0|||
161914448|NCT02765165|584735609|FG001|Treatment Period|Adverse Event|1|||
161914449|NCT02765165|584735610|FG002|Treatment Period|Adverse Event|0|||
161914450|NCT02765165|584735611|FG003|Treatment Period|Adverse Event|0|||
161914451|NCT02765165|584735612|FG004|Treatment Period|Adverse Event|0|||
161914452|NCT02765165|584735613|FG005|Treatment Period|Adverse Event|0|||
161914453|NCT02765165|584735614|FG006|Treatment Period|Adverse Event|0|||
161914454|NCT02765165|584735608|FG000|Treatment Period|Withdrawal by Subject|0|||
161914455|NCT02765165|584735609|FG001|Treatment Period|Withdrawal by Subject|0|||
161914456|NCT02765165|584735610|FG002|Treatment Period|Withdrawal by Subject|0|||
161914457|NCT02765165|584735611|FG003|Treatment Period|Withdrawal by Subject|0|||
161914458|NCT02765165|584735612|FG004|Treatment Period|Withdrawal by Subject|2|||
161914459|NCT02765165|584735613|FG005|Treatment Period|Withdrawal by Subject|0|||
162150992|NCT02763319|585602838|FG000|Overall Study|Lost to Follow-up|6|||
162150993|NCT02763319|585602839|FG001|Overall Study|Lost to Follow-up|7|||
162150994|NCT02763319|585602838|FG000|Overall Study|Noncompliance with Study Drug|2|||
162150995|NCT02763319|585602839|FG001|Overall Study|Noncompliance with Study Drug|0|||
161914460|NCT02765165|584735614|FG006|Treatment Period|Withdrawal by Subject|0|||
161914461|NCT02765165|584735608|FG000|Treatment Period|Study terminated|0|||
161914462|NCT02765165|584735609|FG001|Treatment Period|Study terminated|0|||
161914463|NCT02765165|584735610|FG002|Treatment Period|Study terminated|0|||
161914464|NCT02765165|584735611|FG003|Treatment Period|Study terminated|0|||
161914465|NCT02765165|584735612|FG004|Treatment Period|Study terminated|0|||
161914466|NCT02765165|584735613|FG005|Treatment Period|Study terminated|1|||
162150996|NCT02763319|585602838|FG000|Overall Study|"Captured as Other in Database"|29|||
162150997|NCT02763319|585602839|FG001|Overall Study|"Captured as Other in Database"|34|||
161914467|NCT02765165|584735614|FG006|Treatment Period|Study terminated|2|||
161914468|NCT02765165|584735608|FG000|Post-treatment Follow-up|Death|1|||
162150998|NCT02763319|585602838|FG000|Overall Study|Physician Decision|1|||
162150999|NCT02763319|585602839|FG001|Overall Study|Physician Decision|7|||
162151000|NCT02763319|585602838|FG000|Overall Study|Progressive Disease|24|||
162151001|NCT02763319|585602839|FG001|Overall Study|Progressive Disease|27|||
161914469|NCT02765165|584735609|FG001|Post-treatment Follow-up|Death|2|||
161914470|NCT02765165|584735610|FG002|Post-treatment Follow-up|Death|1|||
161914471|NCT02765165|584735611|FG003|Post-treatment Follow-up|Death|1|||
161914472|NCT02765165|584735612|FG004|Post-treatment Follow-up|Death|1|||
161914473|NCT02765165|584735613|FG005|Post-treatment Follow-up|Death|1|||
161914474|NCT02765165|584735614|FG006|Post-treatment Follow-up|Death|0|||
161914475|NCT02765165|584735608|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
162012334|NCT02504151|585101745|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
162012335|NCT02504151|585101746|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
162012336|NCT00538902|585101747|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
162012337|NCT00538902|585101748|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
162012338|NCT00538902|585101749|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
162012339|NCT00538902|585101747|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
162012340|NCT00538902|585101748|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
162012341|NCT00538902|585101749|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
162012342|NCT00538902|585101747|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
162012343|NCT00538902|585101748|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
162012344|NCT00538902|585101749|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
162012345|NCT00538902|585101747|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
162012346|NCT00538902|585101748|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
162012347|NCT00538902|585101749|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
162012348|NCT00538902|585101747|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
162012349|NCT00538902|585101748|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
162012350|NCT00538902|585101749|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
162012351|NCT00538902|585101747|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
162012352|NCT00538902|585101748|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
162012353|NCT00538902|585101749|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
162012354|NCT00538902|585101747|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
162012355|NCT00538902|585101748|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
162012356|NCT00538902|585101749|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
162012357|NCT00538902|585101747|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
162012358|NCT00538902|585101748|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
162012359|NCT00538902|585101749|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
162012360|NCT01454102|585101750|FG000|Overall Study|Continuing in the treatment period|0|||
162012361|NCT01454102|585101751|FG001|Overall Study|Continuing in the treatment period|0|||
162012362|NCT01454102|585101752|FG002|Overall Study|Continuing in the treatment period|0|||
162012363|NCT01454102|585101753|FG003|Overall Study|Continuing in the treatment period|0|||
162012364|NCT01454102|585101754|FG004|Overall Study|Continuing in the treatment period|3|||
162012365|NCT01454102|585101755|FG005|Overall Study|Continuing in the treatment period|3|||
162012366|NCT01454102|585101756|FG006|Overall Study|Continuing in the treatment period|2|||
162012367|NCT01454102|585101757|FG007|Overall Study|Continuing in the treatment period|0|||
162012368|NCT01454102|585101758|FG008|Overall Study|Continuing in the treatment period|1|||
162012369|NCT01454102|585101759|FG009|Overall Study|Continuing in the treatment period|0|||
162012370|NCT01454102|585101760|FG010|Overall Study|Continuing in the treatment period|0|||
162012371|NCT01454102|585101761|FG011|Overall Study|Continuing in the treatment period|4|||
162012372|NCT01454102|585101762|FG012|Overall Study|Continuing in the treatment period|7|||
162012373|NCT01454102|585101763|FG013|Overall Study|Continuing in the treatment period|4|||
162012374|NCT01454102|585101764|FG014|Overall Study|Continuing in the treatment period|3|||
162012375|NCT01454102|585101765|FG015|Overall Study|Continuing in the treatment period|1|||
162012376|NCT01782378|585101768|FG000|First Series|Lost to Follow-up|7|||
162012377|NCT01782378|585101769|FG001|First Series|Lost to Follow-up|8|||
162012378|NCT01782378|585101768|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
162012379|NCT01782378|585101769|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
162012380|NCT01782378|585101768|FG000|Second Series|Lost to Follow-up|8|||
162012381|NCT01782378|585101769|FG001|Second Series|Lost to Follow-up|7|||
162012382|NCT01782378|585101768|FG000|Second Series|Did not choose to complete S2 Optional|18|||
162012383|NCT01782378|585101769|FG001|Second Series|Did not choose to complete S2 Optional|0|||
162012384|NCT00705016|585101770|FG000|Overall Study|Adverse Event|6|||
162012385|NCT00705016|585101771|FG001|Overall Study|Adverse Event|11|||
162012386|NCT00705016|585101772|FG002|Overall Study|Adverse Event|10|||
162012387|NCT00705016|585101770|FG000|Overall Study|Death|5|||
162012388|NCT00705016|585101771|FG001|Overall Study|Death|7|||
162012389|NCT00705016|585101772|FG002|Overall Study|Death|5|||
162012390|NCT00705016|585101770|FG000|Overall Study|Protocol Violation|0|||
162012391|NCT00705016|585101771|FG001|Overall Study|Protocol Violation|1|||
162012392|NCT00705016|585101772|FG002|Overall Study|Protocol Violation|1|||
161914476|NCT02765165|584735609|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
161914477|NCT02765165|584735610|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
162151002|NCT02763319|585602838|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
162151003|NCT02763319|585602839|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
162151004|NCT02763319|585602838|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
162151005|NCT02763319|585602839|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
162151006|NCT02763319|585602838|FG000|Overall Study|Withdrawal by Subject|26|||
162151007|NCT02763319|585602839|FG001|Overall Study|Withdrawal by Subject|25|||
162151008|NCT03936660|585602841|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
162151009|NCT03936660|585602842|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
162151010|NCT00722046|585602843|FG000|Overall Study|Adverse Event|0|||
162151011|NCT00722046|585602844|FG001|Overall Study|Adverse Event|1|||
162151012|NCT00722046|585602845|FG002|Overall Study|Adverse Event|2|||
162151013|NCT00722046|585602846|FG003|Overall Study|Adverse Event|1|||
162151014|NCT00722046|585602847|FG004|Overall Study|Adverse Event|2|||
162151015|NCT00722046|585602848|FG005|Overall Study|Adverse Event|1|||
162151016|NCT00722046|585602849|FG006|Overall Study|Adverse Event|0|||
162151017|NCT00722046|585602843|FG000|Overall Study|Death|0|||
162151018|NCT00722046|585602844|FG001|Overall Study|Death|1|||
162151019|NCT00722046|585602845|FG002|Overall Study|Death|0|||
162012393|NCT00705016|585101770|FG000|Overall Study|Withdrawal by Subject|4|||
162012394|NCT00705016|585101771|FG001|Overall Study|Withdrawal by Subject|3|||
162012395|NCT00705016|585101772|FG002|Overall Study|Withdrawal by Subject|2|||
162012396|NCT00705016|585101770|FG000|Overall Study|Progressive Disease|33|||
162012397|NCT00705016|585101771|FG001|Overall Study|Progressive Disease|29|||
162012398|NCT00705016|585101772|FG002|Overall Study|Progressive Disease|33|||
162012399|NCT00705016|585101770|FG000|Overall Study|Symptomatic Deterioration|3|||
162012400|NCT00705016|585101771|FG001|Overall Study|Symptomatic Deterioration|1|||
162012401|NCT00705016|585101772|FG002|Overall Study|Symptomatic Deterioration|1|||
162012402|NCT00705016|585101770|FG000|Overall Study|Other|9|||
162012403|NCT00705016|585101771|FG001|Overall Study|Other|6|||
162012404|NCT00705016|585101772|FG002|Overall Study|Other|6|||
162012405|NCT00942604|585101775|FG000|Overall Study|Protocol Violation|1|||
162012406|NCT00942604|585101776|FG001|Overall Study|Protocol Violation|1|||
162012407|NCT00942604|585101775|FG000|Overall Study|Adverse Event|0|||
162012408|NCT00942604|585101776|FG001|Overall Study|Adverse Event|1|||
162012409|NCT00942604|585101775|FG000|Overall Study|Withdrawal by Subject|0|||
162012410|NCT00942604|585101776|FG001|Overall Study|Withdrawal by Subject|1|||
162012411|NCT00942604|585101775|FG000|Overall Study|Patient relocation|1|||
162012412|NCT00942604|585101776|FG001|Overall Study|Patient relocation|1|||
162012413|NCT01188343|585101777|FG000|Overall Study|Not vaccinated|0|||
162012414|NCT01188343|585101778|FG001|Overall Study|Not vaccinated|2|||
162012415|NCT01188343|585101779|FG002|Overall Study|Not vaccinated|1|||
162012416|NCT01188343|585101777|FG000|Overall Study|Withdrawal by Subject|1|||
162012417|NCT01188343|585101778|FG001|Overall Study|Withdrawal by Subject|24|||
162012418|NCT01188343|585101779|FG002|Overall Study|Withdrawal by Subject|0|||
162012419|NCT04109547|585101780|FG000|Overall Study|Withdrawal by Subject|3|||
162012420|NCT04109547|585101781|FG001|Overall Study|Withdrawal by Subject|2|||
162012421|NCT04109547|585101782|FG002|Overall Study|Withdrawal by Subject|6|||
162012422|NCT04109547|585101783|FG003|Overall Study|Withdrawal by Subject|6|||
162012423|NCT04109547|585101780|FG000|Overall Study|Lost to Follow-up|0|||
162012424|NCT04109547|585101781|FG001|Overall Study|Lost to Follow-up|0|||
162012425|NCT04109547|585101782|FG002|Overall Study|Lost to Follow-up|0|||
162012426|NCT04109547|585101783|FG003|Overall Study|Lost to Follow-up|1|||
162012427|NCT04109547|585101780|FG000|Overall Study|Physician Decision|1|||
162012428|NCT04109547|585101781|FG001|Overall Study|Physician Decision|2|||
162012429|NCT04109547|585101782|FG002|Overall Study|Physician Decision|0|||
162012430|NCT04109547|585101783|FG003|Overall Study|Physician Decision|0|||
162012431|NCT01663103|585101784|FG000|Overall Study|Withdrawal by Subject|1|||
162012432|NCT01663103|585101785|FG001|Overall Study|Withdrawal by Subject|2|||
162012433|NCT01663103|585101784|FG000|Overall Study|Adverse Event|1|||
162012434|NCT01663103|585101785|FG001|Overall Study|Adverse Event|0|||
162151020|NCT00722046|585602846|FG003|Overall Study|Death|0|||
162151021|NCT00722046|585602847|FG004|Overall Study|Death|0|||
162012435|NCT01663103|585101784|FG000|Overall Study|dog bite|1|||
162151022|NCT00722046|585602848|FG005|Overall Study|Death|0|||
162151023|NCT00722046|585602849|FG006|Overall Study|Death|2|||
162151024|NCT00722046|585602843|FG000|Overall Study|Protocol Violation|1|||
162151025|NCT00722046|585602844|FG001|Overall Study|Protocol Violation|0|||
162151026|NCT00722046|585602845|FG002|Overall Study|Protocol Violation|0|||
162151027|NCT00722046|585602846|FG003|Overall Study|Protocol Violation|0|||
162151028|NCT00722046|585602847|FG004|Overall Study|Protocol Violation|0|||
162151029|NCT00722046|585602848|FG005|Overall Study|Protocol Violation|1|||
162151030|NCT00722046|585602849|FG006|Overall Study|Protocol Violation|0|||
162151031|NCT00722046|585602843|FG000|Overall Study|Withdrawal by Subject|3|||
162151032|NCT00722046|585602844|FG001|Overall Study|Withdrawal by Subject|3|||
162151033|NCT00722046|585602845|FG002|Overall Study|Withdrawal by Subject|4|||
162151034|NCT00722046|585602846|FG003|Overall Study|Withdrawal by Subject|4|||
162151035|NCT00722046|585602847|FG004|Overall Study|Withdrawal by Subject|4|||
162151036|NCT00722046|585602848|FG005|Overall Study|Withdrawal by Subject|7|||
162151037|NCT00722046|585602849|FG006|Overall Study|Withdrawal by Subject|3|||
162151038|NCT00722046|585602843|FG000|Overall Study|Randomized, but not treated|1|||
162151039|NCT00722046|585602844|FG001|Overall Study|Randomized, but not treated|1|||
162151040|NCT00722046|585602845|FG002|Overall Study|Randomized, but not treated|0|||
162151041|NCT00722046|585602846|FG003|Overall Study|Randomized, but not treated|2|||
162151042|NCT00722046|585602847|FG004|Overall Study|Randomized, but not treated|0|||
162151043|NCT00722046|585602848|FG005|Overall Study|Randomized, but not treated|0|||
162151044|NCT00722046|585602849|FG006|Overall Study|Randomized, but not treated|0|||
162151045|NCT00722046|585602843|FG000|Overall Study|Other|0|||
162151046|NCT00722046|585602844|FG001|Overall Study|Other|0|||
162151047|NCT00722046|585602845|FG002|Overall Study|Other|1|||
162151048|NCT00722046|585602846|FG003|Overall Study|Other|1|||
162151049|NCT00722046|585602847|FG004|Overall Study|Other|3|||
162151050|NCT00722046|585602848|FG005|Overall Study|Other|2|||
162151051|NCT00722046|585602849|FG006|Overall Study|Other|1|||
162151052|NCT00925587|585602850|FG000|Overall Study|Protocol Specified Criteria|6|||
162151053|NCT00925587|585602851|FG001|Overall Study|Protocol Specified Criteria|6|||
162151054|NCT00925587|585602850|FG000|Overall Study|Physician Decision|4|||
162151055|NCT00925587|585602851|FG001|Overall Study|Physician Decision|1|||
162151056|NCT00925587|585602850|FG000|Overall Study|Protocol Violation|6|||
162151057|NCT00925587|585602851|FG001|Overall Study|Protocol Violation|4|||
162151058|NCT00925587|585602850|FG000|Overall Study|Withdrawal by Subject|9|||
162151059|NCT00925587|585602851|FG001|Overall Study|Withdrawal by Subject|6|||
162151060|NCT00925587|585602850|FG000|Overall Study|Death|5|||
162151061|NCT00925587|585602851|FG001|Overall Study|Death|5|||
162151062|NCT00925587|585602850|FG000|Overall Study|Adverse Event|6|||
162151063|NCT00925587|585602851|FG001|Overall Study|Adverse Event|2|||
162151064|NCT00925587|585602850|FG000|Overall Study|Lost to Follow-up|0|||
162151065|NCT00925587|585602851|FG001|Overall Study|Lost to Follow-up|1|||
162151066|NCT02271854|585602859|FG000|Overall Study|Withdrawal by Subject|2|||
162151067|NCT02271854|585602859|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
162151068|NCT02271854|585602859|FG000|Overall Study|Lost to Follow-up|1|||
162151069|NCT01571596|585602860|FG000|Overall Study|Adverse Event|2|||
162151070|NCT01571596|585602861|FG001|Overall Study|Adverse Event|0|||
162151071|NCT01571596|585602862|FG002|Overall Study|Adverse Event|0|||
162151072|NCT01571596|585602860|FG000|Overall Study|Study Terminated by the Sponsor|0|||
162151073|NCT01571596|585602861|FG001|Overall Study|Study Terminated by the Sponsor|1|||
162151074|NCT01571596|585602862|FG002|Overall Study|Study Terminated by the Sponsor|1|||
162151075|NCT01582100|585602867|FG000|Overall Study|Adverse Event|1|||
162151076|NCT01582100|585602867|FG000|Overall Study|Withdrawal by Subject|1|||
162151077|NCT00774397|585602870|FG000|Overall Study|Adverse Event|1|||
162151078|NCT00774397|585602871|FG001|Overall Study|Adverse Event|3|||
162151079|NCT00774397|585602872|FG002|Overall Study|Adverse Event|16|||
162151080|NCT00774397|585602873|FG003|Overall Study|Adverse Event|8|||
162151081|NCT00774397|585602874|FG004|Overall Study|Adverse Event|8|||
162151082|NCT00774397|585602875|FG005|Overall Study|Adverse Event|3|||
162151083|NCT00774397|585602876|FG006|Overall Study|Adverse Event|16|||
162151084|NCT00774397|585602870|FG000|Overall Study|Lack of Efficacy|11|||
162151085|NCT00774397|585602871|FG001|Overall Study|Lack of Efficacy|4|||
162151086|NCT00774397|585602872|FG002|Overall Study|Lack of Efficacy|5|||
162151087|NCT00774397|585602873|FG003|Overall Study|Lack of Efficacy|3|||
162151088|NCT00774397|585602874|FG004|Overall Study|Lack of Efficacy|27|||
162151089|NCT00774397|585602875|FG005|Overall Study|Lack of Efficacy|15|||
162151090|NCT00774397|585602876|FG006|Overall Study|Lack of Efficacy|9|||
162151091|NCT00774397|585602870|FG000|Overall Study|Protocol Violation|0|||
162151092|NCT00774397|585602871|FG001|Overall Study|Protocol Violation|1|||
162151093|NCT00774397|585602872|FG002|Overall Study|Protocol Violation|3|||
162151094|NCT00774397|585602873|FG003|Overall Study|Protocol Violation|1|||
162151095|NCT00774397|585602874|FG004|Overall Study|Protocol Violation|2|||
162151096|NCT00774397|585602875|FG005|Overall Study|Protocol Violation|1|||
162151097|NCT00774397|585602876|FG006|Overall Study|Protocol Violation|0|||
162151098|NCT00774397|585602870|FG000|Overall Study|Lost to Follow-up|0|||
162151099|NCT00774397|585602871|FG001|Overall Study|Lost to Follow-up|1|||
162151100|NCT00774397|585602872|FG002|Overall Study|Lost to Follow-up|1|||
162151101|NCT00774397|585602873|FG003|Overall Study|Lost to Follow-up|1|||
162151102|NCT00774397|585602874|FG004|Overall Study|Lost to Follow-up|0|||
162151103|NCT00774397|585602875|FG005|Overall Study|Lost to Follow-up|1|||
162151104|NCT00774397|585602876|FG006|Overall Study|Lost to Follow-up|0|||
162151105|NCT00774397|585602870|FG000|Overall Study|Refused to continue trial medication|1|||
162151106|NCT00774397|585602871|FG001|Overall Study|Refused to continue trial medication|3|||
162151107|NCT00774397|585602872|FG002|Overall Study|Refused to continue trial medication|2|||
162151108|NCT00774397|585602873|FG003|Overall Study|Refused to continue trial medication|2|||
162151109|NCT00774397|585602874|FG004|Overall Study|Refused to continue trial medication|6|||
162151110|NCT00774397|585602875|FG005|Overall Study|Refused to continue trial medication|2|||
162151111|NCT00774397|585602876|FG006|Overall Study|Refused to continue trial medication|3|||
162151112|NCT00774397|585602870|FG000|Overall Study|Not treated|0|||
162151113|NCT00774397|585602871|FG001|Overall Study|Not treated|0|||
162151114|NCT00774397|585602872|FG002|Overall Study|Not treated|0|||
162151115|NCT00774397|585602873|FG003|Overall Study|Not treated|0|||
162151116|NCT00774397|585602874|FG004|Overall Study|Not treated|1|||
162151117|NCT00774397|585602875|FG005|Overall Study|Not treated|0|||
162151118|NCT00774397|585602876|FG006|Overall Study|Not treated|1|||
162151119|NCT00774397|585602870|FG000|Overall Study|Other than those stated above|1|||
162151120|NCT00774397|585602871|FG001|Overall Study|Other than those stated above|1|||
162151121|NCT00774397|585602872|FG002|Overall Study|Other than those stated above|3|||
162151122|NCT00774397|585602873|FG003|Overall Study|Other than those stated above|2|||
162151123|NCT00774397|585602874|FG004|Overall Study|Other than those stated above|2|||
162151124|NCT00774397|585602875|FG005|Overall Study|Other than those stated above|0|||
162151125|NCT00774397|585602876|FG006|Overall Study|Other than those stated above|1|||
162151126|NCT02499159|585602877|FG000|Randomization|Protocol Violation|1|||
162151127|NCT02499159|585602878|FG001|Randomization|Protocol Violation|1|||
162151128|NCT02499159|585602877|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
162151129|NCT02499159|585602878|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
162151130|NCT02499159|585602877|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
162151131|NCT02499159|585602878|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
162151132|NCT02499159|585602877|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
162151133|NCT02499159|585602878|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
162151134|NCT02499159|585602877|FG000|30-Day Follow-Up Phone Call|Other|1|||
162151135|NCT02499159|585602878|FG001|30-Day Follow-Up Phone Call|Other|0|||
162151136|NCT02242487|585602879|FG000|Overall Study|Adverse Event|13|||
162151137|NCT02242487|585602880|FG001|Overall Study|Adverse Event|15|||
162151138|NCT02242487|585602879|FG000|Overall Study|Lack of Efficacy|4|||
162151139|NCT02242487|585602880|FG001|Overall Study|Lack of Efficacy|6|||
162151140|NCT02242487|585602879|FG000|Overall Study|Protocol Violation|2|||
162151141|NCT02242487|585602880|FG001|Overall Study|Protocol Violation|0|||
162151142|NCT02242487|585602879|FG000|Overall Study|Lost to Follow-up|2|||
162151143|NCT02242487|585602880|FG001|Overall Study|Lost to Follow-up|1|||
162151144|NCT02242487|585602879|FG000|Overall Study|Other - Miscellaneous|4|||
162151145|NCT02242487|585602880|FG001|Overall Study|Other - Miscellaneous|6|||
162012436|NCT01663103|585101785|FG001|Overall Study|dog bite|0|||
162012437|NCT01499355|585101790|FG000|Run-In Period|Study Termination|15|||
162012438|NCT01499355|585101791|FG001|Run-In Period|Study Termination|0|||
162012439|NCT01499355|585101792|FG002|Run-In Period|Study Termination|0|||
162012440|NCT01499355|585101793|FG003|Run-In Period|Study Termination|0|||
162012441|NCT01499355|585101790|FG000|Run-In Period|Other|3|||
162012442|NCT01499355|585101791|FG001|Run-In Period|Other|0|||
162012443|NCT01499355|585101792|FG002|Run-In Period|Other|0|||
162012444|NCT01499355|585101793|FG003|Run-In Period|Other|0|||
162012445|NCT01499355|585101790|FG000|Run-In Period|Death|2|||
162012446|NCT01499355|585101791|FG001|Run-In Period|Death|0|||
162012447|NCT01499355|585101792|FG002|Run-In Period|Death|0|||
162151146|NCT02242487|585602879|FG000|Overall Study|Withdrawal by Subject|37|||
162151147|NCT02242487|585602880|FG001|Overall Study|Withdrawal by Subject|19|||
162151148|NCT03644849|585602881|FG000|Overall Study|Lost to Follow-up|1|||
162151149|NCT03644849|585602882|FG001|Overall Study|Lost to Follow-up|3|||
162151150|NCT02564744|585602883|FG000|Overall Study|Investigator decision|0|||
162151151|NCT02564744|585602884|FG001|Overall Study|Investigator decision|0|||
162151152|NCT02564744|585602885|FG002|Overall Study|Investigator decision|0|||
162151153|NCT02564744|585602886|FG003|Overall Study|Investigator decision|0|||
162151154|NCT02564744|585602887|FG004|Overall Study|Investigator decision|1|||
162151155|NCT02564744|585602883|FG000|Overall Study|Death|10|||
162151156|NCT02564744|585602884|FG001|Overall Study|Death|5|||
162151157|NCT02564744|585602885|FG002|Overall Study|Death|4|||
162012448|NCT01499355|585101793|FG003|Run-In Period|Death|0|||
162012449|NCT01499355|585101790|FG000|Run-In Period|Investigator Decision|2|||
162012450|NCT01499355|585101791|FG001|Run-In Period|Investigator Decision|0|||
162012451|NCT01499355|585101792|FG002|Run-In Period|Investigator Decision|0|||
162151158|NCT02564744|585602886|FG003|Overall Study|Death|16|||
162151159|NCT02564744|585602887|FG004|Overall Study|Death|16|||
162151160|NCT02564744|585602883|FG000|Overall Study|End of study Page Missing|0|||
162151161|NCT02564744|585602884|FG001|Overall Study|End of study Page Missing|0|||
162151162|NCT02564744|585602885|FG002|Overall Study|End of study Page Missing|3|||
162151163|NCT02564744|585602886|FG003|Overall Study|End of study Page Missing|3|||
162151164|NCT02564744|585602887|FG004|Overall Study|End of study Page Missing|0|||
162151165|NCT02564744|585602883|FG000|Overall Study|Subject Withdrew Consent|1|||
162151166|NCT02564744|585602884|FG001|Overall Study|Subject Withdrew Consent|1|||
162151167|NCT02564744|585602885|FG002|Overall Study|Subject Withdrew Consent|1|||
162151168|NCT02564744|585602886|FG003|Overall Study|Subject Withdrew Consent|0|||
162151169|NCT02564744|585602887|FG004|Overall Study|Subject Withdrew Consent|2|||
162151170|NCT02564744|585602883|FG000|Overall Study|Lost to Follow-up|0|||
162151171|NCT02564744|585602884|FG001|Overall Study|Lost to Follow-up|1|||
162151172|NCT02564744|585602885|FG002|Overall Study|Lost to Follow-up|0|||
162151173|NCT02564744|585602886|FG003|Overall Study|Lost to Follow-up|0|||
162151174|NCT02564744|585602887|FG004|Overall Study|Lost to Follow-up|1|||
162151175|NCT02564744|585602883|FG000|Overall Study|Reason not specified|1|||
162151176|NCT02564744|585602884|FG001|Overall Study|Reason not specified|0|||
162151177|NCT02564744|585602885|FG002|Overall Study|Reason not specified|0|||
162151178|NCT02564744|585602886|FG003|Overall Study|Reason not specified|0|||
162151179|NCT02564744|585602887|FG004|Overall Study|Reason not specified|0|||
162151180|NCT00979992|585602889|FG000|Overall Study|Ineligible - inadequate pathology|1|||
162151181|NCT00979992|585602889|FG000|Overall Study|Ineligible - wrong cell type|2|||
162151182|NCT00979992|585602889|FG000|Overall Study|Refused - Never Treated|2|||
162151183|NCT01140048|585602899|FG000|Overall Study|Physician Decision|1|||
162151184|NCT01140048|585602899|FG000|Overall Study|Withdrawal by Subject|13|||
162151185|NCT01140048|585602899|FG000|Overall Study|Lost to Follow-up|31|||
162151186|NCT02888080|585602900|FG000|Overall Study|Subject / Guardian decision|1|||
162151187|NCT02888080|585602901|FG001|Overall Study|Subject / Guardian decision|3|||
162151188|NCT02888080|585602900|FG000|Overall Study|New Therapy for study indication|1|||
162151189|NCT02888080|585602901|FG001|Overall Study|New Therapy for study indication|0|||
162151190|NCT02888080|585602900|FG000|Overall Study|Lack of Efficacy|0|||
162151191|NCT02888080|585602901|FG001|Overall Study|Lack of Efficacy|1|||
162151192|NCT02888080|585602900|FG000|Overall Study|Adverse Event|0|||
162151193|NCT02888080|585602901|FG001|Overall Study|Adverse Event|1|||
162151194|NCT01039688|585602902|FG000|Overall Study|Adverse Event|38|||
162151195|NCT01039688|585602903|FG001|Overall Study|Adverse Event|39|||
162151196|NCT01039688|585602904|FG002|Overall Study|Adverse Event|24|||
162151197|NCT01039688|585602902|FG000|Overall Study|Lack of Efficacy|20|||
162151198|NCT01039688|585602903|FG001|Overall Study|Lack of Efficacy|11|||
162151199|NCT01039688|585602904|FG002|Overall Study|Lack of Efficacy|26|||
162151200|NCT01039688|585602902|FG000|Overall Study|Lost to Follow-up|11|||
162151201|NCT01039688|585602903|FG001|Overall Study|Lost to Follow-up|9|||
162151202|NCT01039688|585602904|FG002|Overall Study|Lost to Follow-up|5|||
162151203|NCT01039688|585602902|FG000|Overall Study|Other|13|||
162151204|NCT01039688|585602903|FG001|Overall Study|Other|25|||
162151205|NCT01039688|585602904|FG002|Overall Study|Other|12|||
162151206|NCT01039688|585602902|FG000|Overall Study|Withdrawal by Subject|23|||
162151207|NCT01039688|585602903|FG001|Overall Study|Withdrawal by Subject|27|||
162151208|NCT01039688|585602904|FG002|Overall Study|Withdrawal by Subject|13|||
162151209|NCT01039688|585602902|FG000|Overall Study|Death|2|||
162151210|NCT01039688|585602903|FG001|Overall Study|Death|0|||
161914478|NCT02765165|584735611|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
161914479|NCT02765165|584735612|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
161914480|NCT02765165|584735613|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
161914481|NCT02765165|584735614|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
162151211|NCT01039688|585602904|FG002|Overall Study|Death|0|||
162151212|NCT03844269|585602910|FG000|Overall Study|Withdrawal pre-intervention|1|||
162151213|NCT03844269|585602910|FG000|Overall Study|Did not complete the intervention|2|||
162151214|NCT03737240|585602918|FG000|Overall Study|Lost to Follow-up|16|||
162151215|NCT03737240|585602919|FG001|Overall Study|Lost to Follow-up|15|||
162151216|NCT00891930|585602920|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
162151217|NCT00891930|585602920|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
162151218|NCT00891930|585602920|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
162151219|NCT00891930|585602920|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
162151220|NCT00891930|585602920|FG000|Part 2 Panitumumab + AMG479|Death|30|||
162151221|NCT02512965|585602923|FG000|Overall Study|Withdrawal by Subject|0|||
162151222|NCT02512965|585602924|FG001|Overall Study|Withdrawal by Subject|4|||
162151223|NCT05001945|585602928|FG000|Overall Study|Adverse Event|0|||
162151224|NCT05001945|585602929|FG001|Overall Study|Adverse Event|0|||
162151225|NCT05001945|585602930|FG002|Overall Study|Adverse Event|0|||
162151226|NCT05001945|585602931|FG003|Overall Study|Adverse Event|1|||
162151227|NCT05001945|585602932|FG004|Overall Study|Adverse Event|0|||
162151228|NCT05001945|585602933|FG005|Overall Study|Adverse Event|0|||
162151229|NCT05001945|585602934|FG006|Overall Study|Adverse Event|0|||
161810185|NCT00089661|584347719|FG000|Overall Study|Ineligibility determined|4|||
161810186|NCT00089661|584347720|FG001|Overall Study|Ineligibility determined|4|||
161810187|NCT00089661|584347719|FG000|Overall Study|Noncompliance|2|||
161810188|NCT00089661|584347720|FG001|Overall Study|Noncompliance|4|||
161810189|NCT00089661|584347719|FG000|Overall Study|Other|2|||
161810190|NCT00089661|584347720|FG001|Overall Study|Other|1|||
161810191|NCT01273805|584347721|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
161810192|NCT01273805|584347722|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
161810193|NCT02647944|584347723|FG000|Overall Study|Withdrawal by Subject|0|||
161810194|NCT02647944|584347724|FG001|Overall Study|Withdrawal by Subject|3|||
161810195|NCT02647944|584347723|FG000|Overall Study|Adverse Event|2|||
161810196|NCT02647944|584347724|FG001|Overall Study|Adverse Event|0|||
161810197|NCT02077465|584347725|FG000|Overall Study|Withdrew Consent|0|||
161810198|NCT02077465|584347726|FG001|Overall Study|Withdrew Consent|1|||
161810199|NCT02077465|584347725|FG000|Overall Study|Lost to Follow-up|1|||
161810200|NCT02077465|584347726|FG001|Overall Study|Lost to Follow-up|0|||
161810201|NCT02576938|584347730|FG000|Overall Study|Adverse Event|5|||
162151230|NCT05001945|585602935|FG007|Overall Study|Adverse Event|0|||
162151231|NCT05001945|585602928|FG000|Overall Study|Lost to Follow-up|0|||
162151232|NCT05001945|585602929|FG001|Overall Study|Lost to Follow-up|1|||
162151233|NCT05001945|585602930|FG002|Overall Study|Lost to Follow-up|1|||
162151234|NCT05001945|585602931|FG003|Overall Study|Lost to Follow-up|2|||
162151235|NCT05001945|585602932|FG004|Overall Study|Lost to Follow-up|0|||
162151236|NCT05001945|585602933|FG005|Overall Study|Lost to Follow-up|1|||
162151237|NCT05001945|585602934|FG006|Overall Study|Lost to Follow-up|0|||
162151238|NCT05001945|585602935|FG007|Overall Study|Lost to Follow-up|0|||
162151239|NCT05001945|585602928|FG000|Overall Study|Protocol Violation|1|||
162151240|NCT05001945|585602929|FG001|Overall Study|Protocol Violation|0|||
162151241|NCT05001945|585602930|FG002|Overall Study|Protocol Violation|1|||
162151242|NCT05001945|585602931|FG003|Overall Study|Protocol Violation|1|||
162151243|NCT05001945|585602932|FG004|Overall Study|Protocol Violation|0|||
162151244|NCT05001945|585602933|FG005|Overall Study|Protocol Violation|1|||
162151245|NCT05001945|585602934|FG006|Overall Study|Protocol Violation|0|||
162151246|NCT05001945|585602935|FG007|Overall Study|Protocol Violation|0|||
162151247|NCT05001945|585602928|FG000|Overall Study|Withdrawal by Subject|0|||
162151248|NCT05001945|585602929|FG001|Overall Study|Withdrawal by Subject|0|||
162151249|NCT05001945|585602930|FG002|Overall Study|Withdrawal by Subject|0|||
162151250|NCT05001945|585602931|FG003|Overall Study|Withdrawal by Subject|1|||
162151251|NCT05001945|585602932|FG004|Overall Study|Withdrawal by Subject|1|||
162151252|NCT05001945|585602933|FG005|Overall Study|Withdrawal by Subject|1|||
162151253|NCT05001945|585602934|FG006|Overall Study|Withdrawal by Subject|0|||
162151254|NCT05001945|585602935|FG007|Overall Study|Withdrawal by Subject|1|||
162151255|NCT05001945|585602928|FG000|Overall Study|Not specified by Investigator|0|||
162151256|NCT05001945|585602929|FG001|Overall Study|Not specified by Investigator|3|||
162151257|NCT05001945|585602930|FG002|Overall Study|Not specified by Investigator|0|||
162151258|NCT05001945|585602931|FG003|Overall Study|Not specified by Investigator|0|||
162151259|NCT05001945|585602932|FG004|Overall Study|Not specified by Investigator|1|||
162151260|NCT05001945|585602933|FG005|Overall Study|Not specified by Investigator|0|||
162151261|NCT05001945|585602934|FG006|Overall Study|Not specified by Investigator|0|||
162151262|NCT05001945|585602935|FG007|Overall Study|Not specified by Investigator|0|||
162151263|NCT02570711|585602936|FG000|Overall Study|Death|1|||
162151264|NCT02570711|585602937|FG001|Overall Study|Death|0|||
162151265|NCT02570711|585602936|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
162151266|NCT02570711|585602937|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
162151267|NCT01369498|585602938|FG000|Overall Study|Lack of Efficacy|9|||
162151268|NCT01369498|585602939|FG001|Overall Study|Lack of Efficacy|9|||
162151269|NCT01369498|585602940|FG002|Overall Study|Lack of Efficacy|1|||
162151270|NCT01369498|585602941|FG003|Overall Study|Lack of Efficacy|3|||
162151271|NCT01369498|585602938|FG000|Overall Study|Adverse Event|1|||
162151272|NCT01369498|585602939|FG001|Overall Study|Adverse Event|2|||
162151273|NCT01369498|585602940|FG002|Overall Study|Adverse Event|0|||
162151274|NCT01369498|585602941|FG003|Overall Study|Adverse Event|1|||
162151275|NCT01369498|585602938|FG000|Overall Study|Withdrawal of Consent|0|||
162151276|NCT01369498|585602939|FG001|Overall Study|Withdrawal of Consent|1|||
162151277|NCT01369498|585602940|FG002|Overall Study|Withdrawal of Consent|1|||
162151278|NCT01369498|585602941|FG003|Overall Study|Withdrawal of Consent|1|||
162151279|NCT01369498|585602938|FG000|Overall Study|Death|0|||
162151280|NCT01369498|585602939|FG001|Overall Study|Death|0|||
162151281|NCT01369498|585602940|FG002|Overall Study|Death|1|||
162151282|NCT01369498|585602941|FG003|Overall Study|Death|0|||
162151283|NCT01369498|585602938|FG000|Overall Study|Investigator's Discretion|1|||
162151284|NCT01369498|585602939|FG001|Overall Study|Investigator's Discretion|0|||
162151285|NCT01369498|585602940|FG002|Overall Study|Investigator's Discretion|1|||
162151286|NCT01369498|585602941|FG003|Overall Study|Investigator's Discretion|3|||
162151287|NCT01369498|585602938|FG000|Overall Study|Unknown Reason|1|||
162151288|NCT01369498|585602939|FG001|Overall Study|Unknown Reason|0|||
162151289|NCT01369498|585602940|FG002|Overall Study|Unknown Reason|11|||
162151290|NCT01369498|585602941|FG003|Overall Study|Unknown Reason|6|||
162151291|NCT01369498|585602938|FG000|Overall Study|Disease Progression|0|||
162151292|NCT01369498|585602939|FG001|Overall Study|Disease Progression|0|||
162151293|NCT01369498|585602940|FG002|Overall Study|Disease Progression|0|||
162151294|NCT01369498|585602941|FG003|Overall Study|Disease Progression|1|||
162151295|NCT00545077|585602943|FG000|Overall Study|Treatment not received|5|||
162012452|NCT01499355|585101793|FG003|Run-In Period|Investigator Decision|0|||
162151296|NCT00545077|585602944|FG001|Overall Study|Treatment not received|1|||
162151297|NCT00545077|585602943|FG000|Overall Study|Disease Progression|131|||
162151298|NCT00545077|585602944|FG001|Overall Study|Disease Progression|98|||
162151299|NCT00545077|585602943|FG000|Overall Study|Withdrawal by Subject|3|||
162151300|NCT00545077|585602944|FG001|Overall Study|Withdrawal by Subject|14|||
162151301|NCT00545077|585602943|FG000|Overall Study|Physician Decision|6|||
162151302|NCT00545077|585602944|FG001|Overall Study|Physician Decision|3|||
162151303|NCT00545077|585602943|FG000|Overall Study|Lost to Follow-up|2|||
162151304|NCT00545077|585602944|FG001|Overall Study|Lost to Follow-up|0|||
162151305|NCT00545077|585602943|FG000|Overall Study|Protocol Violation|1|||
162151306|NCT00545077|585602944|FG001|Overall Study|Protocol Violation|0|||
162151307|NCT00545077|585602943|FG000|Overall Study|Adverse Event|0|||
162151308|NCT00545077|585602944|FG001|Overall Study|Adverse Event|31|||
162151309|NCT00545077|585602943|FG000|Overall Study|Death|0|||
162151310|NCT00545077|585602944|FG001|Overall Study|Death|8|||
162151311|NCT02957136|585602951|FG000|Overall Study|Withdrawal by Subject|2|||
162151312|NCT02957136|585602952|FG001|Overall Study|Withdrawal by Subject|1|||
162151313|NCT00439569|585602954|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
162151314|NCT00439569|585602954|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
162151315|NCT00439569|585602954|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
162151316|NCT02755116|585602955|FG000|Overall Study|surgery converted to open, pt admitted|3|||
162151317|NCT02755116|585602956|FG001|Overall Study|surgery converted to open, pt admitted|1|||
162151318|NCT01124734|585602957|FG000|Overall Study|Disease progression|13|||
162151319|NCT01124734|585602957|FG000|Overall Study|Adverse Event|1|||
162151320|NCT01124734|585602957|FG000|Overall Study|Withdrawal by Subject|1|||
162151321|NCT01124734|585602957|FG000|Overall Study|Elected for alternative treatment|2|||
162151322|NCT02423798|585602958|FG000|Overall Study|Withdrawal by Subject|3|||
162151323|NCT00939510|585602959|FG000|Overall Study|Withdrawal by Subject|1|||
162151324|NCT01202955|585602960|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
162151325|NCT01202955|585602961|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
162151326|NCT00159783|585602966|FG000|Overall Study|Adverse Event|5|||
162151327|NCT00159783|585602967|FG001|Overall Study|Adverse Event|7|||
162151328|NCT00159783|585602968|FG002|Overall Study|Adverse Event|9|||
162151329|NCT00159783|585602966|FG000|Overall Study|Lack of Efficacy|1|||
162151330|NCT00159783|585602967|FG001|Overall Study|Lack of Efficacy|2|||
162151331|NCT00159783|585602968|FG002|Overall Study|Lack of Efficacy|3|||
162151332|NCT00159783|585602966|FG000|Overall Study|Withdrawal by Subject|7|||
162151333|NCT00159783|585602967|FG001|Overall Study|Withdrawal by Subject|11|||
162151334|NCT00159783|585602968|FG002|Overall Study|Withdrawal by Subject|12|||
162151335|NCT00159783|585602966|FG000|Overall Study|Lost to Follow-up|6|||
162151336|NCT00159783|585602967|FG001|Overall Study|Lost to Follow-up|5|||
162151337|NCT00159783|585602968|FG002|Overall Study|Lost to Follow-up|11|||
162151338|NCT00159783|585602966|FG000|Overall Study|Other|0|||
162151339|NCT00159783|585602967|FG001|Overall Study|Other|2|||
162151340|NCT00159783|585602968|FG002|Overall Study|Other|4|||
162151341|NCT00305695|585602969|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
162151342|NCT00305695|585602970|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
162151343|NCT00305695|585602969|FG000|Overall Study|Did not have baseline scan|1|||
162151344|NCT00305695|585602970|FG001|Overall Study|Did not have baseline scan|1|||
162151345|NCT01597258|585602971|FG000|Overall Study|No Drug Administration|1|||
162151346|NCT04789408|585602972|FG000|Overall Study|Death|4|||
162151347|NCT04789408|585602973|FG001|Overall Study|Death|3|||
162151348|NCT04789408|585602974|FG002|Overall Study|Death|6|||
162151349|NCT04789408|585602972|FG000|Overall Study|Did not meet eligibility criteria|1|||
162151350|NCT04789408|585602973|FG001|Overall Study|Did not meet eligibility criteria|0|||
162151351|NCT04789408|585602974|FG002|Overall Study|Did not meet eligibility criteria|0|||
162151352|NCT04789408|585602972|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
162151353|NCT04789408|585602973|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
162151354|NCT04789408|585602974|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
162151355|NCT05938413|585604482|FG000|Overall Study|Lost to Follow-up|1|||
162151356|NCT05938413|585604483|FG001|Overall Study|Lost to Follow-up|7|||
162151357|NCT05938413|585604482|FG000|Overall Study|Withdrawal by Subject|1|||
162151358|NCT05938413|585604483|FG001|Overall Study|Withdrawal by Subject|1|||
162151359|NCT03312907|585604484|FG000|Overall Study|Adverse Event|1|||
162151360|NCT03312907|585604485|FG001|Overall Study|Adverse Event|6|||
162151361|NCT03312907|585604486|FG002|Overall Study|Adverse Event|1|||
162151362|NCT03312907|585604484|FG000|Overall Study|Protocol Violation|2|||
162151363|NCT03312907|585604485|FG001|Overall Study|Protocol Violation|3|||
162151364|NCT03312907|585604486|FG002|Overall Study|Protocol Violation|4|||
162151365|NCT03312907|585604484|FG000|Overall Study|Lost to Follow-up|2|||
162151366|NCT03312907|585604485|FG001|Overall Study|Lost to Follow-up|3|||
162151367|NCT03312907|585604486|FG002|Overall Study|Lost to Follow-up|2|||
162151368|NCT03312907|585604484|FG000|Overall Study|Physician Decision|3|||
162151369|NCT03312907|585604485|FG001|Overall Study|Physician Decision|4|||
162151370|NCT03312907|585604486|FG002|Overall Study|Physician Decision|2|||
162151371|NCT03312907|585604484|FG000|Overall Study|Withdrawal by Subject|9|||
162151372|NCT03312907|585604485|FG001|Overall Study|Withdrawal by Subject|14|||
162151373|NCT03312907|585604486|FG002|Overall Study|Withdrawal by Subject|10|||
162151374|NCT00840177|585604494|FG000|Overall Study|Adverse Event|5|||
162151375|NCT00840177|585604495|FG001|Overall Study|Adverse Event|1|||
162151376|NCT00840177|585604496|FG002|Overall Study|Adverse Event|1|||
162151377|NCT00840177|585604494|FG000|Overall Study|Refusal unrelated to adverse events|1|||
162151378|NCT00840177|585604495|FG001|Overall Study|Refusal unrelated to adverse events|0|||
162151379|NCT00840177|585604496|FG002|Overall Study|Refusal unrelated to adverse events|1|||
162151380|NCT00840177|585604494|FG000|Overall Study|Progression/relapse|2|||
162151381|NCT00840177|585604495|FG001|Overall Study|Progression/relapse|0|||
162151382|NCT00840177|585604496|FG002|Overall Study|Progression/relapse|0|||
162151383|NCT00840177|585604494|FG000|Overall Study|Death|4|||
162151384|NCT00840177|585604495|FG001|Overall Study|Death|5|||
162151385|NCT00840177|585604496|FG002|Overall Study|Death|5|||
162151386|NCT00840177|585604494|FG000|Overall Study|not protocol specified|6|||
162151387|NCT00840177|585604495|FG001|Overall Study|not protocol specified|3|||
162151388|NCT00840177|585604496|FG002|Overall Study|not protocol specified|0|||
162151389|NCT00840177|585604494|FG000|Overall Study|Ineligible|0|||
162151390|NCT00840177|585604495|FG001|Overall Study|Ineligible|0|||
162151391|NCT00840177|585604496|FG002|Overall Study|Ineligible|3|||
162151392|NCT00840177|585604494|FG000|Overall Study|Did not start treatment|0|||
162151393|NCT00840177|585604495|FG001|Overall Study|Did not start treatment|0|||
162151394|NCT00840177|585604496|FG002|Overall Study|Did not start treatment|1|||
162151395|NCT01599793|585604502|FG000|Overall Study|Adverse Event|2|||
162151396|NCT02652442|585604515|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
162151397|NCT02252042|585604516|FG000|Overall Study|Adverse Event|9|||
162151398|NCT02252042|585604517|FG001|Overall Study|Adverse Event|6|||
162151399|NCT02252042|585604516|FG000|Overall Study|Death|209|||
162151400|NCT02252042|585604517|FG001|Overall Study|Death|217|||
162151401|NCT02252042|585604516|FG000|Overall Study|Physician Decision|0|||
162151402|NCT02252042|585604517|FG001|Overall Study|Physician Decision|2|||
162151403|NCT02252042|585604516|FG000|Overall Study|Transferred to Extension Study|7|||
162151404|NCT02252042|585604517|FG001|Overall Study|Transferred to Extension Study|1|||
162151405|NCT02252042|585604516|FG000|Overall Study|Did Not Continue on Extension Study|7|||
162151406|NCT02252042|585604517|FG001|Overall Study|Did Not Continue on Extension Study|2|||
162151407|NCT02252042|585604516|FG000|Overall Study|Withdrawal by Subject|15|||
162151408|NCT02252042|585604517|FG001|Overall Study|Withdrawal by Subject|20|||
162151409|NCT02593149|585604520|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
162151410|NCT02593149|585604521|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
162151411|NCT02593149|585604520|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
162151412|NCT02593149|585604521|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
162151413|NCT01177670|585604522|FG000|Overall Study|Study Terminated|115|||
162151414|NCT01177670|585604522|FG000|Overall Study|Physician Decision|50|||
162151415|NCT01177670|585604522|FG000|Overall Study|Withdrawal by Subject|4|||
162151416|NCT01636687|585604523|FG000|Induction Period|Withdrawal by Subject|1|||
162151417|NCT01636687|585604524|FG001|Induction Period|Withdrawal by Subject|0|||
162151418|NCT01636687|585604525|FG002|Induction Period|Withdrawal by Subject|0|||
162151419|NCT01636687|585604526|FG003|Induction Period|Withdrawal by Subject|0|||
162151420|NCT01636687|585604527|FG004|Induction Period|Withdrawal by Subject|0|||
162151421|NCT01636687|585604523|FG000|Induction Period|Adverse Event|1|||
162151422|NCT01636687|585604524|FG001|Induction Period|Adverse Event|0|||
162151423|NCT01636687|585604525|FG002|Induction Period|Adverse Event|0|||
162151424|NCT01636687|585604526|FG003|Induction Period|Adverse Event|0|||
162151425|NCT01636687|585604527|FG004|Induction Period|Adverse Event|1|||
162151426|NCT01636687|585604523|FG000|Induction Period|Lack of Efficacy|0|||
162151427|NCT01636687|585604524|FG001|Induction Period|Lack of Efficacy|0|||
162151428|NCT01636687|585604525|FG002|Induction Period|Lack of Efficacy|0|||
162151429|NCT01636687|585604526|FG003|Induction Period|Lack of Efficacy|0|||
162151430|NCT01636687|585604527|FG004|Induction Period|Lack of Efficacy|1|||
162151431|NCT01636687|585604523|FG000|Induction Period|Physician Decision|1|||
162151432|NCT01636687|585604524|FG001|Induction Period|Physician Decision|0|||
162151433|NCT01636687|585604525|FG002|Induction Period|Physician Decision|0|||
162151434|NCT01636687|585604526|FG003|Induction Period|Physician Decision|0|||
162151435|NCT01636687|585604527|FG004|Induction Period|Physician Decision|0|||
162151436|NCT01636687|585604523|FG000|Maintenance Period|Withdrawal by Subject|2|||
162151437|NCT01636687|585604524|FG001|Maintenance Period|Withdrawal by Subject|0|||
162151438|NCT01636687|585604525|FG002|Maintenance Period|Withdrawal by Subject|2|||
162151439|NCT01636687|585604526|FG003|Maintenance Period|Withdrawal by Subject|0|||
161810202|NCT02576938|584347731|FG001|Overall Study|Adverse Event|3|||
161810203|NCT02576938|584347732|FG002|Overall Study|Adverse Event|6|||
161810204|NCT02576938|584347730|FG000|Overall Study|Protocol Violation|1|||
161810205|NCT02576938|584347731|FG001|Overall Study|Protocol Violation|1|||
161810206|NCT02576938|584347732|FG002|Overall Study|Protocol Violation|1|||
161810207|NCT02576938|584347730|FG000|Overall Study|Withdrawal by Subject|3|||
161810208|NCT02576938|584347731|FG001|Overall Study|Withdrawal by Subject|2|||
162151440|NCT01636687|585604527|FG004|Maintenance Period|Withdrawal by Subject|0|||
161810209|NCT02576938|584347732|FG002|Overall Study|Withdrawal by Subject|4|||
161810210|NCT02576938|584347730|FG000|Overall Study|Lack of Efficacy|9|||
161810211|NCT02576938|584347731|FG001|Overall Study|Lack of Efficacy|4|||
162151441|NCT01636687|585604523|FG000|Maintenance Period|Adverse Event|1|||
162151442|NCT01636687|585604524|FG001|Maintenance Period|Adverse Event|0|||
162151443|NCT01636687|585604525|FG002|Maintenance Period|Adverse Event|0|||
162151444|NCT01636687|585604526|FG003|Maintenance Period|Adverse Event|0|||
162151445|NCT01636687|585604527|FG004|Maintenance Period|Adverse Event|0|||
162151446|NCT01636687|585604523|FG000|Maintenance Period|Lack of Efficacy|4|||
162012453|NCT01499355|585101790|FG000|Run-In Period|Consent Withdrawn|1|||
162012454|NCT01499355|585101791|FG001|Run-In Period|Consent Withdrawn|0|||
162012455|NCT01499355|585101792|FG002|Run-In Period|Consent Withdrawn|0|||
162151447|NCT01636687|585604524|FG001|Maintenance Period|Lack of Efficacy|1|||
162151448|NCT01636687|585604525|FG002|Maintenance Period|Lack of Efficacy|0|||
162151449|NCT01636687|585604526|FG003|Maintenance Period|Lack of Efficacy|0|||
162151450|NCT01636687|585604527|FG004|Maintenance Period|Lack of Efficacy|0|||
162151451|NCT01636687|585604523|FG000|Maintenance Period|Lost to Follow-up|1|||
162151452|NCT01636687|585604524|FG001|Maintenance Period|Lost to Follow-up|1|||
162151453|NCT01636687|585604525|FG002|Maintenance Period|Lost to Follow-up|0|||
162151454|NCT01636687|585604526|FG003|Maintenance Period|Lost to Follow-up|0|||
162151455|NCT01636687|585604527|FG004|Maintenance Period|Lost to Follow-up|1|||
162151456|NCT01636687|585604523|FG000|Maintenance Period|Physician Decision|0|||
162151457|NCT01636687|585604524|FG001|Maintenance Period|Physician Decision|0|||
162151458|NCT01636687|585604525|FG002|Maintenance Period|Physician Decision|0|||
162151459|NCT01636687|585604526|FG003|Maintenance Period|Physician Decision|0|||
162151460|NCT01636687|585604527|FG004|Maintenance Period|Physician Decision|1|||
162151461|NCT01636687|585604523|FG000|Extension Period|technical problems|0|||
162151462|NCT01636687|585604524|FG001|Extension Period|technical problems|1|||
162151463|NCT01636687|585604525|FG002|Extension Period|technical problems|2|||
162151464|NCT01636687|585604526|FG003|Extension Period|technical problems|1|||
162151465|NCT01636687|585604527|FG004|Extension Period|technical problems|0|||
162151466|NCT01636687|585604523|FG000|Extension Period|Adverse Event|4|||
162151467|NCT01636687|585604524|FG001|Extension Period|Adverse Event|3|||
162151468|NCT01636687|585604525|FG002|Extension Period|Adverse Event|2|||
162151469|NCT01636687|585604526|FG003|Extension Period|Adverse Event|1|||
162151470|NCT01636687|585604527|FG004|Extension Period|Adverse Event|0|||
162151471|NCT01636687|585604523|FG000|Extension Period|Lack of Efficacy|7|||
162151472|NCT01636687|585604524|FG001|Extension Period|Lack of Efficacy|0|||
162151473|NCT01636687|585604525|FG002|Extension Period|Lack of Efficacy|2|||
162151474|NCT01636687|585604526|FG003|Extension Period|Lack of Efficacy|1|||
162151475|NCT01636687|585604527|FG004|Extension Period|Lack of Efficacy|0|||
162151476|NCT01636687|585604523|FG000|Extension Period|Lost to Follow-up|1|||
162151477|NCT01636687|585604524|FG001|Extension Period|Lost to Follow-up|0|||
162151478|NCT01636687|585604525|FG002|Extension Period|Lost to Follow-up|1|||
162151479|NCT01636687|585604526|FG003|Extension Period|Lost to Follow-up|0|||
162151480|NCT01636687|585604527|FG004|Extension Period|Lost to Follow-up|0|||
162151481|NCT01636687|585604523|FG000|Extension Period|Physician Decision|1|||
162151482|NCT01636687|585604524|FG001|Extension Period|Physician Decision|0|||
162151483|NCT01636687|585604525|FG002|Extension Period|Physician Decision|0|||
162151484|NCT01636687|585604526|FG003|Extension Period|Physician Decision|1|||
162151485|NCT01636687|585604527|FG004|Extension Period|Physician Decision|0|||
162151486|NCT01636687|585604523|FG000|Extension Period|study terminated by sponsor|33|||
162151487|NCT01636687|585604524|FG001|Extension Period|study terminated by sponsor|50|||
162151488|NCT01636687|585604525|FG002|Extension Period|study terminated by sponsor|17|||
162151489|NCT01636687|585604526|FG003|Extension Period|study terminated by sponsor|23|||
162151490|NCT01636687|585604527|FG004|Extension Period|study terminated by sponsor|0|||
162151491|NCT01636687|585604523|FG000|Extension Period|Withdrawal by Subject|1|||
162151492|NCT01636687|585604524|FG001|Extension Period|Withdrawal by Subject|0|||
162151493|NCT01636687|585604525|FG002|Extension Period|Withdrawal by Subject|1|||
162151494|NCT01636687|585604526|FG003|Extension Period|Withdrawal by Subject|1|||
162151495|NCT01636687|585604527|FG004|Extension Period|Withdrawal by Subject|0|||
162151496|NCT01636687|585604523|FG000|Follow-up Period|Withdrawal by Subject|1|||
162151497|NCT01636687|585604524|FG001|Follow-up Period|Withdrawal by Subject|0|||
162151498|NCT01636687|585604525|FG002|Follow-up Period|Withdrawal by Subject|0|||
162151499|NCT01636687|585604526|FG003|Follow-up Period|Withdrawal by Subject|0|||
162151500|NCT01636687|585604527|FG004|Follow-up Period|Withdrawal by Subject|1|||
162151501|NCT00636207|585604528|FG000|Overall Study|Adverse Event|1|||
162151502|NCT00636207|585604529|FG001|Overall Study|Adverse Event|0|||
162151503|NCT00636207|585604530|FG002|Overall Study|Adverse Event|0|||
162151504|NCT00636207|585604531|FG003|Overall Study|Adverse Event|0|||
162151505|NCT00636207|585604532|FG004|Overall Study|Adverse Event|0|||
162151506|NCT00636207|585604533|FG005|Overall Study|Adverse Event|0|||
162012456|NCT01499355|585101793|FG003|Run-In Period|Consent Withdrawn|0|||
162151507|NCT00636207|585604534|FG006|Overall Study|Adverse Event|0|||
162151508|NCT00636207|585604528|FG000|Overall Study|Withdrawal by Subject|0|||
162151509|NCT00636207|585604529|FG001|Overall Study|Withdrawal by Subject|1|||
162151510|NCT00636207|585604530|FG002|Overall Study|Withdrawal by Subject|0|||
162151511|NCT00636207|585604531|FG003|Overall Study|Withdrawal by Subject|0|||
162151512|NCT00636207|585604532|FG004|Overall Study|Withdrawal by Subject|1|||
162151513|NCT00636207|585604533|FG005|Overall Study|Withdrawal by Subject|0|||
162151514|NCT00636207|585604534|FG006|Overall Study|Withdrawal by Subject|0|||
162151515|NCT00666276|585604537|FG000|Overall Study|Protocol Violation|34|||
162151516|NCT02594735|585604538|FG000|Overall Study|Adverse Event|1|||
162151517|NCT00101010|585604539|FG000|Overall Study|Physician Decision|1|||
162151518|NCT00364013|585604546|FG000|Overall Study|Ineligibility determined|4|||
162151519|NCT00364013|585604547|FG001|Overall Study|Ineligibility determined|2|||
162151520|NCT00364013|585604546|FG000|Overall Study|Adverse Event|4|||
162151521|NCT00364013|585604547|FG001|Overall Study|Adverse Event|3|||
162151522|NCT00364013|585604546|FG000|Overall Study|Withdrawal by Subject|13|||
162151523|NCT00364013|585604547|FG001|Overall Study|Withdrawal by Subject|18|||
162151524|NCT00364013|585604546|FG000|Overall Study|Physician Decision|3|||
162151525|NCT00364013|585604547|FG001|Overall Study|Physician Decision|3|||
162151526|NCT00364013|585604546|FG000|Overall Study|Lost to Follow-up|10|||
162151527|NCT00364013|585604547|FG001|Overall Study|Lost to Follow-up|3|||
162151528|NCT00364013|585604546|FG000|Overall Study|Protocol-specified criteria|6|||
162151529|NCT00364013|585604547|FG001|Overall Study|Protocol-specified criteria|6|||
162151530|NCT00364013|585604546|FG000|Overall Study|Other|41|||
162151531|NCT00364013|585604547|FG001|Overall Study|Other|47|||
162151532|NCT00364013|585604546|FG000|Overall Study|Ongoing|20|||
162151533|NCT00364013|585604547|FG001|Overall Study|Ongoing|13|||
162151534|NCT00835770|585604554|FG000|Overall Study|MS Relapse|17|||
162151535|NCT00835770|585604555|FG001|Overall Study|MS Relapse|23|||
162151536|NCT00835770|585604554|FG000|Overall Study|MS Progression|14|||
162151537|NCT00835770|585604555|FG001|Overall Study|MS Progression|9|||
162151538|NCT00835770|585604554|FG000|Overall Study|Adverse Event|113|||
162151539|NCT00835770|585604555|FG001|Overall Study|Adverse Event|124|||
162151540|NCT00835770|585604554|FG000|Overall Study|Lost to Follow-up|22|||
162151541|NCT00835770|585604555|FG001|Overall Study|Lost to Follow-up|19|||
162151542|NCT00835770|585604554|FG000|Overall Study|Consent Withdrawn|144|||
162151543|NCT00835770|585604555|FG001|Overall Study|Consent Withdrawn|156|||
162151544|NCT00835770|585604554|FG000|Overall Study|Investigator Decision|42|||
162151545|NCT00835770|585604555|FG001|Overall Study|Investigator Decision|42|||
162151546|NCT00835770|585604554|FG000|Overall Study|Participant Non-Compliance|11|||
162151547|NCT00835770|585604555|FG001|Overall Study|Participant Non-Compliance|9|||
162151548|NCT00835770|585604554|FG000|Overall Study|Death|4|||
162151549|NCT00835770|585604555|FG001|Overall Study|Death|6|||
162151550|NCT00835770|585604554|FG000|Overall Study|Other|115|||
162151551|NCT00835770|585604555|FG001|Overall Study|Other|104|||
162151552|NCT00835770|585604554|FG000|Overall Study|Other|2|||
162151553|NCT00835770|585604555|FG001|Overall Study|Other|1|||
162151554|NCT01185782|585604556|FG000|Overall Study|Adverse Event|0|||
162151555|NCT01185782|585604557|FG001|Overall Study|Adverse Event|1|||
162151556|NCT01185782|585604556|FG000|Overall Study|Protocol Violation|1|||
162151557|NCT01185782|585604557|FG001|Overall Study|Protocol Violation|0|||
162151558|NCT01185782|585604556|FG000|Overall Study|Poor Response to Treatment|3|||
162151559|NCT01185782|585604557|FG001|Overall Study|Poor Response to Treatment|1|||
162151560|NCT01185782|585604556|FG000|Overall Study|Other|2|||
162151561|NCT01185782|585604557|FG001|Overall Study|Other|5|||
162151562|NCT01185782|585604556|FG000|Overall Study|Randomized but not treated|0|||
162151563|NCT01185782|585604557|FG001|Overall Study|Randomized but not treated|4|||
162151564|NCT02507752|585604558|FG000|Overall Study|Adverse Event|1|||
162151565|NCT02507752|585604558|FG000|Overall Study|Protocol Violation|6|||
162151566|NCT02507752|585604558|FG000|Overall Study|Lost to Follow-up|7|||
162151567|NCT02507752|585604558|FG000|Overall Study|Infusion reaction at first infusion|1|||
162151568|NCT02507752|585604558|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
162151569|NCT02507752|585604558|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
162151570|NCT02202499|585604562|FG000|Overall Study|Cancer diagnosis|0|||
162151571|NCT02202499|585604563|FG001|Overall Study|Cancer diagnosis|0|||
162151572|NCT02202499|585604564|FG002|Overall Study|Cancer diagnosis|1|||
162151573|NCT02202499|585604562|FG000|Overall Study|Moved from area|0|||
162151574|NCT02202499|585604563|FG001|Overall Study|Moved from area|0|||
162151575|NCT02202499|585604564|FG002|Overall Study|Moved from area|1|||
162151576|NCT02202499|585604562|FG000|Overall Study|Declined before randomization|1|||
161810212|NCT02576938|584347732|FG002|Overall Study|Lack of Efficacy|0|||
162151577|NCT02202499|585604563|FG001|Overall Study|Declined before randomization|0|||
162151578|NCT02202499|585604564|FG002|Overall Study|Declined before randomization|0|||
162151579|NCT02202499|585604562|FG000|Overall Study|Auto accident|1|||
161810213|NCT02576938|584347730|FG000|Overall Study|Lost to Follow-up|2|||
161810214|NCT02576938|584347731|FG001|Overall Study|Lost to Follow-up|0|||
161810215|NCT02576938|584347732|FG002|Overall Study|Lost to Follow-up|1|||
162151580|NCT02202499|585604563|FG001|Overall Study|Auto accident|0|||
162151581|NCT02202499|585604564|FG002|Overall Study|Auto accident|0|||
162151582|NCT00535145|585604566|FG000|Phase I|Adverse Event|3|||
162151583|NCT00535145|585604566|FG000|Phase I|Lost to Follow-up|7|||
162151584|NCT00535145|585604566|FG000|Phase I|Withdrawal by Subject|6|||
162151585|NCT00535145|585604566|FG000|Phase I|(eligibility)|8|||
162151586|NCT00535145|585604566|FG000|Phase I|(protocol violation)|1|||
162151587|NCT00535145|585604566|FG000|Phase I|(PI decision)|1|||
162151588|NCT00535145|585604566|FG000|Phase I|(diagnosis)|3|||
162151589|NCT00535145|585604566|FG000|Phase II|Adverse Event|2|||
162151590|NCT00535145|585604566|FG000|Phase II|Lack of Efficacy|1|||
162151591|NCT00535145|585604566|FG000|Phase II|Lost to Follow-up|5|||
162012457|NCT01499355|585101790|FG000|Run-In Period|Adverse Event|8|||
162012458|NCT01499355|585101791|FG001|Run-In Period|Adverse Event|0|||
162012459|NCT01499355|585101792|FG002|Run-In Period|Adverse Event|0|||
162012460|NCT01499355|585101793|FG003|Run-In Period|Adverse Event|0|||
162012461|NCT01499355|585101790|FG000|Double-Blind Period|Adverse Event|0|||
162012462|NCT01499355|585101791|FG001|Double-Blind Period|Adverse Event|2|||
162012463|NCT01499355|585101792|FG002|Double-Blind Period|Adverse Event|3|||
162012464|NCT01499355|585101793|FG003|Double-Blind Period|Adverse Event|2|||
162012465|NCT01499355|585101790|FG000|Double-Blind Period|Study Termination|0|||
162012466|NCT01499355|585101791|FG001|Double-Blind Period|Study Termination|18|||
162012467|NCT01499355|585101792|FG002|Double-Blind Period|Study Termination|16|||
162012468|NCT01499355|585101793|FG003|Double-Blind Period|Study Termination|14|||
162012469|NCT01499355|585101790|FG000|Double-Blind Period|Other|0|||
162012470|NCT01499355|585101791|FG001|Double-Blind Period|Other|1|||
162012471|NCT01499355|585101792|FG002|Double-Blind Period|Other|2|||
162012472|NCT01499355|585101793|FG003|Double-Blind Period|Other|2|||
162012473|NCT01499355|585101790|FG000|Double-Blind Period|Death|0|||
162012474|NCT01499355|585101791|FG001|Double-Blind Period|Death|1|||
162012475|NCT01499355|585101792|FG002|Double-Blind Period|Death|0|||
162012476|NCT01499355|585101793|FG003|Double-Blind Period|Death|0|||
162012477|NCT01499355|585101790|FG000|Double-Blind Period|Investigator Decision|0|||
162012478|NCT01499355|585101791|FG001|Double-Blind Period|Investigator Decision|0|||
162012479|NCT01499355|585101792|FG002|Double-Blind Period|Investigator Decision|3|||
162012480|NCT01499355|585101793|FG003|Double-Blind Period|Investigator Decision|3|||
162012481|NCT01499355|585101790|FG000|Double-Blind Period|Consent Withdrawn|0|||
162012482|NCT01499355|585101791|FG001|Double-Blind Period|Consent Withdrawn|0|||
162012483|NCT01499355|585101792|FG002|Double-Blind Period|Consent Withdrawn|1|||
162012484|NCT01499355|585101793|FG003|Double-Blind Period|Consent Withdrawn|2|||
162012485|NCT01499355|585101790|FG000|Double-Blind Period|Lost to Follow-up|0|||
162012486|NCT01499355|585101791|FG001|Double-Blind Period|Lost to Follow-up|1|||
162012487|NCT01499355|585101792|FG002|Double-Blind Period|Lost to Follow-up|0|||
162012488|NCT01499355|585101793|FG003|Double-Blind Period|Lost to Follow-up|0|||
162012489|NCT04119414|585101794|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
162012490|NCT00993967|585101804|FG000|Overall Study|Adverse Event|8|||
162012491|NCT00993967|585101804|FG000|Overall Study|Death|1|||
162012492|NCT00993967|585101804|FG000|Overall Study|Lost to Follow-up|14|||
162012493|NCT00993967|585101804|FG000|Overall Study|Withdrawal by Subject|36|||
162012494|NCT00993967|585101804|FG000|Overall Study|Protocol Violation|2|||
162012495|NCT03313037|585101813|FG000|Overall Study|Protocol Violation|4|||
162151592|NCT00535145|585604566|FG000|Phase II|Withdrawal by Subject|5|||
162151593|NCT00535145|585604566|FG000|Phase II|Subject non-compliance|2|||
162151594|NCT05082935|585604569|FG000|Overall Study|Lost to Follow-up|549|||
162151595|NCT05082935|585604570|FG001|Overall Study|Lost to Follow-up|631|||
162151596|NCT05082935|585604569|FG000|Overall Study|Withdrawal by Subject|27|||
162151597|NCT05082935|585604570|FG001|Overall Study|Withdrawal by Subject|58|||
162151598|NCT02928224|585604574|FG000|Overall Study|Lost to Follow-up|1|||
162151599|NCT02928224|585604575|FG001|Overall Study|Lost to Follow-up|1|||
162151600|NCT02928224|585604576|FG002|Overall Study|Lost to Follow-up|3|||
162151601|NCT02928224|585604577|FG003|Overall Study|Lost to Follow-up|0|||
162151602|NCT02928224|585604574|FG000|Overall Study|Death|30|||
162151603|NCT02928224|585604575|FG001|Overall Study|Death|209|||
162151604|NCT02928224|585604576|FG002|Overall Study|Death|193|||
162151605|NCT02928224|585604577|FG003|Overall Study|Death|198|||
162151606|NCT02928224|585604574|FG000|Overall Study|Withdrawal by Subject|0|||
162151607|NCT02928224|585604575|FG001|Overall Study|Withdrawal by Subject|3|||
162151608|NCT02928224|585604576|FG002|Overall Study|Withdrawal by Subject|7|||
162151609|NCT02928224|585604577|FG003|Overall Study|Withdrawal by Subject|20|||
162151610|NCT02928224|585604574|FG000|Overall Study|Study participation terminated by sponsor|3|||
162151611|NCT02928224|585604575|FG001|Overall Study|Study participation terminated by sponsor|8|||
162151612|NCT02928224|585604576|FG002|Overall Study|Study participation terminated by sponsor|12|||
162151613|NCT02928224|585604577|FG003|Overall Study|Study participation terminated by sponsor|3|||
162151614|NCT02928224|585604574|FG000|Overall Study|Other|3|||
162151615|NCT02928224|585604575|FG001|Overall Study|Other|3|||
162151616|NCT02928224|585604576|FG002|Overall Study|Other|5|||
162151617|NCT02928224|585604577|FG003|Overall Study|Other|0|||
162151618|NCT02538107|585604578|FG000|Overall Study|Did not receive any Mircera dose|11|||
162151619|NCT02538107|585604578|FG000|Overall Study|Missing|5|||
162151620|NCT02538107|585604578|FG000|Overall Study|Necessity of dialysis|20|||
162151621|NCT02538107|585604578|FG000|Overall Study|Administration of other ESA|11|||
162151622|NCT02538107|585604578|FG000|Overall Study|No further treatment necessary|18|||
162151623|NCT02538107|585604578|FG000|Overall Study|Withdrawal by Subject|17|||
162151624|NCT02538107|585604578|FG000|Overall Study|Death|4|||
162151625|NCT02538107|585604578|FG000|Overall Study|Administrative reason|5|||
162151626|NCT02538107|585604578|FG000|Overall Study|Adverse Event|4|||
162151627|NCT02538107|585604578|FG000|Overall Study|Surgery|1|||
162151628|NCT02538107|585604578|FG000|Overall Study|Other|7|||
162012496|NCT03313037|585101814|FG001|Overall Study|Protocol Violation|1|||
162012497|NCT03313037|585101813|FG000|Overall Study|Other|1|||
162012498|NCT03313037|585101814|FG001|Overall Study|Other|1|||
161810216|NCT02576938|584347730|FG000|Overall Study|Physician Decision|0|||
161810217|NCT02576938|584347731|FG001|Overall Study|Physician Decision|1|||
161810218|NCT02576938|584347732|FG002|Overall Study|Physician Decision|0|||
161810219|NCT02576938|584347730|FG000|Overall Study|Met Exclusion Criteria|0|||
161810220|NCT02576938|584347731|FG001|Overall Study|Met Exclusion Criteria|1|||
161810221|NCT02576938|584347732|FG002|Overall Study|Met Exclusion Criteria|0|||
161810222|NCT00448591|584347733|FG000|Overall Study|Withdrawal by Subject|178|||
161810223|NCT00448591|584347733|FG000|Overall Study|Progressive Disease|1382|||
161810224|NCT00448591|584347733|FG000|Overall Study|Adverse Event|382|||
161810225|NCT00448591|584347733|FG000|Overall Study|Protocol Violation|41|||
161810226|NCT00448591|584347733|FG000|Overall Study|Lost to Follow-up|19|||
161810227|NCT00448591|584347733|FG000|Overall Study|Treatment Regimen Completed|70|||
161810228|NCT00448591|584347733|FG000|Overall Study|Other|154|||
161810229|NCT00448591|584347733|FG000|Overall Study|Termination of Study|70|||
161810230|NCT00571064|584347737|FG000|Overall Study|Adverse Event|13|||
161810231|NCT00571064|584347737|FG000|Overall Study|Protocol Violation|4|||
161810232|NCT00571064|584347737|FG000|Overall Study|Withdrawal by Subject|2|||
161810233|NCT00571064|584347737|FG000|Overall Study|Other|2|||
161810234|NCT01518972|584347740|FG000|Overall Study|Lost to Follow-up|2|||
161810235|NCT01518972|584347741|FG001|Overall Study|Lost to Follow-up|1|||
161810236|NCT01518972|584347740|FG000|Overall Study|Withdrawal by Subject|1|||
161810237|NCT01518972|584347741|FG001|Overall Study|Withdrawal by Subject|0|||
161810238|NCT01518972|584347740|FG000|Overall Study|Moved from area|1|||
161810239|NCT01518972|584347741|FG001|Overall Study|Moved from area|0|||
161810240|NCT01518972|584347740|FG000|Overall Study|Transportation problems|1|||
161810241|NCT01518972|584347741|FG001|Overall Study|Transportation problems|0|||
161810242|NCT01518972|584347740|FG000|Overall Study|Exclusionary medical condition|1|||
161810243|NCT01518972|584347741|FG001|Overall Study|Exclusionary medical condition|0|||
161810244|NCT01518972|584347740|FG000|Overall Study|Missed safety visits|0|||
161810245|NCT01518972|584347741|FG001|Overall Study|Missed safety visits|1|||
161810246|NCT01518972|584347740|FG000|Overall Study|Exclusionary medication|0|||
161810247|NCT01518972|584347741|FG001|Overall Study|Exclusionary medication|1|||
161810248|NCT01518972|584347740|FG000|Overall Study|Declined medication starting on day 12|0|||
161810249|NCT01518972|584347741|FG001|Overall Study|Declined medication starting on day 12|1|||
161914482|NCT02765165|584735608|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
161914483|NCT02765165|584735609|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
161914484|NCT02765165|584735610|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
162012499|NCT03313037|585101813|FG000|Overall Study|Withdrawal by Subject|4|||
162012500|NCT03313037|585101814|FG001|Overall Study|Withdrawal by Subject|3|||
162012501|NCT03313037|585101813|FG000|Overall Study|No longer meets eligibility criteria|1|||
162012502|NCT03313037|585101814|FG001|Overall Study|No longer meets eligibility criteria|7|||
162012503|NCT03313037|585101813|FG000|Overall Study|Lost to Follow-up|9|||
162012504|NCT03313037|585101814|FG001|Overall Study|Lost to Follow-up|8|||
162012505|NCT03313037|585101813|FG000|Overall Study|Randomized but not treated|1|||
162012506|NCT03313037|585101814|FG001|Overall Study|Randomized but not treated|0|||
162012507|NCT02760498|585101815|FG000|Overall Study|Adverse Event|3|||
162012508|NCT02760498|585101816|FG001|Overall Study|Adverse Event|3|||
162012509|NCT02760498|585101817|FG002|Overall Study|Adverse Event|1|||
162012510|NCT02760498|585101818|FG003|Overall Study|Adverse Event|1|||
162012511|NCT02760498|585101819|FG004|Overall Study|Adverse Event|0|||
161810250|NCT00003659|584347743|FG000|Overall Study|Withdrawal by Subject|3|||
161810251|NCT04022954|584347744|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
161810252|NCT04022954|584347744|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
161914485|NCT02765165|584735611|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
161914486|NCT02765165|584735612|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
161914487|NCT02765165|584735613|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
161914488|NCT02765165|584735614|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
161914489|NCT02765165|584735608|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161914490|NCT02765165|584735609|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161914491|NCT02765165|584735610|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
161914492|NCT02765165|584735611|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
161914493|NCT02765165|584735612|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161914494|NCT02765165|584735613|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161914495|NCT02765165|584735614|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
162012512|NCT02760498|585101820|FG005|Overall Study|Adverse Event|6|||
162012513|NCT02760498|585101815|FG000|Overall Study|Death|7|||
161810253|NCT04022954|584347744|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
161810254|NCT03637764|584347745|FG000|Overall Study|Adverse Event|2|||
161810255|NCT03637764|584347746|FG001|Overall Study|Adverse Event|0|||
161810256|NCT03637764|584347747|FG002|Overall Study|Adverse Event|0|||
161810257|NCT03637764|584347748|FG003|Overall Study|Adverse Event|1|||
162012514|NCT02760498|585101816|FG001|Overall Study|Death|5|||
162012515|NCT02760498|585101817|FG002|Overall Study|Death|5|||
162012516|NCT02760498|585101818|FG003|Overall Study|Death|7|||
162151629|NCT02538107|585604578|FG000|Overall Study|Not recorded|7|||
162151630|NCT01278394|585604579|FG000|Overall Study|Lost to Follow-up|1|||
162151631|NCT02471755|585604580|FG000|Overall Study|Withdrawal by Subject|1|||
162151632|NCT02471755|585604581|FG001|Overall Study|Withdrawal by Subject|0|||
162151633|NCT02471755|585604580|FG000|Overall Study|Lost to Follow-up|0|||
162151634|NCT02471755|585604581|FG001|Overall Study|Lost to Follow-up|1|||
162151635|NCT00958633|585604584|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
162151636|NCT00958633|585604585|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
162151637|NCT00958633|585604586|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
162151638|NCT00958633|585604584|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
162151639|NCT00958633|585604585|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
162151640|NCT00958633|585604586|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
162151641|NCT00958633|585604584|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
162151642|NCT00958633|585604585|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
162151643|NCT00958633|585604586|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
162151644|NCT00958633|585604584|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
162151645|NCT00958633|585604585|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
162151646|NCT00958633|585604586|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
162151647|NCT00958633|585604584|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
162151648|NCT00958633|585604585|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
162151649|NCT00958633|585604586|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
162151650|NCT00958633|585604584|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
162151651|NCT00958633|585604585|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
162151652|NCT00958633|585604586|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
162151653|NCT00958633|585604584|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
162151654|NCT00958633|585604585|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
162151655|NCT00958633|585604586|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
162151656|NCT00094575|585604591|FG000|Overall Study|Death|146|||
162151657|NCT00094575|585604592|FG001|Overall Study|Death|146|||
162151658|NCT00794118|585604593|FG000|Overall Study|Lost to Follow-up|16|||
162151659|NCT00794118|585604593|FG000|Overall Study|Withdrawal by Subject|9|||
162151660|NCT00794118|585604593|FG000|Overall Study|Changed hospital center|2|||
162151661|NCT00837616|585604596|FG000|Overall Study|Withdrawal by Subject|0|||
161810258|NCT03637764|584347745|FG000|Overall Study|Progressive Disease|23|||
161810259|NCT03637764|584347746|FG001|Overall Study|Progressive Disease|23|||
161810260|NCT03637764|584347747|FG002|Overall Study|Progressive Disease|18|||
162151662|NCT00837616|585604597|FG001|Overall Study|Withdrawal by Subject|1|||
162151663|NCT03512756|585604605|FG000|Part 1|Death|23|||
162151664|NCT03512756|585604606|FG001|Part 1|Death|18|||
162151665|NCT03512756|585604607|FG002|Part 1|Death|0|||
162151666|NCT03512756|585604608|FG003|Part 1|Death|0|||
162151667|NCT03512756|585604605|FG000|Part 1|Lost to Follow-up|0|||
162151668|NCT03512756|585604606|FG001|Part 1|Lost to Follow-up|3|||
162151669|NCT03512756|585604607|FG002|Part 1|Lost to Follow-up|0|||
162151670|NCT03512756|585604608|FG003|Part 1|Lost to Follow-up|0|||
162151671|NCT03512756|585604605|FG000|Part 1|Physician Decision|0|||
162151672|NCT03512756|585604606|FG001|Part 1|Physician Decision|1|||
162151673|NCT03512756|585604607|FG002|Part 1|Physician Decision|0|||
162151674|NCT03512756|585604608|FG003|Part 1|Physician Decision|0|||
162151675|NCT03512756|585604605|FG000|Part 1|Withdrawal by Subject|2|||
162151676|NCT03512756|585604606|FG001|Part 1|Withdrawal by Subject|2|||
162151677|NCT03512756|585604607|FG002|Part 1|Withdrawal by Subject|0|||
162151678|NCT03512756|585604608|FG003|Part 1|Withdrawal by Subject|0|||
162151679|NCT03512756|585604605|FG000|Part 2|Death|0|||
162151680|NCT03512756|585604606|FG001|Part 2|Death|0|||
162151681|NCT03512756|585604607|FG002|Part 2|Death|32|||
162151682|NCT03512756|585604608|FG003|Part 2|Death|21|||
162151683|NCT03512756|585604605|FG000|Part 2|Lost to Follow-up|0|||
162151684|NCT03512756|585604606|FG001|Part 2|Lost to Follow-up|0|||
162151685|NCT03512756|585604607|FG002|Part 2|Lost to Follow-up|1|||
162151686|NCT03512756|585604608|FG003|Part 2|Lost to Follow-up|0|||
162151687|NCT03512756|585604605|FG000|Part 2|Physician Decision|0|||
162151688|NCT03512756|585604606|FG001|Part 2|Physician Decision|0|||
162151689|NCT03512756|585604607|FG002|Part 2|Physician Decision|2|||
162151690|NCT03512756|585604608|FG003|Part 2|Physician Decision|4|||
162151691|NCT03512756|585604605|FG000|Part 2|Study Terminated by Sponsor|0|||
162151692|NCT03512756|585604606|FG001|Part 2|Study Terminated by Sponsor|0|||
162151693|NCT03512756|585604607|FG002|Part 2|Study Terminated by Sponsor|2|||
162151694|NCT03512756|585604608|FG003|Part 2|Study Terminated by Sponsor|6|||
162151695|NCT03512756|585604605|FG000|Part 2|Protocol Violation|0|||
162151696|NCT03512756|585604606|FG001|Part 2|Protocol Violation|0|||
162151697|NCT03512756|585604607|FG002|Part 2|Protocol Violation|1|||
162151698|NCT03512756|585604608|FG003|Part 2|Protocol Violation|0|||
162151699|NCT03512756|585604605|FG000|Part 2|Withdrawal by Subject|0|||
162151700|NCT03512756|585604606|FG001|Part 2|Withdrawal by Subject|0|||
162151701|NCT03512756|585604607|FG002|Part 2|Withdrawal by Subject|3|||
162151702|NCT03512756|585604608|FG003|Part 2|Withdrawal by Subject|9|||
162151703|NCT01212991|585604609|FG000|Double-blind|Lost to Follow-up|8|||
161810261|NCT03637764|584347748|FG003|Overall Study|Progressive Disease|31|||
162151704|NCT01212991|585604610|FG001|Double-blind|Lost to Follow-up|4|||
162151705|NCT01212991|585604611|FG002|Double-blind|Lost to Follow-up|0|||
162151706|NCT01212991|585604609|FG000|Double-blind|Death|699|||
162151707|NCT01212991|585604610|FG001|Double-blind|Death|550|||
162151708|NCT01212991|585604611|FG002|Double-blind|Death|0|||
162151709|NCT01212991|585604609|FG000|Double-blind|Withdrawal by Subject|16|||
162151710|NCT01212991|585604610|FG001|Double-blind|Withdrawal by Subject|19|||
162151711|NCT01212991|585604611|FG002|Double-blind|Withdrawal by Subject|0|||
162151712|NCT01212991|585604609|FG000|Double-blind|Other|7|||
162151713|NCT01212991|585604610|FG001|Double-blind|Other|0|||
162151714|NCT01212991|585604611|FG002|Double-blind|Other|0|||
162151715|NCT01212991|585604609|FG000|Double-blind|Sponsor decision|142|||
162151716|NCT01212991|585604610|FG001|Double-blind|Sponsor decision|38|||
162151717|NCT01212991|585604611|FG002|Double-blind|Sponsor decision|0|||
162151718|NCT01212991|585604609|FG000|Open-label|Death|0|||
162151719|NCT01212991|585604610|FG001|Open-label|Death|0|||
162151720|NCT01212991|585604611|FG002|Open-label|Death|166|||
162151721|NCT01212991|585604609|FG000|Open-label|Lost to Follow-up|0|||
162151722|NCT01212991|585604610|FG001|Open-label|Lost to Follow-up|0|||
162151723|NCT01212991|585604611|FG002|Open-label|Lost to Follow-up|5|||
162151724|NCT01212991|585604609|FG000|Open-label|Withdrawal by Subject|0|||
162151725|NCT01212991|585604610|FG001|Open-label|Withdrawal by Subject|0|||
162151726|NCT01212991|585604611|FG002|Open-label|Withdrawal by Subject|7|||
162151727|NCT01212991|585604609|FG000|Open-label|Sponsor decision|0|||
162151728|NCT01212991|585604610|FG001|Open-label|Sponsor decision|0|||
161914496|NCT02765165|584735608|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
161914497|NCT02765165|584735609|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
162151729|NCT01212991|585604611|FG002|Open-label|Sponsor decision|53|||
162151730|NCT01212991|585604609|FG000|Open-label|Other|0|||
162151731|NCT01212991|585604610|FG001|Open-label|Other|0|||
162151732|NCT01212991|585604611|FG002|Open-label|Other|3|||
162151733|NCT04411056|585606184|FG000|Overall Study|surgery cancelled|1|||
162151734|NCT04411056|585606185|FG001|Overall Study|surgery cancelled|0|||
162151735|NCT04411056|585606184|FG000|Overall Study|Equipment problem during intubation|0|||
162151736|NCT04411056|585606185|FG001|Overall Study|Equipment problem during intubation|1|||
162151737|NCT04623008|585606186|FG000|Baseline to T2|Withdrawal by Subject|4|||
162151738|NCT04623008|585606187|FG001|Baseline to T2|Withdrawal by Subject|2|||
162151739|NCT04623008|585606186|FG000|Baseline to T3|Withdrawal by Subject|4|||
162151740|NCT04623008|585606187|FG001|Baseline to T3|Withdrawal by Subject|2|||
162151741|NCT05985044|585606203|FG000|Overall Study|Death|6|||
162151742|NCT05985044|585606203|FG000|Overall Study|Lost to Follow-up|4|||
162151743|NCT05985044|585606203|FG000|Overall Study|Incapacitation|3|||
162151744|NCT05985044|585606203|FG000|Overall Study|Withdrawal by Subject|2|||
162151745|NCT04688450|585606205|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
162151746|NCT04688450|585606205|FG000|Overall Study|Withdrawal by Subject|1|||
162151747|NCT03481777|585606210|FG000|Overall Study|Withdrawal by Subject|36|||
162151748|NCT03481777|585606211|FG001|Overall Study|Withdrawal by Subject|31|||
162151749|NCT03481777|585606210|FG000|Overall Study|Non stroke = non target population|277|||
162151750|NCT03481777|585606211|FG001|Overall Study|Non stroke = non target population|254|||
162151751|NCT03189524|585606212|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
162151752|NCT03189524|585606213|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
162151753|NCT03189524|585606214|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
162151754|NCT03189524|585606212|FG000|Overall Study|Death|2|||
162151755|NCT03189524|585606213|FG001|Overall Study|Death|2|||
162151756|NCT03189524|585606214|FG002|Overall Study|Death|1|||
162151757|NCT03189524|585606212|FG000|Overall Study|Lost to Follow-up|1|||
162151758|NCT03189524|585606213|FG001|Overall Study|Lost to Follow-up|0|||
162151759|NCT03189524|585606214|FG002|Overall Study|Lost to Follow-up|8|||
162151760|NCT03189524|585606212|FG000|Overall Study|Withdrawal by Subject|1|||
162151761|NCT03189524|585606213|FG001|Overall Study|Withdrawal by Subject|1|||
161914498|NCT02765165|584735610|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
162151762|NCT03189524|585606214|FG002|Overall Study|Withdrawal by Subject|3|||
162151763|NCT03189524|585606212|FG000|Overall Study|Progressive Disease|0|||
162151764|NCT03189524|585606213|FG001|Overall Study|Progressive Disease|2|||
161914499|NCT02765165|584735611|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
161914500|NCT02765165|584735612|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
161914501|NCT02765165|584735613|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
162151765|NCT03189524|585606214|FG002|Overall Study|Progressive Disease|0|||
162151766|NCT01780298|585606215|FG000|Overall Study|Physician Decision|1|||
162151767|NCT01780298|585606216|FG001|Overall Study|Physician Decision|5|||
162151768|NCT01780298|585606217|FG002|Overall Study|Physician Decision|1|||
162151769|NCT01780298|585606218|FG003|Overall Study|Physician Decision|1|||
162151770|NCT01780298|585606215|FG000|Overall Study|Subject not matched|1|||
162151771|NCT01780298|585606216|FG001|Overall Study|Subject not matched|0|||
162151772|NCT01780298|585606217|FG002|Overall Study|Subject not matched|1|||
162151773|NCT01780298|585606218|FG003|Overall Study|Subject not matched|0|||
162151774|NCT01780298|585606215|FG000|Overall Study|Adverse Event|0|||
162151775|NCT01780298|585606216|FG001|Overall Study|Adverse Event|0|||
162151776|NCT01780298|585606217|FG002|Overall Study|Adverse Event|2|||
162151777|NCT01780298|585606218|FG003|Overall Study|Adverse Event|0|||
162151778|NCT02300298|585606229|FG000|Disposition for Nintedanib|Progressive disease|10|||
162151779|NCT02300298|585606230|FG001|Disposition for Nintedanib|Progressive disease|0|||
162151780|NCT02300298|585606229|FG000|Disposition for Docetaxel|Progressive disease|0|||
162151781|NCT02300298|585606230|FG001|Disposition for Docetaxel|Progressive disease|6|||
162151782|NCT02300298|585606229|FG000|Disposition for Docetaxel|other adverse event|0|||
162151783|NCT02300298|585606230|FG001|Disposition for Docetaxel|other adverse event|4|||
162151784|NCT02407249|585606231|FG000|Overall Study|Did not complete 12-month follow-up|13|||
162151785|NCT02407249|585606231|FG000|Overall Study|Not treated|13|||
162151786|NCT01391832|585606232|FG000|Overall Study|Withdrawal by Subject|21|||
162151787|NCT01391832|585606233|FG001|Overall Study|Withdrawal by Subject|22|||
162151788|NCT01391832|585606232|FG000|Overall Study|Lost to Follow-up|0|||
162151789|NCT01391832|585606233|FG001|Overall Study|Lost to Follow-up|1|||
162151790|NCT03345901|585606234|FG000|Overall Study|The study was terminated|18|||
162151791|NCT04252586|585606235|FG000|Overall Study|Withdrawal by parent/guardian|3|||
162151792|NCT04252586|585606235|FG000|Overall Study|Adverse Event|1|||
162151793|NCT04252586|585606235|FG000|Overall Study|Death|2|||
162151794|NCT04252586|585606235|FG000|Overall Study|Study terminated by sponsor|4|||
162151795|NCT04252586|585606235|FG000|Overall Study|Sponsor request|10|||
162151796|NCT04252586|585606235|FG000|Overall Study|Did not complete treatment period|1|||
162151797|NCT00232180|585606236|FG000|Double-blind (DB) Phase|Death|186|||
162151798|NCT00232180|585606237|FG001|Double-blind (DB) Phase|Death|222|||
162151799|NCT00232180|585606238|FG002|Double-blind (DB) Phase|Death|0|||
162151800|NCT00232180|585606236|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
162151801|NCT00232180|585606237|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
162151802|NCT00232180|585606238|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
162151803|NCT00232180|585606236|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
162151804|NCT00232180|585606237|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
162151805|NCT00232180|585606238|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
162151806|NCT00232180|585606236|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
162151807|NCT00232180|585606237|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
162151808|NCT00232180|585606238|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
162151809|NCT00232180|585606236|FG000|Double-blind (DB) Phase|Adverse Event|83|||
162151810|NCT00232180|585606237|FG001|Double-blind (DB) Phase|Adverse Event|100|||
162151811|NCT00232180|585606238|FG002|Double-blind (DB) Phase|Adverse Event|0|||
162151812|NCT00232180|585606236|FG000|Double-blind (DB) Phase|Other|70|||
161810262|NCT03637764|584347745|FG000|Overall Study|Withdrawal by Subject|1|||
161810263|NCT03637764|584347746|FG001|Overall Study|Withdrawal by Subject|3|||
161810264|NCT03637764|584347747|FG002|Overall Study|Withdrawal by Subject|0|||
161810265|NCT03637764|584347748|FG003|Overall Study|Withdrawal by Subject|1|||
161810266|NCT02648438|584347749|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161810267|NCT02648438|584347750|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
161810268|NCT02648438|584347751|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
161810269|NCT02648438|584347749|FG000|Overall Study|Protocol Violation|2|||
161810270|NCT02648438|584347750|FG001|Overall Study|Protocol Violation|0|||
161810271|NCT02648438|584347751|FG002|Overall Study|Protocol Violation|0|||
161810272|NCT02648438|584347749|FG000|Overall Study|Withdrawal by Subject|1|||
161810273|NCT02648438|584347750|FG001|Overall Study|Withdrawal by Subject|1|||
161810274|NCT02648438|584347751|FG002|Overall Study|Withdrawal by Subject|0|||
161810275|NCT03138967|584347754|FG000|Overall Study|Death|0|||
161810276|NCT03138967|584347755|FG001|Overall Study|Death|1|||
161810277|NCT03138967|584347754|FG000|Overall Study|Physician Decision|1|||
161810278|NCT03138967|584347755|FG001|Overall Study|Physician Decision|3|||
161810279|NCT04604275|584347756|FG000|Washout-1 Week|Withdrawal by Subject|1|||
161810280|NCT04604275|584347757|FG001|Washout-1 Week|Withdrawal by Subject|0|||
161810281|NCT04405570|584347758|FG000|Overall Study|Adverse Event|0|||
161810282|NCT04405570|584347759|FG001|Overall Study|Adverse Event|1|||
161810283|NCT04405570|584347760|FG002|Overall Study|Adverse Event|1|||
161810284|NCT04405570|584347761|FG003|Overall Study|Adverse Event|1|||
161810285|NCT04405570|584347758|FG000|Overall Study|Lost to Follow-up|0|||
161810286|NCT04405570|584347759|FG001|Overall Study|Lost to Follow-up|1|||
161810287|NCT04405570|584347760|FG002|Overall Study|Lost to Follow-up|0|||
161810288|NCT04405570|584347761|FG003|Overall Study|Lost to Follow-up|0|||
161810289|NCT04405570|584347758|FG000|Overall Study|Physician Decision|0|||
161810290|NCT04405570|584347759|FG001|Overall Study|Physician Decision|0|||
161810291|NCT04405570|584347760|FG002|Overall Study|Physician Decision|1|||
161810292|NCT04405570|584347761|FG003|Overall Study|Physician Decision|0|||
161810293|NCT04405570|584347758|FG000|Overall Study|Withdrawal by Subject|0|||
161810294|NCT04405570|584347759|FG001|Overall Study|Withdrawal by Subject|1|||
162151813|NCT00232180|585606237|FG001|Double-blind (DB) Phase|Other|75|||
162151814|NCT00232180|585606238|FG002|Double-blind (DB) Phase|Other|0|||
162151815|NCT00232180|585606236|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
162151816|NCT00232180|585606237|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
162151817|NCT00232180|585606238|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
162151818|NCT00232180|585606236|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
162151819|NCT00232180|585606237|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
162151820|NCT00232180|585606238|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
162151821|NCT00232180|585606236|FG000|Open Label Phase|Death|0|||
162151822|NCT00232180|585606237|FG001|Open Label Phase|Death|0|||
162151823|NCT00232180|585606238|FG002|Open Label Phase|Death|48|||
162151824|NCT00232180|585606236|FG000|Open Label Phase|Lost to Follow-up|0|||
162151825|NCT00232180|585606237|FG001|Open Label Phase|Lost to Follow-up|0|||
162151826|NCT00232180|585606238|FG002|Open Label Phase|Lost to Follow-up|5|||
162151827|NCT00232180|585606236|FG000|Open Label Phase|Protocol Violation|0|||
162151828|NCT00232180|585606237|FG001|Open Label Phase|Protocol Violation|0|||
162151829|NCT00232180|585606238|FG002|Open Label Phase|Protocol Violation|3|||
162151830|NCT00232180|585606236|FG000|Open Label Phase|Study terminated by sponsor|0|||
162151831|NCT00232180|585606237|FG001|Open Label Phase|Study terminated by sponsor|0|||
162151832|NCT00232180|585606238|FG002|Open Label Phase|Study terminated by sponsor|3|||
162151833|NCT00232180|585606236|FG000|Open Label Phase|Withdrawal by Subject|0|||
162151834|NCT00232180|585606237|FG001|Open Label Phase|Withdrawal by Subject|0|||
162151835|NCT00232180|585606238|FG002|Open Label Phase|Withdrawal by Subject|37|||
162151836|NCT00232180|585606236|FG000|Open Label Phase|Other|0|||
162151837|NCT00232180|585606237|FG001|Open Label Phase|Other|0|||
161914502|NCT02765165|584735614|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
161914503|NCT02765165|584735608|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
161914504|NCT02765165|584735609|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
161914505|NCT02765165|584735610|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
161914506|NCT02765165|584735611|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
161914507|NCT02765165|584735612|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
161914508|NCT02765165|584735613|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
161914509|NCT02765165|584735614|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
161914510|NCT02382939|584735617|FG000|Overall Study|Adverse Event|1|||
161914511|NCT02382939|584735618|FG001|Overall Study|Adverse Event|1|||
161914512|NCT02382939|584735617|FG000|Overall Study|Withdrawal by Subject|2|||
161914513|NCT02382939|584735618|FG001|Overall Study|Withdrawal by Subject|2|||
161914514|NCT01189266|584735621|FG000|Overall Study|Adverse Event|1|||
161914515|NCT01189266|584735622|FG001|Overall Study|Adverse Event|0|||
161914516|NCT01189266|584735623|FG002|Overall Study|Adverse Event|5|||
161914517|NCT01189266|584735621|FG000|Overall Study|Death|0|||
161914518|NCT01189266|584735622|FG001|Overall Study|Death|0|||
161914519|NCT01189266|584735623|FG002|Overall Study|Death|5|||
161914520|NCT01189266|584735621|FG000|Overall Study|Lack of Efficacy|4|||
161914521|NCT01189266|584735622|FG001|Overall Study|Lack of Efficacy|5|||
161914522|NCT01189266|584735623|FG002|Overall Study|Lack of Efficacy|44|||
161914523|NCT01189266|584735621|FG000|Overall Study|Physician Decision|0|||
161914524|NCT01189266|584735622|FG001|Overall Study|Physician Decision|0|||
161914525|NCT01189266|584735623|FG002|Overall Study|Physician Decision|1|||
161914526|NCT01189266|584735621|FG000|Overall Study|Protocol Violation|0|||
161914527|NCT01189266|584735622|FG001|Overall Study|Protocol Violation|1|||
161914528|NCT01189266|584735623|FG002|Overall Study|Protocol Violation|1|||
161914529|NCT01189266|584735621|FG000|Overall Study|Withdrawal by Subject|0|||
161914530|NCT01189266|584735622|FG001|Overall Study|Withdrawal by Subject|0|||
161914531|NCT01189266|584735623|FG002|Overall Study|Withdrawal by Subject|1|||
161914532|NCT01189266|584735621|FG000|Overall Study|Patient refuses further therapy|1|||
161914533|NCT01189266|584735622|FG001|Overall Study|Patient refuses further therapy|0|||
161914534|NCT01189266|584735623|FG002|Overall Study|Patient refuses further therapy|7|||
161914535|NCT01189266|584735621|FG000|Overall Study|No treatment|0|||
161914536|NCT01189266|584735622|FG001|Overall Study|No treatment|0|||
162151838|NCT00232180|585606238|FG002|Open Label Phase|Other|16|||
162151839|NCT00232180|585606236|FG000|Open Label Phase|Adverse Event|0|||
162151840|NCT00232180|585606237|FG001|Open Label Phase|Adverse Event|0|||
162151841|NCT00232180|585606238|FG002|Open Label Phase|Adverse Event|25|||
162151842|NCT00232180|585606236|FG000|Open Label Phase|Laboratory abnormality|0|||
162151843|NCT00232180|585606237|FG001|Open Label Phase|Laboratory abnormality|0|||
162151844|NCT00232180|585606238|FG002|Open Label Phase|Laboratory abnormality|10|||
162151845|NCT00232180|585606236|FG000|Open Label Phase|Randomized but not treated|0|||
162151846|NCT00232180|585606237|FG001|Open Label Phase|Randomized but not treated|0|||
162151847|NCT00232180|585606238|FG002|Open Label Phase|Randomized but not treated|1|||
162151848|NCT02748317|585606239|FG000|Overall Study|Withdrawal by Subject|14|||
162151849|NCT02748317|585606239|FG000|Overall Study|Lost to Follow-up|8|||
161914537|NCT01189266|584735623|FG002|Overall Study|No treatment|1|||
161914538|NCT00321763|584735624|FG000|Overall Study|Adverse Event|1|||
161914539|NCT00321763|584735625|FG001|Overall Study|Adverse Event|1|||
162151850|NCT02748317|585606239|FG000|Overall Study|Death|1|||
162151851|NCT03452189|585606240|FG000|First Intervention (3 Months)|Adverse Event|1|||
162151852|NCT03452189|585606241|FG001|First Intervention (3 Months)|Adverse Event|0|||
162151853|NCT03452189|585606240|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
161914540|NCT00321763|584735626|FG002|Overall Study|Adverse Event|0|||
161914541|NCT00321763|584735627|FG003|Overall Study|Adverse Event|1|||
161914542|NCT00321763|584735624|FG000|Overall Study|Withdrawal by Subject|2|||
161914543|NCT00321763|584735625|FG001|Overall Study|Withdrawal by Subject|0|||
161914544|NCT00321763|584735626|FG002|Overall Study|Withdrawal by Subject|1|||
161914545|NCT00321763|584735627|FG003|Overall Study|Withdrawal by Subject|0|||
161914546|NCT00321763|584735624|FG000|Overall Study|Lost to Follow-up|3|||
161914547|NCT00321763|584735625|FG001|Overall Study|Lost to Follow-up|1|||
161914548|NCT00321763|584735626|FG002|Overall Study|Lost to Follow-up|5|||
161914549|NCT00321763|584735627|FG003|Overall Study|Lost to Follow-up|4|||
161914550|NCT03530696|584735631|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
161914551|NCT03530696|584735632|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
161914552|NCT01129128|584735633|FG000|Overall Study|Lost to Follow-up|2|||
161914553|NCT01129128|584735634|FG001|Overall Study|Lost to Follow-up|2|||
161914554|NCT01129128|584735635|FG002|Overall Study|Lost to Follow-up|1|||
161914555|NCT01129128|584735633|FG000|Overall Study|Protocol Violation|0|||
161914556|NCT01129128|584735634|FG001|Overall Study|Protocol Violation|1|||
161914557|NCT01129128|584735635|FG002|Overall Study|Protocol Violation|0|||
161914558|NCT01129128|584735633|FG000|Overall Study|Withdrawal by Subject|0|||
161914559|NCT01129128|584735634|FG001|Overall Study|Withdrawal by Subject|1|||
161914560|NCT01129128|584735635|FG002|Overall Study|Withdrawal by Subject|3|||
161914561|NCT01129128|584735633|FG000|Overall Study|Physician Decision|1|||
161914562|NCT01129128|584735634|FG001|Overall Study|Physician Decision|0|||
161914563|NCT01129128|584735635|FG002|Overall Study|Physician Decision|0|||
161914564|NCT01311661|584735638|FG000|Overall Study|Adverse Event|2|||
161914565|NCT01311661|584735638|FG000|Overall Study|Protocol Violation|3|||
161914566|NCT01311661|584735638|FG000|Overall Study|Withdrawal by Subject|2|||
161914567|NCT01900314|584735639|FG000|Overall Study|Lost to Follow-up|1|||
161914568|NCT01900314|584735640|FG001|Overall Study|Lost to Follow-up|0|||
161914569|NCT01900314|584735639|FG000|Overall Study|Protocol Violation|0|||
161914570|NCT01900314|584735640|FG001|Overall Study|Protocol Violation|1|||
161914571|NCT01900314|584735639|FG000|Overall Study|Withdrawal by Subject|3|||
161914572|NCT01900314|584735640|FG001|Overall Study|Withdrawal by Subject|3|||
161914573|NCT04759131|584735641|FG000|Overall Study|Investigator's discretion|1|||
161914574|NCT04759131|584735642|FG001|Overall Study|Investigator's discretion|0|||
161914575|NCT04759131|584735641|FG000|Overall Study|Subject withdrawal|1|||
161914576|NCT04759131|584735642|FG001|Overall Study|Subject withdrawal|0|||
161914577|NCT00289276|584735648|FG000|Second Part of FAST Study (Expansion)|Death|0|||
161914578|NCT00289276|584735649|FG001|Second Part of FAST Study (Expansion)|Death|2|||
161914579|NCT00289276|584735648|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
161914580|NCT00289276|584735649|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
161914581|NCT00869960|584735650|FG000|Overall Study|Lost to Follow-up|2|||
161914582|NCT02187783|584735651|FG000|Overall Study|Adverse Event|8|||
161914583|NCT02187783|584735651|FG000|Overall Study|Death|3|||
161914584|NCT02187783|584735651|FG000|Overall Study|Progressive disease|80|||
161914585|NCT02187783|584735651|FG000|Overall Study|Protocol Violation|3|||
161914586|NCT02187783|584735651|FG000|Overall Study|Physician Decision|2|||
161914587|NCT02187783|584735651|FG000|Overall Study|Withdrawal by Subject|9|||
161914588|NCT02187783|584735651|FG000|Overall Study|Study terminated by sponsor|1|||
161914589|NCT00171249|584735652|FG000|Overall Study|Withdrawal by Subject|2|||
161914590|NCT00171249|584735653|FG001|Overall Study|Withdrawal by Subject|0|||
161914591|NCT00171249|584735654|FG002|Overall Study|Withdrawal by Subject|0|||
161914592|NCT00171249|584735655|FG003|Overall Study|Withdrawal by Subject|6|||
161914593|NCT00171249|584735656|FG004|Overall Study|Withdrawal by Subject|0|||
161914594|NCT00171249|584735657|FG005|Overall Study|Withdrawal by Subject|0|||
161914595|NCT00171249|584735658|FG006|Overall Study|Withdrawal by Subject|0|||
161914596|NCT00171249|584735652|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
161914597|NCT00171249|584735653|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161914598|NCT00171249|584735654|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
161914599|NCT00171249|584735655|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
161914600|NCT00171249|584735656|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161914601|NCT00171249|584735657|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
161914602|NCT00171249|584735658|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
161914603|NCT00171249|584735652|FG000|Overall Study|Death|7|||
161914604|NCT00171249|584735653|FG001|Overall Study|Death|1|||
161914605|NCT00171249|584735654|FG002|Overall Study|Death|0|||
161914606|NCT00171249|584735655|FG003|Overall Study|Death|4|||
161914607|NCT00171249|584735656|FG004|Overall Study|Death|0|||
161914608|NCT00171249|584735657|FG005|Overall Study|Death|3|||
161914609|NCT00171249|584735658|FG006|Overall Study|Death|1|||
161914610|NCT00171249|584735652|FG000|Overall Study|Other|10|||
161914611|NCT00171249|584735653|FG001|Overall Study|Other|0|||
161914612|NCT00171249|584735654|FG002|Overall Study|Other|0|||
161914613|NCT00171249|584735655|FG003|Overall Study|Other|43|||
161914614|NCT00171249|584735656|FG004|Overall Study|Other|0|||
161914615|NCT00171249|584735657|FG005|Overall Study|Other|2|||
161914616|NCT00171249|584735658|FG006|Overall Study|Other|0|||
161914617|NCT00171249|584735652|FG000|Overall Study|No Longer Requires Study Drug|4|||
161914618|NCT00171249|584735653|FG001|Overall Study|No Longer Requires Study Drug|0|||
161914619|NCT00171249|584735654|FG002|Overall Study|No Longer Requires Study Drug|0|||
161914620|NCT00171249|584735655|FG003|Overall Study|No Longer Requires Study Drug|3|||
161914621|NCT00171249|584735656|FG004|Overall Study|No Longer Requires Study Drug|0|||
162151854|NCT03452189|585606241|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
162151855|NCT02724592|585606242|FG000|Overall Study|Lost to Follow-up|4|||
162151856|NCT02724592|585606243|FG001|Overall Study|Lost to Follow-up|1|||
162151857|NCT00434304|585606244|FG000|Overall Study|Adverse Event|14|||
162151858|NCT00434304|585606244|FG000|Overall Study|Lack of Efficacy|2|||
162151859|NCT00434304|585606244|FG000|Overall Study|Withdrawal by Subject|4|||
162151860|NCT05262738|585606245|FG000|Overall Study|Withdrawal by Subject|1|||
162151861|NCT05262738|585606246|FG001|Overall Study|Withdrawal by Subject|0|||
162151862|NCT01424397|585606250|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
162151863|NCT01424397|585606251|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
162151864|NCT01424397|585606252|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
162151865|NCT01424397|585606253|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
162151866|NCT01424397|585606254|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
162151867|NCT01424397|585606255|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
162151868|NCT01424397|585606256|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
162151869|NCT01424397|585606257|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
162151870|NCT01424397|585606258|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
162151871|NCT01424397|585606259|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
162151872|NCT01424397|585606260|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
162151873|NCT01424397|585606261|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
162151874|NCT01149369|585606262|FG000|Overall Study|Adverse Event|6|||
162151875|NCT01149369|585606263|FG001|Overall Study|Adverse Event|3|||
162151876|NCT02767765|585606264|FG000|Overall Study|Adverse Event|4|||
162151877|NCT02767765|585606264|FG000|Overall Study|Death|1|||
162151878|NCT02767765|585606264|FG000|Overall Study|Insufficient response|1|||
162151879|NCT02767765|585606264|FG000|Overall Study|Lost to Follow-up|2|||
162151880|NCT02767765|585606264|FG000|Overall Study|Investigator decision|1|||
162151881|NCT02767765|585606264|FG000|Overall Study|Non-Compliance|1|||
162151882|NCT02767765|585606264|FG000|Overall Study|Withdrawal by Subject|1|||
162151883|NCT01951170|585606265|FG000|Overall Study|Investigator decision|1|||
161914622|NCT00171249|584735657|FG005|Overall Study|No Longer Requires Study Drug|5|||
162151884|NCT01972724|585606270|FG000|Double-Blind|Rescue Criteria Met|1|||
162151885|NCT01972724|585606271|FG001|Double-Blind|Rescue Criteria Met|0|||
162151886|NCT01972724|585606272|FG002|Double-Blind|Rescue Criteria Met|0|||
161914623|NCT00171249|584735658|FG006|Overall Study|No Longer Requires Study Drug|0|||
161914624|NCT00171249|584735652|FG000|Overall Study|Administrative Problems|1|||
161914625|NCT00171249|584735653|FG001|Overall Study|Administrative Problems|0|||
162151887|NCT01972724|585606270|FG000|Double-Blind|Adverse Event|1|||
162151888|NCT01972724|585606271|FG001|Double-Blind|Adverse Event|0|||
162151889|NCT01972724|585606272|FG002|Double-Blind|Adverse Event|0|||
162151890|NCT01972724|585606270|FG000|Double-Blind|Withdrawal of Consent|2|||
162151891|NCT01972724|585606271|FG001|Double-Blind|Withdrawal of Consent|1|||
162151892|NCT01972724|585606272|FG002|Double-Blind|Withdrawal of Consent|0|||
162151893|NCT01972724|585606270|FG000|Double-Blind|Significant Protocol Deviation|5|||
161914626|NCT00171249|584735654|FG002|Overall Study|Administrative Problems|0|||
162012517|NCT02760498|585101819|FG004|Overall Study|Death|0|||
162012518|NCT02760498|585101820|FG005|Overall Study|Death|23|||
162012519|NCT02760498|585101815|FG000|Overall Study|Lost to Follow-up|0|||
162012520|NCT02760498|585101816|FG001|Overall Study|Lost to Follow-up|0|||
162012521|NCT02760498|585101817|FG002|Overall Study|Lost to Follow-up|0|||
162012522|NCT02760498|585101818|FG003|Overall Study|Lost to Follow-up|0|||
162012523|NCT02760498|585101819|FG004|Overall Study|Lost to Follow-up|0|||
162012524|NCT02760498|585101820|FG005|Overall Study|Lost to Follow-up|3|||
162012525|NCT02760498|585101815|FG000|Overall Study|Non-compliance with study drug|0|||
162012526|NCT02760498|585101816|FG001|Overall Study|Non-compliance with study drug|2|||
162012527|NCT02760498|585101817|FG002|Overall Study|Non-compliance with study drug|0|||
162012528|NCT02760498|585101818|FG003|Overall Study|Non-compliance with study drug|0|||
162012529|NCT02760498|585101819|FG004|Overall Study|Non-compliance with study drug|0|||
162012530|NCT02760498|585101820|FG005|Overall Study|Non-compliance with study drug|0|||
162012531|NCT02760498|585101815|FG000|Overall Study|Participant decision|1|||
162012532|NCT02760498|585101816|FG001|Overall Study|Participant decision|4|||
162012533|NCT02760498|585101817|FG002|Overall Study|Participant decision|2|||
162012534|NCT02760498|585101818|FG003|Overall Study|Participant decision|2|||
162012535|NCT02760498|585101819|FG004|Overall Study|Participant decision|1|||
162012536|NCT02760498|585101820|FG005|Overall Study|Participant decision|6|||
162012537|NCT02760498|585101815|FG000|Overall Study|Sponsor decision|0|||
162012538|NCT02760498|585101816|FG001|Overall Study|Sponsor decision|0|||
162012539|NCT02760498|585101817|FG002|Overall Study|Sponsor decision|0|||
162012540|NCT02760498|585101818|FG003|Overall Study|Sponsor decision|3|||
162012541|NCT02760498|585101819|FG004|Overall Study|Sponsor decision|0|||
162012542|NCT02760498|585101820|FG005|Overall Study|Sponsor decision|0|||
162012543|NCT02760498|585101815|FG000|Overall Study|Physician Decision|3|||
162012544|NCT02760498|585101816|FG001|Overall Study|Physician Decision|4|||
162012545|NCT02760498|585101817|FG002|Overall Study|Physician Decision|1|||
162012546|NCT02760498|585101818|FG003|Overall Study|Physician Decision|4|||
162012547|NCT02760498|585101819|FG004|Overall Study|Physician Decision|0|||
162012548|NCT02760498|585101820|FG005|Overall Study|Physician Decision|2|||
162012549|NCT02760498|585101815|FG000|Overall Study|Disease progression|21|||
162012550|NCT02760498|585101816|FG001|Overall Study|Disease progression|19|||
162012551|NCT02760498|585101817|FG002|Overall Study|Disease progression|20|||
162012552|NCT02760498|585101818|FG003|Overall Study|Disease progression|18|||
162012553|NCT02760498|585101819|FG004|Overall Study|Disease progression|4|||
162012554|NCT02760498|585101820|FG005|Overall Study|Disease progression|55|||
162012555|NCT02760498|585101815|FG000|Overall Study|Withdrawal by Subject|4|||
162012556|NCT02760498|585101816|FG001|Overall Study|Withdrawal by Subject|7|||
162012557|NCT02760498|585101817|FG002|Overall Study|Withdrawal by Subject|5|||
162012558|NCT02760498|585101818|FG003|Overall Study|Withdrawal by Subject|1|||
162012559|NCT02760498|585101819|FG004|Overall Study|Withdrawal by Subject|0|||
162012560|NCT02760498|585101820|FG005|Overall Study|Withdrawal by Subject|6|||
162012561|NCT02760498|585101815|FG000|Overall Study|Other than specified|1|||
162012562|NCT02760498|585101816|FG001|Overall Study|Other than specified|6|||
162012563|NCT02760498|585101817|FG002|Overall Study|Other than specified|0|||
162012564|NCT02760498|585101818|FG003|Overall Study|Other than specified|3|||
162012565|NCT02760498|585101819|FG004|Overall Study|Other than specified|1|||
162012566|NCT02760498|585101820|FG005|Overall Study|Other than specified|0|||
162012567|NCT02760498|585101815|FG000|Overall Study|Not treated|0|||
162012568|NCT02760498|585101816|FG001|Overall Study|Not treated|0|||
162012569|NCT02760498|585101817|FG002|Overall Study|Not treated|0|||
162012570|NCT02760498|585101818|FG003|Overall Study|Not treated|0|||
162012571|NCT02760498|585101819|FG004|Overall Study|Not treated|0|||
162012572|NCT02760498|585101820|FG005|Overall Study|Not treated|2|||
162012573|NCT01198977|585101822|FG000|Overall Study|Lost to Follow-up|1|||
162012574|NCT01198977|585101823|FG001|Overall Study|Lost to Follow-up|0|||
162012575|NCT01588522|585101824|FG000|Overall Study|Withdrawal by Subject|1|||
162012576|NCT01588522|585101825|FG001|Overall Study|Withdrawal by Subject|5|||
162012577|NCT01588522|585101826|FG002|Overall Study|Withdrawal by Subject|3|||
162012578|NCT01588522|585101827|FG003|Overall Study|Withdrawal by Subject|1|||
162012579|NCT01588522|585101828|FG004|Overall Study|Withdrawal by Subject|2|||
162012580|NCT01588522|585101829|FG005|Overall Study|Withdrawal by Subject|0|||
162012581|NCT01588522|585101824|FG000|Overall Study|Lack of Efficacy|0|||
162012582|NCT01588522|585101825|FG001|Overall Study|Lack of Efficacy|0|||
162012583|NCT01588522|585101826|FG002|Overall Study|Lack of Efficacy|0|||
162012584|NCT01588522|585101827|FG003|Overall Study|Lack of Efficacy|0|||
162012585|NCT01588522|585101828|FG004|Overall Study|Lack of Efficacy|1|||
162012586|NCT01588522|585101829|FG005|Overall Study|Lack of Efficacy|0|||
162012587|NCT01588522|585101824|FG000|Overall Study|Adverse Event|0|||
162012588|NCT01588522|585101825|FG001|Overall Study|Adverse Event|0|||
162012589|NCT01588522|585101826|FG002|Overall Study|Adverse Event|0|||
162012590|NCT01588522|585101827|FG003|Overall Study|Adverse Event|1|||
162012591|NCT01588522|585101828|FG004|Overall Study|Adverse Event|0|||
162012592|NCT01588522|585101829|FG005|Overall Study|Adverse Event|0|||
162012593|NCT01588522|585101824|FG000|Overall Study|Grade 2 alopecia|1|||
162012594|NCT01588522|585101825|FG001|Overall Study|Grade 2 alopecia|0|||
162012595|NCT01588522|585101826|FG002|Overall Study|Grade 2 alopecia|0|||
162012596|NCT01588522|585101827|FG003|Overall Study|Grade 2 alopecia|0|||
162012597|NCT01588522|585101828|FG004|Overall Study|Grade 2 alopecia|0|||
162012598|NCT01588522|585101829|FG005|Overall Study|Grade 2 alopecia|0|||
162012599|NCT01588522|585101824|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
162012600|NCT01588522|585101825|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
162012601|NCT01588522|585101826|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
162012602|NCT01588522|585101827|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
162012603|NCT01588522|585101828|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
162012604|NCT01588522|585101829|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
162012605|NCT01588522|585101824|FG000|Overall Study|Taken off taxane-based regimen|0|||
162012606|NCT01588522|585101825|FG001|Overall Study|Taken off taxane-based regimen|0|||
162012607|NCT01588522|585101826|FG002|Overall Study|Taken off taxane-based regimen|0|||
162012608|NCT01588522|585101827|FG003|Overall Study|Taken off taxane-based regimen|1|||
162012609|NCT01588522|585101828|FG004|Overall Study|Taken off taxane-based regimen|0|||
162012610|NCT01588522|585101829|FG005|Overall Study|Taken off taxane-based regimen|0|||
162012611|NCT01588522|585101824|FG000|Overall Study|Did not initiate chemotherapy|0|||
162012612|NCT01588522|585101825|FG001|Overall Study|Did not initiate chemotherapy|0|||
162012613|NCT01588522|585101826|FG002|Overall Study|Did not initiate chemotherapy|0|||
162012614|NCT01588522|585101827|FG003|Overall Study|Did not initiate chemotherapy|0|||
162012615|NCT01588522|585101828|FG004|Overall Study|Did not initiate chemotherapy|1|||
162012616|NCT01588522|585101829|FG005|Overall Study|Did not initiate chemotherapy|0|||
162012617|NCT02855125|585101834|FG000|Overall Study|Withdrawal by Subject|2|||
162012618|NCT02855125|585101835|FG001|Overall Study|Withdrawal by Subject|2|||
162012619|NCT02855125|585101834|FG000|Overall Study|Clinical Disease Progression|5|||
162012620|NCT02855125|585101835|FG001|Overall Study|Clinical Disease Progression|4|||
162012621|NCT02855125|585101834|FG000|Overall Study|Radiologic Disease Progression|36|||
162012622|NCT02855125|585101835|FG001|Overall Study|Radiologic Disease Progression|39|||
162012623|NCT02855125|585101834|FG000|Overall Study|Adverse Event|11|||
162012624|NCT02855125|585101835|FG001|Overall Study|Adverse Event|7|||
162012625|NCT02855125|585101834|FG000|Overall Study|Physician Decision|1|||
162012626|NCT02855125|585101835|FG001|Overall Study|Physician Decision|0|||
162012627|NCT02855125|585101834|FG000|Overall Study|On Treatment|9|||
162012628|NCT02855125|585101835|FG001|Overall Study|On Treatment|11|||
162012629|NCT02855125|585101834|FG000|Overall Study|Randomized but not treated|0|||
162012630|NCT02855125|585101835|FG001|Overall Study|Randomized but not treated|1|||
162012631|NCT04467905|585101836|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
162012632|NCT04467905|585101837|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
162012633|NCT04467905|585101838|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
162012634|NCT04467905|585101836|FG000|Overall Study|Conversion to SR|0|||
162012635|NCT04467905|585101837|FG001|Overall Study|Conversion to SR|0|||
162012636|NCT04467905|585101838|FG002|Overall Study|Conversion to SR|3|||
162012637|NCT04467905|585101836|FG000|Overall Study|Technical issue with Holter ECG|0|||
162012638|NCT04467905|585101837|FG001|Overall Study|Technical issue with Holter ECG|0|||
162012639|NCT04467905|585101838|FG002|Overall Study|Technical issue with Holter ECG|3|||
162012640|NCT04467905|585101836|FG000|Overall Study|Hemodynamic instability|0|||
162012641|NCT04467905|585101837|FG001|Overall Study|Hemodynamic instability|0|||
162012642|NCT04467905|585101838|FG002|Overall Study|Hemodynamic instability|1|||
162012643|NCT04467905|585101836|FG000|Overall Study|Site misinterpretation of protocol|0|||
162012644|NCT04467905|585101837|FG001|Overall Study|Site misinterpretation of protocol|0|||
162012645|NCT04467905|585101838|FG002|Overall Study|Site misinterpretation of protocol|1|||
162012646|NCT02514083|585101844|FG000|Overall Study|Adverse Event|1|||
162012647|NCT02017405|585101845|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
162012648|NCT02017405|585101846|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
162012649|NCT02017405|585101847|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
162012650|NCT02017405|585101848|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
162012651|NCT02017405|585101849|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
162012652|NCT02017405|585101850|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
162012653|NCT02017405|585101845|FG000|Open-label Phase|Adverse Event|1|||
162012654|NCT02017405|585101846|FG001|Open-label Phase|Adverse Event|1|||
162012655|NCT02017405|585101847|FG002|Open-label Phase|Adverse Event|0|||
162012656|NCT02017405|585101848|FG003|Open-label Phase|Adverse Event|0|||
162012657|NCT02017405|585101849|FG004|Open-label Phase|Adverse Event|0|||
162012658|NCT02017405|585101850|FG005|Open-label Phase|Adverse Event|0|||
162012659|NCT01899040|585101851|FG000|Overall Study|Randomized in error|0|||
162012660|NCT01899040|585101852|FG001|Overall Study|Randomized in error|1|||
162012661|NCT01899040|585101853|FG002|Overall Study|Randomized in error|1|||
162012662|NCT01899040|585101851|FG000|Overall Study|Adverse Event|3|||
162012663|NCT01899040|585101852|FG001|Overall Study|Adverse Event|1|||
162012664|NCT01899040|585101853|FG002|Overall Study|Adverse Event|2|||
162012665|NCT01899040|585101851|FG000|Overall Study|Unspecified reasons|4|||
162012666|NCT01899040|585101852|FG001|Overall Study|Unspecified reasons|4|||
162012667|NCT01899040|585101853|FG002|Overall Study|Unspecified reasons|0|||
162012668|NCT01899040|585101851|FG000|Overall Study|Compliance issues|1|||
161914627|NCT00171249|584735655|FG003|Overall Study|Administrative Problems|2|||
161914628|NCT00171249|584735656|FG004|Overall Study|Administrative Problems|0|||
161914629|NCT00171249|584735657|FG005|Overall Study|Administrative Problems|0|||
162151894|NCT01972724|585606271|FG001|Double-Blind|Significant Protocol Deviation|8|||
162151895|NCT01972724|585606272|FG002|Double-Blind|Significant Protocol Deviation|0|||
162151896|NCT01972724|585606270|FG000|Open-Label|Withdrew Consent|0|||
162151897|NCT01972724|585606271|FG001|Open-Label|Withdrew Consent|0|||
162151898|NCT01972724|585606272|FG002|Open-Label|Withdrew Consent|3|||
162151899|NCT01972724|585606270|FG000|Open-Label|Significant Protocol Deviation|0|||
162151900|NCT01972724|585606271|FG001|Open-Label|Significant Protocol Deviation|0|||
162151901|NCT01972724|585606272|FG002|Open-Label|Significant Protocol Deviation|2|||
162151902|NCT00277355|585606273|FG000|Overall Study|Withdrawal by Subject|3|||
162151903|NCT00277355|585606274|FG001|Overall Study|Withdrawal by Subject|3|||
162151904|NCT00277355|585606273|FG000|Overall Study|Lost to Follow-up|2|||
162151905|NCT00277355|585606274|FG001|Overall Study|Lost to Follow-up|2|||
162151906|NCT00277355|585606273|FG000|Overall Study|Adverse Event|5|||
162151907|NCT00277355|585606274|FG001|Overall Study|Adverse Event|0|||
162151908|NCT00277355|585606273|FG000|Overall Study|Death|3|||
162151909|NCT00277355|585606274|FG001|Overall Study|Death|0|||
162151910|NCT00277355|585606273|FG000|Overall Study|Physician Decision|1|||
162151911|NCT00277355|585606274|FG001|Overall Study|Physician Decision|0|||
162151912|NCT02675244|585606277|FG000|Overall Study|Death|9|||
162151913|NCT02675244|585606278|FG001|Overall Study|Death|6|||
162151914|NCT02675244|585606277|FG000|Overall Study|Withdrawal by Subject|3|||
162151915|NCT02675244|585606278|FG001|Overall Study|Withdrawal by Subject|6|||
162151916|NCT02675244|585606277|FG000|Overall Study|Lost to Follow-up|1|||
162151917|NCT02675244|585606278|FG001|Overall Study|Lost to Follow-up|1|||
162151918|NCT02675244|585606277|FG000|Overall Study|Ongoing at 2 Years|190|||
162151919|NCT02675244|585606278|FG001|Overall Study|Ongoing at 2 Years|185|||
162151920|NCT04054635|585606282|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
162151921|NCT04054635|585606283|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
162151922|NCT04054635|585606284|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
162151923|NCT04054635|585606282|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
162151924|NCT04054635|585606283|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
162151925|NCT04054635|585606284|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
162151926|NCT01254188|585606290|FG000|Overall Study|Disease Progression|6|||
162151927|NCT01254188|585606290|FG000|Overall Study|Protocol Violation|6|||
162151928|NCT01254188|585606290|FG000|Overall Study|Pregnancy|2|||
162151929|NCT01254188|585606290|FG000|Overall Study|Death|4|||
162151930|NCT01254188|585606290|FG000|Overall Study|Lost to Follow-up|5|||
162151931|NCT01254188|585606290|FG000|Overall Study|Withdrawal by Subject|7|||
162151932|NCT01254188|585606290|FG000|Overall Study|Adverse Event|43|||
162151933|NCT01254188|585606290|FG000|Overall Study|per investigator discretion|20|||
162151934|NCT04530747|585606292|FG000|Overall Study|Withdrawal by Subject|1|||
162151935|NCT04530747|585606293|FG001|Overall Study|Withdrawal by Subject|0|||
162151936|NCT03292913|585606294|FG000|Overall Study|Death|9|||
162151937|NCT03292913|585606295|FG001|Overall Study|Death|3|||
162151938|NCT03292913|585606294|FG000|Overall Study|Lost to Follow-up|49|||
162151939|NCT03292913|585606295|FG001|Overall Study|Lost to Follow-up|49|||
162151940|NCT03292913|585606294|FG000|Overall Study|Withdrawal by Subject|2|||
162151941|NCT03292913|585606295|FG001|Overall Study|Withdrawal by Subject|0|||
162151942|NCT03292913|585606294|FG000|Overall Study|Clinic closed due to COVID|22|||
162151943|NCT03292913|585606295|FG001|Overall Study|Clinic closed due to COVID|36|||
162151944|NCT03950622|585606296|FG000|Overall Study|Withdrawal by Subject|1|||
162151945|NCT03950622|585606297|FG001|Overall Study|Withdrawal by Subject|0|||
162151946|NCT03950622|585606296|FG000|Overall Study|Protocol Deviation|0|||
162151947|NCT03950622|585606297|FG001|Overall Study|Protocol Deviation|1|||
162151948|NCT03950622|585606296|FG000|Overall Study|Physician Decision|1|||
162151949|NCT03950622|585606297|FG001|Overall Study|Physician Decision|0|||
162151950|NCT03950622|585606296|FG000|Overall Study|Lost to Follow-up|5|||
162151951|NCT03950622|585606297|FG001|Overall Study|Lost to Follow-up|5|||
162151952|NCT03950622|585606296|FG000|Overall Study|Death|1|||
162151953|NCT03950622|585606297|FG001|Overall Study|Death|1|||
162151954|NCT03531840|585606301|FG000|Overall Study|Death on study|3|||
161914630|NCT00171249|584735658|FG006|Overall Study|Administrative Problems|0|||
162151955|NCT03531840|585606302|FG001|Overall Study|Death on study|2|||
162151956|NCT03531840|585606303|FG002|Overall Study|Death on study|1|||
162151957|NCT03531840|585606304|FG003|Overall Study|Death on study|2|||
162151958|NCT03531840|585606301|FG000|Overall Study|Death during follow up|2|||
162151959|NCT03531840|585606302|FG001|Overall Study|Death during follow up|3|||
162151960|NCT03531840|585606303|FG002|Overall Study|Death during follow up|4|||
161914631|NCT00171249|584735652|FG000|Overall Study|Adverse Event|3|||
161914632|NCT00171249|584735653|FG001|Overall Study|Adverse Event|1|||
162151961|NCT03531840|585606304|FG003|Overall Study|Death during follow up|1|||
162151962|NCT02267824|585606306|FG000|Overall Study|Pregnancy|1|||
162151963|NCT02267824|585606307|FG001|Overall Study|Pregnancy|1|||
162151964|NCT02267824|585606306|FG000|Overall Study|Lost to Follow-up|4|||
162151965|NCT02267824|585606307|FG001|Overall Study|Lost to Follow-up|0|||
162151966|NCT02267824|585606306|FG000|Overall Study|Protocol Violation|3|||
162151967|NCT02267824|585606307|FG001|Overall Study|Protocol Violation|0|||
162151968|NCT02267824|585606306|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
162151969|NCT02267824|585606307|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
162151970|NCT01546753|585606308|FG000|Overall Study|anxiety|1|||
162151971|NCT01546753|585606309|FG001|Overall Study|anxiety|1|||
162151972|NCT01546753|585606308|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
162151973|NCT01546753|585606309|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
162151974|NCT01102231|585606311|FG000|Overall Study|Protocol Violation|3|||
162151975|NCT01102231|585606311|FG000|Overall Study|Lack of Efficacy|2|||
162151976|NCT01102231|585606311|FG000|Overall Study|Death|2|||
162151977|NCT01102231|585606311|FG000|Overall Study|Adverse Event|3|||
162151978|NCT01102231|585606311|FG000|Overall Study|Withdrawal by Subject|1|||
162151979|NCT01102231|585606311|FG000|Overall Study|Did not received the treatment|4|||
162151980|NCT01236560|585606318|FG000|Overall Study|Adverse Event|0|||
162151981|NCT01236560|585606319|FG001|Overall Study|Adverse Event|2|||
162151982|NCT01236560|585606320|FG002|Overall Study|Adverse Event|1|||
162151983|NCT01236560|585606321|FG003|Overall Study|Adverse Event|3|||
162151984|NCT01236560|585606322|FG004|Overall Study|Adverse Event|0|||
162151985|NCT01236560|585606323|FG005|Overall Study|Adverse Event|0|||
162151986|NCT01236560|585606318|FG000|Overall Study|Death|0|||
162151987|NCT01236560|585606319|FG001|Overall Study|Death|1|||
162151988|NCT01236560|585606320|FG002|Overall Study|Death|0|||
162151989|NCT01236560|585606321|FG003|Overall Study|Death|1|||
162151990|NCT01236560|585606322|FG004|Overall Study|Death|0|||
162151991|NCT01236560|585606323|FG005|Overall Study|Death|0|||
162151992|NCT01236560|585606318|FG000|Overall Study|Lost to Follow-up|0|||
162151993|NCT01236560|585606319|FG001|Overall Study|Lost to Follow-up|1|||
162151994|NCT01236560|585606320|FG002|Overall Study|Lost to Follow-up|1|||
162151995|NCT01236560|585606321|FG003|Overall Study|Lost to Follow-up|0|||
162151996|NCT01236560|585606322|FG004|Overall Study|Lost to Follow-up|0|||
162151997|NCT01236560|585606323|FG005|Overall Study|Lost to Follow-up|0|||
162151998|NCT01236560|585606318|FG000|Overall Study|Physician Decision|0|||
162151999|NCT01236560|585606319|FG001|Overall Study|Physician Decision|1|||
162152000|NCT01236560|585606320|FG002|Overall Study|Physician Decision|8|||
162152001|NCT01236560|585606321|FG003|Overall Study|Physician Decision|0|||
162152002|NCT01236560|585606322|FG004|Overall Study|Physician Decision|0|||
162152003|NCT01236560|585606323|FG005|Overall Study|Physician Decision|0|||
162152004|NCT01236560|585606318|FG000|Overall Study|Withdrawal by Subject|0|||
162152005|NCT01236560|585606319|FG001|Overall Study|Withdrawal by Subject|0|||
162152006|NCT01236560|585606320|FG002|Overall Study|Withdrawal by Subject|1|||
162152007|NCT01236560|585606321|FG003|Overall Study|Withdrawal by Subject|2|||
162152008|NCT01236560|585606322|FG004|Overall Study|Withdrawal by Subject|0|||
162152009|NCT01236560|585606323|FG005|Overall Study|Withdrawal by Subject|0|||
162152010|NCT01236560|585606318|FG000|Overall Study|Progressive disease|5|||
162152011|NCT01236560|585606319|FG001|Overall Study|Progressive disease|19|||
162152012|NCT01236560|585606320|FG002|Overall Study|Progressive disease|9|||
162152013|NCT01236560|585606321|FG003|Overall Study|Progressive disease|16|||
161810295|NCT04405570|584347760|FG002|Overall Study|Withdrawal by Subject|1|||
161810296|NCT04405570|584347761|FG003|Overall Study|Withdrawal by Subject|0|||
161810297|NCT04405570|584347758|FG000|Overall Study|Randomized not dosed|0|||
161810298|NCT04405570|584347759|FG001|Overall Study|Randomized not dosed|2|||
162152014|NCT01236560|585606322|FG004|Overall Study|Progressive disease|0|||
162152015|NCT01236560|585606323|FG005|Overall Study|Progressive disease|0|||
162152016|NCT01576484|585606326|FG000|Overall Study|Adverse Event|1|||
162152017|NCT01576484|585606327|FG001|Overall Study|Adverse Event|1|||
162152018|NCT01576484|585606326|FG000|Overall Study|Protocol Violation|0|||
162152019|NCT01576484|585606327|FG001|Overall Study|Protocol Violation|2|||
162152020|NCT01576484|585606326|FG000|Overall Study|Sponsor Decision|2|||
161914633|NCT00171249|584735654|FG002|Overall Study|Adverse Event|0|||
161914634|NCT00171249|584735655|FG003|Overall Study|Adverse Event|15|||
161914635|NCT00171249|584735656|FG004|Overall Study|Adverse Event|0|||
161914636|NCT00171249|584735657|FG005|Overall Study|Adverse Event|2|||
161914637|NCT00171249|584735658|FG006|Overall Study|Adverse Event|0|||
161914638|NCT00171249|584735652|FG000|Overall Study|Lost to Follow-up|5|||
161914639|NCT00171249|584735653|FG001|Overall Study|Lost to Follow-up|0|||
161914640|NCT00171249|584735654|FG002|Overall Study|Lost to Follow-up|0|||
161914641|NCT00171249|584735655|FG003|Overall Study|Lost to Follow-up|9|||
161914642|NCT00171249|584735656|FG004|Overall Study|Lost to Follow-up|0|||
161914643|NCT00171249|584735657|FG005|Overall Study|Lost to Follow-up|0|||
161914644|NCT00171249|584735658|FG006|Overall Study|Lost to Follow-up|0|||
161914645|NCT00392223|584735659|FG000|Overall Study|Adverse Event|5|||
161914646|NCT00392223|584735660|FG001|Overall Study|Adverse Event|4|||
161914647|NCT00392223|584735659|FG000|Overall Study|Lost to Follow-up|1|||
161914648|NCT00392223|584735660|FG001|Overall Study|Lost to Follow-up|4|||
161914649|NCT00392223|584735659|FG000|Overall Study|Protocol Violation|0|||
161914650|NCT00392223|584735660|FG001|Overall Study|Protocol Violation|3|||
161914651|NCT00392223|584735659|FG000|Overall Study|Withdrawal by Subject|3|||
161914652|NCT00392223|584735660|FG001|Overall Study|Withdrawal by Subject|2|||
161914653|NCT02908347|584735661|FG000|Overall Study|Adverse Event|0|||
162012669|NCT01899040|585101852|FG001|Overall Study|Compliance issues|2|||
162012670|NCT01899040|585101853|FG002|Overall Study|Compliance issues|0|||
162012671|NCT04586205|585101862|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
162012672|NCT04586205|585101863|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
162012673|NCT01417377|585103846|FG000|Overall Study|Lost to Follow-up|12|||
162012674|NCT01417377|585103846|FG000|Overall Study|Enrolled, but not treated|1|||
162012675|NCT02113982|585103847|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
162012676|NCT02113982|585103848|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
162012677|NCT02113982|585103849|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
162012678|NCT02113982|585103850|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
162012679|NCT02113982|585103851|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
162012680|NCT02113982|585103852|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
162012681|NCT02113982|585103853|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
162012682|NCT02113982|585103854|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
162012683|NCT02113982|585103855|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
162012684|NCT02113982|585103856|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
162012685|NCT02113982|585103857|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
162012686|NCT02113982|585103858|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
162012687|NCT02113982|585103859|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
162012688|NCT02113982|585103860|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
162012689|NCT02113982|585103847|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
162012690|NCT02113982|585103848|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
162012691|NCT02113982|585103849|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
162012692|NCT02113982|585103850|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
162012693|NCT02113982|585103851|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
162012694|NCT02113982|585103852|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
162012695|NCT02113982|585103853|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
162012696|NCT02113982|585103854|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
162012697|NCT02113982|585103855|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
162012698|NCT02113982|585103856|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
162012699|NCT02113982|585103857|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
162012700|NCT02113982|585103858|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
162012701|NCT02113982|585103859|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
162012702|NCT02113982|585103860|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
162012703|NCT02113982|585103847|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
162012704|NCT02113982|585103848|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
162012705|NCT02113982|585103849|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
162012706|NCT02113982|585103850|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
162012707|NCT02113982|585103851|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
162012708|NCT02113982|585103852|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
162012709|NCT02113982|585103853|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
162012710|NCT02113982|585103854|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
161914654|NCT02908347|584735662|FG001|Overall Study|Adverse Event|1|||
161914655|NCT02908347|584735661|FG000|Overall Study|Lost to Follow-up|1|||
161914656|NCT02908347|584735662|FG001|Overall Study|Lost to Follow-up|0|||
161914657|NCT05516758|584735668|FG000|Overall Study|Adverse Event|5|||
161914658|NCT05516758|584735669|FG001|Overall Study|Adverse Event|1|||
161914659|NCT05516758|584735670|FG002|Overall Study|Adverse Event|3|||
162152021|NCT01576484|585606327|FG001|Overall Study|Sponsor Decision|8|||
162152022|NCT01576484|585606326|FG000|Overall Study|Withdrawal by Subject|0|||
162152023|NCT01576484|585606327|FG001|Overall Study|Withdrawal by Subject|3|||
162152024|NCT01576484|585606326|FG000|Overall Study|Other|2|||
162152025|NCT01576484|585606327|FG001|Overall Study|Other|5|||
162152026|NCT05061693|585606332|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
162152027|NCT05061693|585606333|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
162152028|NCT05061693|585606334|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
162152029|NCT05061693|585606335|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162152030|NCT05061693|585606336|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162152031|NCT05061693|585606337|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162152032|NCT05061693|585606338|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162152033|NCT05061693|585606339|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162152034|NCT05061693|585606340|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162152035|NCT05061693|585606341|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162152036|NCT05061693|585606342|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162152037|NCT05061693|585606343|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
162152038|NCT05061693|585606332|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
162152039|NCT05061693|585606333|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
162152040|NCT05061693|585606334|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
162152041|NCT05061693|585606335|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
162152042|NCT05061693|585606336|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
162152043|NCT05061693|585606337|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
162152044|NCT05061693|585606338|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
162152045|NCT05061693|585606339|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
162152046|NCT05061693|585606340|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
162152047|NCT05061693|585606341|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
162152048|NCT05061693|585606342|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
162152049|NCT05061693|585606343|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
162152050|NCT05061693|585606332|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
162152051|NCT05061693|585606333|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162152052|NCT05061693|585606334|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162152053|NCT05061693|585606335|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162152054|NCT05061693|585606336|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162152055|NCT05061693|585606337|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162152056|NCT05061693|585606338|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162152057|NCT05061693|585606339|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162152058|NCT05061693|585606340|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162152059|NCT05061693|585606341|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162152060|NCT05061693|585606342|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162152061|NCT05061693|585606343|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
162152062|NCT05061693|585606332|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162152063|NCT05061693|585606333|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162152064|NCT05061693|585606334|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
162152065|NCT05061693|585606335|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162152066|NCT05061693|585606336|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162152067|NCT05061693|585606337|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162152068|NCT05061693|585606338|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162152069|NCT05061693|585606339|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162152070|NCT05061693|585606340|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162152071|NCT05061693|585606341|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161810299|NCT04405570|584347760|FG002|Overall Study|Randomized not dosed|0|||
161810300|NCT04405570|584347761|FG003|Overall Study|Randomized not dosed|0|||
161810301|NCT04499963|584347762|FG000|Overall Study|Adverse Event|3|||
161810302|NCT04499963|584347763|FG001|Overall Study|Adverse Event|0|||
162152072|NCT05061693|585606342|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162152073|NCT05061693|585606343|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
162152074|NCT05061693|585606332|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
161810303|NCT04499963|584347762|FG000|Overall Study|Death|3|||
161810304|NCT04499963|584347763|FG001|Overall Study|Death|0|||
161810305|NCT04499963|584347762|FG000|Overall Study|Lack of Efficacy|7|||
161810306|NCT04499963|584347763|FG001|Overall Study|Lack of Efficacy|0|||
161810307|NCT04499963|584347762|FG000|Overall Study|Lost to Follow-up|2|||
161810308|NCT04499963|584347763|FG001|Overall Study|Lost to Follow-up|0|||
161810309|NCT02601625|584347767|FG000|Overall Study|Lost to Follow-up|0|||
161810310|NCT02601625|584347768|FG001|Overall Study|Lost to Follow-up|0|||
162012711|NCT02113982|585103855|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
162012712|NCT02113982|585103856|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
162012713|NCT02113982|585103857|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
162012714|NCT02113982|585103858|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
162012715|NCT02113982|585103859|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
162012716|NCT02113982|585103860|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
162012717|NCT02113982|585103847|FG000|Stage 1: Dose Escalation|Transplant|0|||
162012718|NCT02113982|585103848|FG001|Stage 1: Dose Escalation|Transplant|1|||
162012719|NCT02113982|585103849|FG002|Stage 1: Dose Escalation|Transplant|0|||
162012720|NCT02113982|585103850|FG003|Stage 1: Dose Escalation|Transplant|0|||
162012721|NCT02113982|585103851|FG004|Stage 1: Dose Escalation|Transplant|0|||
162012722|NCT02113982|585103852|FG005|Stage 1: Dose Escalation|Transplant|1|||
162012723|NCT02113982|585103853|FG006|Stage 1: Dose Escalation|Transplant|0|||
162012724|NCT02113982|585103854|FG007|Stage 1: Dose Escalation|Transplant|0|||
162012725|NCT02113982|585103855|FG008|Stage 1: Dose Escalation|Transplant|0|||
162012726|NCT02113982|585103856|FG009|Stage 1: Dose Escalation|Transplant|0|||
162012727|NCT02113982|585103857|FG010|Stage 1: Dose Escalation|Transplant|0|||
162012728|NCT02113982|585103858|FG011|Stage 1: Dose Escalation|Transplant|0|||
162012729|NCT02113982|585103859|FG012|Stage 1: Dose Escalation|Transplant|0|||
162012730|NCT02113982|585103860|FG013|Stage 1: Dose Escalation|Transplant|0|||
162012731|NCT02113982|585103847|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
162012732|NCT02113982|585103848|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
162012733|NCT02113982|585103849|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
162012734|NCT02113982|585103850|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
162012735|NCT02113982|585103851|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
162012736|NCT02113982|585103852|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
162012737|NCT02113982|585103853|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
162012738|NCT02113982|585103854|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
162012739|NCT02113982|585103855|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
162012740|NCT02113982|585103856|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
162012741|NCT02113982|585103857|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
162012742|NCT02113982|585103858|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
162012743|NCT02113982|585103859|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
162012744|NCT02113982|585103860|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
162012745|NCT02113982|585103847|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
162012746|NCT02113982|585103848|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
162012747|NCT02113982|585103849|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
162012748|NCT02113982|585103850|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
162012749|NCT02113982|585103851|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
162012750|NCT02113982|585103852|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
162012751|NCT02113982|585103853|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
162012752|NCT02113982|585103854|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
162012753|NCT02113982|585103855|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
162012754|NCT02113982|585103856|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
162012755|NCT02113982|585103857|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
162012756|NCT02113982|585103858|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
162012757|NCT02113982|585103859|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
162012758|NCT02113982|585103860|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
162012759|NCT02113982|585103847|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
162012760|NCT02113982|585103848|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
162012761|NCT02113982|585103849|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
162012762|NCT02113982|585103850|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
161810311|NCT02601625|584347769|FG002|Overall Study|Lost to Follow-up|1|||
161810312|NCT02601625|584347770|FG003|Overall Study|Lost to Follow-up|1|||
161810313|NCT00838279|584347771|FG000|Washout|Protocol Violation|1|||
161810314|NCT00838279|584347772|FG001|Washout|Protocol Violation|0|||
162012763|NCT02113982|585103851|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
162012764|NCT02113982|585103852|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
162012765|NCT02113982|585103853|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
162012766|NCT02113982|585103854|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
162012767|NCT02113982|585103855|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
162012768|NCT02113982|585103856|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
162012769|NCT02113982|585103857|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
162012770|NCT02113982|585103858|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
162012771|NCT02113982|585103859|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
162012772|NCT02113982|585103860|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
161810315|NCT00838279|584347771|FG000|Washout|Withdrawal by Subject|0|||
162152075|NCT05061693|585606333|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
162152076|NCT05061693|585606334|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
162152077|NCT05061693|585606335|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
162152078|NCT05061693|585606336|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162152079|NCT05061693|585606337|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162152080|NCT05061693|585606338|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162152081|NCT05061693|585606339|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162152082|NCT05061693|585606340|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162152083|NCT05061693|585606341|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162152084|NCT05061693|585606342|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
162152085|NCT05061693|585606343|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161810316|NCT00838279|584347772|FG001|Washout|Withdrawal by Subject|1|||
161810317|NCT04608188|584347773|FG000|Overall Study|Withdrawal by Subject|4|||
161810318|NCT04608188|584347774|FG001|Overall Study|Withdrawal by Subject|8|||
161810319|NCT04419311|584347776|FG000|Overall Study|Lost to Follow-up|1|||
161810320|NCT04419311|584347777|FG001|Overall Study|Lost to Follow-up|0|||
161810321|NCT03586726|584347780|FG000|Overall Study|Withdrawal by Subject|1|||
161810322|NCT01921062|584347781|FG000|Overall Study|Withdrawal by Subject|0|||
161810323|NCT01921062|584347782|FG001|Overall Study|Withdrawal by Subject|7|||
161810324|NCT01921062|584347781|FG000|Overall Study|Adverse Event|5|||
161810325|NCT01921062|584347782|FG001|Overall Study|Adverse Event|6|||
161810326|NCT01921062|584347781|FG000|Overall Study|Protocol Violation|0|||
161810327|NCT01921062|584347782|FG001|Overall Study|Protocol Violation|1|||
161810328|NCT01921062|584347781|FG000|Overall Study|VMIQ score > 72|4|||
161810329|NCT01921062|584347782|FG001|Overall Study|VMIQ score > 72|1|||
161810330|NCT01921062|584347781|FG000|Overall Study|Logistic error|0|||
161810331|NCT01921062|584347782|FG001|Overall Study|Logistic error|1|||
161810332|NCT00965185|584347783|FG000|Overall Study|Lost to Follow-up|2|||
161810333|NCT00965185|584347784|FG001|Overall Study|Lost to Follow-up|0|||
161810334|NCT00965185|584347783|FG000|Overall Study|Withdrawal by Subject|0|||
161810335|NCT00965185|584347784|FG001|Overall Study|Withdrawal by Subject|1|||
161810336|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
161810337|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
161810338|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
161810339|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
161810340|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
161810341|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
161810342|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
161810343|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
161810344|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
161810345|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
161810346|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
161810347|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
161810348|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
161810349|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
161810350|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
161810351|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
161810352|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
161810353|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
161810354|NCT01045161|584347785|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
161810355|NCT01045161|584347786|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
161810356|NCT01045161|584347787|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
161810357|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
161810358|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
161810359|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
161810360|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
161810361|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
161810362|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
161810363|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
161810364|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
161810365|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
161810366|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
161810367|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
161810368|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
162152086|NCT05061693|585606332|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
162152087|NCT05061693|585606333|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
162152088|NCT05061693|585606334|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
162152089|NCT05061693|585606335|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
162152090|NCT05061693|585606336|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162152091|NCT05061693|585606337|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162152092|NCT05061693|585606338|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162152093|NCT05061693|585606339|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162152094|NCT05061693|585606340|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162152095|NCT05061693|585606341|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162152096|NCT05061693|585606342|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162152097|NCT05061693|585606343|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
162152098|NCT05061693|585606332|FG000|24-week Extension Period|Adverse Event|0|||
162152099|NCT05061693|585606333|FG001|24-week Extension Period|Adverse Event|0|||
162152100|NCT05061693|585606334|FG002|24-week Extension Period|Adverse Event|0|||
162152101|NCT05061693|585606335|FG003|24-week Extension Period|Adverse Event|0|||
162152102|NCT05061693|585606336|FG004|24-week Extension Period|Adverse Event|0|||
162152103|NCT05061693|585606337|FG005|24-week Extension Period|Adverse Event|0|||
162152104|NCT05061693|585606338|FG006|24-week Extension Period|Adverse Event|0|||
162152105|NCT05061693|585606339|FG007|24-week Extension Period|Adverse Event|2|||
162152106|NCT05061693|585606340|FG008|24-week Extension Period|Adverse Event|2|||
162152107|NCT05061693|585606341|FG009|24-week Extension Period|Adverse Event|0|||
162152108|NCT05061693|585606342|FG010|24-week Extension Period|Adverse Event|1|||
162152109|NCT05061693|585606343|FG011|24-week Extension Period|Adverse Event|3|||
162152110|NCT05061693|585606332|FG000|24-week Extension Period|Lack of Efficacy|0|||
162152111|NCT05061693|585606333|FG001|24-week Extension Period|Lack of Efficacy|0|||
162152112|NCT05061693|585606334|FG002|24-week Extension Period|Lack of Efficacy|0|||
162152113|NCT05061693|585606335|FG003|24-week Extension Period|Lack of Efficacy|0|||
162152114|NCT05061693|585606336|FG004|24-week Extension Period|Lack of Efficacy|0|||
162152115|NCT05061693|585606337|FG005|24-week Extension Period|Lack of Efficacy|0|||
162152116|NCT05061693|585606338|FG006|24-week Extension Period|Lack of Efficacy|0|||
162152117|NCT05061693|585606339|FG007|24-week Extension Period|Lack of Efficacy|0|||
162152118|NCT05061693|585606340|FG008|24-week Extension Period|Lack of Efficacy|0|||
162152119|NCT05061693|585606341|FG009|24-week Extension Period|Lack of Efficacy|0|||
162152120|NCT05061693|585606342|FG010|24-week Extension Period|Lack of Efficacy|2|||
162152121|NCT05061693|585606343|FG011|24-week Extension Period|Lack of Efficacy|0|||
162152122|NCT05061693|585606332|FG000|24-week Extension Period|Lost to Follow-up|0|||
162152123|NCT05061693|585606333|FG001|24-week Extension Period|Lost to Follow-up|0|||
162152124|NCT05061693|585606334|FG002|24-week Extension Period|Lost to Follow-up|0|||
162152125|NCT05061693|585606335|FG003|24-week Extension Period|Lost to Follow-up|0|||
162152126|NCT05061693|585606336|FG004|24-week Extension Period|Lost to Follow-up|0|||
162152127|NCT05061693|585606337|FG005|24-week Extension Period|Lost to Follow-up|0|||
162152128|NCT05061693|585606338|FG006|24-week Extension Period|Lost to Follow-up|1|||
162152129|NCT05061693|585606339|FG007|24-week Extension Period|Lost to Follow-up|0|||
162152130|NCT05061693|585606340|FG008|24-week Extension Period|Lost to Follow-up|1|||
162152131|NCT05061693|585606341|FG009|24-week Extension Period|Lost to Follow-up|1|||
162152132|NCT05061693|585606342|FG010|24-week Extension Period|Lost to Follow-up|0|||
162152133|NCT05061693|585606343|FG011|24-week Extension Period|Lost to Follow-up|0|||
162152134|NCT05061693|585606332|FG000|24-week Extension Period|Withdrawal by Subject|0|||
161810369|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
162152135|NCT05061693|585606333|FG001|24-week Extension Period|Withdrawal by Subject|0|||
162152136|NCT05061693|585606334|FG002|24-week Extension Period|Withdrawal by Subject|0|||
162152137|NCT05061693|585606335|FG003|24-week Extension Period|Withdrawal by Subject|0|||
161810370|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
161810371|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
161914660|NCT05516758|584735671|FG003|Overall Study|Adverse Event|0|||
161914661|NCT05516758|584735672|FG004|Overall Study|Adverse Event|1|||
161914662|NCT05516758|584735673|FG005|Overall Study|Adverse Event|3|||
161914663|NCT05516758|584735674|FG006|Overall Study|Adverse Event|5|||
161914664|NCT05516758|584735668|FG000|Overall Study|Assigned treatment by mistake|1|||
161914665|NCT05516758|584735669|FG001|Overall Study|Assigned treatment by mistake|0|||
161914666|NCT05516758|584735670|FG002|Overall Study|Assigned treatment by mistake|0|||
161914667|NCT05516758|584735671|FG003|Overall Study|Assigned treatment by mistake|0|||
161914668|NCT05516758|584735672|FG004|Overall Study|Assigned treatment by mistake|1|||
161914669|NCT05516758|584735673|FG005|Overall Study|Assigned treatment by mistake|0|||
161914670|NCT05516758|584735674|FG006|Overall Study|Assigned treatment by mistake|0|||
161914671|NCT05516758|584735668|FG000|Overall Study|Lack of Efficacy|6|||
161914672|NCT05516758|584735669|FG001|Overall Study|Lack of Efficacy|0|||
161914673|NCT05516758|584735670|FG002|Overall Study|Lack of Efficacy|2|||
161914674|NCT05516758|584735671|FG003|Overall Study|Lack of Efficacy|0|||
161914675|NCT05516758|584735672|FG004|Overall Study|Lack of Efficacy|3|||
161914676|NCT05516758|584735673|FG005|Overall Study|Lack of Efficacy|6|||
161914677|NCT05516758|584735674|FG006|Overall Study|Lack of Efficacy|3|||
161914678|NCT05516758|584735668|FG000|Overall Study|Lost to Follow-up|2|||
161914679|NCT05516758|584735669|FG001|Overall Study|Lost to Follow-up|0|||
161914680|NCT05516758|584735670|FG002|Overall Study|Lost to Follow-up|2|||
161914681|NCT05516758|584735671|FG003|Overall Study|Lost to Follow-up|0|||
161914682|NCT05516758|584735672|FG004|Overall Study|Lost to Follow-up|3|||
161914683|NCT05516758|584735673|FG005|Overall Study|Lost to Follow-up|2|||
161914684|NCT05516758|584735674|FG006|Overall Study|Lost to Follow-up|1|||
161914685|NCT05516758|584735668|FG000|Overall Study|Other- As reported by the site|2|||
161914686|NCT05516758|584735669|FG001|Overall Study|Other- As reported by the site|1|||
161914687|NCT05516758|584735670|FG002|Overall Study|Other- As reported by the site|8|||
161914688|NCT05516758|584735671|FG003|Overall Study|Other- As reported by the site|1|||
161914689|NCT05516758|584735672|FG004|Overall Study|Other- As reported by the site|2|||
161914690|NCT05516758|584735673|FG005|Overall Study|Other- As reported by the site|3|||
161914691|NCT05516758|584735674|FG006|Overall Study|Other- As reported by the site|8|||
161914692|NCT05516758|584735668|FG000|Overall Study|Physician Decision|1|||
161914693|NCT05516758|584735669|FG001|Overall Study|Physician Decision|0|||
161914694|NCT05516758|584735670|FG002|Overall Study|Physician Decision|7|||
161914695|NCT05516758|584735671|FG003|Overall Study|Physician Decision|0|||
161914696|NCT05516758|584735672|FG004|Overall Study|Physician Decision|1|||
161914697|NCT05516758|584735673|FG005|Overall Study|Physician Decision|1|||
161914698|NCT05516758|584735674|FG006|Overall Study|Physician Decision|2|||
161914699|NCT05516758|584735668|FG000|Overall Study|Protocol Deviation|1|||
161914700|NCT05516758|584735669|FG001|Overall Study|Protocol Deviation|0|||
161914701|NCT05516758|584735670|FG002|Overall Study|Protocol Deviation|0|||
161914702|NCT05516758|584735671|FG003|Overall Study|Protocol Deviation|0|||
161914703|NCT05516758|584735672|FG004|Overall Study|Protocol Deviation|0|||
161914704|NCT05516758|584735673|FG005|Overall Study|Protocol Deviation|1|||
161914705|NCT05516758|584735674|FG006|Overall Study|Protocol Deviation|5|||
161914706|NCT05516758|584735668|FG000|Overall Study|Withdrawal by Subject|11|||
161914707|NCT05516758|584735669|FG001|Overall Study|Withdrawal by Subject|1|||
161914708|NCT05516758|584735670|FG002|Overall Study|Withdrawal by Subject|15|||
161914709|NCT05516758|584735671|FG003|Overall Study|Withdrawal by Subject|2|||
161914710|NCT05516758|584735672|FG004|Overall Study|Withdrawal by Subject|7|||
161914711|NCT05516758|584735673|FG005|Overall Study|Withdrawal by Subject|7|||
161914712|NCT05516758|584735674|FG006|Overall Study|Withdrawal by Subject|6|||
161914713|NCT05516758|584735668|FG000|Overall Study|Death|1|||
161914714|NCT05516758|584735669|FG001|Overall Study|Death|0|||
161914715|NCT05516758|584735670|FG002|Overall Study|Death|0|||
161914716|NCT05516758|584735671|FG003|Overall Study|Death|0|||
161914717|NCT05516758|584735672|FG004|Overall Study|Death|0|||
161914718|NCT05516758|584735673|FG005|Overall Study|Death|0|||
161914719|NCT05516758|584735674|FG006|Overall Study|Death|0|||
161914720|NCT05516758|584735668|FG000|Overall Study|Non-compliance With Study Drug|0|||
161914721|NCT05516758|584735669|FG001|Overall Study|Non-compliance With Study Drug|0|||
161914722|NCT05516758|584735670|FG002|Overall Study|Non-compliance With Study Drug|1|||
161914723|NCT05516758|584735671|FG003|Overall Study|Non-compliance With Study Drug|0|||
161914724|NCT05516758|584735672|FG004|Overall Study|Non-compliance With Study Drug|0|||
162152138|NCT05061693|585606336|FG004|24-week Extension Period|Withdrawal by Subject|0|||
162152139|NCT05061693|585606337|FG005|24-week Extension Period|Withdrawal by Subject|0|||
162152140|NCT05061693|585606338|FG006|24-week Extension Period|Withdrawal by Subject|0|||
162152141|NCT05061693|585606339|FG007|24-week Extension Period|Withdrawal by Subject|0|||
162152142|NCT05061693|585606340|FG008|24-week Extension Period|Withdrawal by Subject|1|||
162152143|NCT05061693|585606341|FG009|24-week Extension Period|Withdrawal by Subject|2|||
162152144|NCT05061693|585606342|FG010|24-week Extension Period|Withdrawal by Subject|2|||
162152145|NCT05061693|585606343|FG011|24-week Extension Period|Withdrawal by Subject|1|||
162152146|NCT05061693|585606332|FG000|24-week Extension Period|Sponsor Decision|0|||
162152147|NCT05061693|585606333|FG001|24-week Extension Period|Sponsor Decision|0|||
162152148|NCT05061693|585606334|FG002|24-week Extension Period|Sponsor Decision|0|||
162152149|NCT05061693|585606335|FG003|24-week Extension Period|Sponsor Decision|0|||
162152150|NCT05061693|585606336|FG004|24-week Extension Period|Sponsor Decision|0|||
162152151|NCT05061693|585606337|FG005|24-week Extension Period|Sponsor Decision|0|||
162152152|NCT05061693|585606338|FG006|24-week Extension Period|Sponsor Decision|0|||
162152153|NCT05061693|585606339|FG007|24-week Extension Period|Sponsor Decision|1|||
162152154|NCT05061693|585606340|FG008|24-week Extension Period|Sponsor Decision|0|||
162152155|NCT05061693|585606341|FG009|24-week Extension Period|Sponsor Decision|0|||
162152156|NCT05061693|585606342|FG010|24-week Extension Period|Sponsor Decision|0|||
162152157|NCT05061693|585606343|FG011|24-week Extension Period|Sponsor Decision|0|||
162152158|NCT05061693|585606332|FG000|24-week Extension Period|Site Closure|0|||
162152159|NCT05061693|585606333|FG001|24-week Extension Period|Site Closure|0|||
162152160|NCT05061693|585606334|FG002|24-week Extension Period|Site Closure|0|||
162152161|NCT05061693|585606335|FG003|24-week Extension Period|Site Closure|0|||
162152162|NCT05061693|585606336|FG004|24-week Extension Period|Site Closure|0|||
162152163|NCT05061693|585606337|FG005|24-week Extension Period|Site Closure|0|||
162152164|NCT05061693|585606338|FG006|24-week Extension Period|Site Closure|0|||
162152165|NCT05061693|585606339|FG007|24-week Extension Period|Site Closure|0|||
162152166|NCT05061693|585606340|FG008|24-week Extension Period|Site Closure|1|||
162152167|NCT05061693|585606341|FG009|24-week Extension Period|Site Closure|0|||
162152168|NCT05061693|585606342|FG010|24-week Extension Period|Site Closure|0|||
162152169|NCT05061693|585606343|FG011|24-week Extension Period|Site Closure|1|||
162152170|NCT03823911|585606344|FG000|Overall Study|Lost to Follow-up|1|||
162152171|NCT03823911|585606345|FG001|Overall Study|Lost to Follow-up|5|||
162152172|NCT03823911|585606346|FG002|Overall Study|Lost to Follow-up|2|||
162152173|NCT03823911|585606344|FG000|Overall Study|Did not meet eligibility criteria|13|||
162152174|NCT03823911|585606345|FG001|Overall Study|Did not meet eligibility criteria|7|||
162152175|NCT03823911|585606346|FG002|Overall Study|Did not meet eligibility criteria|4|||
162152176|NCT03823911|585606344|FG000|Overall Study|Death|0|||
162152177|NCT03823911|585606345|FG001|Overall Study|Death|1|||
162152178|NCT03823911|585606346|FG002|Overall Study|Death|0|||
162152179|NCT00311363|585606347|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
162152180|NCT00311363|585606348|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
162152181|NCT00311363|585606349|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
162152182|NCT00311363|585606347|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
162152183|NCT00311363|585606348|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
162152184|NCT00311363|585606349|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
162152185|NCT00311363|585606347|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
162152186|NCT00311363|585606348|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
162152187|NCT00311363|585606349|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
162152188|NCT00311363|585606347|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
162152189|NCT00311363|585606348|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
162152190|NCT00311363|585606349|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
162152191|NCT00311363|585606347|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
162152192|NCT00311363|585606348|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
162152193|NCT00311363|585606349|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
162152194|NCT00311363|585606347|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
162152195|NCT00311363|585606348|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
162152196|NCT00311363|585606349|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
162152197|NCT00311363|585606347|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
162152198|NCT00311363|585606348|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
162152199|NCT00311363|585606349|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
162152200|NCT00311363|585606347|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
162152201|NCT00311363|585606348|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
162152202|NCT00311363|585606349|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
162152203|NCT00311363|585606347|FG000|24-Week Single-Blind Treatment Period|Death|1|||
162152204|NCT00311363|585606348|FG001|24-Week Single-Blind Treatment Period|Death|0|||
162152205|NCT00311363|585606349|FG002|24-Week Single-Blind Treatment Period|Death|0|||
162152206|NCT00311363|585606347|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
162152207|NCT00311363|585606348|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
162152208|NCT00311363|585606349|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
162152209|NCT00311363|585606347|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
162152210|NCT00311363|585606348|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
162152211|NCT00311363|585606349|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
162152212|NCT00311363|585606347|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
162152213|NCT00311363|585606348|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
162152214|NCT00311363|585606349|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
162152215|NCT00311363|585606347|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
162152216|NCT00311363|585606348|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
162152217|NCT00311363|585606349|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
162152218|NCT00311363|585606347|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
162152219|NCT00311363|585606348|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
162152220|NCT00311363|585606349|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
162152221|NCT00311363|585606347|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
162152222|NCT00311363|585606348|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
162152223|NCT00311363|585606349|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
162152224|NCT00206375|585606350|FG000|Overall Study|Lost to Follow-up|1|||
162152225|NCT00206375|585606351|FG001|Overall Study|Lost to Follow-up|0|||
162152226|NCT00206375|585606352|FG002|Overall Study|Lost to Follow-up|0|||
162152227|NCT00206375|585606350|FG000|Overall Study|Withdrawal by Subject|2|||
162152228|NCT00206375|585606351|FG001|Overall Study|Withdrawal by Subject|1|||
162152229|NCT00206375|585606352|FG002|Overall Study|Withdrawal by Subject|3|||
162152230|NCT00206375|585606350|FG000|Overall Study|Study terminated due to lack of funds|0|||
162152231|NCT00206375|585606351|FG001|Overall Study|Study terminated due to lack of funds|1|||
162152232|NCT00206375|585606352|FG002|Overall Study|Study terminated due to lack of funds|1|||
162152233|NCT03473340|585606353|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
162152234|NCT03473340|585606354|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
162152235|NCT03473340|585606353|FG000|Overall Study|Withdrawal by Subject|1|||
162152236|NCT03473340|585606354|FG001|Overall Study|Withdrawal by Subject|0|||
162152237|NCT03473340|585606353|FG000|Overall Study|Lost to Follow-up|1|||
162152238|NCT03473340|585606354|FG001|Overall Study|Lost to Follow-up|2|||
162152239|NCT02079844|585606355|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
162152240|NCT02079844|585606356|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
162152241|NCT02079844|585606357|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
162152242|NCT02079844|585606355|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
162152243|NCT02079844|585606356|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
162152244|NCT02079844|585606357|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
162152245|NCT01420549|585606358|FG000|Overall Study|Adverse Event|1|||
162152246|NCT01420549|585606359|FG001|Overall Study|Adverse Event|1|||
162152247|NCT01420549|585606358|FG000|Overall Study|Lost to Follow-up|2|||
162152248|NCT01420549|585606359|FG001|Overall Study|Lost to Follow-up|2|||
162152249|NCT01420549|585606358|FG000|Overall Study|Protocol Violation|0|||
162152250|NCT01420549|585606359|FG001|Overall Study|Protocol Violation|1|||
162152251|NCT01420549|585606358|FG000|Overall Study|Non-adherence to medication|4|||
162152252|NCT01420549|585606359|FG001|Overall Study|Non-adherence to medication|1|||
162152253|NCT03394885|585606360|FG000|Overall Study|Adverse Event|4|||
162152254|NCT03394885|585606360|FG000|Overall Study|Lack of Efficacy|1|||
162152255|NCT03394885|585606360|FG000|Overall Study|Physician Decision|1|||
162152256|NCT03394885|585606360|FG000|Overall Study|Withdrawal by Subject|8|||
162152257|NCT03394885|585606360|FG000|Overall Study|Alternative Therapy|1|||
162152258|NCT00203411|585606361|FG000|Follow-up|Progressive Disease|4|||
162236423|NCT00757588|585916949|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
162236424|NCT00757588|585916948|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
162236425|NCT00757588|585916949|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
162236426|NCT00757588|585916948|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
162236427|NCT00757588|585916949|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
162236428|NCT00757588|585916948|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
162236429|NCT00757588|585916949|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
162236430|NCT00757588|585916948|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
162236431|NCT00757588|585916949|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
162236432|NCT02563522|585916950|FG000|Overall Study|Adverse Event|2|||
162236433|NCT02563522|585916951|FG001|Overall Study|Adverse Event|3|||
162236434|NCT02563522|585916950|FG000|Overall Study|Lost to Follow-up|1|||
162236435|NCT02563522|585916951|FG001|Overall Study|Lost to Follow-up|0|||
162236436|NCT02563522|585916950|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
162236437|NCT02563522|585916951|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
162236438|NCT01052103|585916952|FG000|Overall Study|Adverse Event|10|||
162236439|NCT01052103|585916953|FG001|Overall Study|Adverse Event|6|||
162236440|NCT01052103|585916952|FG000|Overall Study|Entry Criteria Not Met|3|||
162236441|NCT01052103|585916953|FG001|Overall Study|Entry Criteria Not Met|1|||
162236442|NCT01052103|585916952|FG000|Overall Study|Lost to Follow-up|3|||
162152259|NCT03122886|585607571|FG000|Overall Study|Withdrawal by Subject|1|||
162152260|NCT03122886|585607572|FG001|Overall Study|Withdrawal by Subject|2|||
162152261|NCT02279095|585607575|FG000|Overall Study|Non-Compliance|1|||
162152262|NCT02279095|585607575|FG000|Overall Study|Withdrawal by Subject|8|||
162152263|NCT02279095|585607575|FG000|Overall Study|Adverse Event|2|||
162152264|NCT02279095|585607575|FG000|Overall Study|Other|7|||
162152265|NCT02279095|585607575|FG000|Overall Study|Lost to Follow-up|1|||
162152266|NCT02544074|585607578|FG000|Overall Study|Withdrawal by Subject|0|||
162152267|NCT02544074|585607579|FG001|Overall Study|Withdrawal by Subject|1|||
162152268|NCT02544074|585607580|FG002|Overall Study|Withdrawal by Subject|0|||
162152269|NCT02544074|585607581|FG003|Overall Study|Withdrawal by Subject|0|||
162152270|NCT02544074|585607582|FG004|Overall Study|Withdrawal by Subject|0|||
162152271|NCT02544074|585607583|FG005|Overall Study|Withdrawal by Subject|0|||
162152272|NCT02544074|585607584|FG006|Overall Study|Withdrawal by Subject|0|||
162152273|NCT02544074|585607585|FG007|Overall Study|Withdrawal by Subject|0|||
162152274|NCT02544074|585607586|FG008|Overall Study|Withdrawal by Subject|0|||
162152275|NCT02544074|585607587|FG009|Overall Study|Withdrawal by Subject|0|||
162152276|NCT02544074|585607588|FG010|Overall Study|Withdrawal by Subject|0|||
162152277|NCT02544074|585607589|FG011|Overall Study|Withdrawal by Subject|0|||
162152278|NCT02544074|585607590|FG012|Overall Study|Withdrawal by Subject|0|||
162152279|NCT02544074|585607591|FG013|Overall Study|Withdrawal by Subject|0|||
162152280|NCT02544074|585607592|FG014|Overall Study|Withdrawal by Subject|0|||
162152281|NCT02544074|585607593|FG015|Overall Study|Withdrawal by Subject|0|||
162152282|NCT02544074|585607594|FG016|Overall Study|Withdrawal by Subject|0|||
162152283|NCT02544074|585607595|FG017|Overall Study|Withdrawal by Subject|0|||
162152284|NCT02544074|585607596|FG018|Overall Study|Withdrawal by Subject|0|||
162152285|NCT02544074|585607597|FG019|Overall Study|Withdrawal by Subject|0|||
162152286|NCT02544074|585607598|FG020|Overall Study|Withdrawal by Subject|0|||
162152287|NCT02544074|585607578|FG000|Overall Study|Tablet error|0|||
162152288|NCT02544074|585607579|FG001|Overall Study|Tablet error|0|||
162152289|NCT02544074|585607580|FG002|Overall Study|Tablet error|0|||
162152290|NCT02544074|585607581|FG003|Overall Study|Tablet error|0|||
162152291|NCT02544074|585607582|FG004|Overall Study|Tablet error|0|||
162152292|NCT02544074|585607583|FG005|Overall Study|Tablet error|1|||
161914725|NCT05516758|584735673|FG005|Overall Study|Non-compliance With Study Drug|0|||
161914726|NCT05516758|584735674|FG006|Overall Study|Non-compliance With Study Drug|0|||
161914727|NCT05516758|584735668|FG000|Overall Study|Site Terminated by Sponsor|2|||
162152293|NCT02544074|585607584|FG006|Overall Study|Tablet error|0|||
162152294|NCT02544074|585607585|FG007|Overall Study|Tablet error|0|||
162152295|NCT02544074|585607586|FG008|Overall Study|Tablet error|0|||
162152296|NCT02544074|585607587|FG009|Overall Study|Tablet error|1|||
162152297|NCT02544074|585607588|FG010|Overall Study|Tablet error|0|||
162152298|NCT02544074|585607589|FG011|Overall Study|Tablet error|0|||
162152299|NCT02544074|585607590|FG012|Overall Study|Tablet error|0|||
161914728|NCT05516758|584735669|FG001|Overall Study|Site Terminated by Sponsor|0|||
162152300|NCT02544074|585607591|FG013|Overall Study|Tablet error|0|||
162152301|NCT02544074|585607592|FG014|Overall Study|Tablet error|0|||
162152302|NCT02544074|585607593|FG015|Overall Study|Tablet error|0|||
162152303|NCT02544074|585607594|FG016|Overall Study|Tablet error|0|||
162152304|NCT02544074|585607595|FG017|Overall Study|Tablet error|0|||
162152305|NCT02544074|585607596|FG018|Overall Study|Tablet error|0|||
162152306|NCT02544074|585607597|FG019|Overall Study|Tablet error|0|||
162152307|NCT02544074|585607598|FG020|Overall Study|Tablet error|0|||
162152308|NCT05672667|585607600|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
162152309|NCT04524390|585607601|FG000|Double Blind|Consent Withdrawal by subject|2|||
162152310|NCT04524390|585607602|FG001|Double Blind|Consent Withdrawal by subject|1|||
162152311|NCT04524390|585607603|FG002|Double Blind|Consent Withdrawal by subject|0|||
162152312|NCT04524390|585607601|FG000|Double Blind|Adverse Event|5|||
162152313|NCT04524390|585607602|FG001|Double Blind|Adverse Event|3|||
162152314|NCT04524390|585607603|FG002|Double Blind|Adverse Event|0|||
162152315|NCT04524390|585607601|FG000|Double Blind|Liver Transplant|5|||
162152316|NCT04524390|585607602|FG001|Double Blind|Liver Transplant|6|||
162152317|NCT04524390|585607603|FG002|Double Blind|Liver Transplant|0|||
162152318|NCT04524390|585607601|FG000|Double Blind|Disease Progression|0|||
162152319|NCT04524390|585607602|FG001|Double Blind|Disease Progression|1|||
162152320|NCT04524390|585607603|FG002|Double Blind|Disease Progression|0|||
162152321|NCT04524390|585607601|FG000|Open-Label|Drug interruption criteria|0|||
162152322|NCT04524390|585607602|FG001|Open-Label|Drug interruption criteria|0|||
162152323|NCT04524390|585607603|FG002|Open-Label|Drug interruption criteria|1|||
162152324|NCT04524390|585607601|FG000|Open-Label|Liver Transplant|0|||
162152325|NCT04524390|585607602|FG001|Open-Label|Liver Transplant|0|||
162152326|NCT04524390|585607603|FG002|Open-Label|Liver Transplant|1|||
162152327|NCT04524390|585607601|FG000|Open-Label|Disease Progression|0|||
162152328|NCT04524390|585607602|FG001|Open-Label|Disease Progression|0|||
162152329|NCT04524390|585607603|FG002|Open-Label|Disease Progression|1|||
162152330|NCT04524390|585607601|FG000|Open-Label|Adverse Event|0|||
162152331|NCT04524390|585607602|FG001|Open-Label|Adverse Event|0|||
162152332|NCT04524390|585607603|FG002|Open-Label|Adverse Event|3|||
162152333|NCT04524390|585607601|FG000|Open-Label|Study Termination by sponsor|0|||
162152334|NCT04524390|585607602|FG001|Open-Label|Study Termination by sponsor|0|||
162152335|NCT04524390|585607603|FG002|Open-Label|Study Termination by sponsor|45|||
162152336|NCT03613740|585607604|FG000|Overall Study|Lost to Follow-up|1|||
162152337|NCT03613740|585607605|FG001|Overall Study|Lost to Follow-up|1|||
162152338|NCT01693120|585607606|FG000|Enrollment|Lost to Follow-up|1|||
162152339|NCT01693120|585607606|FG000|Enrollment|Withdrawal by Subject|10|||
162152340|NCT01693120|585607606|FG000|Enrollment|Protocol Violation|46|||
162152341|NCT01693120|585607606|FG000|Enrollment|Physician Decision|3|||
162152342|NCT01693120|585607606|FG000|Enrollment|Adverse Event|1|||
162152343|NCT01693120|585607606|FG000|Enrollment|Study closed|8|||
162152344|NCT01693120|585607606|FG000|Enrollment|Other|1|||
162152345|NCT01693120|585607606|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
162152346|NCT01693120|585607606|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
162152347|NCT01693120|585607606|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
162152348|NCT01693120|585607606|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
162152349|NCT01693120|585607606|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
162152350|NCT02597920|585607619|FG000|Overall Study|Worsening of other pre-existing disease|0|||
162152351|NCT02597920|585607620|FG001|Overall Study|Worsening of other pre-existing disease|1|||
162152352|NCT02597920|585607621|FG002|Overall Study|Worsening of other pre-existing disease|0|||
161914729|NCT05516758|584735670|FG002|Overall Study|Site Terminated by Sponsor|0|||
161914730|NCT05516758|584735671|FG003|Overall Study|Site Terminated by Sponsor|0|||
161914731|NCT05516758|584735672|FG004|Overall Study|Site Terminated by Sponsor|0|||
161914732|NCT05516758|584735673|FG005|Overall Study|Site Terminated by Sponsor|0|||
161914733|NCT05516758|584735674|FG006|Overall Study|Site Terminated by Sponsor|0|||
161914734|NCT05516758|584735668|FG000|Overall Study|Study Terminated by Sponsor|4|||
161914735|NCT05516758|584735669|FG001|Overall Study|Study Terminated by Sponsor|0|||
161914736|NCT05516758|584735670|FG002|Overall Study|Study Terminated by Sponsor|3|||
161914737|NCT05516758|584735671|FG003|Overall Study|Study Terminated by Sponsor|0|||
161914738|NCT05516758|584735672|FG004|Overall Study|Study Terminated by Sponsor|2|||
161914739|NCT05516758|584735673|FG005|Overall Study|Study Terminated by Sponsor|3|||
161914740|NCT05516758|584735674|FG006|Overall Study|Study Terminated by Sponsor|0|||
161914741|NCT05516758|584735668|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
161914742|NCT05516758|584735669|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
161914743|NCT05516758|584735670|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
161914744|NCT05516758|584735671|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
162152353|NCT02597920|585607619|FG000|Overall Study|Other adverse event|20|||
162152354|NCT02597920|585607620|FG001|Overall Study|Other adverse event|30|||
162152355|NCT02597920|585607621|FG002|Overall Study|Other adverse event|0|||
162152356|NCT02597920|585607619|FG000|Overall Study|Lost to Follow-up|7|||
162152357|NCT02597920|585607620|FG001|Overall Study|Lost to Follow-up|9|||
162152358|NCT02597920|585607621|FG002|Overall Study|Lost to Follow-up|0|||
162152359|NCT02597920|585607619|FG000|Overall Study|Refuse to continue in the study|3|||
162152360|NCT02597920|585607620|FG001|Overall Study|Refuse to continue in the study|13|||
162152361|NCT02597920|585607621|FG002|Overall Study|Refuse to continue in the study|1|||
162152362|NCT02597920|585607619|FG000|Overall Study|Other than specified|10|||
162152363|NCT02597920|585607620|FG001|Overall Study|Other than specified|31|||
162152364|NCT02597920|585607621|FG002|Overall Study|Other than specified|5|||
162152365|NCT02597920|585607619|FG000|Overall Study|Other|1|||
162152366|NCT02597920|585607620|FG001|Overall Study|Other|0|||
162152367|NCT02597920|585607621|FG002|Overall Study|Other|0|||
162152368|NCT00668863|585607622|FG000|Overall Study|Objective Progression or Relapse|42|||
162152369|NCT00668863|585607622|FG000|Overall Study|Adverse Event|13|||
162152370|NCT00668863|585607622|FG000|Overall Study|Study Terminated by Sponsor|8|||
162152371|NCT00668863|585607622|FG000|Overall Study|Global Deterioration of Health Status|4|||
162152372|NCT00668863|585607622|FG000|Overall Study|Withdrawal by Subject|1|||
162152373|NCT00668863|585607622|FG000|Overall Study|Surgery|1|||
162152374|NCT00668863|585607622|FG000|Overall Study|Subject's work scheduling problem|1|||
162152375|NCT00668863|585607622|FG000|Overall Study|Physician Decision|1|||
162152376|NCT01068743|585607625|FG000|Period 3|Adverse Event|0|||
162152377|NCT01068743|585607626|FG001|Period 3|Adverse Event|1|||
162152378|NCT01068743|585607627|FG002|Period 3|Adverse Event|0|||
162152379|NCT01068743|585607628|FG003|Period 3|Adverse Event|0|||
162152380|NCT00293293|585607629|FG000|Overall Study|Withdrawal by Subject|1|||
162152381|NCT00293293|585607630|FG001|Overall Study|Withdrawal by Subject|1|||
162152382|NCT00293293|585607629|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
162152383|NCT00293293|585607630|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
162152384|NCT00293293|585607629|FG000|Overall Study|Patient discontinued chemotherapy|0|||
162152385|NCT00293293|585607630|FG001|Overall Study|Patient discontinued chemotherapy|1|||
162152386|NCT03740009|585607631|FG000|Overall Study|Physician Decision|9|||
162152387|NCT03740009|585607631|FG000|Overall Study|Lost to Follow-up|1|||
162152388|NCT01061151|585607632|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
162152389|NCT01061151|585607633|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
162152390|NCT01061151|585607634|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
162152391|NCT01061151|585607635|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
162152392|NCT01061151|585607632|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
162152393|NCT01061151|585607633|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
161914745|NCT05516758|584735672|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
162152394|NCT01061151|585607634|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
161914746|NCT05516758|584735673|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
161914747|NCT05516758|584735674|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
162152395|NCT01061151|585607635|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
162152396|NCT01061151|585607632|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
162152397|NCT01061151|585607633|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
161914748|NCT05516758|584735668|FG000|Overall Study|Other|0|||
161914749|NCT05516758|584735669|FG001|Overall Study|Other|0|||
161914750|NCT05516758|584735670|FG002|Overall Study|Other|0|||
162152398|NCT01061151|585607634|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
162152399|NCT01061151|585607635|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
162152400|NCT01061151|585607632|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
162152401|NCT01061151|585607633|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
162152402|NCT01061151|585607634|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
162152403|NCT01061151|585607635|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
162152404|NCT01061151|585607632|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
162152405|NCT01061151|585607633|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
162152406|NCT01061151|585607634|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
162152407|NCT01061151|585607635|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
161914751|NCT05516758|584735671|FG003|Overall Study|Other|0|||
161914752|NCT05516758|584735672|FG004|Overall Study|Other|0|||
161914753|NCT05516758|584735673|FG005|Overall Study|Other|0|||
161914754|NCT05516758|584735674|FG006|Overall Study|Other|1|||
161914755|NCT01316575|584735675|FG000|Overall Study|Withdrawal by Subject|2|||
161914756|NCT01316575|584735676|FG001|Overall Study|Withdrawal by Subject|0|||
161914757|NCT01316575|584735675|FG000|Overall Study|Required alternate treatment|0|||
161914758|NCT01316575|584735676|FG001|Overall Study|Required alternate treatment|1|||
161914759|NCT00402831|584735677|FG000|Overall Study|Lost to Follow-up|1|||
161914760|NCT00402831|584735678|FG001|Overall Study|Lost to Follow-up|2|||
161914761|NCT00402831|584735677|FG000|Overall Study|Non-compliance with protocol|0|||
161914762|NCT00402831|584735678|FG001|Overall Study|Non-compliance with protocol|1|||
161914763|NCT02792504|584735679|FG000|Overall Study|Lost to Follow-up|24|||
161914764|NCT02792504|584735679|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
162152408|NCT01061151|585607632|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
161914765|NCT02814526|584735686|FG000|Overall Study|Adverse Event|4|||
161914766|NCT02814526|584735687|FG001|Overall Study|Adverse Event|3|||
161914767|NCT02814526|584735686|FG000|Overall Study|Death|1|||
161914768|NCT02814526|584735687|FG001|Overall Study|Death|1|||
161914769|NCT02814526|584735686|FG000|Overall Study|Lost to Follow-up|3|||
162152409|NCT01061151|585607633|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
162152410|NCT01061151|585607634|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
162152411|NCT01061151|585607635|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
162152412|NCT01061151|585607632|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
162152413|NCT01061151|585607633|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
162152414|NCT01061151|585607634|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
162152415|NCT01061151|585607635|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
162152416|NCT01061151|585607632|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
162152417|NCT01061151|585607633|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
162152418|NCT01061151|585607634|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
162152419|NCT01061151|585607635|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
162152420|NCT01061151|585607632|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
162152421|NCT01061151|585607633|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
162152422|NCT01061151|585607634|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
162152423|NCT01061151|585607635|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
162152424|NCT01061151|585607632|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
162152425|NCT01061151|585607633|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
162152426|NCT01061151|585607634|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
162152427|NCT01061151|585607635|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
162152428|NCT01061151|585607632|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
162152429|NCT01061151|585607633|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
162152430|NCT01061151|585607634|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
162152431|NCT01061151|585607635|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
162152432|NCT01061151|585607632|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
162152433|NCT01061151|585607633|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
162152434|NCT01061151|585607634|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
162152435|NCT01061151|585607635|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
162152436|NCT01061151|585607632|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
162152437|NCT01061151|585607633|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
162152438|NCT01061151|585607634|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
162152439|NCT01061151|585607635|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
162152440|NCT01061151|585607632|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
162152441|NCT01061151|585607633|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
162152442|NCT01061151|585607634|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
162152443|NCT01061151|585607635|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
162152444|NCT01061151|585607632|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
162152445|NCT01061151|585607633|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
162152446|NCT01061151|585607634|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
162152447|NCT01061151|585607635|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
162152448|NCT00960141|585607639|FG000|Overall Study|Adverse Event|4|||
162152449|NCT00960141|585607640|FG001|Overall Study|Adverse Event|8|||
162152450|NCT00960141|585607641|FG002|Overall Study|Adverse Event|2|||
162152451|NCT00960141|585607639|FG000|Overall Study|Lack of Efficacy|3|||
162152452|NCT00960141|585607640|FG001|Overall Study|Lack of Efficacy|4|||
162152453|NCT00960141|585607641|FG002|Overall Study|Lack of Efficacy|2|||
162152454|NCT00960141|585607639|FG000|Overall Study|Lost to Follow-up|1|||
162152455|NCT00960141|585607640|FG001|Overall Study|Lost to Follow-up|0|||
162152456|NCT00960141|585607641|FG002|Overall Study|Lost to Follow-up|0|||
162152457|NCT00960141|585607639|FG000|Overall Study|Protocol Violation|1|||
162152458|NCT00960141|585607640|FG001|Overall Study|Protocol Violation|3|||
162152459|NCT00960141|585607641|FG002|Overall Study|Protocol Violation|2|||
162152460|NCT00960141|585607639|FG000|Overall Study|Withdrawal by Subject|1|||
162152461|NCT00960141|585607640|FG001|Overall Study|Withdrawal by Subject|2|||
162152462|NCT00960141|585607641|FG002|Overall Study|Withdrawal by Subject|1|||
162152463|NCT03036813|585607642|FG000|Overall Study|Adverse Event|6|||
162152464|NCT03036813|585607643|FG001|Overall Study|Adverse Event|11|||
162152465|NCT03036813|585607644|FG002|Overall Study|Adverse Event|6|||
162152466|NCT03036813|585607642|FG000|Overall Study|Withdrawal by Subject|12|||
162152467|NCT03036813|585607643|FG001|Overall Study|Withdrawal by Subject|6|||
162152468|NCT03036813|585607644|FG002|Overall Study|Withdrawal by Subject|10|||
162152469|NCT03036813|585607642|FG000|Overall Study|Lost to Follow-up|1|||
162152470|NCT03036813|585607643|FG001|Overall Study|Lost to Follow-up|1|||
162152471|NCT03036813|585607644|FG002|Overall Study|Lost to Follow-up|0|||
162152472|NCT03036813|585607642|FG000|Overall Study|Physician Decision|2|||
162152473|NCT03036813|585607643|FG001|Overall Study|Physician Decision|1|||
162152474|NCT03036813|585607644|FG002|Overall Study|Physician Decision|1|||
162152475|NCT03036813|585607642|FG000|Overall Study|Non-Compliance|1|||
162152476|NCT03036813|585607643|FG001|Overall Study|Non-Compliance|5|||
162152477|NCT03036813|585607644|FG002|Overall Study|Non-Compliance|3|||
162152478|NCT03036813|585607642|FG000|Overall Study|Pregnancy|0|||
162152479|NCT03036813|585607643|FG001|Overall Study|Pregnancy|0|||
162152480|NCT03036813|585607644|FG002|Overall Study|Pregnancy|1|||
162152481|NCT03036813|585607642|FG000|Overall Study|Other|0|||
162152482|NCT03036813|585607643|FG001|Overall Study|Other|3|||
162152483|NCT03036813|585607644|FG002|Overall Study|Other|5|||
162152484|NCT00546754|585607645|FG000|Overall Study|Serious Adverse Event|1|||
162152485|NCT00546754|585607646|FG001|Overall Study|Serious Adverse Event|1|||
162152486|NCT00546754|585607645|FG000|Overall Study|Adverse Event|11|||
162152487|NCT00546754|585607646|FG001|Overall Study|Adverse Event|16|||
162152488|NCT00546754|585607645|FG000|Overall Study|Lack of Efficacy|1|||
162152489|NCT00546754|585607646|FG001|Overall Study|Lack of Efficacy|1|||
162152490|NCT00546754|585607645|FG000|Overall Study|Lost to Follow-up|9|||
162152491|NCT00546754|585607646|FG001|Overall Study|Lost to Follow-up|15|||
162152492|NCT00546754|585607645|FG000|Overall Study|Protocol Violation|3|||
162152493|NCT00546754|585607646|FG001|Overall Study|Protocol Violation|0|||
162152494|NCT00546754|585607645|FG000|Overall Study|Withdrawal by Subject|6|||
162152495|NCT00546754|585607646|FG001|Overall Study|Withdrawal by Subject|7|||
162152496|NCT00546754|585607645|FG000|Overall Study|Dyspnea|1|||
162152497|NCT00546754|585607646|FG001|Overall Study|Dyspnea|0|||
162152498|NCT00546754|585607645|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
162152499|NCT00546754|585607646|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
162152500|NCT00546754|585607645|FG000|Overall Study|Hip Replacement|1|||
162152501|NCT00546754|585607646|FG001|Overall Study|Hip Replacement|0|||
162152502|NCT00546754|585607645|FG000|Overall Study|Suicide|1|||
162152503|NCT00546754|585607646|FG001|Overall Study|Suicide|0|||
162152504|NCT00546754|585607645|FG000|Overall Study|Missing Cooperation|1|||
162152505|NCT00546754|585607646|FG001|Overall Study|Missing Cooperation|0|||
162152506|NCT00546754|585607645|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
162152507|NCT00546754|585607646|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
162152508|NCT00546754|585607645|FG000|Overall Study|Patient's Decision|0|||
161914770|NCT02814526|584735687|FG001|Overall Study|Lost to Follow-up|4|||
162152509|NCT00546754|585607646|FG001|Overall Study|Patient's Decision|1|||
162152510|NCT00546754|585607645|FG000|Overall Study|Missing|14|||
162152511|NCT00546754|585607646|FG001|Overall Study|Missing|7|||
162152512|NCT00396084|585607651|FG000|Overall Study|Adverse Event|0|||
162152513|NCT00396084|585607652|FG001|Overall Study|Adverse Event|0|||
162152514|NCT00396084|585607653|FG002|Overall Study|Adverse Event|0|||
162152515|NCT00396084|585607654|FG003|Overall Study|Adverse Event|0|||
162152516|NCT00396084|585607655|FG004|Overall Study|Adverse Event|1|||
162152517|NCT00396084|585607656|FG005|Overall Study|Adverse Event|2|||
162152518|NCT00396084|585607651|FG000|Overall Study|Withdrawal by Subject|0|||
162152519|NCT00396084|585607652|FG001|Overall Study|Withdrawal by Subject|0|||
162152520|NCT00396084|585607653|FG002|Overall Study|Withdrawal by Subject|0|||
162152521|NCT00396084|585607654|FG003|Overall Study|Withdrawal by Subject|1|||
162152522|NCT00396084|585607655|FG004|Overall Study|Withdrawal by Subject|0|||
162152523|NCT00396084|585607656|FG005|Overall Study|Withdrawal by Subject|0|||
162152524|NCT04009577|585607659|FG000|Core Study|Adverse Event|1|||
162152525|NCT04009577|585607660|FG001|Core Study|Adverse Event|0|||
162152526|NCT04009577|585607661|FG002|Core Study|Adverse Event|2|||
162152527|NCT04009577|585607662|FG003|Core Study|Adverse Event|4|||
162152528|NCT04009577|585607659|FG000|Core Study|Withdrawal by Subject|0|||
162152529|NCT04009577|585607660|FG001|Core Study|Withdrawal by Subject|0|||
162152530|NCT04009577|585607661|FG002|Core Study|Withdrawal by Subject|2|||
162152531|NCT04009577|585607662|FG003|Core Study|Withdrawal by Subject|0|||
162152532|NCT04009577|585607659|FG000|Core Study|Other|0|||
162152533|NCT04009577|585607660|FG001|Core Study|Other|0|||
162152534|NCT04009577|585607661|FG002|Core Study|Other|0|||
162152535|NCT04009577|585607662|FG003|Core Study|Other|1|||
162152536|NCT04009577|585607659|FG000|Extension Phase|Adverse Event|0|||
162152537|NCT04009577|585607660|FG001|Extension Phase|Adverse Event|0|||
162152538|NCT04009577|585607661|FG002|Extension Phase|Adverse Event|0|||
162152539|NCT04009577|585607662|FG003|Extension Phase|Adverse Event|1|||
162152540|NCT04009577|585607659|FG000|Extension Phase|Inadequate therapeutic effect|0|||
162152541|NCT04009577|585607660|FG001|Extension Phase|Inadequate therapeutic effect|0|||
162152542|NCT04009577|585607661|FG002|Extension Phase|Inadequate therapeutic effect|1|||
162152543|NCT04009577|585607662|FG003|Extension Phase|Inadequate therapeutic effect|0|||
162152544|NCT04009577|585607659|FG000|Extension Phase|Withdrawal by Subject|0|||
162152545|NCT04009577|585607660|FG001|Extension Phase|Withdrawal by Subject|0|||
162152546|NCT04009577|585607661|FG002|Extension Phase|Withdrawal by Subject|1|||
162152547|NCT04009577|585607662|FG003|Extension Phase|Withdrawal by Subject|0|||
162152548|NCT04009577|585607659|FG000|Extension Phase|Not Treated|0|||
162152549|NCT04009577|585607660|FG001|Extension Phase|Not Treated|0|||
161914771|NCT02814526|584735686|FG000|Overall Study|non site physician decision|1|||
162152550|NCT04009577|585607661|FG002|Extension Phase|Not Treated|2|||
162152551|NCT04009577|585607662|FG003|Extension Phase|Not Treated|0|||
162152552|NCT01832480|585607663|FG000|Overall Study|Lost to Follow-up|33|||
162152553|NCT01832480|585607664|FG001|Overall Study|Lost to Follow-up|30|||
162152554|NCT01832480|585607663|FG000|Overall Study|Withdrawal by Subject|0|||
162152555|NCT01832480|585607664|FG001|Overall Study|Withdrawal by Subject|2|||
162152556|NCT01832480|585607663|FG000|Overall Study|post randomization ineligible|8|||
162152557|NCT01832480|585607664|FG001|Overall Study|post randomization ineligible|10|||
162152558|NCT02261467|585607666|FG000|Overall Study|Enrolled in Error|1|||
162152559|NCT02261467|585607667|FG001|Overall Study|Enrolled in Error|0|||
162152560|NCT02261467|585607666|FG000|Overall Study|Protocol Violation|0|||
162152561|NCT02261467|585607667|FG001|Overall Study|Protocol Violation|1|||
162152562|NCT02261467|585607666|FG000|Overall Study|Personal Reasons|17|||
162152563|NCT02261467|585607667|FG001|Overall Study|Personal Reasons|22|||
162152564|NCT02261467|585607666|FG000|Overall Study|Lost to Follow-up|2|||
162152565|NCT02261467|585607667|FG001|Overall Study|Lost to Follow-up|13|||
162152566|NCT02261467|585607666|FG000|Overall Study|Adverse Event|1|||
162152567|NCT02261467|585607667|FG001|Overall Study|Adverse Event|1|||
162152568|NCT04305405|585607670|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162152569|NCT04305405|585607671|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162152570|NCT02674750|585607676|FG000|Overall Study|Death|4|||
162152571|NCT02674750|585607677|FG001|Overall Study|Death|5|||
162152572|NCT02674750|585607678|FG002|Overall Study|Death|8|||
162152573|NCT02674750|585607676|FG000|Overall Study|Lost to Follow-up|0|||
162152574|NCT02674750|585607677|FG001|Overall Study|Lost to Follow-up|8|||
162152575|NCT02674750|585607678|FG002|Overall Study|Lost to Follow-up|0|||
162152576|NCT02674750|585607676|FG000|Overall Study|Lack of Efficacy|1|||
162152577|NCT02674750|585607677|FG001|Overall Study|Lack of Efficacy|17|||
162152578|NCT02674750|585607678|FG002|Overall Study|Lack of Efficacy|3|||
162152579|NCT02674750|585607676|FG000|Overall Study|Withdrawal by Subject|0|||
162152580|NCT02674750|585607677|FG001|Overall Study|Withdrawal by Subject|7|||
162152581|NCT02674750|585607678|FG002|Overall Study|Withdrawal by Subject|1|||
162152582|NCT02674750|585607676|FG000|Overall Study|Other|0|||
162152583|NCT02674750|585607677|FG001|Overall Study|Other|8|||
162152584|NCT02674750|585607678|FG002|Overall Study|Other|0|||
162152585|NCT01685606|585607681|FG000|Overall Study|Withdrawal by Subject|1|||
162152586|NCT01787760|585607682|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
162152587|NCT01787760|585607683|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
162152588|NCT01787760|585607684|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
162152589|NCT01787760|585607682|FG000|Overall Study|Decompensated on left exotropia|0|||
162152590|NCT01787760|585607683|FG001|Overall Study|Decompensated on left exotropia|0|||
162152591|NCT01787760|585607684|FG002|Overall Study|Decompensated on left exotropia|1|||
162152592|NCT01787760|585607682|FG000|Overall Study|Dryness|0|||
162152593|NCT01787760|585607683|FG001|Overall Study|Dryness|1|||
162152594|NCT01787760|585607684|FG002|Overall Study|Dryness|0|||
162152595|NCT01787760|585607682|FG000|Overall Study|Relocation|1|||
162152596|NCT01787760|585607683|FG001|Overall Study|Relocation|1|||
162152597|NCT01787760|585607684|FG002|Overall Study|Relocation|0|||
162152598|NCT01787760|585607682|FG000|Overall Study|Lens discomfort|3|||
162152599|NCT01787760|585607683|FG001|Overall Study|Lens discomfort|0|||
162152600|NCT01787760|585607684|FG002|Overall Study|Lens discomfort|0|||
162152601|NCT01787760|585607682|FG000|Overall Study|Lens handling difficulty|1|||
162152602|NCT01787760|585607683|FG001|Overall Study|Lens handling difficulty|2|||
162152603|NCT01787760|585607684|FG002|Overall Study|Lens handling difficulty|0|||
162152604|NCT01787760|585607682|FG000|Overall Study|Protocol Violation|6|||
162152605|NCT01787760|585607683|FG001|Overall Study|Protocol Violation|0|||
162152606|NCT01787760|585607684|FG002|Overall Study|Protocol Violation|1|||
162152607|NCT01787760|585607682|FG000|Overall Study|Withdrawal by Subject|5|||
162152608|NCT01787760|585607683|FG001|Overall Study|Withdrawal by Subject|1|||
162152609|NCT01787760|585607684|FG002|Overall Study|Withdrawal by Subject|2|||
162152610|NCT01787760|585607682|FG000|Overall Study|Lost to Follow-up|1|||
162152611|NCT01787760|585607683|FG001|Overall Study|Lost to Follow-up|0|||
162152612|NCT01787760|585607684|FG002|Overall Study|Lost to Follow-up|1|||
162152613|NCT01787760|585607682|FG000|Overall Study|Stroke|1|||
162152614|NCT01787760|585607683|FG001|Overall Study|Stroke|0|||
162152615|NCT01787760|585607684|FG002|Overall Study|Stroke|0|||
162152616|NCT01787760|585607682|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
162152617|NCT01787760|585607683|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
162152618|NCT01787760|585607684|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
162152619|NCT01787760|585607682|FG000|Overall Study|Unsatisfactory physiological response|2|||
162152620|NCT01787760|585607683|FG001|Overall Study|Unsatisfactory physiological response|4|||
162152621|NCT01787760|585607684|FG002|Overall Study|Unsatisfactory physiological response|0|||
162152622|NCT01787760|585607682|FG000|Overall Study|Unsatisfactory visual response|1|||
162152623|NCT01787760|585607683|FG001|Overall Study|Unsatisfactory visual response|1|||
162152624|NCT01787760|585607684|FG002|Overall Study|Unsatisfactory visual response|0|||
162152625|NCT01787760|585607682|FG000|Overall Study|Near vision blur|1|||
162152626|NCT01787760|585607683|FG001|Overall Study|Near vision blur|0|||
162152627|NCT01787760|585607684|FG002|Overall Study|Near vision blur|0|||
162152628|NCT01353963|585607685|FG000|Overall Study|Adverse Event|2|||
162152629|NCT04980755|585607686|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
162152630|NCT04980755|585607686|FG000|Body Reprogramming Courses|Work commitment|2|||
162152631|NCT04980755|585607686|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
162236443|NCT01052103|585916953|FG001|Overall Study|Lost to Follow-up|5|||
162236444|NCT01052103|585916952|FG000|Overall Study|Protocol Violation|10|||
162236445|NCT01052103|585916953|FG001|Overall Study|Protocol Violation|4|||
162236446|NCT01052103|585916952|FG000|Overall Study|Scheduling conflict|2|||
162236447|NCT01052103|585916953|FG001|Overall Study|Scheduling conflict|1|||
162236448|NCT01052103|585916952|FG000|Overall Study|Sponsor Decision|2|||
162236449|NCT01052103|585916953|FG001|Overall Study|Sponsor Decision|0|||
162236450|NCT01052103|585916952|FG000|Overall Study|Withdrawal by Subject|3|||
162236451|NCT01052103|585916953|FG001|Overall Study|Withdrawal by Subject|6|||
162236452|NCT01052103|585916952|FG000|Overall Study|Perceived Lack of Efficacy|1|||
162236453|NCT01052103|585916953|FG001|Overall Study|Perceived Lack of Efficacy|0|||
162236454|NCT00666679|585916957|FG000|First Intervention|Lost to Follow-up|1|||
162236455|NCT00666679|585916958|FG001|First Intervention|Lost to Follow-up|0|||
162236456|NCT00666679|585916957|FG000|First Intervention|Protocol Violation|1|||
162236457|NCT00666679|585916958|FG001|First Intervention|Protocol Violation|0|||
162236458|NCT00666679|585916957|FG000|First Intervention|Withdrawal by Subject|1|||
162152632|NCT04980755|585607686|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
162152633|NCT02531113|585607691|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
162152634|NCT02531113|585607691|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
162152635|NCT02531113|585607691|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
162152636|NCT02531113|585607691|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
162152637|NCT02531113|585607691|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
162152638|NCT02531113|585607691|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
162152639|NCT02531113|585607691|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
162152640|NCT02531113|585607691|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
162152641|NCT00632424|585607692|FG000|Overall Study|Disease Progression|17|||
162152642|NCT00632424|585607692|FG000|Overall Study|Study Drug Toxicity|1|||
162152643|NCT00801983|585607693|FG000|Period 1|Lost to Follow-up|2|||
162152644|NCT00801983|585607694|FG001|Period 1|Lost to Follow-up|0|||
162152645|NCT00801983|585607693|FG000|Period 1|Withdrawal by Subject|2|||
162152646|NCT00801983|585607694|FG001|Period 1|Withdrawal by Subject|8|||
162152647|NCT00801983|585607693|FG000|Period 2|Withdrawal by Subject|2|||
162152648|NCT00801983|585607694|FG001|Period 2|Withdrawal by Subject|1|||
162152649|NCT03237481|585609157|FG000|Overall Study|Lost to Follow-up|1|||
162152650|NCT03237481|585609158|FG001|Overall Study|Lost to Follow-up|0|||
162152651|NCT03237481|585609159|FG002|Overall Study|Lost to Follow-up|0|||
162152652|NCT03237481|585609157|FG000|Overall Study|Protocol Violation|1|||
162152653|NCT03237481|585609158|FG001|Overall Study|Protocol Violation|0|||
162152654|NCT03237481|585609159|FG002|Overall Study|Protocol Violation|0|||
162152655|NCT03237481|585609157|FG000|Overall Study|Withdrawal by Subject|3|||
162152656|NCT03237481|585609158|FG001|Overall Study|Withdrawal by Subject|2|||
162152657|NCT03237481|585609159|FG002|Overall Study|Withdrawal by Subject|1|||
162152658|NCT04714320|585609160|FG000|Overall Study|Voluntary Withdrawal|4|||
162152659|NCT04714320|585609161|FG001|Overall Study|Voluntary Withdrawal|1|||
162152660|NCT04714320|585609162|FG002|Overall Study|Voluntary Withdrawal|2|||
162152661|NCT04714320|585609160|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
162152662|NCT04714320|585609161|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
162152663|NCT04714320|585609162|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
162152664|NCT04714320|585609160|FG000|Overall Study|Reason Not Specified|1|||
162152665|NCT04714320|585609161|FG001|Overall Study|Reason Not Specified|3|||
162152666|NCT04714320|585609162|FG002|Overall Study|Reason Not Specified|3|||
162152667|NCT04755660|585609167|FG000|Overall Study|Lost to Follow-up|1|||
162152668|NCT04755660|585609168|FG001|Overall Study|Lost to Follow-up|1|||
162152669|NCT04755660|585609169|FG002|Overall Study|Lost to Follow-up|0|||
162152670|NCT04755660|585609167|FG000|Overall Study|Withdrawal by Subject|0|||
162152671|NCT04755660|585609168|FG001|Overall Study|Withdrawal by Subject|1|||
162152672|NCT04755660|585609169|FG002|Overall Study|Withdrawal by Subject|1|||
162152673|NCT04755660|585609167|FG000|Overall Study|Physician Decision|0|||
162152674|NCT04755660|585609168|FG001|Overall Study|Physician Decision|0|||
162152675|NCT04755660|585609169|FG002|Overall Study|Physician Decision|1|||
162152676|NCT03873779|585609170|FG000|Overall Study|Withdrawal by Subject|1|||
162152677|NCT02581215|585609171|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
162152678|NCT02581215|585609172|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
162152679|NCT02581215|585609171|FG000|Overall Study|Eligibility Criteria Not Met|0|||
162152680|NCT02581215|585609172|FG001|Overall Study|Eligibility Criteria Not Met|1|||
162152681|NCT04279574|585609175|FG000|Overall Study|Death|1|||
162152682|NCT04279574|585609176|FG001|Overall Study|Death|0|||
162152683|NCT04279574|585609175|FG000|Overall Study|lost restoration, tooth fracture|1|||
162152684|NCT04279574|585609176|FG001|Overall Study|lost restoration, tooth fracture|0|||
162152685|NCT04279574|585609175|FG000|Overall Study|Lost to Follow-up|0|||
162152686|NCT04279574|585609176|FG001|Overall Study|Lost to Follow-up|1|||
162152687|NCT04153565|585609178|FG000|Overall Study|Death|13|||
162152688|NCT04723394|585609188|FG000|Overall Study|Adverse Event|0|||
162152689|NCT04723394|585609189|FG001|Overall Study|Adverse Event|3|||
162152690|NCT04723394|585609188|FG000|Overall Study|Death|8|||
162152691|NCT04723394|585609189|FG001|Overall Study|Death|8|||
162152692|NCT04723394|585609188|FG000|Overall Study|Lost to Follow-up|20|||
162152693|NCT04723394|585609189|FG001|Overall Study|Lost to Follow-up|17|||
162152694|NCT04723394|585609188|FG000|Overall Study|Physician Decision|1|||
162152695|NCT04723394|585609189|FG001|Overall Study|Physician Decision|0|||
162152696|NCT04723394|585609188|FG000|Overall Study|Withdrawal by Subject|20|||
162152697|NCT04723394|585609189|FG001|Overall Study|Withdrawal by Subject|34|||
162152698|NCT04723394|585609188|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
162152699|NCT04723394|585609189|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
162152700|NCT00446459|585609190|FG000|8 Months|Protocol Violation|12|||
162152701|NCT00446459|585609190|FG000|12 Months|Protocol Violation|4|||
162152702|NCT00446459|585609190|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
162152703|NCT00858117|585609192|FG000|Treatment on Study|Adverse Event|2|||
162152704|NCT00858117|585609192|FG000|Follow up for 5 Years|Death|4|||
162152705|NCT00858117|585609192|FG000|Follow up for 5 Years|No further data collected for study|9|||
161810372|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
161810373|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
161810374|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
161810375|NCT01045161|584347785|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
161810376|NCT01045161|584347786|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
161810377|NCT01045161|584347787|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
161810378|NCT03686033|584347788|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
161810379|NCT03686033|584347789|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
161810380|NCT03686033|584347790|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
161810381|NCT03686033|584347791|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
161810382|NCT03686033|584347792|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
161810383|NCT03686033|584347793|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
161914772|NCT02814526|584735687|FG001|Overall Study|non site physician decision|0|||
161914773|NCT02814526|584735686|FG000|Overall Study|participant noncompliance|1|||
161914774|NCT02814526|584735687|FG001|Overall Study|participant noncompliance|1|||
161914775|NCT02814526|584735686|FG000|Overall Study|Withdrawal by Subject|20|||
161914776|NCT02814526|584735687|FG001|Overall Study|Withdrawal by Subject|14|||
161914777|NCT02814526|584735686|FG000|Overall Study|safety risk|2|||
161914778|NCT02814526|584735687|FG001|Overall Study|safety risk|1|||
161914779|NCT02814526|584735686|FG000|Overall Study|early termination-study terminated|1|||
161914780|NCT02814526|584735687|FG001|Overall Study|early termination-study terminated|2|||
161914781|NCT02814526|584735686|FG000|Overall Study|Other|0|||
161914782|NCT02814526|584735687|FG001|Overall Study|Other|4|||
161914783|NCT02485860|584735688|FG000|Overall Study|Lost to Follow-up|4|||
161914784|NCT02485860|584735689|FG001|Overall Study|Lost to Follow-up|1|||
161914785|NCT02485860|584735688|FG000|Overall Study|Physician Decision|1|||
161914786|NCT02485860|584735689|FG001|Overall Study|Physician Decision|2|||
161914787|NCT02485860|584735688|FG000|Overall Study|Health context (COVID-19)|1|||
161914788|NCT02485860|584735689|FG001|Overall Study|Health context (COVID-19)|0|||
161914789|NCT01416571|584735690|FG000|Overall Study|Lost to Follow-up|2|||
161914790|NCT03608163|584735691|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
161914791|NCT03608163|584735692|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
161914792|NCT03454555|584737290|FG000|Overall Study|Death|6|||
161914793|NCT03454555|584737291|FG001|Overall Study|Death|6|||
161914794|NCT03454555|584737290|FG000|Overall Study|Lost to Follow-up|31|||
161914795|NCT03454555|584737291|FG001|Overall Study|Lost to Follow-up|12|||
161914796|NCT03454555|584737290|FG000|Overall Study|Physician Decision|2|||
161914797|NCT03454555|584737291|FG001|Overall Study|Physician Decision|6|||
161914798|NCT03454555|584737290|FG000|Overall Study|Withdrawal by Subject|34|||
161914799|NCT03454555|584737291|FG001|Overall Study|Withdrawal by Subject|5|||
161914800|NCT03454555|584737290|FG000|Overall Study|Ineligible|1|||
161914801|NCT03454555|584737291|FG001|Overall Study|Ineligible|5|||
161914802|NCT05493111|584737292|FG000|Overall Study|Adverse Event|3|||
161914803|NCT05493111|584737293|FG001|Overall Study|Adverse Event|4|||
161914804|NCT05493111|584737292|FG000|Overall Study|Withdrawal of Consent|19|||
161914805|NCT05493111|584737293|FG001|Overall Study|Withdrawal of Consent|10|||
161914806|NCT05493111|584737292|FG000|Overall Study|Non-compliance|1|||
161914807|NCT05493111|584737293|FG001|Overall Study|Non-compliance|1|||
161914808|NCT05493111|584737292|FG000|Overall Study|Lost to Follow-up|8|||
161914809|NCT05493111|584737293|FG001|Overall Study|Lost to Follow-up|1|||
161914810|NCT05493111|584737292|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
161914811|NCT05493111|584737293|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
161914812|NCT05493111|584737292|FG000|Overall Study|Withdrawal by Subject|1|||
161914813|NCT05493111|584737293|FG001|Overall Study|Withdrawal by Subject|1|||
161914814|NCT00375752|584737294|FG000|Overall Study|Lack of Efficacy|4|||
161914815|NCT00375752|584737295|FG001|Overall Study|Lack of Efficacy|4|||
161914816|NCT00375752|584737294|FG000|Overall Study|Adverse Event|1|||
161914817|NCT00375752|584737295|FG001|Overall Study|Adverse Event|6|||
161914818|NCT00375752|584737294|FG000|Overall Study|Withdrawal by Subject|6|||
161914819|NCT00375752|584737295|FG001|Overall Study|Withdrawal by Subject|1|||
161914820|NCT00375752|584737294|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
161914821|NCT00375752|584737295|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
161914822|NCT00375752|584737294|FG000|Overall Study|Protocol Violation|0|||
161914823|NCT00375752|584737295|FG001|Overall Study|Protocol Violation|2|||
161914824|NCT00375752|584737294|FG000|Overall Study|Administrative Problems|0|||
161914825|NCT00375752|584737295|FG001|Overall Study|Administrative Problems|1|||
161914826|NCT01140906|584737300|FG000|Overall Study|Adverse Event|7|||
162152706|NCT00371787|585609193|FG000|Overall Study|Withdrawal by Subject|3|||
162152707|NCT00371787|585609194|FG001|Overall Study|Withdrawal by Subject|1|||
161810384|NCT01854047|584347794|FG000|Overall Study|Lack of Efficacy|1|||
161810385|NCT01854047|584347795|FG001|Overall Study|Lack of Efficacy|0|||
161810386|NCT01854047|584347796|FG002|Overall Study|Lack of Efficacy|0|||
161810387|NCT01854047|584347797|FG003|Overall Study|Lack of Efficacy|0|||
161914827|NCT01140906|584737301|FG001|Overall Study|Adverse Event|10|||
161914828|NCT01140906|584737302|FG002|Overall Study|Adverse Event|17|||
161914829|NCT01140906|584737303|FG003|Overall Study|Adverse Event|7|||
161914830|NCT01140906|584737300|FG000|Overall Study|Lack of Efficacy|6|||
162152708|NCT00077675|585609195|FG000|Overall Study|Adverse Event|1|||
162152709|NCT00077675|585609196|FG001|Overall Study|Adverse Event|2|||
162152710|NCT00077675|585609195|FG000|Overall Study|Lost to Follow-up|6|||
162152711|NCT00077675|585609196|FG001|Overall Study|Lost to Follow-up|3|||
162152712|NCT00077675|585609195|FG000|Overall Study|Withdrawal by Subject|1|||
162152713|NCT00077675|585609196|FG001|Overall Study|Withdrawal by Subject|0|||
162152714|NCT00077675|585609195|FG000|Overall Study|Other|0|||
162152715|NCT00077675|585609196|FG001|Overall Study|Other|1|||
162152716|NCT00077675|585609195|FG000|Overall Study|Never received study treatment|3|||
162152717|NCT00077675|585609196|FG001|Overall Study|Never received study treatment|3|||
162152718|NCT02601820|585609197|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
162152719|NCT02601820|585609197|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
162152720|NCT02601820|585609197|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
162152721|NCT02601820|585609197|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
162152722|NCT04532528|585609203|FG000|Overall Study|Adverse Event|12|||
162152723|NCT04532528|585609204|FG001|Overall Study|Adverse Event|17|||
162152724|NCT04532528|585609203|FG000|Overall Study|Withdrawal of consent|16|||
162152725|NCT04532528|585609204|FG001|Overall Study|Withdrawal of consent|17|||
162152726|NCT04532528|585609203|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
162152727|NCT04532528|585609204|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
162152728|NCT04532528|585609203|FG000|Overall Study|Lost to Follow-up|69|||
162152729|NCT04532528|585609204|FG001|Overall Study|Lost to Follow-up|68|||
162152730|NCT04532528|585609203|FG000|Overall Study|Administrative problems|12|||
162152731|NCT04532528|585609204|FG001|Overall Study|Administrative problems|14|||
162152732|NCT04532528|585609203|FG000|Overall Study|Death|3|||
162152733|NCT04532528|585609204|FG001|Overall Study|Death|3|||
162152734|NCT04532528|585609203|FG000|Overall Study|Other|38|||
162152735|NCT04532528|585609204|FG001|Overall Study|Other|46|||
162152736|NCT00665444|585609209|FG000|Overall Study|Physician Decision|1|||
162152737|NCT00665444|585609209|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
162152738|NCT01414738|585609221|FG000|Overall Study|Death|26|||
162152739|NCT01414738|585609221|FG000|Overall Study|Refused testing|5|||
162152740|NCT01414738|585609221|FG000|Overall Study|Lost to Follow-up|2|||
162152741|NCT01414738|585609221|FG000|Overall Study|Refused, disease progression|8|||
162152742|NCT01414738|585609221|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
162152743|NCT01266122|585609222|FG000|Overall Study|Lost to Follow-up|6|||
162152744|NCT01266122|585609223|FG001|Overall Study|Lost to Follow-up|6|||
162152745|NCT03756571|585609224|FG000|Overall Study|Lost to Follow-up|1|||
162152746|NCT03756571|585609225|FG001|Overall Study|Lost to Follow-up|1|||
162152747|NCT02379819|585609226|FG000|Overall Study|Withdrawal by Subject|10|||
162152748|NCT02379819|585609226|FG000|Overall Study|Death|2|||
162152749|NCT02379819|585609226|FG000|Overall Study|Lack of Efficacy|1|||
162152750|NCT02379819|585609226|FG000|Overall Study|Lost to Follow-up|1|||
162152751|NCT00529516|585609227|FG000|Overall Study|Adverse Event|2|||
162152752|NCT00529516|585609228|FG001|Overall Study|Adverse Event|1|||
162152753|NCT00529516|585609229|FG002|Overall Study|Adverse Event|0|||
162152754|NCT00529516|585609227|FG000|Overall Study|Withdrawal by Subject|1|||
162152755|NCT00529516|585609228|FG001|Overall Study|Withdrawal by Subject|1|||
162152756|NCT00529516|585609229|FG002|Overall Study|Withdrawal by Subject|0|||
162152757|NCT00529516|585609227|FG000|Overall Study|Lost to Follow-up|0|||
162152758|NCT00529516|585609228|FG001|Overall Study|Lost to Follow-up|0|||
162152759|NCT00529516|585609229|FG002|Overall Study|Lost to Follow-up|1|||
162152760|NCT03752151|585609230|FG000|Overall Study|Withdrawal by Subject|1|||
162152761|NCT03752151|585609230|FG000|Overall Study|Protocol Violation|1|||
162152762|NCT04056624|585609231|FG000|Overall Study|Withdrawal by Subject|0|||
162152763|NCT04056624|585609232|FG001|Overall Study|Withdrawal by Subject|0|||
162152764|NCT04056624|585609233|FG002|Overall Study|Withdrawal by Subject|1|||
162152765|NCT04056624|585609231|FG000|Overall Study|Protocol Violation|1|||
162152766|NCT04056624|585609232|FG001|Overall Study|Protocol Violation|2|||
162152767|NCT04056624|585609233|FG002|Overall Study|Protocol Violation|0|||
162152768|NCT00703820|585609237|FG000|Overall Study|Adverse Event|12|||
162152769|NCT00703820|585609238|FG001|Overall Study|Adverse Event|17|||
162152770|NCT00703820|585609237|FG000|Overall Study|Death|5|||
162152771|NCT00703820|585609238|FG001|Overall Study|Death|0|||
162152772|NCT00703820|585609237|FG000|Overall Study|Lack of Efficacy|11|||
161810388|NCT01854047|584347798|FG004|Overall Study|Lack of Efficacy|0|||
162152773|NCT00703820|585609238|FG001|Overall Study|Lack of Efficacy|11|||
162152774|NCT00703820|585609237|FG000|Overall Study|Received non-protocol therapy|1|||
162152775|NCT00703820|585609238|FG001|Overall Study|Received non-protocol therapy|0|||
161810389|NCT01854047|584347794|FG000|Overall Study|Poor compliance to protocol|3|||
162152776|NCT00703820|585609237|FG000|Overall Study|Physician Decision|4|||
162152777|NCT00703820|585609238|FG001|Overall Study|Physician Decision|5|||
162152778|NCT00703820|585609237|FG000|Overall Study|Withdrawal by Subject|2|||
162152779|NCT00703820|585609238|FG001|Overall Study|Withdrawal by Subject|1|||
162152780|NCT02092116|585609242|FG000|Overall Study|Withdrawal by Subject|0|||
162152781|NCT02092116|585609243|FG001|Overall Study|Withdrawal by Subject|3|||
162152782|NCT02092116|585609242|FG000|Overall Study|Adverse Event|0|||
162152783|NCT02092116|585609243|FG001|Overall Study|Adverse Event|1|||
162152784|NCT01007396|585609244|FG000|Overall Study|Lost to Follow-up|47|||
162152785|NCT01792830|585609245|FG000|Overall Study|Withdrawal by Subject|22|||
162152786|NCT01792830|585609246|FG001|Overall Study|Withdrawal by Subject|0|||
162152787|NCT01792830|585609247|FG002|Overall Study|Withdrawal by Subject|0|||
162152788|NCT01792830|585609248|FG003|Overall Study|Withdrawal by Subject|2|||
162152789|NCT01792830|585609249|FG004|Overall Study|Withdrawal by Subject|1|||
162152790|NCT01792830|585609250|FG005|Overall Study|Withdrawal by Subject|1|||
162152791|NCT01792830|585609251|FG006|Overall Study|Withdrawal by Subject|1|||
162152792|NCT01792830|585609252|FG007|Overall Study|Withdrawal by Subject|1|||
161810390|NCT01854047|584347795|FG001|Overall Study|Poor compliance to protocol|0|||
161810391|NCT01854047|584347796|FG002|Overall Study|Poor compliance to protocol|2|||
161810392|NCT01854047|584347797|FG003|Overall Study|Poor compliance to protocol|0|||
161810393|NCT01854047|584347798|FG004|Overall Study|Poor compliance to protocol|0|||
161810394|NCT01854047|584347794|FG000|Overall Study|Adverse Event|5|||
161810395|NCT01854047|584347795|FG001|Overall Study|Adverse Event|4|||
161810396|NCT01854047|584347796|FG002|Overall Study|Adverse Event|6|||
162152793|NCT01792830|585609253|FG008|Overall Study|Withdrawal by Subject|7|||
161810397|NCT01854047|584347797|FG003|Overall Study|Adverse Event|10|||
161914831|NCT01140906|584737301|FG001|Overall Study|Lack of Efficacy|8|||
161914832|NCT01140906|584737302|FG002|Overall Study|Lack of Efficacy|2|||
161914833|NCT01140906|584737303|FG003|Overall Study|Lack of Efficacy|1|||
161914834|NCT01140906|584737300|FG000|Overall Study|Non-compliance|0|||
161914835|NCT01140906|584737301|FG001|Overall Study|Non-compliance|1|||
161914836|NCT01140906|584737302|FG002|Overall Study|Non-compliance|0|||
161914837|NCT01140906|584737303|FG003|Overall Study|Non-compliance|1|||
161914838|NCT01140906|584737300|FG000|Overall Study|Protocol Violation|5|||
161914839|NCT01140906|584737301|FG001|Overall Study|Protocol Violation|3|||
161810398|NCT01854047|584347798|FG004|Overall Study|Adverse Event|7|||
162152794|NCT01792830|585609254|FG009|Overall Study|Withdrawal by Subject|0|||
162152795|NCT01792830|585609255|FG010|Overall Study|Withdrawal by Subject|2|||
162152796|NCT01792830|585609245|FG000|Overall Study|Death|3|||
162152797|NCT01792830|585609246|FG001|Overall Study|Death|0|||
162152798|NCT01792830|585609247|FG002|Overall Study|Death|0|||
162012773|NCT02113982|585103847|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
162012774|NCT02113982|585103848|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
162012775|NCT02113982|585103849|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
162012776|NCT02113982|585103850|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
162012777|NCT02113982|585103851|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
162152799|NCT01792830|585609248|FG003|Overall Study|Death|1|||
162152800|NCT01792830|585609249|FG004|Overall Study|Death|0|||
162152801|NCT01792830|585609250|FG005|Overall Study|Death|0|||
162152802|NCT01792830|585609251|FG006|Overall Study|Death|1|||
162152803|NCT01792830|585609252|FG007|Overall Study|Death|0|||
162152804|NCT01792830|585609253|FG008|Overall Study|Death|1|||
162152805|NCT01792830|585609254|FG009|Overall Study|Death|0|||
162152806|NCT01792830|585609255|FG010|Overall Study|Death|1|||
162152807|NCT01792830|585609245|FG000|Overall Study|Adverse Event|0|||
162152808|NCT01792830|585609246|FG001|Overall Study|Adverse Event|0|||
162152809|NCT01792830|585609247|FG002|Overall Study|Adverse Event|0|||
162152810|NCT01792830|585609248|FG003|Overall Study|Adverse Event|0|||
162152811|NCT01792830|585609249|FG004|Overall Study|Adverse Event|0|||
162152812|NCT01792830|585609250|FG005|Overall Study|Adverse Event|0|||
162152813|NCT01792830|585609251|FG006|Overall Study|Adverse Event|0|||
162152814|NCT01792830|585609252|FG007|Overall Study|Adverse Event|0|||
162152815|NCT01792830|585609253|FG008|Overall Study|Adverse Event|1|||
162152816|NCT01792830|585609254|FG009|Overall Study|Adverse Event|0|||
162152817|NCT01792830|585609255|FG010|Overall Study|Adverse Event|0|||
162152818|NCT05274217|585609271|FG000|Overall Study|Study terminated.|11|||
162152819|NCT05274217|585609272|FG001|Overall Study|Study terminated.|0|||
162152820|NCT03811574|585609273|FG000|Overall Study|Withdrawal by Subject|2|||
162152821|NCT03811574|585609274|FG001|Overall Study|Withdrawal by Subject|4|||
162152822|NCT03811574|585609275|FG002|Overall Study|Withdrawal by Subject|0|||
162152823|NCT01697969|585609276|FG000|Overall Study|Did not meet inc/exc criteria|3|||
162152824|NCT00736853|585609281|FG000|Open-Label Period|Physician Decision|2|||
162152825|NCT00736853|585609282|FG001|Open-Label Period|Physician Decision|0|||
162152826|NCT00736853|585609283|FG002|Open-Label Period|Physician Decision|0|||
162152827|NCT00736853|585609281|FG000|Open-Label Period|Adverse Event|31|||
162152828|NCT00736853|585609282|FG001|Open-Label Period|Adverse Event|0|||
162152829|NCT00736853|585609283|FG002|Open-Label Period|Adverse Event|0|||
162152830|NCT00736853|585609281|FG000|Open-Label Period|Withdrawal by Subject|16|||
162152831|NCT00736853|585609282|FG001|Open-Label Period|Withdrawal by Subject|0|||
162152832|NCT00736853|585609283|FG002|Open-Label Period|Withdrawal by Subject|0|||
162152833|NCT00736853|585609281|FG000|Open-Label Period|Started but not treated|42|||
162152834|NCT00736853|585609282|FG001|Open-Label Period|Started but not treated|0|||
162152835|NCT00736853|585609283|FG002|Open-Label Period|Started but not treated|0|||
162152836|NCT00736853|585609281|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
162152837|NCT00736853|585609282|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
162152838|NCT00736853|585609283|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
162152839|NCT00736853|585609281|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
162152840|NCT00736853|585609282|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
162152841|NCT00736853|585609283|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
162152842|NCT00736853|585609281|FG000|Double-Blind Period|Lack of Efficacy|0|||
162152843|NCT00736853|585609282|FG001|Double-Blind Period|Lack of Efficacy|19|||
162152844|NCT00736853|585609283|FG002|Double-Blind Period|Lack of Efficacy|42|||
162152845|NCT00736853|585609281|FG000|Double-Blind Period|Adverse Event|0|||
162152846|NCT00736853|585609282|FG001|Double-Blind Period|Adverse Event|3|||
162152847|NCT00736853|585609283|FG002|Double-Blind Period|Adverse Event|2|||
162152848|NCT00736853|585609281|FG000|Double-Blind Period|Withdrawal by Subject|0|||
162152849|NCT00736853|585609282|FG001|Double-Blind Period|Withdrawal by Subject|1|||
162152850|NCT00736853|585609283|FG002|Double-Blind Period|Withdrawal by Subject|4|||
162152851|NCT00736853|585609281|FG000|Double-Blind Period|Ineligible to participate the study|0|||
162152852|NCT00736853|585609282|FG001|Double-Blind Period|Ineligible to participate the study|1|||
162152853|NCT00736853|585609283|FG002|Double-Blind Period|Ineligible to participate the study|0|||
162152854|NCT01764464|585609284|FG000|First Intervention|Withdrawal by Subject|1|||
162152855|NCT01764464|585609285|FG001|First Intervention|Withdrawal by Subject|0|||
162152856|NCT01764464|585609284|FG000|First Intervention|Lost to Follow-up|1|||
162152857|NCT01764464|585609285|FG001|First Intervention|Lost to Follow-up|0|||
162152858|NCT01764464|585609284|FG000|First Intervention|Adverse Event|0|||
162152859|NCT01764464|585609285|FG001|First Intervention|Adverse Event|2|||
162152860|NCT01764464|585609284|FG000|First Intervention|did not receive study drug|0|||
162152861|NCT01764464|585609285|FG001|First Intervention|did not receive study drug|1|||
162152862|NCT01764464|585609284|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
162152863|NCT01764464|585609285|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
162152864|NCT01616459|585609289|FG000|Overall Study|Adverse Event|1|||
161810399|NCT01854047|584347794|FG000|Overall Study|Randomized but not treated|0|||
161810400|NCT01854047|584347795|FG001|Overall Study|Randomized but not treated|1|||
161810401|NCT01854047|584347796|FG002|Overall Study|Randomized but not treated|2|||
161810402|NCT01854047|584347797|FG003|Overall Study|Randomized but not treated|0|||
161810403|NCT01854047|584347798|FG004|Overall Study|Randomized but not treated|4|||
161810404|NCT01854047|584347794|FG000|Overall Study|Other than specified above|3|||
161810405|NCT01854047|584347795|FG001|Overall Study|Other than specified above|3|||
161810406|NCT01854047|584347796|FG002|Overall Study|Other than specified above|3|||
161810407|NCT01854047|584347797|FG003|Overall Study|Other than specified above|5|||
161810408|NCT01854047|584347798|FG004|Overall Study|Other than specified above|8|||
161810409|NCT02374853|584347806|FG000|Overall Study|Surgery Cancelled|5|||
161810410|NCT02374853|584347807|FG001|Overall Study|Surgery Cancelled|11|||
161810411|NCT02281084|584347810|FG000|Overall Study|Death|21|||
161810412|NCT02281084|584347811|FG001|Overall Study|Death|18|||
161810413|NCT02281084|584347812|FG002|Overall Study|Death|3|||
161914840|NCT01140906|584737302|FG002|Overall Study|Protocol Violation|2|||
161914841|NCT01140906|584737303|FG003|Overall Study|Protocol Violation|1|||
161810414|NCT02281084|584347813|FG003|Overall Study|Death|5|||
161914842|NCT01140906|584737300|FG000|Overall Study|Withdrawal of consent|6|||
161810415|NCT02281084|584347810|FG000|Overall Study|Adverse Event|1|||
162152865|NCT01616459|585609290|FG001|Overall Study|Adverse Event|1|||
162152866|NCT01616459|585609291|FG002|Overall Study|Adverse Event|2|||
162152867|NCT01616459|585609292|FG003|Overall Study|Adverse Event|0|||
162152868|NCT01616459|585609289|FG000|Overall Study|Lost to Follow-up|1|||
162152869|NCT01616459|585609290|FG001|Overall Study|Lost to Follow-up|11|||
162152870|NCT01616459|585609291|FG002|Overall Study|Lost to Follow-up|3|||
162152871|NCT01616459|585609292|FG003|Overall Study|Lost to Follow-up|2|||
162152872|NCT01616459|585609289|FG000|Overall Study|Protocol Violation|0|||
162152873|NCT01616459|585609290|FG001|Overall Study|Protocol Violation|0|||
162152874|NCT01616459|585609291|FG002|Overall Study|Protocol Violation|0|||
162152875|NCT01616459|585609292|FG003|Overall Study|Protocol Violation|2|||
162152876|NCT01616459|585609289|FG000|Overall Study|Withdrawal by Subject|2|||
162152877|NCT01616459|585609290|FG001|Overall Study|Withdrawal by Subject|4|||
162152878|NCT01616459|585609291|FG002|Overall Study|Withdrawal by Subject|4|||
162152879|NCT01616459|585609292|FG003|Overall Study|Withdrawal by Subject|4|||
162152880|NCT01616459|585609289|FG000|Overall Study|Other reason|0|||
162152881|NCT01616459|585609290|FG001|Overall Study|Other reason|1|||
162152882|NCT01616459|585609291|FG002|Overall Study|Other reason|1|||
162152883|NCT01616459|585609292|FG003|Overall Study|Other reason|0|||
162152884|NCT02991807|585610418|FG000|Overall Study|Withdrawal by Subject|2|||
162152885|NCT02991807|585610419|FG001|Overall Study|Withdrawal by Subject|1|||
162152886|NCT02991807|585610418|FG000|Overall Study|Physician Decision|0|||
162152887|NCT02991807|585610419|FG001|Overall Study|Physician Decision|1|||
162152888|NCT02991807|585610418|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
162152889|NCT02991807|585610419|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
162152890|NCT02566902|585610420|FG000|Overall Study|Protocol Violation|2|||
162152891|NCT02566902|585610421|FG001|Overall Study|Protocol Violation|1|||
162152892|NCT01875848|585610422|FG000|Overall Study|Withdrawal by Subject|2|||
162152893|NCT01875848|585610423|FG001|Overall Study|Withdrawal by Subject|0|||
162152894|NCT02411084|585610424|FG000|Overall Study|Lack of Efficacy|6|||
162152895|NCT02411084|585610425|FG001|Overall Study|Lack of Efficacy|3|||
162152896|NCT02411084|585610424|FG000|Overall Study|Death|5|||
162152897|NCT02411084|585610425|FG001|Overall Study|Death|4|||
162152898|NCT02411084|585610424|FG000|Overall Study|Adverse Event|2|||
162152899|NCT02411084|585610425|FG001|Overall Study|Adverse Event|1|||
162152900|NCT02411084|585610424|FG000|Overall Study|Other reasons|0|||
162152901|NCT02411084|585610425|FG001|Overall Study|Other reasons|5|||
162152902|NCT01622868|585610426|FG000|Overall Study|Protocol Violation|7|||
162152903|NCT01622868|585610427|FG001|Overall Study|Protocol Violation|0|||
162152904|NCT03285763|585610429|FG000|Overall Study|Death|470|||
162152905|NCT03285763|585610429|FG000|Overall Study|Lost to Follow-up|18|||
162152906|NCT03285763|585610429|FG000|Overall Study|Physician Decision|2|||
162152907|NCT03285763|585610429|FG000|Overall Study|Study Terminated By Sponsor|79|||
162152908|NCT03285763|585610429|FG000|Overall Study|Withdrawal by Subject|33|||
162152909|NCT02374463|585610431|FG000|Overall Study|Withdrawal by Subject|3|||
162152910|NCT02374463|585610432|FG001|Overall Study|Withdrawal by Subject|3|||
162152911|NCT02647905|585610437|FG000|Overall Study|Lost to Follow-up|1|||
162152912|NCT02647905|585610437|FG000|Overall Study|Withdrawal by Subject|2|||
162152913|NCT02765100|585610438|FG000|Overall Study|subject found ineligible after baseline|1|||
162152914|NCT02765100|585610439|FG001|Overall Study|subject found ineligible after baseline|1|||
162152915|NCT02765100|585610438|FG000|Overall Study|Lost to Follow-up|0|||
162152916|NCT02765100|585610439|FG001|Overall Study|Lost to Follow-up|1|||
162152917|NCT00642850|585610440|FG000|Overall Study|Death|7|||
162152918|NCT00642850|585610440|FG000|Overall Study|Adverse Event|2|||
162152919|NCT00642850|585610440|FG000|Overall Study|Lack of Efficacy|1|||
162152920|NCT00642850|585610440|FG000|Overall Study|Protocol Violation|2|||
162152921|NCT00642850|585610440|FG000|Overall Study|Kidney transplantation|8|||
162152922|NCT00642850|585610440|FG000|Overall Study|Blood transfusion|6|||
162152923|NCT00642850|585610440|FG000|Overall Study|Other reasons|7|||
162152924|NCT00244855|585610441|FG000|Overall Study|Withdrawal by Subject|0|||
162152925|NCT00244855|585610442|FG001|Overall Study|Withdrawal by Subject|1|||
162152926|NCT01236001|585610443|FG000|Overall Study|Adverse Event|5|||
162152927|NCT01236001|585610444|FG001|Overall Study|Adverse Event|14|||
162152928|NCT01236001|585610443|FG000|Overall Study|Lack of Efficacy|6|||
162152929|NCT01236001|585610444|FG001|Overall Study|Lack of Efficacy|6|||
162152930|NCT01236001|585610443|FG000|Overall Study|Lost to Follow-up|6|||
162152931|NCT01236001|585610444|FG001|Overall Study|Lost to Follow-up|1|||
162152932|NCT01236001|585610443|FG000|Overall Study|Incompliance|1|||
162152933|NCT01236001|585610444|FG001|Overall Study|Incompliance|0|||
162152934|NCT01236001|585610443|FG000|Overall Study|Planned Visit After End of Study|0|||
162152935|NCT01236001|585610444|FG001|Overall Study|Planned Visit After End of Study|1|||
161810416|NCT02281084|584347811|FG001|Overall Study|Adverse Event|0|||
161810417|NCT02281084|584347812|FG002|Overall Study|Adverse Event|0|||
161810418|NCT02281084|584347813|FG003|Overall Study|Adverse Event|0|||
161810419|NCT02281084|584347810|FG000|Overall Study|Withdrawal by Subject|2|||
161810420|NCT02281084|584347811|FG001|Overall Study|Withdrawal by Subject|2|||
161810421|NCT02281084|584347812|FG002|Overall Study|Withdrawal by Subject|0|||
161810422|NCT02281084|584347813|FG003|Overall Study|Withdrawal by Subject|0|||
161810423|NCT02281084|584347810|FG000|Overall Study|Site Closure by Sponsor|5|||
161810424|NCT02281084|584347811|FG001|Overall Study|Site Closure by Sponsor|1|||
161810425|NCT02281084|584347812|FG002|Overall Study|Site Closure by Sponsor|2|||
161810426|NCT02281084|584347813|FG003|Overall Study|Site Closure by Sponsor|0|||
161810427|NCT02335658|584347814|FG000|Overall Study|Adverse Event|18|||
161810428|NCT02335658|584347815|FG001|Overall Study|Adverse Event|12|||
161810429|NCT02335658|584347814|FG000|Overall Study|Lack of Efficacy|4|||
161810430|NCT02335658|584347815|FG001|Overall Study|Lack of Efficacy|5|||
161810431|NCT02335658|584347814|FG000|Overall Study|Pregnancy|1|||
161810432|NCT02335658|584347815|FG001|Overall Study|Pregnancy|0|||
161810433|NCT02335658|584347814|FG000|Overall Study|Withdrawal by Subject|13|||
161810434|NCT02335658|584347815|FG001|Overall Study|Withdrawal by Subject|21|||
161810435|NCT02335658|584347814|FG000|Overall Study|non-compliance|2|||
161810436|NCT02335658|584347815|FG001|Overall Study|non-compliance|3|||
161810437|NCT02335658|584347814|FG000|Overall Study|other reason|2|||
161810438|NCT02335658|584347815|FG001|Overall Study|other reason|3|||
161810439|NCT02957942|584347820|FG000|Overall Study|Withdrawal by Subject|0|||
161810440|NCT02957942|584347821|FG001|Overall Study|Withdrawal by Subject|1|||
161810441|NCT02957942|584347820|FG000|Overall Study|Practicing experiment protocol|0|||
161810442|NCT02957942|584347821|FG001|Overall Study|Practicing experiment protocol|6|||
161810443|NCT02655679|584347825|FG000|Overall Study|Adverse Event|0|||
161810444|NCT02655679|584347826|FG001|Overall Study|Adverse Event|1|||
161810445|NCT02655679|584347827|FG002|Overall Study|Adverse Event|0|||
161810446|NCT02655679|584347828|FG003|Overall Study|Adverse Event|0|||
161810447|NCT02655679|584347829|FG004|Overall Study|Adverse Event|0|||
161810448|NCT02655679|584347825|FG000|Overall Study|Withdrawal by Subject|1|||
161810449|NCT02655679|584347826|FG001|Overall Study|Withdrawal by Subject|1|||
161810450|NCT02655679|584347827|FG002|Overall Study|Withdrawal by Subject|0|||
161810451|NCT02655679|584347828|FG003|Overall Study|Withdrawal by Subject|3|||
161810452|NCT02655679|584347829|FG004|Overall Study|Withdrawal by Subject|1|||
161810453|NCT02655679|584347825|FG000|Overall Study|Inability to Comply with the Protocol|1|||
161810454|NCT02655679|584347826|FG001|Overall Study|Inability to Comply with the Protocol|0|||
161810455|NCT02655679|584347827|FG002|Overall Study|Inability to Comply with the Protocol|0|||
161810456|NCT02655679|584347828|FG003|Overall Study|Inability to Comply with the Protocol|0|||
161810457|NCT02655679|584347829|FG004|Overall Study|Inability to Comply with the Protocol|0|||
161810458|NCT02655679|584347825|FG000|Overall Study|Lost to Follow-up|0|||
161810459|NCT02655679|584347826|FG001|Overall Study|Lost to Follow-up|1|||
161810460|NCT02655679|584347827|FG002|Overall Study|Lost to Follow-up|1|||
161810461|NCT02655679|584347828|FG003|Overall Study|Lost to Follow-up|1|||
161914843|NCT01140906|584737301|FG001|Overall Study|Withdrawal of consent|6|||
161810462|NCT02655679|584347829|FG004|Overall Study|Lost to Follow-up|0|||
161810463|NCT02655679|584347825|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161810464|NCT02655679|584347826|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161810465|NCT02655679|584347827|FG002|Overall Study|Other Miscellaneous Reasons|0|||
161810466|NCT02655679|584347828|FG003|Overall Study|Other Miscellaneous Reasons|0|||
162152936|NCT03451721|585610445|FG000|Overall Study|Death|1|||
162152937|NCT03076515|585610448|FG000|Overall Study|DMC decision based on interim analysis|25|||
162152938|NCT03076515|585610449|FG001|Overall Study|DMC decision based on interim analysis|29|||
162152939|NCT00174382|585610450|FG000|Overall Study|Death|2|||
162152940|NCT00174382|585610450|FG000|Overall Study|Adverse Event|19|||
162152941|NCT00174382|585610450|FG000|Overall Study|Withdrawal by Subject|6|||
162152942|NCT00174382|585610450|FG000|Overall Study|Protocol Violation|3|||
162152943|NCT00174382|585610450|FG000|Overall Study|Arrived early for last visit in error|1|||
162152944|NCT00174382|585610450|FG000|Overall Study|Subject felt pill not effective enough|1|||
162152945|NCT00174382|585610450|FG000|Overall Study|Lost to Follow-up|1|||
162152946|NCT03903822|585610451|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
162152947|NCT03903822|585610452|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
162152948|NCT03903822|585610453|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
162152949|NCT03903822|585610454|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
162152950|NCT03903822|585610455|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
162152951|NCT03903822|585610456|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
162152952|NCT03903822|585610457|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
162152953|NCT03903822|585610458|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
162152954|NCT03903822|585610451|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
162152955|NCT03903822|585610452|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
162152956|NCT03903822|585610453|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
162152957|NCT03903822|585610454|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
162152958|NCT03903822|585610455|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
162152959|NCT03903822|585610456|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
162152960|NCT03903822|585610457|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
162152961|NCT03903822|585610458|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
162152962|NCT03903822|585610451|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
162152963|NCT03903822|585610452|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
162152964|NCT03903822|585610453|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
162152965|NCT03903822|585610454|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
162152966|NCT03903822|585610455|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
162152967|NCT03903822|585610456|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
162152968|NCT03903822|585610457|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
162152969|NCT03903822|585610458|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
162152970|NCT03903822|585610451|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
162152971|NCT03903822|585610452|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
162152972|NCT03903822|585610453|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
162152973|NCT03903822|585610454|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
162152974|NCT03903822|585610455|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
162152975|NCT03903822|585610456|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
162152976|NCT03903822|585610457|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
162152977|NCT03903822|585610458|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
162152978|NCT03903822|585610451|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
162152979|NCT03903822|585610452|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
162152980|NCT03903822|585610453|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
162152981|NCT03903822|585610454|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
162152982|NCT03903822|585610455|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
162152983|NCT03903822|585610456|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
162152984|NCT03903822|585610457|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
162152985|NCT03903822|585610458|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
162152986|NCT03903822|585610451|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162152987|NCT03903822|585610452|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162152988|NCT03903822|585610453|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162152989|NCT03903822|585610454|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
162152990|NCT03903822|585610455|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162152991|NCT03903822|585610456|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162152992|NCT03903822|585610457|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162152993|NCT03903822|585610458|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
162152994|NCT03903822|585610451|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
162152995|NCT03903822|585610452|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
162152996|NCT03903822|585610453|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
162152997|NCT03903822|585610454|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
162152998|NCT03903822|585610455|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
162152999|NCT03903822|585610456|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
162153000|NCT03903822|585610457|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
162153001|NCT03903822|585610458|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
162153002|NCT03903822|585610451|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
162153003|NCT03903822|585610452|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
162153004|NCT03903822|585610453|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
162153005|NCT03903822|585610454|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
162153006|NCT03903822|585610455|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
162153007|NCT03903822|585610456|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
162153008|NCT03903822|585610457|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
162153009|NCT03903822|585610458|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
162153010|NCT03903822|585610451|FG000|Treatment Phase (6 Weeks)|Other|2|||
162153011|NCT03903822|585610452|FG001|Treatment Phase (6 Weeks)|Other|1|||
162153012|NCT03903822|585610453|FG002|Treatment Phase (6 Weeks)|Other|0|||
162153013|NCT03903822|585610454|FG003|Treatment Phase (6 Weeks)|Other|0|||
162153014|NCT03903822|585610455|FG004|Treatment Phase (6 Weeks)|Other|1|||
162153015|NCT03903822|585610456|FG005|Treatment Phase (6 Weeks)|Other|1|||
162153016|NCT03903822|585610457|FG006|Treatment Phase (6 Weeks)|Other|0|||
162153017|NCT03903822|585610458|FG007|Treatment Phase (6 Weeks)|Other|0|||
162153018|NCT03903822|585610451|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
162153019|NCT03903822|585610452|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
162153020|NCT03903822|585610453|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
162153021|NCT03903822|585610454|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
162153022|NCT03903822|585610455|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
162153023|NCT03903822|585610456|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
162153024|NCT03903822|585610457|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
162153025|NCT03903822|585610458|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
162153026|NCT03903822|585610451|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162153027|NCT03903822|585610452|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162153028|NCT03903822|585610453|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162153029|NCT03903822|585610454|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162153030|NCT03903822|585610455|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
162153031|NCT03903822|585610456|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162153032|NCT03903822|585610457|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162153033|NCT03903822|585610458|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
162153034|NCT03903822|585610451|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
162153035|NCT03903822|585610452|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
162153036|NCT03903822|585610453|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
162153037|NCT03903822|585610454|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
162153038|NCT03903822|585610455|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
162153039|NCT03903822|585610456|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
162153040|NCT03903822|585610457|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
162153041|NCT03903822|585610458|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
162153042|NCT03903822|585610451|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
162153043|NCT03903822|585610452|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
162153044|NCT03903822|585610453|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
162153045|NCT03903822|585610454|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
162153046|NCT03903822|585610455|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
162153047|NCT03903822|585610456|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
162153048|NCT03903822|585610457|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
162153049|NCT03903822|585610458|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
162153050|NCT03903822|585610451|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
162153051|NCT03903822|585610452|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
162153052|NCT03903822|585610453|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
162153053|NCT03903822|585610454|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
162153054|NCT03903822|585610455|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
162153055|NCT03903822|585610456|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161914844|NCT01140906|584737302|FG002|Overall Study|Withdrawal of consent|2|||
162153056|NCT03903822|585610457|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
162153057|NCT03903822|585610458|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
162153058|NCT03903822|585610451|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162153059|NCT03903822|585610452|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162153060|NCT03903822|585610453|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162153061|NCT03903822|585610454|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162153062|NCT03903822|585610455|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162153063|NCT03903822|585610456|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
162153064|NCT03903822|585610457|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162153065|NCT03903822|585610458|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
162153066|NCT03903822|585610451|FG000|Follow up Phase (4 Weeks)|Other|1|||
162153067|NCT03903822|585610452|FG001|Follow up Phase (4 Weeks)|Other|1|||
162153068|NCT03903822|585610453|FG002|Follow up Phase (4 Weeks)|Other|0|||
162153069|NCT03903822|585610454|FG003|Follow up Phase (4 Weeks)|Other|0|||
162153070|NCT03903822|585610455|FG004|Follow up Phase (4 Weeks)|Other|0|||
162153071|NCT03903822|585610456|FG005|Follow up Phase (4 Weeks)|Other|0|||
162153072|NCT03903822|585610457|FG006|Follow up Phase (4 Weeks)|Other|0|||
162153073|NCT03903822|585610458|FG007|Follow up Phase (4 Weeks)|Other|0|||
162153074|NCT00296036|585610459|FG000|Overall Study|Withdrawal by Subject|1|||
162153075|NCT00296036|585610460|FG001|Overall Study|Withdrawal by Subject|0|||
162153076|NCT00296036|585610461|FG002|Overall Study|Withdrawal by Subject|2|||
162153077|NCT00296036|585610462|FG003|Overall Study|Withdrawal by Subject|1|||
162153078|NCT00296036|585610463|FG004|Overall Study|Withdrawal by Subject|2|||
162153079|NCT00296036|585610464|FG005|Overall Study|Withdrawal by Subject|1|||
162153080|NCT00296036|585610459|FG000|Overall Study|Protocol Violation|0|||
162153081|NCT00296036|585610460|FG001|Overall Study|Protocol Violation|0|||
162153082|NCT00296036|585610461|FG002|Overall Study|Protocol Violation|0|||
162153083|NCT00296036|585610462|FG003|Overall Study|Protocol Violation|0|||
162153084|NCT00296036|585610463|FG004|Overall Study|Protocol Violation|0|||
162153085|NCT00296036|585610464|FG005|Overall Study|Protocol Violation|3|||
162153086|NCT00785512|585610467|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
162153087|NCT00785512|585610468|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
162153088|NCT00785512|585610467|FG000|Overall Study|Adverse Event|0|||
162153089|NCT00785512|585610468|FG001|Overall Study|Adverse Event|0|||
162153090|NCT00785512|585610467|FG000|Overall Study|Lack of Efficacy|0|||
162153091|NCT00785512|585610468|FG001|Overall Study|Lack of Efficacy|2|||
162153092|NCT00785512|585610467|FG000|Overall Study|Withdrawal by Subject|0|||
162153093|NCT00785512|585610468|FG001|Overall Study|Withdrawal by Subject|1|||
162153094|NCT00785512|585610467|FG000|Overall Study|Lost to Follow-up|3|||
162153095|NCT00785512|585610468|FG001|Overall Study|Lost to Follow-up|0|||
162153096|NCT00785512|585610467|FG000|Overall Study|Precedure Refused|0|||
162153097|NCT00785512|585610468|FG001|Overall Study|Precedure Refused|0|||
162153098|NCT00785512|585610467|FG000|Overall Study|IVRS Programing Error|0|||
162153099|NCT00785512|585610468|FG001|Overall Study|IVRS Programing Error|0|||
162153100|NCT00785512|585610467|FG000|Overall Study|Physician Decision|0|||
162153101|NCT00785512|585610468|FG001|Overall Study|Physician Decision|0|||
162153102|NCT00785512|585610467|FG000|Overall Study|Lack of compliance|0|||
162153103|NCT00785512|585610468|FG001|Overall Study|Lack of compliance|1|||
162153104|NCT02574455|585610469|FG000|Overall Study|Death|197|||
162153105|NCT02574455|585610470|FG001|Overall Study|Death|210|||
162153106|NCT02574455|585610469|FG000|Overall Study|Withdrawal of Consent|11|||
162153107|NCT02574455|585610470|FG001|Overall Study|Withdrawal of Consent|28|||
162153108|NCT02574455|585610469|FG000|Overall Study|Lost to Follow-up|4|||
162153109|NCT02574455|585610470|FG001|Overall Study|Lost to Follow-up|4|||
162153110|NCT02574455|585610469|FG000|Overall Study|Sponsor's Decision|55|||
161914845|NCT01140906|584737303|FG003|Overall Study|Withdrawal of consent|2|||
162153111|NCT02574455|585610470|FG001|Overall Study|Sponsor's Decision|20|||
162153112|NCT03144674|585610479|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
162153113|NCT03144674|585610480|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
162153114|NCT03144674|585610481|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
162153115|NCT03144674|585610482|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
162153116|NCT03144674|585610479|FG000|Overall Study|Death|3|||
162153117|NCT03144674|585610480|FG001|Overall Study|Death|2|||
162153118|NCT03144674|585610481|FG002|Overall Study|Death|6|||
162153119|NCT03144674|585610482|FG003|Overall Study|Death|24|||
162153120|NCT03144674|585610479|FG000|Overall Study|Lost to Follow-up|0|||
162153121|NCT03144674|585610480|FG001|Overall Study|Lost to Follow-up|1|||
162153122|NCT03144674|585610481|FG002|Overall Study|Lost to Follow-up|0|||
162153123|NCT03144674|585610482|FG003|Overall Study|Lost to Follow-up|4|||
162153124|NCT03144674|585610479|FG000|Overall Study|Withdrawal by Participant|0|||
162153125|NCT03144674|585610480|FG001|Overall Study|Withdrawal by Participant|0|||
162153126|NCT03144674|585610481|FG002|Overall Study|Withdrawal by Participant|2|||
162153127|NCT03144674|585610482|FG003|Overall Study|Withdrawal by Participant|6|||
162153128|NCT03144674|585610479|FG000|Overall Study|Discharged from the Trust|0|||
162153129|NCT03144674|585610480|FG001|Overall Study|Discharged from the Trust|0|||
162153130|NCT03144674|585610481|FG002|Overall Study|Discharged from the Trust|1|||
162153131|NCT03144674|585610482|FG003|Overall Study|Discharged from the Trust|0|||
162153132|NCT03144674|585610479|FG000|Overall Study|Exclusion Criteria Met|0|||
162153133|NCT03144674|585610480|FG001|Overall Study|Exclusion Criteria Met|0|||
162153134|NCT03144674|585610481|FG002|Overall Study|Exclusion Criteria Met|1|||
162153135|NCT03144674|585610482|FG003|Overall Study|Exclusion Criteria Met|0|||
162153136|NCT03144674|585610479|FG000|Overall Study|Changed Physicians|0|||
162153137|NCT03144674|585610480|FG001|Overall Study|Changed Physicians|0|||
162153138|NCT03144674|585610481|FG002|Overall Study|Changed Physicians|0|||
162153139|NCT03144674|585610482|FG003|Overall Study|Changed Physicians|1|||
162153140|NCT03144674|585610479|FG000|Overall Study|Removed for Safety|0|||
162153141|NCT03144674|585610480|FG001|Overall Study|Removed for Safety|0|||
162153142|NCT03144674|585610481|FG002|Overall Study|Removed for Safety|0|||
162153143|NCT03144674|585610482|FG003|Overall Study|Removed for Safety|1|||
162153144|NCT03144674|585610479|FG000|Overall Study|Site Closed|0|||
162153145|NCT03144674|585610480|FG001|Overall Study|Site Closed|0|||
162153146|NCT03144674|585610481|FG002|Overall Study|Site Closed|0|||
162153147|NCT03144674|585610482|FG003|Overall Study|Site Closed|1|||
162153148|NCT03144674|585610479|FG000|Overall Study|Histological Criteria Not Met|0|||
162153149|NCT03144674|585610480|FG001|Overall Study|Histological Criteria Not Met|0|||
162153150|NCT03144674|585610481|FG002|Overall Study|Histological Criteria Not Met|0|||
162153151|NCT03144674|585610482|FG003|Overall Study|Histological Criteria Not Met|1|||
162153152|NCT03144674|585610479|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
162153153|NCT03144674|585610480|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
162153154|NCT03144674|585610481|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
162153155|NCT03144674|585610482|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
162153156|NCT03144674|585610479|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
162153157|NCT03144674|585610480|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
162153158|NCT03144674|585610481|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
162153159|NCT03144674|585610482|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
162153160|NCT05510245|585610483|FG000|Overall Study|Withdrawal by Subject|1|||
162153161|NCT05510245|585610484|FG001|Overall Study|Withdrawal by Subject|0|||
162153162|NCT05510245|585610485|FG002|Overall Study|Withdrawal by Subject|0|||
162153163|NCT01373346|585610486|FG000|Overall Study|Death|1|||
162153164|NCT01198028|585610487|FG000|Overall Study|Adverse Event|5|||
162153165|NCT01198028|585610487|FG000|Overall Study|Death|3|||
162153166|NCT01198028|585610487|FG000|Overall Study|Physician Decision|2|||
162153167|NCT01395758|585610489|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
162153168|NCT01395758|585610490|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
162153169|NCT01395758|585610491|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
162153170|NCT01565148|585610492|FG000|Overall Study|Withdrawal by Subject|1|||
162153171|NCT01565148|585610493|FG001|Overall Study|Withdrawal by Subject|1|||
162153172|NCT01565148|585610494|FG002|Overall Study|Withdrawal by Subject|1|||
162153173|NCT01565148|585610495|FG003|Overall Study|Withdrawal by Subject|2|||
162153174|NCT01565148|585610492|FG000|Overall Study|Lost to Follow-up|4|||
162153175|NCT01565148|585610493|FG001|Overall Study|Lost to Follow-up|4|||
162153176|NCT01565148|585610494|FG002|Overall Study|Lost to Follow-up|0|||
162153177|NCT01565148|585610495|FG003|Overall Study|Lost to Follow-up|3|||
162153178|NCT01565148|585610492|FG000|Overall Study|Rescue Therapy|8|||
162153179|NCT01565148|585610493|FG001|Overall Study|Rescue Therapy|5|||
162153180|NCT01565148|585610494|FG002|Overall Study|Rescue Therapy|5|||
162153181|NCT01565148|585610495|FG003|Overall Study|Rescue Therapy|8|||
162153182|NCT01565148|585610492|FG000|Overall Study|Death|0|||
162153183|NCT01565148|585610493|FG001|Overall Study|Death|0|||
162153184|NCT01565148|585610494|FG002|Overall Study|Death|1|||
162153185|NCT01565148|585610495|FG003|Overall Study|Death|0|||
162153186|NCT01565148|585610492|FG000|Overall Study|Physician Decision|2|||
162153187|NCT01565148|585610493|FG001|Overall Study|Physician Decision|5|||
162153188|NCT01565148|585610494|FG002|Overall Study|Physician Decision|0|||
162153189|NCT01565148|585610495|FG003|Overall Study|Physician Decision|0|||
162153190|NCT01759771|585610496|FG000|Overall Study|Withdrawal by Subject|1|||
162153191|NCT01759771|585610497|FG001|Overall Study|Withdrawal by Subject|1|||
162153192|NCT00529659|585610500|FG000|Overall Study|Adverse Event|8|||
162153193|NCT00529659|585610501|FG001|Overall Study|Adverse Event|7|||
162153194|NCT00529659|585610500|FG000|Overall Study|Lost to Follow-up|0|||
162153195|NCT00529659|585610501|FG001|Overall Study|Lost to Follow-up|2|||
162153196|NCT00529659|585610500|FG000|Overall Study|Physician Decision|0|||
162153197|NCT00529659|585610501|FG001|Overall Study|Physician Decision|2|||
162153198|NCT00529659|585610500|FG000|Overall Study|Protocol Violation|2|||
162153199|NCT00529659|585610501|FG001|Overall Study|Protocol Violation|6|||
162153200|NCT00529659|585610500|FG000|Overall Study|Withdrawal by Subject|1|||
162153201|NCT00529659|585610501|FG001|Overall Study|Withdrawal by Subject|6|||
162153202|NCT01692730|585610504|FG000|Overall Study|Lost to Follow-up|225|||
162153203|NCT01692730|585610505|FG001|Overall Study|Lost to Follow-up|227|||
162153204|NCT01415349|585610506|FG000|Treatment Period 1|Adverse Event|0|||
162153205|NCT01415349|585610507|FG001|Treatment Period 1|Adverse Event|1|||
162153206|NCT01415349|585610506|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162153207|NCT01415349|585610507|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161810467|NCT02655679|584347829|FG004|Overall Study|Other Miscellaneous Reasons|0|||
161810468|NCT03801707|584347830|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
161810469|NCT01754597|584347831|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
161810470|NCT01754597|584347832|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
161810471|NCT00819741|584347833|FG000|Overall Study|Adverse Event|5|||
161810472|NCT00819741|584347834|FG001|Overall Study|Adverse Event|2|||
161810473|NCT00819741|584347833|FG000|Overall Study|Lack of Efficacy|0|||
161810474|NCT00819741|584347834|FG001|Overall Study|Lack of Efficacy|2|||
161810475|NCT00819741|584347833|FG000|Overall Study|Lost to Follow-up|3|||
161810476|NCT00819741|584347834|FG001|Overall Study|Lost to Follow-up|1|||
161810477|NCT00819741|584347833|FG000|Overall Study|Protocol Violation|3|||
162153208|NCT02139943|585610508|FG000|Overall Study|Adverse Event|0|||
162153209|NCT02139943|585610509|FG001|Overall Study|Adverse Event|1|||
162153210|NCT02139943|585610510|FG002|Overall Study|Adverse Event|2|||
162153211|NCT02139943|585610508|FG000|Overall Study|Lost to Follow-up|3|||
162153212|NCT02139943|585610509|FG001|Overall Study|Lost to Follow-up|2|||
162153213|NCT02139943|585610510|FG002|Overall Study|Lost to Follow-up|2|||
161810478|NCT00819741|584347834|FG001|Overall Study|Protocol Violation|4|||
162153214|NCT02139943|585610508|FG000|Overall Study|Withdrawal by Subject|4|||
162153215|NCT02139943|585610509|FG001|Overall Study|Withdrawal by Subject|3|||
162153216|NCT02139943|585610510|FG002|Overall Study|Withdrawal by Subject|0|||
162153217|NCT02139943|585610508|FG000|Overall Study|Other|0|||
162153218|NCT02139943|585610509|FG001|Overall Study|Other|0|||
162153219|NCT02139943|585610510|FG002|Overall Study|Other|1|||
162153220|NCT02139943|585610508|FG000|Overall Study|Participant wishes to discontinue|2|||
162153221|NCT02139943|585610509|FG001|Overall Study|Participant wishes to discontinue|0|||
162153222|NCT02139943|585610510|FG002|Overall Study|Participant wishes to discontinue|0|||
162153223|NCT02139943|585610508|FG000|Overall Study|Participant in Poor Compliance|1|||
162153224|NCT02139943|585610509|FG001|Overall Study|Participant in Poor Compliance|0|||
162153225|NCT02139943|585610510|FG002|Overall Study|Participant in Poor Compliance|1|||
162153226|NCT02139943|585610508|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
162153227|NCT02139943|585610509|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
162153228|NCT02139943|585610510|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
162153229|NCT01041417|585610511|FG000|Overall Study|Adverse Event|5|||
162153230|NCT01041417|585610512|FG001|Overall Study|Adverse Event|2|||
162153231|NCT01041417|585610511|FG000|Overall Study|Lost to Follow-up|1|||
162153232|NCT01041417|585610512|FG001|Overall Study|Lost to Follow-up|1|||
162153233|NCT01041417|585610511|FG000|Overall Study|Death|1|||
162153234|NCT01041417|585610512|FG001|Overall Study|Death|0|||
162153235|NCT02918071|585610518|FG000|Overall Study|Withdrawal by Subject|2|||
162153236|NCT02918071|585610518|FG000|Overall Study|Lost to Follow-up|1|||
162153237|NCT03960463|585612661|FG000|Overall Study|Withdrawal by Subject|2|||
162153238|NCT03960463|585612662|FG001|Overall Study|Withdrawal by Subject|0|||
162153239|NCT04043455|585612663|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
162153240|NCT04043455|585612664|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
162153241|NCT04043455|585612665|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
162153242|NCT04043455|585612666|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
162153243|NCT04043455|585612667|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
162153244|NCT04043455|585612668|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
162153245|NCT04043455|585612663|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
162153246|NCT04043455|585612664|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
162153247|NCT04043455|585612665|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
162153248|NCT04043455|585612666|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
162153249|NCT04043455|585612667|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
162153250|NCT04043455|585612668|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
162153251|NCT04043455|585612663|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
162153252|NCT04043455|585612664|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
162153253|NCT04043455|585612665|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
162153254|NCT04043455|585612666|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
162153255|NCT04043455|585612667|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
162153256|NCT04043455|585612668|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
162153257|NCT04043455|585612663|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
162153258|NCT04043455|585612664|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
162153259|NCT04043455|585612665|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
162153260|NCT04043455|585612666|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
161810479|NCT00819741|584347833|FG000|Overall Study|Withdrawal by Subject|2|||
161810480|NCT00819741|584347834|FG001|Overall Study|Withdrawal by Subject|2|||
161810481|NCT00819741|584347833|FG000|Overall Study|Unclassified|6|||
161810482|NCT00819741|584347834|FG001|Overall Study|Unclassified|0|||
161810483|NCT00819741|584347833|FG000|Overall Study|Reasons unknown|3|||
161810484|NCT00819741|584347834|FG001|Overall Study|Reasons unknown|3|||
161810485|NCT03447353|584349418|FG000|Overall Study|Failure at Screening Visit|2|||
161810486|NCT03447353|584349418|FG000|Overall Study|Lost to Follow-up|4|||
161810487|NCT03447353|584349418|FG000|Overall Study|Scheduling Conflicts|3|||
161810488|NCT03447353|584349418|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
161810489|NCT02175095|584349419|FG000|Overall Study|Withdrawal by Subject|3|||
161810490|NCT02635750|584349420|FG000|Part 1, Period 2|Adverse Event|1|||
161810491|NCT02635750|584349421|FG001|Part 1, Period 2|Adverse Event|0|||
161810492|NCT02635750|584349422|FG002|Part 1, Period 2|Adverse Event|0|||
161810493|NCT00462345|584349423|FG000|Overall Study|Withdrawal by Subject|2|||
161810494|NCT00462345|584349423|FG000|Overall Study|Did not complete second course|1|||
161810495|NCT02642653|584349427|FG000|Overall Study|Adverse Event|2|||
161810496|NCT02642653|584349428|FG001|Overall Study|Adverse Event|0|||
161810497|NCT02875392|584349432|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
162153261|NCT04043455|585612667|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
162153262|NCT04043455|585612668|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
162153263|NCT04043455|585612663|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
162153264|NCT04043455|585612664|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
161810498|NCT02875392|584349433|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
161810499|NCT00508651|584349437|FG000|Overall Study|Lost to Follow-up|3|||
162153265|NCT04043455|585612665|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
162012778|NCT02113982|585103852|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
162012779|NCT02113982|585103853|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
162012780|NCT02113982|585103854|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
162153266|NCT04043455|585612666|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161810500|NCT00508651|584349438|FG001|Overall Study|Lost to Follow-up|1|||
161810501|NCT00508651|584349437|FG000|Overall Study|Withdrawal by Subject|1|||
161810502|NCT00508651|584349438|FG001|Overall Study|Withdrawal by Subject|1|||
161810503|NCT03874715|584349441|FG000|Overall Study|Adverse Event|2|||
161810504|NCT03874715|584349442|FG001|Overall Study|Adverse Event|0|||
161810505|NCT03874715|584349441|FG000|Overall Study|Poor compliance to protocol|5|||
161810506|NCT03874715|584349442|FG001|Overall Study|Poor compliance to protocol|1|||
161810507|NCT03874715|584349441|FG000|Overall Study|Withdrawal by Subject|1|||
161810508|NCT03874715|584349442|FG001|Overall Study|Withdrawal by Subject|0|||
161810509|NCT03874715|584349441|FG000|Overall Study|Other-unspecified|1|||
161810510|NCT03874715|584349442|FG001|Overall Study|Other-unspecified|0|||
161810511|NCT00934050|584349445|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
161810512|NCT00934050|584349446|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
161810513|NCT00934050|584349447|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
161810514|NCT00934050|584349448|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
161810515|NCT00934050|584349449|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
161810516|NCT00934050|584349450|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
161810517|NCT00934050|584349445|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
161810518|NCT00934050|584349446|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
161810519|NCT00934050|584349447|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
161810520|NCT00934050|584349448|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
161810521|NCT00934050|584349449|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
161810522|NCT00934050|584349450|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
161810523|NCT00934050|584349445|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161810524|NCT00934050|584349446|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161914846|NCT01140906|584737300|FG000|Overall Study|Lost to Follow-up|1|||
161914847|NCT01140906|584737301|FG001|Overall Study|Lost to Follow-up|1|||
161914848|NCT01140906|584737302|FG002|Overall Study|Lost to Follow-up|0|||
161914849|NCT01140906|584737303|FG003|Overall Study|Lost to Follow-up|2|||
161914850|NCT01140906|584737300|FG000|Overall Study|Administrative or other reason|0|||
161914851|NCT01140906|584737301|FG001|Overall Study|Administrative or other reason|5|||
161914852|NCT01140906|584737302|FG002|Overall Study|Administrative or other reason|3|||
161914853|NCT01140906|584737303|FG003|Overall Study|Administrative or other reason|2|||
161914854|NCT01649765|584737304|FG000|Overall Study|Adverse Event|5|||
161914855|NCT01649765|584737305|FG001|Overall Study|Adverse Event|3|||
161914856|NCT01649765|584737304|FG000|Overall Study|Lack of Efficacy|1|||
161914857|NCT01649765|584737305|FG001|Overall Study|Lack of Efficacy|1|||
161914858|NCT01649765|584737304|FG000|Overall Study|Physician Decision|0|||
161914859|NCT01649765|584737305|FG001|Overall Study|Physician Decision|3|||
161914860|NCT01649765|584737304|FG000|Overall Study|Protocol Violation|1|||
161914861|NCT01649765|584737305|FG001|Overall Study|Protocol Violation|0|||
161914862|NCT01649765|584737304|FG000|Overall Study|Withdrawal by Subject|2|||
161914863|NCT01649765|584737305|FG001|Overall Study|Withdrawal by Subject|1|||
161914864|NCT02469233|584737306|FG000|Overall Study|Death|1|||
161914865|NCT02469233|584737307|FG001|Overall Study|Death|1|||
161914866|NCT02469233|584737306|FG000|Overall Study|Lost to post or 6 month follow up|7|||
161914867|NCT02469233|584737307|FG001|Overall Study|Lost to post or 6 month follow up|2|||
161914868|NCT04889040|584737308|FG000|Overall Study|Withdrawal by Subject|3|||
161914869|NCT04889040|584737309|FG001|Overall Study|Withdrawal by Subject|3|||
161914870|NCT04889040|584737308|FG000|Overall Study|Lost to Follow-up|0|||
161914871|NCT04889040|584737309|FG001|Overall Study|Lost to Follow-up|1|||
161914872|NCT04889040|584737308|FG000|Overall Study|Adverse Event|2|||
161914873|NCT04889040|584737309|FG001|Overall Study|Adverse Event|1|||
161914874|NCT00855582|584737314|FG000|Overall Study|Adverse Event|2|||
161914875|NCT00855582|584737315|FG001|Overall Study|Adverse Event|6|||
161914876|NCT00855582|584737316|FG002|Overall Study|Adverse Event|3|||
161914877|NCT00855582|584737314|FG000|Overall Study|Death|1|||
161914878|NCT00855582|584737315|FG001|Overall Study|Death|0|||
161914879|NCT00855582|584737316|FG002|Overall Study|Death|0|||
161914880|NCT00855582|584737314|FG000|Overall Study|Lack of Efficacy|1|||
161914881|NCT00855582|584737315|FG001|Overall Study|Lack of Efficacy|3|||
161914882|NCT00855582|584737316|FG002|Overall Study|Lack of Efficacy|8|||
161914883|NCT00855582|584737314|FG000|Overall Study|Lost to Follow-up|1|||
161914884|NCT00855582|584737315|FG001|Overall Study|Lost to Follow-up|3|||
161914885|NCT00855582|584737316|FG002|Overall Study|Lost to Follow-up|1|||
161914886|NCT00855582|584737314|FG000|Overall Study|Physician Decision|0|||
161914887|NCT00855582|584737315|FG001|Overall Study|Physician Decision|0|||
161914888|NCT00855582|584737316|FG002|Overall Study|Physician Decision|1|||
161914889|NCT00855582|584737314|FG000|Overall Study|Protocol Violation|6|||
161810525|NCT00934050|584349447|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
161914890|NCT00855582|584737315|FG001|Overall Study|Protocol Violation|2|||
161914891|NCT00855582|584737316|FG002|Overall Study|Protocol Violation|6|||
162153267|NCT04043455|585612667|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
162153268|NCT04043455|585612668|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
162153269|NCT04043455|585612663|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
162153270|NCT04043455|585612664|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
162153271|NCT04043455|585612665|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
162153272|NCT04043455|585612666|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
162153273|NCT04043455|585612667|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
162153274|NCT04043455|585612668|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
162153275|NCT04043455|585612663|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
162153276|NCT04043455|585612664|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
162153277|NCT04043455|585612665|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
162153278|NCT04043455|585612666|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
162153279|NCT04043455|585612667|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
162153280|NCT04043455|585612668|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
162153281|NCT04043455|585612663|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
162153282|NCT04043455|585612664|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
162153283|NCT04043455|585612665|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
162153284|NCT04043455|585612666|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
162153285|NCT04043455|585612667|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
162153286|NCT04043455|585612668|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
162153287|NCT04043455|585612663|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
162153288|NCT04043455|585612664|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
162153289|NCT04043455|585612665|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
162153290|NCT04043455|585612666|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
162153291|NCT04043455|585612667|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
162153292|NCT04043455|585612668|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
162153293|NCT04043455|585612663|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
162153294|NCT04043455|585612664|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
162153295|NCT04043455|585612665|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
162153296|NCT04043455|585612666|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
162153297|NCT04043455|585612667|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
162153298|NCT04043455|585612668|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
162153299|NCT04043455|585612663|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
162153300|NCT04043455|585612664|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
162153301|NCT04043455|585612665|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
162153302|NCT04043455|585612666|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
162153303|NCT04043455|585612667|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
162153304|NCT04043455|585612668|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
162153305|NCT03422276|585612669|FG000|Overall Study|Withdrawal by Subject|21|||
162153306|NCT03422276|585612670|FG001|Overall Study|Withdrawal by Subject|25|||
162153307|NCT03422276|585612671|FG002|Overall Study|Withdrawal by Subject|14|||
162153308|NCT03422276|585612672|FG003|Overall Study|Withdrawal by Subject|16|||
162153309|NCT03422276|585612669|FG000|Overall Study|Death|14|||
162153310|NCT03422276|585612670|FG001|Overall Study|Death|21|||
162153311|NCT03422276|585612671|FG002|Overall Study|Death|3|||
162153312|NCT03422276|585612672|FG003|Overall Study|Death|1|||
162153313|NCT03422276|585612669|FG000|Overall Study|Discontinued, ineligible|4|||
162153314|NCT03422276|585612670|FG001|Overall Study|Discontinued, ineligible|3|||
162153315|NCT03422276|585612671|FG002|Overall Study|Discontinued, ineligible|0|||
162153316|NCT03422276|585612672|FG003|Overall Study|Discontinued, ineligible|0|||
162153317|NCT03422276|585612669|FG000|Overall Study|Lost to Follow-up|15|||
162153318|NCT03422276|585612670|FG001|Overall Study|Lost to Follow-up|8|||
162153319|NCT03422276|585612671|FG002|Overall Study|Lost to Follow-up|13|||
162153320|NCT03422276|585612672|FG003|Overall Study|Lost to Follow-up|4|||
162153321|NCT03422276|585612669|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
162153322|NCT03422276|585612670|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
162153323|NCT03422276|585612671|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
162153324|NCT03422276|585612672|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
162153325|NCT03422276|585612669|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
161810526|NCT00934050|584349448|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161810527|NCT00934050|584349449|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161810528|NCT00934050|584349450|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161810529|NCT00934050|584349445|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
161810530|NCT00934050|584349446|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
161810531|NCT00934050|584349447|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
162153326|NCT03422276|585612670|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
162153327|NCT03422276|585612671|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
162153328|NCT03422276|585612672|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
162153329|NCT03422276|585612669|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
162153330|NCT03422276|585612670|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
162153331|NCT03422276|585612671|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
162153332|NCT03422276|585612672|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
162153333|NCT03422276|585612669|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
162153334|NCT03422276|585612670|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
162153335|NCT03422276|585612671|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
162153336|NCT03422276|585612672|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
162153337|NCT03422276|585612669|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
162153338|NCT03422276|585612670|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
162153339|NCT03422276|585612671|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
162153340|NCT03422276|585612672|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
162153341|NCT05194917|585612673|FG000|Overall Study|Lost to Follow-up|7|||
162153342|NCT05194917|585612674|FG001|Overall Study|Lost to Follow-up|5|||
162153343|NCT05194917|585612675|FG002|Overall Study|Lost to Follow-up|6|||
162153344|NCT05194917|585612676|FG003|Overall Study|Lost to Follow-up|5|||
162153345|NCT04922021|585612677|FG000|Overall Study|Withdrawal by Subject|4|||
162153346|NCT04922021|585612678|FG001|Overall Study|Withdrawal by Subject|10|||
162153347|NCT04922021|585612677|FG000|Overall Study|Adverse Event|2|||
162153348|NCT04922021|585612678|FG001|Overall Study|Adverse Event|2|||
162153349|NCT04922021|585612677|FG000|Overall Study|Lack of Efficacy|0|||
162153350|NCT04922021|585612678|FG001|Overall Study|Lack of Efficacy|1|||
162153351|NCT04922021|585612677|FG000|Overall Study|Multiple reasons|1|||
162153352|NCT04922021|585612678|FG001|Overall Study|Multiple reasons|0|||
162153353|NCT04941287|585612688|FG000|Overall Study|Rapid decline before starting treatment|3|||
162153354|NCT04941287|585612689|FG001|Overall Study|Rapid decline before starting treatment|1|||
162153355|NCT01998984|585612694|FG000|Overall Study|Adverse Event|0|||
162153356|NCT01998984|585612695|FG001|Overall Study|Adverse Event|0|||
162153357|NCT01998984|585612696|FG002|Overall Study|Adverse Event|0|||
162153358|NCT01998984|585612697|FG003|Overall Study|Adverse Event|1|||
162153359|NCT01998984|585612694|FG000|Overall Study|Lost to Follow-up|0|||
162153360|NCT01998984|585612695|FG001|Overall Study|Lost to Follow-up|1|||
162153361|NCT01998984|585612696|FG002|Overall Study|Lost to Follow-up|0|||
162153362|NCT01998984|585612697|FG003|Overall Study|Lost to Follow-up|1|||
162153363|NCT01998984|585612694|FG000|Overall Study|Withdrawal by Subject|0|||
162153364|NCT01998984|585612695|FG001|Overall Study|Withdrawal by Subject|0|||
162153365|NCT01998984|585612696|FG002|Overall Study|Withdrawal by Subject|1|||
162153366|NCT01998984|585612697|FG003|Overall Study|Withdrawal by Subject|0|||
162153367|NCT01998984|585612694|FG000|Overall Study|Other|0|||
162153368|NCT01998984|585612695|FG001|Overall Study|Other|0|||
162153369|NCT01998984|585612696|FG002|Overall Study|Other|0|||
162153370|NCT01998984|585612697|FG003|Overall Study|Other|1|||
162153371|NCT02652260|585612698|FG000|Base Study|Pregnancy|0|||
162153372|NCT02652260|585612699|FG001|Base Study|Pregnancy|1|||
162153373|NCT02652260|585612698|FG000|Base Study|Withdrawal by Subject|0|||
162153374|NCT02652260|585612699|FG001|Base Study|Withdrawal by Subject|1|||
162153375|NCT02652260|585612698|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
162153376|NCT02652260|585612699|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
162153377|NCT02652260|585612698|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
162153378|NCT02652260|585612699|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
162153379|NCT02652260|585612698|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
162153380|NCT02652260|585612699|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
162153381|NCT02652260|585612698|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
162153382|NCT02652260|585612699|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
162153383|NCT02652260|585612698|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
162153384|NCT02652260|585612699|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
162153385|NCT02652260|585612698|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
162153386|NCT02652260|585612699|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
162153387|NCT02652260|585612698|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
162153388|NCT02652260|585612699|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
162153389|NCT02652260|585612698|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
162153390|NCT02652260|585612699|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
162153391|NCT02652260|585612698|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
162153392|NCT02652260|585612699|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
162153393|NCT02652260|585612698|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
162153394|NCT02652260|585612699|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
162153395|NCT02652260|585612698|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
162153396|NCT02652260|585612699|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
162153397|NCT02652260|585612698|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
162153398|NCT02652260|585612699|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
162153399|NCT04300647|585612700|FG000|Pre-Crossover|Death|19|||
162153400|NCT04300647|585612701|FG001|Pre-Crossover|Death|58|||
162153401|NCT04300647|585612702|FG002|Pre-Crossover|Death|0|||
162153402|NCT04300647|585612700|FG000|Pre-Crossover|Lost to Follow-up|0|||
162153403|NCT04300647|585612701|FG001|Pre-Crossover|Lost to Follow-up|3|||
162153404|NCT04300647|585612702|FG002|Pre-Crossover|Lost to Follow-up|0|||
162153405|NCT04300647|585612700|FG000|Pre-Crossover|Withdrawal by Subject|2|||
162153406|NCT04300647|585612701|FG001|Pre-Crossover|Withdrawal by Subject|4|||
162153407|NCT04300647|585612702|FG002|Pre-Crossover|Withdrawal by Subject|0|||
162153408|NCT04300647|585612700|FG000|Pre-Crossover|On-going in Study|24|||
162153409|NCT04300647|585612701|FG001|Pre-Crossover|On-going in Study|61|||
162153410|NCT04300647|585612702|FG002|Pre-Crossover|On-going in Study|0|||
162153411|NCT04300647|585612700|FG000|Post-Crossover|Death|0|||
162153412|NCT04300647|585612701|FG001|Post-Crossover|Death|0|||
161810532|NCT00934050|584349448|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
161810533|NCT00934050|584349449|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
161810534|NCT00934050|584349450|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
162153413|NCT04300647|585612702|FG002|Post-Crossover|Death|3|||
162153414|NCT04300647|585612700|FG000|Post-Crossover|Lost to Follow-up|0|||
162153415|NCT04300647|585612701|FG001|Post-Crossover|Lost to Follow-up|0|||
162153416|NCT04300647|585612702|FG002|Post-Crossover|Lost to Follow-up|1|||
162153417|NCT04300647|585612700|FG000|Post-Crossover|Withdrawal by Subject|0|||
162153418|NCT04300647|585612701|FG001|Post-Crossover|Withdrawal by Subject|0|||
162153419|NCT04300647|585612702|FG002|Post-Crossover|Withdrawal by Subject|1|||
162153420|NCT04300647|585612700|FG000|Post-Crossover|On-going in Study|0|||
162153421|NCT04300647|585612701|FG001|Post-Crossover|On-going in Study|0|||
162153422|NCT04300647|585612702|FG002|Post-Crossover|On-going in Study|8|||
162153423|NCT05056246|585612703|FG000|Overall Study|Adverse Event|0|||
162153424|NCT05056246|585612704|FG001|Overall Study|Adverse Event|0|||
162153425|NCT05056246|585612705|FG002|Overall Study|Adverse Event|0|||
162153426|NCT05056246|585612706|FG003|Overall Study|Adverse Event|0|||
162153427|NCT05056246|585612707|FG004|Overall Study|Adverse Event|1|||
162153428|NCT05056246|585612703|FG000|Overall Study|Lost to Follow-up|0|||
162153429|NCT05056246|585612704|FG001|Overall Study|Lost to Follow-up|0|||
162153430|NCT05056246|585612705|FG002|Overall Study|Lost to Follow-up|0|||
162153431|NCT05056246|585612706|FG003|Overall Study|Lost to Follow-up|2|||
162153432|NCT05056246|585612707|FG004|Overall Study|Lost to Follow-up|0|||
162153433|NCT05056246|585612703|FG000|Overall Study|Withdrawal by Subject|0|||
162153434|NCT05056246|585612704|FG001|Overall Study|Withdrawal by Subject|1|||
162153435|NCT05056246|585612705|FG002|Overall Study|Withdrawal by Subject|0|||
162153436|NCT05056246|585612706|FG003|Overall Study|Withdrawal by Subject|0|||
162153437|NCT05056246|585612707|FG004|Overall Study|Withdrawal by Subject|0|||
162153438|NCT05386238|585612708|FG000|Overall Study|Lost to Follow-up|3|||
162153439|NCT05386238|585612709|FG001|Overall Study|Lost to Follow-up|2|||
162153440|NCT05386238|585612708|FG000|Overall Study|Withdrawal by Subject|0|||
162153441|NCT05386238|585612709|FG001|Overall Study|Withdrawal by Subject|1|||
162153442|NCT04907474|585612710|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
162153443|NCT04907474|585612711|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
162153444|NCT01353313|585612714|FG000|Overall Study|Lost to Follow-up|22|||
162153445|NCT01353313|585612715|FG001|Overall Study|Lost to Follow-up|23|||
162153446|NCT01353313|585612714|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
162153447|NCT01353313|585612715|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
162153448|NCT01631214|585612719|FG000|Overall Study|Withdrawal by Subject|276|||
162153449|NCT01631214|585612720|FG001|Overall Study|Withdrawal by Subject|290|||
162153450|NCT01631214|585612719|FG000|Overall Study|Death|113|||
162153451|NCT01631214|585612720|FG001|Overall Study|Death|106|||
162153452|NCT01631214|585612719|FG000|Overall Study|Lost to Follow-up|54|||
162153453|NCT01631214|585612720|FG001|Overall Study|Lost to Follow-up|40|||
162153454|NCT01631214|585612719|FG000|Overall Study|Adverse Event|45|||
162153455|NCT01631214|585612720|FG001|Overall Study|Adverse Event|45|||
162153456|NCT01631214|585612719|FG000|Overall Study|Other|22|||
161810535|NCT00934050|584349445|FG000|Enrolled After 15 Dec 2009|Death|0|||
161810536|NCT00934050|584349446|FG001|Enrolled After 15 Dec 2009|Death|0|||
162153457|NCT01631214|585612720|FG001|Overall Study|Other|19|||
162153458|NCT01631214|585612719|FG000|Overall Study|Noncompliance|16|||
162153459|NCT01631214|585612720|FG001|Overall Study|Noncompliance|15|||
162153460|NCT01631214|585612719|FG000|Overall Study|Requirement for Alternative Therapy|8|||
162153461|NCT01631214|585612720|FG001|Overall Study|Requirement for Alternative Therapy|3|||
162153462|NCT01631214|585612719|FG000|Overall Study|Protocol Deviation|4|||
162153463|NCT01631214|585612720|FG001|Overall Study|Protocol Deviation|3|||
162153464|NCT01631214|585612719|FG000|Overall Study|Ineligibility determined|5|||
162153465|NCT01631214|585612720|FG001|Overall Study|Ineligibility determined|2|||
162153466|NCT01631214|585612719|FG000|Overall Study|Administrative Decision|1|||
162153467|NCT01631214|585612720|FG001|Overall Study|Administrative Decision|0|||
162153468|NCT03575052|585612721|FG000|Overall Study|Adverse Event|6|||
161914892|NCT00855582|584737314|FG000|Overall Study|Entry Criteria Not Met|8|||
161914893|NCT00855582|584737315|FG001|Overall Study|Entry Criteria Not Met|6|||
161914894|NCT00855582|584737316|FG002|Overall Study|Entry Criteria Not Met|3|||
162153469|NCT03575052|585612722|FG001|Overall Study|Adverse Event|10|||
162153470|NCT03575052|585612721|FG000|Overall Study|Not further specified|5|||
162153471|NCT03575052|585612722|FG001|Overall Study|Not further specified|7|||
162153472|NCT03575052|585612721|FG000|Overall Study|Withdrawal by Subject|5|||
162153473|NCT03575052|585612722|FG001|Overall Study|Withdrawal by Subject|6|||
162153474|NCT03575052|585612721|FG000|Overall Study|Lost to Follow-up|3|||
162153475|NCT03575052|585612722|FG001|Overall Study|Lost to Follow-up|0|||
162153476|NCT03575052|585612721|FG000|Overall Study|Death|2|||
162153477|NCT03575052|585612722|FG001|Overall Study|Death|1|||
162153478|NCT03575052|585612721|FG000|Overall Study|Lack of Efficacy|2|||
162153479|NCT03575052|585612722|FG001|Overall Study|Lack of Efficacy|1|||
162153480|NCT03575052|585612721|FG000|Overall Study|Study drug noncompliance|1|||
162153481|NCT03575052|585612722|FG001|Overall Study|Study drug noncompliance|2|||
162153482|NCT03575052|585612721|FG000|Overall Study|Protocol Violation|0|||
162153483|NCT03575052|585612722|FG001|Overall Study|Protocol Violation|2|||
162153484|NCT03575052|585612721|FG000|Overall Study|Physician Decision|1|||
162153485|NCT03575052|585612722|FG001|Overall Study|Physician Decision|0|||
162153486|NCT03624972|585612732|FG000|Overall Study|Lost to Follow-up|2|||
162153487|NCT03624972|585612733|FG001|Overall Study|Lost to Follow-up|0|||
162153488|NCT03624972|585612734|FG002|Overall Study|Lost to Follow-up|0|||
162153489|NCT03624972|585612732|FG000|Overall Study|Withdrawal by Subject|0|||
162153490|NCT03624972|585612733|FG001|Overall Study|Withdrawal by Subject|2|||
162153491|NCT03624972|585612734|FG002|Overall Study|Withdrawal by Subject|0|||
162153492|NCT03112174|585612735|FG000|Overall Study|Withdrawal by Subject|3|||
162153493|NCT03112174|585612736|FG001|Overall Study|Withdrawal by Subject|0|||
162153494|NCT03112174|585612737|FG002|Overall Study|Withdrawal by Subject|11|||
162153495|NCT03112174|585612738|FG003|Overall Study|Withdrawal by Subject|9|||
162153496|NCT03112174|585612739|FG004|Overall Study|Withdrawal by Subject|7|||
162153497|NCT03112174|585612735|FG000|Overall Study|Lost to Follow-up|1|||
162153498|NCT03112174|585612736|FG001|Overall Study|Lost to Follow-up|1|||
162153499|NCT03112174|585612737|FG002|Overall Study|Lost to Follow-up|2|||
162153500|NCT03112174|585612738|FG003|Overall Study|Lost to Follow-up|3|||
162153501|NCT03112174|585612739|FG004|Overall Study|Lost to Follow-up|2|||
162153502|NCT03112174|585612735|FG000|Overall Study|Death|8|||
162153503|NCT03112174|585612736|FG001|Overall Study|Death|3|||
162153504|NCT03112174|585612737|FG002|Overall Study|Death|67|||
162153505|NCT03112174|585612738|FG003|Overall Study|Death|73|||
162153506|NCT03112174|585612739|FG004|Overall Study|Death|18|||
162153507|NCT03112174|585612735|FG000|Overall Study|Other, Not Specified|1|||
162153508|NCT03112174|585612736|FG001|Overall Study|Other, Not Specified|0|||
162153509|NCT03112174|585612737|FG002|Overall Study|Other, Not Specified|1|||
162153510|NCT03112174|585612738|FG003|Overall Study|Other, Not Specified|2|||
162153511|NCT03112174|585612739|FG004|Overall Study|Other, Not Specified|0|||
162153512|NCT04425629|585612740|FG000|Overall Study|Adverse Event|0|||
162153513|NCT04425629|585612741|FG001|Overall Study|Adverse Event|0|||
162153514|NCT04425629|585612742|FG002|Overall Study|Adverse Event|0|||
162153515|NCT04425629|585612743|FG003|Overall Study|Adverse Event|0|||
162153516|NCT04425629|585612744|FG004|Overall Study|Adverse Event|1|||
162153517|NCT04425629|585612745|FG005|Overall Study|Adverse Event|0|||
162153518|NCT04425629|585612746|FG006|Overall Study|Adverse Event|0|||
162153519|NCT04425629|585612747|FG007|Overall Study|Adverse Event|0|||
162153520|NCT04425629|585612748|FG008|Overall Study|Adverse Event|0|||
162153521|NCT04425629|585612749|FG009|Overall Study|Adverse Event|3|||
162153522|NCT04425629|585612750|FG010|Overall Study|Adverse Event|2|||
162153523|NCT04425629|585612751|FG011|Overall Study|Adverse Event|1|||
162153524|NCT04425629|585612752|FG012|Overall Study|Adverse Event|1|||
162153525|NCT04425629|585612753|FG013|Overall Study|Adverse Event|0|||
162153526|NCT04425629|585612754|FG014|Overall Study|Adverse Event|0|||
162153527|NCT04425629|585612755|FG015|Overall Study|Adverse Event|0|||
162153528|NCT04425629|585612756|FG016|Overall Study|Adverse Event|0|||
162153529|NCT04425629|585612757|FG017|Overall Study|Adverse Event|0|||
162153530|NCT04425629|585612758|FG018|Overall Study|Adverse Event|0|||
162153531|NCT04425629|585612740|FG000|Overall Study|Lost to Follow-up|1|||
162153532|NCT04425629|585612741|FG001|Overall Study|Lost to Follow-up|3|||
162153533|NCT04425629|585612742|FG002|Overall Study|Lost to Follow-up|1|||
162153534|NCT04425629|585612743|FG003|Overall Study|Lost to Follow-up|7|||
162153535|NCT04425629|585612744|FG004|Overall Study|Lost to Follow-up|1|||
162153536|NCT04425629|585612745|FG005|Overall Study|Lost to Follow-up|2|||
162153537|NCT04425629|585612746|FG006|Overall Study|Lost to Follow-up|1|||
162153538|NCT04425629|585612747|FG007|Overall Study|Lost to Follow-up|0|||
162153539|NCT04425629|585612748|FG008|Overall Study|Lost to Follow-up|1|||
162153540|NCT04425629|585612749|FG009|Overall Study|Lost to Follow-up|64|||
162153541|NCT04425629|585612750|FG010|Overall Study|Lost to Follow-up|70|||
162153542|NCT04425629|585612751|FG011|Overall Study|Lost to Follow-up|98|||
162153543|NCT04425629|585612752|FG012|Overall Study|Lost to Follow-up|30|||
162153544|NCT04425629|585612753|FG013|Overall Study|Lost to Follow-up|0|||
162153545|NCT04425629|585612754|FG014|Overall Study|Lost to Follow-up|5|||
162153546|NCT04425629|585612755|FG015|Overall Study|Lost to Follow-up|4|||
162153547|NCT04425629|585612756|FG016|Overall Study|Lost to Follow-up|0|||
162153548|NCT04425629|585612757|FG017|Overall Study|Lost to Follow-up|3|||
162153549|NCT04425629|585612758|FG018|Overall Study|Lost to Follow-up|1|||
162153550|NCT04425629|585612740|FG000|Overall Study|Subject Decision|0|||
162153551|NCT04425629|585612741|FG001|Overall Study|Subject Decision|2|||
162153552|NCT04425629|585612742|FG002|Overall Study|Subject Decision|1|||
162153553|NCT04425629|585612743|FG003|Overall Study|Subject Decision|3|||
162153554|NCT04425629|585612744|FG004|Overall Study|Subject Decision|6|||
162153555|NCT04425629|585612745|FG005|Overall Study|Subject Decision|6|||
162153556|NCT04425629|585612746|FG006|Overall Study|Subject Decision|3|||
162153557|NCT04425629|585612747|FG007|Overall Study|Subject Decision|3|||
162153558|NCT04425629|585612748|FG008|Overall Study|Subject Decision|1|||
162153559|NCT04425629|585612749|FG009|Overall Study|Subject Decision|70|||
162153560|NCT04425629|585612750|FG010|Overall Study|Subject Decision|95|||
162153561|NCT04425629|585612751|FG011|Overall Study|Subject Decision|124|||
162153562|NCT04425629|585612752|FG012|Overall Study|Subject Decision|25|||
162153563|NCT04425629|585612753|FG013|Overall Study|Subject Decision|0|||
162153564|NCT04425629|585612754|FG014|Overall Study|Subject Decision|1|||
162153565|NCT04425629|585612755|FG015|Overall Study|Subject Decision|4|||
162153566|NCT04425629|585612756|FG016|Overall Study|Subject Decision|1|||
162153567|NCT04425629|585612757|FG017|Overall Study|Subject Decision|0|||
162153568|NCT04425629|585612758|FG018|Overall Study|Subject Decision|2|||
162153569|NCT04425629|585612740|FG000|Overall Study|Death|0|||
162153570|NCT04425629|585612741|FG001|Overall Study|Death|0|||
162153571|NCT04425629|585612742|FG002|Overall Study|Death|0|||
162153572|NCT04425629|585612743|FG003|Overall Study|Death|0|||
162153573|NCT04425629|585612744|FG004|Overall Study|Death|0|||
162153574|NCT04425629|585612745|FG005|Overall Study|Death|0|||
162153575|NCT04425629|585612746|FG006|Overall Study|Death|0|||
162153576|NCT04425629|585612747|FG007|Overall Study|Death|0|||
162153577|NCT04425629|585612748|FG008|Overall Study|Death|0|||
162153578|NCT04425629|585612749|FG009|Overall Study|Death|11|||
162153579|NCT04425629|585612750|FG010|Overall Study|Death|2|||
162153580|NCT04425629|585612751|FG011|Overall Study|Death|4|||
162153581|NCT04425629|585612752|FG012|Overall Study|Death|0|||
162153582|NCT04425629|585612753|FG013|Overall Study|Death|0|||
162153583|NCT04425629|585612754|FG014|Overall Study|Death|0|||
162153584|NCT04425629|585612755|FG015|Overall Study|Death|0|||
162153585|NCT04425629|585612756|FG016|Overall Study|Death|0|||
162153586|NCT04425629|585612757|FG017|Overall Study|Death|0|||
162153587|NCT04425629|585612758|FG018|Overall Study|Death|0|||
162153588|NCT04425629|585612740|FG000|Overall Study|Sponsor Request|0|||
162153589|NCT04425629|585612741|FG001|Overall Study|Sponsor Request|0|||
162153590|NCT04425629|585612742|FG002|Overall Study|Sponsor Request|0|||
162153591|NCT04425629|585612743|FG003|Overall Study|Sponsor Request|2|||
162153592|NCT04425629|585612744|FG004|Overall Study|Sponsor Request|2|||
162153593|NCT04425629|585612745|FG005|Overall Study|Sponsor Request|2|||
162153594|NCT04425629|585612746|FG006|Overall Study|Sponsor Request|1|||
162153595|NCT04425629|585612747|FG007|Overall Study|Sponsor Request|0|||
162153596|NCT04425629|585612748|FG008|Overall Study|Sponsor Request|0|||
162153597|NCT04425629|585612749|FG009|Overall Study|Sponsor Request|9|||
162153598|NCT04425629|585612750|FG010|Overall Study|Sponsor Request|9|||
162153599|NCT04425629|585612751|FG011|Overall Study|Sponsor Request|10|||
162153600|NCT04425629|585612752|FG012|Overall Study|Sponsor Request|8|||
162153601|NCT04425629|585612753|FG013|Overall Study|Sponsor Request|0|||
162153602|NCT04425629|585612754|FG014|Overall Study|Sponsor Request|0|||
162153603|NCT04425629|585612755|FG015|Overall Study|Sponsor Request|1|||
162153604|NCT04425629|585612756|FG016|Overall Study|Sponsor Request|0|||
162153605|NCT04425629|585612757|FG017|Overall Study|Sponsor Request|0|||
162153606|NCT04425629|585612758|FG018|Overall Study|Sponsor Request|0|||
162153607|NCT04425629|585612740|FG000|Overall Study|Physician Decision|0|||
162153608|NCT04425629|585612741|FG001|Overall Study|Physician Decision|0|||
162153609|NCT04425629|585612742|FG002|Overall Study|Physician Decision|0|||
162153610|NCT04425629|585612743|FG003|Overall Study|Physician Decision|0|||
162153611|NCT04425629|585612744|FG004|Overall Study|Physician Decision|0|||
162153612|NCT04425629|585612745|FG005|Overall Study|Physician Decision|0|||
162153613|NCT04425629|585612746|FG006|Overall Study|Physician Decision|0|||
162153614|NCT04425629|585612747|FG007|Overall Study|Physician Decision|0|||
162153615|NCT04425629|585612748|FG008|Overall Study|Physician Decision|0|||
162153616|NCT04425629|585612749|FG009|Overall Study|Physician Decision|4|||
162153617|NCT04425629|585612750|FG010|Overall Study|Physician Decision|3|||
162153618|NCT04425629|585612751|FG011|Overall Study|Physician Decision|5|||
162153619|NCT04425629|585612752|FG012|Overall Study|Physician Decision|1|||
162153620|NCT04425629|585612753|FG013|Overall Study|Physician Decision|0|||
162153621|NCT04425629|585612754|FG014|Overall Study|Physician Decision|0|||
162153622|NCT04425629|585612755|FG015|Overall Study|Physician Decision|1|||
162153623|NCT04425629|585612756|FG016|Overall Study|Physician Decision|0|||
162153624|NCT04425629|585612757|FG017|Overall Study|Physician Decision|0|||
162153625|NCT04425629|585612758|FG018|Overall Study|Physician Decision|0|||
162153626|NCT04425629|585612740|FG000|Overall Study|Lack of Efficacy|0|||
162153627|NCT04425629|585612741|FG001|Overall Study|Lack of Efficacy|0|||
162153628|NCT04425629|585612742|FG002|Overall Study|Lack of Efficacy|0|||
162153629|NCT04425629|585612743|FG003|Overall Study|Lack of Efficacy|0|||
162153630|NCT04425629|585612744|FG004|Overall Study|Lack of Efficacy|0|||
162153631|NCT04425629|585612745|FG005|Overall Study|Lack of Efficacy|0|||
162153632|NCT04425629|585612746|FG006|Overall Study|Lack of Efficacy|0|||
162153633|NCT04425629|585612747|FG007|Overall Study|Lack of Efficacy|0|||
162153634|NCT04425629|585612748|FG008|Overall Study|Lack of Efficacy|0|||
162153635|NCT04425629|585612749|FG009|Overall Study|Lack of Efficacy|0|||
162153636|NCT04425629|585612750|FG010|Overall Study|Lack of Efficacy|1|||
162153637|NCT04425629|585612751|FG011|Overall Study|Lack of Efficacy|0|||
162153638|NCT04425629|585612752|FG012|Overall Study|Lack of Efficacy|0|||
162153639|NCT04425629|585612753|FG013|Overall Study|Lack of Efficacy|0|||
162153640|NCT04425629|585612754|FG014|Overall Study|Lack of Efficacy|0|||
162153641|NCT04425629|585612755|FG015|Overall Study|Lack of Efficacy|0|||
162153642|NCT04425629|585612756|FG016|Overall Study|Lack of Efficacy|0|||
162153643|NCT04425629|585612757|FG017|Overall Study|Lack of Efficacy|0|||
162153644|NCT04425629|585612758|FG018|Overall Study|Lack of Efficacy|0|||
162153645|NCT00610649|585612761|FG000|Overall Study|Adverse Event|1|||
162153646|NCT00610649|585612762|FG001|Overall Study|Adverse Event|0|||
162153647|NCT00610649|585612763|FG002|Overall Study|Adverse Event|0|||
162153648|NCT00610649|585612764|FG003|Overall Study|Adverse Event|0|||
162153649|NCT00610649|585612765|FG004|Overall Study|Adverse Event|0|||
162153650|NCT00610649|585612766|FG005|Overall Study|Adverse Event|0|||
162153651|NCT00610649|585612767|FG006|Overall Study|Adverse Event|0|||
162153652|NCT00610649|585612768|FG007|Overall Study|Adverse Event|0|||
162153653|NCT00610649|585612769|FG008|Overall Study|Adverse Event|0|||
162153654|NCT00610649|585612770|FG009|Overall Study|Adverse Event|0|||
162153655|NCT00610649|585612771|FG010|Overall Study|Adverse Event|1|||
162153656|NCT00610649|585612761|FG000|Overall Study|Family Emergency|0|||
162153657|NCT00610649|585612762|FG001|Overall Study|Family Emergency|1|||
162153658|NCT00610649|585612763|FG002|Overall Study|Family Emergency|0|||
162153659|NCT00610649|585612764|FG003|Overall Study|Family Emergency|0|||
162153660|NCT00610649|585612765|FG004|Overall Study|Family Emergency|0|||
162153661|NCT00610649|585612766|FG005|Overall Study|Family Emergency|0|||
162153662|NCT00610649|585612767|FG006|Overall Study|Family Emergency|0|||
162153663|NCT00610649|585612768|FG007|Overall Study|Family Emergency|0|||
162153664|NCT00610649|585612769|FG008|Overall Study|Family Emergency|0|||
162153665|NCT00610649|585612770|FG009|Overall Study|Family Emergency|0|||
162153666|NCT00610649|585612771|FG010|Overall Study|Family Emergency|0|||
162153667|NCT00610649|585612761|FG000|Overall Study|Withdrawal by Subject|0|||
162153668|NCT00610649|585612762|FG001|Overall Study|Withdrawal by Subject|0|||
162153669|NCT00610649|585612763|FG002|Overall Study|Withdrawal by Subject|0|||
162153670|NCT00610649|585612764|FG003|Overall Study|Withdrawal by Subject|0|||
162153671|NCT00610649|585612765|FG004|Overall Study|Withdrawal by Subject|0|||
162153672|NCT00610649|585612766|FG005|Overall Study|Withdrawal by Subject|0|||
162153673|NCT00610649|585612767|FG006|Overall Study|Withdrawal by Subject|0|||
162153674|NCT00610649|585612768|FG007|Overall Study|Withdrawal by Subject|0|||
162153675|NCT00610649|585612769|FG008|Overall Study|Withdrawal by Subject|0|||
162153676|NCT00610649|585612770|FG009|Overall Study|Withdrawal by Subject|1|||
162153677|NCT00610649|585612771|FG010|Overall Study|Withdrawal by Subject|0|||
162153678|NCT04259450|585612775|FG000|Overall Study|Adverse event/ Toxicity|0|||
162153679|NCT04259450|585612776|FG001|Overall Study|Adverse event/ Toxicity|3|||
162153680|NCT04259450|585612777|FG002|Overall Study|Adverse event/ Toxicity|0|||
162153681|NCT04259450|585612778|FG003|Overall Study|Adverse event/ Toxicity|1|||
162153682|NCT04259450|585612779|FG004|Overall Study|Adverse event/ Toxicity|0|||
162153683|NCT04259450|585612780|FG005|Overall Study|Adverse event/ Toxicity|0|||
162153684|NCT04259450|585612781|FG006|Overall Study|Adverse event/ Toxicity|0|||
162153685|NCT04259450|585612782|FG007|Overall Study|Adverse event/ Toxicity|1|||
162153686|NCT04259450|585612783|FG008|Overall Study|Adverse event/ Toxicity|0|||
162153687|NCT04259450|585612784|FG009|Overall Study|Adverse event/ Toxicity|3|||
162153688|NCT04259450|585612775|FG000|Overall Study|Disease progression|2|||
162153689|NCT04259450|585612776|FG001|Overall Study|Disease progression|3|||
162153690|NCT04259450|585612777|FG002|Overall Study|Disease progression|4|||
162153691|NCT04259450|585612778|FG003|Overall Study|Disease progression|4|||
162153692|NCT04259450|585612779|FG004|Overall Study|Disease progression|6|||
162153693|NCT04259450|585612780|FG005|Overall Study|Disease progression|6|||
162153694|NCT04259450|585612781|FG006|Overall Study|Disease progression|6|||
162153695|NCT04259450|585612782|FG007|Overall Study|Disease progression|15|||
162153696|NCT04259450|585612783|FG008|Overall Study|Disease progression|6|||
162153697|NCT04259450|585612784|FG009|Overall Study|Disease progression|18|||
162153698|NCT04259450|585612775|FG000|Overall Study|Death|0|||
162153699|NCT04259450|585612776|FG001|Overall Study|Death|0|||
162153700|NCT04259450|585612777|FG002|Overall Study|Death|0|||
162153701|NCT04259450|585612778|FG003|Overall Study|Death|0|||
162153702|NCT04259450|585612779|FG004|Overall Study|Death|0|||
162153703|NCT04259450|585612780|FG005|Overall Study|Death|0|||
162153704|NCT04259450|585612781|FG006|Overall Study|Death|0|||
162153705|NCT04259450|585612782|FG007|Overall Study|Death|1|||
162153706|NCT04259450|585612783|FG008|Overall Study|Death|1|||
162153707|NCT04259450|585612784|FG009|Overall Study|Death|0|||
162153708|NCT04259450|585612775|FG000|Overall Study|Withdrawal by Subject|0|||
162153709|NCT04259450|585612776|FG001|Overall Study|Withdrawal by Subject|0|||
162153710|NCT04259450|585612777|FG002|Overall Study|Withdrawal by Subject|0|||
162153711|NCT04259450|585612778|FG003|Overall Study|Withdrawal by Subject|0|||
162153712|NCT04259450|585612779|FG004|Overall Study|Withdrawal by Subject|0|||
162153713|NCT04259450|585612780|FG005|Overall Study|Withdrawal by Subject|0|||
162153714|NCT04259450|585612781|FG006|Overall Study|Withdrawal by Subject|0|||
162153715|NCT04259450|585612782|FG007|Overall Study|Withdrawal by Subject|1|||
162153716|NCT04259450|585612783|FG008|Overall Study|Withdrawal by Subject|0|||
162153717|NCT04259450|585612784|FG009|Overall Study|Withdrawal by Subject|0|||
162153718|NCT04259450|585612775|FG000|Overall Study|Other than listed|0|||
162153719|NCT04259450|585612776|FG001|Overall Study|Other than listed|0|||
162153720|NCT04259450|585612777|FG002|Overall Study|Other than listed|0|||
162153721|NCT04259450|585612778|FG003|Overall Study|Other than listed|0|||
162153722|NCT04259450|585612779|FG004|Overall Study|Other than listed|0|||
162153723|NCT04259450|585612780|FG005|Overall Study|Other than listed|0|||
162153724|NCT04259450|585612781|FG006|Overall Study|Other than listed|0|||
161810537|NCT00934050|584349447|FG002|Enrolled After 15 Dec 2009|Death|0|||
161810538|NCT00934050|584349448|FG003|Enrolled After 15 Dec 2009|Death|0|||
162153725|NCT04259450|585612782|FG007|Overall Study|Other than listed|1|||
162153726|NCT04259450|585612783|FG008|Overall Study|Other than listed|1|||
162153727|NCT04259450|585612784|FG009|Overall Study|Other than listed|2|||
162153728|NCT00332241|585612785|FG000|Overall Study|Lack of Efficacy|6|||
162153729|NCT00332241|585612786|FG001|Overall Study|Lack of Efficacy|1|||
162153730|NCT00332241|585612785|FG000|Overall Study|Adverse Event|3|||
162153731|NCT00332241|585612786|FG001|Overall Study|Adverse Event|5|||
162153732|NCT00332241|585612785|FG000|Overall Study|Withdrawal by Subject|2|||
162153733|NCT00332241|585612786|FG001|Overall Study|Withdrawal by Subject|1|||
162153734|NCT00332241|585612785|FG000|Overall Study|Lost to Follow-up|4|||
162153735|NCT00332241|585612786|FG001|Overall Study|Lost to Follow-up|1|||
162153736|NCT00542789|585612794|FG000|Overall Study|Adverse Event|18|||
162153737|NCT00542789|585612795|FG001|Overall Study|Adverse Event|17|||
162153738|NCT00542789|585612794|FG000|Overall Study|Withdrawal by Subject|7|||
162153739|NCT00542789|585612795|FG001|Overall Study|Withdrawal by Subject|3|||
162153740|NCT00542789|585612794|FG000|Overall Study|Protocol Violation|8|||
162153741|NCT00542789|585612795|FG001|Overall Study|Protocol Violation|1|||
162153742|NCT00542789|585612794|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
162153743|NCT00542789|585612795|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
162153744|NCT02584829|585612796|FG000|Overall Study|Physician Decision|1|||
162153745|NCT02584829|585612797|FG001|Overall Study|Physician Decision|0|||
161810539|NCT00934050|584349449|FG004|Enrolled After 15 Dec 2009|Death|0|||
161810540|NCT00934050|584349450|FG005|Enrolled After 15 Dec 2009|Death|1|||
161810541|NCT00934050|584349445|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161810542|NCT00934050|584349446|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161810543|NCT00934050|584349447|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
162012781|NCT02113982|585103855|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
162012782|NCT02113982|585103856|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
162153746|NCT02584829|585612796|FG000|Overall Study|Withdrawal by Subject|0|||
162153747|NCT02584829|585612797|FG001|Overall Study|Withdrawal by Subject|1|||
162153748|NCT02584829|585612796|FG000|Overall Study|Progressive Disease|0|||
162153749|NCT02584829|585612797|FG001|Overall Study|Progressive Disease|3|||
162153750|NCT00106080|585612810|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
162153751|NCT00106080|585612811|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
162153752|NCT01839331|585612812|FG000|Overall Study|Early Termination|3|||
162153753|NCT01839331|585612813|FG001|Overall Study|Early Termination|0|||
162153754|NCT01839331|585612814|FG002|Overall Study|Early Termination|1|||
162153755|NCT01839331|585612815|FG003|Overall Study|Early Termination|2|||
162153756|NCT01839331|585612812|FG000|Overall Study|Protocol Violation|1|||
162153757|NCT01839331|585612813|FG001|Overall Study|Protocol Violation|6|||
162153758|NCT01839331|585612814|FG002|Overall Study|Protocol Violation|4|||
162153759|NCT01839331|585612815|FG003|Overall Study|Protocol Violation|3|||
162153760|NCT00761605|585612816|FG000|Overall Study|Adverse Event|26|||
162153761|NCT00761605|585612816|FG000|Overall Study|Death|2|||
162153762|NCT00761605|585612816|FG000|Overall Study|Lack of Efficacy|26|||
162153763|NCT00761605|585612816|FG000|Overall Study|Lost to Follow-up|29|||
162153764|NCT00761605|585612816|FG000|Overall Study|Withdrawal by Subject|37|||
162153765|NCT00761605|585612816|FG000|Overall Study|Other|21|||
162153766|NCT03074331|585612817|FG000|Overall Study|Enrolled but Not Treated|1|||
162153767|NCT03074331|585612817|FG000|Overall Study|Lost to Follow-up|5|||
162153768|NCT03074331|585612817|FG000|Overall Study|Withdrew Consent|1|||
162153769|NCT00350792|585612819|FG000|Overall Study|Adverse Event|11|||
162153770|NCT00350792|585612819|FG000|Overall Study|Death from Study Disease|1|||
162153771|NCT00350792|585612819|FG000|Overall Study|Death from Study Drug Toxicity|1|||
162153772|NCT00350792|585612819|FG000|Overall Study|Death Not Study Drug Related|2|||
162153773|NCT00350792|585612819|FG000|Overall Study|Protocol Violation|1|||
162153774|NCT00350792|585612819|FG000|Overall Study|Withdrawal by Subject|4|||
162153775|NCT00350792|585612819|FG000|Overall Study|Physician Decision|2|||
162153776|NCT00350792|585612819|FG000|Overall Study|Lack of Efficacy|11|||
162153777|NCT03283371|585612820|FG000|Placebo-controlled|Adverse Event|1|||
162153778|NCT03283371|585612821|FG001|Placebo-controlled|Adverse Event|1|||
162012783|NCT02113982|585103857|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
162012784|NCT02113982|585103858|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
162012785|NCT02113982|585103859|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
162012786|NCT02113982|585103860|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
162012787|NCT02113982|585103847|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
162012788|NCT02113982|585103848|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
162012789|NCT02113982|585103849|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
162012790|NCT02113982|585103850|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
162012791|NCT02113982|585103851|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
162012792|NCT02113982|585103852|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
162153779|NCT03283371|585612822|FG002|Placebo-controlled|Adverse Event|0|||
161810544|NCT00934050|584349448|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
162012793|NCT02113982|585103853|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
162012794|NCT02113982|585103854|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
162012795|NCT02113982|585103855|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
162012796|NCT02113982|585103856|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
162012797|NCT02113982|585103857|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
162153780|NCT03283371|585612823|FG003|Placebo-controlled|Adverse Event|0|||
162153781|NCT03283371|585612820|FG000|Placebo-controlled|Lack of Efficacy|1|||
162153782|NCT03283371|585612821|FG001|Placebo-controlled|Lack of Efficacy|0|||
162153783|NCT03283371|585612822|FG002|Placebo-controlled|Lack of Efficacy|0|||
162153784|NCT03283371|585612823|FG003|Placebo-controlled|Lack of Efficacy|0|||
162153785|NCT03283371|585612820|FG000|Placebo-controlled|Withdrawal by Subject|1|||
162153786|NCT03283371|585612821|FG001|Placebo-controlled|Withdrawal by Subject|1|||
162153787|NCT03283371|585612822|FG002|Placebo-controlled|Withdrawal by Subject|0|||
162153788|NCT03283371|585612823|FG003|Placebo-controlled|Withdrawal by Subject|0|||
162153789|NCT03283371|585612820|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
162153790|NCT03283371|585612821|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
162153791|NCT03283371|585612822|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
162153792|NCT03283371|585612823|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
162153793|NCT03283371|585612820|FG000|Open-label Phase|Adverse Event|0|||
162153794|NCT03283371|585612821|FG001|Open-label Phase|Adverse Event|0|||
162153795|NCT03283371|585612822|FG002|Open-label Phase|Adverse Event|2|||
162153796|NCT03283371|585612823|FG003|Open-label Phase|Adverse Event|0|||
162153797|NCT03283371|585612820|FG000|Open-label Phase|Withdrawal by Subject|0|||
162153798|NCT03283371|585612821|FG001|Open-label Phase|Withdrawal by Subject|0|||
162153799|NCT03283371|585612822|FG002|Open-label Phase|Withdrawal by Subject|1|||
162153800|NCT03283371|585612823|FG003|Open-label Phase|Withdrawal by Subject|0|||
162153801|NCT03283371|585612820|FG000|Open-label Phase|Other|0|||
162153802|NCT03283371|585612821|FG001|Open-label Phase|Other|0|||
162153803|NCT03283371|585612822|FG002|Open-label Phase|Other|1|||
162153804|NCT03283371|585612823|FG003|Open-label Phase|Other|1|||
162153805|NCT01290341|585612824|FG000|Overall Study|Protocol Violation|7|||
162153806|NCT01290341|585612825|FG001|Overall Study|Protocol Violation|3|||
162153807|NCT01290341|585612824|FG000|Overall Study|Adverse Event|1|||
162153808|NCT01290341|585612825|FG001|Overall Study|Adverse Event|0|||
162153809|NCT01290341|585612824|FG000|Overall Study|Lost to Follow-up|21|||
162153810|NCT01290341|585612825|FG001|Overall Study|Lost to Follow-up|10|||
162153811|NCT01290341|585612824|FG000|Overall Study|Withdrawal by Subject|19|||
162153812|NCT01290341|585612825|FG001|Overall Study|Withdrawal by Subject|5|||
162153813|NCT01290341|585612824|FG000|Overall Study|Negative baseline culture and others|44|||
162153814|NCT01290341|585612825|FG001|Overall Study|Negative baseline culture and others|11|||
162153815|NCT01943799|585612833|FG000|Overall Study|Lost to Follow-up|0|||
162153816|NCT01943799|585612834|FG001|Overall Study|Lost to Follow-up|1|||
162153817|NCT01943799|585612835|FG002|Overall Study|Lost to Follow-up|1|||
162153818|NCT01943799|585612836|FG003|Overall Study|Lost to Follow-up|0|||
162153819|NCT01943799|585612833|FG000|Overall Study|Protocol Violation|1|||
162153820|NCT01943799|585612834|FG001|Overall Study|Protocol Violation|0|||
162153821|NCT01943799|585612835|FG002|Overall Study|Protocol Violation|0|||
162153822|NCT01943799|585612836|FG003|Overall Study|Protocol Violation|0|||
162153823|NCT01943799|585612833|FG000|Overall Study|Withdrawal by Subject|4|||
162153824|NCT01943799|585612834|FG001|Overall Study|Withdrawal by Subject|2|||
162153825|NCT01943799|585612835|FG002|Overall Study|Withdrawal by Subject|1|||
162153826|NCT01943799|585612836|FG003|Overall Study|Withdrawal by Subject|0|||
162153827|NCT04594759|585612837|FG000|Overall Study|Lost to Follow-up|3|||
162153828|NCT03485950|585612840|FG000|Overall Study|Adverse Event|1|||
162153829|NCT03485950|585612841|FG001|Overall Study|Adverse Event|0|||
162153830|NCT03485950|585612840|FG000|Overall Study|Death|3|||
162153831|NCT03485950|585612841|FG001|Overall Study|Death|2|||
162153832|NCT03485950|585612840|FG000|Overall Study|Withdrawal by Subject|3|||
162153833|NCT03485950|585612841|FG001|Overall Study|Withdrawal by Subject|0|||
162153834|NCT04556981|585612843|FG000|Overall Study|Death|0|||
162153835|NCT04556981|585612844|FG001|Overall Study|Death|1|||
162153836|NCT04556981|585612843|FG000|Overall Study|Lost to Follow-up|2|||
162153837|NCT04556981|585612844|FG001|Overall Study|Lost to Follow-up|11|||
162153838|NCT04556981|585612843|FG000|Overall Study|Moved from the study area|1|||
162153839|NCT04556981|585612844|FG001|Overall Study|Moved from the study area|4|||
162153840|NCT04556981|585612843|FG000|Overall Study|Withdrawal by Subject|2|||
162153841|NCT04556981|585612844|FG001|Overall Study|Withdrawal by Subject|2|||
162153842|NCT04556981|585612843|FG000|Overall Study|Other|2|||
162153843|NCT04556981|585612844|FG001|Overall Study|Other|1|||
162153844|NCT03764475|585612845|FG000|Overall Study|Adverse Event|11|||
162153845|NCT03764475|585612846|FG001|Overall Study|Adverse Event|2|||
162153846|NCT03764475|585612845|FG000|Overall Study|Lost to Follow-up|24|||
161914895|NCT00855582|584737314|FG000|Overall Study|Withdrawal by Subject|7|||
161914896|NCT00855582|584737315|FG001|Overall Study|Withdrawal by Subject|4|||
161914897|NCT00855582|584737316|FG002|Overall Study|Withdrawal by Subject|8|||
161914898|NCT02832037|584737320|FG000|Overall Study|Administrative reasons|0|||
161914899|NCT02832037|584737321|FG001|Overall Study|Administrative reasons|0|||
161914900|NCT02832037|584737322|FG002|Overall Study|Administrative reasons|1|||
161914901|NCT02832037|584737323|FG003|Overall Study|Administrative reasons|0|||
161914902|NCT02832037|584737324|FG004|Overall Study|Administrative reasons|0|||
161914903|NCT02832037|584737320|FG000|Overall Study|Protocol Violation|3|||
161914904|NCT02832037|584737321|FG001|Overall Study|Protocol Violation|0|||
161914905|NCT02832037|584737322|FG002|Overall Study|Protocol Violation|4|||
161914906|NCT02832037|584737323|FG003|Overall Study|Protocol Violation|1|||
161914907|NCT02832037|584737324|FG004|Overall Study|Protocol Violation|2|||
161914908|NCT02832037|584737320|FG000|Overall Study|Lost to Follow-up|2|||
161914909|NCT02832037|584737321|FG001|Overall Study|Lost to Follow-up|0|||
161914910|NCT02832037|584737322|FG002|Overall Study|Lost to Follow-up|3|||
161914911|NCT02832037|584737323|FG003|Overall Study|Lost to Follow-up|0|||
161914912|NCT02832037|584737324|FG004|Overall Study|Lost to Follow-up|5|||
161914913|NCT02832037|584737320|FG000|Overall Study|Withdrawal by Subject|9|||
161914914|NCT02832037|584737321|FG001|Overall Study|Withdrawal by Subject|8|||
161914915|NCT02832037|584737322|FG002|Overall Study|Withdrawal by Subject|0|||
161914916|NCT02832037|584737323|FG003|Overall Study|Withdrawal by Subject|4|||
161914917|NCT02832037|584737324|FG004|Overall Study|Withdrawal by Subject|8|||
161914918|NCT02832037|584737320|FG000|Overall Study|Adverse Event|5|||
161914919|NCT02832037|584737321|FG001|Overall Study|Adverse Event|4|||
161914920|NCT02832037|584737322|FG002|Overall Study|Adverse Event|0|||
161914921|NCT02832037|584737323|FG003|Overall Study|Adverse Event|2|||
161914922|NCT02832037|584737324|FG004|Overall Study|Adverse Event|4|||
161914923|NCT04727749|584737331|FG000|Overall Study|Lost to Follow-up|10|||
161914924|NCT04727749|584737332|FG001|Overall Study|Lost to Follow-up|3|||
161914925|NCT02378181|584737333|FG000|Overall Study|Lost to Follow-up|2|||
161914926|NCT02378181|584737334|FG001|Overall Study|Lost to Follow-up|5|||
161914927|NCT02378181|584737333|FG000|Overall Study|Withdrawal by Subject|1|||
161914928|NCT02378181|584737334|FG001|Overall Study|Withdrawal by Subject|1|||
161914929|NCT02378181|584737333|FG000|Overall Study|Incarcerated|0|||
161914930|NCT02378181|584737334|FG001|Overall Study|Incarcerated|1|||
162012798|NCT02113982|585103858|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
162012799|NCT02113982|585103859|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
161914931|NCT00297167|584737335|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
161914932|NCT00297167|584737336|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
161914933|NCT00297167|584737337|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
161914934|NCT00297167|584737335|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
162012800|NCT02113982|585103860|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
162153847|NCT03764475|585612846|FG001|Overall Study|Lost to Follow-up|10|||
162153848|NCT03764475|585612845|FG000|Overall Study|Withdrawal by Subject|26|||
162153849|NCT03764475|585612846|FG001|Overall Study|Withdrawal by Subject|10|||
162153850|NCT03764475|585612845|FG000|Overall Study|Lack of Efficacy|3|||
162153851|NCT03764475|585612846|FG001|Overall Study|Lack of Efficacy|0|||
162153852|NCT03764475|585612845|FG000|Overall Study|COVID-19 Disruption|2|||
162153853|NCT03764475|585612846|FG001|Overall Study|COVID-19 Disruption|0|||
162153854|NCT00580866|585612847|FG000|Overall Study|Lost to Follow-up|2|||
162153855|NCT00580866|585612848|FG001|Overall Study|Lost to Follow-up|2|||
162153856|NCT02477605|585612852|FG000|Overall Study|Discontinued prior to treatment|1|||
162153857|NCT02477605|585612853|FG001|Overall Study|Discontinued prior to treatment|0|||
162153858|NCT02477605|585612852|FG000|Overall Study|Lost to Follow-up|0|||
162153859|NCT02477605|585612853|FG001|Overall Study|Lost to Follow-up|2|||
161810545|NCT00934050|584349449|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161810546|NCT00934050|584349450|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
161810547|NCT00934050|584349445|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
162153860|NCT02477605|585612852|FG000|Overall Study|Withdrawal by Subject|0|||
162153861|NCT02477605|585612853|FG001|Overall Study|Withdrawal by Subject|1|||
161810548|NCT00934050|584349446|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
161810549|NCT00934050|584349447|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
161914935|NCT00297167|584737336|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
161914936|NCT00297167|584737337|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
161914937|NCT01180777|584737339|FG000|Overall Study|Protocol Violation|6|||
161914938|NCT01180777|584737339|FG000|Overall Study|Poor lens fit|4|||
161914939|NCT01180777|584737339|FG000|Overall Study|Lost to Follow-up|1|||
161914940|NCT01180777|584737339|FG000|Overall Study|Adverse Event|1|||
161914941|NCT04167462|584737340|FG000|Overall Study|Other reasons|3|||
161914942|NCT04167462|584737341|FG001|Overall Study|Other reasons|2|||
161914943|NCT04167462|584737340|FG000|Overall Study|Withdrawal by Subject|6|||
161914944|NCT04167462|584737341|FG001|Overall Study|Withdrawal by Subject|7|||
161914945|NCT04167462|584737340|FG000|Overall Study|Adverse Event|4|||
161914946|NCT04167462|584737341|FG001|Overall Study|Adverse Event|0|||
161914947|NCT04167462|584737340|FG000|Overall Study|Pregnancy|1|||
161914948|NCT04167462|584737341|FG001|Overall Study|Pregnancy|0|||
161914949|NCT04167462|584737340|FG000|Overall Study|Lack of Efficacy|0|||
161914950|NCT04167462|584737341|FG001|Overall Study|Lack of Efficacy|1|||
161914951|NCT02320396|584737342|FG000|Overall Study|Adverse Event|2|||
162153862|NCT02477605|585612852|FG000|Overall Study|Administered gas during surgery|0|||
162153863|NCT02477605|585612853|FG001|Overall Study|Administered gas during surgery|1|||
162153864|NCT00970359|585612855|FG000|Overall Study|Not Treated|4|||
162153865|NCT04200365|585612856|FG000|Overall Study|Adverse Event|2|||
162153866|NCT04200365|585612856|FG000|Overall Study|Progressive Disease|4|||
162153867|NCT04200365|585612856|FG000|Overall Study|Lack of Efficacy|1|||
162153868|NCT04200365|585612856|FG000|Overall Study|Study Closure|4|||
162153869|NCT01499199|585612859|FG000|Overall Study|Adverse Event|1|||
162153870|NCT01499199|585612859|FG000|Overall Study|Lack of Efficacy|1|||
162153871|NCT01199705|585612860|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
162153872|NCT01849055|585612861|FG000|Overall Study|Withdrawal by Subject|0|||
162153873|NCT01849055|585612862|FG001|Overall Study|Withdrawal by Subject|0|||
162153874|NCT01849055|585612863|FG002|Overall Study|Withdrawal by Subject|1|||
162153875|NCT01849055|585612864|FG003|Overall Study|Withdrawal by Subject|0|||
162153876|NCT01849055|585612865|FG004|Overall Study|Withdrawal by Subject|0|||
162153877|NCT01849055|585612866|FG005|Overall Study|Withdrawal by Subject|0|||
162153878|NCT00933400|585612867|FG000|Overall Study|Withdrawal by Subject|21|||
162153879|NCT00933400|585612868|FG001|Overall Study|Withdrawal by Subject|1|||
162153880|NCT00223795|585612869|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
162153881|NCT00223795|585612870|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
162153882|NCT00223795|585612869|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
162153883|NCT00223795|585612870|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
162153884|NCT02409667|585612871|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
162153885|NCT02409667|585612872|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
162153886|NCT02409667|585612873|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
162153887|NCT02409667|585612874|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
162153888|NCT02409667|585612875|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
162153889|NCT02409667|585612871|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
162153890|NCT02409667|585612872|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
162153891|NCT02409667|585612873|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
162153892|NCT02409667|585612874|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
162153893|NCT02409667|585612875|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
162153894|NCT02409667|585612871|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
162153895|NCT02409667|585612872|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
162153896|NCT02409667|585612873|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
162153897|NCT02409667|585612874|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
162153898|NCT02409667|585612875|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
162153899|NCT02409667|585612871|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
162153900|NCT02409667|585612872|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
162153901|NCT02409667|585612873|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
162153902|NCT02409667|585612874|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
162153903|NCT02409667|585612875|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
162153904|NCT02409667|585612871|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
162153905|NCT02409667|585612872|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
162153906|NCT02409667|585612873|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
162153907|NCT02409667|585612874|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
162153908|NCT02409667|585612875|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
162153909|NCT02409667|585612871|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
162236459|NCT00666679|585916958|FG001|First Intervention|Withdrawal by Subject|0|||
161914952|NCT02320396|584737343|FG001|Overall Study|Adverse Event|2|||
161914953|NCT02320396|584737342|FG000|Overall Study|Pregnancy|0|||
161914954|NCT02320396|584737343|FG001|Overall Study|Pregnancy|1|||
161914955|NCT02320396|584737342|FG000|Overall Study|Protocol Violation|0|||
162153910|NCT02409667|585612872|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
162153911|NCT02409667|585612873|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
162153912|NCT02409667|585612874|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
162153913|NCT02409667|585612875|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
162153914|NCT02409667|585612871|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
162153915|NCT02409667|585612872|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161914956|NCT02320396|584737343|FG001|Overall Study|Protocol Violation|1|||
161914957|NCT02320396|584737342|FG000|Overall Study|Withdrawal by Subject|2|||
161914958|NCT02320396|584737343|FG001|Overall Study|Withdrawal by Subject|0|||
162153916|NCT02409667|585612873|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
162153917|NCT02409667|585612874|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
162153918|NCT02409667|585612875|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
162153919|NCT02409667|585612871|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
162153920|NCT02409667|585612872|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
162153921|NCT02409667|585612873|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
162153922|NCT02409667|585612874|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
162153923|NCT02409667|585612875|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
162153924|NCT02409667|585612871|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
162153925|NCT02409667|585612872|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
162153926|NCT02409667|585612873|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
162153927|NCT02409667|585612874|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
162153928|NCT02409667|585612875|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
162153929|NCT02409667|585612871|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
162153930|NCT02409667|585612872|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
162153931|NCT02409667|585612873|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
162153932|NCT02409667|585612874|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
162153933|NCT02409667|585612875|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
162153934|NCT02409667|585612871|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
162153935|NCT02409667|585612872|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
162153936|NCT02409667|585612873|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
162153937|NCT02409667|585612874|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
162153938|NCT02409667|585612875|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
162153939|NCT02409667|585612871|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
162153940|NCT02409667|585612872|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
162153941|NCT02409667|585612873|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
162153942|NCT02409667|585612874|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
162153943|NCT02409667|585612875|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
162153944|NCT02409667|585612871|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
162153945|NCT02409667|585612872|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
162153946|NCT02409667|585612873|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
162153947|NCT02409667|585612874|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
162153948|NCT02409667|585612875|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
162153949|NCT02409667|585612871|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
162153950|NCT02409667|585612872|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
162153951|NCT02409667|585612873|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
162153952|NCT02409667|585612874|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
161810550|NCT00934050|584349448|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
161810551|NCT00934050|584349449|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
161810552|NCT00934050|584349450|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
161810553|NCT00461786|584349451|FG000|Overall Study|Entry Criteria Not Met|2|||
161810554|NCT00461786|584349451|FG000|Overall Study|Inevaluable (Never Treated)|1|||
161810555|NCT03570749|584349456|FG000|Overall Study|Ongoing|26|||
161810556|NCT03570749|584349457|FG001|Overall Study|Ongoing|25|||
161914959|NCT00142415|584737344|FG000|Overall Study|Physician Decision|0|||
161914960|NCT00142415|584737345|FG001|Overall Study|Physician Decision|0|||
161914961|NCT00142415|584737346|FG002|Overall Study|Physician Decision|0|||
161914962|NCT00142415|584737347|FG003|Overall Study|Physician Decision|0|||
161914963|NCT00142415|584737348|FG004|Overall Study|Physician Decision|1|||
162153953|NCT02409667|585612875|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
162153954|NCT02409667|585612871|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
162153955|NCT02409667|585612872|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
162153956|NCT02409667|585612873|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
162153957|NCT02409667|585612874|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
162153958|NCT02409667|585612875|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
162153959|NCT02409667|585612871|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
162153960|NCT02409667|585612872|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
162153961|NCT02409667|585612873|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
162153962|NCT02409667|585612874|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
162153963|NCT02409667|585612875|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
162153964|NCT01925339|585612876|FG000|Overall Study|Adverse Event|2|||
162153965|NCT01925339|585612877|FG001|Overall Study|Adverse Event|0|||
162153966|NCT03783026|585615041|FG000|Treatment Phase|Adverse Event|15|||
162153967|NCT03783026|585615041|FG000|Treatment Phase|Lack of Efficacy|11|||
162153968|NCT03783026|585615041|FG000|Treatment Phase|Withdrawal by Subject|6|||
162153969|NCT03783026|585615041|FG000|Treatment Phase|Lost to Follow-up|2|||
162153970|NCT03783026|585615041|FG000|Treatment Phase|Protocol Deviation|8|||
162153971|NCT03783026|585615041|FG000|Treatment Phase|Did Not Receive Treatment|1|||
162153972|NCT03783026|585615041|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
162153973|NCT04814186|585615042|FG000|Treatment Phase|Adverse Event|1|||
162153974|NCT04814186|585615042|FG000|Treatment Phase|Death|6|||
162153975|NCT04814186|585615042|FG000|Treatment Phase|Withdrawal by Subject|2|||
162153976|NCT04814186|585615042|FG000|Treatment Phase|Other|1|||
162153977|NCT04814186|585615042|FG000|Follow-Up Phase|Adverse Event|1|||
162153978|NCT04814186|585615042|FG000|Follow-Up Phase|Death|6|||
162153979|NCT04814186|585615042|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
162153980|NCT04814186|585615042|FG000|Follow-Up Phase|Other|1|||
162153981|NCT05505045|585615047|FG000|Overall Study|Withdrawal by Subject|2|||
162153982|NCT05505045|585615048|FG001|Overall Study|Withdrawal by Subject|1|||
162153983|NCT01643070|585615049|FG000|Overall Study|Withdrawal by Subject|3|||
162153984|NCT01643070|585615050|FG001|Overall Study|Withdrawal by Subject|1|||
162153985|NCT01643070|585615049|FG000|Overall Study|Death|1|||
162153986|NCT01643070|585615050|FG001|Overall Study|Death|0|||
162153987|NCT01643070|585615049|FG000|Overall Study|Pregressive disease|0|||
162153988|NCT01643070|585615050|FG001|Overall Study|Pregressive disease|2|||
162153989|NCT04201834|585615054|FG000|Overall Study|Screen fail|1|||
162153990|NCT04104321|585615058|FG000|Overall Study|didn't take the study drug|3|||
162153991|NCT04842500|585615059|FG000|Overall Study|Withdrawal by Subject|4|||
162153992|NCT04842500|585615060|FG001|Overall Study|Withdrawal by Subject|1|||
162153993|NCT04842500|585615061|FG002|Overall Study|Withdrawal by Subject|2|||
162153994|NCT04842500|585615062|FG003|Overall Study|Withdrawal by Subject|3|||
162153995|NCT04842500|585615059|FG000|Overall Study|Protocol Violation|1|||
162153996|NCT04842500|585615060|FG001|Overall Study|Protocol Violation|0|||
162153997|NCT04842500|585615061|FG002|Overall Study|Protocol Violation|0|||
162153998|NCT04842500|585615062|FG003|Overall Study|Protocol Violation|1|||
162153999|NCT02980276|585615063|FG000|Overall Study|Withdrawal by Subject|4|||
162154000|NCT02980276|585615064|FG001|Overall Study|Withdrawal by Subject|4|||
162154001|NCT02980276|585615063|FG000|Overall Study|Physician Decision|0|||
162154002|NCT02980276|585615064|FG001|Overall Study|Physician Decision|1|||
162154003|NCT02980276|585615063|FG000|Overall Study|Lost to Follow-up|18|||
162154004|NCT02980276|585615064|FG001|Overall Study|Lost to Follow-up|18|||
162154005|NCT02980276|585615063|FG000|Overall Study|Death|1|||
162154006|NCT02980276|585615064|FG001|Overall Study|Death|0|||
162154007|NCT02980276|585615063|FG000|Overall Study|Miscellaneous other|10|||
162154008|NCT02980276|585615064|FG001|Overall Study|Miscellaneous other|4|||
162154009|NCT02824029|585615069|FG000|Overall Study|Didn't receive treatment|2|||
162154010|NCT02824029|585615069|FG000|Overall Study|Patient decision to discontinue treatment|3|||
162154011|NCT02824029|585615069|FG000|Overall Study|Non-compliant|5|||
162154012|NCT02824029|585615069|FG000|Overall Study|Progression of disease|15|||
162154013|NCT02824029|585615069|FG000|Overall Study|Inadequate response to therapy|2|||
162154014|NCT02824029|585615069|FG000|Overall Study|Possible progression per treating physician|1|||
161914964|NCT00142415|584737349|FG005|Overall Study|Physician Decision|2|||
161914965|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
162154015|NCT04512482|585615072|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
162154016|NCT04512482|585615073|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
162154017|NCT05119855|585615074|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
162154018|NCT05119855|585615075|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
162154019|NCT05119855|585615074|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
161914966|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
162154020|NCT05119855|585615075|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
162154021|NCT05119855|585615074|FG000|Overall Study|Lost to Follow-up|6|||
162154022|NCT05119855|585615075|FG001|Overall Study|Lost to Follow-up|8|||
162154023|NCT00391898|585615080|FG000|Overall Study|Adverse Event|3|||
162154024|NCT00391898|585615081|FG001|Overall Study|Adverse Event|0|||
162154025|NCT00391898|585615080|FG000|Overall Study|Other|8|||
162154026|NCT00391898|585615081|FG001|Overall Study|Other|10|||
162154027|NCT05489484|585615082|FG000|Overall Study|withdrawn|1|||
162154028|NCT02529995|585615083|FG000|Part A|Ongoing Study at Data Cut-off|14|||
162154029|NCT02529995|585615084|FG001|Part A|Ongoing Study at Data Cut-off|16|||
162154030|NCT02529995|585615083|FG000|Part A|Discontinued Study|1|||
162154031|NCT02529995|585615084|FG001|Part A|Discontinued Study|0|||
162154032|NCT02529995|585615083|FG000|Part B|Ongoing Study at Data Cut-off|0|||
162154033|NCT02529995|585615084|FG001|Part B|Ongoing Study at Data Cut-off|7|||
162154034|NCT02529995|585615083|FG000|Part B|Discontinued Study|6|||
162154035|NCT02529995|585615084|FG001|Part B|Discontinued Study|5|||
162154036|NCT00444600|585615085|FG000|Overall Study|Death|7|||
162154037|NCT00444600|585615086|FG001|Overall Study|Death|5|||
162154038|NCT00444600|585615087|FG002|Overall Study|Death|3|||
162154039|NCT00444600|585615088|FG003|Overall Study|Death|2|||
162154040|NCT00444600|585615085|FG000|Overall Study|Dropped|11|||
162154041|NCT00444600|585615086|FG001|Overall Study|Dropped|11|||
162154042|NCT00444600|585615087|FG002|Overall Study|Dropped|7|||
162154043|NCT00444600|585615088|FG003|Overall Study|Dropped|7|||
162154044|NCT00444600|585615085|FG000|Overall Study|Missed visit|1|||
162154045|NCT00444600|585615086|FG001|Overall Study|Missed visit|0|||
162154046|NCT00444600|585615087|FG002|Overall Study|Missed visit|0|||
162154047|NCT00444600|585615088|FG003|Overall Study|Missed visit|1|||
162154048|NCT05132478|585615089|FG000|Overall Study|did not complete survey after consent|1|||
162154049|NCT05132478|585615090|FG001|Overall Study|did not complete survey after consent|1|||
162154050|NCT05132478|585615089|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
162154051|NCT05132478|585615090|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
162154052|NCT02549170|585615091|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
162154053|NCT02549170|585615092|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
162154054|NCT02549170|585615093|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
162154055|NCT02549170|585615094|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
162012801|NCT02113982|585103847|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161810557|NCT03570749|584349458|FG002|Overall Study|Ongoing|25|||
161810558|NCT03570749|584349459|FG003|Overall Study|Ongoing|26|||
161810559|NCT03570749|584349460|FG004|Overall Study|Ongoing|140|||
161810560|NCT03570749|584349461|FG005|Overall Study|Ongoing|142|||
161810561|NCT03570749|584349462|FG006|Overall Study|Ongoing|220|||
161810562|NCT03570749|584349456|FG000|Overall Study|Adverse Event|0|||
161810563|NCT03570749|584349457|FG001|Overall Study|Adverse Event|0|||
161810564|NCT03570749|584349458|FG002|Overall Study|Adverse Event|0|||
161810565|NCT03570749|584349459|FG003|Overall Study|Adverse Event|0|||
161810566|NCT03570749|584349460|FG004|Overall Study|Adverse Event|2|||
161810567|NCT03570749|584349461|FG005|Overall Study|Adverse Event|3|||
161810568|NCT03570749|584349462|FG006|Overall Study|Adverse Event|6|||
161810569|NCT03570749|584349456|FG000|Overall Study|Lack of Efficacy|0|||
161810570|NCT03570749|584349457|FG001|Overall Study|Lack of Efficacy|0|||
161810571|NCT03570749|584349458|FG002|Overall Study|Lack of Efficacy|0|||
161810572|NCT03570749|584349459|FG003|Overall Study|Lack of Efficacy|0|||
161810573|NCT03570749|584349460|FG004|Overall Study|Lack of Efficacy|8|||
161810574|NCT03570749|584349461|FG005|Overall Study|Lack of Efficacy|2|||
162154056|NCT02549170|585615095|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
162154057|NCT02549170|585615091|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
162154058|NCT02549170|585615092|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
162154059|NCT02549170|585615093|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
162154060|NCT02549170|585615094|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
162154061|NCT02549170|585615095|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
162154062|NCT02549170|585615091|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
162154063|NCT02549170|585615092|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
161810575|NCT03570749|584349462|FG006|Overall Study|Lack of Efficacy|7|||
161810576|NCT03570749|584349456|FG000|Overall Study|Lost to Follow-up|0|||
161810577|NCT03570749|584349457|FG001|Overall Study|Lost to Follow-up|0|||
161810578|NCT03570749|584349458|FG002|Overall Study|Lost to Follow-up|0|||
161914967|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
161914968|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
161914969|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
161914970|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
161914971|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
161914972|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
162012802|NCT02113982|585103848|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
161810579|NCT03570749|584349459|FG003|Overall Study|Lost to Follow-up|0|||
161810580|NCT03570749|584349460|FG004|Overall Study|Lost to Follow-up|5|||
161810581|NCT03570749|584349461|FG005|Overall Study|Lost to Follow-up|10|||
161810582|NCT03570749|584349462|FG006|Overall Study|Lost to Follow-up|10|||
161810583|NCT03570749|584349456|FG000|Overall Study|Pregnancy|0|||
161810584|NCT03570749|584349457|FG001|Overall Study|Pregnancy|0|||
161810585|NCT03570749|584349458|FG002|Overall Study|Pregnancy|0|||
161810586|NCT03570749|584349459|FG003|Overall Study|Pregnancy|0|||
161810587|NCT03570749|584349460|FG004|Overall Study|Pregnancy|0|||
161810588|NCT03570749|584349461|FG005|Overall Study|Pregnancy|1|||
161810589|NCT03570749|584349462|FG006|Overall Study|Pregnancy|1|||
161810590|NCT03570749|584349456|FG000|Overall Study|Screen Fail|0|||
162154064|NCT02549170|585615093|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
162154065|NCT02549170|585615094|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
162154066|NCT02549170|585615095|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
162154067|NCT02988817|585615096|FG000|Overall Study|Withdrawal by Subject|1|||
162154068|NCT02988817|585615097|FG001|Overall Study|Withdrawal by Subject|0|||
162154069|NCT02988817|585615098|FG002|Overall Study|Withdrawal by Subject|0|||
162154070|NCT02988817|585615099|FG003|Overall Study|Withdrawal by Subject|1|||
162154071|NCT02988817|585615100|FG004|Overall Study|Withdrawal by Subject|3|||
162154072|NCT02988817|585615101|FG005|Overall Study|Withdrawal by Subject|1|||
162154073|NCT02988817|585615102|FG006|Overall Study|Withdrawal by Subject|2|||
162154074|NCT02988817|585615103|FG007|Overall Study|Withdrawal by Subject|1|||
162154075|NCT02988817|585615104|FG008|Overall Study|Withdrawal by Subject|1|||
162154076|NCT02988817|585615105|FG009|Overall Study|Withdrawal by Subject|1|||
162154077|NCT02988817|585615106|FG010|Overall Study|Withdrawal by Subject|1|||
162154078|NCT02988817|585615107|FG011|Overall Study|Withdrawal by Subject|12|||
162154079|NCT02988817|585615108|FG012|Overall Study|Withdrawal by Subject|6|||
162154080|NCT02988817|585615109|FG013|Overall Study|Withdrawal by Subject|6|||
162154081|NCT02988817|585615110|FG014|Overall Study|Withdrawal by Subject|4|||
162154082|NCT02988817|585615111|FG015|Overall Study|Withdrawal by Subject|5|||
162154083|NCT02988817|585615112|FG016|Overall Study|Withdrawal by Subject|4|||
162154084|NCT02988817|585615113|FG017|Overall Study|Withdrawal by Subject|11|||
162154085|NCT02988817|585615114|FG018|Overall Study|Withdrawal by Subject|4|||
162154086|NCT02988817|585615115|FG019|Overall Study|Withdrawal by Subject|2|||
162012803|NCT02113982|585103849|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
162012804|NCT02113982|585103850|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
162012805|NCT02113982|585103851|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
162012806|NCT02113982|585103852|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
162012807|NCT02113982|585103853|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
162012808|NCT02113982|585103854|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
162012809|NCT02113982|585103855|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
162012810|NCT02113982|585103856|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
162012811|NCT02113982|585103857|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
162012812|NCT02113982|585103858|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
162012813|NCT02113982|585103859|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
162012814|NCT02113982|585103860|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
162012815|NCT02113982|585103847|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162154087|NCT02988817|585615096|FG000|Overall Study|Death|0|||
162154088|NCT02988817|585615097|FG001|Overall Study|Death|1|||
162154089|NCT02988817|585615098|FG002|Overall Study|Death|3|||
162154090|NCT02988817|585615099|FG003|Overall Study|Death|1|||
162154091|NCT02988817|585615100|FG004|Overall Study|Death|6|||
162154092|NCT02988817|585615101|FG005|Overall Study|Death|10|||
162154093|NCT02988817|585615102|FG006|Overall Study|Death|1|||
162154094|NCT02988817|585615103|FG007|Overall Study|Death|2|||
162154095|NCT02988817|585615104|FG008|Overall Study|Death|1|||
162154096|NCT02988817|585615105|FG009|Overall Study|Death|5|||
162154097|NCT02988817|585615106|FG010|Overall Study|Death|1|||
162154098|NCT02988817|585615107|FG011|Overall Study|Death|8|||
162154099|NCT02988817|585615108|FG012|Overall Study|Death|9|||
162154100|NCT02988817|585615109|FG013|Overall Study|Death|17|||
162154101|NCT02988817|585615110|FG014|Overall Study|Death|18|||
162154102|NCT02988817|585615111|FG015|Overall Study|Death|30|||
162154103|NCT02988817|585615112|FG016|Overall Study|Death|17|||
162154104|NCT02988817|585615113|FG017|Overall Study|Death|38|||
162154105|NCT02988817|585615114|FG018|Overall Study|Death|14|||
162154106|NCT02988817|585615115|FG019|Overall Study|Death|16|||
162154107|NCT02988817|585615096|FG000|Overall Study|Other|0|||
162154108|NCT02988817|585615097|FG001|Overall Study|Other|0|||
162154109|NCT02988817|585615098|FG002|Overall Study|Other|0|||
162154110|NCT02988817|585615099|FG003|Overall Study|Other|1|||
162154111|NCT02988817|585615100|FG004|Overall Study|Other|1|||
162154112|NCT02988817|585615101|FG005|Overall Study|Other|0|||
162154113|NCT02988817|585615102|FG006|Overall Study|Other|0|||
162154114|NCT02988817|585615103|FG007|Overall Study|Other|0|||
162154115|NCT02988817|585615104|FG008|Overall Study|Other|0|||
162154116|NCT02988817|585615105|FG009|Overall Study|Other|0|||
162154117|NCT02988817|585615106|FG010|Overall Study|Other|0|||
162154118|NCT02988817|585615107|FG011|Overall Study|Other|0|||
162154119|NCT02988817|585615108|FG012|Overall Study|Other|0|||
162012816|NCT02113982|585103848|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162012817|NCT02113982|585103849|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162154120|NCT02988817|585615109|FG013|Overall Study|Other|0|||
162154121|NCT02988817|585615110|FG014|Overall Study|Other|0|||
162154122|NCT02988817|585615111|FG015|Overall Study|Other|1|||
162154123|NCT02988817|585615112|FG016|Overall Study|Other|0|||
162154124|NCT02988817|585615113|FG017|Overall Study|Other|0|||
162154125|NCT02988817|585615114|FG018|Overall Study|Other|0|||
162154126|NCT02988817|585615115|FG019|Overall Study|Other|0|||
162154127|NCT02988817|585615096|FG000|Overall Study|Lost to Follow-up|0|||
162154128|NCT02988817|585615097|FG001|Overall Study|Lost to Follow-up|0|||
162154129|NCT02988817|585615098|FG002|Overall Study|Lost to Follow-up|0|||
162154130|NCT02988817|585615099|FG003|Overall Study|Lost to Follow-up|0|||
162154131|NCT02988817|585615100|FG004|Overall Study|Lost to Follow-up|0|||
162154132|NCT02988817|585615101|FG005|Overall Study|Lost to Follow-up|0|||
162012818|NCT02113982|585103850|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162012819|NCT02113982|585103851|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162012820|NCT02113982|585103852|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162012821|NCT02113982|585103853|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162012822|NCT02113982|585103854|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
162012823|NCT02113982|585103855|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162012824|NCT02113982|585103856|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162012825|NCT02113982|585103857|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162012826|NCT02113982|585103858|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162012827|NCT02113982|585103859|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162012828|NCT02113982|585103860|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
162012829|NCT02113982|585103847|FG000|Stage 2: Cohort Expansion|Transplant|0|||
162012830|NCT02113982|585103848|FG001|Stage 2: Cohort Expansion|Transplant|0|||
162012831|NCT02113982|585103849|FG002|Stage 2: Cohort Expansion|Transplant|0|||
162012832|NCT02113982|585103850|FG003|Stage 2: Cohort Expansion|Transplant|0|||
162012833|NCT02113982|585103851|FG004|Stage 2: Cohort Expansion|Transplant|0|||
162012834|NCT02113982|585103852|FG005|Stage 2: Cohort Expansion|Transplant|0|||
162012835|NCT02113982|585103853|FG006|Stage 2: Cohort Expansion|Transplant|0|||
162012836|NCT02113982|585103854|FG007|Stage 2: Cohort Expansion|Transplant|0|||
162012837|NCT02113982|585103855|FG008|Stage 2: Cohort Expansion|Transplant|0|||
162012838|NCT02113982|585103856|FG009|Stage 2: Cohort Expansion|Transplant|4|||
162012839|NCT02113982|585103857|FG010|Stage 2: Cohort Expansion|Transplant|2|||
162012840|NCT02113982|585103858|FG011|Stage 2: Cohort Expansion|Transplant|0|||
162012841|NCT02113982|585103859|FG012|Stage 2: Cohort Expansion|Transplant|0|||
162012842|NCT02113982|585103860|FG013|Stage 2: Cohort Expansion|Transplant|0|||
162012843|NCT02113982|585103847|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
162012844|NCT02113982|585103848|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
162012845|NCT02113982|585103849|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
162012846|NCT02113982|585103850|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
162012847|NCT02113982|585103851|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
162012848|NCT02113982|585103852|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
162012849|NCT02113982|585103853|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
162012850|NCT02113982|585103854|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
162012851|NCT02113982|585103855|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
162012852|NCT02113982|585103856|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
162012853|NCT02113982|585103857|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
162012854|NCT02113982|585103858|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
162012855|NCT02113982|585103859|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
162012856|NCT02113982|585103860|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
162012857|NCT02113982|585103847|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
162012858|NCT02113982|585103848|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
162012859|NCT02113982|585103849|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
162012860|NCT02113982|585103850|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
162012861|NCT02113982|585103851|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
162012862|NCT02113982|585103852|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
162012863|NCT02113982|585103853|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
162012864|NCT02113982|585103854|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
162012865|NCT02113982|585103855|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
162012866|NCT02113982|585103856|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
162012867|NCT02113982|585103857|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
162154133|NCT02988817|585615102|FG006|Overall Study|Lost to Follow-up|0|||
162154134|NCT02988817|585615103|FG007|Overall Study|Lost to Follow-up|0|||
162154135|NCT02988817|585615104|FG008|Overall Study|Lost to Follow-up|1|||
162154136|NCT02988817|585615105|FG009|Overall Study|Lost to Follow-up|0|||
162154137|NCT02988817|585615106|FG010|Overall Study|Lost to Follow-up|1|||
162154138|NCT02988817|585615107|FG011|Overall Study|Lost to Follow-up|1|||
162154139|NCT02988817|585615108|FG012|Overall Study|Lost to Follow-up|0|||
162154140|NCT02988817|585615109|FG013|Overall Study|Lost to Follow-up|0|||
162154141|NCT02988817|585615110|FG014|Overall Study|Lost to Follow-up|1|||
162154142|NCT02988817|585615111|FG015|Overall Study|Lost to Follow-up|1|||
162154143|NCT02988817|585615112|FG016|Overall Study|Lost to Follow-up|2|||
162154144|NCT02988817|585615113|FG017|Overall Study|Lost to Follow-up|3|||
162154145|NCT02988817|585615114|FG018|Overall Study|Lost to Follow-up|0|||
162154146|NCT02988817|585615115|FG019|Overall Study|Lost to Follow-up|0|||
162154147|NCT02988817|585615096|FG000|Overall Study|Sponsor decision|0|||
162154148|NCT02988817|585615097|FG001|Overall Study|Sponsor decision|0|||
162154149|NCT02988817|585615098|FG002|Overall Study|Sponsor decision|0|||
162154150|NCT02988817|585615099|FG003|Overall Study|Sponsor decision|0|||
162154151|NCT02988817|585615100|FG004|Overall Study|Sponsor decision|0|||
162154152|NCT02988817|585615101|FG005|Overall Study|Sponsor decision|0|||
162154153|NCT02988817|585615102|FG006|Overall Study|Sponsor decision|0|||
162154154|NCT02988817|585615103|FG007|Overall Study|Sponsor decision|0|||
162154155|NCT02988817|585615104|FG008|Overall Study|Sponsor decision|0|||
162154156|NCT02988817|585615105|FG009|Overall Study|Sponsor decision|0|||
162154157|NCT02988817|585615106|FG010|Overall Study|Sponsor decision|0|||
162154158|NCT02988817|585615107|FG011|Overall Study|Sponsor decision|1|||
162154159|NCT02988817|585615108|FG012|Overall Study|Sponsor decision|1|||
162154160|NCT02988817|585615109|FG013|Overall Study|Sponsor decision|2|||
162154161|NCT02988817|585615110|FG014|Overall Study|Sponsor decision|2|||
162154162|NCT02988817|585615111|FG015|Overall Study|Sponsor decision|6|||
162154163|NCT02988817|585615112|FG016|Overall Study|Sponsor decision|2|||
162154164|NCT02988817|585615113|FG017|Overall Study|Sponsor decision|3|||
162154165|NCT02988817|585615114|FG018|Overall Study|Sponsor decision|2|||
162154166|NCT02988817|585615115|FG019|Overall Study|Sponsor decision|7|||
162154167|NCT02988817|585615096|FG000|Overall Study|Physician Decision|0|||
162154168|NCT02988817|585615097|FG001|Overall Study|Physician Decision|0|||
162154169|NCT02988817|585615098|FG002|Overall Study|Physician Decision|0|||
162154170|NCT02988817|585615099|FG003|Overall Study|Physician Decision|0|||
162154171|NCT02988817|585615100|FG004|Overall Study|Physician Decision|0|||
162154172|NCT02988817|585615101|FG005|Overall Study|Physician Decision|0|||
162154173|NCT02988817|585615102|FG006|Overall Study|Physician Decision|0|||
162154174|NCT02988817|585615103|FG007|Overall Study|Physician Decision|0|||
162154175|NCT02988817|585615104|FG008|Overall Study|Physician Decision|0|||
162154176|NCT02988817|585615105|FG009|Overall Study|Physician Decision|0|||
162154177|NCT02988817|585615106|FG010|Overall Study|Physician Decision|0|||
162154178|NCT02988817|585615107|FG011|Overall Study|Physician Decision|0|||
162012868|NCT02113982|585103858|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
162012869|NCT02113982|585103859|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
162012870|NCT02113982|585103860|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
162012871|NCT02113982|585103847|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
162012872|NCT02113982|585103848|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
162154179|NCT02988817|585615108|FG012|Overall Study|Physician Decision|0|||
162154180|NCT02988817|585615109|FG013|Overall Study|Physician Decision|0|||
162012873|NCT02113982|585103849|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
162154181|NCT02988817|585615110|FG014|Overall Study|Physician Decision|0|||
162154182|NCT02988817|585615111|FG015|Overall Study|Physician Decision|1|||
162012874|NCT02113982|585103850|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
162012875|NCT02113982|585103851|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
162154183|NCT02988817|585615112|FG016|Overall Study|Physician Decision|0|||
162154184|NCT02988817|585615113|FG017|Overall Study|Physician Decision|0|||
162154185|NCT02988817|585615114|FG018|Overall Study|Physician Decision|1|||
162154186|NCT02988817|585615115|FG019|Overall Study|Physician Decision|1|||
162154187|NCT00421889|585615116|FG000|Overall Study|Adverse Event|1|||
162154188|NCT00421889|585615117|FG001|Overall Study|Adverse Event|0|||
162154189|NCT00421889|585615118|FG002|Overall Study|Adverse Event|1|||
162154190|NCT00421889|585615119|FG003|Overall Study|Adverse Event|1|||
162154191|NCT00421889|585615120|FG004|Overall Study|Adverse Event|1|||
162154192|NCT00421889|585615121|FG005|Overall Study|Adverse Event|4|||
162154193|NCT00421889|585615122|FG006|Overall Study|Adverse Event|1|||
162154194|NCT00421889|585615123|FG007|Overall Study|Adverse Event|0|||
162154195|NCT00421889|585615124|FG008|Overall Study|Adverse Event|2|||
162154196|NCT00421889|585615116|FG000|Overall Study|Withdrawal by Subject|1|||
162154197|NCT00421889|585615117|FG001|Overall Study|Withdrawal by Subject|3|||
162154198|NCT00421889|585615118|FG002|Overall Study|Withdrawal by Subject|0|||
162154199|NCT00421889|585615119|FG003|Overall Study|Withdrawal by Subject|0|||
162154200|NCT00421889|585615120|FG004|Overall Study|Withdrawal by Subject|2|||
162154201|NCT00421889|585615121|FG005|Overall Study|Withdrawal by Subject|0|||
162154202|NCT00421889|585615122|FG006|Overall Study|Withdrawal by Subject|0|||
162154203|NCT00421889|585615123|FG007|Overall Study|Withdrawal by Subject|0|||
162154204|NCT00421889|585615124|FG008|Overall Study|Withdrawal by Subject|0|||
162154205|NCT00421889|585615116|FG000|Overall Study|Death|0|||
162154206|NCT00421889|585615117|FG001|Overall Study|Death|0|||
162154207|NCT00421889|585615118|FG002|Overall Study|Death|0|||
162154208|NCT00421889|585615119|FG003|Overall Study|Death|0|||
162154209|NCT00421889|585615120|FG004|Overall Study|Death|1|||
162154210|NCT00421889|585615121|FG005|Overall Study|Death|1|||
162154211|NCT00421889|585615122|FG006|Overall Study|Death|0|||
162154212|NCT00421889|585615123|FG007|Overall Study|Death|0|||
162154213|NCT00421889|585615124|FG008|Overall Study|Death|0|||
162154214|NCT00421889|585615116|FG000|Overall Study|Progressive disease|3|||
162154215|NCT00421889|585615117|FG001|Overall Study|Progressive disease|2|||
162154216|NCT00421889|585615118|FG002|Overall Study|Progressive disease|2|||
162154217|NCT00421889|585615119|FG003|Overall Study|Progressive disease|3|||
162154218|NCT00421889|585615120|FG004|Overall Study|Progressive disease|2|||
162154219|NCT00421889|585615121|FG005|Overall Study|Progressive disease|21|||
162154220|NCT00421889|585615122|FG006|Overall Study|Progressive disease|3|||
162154221|NCT00421889|585615123|FG007|Overall Study|Progressive disease|1|||
162154222|NCT00421889|585615124|FG008|Overall Study|Progressive disease|5|||
162154223|NCT00421889|585615116|FG000|Overall Study|Patient/Investigator request|0|||
162154224|NCT00421889|585615117|FG001|Overall Study|Patient/Investigator request|0|||
162154225|NCT00421889|585615118|FG002|Overall Study|Patient/Investigator request|0|||
162154226|NCT00421889|585615119|FG003|Overall Study|Patient/Investigator request|0|||
162154227|NCT00421889|585615120|FG004|Overall Study|Patient/Investigator request|0|||
162154228|NCT00421889|585615121|FG005|Overall Study|Patient/Investigator request|9|||
162154229|NCT00421889|585615122|FG006|Overall Study|Patient/Investigator request|0|||
162154230|NCT00421889|585615123|FG007|Overall Study|Patient/Investigator request|1|||
162154231|NCT00421889|585615124|FG008|Overall Study|Patient/Investigator request|3|||
162154232|NCT00421889|585615116|FG000|Overall Study|Lost to Follow-up|0|||
162154233|NCT00421889|585615117|FG001|Overall Study|Lost to Follow-up|0|||
162154234|NCT00421889|585615118|FG002|Overall Study|Lost to Follow-up|0|||
162154235|NCT00421889|585615119|FG003|Overall Study|Lost to Follow-up|0|||
162154236|NCT00421889|585615120|FG004|Overall Study|Lost to Follow-up|0|||
162154237|NCT00421889|585615121|FG005|Overall Study|Lost to Follow-up|0|||
162154238|NCT00421889|585615122|FG006|Overall Study|Lost to Follow-up|0|||
162154239|NCT00421889|585615123|FG007|Overall Study|Lost to Follow-up|0|||
162154240|NCT00421889|585615124|FG008|Overall Study|Lost to Follow-up|1|||
162154241|NCT03051165|585615128|FG000|Overall Study|Withdrawal by Subject|1|||
162154242|NCT03051165|585615128|FG000|Overall Study|Early termination of study|12|||
162154243|NCT03684044|585615133|FG000|Overall Study|Adverse Event|3|||
162154244|NCT03684044|585615134|FG001|Overall Study|Adverse Event|0|||
162154245|NCT03684044|585615133|FG000|Overall Study|Death|4|||
162154246|NCT03684044|585615134|FG001|Overall Study|Death|7|||
162154247|NCT03684044|585615133|FG000|Overall Study|Lost to Follow-up|3|||
162154248|NCT03684044|585615134|FG001|Overall Study|Lost to Follow-up|2|||
162154249|NCT03684044|585615133|FG000|Overall Study|Patient Not Available|0|||
162154250|NCT03684044|585615134|FG001|Overall Study|Patient Not Available|2|||
161914973|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
162154251|NCT03684044|585615133|FG000|Overall Study|Physician Decision|1|||
162154252|NCT03684044|585615134|FG001|Overall Study|Physician Decision|0|||
162154253|NCT03684044|585615133|FG000|Overall Study|Withdrawal by Subject|11|||
161914974|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
161942205|NCT02082977|584838335|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
162154254|NCT03684044|585615134|FG001|Overall Study|Withdrawal by Subject|9|||
162154255|NCT03703336|585615135|FG000|Overall Study|Parent withdrew consent|29|||
162154256|NCT03703336|585615136|FG001|Overall Study|Parent withdrew consent|8|||
162154257|NCT03703336|585615135|FG000|Overall Study|Migration|3|||
162154258|NCT03703336|585615136|FG001|Overall Study|Migration|3|||
162154259|NCT03703336|585615135|FG000|Overall Study|Protocol Violation|3|||
162154260|NCT03703336|585615136|FG001|Overall Study|Protocol Violation|1|||
162154261|NCT03703336|585615135|FG000|Overall Study|Physician Decision|2|||
162154262|NCT03703336|585615136|FG001|Overall Study|Physician Decision|0|||
162154263|NCT03703336|585615135|FG000|Overall Study|Adverse Event|0|||
162154264|NCT03703336|585615136|FG001|Overall Study|Adverse Event|2|||
162154265|NCT03703336|585615135|FG000|Overall Study|Lost to Follow-up|1|||
162154266|NCT03703336|585615136|FG001|Overall Study|Lost to Follow-up|0|||
162154267|NCT00595413|585615137|FG000|Overall Study|Adverse Event|0|||
162154268|NCT00595413|585615138|FG001|Overall Study|Adverse Event|2|||
162154269|NCT00595413|585615139|FG002|Overall Study|Adverse Event|1|||
162154270|NCT00595413|585615140|FG003|Overall Study|Adverse Event|1|||
162154271|NCT00595413|585615137|FG000|Overall Study|Lost to Follow-up|2|||
162154272|NCT00595413|585615138|FG001|Overall Study|Lost to Follow-up|2|||
162154273|NCT00595413|585615139|FG002|Overall Study|Lost to Follow-up|1|||
162154274|NCT00595413|585615140|FG003|Overall Study|Lost to Follow-up|3|||
162154275|NCT00595413|585615137|FG000|Overall Study|Death|0|||
162154276|NCT00595413|585615138|FG001|Overall Study|Death|0|||
162154277|NCT00595413|585615139|FG002|Overall Study|Death|1|||
162154278|NCT00595413|585615140|FG003|Overall Study|Death|0|||
162154279|NCT00595413|585615137|FG000|Overall Study|Other|5|||
162154280|NCT00595413|585615138|FG001|Overall Study|Other|1|||
162154281|NCT00595413|585615139|FG002|Overall Study|Other|5|||
162154282|NCT00595413|585615140|FG003|Overall Study|Other|0|||
162154283|NCT00807937|585615141|FG000|Overall Study|Adverse Event|12|||
162154284|NCT00807937|585615142|FG001|Overall Study|Adverse Event|12|||
162154285|NCT00807937|585615143|FG002|Overall Study|Adverse Event|5|||
162154286|NCT00807937|585615144|FG003|Overall Study|Adverse Event|4|||
162154287|NCT00807937|585615141|FG000|Overall Study|Protocol Violation|4|||
162154288|NCT00807937|585615142|FG001|Overall Study|Protocol Violation|5|||
162154289|NCT00807937|585615143|FG002|Overall Study|Protocol Violation|3|||
162154290|NCT00807937|585615144|FG003|Overall Study|Protocol Violation|3|||
162154291|NCT00807937|585615141|FG000|Overall Study|Withdrawal by Subject|5|||
162154292|NCT00807937|585615142|FG001|Overall Study|Withdrawal by Subject|4|||
162154293|NCT00807937|585615143|FG002|Overall Study|Withdrawal by Subject|1|||
162154294|NCT00807937|585615144|FG003|Overall Study|Withdrawal by Subject|4|||
162154295|NCT00807937|585615141|FG000|Overall Study|Lost to Follow-up|4|||
162154296|NCT00807937|585615142|FG001|Overall Study|Lost to Follow-up|0|||
162154297|NCT00807937|585615143|FG002|Overall Study|Lost to Follow-up|2|||
162154298|NCT00807937|585615144|FG003|Overall Study|Lost to Follow-up|1|||
162154299|NCT00807937|585615141|FG000|Overall Study|Lack of Efficacy|0|||
162154300|NCT00807937|585615142|FG001|Overall Study|Lack of Efficacy|0|||
162154301|NCT00807937|585615143|FG002|Overall Study|Lack of Efficacy|1|||
162154302|NCT00807937|585615144|FG003|Overall Study|Lack of Efficacy|2|||
162154303|NCT00807937|585615141|FG000|Overall Study|Intake of prohibited medicine|0|||
162154304|NCT00807937|585615142|FG001|Overall Study|Intake of prohibited medicine|0|||
162154305|NCT00807937|585615143|FG002|Overall Study|Intake of prohibited medicine|2|||
162154306|NCT00807937|585615144|FG003|Overall Study|Intake of prohibited medicine|0|||
162154307|NCT00807937|585615141|FG000|Overall Study|All other reasons (not provided)|2|||
162154308|NCT00807937|585615142|FG001|Overall Study|All other reasons (not provided)|4|||
162154309|NCT00807937|585615143|FG002|Overall Study|All other reasons (not provided)|0|||
162154310|NCT00807937|585615144|FG003|Overall Study|All other reasons (not provided)|1|||
162154311|NCT04629950|585615147|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
162154312|NCT04629950|585615148|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
162154313|NCT04629950|585615149|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
162154314|NCT04629950|585615150|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
162154315|NCT04629950|585615147|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
162154316|NCT04629950|585615148|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
162154317|NCT04629950|585615149|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
162154318|NCT04629950|585615150|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
162154319|NCT04629950|585615147|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
162154320|NCT04629950|585615148|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
162154321|NCT04629950|585615149|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
162154322|NCT04629950|585615150|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
162154323|NCT04629950|585615147|FG000|Extension Study|Withdrawal by Subject|0|||
162154324|NCT04629950|585615148|FG001|Extension Study|Withdrawal by Subject|0|||
162154325|NCT04629950|585615149|FG002|Extension Study|Withdrawal by Subject|1|||
162154326|NCT04629950|585615150|FG003|Extension Study|Withdrawal by Subject|0|||
162154327|NCT04629950|585615147|FG000|Extension Study|Adverse Event|0|||
162154328|NCT04629950|585615148|FG001|Extension Study|Adverse Event|0|||
162154329|NCT04629950|585615149|FG002|Extension Study|Adverse Event|0|||
162154330|NCT04629950|585615150|FG003|Extension Study|Adverse Event|1|||
162154331|NCT03233633|585615151|FG000|Overall Study|Adverse Event|2|||
162154332|NCT03233633|585615151|FG000|Overall Study|Less Than 3 Days of Data|6|||
162154333|NCT02708108|585615152|FG000|Overall Study|Death|1|||
162154334|NCT02708108|585615153|FG001|Overall Study|Death|2|||
162154335|NCT02708108|585615152|FG000|Overall Study|Regimen change|1|||
162154336|NCT02708108|585615153|FG001|Overall Study|Regimen change|0|||
162154337|NCT02708108|585615152|FG000|Overall Study|No MRD and no imaging available|0|||
162154338|NCT02708108|585615153|FG001|Overall Study|No MRD and no imaging available|1|||
162154339|NCT02568683|585615155|FG000|Overall Study|Death|0|||
162154340|NCT02568683|585615156|FG001|Overall Study|Death|2|||
162154341|NCT02568683|585615155|FG000|Overall Study|Withdrew Consent|1|||
162154342|NCT02568683|585615156|FG001|Overall Study|Withdrew Consent|0|||
162154343|NCT02568683|585615155|FG000|Overall Study|Study Terminated By Sponsor|5|||
162154344|NCT02568683|585615156|FG001|Overall Study|Study Terminated By Sponsor|2|||
162154345|NCT01561989|585615159|FG000|Overall Study|accural target not met.|5|||
162154346|NCT01561989|585615160|FG001|Overall Study|accural target not met.|6|||
162154347|NCT01388361|585615169|FG000|Overall Study|Adverse Event|0|||
162154348|NCT01388361|585615170|FG001|Overall Study|Adverse Event|5|||
162154349|NCT01388361|585615171|FG002|Overall Study|Adverse Event|1|||
162154350|NCT01388361|585615169|FG000|Overall Study|Protocol Violation|0|||
162154351|NCT01388361|585615170|FG001|Overall Study|Protocol Violation|0|||
162154352|NCT01388361|585615171|FG002|Overall Study|Protocol Violation|2|||
162154353|NCT01388361|585615169|FG000|Overall Study|Withdrawal criteria|12|||
162154354|NCT01388361|585615170|FG001|Overall Study|Withdrawal criteria|7|||
162154355|NCT01388361|585615171|FG002|Overall Study|Withdrawal criteria|10|||
162154356|NCT01388361|585615169|FG000|Overall Study|Unclassified|0|||
162154357|NCT01388361|585615170|FG001|Overall Study|Unclassified|0|||
162154358|NCT01388361|585615171|FG002|Overall Study|Unclassified|1|||
162154359|NCT05368831|585615174|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
162154360|NCT03565315|585615176|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
162154361|NCT03565315|585615177|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
162154362|NCT03565315|585615178|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
162154363|NCT03565315|585615179|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
162154364|NCT03887650|585615180|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
162154365|NCT03887650|585615181|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
162154366|NCT03887650|585615180|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
162154367|NCT03887650|585615181|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
162154368|NCT03887650|585615180|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
162154369|NCT03887650|585615181|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
162154370|NCT01170962|585615182|FG000|Treatment Period|Lack of Efficacy|96|||
162154371|NCT01170962|585615183|FG001|Treatment Period|Lack of Efficacy|91|||
162154372|NCT01170962|585615184|FG002|Treatment Period|Lack of Efficacy|7|||
162154373|NCT01170962|585615182|FG000|Treatment Period|Adverse Event|11|||
162154374|NCT01170962|585615183|FG001|Treatment Period|Adverse Event|12|||
162154375|NCT01170962|585615184|FG002|Treatment Period|Adverse Event|3|||
162154376|NCT01170962|585615182|FG000|Treatment Period|Withdrawal by Subject|2|||
162154377|NCT01170962|585615183|FG001|Treatment Period|Withdrawal by Subject|1|||
162154378|NCT01170962|585615184|FG002|Treatment Period|Withdrawal by Subject|0|||
162154379|NCT01170962|585615182|FG000|Treatment Period|Lost to Follow-up|1|||
162154380|NCT01170962|585615183|FG001|Treatment Period|Lost to Follow-up|1|||
162154381|NCT01170962|585615184|FG002|Treatment Period|Lost to Follow-up|1|||
162154382|NCT01170962|585615182|FG000|Treatment Period|Participant no longer meets criteria|0|||
162154383|NCT01170962|585615183|FG001|Treatment Period|Participant no longer meets criteria|1|||
162154384|NCT01170962|585615184|FG002|Treatment Period|Participant no longer meets criteria|0|||
162154385|NCT01170962|585615182|FG000|Treatment Period|Request to discontinue treatment|7|||
162154386|NCT01170962|585615183|FG001|Treatment Period|Request to discontinue treatment|3|||
162154387|NCT01170962|585615184|FG002|Treatment Period|Request to discontinue treatment|1|||
162154388|NCT01170962|585615182|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
162154389|NCT01170962|585615183|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
162154390|NCT01170962|585615184|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
162154391|NCT01170962|585615182|FG000|Follow up Period|Withdrawal by Subject|14|||
162154392|NCT01170962|585615183|FG001|Follow up Period|Withdrawal by Subject|10|||
162154393|NCT01170962|585615184|FG002|Follow up Period|Withdrawal by Subject|2|||
162154394|NCT01170962|585615182|FG000|Follow up Period|Lost to Follow-up|13|||
162154395|NCT01170962|585615183|FG001|Follow up Period|Lost to Follow-up|8|||
162154396|NCT01170962|585615184|FG002|Follow up Period|Lost to Follow-up|1|||
162154397|NCT01170962|585615182|FG000|Follow up Period|Death|2|||
162154398|NCT01170962|585615183|FG001|Follow up Period|Death|2|||
162154399|NCT01170962|585615184|FG002|Follow up Period|Death|0|||
162154400|NCT01170962|585615182|FG000|Follow up Period|Others|10|||
162154401|NCT01170962|585615183|FG001|Follow up Period|Others|7|||
162154402|NCT01170962|585615184|FG002|Follow up Period|Others|3|||
162154403|NCT01083316|585615185|FG000|Overall Study|Adverse Event|2|||
162154404|NCT01083316|585615185|FG000|Overall Study|Withdrawal by Subject|1|||
162154405|NCT03942042|585615186|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
162154406|NCT03942042|585615187|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
162154407|NCT03942042|585615186|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
162154408|NCT03942042|585615187|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
162154409|NCT01199575|585615188|FG000|Overall Study|Withdrawal by Subject|5|||
162154410|NCT00704184|585615193|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
162154411|NCT00704184|585615194|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
162154412|NCT00704184|585615195|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
162154413|NCT00704184|585615196|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
162154414|NCT00704184|585615197|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
162154415|NCT00704184|585615193|FG000|Open-Label Treatment|Adverse Event|0|||
162154416|NCT00704184|585615194|FG001|Open-Label Treatment|Adverse Event|0|||
162154417|NCT00704184|585615195|FG002|Open-Label Treatment|Adverse Event|2|||
162154418|NCT00704184|585615196|FG003|Open-Label Treatment|Adverse Event|0|||
162154419|NCT00704184|585615197|FG004|Open-Label Treatment|Adverse Event|1|||
162154420|NCT00704184|585615193|FG000|Open-Label Treatment|Lack of Efficacy|0|||
162154421|NCT00704184|585615194|FG001|Open-Label Treatment|Lack of Efficacy|2|||
162154422|NCT00704184|585615195|FG002|Open-Label Treatment|Lack of Efficacy|2|||
162154423|NCT00704184|585615196|FG003|Open-Label Treatment|Lack of Efficacy|2|||
162154424|NCT00704184|585615197|FG004|Open-Label Treatment|Lack of Efficacy|1|||
162154425|NCT00704184|585615193|FG000|Open-Label Treatment|Physician Decision|0|||
162154426|NCT00704184|585615194|FG001|Open-Label Treatment|Physician Decision|0|||
162154427|NCT00704184|585615195|FG002|Open-Label Treatment|Physician Decision|0|||
162154428|NCT00704184|585615196|FG003|Open-Label Treatment|Physician Decision|0|||
162154429|NCT00704184|585615197|FG004|Open-Label Treatment|Physician Decision|1|||
162154430|NCT00704184|585615193|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
162154431|NCT00704184|585615194|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
162154432|NCT00704184|585615195|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
162154433|NCT00704184|585615196|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
162154434|NCT00704184|585615197|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
162154435|NCT00716859|585615200|FG000|Overall Study|Adverse Event|4|||
162154436|NCT00716859|585615201|FG001|Overall Study|Adverse Event|1|||
162154437|NCT00716859|585615200|FG000|Overall Study|Lack of Efficacy|3|||
162154438|NCT00716859|585615201|FG001|Overall Study|Lack of Efficacy|0|||
162154439|NCT00716859|585615200|FG000|Overall Study|Withdrawal by Subject|1|||
162154440|NCT00716859|585615201|FG001|Overall Study|Withdrawal by Subject|3|||
162154441|NCT00716859|585615200|FG000|Overall Study|Not treated|1|||
162154442|NCT00716859|585615201|FG001|Overall Study|Not treated|1|||
162154443|NCT02178098|585615202|FG000|Overall Study|Withdrawal by Subject|0|||
162154444|NCT02178098|585615203|FG001|Overall Study|Withdrawal by Subject|6|||
162154445|NCT02178098|585615202|FG000|Overall Study|Adverse Event|1|||
162154446|NCT02178098|585615203|FG001|Overall Study|Adverse Event|2|||
162154447|NCT02178098|585615202|FG000|Overall Study|Protocol Violation|1|||
162154448|NCT02178098|585615203|FG001|Overall Study|Protocol Violation|1|||
162154449|NCT02178098|585615202|FG000|Overall Study|Lost to Follow-up|0|||
162154450|NCT02178098|585615203|FG001|Overall Study|Lost to Follow-up|1|||
162154451|NCT02178098|585615202|FG000|Overall Study|Sponsor Request|1|||
162154452|NCT02178098|585615203|FG001|Overall Study|Sponsor Request|0|||
162154453|NCT02178098|585615202|FG000|Overall Study|Other|2|||
162154454|NCT02178098|585615203|FG001|Overall Study|Other|2|||
162154455|NCT01109524|585615209|FG000|Overall Study|Disease Progression|29|||
162154456|NCT01109524|585615209|FG000|Overall Study|Study Drug toxicity|6|||
162154457|NCT01109524|585615209|FG000|Overall Study|Adverse Event|4|||
162154458|NCT01109524|585615209|FG000|Overall Study|Withdrawal by Subject|2|||
162154459|NCT01109524|585615209|FG000|Overall Study|Maximum clinical benefit|3|||
162154460|NCT01109524|585615209|FG000|Overall Study|Death|2|||
162154461|NCT01109524|585615209|FG000|Overall Study|No longer meets criteria|2|||
162012876|NCT02113982|585103852|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
162012877|NCT02113982|585103853|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
162012878|NCT02113982|585103854|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
162012879|NCT02113982|585103855|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
162154462|NCT01109524|585615209|FG000|Overall Study|Participant requested to end treatment|4|||
162154463|NCT01109524|585615209|FG000|Overall Study|Other|5|||
162154464|NCT02769858|585615220|FG000|Overall Study|Withdrawal by Subject|2|||
162154465|NCT04939246|585615221|FG000|After Treatment|Death|4|||
162154466|NCT04939246|585615221|FG000|After Treatment|Lost to Follow-up|1|||
162154467|NCT04939246|585615221|FG000|After Treatment|Discharged to hospice|2|||
162012880|NCT02113982|585103856|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
162012881|NCT02113982|585103857|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
162012882|NCT02113982|585103858|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
162012883|NCT02113982|585103859|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
162012884|NCT02113982|585103860|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
162012885|NCT02113982|585103847|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
162012886|NCT02113982|585103848|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
162154468|NCT04139668|585617061|FG000|Overall Study|Withdrawal by Subject|1|||
162154469|NCT03025789|585617062|FG000|Overall Study|Lack of Efficacy|6|||
162154470|NCT03025789|585617063|FG001|Overall Study|Lack of Efficacy|1|||
162154471|NCT03025789|585617062|FG000|Overall Study|Death|1|||
162154472|NCT03025789|585617063|FG001|Overall Study|Death|0|||
162154473|NCT03025789|585617062|FG000|Overall Study|Withdrawal by Subject|0|||
162154474|NCT03025789|585617063|FG001|Overall Study|Withdrawal by Subject|2|||
162154475|NCT03554265|585617064|FG000|Overall Study|Withdrawal by Subject|2|||
162154476|NCT03554265|585617065|FG001|Overall Study|Withdrawal by Subject|2|||
162012887|NCT02113982|585103849|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
161810591|NCT03570749|584349457|FG001|Overall Study|Screen Fail|0|||
161810592|NCT03570749|584349458|FG002|Overall Study|Screen Fail|0|||
162154477|NCT03554265|585617066|FG002|Overall Study|Withdrawal by Subject|3|||
162154478|NCT03554265|585617064|FG000|Overall Study|Physician Decision|0|||
162154479|NCT03554265|585617065|FG001|Overall Study|Physician Decision|0|||
162154480|NCT03554265|585617066|FG002|Overall Study|Physician Decision|1|||
162154481|NCT04999085|585617069|FG000|Overall Study|Death|1|||
162154482|NCT05057897|585617070|FG000|Overall Study|Site closure|2|||
162154483|NCT05057897|585617071|FG001|Overall Study|Site closure|2|||
161810593|NCT03570749|584349459|FG003|Overall Study|Screen Fail|0|||
161810594|NCT03570749|584349460|FG004|Overall Study|Screen Fail|0|||
161810595|NCT03570749|584349461|FG005|Overall Study|Screen Fail|0|||
162154484|NCT05057897|585617070|FG000|Overall Study|Death|1|||
162154485|NCT05057897|585617071|FG001|Overall Study|Death|0|||
162154486|NCT04540913|585617073|FG000|Overall Study|Withdrawal by Subject|14|||
162154487|NCT04540913|585617074|FG001|Overall Study|Withdrawal by Subject|3|||
162154488|NCT04440176|585617075|FG000|Overall Study|Withdrawal by Subject|5|||
162154489|NCT04440176|585617076|FG001|Overall Study|Withdrawal by Subject|3|||
162154490|NCT04440176|585617075|FG000|Overall Study|Withdrawal by parent/guardian|4|||
162154491|NCT04440176|585617076|FG001|Overall Study|Withdrawal by parent/guardian|5|||
162154492|NCT04440176|585617075|FG000|Overall Study|Adverse Event|2|||
162154493|NCT04440176|585617076|FG001|Overall Study|Adverse Event|6|||
162154494|NCT04440176|585617075|FG000|Overall Study|Lost to Follow-up|22|||
162154495|NCT04440176|585617076|FG001|Overall Study|Lost to Follow-up|23|||
162154496|NCT04440176|585617075|FG000|Overall Study|Medication error without associated adverse event|0|||
161810596|NCT03570749|584349462|FG006|Overall Study|Screen Fail|1|||
161810597|NCT03570749|584349456|FG000|Overall Study|Withdrawal by Subject|2|||
161810598|NCT03570749|584349457|FG001|Overall Study|Withdrawal by Subject|3|||
161810599|NCT03570749|584349458|FG002|Overall Study|Withdrawal by Subject|2|||
161810600|NCT03570749|584349459|FG003|Overall Study|Withdrawal by Subject|1|||
161810601|NCT03570749|584349460|FG004|Overall Study|Withdrawal by Subject|17|||
161810602|NCT03570749|584349461|FG005|Overall Study|Withdrawal by Subject|12|||
161810603|NCT03570749|584349462|FG006|Overall Study|Withdrawal by Subject|15|||
161810604|NCT03570749|584349456|FG000|Overall Study|Other|0|||
161810605|NCT03570749|584349457|FG001|Overall Study|Other|0|||
161810606|NCT03570749|584349458|FG002|Overall Study|Other|0|||
161810607|NCT03570749|584349459|FG003|Overall Study|Other|0|||
161810608|NCT03570749|584349460|FG004|Overall Study|Other|17|||
161810609|NCT03570749|584349461|FG005|Overall Study|Other|14|||
161810610|NCT03570749|584349462|FG006|Overall Study|Other|21|||
162154497|NCT04440176|585617076|FG001|Overall Study|Medication error without associated adverse event|1|||
162012888|NCT02113982|585103850|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
162012889|NCT02113982|585103851|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
162012890|NCT02113982|585103852|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
162012891|NCT02113982|585103853|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
162012892|NCT02113982|585103854|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
162012893|NCT02113982|585103855|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
162012894|NCT02113982|585103856|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
162012895|NCT02113982|585103857|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
162012896|NCT02113982|585103858|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
162012897|NCT02113982|585103859|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
162012898|NCT02113982|585103860|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
162012899|NCT02113982|585103847|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162154498|NCT04440176|585617075|FG000|Overall Study|No longer met eligibility criteria|7|||
162154499|NCT04440176|585617076|FG001|Overall Study|No longer met eligibility criteria|1|||
162154500|NCT04440176|585617075|FG000|Overall Study|Other|1|||
162154501|NCT04440176|585617076|FG001|Overall Study|Other|2|||
162154502|NCT04440176|585617075|FG000|Overall Study|Protocol deviation|6|||
162154503|NCT04440176|585617076|FG001|Overall Study|Protocol deviation|8|||
162154504|NCT04440176|585617075|FG000|Overall Study|Randomized but not vaccinated|6|||
162154505|NCT04440176|585617076|FG001|Overall Study|Randomized but not vaccinated|3|||
162154506|NCT04188379|585617077|FG000|Overall Study|Withdrawal by Subject|10|||
162154507|NCT04188379|585617078|FG001|Overall Study|Withdrawal by Subject|3|||
162154508|NCT04188379|585617077|FG000|Overall Study|Physician Decision|0|||
162154509|NCT04188379|585617078|FG001|Overall Study|Physician Decision|1|||
162154510|NCT04188379|585617077|FG000|Overall Study|Adverse Event|3|||
162154511|NCT04188379|585617078|FG001|Overall Study|Adverse Event|1|||
162154512|NCT04188379|585617077|FG000|Overall Study|Pregnancy|1|||
162154513|NCT04188379|585617078|FG001|Overall Study|Pregnancy|0|||
162154514|NCT04188379|585617077|FG000|Overall Study|Lack of Efficacy|8|||
162154515|NCT04188379|585617078|FG001|Overall Study|Lack of Efficacy|5|||
162154516|NCT04188379|585617077|FG000|Overall Study|Other|0|||
162154517|NCT04188379|585617078|FG001|Overall Study|Other|3|||
162154518|NCT05288283|585617079|FG000|Overall Study|Study Terminated Early|1|||
162154519|NCT05288283|585617080|FG001|Overall Study|Study Terminated Early|1|||
162154520|NCT03990649|585617085|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
162154521|NCT03990649|585617086|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
162154522|NCT03990649|585617087|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
162154523|NCT03990649|585617085|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
162154524|NCT03990649|585617086|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
162154525|NCT03990649|585617087|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
162154526|NCT03990649|585617085|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
162154527|NCT03990649|585617086|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
162154528|NCT03990649|585617087|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
162154529|NCT03990649|585617085|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
162154530|NCT03990649|585617086|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
162154531|NCT03990649|585617087|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
162154532|NCT03990649|585617085|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
162154533|NCT03990649|585617086|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
162154534|NCT03990649|585617087|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
162154535|NCT03990649|585617085|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
162154536|NCT03990649|585617086|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
162154537|NCT03990649|585617087|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
162154538|NCT03990649|585617085|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
162154539|NCT03990649|585617086|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
162154540|NCT03990649|585617087|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
162154541|NCT03050814|585617088|FG000|Overall Study|Screen failures|0|||
162154542|NCT03050814|585617089|FG001|Overall Study|Screen failures|0|||
162154543|NCT03050814|585617090|FG002|Overall Study|Screen failures|4|||
162154544|NCT02706717|585617091|FG000|Overall Study|Withdrawal by Subject|1|||
162154545|NCT02706717|585617092|FG001|Overall Study|Withdrawal by Subject|8|||
162154546|NCT02706717|585617091|FG000|Overall Study|Lost to Follow-up|0|||
162154547|NCT02706717|585617092|FG001|Overall Study|Lost to Follow-up|1|||
162154548|NCT02706717|585617091|FG000|Overall Study|Physician Decision|0|||
162012900|NCT02113982|585103848|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162012901|NCT02113982|585103849|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162012902|NCT02113982|585103850|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162012903|NCT02113982|585103851|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162012904|NCT02113982|585103852|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162012905|NCT02113982|585103853|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162012906|NCT02113982|585103854|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162012907|NCT02113982|585103855|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162012908|NCT02113982|585103856|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162154549|NCT02706717|585617092|FG001|Overall Study|Physician Decision|1|||
162154550|NCT02706717|585617091|FG000|Overall Study|Death|0|||
162154551|NCT02706717|585617092|FG001|Overall Study|Death|1|||
162154552|NCT00978042|585617094|FG000|Initial Treatment Period|Treated in Error|0|||
162012909|NCT02113982|585103857|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162154553|NCT00978042|585617095|FG001|Initial Treatment Period|Treated in Error|3|||
162154554|NCT00978042|585617094|FG000|Initial Treatment Period|Ineligibility|1|||
162154555|NCT00978042|585617095|FG001|Initial Treatment Period|Ineligibility|0|||
162154556|NCT00978042|585617094|FG000|Initial Treatment Period|Lost to Follow-up|21|||
162154557|NCT00978042|585617095|FG001|Initial Treatment Period|Lost to Follow-up|3|||
162154558|NCT00978042|585617094|FG000|Initial Treatment Period|Adverse Event|2|||
162154559|NCT00978042|585617095|FG001|Initial Treatment Period|Adverse Event|0|||
161810611|NCT00561015|584349463|FG000|Overall Study|Adverse Event|0|||
161810612|NCT00561015|584349464|FG001|Overall Study|Adverse Event|0|||
161810613|NCT00561015|584349465|FG002|Overall Study|Adverse Event|0|||
161810614|NCT00561015|584349466|FG003|Overall Study|Adverse Event|0|||
161810615|NCT00561015|584349467|FG004|Overall Study|Adverse Event|1|||
161810616|NCT00561015|584349468|FG005|Overall Study|Adverse Event|0|||
161810617|NCT00561015|584349463|FG000|Overall Study|Lost to Follow-up|2|||
161810618|NCT00561015|584349464|FG001|Overall Study|Lost to Follow-up|0|||
161810619|NCT00561015|584349465|FG002|Overall Study|Lost to Follow-up|0|||
161810620|NCT00561015|584349466|FG003|Overall Study|Lost to Follow-up|1|||
162012910|NCT02113982|585103858|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
162012911|NCT02113982|585103859|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162012912|NCT02113982|585103860|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
162012913|NCT02113982|585103847|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
162012914|NCT02113982|585103848|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
162012915|NCT02113982|585103849|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
162012916|NCT02113982|585103850|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
162012917|NCT02113982|585103851|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
162012918|NCT02113982|585103852|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
162012919|NCT02113982|585103853|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
162012920|NCT02113982|585103854|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
162012921|NCT02113982|585103855|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
162012922|NCT02113982|585103856|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
162012923|NCT02113982|585103857|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
162012924|NCT02113982|585103858|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
162012925|NCT02113982|585103859|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
162012926|NCT02113982|585103860|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
162012927|NCT02113982|585103847|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012928|NCT02113982|585103848|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012929|NCT02113982|585103849|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012930|NCT02113982|585103850|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012931|NCT02113982|585103851|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012932|NCT02113982|585103852|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012933|NCT02113982|585103853|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012934|NCT02113982|585103854|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012935|NCT02113982|585103855|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012936|NCT02113982|585103856|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012937|NCT02113982|585103857|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012938|NCT02113982|585103858|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012939|NCT02113982|585103859|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
162012940|NCT02113982|585103860|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
162012941|NCT02113982|585103847|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
162012942|NCT02113982|585103848|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
162012943|NCT02113982|585103849|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
162012944|NCT02113982|585103850|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
162012945|NCT02113982|585103851|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
162012946|NCT02113982|585103852|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
162012947|NCT02113982|585103853|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
162012948|NCT02113982|585103854|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
162012949|NCT02113982|585103855|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
162012950|NCT02113982|585103856|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
162012951|NCT02113982|585103857|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
162012952|NCT02113982|585103858|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
162012953|NCT02113982|585103859|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
162012954|NCT02113982|585103860|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
162012955|NCT02113982|585103847|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
162012956|NCT02113982|585103848|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
162012957|NCT02113982|585103849|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
162012958|NCT02113982|585103850|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
162012959|NCT02113982|585103851|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
162012960|NCT02113982|585103852|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
162012961|NCT02113982|585103853|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
162012962|NCT02113982|585103854|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
162012963|NCT02113982|585103855|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
162012964|NCT02113982|585103856|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
162012965|NCT02113982|585103857|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
162012966|NCT02113982|585103858|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
161810621|NCT00561015|584349467|FG004|Overall Study|Lost to Follow-up|0|||
161810622|NCT00561015|584349468|FG005|Overall Study|Lost to Follow-up|3|||
161810623|NCT00561015|584349463|FG000|Overall Study|Participant non-compliance|2|||
161810624|NCT00561015|584349464|FG001|Overall Study|Participant non-compliance|0|||
162154560|NCT00978042|585617094|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
162154561|NCT00978042|585617095|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
162154562|NCT00978042|585617094|FG000|Initial Treatment Period|Consent withdrawn|22|||
162154563|NCT00978042|585617095|FG001|Initial Treatment Period|Consent withdrawn|9|||
162154564|NCT00978042|585617094|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
162154565|NCT00978042|585617095|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
162154566|NCT00111813|585617096|FG000|Overall Study|Adverse Event|1|||
162154567|NCT00111813|585617097|FG001|Overall Study|Adverse Event|2|||
162154568|NCT00111813|585617098|FG002|Overall Study|Adverse Event|4|||
162154569|NCT00111813|585617099|FG003|Overall Study|Adverse Event|2|||
162154570|NCT00111813|585617100|FG004|Overall Study|Adverse Event|2|||
162154571|NCT00111813|585617101|FG005|Overall Study|Adverse Event|2|||
162154572|NCT00111813|585617096|FG000|Overall Study|Progressive disease|2|||
162154573|NCT00111813|585617097|FG001|Overall Study|Progressive disease|1|||
162154574|NCT00111813|585617098|FG002|Overall Study|Progressive disease|5|||
162154575|NCT00111813|585617099|FG003|Overall Study|Progressive disease|3|||
162154576|NCT00111813|585617100|FG004|Overall Study|Progressive disease|4|||
162154577|NCT00111813|585617101|FG005|Overall Study|Progressive disease|3|||
162154578|NCT00111813|585617096|FG000|Overall Study|Lack of Efficacy|0|||
162154579|NCT00111813|585617097|FG001|Overall Study|Lack of Efficacy|0|||
162154580|NCT00111813|585617098|FG002|Overall Study|Lack of Efficacy|0|||
162154581|NCT00111813|585617099|FG003|Overall Study|Lack of Efficacy|0|||
162154582|NCT00111813|585617100|FG004|Overall Study|Lack of Efficacy|0|||
162154583|NCT00111813|585617101|FG005|Overall Study|Lack of Efficacy|1|||
162154584|NCT00111813|585617096|FG000|Overall Study|Other|0|||
162154585|NCT00111813|585617097|FG001|Overall Study|Other|0|||
162154586|NCT00111813|585617098|FG002|Overall Study|Other|1|||
162154587|NCT00111813|585617099|FG003|Overall Study|Other|0|||
162154588|NCT00111813|585617100|FG004|Overall Study|Other|0|||
162154589|NCT00111813|585617101|FG005|Overall Study|Other|0|||
162154590|NCT01610297|585617102|FG000|Overall Study|Lost to Follow-up|1|||
162154591|NCT00818246|585617103|FG000|Overall Study|Impossible to match pictures|5|||
162154592|NCT02121002|585617104|FG000|Overall Study|Physician Decision|2|||
162154593|NCT02121002|585617105|FG001|Overall Study|Physician Decision|0|||
162154594|NCT02121002|585617106|FG002|Overall Study|Physician Decision|0|||
162154595|NCT02121002|585617104|FG000|Overall Study|Withdrawal by Subject|3|||
162154596|NCT02121002|585617105|FG001|Overall Study|Withdrawal by Subject|1|||
162154597|NCT02121002|585617106|FG002|Overall Study|Withdrawal by Subject|4|||
162154598|NCT02121002|585617104|FG000|Overall Study|Protocol Violation|1|||
162154599|NCT02121002|585617105|FG001|Overall Study|Protocol Violation|2|||
162154600|NCT02121002|585617106|FG002|Overall Study|Protocol Violation|4|||
162154601|NCT02121002|585617104|FG000|Overall Study|Concomitant therapy|0|||
162154602|NCT02121002|585617105|FG001|Overall Study|Concomitant therapy|1|||
162154603|NCT02121002|585617106|FG002|Overall Study|Concomitant therapy|1|||
162154604|NCT02121002|585617104|FG000|Overall Study|Others|1|||
162154605|NCT02121002|585617105|FG001|Overall Study|Others|0|||
162154606|NCT02121002|585617106|FG002|Overall Study|Others|1|||
162154607|NCT02590432|585617107|FG000|Open-label Treatment Period|Adverse Event|97|||
162154608|NCT02590432|585617108|FG001|Open-label Treatment Period|Adverse Event|79|||
162154609|NCT02590432|585617109|FG002|Open-label Treatment Period|Adverse Event|0|||
162154610|NCT02590432|585617110|FG003|Open-label Treatment Period|Adverse Event|0|||
162154611|NCT02590432|585617111|FG004|Open-label Treatment Period|Adverse Event|0|||
162154612|NCT02590432|585617112|FG005|Open-label Treatment Period|Adverse Event|0|||
162154613|NCT02590432|585617113|FG006|Open-label Treatment Period|Adverse Event|0|||
162154614|NCT02590432|585617114|FG007|Open-label Treatment Period|Adverse Event|0|||
162154615|NCT02590432|585617115|FG008|Open-label Treatment Period|Adverse Event|0|||
162012967|NCT02113982|585103859|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
162012968|NCT02113982|585103860|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
162012969|NCT02113982|585103847|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
162012970|NCT02113982|585103848|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
162012971|NCT02113982|585103849|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
162012972|NCT02113982|585103850|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
162154616|NCT02590432|585617107|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
162154617|NCT02590432|585617108|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
162154618|NCT02590432|585617109|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
162154619|NCT02590432|585617110|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
162154620|NCT02590432|585617111|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
162154621|NCT02590432|585617112|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
162154622|NCT02590432|585617113|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
162154623|NCT02590432|585617114|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
162154624|NCT02590432|585617115|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
162154625|NCT02590432|585617107|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
162012973|NCT02113982|585103851|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
162012974|NCT02113982|585103852|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
162012975|NCT02113982|585103853|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
162012976|NCT02113982|585103854|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
162012977|NCT02113982|585103855|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
162012978|NCT02113982|585103856|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
162012979|NCT02113982|585103857|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
162012980|NCT02113982|585103858|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
162012981|NCT02113982|585103859|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
162012982|NCT02113982|585103860|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
162012983|NCT02113982|585103847|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
162012984|NCT02113982|585103848|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
162012985|NCT02113982|585103849|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161914975|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
161914976|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
161914977|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
161914978|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
161914979|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
161914980|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
161914981|NCT00410163|584737352|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
161914982|NCT00410163|584737353|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
161914983|NCT00410163|584737352|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
161914984|NCT00410163|584737353|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
161914985|NCT00410163|584737352|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
161914986|NCT00410163|584737353|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
161914987|NCT00410163|584737352|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
161914988|NCT00410163|584737353|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
161914989|NCT00410163|584737352|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
161914990|NCT00410163|584737353|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
161914991|NCT00410163|584737352|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
161914992|NCT00410163|584737353|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
161914993|NCT01572792|584737356|FG000|Lead-in Study|Lost to Follow-up|5|||
161914994|NCT01572792|584737357|FG001|Lead-in Study|Lost to Follow-up|9|||
161914995|NCT01572792|584737358|FG002|Lead-in Study|Lost to Follow-up|4|||
162012986|NCT02113982|585103850|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
162012987|NCT02113982|585103851|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
161914996|NCT01572792|584737359|FG003|Lead-in Study|Lost to Follow-up|2|||
161914997|NCT01572792|584737360|FG004|Lead-in Study|Lost to Follow-up|4|||
162012988|NCT02113982|585103852|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
162012989|NCT02113982|585103853|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
162012990|NCT02113982|585103854|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
162012991|NCT02113982|585103855|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
162012992|NCT02113982|585103856|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
162012993|NCT02113982|585103857|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
162012994|NCT02113982|585103858|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
162012995|NCT02113982|585103859|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
162012996|NCT02113982|585103860|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
162012997|NCT02113982|585103847|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162012998|NCT02113982|585103848|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162012999|NCT02113982|585103849|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162013000|NCT02113982|585103850|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162154626|NCT02590432|585617108|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
162154627|NCT02590432|585617109|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
162154628|NCT02590432|585617110|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
162154629|NCT02590432|585617111|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
162154630|NCT02590432|585617112|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
162154631|NCT02590432|585617113|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
162154632|NCT02590432|585617114|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
162154633|NCT02590432|585617115|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
162154634|NCT02590432|585617107|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
162154635|NCT02590432|585617108|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
162154636|NCT02590432|585617109|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
162154637|NCT02590432|585617110|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
162154638|NCT02590432|585617111|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
162154639|NCT02590432|585617112|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
162154640|NCT02590432|585617113|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
162154641|NCT02590432|585617114|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
162154642|NCT02590432|585617115|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
162154643|NCT02590432|585617107|FG000|Open-label Treatment Period|Protocol Violation|10|||
162154644|NCT02590432|585617108|FG001|Open-label Treatment Period|Protocol Violation|4|||
162154645|NCT02590432|585617109|FG002|Open-label Treatment Period|Protocol Violation|0|||
162154646|NCT02590432|585617110|FG003|Open-label Treatment Period|Protocol Violation|0|||
162154647|NCT02590432|585617111|FG004|Open-label Treatment Period|Protocol Violation|0|||
162154648|NCT02590432|585617112|FG005|Open-label Treatment Period|Protocol Violation|0|||
162154649|NCT02590432|585617113|FG006|Open-label Treatment Period|Protocol Violation|0|||
162154650|NCT02590432|585617114|FG007|Open-label Treatment Period|Protocol Violation|0|||
162154651|NCT02590432|585617115|FG008|Open-label Treatment Period|Protocol Violation|0|||
162154652|NCT02590432|585617107|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
162154653|NCT02590432|585617108|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
162154654|NCT02590432|585617109|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162154655|NCT02590432|585617110|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162154656|NCT02590432|585617111|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162154657|NCT02590432|585617112|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162154658|NCT02590432|585617113|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162154659|NCT02590432|585617114|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162154660|NCT02590432|585617115|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
162154661|NCT02590432|585617107|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
162154662|NCT02590432|585617108|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
162154663|NCT02590432|585617109|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162154664|NCT02590432|585617110|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162154665|NCT02590432|585617111|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162154666|NCT02590432|585617112|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162154667|NCT02590432|585617113|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162154668|NCT02590432|585617114|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162154669|NCT02590432|585617115|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
162154670|NCT02590432|585617107|FG000|Double-blind Treatment Period|Adverse Event|0|||
162154671|NCT02590432|585617108|FG001|Double-blind Treatment Period|Adverse Event|0|||
162154672|NCT02590432|585617109|FG002|Double-blind Treatment Period|Adverse Event|14|||
162154673|NCT02590432|585617110|FG003|Double-blind Treatment Period|Adverse Event|12|||
162154674|NCT02590432|585617111|FG004|Double-blind Treatment Period|Adverse Event|6|||
162154675|NCT02590432|585617112|FG005|Double-blind Treatment Period|Adverse Event|22|||
162154676|NCT02590432|585617113|FG006|Double-blind Treatment Period|Adverse Event|20|||
162154677|NCT02590432|585617114|FG007|Double-blind Treatment Period|Adverse Event|0|||
162154678|NCT02590432|585617115|FG008|Double-blind Treatment Period|Adverse Event|0|||
162154679|NCT02590432|585617107|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
162154680|NCT02590432|585617108|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
162154681|NCT02590432|585617109|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
162154682|NCT02590432|585617110|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
162154683|NCT02590432|585617111|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
162154684|NCT02590432|585617112|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
161810625|NCT00561015|584349465|FG002|Overall Study|Participant non-compliance|0|||
161810626|NCT00561015|584349466|FG003|Overall Study|Participant non-compliance|0|||
161810627|NCT00561015|584349467|FG004|Overall Study|Participant non-compliance|0|||
161810628|NCT00561015|584349468|FG005|Overall Study|Participant non-compliance|0|||
161810629|NCT03616535|584349469|FG000|Overall Study|Death|2|||
161810630|NCT03616535|584349470|FG001|Overall Study|Death|0|||
161810631|NCT03616535|584349471|FG002|Overall Study|Death|0|||
161810632|NCT03616535|584349472|FG003|Overall Study|Death|1|||
161810633|NCT03616535|584349469|FG000|Overall Study|Lost to Follow-up|2|||
161810634|NCT03616535|584349470|FG001|Overall Study|Lost to Follow-up|1|||
161810635|NCT03616535|584349471|FG002|Overall Study|Lost to Follow-up|0|||
161810636|NCT03616535|584349472|FG003|Overall Study|Lost to Follow-up|2|||
161810637|NCT03616535|584349469|FG000|Overall Study|Withdrawal by Subject|1|||
161810638|NCT03616535|584349470|FG001|Overall Study|Withdrawal by Subject|2|||
161810639|NCT03616535|584349471|FG002|Overall Study|Withdrawal by Subject|5|||
161810640|NCT03616535|584349472|FG003|Overall Study|Withdrawal by Subject|1|||
161810641|NCT03616535|584349469|FG000|Overall Study|Not specified or change in eligibility|2|||
161810642|NCT03616535|584349470|FG001|Overall Study|Not specified or change in eligibility|3|||
161810643|NCT03616535|584349471|FG002|Overall Study|Not specified or change in eligibility|3|||
161810644|NCT03616535|584349472|FG003|Overall Study|Not specified or change in eligibility|1|||
161810645|NCT00834418|584349475|FG000|Overall Study|Adverse Event|0|||
161810646|NCT00834418|584349476|FG001|Overall Study|Adverse Event|2|||
161810647|NCT01705574|584349477|FG000|Double-Blind Phase|Lost to Follow-up|12|||
161810648|NCT01705574|584349478|FG001|Double-Blind Phase|Lost to Follow-up|16|||
161810649|NCT01705574|584349479|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161810650|NCT01705574|584349480|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161810651|NCT01705574|584349477|FG000|Double-Blind Phase|Adverse Event|3|||
161810652|NCT01705574|584349478|FG001|Double-Blind Phase|Adverse Event|10|||
161810653|NCT01705574|584349479|FG002|Double-Blind Phase|Adverse Event|0|||
161810654|NCT01705574|584349480|FG003|Double-Blind Phase|Adverse Event|0|||
161810655|NCT01705574|584349477|FG000|Double-Blind Phase|Withdrew Consent|8|||
161810656|NCT01705574|584349478|FG001|Double-Blind Phase|Withdrew Consent|5|||
161810657|NCT01705574|584349479|FG002|Double-Blind Phase|Withdrew Consent|0|||
161810658|NCT01705574|584349480|FG003|Double-Blind Phase|Withdrew Consent|0|||
161810659|NCT01705574|584349477|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
161810660|NCT01705574|584349478|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
161810661|NCT01705574|584349479|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
161810662|NCT01705574|584349480|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
161810663|NCT01705574|584349477|FG000|Double-Blind Phase|Pregnancy|1|||
161810664|NCT01705574|584349478|FG001|Double-Blind Phase|Pregnancy|1|||
161810665|NCT01705574|584349479|FG002|Double-Blind Phase|Pregnancy|0|||
161810666|NCT01705574|584349480|FG003|Double-Blind Phase|Pregnancy|0|||
161810667|NCT01705574|584349477|FG000|Double-Blind Phase|Protocol Violation|1|||
161810668|NCT01705574|584349478|FG001|Double-Blind Phase|Protocol Violation|0|||
161810669|NCT01705574|584349479|FG002|Double-Blind Phase|Protocol Violation|0|||
161810670|NCT01705574|584349480|FG003|Double-Blind Phase|Protocol Violation|0|||
161810671|NCT01705574|584349477|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
161810672|NCT01705574|584349478|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
161810673|NCT01705574|584349479|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
161810674|NCT01705574|584349480|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
161810675|NCT01705574|584349477|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
161810676|NCT01705574|584349478|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
161810677|NCT01705574|584349479|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
161810678|NCT01705574|584349480|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
161810679|NCT01705574|584349477|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
161810680|NCT01705574|584349478|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
161810681|NCT01705574|584349479|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
161810682|NCT01705574|584349480|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
162154685|NCT02590432|585617113|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
161810683|NCT01705574|584349477|FG000|Open-Label Extension Phase|Adverse Event|3|||
161810684|NCT01705574|584349478|FG001|Open-Label Extension Phase|Adverse Event|0|||
161810685|NCT01705574|584349479|FG002|Open-Label Extension Phase|Adverse Event|0|||
161810686|NCT01705574|584349480|FG003|Open-Label Extension Phase|Adverse Event|1|||
161810687|NCT01705574|584349477|FG000|Open-Label Extension Phase|Death|2|||
161810688|NCT01705574|584349478|FG001|Open-Label Extension Phase|Death|0|||
161810689|NCT01705574|584349479|FG002|Open-Label Extension Phase|Death|1|||
161810690|NCT01705574|584349480|FG003|Open-Label Extension Phase|Death|0|||
162154686|NCT02590432|585617114|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
161810691|NCT01705574|584349477|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
161810692|NCT01705574|584349478|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
161810693|NCT01705574|584349479|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
161810694|NCT01705574|584349480|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
161810695|NCT01705574|584349477|FG000|Open-Label Extension Phase|Physician Decision|0|||
161810696|NCT01705574|584349478|FG001|Open-Label Extension Phase|Physician Decision|0|||
161810697|NCT01705574|584349479|FG002|Open-Label Extension Phase|Physician Decision|2|||
161810698|NCT01705574|584349480|FG003|Open-Label Extension Phase|Physician Decision|0|||
161810699|NCT01705574|584349477|FG000|Open-Label Extension Phase|Pregnancy|0|||
161810700|NCT01705574|584349478|FG001|Open-Label Extension Phase|Pregnancy|0|||
161810701|NCT01705574|584349479|FG002|Open-Label Extension Phase|Pregnancy|1|||
161810702|NCT01705574|584349480|FG003|Open-Label Extension Phase|Pregnancy|1|||
161810703|NCT02659150|584349481|FG000|Subject Enrollment|Physician Decision|3|||
161810704|NCT02659150|584349481|FG000|Subject Enrollment|Withdrawal by Subject|2|||
161810705|NCT02659150|584349481|FG000|Baseline Imaging|Withdrawal by Subject|1|||
161810706|NCT02659150|584349481|FG000|Baseline Imaging|Physician Decision|1|||
161810707|NCT02659150|584349481|FG000|Study Drug Dosing|Adverse Event|1|||
161810708|NCT02678286|584349482|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
161810709|NCT02678286|584349483|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
161810710|NCT02678286|584349482|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
161810711|NCT02678286|584349483|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
161810712|NCT02678286|584349482|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
161810713|NCT02678286|584349483|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
161810714|NCT02678286|584349482|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
161810715|NCT02678286|584349483|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
161810716|NCT02678286|584349482|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
161810717|NCT02678286|584349483|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
161810718|NCT01827163|584349486|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
161810719|NCT01827163|584349486|FG000|Overall Study|Adverse Event|9|||
161810720|NCT03375463|584349487|FG000|Period 1|Lost to Follow-up|0|||
161810721|NCT03375463|584349488|FG001|Period 1|Lost to Follow-up|0|||
161810722|NCT03375463|584349489|FG002|Period 1|Lost to Follow-up|1|||
161810723|NCT03375463|584349490|FG003|Period 1|Lost to Follow-up|0|||
161810724|NCT03375463|584349491|FG004|Period 1|Lost to Follow-up|0|||
161810725|NCT03375463|584349492|FG005|Period 1|Lost to Follow-up|0|||
161810726|NCT03375463|584349487|FG000|Period 1|Adverse Event|0|||
161810727|NCT03375463|584349488|FG001|Period 1|Adverse Event|0|||
161810728|NCT03375463|584349489|FG002|Period 1|Adverse Event|0|||
161810729|NCT03375463|584349490|FG003|Period 1|Adverse Event|0|||
161810730|NCT03375463|584349491|FG004|Period 1|Adverse Event|1|||
161810731|NCT03375463|584349492|FG005|Period 1|Adverse Event|0|||
161810732|NCT03375463|584349487|FG000|Period 2|Lost to Follow-up|1|||
161810733|NCT03375463|584349488|FG001|Period 2|Lost to Follow-up|1|||
161810734|NCT03375463|584349489|FG002|Period 2|Lost to Follow-up|0|||
161810735|NCT03375463|584349490|FG003|Period 2|Lost to Follow-up|0|||
161810736|NCT03375463|584349491|FG004|Period 2|Lost to Follow-up|0|||
161810737|NCT03375463|584349492|FG005|Period 2|Lost to Follow-up|0|||
161810738|NCT02909907|584349495|FG000|Overall Study|Withdrawal by Subject|0|||
161810739|NCT02909907|584349496|FG001|Overall Study|Withdrawal by Subject|1|||
161810740|NCT02902211|584349497|FG000|First Three Months|Withdrawal by Subject|7|||
161810741|NCT02902211|584349498|FG001|First Three Months|Withdrawal by Subject|3|||
161810742|NCT01513174|584349499|FG000|Overall Study|Inclusion Error|1|||
161810743|NCT01513174|584349500|FG001|Overall Study|Inclusion Error|7|||
161810744|NCT01513174|584349499|FG000|Overall Study|Not receive study treatment|3|||
161810745|NCT01513174|584349500|FG001|Overall Study|Not receive study treatment|1|||
161810746|NCT01900626|584349503|FG000|Overall Study|study was closed due to low enrollment|1|||
161810747|NCT01900626|584349504|FG001|Overall Study|study was closed due to low enrollment|1|||
161810748|NCT03098394|584349512|FG000|Overall Study|Pregnancy|0|||
162013001|NCT02113982|585103851|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162154687|NCT02590432|585617115|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
162154688|NCT02590432|585617107|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
162154689|NCT02590432|585617108|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
162154690|NCT02590432|585617109|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
162154691|NCT02590432|585617110|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
161810749|NCT03098394|584349513|FG001|Overall Study|Pregnancy|1|||
161810750|NCT04408794|584349514|FG000|Overall Study|Adverse Event|43|||
161810751|NCT04408794|584349514|FG000|Overall Study|Infrequent study drug usage|43|||
161810752|NCT04408794|584349514|FG000|Overall Study|Lack of Efficacy|61|||
161810753|NCT04408794|584349514|FG000|Overall Study|Lost to Follow-up|33|||
161810754|NCT04408794|584349514|FG000|Overall Study|Non-compliance|6|||
161810755|NCT04408794|584349514|FG000|Overall Study|Physician Decision|1|||
161810756|NCT04408794|584349514|FG000|Overall Study|Pregnancy|6|||
161810757|NCT04408794|584349514|FG000|Overall Study|Protocol Deviation|9|||
161810758|NCT04408794|584349514|FG000|Overall Study|Sheehan-STS Result|1|||
161810759|NCT04408794|584349514|FG000|Overall Study|Withdrawal by Subject|57|||
161810760|NCT04408794|584349514|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
162013002|NCT02113982|585103852|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162013003|NCT02113982|585103853|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162013004|NCT02113982|585103854|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162013005|NCT02113982|585103855|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162013006|NCT02113982|585103856|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162013007|NCT02113982|585103857|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162013008|NCT02113982|585103858|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162013009|NCT02113982|585103859|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
162013010|NCT02113982|585103860|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
162013011|NCT02113982|585103847|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
162013012|NCT02113982|585103848|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
161810761|NCT04408794|584349514|FG000|Overall Study|Never Treated Migraine|5|||
161810762|NCT02159950|584349521|FG000|Overall Study|Adverse Event|0|||
161810763|NCT02159950|584349522|FG001|Overall Study|Adverse Event|1|||
161810764|NCT02159950|584349521|FG000|Overall Study|Progression|0|||
161810765|NCT02159950|584349522|FG001|Overall Study|Progression|1|||
161810766|NCT03872128|584349525|FG000|Overall Study|Dropped out before treatment|1|||
161810767|NCT03872128|584349526|FG001|Overall Study|Dropped out before treatment|0|||
161810768|NCT03872128|584349527|FG002|Overall Study|Dropped out before treatment|4|||
161810769|NCT03872128|584349525|FG000|Overall Study|Lost to Follow-up|2|||
161810770|NCT03872128|584349526|FG001|Overall Study|Lost to Follow-up|5|||
161810771|NCT03872128|584349527|FG002|Overall Study|Lost to Follow-up|8|||
161810772|NCT04400890|584349532|FG000|Overall Study|Withdrawal by Subject|3|||
161810773|NCT04400890|584349533|FG001|Overall Study|Withdrawal by Subject|2|||
161810774|NCT03925532|584349534|FG000|Overall Study|Lost to Follow-up|1|||
161810775|NCT02258074|584349535|FG000|Overall Study|Withdrawal by Subject|1|||
161810776|NCT02258074|584349536|FG001|Overall Study|Withdrawal by Subject|0|||
162154692|NCT02590432|585617111|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
162154693|NCT02590432|585617112|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
162154694|NCT02590432|585617113|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
162154695|NCT02590432|585617114|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
162154696|NCT02590432|585617115|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
162154697|NCT02590432|585617107|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
162154698|NCT02590432|585617108|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
162154699|NCT02590432|585617109|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
161810777|NCT02258074|584349537|FG002|Overall Study|Withdrawal by Subject|0|||
161810778|NCT02258074|584349538|FG003|Overall Study|Withdrawal by Subject|0|||
162154700|NCT02590432|585617110|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
162154701|NCT02590432|585617111|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
162154702|NCT02590432|585617112|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
162154703|NCT02590432|585617113|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
162154704|NCT02590432|585617114|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
162154705|NCT02590432|585617115|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
162154706|NCT02590432|585617107|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162154707|NCT02590432|585617108|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162154708|NCT02590432|585617109|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162154709|NCT02590432|585617110|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162154710|NCT02590432|585617111|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162154711|NCT02590432|585617112|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
162154712|NCT02590432|585617113|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162154713|NCT02590432|585617114|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
162154714|NCT02590432|585617115|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161810779|NCT05446870|584349539|FG000|Overall Study|Death|6|||
161810780|NCT05446870|584349540|FG001|Overall Study|Death|5|||
161810781|NCT05446870|584349539|FG000|Overall Study|Lost to Follow-up|0|||
161810782|NCT05446870|584349540|FG001|Overall Study|Lost to Follow-up|1|||
161810783|NCT05446870|584349539|FG000|Overall Study|Physician Decision|52|||
161810784|NCT05446870|584349540|FG001|Overall Study|Physician Decision|53|||
161810785|NCT05446870|584349539|FG000|Overall Study|Withdrawal by Subject|3|||
161810786|NCT05446870|584349540|FG001|Overall Study|Withdrawal by Subject|3|||
161810787|NCT01615198|584349543|FG000|Overall Study|Withdrawal by Subject|5|||
161810788|NCT01615198|584349544|FG001|Overall Study|Withdrawal by Subject|5|||
161810789|NCT01615198|584349543|FG000|Overall Study|Protocol deviation|1|||
161810790|NCT01615198|584349544|FG001|Overall Study|Protocol deviation|1|||
161810791|NCT01615198|584349543|FG000|Overall Study|Physician Decision|5|||
161810792|NCT01615198|584349544|FG001|Overall Study|Physician Decision|1|||
161810793|NCT01615198|584349543|FG000|Overall Study|Lost to Follow-up|1|||
161914998|NCT01572792|584737356|FG000|Lead-in Study|Withdrawal by Subject|22|||
162154715|NCT02590432|585617107|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162154716|NCT02590432|585617108|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162154717|NCT02590432|585617109|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162154718|NCT02590432|585617110|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162154719|NCT02590432|585617111|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162154720|NCT02590432|585617112|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162154721|NCT02590432|585617113|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
162154722|NCT02590432|585617114|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
162154723|NCT02590432|585617115|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
162154724|NCT02590432|585617107|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162154725|NCT02590432|585617108|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162154726|NCT02590432|585617109|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162154727|NCT02590432|585617110|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162154728|NCT02590432|585617111|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162154729|NCT02590432|585617112|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162154730|NCT02590432|585617113|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162154731|NCT02590432|585617114|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
162154732|NCT02590432|585617115|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
162154733|NCT02590432|585617107|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162154734|NCT02590432|585617108|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162154735|NCT02590432|585617109|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162154736|NCT02590432|585617110|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162154737|NCT02590432|585617111|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162154738|NCT02590432|585617112|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162154739|NCT02590432|585617113|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
162154740|NCT02590432|585617114|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
162154741|NCT02590432|585617115|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
162154742|NCT02590432|585617107|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162154743|NCT02590432|585617108|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162154744|NCT02590432|585617109|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162154745|NCT02590432|585617110|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162154746|NCT02590432|585617111|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162154747|NCT02590432|585617112|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162154748|NCT02590432|585617113|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162154749|NCT02590432|585617114|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
162154750|NCT02590432|585617115|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
162154751|NCT02590432|585617107|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162154752|NCT02590432|585617108|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162154753|NCT02590432|585617109|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162154754|NCT02590432|585617110|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162154755|NCT02590432|585617111|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162154756|NCT02590432|585617112|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162154757|NCT02590432|585617113|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162154758|NCT02590432|585617114|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
162154759|NCT02590432|585617115|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
162154760|NCT02590432|585617107|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161810794|NCT01615198|584349544|FG001|Overall Study|Lost to Follow-up|1|||
161914999|NCT01572792|584737357|FG001|Lead-in Study|Withdrawal by Subject|11|||
161915000|NCT01572792|584737358|FG002|Lead-in Study|Withdrawal by Subject|12|||
161810795|NCT01615198|584349543|FG000|Overall Study|Lack of Efficacy|1|||
161810796|NCT01615198|584349544|FG001|Overall Study|Lack of Efficacy|6|||
162154761|NCT02590432|585617108|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162154762|NCT02590432|585617109|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162154763|NCT02590432|585617110|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162154764|NCT02590432|585617111|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162154765|NCT02590432|585617112|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162154766|NCT02590432|585617113|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162154767|NCT02590432|585617114|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
161810797|NCT01615198|584349543|FG000|Overall Study|Adverse Event|11|||
161810798|NCT01615198|584349544|FG001|Overall Study|Adverse Event|5|||
161810799|NCT01686438|584349545|FG000|Overall Study|Lost to Follow-up|8|||
161810800|NCT01686438|584349546|FG001|Overall Study|Lost to Follow-up|9|||
161810801|NCT01686438|584349547|FG002|Overall Study|Lost to Follow-up|10|||
161810802|NCT01686438|584349545|FG000|Overall Study|Adverse Event|0|||
161810803|NCT01686438|584349546|FG001|Overall Study|Adverse Event|0|||
161810804|NCT01686438|584349547|FG002|Overall Study|Adverse Event|1|||
161810805|NCT01686438|584349545|FG000|Overall Study|Protocol Violation|0|||
161810806|NCT01686438|584349546|FG001|Overall Study|Protocol Violation|0|||
161810807|NCT01686438|584349547|FG002|Overall Study|Protocol Violation|1|||
161810808|NCT01686438|584349545|FG000|Overall Study|Withdrawal by Subject|0|||
161810809|NCT01686438|584349546|FG001|Overall Study|Withdrawal by Subject|0|||
161810810|NCT01686438|584349547|FG002|Overall Study|Withdrawal by Subject|1|||
161810811|NCT00984126|584349548|FG000|Overall Study|Protocol Violation|0|||
161810812|NCT00984126|584349549|FG001|Overall Study|Protocol Violation|0|||
161810813|NCT00984126|584349550|FG002|Overall Study|Protocol Violation|1|||
161810814|NCT00984126|584349551|FG003|Overall Study|Protocol Violation|2|||
161810815|NCT00984126|584349548|FG000|Overall Study|Adverse Event|0|||
161810816|NCT00984126|584349549|FG001|Overall Study|Adverse Event|0|||
161810817|NCT00984126|584349550|FG002|Overall Study|Adverse Event|0|||
161810818|NCT00984126|584349551|FG003|Overall Study|Adverse Event|2|||
161810819|NCT00984126|584349548|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
161810820|NCT00984126|584349549|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
161810821|NCT00984126|584349550|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
161810822|NCT00984126|584349551|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
161810823|NCT00984126|584349548|FG000|Overall Study|Withdrawal criteria|0|||
161810824|NCT00984126|584349549|FG001|Overall Study|Withdrawal criteria|1|||
161810825|NCT00984126|584349550|FG002|Overall Study|Withdrawal criteria|3|||
161810826|NCT00984126|584349551|FG003|Overall Study|Withdrawal criteria|9|||
161810827|NCT01029340|584349554|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
161810828|NCT01029340|584349555|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
161810829|NCT01029340|584349556|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
161810830|NCT01029340|584349557|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
161810831|NCT01029340|584349558|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
161810832|NCT01029340|584349559|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
161810833|NCT01029340|584349554|FG000|Part B Treatment Period|Protocol Violation|0|||
161810834|NCT01029340|584349555|FG001|Part B Treatment Period|Protocol Violation|0|||
161810835|NCT01029340|584349556|FG002|Part B Treatment Period|Protocol Violation|1|||
161810836|NCT01029340|584349557|FG003|Part B Treatment Period|Protocol Violation|0|||
161810837|NCT01029340|584349558|FG004|Part B Treatment Period|Protocol Violation|0|||
161810838|NCT01029340|584349559|FG005|Part B Treatment Period|Protocol Violation|0|||
161810839|NCT01029340|584349554|FG000|Extension Period|Adverse Event|0|||
161810840|NCT01029340|584349555|FG001|Extension Period|Adverse Event|0|||
161810841|NCT01029340|584349556|FG002|Extension Period|Adverse Event|0|||
161810842|NCT01029340|584349557|FG003|Extension Period|Adverse Event|0|||
161810843|NCT01029340|584349558|FG004|Extension Period|Adverse Event|0|||
161810844|NCT01029340|584349559|FG005|Extension Period|Adverse Event|1|||
161810845|NCT01029340|584349554|FG000|Extension Period|starting another study|0|||
161810846|NCT01029340|584349555|FG001|Extension Period|starting another study|0|||
161810847|NCT01029340|584349556|FG002|Extension Period|starting another study|0|||
161810848|NCT01029340|584349557|FG003|Extension Period|starting another study|0|||
161810849|NCT01029340|584349558|FG004|Extension Period|starting another study|0|||
161810850|NCT01029340|584349559|FG005|Extension Period|starting another study|8|||
161810851|NCT01029340|584349554|FG000|Extension Period|non-compliance|0|||
161810852|NCT01029340|584349555|FG001|Extension Period|non-compliance|0|||
161810853|NCT01029340|584349556|FG002|Extension Period|non-compliance|0|||
161810854|NCT01029340|584349557|FG003|Extension Period|non-compliance|0|||
161810855|NCT01029340|584349558|FG004|Extension Period|non-compliance|0|||
161810856|NCT01029340|584349559|FG005|Extension Period|non-compliance|1|||
161810857|NCT01029340|584349554|FG000|Extension Period|Withdrawal by Subject|0|||
161810858|NCT01029340|584349555|FG001|Extension Period|Withdrawal by Subject|0|||
161810859|NCT01029340|584349556|FG002|Extension Period|Withdrawal by Subject|0|||
161810860|NCT01029340|584349557|FG003|Extension Period|Withdrawal by Subject|0|||
161810861|NCT01029340|584349558|FG004|Extension Period|Withdrawal by Subject|0|||
161810862|NCT01029340|584349559|FG005|Extension Period|Withdrawal by Subject|1|||
161810863|NCT01029340|584349554|FG000|Extension Period|Physician Decision|0|||
162013013|NCT02113982|585103849|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
162013014|NCT02113982|585103850|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
162013015|NCT02113982|585103851|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
162013016|NCT02113982|585103852|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
162013017|NCT02113982|585103853|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
162013018|NCT02113982|585103854|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
162013019|NCT02113982|585103855|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
162013020|NCT02113982|585103856|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
162013021|NCT02113982|585103857|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
162013022|NCT02113982|585103858|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
162013023|NCT02113982|585103859|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
162013024|NCT02113982|585103860|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
162013025|NCT01772316|585103862|FG000|Overall Study|Serious adverse event|1|||
162013026|NCT01772316|585103862|FG000|Overall Study|Inform consent withdrawn|1|||
162013027|NCT01772316|585103862|FG000|Overall Study|Withdrawn by sponsor decision|5|||
162013028|NCT02085161|585103863|FG000|Overall Study|Not Treated|1|||
162013029|NCT02085161|585103864|FG001|Overall Study|Not Treated|0|||
162013030|NCT02085161|585103865|FG002|Overall Study|Not Treated|0|||
162013031|NCT02085161|585103866|FG003|Overall Study|Not Treated|0|||
162013032|NCT02085161|585103863|FG000|Overall Study|Adverse Event|8|||
162013033|NCT02085161|585103864|FG001|Overall Study|Adverse Event|5|||
162013034|NCT02085161|585103865|FG002|Overall Study|Adverse Event|4|||
162013035|NCT02085161|585103866|FG003|Overall Study|Adverse Event|5|||
162013036|NCT02085161|585103863|FG000|Overall Study|Protocol Violation|0|||
162013037|NCT02085161|585103864|FG001|Overall Study|Protocol Violation|1|||
162013038|NCT02085161|585103865|FG002|Overall Study|Protocol Violation|0|||
162013039|NCT02085161|585103866|FG003|Overall Study|Protocol Violation|1|||
162013040|NCT02085161|585103863|FG000|Overall Study|Withdrawal by Subject|2|||
162013041|NCT02085161|585103864|FG001|Overall Study|Withdrawal by Subject|4|||
162013042|NCT02085161|585103865|FG002|Overall Study|Withdrawal by Subject|0|||
162013043|NCT02085161|585103866|FG003|Overall Study|Withdrawal by Subject|3|||
162013044|NCT02085161|585103863|FG000|Overall Study|Other Reason|1|||
161810864|NCT01029340|584349555|FG001|Extension Period|Physician Decision|0|||
161810865|NCT01029340|584349556|FG002|Extension Period|Physician Decision|0|||
161810866|NCT01029340|584349557|FG003|Extension Period|Physician Decision|0|||
161810867|NCT01029340|584349558|FG004|Extension Period|Physician Decision|0|||
161810868|NCT01029340|584349559|FG005|Extension Period|Physician Decision|1|||
161810869|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
161810870|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
162154768|NCT02590432|585617115|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
162154769|NCT02590432|585617107|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161810871|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
161810872|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
161810873|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
161810874|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
161810875|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
161810876|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
162013045|NCT02085161|585103864|FG001|Overall Study|Other Reason|0|||
162013046|NCT02085161|585103865|FG002|Overall Study|Other Reason|1|||
162013047|NCT02085161|585103866|FG003|Overall Study|Other Reason|1|||
162013048|NCT00068692|585103877|FG000|Step 1: Registration|Disese progression/relapse|5|||
162013049|NCT00068692|585103878|FG001|Step 1: Registration|Disese progression/relapse|0|||
162013050|NCT00068692|585103879|FG002|Step 1: Registration|Disese progression/relapse|0|||
162013051|NCT00068692|585103880|FG003|Step 1: Registration|Disese progression/relapse|0|||
162013052|NCT00068692|585103881|FG004|Step 1: Registration|Disese progression/relapse|0|||
162154770|NCT02590432|585617108|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162154771|NCT02590432|585617109|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162154772|NCT02590432|585617110|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162154773|NCT02590432|585617111|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162154774|NCT02590432|585617112|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162154775|NCT02590432|585617113|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162154776|NCT02590432|585617114|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
162154777|NCT02590432|585617115|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
162154778|NCT00409838|585617116|FG000|Short-term Period|Adverse Event|0|||
161810877|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
161810878|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
161810879|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
161810880|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
162013053|NCT00068692|585103882|FG005|Step 1: Registration|Disese progression/relapse|0|||
161810881|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
161810882|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
161810883|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
161810884|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
161810885|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
161810886|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
161810887|NCT02009163|584349564|FG000|Open-label Period (Non-randomized)|Other|13|||
161810888|NCT02009163|584349565|FG001|Open-label Period (Non-randomized)|Other|0|||
161810889|NCT02009163|584349566|FG002|Open-label Period (Non-randomized)|Other|0|||
161810890|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
161810891|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
162013054|NCT00068692|585103883|FG006|Step 1: Registration|Disese progression/relapse|0|||
162013055|NCT00068692|585103884|FG007|Step 1: Registration|Disese progression/relapse|0|||
162013056|NCT00068692|585103877|FG000|Step 1: Registration|Adverse Event|7|||
162013057|NCT00068692|585103878|FG001|Step 1: Registration|Adverse Event|0|||
162013058|NCT00068692|585103879|FG002|Step 1: Registration|Adverse Event|0|||
162013059|NCT00068692|585103880|FG003|Step 1: Registration|Adverse Event|0|||
162013060|NCT00068692|585103881|FG004|Step 1: Registration|Adverse Event|0|||
162013061|NCT00068692|585103882|FG005|Step 1: Registration|Adverse Event|0|||
162154779|NCT00409838|585617117|FG001|Short-term Period|Adverse Event|1|||
162154780|NCT00409838|585617116|FG000|Short-term Period|Lost to Follow-up|0|||
162154781|NCT00409838|585617117|FG001|Short-term Period|Lost to Follow-up|1|||
162154782|NCT00409838|585617116|FG000|Short-term Period|Withdrawal by Subject|2|||
162154783|NCT00409838|585617117|FG001|Short-term Period|Withdrawal by Subject|3|||
162154784|NCT00409838|585617116|FG000|Short-term Period|Never Treated|1|||
162154785|NCT00409838|585617117|FG001|Short-term Period|Never Treated|0|||
162154786|NCT00409838|585617116|FG000|Long-term Extension Period|Adverse Event|10|||
162154787|NCT00409838|585617117|FG001|Long-term Extension Period|Adverse Event|0|||
162154788|NCT00409838|585617116|FG000|Long-term Extension Period|Death|1|||
162154789|NCT00409838|585617117|FG001|Long-term Extension Period|Death|0|||
162154790|NCT00409838|585617116|FG000|Long-term Extension Period|Lack of Efficacy|2|||
162154791|NCT00409838|585617117|FG001|Long-term Extension Period|Lack of Efficacy|0|||
162154792|NCT00409838|585617116|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
162154793|NCT00409838|585617117|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
162154794|NCT00409838|585617116|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
162154795|NCT00409838|585617117|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
162154796|NCT00409838|585617116|FG000|Long-term Extension Period|Pregnancy|1|||
162154797|NCT00409838|585617117|FG001|Long-term Extension Period|Pregnancy|0|||
162154798|NCT04788641|585617119|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
162154799|NCT04788641|585617120|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
162154800|NCT04788641|585617121|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
162154801|NCT04788641|585617122|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
162154802|NCT04788641|585617119|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
162154803|NCT04788641|585617120|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
162154804|NCT04788641|585617121|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
162154805|NCT04788641|585617122|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
162154806|NCT04788641|585617119|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
162154807|NCT04788641|585617120|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
162154808|NCT04788641|585617121|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
162154809|NCT04788641|585617122|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
162154810|NCT01250769|585617123|FG000|Overall Study|Withdrawal by Subject|0|||
162154811|NCT01250769|585617124|FG001|Overall Study|Withdrawal by Subject|1|||
162154812|NCT01250769|585617125|FG002|Overall Study|Withdrawal by Subject|1|||
162154813|NCT01250769|585617126|FG003|Overall Study|Withdrawal by Subject|0|||
162154814|NCT01250769|585617123|FG000|Overall Study|Adverse Event|0|||
162154815|NCT01250769|585617124|FG001|Overall Study|Adverse Event|0|||
162154816|NCT01250769|585617125|FG002|Overall Study|Adverse Event|1|||
162154817|NCT01250769|585617126|FG003|Overall Study|Adverse Event|0|||
162154818|NCT01985334|585617127|FG000|Overall Study|Administrative problems|1|||
162154819|NCT01985334|585617128|FG001|Overall Study|Administrative problems|1|||
162154820|NCT01985334|585617129|FG002|Overall Study|Administrative problems|0|||
162154821|NCT01985334|585617130|FG003|Overall Study|Administrative problems|2|||
162154822|NCT01985334|585617131|FG004|Overall Study|Administrative problems|0|||
162154823|NCT01985334|585617132|FG005|Overall Study|Administrative problems|1|||
162154824|NCT01985334|585617133|FG006|Overall Study|Administrative problems|1|||
162154825|NCT01985334|585617134|FG007|Overall Study|Administrative problems|3|||
162154826|NCT01985334|585617127|FG000|Overall Study|Death|1|||
162154827|NCT01985334|585617128|FG001|Overall Study|Death|0|||
162154828|NCT01985334|585617129|FG002|Overall Study|Death|0|||
162154829|NCT01985334|585617130|FG003|Overall Study|Death|3|||
162154830|NCT01985334|585617131|FG004|Overall Study|Death|0|||
162013062|NCT00068692|585103883|FG006|Step 1: Registration|Adverse Event|0|||
162013063|NCT00068692|585103884|FG007|Step 1: Registration|Adverse Event|0|||
161810892|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
161810893|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
161810894|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
161810895|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
161810896|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Adverse Event|0|||
161810897|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Adverse Event|0|||
161810898|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Adverse Event|6|||
161810899|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
162013064|NCT00068692|585103877|FG000|Step 1: Registration|Death|1|||
162013065|NCT00068692|585103878|FG001|Step 1: Registration|Death|0|||
162013066|NCT00068692|585103879|FG002|Step 1: Registration|Death|0|||
162013067|NCT00068692|585103880|FG003|Step 1: Registration|Death|0|||
162013068|NCT00068692|585103881|FG004|Step 1: Registration|Death|0|||
162013069|NCT00068692|585103882|FG005|Step 1: Registration|Death|0|||
162013070|NCT00068692|585103883|FG006|Step 1: Registration|Death|0|||
162013071|NCT00068692|585103884|FG007|Step 1: Registration|Death|0|||
162013072|NCT00068692|585103877|FG000|Step 1: Registration|Withdrawal by Subject|11|||
162013073|NCT00068692|585103878|FG001|Step 1: Registration|Withdrawal by Subject|0|||
162013074|NCT00068692|585103879|FG002|Step 1: Registration|Withdrawal by Subject|0|||
162013075|NCT00068692|585103880|FG003|Step 1: Registration|Withdrawal by Subject|0|||
162013076|NCT00068692|585103881|FG004|Step 1: Registration|Withdrawal by Subject|0|||
162013077|NCT00068692|585103882|FG005|Step 1: Registration|Withdrawal by Subject|0|||
162013078|NCT00068692|585103883|FG006|Step 1: Registration|Withdrawal by Subject|0|||
162013079|NCT00068692|585103884|FG007|Step 1: Registration|Withdrawal by Subject|0|||
162154831|NCT01985334|585617132|FG005|Overall Study|Death|0|||
162154832|NCT01985334|585617133|FG006|Overall Study|Death|1|||
162154833|NCT01985334|585617134|FG007|Overall Study|Death|2|||
162154834|NCT01985334|585617127|FG000|Overall Study|Worsening of disease|0|||
162154835|NCT01985334|585617128|FG001|Overall Study|Worsening of disease|0|||
162013080|NCT00068692|585103877|FG000|Step 1: Registration|Alternative therapy|2|||
162013081|NCT00068692|585103878|FG001|Step 1: Registration|Alternative therapy|0|||
162013082|NCT00068692|585103879|FG002|Step 1: Registration|Alternative therapy|0|||
162013083|NCT00068692|585103880|FG003|Step 1: Registration|Alternative therapy|0|||
162013084|NCT00068692|585103881|FG004|Step 1: Registration|Alternative therapy|0|||
162013085|NCT00068692|585103882|FG005|Step 1: Registration|Alternative therapy|0|||
162013086|NCT00068692|585103883|FG006|Step 1: Registration|Alternative therapy|0|||
162013087|NCT00068692|585103884|FG007|Step 1: Registration|Alternative therapy|0|||
162013088|NCT00068692|585103877|FG000|Step 1: Registration|Complicating disease|2|||
162013089|NCT00068692|585103878|FG001|Step 1: Registration|Complicating disease|0|||
162013090|NCT00068692|585103879|FG002|Step 1: Registration|Complicating disease|0|||
162154836|NCT01985334|585617129|FG002|Overall Study|Worsening of disease|0|||
162154837|NCT01985334|585617130|FG003|Overall Study|Worsening of disease|1|||
162154838|NCT01985334|585617131|FG004|Overall Study|Worsening of disease|0|||
162154839|NCT01985334|585617132|FG005|Overall Study|Worsening of disease|3|||
162154840|NCT01985334|585617133|FG006|Overall Study|Worsening of disease|0|||
162154841|NCT01985334|585617134|FG007|Overall Study|Worsening of disease|1|||
162154842|NCT01985334|585617127|FG000|Overall Study|Other|2|||
162154843|NCT01985334|585617128|FG001|Overall Study|Other|9|||
162154844|NCT01985334|585617129|FG002|Overall Study|Other|7|||
161810900|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
162154845|NCT01985334|585617130|FG003|Overall Study|Other|17|||
162154846|NCT01985334|585617131|FG004|Overall Study|Other|4|||
162154847|NCT01985334|585617132|FG005|Overall Study|Other|8|||
162154848|NCT01985334|585617133|FG006|Overall Study|Other|4|||
162154849|NCT01985334|585617134|FG007|Overall Study|Other|7|||
162154850|NCT01985334|585617127|FG000|Overall Study|Protocol deviation|6|||
162154851|NCT01985334|585617128|FG001|Overall Study|Protocol deviation|31|||
162154852|NCT01985334|585617129|FG002|Overall Study|Protocol deviation|25|||
162154853|NCT01985334|585617130|FG003|Overall Study|Protocol deviation|84|||
162154854|NCT01985334|585617131|FG004|Overall Study|Protocol deviation|17|||
162154855|NCT01985334|585617132|FG005|Overall Study|Protocol deviation|47|||
162154856|NCT01985334|585617133|FG006|Overall Study|Protocol deviation|15|||
162154857|NCT01985334|585617134|FG007|Overall Study|Protocol deviation|42|||
162154858|NCT01985334|585617127|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
162154859|NCT01985334|585617128|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
162154860|NCT01985334|585617129|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
162154861|NCT01985334|585617130|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
161810901|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
162013091|NCT00068692|585103880|FG003|Step 1: Registration|Complicating disease|0|||
162013092|NCT00068692|585103881|FG004|Step 1: Registration|Complicating disease|0|||
162013093|NCT00068692|585103882|FG005|Step 1: Registration|Complicating disease|0|||
162013094|NCT00068692|585103883|FG006|Step 1: Registration|Complicating disease|0|||
162013095|NCT00068692|585103884|FG007|Step 1: Registration|Complicating disease|0|||
161915001|NCT01572792|584737359|FG003|Lead-in Study|Withdrawal by Subject|24|||
161915002|NCT01572792|584737360|FG004|Lead-in Study|Withdrawal by Subject|11|||
161915003|NCT01572792|584737356|FG000|Lead-in Study|Protocol Violation|19|||
161915004|NCT01572792|584737357|FG001|Lead-in Study|Protocol Violation|10|||
161915005|NCT01572792|584737358|FG002|Lead-in Study|Protocol Violation|12|||
161915006|NCT01572792|584737359|FG003|Lead-in Study|Protocol Violation|13|||
161915007|NCT01572792|584737360|FG004|Lead-in Study|Protocol Violation|21|||
161915008|NCT01572792|584737356|FG000|Lead-in Study|Lack of Efficacy|20|||
161915009|NCT01572792|584737357|FG001|Lead-in Study|Lack of Efficacy|5|||
161915010|NCT01572792|584737358|FG002|Lead-in Study|Lack of Efficacy|4|||
161915011|NCT01572792|584737359|FG003|Lead-in Study|Lack of Efficacy|8|||
161915012|NCT01572792|584737360|FG004|Lead-in Study|Lack of Efficacy|10|||
161915013|NCT01572792|584737356|FG000|Lead-in Study|Adverse Event|21|||
161915014|NCT01572792|584737357|FG001|Lead-in Study|Adverse Event|21|||
161915015|NCT01572792|584737358|FG002|Lead-in Study|Adverse Event|22|||
161915016|NCT01572792|584737359|FG003|Lead-in Study|Adverse Event|16|||
161915017|NCT01572792|584737360|FG004|Lead-in Study|Adverse Event|14|||
161915018|NCT01572792|584737356|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
161915019|NCT01572792|584737357|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
161915020|NCT01572792|584737358|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
161915021|NCT01572792|584737359|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
161915022|NCT01572792|584737360|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
161915023|NCT01572792|584737356|FG000|Extension Study|Lost to Follow-up|6|||
161810902|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
162013096|NCT00068692|585103877|FG000|Step 1: Registration|Protocol Violation|1|||
161810903|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
161810904|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
161810905|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Pregnancy|0|||
161810906|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Pregnancy|0|||
161810907|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Pregnancy|2|||
161810908|NCT02009163|584349564|FG000|Randomized-withdrawal Period|Other|0|||
161810909|NCT02009163|584349565|FG001|Randomized-withdrawal Period|Other|9|||
161810910|NCT02009163|584349566|FG002|Randomized-withdrawal Period|Other|5|||
161810911|NCT02453386|584349567|FG000|Overall Study|Adverse Event|22|||
161810912|NCT02453386|584349568|FG001|Overall Study|Adverse Event|30|||
161810913|NCT02453386|584349569|FG002|Overall Study|Adverse Event|15|||
161810914|NCT02453386|584349567|FG000|Overall Study|Protocol Violation|1|||
161810915|NCT02453386|584349568|FG001|Overall Study|Protocol Violation|0|||
161810916|NCT02453386|584349569|FG002|Overall Study|Protocol Violation|1|||
161810917|NCT02453386|584349567|FG000|Overall Study|Withdrawal by Subject|10|||
161810918|NCT02453386|584349568|FG001|Overall Study|Withdrawal by Subject|9|||
161810919|NCT02453386|584349569|FG002|Overall Study|Withdrawal by Subject|9|||
161810920|NCT02453386|584349567|FG000|Overall Study|Sponsor Terminated Study|14|||
161810921|NCT02453386|584349568|FG001|Overall Study|Sponsor Terminated Study|8|||
161810922|NCT02453386|584349569|FG002|Overall Study|Sponsor Terminated Study|11|||
161810923|NCT02453386|584349567|FG000|Overall Study|Subject Terminated by Sponsor|1|||
161810924|NCT02453386|584349568|FG001|Overall Study|Subject Terminated by Sponsor|1|||
161810925|NCT02453386|584349569|FG002|Overall Study|Subject Terminated by Sponsor|1|||
161810926|NCT02453386|584349567|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
161810927|NCT02453386|584349568|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
161810928|NCT02453386|584349569|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
161810929|NCT02453386|584349567|FG000|Overall Study|Lost to Follow-up|0|||
161810930|NCT02453386|584349568|FG001|Overall Study|Lost to Follow-up|0|||
161810931|NCT02453386|584349569|FG002|Overall Study|Lost to Follow-up|1|||
161810932|NCT02453386|584349567|FG000|Overall Study|Other|1|||
161810933|NCT02453386|584349568|FG001|Overall Study|Other|0|||
161810934|NCT02453386|584349569|FG002|Overall Study|Other|1|||
161810935|NCT00359281|584349570|FG000|Overall Study|Adverse Event|1|||
161810936|NCT00359281|584349571|FG001|Overall Study|Adverse Event|0|||
161810937|NCT00359281|584349572|FG002|Overall Study|Adverse Event|0|||
161810938|NCT00359281|584349573|FG003|Overall Study|Adverse Event|0|||
161810939|NCT00359281|584349574|FG004|Overall Study|Adverse Event|0|||
161810940|NCT00359281|584349575|FG005|Overall Study|Adverse Event|0|||
161810941|NCT00359281|584349576|FG006|Overall Study|Adverse Event|1|||
161810942|NCT00359281|584349577|FG007|Overall Study|Adverse Event|0|||
161810943|NCT00359281|584349578|FG008|Overall Study|Adverse Event|0|||
161810944|NCT00359281|584349570|FG000|Overall Study|Withdrawal by Subject|0|||
161810945|NCT00359281|584349571|FG001|Overall Study|Withdrawal by Subject|0|||
161810946|NCT00359281|584349572|FG002|Overall Study|Withdrawal by Subject|0|||
161810947|NCT00359281|584349573|FG003|Overall Study|Withdrawal by Subject|0|||
161810948|NCT00359281|584349574|FG004|Overall Study|Withdrawal by Subject|0|||
161810949|NCT00359281|584349575|FG005|Overall Study|Withdrawal by Subject|0|||
161810950|NCT00359281|584349576|FG006|Overall Study|Withdrawal by Subject|1|||
161810951|NCT00359281|584349577|FG007|Overall Study|Withdrawal by Subject|0|||
161810952|NCT00359281|584349578|FG008|Overall Study|Withdrawal by Subject|0|||
161810953|NCT01289262|584349581|FG000|Overall Study|Lost to Follow-up|29|||
161915024|NCT01572792|584737357|FG001|Extension Study|Lost to Follow-up|2|||
161915025|NCT01572792|584737358|FG002|Extension Study|Lost to Follow-up|0|||
161915026|NCT01572792|584737359|FG003|Extension Study|Lost to Follow-up|3|||
161915027|NCT01572792|584737360|FG004|Extension Study|Lost to Follow-up|3|||
161915028|NCT01572792|584737356|FG000|Extension Study|Withdrawal by Subject|7|||
161915029|NCT01572792|584737357|FG001|Extension Study|Withdrawal by Subject|6|||
161915030|NCT01572792|584737358|FG002|Extension Study|Withdrawal by Subject|11|||
161915031|NCT01572792|584737359|FG003|Extension Study|Withdrawal by Subject|8|||
161915032|NCT01572792|584737360|FG004|Extension Study|Withdrawal by Subject|14|||
161915033|NCT01572792|584737356|FG000|Extension Study|Protocol Violation|0|||
161915034|NCT01572792|584737357|FG001|Extension Study|Protocol Violation|4|||
161915035|NCT01572792|584737358|FG002|Extension Study|Protocol Violation|3|||
161915036|NCT01572792|584737359|FG003|Extension Study|Protocol Violation|4|||
162013097|NCT00068692|585103878|FG001|Step 1: Registration|Protocol Violation|0|||
161810954|NCT01289262|584349582|FG001|Overall Study|Lost to Follow-up|16|||
161810955|NCT01289262|584349581|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
161810956|NCT01289262|584349582|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
161810957|NCT01415986|584349585|FG000|Overall Study|Lost to Follow-up|1|||
161810958|NCT01474551|584349586|FG000|Overall Study|Death|1|||
161810959|NCT03122457|584349595|FG000|Overall Study|Withdrawal by Subject|6|||
161810960|NCT00446563|584349599|FG000|Overall Study|Adverse Event|4|||
161810961|NCT00446563|584349600|FG001|Overall Study|Adverse Event|3|||
161915037|NCT01572792|584737360|FG004|Extension Study|Protocol Violation|3|||
162013098|NCT00068692|585103879|FG002|Step 1: Registration|Protocol Violation|0|||
162013099|NCT00068692|585103880|FG003|Step 1: Registration|Protocol Violation|0|||
162013100|NCT00068692|585103881|FG004|Step 1: Registration|Protocol Violation|0|||
162013101|NCT00068692|585103882|FG005|Step 1: Registration|Protocol Violation|0|||
162013102|NCT00068692|585103883|FG006|Step 1: Registration|Protocol Violation|0|||
162013103|NCT00068692|585103884|FG007|Step 1: Registration|Protocol Violation|0|||
162013104|NCT00068692|585103877|FG000|Step 1: Registration|Not eligible|6|||
162013105|NCT00068692|585103878|FG001|Step 1: Registration|Not eligible|0|||
162013106|NCT00068692|585103879|FG002|Step 1: Registration|Not eligible|0|||
162013107|NCT00068692|585103880|FG003|Step 1: Registration|Not eligible|0|||
162013108|NCT00068692|585103881|FG004|Step 1: Registration|Not eligible|0|||
162013109|NCT00068692|585103882|FG005|Step 1: Registration|Not eligible|0|||
162013110|NCT00068692|585103883|FG006|Step 1: Registration|Not eligible|0|||
162013111|NCT00068692|585103884|FG007|Step 1: Registration|Not eligible|0|||
162013112|NCT00068692|585103877|FG000|Step 1: Registration|Other|2|||
162013113|NCT00068692|585103878|FG001|Step 1: Registration|Other|0|||
162013114|NCT00068692|585103879|FG002|Step 1: Registration|Other|0|||
162013115|NCT00068692|585103880|FG003|Step 1: Registration|Other|0|||
162013116|NCT00068692|585103881|FG004|Step 1: Registration|Other|0|||
162013117|NCT00068692|585103882|FG005|Step 1: Registration|Other|0|||
162013118|NCT00068692|585103883|FG006|Step 1: Registration|Other|0|||
162013119|NCT00068692|585103884|FG007|Step 1: Registration|Other|0|||
162013120|NCT00068692|585103877|FG000|Step 1: Registration|Not start protocol therapy|3|||
162013121|NCT00068692|585103878|FG001|Step 1: Registration|Not start protocol therapy|0|||
162013122|NCT00068692|585103879|FG002|Step 1: Registration|Not start protocol therapy|0|||
162013123|NCT00068692|585103880|FG003|Step 1: Registration|Not start protocol therapy|0|||
162013124|NCT00068692|585103881|FG004|Step 1: Registration|Not start protocol therapy|0|||
162013125|NCT00068692|585103882|FG005|Step 1: Registration|Not start protocol therapy|0|||
162013126|NCT00068692|585103883|FG006|Step 1: Registration|Not start protocol therapy|0|||
162013127|NCT00068692|585103884|FG007|Step 1: Registration|Not start protocol therapy|0|||
162013128|NCT00068692|585103877|FG000|Step 1: Registration|Registered but not randomized|0|||
162013129|NCT00068692|585103878|FG001|Step 1: Registration|Registered but not randomized|1|||
162013130|NCT00068692|585103879|FG002|Step 1: Registration|Registered but not randomized|0|||
162013131|NCT00068692|585103880|FG003|Step 1: Registration|Registered but not randomized|0|||
162013132|NCT00068692|585103881|FG004|Step 1: Registration|Registered but not randomized|0|||
162013133|NCT00068692|585103882|FG005|Step 1: Registration|Registered but not randomized|0|||
162013134|NCT00068692|585103883|FG006|Step 1: Registration|Registered but not randomized|0|||
162013135|NCT00068692|585103884|FG007|Step 1: Registration|Registered but not randomized|0|||
162013136|NCT00068692|585103877|FG000|Step 2: Randomization|Disesae progression/replase|0|||
162013137|NCT00068692|585103878|FG001|Step 2: Randomization|Disesae progression/replase|0|||
162013138|NCT00068692|585103879|FG002|Step 2: Randomization|Disesae progression/replase|1|||
162013139|NCT00068692|585103880|FG003|Step 2: Randomization|Disesae progression/replase|1|||
162013140|NCT00068692|585103881|FG004|Step 2: Randomization|Disesae progression/replase|0|||
162013141|NCT00068692|585103882|FG005|Step 2: Randomization|Disesae progression/replase|0|||
162013142|NCT00068692|585103883|FG006|Step 2: Randomization|Disesae progression/replase|0|||
162013143|NCT00068692|585103884|FG007|Step 2: Randomization|Disesae progression/replase|0|||
162013144|NCT00068692|585103877|FG000|Step 2: Randomization|Adverse Event|0|||
162013145|NCT00068692|585103878|FG001|Step 2: Randomization|Adverse Event|0|||
162013146|NCT00068692|585103879|FG002|Step 2: Randomization|Adverse Event|4|||
161810962|NCT00446563|584349599|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161810963|NCT00446563|584349600|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161810964|NCT00446563|584349599|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161810965|NCT00446563|584349600|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161810966|NCT00446563|584349599|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161810967|NCT00446563|584349600|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161810968|NCT00446563|584349599|FG000|Overall Study|Withdrawal by Subject|2|||
161810969|NCT00446563|584349600|FG001|Overall Study|Withdrawal by Subject|1|||
161810970|NCT00446563|584349599|FG000|Overall Study|Administrative problems|0|||
161810971|NCT00446563|584349600|FG001|Overall Study|Administrative problems|1|||
161810972|NCT03769025|584349601|FG000|Overall Study|Withdrawal by Subject|1|||
161810973|NCT03769025|584349602|FG001|Overall Study|Withdrawal by Subject|1|||
161810974|NCT03769025|584349601|FG000|Overall Study|Lost to Follow-up|4|||
161810975|NCT03769025|584349602|FG001|Overall Study|Lost to Follow-up|3|||
161810976|NCT01169558|584349603|FG000|Overall Study|Disease progression|98|||
161810977|NCT01169558|584349603|FG000|Overall Study|Adverse Event|25|||
161810978|NCT01169558|584349603|FG000|Overall Study|Withdrawal of Consent|8|||
161810979|NCT01169558|584349603|FG000|Overall Study|Medical Decision|7|||
161810980|NCT01169558|584349603|FG000|Overall Study|Stable Disease|4|||
161810981|NCT01169558|584349603|FG000|Overall Study|Lost to Follow-up|4|||
161810982|NCT01169558|584349603|FG000|Overall Study|Need for Surgery|4|||
161810983|NCT01169558|584349603|FG000|Overall Study|Non-compliance|2|||
161810984|NCT01169558|584349603|FG000|Overall Study|Protocol Violation|2|||
161810985|NCT01169558|584349603|FG000|Overall Study|Partial response|2|||
161810986|NCT02911701|584349606|FG000|Overall Study|Withdrawal by Subject|2|||
161810987|NCT02911701|584349607|FG001|Overall Study|Withdrawal by Subject|4|||
161810988|NCT02911701|584349606|FG000|Overall Study|Adverse Event|1|||
161810989|NCT02911701|584349607|FG001|Overall Study|Adverse Event|0|||
161810990|NCT04659603|584349610|FG000|Overall Study|Study terminated by sponsor|0|||
161810991|NCT04659603|584349611|FG001|Overall Study|Study terminated by sponsor|0|||
161810992|NCT04659603|584349612|FG002|Overall Study|Study terminated by sponsor|2|||
161810993|NCT04659603|584349610|FG000|Overall Study|Withdrawal by Subject|0|||
161810994|NCT04659603|584349611|FG001|Overall Study|Withdrawal by Subject|5|||
161810995|NCT04659603|584349612|FG002|Overall Study|Withdrawal by Subject|0|||
161810996|NCT04659603|584349610|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
161810997|NCT04659603|584349611|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
161810998|NCT04659603|584349612|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
161810999|NCT01110005|584349613|FG000|Overall Study|ineligible|1|||
161811000|NCT01110005|584349614|FG001|Overall Study|ineligible|2|||
161811001|NCT01110005|584349613|FG000|Overall Study|missing consent|3|||
161811002|NCT01110005|584349614|FG001|Overall Study|missing consent|2|||
161811003|NCT01110005|584349613|FG000|Overall Study|Withdrawal by Subject|0|||
161811004|NCT01110005|584349614|FG001|Overall Study|Withdrawal by Subject|1|||
161811005|NCT04646213|584349615|FG000|Overall Study|Physician Decision|3|||
161811006|NCT04646213|584349615|FG000|Overall Study|Withdrawal by Subject|2|||
161811007|NCT02441309|584349616|FG000|Overall Study|Disease progression|2|||
161811008|NCT02441309|584349617|FG001|Overall Study|Disease progression|1|||
161811009|NCT02441309|584349618|FG002|Overall Study|Disease progression|2|||
161811010|NCT02441309|584349616|FG000|Overall Study|Adverse Event|0|||
161811011|NCT02441309|584349617|FG001|Overall Study|Adverse Event|1|||
161811012|NCT02441309|584349618|FG002|Overall Study|Adverse Event|0|||
161811013|NCT02441309|584349616|FG000|Overall Study|Withdrawal by Subject|1|||
161811014|NCT02441309|584349617|FG001|Overall Study|Withdrawal by Subject|0|||
161811015|NCT02441309|584349618|FG002|Overall Study|Withdrawal by Subject|1|||
161811016|NCT02820350|584349635|FG000|Overall Study|Withdrawal by Subject|3|||
161811017|NCT02820350|584349635|FG000|Overall Study|Death|4|||
161811018|NCT02057835|584351342|FG000|Overall Study|Withdrawal by Subject|0|||
161811019|NCT02057835|584351343|FG001|Overall Study|Withdrawal by Subject|2|||
161811020|NCT02057835|584351344|FG002|Overall Study|Withdrawal by Subject|0|||
162154862|NCT01985334|585617131|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
161811021|NCT02057835|584351345|FG003|Overall Study|Withdrawal by Subject|0|||
161811022|NCT02057835|584351346|FG004|Overall Study|Withdrawal by Subject|0|||
161811023|NCT02057835|584351347|FG005|Overall Study|Withdrawal by Subject|0|||
161811024|NCT02057835|584351348|FG006|Overall Study|Withdrawal by Subject|0|||
161811025|NCT02057835|584351349|FG007|Overall Study|Withdrawal by Subject|0|||
161811026|NCT02057835|584351350|FG008|Overall Study|Withdrawal by Subject|0|||
161811027|NCT02057835|584351351|FG009|Overall Study|Withdrawal by Subject|0|||
161811028|NCT02222818|584351352|FG000|Period 1|Eligibility criteria not met|0|||
161811029|NCT02222818|584351353|FG001|Period 1|Eligibility criteria not met|3|||
161811030|NCT00834717|584351354|FG000|First Intervention|Adverse Event|1|||
161811031|NCT00834717|584351355|FG001|First Intervention|Adverse Event|0|||
161811032|NCT00834717|584351354|FG000|First Intervention|Withdrawal by Subject|0|||
161811033|NCT00834717|584351355|FG001|First Intervention|Withdrawal by Subject|1|||
161811034|NCT01660243|584351356|FG000|Overall Study|Adverse Event|1|||
161811035|NCT01660243|584351357|FG001|Overall Study|Adverse Event|0|||
161811036|NCT01660243|584351358|FG002|Overall Study|Adverse Event|1|||
161811037|NCT01660243|584351359|FG003|Overall Study|Adverse Event|0|||
162013147|NCT00068692|585103880|FG003|Step 2: Randomization|Adverse Event|2|||
162013148|NCT00068692|585103881|FG004|Step 2: Randomization|Adverse Event|2|||
162013149|NCT00068692|585103882|FG005|Step 2: Randomization|Adverse Event|3|||
162013150|NCT00068692|585103883|FG006|Step 2: Randomization|Adverse Event|4|||
161811038|NCT01660243|584351356|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
161811039|NCT01660243|584351357|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
161811040|NCT01660243|584351358|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
161811041|NCT01660243|584351359|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
161811042|NCT01660243|584351356|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
161811043|NCT01660243|584351357|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
161811044|NCT01660243|584351358|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
161811045|NCT01660243|584351359|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
161811046|NCT01660243|584351356|FG000|Overall Study|Randomization error|0|||
161811047|NCT01660243|584351357|FG001|Overall Study|Randomization error|0|||
161811048|NCT01660243|584351358|FG002|Overall Study|Randomization error|0|||
162013151|NCT00068692|585103884|FG007|Step 2: Randomization|Adverse Event|4|||
162013152|NCT00068692|585103877|FG000|Step 2: Randomization|Death|0|||
162013153|NCT00068692|585103878|FG001|Step 2: Randomization|Death|0|||
162013154|NCT00068692|585103879|FG002|Step 2: Randomization|Death|0|||
162013155|NCT00068692|585103880|FG003|Step 2: Randomization|Death|0|||
162013156|NCT00068692|585103881|FG004|Step 2: Randomization|Death|1|||
162013157|NCT00068692|585103882|FG005|Step 2: Randomization|Death|0|||
162013158|NCT00068692|585103883|FG006|Step 2: Randomization|Death|0|||
162013159|NCT00068692|585103884|FG007|Step 2: Randomization|Death|1|||
162013160|NCT00068692|585103877|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
162013161|NCT00068692|585103878|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
162013162|NCT00068692|585103879|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
162013163|NCT00068692|585103880|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
162013164|NCT00068692|585103881|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
162013165|NCT00068692|585103882|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
162013166|NCT00068692|585103883|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
162013167|NCT00068692|585103884|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
162013168|NCT00068692|585103877|FG000|Step 2: Randomization|alternative therapy|0|||
162013169|NCT00068692|585103878|FG001|Step 2: Randomization|alternative therapy|0|||
162013170|NCT00068692|585103879|FG002|Step 2: Randomization|alternative therapy|0|||
162013171|NCT00068692|585103880|FG003|Step 2: Randomization|alternative therapy|1|||
162013172|NCT00068692|585103881|FG004|Step 2: Randomization|alternative therapy|1|||
162013173|NCT00068692|585103882|FG005|Step 2: Randomization|alternative therapy|0|||
162013174|NCT00068692|585103883|FG006|Step 2: Randomization|alternative therapy|0|||
162013175|NCT00068692|585103884|FG007|Step 2: Randomization|alternative therapy|0|||
162013176|NCT00068692|585103877|FG000|Step 2: Randomization|Physician Decision|0|||
162013177|NCT00068692|585103878|FG001|Step 2: Randomization|Physician Decision|0|||
162013178|NCT00068692|585103879|FG002|Step 2: Randomization|Physician Decision|0|||
162013179|NCT00068692|585103880|FG003|Step 2: Randomization|Physician Decision|1|||
162013180|NCT00068692|585103881|FG004|Step 2: Randomization|Physician Decision|1|||
162013181|NCT00068692|585103882|FG005|Step 2: Randomization|Physician Decision|0|||
162013182|NCT00068692|585103883|FG006|Step 2: Randomization|Physician Decision|0|||
162013183|NCT00068692|585103884|FG007|Step 2: Randomization|Physician Decision|0|||
162013184|NCT00068692|585103877|FG000|Step 2: Randomization|Other|0|||
162013185|NCT00068692|585103878|FG001|Step 2: Randomization|Other|0|||
162013186|NCT00068692|585103879|FG002|Step 2: Randomization|Other|0|||
162013187|NCT00068692|585103880|FG003|Step 2: Randomization|Other|1|||
162013188|NCT00068692|585103881|FG004|Step 2: Randomization|Other|0|||
162013189|NCT00068692|585103882|FG005|Step 2: Randomization|Other|1|||
162013190|NCT00068692|585103883|FG006|Step 2: Randomization|Other|0|||
162013191|NCT00068692|585103884|FG007|Step 2: Randomization|Other|0|||
162013192|NCT00068692|585103877|FG000|Step 2: Randomization|never start protocol therapy|0|||
162013193|NCT00068692|585103878|FG001|Step 2: Randomization|never start protocol therapy|0|||
162013194|NCT00068692|585103879|FG002|Step 2: Randomization|never start protocol therapy|1|||
162013195|NCT00068692|585103880|FG003|Step 2: Randomization|never start protocol therapy|0|||
162013196|NCT00068692|585103881|FG004|Step 2: Randomization|never start protocol therapy|1|||
162013197|NCT00068692|585103882|FG005|Step 2: Randomization|never start protocol therapy|0|||
162013198|NCT00068692|585103883|FG006|Step 2: Randomization|never start protocol therapy|0|||
162013199|NCT00068692|585103884|FG007|Step 2: Randomization|never start protocol therapy|0|||
162013200|NCT01600716|585103886|FG000|Overall Study|Other Reasons|3|||
162013201|NCT01600716|585103887|FG001|Overall Study|Other Reasons|1|||
161811049|NCT01660243|584351359|FG003|Overall Study|Randomization error|1|||
161811050|NCT04299087|584351360|FG000|Overall Study|Lost to Follow-up|2|||
161811051|NCT04299087|584351361|FG001|Overall Study|Lost to Follow-up|1|||
161811052|NCT03025087|584351362|FG000|Overall Study|Physician Decision|3|||
161811053|NCT03025087|584351363|FG001|Overall Study|Physician Decision|3|||
161811054|NCT03025087|584351364|FG002|Overall Study|Physician Decision|0|||
161811055|NCT03025087|584351365|FG003|Overall Study|Physician Decision|0|||
161811056|NCT03025087|584351366|FG004|Overall Study|Physician Decision|0|||
161811057|NCT03025087|584351362|FG000|Overall Study|Withdrawal by Subject|1|||
161811058|NCT03025087|584351363|FG001|Overall Study|Withdrawal by Subject|1|||
161811059|NCT03025087|584351364|FG002|Overall Study|Withdrawal by Subject|0|||
161811060|NCT03025087|584351365|FG003|Overall Study|Withdrawal by Subject|0|||
162013202|NCT01600716|585103886|FG000|Overall Study|Personal Reasons|0|||
162013203|NCT01600716|585103887|FG001|Overall Study|Personal Reasons|2|||
162013204|NCT01600716|585103886|FG000|Overall Study|Lost to Follow-up|0|||
162013205|NCT01600716|585103887|FG001|Overall Study|Lost to Follow-up|2|||
162013206|NCT01600716|585103886|FG000|Overall Study|Pregnancy|1|||
161811061|NCT03025087|584351366|FG004|Overall Study|Withdrawal by Subject|0|||
161811062|NCT03025087|584351362|FG000|Overall Study|Unable to complete MRI|2|||
161811063|NCT03025087|584351363|FG001|Overall Study|Unable to complete MRI|2|||
161811064|NCT03025087|584351364|FG002|Overall Study|Unable to complete MRI|0|||
161811065|NCT03025087|584351365|FG003|Overall Study|Unable to complete MRI|0|||
161811066|NCT03025087|584351366|FG004|Overall Study|Unable to complete MRI|0|||
161811067|NCT00594035|584351367|FG000|Overall Study|Lost to Follow-up|1|||
161811068|NCT00594035|584351368|FG001|Overall Study|Lost to Follow-up|1|||
161811069|NCT00594035|584351367|FG000|Overall Study|Withdrawal by Subject|1|||
162013207|NCT01600716|585103887|FG001|Overall Study|Pregnancy|0|||
162013208|NCT01600716|585103886|FG000|Overall Study|Lack of Efficacy|2|||
162013209|NCT01600716|585103887|FG001|Overall Study|Lack of Efficacy|1|||
162013210|NCT01600716|585103886|FG000|Overall Study|Adverse Event|1|||
162013211|NCT01600716|585103887|FG001|Overall Study|Adverse Event|1|||
162013212|NCT03557034|585103890|FG000|Overall Study|Withdrawal by Subject|1|||
162013213|NCT03557034|585103891|FG001|Overall Study|Withdrawal by Subject|0|||
162013214|NCT00123422|585103892|FG000|Overall Study|Physician Decision|2|||
162013215|NCT00123422|585103893|FG001|Overall Study|Physician Decision|2|||
162013216|NCT00123422|585103894|FG002|Overall Study|Physician Decision|6|||
162013217|NCT00123422|585103892|FG000|Overall Study|Withdrawal by Subject|1|||
162013218|NCT00123422|585103893|FG001|Overall Study|Withdrawal by Subject|2|||
162013219|NCT00123422|585103894|FG002|Overall Study|Withdrawal by Subject|2|||
162013220|NCT00123422|585103892|FG000|Overall Study|Lost to Follow-up|1|||
162013221|NCT00123422|585103893|FG001|Overall Study|Lost to Follow-up|2|||
162013222|NCT00123422|585103894|FG002|Overall Study|Lost to Follow-up|2|||
162013223|NCT04646044|585103899|FG000|Overall Study|Lost to Follow-up|0|||
162013224|NCT04646044|585103900|FG001|Overall Study|Lost to Follow-up|0|||
162013225|NCT04646044|585103901|FG002|Overall Study|Lost to Follow-up|1|||
162013226|NCT04646044|585103902|FG003|Overall Study|Lost to Follow-up|0|||
162013227|NCT04646044|585103899|FG000|Overall Study|Withdrawal by Subject|0|||
162013228|NCT04646044|585103900|FG001|Overall Study|Withdrawal by Subject|1|||
162013229|NCT04646044|585103901|FG002|Overall Study|Withdrawal by Subject|0|||
162013230|NCT04646044|585103902|FG003|Overall Study|Withdrawal by Subject|0|||
162013231|NCT01938716|585103903|FG000|Overall Study|Physician Decision|2|||
162013232|NCT01938716|585103903|FG000|Overall Study|Withdrawal by Subject|2|||
162013233|NCT01908803|585103904|FG000|Overall Study|Adverse Event|1|||
162013234|NCT01908803|585103905|FG001|Overall Study|Adverse Event|0|||
162013235|NCT01908803|585103904|FG000|Overall Study|Physician Decision|0|||
162013236|NCT01908803|585103905|FG001|Overall Study|Physician Decision|1|||
162013237|NCT01908803|585103904|FG000|Overall Study|Withdrawal by Subject|1|||
162013238|NCT01908803|585103905|FG001|Overall Study|Withdrawal by Subject|0|||
162013239|NCT01908803|585103904|FG000|Overall Study|Randomization Error|1|||
162013240|NCT01908803|585103905|FG001|Overall Study|Randomization Error|0|||
162013241|NCT01908803|585103904|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
162013242|NCT01908803|585103905|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
162013243|NCT00823615|585103906|FG000|Period 2|Lost to Follow-up|2|||
162013244|NCT00823615|585103907|FG001|Period 2|Lost to Follow-up|0|||
162013245|NCT00823615|585103906|FG000|Period 2|Time/Job Conflict|1|||
162013246|NCT00823615|585103907|FG001|Period 2|Time/Job Conflict|2|||
162013247|NCT02446899|585103908|FG000|Overall Study|Adverse Event|4|||
162013248|NCT02446899|585103909|FG001|Overall Study|Adverse Event|7|||
162013249|NCT02446899|585103908|FG000|Overall Study|Condition Under Investigation Worsened|1|||
162013250|NCT02446899|585103909|FG001|Overall Study|Condition Under Investigation Worsened|4|||
162013251|NCT02446899|585103908|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
162013252|NCT02446899|585103909|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
162013253|NCT02446899|585103908|FG000|Overall Study|Lack of Efficacy|2|||
162013254|NCT02446899|585103909|FG001|Overall Study|Lack of Efficacy|8|||
162013255|NCT02446899|585103908|FG000|Overall Study|Lost to Follow-up|1|||
162013256|NCT02446899|585103909|FG001|Overall Study|Lost to Follow-up|3|||
162013257|NCT02446899|585103908|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
162013258|NCT02446899|585103909|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
162013259|NCT02446899|585103908|FG000|Overall Study|Withdrawal by Subject|11|||
162013260|NCT02446899|585103909|FG001|Overall Study|Withdrawal by Subject|19|||
162013261|NCT02446899|585103908|FG000|Overall Study|Miscellaneous|5|||
162013262|NCT02446899|585103909|FG001|Overall Study|Miscellaneous|4|||
162013263|NCT02446899|585103908|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
162013264|NCT02446899|585103909|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
162013265|NCT01002339|585103910|FG000|Overall Study|Withdrawal by Subject|0|||
162013266|NCT01002339|585103911|FG001|Overall Study|Withdrawal by Subject|1|||
162013267|NCT01002339|585103912|FG002|Overall Study|Withdrawal by Subject|0|||
162013268|NCT01002339|585103910|FG000|Overall Study|Incorrect treatment assignment|0|||
162013269|NCT01002339|585103911|FG001|Overall Study|Incorrect treatment assignment|0|||
162013270|NCT01002339|585103912|FG002|Overall Study|Incorrect treatment assignment|1|||
162013271|NCT01002339|585103910|FG000|Overall Study|Protocol Violation|0|||
162013272|NCT01002339|585103911|FG001|Overall Study|Protocol Violation|0|||
162013273|NCT01002339|585103912|FG002|Overall Study|Protocol Violation|2|||
162013274|NCT01002339|585103910|FG000|Overall Study|Lung cancer detected before transplant|0|||
162013275|NCT01002339|585103911|FG001|Overall Study|Lung cancer detected before transplant|0|||
162013276|NCT01002339|585103912|FG002|Overall Study|Lung cancer detected before transplant|1|||
162013277|NCT01002339|585103910|FG000|Overall Study|Randomized. Not transplanted|0|||
162013278|NCT01002339|585103911|FG001|Overall Study|Randomized. Not transplanted|0|||
162013279|NCT01002339|585103912|FG002|Overall Study|Randomized. Not transplanted|1|||
162013280|NCT00742235|585103913|FG000|Overall Study|Lost to Follow-up|0|||
162013281|NCT00742235|585103914|FG001|Overall Study|Lost to Follow-up|31|||
162013282|NCT00433004|585103915|FG000|Overall Study|Lost to Follow-up|5|||
161811070|NCT00594035|584351368|FG001|Overall Study|Withdrawal by Subject|0|||
161811071|NCT00594035|584351367|FG000|Overall Study|Subject transferred to nursing home|0|||
161811072|NCT00594035|584351368|FG001|Overall Study|Subject transferred to nursing home|1|||
161811073|NCT00594035|584351367|FG000|Overall Study|Subject couldn't return due to job|0|||
161811074|NCT00594035|584351368|FG001|Overall Study|Subject couldn't return due to job|1|||
161811075|NCT00795821|584351369|FG000|Acute Treatment Phase|Adverse Event|23|||
161811076|NCT00795821|584351370|FG001|Acute Treatment Phase|Adverse Event|4|||
161811077|NCT00795821|584351369|FG000|Acute Treatment Phase|Death|1|||
161811078|NCT00795821|584351370|FG001|Acute Treatment Phase|Death|0|||
161811079|NCT00795821|584351369|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
161811080|NCT00795821|584351370|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
161811081|NCT00795821|584351369|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
161811082|NCT00795821|584351370|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
161811083|NCT00795821|584351369|FG000|Acute Treatment Phase|Physician Decision|1|||
161811084|NCT00795821|584351370|FG001|Acute Treatment Phase|Physician Decision|1|||
161811085|NCT00795821|584351369|FG000|Acute Treatment Phase|Protocol Violation|1|||
161811086|NCT00795821|584351370|FG001|Acute Treatment Phase|Protocol Violation|2|||
161811087|NCT00795821|584351369|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
161811088|NCT00795821|584351370|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
161811089|NCT00795821|584351369|FG000|Long-term Extension Phase|Adverse Event|25|||
161811090|NCT00795821|584351370|FG001|Long-term Extension Phase|Adverse Event|32|||
161811091|NCT00795821|584351369|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
161811092|NCT00795821|584351370|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
161811093|NCT00795821|584351369|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
161811094|NCT00795821|584351370|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
161811095|NCT00795821|584351369|FG000|Long-term Extension Phase|Physician Decision|1|||
161811096|NCT00795821|584351370|FG001|Long-term Extension Phase|Physician Decision|2|||
161811097|NCT00795821|584351369|FG000|Long-term Extension Phase|Protocol Violation|3|||
161811098|NCT00795821|584351370|FG001|Long-term Extension Phase|Protocol Violation|5|||
161811099|NCT00795821|584351369|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
161811100|NCT00795821|584351370|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
161811101|NCT00795821|584351369|FG000|Taper Phase|Adverse Event|2|||
161915038|NCT01572792|584737356|FG000|Extension Study|Lack of Efficacy|2|||
161915039|NCT01572792|584737357|FG001|Extension Study|Lack of Efficacy|3|||
161915040|NCT01572792|584737358|FG002|Extension Study|Lack of Efficacy|3|||
161915041|NCT01572792|584737359|FG003|Extension Study|Lack of Efficacy|2|||
161915042|NCT01572792|584737360|FG004|Extension Study|Lack of Efficacy|2|||
161915043|NCT01572792|584737356|FG000|Extension Study|Adverse Event|7|||
161915044|NCT01572792|584737357|FG001|Extension Study|Adverse Event|6|||
161915045|NCT01572792|584737358|FG002|Extension Study|Adverse Event|5|||
161915046|NCT01572792|584737359|FG003|Extension Study|Adverse Event|6|||
161915047|NCT01572792|584737360|FG004|Extension Study|Adverse Event|4|||
161915048|NCT01572792|584737356|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
161915049|NCT01572792|584737357|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
161915050|NCT01572792|584737358|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
161915051|NCT01572792|584737359|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
161915052|NCT01572792|584737360|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
161915053|NCT03692949|584737366|FG000|Overall Study|Lost to Follow-up|0|||
161915054|NCT03692949|584737367|FG001|Overall Study|Lost to Follow-up|0|||
161915055|NCT03692949|584737368|FG002|Overall Study|Lost to Follow-up|0|||
161915056|NCT03692949|584737369|FG003|Overall Study|Lost to Follow-up|0|||
161915057|NCT03692949|584737370|FG004|Overall Study|Lost to Follow-up|0|||
161915058|NCT03692949|584737371|FG005|Overall Study|Lost to Follow-up|0|||
161915059|NCT03692949|584737372|FG006|Overall Study|Lost to Follow-up|0|||
161915060|NCT03692949|584737373|FG007|Overall Study|Lost to Follow-up|1|||
161915061|NCT03197129|584737375|FG000|Overall Study|did not answer the VPT: shyness|4|||
161915062|NCT03197129|584737376|FG001|Overall Study|did not answer the VPT: shyness|5|||
161915063|NCT04848480|584737379|FG000|Main Phase (26 Weeks)|Death|1|||
161811102|NCT00795821|584351370|FG001|Taper Phase|Adverse Event|0|||
161811103|NCT00795821|584351369|FG000|Taper Phase|Lost to Follow-up|1|||
161811104|NCT00795821|584351370|FG001|Taper Phase|Lost to Follow-up|0|||
161811105|NCT00795821|584351369|FG000|Taper Phase|Physician Decision|2|||
161811106|NCT00795821|584351370|FG001|Taper Phase|Physician Decision|0|||
161811107|NCT00795821|584351369|FG000|Taper Phase|Withdrawal by Subject|4|||
161811108|NCT00795821|584351370|FG001|Taper Phase|Withdrawal by Subject|0|||
161811109|NCT01376037|584351375|FG000|Overall Study|Lost to Follow-up|0|||
161811110|NCT01376037|584351376|FG001|Overall Study|Lost to Follow-up|2|||
161811111|NCT02328040|584351377|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
161811112|NCT02328040|584351378|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
161811113|NCT02149420|584351379|FG000|Core Study|Administrative problems|0|||
161811114|NCT02149420|584351380|FG001|Core Study|Administrative problems|1|||
161811115|NCT02149420|584351381|FG002|Core Study|Administrative problems|2|||
161811116|NCT02149420|584351379|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
161915064|NCT04848480|584737380|FG001|Main Phase (26 Weeks)|Death|0|||
161915065|NCT04848480|584737379|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
162013283|NCT00433004|585103916|FG001|Overall Study|Lost to Follow-up|7|||
161915066|NCT04848480|584737380|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
161915067|NCT04848480|584737379|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
161915068|NCT04848480|584737380|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
161915069|NCT04848480|584737379|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
161915070|NCT04848480|584737380|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
161915071|NCT04848480|584737379|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
161915072|NCT04848480|584737380|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
161915073|NCT04848480|584737379|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
161915074|NCT04848480|584737380|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
161915075|NCT05219162|584737381|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
161915076|NCT05219162|584737381|FG000|Overall Study|Withdrawal by Subject|23|||
162154863|NCT01985334|585617132|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
162154864|NCT01985334|585617133|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
162154865|NCT01985334|585617134|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
162154866|NCT01985334|585617127|FG000|Overall Study|Subject withdrawal of consent|3|||
162154867|NCT01985334|585617128|FG001|Overall Study|Subject withdrawal of consent|6|||
162154868|NCT01985334|585617129|FG002|Overall Study|Subject withdrawal of consent|2|||
162154869|NCT01985334|585617130|FG003|Overall Study|Subject withdrawal of consent|28|||
162154870|NCT01985334|585617131|FG004|Overall Study|Subject withdrawal of consent|4|||
162154871|NCT01985334|585617132|FG005|Overall Study|Subject withdrawal of consent|19|||
162154872|NCT01985334|585617133|FG006|Overall Study|Subject withdrawal of consent|0|||
162154873|NCT01985334|585617134|FG007|Overall Study|Subject withdrawal of consent|20|||
162154874|NCT01985334|585617127|FG000|Overall Study|Adverse Event|0|||
162154875|NCT01985334|585617128|FG001|Overall Study|Adverse Event|8|||
162154876|NCT01985334|585617129|FG002|Overall Study|Adverse Event|2|||
162154877|NCT01985334|585617130|FG003|Overall Study|Adverse Event|26|||
161915077|NCT04428151|584737382|FG000|Overall Study|Death|100|||
162154878|NCT01985334|585617131|FG004|Overall Study|Adverse Event|3|||
162013284|NCT03910244|585103918|FG000|Overall Study|Adverse Event|14|||
162013285|NCT03910244|585103919|FG001|Overall Study|Adverse Event|0|||
162013286|NCT03910244|585103918|FG000|Overall Study|Death|1|||
162013287|NCT03910244|585103919|FG001|Overall Study|Death|0|||
162013288|NCT03910244|585103918|FG000|Overall Study|Lost to Follow-up|0|||
162013289|NCT03910244|585103919|FG001|Overall Study|Lost to Follow-up|2|||
162013290|NCT03910244|585103918|FG000|Overall Study|Joint withdrawal decision|1|||
162013291|NCT03910244|585103919|FG001|Overall Study|Joint withdrawal decision|0|||
162013292|NCT03910244|585103918|FG000|Overall Study|Study Terminated by Sponsor|7|||
162013293|NCT03910244|585103919|FG001|Overall Study|Study Terminated by Sponsor|4|||
162013294|NCT03910244|585103918|FG000|Overall Study|Physician Decision|1|||
162013295|NCT03910244|585103919|FG001|Overall Study|Physician Decision|0|||
162013296|NCT03910244|585103918|FG000|Overall Study|Protocol Violation|1|||
162013297|NCT03910244|585103919|FG001|Overall Study|Protocol Violation|0|||
162013298|NCT03910244|585103918|FG000|Overall Study|Withdrawal by Subject|7|||
162013299|NCT03910244|585103919|FG001|Overall Study|Withdrawal by Subject|2|||
162013300|NCT01106690|585103920|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
162013301|NCT01106690|585103921|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
162013302|NCT01106690|585103922|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
162013303|NCT01106690|585103920|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
162013304|NCT01106690|585103921|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
162013305|NCT01106690|585103922|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
162013306|NCT01106690|585103920|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
162013307|NCT01106690|585103921|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
162013308|NCT01106690|585103922|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
162013309|NCT01106690|585103920|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
162013310|NCT01106690|585103921|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
162013311|NCT01106690|585103922|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
162013312|NCT01106690|585103920|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
162013313|NCT01106690|585103921|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
162013314|NCT01106690|585103922|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
162013315|NCT01106690|585103920|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
162013316|NCT01106690|585103921|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
162013317|NCT01106690|585103922|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
162013318|NCT01106690|585103920|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
162154879|NCT01985334|585617132|FG005|Overall Study|Adverse Event|18|||
162154880|NCT01985334|585617133|FG006|Overall Study|Adverse Event|3|||
162154881|NCT01985334|585617134|FG007|Overall Study|Adverse Event|15|||
162154882|NCT01985334|585617127|FG000|Overall Study|Other|4|||
162154883|NCT01985334|585617128|FG001|Overall Study|Other|2|||
162154884|NCT01985334|585617129|FG002|Overall Study|Other|3|||
162154885|NCT01985334|585617130|FG003|Overall Study|Other|10|||
162154886|NCT01985334|585617131|FG004|Overall Study|Other|1|||
162154887|NCT01985334|585617132|FG005|Overall Study|Other|6|||
162154888|NCT01985334|585617133|FG006|Overall Study|Other|2|||
162154889|NCT01985334|585617134|FG007|Overall Study|Other|2|||
162154890|NCT01985334|585617127|FG000|Overall Study|Medication non-compliance|0|||
162154891|NCT01985334|585617128|FG001|Overall Study|Medication non-compliance|4|||
162154892|NCT01985334|585617129|FG002|Overall Study|Medication non-compliance|1|||
162154893|NCT01985334|585617130|FG003|Overall Study|Medication non-compliance|6|||
162154894|NCT01985334|585617131|FG004|Overall Study|Medication non-compliance|2|||
162154895|NCT01985334|585617132|FG005|Overall Study|Medication non-compliance|3|||
162154896|NCT01985334|585617133|FG006|Overall Study|Medication non-compliance|1|||
162154897|NCT01985334|585617134|FG007|Overall Study|Medication non-compliance|3|||
162154898|NCT01985334|585617127|FG000|Overall Study|Use of prohibited treatment|1|||
162154899|NCT01985334|585617128|FG001|Overall Study|Use of prohibited treatment|4|||
162154900|NCT01985334|585617129|FG002|Overall Study|Use of prohibited treatment|1|||
162154901|NCT01985334|585617130|FG003|Overall Study|Use of prohibited treatment|2|||
162154902|NCT01985334|585617131|FG004|Overall Study|Use of prohibited treatment|1|||
162154903|NCT01985334|585617132|FG005|Overall Study|Use of prohibited treatment|6|||
162154904|NCT01985334|585617133|FG006|Overall Study|Use of prohibited treatment|2|||
162154905|NCT01985334|585617134|FG007|Overall Study|Use of prohibited treatment|0|||
162154906|NCT01985334|585617127|FG000|Overall Study|Investigator decision|0|||
162154907|NCT01985334|585617128|FG001|Overall Study|Investigator decision|3|||
162154908|NCT01985334|585617129|FG002|Overall Study|Investigator decision|0|||
162154909|NCT01985334|585617130|FG003|Overall Study|Investigator decision|7|||
162154910|NCT01985334|585617131|FG004|Overall Study|Investigator decision|1|||
162154911|NCT01985334|585617132|FG005|Overall Study|Investigator decision|1|||
162154912|NCT01985334|585617133|FG006|Overall Study|Investigator decision|0|||
162154913|NCT01985334|585617134|FG007|Overall Study|Investigator decision|4|||
162154914|NCT01985334|585617127|FG000|Overall Study|Lost to Follow-up|0|||
162154915|NCT01985334|585617128|FG001|Overall Study|Lost to Follow-up|2|||
162154916|NCT01985334|585617129|FG002|Overall Study|Lost to Follow-up|0|||
162154917|NCT01985334|585617130|FG003|Overall Study|Lost to Follow-up|3|||
162154918|NCT01985334|585617131|FG004|Overall Study|Lost to Follow-up|1|||
162154919|NCT01985334|585617132|FG005|Overall Study|Lost to Follow-up|4|||
162154920|NCT01985334|585617133|FG006|Overall Study|Lost to Follow-up|0|||
162154921|NCT01985334|585617134|FG007|Overall Study|Lost to Follow-up|3|||
162154922|NCT00093015|585617135|FG000|Overall Study|Withdrawal by Subject|194|||
162154923|NCT00093015|585617136|FG001|Overall Study|Withdrawal by Subject|171|||
162154924|NCT00093015|585617135|FG000|Overall Study|Lost to Follow-up|96|||
162154925|NCT00093015|585617136|FG001|Overall Study|Lost to Follow-up|108|||
162154926|NCT00093015|585617135|FG000|Overall Study|Death|375|||
162154927|NCT00093015|585617136|FG001|Overall Study|Death|385|||
162154928|NCT03951805|585617141|FG000|Overall Study|Adverse Event|1|||
162154929|NCT03951805|585617142|FG001|Overall Study|Adverse Event|0|||
161915078|NCT04428151|584737383|FG001|Overall Study|Death|86|||
161915079|NCT04428151|584737384|FG002|Overall Study|Death|57|||
161915080|NCT04428151|584737382|FG000|Overall Study|Lost to Follow-up|1|||
161915081|NCT04428151|584737383|FG001|Overall Study|Lost to Follow-up|1|||
161915082|NCT04428151|584737384|FG002|Overall Study|Lost to Follow-up|0|||
161915083|NCT04428151|584737382|FG000|Overall Study|Withdrawal by Subject|2|||
161915084|NCT04428151|584737383|FG001|Overall Study|Withdrawal by Subject|2|||
161915085|NCT04428151|584737384|FG002|Overall Study|Withdrawal by Subject|3|||
161915086|NCT04428151|584737382|FG000|Overall Study|Participant Ongoing in Study|41|||
161915087|NCT04428151|584737383|FG001|Overall Study|Participant Ongoing in Study|53|||
161915088|NCT04428151|584737384|FG002|Overall Study|Participant Ongoing in Study|28|||
161915089|NCT01114724|584737385|FG000|Overall Study|Death|8|||
161915090|NCT01114724|584737385|FG000|Overall Study|Lost to Follow-up|1|||
161915091|NCT01114724|584737385|FG000|Overall Study|Withdrawal by Subject|1|||
161915092|NCT02273167|584737393|FG000|Overall Study|Adverse Event|1|||
161915093|NCT02273167|584737394|FG001|Overall Study|Adverse Event|0|||
161915094|NCT02273167|584737395|FG002|Overall Study|Adverse Event|0|||
161915095|NCT02273167|584737393|FG000|Overall Study|Protocol Violation|3|||
161915096|NCT02273167|584737394|FG001|Overall Study|Protocol Violation|1|||
161915097|NCT02273167|584737395|FG002|Overall Study|Protocol Violation|1|||
161915098|NCT02273167|584737393|FG000|Overall Study|Lost to Follow-up|0|||
161915099|NCT02273167|584737394|FG001|Overall Study|Lost to Follow-up|1|||
161915100|NCT02273167|584737395|FG002|Overall Study|Lost to Follow-up|1|||
161915101|NCT02273167|584737393|FG000|Overall Study|Withdrawal by Subject|10|||
161915102|NCT02273167|584737394|FG001|Overall Study|Withdrawal by Subject|12|||
161915103|NCT02273167|584737395|FG002|Overall Study|Withdrawal by Subject|11|||
161915104|NCT02273167|584737393|FG000|Overall Study|Various|10|||
161915105|NCT02273167|584737394|FG001|Overall Study|Various|9|||
161915106|NCT02273167|584737395|FG002|Overall Study|Various|8|||
161915107|NCT03082729|584737396|FG000|Overall Study|Lost to Follow-up|7|||
161915108|NCT03082729|584737396|FG000|Overall Study|Physician Decision|2|||
161915109|NCT03082729|584737396|FG000|Overall Study|Withdrawal by Subject|1|||
161915110|NCT03082729|584737396|FG000|Overall Study|Lack of Efficacy|9|||
161915111|NCT03082729|584737396|FG000|Overall Study|Adverse Event|4|||
161915112|NCT03082729|584737396|FG000|Overall Study|Protocol Violation|6|||
161915113|NCT03082729|584737396|FG000|Overall Study|Fear of study procedure|1|||
161915114|NCT03082729|584737396|FG000|Overall Study|Scheduling conflict|1|||
161915115|NCT03836053|584738868|FG000|Overall Study|Protocol-specified criteria|0|||
161915116|NCT03836053|584738869|FG001|Overall Study|Protocol-specified criteria|2|||
161915117|NCT03836053|584738870|FG002|Overall Study|Protocol-specified criteria|1|||
161915118|NCT03836053|584738868|FG000|Overall Study|Death|1|||
161915119|NCT03836053|584738869|FG001|Overall Study|Death|6|||
161915120|NCT03836053|584738870|FG002|Overall Study|Death|4|||
161915121|NCT03836053|584738868|FG000|Overall Study|Withdrawal of consent from study|0|||
161915122|NCT03836053|584738869|FG001|Overall Study|Withdrawal of consent from study|0|||
161915123|NCT03836053|584738870|FG002|Overall Study|Withdrawal of consent from study|1|||
161915124|NCT03836053|584738868|FG000|Overall Study|Decision by sponsor|0|||
161915125|NCT03836053|584738869|FG001|Overall Study|Decision by sponsor|2|||
161915126|NCT03836053|584738870|FG002|Overall Study|Decision by sponsor|4|||
161915127|NCT03846479|584738871|FG000|Overall Study|Death|8|||
161915128|NCT03846479|584738871|FG000|Overall Study|Lost to Follow-up|1|||
161915129|NCT02332707|584738872|FG000|Overall Study|Adverse Event|0|||
161915130|NCT02332707|584738873|FG001|Overall Study|Adverse Event|0|||
161915131|NCT02332707|584738874|FG002|Overall Study|Adverse Event|0|||
161915132|NCT02332707|584738875|FG003|Overall Study|Adverse Event|0|||
161915133|NCT02332707|584738876|FG004|Overall Study|Adverse Event|0|||
161915134|NCT02332707|584738877|FG005|Overall Study|Adverse Event|0|||
161915135|NCT02332707|584738878|FG006|Overall Study|Adverse Event|0|||
162154930|NCT03951805|585617143|FG002|Overall Study|Adverse Event|0|||
162154931|NCT03951805|585617144|FG003|Overall Study|Adverse Event|0|||
161915136|NCT02332707|584738879|FG007|Overall Study|Adverse Event|0|||
161915137|NCT02332707|584738880|FG008|Overall Study|Adverse Event|0|||
161915138|NCT02332707|584738881|FG009|Overall Study|Adverse Event|0|||
161915139|NCT02332707|584738882|FG010|Overall Study|Adverse Event|0|||
161915140|NCT02332707|584738883|FG011|Overall Study|Adverse Event|0|||
161915141|NCT02332707|584738884|FG012|Overall Study|Adverse Event|1|||
161915142|NCT02332707|584738885|FG013|Overall Study|Adverse Event|0|||
162013319|NCT01106690|585103921|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
162013320|NCT01106690|585103922|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
162013321|NCT01106690|585103920|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
162013322|NCT01106690|585103921|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
162013323|NCT01106690|585103922|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
162013324|NCT01106690|585103920|FG000|Core Period: Baseline to Week 26|Other|10|||
162013325|NCT01106690|585103921|FG001|Core Period: Baseline to Week 26|Other|2|||
162013326|NCT01106690|585103922|FG002|Core Period: Baseline to Week 26|Other|6|||
162013327|NCT01106690|585103920|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
162013328|NCT01106690|585103921|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
162013329|NCT01106690|585103922|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161811117|NCT02149420|584351380|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
161811118|NCT02149420|584351381|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
161811119|NCT00440518|584351382|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
161811120|NCT00440518|584351383|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
161811121|NCT00440518|584351384|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
161811122|NCT00440518|584351382|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
161811123|NCT00440518|584351383|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
161811124|NCT00440518|584351384|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
161811125|NCT00440518|584351382|FG000|Randomized /Titration Period|Protocol Deviation|1|||
161811126|NCT00440518|584351383|FG001|Randomized /Titration Period|Protocol Deviation|0|||
161811127|NCT00440518|584351384|FG002|Randomized /Titration Period|Protocol Deviation|0|||
161811128|NCT00440518|584351382|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
161811129|NCT00440518|584351383|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
161811130|NCT00440518|584351384|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
161811131|NCT00440518|584351382|FG000|Randomized /Titration Period|Other|1|||
161811132|NCT00440518|584351383|FG001|Randomized /Titration Period|Other|0|||
161811133|NCT00440518|584351384|FG002|Randomized /Titration Period|Other|0|||
161811134|NCT00440518|584351382|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
161811135|NCT00440518|584351383|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
161811136|NCT00440518|584351384|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
161811137|NCT00440518|584351382|FG000|Randomized /Titration Period|Adverse Event|2|||
161811138|NCT00440518|584351383|FG001|Randomized /Titration Period|Adverse Event|3|||
161811139|NCT00440518|584351384|FG002|Randomized /Titration Period|Adverse Event|0|||
161811140|NCT00440518|584351382|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
161811141|NCT00440518|584351383|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
161811142|NCT00440518|584351384|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
161811143|NCT00440518|584351382|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
161811144|NCT00440518|584351383|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
161811145|NCT00440518|584351384|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
161811146|NCT00440518|584351382|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
161811147|NCT00440518|584351383|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
161811148|NCT00440518|584351384|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
161811149|NCT00440518|584351382|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
161811150|NCT00440518|584351383|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
161811151|NCT00440518|584351384|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
161811152|NCT00440518|584351382|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
161915143|NCT02332707|584738886|FG014|Overall Study|Adverse Event|0|||
161915144|NCT02332707|584738887|FG015|Overall Study|Adverse Event|0|||
161915145|NCT02332707|584738888|FG016|Overall Study|Adverse Event|0|||
161915146|NCT02332707|584738889|FG017|Overall Study|Adverse Event|0|||
161915147|NCT02332707|584738872|FG000|Overall Study|Lost to Follow-up|0|||
161915148|NCT02332707|584738873|FG001|Overall Study|Lost to Follow-up|0|||
161915149|NCT02332707|584738874|FG002|Overall Study|Lost to Follow-up|0|||
161915150|NCT02332707|584738875|FG003|Overall Study|Lost to Follow-up|0|||
161915151|NCT02332707|584738876|FG004|Overall Study|Lost to Follow-up|0|||
161915152|NCT02332707|584738877|FG005|Overall Study|Lost to Follow-up|1|||
161915153|NCT02332707|584738878|FG006|Overall Study|Lost to Follow-up|0|||
161915154|NCT02332707|584738879|FG007|Overall Study|Lost to Follow-up|0|||
161915155|NCT02332707|584738880|FG008|Overall Study|Lost to Follow-up|0|||
161915156|NCT02332707|584738881|FG009|Overall Study|Lost to Follow-up|0|||
161915157|NCT02332707|584738882|FG010|Overall Study|Lost to Follow-up|2|||
161915158|NCT02332707|584738883|FG011|Overall Study|Lost to Follow-up|0|||
161915159|NCT02332707|584738884|FG012|Overall Study|Lost to Follow-up|3|||
161915160|NCT02332707|584738885|FG013|Overall Study|Lost to Follow-up|0|||
161915161|NCT02332707|584738886|FG014|Overall Study|Lost to Follow-up|0|||
161915162|NCT02332707|584738887|FG015|Overall Study|Lost to Follow-up|0|||
161915163|NCT02332707|584738888|FG016|Overall Study|Lost to Follow-up|0|||
161915164|NCT02332707|584738889|FG017|Overall Study|Lost to Follow-up|0|||
161915165|NCT02332707|584738872|FG000|Overall Study|Physician Decision|0|||
161915166|NCT02332707|584738873|FG001|Overall Study|Physician Decision|0|||
161915167|NCT02332707|584738874|FG002|Overall Study|Physician Decision|0|||
161915168|NCT02332707|584738875|FG003|Overall Study|Physician Decision|1|||
161915169|NCT02332707|584738876|FG004|Overall Study|Physician Decision|0|||
161915170|NCT02332707|584738877|FG005|Overall Study|Physician Decision|0|||
161915171|NCT02332707|584738878|FG006|Overall Study|Physician Decision|0|||
161915172|NCT02332707|584738879|FG007|Overall Study|Physician Decision|0|||
161915173|NCT02332707|584738880|FG008|Overall Study|Physician Decision|0|||
161915174|NCT02332707|584738881|FG009|Overall Study|Physician Decision|0|||
161915175|NCT02332707|584738882|FG010|Overall Study|Physician Decision|0|||
161915176|NCT02332707|584738883|FG011|Overall Study|Physician Decision|0|||
161915177|NCT02332707|584738884|FG012|Overall Study|Physician Decision|1|||
161915178|NCT02332707|584738885|FG013|Overall Study|Physician Decision|0|||
161915179|NCT02332707|584738886|FG014|Overall Study|Physician Decision|0|||
162154932|NCT01198145|585617147|FG000|Overall Study|Withdrawal by Subject|1|||
162154933|NCT01198145|585617148|FG001|Overall Study|Withdrawal by Subject|1|||
162013330|NCT01106690|585103920|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
162013331|NCT01106690|585103921|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
162013332|NCT01106690|585103922|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
162013333|NCT01106690|585103920|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
162013334|NCT01106690|585103921|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
162013335|NCT01106690|585103922|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
162154934|NCT00603954|585617149|FG000|Overall Study|Protocol Violation|1|||
162154935|NCT00603954|585617150|FG001|Overall Study|Protocol Violation|2|||
162154936|NCT02528188|585617151|FG000|Overall Study|Adverse Event|23|||
162154937|NCT02528188|585617152|FG001|Overall Study|Adverse Event|22|||
162154938|NCT02528188|585617153|FG002|Overall Study|Adverse Event|8|||
162154939|NCT02528188|585617151|FG000|Overall Study|Protocol Violation|4|||
162154940|NCT02528188|585617152|FG001|Overall Study|Protocol Violation|6|||
162154941|NCT02528188|585617153|FG002|Overall Study|Protocol Violation|4|||
162154942|NCT02528188|585617151|FG000|Overall Study|Lack of Efficacy|19|||
162154943|NCT02528188|585617152|FG001|Overall Study|Lack of Efficacy|21|||
162154944|NCT02528188|585617153|FG002|Overall Study|Lack of Efficacy|22|||
162154945|NCT02528188|585617151|FG000|Overall Study|Withdrawal by Subject|97|||
162154946|NCT02528188|585617152|FG001|Overall Study|Withdrawal by Subject|104|||
162154947|NCT02528188|585617153|FG002|Overall Study|Withdrawal by Subject|100|||
162154948|NCT02528188|585617151|FG000|Overall Study|Lost to Follow-up|25|||
162154949|NCT02528188|585617152|FG001|Overall Study|Lost to Follow-up|21|||
162154950|NCT02528188|585617153|FG002|Overall Study|Lost to Follow-up|31|||
162154951|NCT02528188|585617151|FG000|Overall Study|Death|4|||
162154952|NCT02528188|585617152|FG001|Overall Study|Death|4|||
162154953|NCT02528188|585617153|FG002|Overall Study|Death|0|||
162154954|NCT02528188|585617151|FG000|Overall Study|Other|89|||
162154955|NCT02528188|585617152|FG001|Overall Study|Other|91|||
162154956|NCT02528188|585617153|FG002|Overall Study|Other|74|||
162154957|NCT02528188|585617151|FG000|Overall Study|Randomized but not treated|6|||
162154958|NCT02528188|585617152|FG001|Overall Study|Randomized but not treated|7|||
162154959|NCT02528188|585617153|FG002|Overall Study|Randomized but not treated|12|||
162154960|NCT01239316|585617160|FG000|Overall Study|Progression/Relapse|11|||
162154961|NCT01239316|585617160|FG000|Overall Study|Adverse Event|1|||
162154962|NCT02299375|585617165|FG000|Overall Study|Adverse Event, serious fatal|1|||
162154963|NCT02299375|585617166|FG001|Overall Study|Adverse Event, serious fatal|3|||
162154964|NCT02299375|585617165|FG000|Overall Study|Adverse Event, non-fatal|8|||
162154965|NCT02299375|585617166|FG001|Overall Study|Adverse Event, non-fatal|9|||
162154966|NCT02299375|585617165|FG000|Overall Study|Lack of Efficacy|1|||
162154967|NCT02299375|585617166|FG001|Overall Study|Lack of Efficacy|3|||
162154968|NCT02299375|585617165|FG000|Overall Study|Protocol Violation|1|||
162154969|NCT02299375|585617166|FG001|Overall Study|Protocol Violation|3|||
162154970|NCT02299375|585617165|FG000|Overall Study|Other: Met stopping criteria|1|||
162154971|NCT02299375|585617166|FG001|Overall Study|Other: Met stopping criteria|0|||
162154972|NCT02299375|585617165|FG000|Overall Study|Other: Study closed/terminated|66|||
162154973|NCT02299375|585617166|FG001|Overall Study|Other: Study closed/terminated|55|||
162154974|NCT02299375|585617165|FG000|Overall Study|Lost to Follow-up|0|||
162154975|NCT02299375|585617166|FG001|Overall Study|Lost to Follow-up|2|||
162154976|NCT02299375|585617165|FG000|Overall Study|Physician Decision|1|||
162154977|NCT02299375|585617166|FG001|Overall Study|Physician Decision|1|||
162154978|NCT02299375|585617165|FG000|Overall Study|Withdrawal by Subject|1|||
162154979|NCT02299375|585617166|FG001|Overall Study|Withdrawal by Subject|4|||
162154980|NCT00411216|585617170|FG000|Overall Study|Ten participants were entered into the c|0|||
162154981|NCT00411216|585617171|FG001|Overall Study|Ten participants were entered into the c|2|||
162154982|NCT01205048|585617172|FG000|Overall Study|Withdrawal by Subject|14|||
162154983|NCT01205048|585617172|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
162154984|NCT01205048|585617172|FG000|Overall Study|Lost to Follow-up|4|||
162154985|NCT01205048|585617172|FG000|Overall Study|Other|2|||
162154986|NCT00823472|585617173|FG000|Overall Study|Physician Decision|24|||
162013336|NCT01106690|585103920|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
162013337|NCT01106690|585103921|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
162013338|NCT01106690|585103922|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
162013339|NCT01106690|585103920|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
162013340|NCT01106690|585103921|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
162013341|NCT01106690|585103922|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
162013342|NCT01106690|585103920|FG000|Extension Period: Week 26 to Week 52|Other|8|||
162013343|NCT01106690|585103921|FG001|Extension Period: Week 26 to Week 52|Other|3|||
162013344|NCT01106690|585103922|FG002|Extension Period: Week 26 to Week 52|Other|4|||
162013345|NCT01106690|585103920|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
162013346|NCT01106690|585103921|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
162013347|NCT01106690|585103922|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
162013348|NCT02346721|585103923|FG000|Overall Study|Withdrew Consent|3|||
162013349|NCT02346721|585103923|FG000|Overall Study|Lack of Efficacy|1|||
162013350|NCT03219528|585103928|FG000|Overall Study|Lost to Follow-up|5|||
162013351|NCT03219528|585103929|FG001|Overall Study|Lost to Follow-up|4|||
162013352|NCT03219528|585103928|FG000|Overall Study|Withdrawal by Subject|4|||
162013353|NCT03219528|585103929|FG001|Overall Study|Withdrawal by Subject|4|||
162013354|NCT00790842|585103930|FG000|Dose Level 1|Adverse Event|1|||
162013355|NCT00790842|585103931|FG001|Dose Level 1|Adverse Event|0|||
162013356|NCT00790842|585103932|FG002|Dose Level 1|Adverse Event|0|||
162013357|NCT00790842|585103933|FG003|Dose Level 1|Adverse Event|2|||
162013358|NCT00790842|585103934|FG004|Dose Level 1|Adverse Event|0|||
162013359|NCT00790842|585103935|FG005|Dose Level 1|Adverse Event|0|||
162013360|NCT00790842|585103936|FG006|Dose Level 1|Adverse Event|0|||
162013361|NCT00790842|585103937|FG007|Dose Level 1|Adverse Event|1|||
162013362|NCT00790842|585103938|FG008|Dose Level 1|Adverse Event|0|||
162013363|NCT00790842|585103939|FG009|Dose Level 1|Adverse Event|0|||
162013364|NCT00790842|585103940|FG010|Dose Level 1|Adverse Event|0|||
162013365|NCT00790842|585103930|FG000|Dose Level 1|Physician Decision|1|||
162013366|NCT00790842|585103931|FG001|Dose Level 1|Physician Decision|0|||
161811153|NCT00440518|584351383|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
161811154|NCT00440518|584351384|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
161811155|NCT00440518|584351382|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
161811156|NCT00440518|584351383|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
161811157|NCT00440518|584351384|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
161811158|NCT02146105|584351385|FG000|Overall Study|Adverse Event|1|||
161811159|NCT02146105|584351385|FG000|Overall Study|Withdrawal by Subject|5|||
161811160|NCT01319383|584351386|FG000|Overall Study|No ex vivo or in vivo response|4|||
161811161|NCT01319383|584351387|FG001|Overall Study|No ex vivo or in vivo response|0|||
161811162|NCT01319383|584351386|FG000|Overall Study|Physician Decision|3|||
161811163|NCT01319383|584351387|FG001|Overall Study|Physician Decision|0|||
161811164|NCT01319383|584351386|FG000|Overall Study|Lack of Efficacy|5|||
161811165|NCT01319383|584351387|FG001|Overall Study|Lack of Efficacy|9|||
161811166|NCT01319383|584351386|FG000|Overall Study|No in vivo response to interval doses|0|||
161811167|NCT01319383|584351387|FG001|Overall Study|No in vivo response to interval doses|1|||
161811168|NCT03086460|584351390|FG000|Study Participants|Lost to Follow-up|2|||
161811169|NCT03086460|584351390|FG000|Study Participants|Protocol Violation|1|||
161811170|NCT03086460|584351390|FG000|Study Participants|Withdrawal by Subject|6|||
161811171|NCT03086460|584351390|FG000|Treatment A|Lost to Follow-up|1|||
161811172|NCT03086460|584351390|FG000|Treatment A|Protocol Violation|1|||
161811173|NCT03086460|584351390|FG000|Treatment A|Withdrawal by Subject|2|||
161811174|NCT03086460|584351390|FG000|Treatment C|Withdrawal by Subject|2|||
161811175|NCT03086460|584351390|FG000|Treatment E|Lost to Follow-up|1|||
161811176|NCT03086460|584351390|FG000|Treatment E|Withdrawal by Subject|3|||
161811177|NCT02718326|584351393|FG000|Overall Study|Adverse Event|4|||
161811178|NCT02718326|584351394|FG001|Overall Study|Adverse Event|9|||
161811179|NCT02718326|584351395|FG002|Overall Study|Adverse Event|0|||
161811180|NCT02718326|584351393|FG000|Overall Study|Death|8|||
161811181|NCT02718326|584351394|FG001|Overall Study|Death|1|||
161811182|NCT02718326|584351395|FG002|Overall Study|Death|2|||
161811183|NCT02718326|584351393|FG000|Overall Study|Withdrawal by Subject|4|||
161811184|NCT02718326|584351394|FG001|Overall Study|Withdrawal by Subject|9|||
161811185|NCT02718326|584351395|FG002|Overall Study|Withdrawal by Subject|6|||
161811186|NCT02718326|584351393|FG000|Overall Study|Lost to Follow-up|18|||
162013367|NCT00790842|585103932|FG002|Dose Level 1|Physician Decision|0|||
162013368|NCT00790842|585103933|FG003|Dose Level 1|Physician Decision|0|||
161811187|NCT02718326|584351394|FG001|Overall Study|Lost to Follow-up|5|||
161811188|NCT02718326|584351395|FG002|Overall Study|Lost to Follow-up|14|||
161811189|NCT02718326|584351393|FG000|Overall Study|Protocol Deviation|1|||
161811190|NCT02718326|584351394|FG001|Overall Study|Protocol Deviation|0|||
161811191|NCT02718326|584351395|FG002|Overall Study|Protocol Deviation|0|||
161811192|NCT02718326|584351393|FG000|Overall Study|Pregnancy|1|||
161811193|NCT02718326|584351394|FG001|Overall Study|Pregnancy|0|||
161811194|NCT02718326|584351395|FG002|Overall Study|Pregnancy|0|||
162013369|NCT00790842|585103934|FG004|Dose Level 1|Physician Decision|0|||
162013370|NCT00790842|585103935|FG005|Dose Level 1|Physician Decision|0|||
162013371|NCT00790842|585103936|FG006|Dose Level 1|Physician Decision|0|||
162013372|NCT00790842|585103937|FG007|Dose Level 1|Physician Decision|1|||
162013373|NCT00790842|585103938|FG008|Dose Level 1|Physician Decision|0|||
162013374|NCT00790842|585103939|FG009|Dose Level 1|Physician Decision|0|||
162013375|NCT00790842|585103940|FG010|Dose Level 1|Physician Decision|0|||
162013376|NCT00790842|585103930|FG000|Dose Level 1|Withdrawal by Subject|1|||
162013377|NCT00790842|585103931|FG001|Dose Level 1|Withdrawal by Subject|0|||
162013378|NCT00790842|585103932|FG002|Dose Level 1|Withdrawal by Subject|0|||
162013379|NCT00790842|585103933|FG003|Dose Level 1|Withdrawal by Subject|0|||
162013380|NCT00790842|585103934|FG004|Dose Level 1|Withdrawal by Subject|0|||
162154987|NCT00823472|585617174|FG001|Overall Study|Physician Decision|28|||
162154988|NCT01251354|585617179|FG000|Overall Study|Adverse Event|1|||
162154989|NCT01251354|585617179|FG000|Overall Study|Investigator's Decision|1|||
161811195|NCT06195579|584351399|FG000|Overall Study|Withdrawal by Subject|1|||
162013381|NCT00790842|585103935|FG005|Dose Level 1|Withdrawal by Subject|0|||
161811196|NCT02545283|584351400|FG000|Overall Study|Lost to Follow-up|2|||
161811197|NCT02545283|584351401|FG001|Overall Study|Lost to Follow-up|4|||
161811198|NCT02545283|584351400|FG000|Overall Study|Withdrawal by Subject|5|||
161811199|NCT02545283|584351401|FG001|Overall Study|Withdrawal by Subject|9|||
161811200|NCT02545283|584351400|FG000|Overall Study|Death|109|||
161811201|NCT02545283|584351401|FG001|Overall Study|Death|211|||
161811202|NCT02545283|584351400|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
161811203|NCT02545283|584351401|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
161811204|NCT02545283|584351400|FG000|Overall Study|Study Terminated By Sponsor|33|||
161811205|NCT02545283|584351401|FG001|Overall Study|Study Terminated By Sponsor|71|||
161811206|NCT02436005|584351402|FG000|Second Intervention|Adverse Event|0|||
161811207|NCT02436005|584351403|FG001|Second Intervention|Adverse Event|1|||
161811208|NCT00583453|584351404|FG000|Overall Study|discontinued intervention|0|||
161811209|NCT00583453|584351405|FG001|Overall Study|discontinued intervention|2|||
161811210|NCT00905606|584351406|FG000|Period 1|Adverse Event|0|||
161811211|NCT00905606|584351407|FG001|Period 1|Adverse Event|1|||
161811212|NCT00905606|584351406|FG000|Washout|Withdrawal by Subject|1|||
161811213|NCT00905606|584351407|FG001|Washout|Withdrawal by Subject|0|||
161811214|NCT03868891|584351410|FG000|Overall Study|Adverse Event|1|||
161811215|NCT03868891|584351411|FG001|Overall Study|Adverse Event|0|||
161811216|NCT03868891|584351410|FG000|Overall Study|Lost to Follow-up|2|||
161811217|NCT03868891|584351411|FG001|Overall Study|Lost to Follow-up|1|||
161811218|NCT03868891|584351410|FG000|Overall Study|COVID-19 Restrictions|1|||
161811219|NCT03868891|584351411|FG001|Overall Study|COVID-19 Restrictions|2|||
161811220|NCT02246920|584351412|FG000|Overall Study|Adverse Event|3|||
161811221|NCT02246920|584351413|FG001|Overall Study|Adverse Event|1|||
161811222|NCT02246920|584351414|FG002|Overall Study|Adverse Event|1|||
161811223|NCT02246920|584351412|FG000|Overall Study|Lost to Follow-up|2|||
161811224|NCT02246920|584351413|FG001|Overall Study|Lost to Follow-up|1|||
161811225|NCT02246920|584351414|FG002|Overall Study|Lost to Follow-up|0|||
161811226|NCT02246920|584351412|FG000|Overall Study|Protocol Violation|2|||
161811227|NCT02246920|584351413|FG001|Overall Study|Protocol Violation|5|||
161811228|NCT02246920|584351414|FG002|Overall Study|Protocol Violation|1|||
161811229|NCT02246920|584351412|FG000|Overall Study|Withdrawal by Subject|0|||
161811230|NCT02246920|584351413|FG001|Overall Study|Withdrawal by Subject|0|||
161811231|NCT02246920|584351414|FG002|Overall Study|Withdrawal by Subject|1|||
161811232|NCT01363765|584351415|FG000|Overall Study|non-diagnostic|2621|||
161811233|NCT01363765|584351416|FG001|Overall Study|non-diagnostic|1124|||
161811234|NCT01363765|584351415|FG000|Overall Study|duplicate records|736|||
161811235|NCT01363765|584351416|FG001|Overall Study|duplicate records|3177|||
161811236|NCT01363765|584351415|FG000|Overall Study|non-resident|156|||
161811237|NCT01363765|584351416|FG001|Overall Study|non-resident|76|||
161811238|NCT01363765|584351415|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
161811239|NCT01363765|584351416|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
161811240|NCT01363765|584351415|FG000|Overall Study|smear during intervention|2170|||
161811241|NCT01363765|584351416|FG001|Overall Study|smear during intervention|0|||
161811242|NCT00609674|584351417|FG000|Overall Study|Adverse Event|1|||
161811243|NCT00609674|584351418|FG001|Overall Study|Adverse Event|1|||
161811244|NCT00609674|584351417|FG000|Overall Study|Protocol Violation|3|||
161811245|NCT00609674|584351418|FG001|Overall Study|Protocol Violation|5|||
161811246|NCT00609674|584351417|FG000|Overall Study|Lost to Follow-up|1|||
161811247|NCT00609674|584351418|FG001|Overall Study|Lost to Follow-up|0|||
162013382|NCT00790842|585103936|FG006|Dose Level 1|Withdrawal by Subject|0|||
162013383|NCT00790842|585103937|FG007|Dose Level 1|Withdrawal by Subject|0|||
162013384|NCT00790842|585103938|FG008|Dose Level 1|Withdrawal by Subject|0|||
162013385|NCT00790842|585103939|FG009|Dose Level 1|Withdrawal by Subject|0|||
162154990|NCT01251354|585617179|FG000|Overall Study|Disease Progression|4|||
161811248|NCT00609674|584351417|FG000|Overall Study|Withdrew consent|2|||
161811249|NCT00609674|584351418|FG001|Overall Study|Withdrew consent|1|||
161811250|NCT03285594|584351422|FG000|Overall Study|At the Participant's Own Request|10|||
161811251|NCT03285594|584351423|FG001|Overall Study|At the Participant's Own Request|5|||
162154991|NCT04992390|585617186|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
162154992|NCT04992390|585617187|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
162154993|NCT04992390|585617188|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
162154994|NCT04992390|585617186|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
162154995|NCT04992390|585617187|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
162154996|NCT04992390|585617188|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
162154997|NCT04992390|585617186|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
162154998|NCT04992390|585617187|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
162013386|NCT00790842|585103940|FG010|Dose Level 1|Withdrawal by Subject|0|||
162013387|NCT00790842|585103930|FG000|Dose Level 2|Death|0|||
162013388|NCT00790842|585103931|FG001|Dose Level 2|Death|1|||
162154999|NCT04992390|585617188|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
162155000|NCT04992390|585617186|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
162155001|NCT04992390|585617187|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
162013389|NCT00790842|585103932|FG002|Dose Level 2|Death|0|||
161811252|NCT03285594|584351424|FG002|Overall Study|At the Participant's Own Request|21|||
162013390|NCT00790842|585103933|FG003|Dose Level 2|Death|0|||
162013391|NCT00790842|585103934|FG004|Dose Level 2|Death|1|||
162013392|NCT00790842|585103935|FG005|Dose Level 2|Death|0|||
162013393|NCT00790842|585103936|FG006|Dose Level 2|Death|0|||
162013394|NCT00790842|585103937|FG007|Dose Level 2|Death|0|||
162013395|NCT00790842|585103938|FG008|Dose Level 2|Death|0|||
162013396|NCT00790842|585103939|FG009|Dose Level 2|Death|0|||
162013397|NCT00790842|585103940|FG010|Dose Level 2|Death|0|||
162013398|NCT00790842|585103930|FG000|Dose Level 2|Physician Decision|0|||
162013399|NCT00790842|585103931|FG001|Dose Level 2|Physician Decision|1|||
162013400|NCT00790842|585103932|FG002|Dose Level 2|Physician Decision|0|||
162013401|NCT00790842|585103933|FG003|Dose Level 2|Physician Decision|0|||
162013402|NCT00790842|585103934|FG004|Dose Level 2|Physician Decision|0|||
162013403|NCT00790842|585103935|FG005|Dose Level 2|Physician Decision|0|||
162013404|NCT00790842|585103936|FG006|Dose Level 2|Physician Decision|0|||
162013405|NCT00790842|585103937|FG007|Dose Level 2|Physician Decision|0|||
162013406|NCT00790842|585103938|FG008|Dose Level 2|Physician Decision|0|||
162013407|NCT00790842|585103939|FG009|Dose Level 2|Physician Decision|0|||
162013408|NCT00790842|585103940|FG010|Dose Level 2|Physician Decision|0|||
162013409|NCT00790842|585103930|FG000|Dose Level 2|Withdrawal by Subject|0|||
162013410|NCT00790842|585103931|FG001|Dose Level 2|Withdrawal by Subject|1|||
162013411|NCT00790842|585103932|FG002|Dose Level 2|Withdrawal by Subject|0|||
162013412|NCT00790842|585103933|FG003|Dose Level 2|Withdrawal by Subject|0|||
162013413|NCT00790842|585103934|FG004|Dose Level 2|Withdrawal by Subject|0|||
162013414|NCT00790842|585103935|FG005|Dose Level 2|Withdrawal by Subject|0|||
162013415|NCT00790842|585103936|FG006|Dose Level 2|Withdrawal by Subject|0|||
162013416|NCT00790842|585103937|FG007|Dose Level 2|Withdrawal by Subject|0|||
162013417|NCT00790842|585103938|FG008|Dose Level 2|Withdrawal by Subject|0|||
162013418|NCT00790842|585103939|FG009|Dose Level 2|Withdrawal by Subject|0|||
162013419|NCT00790842|585103940|FG010|Dose Level 2|Withdrawal by Subject|0|||
162013420|NCT00790842|585103930|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
162013421|NCT00790842|585103931|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
162013422|NCT00790842|585103932|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
162013423|NCT00790842|585103933|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
162013424|NCT00790842|585103934|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
162013425|NCT00790842|585103935|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
162013426|NCT00790842|585103936|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
162013427|NCT00790842|585103937|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
162013428|NCT00790842|585103938|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
162013429|NCT00790842|585103939|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
162013430|NCT00790842|585103940|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
162013431|NCT00790842|585103930|FG000|Dose Level 3|Adverse Event|0|||
162013432|NCT00790842|585103931|FG001|Dose Level 3|Adverse Event|0|||
162013433|NCT00790842|585103932|FG002|Dose Level 3|Adverse Event|1|||
162013434|NCT00790842|585103933|FG003|Dose Level 3|Adverse Event|0|||
162013435|NCT00790842|585103934|FG004|Dose Level 3|Adverse Event|0|||
162013436|NCT00790842|585103935|FG005|Dose Level 3|Adverse Event|0|||
162013437|NCT00790842|585103936|FG006|Dose Level 3|Adverse Event|0|||
162013438|NCT00790842|585103937|FG007|Dose Level 3|Adverse Event|0|||
162013439|NCT00790842|585103938|FG008|Dose Level 3|Adverse Event|0|||
162013440|NCT00790842|585103939|FG009|Dose Level 3|Adverse Event|0|||
162013441|NCT00790842|585103940|FG010|Dose Level 3|Adverse Event|0|||
162013442|NCT00790842|585103930|FG000|Dose Level 3|Withdrawal by Subject|0|||
162013443|NCT00790842|585103931|FG001|Dose Level 3|Withdrawal by Subject|0|||
162013444|NCT00790842|585103932|FG002|Dose Level 3|Withdrawal by Subject|3|||
162013445|NCT00790842|585103933|FG003|Dose Level 3|Withdrawal by Subject|0|||
162013446|NCT00790842|585103934|FG004|Dose Level 3|Withdrawal by Subject|0|||
162013447|NCT00790842|585103935|FG005|Dose Level 3|Withdrawal by Subject|0|||
162013448|NCT00790842|585103936|FG006|Dose Level 3|Withdrawal by Subject|0|||
161811253|NCT03285594|584351422|FG000|Overall Study|Adverse Event|2|||
161811254|NCT03285594|584351423|FG001|Overall Study|Adverse Event|2|||
161811255|NCT03285594|584351424|FG002|Overall Study|Adverse Event|6|||
161811256|NCT03285594|584351422|FG000|Overall Study|Poor Compliance to Protocol|0|||
161811257|NCT03285594|584351423|FG001|Overall Study|Poor Compliance to Protocol|0|||
161811258|NCT03285594|584351424|FG002|Overall Study|Poor Compliance to Protocol|1|||
161811259|NCT03285594|584351422|FG000|Overall Study|Lost to Follow-up|0|||
161811260|NCT03285594|584351423|FG001|Overall Study|Lost to Follow-up|0|||
161811261|NCT03285594|584351424|FG002|Overall Study|Lost to Follow-up|1|||
161811262|NCT03285594|584351422|FG000|Overall Study|Reason Not Specified|3|||
162013449|NCT00790842|585103937|FG007|Dose Level 3|Withdrawal by Subject|0|||
162013450|NCT00790842|585103938|FG008|Dose Level 3|Withdrawal by Subject|0|||
162013451|NCT00790842|585103939|FG009|Dose Level 3|Withdrawal by Subject|2|||
162013452|NCT00790842|585103940|FG010|Dose Level 3|Withdrawal by Subject|0|||
162013453|NCT00790842|585103930|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
162013454|NCT00790842|585103931|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
162013455|NCT00790842|585103932|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
162013456|NCT00790842|585103933|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
161811263|NCT03285594|584351423|FG001|Overall Study|Reason Not Specified|4|||
161811264|NCT03285594|584351424|FG002|Overall Study|Reason Not Specified|8|||
162013457|NCT00790842|585103934|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
162013458|NCT00790842|585103935|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
162013459|NCT00790842|585103936|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
162013460|NCT00790842|585103937|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
162013461|NCT00790842|585103938|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
162013462|NCT00790842|585103939|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
162013463|NCT00790842|585103940|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
162013464|NCT00790842|585103930|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
162013465|NCT00790842|585103931|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
162013466|NCT00790842|585103932|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
162013467|NCT00790842|585103933|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
162013468|NCT00790842|585103934|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
162013469|NCT00790842|585103935|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
162013470|NCT00790842|585103936|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
162013471|NCT00790842|585103937|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
162013472|NCT00790842|585103938|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
162013473|NCT00790842|585103939|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
162013474|NCT00790842|585103940|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
162013475|NCT00790842|585103930|FG000|Dose Level 4|Adverse Event|0|||
162013476|NCT00790842|585103931|FG001|Dose Level 4|Adverse Event|0|||
162013477|NCT00790842|585103932|FG002|Dose Level 4|Adverse Event|0|||
162013478|NCT00790842|585103933|FG003|Dose Level 4|Adverse Event|0|||
162013479|NCT00790842|585103934|FG004|Dose Level 4|Adverse Event|0|||
162013480|NCT00790842|585103935|FG005|Dose Level 4|Adverse Event|0|||
162013481|NCT00790842|585103936|FG006|Dose Level 4|Adverse Event|1|||
162013482|NCT00790842|585103937|FG007|Dose Level 4|Adverse Event|0|||
162155002|NCT04992390|585617188|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
162155003|NCT04992390|585617186|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
162155004|NCT04992390|585617187|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
162155005|NCT04992390|585617188|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
162155006|NCT04992390|585617186|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
162155007|NCT04992390|585617187|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
162155008|NCT04992390|585617188|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
162155009|NCT04992390|585617186|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
162155010|NCT04992390|585617187|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
162155011|NCT04992390|585617188|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
162155012|NCT04992390|585617186|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
162155013|NCT04992390|585617187|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
162155014|NCT04992390|585617188|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
162155015|NCT04992390|585617186|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
162155016|NCT04992390|585617187|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
162155017|NCT04992390|585617188|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
162155018|NCT04992390|585617186|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
162155019|NCT04992390|585617187|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
162155020|NCT04992390|585617188|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
162155021|NCT04992390|585617186|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
162155022|NCT04992390|585617187|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
162155023|NCT04992390|585617188|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
162155024|NCT04992390|585617186|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
162155025|NCT04992390|585617187|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
162155026|NCT04992390|585617188|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
162155027|NCT04992390|585617186|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
162155028|NCT04992390|585617187|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
162155029|NCT04992390|585617188|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
162155030|NCT04992390|585617186|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
162155031|NCT04992390|585617187|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
162155032|NCT04992390|585617188|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
162155033|NCT04992390|585617186|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
162155034|NCT04992390|585617187|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
162155035|NCT04992390|585617188|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
162155036|NCT04992390|585617186|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
162155037|NCT04992390|585617187|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
162155038|NCT04992390|585617188|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
162155039|NCT01853748|585619267|FG000|Allocation|Withdrawal by Subject|1|||
162013483|NCT00790842|585103938|FG008|Dose Level 4|Adverse Event|0|||
162013484|NCT00790842|585103939|FG009|Dose Level 4|Adverse Event|0|||
162013485|NCT00790842|585103940|FG010|Dose Level 4|Adverse Event|0|||
161811265|NCT00834431|584351425|FG000|First Intervention|Adverse Event|0|||
162013486|NCT00790842|585103930|FG000|Dose Level 4|Physician Decision|0|||
162013487|NCT00790842|585103931|FG001|Dose Level 4|Physician Decision|0|||
162013488|NCT00790842|585103932|FG002|Dose Level 4|Physician Decision|0|||
162013489|NCT00790842|585103933|FG003|Dose Level 4|Physician Decision|0|||
162013490|NCT00790842|585103934|FG004|Dose Level 4|Physician Decision|0|||
162013491|NCT00790842|585103935|FG005|Dose Level 4|Physician Decision|0|||
162013492|NCT00790842|585103936|FG006|Dose Level 4|Physician Decision|1|||
162013493|NCT00790842|585103937|FG007|Dose Level 4|Physician Decision|0|||
162013494|NCT00790842|585103938|FG008|Dose Level 4|Physician Decision|0|||
162013495|NCT00790842|585103939|FG009|Dose Level 4|Physician Decision|0|||
162013496|NCT00790842|585103940|FG010|Dose Level 4|Physician Decision|1|||
162013497|NCT00790842|585103930|FG000|Dose Level 4|Withdrawal by Subject|0|||
162013498|NCT00790842|585103931|FG001|Dose Level 4|Withdrawal by Subject|0|||
162013499|NCT00790842|585103932|FG002|Dose Level 4|Withdrawal by Subject|0|||
162013500|NCT00790842|585103933|FG003|Dose Level 4|Withdrawal by Subject|0|||
162013501|NCT00790842|585103934|FG004|Dose Level 4|Withdrawal by Subject|0|||
162013502|NCT00790842|585103935|FG005|Dose Level 4|Withdrawal by Subject|0|||
162013503|NCT00790842|585103936|FG006|Dose Level 4|Withdrawal by Subject|0|||
162013504|NCT00790842|585103937|FG007|Dose Level 4|Withdrawal by Subject|0|||
162013505|NCT00790842|585103938|FG008|Dose Level 4|Withdrawal by Subject|0|||
162013506|NCT00790842|585103939|FG009|Dose Level 4|Withdrawal by Subject|0|||
162013507|NCT00790842|585103940|FG010|Dose Level 4|Withdrawal by Subject|1|||
162013508|NCT00790842|585103930|FG000|Expansion Cohort|Adverse Event|0|||
162013509|NCT00790842|585103931|FG001|Expansion Cohort|Adverse Event|0|||
162013510|NCT00790842|585103932|FG002|Expansion Cohort|Adverse Event|0|||
162013511|NCT00790842|585103933|FG003|Expansion Cohort|Adverse Event|0|||
162013512|NCT00790842|585103934|FG004|Expansion Cohort|Adverse Event|0|||
162013513|NCT00790842|585103935|FG005|Expansion Cohort|Adverse Event|0|||
162013514|NCT00790842|585103936|FG006|Expansion Cohort|Adverse Event|1|||
162013515|NCT00790842|585103937|FG007|Expansion Cohort|Adverse Event|0|||
162013516|NCT00790842|585103938|FG008|Expansion Cohort|Adverse Event|0|||
162013517|NCT00790842|585103939|FG009|Expansion Cohort|Adverse Event|0|||
162013518|NCT00790842|585103940|FG010|Expansion Cohort|Adverse Event|0|||
162013519|NCT00790842|585103930|FG000|Expansion Cohort|Death|0|||
162013520|NCT00790842|585103931|FG001|Expansion Cohort|Death|0|||
162013521|NCT00790842|585103932|FG002|Expansion Cohort|Death|2|||
162013522|NCT00790842|585103933|FG003|Expansion Cohort|Death|0|||
162155040|NCT01853748|585619268|FG001|Allocation|Withdrawal by Subject|13|||
162155041|NCT01853748|585619267|FG000|Allocation|not sufficient to receive intervention|0|||
162155042|NCT01853748|585619268|FG001|Allocation|not sufficient to receive intervention|1|||
162155043|NCT01853748|585619267|FG000|Follow-Up|Withdrawal by Subject|7|||
162155044|NCT01853748|585619268|FG001|Follow-Up|Withdrawal by Subject|6|||
162155045|NCT01853748|585619267|FG000|Follow-Up|Adverse Event|67|||
162155046|NCT01853748|585619268|FG001|Follow-Up|Adverse Event|7|||
162155047|NCT01853748|585619267|FG000|Follow-Up|not available for data collection|16|||
162155048|NCT01853748|585619268|FG001|Follow-Up|not available for data collection|4|||
162155049|NCT00780416|585619273|FG000|Overall Study|Physician Decision|3|||
162155050|NCT00780416|585619274|FG001|Overall Study|Physician Decision|3|||
162155051|NCT00780416|585619273|FG000|Overall Study|Protocol Violation|1|||
162155052|NCT00780416|585619274|FG001|Overall Study|Protocol Violation|0|||
162155053|NCT00780416|585619273|FG000|Overall Study|Withdrawal by Subject|8|||
162155054|NCT00780416|585619274|FG001|Overall Study|Withdrawal by Subject|6|||
162155055|NCT02916706|585619275|FG000|Overall Study|Adverse Event|0|||
162155056|NCT02916706|585619276|FG001|Overall Study|Adverse Event|1|||
162155057|NCT02916706|585619275|FG000|Overall Study|Lost to Follow-up|0|||
162155058|NCT02916706|585619276|FG001|Overall Study|Lost to Follow-up|1|||
162155059|NCT02916706|585619275|FG000|Overall Study|Physician Decision|1|||
162155060|NCT02916706|585619276|FG001|Overall Study|Physician Decision|0|||
162155061|NCT02916706|585619275|FG000|Overall Study|Protocol Violation|3|||
162155062|NCT02916706|585619276|FG001|Overall Study|Protocol Violation|1|||
162155063|NCT02916706|585619275|FG000|Overall Study|Withdrawal by Subject|6|||
162155064|NCT02916706|585619276|FG001|Overall Study|Withdrawal by Subject|9|||
162155065|NCT02916706|585619275|FG000|Overall Study|Other|5|||
162155066|NCT02916706|585619276|FG001|Overall Study|Other|19|||
162155067|NCT02723955|585619277|FG000|Escalation Phase|Death|1|||
162155068|NCT02723955|585619278|FG001|Escalation Phase|Death|1|||
162155069|NCT02723955|585619279|FG002|Escalation Phase|Death|2|||
162155070|NCT02723955|585619280|FG003|Escalation Phase|Death|7|||
162155071|NCT02723955|585619281|FG004|Escalation Phase|Death|18|||
162155072|NCT02723955|585619282|FG005|Escalation Phase|Death|17|||
162155073|NCT02723955|585619283|FG006|Escalation Phase|Death|11|||
162155074|NCT02723955|585619284|FG007|Escalation Phase|Death|21|||
162155075|NCT02723955|585619285|FG008|Escalation Phase|Death|3|||
162155076|NCT02723955|585619286|FG009|Escalation Phase|Death|0|||
162155077|NCT02723955|585619287|FG010|Escalation Phase|Death|0|||
162155078|NCT02723955|585619288|FG011|Escalation Phase|Death|0|||
162155079|NCT02723955|585619289|FG012|Escalation Phase|Death|2|||
162155080|NCT02723955|585619290|FG013|Escalation Phase|Death|4|||
162155081|NCT02723955|585619291|FG014|Escalation Phase|Death|5|||
162155082|NCT02723955|585619292|FG015|Escalation Phase|Death|6|||
162155083|NCT02723955|585619293|FG016|Escalation Phase|Death|6|||
162155084|NCT02723955|585619294|FG017|Escalation Phase|Death|7|||
162155085|NCT02723955|585619295|FG018|Escalation Phase|Death|1|||
162155086|NCT02723955|585619296|FG019|Escalation Phase|Death|3|||
162155087|NCT02723955|585619297|FG020|Escalation Phase|Death|13|||
162155088|NCT02723955|585619298|FG021|Escalation Phase|Death|3|||
162155089|NCT02723955|585619299|FG022|Escalation Phase|Death|2|||
162155090|NCT02723955|585619300|FG023|Escalation Phase|Death|4|||
162155091|NCT02723955|585619301|FG024|Escalation Phase|Death|31|||
162155092|NCT02723955|585619302|FG025|Escalation Phase|Death|7|||
161811266|NCT00834431|584351426|FG001|First Intervention|Adverse Event|1|||
161811267|NCT00834431|584351425|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
161811268|NCT00834431|584351426|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161811269|NCT00556322|584351431|FG000|Overall Study|Insufficient therapeutic response|158|||
161811270|NCT00556322|584351432|FG001|Overall Study|Insufficient therapeutic response|168|||
161811271|NCT00556322|584351431|FG000|Overall Study|Adverse Event|7|||
161811272|NCT00556322|584351432|FG001|Overall Study|Adverse Event|4|||
161811273|NCT00556322|584351431|FG000|Overall Study|Other|4|||
161811274|NCT00556322|584351432|FG001|Overall Study|Other|1|||
161811275|NCT00556322|584351431|FG000|Overall Study|Lost to Follow-up|5|||
161811276|NCT00556322|584351432|FG001|Overall Study|Lost to Follow-up|3|||
161811277|NCT00556322|584351431|FG000|Overall Study|Withdrawal by Subject|19|||
162155093|NCT02723955|585619303|FG026|Escalation Phase|Death|13|||
162155094|NCT02723955|585619304|FG027|Escalation Phase|Death|0|||
162155095|NCT02723955|585619305|FG028|Escalation Phase|Death|1|||
162155096|NCT02723955|585619306|FG029|Escalation Phase|Death|0|||
162155097|NCT02723955|585619307|FG030|Escalation Phase|Death|0|||
162155098|NCT02723955|585619308|FG031|Escalation Phase|Death|0|||
162155099|NCT02723955|585619309|FG032|Escalation Phase|Death|0|||
162155100|NCT02723955|585619310|FG033|Escalation Phase|Death|0|||
162155101|NCT02723955|585619311|FG034|Escalation Phase|Death|0|||
162155102|NCT02723955|585619312|FG035|Escalation Phase|Death|0|||
162155103|NCT02723955|585619313|FG036|Escalation Phase|Death|0|||
162155104|NCT02723955|585619314|FG037|Escalation Phase|Death|0|||
162155105|NCT02723955|585619315|FG038|Escalation Phase|Death|0|||
161811278|NCT00556322|584351432|FG001|Overall Study|Withdrawal by Subject|7|||
162155106|NCT02723955|585619316|FG039|Escalation Phase|Death|0|||
162155107|NCT02723955|585619317|FG040|Escalation Phase|Death|0|||
162155108|NCT02723955|585619318|FG041|Escalation Phase|Death|0|||
162155109|NCT02723955|585619319|FG042|Escalation Phase|Death|0|||
162013523|NCT00790842|585103934|FG004|Expansion Cohort|Death|0|||
162013524|NCT00790842|585103935|FG005|Expansion Cohort|Death|0|||
162013525|NCT00790842|585103936|FG006|Expansion Cohort|Death|0|||
162013526|NCT00790842|585103937|FG007|Expansion Cohort|Death|0|||
162013527|NCT00790842|585103938|FG008|Expansion Cohort|Death|0|||
162013528|NCT00790842|585103939|FG009|Expansion Cohort|Death|0|||
162013529|NCT00790842|585103940|FG010|Expansion Cohort|Death|0|||
162013530|NCT00790842|585103930|FG000|Expansion Cohort|Physician Decision|0|||
162013531|NCT00790842|585103931|FG001|Expansion Cohort|Physician Decision|0|||
162013532|NCT00790842|585103932|FG002|Expansion Cohort|Physician Decision|1|||
162013533|NCT00790842|585103933|FG003|Expansion Cohort|Physician Decision|0|||
162013534|NCT00790842|585103934|FG004|Expansion Cohort|Physician Decision|0|||
162013535|NCT00790842|585103935|FG005|Expansion Cohort|Physician Decision|0|||
162013536|NCT00790842|585103936|FG006|Expansion Cohort|Physician Decision|0|||
162013537|NCT00790842|585103937|FG007|Expansion Cohort|Physician Decision|0|||
162155110|NCT02723955|585619277|FG000|Escalation Phase|Lost to Follow-up|0|||
162155111|NCT02723955|585619278|FG001|Escalation Phase|Lost to Follow-up|0|||
162155112|NCT02723955|585619279|FG002|Escalation Phase|Lost to Follow-up|0|||
162155113|NCT02723955|585619280|FG003|Escalation Phase|Lost to Follow-up|0|||
162155114|NCT02723955|585619281|FG004|Escalation Phase|Lost to Follow-up|0|||
162155115|NCT02723955|585619282|FG005|Escalation Phase|Lost to Follow-up|2|||
162155116|NCT02723955|585619283|FG006|Escalation Phase|Lost to Follow-up|1|||
162155117|NCT02723955|585619284|FG007|Escalation Phase|Lost to Follow-up|1|||
162155118|NCT02723955|585619285|FG008|Escalation Phase|Lost to Follow-up|1|||
162155119|NCT02723955|585619286|FG009|Escalation Phase|Lost to Follow-up|0|||
162155120|NCT02723955|585619287|FG010|Escalation Phase|Lost to Follow-up|0|||
162155121|NCT02723955|585619288|FG011|Escalation Phase|Lost to Follow-up|0|||
162155122|NCT02723955|585619289|FG012|Escalation Phase|Lost to Follow-up|1|||
162155123|NCT02723955|585619290|FG013|Escalation Phase|Lost to Follow-up|0|||
162155124|NCT02723955|585619291|FG014|Escalation Phase|Lost to Follow-up|0|||
162155125|NCT02723955|585619292|FG015|Escalation Phase|Lost to Follow-up|0|||
162155126|NCT02723955|585619293|FG016|Escalation Phase|Lost to Follow-up|1|||
162155127|NCT02723955|585619294|FG017|Escalation Phase|Lost to Follow-up|2|||
162155128|NCT02723955|585619295|FG018|Escalation Phase|Lost to Follow-up|0|||
162155129|NCT02723955|585619296|FG019|Escalation Phase|Lost to Follow-up|1|||
162155130|NCT02723955|585619297|FG020|Escalation Phase|Lost to Follow-up|2|||
162155131|NCT02723955|585619298|FG021|Escalation Phase|Lost to Follow-up|1|||
162155132|NCT02723955|585619299|FG022|Escalation Phase|Lost to Follow-up|0|||
162155133|NCT02723955|585619300|FG023|Escalation Phase|Lost to Follow-up|0|||
162155134|NCT02723955|585619301|FG024|Escalation Phase|Lost to Follow-up|1|||
162155135|NCT02723955|585619302|FG025|Escalation Phase|Lost to Follow-up|1|||
162155136|NCT02723955|585619303|FG026|Escalation Phase|Lost to Follow-up|3|||
162155137|NCT02723955|585619304|FG027|Escalation Phase|Lost to Follow-up|0|||
162155138|NCT02723955|585619305|FG028|Escalation Phase|Lost to Follow-up|1|||
162155139|NCT02723955|585619306|FG029|Escalation Phase|Lost to Follow-up|0|||
162155140|NCT02723955|585619307|FG030|Escalation Phase|Lost to Follow-up|0|||
162155141|NCT02723955|585619308|FG031|Escalation Phase|Lost to Follow-up|0|||
162155142|NCT02723955|585619309|FG032|Escalation Phase|Lost to Follow-up|0|||
162155143|NCT02723955|585619310|FG033|Escalation Phase|Lost to Follow-up|0|||
162155144|NCT02723955|585619311|FG034|Escalation Phase|Lost to Follow-up|0|||
162155145|NCT02723955|585619312|FG035|Escalation Phase|Lost to Follow-up|0|||
162155146|NCT02723955|585619313|FG036|Escalation Phase|Lost to Follow-up|0|||
162155147|NCT02723955|585619314|FG037|Escalation Phase|Lost to Follow-up|0|||
162155148|NCT02723955|585619315|FG038|Escalation Phase|Lost to Follow-up|0|||
162155149|NCT02723955|585619316|FG039|Escalation Phase|Lost to Follow-up|0|||
161811279|NCT00556322|584351431|FG000|Overall Study|Protocol Violation|5|||
161811280|NCT00556322|584351432|FG001|Overall Study|Protocol Violation|1|||
161811281|NCT00556322|584351431|FG000|Overall Study|Ongoing at data cutoff|3|||
161811282|NCT00556322|584351432|FG001|Overall Study|Ongoing at data cutoff|5|||
161811283|NCT00556322|584351431|FG000|Overall Study|Death|20|||
161811284|NCT00556322|584351432|FG001|Overall Study|Death|14|||
161811285|NCT03733444|584351433|FG000|Overall Study|Adverse Event|8|||
161811286|NCT03733444|584351434|FG001|Overall Study|Adverse Event|10|||
161811287|NCT03733444|584351435|FG002|Overall Study|Adverse Event|5|||
161811288|NCT03733444|584351433|FG000|Overall Study|Death|20|||
161811289|NCT03733444|584351434|FG001|Overall Study|Death|19|||
161811290|NCT03733444|584351435|FG002|Overall Study|Death|11|||
161811291|NCT03733444|584351433|FG000|Overall Study|Lost to Follow-up|3|||
161811292|NCT03733444|584351434|FG001|Overall Study|Lost to Follow-up|0|||
161811293|NCT03733444|584351435|FG002|Overall Study|Lost to Follow-up|1|||
161811294|NCT03733444|584351433|FG000|Overall Study|Lack of Efficacy|0|||
161811295|NCT03733444|584351434|FG001|Overall Study|Lack of Efficacy|1|||
161811296|NCT03733444|584351435|FG002|Overall Study|Lack of Efficacy|1|||
161811297|NCT03733444|584351433|FG000|Overall Study|Physician Decision|2|||
161811298|NCT03733444|584351434|FG001|Overall Study|Physician Decision|1|||
161811299|NCT03733444|584351435|FG002|Overall Study|Physician Decision|0|||
161811300|NCT03733444|584351433|FG000|Overall Study|Protocol Violation|2|||
161915180|NCT02332707|584738887|FG015|Overall Study|Physician Decision|0|||
161915181|NCT02332707|584738888|FG016|Overall Study|Physician Decision|0|||
161915182|NCT02332707|584738889|FG017|Overall Study|Physician Decision|0|||
161915183|NCT02332707|584738872|FG000|Overall Study|Withdrawal by Subject|0|||
161915184|NCT02332707|584738873|FG001|Overall Study|Withdrawal by Subject|0|||
161915185|NCT02332707|584738874|FG002|Overall Study|Withdrawal by Subject|1|||
161915186|NCT02332707|584738875|FG003|Overall Study|Withdrawal by Subject|0|||
161915187|NCT02332707|584738876|FG004|Overall Study|Withdrawal by Subject|0|||
161915188|NCT02332707|584738877|FG005|Overall Study|Withdrawal by Subject|0|||
161915189|NCT02332707|584738878|FG006|Overall Study|Withdrawal by Subject|0|||
161915190|NCT02332707|584738879|FG007|Overall Study|Withdrawal by Subject|0|||
161915191|NCT02332707|584738880|FG008|Overall Study|Withdrawal by Subject|0|||
162013538|NCT00790842|585103938|FG008|Expansion Cohort|Physician Decision|0|||
162013539|NCT00790842|585103939|FG009|Expansion Cohort|Physician Decision|0|||
162155150|NCT02723955|585619317|FG040|Escalation Phase|Lost to Follow-up|0|||
162155151|NCT02723955|585619318|FG041|Escalation Phase|Lost to Follow-up|0|||
161811301|NCT03733444|584351434|FG001|Overall Study|Protocol Violation|1|||
161811302|NCT03733444|584351435|FG002|Overall Study|Protocol Violation|0|||
161811303|NCT03733444|584351433|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
161811304|NCT03733444|584351434|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
161811305|NCT03733444|584351435|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
161811306|NCT03733444|584351433|FG000|Overall Study|Study Terminated by Sponsor|203|||
161811307|NCT03733444|584351434|FG001|Overall Study|Study Terminated by Sponsor|209|||
161811308|NCT03733444|584351435|FG002|Overall Study|Study Terminated by Sponsor|221|||
161811309|NCT03733444|584351433|FG000|Overall Study|Withdrawal by Subject|19|||
161811310|NCT03733444|584351434|FG001|Overall Study|Withdrawal by Subject|18|||
161811311|NCT03733444|584351435|FG002|Overall Study|Withdrawal by Subject|16|||
161811312|NCT03733444|584351433|FG000|Overall Study|Miscellaneous|1|||
161811313|NCT03733444|584351434|FG001|Overall Study|Miscellaneous|0|||
161811314|NCT03733444|584351435|FG002|Overall Study|Miscellaneous|1|||
161811315|NCT03733444|584351433|FG000|Overall Study|Not Treated|1|||
161811316|NCT03733444|584351434|FG001|Overall Study|Not Treated|2|||
161811317|NCT03733444|584351435|FG002|Overall Study|Not Treated|1|||
161811318|NCT01913405|584351436|FG000|Overall Study|Withdrawal by Subject|1|||
161811319|NCT01913405|584351436|FG000|Overall Study|Adverse Event|1|||
161811320|NCT02689505|584351437|FG000|Overall Study|Progressive disease|2|||
161811321|NCT02689505|584351438|FG001|Overall Study|Progressive disease|2|||
161811322|NCT02689505|584351439|FG002|Overall Study|Progressive disease|3|||
161811323|NCT02689505|584351440|FG003|Overall Study|Progressive disease|9|||
161811324|NCT02689505|584351441|FG004|Overall Study|Progressive disease|1|||
161811325|NCT02689505|584351437|FG000|Overall Study|Dose Limiting Toxicity|0|||
161811326|NCT02689505|584351438|FG001|Overall Study|Dose Limiting Toxicity|1|||
161811327|NCT02689505|584351439|FG002|Overall Study|Dose Limiting Toxicity|0|||
161811328|NCT02689505|584351440|FG003|Overall Study|Dose Limiting Toxicity|0|||
161811329|NCT02689505|584351441|FG004|Overall Study|Dose Limiting Toxicity|2|||
161811330|NCT02689505|584351437|FG000|Overall Study|Other AE or clinical progression|0|||
161811331|NCT02689505|584351438|FG001|Overall Study|Other AE or clinical progression|2|||
161811332|NCT02689505|584351439|FG002|Overall Study|Other AE or clinical progression|0|||
161811333|NCT02689505|584351440|FG003|Overall Study|Other AE or clinical progression|2|||
161811334|NCT02689505|584351441|FG004|Overall Study|Other AE or clinical progression|0|||
161811335|NCT04108858|584351442|FG000|Overall Study|Adverse Event|1|||
161811336|NCT03663179|584351443|FG000|Overall Study|Withdrawal by Subject|2|||
161811337|NCT03663179|584351444|FG001|Overall Study|Withdrawal by Subject|0|||
161811338|NCT03663179|584351443|FG000|Overall Study|Lost to Follow-up|1|||
161811339|NCT03663179|584351444|FG001|Overall Study|Lost to Follow-up|1|||
161811340|NCT03663179|584351443|FG000|Overall Study|Revealed exclusionary condition|1|||
161811341|NCT03663179|584351444|FG001|Overall Study|Revealed exclusionary condition|0|||
161811342|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
161811343|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
161811344|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
161811345|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
161811346|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
161811347|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
161811348|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161811349|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161811350|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
161811351|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
161811352|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
161811353|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
161811354|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
161811355|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
161811356|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
161915192|NCT02332707|584738881|FG009|Overall Study|Withdrawal by Subject|3|||
161915193|NCT02332707|584738882|FG010|Overall Study|Withdrawal by Subject|0|||
162155152|NCT02723955|585619319|FG042|Escalation Phase|Lost to Follow-up|0|||
161915194|NCT02332707|584738883|FG011|Overall Study|Withdrawal by Subject|0|||
161915195|NCT02332707|584738884|FG012|Overall Study|Withdrawal by Subject|0|||
161915196|NCT02332707|584738885|FG013|Overall Study|Withdrawal by Subject|0|||
161915197|NCT02332707|584738886|FG014|Overall Study|Withdrawal by Subject|0|||
161915198|NCT02332707|584738887|FG015|Overall Study|Withdrawal by Subject|0|||
161915199|NCT02332707|584738888|FG016|Overall Study|Withdrawal by Subject|0|||
161915200|NCT02332707|584738889|FG017|Overall Study|Withdrawal by Subject|0|||
161915201|NCT01473134|584738890|FG000|Overall Study|Lost to Follow-up|21|||
161915202|NCT01473134|584738891|FG001|Overall Study|Lost to Follow-up|13|||
161915203|NCT01473134|584738890|FG000|Overall Study|Protocol Violation|32|||
161915204|NCT01473134|584738891|FG001|Overall Study|Protocol Violation|19|||
161915205|NCT01473134|584738890|FG000|Overall Study|Withdrawal by Subject|1|||
161915206|NCT01473134|584738891|FG001|Overall Study|Withdrawal by Subject|2|||
161915207|NCT01473134|584738890|FG000|Overall Study|Death|0|||
161915208|NCT01473134|584738891|FG001|Overall Study|Death|1|||
161915209|NCT01473134|584738890|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
161915210|NCT01473134|584738891|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
161915211|NCT04761822|584738896|FG000|Overall Study|Adverse Event|3|||
161915212|NCT04761822|584738897|FG001|Overall Study|Adverse Event|1|||
161915213|NCT04761822|584738898|FG002|Overall Study|Adverse Event|1|||
161915214|NCT04761822|584738899|FG003|Overall Study|Adverse Event|3|||
161915215|NCT04761822|584738896|FG000|Overall Study|Lost to Follow-up|1|||
161915216|NCT04761822|584738897|FG001|Overall Study|Lost to Follow-up|0|||
161915217|NCT04761822|584738898|FG002|Overall Study|Lost to Follow-up|2|||
161915218|NCT04761822|584738899|FG003|Overall Study|Lost to Follow-up|3|||
161915219|NCT04761822|584738896|FG000|Overall Study|Physician Decision|0|||
161915220|NCT04761822|584738897|FG001|Overall Study|Physician Decision|1|||
161915221|NCT04761822|584738898|FG002|Overall Study|Physician Decision|0|||
161915222|NCT04761822|584738899|FG003|Overall Study|Physician Decision|0|||
161915223|NCT04761822|584738896|FG000|Overall Study|Withdrawal by Subject|3|||
161915224|NCT04761822|584738897|FG001|Overall Study|Withdrawal by Subject|8|||
161915225|NCT04761822|584738898|FG002|Overall Study|Withdrawal by Subject|1|||
161915226|NCT04761822|584738899|FG003|Overall Study|Withdrawal by Subject|11|||
161915227|NCT04761822|584738896|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
161915228|NCT04761822|584738897|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
161915229|NCT04761822|584738898|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
161915230|NCT04761822|584738899|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
161915231|NCT04761822|584738896|FG000|Overall Study|Participant requested unblinding|0|||
161915232|NCT04761822|584738897|FG001|Overall Study|Participant requested unblinding|0|||
161915233|NCT04761822|584738898|FG002|Overall Study|Participant requested unblinding|0|||
161915234|NCT04761822|584738899|FG003|Overall Study|Participant requested unblinding|1|||
161915235|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
161915236|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
161915237|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Death|1|||
161915238|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Death|3|||
161915239|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
161915240|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
161915241|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
161915242|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
161915243|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
161915244|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
161915245|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
161915246|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
161915247|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
161915248|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
161915249|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
161915250|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
161915251|NCT00362232|584738900|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
161915252|NCT00362232|584738901|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
161915253|NCT00362232|584738900|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
161915254|NCT00362232|584738901|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
161915255|NCT00362232|584738900|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
161915256|NCT00362232|584738901|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
161915257|NCT00362232|584738900|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
161915258|NCT00362232|584738901|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
161915259|NCT00362232|584738900|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
161915260|NCT00362232|584738901|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
161915261|NCT02233413|584738906|FG000|Overall Study|Lost to Follow-up|7|||
161915262|NCT02233413|584738907|FG001|Overall Study|Lost to Follow-up|9|||
161915263|NCT02233413|584738906|FG000|Overall Study|Withdrawal by Subject|4|||
161915264|NCT02233413|584738907|FG001|Overall Study|Withdrawal by Subject|5|||
161915265|NCT01799889|584738908|FG000|Overall Study|Adverse Event|4|||
161915266|NCT01799889|584738909|FG001|Overall Study|Adverse Event|4|||
161915267|NCT01799889|584738910|FG002|Overall Study|Adverse Event|5|||
161915268|NCT01799889|584738911|FG003|Overall Study|Adverse Event|1|||
161915269|NCT01799889|584738912|FG004|Overall Study|Adverse Event|11|||
161915270|NCT01799889|584738913|FG005|Overall Study|Adverse Event|1|||
161915271|NCT01799889|584738914|FG006|Overall Study|Adverse Event|5|||
161915272|NCT01799889|584738915|FG007|Overall Study|Adverse Event|2|||
161915273|NCT01799889|584738916|FG008|Overall Study|Adverse Event|3|||
161915274|NCT01799889|584738917|FG009|Overall Study|Adverse Event|1|||
161915275|NCT01799889|584738918|FG010|Overall Study|Adverse Event|1|||
161915276|NCT01799889|584738919|FG011|Overall Study|Adverse Event|0|||
161915277|NCT01799889|584738908|FG000|Overall Study|Death|1|||
161915278|NCT01799889|584738909|FG001|Overall Study|Death|0|||
161915279|NCT01799889|584738910|FG002|Overall Study|Death|5|||
161915280|NCT01799889|584738911|FG003|Overall Study|Death|3|||
161915281|NCT01799889|584738912|FG004|Overall Study|Death|1|||
161915282|NCT01799889|584738913|FG005|Overall Study|Death|0|||
161915283|NCT01799889|584738914|FG006|Overall Study|Death|0|||
161915284|NCT01799889|584738915|FG007|Overall Study|Death|0|||
161915285|NCT01799889|584738916|FG008|Overall Study|Death|1|||
161915286|NCT01799889|584738917|FG009|Overall Study|Death|0|||
161915287|NCT01799889|584738918|FG010|Overall Study|Death|1|||
161915288|NCT01799889|584738919|FG011|Overall Study|Death|0|||
161915289|NCT01799889|584738908|FG000|Overall Study|Lack of Efficacy|1|||
161915290|NCT01799889|584738909|FG001|Overall Study|Lack of Efficacy|1|||
161915291|NCT01799889|584738910|FG002|Overall Study|Lack of Efficacy|0|||
161915292|NCT01799889|584738911|FG003|Overall Study|Lack of Efficacy|1|||
161915293|NCT01799889|584738912|FG004|Overall Study|Lack of Efficacy|2|||
161915294|NCT01799889|584738913|FG005|Overall Study|Lack of Efficacy|2|||
161915295|NCT01799889|584738914|FG006|Overall Study|Lack of Efficacy|0|||
161915296|NCT01799889|584738915|FG007|Overall Study|Lack of Efficacy|0|||
161915297|NCT01799889|584738916|FG008|Overall Study|Lack of Efficacy|2|||
161915298|NCT01799889|584738917|FG009|Overall Study|Lack of Efficacy|0|||
161915299|NCT01799889|584738918|FG010|Overall Study|Lack of Efficacy|1|||
161915300|NCT01799889|584738919|FG011|Overall Study|Lack of Efficacy|0|||
161915301|NCT01799889|584738908|FG000|Overall Study|Lost to Follow-up|0|||
161915302|NCT01799889|584738909|FG001|Overall Study|Lost to Follow-up|1|||
161915303|NCT01799889|584738910|FG002|Overall Study|Lost to Follow-up|0|||
161915304|NCT01799889|584738911|FG003|Overall Study|Lost to Follow-up|0|||
161915305|NCT01799889|584738912|FG004|Overall Study|Lost to Follow-up|0|||
161915306|NCT01799889|584738913|FG005|Overall Study|Lost to Follow-up|0|||
161915307|NCT01799889|584738914|FG006|Overall Study|Lost to Follow-up|0|||
161915308|NCT01799889|584738915|FG007|Overall Study|Lost to Follow-up|0|||
161915309|NCT01799889|584738916|FG008|Overall Study|Lost to Follow-up|0|||
161915310|NCT01799889|584738917|FG009|Overall Study|Lost to Follow-up|0|||
161915311|NCT01799889|584738918|FG010|Overall Study|Lost to Follow-up|0|||
161915312|NCT01799889|584738919|FG011|Overall Study|Lost to Follow-up|0|||
161915313|NCT01799889|584738908|FG000|Overall Study|Physician Decision|3|||
161915314|NCT01799889|584738909|FG001|Overall Study|Physician Decision|2|||
161915315|NCT01799889|584738910|FG002|Overall Study|Physician Decision|4|||
161915316|NCT01799889|584738911|FG003|Overall Study|Physician Decision|4|||
161915317|NCT01799889|584738912|FG004|Overall Study|Physician Decision|5|||
161915318|NCT01799889|584738913|FG005|Overall Study|Physician Decision|5|||
161915319|NCT01799889|584738914|FG006|Overall Study|Physician Decision|5|||
161915320|NCT01799889|584738915|FG007|Overall Study|Physician Decision|2|||
161915321|NCT01799889|584738916|FG008|Overall Study|Physician Decision|6|||
161915322|NCT01799889|584738917|FG009|Overall Study|Physician Decision|0|||
161915323|NCT01799889|584738918|FG010|Overall Study|Physician Decision|0|||
161915324|NCT01799889|584738919|FG011|Overall Study|Physician Decision|1|||
161915325|NCT01799889|584738908|FG000|Overall Study|Progressive Disease|30|||
161915326|NCT01799889|584738909|FG001|Overall Study|Progressive Disease|26|||
161915327|NCT01799889|584738910|FG002|Overall Study|Progressive Disease|25|||
162013540|NCT00790842|585103940|FG010|Expansion Cohort|Physician Decision|0|||
162013541|NCT00790842|585103930|FG000|Expansion Cohort|Withdrawal by Subject|0|||
161915328|NCT01799889|584738911|FG003|Overall Study|Progressive Disease|30|||
161915329|NCT01799889|584738912|FG004|Overall Study|Progressive Disease|23|||
162013542|NCT00790842|585103931|FG001|Expansion Cohort|Withdrawal by Subject|0|||
162013543|NCT00790842|585103932|FG002|Expansion Cohort|Withdrawal by Subject|3|||
162013544|NCT00790842|585103933|FG003|Expansion Cohort|Withdrawal by Subject|0|||
161915330|NCT01799889|584738913|FG005|Overall Study|Progressive Disease|9|||
161915331|NCT01799889|584738914|FG006|Overall Study|Progressive Disease|8|||
161915332|NCT01799889|584738915|FG007|Overall Study|Progressive Disease|13|||
161915333|NCT01799889|584738916|FG008|Overall Study|Progressive Disease|18|||
161915334|NCT01799889|584738917|FG009|Overall Study|Progressive Disease|5|||
161915335|NCT01799889|584738918|FG010|Overall Study|Progressive Disease|3|||
161915336|NCT01799889|584738919|FG011|Overall Study|Progressive Disease|1|||
161915337|NCT01799889|584738908|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
161915338|NCT01799889|584738909|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
161915339|NCT01799889|584738910|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
161915340|NCT01799889|584738911|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
161915341|NCT01799889|584738912|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
161915342|NCT01799889|584738913|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
161811357|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
161811358|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
161811359|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
161811360|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
161811361|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
161811362|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Death|0|||
161811363|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Death|1|||
161811364|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Death|0|||
161811365|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Death|0|||
161811366|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
161915343|NCT01799889|584738914|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
161915344|NCT01799889|584738915|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
161915345|NCT01799889|584738916|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
161915346|NCT01799889|584738917|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
161915347|NCT01799889|584738918|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
161915348|NCT01799889|584738919|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
161915349|NCT01799889|584738908|FG000|Overall Study|Study Terminated By Sponsor|1|||
161915350|NCT01799889|584738909|FG001|Overall Study|Study Terminated By Sponsor|0|||
161915351|NCT01799889|584738910|FG002|Overall Study|Study Terminated By Sponsor|0|||
161915352|NCT01799889|584738911|FG003|Overall Study|Study Terminated By Sponsor|0|||
161915353|NCT01799889|584738912|FG004|Overall Study|Study Terminated By Sponsor|2|||
161915354|NCT01799889|584738913|FG005|Overall Study|Study Terminated By Sponsor|1|||
161915355|NCT01799889|584738914|FG006|Overall Study|Study Terminated By Sponsor|0|||
161915356|NCT01799889|584738915|FG007|Overall Study|Study Terminated By Sponsor|2|||
161915357|NCT01799889|584738916|FG008|Overall Study|Study Terminated By Sponsor|1|||
161915358|NCT01799889|584738917|FG009|Overall Study|Study Terminated By Sponsor|1|||
161915359|NCT01799889|584738918|FG010|Overall Study|Study Terminated By Sponsor|0|||
161915360|NCT01799889|584738919|FG011|Overall Study|Study Terminated By Sponsor|0|||
161915361|NCT01799889|584738908|FG000|Overall Study|Withdrawal by Subject|1|||
161915362|NCT01799889|584738909|FG001|Overall Study|Withdrawal by Subject|6|||
161915363|NCT01799889|584738910|FG002|Overall Study|Withdrawal by Subject|4|||
161915364|NCT01799889|584738911|FG003|Overall Study|Withdrawal by Subject|0|||
161915365|NCT01799889|584738912|FG004|Overall Study|Withdrawal by Subject|5|||
161915366|NCT01799889|584738913|FG005|Overall Study|Withdrawal by Subject|1|||
162013545|NCT00790842|585103934|FG004|Expansion Cohort|Withdrawal by Subject|0|||
162013546|NCT00790842|585103935|FG005|Expansion Cohort|Withdrawal by Subject|0|||
162013547|NCT00790842|585103936|FG006|Expansion Cohort|Withdrawal by Subject|0|||
162013548|NCT00790842|585103937|FG007|Expansion Cohort|Withdrawal by Subject|0|||
162013549|NCT00790842|585103938|FG008|Expansion Cohort|Withdrawal by Subject|0|||
161811367|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
161811368|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
161811369|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
161811370|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
161811371|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
161811372|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
161811373|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
161811374|NCT01940341|584351448|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161811375|NCT01940341|584351449|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
161811376|NCT01940341|584351450|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161811377|NCT01940341|584351451|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161811378|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
161811379|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
161811380|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
161811381|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
161811382|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
161811383|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
161811384|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
161811385|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
161811386|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161811387|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161811388|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
161811389|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161811390|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
161915367|NCT01799889|584738914|FG006|Overall Study|Withdrawal by Subject|3|||
161915368|NCT01799889|584738915|FG007|Overall Study|Withdrawal by Subject|1|||
161915369|NCT01799889|584738916|FG008|Overall Study|Withdrawal by Subject|2|||
161915370|NCT01799889|584738917|FG009|Overall Study|Withdrawal by Subject|1|||
161915371|NCT01799889|584738918|FG010|Overall Study|Withdrawal by Subject|1|||
162013550|NCT00790842|585103939|FG009|Expansion Cohort|Withdrawal by Subject|0|||
161915372|NCT01799889|584738919|FG011|Overall Study|Withdrawal by Subject|1|||
161915373|NCT01799889|584738908|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161915374|NCT01799889|584738909|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161915375|NCT01799889|584738910|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161915376|NCT01799889|584738911|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161915377|NCT01799889|584738912|FG004|Overall Study|Non-Compliance With Study Drug|0|||
161915378|NCT01799889|584738913|FG005|Overall Study|Non-Compliance With Study Drug|1|||
161915379|NCT01799889|584738914|FG006|Overall Study|Non-Compliance With Study Drug|0|||
161915380|NCT01799889|584738915|FG007|Overall Study|Non-Compliance With Study Drug|0|||
161915381|NCT01799889|584738916|FG008|Overall Study|Non-Compliance With Study Drug|0|||
161915382|NCT01799889|584738917|FG009|Overall Study|Non-Compliance With Study Drug|0|||
161915383|NCT01799889|584738918|FG010|Overall Study|Non-Compliance With Study Drug|0|||
161915384|NCT01799889|584738919|FG011|Overall Study|Non-Compliance With Study Drug|0|||
161915385|NCT06217380|584738920|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
161811391|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
161811392|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
161811393|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
161811394|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161811395|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161811396|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
161811397|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161811398|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
161811399|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
161811400|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
161811401|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
161811402|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161811403|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161811404|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
161811405|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161811406|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161811407|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161811408|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161811409|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
161811410|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161811411|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161811412|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161811413|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
161811414|NCT01940341|584351448|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
161811415|NCT01940341|584351449|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
161811416|NCT01940341|584351450|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
161811417|NCT01940341|584351451|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
161811418|NCT03792477|584351456|FG000|Overall Study|Adverse Event|0|||
161811419|NCT03792477|584351457|FG001|Overall Study|Adverse Event|0|||
161811420|NCT03792477|584351458|FG002|Overall Study|Adverse Event|0|||
161811421|NCT03792477|584351459|FG003|Overall Study|Adverse Event|1|||
161811422|NCT03792477|584351460|FG004|Overall Study|Adverse Event|0|||
161811423|NCT03792477|584351456|FG000|Overall Study|Lost to Follow-up|0|||
161811424|NCT03792477|584351457|FG001|Overall Study|Lost to Follow-up|0|||
161811425|NCT03792477|584351458|FG002|Overall Study|Lost to Follow-up|2|||
161811426|NCT03792477|584351459|FG003|Overall Study|Lost to Follow-up|0|||
161811427|NCT03792477|584351460|FG004|Overall Study|Lost to Follow-up|0|||
161811428|NCT03792477|584351456|FG000|Overall Study|Other|0|||
161811429|NCT03792477|584351457|FG001|Overall Study|Other|0|||
161811430|NCT03792477|584351458|FG002|Overall Study|Other|0|||
161811431|NCT03792477|584351459|FG003|Overall Study|Other|0|||
161811432|NCT03792477|584351460|FG004|Overall Study|Other|1|||
161811433|NCT03134222|584351465|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
161811434|NCT03134222|584351466|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
161811435|NCT03134222|584351467|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
161811436|NCT03134222|584351468|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
161811437|NCT03134222|584351469|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
161811438|NCT03134222|584351465|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
161811439|NCT03134222|584351466|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
161811440|NCT03134222|584351467|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
161811441|NCT03134222|584351468|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
161811442|NCT03134222|584351469|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
161811443|NCT03134222|584351465|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
161811444|NCT03134222|584351466|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
161811445|NCT03134222|584351467|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
161811446|NCT03134222|584351468|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
161811447|NCT03134222|584351469|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
161811448|NCT03134222|584351465|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
161811449|NCT03134222|584351466|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
161811450|NCT03134222|584351467|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
161811451|NCT03134222|584351468|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
161811452|NCT03134222|584351469|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
161811453|NCT03134222|584351465|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
161811454|NCT03134222|584351466|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
161811455|NCT03134222|584351467|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
161811456|NCT03134222|584351468|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
161811457|NCT03134222|584351469|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
161811458|NCT03134222|584351465|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
161811459|NCT03134222|584351466|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
161811460|NCT03134222|584351467|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
161811461|NCT03134222|584351468|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
161811462|NCT03134222|584351469|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
161811463|NCT03134222|584351465|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
161811464|NCT03134222|584351466|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
161811465|NCT03134222|584351467|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
161811466|NCT03134222|584351468|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
161811467|NCT03134222|584351469|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
161811468|NCT03134222|584351465|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
161811469|NCT03134222|584351466|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
161811470|NCT03134222|584351467|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
161811471|NCT03134222|584351468|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
161811472|NCT03134222|584351469|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
161811473|NCT02605928|584351470|FG000|Overall Study|Model tuning phase|28|||
161811474|NCT02605928|584351470|FG000|Overall Study|Lack of Efficacy|5|||
161811475|NCT03482882|584351473|FG000|Overall Study|Adverse Event|3|||
161811476|NCT03482882|584351473|FG000|Overall Study|Lost to Follow-up|1|||
161811477|NCT03482882|584351473|FG000|Overall Study|Protocol Violation|2|||
161811478|NCT03482882|584351473|FG000|Overall Study|Not further specified|1|||
161811479|NCT05341622|584351480|FG000|Overall Study|Death|0|||
161811480|NCT05341622|584351481|FG001|Overall Study|Death|0|||
161811481|NCT05341622|584351482|FG002|Overall Study|Death|0|||
161811482|NCT05341622|584351483|FG003|Overall Study|Death|0|||
161811483|NCT05341622|584351484|FG004|Overall Study|Death|1|||
161811484|NCT05341622|584351485|FG005|Overall Study|Death|0|||
161811485|NCT05341622|584351486|FG006|Overall Study|Death|0|||
161811486|NCT05341622|584351487|FG007|Overall Study|Death|1|||
161811487|NCT05341622|584351480|FG000|Overall Study|Invalid Address|0|||
161811488|NCT05341622|584351481|FG001|Overall Study|Invalid Address|1|||
161811489|NCT05341622|584351482|FG002|Overall Study|Invalid Address|0|||
161811490|NCT05341622|584351483|FG003|Overall Study|Invalid Address|0|||
161811491|NCT05341622|584351484|FG004|Overall Study|Invalid Address|0|||
161811492|NCT05341622|584351485|FG005|Overall Study|Invalid Address|0|||
161811493|NCT05341622|584351486|FG006|Overall Study|Invalid Address|0|||
161811494|NCT05341622|584351487|FG007|Overall Study|Invalid Address|0|||
161811495|NCT05341622|584351480|FG000|Overall Study|Ineligible|26|||
161811496|NCT05341622|584351481|FG001|Overall Study|Ineligible|21|||
161811497|NCT05341622|584351482|FG002|Overall Study|Ineligible|28|||
161811498|NCT05341622|584351483|FG003|Overall Study|Ineligible|24|||
161811499|NCT05341622|584351484|FG004|Overall Study|Ineligible|29|||
161811500|NCT05341622|584351485|FG005|Overall Study|Ineligible|31|||
161811501|NCT05341622|584351486|FG006|Overall Study|Ineligible|28|||
161811502|NCT05341622|584351487|FG007|Overall Study|Ineligible|26|||
161811503|NCT02658084|584351488|FG000|Overall Study|Withdrawal by Subject|1|||
161811504|NCT02658084|584351489|FG001|Overall Study|Withdrawal by Subject|0|||
161811505|NCT02658084|584351488|FG000|Overall Study|Study Termination|1|||
161915386|NCT06217380|584738920|FG000|Overall Study|Physician Decision|1|||
161915387|NCT06217380|584738920|FG000|Overall Study|Withdrawal by Subject|2|||
161915388|NCT06633965|584738921|FG000|Overall Study|Withdrawal by Subject|0|||
161915389|NCT06633965|584738922|FG001|Overall Study|Withdrawal by Subject|1|||
161811506|NCT02658084|584351489|FG001|Overall Study|Study Termination|0|||
161811507|NCT03290781|584351490|FG000|Overall Study|Adverse Event|5|||
161811508|NCT03290781|584351491|FG001|Overall Study|Adverse Event|7|||
161811509|NCT03290781|584351492|FG002|Overall Study|Adverse Event|4|||
161811510|NCT03290781|584351493|FG003|Overall Study|Adverse Event|1|||
161811511|NCT03290781|584351494|FG004|Overall Study|Adverse Event|0|||
161811512|NCT03290781|584351495|FG005|Overall Study|Adverse Event|0|||
161811513|NCT03290781|584351496|FG006|Overall Study|Adverse Event|0|||
161811514|NCT03290781|584351490|FG000|Overall Study|Death|0|||
161811515|NCT03290781|584351491|FG001|Overall Study|Death|0|||
162013551|NCT00790842|585103940|FG010|Expansion Cohort|Withdrawal by Subject|0|||
162155153|NCT02723955|585619277|FG000|Escalation Phase|Physician Decision|0|||
162155154|NCT02723955|585619278|FG001|Escalation Phase|Physician Decision|0|||
162155155|NCT02723955|585619279|FG002|Escalation Phase|Physician Decision|0|||
161811516|NCT03290781|584351492|FG002|Overall Study|Death|1|||
161811517|NCT03290781|584351493|FG003|Overall Study|Death|0|||
161811518|NCT03290781|584351494|FG004|Overall Study|Death|1|||
161811519|NCT03290781|584351495|FG005|Overall Study|Death|0|||
161811520|NCT03290781|584351496|FG006|Overall Study|Death|0|||
161811521|NCT03290781|584351490|FG000|Overall Study|Withdrawal by Subject|6|||
161811522|NCT03290781|584351491|FG001|Overall Study|Withdrawal by Subject|5|||
161811523|NCT03290781|584351492|FG002|Overall Study|Withdrawal by Subject|9|||
161811524|NCT03290781|584351493|FG003|Overall Study|Withdrawal by Subject|10|||
161811525|NCT03290781|584351494|FG004|Overall Study|Withdrawal by Subject|1|||
161811526|NCT03290781|584351495|FG005|Overall Study|Withdrawal by Subject|2|||
161811527|NCT03290781|584351496|FG006|Overall Study|Withdrawal by Subject|0|||
161811528|NCT03290781|584351490|FG000|Overall Study|Physician Decision|0|||
161811529|NCT03290781|584351491|FG001|Overall Study|Physician Decision|1|||
161811530|NCT03290781|584351492|FG002|Overall Study|Physician Decision|0|||
161811531|NCT03290781|584351493|FG003|Overall Study|Physician Decision|0|||
161811532|NCT03290781|584351494|FG004|Overall Study|Physician Decision|0|||
161811533|NCT03290781|584351495|FG005|Overall Study|Physician Decision|0|||
161811534|NCT03290781|584351496|FG006|Overall Study|Physician Decision|0|||
161811535|NCT03290781|584351490|FG000|Overall Study|Site Terminated by Sponsor|1|||
161811536|NCT03290781|584351491|FG001|Overall Study|Site Terminated by Sponsor|0|||
161811537|NCT03290781|584351492|FG002|Overall Study|Site Terminated by Sponsor|2|||
161811538|NCT03290781|584351493|FG003|Overall Study|Site Terminated by Sponsor|1|||
161811539|NCT03290781|584351494|FG004|Overall Study|Site Terminated by Sponsor|0|||
161811540|NCT03290781|584351495|FG005|Overall Study|Site Terminated by Sponsor|0|||
161811541|NCT03290781|584351496|FG006|Overall Study|Site Terminated by Sponsor|0|||
161811542|NCT03290781|584351490|FG000|Overall Study|Lost to Follow-up|0|||
161811543|NCT03290781|584351491|FG001|Overall Study|Lost to Follow-up|0|||
161811544|NCT03290781|584351492|FG002|Overall Study|Lost to Follow-up|0|||
161811545|NCT03290781|584351493|FG003|Overall Study|Lost to Follow-up|1|||
161811546|NCT03290781|584351494|FG004|Overall Study|Lost to Follow-up|0|||
161811547|NCT03290781|584351495|FG005|Overall Study|Lost to Follow-up|0|||
161811548|NCT03290781|584351496|FG006|Overall Study|Lost to Follow-up|0|||
161811549|NCT03290781|584351490|FG000|Overall Study|Protocol Deviation|2|||
161811550|NCT03290781|584351491|FG001|Overall Study|Protocol Deviation|0|||
161811551|NCT03290781|584351492|FG002|Overall Study|Protocol Deviation|0|||
161811552|NCT03290781|584351493|FG003|Overall Study|Protocol Deviation|1|||
161811553|NCT03290781|584351494|FG004|Overall Study|Protocol Deviation|0|||
161811554|NCT03290781|584351495|FG005|Overall Study|Protocol Deviation|0|||
161811555|NCT03290781|584351496|FG006|Overall Study|Protocol Deviation|0|||
161811556|NCT03290781|584351490|FG000|Overall Study|Disease Relapse|32|||
161811557|NCT03290781|584351491|FG001|Overall Study|Disease Relapse|5|||
161811558|NCT03290781|584351492|FG002|Overall Study|Disease Relapse|38|||
161811559|NCT03290781|584351493|FG003|Overall Study|Disease Relapse|7|||
161811560|NCT03290781|584351494|FG004|Overall Study|Disease Relapse|3|||
161811561|NCT03290781|584351495|FG005|Overall Study|Disease Relapse|1|||
161811562|NCT03290781|584351496|FG006|Overall Study|Disease Relapse|4|||
161811563|NCT03290781|584351490|FG000|Overall Study|Other|3|||
161811564|NCT03290781|584351491|FG001|Overall Study|Other|0|||
161811565|NCT03290781|584351492|FG002|Overall Study|Other|2|||
161811566|NCT03290781|584351493|FG003|Overall Study|Other|2|||
161811567|NCT03290781|584351494|FG004|Overall Study|Other|0|||
161811568|NCT03290781|584351495|FG005|Overall Study|Other|0|||
161811569|NCT03290781|584351496|FG006|Overall Study|Other|0|||
161811570|NCT04611789|584351497|FG000|Overall Study|Lost to Follow-up|1|||
161811571|NCT04611789|584351498|FG001|Overall Study|Lost to Follow-up|0|||
161811572|NCT04611789|584351499|FG002|Overall Study|Lost to Follow-up|0|||
161811573|NCT05152576|584351501|FG000|Overall Study|Lost to Follow-up|3|||
161811574|NCT05152576|584351502|FG001|Overall Study|Lost to Follow-up|0|||
161811575|NCT05152576|584351503|FG002|Overall Study|Lost to Follow-up|0|||
161811576|NCT05152576|584351504|FG003|Overall Study|Lost to Follow-up|1|||
161811577|NCT05152576|584351501|FG000|Overall Study|Withdrawal by Subject|0|||
161811578|NCT05152576|584351502|FG001|Overall Study|Withdrawal by Subject|1|||
161811579|NCT05152576|584351503|FG002|Overall Study|Withdrawal by Subject|0|||
161811580|NCT05152576|584351504|FG003|Overall Study|Withdrawal by Subject|1|||
161811581|NCT05152576|584351501|FG000|Overall Study|Other|2|||
161811582|NCT05152576|584351502|FG001|Overall Study|Other|0|||
161811583|NCT05152576|584351503|FG002|Overall Study|Other|0|||
161811584|NCT05152576|584351504|FG003|Overall Study|Other|0|||
161811585|NCT00859430|584351505|FG000|First Intervention|Withdrawal by Subject|0|||
161811586|NCT00859430|584351506|FG001|First Intervention|Withdrawal by Subject|1|||
161811587|NCT02286739|584353029|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
161811588|NCT02286739|584353030|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
161811589|NCT02286739|584353029|FG000|Overall Study|No Verasense type documented|0|||
161811590|NCT02286739|584353030|FG001|Overall Study|No Verasense type documented|23|||
161811591|NCT02286739|584353029|FG000|Overall Study|Adverse Event|1|||
162013552|NCT00790842|585103930|FG000|Expansion Cohort|Study Closure|0|||
161915390|NCT00300053|584738925|FG000|Overall Study|Patient/Caregiver Preference|2|||
161915391|NCT00300053|584738926|FG001|Overall Study|Patient/Caregiver Preference|2|||
161915392|NCT00300053|584738927|FG002|Overall Study|Patient/Caregiver Preference|3|||
161915393|NCT00300053|584738925|FG000|Overall Study|Death|0|||
161915394|NCT00300053|584738926|FG001|Overall Study|Death|0|||
161915395|NCT00300053|584738927|FG002|Overall Study|Death|3|||
161915396|NCT00300053|584738925|FG000|Overall Study|Lost to Follow-up|0|||
161915397|NCT00300053|584738926|FG001|Overall Study|Lost to Follow-up|1|||
161915398|NCT00300053|584738927|FG002|Overall Study|Lost to Follow-up|0|||
161915399|NCT01963611|584738931|FG000|Overall Study|Adverse Event|1|||
162013553|NCT00790842|585103931|FG001|Expansion Cohort|Study Closure|0|||
162013554|NCT00790842|585103932|FG002|Expansion Cohort|Study Closure|1|||
162155156|NCT02723955|585619280|FG003|Escalation Phase|Physician Decision|0|||
162155157|NCT02723955|585619281|FG004|Escalation Phase|Physician Decision|0|||
162013555|NCT00790842|585103933|FG003|Expansion Cohort|Study Closure|0|||
162013556|NCT00790842|585103934|FG004|Expansion Cohort|Study Closure|0|||
162013557|NCT00790842|585103935|FG005|Expansion Cohort|Study Closure|0|||
162013558|NCT00790842|585103936|FG006|Expansion Cohort|Study Closure|0|||
162013559|NCT00790842|585103937|FG007|Expansion Cohort|Study Closure|0|||
162013560|NCT00790842|585103938|FG008|Expansion Cohort|Study Closure|0|||
162013561|NCT00790842|585103939|FG009|Expansion Cohort|Study Closure|0|||
162013562|NCT00790842|585103940|FG010|Expansion Cohort|Study Closure|0|||
162013563|NCT03809104|585103941|FG000|Overall Study|Withdrawal by Subject|3|||
162013564|NCT05029362|585103942|FG000|Overall Study|Lost to Follow-up|9|||
162013565|NCT00419952|585103946|FG000|Overall Study|Adverse Event|8|||
162013566|NCT00419952|585103947|FG001|Overall Study|Adverse Event|10|||
162013567|NCT00419952|585103946|FG000|Overall Study|Withdrawal by Subject|44|||
162013568|NCT00419952|585103947|FG001|Overall Study|Withdrawal by Subject|43|||
162013569|NCT00419952|585103946|FG000|Overall Study|Lost to Follow-up|43|||
162013570|NCT00419952|585103947|FG001|Overall Study|Lost to Follow-up|34|||
162013571|NCT00419952|585103946|FG000|Overall Study|Protocol Violation|32|||
162013572|NCT00419952|585103947|FG001|Overall Study|Protocol Violation|24|||
162013573|NCT00419952|585103946|FG000|Overall Study|Pregnancy|4|||
162013574|NCT00419952|585103947|FG001|Overall Study|Pregnancy|2|||
162013575|NCT00419952|585103946|FG000|Overall Study|Physician Decision|1|||
162013576|NCT00419952|585103947|FG001|Overall Study|Physician Decision|3|||
162013577|NCT00419952|585103946|FG000|Overall Study|Incorrectly enrolled|10|||
162013578|NCT00419952|585103947|FG001|Overall Study|Incorrectly enrolled|3|||
162013579|NCT00419952|585103946|FG000|Overall Study|Intake of prohibited medication|2|||
162013580|NCT00419952|585103947|FG001|Overall Study|Intake of prohibited medication|2|||
162013581|NCT00419952|585103946|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
162013582|NCT00419952|585103947|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
162013583|NCT00419952|585103946|FG000|Overall Study|Diary or medication non-compliance|2|||
162013584|NCT00419952|585103947|FG001|Overall Study|Diary or medication non-compliance|4|||
162013585|NCT00419952|585103946|FG000|Overall Study|Abnormal ECG|1|||
162013586|NCT00419952|585103947|FG001|Overall Study|Abnormal ECG|0|||
162013587|NCT03126591|585103952|FG000|Overall Study|Death|6|||
162013588|NCT03126591|585103953|FG001|Overall Study|Death|3|||
162013589|NCT03126591|585103954|FG002|Overall Study|Death|17|||
162013590|NCT03126591|585103952|FG000|Overall Study|Progressive Disease|0|||
162013591|NCT03126591|585103953|FG001|Overall Study|Progressive Disease|1|||
162013592|NCT03126591|585103954|FG002|Overall Study|Progressive Disease|2|||
162013593|NCT03126591|585103952|FG000|Overall Study|Terminated by Sponsor|0|||
162013594|NCT03126591|585103953|FG001|Overall Study|Terminated by Sponsor|1|||
162013595|NCT03126591|585103954|FG002|Overall Study|Terminated by Sponsor|4|||
162013596|NCT03126591|585103952|FG000|Overall Study|Withdrawal by Subject|1|||
162013597|NCT03126591|585103953|FG001|Overall Study|Withdrawal by Subject|1|||
162013598|NCT03126591|585103954|FG002|Overall Study|Withdrawal by Subject|4|||
162013599|NCT03722238|585103957|FG000|Overall Study|Protocol Violation|1|||
162013600|NCT03722238|585103958|FG001|Overall Study|Protocol Violation|0|||
162013601|NCT03722238|585103957|FG000|Overall Study|Physician Decision|1|||
162013602|NCT03722238|585103958|FG001|Overall Study|Physician Decision|0|||
162013603|NCT03722238|585103957|FG000|Overall Study|Death|1|||
162013604|NCT03722238|585103958|FG001|Overall Study|Death|0|||
162013605|NCT03722238|585103957|FG000|Overall Study|Lost to Follow-up|6|||
162013606|NCT03722238|585103958|FG001|Overall Study|Lost to Follow-up|0|||
162013607|NCT03722238|585103957|FG000|Overall Study|Partial missing data|44|||
162013608|NCT03722238|585103958|FG001|Overall Study|Partial missing data|1|||
162013609|NCT03722238|585103957|FG000|Overall Study|Withdrawal by Subject|2|||
162013610|NCT03722238|585103958|FG001|Overall Study|Withdrawal by Subject|0|||
162013611|NCT03722238|585103957|FG000|Overall Study|Other|4|||
162155158|NCT02723955|585619282|FG005|Escalation Phase|Physician Decision|2|||
161915400|NCT01963611|584738932|FG001|Overall Study|Adverse Event|1|||
162155159|NCT02723955|585619283|FG006|Escalation Phase|Physician Decision|0|||
162155160|NCT02723955|585619284|FG007|Escalation Phase|Physician Decision|0|||
162013612|NCT03722238|585103958|FG001|Overall Study|Other|0|||
162013613|NCT03722238|585103957|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
161915401|NCT01963611|584738933|FG002|Overall Study|Adverse Event|3|||
161915402|NCT01963611|584738934|FG003|Overall Study|Adverse Event|4|||
161915403|NCT01963611|584738935|FG004|Overall Study|Adverse Event|3|||
161915404|NCT01963611|584738931|FG000|Overall Study|Protocol Violation|0|||
161915405|NCT01963611|584738932|FG001|Overall Study|Protocol Violation|0|||
161915406|NCT01963611|584738933|FG002|Overall Study|Protocol Violation|0|||
161915407|NCT01963611|584738934|FG003|Overall Study|Protocol Violation|1|||
161915408|NCT01963611|584738935|FG004|Overall Study|Protocol Violation|0|||
161915409|NCT01963611|584738931|FG000|Overall Study|Lack of Efficacy|0|||
161915410|NCT01963611|584738932|FG001|Overall Study|Lack of Efficacy|0|||
161915411|NCT01963611|584738933|FG002|Overall Study|Lack of Efficacy|0|||
161915412|NCT01963611|584738934|FG003|Overall Study|Lack of Efficacy|1|||
161915413|NCT01963611|584738935|FG004|Overall Study|Lack of Efficacy|0|||
161915414|NCT01963611|584738931|FG000|Overall Study|Withdrawal by Subject|3|||
161915415|NCT01963611|584738932|FG001|Overall Study|Withdrawal by Subject|2|||
161915416|NCT01963611|584738933|FG002|Overall Study|Withdrawal by Subject|1|||
161915417|NCT01963611|584738934|FG003|Overall Study|Withdrawal by Subject|1|||
161915418|NCT01963611|584738935|FG004|Overall Study|Withdrawal by Subject|3|||
161915419|NCT01963611|584738931|FG000|Overall Study|Other|47|||
161915420|NCT01963611|584738932|FG001|Overall Study|Other|46|||
161915421|NCT01963611|584738933|FG002|Overall Study|Other|48|||
161915422|NCT01963611|584738934|FG003|Overall Study|Other|45|||
161915423|NCT01963611|584738935|FG004|Overall Study|Other|45|||
161915424|NCT01126424|584738937|FG000|Overall Study|Adverse Event|0|||
161915425|NCT01126424|584738938|FG001|Overall Study|Adverse Event|0|||
161915426|NCT01126424|584738939|FG002|Overall Study|Adverse Event|0|||
161915427|NCT01126424|584738940|FG003|Overall Study|Adverse Event|0|||
161915428|NCT01126424|584738941|FG004|Overall Study|Adverse Event|1|||
161915429|NCT01126424|584738942|FG005|Overall Study|Adverse Event|0|||
161915430|NCT01126424|584738937|FG000|Overall Study|Withdrawal by Subject|0|||
161915431|NCT01126424|584738938|FG001|Overall Study|Withdrawal by Subject|0|||
161915432|NCT01126424|584738939|FG002|Overall Study|Withdrawal by Subject|1|||
161915433|NCT01126424|584738940|FG003|Overall Study|Withdrawal by Subject|3|||
161915434|NCT01126424|584738941|FG004|Overall Study|Withdrawal by Subject|1|||
161915435|NCT01126424|584738942|FG005|Overall Study|Withdrawal by Subject|0|||
161915436|NCT02127671|584738943|FG000|Overall Study|Death|2|||
161915437|NCT02127671|584738944|FG001|Overall Study|Death|2|||
161915438|NCT02127671|584738943|FG000|Overall Study|Lost to Follow-up|4|||
161915439|NCT02127671|584738944|FG001|Overall Study|Lost to Follow-up|2|||
161915440|NCT02127671|584738943|FG000|Overall Study|Physician Decision|1|||
161915441|NCT02127671|584738944|FG001|Overall Study|Physician Decision|0|||
161915442|NCT02127671|584738943|FG000|Overall Study|incarceration|0|||
161915443|NCT02127671|584738944|FG001|Overall Study|incarceration|1|||
161915444|NCT02127671|584738943|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
161915445|NCT02127671|584738944|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
161915446|NCT02394275|584738945|FG000|Overall Study|Adverse Event|22|||
162013614|NCT03722238|585103958|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
161915447|NCT02394275|584738945|FG000|Overall Study|Lost to Follow-up|7|||
161915448|NCT00782067|584738947|FG000|Overall Study|Adverse Event|35|||
161915449|NCT00782067|584738947|FG000|Overall Study|Subject withdrew consent|11|||
161915450|NCT00782067|584738947|FG000|Overall Study|Lost to Follow-up|2|||
161915451|NCT00782067|584738947|FG000|Overall Study|Administrative problems|14|||
161915452|NCT00782067|584738947|FG000|Overall Study|Death|9|||
161915453|NCT00782067|584738947|FG000|Overall Study|Disease progression|43|||
161915454|NCT00782067|584738947|FG000|Overall Study|Protocol deviation|2|||
161915455|NCT02471183|584738948|FG000|Main Treatment Period|Adverse Event|1|||
161915456|NCT02471183|584738948|FG000|Main Treatment Period|Withdrawal by Subject|1|||
161915457|NCT02471183|584738948|FG000|Extended Treatment Period|Lack of Efficacy|1|||
161915458|NCT00614393|584738950|FG000|Overall Study|Adverse Event|20|||
161915459|NCT00614393|584738951|FG001|Overall Study|Adverse Event|2|||
161915460|NCT00614393|584738952|FG002|Overall Study|Adverse Event|3|||
161915461|NCT00614393|584738953|FG003|Overall Study|Adverse Event|13|||
161915462|NCT00614393|584738954|FG004|Overall Study|Adverse Event|21|||
161915463|NCT00614393|584738950|FG000|Overall Study|Lost to Follow-up|0|||
161915464|NCT00614393|584738951|FG001|Overall Study|Lost to Follow-up|0|||
161915465|NCT00614393|584738952|FG002|Overall Study|Lost to Follow-up|0|||
161915466|NCT00614393|584738953|FG003|Overall Study|Lost to Follow-up|1|||
161811592|NCT02286739|584353030|FG001|Overall Study|Adverse Event|2|||
161811593|NCT02286739|584353029|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
161811594|NCT02286739|584353030|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
161811595|NCT00834795|584353031|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
161811596|NCT00834795|584353032|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
161811597|NCT00834795|584353031|FG000|Second Intervention|Adverse Event|1|||
161811598|NCT00834795|584353032|FG001|Second Intervention|Adverse Event|0|||
161811599|NCT03697109|584353040|FG000|Open-label (OL) Phase|Adverse Event|24|||
161811600|NCT03697109|584353041|FG001|Open-label (OL) Phase|Adverse Event|0|||
161811601|NCT03697109|584353042|FG002|Open-label (OL) Phase|Adverse Event|0|||
161811602|NCT03697109|584353040|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
161811603|NCT03697109|584353041|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
161811604|NCT03697109|584353042|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
161811605|NCT03697109|584353040|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
161811606|NCT03697109|584353041|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
161811607|NCT03697109|584353042|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
161811608|NCT03697109|584353040|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
161811609|NCT03697109|584353041|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
161811610|NCT03697109|584353042|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
161811611|NCT03697109|584353040|FG000|Open-label (OL) Phase|Physician Decision|2|||
161811612|NCT03697109|584353041|FG001|Open-label (OL) Phase|Physician Decision|0|||
161811613|NCT03697109|584353042|FG002|Open-label (OL) Phase|Physician Decision|0|||
161811614|NCT03697109|584353040|FG000|Open-label (OL) Phase|Death|2|||
161811615|NCT03697109|584353041|FG001|Open-label (OL) Phase|Death|0|||
161811616|NCT03697109|584353042|FG002|Open-label (OL) Phase|Death|0|||
161811617|NCT03697109|584353040|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
161811618|NCT03697109|584353041|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
161811619|NCT03697109|584353042|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
161811620|NCT03697109|584353040|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
161811621|NCT03697109|584353041|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
161811622|NCT03697109|584353042|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
161811623|NCT03697109|584353040|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
161811624|NCT03697109|584353041|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
161811625|NCT03697109|584353042|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
161811626|NCT02301975|584353046|FG000|Overall Study|Adverse Event|8|||
161811627|NCT02301975|584353047|FG001|Overall Study|Adverse Event|3|||
161811628|NCT02301975|584353048|FG002|Overall Study|Adverse Event|2|||
161811629|NCT02301975|584353046|FG000|Overall Study|Lack of Efficacy|1|||
161811630|NCT02301975|584353047|FG001|Overall Study|Lack of Efficacy|1|||
161811631|NCT02301975|584353048|FG002|Overall Study|Lack of Efficacy|1|||
161811632|NCT02301975|584353046|FG000|Overall Study|Protocol Violation|3|||
161811633|NCT02301975|584353047|FG001|Overall Study|Protocol Violation|5|||
161811634|NCT02301975|584353048|FG002|Overall Study|Protocol Violation|3|||
161811635|NCT02301975|584353046|FG000|Overall Study|Lost to Follow-up|0|||
161811636|NCT02301975|584353047|FG001|Overall Study|Lost to Follow-up|2|||
161811637|NCT02301975|584353048|FG002|Overall Study|Lost to Follow-up|2|||
161811638|NCT02301975|584353046|FG000|Overall Study|Physician Decision|4|||
161811639|NCT02301975|584353047|FG001|Overall Study|Physician Decision|2|||
161811640|NCT02301975|584353048|FG002|Overall Study|Physician Decision|3|||
161811641|NCT02301975|584353046|FG000|Overall Study|Withdrawal by Subject|15|||
161811642|NCT02301975|584353047|FG001|Overall Study|Withdrawal by Subject|12|||
161811643|NCT02301975|584353048|FG002|Overall Study|Withdrawal by Subject|11|||
161811644|NCT00835991|584353049|FG000|First Intervention|Adverse Event|0|||
161811645|NCT00835991|584353050|FG001|First Intervention|Adverse Event|1|||
161811646|NCT00835991|584353049|FG000|Washout|Protocol Violation|0|||
161811647|NCT00835991|584353050|FG001|Washout|Protocol Violation|2|||
161811648|NCT00835991|584353049|FG000|Washout|Withdrawal by Subject|3|||
161811649|NCT00835991|584353050|FG001|Washout|Withdrawal by Subject|1|||
161811650|NCT04278560|584353051|FG000|Overall Study|Adverse Event|1|||
161811651|NCT04278560|584353052|FG001|Overall Study|Adverse Event|2|||
161811652|NCT04278560|584353051|FG000|Overall Study|Withdrawal by Subject|0|||
161811653|NCT04278560|584353052|FG001|Overall Study|Withdrawal by Subject|1|||
161811654|NCT00163657|584353053|FG000|Overall Study|Death|12|||
161811655|NCT00163657|584353054|FG001|Overall Study|Death|14|||
161811656|NCT00163657|584353055|FG002|Overall Study|Death|19|||
161811657|NCT00163657|584353053|FG000|Overall Study|graft loss|4|||
161811658|NCT00163657|584353054|FG001|Overall Study|graft loss|1|||
161811659|NCT00163657|584353055|FG002|Overall Study|graft loss|2|||
161811660|NCT00163657|584353053|FG000|Overall Study|Withdrawal by Subject|2|||
161811661|NCT00163657|584353054|FG001|Overall Study|Withdrawal by Subject|3|||
161811662|NCT00163657|584353055|FG002|Overall Study|Withdrawal by Subject|2|||
161811663|NCT00163657|584353053|FG000|Overall Study|Physician Decision|0|||
161811664|NCT00163657|584353054|FG001|Overall Study|Physician Decision|1|||
161915467|NCT00614393|584738954|FG004|Overall Study|Lost to Follow-up|2|||
161811665|NCT00163657|584353055|FG002|Overall Study|Physician Decision|1|||
161811666|NCT00163657|584353053|FG000|Overall Study|Non Compliance|1|||
161915468|NCT00614393|584738950|FG000|Overall Study|Physician Decision|17|||
161915469|NCT00614393|584738951|FG001|Overall Study|Physician Decision|0|||
161915470|NCT00614393|584738952|FG002|Overall Study|Physician Decision|1|||
161915471|NCT00614393|584738953|FG003|Overall Study|Physician Decision|8|||
161915472|NCT00614393|584738954|FG004|Overall Study|Physician Decision|9|||
161915473|NCT00614393|584738950|FG000|Overall Study|Progressive Disease|118|||
161915474|NCT00614393|584738951|FG001|Overall Study|Progressive Disease|5|||
161915475|NCT00614393|584738952|FG002|Overall Study|Progressive Disease|5|||
161915476|NCT00614393|584738953|FG003|Overall Study|Progressive Disease|138|||
161915477|NCT00614393|584738954|FG004|Overall Study|Progressive Disease|130|||
161915478|NCT00614393|584738950|FG000|Overall Study|Protocol Violation|1|||
161915479|NCT00614393|584738951|FG001|Overall Study|Protocol Violation|0|||
161915480|NCT00614393|584738952|FG002|Overall Study|Protocol Violation|0|||
161915481|NCT00614393|584738953|FG003|Overall Study|Protocol Violation|0|||
161915482|NCT00614393|584738954|FG004|Overall Study|Protocol Violation|0|||
161915483|NCT00614393|584738950|FG000|Overall Study|Terminated by Sponsor|0|||
161915484|NCT00614393|584738951|FG001|Overall Study|Terminated by Sponsor|0|||
161915485|NCT00614393|584738952|FG002|Overall Study|Terminated by Sponsor|0|||
161915486|NCT00614393|584738953|FG003|Overall Study|Terminated by Sponsor|0|||
161915487|NCT00614393|584738954|FG004|Overall Study|Terminated by Sponsor|1|||
161915488|NCT00614393|584738950|FG000|Overall Study|Withdrawal by Subject|20|||
161915489|NCT00614393|584738951|FG001|Overall Study|Withdrawal by Subject|1|||
161915490|NCT00614393|584738952|FG002|Overall Study|Withdrawal by Subject|1|||
161915491|NCT00614393|584738953|FG003|Overall Study|Withdrawal by Subject|16|||
161915492|NCT00614393|584738954|FG004|Overall Study|Withdrawal by Subject|13|||
161915493|NCT00614393|584738950|FG000|Overall Study|Other|4|||
161915494|NCT00614393|584738951|FG001|Overall Study|Other|0|||
161915495|NCT00614393|584738952|FG002|Overall Study|Other|0|||
161915496|NCT00614393|584738953|FG003|Overall Study|Other|4|||
161915497|NCT00614393|584738954|FG004|Overall Study|Other|2|||
161915498|NCT00614393|584738950|FG000|Overall Study|Not Treated|0|||
161915499|NCT00614393|584738951|FG001|Overall Study|Not Treated|0|||
161915500|NCT00614393|584738952|FG002|Overall Study|Not Treated|0|||
161915501|NCT00614393|584738953|FG003|Overall Study|Not Treated|0|||
161915502|NCT00614393|584738954|FG004|Overall Study|Not Treated|2|||
161915503|NCT02328105|584738955|FG000|Overall Study|Death|6|||
161915504|NCT02328105|584738955|FG000|Overall Study|Withdrawal by Subject|1|||
161915505|NCT02328105|584738955|FG000|Overall Study|Still On Study in Follow-Up|4|||
161915506|NCT03286504|584738962|FG000|Overall Study|Lost to Follow-up|19|||
161915507|NCT03286504|584738963|FG001|Overall Study|Lost to Follow-up|16|||
161915508|NCT00141921|584738966|FG000|Overall Study|Remain on Study|28|||
161915509|NCT00141921|584738966|FG000|Overall Study|Withdrawal by Subject|42|||
161915510|NCT00141921|584738966|FG000|Overall Study|Lost to Follow-up|19|||
161915511|NCT00141921|584738966|FG000|Overall Study|Noncompliance|17|||
161915512|NCT00141921|584738966|FG000|Overall Study|Disease Progression|7|||
161915513|NCT00141921|584738966|FG000|Overall Study|Protocol Deviation|7|||
161915514|NCT00141921|584738966|FG000|Overall Study|Adverse Event|5|||
161915515|NCT00141921|584738966|FG000|Overall Study|Administrative Decision|2|||
161915516|NCT00141921|584738966|FG000|Overall Study|Pregnancy|4|||
161915517|NCT00141921|584738966|FG000|Overall Study|Ineligibility Determined|2|||
161915518|NCT00141921|584738966|FG000|Overall Study|Other|8|||
161915519|NCT03320369|584738967|FG000|Overall Study|Adverse Event|1|||
161915520|NCT03320369|584738967|FG000|Overall Study|Withdrawal by Subject|2|||
161915521|NCT03813654|584738968|FG000|Overall Study|Protocol Violation|0|||
161915522|NCT03813654|584738969|FG001|Overall Study|Protocol Violation|1|||
161915523|NCT03813654|584738970|FG002|Overall Study|Protocol Violation|2|||
161915524|NCT03813654|584738968|FG000|Overall Study|Withdrawal by Subject|1|||
161915525|NCT03813654|584738969|FG001|Overall Study|Withdrawal by Subject|0|||
161915526|NCT03813654|584738970|FG002|Overall Study|Withdrawal by Subject|0|||
161915527|NCT02783690|584738993|FG000|Overall Study|Withdrawal by Subject|3|||
161915528|NCT02783690|584738994|FG001|Overall Study|Withdrawal by Subject|3|||
161915529|NCT04585893|584738995|FG000|Overall Study|Death|1|||
161915530|NCT04585893|584738996|FG001|Overall Study|Death|0|||
161915531|NCT06178991|584738999|FG000|Overall Study|Withdrawal by Subject|2|||
161915532|NCT06178991|584739000|FG001|Overall Study|Withdrawal by Subject|6|||
161915533|NCT06178991|584739001|FG002|Overall Study|Withdrawal by Subject|44|||
161915534|NCT06178991|584739002|FG003|Overall Study|Withdrawal by Subject|23|||
161915535|NCT06178991|584739003|FG004|Overall Study|Withdrawal by Subject|7|||
161915536|NCT06178991|584739004|FG005|Overall Study|Withdrawal by Subject|7|||
161915537|NCT06178991|584739005|FG006|Overall Study|Withdrawal by Subject|7|||
161915538|NCT06178991|584739006|FG007|Overall Study|Withdrawal by Subject|5|||
161915539|NCT06178991|584738999|FG000|Overall Study|Lost to Follow-up|2|||
161915540|NCT06178991|584739000|FG001|Overall Study|Lost to Follow-up|4|||
161915541|NCT06178991|584739001|FG002|Overall Study|Lost to Follow-up|133|||
161915542|NCT06178991|584739002|FG003|Overall Study|Lost to Follow-up|65|||
161915543|NCT06178991|584739003|FG004|Overall Study|Lost to Follow-up|68|||
161915544|NCT06178991|584739004|FG005|Overall Study|Lost to Follow-up|57|||
161915545|NCT06178991|584739005|FG006|Overall Study|Lost to Follow-up|25|||
161915546|NCT06178991|584739006|FG007|Overall Study|Lost to Follow-up|18|||
161915547|NCT06178991|584738999|FG000|Overall Study|Death|1|||
161915548|NCT06178991|584739000|FG001|Overall Study|Death|0|||
161915549|NCT06178991|584739001|FG002|Overall Study|Death|2|||
161915550|NCT06178991|584739002|FG003|Overall Study|Death|1|||
161915551|NCT06178991|584739003|FG004|Overall Study|Death|1|||
161915552|NCT06178991|584739004|FG005|Overall Study|Death|0|||
161915553|NCT06178991|584739005|FG006|Overall Study|Death|1|||
161915554|NCT06178991|584739006|FG007|Overall Study|Death|1|||
161915555|NCT06178991|584738999|FG000|Overall Study|Randomized but not Vaccinated|4|||
161915556|NCT06178991|584739000|FG001|Overall Study|Randomized but not Vaccinated|1|||
161915557|NCT06178991|584739001|FG002|Overall Study|Randomized but not Vaccinated|15|||
161915558|NCT06178991|584739002|FG003|Overall Study|Randomized but not Vaccinated|9|||
161915559|NCT06178991|584739003|FG004|Overall Study|Randomized but not Vaccinated|8|||
161915560|NCT06178991|584739004|FG005|Overall Study|Randomized but not Vaccinated|4|||
161915561|NCT06178991|584739005|FG006|Overall Study|Randomized but not Vaccinated|2|||
161915562|NCT06178991|584739006|FG007|Overall Study|Randomized but not Vaccinated|2|||
161915563|NCT06178991|584738999|FG000|Overall Study|Other: Unspecified|0|||
161915564|NCT06178991|584739000|FG001|Overall Study|Other: Unspecified|1|||
161915565|NCT06178991|584739001|FG002|Overall Study|Other: Unspecified|7|||
161915566|NCT06178991|584739002|FG003|Overall Study|Other: Unspecified|6|||
161915567|NCT06178991|584739003|FG004|Overall Study|Other: Unspecified|1|||
161915568|NCT06178991|584739004|FG005|Overall Study|Other: Unspecified|1|||
161915569|NCT06178991|584739005|FG006|Overall Study|Other: Unspecified|1|||
161915570|NCT06178991|584739006|FG007|Overall Study|Other: Unspecified|0|||
161915571|NCT06178991|584738999|FG000|Overall Study|Physician Decision|0|||
161915572|NCT06178991|584739000|FG001|Overall Study|Physician Decision|0|||
161915573|NCT06178991|584739001|FG002|Overall Study|Physician Decision|2|||
161915574|NCT06178991|584739002|FG003|Overall Study|Physician Decision|0|||
161915575|NCT06178991|584739003|FG004|Overall Study|Physician Decision|2|||
161915576|NCT06178991|584739004|FG005|Overall Study|Physician Decision|1|||
161915577|NCT06178991|584739005|FG006|Overall Study|Physician Decision|0|||
161915578|NCT06178991|584739006|FG007|Overall Study|Physician Decision|0|||
161915579|NCT06178991|584738999|FG000|Overall Study|Protocol Violation|0|||
161915580|NCT06178991|584739000|FG001|Overall Study|Protocol Violation|0|||
162013615|NCT03722238|585103957|FG000|Overall Study|Did not meet risk classification group criteria|90|||
162013616|NCT03722238|585103958|FG001|Overall Study|Did not meet risk classification group criteria|0|||
162013617|NCT03722238|585103957|FG000|Overall Study|Did not sign consent|17|||
161915581|NCT06178991|584739001|FG002|Overall Study|Protocol Violation|1|||
161915582|NCT06178991|584739002|FG003|Overall Study|Protocol Violation|0|||
161915583|NCT06178991|584739003|FG004|Overall Study|Protocol Violation|0|||
161915584|NCT06178991|584739004|FG005|Overall Study|Protocol Violation|0|||
161915585|NCT06178991|584739005|FG006|Overall Study|Protocol Violation|0|||
161915586|NCT06178991|584739006|FG007|Overall Study|Protocol Violation|0|||
161915587|NCT01366092|584739010|FG000|Overall Study|Progressive cGVHD|2|||
161915588|NCT01366092|584739010|FG000|Overall Study|Physician Decision|1|||
162013618|NCT03722238|585103958|FG001|Overall Study|Did not sign consent|0|||
161811667|NCT00163657|584353054|FG001|Overall Study|Non Compliance|0|||
161811668|NCT00163657|584353055|FG002|Overall Study|Non Compliance|0|||
161811669|NCT00163657|584353053|FG000|Overall Study|Lost to Follow-up|1|||
161811670|NCT00163657|584353054|FG001|Overall Study|Lost to Follow-up|3|||
161811671|NCT00163657|584353055|FG002|Overall Study|Lost to Follow-up|10|||
161811672|NCT00163657|584353053|FG000|Overall Study|Other reason|0|||
161811673|NCT00163657|584353054|FG001|Overall Study|Other reason|1|||
161811674|NCT00163657|584353055|FG002|Overall Study|Other reason|3|||
161811675|NCT01531894|584353056|FG000|Overall Study|Physician Decision|8|||
161811676|NCT01531894|584353056|FG000|Overall Study|Death|1|||
161811677|NCT03635320|584353057|FG000|Overall Study|not implanted the device|1|||
161811678|NCT03635320|584353058|FG001|Overall Study|not implanted the device|2|||
161811679|NCT03635320|584353057|FG000|Overall Study|Withdrawal by Subject|11|||
161811680|NCT03635320|584353058|FG001|Overall Study|Withdrawal by Subject|6|||
161811681|NCT01558635|584353059|FG000|Overall Study|Death|1|||
161811682|NCT01558635|584353059|FG000|Overall Study|Withdrawal by Subject|2|||
161811683|NCT01558635|584353059|FG000|Overall Study|Physician Decision|1|||
161811684|NCT01558635|584353059|FG000|Overall Study|Subject received other treatment|1|||
161811685|NCT01558635|584353059|FG000|Overall Study|Reveal XT was explanted|1|||
161811686|NCT04994535|584353060|FG000|Overall Study|Lost to Follow-up|7|||
161811687|NCT04994535|584353061|FG001|Overall Study|Lost to Follow-up|7|||
161915589|NCT01366092|584739010|FG000|Overall Study|Withdrawal by Subject|1|||
161915590|NCT03353220|584739015|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
161915591|NCT03353220|584739016|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
161915592|NCT03586479|584739017|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
161915593|NCT03586479|584739018|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
161915594|NCT03586479|584739019|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
161915595|NCT03586479|584739017|FG000|Overall Study|Protocol Violation|2|||
161915596|NCT03586479|584739018|FG001|Overall Study|Protocol Violation|0|||
161915597|NCT03586479|584739019|FG002|Overall Study|Protocol Violation|0|||
161915598|NCT03586479|584739017|FG000|Overall Study|Lost to Follow-up|1|||
161915599|NCT03586479|584739018|FG001|Overall Study|Lost to Follow-up|1|||
161915600|NCT03586479|584739019|FG002|Overall Study|Lost to Follow-up|2|||
161915601|NCT03586479|584739017|FG000|Overall Study|Behavioral Issues|1|||
161915602|NCT03586479|584739018|FG001|Overall Study|Behavioral Issues|0|||
161915603|NCT03586479|584739019|FG002|Overall Study|Behavioral Issues|0|||
161915604|NCT00661388|584739021|FG000|Overall Study|Adverse Event|14|||
161915605|NCT00661388|584739021|FG000|Overall Study|Protocol Violation|7|||
161915606|NCT00661388|584739021|FG000|Overall Study|Renal transplantation|1|||
161915607|NCT00661388|584739021|FG000|Overall Study|Dialysis initiation|1|||
161915608|NCT00661388|584739021|FG000|Overall Study|Administrative reasons|1|||
161915609|NCT02472405|584740491|FG000|Overall Study|Lost to Follow-up|9|||
161915610|NCT02472405|584740491|FG000|Overall Study|Adverse Event|1|||
161915611|NCT03095287|584740492|FG000|Overall Study|Treatment Failure|1|||
161915612|NCT03095287|584740492|FG000|Overall Study|Adverse Event|1|||
161915613|NCT01431976|584740495|FG000|Overall Study|Adverse Event|6|||
161915614|NCT01431976|584740495|FG000|Overall Study|Lack of Efficacy|2|||
161915615|NCT01431976|584740495|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
161915616|NCT01431976|584740495|FG000|Overall Study|Physician Decision|1|||
161915617|NCT01431976|584740495|FG000|Overall Study|Withdrawal by Subject|1|||
161915618|NCT01294514|584740496|FG000|Overall Study|Excluded due to Arrhythmia|1|||
161915619|NCT01013753|584740503|FG000|Overall Study|Adverse Event|8|||
161915620|NCT01013753|584740503|FG000|Overall Study|Protocol Violation|3|||
161915621|NCT01013753|584740503|FG000|Overall Study|Lost to Follow-up|1|||
161915622|NCT01013753|584740503|FG000|Overall Study|Withdrawal by Subject|2|||
162013619|NCT03722238|585103957|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
162013620|NCT03722238|585103958|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
162013621|NCT03722238|585103957|FG000|Overall Study|Not willing to purchase study medication|142|||
162013622|NCT03722238|585103958|FG001|Overall Study|Not willing to purchase study medication|0|||
162013623|NCT03722238|585103957|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
162013624|NCT03722238|585103958|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
162013625|NCT02085460|585103959|FG000|Overall Study|Adverse Event|2|||
162013626|NCT02085460|585103960|FG001|Overall Study|Adverse Event|2|||
162013627|NCT02085460|585103961|FG002|Overall Study|Adverse Event|1|||
162013628|NCT02085460|585103959|FG000|Overall Study|Physician Decision|1|||
162013629|NCT02085460|585103960|FG001|Overall Study|Physician Decision|1|||
162013630|NCT02085460|585103961|FG002|Overall Study|Physician Decision|2|||
162013631|NCT02085460|585103959|FG000|Overall Study|Withdrawal by Subject|11|||
162013632|NCT02085460|585103960|FG001|Overall Study|Withdrawal by Subject|5|||
162013633|NCT02085460|585103961|FG002|Overall Study|Withdrawal by Subject|7|||
162155161|NCT02723955|585619285|FG008|Escalation Phase|Physician Decision|0|||
162155162|NCT02723955|585619286|FG009|Escalation Phase|Physician Decision|0|||
162155163|NCT02723955|585619287|FG010|Escalation Phase|Physician Decision|0|||
162155164|NCT02723955|585619288|FG011|Escalation Phase|Physician Decision|0|||
162155165|NCT02723955|585619289|FG012|Escalation Phase|Physician Decision|0|||
161915623|NCT01013753|584740503|FG000|Overall Study|Other|2|||
162013634|NCT01285323|585103962|FG000|Overall Study|Adverse Event|9|||
162013635|NCT01285323|585103963|FG001|Overall Study|Adverse Event|8|||
162013636|NCT01285323|585103962|FG000|Overall Study|Lack of Efficacy|4|||
162013637|NCT01285323|585103963|FG001|Overall Study|Lack of Efficacy|2|||
162013638|NCT01285323|585103962|FG000|Overall Study|Withdrawal by Subject|15|||
162013639|NCT01285323|585103963|FG001|Overall Study|Withdrawal by Subject|11|||
162013640|NCT01285323|585103962|FG000|Overall Study|Protocol Violation|1|||
162013641|NCT01285323|585103963|FG001|Overall Study|Protocol Violation|2|||
162013642|NCT01285323|585103962|FG000|Overall Study|Non-compliance with study procedures|2|||
162013643|NCT01285323|585103963|FG001|Overall Study|Non-compliance with study procedures|3|||
162013644|NCT01285323|585103962|FG000|Overall Study|Lost to Follow-up|1|||
162013645|NCT01285323|585103963|FG001|Overall Study|Lost to Follow-up|1|||
162155166|NCT02723955|585619290|FG013|Escalation Phase|Physician Decision|0|||
162155167|NCT02723955|585619291|FG014|Escalation Phase|Physician Decision|0|||
162155168|NCT02723955|585619292|FG015|Escalation Phase|Physician Decision|0|||
161915624|NCT05350423|584740504|FG000|Overall Study|Lost to Follow-up|3|||
161915625|NCT05350423|584740505|FG001|Overall Study|Lost to Follow-up|3|||
162013646|NCT01285323|585103962|FG000|Overall Study|Other|1|||
162013647|NCT01285323|585103963|FG001|Overall Study|Other|3|||
162013648|NCT02606643|585103964|FG000|Overall Study|did not meet inclusion criteria|1|||
161811688|NCT04994535|584353060|FG000|Overall Study|Withdrawal by Subject|10|||
161811689|NCT04994535|584353061|FG001|Overall Study|Withdrawal by Subject|7|||
161811690|NCT04994535|584353060|FG000|Overall Study|Other|1|||
161811691|NCT04994535|584353061|FG001|Overall Study|Other|1|||
161811692|NCT01158118|584353062|FG000|Overall Study|Screen failure|1|||
161811693|NCT01158118|584353063|FG001|Overall Study|Screen failure|0|||
161811694|NCT01158118|584353062|FG000|Overall Study|Donor match was a screen failure|0|||
161811695|NCT01158118|584353063|FG001|Overall Study|Donor match was a screen failure|1|||
161811696|NCT01158118|584353062|FG000|Overall Study|Suffered stroke prior to transplant|0|||
161811697|NCT01158118|584353063|FG001|Overall Study|Suffered stroke prior to transplant|1|||
161811698|NCT01158118|584353062|FG000|Overall Study|Death|0|||
161811699|NCT01158118|584353063|FG001|Overall Study|Death|1|||
161811700|NCT00604162|584353064|FG000|Overall Study|Physician Decision|3|||
161811701|NCT00604162|584353064|FG000|Overall Study|Withdrawal by Subject|1|||
161811702|NCT00960297|584353076|FG000|Overall Study|Physician Decision|1|||
161811703|NCT00960297|584353076|FG000|Overall Study|Venous port infection|1|||
161811704|NCT00960297|584353076|FG000|Overall Study|Disease progression|1|||
161811705|NCT03247972|584353081|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
161811706|NCT03247972|584353081|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
161811707|NCT00968812|584353082|FG000|Overall Study|Adverse Event|30|||
161811708|NCT00968812|584353083|FG001|Overall Study|Adverse Event|46|||
161811709|NCT00968812|584353084|FG002|Overall Study|Adverse Event|33|||
161811710|NCT00968812|584353082|FG000|Overall Study|Death|2|||
161811711|NCT00968812|584353083|FG001|Overall Study|Death|2|||
161811712|NCT00968812|584353084|FG002|Overall Study|Death|1|||
161811713|NCT00968812|584353082|FG000|Overall Study|Lack of Efficacy|9|||
161811714|NCT00968812|584353083|FG001|Overall Study|Lack of Efficacy|7|||
161811715|NCT00968812|584353084|FG002|Overall Study|Lack of Efficacy|16|||
161811716|NCT00968812|584353082|FG000|Overall Study|Lost to Follow-up|17|||
161811717|NCT00968812|584353083|FG001|Overall Study|Lost to Follow-up|12|||
161811718|NCT00968812|584353084|FG002|Overall Study|Lost to Follow-up|11|||
161811719|NCT00968812|584353082|FG000|Overall Study|Physician Decision|8|||
161811720|NCT00968812|584353083|FG001|Overall Study|Physician Decision|5|||
161811721|NCT00968812|584353084|FG002|Overall Study|Physician Decision|9|||
161811722|NCT00968812|584353082|FG000|Overall Study|Protocol Violation|7|||
161811723|NCT00968812|584353083|FG001|Overall Study|Protocol Violation|4|||
161811724|NCT00968812|584353084|FG002|Overall Study|Protocol Violation|3|||
161811725|NCT00968812|584353082|FG000|Overall Study|Withdrawal by Subject|17|||
161811726|NCT00968812|584353083|FG001|Overall Study|Withdrawal by Subject|23|||
161811727|NCT00968812|584353084|FG002|Overall Study|Withdrawal by Subject|25|||
161811728|NCT00968812|584353082|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
161811729|NCT00968812|584353083|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
161811730|NCT00968812|584353084|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
161811731|NCT00968812|584353082|FG000|Overall Study|Noncompliance with study drug|4|||
161811732|NCT00968812|584353083|FG001|Overall Study|Noncompliance with study drug|1|||
161811733|NCT00968812|584353084|FG002|Overall Study|Noncompliance with study drug|6|||
161811734|NCT00968812|584353082|FG000|Overall Study|Unable to take rescue therapy|12|||
161915626|NCT05350423|584740504|FG000|Overall Study|screen failure|5|||
161915627|NCT05350423|584740505|FG001|Overall Study|screen failure|6|||
161915628|NCT02097277|584740506|FG000|Overall Study|Subject no longer meets study criteria|0|||
161915629|NCT02097277|584740507|FG001|Overall Study|Subject no longer meets study criteria|1|||
161915630|NCT02097277|584740508|FG002|Overall Study|Subject no longer meets study criteria|0|||
161915631|NCT02097277|584740509|FG003|Overall Study|Subject no longer meets study criteria|1|||
161915632|NCT02097277|584740510|FG004|Overall Study|Subject no longer meets study criteria|0|||
161915633|NCT02097277|584740506|FG000|Overall Study|Subject request to discontinue treatment|0|||
161915634|NCT02097277|584740507|FG001|Overall Study|Subject request to discontinue treatment|0|||
161915635|NCT02097277|584740508|FG002|Overall Study|Subject request to discontinue treatment|0|||
161915636|NCT02097277|584740509|FG003|Overall Study|Subject request to discontinue treatment|0|||
161915637|NCT02097277|584740510|FG004|Overall Study|Subject request to discontinue treatment|1|||
161915638|NCT02097277|584740506|FG000|Overall Study|Lost to Follow-up|0|||
161915639|NCT02097277|584740507|FG001|Overall Study|Lost to Follow-up|1|||
161915640|NCT02097277|584740508|FG002|Overall Study|Lost to Follow-up|1|||
161915641|NCT02097277|584740509|FG003|Overall Study|Lost to Follow-up|0|||
161915642|NCT02097277|584740510|FG004|Overall Study|Lost to Follow-up|0|||
161915643|NCT02097277|584740506|FG000|Overall Study|Withdrawal by Subject|2|||
161915644|NCT02097277|584740507|FG001|Overall Study|Withdrawal by Subject|1|||
161811735|NCT00968812|584353083|FG001|Overall Study|Unable to take rescue therapy|12|||
161811736|NCT00968812|584353084|FG002|Overall Study|Unable to take rescue therapy|17|||
161811737|NCT00968812|584353082|FG000|Overall Study|Other|25|||
161811738|NCT00968812|584353083|FG001|Overall Study|Other|37|||
161915645|NCT02097277|584740508|FG002|Overall Study|Withdrawal by Subject|0|||
161915646|NCT02097277|584740509|FG003|Overall Study|Withdrawal by Subject|1|||
161915647|NCT02097277|584740510|FG004|Overall Study|Withdrawal by Subject|0|||
161915648|NCT02097277|584740506|FG000|Overall Study|Adverse Event|0|||
161811739|NCT00968812|584353084|FG002|Overall Study|Other|40|||
161811740|NCT00834340|584353085|FG000|Washout|Adverse Event|1|||
161915649|NCT02097277|584740507|FG001|Overall Study|Adverse Event|0|||
162155169|NCT02723955|585619293|FG016|Escalation Phase|Physician Decision|0|||
162155170|NCT02723955|585619294|FG017|Escalation Phase|Physician Decision|0|||
162155171|NCT02723955|585619295|FG018|Escalation Phase|Physician Decision|0|||
162155172|NCT02723955|585619296|FG019|Escalation Phase|Physician Decision|0|||
162155173|NCT02723955|585619297|FG020|Escalation Phase|Physician Decision|0|||
162155174|NCT02723955|585619298|FG021|Escalation Phase|Physician Decision|0|||
162155175|NCT02723955|585619299|FG022|Escalation Phase|Physician Decision|0|||
162155176|NCT02723955|585619300|FG023|Escalation Phase|Physician Decision|0|||
162155177|NCT02723955|585619301|FG024|Escalation Phase|Physician Decision|0|||
162155178|NCT02723955|585619302|FG025|Escalation Phase|Physician Decision|0|||
162155179|NCT02723955|585619303|FG026|Escalation Phase|Physician Decision|2|||
162155180|NCT02723955|585619304|FG027|Escalation Phase|Physician Decision|0|||
162155181|NCT02723955|585619305|FG028|Escalation Phase|Physician Decision|0|||
162155182|NCT02723955|585619306|FG029|Escalation Phase|Physician Decision|0|||
162155183|NCT02723955|585619307|FG030|Escalation Phase|Physician Decision|0|||
162155184|NCT02723955|585619308|FG031|Escalation Phase|Physician Decision|0|||
162155185|NCT02723955|585619309|FG032|Escalation Phase|Physician Decision|0|||
162155186|NCT02723955|585619310|FG033|Escalation Phase|Physician Decision|0|||
162155187|NCT02723955|585619311|FG034|Escalation Phase|Physician Decision|0|||
162155188|NCT02723955|585619312|FG035|Escalation Phase|Physician Decision|0|||
162155189|NCT02723955|585619313|FG036|Escalation Phase|Physician Decision|0|||
162155190|NCT02723955|585619314|FG037|Escalation Phase|Physician Decision|0|||
162155191|NCT02723955|585619315|FG038|Escalation Phase|Physician Decision|0|||
162155192|NCT02723955|585619316|FG039|Escalation Phase|Physician Decision|0|||
162155193|NCT02723955|585619317|FG040|Escalation Phase|Physician Decision|0|||
162155194|NCT02723955|585619318|FG041|Escalation Phase|Physician Decision|0|||
162155195|NCT02723955|585619319|FG042|Escalation Phase|Physician Decision|0|||
162155196|NCT02723955|585619277|FG000|Escalation Phase|Withdrawal by Subject|0|||
162155197|NCT02723955|585619278|FG001|Escalation Phase|Withdrawal by Subject|0|||
162155198|NCT02723955|585619279|FG002|Escalation Phase|Withdrawal by Subject|0|||
162155199|NCT02723955|585619280|FG003|Escalation Phase|Withdrawal by Subject|0|||
162013649|NCT02606643|585103965|FG001|Overall Study|did not meet inclusion criteria|3|||
162013650|NCT02158546|585103972|FG000|Overall Study|Physician Decision|0|||
162013651|NCT02158546|585103973|FG001|Overall Study|Physician Decision|1|||
162013652|NCT02158546|585103974|FG002|Overall Study|Physician Decision|0|||
162013653|NCT02158546|585103975|FG003|Overall Study|Physician Decision|0|||
162013654|NCT02158546|585103972|FG000|Overall Study|Non-compliance|0|||
162013655|NCT02158546|585103973|FG001|Overall Study|Non-compliance|1|||
162013656|NCT02158546|585103974|FG002|Overall Study|Non-compliance|0|||
162013657|NCT02158546|585103975|FG003|Overall Study|Non-compliance|1|||
162013658|NCT02158546|585103972|FG000|Overall Study|Failure to meet eligibility criteria|0|||
162013659|NCT02158546|585103973|FG001|Overall Study|Failure to meet eligibility criteria|1|||
162013660|NCT02158546|585103974|FG002|Overall Study|Failure to meet eligibility criteria|0|||
162013661|NCT02158546|585103975|FG003|Overall Study|Failure to meet eligibility criteria|0|||
162013662|NCT02158546|585103972|FG000|Overall Study|Lack of Efficacy|1|||
162013663|NCT02158546|585103973|FG001|Overall Study|Lack of Efficacy|1|||
162013664|NCT02158546|585103974|FG002|Overall Study|Lack of Efficacy|0|||
162013665|NCT02158546|585103975|FG003|Overall Study|Lack of Efficacy|0|||
162013666|NCT02158546|585103972|FG000|Overall Study|Adverse Event|2|||
162013667|NCT02158546|585103973|FG001|Overall Study|Adverse Event|2|||
162013668|NCT02158546|585103974|FG002|Overall Study|Adverse Event|0|||
162013669|NCT02158546|585103975|FG003|Overall Study|Adverse Event|0|||
162013670|NCT02158546|585103972|FG000|Overall Study|Withdrawal by Subject|6|||
162013671|NCT02158546|585103973|FG001|Overall Study|Withdrawal by Subject|2|||
162013672|NCT02158546|585103974|FG002|Overall Study|Withdrawal by Subject|1|||
162013673|NCT02158546|585103975|FG003|Overall Study|Withdrawal by Subject|0|||
162013674|NCT02158546|585103972|FG000|Overall Study|Lost to Follow-up|5|||
162013675|NCT02158546|585103973|FG001|Overall Study|Lost to Follow-up|4|||
162013676|NCT02158546|585103974|FG002|Overall Study|Lost to Follow-up|0|||
162013677|NCT02158546|585103975|FG003|Overall Study|Lost to Follow-up|1|||
162013678|NCT02158546|585103972|FG000|Overall Study|Site Excluded|5|||
162013679|NCT02158546|585103973|FG001|Overall Study|Site Excluded|5|||
162013680|NCT02158546|585103974|FG002|Overall Study|Site Excluded|3|||
162013681|NCT02158546|585103975|FG003|Overall Study|Site Excluded|4|||
162013682|NCT02351817|585103977|FG000|Period 1|Adverse Event|1|||
162013683|NCT02351817|585103978|FG001|Period 1|Adverse Event|2|||
162013684|NCT02351817|585103977|FG000|Period 1|Lack of Efficacy|0|||
162013685|NCT02351817|585103978|FG001|Period 1|Lack of Efficacy|1|||
162013686|NCT02351817|585103977|FG000|Period 2|Adverse Event|0|||
162013687|NCT02351817|585103978|FG001|Period 2|Adverse Event|2|||
162013688|NCT02351817|585103977|FG000|Period 2|Protocol Violation|1|||
162013689|NCT02351817|585103978|FG001|Period 2|Protocol Violation|0|||
162013690|NCT02488915|585103981|FG000|Overall Study|Death|21|||
162013691|NCT02488915|585103981|FG000|Overall Study|Lost to Follow-up|4|||
162013692|NCT02488915|585103981|FG000|Overall Study|Withdrawal by Subject|1|||
162013693|NCT00891904|585103988|FG000|Overall Study|Death|1|||
162013694|NCT00891904|585103988|FG000|Overall Study|Adverse Event|1|||
162013695|NCT01046396|585103989|FG000|Overall Study|Withdrawal by Subject|5|||
162013696|NCT01208207|585103990|FG000|Part I|Adverse Event|19|||
161915650|NCT02097277|584740508|FG002|Overall Study|Adverse Event|1|||
161915651|NCT02097277|584740509|FG003|Overall Study|Adverse Event|2|||
161915652|NCT02097277|584740510|FG004|Overall Study|Adverse Event|0|||
161915653|NCT01461551|584740514|FG000|Overall Study|Physician Decision|2|||
161915654|NCT01461551|584740515|FG001|Overall Study|Physician Decision|1|||
161915655|NCT01461551|584740516|FG002|Overall Study|Physician Decision|2|||
161915656|NCT00303186|584740517|FG000|Overall Study|Other|52|||
161915657|NCT02326883|584740518|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
161915658|NCT02326883|584740519|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
161915659|NCT02326883|584740520|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
161915660|NCT01385176|584740521|FG000|Randomization Phase|Death|1|||
161915661|NCT01385176|584740522|FG001|Randomization Phase|Death|2|||
161915662|NCT01385176|584740521|FG000|6-18 Month All VNS Active|Death|1|||
161915663|NCT01385176|584740522|FG001|6-18 Month All VNS Active|Death|2|||
162013697|NCT01208207|585103991|FG001|Part I|Adverse Event|2|||
162013698|NCT01208207|585103992|FG002|Part I|Adverse Event|6|||
162013699|NCT01208207|585103993|FG003|Part I|Adverse Event|0|||
162013700|NCT01208207|585103994|FG004|Part I|Adverse Event|0|||
162013701|NCT01208207|585103995|FG005|Part I|Adverse Event|0|||
162013702|NCT01208207|585103996|FG006|Part I|Adverse Event|0|||
162013703|NCT01208207|585103990|FG000|Part I|Lack of Efficacy|21|||
162155200|NCT02723955|585619281|FG004|Escalation Phase|Withdrawal by Subject|1|||
162155201|NCT02723955|585619282|FG005|Escalation Phase|Withdrawal by Subject|1|||
162155202|NCT02723955|585619283|FG006|Escalation Phase|Withdrawal by Subject|1|||
162155203|NCT02723955|585619284|FG007|Escalation Phase|Withdrawal by Subject|1|||
162155204|NCT02723955|585619285|FG008|Escalation Phase|Withdrawal by Subject|0|||
162155205|NCT02723955|585619286|FG009|Escalation Phase|Withdrawal by Subject|0|||
162155206|NCT02723955|585619287|FG010|Escalation Phase|Withdrawal by Subject|0|||
162155207|NCT02723955|585619288|FG011|Escalation Phase|Withdrawal by Subject|0|||
162155208|NCT02723955|585619289|FG012|Escalation Phase|Withdrawal by Subject|1|||
162155209|NCT02723955|585619290|FG013|Escalation Phase|Withdrawal by Subject|0|||
162155210|NCT02723955|585619291|FG014|Escalation Phase|Withdrawal by Subject|0|||
162155211|NCT02723955|585619292|FG015|Escalation Phase|Withdrawal by Subject|0|||
162155212|NCT02723955|585619293|FG016|Escalation Phase|Withdrawal by Subject|1|||
162155213|NCT02723955|585619294|FG017|Escalation Phase|Withdrawal by Subject|0|||
162155214|NCT02723955|585619295|FG018|Escalation Phase|Withdrawal by Subject|0|||
162155215|NCT02723955|585619296|FG019|Escalation Phase|Withdrawal by Subject|0|||
162155216|NCT02723955|585619297|FG020|Escalation Phase|Withdrawal by Subject|0|||
162155217|NCT02723955|585619298|FG021|Escalation Phase|Withdrawal by Subject|0|||
162155218|NCT02723955|585619299|FG022|Escalation Phase|Withdrawal by Subject|0|||
162155219|NCT02723955|585619300|FG023|Escalation Phase|Withdrawal by Subject|2|||
162155220|NCT02723955|585619301|FG024|Escalation Phase|Withdrawal by Subject|0|||
162155221|NCT02723955|585619302|FG025|Escalation Phase|Withdrawal by Subject|1|||
162155222|NCT02723955|585619303|FG026|Escalation Phase|Withdrawal by Subject|0|||
162155223|NCT02723955|585619304|FG027|Escalation Phase|Withdrawal by Subject|0|||
162155224|NCT02723955|585619305|FG028|Escalation Phase|Withdrawal by Subject|1|||
162155225|NCT02723955|585619306|FG029|Escalation Phase|Withdrawal by Subject|0|||
162155226|NCT02723955|585619307|FG030|Escalation Phase|Withdrawal by Subject|0|||
162155227|NCT02723955|585619308|FG031|Escalation Phase|Withdrawal by Subject|0|||
162155228|NCT02723955|585619309|FG032|Escalation Phase|Withdrawal by Subject|0|||
162155229|NCT02723955|585619310|FG033|Escalation Phase|Withdrawal by Subject|0|||
162155230|NCT02723955|585619311|FG034|Escalation Phase|Withdrawal by Subject|0|||
162155231|NCT02723955|585619312|FG035|Escalation Phase|Withdrawal by Subject|0|||
162155232|NCT02723955|585619313|FG036|Escalation Phase|Withdrawal by Subject|0|||
162155233|NCT02723955|585619314|FG037|Escalation Phase|Withdrawal by Subject|0|||
162155234|NCT02723955|585619315|FG038|Escalation Phase|Withdrawal by Subject|0|||
162155235|NCT02723955|585619316|FG039|Escalation Phase|Withdrawal by Subject|0|||
162155236|NCT02723955|585619317|FG040|Escalation Phase|Withdrawal by Subject|0|||
162155237|NCT02723955|585619318|FG041|Escalation Phase|Withdrawal by Subject|0|||
162155238|NCT02723955|585619319|FG042|Escalation Phase|Withdrawal by Subject|0|||
162155239|NCT02723955|585619277|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155240|NCT02723955|585619278|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155241|NCT02723955|585619279|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155242|NCT02723955|585619280|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155243|NCT02723955|585619281|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
162155244|NCT02723955|585619282|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
162155245|NCT02723955|585619283|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
162155246|NCT02723955|585619284|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
162155247|NCT02723955|585619285|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
162155248|NCT02723955|585619286|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155249|NCT02723955|585619287|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155250|NCT02723955|585619288|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155251|NCT02723955|585619289|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155252|NCT02723955|585619290|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155253|NCT02723955|585619291|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155254|NCT02723955|585619292|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155255|NCT02723955|585619293|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155256|NCT02723955|585619294|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155257|NCT02723955|585619295|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155258|NCT02723955|585619296|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155259|NCT02723955|585619297|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155260|NCT02723955|585619298|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155261|NCT02723955|585619299|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162236460|NCT00666679|585916957|FG000|First Intervention|Randomized did not start treatment|1|||
161811741|NCT00834340|584353086|FG001|Washout|Adverse Event|0|||
161811742|NCT00834340|584353085|FG000|Washout|Withdrawal by Subject|1|||
161811743|NCT00834340|584353086|FG001|Washout|Withdrawal by Subject|0|||
161811744|NCT00395694|584353087|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
161811745|NCT00395694|584353088|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
161811746|NCT00395694|584353087|FG000|Continuation Phase|Adverse Event|1|||
161811747|NCT00395694|584353088|FG001|Continuation Phase|Adverse Event|0|||
161915664|NCT01385176|584740521|FG000|6-18 Month All VNS Active|Physician Decision|0|||
161915665|NCT01385176|584740522|FG001|6-18 Month All VNS Active|Physician Decision|1|||
161915666|NCT01385176|584740521|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
161915667|NCT01385176|584740522|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
161915668|NCT01385176|584740521|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
161915669|NCT01385176|584740522|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
161915670|NCT00284856|584740523|FG000|Overall Study|Adverse Event|3|||
161915671|NCT00284856|584740524|FG001|Overall Study|Adverse Event|3|||
161915672|NCT00284856|584740525|FG002|Overall Study|Adverse Event|3|||
161915673|NCT00284856|584740523|FG000|Overall Study|Lack of Efficacy|2|||
161915674|NCT00284856|584740524|FG001|Overall Study|Lack of Efficacy|1|||
161915675|NCT00284856|584740525|FG002|Overall Study|Lack of Efficacy|8|||
161915676|NCT00284856|584740523|FG000|Overall Study|Lost to Follow-up|25|||
161915677|NCT00284856|584740524|FG001|Overall Study|Lost to Follow-up|21|||
161915678|NCT00284856|584740525|FG002|Overall Study|Lost to Follow-up|22|||
161915679|NCT00284856|584740523|FG000|Overall Study|Protocol Violation|5|||
161915680|NCT00284856|584740524|FG001|Overall Study|Protocol Violation|4|||
161915681|NCT00284856|584740525|FG002|Overall Study|Protocol Violation|5|||
161915682|NCT00284856|584740523|FG000|Overall Study|Withdrawal by Subject|12|||
161915683|NCT00284856|584740524|FG001|Overall Study|Withdrawal by Subject|16|||
162013704|NCT01208207|585103991|FG001|Part I|Lack of Efficacy|3|||
161811748|NCT00395694|584353087|FG000|Continuation Phase|Lack of Efficacy|12|||
161811749|NCT00395694|584353088|FG001|Continuation Phase|Lack of Efficacy|11|||
161811750|NCT00395694|584353087|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
161811751|NCT00395694|584353088|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
161811752|NCT00395694|584353087|FG000|Continuation Phase|Poor Compliance|1|||
161811753|NCT00395694|584353088|FG001|Continuation Phase|Poor Compliance|0|||
161915684|NCT00284856|584740525|FG002|Overall Study|Withdrawal by Subject|18|||
161915685|NCT00284856|584740523|FG000|Overall Study|Other|4|||
161915686|NCT00284856|584740524|FG001|Overall Study|Other|5|||
161915687|NCT00284856|584740525|FG002|Overall Study|Other|4|||
161915688|NCT01056536|584740526|FG000|Overall Study|Lost to Follow-up|202|||
161915689|NCT01056536|584740527|FG001|Overall Study|Lost to Follow-up|116|||
161915690|NCT01056536|584740528|FG002|Overall Study|Lost to Follow-up|248|||
161915691|NCT05853120|584740529|FG000|Overall Study|Lost to Follow-up|4|||
162013705|NCT01208207|585103992|FG002|Part I|Lack of Efficacy|2|||
162155262|NCT02723955|585619300|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155263|NCT02723955|585619301|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155264|NCT02723955|585619302|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155265|NCT02723955|585619303|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155266|NCT02723955|585619304|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155267|NCT02723955|585619305|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155268|NCT02723955|585619306|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155269|NCT02723955|585619307|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155270|NCT02723955|585619308|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155271|NCT02723955|585619309|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155272|NCT02723955|585619310|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155273|NCT02723955|585619311|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155274|NCT02723955|585619312|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155275|NCT02723955|585619313|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155276|NCT02723955|585619314|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155277|NCT02723955|585619315|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155278|NCT02723955|585619316|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155279|NCT02723955|585619317|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155280|NCT02723955|585619318|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155281|NCT02723955|585619319|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
162155282|NCT02723955|585619277|FG000|Escalation Phase|Site Closed|0|||
162155283|NCT02723955|585619278|FG001|Escalation Phase|Site Closed|0|||
162155284|NCT02723955|585619279|FG002|Escalation Phase|Site Closed|0|||
162155285|NCT02723955|585619280|FG003|Escalation Phase|Site Closed|0|||
162155286|NCT02723955|585619281|FG004|Escalation Phase|Site Closed|0|||
162155287|NCT02723955|585619282|FG005|Escalation Phase|Site Closed|0|||
162155288|NCT02723955|585619283|FG006|Escalation Phase|Site Closed|0|||
162155289|NCT02723955|585619284|FG007|Escalation Phase|Site Closed|0|||
162155290|NCT02723955|585619285|FG008|Escalation Phase|Site Closed|0|||
162155291|NCT02723955|585619286|FG009|Escalation Phase|Site Closed|0|||
162155292|NCT02723955|585619287|FG010|Escalation Phase|Site Closed|0|||
162155293|NCT02723955|585619288|FG011|Escalation Phase|Site Closed|0|||
162155294|NCT02723955|585619289|FG012|Escalation Phase|Site Closed|0|||
162155295|NCT02723955|585619290|FG013|Escalation Phase|Site Closed|0|||
162155296|NCT02723955|585619291|FG014|Escalation Phase|Site Closed|0|||
162155297|NCT02723955|585619292|FG015|Escalation Phase|Site Closed|1|||
161811754|NCT00395694|584353087|FG000|Continuation Phase|Withdrawal by Subject|0|||
161811755|NCT00395694|584353088|FG001|Continuation Phase|Withdrawal by Subject|2|||
161811756|NCT04238754|584353092|FG000|Washout - 1 Week|Lost to Follow-up|1|||
161811757|NCT04238754|584353093|FG001|Washout - 1 Week|Lost to Follow-up|0|||
161811758|NCT01175018|584353097|FG000|Overall Study|Adverse Event|3|||
161811759|NCT01175018|584353098|FG001|Overall Study|Adverse Event|1|||
161811760|NCT01788423|584353104|FG000|Overall Study|See Comments in Completed (above)|0|||
161811761|NCT01788423|584353105|FG001|Overall Study|See Comments in Completed (above)|4|||
161811762|NCT01788423|584353106|FG002|Overall Study|See Comments in Completed (above)|5|||
161811763|NCT00835263|584353107|FG000|Second Intervention|Adverse Event|1|||
161811764|NCT00835263|584353108|FG001|Second Intervention|Adverse Event|0|||
161811765|NCT03249454|584353109|FG000|Overall Study|Withdrawal by Subject|0|||
161811766|NCT03249454|584353110|FG001|Overall Study|Withdrawal by Subject|0|||
161811767|NCT03249454|584353111|FG002|Overall Study|Withdrawal by Subject|0|||
161811768|NCT03249454|584353112|FG003|Overall Study|Withdrawal by Subject|0|||
161811769|NCT03249454|584353113|FG004|Overall Study|Withdrawal by Subject|0|||
161811770|NCT03249454|584353114|FG005|Overall Study|Withdrawal by Subject|0|||
161811771|NCT03249454|584353115|FG006|Overall Study|Withdrawal by Subject|0|||
161811772|NCT03249454|584353116|FG007|Overall Study|Withdrawal by Subject|0|||
161811773|NCT03249454|584353117|FG008|Overall Study|Withdrawal by Subject|0|||
161811774|NCT03249454|584353118|FG009|Overall Study|Withdrawal by Subject|1|||
161811775|NCT03249454|584353119|FG010|Overall Study|Withdrawal by Subject|1|||
161811776|NCT03987191|584353122|FG000|Overall Study|COVID-19 related research disruption|0|||
161811777|NCT03987191|584353123|FG001|Overall Study|COVID-19 related research disruption|2|||
161811778|NCT01020474|584353124|FG000|Overall Study|Adverse Event|4|||
162013706|NCT01208207|585103993|FG003|Part I|Lack of Efficacy|0|||
162013707|NCT01208207|585103994|FG004|Part I|Lack of Efficacy|0|||
162013708|NCT01208207|585103995|FG005|Part I|Lack of Efficacy|0|||
162013709|NCT01208207|585103996|FG006|Part I|Lack of Efficacy|0|||
162013710|NCT01208207|585103990|FG000|Part I|Lost to Follow-up|6|||
162013711|NCT01208207|585103991|FG001|Part I|Lost to Follow-up|1|||
162013712|NCT01208207|585103992|FG002|Part I|Lost to Follow-up|0|||
162013713|NCT01208207|585103993|FG003|Part I|Lost to Follow-up|0|||
162013714|NCT01208207|585103994|FG004|Part I|Lost to Follow-up|0|||
162013715|NCT01208207|585103995|FG005|Part I|Lost to Follow-up|0|||
162013716|NCT01208207|585103996|FG006|Part I|Lost to Follow-up|0|||
162013717|NCT01208207|585103990|FG000|Part I|Non-Compliance With Study Drug|1|||
162013718|NCT01208207|585103991|FG001|Part I|Non-Compliance With Study Drug|0|||
162013719|NCT01208207|585103992|FG002|Part I|Non-Compliance With Study Drug|1|||
162013720|NCT01208207|585103993|FG003|Part I|Non-Compliance With Study Drug|0|||
162013721|NCT01208207|585103994|FG004|Part I|Non-Compliance With Study Drug|0|||
162013722|NCT01208207|585103995|FG005|Part I|Non-Compliance With Study Drug|0|||
162013723|NCT01208207|585103996|FG006|Part I|Non-Compliance With Study Drug|0|||
162013724|NCT01208207|585103990|FG000|Part I|Physician Decision|0|||
162013725|NCT01208207|585103991|FG001|Part I|Physician Decision|1|||
162013726|NCT01208207|585103992|FG002|Part I|Physician Decision|0|||
162013727|NCT01208207|585103993|FG003|Part I|Physician Decision|0|||
162013728|NCT01208207|585103994|FG004|Part I|Physician Decision|0|||
162013729|NCT01208207|585103995|FG005|Part I|Physician Decision|0|||
162013730|NCT01208207|585103996|FG006|Part I|Physician Decision|0|||
162013731|NCT01208207|585103990|FG000|Part I|Progressive Disease|1|||
162013732|NCT01208207|585103991|FG001|Part I|Progressive Disease|0|||
162013733|NCT01208207|585103992|FG002|Part I|Progressive Disease|0|||
162013734|NCT01208207|585103993|FG003|Part I|Progressive Disease|0|||
162013735|NCT01208207|585103994|FG004|Part I|Progressive Disease|0|||
162013736|NCT01208207|585103995|FG005|Part I|Progressive Disease|0|||
162013737|NCT01208207|585103996|FG006|Part I|Progressive Disease|0|||
162013738|NCT01208207|585103990|FG000|Part I|Protocol Violation|8|||
162013739|NCT01208207|585103991|FG001|Part I|Protocol Violation|0|||
162013740|NCT01208207|585103992|FG002|Part I|Protocol Violation|2|||
162013741|NCT01208207|585103993|FG003|Part I|Protocol Violation|0|||
162013742|NCT01208207|585103994|FG004|Part I|Protocol Violation|0|||
162013743|NCT01208207|585103995|FG005|Part I|Protocol Violation|0|||
162013744|NCT01208207|585103996|FG006|Part I|Protocol Violation|0|||
162013745|NCT01208207|585103990|FG000|Part I|Withdrawal by Subject|14|||
162013746|NCT01208207|585103991|FG001|Part I|Withdrawal by Subject|4|||
162013747|NCT01208207|585103992|FG002|Part I|Withdrawal by Subject|4|||
162013748|NCT01208207|585103993|FG003|Part I|Withdrawal by Subject|0|||
162013749|NCT01208207|585103994|FG004|Part I|Withdrawal by Subject|0|||
162013750|NCT01208207|585103995|FG005|Part I|Withdrawal by Subject|0|||
162013751|NCT01208207|585103996|FG006|Part I|Withdrawal by Subject|0|||
162013752|NCT01208207|585103990|FG000|Part II|Withdrawal by Subject|0|||
162013753|NCT01208207|585103991|FG001|Part II|Withdrawal by Subject|0|||
162013754|NCT01208207|585103992|FG002|Part II|Withdrawal by Subject|0|||
162013755|NCT01208207|585103993|FG003|Part II|Withdrawal by Subject|10|||
162013756|NCT01208207|585103994|FG004|Part II|Withdrawal by Subject|9|||
162013757|NCT01208207|585103995|FG005|Part II|Withdrawal by Subject|3|||
162013758|NCT01208207|585103996|FG006|Part II|Withdrawal by Subject|5|||
162013759|NCT01208207|585103990|FG000|Part II|Adverse Event|0|||
162013760|NCT01208207|585103991|FG001|Part II|Adverse Event|0|||
162013761|NCT01208207|585103992|FG002|Part II|Adverse Event|0|||
162155298|NCT02723955|585619293|FG016|Escalation Phase|Site Closed|0|||
162155299|NCT02723955|585619294|FG017|Escalation Phase|Site Closed|2|||
162155300|NCT02723955|585619295|FG018|Escalation Phase|Site Closed|0|||
162155301|NCT02723955|585619296|FG019|Escalation Phase|Site Closed|0|||
162155302|NCT02723955|585619297|FG020|Escalation Phase|Site Closed|1|||
162155303|NCT02723955|585619298|FG021|Escalation Phase|Site Closed|0|||
162155304|NCT02723955|585619299|FG022|Escalation Phase|Site Closed|0|||
162155305|NCT02723955|585619300|FG023|Escalation Phase|Site Closed|0|||
162155306|NCT02723955|585619301|FG024|Escalation Phase|Site Closed|3|||
162155307|NCT02723955|585619302|FG025|Escalation Phase|Site Closed|1|||
162155308|NCT02723955|585619303|FG026|Escalation Phase|Site Closed|3|||
162155309|NCT02723955|585619304|FG027|Escalation Phase|Site Closed|1|||
162155310|NCT02723955|585619305|FG028|Escalation Phase|Site Closed|1|||
162155311|NCT02723955|585619306|FG029|Escalation Phase|Site Closed|0|||
162155312|NCT02723955|585619307|FG030|Escalation Phase|Site Closed|0|||
162155313|NCT02723955|585619308|FG031|Escalation Phase|Site Closed|0|||
162155314|NCT02723955|585619309|FG032|Escalation Phase|Site Closed|0|||
162155315|NCT02723955|585619310|FG033|Escalation Phase|Site Closed|0|||
162155316|NCT02723955|585619311|FG034|Escalation Phase|Site Closed|0|||
162155317|NCT02723955|585619312|FG035|Escalation Phase|Site Closed|0|||
162155318|NCT02723955|585619313|FG036|Escalation Phase|Site Closed|0|||
162155319|NCT02723955|585619314|FG037|Escalation Phase|Site Closed|0|||
162155320|NCT02723955|585619315|FG038|Escalation Phase|Site Closed|0|||
162155321|NCT02723955|585619316|FG039|Escalation Phase|Site Closed|0|||
162155322|NCT02723955|585619317|FG040|Escalation Phase|Site Closed|0|||
162155323|NCT02723955|585619318|FG041|Escalation Phase|Site Closed|0|||
162155324|NCT02723955|585619319|FG042|Escalation Phase|Site Closed|0|||
162155325|NCT02723955|585619277|FG000|Expansion Phase|Death|0|||
162155326|NCT02723955|585619278|FG001|Expansion Phase|Death|0|||
162155327|NCT02723955|585619279|FG002|Expansion Phase|Death|0|||
162155328|NCT02723955|585619280|FG003|Expansion Phase|Death|0|||
162155329|NCT02723955|585619281|FG004|Expansion Phase|Death|0|||
162155330|NCT02723955|585619282|FG005|Expansion Phase|Death|0|||
162155331|NCT02723955|585619283|FG006|Expansion Phase|Death|0|||
162155332|NCT02723955|585619284|FG007|Expansion Phase|Death|0|||
162013762|NCT01208207|585103993|FG003|Part II|Adverse Event|5|||
161811779|NCT01020474|584353125|FG001|Overall Study|Adverse Event|4|||
161811780|NCT01020474|584353124|FG000|Overall Study|Protocol Violation|0|||
161811781|NCT01020474|584353125|FG001|Overall Study|Protocol Violation|2|||
161811782|NCT01020474|584353124|FG000|Overall Study|Withdrawal by Subject|5|||
162013763|NCT01208207|585103994|FG004|Part II|Adverse Event|9|||
162013764|NCT01208207|585103995|FG005|Part II|Adverse Event|4|||
162013765|NCT01208207|585103996|FG006|Part II|Adverse Event|2|||
162013766|NCT01208207|585103990|FG000|Part II|Lack of Efficacy|0|||
162013767|NCT01208207|585103991|FG001|Part II|Lack of Efficacy|0|||
162013768|NCT01208207|585103992|FG002|Part II|Lack of Efficacy|0|||
162013769|NCT01208207|585103993|FG003|Part II|Lack of Efficacy|6|||
162013770|NCT01208207|585103994|FG004|Part II|Lack of Efficacy|4|||
162013771|NCT01208207|585103995|FG005|Part II|Lack of Efficacy|3|||
162013772|NCT01208207|585103996|FG006|Part II|Lack of Efficacy|3|||
162013773|NCT01208207|585103990|FG000|Part II|Lost to Follow-up|0|||
162013774|NCT01208207|585103991|FG001|Part II|Lost to Follow-up|0|||
162013775|NCT01208207|585103992|FG002|Part II|Lost to Follow-up|0|||
162013776|NCT01208207|585103993|FG003|Part II|Lost to Follow-up|4|||
162013777|NCT01208207|585103994|FG004|Part II|Lost to Follow-up|0|||
162013778|NCT01208207|585103995|FG005|Part II|Lost to Follow-up|2|||
162013779|NCT01208207|585103996|FG006|Part II|Lost to Follow-up|1|||
162155333|NCT02723955|585619285|FG008|Expansion Phase|Death|0|||
162155334|NCT02723955|585619286|FG009|Expansion Phase|Death|25|||
161811783|NCT01020474|584353125|FG001|Overall Study|Withdrawal by Subject|7|||
161811784|NCT01020474|584353124|FG000|Overall Study|Other Reasons|1|||
161811785|NCT01020474|584353125|FG001|Overall Study|Other Reasons|1|||
161811786|NCT01020474|584353124|FG000|Overall Study|Insufficient Clinical Response|0|||
161811787|NCT01020474|584353125|FG001|Overall Study|Insufficient Clinical Response|3|||
161811788|NCT03256695|584353127|FG000|Overall Study|Adverse Event|8|||
161811789|NCT03256695|584353127|FG000|Overall Study|Death|2|||
161811790|NCT03256695|584353127|FG000|Overall Study|Withdrawal by Subject|14|||
161811791|NCT03256695|584353127|FG000|Overall Study|Non-compliance with study drug|1|||
161811792|NCT03256695|584353127|FG000|Overall Study|Lost to Follow-up|3|||
162013780|NCT01208207|585103990|FG000|Part II|Non-Compliance With Study Drug|0|||
162013781|NCT01208207|585103991|FG001|Part II|Non-Compliance With Study Drug|0|||
162013782|NCT01208207|585103992|FG002|Part II|Non-Compliance With Study Drug|0|||
162155335|NCT02723955|585619287|FG010|Expansion Phase|Death|69|||
162155336|NCT02723955|585619288|FG011|Expansion Phase|Death|48|||
162155337|NCT02723955|585619289|FG012|Expansion Phase|Death|0|||
162155338|NCT02723955|585619290|FG013|Expansion Phase|Death|0|||
162155339|NCT02723955|585619291|FG014|Expansion Phase|Death|0|||
162155340|NCT02723955|585619292|FG015|Expansion Phase|Death|0|||
162013783|NCT01208207|585103993|FG003|Part II|Non-Compliance With Study Drug|4|||
162013784|NCT01208207|585103994|FG004|Part II|Non-Compliance With Study Drug|1|||
162155341|NCT02723955|585619293|FG016|Expansion Phase|Death|0|||
162155342|NCT02723955|585619294|FG017|Expansion Phase|Death|0|||
162155343|NCT02723955|585619295|FG018|Expansion Phase|Death|0|||
162155344|NCT02723955|585619296|FG019|Expansion Phase|Death|0|||
162155345|NCT02723955|585619297|FG020|Expansion Phase|Death|0|||
162155346|NCT02723955|585619298|FG021|Expansion Phase|Death|0|||
162155347|NCT02723955|585619299|FG022|Expansion Phase|Death|0|||
162155348|NCT02723955|585619300|FG023|Expansion Phase|Death|0|||
162155349|NCT02723955|585619301|FG024|Expansion Phase|Death|0|||
162155350|NCT02723955|585619302|FG025|Expansion Phase|Death|0|||
162155351|NCT02723955|585619303|FG026|Expansion Phase|Death|0|||
162155352|NCT02723955|585619304|FG027|Expansion Phase|Death|0|||
162155353|NCT02723955|585619305|FG028|Expansion Phase|Death|0|||
162155354|NCT02723955|585619306|FG029|Expansion Phase|Death|12|||
162155355|NCT02723955|585619307|FG030|Expansion Phase|Death|202|||
162155356|NCT02723955|585619308|FG031|Expansion Phase|Death|31|||
162155357|NCT02723955|585619309|FG032|Expansion Phase|Death|17|||
162155358|NCT02723955|585619310|FG033|Expansion Phase|Death|2|||
162155359|NCT02723955|585619311|FG034|Expansion Phase|Death|3|||
162155360|NCT02723955|585619312|FG035|Expansion Phase|Death|3|||
162155361|NCT02723955|585619313|FG036|Expansion Phase|Death|1|||
162155362|NCT02723955|585619314|FG037|Expansion Phase|Death|0|||
162155363|NCT02723955|585619315|FG038|Expansion Phase|Death|0|||
162155364|NCT02723955|585619316|FG039|Expansion Phase|Death|0|||
162155365|NCT02723955|585619317|FG040|Expansion Phase|Death|0|||
162155366|NCT02723955|585619318|FG041|Expansion Phase|Death|0|||
162155367|NCT02723955|585619319|FG042|Expansion Phase|Death|0|||
162155368|NCT02723955|585619277|FG000|Expansion Phase|Lost to Follow-up|0|||
162155369|NCT02723955|585619278|FG001|Expansion Phase|Lost to Follow-up|0|||
162155370|NCT02723955|585619279|FG002|Expansion Phase|Lost to Follow-up|0|||
162155371|NCT02723955|585619280|FG003|Expansion Phase|Lost to Follow-up|0|||
162155372|NCT02723955|585619281|FG004|Expansion Phase|Lost to Follow-up|0|||
162155373|NCT02723955|585619282|FG005|Expansion Phase|Lost to Follow-up|0|||
162155374|NCT02723955|585619283|FG006|Expansion Phase|Lost to Follow-up|0|||
162155375|NCT02723955|585619284|FG007|Expansion Phase|Lost to Follow-up|0|||
162155376|NCT02723955|585619285|FG008|Expansion Phase|Lost to Follow-up|0|||
162155377|NCT02723955|585619286|FG009|Expansion Phase|Lost to Follow-up|0|||
162155378|NCT02723955|585619287|FG010|Expansion Phase|Lost to Follow-up|4|||
162155379|NCT02723955|585619288|FG011|Expansion Phase|Lost to Follow-up|1|||
162155380|NCT02723955|585619289|FG012|Expansion Phase|Lost to Follow-up|0|||
162155381|NCT02723955|585619290|FG013|Expansion Phase|Lost to Follow-up|0|||
162155382|NCT02723955|585619291|FG014|Expansion Phase|Lost to Follow-up|0|||
162155383|NCT02723955|585619292|FG015|Expansion Phase|Lost to Follow-up|0|||
162155384|NCT02723955|585619293|FG016|Expansion Phase|Lost to Follow-up|0|||
162155385|NCT02723955|585619294|FG017|Expansion Phase|Lost to Follow-up|0|||
162155386|NCT02723955|585619295|FG018|Expansion Phase|Lost to Follow-up|0|||
162155387|NCT02723955|585619296|FG019|Expansion Phase|Lost to Follow-up|0|||
162155388|NCT02723955|585619297|FG020|Expansion Phase|Lost to Follow-up|0|||
162155389|NCT02723955|585619298|FG021|Expansion Phase|Lost to Follow-up|0|||
162155390|NCT02723955|585619299|FG022|Expansion Phase|Lost to Follow-up|0|||
162155391|NCT02723955|585619300|FG023|Expansion Phase|Lost to Follow-up|0|||
162155392|NCT02723955|585619301|FG024|Expansion Phase|Lost to Follow-up|0|||
162155393|NCT02723955|585619302|FG025|Expansion Phase|Lost to Follow-up|0|||
162155394|NCT02723955|585619303|FG026|Expansion Phase|Lost to Follow-up|0|||
162155395|NCT02723955|585619304|FG027|Expansion Phase|Lost to Follow-up|0|||
161915692|NCT05853120|584740530|FG001|Overall Study|Lost to Follow-up|4|||
161915693|NCT05853120|584740529|FG000|Overall Study|Physician Decision|3|||
161915694|NCT05853120|584740530|FG001|Overall Study|Physician Decision|0|||
161915695|NCT05853120|584740529|FG000|Overall Study|Withdrawal by Subject|5|||
161915696|NCT05853120|584740530|FG001|Overall Study|Withdrawal by Subject|2|||
161915697|NCT00790036|584740531|FG000|Overall Study|Abnormal lab values|3|||
161915698|NCT00790036|584740532|FG001|Overall Study|Abnormal lab values|2|||
162155396|NCT02723955|585619305|FG028|Expansion Phase|Lost to Follow-up|0|||
162155397|NCT02723955|585619306|FG029|Expansion Phase|Lost to Follow-up|1|||
162155398|NCT02723955|585619307|FG030|Expansion Phase|Lost to Follow-up|19|||
162155399|NCT02723955|585619308|FG031|Expansion Phase|Lost to Follow-up|2|||
162155400|NCT02723955|585619309|FG032|Expansion Phase|Lost to Follow-up|1|||
162155401|NCT02723955|585619310|FG033|Expansion Phase|Lost to Follow-up|0|||
162155402|NCT02723955|585619311|FG034|Expansion Phase|Lost to Follow-up|0|||
162155403|NCT02723955|585619312|FG035|Expansion Phase|Lost to Follow-up|0|||
162155404|NCT02723955|585619313|FG036|Expansion Phase|Lost to Follow-up|0|||
162155405|NCT02723955|585619314|FG037|Expansion Phase|Lost to Follow-up|0|||
162155406|NCT02723955|585619315|FG038|Expansion Phase|Lost to Follow-up|0|||
162155407|NCT02723955|585619316|FG039|Expansion Phase|Lost to Follow-up|0|||
162155408|NCT02723955|585619317|FG040|Expansion Phase|Lost to Follow-up|0|||
162155409|NCT02723955|585619318|FG041|Expansion Phase|Lost to Follow-up|0|||
162155410|NCT02723955|585619319|FG042|Expansion Phase|Lost to Follow-up|0|||
162155411|NCT02723955|585619277|FG000|Expansion Phase|Physician Decision|0|||
162155412|NCT02723955|585619278|FG001|Expansion Phase|Physician Decision|0|||
162155413|NCT02723955|585619279|FG002|Expansion Phase|Physician Decision|0|||
162155414|NCT02723955|585619280|FG003|Expansion Phase|Physician Decision|0|||
162155415|NCT02723955|585619281|FG004|Expansion Phase|Physician Decision|0|||
162155416|NCT02723955|585619282|FG005|Expansion Phase|Physician Decision|0|||
162155417|NCT02723955|585619283|FG006|Expansion Phase|Physician Decision|0|||
162155418|NCT02723955|585619284|FG007|Expansion Phase|Physician Decision|0|||
162155419|NCT02723955|585619285|FG008|Expansion Phase|Physician Decision|0|||
162155420|NCT02723955|585619286|FG009|Expansion Phase|Physician Decision|0|||
162155421|NCT02723955|585619287|FG010|Expansion Phase|Physician Decision|0|||
162155422|NCT02723955|585619288|FG011|Expansion Phase|Physician Decision|0|||
162155423|NCT02723955|585619289|FG012|Expansion Phase|Physician Decision|0|||
162155424|NCT02723955|585619290|FG013|Expansion Phase|Physician Decision|0|||
162155425|NCT02723955|585619291|FG014|Expansion Phase|Physician Decision|0|||
162155426|NCT02723955|585619292|FG015|Expansion Phase|Physician Decision|0|||
162155427|NCT02723955|585619293|FG016|Expansion Phase|Physician Decision|0|||
162155428|NCT02723955|585619294|FG017|Expansion Phase|Physician Decision|0|||
162155429|NCT02723955|585619295|FG018|Expansion Phase|Physician Decision|0|||
162155430|NCT02723955|585619296|FG019|Expansion Phase|Physician Decision|0|||
162155431|NCT02723955|585619297|FG020|Expansion Phase|Physician Decision|0|||
162155432|NCT02723955|585619298|FG021|Expansion Phase|Physician Decision|0|||
162155433|NCT02723955|585619299|FG022|Expansion Phase|Physician Decision|0|||
162155434|NCT02723955|585619300|FG023|Expansion Phase|Physician Decision|0|||
162155435|NCT02723955|585619301|FG024|Expansion Phase|Physician Decision|0|||
162155436|NCT02723955|585619302|FG025|Expansion Phase|Physician Decision|0|||
162155437|NCT02723955|585619303|FG026|Expansion Phase|Physician Decision|0|||
162155438|NCT02723955|585619304|FG027|Expansion Phase|Physician Decision|0|||
162155439|NCT02723955|585619305|FG028|Expansion Phase|Physician Decision|0|||
162155440|NCT02723955|585619306|FG029|Expansion Phase|Physician Decision|0|||
162155441|NCT02723955|585619307|FG030|Expansion Phase|Physician Decision|1|||
162155442|NCT02723955|585619308|FG031|Expansion Phase|Physician Decision|1|||
162155443|NCT02723955|585619309|FG032|Expansion Phase|Physician Decision|0|||
162155444|NCT02723955|585619310|FG033|Expansion Phase|Physician Decision|0|||
162155445|NCT02723955|585619311|FG034|Expansion Phase|Physician Decision|0|||
162155446|NCT02723955|585619312|FG035|Expansion Phase|Physician Decision|0|||
162155447|NCT02723955|585619313|FG036|Expansion Phase|Physician Decision|0|||
162155448|NCT02723955|585619314|FG037|Expansion Phase|Physician Decision|0|||
162155449|NCT02723955|585619315|FG038|Expansion Phase|Physician Decision|0|||
162155450|NCT02723955|585619316|FG039|Expansion Phase|Physician Decision|0|||
162155451|NCT02723955|585619317|FG040|Expansion Phase|Physician Decision|0|||
162155452|NCT02723955|585619318|FG041|Expansion Phase|Physician Decision|0|||
162155453|NCT02723955|585619319|FG042|Expansion Phase|Physician Decision|0|||
162155454|NCT02723955|585619277|FG000|Expansion Phase|Withdrawal by Subject|0|||
161915699|NCT00790036|584740531|FG000|Overall Study|Administrative problems|5|||
162155455|NCT02723955|585619278|FG001|Expansion Phase|Withdrawal by Subject|0|||
162155456|NCT02723955|585619279|FG002|Expansion Phase|Withdrawal by Subject|0|||
162155457|NCT02723955|585619280|FG003|Expansion Phase|Withdrawal by Subject|0|||
162155458|NCT02723955|585619281|FG004|Expansion Phase|Withdrawal by Subject|0|||
162155459|NCT02723955|585619282|FG005|Expansion Phase|Withdrawal by Subject|0|||
162155460|NCT02723955|585619283|FG006|Expansion Phase|Withdrawal by Subject|0|||
162155461|NCT02723955|585619284|FG007|Expansion Phase|Withdrawal by Subject|0|||
162155462|NCT02723955|585619285|FG008|Expansion Phase|Withdrawal by Subject|0|||
162155463|NCT02723955|585619286|FG009|Expansion Phase|Withdrawal by Subject|2|||
162155464|NCT02723955|585619287|FG010|Expansion Phase|Withdrawal by Subject|1|||
162155465|NCT02723955|585619288|FG011|Expansion Phase|Withdrawal by Subject|0|||
162155466|NCT02723955|585619289|FG012|Expansion Phase|Withdrawal by Subject|0|||
162155467|NCT02723955|585619290|FG013|Expansion Phase|Withdrawal by Subject|0|||
162155468|NCT02723955|585619291|FG014|Expansion Phase|Withdrawal by Subject|0|||
162155469|NCT02723955|585619292|FG015|Expansion Phase|Withdrawal by Subject|0|||
162155470|NCT02723955|585619293|FG016|Expansion Phase|Withdrawal by Subject|0|||
162155471|NCT02723955|585619294|FG017|Expansion Phase|Withdrawal by Subject|0|||
162155472|NCT02723955|585619295|FG018|Expansion Phase|Withdrawal by Subject|0|||
162155473|NCT02723955|585619296|FG019|Expansion Phase|Withdrawal by Subject|0|||
162155474|NCT02723955|585619297|FG020|Expansion Phase|Withdrawal by Subject|0|||
162155475|NCT02723955|585619298|FG021|Expansion Phase|Withdrawal by Subject|0|||
162155476|NCT02723955|585619299|FG022|Expansion Phase|Withdrawal by Subject|0|||
162155477|NCT02723955|585619300|FG023|Expansion Phase|Withdrawal by Subject|0|||
162155478|NCT02723955|585619301|FG024|Expansion Phase|Withdrawal by Subject|0|||
162155479|NCT02723955|585619302|FG025|Expansion Phase|Withdrawal by Subject|0|||
162155480|NCT02723955|585619303|FG026|Expansion Phase|Withdrawal by Subject|0|||
162155481|NCT02723955|585619304|FG027|Expansion Phase|Withdrawal by Subject|0|||
161915700|NCT00790036|584740532|FG001|Overall Study|Administrative problems|9|||
162155482|NCT02723955|585619305|FG028|Expansion Phase|Withdrawal by Subject|0|||
162155483|NCT02723955|585619306|FG029|Expansion Phase|Withdrawal by Subject|0|||
162155484|NCT02723955|585619307|FG030|Expansion Phase|Withdrawal by Subject|8|||
162155485|NCT02723955|585619308|FG031|Expansion Phase|Withdrawal by Subject|4|||
162155486|NCT02723955|585619309|FG032|Expansion Phase|Withdrawal by Subject|0|||
162155487|NCT02723955|585619310|FG033|Expansion Phase|Withdrawal by Subject|0|||
162155488|NCT02723955|585619311|FG034|Expansion Phase|Withdrawal by Subject|0|||
162155489|NCT02723955|585619312|FG035|Expansion Phase|Withdrawal by Subject|1|||
162155490|NCT02723955|585619313|FG036|Expansion Phase|Withdrawal by Subject|0|||
162155491|NCT02723955|585619314|FG037|Expansion Phase|Withdrawal by Subject|0|||
162155492|NCT02723955|585619315|FG038|Expansion Phase|Withdrawal by Subject|0|||
162155493|NCT02723955|585619316|FG039|Expansion Phase|Withdrawal by Subject|0|||
162155494|NCT02723955|585619317|FG040|Expansion Phase|Withdrawal by Subject|0|||
162155495|NCT02723955|585619318|FG041|Expansion Phase|Withdrawal by Subject|0|||
162155496|NCT02723955|585619319|FG042|Expansion Phase|Withdrawal by Subject|0|||
162155497|NCT02723955|585619277|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155498|NCT02723955|585619278|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155499|NCT02723955|585619279|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155500|NCT02723955|585619280|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155501|NCT02723955|585619281|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155502|NCT02723955|585619282|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155503|NCT02723955|585619283|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155504|NCT02723955|585619284|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155505|NCT02723955|585619285|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155506|NCT02723955|585619286|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
162155507|NCT02723955|585619287|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
162155508|NCT02723955|585619288|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
162155509|NCT02723955|585619289|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155510|NCT02723955|585619290|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155511|NCT02723955|585619291|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155512|NCT02723955|585619292|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155513|NCT02723955|585619293|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155514|NCT02723955|585619294|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155515|NCT02723955|585619295|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162013785|NCT01208207|585103995|FG005|Part II|Non-Compliance With Study Drug|1|||
162013786|NCT01208207|585103996|FG006|Part II|Non-Compliance With Study Drug|0|||
162013787|NCT01208207|585103990|FG000|Part II|Physician Decision|0|||
162013788|NCT01208207|585103991|FG001|Part II|Physician Decision|0|||
162013789|NCT01208207|585103992|FG002|Part II|Physician Decision|0|||
162013790|NCT01208207|585103993|FG003|Part II|Physician Decision|1|||
162013791|NCT01208207|585103994|FG004|Part II|Physician Decision|0|||
162013792|NCT01208207|585103995|FG005|Part II|Physician Decision|2|||
162013793|NCT01208207|585103996|FG006|Part II|Physician Decision|0|||
162013794|NCT01208207|585103990|FG000|Part II|Protocol Violation|0|||
162013795|NCT01208207|585103991|FG001|Part II|Protocol Violation|0|||
162013796|NCT01208207|585103992|FG002|Part II|Protocol Violation|0|||
162013797|NCT01208207|585103993|FG003|Part II|Protocol Violation|1|||
162013798|NCT01208207|585103994|FG004|Part II|Protocol Violation|0|||
162013799|NCT01208207|585103995|FG005|Part II|Protocol Violation|0|||
162013800|NCT01208207|585103996|FG006|Part II|Protocol Violation|0|||
162013801|NCT01208207|585103990|FG000|Part II|Technical Problems|0|||
162013802|NCT01208207|585103991|FG001|Part II|Technical Problems|0|||
162013803|NCT01208207|585103992|FG002|Part II|Technical Problems|0|||
162013804|NCT01208207|585103993|FG003|Part II|Technical Problems|1|||
162013805|NCT01208207|585103994|FG004|Part II|Technical Problems|0|||
162013806|NCT01208207|585103995|FG005|Part II|Technical Problems|1|||
162013807|NCT01208207|585103996|FG006|Part II|Technical Problems|0|||
162013808|NCT04041414|585103999|FG000|Overall Study|Lost to Follow-up|1|||
162013809|NCT04041414|585104000|FG001|Overall Study|Lost to Follow-up|2|||
162013810|NCT00665652|585104001|FG000|Overall Study|Adverse Event|4|||
162013811|NCT00665652|585104001|FG000|Overall Study|Death|1|||
162013812|NCT00665652|585104001|FG000|Overall Study|No longer met inclusion criteria.|1|||
162013813|NCT01605799|585104012|FG000|Overall Study|Withdrawal by Subject|2|||
162013814|NCT01605799|585104013|FG001|Overall Study|Withdrawal by Subject|1|||
162013815|NCT01055197|585104016|FG000|Overall Study|Protocol Violation|7|||
162013816|NCT01055197|585104017|FG001|Overall Study|Protocol Violation|2|||
162013817|NCT01055197|585104016|FG000|Overall Study|Withdrawal by Subject|2|||
162013818|NCT01055197|585104017|FG001|Overall Study|Withdrawal by Subject|0|||
162013819|NCT00734539|585104018|FG000|Main Study|Death|33|||
162013820|NCT00734539|585104019|FG001|Main Study|Death|32|||
162155516|NCT02723955|585619296|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155517|NCT02723955|585619297|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155518|NCT02723955|585619298|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155519|NCT02723955|585619299|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155520|NCT02723955|585619300|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155521|NCT02723955|585619301|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155522|NCT02723955|585619302|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155523|NCT02723955|585619303|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155524|NCT02723955|585619304|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155525|NCT02723955|585619305|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155526|NCT02723955|585619306|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155527|NCT02723955|585619307|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
162155528|NCT02723955|585619308|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155529|NCT02723955|585619309|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155530|NCT02723955|585619310|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155531|NCT02723955|585619311|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155532|NCT02723955|585619312|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155533|NCT02723955|585619313|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155534|NCT02723955|585619314|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155535|NCT02723955|585619315|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155536|NCT02723955|585619316|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155537|NCT02723955|585619317|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155538|NCT02723955|585619318|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161811793|NCT03256695|584353127|FG000|Overall Study|Lack of Efficacy|3|||
161811794|NCT03256695|584353127|FG000|Overall Study|Protocol Violation|5|||
161811795|NCT03256695|584353127|FG000|Overall Study|Other than specified|3|||
161811796|NCT01103713|584353133|FG000|Overall Study|Lost to Follow-up|2|||
161811797|NCT01103713|584353133|FG000|Overall Study|Withdrawal by Subject|8|||
161811798|NCT01103713|584353133|FG000|Overall Study|Study terminated by sponsor|2|||
161811799|NCT01103713|584353133|FG000|Overall Study|Other|1|||
161811800|NCT02089685|584353134|FG000|Overall Study|Adverse Event|1|||
161811801|NCT02089685|584353135|FG001|Overall Study|Adverse Event|0|||
161811802|NCT02089685|584353136|FG002|Overall Study|Adverse Event|0|||
161811803|NCT02089685|584353137|FG003|Overall Study|Adverse Event|0|||
161811804|NCT02089685|584353138|FG004|Overall Study|Adverse Event|1|||
161811805|NCT02089685|584353139|FG005|Overall Study|Adverse Event|0|||
161811806|NCT02089685|584353134|FG000|Overall Study|Clinical Progression|4|||
161811807|NCT02089685|584353135|FG001|Overall Study|Clinical Progression|0|||
161811808|NCT02089685|584353136|FG002|Overall Study|Clinical Progression|0|||
161811809|NCT02089685|584353137|FG003|Overall Study|Clinical Progression|5|||
161811810|NCT02089685|584353138|FG004|Overall Study|Clinical Progression|1|||
161811811|NCT02089685|584353139|FG005|Overall Study|Clinical Progression|2|||
161811812|NCT02089685|584353134|FG000|Overall Study|Excluded Medication|1|||
161811813|NCT02089685|584353135|FG001|Overall Study|Excluded Medication|0|||
161811814|NCT02089685|584353136|FG002|Overall Study|Excluded Medication|0|||
161811815|NCT02089685|584353137|FG003|Overall Study|Excluded Medication|11|||
161811816|NCT02089685|584353138|FG004|Overall Study|Excluded Medication|2|||
161811817|NCT02089685|584353139|FG005|Overall Study|Excluded Medication|1|||
161811818|NCT02089685|584353134|FG000|Overall Study|Progressive disease|13|||
161811819|NCT02089685|584353135|FG001|Overall Study|Progressive disease|10|||
161811820|NCT02089685|584353136|FG002|Overall Study|Progressive disease|3|||
161811821|NCT02089685|584353137|FG003|Overall Study|Progressive disease|51|||
161811822|NCT02089685|584353138|FG004|Overall Study|Progressive disease|17|||
161811823|NCT02089685|584353139|FG005|Overall Study|Progressive disease|12|||
161811824|NCT02089685|584353134|FG000|Overall Study|Follow up ended by sponsor|2|||
161811825|NCT02089685|584353135|FG001|Overall Study|Follow up ended by sponsor|2|||
161811826|NCT02089685|584353136|FG002|Overall Study|Follow up ended by sponsor|0|||
161811827|NCT02089685|584353137|FG003|Overall Study|Follow up ended by sponsor|70|||
161811828|NCT02089685|584353138|FG004|Overall Study|Follow up ended by sponsor|26|||
161811829|NCT02089685|584353139|FG005|Overall Study|Follow up ended by sponsor|26|||
161811830|NCT02089685|584353134|FG000|Overall Study|Withdrawal by Subject|0|||
161811831|NCT02089685|584353135|FG001|Overall Study|Withdrawal by Subject|2|||
161811832|NCT02089685|584353136|FG002|Overall Study|Withdrawal by Subject|0|||
161915701|NCT00790036|584740531|FG000|Overall Study|Adverse Event|113|||
161915702|NCT00790036|584740532|FG001|Overall Study|Adverse Event|44|||
161915703|NCT00790036|584740531|FG000|Overall Study|Death|1|||
161915704|NCT00790036|584740532|FG001|Overall Study|Death|0|||
161915705|NCT00790036|584740531|FG000|Overall Study|Disease progression|24|||
161915706|NCT00790036|584740532|FG001|Overall Study|Disease progression|48|||
161915707|NCT00790036|584740531|FG000|Overall Study|Lost to Follow-up|1|||
161915708|NCT00790036|584740532|FG001|Overall Study|Lost to Follow-up|2|||
161915709|NCT00790036|584740531|FG000|Overall Study|Protocol Violation|10|||
161915710|NCT00790036|584740532|FG001|Overall Study|Protocol Violation|2|||
161915711|NCT00790036|584740531|FG000|Overall Study|Withdrawal by Subject|18|||
161915712|NCT00790036|584740532|FG001|Overall Study|Withdrawal by Subject|7|||
161915713|NCT00790036|584740531|FG000|Overall Study|Subject/guardian decision|20|||
161915714|NCT00790036|584740532|FG001|Overall Study|Subject/guardian decision|7|||
161915715|NCT01285518|584740533|FG000|Overall Study|Lost to Follow-up|0|||
161915716|NCT01285518|584740534|FG001|Overall Study|Lost to Follow-up|0|||
161915717|NCT01285518|584740535|FG002|Overall Study|Lost to Follow-up|0|||
161915718|NCT01285518|584740536|FG003|Overall Study|Lost to Follow-up|0|||
161915719|NCT01285518|584740537|FG004|Overall Study|Lost to Follow-up|0|||
161915720|NCT01285518|584740538|FG005|Overall Study|Lost to Follow-up|1|||
161915721|NCT01285518|584740539|FG006|Overall Study|Lost to Follow-up|0|||
161915722|NCT01285518|584740540|FG007|Overall Study|Lost to Follow-up|0|||
161915723|NCT00639509|584740547|FG000|Overall Study|Death|1|||
161915724|NCT02921256|584740548|FG000|Arm 1a v. Arm II|Adverse Event|6|||
161915725|NCT02921256|584740549|FG001|Arm 1a v. Arm II|Adverse Event|15|||
161915726|NCT02921256|584740550|FG002|Arm 1a v. Arm II|Adverse Event|0|||
161915727|NCT02921256|584740548|FG000|Arm 1a v. Arm II|Death|0|||
161915728|NCT02921256|584740549|FG001|Arm 1a v. Arm II|Death|2|||
161915729|NCT02921256|584740550|FG002|Arm 1a v. Arm II|Death|0|||
161915730|NCT02921256|584740548|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
161915731|NCT02921256|584740549|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
161915732|NCT02921256|584740550|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
161915733|NCT02921256|584740548|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
161915734|NCT02921256|584740549|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
161915735|NCT02921256|584740550|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
161915736|NCT02921256|584740548|FG000|Arm 1a v. Arm II|Physician Decision|1|||
161915737|NCT02921256|584740549|FG001|Arm 1a v. Arm II|Physician Decision|1|||
161915738|NCT02921256|584740550|FG002|Arm 1a v. Arm II|Physician Decision|0|||
161915739|NCT02921256|584740548|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
161915740|NCT02921256|584740549|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
161915741|NCT02921256|584740550|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
161915742|NCT02921256|584740548|FG000|Arm Ib v Arm III|Adverse Event|9|||
161915743|NCT02921256|584740549|FG001|Arm Ib v Arm III|Adverse Event|0|||
161915744|NCT02921256|584740550|FG002|Arm Ib v Arm III|Adverse Event|4|||
162155539|NCT02723955|585619319|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
162155540|NCT02723955|585619277|FG000|Expansion Phase|Site Closed|0|||
162155541|NCT02723955|585619278|FG001|Expansion Phase|Site Closed|0|||
162155542|NCT02723955|585619279|FG002|Expansion Phase|Site Closed|0|||
162155543|NCT02723955|585619280|FG003|Expansion Phase|Site Closed|0|||
162155544|NCT02723955|585619281|FG004|Expansion Phase|Site Closed|0|||
162155545|NCT02723955|585619282|FG005|Expansion Phase|Site Closed|0|||
162155546|NCT02723955|585619283|FG006|Expansion Phase|Site Closed|0|||
162013821|NCT00734539|585104018|FG000|Main Study|Physician Decision|2|||
162013822|NCT00734539|585104019|FG001|Main Study|Physician Decision|0|||
162013823|NCT00734539|585104018|FG000|Main Study|Withdrawal by Subject|1|||
162013824|NCT00734539|585104019|FG001|Main Study|Withdrawal by Subject|3|||
162013825|NCT00734539|585104018|FG000|Main Study|Enrolled in error; ineligible|1|||
162013826|NCT00734539|585104019|FG001|Main Study|Enrolled in error; ineligible|0|||
162013827|NCT00830440|585104020|FG000|Overall Study|Protocol Violation|1|||
162013828|NCT00830440|585104021|FG001|Overall Study|Protocol Violation|0|||
162013829|NCT00830440|585104020|FG000|Overall Study|Withdrawal by Subject|1|||
162013830|NCT00830440|585104021|FG001|Overall Study|Withdrawal by Subject|0|||
162013831|NCT00830440|585104020|FG000|Overall Study|unsuccessful procedure|4|||
162013832|NCT00830440|585104021|FG001|Overall Study|unsuccessful procedure|0|||
162013833|NCT00830440|585104020|FG000|Overall Study|Adverse Event|2|||
162013834|NCT00830440|585104021|FG001|Overall Study|Adverse Event|0|||
162013835|NCT01656408|585104022|FG000|Overall Study|Adverse Event|0|||
162013836|NCT01656408|585104023|FG001|Overall Study|Adverse Event|0|||
162013837|NCT01656408|585104024|FG002|Overall Study|Adverse Event|1|||
162013838|NCT01656408|585104025|FG003|Overall Study|Adverse Event|0|||
162013839|NCT01656408|585104026|FG004|Overall Study|Adverse Event|0|||
162013840|NCT01656408|585104027|FG005|Overall Study|Adverse Event|1|||
162013841|NCT01656408|585104028|FG006|Overall Study|Adverse Event|1|||
162013842|NCT01656408|585104029|FG007|Overall Study|Adverse Event|0|||
162013843|NCT01656408|585104030|FG008|Overall Study|Adverse Event|1|||
162013844|NCT01656408|585104031|FG009|Overall Study|Adverse Event|0|||
162013845|NCT01656408|585104022|FG000|Overall Study|Physician Decision|1|||
162013846|NCT01656408|585104023|FG001|Overall Study|Physician Decision|0|||
162013847|NCT01656408|585104024|FG002|Overall Study|Physician Decision|1|||
162013848|NCT01656408|585104025|FG003|Overall Study|Physician Decision|0|||
162013849|NCT01656408|585104026|FG004|Overall Study|Physician Decision|1|||
162013850|NCT01656408|585104027|FG005|Overall Study|Physician Decision|1|||
162013851|NCT01656408|585104028|FG006|Overall Study|Physician Decision|0|||
162013852|NCT01656408|585104029|FG007|Overall Study|Physician Decision|1|||
162013853|NCT01656408|585104030|FG008|Overall Study|Physician Decision|1|||
162013854|NCT01656408|585104031|FG009|Overall Study|Physician Decision|3|||
162013855|NCT01721044|585104032|FG000|Treatment Period|Adverse Event|7|||
162013856|NCT01721044|585104033|FG001|Treatment Period|Adverse Event|7|||
162013857|NCT01721044|585104034|FG002|Treatment Period|Adverse Event|10|||
162013858|NCT01721044|585104032|FG000|Treatment Period|Death|0|||
162013859|NCT01721044|585104033|FG001|Treatment Period|Death|0|||
162013860|NCT01721044|585104034|FG002|Treatment Period|Death|1|||
162013861|NCT01721044|585104032|FG000|Treatment Period|Lack of Efficacy|16|||
162013862|NCT01721044|585104033|FG001|Treatment Period|Lack of Efficacy|4|||
162013863|NCT01721044|585104034|FG002|Treatment Period|Lack of Efficacy|4|||
162013864|NCT01721044|585104032|FG000|Treatment Period|Lost to Follow-up|0|||
162013865|NCT01721044|585104033|FG001|Treatment Period|Lost to Follow-up|0|||
162013866|NCT01721044|585104034|FG002|Treatment Period|Lost to Follow-up|1|||
162155547|NCT02723955|585619284|FG007|Expansion Phase|Site Closed|0|||
162155548|NCT02723955|585619285|FG008|Expansion Phase|Site Closed|0|||
162155549|NCT02723955|585619286|FG009|Expansion Phase|Site Closed|1|||
162155550|NCT02723955|585619287|FG010|Expansion Phase|Site Closed|2|||
162155551|NCT02723955|585619288|FG011|Expansion Phase|Site Closed|6|||
162155552|NCT02723955|585619289|FG012|Expansion Phase|Site Closed|0|||
162155553|NCT02723955|585619290|FG013|Expansion Phase|Site Closed|0|||
162155554|NCT02723955|585619291|FG014|Expansion Phase|Site Closed|0|||
162155555|NCT02723955|585619292|FG015|Expansion Phase|Site Closed|0|||
162155556|NCT02723955|585619293|FG016|Expansion Phase|Site Closed|0|||
162155557|NCT02723955|585619294|FG017|Expansion Phase|Site Closed|0|||
162155558|NCT02723955|585619295|FG018|Expansion Phase|Site Closed|0|||
162155559|NCT02723955|585619296|FG019|Expansion Phase|Site Closed|0|||
162155560|NCT02723955|585619297|FG020|Expansion Phase|Site Closed|0|||
162155561|NCT02723955|585619298|FG021|Expansion Phase|Site Closed|0|||
162155562|NCT02723955|585619299|FG022|Expansion Phase|Site Closed|0|||
162155563|NCT02723955|585619300|FG023|Expansion Phase|Site Closed|0|||
162155564|NCT02723955|585619301|FG024|Expansion Phase|Site Closed|0|||
162155565|NCT02723955|585619302|FG025|Expansion Phase|Site Closed|0|||
162155566|NCT02723955|585619303|FG026|Expansion Phase|Site Closed|0|||
162155567|NCT02723955|585619304|FG027|Expansion Phase|Site Closed|0|||
162155568|NCT02723955|585619305|FG028|Expansion Phase|Site Closed|0|||
162013867|NCT01721044|585104032|FG000|Treatment Period|Physician Decision|1|||
162013868|NCT01721044|585104033|FG001|Treatment Period|Physician Decision|0|||
162013869|NCT01721044|585104034|FG002|Treatment Period|Physician Decision|2|||
162013870|NCT01721044|585104032|FG000|Treatment Period|Protocol Violation|1|||
162013871|NCT01721044|585104033|FG001|Treatment Period|Protocol Violation|0|||
162013872|NCT01721044|585104034|FG002|Treatment Period|Protocol Violation|0|||
162013873|NCT01721044|585104032|FG000|Treatment Period|Withdrawal by Subject|7|||
162013874|NCT01721044|585104033|FG001|Treatment Period|Withdrawal by Subject|6|||
162013875|NCT01721044|585104034|FG002|Treatment Period|Withdrawal by Subject|1|||
162013876|NCT04634253|585104035|FG000|Overall Study|Adverse Event|1|||
162155569|NCT02723955|585619306|FG029|Expansion Phase|Site Closed|0|||
162155570|NCT02723955|585619307|FG030|Expansion Phase|Site Closed|8|||
162155571|NCT02723955|585619308|FG031|Expansion Phase|Site Closed|4|||
162155572|NCT02723955|585619309|FG032|Expansion Phase|Site Closed|2|||
162155573|NCT02723955|585619310|FG033|Expansion Phase|Site Closed|2|||
162155574|NCT02723955|585619311|FG034|Expansion Phase|Site Closed|0|||
162155575|NCT02723955|585619312|FG035|Expansion Phase|Site Closed|0|||
162155576|NCT02723955|585619313|FG036|Expansion Phase|Site Closed|0|||
162155577|NCT02723955|585619314|FG037|Expansion Phase|Site Closed|0|||
162155578|NCT02723955|585619315|FG038|Expansion Phase|Site Closed|0|||
162155579|NCT02723955|585619316|FG039|Expansion Phase|Site Closed|0|||
162155580|NCT02723955|585619317|FG040|Expansion Phase|Site Closed|0|||
162155581|NCT02723955|585619318|FG041|Expansion Phase|Site Closed|0|||
162155582|NCT02723955|585619319|FG042|Expansion Phase|Site Closed|0|||
162155583|NCT02723955|585619277|FG000|Crossover/ Re-treatment Phase|Death|0|||
162155584|NCT02723955|585619278|FG001|Crossover/ Re-treatment Phase|Death|0|||
162155585|NCT02723955|585619279|FG002|Crossover/ Re-treatment Phase|Death|0|||
162155586|NCT02723955|585619280|FG003|Crossover/ Re-treatment Phase|Death|0|||
162155587|NCT02723955|585619281|FG004|Crossover/ Re-treatment Phase|Death|0|||
162155588|NCT02723955|585619282|FG005|Crossover/ Re-treatment Phase|Death|0|||
162155589|NCT02723955|585619283|FG006|Crossover/ Re-treatment Phase|Death|0|||
162155590|NCT02723955|585619284|FG007|Crossover/ Re-treatment Phase|Death|0|||
162155591|NCT02723955|585619285|FG008|Crossover/ Re-treatment Phase|Death|0|||
162013877|NCT04634253|585104036|FG001|Overall Study|Adverse Event|1|||
162013878|NCT04634253|585104037|FG002|Overall Study|Adverse Event|0|||
162013879|NCT04634253|585104035|FG000|Overall Study|Physician Decision|0|||
162013880|NCT04634253|585104036|FG001|Overall Study|Physician Decision|1|||
162013881|NCT04634253|585104037|FG002|Overall Study|Physician Decision|0|||
162013882|NCT04634253|585104035|FG000|Overall Study|Withdrawal by Subject|1|||
162013883|NCT04634253|585104036|FG001|Overall Study|Withdrawal by Subject|0|||
162013884|NCT04634253|585104037|FG002|Overall Study|Withdrawal by Subject|3|||
162013885|NCT02420821|585104048|FG000|Overall Study|Lost to Follow-up|6|||
162013886|NCT02420821|585104049|FG001|Overall Study|Lost to Follow-up|6|||
162013887|NCT02420821|585104048|FG000|Overall Study|Non-compliance|0|||
162013888|NCT02420821|585104049|FG001|Overall Study|Non-compliance|2|||
162013889|NCT02420821|585104048|FG000|Overall Study|Physician Decision|6|||
162013890|NCT02420821|585104049|FG001|Overall Study|Physician Decision|2|||
162013891|NCT02420821|585104048|FG000|Overall Study|Withdrawal by Subject|32|||
162013892|NCT02420821|585104049|FG001|Overall Study|Withdrawal by Subject|25|||
162013893|NCT02420821|585104048|FG000|Overall Study|Death|270|||
162013894|NCT02420821|585104049|FG001|Overall Study|Death|263|||
162013895|NCT02420821|585104048|FG000|Overall Study|Study Terminated By Sponsor|145|||
162013896|NCT02420821|585104049|FG001|Overall Study|Study Terminated By Sponsor|149|||
162013897|NCT02420821|585104048|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
162013898|NCT02420821|585104049|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
161811833|NCT02089685|584353137|FG003|Overall Study|Withdrawal by Subject|8|||
161811834|NCT02089685|584353138|FG004|Overall Study|Withdrawal by Subject|1|||
162013899|NCT02420821|585104048|FG000|Overall Study|Adverse Event|0|||
162013900|NCT02420821|585104049|FG001|Overall Study|Adverse Event|1|||
162013901|NCT02420821|585104048|FG000|Overall Study|Protinuria|0|||
162013902|NCT02420821|585104049|FG001|Overall Study|Protinuria|1|||
162013903|NCT02420821|585104048|FG000|Overall Study|Progressive Disease|1|||
162013904|NCT02420821|585104049|FG001|Overall Study|Progressive Disease|1|||
162013905|NCT02420821|585104048|FG000|Overall Study|Disease Progression|0|||
162013906|NCT02420821|585104049|FG001|Overall Study|Disease Progression|1|||
162013907|NCT02420821|585104048|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
162013908|NCT02420821|585104049|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
162155592|NCT02723955|585619286|FG009|Crossover/ Re-treatment Phase|Death|0|||
162155593|NCT02723955|585619287|FG010|Crossover/ Re-treatment Phase|Death|0|||
162155594|NCT02723955|585619288|FG011|Crossover/ Re-treatment Phase|Death|0|||
162155595|NCT02723955|585619289|FG012|Crossover/ Re-treatment Phase|Death|0|||
161811835|NCT02089685|584353139|FG005|Overall Study|Withdrawal by Subject|1|||
161811836|NCT02089685|584353134|FG000|Overall Study|Status not recorded|1|||
161811837|NCT02089685|584353135|FG001|Overall Study|Status not recorded|0|||
161811838|NCT02089685|584353136|FG002|Overall Study|Status not recorded|0|||
161811839|NCT02089685|584353137|FG003|Overall Study|Status not recorded|0|||
161811840|NCT02089685|584353138|FG004|Overall Study|Status not recorded|1|||
161811841|NCT02089685|584353139|FG005|Overall Study|Status not recorded|0|||
161811842|NCT02089685|584353134|FG000|Overall Study|Death|0|||
161811843|NCT02089685|584353135|FG001|Overall Study|Death|0|||
162013909|NCT01457703|585104051|FG000|Overall Study|Screen Failure|5|||
162013910|NCT01457703|585104052|FG001|Overall Study|Screen Failure|7|||
162013911|NCT01457703|585104051|FG000|Overall Study|Withdrawal by Subject|1|||
162013912|NCT01457703|585104052|FG001|Overall Study|Withdrawal by Subject|4|||
162013913|NCT01658436|585104053|FG000|Overall Study|Adverse Event|6|||
162013914|NCT01658436|585104054|FG001|Overall Study|Adverse Event|5|||
162013915|NCT01658436|585104053|FG000|Overall Study|Physician Decision|1|||
162013916|NCT01658436|585104054|FG001|Overall Study|Physician Decision|0|||
161811844|NCT02089685|584353136|FG002|Overall Study|Death|0|||
161811845|NCT02089685|584353137|FG003|Overall Study|Death|7|||
161915745|NCT02921256|584740548|FG000|Arm Ib v Arm III|Death|1|||
161915746|NCT02921256|584740549|FG001|Arm Ib v Arm III|Death|0|||
161915747|NCT02921256|584740550|FG002|Arm Ib v Arm III|Death|1|||
161915748|NCT02921256|584740548|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
161915749|NCT02921256|584740549|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
161915750|NCT02921256|584740550|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
161915751|NCT02921256|584740548|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
161915752|NCT02921256|584740549|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
161915753|NCT02921256|584740550|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
161915754|NCT02921256|584740548|FG000|Arm Ib v Arm III|Physician Decision|4|||
161915755|NCT02921256|584740549|FG001|Arm Ib v Arm III|Physician Decision|0|||
161915756|NCT02921256|584740550|FG002|Arm Ib v Arm III|Physician Decision|1|||
161915757|NCT02921256|584740548|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
161915758|NCT02921256|584740549|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
161915759|NCT02921256|584740550|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
161915760|NCT03507790|584740551|FG000|Overall Study|Adverse Event|0|||
161915761|NCT03507790|584740552|FG001|Overall Study|Adverse Event|11|||
162155596|NCT02723955|585619290|FG013|Crossover/ Re-treatment Phase|Death|0|||
162155597|NCT02723955|585619291|FG014|Crossover/ Re-treatment Phase|Death|0|||
162155598|NCT02723955|585619292|FG015|Crossover/ Re-treatment Phase|Death|0|||
162155599|NCT02723955|585619293|FG016|Crossover/ Re-treatment Phase|Death|0|||
162155600|NCT02723955|585619294|FG017|Crossover/ Re-treatment Phase|Death|0|||
162155601|NCT02723955|585619295|FG018|Crossover/ Re-treatment Phase|Death|0|||
162155602|NCT02723955|585619296|FG019|Crossover/ Re-treatment Phase|Death|0|||
162155603|NCT02723955|585619297|FG020|Crossover/ Re-treatment Phase|Death|0|||
162155604|NCT02723955|585619298|FG021|Crossover/ Re-treatment Phase|Death|0|||
162155605|NCT02723955|585619299|FG022|Crossover/ Re-treatment Phase|Death|0|||
162155606|NCT02723955|585619300|FG023|Crossover/ Re-treatment Phase|Death|0|||
162155607|NCT02723955|585619301|FG024|Crossover/ Re-treatment Phase|Death|0|||
162155608|NCT02723955|585619302|FG025|Crossover/ Re-treatment Phase|Death|0|||
162155609|NCT02723955|585619303|FG026|Crossover/ Re-treatment Phase|Death|0|||
162155610|NCT02723955|585619304|FG027|Crossover/ Re-treatment Phase|Death|0|||
162155611|NCT02723955|585619305|FG028|Crossover/ Re-treatment Phase|Death|0|||
162155612|NCT02723955|585619306|FG029|Crossover/ Re-treatment Phase|Death|0|||
162155613|NCT02723955|585619307|FG030|Crossover/ Re-treatment Phase|Death|0|||
162155614|NCT02723955|585619308|FG031|Crossover/ Re-treatment Phase|Death|0|||
162155615|NCT02723955|585619309|FG032|Crossover/ Re-treatment Phase|Death|0|||
162155616|NCT02723955|585619310|FG033|Crossover/ Re-treatment Phase|Death|0|||
162155617|NCT02723955|585619311|FG034|Crossover/ Re-treatment Phase|Death|0|||
162155618|NCT02723955|585619312|FG035|Crossover/ Re-treatment Phase|Death|0|||
162155619|NCT02723955|585619313|FG036|Crossover/ Re-treatment Phase|Death|0|||
162155620|NCT02723955|585619314|FG037|Crossover/ Re-treatment Phase|Death|1|||
162155621|NCT02723955|585619315|FG038|Crossover/ Re-treatment Phase|Death|14|||
162155622|NCT02723955|585619316|FG039|Crossover/ Re-treatment Phase|Death|32|||
162155623|NCT02723955|585619317|FG040|Crossover/ Re-treatment Phase|Death|2|||
162155624|NCT02723955|585619318|FG041|Crossover/ Re-treatment Phase|Death|1|||
162155625|NCT02723955|585619319|FG042|Crossover/ Re-treatment Phase|Death|0|||
162155626|NCT02723955|585619277|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155627|NCT02723955|585619278|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155628|NCT02723955|585619279|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155629|NCT02723955|585619280|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155630|NCT02723955|585619281|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155631|NCT02723955|585619282|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155632|NCT02723955|585619283|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155633|NCT02723955|585619284|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155634|NCT02723955|585619285|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155635|NCT02723955|585619286|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155636|NCT02723955|585619287|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155637|NCT02723955|585619288|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155638|NCT02723955|585619289|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155639|NCT02723955|585619290|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155640|NCT02723955|585619291|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155641|NCT02723955|585619292|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155642|NCT02723955|585619293|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155643|NCT02723955|585619294|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155644|NCT02723955|585619295|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155645|NCT02723955|585619296|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155646|NCT02723955|585619297|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155647|NCT02723955|585619298|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155648|NCT02723955|585619299|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161915762|NCT03507790|584740553|FG002|Overall Study|Adverse Event|3|||
161915763|NCT03507790|584740551|FG000|Overall Study|Withdrawal by Subject|2|||
161915764|NCT03507790|584740552|FG001|Overall Study|Withdrawal by Subject|0|||
161915765|NCT03507790|584740553|FG002|Overall Study|Withdrawal by Subject|0|||
162155649|NCT02723955|585619300|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155650|NCT02723955|585619301|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155651|NCT02723955|585619302|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155652|NCT02723955|585619303|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155653|NCT02723955|585619304|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155654|NCT02723955|585619305|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155655|NCT02723955|585619306|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155656|NCT02723955|585619307|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155657|NCT02723955|585619308|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155658|NCT02723955|585619309|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155659|NCT02723955|585619310|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155660|NCT02723955|585619311|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155661|NCT02723955|585619312|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155662|NCT02723955|585619313|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155663|NCT02723955|585619314|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155664|NCT02723955|585619315|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155665|NCT02723955|585619316|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
162155666|NCT02723955|585619317|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155667|NCT02723955|585619318|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155668|NCT02723955|585619319|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
162155669|NCT02723955|585619277|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155670|NCT02723955|585619278|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155671|NCT02723955|585619279|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155672|NCT02723955|585619280|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155673|NCT02723955|585619281|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155674|NCT02723955|585619282|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155675|NCT02723955|585619283|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155676|NCT02723955|585619284|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155677|NCT02723955|585619285|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155678|NCT02723955|585619286|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155679|NCT02723955|585619287|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155680|NCT02723955|585619288|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155681|NCT02723955|585619289|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155682|NCT02723955|585619290|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155683|NCT02723955|585619291|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155684|NCT02723955|585619292|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155685|NCT02723955|585619293|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155686|NCT02723955|585619294|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155687|NCT02723955|585619295|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155688|NCT02723955|585619296|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155689|NCT02723955|585619297|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155690|NCT02723955|585619298|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155691|NCT02723955|585619299|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155692|NCT02723955|585619300|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155693|NCT02723955|585619301|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155694|NCT02723955|585619302|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155695|NCT02723955|585619303|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155696|NCT02723955|585619304|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155697|NCT02723955|585619305|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155698|NCT02723955|585619306|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155699|NCT02723955|585619307|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155700|NCT02723955|585619308|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
161811846|NCT02089685|584353138|FG004|Overall Study|Death|2|||
161811847|NCT02089685|584353139|FG005|Overall Study|Death|5|||
162155701|NCT02723955|585619309|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155702|NCT02723955|585619310|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155703|NCT02723955|585619311|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155704|NCT02723955|585619312|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155705|NCT02723955|585619313|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155706|NCT02723955|585619314|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155707|NCT02723955|585619315|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
162155708|NCT02723955|585619316|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
162155709|NCT02723955|585619317|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155710|NCT02723955|585619318|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
162155711|NCT02723955|585619319|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
162155712|NCT02723955|585619277|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
162155713|NCT02723955|585619278|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
162155714|NCT02723955|585619279|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
162155715|NCT02723955|585619280|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
162155716|NCT02723955|585619281|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
162013917|NCT01658436|585104053|FG000|Overall Study|Progressive disease|12|||
162013918|NCT01658436|585104054|FG001|Overall Study|Progressive disease|4|||
161811848|NCT02089685|584353134|FG000|Overall Study|Lost to Follow-up|0|||
161811849|NCT02089685|584353135|FG001|Overall Study|Lost to Follow-up|0|||
161811850|NCT02089685|584353136|FG002|Overall Study|Lost to Follow-up|0|||
161811851|NCT02089685|584353137|FG003|Overall Study|Lost to Follow-up|1|||
161811852|NCT02089685|584353138|FG004|Overall Study|Lost to Follow-up|0|||
161811853|NCT02089685|584353139|FG005|Overall Study|Lost to Follow-up|0|||
161811854|NCT02089685|584353134|FG000|Overall Study|Physician Decision|0|||
161811855|NCT02089685|584353135|FG001|Overall Study|Physician Decision|0|||
161811856|NCT02089685|584353136|FG002|Overall Study|Physician Decision|0|||
161811857|NCT02089685|584353137|FG003|Overall Study|Physician Decision|0|||
161811858|NCT02089685|584353138|FG004|Overall Study|Physician Decision|0|||
161811859|NCT02089685|584353139|FG005|Overall Study|Physician Decision|4|||
161811860|NCT02089685|584353134|FG000|Overall Study|Screen failure|1|||
161811861|NCT02089685|584353135|FG001|Overall Study|Screen failure|0|||
161811862|NCT02089685|584353136|FG002|Overall Study|Screen failure|0|||
161811863|NCT02089685|584353137|FG003|Overall Study|Screen failure|0|||
161811864|NCT02089685|584353138|FG004|Overall Study|Screen failure|0|||
161811865|NCT02089685|584353139|FG005|Overall Study|Screen failure|0|||
161811866|NCT04887415|584353140|FG000|Overall Study|Lost to Follow-up|2|||
161811867|NCT00840411|584353141|FG000|First Intervention|Adverse Event|1|||
161811868|NCT00840411|584353142|FG001|First Intervention|Adverse Event|0|||
161811869|NCT00840411|584353141|FG000|Washout|Withdrawal by Subject|1|||
161811870|NCT00840411|584353142|FG001|Washout|Withdrawal by Subject|0|||
161811871|NCT00657553|584353144|FG000|Overall Study|low accrual, no analysis run|5|||
161811872|NCT00657553|584353145|FG001|Overall Study|low accrual, no analysis run|5|||
161811873|NCT01566721|584353146|FG000|Treatment Period|Withdrawal by Subject|35|||
161811874|NCT01566721|584353147|FG001|Treatment Period|Withdrawal by Subject|9|||
161811875|NCT01566721|584353146|FG000|Treatment Period|Disease Progression/Recurrence|37|||
161811876|NCT01566721|584353147|FG001|Treatment Period|Disease Progression/Recurrence|13|||
161811877|NCT01566721|584353146|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
161811878|NCT01566721|584353147|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
161811879|NCT01566721|584353146|FG000|Treatment Period|Other|13|||
161811880|NCT01566721|584353147|FG001|Treatment Period|Other|2|||
161811881|NCT01566721|584353146|FG000|Treatment Period|Lack of Compliance|5|||
161811882|NCT01566721|584353147|FG001|Treatment Period|Lack of Compliance|1|||
161811883|NCT01566721|584353146|FG000|Treatment Period|Adverse Event|100|||
161811884|NCT01566721|584353147|FG001|Treatment Period|Adverse Event|30|||
161811885|NCT01566721|584353146|FG000|Treatment Period|Pregnancy|1|||
161811886|NCT01566721|584353147|FG001|Treatment Period|Pregnancy|0|||
161811887|NCT01566721|584353146|FG000|Safety Follow-up|Physician Decision|6|||
161811888|NCT01566721|584353147|FG001|Safety Follow-up|Physician Decision|4|||
161811889|NCT01566721|584353146|FG000|Safety Follow-up|Lost to Follow-up|101|||
161811890|NCT01566721|584353147|FG001|Safety Follow-up|Lost to Follow-up|48|||
161811891|NCT01566721|584353146|FG000|Safety Follow-up|Withdrawal by Subject|155|||
161811892|NCT01566721|584353147|FG001|Safety Follow-up|Withdrawal by Subject|49|||
161811893|NCT01566721|584353146|FG000|Safety Follow-up|Death|28|||
161811894|NCT01566721|584353147|FG001|Safety Follow-up|Death|4|||
161811895|NCT01566721|584353146|FG000|Safety Follow-up|Non-compliance|7|||
161811896|NCT01566721|584353147|FG001|Safety Follow-up|Non-compliance|3|||
161811897|NCT01566721|584353146|FG000|Safety Follow-up|Protocol Violation|7|||
161811898|NCT01566721|584353147|FG001|Safety Follow-up|Protocol Violation|0|||
161811899|NCT01566721|584353146|FG000|Safety Follow-up|Site closure|2|||
161811900|NCT01566721|584353147|FG001|Safety Follow-up|Site closure|3|||
161811901|NCT01566721|584353146|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
161811902|NCT01566721|584353147|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
161811903|NCT01566721|584353146|FG000|Safety Follow-up|Missing|7|||
161811904|NCT01566721|584353147|FG001|Safety Follow-up|Missing|2|||
161811905|NCT01566721|584353146|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
161811906|NCT01566721|584353147|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
161811907|NCT01566721|584353146|FG000|Safety Follow-up|Sponsor decision|1|||
161811908|NCT01566721|584353147|FG001|Safety Follow-up|Sponsor decision|0|||
161811909|NCT01566721|584353146|FG000|Safety Follow-up|Adverse Event|8|||
161811910|NCT01566721|584353147|FG001|Safety Follow-up|Adverse Event|4|||
161811911|NCT00811655|584353152|FG000|Overall Study|Physician Decision|1|||
161811912|NCT00119015|584353154|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
161811913|NCT00119015|584353155|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
161811914|NCT00119015|584353156|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
162013919|NCT01658436|585104053|FG000|Overall Study|Study terminated by sponsor|0|||
161811915|NCT00787254|584353159|FG000|Overall Study|Adverse Event|24|||
161811916|NCT00787254|584353160|FG001|Overall Study|Adverse Event|23|||
161811917|NCT00787254|584353159|FG000|Overall Study|Protocol Violation|26|||
161811918|NCT00787254|584353160|FG001|Overall Study|Protocol Violation|23|||
161811919|NCT00787254|584353159|FG000|Overall Study|Withdrawal by Subject|16|||
161811920|NCT00787254|584353160|FG001|Overall Study|Withdrawal by Subject|11|||
161811921|NCT00787254|584353159|FG000|Overall Study|Lack of Efficacy|4|||
161811922|NCT00787254|584353160|FG001|Overall Study|Lack of Efficacy|15|||
162155717|NCT02723955|585619282|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
162155718|NCT02723955|585619283|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
162155719|NCT02723955|585619284|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
162155720|NCT02723955|585619285|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
162155721|NCT02723955|585619286|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
162155722|NCT02723955|585619287|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
162155723|NCT02723955|585619288|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
162155724|NCT02723955|585619289|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
162155725|NCT02723955|585619290|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
162155726|NCT02723955|585619291|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
162155727|NCT02723955|585619292|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
162155728|NCT02723955|585619293|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
162155729|NCT02723955|585619294|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
162155730|NCT02723955|585619295|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
162155731|NCT02723955|585619296|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
162155732|NCT02723955|585619297|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
162155733|NCT02723955|585619298|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
162155734|NCT02723955|585619299|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
162155735|NCT02723955|585619300|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
162155736|NCT02723955|585619301|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
162155737|NCT02723955|585619302|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
162155738|NCT02723955|585619303|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
162155739|NCT02723955|585619304|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
162155740|NCT02723955|585619305|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
162155741|NCT02723955|585619306|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
162155742|NCT02723955|585619307|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
162155743|NCT02723955|585619308|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
162155744|NCT02723955|585619309|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
162155745|NCT02723955|585619310|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
162155746|NCT02723955|585619311|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
162155747|NCT02723955|585619312|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
162155748|NCT02723955|585619313|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
162155749|NCT02723955|585619314|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
162155750|NCT02723955|585619315|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
162155751|NCT02723955|585619316|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
162155752|NCT02723955|585619317|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
161915766|NCT03507790|584740551|FG000|Overall Study|Subject moved to another location|1|||
161915767|NCT03507790|584740552|FG001|Overall Study|Subject moved to another location|2|||
161915768|NCT03507790|584740553|FG002|Overall Study|Subject moved to another location|0|||
161915769|NCT03507790|584740551|FG000|Overall Study|Non-compliance with study drug|0|||
162155753|NCT02723955|585619318|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
162155754|NCT02723955|585619319|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
162155755|NCT03088813|585619322|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
162155756|NCT03088813|585619323|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
162155757|NCT03088813|585619324|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
162155758|NCT03088813|585619325|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
162155759|NCT03088813|585619322|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
162155760|NCT03088813|585619323|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
162155761|NCT03088813|585619324|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
162155762|NCT03088813|585619325|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
162155763|NCT03088813|585619322|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
162155764|NCT03088813|585619323|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
162155765|NCT03088813|585619324|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
162155766|NCT03088813|585619325|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
162155767|NCT03088813|585619322|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
162155768|NCT03088813|585619323|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
162155769|NCT03088813|585619324|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
162155770|NCT03088813|585619325|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
162155771|NCT03088813|585619322|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
162155772|NCT03088813|585619323|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
162155773|NCT03088813|585619324|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
162155774|NCT03088813|585619325|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
162155775|NCT03088813|585619322|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
162155776|NCT03088813|585619323|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
162155777|NCT03088813|585619324|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
162155778|NCT03088813|585619325|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
162155779|NCT03088813|585619322|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
162155780|NCT03088813|585619323|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
162155781|NCT03088813|585619324|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
162155782|NCT03088813|585619325|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
162155783|NCT04878354|585619326|FG000|Overall Study|Adverse Event|4|||
162155784|NCT04878354|585619327|FG001|Overall Study|Adverse Event|13|||
162155785|NCT04878354|585619326|FG000|Overall Study|Withdrawal by Subject|14|||
162155786|NCT04878354|585619327|FG001|Overall Study|Withdrawal by Subject|12|||
162155787|NCT04878354|585619326|FG000|Overall Study|Lost to Follow-up|4|||
162155788|NCT04878354|585619327|FG001|Overall Study|Lost to Follow-up|1|||
162155789|NCT04878354|585619326|FG000|Overall Study|Lack of Efficacy|1|||
162155790|NCT04878354|585619327|FG001|Overall Study|Lack of Efficacy|0|||
162155791|NCT04878354|585619326|FG000|Overall Study|Protocol Violation|0|||
162155792|NCT04878354|585619327|FG001|Overall Study|Protocol Violation|1|||
162155793|NCT04878354|585619326|FG000|Overall Study|"Reason stated as other in CRF"|2|||
162155794|NCT04878354|585619327|FG001|Overall Study|"Reason stated as other in CRF"|3|||
162155795|NCT01903811|585619335|FG000|Overall Study|No measurable disease|1|||
162155796|NCT01903811|585619336|FG001|Overall Study|No measurable disease|1|||
162155797|NCT01903811|585619335|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
162155798|NCT01903811|585619336|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
162155799|NCT01903811|585619335|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
162155800|NCT01903811|585619336|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
162155801|NCT01903811|585619335|FG000|Overall Study|Withdrawal by Subject|0|||
162155802|NCT01903811|585619336|FG001|Overall Study|Withdrawal by Subject|1|||
162155803|NCT02118961|585619337|FG000|Overall Study|Withdrawal by Subject|1|||
162155804|NCT02118961|585619338|FG001|Overall Study|Withdrawal by Subject|0|||
162155805|NCT02992925|585619341|FG000|Cohort 2|Physician Decision|0|||
162155806|NCT02992925|585619342|FG001|Cohort 2|Physician Decision|0|||
162155807|NCT02992925|585619343|FG002|Cohort 2|Physician Decision|1|||
162155808|NCT02992925|585619344|FG003|Cohort 2|Physician Decision|0|||
162155809|NCT02992925|585619341|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
162155810|NCT02992925|585619342|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
162155811|NCT02992925|585619343|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
162155812|NCT02992925|585619344|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
162155813|NCT05678998|585619345|FG000|Overall Study|Withdrawal by Subject|1|||
162155814|NCT05678998|585619346|FG001|Overall Study|Withdrawal by Subject|1|||
162155815|NCT05678998|585619347|FG002|Overall Study|Withdrawal by Subject|3|||
162155816|NCT05678998|585619348|FG003|Overall Study|Withdrawal by Subject|0|||
162155817|NCT05678998|585619349|FG004|Overall Study|Withdrawal by Subject|1|||
162155818|NCT05678998|585619345|FG000|Overall Study|Lost to Follow-up|0|||
162155819|NCT05678998|585619346|FG001|Overall Study|Lost to Follow-up|0|||
162155820|NCT05678998|585619347|FG002|Overall Study|Lost to Follow-up|0|||
162155821|NCT05678998|585619348|FG003|Overall Study|Lost to Follow-up|0|||
162155822|NCT05678998|585619349|FG004|Overall Study|Lost to Follow-up|1|||
162155823|NCT05678998|585619345|FG000|Overall Study|Death|0|||
162155824|NCT05678998|585619346|FG001|Overall Study|Death|0|||
162155825|NCT05678998|585619347|FG002|Overall Study|Death|0|||
162155826|NCT05678998|585619348|FG003|Overall Study|Death|3|||
162155827|NCT05678998|585619349|FG004|Overall Study|Death|4|||
162155828|NCT05678998|585619345|FG000|Overall Study|Other|0|||
162155829|NCT05678998|585619346|FG001|Overall Study|Other|0|||
162155830|NCT05678998|585619347|FG002|Overall Study|Other|0|||
162155831|NCT05678998|585619348|FG003|Overall Study|Other|2|||
162155832|NCT05678998|585619349|FG004|Overall Study|Other|1|||
162155833|NCT05773313|585619350|FG000|Overall Study|Lost to Follow-up|3|||
162155834|NCT05137236|585619351|FG000|Part A|Other than Specified|1|||
162155835|NCT05137236|585619352|FG001|Part A|Other than Specified|0|||
162155836|NCT05137236|585619353|FG002|Part A|Other than Specified|0|||
162155837|NCT05137236|585619354|FG003|Part A|Other than Specified|0|||
162155838|NCT05137236|585619355|FG004|Part A|Other than Specified|0|||
162155839|NCT05137236|585619356|FG005|Part A|Other than Specified|0|||
162155840|NCT05137236|585619357|FG006|Part A|Other than Specified|0|||
162155841|NCT05137236|585619358|FG007|Part A|Other than Specified|0|||
162155842|NCT05137236|585619351|FG000|Part A|Withdrawal by Subject|0|||
162155843|NCT05137236|585619352|FG001|Part A|Withdrawal by Subject|4|||
162155844|NCT05137236|585619353|FG002|Part A|Withdrawal by Subject|1|||
162155845|NCT05137236|585619354|FG003|Part A|Withdrawal by Subject|1|||
162155846|NCT05137236|585619355|FG004|Part A|Withdrawal by Subject|3|||
162155847|NCT05137236|585619356|FG005|Part A|Withdrawal by Subject|2|||
162155848|NCT05137236|585619357|FG006|Part A|Withdrawal by Subject|0|||
162155849|NCT05137236|585619358|FG007|Part A|Withdrawal by Subject|0|||
162155850|NCT05137236|585619351|FG000|Part A|Lost to Follow-up|5|||
162155851|NCT05137236|585619352|FG001|Part A|Lost to Follow-up|7|||
162155852|NCT05137236|585619353|FG002|Part A|Lost to Follow-up|1|||
162155853|NCT05137236|585619354|FG003|Part A|Lost to Follow-up|3|||
162155854|NCT05137236|585619355|FG004|Part A|Lost to Follow-up|3|||
162155855|NCT05137236|585619356|FG005|Part A|Lost to Follow-up|8|||
162155856|NCT05137236|585619357|FG006|Part A|Lost to Follow-up|0|||
162155857|NCT05137236|585619358|FG007|Part A|Lost to Follow-up|0|||
162155858|NCT05137236|585619351|FG000|Part B|Withdrawal by Subject|0|||
162155859|NCT05137236|585619352|FG001|Part B|Withdrawal by Subject|0|||
162155860|NCT05137236|585619353|FG002|Part B|Withdrawal by Subject|0|||
162155861|NCT05137236|585619354|FG003|Part B|Withdrawal by Subject|0|||
162155862|NCT05137236|585619355|FG004|Part B|Withdrawal by Subject|0|||
162155863|NCT05137236|585619356|FG005|Part B|Withdrawal by Subject|0|||
162155864|NCT05137236|585619357|FG006|Part B|Withdrawal by Subject|0|||
162013920|NCT01658436|585104054|FG001|Overall Study|Study terminated by sponsor|1|||
162013921|NCT01658436|585104053|FG000|Overall Study|Subject/guardian decision|0|||
162155865|NCT05137236|585619358|FG007|Part B|Withdrawal by Subject|2|||
162155866|NCT05137236|585619351|FG000|Part B|Lost to Follow-up|0|||
162155867|NCT05137236|585619352|FG001|Part B|Lost to Follow-up|0|||
162155868|NCT05137236|585619353|FG002|Part B|Lost to Follow-up|0|||
162155869|NCT05137236|585619354|FG003|Part B|Lost to Follow-up|0|||
162155870|NCT05137236|585619355|FG004|Part B|Lost to Follow-up|0|||
162155871|NCT05137236|585619356|FG005|Part B|Lost to Follow-up|0|||
162155872|NCT05137236|585619357|FG006|Part B|Lost to Follow-up|5|||
162155873|NCT05137236|585619358|FG007|Part B|Lost to Follow-up|5|||
162155874|NCT05137236|585619351|FG000|Part B|Death|0|||
162155875|NCT05137236|585619352|FG001|Part B|Death|0|||
162155876|NCT05137236|585619353|FG002|Part B|Death|0|||
162155877|NCT05137236|585619354|FG003|Part B|Death|0|||
162155878|NCT05137236|585619355|FG004|Part B|Death|0|||
162155879|NCT05137236|585619356|FG005|Part B|Death|0|||
162155880|NCT05137236|585619357|FG006|Part B|Death|0|||
162155881|NCT05137236|585619358|FG007|Part B|Death|2|||
162155882|NCT01534494|585619359|FG000|Overall Study|Withdrawal by Subject|1|||
162155883|NCT00802464|585619360|FG000|Month 0 - Month 8|Adverse Event|0|||
162155884|NCT00802464|585619361|FG001|Month 0 - Month 8|Adverse Event|1|||
162155885|NCT00802464|585619362|FG002|Month 0 - Month 8|Adverse Event|1|||
162155886|NCT00802464|585619363|FG003|Month 0 - Month 8|Adverse Event|2|||
162155887|NCT00802464|585619360|FG000|Month 0 - Month 8|Protocol Violation|0|||
162155888|NCT00802464|585619361|FG001|Month 0 - Month 8|Protocol Violation|0|||
162155889|NCT00802464|585619362|FG002|Month 0 - Month 8|Protocol Violation|1|||
162155890|NCT00802464|585619363|FG003|Month 0 - Month 8|Protocol Violation|0|||
162155891|NCT00802464|585619360|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
162155892|NCT00802464|585619361|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
162155893|NCT00802464|585619362|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
162155894|NCT00802464|585619363|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
162155895|NCT00802464|585619360|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
162155896|NCT00802464|585619361|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
162155897|NCT00802464|585619362|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
162155898|NCT00802464|585619363|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
162155899|NCT00802464|585619360|FG000|Month 0 - Month 8|Other|0|||
162155900|NCT00802464|585619361|FG001|Month 0 - Month 8|Other|0|||
162155901|NCT00802464|585619362|FG002|Month 0 - Month 8|Other|1|||
162155902|NCT00802464|585619363|FG003|Month 0 - Month 8|Other|0|||
162155903|NCT00802464|585619360|FG000|Month 8 - Month 14|Adverse Event|0|||
162155904|NCT00802464|585619361|FG001|Month 8 - Month 14|Adverse Event|1|||
162155905|NCT00802464|585619362|FG002|Month 8 - Month 14|Adverse Event|0|||
162155906|NCT00802464|585619363|FG003|Month 8 - Month 14|Adverse Event|0|||
162155907|NCT00802464|585619360|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
162155908|NCT00802464|585619361|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
162155909|NCT00802464|585619362|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
162155910|NCT00802464|585619363|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
162013922|NCT01658436|585104054|FG001|Overall Study|Subject/guardian decision|1|||
162013923|NCT01658436|585104053|FG000|Overall Study|Death|1|||
162013924|NCT01658436|585104054|FG001|Overall Study|Death|0|||
162013925|NCT01318915|585104057|FG000|Overall Study|Lost to Follow-up|1|||
162013926|NCT03987503|585104058|FG000|Overall Study|Lost to Follow-up|20|||
162155911|NCT00802464|585619360|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
162155912|NCT00802464|585619361|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
162155913|NCT00802464|585619362|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
162013927|NCT03987503|585104058|FG000|Overall Study|Withdrawal by Subject|2|||
162013928|NCT00926237|585104059|FG000|Overall Study|Withdrawal by Subject|2|||
162013929|NCT00926237|585104060|FG001|Overall Study|Withdrawal by Subject|1|||
162013930|NCT03067077|585104067|FG000|Overall Study|Did not receive surgery|4|||
162013931|NCT03067077|585104068|FG001|Overall Study|Did not receive surgery|5|||
162013932|NCT03067077|585104067|FG000|Overall Study|Lost to Follow-up|3|||
162013933|NCT03067077|585104068|FG001|Overall Study|Lost to Follow-up|2|||
162013934|NCT02202759|585105539|FG000|Overall Study|Study Terminated by Sponsor|3|||
162155914|NCT00802464|585619363|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
162155915|NCT00402246|585619364|FG000|Overall Study|Death|62|||
162155916|NCT00402246|585619365|FG001|Overall Study|Death|58|||
162155917|NCT00402246|585619364|FG000|Overall Study|Lost to Follow-up|20|||
162155918|NCT00402246|585619365|FG001|Overall Study|Lost to Follow-up|28|||
162013935|NCT02202759|585105540|FG001|Overall Study|Study Terminated by Sponsor|3|||
162013936|NCT02202759|585105541|FG002|Overall Study|Study Terminated by Sponsor|3|||
162013937|NCT02202759|585105539|FG000|Overall Study|Withdrawal by Subject|2|||
162155919|NCT00402246|585619364|FG000|Overall Study|Withdrawal by Subject|72|||
162155920|NCT00402246|585619365|FG001|Overall Study|Withdrawal by Subject|87|||
162155921|NCT00402246|585619364|FG000|Overall Study|Physician Decision|24|||
162013938|NCT02202759|585105540|FG001|Overall Study|Withdrawal by Subject|1|||
162155922|NCT00402246|585619365|FG001|Overall Study|Physician Decision|26|||
162155923|NCT00402246|585619364|FG000|Overall Study|Protocol Violation|25|||
161811923|NCT00787254|584353159|FG000|Overall Study|NSAIDs discontinuation|1|||
161811924|NCT00787254|584353160|FG001|Overall Study|NSAIDs discontinuation|2|||
161811925|NCT00787254|584353159|FG000|Overall Study|Institution closed|1|||
161811926|NCT00787254|584353160|FG001|Overall Study|Institution closed|0|||
161811927|NCT00787254|584353159|FG000|Overall Study|Physician Decision|4|||
161811928|NCT00787254|584353160|FG001|Overall Study|Physician Decision|8|||
161811929|NCT00316186|584353161|FG000|Overall Study|Adverse Event|6|||
161811930|NCT00316186|584353161|FG000|Overall Study|Disease Progression|4|||
161811931|NCT00316186|584353161|FG000|Overall Study|Lost to Follow-up|1|||
161811932|NCT00316186|584353161|FG000|Overall Study|Other|1|||
161811933|NCT01802320|584353164|FG000|Overall Study|Death|1|||
161811934|NCT01802320|584353164|FG000|Overall Study|Withdrawal by Subject|1|||
161811935|NCT05265624|584355009|FG000|Overall Study|Lost to Follow-up|3|||
161811936|NCT05265624|584355010|FG001|Overall Study|Lost to Follow-up|0|||
161811937|NCT05265624|584355009|FG000|Overall Study|Withdrawal by Subject|1|||
161811938|NCT05265624|584355010|FG001|Overall Study|Withdrawal by Subject|0|||
161811939|NCT00001703|584355011|FG000|Overall Study|progressed disease|2|||
161811940|NCT00001703|584355011|FG000|Overall Study|No evidence of disease|1|||
161811941|NCT00001703|584355011|FG000|Overall Study|recurrent disease|2|||
161811942|NCT00665925|584355012|FG000|Overall Study|Lack of Efficacy|10|||
161811943|NCT00665925|584355013|FG001|Overall Study|Lack of Efficacy|8|||
161811944|NCT00665925|584355014|FG002|Overall Study|Lack of Efficacy|9|||
161811945|NCT00665925|584355015|FG003|Overall Study|Lack of Efficacy|8|||
161811946|NCT00665925|584355012|FG000|Overall Study|Lost to Follow-up|1|||
161811947|NCT00665925|584355013|FG001|Overall Study|Lost to Follow-up|2|||
161811948|NCT00665925|584355014|FG002|Overall Study|Lost to Follow-up|2|||
161811949|NCT00665925|584355015|FG003|Overall Study|Lost to Follow-up|2|||
161811950|NCT00665925|584355012|FG000|Overall Study|Withdrawal by Subject|2|||
161811951|NCT00665925|584355013|FG001|Overall Study|Withdrawal by Subject|2|||
161811952|NCT00665925|584355014|FG002|Overall Study|Withdrawal by Subject|3|||
161811953|NCT00665925|584355015|FG003|Overall Study|Withdrawal by Subject|2|||
161811954|NCT00665925|584355012|FG000|Overall Study|Physician Decision|0|||
161811955|NCT00665925|584355013|FG001|Overall Study|Physician Decision|0|||
161811956|NCT00665925|584355014|FG002|Overall Study|Physician Decision|1|||
161811957|NCT00665925|584355015|FG003|Overall Study|Physician Decision|2|||
161811958|NCT00665925|584355012|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
161811959|NCT00665925|584355013|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
161811960|NCT00665925|584355014|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
161811961|NCT00665925|584355015|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
161811962|NCT00665925|584355012|FG000|Overall Study|Adverse Event|1|||
161811963|NCT00665925|584355013|FG001|Overall Study|Adverse Event|5|||
161811964|NCT00665925|584355014|FG002|Overall Study|Adverse Event|10|||
161811965|NCT00665925|584355015|FG003|Overall Study|Adverse Event|5|||
161811966|NCT00665925|584355012|FG000|Overall Study|Enrolled by mistake|0|||
161811967|NCT00665925|584355013|FG001|Overall Study|Enrolled by mistake|0|||
161811968|NCT00665925|584355014|FG002|Overall Study|Enrolled by mistake|0|||
161811969|NCT00665925|584355015|FG003|Overall Study|Enrolled by mistake|1|||
161811970|NCT00665925|584355012|FG000|Overall Study|Due to exclusion criteria|1|||
161811971|NCT00665925|584355013|FG001|Overall Study|Due to exclusion criteria|0|||
161811972|NCT00665925|584355014|FG002|Overall Study|Due to exclusion criteria|0|||
161811973|NCT00665925|584355015|FG003|Overall Study|Due to exclusion criteria|0|||
161811974|NCT04035187|584355018|FG000|Overall Study|Withdrawal by Subject|2|||
161811975|NCT04035187|584355019|FG001|Overall Study|Withdrawal by Subject|1|||
161811976|NCT04035187|584355020|FG002|Overall Study|Withdrawal by Subject|0|||
161811977|NCT04035187|584355021|FG003|Overall Study|Withdrawal by Subject|0|||
161811978|NCT04035187|584355018|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
161811979|NCT04035187|584355019|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
161811980|NCT04035187|584355020|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
161811981|NCT04035187|584355021|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
161915770|NCT03507790|584740552|FG001|Overall Study|Non-compliance with study drug|0|||
161915771|NCT03507790|584740553|FG002|Overall Study|Non-compliance with study drug|1|||
161915772|NCT03507790|584740551|FG000|Overall Study|COVID 19 Pandemic|0|||
162155924|NCT00402246|585619365|FG001|Overall Study|Protocol Violation|24|||
162155925|NCT00402246|585619364|FG000|Overall Study|Missed Final Visit|1|||
162155926|NCT00402246|585619365|FG001|Overall Study|Missed Final Visit|2|||
162155927|NCT00402246|585619364|FG000|Overall Study|Insurance Issues|2|||
162155928|NCT00402246|585619365|FG001|Overall Study|Insurance Issues|1|||
162155929|NCT00402246|585619364|FG000|Overall Study|Heart Transplant|0|||
162155930|NCT00402246|585619365|FG001|Overall Study|Heart Transplant|1|||
162155931|NCT00402246|585619364|FG000|Overall Study|Patient's device explanted|6|||
162155932|NCT00402246|585619365|FG001|Overall Study|Patient's device explanted|2|||
162155933|NCT00402246|585619364|FG000|Overall Study|Center Closure|5|||
162155934|NCT00402246|585619365|FG001|Overall Study|Center Closure|3|||
162155935|NCT00402246|585619364|FG000|Overall Study|Deterioriating Condition|3|||
162155936|NCT00402246|585619365|FG001|Overall Study|Deterioriating Condition|2|||
162155937|NCT02622568|585619375|FG000|Overall Study|Lost to Follow-up|5|||
162155938|NCT02622568|585619376|FG001|Overall Study|Lost to Follow-up|5|||
162155939|NCT01939899|585619377|FG000|Lead-in Dose Finding Phase|Death|0|||
162155940|NCT01939899|585619378|FG001|Lead-in Dose Finding Phase|Death|3|||
162155941|NCT01939899|585619379|FG002|Lead-in Dose Finding Phase|Death|1|||
162155942|NCT01939899|585619380|FG003|Lead-in Dose Finding Phase|Death|0|||
162155943|NCT01939899|585619381|FG004|Lead-in Dose Finding Phase|Death|0|||
162155944|NCT01939899|585619377|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
162155945|NCT01939899|585619378|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
162155946|NCT01939899|585619379|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
162155947|NCT01939899|585619380|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
162155948|NCT01939899|585619381|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
162155949|NCT01939899|585619377|FG000|Lead-in Dose Finding Phase|Other|0|||
162155950|NCT01939899|585619378|FG001|Lead-in Dose Finding Phase|Other|0|||
162155951|NCT01939899|585619379|FG002|Lead-in Dose Finding Phase|Other|1|||
162155952|NCT01939899|585619380|FG003|Lead-in Dose Finding Phase|Other|0|||
162155953|NCT01939899|585619381|FG004|Lead-in Dose Finding Phase|Other|0|||
162155954|NCT01939899|585619377|FG000|Phase 2|Withdrawal by Subject|0|||
162155955|NCT01939899|585619378|FG001|Phase 2|Withdrawal by Subject|0|||
162155956|NCT01939899|585619379|FG002|Phase 2|Withdrawal by Subject|0|||
162155957|NCT01939899|585619380|FG003|Phase 2|Withdrawal by Subject|2|||
162155958|NCT01939899|585619381|FG004|Phase 2|Withdrawal by Subject|0|||
162155959|NCT01939899|585619377|FG000|Phase 2|Disease Progression|0|||
162155960|NCT01939899|585619378|FG001|Phase 2|Disease Progression|0|||
162155961|NCT01939899|585619379|FG002|Phase 2|Disease Progression|0|||
162155962|NCT01939899|585619380|FG003|Phase 2|Disease Progression|9|||
162155963|NCT01939899|585619381|FG004|Phase 2|Disease Progression|1|||
162155964|NCT02015520|585619386|FG000|Overall Study|Lack of Efficacy|1|||
162155965|NCT02015520|585619387|FG001|Overall Study|Lack of Efficacy|0|||
162155966|NCT02015520|585619388|FG002|Overall Study|Lack of Efficacy|3|||
162155967|NCT02015520|585619389|FG003|Overall Study|Lack of Efficacy|2|||
162155968|NCT02015520|585619386|FG000|Overall Study|Adverse Event|0|||
162155969|NCT02015520|585619387|FG001|Overall Study|Adverse Event|0|||
162155970|NCT02015520|585619388|FG002|Overall Study|Adverse Event|0|||
162155971|NCT02015520|585619389|FG003|Overall Study|Adverse Event|1|||
162155972|NCT02015520|585619386|FG000|Overall Study|Withdrawal by Subject|2|||
162155973|NCT02015520|585619387|FG001|Overall Study|Withdrawal by Subject|2|||
162155974|NCT02015520|585619388|FG002|Overall Study|Withdrawal by Subject|1|||
162155975|NCT02015520|585619389|FG003|Overall Study|Withdrawal by Subject|0|||
162155976|NCT02015520|585619386|FG000|Overall Study|Death|1|||
162155977|NCT02015520|585619387|FG001|Overall Study|Death|0|||
162155978|NCT02015520|585619388|FG002|Overall Study|Death|0|||
162155979|NCT02015520|585619389|FG003|Overall Study|Death|0|||
162155980|NCT02015520|585619386|FG000|Overall Study|Lost to Follow-up|0|||
162155981|NCT02015520|585619387|FG001|Overall Study|Lost to Follow-up|0|||
162155982|NCT02015520|585619388|FG002|Overall Study|Lost to Follow-up|1|||
162155983|NCT02015520|585619389|FG003|Overall Study|Lost to Follow-up|0|||
162155984|NCT02015520|585619386|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
162155985|NCT02015520|585619387|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
162155986|NCT02015520|585619388|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
162155987|NCT02015520|585619389|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
162155988|NCT02015520|585619386|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
162155989|NCT02015520|585619387|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
162155990|NCT02015520|585619388|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
162155991|NCT02015520|585619389|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
162155992|NCT01854385|585619393|FG000|Pre-Treatment|Withdrawal by Subject|4|||
162155993|NCT01854385|585619393|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
162155994|NCT01854385|585619393|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
162155995|NCT01854385|585619393|FG000|Pre-Treatment|Unable to come for study visits|1|||
162155996|NCT01854385|585619393|FG000|Treatment|Lost to Follow-up|1|||
162155997|NCT02932579|585619394|FG000|Overall Study|Withdrawal by Subject|4|||
162155998|NCT02932579|585619395|FG001|Overall Study|Withdrawal by Subject|1|||
162155999|NCT04759833|585619398|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
162156000|NCT04759833|585619399|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
162156001|NCT04759833|585619400|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
162156002|NCT04759833|585619401|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
162156003|NCT04759833|585619402|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
162156004|NCT04759833|585619398|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
162156005|NCT04759833|585619399|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
162156006|NCT04759833|585619400|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
162156007|NCT04759833|585619401|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
162156008|NCT04759833|585619402|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
162156009|NCT04759833|585619398|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
162156010|NCT04759833|585619399|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
162156011|NCT04759833|585619400|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
162156012|NCT04759833|585619401|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
162156013|NCT04759833|585619402|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
162156014|NCT04759833|585619398|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
162156015|NCT04759833|585619399|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
162156016|NCT04759833|585619400|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
162156017|NCT04759833|585619401|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
162156018|NCT04759833|585619402|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
162156019|NCT04759833|585619398|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
162156020|NCT04759833|585619399|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
162156021|NCT04759833|585619400|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
162156022|NCT04759833|585619401|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
162156023|NCT04759833|585619402|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
162156024|NCT04759833|585619398|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
162156025|NCT04759833|585619399|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
162156026|NCT04759833|585619400|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
162156027|NCT04759833|585619401|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
162156028|NCT04759833|585619402|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
162156029|NCT04759833|585619398|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
162156030|NCT04759833|585619399|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
162156031|NCT04759833|585619400|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
162156032|NCT04759833|585619401|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
162156033|NCT04759833|585619402|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
162156034|NCT04759833|585619398|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
162156035|NCT04759833|585619399|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
162156036|NCT04759833|585619400|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
162156037|NCT04759833|585619401|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
162156038|NCT04759833|585619402|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
162156039|NCT04759833|585619398|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
162156040|NCT04759833|585619399|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
162156041|NCT04759833|585619400|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
162156042|NCT04759833|585619401|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
162156043|NCT04759833|585619402|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
161811982|NCT03165994|584355034|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
161811983|NCT03165994|584355034|FG000|Overall Study|Death|2|||
162156044|NCT04759833|585619398|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
162156045|NCT04759833|585619399|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
162156046|NCT04759833|585619400|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
162156047|NCT04759833|585619401|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
162156048|NCT04759833|585619402|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
162156049|NCT04759833|585619398|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
162156050|NCT04759833|585619399|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
162156051|NCT04759833|585619400|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
162156052|NCT04759833|585619401|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
162156053|NCT04759833|585619402|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
162156054|NCT04759833|585619398|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
162156055|NCT04759833|585619399|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
162156056|NCT04759833|585619400|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
162156057|NCT04759833|585619401|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
162156058|NCT04759833|585619402|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
162156059|NCT04759833|585619398|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
162156060|NCT04759833|585619399|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
162156061|NCT04759833|585619400|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
162156062|NCT04759833|585619401|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
162156063|NCT04759833|585619402|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
162156064|NCT00508924|585619403|FG000|Overall Study|Protocol Violation|0|||
162156065|NCT00508924|585619404|FG001|Overall Study|Protocol Violation|0|||
162156066|NCT00508924|585619405|FG002|Overall Study|Protocol Violation|1|||
162156067|NCT00508924|585619406|FG003|Overall Study|Protocol Violation|1|||
162156068|NCT00630058|585619407|FG000|Overall Study|Adverse Event|1|||
162156069|NCT00630058|585619408|FG001|Overall Study|Adverse Event|1|||
162156070|NCT00630058|585619407|FG000|Overall Study|Withdrawal by Subject|0|||
162156071|NCT00630058|585619408|FG001|Overall Study|Withdrawal by Subject|1|||
162156072|NCT00630058|585619407|FG000|Overall Study|stopping criteria|3|||
162156073|NCT00630058|585619408|FG001|Overall Study|stopping criteria|2|||
161915773|NCT03507790|584740552|FG001|Overall Study|COVID 19 Pandemic|1|||
162156074|NCT00415519|585619413|FG000|Overall Study|Adverse Event|1|||
162156075|NCT00415519|585619414|FG001|Overall Study|Adverse Event|0|||
162156076|NCT00415519|585619413|FG000|Overall Study|Withdrawal by Subject|2|||
162156077|NCT00415519|585619414|FG001|Overall Study|Withdrawal by Subject|0|||
162156078|NCT00415519|585619413|FG000|Overall Study|Patient's convenience|1|||
162156079|NCT00415519|585619414|FG001|Overall Study|Patient's convenience|0|||
162156080|NCT04163718|585619415|FG000|Overall Study|Study terminated|12|||
162156081|NCT04872738|585619419|FG000|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|152|||
162156082|NCT04872738|585619420|FG001|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|15|||
162156083|NCT00781274|585619424|FG000|Overall Study|Withdrawal by Subject|2|||
162156084|NCT04705480|585619426|FG000|Overall Study|Withdrawal by Subject|1|||
162156085|NCT04705480|585619427|FG001|Overall Study|Withdrawal by Subject|0|||
162156086|NCT04705480|585619428|FG002|Overall Study|Withdrawal by Subject|1|||
162156087|NCT04705480|585619426|FG000|Overall Study|Protocol Violation|2|||
162156088|NCT04705480|585619427|FG001|Overall Study|Protocol Violation|0|||
162156089|NCT04705480|585619428|FG002|Overall Study|Protocol Violation|2|||
162156090|NCT04705480|585619426|FG000|Overall Study|Decision to discharge before intervention|2|||
162156091|NCT04705480|585619427|FG001|Overall Study|Decision to discharge before intervention|0|||
162156092|NCT04705480|585619428|FG002|Overall Study|Decision to discharge before intervention|0|||
162156093|NCT04970654|585619429|FG000|Overall Study|Withdrawal by parents/guardian|1|||
162156094|NCT04970654|585619430|FG001|Overall Study|Withdrawal by parents/guardian|2|||
162156095|NCT04970654|585619429|FG000|Overall Study|Unclassified|2|||
162156096|NCT04970654|585619430|FG001|Overall Study|Unclassified|1|||
162156097|NCT04970654|585619429|FG000|Overall Study|Lost to Follow-up|1|||
162156098|NCT04970654|585619430|FG001|Overall Study|Lost to Follow-up|0|||
162156099|NCT04083781|585619435|FG000|Main Part|Physician Decision|0|||
162156100|NCT04083781|585619436|FG001|Main Part|Physician Decision|1|||
162156101|NCT04083781|585619437|FG002|Main Part|Physician Decision|2|||
162156102|NCT04083781|585619438|FG003|Main Part|Physician Decision|0|||
162156103|NCT04083781|585619435|FG000|Main Part|Death|1|||
162156104|NCT04083781|585619436|FG001|Main Part|Death|3|||
162156105|NCT04083781|585619437|FG002|Main Part|Death|1|||
162156106|NCT04083781|585619438|FG003|Main Part|Death|0|||
162156107|NCT04083781|585619435|FG000|Main Part|Withdrawal by Subject|5|||
162156108|NCT04083781|585619436|FG001|Main Part|Withdrawal by Subject|2|||
162156109|NCT04083781|585619437|FG002|Main Part|Withdrawal by Subject|3|||
162156110|NCT04083781|585619438|FG003|Main Part|Withdrawal by Subject|7|||
162156111|NCT04083781|585619435|FG000|Extension Part|Physician Decision|0|||
162156112|NCT04083781|585619436|FG001|Extension Part|Physician Decision|0|||
162156113|NCT04083781|585619437|FG002|Extension Part|Physician Decision|0|||
162156114|NCT04083781|585619438|FG003|Extension Part|Physician Decision|1|||
162156115|NCT04083781|585619435|FG000|Extension Part|Death|0|||
162156116|NCT04083781|585619436|FG001|Extension Part|Death|1|||
162156117|NCT04083781|585619437|FG002|Extension Part|Death|0|||
162156118|NCT04083781|585619438|FG003|Extension Part|Death|1|||
162156119|NCT04083781|585619435|FG000|Extension Part|Withdrawal by Subject|0|||
162156120|NCT04083781|585619436|FG001|Extension Part|Withdrawal by Subject|1|||
162156121|NCT04083781|585619437|FG002|Extension Part|Withdrawal by Subject|0|||
162156122|NCT04083781|585619438|FG003|Extension Part|Withdrawal by Subject|0|||
162156123|NCT04083781|585619435|FG000|Extension Part|Ongoing|13|||
162156124|NCT04083781|585619436|FG001|Extension Part|Ongoing|25|||
162156125|NCT04083781|585619437|FG002|Extension Part|Ongoing|15|||
162156126|NCT04083781|585619438|FG003|Extension Part|Ongoing|51|||
162156127|NCT02998528|585619439|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
162156128|NCT02998528|585619440|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
162156129|NCT02998528|585619441|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
162156130|NCT02998528|585619439|FG000|Randomization Period|Participant withdrew consent|0|||
162156131|NCT02998528|585619440|FG001|Randomization Period|Participant withdrew consent|3|||
162156132|NCT02998528|585619441|FG002|Randomization Period|Participant withdrew consent|0|||
162156133|NCT02998528|585619439|FG000|Randomization Period|Participant no longer meets study criteria|1|||
162013939|NCT02202759|585105541|FG002|Overall Study|Withdrawal by Subject|1|||
162013940|NCT02202759|585105539|FG000|Overall Study|Reason not Specified|4|||
162013941|NCT02202759|585105540|FG001|Overall Study|Reason not Specified|11|||
162013942|NCT02202759|585105541|FG002|Overall Study|Reason not Specified|10|||
162013943|NCT01590888|585105542|FG000|Overall Study|Adverse Event|3|||
162013944|NCT01590888|585105543|FG001|Overall Study|Adverse Event|0|||
162013945|NCT01590888|585105544|FG002|Overall Study|Adverse Event|1|||
162013946|NCT01590888|585105542|FG000|Overall Study|Lost to Follow-up|1|||
162156134|NCT02998528|585619440|FG001|Randomization Period|Participant no longer meets study criteria|3|||
162156135|NCT02998528|585619441|FG002|Randomization Period|Participant no longer meets study criteria|2|||
162156136|NCT02998528|585619439|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
162156137|NCT02998528|585619440|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
162156138|NCT02998528|585619441|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
162156139|NCT02998528|585619439|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
162156140|NCT02998528|585619440|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
162156141|NCT02998528|585619441|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
162156142|NCT02998528|585619439|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
162156143|NCT02998528|585619440|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
162013947|NCT01590888|585105543|FG001|Overall Study|Lost to Follow-up|0|||
162013948|NCT01590888|585105544|FG002|Overall Study|Lost to Follow-up|0|||
162013949|NCT04953728|585105545|FG000|Overall Study|Withdrawal by Subject|3|||
162013950|NCT04953728|585105545|FG000|Overall Study|Physician Decision|1|||
162013951|NCT01646125|585105546|FG000|Overall Study|Untreated|2|||
162013952|NCT01646125|585105547|FG001|Overall Study|Untreated|5|||
162013953|NCT01646125|585105546|FG000|Overall Study|Adverse Event|2|||
162013954|NCT01646125|585105547|FG001|Overall Study|Adverse Event|1|||
162013955|NCT01646125|585105546|FG000|Overall Study|Death|1|||
162156144|NCT02998528|585619441|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
162156145|NCT02998528|585619439|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
162156146|NCT02998528|585619440|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
162156147|NCT02998528|585619441|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
162156148|NCT02998528|585619439|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
162156149|NCT02998528|585619440|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
162156150|NCT02998528|585619441|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
162156151|NCT02998528|585619439|FG000|Neoadjuvant Treatment Period|Death|1|||
162156152|NCT02998528|585619440|FG001|Neoadjuvant Treatment Period|Death|0|||
162156153|NCT02998528|585619441|FG002|Neoadjuvant Treatment Period|Death|0|||
162156154|NCT02998528|585619439|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
162156155|NCT02998528|585619440|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
162156156|NCT02998528|585619441|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
162156157|NCT02998528|585619439|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
162156158|NCT02998528|585619440|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
162156159|NCT02998528|585619441|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
162156160|NCT02998528|585619439|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
162156161|NCT02998528|585619440|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
162156162|NCT02998528|585619441|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
162156163|NCT02998528|585619439|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
162156164|NCT02998528|585619440|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
162156165|NCT02998528|585619441|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
162156166|NCT02998528|585619439|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
162156167|NCT02998528|585619440|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
162156168|NCT02998528|585619441|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
162156169|NCT02998528|585619439|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
162156170|NCT02998528|585619440|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
162156171|NCT02998528|585619441|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
162156172|NCT00591214|585619442|FG000|Overall Study|Physician Decision|7|||
162156173|NCT00591214|585619442|FG000|Overall Study|Withdrawal by Subject|1|||
162156174|NCT03997916|585619443|FG000|Overall Study|Protocol Violation|35|||
162156175|NCT03671811|585619444|FG000|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|4|||
162156176|NCT03671811|585619445|FG001|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|3|||
162156177|NCT02152137|585620873|FG000|Overall Study|Withdrawal by Subject|1|||
162156178|NCT02152137|585620873|FG000|Overall Study|Originally assigned to Arm B|3|||
162156179|NCT03358875|585620874|FG000|Overall Study|Death|409|||
162156180|NCT03358875|585620875|FG001|Overall Study|Death|223|||
162156181|NCT03358875|585620874|FG000|Overall Study|Study Closed by Sponsor|66|||
162156182|NCT03358875|585620875|FG001|Overall Study|Study Closed by Sponsor|29|||
162156183|NCT03358875|585620874|FG000|Overall Study|Withdrawal by Subject|13|||
162156184|NCT03358875|585620875|FG001|Overall Study|Withdrawal by Subject|16|||
162156185|NCT03358875|585620874|FG000|Overall Study|Lost to Follow-up|13|||
162156186|NCT03358875|585620875|FG001|Overall Study|Lost to Follow-up|2|||
162156187|NCT03358875|585620874|FG000|Overall Study|Miscellaneous|33|||
162156188|NCT03358875|585620875|FG001|Overall Study|Miscellaneous|0|||
162156189|NCT03358875|585620874|FG000|Overall Study|Remained on Study|1|||
162156190|NCT03358875|585620875|FG001|Overall Study|Remained on Study|0|||
162156191|NCT05613205|585620890|FG000|Overall Study|Lost to Follow-up|0|||
162156192|NCT05613205|585620891|FG001|Overall Study|Lost to Follow-up|0|||
162156193|NCT05613205|585620892|FG002|Overall Study|Lost to Follow-up|1|||
162156194|NCT05613205|585620893|FG003|Overall Study|Lost to Follow-up|1|||
162156195|NCT05613205|585620894|FG004|Overall Study|Lost to Follow-up|0|||
162156196|NCT05613205|585620890|FG000|Overall Study|Withdrawal by Subject|0|||
162156197|NCT05613205|585620891|FG001|Overall Study|Withdrawal by Subject|0|||
161811984|NCT03165994|584355034|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
161811985|NCT03165994|584355034|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
161811986|NCT03165994|584355034|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
161811987|NCT03165994|584355034|FG000|Overall Study|Miscellaneous|1|||
161811988|NCT03600805|584355045|FG000|Overall Study|Adverse Event|2|||
161811989|NCT03600805|584355046|FG001|Overall Study|Adverse Event|1|||
161811990|NCT03600805|584355047|FG002|Overall Study|Adverse Event|1|||
161811991|NCT03600805|584355048|FG003|Overall Study|Adverse Event|7|||
161811992|NCT03600805|584355045|FG000|Overall Study|Lack of Efficacy|2|||
161811993|NCT03600805|584355046|FG001|Overall Study|Lack of Efficacy|1|||
161811994|NCT03600805|584355047|FG002|Overall Study|Lack of Efficacy|0|||
161811995|NCT03600805|584355048|FG003|Overall Study|Lack of Efficacy|0|||
161915774|NCT03507790|584740553|FG002|Overall Study|COVID 19 Pandemic|0|||
161811996|NCT03600805|584355045|FG000|Overall Study|Withdrawal by Subject|1|||
161811997|NCT03600805|584355046|FG001|Overall Study|Withdrawal by Subject|0|||
161811998|NCT03600805|584355047|FG002|Overall Study|Withdrawal by Subject|0|||
162156198|NCT05613205|585620892|FG002|Overall Study|Withdrawal by Subject|1|||
162156199|NCT05613205|585620893|FG003|Overall Study|Withdrawal by Subject|1|||
162156200|NCT05613205|585620894|FG004|Overall Study|Withdrawal by Subject|0|||
162156201|NCT03103321|585620895|FG000|Overall Study|Protocol Violation|1|||
162156202|NCT03103321|585620896|FG001|Overall Study|Protocol Violation|1|||
162156203|NCT03103321|585620897|FG002|Overall Study|Protocol Violation|1|||
162156204|NCT03103321|585620898|FG003|Overall Study|Protocol Violation|0|||
162156205|NCT03602014|585620901|FG000|Overall Study|Lost to Follow-up|2|||
162156206|NCT03602014|585620902|FG001|Overall Study|Lost to Follow-up|0|||
162156207|NCT03602014|585620903|FG002|Overall Study|Lost to Follow-up|0|||
162156208|NCT06375421|585620904|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
162156209|NCT06375421|585620905|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
162156210|NCT06375421|585620906|FG002|First Intervention (1 Week)|Withdrawal by Subject|1|||
162156211|NCT06375421|585620907|FG003|First Intervention (1 Week)|Withdrawal by Subject|0|||
162156212|NCT05760313|585620913|FG000|Overall Study|Withdrawal by Subject|0|||
162156213|NCT05760313|585620914|FG001|Overall Study|Withdrawal by Subject|0|||
162156214|NCT05760313|585620915|FG002|Overall Study|Withdrawal by Subject|1|||
162156215|NCT05760313|585620913|FG000|Overall Study|Other|1|||
162156216|NCT05760313|585620914|FG001|Overall Study|Other|0|||
162156217|NCT05760313|585620915|FG002|Overall Study|Other|0|||
162156218|NCT00956007|585620916|FG000|Overall Study|Protocol Violation|27|||
162156219|NCT00956007|585620917|FG001|Overall Study|Protocol Violation|23|||
162156220|NCT05228470|585620918|FG000|Overall Study|Death|6|||
162156221|NCT05228470|585620919|FG001|Overall Study|Death|11|||
162156222|NCT05228470|585620918|FG000|Overall Study|Withdrawal by Subject|1|||
162156223|NCT05228470|585620919|FG001|Overall Study|Withdrawal by Subject|8|||
162156224|NCT05228470|585620918|FG000|Overall Study|Ongoing|1|||
162156225|NCT05228470|585620919|FG001|Overall Study|Ongoing|11|||
162156226|NCT03885037|585620920|FG000|Overall Study|Protocol Violation|16|||
162156227|NCT01492686|585620921|FG000|Double-blind Phase|Adverse Event|0|||
162156228|NCT01492686|585620922|FG001|Double-blind Phase|Adverse Event|2|||
162156229|NCT01492686|585620921|FG000|Double-blind Phase|Physician Decision|0|||
162156230|NCT01492686|585620922|FG001|Double-blind Phase|Physician Decision|1|||
162156231|NCT01492686|585620921|FG000|Double-blind Phase|Withdrawal by Subject|0|||
162156232|NCT01492686|585620922|FG001|Double-blind Phase|Withdrawal by Subject|2|||
162156233|NCT01492686|585620921|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
162156234|NCT01492686|585620922|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
162156235|NCT01492686|585620921|FG000|Open-label Phase|Adverse Event|1|||
162156236|NCT01492686|585620922|FG001|Open-label Phase|Adverse Event|2|||
162156237|NCT01492686|585620921|FG000|Open-label Phase|Physician Decision|1|||
162156238|NCT01492686|585620922|FG001|Open-label Phase|Physician Decision|0|||
162156239|NCT01492686|585620921|FG000|Open-label Phase|Withdrawal by Subject|6|||
162156240|NCT01492686|585620922|FG001|Open-label Phase|Withdrawal by Subject|7|||
162156241|NCT01492686|585620921|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
162156242|NCT01492686|585620922|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
162156243|NCT03314987|585620925|FG000|Overall Study|Lost to Follow-up|13|||
162156244|NCT03314987|585620926|FG001|Overall Study|Lost to Follow-up|13|||
162156245|NCT05552963|585620927|FG000|Overall Study|Lost to Follow-up|1|||
162156246|NCT05552963|585620927|FG000|Overall Study|Study catheter was inserted, but PF energy was not delivered due to ECG interference|1|||
162156247|NCT00431834|585620930|FG000|Overall Study|Withdrawal by Subject|7|||
162156248|NCT00431834|585620930|FG000|Overall Study|Death|3|||
162156249|NCT00431834|585620930|FG000|Overall Study|Missed Endpoint Visit|2|||
162156250|NCT00431834|585620930|FG000|Overall Study|Lost to Follow-up|1|||
162156251|NCT05529979|585620933|FG000|Overall Study|Lost to Follow-up|6|||
162156252|NCT05529979|585620933|FG000|Overall Study|Physician Decision|1|||
162156253|NCT05529979|585620933|FG000|Overall Study|non-feasibility cases|4|||
162156254|NCT05529979|585620933|FG000|Overall Study|Lack of Efficacy|3|||
162156255|NCT05529979|585620933|FG000|Overall Study|ablation not performed|1|||
162156256|NCT04191499|585620934|FG000|Overall Study|Adverse Event|1|||
162156257|NCT04191499|585620935|FG001|Overall Study|Adverse Event|0|||
162156258|NCT04191499|585620934|FG000|Overall Study|Death|42|||
162156259|NCT04191499|585620935|FG001|Overall Study|Death|55|||
162156260|NCT04191499|585620934|FG000|Overall Study|Lost to Follow-up|4|||
162156261|NCT04191499|585620935|FG001|Overall Study|Lost to Follow-up|1|||
162156262|NCT04191499|585620934|FG000|Overall Study|Physician Decision|1|||
162156263|NCT04191499|585620935|FG001|Overall Study|Physician Decision|0|||
162156264|NCT04191499|585620934|FG000|Overall Study|Progressive Disease|1|||
162156265|NCT04191499|585620935|FG001|Overall Study|Progressive Disease|0|||
161915775|NCT03507790|584740551|FG000|Overall Study|Lost to Follow-up|0|||
162156266|NCT04191499|585620934|FG000|Overall Study|Symptomatic Deterioration|1|||
162156267|NCT04191499|585620935|FG001|Overall Study|Symptomatic Deterioration|0|||
162156268|NCT04191499|585620934|FG000|Overall Study|Withdrawal by Subject|7|||
162156269|NCT04191499|585620935|FG001|Overall Study|Withdrawal by Subject|11|||
162156270|NCT04191499|585620934|FG000|Overall Study|Ongoing in the study|104|||
162156271|NCT04191499|585620935|FG001|Overall Study|Ongoing in the study|97|||
162156272|NCT03403413|585620938|FG000|Overall Study|Lack of Efficacy|2|||
162156273|NCT02924064|585620939|FG000|Overall Study|Adverse Event|2|||
162156274|NCT02924064|585620940|FG001|Overall Study|Adverse Event|2|||
162156275|NCT02924064|585620939|FG000|Overall Study|Lost to Follow-up|0|||
162156276|NCT02924064|585620940|FG001|Overall Study|Lost to Follow-up|2|||
162156277|NCT02924064|585620939|FG000|Overall Study|Physician Decision|0|||
162156278|NCT02924064|585620940|FG001|Overall Study|Physician Decision|2|||
162156279|NCT02924064|585620939|FG000|Overall Study|Protocol Violation|1|||
162156280|NCT02924064|585620940|FG001|Overall Study|Protocol Violation|3|||
161915776|NCT03507790|584740552|FG001|Overall Study|Lost to Follow-up|1|||
161915777|NCT03507790|584740553|FG002|Overall Study|Lost to Follow-up|0|||
161915778|NCT03507790|584740551|FG000|Overall Study|Discontinuation of the trial at the site|1|||
161915779|NCT03507790|584740552|FG001|Overall Study|Discontinuation of the trial at the site|1|||
161915780|NCT03507790|584740553|FG002|Overall Study|Discontinuation of the trial at the site|0|||
161915781|NCT03507790|584740551|FG000|Overall Study|Randomized in error|0|||
161915782|NCT03507790|584740552|FG001|Overall Study|Randomized in error|0|||
161915783|NCT03507790|584740553|FG002|Overall Study|Randomized in error|1|||
161915784|NCT00157755|584740555|FG000|Overall Study|Death|2|||
161915785|NCT00157755|584740556|FG001|Overall Study|Death|3|||
161915786|NCT00157755|584740557|FG002|Overall Study|Death|3|||
161915787|NCT00157755|584740558|FG003|Overall Study|Death|2|||
161915788|NCT00157755|584740559|FG004|Overall Study|Death|0|||
161915789|NCT00157755|584740560|FG005|Overall Study|Death|0|||
161915790|NCT00157755|584740555|FG000|Overall Study|Lost to Follow-up|0|||
161915791|NCT00157755|584740556|FG001|Overall Study|Lost to Follow-up|0|||
161915792|NCT00157755|584740557|FG002|Overall Study|Lost to Follow-up|1|||
161915793|NCT00157755|584740558|FG003|Overall Study|Lost to Follow-up|0|||
161915794|NCT00157755|584740559|FG004|Overall Study|Lost to Follow-up|0|||
161915795|NCT00157755|584740560|FG005|Overall Study|Lost to Follow-up|0|||
161915796|NCT00157755|584740555|FG000|Overall Study|Withdrawal by Subject|0|||
161915797|NCT00157755|584740556|FG001|Overall Study|Withdrawal by Subject|0|||
161915798|NCT00157755|584740557|FG002|Overall Study|Withdrawal by Subject|1|||
161915799|NCT00157755|584740558|FG003|Overall Study|Withdrawal by Subject|1|||
161915800|NCT00157755|584740559|FG004|Overall Study|Withdrawal by Subject|1|||
161915801|NCT00157755|584740560|FG005|Overall Study|Withdrawal by Subject|2|||
161915802|NCT00157755|584740555|FG000|Overall Study|Explant due to infection|0|||
161915803|NCT00157755|584740556|FG001|Overall Study|Explant due to infection|0|||
161915804|NCT00157755|584740557|FG002|Overall Study|Explant due to infection|1|||
161915805|NCT00157755|584740558|FG003|Overall Study|Explant due to infection|0|||
161915806|NCT00157755|584740559|FG004|Overall Study|Explant due to infection|0|||
161915807|NCT00157755|584740560|FG005|Overall Study|Explant due to infection|0|||
161915808|NCT00157755|584740555|FG000|Overall Study|Medical reason|0|||
161915809|NCT00157755|584740556|FG001|Overall Study|Medical reason|0|||
161915810|NCT00157755|584740557|FG002|Overall Study|Medical reason|1|||
161915811|NCT00157755|584740558|FG003|Overall Study|Medical reason|1|||
161915812|NCT00157755|584740559|FG004|Overall Study|Medical reason|0|||
161915813|NCT00157755|584740560|FG005|Overall Study|Medical reason|0|||
161915814|NCT00157755|584740555|FG000|Overall Study|Study site closure|0|||
161915815|NCT00157755|584740556|FG001|Overall Study|Study site closure|1|||
161915816|NCT00157755|584740557|FG002|Overall Study|Study site closure|0|||
161915817|NCT00157755|584740558|FG003|Overall Study|Study site closure|0|||
161915818|NCT00157755|584740559|FG004|Overall Study|Study site closure|0|||
161915819|NCT00157755|584740560|FG005|Overall Study|Study site closure|0|||
161915820|NCT00157755|584740555|FG000|Overall Study|Subject non-compliance|0|||
161915821|NCT00157755|584740556|FG001|Overall Study|Subject non-compliance|0|||
161915822|NCT00157755|584740557|FG002|Overall Study|Subject non-compliance|0|||
161915823|NCT00157755|584740558|FG003|Overall Study|Subject non-compliance|0|||
161915824|NCT00157755|584740559|FG004|Overall Study|Subject non-compliance|0|||
161915825|NCT00157755|584740560|FG005|Overall Study|Subject non-compliance|1|||
161915826|NCT00157755|584740555|FG000|Overall Study|Study completion|0|||
161915827|NCT00157755|584740556|FG001|Overall Study|Study completion|0|||
161915828|NCT00157755|584740557|FG002|Overall Study|Study completion|0|||
161915829|NCT00157755|584740558|FG003|Overall Study|Study completion|0|||
161915830|NCT00157755|584740559|FG004|Overall Study|Study completion|1|||
161915831|NCT00157755|584740560|FG005|Overall Study|Study completion|2|||
161915832|NCT00671788|584740564|FG000|Overall Study|Adverse Event|8|||
161915833|NCT00671788|584740564|FG000|Overall Study|Refused further treatment|3|||
162156281|NCT02924064|585620939|FG000|Overall Study|Withdrawal by Subject|4|||
162156282|NCT02924064|585620940|FG001|Overall Study|Withdrawal by Subject|5|||
162156283|NCT02924064|585620939|FG000|Overall Study|Other|17|||
162156284|NCT02924064|585620940|FG001|Overall Study|Other|29|||
162156285|NCT00529100|585620943|FG000|Overall Study|Adverse Event|0|||
162156286|NCT00529100|585620944|FG001|Overall Study|Adverse Event|5|||
162156287|NCT00529100|585620943|FG000|Overall Study|Protocol Violation|0|||
162156288|NCT00529100|585620944|FG001|Overall Study|Protocol Violation|1|||
162156289|NCT00529100|585620943|FG000|Overall Study|Progressive Disease|0|||
162156290|NCT00529100|585620944|FG001|Overall Study|Progressive Disease|1|||
162156291|NCT00529100|585620943|FG000|Overall Study|Withdrawal by Subject|0|||
162156292|NCT00529100|585620944|FG001|Overall Study|Withdrawal by Subject|1|||
162156293|NCT00529100|585620943|FG000|Overall Study|Participant Ineligibility|0|||
162156294|NCT00529100|585620944|FG001|Overall Study|Participant Ineligibility|1|||
162156295|NCT05524454|585620946|FG000|Overall Study|Withdrawal by Subject|1|||
162156296|NCT05999435|585620947|FG000|Overall Study|Adverse Event|1|||
162156297|NCT05999435|585620948|FG001|Overall Study|Adverse Event|0|||
162156298|NCT05999435|585620949|FG002|Overall Study|Adverse Event|0|||
162156299|NCT05999435|585620947|FG000|Overall Study|Withdrawal by Subject|2|||
162156300|NCT05999435|585620948|FG001|Overall Study|Withdrawal by Subject|1|||
162156301|NCT05999435|585620949|FG002|Overall Study|Withdrawal by Subject|0|||
162156302|NCT05054725|585620953|FG000|Overall Study|Withdrawal by Subject|3|||
162156303|NCT05054725|585620954|FG001|Overall Study|Withdrawal by Subject|4|||
162156304|NCT05054725|585620953|FG000|Overall Study|Sponsor's Decision to Terminate the Study|0|||
162156305|NCT05054725|585620954|FG001|Overall Study|Sponsor's Decision to Terminate the Study|3|||
162156306|NCT05054725|585620953|FG000|Overall Study|Death|1|||
162156307|NCT05054725|585620954|FG001|Overall Study|Death|21|||
162156308|NCT05054725|585620953|FG000|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|0|||
162156309|NCT05054725|585620954|FG001|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|3|||
162156310|NCT05054725|585620953|FG000|Overall Study|PI's decision that there is no benefit from LTFU|0|||
162156311|NCT05054725|585620954|FG001|Overall Study|PI's decision that there is no benefit from LTFU|6|||
162156312|NCT05054725|585620953|FG000|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|0|||
162156313|NCT05054725|585620954|FG001|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|1|||
162156314|NCT05054725|585620953|FG000|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|0|||
162156315|NCT05054725|585620954|FG001|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|1|||
162156316|NCT05054725|585620953|FG000|Overall Study|Physician discretion due to subject progression|0|||
162156317|NCT05054725|585620954|FG001|Overall Study|Physician discretion due to subject progression|1|||
162156318|NCT03674411|585620955|FG000|Overall Study|Non-treatment|4|||
162156319|NCT03674411|585620956|FG001|Overall Study|Non-treatment|0|||
162156320|NCT04982315|585620957|FG000|Overall Study|Death|1|||
162156321|NCT04982315|585620958|FG001|Overall Study|Death|0|||
162156322|NCT04982315|585620959|FG002|Overall Study|Death|1|||
162156323|NCT04982315|585620957|FG000|Overall Study|Lack of Efficacy|0|||
162156324|NCT04982315|585620958|FG001|Overall Study|Lack of Efficacy|0|||
162156325|NCT04982315|585620959|FG002|Overall Study|Lack of Efficacy|2|||
162156326|NCT04982315|585620957|FG000|Overall Study|Withdrawal by Subject|24|||
162156327|NCT04982315|585620958|FG001|Overall Study|Withdrawal by Subject|1|||
162156328|NCT04982315|585620959|FG002|Overall Study|Withdrawal by Subject|2|||
162156329|NCT04982315|585620957|FG000|Overall Study|Dealing with health/life issues|3|||
162156330|NCT04982315|585620958|FG001|Overall Study|Dealing with health/life issues|4|||
162156331|NCT04982315|585620959|FG002|Overall Study|Dealing with health/life issues|7|||
162156332|NCT04982315|585620957|FG000|Overall Study|Privacy concerns|1|||
162156333|NCT04982315|585620958|FG001|Overall Study|Privacy concerns|0|||
162156334|NCT04982315|585620959|FG002|Overall Study|Privacy concerns|0|||
162156335|NCT04982315|585620957|FG000|Overall Study|Withdrawal by research team|0|||
162156336|NCT04982315|585620958|FG001|Overall Study|Withdrawal by research team|0|||
162156337|NCT04982315|585620959|FG002|Overall Study|Withdrawal by research team|1|||
162156338|NCT00780910|585620960|FG000|Overall Study|Adverse Event|2|||
161915834|NCT00671788|584740564|FG000|Overall Study|Ineligible|1|||
162156339|NCT00861692|585620964|FG000|Overall Study|Death|6|||
162156340|NCT06429163|585620965|FG000|Overall Study|uterine fibroid type 7|1|||
162156341|NCT06429163|585620966|FG001|Overall Study|uterine fibroid type 7|1|||
162156342|NCT06429163|585620967|FG002|Overall Study|uterine fibroid type 7|1|||
162156343|NCT06429163|585620965|FG000|Overall Study|severe adhesions|1|||
162156344|NCT06429163|585620966|FG001|Overall Study|severe adhesions|2|||
162156345|NCT06429163|585620967|FG002|Overall Study|severe adhesions|1|||
162156346|NCT06429163|585620965|FG000|Overall Study|conversion to laparotomy|0|||
162156347|NCT06429163|585620966|FG001|Overall Study|conversion to laparotomy|1|||
162156348|NCT06429163|585620967|FG002|Overall Study|conversion to laparotomy|0|||
162156349|NCT06429163|585620965|FG000|Overall Study|concomitant procedure|1|||
162156350|NCT06429163|585620966|FG001|Overall Study|concomitant procedure|0|||
162156351|NCT06429163|585620967|FG002|Overall Study|concomitant procedure|0|||
162156352|NCT04929483|585620968|FG000|Main Study (24 Weeks)|Adverse Event|1|||
162156353|NCT04929483|585620969|FG001|Main Study (24 Weeks)|Adverse Event|6|||
162156354|NCT04929483|585620970|FG002|Main Study (24 Weeks)|Adverse Event|2|||
162156355|NCT04929483|585620971|FG003|Main Study (24 Weeks)|Adverse Event|1|||
162156356|NCT04929483|585620972|FG004|Main Study (24 Weeks)|Adverse Event|0|||
162156357|NCT04929483|585620973|FG005|Main Study (24 Weeks)|Adverse Event|0|||
162156358|NCT04929483|585620968|FG000|Main Study (24 Weeks)|Withdrawal by Subject|0|||
162156359|NCT04929483|585620969|FG001|Main Study (24 Weeks)|Withdrawal by Subject|3|||
162156360|NCT04929483|585620970|FG002|Main Study (24 Weeks)|Withdrawal by Subject|3|||
162156361|NCT04929483|585620971|FG003|Main Study (24 Weeks)|Withdrawal by Subject|3|||
162156362|NCT04929483|585620972|FG004|Main Study (24 Weeks)|Withdrawal by Subject|0|||
162156363|NCT04929483|585620973|FG005|Main Study (24 Weeks)|Withdrawal by Subject|0|||
162156364|NCT04929483|585620968|FG000|Main Study (24 Weeks)|Lost to Follow-up|0|||
162156365|NCT04929483|585620969|FG001|Main Study (24 Weeks)|Lost to Follow-up|2|||
162156366|NCT04929483|585620970|FG002|Main Study (24 Weeks)|Lost to Follow-up|0|||
162156367|NCT04929483|585620971|FG003|Main Study (24 Weeks)|Lost to Follow-up|2|||
162156368|NCT04929483|585620972|FG004|Main Study (24 Weeks)|Lost to Follow-up|0|||
162156369|NCT04929483|585620973|FG005|Main Study (24 Weeks)|Lost to Follow-up|0|||
162156370|NCT04929483|585620968|FG000|Main Study (24 Weeks)|Physician Decision|0|||
162156371|NCT04929483|585620969|FG001|Main Study (24 Weeks)|Physician Decision|2|||
162156372|NCT04929483|585620970|FG002|Main Study (24 Weeks)|Physician Decision|0|||
162156373|NCT04929483|585620971|FG003|Main Study (24 Weeks)|Physician Decision|0|||
162156374|NCT04929483|585620972|FG004|Main Study (24 Weeks)|Physician Decision|0|||
162156375|NCT04929483|585620973|FG005|Main Study (24 Weeks)|Physician Decision|0|||
162156376|NCT04929483|585620968|FG000|Main Study (24 Weeks)|Protocol Violation|0|||
162156377|NCT04929483|585620969|FG001|Main Study (24 Weeks)|Protocol Violation|0|||
162156378|NCT04929483|585620970|FG002|Main Study (24 Weeks)|Protocol Violation|1|||
162156379|NCT04929483|585620971|FG003|Main Study (24 Weeks)|Protocol Violation|0|||
162156380|NCT04929483|585620972|FG004|Main Study (24 Weeks)|Protocol Violation|0|||
162156381|NCT04929483|585620973|FG005|Main Study (24 Weeks)|Protocol Violation|0|||
162156382|NCT04929483|585620968|FG000|Main Study (24 Weeks)|Randomized in error|0|||
162013956|NCT01646125|585105547|FG001|Overall Study|Death|1|||
162013957|NCT01646125|585105546|FG000|Overall Study|Physician Decision|1|||
162013958|NCT01646125|585105547|FG001|Overall Study|Physician Decision|3|||
162013959|NCT01646125|585105546|FG000|Overall Study|Progressive disease|22|||
162156383|NCT04929483|585620969|FG001|Main Study (24 Weeks)|Randomized in error|1|||
162156384|NCT04929483|585620970|FG002|Main Study (24 Weeks)|Randomized in error|0|||
162156385|NCT04929483|585620971|FG003|Main Study (24 Weeks)|Randomized in error|2|||
162156386|NCT04929483|585620972|FG004|Main Study (24 Weeks)|Randomized in error|0|||
162156387|NCT04929483|585620973|FG005|Main Study (24 Weeks)|Randomized in error|0|||
162156388|NCT04929483|585620968|FG000|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
162156389|NCT04929483|585620969|FG001|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
162156390|NCT04929483|585620970|FG002|Extension Study (24 Weeks)|Withdrawal by Subject|3|||
162156391|NCT04929483|585620971|FG003|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
162013960|NCT01646125|585105547|FG001|Overall Study|Progressive disease|16|||
162156392|NCT04929483|585620972|FG004|Extension Study (24 Weeks)|Withdrawal by Subject|2|||
162156393|NCT04929483|585620973|FG005|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
162156394|NCT04929483|585620968|FG000|Extension Study (24 Weeks)|Lost to Follow-up|0|||
162156395|NCT04929483|585620969|FG001|Extension Study (24 Weeks)|Lost to Follow-up|1|||
162156396|NCT04929483|585620970|FG002|Extension Study (24 Weeks)|Lost to Follow-up|1|||
162156397|NCT04929483|585620971|FG003|Extension Study (24 Weeks)|Lost to Follow-up|0|||
162013961|NCT01646125|585105546|FG000|Overall Study|Study terminated by sponsor|2|||
162156398|NCT04929483|585620972|FG004|Extension Study (24 Weeks)|Lost to Follow-up|1|||
162156399|NCT04929483|585620973|FG005|Extension Study (24 Weeks)|Lost to Follow-up|0|||
162156400|NCT04929483|585620968|FG000|Extension Study (24 Weeks)|Other than specified|1|||
162156401|NCT04929483|585620969|FG001|Extension Study (24 Weeks)|Other than specified|0|||
162156402|NCT04929483|585620970|FG002|Extension Study (24 Weeks)|Other than specified|1|||
162156403|NCT04929483|585620971|FG003|Extension Study (24 Weeks)|Other than specified|0|||
162156404|NCT04929483|585620972|FG004|Extension Study (24 Weeks)|Other than specified|1|||
162156405|NCT04929483|585620973|FG005|Extension Study (24 Weeks)|Other than specified|0|||
162156406|NCT04929483|585620968|FG000|Extension Study (24 Weeks)|Adverse Event|0|||
162156407|NCT04929483|585620969|FG001|Extension Study (24 Weeks)|Adverse Event|2|||
162156408|NCT04929483|585620970|FG002|Extension Study (24 Weeks)|Adverse Event|3|||
162156409|NCT04929483|585620971|FG003|Extension Study (24 Weeks)|Adverse Event|0|||
162156410|NCT04929483|585620972|FG004|Extension Study (24 Weeks)|Adverse Event|0|||
162156411|NCT04929483|585620973|FG005|Extension Study (24 Weeks)|Adverse Event|0|||
162156412|NCT01626885|585620974|FG000|Overall Study|Adverse Event|8|||
162156413|NCT01626885|585620974|FG000|Overall Study|Withdrawal by Subject|4|||
162156414|NCT01143337|585620977|FG000|Overall Study|Adverse Event|3|||
162156415|NCT01143337|585620978|FG001|Overall Study|Adverse Event|9|||
162156416|NCT01143337|585620979|FG002|Overall Study|Adverse Event|5|||
162156417|NCT01143337|585620977|FG000|Overall Study|Lack of Efficacy|6|||
162156418|NCT01143337|585620978|FG001|Overall Study|Lack of Efficacy|2|||
162156419|NCT01143337|585620979|FG002|Overall Study|Lack of Efficacy|1|||
162156420|NCT01143337|585620977|FG000|Overall Study|Protocol Violation|1|||
162156421|NCT01143337|585620978|FG001|Overall Study|Protocol Violation|0|||
162156422|NCT01143337|585620979|FG002|Overall Study|Protocol Violation|0|||
162156423|NCT01143337|585620977|FG000|Overall Study|Withdrawal by Subject|0|||
162156424|NCT01143337|585620978|FG001|Overall Study|Withdrawal by Subject|0|||
162156425|NCT01143337|585620979|FG002|Overall Study|Withdrawal by Subject|1|||
162156426|NCT01143337|585620977|FG000|Overall Study|Other reason|0|||
162156427|NCT01143337|585620978|FG001|Overall Study|Other reason|0|||
162156428|NCT01143337|585620979|FG002|Overall Study|Other reason|5|||
162156429|NCT01466192|585620980|FG000|Overall Study|Physician Decision|1|||
162156430|NCT01466192|585620980|FG000|Overall Study|Withdrawal by Subject|3|||
162156431|NCT05600283|585620981|FG000|Overall Study|Withdrawal by Subject|3|||
162156432|NCT05600283|585620982|FG001|Overall Study|Withdrawal by Subject|8|||
162156433|NCT05600283|585620981|FG000|Overall Study|Invalid Vaginal Swab|2|||
162156434|NCT05600283|585620982|FG001|Overall Study|Invalid Vaginal Swab|2|||
162156435|NCT05600283|585620981|FG000|Overall Study|Missing Clinician Collection|3|||
162156436|NCT05600283|585620982|FG001|Overall Study|Missing Clinician Collection|6|||
162156437|NCT05600283|585620981|FG000|Overall Study|Screen Failure|1|||
162156438|NCT05600283|585620982|FG001|Overall Study|Screen Failure|2|||
162156439|NCT05600283|585620981|FG000|Overall Study|Sample Lost in Transit|1|||
162156440|NCT05600283|585620982|FG001|Overall Study|Sample Lost in Transit|0|||
162156441|NCT01061671|585620983|FG000|Overall Study|Withdrawal by Subject|16|||
162156442|NCT01061671|585620984|FG001|Overall Study|Withdrawal by Subject|20|||
162156443|NCT01061671|585620983|FG000|Overall Study|Lost to Follow-up|3|||
162156444|NCT01061671|585620984|FG001|Overall Study|Lost to Follow-up|5|||
162156445|NCT01061671|585620983|FG000|Overall Study|Death|28|||
162156446|NCT01061671|585620984|FG001|Overall Study|Death|30|||
162156447|NCT00068601|585620985|FG000|Overall Study|Ineligible|11|||
162156448|NCT00068601|585620986|FG001|Overall Study|Ineligible|13|||
162156449|NCT00068601|585620985|FG000|Overall Study|Not evaluable: withdrew consent|5|||
162156450|NCT00068601|585620986|FG001|Overall Study|Not evaluable: withdrew consent|4|||
162156451|NCT00068601|585620985|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
162156452|NCT00068601|585620986|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
162156453|NCT00068601|585620985|FG000|Overall Study|Death|11|||
162156454|NCT00068601|585620986|FG001|Overall Study|Death|3|||
162156455|NCT00068601|585620985|FG000|Overall Study|Lost to Follow-up|3|||
162156456|NCT00068601|585620986|FG001|Overall Study|Lost to Follow-up|2|||
162156457|NCT00068601|585620985|FG000|Overall Study|Missing primary outcome data|30|||
162156458|NCT00068601|585620986|FG001|Overall Study|Missing primary outcome data|34|||
162156459|NCT02468128|585620987|FG000|Overall Study|Protocol Violation|6|||
162156460|NCT02468128|585620988|FG001|Overall Study|Protocol Violation|6|||
162156461|NCT00440011|585620992|FG000|Overall Study|Adverse Event|2|||
162156462|NCT00440011|585620993|FG001|Overall Study|Adverse Event|0|||
162156463|NCT00440011|585620992|FG000|Overall Study|Lost to Follow-up|0|||
162156464|NCT00440011|585620993|FG001|Overall Study|Lost to Follow-up|2|||
162156465|NCT00440011|585620992|FG000|Overall Study|Protocol Violation|1|||
162156466|NCT00440011|585620993|FG001|Overall Study|Protocol Violation|1|||
162156467|NCT00440011|585620992|FG000|Overall Study|Withdrawal by Subject|1|||
162156468|NCT00440011|585620993|FG001|Overall Study|Withdrawal by Subject|0|||
162156469|NCT02321514|585620999|FG000|Overall Study|Death|15|||
162156470|NCT02321514|585620999|FG000|Overall Study|Missed Visit|7|||
162156471|NCT02321514|585620999|FG000|Overall Study|Study Exit|3|||
162156472|NCT00621296|585621000|FG000|Overall Study|Adverse Event|2|||
162156473|NCT00621296|585621000|FG000|Overall Study|Lack of Efficacy|1|||
162156474|NCT00621296|585621000|FG000|Overall Study|Physician Decision|7|||
162156475|NCT00621296|585621000|FG000|Overall Study|Unmatch Criteria|1|||
162156476|NCT00621296|585621000|FG000|Overall Study|Stopping Criteria|3|||
162156477|NCT04166058|585621001|FG000|Overall Study|Adverse Event|1|||
162156478|NCT04166058|585621002|FG001|Overall Study|Adverse Event|1|||
162156479|NCT04166058|585621003|FG002|Overall Study|Adverse Event|0|||
162156480|NCT04166058|585621004|FG003|Overall Study|Adverse Event|0|||
162156481|NCT04166058|585621001|FG000|Overall Study|Withdrawal by Subject|4|||
162156482|NCT04166058|585621002|FG001|Overall Study|Withdrawal by Subject|4|||
162156483|NCT04166058|585621003|FG002|Overall Study|Withdrawal by Subject|1|||
162156484|NCT04166058|585621004|FG003|Overall Study|Withdrawal by Subject|10|||
162156485|NCT04166058|585621001|FG000|Overall Study|Lost to Follow-up|9|||
162156486|NCT04166058|585621002|FG001|Overall Study|Lost to Follow-up|2|||
162156487|NCT04166058|585621003|FG002|Overall Study|Lost to Follow-up|1|||
162156488|NCT04166058|585621004|FG003|Overall Study|Lost to Follow-up|1|||
162156489|NCT04166058|585621001|FG000|Overall Study|Pregnancy|1|||
162156490|NCT04166058|585621002|FG001|Overall Study|Pregnancy|0|||
162156491|NCT04166058|585621003|FG002|Overall Study|Pregnancy|0|||
162156492|NCT04166058|585621004|FG003|Overall Study|Pregnancy|0|||
162156493|NCT04166058|585621001|FG000|Overall Study|Physician Decision|2|||
162156494|NCT04166058|585621002|FG001|Overall Study|Physician Decision|0|||
162156495|NCT04166058|585621003|FG002|Overall Study|Physician Decision|0|||
162156496|NCT04166058|585621004|FG003|Overall Study|Physician Decision|2|||
162156497|NCT04166058|585621001|FG000|Overall Study|Protocol Violation|1|||
162156498|NCT04166058|585621002|FG001|Overall Study|Protocol Violation|0|||
162156499|NCT04166058|585621003|FG002|Overall Study|Protocol Violation|0|||
162156500|NCT04166058|585621004|FG003|Overall Study|Protocol Violation|0|||
162156501|NCT04166058|585621001|FG000|Overall Study|Lack of Efficacy|2|||
162156502|NCT04166058|585621002|FG001|Overall Study|Lack of Efficacy|0|||
162156503|NCT04166058|585621003|FG002|Overall Study|Lack of Efficacy|0|||
162156504|NCT04166058|585621004|FG003|Overall Study|Lack of Efficacy|0|||
162156505|NCT04166058|585621001|FG000|Overall Study|Other|1|||
162156506|NCT04166058|585621002|FG001|Overall Study|Other|0|||
162156507|NCT04166058|585621003|FG002|Overall Study|Other|0|||
162156508|NCT04166058|585621004|FG003|Overall Study|Other|1|||
162156509|NCT04166058|585621001|FG000|Overall Study|Non-compliance with study drug|0|||
162156510|NCT04166058|585621002|FG001|Overall Study|Non-compliance with study drug|0|||
162156511|NCT04166058|585621003|FG002|Overall Study|Non-compliance with study drug|0|||
162156512|NCT04166058|585621004|FG003|Overall Study|Non-compliance with study drug|2|||
162156513|NCT01753570|585621008|FG000|Overall Study|Adverse Event|1|||
162156514|NCT01753570|585621009|FG001|Overall Study|Adverse Event|0|||
162156515|NCT01753570|585621010|FG002|Overall Study|Adverse Event|1|||
162156516|NCT01753570|585621008|FG000|Overall Study|Physician Decision|0|||
162156517|NCT01753570|585621009|FG001|Overall Study|Physician Decision|1|||
162156518|NCT01753570|585621010|FG002|Overall Study|Physician Decision|0|||
162156519|NCT01753570|585621008|FG000|Overall Study|Withdrawal by Subject|1|||
162156520|NCT01753570|585621009|FG001|Overall Study|Withdrawal by Subject|4|||
162156521|NCT01753570|585621010|FG002|Overall Study|Withdrawal by Subject|0|||
162156522|NCT05308316|585621011|FG000|Overall Study|Withdrawal by Subject|2|||
162013962|NCT01646125|585105547|FG001|Overall Study|Study terminated by sponsor|1|||
162013963|NCT01646125|585105546|FG000|Overall Study|Subject/Guardian decision|1|||
162013964|NCT01646125|585105547|FG001|Overall Study|Subject/Guardian decision|1|||
162156523|NCT05308316|585621011|FG000|Overall Study|Physician Decision|1|||
162156524|NCT03891758|585621020|FG000|Overall Study|Adverse Event|2|||
162156525|NCT03891758|585621021|FG001|Overall Study|Adverse Event|0|||
162013965|NCT02105662|585105548|FG000|Overall Study|Lost to Follow-up|5|||
162156526|NCT03891758|585621020|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162013966|NCT02105662|585105548|FG000|Overall Study|Withdrawal by Subject|1|||
162156527|NCT03891758|585621021|FG001|Overall Study|Withdrawal by parent/guardian|2|||
162156528|NCT03584516|585622475|FG000|Part 1|Death|2|||
162156529|NCT03584516|585622476|FG001|Part 1|Death|3|||
162156530|NCT03584516|585622477|FG002|Part 1|Death|0|||
162156531|NCT03584516|585622478|FG003|Part 1|Death|0|||
162156532|NCT03584516|585622479|FG004|Part 1|Death|0|||
162156533|NCT03584516|585622480|FG005|Part 1|Death|0|||
162156534|NCT03584516|585622475|FG000|Part 1|Withdrawal by Subject|2|||
162156535|NCT03584516|585622476|FG001|Part 1|Withdrawal by Subject|0|||
162156536|NCT03584516|585622477|FG002|Part 1|Withdrawal by Subject|0|||
162156537|NCT03584516|585622478|FG003|Part 1|Withdrawal by Subject|0|||
162156538|NCT03584516|585622479|FG004|Part 1|Withdrawal by Subject|0|||
162156539|NCT03584516|585622480|FG005|Part 1|Withdrawal by Subject|0|||
162156540|NCT03584516|585622475|FG000|Part 1|Lost to Follow-up|1|||
162156541|NCT03584516|585622476|FG001|Part 1|Lost to Follow-up|0|||
162156542|NCT03584516|585622477|FG002|Part 1|Lost to Follow-up|0|||
162156543|NCT03584516|585622478|FG003|Part 1|Lost to Follow-up|0|||
162156544|NCT03584516|585622479|FG004|Part 1|Lost to Follow-up|0|||
162156545|NCT03584516|585622480|FG005|Part 1|Lost to Follow-up|0|||
162156546|NCT03584516|585622475|FG000|Part 1|Study Terminated by Sponsor|0|||
162156547|NCT03584516|585622476|FG001|Part 1|Study Terminated by Sponsor|2|||
162156548|NCT03584516|585622477|FG002|Part 1|Study Terminated by Sponsor|0|||
162156549|NCT03584516|585622478|FG003|Part 1|Study Terminated by Sponsor|0|||
162156550|NCT03584516|585622479|FG004|Part 1|Study Terminated by Sponsor|0|||
162156551|NCT03584516|585622480|FG005|Part 1|Study Terminated by Sponsor|0|||
162156552|NCT03584516|585622475|FG000|Part 1 Expansion|Death|0|||
162156553|NCT03584516|585622476|FG001|Part 1 Expansion|Death|0|||
162156554|NCT03584516|585622477|FG002|Part 1 Expansion|Death|9|||
162156555|NCT03584516|585622478|FG003|Part 1 Expansion|Death|8|||
162156556|NCT03584516|585622479|FG004|Part 1 Expansion|Death|4|||
162156557|NCT03584516|585622480|FG005|Part 1 Expansion|Death|5|||
162156558|NCT03584516|585622475|FG000|Part 1 Expansion|Lost to Follow-up|0|||
162156559|NCT03584516|585622476|FG001|Part 1 Expansion|Lost to Follow-up|0|||
162156560|NCT03584516|585622477|FG002|Part 1 Expansion|Lost to Follow-up|0|||
162156561|NCT03584516|585622478|FG003|Part 1 Expansion|Lost to Follow-up|1|||
162156562|NCT03584516|585622479|FG004|Part 1 Expansion|Lost to Follow-up|0|||
162156563|NCT03584516|585622480|FG005|Part 1 Expansion|Lost to Follow-up|0|||
162156564|NCT03584516|585622475|FG000|Part 1 Expansion|Physician Decision|0|||
162156565|NCT03584516|585622476|FG001|Part 1 Expansion|Physician Decision|0|||
162156566|NCT03584516|585622477|FG002|Part 1 Expansion|Physician Decision|4|||
162156567|NCT03584516|585622478|FG003|Part 1 Expansion|Physician Decision|3|||
162156568|NCT03584516|585622479|FG004|Part 1 Expansion|Physician Decision|2|||
162156569|NCT03584516|585622480|FG005|Part 1 Expansion|Physician Decision|3|||
162156570|NCT03584516|585622475|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
162156571|NCT03584516|585622476|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
162156572|NCT03584516|585622477|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
162156573|NCT03584516|585622478|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
162156574|NCT03584516|585622479|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
162156575|NCT03584516|585622480|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
162156576|NCT03584516|585622475|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
162156577|NCT03584516|585622476|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
162156578|NCT03584516|585622477|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
162156579|NCT03584516|585622478|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
162156580|NCT03584516|585622479|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
162156581|NCT03584516|585622480|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
162156582|NCT03584516|585622475|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161811999|NCT03600805|584355048|FG003|Overall Study|Withdrawal by Subject|1|||
161812000|NCT03600805|584355045|FG000|Overall Study|Other unspecified|14|||
161812001|NCT03600805|584355046|FG001|Overall Study|Other unspecified|6|||
161812002|NCT03600805|584355047|FG002|Overall Study|Other unspecified|7|||
161812003|NCT03600805|584355048|FG003|Overall Study|Other unspecified|11|||
161812004|NCT00804856|584355054|FG000|Overall Study|Progressive Disease|3|||
161812005|NCT00804856|584355055|FG001|Overall Study|Progressive Disease|2|||
161812006|NCT00804856|584355056|FG002|Overall Study|Progressive Disease|4|||
161812007|NCT00804856|584355057|FG003|Overall Study|Progressive Disease|6|||
161812008|NCT00804856|584355058|FG004|Overall Study|Progressive Disease|4|||
161812009|NCT00804856|584355059|FG005|Overall Study|Progressive Disease|1|||
161812010|NCT00804856|584355060|FG006|Overall Study|Progressive Disease|8|||
161812011|NCT00804856|584355061|FG007|Overall Study|Progressive Disease|2|||
161812012|NCT00804856|584355062|FG008|Overall Study|Progressive Disease|4|||
161812013|NCT00804856|584355063|FG009|Overall Study|Progressive Disease|5|||
161812014|NCT00804856|584355064|FG010|Overall Study|Progressive Disease|12|||
161812015|NCT00804856|584355065|FG011|Overall Study|Progressive Disease|2|||
161812016|NCT00804856|584355066|FG012|Overall Study|Progressive Disease|2|||
162156583|NCT03584516|585622476|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
162156584|NCT03584516|585622477|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
162156585|NCT03584516|585622478|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
161812017|NCT00804856|584355067|FG013|Overall Study|Progressive Disease|26|||
162156586|NCT03584516|585622479|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
162156587|NCT03584516|585622480|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161812018|NCT00804856|584355068|FG014|Overall Study|Progressive Disease|20|||
161812019|NCT00804856|584355054|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812020|NCT00804856|584355055|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812021|NCT00804856|584355056|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812022|NCT00804856|584355057|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162156588|NCT03584516|585622475|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
162156589|NCT03584516|585622476|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
162156590|NCT03584516|585622477|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
162156591|NCT03584516|585622478|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
162156592|NCT03584516|585622479|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
162156593|NCT03584516|585622480|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
162156594|NCT05846646|585622482|FG000|Overall Study|Physician Decision|1|||
162156595|NCT05846646|585622483|FG001|Overall Study|Physician Decision|0|||
162156596|NCT05846646|585622484|FG002|Overall Study|Physician Decision|0|||
162156597|NCT05846646|585622482|FG000|Overall Study|Lack of Efficacy|1|||
162156598|NCT05846646|585622483|FG001|Overall Study|Lack of Efficacy|1|||
162156599|NCT05846646|585622484|FG002|Overall Study|Lack of Efficacy|0|||
162156600|NCT05846646|585622482|FG000|Overall Study|Early Study Termination|1|||
162156601|NCT05846646|585622483|FG001|Overall Study|Early Study Termination|2|||
162156602|NCT05846646|585622484|FG002|Overall Study|Early Study Termination|0|||
162156603|NCT01443845|585622490|FG000|Overall Study|Protocol Violation|43|||
162156604|NCT01443845|585622491|FG001|Overall Study|Protocol Violation|45|||
162156605|NCT01443845|585622490|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
162156606|NCT01443845|585622491|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
162156607|NCT01443845|585622490|FG000|Overall Study|Deterioration in pulmonary function|1|||
162156608|NCT01443845|585622491|FG001|Overall Study|Deterioration in pulmonary function|4|||
162156609|NCT01443845|585622490|FG000|Overall Study|Lack of Efficacy|10|||
162156610|NCT01443845|585622491|FG001|Overall Study|Lack of Efficacy|5|||
162156611|NCT01443845|585622490|FG000|Overall Study|Adverse Event|64|||
162156612|NCT01443845|585622491|FG001|Overall Study|Adverse Event|138|||
162156613|NCT01443845|585622490|FG000|Overall Study|Withdrawal by Subject|63|||
162156614|NCT01443845|585622491|FG001|Overall Study|Withdrawal by Subject|67|||
162156615|NCT01443845|585622490|FG000|Overall Study|Military Conflict - Site Terminated|20|||
162156616|NCT01443845|585622491|FG001|Overall Study|Military Conflict - Site Terminated|21|||
162013967|NCT03349034|585105553|FG000|Overall Study|catheters dislodged during transport|2|||
162013968|NCT03349034|585105554|FG001|Overall Study|catheters dislodged during transport|0|||
162013969|NCT03349034|585105553|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
162013970|NCT03349034|585105554|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
162013971|NCT03349034|585105553|FG000|Overall Study|soft tissue flap used|1|||
162013972|NCT03349034|585105554|FG001|Overall Study|soft tissue flap used|0|||
162013973|NCT03349034|585105553|FG000|Overall Study|Other|0|||
162013974|NCT03349034|585105554|FG001|Overall Study|Other|1|||
162013975|NCT01759446|585105555|FG000|Overall Study|Protocol Violation|1|||
162013976|NCT01759446|585105556|FG001|Overall Study|Protocol Violation|0|||
162013977|NCT01759446|585105557|FG002|Overall Study|Protocol Violation|1|||
162013978|NCT01759446|585105558|FG003|Overall Study|Protocol Violation|0|||
162013979|NCT01759446|585105559|FG004|Overall Study|Protocol Violation|0|||
162156617|NCT01443845|585622490|FG000|Overall Study|Lost to Follow-up|9|||
161915835|NCT00671788|584740564|FG000|Overall Study|MD Decision|1|||
161915836|NCT00671788|584740564|FG000|Overall Study|Other|1|||
161915837|NCT01035138|584740565|FG000|Overall Study|Adverse Event|4|||
161915838|NCT01035138|584740566|FG001|Overall Study|Adverse Event|0|||
161915839|NCT01035138|584740567|FG002|Overall Study|Adverse Event|2|||
161915840|NCT01035138|584740565|FG000|Overall Study|Caregiver Decision|2|||
161915841|NCT01035138|584740566|FG001|Overall Study|Caregiver Decision|0|||
161915842|NCT01035138|584740567|FG002|Overall Study|Caregiver Decision|1|||
161915843|NCT01035138|584740565|FG000|Overall Study|Withdrawal by Subject|1|||
162156618|NCT01443845|585622491|FG001|Overall Study|Lost to Follow-up|13|||
162156619|NCT01471691|585622492|FG000|Overall Study|Lack of Efficacy|0|||
162156620|NCT01471691|585622493|FG001|Overall Study|Lack of Efficacy|1|||
162156621|NCT01808339|585622494|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162156622|NCT01808339|585622495|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162156623|NCT01808339|585622496|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162156624|NCT01808339|585622497|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
162156625|NCT01808339|585622498|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
162156626|NCT01808339|585622499|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
162156627|NCT01808339|585622494|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162156628|NCT01808339|585622495|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
162156629|NCT01808339|585622496|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162156630|NCT01808339|585622497|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
162156631|NCT01808339|585622498|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162156632|NCT01808339|585622499|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162156633|NCT01808339|585622494|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162156634|NCT01808339|585622495|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162156635|NCT01808339|585622496|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
162156636|NCT01808339|585622497|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162013980|NCT01759446|585105555|FG000|Overall Study|Withdrawal by Subject|0|||
162013981|NCT01759446|585105556|FG001|Overall Study|Withdrawal by Subject|1|||
161915844|NCT01035138|584740566|FG001|Overall Study|Withdrawal by Subject|0|||
161915845|NCT01035138|584740567|FG002|Overall Study|Withdrawal by Subject|0|||
161915846|NCT01035138|584740565|FG000|Overall Study|Physician Decision|0|||
162156637|NCT01808339|585622498|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162156638|NCT01808339|585622499|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
162156639|NCT02461628|585622500|FG000|Overall Study|Refused to complete survey|4|||
162156640|NCT02461628|585622501|FG001|Overall Study|Refused to complete survey|7|||
162156641|NCT02462759|585622503|FG000|Part 1: Double Blind|Death|1|||
162156642|NCT02462759|585622504|FG001|Part 1: Double Blind|Death|0|||
162156643|NCT02462759|585622505|FG002|Part 1: Double Blind|Death|0|||
162156644|NCT02088853|585622506|FG000|Overall Study|Pregnancy|1|||
162156645|NCT02088853|585622507|FG001|Overall Study|Pregnancy|0|||
162156646|NCT04704284|585622513|FG000|Overall Study|Withdrawal by Subject|1|||
162156647|NCT03930420|585622524|FG000|Overall Study|Withdrawal by Subject|7|||
162156648|NCT03930420|585622525|FG001|Overall Study|Withdrawal by Subject|9|||
162156649|NCT00609336|585622526|FG000|Overall Study|Protocol Violation|3|||
162156650|NCT00609336|585622526|FG000|Overall Study|Death|1|||
162156651|NCT00609336|585622526|FG000|Overall Study|LA or Met at Surgery|9|||
162156652|NCT00567489|585622527|FG000|Overall Study|Adverse Event|6|||
162156653|NCT00567489|585622528|FG001|Overall Study|Adverse Event|14|||
162156654|NCT00567489|585622527|FG000|Overall Study|Physician Decision|0|||
162156655|NCT00567489|585622528|FG001|Overall Study|Physician Decision|4|||
162156656|NCT00567489|585622527|FG000|Overall Study|Withdrawal by Subject|0|||
162156657|NCT00567489|585622528|FG001|Overall Study|Withdrawal by Subject|2|||
162156658|NCT00567489|585622527|FG000|Overall Study|Renal Transplantation|0|||
162156659|NCT00567489|585622528|FG001|Overall Study|Renal Transplantation|3|||
162156660|NCT00567489|585622527|FG000|Overall Study|Other|1|||
162156661|NCT00567489|585622528|FG001|Overall Study|Other|0|||
162156662|NCT00331136|585622534|FG000|Overall Study|Adverse Event|3|||
162156663|NCT00331136|585622535|FG001|Overall Study|Adverse Event|5|||
161915847|NCT01035138|584740566|FG001|Overall Study|Physician Decision|0|||
161915848|NCT01035138|584740567|FG002|Overall Study|Physician Decision|1|||
161915849|NCT01035138|584740565|FG000|Overall Study|Sponsor Decision|66|||
161915850|NCT01035138|584740566|FG001|Overall Study|Sponsor Decision|60|||
161915851|NCT01035138|584740567|FG002|Overall Study|Sponsor Decision|42|||
161915852|NCT01035138|584740565|FG000|Overall Study|Lost to Follow-up|0|||
161915853|NCT01035138|584740566|FG001|Overall Study|Lost to Follow-up|0|||
161915854|NCT01035138|584740567|FG002|Overall Study|Lost to Follow-up|1|||
161915855|NCT02966834|584740568|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161915856|NCT02966834|584740569|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161915857|NCT02966834|584740570|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161915858|NCT02966834|584740571|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161812023|NCT00804856|584355058|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161812024|NCT00804856|584355059|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812025|NCT00804856|584355060|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812026|NCT00804856|584355061|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812027|NCT00804856|584355062|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812028|NCT00804856|584355063|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812029|NCT00804856|584355064|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812030|NCT00804856|584355065|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812031|NCT00804856|584355066|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812032|NCT00804856|584355067|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161812033|NCT00804856|584355068|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161812034|NCT00804856|584355054|FG000|Overall Study|Other Adverse Event|1|||
161812035|NCT00804856|584355055|FG001|Overall Study|Other Adverse Event|1|||
161812036|NCT00804856|584355056|FG002|Overall Study|Other Adverse Event|1|||
161812037|NCT00804856|584355057|FG003|Overall Study|Other Adverse Event|2|||
161812038|NCT00804856|584355058|FG004|Overall Study|Other Adverse Event|2|||
161812039|NCT00804856|584355059|FG005|Overall Study|Other Adverse Event|1|||
161812040|NCT00804856|584355060|FG006|Overall Study|Other Adverse Event|3|||
161812041|NCT00804856|584355061|FG007|Overall Study|Other Adverse Event|0|||
161812042|NCT00804856|584355062|FG008|Overall Study|Other Adverse Event|0|||
161812043|NCT00804856|584355063|FG009|Overall Study|Other Adverse Event|1|||
161812044|NCT00804856|584355064|FG010|Overall Study|Other Adverse Event|5|||
161812045|NCT00804856|584355065|FG011|Overall Study|Other Adverse Event|2|||
161812046|NCT00804856|584355066|FG012|Overall Study|Other Adverse Event|0|||
161812047|NCT00804856|584355067|FG013|Overall Study|Other Adverse Event|6|||
161812048|NCT00804856|584355068|FG014|Overall Study|Other Adverse Event|13|||
161812049|NCT00804856|584355054|FG000|Overall Study|Non compliance with protocol|0|||
161812050|NCT00804856|584355055|FG001|Overall Study|Non compliance with protocol|0|||
161812051|NCT00804856|584355056|FG002|Overall Study|Non compliance with protocol|0|||
161812052|NCT00804856|584355057|FG003|Overall Study|Non compliance with protocol|0|||
161812053|NCT00804856|584355058|FG004|Overall Study|Non compliance with protocol|0|||
161812054|NCT00804856|584355059|FG005|Overall Study|Non compliance with protocol|0|||
161812055|NCT00804856|584355060|FG006|Overall Study|Non compliance with protocol|0|||
161812056|NCT00804856|584355061|FG007|Overall Study|Non compliance with protocol|0|||
161812057|NCT00804856|584355062|FG008|Overall Study|Non compliance with protocol|0|||
161812058|NCT00804856|584355063|FG009|Overall Study|Non compliance with protocol|0|||
161812059|NCT00804856|584355064|FG010|Overall Study|Non compliance with protocol|0|||
161812060|NCT00804856|584355065|FG011|Overall Study|Non compliance with protocol|0|||
161812061|NCT00804856|584355066|FG012|Overall Study|Non compliance with protocol|0|||
161812062|NCT00804856|584355067|FG013|Overall Study|Non compliance with protocol|2|||
161812063|NCT00804856|584355068|FG014|Overall Study|Non compliance with protocol|0|||
161812064|NCT00804856|584355054|FG000|Overall Study|Refused to continue medication|0|||
161812065|NCT00804856|584355055|FG001|Overall Study|Refused to continue medication|0|||
161812066|NCT00804856|584355056|FG002|Overall Study|Refused to continue medication|0|||
161812067|NCT00804856|584355057|FG003|Overall Study|Refused to continue medication|1|||
161812068|NCT00804856|584355058|FG004|Overall Study|Refused to continue medication|1|||
161812069|NCT00804856|584355059|FG005|Overall Study|Refused to continue medication|0|||
161812070|NCT00804856|584355060|FG006|Overall Study|Refused to continue medication|0|||
161812071|NCT00804856|584355061|FG007|Overall Study|Refused to continue medication|0|||
161812072|NCT00804856|584355062|FG008|Overall Study|Refused to continue medication|0|||
161812073|NCT00804856|584355063|FG009|Overall Study|Refused to continue medication|0|||
161812074|NCT00804856|584355064|FG010|Overall Study|Refused to continue medication|3|||
161812075|NCT00804856|584355065|FG011|Overall Study|Refused to continue medication|0|||
161812076|NCT00804856|584355066|FG012|Overall Study|Refused to continue medication|1|||
161812077|NCT00804856|584355067|FG013|Overall Study|Refused to continue medication|1|||
161812078|NCT00804856|584355068|FG014|Overall Study|Refused to continue medication|5|||
161812079|NCT00804856|584355054|FG000|Overall Study|Other reason than listed above|0|||
161812080|NCT00804856|584355055|FG001|Overall Study|Other reason than listed above|0|||
161812081|NCT00804856|584355056|FG002|Overall Study|Other reason than listed above|0|||
161812082|NCT00804856|584355057|FG003|Overall Study|Other reason than listed above|0|||
161812083|NCT00804856|584355058|FG004|Overall Study|Other reason than listed above|0|||
161812084|NCT00804856|584355059|FG005|Overall Study|Other reason than listed above|1|||
161812085|NCT00804856|584355060|FG006|Overall Study|Other reason than listed above|0|||
161812086|NCT00804856|584355061|FG007|Overall Study|Other reason than listed above|0|||
161812087|NCT00804856|584355062|FG008|Overall Study|Other reason than listed above|1|||
161812088|NCT00804856|584355063|FG009|Overall Study|Other reason than listed above|0|||
161812089|NCT00804856|584355064|FG010|Overall Study|Other reason than listed above|3|||
161812090|NCT00804856|584355065|FG011|Overall Study|Other reason than listed above|1|||
161812091|NCT00804856|584355066|FG012|Overall Study|Other reason than listed above|1|||
161812092|NCT00804856|584355067|FG013|Overall Study|Other reason than listed above|10|||
162156664|NCT00331136|585622536|FG002|Overall Study|Adverse Event|0|||
162156665|NCT00331136|585622537|FG003|Overall Study|Adverse Event|1|||
161812093|NCT00804856|584355068|FG014|Overall Study|Other reason than listed above|3|||
161812094|NCT03343535|584355069|FG000|Overall Study|Lost to Follow-up|1|||
161812095|NCT03343535|584355069|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
161812096|NCT03343535|584355069|FG000|Overall Study|Death|12|||
162156666|NCT00331136|585622534|FG000|Overall Study|Withdrawal by Subject|0|||
162156667|NCT00331136|585622535|FG001|Overall Study|Withdrawal by Subject|1|||
162156668|NCT00331136|585622536|FG002|Overall Study|Withdrawal by Subject|0|||
162156669|NCT00331136|585622537|FG003|Overall Study|Withdrawal by Subject|0|||
162156670|NCT00331136|585622534|FG000|Overall Study|Lost to Follow-up|0|||
162156671|NCT00331136|585622535|FG001|Overall Study|Lost to Follow-up|1|||
162156672|NCT00331136|585622536|FG002|Overall Study|Lost to Follow-up|0|||
162156673|NCT00331136|585622537|FG003|Overall Study|Lost to Follow-up|0|||
162156674|NCT00331136|585622534|FG000|Overall Study|Protocol Violation|1|||
162156675|NCT00331136|585622535|FG001|Overall Study|Protocol Violation|0|||
162156676|NCT00331136|585622536|FG002|Overall Study|Protocol Violation|0|||
162156677|NCT00331136|585622537|FG003|Overall Study|Protocol Violation|0|||
162156678|NCT00331136|585622534|FG000|Overall Study|Not treated|1|||
162156679|NCT00331136|585622535|FG001|Overall Study|Not treated|0|||
162156680|NCT00331136|585622536|FG002|Overall Study|Not treated|0|||
162156681|NCT00331136|585622537|FG003|Overall Study|Not treated|0|||
162156682|NCT00419341|585622538|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
162156683|NCT00419341|585622538|FG000|Wash in/Wash Out Period|Adverse Event|2|||
162156684|NCT00419341|585622538|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
162156685|NCT00419341|585622538|FG000|Efficacy Period|Withdrawal by Subject|6|||
162156686|NCT00419341|585622538|FG000|Efficacy Period|Protocol Violation|1|||
162156687|NCT00419341|585622538|FG000|Efficacy Period|Lost to Follow-up|1|||
162156688|NCT00419341|585622538|FG000|Efficacy Period|Non-compliance|1|||
162156689|NCT00419341|585622538|FG000|Efficacy Period|Termination of study site|1|||
162156690|NCT02692417|585622539|FG000|Overall Study|Withdrawal by Subject|5|||
162156691|NCT02692417|585622540|FG001|Overall Study|Withdrawal by Subject|1|||
162156692|NCT02692417|585622539|FG000|Overall Study|Adverse Event|1|||
162156693|NCT02692417|585622540|FG001|Overall Study|Adverse Event|0|||
162156694|NCT04578106|585622551|FG000|Follow-up after 1 year|Lost to Follow-up|1|||
162156695|NCT04690556|585622552|FG000|Overall Study|Adverse Event|6|||
162156696|NCT04690556|585622553|FG001|Overall Study|Adverse Event|4|||
162156697|NCT04690556|585622552|FG000|Overall Study|Death|3|||
161812097|NCT03049748|584355074|FG000|Overall Study|Lost to Follow-up|1|||
161812098|NCT03049748|584355075|FG001|Overall Study|Lost to Follow-up|0|||
161812099|NCT03049748|584355074|FG000|Overall Study|Death|3|||
161812100|NCT03049748|584355075|FG001|Overall Study|Death|0|||
161812101|NCT03049748|584355074|FG000|Overall Study|Withdrawal by Subject|0|||
161812102|NCT03049748|584355075|FG001|Overall Study|Withdrawal by Subject|3|||
161812103|NCT03049748|584355074|FG000|Overall Study|Protocol Violation|0|||
162156698|NCT04690556|585622553|FG001|Overall Study|Death|4|||
162156699|NCT04690556|585622552|FG000|Overall Study|Lost to Follow-up|3|||
162156700|NCT04690556|585622553|FG001|Overall Study|Lost to Follow-up|2|||
162156701|NCT04690556|585622552|FG000|Overall Study|Protocol Violation|1|||
162156702|NCT04690556|585622553|FG001|Overall Study|Protocol Violation|4|||
162156703|NCT04690556|585622552|FG000|Overall Study|Physician Decision|2|||
162156704|NCT04690556|585622553|FG001|Overall Study|Physician Decision|0|||
162156705|NCT04690556|585622552|FG000|Overall Study|Withdrawal by Subject|25|||
162156706|NCT04690556|585622553|FG001|Overall Study|Withdrawal by Subject|17|||
162156707|NCT04690556|585622552|FG000|Overall Study|Prohibited medications and other reasons|3|||
162156708|NCT04690556|585622553|FG001|Overall Study|Prohibited medications and other reasons|1|||
162156709|NCT00497198|585622554|FG000|Overall Study|Adverse Event|4|||
162156710|NCT00497198|585622555|FG001|Overall Study|Adverse Event|2|||
162156711|NCT00497198|585622554|FG000|Overall Study|Physician Decision|1|||
162156712|NCT00497198|585622555|FG001|Overall Study|Physician Decision|2|||
162156713|NCT00497198|585622554|FG000|Overall Study|Withdrawal by Subject|0|||
162156714|NCT00497198|585622555|FG001|Overall Study|Withdrawal by Subject|1|||
162156715|NCT00424463|585622558|FG000|Overall Study|Adverse Event|2|||
162156716|NCT00424463|585622559|FG001|Overall Study|Adverse Event|3|||
162156717|NCT00424463|585622560|FG002|Overall Study|Adverse Event|2|||
162156718|NCT00424463|585622558|FG000|Overall Study|Physician Decision|0|||
162156719|NCT00424463|585622559|FG001|Overall Study|Physician Decision|2|||
162156720|NCT00424463|585622560|FG002|Overall Study|Physician Decision|2|||
162156721|NCT00424463|585622558|FG000|Overall Study|Withdrawal by Subject|4|||
162156722|NCT00424463|585622559|FG001|Overall Study|Withdrawal by Subject|2|||
162156723|NCT00424463|585622560|FG002|Overall Study|Withdrawal by Subject|5|||
162156724|NCT00424463|585622558|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
162156725|NCT00424463|585622559|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
162156726|NCT00424463|585622560|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
162156727|NCT00424463|585622558|FG000|Overall Study|Patient's convenience|0|||
162156728|NCT00424463|585622559|FG001|Overall Study|Patient's convenience|0|||
162156729|NCT00424463|585622560|FG002|Overall Study|Patient's convenience|1|||
162156730|NCT03570892|585622561|FG000|Overall Study|Death|51|||
162156731|NCT03570892|585622562|FG001|Overall Study|Death|45|||
162156732|NCT03570892|585622561|FG000|Overall Study|Subject decision|5|||
162156733|NCT03570892|585622562|FG001|Overall Study|Subject decision|3|||
162156734|NCT03570892|585622561|FG000|Overall Study|Protocol Violation|1|||
162156735|NCT03570892|585622562|FG001|Overall Study|Protocol Violation|4|||
162156736|NCT03570892|585622561|FG000|Overall Study|Physician Decision|0|||
162156737|NCT03570892|585622562|FG001|Overall Study|Physician Decision|2|||
162156738|NCT04434729|585622563|FG000|Overall Study|Adverse Event|1|||
162156739|NCT04434729|585622563|FG000|Overall Study|Physician Decision|1|||
162156740|NCT00975819|585622564|FG000|Overall Study|Lack of Efficacy|8|||
162156741|NCT00975819|585622564|FG000|Overall Study|Adverse Event|2|||
162156742|NCT00975819|585622564|FG000|Overall Study|Physician Decision|2|||
162156743|NCT00975819|585622564|FG000|Overall Study|Withdrawal by Subject|2|||
162156744|NCT00975819|585622564|FG000|Overall Study|Protocol Violation|1|||
162156745|NCT01968109|585622565|FG000|Overall Study|DISEASE PROGRESSION|4|||
162156746|NCT01968109|585622566|FG001|Overall Study|DISEASE PROGRESSION|4|||
162156747|NCT01968109|585622567|FG002|Overall Study|DISEASE PROGRESSION|3|||
162156748|NCT01968109|585622568|FG003|Overall Study|DISEASE PROGRESSION|9|||
162156749|NCT01968109|585622569|FG004|Overall Study|DISEASE PROGRESSION|5|||
162156750|NCT01968109|585622570|FG005|Overall Study|DISEASE PROGRESSION|6|||
162156751|NCT01968109|585622571|FG006|Overall Study|DISEASE PROGRESSION|6|||
162156752|NCT01968109|585622572|FG007|Overall Study|DISEASE PROGRESSION|6|||
162156753|NCT01968109|585622573|FG008|Overall Study|DISEASE PROGRESSION|4|||
162156754|NCT01968109|585622574|FG009|Overall Study|DISEASE PROGRESSION|5|||
162156755|NCT01968109|585622575|FG010|Overall Study|DISEASE PROGRESSION|8|||
162156756|NCT01968109|585622576|FG011|Overall Study|DISEASE PROGRESSION|4|||
162156757|NCT01968109|585622577|FG012|Overall Study|DISEASE PROGRESSION|7|||
162156758|NCT01968109|585622578|FG013|Overall Study|DISEASE PROGRESSION|14|||
162156759|NCT01968109|585622579|FG014|Overall Study|DISEASE PROGRESSION|14|||
162156760|NCT01968109|585622580|FG015|Overall Study|DISEASE PROGRESSION|13|||
162156761|NCT01968109|585622581|FG016|Overall Study|DISEASE PROGRESSION|34|||
162156762|NCT01968109|585622582|FG017|Overall Study|DISEASE PROGRESSION|20|||
162156763|NCT01968109|585622583|FG018|Overall Study|DISEASE PROGRESSION|54|||
162156764|NCT01968109|585622584|FG019|Overall Study|DISEASE PROGRESSION|46|||
161812104|NCT03049748|584355075|FG001|Overall Study|Protocol Violation|2|||
162156765|NCT01968109|585622585|FG020|Overall Study|DISEASE PROGRESSION|77|||
161812105|NCT03049748|584355074|FG000|Overall Study|Moved out of state (relocation)|0|||
161812106|NCT03049748|584355075|FG001|Overall Study|Moved out of state (relocation)|1|||
162156766|NCT01968109|585622586|FG021|Overall Study|DISEASE PROGRESSION|25|||
162156767|NCT01968109|585622587|FG022|Overall Study|DISEASE PROGRESSION|47|||
162156768|NCT01968109|585622588|FG023|Overall Study|DISEASE PROGRESSION|125|||
162156769|NCT01968109|585622589|FG024|Overall Study|DISEASE PROGRESSION|155|||
162156770|NCT01968109|585622590|FG025|Overall Study|DISEASE PROGRESSION|63|||
162156771|NCT01968109|585622591|FG026|Overall Study|DISEASE PROGRESSION|65|||
162156772|NCT01968109|585622592|FG027|Overall Study|DISEASE PROGRESSION|137|||
162156773|NCT01968109|585622593|FG028|Overall Study|DISEASE PROGRESSION|35|||
162156774|NCT01968109|585622594|FG029|Overall Study|DISEASE PROGRESSION|23|||
162156775|NCT01968109|585622595|FG030|Overall Study|DISEASE PROGRESSION|71|||
162156776|NCT01968109|585622565|FG000|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162156777|NCT01968109|585622566|FG001|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162156778|NCT01968109|585622567|FG002|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162156779|NCT01968109|585622568|FG003|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162156780|NCT01968109|585622569|FG004|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162156781|NCT01968109|585622570|FG005|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162156782|NCT01968109|585622571|FG006|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162156783|NCT01968109|585622572|FG007|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162156784|NCT01968109|585622573|FG008|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162156785|NCT01968109|585622574|FG009|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162156786|NCT01968109|585622575|FG010|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162156787|NCT01968109|585622576|FG011|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162156788|NCT01968109|585622577|FG012|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162156789|NCT01968109|585622578|FG013|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162156790|NCT01968109|585622579|FG014|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162156791|NCT01968109|585622580|FG015|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162156792|NCT01968109|585622581|FG016|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162156793|NCT01968109|585622582|FG017|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162156794|NCT01968109|585622583|FG018|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
162156795|NCT01968109|585622584|FG019|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162156796|NCT01968109|585622585|FG020|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
162156797|NCT01968109|585622586|FG021|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
162156798|NCT01968109|585622587|FG022|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
162156799|NCT01968109|585622588|FG023|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|4|||
162156800|NCT01968109|585622589|FG024|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|7|||
162156801|NCT01968109|585622590|FG025|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
162156802|NCT01968109|585622591|FG026|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
162156803|NCT01968109|585622592|FG027|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
162156804|NCT01968109|585622593|FG028|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|8|||
162156805|NCT01968109|585622594|FG029|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|12|||
162156806|NCT01968109|585622595|FG030|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
162156807|NCT01968109|585622565|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
162156808|NCT01968109|585622566|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
162156809|NCT01968109|585622567|FG002|Overall Study|STUDY DRUG TOXICITY|1|||
162156810|NCT01968109|585622568|FG003|Overall Study|STUDY DRUG TOXICITY|2|||
162156811|NCT01968109|585622569|FG004|Overall Study|STUDY DRUG TOXICITY|1|||
162156812|NCT01968109|585622570|FG005|Overall Study|STUDY DRUG TOXICITY|1|||
162156813|NCT01968109|585622571|FG006|Overall Study|STUDY DRUG TOXICITY|1|||
162156814|NCT01968109|585622572|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
162156815|NCT01968109|585622573|FG008|Overall Study|STUDY DRUG TOXICITY|2|||
162156816|NCT01968109|585622574|FG009|Overall Study|STUDY DRUG TOXICITY|1|||
162156817|NCT01968109|585622575|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
162156818|NCT01968109|585622576|FG011|Overall Study|STUDY DRUG TOXICITY|2|||
162156819|NCT01968109|585622577|FG012|Overall Study|STUDY DRUG TOXICITY|0|||
162156820|NCT01968109|585622578|FG013|Overall Study|STUDY DRUG TOXICITY|2|||
162156821|NCT01968109|585622579|FG014|Overall Study|STUDY DRUG TOXICITY|2|||
162156822|NCT01968109|585622580|FG015|Overall Study|STUDY DRUG TOXICITY|4|||
162156823|NCT01968109|585622581|FG016|Overall Study|STUDY DRUG TOXICITY|11|||
162156824|NCT01968109|585622582|FG017|Overall Study|STUDY DRUG TOXICITY|3|||
162156825|NCT01968109|585622583|FG018|Overall Study|STUDY DRUG TOXICITY|4|||
162156826|NCT01968109|585622584|FG019|Overall Study|STUDY DRUG TOXICITY|9|||
162156827|NCT01968109|585622585|FG020|Overall Study|STUDY DRUG TOXICITY|6|||
162156828|NCT01968109|585622586|FG021|Overall Study|STUDY DRUG TOXICITY|4|||
162156829|NCT01968109|585622587|FG022|Overall Study|STUDY DRUG TOXICITY|3|||
161812107|NCT01735994|584355076|FG000|Overall Study|Withdrawal by Subject|6|||
161812108|NCT01735994|584355077|FG001|Overall Study|Withdrawal by Subject|4|||
161812109|NCT01735994|584355076|FG000|Overall Study|Injury|2|||
161812110|NCT01735994|584355077|FG001|Overall Study|Injury|0|||
161812111|NCT01735994|584355076|FG000|Overall Study|Kicked off team|5|||
161812112|NCT01735994|584355077|FG001|Overall Study|Kicked off team|0|||
161812113|NCT01735994|584355076|FG000|Overall Study|Lost to Follow-up|50|||
161812114|NCT01735994|584355077|FG001|Overall Study|Lost to Follow-up|62|||
161812115|NCT03437265|584355083|FG000|Overall Study|Protocol Violation|6|||
161915859|NCT02966834|584740572|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
161915860|NCT02966834|584740573|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161915861|NCT02966834|584740568|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
161915862|NCT02966834|584740569|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161915863|NCT02966834|584740570|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161915864|NCT02966834|584740571|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161915865|NCT02966834|584740572|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
162156830|NCT01968109|585622588|FG023|Overall Study|STUDY DRUG TOXICITY|8|||
161812116|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
161812117|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
161812118|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
161812119|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
161812120|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
161812121|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
161812122|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
161812123|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
161812124|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
161812125|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
161812126|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
161812127|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
161812128|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
161812129|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
161812130|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
161812131|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
161812132|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
161812133|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
161812134|NCT01667679|584355093|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
161812135|NCT01667679|584355094|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
161812136|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
161812137|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
161812138|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
161812139|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
161812140|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
161812141|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
161812142|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
161812143|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
161812144|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
161812145|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
161812146|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
161812147|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
161812148|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
161812149|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
161812150|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
161812151|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
161812152|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
161812153|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
161812154|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
161812155|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
161812156|NCT01667679|584355093|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
161812157|NCT01667679|584355094|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
161812158|NCT01444378|584355101|FG000|Overall Study|Lost to Follow-up|1|||
161812159|NCT01444378|584355101|FG000|Overall Study|Withdrawal by Subject|1|||
161812160|NCT01444378|584355101|FG000|Overall Study|Death|3|||
161812161|NCT01444378|584355101|FG000|Overall Study|Administrative Closure Of The Study|2|||
161812162|NCT01444378|584355101|FG000|Overall Study|Missed Visits|10|||
161812163|NCT02911792|584355102|FG000|Overall Study|Lost to Follow-up|3|||
161812164|NCT02911792|584355103|FG001|Overall Study|Lost to Follow-up|3|||
161812165|NCT02911792|584355104|FG002|Overall Study|Lost to Follow-up|3|||
161812166|NCT02911792|584355105|FG003|Overall Study|Lost to Follow-up|3|||
161812167|NCT00840073|584355108|FG000|Second Intervention|Missed 72 hour blood draw|1|||
161812168|NCT00840073|584355109|FG001|Second Intervention|Missed 72 hour blood draw|1|||
161812169|NCT00107991|584355110|FG000|Eligibility Assessment|Disease not severe enough|7|||
161812170|NCT00107991|584355110|FG000|Eligibility Assessment|Unwilling to participate|7|||
161812171|NCT00107991|584355110|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
161812172|NCT00107991|584355110|FG000|Eligibility Assessment|Abnormal labs|2|||
161812173|NCT00107991|584355110|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
161812174|NCT00107991|584355110|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
161812175|NCT00107991|584355110|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
161812176|NCT00107991|584355110|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
161812177|NCT00107991|584355110|FG000|12 Week Treatment Period|Adverse Event|1|||
161812178|NCT00107991|584355110|FG000|12 Week Treatment Period|Protocol Violation|1|||
161812179|NCT00107991|584355110|FG000|12 Week Treatment Period|Incarcerated|1|||
161915866|NCT02966834|584740573|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161812180|NCT00107991|584355110|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
161812181|NCT03669861|584355111|FG000|Overall Study|Disease Flare|5|||
161812182|NCT03669861|584355111|FG000|Overall Study|Lack of Efficacy|2|||
161812183|NCT02760927|584355112|FG000|Overall Study|Tube Slippage from Device|1|||
162156831|NCT01968109|585622589|FG024|Overall Study|STUDY DRUG TOXICITY|9|||
162156832|NCT01968109|585622590|FG025|Overall Study|STUDY DRUG TOXICITY|8|||
162156833|NCT01968109|585622591|FG026|Overall Study|STUDY DRUG TOXICITY|3|||
162156834|NCT01968109|585622592|FG027|Overall Study|STUDY DRUG TOXICITY|9|||
162156835|NCT01968109|585622593|FG028|Overall Study|STUDY DRUG TOXICITY|14|||
162156836|NCT01968109|585622594|FG029|Overall Study|STUDY DRUG TOXICITY|21|||
162156837|NCT01968109|585622595|FG030|Overall Study|STUDY DRUG TOXICITY|9|||
162156838|NCT01968109|585622565|FG000|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156839|NCT01968109|585622566|FG001|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156840|NCT01968109|585622567|FG002|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156841|NCT01968109|585622568|FG003|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156842|NCT01968109|585622569|FG004|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156843|NCT01968109|585622570|FG005|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156844|NCT01968109|585622571|FG006|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156845|NCT01968109|585622572|FG007|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162156846|NCT01968109|585622573|FG008|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156847|NCT01968109|585622574|FG009|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156848|NCT01968109|585622575|FG010|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156849|NCT01968109|585622576|FG011|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156850|NCT01968109|585622577|FG012|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156851|NCT01968109|585622578|FG013|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156852|NCT01968109|585622579|FG014|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156853|NCT01968109|585622580|FG015|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156854|NCT01968109|585622581|FG016|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156855|NCT01968109|585622582|FG017|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156856|NCT01968109|585622583|FG018|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162156857|NCT01968109|585622584|FG019|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162156858|NCT01968109|585622585|FG020|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162156859|NCT01968109|585622586|FG021|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162156860|NCT01968109|585622587|FG022|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156861|NCT01968109|585622588|FG023|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156862|NCT01968109|585622589|FG024|Overall Study|SUBJECT WITHDREW CONSENT|3|||
162156863|NCT01968109|585622590|FG025|Overall Study|SUBJECT WITHDREW CONSENT|2|||
162156864|NCT01968109|585622591|FG026|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162156865|NCT01968109|585622592|FG027|Overall Study|SUBJECT WITHDREW CONSENT|4|||
162156866|NCT01968109|585622593|FG028|Overall Study|SUBJECT WITHDREW CONSENT|0|||
162156867|NCT01968109|585622594|FG029|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162156868|NCT01968109|585622595|FG030|Overall Study|SUBJECT WITHDREW CONSENT|1|||
162156869|NCT01968109|585622565|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162156870|NCT01968109|585622566|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162156871|NCT01968109|585622567|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162156872|NCT01968109|585622568|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162156873|NCT01968109|585622569|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162156874|NCT01968109|585622570|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162156875|NCT01968109|585622571|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162156876|NCT01968109|585622572|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162156877|NCT01968109|585622573|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
162156878|NCT01968109|585622574|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
162156879|NCT01968109|585622575|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162156880|NCT01968109|585622576|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
162156881|NCT01968109|585622577|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162156882|NCT01968109|585622578|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
162156883|NCT01968109|585622579|FG014|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162156884|NCT01968109|585622580|FG015|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
162156885|NCT01968109|585622581|FG016|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
162156886|NCT01968109|585622582|FG017|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
162156887|NCT01968109|585622583|FG018|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
162156888|NCT01968109|585622584|FG019|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
161812184|NCT00705666|584355113|FG000|Overall Study|No post-treatment questionnaire|279|||
162156889|NCT01968109|585622585|FG020|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
162156890|NCT01968109|585622586|FG021|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
162156891|NCT01968109|585622587|FG022|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
162156892|NCT01968109|585622588|FG023|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161812185|NCT00705666|584355113|FG000|Overall Study|Withdrawal by Subject|21|||
162156893|NCT01968109|585622589|FG024|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|5|||
162156894|NCT01968109|585622590|FG025|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|6|||
161812186|NCT00705666|584355113|FG000|Overall Study|Physician Decision|7|||
161812187|NCT00705666|584355113|FG000|Overall Study|Lost to Follow-up|5|||
161812188|NCT00705666|584355113|FG000|Overall Study|Death|1|||
161812189|NCT00705666|584355113|FG000|Overall Study|Adverse Event|4|||
161812190|NCT00705666|584355113|FG000|Overall Study|Other|12|||
161812191|NCT00705666|584355113|FG000|Overall Study|Other|2|||
162156895|NCT01968109|585622591|FG026|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
162156896|NCT01968109|585622592|FG027|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
162156897|NCT01968109|585622593|FG028|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
162156898|NCT01968109|585622594|FG029|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
162156899|NCT01968109|585622595|FG030|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
162156900|NCT01968109|585622565|FG000|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156901|NCT01968109|585622566|FG001|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156902|NCT01968109|585622567|FG002|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162013982|NCT01759446|585105557|FG002|Overall Study|Withdrawal by Subject|0|||
162013983|NCT01759446|585105558|FG003|Overall Study|Withdrawal by Subject|1|||
162013984|NCT01759446|585105559|FG004|Overall Study|Withdrawal by Subject|0|||
162013985|NCT01760733|585105560|FG000|Waiting List|Death|18|||
162013986|NCT01760733|585105560|FG000|Waiting List|Removed from waiting list|41|||
162013987|NCT01760733|585105560|FG000|Waiting List|Not received a transplant yet|13|||
162013988|NCT01760733|585105560|FG000|Transplanted|Not reached 10 years post transplant|184|||
162013989|NCT01760733|585105560|FG000|Transplanted|Death|26|||
162013990|NCT01760733|585105560|FG000|Transplanted|Graft loss|7|||
162013991|NCT00815659|585105563|FG000|Overall Study|Adverse Event|9|||
162013992|NCT00815659|585105563|FG000|Overall Study|Withdrawal by Subject|9|||
162013993|NCT00815659|585105563|FG000|Overall Study|Lost to Follow-up|4|||
162013994|NCT00815659|585105563|FG000|Overall Study|Protocol Violation|1|||
162013995|NCT00719472|585105564|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
162013996|NCT00719472|585105564|FG000|Enrolled in Study|Subject decision to withdraw|8|||
162013997|NCT00719472|585105564|FG000|Enrolled in Study|Various Reasons|17|||
162013998|NCT00719472|585105564|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
162013999|NCT00719472|585105564|FG000|Received Cycle 1 Treatment|Death|5|||
162014000|NCT00719472|585105564|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
162014001|NCT00719472|585105564|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
162014002|NCT00719472|585105564|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
162014003|NCT00719472|585105564|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
162014004|NCT00719472|585105564|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
162014005|NCT00719472|585105564|FG000|Received Cycle 2 Treatment|Death|6|||
162014006|NCT00719472|585105564|FG000|Received Cycle 2 Treatment|Disease progression|3|||
162014007|NCT00719472|585105564|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
162014008|NCT00719472|585105564|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
162014009|NCT00719472|585105564|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
162014010|NCT00719472|585105564|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
162014011|NCT03584789|585105568|FG000|Overall Study|refused EHR permission|19|||
162014012|NCT03584789|585105569|FG001|Overall Study|refused EHR permission|28|||
161812192|NCT00705666|584355113|FG000|Overall Study|Lack of data|3|||
161812193|NCT00705666|584355113|FG000|Overall Study|Untreated|5|||
162014013|NCT03584789|585105570|FG002|Overall Study|refused EHR permission|23|||
162014014|NCT03584789|585105568|FG000|Overall Study|patients tied to a provider who retired|0|||
162014015|NCT03584789|585105569|FG001|Overall Study|patients tied to a provider who retired|0|||
162014016|NCT03584789|585105570|FG002|Overall Study|patients tied to a provider who retired|3|||
162014017|NCT00602472|585105572|FG000|Overall Study|Adverse Event|5|||
162014018|NCT00602472|585105573|FG001|Overall Study|Adverse Event|23|||
162014019|NCT00602472|585105572|FG000|Overall Study|Protocol Violation|4|||
162156903|NCT01968109|585622568|FG003|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162014020|NCT00602472|585105573|FG001|Overall Study|Protocol Violation|19|||
162014021|NCT00602472|585105572|FG000|Overall Study|Withdrawal by Subject|8|||
162014022|NCT00602472|585105573|FG001|Overall Study|Withdrawal by Subject|14|||
162014023|NCT00602472|585105572|FG000|Overall Study|Other incl. lack of efficacy|4|||
162014024|NCT00602472|585105573|FG001|Overall Study|Other incl. lack of efficacy|2|||
162014025|NCT04730271|585105574|FG000|Overall Study|Adverse Event|0|||
162014026|NCT04730271|585105575|FG001|Overall Study|Adverse Event|2|||
162014027|NCT04730271|585105574|FG000|Overall Study|Withdrawal by Subject|1|||
162014028|NCT04730271|585105575|FG001|Overall Study|Withdrawal by Subject|1|||
162014029|NCT04730271|585105574|FG000|Overall Study|Protocol Violation|7|||
162014030|NCT04730271|585105575|FG001|Overall Study|Protocol Violation|13|||
162014031|NCT04730271|585105574|FG000|Overall Study|Lost to Follow-up|3|||
162014032|NCT04730271|585105575|FG001|Overall Study|Lost to Follow-up|3|||
162014033|NCT04730271|585105574|FG000|Overall Study|Death|1|||
162014034|NCT04730271|585105575|FG001|Overall Study|Death|0|||
162014035|NCT00998296|585105576|FG000|Overall Study|Progressive disease|0|||
162014036|NCT00998296|585105577|FG001|Overall Study|Progressive disease|1|||
162014037|NCT00998296|585105578|FG002|Overall Study|Progressive disease|0|||
162014038|NCT00998296|585105579|FG003|Overall Study|Progressive disease|0|||
162014039|NCT00998296|585105580|FG004|Overall Study|Progressive disease|0|||
162014040|NCT00998296|585105581|FG005|Overall Study|Progressive disease|0|||
162014041|NCT00998296|585105582|FG006|Overall Study|Progressive disease|1|||
162014042|NCT00998296|585105583|FG007|Overall Study|Progressive disease|0|||
162014043|NCT00998296|585105584|FG008|Overall Study|Progressive disease|0|||
162156904|NCT01968109|585622569|FG004|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156905|NCT01968109|585622570|FG005|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162156906|NCT01968109|585622571|FG006|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156907|NCT01968109|585622572|FG007|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156908|NCT01968109|585622573|FG008|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162156909|NCT01968109|585622574|FG009|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156910|NCT01968109|585622575|FG010|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156911|NCT01968109|585622576|FG011|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156912|NCT01968109|585622577|FG012|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156913|NCT01968109|585622578|FG013|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156914|NCT01968109|585622579|FG014|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156915|NCT01968109|585622580|FG015|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
162156916|NCT01968109|585622581|FG016|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
162156917|NCT01968109|585622582|FG017|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162156918|NCT01968109|585622583|FG018|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162156919|NCT01968109|585622584|FG019|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162156920|NCT01968109|585622585|FG020|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
162156921|NCT01968109|585622586|FG021|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162156922|NCT01968109|585622587|FG022|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156923|NCT01968109|585622588|FG023|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
162156924|NCT01968109|585622589|FG024|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|5|||
162156925|NCT01968109|585622590|FG025|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156926|NCT01968109|585622591|FG026|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162156927|NCT01968109|585622592|FG027|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|2|||
162156928|NCT01968109|585622593|FG028|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156929|NCT01968109|585622594|FG029|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
162156930|NCT01968109|585622595|FG030|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
162156931|NCT01968109|585622565|FG000|Overall Study|OTHER REASONS|0|||
162156932|NCT01968109|585622566|FG001|Overall Study|OTHER REASONS|0|||
162156933|NCT01968109|585622567|FG002|Overall Study|OTHER REASONS|0|||
162156934|NCT01968109|585622568|FG003|Overall Study|OTHER REASONS|1|||
162156935|NCT01968109|585622569|FG004|Overall Study|OTHER REASONS|0|||
162156936|NCT01968109|585622570|FG005|Overall Study|OTHER REASONS|0|||
162156937|NCT01968109|585622571|FG006|Overall Study|OTHER REASONS|0|||
162156938|NCT01968109|585622572|FG007|Overall Study|OTHER REASONS|0|||
162156939|NCT01968109|585622573|FG008|Overall Study|OTHER REASONS|0|||
162156940|NCT01968109|585622574|FG009|Overall Study|OTHER REASONS|0|||
162156941|NCT01968109|585622575|FG010|Overall Study|OTHER REASONS|0|||
162156942|NCT01968109|585622576|FG011|Overall Study|OTHER REASONS|1|||
162156943|NCT01968109|585622577|FG012|Overall Study|OTHER REASONS|0|||
162156944|NCT01968109|585622578|FG013|Overall Study|OTHER REASONS|0|||
162156945|NCT01968109|585622579|FG014|Overall Study|OTHER REASONS|1|||
162156946|NCT01968109|585622580|FG015|Overall Study|OTHER REASONS|1|||
162156947|NCT01968109|585622581|FG016|Overall Study|OTHER REASONS|1|||
162156948|NCT01968109|585622582|FG017|Overall Study|OTHER REASONS|0|||
162156949|NCT01968109|585622583|FG018|Overall Study|OTHER REASONS|0|||
162156950|NCT01968109|585622584|FG019|Overall Study|OTHER REASONS|0|||
162156951|NCT01968109|585622585|FG020|Overall Study|OTHER REASONS|0|||
162156952|NCT01968109|585622586|FG021|Overall Study|OTHER REASONS|2|||
162156953|NCT01968109|585622587|FG022|Overall Study|OTHER REASONS|0|||
162156954|NCT01968109|585622588|FG023|Overall Study|OTHER REASONS|0|||
162156955|NCT01968109|585622589|FG024|Overall Study|OTHER REASONS|3|||
162156956|NCT01968109|585622590|FG025|Overall Study|OTHER REASONS|0|||
162156957|NCT01968109|585622591|FG026|Overall Study|OTHER REASONS|3|||
162156958|NCT01968109|585622592|FG027|Overall Study|OTHER REASONS|3|||
162156959|NCT01968109|585622593|FG028|Overall Study|OTHER REASONS|6|||
162156960|NCT01968109|585622594|FG029|Overall Study|OTHER REASONS|7|||
162156961|NCT01968109|585622595|FG030|Overall Study|OTHER REASONS|3|||
162156962|NCT01968109|585622565|FG000|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156963|NCT01968109|585622566|FG001|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156964|NCT01968109|585622567|FG002|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156965|NCT01968109|585622568|FG003|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156966|NCT01968109|585622569|FG004|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156967|NCT01968109|585622570|FG005|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156968|NCT01968109|585622571|FG006|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156969|NCT01968109|585622572|FG007|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156970|NCT01968109|585622573|FG008|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156971|NCT01968109|585622574|FG009|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156972|NCT01968109|585622575|FG010|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162014044|NCT00998296|585105585|FG009|Overall Study|Progressive disease|14|||
162156973|NCT01968109|585622576|FG011|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156974|NCT01968109|585622577|FG012|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156975|NCT01968109|585622578|FG013|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156976|NCT01968109|585622579|FG014|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156977|NCT01968109|585622580|FG015|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156978|NCT01968109|585622581|FG016|Overall Study|MAXIMUM CLINICAL BENEFIT|5|||
162156979|NCT01968109|585622582|FG017|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
162156980|NCT01968109|585622583|FG018|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156981|NCT01968109|585622584|FG019|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
162156982|NCT01968109|585622585|FG020|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
162156983|NCT01968109|585622586|FG021|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156984|NCT01968109|585622587|FG022|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156985|NCT01968109|585622588|FG023|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156986|NCT01968109|585622589|FG024|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
162156987|NCT01968109|585622590|FG025|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
162156988|NCT01968109|585622591|FG026|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
162156989|NCT01968109|585622592|FG027|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
162156990|NCT01968109|585622593|FG028|Overall Study|MAXIMUM CLINICAL BENEFIT|3|||
162156991|NCT01968109|585622594|FG029|Overall Study|MAXIMUM CLINICAL BENEFIT|6|||
162156992|NCT01968109|585622595|FG030|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
162156993|NCT01968109|585622565|FG000|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162156994|NCT01968109|585622566|FG001|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162156995|NCT01968109|585622567|FG002|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162156996|NCT01968109|585622568|FG003|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162156997|NCT01968109|585622569|FG004|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162156998|NCT01968109|585622570|FG005|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162156999|NCT01968109|585622571|FG006|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157000|NCT01968109|585622572|FG007|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157001|NCT01968109|585622573|FG008|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157002|NCT01968109|585622574|FG009|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157003|NCT01968109|585622575|FG010|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157004|NCT01968109|585622576|FG011|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157005|NCT01968109|585622577|FG012|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157006|NCT01968109|585622578|FG013|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157007|NCT01968109|585622579|FG014|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157008|NCT01968109|585622580|FG015|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157009|NCT01968109|585622581|FG016|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157010|NCT01968109|585622582|FG017|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157011|NCT01968109|585622583|FG018|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157012|NCT01968109|585622584|FG019|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157013|NCT01968109|585622585|FG020|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|1|||
162157014|NCT01968109|585622586|FG021|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157015|NCT01968109|585622587|FG022|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157016|NCT01968109|585622588|FG023|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|3|||
162157017|NCT01968109|585622589|FG024|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157018|NCT01968109|585622590|FG025|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157019|NCT01968109|585622591|FG026|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157020|NCT01968109|585622592|FG027|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157021|NCT01968109|585622593|FG028|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157022|NCT01968109|585622594|FG029|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157023|NCT01968109|585622595|FG030|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
162157024|NCT01968109|585622565|FG000|Overall Study|Death|0|||
162157025|NCT01968109|585622566|FG001|Overall Study|Death|0|||
162157026|NCT01968109|585622567|FG002|Overall Study|Death|0|||
161942206|NCT02082977|584838336|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
162157027|NCT01968109|585622568|FG003|Overall Study|Death|0|||
162157028|NCT01968109|585622569|FG004|Overall Study|Death|0|||
162157029|NCT01968109|585622570|FG005|Overall Study|Death|0|||
162157030|NCT01968109|585622571|FG006|Overall Study|Death|0|||
162157031|NCT01968109|585622572|FG007|Overall Study|Death|0|||
162157032|NCT01968109|585622573|FG008|Overall Study|Death|0|||
162157033|NCT01968109|585622574|FG009|Overall Study|Death|0|||
162157034|NCT01968109|585622575|FG010|Overall Study|Death|0|||
162157035|NCT01968109|585622576|FG011|Overall Study|Death|0|||
162157036|NCT01968109|585622577|FG012|Overall Study|Death|0|||
162157037|NCT01968109|585622578|FG013|Overall Study|Death|0|||
162157038|NCT01968109|585622579|FG014|Overall Study|Death|0|||
162157039|NCT01968109|585622580|FG015|Overall Study|Death|0|||
162157040|NCT01968109|585622581|FG016|Overall Study|Death|0|||
162157041|NCT01968109|585622582|FG017|Overall Study|Death|0|||
162157042|NCT01968109|585622583|FG018|Overall Study|Death|0|||
162157043|NCT01968109|585622584|FG019|Overall Study|Death|0|||
162157044|NCT01968109|585622585|FG020|Overall Study|Death|0|||
162157045|NCT01968109|585622586|FG021|Overall Study|Death|1|||
162157046|NCT01968109|585622587|FG022|Overall Study|Death|0|||
162157047|NCT01968109|585622588|FG023|Overall Study|Death|0|||
162157048|NCT01968109|585622589|FG024|Overall Study|Death|0|||
162157049|NCT01968109|585622590|FG025|Overall Study|Death|0|||
162157050|NCT01968109|585622591|FG026|Overall Study|Death|0|||
162157051|NCT01968109|585622592|FG027|Overall Study|Death|0|||
162157052|NCT01968109|585622593|FG028|Overall Study|Death|0|||
162157053|NCT01968109|585622594|FG029|Overall Study|Death|0|||
162157054|NCT01968109|585622595|FG030|Overall Study|Death|1|||
162157055|NCT06938230|585622599|FG000|Overall Study|Lost to Follow-up|56|||
162157056|NCT06938230|585622600|FG001|Overall Study|Lost to Follow-up|18|||
162157057|NCT03899792|585622604|FG000|Phase 2|Ongoing Treatment|0|||
162157058|NCT03899792|585622605|FG001|Phase 2|Ongoing Treatment|13|||
162157059|NCT03899792|585622606|FG002|Phase 2|Ongoing Treatment|14|||
162157060|NCT03899792|585622607|FG003|Phase 2|Ongoing Treatment|2|||
162157061|NCT03899792|585622604|FG000|Phase 2|Death|0|||
162157062|NCT03899792|585622605|FG001|Phase 2|Death|0|||
162157063|NCT03899792|585622606|FG002|Phase 2|Death|0|||
162157064|NCT03899792|585622607|FG003|Phase 2|Death|4|||
162157065|NCT03899792|585622604|FG000|Phase 2|Lost to Follow-up|0|||
162157066|NCT03899792|585622605|FG001|Phase 2|Lost to Follow-up|1|||
162157067|NCT03899792|585622606|FG002|Phase 2|Lost to Follow-up|1|||
162157068|NCT03899792|585622607|FG003|Phase 2|Lost to Follow-up|0|||
161812194|NCT02964039|584355115|FG000|Overall Study|Medical reason unrelated to study participation|1|||
161812195|NCT02964039|584355116|FG001|Overall Study|Medical reason unrelated to study participation|0|||
161812196|NCT02964039|584355117|FG002|Overall Study|Medical reason unrelated to study participation|3|||
161812197|NCT02964039|584355115|FG000|Overall Study|Research shutdown due to pandemic|2|||
161812198|NCT02964039|584355116|FG001|Overall Study|Research shutdown due to pandemic|0|||
161812199|NCT02964039|584355117|FG002|Overall Study|Research shutdown due to pandemic|1|||
161812200|NCT02964039|584355115|FG000|Overall Study|Withdrawal by Subject|0|||
161812201|NCT02964039|584355116|FG001|Overall Study|Withdrawal by Subject|1|||
161812202|NCT02964039|584355117|FG002|Overall Study|Withdrawal by Subject|0|||
161812203|NCT02964039|584355115|FG000|Overall Study|Lost to Follow-up|1|||
161812204|NCT02964039|584355116|FG001|Overall Study|Lost to Follow-up|0|||
161812205|NCT02964039|584355117|FG002|Overall Study|Lost to Follow-up|1|||
161812206|NCT02645409|584355118|FG000|Overall Study|Withdrawal by Subject|3|||
161812207|NCT02645409|584355119|FG001|Overall Study|Withdrawal by Subject|0|||
161812208|NCT02645409|584355118|FG000|Overall Study|Physician Decision|1|||
161812209|NCT02645409|584355119|FG001|Overall Study|Physician Decision|0|||
161812210|NCT03552393|584355124|FG000|Core Period|Kidney Transplant|1|||
161812211|NCT03552393|584355124|FG000|Core Period|Prohibited Medication|1|||
161812212|NCT03552393|584355124|FG000|Safety Extension Period|Kidney Transplant|4|||
161812213|NCT05646251|584355127|FG000|Overall Study|Physician Decision|1|||
161812214|NCT05646251|584355128|FG001|Overall Study|Physician Decision|0|||
161812215|NCT05646251|584355129|FG002|Overall Study|Physician Decision|2|||
161812216|NCT01576042|584355131|FG000|Overall Study|Physician Decision|2|||
161812217|NCT01576042|584355132|FG001|Overall Study|Physician Decision|0|||
161812218|NCT00465270|584355133|FG000|Overall Study|Death|7|||
161812219|NCT00465270|584355134|FG001|Overall Study|Death|11|||
161812220|NCT00465270|584355133|FG000|Overall Study|Withdrawal by Subject|34|||
161812221|NCT00465270|584355134|FG001|Overall Study|Withdrawal by Subject|78|||
161812222|NCT00465270|584355133|FG000|Overall Study|Lost to Follow-up|60|||
161812223|NCT00465270|584355134|FG001|Overall Study|Lost to Follow-up|67|||
161812224|NCT00465270|584355133|FG000|Overall Study|Investigator request|3|||
161812225|NCT00465270|584355134|FG001|Overall Study|Investigator request|4|||
161812226|NCT03233724|584355135|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
161812227|NCT03233724|584355136|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
162157069|NCT03899792|585622604|FG000|Phase 2|Withdrawal by Subject|0|||
162157070|NCT03899792|585622605|FG001|Phase 2|Withdrawal by Subject|1|||
162157071|NCT03899792|585622606|FG002|Phase 2|Withdrawal by Subject|0|||
162157072|NCT03899792|585622607|FG003|Phase 2|Withdrawal by Subject|0|||
161812228|NCT03233724|584355137|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
162157073|NCT00330681|585622608|FG000|Overall Study|Adverse Event|3|||
162157074|NCT00330681|585622609|FG001|Overall Study|Adverse Event|6|||
162157075|NCT00330681|585622608|FG000|Overall Study|Protocol Violation|0|||
162157076|NCT00330681|585622609|FG001|Overall Study|Protocol Violation|1|||
162157077|NCT00330681|585622608|FG000|Overall Study|Withdrawal by Subject|5|||
162157078|NCT00330681|585622609|FG001|Overall Study|Withdrawal by Subject|5|||
162157079|NCT00330681|585622608|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
162157080|NCT00330681|585622609|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
162157081|NCT04310735|585623791|FG000|Overall Study|Withdrawal by Subject|1|||
162157082|NCT04310735|585623792|FG001|Overall Study|Withdrawal by Subject|3|||
162157083|NCT04310735|585623793|FG002|Overall Study|Withdrawal by Subject|8|||
162157084|NCT04310735|585623791|FG000|Overall Study|Equipment malfunction|0|||
162157085|NCT04310735|585623792|FG001|Overall Study|Equipment malfunction|1|||
162157086|NCT04310735|585623793|FG002|Overall Study|Equipment malfunction|0|||
162157087|NCT03012841|585623794|FG000|Overall Study|Protocol Violation|0|||
162157088|NCT03012841|585623795|FG001|Overall Study|Protocol Violation|10|||
162157089|NCT03012841|585623794|FG000|Overall Study|Lost to Follow-up|6|||
162157090|NCT03012841|585623795|FG001|Overall Study|Lost to Follow-up|1|||
162157091|NCT03012841|585623794|FG000|Overall Study|Withdrawal by Subject|6|||
161812229|NCT03233724|584355138|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
161812230|NCT03233724|584355139|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
161812231|NCT03233724|584355135|FG000|Phase I Dose Escalation|Best interest of participant|1|||
161812232|NCT03233724|584355136|FG001|Phase I Dose Escalation|Best interest of participant|1|||
161812233|NCT03233724|584355137|FG002|Phase I Dose Escalation|Best interest of participant|1|||
161812234|NCT03233724|584355138|FG003|Phase I Dose Escalation|Best interest of participant|0|||
161812235|NCT03233724|584355139|FG004|Phase I Dose Escalation|Best interest of participant|0|||
161812236|NCT03233724|584355135|FG000|Phase I Dose Escalation|Physician Decision|0|||
161812237|NCT03233724|584355136|FG001|Phase I Dose Escalation|Physician Decision|0|||
161812238|NCT03233724|584355137|FG002|Phase I Dose Escalation|Physician Decision|1|||
161812239|NCT03233724|584355138|FG003|Phase I Dose Escalation|Physician Decision|0|||
161812240|NCT03233724|584355139|FG004|Phase I Dose Escalation|Physician Decision|0|||
161812241|NCT03233724|584355135|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
161812242|NCT03233724|584355136|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
161812243|NCT03233724|584355137|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
161812244|NCT03233724|584355138|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
161812245|NCT03233724|584355139|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
161812246|NCT00651820|584355142|FG000|Overall Study|Lost to Follow-up|2|||
161915867|NCT02966834|584740568|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
161915868|NCT02966834|584740569|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
161812247|NCT02388191|584355143|FG000|Overall Study|Patient did not receive IUD|1|||
162157092|NCT03012841|585623795|FG001|Overall Study|Withdrawal by Subject|0|||
162157093|NCT03012841|585623794|FG000|Overall Study|Unable to complete 12 month visit|6|||
161812248|NCT02388191|584355144|FG001|Overall Study|Patient did not receive IUD|0|||
161812249|NCT01911676|584355145|FG000|Period 1 of Study|Withdrawal by Subject|4|||
161812250|NCT01911676|584355146|FG001|Period 1 of Study|Withdrawal by Subject|2|||
161812251|NCT01911676|584355147|FG002|Period 1 of Study|Withdrawal by Subject|1|||
161812252|NCT01911676|584355148|FG003|Period 1 of Study|Withdrawal by Subject|2|||
161812253|NCT01911676|584355145|FG000|Period 1 of Study|Physician Decision|2|||
161812254|NCT01911676|584355146|FG001|Period 1 of Study|Physician Decision|0|||
161812255|NCT01911676|584355147|FG002|Period 1 of Study|Physician Decision|0|||
161812256|NCT01911676|584355148|FG003|Period 1 of Study|Physician Decision|1|||
161812257|NCT01911676|584355145|FG000|Period 2 of Study|Physician Decision|2|||
161812258|NCT01911676|584355146|FG001|Period 2 of Study|Physician Decision|0|||
161812259|NCT01911676|584355147|FG002|Period 2 of Study|Physician Decision|0|||
161812260|NCT01911676|584355148|FG003|Period 2 of Study|Physician Decision|1|||
161812261|NCT01911676|584355145|FG000|Period 2 of Study|Lost to Follow-up|0|||
161812262|NCT01911676|584355146|FG001|Period 2 of Study|Lost to Follow-up|0|||
161812263|NCT01911676|584355147|FG002|Period 2 of Study|Lost to Follow-up|0|||
161812264|NCT01911676|584355148|FG003|Period 2 of Study|Lost to Follow-up|1|||
161812265|NCT00773253|584355151|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
162014045|NCT00998296|585105586|FG010|Overall Study|Progressive disease|5|||
162014046|NCT00998296|585105576|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
161812266|NCT00773253|584355152|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
161812267|NCT03173547|584355153|FG000|Overall Study|Adverse Event|2|||
161812268|NCT03173547|584355154|FG001|Overall Study|Adverse Event|0|||
161812269|NCT03173547|584355153|FG000|Overall Study|Withdrawal by Subject|2|||
162014047|NCT00998296|585105577|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
162014048|NCT00998296|585105578|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
162014049|NCT00998296|585105579|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
162014050|NCT00998296|585105580|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
162014051|NCT00998296|585105581|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
162014052|NCT00998296|585105582|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
162014053|NCT00998296|585105583|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
162014054|NCT00998296|585105584|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
162014055|NCT00998296|585105585|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
162014056|NCT00998296|585105586|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
162014057|NCT00998296|585105576|FG000|Overall Study|Other adverse event|0|||
162014058|NCT00998296|585105577|FG001|Overall Study|Other adverse event|0|||
162014059|NCT00998296|585105578|FG002|Overall Study|Other adverse event|0|||
162014060|NCT00998296|585105579|FG003|Overall Study|Other adverse event|0|||
162014061|NCT00998296|585105580|FG004|Overall Study|Other adverse event|1|||
162014062|NCT00998296|585105581|FG005|Overall Study|Other adverse event|0|||
162014063|NCT00998296|585105582|FG006|Overall Study|Other adverse event|0|||
162014064|NCT00998296|585105583|FG007|Overall Study|Other adverse event|0|||
162014065|NCT00998296|585105584|FG008|Overall Study|Other adverse event|0|||
162014066|NCT00998296|585105585|FG009|Overall Study|Other adverse event|1|||
162014067|NCT00998296|585105586|FG010|Overall Study|Other adverse event|2|||
162014068|NCT00998296|585105576|FG000|Overall Study|Refused to continue taking trial med.|0|||
162014069|NCT00998296|585105577|FG001|Overall Study|Refused to continue taking trial med.|0|||
162014070|NCT00998296|585105578|FG002|Overall Study|Refused to continue taking trial med.|0|||
162014071|NCT00998296|585105579|FG003|Overall Study|Refused to continue taking trial med.|0|||
162014072|NCT00998296|585105580|FG004|Overall Study|Refused to continue taking trial med.|0|||
162014073|NCT00998296|585105581|FG005|Overall Study|Refused to continue taking trial med.|0|||
162014074|NCT00998296|585105582|FG006|Overall Study|Refused to continue taking trial med.|0|||
162014075|NCT00998296|585105583|FG007|Overall Study|Refused to continue taking trial med.|0|||
162014076|NCT00998296|585105584|FG008|Overall Study|Refused to continue taking trial med.|0|||
162014077|NCT00998296|585105585|FG009|Overall Study|Refused to continue taking trial med.|2|||
162014078|NCT00998296|585105586|FG010|Overall Study|Refused to continue taking trial med.|0|||
162014079|NCT00998296|585105576|FG000|Overall Study|Reason other than those specified above|0|||
162014080|NCT00998296|585105577|FG001|Overall Study|Reason other than those specified above|0|||
162014081|NCT00998296|585105578|FG002|Overall Study|Reason other than those specified above|0|||
162014082|NCT00998296|585105579|FG003|Overall Study|Reason other than those specified above|0|||
162014083|NCT00998296|585105580|FG004|Overall Study|Reason other than those specified above|0|||
162014084|NCT00998296|585105581|FG005|Overall Study|Reason other than those specified above|0|||
162014085|NCT00998296|585105582|FG006|Overall Study|Reason other than those specified above|0|||
161812270|NCT03173547|584355154|FG001|Overall Study|Withdrawal by Subject|2|||
162014086|NCT00998296|585105583|FG007|Overall Study|Reason other than those specified above|0|||
162014087|NCT00998296|585105584|FG008|Overall Study|Reason other than those specified above|0|||
162014088|NCT00998296|585105585|FG009|Overall Study|Reason other than those specified above|1|||
162014089|NCT00998296|585105586|FG010|Overall Study|Reason other than those specified above|0|||
161812271|NCT02530905|584355155|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
161812272|NCT02530905|584355156|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
162157094|NCT03012841|585623795|FG001|Overall Study|Unable to complete 12 month visit|0|||
162157095|NCT03012841|585623794|FG000|Overall Study|Subject relocation|1|||
162157096|NCT03012841|585623795|FG001|Overall Study|Subject relocation|0|||
162157097|NCT03012841|585623794|FG000|Overall Study|Seasonal winter travel|1|||
162157098|NCT03012841|585623795|FG001|Overall Study|Seasonal winter travel|0|||
162157099|NCT03012841|585623794|FG000|Overall Study|Physician Decision|0|||
162157100|NCT03012841|585623795|FG001|Overall Study|Physician Decision|2|||
162157101|NCT03012841|585623794|FG000|Overall Study|No ablation performed|0|||
162157102|NCT03012841|585623795|FG001|Overall Study|No ablation performed|2|||
162157103|NCT03012841|585623794|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
162157104|NCT03012841|585623795|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
162157105|NCT03012841|585623794|FG000|Overall Study|Insurance change|0|||
162157106|NCT03012841|585623795|FG001|Overall Study|Insurance change|1|||
162157107|NCT05696080|585623796|FG000|Overall Study|Lost to Follow-up|2|||
162157108|NCT05696080|585623797|FG001|Overall Study|Lost to Follow-up|1|||
162157109|NCT05696080|585623796|FG000|Overall Study|Physician Decision|1|||
162157110|NCT05696080|585623797|FG001|Overall Study|Physician Decision|0|||
162157111|NCT05696080|585623796|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162157112|NCT05696080|585623797|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
162157113|NCT05696080|585623796|FG000|Overall Study|Withdrawal by Subject|12|||
162157114|NCT05696080|585623797|FG001|Overall Study|Withdrawal by Subject|0|||
162157115|NCT03398200|585623798|FG000|Overall Study|Withdrawal by Subject|0|||
162157116|NCT03398200|585623799|FG001|Overall Study|Withdrawal by Subject|1|||
162157117|NCT04065048|585623800|FG000|Overall Study|Withdrawal by Subject|1|||
162157118|NCT04065048|585623801|FG001|Overall Study|Withdrawal by Subject|2|||
162157119|NCT04065048|585623802|FG002|Overall Study|Withdrawal by Subject|1|||
162157120|NCT04065048|585623803|FG003|Overall Study|Withdrawal by Subject|1|||
162157121|NCT04065048|585623800|FG000|Overall Study|Adverse Event|1|||
162157122|NCT04065048|585623801|FG001|Overall Study|Adverse Event|0|||
162157123|NCT04065048|585623802|FG002|Overall Study|Adverse Event|1|||
162157124|NCT04065048|585623803|FG003|Overall Study|Adverse Event|0|||
162157125|NCT03397108|585623804|FG000|Overall Study|Lost to Follow-up|15|||
162157126|NCT03397108|585623805|FG001|Overall Study|Lost to Follow-up|0|||
162157127|NCT03397108|585623804|FG000|Overall Study|Insufficient milk production|3|||
162157128|NCT03397108|585623805|FG001|Overall Study|Insufficient milk production|2|||
162157129|NCT03397108|585623804|FG000|Overall Study|Withdrawal by Subject|2|||
162157130|NCT03397108|585623805|FG001|Overall Study|Withdrawal by Subject|0|||
162157131|NCT05096819|585623808|FG000|Overall Study|Withdrawal by Subject|3|||
162157132|NCT05096819|585623809|FG001|Overall Study|Withdrawal by Subject|0|||
162157133|NCT03324984|585623810|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
162157134|NCT03324984|585623811|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
162157135|NCT04607044|585623814|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
162157136|NCT04607044|585623814|FG000|Overall Study|Adverse Event|1|||
162157137|NCT04607044|585623814|FG000|Overall Study|Did not receive study device|3|||
162157138|NCT04607044|585623814|FG000|Overall Study|Death|1|||
162157139|NCT05403801|585623815|FG000|Overall Study|Withdrawal by Subject|2|||
162157140|NCT04337372|585623819|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
162157141|NCT04337372|585623820|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
162157142|NCT04337372|585623821|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
162157143|NCT04337372|585623822|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
162157144|NCT04337372|585623819|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
162157145|NCT04337372|585623820|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
162157146|NCT04337372|585623821|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
162157147|NCT04337372|585623822|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
162157148|NCT04337372|585623819|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
162157149|NCT04337372|585623820|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
162157150|NCT04337372|585623821|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
162157151|NCT04337372|585623822|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
162157152|NCT04337372|585623819|FG000|Day 2: EEG Measures|Protocol Violation|6|||
161812273|NCT02530905|584355157|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
161812274|NCT01231906|584355158|FG000|Overall Study|Lack of Efficacy|75|||
161812275|NCT01231906|584355159|FG001|Overall Study|Lack of Efficacy|68|||
161812276|NCT01231906|584355158|FG000|Overall Study|Lost to Follow-up|1|||
161812277|NCT01231906|584355159|FG001|Overall Study|Lost to Follow-up|0|||
161812278|NCT01231906|584355158|FG000|Overall Study|Physician Decision|34|||
161812279|NCT01231906|584355159|FG001|Overall Study|Physician Decision|24|||
161915869|NCT02966834|584740570|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
162157153|NCT04337372|585623820|FG001|Day 2: EEG Measures|Protocol Violation|6|||
162157154|NCT04337372|585623821|FG002|Day 2: EEG Measures|Protocol Violation|5|||
162157155|NCT04337372|585623822|FG003|Day 2: EEG Measures|Protocol Violation|17|||
162157156|NCT05307783|585623823|FG000|Overall Study|Death|7|||
162157157|NCT05307783|585623823|FG000|Overall Study|Lost to Follow-up|4|||
162157158|NCT04883645|585623824|FG000|Overall Study|Death|1|||
161812280|NCT01231906|584355158|FG000|Overall Study|Withdrawal by Subject|0|||
162157159|NCT03460236|585623826|FG000|Overall Study|failed radiographic screening|16|||
162157160|NCT03460236|585623826|FG000|Overall Study|Withdrawal by Subject|11|||
162157161|NCT06194214|585623827|FG000|Overall Study|Adverse Event|1|||
162157162|NCT04869982|585623831|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
162157163|NCT04869982|585623832|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
162157164|NCT04869982|585623831|FG000|Overall Study|Migrated / moved from the study area|1|||
162157165|NCT04869982|585623832|FG001|Overall Study|Migrated / moved from the study area|1|||
162157166|NCT04869982|585623831|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
162157167|NCT04869982|585623832|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
162157168|NCT04869982|585623831|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
162157169|NCT04869982|585623832|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
162157170|NCT04869982|585623831|FG000|Overall Study|Solicited adverse event|2|||
162157171|NCT04869982|585623832|FG001|Overall Study|Solicited adverse event|1|||
162157172|NCT04608045|585623833|FG000|Overall Study|Physician Decision|1|||
162157173|NCT02473250|585623835|FG000|Overall Study|Lost to Follow-up|10|||
162157174|NCT02473250|585623835|FG000|Overall Study|Physician Decision|5|||
162157175|NCT02473250|585623835|FG000|Overall Study|Did not tolerate medication washout|3|||
162157176|NCT02473250|585623835|FG000|Overall Study|Antidepressant effect of divalproex|2|||
162157177|NCT04847999|585623836|FG000|Overall Study|Lost to Follow-up|0|||
162157178|NCT04847999|585623837|FG001|Overall Study|Lost to Follow-up|1|||
162157179|NCT01704079|585623841|FG000|Overall Study|Withdrawal by Subject|5|||
162157180|NCT01704079|585623842|FG001|Overall Study|Withdrawal by Subject|7|||
162157181|NCT01704079|585623841|FG000|Overall Study|Lost to Follow-up|2|||
162157182|NCT01704079|585623842|FG001|Overall Study|Lost to Follow-up|5|||
162157183|NCT01704079|585623841|FG000|Overall Study|Adverse Event|4|||
162157184|NCT01704079|585623842|FG001|Overall Study|Adverse Event|7|||
162157185|NCT01704079|585623841|FG000|Overall Study|Protocol Violation|1|||
162157186|NCT01704079|585623842|FG001|Overall Study|Protocol Violation|0|||
162157187|NCT01704079|585623841|FG000|Overall Study|Subject noncompliance|2|||
162157188|NCT01704079|585623842|FG001|Overall Study|Subject noncompliance|3|||
162157189|NCT01704079|585623841|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
162157190|NCT01704079|585623842|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
162157191|NCT04300231|585623843|FG000|Overall Study|Protocol Violation|4|||
162157192|NCT04300231|585623844|FG001|Overall Study|Protocol Violation|3|||
162157193|NCT04300231|585623845|FG002|Overall Study|Protocol Violation|0|||
162157194|NCT04300231|585623846|FG003|Overall Study|Protocol Violation|2|||
162157195|NCT00243503|585623852|FG000|Overall Study|Adverse Event|11|||
162157196|NCT00243503|585623852|FG000|Overall Study|Withdrawal by Subject|1|||
162157197|NCT00243503|585623852|FG000|Overall Study|Lack of Efficacy|44|||
162157198|NCT00243503|585623852|FG000|Overall Study|Death|1|||
162157199|NCT00243503|585623852|FG000|Overall Study|Other|1|||
162157200|NCT00520546|585623856|FG000|Overall Study|Withdrawal by Subject|1|||
162157201|NCT00520546|585623856|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
162157202|NCT03988023|585623858|FG000|Overall Study|Non-compliance|3|||
162157203|NCT03988023|585623859|FG001|Overall Study|Non-compliance|0|||
162157204|NCT03988023|585623858|FG000|Overall Study|Withdrawal by Subject|39|||
162157205|NCT03988023|585623859|FG001|Overall Study|Withdrawal by Subject|37|||
162157206|NCT03988023|585623858|FG000|Overall Study|Adverse Event|0|||
162157207|NCT03988023|585623859|FG001|Overall Study|Adverse Event|2|||
162157208|NCT03988023|585623858|FG000|Overall Study|Physician Decision|0|||
162157209|NCT03988023|585623859|FG001|Overall Study|Physician Decision|1|||
162157210|NCT03988023|585623858|FG000|Overall Study|Lost to Follow-up|5|||
162157211|NCT03988023|585623859|FG001|Overall Study|Lost to Follow-up|8|||
162157212|NCT03988023|585623858|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
162157213|NCT03988023|585623859|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
162157214|NCT03988023|585623858|FG000|Overall Study|Lack of Efficacy|3|||
162157215|NCT03988023|585623859|FG001|Overall Study|Lack of Efficacy|1|||
162157216|NCT03988023|585623858|FG000|Overall Study|COVID-19 pandemic|225|||
162157217|NCT03988023|585623859|FG001|Overall Study|COVID-19 pandemic|227|||
162157218|NCT02101281|585623860|FG000|Overall Study|Adverse Event|0|||
162157219|NCT02101281|585623861|FG001|Overall Study|Adverse Event|1|||
162157220|NCT03733119|585623862|FG000|Overall Study|Physician Decision|2|||
162157221|NCT03733119|585623863|FG001|Overall Study|Physician Decision|1|||
162157222|NCT03733119|585623862|FG000|Overall Study|ineligible to treat per protocol|0|||
161812281|NCT01231906|584355159|FG001|Overall Study|Withdrawal by Subject|4|||
162014090|NCT04396639|585105587|FG000|Overall Study|Withdrawal by Subject|1|||
162157223|NCT03733119|585623863|FG001|Overall Study|ineligible to treat per protocol|1|||
162157224|NCT02554786|585623866|FG000|Overall Study|Subject/guardian decision|29|||
162157225|NCT02554786|585623867|FG001|Overall Study|Subject/guardian decision|17|||
162157226|NCT02554786|585623868|FG002|Overall Study|Subject/guardian decision|18|||
162157227|NCT02554786|585623869|FG003|Overall Study|Subject/guardian decision|30|||
162157228|NCT02554786|585623870|FG004|Overall Study|Subject/guardian decision|20|||
162157229|NCT02554786|585623866|FG000|Overall Study|Lost to Follow-up|4|||
162157230|NCT02554786|585623867|FG001|Overall Study|Lost to Follow-up|3|||
161812282|NCT01231906|584355158|FG000|Overall Study|Ineligible|10|||
161812283|NCT01231906|584355159|FG001|Overall Study|Ineligible|3|||
161812284|NCT01231906|584355158|FG000|Overall Study|No treatment|1|||
161812285|NCT01231906|584355159|FG001|Overall Study|No treatment|2|||
161812286|NCT01136174|584355160|FG000|Overall Study|Adverse Event|0|||
161812287|NCT01136174|584355161|FG001|Overall Study|Adverse Event|0|||
161812288|NCT01136174|584355162|FG002|Overall Study|Adverse Event|0|||
161812289|NCT01136174|584355163|FG003|Overall Study|Adverse Event|4|||
161812290|NCT01249651|584355166|FG000|Overall Study|Withdrawal by Subject|4|||
161812291|NCT01249651|584355166|FG000|Overall Study|Adverse Event|1|||
161812292|NCT01249651|584355166|FG000|Overall Study|Protocol Violation|1|||
161812293|NCT01249651|584355166|FG000|Overall Study|Sponsor Decision|1|||
161812294|NCT03873272|584355173|FG000|Overall Study|Withdrawal by Subject|2|||
161812295|NCT03873272|584355174|FG001|Overall Study|Withdrawal by Subject|0|||
161812296|NCT03873272|584355175|FG002|Overall Study|Withdrawal by Subject|1|||
161812297|NCT03873272|584355173|FG000|Overall Study|Death|0|||
161812298|NCT03873272|584355174|FG001|Overall Study|Death|2|||
161812299|NCT03873272|584355175|FG002|Overall Study|Death|1|||
161812300|NCT03761173|584355176|FG000|Overall Study|Lost to Follow-up|93|||
161812301|NCT03761173|584355176|FG000|Overall Study|Withdrawal by Subject|74|||
161812302|NCT03761173|584355176|FG000|Overall Study|Death|45|||
161812303|NCT03761173|584355176|FG000|Overall Study|Withdrawal for Other Reasons|29|||
161812304|NCT03761173|584355176|FG000|Overall Study|Protocol Violation|1|||
161812305|NCT01952691|584356151|FG000|Overall Study|Lost to Follow-up|2|||
161812306|NCT05776901|584356152|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
161812307|NCT02255149|584356157|FG000|Overall Study|Lost to Follow-up|2|||
161812308|NCT02255149|584356157|FG000|Overall Study|Withdrawal by Subject|1|||
161812309|NCT02255149|584356157|FG000|Overall Study|Withdrawal by PI|1|||
161812310|NCT02255149|584356157|FG000|Overall Study|Implant Failure|1|||
161812311|NCT00373256|584356158|FG000|Overall Study|Adverse Event (AE)|1|||
161812312|NCT00373256|584356159|FG001|Overall Study|Adverse Event (AE)|5|||
161812313|NCT00373256|584356158|FG000|Overall Study|Lost to Follow-up|2|||
161812314|NCT00373256|584356159|FG001|Overall Study|Lost to Follow-up|1|||
161812315|NCT00373256|584356158|FG000|Overall Study|Death|9|||
161812316|NCT00373256|584356159|FG001|Overall Study|Death|8|||
161812317|NCT00373256|584356158|FG000|Overall Study|Objective Progression or Relapse|111|||
161812318|NCT00373256|584356159|FG001|Overall Study|Objective Progression or Relapse|104|||
161812319|NCT00373256|584356158|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
161812320|NCT00373256|584356159|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
161812321|NCT00373256|584356158|FG000|Overall Study|Other|73|||
161812322|NCT00373256|584356159|FG001|Overall Study|Other|107|||
161812323|NCT00373256|584356158|FG000|Overall Study|Protocol Violation|0|||
161812324|NCT00373256|584356159|FG001|Overall Study|Protocol Violation|2|||
161812325|NCT00373256|584356158|FG000|Overall Study|Study Terminated by Sponsor|41|||
161812326|NCT00373256|584356159|FG001|Overall Study|Study Terminated by Sponsor|13|||
161812327|NCT03032172|584356162|FG000|Treatment Period|Adverse Event|0|||
161812328|NCT03032172|584356163|FG001|Treatment Period|Adverse Event|1|||
161812329|NCT03032172|584356164|FG002|Treatment Period|Adverse Event|0|||
161812330|NCT03032172|584356165|FG003|Treatment Period|Adverse Event|0|||
161812331|NCT03032172|584356166|FG004|Treatment Period|Adverse Event|0|||
161812332|NCT03032172|584356167|FG005|Treatment Period|Adverse Event|0|||
161812333|NCT03032172|584356168|FG006|Treatment Period|Adverse Event|0|||
161812334|NCT03032172|584356169|FG007|Treatment Period|Adverse Event|0|||
161812335|NCT03032172|584356162|FG000|Treatment Period|Lack of Efficacy|0|||
161812336|NCT03032172|584356163|FG001|Treatment Period|Lack of Efficacy|1|||
161812337|NCT03032172|584356164|FG002|Treatment Period|Lack of Efficacy|0|||
161812338|NCT03032172|584356165|FG003|Treatment Period|Lack of Efficacy|0|||
161812339|NCT03032172|584356166|FG004|Treatment Period|Lack of Efficacy|0|||
161812340|NCT03032172|584356167|FG005|Treatment Period|Lack of Efficacy|0|||
161812341|NCT03032172|584356168|FG006|Treatment Period|Lack of Efficacy|0|||
161812342|NCT03032172|584356169|FG007|Treatment Period|Lack of Efficacy|0|||
161812343|NCT03032172|584356162|FG000|Treatment Period|Non-compliance With Study Drug|0|||
161812344|NCT03032172|584356163|FG001|Treatment Period|Non-compliance With Study Drug|1|||
161812345|NCT03032172|584356164|FG002|Treatment Period|Non-compliance With Study Drug|0|||
161812346|NCT03032172|584356165|FG003|Treatment Period|Non-compliance With Study Drug|0|||
162014091|NCT04396639|585105587|FG000|Overall Study|Other|1|||
161812347|NCT03032172|584356166|FG004|Treatment Period|Non-compliance With Study Drug|0|||
161812348|NCT03032172|584356167|FG005|Treatment Period|Non-compliance With Study Drug|0|||
161812349|NCT03032172|584356168|FG006|Treatment Period|Non-compliance With Study Drug|0|||
162157231|NCT02554786|585623868|FG002|Overall Study|Lost to Follow-up|4|||
162157232|NCT02554786|585623869|FG003|Overall Study|Lost to Follow-up|2|||
162157233|NCT02554786|585623870|FG004|Overall Study|Lost to Follow-up|2|||
162157234|NCT02554786|585623866|FG000|Overall Study|Protocol deviation|1|||
162157235|NCT02554786|585623867|FG001|Overall Study|Protocol deviation|3|||
162157236|NCT02554786|585623868|FG002|Overall Study|Protocol deviation|3|||
162157237|NCT02554786|585623869|FG003|Overall Study|Protocol deviation|4|||
162157238|NCT02554786|585623870|FG004|Overall Study|Protocol deviation|2|||
162157239|NCT02554786|585623866|FG000|Overall Study|Technical problems|1|||
162157240|NCT02554786|585623867|FG001|Overall Study|Technical problems|1|||
162157241|NCT02554786|585623868|FG002|Overall Study|Technical problems|0|||
162157242|NCT02554786|585623869|FG003|Overall Study|Technical problems|2|||
162157243|NCT02554786|585623870|FG004|Overall Study|Technical problems|1|||
162157244|NCT02554786|585623866|FG000|Overall Study|Adverse Event|0|||
162157245|NCT02554786|585623867|FG001|Overall Study|Adverse Event|0|||
162157246|NCT02554786|585623868|FG002|Overall Study|Adverse Event|0|||
162157247|NCT02554786|585623869|FG003|Overall Study|Adverse Event|0|||
162157248|NCT02554786|585623870|FG004|Overall Study|Adverse Event|2|||
162157249|NCT02554786|585623866|FG000|Overall Study|Death|0|||
162157250|NCT02554786|585623867|FG001|Overall Study|Death|0|||
162157251|NCT02554786|585623868|FG002|Overall Study|Death|0|||
162157252|NCT02554786|585623869|FG003|Overall Study|Death|1|||
162157253|NCT02554786|585623870|FG004|Overall Study|Death|0|||
162157254|NCT02554786|585623866|FG000|Overall Study|Non-compliance with study treatment|0|||
162157255|NCT02554786|585623867|FG001|Overall Study|Non-compliance with study treatment|1|||
162157256|NCT02554786|585623868|FG002|Overall Study|Non-compliance with study treatment|1|||
162157257|NCT02554786|585623869|FG003|Overall Study|Non-compliance with study treatment|0|||
162157258|NCT02554786|585623870|FG004|Overall Study|Non-compliance with study treatment|1|||
162157259|NCT02554786|585623866|FG000|Overall Study|Physician Decision|0|||
162157260|NCT02554786|585623867|FG001|Overall Study|Physician Decision|1|||
162157261|NCT02554786|585623868|FG002|Overall Study|Physician Decision|4|||
162157262|NCT02554786|585623869|FG003|Overall Study|Physician Decision|1|||
162157263|NCT02554786|585623870|FG004|Overall Study|Physician Decision|1|||
162157264|NCT02554786|585623866|FG000|Overall Study|Pregnancy|0|||
162157265|NCT02554786|585623867|FG001|Overall Study|Pregnancy|0|||
162157266|NCT02554786|585623868|FG002|Overall Study|Pregnancy|0|||
162157267|NCT02554786|585623869|FG003|Overall Study|Pregnancy|1|||
162157268|NCT02554786|585623870|FG004|Overall Study|Pregnancy|1|||
162157269|NCT05052996|585623871|FG000|Overall Study|Still on study|0|||
162157270|NCT05052996|585623872|FG001|Overall Study|Still on study|0|||
162157271|NCT05052996|585623873|FG002|Overall Study|Still on study|47|||
162157272|NCT05052996|585623874|FG003|Overall Study|Still on study|44|||
162157273|NCT05052996|585623871|FG000|Overall Study|Cohort terminated by sponsor|21|||
162157274|NCT05052996|585623872|FG001|Overall Study|Cohort terminated by sponsor|12|||
162157275|NCT05052996|585623873|FG002|Overall Study|Cohort terminated by sponsor|0|||
162157276|NCT05052996|585623874|FG003|Overall Study|Cohort terminated by sponsor|0|||
162157277|NCT05052996|585623871|FG000|Overall Study|Withdrew consent|1|||
162157278|NCT05052996|585623872|FG001|Overall Study|Withdrew consent|0|||
162157279|NCT05052996|585623873|FG002|Overall Study|Withdrew consent|1|||
162157280|NCT05052996|585623874|FG003|Overall Study|Withdrew consent|2|||
162157281|NCT05052996|585623871|FG000|Overall Study|Lost to Follow-up|1|||
162157282|NCT05052996|585623872|FG001|Overall Study|Lost to Follow-up|0|||
162157283|NCT05052996|585623873|FG002|Overall Study|Lost to Follow-up|0|||
162157284|NCT05052996|585623874|FG003|Overall Study|Lost to Follow-up|2|||
162157285|NCT05052996|585623871|FG000|Overall Study|Adverse Event|0|||
162014092|NCT01544335|585105590|FG000|Overall Study|Lost to Follow-up|27|||
162014093|NCT01544335|585105590|FG000|Overall Study|Death|4|||
162014094|NCT01544335|585105590|FG000|Overall Study|Disease progression|3|||
162014095|NCT01544335|585105590|FG000|Overall Study|Baseline Measurements not Available|19|||
161812350|NCT03032172|584356169|FG007|Treatment Period|Non-compliance With Study Drug|0|||
161812351|NCT03032172|584356162|FG000|Treatment Period|Reason Not Specified|0|||
161812352|NCT03032172|584356163|FG001|Treatment Period|Reason Not Specified|4|||
161812353|NCT03032172|584356164|FG002|Treatment Period|Reason Not Specified|1|||
162014096|NCT01532986|585105596|FG000|Overall Study|Death|9|||
162157286|NCT05052996|585623872|FG001|Overall Study|Adverse Event|0|||
162157287|NCT05052996|585623873|FG002|Overall Study|Adverse Event|2|||
162157288|NCT05052996|585623874|FG003|Overall Study|Adverse Event|0|||
162157289|NCT05052996|585623871|FG000|Overall Study|Randomized but never treated|0|||
162157290|NCT05052996|585623872|FG001|Overall Study|Randomized but never treated|0|||
162157291|NCT05052996|585623873|FG002|Overall Study|Randomized but never treated|1|||
162157292|NCT05052996|585623874|FG003|Overall Study|Randomized but never treated|1|||
162157293|NCT05052996|585623871|FG000|Overall Study|Protocol Violation|1|||
162157294|NCT05052996|585623872|FG001|Overall Study|Protocol Violation|0|||
162157295|NCT05052996|585623873|FG002|Overall Study|Protocol Violation|0|||
162157296|NCT05052996|585623874|FG003|Overall Study|Protocol Violation|0|||
162157297|NCT01695954|585623875|FG000|Overall Study|Withdrawal by Subject|4|||
162157298|NCT01695954|585623876|FG001|Overall Study|Withdrawal by Subject|0|||
162157299|NCT01695954|585623875|FG000|Overall Study|Adverse Event|0|||
162014097|NCT01532986|585105597|FG001|Overall Study|Death|9|||
162014098|NCT01532986|585105596|FG000|Overall Study|Withdrawal by Subject|7|||
162014099|NCT01532986|585105597|FG001|Overall Study|Withdrawal by Subject|10|||
162014100|NCT01532986|585105596|FG000|Overall Study|Physician Decision|7|||
162014101|NCT01532986|585105597|FG001|Overall Study|Physician Decision|5|||
162014102|NCT00885170|585105600|FG000|Overall Study|Adverse Event|12|||
162014103|NCT00885170|585105601|FG001|Overall Study|Adverse Event|4|||
162014104|NCT00885170|585105600|FG000|Overall Study|Excessive bone loss|6|||
162014105|NCT00885170|585105601|FG001|Overall Study|Excessive bone loss|3|||
162014106|NCT00885170|585105600|FG000|Overall Study|Lost to Follow-up|2|||
162014107|NCT00885170|585105601|FG001|Overall Study|Lost to Follow-up|1|||
162014108|NCT00885170|585105600|FG000|Overall Study|Physician Decision|2|||
162014109|NCT00885170|585105601|FG001|Overall Study|Physician Decision|1|||
162014110|NCT00885170|585105600|FG000|Overall Study|Protocol Violation|3|||
162014111|NCT00885170|585105601|FG001|Overall Study|Protocol Violation|1|||
162014112|NCT00885170|585105600|FG000|Overall Study|Withdrawal by Subject|13|||
162014113|NCT00885170|585105601|FG001|Overall Study|Withdrawal by Subject|13|||
162014114|NCT03771664|585105602|FG000|Overall Study|Adverse Event|1|||
162014115|NCT03771664|585105603|FG001|Overall Study|Adverse Event|0|||
162014116|NCT03771664|585105602|FG000|Overall Study|Lost to Follow-up|1|||
162014117|NCT03771664|585105603|FG001|Overall Study|Lost to Follow-up|0|||
162014118|NCT03771664|585105602|FG000|Overall Study|Withdrawal by Participant|1|||
162014119|NCT03771664|585105603|FG001|Overall Study|Withdrawal by Participant|4|||
162014120|NCT03771664|585105602|FG000|Overall Study|Randomized but not Treated|0|||
162014121|NCT03771664|585105603|FG001|Overall Study|Randomized but not Treated|1|||
162014122|NCT02120898|585105604|FG000|Overall Study|Withdrawal by Subject|4|||
162014123|NCT02120898|585105605|FG001|Overall Study|Withdrawal by Subject|2|||
162014124|NCT02120898|585105606|FG002|Overall Study|Withdrawal by Subject|2|||
162014125|NCT02120898|585105604|FG000|Overall Study|Non-compliance with study drug|3|||
162014126|NCT02120898|585105605|FG001|Overall Study|Non-compliance with study drug|0|||
162014127|NCT02120898|585105606|FG002|Overall Study|Non-compliance with study drug|0|||
162014128|NCT02120898|585105604|FG000|Overall Study|Adverse Event|1|||
162014129|NCT02120898|585105605|FG001|Overall Study|Adverse Event|2|||
162014130|NCT02120898|585105606|FG002|Overall Study|Adverse Event|1|||
162014131|NCT02120898|585105604|FG000|Overall Study|Protocol Violation|1|||
162014132|NCT02120898|585105605|FG001|Overall Study|Protocol Violation|2|||
162014133|NCT02120898|585105606|FG002|Overall Study|Protocol Violation|0|||
162014134|NCT02120898|585105604|FG000|Overall Study|Lost to Follow-up|0|||
162014135|NCT02120898|585105605|FG001|Overall Study|Lost to Follow-up|0|||
162014136|NCT02120898|585105606|FG002|Overall Study|Lost to Follow-up|1|||
162014137|NCT00561925|585105607|FG000|14 Day Lead-In Period|Adverse Event|38|||
162014138|NCT00561925|585105608|FG001|14 Day Lead-In Period|Adverse Event|0|||
162014139|NCT00561925|585105609|FG002|14 Day Lead-In Period|Adverse Event|0|||
162014140|NCT00561925|585105610|FG003|14 Day Lead-In Period|Adverse Event|0|||
162014141|NCT00561925|585105611|FG004|14 Day Lead-In Period|Adverse Event|0|||
162014142|NCT00561925|585105607|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
162014143|NCT00561925|585105608|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
162014144|NCT00561925|585105609|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
162014145|NCT00561925|585105610|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
162014146|NCT00561925|585105611|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
162014147|NCT00561925|585105607|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
162014148|NCT00561925|585105608|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
162014149|NCT00561925|585105609|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
162014150|NCT00561925|585105610|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
162014151|NCT00561925|585105611|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
162014152|NCT00561925|585105607|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
162014153|NCT00561925|585105608|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
162014154|NCT00561925|585105609|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
162014155|NCT00561925|585105610|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
162014156|NCT00561925|585105611|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
162014157|NCT00561925|585105607|FG000|14 Day Lead-In Period|Other|5|||
162014158|NCT00561925|585105608|FG001|14 Day Lead-In Period|Other|0|||
162014159|NCT00561925|585105609|FG002|14 Day Lead-In Period|Other|0|||
162014160|NCT00561925|585105610|FG003|14 Day Lead-In Period|Other|0|||
162014161|NCT00561925|585105611|FG004|14 Day Lead-In Period|Other|0|||
162014162|NCT00561925|585105607|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
162014163|NCT00561925|585105608|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
162014164|NCT00561925|585105609|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
162014165|NCT00561925|585105610|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
162014166|NCT00561925|585105611|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
162014167|NCT00561925|585105607|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
162014168|NCT00561925|585105608|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
162014169|NCT00561925|585105609|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
162014170|NCT00561925|585105610|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
162014171|NCT00561925|585105611|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
162014172|NCT00561925|585105607|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
162157300|NCT01695954|585623876|FG001|Overall Study|Adverse Event|2|||
162157301|NCT01248936|585623878|FG000|Overall Study|Sponsor Decision|259|||
162157302|NCT01248936|585623878|FG000|Overall Study|Progression of Disease|50|||
162157303|NCT01248936|585623878|FG000|Overall Study|Death|26|||
162157304|NCT01248936|585623878|FG000|Overall Study|Withdrawal of Consent|20|||
162157305|NCT01248936|585623878|FG000|Overall Study|Adverse Event|8|||
162157306|NCT01248936|585623878|FG000|Overall Study|Lost to Follow-up|7|||
162157307|NCT01248936|585623878|FG000|Overall Study|Refused Treatment|1|||
162157308|NCT01248936|585623878|FG000|Overall Study|Other reason|3|||
162157309|NCT05609032|585623879|FG000|Overall Study|Lost to Follow-up|3|||
162157310|NCT05609032|585623880|FG001|Overall Study|Lost to Follow-up|1|||
162157311|NCT05609032|585623879|FG000|Overall Study|Withdrawal by Subject|1|||
162157312|NCT05609032|585623880|FG001|Overall Study|Withdrawal by Subject|0|||
162157313|NCT03664960|585623890|FG000|Overall Study|Adverse Event|0|||
162157314|NCT03664960|585623891|FG001|Overall Study|Adverse Event|3|||
162157315|NCT03664960|585623890|FG000|Overall Study|Lost to Follow-up|3|||
162157316|NCT03664960|585623891|FG001|Overall Study|Lost to Follow-up|2|||
162157317|NCT03664960|585623890|FG000|Overall Study|Physician Decision|1|||
162157318|NCT03664960|585623891|FG001|Overall Study|Physician Decision|0|||
162157319|NCT03664960|585623890|FG000|Overall Study|Withdrawal by Subject|3|||
162157320|NCT03664960|585623891|FG001|Overall Study|Withdrawal by Subject|14|||
162157321|NCT03664960|585623890|FG000|Overall Study|Sponsor Decision|1|||
162157322|NCT03664960|585623891|FG001|Overall Study|Sponsor Decision|1|||
162157323|NCT03664960|585623890|FG000|Overall Study|Other|1|||
162157324|NCT03664960|585623891|FG001|Overall Study|Other|2|||
162157325|NCT04019444|585623892|FG000|Overall Study|Withdrawal by Subject|0|||
162157326|NCT04019444|585623893|FG001|Overall Study|Withdrawal by Subject|1|||
162157327|NCT04019444|585623894|FG002|Overall Study|Withdrawal by Subject|0|||
162157328|NCT04019444|585623895|FG003|Overall Study|Withdrawal by Subject|1|||
162157329|NCT04019444|585623892|FG000|Overall Study|Solicited Event|0|||
162157330|NCT04019444|585623893|FG001|Overall Study|Solicited Event|0|||
162157331|NCT04019444|585623894|FG002|Overall Study|Solicited Event|2|||
162157332|NCT04019444|585623895|FG003|Overall Study|Solicited Event|0|||
162157333|NCT01207492|585623896|FG000|Overall Study|Still on study|1|||
162157334|NCT01207492|585623896|FG000|Overall Study|Withdrawal by Subject|9|||
162157335|NCT01207492|585623896|FG000|Overall Study|Physician Decision|1|||
162157336|NCT01207492|585623896|FG000|Overall Study|Progressive disease|3|||
162157337|NCT01207492|585623896|FG000|Overall Study|Toxicity|1|||
162157338|NCT05028582|585623898|FG000|Overall Study|Lost to Follow-up|11|||
162157339|NCT05028582|585623899|FG001|Overall Study|Lost to Follow-up|9|||
162157340|NCT05028582|585623898|FG000|Overall Study|Withdrawal by Subject|9|||
162157341|NCT05028582|585623899|FG001|Overall Study|Withdrawal by Subject|10|||
162157342|NCT05028582|585623898|FG000|Overall Study|Adverse Event|5|||
162157343|NCT05028582|585623899|FG001|Overall Study|Adverse Event|2|||
162157344|NCT05028582|585623898|FG000|Overall Study|Miscellaneous|3|||
162157345|NCT05028582|585623899|FG001|Overall Study|Miscellaneous|2|||
162157346|NCT05028582|585623898|FG000|Overall Study|Lack of Efficacy|3|||
161812354|NCT03032172|584356165|FG003|Treatment Period|Reason Not Specified|0|||
161812355|NCT03032172|584356166|FG004|Treatment Period|Reason Not Specified|0|||
161812356|NCT03032172|584356167|FG005|Treatment Period|Reason Not Specified|0|||
161812357|NCT03032172|584356168|FG006|Treatment Period|Reason Not Specified|0|||
161812358|NCT03032172|584356169|FG007|Treatment Period|Reason Not Specified|0|||
161812359|NCT03032172|584356162|FG000|Treatment Period|Physician Decision|0|||
161812360|NCT03032172|584356163|FG001|Treatment Period|Physician Decision|2|||
161812361|NCT03032172|584356164|FG002|Treatment Period|Physician Decision|1|||
161812362|NCT03032172|584356165|FG003|Treatment Period|Physician Decision|0|||
161812363|NCT03032172|584356166|FG004|Treatment Period|Physician Decision|0|||
161812364|NCT03032172|584356167|FG005|Treatment Period|Physician Decision|0|||
162157347|NCT05028582|585623899|FG001|Overall Study|Lack of Efficacy|1|||
162157348|NCT05028582|585623898|FG000|Overall Study|Physician Decision|0|||
162157349|NCT05028582|585623899|FG001|Overall Study|Physician Decision|1|||
161812365|NCT03032172|584356168|FG006|Treatment Period|Physician Decision|0|||
161812366|NCT03032172|584356169|FG007|Treatment Period|Physician Decision|0|||
161812367|NCT03032172|584356162|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
162157350|NCT04278586|585625384|FG000|Overall Study|Withdrawal by Subject|13|||
162157351|NCT04278586|585625385|FG001|Overall Study|Withdrawal by Subject|6|||
162157352|NCT04278586|585625384|FG000|Overall Study|Lost to Follow-up|37|||
162157353|NCT04278586|585625385|FG001|Overall Study|Lost to Follow-up|24|||
162157354|NCT03954184|585625392|FG000|Overall Study|Lost to Follow-up|500|||
162157355|NCT03954184|585625393|FG001|Overall Study|Lost to Follow-up|0|||
162157356|NCT05215847|585625394|FG000|Overall Study|Lost to Follow-up|1|||
162157357|NCT02879448|585625395|FG000|Overall Study|Death|251|||
162157358|NCT02879448|585625396|FG001|Overall Study|Death|263|||
162157359|NCT02879448|585625395|FG000|Overall Study|Lost to Follow-up|23|||
162157360|NCT02879448|585625396|FG001|Overall Study|Lost to Follow-up|28|||
162157361|NCT02879448|585625395|FG000|Overall Study|Withdrawal by Subject|42|||
161812368|NCT03032172|584356163|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
162157362|NCT02879448|585625396|FG001|Overall Study|Withdrawal by Subject|79|||
162157363|NCT02879448|585625395|FG000|Overall Study|Other Reasons|8|||
162157364|NCT02879448|585625396|FG001|Overall Study|Other Reasons|12|||
162157365|NCT02819843|585625406|FG000|Overall Study|Disease progression before RT|0|||
162157366|NCT02819843|585625407|FG001|Overall Study|Disease progression before RT|1|||
162157367|NCT04732494|585625408|FG000|Overall Study|Death|39|||
162157368|NCT04732494|585625409|FG001|Overall Study|Death|36|||
162157369|NCT04732494|585625408|FG000|Overall Study|Study Closed by Sponsor|20|||
162157370|NCT04732494|585625409|FG001|Overall Study|Study Closed by Sponsor|15|||
162157371|NCT04732494|585625408|FG000|Overall Study|Withdrawal by Subject|2|||
162157372|NCT04732494|585625409|FG001|Overall Study|Withdrawal by Subject|7|||
162157373|NCT04732494|585625408|FG000|Overall Study|Lost to Follow-up|1|||
162157374|NCT04732494|585625409|FG001|Overall Study|Lost to Follow-up|5|||
162157375|NCT03055858|585625410|FG000|Overall Study|Death|9|||
162157376|NCT03055858|585625410|FG000|Overall Study|Withdrawal by Subject|11|||
162157377|NCT03055858|585625410|FG000|Overall Study|Lost to Follow-up|6|||
162157378|NCT03055858|585625410|FG000|Overall Study|Missed Follow-Up Visits|18|||
162157379|NCT02728557|585625411|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
162157380|NCT02728557|585625412|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
162157381|NCT02728557|585625411|FG000|Overall Study|Dissatisfaction with research tasks|0|||
162157382|NCT02728557|585625412|FG001|Overall Study|Dissatisfaction with research tasks|1|||
162157383|NCT02728557|585625411|FG000|Overall Study|Scheduling or change in availability|1|||
162157384|NCT02728557|585625412|FG001|Overall Study|Scheduling or change in availability|1|||
162157385|NCT03416010|585625413|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
162157386|NCT03416010|585625414|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
162157387|NCT03416010|585625413|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
162157388|NCT03416010|585625414|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
162157389|NCT03416010|585625413|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
162157390|NCT03416010|585625414|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
162157391|NCT03416010|585625413|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
162157392|NCT03416010|585625414|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
162157393|NCT03416010|585625413|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
162157394|NCT03416010|585625414|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
162157395|NCT03416010|585625413|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
162157396|NCT03416010|585625414|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
162157397|NCT03416010|585625413|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
162157398|NCT03416010|585625414|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
162157399|NCT03948763|585625415|FG000|Overall Study|Sponsor's decision|0|||
162157400|NCT03948763|585625416|FG001|Overall Study|Sponsor's decision|2|||
162157401|NCT03948763|585625417|FG002|Overall Study|Sponsor's decision|6|||
162157402|NCT03948763|585625418|FG003|Overall Study|Sponsor's decision|4|||
162157403|NCT03948763|585625419|FG004|Overall Study|Sponsor's decision|0|||
162157404|NCT03948763|585625415|FG000|Overall Study|Physician Decision|0|||
162157405|NCT03948763|585625416|FG001|Overall Study|Physician Decision|0|||
162157406|NCT03948763|585625417|FG002|Overall Study|Physician Decision|1|||
162157407|NCT03948763|585625418|FG003|Overall Study|Physician Decision|0|||
162157408|NCT03948763|585625419|FG004|Overall Study|Physician Decision|0|||
162157409|NCT03948763|585625415|FG000|Overall Study|Lost to Follow-up|0|||
162157410|NCT03948763|585625416|FG001|Overall Study|Lost to Follow-up|0|||
162157411|NCT03948763|585625417|FG002|Overall Study|Lost to Follow-up|0|||
162157412|NCT03948763|585625418|FG003|Overall Study|Lost to Follow-up|0|||
162157413|NCT03948763|585625419|FG004|Overall Study|Lost to Follow-up|1|||
162157414|NCT03948763|585625415|FG000|Overall Study|Death|2|||
162157415|NCT03948763|585625416|FG001|Overall Study|Death|12|||
162157416|NCT03948763|585625417|FG002|Overall Study|Death|13|||
162157417|NCT03948763|585625418|FG003|Overall Study|Death|10|||
162157418|NCT03948763|585625419|FG004|Overall Study|Death|11|||
162157419|NCT03948763|585625415|FG000|Overall Study|Withdrawal by Subject|1|||
162157420|NCT03948763|585625416|FG001|Overall Study|Withdrawal by Subject|1|||
162157421|NCT03948763|585625417|FG002|Overall Study|Withdrawal by Subject|0|||
161812369|NCT03032172|584356164|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
161812370|NCT03032172|584356165|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
161812371|NCT03032172|584356166|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161812372|NCT03032172|584356167|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161812373|NCT03032172|584356168|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
162157422|NCT03948763|585625418|FG003|Overall Study|Withdrawal by Subject|2|||
162157423|NCT03948763|585625419|FG004|Overall Study|Withdrawal by Subject|4|||
162157424|NCT06629454|585625423|FG000|Overall Study|Withdraw by Clinician Decision|1|||
162157425|NCT06023082|585625424|FG000|Overall Study|Withdrawal by Subject|2|||
162157426|NCT06023082|585625424|FG000|Overall Study|Lost to Follow-up|15|||
162157427|NCT06023082|585625424|FG000|Overall Study|Side effects|5|||
162157428|NCT05986565|585625425|FG000|Overall Study|Lost to Follow-up|8|||
161812374|NCT03032172|584356169|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161812375|NCT03032172|584356162|FG000|Treatment Period|Withdrawal by Subject|2|||
161812376|NCT03032172|584356163|FG001|Treatment Period|Withdrawal by Subject|0|||
162014173|NCT00561925|585105608|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
162014174|NCT00561925|585105609|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
162014175|NCT00561925|585105610|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
162014176|NCT00561925|585105611|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
162014177|NCT00561925|585105607|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
162014178|NCT00561925|585105608|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
162014179|NCT00561925|585105609|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
162014180|NCT00561925|585105610|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
162014181|NCT00561925|585105611|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
162014182|NCT00561925|585105607|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
162014183|NCT00561925|585105608|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
162014184|NCT00561925|585105609|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
162014185|NCT00561925|585105610|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
162014186|NCT00561925|585105611|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
162014187|NCT00561925|585105607|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
162014188|NCT00561925|585105608|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
162014189|NCT00561925|585105609|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
162014190|NCT00561925|585105610|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
162014191|NCT00561925|585105611|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
162014192|NCT00561925|585105607|FG000|144-week Double-blind, Double-dummy|Death|0|||
162014193|NCT00561925|585105608|FG001|144-week Double-blind, Double-dummy|Death|6|||
162014194|NCT00561925|585105609|FG002|144-week Double-blind, Double-dummy|Death|3|||
162014195|NCT00561925|585105610|FG003|144-week Double-blind, Double-dummy|Death|0|||
162014196|NCT00561925|585105611|FG004|144-week Double-blind, Double-dummy|Death|0|||
162014197|NCT00561925|585105607|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
162014198|NCT00561925|585105608|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
162014199|NCT00561925|585105609|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
162014200|NCT00561925|585105610|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
162014201|NCT00561925|585105611|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
162014202|NCT00561925|585105607|FG000|144-week Double-blind, Double-dummy|Other|0|||
162014203|NCT00561925|585105608|FG001|144-week Double-blind, Double-dummy|Other|8|||
162014204|NCT00561925|585105609|FG002|144-week Double-blind, Double-dummy|Other|11|||
162014205|NCT00561925|585105610|FG003|144-week Double-blind, Double-dummy|Other|0|||
162014206|NCT00561925|585105611|FG004|144-week Double-blind, Double-dummy|Other|0|||
162014207|NCT00561925|585105607|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
162014208|NCT00561925|585105608|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
162014209|NCT00561925|585105609|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
162014210|NCT00561925|585105610|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
162014211|NCT00561925|585105611|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
162014212|NCT00684021|585105612|FG000|Overall Study|MRI Contraindicated|1|||
162014213|NCT00684021|585105613|FG001|Overall Study|MRI Contraindicated|1|||
162014214|NCT00684021|585105614|FG002|Overall Study|MRI Contraindicated|1|||
162014215|NCT00684021|585105615|FG003|Overall Study|MRI Contraindicated|0|||
162014216|NCT00684021|585105612|FG000|Overall Study|MRI not performed|0|||
162014217|NCT00684021|585105613|FG001|Overall Study|MRI not performed|1|||
162014218|NCT00684021|585105614|FG002|Overall Study|MRI not performed|1|||
162014219|NCT00684021|585105615|FG003|Overall Study|MRI not performed|2|||
162014220|NCT00684021|585105612|FG000|Overall Study|Death|1|||
162014221|NCT00684021|585105613|FG001|Overall Study|Death|0|||
162014222|NCT00684021|585105614|FG002|Overall Study|Death|0|||
162014223|NCT00684021|585105615|FG003|Overall Study|Death|0|||
162014224|NCT02161016|585105619|FG000|Overall Study|withdrawn by IRB|1|||
162014225|NCT02556177|585105623|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
162014226|NCT02556177|585105624|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
162014227|NCT03818321|585105627|FG000|Overall Study|Withdrawal by Subject|1|||
162014228|NCT03818321|585105628|FG001|Overall Study|Withdrawal by Subject|2|||
162014229|NCT00275509|585105629|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
162014230|NCT00275509|585105630|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
162014231|NCT00380367|585105632|FG000|Overall Study|Lost to Follow-up|1|||
162014232|NCT00380367|585105632|FG000|Overall Study|Withdrawal by Subject|1|||
162014233|NCT03486834|585105638|FG000|Overall Study|Withdrawal by Subject|46|||
162014234|NCT03486834|585105639|FG001|Overall Study|Withdrawal by Subject|46|||
162014235|NCT03486834|585105640|FG002|Overall Study|Withdrawal by Subject|52|||
162014236|NCT03486834|585105638|FG000|Overall Study|Adverse Event|8|||
162014237|NCT03486834|585105639|FG001|Overall Study|Adverse Event|7|||
162014238|NCT03486834|585105640|FG002|Overall Study|Adverse Event|0|||
162014239|NCT03486834|585105638|FG000|Overall Study|Lost to Follow-up|41|||
162014240|NCT03486834|585105639|FG001|Overall Study|Lost to Follow-up|24|||
162014241|NCT03486834|585105640|FG002|Overall Study|Lost to Follow-up|39|||
162014242|NCT03486834|585105638|FG000|Overall Study|Non-compliance with Study Drug|2|||
162014243|NCT03486834|585105639|FG001|Overall Study|Non-compliance with Study Drug|2|||
162014244|NCT03486834|585105640|FG002|Overall Study|Non-compliance with Study Drug|0|||
162014245|NCT03486834|585105638|FG000|Overall Study|Physician Decision|5|||
162014246|NCT03486834|585105639|FG001|Overall Study|Physician Decision|2|||
162014247|NCT03486834|585105640|FG002|Overall Study|Physician Decision|3|||
162014248|NCT03486834|585105638|FG000|Overall Study|Pregnancy|10|||
162014249|NCT03486834|585105639|FG001|Overall Study|Pregnancy|12|||
162014250|NCT03486834|585105640|FG002|Overall Study|Pregnancy|12|||
162014251|NCT03486834|585105638|FG000|Overall Study|Protocol Deviation|2|||
162014252|NCT03486834|585105639|FG001|Overall Study|Protocol Deviation|3|||
162014253|NCT03486834|585105640|FG002|Overall Study|Protocol Deviation|3|||
162014254|NCT03486834|585105638|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162014255|NCT03486834|585105639|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
162014256|NCT03486834|585105640|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
162014257|NCT03486834|585105638|FG000|Overall Study|Randomized but not treated|4|||
162014258|NCT03486834|585105639|FG001|Overall Study|Randomized but not treated|4|||
162014259|NCT03486834|585105640|FG002|Overall Study|Randomized but not treated|1|||
162014260|NCT00432172|585105641|FG000|Overall Study|Physician Decision|0|||
162014261|NCT00432172|585105642|FG001|Overall Study|Physician Decision|0|||
162014262|NCT00432172|585105643|FG002|Overall Study|Physician Decision|2|||
162157429|NCT05986565|585625426|FG001|Overall Study|Lost to Follow-up|3|||
162157430|NCT05986565|585625425|FG000|Overall Study|Withdrawal by Subject|0|||
162157431|NCT05986565|585625426|FG001|Overall Study|Withdrawal by Subject|1|||
162157432|NCT00670046|585625427|FG000|Overall Study|Lost to Follow-up|1|||
162157433|NCT00670046|585625428|FG001|Overall Study|Lost to Follow-up|1|||
162157434|NCT00670046|585625427|FG000|Overall Study|Withdrawal by Subject|0|||
162157435|NCT00670046|585625428|FG001|Overall Study|Withdrawal by Subject|1|||
162157436|NCT02006758|585625448|FG000|Overall Study|Protocol Violation|1|||
162157437|NCT02006758|585625448|FG000|Overall Study|Death|1|||
162157438|NCT02006758|585625448|FG000|Overall Study|Lost to Follow-up|4|||
162157439|NCT02006758|585625448|FG000|Overall Study|Withdrawal by Subject|4|||
162157440|NCT02006758|585625448|FG000|Overall Study|Procedurally excluded|1|||
162157441|NCT02006758|585625448|FG000|Overall Study|Other|2|||
162157442|NCT02740231|585625449|FG000|Overall Study|Withdrawal by Subject|1|||
162157443|NCT02740231|585625450|FG001|Overall Study|Withdrawal by Subject|1|||
162157444|NCT02740231|585625451|FG002|Overall Study|Withdrawal by Subject|1|||
162157445|NCT02740231|585625452|FG003|Overall Study|Withdrawal by Subject|0|||
162157446|NCT02740231|585625449|FG000|Overall Study|Lack of Efficacy|0|||
162157447|NCT02740231|585625450|FG001|Overall Study|Lack of Efficacy|1|||
162157448|NCT02740231|585625451|FG002|Overall Study|Lack of Efficacy|0|||
162157449|NCT02740231|585625452|FG003|Overall Study|Lack of Efficacy|4|||
162157450|NCT02740231|585625449|FG000|Overall Study|Lost to Follow-up|1|||
162157451|NCT02740231|585625450|FG001|Overall Study|Lost to Follow-up|3|||
162157452|NCT02740231|585625451|FG002|Overall Study|Lost to Follow-up|0|||
162157453|NCT02740231|585625452|FG003|Overall Study|Lost to Follow-up|3|||
162157454|NCT02740231|585625449|FG000|Overall Study|Adverse Event|0|||
162157455|NCT02740231|585625450|FG001|Overall Study|Adverse Event|1|||
162157456|NCT02740231|585625451|FG002|Overall Study|Adverse Event|0|||
162157457|NCT02740231|585625452|FG003|Overall Study|Adverse Event|1|||
162157458|NCT00914589|585625453|FG000|Overall Study|Adverse Event|1|||
162157459|NCT00914589|585625454|FG001|Overall Study|Adverse Event|0|||
162157460|NCT00914589|585625455|FG002|Overall Study|Adverse Event|1|||
162157461|NCT00914589|585625453|FG000|Overall Study|Protocol Violation|8|||
162157462|NCT00914589|585625454|FG001|Overall Study|Protocol Violation|6|||
162157463|NCT00914589|585625455|FG002|Overall Study|Protocol Violation|3|||
162157464|NCT00914589|585625453|FG000|Overall Study|unclassified|16|||
162157465|NCT00914589|585625454|FG001|Overall Study|unclassified|9|||
162157466|NCT00914589|585625455|FG002|Overall Study|unclassified|7|||
162157467|NCT00914589|585625453|FG000|Overall Study|Death|0|||
162157468|NCT00914589|585625454|FG001|Overall Study|Death|1|||
162157469|NCT00914589|585625455|FG002|Overall Study|Death|1|||
162157470|NCT04583423|585625461|FG000|Overall Study|Lost to Follow-up|0|||
162157471|NCT04583423|585625462|FG001|Overall Study|Lost to Follow-up|1|||
162157472|NCT04583423|585625463|FG002|Overall Study|Lost to Follow-up|0|||
162157473|NCT04583423|585625464|FG003|Overall Study|Lost to Follow-up|2|||
162157474|NCT04583423|585625461|FG000|Overall Study|Study Terminated by Sponsor|32|||
162157475|NCT04583423|585625462|FG001|Overall Study|Study Terminated by Sponsor|35|||
162157476|NCT04583423|585625463|FG002|Overall Study|Study Terminated by Sponsor|36|||
162157477|NCT04583423|585625464|FG003|Overall Study|Study Terminated by Sponsor|33|||
162157478|NCT04583423|585625461|FG000|Overall Study|Withdrawal by Subject|3|||
162157479|NCT04583423|585625462|FG001|Overall Study|Withdrawal by Subject|1|||
162157480|NCT04583423|585625463|FG002|Overall Study|Withdrawal by Subject|2|||
162157481|NCT04583423|585625464|FG003|Overall Study|Withdrawal by Subject|1|||
162157482|NCT05575076|585625465|FG000|Overall Study|Adverse Event|24|||
162157483|NCT05575076|585625465|FG000|Overall Study|Death|7|||
162157484|NCT05575076|585625465|FG000|Overall Study|Lost to Follow-up|16|||
162157485|NCT05575076|585625465|FG000|Overall Study|Non-Compliance|3|||
162157486|NCT05575076|585625465|FG000|Overall Study|Physician Decision|6|||
162157487|NCT05575076|585625465|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
162157488|NCT05575076|585625465|FG000|Overall Study|Withdrawal by Subject|71|||
162157489|NCT05575076|585625465|FG000|Overall Study|Study Terminated by Sponsor|630|||
162157490|NCT05575076|585625465|FG000|Overall Study|Other|17|||
162014263|NCT00432172|585105644|FG003|Overall Study|Physician Decision|0|||
162014264|NCT00432172|585105641|FG000|Overall Study|Adverse Event|4|||
162014265|NCT00432172|585105642|FG001|Overall Study|Adverse Event|2|||
162157491|NCT00510887|585625466|FG000|Overall Study|Lost to Follow-up|1|||
162157492|NCT01736215|585625476|FG000|Overall Study|Early termination of erythropoietin use|1|||
162157493|NCT01736215|585625476|FG000|Overall Study|Adverse Event|4|||
162157494|NCT01736215|585625476|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
162157495|NCT01736215|585625476|FG000|Overall Study|Insufficient data to perform analysis|8|||
162157496|NCT03447249|585625479|FG000|Overall Study|Adverse Event|1|||
162157497|NCT03447249|585625480|FG001|Overall Study|Adverse Event|0|||
162157498|NCT03447249|585625479|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
162157499|NCT03447249|585625480|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
162157500|NCT03447249|585625479|FG000|Overall Study|Other|3|||
162157501|NCT03447249|585625480|FG001|Overall Study|Other|0|||
162157502|NCT02376790|585625481|FG000|Overall Study|Withdrawal by Subject|43|||
162157503|NCT02376790|585625482|FG001|Overall Study|Withdrawal by Subject|36|||
161812377|NCT03032172|584356164|FG002|Treatment Period|Withdrawal by Subject|3|||
161812378|NCT03032172|584356165|FG003|Treatment Period|Withdrawal by Subject|0|||
161812379|NCT03032172|584356166|FG004|Treatment Period|Withdrawal by Subject|0|||
161812380|NCT03032172|584356167|FG005|Treatment Period|Withdrawal by Subject|0|||
161812381|NCT03032172|584356168|FG006|Treatment Period|Withdrawal by Subject|0|||
161812382|NCT03032172|584356169|FG007|Treatment Period|Withdrawal by Subject|0|||
161812383|NCT03032172|584356162|FG000|Open-label Extension Period|Death|0|||
161812384|NCT03032172|584356163|FG001|Open-label Extension Period|Death|0|||
161812385|NCT03032172|584356164|FG002|Open-label Extension Period|Death|0|||
161812386|NCT03032172|584356165|FG003|Open-label Extension Period|Death|0|||
161812387|NCT03032172|584356166|FG004|Open-label Extension Period|Death|0|||
161812388|NCT03032172|584356167|FG005|Open-label Extension Period|Death|0|||
161812389|NCT03032172|584356168|FG006|Open-label Extension Period|Death|0|||
161812390|NCT03032172|584356169|FG007|Open-label Extension Period|Death|2|||
161812391|NCT03032172|584356162|FG000|Open-label Extension Period|Reason Not Specified|0|||
161812392|NCT03032172|584356163|FG001|Open-label Extension Period|Reason Not Specified|0|||
161812393|NCT03032172|584356164|FG002|Open-label Extension Period|Reason Not Specified|0|||
161812394|NCT03032172|584356165|FG003|Open-label Extension Period|Reason Not Specified|0|||
161812395|NCT03032172|584356166|FG004|Open-label Extension Period|Reason Not Specified|0|||
161812396|NCT03032172|584356167|FG005|Open-label Extension Period|Reason Not Specified|5|||
161812397|NCT03032172|584356168|FG006|Open-label Extension Period|Reason Not Specified|3|||
161812398|NCT03032172|584356169|FG007|Open-label Extension Period|Reason Not Specified|0|||
161812399|NCT03032172|584356162|FG000|Open-label Extension Period|Pregnancy|0|||
161812400|NCT03032172|584356163|FG001|Open-label Extension Period|Pregnancy|0|||
161812401|NCT03032172|584356164|FG002|Open-label Extension Period|Pregnancy|0|||
161812402|NCT03032172|584356165|FG003|Open-label Extension Period|Pregnancy|0|||
161812403|NCT03032172|584356166|FG004|Open-label Extension Period|Pregnancy|0|||
161812404|NCT03032172|584356167|FG005|Open-label Extension Period|Pregnancy|0|||
161812405|NCT03032172|584356168|FG006|Open-label Extension Period|Pregnancy|1|||
161812406|NCT03032172|584356169|FG007|Open-label Extension Period|Pregnancy|0|||
161812407|NCT03032172|584356162|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
161812408|NCT03032172|584356163|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
161812409|NCT03032172|584356164|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
161812410|NCT03032172|584356165|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
161812411|NCT03032172|584356166|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
161812412|NCT03032172|584356167|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
161812413|NCT03032172|584356168|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
161812414|NCT03032172|584356169|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
161812415|NCT06144424|584356174|FG000|Overall Study|Withdrawal by Subject|2|||
161812416|NCT06144424|584356175|FG001|Overall Study|Withdrawal by Subject|0|||
161812417|NCT06144424|584356174|FG000|Overall Study|Incarceration|1|||
161812418|NCT06144424|584356175|FG001|Overall Study|Incarceration|0|||
161812419|NCT06284525|584356177|FG000|Overall Study|Withdrawal by Subject|1|||
161812420|NCT00834522|584356178|FG000|Washout|Adverse Event|1|||
161812421|NCT00834522|584356179|FG001|Washout|Adverse Event|0|||
161812422|NCT00834522|584356178|FG000|Washout|Withdrawal by Subject|2|||
161812423|NCT00834522|584356179|FG001|Washout|Withdrawal by Subject|1|||
161812424|NCT00519194|584356180|FG000|Overall Study|Withdrawal by Subject|9|||
161812425|NCT00519194|584356180|FG000|Overall Study|Death|9|||
161812426|NCT00519194|584356180|FG000|Overall Study|Lost to Follow-up|3|||
161812427|NCT01111461|584356181|FG000|Overall Study|Adverse Event|32|||
161812428|NCT01111461|584356181|FG000|Overall Study|Participant choice|11|||
161812429|NCT01111461|584356181|FG000|Overall Study|Lost to Follow-up|1|||
161812430|NCT01111461|584356181|FG000|Overall Study|Withdrawal by Subject|1|||
161812431|NCT01111461|584356181|FG000|Overall Study|Other|6|||
161812432|NCT03415308|584356192|FG000|Overall Study|Lost to Follow-up|0|||
161812433|NCT03415308|584356193|FG001|Overall Study|Lost to Follow-up|0|||
161812434|NCT03415308|584356194|FG002|Overall Study|Lost to Follow-up|1|||
161812435|NCT03415308|584356192|FG000|Overall Study|Scheduling Conflicts|0|||
161812436|NCT03415308|584356193|FG001|Overall Study|Scheduling Conflicts|0|||
161812437|NCT03415308|584356194|FG002|Overall Study|Scheduling Conflicts|7|||
161812438|NCT01471353|584356197|FG000|Overall Study|remain on study|3|||
161812439|NCT03123094|584356199|FG000|Overall Study|Withdrawal by Subject|0|||
161812440|NCT03123094|584356200|FG001|Overall Study|Withdrawal by Subject|2|||
161812441|NCT03123094|584356201|FG002|Overall Study|Withdrawal by Subject|1|||
161812442|NCT03123094|584356202|FG003|Overall Study|Withdrawal by Subject|0|||
161812443|NCT03123094|584356203|FG004|Overall Study|Withdrawal by Subject|1|||
161812444|NCT00736190|584356204|FG000|Overall Study|Pregnancy|1|||
161812445|NCT00736190|584356204|FG000|Overall Study|Withdrawal by Subject|1|||
161812446|NCT00736190|584356204|FG000|Overall Study|Adverse Event|1|||
161812447|NCT03246503|584356205|FG000|Overall Study|Lost to Follow-up|23|||
161812448|NCT03246503|584356205|FG000|Overall Study|Withdrawal by Subject|20|||
162157504|NCT02376790|585625483|FG002|Overall Study|Withdrawal by Subject|37|||
162157505|NCT02376790|585625481|FG000|Overall Study|Decision by Sponsor|2|||
162014266|NCT00432172|585105643|FG002|Overall Study|Adverse Event|4|||
162014267|NCT00432172|585105644|FG003|Overall Study|Adverse Event|3|||
162014268|NCT00432172|585105641|FG000|Overall Study|Disease progression|0|||
162014269|NCT00432172|585105642|FG001|Overall Study|Disease progression|2|||
162014270|NCT00432172|585105643|FG002|Overall Study|Disease progression|5|||
162014271|NCT00432172|585105644|FG003|Overall Study|Disease progression|1|||
162014272|NCT00432172|585105641|FG000|Overall Study|Withdrawal by Subject|0|||
162014273|NCT00432172|585105642|FG001|Overall Study|Withdrawal by Subject|1|||
162014274|NCT00432172|585105643|FG002|Overall Study|Withdrawal by Subject|0|||
162014275|NCT00432172|585105644|FG003|Overall Study|Withdrawal by Subject|2|||
162014276|NCT00432172|585105641|FG000|Overall Study|No treatment received|2|||
162014277|NCT00432172|585105642|FG001|Overall Study|No treatment received|2|||
162014278|NCT00432172|585105643|FG002|Overall Study|No treatment received|0|||
162014279|NCT00432172|585105644|FG003|Overall Study|No treatment received|1|||
162014280|NCT00935584|585105645|FG000|Overall Study|Withdrawal by Subject|9|||
162014281|NCT00935584|585105646|FG001|Overall Study|Withdrawal by Subject|0|||
162014282|NCT00935584|585105645|FG000|Overall Study|Death|3|||
162014283|NCT00935584|585105646|FG001|Overall Study|Death|0|||
162014284|NCT00935584|585105645|FG000|Overall Study|Lost to Follow-up|8|||
162014285|NCT00935584|585105646|FG001|Overall Study|Lost to Follow-up|0|||
162014286|NCT00935584|585105645|FG000|Overall Study|No show|9|||
162014287|NCT00935584|585105646|FG001|Overall Study|No show|0|||
162014288|NCT00935584|585105645|FG000|Overall Study|Relocated|3|||
162014289|NCT00935584|585105646|FG001|Overall Study|Relocated|0|||
162014290|NCT00935584|585105645|FG000|Overall Study|Patient changed provider|3|||
162014291|NCT00935584|585105646|FG001|Overall Study|Patient changed provider|0|||
162014292|NCT00935584|585105645|FG000|Overall Study|Provider dropped out of study|14|||
162014293|NCT00935584|585105646|FG001|Overall Study|Provider dropped out of study|4|||
162014294|NCT00687193|585105647|FG000|Overall Study|Adverse Event|0|||
162014295|NCT00687193|585105648|FG001|Overall Study|Adverse Event|1|||
162014296|NCT00687193|585105649|FG002|Overall Study|Adverse Event|2|||
162014297|NCT00687193|585105650|FG003|Overall Study|Adverse Event|3|||
162014298|NCT00687193|585105651|FG004|Overall Study|Adverse Event|0|||
162014299|NCT00687193|585105652|FG005|Overall Study|Adverse Event|2|||
162014300|NCT00687193|585105647|FG000|Overall Study|Lack of Efficacy|1|||
162014301|NCT00687193|585105648|FG001|Overall Study|Lack of Efficacy|1|||
162014302|NCT00687193|585105649|FG002|Overall Study|Lack of Efficacy|0|||
162014303|NCT00687193|585105650|FG003|Overall Study|Lack of Efficacy|0|||
162014304|NCT00687193|585105651|FG004|Overall Study|Lack of Efficacy|0|||
162014305|NCT00687193|585105652|FG005|Overall Study|Lack of Efficacy|2|||
162014306|NCT00687193|585105647|FG000|Overall Study|Protocol Violation|1|||
162014307|NCT00687193|585105648|FG001|Overall Study|Protocol Violation|2|||
162014308|NCT00687193|585105649|FG002|Overall Study|Protocol Violation|0|||
162014309|NCT00687193|585105650|FG003|Overall Study|Protocol Violation|1|||
162014310|NCT00687193|585105651|FG004|Overall Study|Protocol Violation|2|||
162014311|NCT00687193|585105652|FG005|Overall Study|Protocol Violation|0|||
162014312|NCT02129699|585105653|FG000|Overall Study|Did not start treatment|3|||
162014313|NCT02129699|585105654|FG001|Overall Study|Did not start treatment|2|||
162014314|NCT01394016|585105655|FG000|Overall Study|Progressive Disease|2|||
162014315|NCT01394016|585105656|FG001|Overall Study|Progressive Disease|0|||
162014316|NCT01394016|585105657|FG002|Overall Study|Progressive Disease|0|||
162014317|NCT01394016|585105658|FG003|Overall Study|Progressive Disease|0|||
162014318|NCT01394016|585105659|FG004|Overall Study|Progressive Disease|0|||
162014319|NCT01394016|585105660|FG005|Overall Study|Progressive Disease|0|||
162014320|NCT01394016|585105661|FG006|Overall Study|Progressive Disease|0|||
162014321|NCT01394016|585105662|FG007|Overall Study|Progressive Disease|0|||
162014322|NCT01394016|585105663|FG008|Overall Study|Progressive Disease|0|||
162014323|NCT01394016|585105664|FG009|Overall Study|Progressive Disease|0|||
162014324|NCT01394016|585105665|FG010|Overall Study|Progressive Disease|0|||
162014325|NCT01394016|585105666|FG011|Overall Study|Progressive Disease|0|||
162014326|NCT01394016|585105667|FG012|Overall Study|Progressive Disease|0|||
162014327|NCT01394016|585105668|FG013|Overall Study|Progressive Disease|0|||
162014328|NCT01394016|585105669|FG014|Overall Study|Progressive Disease|0|||
162014329|NCT01394016|585105670|FG015|Overall Study|Progressive Disease|0|||
162157506|NCT02376790|585625482|FG001|Overall Study|Decision by Sponsor|1|||
162157507|NCT02376790|585625483|FG002|Overall Study|Decision by Sponsor|4|||
162157508|NCT02376790|585625481|FG000|Overall Study|Lost to Follow-up|15|||
162157509|NCT02376790|585625482|FG001|Overall Study|Lost to Follow-up|10|||
162157510|NCT02376790|585625483|FG002|Overall Study|Lost to Follow-up|12|||
162157511|NCT00988858|585625484|FG000|Overall Study|Adverse Event|7|||
162157512|NCT00988858|585625484|FG000|Overall Study|Death|1|||
162157513|NCT00988858|585625484|FG000|Overall Study|Physician Decision|1|||
162157514|NCT00988858|585625484|FG000|Overall Study|Sponsor Decision|1|||
162157515|NCT02238483|585625485|FG000|Overall Study|Withdrawal by Subject|2|||
162157516|NCT02238483|585625486|FG001|Overall Study|Withdrawal by Subject|7|||
162157517|NCT02238483|585625485|FG000|Overall Study|Lost to Follow-up|1|||
162157518|NCT02238483|585625486|FG001|Overall Study|Lost to Follow-up|1|||
162157519|NCT02238483|585625485|FG000|Overall Study|Protocol Violation|1|||
162157520|NCT02238483|585625486|FG001|Overall Study|Protocol Violation|2|||
162157521|NCT02238483|585625485|FG000|Overall Study|Death|1|||
162157522|NCT02238483|585625486|FG001|Overall Study|Death|0|||
162157523|NCT02238483|585625485|FG000|Overall Study|Adverse Event|7|||
162157524|NCT02238483|585625486|FG001|Overall Study|Adverse Event|3|||
162157525|NCT02238483|585625485|FG000|Overall Study|Withdrawn due to physician decision|1|||
162157526|NCT02238483|585625486|FG001|Overall Study|Withdrawn due to physician decision|0|||
162157527|NCT02238483|585625485|FG000|Overall Study|Completion status not recorded|1|||
162157528|NCT02238483|585625486|FG001|Overall Study|Completion status not recorded|1|||
162157529|NCT02238483|585625485|FG000|Overall Study|Illness in family member|1|||
162157530|NCT02238483|585625486|FG001|Overall Study|Illness in family member|0|||
162157531|NCT02538341|585625487|FG000|Overall Study|Lost to Follow-up|51|||
162157532|NCT02538341|585625488|FG001|Overall Study|Lost to Follow-up|46|||
162157533|NCT02538341|585625487|FG000|Overall Study|Withdrawal by Subject|3|||
162157534|NCT02538341|585625488|FG001|Overall Study|Withdrawal by Subject|1|||
162157535|NCT02538341|585625487|FG000|Overall Study|Death|2|||
162157536|NCT02538341|585625488|FG001|Overall Study|Death|0|||
162157537|NCT02372253|585625489|FG000|Overall Study|Non Compliance|2|||
162157538|NCT02372253|585625490|FG001|Overall Study|Non Compliance|0|||
162157539|NCT01803555|585625491|FG000|Overall Study|Adverse Event|3|||
162157540|NCT01803555|585625492|FG001|Overall Study|Adverse Event|2|||
162157541|NCT01803555|585625491|FG000|Overall Study|Withdrawal by Subject|3|||
162157542|NCT01803555|585625492|FG001|Overall Study|Withdrawal by Subject|3|||
162157543|NCT01803555|585625491|FG000|Overall Study|Non-compliance|1|||
162157544|NCT01803555|585625492|FG001|Overall Study|Non-compliance|1|||
162157545|NCT01803555|585625491|FG000|Overall Study|Protocol Violation|3|||
162157546|NCT01803555|585625492|FG001|Overall Study|Protocol Violation|5|||
162157547|NCT01803555|585625491|FG000|Overall Study|Lost to Follow-up|0|||
162157548|NCT01803555|585625492|FG001|Overall Study|Lost to Follow-up|2|||
162157549|NCT01803555|585625491|FG000|Overall Study|Other than specified|3|||
162157550|NCT01803555|585625492|FG001|Overall Study|Other than specified|5|||
162157551|NCT00393484|585625493|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
162157552|NCT00393484|585625494|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
162157553|NCT00393484|585625493|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
162157554|NCT00393484|585625494|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
162157555|NCT00393484|585625493|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
162157556|NCT00393484|585625494|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
161812449|NCT03246503|584356205|FG000|Overall Study|Physician Decision|5|||
162014330|NCT01394016|585105671|FG016|Overall Study|Progressive Disease|0|||
162014331|NCT01394016|585105672|FG017|Overall Study|Progressive Disease|0|||
162014332|NCT01394016|585105673|FG018|Overall Study|Progressive Disease|0|||
162157557|NCT00393484|585625493|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
162157558|NCT00393484|585625494|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
161812450|NCT03246503|584356205|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
161812451|NCT05014828|584356206|FG000|Overall Study|Study Completed by Sponsor|16|||
161812452|NCT05014828|584356207|FG001|Overall Study|Study Completed by Sponsor|16|||
161812453|NCT05014828|584356208|FG002|Overall Study|Study Completed by Sponsor|3|||
162014333|NCT01394016|585105655|FG000|Overall Study|Withdrawal by Subject|0|||
162157559|NCT00393484|585625493|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
162157560|NCT00393484|585625494|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
162157561|NCT00393484|585625493|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
162157562|NCT00393484|585625494|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
162157563|NCT00393484|585625493|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
162157564|NCT00393484|585625494|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
162157565|NCT00393484|585625493|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
162157566|NCT00393484|585625494|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
162157567|NCT00393484|585625493|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
162157568|NCT00393484|585625494|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
162157569|NCT00393484|585625493|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
162157570|NCT00393484|585625494|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
162157571|NCT03201562|585625495|FG000|Overall Study|Physician Decision|0|||
162157572|NCT03201562|585625496|FG001|Overall Study|Physician Decision|0|||
162157573|NCT03201562|585625497|FG002|Overall Study|Physician Decision|1|||
162157574|NCT03201562|585625495|FG000|Overall Study|Adverse Event|0|||
162157575|NCT03201562|585625496|FG001|Overall Study|Adverse Event|0|||
162157576|NCT03201562|585625497|FG002|Overall Study|Adverse Event|1|||
162157577|NCT03201562|585625495|FG000|Overall Study|Lost to Follow-up|0|||
162157578|NCT03201562|585625496|FG001|Overall Study|Lost to Follow-up|1|||
162157579|NCT03201562|585625497|FG002|Overall Study|Lost to Follow-up|2|||
162157580|NCT01551355|585625510|FG000|Overall Study|Lost to Follow-up|51|||
162157581|NCT01551355|585625511|FG001|Overall Study|Lost to Follow-up|49|||
162157582|NCT01551355|585625512|FG002|Overall Study|Lost to Follow-up|34|||
162157583|NCT01551355|585625513|FG003|Overall Study|Lost to Follow-up|24|||
162157584|NCT01551355|585625514|FG004|Overall Study|Lost to Follow-up|9|||
162157585|NCT01551355|585625515|FG005|Overall Study|Lost to Follow-up|6|||
162157586|NCT00031694|585625516|FG000|Overall Study|Adverse Event|12|||
162157587|NCT00031694|585625516|FG000|Overall Study|Death|2|||
162157588|NCT00031694|585625516|FG000|Overall Study|Withdrawal by Subject|5|||
162157589|NCT01538719|585625521|FG000|Overall Study|Lost to Follow-up|2|||
162157590|NCT01538719|585625522|FG001|Overall Study|Lost to Follow-up|0|||
162157591|NCT01255670|585625525|FG000|Overall Study|Adverse Event|10|||
162157592|NCT01255670|585625526|FG001|Overall Study|Adverse Event|10|||
162157593|NCT01255670|585625525|FG000|Overall Study|Lost to Follow-up|16|||
162157594|NCT01255670|585625526|FG001|Overall Study|Lost to Follow-up|10|||
162157595|NCT03892564|585625527|FG000|Overall Study|Withdrawal by Subject|2|||
162157596|NCT03807778|585625528|FG000|Overall Study|Adverse Event|0|||
162157597|NCT03807778|585625529|FG001|Overall Study|Adverse Event|0|||
162157598|NCT03807778|585625530|FG002|Overall Study|Adverse Event|3|||
162157599|NCT03807778|585625531|FG003|Overall Study|Adverse Event|5|||
162157600|NCT03807778|585625528|FG000|Overall Study|Progressive Disease|4|||
162157601|NCT03807778|585625529|FG001|Overall Study|Progressive Disease|2|||
162157602|NCT03807778|585625530|FG002|Overall Study|Progressive Disease|8|||
162157603|NCT03807778|585625531|FG003|Overall Study|Progressive Disease|15|||
162157604|NCT03807778|585625528|FG000|Overall Study|Symptomatic Deterioration|0|||
162157605|NCT03807778|585625529|FG001|Overall Study|Symptomatic Deterioration|1|||
162157606|NCT03807778|585625530|FG002|Overall Study|Symptomatic Deterioration|0|||
162157607|NCT03807778|585625531|FG003|Overall Study|Symptomatic Deterioration|1|||
162157608|NCT03807778|585625528|FG000|Overall Study|Withdrawal by Subject|0|||
162157609|NCT03807778|585625529|FG001|Overall Study|Withdrawal by Subject|1|||
162157610|NCT03807778|585625530|FG002|Overall Study|Withdrawal by Subject|0|||
162157611|NCT03807778|585625531|FG003|Overall Study|Withdrawal by Subject|1|||
162157612|NCT03807778|585625528|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
162157613|NCT03807778|585625529|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
162157614|NCT03807778|585625530|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
162157615|NCT03807778|585625531|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
162157616|NCT03582722|585625532|FG000|Overall Study|Lost to Follow-up|1|||
162157617|NCT03582722|585625533|FG001|Overall Study|Lost to Follow-up|4|||
161812454|NCT05014828|584356209|FG003|Overall Study|Study Completed by Sponsor|3|||
162014334|NCT01394016|585105656|FG001|Overall Study|Withdrawal by Subject|0|||
162014335|NCT01394016|585105657|FG002|Overall Study|Withdrawal by Subject|0|||
162014336|NCT01394016|585105658|FG003|Overall Study|Withdrawal by Subject|0|||
162014337|NCT01394016|585105659|FG004|Overall Study|Withdrawal by Subject|0|||
162157618|NCT03582722|585625532|FG000|Overall Study|Withdrawal by Subject|3|||
162157619|NCT03582722|585625533|FG001|Overall Study|Withdrawal by Subject|3|||
162157620|NCT01216176|585627045|FG000|Overall Study|Adverse Event|0|||
162157621|NCT01216176|585627046|FG001|Overall Study|Adverse Event|8|||
162014338|NCT01394016|585105660|FG005|Overall Study|Withdrawal by Subject|0|||
162157622|NCT01216176|585627047|FG002|Overall Study|Adverse Event|0|||
162157623|NCT01216176|585627045|FG000|Overall Study|Physician Decision|0|||
162157624|NCT01216176|585627046|FG001|Overall Study|Physician Decision|0|||
162157625|NCT01216176|585627047|FG002|Overall Study|Physician Decision|1|||
161915870|NCT02966834|584740571|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
161915871|NCT02966834|584740572|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
161915872|NCT02966834|584740573|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
161915873|NCT02966834|584740568|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
161915874|NCT02966834|584740569|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
161915875|NCT02966834|584740570|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
161915876|NCT02966834|584740571|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
161915877|NCT02966834|584740572|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
161915878|NCT02966834|584740573|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
161915879|NCT02966834|584740568|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161915880|NCT02966834|584740569|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161915881|NCT02966834|584740570|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161915882|NCT02966834|584740571|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
161915883|NCT02966834|584740572|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161915884|NCT02966834|584740573|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161915885|NCT02966834|584740568|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
161915886|NCT02966834|584740569|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
161915887|NCT02966834|584740570|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
161915888|NCT02966834|584740571|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
161915889|NCT02966834|584740572|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
161915890|NCT02966834|584740573|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
161915891|NCT04739800|584740577|FG000|Overall Study|Adverse Event|2|||
161915892|NCT04739800|584740578|FG001|Overall Study|Adverse Event|1|||
161915893|NCT04739800|584740579|FG002|Overall Study|Adverse Event|4|||
161915894|NCT04739800|584740580|FG003|Overall Study|Adverse Event|5|||
161915895|NCT04739800|584740577|FG000|Overall Study|Never Treated|2|||
161915896|NCT04739800|584740578|FG001|Overall Study|Never Treated|0|||
161915897|NCT04739800|584740579|FG002|Overall Study|Never Treated|1|||
161915898|NCT04739800|584740580|FG003|Overall Study|Never Treated|1|||
161915899|NCT04739800|584740577|FG000|Overall Study|On Treatment|5|||
161915900|NCT04739800|584740578|FG001|Overall Study|On Treatment|9|||
161915901|NCT04739800|584740579|FG002|Overall Study|On Treatment|9|||
161915902|NCT04739800|584740580|FG003|Overall Study|On Treatment|9|||
161915903|NCT04739800|584740577|FG000|Overall Study|Symptomatic Deterioration|1|||
161915904|NCT04739800|584740578|FG001|Overall Study|Symptomatic Deterioration|1|||
161915905|NCT04739800|584740579|FG002|Overall Study|Symptomatic Deterioration|3|||
161915906|NCT04739800|584740580|FG003|Overall Study|Symptomatic Deterioration|0|||
161915907|NCT04739800|584740577|FG000|Overall Study|Withdrawal by Subject|1|||
161915908|NCT04739800|584740578|FG001|Overall Study|Withdrawal by Subject|2|||
161915909|NCT04739800|584740579|FG002|Overall Study|Withdrawal by Subject|1|||
161915910|NCT04739800|584740580|FG003|Overall Study|Withdrawal by Subject|3|||
161915911|NCT04739800|584740577|FG000|Overall Study|Other Reason|1|||
161915912|NCT04739800|584740578|FG001|Overall Study|Other Reason|3|||
161915913|NCT04739800|584740579|FG002|Overall Study|Other Reason|5|||
161915914|NCT04739800|584740580|FG003|Overall Study|Other Reason|4|||
161915915|NCT03415178|584740582|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
161915916|NCT03415178|584740583|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
161915917|NCT03415178|584740582|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
161915918|NCT03415178|584740583|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
161915919|NCT04880850|584740584|FG000|Overall Study|Death|2|||
161915920|NCT04880850|584740585|FG001|Overall Study|Death|1|||
161915921|NCT04880850|584740584|FG000|Overall Study|Lost to Follow-up|3|||
161915922|NCT04880850|584740585|FG001|Overall Study|Lost to Follow-up|6|||
161915923|NCT04880850|584740584|FG000|Overall Study|Physician Decision|2|||
161915924|NCT04880850|584740585|FG001|Overall Study|Physician Decision|1|||
161915925|NCT04880850|584740584|FG000|Overall Study|Withdrawal by Subject|9|||
161915926|NCT04880850|584740585|FG001|Overall Study|Withdrawal by Subject|10|||
161915927|NCT03907488|584740586|FG000|Overall Study|Adverse Event|20|||
161915928|NCT03907488|584740587|FG001|Overall Study|Adverse Event|20|||
161915929|NCT03907488|584740586|FG000|Overall Study|Withdrawal by Subject|9|||
161915930|NCT03907488|584740587|FG001|Overall Study|Withdrawal by Subject|13|||
161915931|NCT03907488|584740586|FG000|Overall Study|Lack of Efficacy|0|||
161915932|NCT03907488|584740587|FG001|Overall Study|Lack of Efficacy|9|||
161915933|NCT03907488|584740586|FG000|Overall Study|Death|3|||
161915934|NCT03907488|584740587|FG001|Overall Study|Death|8|||
161915935|NCT03907488|584740586|FG000|Overall Study|not protocol specified|5|||
161915936|NCT03907488|584740587|FG001|Overall Study|not protocol specified|8|||
161915937|NCT03907488|584740586|FG000|Overall Study|Ineligible|9|||
161812455|NCT05014828|584356206|FG000|Overall Study|Death|11|||
161812456|NCT05014828|584356207|FG001|Overall Study|Death|6|||
161812457|NCT05014828|584356208|FG002|Overall Study|Death|0|||
161812458|NCT05014828|584356209|FG003|Overall Study|Death|0|||
161812459|NCT05014828|584356206|FG000|Overall Study|Lost to Follow-up|0|||
161812460|NCT05014828|584356207|FG001|Overall Study|Lost to Follow-up|0|||
161812461|NCT05014828|584356208|FG002|Overall Study|Lost to Follow-up|2|||
161812462|NCT05014828|584356209|FG003|Overall Study|Lost to Follow-up|0|||
161812463|NCT05014828|584356206|FG000|Overall Study|Miscellaneous.|0|||
161812464|NCT05014828|584356207|FG001|Overall Study|Miscellaneous.|1|||
161812465|NCT05014828|584356208|FG002|Overall Study|Miscellaneous.|0|||
161812466|NCT05014828|584356209|FG003|Overall Study|Miscellaneous.|0|||
161812467|NCT02682238|584356212|FG000|Overall Study|Lost to Follow-up|0|||
161812468|NCT02682238|584356213|FG001|Overall Study|Lost to Follow-up|2|||
161812469|NCT02682238|584356212|FG000|Overall Study|Withdrawal by Subject|1|||
161812470|NCT02682238|584356213|FG001|Overall Study|Withdrawal by Subject|0|||
161812471|NCT02682238|584356212|FG000|Overall Study|Adverse Event|1|||
161812472|NCT02682238|584356213|FG001|Overall Study|Adverse Event|0|||
161812473|NCT02682238|584356212|FG000|Overall Study|Non-compliance with Study Drug|1|||
161812474|NCT02682238|584356213|FG001|Overall Study|Non-compliance with Study Drug|0|||
161812475|NCT02682238|584356212|FG000|Overall Study|Non-compliance with Protocol|0|||
161812476|NCT02682238|584356213|FG001|Overall Study|Non-compliance with Protocol|2|||
161812477|NCT01370317|584356214|FG000|Overall Study|Participant withdrew consent|1|||
161812478|NCT01370317|584356215|FG001|Overall Study|Participant withdrew consent|0|||
161812479|NCT01370317|584356214|FG000|Overall Study|Protocol deviation|0|||
161812480|NCT01370317|584356215|FG001|Overall Study|Protocol deviation|1|||
161812481|NCT00075478|584356216|FG000|Overall Study|not eligible|1|||
162014339|NCT01394016|585105661|FG006|Overall Study|Withdrawal by Subject|0|||
162014340|NCT01394016|585105662|FG007|Overall Study|Withdrawal by Subject|1|||
162014341|NCT01394016|585105663|FG008|Overall Study|Withdrawal by Subject|1|||
162014342|NCT01394016|585105664|FG009|Overall Study|Withdrawal by Subject|1|||
162014343|NCT01394016|585105665|FG010|Overall Study|Withdrawal by Subject|4|||
162014344|NCT01394016|585105666|FG011|Overall Study|Withdrawal by Subject|0|||
162014345|NCT01394016|585105667|FG012|Overall Study|Withdrawal by Subject|0|||
162014346|NCT01394016|585105668|FG013|Overall Study|Withdrawal by Subject|3|||
162014347|NCT01394016|585105669|FG014|Overall Study|Withdrawal by Subject|1|||
162014348|NCT01394016|585105670|FG015|Overall Study|Withdrawal by Subject|3|||
162014349|NCT01394016|585105671|FG016|Overall Study|Withdrawal by Subject|1|||
162014350|NCT01394016|585105672|FG017|Overall Study|Withdrawal by Subject|1|||
162014351|NCT01394016|585105673|FG018|Overall Study|Withdrawal by Subject|2|||
162014352|NCT01394016|585105655|FG000|Overall Study|Adverse Event|0|||
162014353|NCT01394016|585105656|FG001|Overall Study|Adverse Event|0|||
162014354|NCT01394016|585105657|FG002|Overall Study|Adverse Event|0|||
162014355|NCT01394016|585105658|FG003|Overall Study|Adverse Event|0|||
162014356|NCT01394016|585105659|FG004|Overall Study|Adverse Event|0|||
162014357|NCT01394016|585105660|FG005|Overall Study|Adverse Event|0|||
162014358|NCT01394016|585105661|FG006|Overall Study|Adverse Event|0|||
162014359|NCT01394016|585105662|FG007|Overall Study|Adverse Event|0|||
162014360|NCT01394016|585105663|FG008|Overall Study|Adverse Event|0|||
162014361|NCT01394016|585105664|FG009|Overall Study|Adverse Event|1|||
162014362|NCT01394016|585105665|FG010|Overall Study|Adverse Event|0|||
162014363|NCT01394016|585105666|FG011|Overall Study|Adverse Event|0|||
162014364|NCT01394016|585105667|FG012|Overall Study|Adverse Event|0|||
162014365|NCT01394016|585105668|FG013|Overall Study|Adverse Event|0|||
162014366|NCT01394016|585105669|FG014|Overall Study|Adverse Event|0|||
162014367|NCT01394016|585105670|FG015|Overall Study|Adverse Event|0|||
162014368|NCT01394016|585105671|FG016|Overall Study|Adverse Event|1|||
162014369|NCT01394016|585105672|FG017|Overall Study|Adverse Event|1|||
162014370|NCT01394016|585105673|FG018|Overall Study|Adverse Event|0|||
162014371|NCT01394016|585105655|FG000|Overall Study|Sponsor Decision|0|||
162014372|NCT01394016|585105656|FG001|Overall Study|Sponsor Decision|0|||
162014373|NCT01394016|585105657|FG002|Overall Study|Sponsor Decision|0|||
162157626|NCT03481660|585627050|FG000|Overall Study|Adverse Event|5|||
162157627|NCT03481660|585627051|FG001|Overall Study|Adverse Event|4|||
162157628|NCT03481660|585627050|FG000|Overall Study|Death|13|||
161812482|NCT00075478|584356217|FG001|Overall Study|not eligible|0|||
161812483|NCT00075478|584356216|FG000|Overall Study|Physician Decision|0|||
161812484|NCT00075478|584356217|FG001|Overall Study|Physician Decision|1|||
162014374|NCT01394016|585105658|FG003|Overall Study|Sponsor Decision|0|||
162014375|NCT01394016|585105659|FG004|Overall Study|Sponsor Decision|0|||
162014376|NCT01394016|585105660|FG005|Overall Study|Sponsor Decision|0|||
162014377|NCT01394016|585105661|FG006|Overall Study|Sponsor Decision|0|||
162014378|NCT01394016|585105662|FG007|Overall Study|Sponsor Decision|0|||
162014379|NCT01394016|585105663|FG008|Overall Study|Sponsor Decision|0|||
162014380|NCT01394016|585105664|FG009|Overall Study|Sponsor Decision|0|||
162014381|NCT01394016|585105665|FG010|Overall Study|Sponsor Decision|0|||
162014382|NCT01394016|585105666|FG011|Overall Study|Sponsor Decision|0|||
162014383|NCT01394016|585105667|FG012|Overall Study|Sponsor Decision|1|||
162014384|NCT01394016|585105668|FG013|Overall Study|Sponsor Decision|0|||
162157629|NCT03481660|585627051|FG001|Overall Study|Death|9|||
162157630|NCT03481660|585627050|FG000|Overall Study|Lost to Follow-up|2|||
162157631|NCT03481660|585627051|FG001|Overall Study|Lost to Follow-up|2|||
162157632|NCT03481660|585627050|FG000|Overall Study|Physician Decision|2|||
162157633|NCT03481660|585627051|FG001|Overall Study|Physician Decision|3|||
162157634|NCT03481660|585627050|FG000|Overall Study|Withdrawal by Subject|14|||
162157635|NCT03481660|585627051|FG001|Overall Study|Withdrawal by Subject|7|||
162157636|NCT03651895|585627054|FG000|First Drug Assignment|Adverse Event|4|||
162157637|NCT03651895|585627055|FG001|First Drug Assignment|Adverse Event|5|||
162157638|NCT03651895|585627054|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
162157639|NCT03651895|585627055|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
162157640|NCT03433339|585627056|FG000|Overall Study|Lost to Follow-up|2|||
162157641|NCT03433339|585627057|FG001|Overall Study|Lost to Follow-up|0|||
162157642|NCT03433339|585627056|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
162157643|NCT03433339|585627057|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
162157644|NCT03433339|585627056|FG000|Overall Study|Withdrawal by Subject|0|||
162157645|NCT03433339|585627057|FG001|Overall Study|Withdrawal by Subject|2|||
162157646|NCT01898494|585627061|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
162157647|NCT01898494|585627062|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
162157648|NCT01898494|585627063|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
162157649|NCT01898494|585627064|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
162157650|NCT01898494|585627065|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
162157651|NCT01898494|585627061|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
162157652|NCT01898494|585627062|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
162157653|NCT01898494|585627063|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
162157654|NCT01898494|585627064|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
162157655|NCT01898494|585627065|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
162157656|NCT01898494|585627061|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
162157657|NCT01898494|585627062|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
162157658|NCT01898494|585627063|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
162157659|NCT01898494|585627064|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
162157660|NCT01898494|585627065|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
162157661|NCT01898494|585627061|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
162157662|NCT01898494|585627062|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
162157663|NCT01898494|585627063|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
162157664|NCT01898494|585627064|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
162157665|NCT01898494|585627065|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
162157666|NCT01898494|585627061|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
162157667|NCT01898494|585627062|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
162157668|NCT01898494|585627063|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
162157669|NCT01898494|585627064|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
162157670|NCT01898494|585627065|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
162157671|NCT01898494|585627061|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
162157672|NCT01898494|585627062|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
162157673|NCT01898494|585627063|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
162157674|NCT01898494|585627064|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
162157675|NCT01898494|585627065|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
162157676|NCT01898494|585627061|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
162157677|NCT01898494|585627062|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
162157678|NCT01898494|585627063|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
162157679|NCT01898494|585627064|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
162157680|NCT01898494|585627065|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
162157681|NCT01898494|585627061|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
162157682|NCT01898494|585627062|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
162157683|NCT01898494|585627063|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
162157684|NCT01898494|585627064|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
162157685|NCT01898494|585627065|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
162157686|NCT01898494|585627061|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
162157687|NCT01898494|585627062|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
162157688|NCT01898494|585627063|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
162157689|NCT01898494|585627064|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
162157690|NCT01898494|585627065|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
162157691|NCT01898494|585627061|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
162157692|NCT01898494|585627062|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
162157693|NCT01898494|585627063|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
162157694|NCT01898494|585627064|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
162157695|NCT01898494|585627065|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
162157696|NCT01898494|585627061|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
162157697|NCT01898494|585627062|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
162157698|NCT01898494|585627063|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
162157699|NCT01898494|585627064|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
162157700|NCT01898494|585627065|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
162157701|NCT01898494|585627061|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
162157702|NCT01898494|585627062|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
162157703|NCT01898494|585627063|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
162157704|NCT01898494|585627064|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
162157705|NCT01898494|585627065|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
162157706|NCT01898494|585627061|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
162157707|NCT01898494|585627062|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
162157708|NCT01898494|585627063|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
162157709|NCT01898494|585627064|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
162157710|NCT01898494|585627065|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
162157711|NCT01898494|585627061|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
162157712|NCT01898494|585627062|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
162157713|NCT01898494|585627063|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
162157714|NCT01898494|585627064|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
162157715|NCT01898494|585627065|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
162157716|NCT01718743|585627066|FG000|Overall Study|Physician Decision|7|||
162157717|NCT01718743|585627066|FG000|Overall Study|Withdrawal by Subject|14|||
162157718|NCT01718743|585627066|FG000|Overall Study|Progressive Disease|22|||
162157719|NCT01718743|585627066|FG000|Overall Study|Toxicity|1|||
162157720|NCT01718743|585627066|FG000|Overall Study|Malignancy|1|||
162157721|NCT05136404|585627067|FG000|Period 1|Adverse Event|0|||
162157722|NCT05136404|585627068|FG001|Period 1|Adverse Event|1|||
162157723|NCT05136404|585627069|FG002|Period 1|Adverse Event|1|||
162157724|NCT05136404|585627067|FG000|Period 2|Inappropriate Behavior|0|||
162157725|NCT05136404|585627068|FG001|Period 2|Inappropriate Behavior|0|||
162157726|NCT05136404|585627069|FG002|Period 2|Inappropriate Behavior|1|||
162157727|NCT05136404|585627067|FG000|Period 3|Adverse Event|0|||
162157728|NCT05136404|585627068|FG001|Period 3|Adverse Event|0|||
162157729|NCT05136404|585627069|FG002|Period 3|Adverse Event|1|||
162157730|NCT02553642|585627075|FG000|Overall Study|Withdrawal by Subject|0|||
162157731|NCT02553642|585627076|FG001|Overall Study|Withdrawal by Subject|3|||
162157732|NCT02553642|585627075|FG000|Overall Study|Physician Decision|0|||
162157733|NCT02553642|585627076|FG001|Overall Study|Physician Decision|1|||
162157734|NCT02553642|585627075|FG000|Overall Study|Additional cancer dx|0|||
162157735|NCT02553642|585627076|FG001|Overall Study|Additional cancer dx|1|||
162157736|NCT02553642|585627075|FG000|Overall Study|Never started treatment|0|||
162157737|NCT02553642|585627076|FG001|Overall Study|Never started treatment|1|||
162236461|NCT00666679|585916958|FG001|First Intervention|Randomized did not start treatment|1|||
162236462|NCT00666679|585916957|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
162236463|NCT00666679|585916958|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
162236464|NCT00666679|585916957|FG000|Washout Period of 1 Week|Protocol Violation|0|||
162236465|NCT00666679|585916958|FG001|Washout Period of 1 Week|Protocol Violation|1|||
162236466|NCT00666679|585916957|FG000|Second Intervention|Adverse Event|1|||
162236467|NCT00666679|585916958|FG001|Second Intervention|Adverse Event|0|||
162236468|NCT00666679|585916957|FG000|Second Intervention|Death|0|||
162236469|NCT00666679|585916958|FG001|Second Intervention|Death|1|||
162236470|NCT04874415|585916959|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162236471|NCT04874415|585916960|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162236472|NCT04874415|585916961|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162236473|NCT04874415|585916962|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162236474|NCT04874415|585916963|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162236475|NCT04874415|585916964|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162236476|NCT04874415|585916965|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
162236477|NCT04874415|585916966|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162236478|NCT04874415|585916967|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
162236479|NCT04874415|585916968|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
162236480|NCT04874415|585916969|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162236481|NCT04874415|585916970|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
162236482|NCT04874415|585916971|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
162236483|NCT04874415|585916972|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
162236484|NCT04874415|585916973|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
162236485|NCT04874415|585916974|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
162236486|NCT04874415|585916959|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
162236487|NCT04874415|585916960|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
162157738|NCT01820260|585627078|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157739|NCT01820260|585627079|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157740|NCT01820260|585627080|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157741|NCT01820260|585627081|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157742|NCT01820260|585627082|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157743|NCT01820260|585627083|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157744|NCT01820260|585627084|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
162157745|NCT01820260|585627085|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157746|NCT01820260|585627086|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157747|NCT01820260|585627087|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157748|NCT01820260|585627088|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157749|NCT01820260|585627089|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157750|NCT01820260|585627090|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157751|NCT01820260|585627091|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
162157752|NCT01820260|585627078|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162157753|NCT01820260|585627079|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162157754|NCT01820260|585627080|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162157755|NCT01820260|585627081|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162157756|NCT01820260|585627082|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162157757|NCT01820260|585627083|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162157758|NCT01820260|585627084|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162157759|NCT01820260|585627085|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162157760|NCT01820260|585627086|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162157761|NCT01820260|585627087|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
162157762|NCT01820260|585627088|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161812485|NCT00824291|584356223|FG000|Overall Study|Adverse Event|15|||
161812486|NCT00824291|584356224|FG001|Overall Study|Adverse Event|6|||
162014385|NCT01394016|585105669|FG014|Overall Study|Sponsor Decision|0|||
162014386|NCT01394016|585105670|FG015|Overall Study|Sponsor Decision|0|||
162014387|NCT01394016|585105671|FG016|Overall Study|Sponsor Decision|0|||
162014388|NCT01394016|585105672|FG017|Overall Study|Sponsor Decision|0|||
162014389|NCT01394016|585105673|FG018|Overall Study|Sponsor Decision|0|||
162014390|NCT01394016|585105655|FG000|Overall Study|Lost to Follow-up|0|||
162014391|NCT01394016|585105656|FG001|Overall Study|Lost to Follow-up|0|||
162014392|NCT01394016|585105657|FG002|Overall Study|Lost to Follow-up|0|||
162014393|NCT01394016|585105658|FG003|Overall Study|Lost to Follow-up|0|||
162014394|NCT01394016|585105659|FG004|Overall Study|Lost to Follow-up|0|||
162014395|NCT01394016|585105660|FG005|Overall Study|Lost to Follow-up|0|||
162014396|NCT01394016|585105661|FG006|Overall Study|Lost to Follow-up|0|||
162014397|NCT01394016|585105662|FG007|Overall Study|Lost to Follow-up|0|||
162014398|NCT01394016|585105663|FG008|Overall Study|Lost to Follow-up|0|||
162014399|NCT01394016|585105664|FG009|Overall Study|Lost to Follow-up|0|||
162014400|NCT01394016|585105665|FG010|Overall Study|Lost to Follow-up|0|||
162014401|NCT01394016|585105666|FG011|Overall Study|Lost to Follow-up|0|||
162014402|NCT01394016|585105667|FG012|Overall Study|Lost to Follow-up|0|||
162014403|NCT01394016|585105668|FG013|Overall Study|Lost to Follow-up|0|||
162014404|NCT01394016|585105669|FG014|Overall Study|Lost to Follow-up|0|||
162014405|NCT01394016|585105670|FG015|Overall Study|Lost to Follow-up|0|||
162014406|NCT01394016|585105671|FG016|Overall Study|Lost to Follow-up|0|||
162014407|NCT01394016|585105672|FG017|Overall Study|Lost to Follow-up|0|||
162014408|NCT01394016|585105673|FG018|Overall Study|Lost to Follow-up|1|||
162014409|NCT03534804|585105674|FG000|Overall Study|Withdrawal by Subject|1|||
162014410|NCT04161157|585105678|FG000|Overall Study|Lost to Follow-up|4|||
162014411|NCT04161157|585105678|FG000|Overall Study|Death|3|||
162014412|NCT04161157|585105678|FG000|Overall Study|Ineligible|2|||
162014413|NCT04161157|585105678|FG000|Overall Study|Withdrawal by Subject|4|||
162014414|NCT05786651|585105682|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
162014415|NCT02331277|585106926|FG000|Overall Study|Withdrawal by Subject|1|||
162014416|NCT02331277|585106927|FG001|Overall Study|Withdrawal by Subject|0|||
162014417|NCT01071798|585106929|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
161812487|NCT00824291|584356223|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
162014418|NCT01071798|585106929|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
162014419|NCT01071798|585106929|FG000|Participants Who Received One Cycle|Patient requirement|20|||
162014420|NCT01071798|585106929|FG000|Participants Who Received One Cycle|Death|5|||
162014421|NCT01071798|585106929|FG000|Participants Who Received One Cycle|Change of therapy|6|||
162014422|NCT01071798|585106929|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
162014423|NCT01071798|585106929|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
162014424|NCT01071798|585106929|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
162014425|NCT01071798|585106929|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
162014426|NCT01071798|585106929|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
162014427|NCT03085797|585106932|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
162014428|NCT03085797|585106933|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
162014429|NCT03085797|585106932|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
162014430|NCT03085797|585106933|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
162014431|NCT03085797|585106932|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
162014432|NCT03085797|585106933|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
162014433|NCT04050202|585106938|FG000|Overall Study|Lost to Follow-up|2|||
162014434|NCT01554241|585106939|FG000|Overall Study|Death|3|||
162014435|NCT01554241|585106940|FG001|Overall Study|Death|1|||
162014436|NCT01554241|585106941|FG002|Overall Study|Death|1|||
162014437|NCT01554241|585106942|FG003|Overall Study|Death|0|||
162014438|NCT01554241|585106939|FG000|Overall Study|protocol specified renal stone|0|||
162014439|NCT01554241|585106940|FG001|Overall Study|protocol specified renal stone|0|||
162014440|NCT01554241|585106941|FG002|Overall Study|protocol specified renal stone|0|||
162014441|NCT01554241|585106942|FG003|Overall Study|protocol specified renal stone|1|||
162014442|NCT01554241|585106939|FG000|Overall Study|protocol specified change in eGFR|0|||
162014443|NCT01554241|585106940|FG001|Overall Study|protocol specified change in eGFR|0|||
162014444|NCT01554241|585106941|FG002|Overall Study|protocol specified change in eGFR|1|||
161812488|NCT00824291|584356224|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
161812489|NCT00824291|584356223|FG000|Overall Study|Lost to Follow-up|11|||
161812490|NCT00824291|584356224|FG001|Overall Study|Lost to Follow-up|9|||
161812491|NCT00824291|584356223|FG000|Overall Study|Non-compliance|1|||
161812492|NCT00824291|584356224|FG001|Overall Study|Non-compliance|1|||
161812493|NCT00824291|584356223|FG000|Overall Study|Protocol Violation|4|||
161812494|NCT00824291|584356224|FG001|Overall Study|Protocol Violation|1|||
161812495|NCT00824291|584356223|FG000|Overall Study|Withdrawal by Subject|14|||
162014445|NCT01554241|585106942|FG003|Overall Study|protocol specified change in eGFR|0|||
162014446|NCT01554241|585106939|FG000|Overall Study|Withdrawal by Subject|0|||
162014447|NCT01554241|585106940|FG001|Overall Study|Withdrawal by Subject|0|||
162014448|NCT01554241|585106941|FG002|Overall Study|Withdrawal by Subject|2|||
162014449|NCT01554241|585106942|FG003|Overall Study|Withdrawal by Subject|0|||
162014450|NCT05661409|585106943|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
162014451|NCT05661409|585106944|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
162014452|NCT05661409|585106945|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
162014453|NCT05661409|585106946|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
162014454|NCT05661409|585106947|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
162014455|NCT05661409|585106948|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
162014456|NCT05661409|585106943|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
162014457|NCT05661409|585106944|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
162014458|NCT05661409|585106945|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
162014459|NCT05661409|585106946|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
162014460|NCT05661409|585106947|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
162014461|NCT05661409|585106948|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
162014462|NCT05661409|585106943|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
162014463|NCT05661409|585106944|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
162014464|NCT05661409|585106945|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
162014465|NCT05661409|585106946|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
162014466|NCT05661409|585106947|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
162014467|NCT05661409|585106948|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
162014468|NCT05661409|585106943|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
162014469|NCT05661409|585106944|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
162014470|NCT05661409|585106945|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
162014471|NCT05661409|585106946|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
162014472|NCT05661409|585106947|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
162014473|NCT05661409|585106948|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
162014474|NCT05661409|585106943|FG000|Overall Study|Miscommu-nication about administration|0|||
162014475|NCT05661409|585106944|FG001|Overall Study|Miscommu-nication about administration|0|||
162014476|NCT05661409|585106945|FG002|Overall Study|Miscommu-nication about administration|0|||
162014477|NCT05661409|585106946|FG003|Overall Study|Miscommu-nication about administration|0|||
162014478|NCT05661409|585106947|FG004|Overall Study|Miscommu-nication about administration|0|||
162014479|NCT05661409|585106948|FG005|Overall Study|Miscommu-nication about administration|1|||
162014480|NCT00724698|585106953|FG000|Overall Study|Adverse Event|9|||
162014481|NCT00724698|585106953|FG000|Overall Study|Failure of Therapy|4|||
162014482|NCT00724698|585106953|FG000|Overall Study|Poor Compliance|16|||
162157763|NCT01820260|585627089|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162014483|NCT00724698|585106953|FG000|Overall Study|Lost to Follow-up|36|||
162014484|NCT00724698|585106953|FG000|Overall Study|No Info|25|||
162014485|NCT01411891|585106956|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
162014486|NCT01411891|585106957|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
162014487|NCT01075685|585106958|FG000|Overall Study|Protocol Violation|9|||
162157764|NCT01820260|585627090|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162157765|NCT01820260|585627091|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
162157766|NCT05444192|585627092|FG000|Overall Study|Lost to Follow-up|1|||
162157767|NCT05444192|585627093|FG001|Overall Study|Lost to Follow-up|0|||
162157768|NCT04424927|585627097|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
162157769|NCT04424927|585627098|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
162157770|NCT04424927|585627099|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
162157771|NCT04424927|585627100|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
162157772|NCT04424927|585627101|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
162157773|NCT04424927|585627097|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
162157774|NCT04424927|585627098|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
162157775|NCT04424927|585627099|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
162157776|NCT04424927|585627100|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
162157777|NCT04424927|585627101|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
162157778|NCT04424927|585627097|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
162157779|NCT04424927|585627098|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
162157780|NCT04424927|585627099|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
162157781|NCT04424927|585627100|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
162157782|NCT04424927|585627101|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
162157783|NCT04424927|585627097|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
162157784|NCT04424927|585627098|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
162157785|NCT04424927|585627099|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
162157786|NCT04424927|585627100|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
162157787|NCT04424927|585627101|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
162157788|NCT04424927|585627097|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
162157789|NCT04424927|585627098|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
162157790|NCT04424927|585627099|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
162157791|NCT04424927|585627100|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
162157792|NCT04424927|585627101|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
162157793|NCT04424927|585627097|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
162157794|NCT04424927|585627098|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
162157795|NCT04424927|585627099|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
162157796|NCT04424927|585627100|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
162157797|NCT04424927|585627101|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
162157798|NCT04424927|585627097|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
162157799|NCT04424927|585627098|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
162157800|NCT04424927|585627099|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
162157801|NCT04424927|585627100|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
162157802|NCT04424927|585627101|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
162157803|NCT04424927|585627097|FG000|Double-blind Period (24 Weeks)|Other|0|||
162157804|NCT04424927|585627098|FG001|Double-blind Period (24 Weeks)|Other|1|||
162157805|NCT04424927|585627099|FG002|Double-blind Period (24 Weeks)|Other|3|||
162157806|NCT04424927|585627100|FG003|Double-blind Period (24 Weeks)|Other|1|||
162157807|NCT04424927|585627101|FG004|Double-blind Period (24 Weeks)|Other|0|||
162157808|NCT00505934|585627103|FG000|Overall Study|Adverse Event|1|||
162157809|NCT00505934|585627103|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
162157810|NCT00505934|585627103|FG000|Overall Study|Other: IV dose needed to be changed|1|||
162157811|NCT01046136|585627106|FG000|Overall Study|Withdrawal by Subject|0|||
162157812|NCT01046136|585627107|FG001|Overall Study|Withdrawal by Subject|4|||
162157813|NCT01046136|585627106|FG000|Overall Study|Physician Decision|1|||
162157814|NCT01046136|585627107|FG001|Overall Study|Physician Decision|1|||
162157815|NCT01046136|585627106|FG000|Overall Study|Lost to Follow-up|3|||
162157816|NCT01046136|585627107|FG001|Overall Study|Lost to Follow-up|3|||
162157817|NCT02058108|585627108|FG000|Overall Study|Abnormal Laboratory Values|0|||
162157818|NCT02058108|585627109|FG001|Overall Study|Abnormal Laboratory Values|1|||
162157819|NCT02058108|585627108|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
162157820|NCT02058108|585627109|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
162157821|NCT02058108|585627108|FG000|Overall Study|No longer requires study drug|0|||
162157822|NCT02058108|585627109|FG001|Overall Study|No longer requires study drug|1|||
162157823|NCT02058108|585627108|FG000|Overall Study|Withdrawal by Subject|1|||
162157824|NCT02058108|585627109|FG001|Overall Study|Withdrawal by Subject|0|||
162157825|NCT02058108|585627108|FG000|Overall Study|Administrative problems|3|||
162157826|NCT02058108|585627109|FG001|Overall Study|Administrative problems|3|||
162157827|NCT02058108|585627108|FG000|Overall Study|Protocol Violation|0|||
162157828|NCT02058108|585627109|FG001|Overall Study|Protocol Violation|1|||
162157829|NCT01376700|585627113|FG000|Overall Study|Sponsor terminated study early|8|||
162157830|NCT01376700|585627113|FG000|Overall Study|Low or high titer inhibitor|8|||
162157831|NCT00727909|585627114|FG000|Overall Study|Withdrawal by Subject|5|||
162157832|NCT00727909|585627115|FG001|Overall Study|Withdrawal by Subject|11|||
162157833|NCT00727909|585627116|FG002|Overall Study|Withdrawal by Subject|8|||
162157834|NCT00727909|585627117|FG003|Overall Study|Withdrawal by Subject|5|||
162157835|NCT00727909|585627114|FG000|Overall Study|Death|0|||
162157836|NCT00727909|585627115|FG001|Overall Study|Death|0|||
162157837|NCT00727909|585627116|FG002|Overall Study|Death|1|||
162157838|NCT00727909|585627117|FG003|Overall Study|Death|0|||
162157839|NCT01696773|585627118|FG000|Days 15-27, Washout|Adverse Event|1|||
162157840|NCT01696773|585627119|FG001|Days 15-27, Washout|Adverse Event|0|||
162157841|NCT01121991|585627120|FG000|Overall Study|Lack of Ovarian Response|2|||
162157842|NCT01121991|585627120|FG000|Overall Study|No Oocytes Retrieved|3|||
162157843|NCT01121991|585627120|FG000|Overall Study|No Fertilization|1|||
162157844|NCT04110054|585627121|FG000|Overall Study|COVID-19 reason other than AE|0|||
162157845|NCT04110054|585627122|FG001|Overall Study|COVID-19 reason other than AE|0|||
162157846|NCT04110054|585627123|FG002|Overall Study|COVID-19 reason other than AE|2|||
162157847|NCT04110054|585627124|FG003|Overall Study|COVID-19 reason other than AE|0|||
162157848|NCT04110054|585627121|FG000|Overall Study|Withdrawal by Subject|0|||
162157849|NCT04110054|585627122|FG001|Overall Study|Withdrawal by Subject|3|||
162157850|NCT04110054|585627123|FG002|Overall Study|Withdrawal by Subject|2|||
162157851|NCT04110054|585627124|FG003|Overall Study|Withdrawal by Subject|0|||
162157852|NCT04110054|585627121|FG000|Overall Study|Adverse Event|1|||
162157853|NCT04110054|585627122|FG001|Overall Study|Adverse Event|1|||
162157854|NCT04110054|585627123|FG002|Overall Study|Adverse Event|4|||
162157855|NCT04110054|585627124|FG003|Overall Study|Adverse Event|3|||
162157856|NCT01000480|585627126|FG000|Induction Phase|Adverse Event|2|||
162157857|NCT01000480|585627126|FG000|Induction Phase|Lost to Follow-up|1|||
162157858|NCT01000480|585627126|FG000|Induction Phase|Physician Decision|1|||
162157859|NCT01000480|585627126|FG000|Induction Phase|Entry Criteria Not Met|3|||
162157860|NCT01000480|585627126|FG000|Concurrent Therapy Phase|Adverse Event|4|||
162157861|NCT01000480|585627126|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
162157862|NCT01000480|585627126|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
162157863|NCT01000480|585627126|FG000|Concurrent Therapy Phase|Physician Decision|1|||
162157864|NCT03655262|585627131|FG000|Overall Study|Withdrawal by Subject|0|||
162157865|NCT03655262|585627132|FG001|Overall Study|Withdrawal by Subject|0|||
162157866|NCT03655262|585627133|FG002|Overall Study|Withdrawal by Subject|1|||
162157867|NCT04149002|585627143|FG000|Overall Study|Lost to Follow-up|1|||
162157868|NCT04149002|585627144|FG001|Overall Study|Lost to Follow-up|0|||
162157869|NCT04149002|585627143|FG000|Overall Study|Withdrawal by Subject|1|||
162157870|NCT04149002|585627144|FG001|Overall Study|Withdrawal by Subject|0|||
162157871|NCT06061081|585627145|FG000|Overall Study|Withdrawal by Subject|1|||
162157872|NCT06061081|585627146|FG001|Overall Study|Withdrawal by Subject|0|||
162157873|NCT06061081|585627147|FG002|Overall Study|Withdrawal by Subject|0|||
162157874|NCT06061081|585627148|FG003|Overall Study|Withdrawal by Subject|0|||
162157875|NCT06061081|585627149|FG004|Overall Study|Withdrawal by Subject|0|||
162157876|NCT03330795|585627150|FG000|Overall Study|Death|3|||
162157877|NCT03330795|585627150|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
162157878|NCT03014453|585627151|FG000|Overall Study|Lost to Follow-up|12|||
162157879|NCT03014453|585627151|FG000|Overall Study|Discontinued GER|3|||
162157880|NCT03014453|585627151|FG000|Overall Study|Excluded|19|||
162157881|NCT03014453|585627151|FG000|Overall Study|Refused to take part in|37|||
162157882|NCT03750968|585627159|FG000|Overall Study|Adverse Event|2|||
162157883|NCT03750968|585627160|FG001|Overall Study|Adverse Event|0|||
162157884|NCT03750968|585627159|FG000|Overall Study|Lost to Follow-up|1|||
162157885|NCT03750968|585627160|FG001|Overall Study|Lost to Follow-up|3|||
162157886|NCT02539225|585627161|FG000|Part A|Adverse Event|13|||
162157887|NCT02539225|585627162|FG001|Part A|Adverse Event|4|||
162157888|NCT02539225|585627161|FG000|Part A|Withdrawal by Subject|2|||
162157889|NCT02539225|585627162|FG001|Part A|Withdrawal by Subject|4|||
162157890|NCT02539225|585627161|FG000|Part A|Physician Decision|4|||
162157891|NCT02539225|585627162|FG001|Part A|Physician Decision|7|||
162157892|NCT02539225|585627161|FG000|Part A|Did Not Receive study Drug|1|||
162157893|NCT02539225|585627162|FG001|Part A|Did Not Receive study Drug|1|||
162157894|NCT02539225|585627161|FG000|Pre Treatment for Part B|Progressive disease|1|||
162157895|NCT02539225|585627162|FG001|Pre Treatment for Part B|Progressive disease|1|||
162157896|NCT02539225|585627161|FG000|Pre Treatment for Part B|Adverse Event|1|||
162157897|NCT02539225|585627162|FG001|Pre Treatment for Part B|Adverse Event|1|||
162157898|NCT02539225|585627161|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
162157899|NCT02539225|585627162|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
162157900|NCT02539225|585627161|FG000|Pre Treatment for Part B|Physician Decision|2|||
162157901|NCT02539225|585627162|FG001|Pre Treatment for Part B|Physician Decision|0|||
162157902|NCT02539225|585627161|FG000|Part B|Adverse Event|4|||
162157903|NCT02539225|585627162|FG001|Part B|Adverse Event|4|||
162157904|NCT02539225|585627161|FG000|Part B|Withdrawal by Subject|0|||
162157905|NCT02539225|585627162|FG001|Part B|Withdrawal by Subject|3|||
162157906|NCT02539225|585627161|FG000|Part B|Physician Decision|0|||
162157907|NCT02539225|585627162|FG001|Part B|Physician Decision|9|||
162157908|NCT03101371|585627170|FG000|Overall Study|Physician Decision|0|||
162157909|NCT03101371|585627171|FG001|Overall Study|Physician Decision|1|||
162157910|NCT03101371|585627170|FG000|Overall Study|Lost to Follow-up|1|||
162157911|NCT03101371|585627171|FG001|Overall Study|Lost to Follow-up|4|||
162157912|NCT03101371|585627170|FG000|Overall Study|Did not meet eligibility criteria|2|||
162157913|NCT03101371|585627171|FG001|Overall Study|Did not meet eligibility criteria|1|||
162157914|NCT02318134|585627172|FG000|Overall Study|Withdrawal by Subject|2|||
162157915|NCT02318134|585627173|FG001|Overall Study|Withdrawal by Subject|1|||
162157916|NCT01094184|585627174|FG000|Overall Study|Death|35|||
162157917|NCT01094184|585627175|FG001|Overall Study|Death|11|||
162157918|NCT03988842|585627176|FG000|Overall Study|Death|1|||
161812496|NCT00824291|584356224|FG001|Overall Study|Withdrawal by Subject|8|||
161812497|NCT00824291|584356223|FG000|Overall Study|Lack of Efficacy|7|||
161812498|NCT00824291|584356224|FG001|Overall Study|Lack of Efficacy|8|||
162157919|NCT04766034|585627177|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
162157920|NCT04766034|585627178|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161812499|NCT00824291|584356223|FG000|Overall Study|Participant on prohibited medication|1|||
162157921|NCT04766034|585627179|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
162157922|NCT04766034|585627180|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
162157923|NCT04766034|585627181|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
162157924|NCT04766034|585627177|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
162157925|NCT04766034|585627178|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
162157926|NCT04766034|585627179|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
162157927|NCT04766034|585627180|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
162157928|NCT04766034|585627181|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
162157929|NCT04766034|585627177|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
162157930|NCT04766034|585627178|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
162157931|NCT04766034|585627179|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
162157932|NCT04766034|585627180|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
162157933|NCT04766034|585627181|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
162157934|NCT04766034|585627177|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
162157935|NCT04766034|585627178|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
162157936|NCT04766034|585627179|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
162157937|NCT04766034|585627180|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
162157938|NCT04766034|585627181|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
162157939|NCT01976312|585627182|FG000|Overall Study|Pregnancy|0|||
162157940|NCT01976312|585627183|FG001|Overall Study|Pregnancy|1|||
162157941|NCT01976312|585627182|FG000|Overall Study|Lost to Follow-up|2|||
162157942|NCT01976312|585627183|FG001|Overall Study|Lost to Follow-up|0|||
162157943|NCT01976312|585627182|FG000|Overall Study|Withdrawal by Subject|7|||
162157944|NCT01976312|585627183|FG001|Overall Study|Withdrawal by Subject|2|||
162157945|NCT01976312|585627182|FG000|Overall Study|Adverse Event|6|||
162157946|NCT01976312|585627183|FG001|Overall Study|Adverse Event|6|||
162157947|NCT01976312|585627182|FG000|Overall Study|Protocol Violation|2|||
162157948|NCT01976312|585627183|FG001|Overall Study|Protocol Violation|0|||
162157949|NCT02556138|585627184|FG000|Overall Study|Withdrawal by Subject|1|||
162157950|NCT03939312|585627185|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
162157951|NCT03939312|585627185|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
162157952|NCT03939312|585627185|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
162157953|NCT03939312|585627185|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
162157954|NCT03939312|585627185|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
162157955|NCT03939312|585627185|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
162157956|NCT03939312|585627185|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
162157957|NCT03939312|585627185|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
162157958|NCT03939312|585627185|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
162157959|NCT03939312|585627185|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
162157960|NCT03939312|585627185|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
162157961|NCT03939312|585627185|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
162157962|NCT01609218|585627187|FG000|Period 1|Adverse Event|3|||
162157963|NCT01609218|585627188|FG001|Period 1|Adverse Event|5|||
162157964|NCT01609218|585627187|FG000|Period 1|Sponsor Decision|0|||
162157965|NCT01609218|585627188|FG001|Period 1|Sponsor Decision|1|||
162157966|NCT01609218|585627187|FG000|Period 2|Adverse Event|1|||
162157967|NCT01609218|585627188|FG001|Period 2|Adverse Event|0|||
162157968|NCT02807779|585627191|FG000|Overall Study|Lost to Follow-up|1|||
162157969|NCT02807779|585627192|FG001|Overall Study|Lost to Follow-up|0|||
162157970|NCT02807779|585627193|FG002|Overall Study|Lost to Follow-up|0|||
162157971|NCT02807779|585627191|FG000|Overall Study|Physician Decision|2|||
162157972|NCT02807779|585627192|FG001|Overall Study|Physician Decision|0|||
162157973|NCT02807779|585627193|FG002|Overall Study|Physician Decision|1|||
162157974|NCT02807779|585627191|FG000|Overall Study|Death|1|||
162157975|NCT02807779|585627192|FG001|Overall Study|Death|1|||
162157976|NCT02807779|585627193|FG002|Overall Study|Death|0|||
162157977|NCT02576509|585629335|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
162157978|NCT02576509|585629336|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
162157979|NCT02576509|585629335|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
162157980|NCT02576509|585629336|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
162157981|NCT02576509|585629335|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
161915938|NCT03907488|584740587|FG001|Overall Study|Ineligible|15|||
161915939|NCT01093846|584740589|FG000|Overall Study|Adverse Event|0|||
161915940|NCT01093846|584740590|FG001|Overall Study|Adverse Event|0|||
162157982|NCT02576509|585629336|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
162157983|NCT02576509|585629335|FG000|Treatment Period|Disease progression|263|||
162157984|NCT02576509|585629336|FG001|Treatment Period|Disease progression|244|||
162157985|NCT02576509|585629335|FG000|Treatment Period|Study drug toxicity|37|||
162157986|NCT02576509|585629336|FG001|Treatment Period|Study drug toxicity|41|||
162157987|NCT02576509|585629335|FG000|Treatment Period|Death|1|||
162157988|NCT02576509|585629336|FG001|Treatment Period|Death|1|||
162157989|NCT02576509|585629335|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
162157990|NCT02576509|585629336|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
162157991|NCT02576509|585629335|FG000|Treatment Period|Participant request to stop treatment|8|||
162157992|NCT02576509|585629336|FG001|Treatment Period|Participant request to stop treatment|18|||
162157993|NCT02576509|585629335|FG000|Treatment Period|Participant withdrew consent|3|||
162157994|NCT02576509|585629336|FG001|Treatment Period|Participant withdrew consent|7|||
162157995|NCT02576509|585629335|FG000|Treatment Period|Lost to Follow-up|0|||
162157996|NCT02576509|585629336|FG001|Treatment Period|Lost to Follow-up|1|||
162157997|NCT02576509|585629335|FG000|Treatment Period|Maximum clinical benefit|1|||
162157998|NCT02576509|585629336|FG001|Treatment Period|Maximum clinical benefit|0|||
162157999|NCT02576509|585629335|FG000|Treatment Period|Poor/non-compliance|1|||
162158000|NCT02576509|585629336|FG001|Treatment Period|Poor/non-compliance|1|||
162158001|NCT02576509|585629335|FG000|Treatment Period|Participant no longer meets criteria|1|||
162158002|NCT02576509|585629336|FG001|Treatment Period|Participant no longer meets criteria|0|||
162158003|NCT02576509|585629335|FG000|Treatment Period|Other reason|12|||
162158004|NCT02576509|585629336|FG001|Treatment Period|Other reason|8|||
162158005|NCT02576509|585629335|FG000|Treatment Period|NOT REPORTED|1|||
162158006|NCT02576509|585629336|FG001|Treatment Period|NOT REPORTED|0|||
162158007|NCT02576509|585629335|FG000|Treatment Period|Administrative reason by sponsor|0|||
162158008|NCT02576509|585629336|FG001|Treatment Period|Administrative reason by sponsor|1|||
162158009|NCT03725722|585629339|FG000|Overall Study|Lack of Efficacy|2|||
162158010|NCT03725722|585629340|FG001|Overall Study|Lack of Efficacy|1|||
162158011|NCT03725722|585629341|FG002|Overall Study|Lack of Efficacy|2|||
162158012|NCT03725722|585629342|FG003|Overall Study|Lack of Efficacy|0|||
162158013|NCT03725722|585629343|FG004|Overall Study|Lack of Efficacy|2|||
162158014|NCT03725722|585629339|FG000|Overall Study|Adverse Event|2|||
162158015|NCT03725722|585629340|FG001|Overall Study|Adverse Event|2|||
162158016|NCT03725722|585629341|FG002|Overall Study|Adverse Event|1|||
162158017|NCT03725722|585629342|FG003|Overall Study|Adverse Event|0|||
162158018|NCT03725722|585629343|FG004|Overall Study|Adverse Event|6|||
162158019|NCT03725722|585629339|FG000|Overall Study|Withdrawal by Subject|4|||
162158020|NCT03725722|585629340|FG001|Overall Study|Withdrawal by Subject|1|||
162158021|NCT03725722|585629341|FG002|Overall Study|Withdrawal by Subject|0|||
162158022|NCT03725722|585629342|FG003|Overall Study|Withdrawal by Subject|4|||
162158023|NCT03725722|585629343|FG004|Overall Study|Withdrawal by Subject|4|||
162158024|NCT03725722|585629339|FG000|Overall Study|Lost to Follow-up|3|||
162158025|NCT03725722|585629340|FG001|Overall Study|Lost to Follow-up|1|||
162158026|NCT03725722|585629341|FG002|Overall Study|Lost to Follow-up|2|||
162158027|NCT03725722|585629342|FG003|Overall Study|Lost to Follow-up|2|||
162158028|NCT03725722|585629343|FG004|Overall Study|Lost to Follow-up|1|||
162158029|NCT03725722|585629339|FG000|Overall Study|Personal reasons|0|||
162158030|NCT03725722|585629340|FG001|Overall Study|Personal reasons|0|||
162158031|NCT03725722|585629341|FG002|Overall Study|Personal reasons|1|||
161812500|NCT00824291|584356224|FG001|Overall Study|Participant on prohibited medication|0|||
161812501|NCT00123734|584356229|FG000|Overall Study|Death|3|||
161812502|NCT00123734|584356229|FG000|Overall Study|Lost to Follow-up|3|||
161812503|NCT00123734|584356229|FG000|Overall Study|Dropout|1|||
161812504|NCT00123734|584356229|FG000|Overall Study|Withdrawal by Subject|1|||
161812505|NCT00113386|584356230|FG000|Overall Study|Withdrawal by Subject|1|||
161812506|NCT00113386|584356231|FG001|Overall Study|Withdrawal by Subject|0|||
161812507|NCT00113386|584356230|FG000|Overall Study|Physician Decision|0|||
162158032|NCT03725722|585629342|FG003|Overall Study|Personal reasons|0|||
162158033|NCT03725722|585629343|FG004|Overall Study|Personal reasons|1|||
162158034|NCT03725722|585629339|FG000|Overall Study|COVID-19 situation|0|||
162158035|NCT03725722|585629340|FG001|Overall Study|COVID-19 situation|1|||
162158036|NCT03725722|585629341|FG002|Overall Study|COVID-19 situation|0|||
162158037|NCT03725722|585629342|FG003|Overall Study|COVID-19 situation|0|||
162158038|NCT03725722|585629343|FG004|Overall Study|COVID-19 situation|0|||
162158039|NCT01600014|585629344|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
161812508|NCT00113386|584356231|FG001|Overall Study|Physician Decision|1|||
161812509|NCT00113386|584356230|FG000|Overall Study|Toxicity|3|||
162158040|NCT01600014|585629345|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
162158041|NCT01600014|585629344|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
162158042|NCT01600014|585629345|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
162158043|NCT01600014|585629344|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
162158044|NCT01600014|585629345|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
161812510|NCT00113386|584356231|FG001|Overall Study|Toxicity|0|||
162158045|NCT01600014|585629344|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
162158046|NCT01600014|585629345|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
162014488|NCT01075685|585106959|FG001|Overall Study|Protocol Violation|1|||
162014489|NCT01075685|585106958|FG000|Overall Study|Withdrawal by Subject|20|||
162014490|NCT01075685|585106959|FG001|Overall Study|Withdrawal by Subject|5|||
162014491|NCT01075685|585106958|FG000|Overall Study|Lost to Follow-up|563|||
162014492|NCT01075685|585106959|FG001|Overall Study|Lost to Follow-up|220|||
162014493|NCT03196349|585106962|FG000|Overall Study|Did not receive study drug|0|||
162014494|NCT03196349|585106963|FG001|Overall Study|Did not receive study drug|1|||
162014495|NCT03196349|585106964|FG002|Overall Study|Did not receive study drug|2|||
162014496|NCT03196349|585106962|FG000|Overall Study|No data entered|2|||
162014497|NCT03196349|585106963|FG001|Overall Study|No data entered|4|||
162014498|NCT03196349|585106964|FG002|Overall Study|No data entered|0|||
162014499|NCT03196349|585106962|FG000|Overall Study|Study Terminated early|15|||
162014500|NCT03196349|585106963|FG001|Overall Study|Study Terminated early|9|||
162014501|NCT03196349|585106964|FG002|Overall Study|Study Terminated early|11|||
162014502|NCT03388164|585106969|FG000|Overall Study|Withdrawal by Subject|3|||
162014503|NCT03388164|585106970|FG001|Overall Study|Withdrawal by Subject|1|||
162014504|NCT03967444|585106971|FG000|Overall Study|Lost to Follow-up|1|||
162014505|NCT03967444|585106972|FG001|Overall Study|Lost to Follow-up|2|||
162014506|NCT00499083|585106980|FG000|Overall Study|Not evaluable|3|||
162014507|NCT00686686|585106981|FG000|Overall Study|Non-compliance|1|||
162014508|NCT00686686|585106981|FG000|Overall Study|Adverse Event|2|||
162014509|NCT00686686|585106981|FG000|Overall Study|Lost to Follow-up|3|||
162014510|NCT00477386|585106982|FG000|Overall Study|Adverse Event|4|||
162014511|NCT00477386|585106983|FG001|Overall Study|Adverse Event|8|||
162014512|NCT00477386|585106982|FG000|Overall Study|Disease progression, relapse|3|||
162014513|NCT00477386|585106983|FG001|Overall Study|Disease progression, relapse|4|||
162014514|NCT00477386|585106982|FG000|Overall Study|Disease progression, refractory|1|||
162014515|NCT00477386|585106983|FG001|Overall Study|Disease progression, refractory|3|||
162014516|NCT00477386|585106982|FG000|Overall Study|Other|1|||
162014517|NCT00477386|585106983|FG001|Overall Study|Other|2|||
162014518|NCT00477386|585106982|FG000|Overall Study|Physician Decision|1|||
162014519|NCT00477386|585106983|FG001|Overall Study|Physician Decision|0|||
162014520|NCT00477386|585106982|FG000|Overall Study|Withdrawal by Subject|1|||
162014521|NCT00477386|585106983|FG001|Overall Study|Withdrawal by Subject|0|||
162014522|NCT01254422|585106984|FG000|Overall Study|Protocol Violation|1|||
162014523|NCT01254422|585106985|FG001|Overall Study|Protocol Violation|0|||
162014524|NCT01254422|585106984|FG000|Overall Study|Adverse Event|1|||
162014525|NCT01254422|585106985|FG001|Overall Study|Adverse Event|0|||
162014526|NCT01254422|585106984|FG000|Overall Study|Serious adverse event|0|||
162014527|NCT01254422|585106985|FG001|Overall Study|Serious adverse event|1|||
162014528|NCT01254422|585106984|FG000|Overall Study|Lost to Follow-up|1|||
162014529|NCT01254422|585106985|FG001|Overall Study|Lost to Follow-up|0|||
162014530|NCT00643162|585106986|FG000|Overall Study|Withdrawal by Subject|1|||
162014531|NCT00643162|585106987|FG001|Overall Study|Withdrawal by Subject|1|||
162014532|NCT01812252|585106990|FG000|Overall Study|Persistent Disease|1|||
162014533|NCT01812252|585106991|FG001|Overall Study|Persistent Disease|0|||
162014534|NCT01812252|585106990|FG000|Overall Study|Not transplanted|11|||
162014535|NCT01812252|585106991|FG001|Overall Study|Not transplanted|11|||
162014536|NCT01812252|585106990|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
162014537|NCT01812252|585106991|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
162014538|NCT01812252|585106990|FG000|Overall Study|Withdrawal by Subject|1|||
162014539|NCT01812252|585106991|FG001|Overall Study|Withdrawal by Subject|1|||
162014540|NCT01812252|585106990|FG000|Overall Study|Screen Failure|1|||
162014541|NCT01812252|585106991|FG001|Overall Study|Screen Failure|0|||
162014542|NCT03739203|585106996|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
162014543|NCT03739203|585106997|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
162014544|NCT03739203|585106998|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
162014545|NCT03739203|585106996|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
162014546|NCT03739203|585106997|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
162014547|NCT03739203|585106998|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
162014548|NCT03739203|585106996|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
162014549|NCT03739203|585106997|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
162236488|NCT04874415|585916961|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
162014550|NCT03739203|585106998|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
162014551|NCT03739203|585106996|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
162014552|NCT03739203|585106997|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
162014553|NCT03739203|585106998|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
162014554|NCT03739203|585106996|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
162014555|NCT03739203|585106997|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
162014556|NCT03739203|585106998|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
162014557|NCT03739203|585106996|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
162014558|NCT03739203|585106997|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
162014559|NCT03739203|585106998|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
162158047|NCT01600014|585629344|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
162158048|NCT01600014|585629345|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
162158049|NCT01600014|585629344|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
162158050|NCT01600014|585629345|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
162158051|NCT01600014|585629344|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
162158052|NCT01600014|585629345|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
162158053|NCT01600014|585629344|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
162158054|NCT01600014|585629345|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
162158055|NCT01600014|585629344|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
162158056|NCT01600014|585629345|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
162158057|NCT01600014|585629344|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
162158058|NCT01600014|585629345|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
162158059|NCT01600014|585629344|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
162158060|NCT01600014|585629345|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
162158061|NCT01600014|585629344|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
162158062|NCT01600014|585629345|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
162158063|NCT01600014|585629344|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
162158064|NCT01600014|585629345|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
162158065|NCT01600014|585629344|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
162158066|NCT01600014|585629345|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
162158067|NCT01600014|585629344|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
162158068|NCT01600014|585629345|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
162158069|NCT01600014|585629344|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
162158070|NCT01600014|585629345|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
162158071|NCT01600014|585629344|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
162158072|NCT01600014|585629345|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
162158073|NCT02791230|585629349|FG000|Overall Study|Adverse Event|10|||
162158074|NCT02791230|585629350|FG001|Overall Study|Adverse Event|9|||
162158075|NCT02791230|585629351|FG002|Overall Study|Adverse Event|66|||
162158076|NCT02791230|585629349|FG000|Overall Study|Death|38|||
162158077|NCT02791230|585629350|FG001|Overall Study|Death|25|||
162158078|NCT02791230|585629351|FG002|Overall Study|Death|184|||
162158079|NCT02791230|585629349|FG000|Overall Study|Lack of Efficacy|1|||
162158080|NCT02791230|585629350|FG001|Overall Study|Lack of Efficacy|0|||
162158081|NCT02791230|585629351|FG002|Overall Study|Lack of Efficacy|3|||
162158082|NCT02791230|585629349|FG000|Overall Study|Lost to Follow-up|0|||
162158083|NCT02791230|585629350|FG001|Overall Study|Lost to Follow-up|0|||
162158084|NCT02791230|585629351|FG002|Overall Study|Lost to Follow-up|10|||
162158085|NCT02791230|585629349|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
162158086|NCT02791230|585629350|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
162158087|NCT02791230|585629351|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
162158088|NCT02791230|585629349|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
162158089|NCT02791230|585629350|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
162158090|NCT02791230|585629351|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
162158091|NCT02791230|585629349|FG000|Overall Study|Study sites terminated by sponsor|1|||
162158092|NCT02791230|585629350|FG001|Overall Study|Study sites terminated by sponsor|0|||
162158093|NCT02791230|585629351|FG002|Overall Study|Study sites terminated by sponsor|5|||
162158094|NCT02791230|585629349|FG000|Overall Study|Other|9|||
162158095|NCT02791230|585629350|FG001|Overall Study|Other|1|||
162158096|NCT02791230|585629351|FG002|Overall Study|Other|28|||
162158097|NCT02791230|585629349|FG000|Overall Study|Protocol Violation|0|||
162158098|NCT02791230|585629350|FG001|Overall Study|Protocol Violation|0|||
162158099|NCT02791230|585629351|FG002|Overall Study|Protocol Violation|4|||
162014560|NCT03739203|585106996|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
162014561|NCT03739203|585106997|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
162014562|NCT03739203|585106998|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
162014563|NCT03739203|585106996|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
162158100|NCT02791230|585629349|FG000|Overall Study|Withdrawal by Subject|24|||
162158101|NCT02791230|585629350|FG001|Overall Study|Withdrawal by Subject|13|||
162158102|NCT02791230|585629351|FG002|Overall Study|Withdrawal by Subject|172|||
162158103|NCT02791230|585629349|FG000|Overall Study|Enrolled but not treated|0|||
162158104|NCT02791230|585629350|FG001|Overall Study|Enrolled but not treated|0|||
162158105|NCT02791230|585629351|FG002|Overall Study|Enrolled but not treated|5|||
162158106|NCT00212355|585629352|FG000|Overall Study|Adverse Event|1|||
162158107|NCT00212355|585629352|FG000|Overall Study|Withdrawal by Subject|1|||
162158108|NCT00212355|585629352|FG000|Overall Study|A change of address|1|||
162158109|NCT00186992|585629360|FG000|Overall Study|Withdrawal by Subject|5|||
162158110|NCT00186992|585629360|FG000|Overall Study|Physician's discretion|13|||
162158111|NCT00186992|585629360|FG000|Overall Study|PI Discretion|4|||
162158112|NCT00186992|585629360|FG000|Overall Study|Ineligible|2|||
162158113|NCT00186992|585629360|FG000|Overall Study|Lost to Follow-up|2|||
162158114|NCT00186992|585629360|FG000|Overall Study|Still on Study|9|||
162158115|NCT03683069|585629361|FG000|Overall Study|see limitations|12|||
162158116|NCT03683069|585629362|FG001|Overall Study|see limitations|13|||
162158117|NCT03821844|585629363|FG000|Overall Study|Death|37|||
162158118|NCT03821844|585629364|FG001|Overall Study|Death|31|||
162158119|NCT03821844|585629363|FG000|Overall Study|Discharged|10|||
162158120|NCT03821844|585629364|FG001|Overall Study|Discharged|14|||
162158121|NCT03821844|585629363|FG000|Overall Study|Not present in facility at followup|2|||
162158122|NCT03821844|585629364|FG001|Overall Study|Not present in facility at followup|3|||
162158123|NCT05104697|585629365|FG000|Overall Study|Withdrawal by Subject|0|||
162158124|NCT05104697|585629366|FG001|Overall Study|Withdrawal by Subject|1|||
162158125|NCT03913195|585629367|FG000|Overall Study|Adverse Event|0|||
162158126|NCT03913195|585629368|FG001|Overall Study|Adverse Event|0|||
162158127|NCT03913195|585629369|FG002|Overall Study|Adverse Event|1|||
162158128|NCT03913195|585629370|FG003|Overall Study|Adverse Event|1|||
162158129|NCT03913195|585629371|FG004|Overall Study|Adverse Event|0|||
162158130|NCT03913195|585629367|FG000|Overall Study|Withdrawal by Subject|0|||
162158131|NCT03913195|585629368|FG001|Overall Study|Withdrawal by Subject|0|||
162158132|NCT03913195|585629369|FG002|Overall Study|Withdrawal by Subject|1|||
162158133|NCT03913195|585629370|FG003|Overall Study|Withdrawal by Subject|0|||
162158134|NCT03913195|585629371|FG004|Overall Study|Withdrawal by Subject|1|||
162158135|NCT03913195|585629367|FG000|Overall Study|non adherence to study|0|||
162158136|NCT03913195|585629368|FG001|Overall Study|non adherence to study|0|||
162158137|NCT03913195|585629369|FG002|Overall Study|non adherence to study|1|||
162158138|NCT03913195|585629370|FG003|Overall Study|non adherence to study|0|||
162158139|NCT03913195|585629371|FG004|Overall Study|non adherence to study|0|||
162158140|NCT05307978|585629372|FG000|Overall Study|Lost to Follow-up|0|||
162158141|NCT05307978|585629373|FG001|Overall Study|Lost to Follow-up|1|||
162158142|NCT05307978|585629374|FG002|Overall Study|Lost to Follow-up|0|||
162158143|NCT05307978|585629375|FG003|Overall Study|Lost to Follow-up|4|||
162158144|NCT05307978|585629376|FG004|Overall Study|Lost to Follow-up|0|||
162158145|NCT05307978|585629377|FG005|Overall Study|Lost to Follow-up|0|||
162158146|NCT05307978|585629378|FG006|Overall Study|Lost to Follow-up|1|||
162158147|NCT05075408|585629379|FG000|Overall Study|Withdrawal by Subject|5|||
162158148|NCT05075408|585629380|FG001|Overall Study|Withdrawal by Subject|3|||
162158149|NCT05075408|585629381|FG002|Overall Study|Withdrawal by Subject|4|||
162158150|NCT05075408|585629379|FG000|Overall Study|Adverse Event|5|||
162158151|NCT05075408|585629380|FG001|Overall Study|Adverse Event|7|||
162158152|NCT05075408|585629381|FG002|Overall Study|Adverse Event|8|||
162158153|NCT05075408|585629379|FG000|Overall Study|Protocol Violation|0|||
162158154|NCT05075408|585629380|FG001|Overall Study|Protocol Violation|1|||
162158155|NCT05075408|585629381|FG002|Overall Study|Protocol Violation|0|||
162158156|NCT05075408|585629379|FG000|Overall Study|Lost to Follow-up|2|||
162158157|NCT05075408|585629380|FG001|Overall Study|Lost to Follow-up|1|||
162158158|NCT05075408|585629381|FG002|Overall Study|Lost to Follow-up|1|||
162158159|NCT05075408|585629379|FG000|Overall Study|Physician Decision|1|||
162158160|NCT05075408|585629380|FG001|Overall Study|Physician Decision|0|||
162158161|NCT05075408|585629381|FG002|Overall Study|Physician Decision|0|||
162158162|NCT05075408|585629379|FG000|Overall Study|Other-unspecified|3|||
162158163|NCT05075408|585629380|FG001|Overall Study|Other-unspecified|2|||
162158164|NCT05075408|585629381|FG002|Overall Study|Other-unspecified|0|||
162158165|NCT03416023|585629382|FG000|Overall Study|Exclusion criteria failure|1|||
162158166|NCT03416023|585629382|FG000|Overall Study|Withdrawal by Subject|6|||
162158167|NCT03416023|585629382|FG000|Overall Study|Explanted|7|||
162158168|NCT03416023|585629382|FG000|Overall Study|Physician Decision|1|||
162158169|NCT03416023|585629382|FG000|Overall Study|Lost to Follow-up|1|||
162158170|NCT03416023|585629382|FG000|Overall Study|Death|1|||
162158171|NCT02837510|585629383|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
161812511|NCT00113386|584356230|FG000|Overall Study|Ineligible|1|||
162014564|NCT03739203|585106997|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
162014565|NCT03739203|585106998|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
162014566|NCT03739203|585106996|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
162014567|NCT03739203|585106997|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
162014568|NCT03739203|585106998|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
162014569|NCT03739203|585106996|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
162014570|NCT03739203|585106997|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
162014571|NCT03739203|585106998|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
162014572|NCT03739203|585106996|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
162014573|NCT03739203|585106997|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
162014574|NCT03739203|585106998|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
162014575|NCT03023397|585106999|FG000|Run-In|Failed screening allergen challenge|1|||
162014576|NCT03023397|585107000|FG001|Run-In|Failed screening allergen challenge|0|||
162014577|NCT03023397|585107001|FG002|Run-In|Failed screening allergen challenge|0|||
162014578|NCT03023397|585106999|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
162014579|NCT03023397|585107000|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
162014580|NCT03023397|585107001|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
162014581|NCT01519921|585107005|FG000|Overall Study|Adverse Event|10|||
162014582|NCT01519921|585107006|FG001|Overall Study|Adverse Event|9|||
162014583|NCT01519921|585107005|FG000|Overall Study|Lack of Efficacy|4|||
162014584|NCT01519921|585107006|FG001|Overall Study|Lack of Efficacy|3|||
162014585|NCT01519921|585107005|FG000|Overall Study|Withdrawal by Subject|3|||
162014586|NCT01519921|585107006|FG001|Overall Study|Withdrawal by Subject|0|||
162014587|NCT01519921|585107005|FG000|Overall Study|Lost to Follow-up|2|||
162014588|NCT01519921|585107006|FG001|Overall Study|Lost to Follow-up|1|||
162014589|NCT01519921|585107005|FG000|Overall Study|Treatment refusal|2|||
162014590|NCT01519921|585107006|FG001|Overall Study|Treatment refusal|1|||
162014591|NCT01519921|585107005|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
162014592|NCT01519921|585107006|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
162014593|NCT00363480|585107007|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
162014594|NCT00363480|585107007|FG000|Overall Study|Adverse Event|4|||
162014595|NCT00363480|585107007|FG000|Overall Study|Lost to Follow-up|5|||
162014596|NCT00363480|585107007|FG000|Overall Study|Withdrawal by Subject|5|||
162014597|NCT00363480|585107007|FG000|Overall Study|Non-compliance of subject|1|||
162014598|NCT00363480|585107007|FG000|Overall Study|Participant discontinued on its own|1|||
162014599|NCT03133793|585107012|FG000|Overall Study|Withdrawal by Subject|0|||
162014600|NCT03133793|585107013|FG001|Overall Study|Withdrawal by Subject|4|||
162014601|NCT03133793|585107014|FG002|Overall Study|Withdrawal by Subject|2|||
162014602|NCT03133793|585107015|FG003|Overall Study|Withdrawal by Subject|4|||
162014603|NCT03133793|585107012|FG000|Overall Study|Lost to Follow-up|1|||
162014604|NCT03133793|585107013|FG001|Overall Study|Lost to Follow-up|0|||
162014605|NCT03133793|585107014|FG002|Overall Study|Lost to Follow-up|2|||
162014606|NCT03133793|585107015|FG003|Overall Study|Lost to Follow-up|0|||
162014607|NCT03133793|585107012|FG000|Overall Study|Death|0|||
162014608|NCT03133793|585107013|FG001|Overall Study|Death|0|||
162014609|NCT03133793|585107014|FG002|Overall Study|Death|0|||
162014610|NCT03133793|585107015|FG003|Overall Study|Death|1|||
162014611|NCT00960999|585107017|FG000|Overall Study|Withdrawal by Subject|1|||
162014612|NCT00960999|585107018|FG001|Overall Study|Withdrawal by Subject|0|||
162014613|NCT00960999|585107017|FG000|Overall Study|Protocol Violation|5|||
161812512|NCT00113386|584356231|FG001|Overall Study|Ineligible|2|||
161812513|NCT00113386|584356230|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
161812514|NCT00113386|584356231|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
161812515|NCT02849457|584356232|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
161812516|NCT02849457|584356233|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
161812517|NCT02849457|584356234|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
161812518|NCT02849457|584356235|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
161812519|NCT01778010|584356239|FG000|Overall Study|Withdrawal by Subject|2|||
162014614|NCT00960999|585107018|FG001|Overall Study|Protocol Violation|2|||
162014615|NCT00960999|585107017|FG000|Overall Study|RT dose constraints not met|2|||
162014616|NCT00960999|585107018|FG001|Overall Study|RT dose constraints not met|0|||
162014617|NCT00888940|585107019|FG000|Overall Study|Adverse Event|12|||
162014618|NCT00888940|585107020|FG001|Overall Study|Adverse Event|3|||
162014619|NCT00888940|585107019|FG000|Overall Study|Lost to Follow-up|5|||
162014620|NCT00888940|585107020|FG001|Overall Study|Lost to Follow-up|5|||
162014621|NCT00888940|585107019|FG000|Overall Study|Randomized Not Treated|11|||
162014622|NCT00888940|585107020|FG001|Overall Study|Randomized Not Treated|13|||
162014623|NCT02536963|585107021|FG000|Overall Study|Withdrawal by Subject|18|||
162014624|NCT02668393|585107022|FG000|Overall Study|Progressive disease|6|||
162014625|NCT02668393|585107023|FG001|Overall Study|Progressive disease|3|||
161915941|NCT01093846|584740591|FG002|Overall Study|Adverse Event|1|||
161915942|NCT01093846|584740589|FG000|Overall Study|Lack of Efficacy|0|||
161915943|NCT01093846|584740590|FG001|Overall Study|Lack of Efficacy|0|||
161915944|NCT01093846|584740591|FG002|Overall Study|Lack of Efficacy|4|||
161915945|NCT01093846|584740589|FG000|Overall Study|Condition no longer required study drug|1|||
161915946|NCT01093846|584740590|FG001|Overall Study|Condition no longer required study drug|1|||
161915947|NCT01093846|584740591|FG002|Overall Study|Condition no longer required study drug|1|||
161915948|NCT01093846|584740589|FG000|Overall Study|Administrative Problems|18|||
161915949|NCT01093846|584740590|FG001|Overall Study|Administrative Problems|17|||
161915950|NCT01093846|584740591|FG002|Overall Study|Administrative Problems|15|||
161915951|NCT02781324|584740592|FG000|Overall Study|Withdrawal by Subject|1|||
161915952|NCT02781324|584740593|FG001|Overall Study|Withdrawal by Subject|0|||
161915953|NCT02781324|584740592|FG000|Overall Study|Physician Decision|1|||
161915954|NCT02781324|584740593|FG001|Overall Study|Physician Decision|2|||
161915955|NCT03074500|584740594|FG000|Overall Study|Lost to Follow-up|1|||
161915956|NCT03074500|584740595|FG001|Overall Study|Lost to Follow-up|0|||
161915957|NCT03074500|584740596|FG002|Overall Study|Lost to Follow-up|0|||
161915958|NCT03074500|584740594|FG000|Overall Study|Lack of Efficacy|0|||
161915959|NCT03074500|584740595|FG001|Overall Study|Lack of Efficacy|1|||
161915960|NCT03074500|584740596|FG002|Overall Study|Lack of Efficacy|0|||
161915961|NCT03074500|584740594|FG000|Overall Study|Adverse Event|0|||
161915962|NCT03074500|584740595|FG001|Overall Study|Adverse Event|0|||
161915963|NCT03074500|584740596|FG002|Overall Study|Adverse Event|1|||
161915964|NCT03321721|584740597|FG000|Overall Study|Lost to Follow-up|4|||
161915965|NCT03321721|584740598|FG001|Overall Study|Lost to Follow-up|8|||
161915966|NCT03321721|584740599|FG002|Overall Study|Lost to Follow-up|11|||
161915967|NCT05020015|584742340|FG000|Overall Study|Ongoing on study|1|||
161915968|NCT05020015|584742341|FG001|Overall Study|Ongoing on study|3|||
161915969|NCT05020015|584742342|FG002|Overall Study|Ongoing on study|4|||
161915970|NCT05020015|584742343|FG003|Overall Study|Ongoing on study|7|||
161915971|NCT05020015|584742340|FG000|Overall Study|Death|2|||
161915972|NCT05020015|584742341|FG001|Overall Study|Death|3|||
161915973|NCT05020015|584742342|FG002|Overall Study|Death|4|||
161915974|NCT05020015|584742343|FG003|Overall Study|Death|0|||
161915975|NCT05020015|584742340|FG000|Overall Study|Withdrawal by Subject|0|||
161915976|NCT05020015|584742341|FG001|Overall Study|Withdrawal by Subject|0|||
161915977|NCT05020015|584742342|FG002|Overall Study|Withdrawal by Subject|1|||
161915978|NCT05020015|584742343|FG003|Overall Study|Withdrawal by Subject|0|||
161915979|NCT05020015|584742340|FG000|Overall Study|Reason Not Specified|0|||
161915980|NCT05020015|584742341|FG001|Overall Study|Reason Not Specified|0|||
161915981|NCT05020015|584742342|FG002|Overall Study|Reason Not Specified|2|||
161915982|NCT05020015|584742343|FG003|Overall Study|Reason Not Specified|0|||
161915983|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
161915984|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
161915985|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
161915986|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
161915987|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
161915988|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
161915989|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
161915990|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
161915991|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
161915992|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
161915993|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
161915994|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
161915995|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
161915996|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
161915997|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
161915998|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
161915999|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
161916000|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
161916001|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
161916002|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
161916003|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
161916004|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
161916005|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
161916006|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
161916007|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
161916008|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
161916009|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
162158172|NCT02837510|585629384|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
162158173|NCT02837510|585629383|FG000|Washout (2 Weeks)|Adverse Event|0|||
162158174|NCT02837510|585629384|FG001|Washout (2 Weeks)|Adverse Event|1|||
162158175|NCT02837510|585629383|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
162158176|NCT02837510|585629384|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
162158177|NCT02837510|585629383|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
162158178|NCT02837510|585629384|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
162158179|NCT02837510|585629383|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
162158180|NCT02837510|585629384|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
162158181|NCT02837510|585629383|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
162158182|NCT02837510|585629384|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
162158183|NCT05419505|585629386|FG000|Overall Study|Adverse Event|0|||
162158184|NCT05419505|585629387|FG001|Overall Study|Adverse Event|0|||
162158185|NCT05419505|585629388|FG002|Overall Study|Adverse Event|0|||
162158186|NCT05419505|585629389|FG003|Overall Study|Adverse Event|1|||
162158187|NCT05419505|585629390|FG004|Overall Study|Adverse Event|0|||
162158188|NCT05419505|585629391|FG005|Overall Study|Adverse Event|0|||
162158189|NCT05419505|585629392|FG006|Overall Study|Adverse Event|0|||
162158190|NCT05419505|585629393|FG007|Overall Study|Adverse Event|0|||
162158191|NCT05419505|585629386|FG000|Overall Study|Withdrawal by Subject|1|||
162158192|NCT05419505|585629387|FG001|Overall Study|Withdrawal by Subject|2|||
162158193|NCT05419505|585629388|FG002|Overall Study|Withdrawal by Subject|0|||
162158194|NCT05419505|585629389|FG003|Overall Study|Withdrawal by Subject|0|||
162158195|NCT05419505|585629390|FG004|Overall Study|Withdrawal by Subject|0|||
162158196|NCT05419505|585629391|FG005|Overall Study|Withdrawal by Subject|0|||
162158197|NCT05419505|585629392|FG006|Overall Study|Withdrawal by Subject|1|||
162014626|NCT02668393|585107022|FG000|Overall Study|Adverse Event|0|||
161916010|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
161916011|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
161916012|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
161916013|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
161916014|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
161916015|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
161916016|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
161916017|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
161916018|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
161916019|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
161916020|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
161916021|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
161916022|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
161916023|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
161916024|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
161916025|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
161916026|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
161916027|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
161916028|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
161916029|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
161916030|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
162014627|NCT02668393|585107023|FG001|Overall Study|Adverse Event|2|||
162014628|NCT02668393|585107022|FG000|Overall Study|Withdrawal from the trial|0|||
162014629|NCT02668393|585107023|FG001|Overall Study|Withdrawal from the trial|1|||
162014630|NCT02668393|585107022|FG000|Overall Study|Lack of benefit and side effects|1|||
162158198|NCT05419505|585629393|FG007|Overall Study|Withdrawal by Subject|0|||
162158199|NCT05419505|585629386|FG000|Overall Study|Lost to Follow-up|2|||
162158200|NCT05419505|585629387|FG001|Overall Study|Lost to Follow-up|1|||
162158201|NCT05419505|585629388|FG002|Overall Study|Lost to Follow-up|0|||
162158202|NCT05419505|585629389|FG003|Overall Study|Lost to Follow-up|0|||
161812520|NCT01778010|584356239|FG000|Overall Study|abnormal ECG before meds|1|||
161812521|NCT01778010|584356239|FG000|Overall Study|Arrested|1|||
161812522|NCT01778010|584356239|FG000|Overall Study|rash while on placebo|1|||
161812523|NCT02159183|584356242|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
161812524|NCT02159183|584356243|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
161812525|NCT02159183|584356242|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
161812526|NCT02159183|584356243|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
161812527|NCT02159183|584356242|FG000|Analysis After the 36 Months Follow-up|Death|0|||
161812528|NCT02159183|584356243|FG001|Analysis After the 36 Months Follow-up|Death|1|||
162158203|NCT05419505|585629390|FG004|Overall Study|Lost to Follow-up|1|||
162158204|NCT05419505|585629391|FG005|Overall Study|Lost to Follow-up|2|||
162158205|NCT05419505|585629392|FG006|Overall Study|Lost to Follow-up|0|||
162158206|NCT05419505|585629393|FG007|Overall Study|Lost to Follow-up|1|||
161812529|NCT02159183|584356242|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
161812530|NCT02159183|584356243|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
161812531|NCT02159183|584356242|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
161812532|NCT02159183|584356243|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
161812533|NCT02558491|584356245|FG000|First Invention|Withdrawal by Subject|3|||
161812534|NCT02558491|584356246|FG001|First Invention|Withdrawal by Subject|1|||
161812535|NCT02558491|584356245|FG000|First Invention|Data collection issues|1|||
161812536|NCT02558491|584356246|FG001|First Invention|Data collection issues|0|||
161812537|NCT02558491|584356245|FG000|First Invention|Stopping criteria|0|||
161812538|NCT02558491|584356246|FG001|First Invention|Stopping criteria|1|||
161812539|NCT02558491|584356245|FG000|First Invention|Changed parameters during trial|1|||
161812540|NCT02558491|584356246|FG001|First Invention|Changed parameters during trial|0|||
161812541|NCT02558491|584356245|FG000|Second Intervention|Withdrawal by Subject|1|||
161812542|NCT02558491|584356246|FG001|Second Intervention|Withdrawal by Subject|0|||
161812543|NCT02558491|584356245|FG000|Second Intervention|Stopping Criteria|1|||
161812544|NCT02558491|584356246|FG001|Second Intervention|Stopping Criteria|0|||
161812545|NCT00429416|584356247|FG000|Overall Study|Death|1|||
161812546|NCT00415363|584356249|FG000|Overall Study|Withdrawal by Subject|4|||
161812547|NCT00415363|584356250|FG001|Overall Study|Withdrawal by Subject|4|||
161812548|NCT00415363|584356249|FG000|Overall Study|Adverse Event|4|||
161812549|NCT00415363|584356250|FG001|Overall Study|Adverse Event|4|||
161812550|NCT00415363|584356249|FG000|Overall Study|Lost to Follow-up|2|||
161812551|NCT00415363|584356250|FG001|Overall Study|Lost to Follow-up|1|||
161812552|NCT00415363|584356249|FG000|Overall Study|Physician Decision|3|||
161812553|NCT00415363|584356250|FG001|Overall Study|Physician Decision|1|||
161812554|NCT00415363|584356249|FG000|Overall Study|Death|16|||
161812555|NCT00415363|584356250|FG001|Overall Study|Death|12|||
161812556|NCT00415363|584356249|FG000|Overall Study|Progressive disease|26|||
161812557|NCT00415363|584356250|FG001|Overall Study|Progressive disease|32|||
161812558|NCT00813592|584356252|FG000|Overall Study|Disease assessment was not completed per|2|||
161812559|NCT01588236|584356261|FG000|Overall Study|Adverse Event|5|||
161812560|NCT01588236|584356262|FG001|Overall Study|Adverse Event|4|||
161812561|NCT01588236|584356263|FG002|Overall Study|Adverse Event|1|||
161812562|NCT01588236|584356261|FG000|Overall Study|Lost to Follow-up|8|||
161812563|NCT01588236|584356262|FG001|Overall Study|Lost to Follow-up|13|||
161812564|NCT01588236|584356263|FG002|Overall Study|Lost to Follow-up|6|||
161812565|NCT01588236|584356261|FG000|Overall Study|Physician Decision|1|||
161812566|NCT01588236|584356262|FG001|Overall Study|Physician Decision|2|||
161812567|NCT01588236|584356263|FG002|Overall Study|Physician Decision|0|||
161812568|NCT01588236|584356261|FG000|Overall Study|Protocol Violation|0|||
161812569|NCT01588236|584356262|FG001|Overall Study|Protocol Violation|1|||
161812570|NCT01588236|584356263|FG002|Overall Study|Protocol Violation|1|||
161812571|NCT01588236|584356261|FG000|Overall Study|Withdrawal by Subject|14|||
161812572|NCT01588236|584356262|FG001|Overall Study|Withdrawal by Subject|16|||
161812573|NCT01588236|584356263|FG002|Overall Study|Withdrawal by Subject|18|||
161812574|NCT01588236|584356261|FG000|Overall Study|Exclusion Criteria met during study|2|||
161812575|NCT01588236|584356262|FG001|Overall Study|Exclusion Criteria met during study|1|||
161812576|NCT01588236|584356263|FG002|Overall Study|Exclusion Criteria met during study|0|||
161812577|NCT01588236|584356261|FG000|Overall Study|sponsor decision|1|||
161812578|NCT01588236|584356262|FG001|Overall Study|sponsor decision|6|||
161812579|NCT01588236|584356263|FG002|Overall Study|sponsor decision|2|||
161812580|NCT00199901|584357287|FG000|Overall Study|Protocol Violation|2|||
161812581|NCT00199901|584357288|FG001|Overall Study|Protocol Violation|0|||
161812582|NCT00199901|584357287|FG000|Overall Study|Withdrawal by Subject|1|||
161812583|NCT00199901|584357288|FG001|Overall Study|Withdrawal by Subject|0|||
161812584|NCT00199901|584357287|FG000|Overall Study|Progressive Disease|24|||
161812585|NCT00199901|584357288|FG001|Overall Study|Progressive Disease|24|||
161812586|NCT01958294|584357296|FG000|Overall Study|Clinical Circumstances|2|||
161812587|NCT02566850|584357298|FG000|Overall Study|Protocol Violation|1|||
161812588|NCT00682461|584357299|FG000|Overall Study|Adverse Event|5|||
161812589|NCT00682461|584357300|FG001|Overall Study|Adverse Event|7|||
161812590|NCT00682461|584357299|FG000|Overall Study|Lost to Follow-up|8|||
161812591|NCT00682461|584357300|FG001|Overall Study|Lost to Follow-up|5|||
161812592|NCT00682461|584357299|FG000|Overall Study|Withdrawal by Subject|12|||
161812593|NCT00682461|584357300|FG001|Overall Study|Withdrawal by Subject|19|||
161812594|NCT06298396|584357313|FG000|Default MAP|Protocol Violation|1|||
161812595|NCT06137781|584357314|FG000|Baseline measurements|Lost to Follow-up|2|||
161812596|NCT06137781|584357314|FG000|Baseline measurements|Withdrawal by Subject|1|||
161812597|NCT06137781|584357314|FG000|Baseline measurements|Expedited surgery|1|||
161812598|NCT06137781|584357314|FG000|Intervention period|Lost to Follow-up|2|||
161812599|NCT06137781|584357314|FG000|Intervention period|Withdrawal by Subject|3|||
161812600|NCT06137781|584357314|FG000|Intervention period|Expedited surgery|1|||
161812601|NCT06137781|584357314|FG000|Intervention period|Adverse Event|1|||
161812602|NCT05604170|584357319|FG000|Overall Study|Lack of Efficacy|5|||
161812603|NCT05604170|584357319|FG000|Overall Study|Adverse Event|6|||
161812604|NCT05604170|584357319|FG000|Overall Study|Physician Decision|6|||
161812605|NCT05604170|584357319|FG000|Overall Study|Lost to Follow-up|6|||
161812606|NCT05604170|584357319|FG000|Overall Study|Withdrawal by Subject|11|||
161916031|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
161916032|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
161916033|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
161916034|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
161916035|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
161916036|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
161916037|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
162158207|NCT02780388|585629396|FG000|Overall Study|Lost to Follow-up|0|||
162158208|NCT02780388|585629397|FG001|Overall Study|Lost to Follow-up|1|||
162158209|NCT02780388|585629398|FG002|Overall Study|Lost to Follow-up|0|||
162158210|NCT02780388|585629399|FG003|Overall Study|Lost to Follow-up|0|||
162158211|NCT02780388|585629400|FG004|Overall Study|Lost to Follow-up|0|||
162158212|NCT02780388|585629396|FG000|Overall Study|Withdrawal by Subject|1|||
162158213|NCT02780388|585629397|FG001|Overall Study|Withdrawal by Subject|1|||
162158214|NCT02780388|585629398|FG002|Overall Study|Withdrawal by Subject|0|||
162158215|NCT02780388|585629399|FG003|Overall Study|Withdrawal by Subject|0|||
162158216|NCT02780388|585629400|FG004|Overall Study|Withdrawal by Subject|0|||
162158217|NCT04527146|585629401|FG000|Overall Study|Withdrawal by Subject|12|||
162158218|NCT04527146|585629402|FG001|Overall Study|Withdrawal by Subject|15|||
162158219|NCT04527146|585629403|FG002|Overall Study|Withdrawal by Subject|7|||
162158220|NCT04527146|585629404|FG003|Overall Study|Withdrawal by Subject|16|||
161916038|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
161916039|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
161916040|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
161916041|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
161916042|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
161916043|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
161916044|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
161916045|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
161916046|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
161916047|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
161916048|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
161916049|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
161916050|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
161916051|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
161916052|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
161916053|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
161916054|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
161916055|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
161916056|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
161916057|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
161916058|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
161916059|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
161916060|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
161916061|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
161916062|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
161916063|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
161916064|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
161916065|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
161916066|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
161916067|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
161916068|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
161916069|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
161916070|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
161916071|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
161916072|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
161916073|NCT00090103|584742346|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
161916074|NCT00090103|584742347|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
161916075|NCT00090103|584742348|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
161916076|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
161916077|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
161916078|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
162158221|NCT04527146|585629401|FG000|Overall Study|Lost to Follow-up|13|||
162158222|NCT04527146|585629402|FG001|Overall Study|Lost to Follow-up|9|||
161916079|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
161916080|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
161916081|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
161916082|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
161916083|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
161916084|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
161916085|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
161916086|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
161916087|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
161916088|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
161916089|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
161916090|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
161916091|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
161916092|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
161916093|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
161916094|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
161916095|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
161916096|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
161916097|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
161916098|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
161916099|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
161916100|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
161916101|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
161916102|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
161916103|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
162014631|NCT02668393|585107023|FG001|Overall Study|Lack of benefit and side effects|0|||
161916104|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
161916105|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
161916106|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
161916107|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
161916108|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
161916109|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
162014632|NCT02141204|585107024|FG000|Overall Study|Lost to Follow-up|2|||
162014633|NCT02141204|585107025|FG001|Overall Study|Lost to Follow-up|1|||
162014634|NCT02141204|585107024|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
162014635|NCT02141204|585107025|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
161812607|NCT05604170|584357319|FG000|Overall Study|Early study termination by sponsor|77|||
161812608|NCT05604170|584357319|FG000|Overall Study|Other|6|||
161812609|NCT01547286|584357322|FG000|Overall Study|Did not meet all eligibility criteria|1|||
161812610|NCT01547286|584357322|FG000|Overall Study|Physician Decision|1|||
161812611|NCT00081653|584357324|FG000|Overall Study|Adverse Event|23|||
161812612|NCT00081653|584357325|FG001|Overall Study|Adverse Event|17|||
161812613|NCT00081653|584357324|FG000|Overall Study|Lost to Follow-up|2|||
161812614|NCT00081653|584357325|FG001|Overall Study|Lost to Follow-up|4|||
161812615|NCT00081653|584357324|FG000|Overall Study|Refused Treatment|18|||
161812616|NCT00081653|584357325|FG001|Overall Study|Refused Treatment|14|||
161812617|NCT00081653|584357324|FG000|Overall Study|Low bone mineral density|1|||
161812618|NCT00081653|584357325|FG001|Overall Study|Low bone mineral density|0|||
161812619|NCT00081653|584357324|FG000|Overall Study|Bone loss|2|||
161812620|NCT00081653|584357325|FG001|Overall Study|Bone loss|0|||
161812621|NCT00081653|584357324|FG000|Overall Study|Participant leaving country|1|||
161812622|NCT00081653|584357325|FG001|Overall Study|Participant leaving country|0|||
161812623|NCT00081653|584357324|FG000|Overall Study|Loss of bone mass|0|||
161812624|NCT00081653|584357325|FG001|Overall Study|Loss of bone mass|2|||
161812625|NCT00392665|584357326|FG000|Overall Study|Death|16|||
161812626|NCT00392665|584357327|FG001|Overall Study|Death|14|||
161812627|NCT00392665|584357326|FG000|Overall Study|Lost to Follow-up|1|||
161812628|NCT00392665|584357327|FG001|Overall Study|Lost to Follow-up|1|||
161812629|NCT03673670|584357328|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
161812630|NCT03673670|584357329|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161812631|NCT03673670|584357330|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161812632|NCT03673670|584357331|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161812633|NCT03673670|584357332|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161812634|NCT03673670|584357333|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161812635|NCT03673670|584357328|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
161812636|NCT03673670|584357329|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
161812637|NCT03673670|584357330|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
161812638|NCT03673670|584357331|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
161812639|NCT03673670|584357332|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
161916110|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
161916111|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
161916112|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
161916113|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
161916114|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
161916115|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
161916116|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
161916117|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
161916118|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
162158223|NCT04527146|585629403|FG002|Overall Study|Lost to Follow-up|16|||
162158224|NCT04527146|585629404|FG003|Overall Study|Lost to Follow-up|13|||
162158225|NCT04527146|585629401|FG000|Overall Study|Death|0|||
162158226|NCT04527146|585629402|FG001|Overall Study|Death|1|||
162158227|NCT04527146|585629403|FG002|Overall Study|Death|1|||
162158228|NCT04527146|585629404|FG003|Overall Study|Death|0|||
162158229|NCT04527146|585629401|FG000|Overall Study|Adverse Event|0|||
162158230|NCT04527146|585629402|FG001|Overall Study|Adverse Event|0|||
162158231|NCT04527146|585629403|FG002|Overall Study|Adverse Event|1|||
162158232|NCT04527146|585629404|FG003|Overall Study|Adverse Event|0|||
162158233|NCT04527146|585629401|FG000|Overall Study|Ineligible after randomization|2|||
162158234|NCT04527146|585629402|FG001|Overall Study|Ineligible after randomization|0|||
161916119|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
161916120|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
161916121|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
161916122|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
162014636|NCT02141204|585107024|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
161916123|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
161916124|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Death|1|||
161916125|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Death|0|||
161916126|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Death|1|||
161916127|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
161916128|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
161916129|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
161916130|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
161916131|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
161916132|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
161916133|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
161916134|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
161916135|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
161916136|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
162014637|NCT02141204|585107025|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
162014638|NCT02141204|585107024|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
162014639|NCT02141204|585107025|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
162014640|NCT00515619|585107028|FG000|Overall Study|Adverse Event|34|||
162014641|NCT00515619|585107028|FG000|Overall Study|Lack of Efficacy|92|||
161916137|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
161916138|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
161916139|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
161916140|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
161916141|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
161916142|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
161916143|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
161916144|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
161916145|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
161916146|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
161916147|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
161916148|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Depression|0|||
161916149|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Depression|1|||
161916150|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Depression|0|||
161916151|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
161916152|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
161916153|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
162014642|NCT00515619|585107028|FG000|Overall Study|Withdrawal by Subject|66|||
162014643|NCT00515619|585107028|FG000|Overall Study|Protocol Violation|3|||
161916154|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Jailed|0|||
161916155|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Jailed|1|||
162014644|NCT00515619|585107028|FG000|Overall Study|Lost to Follow-up|4|||
162014645|NCT00515619|585107028|FG000|Overall Study|Unsatisfactory compliance|6|||
162158235|NCT04527146|585629403|FG002|Overall Study|Ineligible after randomization|2|||
162158236|NCT04527146|585629404|FG003|Overall Study|Ineligible after randomization|2|||
162158237|NCT04527146|585629401|FG000|Overall Study|Moved to a different group|6|||
162158238|NCT04527146|585629402|FG001|Overall Study|Moved to a different group|3|||
162158239|NCT04527146|585629403|FG002|Overall Study|Moved to a different group|0|||
162158240|NCT04527146|585629404|FG003|Overall Study|Moved to a different group|2|||
162158241|NCT05510232|585629405|FG000|Overall Study|Withdrawal by Subject|2|||
162158242|NCT05510232|585629406|FG001|Overall Study|Withdrawal by Subject|7|||
162158243|NCT05510232|585629407|FG002|Overall Study|Withdrawal by Subject|6|||
162158244|NCT05687903|585629417|FG000|Overall Study|Protocol Deviation|1|||
162158245|NCT05687903|585629418|FG001|Overall Study|Protocol Deviation|1|||
162158246|NCT05687903|585629419|FG002|Overall Study|Protocol Deviation|0|||
162158247|NCT05687903|585629420|FG003|Overall Study|Protocol Deviation|1|||
162158248|NCT05687903|585629421|FG004|Overall Study|Protocol Deviation|0|||
162158249|NCT04468776|585629422|FG000|Overall Study|Lost to Follow-up|4|||
162158250|NCT04468776|585629423|FG001|Overall Study|Lost to Follow-up|3|||
162158251|NCT04468776|585629424|FG002|Overall Study|Lost to Follow-up|4|||
162158252|NCT04468776|585629422|FG000|Overall Study|Withdrawal by Subject|1|||
162158253|NCT04468776|585629423|FG001|Overall Study|Withdrawal by Subject|10|||
162158254|NCT04468776|585629424|FG002|Overall Study|Withdrawal by Subject|4|||
162158255|NCT04468776|585629422|FG000|Overall Study|Physician Decision|0|||
162158256|NCT04468776|585629423|FG001|Overall Study|Physician Decision|1|||
162158257|NCT04468776|585629424|FG002|Overall Study|Physician Decision|1|||
162158258|NCT04855760|585629425|FG000|Overall Study|Adverse Event|21|||
162158259|NCT04855760|585629425|FG000|Overall Study|Withdrawal by Subject|116|||
162158260|NCT04855760|585629425|FG000|Overall Study|Lack of Efficacy|21|||
162158261|NCT04855760|585629425|FG000|Overall Study|Lost to Follow-up|49|||
162158262|NCT04855760|585629425|FG000|Overall Study|Protocol Violation|2|||
162158263|NCT04855760|585629425|FG000|Overall Study|Physician Decision|5|||
162158264|NCT04855760|585629425|FG000|Overall Study|Pregnancy|1|||
162158265|NCT04855760|585629425|FG000|Overall Study|Non-Compliance with Study Drug|11|||
162158266|NCT04855760|585629425|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
162158267|NCT04855760|585629425|FG000|Overall Study|Study Completed by Sponsor|202|||
162158268|NCT04855760|585629425|FG000|Overall Study|Other|13|||
162158269|NCT04840199|585629428|FG000|Overall Study|Study Terminated by Sponsor|8|||
162158270|NCT04840199|585629429|FG001|Overall Study|Study Terminated by Sponsor|9|||
162158271|NCT04840199|585629428|FG000|Overall Study|Lost to Follow-up|0|||
162158272|NCT04840199|585629429|FG001|Overall Study|Lost to Follow-up|2|||
162158273|NCT04840199|585629428|FG000|Overall Study|Withdrawal by Subject|2|||
162158274|NCT04840199|585629429|FG001|Overall Study|Withdrawal by Subject|0|||
162158275|NCT04840199|585629428|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
162158276|NCT04840199|585629429|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
162158277|NCT03857620|585629431|FG000|Overall Study|Death|4|||
162158278|NCT03857620|585629432|FG001|Overall Study|Death|5|||
162158279|NCT03857620|585629433|FG002|Overall Study|Death|7|||
162158280|NCT03857620|585629431|FG000|Overall Study|Lost to Follow-up|2|||
162158281|NCT03857620|585629432|FG001|Overall Study|Lost to Follow-up|5|||
162158282|NCT03857620|585629433|FG002|Overall Study|Lost to Follow-up|3|||
162158283|NCT03857620|585629431|FG000|Overall Study|Disease progression or relapse after study registration|1|||
162158284|NCT03857620|585629432|FG001|Overall Study|Disease progression or relapse after study registration|5|||
162158285|NCT03857620|585629433|FG002|Overall Study|Disease progression or relapse after study registration|1|||
162158286|NCT03857620|585629431|FG000|Overall Study|Ineligible|5|||
162158287|NCT03857620|585629432|FG001|Overall Study|Ineligible|0|||
162158288|NCT03857620|585629433|FG002|Overall Study|Ineligible|2|||
162158289|NCT03857620|585629431|FG000|Overall Study|No malignancy|1|||
162158290|NCT03857620|585629432|FG001|Overall Study|No malignancy|0|||
162158291|NCT03857620|585629433|FG002|Overall Study|No malignancy|1|||
162158292|NCT03857620|585629431|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
162158293|NCT03857620|585629432|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
162158294|NCT03857620|585629433|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
162158295|NCT03857620|585629431|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
162158296|NCT03857620|585629432|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
162158297|NCT03857620|585629433|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
162158298|NCT03857620|585629431|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
161916156|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Jailed|0|||
161916157|NCT00090103|584742346|FG000|16-Week Safety Follow-up Period|Other|0|||
161916158|NCT00090103|584742347|FG001|16-Week Safety Follow-up Period|Other|1|||
161916159|NCT00090103|584742348|FG002|16-Week Safety Follow-up Period|Other|0|||
161916160|NCT00947544|584742351|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
162158299|NCT03857620|585629432|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
162158300|NCT03857620|585629433|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
162158301|NCT03857620|585629431|FG000|Overall Study|Surgery not performed, patient decision|0|||
162158302|NCT03857620|585629432|FG001|Overall Study|Surgery not performed, patient decision|3|||
162158303|NCT03857620|585629433|FG002|Overall Study|Surgery not performed, patient decision|1|||
162158304|NCT03857620|585629431|FG000|Overall Study|Surgery not performed, other reason|3|||
162158305|NCT03857620|585629432|FG001|Overall Study|Surgery not performed, other reason|1|||
162158306|NCT03857620|585629433|FG002|Overall Study|Surgery not performed, other reason|4|||
162158307|NCT03857620|585629431|FG000|Overall Study|Worsening performance status after surgery performed|0|||
162158308|NCT03857620|585629432|FG001|Overall Study|Worsening performance status after surgery performed|1|||
162158309|NCT03857620|585629433|FG002|Overall Study|Worsening performance status after surgery performed|1|||
162158310|NCT04118452|585629434|FG000|Overall Study|Lost to Follow-up|5|||
162158311|NCT04118452|585629435|FG001|Overall Study|Lost to Follow-up|5|||
162158312|NCT04118452|585629434|FG000|Overall Study|Withdrawal by Subject|17|||
162158313|NCT04118452|585629435|FG001|Overall Study|Withdrawal by Subject|17|||
162158314|NCT04868110|585629444|FG000|Overall Study|Withdrawal by Subject|3|||
162158315|NCT04868110|585629445|FG001|Overall Study|Withdrawal by Subject|4|||
162158316|NCT03446157|585629447|FG000|Overall Study|Death|11|||
162158317|NCT03446157|585629448|FG001|Overall Study|Death|9|||
162158318|NCT03446157|585629447|FG000|Overall Study|Lost to Follow-up|0|||
162158319|NCT03446157|585629448|FG001|Overall Study|Lost to Follow-up|1|||
162158320|NCT03446157|585629447|FG000|Overall Study|Withdrawal by Subject|2|||
162158321|NCT03446157|585629448|FG001|Overall Study|Withdrawal by Subject|1|||
162158322|NCT02386553|585629449|FG000|Overall Study|Reason Not Specified|1|||
162158323|NCT02386553|585629450|FG001|Overall Study|Reason Not Specified|1|||
162158324|NCT02386553|585629449|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
162158325|NCT02386553|585629450|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
162158326|NCT05623345|585629459|FG000|Overall Study|Withdrawal by Subject|14|||
162158327|NCT05623345|585629460|FG001|Overall Study|Withdrawal by Subject|0|||
162158328|NCT05623345|585629461|FG002|Overall Study|Withdrawal by Subject|9|||
162158329|NCT05623345|585629462|FG003|Overall Study|Withdrawal by Subject|20|||
162158330|NCT05623345|585629459|FG000|Overall Study|Lost to Follow-up|3|||
162158331|NCT05623345|585629460|FG001|Overall Study|Lost to Follow-up|0|||
162158332|NCT05623345|585629461|FG002|Overall Study|Lost to Follow-up|7|||
162158333|NCT05623345|585629462|FG003|Overall Study|Lost to Follow-up|2|||
162158334|NCT05623345|585629459|FG000|Overall Study|Termination of Study By Sponsor|37|||
162158335|NCT05623345|585629460|FG001|Overall Study|Termination of Study By Sponsor|4|||
162158336|NCT05623345|585629461|FG002|Overall Study|Termination of Study By Sponsor|40|||
162158337|NCT05623345|585629462|FG003|Overall Study|Termination of Study By Sponsor|38|||
162158338|NCT05384730|585629463|FG000|Overall Study|Adverse Event|1|||
162158339|NCT05384730|585629464|FG001|Overall Study|Adverse Event|0|||
162158340|NCT05384730|585629463|FG000|Overall Study|Lack of social support|2|||
162158341|NCT05384730|585629464|FG001|Overall Study|Lack of social support|0|||
162158342|NCT05384730|585629463|FG000|Overall Study|Hospital readmission|2|||
162158343|NCT05384730|585629464|FG001|Overall Study|Hospital readmission|0|||
162158344|NCT05384730|585629463|FG000|Overall Study|Disease progression|5|||
162158345|NCT05384730|585629464|FG001|Overall Study|Disease progression|0|||
162158346|NCT05384730|585629463|FG000|Overall Study|Overwhelmed with College commitments|0|||
162158347|NCT05384730|585629464|FG001|Overall Study|Overwhelmed with College commitments|2|||
162158348|NCT01619410|585629467|FG000|Overall Study|Lost to Follow-up|7|||
162158349|NCT01619410|585629468|FG001|Overall Study|Lost to Follow-up|4|||
162158350|NCT05782231|585629476|FG000|Overall Study|Withdrawal by Subject|1|||
162158351|NCT02252172|585629477|FG000|Overall Study|Lost to Follow-up|9|||
162158352|NCT02252172|585629478|FG001|Overall Study|Lost to Follow-up|6|||
162158353|NCT02252172|585629477|FG000|Overall Study|Death|218|||
162158354|NCT02252172|585629478|FG001|Overall Study|Death|175|||
162158355|NCT02252172|585629477|FG000|Overall Study|Withdrawal by Subject|20|||
162158356|NCT02252172|585629478|FG001|Overall Study|Withdrawal by Subject|15|||
162158357|NCT02252172|585629477|FG000|Overall Study|Physician Decision|0|||
162158358|NCT02252172|585629478|FG001|Overall Study|Physician Decision|1|||
162158359|NCT02252172|585629477|FG000|Overall Study|End of data collection|122|||
162158360|NCT02252172|585629478|FG001|Overall Study|End of data collection|170|||
162158361|NCT02252172|585629477|FG000|Overall Study|Site closure|0|||
162014646|NCT00515619|585107028|FG000|Overall Study|Other: Site discontinuing trials|2|||
162014647|NCT00515619|585107028|FG000|Overall Study|Other: Subject cannot attend visits|2|||
162014648|NCT00515619|585107028|FG000|Overall Study|Other: Subject required surgery|1|||
162014649|NCT00515619|585107028|FG000|Overall Study|Other: Subject moved to another country|1|||
162014650|NCT00515619|585107028|FG000|Overall Study|Other: Investigator decision|1|||
162014651|NCT00515619|585107028|FG000|Overall Study|Other: Subject became pregnant|1|||
162158362|NCT02252172|585629478|FG001|Overall Study|Site closure|1|||
162158363|NCT03830866|585629479|FG000|Overall Study|Death|90|||
162158364|NCT03830866|585629480|FG001|Overall Study|Death|111|||
162158365|NCT03830866|585629479|FG000|Overall Study|Lost to Follow-up|7|||
162158366|NCT03830866|585629480|FG001|Overall Study|Lost to Follow-up|7|||
162158367|NCT03830866|585629479|FG000|Overall Study|Withdrawal by Subject|19|||
162158368|NCT03830866|585629480|FG001|Overall Study|Withdrawal by Subject|16|||
162158369|NCT03830866|585629479|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
162158370|NCT03830866|585629480|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
162158371|NCT03830866|585629479|FG000|Overall Study|Other|1|||
162158372|NCT03830866|585629480|FG001|Overall Study|Other|1|||
162158373|NCT01426412|585629481|FG000|Overall Study|Withdrawal by Subject|1|||
162158374|NCT01426412|585629482|FG001|Overall Study|Withdrawal by Subject|0|||
162158375|NCT01426412|585629483|FG002|Overall Study|Withdrawal by Subject|0|||
162158376|NCT01426412|585629484|FG003|Overall Study|Withdrawal by Subject|0|||
162158377|NCT01426412|585629485|FG004|Overall Study|Withdrawal by Subject|1|||
162158378|NCT01426412|585629486|FG005|Overall Study|Withdrawal by Subject|0|||
162158379|NCT01426412|585629487|FG006|Overall Study|Withdrawal by Subject|0|||
162158380|NCT01426412|585629488|FG007|Overall Study|Withdrawal by Subject|3|||
162158381|NCT01426412|585629489|FG008|Overall Study|Withdrawal by Subject|1|||
162158382|NCT00262301|585629492|FG000|Double-blind Phase|Lost to Follow-up|1|||
162158383|NCT00262301|585629493|FG001|Double-blind Phase|Lost to Follow-up|0|||
162158384|NCT00262301|585629494|FG002|Double-blind Phase|Lost to Follow-up|0|||
162158385|NCT00262301|585629492|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
162158386|NCT00262301|585629493|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
162158387|NCT00262301|585629494|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
162158388|NCT00976495|585629495|FG000|Overall Study|Withdrawal by Subject|0|||
162158389|NCT00976495|585629496|FG001|Overall Study|Withdrawal by Subject|1|||
162158390|NCT00976495|585629497|FG002|Overall Study|Withdrawal by Subject|0|||
162158391|NCT04154384|585629498|FG000|Overall Study|Lost to Follow-up|24|||
162158392|NCT04154384|585629499|FG001|Overall Study|Lost to Follow-up|33|||
162158393|NCT04154384|585629500|FG002|Overall Study|Lost to Follow-up|0|||
162158394|NCT04154384|585629498|FG000|Overall Study|Withdrawal by Subject|7|||
162158395|NCT04154384|585629499|FG001|Overall Study|Withdrawal by Subject|18|||
162158396|NCT04154384|585629500|FG002|Overall Study|Withdrawal by Subject|0|||
162158397|NCT04154384|585629498|FG000|Overall Study|Missing outcome data|1|||
162158398|NCT04154384|585629499|FG001|Overall Study|Missing outcome data|0|||
162158399|NCT04154384|585629500|FG002|Overall Study|Missing outcome data|0|||
162158400|NCT04732338|585629505|FG000|Overall Study|Lost to Follow-up|3|||
162158401|NCT04732338|585629506|FG001|Overall Study|Lost to Follow-up|3|||
162158402|NCT04484935|585629507|FG000|Overall Study|Other|0|||
162158403|NCT04484935|585629508|FG001|Overall Study|Other|1|||
162158404|NCT04484935|585629507|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162158405|NCT04484935|585629508|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162158406|NCT04484935|585629507|FG000|Overall Study|Lost to Follow-up|1|||
162158407|NCT04484935|585629508|FG001|Overall Study|Lost to Follow-up|0|||
162014652|NCT00515619|585107028|FG000|Overall Study|Other: Request from sponsor|1|||
162014653|NCT00515619|585107028|FG000|Overall Study|Other: Drug available on license|1|||
162014654|NCT00515619|585107028|FG000|Overall Study|Other: Subject interested in other AED|1|||
162014655|NCT02379091|585107029|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162014656|NCT02379091|585107030|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
162014657|NCT02379091|585107031|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
162014658|NCT02379091|585107032|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
162014659|NCT02379091|585107029|FG000|Overall Study|Principal Investigator Discretion|0|||
162158408|NCT04484935|585629507|FG000|Overall Study|Death|2|||
161916161|NCT00947544|584742352|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
161916162|NCT02566005|584742354|FG000|Overall Study|vaginal bleeding|0|||
161916163|NCT02566005|584742355|FG001|Overall Study|vaginal bleeding|1|||
161916164|NCT02566005|584742354|FG000|Overall Study|received foley|8|||
161916165|NCT02566005|584742355|FG001|Overall Study|received foley|0|||
161916166|NCT02566005|584742354|FG000|Overall Study|did not receive foley|0|||
162158409|NCT04484935|585629508|FG001|Overall Study|Death|1|||
162158410|NCT02759016|585629512|FG000|Overall Study|Not treated with BI 836826|1|||
162158411|NCT02759016|585629513|FG001|Overall Study|Not treated with BI 836826|0|||
161916167|NCT02566005|584742355|FG001|Overall Study|did not receive foley|1|||
162014660|NCT02379091|585107030|FG001|Overall Study|Principal Investigator Discretion|1|||
161916168|NCT02566005|584742354|FG000|Overall Study|labor after randomization|0|||
161916169|NCT02566005|584742355|FG001|Overall Study|labor after randomization|4|||
161916170|NCT01134042|584742358|FG000|Overall Study|Adverse Event|3|||
162014661|NCT02379091|585107031|FG002|Overall Study|Principal Investigator Discretion|0|||
162014662|NCT02379091|585107032|FG003|Overall Study|Principal Investigator Discretion|0|||
162014663|NCT02379091|585107029|FG000|Overall Study|Lost to Follow-up|0|||
162158412|NCT02759016|585629512|FG000|Overall Study|Progressive disease|1|||
162158413|NCT02759016|585629513|FG001|Overall Study|Progressive disease|0|||
162158414|NCT02759016|585629512|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
162158415|NCT02759016|585629513|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
162158416|NCT02759016|585629512|FG000|Overall Study|Other not defined above|2|||
162158417|NCT02759016|585629513|FG001|Overall Study|Other not defined above|1|||
162158418|NCT02891915|585629518|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
161916171|NCT01134042|584742359|FG001|Overall Study|Adverse Event|7|||
161916172|NCT01134042|584742360|FG002|Overall Study|Adverse Event|2|||
162014664|NCT02379091|585107030|FG001|Overall Study|Lost to Follow-up|0|||
162158419|NCT02891915|585629519|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
162158420|NCT02891915|585629518|FG000|Overall Study|Withdrawal by Subject|3|||
162158421|NCT02891915|585629519|FG001|Overall Study|Withdrawal by Subject|3|||
162158422|NCT02891915|585629518|FG000|Overall Study|Became Ineligible After Enrollment|2|||
162158423|NCT02891915|585629519|FG001|Overall Study|Became Ineligible After Enrollment|1|||
162158424|NCT02891915|585629518|FG000|Overall Study|Lost to Follow-up|1|||
162158425|NCT02891915|585629519|FG001|Overall Study|Lost to Follow-up|4|||
162158426|NCT02891915|585629518|FG000|Overall Study|Physician Decision|1|||
162158427|NCT02891915|585629519|FG001|Overall Study|Physician Decision|0|||
162158428|NCT05094141|585629522|FG000|Overall Study|Death|0|||
162158429|NCT05094141|585629523|FG001|Overall Study|Death|0|||
162158430|NCT05094141|585629524|FG002|Overall Study|Death|1|||
162158431|NCT05094141|585629522|FG000|Overall Study|Withdrawal by Subject|0|||
162158432|NCT05094141|585629523|FG001|Overall Study|Withdrawal by Subject|0|||
162158433|NCT05094141|585629524|FG002|Overall Study|Withdrawal by Subject|1|||
162158434|NCT05094141|585629522|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
162158435|NCT05094141|585629523|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
162158436|NCT05094141|585629524|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
162158437|NCT05094141|585629522|FG000|Overall Study|Did not participate in randomization|0|||
162158438|NCT05094141|585629523|FG001|Overall Study|Did not participate in randomization|0|||
162158439|NCT05094141|585629524|FG002|Overall Study|Did not participate in randomization|33|||
162158440|NCT03398148|585631156|FG000|Substudy 1 Period 1|Adverse Event|5|||
162158441|NCT03398148|585631157|FG001|Substudy 1 Period 1|Adverse Event|2|||
162158442|NCT03398148|585631158|FG002|Substudy 1 Period 1|Adverse Event|2|||
162158443|NCT03398148|585631159|FG003|Substudy 1 Period 1|Adverse Event|0|||
162158444|NCT03398148|585631160|FG004|Substudy 1 Period 1|Adverse Event|8|||
162158445|NCT03398148|585631161|FG005|Substudy 1 Period 1|Adverse Event|0|||
162158446|NCT03398148|585631162|FG006|Substudy 1 Period 1|Adverse Event|0|||
162158447|NCT03398148|585631163|FG007|Substudy 1 Period 1|Adverse Event|0|||
162158448|NCT03398148|585631164|FG008|Substudy 1 Period 1|Adverse Event|0|||
162158449|NCT03398148|585631165|FG009|Substudy 1 Period 1|Adverse Event|0|||
162158450|NCT03398148|585631166|FG010|Substudy 1 Period 1|Adverse Event|0|||
162158451|NCT03398148|585631167|FG011|Substudy 1 Period 1|Adverse Event|0|||
162158452|NCT03398148|585631168|FG012|Substudy 1 Period 1|Adverse Event|0|||
162158453|NCT03398148|585631169|FG013|Substudy 1 Period 1|Adverse Event|0|||
162158454|NCT03398148|585631170|FG014|Substudy 1 Period 1|Adverse Event|0|||
162158455|NCT03398148|585631156|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
162158456|NCT03398148|585631157|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
162158457|NCT03398148|585631158|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162158458|NCT03398148|585631159|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
162158459|NCT03398148|585631160|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
162158460|NCT03398148|585631161|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162158461|NCT03398148|585631162|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162158462|NCT03398148|585631163|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162158463|NCT03398148|585631164|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162158464|NCT03398148|585631165|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162158465|NCT03398148|585631166|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162158466|NCT03398148|585631167|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162158467|NCT03398148|585631168|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162158468|NCT03398148|585631169|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162158469|NCT03398148|585631170|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
162158470|NCT03398148|585631156|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
162158471|NCT03398148|585631157|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
162158472|NCT03398148|585631158|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
162158473|NCT03398148|585631159|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
161812640|NCT03673670|584357333|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
161812641|NCT03673670|584357328|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
161812642|NCT03673670|584357329|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
161812643|NCT03673670|584357330|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
161812644|NCT03673670|584357331|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
161812645|NCT03673670|584357332|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
161812646|NCT03673670|584357333|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
161812647|NCT03673670|584357328|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161812648|NCT03673670|584357329|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161812649|NCT03673670|584357330|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161812650|NCT03673670|584357331|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161812651|NCT03673670|584357332|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161812652|NCT03673670|584357333|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
162158474|NCT03398148|585631160|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
162158475|NCT03398148|585631161|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
162158476|NCT03398148|585631162|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
162158477|NCT03398148|585631163|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
162158478|NCT03398148|585631164|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
162158479|NCT03398148|585631165|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
162158480|NCT03398148|585631166|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
162158481|NCT03398148|585631167|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
162158482|NCT03398148|585631168|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
162158483|NCT03398148|585631169|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
162158484|NCT03398148|585631170|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
162158485|NCT03398148|585631156|FG000|Substudy 1 Period 1|Other|0|||
162158486|NCT03398148|585631157|FG001|Substudy 1 Period 1|Other|1|||
162158487|NCT03398148|585631158|FG002|Substudy 1 Period 1|Other|0|||
162158488|NCT03398148|585631159|FG003|Substudy 1 Period 1|Other|0|||
162158489|NCT03398148|585631160|FG004|Substudy 1 Period 1|Other|3|||
162158490|NCT03398148|585631161|FG005|Substudy 1 Period 1|Other|0|||
162158491|NCT03398148|585631162|FG006|Substudy 1 Period 1|Other|0|||
162158492|NCT03398148|585631163|FG007|Substudy 1 Period 1|Other|0|||
162158493|NCT03398148|585631164|FG008|Substudy 1 Period 1|Other|0|||
162158494|NCT03398148|585631165|FG009|Substudy 1 Period 1|Other|0|||
162158495|NCT03398148|585631166|FG010|Substudy 1 Period 1|Other|0|||
162158496|NCT03398148|585631167|FG011|Substudy 1 Period 1|Other|0|||
162158497|NCT03398148|585631168|FG012|Substudy 1 Period 1|Other|0|||
162158498|NCT03398148|585631169|FG013|Substudy 1 Period 1|Other|0|||
162158499|NCT03398148|585631170|FG014|Substudy 1 Period 1|Other|0|||
162158500|NCT03398148|585631156|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158501|NCT03398148|585631157|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158502|NCT03398148|585631158|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158503|NCT03398148|585631159|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158504|NCT03398148|585631160|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
162158505|NCT03398148|585631161|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158506|NCT03398148|585631162|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158507|NCT03398148|585631163|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158508|NCT03398148|585631164|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158509|NCT03398148|585631165|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158510|NCT03398148|585631166|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158511|NCT03398148|585631167|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158512|NCT03398148|585631168|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158513|NCT03398148|585631169|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158514|NCT03398148|585631170|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
162158515|NCT03398148|585631156|FG000|Substudy 1 Period 2|Adverse Event|0|||
162158516|NCT03398148|585631157|FG001|Substudy 1 Period 2|Adverse Event|0|||
162158517|NCT03398148|585631158|FG002|Substudy 1 Period 2|Adverse Event|0|||
162158518|NCT03398148|585631159|FG003|Substudy 1 Period 2|Adverse Event|0|||
162158519|NCT03398148|585631160|FG004|Substudy 1 Period 2|Adverse Event|0|||
162158520|NCT03398148|585631161|FG005|Substudy 1 Period 2|Adverse Event|2|||
162158521|NCT03398148|585631162|FG006|Substudy 1 Period 2|Adverse Event|4|||
162158522|NCT03398148|585631163|FG007|Substudy 1 Period 2|Adverse Event|0|||
162158523|NCT03398148|585631164|FG008|Substudy 1 Period 2|Adverse Event|0|||
162158524|NCT03398148|585631165|FG009|Substudy 1 Period 2|Adverse Event|0|||
162158525|NCT03398148|585631166|FG010|Substudy 1 Period 2|Adverse Event|0|||
162158526|NCT03398148|585631167|FG011|Substudy 1 Period 2|Adverse Event|0|||
162158527|NCT03398148|585631168|FG012|Substudy 1 Period 2|Adverse Event|0|||
162158528|NCT03398148|585631169|FG013|Substudy 1 Period 2|Adverse Event|0|||
162158529|NCT03398148|585631170|FG014|Substudy 1 Period 2|Adverse Event|0|||
162158530|NCT03398148|585631156|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162158531|NCT03398148|585631157|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162014665|NCT02379091|585107031|FG002|Overall Study|Lost to Follow-up|0|||
162158532|NCT03398148|585631158|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162158533|NCT03398148|585631159|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162158534|NCT03398148|585631160|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161812653|NCT03673670|584357328|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
161812654|NCT03673670|584357329|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
161812655|NCT03673670|584357330|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
161812656|NCT03673670|584357331|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
161812657|NCT03673670|584357332|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
161812658|NCT03673670|584357333|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
161812659|NCT03673670|584357328|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
161812660|NCT03673670|584357329|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162158535|NCT03398148|585631161|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162158536|NCT03398148|585631162|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
162158537|NCT03398148|585631163|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
161812661|NCT03673670|584357330|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162158538|NCT03398148|585631164|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162158539|NCT03398148|585631165|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162158540|NCT03398148|585631166|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162158541|NCT03398148|585631167|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162158542|NCT03398148|585631168|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162158543|NCT03398148|585631169|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162158544|NCT03398148|585631170|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
162158545|NCT03398148|585631156|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
162158546|NCT03398148|585631157|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
162158547|NCT03398148|585631158|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
162158548|NCT03398148|585631159|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
162158549|NCT03398148|585631160|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
162158550|NCT03398148|585631161|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
162158551|NCT03398148|585631162|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
162158552|NCT03398148|585631163|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
162158553|NCT03398148|585631164|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
162158554|NCT03398148|585631165|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
162158555|NCT03398148|585631166|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
162158556|NCT03398148|585631167|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
162158557|NCT03398148|585631168|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
162158558|NCT03398148|585631169|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
162158559|NCT03398148|585631170|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
162158560|NCT03398148|585631156|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158561|NCT03398148|585631157|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158562|NCT03398148|585631158|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158563|NCT03398148|585631159|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158564|NCT03398148|585631160|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158565|NCT03398148|585631161|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158566|NCT03398148|585631162|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
162158567|NCT03398148|585631163|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158568|NCT03398148|585631164|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158569|NCT03398148|585631165|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158570|NCT03398148|585631166|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158571|NCT03398148|585631167|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158572|NCT03398148|585631168|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158573|NCT03398148|585631169|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158574|NCT03398148|585631170|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158575|NCT03398148|585631156|FG000|Substudy 1 Period 2|Other|0|||
162158576|NCT03398148|585631157|FG001|Substudy 1 Period 2|Other|0|||
162158577|NCT03398148|585631158|FG002|Substudy 1 Period 2|Other|0|||
162158578|NCT03398148|585631159|FG003|Substudy 1 Period 2|Other|0|||
162158579|NCT03398148|585631160|FG004|Substudy 1 Period 2|Other|0|||
162158580|NCT03398148|585631161|FG005|Substudy 1 Period 2|Other|0|||
162158581|NCT03398148|585631162|FG006|Substudy 1 Period 2|Other|1|||
162158582|NCT03398148|585631163|FG007|Substudy 1 Period 2|Other|0|||
162158583|NCT03398148|585631164|FG008|Substudy 1 Period 2|Other|0|||
162158584|NCT03398148|585631165|FG009|Substudy 1 Period 2|Other|0|||
162158585|NCT03398148|585631166|FG010|Substudy 1 Period 2|Other|0|||
162158586|NCT03398148|585631167|FG011|Substudy 1 Period 2|Other|0|||
162158587|NCT03398148|585631168|FG012|Substudy 1 Period 2|Other|0|||
162158588|NCT03398148|585631169|FG013|Substudy 1 Period 2|Other|0|||
162158589|NCT03398148|585631170|FG014|Substudy 1 Period 2|Other|0|||
162158590|NCT03398148|585631156|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158591|NCT03398148|585631157|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158592|NCT03398148|585631158|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158593|NCT03398148|585631159|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158594|NCT03398148|585631160|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158595|NCT03398148|585631161|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158596|NCT03398148|585631162|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
162158597|NCT03398148|585631163|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158598|NCT03398148|585631164|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158599|NCT03398148|585631165|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158600|NCT03398148|585631166|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158601|NCT03398148|585631167|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158602|NCT03398148|585631168|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158603|NCT03398148|585631169|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158604|NCT03398148|585631170|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
162158605|NCT03398148|585631156|FG000|Substudy 2 Period 1|Adverse Event|0|||
162158606|NCT03398148|585631157|FG001|Substudy 2 Period 1|Adverse Event|0|||
162158607|NCT03398148|585631158|FG002|Substudy 2 Period 1|Adverse Event|0|||
162158608|NCT03398148|585631159|FG003|Substudy 2 Period 1|Adverse Event|0|||
162158609|NCT03398148|585631160|FG004|Substudy 2 Period 1|Adverse Event|0|||
162158610|NCT03398148|585631161|FG005|Substudy 2 Period 1|Adverse Event|0|||
162158611|NCT03398148|585631162|FG006|Substudy 2 Period 1|Adverse Event|0|||
162158612|NCT03398148|585631163|FG007|Substudy 2 Period 1|Adverse Event|0|||
162158613|NCT03398148|585631164|FG008|Substudy 2 Period 1|Adverse Event|0|||
162158614|NCT03398148|585631165|FG009|Substudy 2 Period 1|Adverse Event|12|||
162158615|NCT03398148|585631166|FG010|Substudy 2 Period 1|Adverse Event|2|||
162158616|NCT03398148|585631167|FG011|Substudy 2 Period 1|Adverse Event|0|||
162158617|NCT03398148|585631168|FG012|Substudy 2 Period 1|Adverse Event|0|||
162158618|NCT03398148|585631169|FG013|Substudy 2 Period 1|Adverse Event|0|||
162158619|NCT03398148|585631170|FG014|Substudy 2 Period 1|Adverse Event|0|||
162158620|NCT03398148|585631156|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162158621|NCT03398148|585631157|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161916173|NCT01134042|584742358|FG000|Overall Study|Lack of Efficacy|21|||
161916174|NCT01134042|584742359|FG001|Overall Study|Lack of Efficacy|6|||
161916175|NCT01134042|584742360|FG002|Overall Study|Lack of Efficacy|18|||
161916176|NCT01134042|584742358|FG000|Overall Study|Protocol Violation|5|||
161916177|NCT01134042|584742359|FG001|Overall Study|Protocol Violation|3|||
161916178|NCT01134042|584742360|FG002|Overall Study|Protocol Violation|5|||
161916179|NCT01134042|584742358|FG000|Overall Study|Lost to Follow-up|2|||
161916180|NCT01134042|584742359|FG001|Overall Study|Lost to Follow-up|0|||
161916181|NCT01134042|584742360|FG002|Overall Study|Lost to Follow-up|1|||
161916182|NCT01134042|584742358|FG000|Overall Study|Physician Decision|4|||
161916183|NCT01134042|584742359|FG001|Overall Study|Physician Decision|8|||
161916184|NCT01134042|584742360|FG002|Overall Study|Physician Decision|1|||
161916185|NCT01134042|584742358|FG000|Overall Study|Withdrawal by Subject|13|||
162014666|NCT02379091|585107032|FG003|Overall Study|Lost to Follow-up|1|||
161916186|NCT01134042|584742359|FG001|Overall Study|Withdrawal by Subject|4|||
161916187|NCT01134042|584742360|FG002|Overall Study|Withdrawal by Subject|7|||
161916188|NCT03345004|584742361|FG000|Overall Study|Physician Decision|1|||
161916189|NCT03345004|584742362|FG001|Overall Study|Physician Decision|0|||
161916190|NCT03345004|584742361|FG000|Overall Study|Withdrawal by Subject|0|||
161916191|NCT03345004|584742362|FG001|Overall Study|Withdrawal by Subject|1|||
161916192|NCT01091259|584742367|FG000|Overall Study|Adverse Event|3|||
161916193|NCT01091259|584742367|FG000|Overall Study|Lack of Efficacy|2|||
161916194|NCT00984867|584742368|FG000|Overall Study|Adverse Event|3|||
161916195|NCT00984867|584742369|FG001|Overall Study|Adverse Event|7|||
161916196|NCT00984867|584742368|FG000|Overall Study|Death|1|||
161916197|NCT00984867|584742369|FG001|Overall Study|Death|0|||
161916198|NCT00984867|584742368|FG000|Overall Study|Withdrawal by Subject|13|||
161916199|NCT00984867|584742369|FG001|Overall Study|Withdrawal by Subject|4|||
161916200|NCT00984867|584742368|FG000|Overall Study|Lost to Follow-up|3|||
161916201|NCT00984867|584742369|FG001|Overall Study|Lost to Follow-up|4|||
161916202|NCT00984867|584742368|FG000|Overall Study|Poor/non-compliance|0|||
161916203|NCT00984867|584742369|FG001|Overall Study|Poor/non-compliance|1|||
161916204|NCT00984867|584742368|FG000|Overall Study|Subject no longer meets study criteria|1|||
161916205|NCT00984867|584742369|FG001|Overall Study|Subject no longer meets study criteria|1|||
161916206|NCT00984867|584742368|FG000|Overall Study|site closing|1|||
161916207|NCT00984867|584742369|FG001|Overall Study|site closing|0|||
161916208|NCT00984867|584742368|FG000|Overall Study|lack of efficacy and subject compliance|1|||
162014667|NCT02379091|585107029|FG000|Overall Study|Voluntary Withdrawal|2|||
162014668|NCT02379091|585107030|FG001|Overall Study|Voluntary Withdrawal|5|||
162014669|NCT02379091|585107031|FG002|Overall Study|Voluntary Withdrawal|2|||
162014670|NCT02379091|585107032|FG003|Overall Study|Voluntary Withdrawal|4|||
162014671|NCT02379091|585107029|FG000|Overall Study|Study Termination|7|||
162014672|NCT02379091|585107030|FG001|Overall Study|Study Termination|2|||
162014673|NCT02379091|585107031|FG002|Overall Study|Study Termination|5|||
162014674|NCT02379091|585107032|FG003|Overall Study|Study Termination|8|||
162014675|NCT02379091|585107029|FG000|Overall Study|Lack of Efficacy|3|||
162014676|NCT02379091|585107030|FG001|Overall Study|Lack of Efficacy|0|||
162014677|NCT02379091|585107031|FG002|Overall Study|Lack of Efficacy|0|||
162014678|NCT02379091|585107032|FG003|Overall Study|Lack of Efficacy|0|||
162014679|NCT03326713|585107034|FG000|Overall Study|Death|2|||
162014680|NCT03326713|585107035|FG001|Overall Study|Death|1|||
162014681|NCT03326713|585107036|FG002|Overall Study|Death|0|||
162014682|NCT03326713|585107034|FG000|Overall Study|Lost to Follow-up|20|||
162014683|NCT03326713|585107035|FG001|Overall Study|Lost to Follow-up|21|||
161916209|NCT00984867|584742369|FG001|Overall Study|lack of efficacy and subject compliance|0|||
161916210|NCT00671060|584742370|FG000|Overall Study|Protocol Violation|1|||
161916211|NCT00671060|584742371|FG001|Overall Study|Protocol Violation|0|||
161916212|NCT00671060|584742370|FG000|Overall Study|Physician Decision|0|||
161916213|NCT00671060|584742371|FG001|Overall Study|Physician Decision|1|||
161916214|NCT01541748|584742372|FG000|Overall Study|Lost to Follow-up|17|||
161916215|NCT01541748|584742372|FG000|Overall Study|Moved out of state|1|||
161916216|NCT01541748|584742372|FG000|Overall Study|Withdrawal by Subject|7|||
161916217|NCT01541748|584742372|FG000|Overall Study|Screen failure|5|||
161916218|NCT01541748|584742372|FG000|Overall Study|Did not receive study device|1|||
161916219|NCT00626639|584742380|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
161916220|NCT00626639|584742381|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
161916221|NCT01155141|584742382|FG000|Overall Study|Withdrawal by Subject|1|||
161916222|NCT01155141|584742382|FG000|Overall Study|Screen Failure|1|||
161916223|NCT03473197|584742383|FG000|Overall Study|Adverse Event|4|||
161916224|NCT03473197|584742383|FG000|Overall Study|Lost to Follow-up|1|||
161916225|NCT03473197|584742383|FG000|Overall Study|Withdrawal by Subject|5|||
161916226|NCT00785629|584742386|FG000|Overall Study|Adverse Event|2|||
161916227|NCT00785629|584742387|FG001|Overall Study|Adverse Event|1|||
162014684|NCT03326713|585107036|FG002|Overall Study|Lost to Follow-up|33|||
162014685|NCT03326713|585107034|FG000|Overall Study|Withdrawal by Subject|1|||
162014686|NCT03326713|585107035|FG001|Overall Study|Withdrawal by Subject|2|||
162014687|NCT03326713|585107036|FG002|Overall Study|Withdrawal by Subject|11|||
162014688|NCT03326713|585107034|FG000|Overall Study|Found Ineligible|11|||
162014689|NCT03326713|585107035|FG001|Overall Study|Found Ineligible|11|||
162158622|NCT03398148|585631158|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162158623|NCT03398148|585631159|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162158624|NCT03398148|585631160|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162158625|NCT03398148|585631161|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162158626|NCT03398148|585631162|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162158627|NCT03398148|585631163|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162158628|NCT03398148|585631164|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162158629|NCT03398148|585631165|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
162158630|NCT03398148|585631166|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
162158631|NCT03398148|585631167|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162158632|NCT03398148|585631168|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162158633|NCT03398148|585631169|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162158634|NCT03398148|585631170|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
162158635|NCT03398148|585631156|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
162158636|NCT03398148|585631157|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
162158637|NCT03398148|585631158|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
162158638|NCT03398148|585631159|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
162158639|NCT03398148|585631160|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
162158640|NCT03398148|585631161|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
162158641|NCT03398148|585631162|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
162158642|NCT03398148|585631163|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
162158643|NCT03398148|585631164|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
162158644|NCT03398148|585631165|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
162158645|NCT03398148|585631166|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
162158646|NCT03398148|585631167|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
162158647|NCT03398148|585631168|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
162158648|NCT03398148|585631169|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
162158649|NCT03398148|585631170|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
162014690|NCT03326713|585107036|FG002|Overall Study|Found Ineligible|8|||
162014691|NCT00771758|585107037|FG000|Overall Study|Adverse Event|2|||
162014692|NCT00771758|585107038|FG001|Overall Study|Adverse Event|8|||
162014693|NCT00771758|585107039|FG002|Overall Study|Adverse Event|1|||
162014694|NCT00771758|585107037|FG000|Overall Study|Lack of Efficacy|0|||
162014695|NCT00771758|585107038|FG001|Overall Study|Lack of Efficacy|2|||
162014696|NCT00771758|585107039|FG002|Overall Study|Lack of Efficacy|1|||
162014697|NCT00771758|585107037|FG000|Overall Study|Lost to Follow-up|1|||
162014698|NCT00771758|585107038|FG001|Overall Study|Lost to Follow-up|0|||
162014699|NCT00771758|585107039|FG002|Overall Study|Lost to Follow-up|0|||
162014700|NCT00771758|585107037|FG000|Overall Study|Protocol Violation|1|||
162014701|NCT00771758|585107038|FG001|Overall Study|Protocol Violation|0|||
162014702|NCT00771758|585107039|FG002|Overall Study|Protocol Violation|0|||
162014703|NCT00771758|585107037|FG000|Overall Study|Withdrawal by Subject|1|||
162014704|NCT00771758|585107038|FG001|Overall Study|Withdrawal by Subject|0|||
162014705|NCT00771758|585107039|FG002|Overall Study|Withdrawal by Subject|0|||
162014706|NCT00771758|585107037|FG000|Overall Study|Other|3|||
162014707|NCT00771758|585107038|FG001|Overall Study|Other|2|||
162014708|NCT00771758|585107039|FG002|Overall Study|Other|0|||
162014709|NCT02991768|585107045|FG000|Overall Study|Physician Decision|4|||
161812662|NCT03673670|584357331|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
161812663|NCT03673670|584357332|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
162014710|NCT02273596|585108546|FG000|24-Week Treatment Period|Adverse Event|3|||
162014711|NCT02273596|585108546|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
162014712|NCT02273596|585108546|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
162014713|NCT02273596|585108546|FG000|24-Week Treatment Period|Physician Decision|1|||
162014714|NCT02273596|585108546|FG000|24-Week Treatment Period|Protocol Deviation|1|||
162014715|NCT02273596|585108546|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
162014716|NCT02273596|585108546|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
162014717|NCT02273596|585108546|FG000|Extension Period|Lost to Follow-up|1|||
162014718|NCT02273596|585108546|FG000|Extension Period|Protocol Deviation|1|||
162014719|NCT02139592|585108548|FG000|Overall Study|Case Report Forms Uncollected|8|||
162158650|NCT03398148|585631156|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158651|NCT03398148|585631157|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158652|NCT03398148|585631158|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158653|NCT03398148|585631159|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158654|NCT03398148|585631160|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158655|NCT03398148|585631161|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158656|NCT03398148|585631162|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158657|NCT03398148|585631163|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158658|NCT03398148|585631164|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162014720|NCT02873702|585108553|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
162014721|NCT02873702|585108554|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
162014722|NCT02873702|585108555|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
162014723|NCT02873702|585108556|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
162014724|NCT02873702|585108553|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
162158659|NCT03398148|585631165|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158660|NCT03398148|585631166|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
162158661|NCT03398148|585631167|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158662|NCT03398148|585631168|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158663|NCT03398148|585631169|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158664|NCT03398148|585631170|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
162158665|NCT03398148|585631156|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158666|NCT03398148|585631157|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158667|NCT03398148|585631158|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158668|NCT03398148|585631159|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158669|NCT03398148|585631160|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158670|NCT03398148|585631161|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158671|NCT03398148|585631162|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158672|NCT03398148|585631163|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158673|NCT03398148|585631164|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158674|NCT03398148|585631165|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158675|NCT03398148|585631166|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
162158676|NCT03398148|585631167|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158677|NCT03398148|585631168|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158678|NCT03398148|585631169|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158679|NCT03398148|585631170|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
162158680|NCT03398148|585631156|FG000|Substudy 2 Period 1|Other|0|||
162158681|NCT03398148|585631157|FG001|Substudy 2 Period 1|Other|0|||
162158682|NCT03398148|585631158|FG002|Substudy 2 Period 1|Other|0|||
162158683|NCT03398148|585631159|FG003|Substudy 2 Period 1|Other|0|||
162158684|NCT03398148|585631160|FG004|Substudy 2 Period 1|Other|0|||
162158685|NCT03398148|585631161|FG005|Substudy 2 Period 1|Other|0|||
162158686|NCT03398148|585631162|FG006|Substudy 2 Period 1|Other|0|||
162158687|NCT03398148|585631163|FG007|Substudy 2 Period 1|Other|0|||
162158688|NCT03398148|585631164|FG008|Substudy 2 Period 1|Other|0|||
162158689|NCT03398148|585631165|FG009|Substudy 2 Period 1|Other|4|||
162158690|NCT03398148|585631166|FG010|Substudy 2 Period 1|Other|4|||
162158691|NCT03398148|585631167|FG011|Substudy 2 Period 1|Other|0|||
162158692|NCT03398148|585631168|FG012|Substudy 2 Period 1|Other|0|||
162158693|NCT03398148|585631169|FG013|Substudy 2 Period 1|Other|0|||
162158694|NCT03398148|585631170|FG014|Substudy 2 Period 1|Other|0|||
162158695|NCT03398148|585631156|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158696|NCT03398148|585631157|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158697|NCT03398148|585631158|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158698|NCT03398148|585631159|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158699|NCT03398148|585631160|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158700|NCT03398148|585631161|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158701|NCT03398148|585631162|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158702|NCT03398148|585631163|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158703|NCT03398148|585631164|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158704|NCT03398148|585631165|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158705|NCT03398148|585631166|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
162158706|NCT03398148|585631167|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158707|NCT03398148|585631168|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158708|NCT03398148|585631169|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158709|NCT03398148|585631170|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
162158710|NCT03398148|585631156|FG000|Substudy 2 Period 2|Adverse Event|0|||
162158711|NCT03398148|585631157|FG001|Substudy 2 Period 2|Adverse Event|0|||
162158712|NCT03398148|585631158|FG002|Substudy 2 Period 2|Adverse Event|0|||
162158713|NCT03398148|585631159|FG003|Substudy 2 Period 2|Adverse Event|0|||
162158714|NCT03398148|585631160|FG004|Substudy 2 Period 2|Adverse Event|0|||
162158715|NCT03398148|585631161|FG005|Substudy 2 Period 2|Adverse Event|0|||
162158716|NCT03398148|585631162|FG006|Substudy 2 Period 2|Adverse Event|0|||
161812664|NCT03673670|584357333|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
162158717|NCT03398148|585631163|FG007|Substudy 2 Period 2|Adverse Event|0|||
162158718|NCT03398148|585631164|FG008|Substudy 2 Period 2|Adverse Event|0|||
162158719|NCT03398148|585631165|FG009|Substudy 2 Period 2|Adverse Event|0|||
162158720|NCT03398148|585631166|FG010|Substudy 2 Period 2|Adverse Event|0|||
162158721|NCT03398148|585631167|FG011|Substudy 2 Period 2|Adverse Event|0|||
162158722|NCT03398148|585631168|FG012|Substudy 2 Period 2|Adverse Event|0|||
162158723|NCT03398148|585631169|FG013|Substudy 2 Period 2|Adverse Event|1|||
162158724|NCT03398148|585631170|FG014|Substudy 2 Period 2|Adverse Event|3|||
162158725|NCT03398148|585631156|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
162158726|NCT03398148|585631157|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
162158727|NCT03398148|585631158|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
162158728|NCT03398148|585631159|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
162158729|NCT03398148|585631160|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
161812665|NCT03673670|584357328|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
161812666|NCT03673670|584357329|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
161812667|NCT03673670|584357330|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
162158730|NCT03398148|585631161|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
162158731|NCT03398148|585631162|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
162158732|NCT03398148|585631163|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
162158733|NCT03398148|585631164|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
162158734|NCT03398148|585631165|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
162158735|NCT03398148|585631166|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
162158736|NCT03398148|585631167|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
162158737|NCT03398148|585631168|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
162158738|NCT03398148|585631169|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
162158739|NCT03398148|585631170|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
162158740|NCT03398148|585631156|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162158741|NCT03398148|585631157|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162158742|NCT03398148|585631158|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162158743|NCT03398148|585631159|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162158744|NCT03398148|585631160|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162158745|NCT03398148|585631161|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162158746|NCT03398148|585631162|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162158747|NCT03398148|585631163|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162158748|NCT03398148|585631164|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162158749|NCT03398148|585631165|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162158750|NCT03398148|585631166|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162158751|NCT03398148|585631167|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
162158752|NCT03398148|585631168|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
162158753|NCT03398148|585631169|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
162158754|NCT03398148|585631170|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
162158755|NCT03398148|585631156|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
162158756|NCT03398148|585631157|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
162158757|NCT03398148|585631158|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
162158758|NCT03398148|585631159|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
162158759|NCT03398148|585631160|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
162158760|NCT03398148|585631161|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
162158761|NCT03398148|585631162|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
162158762|NCT03398148|585631163|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
162158763|NCT03398148|585631164|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
161916228|NCT00785629|584742388|FG002|Overall Study|Adverse Event|1|||
161916229|NCT00785629|584742389|FG003|Overall Study|Adverse Event|5|||
161916230|NCT00785629|584742386|FG000|Overall Study|Protocol Violation|1|||
161916231|NCT00785629|584742387|FG001|Overall Study|Protocol Violation|2|||
161916232|NCT00785629|584742388|FG002|Overall Study|Protocol Violation|4|||
161916233|NCT00785629|584742389|FG003|Overall Study|Protocol Violation|5|||
161916234|NCT00785629|584742386|FG000|Overall Study|administrative decision|5|||
161916235|NCT00785629|584742387|FG001|Overall Study|administrative decision|1|||
161916236|NCT00785629|584742388|FG002|Overall Study|administrative decision|3|||
161916237|NCT00785629|584742389|FG003|Overall Study|administrative decision|4|||
161916238|NCT00785629|584742386|FG000|Overall Study|Withdrawal by Subject|0|||
161916239|NCT00785629|584742387|FG001|Overall Study|Withdrawal by Subject|1|||
161916240|NCT00785629|584742388|FG002|Overall Study|Withdrawal by Subject|2|||
161916241|NCT00785629|584742389|FG003|Overall Study|Withdrawal by Subject|2|||
161916242|NCT02020941|584742390|FG000|Overall Study|Adverse Event|1|||
161916243|NCT02020941|584742390|FG000|Overall Study|Physician Decision|2|||
161916244|NCT02020941|584742390|FG000|Overall Study|Withdrawal by Subject|1|||
161916245|NCT02020941|584742390|FG000|Overall Study|Disease Progression|4|||
161916246|NCT02107898|584742393|FG000|Overall Study|Adverse Event|4|||
161916247|NCT02107898|584742394|FG001|Overall Study|Adverse Event|7|||
161916248|NCT02107898|584742393|FG000|Overall Study|Poor compliance to protocol|0|||
161916249|NCT02107898|584742394|FG001|Overall Study|Poor compliance to protocol|1|||
161916250|NCT02107898|584742393|FG000|Overall Study|Participant moved|0|||
161916251|NCT02107898|584742394|FG001|Overall Study|Participant moved|2|||
161916252|NCT02107898|584742393|FG000|Overall Study|Consent withdrawn by participant|2|||
161916253|NCT02107898|584742394|FG001|Overall Study|Consent withdrawn by participant|1|||
161916254|NCT02107898|584742393|FG000|Overall Study|Randomized but not treated|0|||
162158764|NCT03398148|585631165|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
162158765|NCT03398148|585631166|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
162158766|NCT03398148|585631167|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
162158767|NCT03398148|585631168|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
162158768|NCT03398148|585631169|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
162158769|NCT03398148|585631170|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
161916255|NCT02107898|584742394|FG001|Overall Study|Randomized but not treated|1|||
161916256|NCT00634504|584742395|FG000|Overall Study|Protocol Violation|1|||
161916257|NCT00634504|584742396|FG001|Overall Study|Protocol Violation|0|||
161916258|NCT03329989|584742397|FG000|Overall Study|Withdrawal by Subject|9|||
161916259|NCT03329989|584742397|FG000|Overall Study|Lost to Follow-up|8|||
161916260|NCT03329989|584742397|FG000|Overall Study|Adverse Event|5|||
162158770|NCT03398148|585631156|FG000|Substudy 2 Period 2|Other|0|||
161916261|NCT03329989|584742397|FG000|Overall Study|Protocol Violation|1|||
161916262|NCT01283386|584742398|FG000|Overall Study|Death|2|||
161916263|NCT01283386|584742399|FG001|Overall Study|Death|0|||
162158771|NCT03398148|585631157|FG001|Substudy 2 Period 2|Other|0|||
162158772|NCT03398148|585631158|FG002|Substudy 2 Period 2|Other|0|||
162158773|NCT03398148|585631159|FG003|Substudy 2 Period 2|Other|0|||
162158774|NCT03398148|585631160|FG004|Substudy 2 Period 2|Other|0|||
162158775|NCT03398148|585631161|FG005|Substudy 2 Period 2|Other|0|||
162158776|NCT03398148|585631162|FG006|Substudy 2 Period 2|Other|0|||
162158777|NCT03398148|585631163|FG007|Substudy 2 Period 2|Other|0|||
162158778|NCT03398148|585631164|FG008|Substudy 2 Period 2|Other|0|||
162158779|NCT03398148|585631165|FG009|Substudy 2 Period 2|Other|0|||
162158780|NCT03398148|585631166|FG010|Substudy 2 Period 2|Other|0|||
162158781|NCT03398148|585631167|FG011|Substudy 2 Period 2|Other|0|||
162158782|NCT03398148|585631168|FG012|Substudy 2 Period 2|Other|0|||
162158783|NCT03398148|585631169|FG013|Substudy 2 Period 2|Other|1|||
162158784|NCT03398148|585631170|FG014|Substudy 2 Period 2|Other|1|||
162158785|NCT03398148|585631156|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158786|NCT03398148|585631157|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158787|NCT03398148|585631158|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158788|NCT03398148|585631159|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158789|NCT03398148|585631160|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158790|NCT03398148|585631161|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158791|NCT03398148|585631162|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158792|NCT03398148|585631163|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158793|NCT03398148|585631164|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158794|NCT03398148|585631165|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158795|NCT03398148|585631166|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158796|NCT03398148|585631167|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158797|NCT03398148|585631168|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
162158798|NCT03398148|585631169|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
162158799|NCT03398148|585631170|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
162158800|NCT03899961|585631171|FG000|Overall Study|-delivery prior to|2|||
162158801|NCT03899961|585631172|FG001|Overall Study|-delivery prior to|7|||
162158802|NCT03899961|585631171|FG000|Overall Study|req general anesth|1|||
162158803|NCT03899961|585631172|FG001|Overall Study|req general anesth|2|||
162158804|NCT03899961|585631171|FG000|Overall Study|capacity|5|||
162158805|NCT03899961|585631172|FG001|Overall Study|capacity|6|||
162158806|NCT03899961|585631171|FG000|Overall Study|Withdrawal by Subject|1|||
162158807|NCT03899961|585631172|FG001|Overall Study|Withdrawal by Subject|1|||
162158808|NCT05107401|585631173|FG000|Overall Study|Lost to Follow-up|13|||
162158809|NCT05107401|585631174|FG001|Overall Study|Lost to Follow-up|12|||
162158810|NCT05952076|585631177|FG000|Overall Study|Death|1|||
162158811|NCT05952076|585631178|FG001|Overall Study|Death|1|||
162158812|NCT05952076|585631177|FG000|Overall Study|Lost to Follow-up|0|||
162158813|NCT05952076|585631178|FG001|Overall Study|Lost to Follow-up|1|||
162158814|NCT04905407|585631179|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
162158815|NCT04905407|585631180|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
162158816|NCT04905407|585631181|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
162158817|NCT04905407|585631182|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
162158818|NCT04905407|585631179|FG000|Part 1 and Part 2|Death|7|||
162158819|NCT04905407|585631180|FG001|Part 1 and Part 2|Death|7|||
162158820|NCT04905407|585631181|FG002|Part 1 and Part 2|Death|7|||
162158821|NCT04905407|585631182|FG003|Part 1 and Part 2|Death|0|||
162158822|NCT04905407|585631179|FG000|Part 1 and Part 2|Other than specified|0|||
162158823|NCT04905407|585631180|FG001|Part 1 and Part 2|Other than specified|0|||
162158824|NCT04905407|585631181|FG002|Part 1 and Part 2|Other than specified|1|||
162158825|NCT04905407|585631182|FG003|Part 1 and Part 2|Other than specified|0|||
162158826|NCT04905407|585631179|FG000|Part 3|Death|0|||
162158827|NCT04905407|585631180|FG001|Part 3|Death|0|||
162158828|NCT04905407|585631181|FG002|Part 3|Death|0|||
162158829|NCT04905407|585631182|FG003|Part 3|Death|2|||
162158830|NCT00150813|585631185|FG000|Overall Study|Adverse Event|1|||
162158831|NCT00150813|585631185|FG000|Overall Study|Lack of Efficacy|1|||
162158832|NCT00150813|585631185|FG000|Overall Study|Lost to Follow-up|5|||
162158833|NCT00150813|585631185|FG000|Overall Study|Withdrawal by Subject|5|||
162158834|NCT00150813|585631185|FG000|Overall Study|Remission|3|||
162158835|NCT00150813|585631185|FG000|Overall Study|Planned pregancy|1|||
162158836|NCT00150813|585631185|FG000|Overall Study|Switch to commercially available LEV|2|||
162158837|NCT00894543|585631186|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
161812668|NCT03673670|584357331|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
161812669|NCT03673670|584357332|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
161812670|NCT03673670|584357333|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
161812671|NCT01058668|584357334|FG000|Double-blind Treatment Phase|Adverse Event|8|||
161812672|NCT01058668|584357335|FG001|Double-blind Treatment Phase|Adverse Event|15|||
161812673|NCT01058668|584357336|FG002|Double-blind Treatment Phase|Adverse Event|25|||
161812674|NCT01058668|584357334|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
161812675|NCT01058668|584357335|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
161812676|NCT01058668|584357336|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
162158838|NCT00894543|585631187|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
162158839|NCT00894543|585631186|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
162158840|NCT00894543|585631187|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
162158841|NCT04579250|585631188|FG000|Overall Study|Withdrawal by Subject|1|||
162158842|NCT04579250|585631189|FG001|Overall Study|Withdrawal by Subject|1|||
162158843|NCT04579250|585631190|FG002|Overall Study|Withdrawal by Subject|0|||
162158844|NCT04579250|585631188|FG000|Overall Study|Lost to Follow-up|1|||
161812677|NCT01058668|584357334|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
161812678|NCT01058668|584357335|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
161812679|NCT01058668|584357336|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
161812680|NCT01058668|584357334|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
161812681|NCT01058668|584357335|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
161812682|NCT01058668|584357336|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
161812683|NCT01058668|584357334|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
161812684|NCT01058668|584357335|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
161812685|NCT01058668|584357336|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
161812686|NCT01058668|584357334|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
161812687|NCT01058668|584357335|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
161812688|NCT01058668|584357336|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
161812689|NCT02294786|584357339|FG000|Overall Study|Withdrawal by Subject|0|||
161812690|NCT02294786|584357340|FG001|Overall Study|Withdrawal by Subject|1|||
161812691|NCT02294786|584357339|FG000|Overall Study|Physician Decision|6|||
161812692|NCT02294786|584357340|FG001|Overall Study|Physician Decision|7|||
161812693|NCT02294786|584357339|FG000|Overall Study|Lost to Follow-up|1|||
161812694|NCT02294786|584357340|FG001|Overall Study|Lost to Follow-up|2|||
161812695|NCT02294786|584357339|FG000|Overall Study|Protocol Violation|1|||
161812696|NCT02294786|584357340|FG001|Overall Study|Protocol Violation|0|||
161812697|NCT02294786|584357339|FG000|Overall Study|Adverse Event|1|||
161812698|NCT02294786|584357340|FG001|Overall Study|Adverse Event|1|||
161812699|NCT02294786|584357339|FG000|Overall Study|Death|2|||
161812700|NCT02294786|584357340|FG001|Overall Study|Death|3|||
161812701|NCT03261167|584357341|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
161812702|NCT03261167|584357342|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
161812703|NCT03261167|584357341|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
161812704|NCT03261167|584357342|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
161812705|NCT03261167|584357341|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
161812706|NCT03261167|584357342|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
161812707|NCT03261167|584357341|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
161812708|NCT03261167|584357342|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
161812709|NCT03261167|584357341|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
161812710|NCT03261167|584357342|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
161812711|NCT03406156|584357349|FG000|Overall Study|Death|9|||
161812712|NCT03406156|584357350|FG001|Overall Study|Death|3|||
161812713|NCT03406156|584357349|FG000|Overall Study|Withdrawal by Subject|1|||
161812714|NCT03406156|584357350|FG001|Overall Study|Withdrawal by Subject|2|||
161812715|NCT03406156|584357349|FG000|Overall Study|COVID-19 infection|1|||
161812716|NCT03406156|584357350|FG001|Overall Study|COVID-19 infection|0|||
161812717|NCT03406156|584357349|FG000|Overall Study|Non-compliance with study procedures|1|||
161812718|NCT03406156|584357350|FG001|Overall Study|Non-compliance with study procedures|1|||
161812719|NCT03406156|584357349|FG000|Overall Study|Lost to Follow-up|0|||
161812720|NCT03406156|584357350|FG001|Overall Study|Lost to Follow-up|2|||
161812721|NCT03406156|584357349|FG000|Overall Study|Other, not specified|72|||
161812722|NCT03406156|584357350|FG001|Overall Study|Other, not specified|28|||
161812723|NCT05479058|584357353|FG000|Overall Study|Withdrawal by Subject|1|||
161812724|NCT05479058|584357354|FG001|Overall Study|Withdrawal by Subject|1|||
161812725|NCT05479058|584357353|FG000|Overall Study|Study terminated by sponsor|10|||
161812726|NCT05479058|584357354|FG001|Overall Study|Study terminated by sponsor|10|||
161812727|NCT05630885|584357355|FG000|Study Completion|Took prohibited medications|2|||
161812728|NCT05630885|584357356|FG001|Study Completion|Took prohibited medications|0|||
161812729|NCT05630885|584357355|FG000|Study Completion|Non-compliance with study drug|1|||
161812730|NCT05630885|584357356|FG001|Study Completion|Non-compliance with study drug|0|||
161812731|NCT05630885|584357355|FG000|Study Completion|Adverse Event|1|||
161812732|NCT05630885|584357356|FG001|Study Completion|Adverse Event|0|||
161812733|NCT05630885|584357355|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
161812734|NCT05630885|584357356|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
162158845|NCT04579250|585631189|FG001|Overall Study|Lost to Follow-up|1|||
161812735|NCT05630885|584357355|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
161812736|NCT05630885|584357356|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
161812737|NCT03419403|584357359|FG000|Overall Study|Withdrawal by Subject|5|||
161812738|NCT03419403|584357360|FG001|Overall Study|Withdrawal by Subject|2|||
162014725|NCT02873702|585108554|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
162014726|NCT02873702|585108555|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
162014727|NCT02873702|585108556|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
162014728|NCT02873702|585108553|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
162014729|NCT02873702|585108554|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
162014730|NCT02873702|585108555|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
162014731|NCT02873702|585108556|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
162014732|NCT02873702|585108553|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
162014733|NCT02873702|585108554|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
161812739|NCT03419403|584357361|FG002|Overall Study|Withdrawal by Subject|5|||
161812740|NCT03419403|584357362|FG003|Overall Study|Withdrawal by Subject|1|||
161812741|NCT03419403|584357359|FG000|Overall Study|Progressive disease (per protocol)|0|||
161812742|NCT03419403|584357360|FG001|Overall Study|Progressive disease (per protocol)|2|||
161812743|NCT03419403|584357361|FG002|Overall Study|Progressive disease (per protocol)|2|||
161812744|NCT03419403|584357362|FG003|Overall Study|Progressive disease (per protocol)|0|||
161812745|NCT03419403|584357359|FG000|Overall Study|Other, not specified|6|||
161812746|NCT03419403|584357360|FG001|Overall Study|Other, not specified|4|||
161812747|NCT03419403|584357361|FG002|Overall Study|Other, not specified|5|||
161812748|NCT03419403|584357362|FG003|Overall Study|Other, not specified|1|||
161812749|NCT03419403|584357359|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
161812750|NCT03419403|584357360|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
161812751|NCT03419403|584357361|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
161812752|NCT03419403|584357362|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
161812753|NCT00505622|584357365|FG000|Overall Study|Adverse Event|5|||
161812754|NCT00505622|584357366|FG001|Overall Study|Adverse Event|6|||
161812755|NCT00505622|584357367|FG002|Overall Study|Adverse Event|4|||
161812756|NCT00505622|584357365|FG000|Overall Study|Protocol Violation|1|||
161812757|NCT00505622|584357366|FG001|Overall Study|Protocol Violation|1|||
161812758|NCT00505622|584357367|FG002|Overall Study|Protocol Violation|0|||
161812759|NCT00505622|584357365|FG000|Overall Study|Withdrawal by Subject|0|||
161812760|NCT00505622|584357366|FG001|Overall Study|Withdrawal by Subject|3|||
161812761|NCT00505622|584357367|FG002|Overall Study|Withdrawal by Subject|2|||
161812762|NCT00505622|584357365|FG000|Overall Study|Study termination by sponsor|115|||
161812763|NCT00505622|584357366|FG001|Overall Study|Study termination by sponsor|98|||
161812764|NCT00505622|584357367|FG002|Overall Study|Study termination by sponsor|90|||
161812765|NCT03084471|584357370|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
161812766|NCT03084471|584357370|FG000|Overall Study|Condition under investigation worsened|84|||
161812767|NCT03084471|584357370|FG000|Overall Study|Lack of therapeutic response|2|||
161812768|NCT03084471|584357370|FG000|Overall Study|Protocol Violation|1|||
161812769|NCT03084471|584357370|FG000|Overall Study|Adverse Event|73|||
161812770|NCT03084471|584357370|FG000|Overall Study|Withdrawal by Subject|12|||
161812771|NCT03084471|584357370|FG000|Overall Study|Disease relapse|181|||
161812772|NCT03084471|584357370|FG000|Overall Study|Subjective disease progression|359|||
161812773|NCT03084471|584357370|FG000|Overall Study|Other (as recorded)|33|||
161812774|NCT03084471|584357370|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
161812775|NCT02414152|584357375|FG000|Overall Study|Withdrawal by Subject|1|||
161812776|NCT02414152|584357375|FG000|Overall Study|Lack of Efficacy|1|||
161812777|NCT01757392|584357376|FG000|Overall Study|Withdrawal by Subject|1|||
161812778|NCT01757392|584357376|FG000|Overall Study|Screen Fail|3|||
161812779|NCT00841698|584357383|FG000|First Intervention|Withdrawal by Subject|1|||
161812780|NCT00841698|584357384|FG001|First Intervention|Withdrawal by Subject|0|||
161812781|NCT04078022|584357389|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
161812782|NCT04078022|584357390|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
161812783|NCT01250912|584357391|FG000|Overall Study|Lost to Follow-up|1|||
161812784|NCT01929863|584357394|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
161812785|NCT01929863|584357395|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
161812786|NCT01929863|584357394|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
161812787|NCT01929863|584357395|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
161812788|NCT01929863|584357394|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
161812789|NCT01929863|584357395|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
161812790|NCT02152163|584357396|FG000|Overall Study|Physician Decision|12|||
161812791|NCT02152163|584357397|FG001|Overall Study|Physician Decision|13|||
161812792|NCT00730691|584357398|FG000|Overall Study|Adverse Event|4|||
161812793|NCT00730691|584357399|FG001|Overall Study|Adverse Event|8|||
161812794|NCT00730691|584357400|FG002|Overall Study|Adverse Event|11|||
161812795|NCT00730691|584357401|FG003|Overall Study|Adverse Event|11|||
161812796|NCT00730691|584357402|FG004|Overall Study|Adverse Event|23|||
161812797|NCT00730691|584357398|FG000|Overall Study|Lack of Efficacy|4|||
161812798|NCT00730691|584357399|FG001|Overall Study|Lack of Efficacy|4|||
161812799|NCT00730691|584357400|FG002|Overall Study|Lack of Efficacy|2|||
161812800|NCT00730691|584357401|FG003|Overall Study|Lack of Efficacy|1|||
161812801|NCT00730691|584357402|FG004|Overall Study|Lack of Efficacy|1|||
161812802|NCT00730691|584357398|FG000|Overall Study|Non-compliance with Study Drug|6|||
162158846|NCT04579250|585631190|FG002|Overall Study|Lost to Follow-up|0|||
162158847|NCT04579250|585631188|FG000|Overall Study|Moved from area|0|||
162158848|NCT04579250|585631189|FG001|Overall Study|Moved from area|1|||
162158849|NCT04579250|585631190|FG002|Overall Study|Moved from area|2|||
162158850|NCT02919449|585631191|FG000|Overall Study|Withdrawal by Subject|1|||
162158851|NCT02919449|585631191|FG000|Overall Study|Investigator decision|1|||
162158852|NCT00411151|585631192|FG000|Overall Study|Death|38|||
162158853|NCT00411151|585631192|FG000|Overall Study|Withdrawal by Subject|2|||
162158854|NCT00411151|585631192|FG000|Overall Study|Lost to Follow-up|2|||
162158855|NCT00411151|585631192|FG000|Overall Study|Protocol Violation|1|||
162158856|NCT00411151|585631192|FG000|Overall Study|Trial prematurely closed|4|||
162158857|NCT04452318|585631196|FG000|Overall Study|Physician Decision|1|||
162158858|NCT04452318|585631197|FG001|Overall Study|Physician Decision|2|||
162158859|NCT04452318|585631198|FG002|Overall Study|Physician Decision|0|||
162158860|NCT04452318|585631199|FG003|Overall Study|Physician Decision|2|||
162158861|NCT04452318|585631200|FG004|Overall Study|Physician Decision|0|||
162158862|NCT04452318|585631201|FG005|Overall Study|Physician Decision|2|||
162158863|NCT04452318|585631202|FG006|Overall Study|Physician Decision|5|||
162014734|NCT02873702|585108555|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
162014735|NCT02873702|585108556|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
162158864|NCT04452318|585631196|FG000|Overall Study|Death|2|||
162158865|NCT04452318|585631197|FG001|Overall Study|Death|3|||
162158866|NCT04452318|585631198|FG002|Overall Study|Death|0|||
162158867|NCT04452318|585631199|FG003|Overall Study|Death|0|||
162158868|NCT04452318|585631200|FG004|Overall Study|Death|0|||
161812803|NCT00730691|584357399|FG001|Overall Study|Non-compliance with Study Drug|1|||
161812804|NCT00730691|584357400|FG002|Overall Study|Non-compliance with Study Drug|6|||
162158869|NCT04452318|585631201|FG005|Overall Study|Death|0|||
162158870|NCT04452318|585631202|FG006|Overall Study|Death|0|||
162158871|NCT04452318|585631196|FG000|Overall Study|Lost to Follow-up|38|||
162158872|NCT04452318|585631197|FG001|Overall Study|Lost to Follow-up|28|||
162158873|NCT04452318|585631198|FG002|Overall Study|Lost to Follow-up|0|||
162158874|NCT04452318|585631199|FG003|Overall Study|Lost to Follow-up|3|||
162158875|NCT04452318|585631200|FG004|Overall Study|Lost to Follow-up|3|||
162158876|NCT04452318|585631201|FG005|Overall Study|Lost to Follow-up|2|||
162158877|NCT04452318|585631202|FG006|Overall Study|Lost to Follow-up|1|||
162158878|NCT04452318|585631196|FG000|Overall Study|Withdrawal by Subject|46|||
162158879|NCT04452318|585631197|FG001|Overall Study|Withdrawal by Subject|40|||
162158880|NCT04452318|585631198|FG002|Overall Study|Withdrawal by Subject|0|||
162158881|NCT04452318|585631199|FG003|Overall Study|Withdrawal by Subject|18|||
162158882|NCT04452318|585631200|FG004|Overall Study|Withdrawal by Subject|6|||
162158883|NCT04452318|585631201|FG005|Overall Study|Withdrawal by Subject|8|||
162158884|NCT04452318|585631202|FG006|Overall Study|Withdrawal by Subject|6|||
162158885|NCT03380390|585631207|FG000|Overall Study|Adverse Event|3|||
162158886|NCT02886286|585631208|FG000|Overall Study|pump motor stall|0|||
162158887|NCT02886286|585631209|FG001|Overall Study|pump motor stall|1|||
162158888|NCT05494788|585631211|FG000|Initial Treatment Period|Adverse Event|2|||
162158889|NCT05494788|585631211|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
162158890|NCT05494788|585631211|FG000|Extension Period|Adverse Event|1|||
162158891|NCT05494788|585631211|FG000|Extension Period|Withdrawal by Subject|1|||
162158892|NCT00539734|585631212|FG000|Overall Study|Protocol Violation|1|||
162158893|NCT03101930|585631213|FG000|Overall Study|Withdrawal by Subject|2|||
162158894|NCT03101930|585631214|FG001|Overall Study|Withdrawal by Subject|1|||
162158895|NCT03101930|585631215|FG002|Overall Study|Withdrawal by Subject|2|||
162158896|NCT02814838|585631216|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
162158897|NCT02814838|585631217|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
162158898|NCT02814838|585631216|FG000|Overall Study|Consent withdrawal|1|||
162158899|NCT02814838|585631217|FG001|Overall Study|Consent withdrawal|1|||
161812805|NCT00730691|584357401|FG003|Overall Study|Non-compliance with Study Drug|3|||
161812806|NCT00730691|584357402|FG004|Overall Study|Non-compliance with Study Drug|3|||
161812807|NCT00730691|584357398|FG000|Overall Study|Protocol Deviations|3|||
161812808|NCT00730691|584357399|FG001|Overall Study|Protocol Deviations|5|||
161812809|NCT00730691|584357400|FG002|Overall Study|Protocol Deviations|3|||
161812810|NCT00730691|584357401|FG003|Overall Study|Protocol Deviations|7|||
162158900|NCT01017146|585631218|FG000|Overall Study|Adverse Event|11|||
162158901|NCT01017146|585631219|FG001|Overall Study|Adverse Event|1|||
162158902|NCT01017146|585631218|FG000|Overall Study|Lost to Follow-up|14|||
162158903|NCT01017146|585631219|FG001|Overall Study|Lost to Follow-up|14|||
162158904|NCT01017146|585631218|FG000|Overall Study|Noncompliance with Study Product|1|||
162158905|NCT01017146|585631219|FG001|Overall Study|Noncompliance with Study Product|1|||
162158906|NCT01017146|585631218|FG000|Overall Study|Withdrawal by Subject|32|||
162158907|NCT01017146|585631219|FG001|Overall Study|Withdrawal by Subject|16|||
162158908|NCT01017146|585631218|FG000|Overall Study|Relocation|0|||
162158909|NCT01017146|585631219|FG001|Overall Study|Relocation|4|||
162158910|NCT01017146|585631218|FG000|Overall Study|Pregnancy|2|||
162158911|NCT01017146|585631219|FG001|Overall Study|Pregnancy|1|||
161812811|NCT00730691|584357402|FG004|Overall Study|Protocol Deviations|5|||
162158912|NCT01017146|585631218|FG000|Overall Study|Protocol Violation|2|||
162158913|NCT01017146|585631219|FG001|Overall Study|Protocol Violation|0|||
161812812|NCT00730691|584357398|FG000|Overall Study|Withdrawal of Consent|7|||
161812813|NCT00730691|584357399|FG001|Overall Study|Withdrawal of Consent|9|||
161812814|NCT00730691|584357400|FG002|Overall Study|Withdrawal of Consent|3|||
161812815|NCT00730691|584357401|FG003|Overall Study|Withdrawal of Consent|6|||
161812816|NCT00730691|584357402|FG004|Overall Study|Withdrawal of Consent|3|||
161812817|NCT00730691|584357398|FG000|Overall Study|Lost to Follow-up|11|||
161812818|NCT00730691|584357399|FG001|Overall Study|Lost to Follow-up|8|||
161812819|NCT00730691|584357400|FG002|Overall Study|Lost to Follow-up|13|||
161812820|NCT00730691|584357401|FG003|Overall Study|Lost to Follow-up|15|||
161812821|NCT00730691|584357402|FG004|Overall Study|Lost to Follow-up|13|||
161812822|NCT00730691|584357398|FG000|Overall Study|Other|1|||
161812823|NCT00730691|584357399|FG001|Overall Study|Other|1|||
161812824|NCT00730691|584357400|FG002|Overall Study|Other|1|||
161812825|NCT00730691|584357401|FG003|Overall Study|Other|2|||
161812826|NCT00730691|584357402|FG004|Overall Study|Other|2|||
161812827|NCT04825275|584359745|FG000|Overall Study|Withdrawal by Subject|1|||
161812828|NCT04825275|584359746|FG001|Overall Study|Withdrawal by Subject|0|||
161812829|NCT05710718|584359752|FG000|Overall Study|Withdrawal by Subject|5|||
161812830|NCT05710718|584359753|FG001|Overall Study|Withdrawal by Subject|1|||
161812831|NCT05710718|584359752|FG000|Overall Study|Lost to Follow-up|0|||
161812832|NCT05710718|584359753|FG001|Overall Study|Lost to Follow-up|1|||
161812833|NCT05710718|584359752|FG000|Overall Study|Death|0|||
161812834|NCT05710718|584359753|FG001|Overall Study|Death|1|||
161812835|NCT04372238|584359754|FG000|Overall Study|Duplicate|3|||
161812836|NCT04372238|584359755|FG001|Overall Study|Duplicate|3|||
161812837|NCT04372238|584359754|FG000|Overall Study|Did not consent for data linkage|6|||
161812838|NCT04372238|584359755|FG001|Overall Study|Did not consent for data linkage|10|||
161812839|NCT02591420|584359756|FG000|Overall Study|Lost to Follow-up|0|||
161812840|NCT02591420|584359757|FG001|Overall Study|Lost to Follow-up|1|||
161812841|NCT02591420|584359758|FG002|Overall Study|Lost to Follow-up|2|||
161812842|NCT04241458|584359759|FG000|Overall Study|Withdrawal by Subject|0|||
161812843|NCT04241458|584359760|FG001|Overall Study|Withdrawal by Subject|0|||
161812844|NCT04241458|584359761|FG002|Overall Study|Withdrawal by Subject|0|||
161812845|NCT04241458|584359762|FG003|Overall Study|Withdrawal by Subject|0|||
161812846|NCT04241458|584359763|FG004|Overall Study|Withdrawal by Subject|1|||
161812847|NCT05005442|584359764|FG000|Overall Study|Death|14|||
161812848|NCT05005442|584359765|FG001|Overall Study|Death|10|||
161812849|NCT05005442|584359766|FG002|Overall Study|Death|8|||
161812850|NCT05005442|584359767|FG003|Overall Study|Death|22|||
161812851|NCT05005442|584359768|FG004|Overall Study|Death|13|||
161812852|NCT05005442|584359769|FG005|Overall Study|Death|15|||
161812853|NCT05005442|584359764|FG000|Overall Study|Lost to Follow-up|0|||
161812854|NCT05005442|584359765|FG001|Overall Study|Lost to Follow-up|2|||
161812855|NCT05005442|584359766|FG002|Overall Study|Lost to Follow-up|0|||
161812856|NCT05005442|584359767|FG003|Overall Study|Lost to Follow-up|0|||
161812857|NCT05005442|584359768|FG004|Overall Study|Lost to Follow-up|1|||
161812858|NCT05005442|584359769|FG005|Overall Study|Lost to Follow-up|0|||
161812859|NCT05005442|584359764|FG000|Overall Study|Physician Decision|0|||
161812860|NCT05005442|584359765|FG001|Overall Study|Physician Decision|0|||
161812861|NCT05005442|584359766|FG002|Overall Study|Physician Decision|1|||
161812862|NCT05005442|584359767|FG003|Overall Study|Physician Decision|0|||
161812863|NCT05005442|584359768|FG004|Overall Study|Physician Decision|2|||
161812864|NCT05005442|584359769|FG005|Overall Study|Physician Decision|0|||
161812865|NCT05005442|584359764|FG000|Overall Study|Sponsor decision|26|||
161812866|NCT05005442|584359765|FG001|Overall Study|Sponsor decision|26|||
162014736|NCT02873702|585108553|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
162014737|NCT02873702|585108554|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
162014738|NCT02873702|585108555|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
162014739|NCT02873702|585108556|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
162014740|NCT01177397|585108557|FG000|Overall Study|Protocol Violation|0|||
162014741|NCT01177397|585108558|FG001|Overall Study|Protocol Violation|0|||
162014742|NCT01177397|585108559|FG002|Overall Study|Protocol Violation|0|||
162014743|NCT01177397|585108560|FG003|Overall Study|Protocol Violation|0|||
162014744|NCT01177397|585108561|FG004|Overall Study|Protocol Violation|0|||
162014745|NCT01177397|585108562|FG005|Overall Study|Protocol Violation|1|||
162014746|NCT01177397|585108563|FG006|Overall Study|Protocol Violation|0|||
162014747|NCT01177397|585108564|FG007|Overall Study|Protocol Violation|0|||
162014748|NCT01177397|585108565|FG008|Overall Study|Protocol Violation|0|||
162014749|NCT01177397|585108566|FG009|Overall Study|Protocol Violation|0|||
161812867|NCT05005442|584359766|FG002|Overall Study|Sponsor decision|10|||
161812868|NCT05005442|584359767|FG003|Overall Study|Sponsor decision|5|||
161812869|NCT05005442|584359768|FG004|Overall Study|Sponsor decision|9|||
161812870|NCT05005442|584359769|FG005|Overall Study|Sponsor decision|12|||
161812871|NCT05005442|584359764|FG000|Overall Study|Withdrawal by Subject|2|||
161812872|NCT05005442|584359765|FG001|Overall Study|Withdrawal by Subject|2|||
161812873|NCT05005442|584359766|FG002|Overall Study|Withdrawal by Subject|1|||
161812874|NCT05005442|584359767|FG003|Overall Study|Withdrawal by Subject|3|||
161812875|NCT05005442|584359768|FG004|Overall Study|Withdrawal by Subject|0|||
161812876|NCT05005442|584359769|FG005|Overall Study|Withdrawal by Subject|5|||
162158914|NCT01017146|585631218|FG000|Overall Study|Took Excluded Medication|2|||
162158915|NCT01017146|585631219|FG001|Overall Study|Took Excluded Medication|0|||
162158916|NCT01017146|585631218|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
162158917|NCT01017146|585631219|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
162158918|NCT01017146|585631218|FG000|Overall Study|Change in Work Situation|1|||
162158919|NCT01017146|585631219|FG001|Overall Study|Change in Work Situation|0|||
162158920|NCT01771731|585631220|FG000|Overall Study|Physician Decision|1|||
162158921|NCT01771731|585631221|FG001|Overall Study|Physician Decision|0|||
162158922|NCT01771731|585631220|FG000|Overall Study|Protocol Violation|0|||
162158923|NCT01771731|585631221|FG001|Overall Study|Protocol Violation|1|||
162158924|NCT01771731|585631220|FG000|Overall Study|Adverse event: Pain Crisis|1|||
162158925|NCT01771731|585631221|FG001|Overall Study|Adverse event: Pain Crisis|1|||
162158926|NCT00087139|585631225|FG000|Overall Study|Adverse Event|18|||
162158927|NCT00087139|585631226|FG001|Overall Study|Adverse Event|17|||
162158928|NCT00087139|585631227|FG002|Overall Study|Adverse Event|13|||
162158929|NCT00087139|585631225|FG000|Overall Study|Death|2|||
162158930|NCT00087139|585631226|FG001|Overall Study|Death|1|||
162158931|NCT00087139|585631227|FG002|Overall Study|Death|0|||
162158932|NCT00087139|585631225|FG000|Overall Study|Withdrawal by Subject|3|||
162158933|NCT00087139|585631226|FG001|Overall Study|Withdrawal by Subject|2|||
162158934|NCT00087139|585631227|FG002|Overall Study|Withdrawal by Subject|2|||
162158935|NCT00087139|585631225|FG000|Overall Study|Physician Decision|1|||
162158936|NCT00087139|585631226|FG001|Overall Study|Physician Decision|1|||
162158937|NCT00087139|585631227|FG002|Overall Study|Physician Decision|1|||
162158938|NCT00087139|585631225|FG000|Overall Study|Disease progression|9|||
162158939|NCT00087139|585631226|FG001|Overall Study|Disease progression|19|||
162158940|NCT00087139|585631227|FG002|Overall Study|Disease progression|12|||
162158941|NCT00087139|585631225|FG000|Overall Study|Ineligible|4|||
162158942|NCT00087139|585631226|FG001|Overall Study|Ineligible|7|||
162158943|NCT00087139|585631227|FG002|Overall Study|Ineligible|4|||
162158944|NCT00087139|585631225|FG000|Overall Study|Symptomatic deterioration|1|||
162158945|NCT00087139|585631226|FG001|Overall Study|Symptomatic deterioration|1|||
162158946|NCT00087139|585631227|FG002|Overall Study|Symptomatic deterioration|3|||
162158947|NCT00087139|585631225|FG000|Overall Study|Use of coumadin|1|||
162158948|NCT00087139|585631226|FG001|Overall Study|Use of coumadin|0|||
162158949|NCT00087139|585631227|FG002|Overall Study|Use of coumadin|0|||
162158950|NCT00087139|585631225|FG000|Overall Study|Response achieved|0|||
162158951|NCT00087139|585631226|FG001|Overall Study|Response achieved|1|||
162158952|NCT00087139|585631227|FG002|Overall Study|Response achieved|0|||
162158953|NCT00087139|585631225|FG000|Overall Study|Extradural disease|0|||
162158954|NCT00087139|585631226|FG001|Overall Study|Extradural disease|0|||
162158955|NCT00087139|585631227|FG002|Overall Study|Extradural disease|1|||
162158956|NCT00073749|585631228|FG000|Overall Study|Disease Progression|2|||
162158957|NCT00073749|585631229|FG001|Overall Study|Disease Progression|0|||
162158958|NCT00073749|585631230|FG002|Overall Study|Disease Progression|3|||
162158959|NCT00073749|585631231|FG003|Overall Study|Disease Progression|2|||
161916264|NCT01283386|584742398|FG000|Overall Study|Withdrawal by Subject|2|||
161916265|NCT01283386|584742399|FG001|Overall Study|Withdrawal by Subject|1|||
161916266|NCT01283386|584742398|FG000|Overall Study|Relapse of underlying disease|1|||
161916267|NCT01283386|584742399|FG001|Overall Study|Relapse of underlying disease|3|||
161916268|NCT01283386|584742398|FG000|Overall Study|Progression of underlying disease|2|||
161916269|NCT01283386|584742399|FG001|Overall Study|Progression of underlying disease|7|||
161916270|NCT01283386|584742398|FG000|Overall Study|Reason not specified|1|||
161916271|NCT01283386|584742399|FG001|Overall Study|Reason not specified|0|||
161916272|NCT01283386|584742398|FG000|Overall Study|Protocol Violation|0|||
161916273|NCT01283386|584742399|FG001|Overall Study|Protocol Violation|1|||
161916274|NCT02469857|584742400|FG000|Overall Study|Death|24|||
161916275|NCT02469857|584742401|FG001|Overall Study|Death|29|||
161916276|NCT02469857|584742400|FG000|Overall Study|Discontinuation|1|||
161916277|NCT02469857|584742401|FG001|Overall Study|Discontinuation|3|||
161916278|NCT00937950|584742402|FG000|Overall Study|Withdrawal by Subject|23|||
161916279|NCT00937950|584742402|FG000|Overall Study|Migrated/moved from study area|27|||
161916280|NCT00937950|584742402|FG000|Overall Study|Lost to Follow-up|144|||
161916281|NCT00937950|584742402|FG000|Overall Study|Missing confirmed|4|||
161916282|NCT00937950|584742402|FG000|Overall Study|Other|18|||
161916283|NCT01137786|584742405|FG000|Overall Study|Lost to Follow-up|0|||
161916284|NCT01137786|584742406|FG001|Overall Study|Lost to Follow-up|2|||
161916285|NCT01137786|584742405|FG000|Overall Study|Withdrawal by Subject|1|||
161916286|NCT01137786|584742406|FG001|Overall Study|Withdrawal by Subject|1|||
161916287|NCT01531153|584742409|FG000|Overall Study|Withdrawal by Subject|10|||
161916288|NCT01531153|584742410|FG001|Overall Study|Withdrawal by Subject|9|||
161916289|NCT01531153|584742411|FG002|Overall Study|Withdrawal by Subject|15|||
162158960|NCT00073749|585631232|FG004|Overall Study|Disease Progression|3|||
162158961|NCT00073749|585631233|FG005|Overall Study|Disease Progression|1|||
162158962|NCT00073749|585631234|FG006|Overall Study|Disease Progression|3|||
162158963|NCT00073749|585631228|FG000|Overall Study|Death|0|||
162158964|NCT00073749|585631229|FG001|Overall Study|Death|1|||
162158965|NCT00073749|585631230|FG002|Overall Study|Death|1|||
162158966|NCT00073749|585631231|FG003|Overall Study|Death|0|||
162158967|NCT00073749|585631232|FG004|Overall Study|Death|0|||
162158968|NCT00073749|585631233|FG005|Overall Study|Death|0|||
162158969|NCT00073749|585631234|FG006|Overall Study|Death|29|||
162158970|NCT00073749|585631228|FG000|Overall Study|Adverse Event|0|||
162158971|NCT00073749|585631229|FG001|Overall Study|Adverse Event|3|||
162158972|NCT00073749|585631230|FG002|Overall Study|Adverse Event|6|||
162158973|NCT00073749|585631231|FG003|Overall Study|Adverse Event|4|||
162158974|NCT00073749|585631232|FG004|Overall Study|Adverse Event|2|||
162158975|NCT00073749|585631233|FG005|Overall Study|Adverse Event|1|||
162158976|NCT00073749|585631234|FG006|Overall Study|Adverse Event|0|||
162158977|NCT00073749|585631228|FG000|Overall Study|Physician Decision|0|||
162158978|NCT00073749|585631229|FG001|Overall Study|Physician Decision|0|||
162158979|NCT00073749|585631230|FG002|Overall Study|Physician Decision|1|||
162158980|NCT00073749|585631231|FG003|Overall Study|Physician Decision|0|||
162158981|NCT00073749|585631232|FG004|Overall Study|Physician Decision|0|||
162158982|NCT00073749|585631233|FG005|Overall Study|Physician Decision|2|||
162158983|NCT00073749|585631234|FG006|Overall Study|Physician Decision|0|||
162158984|NCT00073749|585631228|FG000|Overall Study|Withdrawal by Subject|0|||
162158985|NCT00073749|585631229|FG001|Overall Study|Withdrawal by Subject|1|||
162158986|NCT00073749|585631230|FG002|Overall Study|Withdrawal by Subject|0|||
162158987|NCT00073749|585631231|FG003|Overall Study|Withdrawal by Subject|0|||
162158988|NCT00073749|585631232|FG004|Overall Study|Withdrawal by Subject|1|||
162158989|NCT00073749|585631233|FG005|Overall Study|Withdrawal by Subject|0|||
162158990|NCT00073749|585631234|FG006|Overall Study|Withdrawal by Subject|2|||
162158991|NCT00073749|585631228|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
162158992|NCT00073749|585631229|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
162158993|NCT00073749|585631230|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
162014750|NCT01177397|585108567|FG010|Overall Study|Protocol Violation|0|||
162014751|NCT01177397|585108568|FG011|Overall Study|Protocol Violation|0|||
162014752|NCT01177397|585108557|FG000|Overall Study|Lost to Follow-up|0|||
162014753|NCT01177397|585108558|FG001|Overall Study|Lost to Follow-up|0|||
162014754|NCT01177397|585108559|FG002|Overall Study|Lost to Follow-up|0|||
162014755|NCT01177397|585108560|FG003|Overall Study|Lost to Follow-up|0|||
162014756|NCT01177397|585108561|FG004|Overall Study|Lost to Follow-up|1|||
162014757|NCT01177397|585108562|FG005|Overall Study|Lost to Follow-up|0|||
162014758|NCT01177397|585108563|FG006|Overall Study|Lost to Follow-up|0|||
162014759|NCT01177397|585108564|FG007|Overall Study|Lost to Follow-up|2|||
162014760|NCT01177397|585108565|FG008|Overall Study|Lost to Follow-up|0|||
162014761|NCT01177397|585108566|FG009|Overall Study|Lost to Follow-up|0|||
162014762|NCT01177397|585108567|FG010|Overall Study|Lost to Follow-up|0|||
162014763|NCT01177397|585108568|FG011|Overall Study|Lost to Follow-up|0|||
162014764|NCT01177397|585108557|FG000|Overall Study|Death|0|||
162014765|NCT01177397|585108558|FG001|Overall Study|Death|0|||
162014766|NCT01177397|585108559|FG002|Overall Study|Death|1|||
162014767|NCT01177397|585108560|FG003|Overall Study|Death|1|||
162014768|NCT01177397|585108561|FG004|Overall Study|Death|0|||
162014769|NCT01177397|585108562|FG005|Overall Study|Death|0|||
162014770|NCT01177397|585108563|FG006|Overall Study|Death|0|||
162014771|NCT01177397|585108564|FG007|Overall Study|Death|5|||
162014772|NCT01177397|585108565|FG008|Overall Study|Death|2|||
162014773|NCT01177397|585108566|FG009|Overall Study|Death|1|||
162014774|NCT01177397|585108567|FG010|Overall Study|Death|0|||
162014775|NCT01177397|585108568|FG011|Overall Study|Death|0|||
162014776|NCT01177397|585108557|FG000|Overall Study|Withdrawal by Subject|0|||
162014777|NCT01177397|585108558|FG001|Overall Study|Withdrawal by Subject|0|||
162014778|NCT01177397|585108559|FG002|Overall Study|Withdrawal by Subject|1|||
162014779|NCT01177397|585108560|FG003|Overall Study|Withdrawal by Subject|1|||
162014780|NCT01177397|585108561|FG004|Overall Study|Withdrawal by Subject|1|||
162014781|NCT01177397|585108562|FG005|Overall Study|Withdrawal by Subject|2|||
162014782|NCT01177397|585108563|FG006|Overall Study|Withdrawal by Subject|0|||
162014783|NCT01177397|585108564|FG007|Overall Study|Withdrawal by Subject|5|||
162014784|NCT01177397|585108565|FG008|Overall Study|Withdrawal by Subject|9|||
162158994|NCT00073749|585631231|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
162158995|NCT00073749|585631232|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
162158996|NCT00073749|585631233|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
162158997|NCT00073749|585631234|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
162158998|NCT00073749|585631228|FG000|Overall Study|Lost to Follow-up|0|||
162158999|NCT00073749|585631229|FG001|Overall Study|Lost to Follow-up|0|||
162159000|NCT00073749|585631230|FG002|Overall Study|Lost to Follow-up|0|||
162159001|NCT00073749|585631231|FG003|Overall Study|Lost to Follow-up|0|||
162014785|NCT01177397|585108566|FG009|Overall Study|Withdrawal by Subject|1|||
162014786|NCT01177397|585108567|FG010|Overall Study|Withdrawal by Subject|1|||
162014787|NCT01177397|585108568|FG011|Overall Study|Withdrawal by Subject|0|||
162014788|NCT01177397|585108557|FG000|Overall Study|Adverse Event|0|||
162159002|NCT00073749|585631232|FG004|Overall Study|Lost to Follow-up|0|||
162159003|NCT00073749|585631233|FG005|Overall Study|Lost to Follow-up|0|||
162014789|NCT01177397|585108558|FG001|Overall Study|Adverse Event|0|||
162014790|NCT01177397|585108559|FG002|Overall Study|Adverse Event|1|||
162014791|NCT01177397|585108560|FG003|Overall Study|Adverse Event|2|||
162014792|NCT01177397|585108561|FG004|Overall Study|Adverse Event|0|||
162159004|NCT00073749|585631234|FG006|Overall Study|Lost to Follow-up|2|||
162159005|NCT00073749|585631228|FG000|Overall Study|Other|0|||
162159006|NCT00073749|585631229|FG001|Overall Study|Other|0|||
162159007|NCT00073749|585631230|FG002|Overall Study|Other|0|||
162159008|NCT00073749|585631231|FG003|Overall Study|Other|0|||
162159009|NCT00073749|585631232|FG004|Overall Study|Other|0|||
162159010|NCT00073749|585631233|FG005|Overall Study|Other|2|||
162159011|NCT00073749|585631234|FG006|Overall Study|Other|0|||
162159012|NCT02272816|585631235|FG000|Overall Study|Adverse Event|1|||
162159013|NCT04095104|585631244|FG000|Overall Study|Withdrawal by Subject|0|||
162159014|NCT04095104|585631245|FG001|Overall Study|Withdrawal by Subject|1|||
162159015|NCT01136876|585631246|FG000|Overall Study|Lost to Follow-up|0|||
162159016|NCT01136876|585631247|FG001|Overall Study|Lost to Follow-up|1|||
162159017|NCT01136876|585631246|FG000|Overall Study|Physician Decision|3|||
162159018|NCT01136876|585631247|FG001|Overall Study|Physician Decision|5|||
162159019|NCT01136876|585631246|FG000|Overall Study|Missing NGAL measurement|2|||
162159020|NCT01136876|585631247|FG001|Overall Study|Missing NGAL measurement|5|||
162159021|NCT05321069|585631248|FG000|Overall Study|Adverse Event|52|||
162159022|NCT05321069|585631249|FG001|Overall Study|Adverse Event|52|||
162159023|NCT05321069|585631250|FG002|Overall Study|Adverse Event|64|||
162159024|NCT05321069|585631248|FG000|Overall Study|Protocol Violation|1|||
162159025|NCT05321069|585631249|FG001|Overall Study|Protocol Violation|1|||
162159026|NCT05321069|585631250|FG002|Overall Study|Protocol Violation|0|||
162159027|NCT05321069|585631248|FG000|Overall Study|Withdrawal by Subject|23|||
162159028|NCT05321069|585631249|FG001|Overall Study|Withdrawal by Subject|18|||
161812877|NCT05005442|584359764|FG000|Overall Study|Site terminated by sponsor|0|||
161812878|NCT05005442|584359765|FG001|Overall Study|Site terminated by sponsor|2|||
161812879|NCT05005442|584359766|FG002|Overall Study|Site terminated by sponsor|0|||
162159029|NCT05321069|585631250|FG002|Overall Study|Withdrawal by Subject|12|||
162159030|NCT05321069|585631248|FG000|Overall Study|Lost to Follow-up|1|||
162159031|NCT05321069|585631249|FG001|Overall Study|Lost to Follow-up|0|||
162159032|NCT05321069|585631250|FG002|Overall Study|Lost to Follow-up|1|||
162159033|NCT05321069|585631248|FG000|Overall Study|No reason stated by the participants|23|||
162159034|NCT05321069|585631249|FG001|Overall Study|No reason stated by the participants|22|||
162159035|NCT05321069|585631250|FG002|Overall Study|No reason stated by the participants|16|||
162159036|NCT05321069|585631248|FG000|Overall Study|Lack of Efficacy|1|||
162159037|NCT05321069|585631249|FG001|Overall Study|Lack of Efficacy|1|||
162159038|NCT05321069|585631250|FG002|Overall Study|Lack of Efficacy|0|||
162159039|NCT05048186|585631253|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
162159040|NCT05048186|585631254|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
162159041|NCT05048186|585631253|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
162159042|NCT05048186|585631254|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
162159043|NCT02412748|585631255|FG000|Overall Study|Lost to Follow-up|38|||
162159044|NCT02412748|585631256|FG001|Overall Study|Lost to Follow-up|39|||
162159045|NCT04218266|585631259|FG000|Overall Study|Death|1|||
162159046|NCT04218266|585631260|FG001|Overall Study|Death|2|||
162159047|NCT04218266|585631261|FG002|Overall Study|Death|3|||
162159048|NCT04218266|585631259|FG000|Overall Study|Adverse Event|13|||
162159049|NCT04218266|585631260|FG001|Overall Study|Adverse Event|14|||
162159050|NCT04218266|585631261|FG002|Overall Study|Adverse Event|11|||
162159051|NCT04218266|585631259|FG000|Overall Study|Other|7|||
162159052|NCT04218266|585631260|FG001|Overall Study|Other|5|||
162159053|NCT04218266|585631261|FG002|Overall Study|Other|14|||
162159054|NCT04218266|585631259|FG000|Overall Study|Physician Decision|1|||
162159055|NCT04218266|585631260|FG001|Overall Study|Physician Decision|3|||
162159056|NCT04218266|585631261|FG002|Overall Study|Physician Decision|2|||
162159057|NCT04218266|585631259|FG000|Overall Study|Non-compliance with study drug|0|||
162159058|NCT04218266|585631260|FG001|Overall Study|Non-compliance with study drug|0|||
162159059|NCT04218266|585631261|FG002|Overall Study|Non-compliance with study drug|1|||
162159060|NCT04218266|585631259|FG000|Overall Study|Withdrawal by Subject|1|||
162159061|NCT04218266|585631260|FG001|Overall Study|Withdrawal by Subject|3|||
162159062|NCT04218266|585631261|FG002|Overall Study|Withdrawal by Subject|1|||
162159063|NCT04218266|585631259|FG000|Overall Study|Study drug never administered|2|||
162159064|NCT04218266|585631260|FG001|Overall Study|Study drug never administered|0|||
162159065|NCT04218266|585631261|FG002|Overall Study|Study drug never administered|0|||
162159066|NCT00001277|585631262|FG000|Overall Study|Adverse Event|0|||
162159067|NCT00001277|585631263|FG001|Overall Study|Adverse Event|0|||
162159068|NCT00001277|585631264|FG002|Overall Study|Adverse Event|1|||
162159069|NCT00001277|585631262|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
162159070|NCT00001277|585631263|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
162159071|NCT00001277|585631264|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
162159072|NCT00065260|585631265|FG000|Overall Study|Death|0|||
161812880|NCT05005442|584359767|FG003|Overall Study|Site terminated by sponsor|0|||
162159073|NCT00065260|585631266|FG001|Overall Study|Death|1|||
162159074|NCT00088413|585631270|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
162159075|NCT00088413|585631271|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
162159076|NCT00088413|585631272|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
162159077|NCT00088413|585631273|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
162159078|NCT00088413|585631270|FG000|Overall Study|Adverse Events/Side Effects|0|||
162159079|NCT00088413|585631271|FG001|Overall Study|Adverse Events/Side Effects|1|||
162159080|NCT00088413|585631272|FG002|Overall Study|Adverse Events/Side Effects|1|||
162159081|NCT00088413|585631273|FG003|Overall Study|Adverse Events/Side Effects|0|||
162159082|NCT00088413|585631270|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
162159083|NCT00088413|585631271|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
162159084|NCT00088413|585631272|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
162159085|NCT00088413|585631273|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
162159086|NCT00088413|585631270|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
162159087|NCT00088413|585631271|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
162159088|NCT00088413|585631272|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
162159089|NCT00088413|585631273|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
162159090|NCT00088413|585631270|FG000|Overall Study|Death|0|||
162159091|NCT00088413|585631271|FG001|Overall Study|Death|1|||
162159092|NCT00088413|585631272|FG002|Overall Study|Death|0|||
162159093|NCT00088413|585631273|FG003|Overall Study|Death|0|||
162159094|NCT00088413|585631270|FG000|Overall Study|Progressive disease|9|||
162159095|NCT00088413|585631271|FG001|Overall Study|Progressive disease|11|||
162159096|NCT00088413|585631272|FG002|Overall Study|Progressive disease|8|||
162159097|NCT00088413|585631273|FG003|Overall Study|Progressive disease|14|||
162159098|NCT00088413|585631270|FG000|Overall Study|Other|0|||
162159099|NCT00088413|585631271|FG001|Overall Study|Other|1|||
162159100|NCT00088413|585631272|FG002|Overall Study|Other|0|||
162159101|NCT00088413|585631273|FG003|Overall Study|Other|0|||
162159102|NCT00088413|585631270|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
162159103|NCT00088413|585631271|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
162159104|NCT00088413|585631272|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
162159105|NCT00088413|585631273|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
162159106|NCT04820686|585631274|FG000|Overall Study|Withdrawal by Subject|5|||
162159107|NCT04820686|585631275|FG001|Overall Study|Withdrawal by Subject|2|||
162159108|NCT04820686|585631276|FG002|Overall Study|Withdrawal by Subject|3|||
162159109|NCT04820686|585631274|FG000|Overall Study|Study Termination|25|||
162159110|NCT04820686|585631275|FG001|Overall Study|Study Termination|13|||
162159111|NCT04820686|585631276|FG002|Overall Study|Study Termination|14|||
162159112|NCT04820686|585631274|FG000|Overall Study|Adverse Event|0|||
162159113|NCT04820686|585631275|FG001|Overall Study|Adverse Event|1|||
162159114|NCT04820686|585631276|FG002|Overall Study|Adverse Event|0|||
162159115|NCT01424670|585631277|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
162159116|NCT01424670|585631278|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
162159117|NCT01424670|585631277|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
162159118|NCT01424670|585631278|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
162159119|NCT01424670|585631277|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
162159120|NCT01424670|585631278|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
162159121|NCT01424670|585631277|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
162159122|NCT01424670|585631278|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
162159123|NCT01424670|585631277|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
162159124|NCT01424670|585631278|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
162159125|NCT01424670|585631277|FG000|Continuation Period|Adverse Event|13|||
162159126|NCT01424670|585631278|FG001|Continuation Period|Adverse Event|5|||
162159127|NCT01424670|585631277|FG000|Continuation Period|Lost to Follow-up|2|||
162159128|NCT01424670|585631278|FG001|Continuation Period|Lost to Follow-up|0|||
162159129|NCT01424670|585631277|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
162159130|NCT01424670|585631278|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
162159131|NCT01424670|585631277|FG000|Continuation Period|Physician Decision|5|||
162159132|NCT01424670|585631278|FG001|Continuation Period|Physician Decision|4|||
162159133|NCT01424670|585631277|FG000|Continuation Period|Withdrawal by Subject|13|||
162159134|NCT01424670|585631278|FG001|Continuation Period|Withdrawal by Subject|4|||
162159135|NCT00761189|585631279|FG000|Overall Study|Adverse Event|42|||
162159136|NCT00761189|585631279|FG000|Overall Study|Lack of Efficacy|45|||
162159137|NCT00761189|585631279|FG000|Overall Study|Lost to Follow-up|36|||
162159138|NCT00761189|585631279|FG000|Overall Study|Withdrawal by Subject|49|||
162159139|NCT00761189|585631279|FG000|Overall Study|Other|13|||
162159140|NCT01494922|585631280|FG000|Overall Study|Adverse Event|1|||
162159141|NCT04048382|585631285|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
162159142|NCT04048382|585631286|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
162159143|NCT04048382|585631285|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
162159144|NCT04048382|585631286|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
162159145|NCT04048382|585631285|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
162159146|NCT04048382|585631286|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
162159147|NCT02119650|585631290|FG000|Overall Study|Adverse Event|3|||
162159148|NCT02119650|585631291|FG001|Overall Study|Adverse Event|4|||
162159149|NCT02119650|585631290|FG000|Overall Study|Subject decision|2|||
162159150|NCT02119650|585631291|FG001|Overall Study|Subject decision|3|||
162159151|NCT02119650|585631290|FG000|Overall Study|Disease progression|11|||
162159152|NCT02119650|585631291|FG001|Overall Study|Disease progression|14|||
162159153|NCT02119650|585631290|FG000|Overall Study|Death|5|||
162159154|NCT02119650|585631291|FG001|Overall Study|Death|1|||
162159155|NCT02119650|585631290|FG000|Overall Study|Noncompliance with study treatment|1|||
162159156|NCT02119650|585631291|FG001|Overall Study|Noncompliance with study treatment|1|||
162159157|NCT02119650|585631290|FG000|Overall Study|Study terminated by the sponsor|1|||
162159158|NCT02119650|585631291|FG001|Overall Study|Study terminated by the sponsor|0|||
162159159|NCT02119650|585631290|FG000|Overall Study|Physician Decision|0|||
162159160|NCT02119650|585631291|FG001|Overall Study|Physician Decision|2|||
162159161|NCT02119650|585631290|FG000|Overall Study|Multiple reasons for termination|2|||
162159162|NCT02119650|585631291|FG001|Overall Study|Multiple reasons for termination|1|||
162159163|NCT01037985|585631293|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
162159164|NCT01037985|585631294|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
162159165|NCT01037985|585631293|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
162159166|NCT01037985|585631294|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
162159167|NCT01037985|585631293|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
162159168|NCT01037985|585631294|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
162159169|NCT01037985|585631293|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
162159170|NCT01037985|585631294|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
162159171|NCT02269475|585631295|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
162159172|NCT02269475|585631296|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
162159173|NCT02269475|585631295|FG000|Overall Study|Withdrawal by Subject|0|||
162159174|NCT02269475|585631296|FG001|Overall Study|Withdrawal by Subject|1|||
162159175|NCT03481816|585631297|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
162159176|NCT03481816|585631298|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
162159177|NCT03481816|585631297|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
162159178|NCT03481816|585631298|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
162159179|NCT03481816|585631297|FG000|Dose Expansion|Withdrawal by Subject|0|||
162159180|NCT03481816|585631298|FG001|Dose Expansion|Withdrawal by Subject|2|||
162159181|NCT03481816|585631297|FG000|Dose Expansion|Physician Decision|0|||
162159182|NCT03481816|585631298|FG001|Dose Expansion|Physician Decision|5|||
162159183|NCT02730871|585631301|FG000|Overall Study|Adverse Event|6|||
162159184|NCT02730871|585631302|FG001|Overall Study|Adverse Event|0|||
162159185|NCT05368558|585631304|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
162159186|NCT05368558|585631305|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
162159187|NCT05368558|585631306|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
162159188|NCT05368558|585631307|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162159189|NCT05368558|585631308|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162159190|NCT05368558|585631309|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162159191|NCT05368558|585631310|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162159192|NCT05368558|585631311|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162159193|NCT05368558|585631312|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162159194|NCT05368558|585631313|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162159195|NCT05368558|585631314|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162159196|NCT05368558|585631315|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
162159197|NCT05368558|585631304|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162159198|NCT05368558|585631305|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162159199|NCT05368558|585631306|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162159200|NCT05368558|585631307|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
162159201|NCT05368558|585631308|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162159202|NCT05368558|585631309|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
162159203|NCT05368558|585631310|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162159204|NCT05368558|585631311|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162159205|NCT05368558|585631312|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162159206|NCT05368558|585631313|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161916290|NCT03483103|584742412|FG000|Pre-Treatment Phase|Other reasons|1|||
161916291|NCT03483103|584742412|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
161916292|NCT03483103|584742412|FG000|Pre-Treatment Phase|Disease-related complications|1|||
161916293|NCT03483103|584742412|FG000|Pre-Treatment Phase|Death|5|||
161916294|NCT03483103|584742412|FG000|Treatment Phase|Withdrawal by Subject|7|||
161916295|NCT03483103|584742412|FG000|Treatment Phase|Other reasons|1|||
161916296|NCT03483103|584742412|FG000|Treatment Phase|Death|23|||
161916297|NCT03483103|584742412|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
161916298|NCT03483103|584742412|FG000|Treatment Phase|Received nonconforming product|1|||
161916299|NCT02475213|584742413|FG000|Overall Study|Adverse Event|2|||
161916300|NCT02475213|584742414|FG001|Overall Study|Adverse Event|0|||
161916301|NCT02475213|584742415|FG002|Overall Study|Adverse Event|0|||
161916302|NCT02475213|584742416|FG003|Overall Study|Adverse Event|1|||
162159207|NCT05368558|585631314|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162159208|NCT05368558|585631315|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
162159209|NCT05368558|585631304|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162159210|NCT05368558|585631305|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162159211|NCT05368558|585631306|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162159212|NCT05368558|585631307|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
162159213|NCT05368558|585631308|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162159214|NCT05368558|585631309|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162159215|NCT05368558|585631310|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162159216|NCT05368558|585631311|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162159217|NCT05368558|585631312|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162159218|NCT05368558|585631313|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162159219|NCT05368558|585631314|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162159220|NCT05368558|585631315|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
162159221|NCT05368558|585631304|FG000|Blinded Extension Period (BEP)|other|0|||
162159222|NCT05368558|585631305|FG001|Blinded Extension Period (BEP)|other|0|||
162159223|NCT05368558|585631306|FG002|Blinded Extension Period (BEP)|other|0|||
162159224|NCT05368558|585631307|FG003|Blinded Extension Period (BEP)|other|0|||
162159225|NCT05368558|585631308|FG004|Blinded Extension Period (BEP)|other|0|||
162159226|NCT05368558|585631309|FG005|Blinded Extension Period (BEP)|other|1|||
162159227|NCT05368558|585631310|FG006|Blinded Extension Period (BEP)|other|0|||
162159228|NCT05368558|585631311|FG007|Blinded Extension Period (BEP)|other|0|||
162159229|NCT05368558|585631312|FG008|Blinded Extension Period (BEP)|other|0|||
162159230|NCT05368558|585631313|FG009|Blinded Extension Period (BEP)|other|0|||
162159231|NCT05368558|585631314|FG010|Blinded Extension Period (BEP)|other|0|||
162159232|NCT05368558|585631315|FG011|Blinded Extension Period (BEP)|other|0|||
162159233|NCT04428112|585631316|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
162159234|NCT04428112|585631317|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
162159235|NCT04428112|585631316|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
162159236|NCT04428112|585631317|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
162159237|NCT04428112|585631316|FG000|Overall Study|Withdrawal by Subject|9|||
162159238|NCT04428112|585631317|FG001|Overall Study|Withdrawal by Subject|4|||
162159239|NCT04428112|585631316|FG000|Overall Study|Lost to Follow-up|27|||
162159240|NCT04428112|585631317|FG001|Overall Study|Lost to Follow-up|7|||
162159241|NCT01303445|585631320|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
162159242|NCT01303445|585631321|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
162159243|NCT01303445|585631320|FG000|Second Intervention (7 Days)|Adverse Event|0|||
162159244|NCT01303445|585631321|FG001|Second Intervention (7 Days)|Adverse Event|2|||
162159245|NCT01303445|585631320|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
162159246|NCT01303445|585631321|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
162159247|NCT01303445|585631320|FG000|Washout (14 Days)|Protocol Violation|1|||
162159248|NCT01303445|585631321|FG001|Washout (14 Days)|Protocol Violation|0|||
162159249|NCT01303445|585631320|FG000|Washout (14 Days)|Lost to Follow-up|0|||
162159250|NCT01303445|585631321|FG001|Washout (14 Days)|Lost to Follow-up|2|||
162159251|NCT01303445|585631320|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
162159252|NCT01303445|585631321|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
162159253|NCT01303445|585631320|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
162159254|NCT01303445|585631321|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
162159255|NCT04459416|585633001|FG000|Overall Study|Lost to Follow-up|2|||
162159256|NCT04459416|585633002|FG001|Overall Study|Lost to Follow-up|0|||
162159257|NCT04459416|585633001|FG000|Overall Study|Withdrawal by Subject|8|||
162159258|NCT04459416|585633002|FG001|Overall Study|Withdrawal by Subject|10|||
162159259|NCT04459416|585633001|FG000|Overall Study|Disease progression|0|||
162159260|NCT04459416|585633002|FG001|Overall Study|Disease progression|3|||
162159261|NCT03744312|585633003|FG000|Overall Study|Withdrawal by Subject|0|||
162159262|NCT03744312|585633004|FG001|Overall Study|Withdrawal by Subject|1|||
162159263|NCT03744312|585633003|FG000|Overall Study|Screen fail|0|||
162159264|NCT03744312|585633004|FG001|Overall Study|Screen fail|1|||
162159265|NCT05134337|585633005|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
162159266|NCT05134337|585633006|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
162159267|NCT04923347|585633007|FG000|Overall Study|Withdrawal by Subject|14|||
162159268|NCT01259401|585633008|FG000|4-month Follow-up|Death|0|||
162159269|NCT01259401|585633009|FG001|4-month Follow-up|Death|1|||
162159270|NCT01259401|585633008|FG000|4-month Follow-up|Lost to Follow-up|0|||
162159271|NCT01259401|585633009|FG001|4-month Follow-up|Lost to Follow-up|1|||
162159272|NCT04924062|585633010|FG000|Overall Study|Death|49|||
162159273|NCT04924062|585633011|FG001|Overall Study|Death|63|||
162159274|NCT04924062|585633010|FG000|Overall Study|Participant On-going|26|||
162159275|NCT04924062|585633011|FG001|Overall Study|Participant On-going|20|||
162159276|NCT05478525|585633014|FG000|Overall Study|Withdrawal by Subject|0|||
162159277|NCT05478525|585633015|FG001|Overall Study|Withdrawal by Subject|1|||
162159278|NCT05478525|585633016|FG002|Overall Study|Withdrawal by Subject|2|||
162159279|NCT05478525|585633017|FG003|Overall Study|Withdrawal by Subject|0|||
162159280|NCT05478525|585633014|FG000|Overall Study|COVID-19 Infection|2|||
162159281|NCT05478525|585633015|FG001|Overall Study|COVID-19 Infection|0|||
162159282|NCT05478525|585633016|FG002|Overall Study|COVID-19 Infection|1|||
162159283|NCT05478525|585633017|FG003|Overall Study|COVID-19 Infection|1|||
162159284|NCT01649271|585633018|FG000|Overall Study|Progressive disease|4|||
162159285|NCT01649271|585633019|FG001|Overall Study|Progressive disease|5|||
162159286|NCT01649271|585633018|FG000|Overall Study|Other Adverse Event|0|||
162159287|NCT01649271|585633019|FG001|Overall Study|Other Adverse Event|2|||
162159288|NCT01649271|585633018|FG000|Overall Study|Withdrawal by Subject|1|||
162159289|NCT01649271|585633019|FG001|Overall Study|Withdrawal by Subject|0|||
162159290|NCT01649271|585633018|FG000|Overall Study|Other than stated above|1|||
162159291|NCT01649271|585633019|FG001|Overall Study|Other than stated above|0|||
162159292|NCT05644002|585633022|FG000|Overall Study|Lost to Follow-up|1|||
162159293|NCT05644002|585633023|FG001|Overall Study|Lost to Follow-up|2|||
162159294|NCT05644002|585633022|FG000|Overall Study|Withdrawal by Subject|0|||
162159295|NCT05644002|585633023|FG001|Overall Study|Withdrawal by Subject|1|||
162159296|NCT05756075|585633028|FG000|Overall Study|Withdrawal by Subject|16|||
162159297|NCT05756075|585633029|FG001|Overall Study|Withdrawal by Subject|9|||
162159298|NCT01991977|585633030|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
162159299|NCT01991977|585633030|FG000|Overall Study|Withdrew after start of treatment|5|||
162159300|NCT04038957|585633032|FG000|Overall Study|Withdrawal by Subject|1|||
162159301|NCT04038957|585633032|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
162159302|NCT02605837|585633034|FG000|Overall Study|Adverse Event|3|||
162159303|NCT02605837|585633035|FG001|Overall Study|Adverse Event|1|||
162159304|NCT02605837|585633034|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162159305|NCT02605837|585633035|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162159306|NCT02605837|585633034|FG000|Overall Study|Withdrawal by Subject|8|||
162159307|NCT02605837|585633035|FG001|Overall Study|Withdrawal by Subject|8|||
162159308|NCT02605837|585633034|FG000|Overall Study|Physician Decision|0|||
162159309|NCT02605837|585633035|FG001|Overall Study|Physician Decision|1|||
162159310|NCT03845465|585633036|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
162159311|NCT03845465|585633037|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
162159312|NCT03845465|585633036|FG000|6-month Data Collection|Withdrawal by Subject|0|||
162159313|NCT03845465|585633037|FG001|6-month Data Collection|Withdrawal by Subject|2|||
162159314|NCT03845465|585633036|FG000|12-month Data Collection|Withdrawal by Subject|0|||
162159315|NCT03845465|585633037|FG001|12-month Data Collection|Withdrawal by Subject|2|||
162159316|NCT05656911|585633042|FG000|Treatment Phase|Physician Decision|2|||
162159317|NCT05656911|585633043|FG001|Treatment Phase|Physician Decision|0|||
162159318|NCT05656911|585633042|FG000|Treatment Phase|Lack of Efficacy|6|||
162159319|NCT05656911|585633043|FG001|Treatment Phase|Lack of Efficacy|3|||
162159320|NCT05656911|585633042|FG000|Treatment Phase|Subject Decision|4|||
162159321|NCT05656911|585633043|FG001|Treatment Phase|Subject Decision|2|||
162159322|NCT05656911|585633042|FG000|Treatment Phase|Other Reasons|1|||
162159323|NCT05656911|585633043|FG001|Treatment Phase|Other Reasons|0|||
162159324|NCT05656911|585633042|FG000|Treatment Phase|Adverse Event|3|||
162159325|NCT05656911|585633043|FG001|Treatment Phase|Adverse Event|1|||
162159326|NCT05656911|585633042|FG000|Follow-up Phase|Subject Decision|0|||
162159327|NCT05656911|585633043|FG001|Follow-up Phase|Subject Decision|1|||
162159328|NCT05656911|585633042|FG000|Follow-up Phase|Missing|1|||
162159329|NCT05656911|585633043|FG001|Follow-up Phase|Missing|0|||
162159330|NCT03547908|585633044|FG000|Blinded Phase|Lost to Follow-up|3|||
162159331|NCT03547908|585633045|FG001|Blinded Phase|Lost to Follow-up|3|||
162159332|NCT03547908|585633046|FG002|Blinded Phase|Lost to Follow-up|0|||
162159333|NCT03547908|585633047|FG003|Blinded Phase|Lost to Follow-up|0|||
162159334|NCT03547908|585633044|FG000|Blinded Phase|Withdrew Consent|2|||
162159335|NCT03547908|585633045|FG001|Blinded Phase|Withdrew Consent|3|||
162159336|NCT03547908|585633046|FG002|Blinded Phase|Withdrew Consent|0|||
162159337|NCT03547908|585633047|FG003|Blinded Phase|Withdrew Consent|0|||
162159338|NCT03547908|585633044|FG000|Blinded Phase|Investigator's Discretion|2|||
162159339|NCT03547908|585633045|FG001|Blinded Phase|Investigator's Discretion|1|||
162159340|NCT03547908|585633046|FG002|Blinded Phase|Investigator's Discretion|0|||
162159341|NCT03547908|585633047|FG003|Blinded Phase|Investigator's Discretion|0|||
162159342|NCT03547908|585633044|FG000|Blinded Phase|Death|2|||
162159343|NCT03547908|585633045|FG001|Blinded Phase|Death|0|||
162159344|NCT03547908|585633046|FG002|Blinded Phase|Death|0|||
162159345|NCT03547908|585633047|FG003|Blinded Phase|Death|0|||
162159346|NCT03547908|585633044|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
162159347|NCT03547908|585633045|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
162159348|NCT03547908|585633046|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
162159349|NCT03547908|585633047|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
162159350|NCT03547908|585633044|FG000|Blinded Phase|Adverse Event|1|||
162159351|NCT03547908|585633045|FG001|Blinded Phase|Adverse Event|0|||
162159352|NCT03547908|585633046|FG002|Blinded Phase|Adverse Event|0|||
162159353|NCT03547908|585633047|FG003|Blinded Phase|Adverse Event|0|||
162159354|NCT03547908|585633044|FG000|Blinded Phase|Randomized But Never Treated|1|||
162159355|NCT03547908|585633045|FG001|Blinded Phase|Randomized But Never Treated|0|||
162159356|NCT03547908|585633046|FG002|Blinded Phase|Randomized But Never Treated|0|||
162159357|NCT03547908|585633047|FG003|Blinded Phase|Randomized But Never Treated|0|||
162159358|NCT03547908|585633044|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
162159359|NCT03547908|585633045|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
162159360|NCT03547908|585633046|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
162159361|NCT03547908|585633047|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
162159362|NCT03547908|585633044|FG000|Open-label Extension Phase|Death|0|||
162159363|NCT03547908|585633045|FG001|Open-label Extension Phase|Death|0|||
162159364|NCT03547908|585633046|FG002|Open-label Extension Phase|Death|1|||
162159365|NCT03547908|585633047|FG003|Open-label Extension Phase|Death|0|||
162159366|NCT04059354|585633056|FG000|Overall Study|COVID-19 pandemic|3|||
162159367|NCT02349412|585633058|FG000|Overall Study|Withdrawal by Subject|7|||
162159368|NCT02349412|585633059|FG001|Overall Study|Withdrawal by Subject|7|||
162159369|NCT05338086|585633062|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
162159370|NCT05338086|585633063|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
162159371|NCT05338086|585633064|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
162159372|NCT05338086|585633065|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
162159373|NCT05338086|585633066|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
162159374|NCT05338086|585633062|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
162159375|NCT05338086|585633063|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
162159376|NCT05338086|585633064|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
162159377|NCT05338086|585633065|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
162159378|NCT05338086|585633066|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
162159379|NCT05338086|585633062|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
162159380|NCT05338086|585633063|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
162159381|NCT05338086|585633064|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
162159382|NCT05338086|585633065|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
162159383|NCT05338086|585633066|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
162159384|NCT05338086|585633062|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
162159385|NCT05338086|585633063|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
162159386|NCT05338086|585633064|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
162159387|NCT05338086|585633065|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
162159388|NCT05338086|585633066|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
162159389|NCT05338086|585633062|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
162159390|NCT05338086|585633063|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
162159391|NCT05338086|585633064|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
162159392|NCT05338086|585633065|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
162159393|NCT05338086|585633066|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
162159394|NCT05338086|585633062|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
162159395|NCT05338086|585633063|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
162159396|NCT05338086|585633064|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
162159397|NCT05338086|585633065|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
162159398|NCT05338086|585633066|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
162159399|NCT05338086|585633062|FG000|Transition Period (M12 to M18)|Death|0|||
162159400|NCT05338086|585633063|FG001|Transition Period (M12 to M18)|Death|0|||
162159401|NCT05338086|585633064|FG002|Transition Period (M12 to M18)|Death|1|||
162159402|NCT05338086|585633065|FG003|Transition Period (M12 to M18)|Death|0|||
162159403|NCT05338086|585633066|FG004|Transition Period (M12 to M18)|Death|0|||
162159404|NCT05338086|585633062|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
162159405|NCT05338086|585633063|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
162159406|NCT05338086|585633064|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
161812881|NCT05005442|584359768|FG004|Overall Study|Site terminated by sponsor|0|||
161812882|NCT05005442|584359769|FG005|Overall Study|Site terminated by sponsor|1|||
161812883|NCT03696160|584359772|FG000|Overall Study|Withdrew before IMP dosing|2|||
161812884|NCT03696160|584359773|FG001|Overall Study|Withdrew before IMP dosing|3|||
162159407|NCT05338086|585633065|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
161812885|NCT00334815|584359774|FG000|Overall Study|Adverse Event|3|||
161812886|NCT00334815|584359775|FG001|Overall Study|Adverse Event|2|||
161812887|NCT00334815|584359774|FG000|Overall Study|Death|0|||
161812888|NCT00334815|584359775|FG001|Overall Study|Death|2|||
161812889|NCT00334815|584359774|FG000|Overall Study|Progression|1|||
162159408|NCT05338086|585633066|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
162159409|NCT05338086|585633062|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
162159410|NCT05338086|585633063|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
162159411|NCT05338086|585633064|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
162159412|NCT05338086|585633065|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
162159413|NCT05338086|585633066|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
162159414|NCT05338086|585633062|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
162159415|NCT05338086|585633063|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
162159416|NCT05338086|585633064|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
162159417|NCT05338086|585633065|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
162159418|NCT05338086|585633066|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
162159419|NCT03424811|585633067|FG000|Overall Study|Lost to Follow-up|9|||
162159420|NCT03424811|585633068|FG001|Overall Study|Lost to Follow-up|0|||
162159421|NCT00567398|585633074|FG000|Overall Study|Adverse Event|6|||
162159422|NCT00567398|585633075|FG001|Overall Study|Adverse Event|14|||
162159423|NCT00567398|585633074|FG000|Overall Study|Physician Decision|0|||
162159424|NCT00567398|585633075|FG001|Overall Study|Physician Decision|4|||
162159425|NCT00567398|585633074|FG000|Overall Study|Withdrawal by Subject|0|||
162159426|NCT00567398|585633075|FG001|Overall Study|Withdrawal by Subject|2|||
162159427|NCT00567398|585633074|FG000|Overall Study|Renal Transplantation|0|||
162159428|NCT00567398|585633075|FG001|Overall Study|Renal Transplantation|3|||
162159429|NCT00567398|585633074|FG000|Overall Study|Other|1|||
162159430|NCT00567398|585633075|FG001|Overall Study|Other|0|||
162159431|NCT03517553|585633076|FG000|Overall Study|Withdrawal by Subject|2|||
162159432|NCT03271151|585633077|FG000|Overall Study|Lost to Follow-up|1|||
162159433|NCT03271151|585633078|FG001|Overall Study|Lost to Follow-up|3|||
162159434|NCT03271151|585633077|FG000|Overall Study|Withdrawal by Subject|1|||
162159435|NCT03271151|585633078|FG001|Overall Study|Withdrawal by Subject|0|||
162159436|NCT04093362|585633081|FG000|Overall Study|Study Termination|1|||
162159437|NCT04093362|585633082|FG001|Overall Study|Study Termination|1|||
162159438|NCT04093362|585633081|FG000|Overall Study|Withdrawal of Consent|1|||
162159439|NCT04093362|585633082|FG001|Overall Study|Withdrawal of Consent|0|||
162159440|NCT04093362|585633081|FG000|Overall Study|Death|1|||
162159441|NCT04093362|585633082|FG001|Overall Study|Death|3|||
162159442|NCT04093362|585633081|FG000|Overall Study|Reason not Specified|1|||
162159443|NCT04093362|585633082|FG001|Overall Study|Reason not Specified|2|||
162159444|NCT02201108|585633085|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
162159445|NCT02201108|585633086|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
162159446|NCT02201108|585633087|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
162159447|NCT02201108|585633085|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
162159448|NCT02201108|585633086|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
162159449|NCT02201108|585633087|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
162159450|NCT02201108|585633085|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
162159451|NCT02201108|585633086|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
162159452|NCT02201108|585633087|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
162159453|NCT02201108|585633085|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
162159454|NCT02201108|585633086|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
162159455|NCT02201108|585633087|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
162159456|NCT02201108|585633085|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
162159457|NCT02201108|585633086|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
162159458|NCT02201108|585633087|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
162159459|NCT02201108|585633085|FG000|Open Label Period (up to Week 192)|Other reason|4|||
162159460|NCT02201108|585633086|FG001|Open Label Period (up to Week 192)|Other reason|7|||
162159461|NCT02201108|585633087|FG002|Open Label Period (up to Week 192)|Other reason|0|||
162159462|NCT02201108|585633085|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
162159463|NCT02201108|585633086|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
162159464|NCT02201108|585633087|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
162014793|NCT01177397|585108562|FG005|Overall Study|Adverse Event|12|||
162014794|NCT01177397|585108563|FG006|Overall Study|Adverse Event|1|||
162014795|NCT01177397|585108564|FG007|Overall Study|Adverse Event|14|||
162014796|NCT01177397|585108565|FG008|Overall Study|Adverse Event|8|||
162014797|NCT01177397|585108566|FG009|Overall Study|Adverse Event|6|||
162014798|NCT01177397|585108567|FG010|Overall Study|Adverse Event|3|||
162159465|NCT02201108|585633085|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
162159466|NCT02201108|585633086|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
162159467|NCT02201108|585633087|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
162159468|NCT02201108|585633085|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
162159469|NCT02201108|585633086|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
162159470|NCT02201108|585633087|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
162159471|NCT03055377|585633097|FG000|Treatment Phase|Lost to Follow-up|28|||
162159472|NCT03055377|585633098|FG001|Treatment Phase|Lost to Follow-up|24|||
162159473|NCT03055377|585633097|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
162159474|NCT03055377|585633098|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
162159475|NCT04143061|585633099|FG000|Overall Study|Protocol Deviation|0|||
162159476|NCT04143061|585633100|FG001|Overall Study|Protocol Deviation|0|||
162159477|NCT04143061|585633101|FG002|Overall Study|Protocol Deviation|0|||
162159478|NCT04143061|585633102|FG003|Overall Study|Protocol Deviation|0|||
162159479|NCT04143061|585633103|FG004|Overall Study|Protocol Deviation|0|||
162159480|NCT04143061|585633104|FG005|Overall Study|Protocol Deviation|0|||
162159481|NCT04143061|585633105|FG006|Overall Study|Protocol Deviation|5|||
162159482|NCT04143061|585633106|FG007|Overall Study|Protocol Deviation|5|||
162159483|NCT04143061|585633099|FG000|Overall Study|Withdrawal by Subject|2|||
162159484|NCT04143061|585633100|FG001|Overall Study|Withdrawal by Subject|0|||
162159485|NCT04143061|585633101|FG002|Overall Study|Withdrawal by Subject|0|||
162159486|NCT04143061|585633102|FG003|Overall Study|Withdrawal by Subject|0|||
162159487|NCT04143061|585633103|FG004|Overall Study|Withdrawal by Subject|0|||
162159488|NCT04143061|585633104|FG005|Overall Study|Withdrawal by Subject|1|||
162159489|NCT04143061|585633105|FG006|Overall Study|Withdrawal by Subject|0|||
162159490|NCT04143061|585633106|FG007|Overall Study|Withdrawal by Subject|0|||
162159491|NCT04143061|585633099|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162159492|NCT04143061|585633100|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162159493|NCT04143061|585633101|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162159494|NCT04143061|585633102|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
162159495|NCT04143061|585633103|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
162159496|NCT04143061|585633104|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
162159497|NCT04143061|585633105|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
162159498|NCT04143061|585633106|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
162159499|NCT03289039|585633107|FG000|Overall Study|Withdrawal by Subject|0|||
162159500|NCT03289039|585633108|FG001|Overall Study|Withdrawal by Subject|1|||
162159501|NCT03289039|585633107|FG000|Overall Study|Became ineligible prior to treatment start|0|||
162159502|NCT03289039|585633108|FG001|Overall Study|Became ineligible prior to treatment start|1|||
162159503|NCT03289039|585633107|FG000|Overall Study|progressed before treatment start|1|||
162159504|NCT03289039|585633108|FG001|Overall Study|progressed before treatment start|0|||
162159505|NCT04586920|585633109|FG000|Overall Study|Lost to Follow-up|0|||
162159506|NCT04586920|585633110|FG001|Overall Study|Lost to Follow-up|0|||
162159507|NCT04586920|585633111|FG002|Overall Study|Lost to Follow-up|0|||
162159508|NCT04586920|585633112|FG003|Overall Study|Lost to Follow-up|0|||
162159509|NCT04586920|585633113|FG004|Overall Study|Lost to Follow-up|0|||
162159510|NCT04586920|585633114|FG005|Overall Study|Lost to Follow-up|0|||
162159511|NCT04586920|585633115|FG006|Overall Study|Lost to Follow-up|1|||
162159512|NCT04586920|585633116|FG007|Overall Study|Lost to Follow-up|1|||
162159513|NCT04586920|585633117|FG008|Overall Study|Lost to Follow-up|0|||
162159514|NCT04586920|585633118|FG009|Overall Study|Lost to Follow-up|1|||
162159515|NCT04586920|585633119|FG010|Overall Study|Lost to Follow-up|0|||
162159516|NCT04586920|585633120|FG011|Overall Study|Lost to Follow-up|0|||
162159517|NCT04586920|585633121|FG012|Overall Study|Lost to Follow-up|0|||
162159518|NCT04586920|585633122|FG013|Overall Study|Lost to Follow-up|1|||
162159519|NCT04586920|585633123|FG014|Overall Study|Lost to Follow-up|0|||
162159520|NCT04586920|585633124|FG015|Overall Study|Lost to Follow-up|0|||
162159521|NCT04586920|585633125|FG016|Overall Study|Lost to Follow-up|0|||
162159522|NCT04586920|585633126|FG017|Overall Study|Lost to Follow-up|0|||
162159523|NCT04586920|585633109|FG000|Overall Study|Withdrawal by Subject|0|||
162159524|NCT04586920|585633110|FG001|Overall Study|Withdrawal by Subject|0|||
162159525|NCT04586920|585633111|FG002|Overall Study|Withdrawal by Subject|0|||
162159526|NCT04586920|585633112|FG003|Overall Study|Withdrawal by Subject|0|||
162159527|NCT04586920|585633113|FG004|Overall Study|Withdrawal by Subject|0|||
162159528|NCT04586920|585633114|FG005|Overall Study|Withdrawal by Subject|0|||
162159529|NCT04586920|585633115|FG006|Overall Study|Withdrawal by Subject|0|||
162159530|NCT04586920|585633116|FG007|Overall Study|Withdrawal by Subject|1|||
162159531|NCT04586920|585633117|FG008|Overall Study|Withdrawal by Subject|0|||
162159532|NCT04586920|585633118|FG009|Overall Study|Withdrawal by Subject|1|||
162159533|NCT04586920|585633119|FG010|Overall Study|Withdrawal by Subject|0|||
162159534|NCT04586920|585633120|FG011|Overall Study|Withdrawal by Subject|1|||
162159535|NCT04586920|585633121|FG012|Overall Study|Withdrawal by Subject|0|||
162159536|NCT04586920|585633122|FG013|Overall Study|Withdrawal by Subject|0|||
162159537|NCT04586920|585633123|FG014|Overall Study|Withdrawal by Subject|0|||
162159538|NCT04586920|585633124|FG015|Overall Study|Withdrawal by Subject|0|||
162159539|NCT04586920|585633125|FG016|Overall Study|Withdrawal by Subject|0|||
162159540|NCT04586920|585633126|FG017|Overall Study|Withdrawal by Subject|0|||
162159541|NCT02287311|585633131|FG000|Cohort 1: Dose Level 1|Death|2|||
162159542|NCT02287311|585633132|FG001|Cohort 1: Dose Level 1|Death|0|||
162159543|NCT02287311|585633133|FG002|Cohort 1: Dose Level 1|Death|0|||
162159544|NCT02287311|585633134|FG003|Cohort 1: Dose Level 1|Death|3|||
162159545|NCT02287311|585633135|FG004|Cohort 1: Dose Level 1|Death|0|||
162159546|NCT02287311|585633136|FG005|Cohort 1: Dose Level 1|Death|0|||
162159547|NCT02287311|585633137|FG006|Cohort 1: Dose Level 1|Death|1|||
162159548|NCT02287311|585633138|FG007|Cohort 1: Dose Level 1|Death|0|||
162159549|NCT02287311|585633139|FG008|Cohort 1: Dose Level 1|Death|0|||
162159550|NCT02287311|585633131|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162159551|NCT02287311|585633132|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162159552|NCT02287311|585633133|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162159553|NCT02287311|585633134|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
162159554|NCT02287311|585633135|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162159555|NCT02287311|585633136|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162159556|NCT02287311|585633137|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
162159557|NCT02287311|585633138|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162159558|NCT02287311|585633139|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
162159559|NCT02287311|585633131|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
162159560|NCT02287311|585633132|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
162159561|NCT02287311|585633133|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
162159562|NCT02287311|585633134|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
162159563|NCT02287311|585633135|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
162159564|NCT02287311|585633136|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
162159565|NCT02287311|585633137|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
162159566|NCT02287311|585633138|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
162159567|NCT02287311|585633139|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
162159568|NCT02287311|585633131|FG000|Cohort 2: Dose Level 2|Death|0|||
162159569|NCT02287311|585633132|FG001|Cohort 2: Dose Level 2|Death|2|||
162159570|NCT02287311|585633133|FG002|Cohort 2: Dose Level 2|Death|0|||
162159571|NCT02287311|585633134|FG003|Cohort 2: Dose Level 2|Death|0|||
162159572|NCT02287311|585633135|FG004|Cohort 2: Dose Level 2|Death|2|||
162159573|NCT02287311|585633136|FG005|Cohort 2: Dose Level 2|Death|0|||
162159574|NCT02287311|585633137|FG006|Cohort 2: Dose Level 2|Death|0|||
162159575|NCT02287311|585633138|FG007|Cohort 2: Dose Level 2|Death|2|||
162159576|NCT02287311|585633139|FG008|Cohort 2: Dose Level 2|Death|0|||
162159577|NCT02287311|585633131|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162159578|NCT02287311|585633132|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162159579|NCT02287311|585633133|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162159580|NCT02287311|585633134|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162159581|NCT02287311|585633135|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
162159582|NCT02287311|585633136|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162159583|NCT02287311|585633137|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162159584|NCT02287311|585633138|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162159585|NCT02287311|585633139|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
162159586|NCT02287311|585633131|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
162159587|NCT02287311|585633132|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
162159588|NCT02287311|585633133|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
162159589|NCT02287311|585633134|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
162159590|NCT02287311|585633135|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
162159591|NCT02287311|585633136|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
162159592|NCT02287311|585633137|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
162159593|NCT02287311|585633138|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
162159594|NCT02287311|585633139|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
162159595|NCT02287311|585633131|FG000|Cohort 3: Dose Level 3|Death|0|||
162159596|NCT02287311|585633132|FG001|Cohort 3: Dose Level 3|Death|0|||
162159597|NCT02287311|585633133|FG002|Cohort 3: Dose Level 3|Death|4|||
162159598|NCT02287311|585633134|FG003|Cohort 3: Dose Level 3|Death|0|||
162159599|NCT02287311|585633135|FG004|Cohort 3: Dose Level 3|Death|0|||
162014799|NCT01177397|585108568|FG011|Overall Study|Adverse Event|7|||
162014800|NCT01177397|585108557|FG000|Overall Study|Disease progression|1|||
162014801|NCT01177397|585108558|FG001|Overall Study|Disease progression|2|||
162014802|NCT01177397|585108559|FG002|Overall Study|Disease progression|5|||
162014803|NCT01177397|585108560|FG003|Overall Study|Disease progression|5|||
162014804|NCT01177397|585108561|FG004|Overall Study|Disease progression|4|||
162014805|NCT01177397|585108562|FG005|Overall Study|Disease progression|10|||
162014806|NCT01177397|585108563|FG006|Overall Study|Disease progression|10|||
162014807|NCT01177397|585108564|FG007|Overall Study|Disease progression|21|||
162159600|NCT02287311|585633136|FG005|Cohort 3: Dose Level 3|Death|4|||
162159601|NCT02287311|585633137|FG006|Cohort 3: Dose Level 3|Death|0|||
162159602|NCT02287311|585633138|FG007|Cohort 3: Dose Level 3|Death|0|||
162159603|NCT02287311|585633139|FG008|Cohort 3: Dose Level 3|Death|2|||
162159604|NCT02287311|585633131|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162159605|NCT02287311|585633132|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162014808|NCT01177397|585108565|FG008|Overall Study|Disease progression|18|||
162014809|NCT01177397|585108566|FG009|Overall Study|Disease progression|12|||
162014810|NCT01177397|585108567|FG010|Overall Study|Disease progression|10|||
162014811|NCT01177397|585108568|FG011|Overall Study|Disease progression|8|||
162014812|NCT01177397|585108557|FG000|Overall Study|Other reasons|0|||
162159606|NCT02287311|585633133|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
162159607|NCT02287311|585633134|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162159608|NCT02287311|585633135|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162159609|NCT02287311|585633136|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
162159610|NCT02287311|585633137|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162159611|NCT02287311|585633138|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162159612|NCT02287311|585633139|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
162159613|NCT02287311|585633131|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162159614|NCT02287311|585633132|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162159615|NCT02287311|585633133|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162159616|NCT02287311|585633134|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162159617|NCT02287311|585633135|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162159618|NCT02287311|585633136|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
161812890|NCT00334815|584359775|FG001|Overall Study|Progression|0|||
161812891|NCT00334815|584359774|FG000|Overall Study|ineligible|1|||
161812892|NCT00334815|584359775|FG001|Overall Study|ineligible|1|||
161812893|NCT00334815|584359774|FG000|Overall Study|patient refused treatment|0|||
161812894|NCT00334815|584359775|FG001|Overall Study|patient refused treatment|1|||
161812895|NCT00334815|584359774|FG000|Overall Study|Physician Decision|2|||
161812896|NCT00334815|584359775|FG001|Overall Study|Physician Decision|4|||
161812897|NCT04970810|584359776|FG000|Overall Study|deemed ineligible after randomization|3|||
161812898|NCT04970810|584359777|FG001|Overall Study|deemed ineligible after randomization|0|||
161812899|NCT04970810|584359778|FG002|Overall Study|deemed ineligible after randomization|4|||
161812900|NCT04742491|584359781|FG000|Overall Study|Death|2|||
161812901|NCT04742491|584359782|FG001|Overall Study|Death|0|||
161812902|NCT04742491|584359781|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
161812903|NCT04742491|584359782|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
161812904|NCT04742491|584359781|FG000|Overall Study|Lost to Follow-up|6|||
161812905|NCT04742491|584359782|FG001|Overall Study|Lost to Follow-up|8|||
162159619|NCT02287311|585633137|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
162159620|NCT02287311|585633138|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161812906|NCT04742491|584359781|FG000|Overall Study|Withdrawal by Subject|4|||
161812907|NCT04742491|584359782|FG001|Overall Study|Withdrawal by Subject|2|||
161812908|NCT04742491|584359781|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
161916303|NCT02475213|584742417|FG004|Overall Study|Adverse Event|1|||
161916304|NCT02475213|584742418|FG005|Overall Study|Adverse Event|4|||
161916305|NCT02475213|584742419|FG006|Overall Study|Adverse Event|6|||
161916306|NCT02475213|584742420|FG007|Overall Study|Adverse Event|2|||
161916307|NCT02475213|584742413|FG000|Overall Study|Physician Decision|1|||
161916308|NCT02475213|584742414|FG001|Overall Study|Physician Decision|1|||
161916309|NCT02475213|584742415|FG002|Overall Study|Physician Decision|1|||
162159621|NCT02287311|585633139|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
162159622|NCT04048681|585633143|FG000|Overall Study|family emergency|0|||
162159623|NCT04048681|585633144|FG001|Overall Study|family emergency|0|||
162159624|NCT04048681|585633145|FG002|Overall Study|family emergency|0|||
162159625|NCT04048681|585633146|FG003|Overall Study|family emergency|1|||
162159626|NCT04048681|585633147|FG004|Overall Study|family emergency|0|||
161916310|NCT02475213|584742416|FG003|Overall Study|Physician Decision|0|||
161916311|NCT02475213|584742417|FG004|Overall Study|Physician Decision|0|||
162159627|NCT02374307|585633150|FG000|3-months Follow-up|Lost to Follow-up|1|||
162159628|NCT02374307|585633151|FG001|3-months Follow-up|Lost to Follow-up|2|||
162159629|NCT02374307|585633150|FG000|3-months Follow-up|Withdrawal by Subject|1|||
162159630|NCT02374307|585633151|FG001|3-months Follow-up|Withdrawal by Subject|4|||
162159631|NCT02374307|585633150|FG000|3-months Follow-up|Death|1|||
162159632|NCT02374307|585633151|FG001|3-months Follow-up|Death|2|||
161916312|NCT02475213|584742418|FG005|Overall Study|Physician Decision|1|||
162159633|NCT02374307|585633150|FG000|3-months Follow-up|Missed first follow-up|5|||
162159634|NCT02374307|585633151|FG001|3-months Follow-up|Missed first follow-up|1|||
161916313|NCT02475213|584742419|FG006|Overall Study|Physician Decision|4|||
161916314|NCT02475213|584742420|FG007|Overall Study|Physician Decision|0|||
161916315|NCT02475213|584742413|FG000|Overall Study|Progressive Disease|3|||
162159635|NCT02374307|585633150|FG000|6-months Follow-up|Lost to Follow-up|1|||
162159636|NCT02374307|585633151|FG001|6-months Follow-up|Lost to Follow-up|2|||
162159637|NCT02374307|585633150|FG000|6-months Follow-up|Death|2|||
162159638|NCT02374307|585633151|FG001|6-months Follow-up|Death|1|||
162159639|NCT02374307|585633150|FG000|6-months Follow-up|Withdrawal by Subject|0|||
162159640|NCT02374307|585633151|FG001|6-months Follow-up|Withdrawal by Subject|3|||
162159641|NCT01989455|585633152|FG000|Overall Study|Adverse Event|0|||
162159642|NCT01989455|585633153|FG001|Overall Study|Adverse Event|1|||
161916316|NCT02475213|584742414|FG001|Overall Study|Progressive Disease|2|||
162159643|NCT01989455|585633154|FG002|Overall Study|Adverse Event|0|||
162159644|NCT01989455|585633155|FG003|Overall Study|Adverse Event|0|||
162159645|NCT01989455|585633156|FG004|Overall Study|Adverse Event|0|||
161812909|NCT04742491|584359782|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
161812910|NCT04742491|584359781|FG000|Overall Study|Participant refused further participation|2|||
161812911|NCT04742491|584359782|FG001|Overall Study|Participant refused further participation|7|||
161916317|NCT02475213|584742415|FG002|Overall Study|Progressive Disease|2|||
161916318|NCT02475213|584742416|FG003|Overall Study|Progressive Disease|13|||
161916319|NCT02475213|584742417|FG004|Overall Study|Progressive Disease|15|||
161916320|NCT02475213|584742418|FG005|Overall Study|Progressive Disease|25|||
162159646|NCT01989455|585633152|FG000|Overall Study|Withdrawal by Subject|0|||
162159647|NCT01989455|585633153|FG001|Overall Study|Withdrawal by Subject|1|||
162159648|NCT01989455|585633154|FG002|Overall Study|Withdrawal by Subject|0|||
162159649|NCT01989455|585633155|FG003|Overall Study|Withdrawal by Subject|0|||
162159650|NCT01989455|585633156|FG004|Overall Study|Withdrawal by Subject|0|||
162159651|NCT01989455|585633152|FG000|Overall Study|Technical problems with infusion|0|||
162159652|NCT01989455|585633153|FG001|Overall Study|Technical problems with infusion|0|||
162159653|NCT01989455|585633154|FG002|Overall Study|Technical problems with infusion|1|||
162159654|NCT01989455|585633155|FG003|Overall Study|Technical problems with infusion|0|||
162159655|NCT01989455|585633156|FG004|Overall Study|Technical problems with infusion|1|||
162159656|NCT00632203|585633157|FG000|Overall Study|Did not start study treatment|1|||
162159657|NCT00632203|585633158|FG001|Overall Study|Did not start study treatment|0|||
162159658|NCT00448669|585633164|FG000|Overall Study|Lost to Follow-up|52|||
162159659|NCT00448669|585633165|FG001|Overall Study|Lost to Follow-up|63|||
162159660|NCT00448669|585633164|FG000|Overall Study|Withdrawal by Subject|90|||
162159661|NCT00448669|585633165|FG001|Overall Study|Withdrawal by Subject|74|||
162159662|NCT00448669|585633164|FG000|Overall Study|Relocated|49|||
162159663|NCT00448669|585633165|FG001|Overall Study|Relocated|36|||
162159664|NCT00448669|585633164|FG000|Overall Study|Were withdrawn by investigator|10|||
162159665|NCT00448669|585633165|FG001|Overall Study|Were withdrawn by investigator|6|||
162159666|NCT00448669|585633164|FG000|Overall Study|Death|2|||
162159667|NCT00448669|585633165|FG001|Overall Study|Death|4|||
162159668|NCT00448669|585633164|FG000|Overall Study|Had other reasons|5|||
162159669|NCT00448669|585633165|FG001|Overall Study|Had other reasons|6|||
162159670|NCT00448669|585633164|FG000|Overall Study|HIV-infected at enrollment|1|||
162159671|NCT00448669|585633165|FG001|Overall Study|HIV-infected at enrollment|2|||
162159672|NCT00448669|585633164|FG000|Overall Study|Never started drug|9|||
162159673|NCT00448669|585633165|FG001|Overall Study|Never started drug|7|||
162159674|NCT04287985|585633166|FG000|Overall Study|Adverse Event|1|||
162159675|NCT04287985|585633167|FG001|Overall Study|Adverse Event|0|||
162159676|NCT04287985|585633168|FG002|Overall Study|Adverse Event|0|||
162159677|NCT04287985|585633169|FG003|Overall Study|Adverse Event|0|||
162159678|NCT04287985|585633166|FG000|Overall Study|Protocol Violation|0|||
162159679|NCT04287985|585633167|FG001|Overall Study|Protocol Violation|1|||
162159680|NCT04287985|585633168|FG002|Overall Study|Protocol Violation|0|||
162159681|NCT04287985|585633169|FG003|Overall Study|Protocol Violation|0|||
162159682|NCT04287985|585633166|FG000|Overall Study|Physician Decision|0|||
162159683|NCT04287985|585633167|FG001|Overall Study|Physician Decision|0|||
162159684|NCT04287985|585633168|FG002|Overall Study|Physician Decision|0|||
162159685|NCT04287985|585633169|FG003|Overall Study|Physician Decision|1|||
162159686|NCT04287985|585633166|FG000|Overall Study|Withdrawal by Subject|2|||
162159687|NCT04287985|585633167|FG001|Overall Study|Withdrawal by Subject|1|||
162159688|NCT04287985|585633168|FG002|Overall Study|Withdrawal by Subject|1|||
162159689|NCT04287985|585633169|FG003|Overall Study|Withdrawal by Subject|2|||
162159690|NCT02638337|585633170|FG000|Overall Study|Adverse Event|6|||
162159691|NCT02638337|585633171|FG001|Overall Study|Adverse Event|10|||
162159692|NCT02638337|585633170|FG000|Overall Study|Protocol Violation|3|||
162159693|NCT02638337|585633171|FG001|Overall Study|Protocol Violation|0|||
161812912|NCT04742491|584359781|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
161812913|NCT04742491|584359782|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
161812914|NCT04742491|584359781|FG000|Overall Study|Other reasons|3|||
161812915|NCT04742491|584359782|FG001|Overall Study|Other reasons|4|||
161812916|NCT03317899|584359783|FG000|Overall Study|Death|6|||
161812917|NCT03317899|584359784|FG001|Overall Study|Death|9|||
161812918|NCT01528696|584359787|FG000|Overall Study|See detailed description|18|||
161812919|NCT01528696|584359788|FG001|Overall Study|See detailed description|19|||
161812920|NCT00446966|584359789|FG000|Overall Study|Lost to Follow-up|10|||
161812921|NCT00446966|584359790|FG001|Overall Study|Lost to Follow-up|7|||
161812922|NCT00836472|584359792|FG000|Washout|Adverse Event|1|||
161812923|NCT00836472|584359793|FG001|Washout|Adverse Event|2|||
161812924|NCT00836472|584359792|FG000|Washout|Withdrawal by Subject|1|||
161812925|NCT00836472|584359793|FG001|Washout|Withdrawal by Subject|1|||
161812926|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
161812927|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
161812928|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
161812929|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
161812930|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162159694|NCT02638337|585633170|FG000|Overall Study|Withdrawal by Subject|13|||
162159695|NCT02638337|585633171|FG001|Overall Study|Withdrawal by Subject|16|||
162159696|NCT02638337|585633170|FG000|Overall Study|Lost to Follow-up|7|||
162159697|NCT02638337|585633171|FG001|Overall Study|Lost to Follow-up|7|||
162159698|NCT02638337|585633170|FG000|Overall Study|Other - Miscellaneous|4|||
162159699|NCT02638337|585633171|FG001|Overall Study|Other - Miscellaneous|3|||
162159700|NCT03771352|585633172|FG000|Overall Study|Screen failure|2|||
162159701|NCT03771352|585633172|FG000|Overall Study|Withdrawal by Subject|2|||
162159702|NCT04315181|585633173|FG000|Overall Study|Non-responsive to drug conditions.|1|||
162159703|NCT01948661|585633174|FG000|Overall Study|Withdrawal by Subject|2|||
162159704|NCT01948661|585633175|FG001|Overall Study|Withdrawal by Subject|4|||
161812931|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
162159705|NCT03271489|585633176|FG000|Double-Blind (DB) Period|Adverse Event|4|||
162159706|NCT03271489|585633177|FG001|Double-Blind (DB) Period|Adverse Event|1|||
162159707|NCT03271489|585633176|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
162159708|NCT03271489|585633177|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
162159709|NCT03271489|585633176|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
162159710|NCT03271489|585633177|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
162159711|NCT03271489|585633176|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
162159712|NCT03271489|585633177|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
162159713|NCT03271489|585633176|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
162159714|NCT03271489|585633177|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
162159715|NCT03271489|585633176|FG000|Double-Blind (DB) Period|Other|6|||
162159716|NCT03271489|585633177|FG001|Double-Blind (DB) Period|Other|1|||
162159717|NCT03271489|585633176|FG000|Double-Blind (DB) Period|Missing|1|||
162159718|NCT03271489|585633177|FG001|Double-Blind (DB) Period|Missing|0|||
162159719|NCT03271489|585633176|FG000|Open-Label (OL) Period|Adverse Event|2|||
162159720|NCT03271489|585633177|FG001|Open-Label (OL) Period|Adverse Event|0|||
162159721|NCT03271489|585633176|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
162159722|NCT03271489|585633177|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
162159723|NCT03271489|585633176|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
162159724|NCT03271489|585633177|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
162159725|NCT03271489|585633176|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
162159726|NCT03271489|585633177|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
162159727|NCT03271489|585633176|FG000|Open-Label (OL) Period|No Specified|2|||
162159728|NCT03271489|585633177|FG001|Open-Label (OL) Period|No Specified|2|||
162159729|NCT03271489|585633176|FG000|Open-Label (OL) Period|Missing|2|||
162159730|NCT03271489|585633177|FG001|Open-Label (OL) Period|Missing|0|||
162159731|NCT03271489|585633176|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
162159732|NCT03271489|585633177|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
162159733|NCT03271489|585633176|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
162159734|NCT03271489|585633177|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
162159735|NCT03271489|585633176|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
162159736|NCT03271489|585633177|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
162159737|NCT03271489|585633176|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
162159738|NCT03271489|585633177|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
162159739|NCT03271489|585633176|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
162159740|NCT03271489|585633177|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
162159741|NCT03271489|585633176|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
162159742|NCT03271489|585633177|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
162159743|NCT03271489|585633176|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
162159744|NCT03271489|585633177|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
162159745|NCT03271489|585633176|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
162159746|NCT03271489|585633177|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
162159747|NCT01127373|585633178|FG000|Overall Study|Not Treated|3|||
162159748|NCT01127373|585633178|FG000|Overall Study|Lost to Follow-up|7|||
162159749|NCT01127373|585633178|FG000|Overall Study|Withdrawal by Subject|1|||
162159750|NCT01127373|585633178|FG000|Overall Study|Disease progression|1|||
162159751|NCT00522951|585633181|FG000|Period 1|body motion|0|||
162159752|NCT00522951|585633182|FG001|Period 1|body motion|1|||
162159753|NCT00522951|585633181|FG000|Washout Period|Adverse Event|0|||
162159754|NCT00522951|585633182|FG001|Washout Period|Adverse Event|1|||
162159755|NCT00522951|585633181|FG000|Washout Period|Death|0|||
162159756|NCT00522951|585633182|FG001|Washout Period|Death|1|||
161812932|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812933|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812934|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812935|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812936|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812937|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812938|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812939|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161812940|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
161812941|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
161812942|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
161812943|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
161916321|NCT02475213|584742419|FG006|Overall Study|Progressive Disease|30|||
162159757|NCT00522951|585633181|FG000|Period 2|Withdrawal by Subject|1|||
162159758|NCT00522951|585633182|FG001|Period 2|Withdrawal by Subject|0|||
162159759|NCT00522951|585633181|FG000|Period 2|residual contrast medium|1|||
162159760|NCT00522951|585633182|FG001|Period 2|residual contrast medium|1|||
162159761|NCT00136435|585633186|FG000|Overall Study|Ineligible|8|||
162159762|NCT00136435|585633186|FG000|Overall Study|Induction Death|1|||
162159763|NCT00136435|585633186|FG000|Overall Study|Induction Failure|10|||
162159764|NCT00136435|585633186|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
162159765|NCT00136435|585633186|FG000|Overall Study|Withdrawal by Subject|3|||
162159766|NCT00136435|585633186|FG000|Overall Study|Adverse Event|19|||
162159767|NCT00136435|585633186|FG000|Overall Study|Relapse|4|||
162159768|NCT00136435|585633186|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
162159769|NCT00390299|585633187|FG000|Overall Study|Cancellation|1|||
162159770|NCT00390299|585633188|FG001|Overall Study|Cancellation|0|||
162159771|NCT00390299|585633189|FG002|Overall Study|Cancellation|0|||
162159772|NCT00390299|585633190|FG003|Overall Study|Cancellation|0|||
162159773|NCT00390299|585633191|FG004|Overall Study|Cancellation|0|||
162159774|NCT04377308|585633192|FG000|Overall Study|Withdrawal by Subject|0|||
162159775|NCT04377308|585633193|FG001|Overall Study|Withdrawal by Subject|1|||
162159776|NCT00709098|585633197|FG000|Double-blind Period|Withdrawal of consent|3|||
162159777|NCT00709098|585633198|FG001|Double-blind Period|Withdrawal of consent|3|||
162159778|NCT00709098|585633199|FG002|Double-blind Period|Withdrawal of consent|0|||
162159779|NCT00709098|585633197|FG000|Double-blind Period|Administrative reason|1|||
162159780|NCT00709098|585633198|FG001|Double-blind Period|Administrative reason|3|||
162159781|NCT00709098|585633199|FG002|Double-blind Period|Administrative reason|0|||
162159782|NCT00709098|585633197|FG000|Double-blind Period|Death|1|||
162159783|NCT00709098|585633198|FG001|Double-blind Period|Death|1|||
162159784|NCT00709098|585633199|FG002|Double-blind Period|Death|0|||
162159785|NCT00709098|585633197|FG000|Double-blind Period|Lost to Follow-up|1|||
162159786|NCT00709098|585633198|FG001|Double-blind Period|Lost to Follow-up|1|||
162159787|NCT00709098|585633199|FG002|Double-blind Period|Lost to Follow-up|0|||
162159788|NCT00709098|585633197|FG000|Open-label Period|Withdrawal of consent|0|||
162159789|NCT00709098|585633198|FG001|Open-label Period|Withdrawal of consent|0|||
162159790|NCT00709098|585633199|FG002|Open-label Period|Withdrawal of consent|7|||
162159791|NCT00709098|585633197|FG000|Open-label Period|Administrative reason|0|||
162159792|NCT00709098|585633198|FG001|Open-label Period|Administrative reason|0|||
162159793|NCT00709098|585633199|FG002|Open-label Period|Administrative reason|5|||
162159794|NCT00709098|585633197|FG000|Open-label Period|Death|0|||
162159795|NCT00709098|585633198|FG001|Open-label Period|Death|0|||
162159796|NCT00709098|585633199|FG002|Open-label Period|Death|1|||
162159797|NCT00709098|585633197|FG000|Open-label Period|Lost to Follow-up|0|||
162159798|NCT00709098|585633198|FG001|Open-label Period|Lost to Follow-up|0|||
162159799|NCT00709098|585633199|FG002|Open-label Period|Lost to Follow-up|1|||
161812944|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812945|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162014813|NCT01177397|585108558|FG001|Overall Study|Other reasons|0|||
162014814|NCT01177397|585108559|FG002|Overall Study|Other reasons|1|||
162014815|NCT01177397|585108560|FG003|Overall Study|Other reasons|0|||
162014816|NCT01177397|585108561|FG004|Overall Study|Other reasons|1|||
162014817|NCT01177397|585108562|FG005|Overall Study|Other reasons|1|||
162014818|NCT01177397|585108563|FG006|Overall Study|Other reasons|2|||
162014819|NCT01177397|585108564|FG007|Overall Study|Other reasons|6|||
162014820|NCT01177397|585108565|FG008|Overall Study|Other reasons|10|||
162014821|NCT01177397|585108566|FG009|Overall Study|Other reasons|8|||
162014822|NCT01177397|585108567|FG010|Overall Study|Other reasons|0|||
162014823|NCT01177397|585108568|FG011|Overall Study|Other reasons|2|||
162014824|NCT01528969|585108569|FG000|Overall Study|absent from the school at baseline|2|||
162014825|NCT01528969|585108570|FG001|Overall Study|absent from the school at baseline|0|||
162014826|NCT02803580|585108571|FG000|Overall Study|Death|13|||
162014827|NCT02803580|585108571|FG000|Overall Study|Lost to Follow-up|19|||
162014828|NCT02803580|585108571|FG000|Overall Study|Withdrawal by Subject|3|||
162014829|NCT02803580|585108571|FG000|Overall Study|Inclusion in clinical trial|1|||
162014830|NCT01358721|585108574|FG000|Overall Study|Withdrawal by Subject|0|||
162014831|NCT01358721|585108575|FG001|Overall Study|Withdrawal by Subject|0|||
162159800|NCT00774852|585633200|FG000|Overall Study|Adverse Event|9|||
162159801|NCT00774852|585633201|FG001|Overall Study|Adverse Event|6|||
162159802|NCT00774852|585633200|FG000|Overall Study|Death|2|||
162014832|NCT01358721|585108576|FG002|Overall Study|Withdrawal by Subject|0|||
162159803|NCT00774852|585633201|FG001|Overall Study|Death|1|||
162159804|NCT00774852|585633200|FG000|Overall Study|Lack of Efficacy|3|||
162159805|NCT00774852|585633201|FG001|Overall Study|Lack of Efficacy|7|||
162159806|NCT00774852|585633200|FG000|Overall Study|Lost to Follow-up|9|||
162159807|NCT00774852|585633201|FG001|Overall Study|Lost to Follow-up|5|||
162159808|NCT00774852|585633200|FG000|Overall Study|Physician Decision|2|||
162159809|NCT00774852|585633201|FG001|Overall Study|Physician Decision|6|||
162014833|NCT01358721|585108577|FG003|Overall Study|Withdrawal by Subject|1|||
162014834|NCT01358721|585108574|FG000|Overall Study|Death|0|||
162159810|NCT00774852|585633200|FG000|Overall Study|Pregnancy|1|||
162159811|NCT00774852|585633201|FG001|Overall Study|Pregnancy|2|||
162159812|NCT00774852|585633200|FG000|Overall Study|Withdrawal by Subject|2|||
162159813|NCT00774852|585633201|FG001|Overall Study|Withdrawal by Subject|2|||
162159814|NCT00774852|585633200|FG000|Overall Study|Non-responder|15|||
162159815|NCT00774852|585633201|FG001|Overall Study|Non-responder|11|||
162159816|NCT00774852|585633200|FG000|Overall Study|Subject non-compliance|0|||
162159817|NCT00774852|585633201|FG001|Overall Study|Subject non-compliance|1|||
162159818|NCT00774852|585633200|FG000|Overall Study|Protocol Violation|1|||
162159819|NCT00774852|585633201|FG001|Overall Study|Protocol Violation|0|||
162159820|NCT00774852|585633200|FG000|Overall Study|Subject received prohibited medication|1|||
162159821|NCT00774852|585633201|FG001|Overall Study|Subject received prohibited medication|0|||
162159822|NCT04994509|585633203|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
162159823|NCT04994509|585633204|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
162159824|NCT04994509|585633205|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
162159825|NCT04994509|585633203|FG000|Overall Study|Withdrew Consent|73|||
162159826|NCT04994509|585633204|FG001|Overall Study|Withdrew Consent|72|||
162159827|NCT04994509|585633205|FG002|Overall Study|Withdrew Consent|46|||
162159828|NCT04994509|585633203|FG000|Overall Study|Lost to Follow-up|39|||
162159829|NCT04994509|585633204|FG001|Overall Study|Lost to Follow-up|36|||
162159830|NCT04994509|585633205|FG002|Overall Study|Lost to Follow-up|26|||
162159831|NCT04994509|585633203|FG000|Overall Study|HIV-1 Infection|4|||
162159832|NCT04994509|585633204|FG001|Overall Study|HIV-1 Infection|20|||
162159833|NCT04994509|585633205|FG002|Overall Study|HIV-1 Infection|12|||
162159834|NCT04994509|585633203|FG000|Overall Study|Investigator's Discretion|9|||
162159835|NCT04994509|585633204|FG001|Overall Study|Investigator's Discretion|8|||
162159836|NCT04994509|585633205|FG002|Overall Study|Investigator's Discretion|11|||
162159837|NCT04994509|585633203|FG000|Overall Study|Randomized but Never Treated|10|||
162159838|NCT04994509|585633204|FG001|Overall Study|Randomized but Never Treated|10|||
162159839|NCT04994509|585633205|FG002|Overall Study|Randomized but Never Treated|3|||
162159840|NCT04994509|585633203|FG000|Overall Study|Pregnancy|5|||
162159841|NCT04994509|585633204|FG001|Overall Study|Pregnancy|5|||
162159842|NCT04994509|585633205|FG002|Overall Study|Pregnancy|0|||
162159843|NCT04994509|585633203|FG000|Overall Study|Death|0|||
162159844|NCT04994509|585633204|FG001|Overall Study|Death|5|||
162159845|NCT04994509|585633205|FG002|Overall Study|Death|0|||
162159846|NCT04994509|585633203|FG000|Overall Study|Adverse Event|2|||
162159847|NCT04994509|585633204|FG001|Overall Study|Adverse Event|1|||
162159848|NCT04994509|585633205|FG002|Overall Study|Adverse Event|0|||
162159849|NCT04994509|585633203|FG000|Overall Study|Non-compliance With Study Drug|1|||
162159850|NCT04994509|585633204|FG001|Overall Study|Non-compliance With Study Drug|1|||
162159851|NCT04994509|585633205|FG002|Overall Study|Non-compliance With Study Drug|1|||
162159852|NCT04994509|585633203|FG000|Overall Study|Withdrew Assent|3|||
162159853|NCT04994509|585633204|FG001|Overall Study|Withdrew Assent|0|||
162159854|NCT04994509|585633205|FG002|Overall Study|Withdrew Assent|0|||
162159855|NCT04994509|585633203|FG000|Overall Study|Protocol Violation|1|||
162159856|NCT04994509|585633204|FG001|Overall Study|Protocol Violation|0|||
162159857|NCT04994509|585633205|FG002|Overall Study|Protocol Violation|0|||
162159858|NCT04402294|585633207|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
162159859|NCT04402294|585633208|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
162159860|NCT04402294|585633207|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
162159861|NCT04402294|585633208|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
162159862|NCT05387447|585635753|FG000|Overall Study|Participants changed their minds about study participation.|3|||
162159863|NCT05387447|585635754|FG001|Overall Study|Participants changed their minds about study participation.|5|||
162159864|NCT01673984|585635755|FG000|Overall Study|Adverse Event|1|||
162159865|NCT01673984|585635756|FG001|Overall Study|Adverse Event|0|||
162159866|NCT01673984|585635755|FG000|Overall Study|Study termination|9|||
162159867|NCT01673984|585635756|FG001|Overall Study|Study termination|6|||
162159868|NCT04178733|585635757|FG000|Overall Study|Investigator Decision|0|||
162159869|NCT04178733|585635758|FG001|Overall Study|Investigator Decision|0|||
162159870|NCT04178733|585635759|FG002|Overall Study|Investigator Decision|0|||
162159871|NCT04178733|585635760|FG003|Overall Study|Investigator Decision|1|||
162159872|NCT04178733|585635761|FG004|Overall Study|Investigator Decision|2|||
162159873|NCT03655132|585635766|FG000|Overall Study|Lost to Follow-up|2|||
162159874|NCT03655132|585635767|FG001|Overall Study|Lost to Follow-up|1|||
162159875|NCT03655132|585635766|FG000|Overall Study|Withdrawal by Subject|0|||
162159876|NCT03655132|585635767|FG001|Overall Study|Withdrawal by Subject|1|||
161812946|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812947|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812948|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
162159877|NCT03655132|585635766|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
162159878|NCT03655132|585635767|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
162159879|NCT02651324|585635769|FG000|Overall Study|drug not administered, due dispensing issue|1|||
162159880|NCT02651324|585635770|FG001|Overall Study|drug not administered, due dispensing issue|0|||
162159881|NCT05919082|585635773|FG000|Overall Study|Adverse Event|3|||
162159882|NCT05919082|585635774|FG001|Overall Study|Adverse Event|0|||
162159883|NCT05919082|585635773|FG000|Overall Study|Lost to Follow-up|0|||
162159884|NCT05919082|585635774|FG001|Overall Study|Lost to Follow-up|1|||
162159885|NCT05919082|585635773|FG000|Overall Study|Withdrawal by Subject|8|||
162159886|NCT05919082|585635774|FG001|Overall Study|Withdrawal by Subject|9|||
162159887|NCT05919082|585635773|FG000|Overall Study|Lack of Efficacy|0|||
162159888|NCT05919082|585635774|FG001|Overall Study|Lack of Efficacy|1|||
162159889|NCT05919082|585635773|FG000|Overall Study|Investigator Decision|1|||
162159890|NCT05919082|585635774|FG001|Overall Study|Investigator Decision|0|||
162159891|NCT04437433|585635788|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
162159892|NCT04437433|585635789|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
162159893|NCT04437433|585635788|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
162159894|NCT04437433|585635789|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
162159895|NCT04437433|585635788|FG000|Overall Study|Adverse Event|9|||
162159896|NCT04437433|585635789|FG001|Overall Study|Adverse Event|0|||
162159897|NCT04437433|585635788|FG000|Overall Study|Lack of Efficacy|4|||
162159898|NCT04437433|585635789|FG001|Overall Study|Lack of Efficacy|0|||
162159899|NCT04437433|585635788|FG000|Overall Study|Withdrawal by Subject|4|||
162159900|NCT04437433|585635789|FG001|Overall Study|Withdrawal by Subject|1|||
162159901|NCT04437433|585635788|FG000|Overall Study|Protocol Deviation|0|||
162159902|NCT04437433|585635789|FG001|Overall Study|Protocol Deviation|1|||
162159903|NCT04437433|585635788|FG000|Overall Study|Other, not specified|0|||
162159904|NCT04437433|585635789|FG001|Overall Study|Other, not specified|1|||
162159905|NCT02365766|585635790|FG000|Overall Study|Withdrawal by Subject|0|||
162159906|NCT02365766|585635791|FG001|Overall Study|Withdrawal by Subject|0|||
162159907|NCT02365766|585635792|FG002|Overall Study|Withdrawal by Subject|1|||
162159908|NCT02365766|585635790|FG000|Overall Study|Eligibility Criteria Not Met|0|||
162159909|NCT02365766|585635791|FG001|Overall Study|Eligibility Criteria Not Met|0|||
162159910|NCT02365766|585635792|FG002|Overall Study|Eligibility Criteria Not Met|1|||
162159911|NCT02724956|585635796|FG000|Overall Study|Physician Decision|1|||
162159912|NCT02724956|585635797|FG001|Overall Study|Physician Decision|0|||
162159913|NCT02724956|585635796|FG000|Overall Study|Lack of Efficacy|0|||
162159914|NCT02724956|585635797|FG001|Overall Study|Lack of Efficacy|1|||
162159915|NCT02724956|585635796|FG000|Overall Study|Withdrawal by Subject|0|||
162159916|NCT02724956|585635797|FG001|Overall Study|Withdrawal by Subject|1|||
162159917|NCT03385629|585635803|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
162159918|NCT03385629|585635804|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
162159919|NCT03385629|585635803|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
162159920|NCT03385629|585635804|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
162159921|NCT03385629|585635803|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
162159922|NCT03385629|585635804|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
162159923|NCT04711135|585635808|FG000|Overall Study|Physician Decision|0|||
162159924|NCT04711135|585635809|FG001|Overall Study|Physician Decision|1|||
162159925|NCT04711135|585635808|FG000|Overall Study|Ongoing treatment|0|||
162159926|NCT04711135|585635809|FG001|Overall Study|Ongoing treatment|1|||
162159927|NCT03578536|585635810|FG000|Overall Study|Lost to Follow-up|1|||
162159928|NCT02538900|585635811|FG000|Overall Study|Death|2|||
162159929|NCT02538900|585635812|FG001|Overall Study|Death|2|||
162159930|NCT02538900|585635813|FG002|Overall Study|Death|2|||
162159931|NCT02538900|585635811|FG000|Overall Study|Withdrawal by Subject|18|||
162159932|NCT02538900|585635812|FG001|Overall Study|Withdrawal by Subject|16|||
162159933|NCT02538900|585635813|FG002|Overall Study|Withdrawal by Subject|15|||
162159934|NCT03732820|585635814|FG000|Overall Study|Death|168|||
162159935|NCT03732820|585635815|FG001|Overall Study|Death|203|||
162159936|NCT03732820|585635814|FG000|Overall Study|Other|2|||
162159937|NCT03732820|585635815|FG001|Overall Study|Other|2|||
162159938|NCT03732820|585635814|FG000|Overall Study|Failure to meet randomisation criteria|1|||
162159939|NCT03732820|585635815|FG001|Overall Study|Failure to meet randomisation criteria|1|||
162159940|NCT03732820|585635814|FG000|Overall Study|Patient decision|14|||
162159941|NCT03732820|585635815|FG001|Overall Study|Patient decision|10|||
162159942|NCT03732820|585635814|FG000|Overall Study|Screen failure|0|||
161812949|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812950|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812951|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812952|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812953|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161812954|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
161812955|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812956|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
161812957|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812958|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812959|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812960|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812961|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812962|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812963|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
162159943|NCT03732820|585635815|FG001|Overall Study|Screen failure|1|||
162159944|NCT03732820|585635814|FG000|Overall Study|Patients ongoing study at data cut off|210|||
162159945|NCT03732820|585635815|FG001|Overall Study|Patients ongoing study at data cut off|178|||
162159946|NCT03732820|585635814|FG000|Overall Study|Lost to Follow-up|4|||
162159947|NCT03732820|585635815|FG001|Overall Study|Lost to Follow-up|2|||
162159948|NCT04436107|585635816|FG000|Overall Study|Sponsor Ended Study|2|||
162159949|NCT04436107|585635817|FG001|Overall Study|Sponsor Ended Study|4|||
162159950|NCT04436107|585635818|FG002|Overall Study|Sponsor Ended Study|8|||
162159951|NCT04436107|585635819|FG003|Overall Study|Sponsor Ended Study|20|||
162159952|NCT04436107|585635816|FG000|Overall Study|Death|3|||
162159953|NCT04436107|585635817|FG001|Overall Study|Death|5|||
162159954|NCT04436107|585635818|FG002|Overall Study|Death|3|||
162159955|NCT04436107|585635819|FG003|Overall Study|Death|18|||
162159956|NCT04436107|585635816|FG000|Overall Study|Withdrawal by Subject|1|||
162159957|NCT04436107|585635817|FG001|Overall Study|Withdrawal by Subject|1|||
162159958|NCT04436107|585635818|FG002|Overall Study|Withdrawal by Subject|0|||
162159959|NCT04436107|585635819|FG003|Overall Study|Withdrawal by Subject|1|||
162159960|NCT01095796|585635820|FG000|Overall Study|Randomized but Not Treated|5|||
162159961|NCT01095796|585635821|FG001|Overall Study|Randomized but Not Treated|2|||
162159962|NCT01095796|585635820|FG000|Overall Study|Adverse Event|9|||
162159963|NCT01095796|585635821|FG001|Overall Study|Adverse Event|19|||
162159964|NCT01095796|585635820|FG000|Overall Study|Death|3|||
162159965|NCT01095796|585635821|FG001|Overall Study|Death|2|||
162159966|NCT01095796|585635820|FG000|Overall Study|Pregnancy|2|||
162159967|NCT01095796|585635821|FG001|Overall Study|Pregnancy|0|||
162159968|NCT01095796|585635820|FG000|Overall Study|Lack of Efficacy|5|||
162159969|NCT01095796|585635821|FG001|Overall Study|Lack of Efficacy|3|||
162159970|NCT01095796|585635820|FG000|Overall Study|Investigator's Discretion|7|||
162159971|NCT01095796|585635821|FG001|Overall Study|Investigator's Discretion|2|||
162159972|NCT01095796|585635820|FG000|Overall Study|Withdrew Consent|16|||
162159973|NCT01095796|585635821|FG001|Overall Study|Withdrew Consent|22|||
162159974|NCT01095796|585635820|FG000|Overall Study|Lost to Follow-up|27|||
162159975|NCT01095796|585635821|FG001|Overall Study|Lost to Follow-up|29|||
162159976|NCT01095796|585635820|FG000|Overall Study|Participant Noncompliance|5|||
162159977|NCT01095796|585635821|FG001|Overall Study|Participant Noncompliance|10|||
162159978|NCT01095796|585635820|FG000|Overall Study|Protocol Violation|1|||
162159979|NCT01095796|585635821|FG001|Overall Study|Protocol Violation|0|||
162159980|NCT01095796|585635820|FG000|Overall Study|Participant Transferred to Another Study|215|||
162159981|NCT01095796|585635821|FG001|Overall Study|Participant Transferred to Another Study|200|||
162159982|NCT00999167|585635824|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
162159983|NCT00999167|585635825|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
162159984|NCT00999167|585635826|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
162159985|NCT00999167|585635824|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
162159986|NCT00999167|585635825|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
162159987|NCT00999167|585635826|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
162159988|NCT00999167|585635824|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
162159989|NCT00999167|585635825|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
162159990|NCT00999167|585635826|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
162159991|NCT00999167|585635824|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
162159992|NCT00999167|585635825|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
162159993|NCT00999167|585635826|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
162159994|NCT00999167|585635824|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
162159995|NCT00999167|585635825|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
162159996|NCT00999167|585635826|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
162159997|NCT00999167|585635824|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
162159998|NCT00999167|585635825|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
162159999|NCT00999167|585635826|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
162160000|NCT00999167|585635824|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
162160001|NCT00999167|585635825|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
162160002|NCT00999167|585635826|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
162160003|NCT00999167|585635824|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
162160004|NCT00999167|585635825|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
162160005|NCT00999167|585635826|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
162160006|NCT00604669|585635833|FG000|Overall Study|lack of information in chart|7|||
162160007|NCT01340066|585635834|FG000|Placebo Run in Period|Screen Failures|27|||
162160008|NCT01340066|585635835|FG001|Placebo Run in Period|Screen Failures|0|||
162160009|NCT01340066|585635836|FG002|Placebo Run in Period|Screen Failures|0|||
162160010|NCT01340066|585635834|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
162160011|NCT01340066|585635835|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
162160012|NCT01340066|585635836|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
162160013|NCT01340066|585635834|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
162160014|NCT01340066|585635835|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
162160015|NCT01340066|585635836|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
162160016|NCT01340066|585635834|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
162160017|NCT01340066|585635835|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
162160018|NCT01340066|585635836|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
162160019|NCT02789020|585635837|FG000|Overall Study|Withdrawal by Subject|6|||
162160020|NCT02789020|585635838|FG001|Overall Study|Withdrawal by Subject|5|||
162160021|NCT03338816|585635853|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
162160022|NCT03338816|585635854|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
162160023|NCT03338816|585635855|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
162160024|NCT03338816|585635856|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
162160025|NCT03338816|585635853|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
162160026|NCT03338816|585635854|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
162160027|NCT03338816|585635855|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
162160028|NCT03338816|585635856|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
162160029|NCT03338816|585635853|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
162160030|NCT03338816|585635854|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
162160031|NCT03338816|585635855|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
162160032|NCT03338816|585635856|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
162160033|NCT03338816|585635853|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
162160034|NCT03338816|585635854|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
162160035|NCT03338816|585635855|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
162160036|NCT03338816|585635856|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
162160037|NCT03338816|585635853|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
162160038|NCT03338816|585635854|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
162160039|NCT03338816|585635855|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
162160040|NCT03338816|585635856|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
162160041|NCT03338816|585635853|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
162160042|NCT03338816|585635854|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
162160043|NCT03338816|585635855|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
162160044|NCT03338816|585635856|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
162160045|NCT03338816|585635853|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
162160046|NCT03338816|585635854|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
162160047|NCT03338816|585635855|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
162160048|NCT03338816|585635856|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
162160049|NCT04238247|585635857|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
162160050|NCT04238247|585635858|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
162160051|NCT04238247|585635859|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
162160052|NCT04238247|585635860|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
162160053|NCT04238247|585635857|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
162160054|NCT04238247|585635858|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
162160055|NCT04238247|585635859|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
162160056|NCT04238247|585635860|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
162160057|NCT04238247|585635857|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
162160058|NCT04238247|585635858|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
162160059|NCT04238247|585635859|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
162160060|NCT04238247|585635860|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
162160061|NCT04238247|585635857|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
162160062|NCT04238247|585635858|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
162160063|NCT04238247|585635859|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
162160064|NCT04238247|585635860|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
162160065|NCT05512962|585635861|FG000|Overall Study|Withdrawal by Subject|1|||
162160066|NCT05512962|585635862|FG001|Overall Study|Withdrawal by Subject|0|||
162160067|NCT04950127|585635863|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
162160068|NCT04950127|585635864|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
162160069|NCT04950127|585635865|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
162160070|NCT04950127|585635866|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
162160071|NCT04950127|585635867|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
162160072|NCT04950127|585635868|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
162160073|NCT04950127|585635863|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
162160074|NCT04950127|585635864|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
162160075|NCT04950127|585635865|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
162160076|NCT04950127|585635866|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
162160077|NCT04950127|585635867|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
162160078|NCT04950127|585635868|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
162160079|NCT04950127|585635863|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
162160080|NCT04950127|585635864|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
161916322|NCT02475213|584742420|FG007|Overall Study|Progressive Disease|10|||
161916323|NCT02475213|584742413|FG000|Overall Study|Death|0|||
161916324|NCT02475213|584742414|FG001|Overall Study|Death|0|||
161916325|NCT02475213|584742415|FG002|Overall Study|Death|0|||
161916326|NCT02475213|584742416|FG003|Overall Study|Death|0|||
161916327|NCT02475213|584742417|FG004|Overall Study|Death|0|||
161916328|NCT02475213|584742418|FG005|Overall Study|Death|4|||
161916329|NCT02475213|584742419|FG006|Overall Study|Death|1|||
161916330|NCT02475213|584742420|FG007|Overall Study|Death|0|||
161916331|NCT02475213|584742413|FG000|Overall Study|Protocol Violation|0|||
161916332|NCT02475213|584742414|FG001|Overall Study|Protocol Violation|0|||
161916333|NCT02475213|584742415|FG002|Overall Study|Protocol Violation|0|||
161916334|NCT02475213|584742416|FG003|Overall Study|Protocol Violation|0|||
161916335|NCT02475213|584742417|FG004|Overall Study|Protocol Violation|1|||
161916336|NCT02475213|584742418|FG005|Overall Study|Protocol Violation|0|||
161916337|NCT02475213|584742419|FG006|Overall Study|Protocol Violation|0|||
161916338|NCT02475213|584742420|FG007|Overall Study|Protocol Violation|0|||
161916339|NCT02475213|584742413|FG000|Overall Study|Withdrawal by Subject|0|||
161916340|NCT02475213|584742414|FG001|Overall Study|Withdrawal by Subject|0|||
161916341|NCT02475213|584742415|FG002|Overall Study|Withdrawal by Subject|0|||
161916342|NCT02475213|584742416|FG003|Overall Study|Withdrawal by Subject|1|||
161916343|NCT02475213|584742417|FG004|Overall Study|Withdrawal by Subject|0|||
161916344|NCT02475213|584742418|FG005|Overall Study|Withdrawal by Subject|2|||
161916345|NCT02475213|584742419|FG006|Overall Study|Withdrawal by Subject|2|||
161916346|NCT02475213|584742420|FG007|Overall Study|Withdrawal by Subject|0|||
161916347|NCT02475213|584742413|FG000|Overall Study|Other|0|||
161916348|NCT02475213|584742414|FG001|Overall Study|Other|0|||
161916349|NCT02475213|584742415|FG002|Overall Study|Other|0|||
161916350|NCT02475213|584742416|FG003|Overall Study|Other|1|||
161916351|NCT02475213|584742417|FG004|Overall Study|Other|3|||
161916352|NCT02475213|584742418|FG005|Overall Study|Other|1|||
161916353|NCT02475213|584742419|FG006|Overall Study|Other|0|||
161916354|NCT02475213|584742420|FG007|Overall Study|Other|0|||
161916355|NCT00505921|584742421|FG000|Overall Study|Ineligible|1|||
161916356|NCT00505921|584742421|FG000|Overall Study|Failed to Mobilize|8|||
161916357|NCT00797563|584742422|FG000|Overall Study|Adverse Event|1|||
161916358|NCT03416179|584742423|FG000|Overall Study|Death|90|||
161916359|NCT03416179|584742424|FG001|Overall Study|Death|87|||
161916360|NCT03416179|584742425|FG002|Overall Study|Death|117|||
161916361|NCT03416179|584742426|FG003|Overall Study|Death|113|||
161916362|NCT03416179|584742423|FG000|Overall Study|Withdrawal by Subject|15|||
161916363|NCT03416179|584742424|FG001|Overall Study|Withdrawal by Subject|20|||
161916364|NCT03416179|584742425|FG002|Overall Study|Withdrawal by Subject|6|||
161916365|NCT03416179|584742426|FG003|Overall Study|Withdrawal by Subject|9|||
161916366|NCT03416179|584742423|FG000|Overall Study|Lost to Follow-up|1|||
161916367|NCT03416179|584742424|FG001|Overall Study|Lost to Follow-up|1|||
161916368|NCT03416179|584742425|FG002|Overall Study|Lost to Follow-up|0|||
161916369|NCT03416179|584742426|FG003|Overall Study|Lost to Follow-up|3|||
161916370|NCT03416179|584742423|FG000|Overall Study|Study participation terminated by Sponsor|93|||
161916371|NCT03416179|584742424|FG001|Overall Study|Study participation terminated by Sponsor|91|||
161916372|NCT03416179|584742425|FG002|Overall Study|Study participation terminated by Sponsor|26|||
161916373|NCT03416179|584742426|FG003|Overall Study|Study participation terminated by Sponsor|31|||
161916374|NCT03416179|584742423|FG000|Overall Study|Other|2|||
161916375|NCT03416179|584742424|FG001|Overall Study|Other|3|||
161916376|NCT03416179|584742425|FG002|Overall Study|Other|1|||
161916377|NCT03416179|584742426|FG003|Overall Study|Other|0|||
161916378|NCT00879658|584742432|FG000|Overall Study|Abnormal laboratory value(s)|3|||
161916379|NCT00879658|584742433|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161916380|NCT00879658|584742434|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161916381|NCT00879658|584742435|FG003|Overall Study|Abnormal laboratory value(s)|1|||
161916382|NCT00879658|584742436|FG004|Overall Study|Abnormal laboratory value(s)|0|||
161916383|NCT00879658|584742437|FG005|Overall Study|Abnormal laboratory value(s)|0|||
161916384|NCT00879658|584742438|FG006|Overall Study|Abnormal laboratory value(s)|0|||
161916385|NCT00879658|584742432|FG000|Overall Study|Administrative problems|2|||
161916386|NCT00879658|584742433|FG001|Overall Study|Administrative problems|1|||
161916387|NCT00879658|584742434|FG002|Overall Study|Administrative problems|0|||
161916388|NCT00879658|584742435|FG003|Overall Study|Administrative problems|1|||
161916389|NCT00879658|584742436|FG004|Overall Study|Administrative problems|0|||
161916390|NCT00879658|584742437|FG005|Overall Study|Administrative problems|0|||
161916391|NCT00879658|584742438|FG006|Overall Study|Administrative problems|0|||
161916392|NCT00879658|584742432|FG000|Overall Study|Adverse Event|6|||
161916393|NCT00879658|584742433|FG001|Overall Study|Adverse Event|4|||
161916394|NCT00879658|584742434|FG002|Overall Study|Adverse Event|3|||
161916395|NCT00879658|584742435|FG003|Overall Study|Adverse Event|1|||
161916396|NCT00879658|584742436|FG004|Overall Study|Adverse Event|2|||
161916397|NCT00879658|584742437|FG005|Overall Study|Adverse Event|0|||
161916398|NCT00879658|584742438|FG006|Overall Study|Adverse Event|0|||
162014835|NCT01358721|585108575|FG001|Overall Study|Death|2|||
161916399|NCT00879658|584742432|FG000|Overall Study|Protocol Violation|1|||
162160081|NCT04950127|585635865|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
162160082|NCT04950127|585635866|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
162160083|NCT04950127|585635867|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
162160084|NCT04950127|585635868|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
162160085|NCT04950127|585635863|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
162160086|NCT04950127|585635864|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
162160087|NCT04950127|585635865|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
162160088|NCT04950127|585635866|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
162160089|NCT04950127|585635867|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
162160090|NCT04950127|585635868|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
162160091|NCT04950127|585635863|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
162160092|NCT04950127|585635864|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
162160093|NCT04950127|585635865|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
162160094|NCT04950127|585635866|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
162160095|NCT04950127|585635867|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
162160096|NCT04950127|585635868|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
162160097|NCT01711632|585635869|FG000|Overall Study|Adverse Event|4|||
162160098|NCT01711632|585635869|FG000|Overall Study|Death|3|||
162160099|NCT01711632|585635869|FG000|Overall Study|Lost to Follow-up|3|||
162160100|NCT01711632|585635869|FG000|Overall Study|Withdrawal by Subject|4|||
162160101|NCT01711632|585635869|FG000|Overall Study|Progressive disease|2|||
162160102|NCT01711632|585635869|FG000|Overall Study|No follow up required in re-treatment|3|||
162160103|NCT01711632|585635869|FG000|Overall Study|No follow up required in re-treatment|3|||
162160104|NCT03517969|585635870|FG000|Overall Study|Never started protocol treatment|3|||
162160105|NCT03517969|585635871|FG001|Overall Study|Never started protocol treatment|5|||
162160106|NCT03517969|585635870|FG000|Overall Study|Disease progression|11|||
162160107|NCT03517969|585635871|FG001|Overall Study|Disease progression|16|||
162160108|NCT03517969|585635870|FG000|Overall Study|PSA progression|8|||
162160109|NCT03517969|585635871|FG001|Overall Study|PSA progression|1|||
162160110|NCT03517969|585635870|FG000|Overall Study|Clinical progression|4|||
162160111|NCT03517969|585635871|FG001|Overall Study|Clinical progression|2|||
162160112|NCT03517969|585635870|FG000|Overall Study|Adverse Event|5|||
162160113|NCT03517969|585635871|FG001|Overall Study|Adverse Event|4|||
162160114|NCT03517969|585635870|FG000|Overall Study|Intercurrent illness|1|||
162160115|NCT03517969|585635871|FG001|Overall Study|Intercurrent illness|2|||
162160116|NCT03517969|585635870|FG000|Overall Study|Death|1|||
162160117|NCT03517969|585635871|FG001|Overall Study|Death|1|||
162160118|NCT03517969|585635870|FG000|Overall Study|Withdrawal by Subject|1|||
162160119|NCT03517969|585635871|FG001|Overall Study|Withdrawal by Subject|2|||
162160120|NCT03517969|585635870|FG000|Overall Study|Physician Decision|1|||
162160121|NCT03517969|585635871|FG001|Overall Study|Physician Decision|1|||
162160122|NCT03517969|585635870|FG000|Overall Study|No clinical benefit|1|||
162160123|NCT03517969|585635871|FG001|Overall Study|No clinical benefit|0|||
162160124|NCT03517969|585635870|FG000|Overall Study|Delayed treatment for dental treatment|1|||
162160125|NCT03517969|585635871|FG001|Overall Study|Delayed treatment for dental treatment|0|||
162160126|NCT03517969|585635870|FG000|Overall Study|Difficult to maintain appointment|0|||
162160127|NCT03517969|585635871|FG001|Overall Study|Difficult to maintain appointment|1|||
162160128|NCT03517969|585635870|FG000|Overall Study|Protocol Violation|0|||
162160129|NCT03517969|585635871|FG001|Overall Study|Protocol Violation|1|||
162160130|NCT02860130|585635872|FG000|Overall Study|Adverse Event|2|||
162160131|NCT02860130|585635873|FG001|Overall Study|Adverse Event|3|||
162160132|NCT02860130|585635872|FG000|Overall Study|Protocol Violation|1|||
162160133|NCT02860130|585635873|FG001|Overall Study|Protocol Violation|1|||
162160134|NCT02860130|585635872|FG000|Overall Study|Withdrawal by Subject|0|||
162160135|NCT02860130|585635873|FG001|Overall Study|Withdrawal by Subject|2|||
162160136|NCT02860130|585635872|FG000|Overall Study|Physician Decision|2|||
162160137|NCT02860130|585635873|FG001|Overall Study|Physician Decision|2|||
162160138|NCT02860130|585635872|FG000|Overall Study|Other|2|||
162160139|NCT02860130|585635873|FG001|Overall Study|Other|1|||
161812964|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812965|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812966|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812967|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161812968|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
161812969|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
161812970|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
161812971|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812972|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812973|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812974|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812975|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812976|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161916400|NCT00879658|584742433|FG001|Overall Study|Protocol Violation|0|||
162160140|NCT02140645|585635876|FG000|Overall Study|Not linked|5489|||
162160141|NCT02140645|585635877|FG001|Overall Study|Not linked|61654|||
162160142|NCT02140645|585635878|FG002|Overall Study|Not linked|4236|||
162160143|NCT02140645|585635879|FG003|Overall Study|Not linked|13833|||
162160144|NCT02140645|585635880|FG004|Overall Study|Not linked|3286|||
162160145|NCT02140645|585635881|FG005|Overall Study|Not linked|70896|||
162160146|NCT01101451|585635882|FG000|Overall Study|Eligible and never treated|0|||
162160147|NCT01101451|585635883|FG001|Overall Study|Eligible and never treated|5|||
162160148|NCT01101451|585635882|FG000|Overall Study|Ineligible and treated|12|||
162160149|NCT01101451|585635883|FG001|Overall Study|Ineligible and treated|8|||
162160150|NCT01101451|585635882|FG000|Overall Study|Ineligible and never treated|2|||
162160151|NCT01101451|585635883|FG001|Overall Study|Ineligible and never treated|2|||
162160152|NCT02965846|585635889|FG000|Overall Study|Lost to Follow-up|1|||
162160153|NCT02965846|585635890|FG001|Overall Study|Lost to Follow-up|0|||
162160154|NCT02965846|585635891|FG002|Overall Study|Lost to Follow-up|0|||
162160155|NCT02965846|585635889|FG000|Overall Study|Withdrawal by Subject|0|||
162160156|NCT02965846|585635890|FG001|Overall Study|Withdrawal by Subject|1|||
162160157|NCT02965846|585635891|FG002|Overall Study|Withdrawal by Subject|0|||
162160158|NCT02965846|585635889|FG000|Overall Study|Study Terminated By Sponsor|4|||
162160159|NCT02965846|585635890|FG001|Overall Study|Study Terminated By Sponsor|4|||
162160160|NCT02965846|585635891|FG002|Overall Study|Study Terminated By Sponsor|0|||
162160161|NCT02965846|585635889|FG000|Overall Study|Participants not randomized|0|||
162160162|NCT02965846|585635890|FG001|Overall Study|Participants not randomized|0|||
162160163|NCT02965846|585635891|FG002|Overall Study|Participants not randomized|33|||
162160164|NCT02794480|585635892|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
162160165|NCT02794480|585635893|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
162160166|NCT02794480|585635894|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
162160167|NCT02794480|585635895|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
162160168|NCT02794480|585635892|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
162160169|NCT02794480|585635893|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
162160170|NCT02794480|585635894|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
162160171|NCT02794480|585635895|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
162160172|NCT02794480|585635892|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162160173|NCT02794480|585635893|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162160174|NCT02794480|585635894|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162160175|NCT02794480|585635895|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
162160176|NCT02794480|585635892|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162160177|NCT02794480|585635893|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
162160178|NCT02794480|585635894|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162160179|NCT02794480|585635895|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
162160180|NCT02794480|585635892|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
162160181|NCT02794480|585635893|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162160182|NCT02794480|585635894|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162160183|NCT02794480|585635895|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
162160184|NCT01070069|585635896|FG000|Overall Study|Death|1|||
162160185|NCT01070069|585635897|FG001|Overall Study|Death|0|||
162160186|NCT01070069|585635898|FG002|Overall Study|Death|2|||
162160187|NCT01070069|585635899|FG003|Overall Study|Death|0|||
162160188|NCT01070069|585635900|FG004|Overall Study|Death|1|||
162160189|NCT01070069|585635896|FG000|Overall Study|Withdrawal by Subject|1|||
162160190|NCT01070069|585635897|FG001|Overall Study|Withdrawal by Subject|1|||
162160191|NCT01070069|585635898|FG002|Overall Study|Withdrawal by Subject|4|||
162160192|NCT01070069|585635899|FG003|Overall Study|Withdrawal by Subject|0|||
162160193|NCT01070069|585635900|FG004|Overall Study|Withdrawal by Subject|0|||
162160194|NCT01070069|585635896|FG000|Overall Study|Lost to Follow-up|4|||
162160195|NCT01070069|585635897|FG001|Overall Study|Lost to Follow-up|1|||
162160196|NCT01070069|585635898|FG002|Overall Study|Lost to Follow-up|0|||
162160197|NCT01070069|585635899|FG003|Overall Study|Lost to Follow-up|0|||
162160198|NCT01070069|585635900|FG004|Overall Study|Lost to Follow-up|3|||
162160199|NCT01747486|585635901|FG000|Stage 1|Physician Decision|3|||
162160200|NCT01747486|585635902|FG001|Stage 1|Physician Decision|0|||
161916401|NCT00879658|584742434|FG002|Overall Study|Protocol Violation|0|||
161916402|NCT00879658|584742435|FG003|Overall Study|Protocol Violation|0|||
161916403|NCT00879658|584742436|FG004|Overall Study|Protocol Violation|0|||
161916404|NCT00879658|584742437|FG005|Overall Study|Protocol Violation|0|||
161916405|NCT00879658|584742438|FG006|Overall Study|Protocol Violation|0|||
161916406|NCT00879658|584742432|FG000|Overall Study|Withdrawal by Subject|3|||
161916407|NCT00879658|584742433|FG001|Overall Study|Withdrawal by Subject|0|||
161916408|NCT00879658|584742434|FG002|Overall Study|Withdrawal by Subject|2|||
161916409|NCT00879658|584742435|FG003|Overall Study|Withdrawal by Subject|0|||
161916410|NCT00879658|584742436|FG004|Overall Study|Withdrawal by Subject|0|||
161916411|NCT00879658|584742437|FG005|Overall Study|Withdrawal by Subject|1|||
161916412|NCT00879658|584742438|FG006|Overall Study|Withdrawal by Subject|0|||
162160201|NCT01747486|585635901|FG000|Stage 1|Withdrawal by Subject|4|||
162014836|NCT01358721|585108576|FG002|Overall Study|Death|0|||
162014837|NCT01358721|585108577|FG003|Overall Study|Death|0|||
162014838|NCT01358721|585108574|FG000|Overall Study|Study Drug Toxicity|1|||
162014839|NCT01358721|585108575|FG001|Overall Study|Study Drug Toxicity|3|||
162014840|NCT01358721|585108576|FG002|Overall Study|Study Drug Toxicity|4|||
162014841|NCT01358721|585108577|FG003|Overall Study|Study Drug Toxicity|5|||
162014842|NCT01358721|585108574|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
162014843|NCT01358721|585108575|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
162014844|NCT01358721|585108576|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
162014845|NCT01358721|585108577|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
162014846|NCT01358721|585108574|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
162014847|NCT01358721|585108575|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
161812977|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812978|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162014848|NCT01358721|585108576|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
162014849|NCT01358721|585108577|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
161812979|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812980|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812981|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161812982|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
161812983|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812984|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
161812985|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812986|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812987|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812988|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812989|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812990|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812991|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812992|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812993|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812994|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812995|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161812996|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161812997|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161812998|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161812999|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813000|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813001|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813002|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813003|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813004|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813005|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813006|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813007|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813008|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813009|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161813010|NCT01695239|584359794|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
161813011|NCT01695239|584359795|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813012|NCT01695239|584359796|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813013|NCT01695239|584359797|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813014|NCT01695239|584359798|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813015|NCT01695239|584359799|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813016|NCT01695239|584359800|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813017|NCT01695239|584359801|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813018|NCT01695239|584359802|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813019|NCT01695239|584359803|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813020|NCT01695239|584359804|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813021|NCT01695239|584359805|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813022|NCT01695239|584359806|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813023|NCT01695239|584359807|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161813024|NCT01695239|584359794|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813025|NCT01695239|584359795|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813026|NCT01695239|584359796|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162014850|NCT01358721|585108574|FG000|Overall Study|Adverse Event related to study drug|1|||
162014851|NCT01358721|585108575|FG001|Overall Study|Adverse Event related to study drug|0|||
162014852|NCT01358721|585108576|FG002|Overall Study|Adverse Event related to study drug|0|||
162160202|NCT01747486|585635902|FG001|Stage 1|Withdrawal by Subject|3|||
162160203|NCT01747486|585635901|FG000|Stage 1|Disease progression|4|||
162160204|NCT01747486|585635902|FG001|Stage 1|Disease progression|9|||
162160205|NCT01747486|585635901|FG000|Stage 1|Death|1|||
162160206|NCT01747486|585635902|FG001|Stage 1|Death|1|||
162160207|NCT01747486|585635901|FG000|Stage 2|Physician Decision|2|||
162160208|NCT01747486|585635902|FG001|Stage 2|Physician Decision|0|||
162160209|NCT01747486|585635901|FG000|Stage 2|Withdrawal by Subject|1|||
162160210|NCT01747486|585635902|FG001|Stage 2|Withdrawal by Subject|0|||
162160211|NCT01747486|585635901|FG000|Stage 2|New Cancer Therapy|3|||
162160212|NCT01747486|585635902|FG001|Stage 2|New Cancer Therapy|0|||
162160213|NCT01747486|585635901|FG000|Stage 2|Disease Progression|3|||
162160214|NCT01747486|585635902|FG001|Stage 2|Disease Progression|0|||
162160215|NCT00632749|585635903|FG000|Overall Study|Progressive disease|3|||
162160216|NCT00632749|585635904|FG001|Overall Study|Progressive disease|2|||
162160217|NCT00632749|585635905|FG002|Overall Study|Progressive disease|2|||
162160218|NCT00632749|585635906|FG003|Overall Study|Progressive disease|2|||
162160219|NCT00632749|585635907|FG004|Overall Study|Progressive disease|4|||
162160220|NCT00632749|585635908|FG005|Overall Study|Progressive disease|4|||
162160221|NCT00632749|585635909|FG006|Overall Study|Progressive disease|3|||
162160222|NCT00632749|585635910|FG007|Overall Study|Progressive disease|2|||
162160223|NCT00632749|585635911|FG008|Overall Study|Progressive disease|3|||
162160224|NCT00632749|585635912|FG009|Overall Study|Progressive disease|2|||
162160225|NCT00632749|585635913|FG010|Overall Study|Progressive disease|4|||
162160226|NCT00632749|585635914|FG011|Overall Study|Progressive disease|3|||
162160227|NCT00632749|585635915|FG012|Overall Study|Progressive disease|2|||
162160228|NCT00632749|585635916|FG013|Overall Study|Progressive disease|4|||
162160229|NCT00632749|585635903|FG000|Overall Study|Other Adverse event|1|||
162160230|NCT00632749|585635904|FG001|Overall Study|Other Adverse event|1|||
162160231|NCT00632749|585635905|FG002|Overall Study|Other Adverse event|1|||
162160232|NCT00632749|585635906|FG003|Overall Study|Other Adverse event|1|||
162160233|NCT00632749|585635907|FG004|Overall Study|Other Adverse event|2|||
162160234|NCT00632749|585635908|FG005|Overall Study|Other Adverse event|4|||
162160235|NCT00632749|585635909|FG006|Overall Study|Other Adverse event|1|||
162160236|NCT00632749|585635910|FG007|Overall Study|Other Adverse event|2|||
162160237|NCT00632749|585635911|FG008|Overall Study|Other Adverse event|2|||
162160238|NCT00632749|585635912|FG009|Overall Study|Other Adverse event|0|||
162160239|NCT00632749|585635913|FG010|Overall Study|Other Adverse event|1|||
162160240|NCT00632749|585635914|FG011|Overall Study|Other Adverse event|0|||
162160241|NCT00632749|585635915|FG012|Overall Study|Other Adverse event|1|||
162160242|NCT00632749|585635916|FG013|Overall Study|Other Adverse event|0|||
162160243|NCT00632749|585635903|FG000|Overall Study|Refuse to continue medication|0|||
162014853|NCT01358721|585108577|FG003|Overall Study|Adverse Event related to study drug|1|||
162014854|NCT01358721|585108574|FG000|Overall Study|Disease Progression|19|||
162014855|NCT01358721|585108575|FG001|Overall Study|Disease Progression|15|||
162014856|NCT01358721|585108576|FG002|Overall Study|Disease Progression|17|||
162014857|NCT01358721|585108577|FG003|Overall Study|Disease Progression|15|||
162014858|NCT01358721|585108574|FG000|Overall Study|Out of State/Unmet Criteria|0|||
162014859|NCT01358721|585108575|FG001|Overall Study|Out of State/Unmet Criteria|0|||
162014860|NCT01358721|585108576|FG002|Overall Study|Out of State/Unmet Criteria|1|||
162014861|NCT01358721|585108577|FG003|Overall Study|Out of State/Unmet Criteria|0|||
162014862|NCT03198507|585108578|FG000|Overall Study|Withdrawal by Subject|1|||
162014863|NCT03198507|585108579|FG001|Overall Study|Withdrawal by Subject|0|||
162014864|NCT04614974|585108580|FG000|Overall Study|Lost to Follow-up|14|||
162014865|NCT04614974|585108581|FG001|Overall Study|Lost to Follow-up|11|||
162014866|NCT00658359|585108583|FG000|Overall Study|Death|3|||
162014867|NCT00658359|585108584|FG001|Overall Study|Death|1|||
162014868|NCT00658359|585108585|FG002|Overall Study|Death|2|||
162014869|NCT00658359|585108583|FG000|Overall Study|Adverse Event|13|||
162014870|NCT00658359|585108584|FG001|Overall Study|Adverse Event|6|||
162014871|NCT00658359|585108585|FG002|Overall Study|Adverse Event|9|||
162014872|NCT00658359|585108583|FG000|Overall Study|Protocol Violation|1|||
162160244|NCT00632749|585635904|FG001|Overall Study|Refuse to continue medication|0|||
162014873|NCT00658359|585108584|FG001|Overall Study|Protocol Violation|0|||
162160245|NCT00632749|585635905|FG002|Overall Study|Refuse to continue medication|0|||
162014874|NCT00658359|585108585|FG002|Overall Study|Protocol Violation|0|||
162014875|NCT00658359|585108583|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
162014876|NCT00658359|585108584|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
162014877|NCT00658359|585108585|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
162014878|NCT00658359|585108583|FG000|Overall Study|Withdrawal by Subject|7|||
162160246|NCT00632749|585635906|FG003|Overall Study|Refuse to continue medication|1|||
162160247|NCT00632749|585635907|FG004|Overall Study|Refuse to continue medication|0|||
162160248|NCT00632749|585635908|FG005|Overall Study|Refuse to continue medication|0|||
162014879|NCT00658359|585108584|FG001|Overall Study|Withdrawal by Subject|4|||
162014880|NCT00658359|585108585|FG002|Overall Study|Withdrawal by Subject|2|||
162014881|NCT00658359|585108583|FG000|Overall Study|Lost to Follow-up|2|||
162160249|NCT00632749|585635909|FG006|Overall Study|Refuse to continue medication|0|||
162160250|NCT00632749|585635910|FG007|Overall Study|Refuse to continue medication|0|||
162160251|NCT00632749|585635911|FG008|Overall Study|Refuse to continue medication|0|||
162160252|NCT00632749|585635912|FG009|Overall Study|Refuse to continue medication|1|||
162160253|NCT00632749|585635913|FG010|Overall Study|Refuse to continue medication|0|||
162160254|NCT00632749|585635914|FG011|Overall Study|Refuse to continue medication|0|||
162160255|NCT00632749|585635915|FG012|Overall Study|Refuse to continue medication|0|||
162160256|NCT00632749|585635916|FG013|Overall Study|Refuse to continue medication|0|||
162160257|NCT00632749|585635903|FG000|Overall Study|Reason other than those specified above|0|||
162160258|NCT00632749|585635904|FG001|Overall Study|Reason other than those specified above|2|||
162160259|NCT00632749|585635905|FG002|Overall Study|Reason other than those specified above|0|||
162160260|NCT00632749|585635906|FG003|Overall Study|Reason other than those specified above|0|||
162160261|NCT00632749|585635907|FG004|Overall Study|Reason other than those specified above|1|||
162160262|NCT00632749|585635908|FG005|Overall Study|Reason other than those specified above|0|||
162160263|NCT00632749|585635909|FG006|Overall Study|Reason other than those specified above|1|||
162160264|NCT00632749|585635910|FG007|Overall Study|Reason other than those specified above|0|||
162160265|NCT00632749|585635911|FG008|Overall Study|Reason other than those specified above|0|||
162160266|NCT00632749|585635912|FG009|Overall Study|Reason other than those specified above|0|||
162160267|NCT00632749|585635913|FG010|Overall Study|Reason other than those specified above|2|||
162160268|NCT00632749|585635914|FG011|Overall Study|Reason other than those specified above|1|||
162160269|NCT00632749|585635915|FG012|Overall Study|Reason other than those specified above|0|||
162160270|NCT00632749|585635916|FG013|Overall Study|Reason other than those specified above|2|||
162160271|NCT00611559|585635917|FG000|Overall Study|Lost to Follow-up|0|||
162160272|NCT00611559|585635918|FG001|Overall Study|Lost to Follow-up|1|||
162160273|NCT00611559|585635919|FG002|Overall Study|Lost to Follow-up|0|||
162160274|NCT00611559|585635917|FG000|Overall Study|Protocol Violation|1|||
162160275|NCT00611559|585635918|FG001|Overall Study|Protocol Violation|0|||
162160276|NCT00611559|585635919|FG002|Overall Study|Protocol Violation|1|||
162160277|NCT00879333|585635920|FG000|Overall Study|Adverse Event|94|||
162160278|NCT00879333|585635921|FG001|Overall Study|Adverse Event|34|||
162160279|NCT00879333|585635920|FG000|Overall Study|Abnormal Laboratory Value|1|||
162160280|NCT00879333|585635921|FG001|Overall Study|Abnormal Laboratory Value|0|||
162160281|NCT00879333|585635920|FG000|Overall Study|Withdrawal by Subject|20|||
162160282|NCT00879333|585635921|FG001|Overall Study|Withdrawal by Subject|7|||
162160283|NCT00879333|585635920|FG000|Overall Study|Lost to Follow-up|2|||
162160284|NCT00879333|585635921|FG001|Overall Study|Lost to Follow-up|1|||
162160285|NCT00879333|585635920|FG000|Overall Study|Administrative Problems|2|||
162160286|NCT00879333|585635921|FG001|Overall Study|Administrative Problems|0|||
162160287|NCT00879333|585635920|FG000|Overall Study|Death|16|||
162160288|NCT00879333|585635921|FG001|Overall Study|Death|5|||
162160289|NCT00879333|585635920|FG000|Overall Study|Disease Progression|292|||
162160290|NCT00879333|585635921|FG001|Overall Study|Disease Progression|169|||
162160291|NCT00879333|585635920|FG000|Overall Study|Protocol Violation|1|||
162160292|NCT00879333|585635921|FG001|Overall Study|Protocol Violation|1|||
162160293|NCT02671435|585635922|FG000|Overall Study|Death|1|||
162160294|NCT02671435|585635923|FG001|Overall Study|Death|3|||
162160295|NCT02671435|585635924|FG002|Overall Study|Death|0|||
162160296|NCT02671435|585635925|FG003|Overall Study|Death|16|||
162160297|NCT02671435|585635926|FG004|Overall Study|Death|14|||
162160298|NCT02671435|585635927|FG005|Overall Study|Death|29|||
162160299|NCT02671435|585635928|FG006|Overall Study|Death|34|||
162160300|NCT02671435|585635929|FG007|Overall Study|Death|28|||
162160301|NCT02671435|585635930|FG008|Overall Study|Death|19|||
162160302|NCT02671435|585635931|FG009|Overall Study|Death|10|||
162160303|NCT02671435|585635932|FG010|Overall Study|Death|8|||
162160304|NCT02671435|585635933|FG011|Overall Study|Death|29|||
162160305|NCT02671435|585635934|FG012|Overall Study|Death|29|||
162160306|NCT02671435|585635935|FG013|Overall Study|Death|29|||
162160307|NCT02671435|585635936|FG014|Overall Study|Death|27|||
162160308|NCT02671435|585635922|FG000|Overall Study|Lost to Follow-up|0|||
162160309|NCT02671435|585635923|FG001|Overall Study|Lost to Follow-up|0|||
161813027|NCT01695239|584359797|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813028|NCT01695239|584359798|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162160310|NCT02671435|585635924|FG002|Overall Study|Lost to Follow-up|1|||
162160311|NCT02671435|585635925|FG003|Overall Study|Lost to Follow-up|0|||
162160312|NCT02671435|585635926|FG004|Overall Study|Lost to Follow-up|1|||
162160313|NCT02671435|585635927|FG005|Overall Study|Lost to Follow-up|1|||
161813029|NCT01695239|584359799|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161916413|NCT00879658|584742432|FG000|Overall Study|Lack of Efficacy|0|||
162160314|NCT02671435|585635928|FG006|Overall Study|Lost to Follow-up|2|||
162160315|NCT02671435|585635929|FG007|Overall Study|Lost to Follow-up|2|||
162160316|NCT02671435|585635930|FG008|Overall Study|Lost to Follow-up|0|||
162160317|NCT02671435|585635931|FG009|Overall Study|Lost to Follow-up|2|||
162160318|NCT02671435|585635932|FG010|Overall Study|Lost to Follow-up|0|||
162160319|NCT02671435|585635933|FG011|Overall Study|Lost to Follow-up|3|||
162160320|NCT02671435|585635934|FG012|Overall Study|Lost to Follow-up|3|||
161916414|NCT00879658|584742433|FG001|Overall Study|Lack of Efficacy|0|||
161916415|NCT00879658|584742434|FG002|Overall Study|Lack of Efficacy|2|||
161916416|NCT00879658|584742435|FG003|Overall Study|Lack of Efficacy|0|||
161813030|NCT01695239|584359800|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813031|NCT01695239|584359801|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
161813032|NCT01695239|584359802|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
162160321|NCT02671435|585635935|FG013|Overall Study|Lost to Follow-up|2|||
162160322|NCT02671435|585635936|FG014|Overall Study|Lost to Follow-up|0|||
162160323|NCT02671435|585635922|FG000|Overall Study|Withdrawal by Subject|2|||
162160324|NCT02671435|585635923|FG001|Overall Study|Withdrawal by Subject|0|||
162160325|NCT02671435|585635924|FG002|Overall Study|Withdrawal by Subject|2|||
162160326|NCT02671435|585635925|FG003|Overall Study|Withdrawal by Subject|2|||
162160327|NCT02671435|585635926|FG004|Overall Study|Withdrawal by Subject|2|||
162160328|NCT02671435|585635927|FG005|Overall Study|Withdrawal by Subject|7|||
162160329|NCT02671435|585635928|FG006|Overall Study|Withdrawal by Subject|2|||
162160330|NCT02671435|585635929|FG007|Overall Study|Withdrawal by Subject|7|||
162160331|NCT02671435|585635930|FG008|Overall Study|Withdrawal by Subject|1|||
162160332|NCT02671435|585635931|FG009|Overall Study|Withdrawal by Subject|1|||
162160333|NCT02671435|585635932|FG010|Overall Study|Withdrawal by Subject|2|||
162160334|NCT02671435|585635933|FG011|Overall Study|Withdrawal by Subject|4|||
162160335|NCT02671435|585635934|FG012|Overall Study|Withdrawal by Subject|4|||
162160336|NCT02671435|585635935|FG013|Overall Study|Withdrawal by Subject|4|||
162160337|NCT02671435|585635936|FG014|Overall Study|Withdrawal by Subject|2|||
162160338|NCT02671435|585635922|FG000|Overall Study|Un-specified|0|||
162160339|NCT02671435|585635923|FG001|Overall Study|Un-specified|0|||
162160340|NCT02671435|585635924|FG002|Overall Study|Un-specified|0|||
162160341|NCT02671435|585635925|FG003|Overall Study|Un-specified|0|||
162160342|NCT02671435|585635926|FG004|Overall Study|Un-specified|1|||
162160343|NCT02671435|585635927|FG005|Overall Study|Un-specified|3|||
162160344|NCT02671435|585635928|FG006|Overall Study|Un-specified|2|||
162160345|NCT02671435|585635929|FG007|Overall Study|Un-specified|3|||
162160346|NCT02671435|585635930|FG008|Overall Study|Un-specified|0|||
162160347|NCT02671435|585635931|FG009|Overall Study|Un-specified|5|||
162160348|NCT02671435|585635932|FG010|Overall Study|Un-specified|8|||
162160349|NCT02671435|585635933|FG011|Overall Study|Un-specified|4|||
162160350|NCT02671435|585635934|FG012|Overall Study|Un-specified|5|||
162160351|NCT02671435|585635935|FG013|Overall Study|Un-specified|9|||
162160352|NCT02671435|585635936|FG014|Overall Study|Un-specified|8|||
162160353|NCT04128319|585635939|FG000|Overall Study|Death|3|||
162160354|NCT00976937|585635940|FG000|Overall Study|Adverse Event|4|||
162160355|NCT00976937|585635941|FG001|Overall Study|Adverse Event|5|||
162160356|NCT00976937|585635940|FG000|Overall Study|Lost to Follow-up|2|||
162160357|NCT00976937|585635941|FG001|Overall Study|Lost to Follow-up|1|||
162160358|NCT00976937|585635940|FG000|Overall Study|Withdrawal by Subject|5|||
162160359|NCT00976937|585635941|FG001|Overall Study|Withdrawal by Subject|3|||
162160360|NCT00976937|585635940|FG000|Overall Study|Poor compliance to protocol|3|||
162160361|NCT00976937|585635941|FG001|Overall Study|Poor compliance to protocol|0|||
162160362|NCT00976937|585635940|FG000|Overall Study|Personal and Familial Reason|2|||
162160363|NCT00976937|585635941|FG001|Overall Study|Personal and Familial Reason|2|||
162160364|NCT01044303|585635944|FG000|Overall Study|Lost to Follow-up|2|||
162160365|NCT01227265|585635945|FG000|Overall Study|Did Not Receive Treatment|1|||
162160366|NCT01227265|585635946|FG001|Overall Study|Did Not Receive Treatment|2|||
162160367|NCT01227265|585635947|FG002|Overall Study|Did Not Receive Treatment|0|||
161813033|NCT01695239|584359803|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813034|NCT01695239|584359804|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813035|NCT01695239|584359805|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813036|NCT01695239|584359806|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813037|NCT01695239|584359807|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161813038|NCT01695239|584359794|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813039|NCT01695239|584359795|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813040|NCT01695239|584359796|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813041|NCT01695239|584359797|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813042|NCT01695239|584359798|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813043|NCT01695239|584359799|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162160368|NCT01227265|585635945|FG000|Overall Study|Administrative|1|||
162160369|NCT01227265|585635946|FG001|Overall Study|Administrative|0|||
162160370|NCT01227265|585635947|FG002|Overall Study|Administrative|2|||
162160371|NCT01227265|585635945|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
162160372|NCT01227265|585635946|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
162160373|NCT01227265|585635947|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
162160374|NCT01227265|585635945|FG000|Overall Study|Protocol Violation|2|||
162160375|NCT01227265|585635946|FG001|Overall Study|Protocol Violation|1|||
162160376|NCT01227265|585635947|FG002|Overall Study|Protocol Violation|0|||
162160377|NCT01227265|585635945|FG000|Overall Study|Withdrawal by Subject|7|||
162160378|NCT01227265|585635946|FG001|Overall Study|Withdrawal by Subject|7|||
162160379|NCT01227265|585635947|FG002|Overall Study|Withdrawal by Subject|3|||
162160380|NCT01227265|585635945|FG000|Overall Study|Lost to Follow-up|2|||
162160381|NCT01227265|585635946|FG001|Overall Study|Lost to Follow-up|0|||
162160382|NCT01227265|585635947|FG002|Overall Study|Lost to Follow-up|3|||
162160383|NCT01227265|585635945|FG000|Overall Study|Adverse Event|6|||
162160384|NCT01227265|585635946|FG001|Overall Study|Adverse Event|10|||
162160385|NCT01227265|585635947|FG002|Overall Study|Adverse Event|5|||
162160386|NCT06450405|585635951|FG000|Overall Study|Study funding terminated.|0|||
162160387|NCT06450405|585635952|FG001|Overall Study|Study funding terminated.|2|||
162160388|NCT03767517|585635953|FG000|Overall Study|Lost to Follow-up|16|||
162160389|NCT03767517|585635954|FG001|Overall Study|Lost to Follow-up|10|||
162160390|NCT03767517|585635953|FG000|Overall Study|Death|2|||
162160391|NCT03767517|585635954|FG001|Overall Study|Death|3|||
162160392|NCT06024174|585635955|FG000|Overall Study|Other Reasons|1|||
162160393|NCT06024174|585635955|FG000|Overall Study|Study terminated by Sponsor|4|||
162160394|NCT03152786|585637372|FG000|Overall Study|Withdrawal by Subject|2|||
162160395|NCT03152786|585637373|FG001|Overall Study|Withdrawal by Subject|1|||
162160396|NCT00979576|585637374|FG000|Combination Treatment Phase|Progressive disease|3|||
162160397|NCT00979576|585637375|FG001|Combination Treatment Phase|Progressive disease|1|||
162160398|NCT00979576|585637376|FG002|Combination Treatment Phase|Progressive disease|5|||
162160399|NCT00979576|585637374|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
162160400|NCT00979576|585637375|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
162160401|NCT00979576|585637376|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
162160402|NCT00979576|585637374|FG000|Combination Treatment Phase|Adverse Event|0|||
162160403|NCT00979576|585637375|FG001|Combination Treatment Phase|Adverse Event|2|||
162160404|NCT00979576|585637376|FG002|Combination Treatment Phase|Adverse Event|2|||
162160405|NCT00979576|585637374|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
162160406|NCT00979576|585637375|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
162160407|NCT00979576|585637376|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
162160408|NCT03438188|585637377|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
162160409|NCT03438188|585637378|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
162160410|NCT03438188|585637379|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
162160411|NCT03438188|585637377|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
162160412|NCT03438188|585637378|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
162160413|NCT03438188|585637379|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
162160414|NCT03438188|585637377|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
162160415|NCT03438188|585637378|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
162160416|NCT03438188|585637379|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
162160417|NCT03438188|585637377|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
162160418|NCT03438188|585637378|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
162160419|NCT03438188|585637379|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
162160420|NCT03438188|585637377|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
162160421|NCT03438188|585637378|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
162160422|NCT03438188|585637379|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
162160423|NCT02163447|585637380|FG000|Overall Study|Withdrawal by Subject|2|||
162160424|NCT02163447|585637381|FG001|Overall Study|Withdrawal by Subject|0|||
162160425|NCT02163447|585637382|FG002|Overall Study|Withdrawal by Subject|1|||
162160426|NCT02163447|585637380|FG000|Overall Study|Lost to Follow-up|1|||
162160427|NCT02163447|585637381|FG001|Overall Study|Lost to Follow-up|3|||
162160428|NCT02163447|585637382|FG002|Overall Study|Lost to Follow-up|0|||
162160429|NCT02163447|585637380|FG000|Overall Study|Moved out of study area|2|||
162160430|NCT02163447|585637381|FG001|Overall Study|Moved out of study area|3|||
162160431|NCT02163447|585637382|FG002|Overall Study|Moved out of study area|2|||
162160432|NCT02163447|585637380|FG000|Overall Study|Became HIV infected at time of delivery|1|||
162160433|NCT02163447|585637381|FG001|Overall Study|Became HIV infected at time of delivery|0|||
162160434|NCT02163447|585637382|FG002|Overall Study|Became HIV infected at time of delivery|0|||
162160435|NCT03157167|585637383|FG000|Overall Study|Withdrawal by Subject|1|||
162160436|NCT03157167|585637384|FG001|Overall Study|Withdrawal by Subject|0|||
162160437|NCT03157167|585637385|FG002|Overall Study|Withdrawal by Subject|0|||
162160438|NCT02597946|585637387|FG000|Overall Study|Withdrawal by Subject|1|||
162160439|NCT02597946|585637387|FG000|Overall Study|Progressive disease|16|||
161916417|NCT00879658|584742436|FG004|Overall Study|Lack of Efficacy|0|||
161916418|NCT00879658|584742437|FG005|Overall Study|Lack of Efficacy|0|||
161916419|NCT00879658|584742438|FG006|Overall Study|Lack of Efficacy|0|||
161916420|NCT00879658|584742432|FG000|Overall Study|misrandomized (never received study med)|0|||
161916421|NCT00879658|584742433|FG001|Overall Study|misrandomized (never received study med)|0|||
161916422|NCT00879658|584742434|FG002|Overall Study|misrandomized (never received study med)|0|||
161916423|NCT00879658|584742435|FG003|Overall Study|misrandomized (never received study med)|1|||
161916424|NCT00879658|584742436|FG004|Overall Study|misrandomized (never received study med)|0|||
161916425|NCT00879658|584742437|FG005|Overall Study|misrandomized (never received study med)|0|||
161916426|NCT00879658|584742438|FG006|Overall Study|misrandomized (never received study med)|0|||
161916427|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
162160440|NCT02597946|585637387|FG000|Overall Study|Other than above|1|||
162160441|NCT03263026|585637388|FG000|Overall Study|Withdrawal by Subject|1|||
162160442|NCT03263026|585637389|FG001|Overall Study|Withdrawal by Subject|0|||
162160443|NCT03263026|585637388|FG000|Overall Study|Death|1|||
162160444|NCT03263026|585637389|FG001|Overall Study|Death|0|||
162160445|NCT03263026|585637388|FG000|Overall Study|Other/ Various|41|||
162160446|NCT03263026|585637389|FG001|Overall Study|Other/ Various|29|||
162160447|NCT01938547|585637398|FG000|Overall Study|Physician Decision|1|||
162160448|NCT04823611|585637405|FG000|Overall Study|Adverse Event|2|||
162160449|NCT04823611|585637406|FG001|Overall Study|Adverse Event|0|||
162160450|NCT04823611|585637407|FG002|Overall Study|Adverse Event|1|||
162160451|NCT04823611|585637408|FG003|Overall Study|Adverse Event|0|||
162160452|NCT04823611|585637409|FG004|Overall Study|Adverse Event|0|||
162160453|NCT04823611|585637410|FG005|Overall Study|Adverse Event|0|||
162160454|NCT04823611|585637411|FG006|Overall Study|Adverse Event|0|||
162160455|NCT05320432|585637412|FG000|Overall Study|Withdrawal by Subject|0|||
162160456|NCT05320432|585637413|FG001|Overall Study|Withdrawal by Subject|2|||
162160457|NCT05038566|585637414|FG000|Overall Study|Technical Difficulties with the Device|0|||
162160458|NCT05038566|585637415|FG001|Overall Study|Technical Difficulties with the Device|1|||
162160459|NCT04850807|585637426|FG000|Overall Study|Death|50|||
162160460|NCT04850807|585637427|FG001|Overall Study|Death|55|||
162160461|NCT04850807|585637426|FG000|Overall Study|Discharged|17|||
162160462|NCT04850807|585637427|FG001|Overall Study|Discharged|13|||
162160463|NCT04850807|585637426|FG000|Overall Study|Incomplete baseline data|3|||
162160464|NCT04850807|585637427|FG001|Overall Study|Incomplete baseline data|2|||
162160465|NCT05141903|585637428|FG000|Overall Study|Withdrawal by Subject|0|||
162160466|NCT05141903|585637429|FG001|Overall Study|Withdrawal by Subject|1|||
162160467|NCT05141903|585637430|FG002|Overall Study|Withdrawal by Subject|1|||
162160468|NCT05141903|585637431|FG003|Overall Study|Withdrawal by Subject|0|||
162160469|NCT05141903|585637432|FG004|Overall Study|Withdrawal by Subject|0|||
162160470|NCT05141903|585637428|FG000|Overall Study|Other|1|||
162160471|NCT05141903|585637429|FG001|Overall Study|Other|1|||
162160472|NCT05141903|585637430|FG002|Overall Study|Other|0|||
162160473|NCT05141903|585637431|FG003|Overall Study|Other|0|||
162160474|NCT05141903|585637432|FG004|Overall Study|Other|0|||
162160475|NCT05439603|585637433|FG000|Overall Study|met withdrawal criteria|2|||
162160476|NCT05461131|585637434|FG000|Overall Study|Lost to Follow-up|0|||
162160477|NCT05461131|585637435|FG001|Overall Study|Lost to Follow-up|2|||
161813044|NCT01695239|584359800|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813045|NCT01695239|584359801|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
161813046|NCT01695239|584359802|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
162014882|NCT00658359|585108584|FG001|Overall Study|Lost to Follow-up|2|||
162014883|NCT00658359|585108585|FG002|Overall Study|Lost to Follow-up|4|||
161813047|NCT01695239|584359803|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813048|NCT01695239|584359804|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813049|NCT01695239|584359805|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813050|NCT01695239|584359806|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813051|NCT01695239|584359807|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161813052|NCT01695239|584359794|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813053|NCT01695239|584359795|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813054|NCT01695239|584359796|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813055|NCT01695239|584359797|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162014884|NCT00658359|585108583|FG000|Overall Study|Lack of Efficacy|0|||
162014885|NCT00658359|585108584|FG001|Overall Study|Lack of Efficacy|1|||
162014886|NCT00658359|585108585|FG002|Overall Study|Lack of Efficacy|0|||
162014887|NCT02754440|585108586|FG000|Overall Study|Protocol Violation|3|||
161813056|NCT01695239|584359798|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813057|NCT01695239|584359799|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813058|NCT01695239|584359800|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
162014888|NCT02754440|585108587|FG001|Overall Study|Protocol Violation|2|||
162014889|NCT02754440|585108588|FG002|Overall Study|Protocol Violation|2|||
162160478|NCT03896516|585637436|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
162160479|NCT03896516|585637437|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
162160480|NCT03896516|585637436|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
162160481|NCT03896516|585637437|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
162160482|NCT03896516|585637436|FG000|Washout Period|Physician Decision|3|||
162160483|NCT03896516|585637437|FG001|Washout Period|Physician Decision|1|||
162160484|NCT03896516|585637436|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
162160485|NCT03896516|585637437|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
162160486|NCT04549168|585637442|FG000|Randomization Phase|Adverse Event|0|||
162160487|NCT04549168|585637443|FG001|Randomization Phase|Adverse Event|0|||
162160488|NCT04549168|585637444|FG002|Randomization Phase|Adverse Event|1|||
162160489|NCT04549168|585637442|FG000|Randomization Phase|Other|0|||
162160490|NCT04549168|585637443|FG001|Randomization Phase|Other|2|||
162160491|NCT04549168|585637444|FG002|Randomization Phase|Other|0|||
162160492|NCT04549168|585637442|FG000|Randomization Phase|Withdrawal by Subject|0|||
161916428|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
161916429|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
161916430|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
161916431|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Death|38|||
161916432|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Death|10|||
161916433|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
161916434|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
161916435|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
161916436|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
161916437|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
161916438|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
161916439|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
161916440|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
161916441|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
161916442|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
162160493|NCT04549168|585637443|FG001|Randomization Phase|Withdrawal by Subject|2|||
162160494|NCT04549168|585637444|FG002|Randomization Phase|Withdrawal by Subject|1|||
162160495|NCT04737772|585637449|FG000|Phase 2 Study|Lost to Follow-up|15|||
162160496|NCT04737772|585637450|FG001|Phase 2 Study|Lost to Follow-up|15|||
162160497|NCT04737772|585637449|FG000|Phase 2 Study|Withdrawal by Subject|0|||
162160498|NCT04737772|585637450|FG001|Phase 2 Study|Withdrawal by Subject|1|||
161916443|NCT02421939|584742444|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
161916444|NCT02421939|584742445|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
161916445|NCT02421939|584742444|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
161916446|NCT02421939|584742445|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
161916447|NCT02421939|584742444|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
161916448|NCT02421939|584742445|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
161916449|NCT02421939|584742444|FG000|Long Term Follow up: up to 3 Years|Death|118|||
161916450|NCT02421939|584742445|FG001|Long Term Follow up: up to 3 Years|Death|65|||
161916451|NCT02421939|584742444|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
162160499|NCT04737772|585637449|FG000|Phase 2 Study|Did not take any coaching calls|4|||
162160500|NCT04737772|585637450|FG001|Phase 2 Study|Did not take any coaching calls|0|||
161916452|NCT02421939|584742445|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
161916453|NCT01925417|584742455|FG000|Overall Study|Withdrawal by Subject|2|||
161916454|NCT01925417|584742455|FG000|Overall Study|Death|1|||
161916455|NCT00655889|584742456|FG000|Overall Study|Inadequate cell growth|1|||
161916456|NCT00655889|584742456|FG000|Overall Study|Protocol Violation|1|||
161916457|NCT03573297|584742460|FG000|Open Label Treatment Period|Adverse Event|67|||
161916458|NCT03573297|584742461|FG001|Open Label Treatment Period|Adverse Event|0|||
161916459|NCT03573297|584742462|FG002|Open Label Treatment Period|Adverse Event|0|||
161916460|NCT03573297|584742463|FG003|Open Label Treatment Period|Adverse Event|0|||
161916461|NCT03573297|584742460|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
161916462|NCT03573297|584742461|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
161916463|NCT03573297|584742462|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
161916464|NCT03573297|584742463|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
161916465|NCT03573297|584742460|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
161916466|NCT03573297|584742461|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
161916467|NCT03573297|584742462|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
161916468|NCT03573297|584742463|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
161916469|NCT03573297|584742460|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
161916470|NCT03573297|584742461|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
161916471|NCT03573297|584742462|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
161916472|NCT03573297|584742463|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
161916473|NCT03573297|584742460|FG000|Open Label Treatment Period|Pregnancy|1|||
161916474|NCT03573297|584742461|FG001|Open Label Treatment Period|Pregnancy|0|||
162160501|NCT04737772|585637449|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
162160502|NCT04737772|585637450|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
162160503|NCT04737772|585637449|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
162160504|NCT04737772|585637450|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
162160505|NCT02549339|585637451|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
162160506|NCT02549339|585637452|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
162160507|NCT02549339|585637451|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
162160508|NCT02549339|585637452|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
162160509|NCT02549339|585637451|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
162160510|NCT02549339|585637452|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
162160511|NCT02549339|585637451|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
161916475|NCT03573297|584742462|FG002|Open Label Treatment Period|Pregnancy|0|||
161916476|NCT03573297|584742463|FG003|Open Label Treatment Period|Pregnancy|0|||
162160512|NCT02549339|585637452|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
162160513|NCT02549339|585637451|FG000|12-month Follow-up|Lack of Efficacy|0|||
162160514|NCT02549339|585637452|FG001|12-month Follow-up|Lack of Efficacy|2|||
162160515|NCT02549339|585637451|FG000|12-month Follow-up|Withdrawal by Subject|8|||
162160516|NCT02549339|585637452|FG001|12-month Follow-up|Withdrawal by Subject|3|||
162160517|NCT02549339|585637451|FG000|12-month Follow-up|Lost to Follow-up|1|||
162160518|NCT02549339|585637452|FG001|12-month Follow-up|Lost to Follow-up|3|||
162160519|NCT02549339|585637451|FG000|12-month Follow-up|Other|0|||
162160520|NCT02549339|585637452|FG001|12-month Follow-up|Other|3|||
162160521|NCT05415410|585637453|FG000|Overall Study|Death|3|||
162160522|NCT05415410|585637454|FG001|Overall Study|Death|6|||
162160523|NCT05415410|585637455|FG002|Overall Study|Death|1|||
161813059|NCT01695239|584359801|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
161813060|NCT01695239|584359802|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813061|NCT01695239|584359803|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813062|NCT01695239|584359804|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813063|NCT01695239|584359805|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813064|NCT01695239|584359806|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813065|NCT01695239|584359807|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161813066|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813067|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813068|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813069|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813070|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813071|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813072|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813073|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813074|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
161813075|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
161813076|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813077|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813078|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813079|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161813080|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
161813081|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
161813082|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
161813083|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
161813084|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
161813085|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
161813086|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
161813087|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
161813088|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
161813089|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
161813090|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
161813091|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
161813092|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
161813093|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
161813094|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813095|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813096|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813097|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813098|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813099|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813100|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813101|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813102|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
161813103|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
161813104|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813105|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813106|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813107|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161813108|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
161813109|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
161813110|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
161813111|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
161813112|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
161813113|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
161813114|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
162160524|NCT05415410|585637453|FG000|Overall Study|Trial Terminated by Sponsor|1|||
162160525|NCT05415410|585637454|FG001|Overall Study|Trial Terminated by Sponsor|5|||
162160526|NCT05415410|585637455|FG002|Overall Study|Trial Terminated by Sponsor|0|||
162160527|NCT05415410|585637453|FG000|Overall Study|Adverse Event|2|||
162160528|NCT05415410|585637454|FG001|Overall Study|Adverse Event|1|||
162160529|NCT05415410|585637455|FG002|Overall Study|Adverse Event|0|||
162160530|NCT05415410|585637453|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
162160531|NCT05415410|585637454|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
162160532|NCT05415410|585637455|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
162160533|NCT05415410|585637453|FG000|Overall Study|Withdrawal by Subject|1|||
162160534|NCT05415410|585637454|FG001|Overall Study|Withdrawal by Subject|0|||
162160535|NCT05415410|585637455|FG002|Overall Study|Withdrawal by Subject|0|||
162160536|NCT05415410|585637453|FG000|Overall Study|Pregnancy|5|||
162160537|NCT05415410|585637454|FG001|Overall Study|Pregnancy|2|||
162160538|NCT05415410|585637455|FG002|Overall Study|Pregnancy|0|||
162160539|NCT04791709|585637456|FG000|Overall Study|Withdrawal by Subject|3|||
162160540|NCT04600752|585637464|FG000|Overall Study|Physician Decision|0|||
162160541|NCT04600752|585637465|FG001|Overall Study|Physician Decision|0|||
162160542|NCT04600752|585637466|FG002|Overall Study|Physician Decision|1|||
162160543|NCT04600752|585637464|FG000|Overall Study|Adverse Event|0|||
162160544|NCT04600752|585637465|FG001|Overall Study|Adverse Event|1|||
162160545|NCT04600752|585637466|FG002|Overall Study|Adverse Event|0|||
162160546|NCT04600752|585637464|FG000|Overall Study|Withdrawal by Subject|2|||
162160547|NCT04600752|585637465|FG001|Overall Study|Withdrawal by Subject|1|||
162160548|NCT04600752|585637466|FG002|Overall Study|Withdrawal by Subject|0|||
162014890|NCT02754440|585108589|FG003|Overall Study|Protocol Violation|6|||
162014891|NCT02754440|585108586|FG000|Overall Study|Adverse Event|3|||
162014892|NCT02754440|585108587|FG001|Overall Study|Adverse Event|1|||
162014893|NCT02754440|585108588|FG002|Overall Study|Adverse Event|0|||
162014894|NCT02754440|585108589|FG003|Overall Study|Adverse Event|9|||
162014895|NCT02754440|585108586|FG000|Overall Study|Withdrawal by Subject|0|||
162014896|NCT02754440|585108587|FG001|Overall Study|Withdrawal by Subject|0|||
162014897|NCT02754440|585108588|FG002|Overall Study|Withdrawal by Subject|0|||
162014898|NCT02754440|585108589|FG003|Overall Study|Withdrawal by Subject|1|||
162014899|NCT02754440|585108586|FG000|Overall Study|Equipment failure|0|||
162014900|NCT02754440|585108587|FG001|Overall Study|Equipment failure|5|||
162014901|NCT02754440|585108588|FG002|Overall Study|Equipment failure|5|||
162014902|NCT02754440|585108589|FG003|Overall Study|Equipment failure|7|||
162014903|NCT02754440|585108586|FG000|Overall Study|Subject issues not resulting in AE|0|||
162014904|NCT02754440|585108587|FG001|Overall Study|Subject issues not resulting in AE|0|||
162014905|NCT02754440|585108588|FG002|Overall Study|Subject issues not resulting in AE|0|||
162014906|NCT02754440|585108589|FG003|Overall Study|Subject issues not resulting in AE|12|||
162014907|NCT02560558|585108590|FG000|Overall Study|Adverse Event|1|||
162014908|NCT02560558|585108591|FG001|Overall Study|Adverse Event|0|||
162014909|NCT02560558|585108590|FG000|Overall Study|Death|0|||
162014910|NCT02560558|585108591|FG001|Overall Study|Death|2|||
162014911|NCT02560558|585108590|FG000|Overall Study|Lost to Follow-up|0|||
162014912|NCT02560558|585108591|FG001|Overall Study|Lost to Follow-up|4|||
162014913|NCT02560558|585108590|FG000|Overall Study|Protocol Violation|3|||
162014914|NCT02560558|585108591|FG001|Overall Study|Protocol Violation|0|||
162014915|NCT02560558|585108590|FG000|Overall Study|Withdrawal by Subject|3|||
162014916|NCT02560558|585108591|FG001|Overall Study|Withdrawal by Subject|0|||
162014917|NCT01189032|585108592|FG000|Overall Study|Adverse Event|1|||
162014918|NCT01189032|585108593|FG001|Overall Study|Adverse Event|3|||
162014919|NCT01189032|585108594|FG002|Overall Study|Adverse Event|4|||
162014920|NCT01189032|585108592|FG000|Overall Study|Lack of Efficacy|2|||
162014921|NCT01189032|585108593|FG001|Overall Study|Lack of Efficacy|3|||
162014922|NCT01189032|585108594|FG002|Overall Study|Lack of Efficacy|0|||
162014923|NCT01189032|585108592|FG000|Overall Study|Withdrawal by Subject|1|||
162160549|NCT04600752|585637464|FG000|Overall Study|Lack of Efficacy|1|||
162160550|NCT04600752|585637465|FG001|Overall Study|Lack of Efficacy|0|||
162160551|NCT04600752|585637466|FG002|Overall Study|Lack of Efficacy|0|||
162160552|NCT04431726|585637467|FG000|Overall Study|Ongoing in the Study|55|||
162160553|NCT00274469|585637468|FG000|Overall Study|Death|63|||
162160554|NCT00274469|585637469|FG001|Overall Study|Death|74|||
162014924|NCT01189032|585108593|FG001|Overall Study|Withdrawal by Subject|0|||
162014925|NCT01189032|585108594|FG002|Overall Study|Withdrawal by Subject|1|||
162014926|NCT01189032|585108592|FG000|Overall Study|Protocol Violation|1|||
162014927|NCT01189032|585108593|FG001|Overall Study|Protocol Violation|1|||
162014928|NCT01189032|585108594|FG002|Overall Study|Protocol Violation|1|||
162014929|NCT01967576|585108599|FG000|Overall Study|Withdrawal by Subject|3|||
162014930|NCT01967576|585108599|FG000|Overall Study|Progressed/Removed from treatment|1|||
162014931|NCT01967576|585108599|FG000|Overall Study|Study closing at site|1|||
162014932|NCT01967576|585108599|FG000|Overall Study|Adverse Event|1|||
162014933|NCT01967576|585108599|FG000|Overall Study|Refused further treatment|1|||
162160555|NCT00274469|585637468|FG000|Overall Study|Did not consent to OS follow-up|16|||
162160556|NCT00274469|585637469|FG001|Overall Study|Did not consent to OS follow-up|19|||
162160557|NCT05450458|585637472|FG000|Overall Study|Lost to Follow-up|4|||
161916477|NCT03573297|584742460|FG000|Open Label Treatment Period|Protocol Violation|17|||
161916478|NCT03573297|584742461|FG001|Open Label Treatment Period|Protocol Violation|0|||
161916479|NCT03573297|584742462|FG002|Open Label Treatment Period|Protocol Violation|0|||
161916480|NCT03573297|584742463|FG003|Open Label Treatment Period|Protocol Violation|0|||
161916481|NCT03573297|584742460|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
161916482|NCT03573297|584742461|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
161916483|NCT03573297|584742462|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
161916484|NCT03573297|584742463|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
161916485|NCT03573297|584742460|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
161916486|NCT03573297|584742461|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
161916487|NCT03573297|584742462|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
161916488|NCT03573297|584742463|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
161916489|NCT03573297|584742460|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
161916490|NCT03573297|584742461|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
161916491|NCT03573297|584742462|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
161916492|NCT03573297|584742463|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
161916493|NCT03573297|584742460|FG000|Open Label Treatment Period|Other, Not Specified|7|||
161916494|NCT03573297|584742461|FG001|Open Label Treatment Period|Other, Not Specified|0|||
161916495|NCT03573297|584742462|FG002|Open Label Treatment Period|Other, Not Specified|0|||
161916496|NCT03573297|584742463|FG003|Open Label Treatment Period|Other, Not Specified|0|||
162160558|NCT05480943|585637473|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
162160559|NCT05480943|585637473|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
162160560|NCT05480943|585637473|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
162160561|NCT05480943|585637473|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
162160562|NCT04999592|585637474|FG000|Overall Study|Withdrawal by Subject|1|||
162160563|NCT04999592|585637475|FG001|Overall Study|Withdrawal by Subject|0|||
162160564|NCT02910713|585637476|FG000|Overall Study|Protocol Violation|2|||
162160565|NCT02910713|585637476|FG000|Overall Study|Subject Choice|4|||
162160566|NCT02910713|585637476|FG000|Overall Study|Received One Application|10|||
162160567|NCT02910713|585637476|FG000|Overall Study|Received Neither Application|18|||
161916497|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
161916498|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
161916499|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
161916500|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
161916501|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161916502|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161916503|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Adverse Event|5|||
161916504|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Adverse Event|1|||
161916505|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
161916506|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
161916507|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
161916508|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
161916509|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161916510|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
161916511|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
161916512|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
161916513|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161916514|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
161916515|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
161916516|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
161916517|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
161916518|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
161916519|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
162014934|NCT02819804|585108600|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
161916520|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
161916521|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
161916522|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
161916523|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
161916524|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
161916525|NCT03573297|584742460|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
161916526|NCT03573297|584742461|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
161916527|NCT03573297|584742462|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
161916528|NCT03573297|584742463|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
161916529|NCT02696798|584742465|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
162014935|NCT02858362|585108601|FG000|Overall Study|Protocol Violation|0|||
162160568|NCT02910713|585637476|FG000|Overall Study|Enrollment cap|7|||
162160569|NCT02910713|585637476|FG000|Overall Study|Investigator Discretion|1|||
162160570|NCT04442126|585637485|FG000|Overall Study|Withdrawal by Subject|0|||
162160571|NCT04442126|585637486|FG001|Overall Study|Withdrawal by Subject|0|||
162160572|NCT04442126|585637487|FG002|Overall Study|Withdrawal by Subject|0|||
162160573|NCT04442126|585637488|FG003|Overall Study|Withdrawal by Subject|2|||
162160574|NCT04442126|585637489|FG004|Overall Study|Withdrawal by Subject|1|||
162160575|NCT04442126|585637490|FG005|Overall Study|Withdrawal by Subject|0|||
162160576|NCT04442126|585637491|FG006|Overall Study|Withdrawal by Subject|1|||
162160577|NCT04442126|585637492|FG007|Overall Study|Withdrawal by Subject|1|||
162160578|NCT04442126|585637493|FG008|Overall Study|Withdrawal by Subject|3|||
162160579|NCT04442126|585637485|FG000|Overall Study|Death|1|||
162160580|NCT04442126|585637486|FG001|Overall Study|Death|0|||
162160581|NCT04442126|585637487|FG002|Overall Study|Death|0|||
162160582|NCT04442126|585637488|FG003|Overall Study|Death|1|||
162160583|NCT04442126|585637489|FG004|Overall Study|Death|2|||
162160584|NCT04442126|585637490|FG005|Overall Study|Death|2|||
162160585|NCT04442126|585637491|FG006|Overall Study|Death|4|||
162160586|NCT04442126|585637492|FG007|Overall Study|Death|1|||
162160587|NCT04442126|585637493|FG008|Overall Study|Death|5|||
162160588|NCT04442126|585637485|FG000|Overall Study|Study Terminated by Sponsor|0|||
162160589|NCT04442126|585637486|FG001|Overall Study|Study Terminated by Sponsor|0|||
162160590|NCT04442126|585637487|FG002|Overall Study|Study Terminated by Sponsor|0|||
162160591|NCT04442126|585637488|FG003|Overall Study|Study Terminated by Sponsor|0|||
162160592|NCT04442126|585637489|FG004|Overall Study|Study Terminated by Sponsor|0|||
162160593|NCT04442126|585637490|FG005|Overall Study|Study Terminated by Sponsor|1|||
162160594|NCT04442126|585637491|FG006|Overall Study|Study Terminated by Sponsor|4|||
162160595|NCT04442126|585637492|FG007|Overall Study|Study Terminated by Sponsor|2|||
162160596|NCT04442126|585637493|FG008|Overall Study|Study Terminated by Sponsor|10|||
162160597|NCT04442126|585637485|FG000|Overall Study|Lost to Follow-up|0|||
161813115|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
161813116|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
161813117|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
161813118|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
161813119|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
161813120|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
161813121|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
161813122|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161916530|NCT02696798|584742466|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
161916531|NCT02696798|584742467|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
161916532|NCT02696798|584742465|FG000|Blinded Treatment Dosing Period|Death|0|||
161916533|NCT02696798|584742466|FG001|Blinded Treatment Dosing Period|Death|0|||
161916534|NCT02696798|584742467|FG002|Blinded Treatment Dosing Period|Death|1|||
161916535|NCT02696798|584742465|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
161916536|NCT02696798|584742466|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
161916537|NCT02696798|584742467|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
161916538|NCT02696798|584742465|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
161916539|NCT02696798|584742466|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
161916540|NCT02696798|584742467|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
161916541|NCT02696798|584742465|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
161916542|NCT02696798|584742466|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
161916543|NCT02696798|584742467|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
161916544|NCT02696798|584742465|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
161916545|NCT02696798|584742466|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
161916546|NCT02696798|584742467|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
161916547|NCT02696798|584742465|FG000|Extended Treatment Period|Adverse Event|1|||
161916548|NCT02696798|584742466|FG001|Extended Treatment Period|Adverse Event|4|||
161916549|NCT02696798|584742467|FG002|Extended Treatment Period|Adverse Event|5|||
161916550|NCT02696798|584742465|FG000|Extended Treatment Period|Lack of Efficacy|7|||
161916551|NCT02696798|584742466|FG001|Extended Treatment Period|Lack of Efficacy|2|||
161916552|NCT02696798|584742467|FG002|Extended Treatment Period|Lack of Efficacy|2|||
161916553|NCT02696798|584742465|FG000|Extended Treatment Period|Lost to Follow-up|1|||
161916554|NCT02696798|584742466|FG001|Extended Treatment Period|Lost to Follow-up|0|||
161916555|NCT02696798|584742467|FG002|Extended Treatment Period|Lost to Follow-up|0|||
161916556|NCT02696798|584742465|FG000|Extended Treatment Period|Physician Decision|0|||
161916557|NCT02696798|584742466|FG001|Extended Treatment Period|Physician Decision|1|||
161916558|NCT02696798|584742467|FG002|Extended Treatment Period|Physician Decision|0|||
161916559|NCT02696798|584742465|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
161916560|NCT02696798|584742466|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
161916561|NCT02696798|584742467|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
161916562|NCT02696798|584742465|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
161916563|NCT02696798|584742466|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
161916564|NCT02696798|584742467|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
161916565|NCT02696798|584742465|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
162014936|NCT02858362|585108602|FG001|Overall Study|Protocol Violation|1|||
162160598|NCT04442126|585637486|FG001|Overall Study|Lost to Follow-up|0|||
162160599|NCT04442126|585637487|FG002|Overall Study|Lost to Follow-up|0|||
162160600|NCT04442126|585637488|FG003|Overall Study|Lost to Follow-up|0|||
162160601|NCT04442126|585637489|FG004|Overall Study|Lost to Follow-up|0|||
162160602|NCT04442126|585637490|FG005|Overall Study|Lost to Follow-up|0|||
162160603|NCT04442126|585637491|FG006|Overall Study|Lost to Follow-up|0|||
162160604|NCT04442126|585637492|FG007|Overall Study|Lost to Follow-up|1|||
162160605|NCT04442126|585637493|FG008|Overall Study|Lost to Follow-up|2|||
162160606|NCT04442126|585637485|FG000|Overall Study|Progressive Disease|0|||
161813123|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813124|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813125|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813126|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813127|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813128|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813129|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813130|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
161813131|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
161813132|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813133|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813134|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161813135|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161916566|NCT02696798|584742466|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
161916567|NCT02696798|584742467|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
161916568|NCT02696798|584742465|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
161916569|NCT02696798|584742466|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
161916570|NCT02696798|584742467|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
161916571|NCT02696798|584742465|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
161916572|NCT02696798|584742466|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
161916573|NCT02696798|584742467|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
161916574|NCT02696798|584742465|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
161916575|NCT02696798|584742466|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
161916576|NCT02696798|584742467|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
161916577|NCT02696798|584742465|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
161916578|NCT02696798|584742466|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
161916579|NCT02696798|584742467|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
161916580|NCT04091451|584742468|FG000|Overall Study|Adverse Event|15|||
161916581|NCT04091451|584742469|FG001|Overall Study|Adverse Event|10|||
161916582|NCT04091451|584742468|FG000|Overall Study|Lost to Follow-up|8|||
161916583|NCT04091451|584742469|FG001|Overall Study|Lost to Follow-up|8|||
161916584|NCT04091451|584742468|FG000|Overall Study|Protocol Violation|5|||
161916585|NCT04091451|584742469|FG001|Overall Study|Protocol Violation|4|||
161916586|NCT04091451|584742468|FG000|Overall Study|Withdrawal by Subject|21|||
161916587|NCT04091451|584742469|FG001|Overall Study|Withdrawal by Subject|27|||
161916588|NCT04091451|584742468|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
161916589|NCT04091451|584742469|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
161916590|NCT04091451|584742468|FG000|Overall Study|Migrated/moved from the study area|3|||
161916591|NCT04091451|584742469|FG001|Overall Study|Migrated/moved from the study area|5|||
161916592|NCT04091451|584742468|FG000|Overall Study|Suspected HZ episode|1|||
161916593|NCT04091451|584742469|FG001|Overall Study|Suspected HZ episode|0|||
161916594|NCT04115059|584744259|FG000|Overall Study|Withdrawal by Subject|1|||
161916595|NCT04115059|584744259|FG000|Overall Study|Lack of Efficacy|2|||
161916596|NCT00630292|584744260|FG000|Overall Study|Withdrawal by Subject|1|||
161916597|NCT00717886|584744262|FG000|Overall Study|Withdrawal by Subject|3|||
161916598|NCT00717886|584744262|FG000|Overall Study|Treatment Failure|1|||
161916599|NCT01553851|584744263|FG000|Overall Study|Adverse Event|2|||
161916600|NCT01553851|584744263|FG000|Overall Study|constipation|1|||
161916601|NCT02313155|584744268|FG000|Overall Study|Lost to Follow-up|0|||
161916602|NCT02313155|584744269|FG001|Overall Study|Lost to Follow-up|1|||
161916603|NCT03822416|584744271|FG000|Overall Study|Lost to Follow-up|1|||
161916604|NCT03822416|584744272|FG001|Overall Study|Lost to Follow-up|0|||
161916605|NCT03822416|584744271|FG000|Overall Study|Withdrawal by Subject|0|||
161916606|NCT03822416|584744272|FG001|Overall Study|Withdrawal by Subject|1|||
161916607|NCT04666298|584744273|FG000|Overall Study|Subject decision|1|||
161916608|NCT04666298|584744274|FG001|Overall Study|Subject decision|0|||
161916609|NCT04666298|584744275|FG002|Overall Study|Subject decision|0|||
161916610|NCT04666298|584744276|FG003|Overall Study|Subject decision|2|||
161916611|NCT04666298|584744273|FG000|Overall Study|Death|1|||
161916612|NCT04666298|584744274|FG001|Overall Study|Death|0|||
161916613|NCT04666298|584744275|FG002|Overall Study|Death|0|||
162160607|NCT04442126|585637486|FG001|Overall Study|Progressive Disease|1|||
161916614|NCT04666298|584744276|FG003|Overall Study|Death|0|||
162160608|NCT04442126|585637487|FG002|Overall Study|Progressive Disease|3|||
162160609|NCT04442126|585637488|FG003|Overall Study|Progressive Disease|0|||
161916615|NCT04666298|584744273|FG000|Overall Study|Lost to Follow-up|0|||
161916616|NCT04666298|584744274|FG001|Overall Study|Lost to Follow-up|0|||
161916617|NCT04666298|584744275|FG002|Overall Study|Lost to Follow-up|0|||
161916618|NCT04666298|584744276|FG003|Overall Study|Lost to Follow-up|1|||
161916619|NCT04666298|584744273|FG000|Overall Study|Physician Decision|0|||
161916620|NCT04666298|584744274|FG001|Overall Study|Physician Decision|0|||
161916621|NCT04666298|584744275|FG002|Overall Study|Physician Decision|0|||
161916622|NCT04666298|584744276|FG003|Overall Study|Physician Decision|1|||
161916623|NCT04666298|584744273|FG000|Overall Study|Protocol deviation|0|||
161916624|NCT04666298|584744274|FG001|Overall Study|Protocol deviation|0|||
161916625|NCT04666298|584744275|FG002|Overall Study|Protocol deviation|1|||
161916626|NCT04666298|584744276|FG003|Overall Study|Protocol deviation|0|||
161916627|NCT00844519|584744277|FG000|Overall Study|Withdrawal by Subject|1|||
161916628|NCT00844519|584744278|FG001|Overall Study|Withdrawal by Subject|1|||
161916629|NCT00844519|584744277|FG000|Overall Study|Adverse Event|1|||
161916630|NCT00844519|584744278|FG001|Overall Study|Adverse Event|0|||
161916631|NCT01303419|584744281|FG000|Overall Study|Discontinuation of study|60|||
161916632|NCT01303419|584744281|FG000|Overall Study|Did not complete both imaging methods|5|||
161916633|NCT01303419|584744281|FG000|Overall Study|Did not meet all I/E after screening|31|||
161916634|NCT06438601|584744282|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
161916635|NCT06438601|584744283|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
161916636|NCT06438601|584744282|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
161916637|NCT06438601|584744283|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
161916638|NCT03329001|584744284|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161916639|NCT03329001|584744285|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161916640|NCT03329001|584744286|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
161916641|NCT03329001|584744287|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
161916642|NCT03329001|584744288|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161916643|NCT03329001|584744289|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161916644|NCT03329001|584744290|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161916645|NCT03329001|584744291|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161916646|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916647|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916648|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916649|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
161916650|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916651|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916652|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916653|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161916654|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161916655|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161916656|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
162160610|NCT04442126|585637489|FG004|Overall Study|Progressive Disease|3|||
162160611|NCT04442126|585637490|FG005|Overall Study|Progressive Disease|0|||
162160612|NCT04442126|585637491|FG006|Overall Study|Progressive Disease|0|||
162160613|NCT04442126|585637492|FG007|Overall Study|Progressive Disease|0|||
162160614|NCT04442126|585637493|FG008|Overall Study|Progressive Disease|0|||
162160615|NCT04442126|585637485|FG000|Overall Study|Other|0|||
162160616|NCT04442126|585637486|FG001|Overall Study|Other|0|||
162160617|NCT04442126|585637487|FG002|Overall Study|Other|0|||
162160618|NCT04442126|585637488|FG003|Overall Study|Other|0|||
162160619|NCT04442126|585637489|FG004|Overall Study|Other|0|||
162160620|NCT04442126|585637490|FG005|Overall Study|Other|0|||
162160621|NCT04442126|585637491|FG006|Overall Study|Other|0|||
162160622|NCT04442126|585637492|FG007|Overall Study|Other|0|||
162160623|NCT04442126|585637493|FG008|Overall Study|Other|1|||
162160624|NCT04623775|585637494|FG000|Randomization|No Longer Meets Study Criteria|2|||
162160625|NCT04623775|585637495|FG001|Randomization|No Longer Meets Study Criteria|1|||
162160626|NCT04623775|585637496|FG002|Randomization|No Longer Meets Study Criteria|0|||
162160627|NCT04623775|585637497|FG003|Randomization|No Longer Meets Study Criteria|0|||
162160628|NCT04623775|585637494|FG000|Randomization|Withdrew Consent|0|||
162160629|NCT04623775|585637495|FG001|Randomization|Withdrew Consent|0|||
162160630|NCT04623775|585637496|FG002|Randomization|Withdrew Consent|0|||
162160631|NCT04623775|585637497|FG003|Randomization|Withdrew Consent|1|||
162160632|NCT04623775|585637494|FG000|Randomization|Other Reasons|0|||
162160633|NCT04623775|585637495|FG001|Randomization|Other Reasons|0|||
162160634|NCT04623775|585637496|FG002|Randomization|Other Reasons|0|||
162014937|NCT02858362|585108603|FG002|Overall Study|Protocol Violation|0|||
162160635|NCT04623775|585637497|FG003|Randomization|Other Reasons|1|||
162160636|NCT04623775|585637494|FG000|Treatment Period|participant withdrew consent|4|||
162160637|NCT04623775|585637495|FG001|Treatment Period|participant withdrew consent|0|||
162160638|NCT04623775|585637496|FG002|Treatment Period|participant withdrew consent|1|||
161916657|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
161916658|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161916659|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161916660|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161916661|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161916662|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916663|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916664|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916665|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
161916666|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916667|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916668|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916669|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161916670|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916671|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916672|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
161916673|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916674|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916675|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916676|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916677|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161916678|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916679|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916680|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
161916681|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916682|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916683|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916684|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916685|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161916686|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161916687|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
162014938|NCT02858362|585108601|FG000|Overall Study|Withdrawal by Subject|1|||
162014939|NCT02858362|585108602|FG001|Overall Study|Withdrawal by Subject|0|||
162014940|NCT02858362|585108603|FG002|Overall Study|Withdrawal by Subject|0|||
162014941|NCT02858362|585108601|FG000|Overall Study|Early Study Termination|0|||
162014942|NCT02858362|585108602|FG001|Overall Study|Early Study Termination|0|||
162014943|NCT02858362|585108603|FG002|Overall Study|Early Study Termination|3|||
162014944|NCT02858362|585108601|FG000|Overall Study|Lost to Follow-up|1|||
162014945|NCT02858362|585108602|FG001|Overall Study|Lost to Follow-up|0|||
162014946|NCT02858362|585108603|FG002|Overall Study|Lost to Follow-up|0|||
162014947|NCT01821118|585108604|FG000|Overall Study|Death|0|||
162014948|NCT01821118|585108605|FG001|Overall Study|Death|1|||
162014949|NCT00345358|585108606|FG000|Primary Vaccination Phase|Other|0|||
162014950|NCT00345358|585108607|FG001|Primary Vaccination Phase|Other|1|||
162014951|NCT00345358|585108608|FG002|Primary Vaccination Phase|Other|1|||
162014952|NCT00345358|585108609|FG003|Primary Vaccination Phase|Other|0|||
162014953|NCT00345358|585108606|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
162014954|NCT00345358|585108607|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
162014955|NCT00345358|585108608|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
162014956|NCT00345358|585108609|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
162014957|NCT00345358|585108606|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
162014958|NCT00345358|585108607|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
162014959|NCT00345358|585108608|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
162014960|NCT00345358|585108609|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
162014961|NCT00345358|585108606|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
162014962|NCT00345358|585108607|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
162014963|NCT00345358|585108608|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
162014964|NCT00345358|585108609|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
162014965|NCT00345358|585108606|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
162014966|NCT00345358|585108607|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
162160639|NCT04623775|585637497|FG003|Treatment Period|participant withdrew consent|2|||
162160640|NCT04623775|585637494|FG000|Treatment Period|Death|3|||
161813136|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813137|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813138|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813139|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813140|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813141|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813142|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813143|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813144|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
161813145|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
161813146|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813147|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813148|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813149|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161813150|NCT01695239|584359794|FG000|Extension Long-Term Extension Periods|Death|0|||
161813151|NCT01695239|584359795|FG001|Extension Long-Term Extension Periods|Death|0|||
161813152|NCT01695239|584359796|FG002|Extension Long-Term Extension Periods|Death|0|||
161813153|NCT01695239|584359797|FG003|Extension Long-Term Extension Periods|Death|0|||
161813154|NCT01695239|584359798|FG004|Extension Long-Term Extension Periods|Death|0|||
161813155|NCT01695239|584359799|FG005|Extension Long-Term Extension Periods|Death|0|||
161813156|NCT01695239|584359800|FG006|Extension Long-Term Extension Periods|Death|0|||
161813157|NCT01695239|584359801|FG007|Extension Long-Term Extension Periods|Death|0|||
161813158|NCT01695239|584359802|FG008|Extension Long-Term Extension Periods|Death|1|||
161813159|NCT01695239|584359803|FG009|Extension Long-Term Extension Periods|Death|0|||
161813160|NCT01695239|584359804|FG010|Extension Long-Term Extension Periods|Death|0|||
161813161|NCT01695239|584359805|FG011|Extension Long-Term Extension Periods|Death|0|||
161813162|NCT01695239|584359806|FG012|Extension Long-Term Extension Periods|Death|0|||
161813163|NCT01695239|584359807|FG013|Extension Long-Term Extension Periods|Death|0|||
161813164|NCT01695239|584359794|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813165|NCT01695239|584359795|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813166|NCT01695239|584359796|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813167|NCT01695239|584359797|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813168|NCT01695239|584359798|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813169|NCT01695239|584359799|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813170|NCT01695239|584359800|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813171|NCT01695239|584359801|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813172|NCT01695239|584359802|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813173|NCT01695239|584359803|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813174|NCT01695239|584359804|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161813175|NCT01695239|584359805|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
161813176|NCT01695239|584359806|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
161813177|NCT01695239|584359807|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
161813178|NCT01695239|584359794|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813179|NCT01695239|584359795|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813180|NCT01695239|584359796|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813181|NCT01695239|584359797|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813182|NCT01695239|584359798|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813183|NCT01695239|584359799|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813184|NCT01695239|584359800|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813185|NCT01695239|584359801|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813186|NCT01695239|584359802|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813187|NCT01695239|584359803|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813188|NCT01695239|584359804|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813189|NCT01695239|584359805|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161813190|NCT01695239|584359806|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
161813191|NCT01695239|584359807|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
161813192|NCT01695239|584359794|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813193|NCT01695239|584359795|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813194|NCT01695239|584359796|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813195|NCT01695239|584359797|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813196|NCT01695239|584359798|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813197|NCT01695239|584359799|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813198|NCT01695239|584359800|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813199|NCT01695239|584359801|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813200|NCT01695239|584359802|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
162160641|NCT04623775|585637495|FG001|Treatment Period|Death|1|||
162160642|NCT04623775|585637496|FG002|Treatment Period|Death|4|||
161813201|NCT01695239|584359803|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813202|NCT01695239|584359804|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813203|NCT01695239|584359805|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813204|NCT01695239|584359806|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
161813205|NCT01695239|584359807|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
161813206|NCT01695239|584359794|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813207|NCT01695239|584359795|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813208|NCT01695239|584359796|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813209|NCT01695239|584359797|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813210|NCT01695239|584359798|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813211|NCT01695239|584359799|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813212|NCT01695239|584359800|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813213|NCT01695239|584359801|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813214|NCT01695239|584359802|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813215|NCT01695239|584359803|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813216|NCT01695239|584359804|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813217|NCT01695239|584359805|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813218|NCT01695239|584359806|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161813219|NCT01695239|584359807|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
161813220|NCT03502811|584359808|FG000|Overall Study|Death|157|||
161813221|NCT03502811|584359808|FG000|Overall Study|Withdrawal by Subject|105|||
161813222|NCT03502811|584359808|FG000|Overall Study|Lost to Follow-up|26|||
161813223|NCT03502811|584359808|FG000|Overall Study|No Visits (Missed)|31|||
161813224|NCT03913377|584359809|FG000|Period 1|Test Article no longer available|0|||
161813225|NCT03913377|584359810|FG001|Period 1|Test Article no longer available|1|||
161813226|NCT03913377|584359811|FG002|Period 1|Test Article no longer available|0|||
161813227|NCT03913377|584359809|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
161813228|NCT03913377|584359810|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
161813229|NCT03913377|584359811|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
161813230|NCT05239195|584359812|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
161813231|NCT05239195|584359813|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
161813232|NCT00933686|584359814|FG000|Overall Study|Protocol Violation|0|||
161813233|NCT00933686|584359815|FG001|Overall Study|Protocol Violation|1|||
161813234|NCT00933686|584359814|FG000|Overall Study|Lost to Follow-up|2|||
161813235|NCT00933686|584359815|FG001|Overall Study|Lost to Follow-up|2|||
161813236|NCT00933686|584359814|FG000|Overall Study|Withdrawal by Subject|6|||
161813237|NCT00933686|584359815|FG001|Overall Study|Withdrawal by Subject|5|||
161813238|NCT00933686|584359814|FG000|Overall Study|Adverse Event|1|||
161813239|NCT00933686|584359815|FG001|Overall Study|Adverse Event|1|||
161813240|NCT00933686|584359814|FG000|Overall Study|Physician Decision|1|||
161813241|NCT00933686|584359815|FG001|Overall Study|Physician Decision|0|||
161813242|NCT00933686|584359814|FG000|Overall Study|Failure to show up at endpoint visits|0|||
161813243|NCT00933686|584359815|FG001|Overall Study|Failure to show up at endpoint visits|2|||
161813244|NCT01244620|584359818|FG000|Overall Study|Study terminated|4|||
161813245|NCT01244620|584359819|FG001|Overall Study|Study terminated|4|||
161813246|NCT01244620|584359820|FG002|Overall Study|Study terminated|4|||
161813247|NCT01244620|584359821|FG003|Overall Study|Study terminated|4|||
161813248|NCT01663233|584359822|FG000|Overall Study|Withdrawal by Subject|3|||
161813249|NCT01663233|584359823|FG001|Overall Study|Withdrawal by Subject|2|||
161813250|NCT01663233|584359822|FG000|Overall Study|Protocol Deviation|1|||
161813251|NCT01663233|584359823|FG001|Overall Study|Protocol Deviation|4|||
161813252|NCT01663233|584359822|FG000|Overall Study|Lost to Follow-up|0|||
161813253|NCT01663233|584359823|FG001|Overall Study|Lost to Follow-up|1|||
161813254|NCT02321098|584359824|FG000|12 Weeks Treament|Lost to Follow-up|1|||
161813255|NCT02321098|584359825|FG001|12 Weeks Treament|Lost to Follow-up|1|||
161813256|NCT02321098|584359826|FG002|12 Weeks Treament|Lost to Follow-up|0|||
161813257|NCT02321098|584359824|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
161813258|NCT02321098|584359825|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
161813259|NCT02321098|584359826|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
161813260|NCT02321098|584359824|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
161813261|NCT02321098|584359825|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
161813262|NCT02321098|584359826|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
162160643|NCT04623775|585637497|FG003|Treatment Period|Death|2|||
162160644|NCT04623775|585637494|FG000|Treatment Period|Lost to Follow-up|0|||
162160645|NCT04623775|585637495|FG001|Treatment Period|Lost to Follow-up|2|||
161813263|NCT02321098|584359824|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
161813264|NCT02321098|584359825|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
161813265|NCT02321098|584359826|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
162160646|NCT04623775|585637496|FG002|Treatment Period|Lost to Follow-up|0|||
162160647|NCT04623775|585637497|FG003|Treatment Period|Lost to Follow-up|0|||
162160648|NCT04623775|585637494|FG000|Treatment Period|poor/non compliance|0|||
162160649|NCT04623775|585637495|FG001|Treatment Period|poor/non compliance|0|||
161813266|NCT00796328|584359829|FG000|Overall Study|experienced hypotension requiring tx|6|||
161813267|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Adverse Event|11|||
161813268|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Adverse Event|23|||
161813269|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Adverse Event|29|||
161813270|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Adverse Event|2|||
161813271|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Adverse Event|8|||
161813272|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
161813273|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
161813274|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
161813275|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
161813276|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
161813277|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
161813278|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
161813279|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
161813280|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
161813281|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
161813282|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
161813283|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
161813284|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
161813285|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
161813286|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
161813287|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
161813288|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
161813289|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
161813290|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
161813291|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
161813292|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
161813293|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
161813294|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
161813295|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
161813296|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
161813297|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
161813298|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
161813299|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
161813300|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
161813301|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
161813302|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Move|0|||
161813303|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Move|1|||
161813304|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Move|0|||
161813305|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Move|0|||
161813306|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Move|0|||
161813307|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
161813308|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
161813309|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
161813310|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
161813311|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
161813312|NCT00318461|584359832|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
161813313|NCT00318461|584359833|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
161813314|NCT00318461|584359834|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
161813315|NCT00318461|584359835|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
161813316|NCT00318461|584359836|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
161813317|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Work commitment|0|||
161813318|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Work commitment|0|||
161813319|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Work commitment|0|||
161813320|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Work commitment|0|||
161813321|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Work commitment|1|||
161813322|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Investigator decision|0|||
161813323|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Investigator decision|0|||
161813324|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Investigator decision|0|||
161813325|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Investigator decision|0|||
161813326|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Investigator decision|1|||
161813327|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Lack of time|1|||
161813328|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Lack of time|0|||
161813329|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Lack of time|0|||
161813330|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Lack of time|0|||
161813331|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Lack of time|0|||
161813332|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
161813333|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
161813334|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
162014967|NCT00345358|585108608|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
161916688|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
161916689|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161916690|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161916691|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161916692|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161916693|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161916694|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916695|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916696|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
161916697|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916698|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916699|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916700|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916701|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161916702|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161916703|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161916704|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
161916705|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
161916706|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161916707|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161916708|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161916709|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161916710|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916711|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916712|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
161916713|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916714|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916715|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916716|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916717|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161916718|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161916719|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161916720|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
161916721|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
161916722|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161916723|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161916724|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161916725|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161916726|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161916727|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161916728|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
161916729|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
161916730|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161916731|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161916732|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161916733|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161916734|NCT03329001|584744284|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161916735|NCT03329001|584744285|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161916736|NCT03329001|584744286|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
162014968|NCT00345358|585108609|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
162014969|NCT00345358|585108606|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
162014970|NCT00345358|585108607|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
162014971|NCT00345358|585108608|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
162014972|NCT00345358|585108609|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
162014973|NCT00131248|585108610|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
162014974|NCT00131248|585108611|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
162014975|NCT05038982|585108614|FG000|Overall Study|Withdrawal by Subject|0|||
162014976|NCT05038982|585108615|FG001|Overall Study|Withdrawal by Subject|2|||
162014977|NCT02592798|585108618|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
162014978|NCT02592798|585108619|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
162014979|NCT02592798|585108618|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
161916737|NCT03329001|584744287|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
161916738|NCT03329001|584744288|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161916739|NCT03329001|584744289|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161916740|NCT03329001|584744290|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161916741|NCT03329001|584744291|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161916742|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916743|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916744|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916745|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
161916746|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916747|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916748|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916749|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161916750|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916751|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916752|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916753|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
161916754|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916755|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916756|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916757|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161916758|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916759|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916760|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
161916761|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916762|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916763|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916764|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916765|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161916766|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161916767|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161916768|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
161916769|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
161916770|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161916771|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161916772|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161916773|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161916774|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916775|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916776|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
161916777|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916778|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916779|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
162014980|NCT02592798|585108619|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
162014981|NCT02592798|585108618|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
162014982|NCT02592798|585108619|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
162014983|NCT02592798|585108618|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
162014984|NCT02592798|585108619|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
162014985|NCT02592798|585108618|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
162014986|NCT02592798|585108619|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
162014987|NCT02592798|585108618|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
162014988|NCT02592798|585108619|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
162014989|NCT02592798|585108618|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
162014990|NCT02592798|585108619|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
162014991|NCT02592798|585108618|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
162014992|NCT02592798|585108619|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
162014993|NCT02592798|585108618|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
162014994|NCT02592798|585108619|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
162014995|NCT02592798|585108618|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
162014996|NCT02592798|585108619|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
161916780|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916781|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161916782|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916783|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916784|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
161916785|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916786|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916787|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916788|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916789|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161916790|NCT03329001|584744284|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916791|NCT03329001|584744285|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916792|NCT03329001|584744286|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916793|NCT03329001|584744287|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
161916794|NCT03329001|584744288|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916795|NCT03329001|584744289|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916796|NCT03329001|584744290|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916797|NCT03329001|584744291|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161916798|NCT03329001|584744284|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916799|NCT03329001|584744285|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916800|NCT03329001|584744286|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916801|NCT03329001|584744287|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916802|NCT03329001|584744288|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916803|NCT03329001|584744289|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
161916804|NCT03329001|584744290|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916805|NCT03329001|584744291|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161916806|NCT03329001|584744284|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916807|NCT03329001|584744285|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916808|NCT03329001|584744286|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916809|NCT03329001|584744287|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916810|NCT03329001|584744288|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
161916811|NCT03329001|584744289|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916812|NCT03329001|584744290|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916813|NCT03329001|584744291|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161916814|NCT03329001|584744284|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161916815|NCT03329001|584744285|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161916816|NCT03329001|584744286|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161916817|NCT03329001|584744287|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161916818|NCT03329001|584744288|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
161916819|NCT03329001|584744289|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
161916820|NCT03329001|584744290|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161916821|NCT03329001|584744291|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161916822|NCT03329001|584744284|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916823|NCT03329001|584744285|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916824|NCT03329001|584744286|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916825|NCT03329001|584744287|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916826|NCT03329001|584744288|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
161916827|NCT03329001|584744289|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916828|NCT03329001|584744290|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916829|NCT03329001|584744291|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161916830|NCT03329001|584744284|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161916831|NCT03329001|584744285|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161916832|NCT03329001|584744286|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
162160650|NCT04623775|585637496|FG002|Treatment Period|poor/non compliance|1|||
162160651|NCT04623775|585637497|FG003|Treatment Period|poor/non compliance|0|||
162160652|NCT04623775|585637494|FG000|Treatment Period|participant no longer meets study criteria|0|||
162160653|NCT04623775|585637495|FG001|Treatment Period|participant no longer meets study criteria|1|||
162160654|NCT04623775|585637496|FG002|Treatment Period|participant no longer meets study criteria|0|||
162160655|NCT04623775|585637497|FG003|Treatment Period|participant no longer meets study criteria|0|||
162160656|NCT04623775|585637494|FG000|Treatment Period|administrative reasons by sponsor|3|||
162160657|NCT04623775|585637495|FG001|Treatment Period|administrative reasons by sponsor|2|||
162160658|NCT04623775|585637496|FG002|Treatment Period|administrative reasons by sponsor|0|||
162160659|NCT04623775|585637497|FG003|Treatment Period|administrative reasons by sponsor|0|||
162160660|NCT04623775|585637494|FG000|Treatment Period|other reasons|2|||
162160661|NCT04623775|585637495|FG001|Treatment Period|other reasons|0|||
162160662|NCT04623775|585637496|FG002|Treatment Period|other reasons|1|||
162160663|NCT04623775|585637497|FG003|Treatment Period|other reasons|1|||
162160664|NCT04623775|585637494|FG000|Treatment Period|disease progression|40|||
162160665|NCT04623775|585637495|FG001|Treatment Period|disease progression|35|||
162160666|NCT04623775|585637496|FG002|Treatment Period|disease progression|63|||
162160667|NCT04623775|585637497|FG003|Treatment Period|disease progression|63|||
162160668|NCT04623775|585637494|FG000|Treatment Period|study drug toxicity|12|||
162160669|NCT04623775|585637495|FG001|Treatment Period|study drug toxicity|15|||
162160670|NCT04623775|585637496|FG002|Treatment Period|study drug toxicity|13|||
162160671|NCT04623775|585637497|FG003|Treatment Period|study drug toxicity|12|||
162160672|NCT04623775|585637494|FG000|Treatment Period|AE unrelated to study drug|4|||
162160673|NCT04623775|585637495|FG001|Treatment Period|AE unrelated to study drug|9|||
162160674|NCT04623775|585637496|FG002|Treatment Period|AE unrelated to study drug|12|||
162160675|NCT04623775|585637497|FG003|Treatment Period|AE unrelated to study drug|9|||
162160676|NCT04623775|585637494|FG000|Treatment Period|participant request to discontinue treatment|0|||
162160677|NCT04623775|585637495|FG001|Treatment Period|participant request to discontinue treatment|2|||
162160678|NCT04623775|585637496|FG002|Treatment Period|participant request to discontinue treatment|2|||
162160679|NCT04623775|585637497|FG003|Treatment Period|participant request to discontinue treatment|0|||
161813335|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
161813336|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
161813337|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
161813338|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
161813339|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
161813340|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
162160680|NCT02525692|585638554|FG000|Overall Study|Withdrawal by Subject|1|||
162160681|NCT02525692|585638555|FG001|Overall Study|Withdrawal by Subject|1|||
161813341|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
161813342|NCT00318461|584359832|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
161813343|NCT00318461|584359833|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
161813344|NCT00318461|584359834|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
161813345|NCT00318461|584359835|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
161813346|NCT00318461|584359836|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
161813347|NCT00318461|584359832|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
161813348|NCT00318461|584359833|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
161813349|NCT00318461|584359834|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
161813350|NCT00318461|584359835|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
161813351|NCT00318461|584359836|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
161813352|NCT00318461|584359832|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
161813353|NCT00318461|584359833|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
161813354|NCT00318461|584359834|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
161813355|NCT00318461|584359835|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
161813356|NCT00318461|584359836|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
161813357|NCT00318461|584359832|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
161813358|NCT00318461|584359833|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
161813359|NCT00318461|584359834|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
161813360|NCT00318461|584359835|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
161813361|NCT00318461|584359836|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
161813362|NCT00318461|584359832|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
161813363|NCT00318461|584359833|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
161813364|NCT00318461|584359834|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
162160682|NCT02525692|585638556|FG002|Overall Study|Withdrawal by Subject|0|||
162160683|NCT02525692|585638557|FG003|Overall Study|Withdrawal by Subject|5|||
162160684|NCT02525692|585638558|FG004|Overall Study|Withdrawal by Subject|0|||
162160685|NCT02525692|585638559|FG005|Overall Study|Withdrawal by Subject|1|||
162160686|NCT02525692|585638554|FG000|Overall Study|Death|16|||
162160687|NCT02525692|585638555|FG001|Overall Study|Death|18|||
162160688|NCT02525692|585638556|FG002|Overall Study|Death|7|||
162160689|NCT02525692|585638557|FG003|Overall Study|Death|20|||
162160690|NCT02525692|585638558|FG004|Overall Study|Death|3|||
162160691|NCT02525692|585638559|FG005|Overall Study|Death|6|||
162160692|NCT02525692|585638554|FG000|Overall Study|Lost to Follow-up|0|||
162160693|NCT02525692|585638555|FG001|Overall Study|Lost to Follow-up|0|||
162160694|NCT02525692|585638556|FG002|Overall Study|Lost to Follow-up|1|||
162160695|NCT02525692|585638557|FG003|Overall Study|Lost to Follow-up|5|||
162160696|NCT02525692|585638558|FG004|Overall Study|Lost to Follow-up|0|||
162160697|NCT02525692|585638559|FG005|Overall Study|Lost to Follow-up|0|||
162160698|NCT02396199|585638560|FG000|Overall Study|Lost to Follow-up|1|||
162160699|NCT02396199|585638560|FG000|Overall Study|Death|4|||
162160700|NCT04112316|585638563|FG000|First Period (8 Weeks)|Protocol Violation|1|||
162160701|NCT04112316|585638564|FG001|First Period (8 Weeks)|Protocol Violation|0|||
162160702|NCT04112316|585638563|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
162160703|NCT04112316|585638564|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
162160704|NCT04247542|585638576|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
162160705|NCT04247542|585638577|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
162160706|NCT04247542|585638578|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
162160707|NCT04247542|585638576|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
162160708|NCT04247542|585638577|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
162160709|NCT04247542|585638578|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
162160710|NCT06066541|585638579|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
162160711|NCT06066541|585638580|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
162160712|NCT06066541|585638581|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
162160713|NCT06066541|585638582|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
161813365|NCT00318461|584359835|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
161813366|NCT00318461|584359836|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
161813367|NCT00318461|584359832|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
161813368|NCT00318461|584359833|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
161813369|NCT00318461|584359834|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
161813370|NCT00318461|584359835|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
161813371|NCT00318461|584359836|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
161813372|NCT00796653|584359837|FG000|Overall Study|Adverse Event|19|||
161813373|NCT00796653|584359838|FG001|Overall Study|Adverse Event|16|||
161813374|NCT00796653|584359839|FG002|Overall Study|Adverse Event|16|||
161813375|NCT00796653|584359840|FG003|Overall Study|Adverse Event|16|||
161813376|NCT00796653|584359837|FG000|Overall Study|Lost to Follow-up|2|||
161813377|NCT00796653|584359838|FG001|Overall Study|Lost to Follow-up|1|||
161813378|NCT00796653|584359839|FG002|Overall Study|Lost to Follow-up|2|||
161813379|NCT00796653|584359840|FG003|Overall Study|Lost to Follow-up|3|||
161813380|NCT00796653|584359837|FG000|Overall Study|Withdrawal by Subject|16|||
161813381|NCT00796653|584359838|FG001|Overall Study|Withdrawal by Subject|8|||
161813382|NCT00796653|584359839|FG002|Overall Study|Withdrawal by Subject|8|||
161813383|NCT00796653|584359840|FG003|Overall Study|Withdrawal by Subject|13|||
161813384|NCT00796653|584359837|FG000|Overall Study|Lack of Efficacy|8|||
161813385|NCT00796653|584359838|FG001|Overall Study|Lack of Efficacy|1|||
161813386|NCT00796653|584359839|FG002|Overall Study|Lack of Efficacy|3|||
161813387|NCT00796653|584359840|FG003|Overall Study|Lack of Efficacy|2|||
161813388|NCT00796653|584359837|FG000|Overall Study|Non compliance with protocol|2|||
161813389|NCT00796653|584359838|FG001|Overall Study|Non compliance with protocol|2|||
161813390|NCT00796653|584359839|FG002|Overall Study|Non compliance with protocol|0|||
161813391|NCT00796653|584359840|FG003|Overall Study|Non compliance with protocol|2|||
161813392|NCT00796653|584359837|FG000|Overall Study|Other reason not described above|4|||
161813393|NCT00796653|584359838|FG001|Overall Study|Other reason not described above|9|||
161813394|NCT00796653|584359839|FG002|Overall Study|Other reason not described above|7|||
161813395|NCT00796653|584359840|FG003|Overall Study|Other reason not described above|4|||
161813396|NCT00835692|584359842|FG000|First Intervention|Withdrawal by Subject|1|||
161813397|NCT00835692|584359843|FG001|First Intervention|Withdrawal by Subject|0|||
161813398|NCT00191815|584359846|FG000|Overall Study|Adverse Event|2|||
161813399|NCT00191815|584359846|FG000|Overall Study|Disease progression or relapse|24|||
161813400|NCT00191815|584359846|FG000|Overall Study|Death|2|||
161813401|NCT00191815|584359846|FG000|Overall Study|Protocol Violation|3|||
161813402|NCT00191815|584359846|FG000|Overall Study|Physician Decision|2|||
161813403|NCT00191815|584359846|FG000|Overall Study|Withdrawal by Subject|7|||
161813404|NCT03644550|584359847|FG000|Overall Study|Withdrawal by Subject|3|||
161813405|NCT03644550|584359847|FG000|Overall Study|Progressive disease|15|||
161813406|NCT01218867|584359848|FG000|Overall Study|Death during treatment|0|||
161813407|NCT01218867|584359849|FG001|Overall Study|Death during treatment|0|||
161813408|NCT01218867|584359850|FG002|Overall Study|Death during treatment|0|||
161813409|NCT01218867|584359851|FG003|Overall Study|Death during treatment|0|||
161813410|NCT01218867|584359852|FG004|Overall Study|Death during treatment|0|||
161813411|NCT01218867|584359853|FG005|Overall Study|Death during treatment|0|||
161813412|NCT01218867|584359854|FG006|Overall Study|Death during treatment|1|||
161813413|NCT01218867|584359855|FG007|Overall Study|Death during treatment|0|||
161813414|NCT01218867|584359856|FG008|Overall Study|Death during treatment|0|||
161813415|NCT01218867|584359857|FG009|Overall Study|Death during treatment|0|||
161813416|NCT01218867|584359858|FG010|Overall Study|Death during treatment|0|||
161813417|NCT00251979|584359859|FG000|Overall Study|Protocol Violation|3|||
161813418|NCT00251979|584359860|FG001|Overall Study|Protocol Violation|5|||
161813419|NCT00251979|584359859|FG000|Overall Study|Adverse Event|11|||
161813420|NCT00251979|584359860|FG001|Overall Study|Adverse Event|17|||
161813421|NCT00251979|584359859|FG000|Overall Study|Withdrawal by Subject|13|||
161916833|NCT03329001|584744287|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161916834|NCT03329001|584744288|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
161916835|NCT03329001|584744289|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
161916836|NCT03329001|584744290|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161916837|NCT03329001|584744291|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161916838|NCT03329001|584744284|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161916839|NCT03329001|584744285|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161916840|NCT03329001|584744286|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161916841|NCT03329001|584744287|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161916842|NCT03329001|584744288|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161916843|NCT03329001|584744289|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161916844|NCT03329001|584744290|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
161916845|NCT03329001|584744291|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
161916846|NCT03329001|584744284|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916847|NCT03329001|584744285|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916848|NCT03329001|584744286|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916849|NCT03329001|584744287|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916850|NCT03329001|584744288|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916851|NCT03329001|584744289|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916852|NCT03329001|584744290|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
161916853|NCT03329001|584744291|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161916854|NCT03329001|584744284|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161916855|NCT03329001|584744285|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161916856|NCT03329001|584744286|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161916857|NCT03329001|584744287|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161916858|NCT03329001|584744288|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161916859|NCT03329001|584744289|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161916860|NCT03329001|584744290|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
161916861|NCT03329001|584744291|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
161916862|NCT03329001|584744284|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161916863|NCT03329001|584744285|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161916864|NCT03329001|584744286|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161916865|NCT03329001|584744287|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161916866|NCT03329001|584744288|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161916867|NCT03329001|584744289|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161916868|NCT03329001|584744290|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
161916869|NCT03329001|584744291|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
161916870|NCT02178956|584744292|FG000|Overall Study|Lost to Follow-up|4|||
161916871|NCT02178956|584744293|FG001|Overall Study|Lost to Follow-up|4|||
161916872|NCT02178956|584744292|FG000|Overall Study|Sponsor terminated study|49|||
161916873|NCT02178956|584744293|FG001|Overall Study|Sponsor terminated study|58|||
161916874|NCT02178956|584744292|FG000|Overall Study|Withdrawal by Subject|15|||
161916875|NCT02178956|584744293|FG001|Overall Study|Withdrawal by Subject|11|||
161916876|NCT02178956|584744292|FG000|Overall Study|Various Reasons|3|||
161916877|NCT02178956|584744293|FG001|Overall Study|Various Reasons|5|||
161916878|NCT02709369|584744299|FG000|Overall Study|Lost to Follow-up|15|||
161916879|NCT02709369|584744299|FG000|Overall Study|Withdrawal by Subject|10|||
161916880|NCT02709369|584744299|FG000|Overall Study|Did not received intervention|2|||
161916881|NCT01104766|584744301|FG000|Overall Study|Did not meet inc/exc criteria|1|||
161916882|NCT01104766|584744302|FG001|Overall Study|Did not meet inc/exc criteria|0|||
161916883|NCT01104766|584744303|FG002|Overall Study|Did not meet inc/exc criteria|0|||
161916884|NCT01104766|584744304|FG003|Overall Study|Did not meet inc/exc criteria|0|||
161916885|NCT01104766|584744301|FG000|Overall Study|Adverse Event|17|||
161916886|NCT01104766|584744302|FG001|Overall Study|Adverse Event|15|||
161916887|NCT01104766|584744303|FG002|Overall Study|Adverse Event|20|||
161916888|NCT01104766|584744304|FG003|Overall Study|Adverse Event|14|||
161916889|NCT01104766|584744301|FG000|Overall Study|Lack of Efficacy|20|||
161916890|NCT01104766|584744302|FG001|Overall Study|Lack of Efficacy|15|||
161916891|NCT01104766|584744303|FG002|Overall Study|Lack of Efficacy|14|||
161916892|NCT01104766|584744304|FG003|Overall Study|Lack of Efficacy|8|||
161916893|NCT01104766|584744301|FG000|Overall Study|Protocol Violation|2|||
161916894|NCT01104766|584744302|FG001|Overall Study|Protocol Violation|0|||
161916895|NCT01104766|584744303|FG002|Overall Study|Protocol Violation|0|||
161916896|NCT01104766|584744304|FG003|Overall Study|Protocol Violation|0|||
161916897|NCT01104766|584744301|FG000|Overall Study|Withdrawal by Subject|17|||
161916898|NCT01104766|584744302|FG001|Overall Study|Withdrawal by Subject|19|||
161916899|NCT01104766|584744303|FG002|Overall Study|Withdrawal by Subject|25|||
161916900|NCT01104766|584744304|FG003|Overall Study|Withdrawal by Subject|15|||
161916901|NCT01104766|584744301|FG000|Overall Study|Lost to Follow-up|1|||
161916902|NCT01104766|584744302|FG001|Overall Study|Lost to Follow-up|2|||
161916903|NCT01104766|584744303|FG002|Overall Study|Lost to Follow-up|1|||
161916904|NCT01104766|584744304|FG003|Overall Study|Lost to Follow-up|1|||
161813422|NCT00251979|584359860|FG001|Overall Study|Withdrawal by Subject|7|||
161813423|NCT00251979|584359859|FG000|Overall Study|Lost to Follow-up|8|||
161813424|NCT00251979|584359860|FG001|Overall Study|Lost to Follow-up|6|||
161813425|NCT00251979|584359859|FG000|Overall Study|Death|3|||
161813426|NCT00251979|584359860|FG001|Overall Study|Death|5|||
161813427|NCT01348789|584359870|FG000|Overall Study|Protocol Violation|2|||
161813428|NCT01348789|584359870|FG000|Overall Study|Withdrawal by Subject|2|||
161813429|NCT01878292|584359871|FG000|Randomized|Protocol Violation|1|||
161813430|NCT01878292|584359872|FG001|Randomized|Protocol Violation|0|||
161813431|NCT01878292|584359873|FG002|Randomized|Protocol Violation|0|||
161813432|NCT01878292|584359871|FG000|Randomized|Lost to Follow-up|1|||
161813433|NCT01878292|584359872|FG001|Randomized|Lost to Follow-up|0|||
161813434|NCT01878292|584359873|FG002|Randomized|Lost to Follow-up|0|||
161813435|NCT01878292|584359871|FG000|Randomized|Adverse Event|1|||
161813436|NCT01878292|584359872|FG001|Randomized|Adverse Event|0|||
161813437|NCT01878292|584359873|FG002|Randomized|Adverse Event|0|||
161813438|NCT01878292|584359871|FG000|Double-blind Treatment Period|Other Reasons|2|||
161813439|NCT01878292|584359872|FG001|Double-blind Treatment Period|Other Reasons|0|||
161813440|NCT01878292|584359873|FG002|Double-blind Treatment Period|Other Reasons|0|||
161813441|NCT01878292|584359871|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
161813442|NCT01878292|584359872|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
161813443|NCT01878292|584359873|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
161813444|NCT01878292|584359871|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
161813445|NCT01878292|584359872|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
161813446|NCT01878292|584359873|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
161813447|NCT01878292|584359871|FG000|Double-blind Treatment Period|Protocol Violation|3|||
161813448|NCT01878292|584359872|FG001|Double-blind Treatment Period|Protocol Violation|4|||
161813449|NCT01878292|584359873|FG002|Double-blind Treatment Period|Protocol Violation|2|||
161813450|NCT01878292|584359871|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
161813451|NCT01878292|584359872|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
161813452|NCT01878292|584359873|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
161813453|NCT01878292|584359871|FG000|Double-blind Treatment Period|Adverse Event|4|||
161813454|NCT01878292|584359872|FG001|Double-blind Treatment Period|Adverse Event|9|||
161813455|NCT01878292|584359873|FG002|Double-blind Treatment Period|Adverse Event|8|||
161813456|NCT01878292|584359871|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
161813457|NCT01878292|584359872|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
161813458|NCT01878292|584359873|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
161916905|NCT01341470|584744305|FG000|Overall Study|Sponsor decision|0|||
161916906|NCT01341470|584744306|FG001|Overall Study|Sponsor decision|0|||
161916907|NCT01341470|584744307|FG002|Overall Study|Sponsor decision|1|||
161916908|NCT01341470|584744308|FG003|Overall Study|Sponsor decision|1|||
161916909|NCT01341470|584744309|FG004|Overall Study|Sponsor decision|0|||
161916910|NCT01341470|584744310|FG005|Overall Study|Sponsor decision|1|||
161916911|NCT05452239|584744314|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
161916912|NCT05452239|584744315|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
161916913|NCT05452239|584744314|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
161916914|NCT05452239|584744315|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
161916915|NCT05452239|584744314|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
161916916|NCT05452239|584744315|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
161916917|NCT05452239|584744314|FG000|Placebo-controlled Period|Randomized but not treated|2|||
161916918|NCT05452239|584744315|FG001|Placebo-controlled Period|Randomized but not treated|2|||
161916919|NCT05452239|584744314|FG000|Placebo-controlled Period|Other than specified|1|||
161916920|NCT05452239|584744315|FG001|Placebo-controlled Period|Other than specified|1|||
161916921|NCT05452239|584744314|FG000|Open-label Period|Withdrawal by Subject|2|||
161916922|NCT05452239|584744315|FG001|Open-label Period|Withdrawal by Subject|1|||
161916923|NCT05452239|584744314|FG000|Open-label Period|Lost to Follow-up|3|||
161916924|NCT05452239|584744315|FG001|Open-label Period|Lost to Follow-up|0|||
161916925|NCT05452239|584744314|FG000|Open-label Period|Other than specified|1|||
161916926|NCT05452239|584744315|FG001|Open-label Period|Other than specified|2|||
161916927|NCT03965923|584744316|FG000|Overall Study|Withdrawal by Subject|1|||
161916928|NCT03965923|584744317|FG001|Overall Study|Withdrawal by Subject|2|||
161916929|NCT03965923|584744318|FG002|Overall Study|Withdrawal by Subject|3|||
161916930|NCT03965923|584744319|FG003|Overall Study|Withdrawal by Subject|1|||
161916931|NCT03965923|584744320|FG004|Overall Study|Withdrawal by Subject|2|||
161813459|NCT00323882|584359874|FG000|Overall Study|Adverse Event|2|||
161916932|NCT03965923|584744321|FG005|Overall Study|Withdrawal by Subject|0|||
161916933|NCT03965923|584744322|FG006|Overall Study|Withdrawal by Subject|4|||
161916934|NCT03965923|584744323|FG007|Overall Study|Withdrawal by Subject|3|||
161916935|NCT03965923|584744324|FG008|Overall Study|Withdrawal by Subject|4|||
161916936|NCT03965923|584744325|FG009|Overall Study|Withdrawal by Subject|0|||
161916937|NCT03965923|584744326|FG010|Overall Study|Withdrawal by Subject|2|||
161916938|NCT03965923|584744327|FG011|Overall Study|Withdrawal by Subject|0|||
161916939|NCT03965923|584744316|FG000|Overall Study|Lost to Follow-up|2|||
161916940|NCT03965923|584744317|FG001|Overall Study|Lost to Follow-up|1|||
161916941|NCT03965923|584744318|FG002|Overall Study|Lost to Follow-up|1|||
161916942|NCT03965923|584744319|FG003|Overall Study|Lost to Follow-up|0|||
161916943|NCT03965923|584744320|FG004|Overall Study|Lost to Follow-up|2|||
161916944|NCT03965923|584744321|FG005|Overall Study|Lost to Follow-up|1|||
161916945|NCT03965923|584744322|FG006|Overall Study|Lost to Follow-up|2|||
161916946|NCT03965923|584744323|FG007|Overall Study|Lost to Follow-up|1|||
161916947|NCT03965923|584744324|FG008|Overall Study|Lost to Follow-up|0|||
161916948|NCT03965923|584744325|FG009|Overall Study|Lost to Follow-up|2|||
161916949|NCT03965923|584744326|FG010|Overall Study|Lost to Follow-up|0|||
161916950|NCT03965923|584744327|FG011|Overall Study|Lost to Follow-up|0|||
161916951|NCT03965923|584744316|FG000|Overall Study|Death|0|||
161916952|NCT03965923|584744317|FG001|Overall Study|Death|0|||
161916953|NCT03965923|584744318|FG002|Overall Study|Death|0|||
161916954|NCT03965923|584744319|FG003|Overall Study|Death|0|||
161916955|NCT03965923|584744320|FG004|Overall Study|Death|0|||
161916956|NCT03965923|584744321|FG005|Overall Study|Death|0|||
161916957|NCT03965923|584744322|FG006|Overall Study|Death|0|||
161916958|NCT03965923|584744323|FG007|Overall Study|Death|1|||
161916959|NCT03965923|584744324|FG008|Overall Study|Death|4|||
161916960|NCT03965923|584744325|FG009|Overall Study|Death|0|||
161916961|NCT03965923|584744326|FG010|Overall Study|Death|4|||
161916962|NCT03965923|584744327|FG011|Overall Study|Death|0|||
161916963|NCT03965923|584744316|FG000|Overall Study|Other reason|0|||
161916964|NCT03965923|584744317|FG001|Overall Study|Other reason|0|||
161916965|NCT03965923|584744318|FG002|Overall Study|Other reason|0|||
161916966|NCT03965923|584744319|FG003|Overall Study|Other reason|1|||
161916967|NCT03965923|584744320|FG004|Overall Study|Other reason|0|||
161916968|NCT03965923|584744321|FG005|Overall Study|Other reason|0|||
161916969|NCT03965923|584744322|FG006|Overall Study|Other reason|0|||
161916970|NCT03965923|584744323|FG007|Overall Study|Other reason|0|||
161916971|NCT03965923|584744324|FG008|Overall Study|Other reason|0|||
161916972|NCT03965923|584744325|FG009|Overall Study|Other reason|0|||
161916973|NCT03965923|584744326|FG010|Overall Study|Other reason|2|||
161916974|NCT03965923|584744327|FG011|Overall Study|Other reason|0|||
161916975|NCT03282097|584744328|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
161916976|NCT03282097|584744329|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
161916977|NCT03282097|584744328|FG000|Intervention Visit Complete|Patient Death|13|||
161916978|NCT03282097|584744329|FG001|Intervention Visit Complete|Patient Death|15|||
161916979|NCT03282097|584744328|FG000|Intervention Visit Complete|Caregiver Death|0|||
161916980|NCT03282097|584744329|FG001|Intervention Visit Complete|Caregiver Death|3|||
161916981|NCT03282097|584744328|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
161916982|NCT03282097|584744329|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
161916983|NCT03282097|584744328|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
161916984|NCT03282097|584744329|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
161916985|NCT03282097|584744328|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
161916986|NCT03282097|584744329|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
161916987|NCT03282097|584744328|FG000|Primary Outcome Data Collection Complete|Missing|2|||
161916988|NCT03282097|584744329|FG001|Primary Outcome Data Collection Complete|Missing|3|||
161916989|NCT03282097|584744328|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
161916990|NCT03282097|584744329|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
161916991|NCT03282097|584744328|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
161916992|NCT03282097|584744329|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
161916993|NCT03282097|584744328|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
161916994|NCT03282097|584744329|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
162014997|NCT02592798|585108618|FG000|Transition From DB2 to OLE|Other reasons|1|||
162014998|NCT02592798|585108619|FG001|Transition From DB2 to OLE|Other reasons|0|||
161916995|NCT02755090|584744330|FG000|Overall Study|equipment malfunction|1|||
161916996|NCT02755090|584744331|FG001|Overall Study|equipment malfunction|0|||
161916997|NCT00207740|584744332|FG000|Overall Study|Adverse Event|4|||
161916998|NCT00207740|584744333|FG001|Overall Study|Adverse Event|14|||
161916999|NCT00207740|584744334|FG002|Overall Study|Adverse Event|14|||
161917000|NCT00207740|584744335|FG003|Overall Study|Adverse Event|11|||
161917001|NCT00207740|584744332|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161917002|NCT00207740|584744333|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161917003|NCT00207740|584744334|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161917004|NCT00207740|584744335|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
161917005|NCT00207740|584744332|FG000|Overall Study|Lost to Follow-up|0|||
161917006|NCT00207740|584744333|FG001|Overall Study|Lost to Follow-up|2|||
161917007|NCT00207740|584744334|FG002|Overall Study|Lost to Follow-up|1|||
161917008|NCT00207740|584744335|FG003|Overall Study|Lost to Follow-up|1|||
161917009|NCT00207740|584744332|FG000|Overall Study|Death|0|||
162014999|NCT02592798|585108618|FG000|Open Label Period (OLE)|Other reasons|0|||
162015000|NCT02592798|585108619|FG001|Open Label Period (OLE)|Other reasons|2|||
162160714|NCT06066541|585638583|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
162160715|NCT06066541|585638584|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
161917010|NCT00207740|584744333|FG001|Overall Study|Death|0|||
161917011|NCT00207740|584744334|FG002|Overall Study|Death|0|||
162160716|NCT06066541|585638585|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
162160717|NCT06066541|585638579|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
162160718|NCT06066541|585638580|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
161917012|NCT00207740|584744335|FG003|Overall Study|Death|1|||
161917013|NCT00207740|584744332|FG000|Overall Study|Sponsor Directive|22|||
161917014|NCT00207740|584744333|FG001|Overall Study|Sponsor Directive|15|||
161917015|NCT00207740|584744334|FG002|Overall Study|Sponsor Directive|16|||
161917016|NCT00207740|584744335|FG003|Overall Study|Sponsor Directive|21|||
161917017|NCT00207740|584744332|FG000|Overall Study|Other|2|||
161917018|NCT00207740|584744333|FG001|Overall Study|Other|10|||
161917019|NCT00207740|584744334|FG002|Overall Study|Other|7|||
161917020|NCT00207740|584744335|FG003|Overall Study|Other|5|||
161917021|NCT03034967|584744338|FG000|Overall Study|Withdrawal by Subject|9|||
161917022|NCT03034967|584744339|FG001|Overall Study|Withdrawal by Subject|2|||
161917023|NCT03034967|584744340|FG002|Overall Study|Withdrawal by Subject|6|||
161917024|NCT03034967|584744341|FG003|Overall Study|Withdrawal by Subject|6|||
161917025|NCT03034967|584744342|FG004|Overall Study|Withdrawal by Subject|9|||
161917026|NCT03034967|584744343|FG005|Overall Study|Withdrawal by Subject|2|||
161917027|NCT03034967|584744338|FG000|Overall Study|Physician Decision|1|||
161917028|NCT03034967|584744339|FG001|Overall Study|Physician Decision|0|||
161917029|NCT03034967|584744340|FG002|Overall Study|Physician Decision|1|||
161917030|NCT03034967|584744341|FG003|Overall Study|Physician Decision|1|||
161917031|NCT03034967|584744342|FG004|Overall Study|Physician Decision|1|||
161917032|NCT03034967|584744343|FG005|Overall Study|Physician Decision|0|||
161917033|NCT03034967|584744338|FG000|Overall Study|Lost to Follow-up|0|||
161917034|NCT03034967|584744339|FG001|Overall Study|Lost to Follow-up|0|||
161917035|NCT03034967|584744340|FG002|Overall Study|Lost to Follow-up|0|||
161917036|NCT03034967|584744341|FG003|Overall Study|Lost to Follow-up|1|||
161917037|NCT03034967|584744342|FG004|Overall Study|Lost to Follow-up|0|||
161917038|NCT03034967|584744343|FG005|Overall Study|Lost to Follow-up|2|||
161917039|NCT03034967|584744338|FG000|Overall Study|Liver function test abnormality|0|||
161917040|NCT03034967|584744339|FG001|Overall Study|Liver function test abnormality|0|||
161917041|NCT03034967|584744340|FG002|Overall Study|Liver function test abnormality|1|||
161917042|NCT03034967|584744341|FG003|Overall Study|Liver function test abnormality|0|||
161917043|NCT03034967|584744342|FG004|Overall Study|Liver function test abnormality|0|||
161917044|NCT03034967|584744343|FG005|Overall Study|Liver function test abnormality|0|||
161917045|NCT03034967|584744338|FG000|Overall Study|Protocol Violation|1|||
161917046|NCT03034967|584744339|FG001|Overall Study|Protocol Violation|0|||
161917047|NCT03034967|584744340|FG002|Overall Study|Protocol Violation|0|||
161917048|NCT03034967|584744341|FG003|Overall Study|Protocol Violation|0|||
162160719|NCT06066541|585638581|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
162160720|NCT06066541|585638582|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
162160721|NCT06066541|585638583|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
162160722|NCT06066541|585638584|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
162160723|NCT06066541|585638585|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
162160724|NCT04533022|585638586|FG000|Overall Study|Withdrawal by Subject|15|||
162160725|NCT04533022|585638586|FG000|Overall Study|Adverse Event|6|||
162160726|NCT04533022|585638586|FG000|Overall Study|Death|1|||
162160727|NCT04533022|585638586|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
162160728|NCT04533022|585638586|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
162160729|NCT03897686|585638587|FG000|Overall Study|Protocol Violation|1|||
162160730|NCT03897686|585638588|FG001|Overall Study|Protocol Violation|1|||
162160731|NCT03897686|585638587|FG000|Overall Study|Withdrawal by Subject|1|||
161917049|NCT03034967|584744342|FG004|Overall Study|Protocol Violation|0|||
161917050|NCT03034967|584744343|FG005|Overall Study|Protocol Violation|2|||
161917051|NCT03034967|584744338|FG000|Overall Study|Lack of Efficacy|0|||
161917052|NCT03034967|584744339|FG001|Overall Study|Lack of Efficacy|1|||
162015001|NCT02592798|585108618|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
161917053|NCT03034967|584744340|FG002|Overall Study|Lack of Efficacy|2|||
162015002|NCT02592798|585108619|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
162015003|NCT02592798|585108618|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
162015004|NCT02592798|585108619|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
162160732|NCT03897686|585638588|FG001|Overall Study|Withdrawal by Subject|1|||
162160733|NCT05415436|585638589|FG000|Overall Study|Surgeon cancelled procedure|1|||
161917054|NCT03034967|584744341|FG003|Overall Study|Lack of Efficacy|1|||
161917055|NCT03034967|584744342|FG004|Overall Study|Lack of Efficacy|1|||
161917056|NCT03034967|584744343|FG005|Overall Study|Lack of Efficacy|0|||
161917057|NCT03034967|584744338|FG000|Overall Study|Adverse Event, non-fatal|3|||
161917058|NCT03034967|584744339|FG001|Overall Study|Adverse Event, non-fatal|1|||
162160734|NCT05415436|585638590|FG001|Overall Study|Surgeon cancelled procedure|0|||
162160735|NCT05415436|585638589|FG000|Overall Study|Death|1|||
162160736|NCT05415436|585638590|FG001|Overall Study|Death|0|||
162160737|NCT05386355|585638601|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
162160738|NCT05386355|585638602|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
162160739|NCT05386355|585638603|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
162160740|NCT05386355|585638604|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
162160741|NCT03775109|585638609|FG000|Overall Study|Adverse Event|1|||
162160742|NCT03775109|585638610|FG001|Overall Study|Adverse Event|0|||
162160743|NCT03775109|585638609|FG000|Overall Study|COVID-19 outbreak|2|||
162160744|NCT03775109|585638610|FG001|Overall Study|COVID-19 outbreak|0|||
162160745|NCT03775109|585638609|FG000|Overall Study|Lost to Follow-up|0|||
162160746|NCT03775109|585638610|FG001|Overall Study|Lost to Follow-up|2|||
162160747|NCT03775109|585638609|FG000|Overall Study|Withdrawal by Subject|1|||
162160748|NCT03775109|585638610|FG001|Overall Study|Withdrawal by Subject|1|||
162160749|NCT03775109|585638609|FG000|Overall Study|Death|0|||
162160750|NCT03775109|585638610|FG001|Overall Study|Death|1|||
162160751|NCT03775109|585638609|FG000|Overall Study|Lack of Efficacy|1|||
162160752|NCT03775109|585638610|FG001|Overall Study|Lack of Efficacy|0|||
162160753|NCT05691452|585638611|FG000|Overall Study|Withdrawal by Subject|1|||
162160754|NCT05691452|585638612|FG001|Overall Study|Withdrawal by Subject|1|||
162160755|NCT05691452|585638613|FG002|Overall Study|Withdrawal by Subject|0|||
162160756|NCT05691452|585638611|FG000|Overall Study|Physician Decision|1|||
162160757|NCT05691452|585638612|FG001|Overall Study|Physician Decision|0|||
162160758|NCT05691452|585638613|FG002|Overall Study|Physician Decision|0|||
162160759|NCT05691452|585638611|FG000|Overall Study|Lost to Follow-up|0|||
161813460|NCT00323882|584359875|FG001|Overall Study|Adverse Event|1|||
161813461|NCT00323882|584359876|FG002|Overall Study|Adverse Event|1|||
161813462|NCT00323882|584359877|FG003|Overall Study|Adverse Event|1|||
161813463|NCT00323882|584359878|FG004|Overall Study|Adverse Event|3|||
161813464|NCT00323882|584359874|FG000|Overall Study|Disease Progression|6|||
161813465|NCT00323882|584359875|FG001|Overall Study|Disease Progression|4|||
161813466|NCT00323882|584359876|FG002|Overall Study|Disease Progression|10|||
161813467|NCT00323882|584359877|FG003|Overall Study|Disease Progression|5|||
161813468|NCT00323882|584359878|FG004|Overall Study|Disease Progression|22|||
161813469|NCT00323882|584359874|FG000|Overall Study|Death|0|||
161813470|NCT00323882|584359875|FG001|Overall Study|Death|1|||
161813471|NCT00323882|584359876|FG002|Overall Study|Death|1|||
161813472|NCT00323882|584359877|FG003|Overall Study|Death|0|||
161813473|NCT00323882|584359878|FG004|Overall Study|Death|5|||
161813474|NCT00323882|584359874|FG000|Overall Study|Lost to Follow-up|0|||
161813475|NCT00323882|584359875|FG001|Overall Study|Lost to Follow-up|0|||
161813476|NCT00323882|584359876|FG002|Overall Study|Lost to Follow-up|1|||
161813477|NCT00323882|584359877|FG003|Overall Study|Lost to Follow-up|0|||
161813478|NCT00323882|584359878|FG004|Overall Study|Lost to Follow-up|1|||
161813479|NCT00323882|584359874|FG000|Overall Study|Other|0|||
161813480|NCT00323882|584359875|FG001|Overall Study|Other|0|||
161813481|NCT00323882|584359876|FG002|Overall Study|Other|0|||
161813482|NCT00323882|584359877|FG003|Overall Study|Other|1|||
161813483|NCT00323882|584359878|FG004|Overall Study|Other|1|||
161813484|NCT03123471|584359887|FG000|Placebo-controlled Phase|Adverse Event|3|||
161813485|NCT03123471|584359888|FG001|Placebo-controlled Phase|Adverse Event|8|||
161813486|NCT03123471|584359887|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
161813487|NCT03123471|584359888|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
161813488|NCT03123471|584359887|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
161813489|NCT03123471|584359888|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
161813490|NCT03123471|584359887|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
161813491|NCT03123471|584359888|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
161813492|NCT03123471|584359887|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
161813493|NCT03123471|584359888|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
161813494|NCT03123471|584359887|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
161813495|NCT03123471|584359888|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
161813496|NCT03123471|584359887|FG000|Placebo-controlled Phase|Miscellaneous|0|||
161813497|NCT03123471|584359888|FG001|Placebo-controlled Phase|Miscellaneous|1|||
161813498|NCT03123471|584359887|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
161813499|NCT03123471|584359888|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
161917059|NCT03034967|584744340|FG002|Overall Study|Adverse Event, non-fatal|2|||
161917060|NCT03034967|584744341|FG003|Overall Study|Adverse Event, non-fatal|0|||
161917061|NCT03034967|584744342|FG004|Overall Study|Adverse Event, non-fatal|2|||
162160760|NCT05691452|585638612|FG001|Overall Study|Lost to Follow-up|0|||
161813500|NCT03123471|584359887|FG000|Apremilast Extension Phase|Adverse Event|1|||
161813501|NCT03123471|584359888|FG001|Apremilast Extension Phase|Adverse Event|5|||
161813502|NCT03123471|584359887|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
161813503|NCT03123471|584359888|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
161813504|NCT03123471|584359887|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
162160761|NCT05691452|585638613|FG002|Overall Study|Lost to Follow-up|1|||
162160762|NCT05691452|585638611|FG000|Overall Study|Adverse Event|0|||
162160763|NCT05691452|585638612|FG001|Overall Study|Adverse Event|0|||
162160764|NCT05691452|585638613|FG002|Overall Study|Adverse Event|1|||
162160765|NCT03739996|585638618|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
162160766|NCT03739996|585638618|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
162160767|NCT03739996|585638618|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
162160768|NCT03739996|585638618|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
162015005|NCT02592798|585108618|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
162015006|NCT02592798|585108619|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
162015007|NCT02592798|585108618|FG000|Open Label Period (OLE)|Adverse Event|0|||
162015008|NCT02592798|585108619|FG001|Open Label Period (OLE)|Adverse Event|1|||
162015009|NCT01216189|585108620|FG000|Overall Study|Lost to Follow-up|21|||
162015010|NCT01216189|585108621|FG001|Overall Study|Lost to Follow-up|3|||
162015011|NCT01216189|585108620|FG000|Overall Study|Death|4|||
162160769|NCT03739996|585638618|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
162015012|NCT01216189|585108621|FG001|Overall Study|Death|2|||
162015013|NCT01143246|585108622|FG000|Overall Study|Adverse Event|24|||
162015014|NCT01143246|585108623|FG001|Overall Study|Adverse Event|28|||
162015015|NCT01143246|585108622|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
162015016|NCT01143246|585108623|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
162015017|NCT01143246|585108622|FG000|Overall Study|Lost to Follow-up|0|||
162015018|NCT01143246|585108623|FG001|Overall Study|Lost to Follow-up|1|||
162015019|NCT01143246|585108622|FG000|Overall Study|Death|16|||
162015020|NCT01143246|585108623|FG001|Overall Study|Death|15|||
162015021|NCT01143246|585108622|FG000|Overall Study|Reason not Specified|3|||
162015022|NCT01143246|585108623|FG001|Overall Study|Reason not Specified|5|||
162015023|NCT01146795|585108624|FG000|Overall Study|Withdrawal by Subject|4|||
162015024|NCT01146795|585108624|FG000|Overall Study|Adverse Event|6|||
161813505|NCT03123471|584359888|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
162015025|NCT01146795|585108624|FG000|Overall Study|Still in treatment at study closure|10|||
162015026|NCT05375760|585108625|FG000|Overall Study|Adverse Event|1|||
162015027|NCT05375760|585108626|FG001|Overall Study|Adverse Event|0|||
162015028|NCT05375760|585108625|FG000|Overall Study|Death|0|||
162160770|NCT03739996|585638618|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
162160771|NCT03739996|585638618|FG000|Step 3 (SOC ART)|Death|1|||
161813506|NCT02358538|584359891|FG000|Through Week 26|Adverse Event|0|||
161813507|NCT02358538|584359892|FG001|Through Week 26|Adverse Event|1|||
161813508|NCT02358538|584359893|FG002|Through Week 26|Adverse Event|1|||
161813509|NCT02358538|584359894|FG003|Through Week 26|Adverse Event|2|||
161813510|NCT02358538|584359891|FG000|Through Week 26|Lack of Efficacy|1|||
161813511|NCT02358538|584359892|FG001|Through Week 26|Lack of Efficacy|1|||
161813512|NCT02358538|584359893|FG002|Through Week 26|Lack of Efficacy|3|||
161813513|NCT02358538|584359894|FG003|Through Week 26|Lack of Efficacy|3|||
161813514|NCT02358538|584359891|FG000|Through Week 26|Withdrawal by Subject|1|||
161813515|NCT02358538|584359892|FG001|Through Week 26|Withdrawal by Subject|0|||
161813516|NCT02358538|584359893|FG002|Through Week 26|Withdrawal by Subject|0|||
161813517|NCT02358538|584359894|FG003|Through Week 26|Withdrawal by Subject|0|||
161813518|NCT02358538|584359891|FG000|Through Week 26|Non-Compliance|0|||
161813519|NCT02358538|584359892|FG001|Through Week 26|Non-Compliance|0|||
161813520|NCT02358538|584359893|FG002|Through Week 26|Non-Compliance|1|||
161813521|NCT02358538|584359894|FG003|Through Week 26|Non-Compliance|0|||
161813522|NCT02358538|584359891|FG000|Through Week 26|Family did not see benefit from IP|1|||
161813523|NCT02358538|584359892|FG001|Through Week 26|Family did not see benefit from IP|0|||
161813524|NCT02358538|584359893|FG002|Through Week 26|Family did not see benefit from IP|0|||
161813525|NCT02358538|584359894|FG003|Through Week 26|Family did not see benefit from IP|0|||
161813526|NCT02358538|584359891|FG000|52 Week Extension Period|Lack of Efficacy|0|||
161813527|NCT02358538|584359892|FG001|52 Week Extension Period|Lack of Efficacy|0|||
161813528|NCT02358538|584359893|FG002|52 Week Extension Period|Lack of Efficacy|2|||
161813529|NCT02358538|584359894|FG003|52 Week Extension Period|Lack of Efficacy|4|||
161813530|NCT01686477|584359895|FG000|Feeding Intervention|Death|1|||
161813531|NCT01686477|584359896|FG001|Feeding Intervention|Death|0|||
161813532|NCT01686477|584359897|FG002|Feeding Intervention|Death|1|||
161813533|NCT01686477|584359895|FG000|Feeding Intervention|Withdrawal by Subject|0|||
161813534|NCT01686477|584359896|FG001|Feeding Intervention|Withdrawal by Subject|6|||
161813535|NCT01686477|584359897|FG002|Feeding Intervention|Withdrawal by Subject|0|||
161813536|NCT01686477|584359895|FG000|Feeding Intervention|Physician Decision|1|||
161813537|NCT01686477|584359896|FG001|Feeding Intervention|Physician Decision|2|||
161813538|NCT01686477|584359897|FG002|Feeding Intervention|Physician Decision|0|||
161813539|NCT01686477|584359895|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
162015029|NCT05375760|585108626|FG001|Overall Study|Death|1|||
162015030|NCT05375760|585108625|FG000|Overall Study|Lost to Follow-up|6|||
162015031|NCT05375760|585108626|FG001|Overall Study|Lost to Follow-up|6|||
161813540|NCT01686477|584359896|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
162015032|NCT05375760|585108625|FG000|Overall Study|Withdrawal by Subject|17|||
162160772|NCT03739996|585638618|FG000|Step 3 (SOC ART)|Participant moved|1|||
161917062|NCT03034967|584744343|FG005|Overall Study|Adverse Event, non-fatal|8|||
161917063|NCT03034967|584744338|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
161917064|NCT03034967|584744339|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
161917065|NCT03034967|584744340|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
161917066|NCT03034967|584744341|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
161917067|NCT03034967|584744342|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
161917068|NCT03034967|584744343|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
161917069|NCT03806296|584744344|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
161917070|NCT03806296|584744345|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
161917071|NCT03806296|584744346|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
161917072|NCT03806296|584744344|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
161917073|NCT03806296|584744345|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
161917074|NCT03806296|584744346|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
161917075|NCT03806296|584744344|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
161917076|NCT03806296|584744345|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
161917077|NCT03806296|584744346|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
161917078|NCT02763566|584744354|FG000|Overall Study|Lost to Follow-up|1|||
161917079|NCT02763566|584744355|FG001|Overall Study|Lost to Follow-up|4|||
161917080|NCT02763566|584744356|FG002|Overall Study|Lost to Follow-up|0|||
161917081|NCT02763566|584744357|FG003|Overall Study|Lost to Follow-up|1|||
161917082|NCT02763566|584744354|FG000|Overall Study|On study treatment at study conclusion|114|||
161917083|NCT02763566|584744355|FG001|Overall Study|On study treatment at study conclusion|34|||
161917084|NCT02763566|584744356|FG002|Overall Study|On study treatment at study conclusion|54|||
161917085|NCT02763566|584744357|FG003|Overall Study|On study treatment at study conclusion|13|||
161917086|NCT02763566|584744354|FG000|Overall Study|Withdrawal by Subject|3|||
161917087|NCT02763566|584744355|FG001|Overall Study|Withdrawal by Subject|1|||
161917088|NCT02763566|584744356|FG002|Overall Study|Withdrawal by Subject|0|||
161917089|NCT02763566|584744357|FG003|Overall Study|Withdrawal by Subject|0|||
161917090|NCT04896385|584744358|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
161917091|NCT04896385|584744359|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
161917092|NCT04896385|584744360|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
161917093|NCT04896385|584744361|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
161917094|NCT04896385|584744358|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
161917095|NCT04896385|584744359|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
161917096|NCT04896385|584744360|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
161917097|NCT04896385|584744361|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
161917098|NCT04896385|584744358|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
161917099|NCT04896385|584744359|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
161917100|NCT04896385|584744360|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
161917101|NCT04896385|584744361|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
161917102|NCT04896385|584744358|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
161917103|NCT04896385|584744359|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
161917104|NCT04896385|584744360|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
161917105|NCT04896385|584744361|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
161917106|NCT04896385|584744358|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
161917107|NCT04896385|584744359|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
161917108|NCT04896385|584744360|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
161917109|NCT04896385|584744361|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
161917110|NCT04896385|584744358|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
161917111|NCT04896385|584744359|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
161917112|NCT04896385|584744360|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
161917113|NCT04896385|584744361|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
161917114|NCT05291689|584744365|FG000|Overall Study|Adverse Event|3|||
161917115|NCT05291689|584744365|FG000|Overall Study|Lack of Efficacy|10|||
161917116|NCT05291689|584744365|FG000|Overall Study|Withdrawal by Subject|4|||
161917117|NCT01931098|584744366|FG000|Overall Study|Withdrawal by Subject|0|||
161917118|NCT01931098|584744367|FG001|Overall Study|Withdrawal by Subject|1|||
161917119|NCT01931098|584744366|FG000|Overall Study|Enrolled in different protocol|0|||
161917120|NCT01931098|584744367|FG001|Overall Study|Enrolled in different protocol|1|||
161917121|NCT01931098|584744366|FG000|Overall Study|Unable to begin trmt:active infection|0|||
161917122|NCT01931098|584744367|FG001|Overall Study|Unable to begin trmt:active infection|1|||
161917123|NCT01931098|584744366|FG000|Overall Study|Refused further treatment|0|||
161917124|NCT01931098|584744367|FG001|Overall Study|Refused further treatment|1|||
161917125|NCT02612155|584744368|FG000|Overall Study|Death|1|||
161917126|NCT02612155|584744369|FG001|Overall Study|Death|1|||
161917127|NCT02612155|584744368|FG000|Overall Study|Lost to Follow-up|2|||
161917128|NCT02612155|584744369|FG001|Overall Study|Lost to Follow-up|2|||
161917129|NCT04235374|584744370|FG000|Overall Study|Death|91|||
161917130|NCT04235374|584744371|FG001|Overall Study|Death|91|||
161917131|NCT04235374|584744370|FG000|Overall Study|Refused|2|||
161917132|NCT04235374|584744371|FG001|Overall Study|Refused|2|||
161917133|NCT04235374|584744370|FG000|Overall Study|Unavailable|12|||
161917134|NCT04235374|584744371|FG001|Overall Study|Unavailable|3|||
161917135|NCT04235374|584744370|FG000|Overall Study|Withdrawal by Subject|0|||
161917136|NCT04235374|584744371|FG001|Overall Study|Withdrawal by Subject|1|||
161917137|NCT04235374|584744370|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
161917138|NCT04235374|584744371|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
161917139|NCT01551173|584744372|FG000|Overall Study|Withdrawal by Subject|11|||
161917140|NCT01551173|584744373|FG001|Overall Study|Withdrawal by Subject|16|||
161917141|NCT01551173|584744372|FG000|Overall Study|Adverse Event|7|||
161917142|NCT01551173|584744373|FG001|Overall Study|Adverse Event|6|||
161917143|NCT01551173|584744372|FG000|Overall Study|Lost to Follow-up|5|||
161917144|NCT01551173|584744373|FG001|Overall Study|Lost to Follow-up|7|||
161917145|NCT01551173|584744372|FG000|Overall Study|Other|5|||
161917146|NCT01551173|584744373|FG001|Overall Study|Other|3|||
161917147|NCT01394276|584744374|FG000|Overall Study|Related Adverse event (AEs)|15|||
161917148|NCT01394276|584744374|FG000|Overall Study|Not related AEs|9|||
161917149|NCT01394276|584744374|FG000|Overall Study|Remission of disease|2|||
161917150|NCT01394276|584744374|FG000|Overall Study|Insufficient therapeutic effect|17|||
161917151|NCT01394276|584744374|FG000|Overall Study|Insufficient compliance|9|||
161917152|NCT01394276|584744374|FG000|Overall Study|Lost to Follow-up|5|||
161917153|NCT01394276|584744374|FG000|Overall Study|Participant moved to another site|1|||
161917154|NCT01394276|584744374|FG000|Overall Study|Pregnancy|1|||
161917155|NCT01394276|584744374|FG000|Overall Study|unavailability of drug at the Hospital|2|||
161917156|NCT01394276|584744374|FG000|Overall Study|Symptoms of concurrent diseases|1|||
161917157|NCT04530344|584744375|FG000|Overall Study|Lost to Follow-up|3|||
161917158|NCT04530344|584744376|FG001|Overall Study|Lost to Follow-up|3|||
161917159|NCT04530344|584744377|FG002|Overall Study|Lost to Follow-up|3|||
161917160|NCT04530344|584744378|FG003|Overall Study|Lost to Follow-up|10|||
161917161|NCT04530344|584744375|FG000|Overall Study|Withdrawal by Subject|14|||
161917162|NCT04530344|584744376|FG001|Overall Study|Withdrawal by Subject|5|||
161917163|NCT04530344|584744377|FG002|Overall Study|Withdrawal by Subject|18|||
161917164|NCT04530344|584744378|FG003|Overall Study|Withdrawal by Subject|33|||
161917165|NCT04530344|584744375|FG000|Overall Study|Adverse Event|0|||
161917166|NCT04530344|584744376|FG001|Overall Study|Adverse Event|0|||
161917167|NCT04530344|584744377|FG002|Overall Study|Adverse Event|0|||
161917168|NCT04530344|584744378|FG003|Overall Study|Adverse Event|1|||
161917169|NCT04530344|584744375|FG000|Overall Study|Lack of Efficacy|0|||
161917170|NCT04530344|584744376|FG001|Overall Study|Lack of Efficacy|0|||
161917171|NCT04530344|584744377|FG002|Overall Study|Lack of Efficacy|0|||
161917172|NCT04530344|584744378|FG003|Overall Study|Lack of Efficacy|1|||
161917173|NCT04530344|584744375|FG000|Overall Study|Physician Decision|0|||
161917174|NCT04530344|584744376|FG001|Overall Study|Physician Decision|0|||
161917175|NCT04530344|584744377|FG002|Overall Study|Physician Decision|1|||
161917176|NCT04530344|584744378|FG003|Overall Study|Physician Decision|1|||
161917177|NCT04530344|584744375|FG000|Overall Study|Pregnancy|0|||
161917178|NCT04530344|584744376|FG001|Overall Study|Pregnancy|0|||
161917179|NCT04530344|584744377|FG002|Overall Study|Pregnancy|2|||
161917180|NCT04530344|584744378|FG003|Overall Study|Pregnancy|1|||
161917181|NCT04530344|584744375|FG000|Overall Study|Protocol Violation|0|||
161917182|NCT04530344|584744376|FG001|Overall Study|Protocol Violation|0|||
161917183|NCT04530344|584744377|FG002|Overall Study|Protocol Violation|0|||
161917184|NCT04530344|584744378|FG003|Overall Study|Protocol Violation|1|||
161917185|NCT04530344|584744375|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
161917186|NCT04530344|584744376|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
161917187|NCT04530344|584744377|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
161917188|NCT04530344|584744378|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
161917189|NCT04530344|584744375|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
161917190|NCT04530344|584744376|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
161917191|NCT04530344|584744377|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
161917192|NCT04530344|584744378|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
162015033|NCT05375760|585108626|FG001|Overall Study|Withdrawal by Subject|19|||
161917193|NCT04530344|584744375|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
161917194|NCT04530344|584744376|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
161917195|NCT04530344|584744377|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
162015034|NCT05375760|585108625|FG000|Overall Study|Dosing halted by FDA|96|||
161917196|NCT04530344|584744378|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
161917197|NCT04530344|584744375|FG000|Overall Study|Personal Reasons|0|||
161917198|NCT04530344|584744376|FG001|Overall Study|Personal Reasons|0|||
161917199|NCT04530344|584744377|FG002|Overall Study|Personal Reasons|0|||
161917200|NCT04530344|584744378|FG003|Overall Study|Personal Reasons|1|||
161917201|NCT04530344|584744375|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
161917202|NCT04530344|584744376|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
161917203|NCT04530344|584744377|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
161917204|NCT04530344|584744378|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
162015035|NCT05375760|585108626|FG001|Overall Study|Dosing halted by FDA|100|||
161917205|NCT01402700|584744379|FG000|Overall Study|Death|3|||
161917206|NCT01402700|584744379|FG000|Overall Study|Withdrawal by Subject|3|||
161917207|NCT01402700|584744379|FG000|Overall Study|Missed Visit|1|||
161917208|NCT01933594|584744380|FG000|Overall Study|Lost to Follow-up|1|||
161917209|NCT01933594|584744381|FG001|Overall Study|Lost to Follow-up|0|||
161917210|NCT01933594|584744382|FG002|Overall Study|Lost to Follow-up|0|||
161917211|NCT01933594|584744383|FG003|Overall Study|Lost to Follow-up|0|||
161917212|NCT01933594|584744384|FG004|Overall Study|Lost to Follow-up|1|||
161917213|NCT01933594|584744385|FG005|Overall Study|Lost to Follow-up|0|||
161917214|NCT01933594|584744380|FG000|Overall Study|Ineligible for subsequent study step|0|||
161917215|NCT01933594|584744381|FG001|Overall Study|Ineligible for subsequent study step|0|||
161917216|NCT01933594|584744382|FG002|Overall Study|Ineligible for subsequent study step|0|||
161917217|NCT01933594|584744383|FG003|Overall Study|Ineligible for subsequent study step|0|||
161917218|NCT01933594|584744384|FG004|Overall Study|Ineligible for subsequent study step|1|||
161917219|NCT01933594|584744385|FG005|Overall Study|Ineligible for subsequent study step|0|||
161917220|NCT05352399|584744399|FG000|Overall Study|Discontinued intervention|6|||
161917221|NCT04478266|584744400|FG000|Overall Study|Adverse Event|20|||
161917222|NCT04478266|584744401|FG001|Overall Study|Adverse Event|21|||
161917223|NCT04478266|584744400|FG000|Overall Study|Progressive disease|146|||
161917224|NCT04478266|584744401|FG001|Overall Study|Progressive disease|168|||
161917225|NCT04478266|584744400|FG000|Overall Study|Poor compliance to protocol|1|||
161917226|NCT04478266|584744401|FG001|Overall Study|Poor compliance to protocol|0|||
161917227|NCT04478266|584744400|FG000|Overall Study|Withdrawal by Subject|19|||
161917228|NCT04478266|584744401|FG001|Overall Study|Withdrawal by Subject|16|||
161917229|NCT04478266|584744400|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
161917230|NCT04478266|584744401|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
161917231|NCT04478266|584744400|FG000|Overall Study|Study terminated by sponsor|33|||
161917232|NCT04478266|584744401|FG001|Overall Study|Study terminated by sponsor|35|||
161917233|NCT04478266|584744400|FG000|Overall Study|Other: unspecified|5|||
161917234|NCT04478266|584744401|FG001|Overall Study|Other: unspecified|7|||
161917235|NCT04478266|584744400|FG000|Overall Study|Randomized but not treated|1|||
161917236|NCT04478266|584744401|FG001|Overall Study|Randomized but not treated|1|||
161917237|NCT04058717|584744402|FG000|Randomization Period|Lost to Follow-up|2|||
161917238|NCT04058717|584744403|FG001|Randomization Period|Lost to Follow-up|3|||
162160773|NCT02728076|585638619|FG000|Overall Study|Physician Decision|4|||
162160774|NCT05054374|585638620|FG000|Overall Study|Withdrawal by Subject|1|||
162160775|NCT05054374|585638621|FG001|Overall Study|Withdrawal by Subject|0|||
162160776|NCT05054374|585638622|FG002|Overall Study|Withdrawal by Subject|0|||
162160777|NCT05054374|585638623|FG003|Overall Study|Withdrawal by Subject|0|||
162160778|NCT05054374|585638620|FG000|Overall Study|Progressive Disease|5|||
162160779|NCT05054374|585638621|FG001|Overall Study|Progressive Disease|0|||
161813541|NCT01686477|584359897|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
161813542|NCT01686477|584359895|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
161813543|NCT01686477|584359896|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
161813544|NCT01686477|584359897|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
161813545|NCT01686477|584359895|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
161813546|NCT01686477|584359896|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
161813547|NCT01686477|584359897|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
161813548|NCT01686477|584359895|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
161813549|NCT01686477|584359896|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
161813550|NCT01686477|584359897|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
161813551|NCT01686477|584359895|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
161813552|NCT01686477|584359896|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
161813553|NCT01686477|584359897|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
161813554|NCT01686477|584359895|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
161813555|NCT01686477|584359896|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
161813556|NCT01686477|584359897|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
161813557|NCT01686477|584359895|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
161813558|NCT01686477|584359896|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
161813559|NCT01686477|584359897|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
161813560|NCT06999265|584359899|FG000|Overall Study|Lost to Follow-up|1|||
161813561|NCT06999265|584359900|FG001|Overall Study|Lost to Follow-up|1|||
161813562|NCT02178787|584359901|FG000|Overall Study|Lost to Follow-up|1|||
161813563|NCT02178787|584359902|FG001|Overall Study|Lost to Follow-up|0|||
161813564|NCT02178787|584359901|FG000|Overall Study|Withdrawal by Subject|0|||
161813565|NCT02178787|584359902|FG001|Overall Study|Withdrawal by Subject|2|||
161813566|NCT02178787|584359901|FG000|Overall Study|No TCD window|3|||
161813567|NCT02178787|584359902|FG001|Overall Study|No TCD window|7|||
161917239|NCT04058717|584744404|FG002|Randomization Period|Lost to Follow-up|4|||
161917240|NCT04058717|584744405|FG003|Randomization Period|Lost to Follow-up|4|||
161917241|NCT04058717|584744402|FG000|Randomization Period|Withdrawal by Subject|1|||
162160780|NCT05054374|585638622|FG002|Overall Study|Progressive Disease|0|||
161917242|NCT04058717|584744403|FG001|Randomization Period|Withdrawal by Subject|3|||
161917243|NCT04058717|584744404|FG002|Randomization Period|Withdrawal by Subject|3|||
161917244|NCT04058717|584744405|FG003|Randomization Period|Withdrawal by Subject|3|||
161917245|NCT04058717|584744402|FG000|Randomization Period|PI decision|0|||
161917246|NCT04058717|584744403|FG001|Randomization Period|PI decision|1|||
161917247|NCT04058717|584744404|FG002|Randomization Period|PI decision|0|||
161917248|NCT04058717|584744405|FG003|Randomization Period|PI decision|0|||
161917249|NCT02799602|584744407|FG000|Overall Study|Protocol Violation|1|||
161917250|NCT02799602|584744408|FG001|Overall Study|Protocol Violation|0|||
162015036|NCT05375760|585108625|FG000|Overall Study|Not compliant with study visit|2|||
162015037|NCT05375760|585108626|FG001|Overall Study|Not compliant with study visit|0|||
161813568|NCT02178787|584359901|FG000|Overall Study|Physician Decision|1|||
161917251|NCT02799602|584744407|FG000|Overall Study|Physician Decision|5|||
161917252|NCT02799602|584744408|FG001|Overall Study|Physician Decision|6|||
161917253|NCT02799602|584744407|FG000|Overall Study|Lost to Follow-up|4|||
161917254|NCT02799602|584744408|FG001|Overall Study|Lost to Follow-up|2|||
161917255|NCT02799602|584744407|FG000|Overall Study|Additional primary malignancy|11|||
161917256|NCT02799602|584744408|FG001|Overall Study|Additional primary malignancy|6|||
161917257|NCT02799602|584744407|FG000|Overall Study|Non-compliance with study drug|14|||
161917258|NCT02799602|584744408|FG001|Overall Study|Non-compliance with study drug|12|||
161917259|NCT02799602|584744407|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
161917260|NCT02799602|584744408|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
161917261|NCT02799602|584744407|FG000|Overall Study|Withdrawal by Subject|26|||
161917262|NCT02799602|584744408|FG001|Overall Study|Withdrawal by Subject|40|||
161917263|NCT02799602|584744407|FG000|Overall Study|Progressive disease - clinical progression|131|||
161917264|NCT02799602|584744408|FG001|Overall Study|Progressive disease - clinical progression|276|||
161917265|NCT02799602|584744407|FG000|Overall Study|Progressive disease - radiological progression|90|||
161917266|NCT02799602|584744408|FG001|Overall Study|Progressive disease - radiological progression|133|||
161917267|NCT02799602|584744407|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
161917268|NCT02799602|584744408|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
161917269|NCT02799602|584744407|FG000|Overall Study|Death|9|||
161917270|NCT02799602|584744408|FG001|Overall Study|Death|5|||
161917271|NCT02799602|584744407|FG000|Overall Study|Other|287|||
161917272|NCT02799602|584744408|FG001|Overall Study|Other|118|||
161917273|NCT02799602|584744407|FG000|Overall Study|Study drug never administered|0|||
161917274|NCT02799602|584744408|FG001|Overall Study|Study drug never administered|3|||
162015038|NCT05375760|585108625|FG000|Overall Study|Physician Decision|1|||
162015039|NCT05375760|585108626|FG001|Overall Study|Physician Decision|0|||
162015040|NCT05375760|585108625|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
162015041|NCT05375760|585108626|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
162015042|NCT05375760|585108625|FG000|Overall Study|Participant moved|1|||
162015043|NCT05375760|585108626|FG001|Overall Study|Participant moved|0|||
162015044|NCT03853109|585108627|FG000|Overall Study|Withdrawal by Subject|0|||
162015045|NCT03853109|585108628|FG001|Overall Study|Withdrawal by Subject|0|||
162015046|NCT03853109|585108629|FG002|Overall Study|Withdrawal by Subject|1|||
162015047|NCT03853109|585108630|FG003|Overall Study|Withdrawal by Subject|2|||
162015048|NCT03853109|585108631|FG004|Overall Study|Withdrawal by Subject|1|||
162015049|NCT03853109|585108632|FG005|Overall Study|Withdrawal by Subject|4|||
162015050|NCT03853109|585108633|FG006|Overall Study|Withdrawal by Subject|5|||
161813569|NCT02178787|584359902|FG001|Overall Study|Physician Decision|0|||
161813570|NCT02430480|584359903|FG000|Overall Study|Death|1|||
161813571|NCT02430480|584359903|FG000|Overall Study|Anesthesia concerns|1|||
161813572|NCT02430480|584359903|FG000|Overall Study|Progressed on treatment|1|||
161813573|NCT01030133|584359904|FG000|Overall Study|failed to experience pain at level 7/10|2|||
161813574|NCT01030133|584359905|FG001|Overall Study|failed to experience pain at level 7/10|2|||
161813575|NCT01097577|584359913|FG000|Overall Study|Adverse Event|0|||
161813576|NCT01097577|584359914|FG001|Overall Study|Adverse Event|1|||
161813577|NCT04493684|584359915|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
161813578|NCT04493684|584359916|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813579|NCT04493684|584359917|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
161813580|NCT04493684|584359918|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813581|NCT04493684|584359919|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813582|NCT04493684|584359920|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
161813583|NCT04493684|584359921|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161917275|NCT01101178|584744413|FG000|Period 1|Withdrawal by Subject|1|||
161917276|NCT01101178|584744414|FG001|Period 1|Withdrawal by Subject|2|||
161917277|NCT01101178|584744413|FG000|Period 1|Positive drug screen|1|||
161917278|NCT01101178|584744414|FG001|Period 1|Positive drug screen|1|||
161917279|NCT01101178|584744413|FG000|Period 1|Adverse Event|2|||
161917280|NCT01101178|584744414|FG001|Period 1|Adverse Event|1|||
162015051|NCT03853109|585108634|FG007|Overall Study|Withdrawal by Subject|3|||
162015052|NCT03853109|585108627|FG000|Overall Study|Decision by Sponsor|0|||
162015053|NCT03853109|585108628|FG001|Overall Study|Decision by Sponsor|0|||
161917281|NCT01101178|584744413|FG000|Period 2|Withdrawal by Subject|0|||
161917282|NCT01101178|584744414|FG001|Period 2|Withdrawal by Subject|1|||
161917283|NCT01850641|584744415|FG000|Overall Study|Physician Decision|1|||
161917284|NCT01850641|584744415|FG000|Overall Study|Decrease in serum phosphorus|1|||
161917285|NCT01850641|584744415|FG000|Overall Study|Decrease in serum calcium|2|||
161917286|NCT01850641|584744415|FG000|Overall Study|Increase in serum ferritin|1|||
161917287|NCT00141817|584744416|FG000|Overall Study|Protocol Violation|0|||
161917288|NCT00141817|584744417|FG001|Overall Study|Protocol Violation|0|||
161917289|NCT00141817|584744418|FG002|Overall Study|Protocol Violation|1|||
161917290|NCT00141817|584744419|FG003|Overall Study|Protocol Violation|0|||
161917291|NCT00141817|584744416|FG000|Overall Study|Parent request|1|||
161917292|NCT00141817|584744417|FG001|Overall Study|Parent request|0|||
161917293|NCT00141817|584744418|FG002|Overall Study|Parent request|0|||
161917294|NCT00141817|584744419|FG003|Overall Study|Parent request|0|||
161917295|NCT00127803|584744420|FG000|Overall Study|Adverse Event|2|||
161917296|NCT00127803|584744421|FG001|Overall Study|Adverse Event|0|||
161917297|NCT00127803|584744422|FG002|Overall Study|Adverse Event|0|||
161917298|NCT00127803|584744423|FG003|Overall Study|Adverse Event|0|||
161917299|NCT00127803|584744420|FG000|Overall Study|Withdrawal by Subject|1|||
161917300|NCT00127803|584744421|FG001|Overall Study|Withdrawal by Subject|0|||
161917301|NCT00127803|584744422|FG002|Overall Study|Withdrawal by Subject|0|||
161917302|NCT00127803|584744423|FG003|Overall Study|Withdrawal by Subject|0|||
161917303|NCT00127803|584744420|FG000|Overall Study|Lost to Follow-up|0|||
161917304|NCT00127803|584744421|FG001|Overall Study|Lost to Follow-up|0|||
161917305|NCT00127803|584744422|FG002|Overall Study|Lost to Follow-up|0|||
161917306|NCT00127803|584744423|FG003|Overall Study|Lost to Follow-up|1|||
161917307|NCT04809974|584745966|FG000|Lead-in Phase|Withdrawal by Subject|3|||
161917308|NCT04809974|584745967|FG001|Lead-in Phase|Withdrawal by Subject|0|||
161917309|NCT04809974|584745968|FG002|Lead-in Phase|Withdrawal by Subject|0|||
161917310|NCT04809974|584745966|FG000|Lead-in Phase|No longer eligible|11|||
161917311|NCT04809974|584745967|FG001|Lead-in Phase|No longer eligible|0|||
161917312|NCT04809974|584745968|FG002|Lead-in Phase|No longer eligible|0|||
161917313|NCT04809974|584745966|FG000|Randomized Phase|Lost to Follow-up|0|||
161917314|NCT04809974|584745967|FG001|Randomized Phase|Lost to Follow-up|1|||
161917315|NCT04809974|584745968|FG002|Randomized Phase|Lost to Follow-up|5|||
161917316|NCT04809974|584745966|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
161917317|NCT04809974|584745967|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
161917318|NCT04809974|584745968|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
161917319|NCT04809974|584745966|FG000|Randomized Phase|Adverse Event|0|||
161917320|NCT04809974|584745967|FG001|Randomized Phase|Adverse Event|1|||
161917321|NCT04809974|584745968|FG002|Randomized Phase|Adverse Event|4|||
161917322|NCT04809974|584745966|FG000|Randomized Phase|Withdrawal by Subject|0|||
161917323|NCT04809974|584745967|FG001|Randomized Phase|Withdrawal by Subject|0|||
161917324|NCT04809974|584745968|FG002|Randomized Phase|Withdrawal by Subject|5|||
161917325|NCT04338581|584745969|FG000|Overall Study|Lack of Efficacy|1|||
161917326|NCT04338581|584745970|FG001|Overall Study|Lack of Efficacy|0|||
161917327|NCT04338581|584745969|FG000|Overall Study|Withdrawal by Subject|4|||
161917328|NCT04338581|584745970|FG001|Overall Study|Withdrawal by Subject|4|||
161917329|NCT04338581|584745969|FG000|Overall Study|Prohibited Medication|1|||
161917330|NCT04338581|584745970|FG001|Overall Study|Prohibited Medication|0|||
161917331|NCT00549055|584745971|FG000|Overall Study|Adverse Event|4|||
161917332|NCT00549055|584745971|FG000|Overall Study|Lack of Efficacy|18|||
161917333|NCT00549055|584745971|FG000|Overall Study|Stabilization|5|||
161917334|NCT00549055|584745971|FG000|Overall Study|Progression to fibrosis|2|||
161917335|NCT00549055|584745971|FG000|Overall Study|Decrease of size|1|||
161917336|NCT00549055|584745971|FG000|Overall Study|Active choroidal neovascula increased|1|||
161917337|NCT00549055|584745971|FG000|Overall Study|Vitreous hemorrhage|1|||
161917338|NCT00549055|584745971|FG000|Overall Study|Growth choroidal neovascularisation|1|||
161917339|NCT00549055|584745971|FG000|Overall Study|Choroidal neovascularization|1|||
161917340|NCT00549055|584745971|FG000|Overall Study|Very low visual acuity (VA)|1|||
161917341|NCT00770809|584745972|FG000|Overall Study|Adverse Event|9|||
161917342|NCT00770809|584745973|FG001|Overall Study|Adverse Event|1|||
161917343|NCT00770809|584745974|FG002|Overall Study|Adverse Event|12|||
161917344|NCT00770809|584745972|FG000|Overall Study|Death|1|||
161917345|NCT00770809|584745973|FG001|Overall Study|Death|0|||
161917346|NCT00770809|584745974|FG002|Overall Study|Death|0|||
161917347|NCT00770809|584745972|FG000|Overall Study|Withdrawal by Subject|3|||
161917348|NCT00770809|584745973|FG001|Overall Study|Withdrawal by Subject|3|||
161917349|NCT00770809|584745974|FG002|Overall Study|Withdrawal by Subject|7|||
161917350|NCT00770809|584745972|FG000|Overall Study|Progression|2|||
161917351|NCT00770809|584745973|FG001|Overall Study|Progression|2|||
161917352|NCT00770809|584745974|FG002|Overall Study|Progression|0|||
161917353|NCT00770809|584745972|FG000|Overall Study|Complicating illness|0|||
161917354|NCT00770809|584745973|FG001|Overall Study|Complicating illness|0|||
161917355|NCT00770809|584745974|FG002|Overall Study|Complicating illness|1|||
161917356|NCT00770809|584745972|FG000|Overall Study|Other Medical Reasons|2|||
161917357|NCT00770809|584745973|FG001|Overall Study|Other Medical Reasons|4|||
161917358|NCT00770809|584745974|FG002|Overall Study|Other Medical Reasons|3|||
161917359|NCT00764517|584745979|FG000|Overall Study|Adverse Event|9|||
161917360|NCT00764517|584745980|FG001|Overall Study|Adverse Event|3|||
161917361|NCT00764517|584745979|FG000|Overall Study|Death|3|||
161917362|NCT00764517|584745980|FG001|Overall Study|Death|11|||
161917363|NCT00764517|584745979|FG000|Overall Study|Physician Decision|3|||
161917364|NCT00764517|584745980|FG001|Overall Study|Physician Decision|0|||
161917365|NCT00770367|584745981|FG000|First Intervention|Withdrawal by Subject|0|||
161917366|NCT00770367|584745982|FG001|First Intervention|Withdrawal by Subject|2|||
161917367|NCT00770367|584745981|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
161917368|NCT00770367|584745982|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
161917369|NCT00770367|584745981|FG000|Second Intervention|Lost to Follow-up|2|||
161917370|NCT00770367|584745982|FG001|Second Intervention|Lost to Follow-up|0|||
161917371|NCT00435942|584745983|FG000|Overall Study|Death|17|||
161917372|NCT00435942|584745984|FG001|Overall Study|Death|10|||
161917373|NCT00435942|584745983|FG000|Overall Study|Withdrawal by Subject|2|||
161917374|NCT00435942|584745984|FG001|Overall Study|Withdrawal by Subject|0|||
161917375|NCT00435942|584745983|FG000|Overall Study|Lost to Follow-up|0|||
161917376|NCT00435942|584745984|FG001|Overall Study|Lost to Follow-up|16|||
161917377|NCT00435942|584745983|FG000|Overall Study|Conversion to Open Repair|1|||
161917378|NCT00435942|584745984|FG001|Overall Study|Conversion to Open Repair|0|||
161917379|NCT00435942|584745983|FG000|Overall Study|Technical Failure|3|||
161917380|NCT00435942|584745984|FG001|Overall Study|Technical Failure|0|||
161917381|NCT00435942|584745983|FG000|Overall Study|Other|0|||
161917382|NCT00435942|584745984|FG001|Overall Study|Other|1|||
161917383|NCT00460798|584745985|FG000|Overall Study|Death|59|||
161917384|NCT00460798|584745985|FG000|Overall Study|Adverse Event|27|||
161917385|NCT00460798|584745985|FG000|Overall Study|Lost to Follow-up|19|||
161917386|NCT00460798|584745985|FG000|Overall Study|Progressive Disease|99|||
161917387|NCT00460798|584745985|FG000|Overall Study|Other|27|||
161917388|NCT00460798|584745985|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
161917389|NCT00460798|584745985|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
161917390|NCT01898130|584745986|FG000|Treatment|Withdrawal by Subject|2|||
161917391|NCT01898130|584745986|FG000|Treatment|Progressive Disease|4|||
161917392|NCT01898130|584745986|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
161917393|NCT04491994|584745990|FG000|Overall Study|Withdrawal by Subject|10|||
161917394|NCT04491994|584745991|FG001|Overall Study|Withdrawal by Subject|5|||
161917395|NCT04491994|584745990|FG000|Overall Study|developed fever > 3 days|4|||
162160781|NCT05054374|585638623|FG003|Overall Study|Progressive Disease|0|||
161917396|NCT04491994|584745991|FG001|Overall Study|developed fever > 3 days|1|||
161917397|NCT04491994|584745990|FG000|Overall Study|Protocol Violation|11|||
161917398|NCT04491994|584745991|FG001|Overall Study|Protocol Violation|2|||
161917399|NCT04491994|584745990|FG000|Overall Study|Lost to Follow-up|4|||
161917400|NCT04491994|584745991|FG001|Overall Study|Lost to Follow-up|3|||
161917401|NCT03517137|584745999|FG000|Overall Study|Lack of Efficacy|1|||
161917402|NCT03517137|584745999|FG000|Overall Study|Adverse Event|2|||
161917403|NCT03517137|584745999|FG000|Overall Study|Withdrawal by Subject|2|||
161917404|NCT03517137|584745999|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
161917405|NCT03575364|584746000|FG000|Overall Study|Death|45|||
161917406|NCT03575364|584746000|FG000|Overall Study|Lost to Follow-up|114|||
161917407|NCT03575364|584746000|FG000|Overall Study|Withdrawal by Subject|21|||
161917408|NCT03575364|584746000|FG000|Overall Study|Physician Decision|11|||
162160782|NCT05691309|585638624|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
162160783|NCT05691309|585638624|FG000|Overall Study|vancomycin levels not evaluable|2|||
162160784|NCT01532388|585638627|FG000|3-month Follow-up|Lost to Follow-up|68|||
162160785|NCT01532388|585638628|FG001|3-month Follow-up|Lost to Follow-up|68|||
162160786|NCT01532388|585638627|FG000|6-month Follow-up|Lost to Follow-up|74|||
161917409|NCT03575364|584746000|FG000|Overall Study|Subject Refused Follow-up|13|||
161917410|NCT03575364|584746000|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
162160787|NCT01532388|585638628|FG001|6-month Follow-up|Lost to Follow-up|66|||
162160788|NCT01532388|585638627|FG000|12-month Follow-up|Lost to Follow-up|69|||
162160789|NCT01532388|585638628|FG001|12-month Follow-up|Lost to Follow-up|67|||
161917411|NCT03575364|584746000|FG000|Overall Study|Patient moved out of the state|1|||
161917412|NCT03575364|584746000|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
161917413|NCT03575364|584746000|FG000|Overall Study|Patient is lost to follow up|1|||
161917414|NCT03575364|584746000|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
161917415|NCT01186770|584746001|FG000|Overall Study|Ineligibility|0|||
161917416|NCT01186770|584746002|FG001|Overall Study|Ineligibility|0|||
161917417|NCT01186770|584746003|FG002|Overall Study|Ineligibility|2|||
161917418|NCT01186770|584746004|FG003|Overall Study|Ineligibility|0|||
161917419|NCT01186770|584746001|FG000|Overall Study|Protocol Violation|7|||
161917420|NCT01186770|584746002|FG001|Overall Study|Protocol Violation|9|||
161917421|NCT01186770|584746003|FG002|Overall Study|Protocol Violation|12|||
162160790|NCT00792636|585638629|FG000|Overall Study|Protocol Violation|17|||
162160791|NCT00792636|585638630|FG001|Overall Study|Protocol Violation|23|||
161917422|NCT01186770|584746004|FG003|Overall Study|Protocol Violation|14|||
161917423|NCT01186770|584746001|FG000|Overall Study|Adverse Event|2|||
161917424|NCT01186770|584746002|FG001|Overall Study|Adverse Event|9|||
161917425|NCT01186770|584746003|FG002|Overall Study|Adverse Event|7|||
161917426|NCT01186770|584746004|FG003|Overall Study|Adverse Event|9|||
161917427|NCT01186770|584746001|FG000|Overall Study|Withdrawal by Subject|15|||
161917428|NCT01186770|584746002|FG001|Overall Study|Withdrawal by Subject|13|||
161917429|NCT01186770|584746003|FG002|Overall Study|Withdrawal by Subject|11|||
161917430|NCT01186770|584746004|FG003|Overall Study|Withdrawal by Subject|17|||
161917431|NCT01186770|584746001|FG000|Overall Study|Lost to Follow-up|10|||
161917432|NCT01186770|584746002|FG001|Overall Study|Lost to Follow-up|6|||
161917433|NCT01186770|584746003|FG002|Overall Study|Lost to Follow-up|14|||
161917434|NCT01186770|584746004|FG003|Overall Study|Lost to Follow-up|9|||
161917435|NCT01186770|584746001|FG000|Overall Study|Insufficient response to treatment|7|||
161917436|NCT01186770|584746002|FG001|Overall Study|Insufficient response to treatment|8|||
161917437|NCT01186770|584746003|FG002|Overall Study|Insufficient response to treatment|5|||
161917438|NCT01186770|584746004|FG003|Overall Study|Insufficient response to treatment|7|||
161917439|NCT01186770|584746001|FG000|Overall Study|Other than specified|0|||
161917440|NCT01186770|584746002|FG001|Overall Study|Other than specified|1|||
161917441|NCT01186770|584746003|FG002|Overall Study|Other than specified|1|||
161917442|NCT01186770|584746004|FG003|Overall Study|Other than specified|2|||
161917443|NCT02567188|584746005|FG000|Overall Study|Death|10|||
161917444|NCT02567188|584746005|FG000|Overall Study|Terminated Mircera Treatment|9|||
161917445|NCT02567188|584746005|FG000|Overall Study|Lost to Follow-up|5|||
161917446|NCT02567188|584746005|FG000|Overall Study|Adverse Event|1|||
161917447|NCT02567188|584746005|FG000|Overall Study|Withdrawal by Subject|1|||
161917448|NCT02567188|584746005|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
161917449|NCT02567188|584746005|FG000|Overall Study|Moved and Changed Clinic|1|||
161917450|NCT02567188|584746005|FG000|Overall Study|Started Hemodialysis|2|||
161917451|NCT02567188|584746005|FG000|Overall Study|Protocol Violation|5|||
161917452|NCT02441283|584746006|FG000|Overall Study|Withdrew consent|15|||
161917453|NCT02441283|584746006|FG000|Overall Study|Lost to Follow-up|42|||
161917454|NCT02441283|584746006|FG000|Overall Study|Death|1|||
161917455|NCT02441283|584746006|FG000|Overall Study|Other, not specified|32|||
161917456|NCT01033136|584746007|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
161917457|NCT01033136|584746008|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
161917458|NCT05383209|584746009|FG000|Overall Study|Adverse Event: Non-ocular|0|||
161917459|NCT05383209|584746010|FG001|Overall Study|Adverse Event: Non-ocular|1|||
161917460|NCT05383209|584746011|FG002|Overall Study|Adverse Event: Non-ocular|0|||
161917461|NCT05383209|584746009|FG000|Overall Study|Lost to Follow-up|2|||
161917462|NCT05383209|584746010|FG001|Overall Study|Lost to Follow-up|1|||
161917463|NCT05383209|584746011|FG002|Overall Study|Lost to Follow-up|4|||
161917464|NCT05383209|584746009|FG000|Overall Study|Withdrawal by Subject|2|||
161917465|NCT05383209|584746010|FG001|Overall Study|Withdrawal by Subject|0|||
161917466|NCT05383209|584746011|FG002|Overall Study|Withdrawal by Subject|1|||
161917467|NCT05383209|584746009|FG000|Overall Study|Death|1|||
161917468|NCT05383209|584746010|FG001|Overall Study|Death|0|||
161917469|NCT05383209|584746011|FG002|Overall Study|Death|0|||
161917470|NCT05383209|584746009|FG000|Overall Study|Other|0|||
161917471|NCT05383209|584746010|FG001|Overall Study|Other|1|||
161917472|NCT05383209|584746011|FG002|Overall Study|Other|0|||
161917473|NCT01369433|584746012|FG000|Overall Study|Adverse Event|31|||
161917474|NCT01369433|584746013|FG001|Overall Study|Adverse Event|1|||
161917475|NCT01369433|584746012|FG000|Overall Study|Required significant surgical procedure|1|||
161917476|NCT01369433|584746013|FG001|Overall Study|Required significant surgical procedure|0|||
161917477|NCT01369433|584746012|FG000|Overall Study|Non-compliance|1|||
161917478|NCT01369433|584746013|FG001|Overall Study|Non-compliance|0|||
161917479|NCT01369433|584746012|FG000|Overall Study|Withdrawal by Subject|5|||
161917480|NCT01369433|584746013|FG001|Overall Study|Withdrawal by Subject|2|||
161917481|NCT01369433|584746012|FG000|Overall Study|Study terminated by Sponsor|67|||
161917482|NCT01369433|584746013|FG001|Overall Study|Study terminated by Sponsor|0|||
161917483|NCT01369433|584746012|FG000|Overall Study|Lost to Follow-up|1|||
161917484|NCT01369433|584746013|FG001|Overall Study|Lost to Follow-up|0|||
161917485|NCT01369433|584746012|FG000|Overall Study|Death|5|||
161917486|NCT01369433|584746013|FG001|Overall Study|Death|0|||
161917487|NCT01369433|584746012|FG000|Overall Study|Investigator discretion|6|||
161917488|NCT01369433|584746013|FG001|Overall Study|Investigator discretion|1|||
161917489|NCT01369433|584746012|FG000|Overall Study|Progressive Disease|92|||
161917490|NCT01369433|584746013|FG001|Overall Study|Progressive Disease|12|||
161917491|NCT02472353|584746016|FG000|Overall Study|Lost to Follow-up|1|||
161917492|NCT02472353|584746017|FG001|Overall Study|Lost to Follow-up|1|||
161917493|NCT02472353|584746016|FG000|Overall Study|Withdrawal by Subject|2|||
161917494|NCT02472353|584746017|FG001|Overall Study|Withdrawal by Subject|1|||
161917495|NCT02472353|584746016|FG000|Overall Study|Study Termination|1|||
161917496|NCT02472353|584746017|FG001|Overall Study|Study Termination|4|||
161917497|NCT02101294|584746018|FG000|Overall Study|Withdrawal by Subject|5|||
161917498|NCT02101294|584746018|FG000|Overall Study|Lost to Follow-up|6|||
161917499|NCT00688597|584746021|FG000|Overall Study|Adverse Event|2|||
161917500|NCT00688597|584746022|FG001|Overall Study|Adverse Event|0|||
161917501|NCT00688597|584746023|FG002|Overall Study|Adverse Event|0|||
161917502|NCT00688597|584746021|FG000|Overall Study|Physician Decision|1|||
161917503|NCT00688597|584746022|FG001|Overall Study|Physician Decision|0|||
161917504|NCT00688597|584746023|FG002|Overall Study|Physician Decision|0|||
161917505|NCT00933933|584746027|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
161917506|NCT00933933|584746028|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
161917507|NCT00933933|584746029|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
161917508|NCT00933933|584746027|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
161917509|NCT00933933|584746028|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
161917510|NCT00933933|584746029|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
162160792|NCT00792636|585638631|FG002|Overall Study|Protocol Violation|20|||
162160793|NCT00792636|585638629|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
162160794|NCT00792636|585638630|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
162160795|NCT00792636|585638631|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
162160796|NCT00792636|585638629|FG000|Overall Study|Lost to Follow-up|13|||
162160797|NCT00792636|585638630|FG001|Overall Study|Lost to Follow-up|19|||
162160798|NCT00792636|585638631|FG002|Overall Study|Lost to Follow-up|14|||
162160799|NCT00792636|585638629|FG000|Overall Study|Withdrew Consent|10|||
162160800|NCT00792636|585638630|FG001|Overall Study|Withdrew Consent|13|||
162160801|NCT00792636|585638631|FG002|Overall Study|Withdrew Consent|9|||
162160802|NCT00792636|585638629|FG000|Overall Study|Lack of Efficacy|3|||
162160803|NCT00792636|585638630|FG001|Overall Study|Lack of Efficacy|4|||
162160804|NCT00792636|585638631|FG002|Overall Study|Lack of Efficacy|13|||
162160805|NCT00792636|585638629|FG000|Overall Study|Adverse Event|4|||
162160806|NCT00792636|585638630|FG001|Overall Study|Adverse Event|2|||
162160807|NCT00792636|585638631|FG002|Overall Study|Adverse Event|3|||
162160808|NCT00792636|585638629|FG000|Overall Study|Investigator Discretion|2|||
162160809|NCT00792636|585638630|FG001|Overall Study|Investigator Discretion|0|||
162160810|NCT00792636|585638631|FG002|Overall Study|Investigator Discretion|2|||
162160811|NCT03069313|585638632|FG000|Overall Study|Adverse Event|5|||
162160812|NCT03580369|585638634|FG000|Overall Study|No treatment due to mis-randomization|1|||
162160813|NCT03580369|585638635|FG001|Overall Study|No treatment due to mis-randomization|0|||
162160814|NCT03580369|585638636|FG002|Overall Study|No treatment due to mis-randomization|0|||
162160815|NCT03580369|585638637|FG003|Overall Study|No treatment due to mis-randomization|0|||
161917511|NCT01995201|584746030|FG000|From Baseline Until Week 24|Adverse Event|4|||
161917512|NCT01995201|584746031|FG001|From Baseline Until Week 24|Adverse Event|15|||
161917513|NCT01995201|584746032|FG002|From Baseline Until Week 24|Adverse Event|0|||
161917514|NCT01995201|584746033|FG003|From Baseline Until Week 24|Adverse Event|0|||
161917515|NCT01995201|584746034|FG004|From Baseline Until Week 24|Adverse Event|0|||
161917516|NCT01995201|584746035|FG005|From Baseline Until Week 24|Adverse Event|0|||
161917517|NCT01995201|584746036|FG006|From Baseline Until Week 24|Adverse Event|0|||
161917518|NCT01995201|584746030|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161917519|NCT01995201|584746031|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
161917520|NCT01995201|584746032|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161917521|NCT01995201|584746033|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161917522|NCT01995201|584746034|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161917523|NCT01995201|584746035|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161917524|NCT01995201|584746036|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161917525|NCT01995201|584746030|FG000|From Baseline Until Week 24|Death|0|||
161917526|NCT01995201|584746031|FG001|From Baseline Until Week 24|Death|1|||
161917527|NCT01995201|584746032|FG002|From Baseline Until Week 24|Death|0|||
161917528|NCT01995201|584746033|FG003|From Baseline Until Week 24|Death|0|||
161917529|NCT01995201|584746034|FG004|From Baseline Until Week 24|Death|0|||
161917530|NCT01995201|584746035|FG005|From Baseline Until Week 24|Death|0|||
161917531|NCT01995201|584746036|FG006|From Baseline Until Week 24|Death|0|||
161917532|NCT01995201|584746030|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
161917533|NCT01995201|584746031|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
162160816|NCT03580369|585638638|FG004|Overall Study|No treatment due to mis-randomization|3|||
162160817|NCT03580369|585638639|FG005|Overall Study|No treatment due to mis-randomization|0|||
162160818|NCT03580369|585638640|FG006|Overall Study|No treatment due to mis-randomization|0|||
161917534|NCT01995201|584746032|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
162160819|NCT03580369|585638641|FG007|Overall Study|No treatment due to mis-randomization|0|||
162160820|NCT03580369|585638634|FG000|Overall Study|Reason unknown|0|||
161917535|NCT01995201|584746033|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
161917536|NCT01995201|584746034|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
161917537|NCT01995201|584746035|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
162015054|NCT03853109|585108629|FG002|Overall Study|Decision by Sponsor|1|||
162160821|NCT03580369|585638635|FG001|Overall Study|Reason unknown|0|||
162160822|NCT03580369|585638636|FG002|Overall Study|Reason unknown|1|||
162160823|NCT03580369|585638637|FG003|Overall Study|Reason unknown|0|||
162160824|NCT03580369|585638638|FG004|Overall Study|Reason unknown|0|||
162160825|NCT03580369|585638639|FG005|Overall Study|Reason unknown|0|||
162160826|NCT03580369|585638640|FG006|Overall Study|Reason unknown|0|||
162160827|NCT03580369|585638641|FG007|Overall Study|Reason unknown|0|||
162160828|NCT03580369|585638634|FG000|Overall Study|Technical problems|0|||
162160829|NCT03580369|585638635|FG001|Overall Study|Technical problems|0|||
162160830|NCT03580369|585638636|FG002|Overall Study|Technical problems|0|||
162160831|NCT03580369|585638637|FG003|Overall Study|Technical problems|0|||
162160832|NCT03580369|585638638|FG004|Overall Study|Technical problems|1|||
162160833|NCT03580369|585638639|FG005|Overall Study|Technical problems|0|||
162160834|NCT03580369|585638640|FG006|Overall Study|Technical problems|2|||
162160835|NCT03580369|585638641|FG007|Overall Study|Technical problems|0|||
162160836|NCT03580369|585638634|FG000|Overall Study|Pregnancy|2|||
162160837|NCT03580369|585638635|FG001|Overall Study|Pregnancy|0|||
162160838|NCT03580369|585638636|FG002|Overall Study|Pregnancy|3|||
162160839|NCT03580369|585638637|FG003|Overall Study|Pregnancy|0|||
162160840|NCT03580369|585638638|FG004|Overall Study|Pregnancy|2|||
162160841|NCT03580369|585638639|FG005|Overall Study|Pregnancy|0|||
162160842|NCT03580369|585638640|FG006|Overall Study|Pregnancy|0|||
162160843|NCT03580369|585638641|FG007|Overall Study|Pregnancy|0|||
162160844|NCT03580369|585638634|FG000|Overall Study|Lost to Follow-up|2|||
162160845|NCT03580369|585638635|FG001|Overall Study|Lost to Follow-up|0|||
162160846|NCT03580369|585638636|FG002|Overall Study|Lost to Follow-up|2|||
162160847|NCT03580369|585638637|FG003|Overall Study|Lost to Follow-up|0|||
162160848|NCT03580369|585638638|FG004|Overall Study|Lost to Follow-up|3|||
162160849|NCT03580369|585638639|FG005|Overall Study|Lost to Follow-up|0|||
162160850|NCT03580369|585638640|FG006|Overall Study|Lost to Follow-up|1|||
162160851|NCT03580369|585638641|FG007|Overall Study|Lost to Follow-up|0|||
162160852|NCT03580369|585638634|FG000|Overall Study|Physician Decision|4|||
162160853|NCT03580369|585638635|FG001|Overall Study|Physician Decision|0|||
162160854|NCT03580369|585638636|FG002|Overall Study|Physician Decision|4|||
162160855|NCT03580369|585638637|FG003|Overall Study|Physician Decision|1|||
162160856|NCT03580369|585638638|FG004|Overall Study|Physician Decision|1|||
162160857|NCT03580369|585638639|FG005|Overall Study|Physician Decision|0|||
162160858|NCT03580369|585638640|FG006|Overall Study|Physician Decision|0|||
162160859|NCT03580369|585638641|FG007|Overall Study|Physician Decision|0|||
162160860|NCT03580369|585638634|FG000|Overall Study|Lack of Efficacy|3|||
162160861|NCT03580369|585638635|FG001|Overall Study|Lack of Efficacy|0|||
162160862|NCT03580369|585638636|FG002|Overall Study|Lack of Efficacy|7|||
162160863|NCT03580369|585638637|FG003|Overall Study|Lack of Efficacy|0|||
162160864|NCT03580369|585638638|FG004|Overall Study|Lack of Efficacy|2|||
162160865|NCT03580369|585638639|FG005|Overall Study|Lack of Efficacy|0|||
161917538|NCT01995201|584746036|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
161917539|NCT01995201|584746030|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
161917540|NCT01995201|584746031|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
161917541|NCT01995201|584746032|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
162015055|NCT03853109|585108630|FG003|Overall Study|Decision by Sponsor|0|||
162015056|NCT03853109|585108631|FG004|Overall Study|Decision by Sponsor|1|||
162015057|NCT03853109|585108632|FG005|Overall Study|Decision by Sponsor|1|||
162015058|NCT03853109|585108633|FG006|Overall Study|Decision by Sponsor|10|||
162015059|NCT03853109|585108634|FG007|Overall Study|Decision by Sponsor|2|||
162015060|NCT03853109|585108627|FG000|Overall Study|Lost to Follow-up|0|||
162015061|NCT03853109|585108628|FG001|Overall Study|Lost to Follow-up|0|||
161917542|NCT01995201|584746033|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
161917543|NCT01995201|584746034|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
161917544|NCT01995201|584746035|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
161917545|NCT01995201|584746036|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
161917546|NCT01995201|584746030|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
161917547|NCT01995201|584746031|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
161917548|NCT01995201|584746032|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
161917549|NCT01995201|584746033|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
161917550|NCT01995201|584746034|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
161917551|NCT01995201|584746035|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
161917552|NCT01995201|584746036|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
162015062|NCT03853109|585108629|FG002|Overall Study|Lost to Follow-up|0|||
162015063|NCT03853109|585108630|FG003|Overall Study|Lost to Follow-up|0|||
162160866|NCT03580369|585638640|FG006|Overall Study|Lack of Efficacy|3|||
162160867|NCT03580369|585638641|FG007|Overall Study|Lack of Efficacy|0|||
162160868|NCT03580369|585638634|FG000|Overall Study|Protocol Violation|6|||
162160869|NCT03580369|585638635|FG001|Overall Study|Protocol Violation|0|||
162160870|NCT03580369|585638636|FG002|Overall Study|Protocol Violation|6|||
162160871|NCT03580369|585638637|FG003|Overall Study|Protocol Violation|1|||
162160872|NCT03580369|585638638|FG004|Overall Study|Protocol Violation|8|||
162160873|NCT03580369|585638639|FG005|Overall Study|Protocol Violation|2|||
162160874|NCT03580369|585638640|FG006|Overall Study|Protocol Violation|1|||
162160875|NCT03580369|585638641|FG007|Overall Study|Protocol Violation|0|||
162160876|NCT03580369|585638634|FG000|Overall Study|Adverse Event|7|||
162160877|NCT03580369|585638635|FG001|Overall Study|Adverse Event|0|||
162160878|NCT03580369|585638636|FG002|Overall Study|Adverse Event|14|||
162160879|NCT03580369|585638637|FG003|Overall Study|Adverse Event|1|||
162160880|NCT03580369|585638638|FG004|Overall Study|Adverse Event|6|||
162160881|NCT03580369|585638639|FG005|Overall Study|Adverse Event|0|||
162160882|NCT03580369|585638640|FG006|Overall Study|Adverse Event|1|||
162160883|NCT03580369|585638641|FG007|Overall Study|Adverse Event|0|||
162160884|NCT03580369|585638634|FG000|Overall Study|Withdrawal by Subject|19|||
162160885|NCT03580369|585638635|FG001|Overall Study|Withdrawal by Subject|0|||
162160886|NCT03580369|585638636|FG002|Overall Study|Withdrawal by Subject|17|||
162160887|NCT03580369|585638637|FG003|Overall Study|Withdrawal by Subject|0|||
162160888|NCT03580369|585638638|FG004|Overall Study|Withdrawal by Subject|16|||
162160889|NCT03580369|585638639|FG005|Overall Study|Withdrawal by Subject|1|||
162160890|NCT03580369|585638640|FG006|Overall Study|Withdrawal by Subject|7|||
162160891|NCT03580369|585638641|FG007|Overall Study|Withdrawal by Subject|0|||
162160892|NCT03912831|585638642|FG000|Overall Study|Death|1|||
162160893|NCT03912831|585638643|FG001|Overall Study|Death|1|||
162160894|NCT03912831|585638644|FG002|Overall Study|Death|1|||
162160895|NCT03912831|585638645|FG003|Overall Study|Death|1|||
162160896|NCT03912831|585638646|FG004|Overall Study|Death|1|||
162160897|NCT03912831|585638647|FG005|Overall Study|Death|1|||
162160898|NCT03912831|585638642|FG000|Overall Study|Reason not Specified|0|||
162160899|NCT03912831|585638643|FG001|Overall Study|Reason not Specified|0|||
162160900|NCT03912831|585638644|FG002|Overall Study|Reason not Specified|0|||
162160901|NCT03912831|585638645|FG003|Overall Study|Reason not Specified|0|||
162160902|NCT03912831|585638646|FG004|Overall Study|Reason not Specified|1|||
162160903|NCT03912831|585638647|FG005|Overall Study|Reason not Specified|0|||
162160904|NCT03912831|585638642|FG000|Overall Study|Withdrawal by Participant|0|||
162160905|NCT03912831|585638643|FG001|Overall Study|Withdrawal by Participant|0|||
161813584|NCT04493684|584359922|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
162015064|NCT03853109|585108631|FG004|Overall Study|Lost to Follow-up|1|||
162015065|NCT03853109|585108632|FG005|Overall Study|Lost to Follow-up|3|||
162015066|NCT03853109|585108633|FG006|Overall Study|Lost to Follow-up|0|||
162015067|NCT03853109|585108634|FG007|Overall Study|Lost to Follow-up|0|||
162015068|NCT03853109|585108627|FG000|Overall Study|Death|2|||
162015069|NCT03853109|585108628|FG001|Overall Study|Death|5|||
162015070|NCT03853109|585108629|FG002|Overall Study|Death|8|||
162015071|NCT03853109|585108630|FG003|Overall Study|Death|10|||
162015072|NCT03853109|585108631|FG004|Overall Study|Death|3|||
162015073|NCT03853109|585108632|FG005|Overall Study|Death|20|||
162015074|NCT03853109|585108633|FG006|Overall Study|Death|10|||
162015075|NCT03853109|585108634|FG007|Overall Study|Death|5|||
162015076|NCT04032093|585108637|FG000|Overall Study|Lost to Follow-up|7|||
162015077|NCT04032093|585108638|FG001|Overall Study|Lost to Follow-up|7|||
162015078|NCT04032093|585108639|FG002|Overall Study|Lost to Follow-up|6|||
162015079|NCT04032093|585108640|FG003|Overall Study|Lost to Follow-up|10|||
162015080|NCT04032093|585108641|FG004|Overall Study|Lost to Follow-up|13|||
162160906|NCT03912831|585638644|FG002|Overall Study|Withdrawal by Participant|0|||
161813585|NCT04493684|584359923|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813586|NCT04493684|584359924|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813587|NCT04493684|584359925|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813588|NCT04493684|584359926|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813589|NCT04493684|584359927|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813590|NCT04493684|584359928|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813591|NCT04493684|584359929|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813592|NCT04493684|584359930|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813593|NCT04493684|584359931|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161813594|NCT04493684|584359915|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
161813595|NCT04493684|584359916|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813596|NCT04493684|584359917|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813597|NCT04493684|584359918|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813598|NCT04493684|584359919|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813599|NCT04493684|584359920|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813600|NCT04493684|584359921|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813601|NCT04493684|584359922|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813602|NCT04493684|584359923|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813603|NCT04493684|584359924|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813604|NCT04493684|584359925|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813605|NCT04493684|584359926|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813606|NCT04493684|584359927|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813607|NCT04493684|584359928|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162015081|NCT04032093|585108642|FG005|Overall Study|Lost to Follow-up|7|||
162015082|NCT04032093|585108643|FG006|Overall Study|Lost to Follow-up|7|||
162015083|NCT04032093|585108644|FG007|Overall Study|Lost to Follow-up|5|||
162160907|NCT03912831|585638645|FG003|Overall Study|Withdrawal by Participant|0|||
162160908|NCT03912831|585638646|FG004|Overall Study|Withdrawal by Participant|1|||
162160909|NCT03912831|585638647|FG005|Overall Study|Withdrawal by Participant|0|||
162160910|NCT01721291|585638649|FG000|Overall Study|Withdrawal by Subject|1|||
162160911|NCT01721291|585638650|FG001|Overall Study|Withdrawal by Subject|0|||
162160912|NCT01721291|585638649|FG000|Overall Study|did not like the treatment|1|||
162160913|NCT01721291|585638650|FG001|Overall Study|did not like the treatment|0|||
162160914|NCT05239039|585638653|FG000|Overall Study|Withdrawal by Subject|0|||
162160915|NCT05239039|585638654|FG001|Overall Study|Withdrawal by Subject|1|||
162160916|NCT03484702|585640106|FG000|Treatment Period|Death|3|||
162160917|NCT03484702|585640107|FG001|Treatment Period|Death|1|||
162160918|NCT03484702|585640108|FG002|Treatment Period|Death|0|||
162160919|NCT03484702|585640109|FG003|Treatment Period|Death|0|||
162160920|NCT03484702|585640110|FG004|Treatment Period|Death|0|||
162160921|NCT03484702|585640111|FG005|Treatment Period|Death|0|||
162160922|NCT03484702|585640106|FG000|Treatment Period|Adverse Event|1|||
162160923|NCT03484702|585640107|FG001|Treatment Period|Adverse Event|0|||
162160924|NCT03484702|585640108|FG002|Treatment Period|Adverse Event|0|||
162160925|NCT03484702|585640109|FG003|Treatment Period|Adverse Event|0|||
162160926|NCT03484702|585640110|FG004|Treatment Period|Adverse Event|0|||
162160927|NCT03484702|585640111|FG005|Treatment Period|Adverse Event|0|||
162160928|NCT03484702|585640106|FG000|Treatment Period|Participant Withdrew from Study|0|||
162160929|NCT03484702|585640107|FG001|Treatment Period|Participant Withdrew from Study|1|||
162160930|NCT03484702|585640108|FG002|Treatment Period|Participant Withdrew from Study|0|||
162160931|NCT03484702|585640109|FG003|Treatment Period|Participant Withdrew from Study|0|||
162160932|NCT03484702|585640110|FG004|Treatment Period|Participant Withdrew from Study|0|||
162160933|NCT03484702|585640111|FG005|Treatment Period|Participant Withdrew from Study|0|||
162160934|NCT03484702|585640106|FG000|Treatment Period|Physician Decision|0|||
162160935|NCT03484702|585640107|FG001|Treatment Period|Physician Decision|1|||
162160936|NCT03484702|585640108|FG002|Treatment Period|Physician Decision|0|||
162160937|NCT03484702|585640109|FG003|Treatment Period|Physician Decision|0|||
162160938|NCT03484702|585640110|FG004|Treatment Period|Physician Decision|0|||
162160939|NCT03484702|585640111|FG005|Treatment Period|Physician Decision|1|||
162160940|NCT01894061|585640116|FG000|Overall Study|Screen failure|1|||
162160941|NCT01894061|585640116|FG000|Overall Study|Withdrawal by Subject|1|||
162160942|NCT00739648|585640117|FG000|Overall Study|Adverse Event|3|||
162160943|NCT00739648|585640118|FG001|Overall Study|Adverse Event|15|||
162160944|NCT00739648|585640117|FG000|Overall Study|Withdrawal by Subject|13|||
162160945|NCT00739648|585640118|FG001|Overall Study|Withdrawal by Subject|25|||
162160946|NCT00739648|585640117|FG000|Overall Study|Lost to Follow-up|4|||
162160947|NCT00739648|585640118|FG001|Overall Study|Lost to Follow-up|7|||
162160948|NCT00739648|585640117|FG000|Overall Study|Death|2|||
162160949|NCT00739648|585640118|FG001|Overall Study|Death|0|||
162160950|NCT00739648|585640117|FG000|Overall Study|Do not know|4|||
162160951|NCT00739648|585640118|FG001|Overall Study|Do not know|6|||
162160952|NCT05110495|585640119|FG000|Overall Study|Lost to Follow-up|1|||
162160953|NCT05110495|585640119|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
162160954|NCT02840474|585640121|FG000|Overall Study|Lost to Follow-up|1|||
162160955|NCT02840474|585640122|FG001|Overall Study|Lost to Follow-up|0|||
162160956|NCT04716634|585640123|FG000|Overall Study|Death|24|||
162160957|NCT04716634|585640124|FG001|Overall Study|Death|24|||
162160958|NCT04716634|585640125|FG002|Overall Study|Death|8|||
162160959|NCT04716634|585640123|FG000|Overall Study|Closed by Sponsor|4|||
162160960|NCT04716634|585640124|FG001|Overall Study|Closed by Sponsor|4|||
162160961|NCT04716634|585640125|FG002|Overall Study|Closed by Sponsor|5|||
162160962|NCT04716634|585640123|FG000|Overall Study|Lost to Follow-up|1|||
162160963|NCT04716634|585640124|FG001|Overall Study|Lost to Follow-up|0|||
162160964|NCT04716634|585640125|FG002|Overall Study|Lost to Follow-up|1|||
162160965|NCT04716634|585640123|FG000|Overall Study|Withdrawal by Subject|0|||
162160966|NCT04716634|585640124|FG001|Overall Study|Withdrawal by Subject|0|||
162160967|NCT04716634|585640125|FG002|Overall Study|Withdrawal by Subject|1|||
162160968|NCT05418296|585640133|FG000|Overall Study|Withdrawal by Subject|4|||
162160969|NCT05418296|585640134|FG001|Overall Study|Withdrawal by Subject|1|||
162160970|NCT04703322|585640136|FG000|Overall Study|Ongoing|8|||
162160971|NCT04703322|585640136|FG000|Overall Study|Withdrawal by Subject|1|||
162160972|NCT04638998|585640137|FG000|Overall Study|Withdrawal by Subject|1|||
162160973|NCT04638998|585640138|FG001|Overall Study|Withdrawal by Subject|3|||
162160974|NCT04419168|585640141|FG000|Overall Study|Protocol Violation|1|||
162160975|NCT04419168|585640142|FG001|Overall Study|Protocol Violation|1|||
162160976|NCT04419168|585640141|FG000|Overall Study|Lost to Follow-up|7|||
162160977|NCT04419168|585640142|FG001|Overall Study|Lost to Follow-up|7|||
162160978|NCT04419168|585640141|FG000|Overall Study|Missed 6-month Visit|48|||
162160979|NCT04419168|585640142|FG001|Overall Study|Missed 6-month Visit|45|||
162160980|NCT03713086|585640146|FG000|Overall Study|Withdrawal by Subject|0|||
162160981|NCT03713086|585640147|FG001|Overall Study|Withdrawal by Subject|2|||
162160982|NCT03713086|585640148|FG002|Overall Study|Withdrawal by Subject|1|||
162160983|NCT03713086|585640149|FG003|Overall Study|Withdrawal by Subject|0|||
162160984|NCT03713086|585640146|FG000|Overall Study|Lost to Follow-up|0|||
161813608|NCT04493684|584359929|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813609|NCT04493684|584359930|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
162160985|NCT03713086|585640147|FG001|Overall Study|Lost to Follow-up|1|||
162160986|NCT03713086|585640148|FG002|Overall Study|Lost to Follow-up|0|||
162160987|NCT03713086|585640149|FG003|Overall Study|Lost to Follow-up|1|||
162160988|NCT05009251|585640150|FG000|Overall Study|Protocol Violation|100|||
162160989|NCT05009251|585640151|FG001|Overall Study|Protocol Violation|105|||
162160990|NCT05009251|585640152|FG002|Overall Study|Protocol Violation|119|||
162160991|NCT05009251|585640153|FG003|Overall Study|Protocol Violation|120|||
162160992|NCT05009251|585640154|FG004|Overall Study|Protocol Violation|119|||
162160993|NCT05009251|585640150|FG000|Overall Study|Death|25|||
162160994|NCT05009251|585640151|FG001|Overall Study|Death|22|||
162160995|NCT05009251|585640152|FG002|Overall Study|Death|24|||
162160996|NCT05009251|585640153|FG003|Overall Study|Death|19|||
162160997|NCT05009251|585640154|FG004|Overall Study|Death|15|||
162160998|NCT05374837|585640160|FG000|Overall Study|Lost to Follow-up|17|||
162160999|NCT05374837|585640161|FG001|Overall Study|Lost to Follow-up|18|||
162161000|NCT05406921|585640164|FG000|Overall Study|Withdrawal by Subject|25|||
162161001|NCT05406921|585640165|FG001|Overall Study|Withdrawal by Subject|0|||
162161002|NCT05406921|585640166|FG002|Overall Study|Withdrawal by Subject|25|||
162161003|NCT05406921|585640164|FG000|Overall Study|Protocol Violation|0|||
162161004|NCT05406921|585640165|FG001|Overall Study|Protocol Violation|12|||
162161005|NCT05406921|585640166|FG002|Overall Study|Protocol Violation|0|||
162161006|NCT04831281|585640169|FG000|Overall Study|Adverse Event|1|||
162161007|NCT04831281|585640170|FG001|Overall Study|Adverse Event|0|||
162161008|NCT04831281|585640171|FG002|Overall Study|Adverse Event|3|||
162161009|NCT04831281|585640169|FG000|Overall Study|Withdrawal by Subject|0|||
162161010|NCT04831281|585640170|FG001|Overall Study|Withdrawal by Subject|1|||
162161011|NCT04831281|585640171|FG002|Overall Study|Withdrawal by Subject|2|||
162161012|NCT04831281|585640169|FG000|Overall Study|Undetermined|1|||
162161013|NCT04831281|585640170|FG001|Overall Study|Undetermined|1|||
162161014|NCT04831281|585640171|FG002|Overall Study|Undetermined|0|||
162161015|NCT02249949|585640172|FG000|Overall Study|Cancelled prior to treatment|2|||
162161016|NCT02097420|585640175|FG000|Overall Study|Death|6|||
162161017|NCT02097420|585640175|FG000|Overall Study|Valve explanted|13|||
162161018|NCT02097420|585640175|FG000|Overall Study|Other Reason|1|||
162161019|NCT01707030|585640192|FG000|Overall Study|Death|1|||
162161020|NCT01707030|585640193|FG001|Overall Study|Death|1|||
162161021|NCT01707030|585640192|FG000|Overall Study|Withdrawal by Subject|2|||
162161022|NCT01707030|585640193|FG001|Overall Study|Withdrawal by Subject|3|||
162161023|NCT01707030|585640192|FG000|Overall Study|Lost to Follow-up|8|||
162161024|NCT01707030|585640193|FG001|Overall Study|Lost to Follow-up|13|||
162161025|NCT04263311|585640194|FG000|Overall Study|Lost to Follow-up|1|||
162161026|NCT04263311|585640195|FG001|Overall Study|Lost to Follow-up|2|||
162161027|NCT04263311|585640196|FG002|Overall Study|Lost to Follow-up|0|||
162161028|NCT04263311|585640194|FG000|Overall Study|Health Issues|1|||
162161029|NCT04263311|585640195|FG001|Overall Study|Health Issues|0|||
162161030|NCT04263311|585640196|FG002|Overall Study|Health Issues|0|||
162161031|NCT04263311|585640194|FG000|Overall Study|Left the country|1|||
162161032|NCT04263311|585640195|FG001|Overall Study|Left the country|0|||
162161033|NCT04263311|585640196|FG002|Overall Study|Left the country|0|||
162161034|NCT04263311|585640194|FG000|Overall Study|Unable to maintain time commitment|1|||
162161035|NCT04263311|585640195|FG001|Overall Study|Unable to maintain time commitment|0|||
162161036|NCT04263311|585640196|FG002|Overall Study|Unable to maintain time commitment|0|||
162161037|NCT04263311|585640194|FG000|Overall Study|No longer interested|1|||
162161038|NCT04263311|585640195|FG001|Overall Study|No longer interested|0|||
162161039|NCT04263311|585640196|FG002|Overall Study|No longer interested|0|||
161917553|NCT01995201|584746030|FG000|From Baseline Until Week 24|Physician Decision|0|||
161917554|NCT01995201|584746031|FG001|From Baseline Until Week 24|Physician Decision|2|||
161917555|NCT01995201|584746032|FG002|From Baseline Until Week 24|Physician Decision|0|||
161917556|NCT01995201|584746033|FG003|From Baseline Until Week 24|Physician Decision|0|||
161917557|NCT01995201|584746034|FG004|From Baseline Until Week 24|Physician Decision|0|||
161917558|NCT01995201|584746035|FG005|From Baseline Until Week 24|Physician Decision|0|||
161917559|NCT01995201|584746036|FG006|From Baseline Until Week 24|Physician Decision|0|||
161917560|NCT01995201|584746030|FG000|From Baseline Until Week 24|Protocol Violation|0|||
161917561|NCT01995201|584746031|FG001|From Baseline Until Week 24|Protocol Violation|9|||
161917562|NCT01995201|584746032|FG002|From Baseline Until Week 24|Protocol Violation|0|||
162161040|NCT04263311|585640194|FG000|Overall Study|Ineligible post consent|0|||
161917563|NCT01995201|584746033|FG003|From Baseline Until Week 24|Protocol Violation|0|||
162015084|NCT04032093|585108645|FG008|Overall Study|Lost to Follow-up|9|||
162015085|NCT04032093|585108646|FG009|Overall Study|Lost to Follow-up|12|||
162161041|NCT04263311|585640195|FG001|Overall Study|Ineligible post consent|0|||
162161042|NCT04263311|585640196|FG002|Overall Study|Ineligible post consent|5|||
162161043|NCT04820855|585640197|FG000|Overall Study|Lost to Follow-up|6|||
162161044|NCT04820855|585640198|FG001|Overall Study|Lost to Follow-up|9|||
162161045|NCT04838262|585640199|FG000|Overall Study|Withdrawal by Subject|9|||
162161046|NCT04838262|585640200|FG001|Overall Study|Withdrawal by Subject|4|||
162161047|NCT02927769|585640201|FG000|Induction Phase|Study drug toxicity|1|||
162161048|NCT02927769|585640202|FG001|Induction Phase|Study drug toxicity|1|||
162161049|NCT02927769|585640201|FG000|Induction Phase|Disease progression|0|||
162161050|NCT02927769|585640202|FG001|Induction Phase|Disease progression|1|||
161917564|NCT01995201|584746034|FG004|From Baseline Until Week 24|Protocol Violation|0|||
161917565|NCT01995201|584746035|FG005|From Baseline Until Week 24|Protocol Violation|0|||
161917566|NCT01995201|584746036|FG006|From Baseline Until Week 24|Protocol Violation|0|||
161917567|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Adverse Event|0|||
161917568|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Adverse Event|0|||
161917569|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Adverse Event|2|||
161917570|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Adverse Event|1|||
161917571|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Adverse Event|1|||
162015086|NCT04032093|585108637|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
162015087|NCT04032093|585108638|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
162015088|NCT04032093|585108639|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
162015089|NCT04032093|585108640|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
162015090|NCT04032093|585108641|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
162015091|NCT04032093|585108642|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
162015092|NCT04032093|585108643|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
162015093|NCT04032093|585108644|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
162015094|NCT04032093|585108645|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
162015095|NCT04032093|585108646|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
162015096|NCT04032093|585108637|FG000|Overall Study|Other|1|||
162015097|NCT04032093|585108638|FG001|Overall Study|Other|0|||
162015098|NCT04032093|585108639|FG002|Overall Study|Other|0|||
162015099|NCT04032093|585108640|FG003|Overall Study|Other|1|||
162015100|NCT04032093|585108641|FG004|Overall Study|Other|1|||
161813610|NCT04493684|584359931|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161813611|NCT04493684|584359915|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813612|NCT04493684|584359916|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813613|NCT04493684|584359917|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813614|NCT04493684|584359918|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813615|NCT04493684|584359919|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813616|NCT04493684|584359920|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813617|NCT04493684|584359921|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
161813618|NCT04493684|584359922|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813619|NCT04493684|584359923|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813620|NCT04493684|584359924|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813621|NCT04493684|584359925|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813622|NCT04493684|584359926|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813623|NCT04493684|584359927|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813624|NCT04493684|584359928|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813625|NCT04493684|584359929|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813626|NCT04493684|584359930|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813627|NCT04493684|584359931|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161813628|NCT04493684|584359915|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
161813629|NCT04493684|584359916|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813630|NCT04493684|584359917|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813631|NCT04493684|584359918|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813632|NCT04493684|584359919|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813633|NCT04493684|584359920|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813634|NCT04493684|584359921|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813635|NCT04493684|584359922|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813636|NCT04493684|584359923|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813637|NCT04493684|584359924|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813638|NCT04493684|584359925|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813639|NCT04493684|584359926|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813640|NCT04493684|584359927|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813641|NCT04493684|584359928|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813642|NCT04493684|584359929|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813643|NCT04493684|584359930|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813644|NCT04493684|584359931|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161813645|NCT04493684|584359915|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813646|NCT04493684|584359916|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813647|NCT04493684|584359917|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813648|NCT04493684|584359918|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813649|NCT04493684|584359919|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813650|NCT04493684|584359920|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
162015101|NCT04032093|585108642|FG005|Overall Study|Other|0|||
161917572|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Adverse Event|3|||
161917573|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Adverse Event|1|||
161917574|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Death|0|||
161917575|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Death|0|||
161917576|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Death|0|||
161917577|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Death|0|||
161917578|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Death|0|||
161917579|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Death|2|||
161917580|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Death|0|||
161917581|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
161917582|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
161917583|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
161917584|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
161917585|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
161917586|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
161917587|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
161917588|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
161917589|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
161917590|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
161917591|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
161917592|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
161917593|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
161917594|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
161917595|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161917596|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161917597|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
161917598|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161917599|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
161917600|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161917601|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161917602|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Physician Decision|0|||
161917603|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Physician Decision|0|||
161917604|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Physician Decision|0|||
161917605|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Physician Decision|0|||
161917606|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Physician Decision|1|||
161917607|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Physician Decision|0|||
161917608|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Physician Decision|0|||
161917609|NCT01995201|584746030|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
161917610|NCT01995201|584746031|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
161917611|NCT01995201|584746032|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
161917612|NCT01995201|584746033|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
161917613|NCT01995201|584746034|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
161917614|NCT01995201|584746035|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
161917615|NCT01995201|584746036|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
161917616|NCT01138046|584746037|FG000|Overall Study|Withdrawal due to death|6|||
161917617|NCT01136915|584746038|FG000|Overall Study|Lost to Follow-up|2|||
161917618|NCT01136915|584746039|FG001|Overall Study|Lost to Follow-up|0|||
161917619|NCT01136915|584746038|FG000|Overall Study|Exclusion criterion met|0|||
161917620|NCT01136915|584746039|FG001|Overall Study|Exclusion criterion met|1|||
161917621|NCT04797169|584746040|FG000|Overall Study|Lost to Follow-up|84|||
161917622|NCT04797169|584746041|FG001|Overall Study|Lost to Follow-up|67|||
161917623|NCT04797169|584746040|FG000|Overall Study|Pregnancy|1|||
161917624|NCT04797169|584746041|FG001|Overall Study|Pregnancy|3|||
161917625|NCT04797169|584746040|FG000|Overall Study|Withdrawal by Subject|27|||
161917626|NCT04797169|584746041|FG001|Overall Study|Withdrawal by Subject|35|||
161813651|NCT04493684|584359921|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813652|NCT04493684|584359922|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813653|NCT04493684|584359923|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813654|NCT04493684|584359924|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813655|NCT04493684|584359925|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813656|NCT04493684|584359926|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813657|NCT04493684|584359927|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813658|NCT04493684|584359928|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813659|NCT04493684|584359929|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813660|NCT04493684|584359930|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813661|NCT04493684|584359931|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161813662|NCT04493684|584359915|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813663|NCT04493684|584359916|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813664|NCT04493684|584359917|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813665|NCT04493684|584359918|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161917627|NCT03916926|584746042|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
161917628|NCT03916926|584746043|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
161917629|NCT03916926|584746042|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
161917630|NCT03916926|584746043|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
161917631|NCT03916926|584746042|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
161917632|NCT03916926|584746043|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
161917633|NCT03916926|584746042|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
161917634|NCT03916926|584746043|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
161917635|NCT03188822|584746048|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
161917636|NCT03188822|584746048|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
161917637|NCT05233761|584746063|FG000|Treatment Period A|Withdrawal by Subject|12|||
161917638|NCT05233761|584746064|FG001|Treatment Period A|Withdrawal by Subject|10|||
161917639|NCT05233761|584746063|FG000|Treatment Period A|Lost to Follow-up|6|||
161917640|NCT05233761|584746064|FG001|Treatment Period A|Lost to Follow-up|12|||
161917641|NCT05233761|584746063|FG000|Treatment Period A|Protocol Violation|8|||
161917642|NCT05233761|584746064|FG001|Treatment Period A|Protocol Violation|15|||
161917643|NCT03314935|584746067|FG000|Phase 1|Death|4|||
161917644|NCT03314935|584746068|FG001|Phase 1|Death|2|||
161917645|NCT03314935|584746069|FG002|Phase 1|Death|5|||
161917646|NCT03314935|584746070|FG003|Phase 1|Death|4|||
161917647|NCT03314935|584746071|FG004|Phase 1|Death|3|||
161917648|NCT03314935|584746072|FG005|Phase 1|Death|4|||
161917649|NCT03314935|584746073|FG006|Phase 1|Death|5|||
161917650|NCT03314935|584746074|FG007|Phase 1|Death|4|||
161917651|NCT03314935|584746075|FG008|Phase 1|Death|3|||
161917652|NCT03314935|584746076|FG009|Phase 1|Death|0|||
162015102|NCT04032093|585108643|FG006|Overall Study|Other|0|||
161917653|NCT03314935|584746077|FG010|Phase 1|Death|0|||
161917654|NCT03314935|584746078|FG011|Phase 1|Death|0|||
161917655|NCT03314935|584746079|FG012|Phase 1|Death|0|||
161917656|NCT03314935|584746080|FG013|Phase 1|Death|0|||
161917657|NCT03314935|584746081|FG014|Phase 1|Death|0|||
161917658|NCT03314935|584746067|FG000|Phase 1|Withdrawal by Subject|2|||
161917659|NCT03314935|584746068|FG001|Phase 1|Withdrawal by Subject|1|||
161917660|NCT03314935|584746069|FG002|Phase 1|Withdrawal by Subject|1|||
161917661|NCT03314935|584746070|FG003|Phase 1|Withdrawal by Subject|2|||
161917662|NCT03314935|584746071|FG004|Phase 1|Withdrawal by Subject|1|||
161917663|NCT03314935|584746072|FG005|Phase 1|Withdrawal by Subject|0|||
161917664|NCT03314935|584746073|FG006|Phase 1|Withdrawal by Subject|1|||
161917665|NCT03314935|584746074|FG007|Phase 1|Withdrawal by Subject|0|||
161917666|NCT03314935|584746075|FG008|Phase 1|Withdrawal by Subject|1|||
161917667|NCT03314935|584746076|FG009|Phase 1|Withdrawal by Subject|0|||
161917668|NCT03314935|584746077|FG010|Phase 1|Withdrawal by Subject|0|||
161917669|NCT03314935|584746078|FG011|Phase 1|Withdrawal by Subject|0|||
161917670|NCT03314935|584746079|FG012|Phase 1|Withdrawal by Subject|0|||
161917671|NCT03314935|584746080|FG013|Phase 1|Withdrawal by Subject|0|||
161917672|NCT03314935|584746081|FG014|Phase 1|Withdrawal by Subject|0|||
161917673|NCT03314935|584746067|FG000|Phase 1|Progressive Disease|2|||
161917674|NCT03314935|584746068|FG001|Phase 1|Progressive Disease|0|||
161917675|NCT03314935|584746069|FG002|Phase 1|Progressive Disease|0|||
161917676|NCT03314935|584746070|FG003|Phase 1|Progressive Disease|1|||
161917677|NCT03314935|584746071|FG004|Phase 1|Progressive Disease|0|||
161917678|NCT03314935|584746072|FG005|Phase 1|Progressive Disease|0|||
161917679|NCT03314935|584746073|FG006|Phase 1|Progressive Disease|0|||
161917680|NCT03314935|584746074|FG007|Phase 1|Progressive Disease|0|||
161917681|NCT03314935|584746075|FG008|Phase 1|Progressive Disease|0|||
161917682|NCT03314935|584746076|FG009|Phase 1|Progressive Disease|0|||
161917683|NCT03314935|584746077|FG010|Phase 1|Progressive Disease|0|||
161917684|NCT03314935|584746078|FG011|Phase 1|Progressive Disease|0|||
161917685|NCT03314935|584746079|FG012|Phase 1|Progressive Disease|0|||
161917686|NCT03314935|584746080|FG013|Phase 1|Progressive Disease|0|||
161917687|NCT03314935|584746081|FG014|Phase 1|Progressive Disease|0|||
161917688|NCT03314935|584746067|FG000|Phase 1|Study Terminated by Sponsor|0|||
161917689|NCT03314935|584746068|FG001|Phase 1|Study Terminated by Sponsor|1|||
161917690|NCT03314935|584746069|FG002|Phase 1|Study Terminated by Sponsor|0|||
161917691|NCT03314935|584746070|FG003|Phase 1|Study Terminated by Sponsor|0|||
161917692|NCT03314935|584746071|FG004|Phase 1|Study Terminated by Sponsor|0|||
161917693|NCT03314935|584746072|FG005|Phase 1|Study Terminated by Sponsor|0|||
161917694|NCT03314935|584746073|FG006|Phase 1|Study Terminated by Sponsor|0|||
161917695|NCT03314935|584746074|FG007|Phase 1|Study Terminated by Sponsor|0|||
161917696|NCT03314935|584746075|FG008|Phase 1|Study Terminated by Sponsor|1|||
161917697|NCT03314935|584746076|FG009|Phase 1|Study Terminated by Sponsor|0|||
161917698|NCT03314935|584746077|FG010|Phase 1|Study Terminated by Sponsor|0|||
161917699|NCT03314935|584746078|FG011|Phase 1|Study Terminated by Sponsor|0|||
161917700|NCT03314935|584746079|FG012|Phase 1|Study Terminated by Sponsor|0|||
161917701|NCT03314935|584746080|FG013|Phase 1|Study Terminated by Sponsor|0|||
161917702|NCT03314935|584746081|FG014|Phase 1|Study Terminated by Sponsor|0|||
161917703|NCT03314935|584746067|FG000|Phase 1|"Captured as Other in Database"|0|||
162015103|NCT04032093|585108644|FG007|Overall Study|Other|0|||
162015104|NCT04032093|585108645|FG008|Overall Study|Other|0|||
162015105|NCT04032093|585108646|FG009|Overall Study|Other|1|||
162015106|NCT04032093|585108637|FG000|Overall Study|Withdrawal by Subject|1|||
162015107|NCT04032093|585108638|FG001|Overall Study|Withdrawal by Subject|3|||
162015108|NCT04032093|585108639|FG002|Overall Study|Withdrawal by Subject|2|||
162015109|NCT04032093|585108640|FG003|Overall Study|Withdrawal by Subject|2|||
162015110|NCT04032093|585108641|FG004|Overall Study|Withdrawal by Subject|3|||
162015111|NCT04032093|585108642|FG005|Overall Study|Withdrawal by Subject|0|||
162015112|NCT04032093|585108643|FG006|Overall Study|Withdrawal by Subject|0|||
162015113|NCT04032093|585108644|FG007|Overall Study|Withdrawal by Subject|0|||
162015114|NCT04032093|585108645|FG008|Overall Study|Withdrawal by Subject|0|||
162015115|NCT04032093|585108646|FG009|Overall Study|Withdrawal by Subject|0|||
162015116|NCT04032093|585108637|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162015117|NCT04032093|585108638|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162015118|NCT04032093|585108639|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162015119|NCT04032093|585108640|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
162015120|NCT04032093|585108641|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
162015121|NCT04032093|585108642|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
162015122|NCT04032093|585108643|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
162015123|NCT04032093|585108644|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
162015124|NCT04032093|585108645|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
162015125|NCT04032093|585108646|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
162015126|NCT04032093|585108637|FG000|Overall Study|Adverse Event|0|||
162015127|NCT04032093|585108638|FG001|Overall Study|Adverse Event|0|||
162015128|NCT04032093|585108639|FG002|Overall Study|Adverse Event|0|||
162015129|NCT04032093|585108640|FG003|Overall Study|Adverse Event|0|||
161813666|NCT04493684|584359919|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813667|NCT04493684|584359920|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813668|NCT04493684|584359921|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813669|NCT04493684|584359922|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813670|NCT04493684|584359923|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813671|NCT04493684|584359924|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813672|NCT04493684|584359925|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813673|NCT04493684|584359926|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
161813674|NCT04493684|584359927|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813675|NCT04493684|584359928|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813676|NCT04493684|584359929|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813677|NCT04493684|584359930|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813678|NCT04493684|584359931|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161813679|NCT04493684|584359915|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813680|NCT04493684|584359916|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813681|NCT04493684|584359917|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813682|NCT04493684|584359918|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813683|NCT04493684|584359919|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813684|NCT04493684|584359920|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813685|NCT04493684|584359921|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813686|NCT04493684|584359922|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813687|NCT04493684|584359923|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813688|NCT04493684|584359924|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813689|NCT04493684|584359925|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813690|NCT04493684|584359926|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813691|NCT04493684|584359927|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813692|NCT04493684|584359928|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813693|NCT04493684|584359929|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813694|NCT04493684|584359930|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
161813695|NCT04493684|584359931|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161813696|NCT04493684|584359915|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813697|NCT04493684|584359916|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813698|NCT04493684|584359917|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813699|NCT04493684|584359918|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813700|NCT04493684|584359919|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813701|NCT04493684|584359920|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813702|NCT04493684|584359921|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813703|NCT04493684|584359922|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
162015130|NCT04032093|585108641|FG004|Overall Study|Adverse Event|0|||
162015131|NCT04032093|585108642|FG005|Overall Study|Adverse Event|0|||
162015132|NCT04032093|585108643|FG006|Overall Study|Adverse Event|0|||
162015133|NCT04032093|585108644|FG007|Overall Study|Adverse Event|0|||
162015134|NCT04032093|585108645|FG008|Overall Study|Adverse Event|0|||
162015135|NCT04032093|585108646|FG009|Overall Study|Adverse Event|1|||
161917704|NCT03314935|584746068|FG001|Phase 1|"Captured as Other in Database"|2|||
161917705|NCT03314935|584746069|FG002|Phase 1|"Captured as Other in Database"|0|||
161917706|NCT03314935|584746070|FG003|Phase 1|"Captured as Other in Database"|0|||
161917707|NCT03314935|584746071|FG004|Phase 1|"Captured as Other in Database"|0|||
162015136|NCT04032093|585108637|FG000|Overall Study|Physician Decision|0|||
162015137|NCT04032093|585108638|FG001|Overall Study|Physician Decision|0|||
161917708|NCT03314935|584746072|FG005|Phase 1|"Captured as Other in Database"|0|||
161917709|NCT03314935|584746073|FG006|Phase 1|"Captured as Other in Database"|1|||
161917710|NCT03314935|584746074|FG007|Phase 1|"Captured as Other in Database"|1|||
161917711|NCT03314935|584746075|FG008|Phase 1|"Captured as Other in Database"|1|||
162015138|NCT04032093|585108639|FG002|Overall Study|Physician Decision|0|||
162015139|NCT04032093|585108640|FG003|Overall Study|Physician Decision|0|||
161917712|NCT03314935|584746076|FG009|Phase 1|"Captured as Other in Database"|0|||
161917713|NCT03314935|584746077|FG010|Phase 1|"Captured as Other in Database"|0|||
161917714|NCT03314935|584746078|FG011|Phase 1|"Captured as Other in Database"|0|||
161917715|NCT03314935|584746079|FG012|Phase 1|"Captured as Other in Database"|0|||
161917716|NCT03314935|584746080|FG013|Phase 1|"Captured as Other in Database"|0|||
161917717|NCT03314935|584746081|FG014|Phase 1|"Captured as Other in Database"|0|||
162015140|NCT04032093|585108641|FG004|Overall Study|Physician Decision|0|||
162015141|NCT04032093|585108642|FG005|Overall Study|Physician Decision|1|||
162015142|NCT04032093|585108643|FG006|Overall Study|Physician Decision|0|||
162015143|NCT04032093|585108644|FG007|Overall Study|Physician Decision|0|||
162015144|NCT04032093|585108645|FG008|Overall Study|Physician Decision|0|||
162015145|NCT04032093|585108646|FG009|Overall Study|Physician Decision|0|||
162015146|NCT02565108|585108647|FG000|Overall Study|Adverse Event|1|||
162015147|NCT02565108|585108648|FG001|Overall Study|Adverse Event|0|||
162015148|NCT02565108|585108647|FG000|Overall Study|Withdrew Consent|1|||
162015149|NCT02565108|585108648|FG001|Overall Study|Withdrew Consent|0|||
162015150|NCT01310075|585108649|FG000|Overall Study|Lost to Follow-up|1|||
162015151|NCT01310075|585108650|FG001|Overall Study|Lost to Follow-up|0|||
162015152|NCT01310075|585108649|FG000|Overall Study|Physician Decision|10|||
162015153|NCT01310075|585108650|FG001|Overall Study|Physician Decision|7|||
162015154|NCT01310075|585108649|FG000|Overall Study|Protocol Violation|2|||
162015155|NCT01310075|585108650|FG001|Overall Study|Protocol Violation|2|||
162015156|NCT01310075|585108649|FG000|Overall Study|Withdrawal by Subject|1|||
162015157|NCT01310075|585108650|FG001|Overall Study|Withdrawal by Subject|1|||
162015158|NCT02745119|585108654|FG000|Overall Study|Adverse Event|1|||
162015159|NCT02745119|585108655|FG001|Overall Study|Adverse Event|0|||
162015160|NCT02745119|585108656|FG002|Overall Study|Adverse Event|1|||
162015161|NCT02745119|585108657|FG003|Overall Study|Adverse Event|3|||
162015162|NCT02745119|585108654|FG000|Overall Study|Death|3|||
162015163|NCT02745119|585108655|FG001|Overall Study|Death|3|||
162015164|NCT02745119|585108656|FG002|Overall Study|Death|0|||
162015165|NCT02745119|585108657|FG003|Overall Study|Death|4|||
162015166|NCT02745119|585108654|FG000|Overall Study|Lost to Follow-up|0|||
162015167|NCT02745119|585108655|FG001|Overall Study|Lost to Follow-up|0|||
162015168|NCT02745119|585108656|FG002|Overall Study|Lost to Follow-up|0|||
162015169|NCT02745119|585108657|FG003|Overall Study|Lost to Follow-up|1|||
162015170|NCT02745119|585108654|FG000|Overall Study|Protocol Deviation|0|||
162015171|NCT02745119|585108655|FG001|Overall Study|Protocol Deviation|0|||
162015172|NCT02745119|585108656|FG002|Overall Study|Protocol Deviation|0|||
162015173|NCT02745119|585108657|FG003|Overall Study|Protocol Deviation|1|||
162015174|NCT02745119|585108654|FG000|Overall Study|Withdrawal by Subject|7|||
162015175|NCT02745119|585108655|FG001|Overall Study|Withdrawal by Subject|15|||
161917718|NCT03314935|584746067|FG000|Phase 1|Lost to Follow-up|0|||
161917719|NCT03314935|584746068|FG001|Phase 1|Lost to Follow-up|0|||
161917720|NCT03314935|584746069|FG002|Phase 1|Lost to Follow-up|0|||
161917721|NCT03314935|584746070|FG003|Phase 1|Lost to Follow-up|0|||
161917722|NCT03314935|584746071|FG004|Phase 1|Lost to Follow-up|0|||
161917723|NCT03314935|584746072|FG005|Phase 1|Lost to Follow-up|0|||
161917724|NCT03314935|584746073|FG006|Phase 1|Lost to Follow-up|0|||
161917725|NCT03314935|584746074|FG007|Phase 1|Lost to Follow-up|0|||
161917726|NCT03314935|584746075|FG008|Phase 1|Lost to Follow-up|1|||
161917727|NCT03314935|584746076|FG009|Phase 1|Lost to Follow-up|0|||
161917728|NCT03314935|584746077|FG010|Phase 1|Lost to Follow-up|0|||
161917729|NCT03314935|584746078|FG011|Phase 1|Lost to Follow-up|0|||
162015176|NCT02745119|585108656|FG002|Overall Study|Withdrawal by Subject|8|||
162015177|NCT02745119|585108657|FG003|Overall Study|Withdrawal by Subject|14|||
162015178|NCT02745119|585108654|FG000|Overall Study|Study Terminated by Sponsor|134|||
162015179|NCT02745119|585108655|FG001|Overall Study|Study Terminated by Sponsor|252|||
162015180|NCT02745119|585108656|FG002|Overall Study|Study Terminated by Sponsor|135|||
162015181|NCT02745119|585108657|FG003|Overall Study|Study Terminated by Sponsor|251|||
162015182|NCT02745119|585108654|FG000|Overall Study|Physician Decision|0|||
162015183|NCT02745119|585108655|FG001|Overall Study|Physician Decision|2|||
161917730|NCT03314935|584746079|FG012|Phase 1|Lost to Follow-up|0|||
162015184|NCT02745119|585108656|FG002|Overall Study|Physician Decision|2|||
162015185|NCT02745119|585108657|FG003|Overall Study|Physician Decision|2|||
161917731|NCT03314935|584746080|FG013|Phase 1|Lost to Follow-up|0|||
161917732|NCT03314935|584746081|FG014|Phase 1|Lost to Follow-up|0|||
161917733|NCT03314935|584746067|FG000|Phase 2|Death|0|||
161917734|NCT03314935|584746068|FG001|Phase 2|Death|0|||
161917735|NCT03314935|584746069|FG002|Phase 2|Death|0|||
161917736|NCT03314935|584746070|FG003|Phase 2|Death|0|||
161917737|NCT03314935|584746071|FG004|Phase 2|Death|0|||
161917738|NCT03314935|584746072|FG005|Phase 2|Death|0|||
161917739|NCT03314935|584746073|FG006|Phase 2|Death|0|||
161917740|NCT03314935|584746074|FG007|Phase 2|Death|0|||
161917741|NCT03314935|584746075|FG008|Phase 2|Death|0|||
161917742|NCT03314935|584746076|FG009|Phase 2|Death|5|||
161917743|NCT03314935|584746077|FG010|Phase 2|Death|20|||
161917744|NCT03314935|584746078|FG011|Phase 2|Death|6|||
161917745|NCT03314935|584746079|FG012|Phase 2|Death|7|||
161917746|NCT03314935|584746080|FG013|Phase 2|Death|6|||
161917747|NCT03314935|584746081|FG014|Phase 2|Death|17|||
161917748|NCT03314935|584746067|FG000|Phase 2|Withdrawal by Subject|0|||
161917749|NCT03314935|584746068|FG001|Phase 2|Withdrawal by Subject|0|||
161917750|NCT03314935|584746069|FG002|Phase 2|Withdrawal by Subject|0|||
161917751|NCT03314935|584746070|FG003|Phase 2|Withdrawal by Subject|0|||
161917752|NCT03314935|584746071|FG004|Phase 2|Withdrawal by Subject|0|||
161917753|NCT03314935|584746072|FG005|Phase 2|Withdrawal by Subject|0|||
161917754|NCT03314935|584746073|FG006|Phase 2|Withdrawal by Subject|0|||
161917755|NCT03314935|584746074|FG007|Phase 2|Withdrawal by Subject|0|||
161917756|NCT03314935|584746075|FG008|Phase 2|Withdrawal by Subject|0|||
161917757|NCT03314935|584746076|FG009|Phase 2|Withdrawal by Subject|1|||
161917758|NCT03314935|584746077|FG010|Phase 2|Withdrawal by Subject|4|||
161917759|NCT03314935|584746078|FG011|Phase 2|Withdrawal by Subject|0|||
161917760|NCT03314935|584746079|FG012|Phase 2|Withdrawal by Subject|1|||
161917761|NCT03314935|584746080|FG013|Phase 2|Withdrawal by Subject|0|||
161917762|NCT03314935|584746081|FG014|Phase 2|Withdrawal by Subject|1|||
161917763|NCT03314935|584746067|FG000|Phase 2|Progressive Disease|0|||
161917764|NCT03314935|584746068|FG001|Phase 2|Progressive Disease|0|||
161917765|NCT03314935|584746069|FG002|Phase 2|Progressive Disease|0|||
161917766|NCT03314935|584746070|FG003|Phase 2|Progressive Disease|0|||
161917767|NCT03314935|584746071|FG004|Phase 2|Progressive Disease|0|||
161917768|NCT03314935|584746072|FG005|Phase 2|Progressive Disease|0|||
161917769|NCT03314935|584746073|FG006|Phase 2|Progressive Disease|0|||
161917770|NCT03314935|584746074|FG007|Phase 2|Progressive Disease|0|||
161917771|NCT03314935|584746075|FG008|Phase 2|Progressive Disease|0|||
161917772|NCT03314935|584746076|FG009|Phase 2|Progressive Disease|1|||
161917773|NCT03314935|584746077|FG010|Phase 2|Progressive Disease|1|||
161917774|NCT03314935|584746078|FG011|Phase 2|Progressive Disease|1|||
161917775|NCT03314935|584746079|FG012|Phase 2|Progressive Disease|2|||
161917776|NCT03314935|584746080|FG013|Phase 2|Progressive Disease|0|||
161917777|NCT03314935|584746081|FG014|Phase 2|Progressive Disease|1|||
161917778|NCT03314935|584746067|FG000|Phase 2|Study Terminated by Sponsor|0|||
161917779|NCT03314935|584746068|FG001|Phase 2|Study Terminated by Sponsor|0|||
161917780|NCT03314935|584746069|FG002|Phase 2|Study Terminated by Sponsor|0|||
161917781|NCT03314935|584746070|FG003|Phase 2|Study Terminated by Sponsor|0|||
161917782|NCT03314935|584746071|FG004|Phase 2|Study Terminated by Sponsor|0|||
161917783|NCT03314935|584746072|FG005|Phase 2|Study Terminated by Sponsor|0|||
161917784|NCT03314935|584746073|FG006|Phase 2|Study Terminated by Sponsor|0|||
161917785|NCT03314935|584746074|FG007|Phase 2|Study Terminated by Sponsor|0|||
162015186|NCT02745119|585108654|FG000|Overall Study|Reason Not Specified|0|||
162015187|NCT02745119|585108655|FG001|Overall Study|Reason Not Specified|2|||
162015188|NCT02745119|585108656|FG002|Overall Study|Reason Not Specified|0|||
162015189|NCT02745119|585108657|FG003|Overall Study|Reason Not Specified|1|||
162015190|NCT01696188|585108658|FG000|Overall Study|Protocol Violation|1|||
162015191|NCT01696188|585108659|FG001|Overall Study|Protocol Violation|1|||
162161051|NCT02927769|585640201|FG000|Intensification Phase|Study drug toxicity|1|||
161917786|NCT03314935|584746075|FG008|Phase 2|Study Terminated by Sponsor|0|||
161917787|NCT03314935|584746076|FG009|Phase 2|Study Terminated by Sponsor|0|||
161917788|NCT03314935|584746077|FG010|Phase 2|Study Terminated by Sponsor|7|||
161917789|NCT03314935|584746078|FG011|Phase 2|Study Terminated by Sponsor|2|||
161917790|NCT03314935|584746079|FG012|Phase 2|Study Terminated by Sponsor|1|||
161917791|NCT03314935|584746080|FG013|Phase 2|Study Terminated by Sponsor|4|||
161917792|NCT03314935|584746081|FG014|Phase 2|Study Terminated by Sponsor|4|||
161917793|NCT03314935|584746067|FG000|Phase 2|Lost to Follow-up|0|||
161917794|NCT03314935|584746068|FG001|Phase 2|Lost to Follow-up|0|||
161917795|NCT03314935|584746069|FG002|Phase 2|Lost to Follow-up|0|||
161917796|NCT03314935|584746070|FG003|Phase 2|Lost to Follow-up|0|||
162015192|NCT02425943|585108660|FG000|Overall Study|Adverse Event|3|||
161917797|NCT03314935|584746071|FG004|Phase 2|Lost to Follow-up|0|||
161917798|NCT03314935|584746072|FG005|Phase 2|Lost to Follow-up|0|||
161917799|NCT03314935|584746073|FG006|Phase 2|Lost to Follow-up|0|||
161917800|NCT03314935|584746074|FG007|Phase 2|Lost to Follow-up|0|||
161917801|NCT03314935|584746075|FG008|Phase 2|Lost to Follow-up|0|||
161917802|NCT03314935|584746076|FG009|Phase 2|Lost to Follow-up|1|||
161917803|NCT03314935|584746077|FG010|Phase 2|Lost to Follow-up|0|||
161917804|NCT03314935|584746078|FG011|Phase 2|Lost to Follow-up|0|||
161917805|NCT03314935|584746079|FG012|Phase 2|Lost to Follow-up|0|||
162015193|NCT02425943|585108661|FG001|Overall Study|Adverse Event|1|||
162015194|NCT02425943|585108660|FG000|Overall Study|Lost to Follow-up|59|||
162015195|NCT02425943|585108661|FG001|Overall Study|Lost to Follow-up|37|||
162015196|NCT02425943|585108660|FG000|Overall Study|Protocol Violation|4|||
162015197|NCT02425943|585108661|FG001|Overall Study|Protocol Violation|1|||
162015198|NCT02425943|585108660|FG000|Overall Study|Withdrawal by Subject|64|||
162015199|NCT02425943|585108661|FG001|Overall Study|Withdrawal by Subject|31|||
162015200|NCT02425943|585108660|FG000|Overall Study|Other|6|||
162015201|NCT02425943|585108661|FG001|Overall Study|Other|0|||
162015202|NCT01209325|585108662|FG000|Overall Study|Lost to Follow-up|24|||
162015203|NCT01209325|585108662|FG000|Overall Study|Adverse Event|1|||
162015204|NCT01209325|585108662|FG000|Overall Study|Relocated|3|||
162015205|NCT01209325|585108662|FG000|Overall Study|Refusal after starting therapy|8|||
162015206|NCT01209325|585108662|FG000|Overall Study|Protocol Violation|4|||
162015207|NCT01209325|585108662|FG000|Overall Study|Refusal prior to therapy|1|||
162015208|NCT01209325|585108662|FG000|Overall Study|Incarceration|2|||
162015209|NCT00174187|585108663|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
162015210|NCT00174187|585108664|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
162015211|NCT00174187|585108665|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
162015212|NCT00174187|585108663|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
162015213|NCT00174187|585108664|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
162015214|NCT00174187|585108665|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
162015215|NCT00174187|585108663|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
162015216|NCT00174187|585108664|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
162015217|NCT00174187|585108665|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
162015218|NCT00174187|585108663|FG000|Period 1 (up to 3 Years)|Other|0|||
162015219|NCT00174187|585108664|FG001|Period 1 (up to 3 Years)|Other|1|||
162015220|NCT00174187|585108665|FG002|Period 1 (up to 3 Years)|Other|0|||
162015221|NCT00174187|585108663|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
162015222|NCT00174187|585108664|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
162015223|NCT00174187|585108665|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
162015224|NCT00174187|585108663|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
162015225|NCT00174187|585108664|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
162015226|NCT00174187|585108665|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
162015227|NCT00174187|585108663|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
162015228|NCT00174187|585108664|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
162015229|NCT00174187|585108665|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
162015230|NCT00174187|585108663|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
162015231|NCT00174187|585108664|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
162015232|NCT00174187|585108665|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
162015233|NCT00174187|585108663|FG000|Period 2 (After 3 Years)|Other|0|||
162015234|NCT00174187|585108664|FG001|Period 2 (After 3 Years)|Other|0|||
162015235|NCT00174187|585108665|FG002|Period 2 (After 3 Years)|Other|5|||
162015236|NCT01285557|585108666|FG000|Overall Study|Death|173|||
162015237|NCT01285557|585108667|FG001|Overall Study|Death|90|||
162015238|NCT01285557|585108666|FG000|Overall Study|Lost to Follow-up|6|||
162015239|NCT01285557|585108667|FG001|Overall Study|Lost to Follow-up|2|||
162015240|NCT01285557|585108666|FG000|Overall Study|Withdrew Consent|6|||
162015241|NCT01285557|585108667|FG001|Overall Study|Withdrew Consent|1|||
162015242|NCT01285557|585108666|FG000|Overall Study|Sponsor Study Termination|23|||
162015243|NCT01285557|585108667|FG001|Overall Study|Sponsor Study Termination|13|||
162015244|NCT01285557|585108666|FG000|Overall Study|Randomized but not treated|1|||
162015245|NCT01285557|585108667|FG001|Overall Study|Randomized but not treated|1|||
162015246|NCT01285557|585108666|FG000|Overall Study|Study follow-up ongoing|28|||
162015247|NCT01285557|585108667|FG001|Overall Study|Study follow-up ongoing|14|||
162015248|NCT01285557|585108666|FG000|Overall Study|Sponsor Decision|2|||
162015249|NCT01285557|585108667|FG001|Overall Study|Sponsor Decision|1|||
162015250|NCT03529422|585108676|FG000|Overall Study|Withdrawal by Subject|1|||
162015251|NCT03529422|585108676|FG000|Overall Study|Protocol Violation|1|||
162015252|NCT03529422|585108676|FG000|Overall Study|Disease progression|2|||
162015253|NCT02000115|585108677|FG000|Overall Study|Death|56|||
162015254|NCT02000115|585108678|FG001|Overall Study|Death|45|||
162015255|NCT02000115|585108679|FG002|Overall Study|Death|0|||
162015256|NCT02000115|585108680|FG003|Overall Study|Death|0|||
162015257|NCT02000115|585108677|FG000|Overall Study|Missed Visit|6|||
162015258|NCT02000115|585108678|FG001|Overall Study|Missed Visit|8|||
162015259|NCT02000115|585108679|FG002|Overall Study|Missed Visit|1|||
162015260|NCT02000115|585108680|FG003|Overall Study|Missed Visit|0|||
162015261|NCT02000115|585108677|FG000|Overall Study|Protocol Violation|2|||
162015262|NCT02000115|585108678|FG001|Overall Study|Protocol Violation|1|||
162015263|NCT02000115|585108679|FG002|Overall Study|Protocol Violation|0|||
162015264|NCT02000115|585108680|FG003|Overall Study|Protocol Violation|0|||
162015265|NCT02000115|585108677|FG000|Overall Study|Physician Decision|2|||
162015266|NCT02000115|585108678|FG001|Overall Study|Physician Decision|0|||
162015267|NCT02000115|585108679|FG002|Overall Study|Physician Decision|0|||
162015268|NCT02000115|585108680|FG003|Overall Study|Physician Decision|0|||
161917806|NCT03314935|584746080|FG013|Phase 2|Lost to Follow-up|0|||
161917807|NCT03314935|584746081|FG014|Phase 2|Lost to Follow-up|1|||
161917808|NCT03314935|584746067|FG000|Phase 2|Physician Decision|0|||
161917809|NCT03314935|584746068|FG001|Phase 2|Physician Decision|0|||
161917810|NCT03314935|584746069|FG002|Phase 2|Physician Decision|0|||
161917811|NCT03314935|584746070|FG003|Phase 2|Physician Decision|0|||
161917812|NCT03314935|584746071|FG004|Phase 2|Physician Decision|0|||
161917813|NCT03314935|584746072|FG005|Phase 2|Physician Decision|0|||
161917814|NCT03314935|584746073|FG006|Phase 2|Physician Decision|0|||
161917815|NCT03314935|584746074|FG007|Phase 2|Physician Decision|0|||
161917816|NCT03314935|584746075|FG008|Phase 2|Physician Decision|0|||
161917817|NCT03314935|584746076|FG009|Phase 2|Physician Decision|0|||
161917818|NCT03314935|584746077|FG010|Phase 2|Physician Decision|1|||
161917819|NCT03314935|584746078|FG011|Phase 2|Physician Decision|0|||
161917820|NCT03314935|584746079|FG012|Phase 2|Physician Decision|0|||
161917821|NCT03314935|584746080|FG013|Phase 2|Physician Decision|0|||
161917822|NCT03314935|584746081|FG014|Phase 2|Physician Decision|0|||
161917823|NCT05252702|584746082|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
161917824|NCT05252702|584746082|FG000|Overall Study|Death|16|||
161917825|NCT05252702|584746082|FG000|Overall Study|System explant|5|||
161917826|NCT05252702|584746082|FG000|Overall Study|Lost to Follow-up|1|||
161917827|NCT05252702|584746082|FG000|Overall Study|Withdrawn by investigator|1|||
161917828|NCT05252702|584746082|FG000|Overall Study|Visit not due|306|||
161917829|NCT05252702|584746082|FG000|Overall Study|Visit within window but not completed|92|||
161917830|NCT05252702|584746082|FG000|Overall Study|Unsuccessful implant|1|||
161917831|NCT04153864|584746083|FG000|Overall Study|Withdrawal by Subject|21|||
161917832|NCT04153864|584746084|FG001|Overall Study|Withdrawal by Subject|7|||
161917833|NCT04153864|584746085|FG002|Overall Study|Withdrawal by Subject|23|||
161917834|NCT04153864|584746086|FG003|Overall Study|Withdrawal by Subject|2|||
161917835|NCT04153864|584746083|FG000|Overall Study|Lost to Follow-up|4|||
161917836|NCT04153864|584746084|FG001|Overall Study|Lost to Follow-up|0|||
161917837|NCT04153864|584746085|FG002|Overall Study|Lost to Follow-up|3|||
161917838|NCT04153864|584746086|FG003|Overall Study|Lost to Follow-up|0|||
161917839|NCT04153864|584746083|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
161917840|NCT04153864|584746084|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
161917841|NCT04153864|584746085|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
161917842|NCT04153864|584746086|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
161917843|NCT01654276|584746088|FG000|Overall Study|Lack of Efficacy|1|||
161917844|NCT01654276|584746088|FG000|Overall Study|Lost to Follow-up|4|||
161917845|NCT01654276|584746088|FG000|Overall Study|Withdrawal by Subject|1|||
161917846|NCT02657551|584746089|FG000|Overall Study|Adverse Event|2|||
161917847|NCT02657551|584746089|FG000|Overall Study|Withdrawal by Subject|1|||
161917848|NCT02657551|584746089|FG000|Overall Study|Non-Compliance|1|||
161917849|NCT02657551|584746089|FG000|Overall Study|Progression / Relapse|4|||
162015269|NCT02000115|585108677|FG000|Overall Study|Withdrawal by Subject|11|||
162015270|NCT02000115|585108678|FG001|Overall Study|Withdrawal by Subject|11|||
162015271|NCT02000115|585108679|FG002|Overall Study|Withdrawal by Subject|0|||
162015272|NCT02000115|585108680|FG003|Overall Study|Withdrawal by Subject|0|||
162015273|NCT02000115|585108677|FG000|Overall Study|Lost to Follow-up|0|||
162015274|NCT02000115|585108678|FG001|Overall Study|Lost to Follow-up|1|||
162015275|NCT02000115|585108679|FG002|Overall Study|Lost to Follow-up|0|||
162015276|NCT02000115|585108680|FG003|Overall Study|Lost to Follow-up|0|||
162015277|NCT02000115|585108677|FG000|Overall Study|Non-compliance|2|||
162015278|NCT02000115|585108678|FG001|Overall Study|Non-compliance|1|||
162015279|NCT02000115|585108679|FG002|Overall Study|Non-compliance|0|||
162015280|NCT02000115|585108680|FG003|Overall Study|Non-compliance|0|||
162015281|NCT02000115|585108677|FG000|Overall Study|Withdrawn on day of randomization|0|||
162015282|NCT02000115|585108678|FG001|Overall Study|Withdrawn on day of randomization|1|||
162015283|NCT02000115|585108679|FG002|Overall Study|Withdrawn on day of randomization|0|||
162015284|NCT02000115|585108680|FG003|Overall Study|Withdrawn on day of randomization|0|||
162015285|NCT02000115|585108677|FG000|Overall Study|Still on Study|0|||
162015286|NCT02000115|585108678|FG001|Overall Study|Still on Study|0|||
162015287|NCT02000115|585108679|FG002|Overall Study|Still on Study|0|||
162015288|NCT02000115|585108680|FG003|Overall Study|Still on Study|53|||
162015289|NCT02484391|585108683|FG000|Overall Study|Lack of Efficacy|15|||
162015290|NCT02484391|585108684|FG001|Overall Study|Lack of Efficacy|14|||
162015291|NCT02484391|585108685|FG002|Overall Study|Lack of Efficacy|3|||
161917858|NCT01192178|584746093|FG000|Overall Study|Withdrawal by Subject|6|||
161917859|NCT01192178|584746094|FG001|Overall Study|Withdrawal by Subject|10|||
161917860|NCT01192178|584746093|FG000|Overall Study|Protocol Violation|10|||
161917861|NCT01192178|584746094|FG001|Overall Study|Protocol Violation|3|||
161917862|NCT01192178|584746093|FG000|Overall Study|Physician Decision|2|||
161917863|NCT01192178|584746094|FG001|Overall Study|Physician Decision|4|||
161917864|NCT01192178|584746093|FG000|Overall Study|Lost to Follow-up|3|||
161917865|NCT01192178|584746094|FG001|Overall Study|Lost to Follow-up|3|||
161917866|NCT01192178|584746093|FG000|Overall Study|Adverse Event|2|||
161917867|NCT01192178|584746094|FG001|Overall Study|Adverse Event|1|||
162015292|NCT02484391|585108683|FG000|Overall Study|Lost to Follow-up|0|||
161917868|NCT01192178|584746093|FG000|Overall Study|Lack of Efficacy|1|||
161917869|NCT01192178|584746094|FG001|Overall Study|Lack of Efficacy|2|||
161917870|NCT00296517|584746095|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
161917871|NCT00296517|584746096|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
161917872|NCT00296517|584746095|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
161917873|NCT00296517|584746096|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
161917874|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
161917875|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
161917876|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
161917877|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
161917878|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
161917879|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
161917880|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
161917881|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
161917882|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
161917883|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
161917884|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
161917885|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
161917886|NCT00296517|584746095|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
161917887|NCT00296517|584746096|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
161917888|NCT02164916|584746097|FG000|Overall Study|Adverse Event|3|||
161917889|NCT02164916|584746098|FG001|Overall Study|Adverse Event|8|||
161917890|NCT02164916|584746097|FG000|Overall Study|Death|1|||
161917891|NCT02164916|584746098|FG001|Overall Study|Death|1|||
161917892|NCT02164916|584746097|FG000|Overall Study|Refusal unrelated to adverse event|3|||
161917893|NCT02164916|584746098|FG001|Overall Study|Refusal unrelated to adverse event|7|||
161917894|NCT02164916|584746097|FG000|Overall Study|Progression|37|||
161917895|NCT02164916|584746098|FG001|Overall Study|Progression|26|||
161917896|NCT02164916|584746097|FG000|Overall Study|Not protocol specified|5|||
161917897|NCT02164916|584746098|FG001|Overall Study|Not protocol specified|1|||
162015293|NCT02484391|585108684|FG001|Overall Study|Lost to Follow-up|0|||
162015294|NCT02484391|585108685|FG002|Overall Study|Lost to Follow-up|2|||
162015295|NCT02484391|585108683|FG000|Overall Study|Physician Decision|1|||
162015296|NCT02484391|585108684|FG001|Overall Study|Physician Decision|3|||
162015297|NCT02484391|585108685|FG002|Overall Study|Physician Decision|0|||
162015298|NCT02484391|585108683|FG000|Overall Study|Went to Transplant|5|||
162015299|NCT02484391|585108684|FG001|Overall Study|Went to Transplant|3|||
162015300|NCT02484391|585108685|FG002|Overall Study|Went to Transplant|2|||
162015301|NCT04922216|585108686|FG000|Overall Study|Withdrawal by Subject|0|||
162015302|NCT04922216|585108687|FG001|Overall Study|Withdrawal by Subject|1|||
162015303|NCT04922216|585108688|FG002|Overall Study|Withdrawal by Subject|0|||
162015304|NCT04922216|585108689|FG003|Overall Study|Withdrawal by Subject|0|||
162015305|NCT04922216|585108690|FG004|Overall Study|Withdrawal by Subject|0|||
162015306|NCT04922216|585108691|FG005|Overall Study|Withdrawal by Subject|0|||
162015307|NCT04922216|585108692|FG006|Overall Study|Withdrawal by Subject|0|||
162015308|NCT04922216|585108693|FG007|Overall Study|Withdrawal by Subject|2|||
162015309|NCT04922216|585108694|FG008|Overall Study|Withdrawal by Subject|0|||
162015310|NCT04922216|585108695|FG009|Overall Study|Withdrawal by Subject|0|||
162015311|NCT04922216|585108696|FG010|Overall Study|Withdrawal by Subject|0|||
162015312|NCT04922216|585108697|FG011|Overall Study|Withdrawal by Subject|0|||
162015313|NCT04922216|585108698|FG012|Overall Study|Withdrawal by Subject|1|||
162015314|NCT04922216|585108699|FG013|Overall Study|Withdrawal by Subject|1|||
162015315|NCT04922216|585108700|FG014|Overall Study|Withdrawal by Subject|1|||
162015316|NCT04922216|585108701|FG015|Overall Study|Withdrawal by Subject|0|||
162015317|NCT04922216|585108702|FG016|Overall Study|Withdrawal by Subject|0|||
162015318|NCT04922216|585108703|FG017|Overall Study|Withdrawal by Subject|1|||
162015319|NCT04922216|585108704|FG018|Overall Study|Withdrawal by Subject|1|||
161917898|NCT02164916|584746097|FG000|Overall Study|Reason under review|1|||
162015320|NCT04922216|585108705|FG019|Overall Study|Withdrawal by Subject|1|||
161917899|NCT02164916|584746098|FG001|Overall Study|Reason under review|6|||
161917900|NCT02164916|584746097|FG000|Overall Study|Not eligible|2|||
161917901|NCT02164916|584746098|FG001|Overall Study|Not eligible|5|||
161917902|NCT00964782|584746101|FG000|Overall Study|Lost to Follow-up|1|||
161917903|NCT00964782|584746102|FG001|Overall Study|Lost to Follow-up|0|||
161917904|NCT00596635|584746105|FG000|Overall Study|Lost to Follow-up|0|||
162015321|NCT04922216|585108706|FG020|Overall Study|Withdrawal by Subject|1|||
162015322|NCT04922216|585108707|FG021|Overall Study|Withdrawal by Subject|0|||
162015323|NCT04922216|585108708|FG022|Overall Study|Withdrawal by Subject|0|||
162015324|NCT04922216|585108709|FG023|Overall Study|Withdrawal by Subject|2|||
162015325|NCT04922216|585108710|FG024|Overall Study|Withdrawal by Subject|0|||
162015326|NCT04922216|585108711|FG025|Overall Study|Withdrawal by Subject|0|||
162015327|NCT04922216|585108712|FG026|Overall Study|Withdrawal by Subject|1|||
161917905|NCT00596635|584746106|FG001|Overall Study|Lost to Follow-up|2|||
161917906|NCT00596635|584746107|FG002|Overall Study|Lost to Follow-up|0|||
161917907|NCT00596635|584746105|FG000|Overall Study|Treatment for symptomatic UTI|4|||
161917908|NCT00596635|584746106|FG001|Overall Study|Treatment for symptomatic UTI|6|||
161917909|NCT00596635|584746107|FG002|Overall Study|Treatment for symptomatic UTI|3|||
161917910|NCT00596635|584746105|FG000|Overall Study|Hip fracture|2|||
161917911|NCT00596635|584746106|FG001|Overall Study|Hip fracture|3|||
161917912|NCT00596635|584746107|FG002|Overall Study|Hip fracture|3|||
161917913|NCT00596635|584746105|FG000|Overall Study|Could not provide urine specimen|1|||
161917914|NCT00596635|584746106|FG001|Overall Study|Could not provide urine specimen|2|||
161917915|NCT00596635|584746107|FG002|Overall Study|Could not provide urine specimen|2|||
161917916|NCT01143324|584746109|FG000|Overall Study|Lost to Follow-up|11|||
161917917|NCT01143324|584746109|FG000|Overall Study|Withdrawal by Subject|4|||
161917918|NCT01143324|584746109|FG000|Overall Study|Explant of the device|4|||
161917919|NCT00858988|584746116|FG000|Analysis|Lactulose unable to be detected in urine|2|||
161917920|NCT00858988|584746117|FG001|Analysis|Lactulose unable to be detected in urine|1|||
161917921|NCT00846365|584746120|FG000|Overall Study|Adverse Event|20|||
161917922|NCT00846365|584746121|FG001|Overall Study|Adverse Event|30|||
161917923|NCT00846365|584746122|FG002|Overall Study|Adverse Event|11|||
161917924|NCT00846365|584746120|FG000|Overall Study|Protocol Violation|5|||
161917925|NCT00846365|584746121|FG001|Overall Study|Protocol Violation|4|||
161917926|NCT00846365|584746122|FG002|Overall Study|Protocol Violation|0|||
161917927|NCT00846365|584746120|FG000|Overall Study|Lost to Follow-up|8|||
161917928|NCT00846365|584746121|FG001|Overall Study|Lost to Follow-up|2|||
161917929|NCT00846365|584746122|FG002|Overall Study|Lost to Follow-up|5|||
161917930|NCT00846365|584746120|FG000|Overall Study|Withdrawal by Subject|11|||
161917931|NCT00846365|584746121|FG001|Overall Study|Withdrawal by Subject|11|||
161917932|NCT00846365|584746122|FG002|Overall Study|Withdrawal by Subject|9|||
161917933|NCT00846365|584746120|FG000|Overall Study|Pregnancy|1|||
161917934|NCT00846365|584746121|FG001|Overall Study|Pregnancy|0|||
161917935|NCT00846365|584746122|FG002|Overall Study|Pregnancy|0|||
161917936|NCT00846365|584746120|FG000|Overall Study|Lack of Efficacy|1|||
161917937|NCT00846365|584746121|FG001|Overall Study|Lack of Efficacy|1|||
162015328|NCT04922216|585108713|FG027|Overall Study|Withdrawal by Subject|0|||
162015329|NCT04922216|585108714|FG028|Overall Study|Withdrawal by Subject|0|||
162015330|NCT04922216|585108715|FG029|Overall Study|Withdrawal by Subject|0|||
161917938|NCT00846365|584746122|FG002|Overall Study|Lack of Efficacy|2|||
162015331|NCT04922216|585108716|FG030|Overall Study|Withdrawal by Subject|1|||
162015332|NCT04922216|585108717|FG031|Overall Study|Withdrawal by Subject|0|||
162015333|NCT04922216|585108686|FG000|Overall Study|Lost to Follow-up|1|||
162015334|NCT04922216|585108687|FG001|Overall Study|Lost to Follow-up|0|||
162015335|NCT04922216|585108688|FG002|Overall Study|Lost to Follow-up|2|||
162015336|NCT04922216|585108689|FG003|Overall Study|Lost to Follow-up|0|||
162015337|NCT04922216|585108690|FG004|Overall Study|Lost to Follow-up|0|||
161917939|NCT00846365|584746120|FG000|Overall Study|Other|9|||
161917940|NCT00846365|584746121|FG001|Overall Study|Other|1|||
161917941|NCT00846365|584746122|FG002|Overall Study|Other|6|||
161917942|NCT01277861|584746130|FG000|Overall Study|Physician Decision|2|||
161917943|NCT01277861|584746131|FG001|Overall Study|Physician Decision|2|||
161917944|NCT05032196|584746132|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161917945|NCT05032196|584746133|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
161917946|NCT05032196|584746134|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161917947|NCT05032196|584746135|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161917948|NCT05032196|584746136|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161917949|NCT05032196|584746137|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161917950|NCT05032196|584746132|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161917951|NCT05032196|584746133|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161917952|NCT05032196|584746134|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161917953|NCT05032196|584746135|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
161917954|NCT05032196|584746136|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161917955|NCT05032196|584746137|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161917956|NCT05032196|584746132|FG000|Period 2 (Multidose)|Physician Decision|0|||
161917957|NCT05032196|584746133|FG001|Period 2 (Multidose)|Physician Decision|0|||
161917958|NCT05032196|584746134|FG002|Period 2 (Multidose)|Physician Decision|0|||
161917959|NCT05032196|584746135|FG003|Period 2 (Multidose)|Physician Decision|0|||
161917960|NCT05032196|584746136|FG004|Period 2 (Multidose)|Physician Decision|1|||
161917961|NCT05032196|584746137|FG005|Period 2 (Multidose)|Physician Decision|0|||
161917962|NCT00857389|584746138|FG000|Overall Study|Did not proceed to transplant|2|||
161917963|NCT00689936|584747146|FG000|Active Treatment Phase|Adverse Event|68|||
161917964|NCT00689936|584747147|FG001|Active Treatment Phase|Adverse Event|71|||
161917965|NCT00689936|584747148|FG002|Active Treatment Phase|Adverse Event|76|||
161917966|NCT00689936|584747146|FG000|Active Treatment Phase|Disease Progression|273|||
161917967|NCT00689936|584747147|FG001|Active Treatment Phase|Disease Progression|362|||
161917968|NCT00689936|584747148|FG002|Active Treatment Phase|Disease Progression|339|||
162015338|NCT04922216|585108691|FG005|Overall Study|Lost to Follow-up|2|||
162015339|NCT04922216|585108692|FG006|Overall Study|Lost to Follow-up|0|||
161917969|NCT00689936|584747146|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
161917970|NCT00689936|584747147|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
162015340|NCT04922216|585108693|FG007|Overall Study|Lost to Follow-up|1|||
161917971|NCT00689936|584747148|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
161917972|NCT00689936|584747146|FG000|Active Treatment Phase|Death|60|||
161917973|NCT00689936|584747147|FG001|Active Treatment Phase|Death|28|||
161917974|NCT00689936|584747148|FG002|Active Treatment Phase|Death|37|||
161917975|NCT00689936|584747146|FG000|Active Treatment Phase|Lost to Follow-up|0|||
161917976|NCT00689936|584747147|FG001|Active Treatment Phase|Lost to Follow-up|2|||
161917977|NCT00689936|584747148|FG002|Active Treatment Phase|Lost to Follow-up|2|||
161917978|NCT00689936|584747146|FG000|Active Treatment Phase|Protocol Violation|2|||
161917979|NCT00689936|584747147|FG001|Active Treatment Phase|Protocol Violation|2|||
161917980|NCT00689936|584747148|FG002|Active Treatment Phase|Protocol Violation|4|||
161917981|NCT00689936|584747146|FG000|Active Treatment Phase|Study Close Out|64|||
161917982|NCT00689936|584747147|FG001|Active Treatment Phase|Study Close Out|26|||
161917983|NCT00689936|584747148|FG002|Active Treatment Phase|Study Close Out|21|||
161917984|NCT00689936|584747146|FG000|Active Treatment Phase|Miscellaneous|52|||
161917985|NCT00689936|584747147|FG001|Active Treatment Phase|Miscellaneous|34|||
161917986|NCT00689936|584747148|FG002|Active Treatment Phase|Miscellaneous|47|||
161917987|NCT00689936|584747146|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
161917988|NCT00689936|584747147|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
161917989|NCT00689936|584747148|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
161917990|NCT06001866|584747155|FG000|Overall Study|Withdrawal by Subject|0|||
161917991|NCT06001866|584747156|FG001|Overall Study|Withdrawal by Subject|2|||
161917992|NCT06001866|584747155|FG000|Overall Study|Protocol Violation|0|||
161917993|NCT06001866|584747156|FG001|Overall Study|Protocol Violation|2|||
161917994|NCT04703192|584747157|FG000|Overall Study|Withdrawal by Subject|2|||
161917995|NCT04703192|584747158|FG001|Overall Study|Withdrawal by Subject|0|||
161917996|NCT04703192|584747157|FG000|Overall Study|Death|3|||
161917997|NCT04703192|584747158|FG001|Overall Study|Death|1|||
161917998|NCT04703192|584747157|FG000|Overall Study|Adverse Event|13|||
161917999|NCT04703192|584747158|FG001|Overall Study|Adverse Event|2|||
161918000|NCT04703192|584747157|FG000|Overall Study|Progressive or Relapsed Disease|46|||
161918001|NCT04703192|584747158|FG001|Overall Study|Progressive or Relapsed Disease|7|||
161918002|NCT04703192|584747157|FG000|Overall Study|Clinical Progression|19|||
161918003|NCT04703192|584747158|FG001|Overall Study|Clinical Progression|8|||
161918004|NCT04703192|584747157|FG000|Overall Study|Lost to Follow-up|1|||
161918005|NCT04703192|584747158|FG001|Overall Study|Lost to Follow-up|0|||
161918006|NCT04703192|584747157|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
161918007|NCT04703192|584747158|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
161918008|NCT04703192|584747157|FG000|Overall Study|Other|5|||
161918009|NCT04703192|584747158|FG001|Overall Study|Other|1|||
161918010|NCT04725188|584747161|FG000|Overall Study|Death|72|||
161918011|NCT04725188|584747162|FG001|Overall Study|Death|69|||
161918012|NCT04725188|584747163|FG002|Overall Study|Death|76|||
161918013|NCT04725188|584747161|FG000|Overall Study|Lost to Follow-up|1|||
161918014|NCT04725188|584747162|FG001|Overall Study|Lost to Follow-up|0|||
161918015|NCT04725188|584747163|FG002|Overall Study|Lost to Follow-up|1|||
161918016|NCT04725188|584747161|FG000|Overall Study|Withdrawal by Subject|2|||
161918017|NCT04725188|584747162|FG001|Overall Study|Withdrawal by Subject|2|||
161918018|NCT04725188|584747163|FG002|Overall Study|Withdrawal by Subject|1|||
161918019|NCT04725188|584747161|FG000|Overall Study|Sponsor Decision|12|||
161918020|NCT04725188|584747162|FG001|Overall Study|Sponsor Decision|12|||
161918021|NCT04725188|584747163|FG002|Overall Study|Sponsor Decision|7|||
161918022|NCT00390013|584747165|FG000|Phase 1|tired|0|||
161918023|NCT00390013|584747166|FG001|Phase 1|tired|0|||
161918024|NCT00390013|584747167|FG002|Phase 1|tired|0|||
161918025|NCT00390013|584747168|FG003|Phase 1|tired|1|||
161918026|NCT00390013|584747165|FG000|Phase 2 First Treatment|tired|1|||
161918027|NCT00390013|584747166|FG001|Phase 2 First Treatment|tired|0|||
161918028|NCT00390013|584747167|FG002|Phase 2 First Treatment|tired|0|||
161918029|NCT00390013|584747168|FG003|Phase 2 First Treatment|tired|0|||
161918030|NCT00390013|584747165|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
161918031|NCT00390013|584747166|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
161918032|NCT00390013|584747167|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
161918033|NCT00390013|584747168|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
161918034|NCT03839641|584747169|FG000|Overall Study|Withdrawal by Subject|1|||
161918035|NCT03839641|584747170|FG001|Overall Study|Withdrawal by Subject|1|||
161918036|NCT04537299|584747177|FG000|Overall Study|Withdrawal by Subject|2|||
161918037|NCT04537299|584747178|FG001|Overall Study|Withdrawal by Subject|0|||
161918038|NCT04537299|584747177|FG000|Overall Study|Protocol Violation|1|||
161918039|NCT04537299|584747178|FG001|Overall Study|Protocol Violation|1|||
161918040|NCT00876343|584747179|FG000|Overall Study|Adverse Event|7|||
161918041|NCT00876343|584747180|FG001|Overall Study|Adverse Event|8|||
161918042|NCT00876343|584747181|FG002|Overall Study|Adverse Event|2|||
161918043|NCT00876343|584747179|FG000|Overall Study|Withdrawal by Subject|4|||
161918044|NCT00876343|584747180|FG001|Overall Study|Withdrawal by Subject|4|||
161918045|NCT00876343|584747181|FG002|Overall Study|Withdrawal by Subject|3|||
161918046|NCT00876343|584747179|FG000|Overall Study|Lack of Efficacy|0|||
161918047|NCT00876343|584747180|FG001|Overall Study|Lack of Efficacy|0|||
161918048|NCT00876343|584747181|FG002|Overall Study|Lack of Efficacy|1|||
161918049|NCT00876343|584747179|FG000|Overall Study|Protocol Violation|4|||
161918050|NCT00876343|584747180|FG001|Overall Study|Protocol Violation|1|||
161918051|NCT00876343|584747181|FG002|Overall Study|Protocol Violation|1|||
161918052|NCT00876343|584747179|FG000|Overall Study|Physician Decision|0|||
161918053|NCT00876343|584747180|FG001|Overall Study|Physician Decision|1|||
161918054|NCT00876343|584747181|FG002|Overall Study|Physician Decision|1|||
161918055|NCT00876343|584747179|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
161918056|NCT00876343|584747180|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
161918057|NCT00876343|584747181|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
161918058|NCT00876343|584747179|FG000|Overall Study|Change of residence or other commitments|2|||
161918059|NCT00876343|584747180|FG001|Overall Study|Change of residence or other commitments|2|||
161918060|NCT00876343|584747181|FG002|Overall Study|Change of residence or other commitments|3|||
161918061|NCT00924898|584747185|FG000|Overall Study|Withdrawal by Subject|2|||
161918062|NCT04717557|584747188|FG000|Overall Study|Withdrawal by Subject|2|||
161918063|NCT04717557|584747189|FG001|Overall Study|Withdrawal by Subject|0|||
161918064|NCT04717557|584747188|FG000|Overall Study|Death|1|||
161918065|NCT04717557|584747189|FG001|Overall Study|Death|0|||
161918066|NCT06354257|584747190|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161918067|NCT06354257|584747190|FG000|Treatment Period 2|Adverse Event|1|||
161918068|NCT02401230|584747191|FG000|Overall Study|Adverse Event|3|||
161918069|NCT02401230|584747192|FG001|Overall Study|Adverse Event|2|||
161918070|NCT02401230|584747193|FG002|Overall Study|Adverse Event|0|||
161918071|NCT02401230|584747191|FG000|Overall Study|Withdrawal by Subject|2|||
161918072|NCT02401230|584747192|FG001|Overall Study|Withdrawal by Subject|1|||
161918073|NCT02401230|584747193|FG002|Overall Study|Withdrawal by Subject|1|||
161918074|NCT02401230|584747191|FG000|Overall Study|Lost to Follow-up|1|||
161918075|NCT02401230|584747192|FG001|Overall Study|Lost to Follow-up|3|||
161918076|NCT02401230|584747193|FG002|Overall Study|Lost to Follow-up|3|||
161918077|NCT00720759|584747198|FG000|Overall Study|Lost to Follow-up|0|||
161918078|NCT00720759|584747199|FG001|Overall Study|Lost to Follow-up|1|||
161918079|NCT00720759|584747200|FG002|Overall Study|Lost to Follow-up|1|||
161918080|NCT00720759|584747201|FG003|Overall Study|Lost to Follow-up|0|||
161918081|NCT02318940|584747202|FG000|Overall Study|lost the record|1|||
161918082|NCT02318940|584747203|FG001|Overall Study|lost the record|0|||
161918083|NCT01047319|584747204|FG000|Overall Study|Teva requested participant withdrawal|3|||
161918084|NCT01047319|584747205|FG001|Overall Study|Teva requested participant withdrawal|0|||
161918085|NCT01047319|584747206|FG002|Overall Study|Teva requested participant withdrawal|1|||
161918086|NCT01047319|584747204|FG000|Overall Study|Protocol Violation|3|||
161918087|NCT01047319|584747205|FG001|Overall Study|Protocol Violation|2|||
161918088|NCT01047319|584747206|FG002|Overall Study|Protocol Violation|4|||
161918089|NCT01047319|584747204|FG000|Overall Study|Lack of Efficacy|4|||
161918090|NCT01047319|584747205|FG001|Overall Study|Lack of Efficacy|3|||
161918091|NCT01047319|584747206|FG002|Overall Study|Lack of Efficacy|3|||
161918092|NCT01047319|584747204|FG000|Overall Study|Death|5|||
161918093|NCT01047319|584747205|FG001|Overall Study|Death|1|||
161918094|NCT01047319|584747206|FG002|Overall Study|Death|5|||
161918095|NCT01047319|584747204|FG000|Overall Study|Pregnancy|13|||
161918096|NCT01047319|584747205|FG001|Overall Study|Pregnancy|8|||
161918097|NCT01047319|584747206|FG002|Overall Study|Pregnancy|8|||
161918098|NCT01047319|584747204|FG000|Overall Study|Physician Decision|12|||
161918099|NCT01047319|584747205|FG001|Overall Study|Physician Decision|9|||
161918100|NCT01047319|584747206|FG002|Overall Study|Physician Decision|10|||
161918101|NCT01047319|584747204|FG000|Overall Study|Lost to Follow-up|14|||
161918102|NCT01047319|584747205|FG001|Overall Study|Lost to Follow-up|10|||
161918103|NCT01047319|584747206|FG002|Overall Study|Lost to Follow-up|10|||
161918104|NCT01047319|584747204|FG000|Overall Study|Adverse Event|16|||
161918105|NCT01047319|584747205|FG001|Overall Study|Adverse Event|27|||
161918106|NCT01047319|584747206|FG002|Overall Study|Adverse Event|21|||
161918107|NCT01047319|584747204|FG000|Overall Study|Withdrawal by Subject|77|||
161918108|NCT01047319|584747205|FG001|Overall Study|Withdrawal by Subject|75|||
161918109|NCT01047319|584747206|FG002|Overall Study|Withdrawal by Subject|87|||
161918110|NCT01047319|584747204|FG000|Overall Study|Study terminated by Sponsor|198|||
161918111|NCT01047319|584747205|FG001|Overall Study|Study terminated by Sponsor|215|||
161918112|NCT01047319|584747206|FG002|Overall Study|Study terminated by Sponsor|203|||
161918113|NCT05759338|584747212|FG000|Overall Study|Withdrawal by Subject|3|||
161918114|NCT04611126|584747213|FG000|Overall Study|TIL expansion unsuccessful|1|||
161918115|NCT04611126|584747214|FG001|Overall Study|TIL expansion unsuccessful|0|||
161918116|NCT05260008|584747215|FG000|Overall Study|Physician Decision|0|||
161918117|NCT05260008|584747216|FG001|Overall Study|Physician Decision|1|||
161918118|NCT05260008|584747217|FG002|Overall Study|Physician Decision|0|||
161918119|NCT05260008|584747218|FG003|Overall Study|Physician Decision|0|||
161918120|NCT01157845|584747221|FG000|Overall Study|Lost to Follow-up|5|||
161918121|NCT01157845|584747221|FG000|Overall Study|Withdrawal by Subject|12|||
161918122|NCT01157845|584747221|FG000|Overall Study|Physician Decision|3|||
161918123|NCT01157845|584747221|FG000|Overall Study|Protocol Violation|13|||
161918124|NCT01157845|584747221|FG000|Overall Study|Study was ended|1|||
161918125|NCT01157845|584747221|FG000|Overall Study|Device malfunction|1|||
161918126|NCT04584788|584747222|FG000|Overall Study|Physician Decision|8|||
161918127|NCT04584788|584747222|FG000|Overall Study|Withdrawal by Subject|1|||
161918128|NCT04584788|584747222|FG000|Overall Study|Adverse Event|3|||
161918129|NCT03311555|584747223|FG000|Overall Study|Adverse Event|1|||
161918130|NCT04284774|584747229|FG000|Overall Study|Progressive disease|5|||
161918131|NCT04817410|584748633|FG000|Overall Study|Withdrawal by Subject|5|||
161918132|NCT04817410|584748633|FG000|Overall Study|Physician Decision|3|||
161918133|NCT03595748|584748634|FG000|Overall Study|Death|11|||
161918134|NCT03595748|584748635|FG001|Overall Study|Death|12|||
161918135|NCT03595748|584748634|FG000|Overall Study|Withdrawal by Subject|28|||
161918136|NCT03595748|584748635|FG001|Overall Study|Withdrawal by Subject|29|||
161918137|NCT03595748|584748634|FG000|Overall Study|Protocol Violation|0|||
161918138|NCT03595748|584748635|FG001|Overall Study|Protocol Violation|1|||
161918139|NCT02328014|584748636|FG000|Overall Study|Adverse Event|1|||
161918140|NCT02328014|584748637|FG001|Overall Study|Adverse Event|0|||
161918141|NCT02328014|584748638|FG002|Overall Study|Adverse Event|0|||
161918142|NCT02328014|584748639|FG003|Overall Study|Adverse Event|1|||
161918143|NCT02328014|584748636|FG000|Overall Study|Death|0|||
161918144|NCT02328014|584748637|FG001|Overall Study|Death|0|||
161918145|NCT02328014|584748638|FG002|Overall Study|Death|0|||
161918146|NCT02328014|584748639|FG003|Overall Study|Death|4|||
161918147|NCT02328014|584748636|FG000|Overall Study|Physician Decision|0|||
161918148|NCT02328014|584748637|FG001|Overall Study|Physician Decision|0|||
161918149|NCT02328014|584748638|FG002|Overall Study|Physician Decision|0|||
161918150|NCT02328014|584748639|FG003|Overall Study|Physician Decision|1|||
161918151|NCT02328014|584748636|FG000|Overall Study|Disease Progression|1|||
161918152|NCT02328014|584748637|FG001|Overall Study|Disease Progression|0|||
161918153|NCT02328014|584748638|FG002|Overall Study|Disease Progression|1|||
161918154|NCT02328014|584748639|FG003|Overall Study|Disease Progression|3|||
161918155|NCT02328014|584748636|FG000|Overall Study|Study Terminated by Sponsor|4|||
161918156|NCT02328014|584748637|FG001|Overall Study|Study Terminated by Sponsor|1|||
161918157|NCT02328014|584748638|FG002|Overall Study|Study Terminated by Sponsor|1|||
161918158|NCT02328014|584748639|FG003|Overall Study|Study Terminated by Sponsor|0|||
161918159|NCT02328014|584748636|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
161918160|NCT02328014|584748637|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
161918161|NCT02328014|584748638|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
161918162|NCT02328014|584748639|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
161918163|NCT02328014|584748636|FG000|Overall Study|Withdrawal by Subject|0|||
161918164|NCT02328014|584748637|FG001|Overall Study|Withdrawal by Subject|0|||
161918165|NCT02328014|584748638|FG002|Overall Study|Withdrawal by Subject|0|||
161918166|NCT02328014|584748639|FG003|Overall Study|Withdrawal by Subject|1|||
161918167|NCT05028569|584748656|FG000|Double-Blind Phase|Death|0|||
161918168|NCT05028569|584748657|FG001|Double-Blind Phase|Death|0|||
161918169|NCT05028569|584748658|FG002|Double-Blind Phase|Death|0|||
161918170|NCT05028569|584748659|FG003|Double-Blind Phase|Death|1|||
161918171|NCT05028569|584748660|FG004|Double-Blind Phase|Death|0|||
161918172|NCT05028569|584748661|FG005|Double-Blind Phase|Death|0|||
161918173|NCT05028569|584748662|FG006|Double-Blind Phase|Death|0|||
161918174|NCT05028569|584748656|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161918175|NCT05028569|584748657|FG001|Double-Blind Phase|Lost to Follow-up|6|||
161918176|NCT05028569|584748658|FG002|Double-Blind Phase|Lost to Follow-up|3|||
161813704|NCT04493684|584359923|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813705|NCT04493684|584359924|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813706|NCT04493684|584359925|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813707|NCT04493684|584359926|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813708|NCT04493684|584359927|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813709|NCT04493684|584359928|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813710|NCT04493684|584359929|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813711|NCT04493684|584359930|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
161813712|NCT04493684|584359931|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161813713|NCT01056484|584361226|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
161813714|NCT01056484|584361227|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
161813715|NCT01056484|584361226|FG000|Randomized Controlled Trial|Physician Decision|1|||
161813716|NCT01056484|584361227|FG001|Randomized Controlled Trial|Physician Decision|0|||
161813717|NCT01056484|584361226|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
161813718|NCT01056484|584361227|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
161813719|NCT01440803|584361230|FG000|Overall Study|Met study stopping rule|2|||
161918177|NCT05028569|584748659|FG003|Double-Blind Phase|Lost to Follow-up|9|||
161918178|NCT05028569|584748660|FG004|Double-Blind Phase|Lost to Follow-up|0|||
161918179|NCT05028569|584748661|FG005|Double-Blind Phase|Lost to Follow-up|0|||
161918180|NCT05028569|584748662|FG006|Double-Blind Phase|Lost to Follow-up|0|||
161918181|NCT05028569|584748656|FG000|Double-Blind Phase|Protocol Deviation|0|||
161918182|NCT05028569|584748657|FG001|Double-Blind Phase|Protocol Deviation|2|||
161918183|NCT05028569|584748658|FG002|Double-Blind Phase|Protocol Deviation|0|||
161918184|NCT05028569|584748659|FG003|Double-Blind Phase|Protocol Deviation|0|||
161918185|NCT05028569|584748660|FG004|Double-Blind Phase|Protocol Deviation|0|||
161918186|NCT05028569|584748661|FG005|Double-Blind Phase|Protocol Deviation|0|||
162015341|NCT04922216|585108694|FG008|Overall Study|Lost to Follow-up|1|||
162015342|NCT04922216|585108695|FG009|Overall Study|Lost to Follow-up|2|||
162015343|NCT04922216|585108696|FG010|Overall Study|Lost to Follow-up|2|||
162015344|NCT04922216|585108697|FG011|Overall Study|Lost to Follow-up|1|||
162015345|NCT04922216|585108698|FG012|Overall Study|Lost to Follow-up|1|||
162015346|NCT04922216|585108699|FG013|Overall Study|Lost to Follow-up|0|||
162015347|NCT04922216|585108700|FG014|Overall Study|Lost to Follow-up|1|||
162015348|NCT04922216|585108701|FG015|Overall Study|Lost to Follow-up|0|||
162015349|NCT04922216|585108702|FG016|Overall Study|Lost to Follow-up|0|||
162015350|NCT04922216|585108703|FG017|Overall Study|Lost to Follow-up|2|||
162015351|NCT04922216|585108704|FG018|Overall Study|Lost to Follow-up|1|||
162015352|NCT04922216|585108705|FG019|Overall Study|Lost to Follow-up|0|||
162015353|NCT04922216|585108706|FG020|Overall Study|Lost to Follow-up|1|||
162015354|NCT04922216|585108707|FG021|Overall Study|Lost to Follow-up|0|||
162015355|NCT04922216|585108708|FG022|Overall Study|Lost to Follow-up|2|||
162015356|NCT04922216|585108709|FG023|Overall Study|Lost to Follow-up|1|||
162015357|NCT04922216|585108710|FG024|Overall Study|Lost to Follow-up|0|||
162015358|NCT04922216|585108711|FG025|Overall Study|Lost to Follow-up|2|||
162015359|NCT04922216|585108712|FG026|Overall Study|Lost to Follow-up|0|||
162015360|NCT04922216|585108713|FG027|Overall Study|Lost to Follow-up|0|||
162015361|NCT04922216|585108714|FG028|Overall Study|Lost to Follow-up|1|||
162015362|NCT04922216|585108715|FG029|Overall Study|Lost to Follow-up|0|||
162015363|NCT04922216|585108716|FG030|Overall Study|Lost to Follow-up|2|||
162015364|NCT04922216|585108717|FG031|Overall Study|Lost to Follow-up|1|||
162015365|NCT03278249|585108718|FG000|Overall Study|Withdrawal by Subject|2|||
162015366|NCT03278249|585108718|FG000|Overall Study|Lost to Follow-up|1|||
161918187|NCT05028569|584748662|FG006|Double-Blind Phase|Protocol Deviation|0|||
161918188|NCT05028569|584748656|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161918189|NCT05028569|584748657|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
161918190|NCT05028569|584748658|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
161918191|NCT05028569|584748659|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
161918192|NCT05028569|584748660|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161918193|NCT05028569|584748661|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
161918194|NCT05028569|584748662|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
162015367|NCT01442103|585110489|FG000|Overall Study|Lost to Follow-up|2|||
162015368|NCT03207763|585110495|FG000|Overall Study|Lost to Follow-up|1|||
162015369|NCT03207763|585110496|FG001|Overall Study|Lost to Follow-up|0|||
162015370|NCT02102204|585110497|FG000|Overall Study|Withdrawal by Subject|137|||
162015371|NCT02102204|585110497|FG000|Overall Study|Death|92|||
162015372|NCT02102204|585110497|FG000|Overall Study|Lost to Follow-up|65|||
162015373|NCT02102204|585110497|FG000|Overall Study|Sponsor Decision|5|||
162015374|NCT02102204|585110497|FG000|Overall Study|Ongoing|5|||
162015375|NCT02605122|585110498|FG000|Overall Study|Withdrawal by Subject|4|||
162015376|NCT02605122|585110499|FG001|Overall Study|Withdrawal by Subject|1|||
162015377|NCT02605122|585110498|FG000|Overall Study|Lost to Follow-up|1|||
162015378|NCT02605122|585110499|FG001|Overall Study|Lost to Follow-up|1|||
162015379|NCT00990704|585110500|FG000|Overall Study|Adverse Event|1|||
162015380|NCT00990704|585110501|FG001|Overall Study|Adverse Event|1|||
162015381|NCT00990704|585110500|FG000|Overall Study|Physician Decision|0|||
162015382|NCT00990704|585110501|FG001|Overall Study|Physician Decision|1|||
162015383|NCT00807001|585110503|FG000|Overall Study|Non-compliance|0|||
162015384|NCT00807001|585110504|FG001|Overall Study|Non-compliance|1|||
162015385|NCT00807001|585110505|FG002|Overall Study|Non-compliance|0|||
162015386|NCT00807001|585110506|FG003|Overall Study|Non-compliance|0|||
162015387|NCT00807001|585110507|FG004|Overall Study|Non-compliance|0|||
162015388|NCT01399372|585110509|FG000|Overall Study|Protocol Violation|3|||
162015389|NCT01399372|585110510|FG001|Overall Study|Protocol Violation|1|||
162015390|NCT03773796|585110511|FG000|Overall Study|Adverse Event|1|||
162015391|NCT03773796|585110511|FG000|Overall Study|Withdrawal by Subject|1|||
162015392|NCT03773796|585110511|FG000|Overall Study|Lack of Efficacy|1|||
162015393|NCT03805659|585110513|FG000|Overall Study|Withdrawal by Subject|0|||
162015394|NCT03805659|585110514|FG001|Overall Study|Withdrawal by Subject|1|||
162015395|NCT01027273|585110516|FG000|Overall Study|Lost to Follow-up|57|||
161918195|NCT05028569|584748656|FG000|Double-Blind Phase|Other, not specified|0|||
161918196|NCT05028569|584748657|FG001|Double-Blind Phase|Other, not specified|5|||
161918197|NCT05028569|584748658|FG002|Double-Blind Phase|Other, not specified|4|||
162015396|NCT01027273|585110517|FG001|Overall Study|Lost to Follow-up|31|||
162015397|NCT01027273|585110516|FG000|Overall Study|Death|2|||
162015398|NCT01027273|585110517|FG001|Overall Study|Death|2|||
162015399|NCT00499616|585110525|FG000|Overall Study|Death|1|||
162015400|NCT00499616|585110526|FG001|Overall Study|Death|5|||
162015401|NCT00499616|585110527|FG002|Overall Study|Death|3|||
162015402|NCT00499616|585110528|FG003|Overall Study|Death|1|||
162015403|NCT00499616|585110525|FG000|Overall Study|Lack of Efficacy|5|||
162015404|NCT00499616|585110526|FG001|Overall Study|Lack of Efficacy|0|||
161918198|NCT05028569|584748659|FG003|Double-Blind Phase|Other, not specified|6|||
162015405|NCT00499616|585110527|FG002|Overall Study|Lack of Efficacy|19|||
162015406|NCT00499616|585110528|FG003|Overall Study|Lack of Efficacy|0|||
161918199|NCT05028569|584748660|FG004|Double-Blind Phase|Other, not specified|0|||
161918200|NCT05028569|584748661|FG005|Double-Blind Phase|Other, not specified|0|||
161918201|NCT05028569|584748662|FG006|Double-Blind Phase|Other, not specified|0|||
161918202|NCT05028569|584748656|FG000|Open-Label Phase|Death|0|||
161918203|NCT05028569|584748657|FG001|Open-Label Phase|Death|0|||
161918204|NCT05028569|584748658|FG002|Open-Label Phase|Death|0|||
161918205|NCT05028569|584748659|FG003|Open-Label Phase|Death|0|||
161918206|NCT05028569|584748660|FG004|Open-Label Phase|Death|0|||
161918207|NCT05028569|584748661|FG005|Open-Label Phase|Death|0|||
161918208|NCT05028569|584748662|FG006|Open-Label Phase|Death|1|||
161918209|NCT05028569|584748656|FG000|Open-Label Phase|Lost to Follow-up|0|||
161918210|NCT05028569|584748657|FG001|Open-Label Phase|Lost to Follow-up|0|||
161918211|NCT05028569|584748658|FG002|Open-Label Phase|Lost to Follow-up|0|||
161918212|NCT05028569|584748659|FG003|Open-Label Phase|Lost to Follow-up|0|||
161918213|NCT05028569|584748660|FG004|Open-Label Phase|Lost to Follow-up|5|||
161918214|NCT05028569|584748661|FG005|Open-Label Phase|Lost to Follow-up|5|||
161918215|NCT05028569|584748662|FG006|Open-Label Phase|Lost to Follow-up|4|||
161918216|NCT05028569|584748656|FG000|Open-Label Phase|Protocol Deviation|0|||
161918217|NCT05028569|584748657|FG001|Open-Label Phase|Protocol Deviation|0|||
161918218|NCT05028569|584748658|FG002|Open-Label Phase|Protocol Deviation|0|||
161918219|NCT05028569|584748659|FG003|Open-Label Phase|Protocol Deviation|0|||
161918220|NCT05028569|584748660|FG004|Open-Label Phase|Protocol Deviation|1|||
161918221|NCT05028569|584748661|FG005|Open-Label Phase|Protocol Deviation|0|||
161918222|NCT05028569|584748662|FG006|Open-Label Phase|Protocol Deviation|0|||
161918223|NCT05028569|584748656|FG000|Open-Label Phase|Pregnancy|0|||
161918224|NCT05028569|584748657|FG001|Open-Label Phase|Pregnancy|0|||
161918225|NCT05028569|584748658|FG002|Open-Label Phase|Pregnancy|0|||
161918226|NCT05028569|584748659|FG003|Open-Label Phase|Pregnancy|0|||
161918227|NCT05028569|584748660|FG004|Open-Label Phase|Pregnancy|0|||
161918228|NCT05028569|584748661|FG005|Open-Label Phase|Pregnancy|1|||
161918229|NCT05028569|584748662|FG006|Open-Label Phase|Pregnancy|0|||
161918230|NCT05028569|584748656|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161918231|NCT05028569|584748657|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161918232|NCT05028569|584748658|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161918233|NCT05028569|584748659|FG003|Open-Label Phase|Withdrawal by Subject|0|||
161918234|NCT05028569|584748660|FG004|Open-Label Phase|Withdrawal by Subject|15|||
161918235|NCT05028569|584748661|FG005|Open-Label Phase|Withdrawal by Subject|8|||
161918236|NCT05028569|584748662|FG006|Open-Label Phase|Withdrawal by Subject|13|||
161918237|NCT05028569|584748656|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
161918238|NCT05028569|584748657|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
161918239|NCT05028569|584748658|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
161918240|NCT05028569|584748659|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
161918241|NCT05028569|584748660|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
161918242|NCT05028569|584748661|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
161918243|NCT05028569|584748662|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
161918244|NCT05028569|584748656|FG000|Open-Label Phase|Other, not specified|0|||
161918245|NCT05028569|584748657|FG001|Open-Label Phase|Other, not specified|0|||
161918246|NCT05028569|584748658|FG002|Open-Label Phase|Other, not specified|0|||
161918247|NCT05028569|584748659|FG003|Open-Label Phase|Other, not specified|0|||
161918248|NCT05028569|584748660|FG004|Open-Label Phase|Other, not specified|6|||
161918249|NCT05028569|584748661|FG005|Open-Label Phase|Other, not specified|5|||
161918250|NCT05028569|584748662|FG006|Open-Label Phase|Other, not specified|7|||
161918251|NCT05028569|584748656|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161918252|NCT05028569|584748657|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161918253|NCT05028569|584748658|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161918254|NCT05028569|584748659|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161918255|NCT05028569|584748660|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161918256|NCT05028569|584748661|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
161918257|NCT05028569|584748662|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161918258|NCT05028569|584748656|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161918259|NCT05028569|584748657|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161918260|NCT05028569|584748658|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161918261|NCT05028569|584748659|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161918262|NCT05028569|584748660|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161918263|NCT05028569|584748661|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161918264|NCT05028569|584748662|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
161918265|NCT04609553|584748663|FG000|Overall Study|Lost to Follow-up|27|||
161918266|NCT04609553|584748664|FG001|Overall Study|Lost to Follow-up|31|||
161918267|NCT04609553|584748665|FG002|Overall Study|Lost to Follow-up|24|||
161918268|NCT04609553|584748663|FG000|Overall Study|Discontinued|12|||
161918269|NCT04609553|584748664|FG001|Overall Study|Discontinued|10|||
161918270|NCT04609553|584748665|FG002|Overall Study|Discontinued|9|||
161918271|NCT01240746|584748666|FG000|Overall Study|Adverse Event|2|||
161918272|NCT01240746|584748667|FG001|Overall Study|Adverse Event|0|||
161918273|NCT01240746|584748668|FG002|Overall Study|Adverse Event|10|||
161918274|NCT01240746|584748666|FG000|Overall Study|Lost to Follow-up|23|||
161918275|NCT01240746|584748667|FG001|Overall Study|Lost to Follow-up|20|||
161918276|NCT01240746|584748668|FG002|Overall Study|Lost to Follow-up|102|||
161918277|NCT01240746|584748666|FG000|Overall Study|Protocol Violation|24|||
161918278|NCT01240746|584748667|FG001|Overall Study|Protocol Violation|15|||
161918279|NCT01240746|584748668|FG002|Overall Study|Protocol Violation|72|||
161918280|NCT01240746|584748666|FG000|Overall Study|Withdrawal by Subject|10|||
161918281|NCT01240746|584748667|FG001|Overall Study|Withdrawal by Subject|13|||
161918282|NCT01240746|584748668|FG002|Overall Study|Withdrawal by Subject|59|||
161918283|NCT01136954|584748669|FG000|Overall Study|Adverse Event|3|||
161918284|NCT01136954|584748670|FG001|Overall Study|Adverse Event|2|||
161918285|NCT01136954|584748669|FG000|Overall Study|Withdrawal by Subject|6|||
161918286|NCT01136954|584748670|FG001|Overall Study|Withdrawal by Subject|2|||
161918287|NCT01136954|584748669|FG000|Overall Study|Lack of Efficacy|14|||
161918288|NCT01136954|584748670|FG001|Overall Study|Lack of Efficacy|13|||
161918289|NCT01136954|584748669|FG000|Overall Study|Physician Decision|0|||
161918290|NCT01136954|584748670|FG001|Overall Study|Physician Decision|1|||
161918291|NCT01136954|584748669|FG000|Overall Study|Other|1|||
161918292|NCT01136954|584748670|FG001|Overall Study|Other|3|||
161918293|NCT02362451|584748688|FG000|Overall Study|Withdrawal by Subject|0|||
161918294|NCT02362451|584748689|FG001|Overall Study|Withdrawal by Subject|1|||
161918295|NCT02362451|584748688|FG000|Overall Study|Lack of Efficacy|2|||
161918296|NCT02362451|584748689|FG001|Overall Study|Lack of Efficacy|0|||
161918297|NCT02362451|584748688|FG000|Overall Study|Progression|1|||
161918298|NCT02362451|584748689|FG001|Overall Study|Progression|0|||
161918299|NCT02362451|584748688|FG000|Overall Study|Participant chose other therapy.|1|||
161918300|NCT02362451|584748689|FG001|Overall Study|Participant chose other therapy.|0|||
161918301|NCT02239328|584748692|FG000|Overall Study|Benign disease noted at time of surgery|6|||
161918302|NCT02239328|584748692|FG000|Overall Study|Equipment or website malfunction|2|||
161918303|NCT02278354|584748697|FG000|Overall Study|Lost to Follow-up|2|||
161918304|NCT02278354|584748698|FG001|Overall Study|Lost to Follow-up|2|||
161918305|NCT02278354|584748697|FG000|Overall Study|Withdrawal by Subject|0|||
161918306|NCT02278354|584748698|FG001|Overall Study|Withdrawal by Subject|1|||
161918307|NCT02278354|584748697|FG000|Overall Study|<10 professional fights|2|||
161918308|NCT02278354|584748698|FG001|Overall Study|<10 professional fights|0|||
161918309|NCT01925794|584748703|FG000|180 Days|Death|2|||
161918310|NCT01925794|584748703|FG000|180 Days|Withdrawal by Subject|2|||
161918311|NCT01925794|584748703|FG000|270 Days|Death|2|||
161918312|NCT01925794|584748703|FG000|270 Days|Protocol Violation|3|||
161918313|NCT01901562|584748704|FG000|Overall Study|Protocol Violation|5|||
161918314|NCT01901562|584748704|FG000|Overall Study|Excluded intraoperatively|4|||
161918315|NCT03126110|584748705|FG000|Phase 1|Death|2|||
161918316|NCT03126110|584748706|FG001|Phase 1|Death|2|||
161918317|NCT03126110|584748707|FG002|Phase 1|Death|4|||
161918318|NCT03126110|584748708|FG003|Phase 1|Death|3|||
161918319|NCT03126110|584748709|FG004|Phase 1|Death|4|||
161918320|NCT03126110|584748710|FG005|Phase 1|Death|4|||
161918321|NCT03126110|584748711|FG006|Phase 1|Death|3|||
161918322|NCT03126110|584748712|FG007|Phase 1|Death|4|||
161918323|NCT03126110|584748713|FG008|Phase 1|Death|5|||
161918324|NCT03126110|584748714|FG009|Phase 1|Death|2|||
161918325|NCT03126110|584748715|FG010|Phase 1|Death|6|||
161918326|NCT03126110|584748716|FG011|Phase 1|Death|0|||
161918327|NCT03126110|584748717|FG012|Phase 1|Death|0|||
161918328|NCT03126110|584748718|FG013|Phase 1|Death|0|||
161918329|NCT03126110|584748719|FG014|Phase 1|Death|0|||
161918330|NCT03126110|584748720|FG015|Phase 1|Death|0|||
161918331|NCT03126110|584748721|FG016|Phase 1|Death|0|||
161918332|NCT03126110|584748705|FG000|Phase 1|Lost to Follow-up|0|||
162015407|NCT00499616|585110525|FG000|Overall Study|Lost to Follow-up|0|||
162015408|NCT00499616|585110526|FG001|Overall Study|Lost to Follow-up|0|||
162015409|NCT00499616|585110527|FG002|Overall Study|Lost to Follow-up|1|||
162015410|NCT00499616|585110528|FG003|Overall Study|Lost to Follow-up|0|||
161918333|NCT03126110|584748706|FG001|Phase 1|Lost to Follow-up|1|||
161918334|NCT03126110|584748707|FG002|Phase 1|Lost to Follow-up|0|||
161918335|NCT03126110|584748708|FG003|Phase 1|Lost to Follow-up|0|||
161918336|NCT03126110|584748709|FG004|Phase 1|Lost to Follow-up|0|||
161918337|NCT03126110|584748710|FG005|Phase 1|Lost to Follow-up|0|||
161918338|NCT03126110|584748711|FG006|Phase 1|Lost to Follow-up|0|||
162015411|NCT00499616|585110525|FG000|Overall Study|Physician Decision|6|||
161918339|NCT03126110|584748712|FG007|Phase 1|Lost to Follow-up|0|||
161918340|NCT03126110|584748713|FG008|Phase 1|Lost to Follow-up|1|||
161918341|NCT03126110|584748714|FG009|Phase 1|Lost to Follow-up|0|||
161918342|NCT03126110|584748715|FG010|Phase 1|Lost to Follow-up|0|||
161918343|NCT03126110|584748716|FG011|Phase 1|Lost to Follow-up|0|||
161918344|NCT03126110|584748717|FG012|Phase 1|Lost to Follow-up|0|||
161918345|NCT03126110|584748718|FG013|Phase 1|Lost to Follow-up|0|||
161918346|NCT03126110|584748719|FG014|Phase 1|Lost to Follow-up|0|||
161918347|NCT03126110|584748720|FG015|Phase 1|Lost to Follow-up|0|||
161918348|NCT03126110|584748721|FG016|Phase 1|Lost to Follow-up|0|||
161918349|NCT03126110|584748705|FG000|Phase 1|Withdrawal by Subject|1|||
161918350|NCT03126110|584748706|FG001|Phase 1|Withdrawal by Subject|0|||
161918351|NCT03126110|584748707|FG002|Phase 1|Withdrawal by Subject|0|||
161918352|NCT03126110|584748708|FG003|Phase 1|Withdrawal by Subject|1|||
161918353|NCT03126110|584748709|FG004|Phase 1|Withdrawal by Subject|1|||
161918354|NCT03126110|584748710|FG005|Phase 1|Withdrawal by Subject|0|||
161918355|NCT03126110|584748711|FG006|Phase 1|Withdrawal by Subject|0|||
161918356|NCT03126110|584748712|FG007|Phase 1|Withdrawal by Subject|0|||
161918357|NCT03126110|584748713|FG008|Phase 1|Withdrawal by Subject|2|||
161918358|NCT03126110|584748714|FG009|Phase 1|Withdrawal by Subject|1|||
161918359|NCT03126110|584748715|FG010|Phase 1|Withdrawal by Subject|0|||
161918360|NCT03126110|584748716|FG011|Phase 1|Withdrawal by Subject|0|||
161918361|NCT03126110|584748717|FG012|Phase 1|Withdrawal by Subject|0|||
161918362|NCT03126110|584748718|FG013|Phase 1|Withdrawal by Subject|0|||
161918363|NCT03126110|584748719|FG014|Phase 1|Withdrawal by Subject|0|||
161918364|NCT03126110|584748720|FG015|Phase 1|Withdrawal by Subject|0|||
161918365|NCT03126110|584748721|FG016|Phase 1|Withdrawal by Subject|0|||
161918366|NCT03126110|584748705|FG000|Phase 1|Safety follow-up no longer necessary|1|||
161918367|NCT03126110|584748706|FG001|Phase 1|Safety follow-up no longer necessary|0|||
161918368|NCT03126110|584748707|FG002|Phase 1|Safety follow-up no longer necessary|0|||
161918369|NCT03126110|584748708|FG003|Phase 1|Safety follow-up no longer necessary|0|||
161918370|NCT03126110|584748709|FG004|Phase 1|Safety follow-up no longer necessary|0|||
161918371|NCT03126110|584748710|FG005|Phase 1|Safety follow-up no longer necessary|0|||
161918372|NCT03126110|584748711|FG006|Phase 1|Safety follow-up no longer necessary|0|||
161918373|NCT03126110|584748712|FG007|Phase 1|Safety follow-up no longer necessary|0|||
161918374|NCT03126110|584748713|FG008|Phase 1|Safety follow-up no longer necessary|0|||
161918375|NCT03126110|584748714|FG009|Phase 1|Safety follow-up no longer necessary|0|||
161918376|NCT03126110|584748715|FG010|Phase 1|Safety follow-up no longer necessary|0|||
161918377|NCT03126110|584748716|FG011|Phase 1|Safety follow-up no longer necessary|0|||
161918378|NCT03126110|584748717|FG012|Phase 1|Safety follow-up no longer necessary|0|||
161918379|NCT03126110|584748718|FG013|Phase 1|Safety follow-up no longer necessary|0|||
161918380|NCT03126110|584748719|FG014|Phase 1|Safety follow-up no longer necessary|0|||
161918381|NCT03126110|584748720|FG015|Phase 1|Safety follow-up no longer necessary|0|||
161918382|NCT03126110|584748721|FG016|Phase 1|Safety follow-up no longer necessary|0|||
161918383|NCT03126110|584748705|FG000|Phase 1|Survival follow-up no longer necessary|0|||
161918384|NCT03126110|584748706|FG001|Phase 1|Survival follow-up no longer necessary|0|||
161918385|NCT03126110|584748707|FG002|Phase 1|Survival follow-up no longer necessary|1|||
161918386|NCT03126110|584748708|FG003|Phase 1|Survival follow-up no longer necessary|0|||
161918387|NCT03126110|584748709|FG004|Phase 1|Survival follow-up no longer necessary|0|||
161918388|NCT03126110|584748710|FG005|Phase 1|Survival follow-up no longer necessary|0|||
161918389|NCT03126110|584748711|FG006|Phase 1|Survival follow-up no longer necessary|0|||
161918390|NCT03126110|584748712|FG007|Phase 1|Survival follow-up no longer necessary|0|||
161918391|NCT03126110|584748713|FG008|Phase 1|Survival follow-up no longer necessary|0|||
161918392|NCT03126110|584748714|FG009|Phase 1|Survival follow-up no longer necessary|0|||
161918393|NCT03126110|584748715|FG010|Phase 1|Survival follow-up no longer necessary|0|||
162015412|NCT00499616|585110526|FG001|Overall Study|Physician Decision|16|||
162015413|NCT00499616|585110527|FG002|Overall Study|Physician Decision|9|||
162015414|NCT00499616|585110528|FG003|Overall Study|Physician Decision|0|||
162015415|NCT00499616|585110525|FG000|Overall Study|Withdrawal by Subject|1|||
162015416|NCT00499616|585110526|FG001|Overall Study|Withdrawal by Subject|0|||
162015417|NCT00499616|585110527|FG002|Overall Study|Withdrawal by Subject|1|||
162015418|NCT00499616|585110528|FG003|Overall Study|Withdrawal by Subject|0|||
162015419|NCT00499616|585110525|FG000|Overall Study|Ineligible|1|||
162015420|NCT00499616|585110526|FG001|Overall Study|Ineligible|2|||
162015421|NCT00499616|585110527|FG002|Overall Study|Ineligible|0|||
162015422|NCT00499616|585110528|FG003|Overall Study|Ineligible|15|||
162015423|NCT00499616|585110525|FG000|Overall Study|Not evaluable|0|||
162015424|NCT00499616|585110526|FG001|Overall Study|Not evaluable|0|||
162015425|NCT00499616|585110527|FG002|Overall Study|Not evaluable|0|||
162015426|NCT00499616|585110528|FG003|Overall Study|Not evaluable|41|||
162015427|NCT00499616|585110525|FG000|Overall Study|Patient/Parent Refusal|1|||
162015428|NCT00499616|585110526|FG001|Overall Study|Patient/Parent Refusal|5|||
162015429|NCT00499616|585110527|FG002|Overall Study|Patient/Parent Refusal|3|||
162015430|NCT00499616|585110528|FG003|Overall Study|Patient/Parent Refusal|0|||
162015431|NCT02636595|585110529|FG000|Overall Study|Lost to Follow-up|1|||
162015432|NCT02636595|585110529|FG000|Overall Study|Other|1|||
162015433|NCT02223858|585110530|FG000|Overall Study|Death|1|||
162015434|NCT02223858|585110531|FG001|Overall Study|Death|1|||
162015435|NCT02223858|585110530|FG000|Overall Study|Lost to Follow-up|6|||
161918394|NCT03126110|584748716|FG011|Phase 1|Survival follow-up no longer necessary|0|||
161918395|NCT03126110|584748717|FG012|Phase 1|Survival follow-up no longer necessary|0|||
161918396|NCT03126110|584748718|FG013|Phase 1|Survival follow-up no longer necessary|0|||
162015436|NCT02223858|585110531|FG001|Overall Study|Lost to Follow-up|11|||
162015437|NCT02223858|585110530|FG000|Overall Study|Withdrawal by Subject|8|||
162015438|NCT02223858|585110531|FG001|Overall Study|Withdrawal by Subject|5|||
162015439|NCT02223858|585110530|FG000|Overall Study|Refused|9|||
162015440|NCT02223858|585110531|FG001|Overall Study|Refused|9|||
162015441|NCT00241839|585110533|FG000|Overall Study|Withdrawal by Subject|18|||
162015442|NCT00241839|585110534|FG001|Overall Study|Withdrawal by Subject|17|||
162015443|NCT00241839|585110533|FG000|Overall Study|Adverse Event|1|||
161918397|NCT03126110|584748719|FG014|Phase 1|Survival follow-up no longer necessary|0|||
161918398|NCT03126110|584748720|FG015|Phase 1|Survival follow-up no longer necessary|0|||
161918399|NCT03126110|584748721|FG016|Phase 1|Survival follow-up no longer necessary|0|||
161918400|NCT03126110|584748705|FG000|Phase 2|Study terminated by the sponsor|0|||
161918401|NCT03126110|584748706|FG001|Phase 2|Study terminated by the sponsor|0|||
161918402|NCT03126110|584748707|FG002|Phase 2|Study terminated by the sponsor|0|||
161918403|NCT03126110|584748708|FG003|Phase 2|Study terminated by the sponsor|0|||
161918404|NCT03126110|584748709|FG004|Phase 2|Study terminated by the sponsor|0|||
161918405|NCT03126110|584748710|FG005|Phase 2|Study terminated by the sponsor|0|||
161918406|NCT03126110|584748711|FG006|Phase 2|Study terminated by the sponsor|0|||
161918407|NCT03126110|584748712|FG007|Phase 2|Study terminated by the sponsor|0|||
161918408|NCT03126110|584748713|FG008|Phase 2|Study terminated by the sponsor|0|||
161918409|NCT03126110|584748714|FG009|Phase 2|Study terminated by the sponsor|0|||
161918410|NCT03126110|584748715|FG010|Phase 2|Study terminated by the sponsor|0|||
161918411|NCT03126110|584748716|FG011|Phase 2|Study terminated by the sponsor|0|||
161918412|NCT03126110|584748717|FG012|Phase 2|Study terminated by the sponsor|0|||
161918413|NCT03126110|584748718|FG013|Phase 2|Study terminated by the sponsor|4|||
161918414|NCT03126110|584748719|FG014|Phase 2|Study terminated by the sponsor|0|||
161918415|NCT03126110|584748720|FG015|Phase 2|Study terminated by the sponsor|0|||
161918416|NCT03126110|584748721|FG016|Phase 2|Study terminated by the sponsor|0|||
161918417|NCT03126110|584748705|FG000|Phase 2|Withdrawal by Subject|0|||
161918418|NCT03126110|584748706|FG001|Phase 2|Withdrawal by Subject|0|||
161918419|NCT03126110|584748707|FG002|Phase 2|Withdrawal by Subject|0|||
161918420|NCT03126110|584748708|FG003|Phase 2|Withdrawal by Subject|0|||
161918421|NCT03126110|584748709|FG004|Phase 2|Withdrawal by Subject|0|||
161918422|NCT03126110|584748710|FG005|Phase 2|Withdrawal by Subject|0|||
161918423|NCT03126110|584748711|FG006|Phase 2|Withdrawal by Subject|0|||
161918424|NCT03126110|584748712|FG007|Phase 2|Withdrawal by Subject|0|||
161918425|NCT03126110|584748713|FG008|Phase 2|Withdrawal by Subject|0|||
161918426|NCT03126110|584748714|FG009|Phase 2|Withdrawal by Subject|0|||
161918427|NCT03126110|584748715|FG010|Phase 2|Withdrawal by Subject|0|||
161918428|NCT03126110|584748716|FG011|Phase 2|Withdrawal by Subject|1|||
161918429|NCT03126110|584748717|FG012|Phase 2|Withdrawal by Subject|3|||
161918430|NCT03126110|584748718|FG013|Phase 2|Withdrawal by Subject|3|||
161918431|NCT03126110|584748719|FG014|Phase 2|Withdrawal by Subject|2|||
162015444|NCT00241839|585110534|FG001|Overall Study|Adverse Event|1|||
162015445|NCT00831181|585110537|FG000|Overall Study|Adverse Event|12|||
162015446|NCT04313244|585110538|FG000|Overall Study|Withdrawal of Consent|3|||
162015447|NCT04313244|585110539|FG001|Overall Study|Withdrawal of Consent|3|||
161813720|NCT01440803|584361231|FG001|Overall Study|Met study stopping rule|1|||
161813721|NCT01440803|584361230|FG000|Overall Study|Lost to Follow-up|0|||
161813722|NCT01440803|584361231|FG001|Overall Study|Lost to Follow-up|2|||
161813723|NCT01440803|584361230|FG000|Overall Study|Withdrawal by Subject|0|||
161813724|NCT01440803|584361231|FG001|Overall Study|Withdrawal by Subject|1|||
161813725|NCT02197416|584361234|FG000|Overall Study|Other reasons|0|||
161813726|NCT02197416|584361235|FG001|Overall Study|Other reasons|2|||
161813727|NCT02197416|584361236|FG002|Overall Study|Other reasons|5|||
161813728|NCT02197416|584361234|FG000|Overall Study|Withdrawal by Subject|0|||
161813729|NCT02197416|584361235|FG001|Overall Study|Withdrawal by Subject|2|||
161813730|NCT02197416|584361236|FG002|Overall Study|Withdrawal by Subject|1|||
161813731|NCT02197416|584361234|FG000|Overall Study|Protocol Violation|1|||
161813732|NCT02197416|584361235|FG001|Overall Study|Protocol Violation|0|||
161813733|NCT02197416|584361236|FG002|Overall Study|Protocol Violation|1|||
161813734|NCT02197416|584361234|FG000|Overall Study|Adverse Event|0|||
161813735|NCT02197416|584361235|FG001|Overall Study|Adverse Event|0|||
161813736|NCT02197416|584361236|FG002|Overall Study|Adverse Event|1|||
161813737|NCT01492439|584361237|FG000|Overall Study|Withdrew from RTE|4|||
161813738|NCT01492439|584361238|FG001|Overall Study|Withdrew from RTE|9|||
161813739|NCT00716625|584361239|FG000|Overall Study|Safety was not Assessable|1|||
161813740|NCT04349267|584361240|FG000|Overall Study|Adverse Event|0|||
161813741|NCT04349267|584361241|FG001|Overall Study|Adverse Event|0|||
161813742|NCT04349267|584361242|FG002|Overall Study|Adverse Event|0|||
161813743|NCT04349267|584361243|FG003|Overall Study|Adverse Event|0|||
161813744|NCT04349267|584361244|FG004|Overall Study|Adverse Event|0|||
161813745|NCT04349267|584361245|FG005|Overall Study|Adverse Event|1|||
161813746|NCT04349267|584361246|FG006|Overall Study|Adverse Event|0|||
161813747|NCT04349267|584361240|FG000|Overall Study|Other reason|0|||
161813748|NCT04349267|584361241|FG001|Overall Study|Other reason|1|||
161813749|NCT04349267|584361242|FG002|Overall Study|Other reason|0|||
161813750|NCT04349267|584361243|FG003|Overall Study|Other reason|0|||
161918432|NCT03126110|584748720|FG015|Phase 2|Withdrawal by Subject|1|||
161918433|NCT03126110|584748721|FG016|Phase 2|Withdrawal by Subject|0|||
161918434|NCT03126110|584748705|FG000|Phase 2|Lost to Follow-up|0|||
161813751|NCT04349267|584361244|FG004|Overall Study|Other reason|1|||
161813752|NCT04349267|584361245|FG005|Overall Study|Other reason|1|||
161813753|NCT04349267|584361246|FG006|Overall Study|Other reason|1|||
161813754|NCT04349267|584361240|FG000|Overall Study|Disease Progression|2|||
161813755|NCT04349267|584361241|FG001|Overall Study|Disease Progression|0|||
161813756|NCT04349267|584361242|FG002|Overall Study|Disease Progression|2|||
161813757|NCT04349267|584361243|FG003|Overall Study|Disease Progression|3|||
161813758|NCT04349267|584361244|FG004|Overall Study|Disease Progression|3|||
161813759|NCT04349267|584361245|FG005|Overall Study|Disease Progression|7|||
161813760|NCT04349267|584361246|FG006|Overall Study|Disease Progression|10|||
161813761|NCT04349267|584361240|FG000|Overall Study|Participant withdrew consent|0|||
161813762|NCT04349267|584361241|FG001|Overall Study|Participant withdrew consent|1|||
161813763|NCT04349267|584361242|FG002|Overall Study|Participant withdrew consent|0|||
161813764|NCT04349267|584361243|FG003|Overall Study|Participant withdrew consent|0|||
161813765|NCT04349267|584361244|FG004|Overall Study|Participant withdrew consent|0|||
161813766|NCT04349267|584361245|FG005|Overall Study|Participant withdrew consent|0|||
161813767|NCT04349267|584361246|FG006|Overall Study|Participant withdrew consent|1|||
161813768|NCT03689400|584361247|FG000|Overall Study|Lost to Follow-up|4|||
161813769|NCT01204294|584361248|FG000|Overall Study|Adverse Event|2|||
161813770|NCT01204294|584361249|FG001|Overall Study|Adverse Event|6|||
161813771|NCT01204294|584361250|FG002|Overall Study|Adverse Event|0|||
161813772|NCT01204294|584361251|FG003|Overall Study|Adverse Event|7|||
161813773|NCT01204294|584361252|FG004|Overall Study|Adverse Event|1|||
161813774|NCT01204294|584361253|FG005|Overall Study|Adverse Event|4|||
161813775|NCT01204294|584361254|FG006|Overall Study|Adverse Event|0|||
161813776|NCT01204294|584361248|FG000|Overall Study|Protocol Violation|1|||
161813777|NCT01204294|584361249|FG001|Overall Study|Protocol Violation|0|||
161813778|NCT01204294|584361250|FG002|Overall Study|Protocol Violation|2|||
161813779|NCT01204294|584361251|FG003|Overall Study|Protocol Violation|1|||
161813780|NCT01204294|584361252|FG004|Overall Study|Protocol Violation|0|||
161813781|NCT01204294|584361253|FG005|Overall Study|Protocol Violation|0|||
161813782|NCT01204294|584361254|FG006|Overall Study|Protocol Violation|0|||
161813783|NCT01204294|584361248|FG000|Overall Study|Withdrawal by Subject|0|||
161813784|NCT01204294|584361249|FG001|Overall Study|Withdrawal by Subject|2|||
161813785|NCT01204294|584361250|FG002|Overall Study|Withdrawal by Subject|2|||
161813786|NCT01204294|584361251|FG003|Overall Study|Withdrawal by Subject|1|||
161813787|NCT01204294|584361252|FG004|Overall Study|Withdrawal by Subject|1|||
161813788|NCT01204294|584361253|FG005|Overall Study|Withdrawal by Subject|1|||
161813789|NCT01204294|584361254|FG006|Overall Study|Withdrawal by Subject|2|||
161813790|NCT01204294|584361248|FG000|Overall Study|Lack of Efficacy|0|||
161813791|NCT01204294|584361249|FG001|Overall Study|Lack of Efficacy|0|||
161813792|NCT01204294|584361250|FG002|Overall Study|Lack of Efficacy|0|||
161813793|NCT01204294|584361251|FG003|Overall Study|Lack of Efficacy|2|||
161813794|NCT01204294|584361252|FG004|Overall Study|Lack of Efficacy|0|||
161813795|NCT01204294|584361253|FG005|Overall Study|Lack of Efficacy|0|||
161813796|NCT01204294|584361254|FG006|Overall Study|Lack of Efficacy|0|||
161813797|NCT01204294|584361248|FG000|Overall Study|Other (house moving)|0|||
161813798|NCT01204294|584361249|FG001|Overall Study|Other (house moving)|0|||
161813799|NCT01204294|584361250|FG002|Overall Study|Other (house moving)|1|||
161813800|NCT01204294|584361251|FG003|Overall Study|Other (house moving)|0|||
161813801|NCT01204294|584361252|FG004|Overall Study|Other (house moving)|0|||
161813802|NCT01204294|584361253|FG005|Overall Study|Other (house moving)|0|||
161813803|NCT01204294|584361254|FG006|Overall Study|Other (house moving)|0|||
161813804|NCT03128723|584361255|FG000|Overall Study|Withdrawal by Subject|2|||
161813805|NCT04618211|584361256|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
161813806|NCT04618211|584361257|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
161813807|NCT04618211|584361258|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
161813808|NCT04618211|584361256|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
161813809|NCT04618211|584361257|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
161813810|NCT04618211|584361258|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
161813811|NCT04618211|584361256|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
161813812|NCT04618211|584361257|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
161813813|NCT04618211|584361258|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
161813814|NCT02075463|584361259|FG000|Overall Study|Adverse Event|3|||
161813815|NCT02075463|584361259|FG000|Overall Study|Par. reached stopping criteria|4|||
161813816|NCT02075463|584361259|FG000|Overall Study|Withdrawal by Subject|1|||
161813817|NCT00673660|584361260|FG000|Overall Study|Lost to Follow-up|107|||
161813818|NCT01527006|584361261|FG000|Core Study|Adverse Event|0|||
161813819|NCT01527006|584361262|FG001|Core Study|Adverse Event|2|||
161813820|NCT01527006|584361261|FG000|Core Study|Lost to Follow-up|0|||
161813821|NCT01527006|584361262|FG001|Core Study|Lost to Follow-up|1|||
161813822|NCT01527006|584361261|FG000|Core Study|Subject Choice|1|||
161813823|NCT01527006|584361262|FG001|Core Study|Subject Choice|0|||
161918435|NCT03126110|584748706|FG001|Phase 2|Lost to Follow-up|0|||
161918436|NCT03126110|584748707|FG002|Phase 2|Lost to Follow-up|0|||
161918437|NCT03126110|584748708|FG003|Phase 2|Lost to Follow-up|0|||
161918438|NCT03126110|584748709|FG004|Phase 2|Lost to Follow-up|0|||
161918439|NCT03126110|584748710|FG005|Phase 2|Lost to Follow-up|0|||
161918440|NCT03126110|584748711|FG006|Phase 2|Lost to Follow-up|0|||
161918441|NCT03126110|584748712|FG007|Phase 2|Lost to Follow-up|0|||
161918442|NCT03126110|584748713|FG008|Phase 2|Lost to Follow-up|0|||
161918443|NCT03126110|584748714|FG009|Phase 2|Lost to Follow-up|0|||
161918444|NCT03126110|584748715|FG010|Phase 2|Lost to Follow-up|0|||
161918445|NCT03126110|584748716|FG011|Phase 2|Lost to Follow-up|1|||
161918446|NCT03126110|584748717|FG012|Phase 2|Lost to Follow-up|1|||
161918447|NCT03126110|584748718|FG013|Phase 2|Lost to Follow-up|1|||
161918448|NCT03126110|584748719|FG014|Phase 2|Lost to Follow-up|2|||
161918449|NCT03126110|584748720|FG015|Phase 2|Lost to Follow-up|0|||
161918450|NCT03126110|584748721|FG016|Phase 2|Lost to Follow-up|0|||
161918451|NCT03126110|584748705|FG000|Phase 2|Death|0|||
161918452|NCT03126110|584748706|FG001|Phase 2|Death|0|||
161918453|NCT03126110|584748707|FG002|Phase 2|Death|0|||
161918454|NCT03126110|584748708|FG003|Phase 2|Death|0|||
161918455|NCT03126110|584748709|FG004|Phase 2|Death|0|||
161918456|NCT03126110|584748710|FG005|Phase 2|Death|0|||
161918457|NCT03126110|584748711|FG006|Phase 2|Death|0|||
161918458|NCT03126110|584748712|FG007|Phase 2|Death|0|||
161918459|NCT03126110|584748713|FG008|Phase 2|Death|0|||
161918460|NCT03126110|584748714|FG009|Phase 2|Death|0|||
161918461|NCT03126110|584748715|FG010|Phase 2|Death|0|||
161918462|NCT03126110|584748716|FG011|Phase 2|Death|6|||
161918463|NCT03126110|584748717|FG012|Phase 2|Death|12|||
161918464|NCT03126110|584748718|FG013|Phase 2|Death|25|||
161918465|NCT03126110|584748719|FG014|Phase 2|Death|11|||
161918466|NCT03126110|584748720|FG015|Phase 2|Death|3|||
161918467|NCT03126110|584748721|FG016|Phase 2|Death|2|||
161918468|NCT03126110|584748705|FG000|Phase 2|Progressive Disease|0|||
161918469|NCT03126110|584748706|FG001|Phase 2|Progressive Disease|0|||
161918470|NCT03126110|584748707|FG002|Phase 2|Progressive Disease|0|||
161918471|NCT03126110|584748708|FG003|Phase 2|Progressive Disease|0|||
161918472|NCT03126110|584748709|FG004|Phase 2|Progressive Disease|0|||
161918473|NCT03126110|584748710|FG005|Phase 2|Progressive Disease|0|||
161918474|NCT03126110|584748711|FG006|Phase 2|Progressive Disease|0|||
161918475|NCT03126110|584748712|FG007|Phase 2|Progressive Disease|0|||
161918476|NCT03126110|584748713|FG008|Phase 2|Progressive Disease|0|||
161918477|NCT03126110|584748714|FG009|Phase 2|Progressive Disease|0|||
161918478|NCT03126110|584748715|FG010|Phase 2|Progressive Disease|0|||
161918479|NCT03126110|584748716|FG011|Phase 2|Progressive Disease|0|||
161918480|NCT03126110|584748717|FG012|Phase 2|Progressive Disease|0|||
161918481|NCT03126110|584748718|FG013|Phase 2|Progressive Disease|1|||
161918482|NCT03126110|584748719|FG014|Phase 2|Progressive Disease|0|||
161918483|NCT03126110|584748720|FG015|Phase 2|Progressive Disease|0|||
161918484|NCT03126110|584748721|FG016|Phase 2|Progressive Disease|0|||
161918485|NCT03126110|584748705|FG000|Phase 2|Started new treatment|0|||
161918486|NCT03126110|584748706|FG001|Phase 2|Started new treatment|0|||
161918487|NCT03126110|584748707|FG002|Phase 2|Started new treatment|0|||
161918488|NCT03126110|584748708|FG003|Phase 2|Started new treatment|0|||
161918489|NCT03126110|584748709|FG004|Phase 2|Started new treatment|0|||
161918490|NCT03126110|584748710|FG005|Phase 2|Started new treatment|0|||
161918491|NCT03126110|584748711|FG006|Phase 2|Started new treatment|0|||
161918492|NCT03126110|584748712|FG007|Phase 2|Started new treatment|0|||
161918493|NCT03126110|584748713|FG008|Phase 2|Started new treatment|0|||
161918494|NCT03126110|584748714|FG009|Phase 2|Started new treatment|0|||
161918495|NCT03126110|584748715|FG010|Phase 2|Started new treatment|0|||
161918496|NCT03126110|584748716|FG011|Phase 2|Started new treatment|0|||
161918497|NCT03126110|584748717|FG012|Phase 2|Started new treatment|0|||
161918498|NCT03126110|584748718|FG013|Phase 2|Started new treatment|0|||
161918499|NCT03126110|584748719|FG014|Phase 2|Started new treatment|1|||
161918500|NCT03126110|584748720|FG015|Phase 2|Started new treatment|0|||
161918501|NCT03126110|584748721|FG016|Phase 2|Started new treatment|0|||
161918502|NCT00314145|584748722|FG000|Overall Study|Withdrawal by Subject|8|||
161918503|NCT00314145|584748723|FG001|Overall Study|Withdrawal by Subject|10|||
161918504|NCT00314145|584748722|FG000|Overall Study|Lost to Follow-up|5|||
161918505|NCT00314145|584748723|FG001|Overall Study|Lost to Follow-up|12|||
161918506|NCT00314145|584748722|FG000|Overall Study|Physician Decision|3|||
161918507|NCT00314145|584748723|FG001|Overall Study|Physician Decision|4|||
161918508|NCT00314145|584748722|FG000|Overall Study|Adverse Event|0|||
161918509|NCT00314145|584748723|FG001|Overall Study|Adverse Event|3|||
161918510|NCT00314145|584748722|FG000|Overall Study|Protocol Violation|3|||
161918511|NCT00314145|584748723|FG001|Overall Study|Protocol Violation|0|||
161918512|NCT00314145|584748722|FG000|Overall Study|Sponsor Decision|2|||
161918513|NCT00314145|584748723|FG001|Overall Study|Sponsor Decision|0|||
161918514|NCT00294658|584748724|FG000|Overall Study|Death|0|||
161918515|NCT00294658|584748725|FG001|Overall Study|Death|1|||
161918516|NCT00294658|584748724|FG000|Overall Study|Lost to Follow-up|4|||
161918517|NCT00294658|584748725|FG001|Overall Study|Lost to Follow-up|0|||
161918518|NCT00294658|584748724|FG000|Overall Study|Physician Decision|1|||
161918519|NCT00294658|584748725|FG001|Overall Study|Physician Decision|2|||
161918520|NCT00294658|584748724|FG000|Overall Study|Pregnancy|0|||
161918521|NCT00294658|584748725|FG001|Overall Study|Pregnancy|1|||
161918522|NCT00294658|584748724|FG000|Overall Study|Withdrawal by Subject|0|||
161918523|NCT00294658|584748725|FG001|Overall Study|Withdrawal by Subject|4|||
161918524|NCT00294658|584748724|FG000|Overall Study|Found to have invasive thymoma|1|||
161918525|NCT00294658|584748725|FG001|Overall Study|Found to have invasive thymoma|0|||
161918526|NCT00294658|584748724|FG000|Overall Study|Patient and family were not satisfied|0|||
161918527|NCT00294658|584748725|FG001|Overall Study|Patient and family were not satisfied|1|||
161918528|NCT00976027|584748727|FG000|Overall Study|Serious Adverse Event|36|||
161918529|NCT00976027|584748728|FG001|Overall Study|Serious Adverse Event|17|||
161918530|NCT00976027|584748727|FG000|Overall Study|Adverse Event|0|||
161918531|NCT00976027|584748728|FG001|Overall Study|Adverse Event|2|||
161918532|NCT00976027|584748727|FG000|Overall Study|Protocol Violation|60|||
161918533|NCT00976027|584748728|FG001|Overall Study|Protocol Violation|27|||
161918534|NCT00976027|584748727|FG000|Overall Study|Lost to Follow-up|208|||
161918535|NCT00976027|584748728|FG001|Overall Study|Lost to Follow-up|103|||
161918536|NCT00976027|584748727|FG000|Overall Study|Withdrawal by Subject|107|||
161918537|NCT00976027|584748728|FG001|Overall Study|Withdrawal by Subject|66|||
161918538|NCT01771107|584748734|FG000|Overall Study|Adverse Event|1|||
161918539|NCT01771107|584748735|FG001|Overall Study|Adverse Event|3|||
161918540|NCT01771107|584748734|FG000|Overall Study|Withdrawal by Subject|0|||
161918541|NCT01771107|584748735|FG001|Overall Study|Withdrawal by Subject|2|||
161918542|NCT01771107|584748734|FG000|Overall Study|Lost to Follow-up|0|||
161918543|NCT01771107|584748735|FG001|Overall Study|Lost to Follow-up|1|||
161918544|NCT01771107|584748734|FG000|Overall Study|participant moved|0|||
161918545|NCT01771107|584748735|FG001|Overall Study|participant moved|1|||
161918546|NCT01771107|584748734|FG000|Overall Study|Other|0|||
161918547|NCT01771107|584748735|FG001|Overall Study|Other|1|||
161918548|NCT03805841|584748736|FG000|Overall Study|Clinical Progression|2|||
161918549|NCT03805841|584748737|FG001|Overall Study|Clinical Progression|0|||
161918550|NCT03805841|584748738|FG002|Overall Study|Clinical Progression|0|||
161918551|NCT03805841|584748736|FG000|Overall Study|Death|0|||
161918552|NCT03805841|584748737|FG001|Overall Study|Death|3|||
161918553|NCT03805841|584748738|FG002|Overall Study|Death|1|||
161918554|NCT03805841|584748736|FG000|Overall Study|Lost to Follow-up|0|||
161918555|NCT03805841|584748737|FG001|Overall Study|Lost to Follow-up|0|||
161918556|NCT03805841|584748738|FG002|Overall Study|Lost to Follow-up|1|||
161918557|NCT03805841|584748736|FG000|Overall Study|Withdrawal by Subject|2|||
161918558|NCT03805841|584748737|FG001|Overall Study|Withdrawal by Subject|3|||
161918559|NCT03805841|584748738|FG002|Overall Study|Withdrawal by Subject|0|||
161918560|NCT03805841|584748736|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
161918561|NCT03805841|584748737|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
161918562|NCT03805841|584748738|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
161918563|NCT05049122|584748741|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
161918564|NCT05049122|584748741|FG000|Overall Study|Participant moved|1|||
161918565|NCT05049122|584748741|FG000|Overall Study|At the direction of the doctor|1|||
161918566|NCT05845619|584748742|FG000|Overall Study|duplicate enrollment|2|||
161918567|NCT05845619|584748743|FG001|Overall Study|duplicate enrollment|2|||
161918568|NCT05845619|584748744|FG002|Overall Study|duplicate enrollment|1|||
161813824|NCT01527006|584361261|FG000|Core Study|Inadequate Therapeutic Effect|1|||
161813825|NCT01527006|584361262|FG001|Core Study|Inadequate Therapeutic Effect|0|||
161813826|NCT01527006|584361261|FG000|Core Study|Withdrawal by Subject|0|||
161813827|NCT01527006|584361262|FG001|Core Study|Withdrawal by Subject|1|||
161813828|NCT01527006|584361261|FG000|Core Study|Other|0|||
161813829|NCT01527006|584361262|FG001|Core Study|Other|2|||
161813830|NCT01527006|584361261|FG000|Extension Phase|Adverse Event|4|||
161813831|NCT01527006|584361262|FG001|Extension Phase|Adverse Event|2|||
161813832|NCT01527006|584361261|FG000|Extension Phase|Lost to Follow-up|0|||
161813833|NCT01527006|584361262|FG001|Extension Phase|Lost to Follow-up|1|||
161813834|NCT01527006|584361261|FG000|Extension Phase|Subject Choice|1|||
161813835|NCT01527006|584361262|FG001|Extension Phase|Subject Choice|1|||
161918569|NCT03621592|584748745|FG000|Overall Study|Lost to Follow-up|1|||
161918570|NCT03621592|584748746|FG001|Overall Study|Lost to Follow-up|0|||
161918571|NCT03621592|584748745|FG000|Overall Study|Lack of Improvement|1|||
161918572|NCT03621592|584748746|FG001|Overall Study|Lack of Improvement|0|||
161813836|NCT01527006|584361261|FG000|Extension Phase|Inadequate therapeutic effect|1|||
161813837|NCT01527006|584361262|FG001|Extension Phase|Inadequate therapeutic effect|1|||
161918573|NCT03621592|584748745|FG000|Overall Study|Preference to receive wound care closer to home|1|||
161918574|NCT03621592|584748746|FG001|Overall Study|Preference to receive wound care closer to home|0|||
161918575|NCT03621592|584748745|FG000|Overall Study|Lack of healing|0|||
161918576|NCT03621592|584748746|FG001|Overall Study|Lack of healing|2|||
161918577|NCT00831844|584748754|FG000|Overall Study|Adverse Event|2|||
161918578|NCT00831844|584748755|FG001|Overall Study|Adverse Event|0|||
161918579|NCT00831844|584748756|FG002|Overall Study|Adverse Event|0|||
161918580|NCT00831844|584748757|FG003|Overall Study|Adverse Event|0|||
161813838|NCT01527006|584361261|FG000|Extension Phase|Other|0|||
161918581|NCT00831844|584748758|FG004|Overall Study|Adverse Event|1|||
161918582|NCT00831844|584748759|FG005|Overall Study|Adverse Event|1|||
161918583|NCT00831844|584748760|FG006|Overall Study|Adverse Event|2|||
161918584|NCT00831844|584748761|FG007|Overall Study|Adverse Event|0|||
161918585|NCT00831844|584748762|FG008|Overall Study|Adverse Event|0|||
161918586|NCT00831844|584748763|FG009|Overall Study|Adverse Event|0|||
161918587|NCT00831844|584748754|FG000|Overall Study|Death|0|||
161918588|NCT00831844|584748755|FG001|Overall Study|Death|0|||
161918589|NCT00831844|584748756|FG002|Overall Study|Death|0|||
161918590|NCT00831844|584748757|FG003|Overall Study|Death|1|||
161918591|NCT00831844|584748758|FG004|Overall Study|Death|0|||
161918592|NCT00831844|584748759|FG005|Overall Study|Death|0|||
161918593|NCT00831844|584748760|FG006|Overall Study|Death|0|||
161918594|NCT00831844|584748761|FG007|Overall Study|Death|0|||
161918595|NCT00831844|584748762|FG008|Overall Study|Death|0|||
161918596|NCT00831844|584748763|FG009|Overall Study|Death|0|||
161918597|NCT00831844|584748754|FG000|Overall Study|Lack of Efficacy|8|||
161918598|NCT00831844|584748755|FG001|Overall Study|Lack of Efficacy|10|||
161918599|NCT00831844|584748756|FG002|Overall Study|Lack of Efficacy|15|||
161918600|NCT00831844|584748757|FG003|Overall Study|Lack of Efficacy|8|||
161918601|NCT00831844|584748758|FG004|Overall Study|Lack of Efficacy|11|||
161918602|NCT00831844|584748759|FG005|Overall Study|Lack of Efficacy|17|||
161918603|NCT00831844|584748760|FG006|Overall Study|Lack of Efficacy|8|||
161918604|NCT00831844|584748761|FG007|Overall Study|Lack of Efficacy|9|||
161918605|NCT00831844|584748762|FG008|Overall Study|Lack of Efficacy|7|||
161918606|NCT00831844|584748763|FG009|Overall Study|Lack of Efficacy|0|||
161918607|NCT00831844|584748754|FG000|Overall Study|Physician Decision|0|||
161918608|NCT00831844|584748755|FG001|Overall Study|Physician Decision|1|||
161918609|NCT00831844|584748756|FG002|Overall Study|Physician Decision|3|||
161918610|NCT00831844|584748757|FG003|Overall Study|Physician Decision|1|||
161918611|NCT00831844|584748758|FG004|Overall Study|Physician Decision|1|||
161918612|NCT00831844|584748759|FG005|Overall Study|Physician Decision|1|||
161918613|NCT00831844|584748760|FG006|Overall Study|Physician Decision|0|||
161918614|NCT00831844|584748761|FG007|Overall Study|Physician Decision|0|||
161918615|NCT00831844|584748762|FG008|Overall Study|Physician Decision|1|||
161918616|NCT00831844|584748763|FG009|Overall Study|Physician Decision|0|||
161918617|NCT00831844|584748754|FG000|Overall Study|Withdrawal by Subject|0|||
161918618|NCT00831844|584748755|FG001|Overall Study|Withdrawal by Subject|0|||
161918619|NCT00831844|584748756|FG002|Overall Study|Withdrawal by Subject|1|||
161918620|NCT00831844|584748757|FG003|Overall Study|Withdrawal by Subject|0|||
161918621|NCT00831844|584748758|FG004|Overall Study|Withdrawal by Subject|0|||
161918622|NCT00831844|584748759|FG005|Overall Study|Withdrawal by Subject|0|||
161918623|NCT00831844|584748760|FG006|Overall Study|Withdrawal by Subject|0|||
161918624|NCT00831844|584748761|FG007|Overall Study|Withdrawal by Subject|1|||
161918625|NCT00831844|584748762|FG008|Overall Study|Withdrawal by Subject|1|||
161918626|NCT00831844|584748763|FG009|Overall Study|Withdrawal by Subject|0|||
161918627|NCT00831844|584748754|FG000|Overall Study|Ineligible|0|||
162015448|NCT04313244|585110538|FG000|Overall Study|Met Exclusion Criteria|1|||
162015449|NCT04313244|585110539|FG001|Overall Study|Met Exclusion Criteria|0|||
162015450|NCT04313244|585110538|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
162015451|NCT04313244|585110539|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
162015452|NCT02976038|585110540|FG000|Overall Study|Physician Decision|22|||
162015453|NCT02976038|585110540|FG000|Overall Study|Withdrawal by Subject|3|||
162015454|NCT02976038|585110540|FG000|Overall Study|Lost to Follow-up|2|||
162015455|NCT02976038|585110540|FG000|Overall Study|Adverse Event|1|||
162015456|NCT05021978|585110543|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
162015457|NCT05021978|585110544|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
162015458|NCT05021978|585110545|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
162015459|NCT05021978|585110546|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
161918628|NCT00831844|584748755|FG001|Overall Study|Ineligible|1|||
162015460|NCT05021978|585110543|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
162015461|NCT05021978|585110544|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
162015462|NCT05021978|585110545|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
162015463|NCT05021978|585110546|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
162015464|NCT00196313|585110547|FG000|Overall Study|Protocol Violation|2|||
161918629|NCT00831844|584748756|FG002|Overall Study|Ineligible|1|||
161918630|NCT00831844|584748757|FG003|Overall Study|Ineligible|0|||
161918631|NCT00831844|584748758|FG004|Overall Study|Ineligible|1|||
161918632|NCT00831844|584748759|FG005|Overall Study|Ineligible|0|||
161918633|NCT00831844|584748760|FG006|Overall Study|Ineligible|0|||
161918634|NCT00831844|584748761|FG007|Overall Study|Ineligible|0|||
162015465|NCT00196313|585110548|FG001|Overall Study|Protocol Violation|3|||
162015466|NCT00196313|585110547|FG000|Overall Study|Withdrawal by Subject|3|||
161918635|NCT00831844|584748762|FG008|Overall Study|Ineligible|0|||
161918636|NCT00831844|584748763|FG009|Overall Study|Ineligible|0|||
161918637|NCT04133909|584748766|FG000|Overall Study|Death|11|||
161918638|NCT04133909|584748767|FG001|Overall Study|Death|11|||
161918639|NCT04133909|584748766|FG000|Overall Study|Adverse Event|4|||
161918640|NCT04133909|584748767|FG001|Overall Study|Adverse Event|5|||
161918641|NCT04133909|584748766|FG000|Overall Study|Lost to Follow-up|3|||
161918642|NCT04133909|584748767|FG001|Overall Study|Lost to Follow-up|5|||
161918643|NCT04133909|584748766|FG000|Overall Study|Physician Decision|4|||
161918644|NCT04133909|584748767|FG001|Overall Study|Physician Decision|7|||
161918645|NCT04133909|584748766|FG000|Overall Study|Withdrawal by Subject|40|||
161918646|NCT04133909|584748767|FG001|Overall Study|Withdrawal by Subject|35|||
161918647|NCT04133909|584748766|FG000|Overall Study|Lack of Efficacy|2|||
161918648|NCT04133909|584748767|FG001|Overall Study|Lack of Efficacy|7|||
161918649|NCT04133909|584748766|FG000|Overall Study|Randomized in error|1|||
161918650|NCT04133909|584748767|FG001|Overall Study|Randomized in error|1|||
161918651|NCT02340949|584748768|FG000|Overall Study|Adverse Event|4|||
161918652|NCT02340949|584748769|FG001|Overall Study|Adverse Event|2|||
161918653|NCT02340949|584748768|FG000|Overall Study|Withdrawal by Subject|2|||
161918654|NCT02340949|584748769|FG001|Overall Study|Withdrawal by Subject|0|||
161918655|NCT02340949|584748768|FG000|Overall Study|Progression disease|6|||
161918656|NCT02340949|584748769|FG001|Overall Study|Progression disease|2|||
161918657|NCT02340949|584748768|FG000|Overall Study|Death|3|||
161918658|NCT02340949|584748769|FG001|Overall Study|Death|0|||
161918659|NCT02340949|584748768|FG000|Overall Study|Physician Decision|1|||
161918660|NCT02340949|584748769|FG001|Overall Study|Physician Decision|0|||
161918661|NCT03980223|584748770|FG000|Overall Study|Lost to Follow-up|3|||
161918662|NCT03980223|584748771|FG001|Overall Study|Lost to Follow-up|7|||
161918663|NCT03980223|584748772|FG002|Overall Study|Lost to Follow-up|10|||
161918664|NCT03980223|584748773|FG003|Overall Study|Lost to Follow-up|8|||
161918665|NCT03980223|584748770|FG000|Overall Study|Withdrawal by Subject|0|||
161918666|NCT03980223|584748771|FG001|Overall Study|Withdrawal by Subject|0|||
161918667|NCT03980223|584748772|FG002|Overall Study|Withdrawal by Subject|1|||
161918668|NCT03980223|584748773|FG003|Overall Study|Withdrawal by Subject|2|||
161918669|NCT03980223|584748770|FG000|Overall Study|Physician Decision|0|||
161918670|NCT03980223|584748771|FG001|Overall Study|Physician Decision|0|||
161918671|NCT03980223|584748772|FG002|Overall Study|Physician Decision|1|||
161918672|NCT03980223|584748773|FG003|Overall Study|Physician Decision|0|||
161918673|NCT03980223|584748770|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
161918674|NCT03980223|584748771|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
161918675|NCT03980223|584748772|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
161918676|NCT03980223|584748773|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
161918677|NCT02460289|584748777|FG000|Overall Study|Adverse Event|1|||
161918678|NCT02460289|584748777|FG000|Overall Study|Withdrawal by Subject|8|||
161918679|NCT02460289|584748777|FG000|Overall Study|Lost to Follow-up|1|||
161918680|NCT02916927|584748778|FG000|Overall Study|Discharged prior to study drug receipt|0|||
161918681|NCT02916927|584748779|FG001|Overall Study|Discharged prior to study drug receipt|2|||
161918682|NCT02916927|584748778|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
161918683|NCT02916927|584748779|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
161918684|NCT02916927|584748778|FG000|Overall Study|Withdrawal before first time point|1|||
161918685|NCT02916927|584748779|FG001|Overall Study|Withdrawal before first time point|0|||
161918686|NCT01020123|584748780|FG000|Main Period|Withdrawal by Subject|6|||
161918687|NCT01020123|584748781|FG001|Main Period|Withdrawal by Subject|5|||
161918688|NCT01020123|584748782|FG002|Main Period|Withdrawal by Subject|3|||
161918689|NCT01020123|584748783|FG003|Main Period|Withdrawal by Subject|1|||
161918690|NCT01020123|584748784|FG004|Main Period|Withdrawal by Subject|6|||
161918691|NCT01020123|584748785|FG005|Main Period|Withdrawal by Subject|3|||
161918692|NCT01020123|584748786|FG006|Main Period|Withdrawal by Subject|2|||
161918693|NCT01020123|584748780|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
161918694|NCT01020123|584748781|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
161918695|NCT01020123|584748782|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
161918696|NCT01020123|584748783|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
161918697|NCT01020123|584748784|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
161918698|NCT01020123|584748785|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
161918699|NCT01020123|584748786|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
161918700|NCT01020123|584748780|FG000|Main Period|Adverse Event|5|||
161918701|NCT01020123|584748781|FG001|Main Period|Adverse Event|2|||
161918702|NCT01020123|584748782|FG002|Main Period|Adverse Event|2|||
161918703|NCT01020123|584748783|FG003|Main Period|Adverse Event|1|||
161918704|NCT01020123|584748784|FG004|Main Period|Adverse Event|1|||
161918705|NCT01020123|584748785|FG005|Main Period|Adverse Event|2|||
161918706|NCT01020123|584748786|FG006|Main Period|Adverse Event|1|||
161918707|NCT01020123|584748780|FG000|Main Period|Protocol Violation|4|||
161918708|NCT01020123|584748781|FG001|Main Period|Protocol Violation|4|||
161918709|NCT01020123|584748782|FG002|Main Period|Protocol Violation|2|||
161918710|NCT01020123|584748783|FG003|Main Period|Protocol Violation|5|||
161918711|NCT01020123|584748784|FG004|Main Period|Protocol Violation|2|||
161918712|NCT01020123|584748785|FG005|Main Period|Protocol Violation|3|||
161918713|NCT01020123|584748786|FG006|Main Period|Protocol Violation|2|||
161918714|NCT01020123|584748780|FG000|Main Period|Lost to Follow-up|0|||
161918715|NCT01020123|584748781|FG001|Main Period|Lost to Follow-up|2|||
161918716|NCT01020123|584748782|FG002|Main Period|Lost to Follow-up|0|||
161918717|NCT01020123|584748783|FG003|Main Period|Lost to Follow-up|0|||
161918718|NCT01020123|584748784|FG004|Main Period|Lost to Follow-up|0|||
161918719|NCT01020123|584748785|FG005|Main Period|Lost to Follow-up|0|||
161918720|NCT01020123|584748786|FG006|Main Period|Lost to Follow-up|0|||
161918721|NCT01020123|584748780|FG000|Main Period|Unclasified|2|||
161918722|NCT01020123|584748781|FG001|Main Period|Unclasified|0|||
161918723|NCT01020123|584748782|FG002|Main Period|Unclasified|1|||
161918724|NCT01020123|584748783|FG003|Main Period|Unclasified|0|||
161918725|NCT01020123|584748784|FG004|Main Period|Unclasified|1|||
161918726|NCT01020123|584748785|FG005|Main Period|Unclasified|3|||
161918727|NCT01020123|584748786|FG006|Main Period|Unclasified|6|||
161918728|NCT01020123|584748780|FG000|Extention Period|Withdrawal by Subject|2|||
161918729|NCT01020123|584748781|FG001|Extention Period|Withdrawal by Subject|1|||
161918730|NCT01020123|584748782|FG002|Extention Period|Withdrawal by Subject|1|||
161918731|NCT01020123|584748783|FG003|Extention Period|Withdrawal by Subject|0|||
161918732|NCT01020123|584748784|FG004|Extention Period|Withdrawal by Subject|0|||
161918733|NCT01020123|584748785|FG005|Extention Period|Withdrawal by Subject|0|||
161918734|NCT01020123|584748786|FG006|Extention Period|Withdrawal by Subject|0|||
161918735|NCT01020123|584748780|FG000|Extention Period|Adverse Event|0|||
161918736|NCT01020123|584748781|FG001|Extention Period|Adverse Event|0|||
161918737|NCT01020123|584748782|FG002|Extention Period|Adverse Event|0|||
161918738|NCT01020123|584748783|FG003|Extention Period|Adverse Event|1|||
161918739|NCT01020123|584748784|FG004|Extention Period|Adverse Event|0|||
161918740|NCT01020123|584748785|FG005|Extention Period|Adverse Event|0|||
161918741|NCT01020123|584748786|FG006|Extention Period|Adverse Event|0|||
161918742|NCT01020123|584748780|FG000|Extention Period|Protocol Violation|1|||
161918743|NCT01020123|584748781|FG001|Extention Period|Protocol Violation|1|||
161918744|NCT01020123|584748782|FG002|Extention Period|Protocol Violation|1|||
161918745|NCT01020123|584748783|FG003|Extention Period|Protocol Violation|0|||
161918746|NCT01020123|584748784|FG004|Extention Period|Protocol Violation|0|||
161918747|NCT01020123|584748785|FG005|Extention Period|Protocol Violation|0|||
161918748|NCT01020123|584748786|FG006|Extention Period|Protocol Violation|1|||
161918749|NCT01020123|584748780|FG000|Extention Period|Lost to Follow-up|0|||
161918750|NCT01020123|584748781|FG001|Extention Period|Lost to Follow-up|0|||
161918751|NCT01020123|584748782|FG002|Extention Period|Lost to Follow-up|0|||
161918752|NCT01020123|584748783|FG003|Extention Period|Lost to Follow-up|0|||
161918753|NCT01020123|584748784|FG004|Extention Period|Lost to Follow-up|0|||
161918754|NCT01020123|584748785|FG005|Extention Period|Lost to Follow-up|2|||
161918755|NCT01020123|584748786|FG006|Extention Period|Lost to Follow-up|0|||
161918756|NCT01349595|584748787|FG000|Overall Study|Lack of funding|2|||
161918757|NCT01349595|584748788|FG001|Overall Study|Lack of funding|2|||
161918758|NCT03479905|584748789|FG000|Overall Study|Other airway method used|4|||
161918759|NCT03479905|584748790|FG001|Overall Study|Other airway method used|5|||
161918760|NCT03479905|584748791|FG002|Overall Study|Other airway method used|5|||
161918761|NCT01706328|584748796|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
161918762|NCT01706328|584748797|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
161918763|NCT01706328|584748798|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
161918764|NCT01706328|584748796|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
161918765|NCT01706328|584748797|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161918766|NCT01706328|584748798|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161918767|NCT01706328|584748796|FG000|2-week Run-in Period|Physician Decision|4|||
161918768|NCT01706328|584748797|FG001|2-week Run-in Period|Physician Decision|0|||
162015467|NCT00196313|585110548|FG001|Overall Study|Withdrawal by Subject|1|||
162015468|NCT00196313|585110547|FG000|Overall Study|Adverse Event|3|||
162015469|NCT00196313|585110548|FG001|Overall Study|Adverse Event|1|||
162015470|NCT00196313|585110547|FG000|Overall Study|Subject Pregnant|1|||
162015471|NCT00196313|585110548|FG001|Overall Study|Subject Pregnant|1|||
162015472|NCT00196313|585110547|FG000|Overall Study|Lost to Follow-up|2|||
162015473|NCT00196313|585110548|FG001|Overall Study|Lost to Follow-up|2|||
162015474|NCT00043979|585110549|FG000|Period 1|recipient with progressive disease|7|||
162015475|NCT00043979|585110550|FG001|Period 1|recipient with progressive disease|4|||
162015476|NCT00043979|585110551|FG002|Period 1|recipient with progressive disease|3|||
161813839|NCT01527006|584361262|FG001|Extension Phase|Other|3|||
161813840|NCT01383486|584361263|FG000|Overall Study|Lost to Follow-up|10|||
161813841|NCT01383486|584361263|FG000|Overall Study|Incomplete information for analysis|2|||
161813842|NCT01383486|584361263|FG000|Overall Study|Did not take any product|6|||
161813843|NCT00245063|584361264|FG000|Overall Study|Adverse Event|6|||
161813844|NCT00245063|584361265|FG001|Overall Study|Adverse Event|5|||
161813845|NCT00245063|584361264|FG000|Overall Study|Death|1|||
161813846|NCT00245063|584361265|FG001|Overall Study|Death|0|||
161813847|NCT01839279|584361268|FG000|Overall Study|Adverse Event|4|||
161813848|NCT01839279|584361269|FG001|Overall Study|Adverse Event|1|||
161918769|NCT01706328|584748798|FG002|2-week Run-in Period|Physician Decision|0|||
161918770|NCT01706328|584748796|FG000|2-week Run-in Period|Adverse Event|4|||
161918771|NCT01706328|584748797|FG001|2-week Run-in Period|Adverse Event|0|||
162015477|NCT03096288|585110553|FG000|Overall Study|Withdrawal by Subject|0|||
162015478|NCT03096288|585110554|FG001|Overall Study|Withdrawal by Subject|1|||
161918772|NCT01706328|584748798|FG002|2-week Run-in Period|Adverse Event|0|||
161918773|NCT01706328|584748796|FG000|2-week Run-in Period|Lost to Follow-up|2|||
161918774|NCT01706328|584748797|FG001|2-week Run-in Period|Lost to Follow-up|0|||
161918775|NCT01706328|584748798|FG002|2-week Run-in Period|Lost to Follow-up|0|||
161918776|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
161918777|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
161918778|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
161918779|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
161918780|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
161918781|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
161918782|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
161918783|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
161918784|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
161918785|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
161918786|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
161918787|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
161918788|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
161918789|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
161918790|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
161918791|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
161918792|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
161918793|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
161918794|NCT01706328|584748796|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161918795|NCT01706328|584748797|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
161918796|NCT01706328|584748798|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
161918797|NCT06481579|584748800|FG000|Overall Study|Death|1|||
161918798|NCT06481579|584748801|FG001|Overall Study|Death|0|||
161918799|NCT06481579|584748800|FG000|Overall Study|Withdrawal by Subject|3|||
161918800|NCT06481579|584748801|FG001|Overall Study|Withdrawal by Subject|0|||
161918801|NCT06481579|584748800|FG000|Overall Study|Other|1|||
161918802|NCT06481579|584748801|FG001|Overall Study|Other|1|||
161918803|NCT04190225|584751312|FG000|Overall Study|Lost to Follow-up|2|||
161918804|NCT04190225|584751313|FG001|Overall Study|Lost to Follow-up|3|||
161918805|NCT04190225|584751312|FG000|Overall Study|Withdrawal by Subject|3|||
161918806|NCT04190225|584751313|FG001|Overall Study|Withdrawal by Subject|2|||
161918807|NCT04190225|584751312|FG000|Overall Study|Unrelated health condition|2|||
161918808|NCT04190225|584751313|FG001|Overall Study|Unrelated health condition|0|||
161918809|NCT01732783|584751314|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
161918810|NCT01732783|584751315|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
161918811|NCT01732783|584751316|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
161918812|NCT01732783|584751314|FG000|Overall Study|Death|13|||
161918813|NCT01732783|584751315|FG001|Overall Study|Death|4|||
161918814|NCT01732783|584751316|FG002|Overall Study|Death|1|||
161918815|NCT01732783|584751314|FG000|Overall Study|Lost to Follow-up|7|||
161918816|NCT01732783|584751315|FG001|Overall Study|Lost to Follow-up|1|||
161918817|NCT01732783|584751316|FG002|Overall Study|Lost to Follow-up|1|||
161918818|NCT01732783|584751314|FG000|Overall Study|Administrative Decision|8|||
161918819|NCT01732783|584751315|FG001|Overall Study|Administrative Decision|2|||
161918820|NCT01732783|584751316|FG002|Overall Study|Administrative Decision|1|||
161918821|NCT01732783|584751314|FG000|Overall Study|Withdrawal by Subject|1|||
161918822|NCT01732783|584751315|FG001|Overall Study|Withdrawal by Subject|0|||
161918823|NCT01732783|584751316|FG002|Overall Study|Withdrawal by Subject|0|||
161918824|NCT04429971|584751317|FG000|Overall Study|Lost to Follow-up|7|||
161918825|NCT04429971|584751318|FG001|Overall Study|Lost to Follow-up|8|||
161918826|NCT03331562|584751319|FG000|Overall Study|Adverse Event|2|||
161918827|NCT03331562|584751320|FG001|Overall Study|Adverse Event|0|||
161918828|NCT03331562|584751319|FG000|Overall Study|Death|1|||
161918829|NCT03331562|584751320|FG001|Overall Study|Death|0|||
161918830|NCT03718000|584751328|FG000|Overall Study|Relocation|2|||
161918831|NCT03718000|584751329|FG001|Overall Study|Relocation|4|||
161918832|NCT03718000|584751328|FG000|Overall Study|Pregnancy|0|||
161918833|NCT03718000|584751329|FG001|Overall Study|Pregnancy|1|||
161918834|NCT05522751|584751335|FG000|Overall Study|Adverse Event|1|||
161918835|NCT04044690|584751337|FG000|Period 1|Lack of Efficacy|1|||
161918836|NCT04044690|584751338|FG001|Period 1|Lack of Efficacy|1|||
161918837|NCT04044690|584751337|FG000|Period 1|Adverse Event|4|||
161918838|NCT04044690|584751338|FG001|Period 1|Adverse Event|2|||
161918839|NCT04044690|584751337|FG000|Period 1|Physician Decision|0|||
161918840|NCT04044690|584751338|FG001|Period 1|Physician Decision|1|||
161918841|NCT04044690|584751337|FG000|Period 1|Withdrawal by Subject|2|||
161918842|NCT04044690|584751338|FG001|Period 1|Withdrawal by Subject|5|||
161918843|NCT04044690|584751337|FG000|Period 1|Protocol Deviation|2|||
161918844|NCT04044690|584751338|FG001|Period 1|Protocol Deviation|0|||
161918845|NCT04044690|584751337|FG000|Period 1|Site Terminated by Sponsor|0|||
161918846|NCT04044690|584751338|FG001|Period 1|Site Terminated by Sponsor|1|||
161918847|NCT04044690|584751337|FG000|Period 1|Study Terminated by Sponsor|0|||
161918848|NCT04044690|584751338|FG001|Period 1|Study Terminated by Sponsor|1|||
161918849|NCT04044690|584751337|FG000|Period 1|Death|1|||
161918850|NCT04044690|584751338|FG001|Period 1|Death|1|||
161918851|NCT04044690|584751337|FG000|Period 1|Other: Unspecified|1|||
161918852|NCT04044690|584751338|FG001|Period 1|Other: Unspecified|0|||
161918853|NCT04044690|584751337|FG000|Period 2|Lack of Efficacy|0|||
161918854|NCT04044690|584751338|FG001|Period 2|Lack of Efficacy|1|||
161918855|NCT04044690|584751337|FG000|Period 2|Adverse Event|0|||
161918856|NCT04044690|584751338|FG001|Period 2|Adverse Event|1|||
161918857|NCT04044690|584751337|FG000|Period 2|Physician Decision|0|||
161918858|NCT04044690|584751338|FG001|Period 2|Physician Decision|2|||
161918859|NCT04044690|584751337|FG000|Period 2|Withdrawal by Subject|5|||
161918860|NCT04044690|584751338|FG001|Period 2|Withdrawal by Subject|5|||
161918861|NCT04044690|584751337|FG000|Period 2|Lost to Follow-up|0|||
161918862|NCT04044690|584751338|FG001|Period 2|Lost to Follow-up|1|||
161918863|NCT04044690|584751337|FG000|Period 2|Site Terminated by Sponsor|1|||
161918864|NCT04044690|584751338|FG001|Period 2|Site Terminated by Sponsor|3|||
161918865|NCT04044690|584751337|FG000|Period 2|Study Terminated by Sponsor|8|||
161918866|NCT04044690|584751338|FG001|Period 2|Study Terminated by Sponsor|3|||
161918867|NCT04044690|584751337|FG000|Period 2|Death|1|||
161918868|NCT04044690|584751338|FG001|Period 2|Death|0|||
161918869|NCT04044690|584751337|FG000|Period 2|Other: Unspecified|1|||
161918870|NCT04044690|584751338|FG001|Period 2|Other: Unspecified|1|||
161918871|NCT04044690|584751337|FG000|Period 3|Site Terminated by Sponsor|1|||
161918872|NCT04044690|584751338|FG001|Period 3|Site Terminated by Sponsor|2|||
161918873|NCT04044690|584751337|FG000|Period 3|Study Terminated by Sponsor|24|||
161918874|NCT04044690|584751338|FG001|Period 3|Study Terminated by Sponsor|18|||
161918875|NCT04044690|584751337|FG000|Period 3|Missing|0|||
161918876|NCT04044690|584751338|FG001|Period 3|Missing|2|||
161918877|NCT01582451|584751344|FG000|Overall Study|Adverse Event|1|||
161918878|NCT01582451|584751345|FG001|Overall Study|Adverse Event|3|||
161918879|NCT01582451|584751344|FG000|Overall Study|Death|3|||
161918880|NCT01582451|584751345|FG001|Overall Study|Death|3|||
161918881|NCT01582451|584751344|FG000|Overall Study|Lost to Follow-up|0|||
161918882|NCT01582451|584751345|FG001|Overall Study|Lost to Follow-up|2|||
161918883|NCT01582451|584751344|FG000|Overall Study|Protocol Violation|11|||
161918884|NCT01582451|584751345|FG001|Overall Study|Protocol Violation|3|||
161918885|NCT01582451|584751344|FG000|Overall Study|Withdrawal by Subject|13|||
161918886|NCT01582451|584751345|FG001|Overall Study|Withdrawal by Subject|9|||
161918887|NCT01582451|584751344|FG000|Overall Study|Physician Decision|3|||
161918888|NCT01582451|584751345|FG001|Overall Study|Physician Decision|0|||
161918889|NCT01582451|584751344|FG000|Overall Study|Sponsor Decision|1|||
161918890|NCT01582451|584751345|FG001|Overall Study|Sponsor Decision|0|||
161918891|NCT00716417|584751348|FG000|Overall Study|Adverse Event|0|||
161918892|NCT00716417|584751349|FG001|Overall Study|Adverse Event|0|||
161918893|NCT00716417|584751350|FG002|Overall Study|Adverse Event|2|||
161918894|NCT00716417|584751351|FG003|Overall Study|Adverse Event|1|||
161918895|NCT00716417|584751352|FG004|Overall Study|Adverse Event|0|||
161918896|NCT00716417|584751353|FG005|Overall Study|Adverse Event|0|||
161918897|NCT00716417|584751354|FG006|Overall Study|Adverse Event|3|||
161918898|NCT00716417|584751355|FG007|Overall Study|Adverse Event|1|||
161918899|NCT00716417|584751356|FG008|Overall Study|Adverse Event|0|||
161918900|NCT00716417|584751357|FG009|Overall Study|Adverse Event|3|||
161918901|NCT00716417|584751348|FG000|Overall Study|Withdrawal by Subject|0|||
161918902|NCT00716417|584751349|FG001|Overall Study|Withdrawal by Subject|1|||
161918903|NCT00716417|584751350|FG002|Overall Study|Withdrawal by Subject|0|||
161813849|NCT01839279|584361270|FG002|Overall Study|Adverse Event|1|||
161813850|NCT01839279|584361268|FG000|Overall Study|Withdrawal by Subject|4|||
161813851|NCT01839279|584361269|FG001|Overall Study|Withdrawal by Subject|1|||
161813852|NCT01839279|584361270|FG002|Overall Study|Withdrawal by Subject|1|||
161813853|NCT01839279|584361268|FG000|Overall Study|Classified as 'Other'|5|||
161813854|NCT01839279|584361269|FG001|Overall Study|Classified as 'Other'|0|||
161813855|NCT01839279|584361270|FG002|Overall Study|Classified as 'Other'|0|||
161813856|NCT05919823|584361274|FG000|Pre-Treatment Period|Screen failure|1|||
161918904|NCT00716417|584751351|FG003|Overall Study|Withdrawal by Subject|2|||
161813857|NCT05919823|584361275|FG001|Pre-Treatment Period|Screen failure|0|||
161813858|NCT05919823|584361276|FG002|Pre-Treatment Period|Screen failure|0|||
161918905|NCT00716417|584751352|FG004|Overall Study|Withdrawal by Subject|0|||
161918906|NCT00716417|584751353|FG005|Overall Study|Withdrawal by Subject|0|||
161918907|NCT00716417|584751354|FG006|Overall Study|Withdrawal by Subject|1|||
161918908|NCT00716417|584751355|FG007|Overall Study|Withdrawal by Subject|0|||
161918909|NCT00716417|584751356|FG008|Overall Study|Withdrawal by Subject|0|||
161918910|NCT00716417|584751357|FG009|Overall Study|Withdrawal by Subject|0|||
161918911|NCT00716417|584751348|FG000|Overall Study|Progressive disease|3|||
161918912|NCT00716417|584751349|FG001|Overall Study|Progressive disease|5|||
161918913|NCT00716417|584751350|FG002|Overall Study|Progressive disease|3|||
161918914|NCT00716417|584751351|FG003|Overall Study|Progressive disease|8|||
161813859|NCT05919823|584361277|FG003|Pre-Treatment Period|Screen failure|0|||
161813860|NCT05919823|584361274|FG000|Pre-Treatment Period|Protocol Violation|0|||
161813861|NCT05919823|584361275|FG001|Pre-Treatment Period|Protocol Violation|1|||
161813862|NCT05919823|584361276|FG002|Pre-Treatment Period|Protocol Violation|0|||
161813863|NCT05919823|584361277|FG003|Pre-Treatment Period|Protocol Violation|0|||
161813864|NCT05919823|584361274|FG000|Double-Blind Period|Adverse Event|8|||
161813865|NCT05919823|584361275|FG001|Double-Blind Period|Adverse Event|9|||
161813866|NCT05919823|584361276|FG002|Double-Blind Period|Adverse Event|0|||
161813867|NCT05919823|584361277|FG003|Double-Blind Period|Adverse Event|0|||
161813868|NCT05919823|584361274|FG000|Double-Blind Period|Protocol Violation|2|||
161813869|NCT05919823|584361275|FG001|Double-Blind Period|Protocol Violation|1|||
161813870|NCT05919823|584361276|FG002|Double-Blind Period|Protocol Violation|0|||
161813871|NCT05919823|584361277|FG003|Double-Blind Period|Protocol Violation|0|||
161813872|NCT05919823|584361274|FG000|Double-Blind Period|Participant withdrew consent|11|||
161813873|NCT05919823|584361275|FG001|Double-Blind Period|Participant withdrew consent|7|||
161813874|NCT05919823|584361276|FG002|Double-Blind Period|Participant withdrew consent|0|||
161813875|NCT05919823|584361277|FG003|Double-Blind Period|Participant withdrew consent|0|||
161813876|NCT05919823|584361274|FG000|Double-Blind Period|Other reasons|2|||
161813877|NCT05919823|584361275|FG001|Double-Blind Period|Other reasons|3|||
161813878|NCT05919823|584361276|FG002|Double-Blind Period|Other reasons|0|||
161813879|NCT05919823|584361277|FG003|Double-Blind Period|Other reasons|0|||
161813880|NCT05919823|584361274|FG000|Open Label Period|Adverse Event|0|||
161813881|NCT05919823|584361275|FG001|Open Label Period|Adverse Event|0|||
161813882|NCT05919823|584361276|FG002|Open Label Period|Adverse Event|2|||
161813883|NCT05919823|584361277|FG003|Open Label Period|Adverse Event|4|||
161813884|NCT05919823|584361274|FG000|Open Label Period|Lost to Follow-up|0|||
161813885|NCT05919823|584361275|FG001|Open Label Period|Lost to Follow-up|0|||
161813886|NCT05919823|584361276|FG002|Open Label Period|Lost to Follow-up|1|||
161813887|NCT05919823|584361277|FG003|Open Label Period|Lost to Follow-up|0|||
161813888|NCT05919823|584361274|FG000|Open Label Period|Protocol Violation|0|||
161813889|NCT05919823|584361275|FG001|Open Label Period|Protocol Violation|0|||
161813890|NCT05919823|584361276|FG002|Open Label Period|Protocol Violation|0|||
161813891|NCT05919823|584361277|FG003|Open Label Period|Protocol Violation|1|||
161813892|NCT05919823|584361274|FG000|Open Label Period|Participant withdrew consent|0|||
161813893|NCT05919823|584361275|FG001|Open Label Period|Participant withdrew consent|0|||
161813894|NCT05919823|584361276|FG002|Open Label Period|Participant withdrew consent|8|||
161813895|NCT05919823|584361277|FG003|Open Label Period|Participant withdrew consent|6|||
161813896|NCT05919823|584361274|FG000|Open Label Period|Death|0|||
161813897|NCT05919823|584361275|FG001|Open Label Period|Death|0|||
161813898|NCT05919823|584361276|FG002|Open Label Period|Death|0|||
161813899|NCT05919823|584361277|FG003|Open Label Period|Death|1|||
161813900|NCT05919823|584361274|FG000|Open Label Period|Other reasons|0|||
161813901|NCT05919823|584361275|FG001|Open Label Period|Other reasons|0|||
161813902|NCT05919823|584361276|FG002|Open Label Period|Other reasons|9|||
161813903|NCT05919823|584361277|FG003|Open Label Period|Other reasons|5|||
161813904|NCT01648582|584361278|FG000|Overall Study|Adverse Event|6|||
161813905|NCT01648582|584361279|FG001|Overall Study|Adverse Event|11|||
161813906|NCT01648582|584361280|FG002|Overall Study|Adverse Event|2|||
161813907|NCT01648582|584361278|FG000|Overall Study|Lost to Follow-up|9|||
161813908|NCT01648582|584361279|FG001|Overall Study|Lost to Follow-up|6|||
161813909|NCT01648582|584361280|FG002|Overall Study|Lost to Follow-up|8|||
161813910|NCT01648582|584361278|FG000|Overall Study|Protocol Violation|1|||
161813911|NCT01648582|584361279|FG001|Overall Study|Protocol Violation|2|||
161813912|NCT01648582|584361280|FG002|Overall Study|Protocol Violation|1|||
161813913|NCT01648582|584361278|FG000|Overall Study|Withdrawal by Subject|15|||
161813914|NCT01648582|584361279|FG001|Overall Study|Withdrawal by Subject|17|||
161813915|NCT01648582|584361280|FG002|Overall Study|Withdrawal by Subject|17|||
161813916|NCT01648582|584361278|FG000|Overall Study|Physician Decision|0|||
161813917|NCT01648582|584361279|FG001|Overall Study|Physician Decision|1|||
161813918|NCT01648582|584361280|FG002|Overall Study|Physician Decision|3|||
161813919|NCT01648582|584361278|FG000|Overall Study|Death|1|||
161813920|NCT01648582|584361279|FG001|Overall Study|Death|0|||
161813921|NCT01648582|584361280|FG002|Overall Study|Death|0|||
161813922|NCT01648582|584361278|FG000|Overall Study|Sponsor Decision|0|||
161813923|NCT01648582|584361279|FG001|Overall Study|Sponsor Decision|1|||
161813924|NCT01648582|584361280|FG002|Overall Study|Sponsor Decision|1|||
161813925|NCT00466167|584361292|FG000|Overall Study|Adverse Event|8|||
161813926|NCT00466167|584361293|FG001|Overall Study|Adverse Event|8|||
161813927|NCT00466167|584361294|FG002|Overall Study|Adverse Event|7|||
161813928|NCT00466167|584361292|FG000|Overall Study|Lack of Efficacy|2|||
161813929|NCT00466167|584361293|FG001|Overall Study|Lack of Efficacy|0|||
161813930|NCT00466167|584361294|FG002|Overall Study|Lack of Efficacy|3|||
161813931|NCT00466167|584361292|FG000|Overall Study|Protocol Violation|1|||
161813932|NCT00466167|584361293|FG001|Overall Study|Protocol Violation|1|||
161813933|NCT00466167|584361294|FG002|Overall Study|Protocol Violation|2|||
161813934|NCT00466167|584361292|FG000|Overall Study|Lost to Follow-up|3|||
161813935|NCT00466167|584361293|FG001|Overall Study|Lost to Follow-up|2|||
161813936|NCT00466167|584361294|FG002|Overall Study|Lost to Follow-up|2|||
161813937|NCT00466167|584361292|FG000|Overall Study|Withdrawal by Subject|4|||
161918915|NCT00716417|584751352|FG004|Overall Study|Progressive disease|0|||
161918916|NCT00716417|584751353|FG005|Overall Study|Progressive disease|3|||
161918917|NCT00716417|584751354|FG006|Overall Study|Progressive disease|3|||
161918918|NCT00716417|584751355|FG007|Overall Study|Progressive disease|1|||
161918919|NCT00716417|584751356|FG008|Overall Study|Progressive disease|5|||
161918920|NCT00716417|584751357|FG009|Overall Study|Progressive disease|0|||
161918921|NCT00716417|584751348|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
161918922|NCT00716417|584751349|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
161918923|NCT00716417|584751350|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
161918924|NCT00716417|584751351|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
161918925|NCT00716417|584751352|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
161918926|NCT00716417|584751353|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
161918927|NCT00716417|584751354|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
161918928|NCT00716417|584751355|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
161918929|NCT00716417|584751356|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
161918930|NCT00716417|584751357|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
161918931|NCT00716417|584751348|FG000|Overall Study|On patient request due to toxicities|0|||
161918932|NCT00716417|584751349|FG001|Overall Study|On patient request due to toxicities|0|||
161918933|NCT00716417|584751350|FG002|Overall Study|On patient request due to toxicities|0|||
161918934|NCT00716417|584751351|FG003|Overall Study|On patient request due to toxicities|0|||
161918935|NCT00716417|584751352|FG004|Overall Study|On patient request due to toxicities|0|||
161918936|NCT00716417|584751353|FG005|Overall Study|On patient request due to toxicities|0|||
161918937|NCT00716417|584751354|FG006|Overall Study|On patient request due to toxicities|0|||
161918938|NCT00716417|584751355|FG007|Overall Study|On patient request due to toxicities|1|||
161918939|NCT00716417|584751356|FG008|Overall Study|On patient request due to toxicities|0|||
161918940|NCT00716417|584751357|FG009|Overall Study|On patient request due to toxicities|0|||
161918941|NCT00487188|584751358|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
161918942|NCT00487188|584751359|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
161918943|NCT00487188|584751360|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
161918944|NCT00487188|584751358|FG000|Induction Phase|Adverse Event|5|||
161918945|NCT00487188|584751359|FG001|Induction Phase|Adverse Event|0|||
161918946|NCT00487188|584751360|FG002|Induction Phase|Adverse Event|0|||
161918947|NCT00487188|584751358|FG000|Induction Phase|Lack of Efficacy|0|||
161918948|NCT00487188|584751359|FG001|Induction Phase|Lack of Efficacy|1|||
161918949|NCT00487188|584751360|FG002|Induction Phase|Lack of Efficacy|0|||
161918950|NCT00487188|584751358|FG000|Induction Phase|Protocol Violation|1|||
161918951|NCT00487188|584751359|FG001|Induction Phase|Protocol Violation|0|||
161918952|NCT00487188|584751360|FG002|Induction Phase|Protocol Violation|0|||
161918953|NCT00487188|584751358|FG000|Induction Phase|Refused Treatment|1|||
161918954|NCT00487188|584751359|FG001|Induction Phase|Refused Treatment|2|||
161918955|NCT00487188|584751360|FG002|Induction Phase|Refused Treatment|0|||
161918956|NCT00487188|584751358|FG000|Induction Phase|Lost to Follow-up|2|||
161918957|NCT00487188|584751359|FG001|Induction Phase|Lost to Follow-up|2|||
161918958|NCT00487188|584751360|FG002|Induction Phase|Lost to Follow-up|0|||
161918959|NCT00487188|584751358|FG000|Induction Phase|Administrative|0|||
161918960|NCT00487188|584751359|FG001|Induction Phase|Administrative|1|||
161918961|NCT00487188|584751360|FG002|Induction Phase|Administrative|0|||
161918962|NCT00487188|584751358|FG000|Maintenance Phase|Adverse Event|1|||
161918963|NCT00487188|584751359|FG001|Maintenance Phase|Adverse Event|0|||
161918964|NCT00487188|584751360|FG002|Maintenance Phase|Adverse Event|0|||
161918965|NCT00487188|584751358|FG000|Maintenance Phase|Death|1|||
161918966|NCT00487188|584751359|FG001|Maintenance Phase|Death|0|||
161918967|NCT00487188|584751360|FG002|Maintenance Phase|Death|0|||
161918968|NCT00487188|584751358|FG000|Maintenance Phase|Lost to Follow-up|1|||
161918969|NCT00487188|584751359|FG001|Maintenance Phase|Lost to Follow-up|0|||
161918970|NCT00487188|584751360|FG002|Maintenance Phase|Lost to Follow-up|0|||
161918971|NCT00487188|584751358|FG000|Maintenance Phase|Administrative|0|||
161918972|NCT00487188|584751359|FG001|Maintenance Phase|Administrative|0|||
161918973|NCT00487188|584751360|FG002|Maintenance Phase|Administrative|1|||
161918974|NCT01838876|584751361|FG000|Overall Study|Adverse Event|49|||
161918975|NCT01838876|584751361|FG000|Overall Study|Insufficient Therapeutic Response|10|||
161918976|NCT01838876|584751361|FG000|Overall Study|Protocol Violation|34|||
161918977|NCT01838876|584751361|FG000|Overall Study|Withdrawal of Consent|33|||
161918978|NCT01838876|584751361|FG000|Overall Study|Lost to Follow-up|21|||
161918979|NCT01838876|584751361|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
161918980|NCT01838876|584751361|FG000|Overall Study|Reason not Specified|7|||
161918981|NCT01838876|584751361|FG000|Overall Study|Did not meet eligibility criteria|78|||
161918982|NCT01682031|584751362|FG000|Overall Study|Withdrawal by Subject|0|||
161918983|NCT01682031|584751363|FG001|Overall Study|Withdrawal by Subject|1|||
161918984|NCT01682031|584751362|FG000|Overall Study|Adverse Event|0|||
161918985|NCT01682031|584751363|FG001|Overall Study|Adverse Event|2|||
161918986|NCT01682031|584751362|FG000|Overall Study|MRI results indicate increased nodul|0|||
161918987|NCT01682031|584751363|FG001|Overall Study|MRI results indicate increased nodul|1|||
161918988|NCT01682031|584751362|FG000|Overall Study|Patient could not swallow tablets|1|||
161918989|NCT01682031|584751363|FG001|Overall Study|Patient could not swallow tablets|0|||
161918990|NCT01682031|584751362|FG000|Overall Study|Patient stopped selenium on his own|0|||
161918991|NCT01682031|584751363|FG001|Overall Study|Patient stopped selenium on his own|1|||
161918992|NCT03881371|584751368|FG000|Overall Study|Adverse Event|8|||
161918993|NCT03881371|584751369|FG001|Overall Study|Adverse Event|9|||
161918994|NCT03881371|584751368|FG000|Overall Study|Death|1|||
161918995|NCT03881371|584751369|FG001|Overall Study|Death|0|||
161918996|NCT03881371|584751368|FG000|Overall Study|Lost to Follow-up|1|||
161918997|NCT03881371|584751369|FG001|Overall Study|Lost to Follow-up|0|||
161918998|NCT03881371|584751368|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161918999|NCT03881371|584751369|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161919000|NCT03881371|584751368|FG000|Overall Study|Physician Decision|3|||
161919001|NCT03881371|584751369|FG001|Overall Study|Physician Decision|3|||
161919002|NCT03881371|584751368|FG000|Overall Study|Withdrawal by Subject|2|||
162015479|NCT03096288|585110555|FG002|Overall Study|Withdrawal by Subject|0|||
162015480|NCT03096288|585110556|FG003|Overall Study|Withdrawal by Subject|1|||
161919003|NCT03881371|584751369|FG001|Overall Study|Withdrawal by Subject|10|||
161919004|NCT03881371|584751368|FG000|Overall Study|Discontinuation from Study|1|||
161919005|NCT03881371|584751369|FG001|Overall Study|Discontinuation from Study|0|||
161919006|NCT00963235|584751375|FG000|Overall Study|Withdrawal by Subject|22|||
162015481|NCT04639258|585110557|FG000|Overall Study|Screen failure|5|||
162015482|NCT04639258|585110557|FG000|Overall Study|Physician Decision|2|||
162015483|NCT04639258|585110557|FG000|Overall Study|Early study termination|3|||
162015484|NCT04639258|585110557|FG000|Overall Study|Withdrawal by Subject|1|||
162015485|NCT00414596|585110559|FG000|Overall Study|Protocol Violation|2|||
162015486|NCT01635153|585110561|FG000|Overall Study|Lost to Follow-up|40|||
162015487|NCT01635153|585110562|FG001|Overall Study|Lost to Follow-up|43|||
162015488|NCT01995838|585110567|FG000|Overall Study|Lost to Follow-up|0|||
162015489|NCT01995838|585110568|FG001|Overall Study|Lost to Follow-up|1|||
162015490|NCT01995838|585110569|FG002|Overall Study|Lost to Follow-up|0|||
162015491|NCT01995838|585110570|FG003|Overall Study|Lost to Follow-up|0|||
162015492|NCT01995838|585110571|FG004|Overall Study|Lost to Follow-up|0|||
162015493|NCT01995838|585110572|FG005|Overall Study|Lost to Follow-up|0|||
162015494|NCT01995838|585110573|FG006|Overall Study|Lost to Follow-up|1|||
162015495|NCT01995838|585110567|FG000|Overall Study|Participant choice|2|||
162015496|NCT01995838|585110568|FG001|Overall Study|Participant choice|0|||
162015497|NCT01995838|585110569|FG002|Overall Study|Participant choice|0|||
162015498|NCT01995838|585110570|FG003|Overall Study|Participant choice|0|||
162015499|NCT01995838|585110571|FG004|Overall Study|Participant choice|0|||
162015500|NCT01995838|585110572|FG005|Overall Study|Participant choice|1|||
162015501|NCT01995838|585110573|FG006|Overall Study|Participant choice|1|||
162015502|NCT01995838|585110567|FG000|Overall Study|Adverse Event|0|||
162015503|NCT01995838|585110568|FG001|Overall Study|Adverse Event|0|||
162015504|NCT01995838|585110569|FG002|Overall Study|Adverse Event|0|||
162015505|NCT01995838|585110570|FG003|Overall Study|Adverse Event|0|||
162015506|NCT01995838|585110571|FG004|Overall Study|Adverse Event|0|||
162015507|NCT01995838|585110572|FG005|Overall Study|Adverse Event|0|||
162015508|NCT01995838|585110573|FG006|Overall Study|Adverse Event|1|||
162015509|NCT01995838|585110567|FG000|Overall Study|Withdrawal by Subject|0|||
162015510|NCT01995838|585110568|FG001|Overall Study|Withdrawal by Subject|0|||
162015511|NCT01995838|585110569|FG002|Overall Study|Withdrawal by Subject|0|||
162015512|NCT01995838|585110570|FG003|Overall Study|Withdrawal by Subject|0|||
162015513|NCT01995838|585110571|FG004|Overall Study|Withdrawal by Subject|1|||
162015514|NCT01995838|585110572|FG005|Overall Study|Withdrawal by Subject|0|||
162015515|NCT01995838|585110573|FG006|Overall Study|Withdrawal by Subject|0|||
162015516|NCT01995838|585110567|FG000|Overall Study|Other|3|||
162015517|NCT01995838|585110568|FG001|Overall Study|Other|1|||
162015518|NCT01995838|585110569|FG002|Overall Study|Other|0|||
162015519|NCT01995838|585110570|FG003|Overall Study|Other|2|||
162015520|NCT01995838|585110571|FG004|Overall Study|Other|1|||
162015521|NCT01995838|585110572|FG005|Overall Study|Other|1|||
162015522|NCT01995838|585110573|FG006|Overall Study|Other|2|||
162015523|NCT00346697|585110574|FG000|Overall Study|Lost to Follow-up|0|||
162015524|NCT00346697|585110575|FG001|Overall Study|Lost to Follow-up|1|||
162015525|NCT01012440|585110576|FG000|Overall Study|Withdrawal by Subject|2|||
162015526|NCT00318643|585110579|FG000|Overall Study|Adverse Event|0|||
161919007|NCT00963235|584751375|FG000|Overall Study|Lost to Follow-up|14|||
161919008|NCT00963235|584751375|FG000|Overall Study|Failed to return|9|||
161919009|NCT00963235|584751375|FG000|Overall Study|Protocol Violation|7|||
162015527|NCT00318643|585110580|FG001|Overall Study|Adverse Event|0|||
162015528|NCT00318643|585110581|FG002|Overall Study|Adverse Event|0|||
162015529|NCT00318643|585110582|FG003|Overall Study|Adverse Event|0|||
162015530|NCT00318643|585110583|FG004|Overall Study|Adverse Event|1|||
161919010|NCT00963235|584751375|FG000|Overall Study|Adverse Event|5|||
161919011|NCT00963235|584751375|FG000|Overall Study|Physician Decision|2|||
161919012|NCT00963235|584751375|FG000|Overall Study|Other|1|||
162015531|NCT00318643|585110579|FG000|Overall Study|Participant's Decision|0|||
162015532|NCT00318643|585110580|FG001|Overall Study|Participant's Decision|0|||
162015533|NCT00318643|585110581|FG002|Overall Study|Participant's Decision|0|||
162015534|NCT00318643|585110582|FG003|Overall Study|Participant's Decision|0|||
161919013|NCT01756235|584751376|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
161919014|NCT05376358|584751377|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
161919015|NCT05376358|584751378|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
161919016|NCT05376358|584751377|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
161919017|NCT05376358|584751378|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
161919018|NCT05376358|584751377|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
161919019|NCT05376358|584751378|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
161919020|NCT05376358|584751377|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
161919021|NCT05376358|584751378|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
161919022|NCT05376358|584751377|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
161919023|NCT05376358|584751378|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
161919024|NCT05376358|584751377|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
162015535|NCT00318643|585110583|FG004|Overall Study|Participant's Decision|1|||
162015536|NCT00318643|585110579|FG000|Overall Study|Investigator's Decision|0|||
161919025|NCT05376358|584751378|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
161919026|NCT04225832|584751379|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
161919027|NCT04225832|584751380|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
161919028|NCT04225832|584751379|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
161919029|NCT04225832|584751380|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
161919030|NCT00311168|584751381|FG000|First Intervention|Withdrawal by Subject|2|||
161919031|NCT00311168|584751382|FG001|First Intervention|Withdrawal by Subject|2|||
161919032|NCT00311168|584751381|FG000|First Intervention|Lost to Follow-up|1|||
161919033|NCT00311168|584751382|FG001|First Intervention|Lost to Follow-up|1|||
161919034|NCT00311168|584751381|FG000|First Intervention|Protocol Violation|1|||
161919035|NCT00311168|584751382|FG001|First Intervention|Protocol Violation|1|||
161919036|NCT00311168|584751381|FG000|First Intervention|Adverse Event|1|||
161919037|NCT00311168|584751382|FG001|First Intervention|Adverse Event|0|||
161919038|NCT00311168|584751381|FG000|First Intervention|Other|2|||
161919039|NCT00311168|584751382|FG001|First Intervention|Other|2|||
161919040|NCT00311168|584751381|FG000|Second Intervention|Lost to Follow-up|9|||
161919041|NCT00311168|584751382|FG001|Second Intervention|Lost to Follow-up|2|||
161919042|NCT00311168|584751381|FG000|Second Intervention|Withdrawal by Subject|0|||
161919043|NCT00311168|584751382|FG001|Second Intervention|Withdrawal by Subject|1|||
161919044|NCT00311168|584751381|FG000|Second Intervention|Other|1|||
161919045|NCT00311168|584751382|FG001|Second Intervention|Other|1|||
161919046|NCT05472142|584751385|FG000|Total Participants|Lost to Follow-up|312|||
161919047|NCT05472142|584751386|FG001|Total Participants|Lost to Follow-up|0|||
161919048|NCT05472142|584751385|FG000|Clinic Patients|Lost to Follow-up|312|||
161919049|NCT05472142|584751386|FG001|Clinic Patients|Lost to Follow-up|0|||
161919050|NCT02452190|584751387|FG000|Overall Study|Withdrawal by Sponsor|1|||
161919051|NCT02452190|584751388|FG001|Overall Study|Withdrawal by Sponsor|3|||
161919052|NCT02452190|584751387|FG000|Overall Study|Pregnancy|1|||
161919053|NCT02452190|584751388|FG001|Overall Study|Pregnancy|0|||
161919054|NCT02452190|584751387|FG000|Overall Study|Investigator's Decision|2|||
161919055|NCT02452190|584751388|FG001|Overall Study|Investigator's Decision|0|||
161919056|NCT02452190|584751387|FG000|Overall Study|Lack of Efficacy|3|||
161919057|NCT02452190|584751388|FG001|Overall Study|Lack of Efficacy|1|||
161919058|NCT02452190|584751387|FG000|Overall Study|Lost to Follow-up|4|||
161919059|NCT02452190|584751388|FG001|Overall Study|Lost to Follow-up|3|||
161919060|NCT02452190|584751387|FG000|Overall Study|Adverse Event|2|||
161919061|NCT02452190|584751388|FG001|Overall Study|Adverse Event|5|||
161919062|NCT02452190|584751387|FG000|Overall Study|Withdrawal by Subject|20|||
161919063|NCT02452190|584751388|FG001|Overall Study|Withdrawal by Subject|11|||
161919064|NCT02452190|584751387|FG000|Overall Study|Noncompliance with study drug|1|||
161919065|NCT02452190|584751388|FG001|Overall Study|Noncompliance with study drug|0|||
161919066|NCT02452190|584751387|FG000|Overall Study|Participant traveled abroad|1|||
161919067|NCT02452190|584751388|FG001|Overall Study|Participant traveled abroad|0|||
161919068|NCT02452190|584751387|FG000|Overall Study|Death|0|||
161919069|NCT02452190|584751388|FG001|Overall Study|Death|1|||
161919070|NCT02327078|584751393|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
161919071|NCT02327078|584751394|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
161919072|NCT02327078|584751395|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
161919073|NCT02327078|584751396|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
161919074|NCT02327078|584751397|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
162015537|NCT00318643|585110580|FG001|Overall Study|Investigator's Decision|0|||
162015538|NCT00318643|585110581|FG002|Overall Study|Investigator's Decision|0|||
162015539|NCT00318643|585110582|FG003|Overall Study|Investigator's Decision|0|||
162015540|NCT00318643|585110583|FG004|Overall Study|Investigator's Decision|1|||
162015541|NCT02691507|585110586|FG000|Overall Study|Missed Visit 3|0|||
162015542|NCT02691507|585110587|FG001|Overall Study|Missed Visit 3|1|||
161813938|NCT00466167|584361293|FG001|Overall Study|Withdrawal by Subject|1|||
161813939|NCT00466167|584361294|FG002|Overall Study|Withdrawal by Subject|6|||
161813940|NCT00466167|584361292|FG000|Overall Study|patient did not meet inclusion criteria|1|||
161813941|NCT00466167|584361293|FG001|Overall Study|patient did not meet inclusion criteria|0|||
161813942|NCT00466167|584361294|FG002|Overall Study|patient did not meet inclusion criteria|1|||
161813943|NCT00466167|584361292|FG000|Overall Study|Not treated|1|||
161813944|NCT00466167|584361293|FG001|Overall Study|Not treated|0|||
161813945|NCT00466167|584361294|FG002|Overall Study|Not treated|0|||
161813946|NCT03199963|584361295|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
161813947|NCT03199963|584361296|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
161813948|NCT03199963|584361295|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
161813949|NCT03199963|584361296|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
161813950|NCT03199963|584361295|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
161813951|NCT03199963|584361296|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
161813952|NCT03199963|584361295|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
161813953|NCT03199963|584361296|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
161813954|NCT03199963|584361295|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
161813955|NCT03199963|584361296|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
161813956|NCT03199963|584361295|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
161813957|NCT03199963|584361296|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
161813958|NCT02105272|584361303|FG000|Overall Study|Adverse Event|1|||
161813959|NCT02105272|584361304|FG001|Overall Study|Adverse Event|2|||
161813960|NCT02105272|584361303|FG000|Overall Study|Physician Decision|0|||
161813961|NCT02105272|584361304|FG001|Overall Study|Physician Decision|1|||
161813962|NCT02105272|584361303|FG000|Overall Study|Protocol Violation|2|||
161813963|NCT02105272|584361304|FG001|Overall Study|Protocol Violation|0|||
161813964|NCT02105272|584361303|FG000|Overall Study|Withdrawal by Subject|2|||
161813965|NCT02105272|584361304|FG001|Overall Study|Withdrawal by Subject|0|||
161813966|NCT03930732|584361305|FG000|Overall Study|Adverse Event|9|||
161813967|NCT03930732|584361306|FG001|Overall Study|Adverse Event|7|||
161813968|NCT03930732|584361305|FG000|Overall Study|Poor compliance to protocol|0|||
161813969|NCT03930732|584361306|FG001|Overall Study|Poor compliance to protocol|1|||
161813970|NCT03930732|584361305|FG000|Overall Study|Withdrawal by Subject|23|||
161813971|NCT03930732|584361306|FG001|Overall Study|Withdrawal by Subject|11|||
161813972|NCT03930732|584361305|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
161813973|NCT03930732|584361306|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
161813974|NCT03930732|584361305|FG000|Overall Study|Other reason not related to COVID-19|5|||
161813975|NCT03930732|584361306|FG001|Overall Study|Other reason not related to COVID-19|8|||
161813976|NCT04128761|584361313|FG000|Overall Study|Lost to Follow-up|5|||
161813977|NCT04128761|584361314|FG001|Overall Study|Lost to Follow-up|6|||
161813978|NCT06539676|584361315|FG000|Overall Study|Early study termination|1|||
161813979|NCT06539676|584361316|FG001|Overall Study|Early study termination|0|||
161813980|NCT06539676|584361317|FG002|Overall Study|Early study termination|6|||
161813981|NCT00830024|584361320|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161813982|NCT00830024|584361321|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
161813983|NCT02554890|584361322|FG000|Double-blind|Adverse Event|45|||
161813984|NCT02554890|584361323|FG001|Double-blind|Adverse Event|51|||
161813985|NCT02554890|584361322|FG000|Double-blind|Death|6|||
161813986|NCT02554890|584361323|FG001|Double-blind|Death|4|||
161813987|NCT02554890|584361322|FG000|Double-blind|Protocol Violation|1|||
161813988|NCT02554890|584361323|FG001|Double-blind|Protocol Violation|1|||
161813989|NCT02554890|584361322|FG000|Double-blind|Physician Decision|4|||
161813990|NCT02554890|584361323|FG001|Double-blind|Physician Decision|3|||
161813991|NCT02554890|584361322|FG000|Double-blind|Subject/Guardian decision|21|||
161813992|NCT02554890|584361323|FG001|Double-blind|Subject/Guardian decision|16|||
161813993|NCT02554890|584361322|FG000|Double-blind|Lost to Follow-up|7|||
161813994|NCT02554890|584361323|FG001|Double-blind|Lost to Follow-up|5|||
161813995|NCT02554890|584361322|FG000|Double-blind|Technical problems|1|||
161813996|NCT02554890|584361323|FG001|Double-blind|Technical problems|0|||
161813997|NCT02554890|584361322|FG000|Double-blind|Withdrawal by Subject|5|||
161813998|NCT02554890|584361323|FG001|Double-blind|Withdrawal by Subject|6|||
161813999|NCT02554890|584361322|FG000|Double-blind|Noncompliance with study treatment|6|||
161814000|NCT02554890|584361323|FG001|Double-blind|Noncompliance with study treatment|5|||
161814001|NCT02554890|584361322|FG000|Open-label|Adverse Event|0|||
161814002|NCT02554890|584361323|FG001|Open-label|Adverse Event|30|||
161814003|NCT02554890|584361322|FG000|Open-label|Death|0|||
161814004|NCT02554890|584361323|FG001|Open-label|Death|1|||
161814005|NCT02554890|584361322|FG000|Open-label|Physician Decision|0|||
161814006|NCT02554890|584361323|FG001|Open-label|Physician Decision|1|||
161814007|NCT02554890|584361322|FG000|Open-label|Subject/Guardian decision|0|||
162015543|NCT02557139|585110588|FG000|Overall Study|Significant liver elevation|1|||
162015544|NCT02557139|585110589|FG001|Overall Study|Significant liver elevation|0|||
162015545|NCT02557139|585110590|FG002|Overall Study|Significant liver elevation|1|||
162015546|NCT02557139|585110588|FG000|Overall Study|Withdrawal by Subject|1|||
162015547|NCT02557139|585110589|FG001|Overall Study|Withdrawal by Subject|0|||
162015548|NCT02557139|585110590|FG002|Overall Study|Withdrawal by Subject|0|||
162015549|NCT02557139|585110588|FG000|Overall Study|Illness of prohibited medication|0|||
162015550|NCT02557139|585110589|FG001|Overall Study|Illness of prohibited medication|0|||
162015551|NCT02557139|585110590|FG002|Overall Study|Illness of prohibited medication|1|||
162015552|NCT02284243|585110591|FG000|Overall Study|Lack of Efficacy|3|||
162015553|NCT02284243|585110592|FG001|Overall Study|Lack of Efficacy|3|||
162015554|NCT02284243|585110591|FG000|Overall Study|Adverse Event|1|||
162015555|NCT02284243|585110592|FG001|Overall Study|Adverse Event|0|||
162015556|NCT02699749|585110595|FG000|Overall Study|Other|0|||
162015557|NCT02699749|585110596|FG001|Overall Study|Other|0|||
162015558|NCT02699749|585110597|FG002|Overall Study|Other|2|||
162015559|NCT02699749|585110598|FG003|Overall Study|Other|0|||
162015560|NCT02699749|585110599|FG004|Overall Study|Other|0|||
162015561|NCT02699749|585110600|FG005|Overall Study|Other|1|||
162015562|NCT02699749|585110601|FG006|Overall Study|Other|1|||
162015563|NCT02699749|585110602|FG007|Overall Study|Other|0|||
162015564|NCT02699749|585110603|FG008|Overall Study|Other|0|||
162015565|NCT02699749|585110604|FG009|Overall Study|Other|0|||
162015566|NCT02699749|585110605|FG010|Overall Study|Other|1|||
162015567|NCT02699749|585110606|FG011|Overall Study|Other|0|||
162015568|NCT02699749|585110607|FG012|Overall Study|Other|0|||
161919075|NCT02327078|584751398|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
161919076|NCT02327078|584751399|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
161919077|NCT02327078|584751400|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
161919078|NCT02327078|584751401|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
161919079|NCT02327078|584751393|FG000|Overall Study|Death|2|||
161919080|NCT02327078|584751394|FG001|Overall Study|Death|4|||
161919081|NCT02327078|584751395|FG002|Overall Study|Death|10|||
161919082|NCT02327078|584751396|FG003|Overall Study|Death|6|||
161919083|NCT02327078|584751397|FG004|Overall Study|Death|4|||
161919084|NCT02327078|584751398|FG005|Overall Study|Death|3|||
161919085|NCT02327078|584751399|FG006|Overall Study|Death|2|||
161919086|NCT02327078|584751400|FG007|Overall Study|Death|51|||
161919087|NCT02327078|584751401|FG008|Overall Study|Death|97|||
161919088|NCT02327078|584751393|FG000|Overall Study|Lost to Follow-up|0|||
161919089|NCT02327078|584751394|FG001|Overall Study|Lost to Follow-up|1|||
161919090|NCT02327078|584751395|FG002|Overall Study|Lost to Follow-up|1|||
161919091|NCT02327078|584751396|FG003|Overall Study|Lost to Follow-up|0|||
161919092|NCT02327078|584751397|FG004|Overall Study|Lost to Follow-up|0|||
161919093|NCT02327078|584751398|FG005|Overall Study|Lost to Follow-up|0|||
161919094|NCT02327078|584751399|FG006|Overall Study|Lost to Follow-up|0|||
161919095|NCT02327078|584751400|FG007|Overall Study|Lost to Follow-up|2|||
161919096|NCT02327078|584751401|FG008|Overall Study|Lost to Follow-up|5|||
161919097|NCT02327078|584751393|FG000|Overall Study|Site Terminated by Sponsor|1|||
161919098|NCT02327078|584751394|FG001|Overall Study|Site Terminated by Sponsor|0|||
161919099|NCT02327078|584751395|FG002|Overall Study|Site Terminated by Sponsor|1|||
161919100|NCT02327078|584751396|FG003|Overall Study|Site Terminated by Sponsor|4|||
161919101|NCT02327078|584751397|FG004|Overall Study|Site Terminated by Sponsor|0|||
161919102|NCT02327078|584751398|FG005|Overall Study|Site Terminated by Sponsor|0|||
161919103|NCT02327078|584751399|FG006|Overall Study|Site Terminated by Sponsor|0|||
161919104|NCT02327078|584751400|FG007|Overall Study|Site Terminated by Sponsor|11|||
161919105|NCT02327078|584751401|FG008|Overall Study|Site Terminated by Sponsor|25|||
161919106|NCT02327078|584751393|FG000|Overall Study|Physician Decision|0|||
161919107|NCT02327078|584751394|FG001|Overall Study|Physician Decision|0|||
162015569|NCT02699749|585110608|FG013|Overall Study|Other|0|||
161919108|NCT02327078|584751395|FG002|Overall Study|Physician Decision|0|||
161919109|NCT02327078|584751396|FG003|Overall Study|Physician Decision|1|||
161919110|NCT02327078|584751397|FG004|Overall Study|Physician Decision|0|||
162015570|NCT02699749|585110595|FG000|Overall Study|Progressive Disease|3|||
162015571|NCT02699749|585110596|FG001|Overall Study|Progressive Disease|3|||
162015572|NCT02699749|585110597|FG002|Overall Study|Progressive Disease|14|||
162015573|NCT02699749|585110598|FG003|Overall Study|Progressive Disease|3|||
162161052|NCT02927769|585640202|FG001|Intensification Phase|Study drug toxicity|0|||
161919111|NCT02327078|584751398|FG005|Overall Study|Physician Decision|0|||
161919112|NCT02327078|584751399|FG006|Overall Study|Physician Decision|0|||
161919113|NCT02327078|584751400|FG007|Overall Study|Physician Decision|0|||
161919114|NCT02327078|584751401|FG008|Overall Study|Physician Decision|1|||
161919115|NCT02327078|584751393|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
161919116|NCT02327078|584751394|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
161919117|NCT02327078|584751395|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
162015574|NCT02699749|585110599|FG004|Overall Study|Progressive Disease|3|||
162015575|NCT02699749|585110600|FG005|Overall Study|Progressive Disease|7|||
162015576|NCT02699749|585110601|FG006|Overall Study|Progressive Disease|5|||
162161053|NCT05524233|585640207|FG000|Overall Study|Lost to Follow-up|2|||
162161054|NCT05524233|585640207|FG000|Overall Study|Adverse Event|2|||
162161055|NCT05524233|585640207|FG000|Overall Study|Withdrawal by Subject|1|||
162161056|NCT02307565|585640209|FG000|Overall Study|Adverse Event|3|||
162161057|NCT02307565|585640210|FG001|Overall Study|Adverse Event|2|||
162161058|NCT02307565|585640209|FG000|Overall Study|Withdrawal by Subject|2|||
162161059|NCT02307565|585640210|FG001|Overall Study|Withdrawal by Subject|2|||
162161060|NCT00650104|585640211|FG000|Overall Study|Adverse Event|17|||
162161061|NCT00650104|585640211|FG000|Overall Study|Death|2|||
162161062|NCT00650104|585640211|FG000|Overall Study|Withdrawal by Subject|11|||
162161063|NCT00650104|585640211|FG000|Overall Study|Physician Decision|7|||
162161064|NCT00650104|585640211|FG000|Overall Study|Lost to Follow-up|1|||
161814008|NCT02554890|584361323|FG001|Open-label|Subject/Guardian decision|11|||
161814009|NCT02554890|584361322|FG000|Open-label|Lost to Follow-up|0|||
161814010|NCT02554890|584361323|FG001|Open-label|Lost to Follow-up|7|||
161814011|NCT02554890|584361322|FG000|Open-label|Technical problems|0|||
161814012|NCT02554890|584361323|FG001|Open-label|Technical problems|1|||
161814013|NCT02554890|584361322|FG000|Open-label|Withdrawal by Subject|0|||
161814014|NCT02554890|584361323|FG001|Open-label|Withdrawal by Subject|1|||
161814015|NCT03649477|584361326|FG000|Overall Study|Adverse Event|2|||
161814016|NCT03649477|584361327|FG001|Overall Study|Adverse Event|0|||
161814017|NCT03649477|584361328|FG002|Overall Study|Adverse Event|0|||
161814018|NCT04544410|584361329|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161814019|NCT04544410|584361330|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161814020|NCT04544410|584361329|FG000|Double-blind Treatment Period|Adverse Event|1|||
161814021|NCT04544410|584361330|FG001|Double-blind Treatment Period|Adverse Event|0|||
161814022|NCT04544410|584361329|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
161814023|NCT04544410|584361330|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161814024|NCT04544410|584361329|FG000|Double-blind Treatment Period|Protocol Violation|1|||
161814025|NCT04544410|584361330|FG001|Double-blind Treatment Period|Protocol Violation|0|||
161814026|NCT04544410|584361329|FG000|Open-Label Treatment Period|Study Terminated|15|||
161814027|NCT04544410|584361330|FG001|Open-Label Treatment Period|Study Terminated|19|||
161814028|NCT04544410|584361329|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
161814029|NCT04544410|584361330|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
161814030|NCT04544410|584361329|FG000|Open-Label Treatment Period|Adverse Event|0|||
161814031|NCT04544410|584361330|FG001|Open-Label Treatment Period|Adverse Event|1|||
161814032|NCT04544410|584361329|FG000|Open-Label Treatment Period|Physician Decision|1|||
161814033|NCT04544410|584361330|FG001|Open-Label Treatment Period|Physician Decision|0|||
161814034|NCT04544410|584361329|FG000|Open-Label Treatment Period|Other|0|||
161814035|NCT04544410|584361330|FG001|Open-Label Treatment Period|Other|1|||
161814036|NCT01624233|584362868|FG000|Period 2 - Induction|Adverse Event|1|||
161814037|NCT01624233|584362868|FG000|Period 3 - Maintenance|Adverse Event|2|||
161814038|NCT01624233|584362868|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
161814039|NCT01624233|584362868|FG000|Period 3 - Maintenance|Physician Decision|2|||
161814040|NCT01624233|584362868|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
161814041|NCT01624233|584362868|FG000|Period 4 - Drug Free Period|Relapsed|61|||
161814042|NCT01624233|584362868|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
161814043|NCT01624233|584362868|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
161814044|NCT01624233|584362868|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
161814045|NCT01624233|584362868|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
161814046|NCT01624233|584362868|FG000|Period 6: Follow-up|Adverse Event|3|||
161814047|NCT01624233|584362868|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
161814048|NCT01624233|584362868|FG000|Period 6: Follow-up|Physician Decision|1|||
161814049|NCT01624233|584362868|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
161814050|NCT03121586|584362869|FG000|Overall Study|Study terminated by sponsor|0|||
161814051|NCT03121586|584362870|FG001|Overall Study|Study terminated by sponsor|0|||
161814052|NCT03121586|584362871|FG002|Overall Study|Study terminated by sponsor|99|||
161814053|NCT03121586|584362869|FG000|Overall Study|Withdrawal by Subject|37|||
161814054|NCT03121586|584362870|FG001|Overall Study|Withdrawal by Subject|14|||
161814055|NCT03121586|584362871|FG002|Overall Study|Withdrawal by Subject|9|||
161814056|NCT03121586|584362869|FG000|Overall Study|Not further specified|6|||
161814057|NCT03121586|584362870|FG001|Overall Study|Not further specified|11|||
161814058|NCT03121586|584362871|FG002|Overall Study|Not further specified|10|||
161814059|NCT03121586|584362869|FG000|Overall Study|Adverse Event|16|||
161814060|NCT03121586|584362870|FG001|Overall Study|Adverse Event|5|||
161814061|NCT03121586|584362871|FG002|Overall Study|Adverse Event|6|||
161814062|NCT03121586|584362869|FG000|Overall Study|Protocol Violation|0|||
161814063|NCT03121586|584362870|FG001|Overall Study|Protocol Violation|5|||
161814064|NCT03121586|584362871|FG002|Overall Study|Protocol Violation|0|||
161814065|NCT03121586|584362869|FG000|Overall Study|Lack of Efficacy|3|||
161814066|NCT03121586|584362870|FG001|Overall Study|Lack of Efficacy|3|||
161814067|NCT03121586|584362871|FG002|Overall Study|Lack of Efficacy|1|||
161814068|NCT03121586|584362869|FG000|Overall Study|Physician Decision|2|||
161814069|NCT03121586|584362870|FG001|Overall Study|Physician Decision|2|||
161814070|NCT03121586|584362871|FG002|Overall Study|Physician Decision|0|||
162161065|NCT00650104|585640211|FG000|Overall Study|Non-compliance|2|||
162161066|NCT00650104|585640211|FG000|Overall Study|Sponsor Terminated Dosing|1|||
162015577|NCT02699749|585110602|FG007|Overall Study|Progressive Disease|5|||
162015578|NCT02699749|585110603|FG008|Overall Study|Progressive Disease|6|||
162015579|NCT02699749|585110604|FG009|Overall Study|Progressive Disease|6|||
161919118|NCT02327078|584751396|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
161919119|NCT02327078|584751397|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
161919120|NCT02327078|584751398|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
161919121|NCT02327078|584751399|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
161919122|NCT02327078|584751400|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
161919123|NCT02327078|584751401|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
161919124|NCT02327078|584751393|FG000|Overall Study|Reason not Specified|0|||
161919125|NCT02327078|584751394|FG001|Overall Study|Reason not Specified|0|||
161919126|NCT02327078|584751395|FG002|Overall Study|Reason not Specified|0|||
161919127|NCT02327078|584751396|FG003|Overall Study|Reason not Specified|0|||
161919128|NCT02327078|584751397|FG004|Overall Study|Reason not Specified|0|||
161919129|NCT02327078|584751398|FG005|Overall Study|Reason not Specified|0|||
161919130|NCT02327078|584751399|FG006|Overall Study|Reason not Specified|0|||
162161067|NCT05633407|585640216|FG000|Overall Study|Physician Decision|2|||
162161068|NCT05633407|585640217|FG001|Overall Study|Physician Decision|0|||
162161069|NCT05633407|585640216|FG000|Overall Study|Adverse Event|1|||
162161070|NCT05633407|585640217|FG001|Overall Study|Adverse Event|0|||
161919131|NCT02327078|584751400|FG007|Overall Study|Reason not Specified|5|||
161919132|NCT02327078|584751401|FG008|Overall Study|Reason not Specified|12|||
161919133|NCT06001021|584751402|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
161919134|NCT06001021|584751403|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
161919135|NCT06001021|584751404|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
161919136|NCT06001021|584751405|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
161919137|NCT06001021|584751406|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
161919138|NCT06001021|584751407|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
161919139|NCT06001021|584751408|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
161919140|NCT06001021|584751402|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
161919141|NCT06001021|584751403|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
161919142|NCT06001021|584751404|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
162161071|NCT05633407|585640216|FG000|Overall Study|Withdrawal by Subject|1|||
162161072|NCT05633407|585640217|FG001|Overall Study|Withdrawal by Subject|0|||
162161073|NCT05633407|585640216|FG000|Overall Study|Other|1|||
162161074|NCT05633407|585640217|FG001|Overall Study|Other|1|||
162161075|NCT04838613|585640219|FG000|Overall Study|Withdrawal by Subject|3|||
162161076|NCT04838613|585640220|FG001|Overall Study|Withdrawal by Subject|6|||
162161077|NCT04838613|585640219|FG000|Overall Study|Protocol Deviation|3|||
162161078|NCT04838613|585640220|FG001|Overall Study|Protocol Deviation|2|||
162161079|NCT04838613|585640219|FG000|Overall Study|Technical Problems|0|||
162161080|NCT04838613|585640220|FG001|Overall Study|Technical Problems|5|||
162161081|NCT04838613|585640219|FG000|Overall Study|Physician Decision|2|||
162161082|NCT04838613|585640220|FG001|Overall Study|Physician Decision|0|||
162161083|NCT04757610|585640221|FG000|Overall Study|Adverse Event|13|||
162161084|NCT04757610|585640222|FG001|Overall Study|Adverse Event|10|||
162161085|NCT04757610|585640223|FG002|Overall Study|Adverse Event|5|||
162161086|NCT04757610|585640221|FG000|Overall Study|Death|5|||
162161087|NCT04757610|585640222|FG001|Overall Study|Death|13|||
162161088|NCT04757610|585640223|FG002|Overall Study|Death|8|||
162161089|NCT04757610|585640221|FG000|Overall Study|Lack of Efficacy|1|||
162161090|NCT04757610|585640222|FG001|Overall Study|Lack of Efficacy|2|||
162161091|NCT04757610|585640223|FG002|Overall Study|Lack of Efficacy|3|||
162161092|NCT04757610|585640221|FG000|Overall Study|Lost to Follow-up|7|||
162161093|NCT04757610|585640222|FG001|Overall Study|Lost to Follow-up|2|||
162161094|NCT04757610|585640223|FG002|Overall Study|Lost to Follow-up|7|||
162161095|NCT04757610|585640221|FG000|Overall Study|Physician Decision|4|||
162161096|NCT04757610|585640222|FG001|Overall Study|Physician Decision|1|||
162161097|NCT04757610|585640223|FG002|Overall Study|Physician Decision|2|||
162161098|NCT04757610|585640221|FG000|Overall Study|Withdrawal by Subject|26|||
162161099|NCT04757610|585640222|FG001|Overall Study|Withdrawal by Subject|25|||
162161100|NCT04757610|585640223|FG002|Overall Study|Withdrawal by Subject|25|||
162161101|NCT04757610|585640221|FG000|Overall Study|Study Terminated by Sponsor|105|||
162161102|NCT04757610|585640222|FG001|Overall Study|Study Terminated by Sponsor|105|||
162161103|NCT04757610|585640223|FG002|Overall Study|Study Terminated by Sponsor|110|||
162161104|NCT04757610|585640221|FG000|Overall Study|Randomized in Error|1|||
162015580|NCT02699749|585110605|FG010|Overall Study|Progressive Disease|5|||
162161105|NCT04757610|585640222|FG001|Overall Study|Randomized in Error|0|||
162161106|NCT04757610|585640223|FG002|Overall Study|Randomized in Error|0|||
162161107|NCT00593489|585640228|FG000|Allocation|did not attend workshop; allocation not|2|||
162161108|NCT00593489|585640229|FG001|Allocation|did not attend workshop; allocation not|1|||
162161109|NCT00951379|585640230|FG000|Overall Study|Adverse Event|4|||
162161110|NCT00951379|585640231|FG001|Overall Study|Adverse Event|1|||
162161111|NCT00951379|585640230|FG000|Overall Study|Withdrawal by Subject|1|||
162161112|NCT00951379|585640231|FG001|Overall Study|Withdrawal by Subject|0|||
162161113|NCT00951379|585640230|FG000|Overall Study|Noncompliance|1|||
162161114|NCT00951379|585640231|FG001|Overall Study|Noncompliance|0|||
162161115|NCT00951379|585640230|FG000|Overall Study|Disease Progression|0|||
162161116|NCT00951379|585640231|FG001|Overall Study|Disease Progression|1|||
162161117|NCT03432858|585640232|FG000|Overall Study|Protocol Violation|2|||
162161118|NCT03432858|585640233|FG001|Overall Study|Protocol Violation|1|||
162161119|NCT03432858|585640234|FG002|Overall Study|Protocol Violation|9|||
162161120|NCT03432858|585640232|FG000|Overall Study|Withdrawal by Subject|0|||
162161121|NCT03432858|585640233|FG001|Overall Study|Withdrawal by Subject|1|||
162161122|NCT03432858|585640234|FG002|Overall Study|Withdrawal by Subject|1|||
161814071|NCT03121586|584362869|FG000|Overall Study|Noncompliance with study drug|5|||
161814072|NCT03121586|584362870|FG001|Overall Study|Noncompliance with study drug|3|||
161814073|NCT03121586|584362871|FG002|Overall Study|Noncompliance with study drug|5|||
161814074|NCT03121586|584362869|FG000|Overall Study|Lost to Follow-up|4|||
161814075|NCT03121586|584362870|FG001|Overall Study|Lost to Follow-up|2|||
161814076|NCT03121586|584362871|FG002|Overall Study|Lost to Follow-up|0|||
161814077|NCT03121586|584362869|FG000|Overall Study|Death|2|||
161814078|NCT03121586|584362870|FG001|Overall Study|Death|0|||
161814079|NCT03121586|584362871|FG002|Overall Study|Death|0|||
161814080|NCT06381102|584362872|FG000|Washout 5 Days|Withdrawal by Subject|0|||
161814081|NCT06381102|584362873|FG001|Washout 5 Days|Withdrawal by Subject|2|||
161814082|NCT02832063|584362875|FG000|Overall Study|Adverse Event|2|||
161814083|NCT02832063|584362876|FG001|Overall Study|Adverse Event|1|||
161814084|NCT02832063|584362875|FG000|Overall Study|Physician Decision|5|||
161814085|NCT02832063|584362876|FG001|Overall Study|Physician Decision|7|||
161814086|NCT02832063|584362875|FG000|Overall Study|Lost to Follow-up|15|||
161814087|NCT02832063|584362876|FG001|Overall Study|Lost to Follow-up|8|||
161814088|NCT02832063|584362875|FG000|Overall Study|Withdrawal by Subject|10|||
161814089|NCT02832063|584362876|FG001|Overall Study|Withdrawal by Subject|21|||
161814090|NCT02832063|584362875|FG000|Overall Study|Other|2|||
161814091|NCT02832063|584362876|FG001|Overall Study|Other|1|||
161814092|NCT03733730|584362877|FG000|Overall Study|Lost to Follow-up|1|||
161814093|NCT03733730|584362878|FG001|Overall Study|Lost to Follow-up|32|||
161814094|NCT03733730|584362877|FG000|Overall Study|Other|1|||
161814095|NCT03733730|584362878|FG001|Overall Study|Other|0|||
161814096|NCT03733730|584362877|FG000|Overall Study|Adverse Event|0|||
161814097|NCT03733730|584362878|FG001|Overall Study|Adverse Event|4|||
161814098|NCT03733730|584362877|FG000|Overall Study|Death|0|||
161814099|NCT03733730|584362878|FG001|Overall Study|Death|5|||
161814100|NCT03733730|584362877|FG000|Overall Study|Withdrawal by Subject|0|||
161814101|NCT03733730|584362878|FG001|Overall Study|Withdrawal by Subject|8|||
161814102|NCT00772603|584362879|FG000|Overall Study|Withdrawal by Subject|11|||
161814103|NCT00772603|584362880|FG001|Overall Study|Withdrawal by Subject|10|||
161814104|NCT00772603|584362881|FG002|Overall Study|Withdrawal by Subject|6|||
161919143|NCT06001021|584751405|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
161919144|NCT06001021|584751406|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
161919145|NCT06001021|584751407|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
161919146|NCT06001021|584751408|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
161919147|NCT03112603|584751410|FG000|End of Randomization Period|Lost to Follow-up|3|||
161919148|NCT03112603|584751411|FG001|End of Randomization Period|Lost to Follow-up|0|||
161919149|NCT03112603|584751412|FG002|End of Randomization Period|Lost to Follow-up|0|||
161919150|NCT03112603|584751410|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
161919151|NCT03112603|584751411|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
161919152|NCT03112603|584751412|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
161919153|NCT03112603|584751410|FG000|End of Randomization Period|Physician Decision|43|||
161919154|NCT03112603|584751411|FG001|End of Randomization Period|Physician Decision|18|||
161919155|NCT03112603|584751412|FG002|End of Randomization Period|Physician Decision|0|||
161919156|NCT03112603|584751410|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
161919157|NCT03112603|584751411|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
161919158|NCT03112603|584751412|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
161919159|NCT03112603|584751410|FG000|End of Randomization Period|Death|10|||
161919160|NCT03112603|584751411|FG001|End of Randomization Period|Death|7|||
161919161|NCT03112603|584751412|FG002|End of Randomization Period|Death|0|||
161919162|NCT03112603|584751410|FG000|End of Randomization Period|Disease Relapse|12|||
161919163|NCT03112603|584751411|FG001|End of Randomization Period|Disease Relapse|7|||
161919164|NCT03112603|584751412|FG002|End of Randomization Period|Disease Relapse|0|||
161919165|NCT03112603|584751410|FG000|End of Randomization Period|Lack of Efficacy|25|||
161919166|NCT03112603|584751411|FG001|End of Randomization Period|Lack of Efficacy|77|||
161814105|NCT00772603|584362879|FG000|Overall Study|Adverse Event|37|||
161814106|NCT00772603|584362880|FG001|Overall Study|Adverse Event|18|||
161814107|NCT00772603|584362881|FG002|Overall Study|Adverse Event|10|||
161814108|NCT00772603|584362879|FG000|Overall Study|Subject Non-compliance|1|||
161814109|NCT00772603|584362880|FG001|Overall Study|Subject Non-compliance|6|||
161814110|NCT00772603|584362881|FG002|Overall Study|Subject Non-compliance|4|||
161814111|NCT00772603|584362879|FG000|Overall Study|Protocol Violation|0|||
161814112|NCT00772603|584362880|FG001|Overall Study|Protocol Violation|1|||
162015581|NCT02699749|585110606|FG011|Overall Study|Progressive Disease|4|||
162015582|NCT02699749|585110607|FG012|Overall Study|Progressive Disease|3|||
162015583|NCT02699749|585110608|FG013|Overall Study|Progressive Disease|5|||
162015584|NCT02699749|585110595|FG000|Overall Study|Death|0|||
162015585|NCT02699749|585110596|FG001|Overall Study|Death|0|||
162015586|NCT02699749|585110597|FG002|Overall Study|Death|0|||
162015587|NCT02699749|585110598|FG003|Overall Study|Death|0|||
162015588|NCT02699749|585110599|FG004|Overall Study|Death|0|||
162015589|NCT02699749|585110600|FG005|Overall Study|Death|0|||
162015590|NCT02699749|585110601|FG006|Overall Study|Death|0|||
162015591|NCT02699749|585110602|FG007|Overall Study|Death|0|||
162015592|NCT02699749|585110603|FG008|Overall Study|Death|0|||
162015593|NCT02699749|585110604|FG009|Overall Study|Death|0|||
162015594|NCT02699749|585110605|FG010|Overall Study|Death|0|||
162015595|NCT02699749|585110606|FG011|Overall Study|Death|0|||
162015596|NCT02699749|585110607|FG012|Overall Study|Death|0|||
162015597|NCT02699749|585110608|FG013|Overall Study|Death|1|||
162015598|NCT02699749|585110595|FG000|Overall Study|Lost to Follow-up|0|||
162015599|NCT02699749|585110596|FG001|Overall Study|Lost to Follow-up|0|||
162015600|NCT02699749|585110597|FG002|Overall Study|Lost to Follow-up|0|||
162015601|NCT02699749|585110598|FG003|Overall Study|Lost to Follow-up|0|||
162015602|NCT02699749|585110599|FG004|Overall Study|Lost to Follow-up|0|||
162015603|NCT02699749|585110600|FG005|Overall Study|Lost to Follow-up|1|||
162015604|NCT02699749|585110601|FG006|Overall Study|Lost to Follow-up|0|||
162015605|NCT02699749|585110602|FG007|Overall Study|Lost to Follow-up|1|||
162015606|NCT02699749|585110603|FG008|Overall Study|Lost to Follow-up|0|||
162015607|NCT02699749|585110604|FG009|Overall Study|Lost to Follow-up|0|||
162015608|NCT02699749|585110605|FG010|Overall Study|Lost to Follow-up|0|||
162015609|NCT02699749|585110606|FG011|Overall Study|Lost to Follow-up|0|||
162015610|NCT02699749|585110607|FG012|Overall Study|Lost to Follow-up|0|||
162015611|NCT02699749|585110608|FG013|Overall Study|Lost to Follow-up|0|||
162015612|NCT02377817|585110610|FG000|Overall Study|Transportation/childcare barriers.|2|||
162015613|NCT02377817|585110611|FG001|Overall Study|Transportation/childcare barriers.|0|||
162015614|NCT02377817|585110610|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
162015615|NCT02377817|585110611|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
162015616|NCT04139018|585110612|FG000|Overall Study|Screen fail|1|||
162015617|NCT04139018|585110613|FG001|Overall Study|Screen fail|0|||
162015618|NCT04139018|585110612|FG000|Overall Study|Withdrawal by Subject|2|||
162015619|NCT04139018|585110613|FG001|Overall Study|Withdrawal by Subject|0|||
162015620|NCT04139018|585110612|FG000|Overall Study|Lost to Follow-up|0|||
162015621|NCT04139018|585110613|FG001|Overall Study|Lost to Follow-up|1|||
162015622|NCT01106248|585110631|FG000|Overall Study|Adverse Event|1|||
162015623|NCT01106248|585110631|FG000|Overall Study|Administrative|2|||
162015624|NCT01160822|585110632|FG000|Overall Study|Adverse Event|0|||
162015625|NCT01160822|585110633|FG001|Overall Study|Adverse Event|0|||
162015626|NCT01160822|585110634|FG002|Overall Study|Adverse Event|0|||
162015627|NCT01160822|585110635|FG003|Overall Study|Adverse Event|0|||
162015628|NCT01160822|585110636|FG004|Overall Study|Adverse Event|1|||
162015629|NCT01160822|585110637|FG005|Overall Study|Adverse Event|2|||
162015630|NCT01160822|585110638|FG006|Overall Study|Adverse Event|5|||
162015631|NCT01160822|585110632|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162015632|NCT01160822|585110633|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162015633|NCT01160822|585110634|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
162015634|NCT01160822|585110635|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
162015635|NCT01160822|585110636|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
162015636|NCT01160822|585110637|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
162015637|NCT01160822|585110638|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
162015638|NCT01160822|585110632|FG000|Overall Study|Withdrawal by Subject|0|||
162015639|NCT01160822|585110633|FG001|Overall Study|Withdrawal by Subject|0|||
162015640|NCT01160822|585110634|FG002|Overall Study|Withdrawal by Subject|0|||
162015641|NCT01160822|585110635|FG003|Overall Study|Withdrawal by Subject|0|||
162015642|NCT01160822|585110636|FG004|Overall Study|Withdrawal by Subject|0|||
162015643|NCT01160822|585110637|FG005|Overall Study|Withdrawal by Subject|0|||
162015644|NCT01160822|585110638|FG006|Overall Study|Withdrawal by Subject|1|||
162015645|NCT01160822|585110632|FG000|Overall Study|Lost to Follow-up|0|||
162015646|NCT01160822|585110633|FG001|Overall Study|Lost to Follow-up|0|||
162015647|NCT01160822|585110634|FG002|Overall Study|Lost to Follow-up|0|||
162015648|NCT01160822|585110635|FG003|Overall Study|Lost to Follow-up|0|||
162015649|NCT01160822|585110636|FG004|Overall Study|Lost to Follow-up|1|||
162015650|NCT01160822|585110637|FG005|Overall Study|Lost to Follow-up|0|||
162015651|NCT01160822|585110638|FG006|Overall Study|Lost to Follow-up|0|||
162015652|NCT01160822|585110632|FG000|Overall Study|Administrative problems|0|||
162015653|NCT01160822|585110633|FG001|Overall Study|Administrative problems|0|||
162015654|NCT01160822|585110634|FG002|Overall Study|Administrative problems|0|||
162015655|NCT01160822|585110635|FG003|Overall Study|Administrative problems|0|||
162015656|NCT01160822|585110636|FG004|Overall Study|Administrative problems|1|||
162015657|NCT01160822|585110637|FG005|Overall Study|Administrative problems|0|||
162015658|NCT01160822|585110638|FG006|Overall Study|Administrative problems|0|||
162015659|NCT01160822|585110632|FG000|Overall Study|Protocol deviation|0|||
162161123|NCT03432858|585640232|FG000|Overall Study|Procedure canceled/rescheduled|0|||
162161124|NCT03432858|585640233|FG001|Overall Study|Procedure canceled/rescheduled|9|||
162161125|NCT03432858|585640234|FG002|Overall Study|Procedure canceled/rescheduled|6|||
162161126|NCT03432858|585640232|FG000|Overall Study|Required postop mobilization with splinting|0|||
162015660|NCT01160822|585110633|FG001|Overall Study|Protocol deviation|0|||
162015661|NCT01160822|585110634|FG002|Overall Study|Protocol deviation|0|||
162015662|NCT01160822|585110635|FG003|Overall Study|Protocol deviation|0|||
162015663|NCT01160822|585110636|FG004|Overall Study|Protocol deviation|2|||
162015664|NCT01160822|585110637|FG005|Overall Study|Protocol deviation|0|||
162015665|NCT01160822|585110638|FG006|Overall Study|Protocol deviation|0|||
162015666|NCT01648751|585110643|FG000|Overall Study|Withdrawal by Subject|2|||
162015667|NCT01648751|585110644|FG001|Overall Study|Withdrawal by Subject|3|||
162015668|NCT03467750|585110646|FG000|Overall Study|Surgery canceled|1|||
162015669|NCT03467750|585110647|FG001|Overall Study|Surgery canceled|0|||
162015670|NCT03467750|585110646|FG000|Overall Study|Protocol Violation|1|||
162015671|NCT03467750|585110647|FG001|Overall Study|Protocol Violation|1|||
162161127|NCT03432858|585640233|FG001|Overall Study|Required postop mobilization with splinting|0|||
162161128|NCT03432858|585640234|FG002|Overall Study|Required postop mobilization with splinting|1|||
162161129|NCT01011946|585640235|FG000|Overall Study|Transferred to another hospital|2|||
162161130|NCT01011946|585640235|FG000|Overall Study|No pathological lab value|1|||
162161131|NCT03527160|585640239|FG000|Overall Study|No urine collected|13|||
162161132|NCT03527160|585640239|FG000|Overall Study|No clinical serum creatinine collected|6|||
162161133|NCT03527160|585640239|FG000|Overall Study|Did not meet inclusion|2|||
162161134|NCT03690206|585640242|FG000|Overall Study|Withdrawal by Subject|2|||
162161135|NCT03690206|585640243|FG001|Overall Study|Withdrawal by Subject|0|||
162161136|NCT03690206|585640244|FG002|Overall Study|Withdrawal by Subject|0|||
162161137|NCT03690206|585640242|FG000|Overall Study|ICF withdrawal|2|||
162161138|NCT03690206|585640243|FG001|Overall Study|ICF withdrawal|0|||
162161139|NCT03690206|585640244|FG002|Overall Study|ICF withdrawal|0|||
162161140|NCT03978637|585640246|FG000|Overall Study|Death|0|||
162161141|NCT03978637|585640247|FG001|Overall Study|Death|2|||
162161142|NCT03978637|585640248|FG002|Overall Study|Death|2|||
162161143|NCT03978637|585640249|FG003|Overall Study|Death|0|||
162161144|NCT03978637|585640246|FG000|Overall Study|Withdrawal by Subject|0|||
162161145|NCT03978637|585640247|FG001|Overall Study|Withdrawal by Subject|0|||
162161146|NCT03978637|585640248|FG002|Overall Study|Withdrawal by Subject|1|||
162161147|NCT03978637|585640249|FG003|Overall Study|Withdrawal by Subject|0|||
162161148|NCT03978637|585640246|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
162161149|NCT03978637|585640247|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
162161150|NCT03978637|585640248|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
162161151|NCT03978637|585640249|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
162161152|NCT01959698|585640250|FG000|Overall Study|Adverse Event|0|||
162161153|NCT01959698|585640251|FG001|Overall Study|Adverse Event|0|||
162161154|NCT01959698|585640252|FG002|Overall Study|Adverse Event|0|||
162161155|NCT01959698|585640253|FG003|Overall Study|Adverse Event|0|||
162161156|NCT01959698|585640254|FG004|Overall Study|Adverse Event|0|||
162161157|NCT01959698|585640255|FG005|Overall Study|Adverse Event|0|||
162161158|NCT01959698|585640256|FG006|Overall Study|Adverse Event|1|||
162161159|NCT01959698|585640250|FG000|Overall Study|Physician Decision|1|||
162161160|NCT01959698|585640251|FG001|Overall Study|Physician Decision|0|||
162161161|NCT01959698|585640252|FG002|Overall Study|Physician Decision|1|||
162161162|NCT01959698|585640253|FG003|Overall Study|Physician Decision|2|||
162161163|NCT01959698|585640254|FG004|Overall Study|Physician Decision|0|||
162161164|NCT01959698|585640255|FG005|Overall Study|Physician Decision|3|||
162161165|NCT01959698|585640256|FG006|Overall Study|Physician Decision|3|||
162161166|NCT03819686|585641704|FG000|Overall Study|Lost to Follow-up|2|||
162161167|NCT03819686|585641705|FG001|Overall Study|Lost to Follow-up|3|||
162161168|NCT06143670|585641706|FG000|Overall Study|Lost to Follow-up|0|||
162161169|NCT06143670|585641707|FG001|Overall Study|Lost to Follow-up|1|||
162161170|NCT06143670|585641706|FG000|Overall Study|Withdrawal by Subject|3|||
162161171|NCT06143670|585641707|FG001|Overall Study|Withdrawal by Subject|0|||
162161172|NCT03625882|585641710|FG000|Overall Study|Protocol Violation|3|||
162161173|NCT05058391|585641711|FG000|Overall Study|Adverse Event|1|||
162161174|NCT03833245|585641714|FG000|Overall Study|Death|0|||
162161175|NCT03833245|585641715|FG001|Overall Study|Death|1|||
162161176|NCT03347383|585641716|FG000|Overall Study|Death|39|||
162015672|NCT03467750|585110646|FG000|Overall Study|Withdrawal by Subject|0|||
162015673|NCT03467750|585110647|FG001|Overall Study|Withdrawal by Subject|1|||
162161177|NCT03347383|585641716|FG000|Overall Study|Withdrawal by Subject|3|||
162161178|NCT03347383|585641716|FG000|Overall Study|Lost to Follow-up|9|||
162161179|NCT04842643|585641718|FG000|Overall Study|Physician Decision|1|||
162161180|NCT04842643|585641718|FG000|Overall Study|Other|1|||
162161181|NCT04173663|585641719|FG000|Overall Study|Withdrawal by Subject|1|||
162161182|NCT04173663|585641720|FG001|Overall Study|Withdrawal by Subject|6|||
162161183|NCT04173663|585641719|FG000|Overall Study|Lost to Follow-up|17|||
162015674|NCT05673876|585110648|FG000|Overall Study|Death|3|||
162161184|NCT04173663|585641720|FG001|Overall Study|Lost to Follow-up|24|||
162161185|NCT04833777|585641726|FG000|Overall Study|Lost to Follow-up|1|||
162161186|NCT04833777|585641727|FG001|Overall Study|Lost to Follow-up|0|||
162161187|NCT03089398|585641735|FG000|Overall Study|Death|4|||
162161188|NCT03089398|585641736|FG001|Overall Study|Death|9|||
162161189|NCT03089398|585641735|FG000|Overall Study|Lost to Follow-up|21|||
162161190|NCT03089398|585641736|FG001|Overall Study|Lost to Follow-up|30|||
162161191|NCT03089398|585641735|FG000|Overall Study|Withdrawal by Subject|2|||
162161192|NCT03089398|585641736|FG001|Overall Study|Withdrawal by Subject|2|||
162161193|NCT02662062|585641737|FG000|Overall Study|Withdrawal by Subject|1|||
162161194|NCT00676715|585641738|FG000|Treatment Period (TP)|Adverse Event|0|||
162161195|NCT00676715|585641739|FG001|Treatment Period (TP)|Adverse Event|3|||
162161196|NCT00676715|585641740|FG002|Treatment Period (TP)|Adverse Event|2|||
161814113|NCT00772603|584362881|FG002|Overall Study|Protocol Violation|1|||
161814114|NCT00772603|584362879|FG000|Overall Study|Lost to Follow-up|1|||
161814115|NCT00772603|584362880|FG001|Overall Study|Lost to Follow-up|5|||
161814116|NCT00772603|584362881|FG002|Overall Study|Lost to Follow-up|2|||
161814117|NCT00772603|584362879|FG000|Overall Study|Physician Decision|0|||
161814118|NCT00772603|584362880|FG001|Overall Study|Physician Decision|0|||
161814119|NCT00772603|584362881|FG002|Overall Study|Physician Decision|1|||
161814120|NCT00772603|584362879|FG000|Overall Study|Other|2|||
161814121|NCT00772603|584362880|FG001|Overall Study|Other|0|||
161814122|NCT00772603|584362881|FG002|Overall Study|Other|2|||
161814123|NCT00835575|584362882|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
161814124|NCT00835575|584362883|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
161814125|NCT01564394|584362886|FG000|Overall Study|Withdrawal by Subject|6|||
161814126|NCT01564394|584362887|FG001|Overall Study|Withdrawal by Subject|10|||
161814127|NCT00859521|584362888|FG000|Washout|Withdrawal by Subject|0|||
161814128|NCT00859521|584362889|FG001|Washout|Withdrawal by Subject|1|||
161814129|NCT01609257|584362890|FG000|Overall Study|Lost to Follow-up|2|||
161814130|NCT01609257|584362891|FG001|Overall Study|Lost to Follow-up|1|||
161814131|NCT01609257|584362890|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
161814132|NCT01609257|584362891|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
161814133|NCT01609257|584362890|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
161814134|NCT01609257|584362891|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
161814135|NCT02125461|584362892|FG000|Overall Study|Withdrawal by Subject|30|||
161814136|NCT02125461|584362893|FG001|Overall Study|Withdrawal by Subject|16|||
161814137|NCT02125461|584362892|FG000|Overall Study|Lost to Follow-up|8|||
161814138|NCT02125461|584362893|FG001|Overall Study|Lost to Follow-up|3|||
161814139|NCT02125461|584362892|FG000|Overall Study|Death|260|||
161814140|NCT02125461|584362893|FG001|Overall Study|Death|149|||
161814141|NCT02125461|584362892|FG000|Overall Study|Missing Termination Reason|0|||
161814142|NCT02125461|584362893|FG001|Overall Study|Missing Termination Reason|1|||
161814143|NCT03552484|584362902|FG000|Overall Study|Death|6|||
161814144|NCT03552484|584362903|FG001|Overall Study|Death|4|||
161814145|NCT03552484|584362902|FG000|Overall Study|Lost to Follow-up|0|||
161814146|NCT03552484|584362903|FG001|Overall Study|Lost to Follow-up|16|||
161814147|NCT03499353|584362904|FG000|Treatment|Adverse Event|3|||
161814148|NCT03499353|584362904|FG000|Treatment|Progressive Disease|10|||
161814149|NCT03499353|584362904|FG000|Treatment|Other|1|||
161814150|NCT03499353|584362904|FG000|Treatment|Withdrawal by Subject|2|||
161814151|NCT03499353|584362904|FG000|Long-Term Follow-up|Death|2|||
161814152|NCT03499353|584362904|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
161814153|NCT03499353|584362904|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
161814154|NCT02241551|584362905|FG000|Overall Study|Adverse Event|1|||
161814155|NCT02241551|584362906|FG001|Overall Study|Adverse Event|0|||
161814156|NCT00469898|584362913|FG000|Overall Study|Adverse Event|7|||
161814157|NCT00469898|584362913|FG000|Overall Study|Withdrawal by Subject|4|||
161814158|NCT00469898|584362913|FG000|Overall Study|Death|4|||
161814159|NCT00469898|584362913|FG000|Overall Study|Disease progression|9|||
161814160|NCT00469898|584362913|FG000|Overall Study|Decreased performance status|1|||
161814161|NCT02663349|584362916|FG000|Overall Study|Withdrawal by Subject|6|||
161814162|NCT02751424|584362924|FG000|Part 2|Adverse Event|0|||
161814163|NCT02751424|584362925|FG001|Part 2|Adverse Event|0|||
161814164|NCT02751424|584362926|FG002|Part 2|Adverse Event|0|||
162161197|NCT00676715|585641741|FG003|Treatment Period (TP)|Adverse Event|2|||
162161198|NCT00676715|585641738|FG000|Treatment Period (TP)|Death|0|||
161814165|NCT02751424|584362927|FG003|Part 2|Adverse Event|0|||
161814166|NCT02751424|584362928|FG004|Part 2|Adverse Event|0|||
161814167|NCT02751424|584362929|FG005|Part 2|Adverse Event|0|||
161814168|NCT02751424|584362930|FG006|Part 2|Adverse Event|0|||
161814169|NCT02751424|584362931|FG007|Part 2|Adverse Event|5|||
161814170|NCT02751424|584362932|FG008|Part 2|Adverse Event|0|||
161814171|NCT00848536|584362933|FG000|Overall Study|Adverse Event|2|||
161814172|NCT00848536|584362934|FG001|Overall Study|Adverse Event|2|||
161814173|NCT00848536|584362933|FG000|Overall Study|Withdrawal by Subject|0|||
161814174|NCT00848536|584362934|FG001|Overall Study|Withdrawal by Subject|1|||
161814175|NCT00848536|584362933|FG000|Overall Study|Protocol Violation|0|||
161814176|NCT00848536|584362934|FG001|Overall Study|Protocol Violation|1|||
161814177|NCT00848536|584362933|FG000|Overall Study|Noncompliance|1|||
162161199|NCT00676715|585641739|FG001|Treatment Period (TP)|Death|0|||
161814178|NCT00848536|584362934|FG001|Overall Study|Noncompliance|0|||
162015675|NCT05673876|585110649|FG001|Overall Study|Death|1|||
162015676|NCT05673876|585110648|FG000|Overall Study|Study Terminated by Sponsor|0|||
162015677|NCT05673876|585110649|FG001|Overall Study|Study Terminated by Sponsor|1|||
162015678|NCT05673876|585110648|FG000|Overall Study|Physician Decision|0|||
161919167|NCT03112603|584751412|FG002|End of Randomization Period|Lack of Efficacy|0|||
161919168|NCT03112603|584751410|FG000|End of Randomization Period|Adverse Event|32|||
161919169|NCT03112603|584751411|FG001|End of Randomization Period|Adverse Event|12|||
161919170|NCT03112603|584751412|FG002|End of Randomization Period|Adverse Event|0|||
161919171|NCT03112603|584751410|FG000|End of Cross Over Period|Death|0|||
161919172|NCT03112603|584751411|FG001|End of Cross Over Period|Death|0|||
162161200|NCT00676715|585641740|FG002|Treatment Period (TP)|Death|1|||
162161201|NCT00676715|585641741|FG003|Treatment Period (TP)|Death|0|||
162161202|NCT00676715|585641738|FG000|Treatment Period (TP)|Failure to return|1|||
162161203|NCT00676715|585641739|FG001|Treatment Period (TP)|Failure to return|0|||
162161204|NCT00676715|585641740|FG002|Treatment Period (TP)|Failure to return|0|||
162161205|NCT00676715|585641741|FG003|Treatment Period (TP)|Failure to return|0|||
162161206|NCT00676715|585641738|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
162015679|NCT05673876|585110649|FG001|Overall Study|Physician Decision|1|||
162015680|NCT05006573|585110652|FG000|Double-blind Treatment Period|Physician Decision|2|||
162015681|NCT05006573|585110653|FG001|Double-blind Treatment Period|Physician Decision|0|||
162015682|NCT05006573|585110652|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
162015683|NCT05006573|585110653|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
162015684|NCT05006573|585110652|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
162015685|NCT05006573|585110653|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
162015686|NCT05006573|585110652|FG000|Double-blind Treatment Period|Protocol Violation|2|||
162015687|NCT05006573|585110653|FG001|Double-blind Treatment Period|Protocol Violation|0|||
162015688|NCT05006573|585110652|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
162161207|NCT00676715|585641739|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
162161208|NCT00676715|585641740|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
162161209|NCT00676715|585641741|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
162161210|NCT00676715|585641738|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
162161211|NCT00676715|585641739|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
161919173|NCT03112603|584751412|FG002|End of Cross Over Period|Death|2|||
161919174|NCT03112603|584751410|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
162161212|NCT00676715|585641740|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
162161213|NCT00676715|585641741|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
162161214|NCT00676715|585641738|FG000|Treatment Period (TP)|Withdrew consent|3|||
162161215|NCT00676715|585641739|FG001|Treatment Period (TP)|Withdrew consent|3|||
162161216|NCT00676715|585641740|FG002|Treatment Period (TP)|Withdrew consent|3|||
162161217|NCT00676715|585641741|FG003|Treatment Period (TP)|Withdrew consent|3|||
162161218|NCT00676715|585641738|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
162161219|NCT00676715|585641739|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
162161220|NCT00676715|585641740|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
162161221|NCT00676715|585641741|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
162161222|NCT00676715|585641738|FG000|Treatment Period (TP)|Administrative|0|||
162161223|NCT00676715|585641739|FG001|Treatment Period (TP)|Administrative|0|||
162161224|NCT00676715|585641740|FG002|Treatment Period (TP)|Administrative|0|||
162161225|NCT00676715|585641741|FG003|Treatment Period (TP)|Administrative|1|||
162161226|NCT00676715|585641738|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
162161227|NCT00676715|585641739|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
162161228|NCT00676715|585641740|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
162161229|NCT00676715|585641741|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
162161230|NCT00676715|585641738|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
162161231|NCT00676715|585641739|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
162161232|NCT00676715|585641740|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
162161233|NCT00676715|585641741|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
162161234|NCT00676715|585641738|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
162161235|NCT00676715|585641739|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
162161236|NCT00676715|585641740|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
162161237|NCT00676715|585641741|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
162161238|NCT00676715|585641738|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
162161239|NCT00676715|585641739|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
162161240|NCT00676715|585641740|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
162015689|NCT05006573|585110653|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
162015690|NCT05006573|585110652|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
162026105|NCT00369629|585152887|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
162161241|NCT00676715|585641741|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
162161242|NCT00676715|585641738|FG000|Treatment-free Period (TFP)|Death|1|||
162161243|NCT00676715|585641739|FG001|Treatment-free Period (TFP)|Death|1|||
162161244|NCT00676715|585641740|FG002|Treatment-free Period (TFP)|Death|1|||
161919175|NCT03112603|584751411|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
162161245|NCT00676715|585641741|FG003|Treatment-free Period (TFP)|Death|0|||
162161246|NCT00676715|585641738|FG000|Open Label Extension (OLE)|Reason not provided|3|||
162161247|NCT00676715|585641739|FG001|Open Label Extension (OLE)|Reason not provided|4|||
162161248|NCT00676715|585641740|FG002|Open Label Extension (OLE)|Reason not provided|1|||
162161249|NCT00676715|585641741|FG003|Open Label Extension (OLE)|Reason not provided|4|||
162161250|NCT00676715|585641738|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
162161251|NCT00676715|585641739|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
162161252|NCT00676715|585641740|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
162161253|NCT00676715|585641741|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
162161254|NCT00676715|585641738|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
162161255|NCT00676715|585641739|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
162161256|NCT00676715|585641740|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
162161257|NCT00676715|585641741|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
162161258|NCT00676715|585641738|FG000|Open Label Extension (OLE)|Adverse Event|0|||
162161259|NCT00676715|585641739|FG001|Open Label Extension (OLE)|Adverse Event|3|||
162161260|NCT00676715|585641740|FG002|Open Label Extension (OLE)|Adverse Event|1|||
162161261|NCT00676715|585641741|FG003|Open Label Extension (OLE)|Adverse Event|0|||
162161262|NCT00676715|585641738|FG000|Open Label Extension (OLE)|Death|2|||
162161263|NCT00676715|585641739|FG001|Open Label Extension (OLE)|Death|0|||
162161264|NCT00676715|585641740|FG002|Open Label Extension (OLE)|Death|2|||
162161265|NCT00676715|585641741|FG003|Open Label Extension (OLE)|Death|2|||
162161266|NCT05249439|585641743|FG000|Overall Study|Withdrawal by Subject|2|||
162161267|NCT05249439|585641744|FG001|Overall Study|Withdrawal by Subject|5|||
162161268|NCT05249439|585641743|FG000|Overall Study|Physician Decision|3|||
162161269|NCT05249439|585641744|FG001|Overall Study|Physician Decision|1|||
162161270|NCT00616967|585641745|FG000|Overall Study|Withdrawal by Subject|0|||
162161271|NCT00616967|585641746|FG001|Overall Study|Withdrawal by Subject|0|||
162161272|NCT00616967|585641747|FG002|Overall Study|Withdrawal by Subject|1|||
162161273|NCT02910583|585641748|FG000|Overall Study|Death|7|||
162161274|NCT02910583|585641749|FG001|Overall Study|Death|3|||
162161275|NCT02910583|585641748|FG000|Overall Study|Lost to Follow-up|1|||
162161276|NCT02910583|585641749|FG001|Overall Study|Lost to Follow-up|0|||
162015691|NCT05006573|585110653|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
162015692|NCT01967238|585110654|FG000|Overall Study|Adverse Event|1|||
162015693|NCT01967238|585110655|FG001|Overall Study|Adverse Event|1|||
162015694|NCT01967238|585110656|FG002|Overall Study|Adverse Event|0|||
162015695|NCT01967238|585110654|FG000|Overall Study|Lost to Follow-up|1|||
162015696|NCT01967238|585110655|FG001|Overall Study|Lost to Follow-up|0|||
162015697|NCT01967238|585110656|FG002|Overall Study|Lost to Follow-up|1|||
162015698|NCT01967238|585110654|FG000|Overall Study|Withdrawal by Subject|0|||
162015699|NCT01967238|585110655|FG001|Overall Study|Withdrawal by Subject|0|||
162015700|NCT01967238|585110656|FG002|Overall Study|Withdrawal by Subject|1|||
162015701|NCT02864394|585110661|FG000|Overall Study|Death|184|||
162015702|NCT02864394|585110662|FG001|Overall Study|Death|189|||
162015703|NCT02864394|585110661|FG000|Overall Study|Lost to Follow-up|0|||
162015704|NCT02864394|585110662|FG001|Overall Study|Lost to Follow-up|2|||
162015705|NCT02864394|585110661|FG000|Overall Study|Sponsor Decision|26|||
162015706|NCT02864394|585110662|FG001|Overall Study|Sponsor Decision|11|||
162015707|NCT02864394|585110661|FG000|Overall Study|Withdrawal by Subject|3|||
162015708|NCT02864394|585110662|FG001|Overall Study|Withdrawal by Subject|10|||
162015709|NCT03751657|585112323|FG000|Overall Study|Physician Decision|0|||
162015710|NCT03751657|585112324|FG001|Overall Study|Physician Decision|1|||
162015711|NCT03751657|585112323|FG000|Overall Study|Withdrawal by Subject|1|||
162015712|NCT03751657|585112324|FG001|Overall Study|Withdrawal by Subject|1|||
162015713|NCT03751657|585112323|FG000|Overall Study|Lost to Follow-up|2|||
162015714|NCT03751657|585112324|FG001|Overall Study|Lost to Follow-up|1|||
162015715|NCT03894813|585112331|FG000|Overall Study|Adverse Event|1|||
162015716|NCT03894813|585112332|FG001|Overall Study|Adverse Event|1|||
162015717|NCT03894813|585112331|FG000|Overall Study|Lack of Efficacy|3|||
162015718|NCT03894813|585112332|FG001|Overall Study|Lack of Efficacy|3|||
162015719|NCT03894813|585112331|FG000|Overall Study|Lost to Follow-up|1|||
162015720|NCT03894813|585112332|FG001|Overall Study|Lost to Follow-up|0|||
162161277|NCT02910583|585641748|FG000|Overall Study|Withdrawal by Subject|12|||
162015721|NCT03894813|585112331|FG000|Overall Study|Pregnancy|2|||
162161278|NCT02910583|585641749|FG001|Overall Study|Withdrawal by Subject|8|||
162161279|NCT02910583|585641748|FG000|Overall Study|Other, Not Specified|6|||
162161280|NCT02910583|585641749|FG001|Overall Study|Other, Not Specified|3|||
162161281|NCT05059262|585641751|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
162161282|NCT05059262|585641752|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
162161283|NCT05059262|585641751|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
162161284|NCT05059262|585641752|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
162015722|NCT03894813|585112332|FG001|Overall Study|Pregnancy|1|||
162015723|NCT03894813|585112331|FG000|Overall Study|Protocol Violation|3|||
162015724|NCT03894813|585112332|FG001|Overall Study|Protocol Violation|7|||
162015725|NCT03894813|585112331|FG000|Overall Study|Withdrawal by Subject|1|||
162015726|NCT03894813|585112332|FG001|Overall Study|Withdrawal by Subject|3|||
162161285|NCT05059262|585641751|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
162161286|NCT05059262|585641752|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
162161287|NCT05059262|585641751|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
162161288|NCT05059262|585641752|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
162161289|NCT05059262|585641751|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
162015727|NCT03894813|585112331|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
162015728|NCT03894813|585112332|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
162015729|NCT02269267|585112334|FG000|Overall Study|Death|5|||
162015730|NCT00145158|585112337|FG000|Overall Study|premature withdrawal|2|||
161919176|NCT03112603|584751412|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
161919177|NCT03112603|584751410|FG000|End of Cross Over Period|Physician Decision|0|||
161919178|NCT03112603|584751411|FG001|End of Cross Over Period|Physician Decision|0|||
161919179|NCT03112603|584751412|FG002|End of Cross Over Period|Physician Decision|29|||
161919180|NCT03112603|584751410|FG000|End of Cross Over Period|Lack of Efficacy|0|||
161919181|NCT03112603|584751411|FG001|End of Cross Over Period|Lack of Efficacy|0|||
161919182|NCT03112603|584751412|FG002|End of Cross Over Period|Lack of Efficacy|8|||
161919183|NCT03112603|584751410|FG000|End of Cross Over Period|Adverse Event|0|||
161919184|NCT03112603|584751411|FG001|End of Cross Over Period|Adverse Event|0|||
161919185|NCT03112603|584751412|FG002|End of Cross Over Period|Adverse Event|6|||
161919186|NCT03112603|584751410|FG000|End of Cross Over Period|Disease Relapse|0|||
161919187|NCT03112603|584751411|FG001|End of Cross Over Period|Disease Relapse|0|||
161919188|NCT03112603|584751412|FG002|End of Cross Over Period|Disease Relapse|2|||
161919189|NCT04092777|584751413|FG000|Overall Study|Lost to Follow-up|28|||
161919190|NCT04092777|584751414|FG001|Overall Study|Lost to Follow-up|46|||
161919191|NCT04092777|584751413|FG000|Overall Study|Withdrawal by Subject|8|||
161919192|NCT04092777|584751414|FG001|Overall Study|Withdrawal by Subject|5|||
161919193|NCT03330197|584751417|FG000|Overall Study|Adverse Event|0|||
161919194|NCT03330197|584751418|FG001|Overall Study|Adverse Event|1|||
162161290|NCT05059262|585641752|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
162161291|NCT05059262|585641751|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
161919195|NCT03330197|584751417|FG000|Overall Study|Withdrawal by Subject|0|||
162015731|NCT00145158|585112338|FG001|Overall Study|premature withdrawal|3|||
162015732|NCT02741518|585112339|FG000|Overall Study|Withdrawal by Subject|1|||
162015733|NCT02741518|585112340|FG001|Overall Study|Withdrawal by Subject|1|||
162015734|NCT00476008|585112341|FG000|Overall Study|Adverse Event|4|||
162015735|NCT00476008|585112342|FG001|Overall Study|Adverse Event|4|||
162015736|NCT00476008|585112341|FG000|Overall Study|Placebo concerns|2|||
162015737|NCT00476008|585112342|FG001|Overall Study|Placebo concerns|2|||
162015738|NCT00476008|585112341|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
162015739|NCT00476008|585112342|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
162015740|NCT00476008|585112341|FG000|Overall Study|Withdrawal by Subject|0|||
162015741|NCT00476008|585112342|FG001|Overall Study|Withdrawal by Subject|1|||
162015742|NCT00476008|585112341|FG000|Overall Study|Death|1|||
162015743|NCT00476008|585112342|FG001|Overall Study|Death|0|||
162015744|NCT01788358|585112343|FG000|Overall Study|Other|11|||
162015745|NCT01788358|585112343|FG000|Overall Study|Logistical difficulties|1|||
162015746|NCT01788358|585112343|FG000|Overall Study|Lost to Follow-up|5|||
162015747|NCT01788358|585112343|FG000|Overall Study|Protocol Violation|3|||
162015748|NCT01788358|585112343|FG000|Overall Study|Withdrawal by Subject|26|||
162015749|NCT01788358|585112343|FG000|Overall Study|Lack of Efficacy|1|||
162015750|NCT01788358|585112343|FG000|Overall Study|Adverse Event|51|||
162015751|NCT01227018|585112344|FG000|Overall Study|Disease progression|9|||
162015752|NCT01227018|585112344|FG000|Overall Study|Toxicity|2|||
162015753|NCT01227018|585112344|FG000|Overall Study|Withdrew after beginning treatment|4|||
162015754|NCT02948634|585112347|FG000|Overall Study|Lack of efficacy and study suspended|10|||
162015755|NCT02948634|585112348|FG001|Overall Study|Lack of efficacy and study suspended|2|||
162015756|NCT00753649|585112353|FG000|Overall Study|Migrated/moved from study area|1|||
161919196|NCT03330197|584751418|FG001|Overall Study|Withdrawal by Subject|1|||
161919197|NCT03765073|584751419|FG000|Stage 1|Lost to Follow-up|1|||
161919198|NCT03765073|584751420|FG001|Stage 1|Lost to Follow-up|0|||
161919199|NCT03765073|584751421|FG002|Stage 1|Lost to Follow-up|0|||
161919200|NCT03765073|584751422|FG003|Stage 1|Lost to Follow-up|0|||
161919201|NCT03765073|584751423|FG004|Stage 1|Lost to Follow-up|0|||
162161292|NCT05059262|585641752|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
162161293|NCT05059262|585641751|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
161919202|NCT03765073|584751424|FG005|Stage 1|Lost to Follow-up|0|||
161919203|NCT03765073|584751425|FG006|Stage 1|Lost to Follow-up|0|||
161919204|NCT03765073|584751426|FG007|Stage 1|Lost to Follow-up|0|||
161919205|NCT03765073|584751427|FG008|Stage 1|Lost to Follow-up|0|||
161919206|NCT03765073|584751428|FG009|Stage 1|Lost to Follow-up|0|||
161919207|NCT03765073|584751429|FG010|Stage 1|Lost to Follow-up|0|||
162015757|NCT00753649|585112354|FG001|Overall Study|Migrated/moved from study area|0|||
162015758|NCT00753649|585112353|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
162015759|NCT00753649|585112354|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
162015760|NCT00753649|585112353|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
162161294|NCT05059262|585641752|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
162161295|NCT05059262|585641751|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
162161296|NCT05059262|585641752|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
162161297|NCT05059262|585641751|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
162161298|NCT05059262|585641752|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
162161299|NCT05021640|585641764|FG000|Overall Study|Lost to Follow-up|0|||
162161300|NCT05021640|585641765|FG001|Overall Study|Lost to Follow-up|0|||
162161301|NCT05021640|585641766|FG002|Overall Study|Lost to Follow-up|0|||
162161302|NCT05021640|585641767|FG003|Overall Study|Lost to Follow-up|0|||
162161303|NCT05021640|585641768|FG004|Overall Study|Lost to Follow-up|1|||
162161304|NCT02312960|585641769|FG000|Overall Study|Death|24|||
162161305|NCT02312960|585641770|FG001|Overall Study|Death|32|||
162161306|NCT02312960|585641771|FG002|Overall Study|Death|25|||
162161307|NCT02312960|585641772|FG003|Overall Study|Death|11|||
162161308|NCT02312960|585641773|FG004|Overall Study|Death|5|||
162161309|NCT02312960|585641774|FG005|Overall Study|Death|5|||
162015761|NCT00753649|585112354|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
162015762|NCT00753649|585112353|FG000|Overall Study|Protocol Violation|2|||
162015763|NCT00753649|585112354|FG001|Overall Study|Protocol Violation|0|||
162161310|NCT02312960|585641775|FG006|Overall Study|Death|8|||
162161311|NCT02312960|585641776|FG007|Overall Study|Death|5|||
162161312|NCT02312960|585641777|FG008|Overall Study|Death|7|||
162161313|NCT02312960|585641778|FG009|Overall Study|Death|3|||
162161314|NCT02312960|585641779|FG010|Overall Study|Death|3|||
162015764|NCT01039519|585112360|FG000|Treatment|Progressive disease|20|||
162015765|NCT01039519|585112360|FG000|Treatment|Treatment failure|2|||
162015766|NCT01039519|585112360|FG000|Treatment|Adverse Event|3|||
162015767|NCT01039519|585112360|FG000|Treatment|Physician Decision|2|||
162015768|NCT01039519|585112360|FG000|Survival Follow-up|Death|23|||
162015769|NCT01039519|585112360|FG000|Survival Follow-up|Sponsor decision|4|||
162015770|NCT01255436|585112363|FG000|Overall Study|Lost to Follow-up|178|||
162161315|NCT02312960|585641780|FG011|Overall Study|Death|1|||
162161316|NCT02312960|585641781|FG012|Overall Study|Death|25|||
162161317|NCT02312960|585641782|FG013|Overall Study|Death|19|||
162161318|NCT02312960|585641769|FG000|Overall Study|Missing|0|||
162015771|NCT01255436|585112364|FG001|Overall Study|Lost to Follow-up|191|||
162015772|NCT01255436|585112363|FG000|Overall Study|Death, stroke, or MI|4|||
162015773|NCT01255436|585112364|FG001|Overall Study|Death, stroke, or MI|3|||
162015774|NCT04816669|585112365|FG000|Part 1|Adverse Event|1|||
162015775|NCT04816669|585112366|FG001|Part 1|Adverse Event|1|||
162015776|NCT04816669|585112367|FG002|Part 1|Adverse Event|0|||
162015777|NCT04816669|585112368|FG003|Part 1|Adverse Event|0|||
162015778|NCT04816669|585112365|FG000|Part 1|Lost to Follow-up|2|||
162015779|NCT04816669|585112366|FG001|Part 1|Lost to Follow-up|2|||
162015780|NCT04816669|585112367|FG002|Part 1|Lost to Follow-up|0|||
162015781|NCT04816669|585112368|FG003|Part 1|Lost to Follow-up|0|||
162015782|NCT04816669|585112365|FG000|Part 1|Protocol Violation|0|||
162015783|NCT04816669|585112366|FG001|Part 1|Protocol Violation|1|||
162015784|NCT04816669|585112367|FG002|Part 1|Protocol Violation|0|||
162015785|NCT04816669|585112368|FG003|Part 1|Protocol Violation|0|||
162015786|NCT04816669|585112365|FG000|Part 1|Withdrawal by Subject|1|||
162015787|NCT04816669|585112366|FG001|Part 1|Withdrawal by Subject|2|||
162015788|NCT04816669|585112367|FG002|Part 1|Withdrawal by Subject|0|||
162015789|NCT04816669|585112368|FG003|Part 1|Withdrawal by Subject|0|||
162015790|NCT04816669|585112365|FG000|Part 2|Other|0|||
162015791|NCT04816669|585112366|FG001|Part 2|Other|0|||
162015792|NCT04816669|585112367|FG002|Part 2|Other|1|||
162015793|NCT04816669|585112368|FG003|Part 2|Other|0|||
162015794|NCT04816669|585112365|FG000|Part 2|Withdrawal by Subject|0|||
162015795|NCT04816669|585112366|FG001|Part 2|Withdrawal by Subject|0|||
162015796|NCT04816669|585112367|FG002|Part 2|Withdrawal by Subject|0|||
162015797|NCT04816669|585112368|FG003|Part 2|Withdrawal by Subject|1|||
162015798|NCT04816669|585112365|FG000|Part 2|Lost to Follow-up|0|||
162015799|NCT04816669|585112366|FG001|Part 2|Lost to Follow-up|0|||
162015800|NCT04816669|585112367|FG002|Part 2|Lost to Follow-up|1|||
162161319|NCT02312960|585641770|FG001|Overall Study|Missing|0|||
162161320|NCT02312960|585641771|FG002|Overall Study|Missing|2|||
162161321|NCT02312960|585641772|FG003|Overall Study|Missing|0|||
161814179|NCT00848536|584362933|FG000|Overall Study|Inadequate Control of IOP|1|||
162015801|NCT04816669|585112368|FG003|Part 2|Lost to Follow-up|0|||
162015802|NCT01229267|585112369|FG000|Overall Study|Adverse Event|4|||
162015803|NCT01229267|585112370|FG001|Overall Study|Adverse Event|6|||
162015804|NCT01229267|585112371|FG002|Overall Study|Adverse Event|3|||
162015805|NCT01229267|585112372|FG003|Overall Study|Adverse Event|2|||
162015806|NCT01229267|585112373|FG004|Overall Study|Adverse Event|10|||
162015807|NCT01229267|585112369|FG000|Overall Study|Death|40|||
162015808|NCT01229267|585112370|FG001|Overall Study|Death|37|||
162015809|NCT01229267|585112371|FG002|Overall Study|Death|35|||
162015810|NCT01229267|585112372|FG003|Overall Study|Death|13|||
162161322|NCT02312960|585641773|FG004|Overall Study|Missing|0|||
162161323|NCT02312960|585641774|FG005|Overall Study|Missing|0|||
162161324|NCT02312960|585641775|FG006|Overall Study|Missing|0|||
162161325|NCT02312960|585641776|FG007|Overall Study|Missing|0|||
162161326|NCT02312960|585641777|FG008|Overall Study|Missing|0|||
162015811|NCT01229267|585112373|FG004|Overall Study|Death|103|||
162015812|NCT01229267|585112369|FG000|Overall Study|Withdrawal by Subject|23|||
162015813|NCT01229267|585112370|FG001|Overall Study|Withdrawal by Subject|22|||
162015814|NCT01229267|585112371|FG002|Overall Study|Withdrawal by Subject|32|||
162015815|NCT01229267|585112372|FG003|Overall Study|Withdrawal by Subject|14|||
162015816|NCT01229267|585112373|FG004|Overall Study|Withdrawal by Subject|59|||
162015817|NCT01229267|585112369|FG000|Overall Study|Protocol Violation|0|||
162015818|NCT01229267|585112370|FG001|Overall Study|Protocol Violation|1|||
162015819|NCT01229267|585112371|FG002|Overall Study|Protocol Violation|0|||
162015820|NCT01229267|585112372|FG003|Overall Study|Protocol Violation|0|||
162015821|NCT01229267|585112373|FG004|Overall Study|Protocol Violation|0|||
162015822|NCT01229267|585112369|FG000|Overall Study|Progressive disease|0|||
162015823|NCT01229267|585112370|FG001|Overall Study|Progressive disease|0|||
162015824|NCT01229267|585112371|FG002|Overall Study|Progressive disease|0|||
162015825|NCT01229267|585112372|FG003|Overall Study|Progressive disease|0|||
162015826|NCT01229267|585112373|FG004|Overall Study|Progressive disease|1|||
162015827|NCT01229267|585112369|FG000|Overall Study|Physician Decision|8|||
162015828|NCT01229267|585112370|FG001|Overall Study|Physician Decision|11|||
162015829|NCT01229267|585112371|FG002|Overall Study|Physician Decision|8|||
162015830|NCT01229267|585112372|FG003|Overall Study|Physician Decision|3|||
162015831|NCT01229267|585112373|FG004|Overall Study|Physician Decision|25|||
162015832|NCT01229267|585112369|FG000|Overall Study|Lost to Follow-up|6|||
162161327|NCT02312960|585641778|FG009|Overall Study|Missing|0|||
162161328|NCT02312960|585641779|FG010|Overall Study|Missing|0|||
162015833|NCT01229267|585112370|FG001|Overall Study|Lost to Follow-up|5|||
162015834|NCT01229267|585112371|FG002|Overall Study|Lost to Follow-up|8|||
162015835|NCT01229267|585112372|FG003|Overall Study|Lost to Follow-up|3|||
162015836|NCT01229267|585112373|FG004|Overall Study|Lost to Follow-up|22|||
162015837|NCT00808080|585112377|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
162015838|NCT01837823|585112380|FG000|Overall Study|Lost to Follow-up|6|||
162015839|NCT03052400|585112381|FG000|Overall Study|Lost to Follow-up|1|||
162015840|NCT03052400|585112382|FG001|Overall Study|Lost to Follow-up|0|||
162015841|NCT03052400|585112381|FG000|Overall Study|Withdrawal by Subject|0|||
162015842|NCT03052400|585112382|FG001|Overall Study|Withdrawal by Subject|1|||
162015843|NCT00867815|585112383|FG000|Overall Study|Lost to Follow-up|1|||
162015844|NCT00001213|585112384|FG000|Overall Study|Death|18|||
162015845|NCT05782179|585112385|FG000|Overall Study|Adverse Event|0|||
162015846|NCT05782179|585112386|FG001|Overall Study|Adverse Event|0|||
162015847|NCT05782179|585112387|FG002|Overall Study|Adverse Event|2|||
162161329|NCT02312960|585641780|FG011|Overall Study|Missing|0|||
162161330|NCT02312960|585641781|FG012|Overall Study|Missing|0|||
162161331|NCT02312960|585641782|FG013|Overall Study|Missing|0|||
162161332|NCT02312960|585641769|FG000|Overall Study|Lost to Follow-up|0|||
162161333|NCT02312960|585641770|FG001|Overall Study|Lost to Follow-up|0|||
162161334|NCT02312960|585641771|FG002|Overall Study|Lost to Follow-up|1|||
162161335|NCT02312960|585641772|FG003|Overall Study|Lost to Follow-up|0|||
162161336|NCT02312960|585641773|FG004|Overall Study|Lost to Follow-up|0|||
162161337|NCT02312960|585641774|FG005|Overall Study|Lost to Follow-up|0|||
162161338|NCT02312960|585641775|FG006|Overall Study|Lost to Follow-up|1|||
162161339|NCT02312960|585641776|FG007|Overall Study|Lost to Follow-up|1|||
162161340|NCT02312960|585641777|FG008|Overall Study|Lost to Follow-up|0|||
162161341|NCT02312960|585641778|FG009|Overall Study|Lost to Follow-up|1|||
162161342|NCT02312960|585641779|FG010|Overall Study|Lost to Follow-up|0|||
162161343|NCT02312960|585641780|FG011|Overall Study|Lost to Follow-up|0|||
162161344|NCT02312960|585641781|FG012|Overall Study|Lost to Follow-up|1|||
162161345|NCT02312960|585641782|FG013|Overall Study|Lost to Follow-up|0|||
162161346|NCT02312960|585641769|FG000|Overall Study|Withdrawal by Subject|1|||
162161347|NCT02312960|585641770|FG001|Overall Study|Withdrawal by Subject|2|||
162161348|NCT02312960|585641771|FG002|Overall Study|Withdrawal by Subject|0|||
162161349|NCT02312960|585641772|FG003|Overall Study|Withdrawal by Subject|0|||
162161350|NCT02312960|585641773|FG004|Overall Study|Withdrawal by Subject|1|||
162161351|NCT02312960|585641774|FG005|Overall Study|Withdrawal by Subject|0|||
162161352|NCT02312960|585641775|FG006|Overall Study|Withdrawal by Subject|1|||
161814180|NCT00848536|584362934|FG001|Overall Study|Inadequate Control of IOP|1|||
161814181|NCT00848536|584362933|FG000|Overall Study|Patient Moved|0|||
162015848|NCT05782179|585112388|FG003|Overall Study|Adverse Event|0|||
162015849|NCT05782179|585112389|FG004|Overall Study|Adverse Event|0|||
162161353|NCT02312960|585641776|FG007|Overall Study|Withdrawal by Subject|2|||
162161354|NCT02312960|585641777|FG008|Overall Study|Withdrawal by Subject|2|||
162161355|NCT02312960|585641778|FG009|Overall Study|Withdrawal by Subject|3|||
162161356|NCT02312960|585641779|FG010|Overall Study|Withdrawal by Subject|0|||
162161357|NCT02312960|585641780|FG011|Overall Study|Withdrawal by Subject|0|||
162161358|NCT02312960|585641781|FG012|Overall Study|Withdrawal by Subject|2|||
162015850|NCT05782179|585112390|FG005|Overall Study|Adverse Event|0|||
162015851|NCT06170242|585112391|FG000|Overall Study|Lost to Follow-up|0|||
162015852|NCT06170242|585112392|FG001|Overall Study|Lost to Follow-up|0|||
162015853|NCT06170242|585112393|FG002|Overall Study|Lost to Follow-up|1|||
162015854|NCT06170242|585112394|FG003|Overall Study|Lost to Follow-up|1|||
162161359|NCT02312960|585641782|FG013|Overall Study|Withdrawal by Subject|0|||
162161360|NCT03131648|585641783|FG000|Initial Treatment Period|Not dosed|2|||
162015855|NCT02558296|585112395|FG000|Completed the Study Through Week 24|Adverse Event|9|||
162015856|NCT02558296|585112396|FG001|Completed the Study Through Week 24|Adverse Event|3|||
162015857|NCT02558296|585112395|FG000|Completed the Study Through Week 24|Death|7|||
162015858|NCT02558296|585112396|FG001|Completed the Study Through Week 24|Death|7|||
162015859|NCT02558296|585112395|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
162015860|NCT02558296|585112396|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
162015861|NCT02558296|585112395|FG000|Completed the Study Through Week 24|Physician Decision|1|||
162015862|NCT02558296|585112396|FG001|Completed the Study Through Week 24|Physician Decision|0|||
162015863|NCT02558296|585112395|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
162015864|NCT02558296|585112396|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
162015865|NCT02558296|585112395|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
162015866|NCT02558296|585112396|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
162015867|NCT02558296|585112395|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
162015868|NCT02558296|585112396|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
162015869|NCT02558296|585112395|FG000|Completed the Study|Adverse Event|14|||
162015870|NCT02558296|585112396|FG001|Completed the Study|Adverse Event|5|||
162015871|NCT02558296|585112395|FG000|Completed the Study|Death|39|||
162015872|NCT02558296|585112396|FG001|Completed the Study|Death|25|||
162015873|NCT02558296|585112395|FG000|Completed the Study|Lost to Follow-up|31|||
162015874|NCT02558296|585112396|FG001|Completed the Study|Lost to Follow-up|23|||
162015875|NCT02558296|585112395|FG000|Completed the Study|Physician Decision|6|||
162015876|NCT02558296|585112396|FG001|Completed the Study|Physician Decision|0|||
162015877|NCT02558296|585112395|FG000|Completed the Study|Protocol Violation|2|||
162015878|NCT02558296|585112396|FG001|Completed the Study|Protocol Violation|1|||
162015879|NCT02558296|585112395|FG000|Completed the Study|Withdrawal by Subject|53|||
162015880|NCT02558296|585112396|FG001|Completed the Study|Withdrawal by Subject|31|||
162015881|NCT02558296|585112395|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
162015882|NCT02558296|585112396|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
162015883|NCT02919995|585112399|FG000|Overall Study|Adverse Event|0|||
162015884|NCT02919995|585112400|FG001|Overall Study|Adverse Event|0|||
162015885|NCT02919995|585112401|FG002|Overall Study|Adverse Event|0|||
162015886|NCT02919995|585112402|FG003|Overall Study|Adverse Event|0|||
162015887|NCT02919995|585112403|FG004|Overall Study|Adverse Event|0|||
162015888|NCT02919995|585112404|FG005|Overall Study|Adverse Event|1|||
162015889|NCT01263197|585112416|FG000|First Intervention (Period 1)|Adverse Event|0|||
162015890|NCT01263197|585112417|FG001|First Intervention (Period 1)|Adverse Event|0|||
162015891|NCT01263197|585112418|FG002|First Intervention (Period 1)|Adverse Event|0|||
162015892|NCT01263197|585112419|FG003|First Intervention (Period 1)|Adverse Event|0|||
162015893|NCT01263197|585112420|FG004|First Intervention (Period 1)|Adverse Event|0|||
162015894|NCT01263197|585112421|FG005|First Intervention (Period 1)|Adverse Event|1|||
162015895|NCT01263197|585112416|FG000|Washout Period 1|Protocol Violation|0|||
162015896|NCT01263197|585112417|FG001|Washout Period 1|Protocol Violation|0|||
162015897|NCT01263197|585112418|FG002|Washout Period 1|Protocol Violation|0|||
162015898|NCT01263197|585112419|FG003|Washout Period 1|Protocol Violation|0|||
162015899|NCT01263197|585112420|FG004|Washout Period 1|Protocol Violation|1|||
162015900|NCT01263197|585112421|FG005|Washout Period 1|Protocol Violation|0|||
162015901|NCT01263197|585112416|FG000|Washout Period 2|Physician Decision|0|||
162015902|NCT01263197|585112417|FG001|Washout Period 2|Physician Decision|0|||
162015903|NCT01263197|585112418|FG002|Washout Period 2|Physician Decision|0|||
162015904|NCT01263197|585112419|FG003|Washout Period 2|Physician Decision|0|||
162015905|NCT01263197|585112420|FG004|Washout Period 2|Physician Decision|0|||
162015906|NCT01263197|585112421|FG005|Washout Period 2|Physician Decision|1|||
162015907|NCT01263197|585112416|FG000|Washout Period 2|Protocol Violation|0|||
162015908|NCT01263197|585112417|FG001|Washout Period 2|Protocol Violation|0|||
162015909|NCT01263197|585112418|FG002|Washout Period 2|Protocol Violation|0|||
162015910|NCT01263197|585112419|FG003|Washout Period 2|Protocol Violation|1|||
162015911|NCT01263197|585112420|FG004|Washout Period 2|Protocol Violation|0|||
162015912|NCT01263197|585112421|FG005|Washout Period 2|Protocol Violation|0|||
162015913|NCT01263197|585112416|FG000|Third Intervention (Period 3)|Adverse Event|0|||
162015914|NCT01263197|585112417|FG001|Third Intervention (Period 3)|Adverse Event|1|||
162015915|NCT01263197|585112418|FG002|Third Intervention (Period 3)|Adverse Event|0|||
162015916|NCT01263197|585112419|FG003|Third Intervention (Period 3)|Adverse Event|0|||
162015917|NCT01263197|585112420|FG004|Third Intervention (Period 3)|Adverse Event|0|||
162015918|NCT01263197|585112421|FG005|Third Intervention (Period 3)|Adverse Event|0|||
162015919|NCT02577718|585112422|FG000|Overall Study|Death|6|||
162015920|NCT02577718|585112422|FG000|Overall Study|Withdrawal by Subject|2|||
162015921|NCT02194985|585112424|FG000|Overall Study|Adverse Event|1|||
162015922|NCT02194985|585112424|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
162015923|NCT02194985|585112424|FG000|Overall Study|Physician Decision|4|||
162161361|NCT03131648|585641784|FG001|Initial Treatment Period|Not dosed|2|||
162015924|NCT02194985|585112424|FG000|Overall Study|Lost to Follow-up|1|||
162161362|NCT03131648|585641785|FG002|Initial Treatment Period|Not dosed|0|||
162015925|NCT02194985|585112424|FG000|Overall Study|Withdrawal by Subject|2|||
162015926|NCT00594815|585112427|FG000|Overall Study|Never Treated|3|||
162015927|NCT00594815|585112427|FG000|Overall Study|Withdrawal by Subject|2|||
162015928|NCT00594815|585112427|FG000|Overall Study|Toxicity|4|||
162015929|NCT01932437|585112429|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
162015930|NCT01932437|585112430|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
162015931|NCT01932437|585112431|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
162161363|NCT03131648|585641786|FG003|Initial Treatment Period|Not dosed|0|||
162161364|NCT03131648|585641787|FG004|Initial Treatment Period|Not dosed|0|||
162161365|NCT03131648|585641788|FG005|Initial Treatment Period|Not dosed|0|||
162161366|NCT03131648|585641789|FG006|Initial Treatment Period|Not dosed|0|||
162161367|NCT03131648|585641790|FG007|Initial Treatment Period|Not dosed|0|||
162161368|NCT03131648|585641783|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
162161369|NCT03131648|585641784|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
162161370|NCT03131648|585641785|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162161371|NCT03131648|585641786|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162161372|NCT03131648|585641787|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162161373|NCT03131648|585641788|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162161374|NCT03131648|585641789|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162161375|NCT03131648|585641790|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162161376|NCT03131648|585641783|FG000|Open-label Treatment|Discontinued IMP|0|||
162161377|NCT03131648|585641784|FG001|Open-label Treatment|Discontinued IMP|0|||
162161378|NCT03131648|585641785|FG002|Open-label Treatment|Discontinued IMP|0|||
161814182|NCT00848536|584362934|FG001|Overall Study|Patient Moved|2|||
161814183|NCT01175135|584362935|FG000|Overall Study|Adverse Event|2|||
161814184|NCT01175135|584362936|FG001|Overall Study|Adverse Event|5|||
161814185|NCT01175135|584362937|FG002|Overall Study|Adverse Event|3|||
162015932|NCT01932437|585112432|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
162015933|NCT01932437|585112433|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
162015934|NCT01932437|585112434|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
162015935|NCT04269889|585112435|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
162015936|NCT00949702|585112440|FG000|Overall Study|Death|40|||
162015937|NCT00949702|585112440|FG000|Overall Study|Disease progression|7|||
162015938|NCT00949702|585112440|FG000|Overall Study|Withdrawal of consent|1|||
162015939|NCT01654302|585112441|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
162015940|NCT01654302|585112442|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
162015941|NCT01094119|585112443|FG000|Overall Study|Lack of Efficacy|2|||
162015942|NCT01094119|585112444|FG001|Overall Study|Lack of Efficacy|4|||
162015943|NCT01286480|585112445|FG000|Overall Study|Withdrawal by Subject|5|||
162015944|NCT01286480|585112446|FG001|Overall Study|Withdrawal by Subject|3|||
162015945|NCT00834093|585112447|FG000|Overall Study|Progressive Disease|3|||
162015946|NCT00834093|585112447|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
162015947|NCT01578486|585112448|FG000|Overall Study|Physician Decision|3|||
162015948|NCT01578486|585112448|FG000|Overall Study|Withdrawal by Subject|2|||
162015949|NCT00357903|585112450|FG000|Overall Study|Adverse Event|87|||
162015950|NCT00357903|585112451|FG001|Overall Study|Adverse Event|4|||
162015951|NCT00357903|585112450|FG000|Overall Study|Death|33|||
162015952|NCT00357903|585112451|FG001|Overall Study|Death|0|||
162015953|NCT00357903|585112450|FG000|Overall Study|Lost to Follow-up|23|||
162015954|NCT00357903|585112451|FG001|Overall Study|Lost to Follow-up|4|||
162015955|NCT00357903|585112450|FG000|Overall Study|Physician Decision|39|||
162015956|NCT00357903|585112451|FG001|Overall Study|Physician Decision|5|||
162015957|NCT00357903|585112450|FG000|Overall Study|Withdrawal by Subject|57|||
162161379|NCT03131648|585641786|FG003|Open-label Treatment|Discontinued IMP|0|||
161814186|NCT01175135|584362938|FG003|Overall Study|Adverse Event|4|||
161814187|NCT01175135|584362935|FG000|Overall Study|Death|1|||
161814188|NCT01175135|584362936|FG001|Overall Study|Death|0|||
161814189|NCT01175135|584362937|FG002|Overall Study|Death|0|||
161814190|NCT01175135|584362938|FG003|Overall Study|Death|0|||
161814191|NCT01175135|584362935|FG000|Overall Study|Lack of Efficacy|4|||
161814192|NCT01175135|584362936|FG001|Overall Study|Lack of Efficacy|5|||
161814193|NCT01175135|584362937|FG002|Overall Study|Lack of Efficacy|0|||
161814194|NCT01175135|584362938|FG003|Overall Study|Lack of Efficacy|5|||
161814195|NCT01175135|584362935|FG000|Overall Study|Lost to Follow-up|1|||
161814196|NCT01175135|584362936|FG001|Overall Study|Lost to Follow-up|2|||
161814197|NCT01175135|584362937|FG002|Overall Study|Lost to Follow-up|0|||
161814198|NCT01175135|584362938|FG003|Overall Study|Lost to Follow-up|0|||
161814199|NCT01175135|584362935|FG000|Overall Study|Protocol Violation|1|||
161814200|NCT01175135|584362936|FG001|Overall Study|Protocol Violation|1|||
162015958|NCT00357903|585112451|FG001|Overall Study|Withdrawal by Subject|7|||
162015959|NCT00357903|585112450|FG000|Overall Study|Completed month 12 only|0|||
162015960|NCT00357903|585112451|FG001|Overall Study|Completed month 12 only|1|||
162015961|NCT00357903|585112450|FG000|Overall Study|Protocol issues|14|||
162015962|NCT00357903|585112451|FG001|Overall Study|Protocol issues|3|||
161814201|NCT01175135|584362937|FG002|Overall Study|Protocol Violation|0|||
161814202|NCT01175135|584362938|FG003|Overall Study|Protocol Violation|0|||
162015963|NCT00357903|585112450|FG000|Overall Study|Response status|61|||
162015964|NCT00357903|585112451|FG001|Overall Study|Response status|9|||
162015965|NCT00357903|585112450|FG000|Overall Study|Other|49|||
162015966|NCT00357903|585112451|FG001|Overall Study|Other|10|||
162015967|NCT01918306|585112452|FG000|Overall Study|progresive disease|4|||
162015968|NCT01918306|585112453|FG001|Overall Study|progresive disease|0|||
161814203|NCT01175135|584362935|FG000|Overall Study|Withdrawal by Subject|4|||
162015969|NCT01918306|585112454|FG002|Overall Study|progresive disease|1|||
162015970|NCT01918306|585112455|FG003|Overall Study|progresive disease|1|||
162015971|NCT01918306|585112452|FG000|Overall Study|Withdrawal by Subject|0|||
162015972|NCT01918306|585112453|FG001|Overall Study|Withdrawal by Subject|0|||
162015973|NCT01918306|585112454|FG002|Overall Study|Withdrawal by Subject|0|||
162015974|NCT01918306|585112455|FG003|Overall Study|Withdrawal by Subject|2|||
162015975|NCT01918306|585112452|FG000|Overall Study|neutropenia|1|||
162015976|NCT01918306|585112453|FG001|Overall Study|neutropenia|0|||
162015977|NCT01918306|585112454|FG002|Overall Study|neutropenia|0|||
162015978|NCT01918306|585112455|FG003|Overall Study|neutropenia|0|||
162015979|NCT01918306|585112452|FG000|Overall Study|Lack of Efficacy|1|||
162015980|NCT01918306|585112453|FG001|Overall Study|Lack of Efficacy|0|||
162015981|NCT01918306|585112454|FG002|Overall Study|Lack of Efficacy|0|||
162015982|NCT01918306|585112455|FG003|Overall Study|Lack of Efficacy|0|||
162015983|NCT01918306|585112452|FG000|Overall Study|progress disease, crossover|0|||
162015984|NCT01918306|585112453|FG001|Overall Study|progress disease, crossover|0|||
162015985|NCT01918306|585112454|FG002|Overall Study|progress disease, crossover|1|||
162015986|NCT01918306|585112455|FG003|Overall Study|progress disease, crossover|0|||
162015987|NCT02908672|585112460|FG000|Run-in Period|Death|12|||
162015988|NCT02908672|585112461|FG001|Run-in Period|Death|10|||
162015989|NCT02908672|585112462|FG002|Run-in Period|Death|0|||
162015990|NCT02908672|585112463|FG003|Run-in Period|Death|0|||
162015991|NCT02908672|585112460|FG000|Run-in Period|Lost to Follow-up|1|||
162015992|NCT02908672|585112461|FG001|Run-in Period|Lost to Follow-up|1|||
162015993|NCT02908672|585112462|FG002|Run-in Period|Lost to Follow-up|0|||
162015994|NCT02908672|585112463|FG003|Run-in Period|Lost to Follow-up|0|||
162015995|NCT02908672|585112460|FG000|Run-in Period|Reason Not Specified|2|||
162015996|NCT02908672|585112461|FG001|Run-in Period|Reason Not Specified|0|||
162015997|NCT02908672|585112462|FG002|Run-in Period|Reason Not Specified|0|||
162015998|NCT02908672|585112463|FG003|Run-in Period|Reason Not Specified|0|||
162015999|NCT02908672|585112460|FG000|Run-in Period|Protocol Violation|1|||
162016000|NCT02908672|585112461|FG001|Run-in Period|Protocol Violation|1|||
162016001|NCT02908672|585112462|FG002|Run-in Period|Protocol Violation|0|||
162016002|NCT02908672|585112463|FG003|Run-in Period|Protocol Violation|0|||
162016003|NCT02908672|585112460|FG000|Run-in Period|Study Ended by Sponsor|5|||
162016004|NCT02908672|585112461|FG001|Run-in Period|Study Ended by Sponsor|1|||
162016005|NCT02908672|585112462|FG002|Run-in Period|Study Ended by Sponsor|0|||
162016006|NCT02908672|585112463|FG003|Run-in Period|Study Ended by Sponsor|0|||
162016007|NCT02908672|585112460|FG000|Run-in Period|Withdrawal by Subject|3|||
162016008|NCT02908672|585112461|FG001|Run-in Period|Withdrawal by Subject|9|||
162016009|NCT02908672|585112462|FG002|Run-in Period|Withdrawal by Subject|0|||
162016010|NCT02908672|585112463|FG003|Run-in Period|Withdrawal by Subject|0|||
162016011|NCT02908672|585112460|FG000|Triple Combination Period|Death|0|||
161814204|NCT01175135|584362936|FG001|Overall Study|Withdrawal by Subject|8|||
161814205|NCT01175135|584362937|FG002|Overall Study|Withdrawal by Subject|5|||
161814206|NCT01175135|584362938|FG003|Overall Study|Withdrawal by Subject|5|||
161814207|NCT01175135|584362935|FG000|Overall Study|Other|3|||
161814208|NCT01175135|584362936|FG001|Overall Study|Other|1|||
161814209|NCT01175135|584362937|FG002|Overall Study|Other|3|||
161814210|NCT01175135|584362938|FG003|Overall Study|Other|0|||
161814211|NCT01175135|584362935|FG000|Overall Study|Randomized But Not Treated|0|||
161814212|NCT01175135|584362936|FG001|Overall Study|Randomized But Not Treated|0|||
161814213|NCT01175135|584362937|FG002|Overall Study|Randomized But Not Treated|1|||
161814214|NCT01175135|584362938|FG003|Overall Study|Randomized But Not Treated|0|||
161814215|NCT01590563|584362941|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
161814216|NCT03534193|584362944|FG000|Overall Study|Lost to Follow-up|1|||
162016012|NCT02908672|585112461|FG001|Triple Combination Period|Death|0|||
162016013|NCT02908672|585112462|FG002|Triple Combination Period|Death|150|||
161814217|NCT03534193|584362945|FG001|Overall Study|Lost to Follow-up|3|||
161814218|NCT02699463|584362946|FG000|Overall Study|Lost to Follow-up|11|||
161814219|NCT02699463|584362947|FG001|Overall Study|Lost to Follow-up|8|||
161814220|NCT02699463|584362946|FG000|Overall Study|Withdrawal by Subject|4|||
162016014|NCT02908672|585112463|FG003|Triple Combination Period|Death|127|||
162016015|NCT02908672|585112460|FG000|Triple Combination Period|Lost to Follow-up|0|||
162016016|NCT02908672|585112461|FG001|Triple Combination Period|Lost to Follow-up|0|||
162016017|NCT02908672|585112462|FG002|Triple Combination Period|Lost to Follow-up|6|||
162016018|NCT02908672|585112463|FG003|Triple Combination Period|Lost to Follow-up|8|||
162016019|NCT02908672|585112460|FG000|Triple Combination Period|Reason Not Specified|0|||
162016020|NCT02908672|585112461|FG001|Triple Combination Period|Reason Not Specified|0|||
162016021|NCT02908672|585112462|FG002|Triple Combination Period|Reason Not Specified|0|||
162016022|NCT02908672|585112463|FG003|Triple Combination Period|Reason Not Specified|1|||
162016023|NCT02908672|585112460|FG000|Triple Combination Period|Physician Decision|0|||
162016024|NCT02908672|585112461|FG001|Triple Combination Period|Physician Decision|0|||
162016025|NCT02908672|585112462|FG002|Triple Combination Period|Physician Decision|1|||
162016026|NCT02908672|585112463|FG003|Triple Combination Period|Physician Decision|1|||
162016027|NCT02908672|585112460|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
162016028|NCT02908672|585112461|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
162016029|NCT02908672|585112462|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
162016030|NCT02908672|585112463|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
162016031|NCT02908672|585112460|FG000|Triple Combination Period|Withdrawal by Subject|0|||
162016032|NCT02908672|585112461|FG001|Triple Combination Period|Withdrawal by Subject|0|||
162016033|NCT02908672|585112462|FG002|Triple Combination Period|Withdrawal by Subject|13|||
162016034|NCT02908672|585112463|FG003|Triple Combination Period|Withdrawal by Subject|16|||
162016035|NCT01185080|585112467|FG000|Overall Study|Adverse Event|1|||
162016036|NCT01185080|585112468|FG001|Overall Study|Adverse Event|1|||
162016037|NCT01185080|585112469|FG002|Overall Study|Adverse Event|0|||
162016038|NCT01185080|585112467|FG000|Overall Study|Personal reasons|0|||
162016039|NCT01185080|585112468|FG001|Overall Study|Personal reasons|0|||
162016040|NCT01185080|585112469|FG002|Overall Study|Personal reasons|1|||
162161380|NCT03131648|585641787|FG004|Open-label Treatment|Discontinued IMP|0|||
161814221|NCT02699463|584362947|FG001|Overall Study|Withdrawal by Subject|1|||
161814222|NCT02488239|584362948|FG000|Overall Study|Death|3|||
161814223|NCT02488239|584362948|FG000|Overall Study|Withdrawal by Subject|3|||
161814224|NCT02488239|584362948|FG000|Overall Study|Physician Decision|2|||
161814225|NCT02488239|584362948|FG000|Overall Study|Consent ineligible|1|||
161814226|NCT02488239|584362948|FG000|Overall Study|Did not undergo implant procedure|1|||
161814227|NCT04414930|584362950|FG000|Overall Study|Withdrawal by Subject|1|||
161814228|NCT04414930|584362951|FG001|Overall Study|Withdrawal by Subject|3|||
161814229|NCT05470699|584362952|FG000|Overall Study|Did not receive intervention|13|||
161814230|NCT05470699|584362952|FG000|Overall Study|Ineligible|1|||
161814231|NCT03325881|584362953|FG000|Overall Study|Protocol Violation|0|||
161814232|NCT03325881|584362954|FG001|Overall Study|Protocol Violation|1|||
161814233|NCT03325881|584362953|FG000|Overall Study|Withdrawal by Subject|0|||
161814234|NCT03325881|584362954|FG001|Overall Study|Withdrawal by Subject|2|||
161814235|NCT03325881|584362953|FG000|Overall Study|Lack of Efficacy|2|||
161814236|NCT03325881|584362954|FG001|Overall Study|Lack of Efficacy|0|||
161814237|NCT03325881|584362953|FG000|Overall Study|Not treated|1|||
161814238|NCT03325881|584362954|FG001|Overall Study|Not treated|0|||
161814239|NCT01848938|584362974|FG000|Overall Study|Lost to Follow-up|1|||
161814240|NCT01848938|584362975|FG001|Overall Study|Lost to Follow-up|1|||
161814241|NCT00909038|584362976|FG000|Overall Study|Protocol Violation|187|||
161814242|NCT00909038|584362976|FG000|Overall Study|Non-evaluable Subjects|230|||
161814243|NCT00207090|584362977|FG000|Overall Study|Study drug toxicity|3|||
161814244|NCT00207090|584362977|FG000|Overall Study|Chest wall mass larger|1|||
161814245|NCT00207090|584362977|FG000|Overall Study|Disease progression/relapse|2|||
161814246|NCT00207090|584362977|FG000|Overall Study|Physician Decision|1|||
161814247|NCT00909753|584362980|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
161814248|NCT00909753|584362981|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
161814249|NCT00909753|584362980|FG000|Period: Second Intervention|Protocol Violation|1|||
161814250|NCT00909753|584362981|FG001|Period: Second Intervention|Protocol Violation|0|||
161814251|NCT03480763|584362986|FG000|Overall Study|Withdrawal by Subject|18|||
161814252|NCT03480763|584362987|FG001|Overall Study|Withdrawal by Subject|10|||
161814253|NCT03480763|584362986|FG000|Overall Study|Lost to Follow-up|4|||
161814254|NCT03480763|584362987|FG001|Overall Study|Lost to Follow-up|7|||
161814255|NCT03480763|584362986|FG000|Overall Study|non-study pneumococcal vaccine|1|||
161814256|NCT03480763|584362987|FG001|Overall Study|non-study pneumococcal vaccine|0|||
161814257|NCT03480763|584362986|FG000|Overall Study|oncological treatment|0|||
161814258|NCT03480763|584362987|FG001|Overall Study|oncological treatment|2|||
161814259|NCT03480763|584362986|FG000|Overall Study|pain with vaccination|1|||
161814260|NCT03480763|584362987|FG001|Overall Study|pain with vaccination|0|||
161814261|NCT01895335|584362988|FG000|Overall Study|Adverse Event|106|||
161814262|NCT01895335|584362988|FG000|Overall Study|Lack of Efficacy|53|||
161814263|NCT01895335|584362988|FG000|Overall Study|Poor Compliance to Protocol|11|||
161814264|NCT01895335|584362988|FG000|Overall Study|Included But Not treated|1|||
161814265|NCT01895335|584362988|FG000|Overall Study|Other than Specified Above|44|||
161814266|NCT01647828|584362989|FG000|Overall Study|Death|3|||
161814267|NCT01647828|584362990|FG001|Overall Study|Death|4|||
161814268|NCT01647828|584362991|FG002|Overall Study|Death|4|||
161814269|NCT01647828|584362992|FG003|Overall Study|Death|5|||
161814270|NCT01647828|584362993|FG004|Overall Study|Death|6|||
162016041|NCT02876601|585112470|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
162161381|NCT03131648|585641788|FG005|Open-label Treatment|Discontinued IMP|0|||
161814271|NCT01647828|584362994|FG005|Overall Study|Death|3|||
161814272|NCT01647828|584362995|FG006|Overall Study|Death|10|||
161814273|NCT01647828|584362996|FG007|Overall Study|Death|60|||
161814274|NCT01647828|584362997|FG008|Overall Study|Death|71|||
161814275|NCT01647828|584362989|FG000|Overall Study|Withdrawal by Subject|2|||
161814276|NCT01647828|584362990|FG001|Overall Study|Withdrawal by Subject|0|||
162016042|NCT02876601|585112471|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
162016043|NCT02876601|585112472|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
162016044|NCT02876601|585112473|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
162016045|NCT06083506|585112475|FG000|Overall Study|Physician Decision|2|||
162016046|NCT06083506|585112475|FG000|Overall Study|Lack of Efficacy|1|||
162016047|NCT04949490|585112476|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
162016048|NCT04949490|585112477|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
162016049|NCT04949490|585112478|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
162016050|NCT04949490|585112479|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
162016051|NCT04949490|585112480|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
162016052|NCT04949490|585112481|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
162016053|NCT04949490|585112476|FG000|Group A and Group B|Withdrawal by Subject|0|||
162016054|NCT04949490|585112477|FG001|Group A and Group B|Withdrawal by Subject|0|||
162016055|NCT04949490|585112478|FG002|Group A and Group B|Withdrawal by Subject|1|||
162016056|NCT04949490|585112479|FG003|Group A and Group B|Withdrawal by Subject|0|||
162016057|NCT04949490|585112480|FG004|Group A and Group B|Withdrawal by Subject|0|||
162016058|NCT04949490|585112481|FG005|Group A and Group B|Withdrawal by Subject|0|||
162016059|NCT04949490|585112476|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
162016060|NCT04949490|585112477|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
162016061|NCT04949490|585112478|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
162016062|NCT04949490|585112479|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
162016063|NCT04949490|585112480|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
162016064|NCT04949490|585112481|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
162016065|NCT04949490|585112476|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
162016066|NCT04949490|585112477|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
162016067|NCT04949490|585112478|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
162016068|NCT04949490|585112479|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
162016069|NCT04949490|585112480|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
161814277|NCT01647828|584362991|FG002|Overall Study|Withdrawal by Subject|0|||
161814278|NCT01647828|584362992|FG003|Overall Study|Withdrawal by Subject|1|||
161814279|NCT01647828|584362993|FG004|Overall Study|Withdrawal by Subject|0|||
161814280|NCT01647828|584362994|FG005|Overall Study|Withdrawal by Subject|0|||
161814281|NCT01647828|584362995|FG006|Overall Study|Withdrawal by Subject|1|||
161814282|NCT01647828|584362996|FG007|Overall Study|Withdrawal by Subject|0|||
161814283|NCT01647828|584362997|FG008|Overall Study|Withdrawal by Subject|2|||
161814284|NCT01647828|584362989|FG000|Overall Study|Study terminated by Sponsor|0|||
161814285|NCT01647828|584362990|FG001|Overall Study|Study terminated by Sponsor|0|||
161814286|NCT01647828|584362991|FG002|Overall Study|Study terminated by Sponsor|0|||
161814287|NCT01647828|584362992|FG003|Overall Study|Study terminated by Sponsor|0|||
161814288|NCT01647828|584362993|FG004|Overall Study|Study terminated by Sponsor|0|||
161814289|NCT01647828|584362994|FG005|Overall Study|Study terminated by Sponsor|0|||
161814290|NCT01647828|584362995|FG006|Overall Study|Study terminated by Sponsor|1|||
161814291|NCT01647828|584362996|FG007|Overall Study|Study terminated by Sponsor|26|||
161814292|NCT01647828|584362997|FG008|Overall Study|Study terminated by Sponsor|16|||
161814293|NCT01647828|584362989|FG000|Overall Study|Lost to Follow-up|0|||
161814294|NCT01647828|584362990|FG001|Overall Study|Lost to Follow-up|0|||
162016070|NCT04949490|585112481|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
162016071|NCT05232682|585112482|FG000|Overall Study|Lost to Follow-up|2|||
162161382|NCT03131648|585641789|FG006|Open-label Treatment|Discontinued IMP|112|||
162161383|NCT03131648|585641790|FG007|Open-label Treatment|Discontinued IMP|0|||
162161384|NCT03131648|585641783|FG000|Open-label Treatment|Completed Week 50|0|||
162161385|NCT03131648|585641784|FG001|Open-label Treatment|Completed Week 50|0|||
162161386|NCT03131648|585641785|FG002|Open-label Treatment|Completed Week 50|0|||
162161387|NCT03131648|585641786|FG003|Open-label Treatment|Completed Week 50|0|||
162161388|NCT03131648|585641787|FG004|Open-label Treatment|Completed Week 50|0|||
162161389|NCT03131648|585641788|FG005|Open-label Treatment|Completed Week 50|0|||
162161390|NCT03131648|585641789|FG006|Open-label Treatment|Completed Week 50|6|||
162161391|NCT03131648|585641790|FG007|Open-label Treatment|Completed Week 50|0|||
162161392|NCT03131648|585641783|FG000|Maintenance Treatment Period|Not dosed|0|||
162161393|NCT03131648|585641784|FG001|Maintenance Treatment Period|Not dosed|0|||
162161394|NCT03131648|585641785|FG002|Maintenance Treatment Period|Not dosed|3|||
162161395|NCT03131648|585641786|FG003|Maintenance Treatment Period|Not dosed|2|||
162161396|NCT03131648|585641787|FG004|Maintenance Treatment Period|Not dosed|1|||
162161397|NCT03131648|585641788|FG005|Maintenance Treatment Period|Not dosed|0|||
162161398|NCT03131648|585641789|FG006|Maintenance Treatment Period|Not dosed|0|||
162161399|NCT03131648|585641790|FG007|Maintenance Treatment Period|Not dosed|0|||
161814295|NCT01647828|584362991|FG002|Overall Study|Lost to Follow-up|0|||
161814296|NCT01647828|584362992|FG003|Overall Study|Lost to Follow-up|0|||
162161400|NCT03131648|585641783|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
161814297|NCT01647828|584362993|FG004|Overall Study|Lost to Follow-up|0|||
161814298|NCT01647828|584362994|FG005|Overall Study|Lost to Follow-up|0|||
162016072|NCT00905164|585112483|FG000|Period 1|Protocol Violation|0|||
162016073|NCT00905164|585112484|FG001|Period 1|Protocol Violation|1|||
162016074|NCT02656693|585114434|FG000|Overall Study|Pregnancy|1|||
162016075|NCT02656693|585114435|FG001|Overall Study|Pregnancy|1|||
162016076|NCT02656693|585114436|FG002|Overall Study|Pregnancy|1|||
162016077|NCT02656693|585114434|FG000|Overall Study|Bariatric surgery|0|||
162016078|NCT02656693|585114435|FG001|Overall Study|Bariatric surgery|1|||
162016079|NCT02656693|585114436|FG002|Overall Study|Bariatric surgery|2|||
162016080|NCT02565784|585114437|FG000|First Treatment|Adverse Event|1|||
162016081|NCT02565784|585114437|FG000|First Treatment|Withdrawal by Subject|1|||
162016082|NCT02565784|585114437|FG000|Second Treatment|Withdrawal by Subject|2|||
162016083|NCT02604160|585114438|FG000|Overall Study|Protocol Violation|0|||
162016084|NCT02604160|585114439|FG001|Overall Study|Protocol Violation|1|||
162016085|NCT02604160|585114438|FG000|Overall Study|Physician Decision|0|||
162016086|NCT02604160|585114439|FG001|Overall Study|Physician Decision|1|||
162016087|NCT01596062|585114440|FG000|Overall Study|Adverse Event|1|||
162016088|NCT01596062|585114441|FG001|Overall Study|Adverse Event|0|||
162016089|NCT01596062|585114442|FG002|Overall Study|Adverse Event|2|||
162016090|NCT01596062|585114440|FG000|Overall Study|Lack of Efficacy|0|||
162016091|NCT01596062|585114441|FG001|Overall Study|Lack of Efficacy|0|||
162016092|NCT01596062|585114442|FG002|Overall Study|Lack of Efficacy|1|||
162016093|NCT01069900|585114443|FG000|Overall Study|Technical problems|0|||
162016094|NCT01069900|585114444|FG001|Overall Study|Technical problems|1|||
162016095|NCT01069900|585114443|FG000|Overall Study|Lost to Follow-up|7|||
162016096|NCT01069900|585114444|FG001|Overall Study|Lost to Follow-up|1|||
162016097|NCT01069900|585114443|FG000|Overall Study|Withdrawal by Subject|6|||
162016098|NCT01069900|585114444|FG001|Overall Study|Withdrawal by Subject|1|||
162016099|NCT01069900|585114443|FG000|Overall Study|Protocol Violation|4|||
162016100|NCT01069900|585114444|FG001|Overall Study|Protocol Violation|1|||
162016101|NCT01069900|585114443|FG000|Overall Study|Insufficient Therapeutic effect|1|||
162016102|NCT01069900|585114444|FG001|Overall Study|Insufficient Therapeutic effect|0|||
162016103|NCT03180840|585114445|FG000|Overall Study|Withdrawal by Subject|1|||
162016104|NCT01168219|585114451|FG000|Overall Study|off study before starting treatment|2|||
162016105|NCT01168219|585114451|FG000|Overall Study|withdrew before transplant|1|||
162016106|NCT01168219|585114451|FG000|Overall Study|ineligible due to CML|2|||
162016107|NCT00337675|585114455|FG000|Overall Study|Adverse Event|10|||
162016108|NCT00337675|585114456|FG001|Overall Study|Adverse Event|9|||
162016109|NCT00337675|585114457|FG002|Overall Study|Adverse Event|19|||
162016110|NCT00337675|585114455|FG000|Overall Study|Lack of Efficacy|10|||
162016111|NCT00337675|585114456|FG001|Overall Study|Lack of Efficacy|7|||
162016112|NCT00337675|585114457|FG002|Overall Study|Lack of Efficacy|9|||
162016113|NCT00337675|585114455|FG000|Overall Study|Lost to Follow-up|22|||
162016114|NCT00337675|585114456|FG001|Overall Study|Lost to Follow-up|19|||
162016115|NCT00337675|585114457|FG002|Overall Study|Lost to Follow-up|17|||
162016116|NCT00337675|585114455|FG000|Overall Study|Physician Decision|9|||
162016117|NCT00337675|585114456|FG001|Overall Study|Physician Decision|17|||
162016118|NCT00337675|585114457|FG002|Overall Study|Physician Decision|14|||
162016119|NCT00337675|585114455|FG000|Overall Study|Protocol Violation|21|||
162016120|NCT00337675|585114456|FG001|Overall Study|Protocol Violation|24|||
162016121|NCT00337675|585114457|FG002|Overall Study|Protocol Violation|19|||
162016122|NCT00337675|585114455|FG000|Overall Study|Withdrawal by Subject|25|||
162016123|NCT00337675|585114456|FG001|Overall Study|Withdrawal by Subject|25|||
162016124|NCT00337675|585114457|FG002|Overall Study|Withdrawal by Subject|19|||
162016125|NCT00337675|585114455|FG000|Overall Study|Progressive Disease|0|||
162016126|NCT00337675|585114456|FG001|Overall Study|Progressive Disease|2|||
162016127|NCT00337675|585114457|FG002|Overall Study|Progressive Disease|0|||
162016128|NCT00337675|585114455|FG000|Overall Study|Trial Terminated|0|||
162016129|NCT00337675|585114456|FG001|Overall Study|Trial Terminated|0|||
162016130|NCT00337675|585114457|FG002|Overall Study|Trial Terminated|2|||
162016131|NCT00859456|585114458|FG000|Overall Study|Adverse Event|3|||
162016132|NCT00859456|585114458|FG000|Overall Study|Progressive disease|2|||
162016133|NCT00859456|585114458|FG000|Overall Study|Non-compliance|3|||
162016134|NCT02015637|585114463|FG000|Overall Study|Lost to Follow-up|3|||
162016135|NCT02015637|585114464|FG001|Overall Study|Lost to Follow-up|5|||
162016136|NCT02015637|585114463|FG000|Overall Study|Adverse Event|3|||
162016137|NCT02015637|585114464|FG001|Overall Study|Adverse Event|0|||
162016138|NCT02015637|585114463|FG000|Overall Study|Did not take study drug|2|||
162016139|NCT02015637|585114464|FG001|Overall Study|Did not take study drug|0|||
162016140|NCT00927953|585114469|FG000|Overall Study|Death|2|||
162016141|NCT00927953|585114470|FG001|Overall Study|Death|1|||
162016142|NCT02863419|585114471|FG000|Overall Study|Lost to Follow-up|0|||
162161401|NCT03131648|585641784|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
162016143|NCT02863419|585114472|FG001|Overall Study|Lost to Follow-up|1|||
162016144|NCT02863419|585114473|FG002|Overall Study|Lost to Follow-up|4|||
162016145|NCT02863419|585114471|FG000|Overall Study|Withdrawal by Subject|5|||
162016146|NCT02863419|585114472|FG001|Overall Study|Withdrawal by Subject|5|||
162016147|NCT02863419|585114473|FG002|Overall Study|Withdrawal by Subject|3|||
162016148|NCT02863419|585114471|FG000|Overall Study|Died|3|||
162016149|NCT02863419|585114472|FG001|Overall Study|Died|4|||
162016150|NCT02863419|585114473|FG002|Overall Study|Died|1|||
162016151|NCT01491607|585114474|FG000|Overall Study|Lost to Follow-up|7|||
162016152|NCT01491607|585114474|FG000|Overall Study|Withdrawal by Subject|3|||
162016153|NCT00297258|585114477|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
162016154|NCT00297258|585114477|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
162016155|NCT00297258|585114477|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
162016156|NCT00297258|585114477|FG000|Overall Study|Intercurrent Illness|3|||
162016157|NCT00297258|585114477|FG000|Overall Study|Intercurrent Death|2|||
162016158|NCT00297258|585114477|FG000|Overall Study|Deteriorization of General Condition|1|||
162016159|NCT00297258|585114477|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
162016160|NCT00297258|585114477|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
162016161|NCT00297258|585114477|FG000|Overall Study|Switch to Commercial Treatment|1|||
162016162|NCT00297258|585114477|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
162016163|NCT02454517|585114478|FG000|Overall Study|Withdrawal by Subject|3|||
162016164|NCT02454517|585114479|FG001|Overall Study|Withdrawal by Subject|0|||
162016165|NCT02454517|585114478|FG000|Overall Study|Lost to Follow-up|4|||
162016166|NCT02454517|585114479|FG001|Overall Study|Lost to Follow-up|7|||
162016167|NCT02454517|585114478|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
162016168|NCT02454517|585114479|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
162016169|NCT03565497|585114480|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
162016170|NCT03565497|585114481|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
162016171|NCT03565497|585114482|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
162016172|NCT03565497|585114480|FG000|Overall Study|Lost to Follow-up|1|||
162016173|NCT03565497|585114481|FG001|Overall Study|Lost to Follow-up|1|||
162016174|NCT03565497|585114482|FG002|Overall Study|Lost to Follow-up|2|||
162016175|NCT03565497|585114480|FG000|Overall Study|Withdrawal by Subject|1|||
162016176|NCT03565497|585114481|FG001|Overall Study|Withdrawal by Subject|1|||
162016177|NCT03565497|585114482|FG002|Overall Study|Withdrawal by Subject|1|||
162016178|NCT01470326|585114483|FG000|Overall Study|Protocol Violation|32|||
162016179|NCT01470326|585114483|FG000|Overall Study|No Drug Administration Information|2|||
162016180|NCT01470326|585114483|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
162016181|NCT02561832|585114486|FG000|Overall Study|Withdrawal by Subject|1|||
162016182|NCT02561832|585114487|FG001|Overall Study|Withdrawal by Subject|1|||
162016183|NCT02561832|585114486|FG000|Overall Study|Adverse Event|3|||
162016184|NCT02561832|585114487|FG001|Overall Study|Adverse Event|0|||
162016185|NCT02561832|585114486|FG000|Overall Study|Disease progression|3|||
162016186|NCT02561832|585114487|FG001|Overall Study|Disease progression|3|||
162016187|NCT01733680|585114495|FG000|Overall Study|Withdrawal by Subject|0|||
162016188|NCT01733680|585114496|FG001|Overall Study|Withdrawal by Subject|1|||
162016189|NCT04139798|585114497|FG000|Overall Study|Withdrawal by Subject|6|||
162016190|NCT04139798|585114498|FG001|Overall Study|Withdrawal by Subject|5|||
162016191|NCT04139798|585114497|FG000|Overall Study|Lost to Follow-up|2|||
162016192|NCT04139798|585114498|FG001|Overall Study|Lost to Follow-up|5|||
162016193|NCT04139798|585114497|FG000|Overall Study|Discontinued|4|||
162016194|NCT04139798|585114498|FG001|Overall Study|Discontinued|2|||
162016195|NCT04139798|585114497|FG000|Overall Study|Adverse Event|1|||
162016196|NCT04139798|585114498|FG001|Overall Study|Adverse Event|3|||
162016197|NCT04139798|585114497|FG000|Overall Study|Protocol Violation|1|||
162016198|NCT04139798|585114498|FG001|Overall Study|Protocol Violation|0|||
162016199|NCT01526733|585114499|FG000|Phase 1|Protocol Violation|1|||
162016200|NCT01526733|585114500|FG001|Phase 1|Protocol Violation|0|||
162016201|NCT01526733|585114499|FG000|Phase 1|Withdrawal by Subject|1|||
162016202|NCT01526733|585114500|FG001|Phase 1|Withdrawal by Subject|1|||
162016203|NCT02839200|585114503|FG000|Overall Study|Withdrawal by Subject|2|||
162016204|NCT02839200|585114504|FG001|Overall Study|Withdrawal by Subject|0|||
162016205|NCT02839200|585114505|FG002|Overall Study|Withdrawal by Subject|1|||
162016206|NCT02839200|585114506|FG003|Overall Study|Withdrawal by Subject|0|||
162016207|NCT02839200|585114507|FG004|Overall Study|Withdrawal by Subject|0|||
162016208|NCT02839200|585114508|FG005|Overall Study|Withdrawal by Subject|1|||
162016209|NCT02839200|585114503|FG000|Overall Study|Lost to Follow-up|2|||
162016210|NCT02839200|585114504|FG001|Overall Study|Lost to Follow-up|0|||
162016211|NCT02839200|585114505|FG002|Overall Study|Lost to Follow-up|0|||
162016212|NCT02839200|585114506|FG003|Overall Study|Lost to Follow-up|0|||
162016213|NCT02839200|585114507|FG004|Overall Study|Lost to Follow-up|1|||
162016214|NCT02839200|585114508|FG005|Overall Study|Lost to Follow-up|0|||
162016215|NCT02839200|585114503|FG000|Overall Study|Adverse Event|0|||
162016216|NCT02839200|585114504|FG001|Overall Study|Adverse Event|0|||
162016217|NCT02839200|585114505|FG002|Overall Study|Adverse Event|0|||
162016218|NCT02839200|585114506|FG003|Overall Study|Adverse Event|0|||
162016219|NCT02839200|585114507|FG004|Overall Study|Adverse Event|1|||
162016220|NCT02839200|585114508|FG005|Overall Study|Adverse Event|0|||
162016221|NCT02839200|585114503|FG000|Overall Study|Randomized in error|0|||
162016222|NCT02839200|585114504|FG001|Overall Study|Randomized in error|1|||
162016223|NCT02839200|585114505|FG002|Overall Study|Randomized in error|0|||
162016224|NCT02839200|585114506|FG003|Overall Study|Randomized in error|0|||
162016225|NCT02839200|585114507|FG004|Overall Study|Randomized in error|0|||
162016226|NCT02839200|585114508|FG005|Overall Study|Randomized in error|0|||
162016227|NCT02952820|585114509|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
162016228|NCT02952820|585114510|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
162016229|NCT02952820|585114511|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
162016230|NCT02952820|585114509|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
162016231|NCT02952820|585114510|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
162016232|NCT02952820|585114511|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
162016233|NCT02952820|585114509|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
162016234|NCT02952820|585114510|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
162016235|NCT02952820|585114511|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
162016236|NCT02952820|585114509|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
162016237|NCT02952820|585114510|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
162016238|NCT02952820|585114511|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
162016239|NCT02952820|585114509|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
162016240|NCT02952820|585114510|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
162016241|NCT02952820|585114511|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
162016242|NCT02952820|585114509|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
162016243|NCT02952820|585114510|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
162016244|NCT02952820|585114511|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
162016245|NCT02952820|585114509|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
162016246|NCT02952820|585114510|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
162016247|NCT02952820|585114511|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
162016248|NCT02952820|585114509|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
162016249|NCT02952820|585114510|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
162016250|NCT02952820|585114511|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
162016251|NCT02952820|585114509|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
162016252|NCT02952820|585114510|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
162016253|NCT02952820|585114511|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
162016254|NCT02952820|585114509|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
162016255|NCT02952820|585114510|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
162016256|NCT02952820|585114511|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
162016257|NCT02952820|585114509|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
162016258|NCT02952820|585114510|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
162016259|NCT02952820|585114511|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
162016260|NCT02952820|585114509|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
162016261|NCT02952820|585114510|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
162016262|NCT02952820|585114511|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
162016263|NCT02952820|585114509|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
162016264|NCT02952820|585114510|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
162016265|NCT02952820|585114511|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
162016266|NCT02952820|585114509|FG000|Active Treatment Period (6 Months)|Not treated|0|||
162016267|NCT02952820|585114510|FG001|Active Treatment Period (6 Months)|Not treated|0|||
162016268|NCT02952820|585114511|FG002|Active Treatment Period (6 Months)|Not treated|1|||
162016269|NCT03614156|585114512|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
162016270|NCT03614156|585114513|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
162016271|NCT03614156|585114514|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
162016272|NCT03614156|585114515|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
162016273|NCT03614156|585114512|FG000|Open-Label Treatment Period|Adverse Event|7|||
162016274|NCT03614156|585114513|FG001|Open-Label Treatment Period|Adverse Event|0|||
162016275|NCT03614156|585114514|FG002|Open-Label Treatment Period|Adverse Event|0|||
162016276|NCT03614156|585114515|FG003|Open-Label Treatment Period|Adverse Event|0|||
162016277|NCT03614156|585114512|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
162016278|NCT03614156|585114513|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
162016279|NCT03614156|585114514|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
162016280|NCT03614156|585114515|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
162016281|NCT03614156|585114512|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
162016282|NCT03614156|585114513|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
162016283|NCT03614156|585114514|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
162016284|NCT03614156|585114515|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
162016285|NCT03614156|585114512|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
162016286|NCT03614156|585114513|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
162016287|NCT03614156|585114514|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
162016288|NCT03614156|585114515|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
162016289|NCT03614156|585114512|FG000|Open-Label Treatment Period|Protocol Violation|2|||
162016290|NCT03614156|585114513|FG001|Open-Label Treatment Period|Protocol Violation|0|||
162016291|NCT03614156|585114514|FG002|Open-Label Treatment Period|Protocol Violation|0|||
162016292|NCT03614156|585114515|FG003|Open-Label Treatment Period|Protocol Violation|0|||
162016293|NCT03614156|585114512|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
162016294|NCT03614156|585114513|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
162016295|NCT03614156|585114514|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
162016296|NCT03614156|585114515|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
162016297|NCT03614156|585114512|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
162016298|NCT03614156|585114513|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
162016299|NCT03614156|585114514|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
162016300|NCT03614156|585114515|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
162016301|NCT03614156|585114512|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
162016302|NCT03614156|585114513|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
162016303|NCT03614156|585114514|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
162016304|NCT03614156|585114515|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
162016305|NCT03614156|585114512|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
162016306|NCT03614156|585114513|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
162016307|NCT03614156|585114514|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
162016308|NCT03614156|585114515|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
162016309|NCT03614156|585114512|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
162016310|NCT03614156|585114513|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
162016311|NCT03614156|585114514|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
162016312|NCT03614156|585114515|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
162016313|NCT03614156|585114512|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
162016314|NCT03614156|585114513|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
162016315|NCT03614156|585114514|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
162016316|NCT03614156|585114515|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
162016317|NCT03614156|585114512|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
162016318|NCT03614156|585114513|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
162016319|NCT03614156|585114514|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
162016320|NCT03614156|585114515|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
162016321|NCT03614156|585114512|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
162016322|NCT03614156|585114513|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
162016323|NCT03614156|585114514|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
162016324|NCT03614156|585114515|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
162016325|NCT03614156|585114512|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
162016326|NCT03614156|585114513|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
162016327|NCT03614156|585114514|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
162016328|NCT03614156|585114515|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
162016329|NCT03614156|585114512|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
162016330|NCT03614156|585114513|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
162016331|NCT03614156|585114514|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
162016332|NCT03614156|585114515|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
162016333|NCT03614156|585114512|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
162016334|NCT03614156|585114513|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
162016335|NCT03614156|585114514|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
162016336|NCT03614156|585114515|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
162016337|NCT03070964|585114517|FG000|Overall Study|Progressive disease|8|||
162016338|NCT03070964|585114517|FG000|Overall Study|Treatment-unrelated adverse event|2|||
162016339|NCT03070964|585114517|FG000|Overall Study|Never treated|1|||
162016340|NCT03070964|585114517|FG000|Overall Study|Physician Decision|1|||
162016341|NCT03070964|585114517|FG000|Overall Study|Withdrawal by Subject|1|||
162016342|NCT03070964|585114517|FG000|Overall Study|Adverse Event|1|||
162016343|NCT00885534|585114518|FG000|Overall Study|Patient deemed ineligible|1|||
162016344|NCT02453711|585114519|FG000|Overall Study|Withdrawal by Subject|5|||
162016345|NCT02453711|585114520|FG001|Overall Study|Withdrawal by Subject|4|||
162016346|NCT02453711|585114521|FG002|Overall Study|Withdrawal by Subject|6|||
162016347|NCT02453711|585114522|FG003|Overall Study|Withdrawal by Subject|4|||
162016348|NCT02453711|585114523|FG004|Overall Study|Withdrawal by Subject|1|||
162016349|NCT02453711|585114524|FG005|Overall Study|Withdrawal by Subject|1|||
162016350|NCT02453711|585114525|FG006|Overall Study|Withdrawal by Subject|0|||
162016351|NCT02453711|585114526|FG007|Overall Study|Withdrawal by Subject|1|||
162016352|NCT02453711|585114527|FG008|Overall Study|Withdrawal by Subject|7|||
162016353|NCT02453711|585114519|FG000|Overall Study|Lost to Follow-up|5|||
162016354|NCT02453711|585114520|FG001|Overall Study|Lost to Follow-up|3|||
162016355|NCT02453711|585114521|FG002|Overall Study|Lost to Follow-up|2|||
162016356|NCT02453711|585114522|FG003|Overall Study|Lost to Follow-up|3|||
162016357|NCT02453711|585114523|FG004|Overall Study|Lost to Follow-up|1|||
162016358|NCT02453711|585114524|FG005|Overall Study|Lost to Follow-up|5|||
162016359|NCT02453711|585114525|FG006|Overall Study|Lost to Follow-up|2|||
162016360|NCT02453711|585114526|FG007|Overall Study|Lost to Follow-up|6|||
162161402|NCT03131648|585641785|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
161919208|NCT03765073|584751430|FG011|Stage 1|Lost to Follow-up|0|||
161919209|NCT03765073|584751431|FG012|Stage 1|Lost to Follow-up|0|||
161919210|NCT03765073|584751432|FG013|Stage 1|Lost to Follow-up|0|||
161919211|NCT03765073|584751433|FG014|Stage 1|Lost to Follow-up|0|||
161919212|NCT03765073|584751434|FG015|Stage 1|Lost to Follow-up|0|||
161919213|NCT03765073|584751435|FG016|Stage 1|Lost to Follow-up|0|||
161919214|NCT03765073|584751436|FG017|Stage 1|Lost to Follow-up|0|||
161919215|NCT03765073|584751437|FG018|Stage 1|Lost to Follow-up|0|||
161919216|NCT03765073|584751438|FG019|Stage 1|Lost to Follow-up|0|||
161919217|NCT03765073|584751439|FG020|Stage 1|Lost to Follow-up|0|||
161919218|NCT03765073|584751419|FG000|Stage 1|Withdrawal by participant|0|||
161919219|NCT03765073|584751420|FG001|Stage 1|Withdrawal by participant|1|||
161919220|NCT03765073|584751421|FG002|Stage 1|Withdrawal by participant|0|||
161919221|NCT03765073|584751422|FG003|Stage 1|Withdrawal by participant|0|||
161919222|NCT03765073|584751423|FG004|Stage 1|Withdrawal by participant|0|||
161919223|NCT03765073|584751424|FG005|Stage 1|Withdrawal by participant|0|||
161919224|NCT03765073|584751425|FG006|Stage 1|Withdrawal by participant|0|||
161919225|NCT03765073|584751426|FG007|Stage 1|Withdrawal by participant|0|||
161919226|NCT03765073|584751427|FG008|Stage 1|Withdrawal by participant|0|||
161919227|NCT03765073|584751428|FG009|Stage 1|Withdrawal by participant|0|||
161919228|NCT03765073|584751429|FG010|Stage 1|Withdrawal by participant|0|||
161919229|NCT03765073|584751430|FG011|Stage 1|Withdrawal by participant|0|||
161919230|NCT03765073|584751431|FG012|Stage 1|Withdrawal by participant|0|||
161919231|NCT03765073|584751432|FG013|Stage 1|Withdrawal by participant|0|||
161919232|NCT03765073|584751433|FG014|Stage 1|Withdrawal by participant|0|||
161919233|NCT03765073|584751434|FG015|Stage 1|Withdrawal by participant|0|||
161919234|NCT03765073|584751435|FG016|Stage 1|Withdrawal by participant|0|||
161919235|NCT03765073|584751436|FG017|Stage 1|Withdrawal by participant|0|||
161919236|NCT03765073|584751437|FG018|Stage 1|Withdrawal by participant|0|||
161919237|NCT03765073|584751438|FG019|Stage 1|Withdrawal by participant|0|||
161919238|NCT03765073|584751439|FG020|Stage 1|Withdrawal by participant|0|||
161919239|NCT03765073|584751419|FG000|Stage 2|Death|0|||
161919240|NCT03765073|584751420|FG001|Stage 2|Death|0|||
161919241|NCT03765073|584751421|FG002|Stage 2|Death|0|||
161919242|NCT03765073|584751422|FG003|Stage 2|Death|0|||
161919243|NCT03765073|584751423|FG004|Stage 2|Death|0|||
161919244|NCT03765073|584751424|FG005|Stage 2|Death|0|||
161919245|NCT03765073|584751425|FG006|Stage 2|Death|0|||
161919246|NCT03765073|584751426|FG007|Stage 2|Death|0|||
161919247|NCT03765073|584751427|FG008|Stage 2|Death|0|||
161919248|NCT03765073|584751428|FG009|Stage 2|Death|1|||
161919249|NCT03765073|584751429|FG010|Stage 2|Death|0|||
161919250|NCT03765073|584751430|FG011|Stage 2|Death|1|||
161919251|NCT03765073|584751431|FG012|Stage 2|Death|0|||
161919252|NCT03765073|584751432|FG013|Stage 2|Death|0|||
161919253|NCT03765073|584751433|FG014|Stage 2|Death|0|||
161919254|NCT03765073|584751434|FG015|Stage 2|Death|0|||
161919255|NCT03765073|584751435|FG016|Stage 2|Death|2|||
161919256|NCT03765073|584751436|FG017|Stage 2|Death|0|||
161919257|NCT03765073|584751437|FG018|Stage 2|Death|0|||
161919258|NCT03765073|584751438|FG019|Stage 2|Death|0|||
161919259|NCT03765073|584751439|FG020|Stage 2|Death|0|||
161919260|NCT03765073|584751419|FG000|Stage 2|Lost to Follow-up|0|||
161919261|NCT03765073|584751420|FG001|Stage 2|Lost to Follow-up|0|||
161919262|NCT03765073|584751421|FG002|Stage 2|Lost to Follow-up|0|||
161919263|NCT03765073|584751422|FG003|Stage 2|Lost to Follow-up|5|||
161919264|NCT03765073|584751423|FG004|Stage 2|Lost to Follow-up|1|||
161919265|NCT03765073|584751424|FG005|Stage 2|Lost to Follow-up|0|||
161919266|NCT03765073|584751425|FG006|Stage 2|Lost to Follow-up|3|||
161919267|NCT03765073|584751426|FG007|Stage 2|Lost to Follow-up|3|||
161919268|NCT03765073|584751427|FG008|Stage 2|Lost to Follow-up|1|||
161919269|NCT03765073|584751428|FG009|Stage 2|Lost to Follow-up|6|||
161919270|NCT03765073|584751429|FG010|Stage 2|Lost to Follow-up|5|||
161919271|NCT03765073|584751430|FG011|Stage 2|Lost to Follow-up|1|||
161919272|NCT03765073|584751431|FG012|Stage 2|Lost to Follow-up|1|||
161919273|NCT03765073|584751432|FG013|Stage 2|Lost to Follow-up|3|||
161919274|NCT03765073|584751433|FG014|Stage 2|Lost to Follow-up|3|||
161919275|NCT03765073|584751434|FG015|Stage 2|Lost to Follow-up|1|||
161919276|NCT03765073|584751435|FG016|Stage 2|Lost to Follow-up|6|||
161919277|NCT03765073|584751436|FG017|Stage 2|Lost to Follow-up|0|||
161919278|NCT03765073|584751437|FG018|Stage 2|Lost to Follow-up|0|||
161919279|NCT03765073|584751438|FG019|Stage 2|Lost to Follow-up|0|||
161919280|NCT03765073|584751439|FG020|Stage 2|Lost to Follow-up|0|||
161919281|NCT03765073|584751419|FG000|Stage 2|Other|0|||
161919282|NCT03765073|584751420|FG001|Stage 2|Other|0|||
161919283|NCT03765073|584751421|FG002|Stage 2|Other|0|||
161919284|NCT03765073|584751422|FG003|Stage 2|Other|0|||
161919285|NCT03765073|584751423|FG004|Stage 2|Other|0|||
161919286|NCT03765073|584751424|FG005|Stage 2|Other|0|||
161919287|NCT03765073|584751425|FG006|Stage 2|Other|0|||
161919288|NCT03765073|584751426|FG007|Stage 2|Other|1|||
161919289|NCT03765073|584751427|FG008|Stage 2|Other|1|||
161919290|NCT03765073|584751428|FG009|Stage 2|Other|3|||
161919291|NCT03765073|584751429|FG010|Stage 2|Other|0|||
161919292|NCT03765073|584751430|FG011|Stage 2|Other|0|||
161919293|NCT03765073|584751431|FG012|Stage 2|Other|0|||
161919294|NCT03765073|584751432|FG013|Stage 2|Other|0|||
161919295|NCT03765073|584751433|FG014|Stage 2|Other|0|||
161919296|NCT03765073|584751434|FG015|Stage 2|Other|1|||
162016361|NCT02453711|585114527|FG008|Overall Study|Lost to Follow-up|6|||
162016362|NCT02453711|585114519|FG000|Overall Study|Death|0|||
162016363|NCT02453711|585114520|FG001|Overall Study|Death|0|||
162016364|NCT02453711|585114521|FG002|Overall Study|Death|0|||
162016365|NCT02453711|585114522|FG003|Overall Study|Death|0|||
162016366|NCT02453711|585114523|FG004|Overall Study|Death|0|||
162016367|NCT02453711|585114524|FG005|Overall Study|Death|0|||
162016368|NCT02453711|585114525|FG006|Overall Study|Death|1|||
162016369|NCT02453711|585114526|FG007|Overall Study|Death|0|||
162016370|NCT02453711|585114527|FG008|Overall Study|Death|0|||
162016371|NCT02453711|585114519|FG000|Overall Study|Unclassified|1|||
162016372|NCT02453711|585114520|FG001|Overall Study|Unclassified|0|||
162016373|NCT02453711|585114521|FG002|Overall Study|Unclassified|1|||
162016374|NCT02453711|585114522|FG003|Overall Study|Unclassified|0|||
162016375|NCT02453711|585114523|FG004|Overall Study|Unclassified|0|||
162016376|NCT02453711|585114524|FG005|Overall Study|Unclassified|0|||
162016377|NCT02453711|585114525|FG006|Overall Study|Unclassified|0|||
162016378|NCT02453711|585114526|FG007|Overall Study|Unclassified|0|||
162016379|NCT02453711|585114527|FG008|Overall Study|Unclassified|0|||
162016380|NCT01587924|585114528|FG000|Overall Study|Adverse Event|0|||
162016381|NCT01587924|585114529|FG001|Overall Study|Adverse Event|2|||
162016382|NCT01587924|585114530|FG002|Overall Study|Adverse Event|0|||
162016383|NCT01587924|585114531|FG003|Overall Study|Adverse Event|0|||
162016384|NCT01587924|585114528|FG000|Overall Study|Protocol Violation|2|||
162016385|NCT01587924|585114529|FG001|Overall Study|Protocol Violation|1|||
162016386|NCT01587924|585114530|FG002|Overall Study|Protocol Violation|2|||
162016387|NCT01587924|585114531|FG003|Overall Study|Protocol Violation|1|||
162016388|NCT01587924|585114528|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
162016389|NCT01587924|585114529|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
162016390|NCT01587924|585114530|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
162016391|NCT01587924|585114531|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
162016392|NCT01587924|585114528|FG000|Overall Study|Withdrawal by Subject|0|||
162016393|NCT01587924|585114529|FG001|Overall Study|Withdrawal by Subject|1|||
162016394|NCT01587924|585114530|FG002|Overall Study|Withdrawal by Subject|1|||
162016395|NCT01587924|585114531|FG003|Overall Study|Withdrawal by Subject|0|||
162016396|NCT00606593|585114533|FG000|Overall Study|Adverse Event|0|||
162016397|NCT00606593|585114534|FG001|Overall Study|Adverse Event|0|||
162016398|NCT00606593|585114535|FG002|Overall Study|Adverse Event|0|||
162016399|NCT00606593|585114536|FG003|Overall Study|Adverse Event|1|||
162016400|NCT00606593|585114537|FG004|Overall Study|Adverse Event|1|||
162016401|NCT00606593|585114538|FG005|Overall Study|Adverse Event|0|||
162016402|NCT00606593|585114539|FG006|Overall Study|Adverse Event|1|||
162016403|NCT00606593|585114540|FG007|Overall Study|Adverse Event|2|||
162016404|NCT00606593|585114541|FG008|Overall Study|Adverse Event|1|||
162016405|NCT00606593|585114542|FG009|Overall Study|Adverse Event|0|||
162016406|NCT00606593|585114533|FG000|Overall Study|Withdrawal of consent|1|||
162016407|NCT00606593|585114534|FG001|Overall Study|Withdrawal of consent|0|||
162016408|NCT00606593|585114535|FG002|Overall Study|Withdrawal of consent|1|||
162016409|NCT00606593|585114536|FG003|Overall Study|Withdrawal of consent|0|||
162016410|NCT00606593|585114537|FG004|Overall Study|Withdrawal of consent|0|||
162016411|NCT00606593|585114538|FG005|Overall Study|Withdrawal of consent|0|||
162016412|NCT00606593|585114539|FG006|Overall Study|Withdrawal of consent|0|||
162016413|NCT00606593|585114540|FG007|Overall Study|Withdrawal of consent|0|||
162016414|NCT00606593|585114541|FG008|Overall Study|Withdrawal of consent|0|||
162016415|NCT00606593|585114542|FG009|Overall Study|Withdrawal of consent|0|||
162016416|NCT00606593|585114533|FG000|Overall Study|Administrative/Other|0|||
162016417|NCT00606593|585114534|FG001|Overall Study|Administrative/Other|0|||
162016418|NCT00606593|585114535|FG002|Overall Study|Administrative/Other|1|||
162016419|NCT00606593|585114536|FG003|Overall Study|Administrative/Other|0|||
162016420|NCT00606593|585114537|FG004|Overall Study|Administrative/Other|0|||
162016421|NCT00606593|585114538|FG005|Overall Study|Administrative/Other|0|||
162016422|NCT00606593|585114539|FG006|Overall Study|Administrative/Other|0|||
162016423|NCT00606593|585114540|FG007|Overall Study|Administrative/Other|0|||
162016424|NCT00606593|585114541|FG008|Overall Study|Administrative/Other|0|||
162016425|NCT00606593|585114542|FG009|Overall Study|Administrative/Other|0|||
162016426|NCT03181529|585114543|FG000|Overall Study|Withdrawal by Subject|1|||
162016427|NCT03181529|585114544|FG001|Overall Study|Withdrawal by Subject|1|||
162016428|NCT03181529|585114543|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
162016429|NCT03181529|585114544|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
162016430|NCT00607373|585114547|FG000|Treatment Period|Adverse Event|0|||
162016431|NCT00607373|585114548|FG001|Treatment Period|Adverse Event|4|||
162016432|NCT00607373|585114547|FG000|Treatment Period|Physician Decision|0|||
162016433|NCT00607373|585114548|FG001|Treatment Period|Physician Decision|1|||
162016434|NCT00607373|585114547|FG000|Treatment Period|Withdrawal by Subject|0|||
162016435|NCT00607373|585114548|FG001|Treatment Period|Withdrawal by Subject|1|||
162016436|NCT00607373|585114547|FG000|Follow-up Period|Other|0|||
162016437|NCT00607373|585114548|FG001|Follow-up Period|Other|1|||
161919297|NCT03765073|584751435|FG016|Stage 2|Other|2|||
161919298|NCT03765073|584751436|FG017|Stage 2|Other|0|||
161919299|NCT03765073|584751437|FG018|Stage 2|Other|0|||
161919300|NCT03765073|584751438|FG019|Stage 2|Other|0|||
161919301|NCT03765073|584751439|FG020|Stage 2|Other|0|||
161919302|NCT03765073|584751419|FG000|Stage 2|Withdrawal by parent/guardian|0|||
161919303|NCT03765073|584751420|FG001|Stage 2|Withdrawal by parent/guardian|0|||
161919304|NCT03765073|584751421|FG002|Stage 2|Withdrawal by parent/guardian|0|||
161919305|NCT03765073|584751422|FG003|Stage 2|Withdrawal by parent/guardian|0|||
161919306|NCT03765073|584751423|FG004|Stage 2|Withdrawal by parent/guardian|0|||
161919307|NCT03765073|584751424|FG005|Stage 2|Withdrawal by parent/guardian|0|||
161919308|NCT03765073|584751425|FG006|Stage 2|Withdrawal by parent/guardian|0|||
161919309|NCT03765073|584751426|FG007|Stage 2|Withdrawal by parent/guardian|0|||
161919310|NCT03765073|584751427|FG008|Stage 2|Withdrawal by parent/guardian|0|||
161919311|NCT03765073|584751428|FG009|Stage 2|Withdrawal by parent/guardian|0|||
161919312|NCT03765073|584751429|FG010|Stage 2|Withdrawal by parent/guardian|3|||
161919313|NCT03765073|584751430|FG011|Stage 2|Withdrawal by parent/guardian|3|||
161919314|NCT03765073|584751431|FG012|Stage 2|Withdrawal by parent/guardian|3|||
161919315|NCT03765073|584751432|FG013|Stage 2|Withdrawal by parent/guardian|1|||
161919316|NCT03765073|584751433|FG014|Stage 2|Withdrawal by parent/guardian|1|||
161919317|NCT03765073|584751434|FG015|Stage 2|Withdrawal by parent/guardian|0|||
161919318|NCT03765073|584751435|FG016|Stage 2|Withdrawal by parent/guardian|3|||
161919319|NCT03765073|584751436|FG017|Stage 2|Withdrawal by parent/guardian|0|||
161919320|NCT03765073|584751437|FG018|Stage 2|Withdrawal by parent/guardian|0|||
161919321|NCT03765073|584751438|FG019|Stage 2|Withdrawal by parent/guardian|0|||
161919322|NCT03765073|584751439|FG020|Stage 2|Withdrawal by parent/guardian|0|||
161919323|NCT03765073|584751419|FG000|Stage 2|Withdrawal by Subject|0|||
161919324|NCT03765073|584751420|FG001|Stage 2|Withdrawal by Subject|0|||
161919325|NCT03765073|584751421|FG002|Stage 2|Withdrawal by Subject|0|||
161919326|NCT03765073|584751422|FG003|Stage 2|Withdrawal by Subject|3|||
161919327|NCT03765073|584751423|FG004|Stage 2|Withdrawal by Subject|3|||
161919328|NCT03765073|584751424|FG005|Stage 2|Withdrawal by Subject|3|||
161919329|NCT03765073|584751425|FG006|Stage 2|Withdrawal by Subject|0|||
161919330|NCT03765073|584751426|FG007|Stage 2|Withdrawal by Subject|1|||
161919331|NCT03765073|584751427|FG008|Stage 2|Withdrawal by Subject|0|||
161919332|NCT03765073|584751428|FG009|Stage 2|Withdrawal by Subject|5|||
161919333|NCT03765073|584751429|FG010|Stage 2|Withdrawal by Subject|0|||
161919334|NCT03765073|584751430|FG011|Stage 2|Withdrawal by Subject|0|||
161919335|NCT03765073|584751431|FG012|Stage 2|Withdrawal by Subject|0|||
161919336|NCT03765073|584751432|FG013|Stage 2|Withdrawal by Subject|0|||
161919337|NCT03765073|584751433|FG014|Stage 2|Withdrawal by Subject|0|||
161919338|NCT03765073|584751434|FG015|Stage 2|Withdrawal by Subject|0|||
161919339|NCT03765073|584751435|FG016|Stage 2|Withdrawal by Subject|0|||
161919340|NCT03765073|584751436|FG017|Stage 2|Withdrawal by Subject|0|||
161919341|NCT03765073|584751437|FG018|Stage 2|Withdrawal by Subject|0|||
161919342|NCT03765073|584751438|FG019|Stage 2|Withdrawal by Subject|0|||
161919343|NCT03765073|584751439|FG020|Stage 2|Withdrawal by Subject|0|||
161919344|NCT03765073|584751419|FG000|Stage 3|Adverse Event|0|||
161919345|NCT03765073|584751420|FG001|Stage 3|Adverse Event|0|||
161919346|NCT03765073|584751421|FG002|Stage 3|Adverse Event|0|||
161919347|NCT03765073|584751422|FG003|Stage 3|Adverse Event|0|||
161919348|NCT03765073|584751423|FG004|Stage 3|Adverse Event|0|||
161919349|NCT03765073|584751424|FG005|Stage 3|Adverse Event|0|||
161919350|NCT03765073|584751425|FG006|Stage 3|Adverse Event|0|||
161919351|NCT03765073|584751426|FG007|Stage 3|Adverse Event|0|||
161919352|NCT03765073|584751427|FG008|Stage 3|Adverse Event|0|||
161919353|NCT03765073|584751428|FG009|Stage 3|Adverse Event|0|||
161919354|NCT03765073|584751429|FG010|Stage 3|Adverse Event|0|||
161919355|NCT03765073|584751430|FG011|Stage 3|Adverse Event|0|||
161919356|NCT03765073|584751431|FG012|Stage 3|Adverse Event|0|||
161919357|NCT03765073|584751432|FG013|Stage 3|Adverse Event|0|||
161919358|NCT03765073|584751433|FG014|Stage 3|Adverse Event|0|||
161919359|NCT03765073|584751434|FG015|Stage 3|Adverse Event|0|||
161919360|NCT03765073|584751435|FG016|Stage 3|Adverse Event|0|||
161919361|NCT03765073|584751436|FG017|Stage 3|Adverse Event|0|||
161919362|NCT03765073|584751437|FG018|Stage 3|Adverse Event|1|||
161919363|NCT03765073|584751438|FG019|Stage 3|Adverse Event|0|||
161919364|NCT03765073|584751439|FG020|Stage 3|Adverse Event|0|||
161919365|NCT03765073|584751419|FG000|Stage 3|Death|0|||
161919366|NCT03765073|584751420|FG001|Stage 3|Death|0|||
161919367|NCT03765073|584751421|FG002|Stage 3|Death|0|||
161919368|NCT03765073|584751422|FG003|Stage 3|Death|0|||
161919369|NCT03765073|584751423|FG004|Stage 3|Death|0|||
161919370|NCT03765073|584751424|FG005|Stage 3|Death|0|||
161919371|NCT03765073|584751425|FG006|Stage 3|Death|0|||
161919372|NCT03765073|584751426|FG007|Stage 3|Death|0|||
161919373|NCT03765073|584751427|FG008|Stage 3|Death|0|||
161919374|NCT03765073|584751428|FG009|Stage 3|Death|0|||
161919375|NCT03765073|584751429|FG010|Stage 3|Death|0|||
161919376|NCT03765073|584751430|FG011|Stage 3|Death|0|||
161919377|NCT03765073|584751431|FG012|Stage 3|Death|0|||
161919378|NCT03765073|584751432|FG013|Stage 3|Death|0|||
161919379|NCT03765073|584751433|FG014|Stage 3|Death|0|||
161919380|NCT03765073|584751434|FG015|Stage 3|Death|0|||
161919381|NCT03765073|584751435|FG016|Stage 3|Death|0|||
162016438|NCT00607373|585114547|FG000|Follow-up Period|Protocol Violation|0|||
162016439|NCT00607373|585114548|FG001|Follow-up Period|Protocol Violation|1|||
162016440|NCT00607373|585114547|FG000|Follow-up Period|Withdrawal by Subject|1|||
162016441|NCT00607373|585114548|FG001|Follow-up Period|Withdrawal by Subject|3|||
162016442|NCT00314795|585114552|FG000|Overall Study|Adverse Event|8|||
162016443|NCT00314795|585114552|FG000|Overall Study|Death|4|||
162016444|NCT00314795|585114552|FG000|Overall Study|Reason not Specified|3|||
162016445|NCT00314795|585114552|FG000|Overall Study|Renal Transplant|3|||
162016446|NCT00314795|585114552|FG000|Overall Study|Participants Withdrew Consent|2|||
162016447|NCT02170077|585114557|FG000|Overall Study|Withdrawal by Subject|3|||
162016448|NCT02170077|585114558|FG001|Overall Study|Withdrawal by Subject|4|||
162016449|NCT02170077|585114559|FG002|Overall Study|Withdrawal by Subject|2|||
162016450|NCT02170077|585114557|FG000|Overall Study|Adverse Event|4|||
162016451|NCT02170077|585114558|FG001|Overall Study|Adverse Event|4|||
162016452|NCT02170077|585114559|FG002|Overall Study|Adverse Event|4|||
162016453|NCT02170077|585114557|FG000|Overall Study|Lost to Follow-up|0|||
162016454|NCT02170077|585114558|FG001|Overall Study|Lost to Follow-up|1|||
162016455|NCT02170077|585114559|FG002|Overall Study|Lost to Follow-up|0|||
162016456|NCT02170077|585114557|FG000|Overall Study|Exclusion criteria|2|||
162016457|NCT02170077|585114558|FG001|Overall Study|Exclusion criteria|2|||
162016458|NCT02170077|585114559|FG002|Overall Study|Exclusion criteria|5|||
162016459|NCT02170077|585114557|FG000|Overall Study|Exacerbation of seizures|0|||
162016460|NCT02170077|585114558|FG001|Overall Study|Exacerbation of seizures|2|||
162016461|NCT02170077|585114559|FG002|Overall Study|Exacerbation of seizures|1|||
162016462|NCT01780974|585114564|FG000|Overall Study|Death|1|||
162016463|NCT01780974|585114565|FG001|Overall Study|Death|0|||
162016464|NCT01780974|585114564|FG000|Overall Study|Adverse Event|1|||
162016465|NCT01780974|585114565|FG001|Overall Study|Adverse Event|3|||
162016466|NCT00759941|585114571|FG000|Overall Study|Use of medication|1|||
162016467|NCT00759941|585114572|FG001|Overall Study|Use of medication|0|||
162016468|NCT00759941|585114571|FG000|Overall Study|Adverse Event|1|||
162016469|NCT00759941|585114572|FG001|Overall Study|Adverse Event|0|||
162016470|NCT00759941|585114571|FG000|Overall Study|Exited in error by site|1|||
162016471|NCT00759941|585114572|FG001|Overall Study|Exited in error by site|1|||
162016472|NCT00354432|585114573|FG000|Overall Study|Adverse Event|3|||
162016473|NCT00354432|585114574|FG001|Overall Study|Adverse Event|1|||
162016474|NCT00354432|585114575|FG002|Overall Study|Adverse Event|5|||
162016475|NCT00354432|585114576|FG003|Overall Study|Adverse Event|5|||
162016476|NCT00354432|585114573|FG000|Overall Study|Off/Toxicity|3|||
162016477|NCT00354432|585114574|FG001|Overall Study|Off/Toxicity|7|||
161814299|NCT01647828|584362995|FG006|Overall Study|Lost to Follow-up|0|||
161814300|NCT01647828|584362996|FG007|Overall Study|Lost to Follow-up|2|||
161814301|NCT01647828|584362997|FG008|Overall Study|Lost to Follow-up|0|||
161814302|NCT00115063|584363000|FG000|Overall Study|Lost to Follow-up|98|||
161814303|NCT00115063|584363001|FG001|Overall Study|Lost to Follow-up|104|||
161814304|NCT00115063|584363000|FG000|Overall Study|Death|1|||
161814305|NCT00115063|584363001|FG001|Overall Study|Death|0|||
161814306|NCT00185458|584363004|FG000|Contraception Phase|Adverse Event|37|||
161814307|NCT00185458|584363004|FG000|Contraception Phase|Lost to Follow-up|10|||
161814308|NCT00185458|584363004|FG000|Contraception Phase|Protocol Violation|2|||
161814309|NCT00185458|584363004|FG000|Contraception Phase|Physician Decision|2|||
161814310|NCT00185458|584363004|FG000|Contraception Phase|Withdrawal by Subject|7|||
161814311|NCT00185458|584363004|FG000|HRT Phase|Adverse Event|18|||
161814312|NCT00185458|584363004|FG000|HRT Phase|Lost to Follow-up|4|||
161814313|NCT00185458|584363004|FG000|HRT Phase|Protocol Violation|2|||
161814314|NCT00185458|584363004|FG000|HRT Phase|Withdrawal by Subject|3|||
161814315|NCT01750294|584363955|FG000|Overall Study|Withdrawal by Subject|1|||
161814316|NCT01750294|584363955|FG000|Overall Study|Safety Endpoint|1|||
161814317|NCT01370733|584363958|FG000|Overall Study|Withdrawal by Subject|8|||
161814318|NCT01370733|584363959|FG001|Overall Study|Withdrawal by Subject|8|||
161814319|NCT01370733|584363958|FG000|Overall Study|Lost to Follow-up|3|||
162016478|NCT00354432|585114575|FG002|Overall Study|Off/Toxicity|5|||
162016479|NCT00354432|585114576|FG003|Overall Study|Off/Toxicity|5|||
162016480|NCT03863080|585114577|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
162016481|NCT03863080|585114578|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
162016482|NCT03863080|585114579|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
162016483|NCT03863080|585114580|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
162016484|NCT03863080|585114577|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
161814320|NCT01370733|584363959|FG001|Overall Study|Lost to Follow-up|0|||
161814321|NCT01370733|584363958|FG000|Overall Study|Adverse Event|2|||
161814322|NCT01370733|584363959|FG001|Overall Study|Adverse Event|4|||
161814323|NCT01370733|584363958|FG000|Overall Study|Lack of Efficacy|3|||
161814324|NCT01370733|584363959|FG001|Overall Study|Lack of Efficacy|5|||
162016485|NCT03863080|585114578|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
162016486|NCT03863080|585114579|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
162016487|NCT03863080|585114580|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
162016488|NCT03863080|585114577|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
162016489|NCT03863080|585114578|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
162016490|NCT03863080|585114579|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
162016491|NCT03863080|585114580|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
162016492|NCT00802945|585114581|FG000|Overall Study|Death|27|||
162016493|NCT00802945|585114582|FG001|Overall Study|Death|23|||
162016494|NCT00802945|585114581|FG000|Overall Study|Terminated by sponsor|8|||
162016495|NCT00802945|585114582|FG001|Overall Study|Terminated by sponsor|12|||
162016496|NCT05307692|585114583|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
162016497|NCT05307692|585114584|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
162016498|NCT05307692|585114585|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
162016499|NCT05307692|585114586|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
162016500|NCT05307692|585114583|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
162016501|NCT05307692|585114584|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
162016502|NCT05307692|585114585|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
162016503|NCT05307692|585114586|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
162016504|NCT05307692|585114583|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
162016505|NCT05307692|585114584|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
162016506|NCT05307692|585114585|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
162016507|NCT05307692|585114586|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
162016508|NCT05307692|585114583|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
161919382|NCT03765073|584751436|FG017|Stage 3|Death|0|||
161919383|NCT03765073|584751437|FG018|Stage 3|Death|0|||
162016509|NCT05307692|585114584|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
162016510|NCT05307692|585114585|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
162016511|NCT05307692|585114586|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
162016512|NCT05307692|585114583|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
162016513|NCT05307692|585114584|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
162016514|NCT05307692|585114585|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
162016515|NCT05307692|585114586|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
162016516|NCT05307692|585114583|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
162016517|NCT05307692|585114584|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
161919384|NCT03765073|584751438|FG019|Stage 3|Death|3|||
161919385|NCT03765073|584751439|FG020|Stage 3|Death|2|||
161919386|NCT03765073|584751419|FG000|Stage 3|Lost to Follow-up|0|||
161919387|NCT03765073|584751420|FG001|Stage 3|Lost to Follow-up|0|||
161919388|NCT03765073|584751421|FG002|Stage 3|Lost to Follow-up|0|||
161919389|NCT03765073|584751422|FG003|Stage 3|Lost to Follow-up|0|||
161919390|NCT03765073|584751423|FG004|Stage 3|Lost to Follow-up|0|||
161919391|NCT03765073|584751424|FG005|Stage 3|Lost to Follow-up|0|||
161919392|NCT03765073|584751425|FG006|Stage 3|Lost to Follow-up|0|||
161919393|NCT03765073|584751426|FG007|Stage 3|Lost to Follow-up|0|||
161919394|NCT03765073|584751427|FG008|Stage 3|Lost to Follow-up|0|||
161919395|NCT03765073|584751428|FG009|Stage 3|Lost to Follow-up|0|||
161919396|NCT03765073|584751429|FG010|Stage 3|Lost to Follow-up|0|||
161919397|NCT03765073|584751430|FG011|Stage 3|Lost to Follow-up|0|||
161919398|NCT03765073|584751431|FG012|Stage 3|Lost to Follow-up|0|||
161919399|NCT03765073|584751432|FG013|Stage 3|Lost to Follow-up|0|||
161919400|NCT03765073|584751433|FG014|Stage 3|Lost to Follow-up|0|||
161919401|NCT03765073|584751434|FG015|Stage 3|Lost to Follow-up|0|||
161919402|NCT03765073|584751435|FG016|Stage 3|Lost to Follow-up|0|||
161919403|NCT03765073|584751436|FG017|Stage 3|Lost to Follow-up|8|||
161919404|NCT03765073|584751437|FG018|Stage 3|Lost to Follow-up|5|||
162016518|NCT05307692|585114585|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
162016519|NCT05307692|585114586|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
162016520|NCT05307692|585114583|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
162016521|NCT05307692|585114584|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
162161403|NCT03131648|585641786|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
162161404|NCT03131648|585641787|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
162161405|NCT03131648|585641788|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
162161406|NCT03131648|585641789|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
162161407|NCT03131648|585641790|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
162161408|NCT03131648|585641783|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162161409|NCT03131648|585641784|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162161410|NCT03131648|585641785|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
162161411|NCT03131648|585641786|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
162161412|NCT03131648|585641787|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
162161413|NCT03131648|585641788|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
162161414|NCT03131648|585641789|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162161415|NCT03131648|585641790|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161919405|NCT03765073|584751438|FG019|Stage 3|Lost to Follow-up|7|||
161919406|NCT03765073|584751439|FG020|Stage 3|Lost to Follow-up|4|||
161919407|NCT03765073|584751419|FG000|Stage 3|No longer meets eligibility criteria|0|||
161919408|NCT03765073|584751420|FG001|Stage 3|No longer meets eligibility criteria|0|||
161919409|NCT03765073|584751421|FG002|Stage 3|No longer meets eligibility criteria|0|||
161919410|NCT03765073|584751422|FG003|Stage 3|No longer meets eligibility criteria|0|||
161919411|NCT03765073|584751423|FG004|Stage 3|No longer meets eligibility criteria|0|||
161919412|NCT03765073|584751424|FG005|Stage 3|No longer meets eligibility criteria|0|||
161919413|NCT03765073|584751425|FG006|Stage 3|No longer meets eligibility criteria|0|||
161919414|NCT03765073|584751426|FG007|Stage 3|No longer meets eligibility criteria|0|||
161919415|NCT03765073|584751427|FG008|Stage 3|No longer meets eligibility criteria|0|||
161919416|NCT03765073|584751428|FG009|Stage 3|No longer meets eligibility criteria|0|||
161919417|NCT03765073|584751429|FG010|Stage 3|No longer meets eligibility criteria|0|||
161919418|NCT03765073|584751430|FG011|Stage 3|No longer meets eligibility criteria|0|||
161919419|NCT03765073|584751431|FG012|Stage 3|No longer meets eligibility criteria|0|||
161919420|NCT03765073|584751432|FG013|Stage 3|No longer meets eligibility criteria|0|||
161919421|NCT03765073|584751433|FG014|Stage 3|No longer meets eligibility criteria|0|||
161919422|NCT03765073|584751434|FG015|Stage 3|No longer meets eligibility criteria|0|||
161919423|NCT03765073|584751435|FG016|Stage 3|No longer meets eligibility criteria|0|||
161919424|NCT03765073|584751436|FG017|Stage 3|No longer meets eligibility criteria|0|||
161919425|NCT03765073|584751437|FG018|Stage 3|No longer meets eligibility criteria|1|||
161919426|NCT03765073|584751438|FG019|Stage 3|No longer meets eligibility criteria|0|||
161919427|NCT03765073|584751439|FG020|Stage 3|No longer meets eligibility criteria|1|||
161919428|NCT03765073|584751419|FG000|Stage 3|Other|0|||
161919429|NCT03765073|584751420|FG001|Stage 3|Other|0|||
161919430|NCT03765073|584751421|FG002|Stage 3|Other|0|||
161919431|NCT03765073|584751422|FG003|Stage 3|Other|0|||
161919432|NCT03765073|584751423|FG004|Stage 3|Other|0|||
161919433|NCT03765073|584751424|FG005|Stage 3|Other|0|||
161919434|NCT03765073|584751425|FG006|Stage 3|Other|0|||
161919435|NCT03765073|584751426|FG007|Stage 3|Other|0|||
161919436|NCT03765073|584751427|FG008|Stage 3|Other|0|||
161919437|NCT03765073|584751428|FG009|Stage 3|Other|0|||
161919438|NCT03765073|584751429|FG010|Stage 3|Other|0|||
161919439|NCT03765073|584751430|FG011|Stage 3|Other|0|||
161919440|NCT03765073|584751431|FG012|Stage 3|Other|0|||
161919441|NCT03765073|584751432|FG013|Stage 3|Other|0|||
161919442|NCT03765073|584751433|FG014|Stage 3|Other|0|||
161919443|NCT03765073|584751434|FG015|Stage 3|Other|0|||
161919444|NCT03765073|584751435|FG016|Stage 3|Other|0|||
161919445|NCT03765073|584751436|FG017|Stage 3|Other|1|||
161919446|NCT03765073|584751437|FG018|Stage 3|Other|2|||
161919447|NCT03765073|584751438|FG019|Stage 3|Other|2|||
161919448|NCT03765073|584751439|FG020|Stage 3|Other|2|||
161919449|NCT03765073|584751419|FG000|Stage 3|Withdrawal by parent/guardian|0|||
161919450|NCT03765073|584751420|FG001|Stage 3|Withdrawal by parent/guardian|0|||
161919451|NCT03765073|584751421|FG002|Stage 3|Withdrawal by parent/guardian|0|||
161919452|NCT03765073|584751422|FG003|Stage 3|Withdrawal by parent/guardian|0|||
161919453|NCT03765073|584751423|FG004|Stage 3|Withdrawal by parent/guardian|0|||
161919454|NCT03765073|584751424|FG005|Stage 3|Withdrawal by parent/guardian|0|||
161919455|NCT03765073|584751425|FG006|Stage 3|Withdrawal by parent/guardian|0|||
161919456|NCT03765073|584751426|FG007|Stage 3|Withdrawal by parent/guardian|0|||
161919457|NCT03765073|584751427|FG008|Stage 3|Withdrawal by parent/guardian|0|||
161919458|NCT03765073|584751428|FG009|Stage 3|Withdrawal by parent/guardian|0|||
161919459|NCT03765073|584751429|FG010|Stage 3|Withdrawal by parent/guardian|0|||
161919460|NCT03765073|584751430|FG011|Stage 3|Withdrawal by parent/guardian|0|||
161919461|NCT03765073|584751431|FG012|Stage 3|Withdrawal by parent/guardian|0|||
161919462|NCT03765073|584751432|FG013|Stage 3|Withdrawal by parent/guardian|0|||
161919463|NCT03765073|584751433|FG014|Stage 3|Withdrawal by parent/guardian|0|||
161919464|NCT03765073|584751434|FG015|Stage 3|Withdrawal by parent/guardian|0|||
161919465|NCT03765073|584751435|FG016|Stage 3|Withdrawal by parent/guardian|0|||
161919466|NCT03765073|584751436|FG017|Stage 3|Withdrawal by parent/guardian|0|||
161919467|NCT03765073|584751437|FG018|Stage 3|Withdrawal by parent/guardian|0|||
161919468|NCT03765073|584751438|FG019|Stage 3|Withdrawal by parent/guardian|6|||
161919469|NCT03765073|584751439|FG020|Stage 3|Withdrawal by parent/guardian|9|||
161919470|NCT03765073|584751419|FG000|Stage 3|Withdrawal by Subject|0|||
161919471|NCT03765073|584751420|FG001|Stage 3|Withdrawal by Subject|0|||
161919472|NCT03765073|584751421|FG002|Stage 3|Withdrawal by Subject|0|||
161919473|NCT03765073|584751422|FG003|Stage 3|Withdrawal by Subject|0|||
161919474|NCT03765073|584751423|FG004|Stage 3|Withdrawal by Subject|0|||
161919475|NCT03765073|584751424|FG005|Stage 3|Withdrawal by Subject|0|||
161919476|NCT03765073|584751425|FG006|Stage 3|Withdrawal by Subject|0|||
161919477|NCT03765073|584751426|FG007|Stage 3|Withdrawal by Subject|0|||
161919478|NCT03765073|584751427|FG008|Stage 3|Withdrawal by Subject|0|||
161919479|NCT03765073|584751428|FG009|Stage 3|Withdrawal by Subject|0|||
161919480|NCT03765073|584751429|FG010|Stage 3|Withdrawal by Subject|0|||
161919481|NCT03765073|584751430|FG011|Stage 3|Withdrawal by Subject|0|||
161919482|NCT03765073|584751431|FG012|Stage 3|Withdrawal by Subject|0|||
161919483|NCT03765073|584751432|FG013|Stage 3|Withdrawal by Subject|0|||
161919484|NCT03765073|584751433|FG014|Stage 3|Withdrawal by Subject|0|||
161919485|NCT03765073|584751434|FG015|Stage 3|Withdrawal by Subject|0|||
161919486|NCT03765073|584751435|FG016|Stage 3|Withdrawal by Subject|0|||
161919487|NCT03765073|584751436|FG017|Stage 3|Withdrawal by Subject|8|||
161919488|NCT03765073|584751437|FG018|Stage 3|Withdrawal by Subject|11|||
161919489|NCT03765073|584751438|FG019|Stage 3|Withdrawal by Subject|0|||
161919490|NCT03765073|584751439|FG020|Stage 3|Withdrawal by Subject|0|||
161919491|NCT02802228|584751440|FG000|Overall Study|Withdrawal by Subject|2|||
161919492|NCT02802228|584751441|FG001|Overall Study|Withdrawal by Subject|0|||
161919493|NCT02802228|584751440|FG000|Overall Study|Lost to Follow-up|1|||
161919494|NCT02802228|584751441|FG001|Overall Study|Lost to Follow-up|0|||
161919495|NCT02802228|584751440|FG000|Overall Study|Adverse Event|1|||
161919496|NCT02802228|584751441|FG001|Overall Study|Adverse Event|0|||
161919497|NCT02802228|584751440|FG000|Overall Study|Physician Decision|1|||
161919498|NCT02802228|584751441|FG001|Overall Study|Physician Decision|0|||
161919499|NCT00695019|584751442|FG000|Overall Study|Withdrawal by Subject|8|||
161919500|NCT00695019|584751443|FG001|Overall Study|Withdrawal by Subject|6|||
162161416|NCT03131648|585641783|FG000|Maintenance Treatment Period|Completed Week 50|0|||
162161417|NCT03131648|585641784|FG001|Maintenance Treatment Period|Completed Week 50|0|||
162161418|NCT03131648|585641785|FG002|Maintenance Treatment Period|Completed Week 50|0|||
162161419|NCT03131648|585641786|FG003|Maintenance Treatment Period|Completed Week 50|0|||
162161420|NCT03131648|585641787|FG004|Maintenance Treatment Period|Completed Week 50|1|||
162161421|NCT03131648|585641788|FG005|Maintenance Treatment Period|Completed Week 50|0|||
162161422|NCT03131648|585641789|FG006|Maintenance Treatment Period|Completed Week 50|0|||
162161423|NCT03131648|585641790|FG007|Maintenance Treatment Period|Completed Week 50|0|||
162161424|NCT03131648|585641783|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
162161425|NCT03131648|585641784|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
162161426|NCT03131648|585641785|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
162161427|NCT03131648|585641786|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
162161428|NCT03131648|585641787|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
162161429|NCT03131648|585641788|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
162161430|NCT03131648|585641789|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
162161431|NCT03131648|585641790|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
162161432|NCT02724878|585641791|FG000|Overall Study|Still on Active Therapy|15|||
162161433|NCT02724878|585641791|FG000|Overall Study|Disease Progression|31|||
162161434|NCT02724878|585641791|FG000|Overall Study|Toxicity|5|||
162161435|NCT02724878|585641791|FG000|Overall Study|Death|1|||
162161436|NCT02724878|585641791|FG000|Overall Study|Withdrawal by Subject|4|||
162161437|NCT02724878|585641791|FG000|Overall Study|Lost to Follow-up|2|||
162161438|NCT02724878|585641791|FG000|Overall Study|Protocol Violation|1|||
162161439|NCT02724878|585641791|FG000|Overall Study|Ineligible for Study Drug|5|||
162161440|NCT02724878|585641791|FG000|Overall Study|not started|1|||
162161441|NCT02954341|585641792|FG000|Overall Study|Attempted Implant unsuccessful|5|||
162161442|NCT02954341|585641792|FG000|Overall Study|Death|90|||
162161443|NCT02954341|585641792|FG000|Overall Study|Withdrawal by Subject|4|||
162161444|NCT02954341|585641792|FG000|Overall Study|Physician Decision|13|||
162161445|NCT02954341|585641792|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
162161446|NCT02954341|585641792|FG000|Overall Study|Not implanted due to physician's decision|1|||
162161447|NCT02954341|585641792|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
162161448|NCT04245501|585641794|FG000|Overall Study|Adverse Event|2|||
162161449|NCT04245501|585641795|FG001|Overall Study|Adverse Event|0|||
162161450|NCT04245501|585641794|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
162161451|NCT04245501|585641795|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
162161452|NCT03436745|585641796|FG000|Overall Study|Ineligible|0|||
162161453|NCT03436745|585641797|FG001|Overall Study|Ineligible|0|||
162161454|NCT03436745|585641798|FG002|Overall Study|Ineligible|1|||
162161455|NCT01772472|585641806|FG000|Overall Study|Death|126|||
162161456|NCT01772472|585641807|FG001|Overall Study|Death|94|||
162161457|NCT01772472|585641806|FG000|Overall Study|Lost to Follow-up|51|||
162161458|NCT01772472|585641807|FG001|Overall Study|Lost to Follow-up|50|||
162161459|NCT01772472|585641806|FG000|Overall Study|Other|9|||
162161460|NCT01772472|585641807|FG001|Overall Study|Other|7|||
162161461|NCT01772472|585641806|FG000|Overall Study|Physician Decision|1|||
162161462|NCT01772472|585641807|FG001|Overall Study|Physician Decision|7|||
161919501|NCT00695019|584751444|FG002|Overall Study|Withdrawal by Subject|4|||
161919502|NCT00695019|584751442|FG000|Overall Study|Protocol Violation|1|||
161919503|NCT00695019|584751443|FG001|Overall Study|Protocol Violation|3|||
161919504|NCT00695019|584751444|FG002|Overall Study|Protocol Violation|1|||
162161463|NCT01772472|585641806|FG000|Overall Study|Withdrawal by Subject|115|||
161814325|NCT01370733|584363958|FG000|Overall Study|Physician Decision|0|||
161814326|NCT01370733|584363959|FG001|Overall Study|Physician Decision|2|||
161814327|NCT01370733|584363958|FG000|Overall Study|Protocol Violation|1|||
161814328|NCT01370733|584363959|FG001|Overall Study|Protocol Violation|3|||
161814329|NCT03676634|584363960|FG000|Overall Study|Red blood cell loss|1|||
162016522|NCT05307692|585114585|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
162161464|NCT01772472|585641807|FG001|Overall Study|Withdrawal by Subject|90|||
162016523|NCT05307692|585114586|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
162016524|NCT05307692|585114583|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
162016525|NCT05307692|585114584|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
162016526|NCT05307692|585114585|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
162016527|NCT05307692|585114586|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
162016528|NCT04500158|585114587|FG000|Overall Study|Physician Decision|17|||
162016529|NCT04500158|585114588|FG001|Overall Study|Physician Decision|11|||
162016530|NCT03493464|585114591|FG000|Overall Study|Surgery not performed|1|||
162016531|NCT04730804|585114592|FG000|Overall Study|Physician Decision|0|||
162016532|NCT04730804|585114593|FG001|Overall Study|Physician Decision|0|||
162016533|NCT04730804|585114594|FG002|Overall Study|Physician Decision|0|||
162016534|NCT04730804|585114595|FG003|Overall Study|Physician Decision|0|||
162016535|NCT04730804|585114596|FG004|Overall Study|Physician Decision|0|||
162016536|NCT04730804|585114597|FG005|Overall Study|Physician Decision|1|||
162016537|NCT04730804|585114592|FG000|Overall Study|Withdrawal by Subject|0|||
162016538|NCT04730804|585114593|FG001|Overall Study|Withdrawal by Subject|0|||
162016539|NCT04730804|585114594|FG002|Overall Study|Withdrawal by Subject|0|||
162016540|NCT04730804|585114595|FG003|Overall Study|Withdrawal by Subject|0|||
162016541|NCT04730804|585114596|FG004|Overall Study|Withdrawal by Subject|1|||
162016542|NCT04730804|585114597|FG005|Overall Study|Withdrawal by Subject|2|||
162016543|NCT01077050|585116216|FG000|Overall Study|Subjects signed ICF could not be located|1|||
162016544|NCT01077050|585116216|FG000|Overall Study|Screen failure|8|||
162016545|NCT00684060|585116217|FG000|Overall Study|Lost to Follow-up|1|||
162016546|NCT00684060|585116218|FG001|Overall Study|Lost to Follow-up|0|||
162016547|NCT00684060|585116217|FG000|Overall Study|New stenosis identified|1|||
162016548|NCT00684060|585116218|FG001|Overall Study|New stenosis identified|0|||
162161465|NCT01772472|585641806|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
162161466|NCT01772472|585641807|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
162161467|NCT02697136|585641808|FG000|Overall Study|Adverse Event|3|||
162161468|NCT02697136|585641809|FG001|Overall Study|Adverse Event|0|||
162161469|NCT04391894|585641810|FG000|Overall Study|Adverse Event|1|||
162161470|NCT04391894|585641811|FG001|Overall Study|Adverse Event|1|||
162161471|NCT04391894|585641812|FG002|Overall Study|Adverse Event|1|||
162161472|NCT04391894|585641813|FG003|Overall Study|Adverse Event|1|||
162161473|NCT04391894|585641814|FG004|Overall Study|Adverse Event|1|||
162161474|NCT04391894|585641810|FG000|Overall Study|Lost to Follow-up|1|||
162161475|NCT04391894|585641811|FG001|Overall Study|Lost to Follow-up|0|||
162161476|NCT04391894|585641812|FG002|Overall Study|Lost to Follow-up|0|||
162161477|NCT04391894|585641813|FG003|Overall Study|Lost to Follow-up|0|||
162161478|NCT04391894|585641814|FG004|Overall Study|Lost to Follow-up|0|||
162161479|NCT04391894|585641810|FG000|Overall Study|Protocol Violation|0|||
162161480|NCT04391894|585641811|FG001|Overall Study|Protocol Violation|0|||
162161481|NCT04391894|585641812|FG002|Overall Study|Protocol Violation|0|||
162161482|NCT04391894|585641813|FG003|Overall Study|Protocol Violation|1|||
162161483|NCT04391894|585641814|FG004|Overall Study|Protocol Violation|0|||
162161484|NCT04391894|585641810|FG000|Overall Study|Withdrawal by Subject|2|||
162161485|NCT04391894|585641811|FG001|Overall Study|Withdrawal by Subject|0|||
162161486|NCT04391894|585641812|FG002|Overall Study|Withdrawal by Subject|3|||
162161487|NCT04391894|585641813|FG003|Overall Study|Withdrawal by Subject|0|||
162161488|NCT04391894|585641814|FG004|Overall Study|Withdrawal by Subject|1|||
162161489|NCT04391894|585641810|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
162161490|NCT04391894|585641811|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
162161491|NCT04391894|585641812|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
162161492|NCT04391894|585641813|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
162161493|NCT04391894|585641814|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
162161494|NCT02323321|585641818|FG000|Overall Study|Re-Transplant|1|||
162161495|NCT02323321|585641818|FG000|Overall Study|Death|12|||
162161496|NCT00446225|585641819|FG000|Overall Study|Protocol Violation|1|||
162161497|NCT00446225|585641820|FG001|Overall Study|Protocol Violation|0|||
162161498|NCT02500758|585641823|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
162161499|NCT02500758|585641824|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
162161500|NCT02500758|585641823|FG000|Washout (1 Week)|Lost to Follow-up|2|||
162161501|NCT02500758|585641824|FG001|Washout (1 Week)|Lost to Follow-up|2|||
162161502|NCT02500758|585641823|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
162161503|NCT02500758|585641824|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
161814330|NCT03676634|584363960|FG000|Overall Study|Out-of-limit pulse|2|||
162161504|NCT02500758|585641823|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
162161505|NCT02500758|585641824|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
161919505|NCT00695019|584751442|FG000|Overall Study|Lack of Efficacy|0|||
161919506|NCT00695019|584751443|FG001|Overall Study|Lack of Efficacy|0|||
161919507|NCT00695019|584751444|FG002|Overall Study|Lack of Efficacy|1|||
161919508|NCT00695019|584751442|FG000|Overall Study|Various|4|||
161919509|NCT00695019|584751443|FG001|Overall Study|Various|5|||
161919510|NCT00695019|584751444|FG002|Overall Study|Various|4|||
161919511|NCT01564407|584751453|FG000|Overall Study|Lost to Follow-up|0|||
161919512|NCT01564407|584751454|FG001|Overall Study|Lost to Follow-up|1|||
161919513|NCT01564407|584751455|FG002|Overall Study|Lost to Follow-up|0|||
161919514|NCT01564407|584751456|FG003|Overall Study|Lost to Follow-up|0|||
161919515|NCT01564407|584751457|FG004|Overall Study|Lost to Follow-up|0|||
161919516|NCT01564407|584751453|FG000|Overall Study|Withdrawal by Subject|0|||
161919517|NCT01564407|584751454|FG001|Overall Study|Withdrawal by Subject|1|||
161919518|NCT01564407|584751455|FG002|Overall Study|Withdrawal by Subject|0|||
161919519|NCT01564407|584751456|FG003|Overall Study|Withdrawal by Subject|0|||
161919520|NCT01564407|584751457|FG004|Overall Study|Withdrawal by Subject|0|||
161919521|NCT01564407|584751453|FG000|Overall Study|funding lost, study ended|0|||
161919522|NCT01564407|584751454|FG001|Overall Study|funding lost, study ended|0|||
161919523|NCT01564407|584751455|FG002|Overall Study|funding lost, study ended|0|||
161919524|NCT01564407|584751456|FG003|Overall Study|funding lost, study ended|1|||
161919525|NCT01564407|584751457|FG004|Overall Study|funding lost, study ended|0|||
161919526|NCT01723774|584751459|FG000|Neoadjuvant|Ki67 > 10%|4|||
161919527|NCT01723774|584751460|FG001|Neoadjuvant|Ki67 > 10%|0|||
161919528|NCT01723774|584751461|FG002|Neoadjuvant|Ki67 > 10%|10|||
161919529|NCT01723774|584751462|FG003|Neoadjuvant|Ki67 > 10%|0|||
162161506|NCT02500758|585641823|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
162161507|NCT02500758|585641824|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
162161508|NCT00220740|585641825|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
162161509|NCT00220740|585641826|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
162161510|NCT00220740|585641825|FG000|Efficacy Period|Adverse Event|1|||
162161511|NCT00220740|585641826|FG001|Efficacy Period|Adverse Event|1|||
162161512|NCT00220740|585641825|FG000|Efficacy Period|Withdrawal by Subject|1|||
162161513|NCT00220740|585641826|FG001|Efficacy Period|Withdrawal by Subject|0|||
162161514|NCT00220740|585641825|FG000|Efficacy Period|Protocol Violation|1|||
162161515|NCT00220740|585641826|FG001|Efficacy Period|Protocol Violation|0|||
162161516|NCT00220740|585641825|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
162161517|NCT00220740|585641826|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
162161518|NCT01057433|585641827|FG000|Overall Study|Adverse Event|1|||
162161519|NCT05792423|585641829|FG000|Overall Study|Withdrawal by Subject|2|||
162161520|NCT01331005|585643694|FG000|Overall Study|Lost to Follow-up|2|||
162161521|NCT01331005|585643695|FG001|Overall Study|Lost to Follow-up|1|||
162161522|NCT01331005|585643694|FG000|Overall Study|Withdrawal by Subject|2|||
162161523|NCT01331005|585643695|FG001|Overall Study|Withdrawal by Subject|3|||
162161524|NCT03161379|585643696|FG000|Overall Study|Withdrawal by Subject|4|||
162161525|NCT03161379|585643696|FG000|Overall Study|disease progression during chemotherapy|5|||
162161526|NCT03161379|585643696|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
162161527|NCT03161379|585643696|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
162161528|NCT03779204|585643698|FG000|Overall Study|Lost to Follow-up|2|||
162161529|NCT03779204|585643699|FG001|Overall Study|Lost to Follow-up|0|||
162161530|NCT03958955|585643700|FG000|Overall Study|Adverse Event|1|||
162161531|NCT02807636|585643701|FG000|Overall Study|Lost to Follow-up|10|||
162161532|NCT02807636|585643702|FG001|Overall Study|Lost to Follow-up|13|||
162161533|NCT02807636|585643703|FG002|Overall Study|Lost to Follow-up|6|||
162161534|NCT02807636|585643701|FG000|Overall Study|Protocol Deviation|1|||
162161535|NCT02807636|585643702|FG001|Overall Study|Protocol Deviation|0|||
162161536|NCT02807636|585643703|FG002|Overall Study|Protocol Deviation|0|||
162161537|NCT02807636|585643701|FG000|Overall Study|Symptomatic Deterioration|0|||
162161538|NCT02807636|585643702|FG001|Overall Study|Symptomatic Deterioration|1|||
162161539|NCT02807636|585643703|FG002|Overall Study|Symptomatic Deterioration|0|||
162161540|NCT02807636|585643701|FG000|Overall Study|Withdrawal by Subject|39|||
162161541|NCT02807636|585643702|FG001|Overall Study|Withdrawal by Subject|28|||
162161542|NCT02807636|585643703|FG002|Overall Study|Withdrawal by Subject|24|||
162161543|NCT02807636|585643701|FG000|Overall Study|Death|303|||
162161544|NCT02807636|585643702|FG001|Overall Study|Death|332|||
162161545|NCT02807636|585643703|FG002|Overall Study|Death|272|||
162161546|NCT02807636|585643701|FG000|Overall Study|Study Terminated By Sponsor|47|||
162161547|NCT02807636|585643702|FG001|Overall Study|Study Terminated By Sponsor|76|||
162161548|NCT02807636|585643703|FG002|Overall Study|Study Terminated By Sponsor|60|||
162161549|NCT02807636|585643701|FG000|Overall Study|Physician Decision|0|||
162161550|NCT02807636|585643702|FG001|Overall Study|Physician Decision|1|||
162161551|NCT02807636|585643703|FG002|Overall Study|Physician Decision|0|||
162161552|NCT03315754|585643706|FG000|Overall Study|COVID-19 complications leading to death|1|||
161919530|NCT01723774|584751459|FG000|Neoadjuvant|Withdrawal by Subject|3|||
161919531|NCT01723774|584751460|FG001|Neoadjuvant|Withdrawal by Subject|1|||
161919532|NCT01723774|584751461|FG002|Neoadjuvant|Withdrawal by Subject|0|||
161919533|NCT01723774|584751462|FG003|Neoadjuvant|Withdrawal by Subject|0|||
161919534|NCT01723774|584751459|FG000|Neoadjuvant|Disease progression|0|||
161814331|NCT02294981|584363961|FG000|Overall Study|Lost to Follow-up|1|||
161814332|NCT00829712|584363962|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
161814333|NCT00829712|584363963|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161814334|NCT01188681|584363964|FG000|Overall Study|bladder cancer|0|||
161814335|NCT01188681|584363965|FG001|Overall Study|bladder cancer|0|||
161814336|NCT01188681|584363966|FG002|Overall Study|bladder cancer|1|||
161814337|NCT01188681|584363967|FG003|Overall Study|bladder cancer|0|||
161814338|NCT01188681|584363964|FG000|Overall Study|Withdrawal by Subject|0|||
161814339|NCT01188681|584363965|FG001|Overall Study|Withdrawal by Subject|0|||
161814340|NCT01188681|584363966|FG002|Overall Study|Withdrawal by Subject|0|||
161814341|NCT01188681|584363967|FG003|Overall Study|Withdrawal by Subject|1|||
161814342|NCT00835536|584363970|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
161814343|NCT00835536|584363971|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
161814344|NCT01004510|584363977|FG000|Overall Study|Adverse Event|1|||
161814345|NCT01983969|584363980|FG000|Overall Study|Disease Progression|0|||
161814346|NCT01983969|584363981|FG001|Overall Study|Disease Progression|1|||
161814347|NCT01983969|584363982|FG002|Overall Study|Disease Progression|0|||
161814348|NCT02911025|584363983|FG000|Overall Study|Lost to Follow-up|3|||
161814349|NCT03719040|584363984|FG000|Overall Study|Withdrawal by Subject|177|||
161814350|NCT03719040|584363984|FG000|Overall Study|Lost to Follow-up|26|||
161814351|NCT00268203|584363985|FG000|Overall Study|Lost to Follow-up|92|||
161814352|NCT00268203|584363985|FG000|Overall Study|Withdrawal by Subject|9|||
161814353|NCT00268203|584363985|FG000|Overall Study|Received Other NHL Therapy|7|||
161814354|NCT00268203|584363985|FG000|Overall Study|Progressive Disease|359|||
161814355|NCT00268203|584363985|FG000|Overall Study|Death|84|||
162161553|NCT03315754|585643706|FG000|Overall Study|insurance coverage issue|1|||
162161554|NCT05227209|585643707|FG000|Overall Study|Adverse Event|11|||
162161555|NCT05227209|585643707|FG000|Overall Study|Lost to Follow-up|1|||
162161556|NCT05227209|585643707|FG000|Overall Study|Withdrawal by Subject|7|||
162161557|NCT05227209|585643707|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
162161558|NCT05633953|585643708|FG000|Overall Study|Adverse Event|7|||
162161559|NCT05633953|585643708|FG000|Overall Study|Death|30|||
161814356|NCT00268203|584363985|FG000|Overall Study|Reason Not Specified|34|||
161814357|NCT00268203|584363985|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
161814358|NCT04589650|584363988|FG000|Overall Study|Subject decision|6|||
161814359|NCT04589650|584363989|FG001|Overall Study|Subject decision|2|||
161814360|NCT04589650|584363990|FG002|Overall Study|Subject decision|2|||
161814361|NCT04589650|584363991|FG003|Overall Study|Subject decision|0|||
161814362|NCT04589650|584363992|FG004|Overall Study|Subject decision|0|||
161814363|NCT04589650|584363993|FG005|Overall Study|Subject decision|0|||
161814364|NCT04589650|584363988|FG000|Overall Study|Adverse Event|3|||
161814365|NCT04589650|584363989|FG001|Overall Study|Adverse Event|1|||
162161560|NCT05633953|585643708|FG000|Overall Study|Lost to Follow-up|1|||
162161561|NCT05633953|585643708|FG000|Overall Study|Osilodrostat discontinued|4|||
161814366|NCT04589650|584363990|FG002|Overall Study|Adverse Event|1|||
162161562|NCT05633953|585643708|FG000|Overall Study|Physician Decision|1|||
161919535|NCT01723774|584751460|FG001|Neoadjuvant|Disease progression|1|||
161919536|NCT01723774|584751461|FG002|Neoadjuvant|Disease progression|1|||
161919537|NCT01723774|584751462|FG003|Neoadjuvant|Disease progression|0|||
161919538|NCT01723774|584751459|FG000|Neoadjuvant|Adverse Event|0|||
161919539|NCT01723774|584751460|FG001|Neoadjuvant|Adverse Event|1|||
161919540|NCT01723774|584751461|FG002|Neoadjuvant|Adverse Event|2|||
161919541|NCT01723774|584751462|FG003|Neoadjuvant|Adverse Event|0|||
161919542|NCT01723774|584751459|FG000|Neoadjuvant|High estradiol|0|||
161919543|NCT01723774|584751460|FG001|Neoadjuvant|High estradiol|1|||
161814367|NCT04589650|584363991|FG003|Overall Study|Adverse Event|1|||
161814368|NCT04589650|584363992|FG004|Overall Study|Adverse Event|0|||
161814369|NCT04589650|584363993|FG005|Overall Study|Adverse Event|1|||
161814370|NCT04589650|584363988|FG000|Overall Study|Physician Decision|1|||
161814371|NCT04589650|584363989|FG001|Overall Study|Physician Decision|1|||
162161563|NCT05633953|585643708|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
162161564|NCT05633953|585643708|FG000|Overall Study|Progressive disease|2|||
162161565|NCT03526861|585643724|FG000|Initial Treatment Period|Not dosed|1|||
162161566|NCT03526861|585643725|FG001|Initial Treatment Period|Not dosed|1|||
162161567|NCT03526861|585643726|FG002|Initial Treatment Period|Not dosed|1|||
162161568|NCT03526861|585643727|FG003|Initial Treatment Period|Not dosed|0|||
162161569|NCT03526861|585643728|FG004|Initial Treatment Period|Not dosed|0|||
162161570|NCT03526861|585643729|FG005|Initial Treatment Period|Not dosed|0|||
162161571|NCT03526861|585643730|FG006|Initial Treatment Period|Not dosed|0|||
162161572|NCT03526861|585643731|FG007|Initial Treatment Period|Not dosed|0|||
162161573|NCT03526861|585643732|FG008|Initial Treatment Period|Not dosed|0|||
162161574|NCT03526861|585643724|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
162161575|NCT03526861|585643725|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
162161576|NCT03526861|585643726|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
162161577|NCT03526861|585643727|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161578|NCT03526861|585643728|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161579|NCT03526861|585643729|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161580|NCT03526861|585643730|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161581|NCT03526861|585643731|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161582|NCT03526861|585643732|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161814372|NCT04589650|584363990|FG002|Overall Study|Physician Decision|0|||
161814373|NCT04589650|584363991|FG003|Overall Study|Physician Decision|0|||
161814374|NCT04589650|584363992|FG004|Overall Study|Physician Decision|0|||
161814375|NCT04589650|584363993|FG005|Overall Study|Physician Decision|0|||
162161583|NCT03526861|585643724|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
162161584|NCT03526861|585643725|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
162161585|NCT03526861|585643726|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
162161586|NCT03526861|585643727|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
162161587|NCT03526861|585643728|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
162161588|NCT03526861|585643729|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
162161589|NCT03526861|585643730|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
162161590|NCT03526861|585643731|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
162161591|NCT03526861|585643732|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
162161592|NCT03526861|585643724|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161593|NCT03526861|585643725|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161594|NCT03526861|585643726|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161595|NCT03526861|585643727|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
162161596|NCT03526861|585643728|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
162161597|NCT03526861|585643729|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161598|NCT03526861|585643730|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
162161599|NCT03526861|585643731|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161600|NCT03526861|585643732|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161601|NCT03526861|585643724|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
162161602|NCT03526861|585643725|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
162161603|NCT03526861|585643726|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
162161604|NCT03526861|585643727|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
162161605|NCT03526861|585643728|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
162161606|NCT03526861|585643729|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
162161607|NCT03526861|585643730|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
162161608|NCT03526861|585643731|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
162161609|NCT03526861|585643732|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
162161610|NCT03526861|585643724|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161611|NCT03526861|585643725|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161612|NCT03526861|585643726|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161613|NCT03526861|585643727|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
162161614|NCT03526861|585643728|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161615|NCT03526861|585643729|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161616|NCT03526861|585643730|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161814376|NCT04589650|584363988|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161814377|NCT04589650|584363989|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161814378|NCT04589650|584363990|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161814379|NCT04589650|584363991|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161814380|NCT04589650|584363992|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
161814381|NCT04589650|584363993|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
161814382|NCT04589650|584363988|FG000|Overall Study|Death|0|||
161814383|NCT04589650|584363989|FG001|Overall Study|Death|0|||
162161617|NCT03526861|585643731|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161618|NCT03526861|585643732|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161619|NCT03526861|585643724|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161620|NCT03526861|585643725|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161621|NCT03526861|585643726|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161622|NCT03526861|585643727|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161623|NCT03526861|585643728|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161624|NCT03526861|585643729|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161625|NCT03526861|585643730|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161626|NCT03526861|585643731|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
162161627|NCT03526861|585643732|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
162161628|NCT03526861|585643724|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162161629|NCT03526861|585643725|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162161630|NCT03526861|585643726|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162161631|NCT03526861|585643727|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162161632|NCT03526861|585643728|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162161633|NCT03526861|585643729|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162161634|NCT03526861|585643730|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162161635|NCT03526861|585643731|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
162161636|NCT03526861|585643732|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
162161637|NCT03526861|585643724|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161638|NCT03526861|585643725|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162236489|NCT04874415|585916962|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
162236490|NCT04874415|585916963|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
162236491|NCT04874415|585916964|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
162236492|NCT04874415|585916965|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
162236493|NCT04874415|585916966|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
162236494|NCT04874415|585916967|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
162236495|NCT04874415|585916968|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
162236496|NCT04874415|585916969|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
162236497|NCT04874415|585916970|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
162236498|NCT04874415|585916971|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
162236499|NCT04874415|585916972|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
162236500|NCT04874415|585916973|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
161814384|NCT04589650|584363990|FG002|Overall Study|Death|0|||
161814385|NCT04589650|584363991|FG003|Overall Study|Death|1|||
162236501|NCT04874415|585916974|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
162236502|NCT04874415|585916959|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236503|NCT04874415|585916960|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236504|NCT04874415|585916961|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236505|NCT04874415|585916962|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236506|NCT04874415|585916963|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
162236507|NCT04874415|585916964|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236508|NCT04874415|585916965|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236509|NCT04874415|585916966|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236510|NCT04874415|585916967|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236511|NCT04874415|585916968|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236718|NCT01395888|585917035|FG002|Treatment Period (TP)|Adverse Event|6|||
161814386|NCT04589650|584363992|FG004|Overall Study|Death|0|||
161814387|NCT04589650|584363993|FG005|Overall Study|Death|0|||
161814388|NCT04589650|584363988|FG000|Overall Study|Guardian Decision|0|||
161814389|NCT04589650|584363989|FG001|Overall Study|Guardian Decision|0|||
161814390|NCT04589650|584363990|FG002|Overall Study|Guardian Decision|0|||
161814391|NCT04589650|584363991|FG003|Overall Study|Guardian Decision|1|||
161814392|NCT04589650|584363992|FG004|Overall Study|Guardian Decision|0|||
161814393|NCT04589650|584363993|FG005|Overall Study|Guardian Decision|0|||
161814394|NCT00950989|584363994|FG000|Overall Study|Death|0|||
161814395|NCT00950989|584363995|FG001|Overall Study|Death|0|||
161814396|NCT00950989|584363996|FG002|Overall Study|Death|1|||
161814397|NCT00950989|584363997|FG003|Overall Study|Death|0|||
161814398|NCT00950989|584363994|FG000|Overall Study|Administrative Decision|0|||
161814399|NCT00950989|584363995|FG001|Overall Study|Administrative Decision|1|||
161814400|NCT00950989|584363996|FG002|Overall Study|Administrative Decision|0|||
161814401|NCT00950989|584363997|FG003|Overall Study|Administrative Decision|0|||
161814402|NCT00950989|584363994|FG000|Overall Study|Disease Progression|0|||
161814403|NCT00950989|584363995|FG001|Overall Study|Disease Progression|0|||
161814404|NCT00950989|584363996|FG002|Overall Study|Disease Progression|1|||
161814405|NCT00950989|584363997|FG003|Overall Study|Disease Progression|0|||
161814406|NCT00950989|584363994|FG000|Overall Study|Withdrawal by Subject|2|||
161814407|NCT00950989|584363995|FG001|Overall Study|Withdrawal by Subject|1|||
161814408|NCT00950989|584363996|FG002|Overall Study|Withdrawal by Subject|0|||
161814409|NCT00950989|584363997|FG003|Overall Study|Withdrawal by Subject|0|||
161814410|NCT00950989|584363994|FG000|Overall Study|Adverse Event|2|||
161814411|NCT00950989|584363995|FG001|Overall Study|Adverse Event|1|||
161814412|NCT00950989|584363996|FG002|Overall Study|Adverse Event|1|||
161814413|NCT00950989|584363997|FG003|Overall Study|Adverse Event|0|||
161814414|NCT03804983|584363998|FG000|Overall Study|Adverse Event|0|||
161814415|NCT03804983|584363999|FG001|Overall Study|Adverse Event|1|||
161814416|NCT03804983|584363998|FG000|Overall Study|Family Obligation|1|||
161814417|NCT03804983|584363999|FG001|Overall Study|Family Obligation|0|||
161814418|NCT03600376|584364000|FG000|Overall Study|Adverse Event|1|||
161814419|NCT03600376|584364001|FG001|Overall Study|Adverse Event|1|||
161814420|NCT03600376|584364000|FG000|Overall Study|Transferred to other facility|1|||
161814421|NCT03600376|584364001|FG001|Overall Study|Transferred to other facility|0|||
161814422|NCT03600376|584364000|FG000|Overall Study|Investigator Decision|0|||
161814423|NCT03600376|584364001|FG001|Overall Study|Investigator Decision|4|||
161814424|NCT03600376|584364000|FG000|Overall Study|Determined to be ineligible for study|0|||
161814425|NCT03600376|584364001|FG001|Overall Study|Determined to be ineligible for study|1|||
161814426|NCT00796562|584364005|FG000|Overall Study|Death|49|||
161814427|NCT05655520|584364006|FG000|Overall Study|Adverse Event|2|||
161814428|NCT05655520|584364007|FG001|Overall Study|Adverse Event|3|||
161814429|NCT05655520|584364006|FG000|Overall Study|Physician Decision|2|||
161814430|NCT05655520|584364007|FG001|Overall Study|Physician Decision|0|||
161814431|NCT05655520|584364006|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161814432|NCT05655520|584364007|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161814433|NCT05655520|584364006|FG000|Overall Study|Lost to Follow-up|1|||
161814434|NCT05655520|584364007|FG001|Overall Study|Lost to Follow-up|0|||
161814435|NCT05655520|584364006|FG000|Overall Study|Withdrawal by Subject|4|||
161814436|NCT05655520|584364007|FG001|Overall Study|Withdrawal by Subject|4|||
161814437|NCT05655520|584364006|FG000|Overall Study|Study Terminated by Sponsor|61|||
161814438|NCT05655520|584364007|FG001|Overall Study|Study Terminated by Sponsor|68|||
161814439|NCT00424047|584364008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
161814440|NCT00424047|584364009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
161814441|NCT00424047|584364008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
161814442|NCT00424047|584364009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
161814443|NCT00424047|584364008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
161814444|NCT00424047|584364009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
161814445|NCT00424047|584364008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
161814446|NCT00424047|584364009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
161814447|NCT00424047|584364008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
161919544|NCT01723774|584751461|FG002|Neoadjuvant|High estradiol|0|||
161919545|NCT01723774|584751462|FG003|Neoadjuvant|High estradiol|0|||
161814448|NCT00424047|584364009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
161814449|NCT00424047|584364008|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
161814450|NCT00424047|584364009|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
161814451|NCT00424047|584364008|FG000|On Study at Time of Unblinding|Adverse Event|22|||
161814452|NCT00424047|584364009|FG001|On Study at Time of Unblinding|Adverse Event|12|||
161814453|NCT00424047|584364008|FG000|On Study at Time of Unblinding|Progression of disease|92|||
161919546|NCT04967222|584751465|FG000|Randomized|Lost to Follow-up|0|||
162161639|NCT03526861|585643726|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161640|NCT03526861|585643727|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161641|NCT03526861|585643728|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161642|NCT03526861|585643729|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161643|NCT03526861|585643730|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161644|NCT03526861|585643731|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
162161645|NCT03526861|585643732|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
162161646|NCT05337748|585643737|FG000|Overall Study|Withdrawal by Subject|1|||
162161647|NCT05337748|585643738|FG001|Overall Study|Withdrawal by Subject|0|||
162161648|NCT05337748|585643737|FG000|Overall Study|Death|1|||
162161649|NCT05337748|585643738|FG001|Overall Study|Death|0|||
161814454|NCT00424047|584364009|FG001|On Study at Time of Unblinding|Progression of disease|128|||
161814455|NCT00424047|584364008|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
161814456|NCT00424047|584364009|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
161814457|NCT00424047|584364008|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
161814458|NCT00424047|584364009|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
162161650|NCT02506959|585643739|FG000|Overall Study|Physician Decision|2|||
162161651|NCT02506959|585643740|FG001|Overall Study|Physician Decision|1|||
162161652|NCT04541706|585643742|FG000|Overall Study|Withdrawal by Subject|3|||
161814459|NCT00424047|584364008|FG000|On Study at Time of Unblinding|Death|11|||
161814460|NCT00424047|584364009|FG001|On Study at Time of Unblinding|Death|11|||
161814461|NCT00424047|584364008|FG000|On Study at Time of Unblinding|Other|5|||
161814462|NCT00424047|584364009|FG001|On Study at Time of Unblinding|Other|4|||
162161653|NCT04541706|585643742|FG000|Overall Study|Progressive disease|33|||
162161654|NCT04541706|585643742|FG000|Overall Study|Physician Decision|1|||
162161655|NCT04541706|585643742|FG000|Overall Study|Lost to Follow-up|2|||
162161656|NCT04541706|585643742|FG000|Overall Study|Death|5|||
162161657|NCT04541706|585643742|FG000|Overall Study|Adverse Event|1|||
162161658|NCT05323084|585643746|FG000|Period 2 - Washout|Lost to Follow-up|0|||
162161659|NCT05323084|585643747|FG001|Period 2 - Washout|Lost to Follow-up|1|||
162161660|NCT01261312|585643748|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
162161661|NCT01261312|585643749|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
162161662|NCT01261312|585643750|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
162161663|NCT01261312|585643751|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162161664|NCT01261312|585643752|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162161665|NCT01261312|585643753|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162161666|NCT01261312|585643754|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162161667|NCT01261312|585643755|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162161668|NCT01261312|585643756|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162161669|NCT01261312|585643757|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162161670|NCT01261312|585643758|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162161671|NCT01261312|585643759|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162161672|NCT01261312|585643760|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
162161673|NCT01261312|585643748|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
162161674|NCT01261312|585643749|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
162161675|NCT01261312|585643750|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162161676|NCT01261312|585643751|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162161677|NCT01261312|585643752|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162161678|NCT01261312|585643753|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162161679|NCT01261312|585643754|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162161680|NCT01261312|585643755|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162161681|NCT01261312|585643756|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162161682|NCT01261312|585643757|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162161683|NCT01261312|585643758|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162161684|NCT01261312|585643759|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162161685|NCT01261312|585643760|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
162161686|NCT01261312|585643748|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
162161687|NCT01261312|585643749|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
162161688|NCT01261312|585643750|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162161689|NCT01261312|585643751|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162161690|NCT01261312|585643752|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162161691|NCT01261312|585643753|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161814463|NCT00424047|584364008|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
162161692|NCT01261312|585643754|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161919547|NCT04967222|584751466|FG001|Randomized|Lost to Follow-up|1|||
161919548|NCT04967222|584751467|FG002|Randomized|Lost to Follow-up|1|||
161919549|NCT04967222|584751465|FG000|Randomized|Physician Decision|0|||
161919550|NCT04967222|584751466|FG001|Randomized|Physician Decision|0|||
161919551|NCT04967222|584751467|FG002|Randomized|Physician Decision|1|||
161919552|NCT04967222|584751465|FG000|Randomized|Withdrawal by Subject|0|||
161919553|NCT04967222|584751466|FG001|Randomized|Withdrawal by Subject|0|||
161919554|NCT04967222|584751467|FG002|Randomized|Withdrawal by Subject|2|||
161919555|NCT04967222|584751465|FG000|Randomized|abnormal finding in MRI|0|||
161919556|NCT04967222|584751466|FG001|Randomized|abnormal finding in MRI|2|||
161919557|NCT04967222|584751467|FG002|Randomized|abnormal finding in MRI|0|||
161919558|NCT02629159|584751468|FG000|Overall Study|Adverse Event|17|||
161919559|NCT02629159|584751469|FG001|Overall Study|Adverse Event|20|||
161919560|NCT02629159|584751470|FG002|Overall Study|Adverse Event|22|||
161919561|NCT02629159|584751468|FG000|Overall Study|Withdrawal by Subject|22|||
161919562|NCT02629159|584751469|FG001|Overall Study|Withdrawal by Subject|11|||
161919563|NCT02629159|584751470|FG002|Overall Study|Withdrawal by Subject|15|||
161919564|NCT02629159|584751468|FG000|Overall Study|Lost to Follow-up|7|||
161919565|NCT02629159|584751469|FG001|Overall Study|Lost to Follow-up|4|||
161919566|NCT02629159|584751470|FG002|Overall Study|Lost to Follow-up|5|||
161919567|NCT02629159|584751468|FG000|Overall Study|Lack of Efficacy|4|||
161919568|NCT02629159|584751469|FG001|Overall Study|Lack of Efficacy|0|||
161919569|NCT02629159|584751470|FG002|Overall Study|Lack of Efficacy|1|||
161919570|NCT02629159|584751468|FG000|Overall Study|Other|6|||
161919571|NCT02629159|584751469|FG001|Overall Study|Other|4|||
161919572|NCT02629159|584751470|FG002|Overall Study|Other|8|||
161919573|NCT05722015|584751472|FG000|Overall Study|Death|57|||
161919574|NCT05722015|584751473|FG001|Overall Study|Death|37|||
161919575|NCT05722015|584751472|FG000|Overall Study|Lost to Follow-up|1|||
161919576|NCT05722015|584751473|FG001|Overall Study|Lost to Follow-up|0|||
161919577|NCT05722015|584751472|FG000|Overall Study|Withdrawal by Subject|5|||
161919578|NCT05722015|584751473|FG001|Overall Study|Withdrawal by Subject|1|||
161919579|NCT05722015|584751472|FG000|Overall Study|Participants Ongoing|188|||
161919580|NCT05722015|584751473|FG001|Overall Study|Participants Ongoing|88|||
161919581|NCT01802281|584751476|FG000|Overall Study|Death|1|||
161919582|NCT01802281|584751477|FG001|Overall Study|Death|2|||
161919583|NCT01802281|584751476|FG000|Overall Study|Withdrawal by Subject|2|||
161919584|NCT01802281|584751477|FG001|Overall Study|Withdrawal by Subject|1|||
161919585|NCT01802281|584751476|FG000|Overall Study|Ineligible|5|||
161919586|NCT01802281|584751477|FG001|Overall Study|Ineligible|3|||
161919587|NCT02685735|584751478|FG000|Overall Study|Surgery Cancelled|4|||
161919588|NCT02685735|584751479|FG001|Overall Study|Surgery Cancelled|9|||
161919589|NCT02685735|584751478|FG000|Overall Study|Adverse Event|10|||
161919590|NCT02685735|584751479|FG001|Overall Study|Adverse Event|3|||
161919591|NCT02685735|584751478|FG000|Overall Study|Preop testing found to be incomplete|2|||
161919592|NCT02685735|584751479|FG001|Overall Study|Preop testing found to be incomplete|2|||
161919593|NCT02685735|584751478|FG000|Overall Study|Withdrawal by Subject|1|||
161919594|NCT02685735|584751479|FG001|Overall Study|Withdrawal by Subject|2|||
161919595|NCT02685735|584751478|FG000|Overall Study|Death|1|||
161919596|NCT02685735|584751479|FG001|Overall Study|Death|0|||
161919597|NCT05020743|584751480|FG000|Overall Study|Enrollment in Interventional Study|2|||
161919598|NCT05020743|584751481|FG001|Overall Study|Enrollment in Interventional Study|9|||
161919599|NCT05020743|584751482|FG002|Overall Study|Enrollment in Interventional Study|0|||
161919600|NCT05020743|584751480|FG000|Overall Study|Withdrawal by Subject|0|||
161919601|NCT05020743|584751481|FG001|Overall Study|Withdrawal by Subject|3|||
161919602|NCT05020743|584751482|FG002|Overall Study|Withdrawal by Subject|1|||
161919603|NCT05020743|584751480|FG000|Overall Study|Lost to Follow-up|1|||
161919604|NCT05020743|584751481|FG001|Overall Study|Lost to Follow-up|0|||
161919605|NCT05020743|584751482|FG002|Overall Study|Lost to Follow-up|0|||
161919606|NCT05020743|584751480|FG000|Overall Study|Study Termination by Sponsor|10|||
161919607|NCT05020743|584751481|FG001|Overall Study|Study Termination by Sponsor|11|||
161919608|NCT05020743|584751482|FG002|Overall Study|Study Termination by Sponsor|10|||
161919609|NCT03488524|584751483|FG000|Overall Study|Withdrawal by Subject|51|||
161919610|NCT03488524|584751483|FG000|Overall Study|Death|19|||
161919611|NCT03488524|584751483|FG000|Overall Study|Study Sponsor|11|||
161919612|NCT03488524|584751483|FG000|Overall Study|Physician Decision|4|||
161919613|NCT03488524|584751483|FG000|Overall Study|Lost to Follow-up|3|||
161919614|NCT02003924|584751484|FG000|Double-blind Phase|Lost to Follow-up|2|||
161919615|NCT02003924|584751485|FG001|Double-blind Phase|Lost to Follow-up|1|||
161919616|NCT02003924|584751486|FG002|Double-blind Phase|Lost to Follow-up|0|||
161919617|NCT02003924|584751484|FG000|Double-blind Phase|Protocol Violation|1|||
161919618|NCT02003924|584751485|FG001|Double-blind Phase|Protocol Violation|2|||
161919619|NCT02003924|584751486|FG002|Double-blind Phase|Protocol Violation|0|||
161919620|NCT02003924|584751484|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
161919621|NCT02003924|584751485|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
161919622|NCT02003924|584751486|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
161919623|NCT02003924|584751484|FG000|Double-blind Phase|Disease Progression|229|||
162161693|NCT01261312|585643755|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162161694|NCT01261312|585643756|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162161695|NCT01261312|585643757|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162161696|NCT01261312|585643758|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162161697|NCT01261312|585643759|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162161698|NCT01261312|585643760|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
162161699|NCT01261312|585643748|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
162161700|NCT01261312|585643749|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
162161701|NCT01261312|585643750|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162161702|NCT01261312|585643751|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162161703|NCT01261312|585643752|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162161704|NCT01261312|585643753|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162161705|NCT01261312|585643754|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162161706|NCT01261312|585643755|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162161707|NCT01261312|585643756|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162161708|NCT01261312|585643757|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162161709|NCT01261312|585643758|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161919624|NCT02003924|584751485|FG001|Double-blind Phase|Disease Progression|247|||
161919625|NCT02003924|584751486|FG002|Double-blind Phase|Disease Progression|0|||
161919626|NCT02003924|584751484|FG000|Double-blind Phase|Adverse Event|120|||
161919627|NCT02003924|584751485|FG001|Double-blind Phase|Adverse Event|31|||
162161710|NCT01261312|585643759|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162161711|NCT01261312|585643760|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
162161712|NCT01261312|585643748|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
162161713|NCT01261312|585643749|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
162161714|NCT01261312|585643750|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
162161715|NCT01261312|585643751|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162161716|NCT01261312|585643752|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162161717|NCT01261312|585643753|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162161718|NCT01261312|585643754|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162161719|NCT01261312|585643755|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162161720|NCT01261312|585643756|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162161721|NCT01261312|585643757|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162161722|NCT01261312|585643758|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162161723|NCT01261312|585643759|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162161724|NCT01261312|585643760|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
162161725|NCT01261312|585643748|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
162161726|NCT01261312|585643749|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
162161727|NCT01261312|585643750|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
162161728|NCT01261312|585643751|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162161729|NCT01261312|585643752|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162161730|NCT01261312|585643753|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162161731|NCT01261312|585643754|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162161732|NCT01261312|585643755|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162161733|NCT01261312|585643756|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162161734|NCT01261312|585643757|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162161735|NCT01261312|585643758|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162161736|NCT01261312|585643759|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162161737|NCT01261312|585643760|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
162161738|NCT01261312|585643748|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
162161739|NCT01261312|585643749|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162161740|NCT01261312|585643750|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
162161741|NCT01261312|585643751|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162161742|NCT01261312|585643752|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162161743|NCT01261312|585643753|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162161744|NCT01261312|585643754|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162161745|NCT01261312|585643755|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162161746|NCT01261312|585643756|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162161747|NCT01261312|585643757|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162161748|NCT01261312|585643758|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162161749|NCT01261312|585643759|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161919628|NCT02003924|584751486|FG002|Double-blind Phase|Adverse Event|0|||
162161750|NCT01261312|585643760|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
162161751|NCT01261312|585643748|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162161752|NCT01261312|585643749|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162161753|NCT01261312|585643750|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162161754|NCT01261312|585643751|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
161919629|NCT02003924|584751484|FG000|Double-blind Phase|Randomized But not Treated|3|||
161919630|NCT02003924|584751485|FG001|Double-blind Phase|Randomized But not Treated|3|||
162161755|NCT01261312|585643752|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
162161756|NCT01261312|585643753|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
161919631|NCT02003924|584751486|FG002|Double-blind Phase|Randomized But not Treated|0|||
161919632|NCT02003924|584751484|FG000|Double-blind Phase|Other|29|||
161919633|NCT02003924|584751485|FG001|Double-blind Phase|Other|50|||
161919634|NCT02003924|584751486|FG002|Double-blind Phase|Other|0|||
161919635|NCT02003924|584751484|FG000|Open-label Phase|Lost to Follow-up|0|||
161919636|NCT02003924|584751485|FG001|Open-label Phase|Lost to Follow-up|0|||
161919637|NCT02003924|584751486|FG002|Open-label Phase|Lost to Follow-up|1|||
161919638|NCT02003924|584751484|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
161919639|NCT02003924|584751485|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
161919640|NCT02003924|584751486|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
161919641|NCT02003924|584751484|FG000|Open-label Phase|Disease Progression|59|||
161919642|NCT02003924|584751485|FG001|Open-label Phase|Disease Progression|0|||
161919643|NCT02003924|584751486|FG002|Open-label Phase|Disease Progression|5|||
161919644|NCT02003924|584751484|FG000|Open-label Phase|Adverse Event|25|||
161919645|NCT02003924|584751485|FG001|Open-label Phase|Adverse Event|0|||
161919646|NCT02003924|584751486|FG002|Open-label Phase|Adverse Event|10|||
161919647|NCT02003924|584751484|FG000|Open-label Phase|Other|7|||
161919648|NCT02003924|584751485|FG001|Open-label Phase|Other|0|||
161919649|NCT02003924|584751486|FG002|Open-label Phase|Other|0|||
161919650|NCT02003924|584751484|FG000|Long-term Follow-up Phase|Death|288|||
161919651|NCT02003924|584751485|FG001|Long-term Follow-up Phase|Death|174|||
161919652|NCT02003924|584751486|FG002|Long-term Follow-up Phase|Death|4|||
161919653|NCT02003924|584751484|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
161919654|NCT02003924|584751485|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
161919655|NCT02003924|584751486|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
161919656|NCT02003924|584751484|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
161919657|NCT02003924|584751485|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
161919658|NCT02003924|584751486|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
161919659|NCT02003924|584751484|FG000|Long-term Follow-up Phase|Other|5|||
161919660|NCT02003924|584751485|FG001|Long-term Follow-up Phase|Other|2|||
161919661|NCT02003924|584751486|FG002|Long-term Follow-up Phase|Other|1|||
161919662|NCT00315445|584751487|FG000|Overall Study|Adverse Event|7|||
161919663|NCT00315445|584751488|FG001|Overall Study|Adverse Event|12|||
161919664|NCT00315445|584751489|FG002|Overall Study|Adverse Event|15|||
161919665|NCT00315445|584751487|FG000|Overall Study|Lack of Efficacy|16|||
161919666|NCT00315445|584751488|FG001|Overall Study|Lack of Efficacy|1|||
161919667|NCT00315445|584751489|FG002|Overall Study|Lack of Efficacy|7|||
161919668|NCT00315445|584751487|FG000|Overall Study|Lost to Follow-up|1|||
161919669|NCT00315445|584751488|FG001|Overall Study|Lost to Follow-up|0|||
161919670|NCT00315445|584751489|FG002|Overall Study|Lost to Follow-up|1|||
161919671|NCT00315445|584751487|FG000|Overall Study|Protocol Violation|2|||
161919672|NCT00315445|584751488|FG001|Overall Study|Protocol Violation|0|||
161919673|NCT00315445|584751489|FG002|Overall Study|Protocol Violation|1|||
161919674|NCT00315445|584751487|FG000|Overall Study|Other|1|||
161919675|NCT00315445|584751488|FG001|Overall Study|Other|3|||
162161757|NCT01261312|585643754|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162161758|NCT01261312|585643755|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162161759|NCT01261312|585643756|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162161760|NCT01261312|585643757|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162161761|NCT01261312|585643758|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
162161762|NCT01261312|585643759|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161919676|NCT00315445|584751489|FG002|Overall Study|Other|0|||
161919677|NCT01299909|584751490|FG000|Overall Study|Lost to Follow-up|22|||
161919678|NCT01299909|584751491|FG001|Overall Study|Lost to Follow-up|18|||
161919679|NCT01299909|584751492|FG002|Overall Study|Lost to Follow-up|17|||
161919680|NCT01811238|584751493|FG000|Overall Study|Withdrawal by Subject|42|||
161919681|NCT01811238|584751493|FG000|Overall Study|Adverse Event|25|||
162161763|NCT01261312|585643760|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161919682|NCT01811238|584751493|FG000|Overall Study|Protocol Violation|4|||
161919683|NCT01811238|584751493|FG000|Overall Study|Lack of Efficacy|4|||
161919684|NCT01811238|584751493|FG000|Overall Study|subject refused study medication|6|||
161919685|NCT01155570|584751494|FG000|Overall Study|Adverse Event|39|||
161919686|NCT01155570|584751494|FG000|Overall Study|Lack of Efficacy|46|||
161919687|NCT01155570|584751494|FG000|Overall Study|Participant's Economic Reasons|17|||
161919688|NCT01155570|584751494|FG000|Overall Study|No Hospital Visits|7|||
161919689|NCT01155570|584751494|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
162161764|NCT01261312|585643748|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162161765|NCT01261312|585643749|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162161766|NCT01261312|585643750|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162161767|NCT01261312|585643751|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162161768|NCT01261312|585643752|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
162161769|NCT01261312|585643753|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
162161770|NCT01261312|585643754|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162161771|NCT01261312|585643755|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162161772|NCT01261312|585643756|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162161773|NCT01261312|585643757|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162161774|NCT01261312|585643758|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162161775|NCT01261312|585643759|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
162161776|NCT01261312|585643760|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161814464|NCT00424047|584364009|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
161814465|NCT00424047|584364008|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
161814466|NCT00424047|584364009|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
161814467|NCT00424047|584364008|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
161814468|NCT00424047|584364009|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
161814469|NCT00424047|584364008|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
161814470|NCT00424047|584364009|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
161814471|NCT00424047|584364008|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
161814472|NCT00424047|584364009|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
161814473|NCT01229150|584364013|FG000|Overall Study|Toxicity|2|||
161814474|NCT01229150|584364014|FG001|Overall Study|Toxicity|2|||
161814475|NCT01229150|584364015|FG002|Overall Study|Toxicity|0|||
161814476|NCT01229150|584364016|FG003|Overall Study|Toxicity|0|||
161814477|NCT05248204|584364017|FG000|Overall Study|Lost to Follow-up|13|||
161814478|NCT05248204|584364018|FG001|Overall Study|Lost to Follow-up|13|||
161814479|NCT05248204|584364017|FG000|Overall Study|Protocol Violation|1|||
161814480|NCT05248204|584364018|FG001|Overall Study|Protocol Violation|0|||
161814481|NCT03100344|584364019|FG000|Overall Study|Adverse Event|0|||
161814482|NCT03100344|584364020|FG001|Overall Study|Adverse Event|3|||
161814483|NCT03100344|584364021|FG002|Overall Study|Adverse Event|2|||
161814484|NCT03100344|584364022|FG003|Overall Study|Adverse Event|3|||
161814485|NCT03100344|584364019|FG000|Overall Study|Lack of Efficacy|2|||
161814486|NCT03100344|584364020|FG001|Overall Study|Lack of Efficacy|0|||
161814487|NCT03100344|584364021|FG002|Overall Study|Lack of Efficacy|0|||
161814488|NCT03100344|584364022|FG003|Overall Study|Lack of Efficacy|0|||
161814489|NCT03100344|584364019|FG000|Overall Study|Protocol Violation|1|||
161814490|NCT03100344|584364020|FG001|Overall Study|Protocol Violation|0|||
161814491|NCT03100344|584364021|FG002|Overall Study|Protocol Violation|0|||
161814492|NCT03100344|584364022|FG003|Overall Study|Protocol Violation|0|||
161814493|NCT03100344|584364019|FG000|Overall Study|Withdrawal by Subject|10|||
161814494|NCT03100344|584364020|FG001|Overall Study|Withdrawal by Subject|7|||
161814495|NCT03100344|584364021|FG002|Overall Study|Withdrawal by Subject|4|||
161814496|NCT03100344|584364022|FG003|Overall Study|Withdrawal by Subject|8|||
161814497|NCT03100344|584364019|FG000|Overall Study|Lost to Follow-up|1|||
161814498|NCT03100344|584364020|FG001|Overall Study|Lost to Follow-up|1|||
161814499|NCT03100344|584364021|FG002|Overall Study|Lost to Follow-up|1|||
161814500|NCT03100344|584364022|FG003|Overall Study|Lost to Follow-up|1|||
161814501|NCT01010503|584364023|FG000|Overall Study|Adverse Event|1|||
161814502|NCT01010503|584364023|FG000|Overall Study|Death|1|||
161814503|NCT06336356|584364024|FG000|Overall Study|Withdrawal by Subject|1|||
161814504|NCT06336356|584364025|FG001|Overall Study|Withdrawal by Subject|0|||
161814505|NCT06336356|584364024|FG000|Overall Study|Lost to Follow Up|1|||
161814506|NCT06336356|584364025|FG001|Overall Study|Lost to Follow Up|0|||
161814507|NCT04827394|584364030|FG000|Overall Study|Physician Decision|0|||
161814508|NCT04827394|584364031|FG001|Overall Study|Physician Decision|2|||
161814509|NCT01154231|584364032|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
161814510|NCT01154231|584364032|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
161814511|NCT06041256|584364033|FG000|Overall Study|Withdrawal by Subject|1|||
161814512|NCT06041256|584364034|FG001|Overall Study|Withdrawal by Subject|0|||
161814513|NCT06041256|584364035|FG002|Overall Study|Withdrawal by Subject|3|||
161814514|NCT06041256|584364036|FG003|Overall Study|Withdrawal by Subject|1|||
161814515|NCT06041256|584364037|FG004|Overall Study|Withdrawal by Subject|1|||
161814516|NCT06041256|584364033|FG000|Overall Study|Rescue|17|||
161814517|NCT06041256|584364034|FG001|Overall Study|Rescue|6|||
161814518|NCT06041256|584364035|FG002|Overall Study|Rescue|9|||
161814519|NCT06041256|584364036|FG003|Overall Study|Rescue|6|||
162161777|NCT01261312|585643748|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161814520|NCT06041256|584364037|FG004|Overall Study|Rescue|2|||
161814521|NCT01963728|584364038|FG000|Overall Study|Study terminated early|0|||
161814522|NCT01963728|584364039|FG001|Overall Study|Study terminated early|1|||
161814523|NCT03578809|584365317|FG000|Overall Study|Death|0|||
161814524|NCT03578809|584365318|FG001|Overall Study|Death|2|||
161814525|NCT03578809|584365319|FG002|Overall Study|Death|0|||
161919690|NCT01155570|584751494|FG000|Overall Study|Adverse Event + Other Reasons|7|||
161919691|NCT01155570|584751494|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
161919692|NCT01155570|584751494|FG000|Overall Study|Other Reasons|23|||
161919693|NCT01922934|584751495|FG000|Eligible Patients|Death|0|||
161919694|NCT01922934|584751496|FG001|Eligible Patients|Death|7|||
161919695|NCT01922934|584751495|FG000|Eligible Patients|Physician Decision|17|||
161919696|NCT01922934|584751496|FG001|Eligible Patients|Physician Decision|0|||
161919697|NCT01922934|584751495|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
161919698|NCT01922934|584751496|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
161919699|NCT01922934|584751495|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
161919700|NCT01922934|584751496|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
161919701|NCT01922934|584751495|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
161919702|NCT01922934|584751496|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
161919703|NCT01922934|584751495|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
161919704|NCT01922934|584751496|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
161919705|NCT02774889|584751499|FG000|Overall Study|Lost to Follow-up|2|||
161919706|NCT02774889|584751500|FG001|Overall Study|Lost to Follow-up|1|||
161919707|NCT00724945|584751501|FG000|Period 1|non-compliance|1|||
161919708|NCT00724945|584751502|FG001|Period 1|non-compliance|0|||
161919709|NCT00724945|584751501|FG000|Period 1|Adverse Event|1|||
161919710|NCT00724945|584751502|FG001|Period 1|Adverse Event|1|||
161919711|NCT00724945|584751501|FG000|Period 1|Lost to Follow-up|1|||
161919712|NCT00724945|584751502|FG001|Period 1|Lost to Follow-up|0|||
161919713|NCT00724945|584751501|FG000|Period 2|lens comfort issue|3|||
161919714|NCT00724945|584751502|FG001|Period 2|lens comfort issue|0|||
161919715|NCT00724945|584751501|FG000|Period 2|lens physiology issue|1|||
161919716|NCT00724945|584751502|FG001|Period 2|lens physiology issue|0|||
161919717|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
161919718|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
161919719|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
161919720|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
161919721|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
161919722|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
161919723|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
161919724|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
161919725|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
161919726|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
161919727|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
161919728|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
161919729|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
161919730|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
161919731|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
161919732|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
161919733|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
161919734|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
161919735|NCT01069939|584751503|FG000|Randomised and Included in the Analyses|Removal|1|||
161919736|NCT01069939|584751504|FG001|Randomised and Included in the Analyses|Removal|0|||
161919737|NCT05166876|584751505|FG000|Overall Study|Withdrawal by Subject|1|||
161919738|NCT05166876|584751506|FG001|Overall Study|Withdrawal by Subject|0|||
161919739|NCT05166876|584751507|FG002|Overall Study|Withdrawal by Subject|0|||
161919740|NCT00658528|584751508|FG000|Overall Study|Adverse Event|5|||
162161778|NCT01261312|585643749|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162161779|NCT01261312|585643750|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162161780|NCT01261312|585643751|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162161781|NCT01261312|585643752|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
162161782|NCT01261312|585643753|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
162161783|NCT01261312|585643754|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162161784|NCT01261312|585643755|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162161785|NCT01261312|585643756|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162161786|NCT01261312|585643757|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162161787|NCT01261312|585643758|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162161788|NCT01261312|585643759|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
162161789|NCT01261312|585643760|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161919741|NCT00658528|584751509|FG001|Overall Study|Adverse Event|7|||
162161790|NCT01261312|585643748|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
162161791|NCT01261312|585643749|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
161919742|NCT00658528|584751508|FG000|Overall Study|Lost to Follow-up|14|||
161919743|NCT00658528|584751509|FG001|Overall Study|Lost to Follow-up|22|||
161919744|NCT00658528|584751508|FG000|Overall Study|Withdrawal by Subject|8|||
161919745|NCT00658528|584751509|FG001|Overall Study|Withdrawal by Subject|6|||
161919746|NCT00658528|584751508|FG000|Overall Study|Withdrawal of consent|5|||
161919747|NCT00658528|584751509|FG001|Overall Study|Withdrawal of consent|6|||
161919748|NCT00658528|584751508|FG000|Overall Study|Other|8|||
161919749|NCT00658528|584751509|FG001|Overall Study|Other|4|||
161919750|NCT01147458|584751516|FG000|First Intervention|Study terminated by sponsor|8|||
161919751|NCT01147458|584751517|FG001|First Intervention|Study terminated by sponsor|8|||
161919752|NCT01147458|584751518|FG002|First Intervention|Study terminated by sponsor|7|||
161919753|NCT01147458|584751519|FG003|First Intervention|Study terminated by sponsor|8|||
161919754|NCT01147458|584751516|FG000|First Intervention|Protocol Violation|2|||
161919755|NCT01147458|584751517|FG001|First Intervention|Protocol Violation|3|||
161919756|NCT01147458|584751518|FG002|First Intervention|Protocol Violation|2|||
161919757|NCT01147458|584751519|FG003|First Intervention|Protocol Violation|3|||
161919758|NCT01147458|584751516|FG000|First Intervention|Withdrawal by Subject|3|||
161919759|NCT01147458|584751517|FG001|First Intervention|Withdrawal by Subject|0|||
161919760|NCT01147458|584751518|FG002|First Intervention|Withdrawal by Subject|1|||
161919761|NCT01147458|584751519|FG003|First Intervention|Withdrawal by Subject|0|||
161919762|NCT01147458|584751516|FG000|First Intervention|Adverse Event|0|||
161919763|NCT01147458|584751517|FG001|First Intervention|Adverse Event|3|||
161919764|NCT01147458|584751518|FG002|First Intervention|Adverse Event|2|||
161919765|NCT01147458|584751519|FG003|First Intervention|Adverse Event|3|||
161919766|NCT01147458|584751516|FG000|First Intervention|Other|1|||
161919767|NCT01147458|584751517|FG001|First Intervention|Other|2|||
161919768|NCT01147458|584751518|FG002|First Intervention|Other|0|||
161919769|NCT01147458|584751519|FG003|First Intervention|Other|0|||
161919770|NCT01147458|584751516|FG000|Second Intervention|Study terminated by sponsor|7|||
161919771|NCT01147458|584751517|FG001|Second Intervention|Study terminated by sponsor|5|||
161919772|NCT01147458|584751518|FG002|Second Intervention|Study terminated by sponsor|5|||
161919773|NCT01147458|584751519|FG003|Second Intervention|Study terminated by sponsor|3|||
161919774|NCT01147458|584751516|FG000|Second Intervention|Protocol Violation|0|||
161919775|NCT01147458|584751517|FG001|Second Intervention|Protocol Violation|1|||
161919776|NCT01147458|584751518|FG002|Second Intervention|Protocol Violation|1|||
161919777|NCT01147458|584751519|FG003|Second Intervention|Protocol Violation|0|||
161919778|NCT01147458|584751516|FG000|Second Intervention|Withdrawal by Subject|0|||
161919779|NCT01147458|584751517|FG001|Second Intervention|Withdrawal by Subject|1|||
161919780|NCT01147458|584751518|FG002|Second Intervention|Withdrawal by Subject|0|||
161919781|NCT01147458|584751519|FG003|Second Intervention|Withdrawal by Subject|0|||
161919782|NCT01147458|584751516|FG000|Second Intervention|Adverse Event|2|||
161919783|NCT01147458|584751517|FG001|Second Intervention|Adverse Event|0|||
161919784|NCT01147458|584751518|FG002|Second Intervention|Adverse Event|1|||
161919785|NCT01147458|584751519|FG003|Second Intervention|Adverse Event|1|||
161919786|NCT01147458|584751516|FG000|Second Intervention|Other|0|||
161919787|NCT01147458|584751517|FG001|Second Intervention|Other|0|||
161919788|NCT01147458|584751518|FG002|Second Intervention|Other|1|||
161919789|NCT01147458|584751519|FG003|Second Intervention|Other|0|||
162161792|NCT01261312|585643750|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
162161793|NCT01261312|585643751|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
162161794|NCT01261312|585643752|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
162161795|NCT01261312|585643753|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
162161796|NCT01261312|585643754|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
162161797|NCT01261312|585643755|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
162016549|NCT00684060|585116217|FG000|Overall Study|Unable to collect MRI|1|||
162016550|NCT00684060|585116218|FG001|Overall Study|Unable to collect MRI|2|||
162161798|NCT01261312|585643756|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
161919790|NCT02811159|584751531|FG000|Treatment Course 1|Lost to Follow-up|1|||
161919791|NCT04603066|584751532|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
161919792|NCT04603066|584751533|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
161919793|NCT04409002|584751534|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
161919794|NCT00580840|584753160|FG000|Run-in|Adverse Event|17|||
161919795|NCT00580840|584753161|FG001|Run-in|Adverse Event|0|||
161919796|NCT00580840|584753162|FG002|Run-in|Adverse Event|0|||
161919797|NCT00580840|584753163|FG003|Run-in|Adverse Event|0|||
161919798|NCT00580840|584753160|FG000|Run-in|Lack of Efficacy|93|||
161919799|NCT00580840|584753161|FG001|Run-in|Lack of Efficacy|0|||
161919800|NCT00580840|584753162|FG002|Run-in|Lack of Efficacy|0|||
161919801|NCT00580840|584753163|FG003|Run-in|Lack of Efficacy|0|||
162016551|NCT00684060|585116217|FG000|Overall Study|Death|0|||
162161799|NCT01261312|585643757|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
161919802|NCT00580840|584753160|FG000|Run-in|Loss of Efficacy|1|||
161919803|NCT00580840|584753161|FG001|Run-in|Loss of Efficacy|0|||
161919804|NCT00580840|584753162|FG002|Run-in|Loss of Efficacy|0|||
161919805|NCT00580840|584753163|FG003|Run-in|Loss of Efficacy|0|||
161919806|NCT00580840|584753160|FG000|Run-in|Lost to Follow-up|4|||
161919807|NCT00580840|584753161|FG001|Run-in|Lost to Follow-up|0|||
161919808|NCT00580840|584753162|FG002|Run-in|Lost to Follow-up|0|||
161919809|NCT00580840|584753163|FG003|Run-in|Lost to Follow-up|0|||
161919810|NCT00580840|584753160|FG000|Run-in|Withdrawal by Subject|5|||
162161800|NCT01261312|585643758|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
162161801|NCT01261312|585643759|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
161814526|NCT03578809|584365320|FG003|Overall Study|Death|1|||
161814527|NCT03578809|584365317|FG000|Overall Study|Lost to Follow-up|0|||
161814528|NCT03578809|584365318|FG001|Overall Study|Lost to Follow-up|1|||
161814529|NCT03578809|584365319|FG002|Overall Study|Lost to Follow-up|0|||
161814530|NCT03578809|584365320|FG003|Overall Study|Lost to Follow-up|0|||
161814531|NCT03578809|584365317|FG000|Overall Study|Withdrawal by Subject|3|||
161814532|NCT03578809|584365318|FG001|Overall Study|Withdrawal by Subject|5|||
161814533|NCT03578809|584365319|FG002|Overall Study|Withdrawal by Subject|2|||
161814534|NCT03578809|584365320|FG003|Overall Study|Withdrawal by Subject|0|||
161814535|NCT03578809|584365317|FG000|Overall Study|Other|3|||
161814536|NCT03578809|584365318|FG001|Overall Study|Other|6|||
161814537|NCT03578809|584365319|FG002|Overall Study|Other|2|||
161814538|NCT03578809|584365320|FG003|Overall Study|Other|8|||
161814539|NCT03599193|584365321|FG000|Overall Study|Adverse Event|0|||
161814540|NCT03599193|584365322|FG001|Overall Study|Adverse Event|2|||
161814541|NCT03599193|584365321|FG000|Overall Study|Withdrawal by Subject|1|||
161814542|NCT03599193|584365322|FG001|Overall Study|Withdrawal by Subject|0|||
161814543|NCT03599193|584365321|FG000|Overall Study|Protocol Violation|1|||
161814544|NCT03599193|584365322|FG001|Overall Study|Protocol Violation|0|||
161814545|NCT03599193|584365321|FG000|Overall Study|Lost to Follow-up|0|||
161814546|NCT03599193|584365322|FG001|Overall Study|Lost to Follow-up|1|||
161814547|NCT00835705|584365323|FG000|First Intervention|Difficulty with vein|1|||
161814548|NCT00835705|584365324|FG001|First Intervention|Difficulty with vein|0|||
161814549|NCT00835705|584365323|FG000|Second Intervention|Difficulty with vein|1|||
161814550|NCT00835705|584365324|FG001|Second Intervention|Difficulty with vein|0|||
161814551|NCT01116739|584365325|FG000|Overall Study|Child had 2 years of HS|110|||
161814552|NCT01116739|584365326|FG001|Overall Study|Child had 2 years of HS|128|||
161814553|NCT01116739|584365325|FG000|Overall Study|Withdrawal by Subject|6|||
161814554|NCT01116739|584365326|FG001|Overall Study|Withdrawal by Subject|0|||
161814555|NCT01116739|584365325|FG000|Overall Study|child too young|2|||
161814556|NCT01116739|584365326|FG001|Overall Study|child too young|6|||
161814557|NCT01116739|584365325|FG000|Overall Study|child not enrolled in head start|10|||
161814558|NCT01116739|584365326|FG001|Overall Study|child not enrolled in head start|2|||
161814559|NCT01116739|584365325|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
161814560|NCT01116739|584365326|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
161814561|NCT05090839|584365327|FG000|Overall Study|Lost to Follow-up|2|||
161814562|NCT05090839|584365328|FG001|Overall Study|Lost to Follow-up|3|||
161814563|NCT05090839|584365329|FG002|Overall Study|Lost to Follow-up|1|||
161814564|NCT05090839|584365330|FG003|Overall Study|Lost to Follow-up|1|||
161814565|NCT01987765|584365333|FG000|Overall Study|Protocol Violation|65|||
161814566|NCT01987765|584365333|FG000|Overall Study|Lost to Follow-up|37|||
161814567|NCT00443651|584365338|FG000|Overall Study|Death|1|||
161814568|NCT00443651|584365339|FG001|Overall Study|Death|5|||
161814569|NCT00443651|584365338|FG000|Overall Study|Adverse Event|5|||
161814570|NCT00443651|584365339|FG001|Overall Study|Adverse Event|6|||
161814571|NCT00443651|584365338|FG000|Overall Study|Lost to Follow-up|18|||
161814572|NCT00443651|584365339|FG001|Overall Study|Lost to Follow-up|12|||
161814573|NCT00443651|584365338|FG000|Overall Study|Patient's/Guardian's Decision|58|||
161814574|NCT00443651|584365339|FG001|Overall Study|Patient's/Guardian's Decision|30|||
161814575|NCT00443651|584365338|FG000|Overall Study|Physician Decision|13|||
161814576|NCT00443651|584365339|FG001|Overall Study|Physician Decision|4|||
161814577|NCT00443651|584365338|FG000|Overall Study|Pregnancy|0|||
161814578|NCT00443651|584365339|FG001|Overall Study|Pregnancy|1|||
161814579|NCT03606174|584365340|FG000|Overall Study|Death|37|||
161814580|NCT03606174|584365341|FG001|Overall Study|Death|15|||
161814581|NCT03606174|584365342|FG002|Overall Study|Death|15|||
161814582|NCT03606174|584365343|FG003|Overall Study|Death|7|||
161814583|NCT03606174|584365344|FG004|Overall Study|Death|35|||
161814584|NCT03606174|584365345|FG005|Overall Study|Death|12|||
162161802|NCT01261312|585643760|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
162161803|NCT01261312|585643748|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162161804|NCT01261312|585643749|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162161805|NCT01261312|585643750|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162161806|NCT01261312|585643751|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162161807|NCT01261312|585643752|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162161808|NCT01261312|585643753|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
162161809|NCT01261312|585643754|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162161810|NCT01261312|585643755|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161814585|NCT03606174|584365346|FG006|Overall Study|Death|35|||
161814586|NCT03606174|584365347|FG007|Overall Study|Death|8|||
161814587|NCT03606174|584365348|FG008|Overall Study|Death|5|||
161814588|NCT03606174|584365349|FG009|Overall Study|Death|3|||
161814589|NCT03606174|584365350|FG010|Overall Study|Death|0|||
161814590|NCT03606174|584365340|FG000|Overall Study|Lost to Follow-up|0|||
161814591|NCT03606174|584365341|FG001|Overall Study|Lost to Follow-up|0|||
161814592|NCT03606174|584365342|FG002|Overall Study|Lost to Follow-up|0|||
161814593|NCT03606174|584365343|FG003|Overall Study|Lost to Follow-up|0|||
161814594|NCT03606174|584365344|FG004|Overall Study|Lost to Follow-up|1|||
162016552|NCT00684060|585116218|FG001|Overall Study|Death|1|||
162016553|NCT00702715|585116219|FG000|Overall Study|Lost to Follow-up|1|||
162016554|NCT00702715|585116220|FG001|Overall Study|Lost to Follow-up|0|||
162016555|NCT03126344|585116235|FG000|Overall Study|Lost to Follow-up|0|||
162016556|NCT03126344|585116236|FG001|Overall Study|Lost to Follow-up|0|||
162016557|NCT03126344|585116237|FG002|Overall Study|Lost to Follow-up|5|||
162016558|NCT01715857|585116238|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
162016559|NCT02563067|585116239|FG000|Overall Study|Subject/guardian decision|14|||
162016560|NCT02563067|585116240|FG001|Overall Study|Subject/guardian decision|20|||
162016561|NCT02563067|585116241|FG002|Overall Study|Subject/guardian decision|16|||
162016562|NCT02563067|585116239|FG000|Overall Study|Physician Decision|0|||
162016563|NCT02563067|585116240|FG001|Overall Study|Physician Decision|1|||
162016564|NCT02563067|585116241|FG002|Overall Study|Physician Decision|3|||
161814595|NCT03606174|584365345|FG005|Overall Study|Lost to Follow-up|1|||
161814596|NCT03606174|584365346|FG006|Overall Study|Lost to Follow-up|0|||
161814597|NCT03606174|584365347|FG007|Overall Study|Lost to Follow-up|0|||
161814598|NCT03606174|584365348|FG008|Overall Study|Lost to Follow-up|0|||
161814599|NCT03606174|584365349|FG009|Overall Study|Lost to Follow-up|0|||
161814600|NCT03606174|584365350|FG010|Overall Study|Lost to Follow-up|0|||
161814601|NCT03606174|584365340|FG000|Overall Study|Withdrawal by Subject|6|||
161814602|NCT03606174|584365341|FG001|Overall Study|Withdrawal by Subject|0|||
161814603|NCT03606174|584365342|FG002|Overall Study|Withdrawal by Subject|0|||
161814604|NCT03606174|584365343|FG003|Overall Study|Withdrawal by Subject|1|||
161814605|NCT03606174|584365344|FG004|Overall Study|Withdrawal by Subject|2|||
161814606|NCT03606174|584365345|FG005|Overall Study|Withdrawal by Subject|1|||
161814607|NCT03606174|584365346|FG006|Overall Study|Withdrawal by Subject|4|||
161814608|NCT03606174|584365347|FG007|Overall Study|Withdrawal by Subject|0|||
161814609|NCT03606174|584365348|FG008|Overall Study|Withdrawal by Subject|0|||
161814610|NCT03606174|584365349|FG009|Overall Study|Withdrawal by Subject|0|||
161814611|NCT03606174|584365350|FG010|Overall Study|Withdrawal by Subject|1|||
161814612|NCT03606174|584365340|FG000|Overall Study|Study Terminated by Sponsor|5|||
161814613|NCT03606174|584365341|FG001|Overall Study|Study Terminated by Sponsor|7|||
161814614|NCT03606174|584365342|FG002|Overall Study|Study Terminated by Sponsor|3|||
161814615|NCT03606174|584365343|FG003|Overall Study|Study Terminated by Sponsor|0|||
161814616|NCT03606174|584365344|FG004|Overall Study|Study Terminated by Sponsor|11|||
161814617|NCT03606174|584365345|FG005|Overall Study|Study Terminated by Sponsor|6|||
161814618|NCT03606174|584365346|FG006|Overall Study|Study Terminated by Sponsor|12|||
161814619|NCT03606174|584365347|FG007|Overall Study|Study Terminated by Sponsor|1|||
161814620|NCT03606174|584365348|FG008|Overall Study|Study Terminated by Sponsor|3|||
161814621|NCT03606174|584365349|FG009|Overall Study|Study Terminated by Sponsor|1|||
161814622|NCT03606174|584365350|FG010|Overall Study|Study Terminated by Sponsor|2|||
161814623|NCT03606174|584365340|FG000|Overall Study|Miscellaneous|1|||
161814624|NCT03606174|584365341|FG001|Overall Study|Miscellaneous|1|||
161814625|NCT03606174|584365342|FG002|Overall Study|Miscellaneous|0|||
161814626|NCT03606174|584365343|FG003|Overall Study|Miscellaneous|1|||
161814627|NCT03606174|584365344|FG004|Overall Study|Miscellaneous|4|||
161814628|NCT03606174|584365345|FG005|Overall Study|Miscellaneous|7|||
161814629|NCT03606174|584365346|FG006|Overall Study|Miscellaneous|5|||
161814630|NCT03606174|584365347|FG007|Overall Study|Miscellaneous|0|||
161814631|NCT03606174|584365348|FG008|Overall Study|Miscellaneous|0|||
161814632|NCT03606174|584365349|FG009|Overall Study|Miscellaneous|0|||
161814633|NCT03606174|584365350|FG010|Overall Study|Miscellaneous|1|||
161814634|NCT01896934|584365353|FG000|Overall Study|Adverse Event|1|||
161814635|NCT01896934|584365353|FG000|Overall Study|Withdrawal by Subject|1|||
161814636|NCT00316277|584365355|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
161814637|NCT00316277|584365356|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
161814638|NCT00316277|584365355|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
161814639|NCT00316277|584365356|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
161814640|NCT00316277|584365355|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
161814641|NCT00316277|584365356|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
161814642|NCT00316277|584365355|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
161814643|NCT00316277|584365356|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
161814644|NCT00316277|584365355|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
161814645|NCT00316277|584365356|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
161814646|NCT01572662|584365357|FG000|Overall Study|Withdrawal by Subject|1|||
161814647|NCT01572662|584365358|FG001|Overall Study|Withdrawal by Subject|0|||
161814648|NCT01572662|584365357|FG000|Overall Study|Physician Decision|0|||
161814649|NCT01572662|584365358|FG001|Overall Study|Physician Decision|1|||
161814650|NCT03364192|584365359|FG000|Overall Study|Ineligible|10|||
161814651|NCT03364192|584365359|FG000|Overall Study|Withdrawal by Subject|5|||
161814652|NCT03364192|584365359|FG000|Overall Study|Lost to Follow-up|1|||
161814653|NCT04692155|584365360|FG000|Overall Study|Death|1|||
161814654|NCT04547192|584365361|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
161814655|NCT04547192|584365362|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
162016565|NCT02563067|585116239|FG000|Overall Study|Lost to Follow-up|1|||
162016566|NCT02563067|585116240|FG001|Overall Study|Lost to Follow-up|2|||
161919811|NCT00580840|584753161|FG001|Run-in|Withdrawal by Subject|0|||
161919812|NCT00580840|584753162|FG002|Run-in|Withdrawal by Subject|0|||
161919813|NCT00580840|584753163|FG003|Run-in|Withdrawal by Subject|0|||
161919814|NCT00580840|584753160|FG000|Run-in|Other: Per Sponsor Request|2|||
161919815|NCT00580840|584753161|FG001|Run-in|Other: Per Sponsor Request|0|||
161919816|NCT00580840|584753162|FG002|Run-in|Other: Per Sponsor Request|0|||
161919817|NCT00580840|584753163|FG003|Run-in|Other: Per Sponsor Request|0|||
161919818|NCT00580840|584753160|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
161919819|NCT00580840|584753161|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
161919820|NCT00580840|584753162|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
161919821|NCT00580840|584753163|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
161919822|NCT00580840|584753160|FG000|Run-in|Other: Exclusionary Lab Value|1|||
161919823|NCT00580840|584753161|FG001|Run-in|Other: Exclusionary Lab Value|0|||
161919824|NCT00580840|584753162|FG002|Run-in|Other: Exclusionary Lab Value|0|||
161919825|NCT00580840|584753163|FG003|Run-in|Other: Exclusionary Lab Value|0|||
161919826|NCT00580840|584753160|FG000|Double-Blind|Adverse Event|0|||
161919827|NCT00580840|584753161|FG001|Double-Blind|Adverse Event|3|||
161919828|NCT00580840|584753162|FG002|Double-Blind|Adverse Event|4|||
161919829|NCT00580840|584753163|FG003|Double-Blind|Adverse Event|1|||
161919830|NCT00580840|584753160|FG000|Double-Blind|Loss of Efficacy|0|||
161919831|NCT00580840|584753161|FG001|Double-Blind|Loss of Efficacy|1|||
161919832|NCT00580840|584753162|FG002|Double-Blind|Loss of Efficacy|2|||
161919833|NCT00580840|584753163|FG003|Double-Blind|Loss of Efficacy|10|||
161919834|NCT00580840|584753160|FG000|Double-Blind|Lost to Follow-up|0|||
161919835|NCT00580840|584753161|FG001|Double-Blind|Lost to Follow-up|1|||
161919836|NCT00580840|584753162|FG002|Double-Blind|Lost to Follow-up|0|||
161919837|NCT00580840|584753163|FG003|Double-Blind|Lost to Follow-up|2|||
161919838|NCT00580840|584753160|FG000|Double-Blind|Withdrawal by Subject|0|||
161919839|NCT00580840|584753161|FG001|Double-Blind|Withdrawal by Subject|1|||
161919840|NCT00580840|584753162|FG002|Double-Blind|Withdrawal by Subject|2|||
161919841|NCT00580840|584753163|FG003|Double-Blind|Withdrawal by Subject|2|||
161919842|NCT00580840|584753160|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
161919843|NCT00580840|584753161|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
161919844|NCT00580840|584753162|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
161919845|NCT00580840|584753163|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
161919846|NCT00580840|584753160|FG000|Double-Blind|Other: Forbidden Medication|0|||
161919847|NCT00580840|584753161|FG001|Double-Blind|Other: Forbidden Medication|0|||
161919848|NCT00580840|584753162|FG002|Double-Blind|Other: Forbidden Medication|1|||
161919849|NCT00580840|584753163|FG003|Double-Blind|Other: Forbidden Medication|0|||
161919850|NCT04435626|584753166|FG000|Overall Study|Lost to Follow-up|1|||
161919851|NCT04435626|584753167|FG001|Overall Study|Lost to Follow-up|5|||
161919852|NCT04435626|584753166|FG000|Overall Study|Withdrawal by Subject|6|||
161919853|NCT04435626|584753167|FG001|Overall Study|Withdrawal by Subject|7|||
161919854|NCT04435626|584753166|FG000|Overall Study|major GCP violations|8|||
161919855|NCT04435626|584753167|FG001|Overall Study|major GCP violations|7|||
161919856|NCT01160614|584753175|FG000|Overall Study|Withdrawal by Subject|0|||
162016567|NCT02563067|585116241|FG002|Overall Study|Lost to Follow-up|0|||
162016568|NCT02563067|585116239|FG000|Overall Study|Technical problems|0|||
162016569|NCT02563067|585116240|FG001|Overall Study|Technical problems|1|||
162016570|NCT02563067|585116241|FG002|Overall Study|Technical problems|0|||
162016571|NCT02563067|585116239|FG000|Overall Study|Lack of Efficacy|1|||
162016572|NCT02563067|585116240|FG001|Overall Study|Lack of Efficacy|0|||
162016573|NCT02563067|585116241|FG002|Overall Study|Lack of Efficacy|0|||
162016574|NCT02563067|585116239|FG000|Overall Study|Death|0|||
161919857|NCT01160614|584753176|FG001|Overall Study|Withdrawal by Subject|2|||
161919858|NCT00984399|584753177|FG000|Overall Study|Adverse Event|0|||
161919859|NCT00984399|584753178|FG001|Overall Study|Adverse Event|1|||
161919860|NCT00984399|584753177|FG000|Overall Study|Physician Decision|1|||
161919861|NCT00984399|584753178|FG001|Overall Study|Physician Decision|0|||
161919862|NCT00984399|584753177|FG000|Overall Study|Withdrawal by Subject|1|||
162016575|NCT02563067|585116240|FG001|Overall Study|Death|1|||
162016576|NCT02563067|585116241|FG002|Overall Study|Death|1|||
162016577|NCT02563067|585116239|FG000|Overall Study|Adverse Event|2|||
162016578|NCT02563067|585116240|FG001|Overall Study|Adverse Event|1|||
162016579|NCT02563067|585116241|FG002|Overall Study|Adverse Event|0|||
162016580|NCT02563067|585116239|FG000|Overall Study|Death post Treatment/safety period|1|||
162016581|NCT02563067|585116240|FG001|Overall Study|Death post Treatment/safety period|0|||
162016582|NCT02563067|585116241|FG002|Overall Study|Death post Treatment/safety period|0|||
162016583|NCT03544333|585116246|FG000|Overall Study|Withdrawal by Subject|1|||
162016584|NCT03544333|585116247|FG001|Overall Study|Withdrawal by Subject|0|||
162016585|NCT00475306|585116248|FG000|Overall Study|Protocol Violation|1|||
162016586|NCT00475306|585116249|FG001|Overall Study|Protocol Violation|1|||
162016587|NCT00475306|585116250|FG002|Overall Study|Protocol Violation|0|||
162016588|NCT00475306|585116251|FG003|Overall Study|Protocol Violation|1|||
162016589|NCT02405442|585116253|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
162016590|NCT02405442|585116254|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
162016591|NCT02405442|585116255|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
162016592|NCT02405442|585116256|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
162016593|NCT02405442|585116253|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
162016594|NCT02405442|585116254|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
162016595|NCT02405442|585116255|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
162016596|NCT02405442|585116256|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
162016597|NCT02405442|585116253|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
162016598|NCT02405442|585116254|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
161814656|NCT04547192|584365363|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
161814657|NCT04547192|584365364|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
161814658|NCT04547192|584365361|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
161814659|NCT04547192|584365362|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
161814660|NCT04547192|584365363|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
161814661|NCT04547192|584365364|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
161814662|NCT04547192|584365361|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
161814663|NCT04547192|584365362|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
161814664|NCT04547192|584365363|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
161814665|NCT04547192|584365364|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
161814666|NCT04547192|584365361|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
161814667|NCT04547192|584365362|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
161814668|NCT04547192|584365363|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
161814669|NCT04547192|584365364|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
161814670|NCT04547192|584365361|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
161814671|NCT04547192|584365362|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
161814672|NCT04547192|584365363|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
161814673|NCT04547192|584365364|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
161814674|NCT01535222|584365365|FG000|Overall Study|Inclusion/exclusion|0|||
161814675|NCT01535222|584365366|FG001|Overall Study|Inclusion/exclusion|0|||
161814676|NCT01535222|584365367|FG002|Overall Study|Inclusion/exclusion|1|||
161814677|NCT01535222|584365368|FG003|Overall Study|Inclusion/exclusion|0|||
161814678|NCT01535222|584365369|FG004|Overall Study|Inclusion/exclusion|0|||
161814679|NCT01535222|584365370|FG005|Overall Study|Inclusion/exclusion|0|||
161814680|NCT00935012|584365373|FG000|Overall Study|Death|19|||
161814681|NCT00935012|584365373|FG000|Overall Study|Withdrawal by Subject|3|||
161814682|NCT00935012|584365373|FG000|Overall Study|Other|5|||
161814683|NCT00935012|584365373|FG000|Overall Study|Adverse Event|2|||
161814684|NCT01442155|584365374|FG000|Overall Study|Complete remission|35|||
161814685|NCT01442155|584365374|FG000|Overall Study|Recurrence|26|||
161814686|NCT01442155|584365374|FG000|Overall Study|Adverse Event|2|||
161814687|NCT01442155|584365374|FG000|Overall Study|Lost to Follow-up|2|||
161814688|NCT01484912|584365383|FG000|Overall Study|Withdrawal by Subject|1|||
161814689|NCT01484912|584365384|FG001|Overall Study|Withdrawal by Subject|0|||
161814690|NCT01484912|584365383|FG000|Overall Study|Physician Decision|0|||
161814691|NCT01484912|584365384|FG001|Overall Study|Physician Decision|1|||
161814692|NCT04345653|584365385|FG000|Overall Study|Withdrawal by Subject|2|||
161814693|NCT00418938|584365386|FG000|Overall Study|Reimbursement|1|||
161814694|NCT00418938|584365387|FG001|Overall Study|Reimbursement|0|||
161814695|NCT00418938|584365386|FG000|Overall Study|Administrative decision|3|||
161814696|NCT00418938|584365387|FG001|Overall Study|Administrative decision|3|||
161814697|NCT00418938|584365386|FG000|Overall Study|Withdrawal by Subject|16|||
161814698|NCT00418938|584365387|FG001|Overall Study|Withdrawal by Subject|15|||
161814699|NCT00418938|584365386|FG000|Overall Study|Lost to Follow-up|1|||
161814700|NCT00418938|584365387|FG001|Overall Study|Lost to Follow-up|3|||
161814701|NCT00418938|584365386|FG000|Overall Study|Adverse Event|1|||
161814702|NCT00418938|584365387|FG001|Overall Study|Adverse Event|1|||
161814703|NCT00418938|584365386|FG000|Overall Study|On-going|1|||
162016599|NCT02405442|585116255|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
162016600|NCT02405442|585116256|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
161919863|NCT00984399|584753178|FG001|Overall Study|Withdrawal by Subject|1|||
161919864|NCT00984399|584753177|FG000|Overall Study|Protocol Violation|0|||
161919865|NCT00984399|584753178|FG001|Overall Study|Protocol Violation|1|||
161919866|NCT00984399|584753177|FG000|Overall Study|Pts did not start treatment|2|||
161919867|NCT00984399|584753178|FG001|Overall Study|Pts did not start treatment|2|||
161919868|NCT05248386|584753180|FG000|Overall Study|Technical problems|0|||
161919869|NCT05248386|584753181|FG001|Overall Study|Technical problems|1|||
161919870|NCT05248386|584753180|FG000|Overall Study|Withdrawal by Subject|15|||
161919871|NCT05248386|584753181|FG001|Overall Study|Withdrawal by Subject|10|||
161919872|NCT05248386|584753180|FG000|Overall Study|Physician Decision|0|||
161919873|NCT05248386|584753181|FG001|Overall Study|Physician Decision|1|||
161919874|NCT05248386|584753180|FG000|Overall Study|Adverse Event|2|||
161919875|NCT05248386|584753181|FG001|Overall Study|Adverse Event|4|||
161919876|NCT05248386|584753180|FG000|Overall Study|Other|1|||
161919877|NCT05248386|584753181|FG001|Overall Study|Other|0|||
161919878|NCT05248386|584753180|FG000|Overall Study|Lack of Efficacy|14|||
161919879|NCT05248386|584753181|FG001|Overall Study|Lack of Efficacy|12|||
161919880|NCT01910441|584753182|FG000|Overall Study|Sponsor decision|0|||
161919881|NCT01910441|584753183|FG001|Overall Study|Sponsor decision|2|||
161919882|NCT01910441|584753182|FG000|Overall Study|Lost to Follow-up|6|||
161919883|NCT01910441|584753183|FG001|Overall Study|Lost to Follow-up|5|||
161919884|NCT01910441|584753182|FG000|Overall Study|Withdrawal by Subject|0|||
161919885|NCT01910441|584753183|FG001|Overall Study|Withdrawal by Subject|1|||
161919886|NCT01910441|584753182|FG000|Overall Study|Non-compliance|0|||
161919887|NCT01910441|584753183|FG001|Overall Study|Non-compliance|1|||
161919888|NCT01910441|584753182|FG000|Overall Study|Adverse Event|1|||
161919889|NCT01910441|584753183|FG001|Overall Study|Adverse Event|0|||
161919890|NCT01910441|584753182|FG000|Overall Study|Physician Decision|0|||
161919891|NCT01910441|584753183|FG001|Overall Study|Physician Decision|1|||
161919892|NCT02964182|584753184|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161919893|NCT02964182|584753185|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
161919894|NCT02964182|584753186|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161919895|NCT02964182|584753187|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161919896|NCT02964182|584753188|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161919897|NCT02964182|584753189|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
161919898|NCT02964182|584753190|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161919899|NCT02964182|584753191|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161919900|NCT02964182|584753184|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919901|NCT02964182|584753185|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919902|NCT02964182|584753186|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919903|NCT02964182|584753187|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919904|NCT02964182|584753188|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919905|NCT02964182|584753189|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
161919906|NCT02964182|584753190|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919907|NCT02964182|584753191|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161919908|NCT02964182|584753184|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161919909|NCT02964182|584753185|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
161919910|NCT02964182|584753186|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161919911|NCT02964182|584753187|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161919912|NCT02964182|584753188|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161919913|NCT02964182|584753189|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
161919914|NCT02964182|584753190|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161919915|NCT02964182|584753191|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161919916|NCT02964182|584753184|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161919917|NCT02964182|584753185|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161919918|NCT02964182|584753186|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
161919919|NCT02964182|584753187|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
161919920|NCT02964182|584753188|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161919921|NCT02964182|584753189|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161919922|NCT02964182|584753190|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
161919923|NCT02964182|584753191|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161919924|NCT02964182|584753184|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161919925|NCT02964182|584753185|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161919926|NCT02964182|584753186|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
161919927|NCT02964182|584753187|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
161919928|NCT02964182|584753188|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161919929|NCT02964182|584753189|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161919930|NCT02964182|584753190|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161919931|NCT02964182|584753191|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
161919932|NCT02964182|584753184|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161919933|NCT02964182|584753185|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161919934|NCT02964182|584753186|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
161919935|NCT02964182|584753187|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
161919936|NCT02964182|584753188|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161919937|NCT02964182|584753189|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161919938|NCT02964182|584753190|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161919939|NCT02964182|584753191|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161919940|NCT02964182|584753184|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161919941|NCT02964182|584753185|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161919942|NCT02964182|584753186|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
161919943|NCT02964182|584753187|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
161919944|NCT02964182|584753188|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161919945|NCT02964182|584753189|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161919946|NCT02964182|584753190|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
161919947|NCT02964182|584753191|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161919948|NCT03636477|584753193|FG000|Overall Study|Adverse Event|0|||
161919949|NCT03636477|584753194|FG001|Overall Study|Adverse Event|0|||
161919950|NCT03636477|584753195|FG002|Overall Study|Adverse Event|1|||
161919951|NCT02382380|584753197|FG000|Overall Study|Withdrawal by Subject|2|||
161919952|NCT02382380|584753198|FG001|Overall Study|Withdrawal by Subject|2|||
161919953|NCT02382380|584753197|FG000|Overall Study|Lost to Follow-up|0|||
161919954|NCT02382380|584753198|FG001|Overall Study|Lost to Follow-up|1|||
161919955|NCT01295944|584753199|FG000|Overall Study|Switched to alternative treatment|1|||
161919956|NCT01295944|584753199|FG000|Overall Study|Ineligible|9|||
161919957|NCT01295944|584753199|FG000|Overall Study|Withdrawal by Subject|1|||
161919958|NCT01295944|584753199|FG000|Overall Study|Participant chose to be treated in Peru|1|||
161919959|NCT01295944|584753199|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
162161811|NCT01261312|585643756|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162161812|NCT01261312|585643757|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162161813|NCT01261312|585643758|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162161814|NCT01261312|585643759|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162161815|NCT01261312|585643760|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
162161816|NCT01261312|585643748|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162161817|NCT01261312|585643749|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162161818|NCT01261312|585643750|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162161819|NCT01261312|585643751|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
162161820|NCT01261312|585643752|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
162161821|NCT01261312|585643753|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
162161822|NCT01261312|585643754|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162161823|NCT01261312|585643755|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162161824|NCT01261312|585643756|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161919960|NCT01295944|584753199|FG000|Overall Study|Physician Decision|1|||
161919961|NCT01295944|584753199|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
161919962|NCT01295944|584753199|FG000|Overall Study|Disease progression|4|||
161919963|NCT01295944|584753199|FG000|Overall Study|Transferred care before starting new treatment|1|||
161919964|NCT03785366|584753207|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
161919965|NCT03785366|584753208|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
161919966|NCT03785366|584753207|FG000|Overall Study|Lost to Follow-up|1|||
162161825|NCT01261312|585643757|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162161826|NCT01261312|585643758|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162161827|NCT01261312|585643759|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162161828|NCT01261312|585643760|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
162161829|NCT01261312|585643748|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162161830|NCT01261312|585643749|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161919967|NCT03785366|584753208|FG001|Overall Study|Lost to Follow-up|0|||
161919968|NCT03785366|584753207|FG000|Overall Study|Partial IUD Expulsion|0|||
161919969|NCT03785366|584753208|FG001|Overall Study|Partial IUD Expulsion|2|||
161919970|NCT03785366|584753207|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
161919971|NCT03785366|584753208|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
161919972|NCT05168800|584753209|FG000|Time 1 Survey|Did not start T1 survey|182|||
162161831|NCT01261312|585643750|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162161832|NCT01261312|585643751|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
162161833|NCT01261312|585643752|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
161919973|NCT05168800|584753210|FG001|Time 1 Survey|Did not start T1 survey|150|||
161919974|NCT05168800|584753211|FG002|Time 1 Survey|Did not start T1 survey|140|||
161919975|NCT05168800|584753209|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
161919976|NCT05168800|584753210|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
161919977|NCT05168800|584753211|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
161919978|NCT05168800|584753209|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
162161834|NCT01261312|585643753|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
161919979|NCT05168800|584753210|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
162161835|NCT01261312|585643754|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162161836|NCT01261312|585643755|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162161837|NCT01261312|585643756|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161919980|NCT05168800|584753211|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
161919981|NCT05168800|584753209|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
161919982|NCT05168800|584753210|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
161919983|NCT05168800|584753211|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
161919984|NCT05168800|584753209|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
161919985|NCT05168800|584753210|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
161919986|NCT05168800|584753211|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
161919987|NCT05168800|584753209|FG000|Time 1 Survey|Withdrawal by Subject|6|||
161919988|NCT05168800|584753210|FG001|Time 1 Survey|Withdrawal by Subject|3|||
161919989|NCT05168800|584753211|FG002|Time 1 Survey|Withdrawal by Subject|2|||
161919990|NCT05168800|584753209|FG000|Time 2 Survey|Already excluded at Time 1|228|||
161919991|NCT05168800|584753210|FG001|Time 2 Survey|Already excluded at Time 1|202|||
161919992|NCT05168800|584753211|FG002|Time 2 Survey|Already excluded at Time 1|173|||
161919993|NCT05168800|584753209|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
161919994|NCT05168800|584753210|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
161919995|NCT05168800|584753211|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
161919996|NCT05168800|584753209|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
161919997|NCT05168800|584753210|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
161919998|NCT05168800|584753211|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
161919999|NCT05168800|584753209|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
161920000|NCT05168800|584753210|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
161920001|NCT05168800|584753211|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
161920002|NCT05168800|584753209|FG000|Time 2 Survey|Withdrawal by Subject|1|||
161920003|NCT05168800|584753210|FG001|Time 2 Survey|Withdrawal by Subject|0|||
161920004|NCT05168800|584753211|FG002|Time 2 Survey|Withdrawal by Subject|1|||
161920005|NCT05168800|584753209|FG000|Time 3 Survey|Already excluded at Time 1|228|||
161920006|NCT05168800|584753210|FG001|Time 3 Survey|Already excluded at Time 1|200|||
161920007|NCT05168800|584753211|FG002|Time 3 Survey|Already excluded at Time 1|173|||
161920008|NCT05168800|584753209|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
161920009|NCT05168800|584753210|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
161920010|NCT05168800|584753211|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
161920011|NCT05168800|584753209|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
161920012|NCT05168800|584753210|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
161920013|NCT05168800|584753211|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
161920014|NCT05168800|584753209|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
161920015|NCT05168800|584753210|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
161920016|NCT05168800|584753211|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
161920017|NCT03240874|584753212|FG000|Overall Study|Lost to Follow-up|0|||
161920018|NCT03240874|584753213|FG001|Overall Study|Lost to Follow-up|2|||
161920019|NCT03240874|584753214|FG002|Overall Study|Lost to Follow-up|4|||
161920020|NCT03240874|584753215|FG003|Overall Study|Lost to Follow-up|1|||
161920021|NCT04958707|584753216|FG000|Post Intervention|Withdrawal by Subject|1|||
161920022|NCT04958707|584753217|FG001|Post Intervention|Withdrawal by Subject|0|||
161920023|NCT04958707|584753218|FG002|Post Intervention|Withdrawal by Subject|0|||
161920024|NCT04958707|584753216|FG000|3 Months Follow- up|Lost to Follow-up|0|||
161920025|NCT04958707|584753217|FG001|3 Months Follow- up|Lost to Follow-up|3|||
162016601|NCT02405442|585116253|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
162016602|NCT02405442|585116254|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
162016603|NCT02405442|585116255|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
162016604|NCT02405442|585116256|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
162016605|NCT02405442|585116253|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
162016606|NCT02405442|585116254|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
162016607|NCT02405442|585116255|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
162016608|NCT02405442|585116256|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
162016609|NCT02405442|585116253|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
162016610|NCT02405442|585116254|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
162016611|NCT02405442|585116255|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
162016612|NCT02405442|585116256|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
162016613|NCT02405442|585116253|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
162016614|NCT02405442|585116254|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
162016615|NCT02405442|585116255|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
162016616|NCT02405442|585116256|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
162016617|NCT02405442|585116253|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
162016618|NCT02405442|585116254|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
162016619|NCT02405442|585116255|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
162016620|NCT02405442|585116256|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
161920026|NCT04958707|584753218|FG002|3 Months Follow- up|Lost to Follow-up|0|||
161920027|NCT04958707|584753216|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
161920028|NCT04958707|584753217|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
161920029|NCT04958707|584753218|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
161920030|NCT04279522|584753221|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
161920031|NCT04279522|584753222|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
161920032|NCT04279522|584753221|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
161920033|NCT04279522|584753222|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
161920034|NCT04279522|584753221|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
161920035|NCT04279522|584753222|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
161920036|NCT04279522|584753221|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
161920037|NCT04279522|584753222|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
161920038|NCT04279522|584753221|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
161920039|NCT04279522|584753222|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
161920040|NCT04279522|584753221|FG000|Period 2: Open Label Phase|Physician Decision|0|||
161920041|NCT04279522|584753222|FG001|Period 2: Open Label Phase|Physician Decision|3|||
161920042|NCT04279522|584753221|FG000|Period 2: Open Label Phase|Adverse Event|0|||
162161838|NCT01261312|585643757|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162161839|NCT01261312|585643758|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
162161840|NCT01261312|585643759|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161920043|NCT04279522|584753222|FG001|Period 2: Open Label Phase|Adverse Event|1|||
162161841|NCT01261312|585643760|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161920044|NCT04279522|584753221|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
161920045|NCT04279522|584753222|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
161920046|NCT02783274|584753235|FG000|Overall Study|Withdrawal by Subject|16|||
161920047|NCT02783274|584753235|FG000|Overall Study|Physician Decision|6|||
161920048|NCT02783274|584753235|FG000|Overall Study|Death|9|||
161920049|NCT02783274|584753235|FG000|Overall Study|Lost to Follow-up|22|||
161920050|NCT02783274|584753235|FG000|Overall Study|Other|22|||
161920051|NCT05567172|584753239|FG000|Overall Study|Death|3|||
161920052|NCT05523297|584753240|FG000|Overall Study|Death|7|||
161920053|NCT05523297|584753241|FG001|Overall Study|Death|8|||
161920054|NCT05523297|584753240|FG000|Overall Study|Lost to Follow-up|2|||
161920055|NCT05523297|584753241|FG001|Overall Study|Lost to Follow-up|1|||
161920056|NCT03168672|584753244|FG000|Overall Study|Withdrawal by Subject|13|||
161920057|NCT03168672|584753244|FG000|Overall Study|Death|3|||
161920058|NCT03168672|584753244|FG000|Overall Study|Investigator's Decision|137|||
161920059|NCT03168672|584753244|FG000|Overall Study|Adverse Event|1|||
161920060|NCT03168672|584753244|FG000|Overall Study|Other|2|||
161920061|NCT03168672|584753244|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
161920062|NCT02246777|584753245|FG000|Overall Study|Adverse Event|2|||
161920063|NCT02246777|584753245|FG000|Overall Study|Change of residence|1|||
161920064|NCT00927472|584753246|FG000|Overall Study|Withdrawal by Subject|10|||
161920065|NCT00927472|584753247|FG001|Overall Study|Withdrawal by Subject|11|||
161920066|NCT00927472|584753246|FG000|Overall Study|Lost to Follow-up|1|||
161920067|NCT00927472|584753247|FG001|Overall Study|Lost to Follow-up|6|||
161920068|NCT00927472|584753246|FG000|Overall Study|Protocol Violation|0|||
161920069|NCT00927472|584753247|FG001|Overall Study|Protocol Violation|1|||
161920070|NCT00927472|584753246|FG000|Overall Study|Post treatment Assessment out of window|0|||
161920071|NCT00927472|584753247|FG001|Overall Study|Post treatment Assessment out of window|4|||
161920072|NCT00433537|584753248|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
161920073|NCT00433537|584753249|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
161920074|NCT00433537|584753250|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
161920075|NCT00433537|584753248|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
161920076|NCT00433537|584753249|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
161920077|NCT00433537|584753250|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
161920078|NCT00433537|584753248|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
162161842|NCT01261312|585643748|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162161843|NCT01261312|585643749|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162161844|NCT01261312|585643750|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162161845|NCT01261312|585643751|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162161846|NCT01261312|585643752|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162161847|NCT01261312|585643753|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162161848|NCT01261312|585643754|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
162161849|NCT01261312|585643755|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
162161850|NCT01261312|585643756|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
162161851|NCT01261312|585643757|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162161852|NCT01261312|585643758|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161920079|NCT00433537|584753249|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
161920080|NCT00433537|584753250|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
162161853|NCT01261312|585643759|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161920081|NCT00433537|584753248|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
161920082|NCT00433537|584753249|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
161920083|NCT00433537|584753250|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
162161854|NCT01261312|585643760|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
162161855|NCT01261312|585643748|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162161856|NCT01261312|585643749|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162161857|NCT01261312|585643750|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162161858|NCT01261312|585643751|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162161859|NCT01261312|585643752|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162161860|NCT01261312|585643753|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162161861|NCT01261312|585643754|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161920084|NCT00433537|584753248|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
161920085|NCT00433537|584753249|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
161920086|NCT00433537|584753250|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
161920087|NCT00433537|584753248|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
161920088|NCT00433537|584753249|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
161920089|NCT00433537|584753250|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
161920090|NCT00433537|584753248|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
161920091|NCT00433537|584753249|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
161920092|NCT00433537|584753250|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
161920093|NCT00433537|584753248|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
161920094|NCT00433537|584753249|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
161920095|NCT00433537|584753250|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
161920096|NCT00433537|584753248|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
161920097|NCT00433537|584753249|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
161920098|NCT00433537|584753250|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
161920099|NCT04707469|584753251|FG000|Overall Study|Site closure|0|||
161920100|NCT04707469|584753252|FG001|Overall Study|Site closure|2|||
161920101|NCT04707469|584753253|FG002|Overall Study|Site closure|0|||
161920102|NCT04707469|584753251|FG000|Overall Study|Physician Decision|2|||
161920103|NCT04707469|584753252|FG001|Overall Study|Physician Decision|2|||
161920104|NCT04707469|584753253|FG002|Overall Study|Physician Decision|2|||
161920105|NCT04707469|584753251|FG000|Overall Study|Death|1|||
161920106|NCT04707469|584753252|FG001|Overall Study|Death|6|||
161920107|NCT04707469|584753253|FG002|Overall Study|Death|2|||
161920108|NCT04707469|584753251|FG000|Overall Study|Lost to Follow-up|9|||
161920109|NCT04707469|584753252|FG001|Overall Study|Lost to Follow-up|19|||
161920110|NCT04707469|584753253|FG002|Overall Study|Lost to Follow-up|14|||
161920111|NCT04707469|584753251|FG000|Overall Study|Withdrawal by Subject|17|||
161920112|NCT04707469|584753252|FG001|Overall Study|Withdrawal by Subject|16|||
161920113|NCT04707469|584753253|FG002|Overall Study|Withdrawal by Subject|12|||
161920114|NCT04635423|584753266|FG000|Overall Study|Ongoing|493|||
161920115|NCT04635423|584753267|FG001|Overall Study|Ongoing|501|||
161920116|NCT04635423|584753266|FG000|Overall Study|Withdrawal by Subject|36|||
161920117|NCT04635423|584753267|FG001|Overall Study|Withdrawal by Subject|29|||
161920118|NCT05556057|584753268|FG000|Overall Study|Lost to Follow-up|5|||
161920119|NCT05556057|584753269|FG001|Overall Study|Lost to Follow-up|4|||
161920120|NCT05556057|584753268|FG000|Overall Study|Withdrawal by Subject|0|||
161920121|NCT05556057|584753269|FG001|Overall Study|Withdrawal by Subject|2|||
161920122|NCT00830765|584753280|FG000|Overall Study|Protocol Violation|3|||
161920123|NCT00830765|584753281|FG001|Overall Study|Protocol Violation|2|||
161920124|NCT02390284|584753282|FG000|Overall Study|Physician Decision|0|||
161920125|NCT02390284|584753283|FG001|Overall Study|Physician Decision|0|||
161920126|NCT02390284|584753284|FG002|Overall Study|Physician Decision|9|||
161920127|NCT01977846|584753285|FG000|Total Study - Prospective|Death|0|||
161920128|NCT01977846|584753286|FG001|Total Study - Prospective|Death|1|||
161920129|NCT01977846|584753285|FG000|Total Study - Prospective|Lost to Follow-up|0|||
161920130|NCT01977846|584753286|FG001|Total Study - Prospective|Lost to Follow-up|8|||
161920131|NCT01977846|584753285|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
161920132|NCT01977846|584753286|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
161920133|NCT01977846|584753285|FG000|Total Study - Prospective|Not available at time of visit|0|||
161920134|NCT01977846|584753286|FG001|Total Study - Prospective|Not available at time of visit|5|||
161920135|NCT01977846|584753285|FG000|Total Study - Prospective|No show|0|||
161920136|NCT01977846|584753286|FG001|Total Study - Prospective|No show|1|||
161920137|NCT01977846|584753285|FG000|Total Study - Prospective|Protocol Violation|0|||
161920138|NCT01977846|584753286|FG001|Total Study - Prospective|Protocol Violation|1|||
161920139|NCT00143507|584754523|FG000|Overall Study|Death|572|||
161920140|NCT00143507|584754524|FG001|Overall Study|Death|547|||
161920141|NCT00143507|584754523|FG000|Overall Study|Withdrawal by Subject|114|||
161920142|NCT00143507|584754524|FG001|Overall Study|Withdrawal by Subject|102|||
161920143|NCT00143507|584754523|FG000|Overall Study|Lost to Follow-up|1|||
161920144|NCT00143507|584754524|FG001|Overall Study|Lost to Follow-up|0|||
161920145|NCT00143507|584754523|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
161920146|NCT00143507|584754524|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
161920147|NCT00177671|584754525|FG000|Overall Study|Withdrawal by Subject|5|||
161920148|NCT00177671|584754526|FG001|Overall Study|Withdrawal by Subject|6|||
161920149|NCT00177671|584754525|FG000|Overall Study|medical complications|2|||
161920150|NCT00177671|584754526|FG001|Overall Study|medical complications|0|||
161920151|NCT00177671|584754525|FG000|Overall Study|Adverse Event|6|||
161920152|NCT00177671|584754526|FG001|Overall Study|Adverse Event|0|||
161920153|NCT00177671|584754525|FG000|Overall Study|Physician Decision|12|||
161920154|NCT00177671|584754526|FG001|Overall Study|Physician Decision|8|||
161920155|NCT00690898|584754527|FG000|SCREENING|Screen failure|18|||
161920156|NCT00690898|584754527|FG000|TREATMENT|Adverse Event|3|||
161920157|NCT00690898|584754527|FG000|TREATMENT|Lack of Efficacy|18|||
161920158|NCT00690898|584754527|FG000|TREATMENT|Withdrawal by Subject|4|||
161920159|NCT00690898|584754527|FG000|TREATMENT|Other (not otherwise specified)|1|||
161920160|NCT01121926|584754528|FG000|First Intervention Period|Adverse Event|1|||
161920161|NCT01121926|584754529|FG001|First Intervention Period|Adverse Event|0|||
161920162|NCT01121926|584754528|FG000|Washout Period|Adverse Event|0|||
161920163|NCT01121926|584754529|FG001|Washout Period|Adverse Event|1|||
161920164|NCT01121926|584754528|FG000|Washout Period|Positive pregnancy test|0|||
161920165|NCT01121926|584754529|FG001|Washout Period|Positive pregnancy test|1|||
161920166|NCT02782468|584754530|FG000|Overall Study|Progressive Disease|2|||
161920167|NCT02782468|584754531|FG001|Overall Study|Progressive Disease|5|||
161920168|NCT02782468|584754532|FG002|Overall Study|Progressive Disease|0|||
161920169|NCT02782468|584754533|FG003|Overall Study|Progressive Disease|4|||
161920170|NCT02782468|584754530|FG000|Overall Study|Adverse Event|0|||
161920171|NCT02782468|584754531|FG001|Overall Study|Adverse Event|2|||
161920172|NCT02782468|584754532|FG002|Overall Study|Adverse Event|2|||
161920173|NCT02782468|584754533|FG003|Overall Study|Adverse Event|3|||
161920174|NCT02782468|584754530|FG000|Overall Study|Other|0|||
161920175|NCT02782468|584754531|FG001|Overall Study|Other|0|||
161920176|NCT02782468|584754532|FG002|Overall Study|Other|1|||
161920177|NCT02782468|584754533|FG003|Overall Study|Other|1|||
161920178|NCT02782468|584754530|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
161920179|NCT02782468|584754531|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
161920180|NCT02782468|584754532|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
161920181|NCT02782468|584754533|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
161920182|NCT02782468|584754530|FG000|Overall Study|Symptomatic Deterioration|0|||
161920183|NCT02782468|584754531|FG001|Overall Study|Symptomatic Deterioration|0|||
161920184|NCT02782468|584754532|FG002|Overall Study|Symptomatic Deterioration|0|||
161920185|NCT02782468|584754533|FG003|Overall Study|Symptomatic Deterioration|1|||
161920186|NCT02782468|584754530|FG000|Overall Study|Withdrawal by Subject|1|||
161920187|NCT02782468|584754531|FG001|Overall Study|Withdrawal by Subject|0|||
161920188|NCT02782468|584754532|FG002|Overall Study|Withdrawal by Subject|0|||
161920189|NCT02782468|584754533|FG003|Overall Study|Withdrawal by Subject|0|||
161920190|NCT00356590|584754534|FG000|Overall Study|Adverse Event|54|||
161920191|NCT00356590|584754534|FG000|Overall Study|Death|10|||
161920192|NCT00356590|584754534|FG000|Overall Study|Lost to Follow-up|35|||
161920193|NCT00356590|584754534|FG000|Overall Study|Physician Decision|46|||
161920194|NCT00356590|584754534|FG000|Overall Study|Withdrawal by Subject|41|||
161920195|NCT00356590|584754534|FG000|Overall Study|Completed month 12 only|2|||
161920196|NCT00356590|584754534|FG000|Overall Study|Protocol issues|6|||
161920197|NCT00356590|584754534|FG000|Overall Study|Response status|28|||
161920198|NCT00356590|584754534|FG000|Overall Study|Other|52|||
161920199|NCT01496456|584754536|FG000|Overall Study|Protocol Violation|1|||
161920200|NCT01496456|584754536|FG000|Overall Study|Lost to Follow-up|7|||
161920201|NCT04919161|584754537|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
161920202|NCT04919161|584754538|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
161920203|NCT04919161|584754537|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
161920204|NCT04919161|584754538|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
161920205|NCT04919161|584754537|FG000|Overall Study|Acute ankle sprain after session 1|0|||
161920206|NCT04919161|584754538|FG001|Overall Study|Acute ankle sprain after session 1|1|||
161920207|NCT02175758|584754539|FG000|Treatment Phase|Lost to Follow-up|0|||
161920208|NCT02175758|584754540|FG001|Treatment Phase|Lost to Follow-up|1|||
161920209|NCT02175758|584754541|FG002|Treatment Phase|Lost to Follow-up|0|||
161920210|NCT02175758|584754542|FG003|Treatment Phase|Lost to Follow-up|0|||
161920211|NCT02175758|584754543|FG004|Treatment Phase|Lost to Follow-up|0|||
161920212|NCT02175758|584754544|FG005|Treatment Phase|Lost to Follow-up|0|||
161920213|NCT02175758|584754539|FG000|Treatment Phase|Adverse Event|0|||
161920214|NCT02175758|584754540|FG001|Treatment Phase|Adverse Event|0|||
161920215|NCT02175758|584754541|FG002|Treatment Phase|Adverse Event|0|||
161920216|NCT02175758|584754542|FG003|Treatment Phase|Adverse Event|0|||
161920217|NCT02175758|584754543|FG004|Treatment Phase|Adverse Event|1|||
161920218|NCT02175758|584754544|FG005|Treatment Phase|Adverse Event|0|||
161920219|NCT02489773|584754545|FG000|Overall Study|Lost to Follow-up|4|||
161920220|NCT02489773|584754546|FG001|Overall Study|Lost to Follow-up|1|||
161920221|NCT02489773|584754545|FG000|Overall Study|Physician Decision|1|||
161920222|NCT02489773|584754546|FG001|Overall Study|Physician Decision|0|||
161920223|NCT02489773|584754545|FG000|Overall Study|Withdrawal by Subject|1|||
161920224|NCT02489773|584754546|FG001|Overall Study|Withdrawal by Subject|0|||
161920225|NCT02489773|584754545|FG000|Overall Study|Leave the country or the state|1|||
161920226|NCT02489773|584754546|FG001|Overall Study|Leave the country or the state|1|||
161920227|NCT00712920|584754547|FG000|Overall Study|Adverse Event|3|||
161920228|NCT00712920|584754548|FG001|Overall Study|Adverse Event|4|||
161920229|NCT00712920|584754549|FG002|Overall Study|Adverse Event|7|||
161920230|NCT00712920|584754547|FG000|Overall Study|Withdrawal by Subject|4|||
161920231|NCT00712920|584754548|FG001|Overall Study|Withdrawal by Subject|2|||
161920232|NCT00712920|584754549|FG002|Overall Study|Withdrawal by Subject|1|||
161920233|NCT00712920|584754547|FG000|Overall Study|Lost to Follow-up|1|||
161920234|NCT00712920|584754548|FG001|Overall Study|Lost to Follow-up|4|||
161920235|NCT00712920|584754549|FG002|Overall Study|Lost to Follow-up|0|||
161920236|NCT00712920|584754547|FG000|Overall Study|Lack of Efficacy|1|||
161920237|NCT00712920|584754548|FG001|Overall Study|Lack of Efficacy|0|||
161920238|NCT00712920|584754549|FG002|Overall Study|Lack of Efficacy|1|||
161920239|NCT00712920|584754547|FG000|Overall Study|Other|5|||
161920240|NCT00712920|584754548|FG001|Overall Study|Other|7|||
161920241|NCT00712920|584754549|FG002|Overall Study|Other|3|||
161920242|NCT00712920|584754547|FG000|Overall Study|Non-compliance|3|||
161920243|NCT00712920|584754548|FG001|Overall Study|Non-compliance|0|||
161920244|NCT00712920|584754549|FG002|Overall Study|Non-compliance|0|||
161920245|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
161920246|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
161920247|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
161920248|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
161920249|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
161920250|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
161920251|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161920252|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161920253|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
161920254|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
161920255|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
161920256|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
161920257|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
161920258|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
161920259|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
161920260|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
161920261|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161920262|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
161920263|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161920264|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161920265|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
161920266|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
161920267|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
161920268|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
161920269|NCT00620542|584754553|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
161920270|NCT00620542|584754554|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
161920271|NCT00620542|584754555|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
161920272|NCT00620542|584754556|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
161920273|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
161920274|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
161920275|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
161920276|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
161920277|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
161920278|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
161920279|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
161920280|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
161920281|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
161920282|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
161920283|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
161920284|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
161920285|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
161920286|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
161920287|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
161920288|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
161920289|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
161920290|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
161920291|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
161920292|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
161920293|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
161920294|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
161920295|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
161920296|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
161920297|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
161920298|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
161920299|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
161920300|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
161920301|NCT00620542|584754553|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
161920302|NCT00620542|584754554|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
161920303|NCT00620542|584754555|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
161920304|NCT00620542|584754556|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
161920305|NCT02550795|584754563|FG000|Overall Study|Physician Decision|0|||
161920306|NCT02550795|584754564|FG001|Overall Study|Physician Decision|1|||
161920307|NCT02550795|584754565|FG002|Overall Study|Physician Decision|0|||
161920308|NCT02225587|584754566|FG000|Overall Study|Adverse Event|5|||
161920309|NCT02225587|584754567|FG001|Overall Study|Adverse Event|5|||
161920310|NCT02225587|584754566|FG000|Overall Study|Lost to Follow-up|5|||
161920311|NCT02225587|584754567|FG001|Overall Study|Lost to Follow-up|5|||
161920312|NCT02225587|584754566|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161920313|NCT02225587|584754567|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161920314|NCT02225587|584754566|FG000|Overall Study|Physician Decision|2|||
161920315|NCT02225587|584754567|FG001|Overall Study|Physician Decision|0|||
161920316|NCT02225587|584754566|FG000|Overall Study|Protocol Violation|1|||
161920317|NCT02225587|584754567|FG001|Overall Study|Protocol Violation|0|||
161920318|NCT02225587|584754566|FG000|Overall Study|Participant Moved|1|||
161920319|NCT02225587|584754567|FG001|Overall Study|Participant Moved|0|||
161920320|NCT02225587|584754566|FG000|Overall Study|Withdrawal by Subject|13|||
161920321|NCT02225587|584754567|FG001|Overall Study|Withdrawal by Subject|28|||
161920322|NCT03483584|584754570|FG000|Overall Study|Lost to Follow-up|40|||
161920323|NCT03483584|584754571|FG001|Overall Study|Lost to Follow-up|7|||
161920324|NCT03483584|584754570|FG000|Overall Study|Withdrawal by Subject|4|||
161920325|NCT03483584|584754571|FG001|Overall Study|Withdrawal by Subject|1|||
161920326|NCT02879695|584754572|FG000|Overall Study|Did not start study treatment|2|||
161920327|NCT02879695|584754573|FG001|Overall Study|Did not start study treatment|0|||
161920328|NCT02879695|584754574|FG002|Overall Study|Did not start study treatment|3|||
161920329|NCT02879695|584754575|FG003|Overall Study|Did not start study treatment|0|||
161920330|NCT04063163|584754576|FG000|Overall Study|Death|281|||
161920331|NCT04063163|584754577|FG001|Overall Study|Death|166|||
161920332|NCT04063163|584754576|FG000|Overall Study|Lost to Follow-up|12|||
161920333|NCT04063163|584754577|FG001|Overall Study|Lost to Follow-up|8|||
161920334|NCT04063163|584754576|FG000|Overall Study|Withdrawal by Subject|19|||
161920335|NCT04063163|584754577|FG001|Overall Study|Withdrawal by Subject|10|||
161920336|NCT02572167|584754578|FG000|Overall Study|Withdrawal by Subject|0|||
161814704|NCT00418938|584365387|FG001|Overall Study|On-going|1|||
161814705|NCT00418938|584365386|FG000|Overall Study|Ineligibility Determined|1|||
161814706|NCT00418938|584365387|FG001|Overall Study|Ineligibility Determined|0|||
161814707|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
161814708|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
161814709|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
161814710|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
161814711|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
161814712|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
161814713|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Death|9|||
161814714|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Death|7|||
161814715|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Death|14|||
161814716|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Death|7|||
161814717|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Death|0|||
161814718|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Death|0|||
161814719|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
161814720|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
161814721|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
161814722|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
161814723|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
161814724|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
161814725|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Other Event|49|||
161814726|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Other Event|52|||
161814727|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Other Event|41|||
161814728|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Other Event|58|||
161814729|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Other Event|0|||
161814730|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Other Event|0|||
161814731|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
161814732|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
161814733|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
161814734|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
161814735|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
161814736|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
161814737|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
161814738|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
161814739|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
161814740|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
161814741|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
161814742|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
161814743|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
161814744|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
161814745|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
161814746|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
161814747|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
161814748|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
161814749|NCT00205777|584365388|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
161814750|NCT00205777|584365389|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
161814751|NCT00205777|584365390|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
161814752|NCT00205777|584365391|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
161814753|NCT00205777|584365392|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
161814754|NCT00205777|584365393|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
161814755|NCT00205777|584365388|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
161814756|NCT00205777|584365389|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
161814757|NCT00205777|584365390|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
161814758|NCT00205777|584365391|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
161814759|NCT00205777|584365392|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
161814760|NCT00205777|584365393|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
161814761|NCT00205777|584365388|FG000|Completed Core Study, Entered SE I|Other Event|52|||
161814762|NCT00205777|584365389|FG001|Completed Core Study, Entered SE I|Other Event|46|||
161814763|NCT00205777|584365390|FG002|Completed Core Study, Entered SE I|Other Event|47|||
161814764|NCT00205777|584365391|FG003|Completed Core Study, Entered SE I|Other Event|50|||
161814765|NCT00205777|584365392|FG004|Completed Core Study, Entered SE I|Other Event|0|||
161814766|NCT00205777|584365393|FG005|Completed Core Study, Entered SE I|Other Event|0|||
161814767|NCT00205777|584365388|FG000|Study Extension I|Adverse Event|57|||
161814768|NCT00205777|584365389|FG001|Study Extension I|Adverse Event|0|||
161814769|NCT00205777|584365390|FG002|Study Extension I|Adverse Event|0|||
161814770|NCT00205777|584365391|FG003|Study Extension I|Adverse Event|61|||
161814771|NCT00205777|584365392|FG004|Study Extension I|Adverse Event|58|||
161814772|NCT00205777|584365393|FG005|Study Extension I|Adverse Event|0|||
161814773|NCT00205777|584365388|FG000|Study Extension I|Death|5|||
161814774|NCT00205777|584365389|FG001|Study Extension I|Death|0|||
161814775|NCT00205777|584365390|FG002|Study Extension I|Death|0|||
161920337|NCT02572167|584754579|FG001|Overall Study|Withdrawal by Subject|3|||
161920338|NCT02572167|584754580|FG002|Overall Study|Withdrawal by Subject|0|||
161920339|NCT02572167|584754578|FG000|Overall Study|Lost to Follow-up|2|||
161920340|NCT02572167|584754579|FG001|Overall Study|Lost to Follow-up|5|||
161920341|NCT02572167|584754580|FG002|Overall Study|Lost to Follow-up|3|||
161920342|NCT02572167|584754578|FG000|Overall Study|Death|0|||
161920343|NCT02572167|584754579|FG001|Overall Study|Death|8|||
161920344|NCT02572167|584754580|FG002|Overall Study|Death|3|||
161920345|NCT02572167|584754578|FG000|Overall Study|Did not meet inclusion criteria|0|||
161920346|NCT02572167|584754579|FG001|Overall Study|Did not meet inclusion criteria|0|||
161920347|NCT02572167|584754580|FG002|Overall Study|Did not meet inclusion criteria|1|||
161920348|NCT02572167|584754578|FG000|Overall Study|Study closure by Sponsor|4|||
161920349|NCT02572167|584754579|FG001|Overall Study|Study closure by Sponsor|40|||
161920350|NCT02572167|584754580|FG002|Overall Study|Study closure by Sponsor|24|||
161920351|NCT00005047|584754581|FG000|Overall Study|Withdrawal by Subject|12|||
161920352|NCT00005047|584754582|FG001|Overall Study|Withdrawal by Subject|0|||
161920353|NCT00005047|584754583|FG002|Overall Study|Withdrawal by Subject|0|||
161920354|NCT00005047|584754584|FG003|Overall Study|Withdrawal by Subject|0|||
161920355|NCT00005047|584754581|FG000|Overall Study|Adverse Event|5|||
161920356|NCT00005047|584754582|FG001|Overall Study|Adverse Event|0|||
161920357|NCT00005047|584754583|FG002|Overall Study|Adverse Event|0|||
161920358|NCT00005047|584754584|FG003|Overall Study|Adverse Event|0|||
161920359|NCT00005047|584754581|FG000|Overall Study|Lost to Follow-up|1|||
161920360|NCT00005047|584754582|FG001|Overall Study|Lost to Follow-up|0|||
161920361|NCT00005047|584754583|FG002|Overall Study|Lost to Follow-up|0|||
161920362|NCT00005047|584754584|FG003|Overall Study|Lost to Follow-up|0|||
161920363|NCT00005047|584754581|FG000|Overall Study|Lack of Efficacy|1|||
161920364|NCT00005047|584754582|FG001|Overall Study|Lack of Efficacy|0|||
161920365|NCT00005047|584754583|FG002|Overall Study|Lack of Efficacy|0|||
161920366|NCT00005047|584754584|FG003|Overall Study|Lack of Efficacy|0|||
161920367|NCT03036254|584754587|FG000|Overall Study|Adverse Event|6|||
161920368|NCT03036254|584754588|FG001|Overall Study|Adverse Event|4|||
161920369|NCT03036254|584754587|FG000|Overall Study|Death|3|||
161920370|NCT03036254|584754588|FG001|Overall Study|Death|1|||
161920371|NCT03036254|584754587|FG000|Overall Study|Lack of Efficacy|5|||
161920372|NCT03036254|584754588|FG001|Overall Study|Lack of Efficacy|1|||
161920373|NCT03036254|584754587|FG000|Overall Study|Withdrawal by Subject|3|||
161920374|NCT03036254|584754588|FG001|Overall Study|Withdrawal by Subject|5|||
161920375|NCT04556097|584754589|FG000|Overall Study|Death|0|||
161920376|NCT04556097|584754590|FG001|Overall Study|Death|5|||
161920377|NCT04556097|584754591|FG002|Overall Study|Death|0|||
161920378|NCT04556097|584754592|FG003|Overall Study|Death|0|||
161920379|NCT04556097|584754589|FG000|Overall Study|No caregiver|43|||
161920380|NCT04556097|584754590|FG001|Overall Study|No caregiver|53|||
161920381|NCT04556097|584754591|FG002|Overall Study|No caregiver|0|||
162161862|NCT01261312|585643755|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
162161863|NCT01261312|585643756|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
162161864|NCT01261312|585643757|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161920382|NCT04556097|584754592|FG003|Overall Study|No caregiver|0|||
161920383|NCT04556097|584754589|FG000|Overall Study|Ineligible, SNF|2|||
161920384|NCT04556097|584754590|FG001|Overall Study|Ineligible, SNF|2|||
161920385|NCT04556097|584754591|FG002|Overall Study|Ineligible, SNF|0|||
162016621|NCT02405442|585116253|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
162016622|NCT02405442|585116254|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
162016623|NCT02405442|585116255|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
162016624|NCT02405442|585116256|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
162016625|NCT02405442|585116253|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
162016626|NCT02405442|585116254|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
162016627|NCT02405442|585116255|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
162016628|NCT02405442|585116256|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
162016629|NCT02405442|585116253|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
162016630|NCT02405442|585116254|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
162016631|NCT02405442|585116255|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
162016632|NCT02405442|585116256|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
162016633|NCT02405442|585116253|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
162016634|NCT02405442|585116254|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
162016635|NCT02405442|585116255|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
162016636|NCT02405442|585116256|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
162161865|NCT01261312|585643758|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162161866|NCT01261312|585643759|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161920386|NCT04556097|584754592|FG003|Overall Study|Ineligible, SNF|0|||
161920387|NCT04556097|584754589|FG000|Overall Study|Ineligible, health|3|||
161920388|NCT04556097|584754590|FG001|Overall Study|Ineligible, health|4|||
161920389|NCT04556097|584754591|FG002|Overall Study|Ineligible, health|0|||
161920390|NCT04556097|584754592|FG003|Overall Study|Ineligible, health|0|||
161920391|NCT04556097|584754589|FG000|Overall Study|Ineligible, language|0|||
161814776|NCT00205777|584365391|FG003|Study Extension I|Death|1|||
161814777|NCT00205777|584365392|FG004|Study Extension I|Death|2|||
161814778|NCT00205777|584365393|FG005|Study Extension I|Death|0|||
161814779|NCT00205777|584365388|FG000|Study Extension I|Withdrawal by Subject|99|||
161814780|NCT00205777|584365389|FG001|Study Extension I|Withdrawal by Subject|0|||
161814781|NCT00205777|584365390|FG002|Study Extension I|Withdrawal by Subject|0|||
161814782|NCT00205777|584365391|FG003|Study Extension I|Withdrawal by Subject|106|||
161814783|NCT00205777|584365392|FG004|Study Extension I|Withdrawal by Subject|89|||
161814784|NCT00205777|584365393|FG005|Study Extension I|Withdrawal by Subject|0|||
161814785|NCT00205777|584365388|FG000|Study Extension I|Protocol Violation|4|||
161814786|NCT00205777|584365389|FG001|Study Extension I|Protocol Violation|0|||
161814787|NCT00205777|584365390|FG002|Study Extension I|Protocol Violation|0|||
161814788|NCT00205777|584365391|FG003|Study Extension I|Protocol Violation|8|||
161814789|NCT00205777|584365392|FG004|Study Extension I|Protocol Violation|8|||
161814790|NCT00205777|584365393|FG005|Study Extension I|Protocol Violation|0|||
161814791|NCT00205777|584365388|FG000|Study Extension I|Lack of Efficacy|0|||
161814792|NCT00205777|584365389|FG001|Study Extension I|Lack of Efficacy|0|||
161814793|NCT00205777|584365390|FG002|Study Extension I|Lack of Efficacy|0|||
161814794|NCT00205777|584365391|FG003|Study Extension I|Lack of Efficacy|1|||
161814795|NCT00205777|584365392|FG004|Study Extension I|Lack of Efficacy|2|||
161814796|NCT00205777|584365393|FG005|Study Extension I|Lack of Efficacy|0|||
161814797|NCT00205777|584365388|FG000|Study Extension I|Failed to return|15|||
161814798|NCT00205777|584365389|FG001|Study Extension I|Failed to return|0|||
161814799|NCT00205777|584365390|FG002|Study Extension I|Failed to return|0|||
161814800|NCT00205777|584365391|FG003|Study Extension I|Failed to return|17|||
161814801|NCT00205777|584365392|FG004|Study Extension I|Failed to return|13|||
161814802|NCT00205777|584365393|FG005|Study Extension I|Failed to return|0|||
161814803|NCT00205777|584365388|FG000|Study Extension I|Other Event|34|||
161814804|NCT00205777|584365389|FG001|Study Extension I|Other Event|0|||
161814805|NCT00205777|584365390|FG002|Study Extension I|Other Event|0|||
161814806|NCT00205777|584365391|FG003|Study Extension I|Other Event|34|||
161814807|NCT00205777|584365392|FG004|Study Extension I|Other Event|29|||
161814808|NCT00205777|584365393|FG005|Study Extension I|Other Event|0|||
161814809|NCT00205777|584365388|FG000|Study Extension I|Withdrawn as per protocol|0|||
161814810|NCT00205777|584365389|FG001|Study Extension I|Withdrawn as per protocol|0|||
161814811|NCT00205777|584365390|FG002|Study Extension I|Withdrawn as per protocol|1070|||
161814812|NCT00205777|584365391|FG003|Study Extension I|Withdrawn as per protocol|0|||
161814813|NCT00205777|584365392|FG004|Study Extension I|Withdrawn as per protocol|0|||
161814814|NCT00205777|584365393|FG005|Study Extension I|Withdrawn as per protocol|0|||
161814815|NCT00205777|584365388|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
161920392|NCT04556097|584754590|FG001|Overall Study|Ineligible, language|1|||
161920393|NCT04556097|584754591|FG002|Overall Study|Ineligible, language|0|||
161920394|NCT04556097|584754592|FG003|Overall Study|Ineligible, language|0|||
161920395|NCT04556097|584754589|FG000|Overall Study|Ineligible, no longer in care management|0|||
161920396|NCT04556097|584754590|FG001|Overall Study|Ineligible, no longer in care management|2|||
161920397|NCT04556097|584754591|FG002|Overall Study|Ineligible, no longer in care management|1|||
161920398|NCT04556097|584754592|FG003|Overall Study|Ineligible, no longer in care management|0|||
161920399|NCT04556097|584754589|FG000|Overall Study|No dementia|13|||
161920400|NCT04556097|584754590|FG001|Overall Study|No dementia|3|||
161920401|NCT04556097|584754591|FG002|Overall Study|No dementia|0|||
161920402|NCT04556097|584754592|FG003|Overall Study|No dementia|0|||
161920403|NCT04556097|584754589|FG000|Overall Study|Missing identifier|2|||
161920404|NCT04556097|584754590|FG001|Overall Study|Missing identifier|4|||
161920405|NCT04556097|584754591|FG002|Overall Study|Missing identifier|0|||
161920406|NCT04556097|584754592|FG003|Overall Study|Missing identifier|0|||
161920407|NCT04556097|584754589|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
161920408|NCT04556097|584754590|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
161920409|NCT04556097|584754591|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
161920410|NCT04556097|584754592|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
161920411|NCT05436613|584754593|FG000|Overall Study|Lost to Follow-up|9|||
161920412|NCT05436613|584754593|FG000|Overall Study|Withdrawal by Subject|3|||
161920413|NCT05317546|584754596|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
161920414|NCT05317546|584754597|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
161920415|NCT04364646|584754598|FG000|Overall Study|Lost to Follow-up|1|||
161920416|NCT04364646|584754599|FG001|Overall Study|Lost to Follow-up|0|||
161920417|NCT04364646|584754598|FG000|Overall Study|Withdrawal by Subject|7|||
161920418|NCT04364646|584754599|FG001|Overall Study|Withdrawal by Subject|14|||
161920419|NCT04364646|584754598|FG000|Overall Study|Protocol Violation|4|||
161920420|NCT04364646|584754599|FG001|Overall Study|Protocol Violation|5|||
161920421|NCT02555878|584754613|FG000|Overall Study|Lost to Follow-up|2|||
161920422|NCT02555878|584754614|FG001|Overall Study|Lost to Follow-up|3|||
161920423|NCT02555878|584754613|FG000|Overall Study|Withdrawal by Subject|48|||
161920424|NCT02555878|584754614|FG001|Overall Study|Withdrawal by Subject|48|||
161920425|NCT02555878|584754613|FG000|Overall Study|Adverse Event|12|||
161920426|NCT02555878|584754614|FG001|Overall Study|Adverse Event|8|||
161920427|NCT02555878|584754613|FG000|Overall Study|Death|74|||
161920428|NCT02555878|584754614|FG001|Overall Study|Death|59|||
161920429|NCT02555878|584754613|FG000|Overall Study|Protocol Violation|1|||
161920430|NCT02555878|584754614|FG001|Overall Study|Protocol Violation|2|||
161920431|NCT02555878|584754613|FG000|Overall Study|Physician Decision|12|||
161920432|NCT02555878|584754614|FG001|Overall Study|Physician Decision|13|||
161920433|NCT02555878|584754613|FG000|Overall Study|Other|17|||
161920434|NCT02555878|584754614|FG001|Overall Study|Other|17|||
161920435|NCT00765076|584754615|FG000|Overall Study|Adverse Event|1|||
161920436|NCT00765076|584754616|FG001|Overall Study|Adverse Event|0|||
161920437|NCT00765076|584754617|FG002|Overall Study|Adverse Event|0|||
161920438|NCT00765076|584754615|FG000|Overall Study|Withdrawal by Subject|0|||
161920439|NCT00765076|584754616|FG001|Overall Study|Withdrawal by Subject|0|||
161920440|NCT00765076|584754617|FG002|Overall Study|Withdrawal by Subject|1|||
161920441|NCT01164475|584754618|FG000|Overall Study|Lack of Efficacy|1|||
161920442|NCT01164475|584754619|FG001|Overall Study|Lack of Efficacy|0|||
161920443|NCT01164475|584754618|FG000|Overall Study|Other|0|||
161920444|NCT01164475|584754619|FG001|Overall Study|Other|1|||
161920445|NCT01164475|584754618|FG000|Overall Study|Progressive disease|0|||
161920446|NCT01164475|584754619|FG001|Overall Study|Progressive disease|1|||
161920447|NCT01164475|584754618|FG000|Overall Study|Protocol Violation|1|||
161920448|NCT01164475|584754619|FG001|Overall Study|Protocol Violation|0|||
161920449|NCT02335944|584754620|FG000|Treatment Phase|Progressive Disease|2|||
161920450|NCT02335944|584754621|FG001|Treatment Phase|Progressive Disease|5|||
161920451|NCT02335944|584754622|FG002|Treatment Phase|Progressive Disease|2|||
161920452|NCT02335944|584754623|FG003|Treatment Phase|Progressive Disease|11|||
161920453|NCT02335944|584754624|FG004|Treatment Phase|Progressive Disease|4|||
161920454|NCT02335944|584754625|FG005|Treatment Phase|Progressive Disease|25|||
161920455|NCT02335944|584754626|FG006|Treatment Phase|Progressive Disease|2|||
161920456|NCT02335944|584754627|FG007|Treatment Phase|Progressive Disease|30|||
161920457|NCT02335944|584754628|FG008|Treatment Phase|Progressive Disease|27|||
162161867|NCT01261312|585643760|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
162161868|NCT01261312|585643748|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161920458|NCT02335944|584754629|FG009|Treatment Phase|Progressive Disease|0|||
161920459|NCT02335944|584754620|FG000|Treatment Phase|Adverse Event|2|||
161920460|NCT02335944|584754621|FG001|Treatment Phase|Adverse Event|0|||
161920461|NCT02335944|584754622|FG002|Treatment Phase|Adverse Event|0|||
161920462|NCT02335944|584754623|FG003|Treatment Phase|Adverse Event|2|||
161920463|NCT02335944|584754624|FG004|Treatment Phase|Adverse Event|1|||
161920464|NCT02335944|584754625|FG005|Treatment Phase|Adverse Event|15|||
161920465|NCT02335944|584754626|FG006|Treatment Phase|Adverse Event|0|||
161920466|NCT02335944|584754627|FG007|Treatment Phase|Adverse Event|5|||
161920467|NCT02335944|584754628|FG008|Treatment Phase|Adverse Event|7|||
161920468|NCT02335944|584754629|FG009|Treatment Phase|Adverse Event|0|||
161920469|NCT02335944|584754620|FG000|Treatment Phase|Physician Decision|0|||
161920470|NCT02335944|584754621|FG001|Treatment Phase|Physician Decision|0|||
161920471|NCT02335944|584754622|FG002|Treatment Phase|Physician Decision|0|||
161920472|NCT02335944|584754623|FG003|Treatment Phase|Physician Decision|1|||
161920473|NCT02335944|584754624|FG004|Treatment Phase|Physician Decision|0|||
161920474|NCT02335944|584754625|FG005|Treatment Phase|Physician Decision|6|||
161920475|NCT02335944|584754626|FG006|Treatment Phase|Physician Decision|1|||
161920476|NCT02335944|584754627|FG007|Treatment Phase|Physician Decision|2|||
161920477|NCT02335944|584754628|FG008|Treatment Phase|Physician Decision|1|||
161920478|NCT02335944|584754629|FG009|Treatment Phase|Physician Decision|0|||
161920479|NCT02335944|584754620|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
161920480|NCT02335944|584754621|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
161920481|NCT02335944|584754622|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
161920482|NCT02335944|584754623|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
161920483|NCT02335944|584754624|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
161920484|NCT02335944|584754625|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
161920485|NCT02335944|584754626|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
161920486|NCT02335944|584754627|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
161920487|NCT02335944|584754628|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
161920488|NCT02335944|584754629|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
161920489|NCT02335944|584754620|FG000|Treatment Phase|Subject/Guardian Decision|0|||
161920490|NCT02335944|584754621|FG001|Treatment Phase|Subject/Guardian Decision|0|||
161920491|NCT02335944|584754622|FG002|Treatment Phase|Subject/Guardian Decision|1|||
161920492|NCT02335944|584754623|FG003|Treatment Phase|Subject/Guardian Decision|0|||
161920493|NCT02335944|584754624|FG004|Treatment Phase|Subject/Guardian Decision|0|||
161920494|NCT02335944|584754625|FG005|Treatment Phase|Subject/Guardian Decision|1|||
161920495|NCT02335944|584754626|FG006|Treatment Phase|Subject/Guardian Decision|0|||
161920496|NCT02335944|584754627|FG007|Treatment Phase|Subject/Guardian Decision|4|||
161920497|NCT02335944|584754628|FG008|Treatment Phase|Subject/Guardian Decision|0|||
161920498|NCT02335944|584754629|FG009|Treatment Phase|Subject/Guardian Decision|0|||
161920499|NCT02335944|584754620|FG000|Post-treatment Follow-up|Progressive Disease|0|||
161920500|NCT02335944|584754621|FG001|Post-treatment Follow-up|Progressive Disease|0|||
161920501|NCT02335944|584754622|FG002|Post-treatment Follow-up|Progressive Disease|0|||
162016637|NCT02405442|585116253|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
162016638|NCT02405442|585116254|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
162016639|NCT02405442|585116255|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
162016640|NCT02405442|585116256|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
162016641|NCT02405442|585116253|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
162016642|NCT02405442|585116254|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
162016643|NCT02405442|585116255|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
162016644|NCT02405442|585116256|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
162016645|NCT01499277|585116259|FG000|Overall Study|Adverse Event|3|||
162016646|NCT01499277|585116260|FG001|Overall Study|Adverse Event|6|||
162016647|NCT01499277|585116259|FG000|Overall Study|Death|3|||
162016648|NCT01499277|585116260|FG001|Overall Study|Death|2|||
162016649|NCT01499277|585116259|FG000|Overall Study|Lost to Follow-up|15|||
162016650|NCT01499277|585116260|FG001|Overall Study|Lost to Follow-up|8|||
162016651|NCT01499277|585116259|FG000|Overall Study|Protocol Violation|2|||
162016652|NCT01499277|585116260|FG001|Overall Study|Protocol Violation|3|||
162016653|NCT01499277|585116259|FG000|Overall Study|Withdrawal by Subject|16|||
162016654|NCT01499277|585116260|FG001|Overall Study|Withdrawal by Subject|6|||
162016655|NCT01499277|585116259|FG000|Overall Study|Lack of therapeutic response and other|8|||
161920502|NCT02335944|584754623|FG003|Post-treatment Follow-up|Progressive Disease|1|||
161920503|NCT02335944|584754624|FG004|Post-treatment Follow-up|Progressive Disease|0|||
161920504|NCT02335944|584754625|FG005|Post-treatment Follow-up|Progressive Disease|9|||
161920505|NCT02335944|584754626|FG006|Post-treatment Follow-up|Progressive Disease|0|||
161920506|NCT02335944|584754627|FG007|Post-treatment Follow-up|Progressive Disease|2|||
161920507|NCT02335944|584754628|FG008|Post-treatment Follow-up|Progressive Disease|3|||
161920508|NCT02335944|584754629|FG009|Post-treatment Follow-up|Progressive Disease|0|||
161920509|NCT02335944|584754620|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
162016656|NCT01499277|585116260|FG001|Overall Study|Lack of therapeutic response and other|7|||
162016657|NCT00372593|585116261|FG000|Overall Study|Adverse Event|43|||
161920510|NCT02335944|584754621|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920511|NCT02335944|584754622|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920512|NCT02335944|584754623|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920513|NCT02335944|584754624|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161814816|NCT00205777|584365389|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
161814817|NCT00205777|584365390|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
161814818|NCT00205777|584365391|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
161814819|NCT00205777|584365392|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
161814820|NCT00205777|584365393|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
161814821|NCT00205777|584365388|FG000|Study Extension II|Adverse Event|0|||
161814822|NCT00205777|584365389|FG001|Study Extension II|Adverse Event|0|||
161814823|NCT00205777|584365390|FG002|Study Extension II|Adverse Event|0|||
161814824|NCT00205777|584365391|FG003|Study Extension II|Adverse Event|14|||
161814825|NCT00205777|584365392|FG004|Study Extension II|Adverse Event|0|||
161814826|NCT00205777|584365393|FG005|Study Extension II|Adverse Event|30|||
161814827|NCT00205777|584365388|FG000|Study Extension II|Death|0|||
161814828|NCT00205777|584365389|FG001|Study Extension II|Death|0|||
161814829|NCT00205777|584365390|FG002|Study Extension II|Death|0|||
162161869|NCT01261312|585643749|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162161870|NCT01261312|585643750|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162161871|NCT01261312|585643751|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162161872|NCT01261312|585643752|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162161873|NCT01261312|585643753|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162161874|NCT01261312|585643754|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
161920514|NCT02335944|584754625|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
161920515|NCT02335944|584754626|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920516|NCT02335944|584754627|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920517|NCT02335944|584754628|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920518|NCT02335944|584754629|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161920519|NCT02335944|584754620|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
162161875|NCT01261312|585643755|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
162161876|NCT01261312|585643756|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
162161877|NCT01261312|585643757|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162161878|NCT01261312|585643758|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162161879|NCT01261312|585643759|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162161880|NCT01261312|585643760|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
162161881|NCT01261312|585643748|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
162161882|NCT01261312|585643749|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
162161883|NCT01261312|585643750|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
162161884|NCT01261312|585643751|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
162161885|NCT01261312|585643752|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
162161886|NCT01261312|585643753|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
161920520|NCT02335944|584754621|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920521|NCT02335944|584754622|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
162161887|NCT01261312|585643754|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
162161888|NCT01261312|585643755|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
162161889|NCT01261312|585643756|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
162161890|NCT01261312|585643757|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
162161891|NCT01261312|585643758|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
162161892|NCT01261312|585643759|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
162161893|NCT01261312|585643760|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
162161894|NCT01261312|585643748|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162161895|NCT01261312|585643749|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162161896|NCT01261312|585643750|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162161897|NCT01261312|585643751|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162161898|NCT01261312|585643752|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162161899|NCT01261312|585643753|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162016658|NCT00372593|585116262|FG001|Overall Study|Adverse Event|45|||
162016659|NCT00372593|585116263|FG002|Overall Study|Adverse Event|0|||
162016660|NCT00372593|585116261|FG000|Overall Study|Death|16|||
162016661|NCT00372593|585116262|FG001|Overall Study|Death|20|||
162016662|NCT00372593|585116263|FG002|Overall Study|Death|1|||
162016663|NCT00372593|585116261|FG000|Overall Study|Lack of Efficacy|82|||
161920522|NCT02335944|584754623|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920523|NCT02335944|584754624|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920524|NCT02335944|584754625|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920525|NCT02335944|584754626|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920526|NCT02335944|584754627|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
161920527|NCT02335944|584754628|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920528|NCT02335944|584754629|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
161920529|NCT02335944|584754620|FG000|Post-treatment Follow-up|Adverse Event|0|||
161920530|NCT02335944|584754621|FG001|Post-treatment Follow-up|Adverse Event|0|||
161920531|NCT02335944|584754622|FG002|Post-treatment Follow-up|Adverse Event|0|||
161920532|NCT02335944|584754623|FG003|Post-treatment Follow-up|Adverse Event|0|||
161920533|NCT02335944|584754624|FG004|Post-treatment Follow-up|Adverse Event|0|||
161920534|NCT02335944|584754625|FG005|Post-treatment Follow-up|Adverse Event|1|||
161920535|NCT02335944|584754626|FG006|Post-treatment Follow-up|Adverse Event|0|||
161920536|NCT02335944|584754627|FG007|Post-treatment Follow-up|Adverse Event|0|||
161920537|NCT02335944|584754628|FG008|Post-treatment Follow-up|Adverse Event|0|||
161920538|NCT02335944|584754629|FG009|Post-treatment Follow-up|Adverse Event|0|||
161920539|NCT02335944|584754620|FG000|Post-treatment Follow-up|Death|0|||
161920540|NCT02335944|584754621|FG001|Post-treatment Follow-up|Death|0|||
161920541|NCT02335944|584754622|FG002|Post-treatment Follow-up|Death|0|||
161920542|NCT02335944|584754623|FG003|Post-treatment Follow-up|Death|1|||
161920543|NCT02335944|584754624|FG004|Post-treatment Follow-up|Death|0|||
161920544|NCT02335944|584754625|FG005|Post-treatment Follow-up|Death|1|||
161920545|NCT02335944|584754626|FG006|Post-treatment Follow-up|Death|0|||
162016664|NCT00372593|585116262|FG001|Overall Study|Lack of Efficacy|71|||
162016665|NCT00372593|585116263|FG002|Overall Study|Lack of Efficacy|2|||
162016666|NCT00372593|585116261|FG000|Overall Study|Lost to Follow-up|1|||
162016667|NCT00372593|585116262|FG001|Overall Study|Lost to Follow-up|0|||
162016668|NCT00372593|585116263|FG002|Overall Study|Lost to Follow-up|0|||
162016669|NCT00372593|585116261|FG000|Overall Study|Physician Decision|42|||
162016670|NCT00372593|585116262|FG001|Overall Study|Physician Decision|41|||
162016671|NCT00372593|585116263|FG002|Overall Study|Physician Decision|0|||
162016672|NCT00372593|585116261|FG000|Overall Study|Ineligible|20|||
162016673|NCT00372593|585116262|FG001|Overall Study|Ineligible|21|||
162016674|NCT00372593|585116263|FG002|Overall Study|Ineligible|1|||
162016675|NCT00330967|585116264|FG000|Overall Study|Withdrawal by Subject|0|||
162016676|NCT00330967|585116265|FG001|Overall Study|Withdrawal by Subject|5|||
162016677|NCT00330967|585116264|FG000|Overall Study|Physician Decision|0|||
162161900|NCT01261312|585643754|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
162161901|NCT01261312|585643755|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
161920546|NCT02335944|584754627|FG007|Post-treatment Follow-up|Death|0|||
161920547|NCT02335944|584754628|FG008|Post-treatment Follow-up|Death|0|||
161920548|NCT02335944|584754629|FG009|Post-treatment Follow-up|Death|0|||
161920549|NCT02335944|584754620|FG000|Post-treatment Follow-up|Physician Decision|1|||
161920550|NCT02335944|584754621|FG001|Post-treatment Follow-up|Physician Decision|0|||
161920551|NCT02335944|584754622|FG002|Post-treatment Follow-up|Physician Decision|0|||
162016678|NCT00330967|585116265|FG001|Overall Study|Physician Decision|9|||
162016679|NCT01317277|585116268|FG000|Overall Study|Lost to Follow-up|3|||
162016680|NCT01317277|585116269|FG001|Overall Study|Lost to Follow-up|1|||
162161902|NCT01261312|585643756|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
162161903|NCT01261312|585643757|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162161904|NCT01261312|585643758|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162161905|NCT01261312|585643759|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162161906|NCT01261312|585643760|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
162161907|NCT01261312|585643748|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162161908|NCT01261312|585643749|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162161909|NCT01261312|585643750|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162161910|NCT01261312|585643751|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162161911|NCT01261312|585643752|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162161912|NCT01261312|585643753|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162161913|NCT01261312|585643754|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
162161914|NCT01261312|585643755|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
162161915|NCT01261312|585643756|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
162161916|NCT01261312|585643757|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162161917|NCT01261312|585643758|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162161918|NCT01261312|585643759|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162161919|NCT01261312|585643760|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
162161920|NCT01261312|585643748|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161920552|NCT02335944|584754623|FG003|Post-treatment Follow-up|Physician Decision|0|||
162016681|NCT01317277|585116268|FG000|Overall Study|Lost MEMS|1|||
162016682|NCT01317277|585116269|FG001|Overall Study|Lost MEMS|1|||
161920553|NCT02335944|584754624|FG004|Post-treatment Follow-up|Physician Decision|0|||
161920554|NCT02335944|584754625|FG005|Post-treatment Follow-up|Physician Decision|0|||
161920555|NCT02335944|584754626|FG006|Post-treatment Follow-up|Physician Decision|0|||
161920556|NCT02335944|584754627|FG007|Post-treatment Follow-up|Physician Decision|1|||
161920557|NCT02335944|584754628|FG008|Post-treatment Follow-up|Physician Decision|0|||
161920558|NCT02335944|584754629|FG009|Post-treatment Follow-up|Physician Decision|0|||
161920559|NCT00832975|584754630|FG000|Overall Study|Lost to Follow-up|7|||
161920560|NCT00832975|584754630|FG000|Overall Study|Protocol Violation|6|||
161814830|NCT00205777|584365391|FG003|Study Extension II|Death|2|||
161814831|NCT00205777|584365392|FG004|Study Extension II|Death|0|||
161814832|NCT00205777|584365393|FG005|Study Extension II|Death|5|||
161814833|NCT00205777|584365388|FG000|Study Extension II|Withdrawal by Subject|0|||
161814834|NCT00205777|584365389|FG001|Study Extension II|Withdrawal by Subject|0|||
161814835|NCT00205777|584365390|FG002|Study Extension II|Withdrawal by Subject|0|||
161814836|NCT00205777|584365391|FG003|Study Extension II|Withdrawal by Subject|35|||
161814837|NCT00205777|584365392|FG004|Study Extension II|Withdrawal by Subject|0|||
161814838|NCT00205777|584365393|FG005|Study Extension II|Withdrawal by Subject|59|||
161814839|NCT00205777|584365388|FG000|Study Extension II|Protocol Violation|0|||
161814840|NCT00205777|584365389|FG001|Study Extension II|Protocol Violation|0|||
161814841|NCT00205777|584365390|FG002|Study Extension II|Protocol Violation|0|||
161814842|NCT00205777|584365391|FG003|Study Extension II|Protocol Violation|1|||
162016683|NCT01317277|585116268|FG000|Overall Study|Unable to comply with intervention|1|||
161920561|NCT00832975|584754630|FG000|Overall Study|Death|5|||
161920562|NCT00832975|584754630|FG000|Overall Study|Physician Decision|4|||
161920563|NCT00832975|584754630|FG000|Overall Study|Withdrawal by Subject|3|||
161920564|NCT00832975|584754630|FG000|Overall Study|Other reasons|14|||
161920565|NCT06081829|584754633|FG000|Overall Study|Participants still on-study|8|||
161920566|NCT06081829|584754633|FG000|Overall Study|Death|4|||
161920567|NCT01525589|584754634|FG000|Overall Study|Non-treatment-related AE|1|||
161920568|NCT01525589|584754635|FG001|Overall Study|Non-treatment-related AE|0|||
161920569|NCT01525589|584754636|FG002|Overall Study|Non-treatment-related AE|0|||
161920570|NCT01525589|584754634|FG000|Overall Study|Progressive disease|48|||
161920571|NCT01525589|584754635|FG001|Overall Study|Progressive disease|15|||
161920572|NCT01525589|584754636|FG002|Overall Study|Progressive disease|29|||
161920573|NCT01525589|584754634|FG000|Overall Study|Never treated|2|||
161920574|NCT01525589|584754635|FG001|Overall Study|Never treated|0|||
161920575|NCT01525589|584754636|FG002|Overall Study|Never treated|0|||
161920576|NCT01525589|584754634|FG000|Overall Study|Physician Decision|4|||
161920577|NCT01525589|584754635|FG001|Overall Study|Physician Decision|2|||
162161921|NCT01261312|585643749|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162161922|NCT01261312|585643750|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162161923|NCT01261312|585643751|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162161924|NCT01261312|585643752|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162161925|NCT01261312|585643753|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162161926|NCT01261312|585643754|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
162161927|NCT01261312|585643755|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
162161928|NCT01261312|585643756|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
162161929|NCT01261312|585643757|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162161930|NCT01261312|585643758|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162161931|NCT01261312|585643759|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162161932|NCT01261312|585643760|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
162161933|NCT01261312|585643748|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162161934|NCT01261312|585643749|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162161935|NCT01261312|585643750|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162161936|NCT01261312|585643751|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162161937|NCT01261312|585643752|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162161938|NCT01261312|585643753|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162161939|NCT01261312|585643754|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162161940|NCT01261312|585643755|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162161941|NCT01261312|585643756|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
162161942|NCT01261312|585643757|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
162161943|NCT01261312|585643758|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
162161944|NCT01261312|585643759|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
162161945|NCT01261312|585643760|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
162161946|NCT01261312|585643748|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162161947|NCT01261312|585643749|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162161948|NCT01261312|585643750|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162161949|NCT01261312|585643751|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162161950|NCT01261312|585643752|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162161951|NCT01261312|585643753|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162161952|NCT01261312|585643754|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162161953|NCT01261312|585643755|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162161954|NCT01261312|585643756|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162161955|NCT01261312|585643757|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
162161956|NCT01261312|585643758|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
162161957|NCT01261312|585643759|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
162161958|NCT01261312|585643760|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
162161959|NCT01261312|585643748|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162161960|NCT01261312|585643749|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162161961|NCT01261312|585643750|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162161962|NCT01261312|585643751|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162161963|NCT01261312|585643752|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162161964|NCT01261312|585643753|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162161965|NCT01261312|585643754|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162161966|NCT01261312|585643755|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162161967|NCT01261312|585643756|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
162161968|NCT01261312|585643757|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
162161969|NCT01261312|585643758|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
161920578|NCT01525589|584754636|FG002|Overall Study|Physician Decision|2|||
162161970|NCT01261312|585643759|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
162161971|NCT01261312|585643760|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
162161972|NCT01261312|585643748|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162161973|NCT01261312|585643749|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162161974|NCT01261312|585643750|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162161975|NCT01261312|585643751|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162161976|NCT01261312|585643752|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162161977|NCT01261312|585643753|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162161978|NCT01261312|585643754|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162161979|NCT01261312|585643755|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161920579|NCT01525589|584754634|FG000|Overall Study|Death|0|||
161920580|NCT01525589|584754635|FG001|Overall Study|Death|0|||
161920581|NCT01525589|584754636|FG002|Overall Study|Death|2|||
161920582|NCT01525589|584754634|FG000|Overall Study|Treatment-related AE|1|||
161920583|NCT01525589|584754635|FG001|Overall Study|Treatment-related AE|1|||
161920584|NCT01525589|584754636|FG002|Overall Study|Treatment-related AE|2|||
161920585|NCT01525589|584754634|FG000|Overall Study|Other reasons|0|||
161920586|NCT01525589|584754635|FG001|Overall Study|Other reasons|1|||
161920587|NCT01525589|584754636|FG002|Overall Study|Other reasons|0|||
161920588|NCT01525589|584754634|FG000|Overall Study|Withdrawal by Subject|0|||
161920589|NCT01525589|584754635|FG001|Overall Study|Withdrawal by Subject|1|||
161920590|NCT01525589|584754636|FG002|Overall Study|Withdrawal by Subject|0|||
161920591|NCT04835441|584754638|FG000|Overall Study|Physician Decision|4|||
161920592|NCT04835441|584754639|FG001|Overall Study|Physician Decision|4|||
161920593|NCT04835441|584754638|FG000|Overall Study|Other|1|||
161920594|NCT04835441|584754639|FG001|Overall Study|Other|1|||
161920595|NCT04835441|584754638|FG000|Overall Study|Lost to Follow-up|0|||
161920596|NCT04835441|584754639|FG001|Overall Study|Lost to Follow-up|1|||
161920597|NCT05253807|584754640|FG000|Overall Study|Death|1|||
161920598|NCT05253807|584754641|FG001|Overall Study|Death|4|||
161920599|NCT05253807|584754640|FG000|Overall Study|Withdrawal by Subject|1|||
161920600|NCT05253807|584754641|FG001|Overall Study|Withdrawal by Subject|0|||
161920601|NCT05253807|584754640|FG000|Overall Study|Study Terminated by Sponsor|1|||
161920602|NCT05253807|584754641|FG001|Overall Study|Study Terminated by Sponsor|1|||
161920603|NCT02145390|584754644|FG000|Overall Study|Withdrawal by Subject|1|||
161920604|NCT02293499|584755757|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
161942207|NCT02082977|584838337|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161814843|NCT00205777|584365392|FG004|Study Extension II|Protocol Violation|0|||
161814844|NCT00205777|584365393|FG005|Study Extension II|Protocol Violation|10|||
161814845|NCT00205777|584365388|FG000|Study Extension II|Lack of Efficacy|0|||
161814846|NCT00205777|584365389|FG001|Study Extension II|Lack of Efficacy|0|||
161814847|NCT00205777|584365390|FG002|Study Extension II|Lack of Efficacy|0|||
162016684|NCT01317277|585116269|FG001|Overall Study|Unable to comply with intervention|0|||
162016685|NCT01317277|585116268|FG000|Overall Study|Withdrawal by Subject|1|||
162016686|NCT01317277|585116269|FG001|Overall Study|Withdrawal by Subject|0|||
162016687|NCT01317277|585116268|FG000|Overall Study|Adverse Event|1|||
162016688|NCT01317277|585116269|FG001|Overall Study|Adverse Event|0|||
162016689|NCT00473382|585116274|FG000|Core Study|Adverse Event|3|||
162016690|NCT00473382|585116275|FG001|Core Study|Adverse Event|1|||
162016691|NCT00473382|585116276|FG002|Core Study|Adverse Event|1|||
162016692|NCT00473382|585116274|FG000|Core Study|Death|3|||
162016693|NCT00473382|585116275|FG001|Core Study|Death|5|||
162016694|NCT00473382|585116276|FG002|Core Study|Death|10|||
162016695|NCT00473382|585116274|FG000|Core Study|Lost to Follow-up|3|||
162016696|NCT00473382|585116275|FG001|Core Study|Lost to Follow-up|3|||
162016697|NCT00473382|585116276|FG002|Core Study|Lost to Follow-up|3|||
162016698|NCT00473382|585116274|FG000|Core Study|Physician Decision|1|||
162016699|NCT00473382|585116275|FG001|Core Study|Physician Decision|2|||
162016700|NCT00473382|585116276|FG002|Core Study|Physician Decision|2|||
162016701|NCT00473382|585116274|FG000|Core Study|Subject non-compliance|5|||
162016702|NCT00473382|585116275|FG001|Core Study|Subject non-compliance|2|||
162016703|NCT00473382|585116276|FG002|Core Study|Subject non-compliance|1|||
162016704|NCT00473382|585116274|FG000|Core Study|Subject needed other treatment|1|||
162016705|NCT00473382|585116275|FG001|Core Study|Subject needed other treatment|3|||
162016706|NCT00473382|585116276|FG002|Core Study|Subject needed other treatment|2|||
162016707|NCT00473382|585116274|FG000|Core Study|Subject's decision|12|||
162016708|NCT00473382|585116275|FG001|Core Study|Subject's decision|11|||
162016709|NCT00473382|585116276|FG002|Core Study|Subject's decision|10|||
162016710|NCT00473382|585116274|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
162016711|NCT00473382|585116275|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
162016712|NCT00473382|585116276|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
162016713|NCT00473382|585116274|FG000|Open-label Extension Through Month 48|Death|1|||
162016714|NCT00473382|585116275|FG001|Open-label Extension Through Month 48|Death|3|||
162016715|NCT00473382|585116276|FG002|Open-label Extension Through Month 48|Death|3|||
162016716|NCT00473382|585116274|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
162016717|NCT00473382|585116275|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
162016718|NCT00473382|585116276|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
162016719|NCT00473382|585116274|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
162016720|NCT00473382|585116275|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
162016721|NCT00473382|585116276|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
162016722|NCT00473382|585116274|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
161920605|NCT02293499|584755758|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
161920606|NCT02293499|584755759|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
161920607|NCT02293499|584755757|FG000|Intervention - Camp|Withdrawal by Subject|3|||
161920608|NCT02293499|584755758|FG001|Intervention - Camp|Withdrawal by Subject|6|||
161920609|NCT02293499|584755759|FG002|Intervention - Camp|Withdrawal by Subject|2|||
161920610|NCT02293499|584755757|FG000|Intervention - Camp|these are those not showing up at camp|24|||
161920611|NCT02293499|584755758|FG001|Intervention - Camp|these are those not showing up at camp|28|||
161920612|NCT02293499|584755759|FG002|Intervention - Camp|these are those not showing up at camp|4|||
161920613|NCT02293499|584755757|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
161920614|NCT02293499|584755758|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
161920615|NCT02293499|584755759|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
161920616|NCT02293499|584755757|FG000|3 Month Follow Up|Lost to Follow-up|14|||
161920617|NCT02293499|584755758|FG001|3 Month Follow Up|Lost to Follow-up|15|||
161920618|NCT02293499|584755759|FG002|3 Month Follow Up|Lost to Follow-up|6|||
161920619|NCT02293499|584755757|FG000|6 Month Follow Up|Lost to Follow-up|17|||
161920620|NCT02293499|584755758|FG001|6 Month Follow Up|Lost to Follow-up|27|||
161920621|NCT02293499|584755759|FG002|6 Month Follow Up|Lost to Follow-up|6|||
161920622|NCT02293499|584755757|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
161920623|NCT02293499|584755758|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
161920624|NCT02293499|584755759|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
161920625|NCT02293499|584755757|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
161920626|NCT02293499|584755758|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
161920627|NCT02293499|584755759|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
161920628|NCT02293499|584755757|FG000|9 Month Follow Up|Lost to Follow-up|24|||
161920629|NCT02293499|584755758|FG001|9 Month Follow Up|Lost to Follow-up|28|||
161920630|NCT02293499|584755759|FG002|9 Month Follow Up|Lost to Follow-up|4|||
161920631|NCT02293499|584755757|FG000|12 Month Follow Up|Lost to Follow-up|26|||
161920632|NCT02293499|584755758|FG001|12 Month Follow Up|Lost to Follow-up|25|||
161920633|NCT02293499|584755759|FG002|12 Month Follow Up|Lost to Follow-up|6|||
161920634|NCT02293499|584755757|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
161920635|NCT02293499|584755758|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
161920636|NCT02293499|584755759|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
161920637|NCT02293499|584755757|FG000|15 Month Follow Up|Lost to Follow-up|22|||
161920638|NCT02293499|584755758|FG001|15 Month Follow Up|Lost to Follow-up|22|||
161920639|NCT02293499|584755759|FG002|15 Month Follow Up|Lost to Follow-up|7|||
161920640|NCT05977868|584755760|FG000|Overall Study|Withdrawal by Subject|1|||
161920641|NCT05977868|584755761|FG001|Overall Study|Withdrawal by Subject|2|||
161920642|NCT05977868|584755760|FG000|Overall Study|Transitioned to comfort care|1|||
161920643|NCT05977868|584755761|FG001|Overall Study|Transitioned to comfort care|0|||
161920644|NCT00876395|584755762|FG000|Overall Study|Untreated|8|||
161920645|NCT00876395|584755763|FG001|Overall Study|Untreated|1|||
161920646|NCT00876395|584755762|FG000|Overall Study|Adverse Event|63|||
161920647|NCT00876395|584755763|FG001|Overall Study|Adverse Event|11|||
161920648|NCT00876395|584755762|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161920649|NCT00876395|584755763|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161920650|NCT00876395|584755762|FG000|Overall Study|Disease progression|259|||
161920651|NCT00876395|584755763|FG001|Overall Study|Disease progression|162|||
161920652|NCT00876395|584755762|FG000|Overall Study|New cancer therapy|25|||
161920653|NCT00876395|584755763|FG001|Overall Study|New cancer therapy|7|||
161920654|NCT00876395|584755762|FG000|Overall Study|Protocol Violation|5|||
161920655|NCT00876395|584755763|FG001|Overall Study|Protocol Violation|2|||
161920656|NCT00876395|584755762|FG000|Overall Study|Withdrawal by Subject|66|||
161920657|NCT00876395|584755763|FG001|Overall Study|Withdrawal by Subject|33|||
161920658|NCT00876395|584755762|FG000|Overall Study|Lost to Follow-up|2|||
161920659|NCT00876395|584755763|FG001|Overall Study|Lost to Follow-up|0|||
161920660|NCT00876395|584755762|FG000|Overall Study|Administrative problems|39|||
161920661|NCT00876395|584755763|FG001|Overall Study|Administrative problems|23|||
161920662|NCT00876395|584755762|FG000|Overall Study|Death|12|||
161920663|NCT00876395|584755763|FG001|Overall Study|Death|0|||
161920664|NCT01787838|584755772|FG000|Overall Study|refused|1413|||
161920665|NCT01991314|584755791|FG000|Overall Study|Adverse Event|5|||
161920666|NCT01991314|584755792|FG001|Overall Study|Adverse Event|1|||
161920667|NCT01991314|584755791|FG000|Overall Study|Lost to Follow-up|6|||
161920668|NCT01991314|584755792|FG001|Overall Study|Lost to Follow-up|10|||
161920669|NCT03915067|584755794|FG000|Overall Study|Adverse Event|0|||
161920670|NCT03915067|584755795|FG001|Overall Study|Adverse Event|0|||
161920671|NCT03915067|584755796|FG002|Overall Study|Adverse Event|1|||
161920672|NCT03915067|584755794|FG000|Overall Study|Withdrawal by Subject|4|||
161920673|NCT03915067|584755795|FG001|Overall Study|Withdrawal by Subject|3|||
161920674|NCT03915067|584755796|FG002|Overall Study|Withdrawal by Subject|0|||
161920675|NCT03915067|584755794|FG000|Overall Study|Lost to Follow-up|3|||
161920676|NCT03915067|584755795|FG001|Overall Study|Lost to Follow-up|2|||
161920677|NCT03915067|584755796|FG002|Overall Study|Lost to Follow-up|0|||
161920678|NCT03915067|584755794|FG000|Overall Study|Protocol Deviation|0|||
161920679|NCT03915067|584755795|FG001|Overall Study|Protocol Deviation|0|||
161920680|NCT03915067|584755796|FG002|Overall Study|Protocol Deviation|1|||
161920681|NCT03915067|584755794|FG000|Overall Study|Covid-19 Related Issues|2|||
161920682|NCT03915067|584755795|FG001|Overall Study|Covid-19 Related Issues|4|||
161920683|NCT03915067|584755796|FG002|Overall Study|Covid-19 Related Issues|4|||
161920684|NCT03915067|584755794|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
161920685|NCT03915067|584755795|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
161920686|NCT03915067|584755796|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
161920687|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
161920688|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
161920689|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
161920690|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
161920691|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
161920692|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
161920693|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
161920694|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
161920695|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
161920696|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
161920697|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Death|0|||
161920698|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Death|0|||
161920699|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Death|1|||
161920700|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Death|0|||
161920701|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Death|0|||
162016723|NCT00473382|585116275|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
162016724|NCT00473382|585116276|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
162016725|NCT00473382|585116274|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
162016726|NCT00473382|585116275|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
162016727|NCT00473382|585116276|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
162016728|NCT00473382|585116274|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
162016729|NCT00473382|585116275|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
162016730|NCT00473382|585116276|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
162016731|NCT00473382|585116274|FG000|Open-label Extension Through Month 60|Death|1|||
161920702|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
161920703|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
161920704|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
161920705|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
161920706|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
161920707|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Other|2|||
161920708|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Other|1|||
161920709|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Other|0|||
161920710|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Other|0|||
161920711|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Other|0|||
161920712|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
161920713|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
161920714|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
161920715|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
161920716|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
161920717|NCT03317496|584755797|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
161920718|NCT03317496|584755798|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
161920719|NCT03317496|584755799|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
161920720|NCT03317496|584755800|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
161920721|NCT03317496|584755801|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
161920722|NCT03317496|584755797|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
161920723|NCT03317496|584755798|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
161920724|NCT03317496|584755799|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
161920725|NCT03317496|584755800|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
161920726|NCT03317496|584755801|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
161920727|NCT03317496|584755797|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
161920728|NCT03317496|584755798|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
161920729|NCT03317496|584755799|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
161920730|NCT03317496|584755800|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
161920731|NCT03317496|584755801|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
161920732|NCT03317496|584755797|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
162016732|NCT00473382|585116275|FG001|Open-label Extension Through Month 60|Death|7|||
161920733|NCT03317496|584755798|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
161920734|NCT03317496|584755799|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
161920735|NCT03317496|584755800|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
161920736|NCT03317496|584755801|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
161920737|NCT03317496|584755797|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
161920738|NCT03317496|584755798|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
161920739|NCT03317496|584755799|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
161920740|NCT03317496|584755800|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
161920741|NCT03317496|584755801|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
161920742|NCT03317496|584755797|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
161920743|NCT03317496|584755798|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
161920744|NCT03317496|584755799|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
161814848|NCT00205777|584365391|FG003|Study Extension II|Lack of Efficacy|0|||
161814849|NCT00205777|584365392|FG004|Study Extension II|Lack of Efficacy|0|||
161814850|NCT00205777|584365393|FG005|Study Extension II|Lack of Efficacy|1|||
161814851|NCT00205777|584365388|FG000|Study Extension II|Failed to return|0|||
161814852|NCT00205777|584365389|FG001|Study Extension II|Failed to return|0|||
161814853|NCT00205777|584365390|FG002|Study Extension II|Failed to return|0|||
161814854|NCT00205777|584365391|FG003|Study Extension II|Failed to return|14|||
161814855|NCT00205777|584365392|FG004|Study Extension II|Failed to return|0|||
161814856|NCT00205777|584365393|FG005|Study Extension II|Failed to return|26|||
161814857|NCT00205777|584365388|FG000|Study Extension II|Other Event|0|||
161814858|NCT00205777|584365389|FG001|Study Extension II|Other Event|0|||
161814859|NCT00205777|584365390|FG002|Study Extension II|Other Event|0|||
161814860|NCT00205777|584365391|FG003|Study Extension II|Other Event|12|||
161814861|NCT00205777|584365392|FG004|Study Extension II|Other Event|0|||
161814862|NCT00205777|584365393|FG005|Study Extension II|Other Event|20|||
161814863|NCT00205777|584365388|FG000|Study Extension II|Enrolled but not treated|0|||
161814864|NCT00205777|584365389|FG001|Study Extension II|Enrolled but not treated|0|||
161814865|NCT00205777|584365390|FG002|Study Extension II|Enrolled but not treated|0|||
161814866|NCT00205777|584365391|FG003|Study Extension II|Enrolled but not treated|71|||
161814867|NCT00205777|584365392|FG004|Study Extension II|Enrolled but not treated|0|||
161814868|NCT00205777|584365393|FG005|Study Extension II|Enrolled but not treated|131|||
161814869|NCT00700739|584365397|FG000|Overall Study|Lost to Follow-up|4|||
161814870|NCT00700739|584365398|FG001|Overall Study|Lost to Follow-up|4|||
161814871|NCT00003470|584365402|FG000|Overall Study|Not evaluable|6|||
161814872|NCT02923349|584365415|FG000|Overall Study|Other|1|||
161814873|NCT02923349|584365416|FG001|Overall Study|Other|2|||
161814874|NCT02923349|584365417|FG002|Overall Study|Other|4|||
161814875|NCT02923349|584365418|FG003|Overall Study|Other|1|||
161814876|NCT02923349|584365419|FG004|Overall Study|Other|3|||
161814877|NCT02923349|584365420|FG005|Overall Study|Other|0|||
161814878|NCT02923349|584365421|FG006|Overall Study|Other|1|||
161814879|NCT02923349|584365415|FG000|Overall Study|Withdrawal by Subject|2|||
161814880|NCT02923349|584365416|FG001|Overall Study|Withdrawal by Subject|2|||
161814881|NCT02923349|584365417|FG002|Overall Study|Withdrawal by Subject|8|||
161814882|NCT02923349|584365418|FG003|Overall Study|Withdrawal by Subject|10|||
161920745|NCT03317496|584755800|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
161920746|NCT03317496|584755801|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
161920747|NCT03317496|584755797|FG000|Phase 2: Treatment|Adverse Event|0|||
161920748|NCT03317496|584755798|FG001|Phase 2: Treatment|Adverse Event|0|||
161920749|NCT03317496|584755799|FG002|Phase 2: Treatment|Adverse Event|0|||
161920750|NCT03317496|584755800|FG003|Phase 2: Treatment|Adverse Event|0|||
161920751|NCT03317496|584755801|FG004|Phase 2: Treatment|Adverse Event|6|||
161920752|NCT03317496|584755797|FG000|Phase 2: Treatment|Progressive disease|0|||
161920753|NCT03317496|584755798|FG001|Phase 2: Treatment|Progressive disease|0|||
161920754|NCT03317496|584755799|FG002|Phase 2: Treatment|Progressive disease|0|||
161920755|NCT03317496|584755800|FG003|Phase 2: Treatment|Progressive disease|0|||
161920756|NCT03317496|584755801|FG004|Phase 2: Treatment|Progressive disease|22|||
161920757|NCT03317496|584755797|FG000|Phase 2: Treatment|Other|0|||
161920758|NCT03317496|584755798|FG001|Phase 2: Treatment|Other|0|||
161920759|NCT03317496|584755799|FG002|Phase 2: Treatment|Other|0|||
161920760|NCT03317496|584755800|FG003|Phase 2: Treatment|Other|0|||
162016733|NCT00473382|585116276|FG002|Open-label Extension Through Month 60|Death|4|||
162016734|NCT00473382|585116274|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
162016735|NCT00473382|585116275|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
162016736|NCT00473382|585116276|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
162016737|NCT00473382|585116274|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
162016738|NCT00473382|585116275|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
162016739|NCT00473382|585116276|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
162016740|NCT00473382|585116274|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
161920761|NCT03317496|584755801|FG004|Phase 2: Treatment|Other|4|||
161920762|NCT03317496|584755797|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
161920763|NCT03317496|584755798|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
161814883|NCT02923349|584365419|FG004|Overall Study|Withdrawal by Subject|12|||
161814884|NCT02923349|584365420|FG005|Overall Study|Withdrawal by Subject|3|||
161814885|NCT02923349|584365421|FG006|Overall Study|Withdrawal by Subject|0|||
161814886|NCT02923349|584365415|FG000|Overall Study|Physician Decision|0|||
161814887|NCT02923349|584365416|FG001|Overall Study|Physician Decision|0|||
161814888|NCT02923349|584365417|FG002|Overall Study|Physician Decision|0|||
161814889|NCT02923349|584365418|FG003|Overall Study|Physician Decision|1|||
161814890|NCT02923349|584365419|FG004|Overall Study|Physician Decision|1|||
161814891|NCT02923349|584365420|FG005|Overall Study|Physician Decision|0|||
161814892|NCT02923349|584365421|FG006|Overall Study|Physician Decision|2|||
161814893|NCT02923349|584365415|FG000|Overall Study|Lost to Follow-up|0|||
161814894|NCT02923349|584365416|FG001|Overall Study|Lost to Follow-up|0|||
161814895|NCT02923349|584365417|FG002|Overall Study|Lost to Follow-up|3|||
161814896|NCT02923349|584365418|FG003|Overall Study|Lost to Follow-up|0|||
161814897|NCT02923349|584365419|FG004|Overall Study|Lost to Follow-up|1|||
161814898|NCT02923349|584365420|FG005|Overall Study|Lost to Follow-up|1|||
161814899|NCT02923349|584365421|FG006|Overall Study|Lost to Follow-up|0|||
161814900|NCT02923349|584365415|FG000|Overall Study|Death|1|||
161814901|NCT02923349|584365416|FG001|Overall Study|Death|0|||
161814902|NCT02923349|584365417|FG002|Overall Study|Death|2|||
161814903|NCT02923349|584365418|FG003|Overall Study|Death|4|||
161814904|NCT02923349|584365419|FG004|Overall Study|Death|2|||
161814905|NCT02923349|584365420|FG005|Overall Study|Death|3|||
161814906|NCT02923349|584365421|FG006|Overall Study|Death|0|||
161814907|NCT01473953|584365424|FG000|Overall Study|Other|1|||
161814908|NCT01473953|584365425|FG001|Overall Study|Other|0|||
161814909|NCT01473953|584365426|FG002|Overall Study|Other|0|||
161814910|NCT01473953|584365427|FG003|Overall Study|Other|0|||
161814911|NCT01473953|584365428|FG004|Overall Study|Other|0|||
161814912|NCT00725322|584365429|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
161814913|NCT00725322|584365430|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
161814914|NCT00725322|584365429|FG000|Washout (28 Days)|Protocol Violation|0|||
161814915|NCT00725322|584365430|FG001|Washout (28 Days)|Protocol Violation|1|||
161814916|NCT05871151|584365431|FG000|Overall Study|Lost to Follow-up|1|||
161814917|NCT05871151|584365432|FG001|Overall Study|Lost to Follow-up|0|||
161814918|NCT05871151|584365431|FG000|Overall Study|Unrelated illness|0|||
161814919|NCT05871151|584365432|FG001|Overall Study|Unrelated illness|1|||
161814920|NCT03114891|584365433|FG000|First Treatment Round|Lost to Follow-up|0|||
161814921|NCT03114891|584365434|FG001|First Treatment Round|Lost to Follow-up|1|||
161814922|NCT03114891|584365435|FG002|First Treatment Round|Lost to Follow-up|1|||
161814923|NCT03114891|584365436|FG003|First Treatment Round|Lost to Follow-up|0|||
161814924|NCT03114891|584365433|FG000|First Treatment Round|Withdrawal by Subject|0|||
161814925|NCT03114891|584365434|FG001|First Treatment Round|Withdrawal by Subject|2|||
161814926|NCT03114891|584365435|FG002|First Treatment Round|Withdrawal by Subject|0|||
161814927|NCT03114891|584365436|FG003|First Treatment Round|Withdrawal by Subject|1|||
161814928|NCT03114891|584365433|FG000|3 Week Break|Lost to Follow-up|1|||
161814929|NCT03114891|584365434|FG001|3 Week Break|Lost to Follow-up|0|||
161814930|NCT03114891|584365435|FG002|3 Week Break|Lost to Follow-up|0|||
161814931|NCT03114891|584365436|FG003|3 Week Break|Lost to Follow-up|1|||
161814932|NCT03114891|584365433|FG000|3 Week Break|Withdrawal by Subject|0|||
161814933|NCT03114891|584365434|FG001|3 Week Break|Withdrawal by Subject|1|||
161814934|NCT03114891|584365435|FG002|3 Week Break|Withdrawal by Subject|0|||
161814935|NCT03114891|584365436|FG003|3 Week Break|Withdrawal by Subject|0|||
161814936|NCT03114891|584365433|FG000|Second Treatment Round|Lost to Follow-up|1|||
161814937|NCT03114891|584365434|FG001|Second Treatment Round|Lost to Follow-up|0|||
161814938|NCT03114891|584365435|FG002|Second Treatment Round|Lost to Follow-up|0|||
161814939|NCT03114891|584365436|FG003|Second Treatment Round|Lost to Follow-up|0|||
161814940|NCT03114891|584365433|FG000|Second Treatment Round|Physician Decision|1|||
161814941|NCT03114891|584365434|FG001|Second Treatment Round|Physician Decision|0|||
161814942|NCT03114891|584365435|FG002|Second Treatment Round|Physician Decision|0|||
161814943|NCT03114891|584365436|FG003|Second Treatment Round|Physician Decision|0|||
161814944|NCT00830258|584366820|FG000|First Intervention|Adverse Event|1|||
161814945|NCT00830258|584366821|FG001|First Intervention|Adverse Event|0|||
161814946|NCT00830258|584366820|FG000|Washout: 7 Days|Protocol Violation|1|||
161814947|NCT00830258|584366821|FG001|Washout: 7 Days|Protocol Violation|0|||
161814948|NCT00798603|584366822|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
161814949|NCT00798603|584366822|FG000|Overall Study|Withdrawal by Subject|10|||
161814950|NCT00798603|584366822|FG000|Overall Study|Adverse Event|22|||
161814951|NCT00798603|584366822|FG000|Overall Study|Physician Decision|1|||
161814952|NCT00798603|584366822|FG000|Overall Study|Lack of insurance coverage|1|||
161814953|NCT05511935|584366823|FG000|Overall Study|Lost to Follow-up|9|||
161814954|NCT05511935|584366824|FG001|Overall Study|Lost to Follow-up|27|||
161814955|NCT04406194|584366825|FG000|Period 1|Withdrawal by Subject|0|||
161814956|NCT04406194|584366826|FG001|Period 1|Withdrawal by Subject|1|||
161814957|NCT04102345|584366827|FG000|Overall Study|Withdrawal by Subject|1|||
161814958|NCT04102345|584366828|FG001|Overall Study|Withdrawal by Subject|0|||
162161980|NCT01261312|585643756|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
162161981|NCT01261312|585643757|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
162161982|NCT01261312|585643758|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
162161983|NCT01261312|585643759|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
162161984|NCT01261312|585643760|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
162161985|NCT01261312|585643748|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162161986|NCT01261312|585643749|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162161987|NCT01261312|585643750|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162161988|NCT01261312|585643751|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162161989|NCT01261312|585643752|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162161990|NCT01261312|585643753|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162161991|NCT01261312|585643754|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162161992|NCT01261312|585643755|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162161993|NCT01261312|585643756|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
162161994|NCT01261312|585643757|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
162161995|NCT01261312|585643758|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
162161996|NCT01261312|585643759|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
162161997|NCT01261312|585643760|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
162161998|NCT01261312|585643748|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162161999|NCT01261312|585643749|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162162000|NCT01261312|585643750|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162162001|NCT01261312|585643751|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162162002|NCT01261312|585643752|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162162003|NCT01261312|585643753|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162162004|NCT01261312|585643754|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162162005|NCT01261312|585643755|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162162006|NCT01261312|585643756|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
162162007|NCT01261312|585643757|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
162162008|NCT01261312|585643758|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
162162009|NCT01261312|585643759|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
162162010|NCT01261312|585643760|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
162162011|NCT01261312|585643748|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162162012|NCT01261312|585643749|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162162013|NCT01261312|585643750|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162162014|NCT01261312|585643751|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162162015|NCT01261312|585643752|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161814959|NCT02888756|584366829|FG000|Analytical Treatment Interruption|Physician Decision|10|||
161814960|NCT02888756|584366830|FG001|Analytical Treatment Interruption|Physician Decision|6|||
161814961|NCT02888756|584366831|FG002|Analytical Treatment Interruption|Physician Decision|5|||
161814962|NCT01015287|584366834|FG000|Overall Study|Death|21|||
161814963|NCT01015287|584366835|FG001|Overall Study|Death|16|||
161814964|NCT01015287|584366834|FG000|Overall Study|Adverse Event|1|||
161814965|NCT01015287|584366835|FG001|Overall Study|Adverse Event|0|||
161814966|NCT01015287|584366834|FG000|Overall Study|Sponsor Decision|3|||
161814967|NCT01015287|584366835|FG001|Overall Study|Sponsor Decision|7|||
161814968|NCT01015287|584366834|FG000|Overall Study|Physician Decision|19|||
161920764|NCT03317496|584755799|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
162162016|NCT01261312|585643753|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162162017|NCT01261312|585643754|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162162018|NCT01261312|585643755|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162162019|NCT01261312|585643756|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
162162020|NCT01261312|585643757|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
162162021|NCT01261312|585643758|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
162162022|NCT01261312|585643759|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
162162023|NCT01261312|585643760|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
162162024|NCT04294225|585643761|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
162162025|NCT04294225|585643761|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
162162026|NCT04294225|585643761|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
161814969|NCT01015287|584366835|FG001|Overall Study|Physician Decision|21|||
162162027|NCT04294225|585643761|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
162162028|NCT04294225|585643761|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
162162029|NCT04812535|585643769|FG000|Overall Study|Withdrawal by Subject|0|||
162162030|NCT04812535|585643770|FG001|Overall Study|Withdrawal by Subject|0|||
162162031|NCT04812535|585643771|FG002|Overall Study|Withdrawal by Subject|0|||
162162032|NCT04812535|585643772|FG003|Overall Study|Withdrawal by Subject|1|||
162162033|NCT04812535|585643769|FG000|Overall Study|Death|7|||
162162034|NCT04812535|585643770|FG001|Overall Study|Death|2|||
162162035|NCT04812535|585643771|FG002|Overall Study|Death|4|||
162162036|NCT04812535|585643772|FG003|Overall Study|Death|1|||
162162037|NCT04812535|585643769|FG000|Overall Study|Due to premature study termination by sponsor|2|||
162162038|NCT04812535|585643770|FG001|Overall Study|Due to premature study termination by sponsor|0|||
162162039|NCT04812535|585643771|FG002|Overall Study|Due to premature study termination by sponsor|1|||
162162040|NCT04812535|585643772|FG003|Overall Study|Due to premature study termination by sponsor|3|||
162162041|NCT03336333|585643773|FG000|Overall Study|Remained on study at time of data cut-off|202|||
162162042|NCT03336333|585643774|FG001|Overall Study|Remained on study at time of data cut-off|219|||
162162043|NCT03336333|585643775|FG002|Overall Study|Remained on study at time of data cut-off|102|||
161814970|NCT01015287|584366834|FG000|Overall Study|Withdrawal by Subject|14|||
161814971|NCT01015287|584366835|FG001|Overall Study|Withdrawal by Subject|19|||
161814972|NCT01015287|584366834|FG000|Overall Study|Entry Criteria not Met|11|||
161814973|NCT01015287|584366835|FG001|Overall Study|Entry Criteria not Met|14|||
161814974|NCT01015287|584366834|FG000|Overall Study|Lost to Follow-up|2|||
161814975|NCT01015287|584366835|FG001|Overall Study|Lost to Follow-up|1|||
162162044|NCT03336333|585643773|FG000|Overall Study|Death|14|||
162162045|NCT03336333|585643774|FG001|Overall Study|Death|16|||
162162046|NCT03336333|585643775|FG002|Overall Study|Death|8|||
162162047|NCT03336333|585643773|FG000|Overall Study|Withdrawal by Subject|16|||
162162048|NCT03336333|585643774|FG001|Overall Study|Withdrawal by Subject|5|||
162162049|NCT03336333|585643775|FG002|Overall Study|Withdrawal by Subject|1|||
162162050|NCT03336333|585643773|FG000|Overall Study|Physician Decision|5|||
162162051|NCT03336333|585643774|FG001|Overall Study|Physician Decision|1|||
162162052|NCT03336333|585643775|FG002|Overall Study|Physician Decision|0|||
162162053|NCT03336333|585643773|FG000|Overall Study|Lost to Follow-up|1|||
162162054|NCT03336333|585643774|FG001|Overall Study|Lost to Follow-up|0|||
162162055|NCT03336333|585643775|FG002|Overall Study|Lost to Follow-up|0|||
162162056|NCT00931710|585643778|FG000|Overall Study|Adverse Event|16|||
162162057|NCT00931710|585643779|FG001|Overall Study|Adverse Event|10|||
162016741|NCT00473382|585116275|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
162016742|NCT00473382|585116276|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
162016743|NCT00473382|585116274|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
162016744|NCT00473382|585116275|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
162016745|NCT00473382|585116276|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
162016746|NCT02999672|585116277|FG000|Overall Study|Death|0|||
162016747|NCT02999672|585116278|FG001|Overall Study|Death|1|||
162016748|NCT02999672|585116277|FG000|Overall Study|Study Terminated by Sponsor|0|||
162016749|NCT02999672|585116278|FG001|Overall Study|Study Terminated by Sponsor|1|||
161814976|NCT01015287|584366834|FG000|Overall Study|Protocol Violation|1|||
161814977|NCT01015287|584366835|FG001|Overall Study|Protocol Violation|1|||
161814978|NCT01592240|584366836|FG000|Overall Study|Adverse Event|1|||
161814979|NCT01592240|584366837|FG001|Overall Study|Adverse Event|0|||
161814980|NCT01592240|584366838|FG002|Overall Study|Adverse Event|0|||
161814981|NCT01592240|584366839|FG003|Overall Study|Adverse Event|1|||
161814982|NCT01592240|584366840|FG004|Overall Study|Adverse Event|1|||
161814983|NCT01592240|584366841|FG005|Overall Study|Adverse Event|0|||
161814984|NCT01592240|584366842|FG006|Overall Study|Adverse Event|0|||
161814985|NCT01592240|584366836|FG000|Overall Study|Death|0|||
161814986|NCT01592240|584366837|FG001|Overall Study|Death|1|||
161814987|NCT01592240|584366838|FG002|Overall Study|Death|0|||
161814988|NCT01592240|584366839|FG003|Overall Study|Death|0|||
161814989|NCT01592240|584366840|FG004|Overall Study|Death|0|||
161814990|NCT01592240|584366841|FG005|Overall Study|Death|0|||
161814991|NCT01592240|584366842|FG006|Overall Study|Death|0|||
161814992|NCT01592240|584366836|FG000|Overall Study|Lost to Follow-up|1|||
161814993|NCT01592240|584366837|FG001|Overall Study|Lost to Follow-up|3|||
161814994|NCT01592240|584366838|FG002|Overall Study|Lost to Follow-up|1|||
161814995|NCT01592240|584366839|FG003|Overall Study|Lost to Follow-up|0|||
161814996|NCT01592240|584366840|FG004|Overall Study|Lost to Follow-up|3|||
161814997|NCT01592240|584366841|FG005|Overall Study|Lost to Follow-up|2|||
161814998|NCT01592240|584366842|FG006|Overall Study|Lost to Follow-up|0|||
161814999|NCT01592240|584366836|FG000|Overall Study|Protocol Violation|0|||
161815000|NCT01592240|584366837|FG001|Overall Study|Protocol Violation|0|||
161815001|NCT01592240|584366838|FG002|Overall Study|Protocol Violation|0|||
161815002|NCT01592240|584366839|FG003|Overall Study|Protocol Violation|0|||
162016750|NCT02999672|585116277|FG000|Overall Study|Progressive Disease|9|||
162016751|NCT02999672|585116278|FG001|Overall Study|Progressive Disease|5|||
162016752|NCT02999672|585116277|FG000|Overall Study|Adverse Event|4|||
162016753|NCT02999672|585116278|FG001|Overall Study|Adverse Event|0|||
162162058|NCT00931710|585643778|FG000|Overall Study|Abnormal test procedure results|2|||
162162059|NCT00931710|585643779|FG001|Overall Study|Abnormal test procedure results|0|||
161815003|NCT01592240|584366840|FG004|Overall Study|Protocol Violation|0|||
161815004|NCT01592240|584366841|FG005|Overall Study|Protocol Violation|1|||
161815005|NCT01592240|584366842|FG006|Overall Study|Protocol Violation|0|||
161815006|NCT01592240|584366836|FG000|Overall Study|Withdrawal by Subject|0|||
162016754|NCT01166282|585116279|FG000|Open-label Period|Adverse Event|0|||
162162060|NCT00931710|585643778|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
162162061|NCT00931710|585643779|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
162162062|NCT00931710|585643778|FG000|Overall Study|Patient withdrew consent|4|||
162162063|NCT00931710|585643779|FG001|Overall Study|Patient withdrew consent|9|||
162162064|NCT00931710|585643778|FG000|Overall Study|Lost to Follow-up|6|||
161815007|NCT01592240|584366837|FG001|Overall Study|Withdrawal by Subject|4|||
161815008|NCT01592240|584366838|FG002|Overall Study|Withdrawal by Subject|4|||
161815009|NCT01592240|584366839|FG003|Overall Study|Withdrawal by Subject|1|||
161815010|NCT01592240|584366840|FG004|Overall Study|Withdrawal by Subject|3|||
162162065|NCT00931710|585643779|FG001|Overall Study|Lost to Follow-up|5|||
161815011|NCT01592240|584366841|FG005|Overall Study|Withdrawal by Subject|0|||
161815012|NCT01592240|584366842|FG006|Overall Study|Withdrawal by Subject|2|||
161815013|NCT01592240|584366836|FG000|Overall Study|Other|0|||
161815014|NCT01592240|584366837|FG001|Overall Study|Other|3|||
161815015|NCT01592240|584366838|FG002|Overall Study|Other|1|||
161815016|NCT01592240|584366839|FG003|Overall Study|Other|1|||
161815017|NCT01592240|584366840|FG004|Overall Study|Other|0|||
161815018|NCT01592240|584366841|FG005|Overall Study|Other|0|||
161815019|NCT01592240|584366842|FG006|Overall Study|Other|1|||
161815020|NCT01592240|584366836|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
161815021|NCT01592240|584366837|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
161815022|NCT01592240|584366838|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
161815023|NCT01592240|584366839|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
161815024|NCT01592240|584366840|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
161815025|NCT01592240|584366841|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
161815026|NCT01592240|584366842|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
161815027|NCT01117623|584366843|FG000|Overall Study|Adverse Event|0|||
161815028|NCT01117623|584366844|FG001|Overall Study|Adverse Event|2|||
161815029|NCT01117623|584366845|FG002|Overall Study|Adverse Event|4|||
161815030|NCT01117623|584366846|FG003|Overall Study|Adverse Event|0|||
161815031|NCT01117623|584366847|FG004|Overall Study|Adverse Event|2|||
161815032|NCT01117623|584366848|FG005|Overall Study|Adverse Event|0|||
161815033|NCT01117623|584366849|FG006|Overall Study|Adverse Event|0|||
161815034|NCT01117623|584366850|FG007|Overall Study|Adverse Event|2|||
161815035|NCT01117623|584366843|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
161815036|NCT01117623|584366844|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
161815037|NCT01117623|584366845|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
161815038|NCT01117623|584366846|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
161815039|NCT01117623|584366847|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
161815040|NCT01117623|584366848|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
161815041|NCT01117623|584366849|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
161815042|NCT01117623|584366850|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
161815043|NCT01117623|584366843|FG000|Overall Study|Withdrawal by Subject|0|||
161815044|NCT01117623|584366844|FG001|Overall Study|Withdrawal by Subject|0|||
161815045|NCT01117623|584366845|FG002|Overall Study|Withdrawal by Subject|2|||
161815046|NCT01117623|584366846|FG003|Overall Study|Withdrawal by Subject|0|||
161815047|NCT01117623|584366847|FG004|Overall Study|Withdrawal by Subject|0|||
161815048|NCT01117623|584366848|FG005|Overall Study|Withdrawal by Subject|1|||
161815049|NCT01117623|584366849|FG006|Overall Study|Withdrawal by Subject|1|||
161815050|NCT01117623|584366850|FG007|Overall Study|Withdrawal by Subject|1|||
161815051|NCT01117623|584366843|FG000|Overall Study|Non-compliance with study medication|0|||
161815052|NCT01117623|584366844|FG001|Overall Study|Non-compliance with study medication|0|||
161815053|NCT01117623|584366845|FG002|Overall Study|Non-compliance with study medication|0|||
161815054|NCT01117623|584366846|FG003|Overall Study|Non-compliance with study medication|0|||
161815055|NCT01117623|584366847|FG004|Overall Study|Non-compliance with study medication|0|||
161815056|NCT01117623|584366848|FG005|Overall Study|Non-compliance with study medication|0|||
161815057|NCT01117623|584366849|FG006|Overall Study|Non-compliance with study medication|0|||
161815058|NCT01117623|584366850|FG007|Overall Study|Non-compliance with study medication|1|||
161815059|NCT01117623|584366843|FG000|Overall Study|Invest. text: completed all planned txs|0|||
161815060|NCT01117623|584366844|FG001|Overall Study|Invest. text: completed all planned txs|0|||
161815061|NCT01117623|584366845|FG002|Overall Study|Invest. text: completed all planned txs|0|||
161815062|NCT01117623|584366846|FG003|Overall Study|Invest. text: completed all planned txs|0|||
161815063|NCT01117623|584366847|FG004|Overall Study|Invest. text: completed all planned txs|0|||
161815064|NCT01117623|584366848|FG005|Overall Study|Invest. text: completed all planned txs|1|||
161815065|NCT01117623|584366849|FG006|Overall Study|Invest. text: completed all planned txs|0|||
161815066|NCT01117623|584366850|FG007|Overall Study|Invest. text: completed all planned txs|0|||
161815067|NCT01205035|584366854|FG000|Overall Study|Withdrawal by Subject|1|||
161815068|NCT01205035|584366855|FG001|Overall Study|Withdrawal by Subject|0|||
161815069|NCT01205035|584366854|FG000|Overall Study|Physician Decision|1|||
161815070|NCT01205035|584366855|FG001|Overall Study|Physician Decision|0|||
161815071|NCT02727192|584366862|FG000|Overall Study|Lost to Follow-up|1|||
161815072|NCT02727192|584366863|FG001|Overall Study|Lost to Follow-up|0|||
161920765|NCT03317496|584755800|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
162162066|NCT00931710|585643778|FG000|Overall Study|Protocol deviation|1|||
161815073|NCT02727192|584366864|FG002|Overall Study|Lost to Follow-up|0|||
161815074|NCT00928057|584366866|FG000|Overall Study|Adverse Event|1|||
161815075|NCT00928057|584366867|FG001|Overall Study|Adverse Event|2|||
161815076|NCT00928057|584366866|FG000|Overall Study|Withdrawal by Subject|1|||
162162067|NCT00931710|585643779|FG001|Overall Study|Protocol deviation|2|||
161815077|NCT00928057|584366867|FG001|Overall Study|Withdrawal by Subject|0|||
161815078|NCT00928057|584366866|FG000|Overall Study|Lost to Follow-up|0|||
161815079|NCT00928057|584366867|FG001|Overall Study|Lost to Follow-up|1|||
162162068|NCT04401800|585643780|FG000|Overall Study|Death|17|||
161920766|NCT03317496|584755801|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
161920767|NCT03317496|584755797|FG000|Phase 2: Treatment|Physician Decision|0|||
161920768|NCT03317496|584755798|FG001|Phase 2: Treatment|Physician Decision|0|||
161920769|NCT03317496|584755799|FG002|Phase 2: Treatment|Physician Decision|0|||
161920770|NCT03317496|584755800|FG003|Phase 2: Treatment|Physician Decision|0|||
161920771|NCT03317496|584755801|FG004|Phase 2: Treatment|Physician Decision|1|||
161920772|NCT03317496|584755797|FG000|Phase 2: Treatment|Death|0|||
161920773|NCT03317496|584755798|FG001|Phase 2: Treatment|Death|0|||
161920774|NCT03317496|584755799|FG002|Phase 2: Treatment|Death|0|||
161920775|NCT03317496|584755800|FG003|Phase 2: Treatment|Death|0|||
161920776|NCT03317496|584755801|FG004|Phase 2: Treatment|Death|1|||
161920777|NCT03317496|584755797|FG000|Phase 2: Follow-up|Death|0|||
161920778|NCT03317496|584755798|FG001|Phase 2: Follow-up|Death|0|||
161920779|NCT03317496|584755799|FG002|Phase 2: Follow-up|Death|0|||
161920780|NCT03317496|584755800|FG003|Phase 2: Follow-up|Death|0|||
161920781|NCT03317496|584755801|FG004|Phase 2: Follow-up|Death|24|||
161920782|NCT03317496|584755797|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
162162069|NCT04401800|585643780|FG000|Overall Study|Lost to Follow-up|5|||
162162070|NCT04401800|585643780|FG000|Overall Study|Withdrawal by Subject|4|||
162162071|NCT04927065|585643781|FG000|First Booster|Adverse Event|1|||
162162072|NCT04927065|585643782|FG001|First Booster|Adverse Event|0|||
162162073|NCT04927065|585643783|FG002|First Booster|Adverse Event|0|||
162162074|NCT04927065|585643784|FG003|First Booster|Adverse Event|0|||
162162075|NCT04927065|585643785|FG004|First Booster|Adverse Event|0|||
162162076|NCT04927065|585643786|FG005|First Booster|Adverse Event|0|||
162162077|NCT04927065|585643787|FG006|First Booster|Adverse Event|0|||
162162078|NCT04927065|585643788|FG007|First Booster|Adverse Event|1|||
162162079|NCT04927065|585643789|FG008|First Booster|Adverse Event|0|||
162162080|NCT04927065|585643790|FG009|First Booster|Adverse Event|0|||
162162081|NCT04927065|585643791|FG010|First Booster|Adverse Event|0|||
162162082|NCT04927065|585643792|FG011|First Booster|Adverse Event|0|||
162162083|NCT04927065|585643793|FG012|First Booster|Adverse Event|0|||
162162084|NCT04927065|585643794|FG013|First Booster|Adverse Event|0|||
162162085|NCT04927065|585643795|FG014|First Booster|Adverse Event|0|||
162162086|NCT04927065|585643796|FG015|First Booster|Adverse Event|0|||
162162087|NCT04927065|585643781|FG000|First Booster|Death|1|||
162162088|NCT04927065|585643782|FG001|First Booster|Death|0|||
162162089|NCT04927065|585643783|FG002|First Booster|Death|0|||
162162090|NCT04927065|585643784|FG003|First Booster|Death|1|||
162162091|NCT04927065|585643785|FG004|First Booster|Death|0|||
162162092|NCT04927065|585643786|FG005|First Booster|Death|1|||
162162093|NCT04927065|585643787|FG006|First Booster|Death|0|||
162162094|NCT04927065|585643788|FG007|First Booster|Death|0|||
162162095|NCT04927065|585643789|FG008|First Booster|Death|0|||
162162096|NCT04927065|585643790|FG009|First Booster|Death|0|||
162162097|NCT04927065|585643791|FG010|First Booster|Death|0|||
162162098|NCT04927065|585643792|FG011|First Booster|Death|0|||
162162099|NCT04927065|585643793|FG012|First Booster|Death|0|||
162162100|NCT04927065|585643794|FG013|First Booster|Death|0|||
162162101|NCT04927065|585643795|FG014|First Booster|Death|0|||
162162102|NCT04927065|585643796|FG015|First Booster|Death|0|||
162162103|NCT04927065|585643781|FG000|First Booster|Lost to Follow-up|8|||
162162104|NCT04927065|585643782|FG001|First Booster|Lost to Follow-up|20|||
162162105|NCT04927065|585643783|FG002|First Booster|Lost to Follow-up|0|||
162162106|NCT04927065|585643784|FG003|First Booster|Lost to Follow-up|11|||
162162107|NCT04927065|585643785|FG004|First Booster|Lost to Follow-up|43|||
162162108|NCT04927065|585643786|FG005|First Booster|Lost to Follow-up|30|||
162162109|NCT04927065|585643787|FG006|First Booster|Lost to Follow-up|28|||
162162110|NCT04927065|585643788|FG007|First Booster|Lost to Follow-up|23|||
162162111|NCT04927065|585643789|FG008|First Booster|Lost to Follow-up|4|||
161920783|NCT03317496|584755798|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
161920784|NCT03317496|584755799|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
161920785|NCT03317496|584755800|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
161920786|NCT03317496|584755801|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
161920787|NCT03317496|584755797|FG000|Phase 2: Follow-up|Other|0|||
161920788|NCT03317496|584755798|FG001|Phase 2: Follow-up|Other|0|||
162162112|NCT04927065|585643790|FG009|First Booster|Lost to Follow-up|15|||
162162113|NCT04927065|585643791|FG010|First Booster|Lost to Follow-up|0|||
162162114|NCT04927065|585643792|FG011|First Booster|Lost to Follow-up|0|||
162162115|NCT04927065|585643793|FG012|First Booster|Lost to Follow-up|0|||
162162116|NCT04927065|585643794|FG013|First Booster|Lost to Follow-up|0|||
161920789|NCT03317496|584755799|FG002|Phase 2: Follow-up|Other|0|||
161920790|NCT03317496|584755800|FG003|Phase 2: Follow-up|Other|0|||
162162117|NCT04927065|585643795|FG014|First Booster|Lost to Follow-up|0|||
162162118|NCT04927065|585643796|FG015|First Booster|Lost to Follow-up|0|||
162162119|NCT04927065|585643781|FG000|First Booster|Physician Decision|1|||
162162120|NCT04927065|585643782|FG001|First Booster|Physician Decision|0|||
162162121|NCT04927065|585643783|FG002|First Booster|Physician Decision|0|||
162162122|NCT04927065|585643784|FG003|First Booster|Physician Decision|3|||
162162123|NCT04927065|585643785|FG004|First Booster|Physician Decision|1|||
162162124|NCT04927065|585643786|FG005|First Booster|Physician Decision|1|||
162162125|NCT04927065|585643787|FG006|First Booster|Physician Decision|0|||
162162126|NCT04927065|585643788|FG007|First Booster|Physician Decision|3|||
162162127|NCT04927065|585643789|FG008|First Booster|Physician Decision|0|||
162162128|NCT04927065|585643790|FG009|First Booster|Physician Decision|0|||
162162129|NCT04927065|585643791|FG010|First Booster|Physician Decision|0|||
162162130|NCT04927065|585643792|FG011|First Booster|Physician Decision|0|||
162162131|NCT04927065|585643793|FG012|First Booster|Physician Decision|0|||
162162132|NCT04927065|585643794|FG013|First Booster|Physician Decision|0|||
162162133|NCT04927065|585643795|FG014|First Booster|Physician Decision|0|||
162162134|NCT04927065|585643796|FG015|First Booster|Physician Decision|0|||
162162135|NCT04927065|585643781|FG000|First Booster|Protocol Violation|4|||
162162136|NCT04927065|585643782|FG001|First Booster|Protocol Violation|4|||
162162137|NCT04927065|585643783|FG002|First Booster|Protocol Violation|0|||
162162138|NCT04927065|585643784|FG003|First Booster|Protocol Violation|3|||
162162139|NCT04927065|585643785|FG004|First Booster|Protocol Violation|0|||
162162140|NCT04927065|585643786|FG005|First Booster|Protocol Violation|0|||
162162141|NCT04927065|585643787|FG006|First Booster|Protocol Violation|0|||
162162142|NCT04927065|585643788|FG007|First Booster|Protocol Violation|2|||
162162143|NCT04927065|585643789|FG008|First Booster|Protocol Violation|0|||
162162144|NCT04927065|585643790|FG009|First Booster|Protocol Violation|0|||
162162145|NCT04927065|585643791|FG010|First Booster|Protocol Violation|0|||
161815080|NCT00928057|584366866|FG000|Overall Study|Protocol Violation|0|||
162016755|NCT01166282|585116280|FG001|Open-label Period|Adverse Event|0|||
162162146|NCT04927065|585643792|FG011|First Booster|Protocol Violation|0|||
162162147|NCT04927065|585643793|FG012|First Booster|Protocol Violation|0|||
162162148|NCT04927065|585643794|FG013|First Booster|Protocol Violation|0|||
162162149|NCT04927065|585643795|FG014|First Booster|Protocol Violation|0|||
162162150|NCT04927065|585643796|FG015|First Booster|Protocol Violation|0|||
162162151|NCT04927065|585643781|FG000|First Booster|Withdrawal by Subject|8|||
162162152|NCT04927065|585643782|FG001|First Booster|Withdrawal by Subject|23|||
161815081|NCT00928057|584366867|FG001|Overall Study|Protocol Violation|1|||
161815082|NCT05497557|584366868|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
161815083|NCT05497557|584366869|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
161815084|NCT05497557|584366870|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
161815085|NCT03206749|584366871|FG000|Overall Study|Withdrawal of consent|5|||
161815086|NCT03206749|584366872|FG001|Overall Study|Withdrawal of consent|3|||
161815087|NCT03206749|584366873|FG002|Overall Study|Withdrawal of consent|6|||
161815088|NCT03206749|584366871|FG000|Overall Study|Lost to Follow-up|0|||
161815089|NCT03206749|584366872|FG001|Overall Study|Lost to Follow-up|0|||
161815090|NCT03206749|584366873|FG002|Overall Study|Lost to Follow-up|1|||
161815091|NCT04590027|584366875|FG000|Overall Study|Lost to Follow-up|17|||
161815092|NCT04590027|584366876|FG001|Overall Study|Lost to Follow-up|14|||
161815093|NCT04590027|584366875|FG000|Overall Study|Protocol Violation|0|||
161815094|NCT04590027|584366876|FG001|Overall Study|Protocol Violation|3|||
161815095|NCT00927069|584366879|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
161815096|NCT00927069|584366880|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
161815097|NCT00927069|584366881|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
161815098|NCT00927069|584366882|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
161815099|NCT00927069|584366879|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
161815100|NCT00927069|584366880|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
161815101|NCT00927069|584366881|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
161815102|NCT00927069|584366882|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
161815103|NCT00927069|584366879|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
162162153|NCT04927065|585643783|FG002|First Booster|Withdrawal by Subject|0|||
162162154|NCT04927065|585643784|FG003|First Booster|Withdrawal by Subject|19|||
161815104|NCT00927069|584366880|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
161815105|NCT00927069|584366881|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
161815106|NCT00927069|584366882|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
161815107|NCT00927069|584366879|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
161815108|NCT00927069|584366880|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
161815109|NCT00927069|584366881|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
161815110|NCT00927069|584366882|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
161815111|NCT00927069|584366879|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
161815112|NCT00927069|584366880|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
161815113|NCT00927069|584366881|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
161815114|NCT00927069|584366882|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
161815115|NCT04089553|584366883|FG000|Overall Study|Death|1|||
161815116|NCT04089553|584366884|FG001|Overall Study|Death|1|||
161815117|NCT04089553|584366883|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
161815118|NCT04089553|584366884|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
161815119|NCT04089553|584366883|FG000|Overall Study|Withdrawal by Subject|3|||
161815120|NCT04089553|584366884|FG001|Overall Study|Withdrawal by Subject|3|||
161815121|NCT04089553|584366883|FG000|Overall Study|Physician Decision|1|||
161815122|NCT04089553|584366884|FG001|Overall Study|Physician Decision|0|||
161815123|NCT04089553|584366883|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
161815124|NCT04089553|584366884|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
161815125|NCT04089553|584366883|FG000|Overall Study|Other|1|||
161815126|NCT04089553|584366884|FG001|Overall Study|Other|0|||
161815127|NCT04089553|584366883|FG000|Overall Study|Adverse Event|1|||
161815128|NCT04089553|584366884|FG001|Overall Study|Adverse Event|1|||
161815129|NCT03497130|584366885|FG000|Overall Study|Lost to Follow-up|1|||
161815130|NCT03497130|584366886|FG001|Overall Study|Lost to Follow-up|1|||
161815131|NCT04631562|584366887|FG000|Overall Study|Withdrawal by Subject|0|||
161815132|NCT04631562|584366888|FG001|Overall Study|Withdrawal by Subject|0|||
161815133|NCT04631562|584366889|FG002|Overall Study|Withdrawal by Subject|0|||
161815134|NCT04631562|584366890|FG003|Overall Study|Withdrawal by Subject|0|||
161815135|NCT04631562|584366891|FG004|Overall Study|Withdrawal by Subject|0|||
161815136|NCT04631562|584366892|FG005|Overall Study|Withdrawal by Subject|0|||
161815137|NCT04631562|584366893|FG006|Overall Study|Withdrawal by Subject|0|||
161815138|NCT04631562|584366894|FG007|Overall Study|Withdrawal by Subject|1|||
161815139|NCT04631562|584366895|FG008|Overall Study|Withdrawal by Subject|0|||
161815140|NCT04631562|584366887|FG000|Overall Study|Other|0|||
161815141|NCT04631562|584366888|FG001|Overall Study|Other|0|||
161815142|NCT04631562|584366889|FG002|Overall Study|Other|0|||
161815143|NCT04631562|584366890|FG003|Overall Study|Other|0|||
161815144|NCT04631562|584366891|FG004|Overall Study|Other|0|||
161815145|NCT04631562|584366892|FG005|Overall Study|Other|0|||
161815146|NCT04631562|584366893|FG006|Overall Study|Other|0|||
162162155|NCT04927065|585643785|FG004|First Booster|Withdrawal by Subject|20|||
162162156|NCT04927065|585643786|FG005|First Booster|Withdrawal by Subject|15|||
162162157|NCT04927065|585643787|FG006|First Booster|Withdrawal by Subject|6|||
162162158|NCT04927065|585643788|FG007|First Booster|Withdrawal by Subject|24|||
162162159|NCT04927065|585643789|FG008|First Booster|Withdrawal by Subject|0|||
162162160|NCT04927065|585643790|FG009|First Booster|Withdrawal by Subject|4|||
162162161|NCT04927065|585643791|FG010|First Booster|Withdrawal by Subject|0|||
162162162|NCT04927065|585643792|FG011|First Booster|Withdrawal by Subject|0|||
162162163|NCT04927065|585643793|FG012|First Booster|Withdrawal by Subject|0|||
162162164|NCT04927065|585643794|FG013|First Booster|Withdrawal by Subject|0|||
162162165|NCT04927065|585643795|FG014|First Booster|Withdrawal by Subject|0|||
162162166|NCT04927065|585643796|FG015|First Booster|Withdrawal by Subject|0|||
162162167|NCT04927065|585643781|FG000|First Booster|Other Than Specified|1|||
162162168|NCT04927065|585643782|FG001|First Booster|Other Than Specified|1|||
162162169|NCT04927065|585643783|FG002|First Booster|Other Than Specified|0|||
162162170|NCT04927065|585643784|FG003|First Booster|Other Than Specified|1|||
161815147|NCT04631562|584366894|FG007|Overall Study|Other|0|||
161815148|NCT04631562|584366895|FG008|Overall Study|Other|1|||
161815149|NCT04631562|584366887|FG000|Overall Study|Lost to Follow-up|0|||
161815150|NCT04631562|584366888|FG001|Overall Study|Lost to Follow-up|0|||
161815151|NCT04631562|584366889|FG002|Overall Study|Lost to Follow-up|0|||
161815152|NCT04631562|584366890|FG003|Overall Study|Lost to Follow-up|1|||
161815153|NCT04631562|584366891|FG004|Overall Study|Lost to Follow-up|0|||
161815154|NCT04631562|584366892|FG005|Overall Study|Lost to Follow-up|0|||
161815155|NCT04631562|584366893|FG006|Overall Study|Lost to Follow-up|0|||
161815156|NCT04631562|584366894|FG007|Overall Study|Lost to Follow-up|0|||
161815157|NCT04631562|584366895|FG008|Overall Study|Lost to Follow-up|0|||
161815158|NCT04631562|584366887|FG000|Overall Study|Adverse Event|0|||
161815159|NCT04631562|584366888|FG001|Overall Study|Adverse Event|0|||
161815160|NCT04631562|584366889|FG002|Overall Study|Adverse Event|0|||
161815161|NCT04631562|584366890|FG003|Overall Study|Adverse Event|0|||
161815162|NCT04631562|584366891|FG004|Overall Study|Adverse Event|0|||
161815163|NCT04631562|584366892|FG005|Overall Study|Adverse Event|0|||
161815164|NCT04631562|584366893|FG006|Overall Study|Adverse Event|1|||
161815165|NCT04631562|584366894|FG007|Overall Study|Adverse Event|0|||
161815166|NCT04631562|584366895|FG008|Overall Study|Adverse Event|0|||
161815167|NCT03503318|584366896|FG000|Overall Study|Death|1|||
161815168|NCT03503318|584366897|FG001|Overall Study|Death|0|||
161815169|NCT03503318|584366898|FG002|Overall Study|Death|4|||
161815170|NCT03503318|584366896|FG000|Overall Study|Adverse Event|3|||
161815171|NCT03503318|584366897|FG001|Overall Study|Adverse Event|4|||
161815172|NCT03503318|584366898|FG002|Overall Study|Adverse Event|2|||
161815173|NCT03503318|584366896|FG000|Overall Study|Withdrawal by Subject|12|||
161815174|NCT03503318|584366897|FG001|Overall Study|Withdrawal by Subject|17|||
161815175|NCT03503318|584366898|FG002|Overall Study|Withdrawal by Subject|16|||
161815176|NCT03503318|584366896|FG000|Overall Study|Protocol Violation|5|||
161815177|NCT03503318|584366897|FG001|Overall Study|Protocol Violation|0|||
161815178|NCT03503318|584366898|FG002|Overall Study|Protocol Violation|3|||
161815179|NCT03503318|584366896|FG000|Overall Study|Lost to Follow-up|17|||
161815180|NCT03503318|584366897|FG001|Overall Study|Lost to Follow-up|15|||
161815181|NCT03503318|584366898|FG002|Overall Study|Lost to Follow-up|12|||
161815182|NCT03503318|584366896|FG000|Overall Study|Other than specified|1|||
161815183|NCT03503318|584366897|FG001|Overall Study|Other than specified|3|||
161815184|NCT03503318|584366898|FG002|Overall Study|Other than specified|3|||
161815185|NCT01794845|584366901|FG000|Overall Study|Withdrawal by Subject|1|||
161815186|NCT02139826|584366902|FG000|Overall Study|Adverse Event|1|||
161815187|NCT03498560|584366903|FG000|Overall Study|Found Ineligible|2|||
161815188|NCT03498560|584366903|FG000|Overall Study|Withdrawal by Subject|14|||
161815189|NCT03498560|584366903|FG000|Overall Study|Lost to Follow-up|4|||
161815190|NCT03498560|584366903|FG000|Overall Study|Death|1|||
161815191|NCT00867360|584366904|FG000|Overall Study|Withdrawal by Subject|1|||
161815192|NCT00867360|584366905|FG001|Overall Study|Withdrawal by Subject|0|||
161815193|NCT00867360|584366904|FG000|Overall Study|Physician Decision|0|||
161815194|NCT00867360|584366905|FG001|Overall Study|Physician Decision|1|||
161815195|NCT01824576|584366907|FG000|Overall Study|Device deficiency|2|||
161815196|NCT00436163|584366911|FG000|Overall Study|Lost to Follow-up|2|||
161815197|NCT00436163|584366911|FG000|Overall Study|Adverse Event|1|||
161815198|NCT02597049|584366912|FG000|Overall Study|Lost to Follow-up|0|||
161815199|NCT02597049|584366913|FG001|Overall Study|Lost to Follow-up|3|||
161815200|NCT02597049|584366914|FG002|Overall Study|Lost to Follow-up|2|||
161815201|NCT02597049|584366912|FG000|Overall Study|Withdrawal by Subject|2|||
161815202|NCT02597049|584366913|FG001|Overall Study|Withdrawal by Subject|2|||
161920791|NCT03317496|584755801|FG004|Phase 2: Follow-up|Other|1|||
161920792|NCT03317496|584755797|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
162162171|NCT04927065|585643785|FG004|First Booster|Other Than Specified|2|||
161815203|NCT02597049|584366914|FG002|Overall Study|Withdrawal by Subject|1|||
161815204|NCT02597049|584366912|FG000|Overall Study|Adverse Event|2|||
161815205|NCT02597049|584366913|FG001|Overall Study|Adverse Event|0|||
161815206|NCT02597049|584366914|FG002|Overall Study|Adverse Event|0|||
161815207|NCT02597049|584366912|FG000|Overall Study|Death|2|||
161815208|NCT02597049|584366913|FG001|Overall Study|Death|0|||
161815209|NCT02597049|584366914|FG002|Overall Study|Death|0|||
161815210|NCT02597049|584366912|FG000|Overall Study|Noncompliant with Study Visits|1|||
161815211|NCT02597049|584366913|FG001|Overall Study|Noncompliant with Study Visits|0|||
161815212|NCT02597049|584366914|FG002|Overall Study|Noncompliant with Study Visits|0|||
161815213|NCT06647173|584366917|FG000|Overall Study|Lost to Follow-up|24|||
162162172|NCT04927065|585643786|FG005|First Booster|Other Than Specified|3|||
162162173|NCT04927065|585643787|FG006|First Booster|Other Than Specified|2|||
162162174|NCT04927065|585643788|FG007|First Booster|Other Than Specified|6|||
162162175|NCT04927065|585643789|FG008|First Booster|Other Than Specified|0|||
162162176|NCT04927065|585643790|FG009|First Booster|Other Than Specified|4|||
162162177|NCT04927065|585643791|FG010|First Booster|Other Than Specified|0|||
162162178|NCT04927065|585643792|FG011|First Booster|Other Than Specified|0|||
162162179|NCT04927065|585643793|FG012|First Booster|Other Than Specified|0|||
162162180|NCT04927065|585643794|FG013|First Booster|Other Than Specified|0|||
162162181|NCT04927065|585643795|FG014|First Booster|Other Than Specified|0|||
162162182|NCT04927065|585643796|FG015|First Booster|Other Than Specified|0|||
162162183|NCT04927065|585643781|FG000|Second Booster|Death|0|||
162162184|NCT04927065|585643782|FG001|Second Booster|Death|0|||
162162185|NCT04927065|585643783|FG002|Second Booster|Death|0|||
162162186|NCT04927065|585643784|FG003|Second Booster|Death|0|||
162162187|NCT04927065|585643785|FG004|Second Booster|Death|0|||
162162188|NCT04927065|585643786|FG005|Second Booster|Death|0|||
162162189|NCT04927065|585643787|FG006|Second Booster|Death|0|||
162162190|NCT04927065|585643788|FG007|Second Booster|Death|0|||
162162191|NCT04927065|585643789|FG008|Second Booster|Death|0|||
162162192|NCT04927065|585643790|FG009|Second Booster|Death|0|||
162162193|NCT04927065|585643791|FG010|Second Booster|Death|2|||
162162194|NCT04927065|585643792|FG011|Second Booster|Death|0|||
162162195|NCT04927065|585643793|FG012|Second Booster|Death|2|||
162162196|NCT04927065|585643794|FG013|Second Booster|Death|2|||
162162197|NCT04927065|585643795|FG014|Second Booster|Death|0|||
162162198|NCT04927065|585643796|FG015|Second Booster|Death|0|||
162162199|NCT04927065|585643781|FG000|Second Booster|Lost to Follow-up|0|||
162162200|NCT04927065|585643782|FG001|Second Booster|Lost to Follow-up|0|||
162162201|NCT04927065|585643783|FG002|Second Booster|Lost to Follow-up|3|||
162162202|NCT04927065|585643784|FG003|Second Booster|Lost to Follow-up|0|||
162162203|NCT04927065|585643785|FG004|Second Booster|Lost to Follow-up|0|||
162162204|NCT04927065|585643786|FG005|Second Booster|Lost to Follow-up|0|||
162162205|NCT04927065|585643787|FG006|Second Booster|Lost to Follow-up|0|||
162162206|NCT04927065|585643788|FG007|Second Booster|Lost to Follow-up|0|||
162162207|NCT04927065|585643789|FG008|Second Booster|Lost to Follow-up|0|||
162162208|NCT04927065|585643790|FG009|Second Booster|Lost to Follow-up|0|||
162162209|NCT04927065|585643791|FG010|Second Booster|Lost to Follow-up|14|||
162162210|NCT04927065|585643792|FG011|Second Booster|Lost to Follow-up|10|||
162162211|NCT04927065|585643793|FG012|Second Booster|Lost to Follow-up|13|||
162162212|NCT04927065|585643794|FG013|Second Booster|Lost to Follow-up|16|||
162162213|NCT04927065|585643795|FG014|Second Booster|Lost to Follow-up|0|||
162162214|NCT04927065|585643796|FG015|Second Booster|Lost to Follow-up|0|||
162162215|NCT04927065|585643781|FG000|Second Booster|Physician Decision|0|||
162162216|NCT04927065|585643782|FG001|Second Booster|Physician Decision|0|||
162162217|NCT04927065|585643783|FG002|Second Booster|Physician Decision|0|||
162162218|NCT04927065|585643784|FG003|Second Booster|Physician Decision|0|||
162162219|NCT04927065|585643785|FG004|Second Booster|Physician Decision|0|||
162162220|NCT04927065|585643786|FG005|Second Booster|Physician Decision|0|||
162162221|NCT04927065|585643787|FG006|Second Booster|Physician Decision|0|||
162162222|NCT04927065|585643788|FG007|Second Booster|Physician Decision|0|||
162162223|NCT04927065|585643789|FG008|Second Booster|Physician Decision|0|||
162162224|NCT04927065|585643790|FG009|Second Booster|Physician Decision|0|||
162162225|NCT04927065|585643791|FG010|Second Booster|Physician Decision|0|||
162162226|NCT04927065|585643792|FG011|Second Booster|Physician Decision|3|||
162162227|NCT04927065|585643793|FG012|Second Booster|Physician Decision|0|||
162162228|NCT04927065|585643794|FG013|Second Booster|Physician Decision|1|||
162162229|NCT04927065|585643795|FG014|Second Booster|Physician Decision|0|||
162162230|NCT04927065|585643796|FG015|Second Booster|Physician Decision|0|||
162162231|NCT04927065|585643781|FG000|Second Booster|Withdrawal by Subject|0|||
162162232|NCT04927065|585643782|FG001|Second Booster|Withdrawal by Subject|0|||
162162233|NCT04927065|585643783|FG002|Second Booster|Withdrawal by Subject|4|||
162162234|NCT04927065|585643784|FG003|Second Booster|Withdrawal by Subject|0|||
162162235|NCT04927065|585643785|FG004|Second Booster|Withdrawal by Subject|0|||
162162236|NCT04927065|585643786|FG005|Second Booster|Withdrawal by Subject|0|||
162162237|NCT04927065|585643787|FG006|Second Booster|Withdrawal by Subject|0|||
162162238|NCT04927065|585643788|FG007|Second Booster|Withdrawal by Subject|0|||
162162239|NCT04927065|585643789|FG008|Second Booster|Withdrawal by Subject|0|||
162162240|NCT04927065|585643790|FG009|Second Booster|Withdrawal by Subject|0|||
162162241|NCT04927065|585643791|FG010|Second Booster|Withdrawal by Subject|3|||
162162242|NCT04927065|585643792|FG011|Second Booster|Withdrawal by Subject|16|||
162162243|NCT04927065|585643793|FG012|Second Booster|Withdrawal by Subject|13|||
162162244|NCT04927065|585643794|FG013|Second Booster|Withdrawal by Subject|9|||
162162245|NCT04927065|585643795|FG014|Second Booster|Withdrawal by Subject|0|||
162162246|NCT04927065|585643796|FG015|Second Booster|Withdrawal by Subject|0|||
162162247|NCT04927065|585643781|FG000|Second Booster|Other Than Specified|0|||
162162248|NCT04927065|585643782|FG001|Second Booster|Other Than Specified|0|||
162162249|NCT04927065|585643783|FG002|Second Booster|Other Than Specified|0|||
162162250|NCT04927065|585643784|FG003|Second Booster|Other Than Specified|0|||
162162251|NCT04927065|585643785|FG004|Second Booster|Other Than Specified|0|||
162162252|NCT04927065|585643786|FG005|Second Booster|Other Than Specified|0|||
162162253|NCT04927065|585643787|FG006|Second Booster|Other Than Specified|0|||
162162254|NCT04927065|585643788|FG007|Second Booster|Other Than Specified|0|||
162162255|NCT04927065|585643789|FG008|Second Booster|Other Than Specified|0|||
162162256|NCT04927065|585643790|FG009|Second Booster|Other Than Specified|0|||
162162257|NCT04927065|585643791|FG010|Second Booster|Other Than Specified|1|||
162162258|NCT04927065|585643792|FG011|Second Booster|Other Than Specified|1|||
162162259|NCT04927065|585643793|FG012|Second Booster|Other Than Specified|4|||
162162260|NCT04927065|585643794|FG013|Second Booster|Other Than Specified|0|||
162162261|NCT04927065|585643795|FG014|Second Booster|Other Than Specified|0|||
162162262|NCT04927065|585643796|FG015|Second Booster|Other Than Specified|0|||
162162263|NCT04927065|585643781|FG000|Third Booster|Lost to Follow-up|0|||
162162264|NCT04927065|585643782|FG001|Third Booster|Lost to Follow-up|0|||
162162265|NCT04927065|585643783|FG002|Third Booster|Lost to Follow-up|0|||
162162266|NCT04927065|585643784|FG003|Third Booster|Lost to Follow-up|0|||
162162267|NCT04927065|585643785|FG004|Third Booster|Lost to Follow-up|0|||
162162268|NCT04927065|585643786|FG005|Third Booster|Lost to Follow-up|0|||
162162269|NCT04927065|585643787|FG006|Third Booster|Lost to Follow-up|0|||
162162270|NCT04927065|585643788|FG007|Third Booster|Lost to Follow-up|0|||
162162271|NCT04927065|585643789|FG008|Third Booster|Lost to Follow-up|0|||
162162272|NCT04927065|585643790|FG009|Third Booster|Lost to Follow-up|0|||
162162273|NCT04927065|585643791|FG010|Third Booster|Lost to Follow-up|0|||
162162274|NCT04927065|585643792|FG011|Third Booster|Lost to Follow-up|0|||
162162275|NCT04927065|585643793|FG012|Third Booster|Lost to Follow-up|0|||
162162276|NCT04927065|585643794|FG013|Third Booster|Lost to Follow-up|0|||
162162277|NCT04927065|585643795|FG014|Third Booster|Lost to Follow-up|0|||
162162278|NCT04927065|585643796|FG015|Third Booster|Lost to Follow-up|1|||
162162279|NCT04927065|585643781|FG000|Third Booster|Withdrawal by Subject|0|||
162162280|NCT04927065|585643782|FG001|Third Booster|Withdrawal by Subject|0|||
162162281|NCT04927065|585643783|FG002|Third Booster|Withdrawal by Subject|0|||
162162282|NCT04927065|585643784|FG003|Third Booster|Withdrawal by Subject|0|||
162162283|NCT04927065|585643785|FG004|Third Booster|Withdrawal by Subject|0|||
162162284|NCT04927065|585643786|FG005|Third Booster|Withdrawal by Subject|0|||
162162285|NCT04927065|585643787|FG006|Third Booster|Withdrawal by Subject|0|||
162162286|NCT04927065|585643788|FG007|Third Booster|Withdrawal by Subject|0|||
162162287|NCT04927065|585643789|FG008|Third Booster|Withdrawal by Subject|0|||
162162288|NCT04927065|585643790|FG009|Third Booster|Withdrawal by Subject|0|||
162162289|NCT04927065|585643791|FG010|Third Booster|Withdrawal by Subject|0|||
162162290|NCT04927065|585643792|FG011|Third Booster|Withdrawal by Subject|0|||
162162291|NCT04927065|585643793|FG012|Third Booster|Withdrawal by Subject|0|||
162162292|NCT04927065|585643794|FG013|Third Booster|Withdrawal by Subject|0|||
162162293|NCT04927065|585643795|FG014|Third Booster|Withdrawal by Subject|0|||
162162294|NCT04927065|585643796|FG015|Third Booster|Withdrawal by Subject|1|||
162162295|NCT03846505|585643802|FG000|Treatment Phase|Withdrawal by Subject|9|||
162162296|NCT03846505|585643803|FG001|Treatment Phase|Withdrawal by Subject|11|||
162162297|NCT03846505|585643802|FG000|Treatment Phase|Lost to Follow-up|6|||
162162298|NCT03846505|585643803|FG001|Treatment Phase|Lost to Follow-up|2|||
162162299|NCT03846505|585643802|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
162162300|NCT03846505|585643803|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
162162301|NCT03846505|585643802|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
162162302|NCT03846505|585643803|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
162162303|NCT04021602|585643810|FG000|Overall Study|Lost to Follow-up|3|||
162162304|NCT04021602|585643811|FG001|Overall Study|Lost to Follow-up|3|||
162162305|NCT04021602|585643812|FG002|Overall Study|Lost to Follow-up|1|||
162162306|NCT04021602|585643810|FG000|Overall Study|Adverse Event|1|||
162162307|NCT04021602|585643811|FG001|Overall Study|Adverse Event|0|||
162162308|NCT04021602|585643812|FG002|Overall Study|Adverse Event|1|||
162162309|NCT02689284|585643813|FG000|Overall Study|Adverse Event|1|||
162162310|NCT02689284|585643814|FG001|Overall Study|Adverse Event|8|||
162162311|NCT02689284|585643813|FG000|Overall Study|Death|0|||
162162312|NCT02689284|585643814|FG001|Overall Study|Death|1|||
162162313|NCT02689284|585643813|FG000|Overall Study|Physician Decision|1|||
162162314|NCT02689284|585643814|FG001|Overall Study|Physician Decision|2|||
162162315|NCT02689284|585643813|FG000|Overall Study|Withdrawal by Subject|0|||
162162316|NCT02689284|585643814|FG001|Overall Study|Withdrawal by Subject|1|||
162162317|NCT02689284|585643813|FG000|Overall Study|progression of cancer|1|||
162162318|NCT02689284|585643814|FG001|Overall Study|progression of cancer|72|||
162162319|NCT02689284|585643813|FG000|Overall Study|decreased heart function|0|||
162162320|NCT02689284|585643814|FG001|Overall Study|decreased heart function|1|||
162162321|NCT02689284|585643813|FG000|Overall Study|concern for anemia|0|||
162162322|NCT02689284|585643814|FG001|Overall Study|concern for anemia|1|||
162162323|NCT02689284|585643813|FG000|Overall Study|no measurable cancer for evaluation|0|||
162162324|NCT02689284|585643814|FG001|Overall Study|no measurable cancer for evaluation|1|||
162162325|NCT05592418|585643815|FG000|Overall Study|Adverse Event|1|||
162162326|NCT05592418|585643816|FG001|Overall Study|Adverse Event|0|||
162162327|NCT05592418|585643815|FG000|Overall Study|Lost to Follow-up|1|||
162162328|NCT05592418|585643816|FG001|Overall Study|Lost to Follow-up|3|||
162162329|NCT05592418|585643815|FG000|Overall Study|Withdrawal by Subject|2|||
162162330|NCT05592418|585643816|FG001|Overall Study|Withdrawal by Subject|7|||
162162331|NCT03665597|585643817|FG000|Period 1|Adverse Event|1|||
162162332|NCT03665597|585643818|FG001|Period 1|Adverse Event|0|||
162162333|NCT03665597|585643819|FG002|Period 1|Adverse Event|0|||
162162334|NCT03665597|585643820|FG003|Period 1|Adverse Event|1|||
162162335|NCT03665597|585643821|FG004|Period 1|Adverse Event|0|||
162162336|NCT03665597|585643822|FG005|Period 1|Adverse Event|0|||
162162337|NCT03665597|585643823|FG006|Period 1|Adverse Event|0|||
162162338|NCT03665597|585643817|FG000|Period 1|Screen Failure|0|||
162162339|NCT03665597|585643818|FG001|Period 1|Screen Failure|0|||
162162340|NCT03665597|585643819|FG002|Period 1|Screen Failure|0|||
162162341|NCT03665597|585643820|FG003|Period 1|Screen Failure|1|||
162162342|NCT03665597|585643821|FG004|Period 1|Screen Failure|0|||
162162343|NCT03665597|585643822|FG005|Period 1|Screen Failure|0|||
162162344|NCT03665597|585643823|FG006|Period 1|Screen Failure|0|||
162162345|NCT03665597|585643817|FG000|Period 1|Death|0|||
162162346|NCT03665597|585643818|FG001|Period 1|Death|0|||
162162347|NCT03665597|585643819|FG002|Period 1|Death|0|||
161920793|NCT03317496|584755798|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
162162348|NCT03665597|585643820|FG003|Period 1|Death|0|||
162016756|NCT01166282|585116281|FG002|Open-label Period|Adverse Event|6|||
162162349|NCT03665597|585643821|FG004|Period 1|Death|0|||
162162350|NCT03665597|585643822|FG005|Period 1|Death|0|||
162162351|NCT03665597|585643823|FG006|Period 1|Death|45|||
162162352|NCT03665597|585643817|FG000|Period 1|Withdrawal by Subject|0|||
162162353|NCT03665597|585643818|FG001|Period 1|Withdrawal by Subject|0|||
162162354|NCT03665597|585643819|FG002|Period 1|Withdrawal by Subject|0|||
162162355|NCT03665597|585643820|FG003|Period 1|Withdrawal by Subject|0|||
162162356|NCT03665597|585643821|FG004|Period 1|Withdrawal by Subject|0|||
162162357|NCT03665597|585643822|FG005|Period 1|Withdrawal by Subject|0|||
162162358|NCT03665597|585643823|FG006|Period 1|Withdrawal by Subject|5|||
162162359|NCT03665597|585643817|FG000|Period 2|Adverse Event|0|||
162162360|NCT03665597|585643818|FG001|Period 2|Adverse Event|0|||
162162361|NCT03665597|585643819|FG002|Period 2|Adverse Event|0|||
162162362|NCT03665597|585643820|FG003|Period 2|Adverse Event|0|||
162162363|NCT03665597|585643821|FG004|Period 2|Adverse Event|0|||
162162364|NCT03665597|585643822|FG005|Period 2|Adverse Event|1|||
162162365|NCT03665597|585643823|FG006|Period 2|Adverse Event|0|||
162162366|NCT03665597|585643817|FG000|Period 3|Adverse Event|0|||
162162367|NCT03665597|585643818|FG001|Period 3|Adverse Event|1|||
162162368|NCT03665597|585643819|FG002|Period 3|Adverse Event|0|||
162162369|NCT03665597|585643820|FG003|Period 3|Adverse Event|0|||
162162370|NCT03665597|585643821|FG004|Period 3|Adverse Event|0|||
162162371|NCT03665597|585643822|FG005|Period 3|Adverse Event|0|||
162162372|NCT03665597|585643823|FG006|Period 3|Adverse Event|0|||
162162373|NCT03665597|585643817|FG000|Period 3|Death|0|||
162162374|NCT03665597|585643818|FG001|Period 3|Death|0|||
162162375|NCT03665597|585643819|FG002|Period 3|Death|0|||
162162376|NCT03665597|585643820|FG003|Period 3|Death|0|||
162162377|NCT03665597|585643821|FG004|Period 3|Death|1|||
162162378|NCT03665597|585643822|FG005|Period 3|Death|0|||
162162379|NCT03665597|585643823|FG006|Period 3|Death|0|||
162162380|NCT03665597|585643817|FG000|Period 4|Adverse Event|2|||
162162381|NCT03665597|585643818|FG001|Period 4|Adverse Event|2|||
162162382|NCT03665597|585643819|FG002|Period 4|Adverse Event|2|||
162162383|NCT03665597|585643820|FG003|Period 4|Adverse Event|2|||
162162384|NCT03665597|585643821|FG004|Period 4|Adverse Event|1|||
162162385|NCT03665597|585643822|FG005|Period 4|Adverse Event|0|||
162162386|NCT03665597|585643823|FG006|Period 4|Adverse Event|0|||
162162387|NCT03665597|585643817|FG000|Period 4|Death|0|||
162162388|NCT03665597|585643818|FG001|Period 4|Death|0|||
162162389|NCT03665597|585643819|FG002|Period 4|Death|2|||
162162390|NCT03665597|585643820|FG003|Period 4|Death|0|||
161815214|NCT01120028|584366918|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
162162391|NCT03665597|585643821|FG004|Period 4|Death|0|||
162162392|NCT03665597|585643822|FG005|Period 4|Death|0|||
162162393|NCT03665597|585643823|FG006|Period 4|Death|0|||
162162394|NCT03665597|585643817|FG000|Period 4|Physician Decision|1|||
162162395|NCT03665597|585643818|FG001|Period 4|Physician Decision|2|||
162162396|NCT03665597|585643819|FG002|Period 4|Physician Decision|0|||
162162397|NCT03665597|585643820|FG003|Period 4|Physician Decision|0|||
161815215|NCT01120028|584366919|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
161815216|NCT01120028|584366920|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
161815217|NCT01120028|584366921|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
162162398|NCT03665597|585643821|FG004|Period 4|Physician Decision|0|||
162162399|NCT03665597|585643822|FG005|Period 4|Physician Decision|0|||
162162400|NCT03665597|585643823|FG006|Period 4|Physician Decision|0|||
162162401|NCT04450342|585643826|FG000|Overall Study|Adverse Event|1|||
162162402|NCT04450342|585643827|FG001|Overall Study|Adverse Event|1|||
162162403|NCT04450342|585643828|FG002|Overall Study|Adverse Event|0|||
162162404|NCT04450342|585643826|FG000|Overall Study|Device not used|1|||
162162405|NCT04450342|585643827|FG001|Overall Study|Device not used|0|||
162162406|NCT04450342|585643828|FG002|Overall Study|Device not used|0|||
162162407|NCT04450342|585643826|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
162162408|NCT04450342|585643827|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
162162409|NCT04450342|585643828|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
162162410|NCT04450342|585643826|FG000|Overall Study|Physician Decision|1|||
162162411|NCT04450342|585643827|FG001|Overall Study|Physician Decision|0|||
162162412|NCT04450342|585643828|FG002|Overall Study|Physician Decision|1|||
162162413|NCT04450342|585643826|FG000|Overall Study|Protocol Deviation|0|||
162162414|NCT04450342|585643827|FG001|Overall Study|Protocol Deviation|1|||
162162415|NCT04450342|585643828|FG002|Overall Study|Protocol Deviation|0|||
162162416|NCT04450342|585643826|FG000|Overall Study|Reoperation|1|||
162162417|NCT04450342|585643827|FG001|Overall Study|Reoperation|1|||
162162418|NCT04450342|585643828|FG002|Overall Study|Reoperation|0|||
162162419|NCT04450342|585643826|FG000|Overall Study|Screen Failures|0|||
162162420|NCT04450342|585643827|FG001|Overall Study|Screen Failures|0|||
162162421|NCT04450342|585643828|FG002|Overall Study|Screen Failures|2|||
162162422|NCT04450342|585643826|FG000|Overall Study|Site Terminated by Sponsor|1|||
162162423|NCT04450342|585643827|FG001|Overall Study|Site Terminated by Sponsor|1|||
162162424|NCT04450342|585643828|FG002|Overall Study|Site Terminated by Sponsor|1|||
162162425|NCT04450342|585643826|FG000|Overall Study|Study Terminated by Sponsor|31|||
162162426|NCT04450342|585643827|FG001|Overall Study|Study Terminated by Sponsor|29|||
162162427|NCT04450342|585643828|FG002|Overall Study|Study Terminated by Sponsor|6|||
162162428|NCT04450342|585643826|FG000|Overall Study|Withdrawal by Subject|0|||
162162429|NCT04450342|585643827|FG001|Overall Study|Withdrawal by Subject|1|||
162162430|NCT04450342|585643828|FG002|Overall Study|Withdrawal by Subject|2|||
162162431|NCT05481320|585643829|FG000|Overall Study|Withdrawal by Subject|1|||
162162432|NCT05481320|585643830|FG001|Overall Study|Withdrawal by Subject|1|||
162162433|NCT05481320|585643829|FG000|Overall Study|Care recipent passed away|0|||
162162434|NCT05481320|585643830|FG001|Overall Study|Care recipent passed away|1|||
162162435|NCT05481320|585643829|FG000|Overall Study|Out-of-window assessment|0|||
162162436|NCT05481320|585643830|FG001|Overall Study|Out-of-window assessment|1|||
162162437|NCT05481320|585643829|FG000|Overall Study|No longer a primary caregiver|3|||
162162438|NCT05481320|585643830|FG001|Overall Study|No longer a primary caregiver|0|||
162162439|NCT05481320|585643829|FG000|Overall Study|Unable to contact|1|||
162162440|NCT05481320|585643830|FG001|Overall Study|Unable to contact|0|||
162162441|NCT02874534|585643831|FG000|Overall Study|Withdrawal by Subject|5|||
162162442|NCT02874534|585643832|FG001|Overall Study|Withdrawal by Subject|8|||
162162443|NCT02874534|585643831|FG000|Overall Study|Lost to Follow-up|2|||
162162444|NCT02874534|585643832|FG001|Overall Study|Lost to Follow-up|2|||
162162445|NCT02874534|585643831|FG000|Overall Study|Ongoing in study|1|||
162162446|NCT02874534|585643832|FG001|Overall Study|Ongoing in study|1|||
162162447|NCT02923180|585643833|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
162162448|NCT02923180|585643833|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
162162449|NCT05198310|585643834|FG000|Overall Study|Lost to Follow-up|0|||
162162450|NCT05198310|585643835|FG001|Overall Study|Lost to Follow-up|1|||
162162451|NCT05198310|585643836|FG002|Overall Study|Lost to Follow-up|0|||
161815218|NCT01120028|584366918|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
161815219|NCT01120028|584366919|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
161815220|NCT01120028|584366920|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
161815221|NCT01120028|584366921|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
161815222|NCT03250117|584366922|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
161815223|NCT03250117|584366923|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
161815224|NCT03250117|584366924|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
161815225|NCT03250117|584366925|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
161815226|NCT04063878|584366926|FG000|Overall Study|Withdrawal by Subject|2|||
161815227|NCT04063878|584366926|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
161815228|NCT02751827|584366927|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
161815229|NCT02751827|584366928|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
161815230|NCT02751827|584366929|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
161815231|NCT01248728|584366930|FG000|Overall Study|Adverse Event|1|||
161815232|NCT01248728|584366931|FG001|Overall Study|Adverse Event|1|||
161815233|NCT01248728|584366930|FG000|Overall Study|Withdrawal by Subject|2|||
161815234|NCT01248728|584366931|FG001|Overall Study|Withdrawal by Subject|1|||
161815235|NCT01248728|584366930|FG000|Overall Study|Lack of Efficacy|1|||
161815236|NCT01248728|584366931|FG001|Overall Study|Lack of Efficacy|0|||
161815237|NCT00147498|584366932|FG000|Overall Study|Adverse Event|1|||
161815238|NCT00147498|584366933|FG001|Overall Study|Adverse Event|6|||
162162452|NCT05198310|585643837|FG003|Overall Study|Lost to Follow-up|0|||
161815239|NCT00147498|584366934|FG002|Overall Study|Adverse Event|7|||
161920794|NCT03317496|584755799|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
161920795|NCT03317496|584755800|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
161920796|NCT03317496|584755801|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
162162453|NCT05198310|585643838|FG004|Overall Study|Lost to Follow-up|0|||
162162454|NCT05198310|585643839|FG005|Overall Study|Lost to Follow-up|0|||
162162455|NCT05198310|585643840|FG006|Overall Study|Lost to Follow-up|0|||
162162456|NCT05198310|585643841|FG007|Overall Study|Lost to Follow-up|0|||
162162457|NCT05198310|585643834|FG000|Overall Study|Withdrawal by Subject|0|||
162162458|NCT05198310|585643835|FG001|Overall Study|Withdrawal by Subject|0|||
162162459|NCT05198310|585643836|FG002|Overall Study|Withdrawal by Subject|0|||
162162460|NCT05198310|585643837|FG003|Overall Study|Withdrawal by Subject|2|||
162162461|NCT05198310|585643838|FG004|Overall Study|Withdrawal by Subject|0|||
162162462|NCT05198310|585643839|FG005|Overall Study|Withdrawal by Subject|2|||
162162463|NCT05198310|585643840|FG006|Overall Study|Withdrawal by Subject|1|||
162162464|NCT05198310|585643841|FG007|Overall Study|Withdrawal by Subject|3|||
162162465|NCT04116736|585643844|FG000|Overall Study|Withdrew consent during study|3|||
162162466|NCT04116736|585643845|FG001|Overall Study|Withdrew consent during study|1|||
162162467|NCT04116736|585643844|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
162162468|NCT04116736|585643845|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
162162469|NCT04116736|585643844|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
162162470|NCT04116736|585643845|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
162162471|NCT04116736|585643844|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
162162472|NCT04116736|585643845|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
162162473|NCT04116736|585643844|FG000|Overall Study|Subject was enrolled in error|2|||
162162474|NCT04116736|585643845|FG001|Overall Study|Subject was enrolled in error|0|||
162162475|NCT04116736|585643844|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
162162476|NCT04116736|585643845|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
162162477|NCT04116736|585643844|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
162162478|NCT04116736|585643845|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
162162479|NCT04116736|585643844|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
162162480|NCT04116736|585643845|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
162162481|NCT03941860|585643852|FG000|Overall Study|Withdrawal by Subject|0|||
162162482|NCT03941860|585643853|FG001|Overall Study|Withdrawal by Subject|1|||
162162483|NCT03361748|585643854|FG000|Overall Study|Death|77|||
162162484|NCT03361748|585643854|FG000|Overall Study|Lost to Follow-up|4|||
162162485|NCT03361748|585643854|FG000|Overall Study|Withdrawal by Subject|20|||
162162486|NCT04093752|585643855|FG000|Overall Study|Adverse Event|7|||
162162487|NCT04093752|585643856|FG001|Overall Study|Adverse Event|19|||
162162488|NCT04093752|585643857|FG002|Overall Study|Adverse Event|18|||
162162489|NCT04093752|585643858|FG003|Overall Study|Adverse Event|4|||
162162490|NCT04093752|585643855|FG000|Overall Study|Withdrawal by Subject|6|||
162162491|NCT04093752|585643856|FG001|Overall Study|Withdrawal by Subject|6|||
162162492|NCT04093752|585643857|FG002|Overall Study|Withdrawal by Subject|8|||
162162493|NCT04093752|585643858|FG003|Overall Study|Withdrawal by Subject|20|||
162162494|NCT04093752|585643855|FG000|Overall Study|Lost to Follow-up|2|||
162162495|NCT04093752|585643856|FG001|Overall Study|Lost to Follow-up|1|||
162162496|NCT04093752|585643857|FG002|Overall Study|Lost to Follow-up|1|||
162162497|NCT04093752|585643858|FG003|Overall Study|Lost to Follow-up|1|||
162162498|NCT04093752|585643855|FG000|Overall Study|Death|0|||
162162499|NCT04093752|585643856|FG001|Overall Study|Death|0|||
162162500|NCT04093752|585643857|FG002|Overall Study|Death|1|||
162162501|NCT04093752|585643858|FG003|Overall Study|Death|2|||
162162502|NCT04093752|585643855|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
162162503|NCT04093752|585643856|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
162162504|NCT04093752|585643857|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
162162505|NCT04093752|585643858|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
162162506|NCT04093752|585643855|FG000|Overall Study|Covid 19|0|||
162162507|NCT04093752|585643856|FG001|Overall Study|Covid 19|0|||
162162508|NCT04093752|585643857|FG002|Overall Study|Covid 19|0|||
162162509|NCT04093752|585643858|FG003|Overall Study|Covid 19|1|||
162162510|NCT04093752|585643855|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
162162511|NCT04093752|585643856|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
162162512|NCT04093752|585643857|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
162162513|NCT04093752|585643858|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
162162514|NCT04093752|585643855|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
162162515|NCT04093752|585643856|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
162162516|NCT04093752|585643857|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
162162517|NCT04093752|585643858|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
162162518|NCT04093752|585643855|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
162162519|NCT04093752|585643856|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
162162520|NCT04093752|585643857|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
162162521|NCT04093752|585643858|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
162162522|NCT04854096|585643861|FG000|Overall Study|Adverse Event|1|||
162162523|NCT04854096|585643862|FG001|Overall Study|Adverse Event|0|||
162162524|NCT04854096|585643861|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
162162525|NCT04854096|585643862|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
162162526|NCT04854096|585643861|FG000|Overall Study|Withdrawal by Subject|1|||
162162527|NCT04854096|585643862|FG001|Overall Study|Withdrawal by Subject|0|||
162162528|NCT04854096|585643861|FG000|Overall Study|Other reasons|1|||
162162529|NCT04854096|585643862|FG001|Overall Study|Other reasons|0|||
162162530|NCT01084707|585643866|FG000|Overall Study|Withdrawal by Subject|6|||
162162531|NCT00901901|585643867|FG000|Treatment Period|Adverse Event|120|||
162162532|NCT00901901|585643868|FG001|Treatment Period|Adverse Event|128|||
162162533|NCT00901901|585643867|FG000|Treatment Period|Withdrawal by Subject|26|||
162162534|NCT00901901|585643868|FG001|Treatment Period|Withdrawal by Subject|24|||
162162535|NCT00901901|585643867|FG000|Treatment Period|Physician Decision|2|||
162162536|NCT00901901|585643868|FG001|Treatment Period|Physician Decision|2|||
162162537|NCT00901901|585643867|FG000|Treatment Period|Lost to Follow-up|3|||
162162538|NCT00901901|585643868|FG001|Treatment Period|Lost to Follow-up|5|||
162162539|NCT00901901|585643867|FG000|Treatment Period|Noncompliance with study medication|4|||
162162540|NCT00901901|585643868|FG001|Treatment Period|Noncompliance with study medication|1|||
162162541|NCT00901901|585643867|FG000|Treatment Period|Missing|1|||
162162542|NCT00901901|585643868|FG001|Treatment Period|Missing|0|||
162162543|NCT00901901|585643867|FG000|Treatment Period|Never treated|0|||
162162544|NCT00901901|585643868|FG001|Treatment Period|Never treated|3|||
162162545|NCT00901901|585643867|FG000|Treatment Period|Protocol driven decision point|0|||
162162546|NCT00901901|585643868|FG001|Treatment Period|Protocol driven decision point|2|||
162162547|NCT00901901|585643867|FG000|Treatment Period|Study terminated by sponsor|2|||
162162548|NCT00901901|585643868|FG001|Treatment Period|Study terminated by sponsor|0|||
162016757|NCT01166282|585116279|FG000|Open-label Period|Withdrawal by Subject|0|||
162016758|NCT01166282|585116280|FG001|Open-label Period|Withdrawal by Subject|0|||
162016759|NCT01166282|585116281|FG002|Open-label Period|Withdrawal by Subject|4|||
162016760|NCT01166282|585116279|FG000|Open-label Period|Lack of Efficacy|0|||
162016761|NCT01166282|585116280|FG001|Open-label Period|Lack of Efficacy|0|||
162016762|NCT01166282|585116281|FG002|Open-label Period|Lack of Efficacy|2|||
162016763|NCT01166282|585116279|FG000|Open-label Period|Remission|0|||
162016764|NCT01166282|585116280|FG001|Open-label Period|Remission|0|||
162016765|NCT01166282|585116281|FG002|Open-label Period|Remission|4|||
162016766|NCT01166282|585116279|FG000|Open-label Period|Irregular Compliance|0|||
162016767|NCT01166282|585116280|FG001|Open-label Period|Irregular Compliance|0|||
162016768|NCT01166282|585116281|FG002|Open-label Period|Irregular Compliance|1|||
162162549|NCT00901901|585643867|FG000|Treatment Period|Protocol Violation|5|||
162162550|NCT00901901|585643868|FG001|Treatment Period|Protocol Violation|9|||
162162551|NCT00901901|585643867|FG000|Treatment Period|Switch to commercial drug|1|||
162162552|NCT00901901|585643868|FG001|Treatment Period|Switch to commercial drug|1|||
162162553|NCT00901901|585643867|FG000|Treatment Period|Transfer to treatment continuation study|5|||
162162554|NCT00901901|585643868|FG001|Treatment Period|Transfer to treatment continuation study|2|||
162162555|NCT00901901|585643867|FG000|Follow-up Period|Death|181|||
162162556|NCT00901901|585643868|FG001|Follow-up Period|Death|208|||
162162557|NCT00901901|585643867|FG000|Follow-up Period|Protocol driven decision point|47|||
162162558|NCT00901901|585643868|FG001|Follow-up Period|Protocol driven decision point|36|||
161815240|NCT00147498|584366935|FG003|Overall Study|Adverse Event|3|||
162162559|NCT00901901|585643867|FG000|Follow-up Period|Withdrawal by Subject|6|||
162162560|NCT00901901|585643868|FG001|Follow-up Period|Withdrawal by Subject|9|||
162162561|NCT00901901|585643867|FG000|Follow-up Period|Lost to Follow-up|12|||
162162562|NCT00901901|585643868|FG001|Follow-up Period|Lost to Follow-up|8|||
162162563|NCT00901901|585643867|FG000|Follow-up Period|Missing|94|||
161815241|NCT00147498|584366932|FG000|Overall Study|Lack of Efficacy|1|||
161815242|NCT00147498|584366933|FG001|Overall Study|Lack of Efficacy|1|||
161815243|NCT00147498|584366934|FG002|Overall Study|Lack of Efficacy|1|||
161815244|NCT00147498|584366935|FG003|Overall Study|Lack of Efficacy|8|||
161815245|NCT00147498|584366932|FG000|Overall Study|Laboratory abnormality|0|||
161815246|NCT00147498|584366933|FG001|Overall Study|Laboratory abnormality|0|||
161815247|NCT00147498|584366934|FG002|Overall Study|Laboratory abnormality|2|||
161815248|NCT00147498|584366935|FG003|Overall Study|Laboratory abnormality|0|||
161815249|NCT00147498|584366932|FG000|Overall Study|Participant defaulted|0|||
161815250|NCT00147498|584366933|FG001|Overall Study|Participant defaulted|1|||
161815251|NCT00147498|584366934|FG002|Overall Study|Participant defaulted|4|||
162162564|NCT00901901|585643868|FG001|Follow-up Period|Missing|80|||
162162565|NCT03930342|585643872|FG000|Overall Study|Lost to Follow-up|70|||
162162566|NCT03930342|585643873|FG001|Overall Study|Lost to Follow-up|77|||
162162567|NCT02742519|585643876|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
162162568|NCT02742519|585643877|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
162162569|NCT02742519|585643878|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
162162570|NCT02742519|585643876|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
162162571|NCT02742519|585643877|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
162162572|NCT02742519|585643878|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
162162573|NCT02742519|585643876|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
161815252|NCT00147498|584366935|FG003|Overall Study|Participant defaulted|3|||
161815253|NCT00147498|584366932|FG000|Overall Study|Other|1|||
162016769|NCT02892448|585116282|FG000|Overall Study|Screening failure|2|||
162162574|NCT02742519|585643877|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
162162575|NCT02742519|585643878|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
162162576|NCT01872078|585643880|FG000|Overall Study|Adverse Event|0|||
162162577|NCT01872078|585643881|FG001|Overall Study|Adverse Event|0|||
162162578|NCT01872078|585643882|FG002|Overall Study|Adverse Event|1|||
162162579|NCT01872078|585643883|FG003|Overall Study|Adverse Event|0|||
162162580|NCT01872078|585643880|FG000|Overall Study|Dose administration non-compliance|0|||
162162581|NCT01872078|585643881|FG001|Overall Study|Dose administration non-compliance|0|||
162162582|NCT01872078|585643882|FG002|Overall Study|Dose administration non-compliance|0|||
162162583|NCT01872078|585643883|FG003|Overall Study|Dose administration non-compliance|1|||
162162584|NCT01872078|585643880|FG000|Overall Study|Protocol Violation|0|||
162162585|NCT01872078|585643881|FG001|Overall Study|Protocol Violation|0|||
162162586|NCT01872078|585643882|FG002|Overall Study|Protocol Violation|1|||
162162587|NCT01872078|585643883|FG003|Overall Study|Protocol Violation|0|||
162162588|NCT01872078|585643880|FG000|Overall Study|Withdrawal by Subject|0|||
162162589|NCT01872078|585643881|FG001|Overall Study|Withdrawal by Subject|0|||
162162590|NCT01872078|585643882|FG002|Overall Study|Withdrawal by Subject|1|||
162162591|NCT01872078|585643883|FG003|Overall Study|Withdrawal by Subject|0|||
162162592|NCT01872078|585643880|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
162162593|NCT01872078|585643881|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
162162594|NCT01872078|585643882|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
162162595|NCT01872078|585643883|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
162162596|NCT01091168|585643884|FG000|Overall Study|Progressive disease|250|||
162162597|NCT01091168|585643885|FG001|Overall Study|Progressive disease|234|||
162162598|NCT01091168|585643884|FG000|Overall Study|Adverse Event|21|||
162162599|NCT01091168|585643885|FG001|Overall Study|Adverse Event|24|||
162162600|NCT01091168|585643884|FG000|Overall Study|Lost to Follow-up|0|||
162162601|NCT01091168|585643885|FG001|Overall Study|Lost to Follow-up|1|||
162162602|NCT01091168|585643884|FG000|Overall Study|Physician, patient's decision, other|27|||
162162603|NCT01091168|585643885|FG001|Overall Study|Physician, patient's decision, other|37|||
162016770|NCT02892448|585116283|FG001|Overall Study|Screening failure|2|||
162016771|NCT02892448|585116284|FG002|Overall Study|Screening failure|1|||
162016772|NCT01262989|585116285|FG000|Period 1|Lost to Follow-up|1|||
162016773|NCT01262989|585116286|FG001|Period 1|Lost to Follow-up|1|||
162016774|NCT01262989|585116285|FG000|Period 1|Intercurrent disease|0|||
162016775|NCT01262989|585116286|FG001|Period 1|Intercurrent disease|1|||
162016776|NCT01262989|585116285|FG000|Period 1|Positive answer for exclusion criteria|0|||
162016777|NCT01262989|585116286|FG001|Period 1|Positive answer for exclusion criteria|1|||
162016778|NCT01262989|585116285|FG000|Period 2|Intercurrent disease|0|||
162162604|NCT04774237|585643888|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
162162605|NCT04774237|585643889|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
162162606|NCT04774237|585643890|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
162162607|NCT04774237|585643891|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
162162608|NCT04774237|585643892|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
162162609|NCT04774237|585643893|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
162162610|NCT00753090|585645893|FG000|Overall Study|Withdrawal by Subject|10|||
162162611|NCT00753090|585645894|FG001|Overall Study|Withdrawal by Subject|10|||
162162612|NCT00753090|585645893|FG000|Overall Study|Death|17|||
162162613|NCT00753090|585645894|FG001|Overall Study|Death|6|||
162162614|NCT00753090|585645893|FG000|Overall Study|Study Prosthesis Removed|12|||
162162615|NCT00753090|585645894|FG001|Overall Study|Study Prosthesis Removed|3|||
162162616|NCT00753090|585645893|FG000|Overall Study|Lost to Follow-up|2|||
162162617|NCT00753090|585645894|FG001|Overall Study|Lost to Follow-up|2|||
162162618|NCT00753090|585645893|FG000|Overall Study|Other|127|||
162162619|NCT00753090|585645894|FG001|Overall Study|Other|75|||
162162620|NCT04052516|585645896|FG000|Overall Study|Withdrawal by Subject|4|||
162162621|NCT04052516|585645897|FG001|Overall Study|Withdrawal by Subject|5|||
162162622|NCT04052516|585645898|FG002|Overall Study|Withdrawal by Subject|6|||
162162623|NCT04052516|585645896|FG000|Overall Study|Adverse Event|3|||
162162624|NCT04052516|585645897|FG001|Overall Study|Adverse Event|2|||
162162625|NCT04052516|585645898|FG002|Overall Study|Adverse Event|8|||
162016779|NCT01262989|585116286|FG001|Period 2|Intercurrent disease|1|||
162162626|NCT04052516|585645896|FG000|Overall Study|Lost to Follow-up|2|||
162162627|NCT04052516|585645897|FG001|Overall Study|Lost to Follow-up|5|||
162162628|NCT04052516|585645898|FG002|Overall Study|Lost to Follow-up|3|||
162162629|NCT04052516|585645896|FG000|Overall Study|Protocol Violation|1|||
162162630|NCT04052516|585645897|FG001|Overall Study|Protocol Violation|1|||
162162631|NCT04052516|585645898|FG002|Overall Study|Protocol Violation|0|||
162162632|NCT04052516|585645896|FG000|Overall Study|Death|1|||
162162633|NCT04052516|585645897|FG001|Overall Study|Death|0|||
162162634|NCT04052516|585645898|FG002|Overall Study|Death|0|||
162162635|NCT04052516|585645896|FG000|Overall Study|Physician Decision|0|||
162162636|NCT04052516|585645897|FG001|Overall Study|Physician Decision|1|||
162162637|NCT04052516|585645898|FG002|Overall Study|Physician Decision|0|||
162162638|NCT04052516|585645896|FG000|Overall Study|Pregnancy|1|||
162162639|NCT04052516|585645897|FG001|Overall Study|Pregnancy|0|||
162162640|NCT04052516|585645898|FG002|Overall Study|Pregnancy|0|||
162162641|NCT04052516|585645896|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
162162642|NCT04052516|585645897|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
162162643|NCT04052516|585645898|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
162162644|NCT04052516|585645896|FG000|Overall Study|Reason not recorded|0|||
162162645|NCT04052516|585645897|FG001|Overall Study|Reason not recorded|1|||
162162646|NCT04052516|585645898|FG002|Overall Study|Reason not recorded|0|||
162162647|NCT03747484|585645902|FG000|Overall Study|Lack of Efficacy|0|||
162162648|NCT03747484|585645903|FG001|Overall Study|Lack of Efficacy|1|||
162162649|NCT03747484|585645904|FG002|Overall Study|Lack of Efficacy|1|||
162162650|NCT03747484|585645905|FG003|Overall Study|Lack of Efficacy|2|||
162162651|NCT03747484|585645906|FG004|Overall Study|Lack of Efficacy|2|||
162162652|NCT05062265|585645913|FG000|Overall Study|Withdrawal by Subject|1|||
162162653|NCT05062265|585645914|FG001|Overall Study|Withdrawal by Subject|0|||
162162654|NCT03101904|585645918|FG000|Wash Out (10 Days)|Adverse Event|1|||
162162655|NCT03101904|585645919|FG001|Wash Out (10 Days)|Adverse Event|0|||
162162656|NCT03101904|585645918|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
162162657|NCT03101904|585645919|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
162162658|NCT04538417|585645920|FG000|Overall Study|Withdrawal by Subject|2|||
162162659|NCT01180634|585645922|FG000|Overall Study|Adverse Event|4|||
162162660|NCT01180634|585645923|FG001|Overall Study|Adverse Event|1|||
162162661|NCT01180634|585645922|FG000|Overall Study|Miscellaneous|2|||
162162662|NCT01180634|585645923|FG001|Overall Study|Miscellaneous|0|||
162162663|NCT01180634|585645922|FG000|Overall Study|Withdrawal by Subject|4|||
162162664|NCT01180634|585645923|FG001|Overall Study|Withdrawal by Subject|0|||
162162665|NCT06311084|585645924|FG000|Overall Study|Lost to Follow-up|14|||
162162666|NCT04725240|585645925|FG000|Overall Study|Adverse Event|2|||
162162667|NCT03393975|585645930|FG000|Urgent Treatment Period|Physician Decision|0|||
162162668|NCT03393975|585645931|FG001|Urgent Treatment Period|Physician Decision|0|||
162162669|NCT03393975|585645932|FG002|Urgent Treatment Period|Physician Decision|0|||
162162670|NCT03393975|585645933|FG003|Urgent Treatment Period|Physician Decision|1|||
162162671|NCT03393975|585645930|FG000|Prophylaxis Period 1|Reason not Specified|0|||
162162672|NCT03393975|585645931|FG001|Prophylaxis Period 1|Reason not Specified|1|||
162162673|NCT03393975|585645932|FG002|Prophylaxis Period 1|Reason not Specified|0|||
162162674|NCT03393975|585645933|FG003|Prophylaxis Period 1|Reason not Specified|0|||
162162675|NCT03393975|585645930|FG000|Prophylaxis Period 2|Reason not Specified|0|||
162162676|NCT03393975|585645931|FG001|Prophylaxis Period 2|Reason not Specified|1|||
162162677|NCT03393975|585645932|FG002|Prophylaxis Period 2|Reason not Specified|0|||
162162678|NCT03393975|585645933|FG003|Prophylaxis Period 2|Reason not Specified|0|||
162162679|NCT04060355|585645936|FG000|Overall Study|Lost to Follow-up|41|||
162162680|NCT01140880|585645937|FG000|Overall Study|Death|0|||
162162681|NCT01140880|585645938|FG001|Overall Study|Death|1|||
162162682|NCT01140880|585645937|FG000|Overall Study|Withdrawal by Subject|6|||
162162683|NCT01140880|585645938|FG001|Overall Study|Withdrawal by Subject|3|||
162162684|NCT01140880|585645937|FG000|Overall Study|Lost to Follow-up|8|||
162162685|NCT01140880|585645938|FG001|Overall Study|Lost to Follow-up|10|||
162162686|NCT01140880|585645937|FG000|Overall Study|Protocol Violation|0|||
162162687|NCT01140880|585645938|FG001|Overall Study|Protocol Violation|30|||
162162688|NCT04421378|585645943|FG000|Overall Study|Adverse Event|2|||
162162689|NCT04421378|585645944|FG001|Overall Study|Adverse Event|7|||
162162690|NCT04421378|585645945|FG002|Overall Study|Adverse Event|0|||
162162691|NCT04421378|585645946|FG003|Overall Study|Adverse Event|1|||
162162692|NCT04421378|585645947|FG004|Overall Study|Adverse Event|0|||
162162693|NCT04421378|585645943|FG000|Overall Study|Physician Decision|1|||
162162694|NCT04421378|585645944|FG001|Overall Study|Physician Decision|2|||
162162695|NCT04421378|585645945|FG002|Overall Study|Physician Decision|0|||
162162696|NCT04421378|585645946|FG003|Overall Study|Physician Decision|0|||
162162697|NCT04421378|585645947|FG004|Overall Study|Physician Decision|0|||
162162698|NCT04421378|585645943|FG000|Overall Study|Progressive Disease|16|||
162162699|NCT04421378|585645944|FG001|Overall Study|Progressive Disease|4|||
162162700|NCT04421378|585645945|FG002|Overall Study|Progressive Disease|18|||
162162701|NCT04421378|585645946|FG003|Overall Study|Progressive Disease|11|||
162162702|NCT04421378|585645947|FG004|Overall Study|Progressive Disease|3|||
162162703|NCT04421378|585645943|FG000|Overall Study|Study Terminated by Sponsor|0|||
162162704|NCT04421378|585645944|FG001|Overall Study|Study Terminated by Sponsor|1|||
162162705|NCT04421378|585645945|FG002|Overall Study|Study Terminated by Sponsor|1|||
162162706|NCT04421378|585645946|FG003|Overall Study|Study Terminated by Sponsor|0|||
162162707|NCT04421378|585645947|FG004|Overall Study|Study Terminated by Sponsor|0|||
162162708|NCT04421378|585645943|FG000|Overall Study|Withdrawal by Subject|3|||
162162709|NCT04421378|585645944|FG001|Overall Study|Withdrawal by Subject|1|||
162162710|NCT04421378|585645945|FG002|Overall Study|Withdrawal by Subject|0|||
162162711|NCT04421378|585645946|FG003|Overall Study|Withdrawal by Subject|2|||
162162712|NCT04421378|585645947|FG004|Overall Study|Withdrawal by Subject|0|||
162162713|NCT04421378|585645943|FG000|Overall Study|Other|1|||
162162714|NCT04421378|585645944|FG001|Overall Study|Other|0|||
162162715|NCT04421378|585645945|FG002|Overall Study|Other|0|||
162162716|NCT04421378|585645946|FG003|Overall Study|Other|0|||
162162717|NCT04421378|585645947|FG004|Overall Study|Other|0|||
162162718|NCT04258709|585645948|FG000|Overall Study|Lost to Follow-up|10|||
162162719|NCT04258709|585645949|FG001|Overall Study|Lost to Follow-up|4|||
162162720|NCT04258709|585645948|FG000|Overall Study|Withdrawal by Subject|1|||
162162721|NCT04258709|585645949|FG001|Overall Study|Withdrawal by Subject|0|||
162162722|NCT04258709|585645948|FG000|Overall Study|Fetal demise|0|||
162162723|NCT04258709|585645949|FG001|Overall Study|Fetal demise|1|||
162162724|NCT04258709|585645948|FG000|Overall Study|Protocol Violation|1|||
162162725|NCT04258709|585645949|FG001|Overall Study|Protocol Violation|1|||
162162726|NCT02592330|585645950|FG000|Overall Study|Withdrawal by Subject|1|||
162162727|NCT02592330|585645951|FG001|Overall Study|Withdrawal by Subject|0|||
162162728|NCT02592330|585645950|FG000|Overall Study|Failed Biopsy|1|||
162162729|NCT02592330|585645951|FG001|Overall Study|Failed Biopsy|0|||
162162730|NCT03090152|585645952|FG000|Overall Study|Withdrawal by Subject|0|||
162162731|NCT03090152|585645953|FG001|Overall Study|Withdrawal by Subject|2|||
162162732|NCT03090152|585645954|FG002|Overall Study|Withdrawal by Subject|1|||
162162733|NCT03090152|585645952|FG000|Overall Study|Surgery Canceled|1|||
162162734|NCT03090152|585645953|FG001|Overall Study|Surgery Canceled|0|||
162162735|NCT03090152|585645954|FG002|Overall Study|Surgery Canceled|0|||
162162736|NCT03090152|585645952|FG000|Overall Study|Epidural catheter could not be placed|0|||
162162737|NCT03090152|585645953|FG001|Overall Study|Epidural catheter could not be placed|2|||
162162738|NCT03090152|585645954|FG002|Overall Study|Epidural catheter could not be placed|0|||
162162739|NCT04673929|585645955|FG000|Overall Study|Death|73|||
162162740|NCT04673929|585645955|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
162162741|NCT05082909|585645959|FG000|Overall Study|Protocol Violation|0|||
162162742|NCT05082909|585645960|FG001|Overall Study|Protocol Violation|0|||
162162743|NCT05082909|585645961|FG002|Overall Study|Protocol Violation|1|||
162162744|NCT05082909|585645962|FG003|Overall Study|Protocol Violation|0|||
162162745|NCT05082909|585645963|FG004|Overall Study|Protocol Violation|0|||
162162746|NCT05082909|585645964|FG005|Overall Study|Protocol Violation|0|||
162162747|NCT04088630|585645965|FG000|Overall Study|Lost to Follow-up|3|||
162162748|NCT04088630|585645966|FG001|Overall Study|Lost to Follow-up|2|||
161815254|NCT00147498|584366933|FG001|Overall Study|Other|1|||
162162749|NCT04088630|585645967|FG002|Overall Study|Lost to Follow-up|6|||
162162750|NCT04088630|585645965|FG000|Overall Study|Death|3|||
162162751|NCT04088630|585645966|FG001|Overall Study|Death|1|||
162162752|NCT04088630|585645967|FG002|Overall Study|Death|1|||
162162753|NCT04088630|585645965|FG000|Overall Study|Physician Decision|0|||
162162754|NCT04088630|585645966|FG001|Overall Study|Physician Decision|1|||
162162755|NCT04088630|585645967|FG002|Overall Study|Physician Decision|1|||
162162756|NCT03175029|585645970|FG000|Overall Study|Withdrawal by Subject|2|||
162162757|NCT03175029|585645971|FG001|Overall Study|Withdrawal by Subject|1|||
162162758|NCT03175029|585645970|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
162162759|NCT03175029|585645971|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
162162760|NCT04089371|585645974|FG000|Overall Study|Withdrawal by Subject|0|||
162162761|NCT04089371|585645975|FG001|Overall Study|Withdrawal by Subject|1|||
162162762|NCT04089371|585645974|FG000|Overall Study|Study terminated early|0|||
162162763|NCT04089371|585645975|FG001|Overall Study|Study terminated early|9|||
162162764|NCT03453619|585645976|FG000|Core Study (Part A)|Physician Decision|0|||
162162765|NCT03453619|585645977|FG001|Core Study (Part A)|Physician Decision|0|||
162162766|NCT03453619|585645978|FG002|Core Study (Part A)|Physician Decision|2|||
162162767|NCT03453619|585645979|FG003|Core Study (Part A)|Physician Decision|0|||
162162768|NCT03453619|585645976|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
162162769|NCT03453619|585645977|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
162162770|NCT03453619|585645978|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
162162771|NCT03453619|585645979|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
162162772|NCT03453619|585645976|FG000|Core Study (Part A)|Other|0|||
162162773|NCT03453619|585645977|FG001|Core Study (Part A)|Other|1|||
162162774|NCT03453619|585645978|FG002|Core Study (Part A)|Other|0|||
162162775|NCT03453619|585645979|FG003|Core Study (Part A)|Other|0|||
162162776|NCT03453619|585645976|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
162162777|NCT03453619|585645977|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
162162778|NCT03453619|585645978|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
162162779|NCT03453619|585645979|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
162162780|NCT03453619|585645976|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
162162781|NCT03453619|585645977|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
162162782|NCT03453619|585645978|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
162162783|NCT03453619|585645979|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
162162784|NCT03453619|585645976|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
162162785|NCT03453619|585645977|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
162162786|NCT03453619|585645978|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
162162787|NCT03453619|585645979|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
162162788|NCT03453619|585645976|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
162162789|NCT03453619|585645977|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
162162790|NCT03453619|585645978|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
162162791|NCT03453619|585645979|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
162162792|NCT04382898|585645980|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
162162793|NCT04382898|585645981|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
162162794|NCT04382898|585645982|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
162162795|NCT04382898|585645983|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
162162796|NCT04382898|585645984|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
162162797|NCT04382898|585645980|FG000|Part 1: Dose Titration|Death|6|||
162162798|NCT04382898|585645981|FG001|Part 1: Dose Titration|Death|0|||
162162799|NCT04382898|585645982|FG002|Part 1: Dose Titration|Death|0|||
162162800|NCT04382898|585645983|FG003|Part 1: Dose Titration|Death|0|||
162162801|NCT04382898|585645984|FG004|Part 1: Dose Titration|Death|0|||
162162802|NCT04382898|585645980|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162162803|NCT04382898|585645981|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162162804|NCT04382898|585645982|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
162162805|NCT04382898|585645983|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162162806|NCT04382898|585645984|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
162162807|NCT04382898|585645980|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
162162808|NCT04382898|585645981|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
162162809|NCT04382898|585645982|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
162162810|NCT04382898|585645983|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
162162811|NCT04382898|585645984|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
162162812|NCT04382898|585645980|FG000|Part 2: Dose Expansion|Death|0|||
162162813|NCT04382898|585645981|FG001|Part 2: Dose Expansion|Death|17|||
162162814|NCT04382898|585645982|FG002|Part 2: Dose Expansion|Death|13|||
162162815|NCT04382898|585645983|FG003|Part 2: Dose Expansion|Death|1|||
162162816|NCT04382898|585645984|FG004|Part 2: Dose Expansion|Death|0|||
162162817|NCT04382898|585645980|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
162162818|NCT04382898|585645981|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
162162819|NCT04382898|585645982|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
161815255|NCT00147498|584366934|FG002|Overall Study|Other|3|||
161815256|NCT00147498|584366935|FG003|Overall Study|Other|3|||
162162820|NCT04382898|585645983|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
162162821|NCT04382898|585645984|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
162162822|NCT04382898|585645980|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
161815257|NCT01841554|584366936|FG000|Overall Study|Death|7|||
162162823|NCT04382898|585645981|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
161815258|NCT01841554|584366936|FG000|Overall Study|No Implantation|1|||
162162824|NCT04382898|585645982|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
162162825|NCT04382898|585645983|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
162162826|NCT04382898|585645984|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
162162827|NCT04382898|585645980|FG000|Part 2: Dose Expansion|Other|0|||
162162828|NCT04382898|585645981|FG001|Part 2: Dose Expansion|Other|0|||
162162829|NCT04382898|585645982|FG002|Part 2: Dose Expansion|Other|1|||
162162830|NCT04382898|585645983|FG003|Part 2: Dose Expansion|Other|0|||
162162831|NCT04382898|585645984|FG004|Part 2: Dose Expansion|Other|0|||
162162832|NCT05229120|585645985|FG000|Overall Study|Withdrawal by Subject|8|||
162162833|NCT03932682|585645988|FG000|Overall Study|Death|1|||
162162834|NCT03932682|585645989|FG001|Overall Study|Death|2|||
162162835|NCT03932682|585645988|FG000|Overall Study|Withdrawal by Subject|37|||
162162836|NCT03932682|585645989|FG001|Overall Study|Withdrawal by Subject|45|||
162162837|NCT03932682|585645988|FG000|Overall Study|Lost to Follow-up|19|||
162162838|NCT03932682|585645989|FG001|Overall Study|Lost to Follow-up|25|||
162162839|NCT03932682|585645988|FG000|Overall Study|Protocol Violation|0|||
162162840|NCT03932682|585645989|FG001|Overall Study|Protocol Violation|2|||
162162841|NCT03932682|585645988|FG000|Overall Study|Other|9|||
162162842|NCT03932682|585645989|FG001|Overall Study|Other|23|||
162162843|NCT04321031|585645990|FG000|Overall Study|Adverse Event|0|||
162162844|NCT04321031|585645991|FG001|Overall Study|Adverse Event|2|||
162162845|NCT04321031|585645992|FG002|Overall Study|Adverse Event|2|||
162162846|NCT04321031|585645993|FG003|Overall Study|Adverse Event|2|||
162162847|NCT04321031|585645994|FG004|Overall Study|Adverse Event|2|||
162162848|NCT04321031|585645995|FG005|Overall Study|Adverse Event|2|||
162162849|NCT04321031|585645996|FG006|Overall Study|Adverse Event|0|||
162162850|NCT04321031|585645990|FG000|Overall Study|Lost to Follow-up|0|||
162162851|NCT04321031|585645991|FG001|Overall Study|Lost to Follow-up|0|||
162162852|NCT04321031|585645992|FG002|Overall Study|Lost to Follow-up|0|||
162162853|NCT04321031|585645993|FG003|Overall Study|Lost to Follow-up|1|||
162162854|NCT04321031|585645994|FG004|Overall Study|Lost to Follow-up|0|||
162162855|NCT04321031|585645995|FG005|Overall Study|Lost to Follow-up|2|||
162162856|NCT04321031|585645996|FG006|Overall Study|Lost to Follow-up|1|||
162162857|NCT04321031|585645990|FG000|Overall Study|Withdrawal by Subject|2|||
162162858|NCT04321031|585645991|FG001|Overall Study|Withdrawal by Subject|2|||
161815259|NCT01841554|584366936|FG000|Overall Study|Discontinued Follow Up|5|||
161815260|NCT01841554|584366936|FG000|Overall Study|Study exit due to secondary intervention|6|||
161815261|NCT01838681|584366937|FG000|Period A|Adverse Event|39|||
161815262|NCT01838681|584366938|FG001|Period A|Adverse Event|0|||
161815263|NCT01838681|584366939|FG002|Period A|Adverse Event|0|||
161815264|NCT01838681|584366940|FG003|Period A|Adverse Event|0|||
161815265|NCT01838681|584366937|FG000|Period A|Lack of Efficacy|21|||
161815266|NCT01838681|584366938|FG001|Period A|Lack of Efficacy|0|||
161815267|NCT01838681|584366939|FG002|Period A|Lack of Efficacy|0|||
161815268|NCT01838681|584366940|FG003|Period A|Lack of Efficacy|0|||
161815269|NCT01838681|584366937|FG000|Period A|Early response|148|||
162162859|NCT04321031|585645992|FG002|Overall Study|Withdrawal by Subject|1|||
162162860|NCT04321031|585645993|FG003|Overall Study|Withdrawal by Subject|3|||
162162861|NCT04321031|585645994|FG004|Overall Study|Withdrawal by Subject|1|||
162162862|NCT04321031|585645995|FG005|Overall Study|Withdrawal by Subject|0|||
162162863|NCT04321031|585645996|FG006|Overall Study|Withdrawal by Subject|1|||
162162864|NCT04321031|585645990|FG000|Overall Study|Non-compliance with study drug|0|||
161815270|NCT01838681|584366938|FG001|Period A|Early response|0|||
161815271|NCT01838681|584366939|FG002|Period A|Early response|0|||
161815272|NCT01838681|584366940|FG003|Period A|Early response|0|||
161815273|NCT01838681|584366937|FG000|Period A|Withdrawal by Subject|70|||
161815274|NCT01838681|584366938|FG001|Period A|Withdrawal by Subject|0|||
162162865|NCT04321031|585645991|FG001|Overall Study|Non-compliance with study drug|0|||
162162866|NCT04321031|585645992|FG002|Overall Study|Non-compliance with study drug|0|||
162162867|NCT04321031|585645993|FG003|Overall Study|Non-compliance with study drug|0|||
162162868|NCT04321031|585645994|FG004|Overall Study|Non-compliance with study drug|0|||
162162869|NCT04321031|585645995|FG005|Overall Study|Non-compliance with study drug|1|||
162162870|NCT04321031|585645996|FG006|Overall Study|Non-compliance with study drug|0|||
162162871|NCT04321031|585645990|FG000|Overall Study|Other|0|||
162162872|NCT04321031|585645991|FG001|Overall Study|Other|0|||
162162873|NCT04321031|585645992|FG002|Overall Study|Other|0|||
162162874|NCT04321031|585645993|FG003|Overall Study|Other|1|||
162162875|NCT04321031|585645994|FG004|Overall Study|Other|0|||
162162876|NCT04321031|585645995|FG005|Overall Study|Other|0|||
162162877|NCT04321031|585645996|FG006|Overall Study|Other|0|||
162162878|NCT04237298|585645997|FG000|Overall Study|Lost to Follow-up|4|||
162162879|NCT04237298|585645998|FG001|Overall Study|Lost to Follow-up|5|||
162162880|NCT04556656|585646002|FG000|Overall Study|Withdrawal by Subject|14|||
162162881|NCT04556656|585646003|FG001|Overall Study|Withdrawal by Subject|12|||
162162882|NCT04556656|585646002|FG000|Overall Study|Physician Decision|1|||
162162883|NCT04556656|585646003|FG001|Overall Study|Physician Decision|0|||
162162884|NCT04556656|585646002|FG000|Overall Study|Adverse Event|4|||
162162885|NCT04556656|585646003|FG001|Overall Study|Adverse Event|7|||
162162886|NCT04556656|585646002|FG000|Overall Study|Death|4|||
162162887|NCT04556656|585646003|FG001|Overall Study|Death|0|||
161815275|NCT01838681|584366939|FG002|Period A|Withdrawal by Subject|0|||
161815276|NCT01838681|584366940|FG003|Period A|Withdrawal by Subject|0|||
162162888|NCT04556656|585646002|FG000|Overall Study|Lost to Follow-up|3|||
162162889|NCT04556656|585646003|FG001|Overall Study|Lost to Follow-up|2|||
162162890|NCT04556656|585646002|FG000|Overall Study|Not further specified|2|||
162162891|NCT04556656|585646003|FG001|Overall Study|Not further specified|1|||
162162892|NCT05536440|585646004|FG000|Overall Study|Adverse Event|0|||
162162893|NCT05536440|585646005|FG001|Overall Study|Adverse Event|0|||
162162894|NCT05536440|585646006|FG002|Overall Study|Adverse Event|0|||
162162895|NCT05536440|585646007|FG003|Overall Study|Adverse Event|0|||
162162896|NCT05536440|585646008|FG004|Overall Study|Adverse Event|0|||
162162897|NCT05536440|585646009|FG005|Overall Study|Adverse Event|0|||
162162898|NCT05536440|585646010|FG006|Overall Study|Adverse Event|0|||
162162899|NCT05536440|585646011|FG007|Overall Study|Adverse Event|0|||
162162900|NCT05536440|585646012|FG008|Overall Study|Adverse Event|1|||
162162901|NCT01566695|585646015|FG000|Overall Study|Lack of Efficacy|1|||
162162902|NCT01566695|585646016|FG001|Overall Study|Lack of Efficacy|0|||
162162903|NCT01566695|585646015|FG000|Overall Study|Adverse Event|3|||
162162904|NCT01566695|585646016|FG001|Overall Study|Adverse Event|0|||
162162905|NCT01566695|585646015|FG000|Overall Study|Death|79|||
162162906|NCT01566695|585646016|FG001|Overall Study|Death|86|||
162162907|NCT01566695|585646015|FG000|Overall Study|Withdrawal by Subject|13|||
162162908|NCT01566695|585646016|FG001|Overall Study|Withdrawal by Subject|12|||
162162909|NCT01566695|585646015|FG000|Overall Study|Lost to Follow-up|0|||
162162910|NCT01566695|585646016|FG001|Overall Study|Lost to Follow-up|3|||
162162911|NCT01566695|585646015|FG000|Overall Study|Other reasons|11|||
162162912|NCT01566695|585646016|FG001|Overall Study|Other reasons|8|||
162162913|NCT01416831|585646018|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
162162914|NCT01416831|585646019|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
162162915|NCT05470400|585646020|FG000|Overall Study|Lost to Follow-up|0|||
162162916|NCT05470400|585646021|FG001|Overall Study|Lost to Follow-up|0|||
162162917|NCT05470400|585646022|FG002|Overall Study|Lost to Follow-up|0|||
162162918|NCT05470400|585646023|FG003|Overall Study|Lost to Follow-up|0|||
162162919|NCT05470400|585646024|FG004|Overall Study|Lost to Follow-up|0|||
162162920|NCT05470400|585646025|FG005|Overall Study|Lost to Follow-up|0|||
162162921|NCT05470400|585646026|FG006|Overall Study|Lost to Follow-up|0|||
162162922|NCT05470400|585646027|FG007|Overall Study|Lost to Follow-up|1|||
162162923|NCT05470400|585646020|FG000|Overall Study|Withdrawal by Subject|1|||
162162924|NCT05470400|585646021|FG001|Overall Study|Withdrawal by Subject|0|||
162162925|NCT05470400|585646022|FG002|Overall Study|Withdrawal by Subject|0|||
162162926|NCT05470400|585646023|FG003|Overall Study|Withdrawal by Subject|0|||
162162927|NCT05470400|585646024|FG004|Overall Study|Withdrawal by Subject|0|||
161815277|NCT01838681|584366937|FG000|Period A|Protocol Violation|16|||
161815278|NCT01838681|584366938|FG001|Period A|Protocol Violation|0|||
162162928|NCT05470400|585646025|FG005|Overall Study|Withdrawal by Subject|1|||
162162929|NCT05470400|585646026|FG006|Overall Study|Withdrawal by Subject|0|||
162162930|NCT05470400|585646027|FG007|Overall Study|Withdrawal by Subject|2|||
162162931|NCT05956002|585646028|FG000|Treatment Period 3|Adverse Event|0|||
162162932|NCT05956002|585646029|FG001|Treatment Period 3|Adverse Event|0|||
162162933|NCT05956002|585646030|FG002|Treatment Period 3|Adverse Event|1|||
162162934|NCT05956002|585646031|FG003|Treatment Period 3|Adverse Event|0|||
162162935|NCT04784559|585646032|FG000|Overall Study|Withdrawal by Subject|3|||
162162936|NCT04784559|585646033|FG001|Overall Study|Withdrawal by Subject|2|||
162162937|NCT04784559|585646034|FG002|Overall Study|Withdrawal by Subject|1|||
162162938|NCT04784559|585646032|FG000|Overall Study|Death|2|||
162162939|NCT04784559|585646033|FG001|Overall Study|Death|1|||
162162940|NCT04784559|585646034|FG002|Overall Study|Death|2|||
162162941|NCT04784559|585646032|FG000|Overall Study|Lost to Follow-up|0|||
162162942|NCT04784559|585646033|FG001|Overall Study|Lost to Follow-up|0|||
162162943|NCT04784559|585646034|FG002|Overall Study|Lost to Follow-up|2|||
162162944|NCT04784559|585646032|FG000|Overall Study|Participant worsened, PI decision|1|||
162162945|NCT04784559|585646033|FG001|Overall Study|Participant worsened, PI decision|0|||
162162946|NCT04784559|585646034|FG002|Overall Study|Participant worsened, PI decision|0|||
162162947|NCT04784559|585646032|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
162162948|NCT04784559|585646033|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
162162949|NCT04784559|585646034|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
162162950|NCT04784559|585646032|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
162162951|NCT04784559|585646033|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
162162952|NCT04784559|585646034|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
162162953|NCT04784559|585646032|FG000|Overall Study|Did not meet all inclusion criteria|0|||
162162954|NCT04784559|585646033|FG001|Overall Study|Did not meet all inclusion criteria|1|||
162162955|NCT04784559|585646034|FG002|Overall Study|Did not meet all inclusion criteria|0|||
162162956|NCT04784559|585646032|FG000|Overall Study|The participant was transferred to IRCU|0|||
162162957|NCT04784559|585646033|FG001|Overall Study|The participant was transferred to IRCU|1|||
162162958|NCT04784559|585646034|FG002|Overall Study|The participant was transferred to IRCU|0|||
162162959|NCT04784559|585646032|FG000|Overall Study|SAE|0|||
162162960|NCT04784559|585646033|FG001|Overall Study|SAE|1|||
162162961|NCT04784559|585646034|FG002|Overall Study|SAE|0|||
162162962|NCT04784559|585646032|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
162162963|NCT04784559|585646033|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
162162964|NCT04784559|585646034|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
162162965|NCT03338790|585646035|FG000|Overall Study|Disease Progression|65|||
162162966|NCT03338790|585646036|FG001|Overall Study|Disease Progression|43|||
162162967|NCT03338790|585646037|FG002|Overall Study|Disease Progression|50|||
162162968|NCT03338790|585646038|FG003|Overall Study|Disease Progression|37|||
162162969|NCT03338790|585646035|FG000|Overall Study|Study Drug Toxicity|9|||
162162970|NCT03338790|585646036|FG001|Overall Study|Study Drug Toxicity|8|||
162162971|NCT03338790|585646037|FG002|Overall Study|Study Drug Toxicity|15|||
162162972|NCT03338790|585646038|FG003|Overall Study|Study Drug Toxicity|0|||
162162973|NCT03338790|585646035|FG000|Overall Study|Death|1|||
162162974|NCT03338790|585646036|FG001|Overall Study|Death|1|||
162162975|NCT03338790|585646037|FG002|Overall Study|Death|1|||
162162976|NCT03338790|585646038|FG003|Overall Study|Death|0|||
162162977|NCT03338790|585646035|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
162162978|NCT03338790|585646036|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
162162979|NCT03338790|585646037|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
162162980|NCT03338790|585646038|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
162162981|NCT03338790|585646035|FG000|Overall Study|Participant request to discontinue study treatment|3|||
162162982|NCT03338790|585646036|FG001|Overall Study|Participant request to discontinue study treatment|3|||
162162983|NCT03338790|585646037|FG002|Overall Study|Participant request to discontinue study treatment|2|||
162162984|NCT03338790|585646038|FG003|Overall Study|Participant request to discontinue study treatment|1|||
162162985|NCT03338790|585646035|FG000|Overall Study|Poor/non-compliance|0|||
162162986|NCT03338790|585646036|FG001|Overall Study|Poor/non-compliance|1|||
162162987|NCT03338790|585646037|FG002|Overall Study|Poor/non-compliance|0|||
162162988|NCT03338790|585646038|FG003|Overall Study|Poor/non-compliance|0|||
162162989|NCT03338790|585646035|FG000|Overall Study|Participant withdrew consent|1|||
162162990|NCT03338790|585646036|FG001|Overall Study|Participant withdrew consent|0|||
162162991|NCT03338790|585646037|FG002|Overall Study|Participant withdrew consent|1|||
162162992|NCT03338790|585646038|FG003|Overall Study|Participant withdrew consent|1|||
162162993|NCT03338790|585646035|FG000|Overall Study|Other reasons|0|||
162162994|NCT03338790|585646036|FG001|Overall Study|Other reasons|5|||
162162995|NCT03338790|585646037|FG002|Overall Study|Other reasons|0|||
162162996|NCT03338790|585646038|FG003|Overall Study|Other reasons|2|||
162162997|NCT03338790|585646035|FG000|Overall Study|Not reported|0|||
162162998|NCT03338790|585646036|FG001|Overall Study|Not reported|0|||
162162999|NCT03338790|585646037|FG002|Overall Study|Not reported|1|||
162163000|NCT03338790|585646038|FG003|Overall Study|Not reported|0|||
162163001|NCT03338790|585646035|FG000|Overall Study|Completed treatment period|1|||
162163002|NCT03338790|585646036|FG001|Overall Study|Completed treatment period|2|||
162163003|NCT03338790|585646037|FG002|Overall Study|Completed treatment period|0|||
162163004|NCT03338790|585646038|FG003|Overall Study|Completed treatment period|0|||
162163005|NCT04588298|585646039|FG000|Overall Study|Adverse Event|0|||
162163006|NCT04588298|585646040|FG001|Overall Study|Adverse Event|0|||
162163007|NCT04588298|585646041|FG002|Overall Study|Adverse Event|1|||
162163008|NCT04588298|585646042|FG003|Overall Study|Adverse Event|0|||
162163009|NCT04588298|585646043|FG004|Overall Study|Adverse Event|2|||
162163010|NCT04588298|585646039|FG000|Overall Study|Withdrawal by Subject|1|||
162163011|NCT04588298|585646040|FG001|Overall Study|Withdrawal by Subject|0|||
162163012|NCT04588298|585646041|FG002|Overall Study|Withdrawal by Subject|0|||
162163013|NCT04588298|585646042|FG003|Overall Study|Withdrawal by Subject|1|||
162163014|NCT04588298|585646043|FG004|Overall Study|Withdrawal by Subject|0|||
162163015|NCT02281955|585646044|FG000|Overall Study|Death|1|||
162163016|NCT03892616|585646045|FG000|Washout Period 2|Met discontinuation criterion|0|||
162163017|NCT03892616|585646046|FG001|Washout Period 2|Met discontinuation criterion|0|||
162163018|NCT03892616|585646047|FG002|Washout Period 2|Met discontinuation criterion|0|||
162163019|NCT03892616|585646048|FG003|Washout Period 2|Met discontinuation criterion|0|||
162163020|NCT03892616|585646049|FG004|Washout Period 2|Met discontinuation criterion|0|||
162163021|NCT03892616|585646050|FG005|Washout Period 2|Met discontinuation criterion|0|||
162163022|NCT03892616|585646051|FG006|Washout Period 2|Met discontinuation criterion|0|||
162163023|NCT03892616|585646052|FG007|Washout Period 2|Met discontinuation criterion|0|||
162163024|NCT03892616|585646053|FG008|Washout Period 2|Met discontinuation criterion|1|||
162163025|NCT03892616|585646054|FG009|Washout Period 2|Met discontinuation criterion|0|||
162163026|NCT03892616|585646055|FG010|Washout Period 2|Met discontinuation criterion|0|||
162163027|NCT03892616|585646056|FG011|Washout Period 2|Met discontinuation criterion|0|||
162163028|NCT03683719|585646057|FG000|Overall Study|Lack of Efficacy|1|||
162163029|NCT03683719|585646058|FG001|Overall Study|Lack of Efficacy|3|||
162163030|NCT03683719|585646059|FG002|Overall Study|Lack of Efficacy|4|||
162163031|NCT03683719|585646060|FG003|Overall Study|Lack of Efficacy|0|||
162163032|NCT03683719|585646061|FG004|Overall Study|Lack of Efficacy|4|||
162163033|NCT03683719|585646057|FG000|Overall Study|Adverse Event|6|||
162163034|NCT03683719|585646058|FG001|Overall Study|Adverse Event|6|||
162163035|NCT03683719|585646059|FG002|Overall Study|Adverse Event|0|||
162163036|NCT03683719|585646060|FG003|Overall Study|Adverse Event|1|||
162163037|NCT03683719|585646061|FG004|Overall Study|Adverse Event|3|||
162163038|NCT03683719|585646057|FG000|Overall Study|Withdrawal by Subject|4|||
162163039|NCT03683719|585646058|FG001|Overall Study|Withdrawal by Subject|4|||
162163040|NCT03683719|585646059|FG002|Overall Study|Withdrawal by Subject|3|||
162163041|NCT03683719|585646060|FG003|Overall Study|Withdrawal by Subject|5|||
162163042|NCT03683719|585646061|FG004|Overall Study|Withdrawal by Subject|5|||
162163043|NCT03683719|585646057|FG000|Overall Study|Lost to Follow-up|1|||
162163044|NCT03683719|585646058|FG001|Overall Study|Lost to Follow-up|0|||
162163045|NCT03683719|585646059|FG002|Overall Study|Lost to Follow-up|0|||
162163046|NCT03683719|585646060|FG003|Overall Study|Lost to Follow-up|1|||
162163047|NCT03683719|585646061|FG004|Overall Study|Lost to Follow-up|1|||
162163048|NCT03683719|585646057|FG000|Overall Study|Other personal reasons|0|||
162163049|NCT03683719|585646058|FG001|Overall Study|Other personal reasons|0|||
162163050|NCT03683719|585646059|FG002|Overall Study|Other personal reasons|1|||
162163051|NCT03683719|585646060|FG003|Overall Study|Other personal reasons|0|||
162163052|NCT03683719|585646061|FG004|Overall Study|Other personal reasons|1|||
162163053|NCT05113966|585647514|FG000|Overall Study|Death|21|||
162163054|NCT05113966|585647514|FG000|Overall Study|Study Terminated by Sponsor|9|||
162163055|NCT04521478|585647515|FG000|Overall Study|Protocol Violation|2|||
162163056|NCT04521478|585647516|FG001|Overall Study|Protocol Violation|0|||
162163057|NCT04521478|585647517|FG002|Overall Study|Protocol Violation|1|||
162163058|NCT04521478|585647518|FG003|Overall Study|Protocol Violation|0|||
162163059|NCT04521478|585647519|FG004|Overall Study|Protocol Violation|0|||
162163060|NCT04521478|585647520|FG005|Overall Study|Protocol Violation|0|||
162163061|NCT04521478|585647515|FG000|Overall Study|Technical Problems|0|||
162163062|NCT04521478|585647516|FG001|Overall Study|Technical Problems|0|||
161683056|NCT00666458|583891220|FG001|Overall Study|Medical history of anemia|0|||
162163063|NCT04521478|585647517|FG002|Overall Study|Technical Problems|0|||
162163064|NCT04521478|585647518|FG003|Overall Study|Technical Problems|1|||
162163065|NCT04521478|585647519|FG004|Overall Study|Technical Problems|0|||
162163066|NCT04521478|585647520|FG005|Overall Study|Technical Problems|0|||
162163067|NCT04521478|585647515|FG000|Overall Study|Burden of Study Procedures|1|||
162163068|NCT04521478|585647516|FG001|Overall Study|Burden of Study Procedures|0|||
162163069|NCT04521478|585647517|FG002|Overall Study|Burden of Study Procedures|0|||
162163070|NCT04521478|585647518|FG003|Overall Study|Burden of Study Procedures|1|||
161815279|NCT01838681|584366939|FG002|Period A|Protocol Violation|0|||
161815280|NCT01838681|584366940|FG003|Period A|Protocol Violation|0|||
162163071|NCT04521478|585647519|FG004|Overall Study|Burden of Study Procedures|0|||
162163072|NCT04521478|585647520|FG005|Overall Study|Burden of Study Procedures|1|||
162163073|NCT04521478|585647515|FG000|Overall Study|Lack of Efficacy|0|||
162163074|NCT04521478|585647516|FG001|Overall Study|Lack of Efficacy|0|||
162163075|NCT04521478|585647517|FG002|Overall Study|Lack of Efficacy|0|||
162163076|NCT04521478|585647518|FG003|Overall Study|Lack of Efficacy|0|||
162163077|NCT04521478|585647519|FG004|Overall Study|Lack of Efficacy|1|||
162163078|NCT04521478|585647520|FG005|Overall Study|Lack of Efficacy|1|||
162163079|NCT04521478|585647515|FG000|Overall Study|Adverse Event|7|||
162163080|NCT04521478|585647516|FG001|Overall Study|Adverse Event|0|||
162163081|NCT04521478|585647517|FG002|Overall Study|Adverse Event|2|||
162163082|NCT04521478|585647518|FG003|Overall Study|Adverse Event|1|||
162163083|NCT04521478|585647519|FG004|Overall Study|Adverse Event|2|||
162163084|NCT04521478|585647520|FG005|Overall Study|Adverse Event|7|||
162163085|NCT04521478|585647515|FG000|Overall Study|No Reason Available|0|||
162163086|NCT04521478|585647516|FG001|Overall Study|No Reason Available|2|||
162163087|NCT04521478|585647517|FG002|Overall Study|No Reason Available|0|||
162163088|NCT04521478|585647518|FG003|Overall Study|No Reason Available|0|||
162163089|NCT04521478|585647519|FG004|Overall Study|No Reason Available|1|||
162163090|NCT04521478|585647520|FG005|Overall Study|No Reason Available|0|||
162163091|NCT04521478|585647515|FG000|Overall Study|Other than listed|3|||
162163092|NCT04521478|585647516|FG001|Overall Study|Other than listed|3|||
162163093|NCT04521478|585647517|FG002|Overall Study|Other than listed|3|||
162163094|NCT04521478|585647518|FG003|Overall Study|Other than listed|2|||
162163095|NCT04521478|585647519|FG004|Overall Study|Other than listed|3|||
162163096|NCT04521478|585647520|FG005|Overall Study|Other than listed|3|||
162163097|NCT04521478|585647515|FG000|Overall Study|Not treated|0|||
162163098|NCT04521478|585647516|FG001|Overall Study|Not treated|0|||
162163099|NCT04521478|585647517|FG002|Overall Study|Not treated|0|||
162163100|NCT04521478|585647518|FG003|Overall Study|Not treated|0|||
162163101|NCT04521478|585647519|FG004|Overall Study|Not treated|0|||
162163102|NCT04521478|585647520|FG005|Overall Study|Not treated|1|||
162163103|NCT02630823|585647535|FG000|Overall Study|Withdrawal by Subject|1|||
162163104|NCT02630823|585647535|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
162163105|NCT02682316|585647547|FG000|Overall Study|Benign Final Pathology|27|||
162163106|NCT02682316|585647548|FG001|Overall Study|Benign Final Pathology|26|||
162163107|NCT02682316|585647547|FG000|Overall Study|Reoperation before 30 days|7|||
162163108|NCT02682316|585647548|FG001|Overall Study|Reoperation before 30 days|6|||
162163109|NCT02682316|585647547|FG000|Overall Study|Ineligible|1|||
162163110|NCT02682316|585647548|FG001|Overall Study|Ineligible|0|||
162163111|NCT02682316|585647547|FG000|Overall Study|Death|1|||
162163112|NCT02682316|585647548|FG001|Overall Study|Death|0|||
162163113|NCT02682316|585647547|FG000|Overall Study|Lost to Follow-up|7|||
162163114|NCT02682316|585647548|FG001|Overall Study|Lost to Follow-up|3|||
162163115|NCT04630262|585647550|FG000|Overall Study|Intraoperative Screen Failure|5|||
162163116|NCT04630262|585647550|FG000|Overall Study|Study terminated prematurely|71|||
162163117|NCT04630262|585647550|FG000|Overall Study|Withdrawal by Subject|2|||
162163118|NCT04630262|585647550|FG000|Overall Study|Physician Decision|2|||
162163119|NCT03692676|585647552|FG000|Overall Study|exclude patients with prior use|4424|||
162163120|NCT03692676|585647553|FG001|Overall Study|exclude patients with prior use|24726|||
162163121|NCT03692676|585647554|FG002|Overall Study|exclude patients with prior use|0|||
161815281|NCT01838681|584366937|FG000|Period A|Non-compliance with IMP|6|||
162163122|NCT03692676|585647555|FG003|Overall Study|exclude patients with prior use|0|||
162163123|NCT03692676|585647552|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
162163124|NCT03692676|585647553|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
162163125|NCT03692676|585647554|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
162163126|NCT03692676|585647555|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
162163127|NCT03692676|585647552|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
162163128|NCT03692676|585647553|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
162163129|NCT03692676|585647554|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
162163130|NCT03692676|585647555|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
162163131|NCT03692676|585647552|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
162163132|NCT03692676|585647553|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
162163133|NCT03692676|585647554|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
162163134|NCT03692676|585647555|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
162163135|NCT03692676|585647552|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
162163136|NCT03692676|585647553|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
162163137|NCT03692676|585647554|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
162163138|NCT03692676|585647555|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
162163139|NCT03692676|585647552|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
162163140|NCT03692676|585647553|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
162163141|NCT03692676|585647554|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
162163142|NCT03692676|585647555|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
162163143|NCT03692676|585647552|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
162163144|NCT03692676|585647553|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
162163145|NCT03692676|585647554|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
162163146|NCT03692676|585647555|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
162163147|NCT03692676|585647552|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
162163148|NCT03692676|585647553|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
162163149|NCT03692676|585647554|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
162163150|NCT03692676|585647555|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
162163151|NCT03692676|585647552|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
162163152|NCT03692676|585647553|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
162163153|NCT03692676|585647554|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
162163154|NCT03692676|585647555|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
162163155|NCT03692676|585647552|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
162163156|NCT03692676|585647553|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
162163157|NCT03692676|585647554|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
162163158|NCT03692676|585647555|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
162163159|NCT03692676|585647552|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
162163160|NCT03692676|585647553|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
162163161|NCT03692676|585647554|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
162163162|NCT03692676|585647555|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
162163163|NCT03692676|585647552|FG000|Overall Study|Other|0|||
162163164|NCT03692676|585647553|FG001|Overall Study|Other|805|||
162163165|NCT03692676|585647554|FG002|Overall Study|Other|758|||
162163166|NCT03692676|585647555|FG003|Overall Study|Other|277|||
162163167|NCT03692676|585647552|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
162163168|NCT03692676|585647553|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
162163169|NCT03692676|585647554|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
162163170|NCT03692676|585647555|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
162163171|NCT03692611|585647556|FG000|Overall Study|Found to be ineligible postrandomization|3|||
162163172|NCT03692611|585647557|FG001|Overall Study|Found to be ineligible postrandomization|0|||
162163173|NCT03988634|585647558|FG000|Double-Blind|Adverse Event|4|||
162163174|NCT03988634|585647559|FG001|Double-Blind|Adverse Event|0|||
162163175|NCT03988634|585647560|FG002|Double-Blind|Adverse Event|0|||
162163176|NCT03988634|585647558|FG000|Double-Blind|Death|18|||
162163177|NCT03988634|585647559|FG001|Double-Blind|Death|26|||
162163178|NCT03988634|585647560|FG002|Double-Blind|Death|0|||
162163179|NCT03988634|585647558|FG000|Double-Blind|Lost to Follow-up|6|||
162163180|NCT03988634|585647559|FG001|Double-Blind|Lost to Follow-up|7|||
162163181|NCT03988634|585647560|FG002|Double-Blind|Lost to Follow-up|0|||
162163182|NCT03988634|585647558|FG000|Double-Blind|Physician Decision|9|||
162163183|NCT03988634|585647559|FG001|Double-Blind|Physician Decision|5|||
162163184|NCT03988634|585647560|FG002|Double-Blind|Physician Decision|0|||
162163185|NCT03988634|585647558|FG000|Double-Blind|Subject decision|24|||
162163186|NCT03988634|585647559|FG001|Double-Blind|Subject decision|13|||
162163187|NCT03988634|585647560|FG002|Double-Blind|Subject decision|0|||
162163188|NCT03988634|585647558|FG000|Open-Label|Adverse Event|0|||
162163189|NCT03988634|585647559|FG001|Open-Label|Adverse Event|0|||
162163190|NCT03988634|585647560|FG002|Open-Label|Adverse Event|7|||
162163191|NCT03988634|585647558|FG000|Open-Label|Physician Decision|0|||
162163192|NCT03988634|585647559|FG001|Open-Label|Physician Decision|0|||
162163193|NCT03988634|585647560|FG002|Open-Label|Physician Decision|1|||
162163194|NCT03988634|585647558|FG000|Open-Label|Technical problems|0|||
162163195|NCT03988634|585647559|FG001|Open-Label|Technical problems|0|||
162163196|NCT03988634|585647560|FG002|Open-Label|Technical problems|1|||
162163197|NCT04083235|585647578|FG000|Overall Study|Death|252|||
162163198|NCT04083235|585647579|FG001|Overall Study|Death|277|||
162163199|NCT04083235|585647578|FG000|Overall Study|Withdrawal by Subject|13|||
162163200|NCT04083235|585647579|FG001|Overall Study|Withdrawal by Subject|17|||
162163201|NCT04083235|585647578|FG000|Overall Study|Lost to Follow-up|1|||
162163202|NCT04083235|585647579|FG001|Overall Study|Lost to Follow-up|1|||
162163203|NCT04083235|585647578|FG000|Overall Study|Does not meet entry criteria|1|||
162163204|NCT04083235|585647579|FG001|Overall Study|Does not meet entry criteria|0|||
162163205|NCT04083235|585647578|FG000|Overall Study|Did not receive treatment|13|||
162163206|NCT04083235|585647579|FG001|Overall Study|Did not receive treatment|8|||
162163207|NCT04083235|585647578|FG000|Overall Study|Ongoing at the time of DCO|44|||
162163208|NCT04083235|585647579|FG001|Overall Study|Ongoing at the time of DCO|7|||
162163209|NCT03016169|585647580|FG000|Overall Study|Lost to Follow-up|4|||
162163210|NCT03016169|585647580|FG000|Overall Study|Death|54|||
162163211|NCT03016169|585647580|FG000|Overall Study|Device Explant|11|||
162163212|NCT03016169|585647580|FG000|Overall Study|Withdrawal by Subject|19|||
162163213|NCT03016169|585647580|FG000|Overall Study|Other Reasons|1|||
162163214|NCT03047928|585647584|FG000|Overall Study|Adverse Event|0|||
162163215|NCT03047928|585647585|FG001|Overall Study|Adverse Event|2|||
162163216|NCT03047928|585647586|FG002|Overall Study|Adverse Event|0|||
162163217|NCT03047928|585647584|FG000|Overall Study|Protocol Violation|0|||
162163218|NCT03047928|585647585|FG001|Overall Study|Protocol Violation|1|||
162163219|NCT03047928|585647586|FG002|Overall Study|Protocol Violation|0|||
162163220|NCT03047928|585647584|FG000|Overall Study|included in another protocol|0|||
162163221|NCT03047928|585647585|FG001|Overall Study|included in another protocol|1|||
162163222|NCT03047928|585647586|FG002|Overall Study|included in another protocol|0|||
162163223|NCT02729311|585647587|FG000|Overall Study|Withdrawal by Subject|8|||
162163224|NCT02729311|585647588|FG001|Overall Study|Withdrawal by Subject|2|||
162163225|NCT05324124|585647589|FG000|Period 1|Withdrawal by Subject|1|||
162163226|NCT05324124|585647590|FG001|Period 1|Withdrawal by Subject|0|||
162163227|NCT05324124|585647589|FG000|Period 1|Physician Decision|0|||
162163228|NCT05324124|585647590|FG001|Period 1|Physician Decision|1|||
162163229|NCT02287610|585647591|FG000|Overall Study|Lost to Follow-up|3|||
162163230|NCT02287610|585647591|FG000|Overall Study|Withdrawal by Subject|8|||
162163231|NCT02287610|585647591|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
162163232|NCT04950660|585647592|FG000|Overall Study|Protocol Violation|4|||
162163233|NCT04950660|585647593|FG001|Overall Study|Protocol Violation|2|||
162163234|NCT04950660|585647592|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
162163235|NCT04950660|585647593|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
162163236|NCT04950660|585647592|FG000|Overall Study|Withdrawal by Subject|0|||
162163237|NCT04950660|585647593|FG001|Overall Study|Withdrawal by Subject|1|||
162163238|NCT04950660|585647592|FG000|Overall Study|Hypotension|1|||
162163239|NCT04950660|585647593|FG001|Overall Study|Hypotension|0|||
162163240|NCT04783935|585647596|FG000|Overall Study|Withdrawal by Subject|6|||
162163241|NCT04783935|585647596|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
162163242|NCT04783935|585647596|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
162163243|NCT04783935|585647596|FG000|Overall Study|Lost to Follow-up|3|||
162163244|NCT04783935|585647596|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
162163245|NCT00601900|585647598|FG000|Overall Study|Withdrawal by Subject|0|||
162163246|NCT00601900|585647599|FG001|Overall Study|Withdrawal by Subject|3|||
162163247|NCT03924986|585647600|FG000|Overall Study|Death|57|||
162163248|NCT03924986|585647601|FG001|Overall Study|Death|66|||
162163249|NCT03924986|585647600|FG000|Overall Study|Study Concluded by Sponsor|51|||
162163250|NCT03924986|585647601|FG001|Overall Study|Study Concluded by Sponsor|41|||
162163251|NCT03924986|585647600|FG000|Overall Study|Withdrawal by Subject|15|||
162163252|NCT03924986|585647601|FG001|Overall Study|Withdrawal by Subject|20|||
162163253|NCT03924986|585647600|FG000|Overall Study|Lost to Follow-up|7|||
162163254|NCT03924986|585647601|FG001|Overall Study|Lost to Follow-up|5|||
162163255|NCT03924986|585647600|FG000|Overall Study|Miscellaneous|1|||
162163256|NCT03924986|585647601|FG001|Overall Study|Miscellaneous|0|||
162163257|NCT05569252|585647602|FG000|Overall Study|Adverse event (central vision loss)|1|||
162163258|NCT05569252|585647603|FG001|Overall Study|Adverse event (central vision loss)|0|||
162163259|NCT05569252|585647604|FG002|Overall Study|Adverse event (central vision loss)|0|||
162163260|NCT05569252|585647605|FG003|Overall Study|Adverse event (central vision loss)|0|||
162163261|NCT05516147|585647606|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
162163262|NCT05371652|585647610|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
162163263|NCT05371652|585647610|FG000|Overall Study|Withdrawal by Subject|12|||
162163264|NCT05371652|585647610|FG000|Overall Study|Adverse Event|1|||
162163265|NCT05371652|585647610|FG000|Overall Study|Other|11|||
162163266|NCT05256706|585647612|FG000|Overall Study|Lost to Follow-up|9|||
162163267|NCT05256706|585647613|FG001|Overall Study|Lost to Follow-up|3|||
162163268|NCT05256706|585647612|FG000|Overall Study|Withdrawal by Subject|7|||
162163269|NCT05256706|585647613|FG001|Overall Study|Withdrawal by Subject|11|||
162163270|NCT05256706|585647612|FG000|Overall Study|Screen Failures|3|||
162163271|NCT05256706|585647613|FG001|Overall Study|Screen Failures|0|||
162163272|NCT04410042|585647614|FG000|Overall Study|Not Eligible|1|||
162163273|NCT04410042|585647615|FG001|Overall Study|Not Eligible|1|||
162163274|NCT01494662|585647616|FG000|Overall Study|Withdrawal by Subject|0|||
162163275|NCT01494662|585647617|FG001|Overall Study|Withdrawal by Subject|0|||
162163276|NCT01494662|585647618|FG002|Overall Study|Withdrawal by Subject|1|||
162163277|NCT01494662|585647619|FG003|Overall Study|Withdrawal by Subject|0|||
162163278|NCT01494662|585647620|FG004|Overall Study|Withdrawal by Subject|0|||
162163279|NCT01494662|585647621|FG005|Overall Study|Withdrawal by Subject|0|||
162163280|NCT01494662|585647622|FG006|Overall Study|Withdrawal by Subject|0|||
162163281|NCT01494662|585647616|FG000|Overall Study|Physician Decision|0|||
162163282|NCT01494662|585647617|FG001|Overall Study|Physician Decision|0|||
162163283|NCT01494662|585647618|FG002|Overall Study|Physician Decision|1|||
162163284|NCT01494662|585647619|FG003|Overall Study|Physician Decision|0|||
162163285|NCT01494662|585647620|FG004|Overall Study|Physician Decision|0|||
162163286|NCT01494662|585647621|FG005|Overall Study|Physician Decision|0|||
162163287|NCT01494662|585647622|FG006|Overall Study|Physician Decision|0|||
162163288|NCT03302494|585647623|FG000|Overall Study|Other|7|||
162163289|NCT03302494|585647624|FG001|Overall Study|Other|4|||
162163290|NCT03302494|585647625|FG002|Overall Study|Other|6|||
162163291|NCT03302494|585647623|FG000|Overall Study|Withdrawal by Subject|10|||
162163292|NCT03302494|585647624|FG001|Overall Study|Withdrawal by Subject|2|||
162163293|NCT03302494|585647625|FG002|Overall Study|Withdrawal by Subject|9|||
162163294|NCT03302494|585647623|FG000|Overall Study|Study Terminated by Sponsor|32|||
162163295|NCT03302494|585647624|FG001|Overall Study|Study Terminated by Sponsor|29|||
162163296|NCT03302494|585647625|FG002|Overall Study|Study Terminated by Sponsor|30|||
162163297|NCT03302494|585647623|FG000|Overall Study|Physician Decision|1|||
162163298|NCT03302494|585647624|FG001|Overall Study|Physician Decision|0|||
162163299|NCT03302494|585647625|FG002|Overall Study|Physician Decision|1|||
162163300|NCT03302494|585647623|FG000|Overall Study|Lost to Follow-up|1|||
162163301|NCT03302494|585647624|FG001|Overall Study|Lost to Follow-up|3|||
162163302|NCT03302494|585647625|FG002|Overall Study|Lost to Follow-up|3|||
162163303|NCT03302494|585647623|FG000|Overall Study|Death|13|||
162163304|NCT03302494|585647624|FG001|Overall Study|Death|11|||
162163305|NCT03302494|585647625|FG002|Overall Study|Death|4|||
162163306|NCT03302494|585647623|FG000|Overall Study|Adverse Event|1|||
162163307|NCT03302494|585647624|FG001|Overall Study|Adverse Event|2|||
162163308|NCT03302494|585647625|FG002|Overall Study|Adverse Event|0|||
162163309|NCT03302494|585647623|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
162163310|NCT03302494|585647624|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
162163311|NCT03302494|585647625|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
162163312|NCT01361711|585647634|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
162163313|NCT01361711|585647634|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
162163314|NCT01361711|585647634|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
162163315|NCT01361711|585647634|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
162163316|NCT01361711|585647634|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
162163317|NCT01361711|585647634|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
162163318|NCT01361711|585647634|FG000|Completed Week 18 of Treatment|Other|9|||
162163319|NCT01361711|585647634|FG000|10 Year Follow-up|Still in follow-up|22|||
162163320|NCT01361711|585647634|FG000|10 Year Follow-up|Death|7|||
162163321|NCT01361711|585647634|FG000|10 Year Follow-up|Developed new cancer|1|||
162163322|NCT01361711|585647634|FG000|10 Year Follow-up|Lost to Follow-up|2|||
162163323|NCT01361711|585647634|FG000|10 Year Follow-up|New treatment started|6|||
162163324|NCT01361711|585647634|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
162163325|NCT01361711|585647634|FG000|10 Year Follow-up|Progressive Disease|1|||
162163326|NCT02596126|585647635|FG000|Overall Study|Lost to Follow-up|12|||
162163327|NCT02596126|585647636|FG001|Overall Study|Lost to Follow-up|21|||
162163328|NCT02596126|585647635|FG000|Overall Study|Protocol Violation|7|||
162163329|NCT02596126|585647636|FG001|Overall Study|Protocol Violation|9|||
162163330|NCT02187003|585649750|FG000|Overall Study|Adverse Event|2|||
162163331|NCT02187003|585649751|FG001|Overall Study|Adverse Event|0|||
162163332|NCT02187003|585649750|FG000|Overall Study|Lost to Follow-up|14|||
161815282|NCT01838681|584366938|FG001|Period A|Non-compliance with IMP|0|||
162163333|NCT02187003|585649751|FG001|Overall Study|Lost to Follow-up|10|||
162163334|NCT02187003|585649750|FG000|Overall Study|Withdrawal by Subject|3|||
162163335|NCT02187003|585649751|FG001|Overall Study|Withdrawal by Subject|7|||
162163336|NCT02187003|585649750|FG000|Overall Study|Protocol Violation|2|||
161815283|NCT01838681|584366939|FG002|Period A|Non-compliance with IMP|0|||
162163337|NCT02187003|585649751|FG001|Overall Study|Protocol Violation|4|||
162163338|NCT02187003|585649750|FG000|Overall Study|Other|5|||
162163339|NCT02187003|585649751|FG001|Overall Study|Other|5|||
162163340|NCT02187003|585649750|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162163341|NCT02187003|585649751|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
162163342|NCT05382936|585649753|FG000|Overall Study|Progressive Disease|3|||
162163343|NCT05382936|585649754|FG001|Overall Study|Progressive Disease|5|||
162163344|NCT05382936|585649755|FG002|Overall Study|Progressive Disease|2|||
162163345|NCT05382936|585649756|FG003|Overall Study|Progressive Disease|5|||
162163346|NCT05382936|585649753|FG000|Overall Study|Adverse Event|0|||
162163347|NCT05382936|585649754|FG001|Overall Study|Adverse Event|1|||
162163348|NCT05382936|585649755|FG002|Overall Study|Adverse Event|1|||
162163349|NCT05382936|585649756|FG003|Overall Study|Adverse Event|0|||
161815284|NCT01838681|584366940|FG003|Period A|Non-compliance with IMP|0|||
161815285|NCT01838681|584366937|FG000|Period A|Lost to Follow-up|4|||
162163350|NCT05382936|585649753|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
162163351|NCT05382936|585649754|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
162163352|NCT05382936|585649755|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
162163353|NCT05382936|585649756|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
162163354|NCT05382936|585649753|FG000|Overall Study|Withdrawal by Subject|0|||
162163355|NCT05382936|585649754|FG001|Overall Study|Withdrawal by Subject|0|||
162163356|NCT05382936|585649755|FG002|Overall Study|Withdrawal by Subject|1|||
162163357|NCT05382936|585649756|FG003|Overall Study|Withdrawal by Subject|1|||
162163358|NCT05063994|585649757|FG000|Cortef Run-In|Withdrawal of Consent|1|||
162163359|NCT05063994|585649758|FG001|Cortef Run-In|Withdrawal of Consent|0|||
162163360|NCT05063994|585649759|FG002|Cortef Run-In|Withdrawal of Consent|0|||
162163361|NCT05063994|585649757|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
162163362|NCT05063994|585649758|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
162163363|NCT05063994|585649759|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
162163364|NCT05063994|585649757|FG000|Treatment|Physician Decision|0|||
162163365|NCT05063994|585649758|FG001|Treatment|Physician Decision|0|||
162163366|NCT05063994|585649759|FG002|Treatment|Physician Decision|1|||
162163367|NCT05063994|585649757|FG000|Treatment|Withdrawal by Subject|0|||
162163368|NCT05063994|585649758|FG001|Treatment|Withdrawal by Subject|0|||
162163369|NCT05063994|585649759|FG002|Treatment|Withdrawal by Subject|1|||
162163370|NCT05063994|585649757|FG000|Treatment|Withdrawal of Consent|0|||
162163371|NCT05063994|585649758|FG001|Treatment|Withdrawal of Consent|0|||
162163372|NCT05063994|585649759|FG002|Treatment|Withdrawal of Consent|1|||
162163373|NCT01195831|585649763|FG000|Overall Study|Lost to Follow-up|2|||
162163374|NCT01195831|585649764|FG001|Overall Study|Lost to Follow-up|4|||
162163375|NCT01195831|585649763|FG000|Overall Study|Withdrawal by Subject|2|||
162163376|NCT01195831|585649764|FG001|Overall Study|Withdrawal by Subject|2|||
162163377|NCT01195831|585649763|FG000|Overall Study|Adverse Event|4|||
162163378|NCT01195831|585649764|FG001|Overall Study|Adverse Event|2|||
162163379|NCT01195831|585649763|FG000|Overall Study|Protocol Violation|0|||
162163380|NCT01195831|585649764|FG001|Overall Study|Protocol Violation|2|||
162163381|NCT04490915|585649766|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
162163382|NCT04490915|585649767|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
162163383|NCT04490915|585649766|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162163384|NCT04490915|585649767|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162163385|NCT04490915|585649766|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162163386|NCT04490915|585649767|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
162163387|NCT04490915|585649766|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
162163388|NCT04490915|585649767|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
162163389|NCT04490915|585649766|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
162163390|NCT04490915|585649767|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
162163391|NCT04490915|585649766|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
162163392|NCT04490915|585649767|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
162163393|NCT04490915|585649766|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
162163394|NCT04490915|585649767|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
162163395|NCT00667251|585649769|FG000|Overall Study|Disease progression|232|||
162163396|NCT00667251|585649770|FG001|Overall Study|Disease progression|203|||
162163397|NCT00667251|585649769|FG000|Overall Study|Toxicity|44|||
162163398|NCT00667251|585649770|FG001|Overall Study|Toxicity|23|||
162163399|NCT00667251|585649769|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
162163400|NCT00667251|585649770|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
162163401|NCT00667251|585649769|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
162163402|NCT00667251|585649770|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
162163403|NCT00667251|585649769|FG000|Overall Study|Symptomatic progression|8|||
162163404|NCT00667251|585649770|FG001|Overall Study|Symptomatic progression|4|||
162163405|NCT00667251|585649769|FG000|Overall Study|Death|6|||
162163406|NCT00667251|585649770|FG001|Overall Study|Death|11|||
162163407|NCT00667251|585649769|FG000|Overall Study|Intercurrent illness|5|||
161815286|NCT01838681|584366938|FG001|Period A|Lost to Follow-up|0|||
162163408|NCT00667251|585649770|FG001|Overall Study|Intercurrent illness|6|||
162163409|NCT00667251|585649769|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
162163410|NCT00667251|585649770|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
162163411|NCT00667251|585649769|FG000|Overall Study|Randomized not Treated|4|||
162163412|NCT00667251|585649770|FG001|Overall Study|Randomized not Treated|1|||
162163413|NCT04024813|585649776|FG000|Overall Study|Study terminated by Sponsor|1|||
162163414|NCT05034952|585649777|FG000|Overall Study|Adverse Event|1|||
162163415|NCT05034952|585649778|FG001|Overall Study|Adverse Event|0|||
162163416|NCT05034952|585649779|FG002|Overall Study|Adverse Event|0|||
162163417|NCT05034952|585649780|FG003|Overall Study|Adverse Event|0|||
162163418|NCT05034952|585649777|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
162163419|NCT05034952|585649778|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
162163420|NCT05034952|585649779|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
162163421|NCT05034952|585649780|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
162163422|NCT05034952|585649777|FG000|Overall Study|Lost to Follow-up|1|||
162163423|NCT05034952|585649778|FG001|Overall Study|Lost to Follow-up|4|||
162163424|NCT05034952|585649779|FG002|Overall Study|Lost to Follow-up|3|||
162163425|NCT05034952|585649780|FG003|Overall Study|Lost to Follow-up|3|||
162163426|NCT05034952|585649777|FG000|Overall Study|Other|0|||
162163427|NCT05034952|585649778|FG001|Overall Study|Other|0|||
162163428|NCT05034952|585649779|FG002|Overall Study|Other|0|||
162163429|NCT05034952|585649780|FG003|Overall Study|Other|1|||
162163430|NCT02437318|585649781|FG000|Overall Study|Progressive disease|207|||
162163431|NCT02437318|585649782|FG001|Overall Study|Progressive disease|240|||
162163432|NCT02437318|585649781|FG000|Overall Study|Subject/guardian decision|24|||
162163433|NCT02437318|585649782|FG001|Overall Study|Subject/guardian decision|11|||
162163434|NCT02437318|585649781|FG000|Overall Study|Physician Decision|29|||
162163435|NCT02437318|585649782|FG001|Overall Study|Physician Decision|22|||
162163436|NCT02437318|585649781|FG000|Overall Study|Adverse Event|14|||
162163437|NCT02437318|585649782|FG001|Overall Study|Adverse Event|4|||
162163438|NCT02437318|585649781|FG000|Overall Study|Death|4|||
162163439|NCT02437318|585649782|FG001|Overall Study|Death|4|||
162163440|NCT02437318|585649781|FG000|Overall Study|Protocol deviation|5|||
162163441|NCT02437318|585649782|FG001|Overall Study|Protocol deviation|7|||
162163442|NCT02437318|585649781|FG000|Overall Study|Sponsor decision|1|||
162163443|NCT02437318|585649782|FG001|Overall Study|Sponsor decision|0|||
162163444|NCT00920621|585649788|FG000|Overall Study|Lost to Follow-up|16|||
162163445|NCT00920621|585649789|FG001|Overall Study|Lost to Follow-up|17|||
162163446|NCT00920621|585649790|FG002|Overall Study|Lost to Follow-up|19|||
162163447|NCT00920621|585649791|FG003|Overall Study|Lost to Follow-up|21|||
162163448|NCT00920621|585649788|FG000|Overall Study|Fetal/neonatal deaths|16|||
162163449|NCT00920621|585649789|FG001|Overall Study|Fetal/neonatal deaths|14|||
162163450|NCT00920621|585649790|FG002|Overall Study|Fetal/neonatal deaths|16|||
162163451|NCT00920621|585649791|FG003|Overall Study|Fetal/neonatal deaths|14|||
162163452|NCT00920621|585649788|FG000|Overall Study|Blood sample not collected|22|||
162163453|NCT00920621|585649789|FG001|Overall Study|Blood sample not collected|14|||
162163454|NCT00920621|585649790|FG002|Overall Study|Blood sample not collected|0|||
162163455|NCT00920621|585649791|FG003|Overall Study|Blood sample not collected|0|||
162163456|NCT06074523|585649792|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
162163457|NCT06074523|585649792|FG000|Overall Study|Withdrawal by Subject|1|||
162163458|NCT05273749|585649793|FG000|Overall Study|Adverse Event|14|||
162163459|NCT05273749|585649794|FG001|Overall Study|Adverse Event|8|||
162163460|NCT05273749|585649793|FG000|Overall Study|Lack of Efficacy|2|||
162163461|NCT05273749|585649794|FG001|Overall Study|Lack of Efficacy|8|||
162163462|NCT05273749|585649793|FG000|Overall Study|Physician Decision|0|||
162163463|NCT05273749|585649794|FG001|Overall Study|Physician Decision|2|||
162163464|NCT05273749|585649793|FG000|Overall Study|Withdrawal by Subject|14|||
162163465|NCT05273749|585649794|FG001|Overall Study|Withdrawal by Subject|16|||
162163466|NCT05273749|585649793|FG000|Overall Study|Lost to Follow-up|10|||
162163467|NCT05273749|585649794|FG001|Overall Study|Lost to Follow-up|10|||
162163468|NCT05273749|585649793|FG000|Overall Study|Pregnancy|1|||
162163469|NCT05273749|585649794|FG001|Overall Study|Pregnancy|0|||
162163470|NCT05273749|585649793|FG000|Overall Study|Non-Compliance|3|||
162163471|NCT05273749|585649794|FG001|Overall Study|Non-Compliance|2|||
162163472|NCT05273749|585649793|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
162163473|NCT05273749|585649794|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
162163474|NCT01426425|585649795|FG000|Overall Study|Exited prior to EP study|22|||
162163475|NCT01426425|585649795|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
162163476|NCT01426425|585649795|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
162163477|NCT03281291|585649801|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
162163478|NCT03281291|585649802|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
162163479|NCT03281291|585649803|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
162163480|NCT03281291|585649804|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
162163481|NCT03281291|585649805|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
162163482|NCT03281291|585649801|FG000|Overall Study|Protocol Deviation|2|||
162163483|NCT03281291|585649802|FG001|Overall Study|Protocol Deviation|0|||
162163484|NCT03281291|585649803|FG002|Overall Study|Protocol Deviation|1|||
162163485|NCT03281291|585649804|FG003|Overall Study|Protocol Deviation|2|||
162163486|NCT03281291|585649805|FG004|Overall Study|Protocol Deviation|1|||
162163487|NCT03281291|585649801|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
162163488|NCT03281291|585649802|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
162163489|NCT03281291|585649803|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
162163490|NCT03281291|585649804|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
162163491|NCT03281291|585649805|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
162163492|NCT03281291|585649801|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
162163493|NCT03281291|585649802|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
162163494|NCT03281291|585649803|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
162163495|NCT03281291|585649804|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
162163496|NCT03281291|585649805|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
162163497|NCT03281291|585649801|FG000|Overall Study|Lost to Follow-up|10|||
162163498|NCT03281291|585649802|FG001|Overall Study|Lost to Follow-up|10|||
162163499|NCT03281291|585649803|FG002|Overall Study|Lost to Follow-up|4|||
162163500|NCT03281291|585649804|FG003|Overall Study|Lost to Follow-up|6|||
162163501|NCT03281291|585649805|FG004|Overall Study|Lost to Follow-up|10|||
162163502|NCT03281291|585649801|FG000|Overall Study|Other|0|||
162163503|NCT03281291|585649802|FG001|Overall Study|Other|2|||
162163504|NCT03281291|585649803|FG002|Overall Study|Other|0|||
162163505|NCT03281291|585649804|FG003|Overall Study|Other|2|||
162163506|NCT03281291|585649805|FG004|Overall Study|Other|1|||
162163507|NCT00512070|585649806|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
162163508|NCT00512070|585649807|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
162163509|NCT00512070|585649808|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
162163510|NCT00512070|585649806|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
162163511|NCT00512070|585649807|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
162163512|NCT00512070|585649808|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
162163513|NCT04956861|585649809|FG000|Overall Study|Withdrawal by Subject|4|||
162163514|NCT04956861|585649810|FG001|Overall Study|Withdrawal by Subject|4|||
162163515|NCT04956861|585649811|FG002|Overall Study|Withdrawal by Subject|2|||
162163516|NCT04956861|585649809|FG000|Overall Study|Physician Decision|4|||
162163517|NCT04956861|585649810|FG001|Overall Study|Physician Decision|5|||
162163518|NCT04956861|585649811|FG002|Overall Study|Physician Decision|1|||
162163519|NCT00961571|585649812|FG000|Overall Study|Physician Decision|39|||
162163520|NCT05862870|585649816|FG000|Overall Study|Lost to Follow-up|3|||
162163521|NCT02900924|585649817|FG000|Overall Study|Death|52|||
162163522|NCT02900924|585649817|FG000|Overall Study|Lost to Follow-up|4|||
162163523|NCT02900924|585649817|FG000|Overall Study|Withdrawal by Subject|20|||
162163524|NCT02900924|585649817|FG000|Overall Study|Missed Visit|33|||
162163525|NCT03143153|585649818|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
162163526|NCT03143153|585649819|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
162163527|NCT03143153|585649820|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
162163528|NCT03143153|585649818|FG000|Pre-Treatment|Participant withdrew consent|0|||
162163529|NCT03143153|585649819|FG001|Pre-Treatment|Participant withdrew consent|1|||
162163530|NCT03143153|585649820|FG002|Pre-Treatment|Participant withdrew consent|12|||
162163531|NCT03143153|585649818|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
162163532|NCT03143153|585649819|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
162163533|NCT03143153|585649820|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
162163534|NCT03143153|585649818|FG000|Pre-Treatment|Other Reasons|1|||
162163535|NCT03143153|585649819|FG001|Pre-Treatment|Other Reasons|2|||
162163536|NCT03143153|585649820|FG002|Pre-Treatment|Other Reasons|1|||
162163537|NCT03143153|585649818|FG000|Pre-Treatment|Disease Progression|1|||
162163538|NCT03143153|585649819|FG001|Pre-Treatment|Disease Progression|1|||
162163539|NCT03143153|585649820|FG002|Pre-Treatment|Disease Progression|2|||
162163540|NCT03143153|585649818|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
162163541|NCT03143153|585649819|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
162163542|NCT03143153|585649820|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
162163543|NCT03143153|585649818|FG000|Treatment|Disease progression|174|||
162163544|NCT03143153|585649819|FG001|Treatment|Disease progression|184|||
162163545|NCT03143153|585649820|FG002|Treatment|Disease progression|193|||
162163546|NCT03143153|585649818|FG000|Treatment|Study drug toxicity|59|||
162163547|NCT03143153|585649819|FG001|Treatment|Study drug toxicity|33|||
162163548|NCT03143153|585649820|FG002|Treatment|Study drug toxicity|40|||
162163549|NCT03143153|585649818|FG000|Treatment|Death|5|||
162163550|NCT03143153|585649819|FG001|Treatment|Death|3|||
162163551|NCT03143153|585649820|FG002|Treatment|Death|4|||
162163552|NCT03143153|585649818|FG000|Treatment|Adverse event unrelated to study drug|19|||
162163553|NCT03143153|585649819|FG001|Treatment|Adverse event unrelated to study drug|28|||
161815287|NCT01838681|584366939|FG002|Period A|Lost to Follow-up|0|||
162163554|NCT03143153|585649820|FG002|Treatment|Adverse event unrelated to study drug|12|||
162163555|NCT03143153|585649818|FG000|Treatment|Participant request to discontinue study treatment|13|||
162163556|NCT03143153|585649819|FG001|Treatment|Participant request to discontinue study treatment|15|||
162163557|NCT03143153|585649820|FG002|Treatment|Participant request to discontinue study treatment|20|||
162163558|NCT03143153|585649818|FG000|Treatment|Participant withdrew consent|3|||
162163559|NCT03143153|585649819|FG001|Treatment|Participant withdrew consent|4|||
162163560|NCT03143153|585649820|FG002|Treatment|Participant withdrew consent|12|||
162163561|NCT03143153|585649818|FG000|Treatment|Pregnancy|1|||
162163562|NCT03143153|585649819|FG001|Treatment|Pregnancy|0|||
162163563|NCT03143153|585649820|FG002|Treatment|Pregnancy|0|||
162163564|NCT03143153|585649818|FG000|Treatment|Maximum clinical benefit|1|||
162163565|NCT03143153|585649819|FG001|Treatment|Maximum clinical benefit|3|||
162163566|NCT03143153|585649820|FG002|Treatment|Maximum clinical benefit|4|||
162163567|NCT03143153|585649818|FG000|Treatment|Completed treatment as per Protocol|13|||
162163568|NCT03143153|585649819|FG001|Treatment|Completed treatment as per Protocol|8|||
162163569|NCT03143153|585649820|FG002|Treatment|Completed treatment as per Protocol|0|||
162163570|NCT03143153|585649818|FG000|Treatment|Other reasons|12|||
162163571|NCT03143153|585649819|FG001|Treatment|Other reasons|7|||
162163572|NCT03143153|585649820|FG002|Treatment|Other reasons|15|||
162163573|NCT03143153|585649818|FG000|Treatment|Not reported|1|||
162163574|NCT03143153|585649819|FG001|Treatment|Not reported|0|||
162163575|NCT03143153|585649820|FG002|Treatment|Not reported|0|||
162163576|NCT02736409|585649821|FG000|Overall Study|Withdrawal by Subject|4|||
162163577|NCT02736409|585649822|FG001|Overall Study|Withdrawal by Subject|2|||
162163578|NCT02736409|585649823|FG002|Overall Study|Withdrawal by Subject|17|||
162163579|NCT02736409|585649824|FG003|Overall Study|Withdrawal by Subject|3|||
162163580|NCT02736409|585649821|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162163581|NCT02736409|585649822|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162163582|NCT02736409|585649823|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162163583|NCT02736409|585649824|FG003|Overall Study|Non-Compliance with Study Drug|1|||
162163584|NCT02736409|585649821|FG000|Overall Study|Adverse Event|0|||
162163585|NCT02736409|585649822|FG001|Overall Study|Adverse Event|1|||
162163586|NCT02736409|585649823|FG002|Overall Study|Adverse Event|5|||
162163587|NCT02736409|585649824|FG003|Overall Study|Adverse Event|4|||
162163588|NCT02736409|585649821|FG000|Overall Study|Other|0|||
162163589|NCT02736409|585649822|FG001|Overall Study|Other|0|||
162163590|NCT02736409|585649823|FG002|Overall Study|Other|1|||
162163591|NCT02736409|585649824|FG003|Overall Study|Other|1|||
162163592|NCT02736409|585649821|FG000|Overall Study|Pregnancy|0|||
162163593|NCT02736409|585649822|FG001|Overall Study|Pregnancy|0|||
162163594|NCT02736409|585649823|FG002|Overall Study|Pregnancy|1|||
162163595|NCT02736409|585649824|FG003|Overall Study|Pregnancy|0|||
162163596|NCT02736409|585649821|FG000|Overall Study|Lost to Follow-up|0|||
162163597|NCT02736409|585649822|FG001|Overall Study|Lost to Follow-up|0|||
162163598|NCT02736409|585649823|FG002|Overall Study|Lost to Follow-up|2|||
162163599|NCT02736409|585649824|FG003|Overall Study|Lost to Follow-up|1|||
162163600|NCT02736409|585649821|FG000|Overall Study|Physician Decision|0|||
162163601|NCT02736409|585649822|FG001|Overall Study|Physician Decision|0|||
162163602|NCT02736409|585649823|FG002|Overall Study|Physician Decision|0|||
162163603|NCT02736409|585649824|FG003|Overall Study|Physician Decision|2|||
162163604|NCT01415154|585649825|FG000|Overall Study|Lack of Efficacy|4|||
162163605|NCT01415154|585649826|FG001|Overall Study|Lack of Efficacy|5|||
162163606|NCT01415154|585649825|FG000|Overall Study|Withdrawal by Subject|7|||
162163607|NCT01415154|585649826|FG001|Overall Study|Withdrawal by Subject|8|||
162163608|NCT01415154|585649825|FG000|Overall Study|Lost to Follow-up|1|||
162163609|NCT01415154|585649826|FG001|Overall Study|Lost to Follow-up|4|||
162163610|NCT01415154|585649825|FG000|Overall Study|Protocol Violation|0|||
162163611|NCT01415154|585649826|FG001|Overall Study|Protocol Violation|1|||
162163612|NCT01415154|585649825|FG000|Overall Study|Satisfactory Response|0|||
162163613|NCT01415154|585649826|FG001|Overall Study|Satisfactory Response|1|||
162163614|NCT01415154|585649825|FG000|Overall Study|Adverse Event|1|||
162163615|NCT01415154|585649826|FG001|Overall Study|Adverse Event|1|||
162163616|NCT03763708|585649830|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
162163617|NCT03763708|585649831|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162163618|NCT03763708|585649832|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162163619|NCT03763708|585649833|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162163620|NCT03763708|585649834|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162163621|NCT03763708|585649835|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162163622|NCT03763708|585649836|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162163623|NCT03763708|585649837|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162163624|NCT03763708|585649838|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
162163625|NCT03763708|585649830|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162163626|NCT03763708|585649831|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162163627|NCT03763708|585649832|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
162163628|NCT03763708|585649833|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162163629|NCT03763708|585649834|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162163630|NCT03763708|585649835|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162163631|NCT03763708|585649836|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162163632|NCT03763708|585649837|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162163633|NCT03763708|585649838|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
162163634|NCT03763708|585649830|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162163635|NCT03763708|585649831|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162163636|NCT03763708|585649832|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162163637|NCT03763708|585649833|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
162163638|NCT03763708|585649834|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162163639|NCT03763708|585649835|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162016780|NCT03599089|585116287|FG000|Overall Study|Lost to Follow-up|1|||
162016781|NCT03599089|585116288|FG001|Overall Study|Lost to Follow-up|0|||
162016782|NCT03599089|585116289|FG002|Overall Study|Lost to Follow-up|0|||
162163640|NCT03763708|585649836|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162163641|NCT03763708|585649837|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162163642|NCT03763708|585649838|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
162163643|NCT03763708|585649830|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162163644|NCT03763708|585649831|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162163645|NCT03763708|585649832|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162163646|NCT03763708|585649833|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162163647|NCT03763708|585649834|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
162163648|NCT03763708|585649835|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162163649|NCT03763708|585649836|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162163650|NCT03763708|585649837|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162163651|NCT03763708|585649838|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
162163652|NCT03763708|585649830|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162163653|NCT03763708|585649831|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162163654|NCT03763708|585649832|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162163655|NCT03763708|585649833|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162163656|NCT03763708|585649834|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162163657|NCT03763708|585649835|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
162163658|NCT03763708|585649836|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162163659|NCT03763708|585649837|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162163660|NCT03763708|585649838|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
162163661|NCT03763708|585649830|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162163662|NCT03763708|585649831|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162163663|NCT03763708|585649832|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162163664|NCT03763708|585649833|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162163665|NCT03763708|585649834|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162163666|NCT03763708|585649835|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162163667|NCT03763708|585649836|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
162163668|NCT03763708|585649837|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162163669|NCT03763708|585649838|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
162163670|NCT03763708|585649830|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
162163671|NCT03763708|585649831|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
162163672|NCT03763708|585649832|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
162163673|NCT03763708|585649833|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
162163674|NCT03763708|585649834|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
162163675|NCT03763708|585649835|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
162163676|NCT03763708|585649836|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
162163677|NCT03763708|585649837|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
162163678|NCT03763708|585649838|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
162163679|NCT03763708|585649830|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
162163680|NCT03763708|585649831|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
162163681|NCT03763708|585649832|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
162016783|NCT03599089|585116290|FG003|Overall Study|Lost to Follow-up|0|||
162016784|NCT03599089|585116287|FG000|Overall Study|Withdrawal by Subject|2|||
162016785|NCT03599089|585116288|FG001|Overall Study|Withdrawal by Subject|1|||
162016786|NCT03599089|585116289|FG002|Overall Study|Withdrawal by Subject|0|||
162016787|NCT03599089|585116290|FG003|Overall Study|Withdrawal by Subject|0|||
162016788|NCT03599089|585116287|FG000|Overall Study|Lack of Efficacy|0|||
162016789|NCT03599089|585116288|FG001|Overall Study|Lack of Efficacy|0|||
162016790|NCT03599089|585116289|FG002|Overall Study|Lack of Efficacy|1|||
162016791|NCT03599089|585116290|FG003|Overall Study|Lack of Efficacy|2|||
162016792|NCT03214666|585116291|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
162016793|NCT03214666|585116292|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
162016794|NCT03214666|585116293|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
162016795|NCT03214666|585116294|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
162016796|NCT03214666|585116295|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
162016797|NCT03214666|585116296|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
162016798|NCT03048578|585116297|FG000|Overall Study|Withdrawal by Subject|5|||
162016799|NCT03048578|585116298|FG001|Overall Study|Withdrawal by Subject|6|||
162016800|NCT03048578|585116297|FG000|Overall Study|Lost to Follow-up|22|||
162016801|NCT03048578|585116298|FG001|Overall Study|Lost to Follow-up|10|||
162016802|NCT03048578|585116297|FG000|Overall Study|Adverse Event|1|||
162016803|NCT03048578|585116298|FG001|Overall Study|Adverse Event|2|||
162016804|NCT03048578|585116297|FG000|Overall Study|Terminated|3|||
162016805|NCT03048578|585116298|FG001|Overall Study|Terminated|2|||
162016806|NCT00459186|585116304|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
162016807|NCT00459186|585116304|FG000|PET Imaging and Assessment|Adverse Event|3|||
162016808|NCT02500797|585116305|FG000|Overall Study|Cancel (rapid disease progression)|0|||
162016809|NCT02500797|585116306|FG001|Overall Study|Cancel (rapid disease progression)|0|||
162016810|NCT02500797|585116307|FG002|Overall Study|Cancel (rapid disease progression)|0|||
162016811|NCT02500797|585116308|FG003|Overall Study|Cancel (rapid disease progression)|0|||
162016812|NCT02500797|585116309|FG004|Overall Study|Cancel (rapid disease progression)|1|||
162016813|NCT02500797|585116310|FG005|Overall Study|Cancel (rapid disease progression)|1|||
162016814|NCT02500797|585116311|FG006|Overall Study|Cancel (rapid disease progression)|0|||
162016815|NCT02500797|585116312|FG007|Overall Study|Cancel (rapid disease progression)|0|||
162016816|NCT02500797|585116305|FG000|Overall Study|Withdrawal by Subject|1|||
162016817|NCT02500797|585116306|FG001|Overall Study|Withdrawal by Subject|0|||
162016818|NCT02500797|585116307|FG002|Overall Study|Withdrawal by Subject|0|||
162016819|NCT02500797|585116308|FG003|Overall Study|Withdrawal by Subject|0|||
162016820|NCT02500797|585116309|FG004|Overall Study|Withdrawal by Subject|0|||
162016821|NCT02500797|585116310|FG005|Overall Study|Withdrawal by Subject|0|||
162016822|NCT02500797|585116311|FG006|Overall Study|Withdrawal by Subject|0|||
162016823|NCT02500797|585116312|FG007|Overall Study|Withdrawal by Subject|0|||
162016824|NCT00357006|585116319|FG000|Overall Study|Lost to Follow-up|1|||
162016825|NCT00357006|585116320|FG001|Overall Study|Lost to Follow-up|2|||
162016826|NCT00357006|585116321|FG002|Overall Study|Lost to Follow-up|1|||
162016827|NCT00357006|585116319|FG000|Overall Study|Withdrawal by Subject|1|||
162016828|NCT00357006|585116320|FG001|Overall Study|Withdrawal by Subject|3|||
162016829|NCT00357006|585116321|FG002|Overall Study|Withdrawal by Subject|2|||
162016830|NCT03710161|585116322|FG000|Overall Study|Study halted due to COVID pandemic|3|||
162016831|NCT03710161|585116323|FG001|Overall Study|Study halted due to COVID pandemic|2|||
162016832|NCT02023697|585116327|FG000|Treatment Period|Radiological progression|13|||
162016833|NCT02023697|585116328|FG001|Treatment Period|Radiological progression|17|||
162016834|NCT02023697|585116329|FG002|Treatment Period|Radiological progression|26|||
162016835|NCT02023697|585116327|FG000|Treatment Period|Never Treated|5|||
162016836|NCT02023697|585116328|FG001|Treatment Period|Never Treated|6|||
162016837|NCT02023697|585116329|FG002|Treatment Period|Never Treated|10|||
162016838|NCT02023697|585116327|FG000|Treatment Period|Adverse Event|13|||
162016839|NCT02023697|585116328|FG001|Treatment Period|Adverse Event|25|||
162016840|NCT02023697|585116329|FG002|Treatment Period|Adverse Event|23|||
162016841|NCT02023697|585116327|FG000|Treatment Period|Logistical difficulties|1|||
162016842|NCT02023697|585116328|FG001|Treatment Period|Logistical difficulties|1|||
162016843|NCT02023697|585116329|FG002|Treatment Period|Logistical difficulties|1|||
162016844|NCT02023697|585116327|FG000|Treatment Period|Clinical progression|10|||
162016845|NCT02023697|585116328|FG001|Treatment Period|Clinical progression|8|||
162016846|NCT02023697|585116329|FG002|Treatment Period|Clinical progression|28|||
162016847|NCT02023697|585116327|FG000|Treatment Period|Withdrawal by Subject|4|||
162016848|NCT02023697|585116328|FG001|Treatment Period|Withdrawal by Subject|5|||
162016849|NCT02023697|585116329|FG002|Treatment Period|Withdrawal by Subject|13|||
162016850|NCT02023697|585116327|FG000|Treatment Period|Safety outcome reached|0|||
162016851|NCT02023697|585116328|FG001|Treatment Period|Safety outcome reached|1|||
162016852|NCT02023697|585116329|FG002|Treatment Period|Safety outcome reached|0|||
162016853|NCT02023697|585116327|FG000|Treatment Period|Physician Decision|0|||
162016854|NCT02023697|585116328|FG001|Treatment Period|Physician Decision|0|||
162016855|NCT02023697|585116329|FG002|Treatment Period|Physician Decision|1|||
162016856|NCT02023697|585116327|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
162016857|NCT02023697|585116328|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
162016858|NCT02023697|585116329|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
162016859|NCT02023697|585116327|FG000|Active Follow-up Period|Lost to Follow-up|1|||
162016860|NCT02023697|585116328|FG001|Active Follow-up Period|Lost to Follow-up|1|||
162016861|NCT02023697|585116329|FG002|Active Follow-up Period|Lost to Follow-up|1|||
162016862|NCT02023697|585116327|FG000|Active Follow-up Period|Deterioration of general condition|1|||
162016863|NCT02023697|585116328|FG001|Active Follow-up Period|Deterioration of general condition|1|||
162016864|NCT02023697|585116329|FG002|Active Follow-up Period|Deterioration of general condition|1|||
162016865|NCT02023697|585116327|FG000|Active Follow-up Period|Other unspecified|2|||
162016866|NCT02023697|585116328|FG001|Active Follow-up Period|Other unspecified|0|||
162016867|NCT02023697|585116329|FG002|Active Follow-up Period|Other unspecified|1|||
162016868|NCT02023697|585116327|FG000|Active Follow-up Period|Clinical progression|0|||
162016869|NCT02023697|585116328|FG001|Active Follow-up Period|Clinical progression|2|||
162016870|NCT02023697|585116329|FG002|Active Follow-up Period|Clinical progression|1|||
162016871|NCT02023697|585116327|FG000|Active Follow-up Period|Radiological progression|0|||
162016872|NCT02023697|585116328|FG001|Active Follow-up Period|Radiological progression|0|||
162016873|NCT02023697|585116329|FG002|Active Follow-up Period|Radiological progression|1|||
162016874|NCT02023697|585116327|FG000|Active Follow-up Period|Death|83|||
162016875|NCT02023697|585116328|FG001|Active Follow-up Period|Death|82|||
162016876|NCT02023697|585116329|FG002|Active Follow-up Period|Death|87|||
162016877|NCT02023697|585116327|FG000|Long-term Follow-up Period|Death|9|||
162016878|NCT02023697|585116328|FG001|Long-term Follow-up Period|Death|6|||
162016879|NCT02023697|585116329|FG002|Long-term Follow-up Period|Death|4|||
162016880|NCT02023697|585116327|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
162016881|NCT02023697|585116328|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
162016882|NCT02023697|585116329|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
162016883|NCT02023697|585116327|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
162016884|NCT02023697|585116328|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
162016885|NCT02023697|585116329|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
162016886|NCT02023697|585116327|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
162016887|NCT02023697|585116328|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
162016888|NCT02023697|585116329|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
162016889|NCT02023697|585116327|FG000|Long-term Follow-up Period|Technical problems|0|||
162016890|NCT02023697|585116328|FG001|Long-term Follow-up Period|Technical problems|0|||
162016891|NCT02023697|585116329|FG002|Long-term Follow-up Period|Technical problems|1|||
162016892|NCT02023697|585116327|FG000|Long-term Follow-up Period|Other unspecified|6|||
162016893|NCT02023697|585116328|FG001|Long-term Follow-up Period|Other unspecified|3|||
162016894|NCT02023697|585116329|FG002|Long-term Follow-up Period|Other unspecified|5|||
162016895|NCT00541385|585116330|FG000|Overall Study|Adverse Event|6|||
162016896|NCT00541385|585116331|FG001|Overall Study|Adverse Event|3|||
162016897|NCT00541385|585116330|FG000|Overall Study|Withdrawal by Subject|2|||
162016898|NCT00541385|585116331|FG001|Overall Study|Withdrawal by Subject|2|||
162016899|NCT00541385|585116330|FG000|Overall Study|Lost to Follow-up|6|||
162016900|NCT00541385|585116331|FG001|Overall Study|Lost to Follow-up|1|||
162016901|NCT00541385|585116330|FG000|Overall Study|Parasite reappearance/malaria|67|||
162016902|NCT00541385|585116331|FG001|Overall Study|Parasite reappearance/malaria|32|||
162016903|NCT01469377|585116332|FG000|Overall Study|Protocol Deviation|7|||
162016904|NCT01469377|585116333|FG001|Overall Study|Protocol Deviation|10|||
162016905|NCT01469377|585116334|FG002|Overall Study|Protocol Deviation|10|||
162016906|NCT01469377|585116332|FG000|Overall Study|Lost to Follow-up|3|||
162016907|NCT01469377|585116333|FG001|Overall Study|Lost to Follow-up|2|||
162016908|NCT01469377|585116334|FG002|Overall Study|Lost to Follow-up|5|||
162016909|NCT01469377|585116332|FG000|Overall Study|Withdrawal of Consent|12|||
162163682|NCT03763708|585649833|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
162163683|NCT03763708|585649834|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
162163684|NCT03763708|585649835|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
162163685|NCT03763708|585649836|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
162163686|NCT03763708|585649837|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
162163687|NCT03763708|585649838|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
162016910|NCT01469377|585116333|FG001|Overall Study|Withdrawal of Consent|14|||
162163688|NCT03763708|585649830|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
162163689|NCT03763708|585649831|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
162016911|NCT01469377|585116334|FG002|Overall Study|Withdrawal of Consent|15|||
162016912|NCT01469377|585116332|FG000|Overall Study|Adverse Event|8|||
162016913|NCT01469377|585116333|FG001|Overall Study|Adverse Event|18|||
162016914|NCT01469377|585116334|FG002|Overall Study|Adverse Event|36|||
162016915|NCT01469377|585116332|FG000|Overall Study|Insufficient Therapeutic Response|3|||
162016916|NCT01469377|585116333|FG001|Overall Study|Insufficient Therapeutic Response|4|||
162016917|NCT01469377|585116334|FG002|Overall Study|Insufficient Therapeutic Response|0|||
162016918|NCT01469377|585116332|FG000|Overall Study|Other Miscellaneous Reasons|2|||
162016919|NCT01469377|585116333|FG001|Overall Study|Other Miscellaneous Reasons|0|||
162016920|NCT01469377|585116334|FG002|Overall Study|Other Miscellaneous Reasons|0|||
162016921|NCT03857867|585116337|FG000|Overall Study|Physician Decision|1|||
162016922|NCT02506244|585116338|FG000|Overall Study|Did not undergo active monitoring|458|||
162163690|NCT03763708|585649832|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
162163691|NCT03763708|585649833|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
162163692|NCT03763708|585649834|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
162016923|NCT02506244|585116339|FG001|Overall Study|Did not undergo active monitoring|459|||
162016924|NCT02506244|585116340|FG002|Overall Study|Did not undergo active monitoring|0|||
162016925|NCT02447003|585116343|FG000|Overall Study|Other|0|||
162016926|NCT02447003|585116344|FG001|Overall Study|Other|4|||
162016927|NCT02447003|585116343|FG000|Overall Study|Site discontinued|0|||
162016928|NCT02447003|585116344|FG001|Overall Study|Site discontinued|2|||
162016929|NCT02447003|585116343|FG000|Overall Study|Physician Decision|0|||
162016930|NCT02447003|585116344|FG001|Overall Study|Physician Decision|1|||
162016931|NCT02447003|585116343|FG000|Overall Study|Withdrawal by Subject|4|||
162016932|NCT02447003|585116344|FG001|Overall Study|Withdrawal by Subject|3|||
162016933|NCT02447003|585116343|FG000|Overall Study|Sponsor Decision|6|||
162016934|NCT02447003|585116344|FG001|Overall Study|Sponsor Decision|11|||
162016935|NCT02447003|585116343|FG000|Overall Study|Progressive Disease|1|||
162016936|NCT02447003|585116344|FG001|Overall Study|Progressive Disease|0|||
162016937|NCT02447003|585116343|FG000|Overall Study|Lost to Follow-up|5|||
162016938|NCT02447003|585116344|FG001|Overall Study|Lost to Follow-up|0|||
162016939|NCT02447003|585116343|FG000|Overall Study|Death|154|||
162016940|NCT02447003|585116344|FG001|Overall Study|Death|63|||
162016941|NCT00750438|585116345|FG000|Overall Study|Protocol Violation|4|||
162016942|NCT00750438|585116346|FG001|Overall Study|Protocol Violation|1|||
162016943|NCT00750438|585116345|FG000|Overall Study|Physician Decision|2|||
162163693|NCT03763708|585649835|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
162016944|NCT00750438|585116346|FG001|Overall Study|Physician Decision|2|||
162016945|NCT00750438|585116345|FG000|Overall Study|Withdrawal by Subject|1|||
162016946|NCT00750438|585116346|FG001|Overall Study|Withdrawal by Subject|1|||
162016947|NCT03848728|585116347|FG000|Overall Study|Death|16|||
162016948|NCT03848728|585116348|FG001|Overall Study|Death|13|||
162016949|NCT03848728|585116347|FG000|Overall Study|Outmigrated to non-study community|98|||
162016950|NCT03848728|585116348|FG001|Overall Study|Outmigrated to non-study community|106|||
162163694|NCT03763708|585649836|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
162163695|NCT03763708|585649837|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
162163696|NCT03763708|585649838|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
162163697|NCT04382404|585649841|FG000|Overall Study|Adverse Event|1|||
162163698|NCT04382404|585649841|FG000|Overall Study|Lost to Follow-up|2|||
162163699|NCT05687916|585649845|FG000|Overall Study|Adverse Event|1|||
162163700|NCT05687916|585649846|FG001|Overall Study|Adverse Event|2|||
162163701|NCT05687916|585649847|FG002|Overall Study|Adverse Event|0|||
162163702|NCT05687916|585649845|FG000|Overall Study|Withdrawal by Subject|1|||
162163703|NCT05687916|585649846|FG001|Overall Study|Withdrawal by Subject|0|||
162163704|NCT05687916|585649847|FG002|Overall Study|Withdrawal by Subject|1|||
162163705|NCT05687916|585649845|FG000|Overall Study|Protocol Violation|0|||
162163706|NCT05687916|585649846|FG001|Overall Study|Protocol Violation|2|||
162163707|NCT05687916|585649847|FG002|Overall Study|Protocol Violation|1|||
162163708|NCT05687916|585649845|FG000|Overall Study|Reason not Specified|1|||
162163709|NCT05687916|585649846|FG001|Overall Study|Reason not Specified|0|||
162016951|NCT03848728|585116347|FG000|Overall Study|Transfered to non-study clinic|32|||
162016952|NCT03848728|585116348|FG001|Overall Study|Transfered to non-study clinic|48|||
162016953|NCT03848728|585116347|FG000|Overall Study|Withdrawal by Subject|1|||
162016954|NCT03848728|585116348|FG001|Overall Study|Withdrawal by Subject|0|||
162016955|NCT00536744|585116351|FG000|Overall Study|Adverse Event|13|||
162016956|NCT00536744|585116352|FG001|Overall Study|Adverse Event|10|||
162016957|NCT00536744|585116351|FG000|Overall Study|Death|2|||
162163710|NCT05687916|585649847|FG002|Overall Study|Reason not Specified|0|||
162163711|NCT03406871|585649851|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
162163712|NCT03406871|585649852|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
162163713|NCT03406871|585649853|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
162163714|NCT03406871|585649851|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
162016958|NCT00536744|585116352|FG001|Overall Study|Death|1|||
162016959|NCT00536744|585116351|FG000|Overall Study|Physician Decision|3|||
162016960|NCT00536744|585116352|FG001|Overall Study|Physician Decision|1|||
162016961|NCT00536744|585116351|FG000|Overall Study|Lost to Follow-up|3|||
162016962|NCT00536744|585116352|FG001|Overall Study|Lost to Follow-up|5|||
162016963|NCT00536744|585116351|FG000|Overall Study|Withdrawal by Subject|7|||
162016964|NCT00536744|585116352|FG001|Overall Study|Withdrawal by Subject|8|||
162016965|NCT00536744|585116351|FG000|Overall Study|PI tried alternative treatment|1|||
162016966|NCT00536744|585116352|FG001|Overall Study|PI tried alternative treatment|3|||
162016967|NCT00787644|585116353|FG000|Overall Study|Lost to Follow-up|1|||
162016968|NCT00787644|585116354|FG001|Overall Study|Lost to Follow-up|1|||
162016969|NCT00787644|585116353|FG000|Overall Study|Withdrawal by Subject|1|||
162016970|NCT00787644|585116354|FG001|Overall Study|Withdrawal by Subject|1|||
162016971|NCT01642589|585116358|FG000|Overall Study|Withdrawal by Subject|1|||
162016972|NCT01642589|585116359|FG001|Overall Study|Withdrawal by Subject|1|||
162016973|NCT01108185|585116360|FG000|Overall Study|Non-compliance|15|||
162016974|NCT01108185|585116360|FG000|Overall Study|Lost to Follow-up|12|||
162016975|NCT02581410|585116365|FG000|Vaccination Phase|Adverse Event|2|||
162016976|NCT02581410|585116366|FG001|Vaccination Phase|Adverse Event|1|||
162016977|NCT02581410|585116365|FG000|Vaccination Phase|Withdrawal by Subject|0|||
162016978|NCT02581410|585116366|FG001|Vaccination Phase|Withdrawal by Subject|1|||
162016979|NCT02581410|585116365|FG000|Vaccination Phase|Migrated/moved from study area|0|||
162016980|NCT02581410|585116366|FG001|Vaccination Phase|Migrated/moved from study area|1|||
162016981|NCT02581410|585116365|FG000|End of Study Phase|Adverse Event|4|||
162016982|NCT02581410|585116366|FG001|End of Study Phase|Adverse Event|3|||
162016983|NCT02581410|585116365|FG000|End of Study Phase|Withdrawal by Subject|1|||
162016984|NCT02581410|585116366|FG001|End of Study Phase|Withdrawal by Subject|2|||
162016985|NCT02581410|585116365|FG000|End of Study Phase|Migrated/moved from study area|0|||
162016986|NCT02581410|585116366|FG001|End of Study Phase|Migrated/moved from study area|3|||
162016987|NCT02581410|585116365|FG000|End of Study Phase|Lost to Follow-up|0|||
162016988|NCT02581410|585116366|FG001|End of Study Phase|Lost to Follow-up|2|||
162016989|NCT02581410|585116365|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
162016990|NCT02581410|585116366|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
162016991|NCT00670748|585116370|FG000|Overall Study|Death during treatment|1|||
162016992|NCT00670748|585116371|FG001|Overall Study|Death during treatment|1|||
162016993|NCT00670748|585116372|FG002|Overall Study|Death during treatment|1|||
162016994|NCT00670748|585116373|FG003|Overall Study|Death during treatment|0|||
162016995|NCT00670748|585116370|FG000|Overall Study|Not off study|2|||
162016996|NCT00670748|585116371|FG001|Overall Study|Not off study|1|||
162163715|NCT03406871|585649852|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
162016997|NCT00670748|585116372|FG002|Overall Study|Not off study|1|||
162163716|NCT03406871|585649853|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
162163717|NCT03406871|585649851|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
162163718|NCT03406871|585649852|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
162016998|NCT00670748|585116373|FG003|Overall Study|Not off study|1|||
162016999|NCT02736578|585116376|FG000|Overall Study|Adverse Event|1|||
162017000|NCT02736578|585116377|FG001|Overall Study|Adverse Event|0|||
162017001|NCT05615922|585116380|FG000|Overall Study|Lost to Follow-up|1|||
162017002|NCT04774094|585116382|FG000|Overall Study|Other|2|||
162017003|NCT04774094|585116382|FG000|Overall Study|Withdrawal by Subject|9|||
162163719|NCT03406871|585649853|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
162163720|NCT03406871|585649851|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
162163721|NCT03406871|585649852|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
162163722|NCT03406871|585649853|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
162163723|NCT03406871|585649851|FG000|Expansion Cohort(Final Analysis)|Death|0|||
162163724|NCT03406871|585649852|FG001|Expansion Cohort(Final Analysis)|Death|1|||
162163725|NCT03406871|585649853|FG002|Expansion Cohort(Final Analysis)|Death|0|||
162163726|NCT03406871|585649851|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
162163727|NCT03406871|585649852|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
162163728|NCT03406871|585649853|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
162163729|NCT04177823|585649861|FG000|Overall Study|Physician Decision|1|||
162163730|NCT04177823|585649861|FG000|Overall Study|Withdrawal by Subject|1|||
162163731|NCT03699709|585649862|FG000|Overall Study|Death|1|||
162163732|NCT03699709|585649863|FG001|Overall Study|Death|2|||
162163733|NCT03699709|585649862|FG000|Overall Study|Lost to Follow-up|10|||
162163734|NCT03699709|585649863|FG001|Overall Study|Lost to Follow-up|3|||
162163735|NCT03699709|585649862|FG000|Overall Study|Withdrawal by Subject|5|||
162163736|NCT03699709|585649863|FG001|Overall Study|Withdrawal by Subject|0|||
162163737|NCT03699709|585649862|FG000|Overall Study|incarcerated|1|||
162163738|NCT03699709|585649863|FG001|Overall Study|incarcerated|0|||
162163739|NCT03699709|585649862|FG000|Overall Study|scheduled, but no show|0|||
162163740|NCT03699709|585649863|FG001|Overall Study|scheduled, but no show|1|||
162163741|NCT02907099|585649864|FG000|Overall Study|Adverse Event|1|||
162163742|NCT02907099|585649864|FG000|Overall Study|Withdrawal by Subject|2|||
162163743|NCT02907099|585649864|FG000|Overall Study|Screen Fail|2|||
162163744|NCT05784662|585649865|FG000|Overall Study|Lost to Follow-up|21|||
162163745|NCT05784662|585649866|FG001|Overall Study|Lost to Follow-up|17|||
162163746|NCT02913872|585649871|FG000|Overall Study|Withdrawal by Subject|1|||
162163747|NCT04739956|585649874|FG000|Overall Study|Withdrawal by Subject|1|||
162163748|NCT04739956|585649875|FG001|Overall Study|Withdrawal by Subject|1|||
162163749|NCT03920111|585649876|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
162163750|NCT03920111|585649877|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
162163751|NCT03920111|585649878|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
162163752|NCT03519581|585649881|FG000|Overall Study|Lost to Follow-up|3|||
162163753|NCT03519581|585649882|FG001|Overall Study|Lost to Follow-up|2|||
162163754|NCT03519581|585649881|FG000|Overall Study|Adverse Event|5|||
162163755|NCT03519581|585649882|FG001|Overall Study|Adverse Event|2|||
162163756|NCT03519581|585649881|FG000|Overall Study|Withdrawal by Subject|2|||
162163757|NCT03519581|585649882|FG001|Overall Study|Withdrawal by Subject|0|||
162163758|NCT03519581|585649881|FG000|Overall Study|Change to insurance|2|||
162163759|NCT03519581|585649882|FG001|Overall Study|Change to insurance|1|||
162163760|NCT03519581|585649881|FG000|Overall Study|Other|2|||
162163761|NCT03519581|585649882|FG001|Overall Study|Other|4|||
162163762|NCT05177848|585649883|FG000|Overall Study|Lost to Follow-up|1|||
162163763|NCT05177848|585649884|FG001|Overall Study|Lost to Follow-up|4|||
162163764|NCT05177848|585649883|FG000|Overall Study|Discontinued|2|||
162163765|NCT05177848|585649884|FG001|Overall Study|Discontinued|1|||
162163766|NCT03110315|585649886|FG000|Overall Study|Withdrawal by Subject|1|||
162163767|NCT03110315|585649887|FG001|Overall Study|Withdrawal by Subject|0|||
161815288|NCT01838681|584366940|FG003|Period A|Lost to Follow-up|0|||
161815289|NCT01838681|584366937|FG000|Period A|Withdrawal before treatment|4|||
161815290|NCT01838681|584366938|FG001|Period A|Withdrawal before treatment|0|||
161815291|NCT01838681|584366939|FG002|Period A|Withdrawal before treatment|0|||
161815292|NCT01838681|584366940|FG003|Period A|Withdrawal before treatment|0|||
161815293|NCT01838681|584366937|FG000|Period A|Administrative or other reasons|17|||
161815294|NCT01838681|584366938|FG001|Period A|Administrative or other reasons|0|||
162017004|NCT04774094|585116382|FG000|Overall Study|Lost to Follow-up|7|||
162017005|NCT04774094|585116382|FG000|Overall Study|Lack of Efficacy|5|||
162017006|NCT04774094|585116382|FG000|Overall Study|Death|17|||
162017007|NCT04774094|585116382|FG000|Overall Study|Adverse Event|4|||
161815295|NCT01838681|584366939|FG002|Period A|Administrative or other reasons|0|||
161815296|NCT01838681|584366940|FG003|Period A|Administrative or other reasons|0|||
162017008|NCT02374450|585116383|FG000|Overall Study|Protocol Violation|0|||
162163768|NCT04322643|585649890|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
162163769|NCT05486078|585649893|FG000|Overall Study|4 drop out and one withdrawn|5|||
162163770|NCT05134233|585649894|FG000|Overall Study|Pregnancy|1|||
162163771|NCT05134233|585649894|FG000|Overall Study|MEP value too low|2|||
162163772|NCT05134233|585649894|FG000|Overall Study|Lost to Follow-up|1|||
161815297|NCT01838681|584366937|FG000|Period B/A+|Adverse Event|0|||
162163773|NCT03978871|585649895|FG000|Overall Study|Lost to Follow-up|11|||
162163774|NCT03978871|585649896|FG001|Overall Study|Lost to Follow-up|12|||
162163775|NCT05710107|585649897|FG000|Overall Study|Withdrawal by Subject|1|||
162163776|NCT05710107|585649898|FG001|Overall Study|Withdrawal by Subject|1|||
162163777|NCT05710107|585649897|FG000|Overall Study|Lost to Follow-up|8|||
162163778|NCT05710107|585649898|FG001|Overall Study|Lost to Follow-up|9|||
162163779|NCT05710107|585649897|FG000|Overall Study|Unable to place assigned block|2|||
162163780|NCT05710107|585649898|FG001|Overall Study|Unable to place assigned block|0|||
162163781|NCT05710107|585649897|FG000|Overall Study|Withdrawn by study team|0|||
162163782|NCT05710107|585649898|FG001|Overall Study|Withdrawn by study team|1|||
162163783|NCT04166773|585649899|FG000|Overall Study|Adverse Event|2|||
162163784|NCT04166773|585649900|FG001|Overall Study|Adverse Event|0|||
162163785|NCT04166773|585649901|FG002|Overall Study|Adverse Event|2|||
162163786|NCT04166773|585649902|FG003|Overall Study|Adverse Event|1|||
162163787|NCT04166773|585649899|FG000|Overall Study|Lost to Follow-up|4|||
162163788|NCT04166773|585649900|FG001|Overall Study|Lost to Follow-up|2|||
162163789|NCT04166773|585649901|FG002|Overall Study|Lost to Follow-up|1|||
162163790|NCT04166773|585649902|FG003|Overall Study|Lost to Follow-up|3|||
162163791|NCT04166773|585649899|FG000|Overall Study|Physician Decision|0|||
162163792|NCT04166773|585649900|FG001|Overall Study|Physician Decision|0|||
162163793|NCT04166773|585649901|FG002|Overall Study|Physician Decision|0|||
162163794|NCT04166773|585649902|FG003|Overall Study|Physician Decision|1|||
162163795|NCT04166773|585649899|FG000|Overall Study|Withdrawal by Subject|1|||
162163796|NCT04166773|585649900|FG001|Overall Study|Withdrawal by Subject|1|||
162163797|NCT04166773|585649901|FG002|Overall Study|Withdrawal by Subject|2|||
162163798|NCT04166773|585649902|FG003|Overall Study|Withdrawal by Subject|5|||
162163799|NCT04072822|585649903|FG000|Treatment|Adverse Event|9|||
162163800|NCT04072822|585649904|FG001|Treatment|Adverse Event|5|||
162163801|NCT04072822|585649903|FG000|Treatment|Met Stopping Criteria|13|||
162163802|NCT04072822|585649904|FG001|Treatment|Met Stopping Criteria|24|||
162163803|NCT04072822|585649903|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
162163804|NCT04072822|585649904|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
162163805|NCT04072822|585649903|FG000|Treatment|Withdrawal by Subject|0|||
162163806|NCT04072822|585649904|FG001|Treatment|Withdrawal by Subject|2|||
162163807|NCT04072822|585649903|FG000|Treatment|Death|0|||
162017009|NCT02374450|585116384|FG001|Overall Study|Protocol Violation|1|||
162017010|NCT02374450|585116385|FG002|Overall Study|Protocol Violation|0|||
162017011|NCT02374450|585116383|FG000|Overall Study|Withdrawal by Subject|91|||
162017012|NCT02374450|585116384|FG001|Overall Study|Withdrawal by Subject|110|||
162017013|NCT02374450|585116385|FG002|Overall Study|Withdrawal by Subject|4|||
162017014|NCT02374450|585116383|FG000|Overall Study|Lost to Follow-up|168|||
162017015|NCT02374450|585116384|FG001|Overall Study|Lost to Follow-up|194|||
162017016|NCT02374450|585116385|FG002|Overall Study|Lost to Follow-up|138|||
162017017|NCT02374450|585116383|FG000|Overall Study|Death|173|||
162017018|NCT02374450|585116384|FG001|Overall Study|Death|185|||
162017019|NCT02374450|585116385|FG002|Overall Study|Death|81|||
162017020|NCT02374450|585116383|FG000|Overall Study|Migrated from the study area|538|||
161815298|NCT01838681|584366938|FG001|Period B/A+|Adverse Event|13|||
162163808|NCT04072822|585649904|FG001|Treatment|Death|2|||
162163809|NCT04072822|585649903|FG000|Treatment|Lost to Follow-up|11|||
162163810|NCT04072822|585649904|FG001|Treatment|Lost to Follow-up|3|||
162163811|NCT04072822|585649903|FG000|Treatment|Physician Decision|1|||
162163812|NCT04072822|585649904|FG001|Treatment|Physician Decision|0|||
162163813|NCT04072822|585649903|FG000|Treatment|Other|7|||
162163814|NCT04072822|585649904|FG001|Treatment|Other|9|||
162163815|NCT04072822|585649903|FG000|Follow-up|Withdrawal by Subject|1|||
162163816|NCT04072822|585649904|FG001|Follow-up|Withdrawal by Subject|0|||
162163817|NCT04072822|585649903|FG000|Follow-up|Lost to Follow-up|5|||
162163818|NCT04072822|585649904|FG001|Follow-up|Lost to Follow-up|4|||
162163819|NCT03269136|585649905|FG000|Part 1: Dose Escalation|Other|0|||
162163820|NCT03269136|585649906|FG001|Part 1: Dose Escalation|Other|0|||
162163821|NCT03269136|585649907|FG002|Part 1: Dose Escalation|Other|0|||
162163822|NCT03269136|585649908|FG003|Part 1: Dose Escalation|Other|0|||
162163823|NCT03269136|585649909|FG004|Part 1: Dose Escalation|Other|0|||
162163824|NCT03269136|585649910|FG005|Part 1: Dose Escalation|Other|0|||
162163825|NCT03269136|585649911|FG006|Part 1: Dose Escalation|Other|0|||
162163826|NCT03269136|585649912|FG007|Part 1: Dose Escalation|Other|0|||
162163827|NCT03269136|585649913|FG008|Part 1: Dose Escalation|Other|0|||
162163828|NCT03269136|585649914|FG009|Part 1: Dose Escalation|Other|0|||
162017021|NCT02374450|585116384|FG001|Overall Study|Migrated from the study area|648|||
162017022|NCT02374450|585116385|FG002|Overall Study|Migrated from the study area|181|||
162017023|NCT02374450|585116383|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
162017024|NCT02374450|585116384|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
162017025|NCT02374450|585116385|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
162163829|NCT03269136|585649915|FG010|Part 1: Dose Escalation|Other|1|||
162163830|NCT03269136|585649916|FG011|Part 1: Dose Escalation|Other|1|||
162163831|NCT03269136|585649917|FG012|Part 1: Dose Escalation|Other|1|||
162163832|NCT03269136|585649918|FG013|Part 1: Dose Escalation|Other|0|||
162163833|NCT03269136|585649919|FG014|Part 1: Dose Escalation|Other|3|||
162163834|NCT03269136|585649920|FG015|Part 1: Dose Escalation|Other|1|||
162163835|NCT03269136|585649921|FG016|Part 1: Dose Escalation|Other|1|||
162163836|NCT03269136|585649922|FG017|Part 1: Dose Escalation|Other|0|||
162163837|NCT03269136|585649905|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
162163838|NCT03269136|585649906|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
162163839|NCT03269136|585649907|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
161815299|NCT01838681|584366939|FG002|Period B/A+|Adverse Event|27|||
162163840|NCT03269136|585649908|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
162017026|NCT02374450|585116383|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
162017027|NCT02374450|585116384|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
161815300|NCT01838681|584366940|FG003|Period B/A+|Adverse Event|16|||
162017028|NCT02374450|585116385|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
162017029|NCT02374450|585116383|FG000|Overall Study|Other|0|||
162017030|NCT02374450|585116384|FG001|Overall Study|Other|21|||
162017031|NCT02374450|585116385|FG002|Overall Study|Other|79|||
162017032|NCT03830892|585117797|FG000|Overall Study|Physician Decision|2|||
162017033|NCT03830892|585117798|FG001|Overall Study|Physician Decision|3|||
161815301|NCT01838681|584366937|FG000|Period B/A+|Lack of Efficacy|0|||
161815302|NCT01838681|584366938|FG001|Period B/A+|Lack of Efficacy|9|||
161815303|NCT01838681|584366939|FG002|Period B/A+|Lack of Efficacy|11|||
161815304|NCT01838681|584366940|FG003|Period B/A+|Lack of Efficacy|6|||
161815305|NCT01838681|584366937|FG000|Period B/A+|Withdrawal by Subject|0|||
161815306|NCT01838681|584366938|FG001|Period B/A+|Withdrawal by Subject|28|||
161815307|NCT01838681|584366939|FG002|Period B/A+|Withdrawal by Subject|35|||
161815308|NCT01838681|584366940|FG003|Period B/A+|Withdrawal by Subject|47|||
161815309|NCT01838681|584366937|FG000|Period B/A+|Protocol Violation|0|||
161815310|NCT01838681|584366938|FG001|Period B/A+|Protocol Violation|1|||
161815311|NCT01838681|584366939|FG002|Period B/A+|Protocol Violation|4|||
161815312|NCT01838681|584366940|FG003|Period B/A+|Protocol Violation|6|||
161815313|NCT01838681|584366937|FG000|Period B/A+|Non-compliance with IMP|0|||
161815314|NCT01838681|584366938|FG001|Period B/A+|Non-compliance with IMP|2|||
161815315|NCT01838681|584366939|FG002|Period B/A+|Non-compliance with IMP|3|||
161815316|NCT01838681|584366940|FG003|Period B/A+|Non-compliance with IMP|3|||
161815317|NCT01838681|584366937|FG000|Period B/A+|Lost to Follow-up|0|||
161815318|NCT01838681|584366938|FG001|Period B/A+|Lost to Follow-up|2|||
161815319|NCT01838681|584366939|FG002|Period B/A+|Lost to Follow-up|5|||
161815320|NCT01838681|584366940|FG003|Period B/A+|Lost to Follow-up|11|||
161815321|NCT01838681|584366937|FG000|Period B/A+|Withdrawal before treatment|0|||
161815322|NCT01838681|584366938|FG001|Period B/A+|Withdrawal before treatment|1|||
161815323|NCT01838681|584366939|FG002|Period B/A+|Withdrawal before treatment|0|||
161815324|NCT01838681|584366940|FG003|Period B/A+|Withdrawal before treatment|0|||
161815325|NCT01838681|584366937|FG000|Period B/A+|Administrative or other reasons|0|||
161815326|NCT01838681|584366938|FG001|Period B/A+|Administrative or other reasons|6|||
161815327|NCT01838681|584366939|FG002|Period B/A+|Administrative or other reasons|10|||
161815328|NCT01838681|584366940|FG003|Period B/A+|Administrative or other reasons|28|||
161815329|NCT00312897|584366941|FG000|Overall Study|Adverse Event|1|||
161815330|NCT00312897|584366942|FG001|Overall Study|Adverse Event|0|||
161815331|NCT00312897|584366941|FG000|Overall Study|Lost to Follow-up|2|||
161815332|NCT00312897|584366942|FG001|Overall Study|Lost to Follow-up|0|||
161815333|NCT00312897|584366941|FG000|Overall Study|Physician Decision|1|||
161815334|NCT00312897|584366942|FG001|Overall Study|Physician Decision|0|||
161815335|NCT00312897|584366941|FG000|Overall Study|Withdrawal by Subject|1|||
161815336|NCT00312897|584366942|FG001|Overall Study|Withdrawal by Subject|3|||
161815337|NCT00312897|584366941|FG000|Overall Study|Pregnancy|1|||
161815338|NCT00312897|584366942|FG001|Overall Study|Pregnancy|0|||
161815339|NCT00312897|584366941|FG000|Overall Study|discontinued prior to getting treatment|0|||
161815340|NCT00312897|584366942|FG001|Overall Study|discontinued prior to getting treatment|3|||
161815341|NCT00902538|584366945|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
161815342|NCT00902538|584366946|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161815343|NCT00902538|584366947|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161815344|NCT00902538|584366948|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161815345|NCT00902538|584366949|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161815346|NCT00902538|584366950|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161815347|NCT00902538|584366945|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
161815348|NCT00902538|584366946|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161815349|NCT00902538|584366947|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161815350|NCT00902538|584366948|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161815351|NCT00902538|584366949|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161815352|NCT00902538|584366950|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
162017034|NCT03830892|585117797|FG000|Overall Study|Study terminated due to COVID|4|||
162017035|NCT03830892|585117798|FG001|Overall Study|Study terminated due to COVID|0|||
161815353|NCT00902538|584366945|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
161815354|NCT00902538|584366946|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161815355|NCT00902538|584366947|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161815356|NCT00902538|584366948|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161815357|NCT00902538|584366949|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161815358|NCT00902538|584366950|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161815359|NCT00902538|584366945|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
161815360|NCT00902538|584366946|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
162017036|NCT03830892|585117797|FG000|Overall Study|Protocol Violation|0|||
162163841|NCT03269136|585649909|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
162163842|NCT03269136|585649910|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
162163843|NCT03269136|585649911|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
162163844|NCT03269136|585649912|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
161815361|NCT00902538|584366947|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161815362|NCT00902538|584366948|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161815363|NCT00902538|584366949|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161815364|NCT00902538|584366950|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161815365|NCT00902538|584366945|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
161815366|NCT00902538|584366946|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161815367|NCT00902538|584366947|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161815368|NCT00902538|584366948|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161815369|NCT00902538|584366949|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161815370|NCT00902538|584366950|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161815371|NCT00902538|584366945|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
162163845|NCT03269136|585649913|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
162163846|NCT03269136|585649914|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
162163847|NCT03269136|585649915|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
162163848|NCT03269136|585649916|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
162163849|NCT03269136|585649917|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
162163850|NCT03269136|585649918|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
162163851|NCT03269136|585649919|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
162163852|NCT03269136|585649920|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
162163853|NCT03269136|585649921|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
162163854|NCT03269136|585649922|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
162163855|NCT03269136|585649905|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163856|NCT03269136|585649906|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163857|NCT03269136|585649907|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163858|NCT03269136|585649908|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163859|NCT03269136|585649909|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163860|NCT03269136|585649910|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163861|NCT03269136|585649911|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163862|NCT03269136|585649912|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
162163863|NCT03269136|585649913|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163864|NCT03269136|585649914|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163865|NCT03269136|585649915|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163866|NCT03269136|585649916|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163867|NCT03269136|585649917|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163868|NCT03269136|585649918|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163869|NCT03269136|585649919|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163870|NCT03269136|585649920|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163871|NCT03269136|585649921|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163872|NCT03269136|585649922|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
162163873|NCT03269136|585649905|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163874|NCT03269136|585649906|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163875|NCT03269136|585649907|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163876|NCT03269136|585649908|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163877|NCT03269136|585649909|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163878|NCT03269136|585649910|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163879|NCT03269136|585649911|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163880|NCT03269136|585649912|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163881|NCT03269136|585649913|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163882|NCT03269136|585649914|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
162163883|NCT03269136|585649915|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163884|NCT03269136|585649916|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163885|NCT03269136|585649917|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163886|NCT03269136|585649918|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163887|NCT03269136|585649919|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163888|NCT03269136|585649920|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163889|NCT03269136|585649921|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163890|NCT03269136|585649922|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
162163891|NCT03269136|585649905|FG000|Part 1: Dose Escalation|Death|0|||
162163892|NCT03269136|585649906|FG001|Part 1: Dose Escalation|Death|0|||
162163893|NCT03269136|585649907|FG002|Part 1: Dose Escalation|Death|0|||
162163894|NCT03269136|585649908|FG003|Part 1: Dose Escalation|Death|0|||
162163895|NCT03269136|585649909|FG004|Part 1: Dose Escalation|Death|0|||
162163896|NCT03269136|585649910|FG005|Part 1: Dose Escalation|Death|0|||
162163897|NCT03269136|585649911|FG006|Part 1: Dose Escalation|Death|0|||
162163898|NCT03269136|585649912|FG007|Part 1: Dose Escalation|Death|0|||
161815372|NCT00902538|584366946|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
161920797|NCT02693418|584755802|FG000|Overall Study|Lost to Follow-up|1|||
161920798|NCT02693418|584755803|FG001|Overall Study|Lost to Follow-up|2|||
161920799|NCT02693418|584755804|FG002|Overall Study|Lost to Follow-up|0|||
161920800|NCT02693418|584755805|FG003|Overall Study|Lost to Follow-up|0|||
162017037|NCT03830892|585117798|FG001|Overall Study|Protocol Violation|1|||
162017038|NCT03830892|585117797|FG000|Overall Study|Withdrawal by Subject|0|||
161815373|NCT00902538|584366947|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
161815374|NCT00902538|584366948|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
161815375|NCT00902538|584366949|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
161815376|NCT00902538|584366950|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
161815377|NCT00902538|584366945|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
161815378|NCT00902538|584366946|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
161815379|NCT00902538|584366947|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
161815380|NCT00902538|584366948|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
161815381|NCT00902538|584366949|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
161815382|NCT00902538|584366950|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
161815383|NCT00902538|584366945|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
161815384|NCT00902538|584366946|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
161815385|NCT00902538|584366947|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
161815386|NCT00902538|584366948|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
161815387|NCT00902538|584366949|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
161815388|NCT00902538|584366950|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
161815389|NCT00902538|584366945|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
161815390|NCT00902538|584366946|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
161920801|NCT02693418|584755806|FG004|Overall Study|Lost to Follow-up|0|||
161920802|NCT02693418|584755802|FG000|Overall Study|Menses during study period|0|||
161920803|NCT02693418|584755803|FG001|Overall Study|Menses during study period|0|||
161920804|NCT02693418|584755804|FG002|Overall Study|Menses during study period|2|||
161920805|NCT02693418|584755805|FG003|Overall Study|Menses during study period|0|||
161920806|NCT02693418|584755806|FG004|Overall Study|Menses during study period|0|||
161920807|NCT01750346|584755807|FG000|Overall Study|Adverse Event|1|||
161920808|NCT01750346|584755808|FG001|Overall Study|Adverse Event|0|||
161920809|NCT01750346|584755809|FG002|Overall Study|Adverse Event|0|||
162017039|NCT03830892|585117798|FG001|Overall Study|Withdrawal by Subject|2|||
162017040|NCT00975689|585117799|FG000|Overall Study|Adverse Event|0|||
162017041|NCT00975689|585117800|FG001|Overall Study|Adverse Event|3|||
161920810|NCT01001104|584755812|FG000|Overall Study|Adverse Event|2|||
161920811|NCT01001104|584755813|FG001|Overall Study|Adverse Event|1|||
161920812|NCT01001104|584755814|FG002|Overall Study|Adverse Event|0|||
161920813|NCT01001104|584755815|FG003|Overall Study|Adverse Event|0|||
161920814|NCT01001104|584755812|FG000|Overall Study|Lost to Follow-up|0|||
161920815|NCT01001104|584755813|FG001|Overall Study|Lost to Follow-up|0|||
161920816|NCT01001104|584755814|FG002|Overall Study|Lost to Follow-up|1|||
161920817|NCT01001104|584755815|FG003|Overall Study|Lost to Follow-up|0|||
161920818|NCT01001104|584755812|FG000|Overall Study|Entry Criteria Not Met|0|||
161920819|NCT01001104|584755813|FG001|Overall Study|Entry Criteria Not Met|0|||
161920820|NCT01001104|584755814|FG002|Overall Study|Entry Criteria Not Met|0|||
161920821|NCT01001104|584755815|FG003|Overall Study|Entry Criteria Not Met|1|||
161920822|NCT01001104|584755812|FG000|Overall Study|Withdrawal by Subject|0|||
161920823|NCT01001104|584755813|FG001|Overall Study|Withdrawal by Subject|0|||
161920824|NCT01001104|584755814|FG002|Overall Study|Withdrawal by Subject|0|||
161920825|NCT01001104|584755815|FG003|Overall Study|Withdrawal by Subject|2|||
161920826|NCT02034591|584755816|FG000|Overall Study|Withdrawal by Subject|0|||
161920827|NCT02034591|584755817|FG001|Overall Study|Withdrawal by Subject|0|||
161920828|NCT02034591|584755818|FG002|Overall Study|Withdrawal by Subject|0|||
161920829|NCT02034591|584755819|FG003|Overall Study|Withdrawal by Subject|0|||
161920830|NCT02034591|584755820|FG004|Overall Study|Withdrawal by Subject|1|||
161920831|NCT02034591|584755821|FG005|Overall Study|Withdrawal by Subject|0|||
161920832|NCT00599313|584755824|FG000|Overall Study|Adverse Event|19|||
161920833|NCT00599313|584755824|FG000|Overall Study|Disease Progression|12|||
161920834|NCT00599313|584755824|FG000|Overall Study|Patient Request|4|||
161920835|NCT00599313|584755824|FG000|Overall Study|Ineligible|1|||
161920836|NCT05350202|584755825|FG000|Visit 1 - Baseline|Not-treated|18|||
161920837|NCT05350202|584755826|FG001|Visit 1 - Baseline|Not-treated|0|||
161920838|NCT05350202|584755825|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
161920839|NCT05350202|584755826|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
161920840|NCT05350202|584755825|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
161920841|NCT05350202|584755826|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
161920842|NCT05350202|584755825|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
161920843|NCT05350202|584755826|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
161920844|NCT05350202|584755825|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
161920845|NCT05350202|584755826|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
161920846|NCT05350202|584755825|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
161920847|NCT05350202|584755826|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
161920848|NCT05350202|584755825|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
161920849|NCT05350202|584755826|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
161920850|NCT02924376|584755831|FG000|Overall Study|Progressive Disease|4|||
161920851|NCT02924376|584755832|FG001|Overall Study|Progressive Disease|0|||
161920852|NCT02924376|584755833|FG002|Overall Study|Progressive Disease|1|||
161920853|NCT02924376|584755834|FG003|Overall Study|Progressive Disease|0|||
161920854|NCT02924376|584755831|FG000|Overall Study|Death|73|||
161920855|NCT02924376|584755832|FG001|Overall Study|Death|18|||
161920856|NCT02924376|584755833|FG002|Overall Study|Death|15|||
161920857|NCT02924376|584755834|FG003|Overall Study|Death|2|||
161920858|NCT02924376|584755831|FG000|Overall Study|Lost to Follow-up|3|||
161920859|NCT02924376|584755832|FG001|Overall Study|Lost to Follow-up|0|||
161920860|NCT02924376|584755833|FG002|Overall Study|Lost to Follow-up|0|||
161920861|NCT02924376|584755834|FG003|Overall Study|Lost to Follow-up|0|||
162163899|NCT03269136|585649913|FG008|Part 1: Dose Escalation|Death|0|||
162163900|NCT03269136|585649914|FG009|Part 1: Dose Escalation|Death|1|||
162163901|NCT03269136|585649915|FG010|Part 1: Dose Escalation|Death|0|||
162163902|NCT03269136|585649916|FG011|Part 1: Dose Escalation|Death|1|||
162163903|NCT03269136|585649917|FG012|Part 1: Dose Escalation|Death|0|||
162163904|NCT03269136|585649918|FG013|Part 1: Dose Escalation|Death|1|||
162163905|NCT03269136|585649919|FG014|Part 1: Dose Escalation|Death|0|||
161920862|NCT02924376|584755831|FG000|Overall Study|Study Terminated by Sponsor|19|||
161920863|NCT02924376|584755832|FG001|Overall Study|Study Terminated by Sponsor|0|||
161920864|NCT02924376|584755833|FG002|Overall Study|Study Terminated by Sponsor|0|||
161920865|NCT02924376|584755834|FG003|Overall Study|Study Terminated by Sponsor|0|||
161920866|NCT02924376|584755831|FG000|Overall Study|Physician Decision|1|||
161920867|NCT02924376|584755832|FG001|Overall Study|Physician Decision|0|||
161920868|NCT02924376|584755833|FG002|Overall Study|Physician Decision|0|||
161920869|NCT02924376|584755834|FG003|Overall Study|Physician Decision|0|||
161920870|NCT02924376|584755831|FG000|Overall Study|Withdrawal by Subject|7|||
162163906|NCT03269136|585649920|FG015|Part 1: Dose Escalation|Death|0|||
162163907|NCT03269136|585649921|FG016|Part 1: Dose Escalation|Death|2|||
162163908|NCT03269136|585649922|FG017|Part 1: Dose Escalation|Death|0|||
161920871|NCT02924376|584755832|FG001|Overall Study|Withdrawal by Subject|2|||
161920872|NCT02924376|584755833|FG002|Overall Study|Withdrawal by Subject|1|||
161920873|NCT02924376|584755834|FG003|Overall Study|Withdrawal by Subject|0|||
161920874|NCT02924376|584755831|FG000|Overall Study|Rolled Over to Another Study|1|||
161920875|NCT02924376|584755832|FG001|Overall Study|Rolled Over to Another Study|0|||
161815391|NCT00902538|584366947|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
161815392|NCT00902538|584366948|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
161815393|NCT00902538|584366949|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
161815394|NCT00902538|584366950|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
161815395|NCT00902538|584366945|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
161815396|NCT00902538|584366946|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
161815397|NCT00902538|584366947|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
161815398|NCT00902538|584366948|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
162163909|NCT03269136|585649905|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
162163910|NCT03269136|585649906|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
162163911|NCT03269136|585649907|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
162163912|NCT03269136|585649908|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
162163913|NCT03269136|585649909|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
162163914|NCT03269136|585649910|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
162163915|NCT03269136|585649911|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
162163916|NCT03269136|585649912|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
162163917|NCT03269136|585649913|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
162163918|NCT03269136|585649914|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
162163919|NCT03269136|585649915|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
162163920|NCT03269136|585649916|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
162163921|NCT03269136|585649917|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
162163922|NCT03269136|585649918|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
162163923|NCT03269136|585649919|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
162163924|NCT03269136|585649920|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
162163925|NCT03269136|585649921|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
162163926|NCT03269136|585649922|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
162163927|NCT03269136|585649905|FG000|Part 1: Dose Escalation|Adverse Event|0|||
162163928|NCT03269136|585649906|FG001|Part 1: Dose Escalation|Adverse Event|0|||
162163929|NCT03269136|585649907|FG002|Part 1: Dose Escalation|Adverse Event|0|||
162163930|NCT03269136|585649908|FG003|Part 1: Dose Escalation|Adverse Event|0|||
162163931|NCT03269136|585649909|FG004|Part 1: Dose Escalation|Adverse Event|0|||
162163932|NCT03269136|585649910|FG005|Part 1: Dose Escalation|Adverse Event|0|||
162163933|NCT03269136|585649911|FG006|Part 1: Dose Escalation|Adverse Event|2|||
162163934|NCT03269136|585649912|FG007|Part 1: Dose Escalation|Adverse Event|0|||
162163935|NCT03269136|585649913|FG008|Part 1: Dose Escalation|Adverse Event|0|||
162163936|NCT03269136|585649914|FG009|Part 1: Dose Escalation|Adverse Event|0|||
162163937|NCT03269136|585649915|FG010|Part 1: Dose Escalation|Adverse Event|1|||
162163938|NCT03269136|585649916|FG011|Part 1: Dose Escalation|Adverse Event|2|||
162163939|NCT03269136|585649917|FG012|Part 1: Dose Escalation|Adverse Event|0|||
162163940|NCT03269136|585649918|FG013|Part 1: Dose Escalation|Adverse Event|1|||
162163941|NCT03269136|585649919|FG014|Part 1: Dose Escalation|Adverse Event|0|||
161815399|NCT00902538|584366949|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
161815400|NCT00902538|584366950|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
161815401|NCT00902538|584366945|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
161815402|NCT00902538|584366946|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
161815403|NCT00902538|584366947|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
161815404|NCT00902538|584366948|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
161815405|NCT00902538|584366949|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
161815406|NCT00902538|584366950|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
161815407|NCT00902538|584366945|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
161815408|NCT00902538|584366946|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
161815409|NCT00902538|584366947|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
161815410|NCT00902538|584366948|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
161815411|NCT00902538|584366949|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
161815412|NCT00902538|584366950|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
161815413|NCT00902538|584366945|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161815414|NCT00902538|584366946|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
161815415|NCT00902538|584366947|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161815416|NCT00902538|584366948|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161815417|NCT00902538|584366949|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161815418|NCT00902538|584366950|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161815419|NCT00902538|584366945|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161815420|NCT00902538|584366946|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
161815421|NCT00902538|584366947|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161815422|NCT00902538|584366948|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161815423|NCT00902538|584366949|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161815424|NCT00902538|584366950|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161815425|NCT00902538|584366945|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
161815426|NCT00902538|584366946|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
161815427|NCT00902538|584366947|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
161815428|NCT00902538|584366948|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
161815429|NCT00902538|584366949|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
161815430|NCT00902538|584366950|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
161815431|NCT00902538|584366945|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
161815432|NCT00902538|584366946|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
162017042|NCT00975689|585117799|FG000|Overall Study|Withdrawal by Subject|1|||
162163942|NCT03269136|585649920|FG015|Part 1: Dose Escalation|Adverse Event|0|||
162163943|NCT03269136|585649921|FG016|Part 1: Dose Escalation|Adverse Event|1|||
162163944|NCT03269136|585649922|FG017|Part 1: Dose Escalation|Adverse Event|0|||
162017043|NCT00975689|585117800|FG001|Overall Study|Withdrawal by Subject|0|||
162017044|NCT00975689|585117799|FG000|Overall Study|Physician Decision|1|||
162017045|NCT00975689|585117800|FG001|Overall Study|Physician Decision|0|||
162017046|NCT02974543|585117803|FG000|Overall Study|Withdrawal by Subject|1|||
162017047|NCT02974543|585117804|FG001|Overall Study|Withdrawal by Subject|0|||
162017048|NCT03534180|585117805|FG000|Overall Study|Withdrawal by Subject|1|||
162163945|NCT03269136|585649905|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
162163946|NCT03269136|585649906|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
162163947|NCT03269136|585649907|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
162163948|NCT03269136|585649908|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
162163949|NCT03269136|585649909|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
162163950|NCT03269136|585649910|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
162163951|NCT03269136|585649911|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
162163952|NCT03269136|585649912|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
162163953|NCT03269136|585649913|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
162163954|NCT03269136|585649914|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
162163955|NCT03269136|585649915|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
162163956|NCT03269136|585649916|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
162163957|NCT03269136|585649917|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
162017049|NCT00220636|585117806|FG000|Overall Study|Withdrawal by Subject|4|||
162017050|NCT01237899|585117807|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
162017051|NCT01237899|585117808|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
162017052|NCT01237899|585117809|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
162017053|NCT01237899|585117810|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
162017054|NCT01237899|585117811|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
162017055|NCT01237899|585117812|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
162017056|NCT01237899|585117813|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
162017057|NCT01237899|585117814|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
162017058|NCT01237899|585117815|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
162017059|NCT01237899|585117816|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
162017060|NCT01237899|585117817|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
162017061|NCT00790088|585117818|FG000|Overall Study|Protocol Violation|11|||
162017062|NCT00790088|585117818|FG000|Overall Study|Withdrawal by Subject|17|||
162017063|NCT00790088|585117818|FG000|Overall Study|Lost to Follow-up|7|||
162017064|NCT00790088|585117818|FG000|Overall Study|Physician Decision|4|||
162017065|NCT02910986|585117819|FG000|Overall Study|non-Latina|14|||
162017066|NCT02910986|585117820|FG001|Overall Study|non-Latina|13|||
162017067|NCT02910986|585117821|FG002|Overall Study|non-Latina|12|||
162017068|NCT02910986|585117819|FG000|Overall Study|Failure to return T! survey|72|||
162017069|NCT02910986|585117820|FG001|Overall Study|Failure to return T! survey|84|||
162017070|NCT02910986|585117821|FG002|Overall Study|Failure to return T! survey|72|||
162017071|NCT02910986|585117819|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
162017072|NCT02910986|585117820|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
162017073|NCT02910986|585117821|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
162163958|NCT03269136|585649918|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
162163959|NCT03269136|585649919|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
161920876|NCT02924376|584755833|FG002|Overall Study|Rolled Over to Another Study|0|||
161920877|NCT02924376|584755834|FG003|Overall Study|Rolled Over to Another Study|0|||
161920878|NCT03608033|584755835|FG000|Treatment Period|Death|0|||
161920879|NCT03608033|584755836|FG001|Treatment Period|Death|1|||
161920880|NCT03608033|584755835|FG000|Treatment Period|Adverse Event|1|||
161920881|NCT03608033|584755836|FG001|Treatment Period|Adverse Event|5|||
161920882|NCT03608033|584755835|FG000|Treatment Period|Lack of Efficacy|4|||
161920883|NCT03608033|584755836|FG001|Treatment Period|Lack of Efficacy|3|||
161920884|NCT03608033|584755835|FG000|Treatment Period|Lost to Follow-up|2|||
161920885|NCT03608033|584755836|FG001|Treatment Period|Lost to Follow-up|6|||
161920886|NCT03608033|584755835|FG000|Treatment Period|Physician Decision|6|||
161920887|NCT03608033|584755836|FG001|Treatment Period|Physician Decision|10|||
161920888|NCT03608033|584755835|FG000|Treatment Period|Pregnancy|1|||
161920889|NCT03608033|584755836|FG001|Treatment Period|Pregnancy|0|||
161920890|NCT03608033|584755835|FG000|Treatment Period|Protocol Violation|1|||
161920891|NCT03608033|584755836|FG001|Treatment Period|Protocol Violation|2|||
161920892|NCT03608033|584755835|FG000|Treatment Period|Withdrawal by Subject|46|||
161920893|NCT03608033|584755836|FG001|Treatment Period|Withdrawal by Subject|45|||
161920894|NCT03608033|584755835|FG000|Treatment Period|Study terminated by sponsor|82|||
162163960|NCT03269136|585649920|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
162163961|NCT03269136|585649921|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
162163962|NCT03269136|585649922|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
162163963|NCT03269136|585649905|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162163964|NCT03269136|585649906|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161920895|NCT03608033|584755836|FG001|Treatment Period|Study terminated by sponsor|68|||
161920896|NCT03608033|584755835|FG000|Treatment Period|Site Terminated by Sponsor|1|||
161920897|NCT03608033|584755836|FG001|Treatment Period|Site Terminated by Sponsor|0|||
161920898|NCT03608033|584755835|FG000|Open-Label Period: OMS721|Adverse Event|1|||
161920899|NCT03608033|584755836|FG001|Open-Label Period: OMS721|Adverse Event|0|||
161920900|NCT03608033|584755835|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
161920901|NCT03608033|584755836|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
161920902|NCT03608033|584755835|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
161920903|NCT03608033|584755836|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
161920904|NCT03608033|584755835|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
161920905|NCT03608033|584755836|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
161920906|NCT03608033|584755835|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
161920907|NCT03608033|584755836|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
161920908|NCT02360579|584755838|FG000|Initial|Death|16|||
161920909|NCT02360579|584755839|FG001|Initial|Death|49|||
161920910|NCT02360579|584755840|FG002|Initial|Death|0|||
161920911|NCT02360579|584755841|FG003|Initial|Death|71|||
161920912|NCT02360579|584755838|FG000|Initial|Lost to Follow-up|0|||
161920913|NCT02360579|584755839|FG001|Initial|Lost to Follow-up|4|||
161920914|NCT02360579|584755840|FG002|Initial|Lost to Follow-up|0|||
161920915|NCT02360579|584755841|FG003|Initial|Lost to Follow-up|1|||
161920916|NCT02360579|584755838|FG000|Initial|Withdrawal by Subject|0|||
161920917|NCT02360579|584755839|FG001|Initial|Withdrawal by Subject|0|||
161920918|NCT02360579|584755840|FG002|Initial|Withdrawal by Subject|0|||
161920919|NCT02360579|584755841|FG003|Initial|Withdrawal by Subject|3|||
161920920|NCT02360579|584755838|FG000|Initial|Other|7|||
161920921|NCT02360579|584755839|FG001|Initial|Other|0|||
161920922|NCT02360579|584755840|FG002|Initial|Other|0|||
161920923|NCT02360579|584755841|FG003|Initial|Other|0|||
161920924|NCT02360579|584755838|FG000|Initial|Did not receive TIL|8|||
161920925|NCT02360579|584755839|FG001|Initial|Did not receive TIL|11|||
161920926|NCT02360579|584755840|FG002|Initial|Did not receive TIL|0|||
161920927|NCT02360579|584755841|FG003|Initial|Did not receive TIL|22|||
162163965|NCT03269136|585649907|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162163966|NCT03269136|585649908|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162163967|NCT03269136|585649909|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162163968|NCT03269136|585649910|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161920928|NCT02360579|584755838|FG000|Retreatment|Death|0|||
161920929|NCT02360579|584755839|FG001|Retreatment|Death|0|||
161920930|NCT02360579|584755840|FG002|Retreatment|Death|11|||
161920931|NCT02360579|584755841|FG003|Retreatment|Death|0|||
161920932|NCT06455111|584755844|FG000|Overall Study|Withdrawal by Subject|11|||
161920933|NCT06455111|584755845|FG001|Overall Study|Withdrawal by Subject|4|||
162163969|NCT03269136|585649911|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162163970|NCT03269136|585649912|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162163971|NCT03269136|585649913|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162163972|NCT03269136|585649914|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162163973|NCT03269136|585649915|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162163974|NCT03269136|585649916|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161920934|NCT03682848|584755846|FG000|Overall Study|Withdrawal by Subject|3|||
161920935|NCT03682848|584755846|FG000|Overall Study|Site closed|5|||
161920936|NCT03682848|584755846|FG000|Overall Study|Protocol Deviation|1|||
161920937|NCT03682848|584755846|FG000|Overall Study|Adverse Event|2|||
161920938|NCT03682848|584755846|FG000|Overall Study|Lack of Efficacy|1|||
162163975|NCT03269136|585649917|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
162163976|NCT03269136|585649918|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
162163977|NCT03269136|585649919|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
162163978|NCT03269136|585649920|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161815433|NCT00902538|584366947|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
161815434|NCT00902538|584366948|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
161815435|NCT00902538|584366949|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
161815436|NCT00902538|584366950|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
161815437|NCT00902538|584366945|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161815438|NCT00902538|584366946|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161815439|NCT00902538|584366947|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161815440|NCT00902538|584366948|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
161815441|NCT00902538|584366949|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161815442|NCT00902538|584366950|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161815443|NCT01279486|584366953|FG000|Overall Study|Lost to Follow-up|1|||
161815444|NCT03215706|584366956|FG000|Randomization|Adverse Event unrelated to study drug|1|||
161815445|NCT03215706|584366957|FG001|Randomization|Adverse Event unrelated to study drug|0|||
161815446|NCT03215706|584366956|FG000|Randomization|participant withdrew consent|1|||
161815447|NCT03215706|584366957|FG001|Randomization|participant withdrew consent|3|||
161815448|NCT03215706|584366956|FG000|Randomization|no longer meets study criteria|1|||
161815449|NCT03215706|584366957|FG001|Randomization|no longer meets study criteria|4|||
161815450|NCT03215706|584366956|FG000|Randomization|other reasons|0|||
161815451|NCT03215706|584366957|FG001|Randomization|other reasons|2|||
161815452|NCT03215706|584366956|FG000|Treatment Period|Disease Progression|184|||
162163979|NCT03269136|585649921|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
162163980|NCT03269136|585649922|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
162163981|NCT03269136|585649905|FG000|Part 2A: Dose Expansion|Other|0|||
162163982|NCT03269136|585649906|FG001|Part 2A: Dose Expansion|Other|0|||
162163983|NCT03269136|585649907|FG002|Part 2A: Dose Expansion|Other|0|||
162163984|NCT03269136|585649908|FG003|Part 2A: Dose Expansion|Other|0|||
162163985|NCT03269136|585649909|FG004|Part 2A: Dose Expansion|Other|0|||
162163986|NCT03269136|585649910|FG005|Part 2A: Dose Expansion|Other|0|||
162163987|NCT03269136|585649911|FG006|Part 2A: Dose Expansion|Other|0|||
162163988|NCT03269136|585649912|FG007|Part 2A: Dose Expansion|Other|0|||
162163989|NCT03269136|585649913|FG008|Part 2A: Dose Expansion|Other|0|||
162163990|NCT03269136|585649914|FG009|Part 2A: Dose Expansion|Other|0|||
162163991|NCT03269136|585649915|FG010|Part 2A: Dose Expansion|Other|0|||
162163992|NCT03269136|585649916|FG011|Part 2A: Dose Expansion|Other|0|||
162163993|NCT03269136|585649917|FG012|Part 2A: Dose Expansion|Other|0|||
162163994|NCT03269136|585649918|FG013|Part 2A: Dose Expansion|Other|0|||
162163995|NCT03269136|585649919|FG014|Part 2A: Dose Expansion|Other|0|||
162163996|NCT03269136|585649920|FG015|Part 2A: Dose Expansion|Other|0|||
162163997|NCT03269136|585649921|FG016|Part 2A: Dose Expansion|Other|0|||
162163998|NCT03269136|585649922|FG017|Part 2A: Dose Expansion|Other|1|||
162163999|NCT03269136|585649905|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164000|NCT03269136|585649906|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164001|NCT03269136|585649907|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164002|NCT03269136|585649908|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164003|NCT03269136|585649909|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164004|NCT03269136|585649910|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164005|NCT03269136|585649911|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164006|NCT03269136|585649912|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164007|NCT03269136|585649913|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164008|NCT03269136|585649914|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164009|NCT03269136|585649915|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164010|NCT03269136|585649916|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164011|NCT03269136|585649917|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164012|NCT03269136|585649918|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164013|NCT03269136|585649919|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164014|NCT03269136|585649920|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164015|NCT03269136|585649921|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
162164016|NCT03269136|585649922|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
162164017|NCT03269136|585649905|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
162164018|NCT03269136|585649906|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
162164019|NCT03269136|585649907|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
162164020|NCT03269136|585649908|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
162164021|NCT03269136|585649909|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
162164022|NCT03269136|585649910|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
162164023|NCT03269136|585649911|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
162164024|NCT03269136|585649912|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
162164025|NCT03269136|585649913|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
161815453|NCT03215706|584366957|FG001|Treatment Period|Disease Progression|174|||
161920939|NCT02337686|584755850|FG000|Overall Study|Adverse Event|1|||
161920940|NCT00970944|584757107|FG000|Overall Study|Death|1|||
162164026|NCT03269136|585649914|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
162164027|NCT03269136|585649915|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
162164028|NCT03269136|585649916|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
162164029|NCT03269136|585649917|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
162164030|NCT03269136|585649918|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
162164031|NCT03269136|585649919|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
162164032|NCT03269136|585649920|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
162164033|NCT03269136|585649921|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
162164034|NCT03269136|585649922|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
162164035|NCT03269136|585649905|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
162164036|NCT03269136|585649906|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
162164037|NCT03269136|585649907|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
162164038|NCT03269136|585649908|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
162164039|NCT03269136|585649909|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
162164040|NCT03269136|585649910|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
162164041|NCT03269136|585649911|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
162164042|NCT03269136|585649912|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
162164043|NCT03269136|585649913|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
162164044|NCT03269136|585649914|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
162164045|NCT03269136|585649915|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
162164046|NCT03269136|585649916|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
162164047|NCT03269136|585649917|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
162164048|NCT03269136|585649918|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
161920941|NCT00970944|584757108|FG001|Overall Study|Death|0|||
162164049|NCT03269136|585649919|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
162164050|NCT03269136|585649920|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
162164051|NCT03269136|585649921|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
162164052|NCT03269136|585649922|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
162164053|NCT03269136|585649905|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
162164054|NCT03269136|585649906|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
162164055|NCT03269136|585649907|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
162164056|NCT03269136|585649908|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
162164057|NCT03269136|585649909|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
162164058|NCT03269136|585649910|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
162164059|NCT03269136|585649911|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
162164060|NCT03269136|585649912|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
162164061|NCT03269136|585649913|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
162164062|NCT03269136|585649914|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
162164063|NCT03269136|585649915|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
162164064|NCT03269136|585649916|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
162164065|NCT03269136|585649917|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
162164066|NCT03269136|585649918|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
162164067|NCT03269136|585649919|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
162164068|NCT03269136|585649920|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
162164069|NCT03269136|585649921|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
162164070|NCT03269136|585649922|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
162164071|NCT03033576|585649923|FG000|Overall Study|Ineligible|1|||
162164072|NCT03033576|585649924|FG001|Overall Study|Ineligible|1|||
162164073|NCT03033576|585649923|FG000|Overall Study|Adverse Event|4|||
162164074|NCT03033576|585649924|FG001|Overall Study|Adverse Event|20|||
162164075|NCT03033576|585649923|FG000|Overall Study|Progression/relapse|9|||
162164076|NCT03033576|585649924|FG001|Overall Study|Progression/relapse|36|||
161815454|NCT03215706|584366956|FG000|Treatment Period|Study Drug Toxicity|70|||
162017074|NCT02910986|585117819|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
162164077|NCT03033576|585649923|FG000|Overall Study|Death|1|||
162164078|NCT03033576|585649924|FG001|Overall Study|Death|1|||
161815455|NCT03215706|584366957|FG001|Treatment Period|Study Drug Toxicity|24|||
161815456|NCT03215706|584366956|FG000|Treatment Period|Death|7|||
161815457|NCT03215706|584366957|FG001|Treatment Period|Death|1|||
161815458|NCT03215706|584366956|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
161815459|NCT03215706|584366957|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
161815460|NCT03215706|584366956|FG000|Treatment Period|Request to D/C treatment|2|||
161815461|NCT03215706|584366957|FG001|Treatment Period|Request to D/C treatment|10|||
161815462|NCT03215706|584366956|FG000|Treatment Period|Participant withdrew consent|4|||
161815463|NCT03215706|584366957|FG001|Treatment Period|Participant withdrew consent|5|||
161815464|NCT03215706|584366956|FG000|Treatment Period|Lost to Follow-up|0|||
161815465|NCT03215706|584366957|FG001|Treatment Period|Lost to Follow-up|1|||
161815466|NCT03215706|584366956|FG000|Treatment Period|Administrative reason by sponsor|0|||
161815467|NCT03215706|584366957|FG001|Treatment Period|Administrative reason by sponsor|2|||
161815468|NCT03215706|584366956|FG000|Treatment Period|other reasons|10|||
161815469|NCT03215706|584366957|FG001|Treatment Period|other reasons|5|||
161815470|NCT03215706|584366956|FG000|Treatment Period|Not reported|1|||
161815471|NCT03215706|584366957|FG001|Treatment Period|Not reported|0|||
161815472|NCT03506633|584368657|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
161815473|NCT03506633|584368658|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
161815474|NCT03247686|584368663|FG000|Overall Study|Withdrawal by Subject|1|||
161815475|NCT03247686|584368664|FG001|Overall Study|Withdrawal by Subject|2|||
161815476|NCT02302716|584368665|FG000|Overall Study|Adverse Event|1|||
161815477|NCT02302716|584368666|FG001|Overall Study|Adverse Event|1|||
161815478|NCT02302716|584368665|FG000|Overall Study|Death|0|||
161815479|NCT02302716|584368666|FG001|Overall Study|Death|1|||
161815480|NCT02302716|584368665|FG000|Overall Study|Lack of Efficacy|0|||
161815481|NCT02302716|584368666|FG001|Overall Study|Lack of Efficacy|1|||
161815482|NCT02302716|584368665|FG000|Overall Study|Lost to Follow-up|2|||
161815483|NCT02302716|584368666|FG001|Overall Study|Lost to Follow-up|4|||
161815484|NCT02302716|584368665|FG000|Overall Study|Physician Decision|3|||
161815485|NCT02302716|584368666|FG001|Overall Study|Physician Decision|4|||
161815486|NCT02302716|584368665|FG000|Overall Study|Withdrawal by Subject|13|||
161815487|NCT02302716|584368666|FG001|Overall Study|Withdrawal by Subject|7|||
161815488|NCT02302716|584368665|FG000|Overall Study|Protocol Violation|0|||
162164079|NCT03033576|585649923|FG000|Overall Study|Patient refusal|1|||
162164080|NCT03033576|585649924|FG001|Overall Study|Patient refusal|6|||
162164081|NCT03033576|585649923|FG000|Overall Study|Other, unspecified reasons|0|||
161815489|NCT02302716|584368666|FG001|Overall Study|Protocol Violation|1|||
161815490|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Subject request|8|||
161815491|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Subject request|11|||
161815492|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
161815493|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
161815494|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
161815495|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
162164082|NCT03033576|585649924|FG001|Overall Study|Other, unspecified reasons|4|||
161815496|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
161815497|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
161815498|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
161815499|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
161815500|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
161815501|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
161815502|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Death|1|||
161815503|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Death|0|||
161815504|NCT00521586|584368671|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
161815505|NCT00521586|584368672|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
161815506|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
161815507|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
161815508|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
161815509|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
161815510|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
161815511|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
162164083|NCT03033576|585649923|FG000|Overall Study|Currently on protocol therapy|0|||
162164084|NCT03033576|585649924|FG001|Overall Study|Currently on protocol therapy|2|||
162164085|NCT01214616|585649925|FG000|Overall Study|Progressive disease|2|||
162164086|NCT01214616|585649926|FG001|Overall Study|Progressive disease|2|||
161815512|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
161815513|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
161815514|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
161815515|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
162164087|NCT01214616|585649927|FG002|Overall Study|Progressive disease|2|||
162164088|NCT01214616|585649928|FG003|Overall Study|Progressive disease|4|||
161815516|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
161815517|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
161815518|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
161815519|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
161815520|NCT00521586|584368671|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
161815521|NCT00521586|584368672|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
161815522|NCT00521586|584368671|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
161815523|NCT00521586|584368672|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
161815524|NCT00521586|584368671|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
161815525|NCT00521586|584368672|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
161815526|NCT00521586|584368671|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
161815527|NCT00521586|584368672|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
161815528|NCT00529763|584368673|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
161815529|NCT00529763|584368674|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
161815530|NCT00529763|584368675|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
161815531|NCT00529763|584368673|FG000|Overall Study|Death|1|||
161920942|NCT00970944|584757107|FG000|Overall Study|Physician Decision|0|||
161920943|NCT00970944|584757108|FG001|Overall Study|Physician Decision|2|||
161920944|NCT02008370|584757109|FG000|Overall Study|Lost to Follow-up|7|||
161920945|NCT00662259|584757110|FG000|Overall Study|Adverse Event|2|||
161920946|NCT00662259|584757111|FG001|Overall Study|Adverse Event|0|||
162164089|NCT01214616|585649925|FG000|Overall Study|Dose limiting toxicity|0|||
162164090|NCT01214616|585649926|FG001|Overall Study|Dose limiting toxicity|2|||
162164091|NCT01214616|585649927|FG002|Overall Study|Dose limiting toxicity|0|||
162164092|NCT01214616|585649928|FG003|Overall Study|Dose limiting toxicity|0|||
162164093|NCT01214616|585649925|FG000|Overall Study|Other adverse events|0|||
162164094|NCT01214616|585649926|FG001|Overall Study|Other adverse events|1|||
162164095|NCT01214616|585649927|FG002|Overall Study|Other adverse events|1|||
162164096|NCT01214616|585649928|FG003|Overall Study|Other adverse events|1|||
162164097|NCT01214616|585649925|FG000|Overall Study|Withdrawal by Subject|1|||
162164098|NCT01214616|585649926|FG001|Overall Study|Withdrawal by Subject|0|||
162164099|NCT01214616|585649927|FG002|Overall Study|Withdrawal by Subject|0|||
162164100|NCT01214616|585649928|FG003|Overall Study|Withdrawal by Subject|1|||
161920947|NCT00972738|584757112|FG000|Overall Study|Adverse Event|7|||
161920948|NCT00972738|584757113|FG001|Overall Study|Adverse Event|1|||
161920949|NCT00972738|584757114|FG002|Overall Study|Adverse Event|8|||
161920950|NCT00972738|584757112|FG000|Overall Study|Protocol Violation|2|||
161920951|NCT00972738|584757113|FG001|Overall Study|Protocol Violation|1|||
162164101|NCT02949362|585649929|FG000|Retrospective Period|Inform consent not signed by participant|4|||
162164102|NCT02949362|585649930|FG001|Retrospective Period|Inform consent not signed by participant|1|||
162164103|NCT02949362|585649931|FG002|Retrospective Period|Inform consent not signed by participant|0|||
161920952|NCT00972738|584757114|FG002|Overall Study|Protocol Violation|3|||
161920953|NCT00972738|584757112|FG000|Overall Study|Lost to Follow-up|1|||
161920954|NCT00972738|584757113|FG001|Overall Study|Lost to Follow-up|0|||
162164104|NCT02949362|585649932|FG003|Retrospective Period|Inform consent not signed by participant|0|||
162164105|NCT02949362|585649929|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
162164106|NCT02949362|585649930|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
162164107|NCT02949362|585649931|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
162164108|NCT02949362|585649932|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
162164109|NCT02949362|585649929|FG000|Prospective Period|Other|0|||
162164110|NCT02949362|585649930|FG001|Prospective Period|Other|0|||
162164111|NCT02949362|585649931|FG002|Prospective Period|Other|0|||
161815532|NCT00529763|584368674|FG001|Overall Study|Death|1|||
161815533|NCT00529763|584368675|FG002|Overall Study|Death|1|||
161815534|NCT00529763|584368673|FG000|Overall Study|Disease Progression|10|||
161815535|NCT00529763|584368674|FG001|Overall Study|Disease Progression|16|||
161815536|NCT00529763|584368675|FG002|Overall Study|Disease Progression|11|||
161815537|NCT00529763|584368673|FG000|Overall Study|Lost to Follow-up|1|||
161815538|NCT00529763|584368674|FG001|Overall Study|Lost to Follow-up|2|||
161815539|NCT00529763|584368675|FG002|Overall Study|Lost to Follow-up|3|||
161815540|NCT00529763|584368673|FG000|Overall Study|Stem Cell Transplant|0|||
161815541|NCT00529763|584368674|FG001|Overall Study|Stem Cell Transplant|3|||
161815542|NCT00529763|584368675|FG002|Overall Study|Stem Cell Transplant|1|||
161815543|NCT00529763|584368673|FG000|Overall Study|Study Drug Toxicity|3|||
161815544|NCT00529763|584368674|FG001|Overall Study|Study Drug Toxicity|6|||
161815545|NCT00529763|584368675|FG002|Overall Study|Study Drug Toxicity|4|||
161815546|NCT00529763|584368673|FG000|Overall Study|Participant Withdrew Consent|2|||
161815547|NCT00529763|584368674|FG001|Overall Study|Participant Withdrew Consent|3|||
161815548|NCT00529763|584368675|FG002|Overall Study|Participant Withdrew Consent|4|||
161815549|NCT00529763|584368673|FG000|Overall Study|Other reasons|2|||
161815550|NCT00529763|584368674|FG001|Overall Study|Other reasons|0|||
161815551|NCT00529763|584368675|FG002|Overall Study|Other reasons|2|||
161815552|NCT00529763|584368673|FG000|Overall Study|Participant request to discontinue treatment|1|||
161815553|NCT00529763|584368674|FG001|Overall Study|Participant request to discontinue treatment|1|||
161815554|NCT00529763|584368675|FG002|Overall Study|Participant request to discontinue treatment|3|||
161815555|NCT03669250|584368676|FG000|Overall Study|Adverse Event|0|||
161815556|NCT03669250|584368677|FG001|Overall Study|Adverse Event|0|||
161815557|NCT03669250|584368678|FG002|Overall Study|Adverse Event|0|||
161815558|NCT03669250|584368679|FG003|Overall Study|Adverse Event|0|||
161815559|NCT03669250|584368680|FG004|Overall Study|Adverse Event|1|||
161815560|NCT03669250|584368681|FG005|Overall Study|Adverse Event|0|||
161815561|NCT03669250|584368676|FG000|Overall Study|Withdrawal by Subject|0|||
161815562|NCT03669250|584368677|FG001|Overall Study|Withdrawal by Subject|1|||
161815563|NCT03669250|584368678|FG002|Overall Study|Withdrawal by Subject|0|||
161815564|NCT03669250|584368679|FG003|Overall Study|Withdrawal by Subject|1|||
161815565|NCT03669250|584368680|FG004|Overall Study|Withdrawal by Subject|0|||
161815566|NCT03669250|584368681|FG005|Overall Study|Withdrawal by Subject|0|||
161815567|NCT00828321|584368682|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
161815568|NCT00828321|584368683|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
161815569|NCT00828321|584368682|FG000|Second Intervention|Protocol Violation|0|||
161815570|NCT00828321|584368683|FG001|Second Intervention|Protocol Violation|1|||
161815571|NCT02997176|584368684|FG000|Overall Study|Adverse Event|0|||
161815572|NCT02997176|584368685|FG001|Overall Study|Adverse Event|0|||
161815573|NCT02997176|584368686|FG002|Overall Study|Adverse Event|0|||
161815574|NCT02997176|584368687|FG003|Overall Study|Adverse Event|8|||
161815575|NCT02997176|584368684|FG000|Overall Study|Progressive Disease|1|||
161815576|NCT02997176|584368685|FG001|Overall Study|Progressive Disease|0|||
161815577|NCT02997176|584368686|FG002|Overall Study|Progressive Disease|1|||
161815578|NCT02997176|584368687|FG003|Overall Study|Progressive Disease|1|||
161815579|NCT02997176|584368684|FG000|Overall Study|Death|0|||
161815580|NCT02997176|584368685|FG001|Overall Study|Death|0|||
161815581|NCT02997176|584368686|FG002|Overall Study|Death|1|||
161815582|NCT02997176|584368687|FG003|Overall Study|Death|1|||
161815583|NCT02997176|584368684|FG000|Overall Study|Withdrawal by Subject|0|||
161815584|NCT02997176|584368685|FG001|Overall Study|Withdrawal by Subject|2|||
161815585|NCT02997176|584368686|FG002|Overall Study|Withdrawal by Subject|0|||
161815586|NCT02997176|584368687|FG003|Overall Study|Withdrawal by Subject|1|||
161815587|NCT04523480|584368688|FG000|Overall Study|Lost to Follow-up|30|||
161815588|NCT04523480|584368689|FG001|Overall Study|Lost to Follow-up|35|||
161815589|NCT04523480|584368690|FG002|Overall Study|Lost to Follow-up|0|||
161815590|NCT00488774|584368691|FG000|Overall Study|Withdrawal of consent|2|||
161815591|NCT00488774|584368692|FG001|Overall Study|Withdrawal of consent|2|||
161815592|NCT00488774|584368693|FG002|Overall Study|Withdrawal of consent|2|||
161815593|NCT00488774|584368694|FG003|Overall Study|Withdrawal of consent|0|||
161815594|NCT00488774|584368691|FG000|Overall Study|Other|6|||
161815595|NCT00488774|584368692|FG001|Overall Study|Other|3|||
161815596|NCT00488774|584368693|FG002|Overall Study|Other|2|||
161815597|NCT00488774|584368694|FG003|Overall Study|Other|2|||
161815598|NCT00488774|584368691|FG000|Overall Study|Lost to Follow-up|0|||
161815599|NCT00488774|584368692|FG001|Overall Study|Lost to Follow-up|0|||
161815600|NCT00488774|584368693|FG002|Overall Study|Lost to Follow-up|1|||
162164112|NCT02949362|585649932|FG003|Prospective Period|Other|4|||
162164113|NCT05268302|585649933|FG000|Overall Study|Death|0|||
162164114|NCT05268302|585649934|FG001|Overall Study|Death|1|||
162164115|NCT02811679|585649935|FG000|Overall Study|Adverse Event|1|||
162164116|NCT02811679|585649935|FG000|Overall Study|Lack of Efficacy|6|||
162164117|NCT02811679|585649935|FG000|Overall Study|Early study closure due to slow accrual|3|||
162164118|NCT05319860|585649936|FG000|Overall Study|Death|1|||
162164119|NCT05319860|585649937|FG001|Overall Study|Death|1|||
162164120|NCT05319860|585649936|FG000|Overall Study|Lost to Follow-up|3|||
162164121|NCT05319860|585649937|FG001|Overall Study|Lost to Follow-up|1|||
162164122|NCT05319860|585649936|FG000|Overall Study|Withdrawal by Subject|1|||
162164123|NCT05319860|585649937|FG001|Overall Study|Withdrawal by Subject|7|||
162164124|NCT04314895|585649938|FG000|Overall Study|Lost to Follow-up|1|||
162164125|NCT04314895|585649938|FG000|Overall Study|Death|10|||
162164126|NCT04314895|585649938|FG000|Overall Study|Physician Decision|2|||
162164127|NCT03648840|585651528|FG000|First IV Infusion Session|Adverse Event|0|||
162164128|NCT03648840|585651529|FG001|First IV Infusion Session|Adverse Event|2|||
162164129|NCT03648840|585651528|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
162164130|NCT03648840|585651529|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
162164131|NCT03648840|585651528|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
162164132|NCT03648840|585651529|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
162164133|NCT03648840|585651528|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
162164134|NCT03648840|585651529|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
162164135|NCT03376321|585651530|FG000|Overall Study|Other|5|||
162164136|NCT03376321|585651531|FG001|Overall Study|Other|1|||
162164137|NCT03376321|585651530|FG000|Overall Study|Withdrawal by Subject|8|||
162164138|NCT03376321|585651531|FG001|Overall Study|Withdrawal by Subject|14|||
162164139|NCT03376321|585651530|FG000|Overall Study|Lost to Follow-up|1|||
162164140|NCT03376321|585651531|FG001|Overall Study|Lost to Follow-up|7|||
162164141|NCT03376321|585651530|FG000|Overall Study|Death|4|||
162164142|NCT03376321|585651531|FG001|Overall Study|Death|0|||
162164143|NCT03376321|585651530|FG000|Overall Study|Randomized, not treated|5|||
162164144|NCT03376321|585651531|FG001|Overall Study|Randomized, not treated|3|||
162164145|NCT02995434|585651532|FG000|Overall Study|Adverse Event|1|||
162164146|NCT02995434|585651533|FG001|Overall Study|Adverse Event|0|||
162164147|NCT02995434|585651532|FG000|Overall Study|Withdrawal by Subject|6|||
162164148|NCT02995434|585651533|FG001|Overall Study|Withdrawal by Subject|3|||
162164149|NCT04150718|585651534|FG000|Overall Study|Withdrawal by Subject|2|||
162164150|NCT04150718|585651535|FG001|Overall Study|Withdrawal by Subject|7|||
162164151|NCT04150718|585651536|FG002|Overall Study|Withdrawal by Subject|1|||
162164152|NCT04150718|585651534|FG000|Overall Study|Lost to Follow-up|1|||
162164153|NCT04150718|585651535|FG001|Overall Study|Lost to Follow-up|2|||
162164154|NCT04150718|585651536|FG002|Overall Study|Lost to Follow-up|0|||
162164155|NCT04150718|585651534|FG000|Overall Study|Ineligible|1|||
162164156|NCT04150718|585651535|FG001|Overall Study|Ineligible|0|||
162164157|NCT04150718|585651536|FG002|Overall Study|Ineligible|10|||
162164158|NCT04034251|585651537|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
162164159|NCT04034251|585651538|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
162164160|NCT04034251|585651539|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
162164161|NCT02543281|585651552|FG000|Overall Study|Lost to Follow-up|0|||
162164162|NCT02543281|585651553|FG001|Overall Study|Lost to Follow-up|0|||
162164163|NCT02543281|585651554|FG002|Overall Study|Lost to Follow-up|1|||
161920955|NCT00972738|584757114|FG002|Overall Study|Lost to Follow-up|1|||
161920956|NCT00972738|584757112|FG000|Overall Study|Lack of Efficacy|5|||
161920957|NCT00972738|584757113|FG001|Overall Study|Lack of Efficacy|1|||
161920958|NCT00972738|584757114|FG002|Overall Study|Lack of Efficacy|11|||
161920959|NCT00972738|584757112|FG000|Overall Study|Withdrawal by Subject|5|||
161920960|NCT00972738|584757113|FG001|Overall Study|Withdrawal by Subject|1|||
161920961|NCT00972738|584757114|FG002|Overall Study|Withdrawal by Subject|4|||
161920962|NCT00972738|584757112|FG000|Overall Study|Moved|0|||
161920963|NCT00972738|584757113|FG001|Overall Study|Moved|0|||
161920964|NCT00972738|584757114|FG002|Overall Study|Moved|1|||
162164164|NCT02530671|585651560|FG000|Overall Study|Lost to Follow-up|2|||
162164165|NCT02530671|585651561|FG001|Overall Study|Lost to Follow-up|0|||
162164166|NCT02530671|585651560|FG000|Overall Study|Withdrawal by Subject|1|||
162164167|NCT02530671|585651561|FG001|Overall Study|Withdrawal by Subject|0|||
162164168|NCT05247489|585651562|FG000|Overall Study|Lost to Follow-up|5|||
162164169|NCT05247489|585651563|FG001|Overall Study|Lost to Follow-up|1|||
162164170|NCT05247489|585651562|FG000|Overall Study|Withdrawal by Subject|6|||
162164171|NCT05247489|585651563|FG001|Overall Study|Withdrawal by Subject|7|||
162164172|NCT05247489|585651562|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
161920965|NCT00972738|584757112|FG000|Overall Study|Other|1|||
161920966|NCT00972738|584757113|FG001|Overall Study|Other|2|||
162164173|NCT05247489|585651563|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
162164174|NCT05247489|585651562|FG000|Overall Study|Left Country|1|||
162164175|NCT05247489|585651563|FG001|Overall Study|Left Country|0|||
162164176|NCT05247489|585651562|FG000|Overall Study|Noncompliance with Investigational Product|1|||
162164177|NCT05247489|585651563|FG001|Overall Study|Noncompliance with Investigational Product|0|||
162164178|NCT05247489|585651562|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
162164179|NCT05247489|585651563|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
162164180|NCT03126019|585651564|FG000|Overall Study|Death|5|||
162164181|NCT03126019|585651565|FG001|Overall Study|Death|27|||
162164182|NCT03126019|585651564|FG000|Overall Study|Lost to Follow-up|2|||
162164183|NCT03126019|585651565|FG001|Overall Study|Lost to Follow-up|4|||
162164184|NCT03126019|585651564|FG000|Overall Study|Withdrawal by Subject|1|||
162164185|NCT03126019|585651565|FG001|Overall Study|Withdrawal by Subject|9|||
162164186|NCT03126019|585651564|FG000|Overall Study|Physician Decision|1|||
162164187|NCT03126019|585651565|FG001|Overall Study|Physician Decision|0|||
162164188|NCT03126019|585651564|FG000|Overall Study|Transitioned to Rollover Study|0|||
162164189|NCT03126019|585651565|FG001|Overall Study|Transitioned to Rollover Study|11|||
162164190|NCT03126019|585651564|FG000|Overall Study|Did Not Return to Site for Care|0|||
162164191|NCT03126019|585651565|FG001|Overall Study|Did Not Return to Site for Care|1|||
162164192|NCT03126019|585651564|FG000|Overall Study|Site Closed|0|||
162164193|NCT03126019|585651565|FG001|Overall Study|Site Closed|1|||
162164194|NCT00170573|585651569|FG000|Overall Study|Violation of inclusion criteria|13|||
162164195|NCT05563246|585651615|FG000|Overall Study|Withdrawal by Subject|1|||
162164196|NCT05563246|585651616|FG001|Overall Study|Withdrawal by Subject|2|||
162164197|NCT05563246|585651617|FG002|Overall Study|Withdrawal by Subject|0|||
162164198|NCT05563246|585651618|FG003|Overall Study|Withdrawal by Subject|0|||
162164199|NCT05563246|585651615|FG000|Overall Study|Protocol Deviation|0|||
162164200|NCT05563246|585651616|FG001|Overall Study|Protocol Deviation|1|||
162164201|NCT05563246|585651617|FG002|Overall Study|Protocol Deviation|0|||
162164202|NCT05563246|585651618|FG003|Overall Study|Protocol Deviation|0|||
162164203|NCT05563246|585651615|FG000|Overall Study|Physician Decision|0|||
162164204|NCT05563246|585651616|FG001|Overall Study|Physician Decision|1|||
162164205|NCT05563246|585651617|FG002|Overall Study|Physician Decision|0|||
162164206|NCT05563246|585651618|FG003|Overall Study|Physician Decision|0|||
162164207|NCT05563246|585651615|FG000|Overall Study|Adverse Event|0|||
162164208|NCT05563246|585651616|FG001|Overall Study|Adverse Event|0|||
162164209|NCT05563246|585651617|FG002|Overall Study|Adverse Event|2|||
162164210|NCT05563246|585651618|FG003|Overall Study|Adverse Event|0|||
162164211|NCT05563246|585651615|FG000|Overall Study|Lost to Follow-up|0|||
162164212|NCT05563246|585651616|FG001|Overall Study|Lost to Follow-up|0|||
162164213|NCT05563246|585651617|FG002|Overall Study|Lost to Follow-up|1|||
162164214|NCT05563246|585651618|FG003|Overall Study|Lost to Follow-up|0|||
162164215|NCT03332017|585651621|FG000|Overall Study|Lost to Follow-up|1|||
162164216|NCT03332017|585651622|FG001|Overall Study|Lost to Follow-up|2|||
162164217|NCT03332017|585651621|FG000|Overall Study|Death|17|||
162164218|NCT03332017|585651622|FG001|Overall Study|Death|16|||
162164219|NCT03332017|585651621|FG000|Overall Study|Withdrawal by Subject|6|||
162164220|NCT03332017|585651622|FG001|Overall Study|Withdrawal by Subject|14|||
162164221|NCT03332017|585651621|FG000|Overall Study|Other|1|||
162164222|NCT03332017|585651622|FG001|Overall Study|Other|3|||
162164223|NCT03332017|585651621|FG000|Overall Study|Remained in Study (Ongoing)|47|||
162164224|NCT03332017|585651622|FG001|Overall Study|Remained in Study (Ongoing)|110|||
162164225|NCT01580488|585651626|FG000|Overall Study|Withdrawal by Subject|1|||
161920967|NCT00972738|584757114|FG002|Overall Study|Other|1|||
162164226|NCT02243709|585651632|FG000|Phase 1|Lost to Follow-up|0|||
162164227|NCT02243709|585651633|FG001|Phase 1|Lost to Follow-up|1|||
162164228|NCT02243709|585651632|FG000|Phase 1|Withdrawal by Subject|1|||
161920968|NCT01793935|584757117|FG000|Overall Study|Pregnancy|1|||
161920969|NCT01793935|584757118|FG001|Overall Study|Pregnancy|0|||
161920970|NCT01793935|584757117|FG000|Overall Study|Protocol Violation|2|||
161920971|NCT01793935|584757118|FG001|Overall Study|Protocol Violation|1|||
161920972|NCT01793935|584757117|FG000|Overall Study|Adverse Event|2|||
161920973|NCT01793935|584757118|FG001|Overall Study|Adverse Event|0|||
161920974|NCT01793935|584757117|FG000|Overall Study|Patient did not take study medication|1|||
161920975|NCT01793935|584757118|FG001|Overall Study|Patient did not take study medication|1|||
161920976|NCT01793935|584757117|FG000|Overall Study|Lost to Follow-up|0|||
161920977|NCT01793935|584757118|FG001|Overall Study|Lost to Follow-up|1|||
161920978|NCT00817063|584757121|FG000|Overall Study|Adverse Event|32|||
162164229|NCT02243709|585651633|FG001|Phase 1|Withdrawal by Subject|0|||
162164230|NCT02243709|585651632|FG000|Phase 1|Protocol Violation|0|||
162164231|NCT02243709|585651633|FG001|Phase 1|Protocol Violation|1|||
162164232|NCT02243709|585651632|FG000|Phase 1|Adverse Event|0|||
162164233|NCT02243709|585651633|FG001|Phase 1|Adverse Event|1|||
162164234|NCT01748448|585651634|FG000|Treatment Period|Consent withdrawn by subject|1|||
162164235|NCT01748448|585651635|FG001|Treatment Period|Consent withdrawn by subject|0|||
162164236|NCT01748448|585651634|FG000|Treatment Period|Adverse Event|1|||
161920979|NCT00817063|584757122|FG001|Overall Study|Adverse Event|13|||
161920980|NCT00817063|584757121|FG000|Overall Study|Death|1|||
161920981|NCT00817063|584757122|FG001|Overall Study|Death|1|||
162164237|NCT01748448|585651635|FG001|Treatment Period|Adverse Event|0|||
162164238|NCT01748448|585651634|FG000|Treatment Period|Personal|0|||
162164239|NCT01748448|585651635|FG001|Treatment Period|Personal|1|||
162164240|NCT06414213|585651641|FG000|Overall Study|Lost to Follow-up|1|||
162164241|NCT06414213|585651642|FG001|Overall Study|Lost to Follow-up|1|||
162164242|NCT06414213|585651643|FG002|Overall Study|Lost to Follow-up|3|||
162164243|NCT03720795|585651644|FG000|Phase 1|Lost to Follow-up|4|||
162164244|NCT03720795|585651644|FG000|Phase 1|Withdrawal by Subject|6|||
162164245|NCT03720795|585651644|FG000|Phase 1|Protocol Violation|1|||
162164246|NCT03720795|585651644|FG000|Phase 1|Other|1|||
162164247|NCT03720795|585651644|FG000|Phase 2|Lost to Follow-up|5|||
162164248|NCT03720795|585651644|FG000|Phase 2|Withdrawal by Subject|10|||
162164249|NCT03720795|585651644|FG000|Phase 2|Protocol Violation|2|||
162164250|NCT03720795|585651644|FG000|3 Month Follow Up|Lost to Follow-up|2|||
162164251|NCT01573442|585651647|FG000|Overall Study|Cancels|9|||
161920982|NCT00817063|584757121|FG000|Overall Study|Lack of Efficacy|33|||
161920983|NCT00817063|584757122|FG001|Overall Study|Lack of Efficacy|86|||
161920984|NCT00817063|584757121|FG000|Overall Study|Failure to Return|13|||
161920985|NCT00817063|584757122|FG001|Overall Study|Failure to Return|12|||
161920986|NCT00817063|584757121|FG000|Overall Study|Violation of Selection at Entry|7|||
161920987|NCT00817063|584757122|FG001|Overall Study|Violation of Selection at Entry|4|||
161920988|NCT00817063|584757121|FG000|Overall Study|Protocol Violation|3|||
161920989|NCT00817063|584757122|FG001|Overall Study|Protocol Violation|8|||
161920990|NCT00817063|584757121|FG000|Overall Study|Withdrawal by Subject|17|||
161920991|NCT00817063|584757122|FG001|Overall Study|Withdrawal by Subject|37|||
161920992|NCT00817063|584757121|FG000|Overall Study|Early Improvement|19|||
161920993|NCT00817063|584757122|FG001|Overall Study|Early Improvement|4|||
161920994|NCT00817063|584757121|FG000|Overall Study|Administrative|10|||
161920995|NCT00817063|584757122|FG001|Overall Study|Administrative|4|||
161920996|NCT00817063|584757121|FG000|Overall Study|Abnormality of Laboratory Test|2|||
161920997|NCT00817063|584757122|FG001|Overall Study|Abnormality of Laboratory Test|1|||
161920998|NCT00529035|584757123|FG000|Overall Study|Withdrawal by Subject|1|||
161920999|NCT03439514|584757124|FG000|Double-Blind Treatment Period|Other|4|||
161921000|NCT03439514|584757125|FG001|Double-Blind Treatment Period|Other|1|||
161921001|NCT03439514|584757124|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
161921002|NCT03439514|584757125|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161921003|NCT03439514|584757124|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
161921004|NCT03439514|584757125|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
161921005|NCT03439514|584757124|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
161921006|NCT03439514|584757125|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
161921007|NCT03439514|584757124|FG000|Double-Blind Treatment Period|Death|1|||
161921008|NCT03439514|584757125|FG001|Double-Blind Treatment Period|Death|2|||
161921009|NCT02636283|584757126|FG000|Overall Study|Adverse Event|2|||
161921010|NCT02636283|584757127|FG001|Overall Study|Adverse Event|0|||
161921011|NCT02636283|584757126|FG000|Overall Study|Trial Terminated Prematurely|0|||
161921012|NCT02636283|584757127|FG001|Overall Study|Trial Terminated Prematurely|3|||
161921013|NCT03418675|584757128|FG000|Overall Study|Lost to Follow-up|13|||
161921014|NCT03418675|584757129|FG001|Overall Study|Lost to Follow-up|10|||
161921015|NCT03418675|584757128|FG000|Overall Study|Adverse Event|2|||
161921016|NCT03418675|584757129|FG001|Overall Study|Adverse Event|0|||
161921017|NCT01879852|584757130|FG000|Overall Study|Withdrawal by Subject|2|||
161921018|NCT01879852|584757131|FG001|Overall Study|Withdrawal by Subject|0|||
161921019|NCT02696616|584757133|FG000|Overall Study|Adverse Event|0|||
161921020|NCT02696616|584757134|FG001|Overall Study|Adverse Event|1|||
161921021|NCT02696616|584757135|FG002|Overall Study|Adverse Event|0|||
162164252|NCT01573442|585651648|FG001|Overall Study|Cancels|10|||
162164253|NCT04763265|585651654|FG000|Overall Study|Adverse Event|1|||
162164254|NCT04763265|585651655|FG001|Overall Study|Adverse Event|0|||
162164255|NCT04763265|585651654|FG000|Overall Study|Lost to Follow-up|2|||
162164256|NCT04763265|585651655|FG001|Overall Study|Lost to Follow-up|4|||
161921022|NCT02696616|584757136|FG003|Overall Study|Adverse Event|0|||
161921023|NCT02696616|584757137|FG004|Overall Study|Adverse Event|0|||
161921024|NCT02696616|584757138|FG005|Overall Study|Adverse Event|0|||
161921025|NCT02696616|584757139|FG006|Overall Study|Adverse Event|0|||
161921026|NCT03086343|584757140|FG000|Period 1|Adverse Event|7|||
161921027|NCT03086343|584757141|FG001|Period 1|Adverse Event|7|||
161921028|NCT03086343|584757142|FG002|Period 1|Adverse Event|0|||
162164257|NCT04763265|585651654|FG000|Overall Study|Withdrawal by Subject|0|||
162164258|NCT04763265|585651655|FG001|Overall Study|Withdrawal by Subject|1|||
162164259|NCT05308004|585651662|FG000|Overall Study|Not seen by Palliative Care NP|0|||
162164260|NCT05308004|585651663|FG001|Overall Study|Not seen by Palliative Care NP|1|||
162164261|NCT04552223|585651670|FG000|Overall Study|Withdrawal by Subject|1|||
162164262|NCT04856163|585651671|FG000|Overall Study|Lost to Follow-up|97|||
162164263|NCT04856163|585651672|FG001|Overall Study|Lost to Follow-up|100|||
162164264|NCT02515773|585651675|FG000|Overall Study|Withdrawal by Subject|12|||
161815601|NCT00488774|584368694|FG003|Overall Study|Lost to Follow-up|1|||
161815602|NCT05523895|584368695|FG000|Overall Study|Adverse Event|2|||
161815603|NCT05523895|584368696|FG001|Overall Study|Adverse Event|1|||
161815604|NCT05523895|584368697|FG002|Overall Study|Adverse Event|1|||
161815605|NCT05523895|584368695|FG000|Overall Study|Lost to Follow-up|0|||
161815606|NCT05523895|584368696|FG001|Overall Study|Lost to Follow-up|1|||
161815607|NCT05523895|584368697|FG002|Overall Study|Lost to Follow-up|2|||
161815608|NCT05523895|584368695|FG000|Overall Study|Noncompliance with study drug|1|||
161815609|NCT05523895|584368696|FG001|Overall Study|Noncompliance with study drug|1|||
161815610|NCT05523895|584368697|FG002|Overall Study|Noncompliance with study drug|1|||
161815611|NCT05523895|584368695|FG000|Overall Study|Protocol Violation|0|||
161815612|NCT05523895|584368696|FG001|Overall Study|Protocol Violation|2|||
161815613|NCT05523895|584368697|FG002|Overall Study|Protocol Violation|0|||
161815614|NCT05523895|584368695|FG000|Overall Study|Withdrawal by Subject|1|||
161815615|NCT05523895|584368696|FG001|Overall Study|Withdrawal by Subject|3|||
161815616|NCT05523895|584368697|FG002|Overall Study|Withdrawal by Subject|1|||
161815617|NCT05523895|584368695|FG000|Overall Study|Not further specified|0|||
161815618|NCT05523895|584368696|FG001|Overall Study|Not further specified|3|||
161815619|NCT05523895|584368697|FG002|Overall Study|Not further specified|1|||
161815620|NCT03674892|584368698|FG000|Overall Study|Lack of Efficacy|5|||
161815621|NCT03674892|584368698|FG000|Overall Study|Lost to Follow-up|3|||
161815622|NCT03674892|584368698|FG000|Overall Study|Migraine|2|||
161815623|NCT03674892|584368698|FG000|Overall Study|Excessive Tearing|1|||
161815624|NCT03674892|584368698|FG000|Overall Study|Increased Eye Pain|1|||
161815625|NCT03674892|584368698|FG000|Overall Study|Increased Facial Pain|1|||
161815626|NCT03674892|584368698|FG000|Overall Study|Sinus Irritation|1|||
161815627|NCT03674892|584368698|FG000|Overall Study|Sinus Infection|1|||
161815628|NCT05099380|584368699|FG000|Overall Study|Subject enrolled in error|1|||
161815629|NCT05099380|584368700|FG001|Overall Study|Subject enrolled in error|0|||
161815630|NCT05099380|584368699|FG000|Overall Study|Study Procedure|1|||
161815631|NCT05099380|584368700|FG001|Overall Study|Study Procedure|0|||
161815632|NCT05099380|584368699|FG000|Overall Study|Protocol Violation|1|||
161815633|NCT05099380|584368700|FG001|Overall Study|Protocol Violation|0|||
161815634|NCT05099380|584368699|FG000|Overall Study|Adverse Event|1|||
161815635|NCT05099380|584368700|FG001|Overall Study|Adverse Event|1|||
161815636|NCT05099380|584368699|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
161815637|NCT05099380|584368700|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
161815638|NCT01959672|584368706|FG000|Overall Study|Death|1|||
161815639|NCT02392195|584368707|FG000|Overall Study|Lost to Follow-up|4|||
161815640|NCT02392195|584368707|FG000|Overall Study|Withdrawal by Subject|4|||
161815641|NCT03276754|584368708|FG000|Overall Study|Withdrawal of informed consent|4|||
161815642|NCT03276754|584368708|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
161815643|NCT03276754|584368708|FG000|Overall Study|Lost to Follow-up|27|||
161815644|NCT03276754|584368708|FG000|Overall Study|No data reported at Month 24|31|||
161815645|NCT03276754|584368708|FG000|Overall Study|Death|39|||
161815646|NCT00545792|584368709|FG000|Overall Study|Withdrawal by Subject|1|||
161815647|NCT05041361|584368711|FG000|Overall Study|Lost to Follow-up|1|||
161815648|NCT05041361|584368712|FG001|Overall Study|Lost to Follow-up|3|||
161815649|NCT01642277|584368713|FG000|Overall Study|Adverse Event|10|||
161815650|NCT01642277|584368714|FG001|Overall Study|Adverse Event|0|||
161815651|NCT01642277|584368713|FG000|Overall Study|Physician Decision|2|||
161815652|NCT01642277|584368714|FG001|Overall Study|Physician Decision|0|||
161815653|NCT01642277|584368713|FG000|Overall Study|Protocol Violation|1|||
161815654|NCT01642277|584368714|FG001|Overall Study|Protocol Violation|0|||
161815655|NCT01642277|584368713|FG000|Overall Study|Withdrawal by Subject|11|||
161815656|NCT01642277|584368714|FG001|Overall Study|Withdrawal by Subject|0|||
161815657|NCT03679598|584368715|FG000|Overall Study|Adverse Event|2|||
161815658|NCT03679598|584368716|FG001|Overall Study|Adverse Event|0|||
161815659|NCT03605342|584368717|FG000|Overall Study|Withdrawal by Subject|9|||
161815660|NCT03605342|584368718|FG001|Overall Study|Withdrawal by Subject|7|||
161815661|NCT03605342|584368717|FG000|Overall Study|Lost to Follow-up|1|||
161815662|NCT03605342|584368718|FG001|Overall Study|Lost to Follow-up|1|||
161815663|NCT02842853|584368721|FG000|Overall Study|Non-compliance with the protocol|3|||
161815664|NCT02842853|584368722|FG001|Overall Study|Non-compliance with the protocol|7|||
161815665|NCT02842853|584368723|FG002|Overall Study|Non-compliance with the protocol|2|||
161815666|NCT02842853|584368724|FG003|Overall Study|Non-compliance with the protocol|5|||
161815667|NCT02842853|584368721|FG000|Overall Study|Subject met exclusion criteria|0|||
161815668|NCT02842853|584368722|FG001|Overall Study|Subject met exclusion criteria|1|||
162164265|NCT02515773|585651676|FG001|Overall Study|Withdrawal by Subject|2|||
162164266|NCT02515773|585651675|FG000|Overall Study|Lost to Follow-up|119|||
162164267|NCT02515773|585651676|FG001|Overall Study|Lost to Follow-up|126|||
162164268|NCT02515773|585651675|FG000|Overall Study|Discharged from Clinic Services|53|||
162164269|NCT02515773|585651676|FG001|Overall Study|Discharged from Clinic Services|84|||
162164270|NCT02515773|585651675|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
162164271|NCT02515773|585651676|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
162164272|NCT02515773|585651675|FG000|Overall Study|Follow-up at non-study site|8|||
162164273|NCT02515773|585651676|FG001|Overall Study|Follow-up at non-study site|16|||
162164274|NCT02515773|585651675|FG000|Overall Study|Moved from area|9|||
162164275|NCT02515773|585651676|FG001|Overall Study|Moved from area|14|||
162164276|NCT04072380|585651678|FG000|Overall Study|Adverse Event|4|||
162164277|NCT04072380|585651679|FG001|Overall Study|Adverse Event|6|||
162164278|NCT04072380|585651680|FG002|Overall Study|Adverse Event|0|||
162164279|NCT04072380|585651678|FG000|Overall Study|Withdrawal by Subject|3|||
162164280|NCT04072380|585651679|FG001|Overall Study|Withdrawal by Subject|1|||
162164281|NCT04072380|585651680|FG002|Overall Study|Withdrawal by Subject|1|||
162164282|NCT04072380|585651678|FG000|Overall Study|Physician Decision|2|||
162164283|NCT04072380|585651679|FG001|Overall Study|Physician Decision|0|||
162164284|NCT04072380|585651680|FG002|Overall Study|Physician Decision|0|||
162164285|NCT04072380|585651678|FG000|Overall Study|Protocol Violation|0|||
162164286|NCT04072380|585651679|FG001|Overall Study|Protocol Violation|2|||
162164287|NCT04072380|585651680|FG002|Overall Study|Protocol Violation|3|||
162164288|NCT04072380|585651678|FG000|Overall Study|Intercurrent Illness and Others|3|||
161815669|NCT02842853|584368723|FG002|Overall Study|Subject met exclusion criteria|0|||
161815670|NCT02842853|584368724|FG003|Overall Study|Subject met exclusion criteria|0|||
161815671|NCT02842853|584368721|FG000|Overall Study|Withdrawal by Subject|11|||
161815672|NCT02842853|584368722|FG001|Overall Study|Withdrawal by Subject|13|||
161815673|NCT02842853|584368723|FG002|Overall Study|Withdrawal by Subject|9|||
161815674|NCT02842853|584368724|FG003|Overall Study|Withdrawal by Subject|8|||
161815675|NCT02842853|584368721|FG000|Overall Study|Lost to Follow-up|9|||
161815676|NCT02842853|584368722|FG001|Overall Study|Lost to Follow-up|13|||
161815677|NCT02842853|584368723|FG002|Overall Study|Lost to Follow-up|10|||
161815678|NCT02842853|584368724|FG003|Overall Study|Lost to Follow-up|11|||
161815679|NCT00918645|584368733|FG000|Overall Study|Withdrawal by Subject|1|||
161815680|NCT05133180|584368736|FG000|Overall Study|Withdrawal of consent|1|||
161815681|NCT05133180|584368737|FG001|Overall Study|Withdrawal of consent|1|||
161815682|NCT05133180|584368736|FG000|Overall Study|Lost to Follow-up|1|||
161815683|NCT05133180|584368737|FG001|Overall Study|Lost to Follow-up|1|||
161815684|NCT05133180|584368736|FG000|Overall Study|Documented disease progression|0|||
161815685|NCT05133180|584368737|FG001|Overall Study|Documented disease progression|1|||
161815686|NCT04723693|584368738|FG000|Overall Study|Withdrawal by Subject|2|||
161815687|NCT02157974|584368739|FG000|Overall Study|Withdrawal by Subject|0|||
161815688|NCT02157974|584368740|FG001|Overall Study|Withdrawal by Subject|1|||
161815689|NCT02157974|584368741|FG002|Overall Study|Withdrawal by Subject|0|||
161921029|NCT03086343|584757143|FG003|Period 1|Adverse Event|1|||
161921030|NCT03086343|584757140|FG000|Period 1|Withdrawal by Subject|6|||
161921031|NCT03086343|584757141|FG001|Period 1|Withdrawal by Subject|10|||
161921032|NCT03086343|584757142|FG002|Period 1|Withdrawal by Subject|0|||
161921033|NCT03086343|584757143|FG003|Period 1|Withdrawal by Subject|0|||
161921034|NCT03086343|584757140|FG000|Period 1|Lost to Follow-up|1|||
161921035|NCT03086343|584757141|FG001|Period 1|Lost to Follow-up|3|||
161921036|NCT03086343|584757142|FG002|Period 1|Lost to Follow-up|1|||
161921037|NCT03086343|584757143|FG003|Period 1|Lost to Follow-up|0|||
161921038|NCT03086343|584757140|FG000|Period 1|Other, Not Specified|10|||
161921039|NCT03086343|584757141|FG001|Period 1|Other, Not Specified|12|||
161921040|NCT03086343|584757142|FG002|Period 1|Other, Not Specified|2|||
161921041|NCT03086343|584757143|FG003|Period 1|Other, Not Specified|1|||
161921042|NCT03086343|584757140|FG000|Period 1|Missing|1|||
161921043|NCT03086343|584757141|FG001|Period 1|Missing|0|||
161921044|NCT03086343|584757142|FG002|Period 1|Missing|0|||
161921045|NCT03086343|584757143|FG003|Period 1|Missing|0|||
161921046|NCT03086343|584757140|FG000|Period 2|Adverse Event|20|||
161921047|NCT03086343|584757141|FG001|Period 2|Adverse Event|11|||
161921048|NCT03086343|584757142|FG002|Period 2|Adverse Event|1|||
161921049|NCT03086343|584757143|FG003|Period 2|Adverse Event|2|||
161921050|NCT03086343|584757140|FG000|Period 2|Withdrawal by Subject|15|||
162164289|NCT04072380|585651679|FG001|Overall Study|Intercurrent Illness and Others|5|||
162164290|NCT04072380|585651680|FG002|Overall Study|Intercurrent Illness and Others|6|||
162164291|NCT03468218|585651686|FG000|Overall Study|Adverse Event|5|||
162164292|NCT03468218|585651686|FG000|Overall Study|Progressive Disease|16|||
161815690|NCT02157974|584368742|FG003|Overall Study|Withdrawal by Subject|0|||
162164293|NCT03468218|585651686|FG000|Overall Study|Death|1|||
162164294|NCT03468218|585651686|FG000|Overall Study|Alternate therapy|1|||
161921051|NCT03086343|584757141|FG001|Period 2|Withdrawal by Subject|25|||
161921052|NCT03086343|584757142|FG002|Period 2|Withdrawal by Subject|2|||
161921053|NCT03086343|584757143|FG003|Period 2|Withdrawal by Subject|2|||
161921054|NCT03086343|584757140|FG000|Period 2|Lost to Follow-up|6|||
161921055|NCT03086343|584757141|FG001|Period 2|Lost to Follow-up|11|||
161921056|NCT03086343|584757142|FG002|Period 2|Lost to Follow-up|1|||
161921057|NCT03086343|584757143|FG003|Period 2|Lost to Follow-up|0|||
161815691|NCT02157974|584368743|FG004|Overall Study|Withdrawal by Subject|0|||
161815692|NCT02157974|584368739|FG000|Overall Study|Screen Failure|0|||
161815693|NCT02157974|584368740|FG001|Overall Study|Screen Failure|1|||
161815694|NCT02157974|584368741|FG002|Overall Study|Screen Failure|0|||
161815695|NCT02157974|584368742|FG003|Overall Study|Screen Failure|0|||
161815696|NCT02157974|584368743|FG004|Overall Study|Screen Failure|0|||
161815697|NCT02157974|584368739|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
161815698|NCT02157974|584368740|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
161815699|NCT02157974|584368741|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
161815700|NCT02157974|584368742|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
161815701|NCT02157974|584368743|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
161815702|NCT03366792|584368746|FG000|Overall Study|Withdrawal by Subject|7|||
161815703|NCT03366792|584368746|FG000|Overall Study|Lost to Follow-up|2|||
161815704|NCT03366792|584368746|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
161815705|NCT03366792|584368746|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
161815706|NCT01808651|584368747|FG000|Study Period 1|Lost to Follow-up|1|||
161815707|NCT01808651|584368748|FG001|Study Period 1|Lost to Follow-up|3|||
161815708|NCT01808651|584368749|FG002|Study Period 1|Lost to Follow-up|0|||
161815709|NCT01808651|584368747|FG000|Study Period 1|Protocol Violation|1|||
161815710|NCT01808651|584368748|FG001|Study Period 1|Protocol Violation|0|||
161815711|NCT01808651|584368749|FG002|Study Period 1|Protocol Violation|1|||
161815712|NCT01808651|584368747|FG000|Study Period 1|Physician Decision|3|||
161815713|NCT01808651|584368748|FG001|Study Period 1|Physician Decision|2|||
161815714|NCT01808651|584368749|FG002|Study Period 1|Physician Decision|0|||
161815715|NCT01808651|584368747|FG000|Study Period 1|Lack of Efficacy|2|||
161815716|NCT01808651|584368748|FG001|Study Period 1|Lack of Efficacy|1|||
161815717|NCT01808651|584368749|FG002|Study Period 1|Lack of Efficacy|0|||
161815718|NCT01808651|584368747|FG000|Study Period 1|Adverse Event|10|||
161815719|NCT01808651|584368748|FG001|Study Period 1|Adverse Event|4|||
161815720|NCT01808651|584368749|FG002|Study Period 1|Adverse Event|1|||
161815721|NCT01808651|584368747|FG000|Study Period 1|Participant Decision|9|||
161815722|NCT01808651|584368748|FG001|Study Period 1|Participant Decision|7|||
161815723|NCT01808651|584368749|FG002|Study Period 1|Participant Decision|3|||
161815724|NCT00216736|584368754|FG000|Overall Study|Lost to Follow-up|1|||
161815725|NCT00216736|584368755|FG001|Overall Study|Lost to Follow-up|1|||
161815726|NCT00807495|584368756|FG000|Overall Study|Adverse Event|6|||
161815727|NCT00807495|584368757|FG001|Overall Study|Adverse Event|3|||
161815728|NCT00807495|584368758|FG002|Overall Study|Adverse Event|1|||
161815729|NCT00807495|584368759|FG003|Overall Study|Adverse Event|1|||
161815730|NCT00807495|584368760|FG004|Overall Study|Adverse Event|2|||
161815731|NCT00807495|584368756|FG000|Overall Study|Withdrawal by Patient|2|||
161815732|NCT00807495|584368757|FG001|Overall Study|Withdrawal by Patient|0|||
161815733|NCT00807495|584368758|FG002|Overall Study|Withdrawal by Patient|1|||
161815734|NCT00807495|584368759|FG003|Overall Study|Withdrawal by Patient|0|||
161815735|NCT00807495|584368760|FG004|Overall Study|Withdrawal by Patient|0|||
161815736|NCT00807495|584368756|FG000|Overall Study|Reason Not Specified|0|||
161815737|NCT00807495|584368757|FG001|Overall Study|Reason Not Specified|3|||
161815738|NCT00807495|584368758|FG002|Overall Study|Reason Not Specified|2|||
161815739|NCT00807495|584368759|FG003|Overall Study|Reason Not Specified|0|||
161815740|NCT00807495|584368760|FG004|Overall Study|Reason Not Specified|3|||
161815741|NCT00841542|584368762|FG000|Period 1|Adverse Event|1|||
161815742|NCT00841542|584368763|FG001|Period 1|Adverse Event|0|||
161815743|NCT03214588|584368764|FG000|Overall Study|Adverse Event|1|||
161815744|NCT03214588|584368765|FG001|Overall Study|Adverse Event|0|||
161815745|NCT03214588|584368766|FG002|Overall Study|Adverse Event|2|||
161815746|NCT03214588|584368764|FG000|Overall Study|Reason Not Specified|0|||
161815747|NCT03214588|584368765|FG001|Overall Study|Reason Not Specified|1|||
162164295|NCT03468218|585651686|FG000|Overall Study|Withdrawal by Subject|2|||
162164296|NCT03719443|585651687|FG000|Overall Study|Lost to Follow-up|0|||
162164297|NCT03719443|585651688|FG001|Overall Study|Lost to Follow-up|0|||
162164298|NCT03719443|585651689|FG002|Overall Study|Lost to Follow-up|1|||
162164299|NCT03719443|585651690|FG003|Overall Study|Lost to Follow-up|0|||
162164300|NCT03719443|585651691|FG004|Overall Study|Lost to Follow-up|1|||
162164301|NCT03719443|585651692|FG005|Overall Study|Lost to Follow-up|0|||
162164302|NCT03719443|585651693|FG006|Overall Study|Lost to Follow-up|1|||
162164303|NCT03719443|585651687|FG000|Overall Study|Withdrawal by Subject|0|||
162164304|NCT03719443|585651688|FG001|Overall Study|Withdrawal by Subject|0|||
162164305|NCT03719443|585651689|FG002|Overall Study|Withdrawal by Subject|1|||
162164306|NCT03719443|585651690|FG003|Overall Study|Withdrawal by Subject|0|||
162164307|NCT03719443|585651691|FG004|Overall Study|Withdrawal by Subject|0|||
162164308|NCT03719443|585651692|FG005|Overall Study|Withdrawal by Subject|0|||
162164309|NCT03719443|585651693|FG006|Overall Study|Withdrawal by Subject|0|||
162164310|NCT03447470|585651698|FG000|Overall Study|Death|0|||
162164311|NCT03447470|585651699|FG001|Overall Study|Death|1|||
162164312|NCT03447470|585651700|FG002|Overall Study|Death|3|||
162164313|NCT03447470|585651701|FG003|Overall Study|Death|0|||
162164314|NCT03447470|585651702|FG004|Overall Study|Death|1|||
162164315|NCT03447470|585651703|FG005|Overall Study|Death|0|||
162164316|NCT03447470|585651704|FG006|Overall Study|Death|3|||
162164317|NCT03447470|585651705|FG007|Overall Study|Death|3|||
162164318|NCT03447470|585651706|FG008|Overall Study|Death|1|||
162164319|NCT03447470|585651698|FG000|Overall Study|Withdrawal by Subject|1|||
162164320|NCT03447470|585651699|FG001|Overall Study|Withdrawal by Subject|0|||
162164321|NCT03447470|585651700|FG002|Overall Study|Withdrawal by Subject|0|||
162164322|NCT03447470|585651701|FG003|Overall Study|Withdrawal by Subject|0|||
162164323|NCT03447470|585651702|FG004|Overall Study|Withdrawal by Subject|1|||
162164324|NCT03447470|585651703|FG005|Overall Study|Withdrawal by Subject|0|||
162164325|NCT03447470|585651704|FG006|Overall Study|Withdrawal by Subject|1|||
162164326|NCT03447470|585651705|FG007|Overall Study|Withdrawal by Subject|1|||
162164327|NCT03447470|585651706|FG008|Overall Study|Withdrawal by Subject|3|||
162164328|NCT03447470|585651698|FG000|Overall Study|Treatment discontinued|3|||
162164329|NCT03447470|585651699|FG001|Overall Study|Treatment discontinued|2|||
162164330|NCT03447470|585651700|FG002|Overall Study|Treatment discontinued|4|||
162164331|NCT03447470|585651701|FG003|Overall Study|Treatment discontinued|6|||
162164332|NCT03447470|585651702|FG004|Overall Study|Treatment discontinued|2|||
162164333|NCT03447470|585651703|FG005|Overall Study|Treatment discontinued|1|||
162164334|NCT03447470|585651704|FG006|Overall Study|Treatment discontinued|2|||
162164335|NCT03447470|585651705|FG007|Overall Study|Treatment discontinued|4|||
162164336|NCT03447470|585651706|FG008|Overall Study|Treatment discontinued|3|||
162164337|NCT02471638|585651709|FG000|Overall Study|Early Term Withdrawal|10|||
162164338|NCT05816551|585654208|FG000|Overall Study|Withdrawal by Subject|0|||
162164339|NCT05816551|585654209|FG001|Overall Study|Withdrawal by Subject|1|||
162164340|NCT05816551|585654208|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
162164341|NCT05816551|585654209|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
162164342|NCT04593472|585654212|FG000|Overall Study|Death|31|||
162164343|NCT04593472|585654213|FG001|Overall Study|Death|27|||
162164344|NCT04593472|585654212|FG000|Overall Study|Withdrawal by Subject|12|||
162164345|NCT04593472|585654213|FG001|Overall Study|Withdrawal by Subject|12|||
162164346|NCT04593472|585654212|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
162164347|NCT04593472|585654213|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
162164348|NCT04593472|585654212|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
162164349|NCT04593472|585654213|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
162164350|NCT04593472|585654212|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
162164351|NCT04593472|585654213|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
161815748|NCT03214588|584368766|FG002|Overall Study|Reason Not Specified|0|||
162164352|NCT04593472|585654212|FG000|Overall Study|Lost to Follow-up|0|||
162164353|NCT04593472|585654213|FG001|Overall Study|Lost to Follow-up|2|||
162164354|NCT04593472|585654212|FG000|Overall Study|Still collecting 24-month assessment|17|||
162164355|NCT04593472|585654213|FG001|Overall Study|Still collecting 24-month assessment|10|||
162164356|NCT04353661|585654217|FG000|Overall Study|Protocol Violation|0|||
162164357|NCT04353661|585654218|FG001|Overall Study|Protocol Violation|0|||
162164358|NCT04353661|585654219|FG002|Overall Study|Protocol Violation|1|||
162164359|NCT04353661|585654217|FG000|Overall Study|Study termination by the Sponsor|1|||
162164360|NCT04353661|585654218|FG001|Overall Study|Study termination by the Sponsor|1|||
162164361|NCT04353661|585654219|FG002|Overall Study|Study termination by the Sponsor|1|||
162164362|NCT02671903|585654225|FG000|Period 0 (Run-In)|Death|0|||
162164363|NCT02671903|585654226|FG001|Period 0 (Run-In)|Death|0|||
162164364|NCT02671903|585654227|FG002|Period 0 (Run-In)|Death|3|||
162164365|NCT02671903|585654225|FG000|Period 0 (Run-In)|Physician Decision|0|||
162164366|NCT02671903|585654226|FG001|Period 0 (Run-In)|Physician Decision|0|||
162164367|NCT02671903|585654227|FG002|Period 0 (Run-In)|Physician Decision|4|||
162164368|NCT02671903|585654225|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
162164369|NCT02671903|585654226|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
162164370|NCT02671903|585654227|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
162164371|NCT02671903|585654225|FG000|Period 0 (Run-In)|Protocol Violation|0|||
162164372|NCT02671903|585654226|FG001|Period 0 (Run-In)|Protocol Violation|0|||
162164373|NCT02671903|585654227|FG002|Period 0 (Run-In)|Protocol Violation|1|||
162164374|NCT02671903|585654225|FG000|Period 0 (Run-In)|Adverse Event|0|||
162164375|NCT02671903|585654226|FG001|Period 0 (Run-In)|Adverse Event|0|||
162164376|NCT02671903|585654227|FG002|Period 0 (Run-In)|Adverse Event|1|||
162164377|NCT02671903|585654225|FG000|Period 0 (Run-In)|Implantation Failure|0|||
162164378|NCT02671903|585654226|FG001|Period 0 (Run-In)|Implantation Failure|0|||
162164379|NCT02671903|585654227|FG002|Period 0 (Run-In)|Implantation Failure|2|||
162164380|NCT02671903|585654225|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
162164381|NCT02671903|585654226|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
162164382|NCT02671903|585654227|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
162164383|NCT03673111|585654240|FG000|Overall Study|Protocol Violation|0|||
162164384|NCT03673111|585654241|FG001|Overall Study|Protocol Violation|0|||
162164385|NCT03673111|585654242|FG002|Overall Study|Protocol Violation|0|||
162164386|NCT03673111|585654243|FG003|Overall Study|Protocol Violation|0|||
162164387|NCT03673111|585654244|FG004|Overall Study|Protocol Violation|0|||
162164388|NCT03673111|585654245|FG005|Overall Study|Protocol Violation|0|||
162164389|NCT03673111|585654246|FG006|Overall Study|Protocol Violation|0|||
162164390|NCT03673111|585654247|FG007|Overall Study|Protocol Violation|0|||
162164391|NCT03673111|585654248|FG008|Overall Study|Protocol Violation|0|||
162164392|NCT03673111|585654249|FG009|Overall Study|Protocol Violation|0|||
162164393|NCT03673111|585654250|FG010|Overall Study|Protocol Violation|1|||
162164394|NCT03673111|585654251|FG011|Overall Study|Protocol Violation|0|||
162164395|NCT03673111|585654252|FG012|Overall Study|Protocol Violation|0|||
162164396|NCT03673111|585654253|FG013|Overall Study|Protocol Violation|0|||
162164397|NCT03673111|585654240|FG000|Overall Study|Adverse Event|1|||
162164398|NCT03673111|585654241|FG001|Overall Study|Adverse Event|0|||
162164399|NCT03673111|585654242|FG002|Overall Study|Adverse Event|0|||
162164400|NCT03673111|585654243|FG003|Overall Study|Adverse Event|0|||
162164401|NCT03673111|585654244|FG004|Overall Study|Adverse Event|0|||
162164402|NCT03673111|585654245|FG005|Overall Study|Adverse Event|0|||
162164403|NCT03673111|585654246|FG006|Overall Study|Adverse Event|0|||
162164404|NCT03673111|585654247|FG007|Overall Study|Adverse Event|0|||
162164405|NCT03673111|585654248|FG008|Overall Study|Adverse Event|0|||
162164406|NCT03673111|585654249|FG009|Overall Study|Adverse Event|0|||
162164407|NCT03673111|585654250|FG010|Overall Study|Adverse Event|0|||
162164408|NCT03673111|585654251|FG011|Overall Study|Adverse Event|0|||
162164409|NCT03673111|585654252|FG012|Overall Study|Adverse Event|0|||
162164410|NCT03673111|585654253|FG013|Overall Study|Adverse Event|0|||
162164411|NCT04485039|585654254|FG000|TPOXX Only|Adverse Event|2|||
162164412|NCT04485039|585654254|FG000|TPOXX Only|Physician Decision|1|||
162164413|NCT04485039|585654254|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
162164414|NCT04485039|585654254|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
162164415|NCT04005716|585654255|FG000|Overall Study|Death|175|||
162164416|NCT04005716|585654256|FG001|Overall Study|Death|196|||
162164417|NCT04005716|585654255|FG000|Overall Study|Withdrawal by Subject|1|||
162164418|NCT04005716|585654256|FG001|Overall Study|Withdrawal by Subject|6|||
162164419|NCT04005716|585654255|FG000|Overall Study|Lost to Follow-up|2|||
162164420|NCT04005716|585654256|FG001|Overall Study|Lost to Follow-up|2|||
162164421|NCT02783300|585654257|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164422|NCT02783300|585654258|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164423|NCT02783300|585654259|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164424|NCT02783300|585654260|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164425|NCT02783300|585654261|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164426|NCT02783300|585654262|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164427|NCT02783300|585654263|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
162164428|NCT02783300|585654264|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164429|NCT02783300|585654265|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164430|NCT02783300|585654266|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164431|NCT02783300|585654267|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164432|NCT02783300|585654268|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164433|NCT02783300|585654269|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164434|NCT02783300|585654270|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164435|NCT02783300|585654271|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164436|NCT02783300|585654272|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164437|NCT02783300|585654273|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164438|NCT02783300|585654274|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164439|NCT02783300|585654275|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164440|NCT02783300|585654276|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164441|NCT02783300|585654277|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161921058|NCT03086343|584757140|FG000|Period 2|COVID-19 Infection|5|||
162164442|NCT02783300|585654278|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164443|NCT02783300|585654279|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164444|NCT02783300|585654280|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164445|NCT02783300|585654281|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164446|NCT02783300|585654282|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164447|NCT02783300|585654283|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
162164448|NCT02783300|585654257|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164449|NCT02783300|585654258|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164450|NCT02783300|585654259|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164451|NCT02783300|585654260|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
162164452|NCT02783300|585654261|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164453|NCT02783300|585654262|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164454|NCT02783300|585654263|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164455|NCT02783300|585654264|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164456|NCT02783300|585654265|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161815749|NCT03808376|584368767|FG000|Overall Study|Withdrawal by Subject|10|||
161815750|NCT02679729|584368768|FG000|Overall Study|Lost to Follow-up|0|||
161815751|NCT02679729|584368769|FG001|Overall Study|Lost to Follow-up|1|||
162017075|NCT02910986|585117820|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
162164457|NCT02783300|585654266|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164458|NCT02783300|585654267|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164459|NCT02783300|585654268|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164460|NCT02783300|585654269|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164461|NCT02783300|585654270|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164462|NCT02783300|585654271|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164463|NCT02783300|585654272|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164464|NCT02783300|585654273|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164465|NCT02783300|585654274|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164466|NCT02783300|585654275|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164467|NCT02783300|585654276|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164468|NCT02783300|585654277|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164469|NCT02783300|585654278|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164470|NCT02783300|585654279|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164471|NCT02783300|585654280|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164472|NCT02783300|585654281|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164473|NCT02783300|585654282|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
162164474|NCT02783300|585654283|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161683057|NCT02554019|583891221|FG000|Overall Study|Withdrawal by Subject|1|||
162164475|NCT02783300|585654257|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
162164476|NCT02783300|585654258|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
162164477|NCT02783300|585654259|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
162164478|NCT02783300|585654260|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
162164479|NCT02783300|585654261|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
162164480|NCT02783300|585654262|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
162164481|NCT02783300|585654263|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
162164482|NCT02783300|585654264|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
162164483|NCT02783300|585654265|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
162164484|NCT02783300|585654266|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
162164485|NCT02783300|585654267|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
162164486|NCT02783300|585654268|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
162164487|NCT02783300|585654269|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
162164488|NCT02783300|585654270|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
162164489|NCT02783300|585654271|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
162164490|NCT02783300|585654272|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
162164491|NCT02783300|585654273|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
162164492|NCT02783300|585654274|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
162164493|NCT02783300|585654275|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
162164494|NCT02783300|585654276|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
162164495|NCT02783300|585654277|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
162164496|NCT02783300|585654278|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
162164497|NCT02783300|585654279|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
162164498|NCT02783300|585654280|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
162164499|NCT02783300|585654281|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
162164500|NCT02783300|585654282|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
162164501|NCT02783300|585654283|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
162164502|NCT02783300|585654257|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164503|NCT02783300|585654258|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164504|NCT02783300|585654259|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164505|NCT02783300|585654260|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164506|NCT02783300|585654261|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164507|NCT02783300|585654262|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164508|NCT02783300|585654263|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
162164509|NCT02783300|585654264|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164510|NCT02783300|585654265|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164511|NCT02783300|585654266|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164512|NCT02783300|585654267|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164513|NCT02783300|585654268|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164514|NCT02783300|585654269|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
162164515|NCT02783300|585654270|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164516|NCT02783300|585654271|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164517|NCT02783300|585654272|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164518|NCT02783300|585654273|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164519|NCT02783300|585654274|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164520|NCT02783300|585654275|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164521|NCT02783300|585654276|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164522|NCT02783300|585654277|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164523|NCT02783300|585654278|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164524|NCT02783300|585654279|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164525|NCT02783300|585654280|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164526|NCT02783300|585654281|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164527|NCT02783300|585654282|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164528|NCT02783300|585654283|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
162164529|NCT02783300|585654257|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164530|NCT02783300|585654258|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164531|NCT02783300|585654259|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164532|NCT02783300|585654260|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162017076|NCT02910986|585117821|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
162017077|NCT03682770|585117832|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
162017078|NCT03682770|585117833|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
162017079|NCT03682770|585117834|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
162017080|NCT03682770|585117835|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
162017081|NCT03682770|585117836|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
162017082|NCT03682770|585117837|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
162017083|NCT03682770|585117838|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
162017084|NCT03682770|585117832|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
162017085|NCT03682770|585117833|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
162017086|NCT03682770|585117834|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
162017087|NCT03682770|585117835|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
162017088|NCT03682770|585117836|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
162017089|NCT03682770|585117837|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
162017090|NCT03682770|585117838|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
162017091|NCT03682770|585117832|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
162017092|NCT03682770|585117833|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
162017093|NCT03682770|585117834|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
162017094|NCT03682770|585117835|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
162017095|NCT03682770|585117836|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
162017096|NCT03682770|585117837|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
162017097|NCT03682770|585117838|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
162017098|NCT03682770|585117832|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
162017099|NCT03682770|585117833|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
162017100|NCT03682770|585117834|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
162017101|NCT03682770|585117835|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
162017102|NCT03682770|585117836|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
162017103|NCT03682770|585117837|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
162017104|NCT03682770|585117838|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
162017105|NCT03682770|585117832|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
162017106|NCT03682770|585117833|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
162017107|NCT03682770|585117834|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
162017108|NCT03682770|585117835|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
162017109|NCT03682770|585117836|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
162164533|NCT02783300|585654261|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
162164534|NCT02783300|585654262|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164535|NCT02783300|585654263|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
162164536|NCT02783300|585654264|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164537|NCT02783300|585654265|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164538|NCT02783300|585654266|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
162164539|NCT02783300|585654267|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164540|NCT02783300|585654268|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164541|NCT02783300|585654269|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
162164542|NCT02783300|585654270|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164543|NCT02783300|585654271|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164544|NCT02783300|585654272|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164545|NCT02783300|585654273|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164546|NCT02783300|585654274|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164547|NCT02783300|585654275|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164548|NCT02783300|585654276|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164549|NCT02783300|585654277|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164550|NCT02783300|585654278|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164551|NCT02783300|585654279|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164552|NCT02783300|585654280|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164553|NCT02783300|585654281|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164554|NCT02783300|585654282|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164555|NCT02783300|585654283|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
162164556|NCT02783300|585654257|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164557|NCT02783300|585654258|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164558|NCT02783300|585654259|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164559|NCT02783300|585654260|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164560|NCT02783300|585654261|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164561|NCT02783300|585654262|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164562|NCT02783300|585654263|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164563|NCT02783300|585654264|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164564|NCT02783300|585654265|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164565|NCT02783300|585654266|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164566|NCT02783300|585654267|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164567|NCT02783300|585654268|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164568|NCT02783300|585654269|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164569|NCT02783300|585654270|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164570|NCT02783300|585654271|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164571|NCT02783300|585654272|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
162164572|NCT02783300|585654273|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164573|NCT02783300|585654274|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
162164574|NCT02783300|585654275|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
162164575|NCT02783300|585654276|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
162164576|NCT02783300|585654277|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164577|NCT02783300|585654278|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164578|NCT02783300|585654279|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164579|NCT02783300|585654280|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164580|NCT02783300|585654281|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
162164581|NCT02783300|585654282|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164582|NCT02783300|585654283|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
162164583|NCT02783300|585654257|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164584|NCT02783300|585654258|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164585|NCT02783300|585654259|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164586|NCT02783300|585654260|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164587|NCT02783300|585654261|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164588|NCT02783300|585654262|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164589|NCT02783300|585654263|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164590|NCT02783300|585654264|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164591|NCT02783300|585654265|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161683058|NCT02554019|583891222|FG001|Overall Study|Withdrawal by Subject|0|||
162164592|NCT02783300|585654266|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164593|NCT02783300|585654267|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164594|NCT02783300|585654268|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164595|NCT02783300|585654269|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164596|NCT02783300|585654270|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164597|NCT02783300|585654271|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164598|NCT02783300|585654272|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164599|NCT02783300|585654273|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
162164600|NCT02783300|585654274|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164601|NCT02783300|585654275|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
162164602|NCT02783300|585654276|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
162164603|NCT02783300|585654277|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164604|NCT02783300|585654278|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164605|NCT02783300|585654279|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164606|NCT02783300|585654280|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164607|NCT02783300|585654281|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164608|NCT02783300|585654282|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164609|NCT02783300|585654283|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
162164610|NCT02783300|585654257|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164611|NCT02783300|585654258|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164612|NCT02783300|585654259|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164613|NCT02783300|585654260|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164614|NCT02783300|585654261|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164615|NCT02783300|585654262|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164616|NCT02783300|585654263|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164617|NCT02783300|585654264|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164618|NCT02783300|585654265|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164619|NCT02783300|585654266|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164620|NCT02783300|585654267|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164621|NCT02783300|585654268|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164622|NCT02783300|585654269|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164623|NCT02783300|585654270|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164624|NCT02783300|585654271|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164625|NCT02783300|585654272|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164626|NCT02783300|585654273|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
162164627|NCT02783300|585654274|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164628|NCT02783300|585654275|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
162164629|NCT02783300|585654276|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
162164630|NCT02783300|585654277|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
162164631|NCT02783300|585654278|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164632|NCT02783300|585654279|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164633|NCT02783300|585654280|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164634|NCT02783300|585654281|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164635|NCT02783300|585654282|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164636|NCT02783300|585654283|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
162164637|NCT02783300|585654257|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164638|NCT02783300|585654258|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164639|NCT02783300|585654259|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164640|NCT02783300|585654260|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164641|NCT02783300|585654261|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164642|NCT02783300|585654262|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164643|NCT02783300|585654263|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164644|NCT02783300|585654264|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164645|NCT02783300|585654265|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164646|NCT02783300|585654266|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164647|NCT02783300|585654267|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164648|NCT02783300|585654268|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164649|NCT02783300|585654269|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164650|NCT02783300|585654270|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164651|NCT02783300|585654271|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164652|NCT02783300|585654272|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
162164653|NCT02783300|585654273|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164654|NCT02783300|585654274|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161815752|NCT02679729|584368770|FG002|Overall Study|Lost to Follow-up|0|||
161815753|NCT02679729|584368771|FG003|Overall Study|Lost to Follow-up|0|||
162164655|NCT02783300|585654275|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164656|NCT02783300|585654276|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164657|NCT02783300|585654277|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164658|NCT02783300|585654278|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164659|NCT02783300|585654279|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
162164660|NCT02783300|585654280|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164661|NCT02783300|585654281|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164662|NCT02783300|585654282|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164663|NCT02783300|585654283|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
162164664|NCT02783300|585654257|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164665|NCT02783300|585654258|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164666|NCT02783300|585654259|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164667|NCT02783300|585654260|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164668|NCT02783300|585654261|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164669|NCT02783300|585654262|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164670|NCT02783300|585654263|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164671|NCT02783300|585654264|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164672|NCT02783300|585654265|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164673|NCT02783300|585654266|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164674|NCT02783300|585654267|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164675|NCT02783300|585654268|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164676|NCT02783300|585654269|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164677|NCT02783300|585654270|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
162164678|NCT02783300|585654271|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
162164679|NCT02783300|585654272|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
162164680|NCT02783300|585654273|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
162164681|NCT02783300|585654274|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164682|NCT02783300|585654275|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
162164683|NCT02783300|585654276|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
162164684|NCT02783300|585654277|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164685|NCT02783300|585654278|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164686|NCT02783300|585654279|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164687|NCT02783300|585654280|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164688|NCT02783300|585654281|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164689|NCT02783300|585654282|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164690|NCT02783300|585654283|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
162164691|NCT02783300|585654257|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164692|NCT02783300|585654258|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164693|NCT02783300|585654259|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164694|NCT02783300|585654260|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164695|NCT02783300|585654261|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164696|NCT02783300|585654262|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164697|NCT02783300|585654263|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161815754|NCT02679729|584368772|FG004|Overall Study|Lost to Follow-up|1|||
162164698|NCT02783300|585654264|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164699|NCT02783300|585654265|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164700|NCT02783300|585654266|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164701|NCT02783300|585654267|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164702|NCT02783300|585654268|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164703|NCT02783300|585654269|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164704|NCT02783300|585654270|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
162164705|NCT02783300|585654271|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
162164706|NCT02783300|585654272|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
162164707|NCT02783300|585654273|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
162164708|NCT02783300|585654274|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
162164709|NCT02783300|585654275|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
162164710|NCT02783300|585654276|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
162164711|NCT02783300|585654277|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
162164712|NCT02783300|585654278|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
162164713|NCT02783300|585654279|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
162164714|NCT02783300|585654280|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
162164715|NCT02783300|585654281|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
162164716|NCT02783300|585654282|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
162164717|NCT02783300|585654283|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
162164718|NCT02783300|585654257|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164719|NCT02783300|585654258|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164720|NCT02783300|585654259|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164721|NCT02783300|585654260|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164722|NCT02783300|585654261|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164723|NCT02783300|585654262|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164724|NCT02783300|585654263|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164725|NCT02783300|585654264|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164726|NCT02783300|585654265|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164727|NCT02783300|585654266|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164728|NCT02783300|585654267|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164729|NCT02783300|585654268|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164730|NCT02783300|585654269|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164731|NCT02783300|585654270|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164732|NCT02783300|585654271|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164733|NCT02783300|585654272|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161921059|NCT03086343|584757141|FG001|Period 2|COVID-19 Infection|0|||
161921060|NCT03086343|584757142|FG002|Period 2|COVID-19 Infection|0|||
162164734|NCT02783300|585654273|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164735|NCT02783300|585654274|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164736|NCT02783300|585654275|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164737|NCT02783300|585654276|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164738|NCT02783300|585654277|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164739|NCT02783300|585654278|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164740|NCT02783300|585654279|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164741|NCT02783300|585654280|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164742|NCT02783300|585654281|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164743|NCT02783300|585654282|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
162164744|NCT02783300|585654283|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
162164745|NCT02783300|585654257|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164746|NCT02783300|585654258|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164747|NCT02783300|585654259|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164748|NCT02783300|585654260|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164749|NCT02783300|585654261|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164750|NCT02783300|585654262|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164751|NCT02783300|585654263|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164752|NCT02783300|585654264|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164753|NCT02783300|585654265|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164754|NCT02783300|585654266|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164755|NCT02783300|585654267|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
161921061|NCT03086343|584757143|FG003|Period 2|COVID-19 Infection|0|||
161921062|NCT03086343|584757140|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
161921063|NCT03086343|584757141|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
161921064|NCT03086343|584757142|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
161921065|NCT03086343|584757143|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
161921066|NCT03086343|584757140|FG000|Period 2|Other, Not Specified|23|||
161921067|NCT03086343|584757141|FG001|Period 2|Other, Not Specified|22|||
161921068|NCT03086343|584757142|FG002|Period 2|Other, Not Specified|2|||
161921069|NCT03086343|584757143|FG003|Period 2|Other, Not Specified|4|||
161921070|NCT04900272|584757144|FG000|Overall Study|Lost to Follow-up|2|||
161921071|NCT04900272|584757144|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
161921072|NCT04900272|584757144|FG000|Overall Study|Withdrawal by Subject|1|||
161921073|NCT01625182|584757146|FG000|Overall Study|Administrative problems|1|||
162017110|NCT03682770|585117837|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
162017111|NCT03682770|585117838|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
162017112|NCT03682770|585117832|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
162017113|NCT03682770|585117833|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
162017114|NCT03682770|585117834|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
162017115|NCT03682770|585117835|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
162017116|NCT03682770|585117836|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
162017117|NCT03682770|585117837|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
162017118|NCT03682770|585117838|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
162017119|NCT03682770|585117832|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
162017120|NCT03682770|585117833|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
162164756|NCT02783300|585654268|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
161921074|NCT01625182|584757147|FG001|Overall Study|Administrative problems|0|||
161921075|NCT01625182|584757146|FG000|Overall Study|Protocol deviation|0|||
162164757|NCT02783300|585654269|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164758|NCT02783300|585654270|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164759|NCT02783300|585654271|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164760|NCT02783300|585654272|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164761|NCT02783300|585654273|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164762|NCT02783300|585654274|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164763|NCT02783300|585654275|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164764|NCT02783300|585654276|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164765|NCT02783300|585654277|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164766|NCT02783300|585654278|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164767|NCT02783300|585654279|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164768|NCT02783300|585654280|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164769|NCT02783300|585654281|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164770|NCT02783300|585654282|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
162164771|NCT02783300|585654283|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
162164772|NCT01744782|585654284|FG000|Overall Study|Death|1|||
162164773|NCT00378105|585654285|FG000|Overall Study|Adverse Event|3|||
162164774|NCT00378105|585654286|FG001|Overall Study|Adverse Event|1|||
162164775|NCT00378105|585654285|FG000|Overall Study|Withdrawal by Subject|3|||
162164776|NCT00378105|585654286|FG001|Overall Study|Withdrawal by Subject|3|||
162164777|NCT00378105|585654285|FG000|Overall Study|Death|1|||
162164778|NCT00378105|585654286|FG001|Overall Study|Death|0|||
162164779|NCT00378105|585654285|FG000|Overall Study|Going to transplant|7|||
162164780|NCT00378105|585654286|FG001|Overall Study|Going to transplant|8|||
162164781|NCT00378105|585654285|FG000|Overall Study|Progressive disease|3|||
162164782|NCT00378105|585654286|FG001|Overall Study|Progressive disease|3|||
162164783|NCT00378105|585654285|FG000|Overall Study|remain on study|3|||
162164784|NCT00378105|585654286|FG001|Overall Study|remain on study|11|||
162164785|NCT00378105|585654285|FG000|Overall Study|Physician Decision|0|||
162164786|NCT00378105|585654286|FG001|Overall Study|Physician Decision|2|||
162164787|NCT00378105|585654285|FG000|Overall Study|Going non-protocol therapy|0|||
162164788|NCT00378105|585654286|FG001|Overall Study|Going non-protocol therapy|1|||
162164789|NCT00378105|585654285|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
162164790|NCT00378105|585654286|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
162164791|NCT03623321|585654287|FG000|Overall Study|Adverse Event|32|||
162164792|NCT03623321|585654287|FG000|Overall Study|Death|9|||
162164793|NCT03623321|585654287|FG000|Overall Study|Lack of Efficacy|9|||
162164794|NCT03623321|585654287|FG000|Overall Study|Lost to Follow-up|6|||
162164795|NCT03623321|585654287|FG000|Overall Study|Noncompliance with study drug|6|||
162164796|NCT03623321|585654287|FG000|Overall Study|Use of prohibited medication|3|||
162164797|NCT03623321|585654287|FG000|Overall Study|Physician Decision|5|||
162164798|NCT03623321|585654287|FG000|Overall Study|Protocol Violation|1|||
162164799|NCT03623321|585654287|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
162164800|NCT03623321|585654287|FG000|Overall Study|Not further specified|43|||
162164801|NCT04241068|585654288|FG000|Core Treatment Period|Adverse Event|91|||
162164802|NCT04241068|585654288|FG000|Core Treatment Period|Change of Treatment|4|||
162164803|NCT04241068|585654288|FG000|Core Treatment Period|Consent Withdrawn|143|||
162164804|NCT04241068|585654288|FG000|Core Treatment Period|Death|26|||
162164805|NCT04241068|585654288|FG000|Core Treatment Period|Disease Progression|67|||
162164806|NCT04241068|585654288|FG000|Core Treatment Period|Investigator Decision|40|||
162164807|NCT04241068|585654288|FG000|Core Treatment Period|Loss of Capacity|9|||
162164808|NCT04241068|585654288|FG000|Core Treatment Period|Lost to Follow-up|11|||
162164809|NCT04241068|585654288|FG000|Core Treatment Period|Relocation|4|||
162164810|NCT04241068|585654288|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
162164811|NCT04241068|585654288|FG000|Core Treatment Period|Study Visit Burden|40|||
162164812|NCT04241068|585654288|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
162164813|NCT04241068|585654288|FG000|Core Treatment Period|Missing|2|||
162164814|NCT04241068|585654288|FG000|Core Treatment Period|Reason Not Specified|41|||
162164815|NCT04241068|585654288|FG000|LTE Period|Adverse Event|19|||
162164816|NCT04241068|585654288|FG000|LTE Period|Change of Treatment|1|||
162164817|NCT04241068|585654288|FG000|LTE Period|Consent Withdrawn|71|||
162164818|NCT04241068|585654288|FG000|LTE Period|Death|8|||
162164819|NCT04241068|585654288|FG000|LTE Period|Disease Progression|11|||
162164820|NCT04241068|585654288|FG000|LTE Period|Investigator Decision|12|||
162164821|NCT04241068|585654288|FG000|LTE Period|Loss of Capacity|2|||
162164822|NCT04241068|585654288|FG000|LTE Period|Lost to Follow-up|7|||
162164823|NCT04241068|585654288|FG000|LTE Period|Relocation|6|||
162164824|NCT04241068|585654288|FG000|LTE Period|Site Terminated by Sponsor|26|||
162164825|NCT04241068|585654288|FG000|LTE Period|Study Terminated by Sponsor|276|||
162164826|NCT04241068|585654288|FG000|LTE Period|Study Visit Burden|10|||
162164827|NCT04241068|585654288|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
162164828|NCT04241068|585654288|FG000|LTE Period|Reason Not Specified|65|||
162164829|NCT04229992|585654293|FG000|Overall Study|Withdrawal by Subject|0|||
162164830|NCT04229992|585654294|FG001|Overall Study|Withdrawal by Subject|2|||
162164831|NCT04229992|585654295|FG002|Overall Study|Withdrawal by Subject|1|||
162164832|NCT04229992|585654296|FG003|Overall Study|Withdrawal by Subject|1|||
162164833|NCT04229992|585654293|FG000|Overall Study|Adverse Event|1|||
162164834|NCT04229992|585654294|FG001|Overall Study|Adverse Event|1|||
162164835|NCT04229992|585654295|FG002|Overall Study|Adverse Event|3|||
162164836|NCT04229992|585654296|FG003|Overall Study|Adverse Event|1|||
162164837|NCT04229992|585654293|FG000|Overall Study|Lost to Follow-up|0|||
162164838|NCT04229992|585654294|FG001|Overall Study|Lost to Follow-up|0|||
162164839|NCT04229992|585654295|FG002|Overall Study|Lost to Follow-up|0|||
162164840|NCT04229992|585654296|FG003|Overall Study|Lost to Follow-up|1|||
162164841|NCT05178316|585654297|FG000|Overall Study|Adverse Event|5|||
162164842|NCT05178316|585654298|FG001|Overall Study|Adverse Event|4|||
162164843|NCT05178316|585654299|FG002|Overall Study|Adverse Event|9|||
162164844|NCT05178316|585654297|FG000|Overall Study|Enrolled in Error|1|||
162164845|NCT05178316|585654298|FG001|Overall Study|Enrolled in Error|2|||
162164846|NCT05178316|585654299|FG002|Overall Study|Enrolled in Error|1|||
162164847|NCT05178316|585654297|FG000|Overall Study|Lost to Follow-up|3|||
162164848|NCT05178316|585654298|FG001|Overall Study|Lost to Follow-up|15|||
162164849|NCT05178316|585654299|FG002|Overall Study|Lost to Follow-up|11|||
162164850|NCT05178316|585654297|FG000|Overall Study|Noncompliance|1|||
162164851|NCT05178316|585654298|FG001|Overall Study|Noncompliance|3|||
162164852|NCT05178316|585654299|FG002|Overall Study|Noncompliance|1|||
162164853|NCT05178316|585654297|FG000|Overall Study|Other|0|||
162164854|NCT05178316|585654298|FG001|Overall Study|Other|1|||
162164855|NCT05178316|585654299|FG002|Overall Study|Other|0|||
162164856|NCT05178316|585654297|FG000|Overall Study|Physician Decision|0|||
162164857|NCT05178316|585654298|FG001|Overall Study|Physician Decision|3|||
162164858|NCT05178316|585654299|FG002|Overall Study|Physician Decision|2|||
162164859|NCT05178316|585654297|FG000|Overall Study|Protocol deviation|1|||
161815755|NCT02679729|584368773|FG005|Overall Study|Lost to Follow-up|0|||
162164860|NCT05178316|585654298|FG001|Overall Study|Protocol deviation|0|||
162164861|NCT05178316|585654299|FG002|Overall Study|Protocol deviation|1|||
162164862|NCT05178316|585654297|FG000|Overall Study|Sponsor decision|1|||
161921076|NCT01625182|584757147|FG001|Overall Study|Protocol deviation|2|||
161921077|NCT01625182|584757146|FG000|Overall Study|Adverse Event|2|||
161921078|NCT01625182|584757147|FG001|Overall Study|Adverse Event|0|||
161921079|NCT01625182|584757146|FG000|Overall Study|Withdrawal by Subject|5|||
161921080|NCT01625182|584757147|FG001|Overall Study|Withdrawal by Subject|1|||
161921081|NCT01625182|584757146|FG000|Overall Study|Lack of Efficacy|12|||
161921082|NCT01625182|584757147|FG001|Overall Study|Lack of Efficacy|8|||
161921083|NCT01500083|584757148|FG000|Overall Study|Adverse Event|4|||
161921084|NCT01500083|584757149|FG001|Overall Study|Adverse Event|17|||
161921085|NCT01500083|584757148|FG000|Overall Study|Death|0|||
161921086|NCT01500083|584757149|FG001|Overall Study|Death|2|||
161921087|NCT01500083|584757148|FG000|Overall Study|Lost to Follow-up|1|||
161921088|NCT01500083|584757149|FG001|Overall Study|Lost to Follow-up|0|||
161921089|NCT01500083|584757148|FG000|Overall Study|Withdrawal of Consent|0|||
161921090|NCT01500083|584757149|FG001|Overall Study|Withdrawal of Consent|1|||
162017121|NCT03682770|585117834|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
162017122|NCT03682770|585117835|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
162017123|NCT03682770|585117836|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
162164863|NCT05178316|585654298|FG001|Overall Study|Sponsor decision|0|||
162017124|NCT03682770|585117837|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
162017125|NCT03682770|585117838|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
162017126|NCT03682770|585117832|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
162017127|NCT03682770|585117833|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
162017128|NCT03682770|585117834|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
162017129|NCT03682770|585117835|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
162017130|NCT03682770|585117836|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
162017131|NCT03682770|585117837|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
162017132|NCT03682770|585117838|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
162017133|NCT03682770|585117832|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
162017134|NCT03682770|585117833|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
162017135|NCT03682770|585117834|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
162017136|NCT03682770|585117835|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
162017137|NCT03682770|585117836|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
162017138|NCT03682770|585117837|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
162017139|NCT03682770|585117838|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
162017140|NCT03682770|585117832|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
162017141|NCT03682770|585117833|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
162017142|NCT03682770|585117834|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
162017143|NCT03682770|585117835|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
162017144|NCT03682770|585117836|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
162017145|NCT03682770|585117837|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
162017146|NCT03682770|585117838|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
162017147|NCT03682770|585117832|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
162017148|NCT03682770|585117833|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
162017149|NCT03682770|585117834|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
162017150|NCT03682770|585117835|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
162017151|NCT03682770|585117836|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
162164864|NCT05178316|585654299|FG002|Overall Study|Sponsor decision|1|||
161921091|NCT01500083|584757148|FG000|Overall Study|Disease Progression|2|||
161921092|NCT01500083|584757149|FG001|Overall Study|Disease Progression|10|||
161921093|NCT01500083|584757148|FG000|Overall Study|Investigator Discretion|3|||
161921094|NCT01500083|584757149|FG001|Overall Study|Investigator Discretion|8|||
161921095|NCT01500083|584757148|FG000|Overall Study|Other Reasons|2|||
161921096|NCT01500083|584757149|FG001|Overall Study|Other Reasons|5|||
161921097|NCT00741611|584757150|FG000|Overall Study|Death|0|||
161921098|NCT00741611|584757151|FG001|Overall Study|Death|0|||
161921099|NCT00741611|584757152|FG002|Overall Study|Death|1|||
161921100|NCT00741611|584757150|FG000|Overall Study|Withdrawal by Subject|0|||
161921101|NCT00741611|584757151|FG001|Overall Study|Withdrawal by Subject|2|||
161921102|NCT00741611|584757152|FG002|Overall Study|Withdrawal by Subject|2|||
161921103|NCT01970371|584757153|FG000|Overall Study|Death|8|||
161921104|NCT01970371|584757154|FG001|Overall Study|Death|13|||
161921105|NCT01970371|584757155|FG002|Overall Study|Death|12|||
161921106|NCT01970371|584757153|FG000|Overall Study|Lost to Follow-up|0|||
161921107|NCT01970371|584757154|FG001|Overall Study|Lost to Follow-up|0|||
161921108|NCT01970371|584757155|FG002|Overall Study|Lost to Follow-up|1|||
161921109|NCT01481779|584757156|FG000|Overall Study|Adverse Event|23|||
161921110|NCT01481779|584757157|FG001|Overall Study|Adverse Event|5|||
161921111|NCT01481779|584757156|FG000|Overall Study|Lost to Follow-up|3|||
161921112|NCT01481779|584757157|FG001|Overall Study|Lost to Follow-up|2|||
161921113|NCT01481779|584757156|FG000|Overall Study|Protocol Violation|2|||
161921114|NCT01481779|584757157|FG001|Overall Study|Protocol Violation|3|||
161921115|NCT01481779|584757156|FG000|Overall Study|Withdrawal by Subject|26|||
161921116|NCT01481779|584757157|FG001|Overall Study|Withdrawal by Subject|13|||
161921117|NCT01481779|584757156|FG000|Overall Study|Physician Decision|13|||
161921118|NCT01481779|584757157|FG001|Overall Study|Physician Decision|4|||
161921119|NCT01481779|584757156|FG000|Overall Study|Sponsor Decision|3|||
161921120|NCT01481779|584757157|FG001|Overall Study|Sponsor Decision|1|||
161921121|NCT01555931|584757160|FG000|Overall Study|Lost to Follow-up|2|||
161921122|NCT01555931|584757161|FG001|Overall Study|Lost to Follow-up|5|||
161921123|NCT01922011|584757162|FG000|Overall Study|Protocol Violation|0|||
161921124|NCT01922011|584757163|FG001|Overall Study|Protocol Violation|1|||
161921125|NCT01922011|584757162|FG000|Overall Study|Physician Decision|0|||
161921126|NCT01922011|584757163|FG001|Overall Study|Physician Decision|1|||
162017152|NCT03682770|585117837|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
162017153|NCT03682770|585117838|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
162017154|NCT03682770|585117832|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
162017155|NCT03682770|585117833|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
162017156|NCT03682770|585117834|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
162017157|NCT03682770|585117835|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
162017158|NCT03682770|585117836|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
162017159|NCT03682770|585117837|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
162017160|NCT03682770|585117838|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
162017161|NCT02362282|585117839|FG000|Overall Study|Withdrawal by Subject|1|||
162017162|NCT02362282|585117840|FG001|Overall Study|Withdrawal by Subject|0|||
162017163|NCT02004093|585117841|FG000|Overall Study|Death|2|||
162017164|NCT02004093|585117842|FG001|Overall Study|Death|1|||
162017165|NCT02004093|585117841|FG000|Overall Study|Lack of Efficacy|66|||
162017166|NCT02004093|585117842|FG001|Overall Study|Lack of Efficacy|62|||
161921127|NCT01922011|584757162|FG000|Overall Study|Parent/Guardian Decision|3|||
161921128|NCT01922011|584757163|FG001|Overall Study|Parent/Guardian Decision|0|||
161921129|NCT01922011|584757162|FG000|Overall Study|Lost to Follow-up|0|||
161921130|NCT01922011|584757163|FG001|Overall Study|Lost to Follow-up|1|||
161921131|NCT01922011|584757162|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
161921132|NCT01922011|584757163|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
162164865|NCT05178316|585654297|FG000|Overall Study|Withdrawal by Subject|5|||
162164866|NCT05178316|585654298|FG001|Overall Study|Withdrawal by Subject|11|||
162164867|NCT05178316|585654299|FG002|Overall Study|Withdrawal by Subject|5|||
162164868|NCT04347161|585654300|FG000|Overall Study|Death|0|||
162164869|NCT04347161|585654301|FG001|Overall Study|Death|2|||
162164870|NCT04347161|585654300|FG000|Overall Study|Withdrawal by Subject|1|||
162164871|NCT04347161|585654301|FG001|Overall Study|Withdrawal by Subject|0|||
162164872|NCT04347161|585654300|FG000|Overall Study|Lost to Follow-up|0|||
162164873|NCT04347161|585654301|FG001|Overall Study|Lost to Follow-up|1|||
162164874|NCT04347161|585654300|FG000|Overall Study|No longer on study medication|1|||
162164875|NCT04347161|585654301|FG001|Overall Study|No longer on study medication|1|||
162164876|NCT04169373|585654302|FG000|Week 1 to Week 14|Adverse Event|1|||
162164877|NCT04169373|585654303|FG001|Week 1 to Week 14|Adverse Event|0|||
162164878|NCT04169373|585654304|FG002|Week 1 to Week 14|Adverse Event|1|||
161815756|NCT02679729|584368774|FG006|Overall Study|Lost to Follow-up|0|||
161815757|NCT02679729|584368775|FG007|Overall Study|Lost to Follow-up|0|||
161815758|NCT02679729|584368776|FG008|Overall Study|Lost to Follow-up|0|||
161815759|NCT02679729|584368768|FG000|Overall Study|Participant decision|0|||
161815760|NCT02679729|584368769|FG001|Overall Study|Participant decision|1|||
161815761|NCT02679729|584368770|FG002|Overall Study|Participant decision|0|||
161815762|NCT02679729|584368771|FG003|Overall Study|Participant decision|0|||
161815763|NCT02679729|584368772|FG004|Overall Study|Participant decision|0|||
161815764|NCT02679729|584368773|FG005|Overall Study|Participant decision|0|||
161815765|NCT02679729|584368774|FG006|Overall Study|Participant decision|1|||
161815766|NCT02679729|584368775|FG007|Overall Study|Participant decision|0|||
161815767|NCT02679729|584368776|FG008|Overall Study|Participant decision|0|||
161815768|NCT00748566|584368777|FG000|Overall Study|Adverse Event|49|||
161815769|NCT00748566|584368777|FG000|Overall Study|Death|1|||
161815770|NCT00748566|584368777|FG000|Overall Study|Lack of Efficacy|12|||
161815771|NCT00748566|584368777|FG000|Overall Study|Lost to Follow-up|1|||
161815772|NCT00748566|584368777|FG000|Overall Study|Protocol Violation|13|||
161815773|NCT00748566|584368777|FG000|Overall Study|Withdrawal by Subject|22|||
161815774|NCT00748566|584368777|FG000|Overall Study|Study terminated by sponsor|5|||
161815775|NCT00748566|584368777|FG000|Overall Study|Other|9|||
161815776|NCT00624286|584368780|FG000|Overall Study|Protocol Deviation|7|||
161815777|NCT00624286|584368781|FG001|Overall Study|Protocol Deviation|9|||
161815778|NCT00624286|584368780|FG000|Overall Study|Adverse Event|6|||
161815779|NCT00624286|584368781|FG001|Overall Study|Adverse Event|3|||
161815780|NCT00624286|584368780|FG000|Overall Study|Withdrawal by Subject|5|||
162164879|NCT04169373|585654305|FG003|Week 1 to Week 14|Adverse Event|2|||
162164880|NCT04169373|585654302|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
162164881|NCT04169373|585654303|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
162164882|NCT04169373|585654304|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
162164883|NCT04169373|585654305|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
162164884|NCT04169373|585654302|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
162164885|NCT04169373|585654303|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
162164886|NCT04169373|585654304|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
162164887|NCT04169373|585654305|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
162164888|NCT04169373|585654302|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
162164889|NCT04169373|585654303|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
162164890|NCT04169373|585654304|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
162164891|NCT04169373|585654305|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
162164892|NCT04169373|585654302|FG000|Week 1 to Week 14|Other|1|||
162164893|NCT04169373|585654303|FG001|Week 1 to Week 14|Other|3|||
162164894|NCT04169373|585654304|FG002|Week 1 to Week 14|Other|3|||
162164895|NCT04169373|585654305|FG003|Week 1 to Week 14|Other|5|||
162164896|NCT04169373|585654302|FG000|Week 14 to Week 52|Adverse Event|1|||
162164897|NCT04169373|585654303|FG001|Week 14 to Week 52|Adverse Event|0|||
162164898|NCT04169373|585654304|FG002|Week 14 to Week 52|Adverse Event|0|||
162164899|NCT04169373|585654305|FG003|Week 14 to Week 52|Adverse Event|1|||
162164900|NCT04169373|585654302|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
162164901|NCT04169373|585654303|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
162164902|NCT04169373|585654304|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
161815781|NCT00624286|584368781|FG001|Overall Study|Withdrawal by Subject|4|||
161815782|NCT00624286|584368780|FG000|Overall Study|Lost to Follow-up|3|||
161815783|NCT00624286|584368781|FG001|Overall Study|Lost to Follow-up|2|||
161815784|NCT00624286|584368780|FG000|Overall Study|Administrative problems|3|||
161815785|NCT00624286|584368781|FG001|Overall Study|Administrative problems|0|||
161815786|NCT00624286|584368780|FG000|Overall Study|Lack of Efficacy|1|||
161815787|NCT00624286|584368781|FG001|Overall Study|Lack of Efficacy|6|||
162164903|NCT04169373|585654305|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
162164904|NCT04169373|585654302|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
162164905|NCT04169373|585654303|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
162164906|NCT04169373|585654304|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
162164907|NCT04169373|585654305|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
162164908|NCT04169373|585654302|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
162164909|NCT04169373|585654303|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
162164910|NCT04169373|585654304|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
162164911|NCT04169373|585654305|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
162164912|NCT04169373|585654302|FG000|Week 14 to Week 52|Other|4|||
162164913|NCT04169373|585654303|FG001|Week 14 to Week 52|Other|5|||
162164914|NCT04169373|585654304|FG002|Week 14 to Week 52|Other|4|||
162164915|NCT04169373|585654305|FG003|Week 14 to Week 52|Other|5|||
162164916|NCT04169373|585654302|FG000|Week 14 to Week 52|Ongoing|0|||
162164917|NCT04169373|585654303|FG001|Week 14 to Week 52|Ongoing|1|||
162164918|NCT04169373|585654304|FG002|Week 14 to Week 52|Ongoing|0|||
162164919|NCT04169373|585654305|FG003|Week 14 to Week 52|Ongoing|0|||
162164920|NCT04610892|585654306|FG000|Overall Study|Adverse Event|1|||
162164921|NCT04610892|585654307|FG001|Overall Study|Adverse Event|0|||
162164922|NCT04610892|585654308|FG002|Overall Study|Adverse Event|0|||
162164923|NCT04610892|585654309|FG003|Overall Study|Adverse Event|1|||
162164924|NCT04610892|585654310|FG004|Overall Study|Adverse Event|3|||
162164925|NCT04610892|585654306|FG000|Overall Study|Death|0|||
162164926|NCT04610892|585654307|FG001|Overall Study|Death|1|||
162164927|NCT04610892|585654308|FG002|Overall Study|Death|0|||
162164928|NCT04610892|585654309|FG003|Overall Study|Death|1|||
162164929|NCT04610892|585654310|FG004|Overall Study|Death|0|||
162164930|NCT04610892|585654306|FG000|Overall Study|Withdrawal by Subject|3|||
162164931|NCT04610892|585654307|FG001|Overall Study|Withdrawal by Subject|2|||
162164932|NCT04610892|585654308|FG002|Overall Study|Withdrawal by Subject|0|||
162164933|NCT04610892|585654309|FG003|Overall Study|Withdrawal by Subject|6|||
162164934|NCT04610892|585654310|FG004|Overall Study|Withdrawal by Subject|6|||
162164935|NCT04610892|585654306|FG000|Overall Study|Subjects who did not receive treatment|1|||
162164936|NCT04610892|585654307|FG001|Overall Study|Subjects who did not receive treatment|0|||
162164937|NCT04610892|585654308|FG002|Overall Study|Subjects who did not receive treatment|0|||
162164938|NCT04610892|585654309|FG003|Overall Study|Subjects who did not receive treatment|0|||
162164939|NCT04610892|585654310|FG004|Overall Study|Subjects who did not receive treatment|2|||
162164940|NCT01413100|585654311|FG000|Overall Study|Withdrawal by Subject|1|||
162164941|NCT05369403|585654312|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
162164942|NCT05369403|585654313|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
162164943|NCT05369403|585654314|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
162164944|NCT05369403|585654312|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
162164945|NCT05369403|585654313|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
162164946|NCT05369403|585654314|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
162164947|NCT05369403|585654312|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
162164948|NCT05369403|585654313|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
162164949|NCT05369403|585654314|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
162164950|NCT05369403|585654312|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
162164951|NCT05369403|585654313|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
162164952|NCT05369403|585654314|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
162164953|NCT05369403|585654312|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
162164954|NCT05369403|585654313|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
162164955|NCT05369403|585654314|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
162164956|NCT05369403|585654312|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
162164957|NCT05369403|585654313|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
162164958|NCT05369403|585654314|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
162164959|NCT05369403|585654312|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
162164960|NCT05369403|585654313|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
162164961|NCT05369403|585654314|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
162164962|NCT05369403|585654312|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
162164963|NCT05369403|585654313|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
162164964|NCT05369403|585654314|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
162164965|NCT05369403|585654312|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
162164966|NCT05369403|585654313|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
162164967|NCT05369403|585654314|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
162164968|NCT05369403|585654312|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
162164969|NCT05369403|585654313|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
162164970|NCT05369403|585654314|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
162164971|NCT05369403|585654312|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
162164972|NCT05369403|585654313|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
162164973|NCT05369403|585654314|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
162164974|NCT03792256|585654315|FG000|Overall Study|Death|0|||
162164975|NCT03792256|585654316|FG001|Overall Study|Death|1|||
161921133|NCT01922011|584757162|FG000|Overall Study|Not Treated|1|||
161921134|NCT01922011|584757163|FG001|Overall Study|Not Treated|0|||
161921135|NCT01922011|584757162|FG000|Overall Study|Lack of willing home health agency|1|||
161921136|NCT01922011|584757163|FG001|Overall Study|Lack of willing home health agency|0|||
161921137|NCT01922011|584757162|FG000|Overall Study|Randomized in error|1|||
161921138|NCT01922011|584757163|FG001|Overall Study|Randomized in error|0|||
161921139|NCT01510756|584757164|FG000|Overall Study|Death|1|||
162164976|NCT03792256|585654315|FG000|Overall Study|Lack of Efficacy|0|||
162164977|NCT03792256|585654316|FG001|Overall Study|Lack of Efficacy|1|||
162164978|NCT03792256|585654315|FG000|Overall Study|Withdrawal by Subject|0|||
162164979|NCT03792256|585654316|FG001|Overall Study|Withdrawal by Subject|1|||
162164980|NCT04760678|585654319|FG000|Overall Study|Death|13|||
162164981|NCT04760678|585654319|FG000|Overall Study|Lost to Follow-up|48|||
162164982|NCT04760678|585654319|FG000|Overall Study|Withdrawal by Subject|1|||
162164983|NCT04562649|585654325|FG000|Overall Study|Withdrawal by Subject|11|||
162164984|NCT04562649|585654326|FG001|Overall Study|Withdrawal by Subject|8|||
162164985|NCT04562649|585654325|FG000|Overall Study|Lost to Follow-up|26|||
162164986|NCT04562649|585654326|FG001|Overall Study|Lost to Follow-up|20|||
162164987|NCT05368103|585654327|FG000|Overall Study|Withdrawal by Subject|4|||
162164988|NCT05368103|585654327|FG000|Overall Study|Lost to Follow-up|1|||
162164989|NCT05368103|585654327|FG000|Overall Study|Lack of Efficacy|3|||
162164990|NCT03675282|585654330|FG000|Overall Study|Lost to Follow-up|4|||
162164991|NCT03675282|585654331|FG001|Overall Study|Lost to Follow-up|8|||
162164992|NCT03675282|585654332|FG002|Overall Study|Lost to Follow-up|1|||
162164993|NCT03675282|585654333|FG003|Overall Study|Lost to Follow-up|0|||
162164994|NCT03675282|585654334|FG004|Overall Study|Lost to Follow-up|2|||
162164995|NCT03675282|585654335|FG005|Overall Study|Lost to Follow-up|7|||
162164996|NCT03675282|585654330|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
162164997|NCT03675282|585654331|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
162164998|NCT03675282|585654332|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
162164999|NCT03675282|585654333|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
162165000|NCT03675282|585654334|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
162165001|NCT03675282|585654335|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
162165002|NCT03675282|585654330|FG000|Overall Study|Physician Decision|1|||
162165003|NCT03675282|585654331|FG001|Overall Study|Physician Decision|0|||
162165004|NCT03675282|585654332|FG002|Overall Study|Physician Decision|0|||
162165005|NCT03675282|585654333|FG003|Overall Study|Physician Decision|0|||
162165006|NCT03675282|585654334|FG004|Overall Study|Physician Decision|0|||
162165007|NCT03675282|585654335|FG005|Overall Study|Physician Decision|0|||
162165008|NCT03232138|585654344|FG000|Overall Study|Physician Decision|1|||
162165009|NCT03232138|585654345|FG001|Overall Study|Physician Decision|0|||
162165010|NCT03232138|585654344|FG000|Overall Study|Adverse Event|2|||
162165011|NCT03232138|585654345|FG001|Overall Study|Adverse Event|0|||
162165012|NCT03232138|585654344|FG000|Overall Study|Withdrawal by Subject|1|||
162165013|NCT03232138|585654345|FG001|Overall Study|Withdrawal by Subject|2|||
162165014|NCT03853746|585654347|FG000|Overall Study|Withdrawal by Subject|1|||
162165015|NCT04359108|585654350|FG000|Overall Study|Withdrawal by Subject|1|||
162165016|NCT04359108|585654351|FG001|Overall Study|Withdrawal by Subject|0|||
162165017|NCT04359108|585654350|FG000|Overall Study|Unable or too feeble to walk independently|0|||
162165018|NCT04359108|585654351|FG001|Overall Study|Unable or too feeble to walk independently|2|||
162165019|NCT04359108|585654350|FG000|Overall Study|Argus II system stopped functioning|0|||
162165020|NCT04359108|585654351|FG001|Overall Study|Argus II system stopped functioning|1|||
162165021|NCT04359108|585654350|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
162165022|NCT04359108|585654351|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
162165023|NCT04176965|585654352|FG000|Overall Study|Death|1|||
162165024|NCT04176965|585654353|FG001|Overall Study|Death|2|||
162165025|NCT04176965|585654352|FG000|Overall Study|Lost to Follow-up|10|||
162165026|NCT04176965|585654353|FG001|Overall Study|Lost to Follow-up|2|||
162165027|NCT04176965|585654352|FG000|Overall Study|Withdrawal by Subject|6|||
162165028|NCT04176965|585654353|FG001|Overall Study|Withdrawal by Subject|1|||
162165029|NCT05434078|585654354|FG000|Overall Study|Lost to Follow-up|2|||
162165030|NCT05434078|585654355|FG001|Overall Study|Lost to Follow-up|1|||
162165031|NCT05434078|585654354|FG000|Overall Study|Withdrawal by Subject|1|||
161921140|NCT01510756|584757164|FG000|Overall Study|Lack of Efficacy|2|||
161921141|NCT01510756|584757164|FG000|Overall Study|Physician Decision|1|||
162165032|NCT05434078|585654355|FG001|Overall Study|Withdrawal by Subject|0|||
162165033|NCT03652688|585654356|FG000|Baseline|Withdrawal by Subject|0|||
162017167|NCT02004093|585117841|FG000|Overall Study|Protocol Violation|0|||
162165034|NCT03652688|585654357|FG001|Baseline|Withdrawal by Subject|3|||
162165035|NCT03652688|585654356|FG000|Follow-up|Lost to Follow-up|56|||
162165036|NCT03652688|585654357|FG001|Follow-up|Lost to Follow-up|54|||
162165037|NCT00554788|585654358|FG000|Overall Study|Adverse Event|0|||
162165038|NCT00554788|585654359|FG001|Overall Study|Adverse Event|1|||
162165039|NCT00554788|585654360|FG002|Overall Study|Adverse Event|2|||
161921142|NCT04398134|584757171|FG000|Overall Study|Adverse Event|0|||
161921143|NCT04398134|584757172|FG001|Overall Study|Adverse Event|0|||
162165040|NCT00554788|585654358|FG000|Overall Study|Lost to Follow-up|4|||
162165041|NCT00554788|585654359|FG001|Overall Study|Lost to Follow-up|3|||
162165042|NCT00554788|585654360|FG002|Overall Study|Lost to Follow-up|3|||
162165043|NCT00554788|585654358|FG000|Overall Study|Physician Decision|1|||
162165044|NCT00554788|585654359|FG001|Overall Study|Physician Decision|1|||
162165045|NCT00554788|585654360|FG002|Overall Study|Physician Decision|3|||
162165046|NCT00554788|585654358|FG000|Overall Study|Withdrawal by Subject|0|||
162165047|NCT00554788|585654359|FG001|Overall Study|Withdrawal by Subject|0|||
162165048|NCT00554788|585654360|FG002|Overall Study|Withdrawal by Subject|1|||
162165049|NCT00554788|585654358|FG000|Overall Study|Refusal of further protocol therapy|0|||
162165050|NCT00554788|585654359|FG001|Overall Study|Refusal of further protocol therapy|1|||
162165051|NCT00554788|585654360|FG002|Overall Study|Refusal of further protocol therapy|1|||
162165052|NCT00554788|585654358|FG000|Overall Study|Progressive disease|0|||
162165053|NCT00554788|585654359|FG001|Overall Study|Progressive disease|0|||
162165054|NCT00554788|585654360|FG002|Overall Study|Progressive disease|3|||
162165055|NCT00554788|585654358|FG000|Overall Study|Ineligible|2|||
162165056|NCT00554788|585654359|FG001|Overall Study|Ineligible|0|||
162165057|NCT00554788|585654360|FG002|Overall Study|Ineligible|1|||
162165058|NCT03197662|585654366|FG000|Overall Study|Withdrawn by family|0|||
162165059|NCT03197662|585654367|FG001|Overall Study|Withdrawn by family|2|||
162165060|NCT03721952|585654368|FG000|Overall Study|Lost to Follow-up|0|||
162165061|NCT03721952|585654369|FG001|Overall Study|Lost to Follow-up|0|||
162165062|NCT03721952|585654370|FG002|Overall Study|Lost to Follow-up|2|||
162165063|NCT03721952|585654371|FG003|Overall Study|Lost to Follow-up|0|||
162165064|NCT03721952|585654372|FG004|Overall Study|Lost to Follow-up|0|||
162165065|NCT03721952|585654368|FG000|Overall Study|Protocol Violation|0|||
162165066|NCT03721952|585654369|FG001|Overall Study|Protocol Violation|1|||
162165067|NCT03721952|585654370|FG002|Overall Study|Protocol Violation|0|||
162165068|NCT03721952|585654371|FG003|Overall Study|Protocol Violation|0|||
162165069|NCT03721952|585654372|FG004|Overall Study|Protocol Violation|0|||
162165070|NCT03721952|585654368|FG000|Overall Study|Withdrawal by Subject|1|||
162165071|NCT03721952|585654369|FG001|Overall Study|Withdrawal by Subject|0|||
162165072|NCT03721952|585654370|FG002|Overall Study|Withdrawal by Subject|40|||
162165073|NCT03721952|585654371|FG003|Overall Study|Withdrawal by Subject|28|||
162165074|NCT03721952|585654372|FG004|Overall Study|Withdrawal by Subject|0|||
162165075|NCT03364647|585654373|FG000|Overall Study|Withdrawal by Subject|3|||
162165076|NCT03364647|585654374|FG001|Overall Study|Withdrawal by Subject|1|||
162165077|NCT03476460|585654375|FG000|Overall Study|Withdrawal by Subject|3|||
162165078|NCT03476460|585654376|FG001|Overall Study|Withdrawal by Subject|2|||
162165079|NCT03476460|585654375|FG000|Overall Study|Non-compliance with treatment|3|||
162165080|NCT03476460|585654376|FG001|Overall Study|Non-compliance with treatment|0|||
162165081|NCT03476460|585654375|FG000|Overall Study|Missing laboratory tests|5|||
162165082|NCT03476460|585654376|FG001|Overall Study|Missing laboratory tests|5|||
162165083|NCT03476460|585654375|FG000|Overall Study|Adverse Event|0|||
162165084|NCT03476460|585654376|FG001|Overall Study|Adverse Event|1|||
162165085|NCT04624633|585654380|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
162165086|NCT04624633|585654381|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
162165087|NCT04624633|585654380|FG000|Overall Study|Death|1|||
162165088|NCT04624633|585654381|FG001|Overall Study|Death|0|||
162165089|NCT01902173|585654385|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
162165090|NCT01902173|585654386|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
162165091|NCT01902173|585654387|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
162165092|NCT01902173|585654388|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
162165093|NCT01902173|585654389|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
162165094|NCT01902173|585654390|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
162165095|NCT01902173|585654385|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
162165096|NCT01902173|585654386|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
162165097|NCT01902173|585654387|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
162165098|NCT01902173|585654388|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
162165099|NCT01902173|585654389|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
162165100|NCT01902173|585654390|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
162165101|NCT01902173|585654385|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
162165102|NCT01902173|585654386|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
162165103|NCT01902173|585654387|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
162165104|NCT01902173|585654388|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
162165105|NCT01902173|585654389|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
162165106|NCT01902173|585654390|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
162165107|NCT01902173|585654385|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
162165108|NCT01902173|585654386|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
162165109|NCT01902173|585654387|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
162165110|NCT01902173|585654388|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
162165111|NCT01902173|585654389|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
162165112|NCT01902173|585654390|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
162165113|NCT01902173|585654385|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
162165114|NCT01902173|585654386|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
162165115|NCT01902173|585654387|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
162165116|NCT01902173|585654388|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
162165117|NCT01902173|585654389|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
162165118|NCT01902173|585654390|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
162165119|NCT01902173|585654385|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
162165120|NCT01902173|585654386|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
162165121|NCT01902173|585654387|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
162165122|NCT01902173|585654388|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
162165123|NCT01902173|585654389|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
162165124|NCT01902173|585654390|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
162165125|NCT01902173|585654385|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
162165126|NCT01902173|585654386|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
162165127|NCT01902173|585654387|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
162165128|NCT01902173|585654388|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
162165129|NCT01902173|585654389|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
162165130|NCT01902173|585654390|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
162165131|NCT01902173|585654385|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
162165132|NCT01902173|585654386|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
162165133|NCT01902173|585654387|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
162165134|NCT01902173|585654388|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
162165135|NCT01902173|585654389|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
162165136|NCT01902173|585654390|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
162165137|NCT01902173|585654385|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
162165138|NCT01902173|585654386|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
162165139|NCT01902173|585654387|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
162165140|NCT01902173|585654388|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
162165141|NCT01902173|585654389|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
162165142|NCT01902173|585654390|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
162165143|NCT01902173|585654385|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
162165144|NCT01902173|585654386|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
162165145|NCT01902173|585654387|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
162165146|NCT01902173|585654388|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
162165147|NCT01902173|585654389|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
162165148|NCT01902173|585654390|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
162165149|NCT01902173|585654385|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
162165150|NCT01902173|585654386|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
162165151|NCT01902173|585654387|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
162165152|NCT01902173|585654388|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
162165153|NCT01902173|585654389|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
162165154|NCT01902173|585654390|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
162165155|NCT01902173|585654385|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
162165156|NCT01902173|585654386|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
162165157|NCT01902173|585654387|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
162165158|NCT01902173|585654388|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
162165159|NCT01902173|585654389|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
162165160|NCT01902173|585654390|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
162165161|NCT01902173|585654385|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
162165162|NCT01902173|585654386|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
162165163|NCT01902173|585654387|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
162165164|NCT01902173|585654388|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
162165165|NCT01902173|585654389|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
162165166|NCT01902173|585654390|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
162165167|NCT01902173|585654385|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
162165168|NCT01902173|585654386|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
162165169|NCT01902173|585654387|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
162165170|NCT01902173|585654388|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
162165171|NCT01902173|585654389|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
162165172|NCT01902173|585654390|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
162165173|NCT03640312|585654395|FG000|Overall Study|Lost to Follow-up|3|||
162165174|NCT03640312|585654396|FG001|Overall Study|Lost to Follow-up|6|||
162165175|NCT03536754|585654397|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
162165176|NCT03536754|585654398|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
162165177|NCT03536754|585654399|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
162165178|NCT03536754|585654400|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
162165179|NCT03536754|585654401|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
162165180|NCT03536754|585654397|FG000|Open Label Extension|Other|0|||
162165181|NCT03536754|585654398|FG001|Open Label Extension|Other|0|||
162165182|NCT03536754|585654399|FG002|Open Label Extension|Other|0|||
162165183|NCT03536754|585654400|FG003|Open Label Extension|Other|0|||
162165184|NCT03536754|585654401|FG004|Open Label Extension|Other|1|||
162165185|NCT03382652|585654404|FG000|Overall Study|Lost to Follow-up|6|||
162165186|NCT03382652|585654404|FG000|Overall Study|Death|4|||
162165187|NCT03382652|585654404|FG000|Overall Study|Revision|5|||
162165188|NCT03382652|585654404|FG000|Overall Study|Patient withdrew|3|||
162165189|NCT03382652|585654404|FG000|Overall Study|Other reasons|21|||
162165190|NCT05008835|585654408|FG000|Overall Study|Adverse Event|5|||
162165191|NCT05008835|585654409|FG001|Overall Study|Adverse Event|2|||
162165192|NCT05008835|585654410|FG002|Overall Study|Adverse Event|1|||
162165193|NCT05008835|585654408|FG000|Overall Study|Lack of Efficacy|0|||
162165194|NCT05008835|585654409|FG001|Overall Study|Lack of Efficacy|0|||
162165195|NCT05008835|585654410|FG002|Overall Study|Lack of Efficacy|1|||
162165196|NCT05008835|585654408|FG000|Overall Study|Study terminated by sponsor|0|||
162165197|NCT05008835|585654409|FG001|Overall Study|Study terminated by sponsor|0|||
162165198|NCT05008835|585654410|FG002|Overall Study|Study terminated by sponsor|1|||
162165199|NCT05008835|585654408|FG000|Overall Study|Not further specified|3|||
162165200|NCT05008835|585654409|FG001|Overall Study|Not further specified|2|||
162165201|NCT05008835|585654410|FG002|Overall Study|Not further specified|1|||
162165202|NCT04876118|585654411|FG000|Overall Study|Pregnancy|1|||
162165203|NCT04876118|585654411|FG000|Overall Study|Withdrawal by Subject|14|||
162165204|NCT05089734|585654412|FG000|Overall Study|Still on study|122|||
162165205|NCT05089734|585654413|FG001|Overall Study|Still on study|101|||
162165206|NCT05089734|585654412|FG000|Overall Study|Death|161|||
162165207|NCT05089734|585654413|FG001|Overall Study|Death|179|||
162165208|NCT05089734|585654412|FG000|Overall Study|Withdrew consent|11|||
162165209|NCT05089734|585654413|FG001|Overall Study|Withdrew consent|24|||
162165210|NCT05089734|585654412|FG000|Overall Study|Lost to Follow-up|5|||
162165211|NCT05089734|585654413|FG001|Overall Study|Lost to Follow-up|0|||
162165212|NCT04806594|585656367|FG000|Overall Study|Withdrawal by Subject|2|||
162165213|NCT04806594|585656367|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
162165214|NCT04390048|585656368|FG000|Overall Study|Withdrawal by Subject|1|||
162165215|NCT04390048|585656369|FG001|Overall Study|Withdrawal by Subject|3|||
162165216|NCT05215314|585656370|FG000|Overall Study|Lost to Follow-up|2|||
162165217|NCT05215314|585656371|FG001|Overall Study|Lost to Follow-up|2|||
162165218|NCT05215314|585656370|FG000|Overall Study|Withdrawal by Subject|2|||
162165219|NCT05215314|585656371|FG001|Overall Study|Withdrawal by Subject|0|||
162165220|NCT05215314|585656370|FG000|Overall Study|Physician Decision|1|||
162165221|NCT05215314|585656371|FG001|Overall Study|Physician Decision|0|||
162165222|NCT04179500|585656372|FG000|Treatment|Withdrawal by Subject|1|||
162165223|NCT04179500|585656372|FG000|Treatment|Adverse Event|2|||
162165224|NCT04179500|585656372|FG000|Treatment|pyrazinamide resistance|1|||
162165225|NCT03138512|585656373|FG000|Randomization|Participants withdrew consent|0|||
162165226|NCT03138512|585656374|FG001|Randomization|Participants withdrew consent|1|||
162165227|NCT03138512|585656375|FG002|Randomization|Participants withdrew consent|1|||
162165228|NCT03138512|585656376|FG003|Randomization|Participants withdrew consent|0|||
162165229|NCT03138512|585656377|FG004|Randomization|Participants withdrew consent|0|||
162165230|NCT03138512|585656373|FG000|Randomization|Participant no longer meets study criteria|0|||
162165231|NCT03138512|585656374|FG001|Randomization|Participant no longer meets study criteria|3|||
162165232|NCT03138512|585656375|FG002|Randomization|Participant no longer meets study criteria|1|||
162165233|NCT03138512|585656376|FG003|Randomization|Participant no longer meets study criteria|1|||
162165234|NCT03138512|585656377|FG004|Randomization|Participant no longer meets study criteria|3|||
162165235|NCT03138512|585656373|FG000|Randomization|Other reasons|1|||
162165236|NCT03138512|585656374|FG001|Randomization|Other reasons|0|||
162165237|NCT03138512|585656375|FG002|Randomization|Other reasons|0|||
162165238|NCT03138512|585656376|FG003|Randomization|Other reasons|0|||
162165239|NCT03138512|585656377|FG004|Randomization|Other reasons|0|||
162165240|NCT03138512|585656373|FG000|Treatment Part A|Disease recurrence|10|||
162165241|NCT03138512|585656374|FG001|Treatment Part A|Disease recurrence|20|||
162165242|NCT03138512|585656375|FG002|Treatment Part A|Disease recurrence|0|||
162165243|NCT03138512|585656376|FG003|Treatment Part A|Disease recurrence|0|||
162165244|NCT03138512|585656377|FG004|Treatment Part A|Disease recurrence|0|||
162165245|NCT03138512|585656373|FG000|Treatment Part A|Study Drug Toxicity|132|||
162165246|NCT03138512|585656374|FG001|Treatment Part A|Study Drug Toxicity|5|||
162165247|NCT03138512|585656375|FG002|Treatment Part A|Study Drug Toxicity|0|||
162165248|NCT03138512|585656376|FG003|Treatment Part A|Study Drug Toxicity|0|||
162165249|NCT03138512|585656377|FG004|Treatment Part A|Study Drug Toxicity|0|||
162165250|NCT03138512|585656373|FG000|Treatment Part A|Death|1|||
162165251|NCT03138512|585656374|FG001|Treatment Part A|Death|0|||
162165252|NCT03138512|585656375|FG002|Treatment Part A|Death|0|||
162165253|NCT03138512|585656376|FG003|Treatment Part A|Death|0|||
162165254|NCT03138512|585656377|FG004|Treatment Part A|Death|0|||
162165255|NCT03138512|585656373|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
162165256|NCT03138512|585656374|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
162165257|NCT03138512|585656375|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
162165258|NCT03138512|585656376|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
162165259|NCT03138512|585656377|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
162165260|NCT03138512|585656373|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
162165261|NCT03138512|585656374|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
162165262|NCT03138512|585656375|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
162165263|NCT03138512|585656376|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
162165264|NCT03138512|585656377|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
162165265|NCT03138512|585656373|FG000|Treatment Part A|Participant withdrew consent|2|||
161815788|NCT00624286|584368780|FG000|Overall Study|Not stated|0|||
162017168|NCT02004093|585117842|FG001|Overall Study|Protocol Violation|1|||
162165266|NCT03138512|585656374|FG001|Treatment Part A|Participant withdrew consent|4|||
162165267|NCT03138512|585656375|FG002|Treatment Part A|Participant withdrew consent|0|||
162165268|NCT03138512|585656376|FG003|Treatment Part A|Participant withdrew consent|0|||
162165269|NCT03138512|585656377|FG004|Treatment Part A|Participant withdrew consent|0|||
162165270|NCT03138512|585656373|FG000|Treatment Part A|Lost to Follow-up|0|||
162165271|NCT03138512|585656374|FG001|Treatment Part A|Lost to Follow-up|1|||
162165272|NCT03138512|585656375|FG002|Treatment Part A|Lost to Follow-up|0|||
162165273|NCT03138512|585656376|FG003|Treatment Part A|Lost to Follow-up|0|||
162165274|NCT03138512|585656377|FG004|Treatment Part A|Lost to Follow-up|0|||
162165275|NCT03138512|585656373|FG000|Treatment Part A|Poor/non-compliance|1|||
162165276|NCT03138512|585656374|FG001|Treatment Part A|Poor/non-compliance|0|||
162165277|NCT03138512|585656375|FG002|Treatment Part A|Poor/non-compliance|0|||
162165278|NCT03138512|585656376|FG003|Treatment Part A|Poor/non-compliance|0|||
162165279|NCT03138512|585656377|FG004|Treatment Part A|Poor/non-compliance|0|||
162165280|NCT03138512|585656373|FG000|Treatment Part A|Pregnancy|0|||
162165281|NCT03138512|585656374|FG001|Treatment Part A|Pregnancy|1|||
162165282|NCT03138512|585656375|FG002|Treatment Part A|Pregnancy|0|||
162165283|NCT03138512|585656376|FG003|Treatment Part A|Pregnancy|0|||
162165284|NCT03138512|585656377|FG004|Treatment Part A|Pregnancy|0|||
162165285|NCT03138512|585656373|FG000|Treatment Part A|Other reasons|11|||
162165286|NCT03138512|585656374|FG001|Treatment Part A|Other reasons|8|||
162165287|NCT03138512|585656375|FG002|Treatment Part A|Other reasons|0|||
162165288|NCT03138512|585656376|FG003|Treatment Part A|Other reasons|0|||
162165289|NCT03138512|585656377|FG004|Treatment Part A|Other reasons|0|||
162165290|NCT03138512|585656373|FG000|Treatment Part B|Disease recurrence|0|||
162165291|NCT03138512|585656374|FG001|Treatment Part B|Disease recurrence|0|||
162165292|NCT03138512|585656375|FG002|Treatment Part B|Disease recurrence|6|||
162165293|NCT03138512|585656376|FG003|Treatment Part B|Disease recurrence|12|||
162165294|NCT03138512|585656377|FG004|Treatment Part B|Disease recurrence|10|||
162165295|NCT03138512|585656373|FG000|Treatment Part B|Study drug toxicity|0|||
162165296|NCT03138512|585656374|FG001|Treatment Part B|Study drug toxicity|0|||
162165297|NCT03138512|585656375|FG002|Treatment Part B|Study drug toxicity|63|||
162165298|NCT03138512|585656376|FG003|Treatment Part B|Study drug toxicity|3|||
162165299|NCT03138512|585656377|FG004|Treatment Part B|Study drug toxicity|45|||
162165300|NCT03138512|585656373|FG000|Treatment Part B|Death|0|||
162165301|NCT03138512|585656374|FG001|Treatment Part B|Death|0|||
162165302|NCT03138512|585656375|FG002|Treatment Part B|Death|1|||
162165303|NCT03138512|585656376|FG003|Treatment Part B|Death|0|||
162165304|NCT03138512|585656377|FG004|Treatment Part B|Death|0|||
162165305|NCT03138512|585656373|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
162165306|NCT03138512|585656374|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
162165307|NCT03138512|585656375|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
162165308|NCT03138512|585656376|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
162165309|NCT03138512|585656377|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
162165310|NCT03138512|585656373|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
162165311|NCT03138512|585656374|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
162165312|NCT03138512|585656375|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
161815789|NCT00624286|584368781|FG001|Overall Study|Not stated|1|||
161815790|NCT00624286|584368780|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161815791|NCT00624286|584368781|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161815792|NCT00624286|584368780|FG000|Overall Study|Death|0|||
161815793|NCT00624286|584368781|FG001|Overall Study|Death|1|||
161815794|NCT01442376|584368786|FG000|Overall Study|Adverse Event|0|||
161815795|NCT01442376|584368787|FG001|Overall Study|Adverse Event|3|||
162165313|NCT03138512|585656376|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
162165314|NCT03138512|585656377|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
162165315|NCT03138512|585656373|FG000|Treatment Part B|Participant withdrew consent|0|||
162165316|NCT03138512|585656374|FG001|Treatment Part B|Participant withdrew consent|0|||
162165317|NCT03138512|585656375|FG002|Treatment Part B|Participant withdrew consent|1|||
162165318|NCT03138512|585656376|FG003|Treatment Part B|Participant withdrew consent|1|||
162165319|NCT03138512|585656377|FG004|Treatment Part B|Participant withdrew consent|2|||
162165320|NCT03138512|585656373|FG000|Treatment Part B|Lost to Follow-up|0|||
162165321|NCT03138512|585656374|FG001|Treatment Part B|Lost to Follow-up|0|||
162165322|NCT03138512|585656375|FG002|Treatment Part B|Lost to Follow-up|0|||
162165323|NCT03138512|585656376|FG003|Treatment Part B|Lost to Follow-up|1|||
162165324|NCT03138512|585656377|FG004|Treatment Part B|Lost to Follow-up|0|||
162165325|NCT03138512|585656373|FG000|Treatment Part B|Poor/non-compliance|0|||
162165326|NCT03138512|585656374|FG001|Treatment Part B|Poor/non-compliance|0|||
162165327|NCT03138512|585656375|FG002|Treatment Part B|Poor/non-compliance|1|||
162165328|NCT03138512|585656376|FG003|Treatment Part B|Poor/non-compliance|1|||
162165329|NCT03138512|585656377|FG004|Treatment Part B|Poor/non-compliance|1|||
162165330|NCT03138512|585656373|FG000|Treatment Part B|Other reasons|0|||
162165331|NCT03138512|585656374|FG001|Treatment Part B|Other reasons|0|||
162165332|NCT03138512|585656375|FG002|Treatment Part B|Other reasons|3|||
162165333|NCT03138512|585656376|FG003|Treatment Part B|Other reasons|1|||
162165334|NCT03138512|585656377|FG004|Treatment Part B|Other reasons|5|||
162165335|NCT03792555|585656384|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
162165336|NCT03792555|585656385|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
162165337|NCT03792555|585656386|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
162165338|NCT03792555|585656384|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
162165339|NCT03792555|585656385|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
162165340|NCT03792555|585656386|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
162165341|NCT03792555|585656384|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
162165342|NCT03792555|585656385|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
162165343|NCT03792555|585656386|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
162165344|NCT03535272|585656393|FG000|Overall Study|Lost to Follow-up|71|||
162165345|NCT03535272|585656394|FG001|Overall Study|Lost to Follow-up|73|||
162165346|NCT02120456|585656396|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162165347|NCT02120456|585656397|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162165348|NCT02120456|585656398|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162165349|NCT02120456|585656399|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162165350|NCT02120456|585656400|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162165351|NCT02120456|585656401|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162165352|NCT02120456|585656402|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
162165353|NCT02120456|585656403|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162165354|NCT02120456|585656404|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
162165355|NCT02120456|585656396|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162165356|NCT02120456|585656397|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161815796|NCT01442376|584368788|FG002|Overall Study|Adverse Event|2|||
161815797|NCT01442376|584368786|FG000|Overall Study|Death|0|||
161815798|NCT01442376|584368787|FG001|Overall Study|Death|1|||
162165357|NCT02120456|585656398|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162165358|NCT02120456|585656399|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162165359|NCT02120456|585656400|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162165360|NCT02120456|585656401|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162165361|NCT02120456|585656402|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
162165362|NCT02120456|585656403|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162165363|NCT02120456|585656404|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
162165364|NCT02120456|585656396|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162165365|NCT02120456|585656397|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162165366|NCT02120456|585656398|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161921144|NCT04398134|584757173|FG002|Overall Study|Adverse Event|1|||
161815799|NCT01442376|584368788|FG002|Overall Study|Death|1|||
161815800|NCT01442376|584368786|FG000|Overall Study|Withdrawal of consent|0|||
161921145|NCT04398134|584757174|FG003|Overall Study|Adverse Event|0|||
162165367|NCT02120456|585656399|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162165368|NCT02120456|585656400|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162165369|NCT02120456|585656401|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162165370|NCT02120456|585656402|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162165371|NCT02120456|585656403|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
162165372|NCT02120456|585656404|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
162165373|NCT05192200|585656405|FG000|Treatment Period|Other|1|||
162165374|NCT05192200|585656405|FG000|Treatment Period|Lack of Efficacy|1|||
162165375|NCT05192200|585656405|FG000|Treatment Period|Withdrawal by Subject|1|||
162165376|NCT05192200|585656405|FG000|Follow-up|Withdrawal by Subject|1|||
162165377|NCT03443323|585656410|FG000|Overall Study|Lost to Follow-up|2|||
162165378|NCT03443323|585656411|FG001|Overall Study|Lost to Follow-up|2|||
162165379|NCT03443323|585656410|FG000|Overall Study|PI withdrawal|1|||
161815801|NCT01442376|584368787|FG001|Overall Study|Withdrawal of consent|0|||
161815802|NCT01442376|584368788|FG002|Overall Study|Withdrawal of consent|1|||
161815803|NCT01442376|584368786|FG000|Overall Study|Patients not treated|2|||
161815804|NCT01442376|584368787|FG001|Overall Study|Patients not treated|3|||
162165380|NCT03443323|585656411|FG001|Overall Study|PI withdrawal|0|||
161815805|NCT01442376|584368788|FG002|Overall Study|Patients not treated|1|||
162165381|NCT04492007|585656415|FG000|Overall Study|Lost to Follow-up|1|||
162165382|NCT04492007|585656416|FG001|Overall Study|Lost to Follow-up|1|||
162165383|NCT04492007|585656417|FG002|Overall Study|Lost to Follow-up|2|||
162165384|NCT04492007|585656418|FG003|Overall Study|Lost to Follow-up|2|||
162165385|NCT04492007|585656415|FG000|Overall Study|Protocol Violation|1|||
162165386|NCT04492007|585656416|FG001|Overall Study|Protocol Violation|1|||
162165387|NCT04492007|585656417|FG002|Overall Study|Protocol Violation|1|||
161815806|NCT01442376|584368786|FG000|Overall Study|Not eligible for subsequent cycles|1|||
161815807|NCT01442376|584368787|FG001|Overall Study|Not eligible for subsequent cycles|2|||
162165388|NCT04492007|585656418|FG003|Overall Study|Protocol Violation|1|||
162165389|NCT04492007|585656415|FG000|Overall Study|Withdrawal by Subject|0|||
162165390|NCT04492007|585656416|FG001|Overall Study|Withdrawal by Subject|0|||
162165391|NCT04492007|585656417|FG002|Overall Study|Withdrawal by Subject|1|||
162165392|NCT04492007|585656418|FG003|Overall Study|Withdrawal by Subject|1|||
162165393|NCT03770273|585656421|FG000|Overall Study|Adverse Event|2|||
162165394|NCT03770273|585656422|FG001|Overall Study|Adverse Event|0|||
162165395|NCT03770273|585656421|FG000|Overall Study|Lost to Follow-up|1|||
162165396|NCT03770273|585656422|FG001|Overall Study|Lost to Follow-up|1|||
162165397|NCT00418886|585656423|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
162165398|NCT00418886|585656424|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
162165399|NCT00418886|585656423|FG000|Randomized Period|Death|122|||
162165400|NCT00418886|585656424|FG001|Randomized Period|Death|147|||
162165401|NCT00418886|585656423|FG000|Randomized Period|Withdrawal by Subject|9|||
162165402|NCT00418886|585656424|FG001|Randomized Period|Withdrawal by Subject|10|||
162165403|NCT00418886|585656423|FG000|Randomized Period|Lost to Follow-up|4|||
162165404|NCT00418886|585656424|FG001|Randomized Period|Lost to Follow-up|6|||
162165405|NCT00418886|585656423|FG000|Randomized Period|withdrawn due to other reason|1|||
162165406|NCT00418886|585656424|FG001|Randomized Period|withdrawn due to other reason|0|||
162165407|NCT00418886|585656423|FG000|Randomized Period|randomised but no treatment received|0|||
162165408|NCT00418886|585656424|FG001|Randomized Period|randomised but no treatment received|1|||
162165409|NCT01999075|585656425|FG000|Overall Study|Lost to Follow-up|0|||
162165410|NCT01999075|585656426|FG001|Overall Study|Lost to Follow-up|2|||
162165411|NCT01999075|585656425|FG000|Overall Study|Withdrawal by Subject|2|||
162165412|NCT01999075|585656426|FG001|Overall Study|Withdrawal by Subject|7|||
162165413|NCT01999075|585656425|FG000|Overall Study|Enrolled in drug trial|3|||
162165414|NCT01999075|585656426|FG001|Overall Study|Enrolled in drug trial|1|||
162165415|NCT01999075|585656425|FG000|Overall Study|Became ineligible|0|||
162165416|NCT01999075|585656426|FG001|Overall Study|Became ineligible|2|||
162165417|NCT03907397|585656429|FG000|Overall Study|Lost to Follow-up|0|||
162165418|NCT03907397|585656430|FG001|Overall Study|Lost to Follow-up|1|||
162165419|NCT03907397|585656429|FG000|Overall Study|Physician Decision|2|||
162165420|NCT03907397|585656430|FG001|Overall Study|Physician Decision|1|||
162165421|NCT03907397|585656429|FG000|Overall Study|Withdrawal by Subject|5|||
162165422|NCT03907397|585656430|FG001|Overall Study|Withdrawal by Subject|4|||
162165423|NCT03907397|585656429|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
162165424|NCT03907397|585656430|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
162165425|NCT05948670|585656438|FG000|Overall Study|Protocol Violation|6|||
162165426|NCT05948670|585656439|FG001|Overall Study|Protocol Violation|8|||
162165427|NCT05948670|585656438|FG000|Overall Study|Withdrawal by Subject|0|||
162165428|NCT05948670|585656439|FG001|Overall Study|Withdrawal by Subject|1|||
162165429|NCT03056040|585656441|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
161815808|NCT01442376|584368788|FG002|Overall Study|Not eligible for subsequent cycles|0|||
162017169|NCT02004093|585117841|FG000|Overall Study|Lost to Follow-up|0|||
162165430|NCT03056040|585656442|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
162165431|NCT03056040|585656441|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
162165432|NCT03056040|585656442|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
162165433|NCT03056040|585656441|FG000|Primary Evaluation Period|Pregnancy|0|||
162165434|NCT03056040|585656442|FG001|Primary Evaluation Period|Pregnancy|1|||
162165435|NCT03056040|585656441|FG000|Primary Evaluation Period|Randomized, not treated|1|||
162165436|NCT03056040|585656442|FG001|Primary Evaluation Period|Randomized, not treated|1|||
162165437|NCT03056040|585656441|FG000|Extension Period|Physician Decision|3|||
162165438|NCT03056040|585656442|FG001|Extension Period|Physician Decision|3|||
162165439|NCT03056040|585656441|FG000|Extension Period|Lost to Follow-up|0|||
162165440|NCT03056040|585656442|FG001|Extension Period|Lost to Follow-up|1|||
162165441|NCT03056040|585656441|FG000|Extension Period|Death|0|||
162165442|NCT03056040|585656442|FG001|Extension Period|Death|3|||
162165443|NCT03056040|585656441|FG000|Extension Period|Withdrawal by Subject|1|||
162165444|NCT03056040|585656442|FG001|Extension Period|Withdrawal by Subject|0|||
162165445|NCT04142788|585656443|FG000|Overall Study|Trial terminated prematurely|2|||
162165446|NCT04142788|585656444|FG001|Overall Study|Trial terminated prematurely|2|||
162165447|NCT05028634|585656448|FG000|Overall Study|Withdrawal by Subject|0|||
162165448|NCT05028634|585656449|FG001|Overall Study|Withdrawal by Subject|1|||
162165449|NCT01997840|585656450|FG000|Overall Study|Lost to Follow-up|0|||
162165450|NCT01997840|585656451|FG001|Overall Study|Lost to Follow-up|0|||
162165451|NCT01997840|585656452|FG002|Overall Study|Lost to Follow-up|1|||
162165452|NCT01997840|585656453|FG003|Overall Study|Lost to Follow-up|0|||
162165453|NCT01997840|585656450|FG000|Overall Study|Withdrawal by participant|0|||
162165454|NCT01997840|585656451|FG001|Overall Study|Withdrawal by participant|0|||
162165455|NCT01997840|585656452|FG002|Overall Study|Withdrawal by participant|8|||
162165456|NCT01997840|585656453|FG003|Overall Study|Withdrawal by participant|1|||
162165457|NCT01997840|585656450|FG000|Overall Study|Physician Decision|0|||
162165458|NCT01997840|585656451|FG001|Overall Study|Physician Decision|0|||
162165459|NCT01997840|585656452|FG002|Overall Study|Physician Decision|3|||
162165460|NCT01997840|585656453|FG003|Overall Study|Physician Decision|0|||
162165461|NCT01997840|585656450|FG000|Overall Study|Progressive disease|3|||
162165462|NCT01997840|585656451|FG001|Overall Study|Progressive disease|4|||
162165463|NCT01997840|585656452|FG002|Overall Study|Progressive disease|57|||
162165464|NCT01997840|585656453|FG003|Overall Study|Progressive disease|8|||
162165465|NCT01997840|585656450|FG000|Overall Study|Other reasons|0|||
162165466|NCT01997840|585656451|FG001|Overall Study|Other reasons|0|||
162165467|NCT01997840|585656452|FG002|Overall Study|Other reasons|1|||
162165468|NCT01997840|585656453|FG003|Overall Study|Other reasons|0|||
162165469|NCT01997840|585656450|FG000|Overall Study|Adverse Event|0|||
162165470|NCT01997840|585656451|FG001|Overall Study|Adverse Event|0|||
162165471|NCT01997840|585656452|FG002|Overall Study|Adverse Event|15|||
162165472|NCT01997840|585656453|FG003|Overall Study|Adverse Event|2|||
162165473|NCT03850678|585656454|FG000|Overall Study|Withdrawal by Subject|3|||
162165474|NCT03850678|585656455|FG001|Overall Study|Withdrawal by Subject|0|||
162165475|NCT03850678|585656454|FG000|Overall Study|Experimenter Error|1|||
162165476|NCT03850678|585656455|FG001|Overall Study|Experimenter Error|1|||
162165477|NCT03850678|585656454|FG000|Overall Study|Did Not Condition To Experiment|7|||
162165478|NCT03850678|585656455|FG001|Overall Study|Did Not Condition To Experiment|2|||
162165479|NCT05311384|585656466|FG000|Overall Study|Uncontrolled health conditions|2|||
162165480|NCT05311384|585656466|FG000|Overall Study|Withdrawal by Subject|1|||
162165481|NCT02724631|585656473|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
162165482|NCT05076708|585656474|FG000|Overall Study|Withdrawal by Subject|4|||
162165483|NCT05076708|585656474|FG000|Overall Study|Lost to study during switch phase|8|||
162165484|NCT02908477|585656475|FG000|Overall Study|Withdrawal by Subject|8|||
162165485|NCT02908477|585656476|FG001|Overall Study|Withdrawal by Subject|28|||
162165486|NCT05590403|585656479|FG000|Overall Study|Lost to Follow-up|13|||
162165487|NCT05590403|585656480|FG001|Overall Study|Lost to Follow-up|1|||
162165488|NCT05590403|585656481|FG002|Overall Study|Lost to Follow-up|7|||
162165489|NCT05590403|585656482|FG003|Overall Study|Lost to Follow-up|3|||
162165490|NCT05590403|585656483|FG004|Overall Study|Lost to Follow-up|4|||
162165491|NCT05590403|585656479|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
162165492|NCT05590403|585656480|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
162165493|NCT05590403|585656481|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
162165494|NCT05590403|585656482|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
162165495|NCT05590403|585656483|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
162165496|NCT05590403|585656479|FG000|Overall Study|Other|2|||
162165497|NCT05590403|585656480|FG001|Overall Study|Other|0|||
162165498|NCT05590403|585656481|FG002|Overall Study|Other|2|||
162017170|NCT02004093|585117842|FG001|Overall Study|Lost to Follow-up|1|||
162165499|NCT05590403|585656482|FG003|Overall Study|Other|2|||
162165500|NCT05590403|585656483|FG004|Overall Study|Other|0|||
162165501|NCT05590403|585656479|FG000|Overall Study|Migrated / moved from the study area|1|||
162165502|NCT05590403|585656480|FG001|Overall Study|Migrated / moved from the study area|1|||
162165503|NCT05590403|585656481|FG002|Overall Study|Migrated / moved from the study area|0|||
162165504|NCT05590403|585656482|FG003|Overall Study|Migrated / moved from the study area|3|||
162165505|NCT05590403|585656483|FG004|Overall Study|Migrated / moved from the study area|1|||
162165506|NCT05590403|585656479|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
162165507|NCT05590403|585656480|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
162165508|NCT05590403|585656481|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
162165509|NCT05590403|585656482|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
162165510|NCT05590403|585656483|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
162165511|NCT04717492|585656486|FG000|Overall Study|Withdrawal by Subject|2|||
162165512|NCT04717492|585656487|FG001|Overall Study|Withdrawal by Subject|13|||
162165513|NCT04717492|585656486|FG000|Overall Study|Lost to Follow-up|2|||
162165514|NCT04717492|585656487|FG001|Overall Study|Lost to Follow-up|9|||
162165515|NCT03766009|585656491|FG000|Usual Care|Death|0|||
162165516|NCT03766009|585656492|FG001|Usual Care|Death|0|||
162165517|NCT03766009|585656493|FG002|Usual Care|Death|0|||
162165518|NCT03766009|585656494|FG003|Usual Care|Death|1|||
162165519|NCT03766009|585656495|FG004|Usual Care|Death|0|||
162165520|NCT03766009|585656496|FG005|Usual Care|Death|0|||
162165521|NCT03766009|585656491|FG000|Usual Care|Lost to Follow-up|0|||
162165522|NCT03766009|585656492|FG001|Usual Care|Lost to Follow-up|0|||
162165523|NCT03766009|585656493|FG002|Usual Care|Lost to Follow-up|0|||
162165524|NCT03766009|585656494|FG003|Usual Care|Lost to Follow-up|1|||
162165525|NCT03766009|585656495|FG004|Usual Care|Lost to Follow-up|0|||
162165526|NCT03766009|585656496|FG005|Usual Care|Lost to Follow-up|0|||
162165527|NCT03766009|585656491|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
162165528|NCT03766009|585656492|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
162165529|NCT03766009|585656493|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
162165530|NCT03766009|585656494|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
162165531|NCT03766009|585656495|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
162165532|NCT03766009|585656496|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
162165533|NCT03766009|585656491|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
162165534|NCT03766009|585656492|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
161815809|NCT04404725|584368789|FG000|First Intervention|Withdrawal by Subject|0|||
161815810|NCT04404725|584368790|FG001|First Intervention|Withdrawal by Subject|2|||
161815811|NCT04404725|584368789|FG000|Second Intervention|Adverse Event|1|||
161815812|NCT04404725|584368790|FG001|Second Intervention|Adverse Event|1|||
161815813|NCT04404725|584368789|FG000|Second Intervention|Withdrawal by Subject|0|||
162165535|NCT03766009|585656493|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
162165536|NCT03766009|585656494|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
162165537|NCT03766009|585656495|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
162165538|NCT03766009|585656496|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
162165539|NCT03766009|585656491|FG000|Usual Care|No treatment or declined surgery|0|||
162165540|NCT03766009|585656492|FG001|Usual Care|No treatment or declined surgery|0|||
162165541|NCT03766009|585656493|FG002|Usual Care|No treatment or declined surgery|0|||
162165542|NCT03766009|585656494|FG003|Usual Care|No treatment or declined surgery|2|||
162165543|NCT03766009|585656495|FG004|Usual Care|No treatment or declined surgery|0|||
162165544|NCT03766009|585656496|FG005|Usual Care|No treatment or declined surgery|0|||
162165545|NCT03766009|585656491|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
162165546|NCT03766009|585656492|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
162165547|NCT03766009|585656493|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
162165548|NCT03766009|585656494|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
162165549|NCT03766009|585656495|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
162165550|NCT03766009|585656496|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
162165551|NCT03766009|585656491|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
162165552|NCT03766009|585656492|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
162165553|NCT03766009|585656493|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
162165554|NCT03766009|585656494|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
162165555|NCT03766009|585656495|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
162165556|NCT03766009|585656496|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
162165557|NCT03766009|585656491|FG000|Usual Care|Ineligible|0|||
162165558|NCT03766009|585656492|FG001|Usual Care|Ineligible|1|||
162165559|NCT03766009|585656493|FG002|Usual Care|Ineligible|0|||
162165560|NCT03766009|585656494|FG003|Usual Care|Ineligible|0|||
162165561|NCT03766009|585656495|FG004|Usual Care|Ineligible|0|||
162165562|NCT03766009|585656496|FG005|Usual Care|Ineligible|0|||
162165563|NCT03766009|585656491|FG000|Usual Care|Other: Staff turnover|0|||
162165564|NCT03766009|585656492|FG001|Usual Care|Other: Staff turnover|0|||
162165565|NCT03766009|585656493|FG002|Usual Care|Other: Staff turnover|0|||
162165566|NCT03766009|585656494|FG003|Usual Care|Other: Staff turnover|0|||
162165567|NCT03766009|585656495|FG004|Usual Care|Other: Staff turnover|0|||
162165568|NCT03766009|585656496|FG005|Usual Care|Other: Staff turnover|2|||
162165569|NCT05071807|585656500|FG000|Overall Study|Withdrawal by Subject|4|||
162165570|NCT05071807|585656501|FG001|Overall Study|Withdrawal by Subject|0|||
162165571|NCT05071807|585656500|FG000|Overall Study|Unrelated medical issues|3|||
162165572|NCT05071807|585656501|FG001|Overall Study|Unrelated medical issues|0|||
162165573|NCT05071807|585656500|FG000|Overall Study|Relocated|0|||
162165574|NCT05071807|585656501|FG001|Overall Study|Relocated|1|||
162165575|NCT04952909|585656502|FG000|Overall Study|Death|3|||
162165576|NCT03150810|585656509|FG000|Overall Study|Death|4|||
162165577|NCT03150810|585656510|FG001|Overall Study|Death|8|||
162165578|NCT03150810|585656511|FG002|Overall Study|Death|7|||
162165579|NCT03150810|585656512|FG003|Overall Study|Death|2|||
162165580|NCT03150810|585656513|FG004|Overall Study|Death|2|||
162165581|NCT03150810|585656514|FG005|Overall Study|Death|10|||
162165582|NCT03150810|585656515|FG006|Overall Study|Death|8|||
162165583|NCT03150810|585656516|FG007|Overall Study|Death|6|||
162165584|NCT03150810|585656517|FG008|Overall Study|Death|18|||
162165585|NCT03150810|585656518|FG009|Overall Study|Death|3|||
162165586|NCT03150810|585656519|FG010|Overall Study|Death|19|||
162165587|NCT03150810|585656520|FG011|Overall Study|Death|1|||
162165588|NCT03150810|585656521|FG012|Overall Study|Death|19|||
162165589|NCT03150810|585656509|FG000|Overall Study|Withdrawal by Subject|0|||
162165590|NCT03150810|585656510|FG001|Overall Study|Withdrawal by Subject|1|||
162165591|NCT03150810|585656511|FG002|Overall Study|Withdrawal by Subject|1|||
162165592|NCT03150810|585656512|FG003|Overall Study|Withdrawal by Subject|1|||
162165593|NCT03150810|585656513|FG004|Overall Study|Withdrawal by Subject|0|||
162165594|NCT03150810|585656514|FG005|Overall Study|Withdrawal by Subject|0|||
162165595|NCT03150810|585656515|FG006|Overall Study|Withdrawal by Subject|2|||
162165596|NCT03150810|585656516|FG007|Overall Study|Withdrawal by Subject|0|||
162165597|NCT03150810|585656517|FG008|Overall Study|Withdrawal by Subject|2|||
162165598|NCT03150810|585656518|FG009|Overall Study|Withdrawal by Subject|0|||
162165599|NCT03150810|585656519|FG010|Overall Study|Withdrawal by Subject|1|||
162165600|NCT03150810|585656520|FG011|Overall Study|Withdrawal by Subject|0|||
162165601|NCT03150810|585656521|FG012|Overall Study|Withdrawal by Subject|1|||
162165602|NCT03150810|585656509|FG000|Overall Study|Sponsor Decision|0|||
162165603|NCT03150810|585656510|FG001|Overall Study|Sponsor Decision|2|||
162165604|NCT03150810|585656511|FG002|Overall Study|Sponsor Decision|0|||
162165605|NCT03150810|585656512|FG003|Overall Study|Sponsor Decision|0|||
161921146|NCT04398134|584757171|FG000|Overall Study|Withdrawal by Subject|2|||
161921147|NCT04398134|584757172|FG001|Overall Study|Withdrawal by Subject|0|||
161921148|NCT04398134|584757173|FG002|Overall Study|Withdrawal by Subject|0|||
161921149|NCT04398134|584757174|FG003|Overall Study|Withdrawal by Subject|1|||
161921150|NCT04398134|584757171|FG000|Overall Study|Study Terminated by Sponsor|30|||
161921151|NCT04398134|584757172|FG001|Overall Study|Study Terminated by Sponsor|11|||
161921152|NCT04398134|584757173|FG002|Overall Study|Study Terminated by Sponsor|32|||
161921153|NCT04398134|584757174|FG003|Overall Study|Study Terminated by Sponsor|11|||
161921154|NCT06420232|584757178|FG000|Overall Study|Withdrawal by Subject|3|||
161921155|NCT01697579|584757180|FG000|Base Study-Cycle 1|Adverse Event|1|||
161921156|NCT01697579|584757181|FG001|Base Study-Cycle 1|Adverse Event|0|||
161921157|NCT01697579|584757182|FG002|Base Study-Cycle 1|Adverse Event|0|||
161921158|NCT01697579|584757183|FG003|Base Study-Cycle 1|Adverse Event|0|||
161921159|NCT01697579|584757184|FG004|Base Study-Cycle 1|Adverse Event|0|||
161921160|NCT01697579|584757185|FG005|Base Study-Cycle 1|Adverse Event|0|||
161921161|NCT01697579|584757186|FG006|Base Study-Cycle 1|Adverse Event|0|||
161921162|NCT01697579|584757180|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
161921163|NCT01697579|584757181|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
162165606|NCT03150810|585656513|FG004|Overall Study|Sponsor Decision|1|||
162165607|NCT03150810|585656514|FG005|Overall Study|Sponsor Decision|1|||
162165608|NCT03150810|585656515|FG006|Overall Study|Sponsor Decision|0|||
162165609|NCT03150810|585656516|FG007|Overall Study|Sponsor Decision|0|||
162165610|NCT03150810|585656517|FG008|Overall Study|Sponsor Decision|1|||
162165611|NCT03150810|585656518|FG009|Overall Study|Sponsor Decision|0|||
162017171|NCT02004093|585117841|FG000|Overall Study|Withdrawal by Subject|3|||
162017172|NCT02004093|585117842|FG001|Overall Study|Withdrawal by Subject|7|||
162165612|NCT03150810|585656519|FG010|Overall Study|Sponsor Decision|0|||
162165613|NCT03150810|585656520|FG011|Overall Study|Sponsor Decision|0|||
162165614|NCT03150810|585656521|FG012|Overall Study|Sponsor Decision|5|||
162165615|NCT03150810|585656509|FG000|Overall Study|Lost to Follow-up|0|||
162165616|NCT03150810|585656510|FG001|Overall Study|Lost to Follow-up|1|||
162165617|NCT03150810|585656511|FG002|Overall Study|Lost to Follow-up|1|||
162165618|NCT03150810|585656512|FG003|Overall Study|Lost to Follow-up|0|||
162165619|NCT03150810|585656513|FG004|Overall Study|Lost to Follow-up|0|||
162165620|NCT03150810|585656514|FG005|Overall Study|Lost to Follow-up|0|||
162165621|NCT03150810|585656515|FG006|Overall Study|Lost to Follow-up|1|||
162165622|NCT03150810|585656516|FG007|Overall Study|Lost to Follow-up|0|||
162165623|NCT03150810|585656517|FG008|Overall Study|Lost to Follow-up|0|||
162165624|NCT03150810|585656518|FG009|Overall Study|Lost to Follow-up|0|||
162165625|NCT03150810|585656519|FG010|Overall Study|Lost to Follow-up|1|||
162165626|NCT03150810|585656520|FG011|Overall Study|Lost to Follow-up|0|||
162165627|NCT03150810|585656521|FG012|Overall Study|Lost to Follow-up|0|||
162165628|NCT03150810|585656509|FG000|Overall Study|Physician Decision|0|||
162165629|NCT03150810|585656510|FG001|Overall Study|Physician Decision|0|||
162165630|NCT03150810|585656511|FG002|Overall Study|Physician Decision|0|||
162165631|NCT03150810|585656512|FG003|Overall Study|Physician Decision|0|||
162165632|NCT03150810|585656513|FG004|Overall Study|Physician Decision|0|||
162165633|NCT03150810|585656514|FG005|Overall Study|Physician Decision|1|||
162165634|NCT03150810|585656515|FG006|Overall Study|Physician Decision|1|||
162165635|NCT03150810|585656516|FG007|Overall Study|Physician Decision|0|||
162165636|NCT03150810|585656517|FG008|Overall Study|Physician Decision|0|||
162165637|NCT03150810|585656518|FG009|Overall Study|Physician Decision|0|||
162165638|NCT03150810|585656519|FG010|Overall Study|Physician Decision|0|||
162165639|NCT03150810|585656520|FG011|Overall Study|Physician Decision|0|||
162165640|NCT03150810|585656521|FG012|Overall Study|Physician Decision|0|||
162165641|NCT03150810|585656509|FG000|Overall Study|Site withdrawal from study|0|||
162165642|NCT03150810|585656510|FG001|Overall Study|Site withdrawal from study|1|||
162165643|NCT03150810|585656511|FG002|Overall Study|Site withdrawal from study|0|||
162165644|NCT03150810|585656512|FG003|Overall Study|Site withdrawal from study|0|||
162165645|NCT03150810|585656513|FG004|Overall Study|Site withdrawal from study|0|||
162165646|NCT03150810|585656514|FG005|Overall Study|Site withdrawal from study|0|||
162165647|NCT03150810|585656515|FG006|Overall Study|Site withdrawal from study|0|||
162165648|NCT03150810|585656516|FG007|Overall Study|Site withdrawal from study|0|||
162165649|NCT03150810|585656517|FG008|Overall Study|Site withdrawal from study|0|||
162165650|NCT03150810|585656518|FG009|Overall Study|Site withdrawal from study|1|||
162165651|NCT03150810|585656519|FG010|Overall Study|Site withdrawal from study|1|||
162165652|NCT03150810|585656520|FG011|Overall Study|Site withdrawal from study|0|||
162165653|NCT03150810|585656521|FG012|Overall Study|Site withdrawal from study|0|||
162165654|NCT03150810|585656509|FG000|Overall Study|Hospice|0|||
162165655|NCT03150810|585656510|FG001|Overall Study|Hospice|0|||
162165656|NCT03150810|585656511|FG002|Overall Study|Hospice|0|||
162165657|NCT03150810|585656512|FG003|Overall Study|Hospice|0|||
162165658|NCT03150810|585656513|FG004|Overall Study|Hospice|0|||
162165659|NCT03150810|585656514|FG005|Overall Study|Hospice|1|||
162165660|NCT03150810|585656515|FG006|Overall Study|Hospice|0|||
162165661|NCT03150810|585656516|FG007|Overall Study|Hospice|0|||
162165662|NCT03150810|585656517|FG008|Overall Study|Hospice|0|||
162165663|NCT03150810|585656518|FG009|Overall Study|Hospice|0|||
162165664|NCT03150810|585656519|FG010|Overall Study|Hospice|0|||
162165665|NCT03150810|585656520|FG011|Overall Study|Hospice|0|||
162165666|NCT03150810|585656521|FG012|Overall Study|Hospice|0|||
162165667|NCT03150810|585656509|FG000|Overall Study|Participant relocated abroad.|0|||
162165668|NCT03150810|585656510|FG001|Overall Study|Participant relocated abroad.|0|||
162165669|NCT03150810|585656511|FG002|Overall Study|Participant relocated abroad.|0|||
162165670|NCT03150810|585656512|FG003|Overall Study|Participant relocated abroad.|0|||
162165671|NCT03150810|585656513|FG004|Overall Study|Participant relocated abroad.|0|||
162165672|NCT03150810|585656514|FG005|Overall Study|Participant relocated abroad.|1|||
162165673|NCT03150810|585656515|FG006|Overall Study|Participant relocated abroad.|0|||
162165674|NCT03150810|585656516|FG007|Overall Study|Participant relocated abroad.|0|||
162165675|NCT03150810|585656517|FG008|Overall Study|Participant relocated abroad.|0|||
162165676|NCT03150810|585656518|FG009|Overall Study|Participant relocated abroad.|0|||
162165677|NCT03150810|585656519|FG010|Overall Study|Participant relocated abroad.|0|||
162165678|NCT03150810|585656520|FG011|Overall Study|Participant relocated abroad.|0|||
162165679|NCT03150810|585656521|FG012|Overall Study|Participant relocated abroad.|0|||
162165680|NCT03150810|585656509|FG000|Overall Study|Transferred care to oncologist|0|||
162165681|NCT03150810|585656510|FG001|Overall Study|Transferred care to oncologist|0|||
162165682|NCT03150810|585656511|FG002|Overall Study|Transferred care to oncologist|0|||
162165683|NCT03150810|585656512|FG003|Overall Study|Transferred care to oncologist|0|||
162165684|NCT03150810|585656513|FG004|Overall Study|Transferred care to oncologist|0|||
162165685|NCT03150810|585656514|FG005|Overall Study|Transferred care to oncologist|0|||
162165686|NCT03150810|585656515|FG006|Overall Study|Transferred care to oncologist|2|||
162165687|NCT03150810|585656516|FG007|Overall Study|Transferred care to oncologist|0|||
162165688|NCT03150810|585656517|FG008|Overall Study|Transferred care to oncologist|0|||
161815814|NCT04404725|584368790|FG001|Second Intervention|Withdrawal by Subject|1|||
162165689|NCT03150810|585656518|FG009|Overall Study|Transferred care to oncologist|0|||
162165690|NCT03150810|585656519|FG010|Overall Study|Transferred care to oncologist|0|||
162165691|NCT03150810|585656520|FG011|Overall Study|Transferred care to oncologist|0|||
162165692|NCT03150810|585656521|FG012|Overall Study|Transferred care to oncologist|0|||
162165693|NCT04526704|585656522|FG000|Overall Study|Adverse Event|1|||
162165694|NCT04526704|585656523|FG001|Overall Study|Adverse Event|0|||
162165695|NCT04526704|585656522|FG000|Overall Study|Physician Decision|1|||
162165696|NCT04526704|585656523|FG001|Overall Study|Physician Decision|0|||
162165697|NCT04526704|585656522|FG000|Overall Study|Withdrawal by Subject|2|||
162165698|NCT04526704|585656523|FG001|Overall Study|Withdrawal by Subject|0|||
162165699|NCT00881621|585656524|FG000|Overall Study|Physician Decision|34|||
162165700|NCT06393088|585656528|FG000|Overall Study|Withdrawal by Subject|0|||
162165701|NCT06393088|585656529|FG001|Overall Study|Withdrawal by Subject|2|||
162165702|NCT03903146|585656530|FG000|Overall Study|Lost to Follow-up|6|||
162165703|NCT03903146|585656531|FG001|Overall Study|Lost to Follow-up|4|||
162165704|NCT03903146|585656530|FG000|Overall Study|Withdrawal by Subject|0|||
162165705|NCT03903146|585656531|FG001|Overall Study|Withdrawal by Subject|1|||
162165706|NCT05551637|585656532|FG000|Overall Study|Lack of Efficacy|0|||
162165707|NCT05551637|585656533|FG001|Overall Study|Lack of Efficacy|6|||
162165708|NCT05551637|585656532|FG000|Overall Study|Lost to Follow-up|1|||
162165709|NCT05551637|585656533|FG001|Overall Study|Lost to Follow-up|1|||
162165710|NCT05179837|585656536|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
162165711|NCT05179837|585656536|FG000|Overall Study|Device malfunctioned|1|||
162165712|NCT05179837|585656536|FG000|Overall Study|Image quality too low|2|||
162165713|NCT04782973|585656537|FG000|Overall Study|Withdrawal by Subject|5|||
162165714|NCT04782973|585656537|FG000|Overall Study|Protocol Violation|6|||
162165715|NCT04782973|585656537|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
162165716|NCT04924660|585656538|FG000|United States|Death|29|||
162165717|NCT04924660|585656539|FG001|United States|Death|32|||
162165718|NCT04924660|585656540|FG002|United States|Death|34|||
162165719|NCT04924660|585656541|FG003|United States|Death|25|||
162165720|NCT04924660|585656542|FG004|United States|Death|26|||
162165721|NCT04924660|585656543|FG005|United States|Death|23|||
162165722|NCT04924660|585656538|FG000|United States|Lost to Follow-up|15|||
162165723|NCT04924660|585656539|FG001|United States|Lost to Follow-up|10|||
162165724|NCT04924660|585656540|FG002|United States|Lost to Follow-up|13|||
162165725|NCT04924660|585656541|FG003|United States|Lost to Follow-up|5|||
162165726|NCT04924660|585656542|FG004|United States|Lost to Follow-up|19|||
162165727|NCT04924660|585656543|FG005|United States|Lost to Follow-up|20|||
162165728|NCT04924660|585656538|FG000|United States|Withdrawal by Subject|8|||
162165729|NCT04924660|585656539|FG001|United States|Withdrawal by Subject|3|||
162165730|NCT04924660|585656540|FG002|United States|Withdrawal by Subject|3|||
162165731|NCT04924660|585656541|FG003|United States|Withdrawal by Subject|3|||
162165732|NCT04924660|585656542|FG004|United States|Withdrawal by Subject|8|||
162165733|NCT04924660|585656543|FG005|United States|Withdrawal by Subject|4|||
162165734|NCT04924660|585656538|FG000|Spain|Death|0|||
162165735|NCT04924660|585656539|FG001|Spain|Death|0|||
162165736|NCT04924660|585656540|FG002|Spain|Death|0|||
162165737|NCT04924660|585656541|FG003|Spain|Death|0|||
162165738|NCT04924660|585656542|FG004|Spain|Death|0|||
162165739|NCT04924660|585656543|FG005|Spain|Death|2|||
162165740|NCT04924660|585656538|FG000|Spain|Lost to Follow-up|0|||
162165741|NCT04924660|585656539|FG001|Spain|Lost to Follow-up|0|||
162165742|NCT04924660|585656540|FG002|Spain|Lost to Follow-up|0|||
162165743|NCT04924660|585656541|FG003|Spain|Lost to Follow-up|0|||
162165744|NCT04924660|585656542|FG004|Spain|Lost to Follow-up|1|||
162165745|NCT04924660|585656543|FG005|Spain|Lost to Follow-up|0|||
162165746|NCT04924660|585656538|FG000|Brazil|Death|0|||
162165747|NCT04924660|585656539|FG001|Brazil|Death|0|||
162165748|NCT04924660|585656540|FG002|Brazil|Death|0|||
162165749|NCT04924660|585656541|FG003|Brazil|Death|0|||
162165750|NCT04924660|585656542|FG004|Brazil|Death|1|||
162165751|NCT04924660|585656543|FG005|Brazil|Death|0|||
162165752|NCT04924660|585656538|FG000|Italy|Lost to Follow-up|0|||
162165753|NCT04924660|585656539|FG001|Italy|Lost to Follow-up|0|||
162165754|NCT04924660|585656540|FG002|Italy|Lost to Follow-up|0|||
162165755|NCT04924660|585656541|FG003|Italy|Lost to Follow-up|0|||
162165756|NCT04924660|585656542|FG004|Italy|Lost to Follow-up|0|||
162165757|NCT04924660|585656543|FG005|Italy|Lost to Follow-up|1|||
162165758|NCT04924660|585656538|FG000|South Africa|Death|0|||
162165759|NCT04924660|585656539|FG001|South Africa|Death|0|||
162165760|NCT04924660|585656540|FG002|South Africa|Death|0|||
162165761|NCT04924660|585656541|FG003|South Africa|Death|0|||
162165762|NCT04924660|585656542|FG004|South Africa|Death|0|||
162165763|NCT04924660|585656543|FG005|South Africa|Death|1|||
162165764|NCT04924660|585656538|FG000|South Africa|Lost to Follow-up|0|||
162165765|NCT04924660|585656539|FG001|South Africa|Lost to Follow-up|0|||
162165766|NCT04924660|585656540|FG002|South Africa|Lost to Follow-up|0|||
162165767|NCT04924660|585656541|FG003|South Africa|Lost to Follow-up|0|||
162165768|NCT04924660|585656542|FG004|South Africa|Lost to Follow-up|0|||
162165769|NCT04924660|585656543|FG005|South Africa|Lost to Follow-up|1|||
162165770|NCT03557697|585656544|FG000|Overall Study|Withdrawal by Subject|2|||
162165771|NCT03557697|585656545|FG001|Overall Study|Withdrawal by Subject|4|||
162165772|NCT04495894|585656556|FG000|Overall Study|Withdrawal by Subject|2|||
162165773|NCT04495894|585656557|FG001|Overall Study|Withdrawal by Subject|0|||
162165774|NCT04495894|585656558|FG002|Overall Study|Withdrawal by Subject|2|||
162165775|NCT04495894|585656559|FG003|Overall Study|Withdrawal by Subject|3|||
162165776|NCT04495894|585656556|FG000|Overall Study|Early termination|0|||
162165777|NCT04495894|585656557|FG001|Overall Study|Early termination|0|||
162165778|NCT04495894|585656558|FG002|Overall Study|Early termination|3|||
162165779|NCT04495894|585656559|FG003|Overall Study|Early termination|0|||
162165780|NCT01000961|585656560|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
162165781|NCT01000961|585656561|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
162165782|NCT01000961|585656560|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
162165783|NCT01000961|585656561|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
162165784|NCT06283173|585658084|FG000|Overall Study|Did not show for first visit|10|||
162165785|NCT06283173|585658084|FG000|Overall Study|Lost to Follow-up|12|||
162165786|NCT06283173|585658084|FG000|Overall Study|Physician Decision|7|||
162165787|NCT03457142|585658087|FG000|Overall Study|Death|1|||
162165788|NCT04060654|585658088|FG000|Overall Study|Withdrawal by Subject|1|||
162165789|NCT04060654|585658088|FG000|Overall Study|Lost to Follow-up|5|||
162165790|NCT03707951|585658089|FG000|Overall Study|Lost to Follow-up|8|||
162165791|NCT03707951|585658090|FG001|Overall Study|Lost to Follow-up|17|||
162165792|NCT03707951|585658089|FG000|Overall Study|Withdrawal by Subject|6|||
162165793|NCT03707951|585658090|FG001|Overall Study|Withdrawal by Subject|6|||
162165794|NCT04887129|585658091|FG000|Overall Study|Lost to Follow-up|0|||
162165795|NCT04887129|585658092|FG001|Overall Study|Lost to Follow-up|24|||
162165796|NCT04887129|585658091|FG000|Overall Study|Withdrawal by Subject|9|||
162165797|NCT04887129|585658092|FG001|Overall Study|Withdrawal by Subject|57|||
162165798|NCT04887129|585658091|FG000|Overall Study|Other|2|||
162165799|NCT04887129|585658092|FG001|Overall Study|Other|9|||
162165800|NCT04533347|585658094|FG000|Overall Study|Adverse Event|1|||
162165801|NCT04533347|585658095|FG001|Overall Study|Adverse Event|2|||
162165802|NCT04533347|585658094|FG000|Overall Study|Lost to Follow-up|2|||
162165803|NCT04533347|585658095|FG001|Overall Study|Lost to Follow-up|0|||
162165804|NCT04533347|585658094|FG000|Overall Study|Withdrawal by Subject|1|||
162165805|NCT04533347|585658095|FG001|Overall Study|Withdrawal by Subject|0|||
162165806|NCT05520190|585658096|FG000|Overall Study|Lost to Follow-up|7|||
162165807|NCT05520190|585658096|FG000|Overall Study|Withdrawal by Subject|2|||
162165808|NCT04896476|585658102|FG000|Overall Study|Withdrawal by Subject|1|||
162165809|NCT04896476|585658102|FG000|Overall Study|Lost to Follow-up|2|||
162165810|NCT03476187|585658103|FG000|Overall Study|Protocol Violation|7|||
162165811|NCT03476187|585658103|FG000|Overall Study|Physician Decision|5|||
162165812|NCT02921230|585658104|FG000|Overall Study|Withdrawal by Subject|20|||
162165813|NCT02921230|585658105|FG001|Overall Study|Withdrawal by Subject|8|||
162165814|NCT02921230|585658104|FG000|Overall Study|Death|12|||
162165815|NCT02921230|585658105|FG001|Overall Study|Death|3|||
162165816|NCT02921230|585658104|FG000|Overall Study|Protocol Violation|17|||
162165817|NCT02921230|585658105|FG001|Overall Study|Protocol Violation|6|||
162165818|NCT02921230|585658104|FG000|Overall Study|Early completion|5|||
162165819|NCT02921230|585658105|FG001|Overall Study|Early completion|1|||
162165820|NCT02921230|585658104|FG000|Overall Study|Pending data entry|1|||
162165821|NCT02921230|585658105|FG001|Overall Study|Pending data entry|0|||
162165822|NCT04274764|585658106|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
162165823|NCT04274764|585658107|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
162165824|NCT05268393|585658112|FG000|Overall Study|Withdrawal by Subject|2|||
162165825|NCT05268393|585658113|FG001|Overall Study|Withdrawal by Subject|1|||
162165826|NCT03396926|585658114|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
162165827|NCT03396926|585658115|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
162165828|NCT02035787|585658116|FG000|Overall Study- 12 Months|Adverse Event|3|||
162165829|NCT02035787|585658117|FG001|Overall Study- 12 Months|Adverse Event|0|||
162165830|NCT02035787|585658116|FG000|Overall Study- 12 Months|Complete response|4|||
162165831|NCT02035787|585658117|FG001|Overall Study- 12 Months|Complete response|1|||
161921164|NCT01697579|584757182|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161921165|NCT01697579|584757183|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161921166|NCT01697579|584757184|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
162165832|NCT02035787|585658116|FG000|Overall Study- 12 Months|Protocol Violation|1|||
162165833|NCT02035787|585658117|FG001|Overall Study- 12 Months|Protocol Violation|1|||
162165834|NCT01396278|585658119|FG000|Overall Study|Adverse Event|0|||
162165835|NCT01396278|585658120|FG001|Overall Study|Adverse Event|0|||
162165836|NCT01396278|585658121|FG002|Overall Study|Adverse Event|0|||
162165837|NCT01396278|585658122|FG003|Overall Study|Adverse Event|2|||
162165838|NCT01396278|585658123|FG004|Overall Study|Adverse Event|0|||
162165839|NCT01396278|585658119|FG000|Overall Study|Withdraw due to trial termination|2|||
162165840|NCT01396278|585658120|FG001|Overall Study|Withdraw due to trial termination|1|||
162165841|NCT01396278|585658121|FG002|Overall Study|Withdraw due to trial termination|1|||
162165842|NCT01396278|585658122|FG003|Overall Study|Withdraw due to trial termination|0|||
162165843|NCT01396278|585658123|FG004|Overall Study|Withdraw due to trial termination|2|||
162165844|NCT00450658|585658124|FG000|Overall Study|Adverse Event|24|||
162165845|NCT00450658|585658125|FG001|Overall Study|Adverse Event|15|||
162165846|NCT00450658|585658124|FG000|Overall Study|Withdrawal by Subject|43|||
162165847|NCT00450658|585658125|FG001|Overall Study|Withdrawal by Subject|26|||
162165848|NCT00450658|585658124|FG000|Overall Study|Lost to Follow-up|22|||
162165849|NCT00450658|585658125|FG001|Overall Study|Lost to Follow-up|5|||
162165850|NCT00450658|585658124|FG000|Overall Study|UGI ulcer|33|||
162165851|NCT00450658|585658125|FG001|Overall Study|UGI ulcer|34|||
162165852|NCT00450658|585658124|FG000|Overall Study|misc|21|||
162165853|NCT00450658|585658125|FG001|Overall Study|misc|10|||
162165854|NCT04727554|585658127|FG000|Overall Study|Lost to Follow-up|0|||
162165855|NCT04727554|585658128|FG001|Overall Study|Lost to Follow-up|1|||
162165856|NCT04727554|585658127|FG000|Overall Study|Death|2|||
162165857|NCT04727554|585658128|FG001|Overall Study|Death|6|||
162165858|NCT04727554|585658127|FG000|Overall Study|Withdrawal by Subject|1|||
162165859|NCT04727554|585658128|FG001|Overall Study|Withdrawal by Subject|0|||
162165860|NCT05763823|585658129|FG000|Overall Study|Death|6|||
162165861|NCT05763823|585658129|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162165862|NCT05763823|585658129|FG000|Overall Study|Withdrawal by Subject|6|||
162165863|NCT00999804|585658132|FG000|Overall Study|Lack of Efficacy|9|||
162165864|NCT00999804|585658133|FG001|Overall Study|Lack of Efficacy|2|||
162165865|NCT00999804|585658132|FG000|Overall Study|Adverse Event|4|||
162165866|NCT00999804|585658133|FG001|Overall Study|Adverse Event|3|||
162165867|NCT00999804|585658132|FG000|Overall Study|Withdrawal by Subject|4|||
162165868|NCT00999804|585658133|FG001|Overall Study|Withdrawal by Subject|0|||
162165869|NCT00999804|585658132|FG000|Overall Study|Death|1|||
162165870|NCT00999804|585658133|FG001|Overall Study|Death|0|||
162165871|NCT00999804|585658132|FG000|Overall Study|Ineligible|3|||
162165872|NCT00999804|585658133|FG001|Overall Study|Ineligible|0|||
162165873|NCT02975882|585658142|FG000|Overall Study|Adverse Event|1|||
162165874|NCT02975882|585658143|FG001|Overall Study|Adverse Event|2|||
162165875|NCT02975882|585658144|FG002|Overall Study|Adverse Event|1|||
162165876|NCT02975882|585658145|FG003|Overall Study|Adverse Event|1|||
162165877|NCT02975882|585658142|FG000|Overall Study|Death|0|||
162165878|NCT02975882|585658143|FG001|Overall Study|Death|1|||
162165879|NCT02975882|585658144|FG002|Overall Study|Death|0|||
161815815|NCT01075516|584368791|FG000|Overall Study|Death|5|||
161815816|NCT01075516|584368792|FG001|Overall Study|Death|9|||
161815817|NCT01075516|584368791|FG000|Overall Study|Lost to Follow-up|10|||
161815818|NCT01075516|584368792|FG001|Overall Study|Lost to Follow-up|2|||
161815819|NCT01075516|584368791|FG000|Overall Study|Withdrawal by Subject|3|||
161815820|NCT01075516|584368792|FG001|Overall Study|Withdrawal by Subject|5|||
161815821|NCT02252016|584368793|FG000|Overall Study|Lost to Follow-up|2|||
161815822|NCT02252016|584368794|FG001|Overall Study|Lost to Follow-up|1|||
162165880|NCT02975882|585658145|FG003|Overall Study|Death|0|||
161815823|NCT02252016|584368793|FG000|Overall Study|Physician Decision|1|||
161815824|NCT02252016|584368794|FG001|Overall Study|Physician Decision|0|||
161815825|NCT02252016|584368793|FG000|Overall Study|Withdrawal by Subject|0|||
162165881|NCT02975882|585658142|FG000|Overall Study|Lack of Efficacy|3|||
162165882|NCT02975882|585658143|FG001|Overall Study|Lack of Efficacy|7|||
162165883|NCT02975882|585658144|FG002|Overall Study|Lack of Efficacy|4|||
162165884|NCT02975882|585658145|FG003|Overall Study|Lack of Efficacy|3|||
162165885|NCT02975882|585658142|FG000|Overall Study|Physician Decision|0|||
162165886|NCT02975882|585658143|FG001|Overall Study|Physician Decision|2|||
162165887|NCT02975882|585658144|FG002|Overall Study|Physician Decision|4|||
162165888|NCT02975882|585658145|FG003|Overall Study|Physician Decision|2|||
162165889|NCT02975882|585658142|FG000|Overall Study|Ineligible|0|||
162165890|NCT02975882|585658143|FG001|Overall Study|Ineligible|1|||
162165891|NCT02975882|585658144|FG002|Overall Study|Ineligible|0|||
162165892|NCT02975882|585658145|FG003|Overall Study|Ineligible|0|||
162165893|NCT05116787|585658146|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
162165894|NCT05116787|585658147|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
162165895|NCT05116787|585658146|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
162165896|NCT05116787|585658147|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
162165897|NCT05116787|585658146|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
162165898|NCT05116787|585658147|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
162165899|NCT05116787|585658146|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
162165900|NCT05116787|585658147|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
162165901|NCT02737436|585658148|FG000|Washout Period|Lost to Follow-up|5|||
162165902|NCT02737436|585658149|FG001|Washout Period|Lost to Follow-up|11|||
162165903|NCT02737436|585658148|FG000|Data Analysis|Scanning data problems|5|||
162165904|NCT02737436|585658149|FG001|Data Analysis|Scanning data problems|8|||
162165905|NCT03936322|585658150|FG000|Overall Study|Lost to Follow-up|1|||
162165906|NCT03936322|585658150|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
162165907|NCT02919683|585658152|FG000|Post-Surgery Follow-Up|Death|2|||
162165908|NCT02919683|585658153|FG001|Post-Surgery Follow-Up|Death|2|||
162165909|NCT02919683|585658152|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
162165910|NCT02919683|585658153|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
162165911|NCT01160211|585658154|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
162165912|NCT01160211|585658155|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
162165913|NCT01160211|585658156|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
162165914|NCT01160211|585658154|FG000|Overall Study|Lost to Follow-up|4|||
162165915|NCT01160211|585658155|FG001|Overall Study|Lost to Follow-up|8|||
162165916|NCT01160211|585658156|FG002|Overall Study|Lost to Follow-up|4|||
162165917|NCT01160211|585658154|FG000|Overall Study|Physician Decision|1|||
162165918|NCT01160211|585658155|FG001|Overall Study|Physician Decision|0|||
162165919|NCT01160211|585658156|FG002|Overall Study|Physician Decision|0|||
162165920|NCT01160211|585658154|FG000|Overall Study|Withdrawal by Subject|4|||
162165921|NCT01160211|585658155|FG001|Overall Study|Withdrawal by Subject|2|||
162165922|NCT01160211|585658156|FG002|Overall Study|Withdrawal by Subject|2|||
162165923|NCT01160211|585658154|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
162165924|NCT01160211|585658155|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
162165925|NCT01160211|585658156|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
162165926|NCT02734290|585658157|FG000|Overall Study|Adverse Event|1|||
162165927|NCT02734290|585658158|FG001|Overall Study|Adverse Event|0|||
162165928|NCT02734290|585658157|FG000|Overall Study|Death|1|||
162165929|NCT02734290|585658158|FG001|Overall Study|Death|0|||
162165930|NCT03829410|585658160|FG000|Overall Study|Adverse Event|1|||
162165931|NCT03829410|585658161|FG001|Overall Study|Adverse Event|0|||
162165932|NCT03829410|585658162|FG002|Overall Study|Adverse Event|1|||
162165933|NCT03829410|585658163|FG003|Overall Study|Adverse Event|4|||
162165934|NCT03829410|585658160|FG000|Overall Study|Physician Decision|0|||
162165935|NCT03829410|585658161|FG001|Overall Study|Physician Decision|0|||
162165936|NCT03829410|585658162|FG002|Overall Study|Physician Decision|0|||
161921167|NCT01697579|584757185|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161921168|NCT01697579|584757186|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161921169|NCT01697579|584757180|FG000|Base Study-Cycle 1|Protocol Violation|0|||
161921170|NCT01697579|584757181|FG001|Base Study-Cycle 1|Protocol Violation|0|||
162165937|NCT03829410|585658163|FG003|Overall Study|Physician Decision|2|||
162165938|NCT03829410|585658160|FG000|Overall Study|Disease Progressing|3|||
162165939|NCT03829410|585658161|FG001|Overall Study|Disease Progressing|4|||
162165940|NCT03829410|585658162|FG002|Overall Study|Disease Progressing|2|||
162165941|NCT03829410|585658163|FG003|Overall Study|Disease Progressing|31|||
162165942|NCT03829410|585658160|FG000|Overall Study|Miscellaneous|2|||
162165943|NCT03829410|585658161|FG001|Overall Study|Miscellaneous|4|||
162165944|NCT03829410|585658162|FG002|Overall Study|Miscellaneous|3|||
162165945|NCT03829410|585658163|FG003|Overall Study|Miscellaneous|10|||
162165946|NCT03158129|585658164|FG000|Overall Study|Adverse Event|0|||
162165947|NCT03158129|585658165|FG001|Overall Study|Adverse Event|1|||
161921171|NCT01697579|584757182|FG002|Base Study-Cycle 1|Protocol Violation|0|||
161921172|NCT01697579|584757183|FG003|Base Study-Cycle 1|Protocol Violation|0|||
162165948|NCT03158129|585658166|FG002|Overall Study|Adverse Event|0|||
162165949|NCT03158129|585658167|FG003|Overall Study|Adverse Event|0|||
162165950|NCT03158129|585658164|FG000|Overall Study|Death|0|||
162165951|NCT03158129|585658165|FG001|Overall Study|Death|0|||
162165952|NCT03158129|585658166|FG002|Overall Study|Death|0|||
162165953|NCT03158129|585658167|FG003|Overall Study|Death|1|||
162165954|NCT03158129|585658164|FG000|Overall Study|High surgical risk|1|||
162165955|NCT03158129|585658165|FG001|Overall Study|High surgical risk|1|||
162165956|NCT03158129|585658166|FG002|Overall Study|High surgical risk|0|||
162165957|NCT03158129|585658167|FG003|Overall Study|High surgical risk|0|||
162165958|NCT03158129|585658164|FG000|Overall Study|Progression|1|||
162165959|NCT03158129|585658165|FG001|Overall Study|Progression|1|||
162165960|NCT03158129|585658166|FG002|Overall Study|Progression|0|||
162165961|NCT03158129|585658167|FG003|Overall Study|Progression|0|||
162165962|NCT03158129|585658164|FG000|Overall Study|Lack of resectability|0|||
162165963|NCT03158129|585658165|FG001|Overall Study|Lack of resectability|1|||
162165964|NCT03158129|585658166|FG002|Overall Study|Lack of resectability|0|||
162165965|NCT03158129|585658167|FG003|Overall Study|Lack of resectability|0|||
162165966|NCT03158129|585658164|FG000|Overall Study|Declined surgery|0|||
162165967|NCT03158129|585658165|FG001|Overall Study|Declined surgery|1|||
162165968|NCT03158129|585658166|FG002|Overall Study|Declined surgery|0|||
162165969|NCT03158129|585658167|FG003|Overall Study|Declined surgery|0|||
162165970|NCT03158129|585658164|FG000|Overall Study|No longer surgical candidate|0|||
162165971|NCT03158129|585658165|FG001|Overall Study|No longer surgical candidate|0|||
162165972|NCT03158129|585658166|FG002|Overall Study|No longer surgical candidate|0|||
162165973|NCT03158129|585658167|FG003|Overall Study|No longer surgical candidate|1|||
162165974|NCT05051124|585658168|FG000|Overall Study|Lost to Follow-up|2|||
162165975|NCT05051124|585658168|FG000|Overall Study|Withdrawal by Subject|1|||
162165976|NCT05051124|585658168|FG000|Overall Study|Residential relocation|2|||
162165977|NCT05051124|585658168|FG000|Overall Study|Death|1|||
162165978|NCT02105766|585658173|FG000|Overall Study|Physician Decision|1|||
162165979|NCT02105766|585658174|FG001|Overall Study|Physician Decision|1|||
162165980|NCT02105766|585658175|FG002|Overall Study|Physician Decision|0|||
162165981|NCT02105766|585658173|FG000|Overall Study|Lost to Follow-up|2|||
162165982|NCT02105766|585658174|FG001|Overall Study|Lost to Follow-up|0|||
162165983|NCT02105766|585658175|FG002|Overall Study|Lost to Follow-up|0|||
162165984|NCT02105766|585658173|FG000|Overall Study|Death|1|||
162165985|NCT02105766|585658174|FG001|Overall Study|Death|1|||
162165986|NCT02105766|585658175|FG002|Overall Study|Death|0|||
162165987|NCT04676022|585658177|FG000|Overall Study|Screen Failure/|1|||
162165988|NCT04676022|585658178|FG001|Overall Study|Screen Failure/|1|||
162165989|NCT04676022|585658179|FG002|Overall Study|Screen Failure/|85|||
162165990|NCT04676022|585658177|FG000|Overall Study|Lost to Follow-up|1|||
162165991|NCT04676022|585658178|FG001|Overall Study|Lost to Follow-up|1|||
162165992|NCT04676022|585658179|FG002|Overall Study|Lost to Follow-up|0|||
162165993|NCT04676022|585658177|FG000|Overall Study|Adverse Event|2|||
162165994|NCT04676022|585658178|FG001|Overall Study|Adverse Event|0|||
162165995|NCT04676022|585658179|FG002|Overall Study|Adverse Event|1|||
162165996|NCT04676022|585658177|FG000|Overall Study|Physician Decision|2|||
162165997|NCT04676022|585658178|FG001|Overall Study|Physician Decision|0|||
162165998|NCT04676022|585658179|FG002|Overall Study|Physician Decision|1|||
162165999|NCT04676022|585658177|FG000|Overall Study|Withdrawal by Subject|3|||
162166000|NCT04676022|585658178|FG001|Overall Study|Withdrawal by Subject|1|||
162166001|NCT04676022|585658179|FG002|Overall Study|Withdrawal by Subject|6|||
162166002|NCT04676022|585658177|FG000|Overall Study|Will not move forward with permanent implant|6|||
162166003|NCT04676022|585658178|FG001|Overall Study|Will not move forward with permanent implant|0|||
162166004|NCT04676022|585658179|FG002|Overall Study|Will not move forward with permanent implant|0|||
162166005|NCT04676022|585658177|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
162166006|NCT04676022|585658178|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
162166007|NCT04676022|585658179|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
162166008|NCT05409183|585658191|FG000|Complete Study|Adverse Event|1|||
162166009|NCT05409183|585658192|FG001|Complete Study|Adverse Event|2|||
162166010|NCT05409183|585658191|FG000|Complete Study|Withdrawal by Subject|3|||
162166011|NCT05409183|585658192|FG001|Complete Study|Withdrawal by Subject|0|||
162166012|NCT02274662|585658193|FG000|Overall Study|Death|1|||
162166013|NCT02274662|585658193|FG000|Overall Study|Lost to Follow-up|3|||
162166014|NCT04806451|585658194|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
162166015|NCT04806451|585658195|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
162166016|NCT04806451|585658194|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
162166017|NCT04806451|585658195|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
162166018|NCT04806451|585658194|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
162166019|NCT04806451|585658195|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
162166020|NCT02936752|585658196|FG000|Overall Study|Death|2|||
162166021|NCT02936752|585658197|FG001|Overall Study|Death|1|||
162166022|NCT02936752|585658196|FG000|Overall Study|Physician Decision|4|||
162166023|NCT02936752|585658197|FG001|Overall Study|Physician Decision|0|||
162166024|NCT02936752|585658196|FG000|Overall Study|Withdrawal by Subject|0|||
162166025|NCT02936752|585658197|FG001|Overall Study|Withdrawal by Subject|2|||
162166026|NCT05746455|585658201|FG000|Overall Study|Discharged from Clinical Service|1|||
162166027|NCT05746455|585658201|FG000|Overall Study|Lost to Follow-up|1|||
162166028|NCT02023866|585658202|FG000|Overall Study|Non-compliance|2|||
162166029|NCT02023866|585658202|FG000|Overall Study|Adverse Event|3|||
162166030|NCT02023866|585658202|FG000|Overall Study|Withdrawal by Subject|1|||
162166031|NCT03307343|585658203|FG000|Overall Study|Withdrawal by Subject|1|||
162166032|NCT03307343|585658204|FG001|Overall Study|Withdrawal by Subject|2|||
162166033|NCT03307343|585658203|FG000|Overall Study|Pregnancy|0|||
162166034|NCT03307343|585658204|FG001|Overall Study|Pregnancy|2|||
162166035|NCT03307343|585658203|FG000|Overall Study|Physician Decision|1|||
162166036|NCT03307343|585658204|FG001|Overall Study|Physician Decision|0|||
162166037|NCT03307343|585658203|FG000|Overall Study|Lost to Follow-up|0|||
162166038|NCT03307343|585658204|FG001|Overall Study|Lost to Follow-up|2|||
162166039|NCT04683744|585658208|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
162166040|NCT04683744|585658209|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
162166041|NCT04683744|585658210|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
162166042|NCT05184192|585658213|FG000|Overall Study|Lost to Follow-up|4|||
162166043|NCT05184192|585658214|FG001|Overall Study|Lost to Follow-up|7|||
162166044|NCT05184192|585658213|FG000|Overall Study|Adverse Event|1|||
162166045|NCT05184192|585658214|FG001|Overall Study|Adverse Event|4|||
162017173|NCT02004093|585117841|FG000|Overall Study|Other|3|||
162166046|NCT05184192|585658213|FG000|Overall Study|PI withdrawal|1|||
162166047|NCT05184192|585658214|FG001|Overall Study|PI withdrawal|2|||
162166048|NCT05184192|585658213|FG000|Overall Study|Withdrew due to adverse effect|1|||
162166049|NCT05184192|585658214|FG001|Overall Study|Withdrew due to adverse effect|0|||
162166050|NCT05184192|585658213|FG000|Overall Study|Medication schedule|1|||
162166051|NCT05184192|585658214|FG001|Overall Study|Medication schedule|0|||
162166052|NCT05184192|585658213|FG000|Overall Study|Concern for adverse effects|0|||
162166053|NCT05184192|585658214|FG001|Overall Study|Concern for adverse effects|4|||
161815826|NCT02252016|584368794|FG001|Overall Study|Withdrawal by Subject|2|||
161815827|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
161815828|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
161815829|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
161815830|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
161815831|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
161815832|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815833|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815834|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815835|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815836|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815837|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815838|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815839|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815840|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815841|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815842|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815843|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815844|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815845|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815846|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
162166054|NCT04295798|585658217|FG000|Overall Study|Lost to Follow-up|1|||
161815847|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815848|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815849|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815850|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815851|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815852|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
161815853|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815854|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
161815855|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815856|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815857|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815858|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815859|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815860|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815861|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815862|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815863|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815864|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162166055|NCT01824394|585658225|FG000|Overall Study|Early Termination|1|||
162166056|NCT01824394|585658226|FG001|Overall Study|Early Termination|1|||
162166057|NCT01824394|585658227|FG002|Overall Study|Early Termination|3|||
162166058|NCT01824394|585658225|FG000|Overall Study|Withdrawn due to Study Termination|91|||
162166059|NCT01824394|585658226|FG001|Overall Study|Withdrawn due to Study Termination|83|||
162166060|NCT01824394|585658227|FG002|Overall Study|Withdrawn due to Study Termination|41|||
162166061|NCT01824394|585658225|FG000|Overall Study|Lost to Follow-up|0|||
162166062|NCT01824394|585658226|FG001|Overall Study|Lost to Follow-up|9|||
162166063|NCT01824394|585658227|FG002|Overall Study|Lost to Follow-up|3|||
162166064|NCT01824394|585658225|FG000|Overall Study|Death|3|||
162166065|NCT01824394|585658226|FG001|Overall Study|Death|2|||
162166066|NCT01824394|585658227|FG002|Overall Study|Death|4|||
162166067|NCT01824394|585658225|FG000|Overall Study|Discontinued Subjects|1|||
162166068|NCT01824394|585658226|FG001|Overall Study|Discontinued Subjects|1|||
162166069|NCT01824394|585658227|FG002|Overall Study|Discontinued Subjects|2|||
162166070|NCT01824394|585658225|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
162166071|NCT01824394|585658226|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
162166072|NCT01824394|585658227|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
162166073|NCT04015167|585658229|FG000|Overall Study|Lost to Follow-up|40|||
162166074|NCT04015167|585658229|FG000|Overall Study|Adverse Event|5|||
162166075|NCT04015167|585658229|FG000|Overall Study|Withdrawal by Subject|2|||
162166076|NCT04015167|585658229|FG000|Overall Study|Subject went to jail|1|||
162166077|NCT04810650|585658231|FG000|Overall Study|Disenrolled in error|0|||
161815865|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815866|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162166078|NCT04810650|585658232|FG001|Overall Study|Disenrolled in error|0|||
161815867|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815868|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815869|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815870|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815871|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815872|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
162166079|NCT04810650|585658233|FG002|Overall Study|Disenrolled in error|0|||
162166080|NCT04810650|585658234|FG003|Overall Study|Disenrolled in error|0|||
162166081|NCT04810650|585658235|FG004|Overall Study|Disenrolled in error|0|||
162166082|NCT04810650|585658236|FG005|Overall Study|Disenrolled in error|0|||
162166083|NCT04810650|585658237|FG006|Overall Study|Disenrolled in error|0|||
162166084|NCT04810650|585658238|FG007|Overall Study|Disenrolled in error|0|||
162166085|NCT04810650|585658239|FG008|Overall Study|Disenrolled in error|1|||
162166086|NCT04810650|585658240|FG009|Overall Study|Disenrolled in error|0|||
162166087|NCT04810650|585658241|FG010|Overall Study|Disenrolled in error|0|||
162166088|NCT04810650|585658242|FG011|Overall Study|Disenrolled in error|0|||
162166089|NCT04810650|585658243|FG012|Overall Study|Disenrolled in error|0|||
162166090|NCT04810650|585658244|FG013|Overall Study|Disenrolled in error|0|||
162166091|NCT04810650|585658231|FG000|Overall Study|Death|0|||
162166092|NCT04810650|585658232|FG001|Overall Study|Death|0|||
161815873|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815874|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815875|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815876|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815877|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161815878|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161921173|NCT01697579|584757184|FG004|Base Study-Cycle 1|Protocol Violation|3|||
162166093|NCT04810650|585658233|FG002|Overall Study|Death|0|||
162166094|NCT04810650|585658234|FG003|Overall Study|Death|0|||
162166095|NCT04810650|585658235|FG004|Overall Study|Death|0|||
162166096|NCT04810650|585658236|FG005|Overall Study|Death|0|||
161815879|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162166097|NCT04810650|585658237|FG006|Overall Study|Death|2|||
162166098|NCT04810650|585658238|FG007|Overall Study|Death|2|||
162166099|NCT04810650|585658239|FG008|Overall Study|Death|0|||
162166100|NCT04810650|585658240|FG009|Overall Study|Death|1|||
161815880|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
161815881|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815882|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162166101|NCT04810650|585658241|FG010|Overall Study|Death|0|||
162166102|NCT04810650|585658242|FG011|Overall Study|Death|0|||
162166103|NCT04810650|585658243|FG012|Overall Study|Death|2|||
162166104|NCT04810650|585658244|FG013|Overall Study|Death|1|||
162166105|NCT04810650|585658231|FG000|Overall Study|Moved/transferred care|0|||
162166106|NCT04810650|585658232|FG001|Overall Study|Moved/transferred care|0|||
162166107|NCT04810650|585658233|FG002|Overall Study|Moved/transferred care|0|||
162166108|NCT04810650|585658234|FG003|Overall Study|Moved/transferred care|0|||
162166109|NCT04810650|585658235|FG004|Overall Study|Moved/transferred care|0|||
162166110|NCT04810650|585658236|FG005|Overall Study|Moved/transferred care|0|||
162166111|NCT04810650|585658237|FG006|Overall Study|Moved/transferred care|0|||
162166112|NCT04810650|585658238|FG007|Overall Study|Moved/transferred care|1|||
162166113|NCT04810650|585658239|FG008|Overall Study|Moved/transferred care|12|||
161815883|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815884|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815885|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815886|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815887|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815888|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815889|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162166114|NCT04810650|585658240|FG009|Overall Study|Moved/transferred care|10|||
162166115|NCT04810650|585658241|FG010|Overall Study|Moved/transferred care|0|||
162166116|NCT04810650|585658242|FG011|Overall Study|Moved/transferred care|0|||
162166117|NCT04810650|585658243|FG012|Overall Study|Moved/transferred care|0|||
162166118|NCT04810650|585658244|FG013|Overall Study|Moved/transferred care|0|||
162166119|NCT04810650|585658231|FG000|Overall Study|Lost to Follow-up|15|||
161815890|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162166120|NCT04810650|585658232|FG001|Overall Study|Lost to Follow-up|12|||
162166121|NCT04810650|585658233|FG002|Overall Study|Lost to Follow-up|7|||
162166122|NCT04810650|585658234|FG003|Overall Study|Lost to Follow-up|9|||
162166123|NCT04810650|585658235|FG004|Overall Study|Lost to Follow-up|10|||
162166124|NCT04810650|585658236|FG005|Overall Study|Lost to Follow-up|6|||
162166125|NCT04810650|585658237|FG006|Overall Study|Lost to Follow-up|0|||
162166126|NCT04810650|585658238|FG007|Overall Study|Lost to Follow-up|0|||
162166127|NCT04810650|585658239|FG008|Overall Study|Lost to Follow-up|0|||
162166128|NCT04810650|585658240|FG009|Overall Study|Lost to Follow-up|0|||
162166129|NCT04810650|585658241|FG010|Overall Study|Lost to Follow-up|1|||
162166130|NCT04810650|585658242|FG011|Overall Study|Lost to Follow-up|0|||
162166131|NCT04810650|585658243|FG012|Overall Study|Lost to Follow-up|3|||
162166132|NCT04810650|585658244|FG013|Overall Study|Lost to Follow-up|9|||
162166133|NCT04810650|585658231|FG000|Overall Study|Participant declined|0|||
162166134|NCT04810650|585658232|FG001|Overall Study|Participant declined|0|||
162166135|NCT04810650|585658233|FG002|Overall Study|Participant declined|0|||
162166136|NCT04810650|585658234|FG003|Overall Study|Participant declined|0|||
162166137|NCT04810650|585658235|FG004|Overall Study|Participant declined|0|||
162166138|NCT04810650|585658236|FG005|Overall Study|Participant declined|0|||
162166139|NCT04810650|585658237|FG006|Overall Study|Participant declined|0|||
162166140|NCT04810650|585658238|FG007|Overall Study|Participant declined|0|||
162166141|NCT04810650|585658239|FG008|Overall Study|Participant declined|0|||
162166142|NCT04810650|585658240|FG009|Overall Study|Participant declined|0|||
162166143|NCT04810650|585658241|FG010|Overall Study|Participant declined|2|||
162166144|NCT04810650|585658242|FG011|Overall Study|Participant declined|0|||
162166145|NCT04810650|585658243|FG012|Overall Study|Participant declined|0|||
162166146|NCT04810650|585658244|FG013|Overall Study|Participant declined|0|||
162166147|NCT05794243|585658245|FG000|Overall Study|Withdrawal by Subject|1|||
162166148|NCT05794243|585658246|FG001|Overall Study|Withdrawal by Subject|0|||
162166149|NCT05794243|585658247|FG002|Overall Study|Withdrawal by Subject|1|||
162166150|NCT05794243|585658245|FG000|Overall Study|Physician Decision|0|||
162166151|NCT05794243|585658246|FG001|Overall Study|Physician Decision|3|||
162166152|NCT05794243|585658247|FG002|Overall Study|Physician Decision|1|||
162166153|NCT05609760|585658253|FG000|Overall Study|Lost to Follow-up|0|||
162166154|NCT05609760|585658254|FG001|Overall Study|Lost to Follow-up|1|||
162166155|NCT05609760|585658253|FG000|Overall Study|Withdrawal by Subject|1|||
162166156|NCT05609760|585658254|FG001|Overall Study|Withdrawal by Subject|0|||
162166157|NCT05179395|585658255|FG000|Overall Study|Lack of Efficacy|1|||
162166158|NCT05093829|585658257|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
162166159|NCT05093829|585658258|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
162166160|NCT05093829|585658259|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
162166161|NCT05093829|585658260|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
162166162|NCT05093829|585658261|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
162166163|NCT01785719|585659972|FG000|4-week Baseline Evaluation|Physician Decision|1|||
162166164|NCT01785719|585659973|FG001|4-week Baseline Evaluation|Physician Decision|0|||
162166165|NCT01785719|585659972|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
162166166|NCT01785719|585659973|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
162166167|NCT01785719|585659972|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
162166168|NCT01785719|585659973|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
162166169|NCT01785719|585659972|FG000|4-week Baseline Evaluation|Pregnancy|0|||
162166170|NCT01785719|585659973|FG001|4-week Baseline Evaluation|Pregnancy|2|||
162166171|NCT01785719|585659972|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
162166172|NCT01785719|585659973|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
162166173|NCT01785719|585659972|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
162166174|NCT01785719|585659973|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
162166175|NCT01785719|585659972|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
162166176|NCT01785719|585659973|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
162166177|NCT01785719|585659972|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
162166178|NCT01785719|585659973|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
161815891|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815892|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815893|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
162166179|NCT01785719|585659972|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
162017174|NCT02004093|585117842|FG001|Overall Study|Other|1|||
162166180|NCT01785719|585659973|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
162166181|NCT01785719|585659972|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
162166182|NCT01785719|585659973|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
162166183|NCT01785719|585659972|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
162017175|NCT04085289|585117843|FG000|Overall Study|Withdrawal by Subject|0|||
162166184|NCT01785719|585659973|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
162166185|NCT01785719|585659972|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
162166186|NCT01785719|585659973|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
162166187|NCT01785719|585659972|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
162166188|NCT01785719|585659973|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
162166189|NCT01785719|585659972|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
162166190|NCT01785719|585659973|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
162166191|NCT01785719|585659972|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
162166192|NCT01785719|585659973|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
162166193|NCT04977947|585659974|FG000|Overall Study|Lost to Follow-up|1|||
162166194|NCT04977947|585659975|FG001|Overall Study|Lost to Follow-up|1|||
162166195|NCT03445988|585659976|FG000|Overall Study|Lost to Follow-up|14|||
162166196|NCT03445988|585659977|FG001|Overall Study|Lost to Follow-up|26|||
162166197|NCT03445988|585659978|FG002|Overall Study|Lost to Follow-up|27|||
162166198|NCT03445988|585659979|FG003|Overall Study|Lost to Follow-up|66|||
162166199|NCT03445988|585659976|FG000|Overall Study|Withdrawal by Subject|7|||
162166200|NCT03445988|585659977|FG001|Overall Study|Withdrawal by Subject|4|||
162166201|NCT03445988|585659978|FG002|Overall Study|Withdrawal by Subject|3|||
162166202|NCT03445988|585659979|FG003|Overall Study|Withdrawal by Subject|5|||
162166203|NCT03445988|585659976|FG000|Overall Study|Death (unrelated to study)|5|||
162166204|NCT03445988|585659977|FG001|Overall Study|Death (unrelated to study)|1|||
162166205|NCT03445988|585659978|FG002|Overall Study|Death (unrelated to study)|2|||
162166206|NCT03445988|585659979|FG003|Overall Study|Death (unrelated to study)|4|||
162166207|NCT05875142|585659980|FG000|Overall Study|Lost to Follow-up|0|||
162166208|NCT05875142|585659981|FG001|Overall Study|Lost to Follow-up|1|||
162166209|NCT05875142|585659982|FG002|Overall Study|Lost to Follow-up|1|||
162166210|NCT03891667|585659985|FG000|Overall Study|Physician Decision|1|||
162166211|NCT03891667|585659986|FG001|Overall Study|Physician Decision|1|||
162166212|NCT03891667|585659985|FG000|Overall Study|COVID related pause|1|||
162166213|NCT03891667|585659986|FG001|Overall Study|COVID related pause|0|||
162166214|NCT03891667|585659985|FG000|Overall Study|Withdrawal by Subject|0|||
162166215|NCT03891667|585659986|FG001|Overall Study|Withdrawal by Subject|1|||
162166216|NCT03891667|585659985|FG000|Overall Study|Adverse Event|0|||
162166217|NCT03891667|585659986|FG001|Overall Study|Adverse Event|1|||
162166218|NCT05659537|585659987|FG000|Overall Study|Adverse Event|5|||
162166219|NCT05659537|585659987|FG000|Overall Study|Lost to Follow-up|4|||
162166220|NCT05659537|585659987|FG000|Overall Study|Withdrawal by Subject|13|||
162166221|NCT05659537|585659987|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
162166222|NCT05659537|585659987|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
162166223|NCT05659537|585659987|FG000|Overall Study|Participant was suffering from anaemia|1|||
162166224|NCT04971395|585659988|FG000|Overall Study|Withdrawal by Subject|0|||
162166225|NCT04971395|585659989|FG001|Overall Study|Withdrawal by Subject|1|||
162166226|NCT04971395|585659990|FG002|Overall Study|Withdrawal by Subject|0|||
162166227|NCT04456517|585659991|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
162166228|NCT04456517|585659992|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
162166229|NCT02924272|585659993|FG000|Overall Study|Site Terminated by Sponsor|4|||
162166230|NCT02924272|585659994|FG001|Overall Study|Site Terminated by Sponsor|1|||
162166231|NCT02924272|585659993|FG000|Overall Study|Withdrawal by Subject|2|||
162166232|NCT02924272|585659994|FG001|Overall Study|Withdrawal by Subject|0|||
162166233|NCT02924272|585659993|FG000|Overall Study|Adverse Event|3|||
162166234|NCT02924272|585659994|FG001|Overall Study|Adverse Event|0|||
162166235|NCT02924272|585659993|FG000|Overall Study|Progressive Disease|11|||
162166236|NCT02924272|585659994|FG001|Overall Study|Progressive Disease|8|||
162166237|NCT02924272|585659993|FG000|Overall Study|Clinical Deterioration|1|||
162166238|NCT02924272|585659994|FG001|Overall Study|Clinical Deterioration|0|||
162166239|NCT02924272|585659993|FG000|Overall Study|Death|1|||
162166240|NCT02924272|585659994|FG001|Overall Study|Death|0|||
162166241|NCT02924272|585659993|FG000|Overall Study|Reason Not Specified|1|||
162166242|NCT02924272|585659994|FG001|Overall Study|Reason Not Specified|0|||
162166243|NCT02100813|585659997|FG000|Overall Study|Adverse Event|0|||
162166244|NCT02100813|585659998|FG001|Overall Study|Adverse Event|0|||
162166245|NCT02100813|585659999|FG002|Overall Study|Adverse Event|0|||
162166246|NCT02100813|585660000|FG003|Overall Study|Adverse Event|0|||
162166247|NCT02100813|585660001|FG004|Overall Study|Adverse Event|0|||
162166248|NCT02100813|585660002|FG005|Overall Study|Adverse Event|0|||
162166249|NCT02100813|585660003|FG006|Overall Study|Adverse Event|0|||
162166250|NCT02100813|585660004|FG007|Overall Study|Adverse Event|1|||
162166251|NCT03575897|585660006|FG000|Overall Study|Lost to Follow-up|12|||
162166252|NCT03575897|585660007|FG001|Overall Study|Lost to Follow-up|13|||
162166253|NCT00506519|585660009|FG000|Overall Study|Death|4|||
162166254|NCT00506519|585660010|FG001|Overall Study|Death|6|||
162166255|NCT00506519|585660011|FG002|Overall Study|Death|0|||
162166256|NCT00506519|585660009|FG000|Overall Study|Adverse Event|1|||
162166257|NCT00506519|585660010|FG001|Overall Study|Adverse Event|0|||
162166258|NCT00506519|585660011|FG002|Overall Study|Adverse Event|0|||
162166259|NCT01186367|585660012|FG000|Overall Study|Lost to Follow-up|7|||
162166260|NCT01186367|585660013|FG001|Overall Study|Lost to Follow-up|4|||
162166261|NCT01186367|585660014|FG002|Overall Study|Lost to Follow-up|7|||
162166262|NCT01186367|585660012|FG000|Overall Study|Did not receive study treatment|0|||
162166263|NCT01186367|585660013|FG001|Overall Study|Did not receive study treatment|1|||
162166264|NCT01186367|585660014|FG002|Overall Study|Did not receive study treatment|0|||
162166265|NCT03867500|585660015|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
162166266|NCT06205407|585660016|FG000|Period 2|Withdrawal by Subject|0|||
162166267|NCT06205407|585660017|FG001|Period 2|Withdrawal by Subject|1|||
162166268|NCT06205407|585660016|FG000|Period 2|Adverse Event|2|||
162166269|NCT06205407|585660017|FG001|Period 2|Adverse Event|1|||
162166270|NCT06491433|585660018|FG000|Overall Study|Protocol Violation|51|||
162166271|NCT06491433|585660018|FG000|Overall Study|consent withdrawal|2|||
162166272|NCT06491433|585660018|FG000|Overall Study|screen failure|1|||
162166273|NCT04749615|585660019|FG000|Overall Study|Lost to Follow-up|6|||
162166274|NCT04749615|585660020|FG001|Overall Study|Lost to Follow-up|10|||
162166275|NCT03611491|585660021|FG000|Overall Study|Lost to Follow-up|1|||
161815894|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815895|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815896|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815897|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815898|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815899|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815900|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815901|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815902|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815903|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815904|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161815905|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
161815906|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815907|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
161815908|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
161815909|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
161815910|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815911|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815912|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815913|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162166276|NCT05894577|585660029|FG000|Overall Study|No receipt of study drug|14|||
162166277|NCT05894577|585660030|FG001|Overall Study|No receipt of study drug|13|||
162166278|NCT05894577|585660029|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
161815914|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815915|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162166279|NCT05894577|585660030|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
162166280|NCT05894577|585660029|FG000|Overall Study|Screen Fail|2|||
162166281|NCT05894577|585660030|FG001|Overall Study|Screen Fail|0|||
162166282|NCT05894577|585660029|FG000|Overall Study|Study drug recall|86|||
162166283|NCT05894577|585660030|FG001|Overall Study|Study drug recall|63|||
162166284|NCT05292365|585660035|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
162166285|NCT05292365|585660036|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
162166286|NCT05292365|585660037|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
162166287|NCT05292365|585660038|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
162166288|NCT05282173|585660039|FG000|Overall Study|Missed|3|||
162166289|NCT05282173|585660040|FG001|Overall Study|Missed|2|||
162166290|NCT05282173|585660041|FG002|Overall Study|Missed|4|||
162166291|NCT03134196|585660046|FG000|Overall Study|Death|2|||
162166292|NCT03134196|585660047|FG001|Overall Study|Death|1|||
162166293|NCT03134196|585660046|FG000|Overall Study|Lost to Follow-up|13|||
162166294|NCT03134196|585660047|FG001|Overall Study|Lost to Follow-up|15|||
162166295|NCT03134196|585660046|FG000|Overall Study|Physician Decision|0|||
162166296|NCT03134196|585660047|FG001|Overall Study|Physician Decision|1|||
162166297|NCT03134196|585660046|FG000|Overall Study|Withdrawal by Subject|19|||
162166298|NCT03134196|585660047|FG001|Overall Study|Withdrawal by Subject|12|||
162166299|NCT03134196|585660046|FG000|Overall Study|Site Unable to Contact Participant|2|||
161815916|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815917|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815918|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815919|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815920|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815921|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162166300|NCT03134196|585660047|FG001|Overall Study|Site Unable to Contact Participant|0|||
162166301|NCT03134196|585660046|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
162166302|NCT03134196|585660047|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
162166303|NCT03134196|585660046|FG000|Overall Study|Scheduling Conflict|1|||
162166304|NCT03134196|585660047|FG001|Overall Study|Scheduling Conflict|0|||
162166305|NCT04064164|585660054|FG000|Overall Study|Withdrawal by Subject|8|||
162166306|NCT04064164|585660055|FG001|Overall Study|Withdrawal by Subject|8|||
162166307|NCT01798498|585660066|FG000|Overall Study|Lost to Follow-up|1|||
162166308|NCT04592549|585660071|FG000|Overall Study|Withdrawal by Subject|0|||
162166309|NCT04592549|585660072|FG001|Overall Study|Withdrawal by Subject|1|||
162166310|NCT04592549|585660073|FG002|Overall Study|Withdrawal by Subject|0|||
162166311|NCT04592549|585660074|FG003|Overall Study|Withdrawal by Subject|1|||
162166312|NCT04592549|585660075|FG004|Overall Study|Withdrawal by Subject|1|||
162166313|NCT04592549|585660076|FG005|Overall Study|Withdrawal by Subject|0|||
162166314|NCT04592549|585660071|FG000|Overall Study|Lost to Follow-up|2|||
162166315|NCT04592549|585660072|FG001|Overall Study|Lost to Follow-up|0|||
162166316|NCT04592549|585660073|FG002|Overall Study|Lost to Follow-up|0|||
162166317|NCT04592549|585660074|FG003|Overall Study|Lost to Follow-up|1|||
162166318|NCT04592549|585660075|FG004|Overall Study|Lost to Follow-up|1|||
162166319|NCT04592549|585660076|FG005|Overall Study|Lost to Follow-up|1|||
162166320|NCT04091750|585660080|FG000|Overall Study|Adverse Event|4|||
162166321|NCT04091750|585660080|FG000|Overall Study|Withdrawal by Subject|1|||
162166322|NCT04625283|585660081|FG000|Overall Study|post randomization exclusion|28|||
162166323|NCT04625283|585660082|FG001|Overall Study|post randomization exclusion|20|||
162166324|NCT05364671|585660083|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
162166325|NCT05364671|585660084|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
162166326|NCT05364671|585660083|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
162166327|NCT05364671|585660084|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
162166328|NCT05364671|585660083|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
162166329|NCT05364671|585660084|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
162166330|NCT05364671|585660083|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
162166331|NCT05364671|585660084|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
162166332|NCT05364671|585660083|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
162166333|NCT05364671|585660084|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
162166334|NCT02761057|585660093|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
162166335|NCT02761057|585660094|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
162166336|NCT02761057|585660095|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
162166337|NCT02761057|585660096|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
162166338|NCT02761057|585660093|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
162166339|NCT02761057|585660094|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
162166340|NCT02761057|585660095|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
162166341|NCT02761057|585660096|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
162166342|NCT02761057|585660093|FG000|Overall Study|Currently On Study Treatment|0|||
162166343|NCT02761057|585660094|FG001|Overall Study|Currently On Study Treatment|3|||
162166344|NCT02761057|585660095|FG002|Overall Study|Currently On Study Treatment|0|||
162166345|NCT02761057|585660096|FG003|Overall Study|Currently On Study Treatment|0|||
162166346|NCT02761057|585660093|FG000|Overall Study|Adverse Event|11|||
162166347|NCT02761057|585660094|FG001|Overall Study|Adverse Event|9|||
162166348|NCT02761057|585660095|FG002|Overall Study|Adverse Event|5|||
162166349|NCT02761057|585660096|FG003|Overall Study|Adverse Event|3|||
162166350|NCT02761057|585660093|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
162166351|NCT02761057|585660094|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
162166352|NCT02761057|585660095|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
162166353|NCT02761057|585660096|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
162166354|NCT02761057|585660093|FG000|Overall Study|Progression/Relapse|29|||
162166355|NCT02761057|585660094|FG001|Overall Study|Progression/Relapse|27|||
162166356|NCT02761057|585660095|FG002|Overall Study|Progression/Relapse|20|||
162166357|NCT02761057|585660096|FG003|Overall Study|Progression/Relapse|23|||
162166358|NCT02761057|585660093|FG000|Overall Study|Death|2|||
162166359|NCT02761057|585660094|FG001|Overall Study|Death|2|||
162166360|NCT02761057|585660095|FG002|Overall Study|Death|1|||
162166361|NCT02761057|585660096|FG003|Overall Study|Death|1|||
162166362|NCT02761057|585660093|FG000|Overall Study|Other - Not Protocol Specified|2|||
162166363|NCT02761057|585660094|FG001|Overall Study|Other - Not Protocol Specified|1|||
162166364|NCT02761057|585660095|FG002|Overall Study|Other - Not Protocol Specified|2|||
162166365|NCT02761057|585660096|FG003|Overall Study|Other - Not Protocol Specified|0|||
162166366|NCT00686335|585660097|FG000|Run-in Period|Adverse Event|1|||
162166367|NCT00686335|585660097|FG000|Run-in Period|asthma exacerbation|1|||
162166368|NCT00686335|585660097|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
162166369|NCT04171999|585660100|FG000|Overall Study|deemed ineligible after randomization|2|||
162166370|NCT04171999|585660101|FG001|Overall Study|deemed ineligible after randomization|1|||
162166371|NCT04277442|585660108|FG000|Overall Study|Death|1|||
162166372|NCT04137289|585660109|FG000|Overall Study|Death|0|||
162166373|NCT04137289|585660110|FG001|Overall Study|Death|0|||
162166374|NCT04137289|585660111|FG002|Overall Study|Death|0|||
162166375|NCT04137289|585660112|FG003|Overall Study|Death|0|||
161921174|NCT01697579|584757185|FG005|Base Study-Cycle 1|Protocol Violation|0|||
161921175|NCT01697579|584757186|FG006|Base Study-Cycle 1|Protocol Violation|0|||
161921176|NCT01697579|584757180|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161921177|NCT01697579|584757181|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
162166376|NCT04137289|585660113|FG004|Overall Study|Death|0|||
162166377|NCT04137289|585660114|FG005|Overall Study|Death|0|||
162166378|NCT04137289|585660115|FG006|Overall Study|Death|1|||
162166379|NCT04137289|585660116|FG007|Overall Study|Death|0|||
162166380|NCT04137289|585660117|FG008|Overall Study|Death|0|||
162166381|NCT04137289|585660109|FG000|Overall Study|Clinical disease progression|0|||
162166382|NCT04137289|585660110|FG001|Overall Study|Clinical disease progression|0|||
162166383|NCT04137289|585660111|FG002|Overall Study|Clinical disease progression|0|||
162166384|NCT04137289|585660112|FG003|Overall Study|Clinical disease progression|4|||
162166385|NCT04137289|585660113|FG004|Overall Study|Clinical disease progression|4|||
162166386|NCT04137289|585660114|FG005|Overall Study|Clinical disease progression|2|||
162166387|NCT04137289|585660115|FG006|Overall Study|Clinical disease progression|5|||
162166388|NCT04137289|585660116|FG007|Overall Study|Clinical disease progression|1|||
162166389|NCT04137289|585660117|FG008|Overall Study|Clinical disease progression|0|||
162166390|NCT04137289|585660109|FG000|Overall Study|Lost to Follow-up|0|||
162166391|NCT04137289|585660110|FG001|Overall Study|Lost to Follow-up|0|||
162166392|NCT04137289|585660111|FG002|Overall Study|Lost to Follow-up|0|||
162166393|NCT04137289|585660112|FG003|Overall Study|Lost to Follow-up|1|||
162166394|NCT04137289|585660113|FG004|Overall Study|Lost to Follow-up|0|||
162166395|NCT04137289|585660114|FG005|Overall Study|Lost to Follow-up|0|||
162166396|NCT04137289|585660115|FG006|Overall Study|Lost to Follow-up|0|||
162166397|NCT04137289|585660116|FG007|Overall Study|Lost to Follow-up|0|||
162166398|NCT04137289|585660117|FG008|Overall Study|Lost to Follow-up|0|||
162166399|NCT04137289|585660109|FG000|Overall Study|Adverse Event|0|||
162166400|NCT04137289|585660110|FG001|Overall Study|Adverse Event|0|||
162166401|NCT04137289|585660111|FG002|Overall Study|Adverse Event|1|||
162166402|NCT04137289|585660112|FG003|Overall Study|Adverse Event|0|||
162166403|NCT04137289|585660113|FG004|Overall Study|Adverse Event|0|||
162166404|NCT04137289|585660114|FG005|Overall Study|Adverse Event|1|||
162166405|NCT04137289|585660115|FG006|Overall Study|Adverse Event|0|||
162166406|NCT04137289|585660116|FG007|Overall Study|Adverse Event|0|||
162166407|NCT04137289|585660117|FG008|Overall Study|Adverse Event|0|||
162166408|NCT04137289|585660109|FG000|Overall Study|Lack of clinical benefit|0|||
162166409|NCT04137289|585660110|FG001|Overall Study|Lack of clinical benefit|0|||
162166410|NCT04137289|585660111|FG002|Overall Study|Lack of clinical benefit|0|||
162166411|NCT04137289|585660112|FG003|Overall Study|Lack of clinical benefit|0|||
162166412|NCT04137289|585660113|FG004|Overall Study|Lack of clinical benefit|0|||
162166413|NCT04137289|585660114|FG005|Overall Study|Lack of clinical benefit|0|||
162166414|NCT04137289|585660115|FG006|Overall Study|Lack of clinical benefit|0|||
162166415|NCT04137289|585660116|FG007|Overall Study|Lack of clinical benefit|0|||
162166416|NCT04137289|585660117|FG008|Overall Study|Lack of clinical benefit|1|||
161815922|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162017176|NCT04085289|585117844|FG001|Overall Study|Withdrawal by Subject|0|||
162017177|NCT04085289|585117845|FG002|Overall Study|Withdrawal by Subject|1|||
162017178|NCT00774566|585117846|FG000|Overall Study|Protocol Violation|18|||
162017179|NCT00774566|585117847|FG001|Overall Study|Protocol Violation|15|||
162017180|NCT04896073|585117848|FG000|Overall Study|Screen failure|0|||
162017181|NCT04896073|585117849|FG001|Overall Study|Screen failure|2|||
162017182|NCT04896073|585117848|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
162017183|NCT04896073|585117849|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
162017184|NCT02304367|585117850|FG000|Overall Study|Lack of Response to Bruosumab|1|||
162017185|NCT02304367|585117850|FG000|Overall Study|Sponsor Decision|3|||
162017186|NCT02304367|585117850|FG000|Overall Study|Death|2|||
162017187|NCT02304367|585117850|FG000|Overall Study|Physician Decision|1|||
162017188|NCT02304367|585117850|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
162166417|NCT04137289|585660109|FG000|Overall Study|Objective disease progression|1|||
162166418|NCT04137289|585660110|FG001|Overall Study|Objective disease progression|1|||
162166419|NCT04137289|585660111|FG002|Overall Study|Objective disease progression|6|||
162166420|NCT04137289|585660112|FG003|Overall Study|Objective disease progression|18|||
162166421|NCT04137289|585660113|FG004|Overall Study|Objective disease progression|12|||
162166422|NCT04137289|585660114|FG005|Overall Study|Objective disease progression|20|||
162166423|NCT04137289|585660115|FG006|Overall Study|Objective disease progression|18|||
162166424|NCT04137289|585660116|FG007|Overall Study|Objective disease progression|7|||
162166425|NCT04137289|585660117|FG008|Overall Study|Objective disease progression|6|||
162166426|NCT03396588|585660118|FG000|Overall Study|Physician Decision|2|||
162166427|NCT03396588|585660119|FG001|Overall Study|Physician Decision|3|||
162166428|NCT00812461|585660121|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
162166429|NCT00812461|585660122|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
162166430|NCT00812461|585660121|FG000|All Treated Patients|Adverse Event|8|||
162166431|NCT00812461|585660122|FG001|All Treated Patients|Adverse Event|15|||
162166432|NCT00812461|585660121|FG000|All Treated Patients|Lack of Efficacy|13|||
162166433|NCT00812461|585660122|FG001|All Treated Patients|Lack of Efficacy|7|||
162166434|NCT00812461|585660121|FG000|All Treated Patients|Non-compliance|6|||
162166435|NCT00812461|585660122|FG001|All Treated Patients|Non-compliance|9|||
162166436|NCT00812461|585660121|FG000|All Treated Patients|Protocol Violation|36|||
162166437|NCT00812461|585660122|FG001|All Treated Patients|Protocol Violation|27|||
162166438|NCT00812461|585660121|FG000|All Treated Patients|Withdrawal by Subject|45|||
162166439|NCT00812461|585660122|FG001|All Treated Patients|Withdrawal by Subject|54|||
162166440|NCT00812461|585660121|FG000|All Treated Patients|Lost to Follow-up|11|||
162166441|NCT00812461|585660122|FG001|All Treated Patients|Lost to Follow-up|14|||
162166442|NCT00812461|585660121|FG000|All Treated Patients|Other Reason|13|||
162166443|NCT00812461|585660122|FG001|All Treated Patients|Other Reason|21|||
162166444|NCT05351554|585660123|FG000|Overall Study|Study terminated by sponsor|1|||
162166445|NCT05030233|585660124|FG000|Overall Study|withdrawn for transfer|1|||
162166446|NCT05030233|585660125|FG001|Overall Study|withdrawn for transfer|0|||
162166447|NCT02727699|585661759|FG000|Overall Study|Adverse Event|2|||
162166448|NCT02727699|585661760|FG001|Overall Study|Adverse Event|0|||
162166449|NCT02727699|585661759|FG000|Overall Study|Withdrawal by Subject|5|||
162166450|NCT02727699|585661760|FG001|Overall Study|Withdrawal by Subject|3|||
162166451|NCT02727699|585661759|FG000|Overall Study|Protocol Violation|0|||
162166452|NCT02727699|585661760|FG001|Overall Study|Protocol Violation|1|||
162166453|NCT02727699|585661759|FG000|Overall Study|Physician Decision|0|||
162166454|NCT02727699|585661760|FG001|Overall Study|Physician Decision|1|||
162166455|NCT02727699|585661759|FG000|Overall Study|Lost to Follow-up|1|||
162166456|NCT02727699|585661760|FG001|Overall Study|Lost to Follow-up|0|||
162166457|NCT02727699|585661759|FG000|Overall Study|Sponsor Decision|1|||
162166458|NCT02727699|585661760|FG001|Overall Study|Sponsor Decision|0|||
162166459|NCT04318548|585661769|FG000|Overall Study|Adverse Event|0|||
162166460|NCT04318548|585661770|FG001|Overall Study|Adverse Event|0|||
162166461|NCT04318548|585661771|FG002|Overall Study|Adverse Event|1|||
162166462|NCT04318548|585661769|FG000|Overall Study|Lost to Follow-up|6|||
162166463|NCT04318548|585661770|FG001|Overall Study|Lost to Follow-up|13|||
162166464|NCT04318548|585661771|FG002|Overall Study|Lost to Follow-up|9|||
162166465|NCT04318548|585661769|FG000|Overall Study|Protocol Violation|1|||
162166466|NCT04318548|585661770|FG001|Overall Study|Protocol Violation|0|||
162166467|NCT04318548|585661771|FG002|Overall Study|Protocol Violation|2|||
162166468|NCT04318548|585661769|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
162166469|NCT04318548|585661770|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
162166470|NCT04318548|585661771|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
162166471|NCT04318548|585661769|FG000|Overall Study|Migrated / moved from the study area|0|||
162166472|NCT04318548|585661770|FG001|Overall Study|Migrated / moved from the study area|0|||
162166473|NCT04318548|585661771|FG002|Overall Study|Migrated / moved from the study area|1|||
162166474|NCT04318548|585661769|FG000|Overall Study|Other|1|||
162166475|NCT04318548|585661770|FG001|Overall Study|Other|2|||
162166476|NCT04318548|585661771|FG002|Overall Study|Other|3|||
162166477|NCT03366649|585661774|FG000|Overall Study|Failed preoperative screening|4|||
162166478|NCT03366649|585661775|FG001|Overall Study|Failed preoperative screening|0|||
162166479|NCT03366649|585661776|FG002|Overall Study|Failed preoperative screening|0|||
162166480|NCT03366649|585661774|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
162166481|NCT03366649|585661775|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
162166482|NCT03366649|585661776|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
162166483|NCT04029688|585661784|FG000|Overall Study|Death|8|||
162166484|NCT04029688|585661785|FG001|Overall Study|Death|3|||
162166485|NCT04029688|585661786|FG002|Overall Study|Death|6|||
162166486|NCT04029688|585661787|FG003|Overall Study|Death|2|||
162166487|NCT04029688|585661788|FG004|Overall Study|Death|5|||
162166488|NCT04029688|585661789|FG005|Overall Study|Death|0|||
162166489|NCT04029688|585661790|FG006|Overall Study|Death|2|||
162166490|NCT04029688|585661791|FG007|Overall Study|Death|3|||
162166491|NCT04029688|585661784|FG000|Overall Study|Study Terminated by Sponsor|0|||
162166492|NCT04029688|585661785|FG001|Overall Study|Study Terminated by Sponsor|0|||
162166493|NCT04029688|585661786|FG002|Overall Study|Study Terminated by Sponsor|0|||
162166494|NCT04029688|585661787|FG003|Overall Study|Study Terminated by Sponsor|0|||
161815923|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162166495|NCT04029688|585661788|FG004|Overall Study|Study Terminated by Sponsor|1|||
162166496|NCT04029688|585661789|FG005|Overall Study|Study Terminated by Sponsor|3|||
162166497|NCT04029688|585661790|FG006|Overall Study|Study Terminated by Sponsor|1|||
162166498|NCT04029688|585661791|FG007|Overall Study|Study Terminated by Sponsor|3|||
162166499|NCT04029688|585661784|FG000|Overall Study|Withdrawal by Subject|0|||
162166500|NCT04029688|585661785|FG001|Overall Study|Withdrawal by Subject|0|||
162166501|NCT04029688|585661786|FG002|Overall Study|Withdrawal by Subject|0|||
162166502|NCT04029688|585661787|FG003|Overall Study|Withdrawal by Subject|1|||
162166503|NCT04029688|585661788|FG004|Overall Study|Withdrawal by Subject|0|||
162166504|NCT04029688|585661789|FG005|Overall Study|Withdrawal by Subject|0|||
161815924|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815925|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815926|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815927|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815928|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
162017189|NCT03527732|585117851|FG000|Overall Study|Lost to Follow-up|21|||
161815929|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815930|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161815931|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
161815932|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
161815933|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
161815934|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
161815935|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
161815936|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162017190|NCT03527732|585117852|FG001|Overall Study|Lost to Follow-up|23|||
161815937|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815938|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
162017191|NCT03527732|585117853|FG002|Overall Study|Lost to Follow-up|80|||
162017192|NCT03527732|585117854|FG003|Overall Study|Lost to Follow-up|62|||
162166505|NCT04029688|585661790|FG006|Overall Study|Withdrawal by Subject|0|||
162166506|NCT04029688|585661791|FG007|Overall Study|Withdrawal by Subject|0|||
162166507|NCT03436290|585661792|FG000|Overall Study|Post-randomization Exclusion|1|||
162166508|NCT03436290|585661793|FG001|Overall Study|Post-randomization Exclusion|0|||
162166509|NCT03436290|585661792|FG000|Overall Study|Death|6|||
162166510|NCT03436290|585661793|FG001|Overall Study|Death|0|||
162166511|NCT03436290|585661792|FG000|Overall Study|Withdrawal by Subject|4|||
162166512|NCT03436290|585661793|FG001|Overall Study|Withdrawal by Subject|0|||
162166513|NCT03436290|585661792|FG000|Overall Study|Protocol Violation|30|||
162166514|NCT03436290|585661793|FG001|Overall Study|Protocol Violation|0|||
162166515|NCT02677298|585661806|FG000|Double Blind Phase|Adverse Event|2|||
162166516|NCT02677298|585661807|FG001|Double Blind Phase|Adverse Event|1|||
162166517|NCT02677298|585661808|FG002|Double Blind Phase|Adverse Event|0|||
162166518|NCT02677298|585661806|FG000|Double Blind Phase|Physician Decision|5|||
162166519|NCT02677298|585661807|FG001|Double Blind Phase|Physician Decision|0|||
162166520|NCT02677298|585661808|FG002|Double Blind Phase|Physician Decision|0|||
162166521|NCT02677298|585661806|FG000|Double Blind Phase|Lost to Follow-up|11|||
161815939|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815940|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815941|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815942|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815943|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815944|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815945|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815946|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815947|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815948|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815949|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815950|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815951|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815952|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815953|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815954|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815955|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815956|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161815957|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|moved|0|||
161815958|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|moved|1|||
161815959|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|moved|1|||
161815960|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|moved|0|||
161815961|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|moved|0|||
161815962|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|moved|0|||
161815963|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|moved|0|||
161815964|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|moved|0|||
161815965|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|moved|0|||
161815966|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|moved|0|||
161815967|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|moved|0|||
161815968|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|moved|0|||
161815969|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|moved|0|||
161815970|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|moved|0|||
161815971|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|moved|0|||
161815972|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|moved|0|||
161815973|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|moved|0|||
161815974|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|moved|0|||
161815975|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|moved|0|||
161815976|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|moved|0|||
161815977|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|moved|0|||
161815978|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|moved|0|||
161815979|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|moved|0|||
161815980|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|moved|0|||
161815981|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|moved|0|||
161815982|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|moved|0|||
161815983|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162017193|NCT03527732|585117855|FG004|Overall Study|Lost to Follow-up|12|||
162166522|NCT02677298|585661807|FG001|Double Blind Phase|Lost to Follow-up|7|||
162166523|NCT02677298|585661808|FG002|Double Blind Phase|Lost to Follow-up|0|||
162166524|NCT02677298|585661806|FG000|Double Blind Phase|Withdrawal by Subject|11|||
162166525|NCT02677298|585661807|FG001|Double Blind Phase|Withdrawal by Subject|8|||
162166526|NCT02677298|585661808|FG002|Double Blind Phase|Withdrawal by Subject|0|||
162166527|NCT02677298|585661806|FG000|Double Blind Phase|No study drug available at site|0|||
162166528|NCT02677298|585661807|FG001|Double Blind Phase|No study drug available at site|1|||
162166529|NCT02677298|585661808|FG002|Double Blind Phase|No study drug available at site|0|||
162166530|NCT02677298|585661806|FG000|Open Label Phase|Adverse Event|0|||
162166531|NCT02677298|585661807|FG001|Open Label Phase|Adverse Event|0|||
162166532|NCT02677298|585661808|FG002|Open Label Phase|Adverse Event|4|||
162166533|NCT02677298|585661806|FG000|Open Label Phase|Physician Decision|0|||
162166534|NCT02677298|585661807|FG001|Open Label Phase|Physician Decision|0|||
162166535|NCT02677298|585661808|FG002|Open Label Phase|Physician Decision|1|||
162166536|NCT02677298|585661806|FG000|Open Label Phase|Lost to Follow-up|0|||
162166537|NCT02677298|585661807|FG001|Open Label Phase|Lost to Follow-up|0|||
162166538|NCT02677298|585661808|FG002|Open Label Phase|Lost to Follow-up|17|||
162166539|NCT02677298|585661806|FG000|Open Label Phase|Withdrawal by Subject|0|||
162166540|NCT02677298|585661807|FG001|Open Label Phase|Withdrawal by Subject|0|||
162166541|NCT02677298|585661808|FG002|Open Label Phase|Withdrawal by Subject|38|||
162166542|NCT03611621|585661809|FG000|Overall Study|Graft loss|3|||
162166543|NCT03611621|585661809|FG000|Overall Study|Death|3|||
162166544|NCT03611621|585661809|FG000|Overall Study|Lost to Follow-up|1|||
162166545|NCT03812679|585661831|FG000|Overall Study|Adverse Event|2|||
162166546|NCT03812679|585661831|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
162166547|NCT03812679|585661831|FG000|Overall Study|Renal transplant|1|||
162166548|NCT03812679|585661831|FG000|Overall Study|Withdrawal by Subject|1|||
162166549|NCT03812679|585661831|FG000|Overall Study|Termination of study|2|||
162166550|NCT03812679|585661831|FG000|Overall Study|Water device replacement|1|||
162166551|NCT05653427|585661832|FG000|Overall Study|Study Terminated by Sponsor|13|||
162166552|NCT02140554|585661844|FG000|Overall Study|Withdrawal of consent|1|||
162166553|NCT02140554|585661845|FG001|Overall Study|Withdrawal of consent|0|||
162166554|NCT02140554|585661846|FG002|Overall Study|Withdrawal of consent|4|||
162166555|NCT02140554|585661844|FG000|Overall Study|Physician Decision|1|||
162166556|NCT02140554|585661845|FG001|Overall Study|Physician Decision|0|||
162166557|NCT02140554|585661846|FG002|Overall Study|Physician Decision|2|||
162166558|NCT02140554|585661844|FG000|Overall Study|Death|0|||
162166559|NCT02140554|585661845|FG001|Overall Study|Death|0|||
162166560|NCT02140554|585661846|FG002|Overall Study|Death|1|||
162166561|NCT02140554|585661844|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
162166562|NCT02140554|585661845|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
162166563|NCT02140554|585661846|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
162166564|NCT03953508|585661848|FG000|Baseline|Lost to Follow-up|3|||
162166565|NCT03953508|585661849|FG001|Baseline|Lost to Follow-up|2|||
162166566|NCT03953508|585661848|FG000|6-month Follow-up|Lost to Follow-up|62|||
162166567|NCT03953508|585661849|FG001|6-month Follow-up|Lost to Follow-up|70|||
162166568|NCT03771417|585661850|FG000|Overall Study|Withdrawal by Subject|1|||
162166569|NCT03771417|585661851|FG001|Overall Study|Withdrawal by Subject|0|||
162166570|NCT03771417|585661852|FG002|Overall Study|Withdrawal by Subject|0|||
162166571|NCT03771417|585661850|FG000|Overall Study|Covid-19 Shutdown|0|||
162166572|NCT03771417|585661851|FG001|Overall Study|Covid-19 Shutdown|1|||
162166573|NCT03771417|585661852|FG002|Overall Study|Covid-19 Shutdown|0|||
162166574|NCT04185298|585661854|FG000|Overall Study|Lost to Follow-up|1|||
162166575|NCT04185298|585661855|FG001|Overall Study|Lost to Follow-up|3|||
162166576|NCT04185298|585661854|FG000|Overall Study|Withdrawal by Subject|0|||
162166577|NCT04185298|585661855|FG001|Overall Study|Withdrawal by Subject|3|||
162166578|NCT03524118|585661856|FG000|Overall Study|Lost to Follow-up|0|||
162166579|NCT03524118|585661857|FG001|Overall Study|Lost to Follow-up|0|||
162166580|NCT03524118|585661858|FG002|Overall Study|Lost to Follow-up|0|||
162166581|NCT03524118|585661859|FG003|Overall Study|Lost to Follow-up|0|||
162166582|NCT03524118|585661860|FG004|Overall Study|Lost to Follow-up|1|||
162166583|NCT03524118|585661861|FG005|Overall Study|Lost to Follow-up|0|||
162166584|NCT03524118|585661856|FG000|Overall Study|Other|0|||
162166585|NCT03524118|585661857|FG001|Overall Study|Other|1|||
162166586|NCT03524118|585661858|FG002|Overall Study|Other|0|||
162166587|NCT03524118|585661859|FG003|Overall Study|Other|0|||
162166588|NCT03524118|585661860|FG004|Overall Study|Other|1|||
161815984|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162166589|NCT03524118|585661861|FG005|Overall Study|Other|1|||
162166590|NCT03524118|585661856|FG000|Overall Study|Physician Decision|0|||
162166591|NCT03524118|585661857|FG001|Overall Study|Physician Decision|0|||
162166592|NCT03524118|585661858|FG002|Overall Study|Physician Decision|0|||
162166593|NCT03524118|585661859|FG003|Overall Study|Physician Decision|0|||
162166594|NCT03524118|585661860|FG004|Overall Study|Physician Decision|1|||
162166595|NCT03524118|585661861|FG005|Overall Study|Physician Decision|0|||
162166596|NCT03524118|585661856|FG000|Overall Study|Protocol Violation|0|||
162166597|NCT03524118|585661857|FG001|Overall Study|Protocol Violation|0|||
162166598|NCT03524118|585661858|FG002|Overall Study|Protocol Violation|1|||
162166599|NCT03524118|585661859|FG003|Overall Study|Protocol Violation|0|||
162166600|NCT03524118|585661860|FG004|Overall Study|Protocol Violation|1|||
162166601|NCT03524118|585661861|FG005|Overall Study|Protocol Violation|0|||
162166602|NCT03524118|585661856|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162166603|NCT03524118|585661857|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162166604|NCT03524118|585661858|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162166605|NCT03524118|585661859|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
162166606|NCT03524118|585661860|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
162166607|NCT03524118|585661861|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
162166608|NCT04650269|585661864|FG000|Overall Study|Death|3|||
162166609|NCT04650269|585661864|FG000|Overall Study|Lost to Follow-up|6|||
162166610|NCT01437709|585661865|FG000|Overall Study|Adverse Event|0|||
162166611|NCT01437709|585661866|FG001|Overall Study|Adverse Event|1|||
162166612|NCT01437709|585661867|FG002|Overall Study|Adverse Event|0|||
162166613|NCT01437709|585661865|FG000|Overall Study|Pt trasnferred care|0|||
162166614|NCT01437709|585661866|FG001|Overall Study|Pt trasnferred care|1|||
162166615|NCT01437709|585661867|FG002|Overall Study|Pt trasnferred care|0|||
162166616|NCT01842542|585661868|FG000|Overall Study|Withdrawal by Subject|2|||
162166617|NCT01842542|585661868|FG000|Overall Study|Lack of Efficacy|1|||
162166618|NCT01842542|585661868|FG000|Overall Study|Protocol Non-compliance|2|||
162166619|NCT01842542|585661868|FG000|Overall Study|Lost to Follow-up|1|||
162166620|NCT02919306|585661869|FG000|Overall Study|Withdrawal by Subject|1|||
162166621|NCT02919306|585661870|FG001|Overall Study|Withdrawal by Subject|0|||
162166622|NCT02919306|585661869|FG000|Overall Study|Protocol Violation|1|||
162166623|NCT02919306|585661870|FG001|Overall Study|Protocol Violation|0|||
162166624|NCT04293055|585661871|FG000|Overall Study|Lost to Follow-up|1|||
162166625|NCT04293055|585661872|FG001|Overall Study|Lost to Follow-up|1|||
162166626|NCT04293055|585661871|FG000|Overall Study|Did not trigger randomization|6|||
162166627|NCT04293055|585661872|FG001|Overall Study|Did not trigger randomization|5|||
162166628|NCT02262728|585661874|FG000|Follow-up Phase (3 Years)|Death|0|||
162166629|NCT02262728|585661875|FG001|Follow-up Phase (3 Years)|Death|1|||
162166630|NCT02262728|585661874|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
162166631|NCT02262728|585661875|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
162166632|NCT02262728|585661874|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
162166633|NCT02262728|585661875|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
162166634|NCT02619838|585661876|FG000|Overall Study|Lost to Follow-up|9|||
162166635|NCT02619838|585661876|FG000|Overall Study|Withdrawal by Subject|15|||
162166636|NCT01715285|585661877|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
162166637|NCT01715285|585661878|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
162166638|NCT01715285|585661879|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
162166639|NCT01715285|585661877|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
162166640|NCT01715285|585661878|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
162166641|NCT01715285|585661879|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
162166642|NCT01715285|585661877|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
162166643|NCT01715285|585661878|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
162166644|NCT01715285|585661879|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
161921178|NCT01697579|584757182|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
162166645|NCT01715285|585661877|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
162166646|NCT01715285|585661878|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
162166647|NCT01715285|585661879|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
161921179|NCT01697579|584757183|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161921180|NCT01697579|584757184|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161921181|NCT01697579|584757185|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
162166648|NCT01715285|585661877|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
162166649|NCT01715285|585661878|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
162166650|NCT01715285|585661879|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
162166651|NCT01715285|585661877|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
162166652|NCT01715285|585661878|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
162166653|NCT01715285|585661879|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
162166654|NCT01715285|585661877|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
162166655|NCT01715285|585661878|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
162166656|NCT01715285|585661879|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
162166657|NCT01715285|585661877|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
162166658|NCT01715285|585661878|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
162166659|NCT01715285|585661879|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
162166660|NCT01715285|585661877|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
162166661|NCT01715285|585661878|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
162166662|NCT01715285|585661879|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
162017194|NCT03527732|585117856|FG005|Overall Study|Lost to Follow-up|20|||
162166663|NCT01715285|585661877|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
162166664|NCT01715285|585661878|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
162166665|NCT01715285|585661879|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
162166666|NCT01715285|585661877|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
162166667|NCT01715285|585661878|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
162166668|NCT01715285|585661879|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
162166669|NCT01715285|585661877|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
162166670|NCT01715285|585661878|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
162166671|NCT01715285|585661879|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
161815985|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815986|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
161815987|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815988|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815989|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
162166672|NCT01715285|585661877|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
162166673|NCT01715285|585661878|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
162166674|NCT01715285|585661879|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
162166675|NCT01715285|585661877|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
162166676|NCT01715285|585661878|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
162166677|NCT01715285|585661879|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
162166678|NCT05020249|585661880|FG000|Overall Study|Protocol Violation|1|||
162166679|NCT05020249|585661881|FG001|Overall Study|Protocol Violation|0|||
162166680|NCT04971681|585661893|FG000|Followup|Lost to Follow-up|1|||
162166681|NCT04971681|585661894|FG001|Followup|Lost to Follow-up|0|||
162166682|NCT04376502|585661895|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
162166683|NCT05603143|585661896|FG000|Overall Study|Withdrew consent|6|||
162166684|NCT05603143|585661897|FG001|Overall Study|Withdrew consent|2|||
162166685|NCT05603143|585661896|FG000|Overall Study|Randomized but never treated|0|||
162166686|NCT05603143|585661897|FG001|Overall Study|Randomized but never treated|3|||
162166687|NCT05603143|585661896|FG000|Overall Study|Adverse Event|2|||
162166688|NCT05603143|585661897|FG001|Overall Study|Adverse Event|0|||
162166689|NCT05603143|585661896|FG000|Overall Study|Death|0|||
162166690|NCT05603143|585661897|FG001|Overall Study|Death|1|||
161815990|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815991|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815992|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815993|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815994|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815995|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815996|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815997|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815998|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161815999|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816000|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816001|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816002|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816003|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816004|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816005|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816006|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816007|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816008|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161816009|NCT00112437|584368804|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816010|NCT00112437|584368805|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816011|NCT00112437|584368806|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816012|NCT00112437|584368807|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816013|NCT00112437|584368808|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
161816014|NCT00112437|584368809|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816015|NCT00112437|584368810|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816016|NCT00112437|584368811|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161921182|NCT01697579|584757186|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
162166691|NCT05603143|585661896|FG000|Overall Study|Investigator's discretion|1|||
162166692|NCT05603143|585661897|FG001|Overall Study|Investigator's discretion|0|||
162166693|NCT05603143|585661896|FG000|Overall Study|Lost to Follow-up|0|||
162166694|NCT05603143|585661897|FG001|Overall Study|Lost to Follow-up|1|||
162166695|NCT05603143|585661896|FG000|Overall Study|Protocol Violation|0|||
162166696|NCT05603143|585661897|FG001|Overall Study|Protocol Violation|1|||
161816017|NCT00112437|584368812|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816018|NCT00112437|584368813|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816019|NCT00112437|584368814|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816020|NCT00112437|584368815|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816021|NCT00112437|584368816|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816022|NCT00112437|584368817|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816023|NCT00112437|584368818|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816024|NCT00112437|584368819|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816025|NCT00112437|584368820|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816026|NCT00112437|584368821|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161921183|NCT01697579|584757180|FG000|Base Study-Cycle 1|Technical Problems|0|||
161921184|NCT01697579|584757181|FG001|Base Study-Cycle 1|Technical Problems|0|||
162166697|NCT04505904|585661898|FG000|Overall Study|Withdrawal by Subject|1|||
162166698|NCT04505904|585661899|FG001|Overall Study|Withdrawal by Subject|2|||
162166699|NCT04505904|585661900|FG002|Overall Study|Withdrawal by Subject|0|||
162166700|NCT04505904|585661901|FG003|Overall Study|Withdrawal by Subject|0|||
162166701|NCT04505904|585661898|FG000|Overall Study|Physician Decision|1|||
162166702|NCT04505904|585661899|FG001|Overall Study|Physician Decision|0|||
162166703|NCT04505904|585661900|FG002|Overall Study|Physician Decision|0|||
162166704|NCT04505904|585661901|FG003|Overall Study|Physician Decision|0|||
162166705|NCT04505904|585661898|FG000|Overall Study|Adverse Event|0|||
162166706|NCT04505904|585661899|FG001|Overall Study|Adverse Event|1|||
162166707|NCT04505904|585661900|FG002|Overall Study|Adverse Event|0|||
162166708|NCT04505904|585661901|FG003|Overall Study|Adverse Event|0|||
162166709|NCT03092518|585661902|FG000|Overall Study|Ineligible|2|||
162166710|NCT01824537|585661903|FG000|Overall Study|Lost to Follow-up|78|||
162166711|NCT01824537|585661904|FG001|Overall Study|Lost to Follow-up|87|||
162166712|NCT02547987|585661905|FG000|Overall Study|Withdrawal by Subject|1|||
162166713|NCT02547987|585661905|FG000|Overall Study|Adverse Event|2|||
162166714|NCT04938492|585661917|FG000|Overall Study|Lost to Follow-up|17|||
162166715|NCT04938492|585661918|FG001|Overall Study|Lost to Follow-up|18|||
162166716|NCT03865498|585661919|FG000|Overall Study|Lack of Efficacy|12|||
162166717|NCT03865498|585661920|FG001|Overall Study|Lack of Efficacy|11|||
162166718|NCT03865498|585661919|FG000|Overall Study|Lost to Follow-up|125|||
162166719|NCT03865498|585661920|FG001|Overall Study|Lost to Follow-up|133|||
162166720|NCT03865498|585661919|FG000|Overall Study|Withdrawal by Subject|2|||
162166721|NCT03865498|585661920|FG001|Overall Study|Withdrawal by Subject|4|||
162166722|NCT01648023|585661921|FG000|Overall Study|Screen Fail Post Randomization|1|||
162166723|NCT01648023|585661922|FG001|Overall Study|Screen Fail Post Randomization|2|||
162166724|NCT05084508|585661923|FG000|Overall Study|Lost to Follow-up|6|||
162166725|NCT05084508|585661924|FG001|Overall Study|Lost to Follow-up|3|||
162166726|NCT05084508|585661925|FG002|Overall Study|Lost to Follow-up|7|||
162166727|NCT05084508|585661926|FG003|Overall Study|Lost to Follow-up|3|||
162166728|NCT05084508|585661923|FG000|Overall Study|Withdrawal by Subject|0|||
162166729|NCT05084508|585661924|FG001|Overall Study|Withdrawal by Subject|2|||
162166730|NCT05084508|585661925|FG002|Overall Study|Withdrawal by Subject|3|||
162166731|NCT05084508|585661926|FG003|Overall Study|Withdrawal by Subject|1|||
162166732|NCT05084508|585661923|FG000|Overall Study|Other|0|||
162166733|NCT05084508|585661924|FG001|Overall Study|Other|0|||
162166734|NCT05084508|585661925|FG002|Overall Study|Other|0|||
162166735|NCT05084508|585661926|FG003|Overall Study|Other|1|||
162166736|NCT05296525|585661927|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
162166737|NCT05296525|585661928|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
162166738|NCT05296525|585661929|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
162166739|NCT05296525|585661930|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
162166740|NCT02547363|585661937|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
162166741|NCT02547363|585661938|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
162166742|NCT02547363|585661937|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
162166743|NCT02547363|585661938|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
162166744|NCT02547363|585661937|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
162166745|NCT02547363|585661938|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
162166746|NCT02547363|585661937|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
162166747|NCT02547363|585661938|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
162166748|NCT02547363|585661937|FG000|12-month Follow-up|Withdrawal by Subject|4|||
162166749|NCT02547363|585661938|FG001|12-month Follow-up|Withdrawal by Subject|3|||
162166750|NCT02547363|585661937|FG000|12-month Follow-up|Lost to Follow-up|4|||
162166751|NCT02547363|585661938|FG001|12-month Follow-up|Lost to Follow-up|1|||
162166752|NCT02547363|585661937|FG000|12-month Follow-up|Lack of Efficacy|1|||
162166753|NCT02547363|585661938|FG001|12-month Follow-up|Lack of Efficacy|1|||
162166754|NCT02547363|585661937|FG000|12-month Follow-up|Other|1|||
162166755|NCT02547363|585661938|FG001|12-month Follow-up|Other|0|||
162166756|NCT03931174|585661939|FG000|Providers|Staff left organization|26|||
162166757|NCT03931174|585661940|FG001|Providers|Staff left organization|25|||
162166758|NCT03931174|585661939|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
162166759|NCT03931174|585661940|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
162166760|NCT03931174|585661939|FG000|Providers|Lost to Follow-up|4|||
162166761|NCT03931174|585661940|FG001|Providers|Lost to Follow-up|4|||
162166762|NCT03931174|585661939|FG000|Patients|Post-consent screening failure|1|||
162166763|NCT03931174|585661940|FG001|Patients|Post-consent screening failure|1|||
162166764|NCT03931174|585661939|FG000|Patients|Death|1|||
162166765|NCT03931174|585661940|FG001|Patients|Death|1|||
162166766|NCT03931174|585661939|FG000|Patients|Lost to Follow-up|60|||
162166767|NCT03931174|585661940|FG001|Patients|Lost to Follow-up|89|||
162166768|NCT05386030|585661941|FG000|Overall Study|Death|1|||
162166769|NCT05386030|585661942|FG001|Overall Study|Death|0|||
162166770|NCT05386030|585661941|FG000|Overall Study|Physician Decision|2|||
162166771|NCT05386030|585661942|FG001|Overall Study|Physician Decision|1|||
162166772|NCT05386030|585661941|FG000|Overall Study|Lost to Follow-up|19|||
162166773|NCT05386030|585661942|FG001|Overall Study|Lost to Follow-up|7|||
162166774|NCT05386030|585661941|FG000|Overall Study|Withdrawal by Subject|20|||
162166775|NCT05386030|585661942|FG001|Overall Study|Withdrawal by Subject|10|||
162166776|NCT05386030|585661941|FG000|Overall Study|Eligibility criteria violation|1|||
162166777|NCT05386030|585661942|FG001|Overall Study|Eligibility criteria violation|1|||
162166778|NCT05386030|585661941|FG000|Overall Study|Personal Reasons|1|||
162166779|NCT05386030|585661942|FG001|Overall Study|Personal Reasons|0|||
162166780|NCT03213691|585661943|FG000|Overall Study|Adverse Event|2|||
162166781|NCT03213691|585661943|FG000|Overall Study|Death|3|||
162166782|NCT03213691|585661943|FG000|Overall Study|Physician Decision|1|||
162166783|NCT03213691|585661943|FG000|Overall Study|Progressive Disease|14|||
162166784|NCT03213691|585661943|FG000|Overall Study|Ineligible|1|||
162166785|NCT03161028|585661944|FG000|Overall Study|Withdrawal by Subject|6|||
162166786|NCT03161028|585661945|FG001|Overall Study|Withdrawal by Subject|4|||
162166787|NCT03161028|585661944|FG000|Overall Study|Adverse Event|5|||
162166788|NCT03161028|585661945|FG001|Overall Study|Adverse Event|1|||
162166789|NCT03161028|585661944|FG000|Overall Study|Study drug side effects|2|||
162166790|NCT03161028|585661945|FG001|Overall Study|Study drug side effects|2|||
162166791|NCT03161028|585661944|FG000|Overall Study|Administrative PD/UP|4|||
162166792|NCT03161028|585661945|FG001|Overall Study|Administrative PD/UP|2|||
162166793|NCT03161028|585661944|FG000|Overall Study|Lost to Follow-up|2|||
162166794|NCT03161028|585661945|FG001|Overall Study|Lost to Follow-up|0|||
162166795|NCT03161028|585661944|FG000|Overall Study|Unable to comply with procedures|1|||
162166796|NCT03161028|585661945|FG001|Overall Study|Unable to comply with procedures|1|||
162166797|NCT03492216|585661948|FG000|Overall Study|Death|1|||
162166798|NCT03492216|585661949|FG001|Overall Study|Death|0|||
162166799|NCT03492216|585661950|FG002|Overall Study|Death|4|||
162166800|NCT03492216|585661951|FG003|Overall Study|Death|0|||
162166801|NCT03492216|585661948|FG000|Overall Study|Withdrawal by Subject|5|||
162166802|NCT03492216|585661949|FG001|Overall Study|Withdrawal by Subject|3|||
162166803|NCT03492216|585661950|FG002|Overall Study|Withdrawal by Subject|1|||
162166804|NCT03492216|585661951|FG003|Overall Study|Withdrawal by Subject|1|||
162166805|NCT03492216|585661948|FG000|Overall Study|Lost to Follow-up|9|||
162166806|NCT03492216|585661949|FG001|Overall Study|Lost to Follow-up|2|||
162166807|NCT03492216|585661950|FG002|Overall Study|Lost to Follow-up|7|||
162166808|NCT03492216|585661951|FG003|Overall Study|Lost to Follow-up|8|||
162166809|NCT03492216|585661948|FG000|Overall Study|Moved|5|||
162166810|NCT03492216|585661949|FG001|Overall Study|Moved|3|||
162166811|NCT03492216|585661950|FG002|Overall Study|Moved|3|||
162166812|NCT03492216|585661951|FG003|Overall Study|Moved|5|||
162166813|NCT03492216|585661948|FG000|Overall Study|Too ill|0|||
162166814|NCT03492216|585661949|FG001|Overall Study|Too ill|1|||
162166815|NCT03492216|585661950|FG002|Overall Study|Too ill|0|||
162166816|NCT03492216|585661951|FG003|Overall Study|Too ill|0|||
162166817|NCT03492216|585661948|FG000|Overall Study|Incarcerated|0|||
162166818|NCT03492216|585661949|FG001|Overall Study|Incarcerated|0|||
162166819|NCT03492216|585661950|FG002|Overall Study|Incarcerated|2|||
162166820|NCT03492216|585661951|FG003|Overall Study|Incarcerated|0|||
162166821|NCT00736723|585661952|FG000|Overall Study|Withdrawal by Subject|4|||
161921185|NCT01697579|584757182|FG002|Base Study-Cycle 1|Technical Problems|1|||
161921186|NCT01697579|584757183|FG003|Base Study-Cycle 1|Technical Problems|1|||
161921187|NCT01697579|584757184|FG004|Base Study-Cycle 1|Technical Problems|0|||
161921188|NCT01697579|584757185|FG005|Base Study-Cycle 1|Technical Problems|0|||
161921189|NCT01697579|584757186|FG006|Base Study-Cycle 1|Technical Problems|0|||
161921190|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Death|0|||
161921191|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Death|0|||
161921192|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Death|0|||
161921193|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Death|0|||
161921194|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Death|0|||
161921195|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Death|0|||
161921196|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Death|2|||
161921197|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161921198|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161921199|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
162017195|NCT03306173|585117857|FG000|Overall Study|Lost to Follow-up|16|||
162166822|NCT00736723|585661953|FG001|Overall Study|Withdrawal by Subject|3|||
162166823|NCT05251909|585663999|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
162166824|NCT05251909|585664000|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
162166825|NCT04019873|585664001|FG000|Overall Study|Discontinued from the treatment|1|||
162166826|NCT04019873|585664002|FG001|Overall Study|Discontinued from the treatment|39|||
162166827|NCT04019873|585664003|FG002|Overall Study|Discontinued from the treatment|2|||
162166828|NCT01606215|585664005|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
162166829|NCT01606215|585664006|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
162166830|NCT04316871|585664012|FG000|Overall Study|Protocol Violation|2|||
162166831|NCT04316871|585664013|FG001|Overall Study|Protocol Violation|2|||
162166832|NCT04316871|585664014|FG002|Overall Study|Protocol Violation|2|||
162166833|NCT04316871|585664015|FG003|Overall Study|Protocol Violation|2|||
162166834|NCT05087992|585664016|FG000|Overall Study|Adverse Event|0|||
162166835|NCT05087992|585664017|FG001|Overall Study|Adverse Event|1|||
162166836|NCT05087992|585664018|FG002|Overall Study|Adverse Event|0|||
162166837|NCT05087992|585664016|FG000|Overall Study|Withdrawal by Subject|2|||
162166838|NCT05087992|585664017|FG001|Overall Study|Withdrawal by Subject|0|||
162166839|NCT05087992|585664018|FG002|Overall Study|Withdrawal by Subject|0|||
162166840|NCT05087992|585664016|FG000|Overall Study|clinical disease progression|3|||
162166841|NCT05087992|585664017|FG001|Overall Study|clinical disease progression|1|||
162166842|NCT05087992|585664018|FG002|Overall Study|clinical disease progression|0|||
162166843|NCT05087992|585664016|FG000|Overall Study|objective disease progression|4|||
162166844|NCT05087992|585664017|FG001|Overall Study|objective disease progression|1|||
162166845|NCT05087992|585664018|FG002|Overall Study|objective disease progression|0|||
162166846|NCT03452579|585664019|FG000|Overall Study|Death|0|||
162166847|NCT03452579|585664020|FG001|Overall Study|Death|1|||
162166848|NCT03452579|585664019|FG000|Overall Study|Withdrawal by Subject|2|||
162166849|NCT03452579|585664020|FG001|Overall Study|Withdrawal by Subject|0|||
162166850|NCT03452579|585664019|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
162166851|NCT03452579|585664020|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
162166852|NCT03452579|585664019|FG000|Overall Study|Physician Decision|1|||
162166853|NCT03452579|585664020|FG001|Overall Study|Physician Decision|1|||
162166854|NCT03452579|585664019|FG000|Overall Study|Adverse Event|1|||
162166855|NCT03452579|585664020|FG001|Overall Study|Adverse Event|4|||
162166856|NCT04858321|585664021|FG000|Overall Study|Withdrawal by Subject|3|||
162166857|NCT05006872|585664024|FG000|Overall Study|Lost to Follow-up|37|||
162166858|NCT05006872|585664025|FG001|Overall Study|Lost to Follow-up|31|||
162166859|NCT04149704|585664030|FG000|Three Month Follow-up|Death|2|||
162166860|NCT04149704|585664031|FG001|Three Month Follow-up|Death|0|||
162166861|NCT04149704|585664032|FG002|Three Month Follow-up|Death|0|||
162166862|NCT04149704|585664033|FG003|Three Month Follow-up|Death|0|||
162166863|NCT04149704|585664030|FG000|Three Month Follow-up|Lost to Follow-up|1|||
162166864|NCT04149704|585664031|FG001|Three Month Follow-up|Lost to Follow-up|4|||
162166865|NCT04149704|585664032|FG002|Three Month Follow-up|Lost to Follow-up|5|||
162166866|NCT04149704|585664033|FG003|Three Month Follow-up|Lost to Follow-up|5|||
162166867|NCT04149704|585664030|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
162166868|NCT04149704|585664031|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
162166869|NCT04149704|585664032|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
162166870|NCT04149704|585664033|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
162166871|NCT04149704|585664030|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
162166872|NCT04149704|585664031|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
162166873|NCT04149704|585664032|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
162166874|NCT04149704|585664033|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
162166875|NCT04332926|585664034|FG000|Overall Study|Withdrawal by Subject|6|||
162166876|NCT04332926|585664034|FG000|Overall Study|Physician Decision|6|||
162166877|NCT04632992|585664044|FG000|Overall Study|Adverse Event|0|||
162166878|NCT04632992|585664045|FG001|Overall Study|Adverse Event|0|||
162166879|NCT04632992|585664046|FG002|Overall Study|Adverse Event|0|||
162166880|NCT04632992|585664047|FG003|Overall Study|Adverse Event|0|||
162166881|NCT04632992|585664048|FG004|Overall Study|Adverse Event|0|||
162166882|NCT04632992|585664049|FG005|Overall Study|Adverse Event|0|||
162166883|NCT04632992|585664050|FG006|Overall Study|Adverse Event|0|||
162166884|NCT04632992|585664051|FG007|Overall Study|Adverse Event|0|||
162166885|NCT04632992|585664052|FG008|Overall Study|Adverse Event|0|||
162166886|NCT04632992|585664053|FG009|Overall Study|Adverse Event|0|||
162166887|NCT04632992|585664054|FG010|Overall Study|Adverse Event|0|||
162166888|NCT04632992|585664055|FG011|Overall Study|Adverse Event|0|||
162166889|NCT04632992|585664056|FG012|Overall Study|Adverse Event|1|||
162166890|NCT04632992|585664057|FG013|Overall Study|Adverse Event|0|||
162166891|NCT04632992|585664044|FG000|Overall Study|Death|17|||
162017196|NCT03306173|585117858|FG001|Overall Study|Lost to Follow-up|23|||
162166892|NCT04632992|585664045|FG001|Overall Study|Death|1|||
162166893|NCT04632992|585664046|FG002|Overall Study|Death|14|||
162166894|NCT04632992|585664047|FG003|Overall Study|Death|14|||
162166895|NCT04632992|585664048|FG004|Overall Study|Death|13|||
162166896|NCT04632992|585664049|FG005|Overall Study|Death|6|||
162166897|NCT04632992|585664050|FG006|Overall Study|Death|7|||
162166898|NCT04632992|585664051|FG007|Overall Study|Death|12|||
162166899|NCT04632992|585664052|FG008|Overall Study|Death|15|||
162166900|NCT04632992|585664053|FG009|Overall Study|Death|20|||
162166901|NCT04632992|585664054|FG010|Overall Study|Death|8|||
162166902|NCT04632992|585664055|FG011|Overall Study|Death|2|||
162166903|NCT04632992|585664056|FG012|Overall Study|Death|10|||
162166904|NCT04632992|585664057|FG013|Overall Study|Death|1|||
162166905|NCT04632992|585664044|FG000|Overall Study|Lost to Follow-up|1|||
162166906|NCT04632992|585664045|FG001|Overall Study|Lost to Follow-up|0|||
162166907|NCT04632992|585664046|FG002|Overall Study|Lost to Follow-up|1|||
162166908|NCT04632992|585664047|FG003|Overall Study|Lost to Follow-up|0|||
162166909|NCT04632992|585664048|FG004|Overall Study|Lost to Follow-up|2|||
162166910|NCT04632992|585664049|FG005|Overall Study|Lost to Follow-up|0|||
162166911|NCT04632992|585664050|FG006|Overall Study|Lost to Follow-up|1|||
162166912|NCT04632992|585664051|FG007|Overall Study|Lost to Follow-up|1|||
162166913|NCT04632992|585664052|FG008|Overall Study|Lost to Follow-up|1|||
162166914|NCT04632992|585664053|FG009|Overall Study|Lost to Follow-up|1|||
162166915|NCT04632992|585664054|FG010|Overall Study|Lost to Follow-up|2|||
162166916|NCT04632992|585664055|FG011|Overall Study|Lost to Follow-up|0|||
162166917|NCT04632992|585664056|FG012|Overall Study|Lost to Follow-up|0|||
162166918|NCT04632992|585664057|FG013|Overall Study|Lost to Follow-up|0|||
162166919|NCT04632992|585664044|FG000|Overall Study|Reason not Specified|2|||
161816027|NCT00112437|584368822|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816028|NCT00112437|584368823|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816029|NCT00112437|584368824|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816030|NCT00112437|584368825|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816031|NCT00112437|584368826|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816032|NCT00112437|584368827|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161816033|NCT00112437|584368828|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162166920|NCT04632992|585664045|FG001|Overall Study|Reason not Specified|0|||
162166921|NCT04632992|585664046|FG002|Overall Study|Reason not Specified|1|||
161816034|NCT00112437|584368829|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
162017197|NCT03306173|585117857|FG000|Overall Study|Withdrawal by Subject|4|||
162017198|NCT03306173|585117858|FG001|Overall Study|Withdrawal by Subject|3|||
162166922|NCT04632992|585664047|FG003|Overall Study|Reason not Specified|1|||
162166923|NCT04632992|585664048|FG004|Overall Study|Reason not Specified|0|||
162166924|NCT04632992|585664049|FG005|Overall Study|Reason not Specified|0|||
162166925|NCT04632992|585664050|FG006|Overall Study|Reason not Specified|0|||
162166926|NCT04632992|585664051|FG007|Overall Study|Reason not Specified|0|||
162166927|NCT04632992|585664052|FG008|Overall Study|Reason not Specified|0|||
162166928|NCT04632992|585664053|FG009|Overall Study|Reason not Specified|0|||
162166929|NCT04632992|585664054|FG010|Overall Study|Reason not Specified|1|||
162166930|NCT04632992|585664055|FG011|Overall Study|Reason not Specified|0|||
162166931|NCT04632992|585664056|FG012|Overall Study|Reason not Specified|0|||
162166932|NCT04632992|585664057|FG013|Overall Study|Reason not Specified|0|||
162166933|NCT04632992|585664044|FG000|Overall Study|Physician Decision|0|||
162166934|NCT04632992|585664045|FG001|Overall Study|Physician Decision|0|||
162166935|NCT04632992|585664046|FG002|Overall Study|Physician Decision|0|||
162166936|NCT04632992|585664047|FG003|Overall Study|Physician Decision|2|||
162166937|NCT04632992|585664048|FG004|Overall Study|Physician Decision|1|||
162166938|NCT04632992|585664049|FG005|Overall Study|Physician Decision|0|||
162166939|NCT04632992|585664050|FG006|Overall Study|Physician Decision|0|||
162017199|NCT03306173|585117857|FG000|Overall Study|Discontinued|4|||
162017200|NCT03306173|585117858|FG001|Overall Study|Discontinued|4|||
162166940|NCT04632992|585664051|FG007|Overall Study|Physician Decision|0|||
162166941|NCT04632992|585664052|FG008|Overall Study|Physician Decision|0|||
162166942|NCT04632992|585664053|FG009|Overall Study|Physician Decision|0|||
162166943|NCT04632992|585664054|FG010|Overall Study|Physician Decision|0|||
162166944|NCT04632992|585664055|FG011|Overall Study|Physician Decision|0|||
162166945|NCT04632992|585664056|FG012|Overall Study|Physician Decision|3|||
162166946|NCT04632992|585664057|FG013|Overall Study|Physician Decision|0|||
162166947|NCT04632992|585664044|FG000|Overall Study|Progressive Disease|0|||
162166948|NCT04632992|585664045|FG001|Overall Study|Progressive Disease|0|||
162166949|NCT04632992|585664046|FG002|Overall Study|Progressive Disease|0|||
162166950|NCT04632992|585664047|FG003|Overall Study|Progressive Disease|0|||
162166951|NCT04632992|585664048|FG004|Overall Study|Progressive Disease|1|||
162166952|NCT04632992|585664049|FG005|Overall Study|Progressive Disease|0|||
162166953|NCT04632992|585664050|FG006|Overall Study|Progressive Disease|0|||
162166954|NCT04632992|585664051|FG007|Overall Study|Progressive Disease|0|||
162166955|NCT04632992|585664052|FG008|Overall Study|Progressive Disease|0|||
162166956|NCT04632992|585664053|FG009|Overall Study|Progressive Disease|1|||
162166957|NCT04632992|585664054|FG010|Overall Study|Progressive Disease|1|||
162166958|NCT04632992|585664055|FG011|Overall Study|Progressive Disease|0|||
162166959|NCT04632992|585664056|FG012|Overall Study|Progressive Disease|2|||
162166960|NCT04632992|585664057|FG013|Overall Study|Progressive Disease|0|||
162166961|NCT04632992|585664044|FG000|Overall Study|Withdrawal by Subject|4|||
162166962|NCT04632992|585664045|FG001|Overall Study|Withdrawal by Subject|1|||
162166963|NCT04632992|585664046|FG002|Overall Study|Withdrawal by Subject|5|||
162166964|NCT04632992|585664047|FG003|Overall Study|Withdrawal by Subject|4|||
162166965|NCT04632992|585664048|FG004|Overall Study|Withdrawal by Subject|3|||
162166966|NCT04632992|585664049|FG005|Overall Study|Withdrawal by Subject|3|||
162166967|NCT04632992|585664050|FG006|Overall Study|Withdrawal by Subject|0|||
162166968|NCT04632992|585664051|FG007|Overall Study|Withdrawal by Subject|5|||
162166969|NCT04632992|585664052|FG008|Overall Study|Withdrawal by Subject|0|||
162166970|NCT04632992|585664053|FG009|Overall Study|Withdrawal by Subject|2|||
162166971|NCT04632992|585664054|FG010|Overall Study|Withdrawal by Subject|8|||
162017201|NCT00573144|585117859|FG000|Overall Study|Withdrawal by Subject|2|||
162166972|NCT04632992|585664055|FG011|Overall Study|Withdrawal by Subject|0|||
162166973|NCT04632992|585664056|FG012|Overall Study|Withdrawal by Subject|1|||
162166974|NCT04632992|585664057|FG013|Overall Study|Withdrawal by Subject|1|||
162166975|NCT02677805|585664058|FG000|Double Blind Phase|Lost to Follow-up|8|||
162166976|NCT02677805|585664059|FG001|Double Blind Phase|Lost to Follow-up|3|||
162166977|NCT02677805|585664060|FG002|Double Blind Phase|Lost to Follow-up|0|||
162166978|NCT02677805|585664058|FG000|Double Blind Phase|Withdrawal by Subject|5|||
162166979|NCT02677805|585664059|FG001|Double Blind Phase|Withdrawal by Subject|2|||
162166980|NCT02677805|585664060|FG002|Double Blind Phase|Withdrawal by Subject|0|||
162166981|NCT02677805|585664058|FG000|Open Label Phase|Lost to Follow-up|0|||
162166982|NCT02677805|585664059|FG001|Open Label Phase|Lost to Follow-up|0|||
162166983|NCT02677805|585664060|FG002|Open Label Phase|Lost to Follow-up|10|||
162166984|NCT02677805|585664058|FG000|Open Label Phase|Withdrawal by Subject|0|||
162166985|NCT02677805|585664059|FG001|Open Label Phase|Withdrawal by Subject|0|||
162166986|NCT02677805|585664060|FG002|Open Label Phase|Withdrawal by Subject|6|||
162166987|NCT04350463|585664065|FG000|Overall Study|Other reason|0|||
162166988|NCT04350463|585664066|FG001|Overall Study|Other reason|0|||
162166989|NCT04350463|585664067|FG002|Overall Study|Other reason|0|||
162166990|NCT04350463|585664068|FG003|Overall Study|Other reason|1|||
162166991|NCT04350463|585664065|FG000|Overall Study|Lost to Follow-up|0|||
162166992|NCT04350463|585664066|FG001|Overall Study|Lost to Follow-up|0|||
161921200|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
162166993|NCT04350463|585664067|FG002|Overall Study|Lost to Follow-up|0|||
162166994|NCT04350463|585664068|FG003|Overall Study|Lost to Follow-up|2|||
162166995|NCT04350463|585664065|FG000|Overall Study|Withdrawal by Subject|4|||
162166996|NCT04350463|585664066|FG001|Overall Study|Withdrawal by Subject|0|||
162166997|NCT04350463|585664067|FG002|Overall Study|Withdrawal by Subject|1|||
162166998|NCT04350463|585664068|FG003|Overall Study|Withdrawal by Subject|4|||
162166999|NCT04350463|585664065|FG000|Overall Study|Adverse Event|0|||
162167000|NCT04350463|585664066|FG001|Overall Study|Adverse Event|0|||
162167001|NCT04350463|585664067|FG002|Overall Study|Adverse Event|0|||
162167002|NCT04350463|585664068|FG003|Overall Study|Adverse Event|2|||
162167003|NCT04350463|585664065|FG000|Overall Study|Death|27|||
162167004|NCT04350463|585664066|FG001|Overall Study|Death|2|||
162167005|NCT04350463|585664067|FG002|Overall Study|Death|13|||
162167006|NCT04350463|585664068|FG003|Overall Study|Death|26|||
162167007|NCT04111536|585664069|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
162167008|NCT04111536|585664070|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
162167009|NCT04111536|585664069|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
162167010|NCT04111536|585664070|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
162167011|NCT04111536|585664069|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
162167012|NCT04111536|585664070|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
162167013|NCT04111536|585664069|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
162167014|NCT04111536|585664070|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
162167015|NCT04652700|585664071|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
162167016|NCT04652700|585664072|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
162167017|NCT04652700|585664071|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
162167018|NCT04652700|585664072|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
162167019|NCT04652700|585664071|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
162167020|NCT04652700|585664072|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
162167021|NCT04652700|585664071|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
162167022|NCT04652700|585664072|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
162167023|NCT04652700|585664071|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
162167024|NCT04652700|585664072|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
162167025|NCT04652700|585664071|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
162167026|NCT04652700|585664072|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
162167027|NCT04652700|585664071|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
162167028|NCT04652700|585664072|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
162167029|NCT04652700|585664071|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
162167030|NCT04652700|585664072|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
162167031|NCT04652700|585664071|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
162167032|NCT04652700|585664072|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
162167033|NCT04187833|585664073|FG000|Overall Study|Withdrawal by Subject|1|||
162167034|NCT06037369|585664077|FG000|Overall Study|Lost to Follow-up|0|||
162167035|NCT06037369|585664078|FG001|Overall Study|Lost to Follow-up|1|||
162167036|NCT04209465|585664079|FG000|Overall Study|Adverse Event|0|||
162167037|NCT04209465|585664080|FG001|Overall Study|Adverse Event|0|||
162167038|NCT04209465|585664081|FG002|Overall Study|Adverse Event|0|||
162167039|NCT04209465|585664082|FG003|Overall Study|Adverse Event|0|||
162167040|NCT04209465|585664083|FG004|Overall Study|Adverse Event|0|||
162167041|NCT04209465|585664084|FG005|Overall Study|Adverse Event|1|||
162167042|NCT04209465|585664085|FG006|Overall Study|Adverse Event|0|||
162167043|NCT04209465|585664086|FG007|Overall Study|Adverse Event|0|||
162167044|NCT04209465|585664087|FG008|Overall Study|Adverse Event|1|||
162167045|NCT04209465|585664088|FG009|Overall Study|Adverse Event|0|||
162167046|NCT04209465|585664089|FG010|Overall Study|Adverse Event|2|||
162167047|NCT04209465|585664090|FG011|Overall Study|Adverse Event|1|||
162167048|NCT04209465|585664091|FG012|Overall Study|Adverse Event|1|||
162167049|NCT04209465|585664079|FG000|Overall Study|Death|1|||
162167050|NCT04209465|585664080|FG001|Overall Study|Death|0|||
162167051|NCT04209465|585664081|FG002|Overall Study|Death|0|||
162167052|NCT04209465|585664082|FG003|Overall Study|Death|0|||
162167053|NCT04209465|585664083|FG004|Overall Study|Death|2|||
162167054|NCT04209465|585664084|FG005|Overall Study|Death|7|||
162167055|NCT04209465|585664085|FG006|Overall Study|Death|2|||
162167056|NCT04209465|585664086|FG007|Overall Study|Death|2|||
162167057|NCT04209465|585664087|FG008|Overall Study|Death|1|||
162167058|NCT04209465|585664088|FG009|Overall Study|Death|1|||
162167059|NCT04209465|585664089|FG010|Overall Study|Death|1|||
162167060|NCT04209465|585664090|FG011|Overall Study|Death|0|||
162167061|NCT04209465|585664091|FG012|Overall Study|Death|10|||
162167062|NCT04209465|585664079|FG000|Overall Study|Physician Decision|0|||
161816035|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
161816036|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
161816037|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
162017202|NCT00573144|585117860|FG001|Overall Study|Withdrawal by Subject|3|||
162167063|NCT04209465|585664080|FG001|Overall Study|Physician Decision|1|||
162167064|NCT04209465|585664081|FG002|Overall Study|Physician Decision|0|||
162167065|NCT04209465|585664082|FG003|Overall Study|Physician Decision|0|||
162167066|NCT04209465|585664083|FG004|Overall Study|Physician Decision|0|||
162167067|NCT04209465|585664084|FG005|Overall Study|Physician Decision|0|||
162167068|NCT04209465|585664085|FG006|Overall Study|Physician Decision|0|||
162167069|NCT04209465|585664086|FG007|Overall Study|Physician Decision|0|||
162167070|NCT04209465|585664087|FG008|Overall Study|Physician Decision|0|||
162167071|NCT04209465|585664088|FG009|Overall Study|Physician Decision|0|||
162167072|NCT04209465|585664089|FG010|Overall Study|Physician Decision|0|||
162167073|NCT04209465|585664090|FG011|Overall Study|Physician Decision|0|||
162167074|NCT04209465|585664091|FG012|Overall Study|Physician Decision|0|||
162167075|NCT04209465|585664079|FG000|Overall Study|Progressive Disease|0|||
162167076|NCT04209465|585664080|FG001|Overall Study|Progressive Disease|0|||
162167077|NCT04209465|585664081|FG002|Overall Study|Progressive Disease|1|||
162167078|NCT04209465|585664082|FG003|Overall Study|Progressive Disease|2|||
162167079|NCT04209465|585664083|FG004|Overall Study|Progressive Disease|8|||
162167080|NCT04209465|585664084|FG005|Overall Study|Progressive Disease|5|||
162167081|NCT04209465|585664085|FG006|Overall Study|Progressive Disease|3|||
162167082|NCT04209465|585664086|FG007|Overall Study|Progressive Disease|4|||
162167083|NCT04209465|585664087|FG008|Overall Study|Progressive Disease|1|||
162167084|NCT04209465|585664088|FG009|Overall Study|Progressive Disease|3|||
162167085|NCT04209465|585664089|FG010|Overall Study|Progressive Disease|2|||
162167086|NCT04209465|585664090|FG011|Overall Study|Progressive Disease|1|||
162167087|NCT04209465|585664091|FG012|Overall Study|Progressive Disease|0|||
162167088|NCT04209465|585664079|FG000|Overall Study|Withdrawal by Subject|0|||
162167089|NCT04209465|585664080|FG001|Overall Study|Withdrawal by Subject|0|||
162167090|NCT04209465|585664081|FG002|Overall Study|Withdrawal by Subject|0|||
162167091|NCT04209465|585664082|FG003|Overall Study|Withdrawal by Subject|0|||
162167092|NCT04209465|585664083|FG004|Overall Study|Withdrawal by Subject|0|||
162167093|NCT04209465|585664084|FG005|Overall Study|Withdrawal by Subject|1|||
162167094|NCT04209465|585664085|FG006|Overall Study|Withdrawal by Subject|2|||
162167095|NCT04209465|585664086|FG007|Overall Study|Withdrawal by Subject|0|||
162167096|NCT04209465|585664087|FG008|Overall Study|Withdrawal by Subject|1|||
162167097|NCT04209465|585664088|FG009|Overall Study|Withdrawal by Subject|0|||
162167098|NCT04209465|585664089|FG010|Overall Study|Withdrawal by Subject|0|||
162167099|NCT04209465|585664090|FG011|Overall Study|Withdrawal by Subject|2|||
162167100|NCT04209465|585664091|FG012|Overall Study|Withdrawal by Subject|2|||
162167101|NCT04209465|585664079|FG000|Overall Study|Lost to Follow-up|0|||
162167102|NCT04209465|585664080|FG001|Overall Study|Lost to Follow-up|0|||
162167103|NCT04209465|585664081|FG002|Overall Study|Lost to Follow-up|0|||
162167104|NCT04209465|585664082|FG003|Overall Study|Lost to Follow-up|0|||
162167105|NCT04209465|585664083|FG004|Overall Study|Lost to Follow-up|0|||
162167106|NCT04209465|585664084|FG005|Overall Study|Lost to Follow-up|1|||
162167107|NCT04209465|585664085|FG006|Overall Study|Lost to Follow-up|0|||
162167108|NCT04209465|585664086|FG007|Overall Study|Lost to Follow-up|0|||
162167109|NCT04209465|585664087|FG008|Overall Study|Lost to Follow-up|1|||
162167110|NCT04209465|585664088|FG009|Overall Study|Lost to Follow-up|0|||
162167111|NCT04209465|585664089|FG010|Overall Study|Lost to Follow-up|0|||
162167112|NCT04209465|585664090|FG011|Overall Study|Lost to Follow-up|1|||
162167113|NCT04209465|585664091|FG012|Overall Study|Lost to Follow-up|0|||
162167114|NCT04209465|585664079|FG000|Overall Study|Started new therapy|0|||
162167115|NCT04209465|585664080|FG001|Overall Study|Started new therapy|0|||
162167116|NCT04209465|585664081|FG002|Overall Study|Started new therapy|0|||
162167117|NCT04209465|585664082|FG003|Overall Study|Started new therapy|0|||
162167118|NCT04209465|585664083|FG004|Overall Study|Started new therapy|0|||
162167119|NCT04209465|585664084|FG005|Overall Study|Started new therapy|1|||
162167120|NCT04209465|585664085|FG006|Overall Study|Started new therapy|0|||
162167121|NCT04209465|585664086|FG007|Overall Study|Started new therapy|0|||
161816038|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
161816039|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
161816040|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
162167122|NCT04209465|585664087|FG008|Overall Study|Started new therapy|0|||
162167123|NCT04209465|585664088|FG009|Overall Study|Started new therapy|0|||
162167124|NCT04209465|585664089|FG010|Overall Study|Started new therapy|0|||
162167125|NCT04209465|585664090|FG011|Overall Study|Started new therapy|0|||
162167126|NCT04209465|585664091|FG012|Overall Study|Started new therapy|0|||
161816041|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
161816042|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
161816043|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
161816044|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
161816045|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
161816046|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
161816047|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
161816048|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
161816049|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
161816050|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
161816051|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
161816052|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
161816053|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
161816054|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
161816055|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
161816056|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
161816057|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
161816058|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
162017203|NCT02637037|585117863|FG000|Overall Study|Positive drug screen at admission|1|||
162167127|NCT04209465|585664079|FG000|Overall Study|Study terminated early by sponsor|0|||
162167128|NCT04209465|585664080|FG001|Overall Study|Study terminated early by sponsor|0|||
162167129|NCT04209465|585664081|FG002|Overall Study|Study terminated early by sponsor|0|||
162167130|NCT04209465|585664082|FG003|Overall Study|Study terminated early by sponsor|0|||
162167131|NCT04209465|585664083|FG004|Overall Study|Study terminated early by sponsor|0|||
162167132|NCT04209465|585664084|FG005|Overall Study|Study terminated early by sponsor|0|||
162167133|NCT04209465|585664085|FG006|Overall Study|Study terminated early by sponsor|3|||
162167134|NCT04209465|585664086|FG007|Overall Study|Study terminated early by sponsor|0|||
162167135|NCT04209465|585664087|FG008|Overall Study|Study terminated early by sponsor|0|||
162167136|NCT04209465|585664088|FG009|Overall Study|Study terminated early by sponsor|0|||
162167137|NCT04209465|585664089|FG010|Overall Study|Study terminated early by sponsor|0|||
162167138|NCT04209465|585664090|FG011|Overall Study|Study terminated early by sponsor|0|||
162167139|NCT04209465|585664091|FG012|Overall Study|Study terminated early by sponsor|3|||
162167140|NCT04209465|585664079|FG000|Overall Study|Other|0|||
162167141|NCT04209465|585664080|FG001|Overall Study|Other|0|||
162167142|NCT04209465|585664081|FG002|Overall Study|Other|0|||
162167143|NCT04209465|585664082|FG003|Overall Study|Other|0|||
162167144|NCT04209465|585664083|FG004|Overall Study|Other|0|||
162167145|NCT04209465|585664084|FG005|Overall Study|Other|0|||
162167146|NCT04209465|585664085|FG006|Overall Study|Other|0|||
162167147|NCT04209465|585664086|FG007|Overall Study|Other|0|||
162167148|NCT04209465|585664087|FG008|Overall Study|Other|1|||
162167149|NCT04209465|585664088|FG009|Overall Study|Other|0|||
162167150|NCT04209465|585664089|FG010|Overall Study|Other|0|||
162167151|NCT04209465|585664090|FG011|Overall Study|Other|0|||
162167152|NCT04209465|585664091|FG012|Overall Study|Other|0|||
162167153|NCT03097549|585664092|FG000|Overall Study|Withdrawal by Subject|1|||
162167154|NCT03097549|585664093|FG001|Overall Study|Withdrawal by Subject|0|||
162167155|NCT03097549|585664092|FG000|Overall Study|Lost to Follow-up|1|||
162167156|NCT03097549|585664093|FG001|Overall Study|Lost to Follow-up|0|||
162167157|NCT05783102|585664094|FG000|Overall Study|Lost to Follow-up|1|||
162167158|NCT05783102|585664094|FG000|Overall Study|Withdrawal by Subject|2|||
162167159|NCT05647304|585664095|FG000|Overall Study|Withdrawal by Subject|1|||
162167160|NCT05647304|585664096|FG001|Overall Study|Withdrawal by Subject|0|||
162167161|NCT04282148|585664099|FG000|Overall Study|Death|7|||
162167162|NCT04282148|585664099|FG000|Overall Study|Withdrawal by Subject|1|||
162167163|NCT04282148|585664099|FG000|Overall Study|Physician Decision|1|||
162167164|NCT02146378|585664100|FG000|Overall Study|No information of administration|2|||
162167165|NCT06215521|585664101|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
162167166|NCT06215521|585664102|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
162167167|NCT06215521|585664103|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
162167168|NCT06215521|585664104|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
162167169|NCT06215521|585664105|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
162167170|NCT06215521|585664106|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
162167171|NCT04096040|585664107|FG000|Overall Study|Protocol Violation|12|||
162167172|NCT04096040|585664107|FG000|Overall Study|Non-compliant site|4|||
161816059|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
161816060|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
161816061|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816062|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
162167173|NCT04973254|585664108|FG000|Overall Study|Not adherent|0|||
162167174|NCT04973254|585664109|FG001|Overall Study|Not adherent|1|||
162167175|NCT04973254|585664110|FG002|Overall Study|Not adherent|0|||
161921201|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161921202|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
161921203|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
161921204|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
161921205|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
161921206|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
161921207|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
161921208|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
162017204|NCT02637037|585117864|FG001|Overall Study|Positive drug screen at admission|0|||
161921209|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
162167176|NCT04044768|585664111|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
162167177|NCT04044768|585664112|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
162167178|NCT05089019|585664113|FG000|Period 1|Withdrawal by Subject|0|||
162167179|NCT05089019|585664114|FG001|Period 1|Withdrawal by Subject|1|||
162167180|NCT05089019|585664113|FG000|Washout Period|Adverse Event|3|||
162167181|NCT05089019|585664114|FG001|Washout Period|Adverse Event|4|||
162167182|NCT05089019|585664113|FG000|Washout Period|Lost to Follow-up|1|||
162167183|NCT05089019|585664114|FG001|Washout Period|Lost to Follow-up|0|||
162167184|NCT05089019|585664113|FG000|Washout Period|Physician Decision|2|||
162167185|NCT05089019|585664114|FG001|Washout Period|Physician Decision|0|||
162167186|NCT05089019|585664113|FG000|Washout Period|Withdrawal by Subject|6|||
162167187|NCT05089019|585664114|FG001|Washout Period|Withdrawal by Subject|3|||
162167188|NCT05089019|585664113|FG000|Period 2|Adverse Event|4|||
162167189|NCT05089019|585664114|FG001|Period 2|Adverse Event|2|||
162167190|NCT05089019|585664113|FG000|Period 2|Lost to Follow-up|1|||
162167191|NCT05089019|585664114|FG001|Period 2|Lost to Follow-up|0|||
162167192|NCT05089019|585664113|FG000|Period 2|Withdrawal by Subject|0|||
162167193|NCT05089019|585664114|FG001|Period 2|Withdrawal by Subject|1|||
162167194|NCT05170009|585664115|FG000|Overall Study|Physician Decision|0|||
162167195|NCT05170009|585664116|FG001|Overall Study|Physician Decision|1|||
162167196|NCT04925986|585664117|FG000|Overall Study|Death|0|||
162167197|NCT04925986|585664118|FG001|Overall Study|Death|0|||
162167198|NCT04925986|585664119|FG002|Overall Study|Death|2|||
162167199|NCT04925986|585664120|FG003|Overall Study|Death|0|||
162167200|NCT04925986|585664117|FG000|Overall Study|Lack of Efficacy|1|||
162167201|NCT04925986|585664118|FG001|Overall Study|Lack of Efficacy|2|||
162167202|NCT04925986|585664119|FG002|Overall Study|Lack of Efficacy|0|||
162167203|NCT04925986|585664120|FG003|Overall Study|Lack of Efficacy|1|||
162167204|NCT04925986|585664117|FG000|Overall Study|Withdrawal by Subject|0|||
162167205|NCT04925986|585664118|FG001|Overall Study|Withdrawal by Subject|0|||
162167206|NCT04925986|585664119|FG002|Overall Study|Withdrawal by Subject|1|||
162167207|NCT04925986|585664120|FG003|Overall Study|Withdrawal by Subject|2|||
162167208|NCT03808818|585664121|FG000|Overall Study|Death|6|||
162167209|NCT03808818|585664122|FG001|Overall Study|Death|6|||
162167210|NCT03808818|585664121|FG000|Overall Study|Withdrawal by Subject|7|||
162167211|NCT03808818|585664122|FG001|Overall Study|Withdrawal by Subject|18|||
162167212|NCT03808818|585664121|FG000|Overall Study|Lost to Follow-up|31|||
162167213|NCT03808818|585664122|FG001|Overall Study|Lost to Follow-up|33|||
162167214|NCT03858634|585664123|FG000|Overall Study|Withdrawal by Subject|1|||
162167215|NCT03858634|585664124|FG001|Overall Study|Withdrawal by Subject|0|||
162167216|NCT03858634|585664123|FG000|Overall Study|Adverse Event|1|||
162167217|NCT03858634|585664124|FG001|Overall Study|Adverse Event|0|||
162167218|NCT03858634|585664123|FG000|Overall Study|Lost to Follow-up|0|||
162167219|NCT03858634|585664124|FG001|Overall Study|Lost to Follow-up|1|||
162167220|NCT03858634|585664123|FG000|Overall Study|Other, Not Specified|1|||
162167221|NCT03858634|585664124|FG001|Overall Study|Other, Not Specified|1|||
162167222|NCT06181760|585664125|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
162167223|NCT06181760|585664126|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
162167224|NCT06181760|585664127|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
162167225|NCT06181760|585664128|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
162167226|NCT05415722|585664130|FG000|Overall Study|Lost to Follow-up|0|||
162167227|NCT05415722|585664131|FG001|Overall Study|Lost to Follow-up|2|||
162167228|NCT05415722|585664132|FG002|Overall Study|Lost to Follow-up|0|||
162167229|NCT05415722|585664133|FG003|Overall Study|Lost to Follow-up|1|||
162167230|NCT05415722|585664134|FG004|Overall Study|Lost to Follow-up|0|||
162167231|NCT05415722|585664135|FG005|Overall Study|Lost to Follow-up|0|||
162167232|NCT05415722|585664136|FG006|Overall Study|Lost to Follow-up|1|||
162167233|NCT05415722|585664130|FG000|Overall Study|Physician Decision|0|||
162167234|NCT05415722|585664131|FG001|Overall Study|Physician Decision|0|||
162017205|NCT02637037|585117863|FG000|Overall Study|Withdrawal by Subject|2|||
162167235|NCT05415722|585664132|FG002|Overall Study|Physician Decision|0|||
162167236|NCT05415722|585664133|FG003|Overall Study|Physician Decision|1|||
162167237|NCT05415722|585664134|FG004|Overall Study|Physician Decision|0|||
162167238|NCT05415722|585664135|FG005|Overall Study|Physician Decision|0|||
162167239|NCT05415722|585664136|FG006|Overall Study|Physician Decision|1|||
162167240|NCT05415722|585664130|FG000|Overall Study|Protocol Violation|0|||
162167241|NCT05415722|585664131|FG001|Overall Study|Protocol Violation|0|||
162167242|NCT05415722|585664132|FG002|Overall Study|Protocol Violation|0|||
162167243|NCT05415722|585664133|FG003|Overall Study|Protocol Violation|1|||
162167244|NCT05415722|585664134|FG004|Overall Study|Protocol Violation|0|||
162167245|NCT05415722|585664135|FG005|Overall Study|Protocol Violation|0|||
162167246|NCT05415722|585664136|FG006|Overall Study|Protocol Violation|0|||
162167247|NCT05415722|585664130|FG000|Overall Study|Sponsor Discretion|0|||
162167248|NCT05415722|585664131|FG001|Overall Study|Sponsor Discretion|0|||
162167249|NCT05415722|585664132|FG002|Overall Study|Sponsor Discretion|0|||
162167250|NCT05415722|585664133|FG003|Overall Study|Sponsor Discretion|0|||
162167251|NCT05415722|585664134|FG004|Overall Study|Sponsor Discretion|1|||
162167252|NCT05415722|585664135|FG005|Overall Study|Sponsor Discretion|1|||
162167253|NCT05415722|585664136|FG006|Overall Study|Sponsor Discretion|0|||
162167254|NCT05415722|585664130|FG000|Overall Study|Withdrawal by Subject|0|||
162167255|NCT05415722|585664131|FG001|Overall Study|Withdrawal by Subject|1|||
162167256|NCT05415722|585664132|FG002|Overall Study|Withdrawal by Subject|0|||
162167257|NCT05415722|585664133|FG003|Overall Study|Withdrawal by Subject|1|||
162167258|NCT05415722|585664134|FG004|Overall Study|Withdrawal by Subject|1|||
162167259|NCT05415722|585664135|FG005|Overall Study|Withdrawal by Subject|0|||
162167260|NCT05415722|585664136|FG006|Overall Study|Withdrawal by Subject|1|||
162167261|NCT04629716|585664137|FG000|Overall Study|Lost to Follow-up|7|||
162167262|NCT04629716|585664138|FG001|Overall Study|Lost to Follow-up|3|||
162167263|NCT03524612|585664139|FG000|Overall Study|Lack of Efficacy|10|||
162167264|NCT03524612|585664139|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
162167265|NCT03524612|585664139|FG000|Overall Study|Adverse Event|10|||
162167266|NCT03524612|585664139|FG000|Overall Study|Withdrawal by Subject|7|||
162167267|NCT03524612|585664139|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
162167268|NCT03524612|585664139|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
162167269|NCT03524612|585664139|FG000|Overall Study|New therapy for study indication|6|||
162167270|NCT03524612|585664139|FG000|Overall Study|Death|3|||
162167271|NCT03524612|585664139|FG000|Overall Study|Lost to Follow-up|2|||
162167272|NCT03524612|585664139|FG000|Overall Study|Protocol Violation|1|||
162167273|NCT04537715|585664141|FG000|Overall Study|Death|3|||
162167274|NCT04537715|585664142|FG001|Overall Study|Death|1|||
162167275|NCT04537715|585664141|FG000|Overall Study|Withdrawal by Subject|3|||
162167276|NCT04537715|585664142|FG001|Overall Study|Withdrawal by Subject|1|||
162167277|NCT04537715|585664141|FG000|Overall Study|Other|4|||
162167278|NCT04537715|585664142|FG001|Overall Study|Other|3|||
162167279|NCT04537715|585664141|FG000|Overall Study|Progressive disease|1|||
162167280|NCT04537715|585664142|FG001|Overall Study|Progressive disease|0|||
162167281|NCT05457647|585664144|FG000|Overall Study|Lost to Follow-up|3|||
162167282|NCT03448107|585664145|FG000|Overall Study|Lost to Follow-up|229|||
162017206|NCT02637037|585117864|FG001|Overall Study|Withdrawal by Subject|1|||
162017207|NCT02637037|585117863|FG000|Overall Study|Adverse Event|1|||
162017208|NCT02637037|585117864|FG001|Overall Study|Adverse Event|0|||
162017209|NCT03339219|585117865|FG000|Overall Study|Death|12|||
162017210|NCT03339219|585117865|FG000|Overall Study|Site Terminated by Sponsor|22|||
162017211|NCT03339219|585117865|FG000|Overall Study|Withdrawal by Subject|1|||
162017212|NCT00074490|585117872|FG000|Overall Study|Progressive malignancy|0|||
162017213|NCT00074490|585117873|FG001|Overall Study|Progressive malignancy|7|||
162017214|NCT00074490|585117874|FG002|Overall Study|Progressive malignancy|0|||
162017215|NCT00074490|585117875|FG003|Overall Study|Progressive malignancy|0|||
162017216|NCT00074490|585117876|FG004|Overall Study|Progressive malignancy|3|||
162167283|NCT03448107|585664146|FG001|Overall Study|Lost to Follow-up|258|||
162167284|NCT03115476|585664147|FG000|LP0084-1369|Death|1|||
162167285|NCT03115476|585664148|FG001|LP0084-1369|Death|0|||
162167286|NCT03115476|585664149|FG002|LP0084-1369|Death|2|||
162167287|NCT03115476|585664147|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
162167288|NCT03115476|585664148|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
162167289|NCT03115476|585664149|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
162167290|NCT02465268|585664154|FG000|Overall Study|Withdrawal by Subject|4|||
162167291|NCT02465268|585664155|FG001|Overall Study|Withdrawal by Subject|3|||
162167292|NCT02465268|585664156|FG002|Overall Study|Withdrawal by Subject|1|||
162167293|NCT02465268|585664154|FG000|Overall Study|Not evaluable per protocol criteria|3|||
162167294|NCT02465268|585664155|FG001|Overall Study|Not evaluable per protocol criteria|2|||
162167295|NCT02465268|585664156|FG002|Overall Study|Not evaluable per protocol criteria|1|||
162167296|NCT02465268|585664154|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
162167297|NCT02465268|585664155|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
162167298|NCT02465268|585664156|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
162167299|NCT02465268|585664154|FG000|Overall Study|Study drug did not pass QA/QC|1|||
162167300|NCT02465268|585664155|FG001|Overall Study|Study drug did not pass QA/QC|0|||
162167301|NCT02465268|585664156|FG002|Overall Study|Study drug did not pass QA/QC|0|||
162167302|NCT02465268|585664154|FG000|Overall Study|Adverse Event|0|||
162167303|NCT02465268|585664155|FG001|Overall Study|Adverse Event|1|||
162167304|NCT02465268|585664156|FG002|Overall Study|Adverse Event|0|||
162167305|NCT02465268|585664154|FG000|Overall Study|Physician Decision|0|||
162167306|NCT02465268|585664155|FG001|Overall Study|Physician Decision|1|||
162167307|NCT02465268|585664156|FG002|Overall Study|Physician Decision|0|||
162167308|NCT03322267|585664158|FG000|Overall Study|Lack of Efficacy|11|||
162167309|NCT03322267|585664158|FG000|Overall Study|Adverse Event|1|||
162167310|NCT03322267|585664158|FG000|Overall Study|Withdrawal by Subject|2|||
162167311|NCT05228457|585664161|FG000|Overall Study|Withdrawal by Subject|1|||
162167312|NCT05228457|585664162|FG001|Overall Study|Withdrawal by Subject|1|||
162167313|NCT01799265|585664169|FG000|Overall Study|Lost to Follow-up|1|||
162167314|NCT01799265|585664170|FG001|Overall Study|Lost to Follow-up|0|||
162167315|NCT01799265|585664169|FG000|Overall Study|Protocol Violation|2|||
162167316|NCT01799265|585664170|FG001|Overall Study|Protocol Violation|1|||
162167317|NCT01799265|585664169|FG000|Overall Study|inadequate sleep study|0|||
162167318|NCT01799265|585664170|FG001|Overall Study|inadequate sleep study|2|||
162167319|NCT03084536|585664174|FG000|Overall Study|Determined to be ineligible|0|||
162167320|NCT03084536|585664175|FG001|Overall Study|Determined to be ineligible|0|||
162167321|NCT03084536|585664176|FG002|Overall Study|Determined to be ineligible|16|||
162167322|NCT03084536|585664174|FG000|Overall Study|Withdrawal by Subject|0|||
162167323|NCT03084536|585664175|FG001|Overall Study|Withdrawal by Subject|0|||
162167324|NCT03084536|585664176|FG002|Overall Study|Withdrawal by Subject|4|||
162167325|NCT03084536|585664174|FG000|Overall Study|Physician Decision|0|||
162167326|NCT03084536|585664175|FG001|Overall Study|Physician Decision|0|||
162167327|NCT03084536|585664176|FG002|Overall Study|Physician Decision|3|||
162167328|NCT03084536|585664174|FG000|Overall Study|Death|0|||
162167329|NCT03084536|585664175|FG001|Overall Study|Death|0|||
162167330|NCT03084536|585664176|FG002|Overall Study|Death|1|||
162167331|NCT03084536|585664174|FG000|Overall Study|Lost to Follow-up|0|||
162167332|NCT03084536|585664175|FG001|Overall Study|Lost to Follow-up|0|||
162167333|NCT03084536|585664176|FG002|Overall Study|Lost to Follow-up|1|||
162167334|NCT03084536|585664174|FG000|Overall Study|Protocol Violation|0|||
162167335|NCT03084536|585664175|FG001|Overall Study|Protocol Violation|0|||
162167336|NCT03084536|585664176|FG002|Overall Study|Protocol Violation|1|||
162167337|NCT03084536|585664174|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
162167338|NCT03084536|585664175|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
162167339|NCT03084536|585664176|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
162167340|NCT05704543|585664177|FG000|Overall Study|Withdrawal by Subject|1|||
162167341|NCT05704543|585664178|FG001|Overall Study|Withdrawal by Subject|1|||
162167342|NCT05704543|585664179|FG002|Overall Study|Withdrawal by Subject|0|||
162167343|NCT05704543|585664180|FG003|Overall Study|Withdrawal by Subject|2|||
162167344|NCT05704543|585664177|FG000|Overall Study|Lost to Follow-up|1|||
162167345|NCT05704543|585664178|FG001|Overall Study|Lost to Follow-up|2|||
162167346|NCT05704543|585664179|FG002|Overall Study|Lost to Follow-up|0|||
162167347|NCT05704543|585664180|FG003|Overall Study|Lost to Follow-up|0|||
162167348|NCT04830800|585664184|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
162167349|NCT04830800|585664185|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
162167350|NCT04830800|585664186|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
162167351|NCT04830800|585664187|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
162167352|NCT04830800|585664188|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
162167353|NCT05302596|585664200|FG000|Overall Study|Withdrawal by Subject|1|||
162167354|NCT05302596|585664201|FG001|Overall Study|Withdrawal by Subject|1|||
162167355|NCT03287817|585666516|FG000|Overall Study|Progressive disease|4|||
162167356|NCT03287817|585666517|FG001|Overall Study|Progressive disease|2|||
162167357|NCT03287817|585666518|FG002|Overall Study|Progressive disease|3|||
162167358|NCT03287817|585666519|FG003|Overall Study|Progressive disease|10|||
162167359|NCT03287817|585666520|FG004|Overall Study|Progressive disease|8|||
162167360|NCT03287817|585666516|FG000|Overall Study|Death|0|||
162167361|NCT03287817|585666517|FG001|Overall Study|Death|0|||
162167362|NCT03287817|585666518|FG002|Overall Study|Death|2|||
162167363|NCT03287817|585666519|FG003|Overall Study|Death|3|||
162167364|NCT03287817|585666520|FG004|Overall Study|Death|4|||
162167365|NCT03287817|585666516|FG000|Overall Study|Physician Decision|0|||
162167366|NCT03287817|585666517|FG001|Overall Study|Physician Decision|0|||
162167367|NCT03287817|585666518|FG002|Overall Study|Physician Decision|0|||
162167368|NCT03287817|585666519|FG003|Overall Study|Physician Decision|1|||
162167369|NCT03287817|585666520|FG004|Overall Study|Physician Decision|0|||
162167370|NCT03287817|585666516|FG000|Overall Study|Withdrawal by Subject|0|||
162167371|NCT03287817|585666517|FG001|Overall Study|Withdrawal by Subject|0|||
162167372|NCT03287817|585666518|FG002|Overall Study|Withdrawal by Subject|0|||
162167373|NCT03287817|585666519|FG003|Overall Study|Withdrawal by Subject|0|||
162167374|NCT03287817|585666520|FG004|Overall Study|Withdrawal by Subject|4|||
162167375|NCT04130438|585666525|FG000|Overall Study|Lost to Follow-up|0|||
162167376|NCT04130438|585666526|FG001|Overall Study|Lost to Follow-up|0|||
162167377|NCT04130438|585666527|FG002|Overall Study|Lost to Follow-up|1|||
162167378|NCT03338933|585666531|FG000|Screening Visit|Lost to Follow-up|1|||
162167379|NCT03338933|585666532|FG001|Screening Visit|Lost to Follow-up|3|||
162167380|NCT03338933|585666533|FG002|Screening Visit|Lost to Follow-up|1|||
162167381|NCT03338933|585666534|FG003|Screening Visit|Lost to Follow-up|4|||
162167382|NCT03338933|585666531|FG000|Screening Visit|Screen fail after consent|2|||
162167383|NCT03338933|585666532|FG001|Screening Visit|Screen fail after consent|7|||
162167384|NCT03338933|585666533|FG002|Screening Visit|Screen fail after consent|1|||
162167385|NCT03338933|585666534|FG003|Screening Visit|Screen fail after consent|4|||
162167386|NCT03338933|585666531|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
162167387|NCT03338933|585666532|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
162167388|NCT03338933|585666533|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
162167389|NCT03338933|585666534|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
162167390|NCT03338933|585666531|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
162167391|NCT03338933|585666532|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
162167392|NCT03338933|585666533|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
162167393|NCT03338933|585666534|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
162167394|NCT03338933|585666531|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
162167395|NCT03338933|585666532|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
162167396|NCT03338933|585666533|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
162167397|NCT03338933|585666534|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
162167398|NCT04764448|585666535|FG000|Overall Study|Study terminated by sponsor|2|||
162167399|NCT04764448|585666536|FG001|Overall Study|Study terminated by sponsor|2|||
162167400|NCT04764448|585666537|FG002|Overall Study|Study terminated by sponsor|5|||
162167401|NCT04764448|585666535|FG000|Overall Study|Withdrawal by Subject|3|||
162167402|NCT04764448|585666536|FG001|Overall Study|Withdrawal by Subject|3|||
162167403|NCT04764448|585666537|FG002|Overall Study|Withdrawal by Subject|1|||
162167404|NCT01084876|585666538|FG000|Main Study Treatment Period|Adverse Event|12|||
162167405|NCT01084876|585666539|FG001|Main Study Treatment Period|Adverse Event|7|||
162167406|NCT01084876|585666538|FG000|Main Study Treatment Period|Disease Progression|41|||
162167407|NCT01084876|585666539|FG001|Main Study Treatment Period|Disease Progression|24|||
162167408|NCT01084876|585666538|FG000|Main Study Treatment Period|Physician Decision|2|||
162167409|NCT01084876|585666539|FG001|Main Study Treatment Period|Physician Decision|0|||
162167410|NCT01084876|585666538|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
162167411|NCT01084876|585666539|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
162167412|NCT01084876|585666538|FG000|Main Study Treatment Period|Other Reason|0|||
162167413|NCT01084876|585666539|FG001|Main Study Treatment Period|Other Reason|1|||
162167414|NCT01084876|585666538|FG000|Main Study Treatment Period|Other|0|||
162167415|NCT01084876|585666539|FG001|Main Study Treatment Period|Other|1|||
162017217|NCT00074490|585117877|FG005|Overall Study|Progressive malignancy|0|||
162167416|NCT01084876|585666538|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
162167417|NCT01084876|585666539|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
162167418|NCT01084876|585666538|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
162167419|NCT01084876|585666539|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
162167420|NCT01084876|585666538|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
162167421|NCT01084876|585666539|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
162167422|NCT01084876|585666538|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
162167423|NCT01084876|585666539|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
162167424|NCT01084876|585666538|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
162167425|NCT01084876|585666539|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
162167426|NCT01084876|585666538|FG000|Treatment Period Beyond Cycle 8|Other|6|||
162167427|NCT01084876|585666539|FG001|Treatment Period Beyond Cycle 8|Other|9|||
162167428|NCT04515576|585666540|FG000|Overall Study|Withdrawal by Subject|0|||
162167429|NCT04515576|585666541|FG001|Overall Study|Withdrawal by Subject|0|||
162167430|NCT04515576|585666542|FG002|Overall Study|Withdrawal by Subject|0|||
162167431|NCT04515576|585666543|FG003|Overall Study|Withdrawal by Subject|0|||
162167432|NCT04515576|585666544|FG004|Overall Study|Withdrawal by Subject|0|||
162167433|NCT04515576|585666545|FG005|Overall Study|Withdrawal by Subject|1|||
162167434|NCT04256941|585666547|FG000|Overall Study|Withdrawal by Subject|0|||
162167435|NCT04256941|585666548|FG001|Overall Study|Withdrawal by Subject|1|||
162167436|NCT04256941|585666547|FG000|Overall Study|Death|1|||
162167437|NCT04256941|585666548|FG001|Overall Study|Death|0|||
162167438|NCT04256941|585666547|FG000|Overall Study|Disease Progession|0|||
162167439|NCT04256941|585666548|FG001|Overall Study|Disease Progession|2|||
162167440|NCT03869866|585666553|FG000|Overall Study|Protocol Violation|1|||
162167441|NCT03869866|585666553|FG000|Overall Study|Withdrawal by Subject|3|||
162167442|NCT06181227|585666554|FG000|Overall Study|Study terminated by sponsor|7|||
162167443|NCT06181227|585666555|FG001|Overall Study|Study terminated by sponsor|9|||
162167444|NCT05543915|585666556|FG000|Overall Study|Lost to Follow-up|0|||
162167445|NCT05543915|585666557|FG001|Overall Study|Lost to Follow-up|1|||
162167446|NCT02577835|585666558|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
162167447|NCT04342494|585666559|FG000|Overall Study|Questionnaire partially completed|1|||
162167448|NCT04342494|585666560|FG001|Overall Study|Questionnaire partially completed|0|||
162167449|NCT04342494|585666561|FG002|Overall Study|Questionnaire partially completed|2|||
162167450|NCT04342494|585666562|FG003|Overall Study|Questionnaire partially completed|0|||
162167451|NCT04342494|585666563|FG004|Overall Study|Questionnaire partially completed|1|||
162167452|NCT04342494|585666559|FG000|Overall Study|Lost to Follow-up|49|||
162167453|NCT04342494|585666560|FG001|Overall Study|Lost to Follow-up|38|||
162167454|NCT04342494|585666561|FG002|Overall Study|Lost to Follow-up|34|||
162167455|NCT04342494|585666562|FG003|Overall Study|Lost to Follow-up|34|||
162167456|NCT04342494|585666563|FG004|Overall Study|Lost to Follow-up|35|||
162167457|NCT05119023|585666565|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
162167458|NCT05119023|585666565|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
162167459|NCT05119023|585666565|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
162167460|NCT03194217|585666566|FG000|Overall Study|Adverse Event|0|||
162167461|NCT03194217|585666567|FG001|Overall Study|Adverse Event|2|||
162167462|NCT03194217|585666568|FG002|Overall Study|Adverse Event|3|||
162167463|NCT03194217|585666569|FG003|Overall Study|Adverse Event|3|||
162167464|NCT03194217|585666566|FG000|Overall Study|Failure to meet randomisation criteria|0|||
162167465|NCT03194217|585666567|FG001|Overall Study|Failure to meet randomisation criteria|0|||
162167466|NCT03194217|585666568|FG002|Overall Study|Failure to meet randomisation criteria|0|||
162167467|NCT03194217|585666569|FG003|Overall Study|Failure to meet randomisation criteria|1|||
162167468|NCT03194217|585666566|FG000|Overall Study|Other|0|||
162167469|NCT03194217|585666567|FG001|Overall Study|Other|1|||
162167470|NCT03194217|585666568|FG002|Overall Study|Other|1|||
162167471|NCT03194217|585666569|FG003|Overall Study|Other|0|||
162167472|NCT02962895|585666570|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
162167473|NCT02962895|585666571|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
162167474|NCT02962895|585666572|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
162167475|NCT02962895|585666573|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
162167476|NCT02962895|585666574|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
162167477|NCT02962895|585666575|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
162167478|NCT02962895|585666576|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
162167479|NCT02962895|585666570|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
162167480|NCT02962895|585666571|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
162167481|NCT02962895|585666572|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
162167482|NCT02962895|585666573|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
162167483|NCT02962895|585666574|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
162167484|NCT02962895|585666575|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
162167485|NCT02962895|585666576|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
162167486|NCT02962895|585666570|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
162167487|NCT02962895|585666571|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
162167488|NCT02962895|585666572|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
162167489|NCT02962895|585666573|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
162167490|NCT02962895|585666574|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
162167491|NCT02962895|585666575|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
162167492|NCT02962895|585666576|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
162167493|NCT02962895|585666570|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
162167494|NCT02962895|585666571|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162167495|NCT02962895|585666572|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162167496|NCT02962895|585666573|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162167497|NCT02962895|585666574|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162167498|NCT02962895|585666575|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162167499|NCT02962895|585666576|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
162167500|NCT02962895|585666570|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
162167501|NCT02962895|585666571|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
162167502|NCT02962895|585666572|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
162167503|NCT02962895|585666573|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
162167504|NCT02962895|585666574|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
162167505|NCT02962895|585666575|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
162167506|NCT02962895|585666576|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
162167507|NCT02962895|585666570|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
162167508|NCT02962895|585666571|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
162167509|NCT02962895|585666572|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
162167510|NCT02962895|585666573|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
162167511|NCT02962895|585666574|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
162167512|NCT02962895|585666575|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
162167513|NCT02962895|585666576|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
162167514|NCT02962895|585666570|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162167515|NCT02962895|585666571|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162167516|NCT02962895|585666572|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162167517|NCT02962895|585666573|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162167518|NCT02962895|585666574|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162167519|NCT02962895|585666575|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
162167520|NCT02962895|585666576|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
162167521|NCT02962895|585666570|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
162167522|NCT02962895|585666571|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
162167523|NCT02962895|585666572|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
162167524|NCT02962895|585666573|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
162167525|NCT02962895|585666574|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
162167526|NCT02962895|585666575|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
162167527|NCT02962895|585666576|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
162167528|NCT02962895|585666570|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
162167529|NCT02962895|585666571|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
162167530|NCT02962895|585666572|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
162167531|NCT02962895|585666573|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
162167532|NCT02962895|585666574|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
162017218|NCT03155841|585117883|FG000|Overall Study|Protocol Violation|3|||
162167533|NCT02962895|585666575|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
162167534|NCT02962895|585666576|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
162167535|NCT02962895|585666570|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
162167536|NCT02962895|585666571|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
162167537|NCT02962895|585666572|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
162167538|NCT02962895|585666573|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
162167539|NCT02962895|585666574|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
162167540|NCT02962895|585666575|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
162167541|NCT02962895|585666576|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
162167542|NCT02962895|585666570|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162167543|NCT02962895|585666571|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162167544|NCT02962895|585666572|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162167545|NCT02962895|585666573|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162167546|NCT02962895|585666574|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
162167547|NCT02962895|585666575|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162167548|NCT02962895|585666576|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
162167549|NCT02962895|585666570|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
162167550|NCT02962895|585666571|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
162167551|NCT02962895|585666572|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
162167552|NCT02962895|585666573|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
162167553|NCT02962895|585666574|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
162167554|NCT02962895|585666575|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
162167555|NCT02962895|585666576|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
162167556|NCT02962895|585666570|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
162167557|NCT02962895|585666571|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
162167558|NCT02962895|585666572|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
162167559|NCT02962895|585666573|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
162167560|NCT02962895|585666574|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
162167561|NCT02962895|585666575|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
162167562|NCT02962895|585666576|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
162167563|NCT02962895|585666570|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
162167564|NCT02962895|585666571|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
162167565|NCT02962895|585666572|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
162167566|NCT02962895|585666573|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
162167567|NCT02962895|585666574|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
162167568|NCT02962895|585666575|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
162167569|NCT02962895|585666576|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
162167570|NCT04509674|585666579|FG000|Overall Study|Not treated|33|||
162167571|NCT04509674|585666580|FG001|Overall Study|Not treated|26|||
162167572|NCT04509674|585666579|FG000|Overall Study|Protocol Violation|9|||
162167573|NCT04509674|585666580|FG001|Overall Study|Protocol Violation|10|||
162167574|NCT04509674|585666579|FG000|Overall Study|Lost to Follow-up|31|||
162167575|NCT04509674|585666580|FG001|Overall Study|Lost to Follow-up|39|||
162167576|NCT04509674|585666579|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
162167577|NCT04509674|585666580|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
162167578|NCT04509674|585666579|FG000|Overall Study|Adverse event, serious fatal event|11|||
162167579|NCT04509674|585666580|FG001|Overall Study|Adverse event, serious fatal event|4|||
162167580|NCT04509674|585666579|FG000|Overall Study|Adverse event, non-fatal event|107|||
162167581|NCT04509674|585666580|FG001|Overall Study|Adverse event, non-fatal event|118|||
162167582|NCT04509674|585666579|FG000|Overall Study|Other reason than listed|106|||
162167583|NCT04509674|585666580|FG001|Overall Study|Other reason than listed|95|||
162167584|NCT06190691|585666590|FG000|Overall Study|Adverse Event|2|||
162167585|NCT06190691|585666591|FG001|Overall Study|Adverse Event|0|||
162167586|NCT06190691|585666592|FG002|Overall Study|Adverse Event|0|||
162167587|NCT06190691|585666593|FG003|Overall Study|Adverse Event|0|||
162167588|NCT03016754|585666595|FG000|Overall Study|Death|5|||
162167589|NCT03016754|585666596|FG001|Overall Study|Death|4|||
162167590|NCT03016754|585666597|FG002|Overall Study|Death|5|||
162167591|NCT03016754|585666598|FG003|Overall Study|Death|1|||
162167592|NCT03016754|585666595|FG000|Overall Study|Lost to Follow-up|23|||
162167593|NCT03016754|585666596|FG001|Overall Study|Lost to Follow-up|17|||
162167594|NCT03016754|585666597|FG002|Overall Study|Lost to Follow-up|4|||
162167595|NCT03016754|585666598|FG003|Overall Study|Lost to Follow-up|2|||
162167596|NCT03016754|585666595|FG000|Overall Study|Withdrawal by Subject|6|||
162167597|NCT03016754|585666596|FG001|Overall Study|Withdrawal by Subject|6|||
162167598|NCT03016754|585666597|FG002|Overall Study|Withdrawal by Subject|2|||
162167599|NCT03016754|585666598|FG003|Overall Study|Withdrawal by Subject|2|||
162167600|NCT03016754|585666595|FG000|Overall Study|Other/Unknown|2|||
162167601|NCT03016754|585666596|FG001|Overall Study|Other/Unknown|4|||
162167602|NCT03016754|585666597|FG002|Overall Study|Other/Unknown|2|||
162167603|NCT03016754|585666598|FG003|Overall Study|Other/Unknown|1|||
162167604|NCT03016754|585666595|FG000|Overall Study|Protocol Violation|0|||
162167605|NCT03016754|585666596|FG001|Overall Study|Protocol Violation|0|||
162167606|NCT03016754|585666597|FG002|Overall Study|Protocol Violation|0|||
162167607|NCT03016754|585666598|FG003|Overall Study|Protocol Violation|4|||
162167608|NCT03896789|585666605|FG000|Baseline|Lost to Follow-up|1|||
162167609|NCT03896789|585666606|FG001|Baseline|Lost to Follow-up|2|||
162167610|NCT03896789|585666605|FG000|Baseline|Death|3|||
162167611|NCT03896789|585666606|FG001|Baseline|Death|6|||
162167612|NCT03896789|585666605|FG000|Post-Randomization|Lost to Follow-up|12|||
162167613|NCT03896789|585666606|FG001|Post-Randomization|Lost to Follow-up|11|||
162167614|NCT03896789|585666605|FG000|Post-Randomization|Death|12|||
162167615|NCT03896789|585666606|FG001|Post-Randomization|Death|13|||
162167616|NCT04473222|585666607|FG000|Overall Study|Lost to Follow-up|13|||
162167617|NCT04473222|585666608|FG001|Overall Study|Lost to Follow-up|13|||
162167618|NCT04473222|585666607|FG000|Overall Study|Withdrawal by Subject|0|||
162167619|NCT04473222|585666608|FG001|Overall Study|Withdrawal by Subject|1|||
162167620|NCT04473222|585666607|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
162167621|NCT04473222|585666608|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
162167622|NCT01098812|585666617|FG000|Overall Study|Death|2|||
162167623|NCT01098812|585666618|FG001|Overall Study|Death|0|||
162167624|NCT01098812|585666619|FG002|Overall Study|Death|1|||
162167625|NCT01098812|585666617|FG000|Overall Study|Lost to Follow-up|0|||
162167626|NCT01098812|585666618|FG001|Overall Study|Lost to Follow-up|1|||
162167627|NCT01098812|585666619|FG002|Overall Study|Lost to Follow-up|0|||
162167628|NCT02319759|585666620|FG000|Week 0 - 16|Lack of Efficacy|1|||
162167629|NCT02319759|585666621|FG001|Week 0 - 16|Lack of Efficacy|0|||
162167630|NCT02319759|585666622|FG002|Week 0 - 16|Lack of Efficacy|0|||
162167631|NCT02319759|585666623|FG003|Week 0 - 16|Lack of Efficacy|0|||
162167632|NCT02319759|585666624|FG004|Week 0 - 16|Lack of Efficacy|0|||
162167633|NCT02319759|585666620|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
162167634|NCT02319759|585666621|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
162167635|NCT02319759|585666622|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
162167636|NCT02319759|585666623|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
162167637|NCT02319759|585666624|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
162167638|NCT02319759|585666620|FG000|Week 16 - 24|Lack of Efficacy|1|||
162167639|NCT02319759|585666621|FG001|Week 16 - 24|Lack of Efficacy|0|||
162167640|NCT02319759|585666622|FG002|Week 16 - 24|Lack of Efficacy|1|||
162167641|NCT02319759|585666623|FG003|Week 16 - 24|Lack of Efficacy|0|||
162167642|NCT02319759|585666624|FG004|Week 16 - 24|Lack of Efficacy|0|||
162167643|NCT02319759|585666620|FG000|Week 16 - 24|Lost to Follow-up|1|||
162167644|NCT02319759|585666621|FG001|Week 16 - 24|Lost to Follow-up|0|||
162167645|NCT02319759|585666622|FG002|Week 16 - 24|Lost to Follow-up|0|||
162167646|NCT02319759|585666623|FG003|Week 16 - 24|Lost to Follow-up|0|||
162167647|NCT02319759|585666624|FG004|Week 16 - 24|Lost to Follow-up|0|||
162167648|NCT02319759|585666620|FG000|Week 16 - 24|Withdrawal by Subject|0|||
162167649|NCT02319759|585666621|FG001|Week 16 - 24|Withdrawal by Subject|0|||
162167650|NCT02319759|585666622|FG002|Week 16 - 24|Withdrawal by Subject|2|||
162167651|NCT02319759|585666623|FG003|Week 16 - 24|Withdrawal by Subject|0|||
162167652|NCT02319759|585666624|FG004|Week 16 - 24|Withdrawal by Subject|0|||
162167653|NCT02319759|585666620|FG000|Week 24 - 56|Adverse Event|0|||
162167654|NCT02319759|585666621|FG001|Week 24 - 56|Adverse Event|0|||
162167655|NCT02319759|585666622|FG002|Week 24 - 56|Adverse Event|2|||
162167656|NCT02319759|585666623|FG003|Week 24 - 56|Adverse Event|0|||
162167657|NCT02319759|585666624|FG004|Week 24 - 56|Adverse Event|0|||
162167658|NCT02319759|585666620|FG000|Week 24 - 56|Lack of Efficacy|0|||
162167659|NCT02319759|585666621|FG001|Week 24 - 56|Lack of Efficacy|0|||
162167660|NCT02319759|585666622|FG002|Week 24 - 56|Lack of Efficacy|0|||
161921210|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
162167661|NCT02319759|585666623|FG003|Week 24 - 56|Lack of Efficacy|2|||
162167662|NCT02319759|585666624|FG004|Week 24 - 56|Lack of Efficacy|1|||
162167663|NCT02319759|585666620|FG000|Week 24 - 56|Withdrawal by Subject|0|||
162167664|NCT02319759|585666621|FG001|Week 24 - 56|Withdrawal by Subject|1|||
162167665|NCT02319759|585666622|FG002|Week 24 - 56|Withdrawal by Subject|0|||
162167666|NCT02319759|585666623|FG003|Week 24 - 56|Withdrawal by Subject|0|||
162167667|NCT02319759|585666624|FG004|Week 24 - 56|Withdrawal by Subject|0|||
161921211|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161921212|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
162167668|NCT02319759|585666620|FG000|Week 24 - 56|Lost to Follow-up|0|||
162167669|NCT02319759|585666621|FG001|Week 24 - 56|Lost to Follow-up|0|||
162167670|NCT02319759|585666622|FG002|Week 24 - 56|Lost to Follow-up|0|||
161921213|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161921214|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161921215|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
162167671|NCT02319759|585666623|FG003|Week 24 - 56|Lost to Follow-up|0|||
162167672|NCT02319759|585666624|FG004|Week 24 - 56|Lost to Follow-up|1|||
162167673|NCT03474679|585666633|FG000|Overall Study|Death|7|||
161921216|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161921217|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
161921218|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161921219|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161921220|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
162017219|NCT03155841|585117884|FG001|Overall Study|Protocol Violation|4|||
162167674|NCT03474679|585666633|FG000|Overall Study|Withdrawal by Subject|1|||
162167675|NCT01539083|585666637|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
162167676|NCT01539083|585666638|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
162167677|NCT01539083|585666639|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
161921221|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
162167678|NCT01539083|585666637|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
162167679|NCT01539083|585666638|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
162167680|NCT01539083|585666639|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
162167681|NCT01539083|585666637|FG000|Before Randomization (VCD Induction)|Death|6|||
162167682|NCT01539083|585666638|FG001|Before Randomization (VCD Induction)|Death|0|||
162017220|NCT04308291|585117885|FG000|Run-In Phase|Withdrawal by Subject|4|||
162017221|NCT04308291|585117885|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
162167683|NCT01539083|585666639|FG002|Before Randomization (VCD Induction)|Death|0|||
161816063|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816064|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816065|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816066|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
162167684|NCT01539083|585666637|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
162167685|NCT01539083|585666638|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
162167686|NCT01539083|585666639|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
162167687|NCT01539083|585666637|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
162167688|NCT01539083|585666638|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
162167689|NCT01539083|585666639|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
162167690|NCT01539083|585666637|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
162167691|NCT01539083|585666638|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
162167692|NCT01539083|585666639|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
162167693|NCT01539083|585666637|FG000|Before Randomization (VCD Induction)|Other|5|||
162167694|NCT01539083|585666638|FG001|Before Randomization (VCD Induction)|Other|0|||
162167695|NCT01539083|585666639|FG002|Before Randomization (VCD Induction)|Other|0|||
162167696|NCT01539083|585666637|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
162167697|NCT01539083|585666638|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
162167698|NCT01539083|585666639|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
162167699|NCT01539083|585666637|FG000|After Randomization (TP and VTP)|Other|0|||
162167700|NCT01539083|585666638|FG001|After Randomization (TP and VTP)|Other|1|||
162167701|NCT01539083|585666639|FG002|After Randomization (TP and VTP)|Other|1|||
162167702|NCT01539083|585666637|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
162167703|NCT01539083|585666638|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
162167704|NCT01539083|585666639|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
162167705|NCT01539083|585666637|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
162167706|NCT01539083|585666638|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
162167707|NCT01539083|585666639|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
162167708|NCT01539083|585666637|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
162167709|NCT01539083|585666638|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
162167710|NCT01539083|585666639|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
162167711|NCT01539083|585666637|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
162167712|NCT01539083|585666638|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
162167713|NCT01539083|585666639|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
162167714|NCT01539083|585666637|FG000|After Randomization (TP and VTP)|Death|0|||
162167715|NCT01539083|585666638|FG001|After Randomization (TP and VTP)|Death|6|||
162167716|NCT01539083|585666639|FG002|After Randomization (TP and VTP)|Death|11|||
162167717|NCT02573493|585666640|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
162167718|NCT02573493|585666641|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
162167719|NCT02573493|585666642|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
162167720|NCT02573493|585666643|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
162167721|NCT04623671|585666644|FG000|Overall Study|Adverse Event|0|||
162167722|NCT04623671|585666645|FG001|Overall Study|Adverse Event|1|||
162167723|NCT04623671|585666644|FG000|Overall Study|Lost to Follow-up|2|||
162167724|NCT04623671|585666645|FG001|Overall Study|Lost to Follow-up|1|||
162167725|NCT04623671|585666644|FG000|Overall Study|Death|5|||
161816067|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
162017222|NCT04308291|585117885|FG000|Study Phase 6-M|Physician Decision|2|||
162017223|NCT04308291|585117885|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
162167726|NCT04623671|585666645|FG001|Overall Study|Death|5|||
162167727|NCT04025554|585666646|FG000|Overall Study|Adverse Event|3|||
162167728|NCT01802788|585666650|FG000|Overall Study|Withdrawal by Subject|102|||
162167729|NCT01802788|585666651|FG001|Overall Study|Withdrawal by Subject|5|||
162167730|NCT01802788|585666650|FG000|Overall Study|Death|382|||
162167731|NCT01802788|585666651|FG001|Overall Study|Death|18|||
162167732|NCT01802788|585666650|FG000|Overall Study|Lost to Follow-up|31|||
162167733|NCT01802788|585666651|FG001|Overall Study|Lost to Follow-up|2|||
162167734|NCT01802788|585666650|FG000|Overall Study|Physician Decision|3|||
162167735|NCT01802788|585666651|FG001|Overall Study|Physician Decision|0|||
162167736|NCT01802788|585666650|FG000|Overall Study|Patient Non-Compliance|1|||
162167737|NCT01802788|585666651|FG001|Overall Study|Patient Non-Compliance|0|||
162167738|NCT01802788|585666650|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
162167739|NCT01802788|585666651|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
162167740|NCT01802788|585666650|FG000|Overall Study|Other Reasons|19|||
162167741|NCT01802788|585666651|FG001|Overall Study|Other Reasons|0|||
162167742|NCT05257486|585666652|FG000|Overall Study|Protocol Violation|3|||
162167743|NCT04542317|585666653|FG000|Overall Study|Care recipients passed away|18|||
162167744|NCT04542317|585666654|FG001|Overall Study|Care recipients passed away|13|||
162167745|NCT04542317|585666653|FG000|Overall Study|No longer a primary caregiver|5|||
162167746|NCT04542317|585666654|FG001|Overall Study|No longer a primary caregiver|1|||
162167747|NCT04542317|585666653|FG000|Overall Study|Withdrawal by Subject|4|||
162167748|NCT04542317|585666654|FG001|Overall Study|Withdrawal by Subject|2|||
162167749|NCT04542317|585666653|FG000|Overall Study|Caregivers passed away|0|||
162167750|NCT04542317|585666654|FG001|Overall Study|Caregivers passed away|2|||
162167751|NCT04700163|585666657|FG000|Overall Study|Lost to Follow-up|0|||
162167752|NCT04700163|585666658|FG001|Overall Study|Lost to Follow-up|0|||
162167753|NCT04700163|585666659|FG002|Overall Study|Lost to Follow-up|0|||
162167754|NCT04700163|585666660|FG003|Overall Study|Lost to Follow-up|0|||
162167755|NCT04700163|585666661|FG004|Overall Study|Lost to Follow-up|0|||
162167756|NCT04700163|585666662|FG005|Overall Study|Lost to Follow-up|1|||
162167757|NCT03848065|585666665|FG000|Overall Study|Death|0|||
162167758|NCT03848065|585666666|FG001|Overall Study|Death|1|||
162167759|NCT03848065|585666667|FG002|Overall Study|Death|0|||
161816068|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816069|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816070|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
161816071|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816072|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816073|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816074|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816075|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816076|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816077|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816078|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816079|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816080|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816081|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816082|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816083|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816084|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816085|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816086|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161816087|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816088|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816089|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816090|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816091|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816092|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816093|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816094|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816095|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
161816096|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816097|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816098|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816099|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816100|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816101|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816102|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816103|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162167760|NCT03848065|585666665|FG000|Overall Study|Lost to Follow-up|0|||
162167761|NCT03848065|585666666|FG001|Overall Study|Lost to Follow-up|0|||
162167762|NCT03848065|585666667|FG002|Overall Study|Lost to Follow-up|1|||
162167763|NCT03848065|585666665|FG000|Overall Study|Physician Decision|0|||
162167764|NCT03848065|585666666|FG001|Overall Study|Physician Decision|0|||
162167765|NCT03848065|585666667|FG002|Overall Study|Physician Decision|1|||
162167766|NCT03270501|585666670|FG000|Overall Study|Screen failure|6|||
161816104|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
162017224|NCT04308291|585117885|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
162017225|NCT04308291|585117885|FG000|Study Phase 12-M|Physician Decision|2|||
162017226|NCT04308291|585117885|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
162017227|NCT04411667|585117886|FG000|Overall Study|Physician Decision|1|||
162017228|NCT04411667|585117887|FG001|Overall Study|Physician Decision|0|||
162017229|NCT00714870|585117891|FG000|Overall Study|Lost to Follow-up|22|||
162017230|NCT00714870|585117892|FG001|Overall Study|Lost to Follow-up|5|||
162017231|NCT00714870|585117891|FG000|Overall Study|patient unable to come b/c back pain|1|||
162017232|NCT00714870|585117892|FG001|Overall Study|patient unable to come b/c back pain|0|||
162017233|NCT00714870|585117891|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
162017234|NCT00714870|585117892|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
162017235|NCT03399552|585117893|FG000|Overall Study|No evidence of disease|1|||
162017236|NCT03399552|585117893|FG000|Overall Study|Unevaluable|1|||
162017237|NCT02357368|585117894|FG000|Overall Study|Lost to Follow-up|0|||
162017238|NCT02357368|585117895|FG001|Overall Study|Lost to Follow-up|0|||
162017239|NCT02357368|585117896|FG002|Overall Study|Lost to Follow-up|0|||
162017240|NCT02357368|585117897|FG003|Overall Study|Lost to Follow-up|1|||
162017241|NCT02357368|585117894|FG000|Overall Study|Pregnancy|3|||
161816105|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816106|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816107|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816108|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816109|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816110|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816111|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816112|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161816113|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816114|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816115|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816116|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816117|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816118|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816119|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816120|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816121|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
161816122|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816123|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816124|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816125|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816126|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816127|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816128|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816129|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816130|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816131|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816132|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816133|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816134|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816135|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
162017242|NCT02357368|585117895|FG001|Overall Study|Pregnancy|2|||
162017243|NCT02357368|585117896|FG002|Overall Study|Pregnancy|0|||
162017244|NCT02357368|585117897|FG003|Overall Study|Pregnancy|0|||
162017245|NCT02357368|585117894|FG000|Overall Study|Withdrawal by Subject|3|||
162017246|NCT02357368|585117895|FG001|Overall Study|Withdrawal by Subject|1|||
162017247|NCT02357368|585117896|FG002|Overall Study|Withdrawal by Subject|1|||
162017248|NCT02357368|585117897|FG003|Overall Study|Withdrawal by Subject|2|||
162017249|NCT01931566|585117898|FG000|Overall Study|Randomized But Not Treated|6|||
161816136|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816137|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
161921222|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161921223|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
161921224|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
161921225|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161921226|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161921227|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161921228|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161921229|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161921230|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
161921231|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161921232|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161921233|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161921234|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161921235|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161921236|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161921237|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
161921238|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
161921239|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161921240|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161921241|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161921242|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161921243|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161921244|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
161921245|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
161921246|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161921247|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161921248|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161921249|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161921250|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161921251|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161921252|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
161921253|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
161921254|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
161921255|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
161921256|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
161921257|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
161921258|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
161921259|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
161921260|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
161921261|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
161921262|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
161921263|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
161921264|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
161921265|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
161921266|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
161921267|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161921268|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161921269|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161921270|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161921271|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
162017250|NCT01931566|585117899|FG001|Overall Study|Randomized But Not Treated|9|||
162017251|NCT01931566|585117900|FG002|Overall Study|Randomized But Not Treated|14|||
162017252|NCT01931566|585117898|FG000|Overall Study|Adverse Event|37|||
162017253|NCT01931566|585117899|FG001|Overall Study|Adverse Event|167|||
162017254|NCT01931566|585117900|FG002|Overall Study|Adverse Event|132|||
162017255|NCT01931566|585117898|FG000|Overall Study|Major Protocol Deviation|5|||
162017256|NCT01931566|585117899|FG001|Overall Study|Major Protocol Deviation|14|||
162017257|NCT01931566|585117900|FG002|Overall Study|Major Protocol Deviation|21|||
162017258|NCT01931566|585117898|FG000|Overall Study|Lost to Follow-up|3|||
162017259|NCT01931566|585117899|FG001|Overall Study|Lost to Follow-up|26|||
162017260|NCT01931566|585117900|FG002|Overall Study|Lost to Follow-up|23|||
162017261|NCT01931566|585117898|FG000|Overall Study|Voluntary Withdrawal|78|||
162017262|NCT01931566|585117899|FG001|Overall Study|Voluntary Withdrawal|245|||
162017263|NCT01931566|585117900|FG002|Overall Study|Voluntary Withdrawal|225|||
162017264|NCT01931566|585117898|FG000|Overall Study|Study Termination|289|||
162017265|NCT01931566|585117899|FG001|Overall Study|Study Termination|968|||
162017266|NCT01931566|585117900|FG002|Overall Study|Study Termination|1037|||
162017267|NCT01931566|585117898|FG000|Overall Study|Reason Not Specified|11|||
162017268|NCT01931566|585117899|FG001|Overall Study|Reason Not Specified|47|||
162017269|NCT01931566|585117900|FG002|Overall Study|Reason Not Specified|53|||
162017270|NCT01931566|585117898|FG000|Overall Study|Missing|0|||
162017271|NCT01931566|585117899|FG001|Overall Study|Missing|0|||
162017272|NCT01931566|585117900|FG002|Overall Study|Missing|1|||
162017273|NCT01147874|585117903|FG000|Overall Study|Adverse Event|5|||
162017274|NCT01147874|585117903|FG000|Overall Study|Investigator's Request|1|||
162017275|NCT01147874|585117903|FG000|Overall Study|Lost to Follow-up|25|||
162017276|NCT01147874|585117903|FG000|Overall Study|Other|5|||
162017277|NCT01147874|585117903|FG000|Overall Study|Protocol Violation|5|||
162017278|NCT01147874|585117903|FG000|Overall Study|Sponsor's Decision|2|||
162017279|NCT01147874|585117903|FG000|Overall Study|Withdrawal by Subject|24|||
162017280|NCT02991040|585117906|FG000|Overall Study|Withdrawal by Subject|2|||
162017281|NCT02991040|585117906|FG000|Overall Study|Lost to Follow-up|2|||
162017282|NCT04287517|585117907|FG000|Overall Study|Withdrawal by Subject|1|||
162017283|NCT04287517|585117908|FG001|Overall Study|Withdrawal by Subject|1|||
162017284|NCT01869764|585117915|FG000|Overall Study|Withdrawal by Subject|0|||
162017285|NCT01869764|585117916|FG001|Overall Study|Withdrawal by Subject|2|||
162017286|NCT02175030|585117917|FG000|Overall Study|Failed screen after consent|7|||
162017287|NCT02175030|585117918|FG001|Overall Study|Failed screen after consent|6|||
162017288|NCT02175030|585117917|FG000|Overall Study|Failed IUD Insertion|20|||
162017289|NCT02175030|585117918|FG001|Overall Study|Failed IUD Insertion|21|||
162017290|NCT02175030|585117917|FG000|Overall Study|Physician Decision|1|||
162017291|NCT02175030|585117918|FG001|Overall Study|Physician Decision|1|||
162017292|NCT02175030|585117917|FG000|Overall Study|Lost to Follow-up|6|||
162017293|NCT02175030|585117918|FG001|Overall Study|Lost to Follow-up|6|||
162017294|NCT02175030|585117917|FG000|Overall Study|Withdrawal by Subject|1|||
162167767|NCT03270501|585666670|FG000|Overall Study|Lost to Follow-up|2|||
162167768|NCT03270501|585666670|FG000|Overall Study|Adverse Event|1|||
162167769|NCT00764751|585666675|FG000|Overall Study|Adverse Event|1|||
162167770|NCT00764751|585666676|FG001|Overall Study|Adverse Event|1|||
162167771|NCT00764751|585666675|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
162167772|NCT00764751|585666676|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
162167773|NCT05270408|585666685|FG000|Started Treatment|Withdrawal by Subject|0|||
162167774|NCT05270408|585666686|FG001|Started Treatment|Withdrawal by Subject|0|||
162167775|NCT05270408|585666687|FG002|Started Treatment|Withdrawal by Subject|3|||
162167776|NCT05270408|585666685|FG000|Started Treatment|Adverse Event|0|||
162167777|NCT05270408|585666686|FG001|Started Treatment|Adverse Event|0|||
162167778|NCT05270408|585666687|FG002|Started Treatment|Adverse Event|1|||
162167779|NCT05270408|585666685|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
162167780|NCT05270408|585666686|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
162167781|NCT05270408|585666687|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
162167782|NCT04338061|585666688|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
162167783|NCT04338061|585666689|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
161816138|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
161816139|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816140|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816141|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816142|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816143|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
162167784|NCT04338061|585666688|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
162167785|NCT04338061|585666689|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
162167786|NCT04338061|585666688|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
162167787|NCT04338061|585666689|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
161816144|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
161816145|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
161816146|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
161816147|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
161816148|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
161816149|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816150|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816151|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816152|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816153|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816154|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816155|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816156|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816157|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816158|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816159|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816160|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816161|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816162|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816163|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816164|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161816165|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816166|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816167|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816168|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816169|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816170|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816171|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816172|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816173|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816174|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
161816175|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816176|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816177|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816178|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816179|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816180|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816181|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816182|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161921272|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
161921273|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
161816183|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816184|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816185|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816186|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816187|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816188|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816189|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161816190|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
162167788|NCT04338061|585666688|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
162167789|NCT04338061|585666689|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
162167790|NCT04338061|585666688|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
162167791|NCT04338061|585666689|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
162167792|NCT04338061|585666688|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
162167793|NCT04338061|585666689|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
162167794|NCT04338061|585666688|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
162167795|NCT04338061|585666689|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
162167796|NCT04338061|585666688|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
162167797|NCT04338061|585666689|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
162167798|NCT04338061|585666688|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
162167799|NCT04338061|585666689|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
162167800|NCT04338061|585666688|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
161816191|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816192|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816193|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
162017295|NCT02175030|585117918|FG001|Overall Study|Withdrawal by Subject|4|||
161816194|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816195|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816196|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816197|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816198|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816199|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816200|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
161816201|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816202|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816203|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816204|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816205|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816206|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
162167801|NCT04338061|585666689|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
162167802|NCT04338061|585666688|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
161816207|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816208|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
161921274|NCT01697579|584757180|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161921275|NCT01697579|584757181|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161921276|NCT01697579|584757182|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161921277|NCT01697579|584757183|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161921278|NCT01697579|584757184|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161921279|NCT01697579|584757185|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161921280|NCT01697579|584757186|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
161921281|NCT01044498|584757187|FG000|Overall Study|Withdrew consent|1|||
161921282|NCT01044498|584757188|FG001|Overall Study|Withdrew consent|1|||
162167803|NCT04338061|585666689|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
162167804|NCT04338061|585666688|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
162167805|NCT04338061|585666689|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
162167806|NCT04074759|585666690|FG000|Overall Study|Withdrawal by Subject|0|||
162167807|NCT04074759|585666691|FG001|Overall Study|Withdrawal by Subject|0|||
162167808|NCT04074759|585666692|FG002|Overall Study|Withdrawal by Subject|0|||
162167809|NCT04074759|585666693|FG003|Overall Study|Withdrawal by Subject|0|||
162167810|NCT04074759|585666694|FG004|Overall Study|Withdrawal by Subject|0|||
162167811|NCT04074759|585666695|FG005|Overall Study|Withdrawal by Subject|2|||
162167812|NCT04074759|585666696|FG006|Overall Study|Withdrawal by Subject|0|||
162167813|NCT04074759|585666697|FG007|Overall Study|Withdrawal by Subject|2|||
162167814|NCT04074759|585666698|FG008|Overall Study|Withdrawal by Subject|1|||
162167815|NCT04074759|585666699|FG009|Overall Study|Withdrawal by Subject|2|||
162167816|NCT04074759|585666700|FG010|Overall Study|Withdrawal by Subject|9|||
162167817|NCT04074759|585666701|FG011|Overall Study|Withdrawal by Subject|2|||
162167818|NCT04074759|585666702|FG012|Overall Study|Withdrawal by Subject|1|||
162167819|NCT04074759|585666703|FG013|Overall Study|Withdrawal by Subject|3|||
162167820|NCT04074759|585666704|FG014|Overall Study|Withdrawal by Subject|2|||
162167821|NCT04074759|585666705|FG015|Overall Study|Withdrawal by Subject|0|||
162167822|NCT04074759|585666706|FG016|Overall Study|Withdrawal by Subject|0|||
162167823|NCT04074759|585666707|FG017|Overall Study|Withdrawal by Subject|3|||
162167824|NCT04074759|585666708|FG018|Overall Study|Withdrawal by Subject|1|||
162167825|NCT04074759|585666690|FG000|Overall Study|Death|1|||
162167826|NCT04074759|585666691|FG001|Overall Study|Death|0|||
162167827|NCT04074759|585666692|FG002|Overall Study|Death|1|||
162167828|NCT04074759|585666693|FG003|Overall Study|Death|1|||
162167829|NCT04074759|585666694|FG004|Overall Study|Death|2|||
162167830|NCT04074759|585666695|FG005|Overall Study|Death|0|||
162167831|NCT04074759|585666696|FG006|Overall Study|Death|1|||
162167832|NCT04074759|585666697|FG007|Overall Study|Death|0|||
161921283|NCT01044498|584757187|FG000|Overall Study|Adverse Event|1|||
161921284|NCT01044498|584757188|FG001|Overall Study|Adverse Event|1|||
162167833|NCT04074759|585666698|FG008|Overall Study|Death|3|||
161816209|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816210|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816211|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816212|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816213|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816214|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816215|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816216|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
161816217|NCT00112437|584368804|FG000|Year 2 (12-Month Extension)|Moved|0|||
161816218|NCT00112437|584368805|FG001|Year 2 (12-Month Extension)|Moved|0|||
161816219|NCT00112437|584368806|FG002|Year 2 (12-Month Extension)|Moved|0|||
161816220|NCT00112437|584368807|FG003|Year 2 (12-Month Extension)|Moved|0|||
161816221|NCT00112437|584368808|FG004|Year 2 (12-Month Extension)|Moved|0|||
161816222|NCT00112437|584368809|FG005|Year 2 (12-Month Extension)|Moved|0|||
161816223|NCT00112437|584368810|FG006|Year 2 (12-Month Extension)|Moved|0|||
161816224|NCT00112437|584368811|FG007|Year 2 (12-Month Extension)|Moved|0|||
161816225|NCT00112437|584368812|FG008|Year 2 (12-Month Extension)|Moved|0|||
161816226|NCT00112437|584368813|FG009|Year 2 (12-Month Extension)|Moved|1|||
161816227|NCT00112437|584368814|FG010|Year 2 (12-Month Extension)|Moved|0|||
161816228|NCT00112437|584368815|FG011|Year 2 (12-Month Extension)|Moved|0|||
161816229|NCT00112437|584368816|FG012|Year 2 (12-Month Extension)|Moved|0|||
161816230|NCT00112437|584368817|FG013|Year 2 (12-Month Extension)|Moved|0|||
161816231|NCT00112437|584368818|FG014|Year 2 (12-Month Extension)|Moved|0|||
161816232|NCT00112437|584368819|FG015|Year 2 (12-Month Extension)|Moved|0|||
161816233|NCT00112437|584368820|FG016|Year 2 (12-Month Extension)|Moved|0|||
161816234|NCT00112437|584368821|FG017|Year 2 (12-Month Extension)|Moved|0|||
161816235|NCT00112437|584368822|FG018|Year 2 (12-Month Extension)|Moved|0|||
161816236|NCT00112437|584368823|FG019|Year 2 (12-Month Extension)|Moved|0|||
161816237|NCT00112437|584368824|FG020|Year 2 (12-Month Extension)|Moved|0|||
161816238|NCT00112437|584368825|FG021|Year 2 (12-Month Extension)|Moved|0|||
161816239|NCT00112437|584368826|FG022|Year 2 (12-Month Extension)|Moved|0|||
161816240|NCT00112437|584368827|FG023|Year 2 (12-Month Extension)|Moved|0|||
161816241|NCT00112437|584368828|FG024|Year 2 (12-Month Extension)|Moved|0|||
161816242|NCT00112437|584368829|FG025|Year 2 (12-Month Extension)|Moved|0|||
161816243|NCT00112437|584368804|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
161816244|NCT00112437|584368805|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
161816245|NCT00112437|584368806|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
161816246|NCT00112437|584368807|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
161816247|NCT00112437|584368808|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
161816248|NCT00112437|584368809|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
161816249|NCT00112437|584368810|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
161816250|NCT00112437|584368811|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
161816251|NCT00112437|584368812|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
161816252|NCT00112437|584368813|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
161816253|NCT00112437|584368814|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
161816254|NCT00112437|584368815|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
161816255|NCT00112437|584368816|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
161816256|NCT00112437|584368817|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
161816257|NCT00112437|584368818|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
161816258|NCT00112437|584368819|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
161816259|NCT00112437|584368820|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
161816260|NCT00112437|584368821|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
161816261|NCT00112437|584368822|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
161816262|NCT00112437|584368823|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
161816263|NCT00112437|584368824|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
161816264|NCT00112437|584368825|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
161816265|NCT00112437|584368826|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
161816266|NCT00112437|584368827|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
161816267|NCT00112437|584368828|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
161816268|NCT00112437|584368829|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
161921285|NCT01044498|584757187|FG000|Overall Study|Other|1|||
161921286|NCT01044498|584757188|FG001|Overall Study|Other|0|||
161816269|NCT00112437|584368804|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816270|NCT00112437|584368805|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816271|NCT00112437|584368806|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816272|NCT00112437|584368807|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816273|NCT00112437|584368808|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816274|NCT00112437|584368809|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816275|NCT00112437|584368810|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816276|NCT00112437|584368811|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816277|NCT00112437|584368812|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816278|NCT00112437|584368813|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816279|NCT00112437|584368814|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816280|NCT00112437|584368815|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
161816281|NCT00112437|584368816|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816282|NCT00112437|584368817|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
161816283|NCT00112437|584368818|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816284|NCT00112437|584368819|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
161816285|NCT00112437|584368820|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816286|NCT00112437|584368821|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816287|NCT00112437|584368822|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
161816288|NCT00112437|584368823|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816289|NCT00112437|584368824|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816290|NCT00112437|584368825|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816291|NCT00112437|584368826|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816292|NCT00112437|584368827|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816293|NCT00112437|584368828|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816294|NCT00112437|584368829|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161816295|NCT00112437|584368804|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816296|NCT00112437|584368805|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816297|NCT00112437|584368806|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816298|NCT00112437|584368807|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816299|NCT00112437|584368808|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816300|NCT00112437|584368809|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816301|NCT00112437|584368810|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816302|NCT00112437|584368811|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816303|NCT00112437|584368812|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816304|NCT00112437|584368813|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162017296|NCT01273519|585117923|FG000|Overall Study|Adverse Event|3|||
162017297|NCT01273519|585117924|FG001|Overall Study|Adverse Event|0|||
162167834|NCT04074759|585666699|FG009|Overall Study|Death|2|||
162167835|NCT04074759|585666700|FG010|Overall Study|Death|4|||
162167836|NCT04074759|585666701|FG011|Overall Study|Death|1|||
162167837|NCT04074759|585666702|FG012|Overall Study|Death|0|||
162167838|NCT04074759|585666703|FG013|Overall Study|Death|2|||
162167839|NCT04074759|585666704|FG014|Overall Study|Death|1|||
162167840|NCT04074759|585666705|FG015|Overall Study|Death|0|||
162167841|NCT04074759|585666706|FG016|Overall Study|Death|1|||
162167842|NCT04074759|585666707|FG017|Overall Study|Death|0|||
162167843|NCT04074759|585666708|FG018|Overall Study|Death|1|||
162167844|NCT04074759|585666690|FG000|Overall Study|Lost to Follow-up|0|||
162167845|NCT04074759|585666691|FG001|Overall Study|Lost to Follow-up|0|||
162167846|NCT04074759|585666692|FG002|Overall Study|Lost to Follow-up|0|||
162167847|NCT04074759|585666693|FG003|Overall Study|Lost to Follow-up|0|||
162167848|NCT04074759|585666694|FG004|Overall Study|Lost to Follow-up|0|||
162167849|NCT04074759|585666695|FG005|Overall Study|Lost to Follow-up|0|||
162167850|NCT04074759|585666696|FG006|Overall Study|Lost to Follow-up|0|||
162167851|NCT04074759|585666697|FG007|Overall Study|Lost to Follow-up|0|||
162167852|NCT04074759|585666698|FG008|Overall Study|Lost to Follow-up|0|||
162167853|NCT04074759|585666699|FG009|Overall Study|Lost to Follow-up|0|||
162167854|NCT04074759|585666700|FG010|Overall Study|Lost to Follow-up|1|||
162167855|NCT04074759|585666701|FG011|Overall Study|Lost to Follow-up|0|||
162167856|NCT04074759|585666702|FG012|Overall Study|Lost to Follow-up|0|||
162167857|NCT04074759|585666703|FG013|Overall Study|Lost to Follow-up|0|||
162167858|NCT04074759|585666704|FG014|Overall Study|Lost to Follow-up|0|||
162167859|NCT04074759|585666705|FG015|Overall Study|Lost to Follow-up|0|||
162017298|NCT01273519|585117925|FG002|Overall Study|Adverse Event|0|||
162017299|NCT01273519|585117923|FG000|Overall Study|Lost to Follow-up|2|||
162017300|NCT01273519|585117924|FG001|Overall Study|Lost to Follow-up|1|||
162017301|NCT01273519|585117925|FG002|Overall Study|Lost to Follow-up|3|||
162167860|NCT04074759|585666706|FG016|Overall Study|Lost to Follow-up|1|||
162167861|NCT04074759|585666707|FG017|Overall Study|Lost to Follow-up|0|||
162167862|NCT04074759|585666708|FG018|Overall Study|Lost to Follow-up|1|||
162167863|NCT04074759|585666690|FG000|Overall Study|Other|0|||
162167864|NCT04074759|585666691|FG001|Overall Study|Other|1|||
162167865|NCT04074759|585666692|FG002|Overall Study|Other|1|||
162167866|NCT04074759|585666693|FG003|Overall Study|Other|0|||
162167867|NCT04074759|585666694|FG004|Overall Study|Other|2|||
162167868|NCT04074759|585666695|FG005|Overall Study|Other|1|||
162167869|NCT04074759|585666696|FG006|Overall Study|Other|2|||
162167870|NCT04074759|585666697|FG007|Overall Study|Other|1|||
162167871|NCT04074759|585666698|FG008|Overall Study|Other|1|||
162167872|NCT04074759|585666699|FG009|Overall Study|Other|4|||
162167873|NCT04074759|585666700|FG010|Overall Study|Other|4|||
162167874|NCT04074759|585666701|FG011|Overall Study|Other|2|||
162167875|NCT04074759|585666702|FG012|Overall Study|Other|0|||
162167876|NCT04074759|585666703|FG013|Overall Study|Other|0|||
162167877|NCT04074759|585666704|FG014|Overall Study|Other|0|||
162167878|NCT04074759|585666705|FG015|Overall Study|Other|1|||
162167879|NCT04074759|585666706|FG016|Overall Study|Other|0|||
162167880|NCT04074759|585666707|FG017|Overall Study|Other|0|||
162167881|NCT04074759|585666708|FG018|Overall Study|Other|0|||
162167882|NCT04074759|585666690|FG000|Overall Study|Missing end of study status|0|||
162167883|NCT04074759|585666691|FG001|Overall Study|Missing end of study status|0|||
162167884|NCT04074759|585666692|FG002|Overall Study|Missing end of study status|0|||
162167885|NCT04074759|585666693|FG003|Overall Study|Missing end of study status|0|||
162167886|NCT04074759|585666694|FG004|Overall Study|Missing end of study status|0|||
162167887|NCT04074759|585666695|FG005|Overall Study|Missing end of study status|0|||
162167888|NCT04074759|585666696|FG006|Overall Study|Missing end of study status|0|||
162167889|NCT04074759|585666697|FG007|Overall Study|Missing end of study status|0|||
162167890|NCT04074759|585666698|FG008|Overall Study|Missing end of study status|0|||
162167891|NCT04074759|585666699|FG009|Overall Study|Missing end of study status|0|||
162167892|NCT04074759|585666700|FG010|Overall Study|Missing end of study status|2|||
162167893|NCT04074759|585666701|FG011|Overall Study|Missing end of study status|0|||
162167894|NCT04074759|585666702|FG012|Overall Study|Missing end of study status|0|||
162167895|NCT04074759|585666703|FG013|Overall Study|Missing end of study status|0|||
162167896|NCT04074759|585666704|FG014|Overall Study|Missing end of study status|0|||
162167897|NCT04074759|585666705|FG015|Overall Study|Missing end of study status|0|||
162167898|NCT04074759|585666706|FG016|Overall Study|Missing end of study status|1|||
162167899|NCT04074759|585666707|FG017|Overall Study|Missing end of study status|0|||
162017302|NCT01273519|585117923|FG000|Overall Study|Lack of Efficacy|8|||
162017303|NCT01273519|585117924|FG001|Overall Study|Lack of Efficacy|3|||
162017304|NCT01273519|585117925|FG002|Overall Study|Lack of Efficacy|4|||
162167900|NCT04074759|585666708|FG018|Overall Study|Missing end of study status|0|||
162167901|NCT03631784|585666709|FG000|Overall Study|Participants Ongoing|1|||
162167902|NCT03631784|585666710|FG001|Overall Study|Participants Ongoing|0|||
162167903|NCT03631784|585666709|FG000|Overall Study|Withdrawal by Subject|3|||
162167904|NCT03631784|585666710|FG001|Overall Study|Withdrawal by Subject|3|||
162167905|NCT03631784|585666709|FG000|Overall Study|Sponsor's Decision|36|||
162167906|NCT03631784|585666710|FG001|Overall Study|Sponsor's Decision|52|||
162167907|NCT03631784|585666709|FG000|Overall Study|Lost to Follow-up|1|||
162167908|NCT03631784|585666710|FG001|Overall Study|Lost to Follow-up|0|||
162167909|NCT03631784|585666709|FG000|Overall Study|Death|71|||
162167910|NCT03631784|585666710|FG001|Overall Study|Death|49|||
162167911|NCT05329220|585666711|FG000|Active Trial Period|Adverse Event|0|||
162167912|NCT05329220|585666712|FG001|Active Trial Period|Adverse Event|0|||
162167913|NCT05329220|585666713|FG002|Active Trial Period|Adverse Event|0|||
162167914|NCT05329220|585666714|FG003|Active Trial Period|Adverse Event|0|||
161921287|NCT02903914|584757193|FG000|Overall Study|Adverse Event|0|||
162167915|NCT05329220|585666715|FG004|Active Trial Period|Adverse Event|1|||
162167916|NCT05329220|585666716|FG005|Active Trial Period|Adverse Event|0|||
162167917|NCT05329220|585666711|FG000|Active Trial Period|Lost to Follow-up|0|||
162167918|NCT05329220|585666712|FG001|Active Trial Period|Lost to Follow-up|0|||
162167919|NCT05329220|585666713|FG002|Active Trial Period|Lost to Follow-up|0|||
162167920|NCT05329220|585666714|FG003|Active Trial Period|Lost to Follow-up|0|||
162167921|NCT05329220|585666715|FG004|Active Trial Period|Lost to Follow-up|32|||
162167922|NCT05329220|585666716|FG005|Active Trial Period|Lost to Follow-up|28|||
162167923|NCT05329220|585666711|FG000|Active Trial Period|Physician Decision|0|||
162167924|NCT05329220|585666712|FG001|Active Trial Period|Physician Decision|0|||
162167925|NCT05329220|585666713|FG002|Active Trial Period|Physician Decision|0|||
162167926|NCT05329220|585666714|FG003|Active Trial Period|Physician Decision|0|||
162167927|NCT05329220|585666715|FG004|Active Trial Period|Physician Decision|2|||
162167928|NCT05329220|585666716|FG005|Active Trial Period|Physician Decision|0|||
162167929|NCT05329220|585666711|FG000|Active Trial Period|Protocol Violation|0|||
162167930|NCT05329220|585666712|FG001|Active Trial Period|Protocol Violation|0|||
162167931|NCT05329220|585666713|FG002|Active Trial Period|Protocol Violation|0|||
162167932|NCT05329220|585666714|FG003|Active Trial Period|Protocol Violation|0|||
162167933|NCT05329220|585666715|FG004|Active Trial Period|Protocol Violation|1|||
162167934|NCT05329220|585666716|FG005|Active Trial Period|Protocol Violation|3|||
162167935|NCT05329220|585666711|FG000|Active Trial Period|Withdrawal by Subject|0|||
162167936|NCT05329220|585666712|FG001|Active Trial Period|Withdrawal by Subject|0|||
162167937|NCT05329220|585666713|FG002|Active Trial Period|Withdrawal by Subject|0|||
162167938|NCT05329220|585666714|FG003|Active Trial Period|Withdrawal by Subject|1|||
162167939|NCT05329220|585666715|FG004|Active Trial Period|Withdrawal by Subject|12|||
162167940|NCT05329220|585666716|FG005|Active Trial Period|Withdrawal by Subject|13|||
162167941|NCT05329220|585666711|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
162167942|NCT05329220|585666712|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
162167943|NCT05329220|585666713|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
162167944|NCT05329220|585666714|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
162167945|NCT05329220|585666715|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
162167946|NCT05329220|585666716|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
162167947|NCT05329220|585666711|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
162167948|NCT05329220|585666712|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
162167949|NCT05329220|585666713|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
162167950|NCT05329220|585666714|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
162167951|NCT05329220|585666715|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
162167952|NCT05329220|585666716|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
162167953|NCT05329220|585666711|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
162167954|NCT05329220|585666712|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
162167955|NCT05329220|585666713|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
162167956|NCT05329220|585666714|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
162167957|NCT05329220|585666715|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
162167958|NCT05329220|585666716|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
162167959|NCT05329220|585666711|FG000|Follow-up Period|Adverse Event|0|||
162167960|NCT05329220|585666712|FG001|Follow-up Period|Adverse Event|0|||
162167961|NCT05329220|585666713|FG002|Follow-up Period|Adverse Event|0|||
162167962|NCT05329220|585666714|FG003|Follow-up Period|Adverse Event|0|||
162167963|NCT05329220|585666715|FG004|Follow-up Period|Adverse Event|2|||
161816305|NCT00112437|584368814|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162167964|NCT05329220|585666716|FG005|Follow-up Period|Adverse Event|1|||
162167965|NCT05329220|585666711|FG000|Follow-up Period|Death|0|||
162167966|NCT05329220|585666712|FG001|Follow-up Period|Death|0|||
162167967|NCT05329220|585666713|FG002|Follow-up Period|Death|1|||
162167968|NCT05329220|585666714|FG003|Follow-up Period|Death|1|||
162167969|NCT05329220|585666715|FG004|Follow-up Period|Death|0|||
162167970|NCT05329220|585666716|FG005|Follow-up Period|Death|1|||
162167971|NCT05329220|585666711|FG000|Follow-up Period|Lost to Follow-up|0|||
162167972|NCT05329220|585666712|FG001|Follow-up Period|Lost to Follow-up|1|||
162167973|NCT05329220|585666713|FG002|Follow-up Period|Lost to Follow-up|2|||
162167974|NCT05329220|585666714|FG003|Follow-up Period|Lost to Follow-up|2|||
162167975|NCT05329220|585666715|FG004|Follow-up Period|Lost to Follow-up|113|||
162167976|NCT05329220|585666716|FG005|Follow-up Period|Lost to Follow-up|89|||
162167977|NCT05329220|585666711|FG000|Follow-up Period|Physician Decision|0|||
162167978|NCT05329220|585666712|FG001|Follow-up Period|Physician Decision|0|||
162167979|NCT05329220|585666713|FG002|Follow-up Period|Physician Decision|0|||
162167980|NCT05329220|585666714|FG003|Follow-up Period|Physician Decision|0|||
162167981|NCT05329220|585666715|FG004|Follow-up Period|Physician Decision|2|||
162167982|NCT05329220|585666716|FG005|Follow-up Period|Physician Decision|2|||
162167983|NCT05329220|585666711|FG000|Follow-up Period|Protocol Violation|0|||
162167984|NCT05329220|585666712|FG001|Follow-up Period|Protocol Violation|0|||
162167985|NCT05329220|585666713|FG002|Follow-up Period|Protocol Violation|0|||
162167986|NCT05329220|585666714|FG003|Follow-up Period|Protocol Violation|0|||
162167987|NCT05329220|585666715|FG004|Follow-up Period|Protocol Violation|0|||
162167988|NCT05329220|585666716|FG005|Follow-up Period|Protocol Violation|1|||
162167989|NCT05329220|585666711|FG000|Follow-up Period|Withdrawal by Subject|0|||
162167990|NCT05329220|585666712|FG001|Follow-up Period|Withdrawal by Subject|0|||
162167991|NCT05329220|585666713|FG002|Follow-up Period|Withdrawal by Subject|1|||
162167992|NCT05329220|585666714|FG003|Follow-up Period|Withdrawal by Subject|1|||
161816306|NCT00112437|584368815|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816307|NCT00112437|584368816|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816308|NCT00112437|584368817|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816309|NCT00112437|584368818|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816310|NCT00112437|584368819|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
161816311|NCT00112437|584368820|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816312|NCT00112437|584368821|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
162167993|NCT05329220|585666715|FG004|Follow-up Period|Withdrawal by Subject|34|||
162167994|NCT05329220|585666716|FG005|Follow-up Period|Withdrawal by Subject|35|||
162167995|NCT05329220|585666711|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
162167996|NCT05329220|585666712|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
162167997|NCT05329220|585666713|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
162167998|NCT05329220|585666714|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
162167999|NCT05329220|585666715|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
162168000|NCT05329220|585666716|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
162168001|NCT05329220|585666711|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
162168002|NCT05329220|585666712|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
162168003|NCT05329220|585666713|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
162168004|NCT05329220|585666714|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
162168005|NCT05329220|585666715|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
162168006|NCT05329220|585666716|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
162168007|NCT05329220|585666711|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
162168008|NCT05329220|585666712|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
162168009|NCT05329220|585666713|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
162168010|NCT05329220|585666714|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
162168011|NCT05329220|585666715|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
162168012|NCT05329220|585666716|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
162168013|NCT05329220|585666711|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
162168014|NCT05329220|585666712|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
162168015|NCT05329220|585666713|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
162168016|NCT05329220|585666714|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
162168017|NCT05329220|585666715|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
162168018|NCT05329220|585666716|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
162168019|NCT05329220|585666711|FG000|Follow-up Period|EARLY TERMINATION|0|||
162168020|NCT05329220|585666712|FG001|Follow-up Period|EARLY TERMINATION|0|||
162168021|NCT05329220|585666713|FG002|Follow-up Period|EARLY TERMINATION|0|||
162168022|NCT05329220|585666714|FG003|Follow-up Period|EARLY TERMINATION|0|||
162168023|NCT05329220|585666715|FG004|Follow-up Period|EARLY TERMINATION|0|||
162168024|NCT05329220|585666716|FG005|Follow-up Period|EARLY TERMINATION|1|||
162168025|NCT05329220|585666711|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
162168026|NCT05329220|585666712|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
162168027|NCT05329220|585666713|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
162168028|NCT05329220|585666714|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
162168029|NCT05329220|585666715|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
162168030|NCT05329220|585666716|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
162168031|NCT05329220|585666711|FG000|Follow-up Period|DROPPED|0|||
162168032|NCT05329220|585666712|FG001|Follow-up Period|DROPPED|0|||
162168033|NCT05329220|585666713|FG002|Follow-up Period|DROPPED|0|||
162168034|NCT05329220|585666714|FG003|Follow-up Period|DROPPED|0|||
162168035|NCT05329220|585666715|FG004|Follow-up Period|DROPPED|0|||
162168036|NCT05329220|585666716|FG005|Follow-up Period|DROPPED|1|||
162168037|NCT05329220|585666711|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
162168038|NCT05329220|585666712|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
162168039|NCT05329220|585666713|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
162168040|NCT05329220|585666714|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
162168041|NCT05329220|585666715|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
162168042|NCT05329220|585666716|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
162168043|NCT04719832|585666725|FG000|Overall Study|Adverse Event|2|||
162168044|NCT04719832|585666726|FG001|Overall Study|Adverse Event|0|||
162168045|NCT04719832|585666725|FG000|Overall Study|Lack of Efficacy|2|||
162168046|NCT04719832|585666726|FG001|Overall Study|Lack of Efficacy|4|||
162168047|NCT04719832|585666725|FG000|Overall Study|Lost to Follow-up|0|||
162168048|NCT04719832|585666726|FG001|Overall Study|Lost to Follow-up|2|||
162168049|NCT04719832|585666725|FG000|Overall Study|Physician Decision|0|||
162168050|NCT04719832|585666726|FG001|Overall Study|Physician Decision|1|||
162168051|NCT04719832|585666725|FG000|Overall Study|Pregnancy|1|||
162168052|NCT04719832|585666726|FG001|Overall Study|Pregnancy|1|||
162168053|NCT04719832|585666725|FG000|Overall Study|Withdrawal by Subject|5|||
162168054|NCT04719832|585666726|FG001|Overall Study|Withdrawal by Subject|5|||
162168055|NCT04719832|585666725|FG000|Overall Study|Randomized, not treated|0|||
162168056|NCT04719832|585666726|FG001|Overall Study|Randomized, not treated|2|||
162168057|NCT04719832|585666725|FG000|Overall Study|GCP violations|4|||
162168058|NCT04719832|585666726|FG001|Overall Study|GCP violations|7|||
161816313|NCT00112437|584368822|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816314|NCT00112437|584368823|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816315|NCT00112437|584368824|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816316|NCT00112437|584368825|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816317|NCT00112437|584368826|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816318|NCT00112437|584368827|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816319|NCT00112437|584368828|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816320|NCT00112437|584368829|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161816321|NCT00112437|584368804|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816322|NCT00112437|584368805|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816323|NCT00112437|584368806|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816324|NCT00112437|584368807|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816325|NCT00112437|584368808|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816326|NCT00112437|584368809|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816327|NCT00112437|584368810|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816328|NCT00112437|584368811|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816329|NCT00112437|584368812|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816330|NCT00112437|584368813|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816331|NCT00112437|584368814|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816332|NCT00112437|584368815|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816333|NCT00112437|584368816|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816334|NCT00112437|584368817|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816335|NCT00112437|584368818|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816336|NCT00112437|584368819|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
161816337|NCT00112437|584368820|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816338|NCT00112437|584368821|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816339|NCT00112437|584368822|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816340|NCT00112437|584368823|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816341|NCT00112437|584368824|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816342|NCT00112437|584368825|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816343|NCT00112437|584368826|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816344|NCT00112437|584368827|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816345|NCT00112437|584368828|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816346|NCT00112437|584368829|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
161816347|NCT00112437|584368804|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816348|NCT00112437|584368805|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816349|NCT00112437|584368806|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816350|NCT00112437|584368807|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816351|NCT00112437|584368808|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816352|NCT00112437|584368809|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816353|NCT00112437|584368810|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816354|NCT00112437|584368811|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816355|NCT00112437|584368812|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816356|NCT00112437|584368813|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816357|NCT00112437|584368814|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816358|NCT00112437|584368815|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
161816359|NCT00112437|584368816|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816360|NCT00112437|584368817|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816361|NCT00112437|584368818|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
161816362|NCT00112437|584368819|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816363|NCT00112437|584368820|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816364|NCT00112437|584368821|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816365|NCT00112437|584368822|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816366|NCT00112437|584368823|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816367|NCT00112437|584368824|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816368|NCT00112437|584368825|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816369|NCT00112437|584368826|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816370|NCT00112437|584368827|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816371|NCT00112437|584368828|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816372|NCT00112437|584368829|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161816373|NCT00112437|584368804|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816374|NCT00112437|584368805|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816375|NCT00112437|584368806|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816376|NCT00112437|584368807|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816377|NCT00112437|584368808|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816378|NCT00112437|584368809|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816379|NCT00112437|584368810|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816380|NCT00112437|584368811|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161669474|NCT04751656|583843078|FG000|Overall Study|Lost to Follow-up|1|||
161669475|NCT01485354|583843084|FG000|Overall Study|Withdrawal by Subject|5|||
161669476|NCT03566810|583843085|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
161669477|NCT03566810|583843086|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
161669478|NCT03566810|583843087|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
161669479|NCT03566810|583843088|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
161669480|NCT01444651|583843091|FG000|Overall Study|Adverse Event|3|||
161669481|NCT01444651|583843092|FG001|Overall Study|Adverse Event|2|||
161669482|NCT01444651|583843091|FG000|Overall Study|Lost to Follow-up|5|||
161669483|NCT01444651|583843092|FG001|Overall Study|Lost to Follow-up|5|||
161669484|NCT01444651|583843091|FG000|Overall Study|Non-fasting|2|||
161669485|NCT01444651|583843092|FG001|Overall Study|Non-fasting|1|||
161669486|NCT01444651|583843091|FG000|Overall Study|Missing data|1|||
161669487|NCT01444651|583843092|FG001|Overall Study|Missing data|1|||
161669488|NCT03338192|583843093|FG000|Year One to Year Two|High Blood Pressure|7|||
161669489|NCT03338192|583843094|FG001|Year One to Year Two|High Blood Pressure|1|||
161669490|NCT03338192|583843093|FG000|Year One to Year Two|HIV +|1|||
161669491|NCT03338192|583843094|FG001|Year One to Year Two|HIV +|0|||
161669492|NCT03338192|583843093|FG000|Year Two to Year Four|High Blood Pressure|1|||
161669493|NCT03338192|583843094|FG001|Year Two to Year Four|High Blood Pressure|0|||
161669494|NCT03338192|583843093|FG000|Year Two to Year Four|HIV +|2|||
161669495|NCT03338192|583843094|FG001|Year Two to Year Four|HIV +|0|||
161669496|NCT03338192|583843093|FG000|Year Four to Year Six|High Blood Pressure|2|||
161669497|NCT03338192|583843094|FG001|Year Four to Year Six|High Blood Pressure|1|||
161669498|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
161669499|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
161669500|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
161669501|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
161669502|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
161669503|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
161669504|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
161669505|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
161669506|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
161669507|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
161669508|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
161669509|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
161669510|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Death|3|||
161669511|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Death|1|||
161669512|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
161669513|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
161669514|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Adverse Event|7|||
161669515|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Adverse Event|8|||
161669516|NCT03236246|583843099|FG000|24-Week Dose Titration Period|Captured as Other|1|||
161669517|NCT03236246|583843100|FG001|24-Week Dose Titration Period|Captured as Other|2|||
161669518|NCT03236246|583843099|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
161669519|NCT03236246|583843100|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
161669520|NCT03236246|583843099|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
161669521|NCT03236246|583843100|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
161669522|NCT03236246|583843099|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
161669523|NCT03236246|583843100|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
161669524|NCT03236246|583843099|FG000|24-Week Dose Maintenance Period|Death|0|||
161669525|NCT03236246|583843100|FG001|24-Week Dose Maintenance Period|Death|1|||
161669526|NCT03236246|583843099|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
161669527|NCT03236246|583843100|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
161669528|NCT02952001|583843101|FG000|Overall Study|Adverse Event|3|||
161669529|NCT02952001|583843102|FG001|Overall Study|Adverse Event|0|||
161669530|NCT02952001|583843101|FG000|Overall Study|Prohibited therapy|10|||
161669531|NCT02952001|583843102|FG001|Overall Study|Prohibited therapy|3|||
161669532|NCT02952001|583843101|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
162017305|NCT01273519|585117923|FG000|Overall Study|Other|6|||
162017306|NCT01273519|585117924|FG001|Overall Study|Other|1|||
161669533|NCT02952001|583843102|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
161669534|NCT01681628|583843105|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
161669535|NCT01681628|583843106|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
161669536|NCT01681628|583843105|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
161669537|NCT01681628|583843106|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
161669538|NCT01681628|583843105|FG000|19 Months Follow-up|Death|1|||
161669539|NCT01681628|583843106|FG001|19 Months Follow-up|Death|0|||
161669540|NCT01681628|583843105|FG000|19 Months Follow-up|Lost to Follow-up|61|||
161669541|NCT01681628|583843106|FG001|19 Months Follow-up|Lost to Follow-up|43|||
161669542|NCT01794520|583843107|FG000|Overall Study|Adverse events- related to progression|0|||
162168059|NCT05192109|585666731|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
162168060|NCT05192109|585666732|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
162168061|NCT05192109|585666733|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
162168062|NCT05192109|585666734|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
162168063|NCT05192109|585666731|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
162168064|NCT05192109|585666732|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
162168065|NCT05192109|585666733|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
162168066|NCT05192109|585666734|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
162168067|NCT04728347|585669076|FG000|Overall Study|Sponsor decision|0|||
162168068|NCT04728347|585669077|FG001|Overall Study|Sponsor decision|0|||
162168069|NCT04728347|585669078|FG002|Overall Study|Sponsor decision|1|||
162168070|NCT04728347|585669079|FG003|Overall Study|Sponsor decision|0|||
162168071|NCT06516705|585669085|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
162168072|NCT06516705|585669086|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
162168073|NCT06516705|585669085|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
162168074|NCT06516705|585669086|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
162168075|NCT06516705|585669085|FG000|T3 ( 3 Month After Education)|covid-19|1|||
162168076|NCT06516705|585669086|FG001|T3 ( 3 Month After Education)|covid-19|2|||
162168077|NCT06516705|585669085|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
162168078|NCT06516705|585669086|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
162168079|NCT06516705|585669085|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
162168080|NCT06516705|585669086|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
162168081|NCT06516705|585669085|FG000|T4 ( 6 Month After Education)|covid-19|3|||
162168082|NCT06516705|585669086|FG001|T4 ( 6 Month After Education)|covid-19|2|||
162168083|NCT06516705|585669085|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
162168084|NCT06516705|585669086|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
162168085|NCT04059484|585669088|FG000|Overall Study|Adverse Event|2|||
162168086|NCT04059484|585669089|FG001|Overall Study|Adverse Event|5|||
162168087|NCT04059484|585669088|FG000|Overall Study|Withdrawal by Subject|5|||
162168088|NCT04059484|585669089|FG001|Overall Study|Withdrawal by Subject|3|||
162168089|NCT04059484|585669088|FG000|Overall Study|Progressive disease|112|||
162168090|NCT04059484|585669089|FG001|Overall Study|Progressive disease|112|||
162168091|NCT04059484|585669088|FG000|Overall Study|Other|8|||
162168092|NCT04059484|585669089|FG001|Overall Study|Other|3|||
162168093|NCT04059484|585669088|FG000|Overall Study|Ongoing|20|||
162168094|NCT04059484|585669089|FG001|Overall Study|Ongoing|20|||
162168095|NCT04719390|585669090|FG000|Overall Study|Withdrawal by Subject|1|||
162168096|NCT04292223|585669091|FG000|Overall Study|Adverse Event|1|||
162168097|NCT04292223|585669091|FG000|Overall Study|Lost to Follow-up|1|||
161816381|NCT00112437|584368812|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816382|NCT00112437|584368813|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816383|NCT00112437|584368814|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
161816384|NCT00112437|584368815|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
161816385|NCT00112437|584368816|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816386|NCT00112437|584368817|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816387|NCT00112437|584368818|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816388|NCT00112437|584368819|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816389|NCT00112437|584368820|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816390|NCT00112437|584368821|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816391|NCT00112437|584368822|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816392|NCT00112437|584368823|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816393|NCT00112437|584368824|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816394|NCT00112437|584368825|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162168098|NCT04292223|585669091|FG000|Overall Study|Noncompliance with study drug|2|||
162168099|NCT04292223|585669091|FG000|Overall Study|Patient moved out of the state|1|||
162168100|NCT00753545|585669092|FG000|Overall Study|Death|98|||
162168101|NCT00753545|585669093|FG001|Overall Study|Death|112|||
162168102|NCT00753545|585669092|FG000|Overall Study|Lost to Follow-up|2|||
162168103|NCT00753545|585669093|FG001|Overall Study|Lost to Follow-up|3|||
161669543|NCT01794520|583843108|FG001|Overall Study|Adverse events- related to progression|0|||
162168104|NCT00753545|585669092|FG000|Overall Study|Protocol Violation|1|||
162168105|NCT00753545|585669093|FG001|Overall Study|Protocol Violation|0|||
162168106|NCT00753545|585669092|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
162168107|NCT00753545|585669093|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
162168108|NCT04633122|585669094|FG000|Overall Study|Remained on treatment|19|||
162168109|NCT04633122|585669095|FG001|Overall Study|Remained on treatment|14|||
162168110|NCT04633122|585669094|FG000|Overall Study|Survival follow-up stopped|22|||
162168111|NCT04633122|585669095|FG001|Overall Study|Survival follow-up stopped|25|||
162168112|NCT03839940|585669096|FG000|Overall Study|Withdrawal by Subject|3|||
162168113|NCT03839940|585669097|FG001|Overall Study|Withdrawal by Subject|0|||
162168114|NCT03839940|585669096|FG000|Overall Study|Protocol Violation|0|||
162168115|NCT03839940|585669097|FG001|Overall Study|Protocol Violation|1|||
162168116|NCT03839940|585669096|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
162168117|NCT03839940|585669097|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
162168118|NCT03241745|585669098|FG000|Overall Study|Adverse Event|7|||
162168119|NCT03241745|585669098|FG000|Overall Study|Death|1|||
162168120|NCT03241745|585669098|FG000|Overall Study|Withdrawal by Subject|5|||
162168121|NCT03241745|585669098|FG000|Overall Study|Treatment delay >28 days|2|||
162168122|NCT03241745|585669098|FG000|Overall Study|Lack of Efficacy|14|||
162168123|NCT02561247|585669099|FG000|Overall Study|Protocol Violation|1|||
162168124|NCT02561247|585669099|FG000|Overall Study|Withdrawal by Subject|1|||
162168125|NCT02561247|585669099|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
162168126|NCT04963270|585669100|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
162168127|NCT04963270|585669101|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
162168128|NCT04963270|585669102|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
162168129|NCT04963270|585669103|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
162168130|NCT04963270|585669100|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161921288|NCT02903914|584757194|FG001|Overall Study|Adverse Event|0|||
162168131|NCT04963270|585669101|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
162168132|NCT04963270|585669102|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
162168133|NCT04963270|585669103|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
162168134|NCT04963270|585669100|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
162168135|NCT04963270|585669101|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
162168136|NCT04963270|585669102|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
162168137|NCT04963270|585669103|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
162168138|NCT04963270|585669100|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
162168139|NCT04963270|585669101|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
162168140|NCT04963270|585669102|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
162168141|NCT04963270|585669103|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
162168142|NCT04963270|585669100|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
162168143|NCT04963270|585669101|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
162168144|NCT04963270|585669102|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
162168145|NCT04963270|585669103|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
162168146|NCT04963270|585669100|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
162168147|NCT04963270|585669101|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
162168148|NCT04963270|585669102|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
162168149|NCT04963270|585669103|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
162168150|NCT04963270|585669100|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
162168151|NCT04963270|585669101|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
162168152|NCT04963270|585669102|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
162168153|NCT04963270|585669103|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
162168154|NCT04963270|585669100|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
162168155|NCT04963270|585669101|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
162168156|NCT04963270|585669102|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
162168157|NCT04963270|585669103|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
162168158|NCT04963270|585669100|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
162168159|NCT04963270|585669101|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
162168160|NCT04963270|585669102|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
162168161|NCT04963270|585669103|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
162168162|NCT04963270|585669100|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
162168163|NCT04963270|585669101|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
162168164|NCT04963270|585669102|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
162168165|NCT04963270|585669103|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
162168166|NCT04963270|585669100|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
162168167|NCT04963270|585669101|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
162168168|NCT04963270|585669102|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
162168169|NCT04963270|585669103|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
162168170|NCT04963270|585669100|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
162168171|NCT04963270|585669101|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
162168172|NCT04963270|585669102|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
162168173|NCT04963270|585669103|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
162168174|NCT04963270|585669100|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
162168175|NCT04963270|585669101|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
162168176|NCT04963270|585669102|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
162168177|NCT04963270|585669103|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
162168178|NCT04963270|585669100|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
162168179|NCT04963270|585669101|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
162168180|NCT04963270|585669102|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
162168181|NCT04963270|585669103|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
162168182|NCT03560609|585669104|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
162168183|NCT03560609|585669105|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
162168184|NCT04908722|585669108|FG000|Overall Study|Protocol deviation|1|||
162168185|NCT04908722|585669109|FG001|Overall Study|Protocol deviation|0|||
162168186|NCT04908722|585669110|FG002|Overall Study|Protocol deviation|0|||
162168187|NCT04908722|585669111|FG003|Overall Study|Protocol deviation|0|||
162168188|NCT04908722|585669112|FG004|Overall Study|Protocol deviation|0|||
162168189|NCT04908722|585669113|FG005|Overall Study|Protocol deviation|1|||
162168190|NCT04908722|585669108|FG000|Overall Study|Lost to Follow-up|33|||
162168191|NCT04908722|585669109|FG001|Overall Study|Lost to Follow-up|33|||
162168192|NCT04908722|585669110|FG002|Overall Study|Lost to Follow-up|36|||
162168193|NCT04908722|585669111|FG003|Overall Study|Lost to Follow-up|30|||
162168194|NCT04908722|585669112|FG004|Overall Study|Lost to Follow-up|32|||
162168195|NCT04908722|585669113|FG005|Overall Study|Lost to Follow-up|34|||
162168196|NCT04908722|585669108|FG000|Overall Study|Physician Decision|1|||
162168197|NCT04908722|585669109|FG001|Overall Study|Physician Decision|1|||
162168198|NCT04908722|585669110|FG002|Overall Study|Physician Decision|1|||
162168199|NCT04908722|585669111|FG003|Overall Study|Physician Decision|2|||
162168200|NCT04908722|585669112|FG004|Overall Study|Physician Decision|0|||
162168201|NCT04908722|585669113|FG005|Overall Study|Physician Decision|0|||
162168202|NCT04908722|585669108|FG000|Overall Study|Death|1|||
162168203|NCT04908722|585669109|FG001|Overall Study|Death|0|||
162168204|NCT04908722|585669110|FG002|Overall Study|Death|0|||
162168205|NCT04908722|585669111|FG003|Overall Study|Death|0|||
162168206|NCT04908722|585669112|FG004|Overall Study|Death|0|||
162168207|NCT04908722|585669113|FG005|Overall Study|Death|1|||
162168208|NCT04908722|585669108|FG000|Overall Study|Withdrawal by Subject|12|||
162168209|NCT04908722|585669109|FG001|Overall Study|Withdrawal by Subject|8|||
162168210|NCT04908722|585669110|FG002|Overall Study|Withdrawal by Subject|7|||
162168211|NCT04908722|585669111|FG003|Overall Study|Withdrawal by Subject|6|||
162168212|NCT04908722|585669112|FG004|Overall Study|Withdrawal by Subject|12|||
162168213|NCT04908722|585669113|FG005|Overall Study|Withdrawal by Subject|14|||
162168214|NCT04908722|585669108|FG000|Overall Study|Other|3|||
162168215|NCT04908722|585669109|FG001|Overall Study|Other|1|||
162168216|NCT04908722|585669110|FG002|Overall Study|Other|3|||
162168217|NCT04908722|585669111|FG003|Overall Study|Other|2|||
162168218|NCT04908722|585669112|FG004|Overall Study|Other|4|||
162168219|NCT04908722|585669113|FG005|Overall Study|Other|1|||
162168220|NCT04908722|585669108|FG000|Overall Study|Initiated prohibited medication|0|||
162168221|NCT04908722|585669109|FG001|Overall Study|Initiated prohibited medication|0|||
162168222|NCT04908722|585669110|FG002|Overall Study|Initiated prohibited medication|0|||
162168223|NCT04908722|585669111|FG003|Overall Study|Initiated prohibited medication|1|||
162168224|NCT04908722|585669112|FG004|Overall Study|Initiated prohibited medication|0|||
162168225|NCT04908722|585669113|FG005|Overall Study|Initiated prohibited medication|1|||
162168226|NCT04908722|585669108|FG000|Overall Study|Randomized but not vaccinated|3|||
162168227|NCT04908722|585669109|FG001|Overall Study|Randomized but not vaccinated|1|||
162168228|NCT04908722|585669110|FG002|Overall Study|Randomized but not vaccinated|2|||
162168229|NCT04908722|585669111|FG003|Overall Study|Randomized but not vaccinated|2|||
162168230|NCT04908722|585669112|FG004|Overall Study|Randomized but not vaccinated|3|||
162168231|NCT04908722|585669113|FG005|Overall Study|Randomized but not vaccinated|4|||
162168232|NCT01369355|585669118|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
162168233|NCT01369355|585669119|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
162168234|NCT01369355|585669120|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
162168235|NCT01369355|585669121|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
162168236|NCT01369355|585669122|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
162168237|NCT01369355|585669123|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
162168238|NCT01369355|585669124|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
162168239|NCT01369355|585669125|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
162168240|NCT01369355|585669126|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
162168241|NCT01369355|585669118|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
162168242|NCT01369355|585669119|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
162168243|NCT01369355|585669120|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
162168244|NCT01369355|585669121|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
162168245|NCT01369355|585669122|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
162168246|NCT01369355|585669123|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
162168247|NCT01369355|585669124|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
162168248|NCT01369355|585669125|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
162168249|NCT01369355|585669126|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
162168250|NCT01369355|585669118|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
162168251|NCT01369355|585669119|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
162168252|NCT01369355|585669120|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
162168253|NCT01369355|585669121|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
162168254|NCT01369355|585669122|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
162168255|NCT01369355|585669123|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
162168256|NCT01369355|585669124|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
162168257|NCT01369355|585669125|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
162168258|NCT01369355|585669126|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
162168259|NCT01369355|585669118|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
162168260|NCT01369355|585669119|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
162168261|NCT01369355|585669120|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
162168262|NCT01369355|585669121|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
162168263|NCT01369355|585669122|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
162168264|NCT01369355|585669123|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
162168265|NCT01369355|585669124|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
162168266|NCT01369355|585669125|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
162168267|NCT01369355|585669126|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
162168268|NCT01369355|585669118|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
162168269|NCT01369355|585669119|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
162168270|NCT01369355|585669120|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
162168271|NCT01369355|585669121|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
162168272|NCT01369355|585669122|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
162168273|NCT01369355|585669123|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
162168274|NCT01369355|585669124|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
162168275|NCT01369355|585669125|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
162168276|NCT01369355|585669126|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
162168277|NCT01369355|585669118|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
162168278|NCT01369355|585669119|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
162168279|NCT01369355|585669120|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
162168280|NCT01369355|585669121|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
162168281|NCT01369355|585669122|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
162168282|NCT01369355|585669123|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
162168283|NCT01369355|585669124|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
162168284|NCT01369355|585669125|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
162168285|NCT01369355|585669126|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
162168286|NCT01369355|585669118|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
162168287|NCT01369355|585669119|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
162168288|NCT01369355|585669120|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
162168289|NCT01369355|585669121|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
162168290|NCT01369355|585669122|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
162168291|NCT01369355|585669123|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
162168292|NCT01369355|585669124|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
162168293|NCT01369355|585669125|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
162168294|NCT01369355|585669126|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
162168295|NCT01369355|585669118|FG000|Long-term Extension (Week 44-272)|Death|0|||
162168296|NCT01369355|585669119|FG001|Long-term Extension (Week 44-272)|Death|0|||
162168297|NCT01369355|585669120|FG002|Long-term Extension (Week 44-272)|Death|0|||
162168298|NCT01369355|585669121|FG003|Long-term Extension (Week 44-272)|Death|0|||
162168299|NCT01369355|585669122|FG004|Long-term Extension (Week 44-272)|Death|0|||
162168300|NCT01369355|585669123|FG005|Long-term Extension (Week 44-272)|Death|0|||
162168301|NCT01369355|585669124|FG006|Long-term Extension (Week 44-272)|Death|0|||
162168302|NCT01369355|585669125|FG007|Long-term Extension (Week 44-272)|Death|1|||
162168303|NCT01369355|585669126|FG008|Long-term Extension (Week 44-272)|Death|3|||
162168304|NCT01369355|585669118|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162168305|NCT01369355|585669119|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162168306|NCT01369355|585669120|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162168307|NCT01369355|585669121|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162168308|NCT01369355|585669122|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162168309|NCT01369355|585669123|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
162168310|NCT01369355|585669124|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
162168311|NCT01369355|585669125|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
162168312|NCT01369355|585669126|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
162168313|NCT01369355|585669118|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162168314|NCT01369355|585669119|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162168315|NCT01369355|585669120|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162168316|NCT01369355|585669121|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162168317|NCT01369355|585669122|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162168318|NCT01369355|585669123|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162168319|NCT01369355|585669124|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
162168320|NCT01369355|585669125|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
162168321|NCT01369355|585669126|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
162168322|NCT01369355|585669118|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
162168323|NCT01369355|585669119|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
162168324|NCT01369355|585669120|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
162168325|NCT01369355|585669121|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
162168326|NCT01369355|585669122|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
162168327|NCT01369355|585669123|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
162168328|NCT01369355|585669124|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
162168329|NCT01369355|585669125|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
162168330|NCT01369355|585669126|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
162168331|NCT01369355|585669118|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
162168332|NCT01369355|585669119|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
162168333|NCT01369355|585669120|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
162168334|NCT01369355|585669121|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
162168335|NCT01369355|585669122|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
162168336|NCT01369355|585669123|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
162168337|NCT01369355|585669124|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
162168338|NCT01369355|585669125|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
162168339|NCT01369355|585669126|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
162168340|NCT01369355|585669118|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
162168341|NCT01369355|585669119|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
162168342|NCT01369355|585669120|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
162168343|NCT01369355|585669121|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
162168344|NCT01369355|585669122|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
162168345|NCT01369355|585669123|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
162168346|NCT01369355|585669124|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
162168347|NCT01369355|585669125|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
162168348|NCT01369355|585669126|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
162168349|NCT01369355|585669118|FG000|Long-term Extension (Week 44-272)|Other|0|||
162168350|NCT01369355|585669119|FG001|Long-term Extension (Week 44-272)|Other|0|||
162168351|NCT01369355|585669120|FG002|Long-term Extension (Week 44-272)|Other|0|||
162168352|NCT01369355|585669121|FG003|Long-term Extension (Week 44-272)|Other|0|||
162168353|NCT01369355|585669122|FG004|Long-term Extension (Week 44-272)|Other|0|||
162168354|NCT01369355|585669123|FG005|Long-term Extension (Week 44-272)|Other|0|||
162168355|NCT01369355|585669124|FG006|Long-term Extension (Week 44-272)|Other|110|||
162168356|NCT01369355|585669125|FG007|Long-term Extension (Week 44-272)|Other|9|||
162168357|NCT01369355|585669126|FG008|Long-term Extension (Week 44-272)|Other|17|||
162168358|NCT06424236|585669131|FG000|Overall Study|Adverse Event|0|||
162168359|NCT06424236|585669132|FG001|Overall Study|Adverse Event|1|||
162168360|NCT06424236|585669133|FG002|Overall Study|Adverse Event|0|||
162168361|NCT06424236|585669131|FG000|Overall Study|Withdrawal by Subject|3|||
162168362|NCT06424236|585669132|FG001|Overall Study|Withdrawal by Subject|1|||
162168363|NCT06424236|585669133|FG002|Overall Study|Withdrawal by Subject|2|||
162168364|NCT06424236|585669131|FG000|Overall Study|Physician Decision|0|||
162168365|NCT06424236|585669132|FG001|Overall Study|Physician Decision|1|||
162168366|NCT06424236|585669133|FG002|Overall Study|Physician Decision|0|||
162168367|NCT06424236|585669131|FG000|Overall Study|Study Terminated by Sponsor|11|||
162168368|NCT06424236|585669132|FG001|Overall Study|Study Terminated by Sponsor|20|||
162168369|NCT06424236|585669133|FG002|Overall Study|Study Terminated by Sponsor|16|||
162168370|NCT06424236|585669131|FG000|Overall Study|Lost to Follow-up|0|||
162168371|NCT06424236|585669132|FG001|Overall Study|Lost to Follow-up|1|||
162168372|NCT06424236|585669133|FG002|Overall Study|Lost to Follow-up|0|||
162168373|NCT06424236|585669131|FG000|Overall Study|Disease Progression|0|||
162168374|NCT06424236|585669132|FG001|Overall Study|Disease Progression|1|||
162168375|NCT06424236|585669133|FG002|Overall Study|Disease Progression|2|||
162168376|NCT06424236|585669131|FG000|Overall Study|Other|0|||
162168377|NCT06424236|585669132|FG001|Overall Study|Other|0|||
162168378|NCT06424236|585669133|FG002|Overall Study|Other|1|||
162168379|NCT01959425|585669135|FG000|Overall Study|Withdrawal by Subject|5|||
162168380|NCT01959425|585669136|FG001|Overall Study|Withdrawal by Subject|4|||
161669544|NCT01794520|583843109|FG002|Overall Study|Adverse events- related to progression|1|||
161669545|NCT01794520|583843110|FG003|Overall Study|Adverse events- related to progression|2|||
161669546|NCT01794520|583843111|FG004|Overall Study|Adverse events- related to progression|0|||
161669547|NCT01794520|583843112|FG005|Overall Study|Adverse events- related to progression|1|||
161816395|NCT00112437|584368826|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161921289|NCT02903914|584757195|FG002|Overall Study|Adverse Event|1|||
162168381|NCT01959425|585669135|FG000|Overall Study|Lost to Follow-up|1|||
162168382|NCT01959425|585669136|FG001|Overall Study|Lost to Follow-up|0|||
162168383|NCT01959425|585669135|FG000|Overall Study|Discontinued Subjects|6|||
162168384|NCT01959425|585669136|FG001|Overall Study|Discontinued Subjects|4|||
162168385|NCT00227344|585669137|FG000|Overall Study|study terminated early|12|||
162168386|NCT00227344|585669138|FG001|Overall Study|study terminated early|5|||
162168387|NCT01987895|585669139|FG000|Overall Study|Withdrawal by Subject|12|||
162168388|NCT01987895|585669140|FG001|Overall Study|Withdrawal by Subject|7|||
162168389|NCT01987895|585669139|FG000|Overall Study|Physician Decision|8|||
162168390|NCT01987895|585669140|FG001|Overall Study|Physician Decision|10|||
162168391|NCT01987895|585669139|FG000|Overall Study|Death|7|||
162168392|NCT01987895|585669140|FG001|Overall Study|Death|7|||
162168393|NCT01987895|585669139|FG000|Overall Study|Lost to Follow-up|3|||
162168394|NCT01987895|585669140|FG001|Overall Study|Lost to Follow-up|5|||
162168395|NCT01987895|585669139|FG000|Overall Study|randomized before giving IC|0|||
162168396|NCT01987895|585669140|FG001|Overall Study|randomized before giving IC|1|||
162168397|NCT02979327|585669141|FG000|First Intervention|Protocol Violation|1|||
162168398|NCT02979327|585669142|FG001|First Intervention|Protocol Violation|0|||
162168399|NCT01073566|585669148|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
162168400|NCT01073566|585669149|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
162168401|NCT05780437|585669152|FG000|Overall Study|Withdrawal by Subject|22|||
162168402|NCT05780437|585669153|FG001|Overall Study|Withdrawal by Subject|16|||
162168403|NCT05499377|585669160|FG000|Overall Study|Withdrawal by Subject|2|||
162168404|NCT05499377|585669161|FG001|Overall Study|Withdrawal by Subject|0|||
162168405|NCT05499377|585669160|FG000|Overall Study|Physician Decision|1|||
162168406|NCT05499377|585669161|FG001|Overall Study|Physician Decision|0|||
162168407|NCT03544281|585669164|FG000|Main Study Phase|Death|3|||
162168408|NCT03544281|585669165|FG001|Main Study Phase|Death|2|||
162168409|NCT03544281|585669166|FG002|Main Study Phase|Death|6|||
162168410|NCT03544281|585669167|FG003|Main Study Phase|Death|8|||
162168411|NCT03544281|585669168|FG004|Main Study Phase|Death|4|||
162168412|NCT03544281|585669169|FG005|Main Study Phase|Death|2|||
162168413|NCT03544281|585669170|FG006|Main Study Phase|Death|4|||
162168414|NCT03544281|585669171|FG007|Main Study Phase|Death|5|||
162168415|NCT03544281|585669172|FG008|Main Study Phase|Death|5|||
162168416|NCT03544281|585669173|FG009|Main Study Phase|Death|8|||
162168417|NCT03544281|585669174|FG010|Main Study Phase|Death|6|||
162168418|NCT03544281|585669175|FG011|Main Study Phase|Death|4|||
162168419|NCT03544281|585669176|FG012|Main Study Phase|Death|0|||
162168420|NCT03544281|585669177|FG013|Main Study Phase|Death|0|||
162168421|NCT03544281|585669178|FG014|Main Study Phase|Death|0|||
162168422|NCT03544281|585669179|FG015|Main Study Phase|Death|0|||
162168423|NCT03544281|585669180|FG016|Main Study Phase|Death|0|||
162168424|NCT03544281|585669181|FG017|Main Study Phase|Death|0|||
162168425|NCT03544281|585669182|FG018|Main Study Phase|Death|0|||
162168426|NCT03544281|585669183|FG019|Main Study Phase|Death|0|||
162168427|NCT03544281|585669184|FG020|Main Study Phase|Death|0|||
162168428|NCT03544281|585669185|FG021|Main Study Phase|Death|0|||
162168429|NCT03544281|585669164|FG000|Main Study Phase|Lost to Follow-up|0|||
162168430|NCT03544281|585669165|FG001|Main Study Phase|Lost to Follow-up|0|||
162168431|NCT03544281|585669166|FG002|Main Study Phase|Lost to Follow-up|0|||
162168432|NCT03544281|585669167|FG003|Main Study Phase|Lost to Follow-up|0|||
162168433|NCT03544281|585669168|FG004|Main Study Phase|Lost to Follow-up|0|||
162168434|NCT03544281|585669169|FG005|Main Study Phase|Lost to Follow-up|0|||
162168435|NCT03544281|585669170|FG006|Main Study Phase|Lost to Follow-up|0|||
162168436|NCT03544281|585669171|FG007|Main Study Phase|Lost to Follow-up|0|||
162168437|NCT03544281|585669172|FG008|Main Study Phase|Lost to Follow-up|0|||
162168438|NCT03544281|585669173|FG009|Main Study Phase|Lost to Follow-up|0|||
162168439|NCT03544281|585669174|FG010|Main Study Phase|Lost to Follow-up|1|||
162168440|NCT03544281|585669175|FG011|Main Study Phase|Lost to Follow-up|0|||
162168441|NCT03544281|585669176|FG012|Main Study Phase|Lost to Follow-up|0|||
162168442|NCT03544281|585669177|FG013|Main Study Phase|Lost to Follow-up|0|||
162168443|NCT03544281|585669178|FG014|Main Study Phase|Lost to Follow-up|0|||
162168444|NCT03544281|585669179|FG015|Main Study Phase|Lost to Follow-up|0|||
161816396|NCT00112437|584368827|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
162168445|NCT03544281|585669180|FG016|Main Study Phase|Lost to Follow-up|0|||
161816397|NCT00112437|584368828|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816398|NCT00112437|584368829|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161816399|NCT00112437|584368804|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816400|NCT00112437|584368805|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816401|NCT00112437|584368806|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816402|NCT00112437|584368807|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162017307|NCT01273519|585117925|FG002|Overall Study|Other|1|||
162168446|NCT03544281|585669181|FG017|Main Study Phase|Lost to Follow-up|0|||
162168447|NCT03544281|585669182|FG018|Main Study Phase|Lost to Follow-up|0|||
162168448|NCT03544281|585669183|FG019|Main Study Phase|Lost to Follow-up|0|||
162168449|NCT03544281|585669184|FG020|Main Study Phase|Lost to Follow-up|0|||
162168450|NCT03544281|585669185|FG021|Main Study Phase|Lost to Follow-up|0|||
162168451|NCT03544281|585669164|FG000|Main Study Phase|Physician Decision|0|||
162168452|NCT03544281|585669165|FG001|Main Study Phase|Physician Decision|0|||
162168453|NCT03544281|585669166|FG002|Main Study Phase|Physician Decision|0|||
162168454|NCT03544281|585669167|FG003|Main Study Phase|Physician Decision|0|||
162168455|NCT03544281|585669168|FG004|Main Study Phase|Physician Decision|0|||
162168456|NCT03544281|585669169|FG005|Main Study Phase|Physician Decision|0|||
162168457|NCT03544281|585669170|FG006|Main Study Phase|Physician Decision|0|||
162168458|NCT03544281|585669171|FG007|Main Study Phase|Physician Decision|1|||
162168459|NCT03544281|585669172|FG008|Main Study Phase|Physician Decision|0|||
161816403|NCT00112437|584368808|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816404|NCT00112437|584368809|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816405|NCT00112437|584368810|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816406|NCT00112437|584368811|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816407|NCT00112437|584368812|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162168460|NCT03544281|585669173|FG009|Main Study Phase|Physician Decision|0|||
162168461|NCT03544281|585669174|FG010|Main Study Phase|Physician Decision|0|||
162168462|NCT03544281|585669175|FG011|Main Study Phase|Physician Decision|0|||
162168463|NCT03544281|585669176|FG012|Main Study Phase|Physician Decision|0|||
162168464|NCT03544281|585669177|FG013|Main Study Phase|Physician Decision|0|||
162168465|NCT03544281|585669178|FG014|Main Study Phase|Physician Decision|0|||
162168466|NCT03544281|585669179|FG015|Main Study Phase|Physician Decision|0|||
162168467|NCT03544281|585669180|FG016|Main Study Phase|Physician Decision|0|||
162168468|NCT03544281|585669181|FG017|Main Study Phase|Physician Decision|0|||
162168469|NCT03544281|585669182|FG018|Main Study Phase|Physician Decision|0|||
162168470|NCT03544281|585669183|FG019|Main Study Phase|Physician Decision|0|||
162168471|NCT03544281|585669184|FG020|Main Study Phase|Physician Decision|0|||
162168472|NCT03544281|585669185|FG021|Main Study Phase|Physician Decision|0|||
162168473|NCT03544281|585669164|FG000|Main Study Phase|Withdrawal by Subject|2|||
162168474|NCT03544281|585669165|FG001|Main Study Phase|Withdrawal by Subject|0|||
162168475|NCT03544281|585669166|FG002|Main Study Phase|Withdrawal by Subject|1|||
162168476|NCT03544281|585669167|FG003|Main Study Phase|Withdrawal by Subject|2|||
162168477|NCT03544281|585669168|FG004|Main Study Phase|Withdrawal by Subject|0|||
162168478|NCT03544281|585669169|FG005|Main Study Phase|Withdrawal by Subject|0|||
162168479|NCT03544281|585669170|FG006|Main Study Phase|Withdrawal by Subject|0|||
162168480|NCT03544281|585669171|FG007|Main Study Phase|Withdrawal by Subject|0|||
162168481|NCT03544281|585669172|FG008|Main Study Phase|Withdrawal by Subject|2|||
162168482|NCT03544281|585669173|FG009|Main Study Phase|Withdrawal by Subject|3|||
162168483|NCT03544281|585669174|FG010|Main Study Phase|Withdrawal by Subject|0|||
162168484|NCT03544281|585669175|FG011|Main Study Phase|Withdrawal by Subject|4|||
162168485|NCT03544281|585669176|FG012|Main Study Phase|Withdrawal by Subject|0|||
162168486|NCT03544281|585669177|FG013|Main Study Phase|Withdrawal by Subject|0|||
161816408|NCT00112437|584368813|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162168487|NCT03544281|585669178|FG014|Main Study Phase|Withdrawal by Subject|0|||
162168488|NCT03544281|585669179|FG015|Main Study Phase|Withdrawal by Subject|0|||
162168489|NCT03544281|585669180|FG016|Main Study Phase|Withdrawal by Subject|0|||
162168490|NCT03544281|585669181|FG017|Main Study Phase|Withdrawal by Subject|0|||
162168491|NCT03544281|585669182|FG018|Main Study Phase|Withdrawal by Subject|0|||
162168492|NCT03544281|585669183|FG019|Main Study Phase|Withdrawal by Subject|0|||
162168493|NCT03544281|585669184|FG020|Main Study Phase|Withdrawal by Subject|0|||
162168494|NCT03544281|585669185|FG021|Main Study Phase|Withdrawal by Subject|0|||
162168495|NCT03544281|585669164|FG000|Main Study Phase|Ongoing|3|||
162168496|NCT03544281|585669165|FG001|Main Study Phase|Ongoing|1|||
162168497|NCT03544281|585669166|FG002|Main Study Phase|Ongoing|2|||
162168498|NCT03544281|585669167|FG003|Main Study Phase|Ongoing|4|||
162168499|NCT03544281|585669168|FG004|Main Study Phase|Ongoing|2|||
162168500|NCT03544281|585669169|FG005|Main Study Phase|Ongoing|4|||
162168501|NCT03544281|585669170|FG006|Main Study Phase|Ongoing|4|||
162168502|NCT03544281|585669171|FG007|Main Study Phase|Ongoing|0|||
162168503|NCT03544281|585669172|FG008|Main Study Phase|Ongoing|2|||
162168504|NCT03544281|585669173|FG009|Main Study Phase|Ongoing|2|||
162168505|NCT03544281|585669174|FG010|Main Study Phase|Ongoing|1|||
162168506|NCT03544281|585669175|FG011|Main Study Phase|Ongoing|0|||
162168507|NCT03544281|585669176|FG012|Main Study Phase|Ongoing|0|||
162168508|NCT03544281|585669177|FG013|Main Study Phase|Ongoing|0|||
162168509|NCT03544281|585669178|FG014|Main Study Phase|Ongoing|0|||
162168510|NCT03544281|585669179|FG015|Main Study Phase|Ongoing|0|||
162168511|NCT03544281|585669180|FG016|Main Study Phase|Ongoing|0|||
162168512|NCT03544281|585669181|FG017|Main Study Phase|Ongoing|0|||
162168513|NCT03544281|585669182|FG018|Main Study Phase|Ongoing|0|||
162168514|NCT03544281|585669183|FG019|Main Study Phase|Ongoing|0|||
161816409|NCT00112437|584368814|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816410|NCT00112437|584368815|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161921290|NCT02903914|584757196|FG003|Overall Study|Adverse Event|0|||
162168515|NCT03544281|585669184|FG020|Main Study Phase|Ongoing|0|||
162168516|NCT03544281|585669185|FG021|Main Study Phase|Ongoing|0|||
162168517|NCT03544281|585669164|FG000|Main Study Phase|Investigator Site Closed|0|||
162168518|NCT03544281|585669165|FG001|Main Study Phase|Investigator Site Closed|0|||
162168519|NCT03544281|585669166|FG002|Main Study Phase|Investigator Site Closed|0|||
162168520|NCT03544281|585669167|FG003|Main Study Phase|Investigator Site Closed|0|||
162168521|NCT03544281|585669168|FG004|Main Study Phase|Investigator Site Closed|0|||
162168522|NCT03544281|585669169|FG005|Main Study Phase|Investigator Site Closed|0|||
162168523|NCT03544281|585669170|FG006|Main Study Phase|Investigator Site Closed|0|||
162168524|NCT03544281|585669171|FG007|Main Study Phase|Investigator Site Closed|0|||
162168525|NCT03544281|585669172|FG008|Main Study Phase|Investigator Site Closed|0|||
162168526|NCT03544281|585669173|FG009|Main Study Phase|Investigator Site Closed|1|||
162168527|NCT03544281|585669174|FG010|Main Study Phase|Investigator Site Closed|0|||
162168528|NCT03544281|585669175|FG011|Main Study Phase|Investigator Site Closed|0|||
161669548|NCT01794520|583843113|FG006|Overall Study|Adverse events- related to progression|0|||
161669549|NCT01794520|583843107|FG000|Overall Study|Adverse event- not related to progression|1|||
161669550|NCT01794520|583843108|FG001|Overall Study|Adverse event- not related to progression|1|||
161669551|NCT01794520|583843109|FG002|Overall Study|Adverse event- not related to progression|0|||
161669552|NCT01794520|583843110|FG003|Overall Study|Adverse event- not related to progression|0|||
162017308|NCT03695367|585117926|FG000|Overall Study|Missed the Day 28 visit.|1|||
162017309|NCT03695367|585117927|FG001|Overall Study|Missed the Day 28 visit.|0|||
162017310|NCT03695367|585117926|FG000|Overall Study|Lost to Follow-up|0|||
162017311|NCT03695367|585117927|FG001|Overall Study|Lost to Follow-up|1|||
162017312|NCT03695367|585117926|FG000|Overall Study|Withdrawal by Subject|0|||
162017313|NCT03695367|585117927|FG001|Overall Study|Withdrawal by Subject|1|||
162017314|NCT03695367|585117926|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
162017315|NCT03695367|585117927|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
162017316|NCT00068419|585117930|FG000|Overall Study|Adverse Event|3|||
162017317|NCT00068419|585117930|FG000|Overall Study|Lack of Efficacy|24|||
162017318|NCT00068419|585117930|FG000|Overall Study|Lost to Follow-up|1|||
162017319|NCT00068419|585117930|FG000|Overall Study|Physician Decision|7|||
162017320|NCT00068419|585117930|FG000|Overall Study|Withdrawal by Subject|14|||
162017321|NCT00068419|585117930|FG000|Overall Study|Ineligible|11|||
162017322|NCT04717336|585117935|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
162017323|NCT04717336|585117936|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
162017324|NCT04717336|585117935|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
162017325|NCT04717336|585117936|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
162017326|NCT02039843|585117937|FG000|Randomization and Observation Period|Adverse Event|2|||
162017327|NCT02039843|585117938|FG001|Randomization and Observation Period|Adverse Event|0|||
162017328|NCT02039843|585117937|FG000|Randomization and Observation Period|Death|1|||
162017329|NCT02039843|585117938|FG001|Randomization and Observation Period|Death|0|||
162017330|NCT02039843|585117937|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
162017331|NCT02039843|585117938|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
162017332|NCT02039843|585117937|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
162017333|NCT02039843|585117938|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
161669553|NCT01794520|583843111|FG004|Overall Study|Adverse event- not related to progression|2|||
161669554|NCT01794520|583843112|FG005|Overall Study|Adverse event- not related to progression|0|||
161669555|NCT01794520|583843113|FG006|Overall Study|Adverse event- not related to progression|0|||
161669556|NCT01794520|583843107|FG000|Overall Study|Progressive disease|5|||
161669557|NCT01794520|583843108|FG001|Overall Study|Progressive disease|6|||
161669558|NCT01794520|583843109|FG002|Overall Study|Progressive disease|2|||
161669559|NCT01794520|583843110|FG003|Overall Study|Progressive disease|5|||
161669560|NCT01794520|583843111|FG004|Overall Study|Progressive disease|27|||
161669561|NCT01794520|583843112|FG005|Overall Study|Progressive disease|18|||
161669562|NCT01794520|583843113|FG006|Overall Study|Progressive disease|0|||
161669563|NCT01794520|583843107|FG000|Overall Study|Withdrew consent|0|||
161669564|NCT01794520|583843108|FG001|Overall Study|Withdrew consent|0|||
161669565|NCT01794520|583843109|FG002|Overall Study|Withdrew consent|1|||
161669566|NCT01794520|583843110|FG003|Overall Study|Withdrew consent|1|||
161669567|NCT01794520|583843111|FG004|Overall Study|Withdrew consent|0|||
161921291|NCT02903914|584757197|FG004|Overall Study|Adverse Event|0|||
161921292|NCT02903914|584757198|FG005|Overall Study|Adverse Event|0|||
161921293|NCT02903914|584757199|FG006|Overall Study|Adverse Event|2|||
161921294|NCT02903914|584757200|FG007|Overall Study|Adverse Event|0|||
161921295|NCT02903914|584757193|FG000|Overall Study|Withdrawal by Subject|3|||
161921296|NCT02903914|584757194|FG001|Overall Study|Withdrawal by Subject|1|||
161921297|NCT02903914|584757195|FG002|Overall Study|Withdrawal by Subject|28|||
162017334|NCT02039843|585117937|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
161669568|NCT01794520|583843112|FG005|Overall Study|Withdrew consent|0|||
161669569|NCT01794520|583843113|FG006|Overall Study|Withdrew consent|0|||
161669570|NCT01794520|583843107|FG000|Overall Study|Lost to Follow-up|0|||
161669571|NCT01794520|583843108|FG001|Overall Study|Lost to Follow-up|0|||
161921298|NCT02903914|584757196|FG003|Overall Study|Withdrawal by Subject|0|||
161921299|NCT02903914|584757197|FG004|Overall Study|Withdrawal by Subject|1|||
162168529|NCT03544281|585669176|FG012|Main Study Phase|Investigator Site Closed|0|||
162168530|NCT03544281|585669177|FG013|Main Study Phase|Investigator Site Closed|0|||
162168531|NCT03544281|585669178|FG014|Main Study Phase|Investigator Site Closed|0|||
162168532|NCT03544281|585669179|FG015|Main Study Phase|Investigator Site Closed|0|||
161669572|NCT01794520|583843109|FG002|Overall Study|Lost to Follow-up|0|||
161669573|NCT01794520|583843110|FG003|Overall Study|Lost to Follow-up|0|||
161669574|NCT01794520|583843111|FG004|Overall Study|Lost to Follow-up|1|||
161669575|NCT01794520|583843112|FG005|Overall Study|Lost to Follow-up|0|||
161669576|NCT01794520|583843113|FG006|Overall Study|Lost to Follow-up|0|||
161669577|NCT01794520|583843107|FG000|Overall Study|Toxicity|0|||
161669578|NCT01794520|583843108|FG001|Overall Study|Toxicity|2|||
161669579|NCT01794520|583843109|FG002|Overall Study|Toxicity|0|||
161669580|NCT01794520|583843110|FG003|Overall Study|Toxicity|0|||
161669581|NCT01794520|583843111|FG004|Overall Study|Toxicity|0|||
161669582|NCT01794520|583843112|FG005|Overall Study|Toxicity|0|||
161669583|NCT01794520|583843113|FG006|Overall Study|Toxicity|0|||
161669584|NCT01794520|583843107|FG000|Overall Study|Study terminated by sponsor|0|||
161669585|NCT01794520|583843108|FG001|Overall Study|Study terminated by sponsor|0|||
161669586|NCT01794520|583843109|FG002|Overall Study|Study terminated by sponsor|1|||
161669587|NCT01794520|583843110|FG003|Overall Study|Study terminated by sponsor|0|||
161669588|NCT01794520|583843111|FG004|Overall Study|Study terminated by sponsor|1|||
161669589|NCT01794520|583843112|FG005|Overall Study|Study terminated by sponsor|0|||
161669590|NCT01794520|583843113|FG006|Overall Study|Study terminated by sponsor|7|||
161669591|NCT01794520|583843107|FG000|Overall Study|Death|0|||
161669592|NCT01794520|583843108|FG001|Overall Study|Death|0|||
161669593|NCT01794520|583843109|FG002|Overall Study|Death|0|||
161669594|NCT01794520|583843110|FG003|Overall Study|Death|0|||
161669595|NCT01794520|583843111|FG004|Overall Study|Death|1|||
161669596|NCT01794520|583843112|FG005|Overall Study|Death|0|||
162168533|NCT03544281|585669180|FG016|Main Study Phase|Investigator Site Closed|0|||
162168534|NCT03544281|585669181|FG017|Main Study Phase|Investigator Site Closed|0|||
162168535|NCT03544281|585669182|FG018|Main Study Phase|Investigator Site Closed|0|||
162168536|NCT03544281|585669183|FG019|Main Study Phase|Investigator Site Closed|0|||
162168537|NCT03544281|585669184|FG020|Main Study Phase|Investigator Site Closed|0|||
162168538|NCT03544281|585669185|FG021|Main Study Phase|Investigator Site Closed|0|||
162168539|NCT03544281|585669164|FG000|Main Study Phase|Did not receive study treatment|0|||
162168540|NCT03544281|585669165|FG001|Main Study Phase|Did not receive study treatment|0|||
162168541|NCT03544281|585669166|FG002|Main Study Phase|Did not receive study treatment|0|||
162168542|NCT03544281|585669167|FG003|Main Study Phase|Did not receive study treatment|0|||
161669597|NCT01794520|583843113|FG006|Overall Study|Death|22|||
161669598|NCT01794520|583843107|FG000|Overall Study|Other, not specified|0|||
161669599|NCT01794520|583843108|FG001|Overall Study|Other, not specified|0|||
161669600|NCT01794520|583843109|FG002|Overall Study|Other, not specified|1|||
161669601|NCT01794520|583843110|FG003|Overall Study|Other, not specified|1|||
161669602|NCT01794520|583843111|FG004|Overall Study|Other, not specified|4|||
161669603|NCT01794520|583843112|FG005|Overall Study|Other, not specified|1|||
161816411|NCT00112437|584368816|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816412|NCT00112437|584368817|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162168543|NCT03544281|585669168|FG004|Main Study Phase|Did not receive study treatment|0|||
162168544|NCT03544281|585669169|FG005|Main Study Phase|Did not receive study treatment|0|||
162168545|NCT03544281|585669170|FG006|Main Study Phase|Did not receive study treatment|1|||
162168546|NCT03544281|585669171|FG007|Main Study Phase|Did not receive study treatment|0|||
162168547|NCT03544281|585669172|FG008|Main Study Phase|Did not receive study treatment|0|||
162168548|NCT03544281|585669173|FG009|Main Study Phase|Did not receive study treatment|0|||
162168549|NCT03544281|585669174|FG010|Main Study Phase|Did not receive study treatment|0|||
162168550|NCT03544281|585669175|FG011|Main Study Phase|Did not receive study treatment|0|||
162168551|NCT03544281|585669176|FG012|Main Study Phase|Did not receive study treatment|0|||
162168552|NCT03544281|585669177|FG013|Main Study Phase|Did not receive study treatment|0|||
162168553|NCT03544281|585669178|FG014|Main Study Phase|Did not receive study treatment|0|||
162168554|NCT03544281|585669179|FG015|Main Study Phase|Did not receive study treatment|0|||
162168555|NCT03544281|585669180|FG016|Main Study Phase|Did not receive study treatment|0|||
162168556|NCT03544281|585669181|FG017|Main Study Phase|Did not receive study treatment|0|||
162168557|NCT03544281|585669182|FG018|Main Study Phase|Did not receive study treatment|0|||
161816413|NCT00112437|584368818|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
162168558|NCT03544281|585669183|FG019|Main Study Phase|Did not receive study treatment|0|||
162168559|NCT03544281|585669184|FG020|Main Study Phase|Did not receive study treatment|0|||
161669604|NCT01794520|583843113|FG006|Overall Study|Other, not specified|2|||
161669605|NCT04796896|583843114|FG000|Overall Study|Adverse Event|1|||
161669606|NCT04796896|583843115|FG001|Overall Study|Adverse Event|0|||
161669607|NCT04796896|583843116|FG002|Overall Study|Adverse Event|0|||
161669608|NCT04796896|583843117|FG003|Overall Study|Adverse Event|0|||
161669609|NCT04796896|583843118|FG004|Overall Study|Adverse Event|0|||
161669610|NCT04796896|583843119|FG005|Overall Study|Adverse Event|1|||
162168560|NCT03544281|585669185|FG021|Main Study Phase|Did not receive study treatment|0|||
161669611|NCT04796896|583843120|FG006|Overall Study|Adverse Event|1|||
161669612|NCT04796896|583843121|FG007|Overall Study|Adverse Event|0|||
162168561|NCT03544281|585669164|FG000|PACT Phase|Adverse Event|0|||
162168562|NCT03544281|585669165|FG001|PACT Phase|Adverse Event|0|||
162168563|NCT03544281|585669166|FG002|PACT Phase|Adverse Event|0|||
162168564|NCT03544281|585669167|FG003|PACT Phase|Adverse Event|0|||
162168565|NCT03544281|585669168|FG004|PACT Phase|Adverse Event|0|||
162168566|NCT03544281|585669169|FG005|PACT Phase|Adverse Event|0|||
162168567|NCT03544281|585669170|FG006|PACT Phase|Adverse Event|0|||
162168568|NCT03544281|585669171|FG007|PACT Phase|Adverse Event|0|||
162168569|NCT03544281|585669172|FG008|PACT Phase|Adverse Event|0|||
162168570|NCT03544281|585669173|FG009|PACT Phase|Adverse Event|0|||
162168571|NCT03544281|585669174|FG010|PACT Phase|Adverse Event|0|||
162168572|NCT03544281|585669175|FG011|PACT Phase|Adverse Event|0|||
162168573|NCT03544281|585669176|FG012|PACT Phase|Adverse Event|1|||
162168574|NCT03544281|585669177|FG013|PACT Phase|Adverse Event|0|||
162168575|NCT03544281|585669178|FG014|PACT Phase|Adverse Event|0|||
162168576|NCT03544281|585669179|FG015|PACT Phase|Adverse Event|0|||
162168577|NCT03544281|585669180|FG016|PACT Phase|Adverse Event|0|||
162168578|NCT03544281|585669181|FG017|PACT Phase|Adverse Event|1|||
162168579|NCT03544281|585669182|FG018|PACT Phase|Adverse Event|1|||
162168580|NCT03544281|585669183|FG019|PACT Phase|Adverse Event|0|||
162168581|NCT03544281|585669184|FG020|PACT Phase|Adverse Event|0|||
162168582|NCT03544281|585669185|FG021|PACT Phase|Adverse Event|0|||
162168583|NCT02547233|585669186|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
162168584|NCT02547233|585669187|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
162168585|NCT02547233|585669186|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
162168586|NCT02547233|585669187|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
162168587|NCT02547233|585669186|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
162168588|NCT02547233|585669187|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
162168589|NCT02547233|585669186|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
162168590|NCT02547233|585669187|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
162168591|NCT02547233|585669186|FG000|12-month Follow-up|Withdrawal by Subject|10|||
162168592|NCT02547233|585669187|FG001|12-month Follow-up|Withdrawal by Subject|10|||
162168593|NCT02547233|585669186|FG000|12-month Follow-up|Lost to Follow-up|3|||
162168594|NCT02547233|585669187|FG001|12-month Follow-up|Lost to Follow-up|3|||
162168595|NCT02547233|585669186|FG000|12-month Follow-up|Lack of Efficacy|1|||
162168596|NCT02547233|585669187|FG001|12-month Follow-up|Lack of Efficacy|2|||
162168597|NCT02547233|585669186|FG000|12-month Follow-up|Protocol Violation|0|||
162168598|NCT02547233|585669187|FG001|12-month Follow-up|Protocol Violation|1|||
162168599|NCT02547233|585669186|FG000|12-month Follow-up|Other|0|||
162168600|NCT02547233|585669187|FG001|12-month Follow-up|Other|1|||
162168601|NCT06019559|585669188|FG000|Overall Study|Withdrawal by Subject|7|||
161816414|NCT00112437|584368819|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816415|NCT00112437|584368820|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816416|NCT00112437|584368821|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816417|NCT00112437|584368822|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816418|NCT00112437|584368823|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816419|NCT00112437|584368824|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
161816420|NCT00112437|584368825|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
162168602|NCT06019559|585669189|FG001|Overall Study|Withdrawal by Subject|6|||
162168603|NCT06019559|585669190|FG002|Overall Study|Withdrawal by Subject|5|||
162168604|NCT06019559|585669188|FG000|Overall Study|Lost to Follow-up|2|||
162168605|NCT06019559|585669189|FG001|Overall Study|Lost to Follow-up|0|||
162168606|NCT06019559|585669190|FG002|Overall Study|Lost to Follow-up|3|||
162168607|NCT05362487|585669191|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
162168608|NCT02310646|585669198|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
162168609|NCT02310646|585669199|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
162168610|NCT02310646|585669198|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
162168611|NCT02310646|585669199|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
162168612|NCT00613106|585669206|FG000|Overall Study|Adverse Event|3|||
162168613|NCT00613106|585669207|FG001|Overall Study|Adverse Event|1|||
162168614|NCT00613106|585669206|FG000|Overall Study|Withdrawal by Subject|6|||
162168615|NCT00613106|585669207|FG001|Overall Study|Withdrawal by Subject|3|||
162168616|NCT00613106|585669206|FG000|Overall Study|Lost to Follow-up|7|||
162168617|NCT00613106|585669207|FG001|Overall Study|Lost to Follow-up|2|||
162168618|NCT00613106|585669206|FG000|Overall Study|misc|4|||
162168619|NCT00613106|585669207|FG001|Overall Study|misc|3|||
162168620|NCT03496168|585669208|FG000|Overall Study|Other Reasons|1|||
162168621|NCT03496168|585669208|FG000|Overall Study|Adverse Event|1|||
162168622|NCT05543629|585669211|FG000|Overall Study|Death|1|||
162168623|NCT05543629|585669212|FG001|Overall Study|Death|0|||
162168624|NCT05543629|585669213|FG002|Overall Study|Death|1|||
162168625|NCT05543629|585669214|FG003|Overall Study|Death|0|||
162168626|NCT05543629|585669215|FG004|Overall Study|Death|0|||
162168627|NCT05543629|585669216|FG005|Overall Study|Death|1|||
162168628|NCT05543629|585669217|FG006|Overall Study|Death|2|||
162168629|NCT05543629|585669218|FG007|Overall Study|Death|2|||
162168630|NCT05543629|585669211|FG000|Overall Study|Other Reasons|0|||
162168631|NCT05543629|585669212|FG001|Overall Study|Other Reasons|0|||
162168632|NCT05543629|585669213|FG002|Overall Study|Other Reasons|0|||
162168633|NCT05543629|585669214|FG003|Overall Study|Other Reasons|0|||
162168634|NCT05543629|585669215|FG004|Overall Study|Other Reasons|1|||
162168635|NCT05543629|585669216|FG005|Overall Study|Other Reasons|0|||
162168636|NCT05543629|585669217|FG006|Overall Study|Other Reasons|0|||
162168637|NCT05543629|585669218|FG007|Overall Study|Other Reasons|0|||
162168638|NCT05543629|585669211|FG000|Overall Study|Physician Decision|0|||
162168639|NCT05543629|585669212|FG001|Overall Study|Physician Decision|0|||
162168640|NCT05543629|585669213|FG002|Overall Study|Physician Decision|3|||
162168641|NCT05543629|585669214|FG003|Overall Study|Physician Decision|0|||
162168642|NCT05543629|585669215|FG004|Overall Study|Physician Decision|0|||
162168643|NCT05543629|585669216|FG005|Overall Study|Physician Decision|0|||
162168644|NCT05543629|585669217|FG006|Overall Study|Physician Decision|1|||
162168645|NCT05543629|585669218|FG007|Overall Study|Physician Decision|0|||
162168646|NCT05543629|585669211|FG000|Overall Study|Study terminated by Sponsor|1|||
162168647|NCT05543629|585669212|FG001|Overall Study|Study terminated by Sponsor|0|||
162168648|NCT05543629|585669213|FG002|Overall Study|Study terminated by Sponsor|0|||
162168649|NCT05543629|585669214|FG003|Overall Study|Study terminated by Sponsor|1|||
162168650|NCT05543629|585669215|FG004|Overall Study|Study terminated by Sponsor|0|||
162168651|NCT05543629|585669216|FG005|Overall Study|Study terminated by Sponsor|4|||
162168652|NCT05543629|585669217|FG006|Overall Study|Study terminated by Sponsor|1|||
162168653|NCT05543629|585669218|FG007|Overall Study|Study terminated by Sponsor|0|||
162168654|NCT05543629|585669211|FG000|Overall Study|Withdrawal by Subject|1|||
162168655|NCT05543629|585669212|FG001|Overall Study|Withdrawal by Subject|1|||
162168656|NCT05543629|585669213|FG002|Overall Study|Withdrawal by Subject|0|||
162168657|NCT05543629|585669214|FG003|Overall Study|Withdrawal by Subject|2|||
162168658|NCT05543629|585669215|FG004|Overall Study|Withdrawal by Subject|1|||
162168659|NCT05543629|585669216|FG005|Overall Study|Withdrawal by Subject|1|||
162168660|NCT05543629|585669217|FG006|Overall Study|Withdrawal by Subject|1|||
162168661|NCT05543629|585669218|FG007|Overall Study|Withdrawal by Subject|1|||
162168662|NCT05543629|585669211|FG000|Overall Study|Not Reported|2|||
162168663|NCT05543629|585669212|FG001|Overall Study|Not Reported|2|||
162168664|NCT05543629|585669213|FG002|Overall Study|Not Reported|0|||
162168665|NCT05543629|585669214|FG003|Overall Study|Not Reported|0|||
162168666|NCT05543629|585669215|FG004|Overall Study|Not Reported|1|||
162168667|NCT05543629|585669216|FG005|Overall Study|Not Reported|1|||
162168668|NCT05543629|585669217|FG006|Overall Study|Not Reported|3|||
162168669|NCT05543629|585669218|FG007|Overall Study|Not Reported|0|||
162168670|NCT04568603|585669219|FG000|Overall Study|Physician Decision|1|||
162168671|NCT04564742|585669220|FG000|Overall Study|Lost to Follow-up|1|||
162168672|NCT04564742|585669221|FG001|Overall Study|Lost to Follow-up|0|||
162168673|NCT04564742|585669220|FG000|Overall Study|Consent Withdrawal|4|||
162168674|NCT04564742|585669221|FG001|Overall Study|Consent Withdrawal|4|||
162168675|NCT03313076|585669225|FG000|Overall Study|Withdrawal by Subject|2|||
162168676|NCT03313076|585669226|FG001|Overall Study|Withdrawal by Subject|0|||
162168677|NCT03313076|585669227|FG002|Overall Study|Withdrawal by Subject|0|||
162168678|NCT03313076|585669228|FG003|Overall Study|Withdrawal by Subject|0|||
162168679|NCT03313076|585669225|FG000|Overall Study|Lost to Follow-up|0|||
162168680|NCT03313076|585669226|FG001|Overall Study|Lost to Follow-up|2|||
162168681|NCT03313076|585669227|FG002|Overall Study|Lost to Follow-up|2|||
162168682|NCT03313076|585669228|FG003|Overall Study|Lost to Follow-up|2|||
162168683|NCT05869383|585669229|FG000|Overall Study|Withdrawal by Subject|2|||
162168684|NCT05869383|585669230|FG001|Overall Study|Withdrawal by Subject|0|||
162168685|NCT04137367|585669239|FG000|Overall Study|Lost to Follow-up|8|||
162168686|NCT04137367|585669240|FG001|Overall Study|Lost to Follow-up|6|||
162168687|NCT04137367|585669241|FG002|Overall Study|Lost to Follow-up|4|||
162168688|NCT05144009|585669242|FG000|Overall Study|Lost to Follow-up|0|||
162168689|NCT05144009|585669243|FG001|Overall Study|Lost to Follow-up|1|||
161669613|NCT04796896|583843122|FG008|Overall Study|Adverse Event|1|||
162168690|NCT05144009|585669242|FG000|Overall Study|Study Termination by the Sponsor|11|||
162168691|NCT05144009|585669243|FG001|Overall Study|Study Termination by the Sponsor|11|||
162168692|NCT05144009|585669242|FG000|Overall Study|Disease Progression|1|||
162168693|NCT05144009|585669243|FG001|Overall Study|Disease Progression|0|||
162168694|NCT05144009|585669242|FG000|Overall Study|Participant Decision|0|||
162168695|NCT05144009|585669243|FG001|Overall Study|Participant Decision|2|||
162168696|NCT05144009|585669242|FG000|Overall Study|Death|5|||
161816421|NCT00112437|584368826|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816422|NCT00112437|584368827|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161921300|NCT02903914|584757198|FG005|Overall Study|Withdrawal by Subject|2|||
161921301|NCT02903914|584757199|FG006|Overall Study|Withdrawal by Subject|12|||
161921302|NCT02903914|584757200|FG007|Overall Study|Withdrawal by Subject|0|||
161921303|NCT02903914|584757193|FG000|Overall Study|Progressive Disease|1|||
161921304|NCT02903914|584757194|FG001|Overall Study|Progressive Disease|0|||
161921305|NCT02903914|584757195|FG002|Overall Study|Progressive Disease|4|||
161921306|NCT02903914|584757196|FG003|Overall Study|Progressive Disease|0|||
161921307|NCT02903914|584757197|FG004|Overall Study|Progressive Disease|0|||
161921308|NCT02903914|584757198|FG005|Overall Study|Progressive Disease|0|||
161921309|NCT02903914|584757199|FG006|Overall Study|Progressive Disease|2|||
161816423|NCT00112437|584368828|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161921310|NCT02903914|584757200|FG007|Overall Study|Progressive Disease|0|||
161816424|NCT00112437|584368829|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161816425|NCT00112437|584368804|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816426|NCT00112437|584368805|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816427|NCT00112437|584368806|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816428|NCT00112437|584368807|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816429|NCT00112437|584368808|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816430|NCT00112437|584368809|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816431|NCT00112437|584368810|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816432|NCT00112437|584368811|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816433|NCT00112437|584368812|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816434|NCT00112437|584368813|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816435|NCT00112437|584368814|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816436|NCT00112437|584368815|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816437|NCT00112437|584368816|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816438|NCT00112437|584368817|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816439|NCT00112437|584368818|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816440|NCT00112437|584368819|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816441|NCT00112437|584368820|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816442|NCT00112437|584368821|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816443|NCT00112437|584368822|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816444|NCT00112437|584368823|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816445|NCT00112437|584368824|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
161816446|NCT00112437|584368825|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816447|NCT00112437|584368826|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816448|NCT00112437|584368827|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816449|NCT00112437|584368828|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816450|NCT00112437|584368829|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161816451|NCT00112437|584368804|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816452|NCT00112437|584368805|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816453|NCT00112437|584368806|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816454|NCT00112437|584368807|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816455|NCT00112437|584368808|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816456|NCT00112437|584368809|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816457|NCT00112437|584368810|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816458|NCT00112437|584368811|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816459|NCT00112437|584368812|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816460|NCT00112437|584368813|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816461|NCT00112437|584368814|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161921311|NCT02903914|584757193|FG000|Overall Study|Death|0|||
161921312|NCT02903914|584757194|FG001|Overall Study|Death|0|||
161921313|NCT02903914|584757195|FG002|Overall Study|Death|9|||
161921314|NCT02903914|584757196|FG003|Overall Study|Death|0|||
162168697|NCT05144009|585669243|FG001|Overall Study|Death|10|||
162168698|NCT02815566|585669248|FG000|Overall Study|Adverse Event|1|||
162168699|NCT02815566|585669249|FG001|Overall Study|Adverse Event|1|||
162168700|NCT02815566|585669248|FG000|Overall Study|Withdrawal by Subject|1|||
162168701|NCT02815566|585669249|FG001|Overall Study|Withdrawal by Subject|0|||
162168702|NCT02815566|585669248|FG000|Overall Study|Lost to Follow-up|0|||
161816462|NCT00112437|584368815|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816463|NCT00112437|584368816|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162168703|NCT02815566|585669249|FG001|Overall Study|Lost to Follow-up|1|||
162168704|NCT04492722|585669251|FG000|Overall Study|Adverse Event|7|||
162168705|NCT04492722|585669252|FG001|Overall Study|Adverse Event|2|||
162168706|NCT04492722|585669253|FG002|Overall Study|Adverse Event|3|||
162168707|NCT04492722|585669254|FG003|Overall Study|Adverse Event|0|||
162168708|NCT04492722|585669251|FG000|Overall Study|Death|0|||
162168709|NCT04492722|585669252|FG001|Overall Study|Death|0|||
162017335|NCT02039843|585117938|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
162017336|NCT02039843|585117937|FG000|Pairing With a Study Dog|Death|1|||
162017337|NCT02039843|585117938|FG001|Pairing With a Study Dog|Death|0|||
162017338|NCT02039843|585117937|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
162017339|NCT02039843|585117938|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
162017340|NCT02039843|585117937|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
162017341|NCT02039843|585117938|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
162017342|NCT02039843|585117937|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
162017343|NCT02039843|585117938|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
162017344|NCT01958164|585117942|FG000|Overall Study|Adverse Event|0|||
162017345|NCT01958164|585117943|FG001|Overall Study|Adverse Event|2|||
162168710|NCT04492722|585669253|FG002|Overall Study|Death|0|||
162168711|NCT04492722|585669254|FG003|Overall Study|Death|1|||
162168712|NCT04492722|585669251|FG000|Overall Study|Lost to Follow-up|0|||
162168713|NCT04492722|585669252|FG001|Overall Study|Lost to Follow-up|1|||
162168714|NCT04492722|585669253|FG002|Overall Study|Lost to Follow-up|0|||
162168715|NCT04492722|585669254|FG003|Overall Study|Lost to Follow-up|1|||
162168716|NCT04492722|585669251|FG000|Overall Study|Physician Decision|0|||
162168717|NCT04492722|585669252|FG001|Overall Study|Physician Decision|3|||
162168718|NCT04492722|585669253|FG002|Overall Study|Physician Decision|1|||
162168719|NCT04492722|585669254|FG003|Overall Study|Physician Decision|1|||
162168720|NCT04492722|585669251|FG000|Overall Study|Withdrawal by Subject|6|||
162168721|NCT04492722|585669252|FG001|Overall Study|Withdrawal by Subject|6|||
162168722|NCT04492722|585669253|FG002|Overall Study|Withdrawal by Subject|0|||
162168723|NCT04492722|585669254|FG003|Overall Study|Withdrawal by Subject|3|||
162168724|NCT04492722|585669251|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
162168725|NCT04492722|585669252|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
162168726|NCT04492722|585669253|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
162168727|NCT04492722|585669254|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
162168728|NCT04492722|585669251|FG000|Overall Study|Due to Covid-19 pandemic|7|||
162168729|NCT04492722|585669252|FG001|Overall Study|Due to Covid-19 pandemic|3|||
162168730|NCT04492722|585669253|FG002|Overall Study|Due to Covid-19 pandemic|7|||
162168731|NCT04492722|585669254|FG003|Overall Study|Due to Covid-19 pandemic|6|||
162168732|NCT04492722|585669251|FG000|Overall Study|Failure to meet randomisation criteria|2|||
162168733|NCT04492722|585669252|FG001|Overall Study|Failure to meet randomisation criteria|3|||
162168734|NCT04492722|585669253|FG002|Overall Study|Failure to meet randomisation criteria|4|||
162168735|NCT04492722|585669254|FG003|Overall Study|Failure to meet randomisation criteria|2|||
162168736|NCT04492722|585669251|FG000|Overall Study|Early termination from the study|54|||
162168737|NCT04492722|585669252|FG001|Overall Study|Early termination from the study|51|||
162168738|NCT04492722|585669253|FG002|Overall Study|Early termination from the study|50|||
162168739|NCT04492722|585669254|FG003|Overall Study|Early termination from the study|50|||
162168740|NCT04492722|585669251|FG000|Overall Study|Missing|3|||
162168741|NCT04492722|585669252|FG001|Overall Study|Missing|0|||
162168742|NCT04492722|585669253|FG002|Overall Study|Missing|0|||
162168743|NCT04492722|585669254|FG003|Overall Study|Missing|5|||
162168744|NCT04492722|585669251|FG000|Overall Study|Participants who did not receive treatment|0|||
162168745|NCT04492722|585669252|FG001|Overall Study|Participants who did not receive treatment|1|||
162168746|NCT04492722|585669253|FG002|Overall Study|Participants who did not receive treatment|4|||
162168747|NCT04492722|585669254|FG003|Overall Study|Participants who did not receive treatment|0|||
162168748|NCT04313972|585669258|FG000|Overall Study|Withdrawal by Subject|0|||
162168749|NCT04313972|585669259|FG001|Overall Study|Withdrawal by Subject|1|||
162168750|NCT05201079|585669273|FG000|Overall Study|Adverse Event|7|||
162168751|NCT05201079|585669274|FG001|Overall Study|Adverse Event|11|||
162168752|NCT05201079|585669273|FG000|Overall Study|Death|1|||
162168753|NCT05201079|585669274|FG001|Overall Study|Death|1|||
162168754|NCT05201079|585669273|FG000|Overall Study|Lack of Efficacy|0|||
162168755|NCT05201079|585669274|FG001|Overall Study|Lack of Efficacy|2|||
162168756|NCT05201079|585669273|FG000|Overall Study|Lost to Follow-up|0|||
162168757|NCT05201079|585669274|FG001|Overall Study|Lost to Follow-up|1|||
162168758|NCT05201079|585669273|FG000|Overall Study|Physician Decision|1|||
162168759|NCT05201079|585669274|FG001|Overall Study|Physician Decision|1|||
162168760|NCT05201079|585669273|FG000|Overall Study|Protocol Violation|1|||
162168761|NCT05201079|585669274|FG001|Overall Study|Protocol Violation|0|||
162168762|NCT05201079|585669273|FG000|Overall Study|Withdrawal by Subject|1|||
162168763|NCT05201079|585669274|FG001|Overall Study|Withdrawal by Subject|0|||
162168764|NCT05201079|585669273|FG000|Overall Study|Forbidden medication|9|||
162168765|NCT05201079|585669274|FG001|Overall Study|Forbidden medication|5|||
162168766|NCT05201079|585669273|FG000|Overall Study|Transfer to another hospital|0|||
162017346|NCT01958164|585117942|FG000|Overall Study|Lost to Follow-up|2|||
162168767|NCT05201079|585669274|FG001|Overall Study|Transfer to another hospital|1|||
162168768|NCT05201079|585669273|FG000|Overall Study|Clinical condition|1|||
162168769|NCT05201079|585669274|FG001|Overall Study|Clinical condition|0|||
162168770|NCT05201079|585669273|FG000|Overall Study|SAE and sepsis|1|||
162168771|NCT05201079|585669274|FG001|Overall Study|SAE and sepsis|0|||
162168772|NCT05835336|585671408|FG000|Overall Study|Withdrawal by Subject|5|||
162168773|NCT05835336|585671408|FG000|Overall Study|Did not complete the personalization process|3|||
162168774|NCT04489771|585671409|FG000|Overall Study|Death|27|||
162168775|NCT04489771|585671410|FG001|Overall Study|Death|25|||
162168776|NCT04489771|585671409|FG000|Overall Study|Withdrawal by Subject|1|||
162168777|NCT04489771|585671410|FG001|Overall Study|Withdrawal by Subject|0|||
162168778|NCT04489771|585671409|FG000|Overall Study|Participants Ongoing in Study|50|||
162168779|NCT04489771|585671410|FG001|Overall Study|Participants Ongoing in Study|51|||
162168780|NCT05579899|585671415|FG000|Overall Study|Lost to Follow-up|3|||
162168781|NCT05579899|585671416|FG001|Overall Study|Lost to Follow-up|1|||
162168782|NCT05579899|585671415|FG000|Overall Study|Adverse Event|0|||
162168783|NCT05579899|585671416|FG001|Overall Study|Adverse Event|3|||
162168784|NCT05579899|585671415|FG000|Overall Study|Pregnancy|0|||
162168785|NCT05579899|585671416|FG001|Overall Study|Pregnancy|1|||
162168786|NCT05579899|585671415|FG000|Overall Study|Withdrawal by Subject|0|||
162168787|NCT05579899|585671416|FG001|Overall Study|Withdrawal by Subject|3|||
162168788|NCT05453773|585671418|FG000|Overall Study|Withdrawal by Subject|3|||
162168789|NCT05453773|585671418|FG000|Overall Study|Lost to Follow-up|3|||
162168790|NCT05453773|585671418|FG000|Overall Study|Difficult Blood Draw|3|||
162168791|NCT02485938|585671421|FG000|Overall Study|Withdrawal of consent|2|||
162168792|NCT02485938|585671422|FG001|Overall Study|Withdrawal of consent|0|||
162168793|NCT00470704|585671423|FG000|Overall Study|Withdrawal by Subject|4|||
162168794|NCT00470704|585671424|FG001|Overall Study|Withdrawal by Subject|3|||
162168795|NCT00470704|585671423|FG000|Overall Study|Relapse/Progression|37|||
162168796|NCT00470704|585671424|FG001|Overall Study|Relapse/Progression|42|||
162168797|NCT00470704|585671423|FG000|Overall Study|toxicity|0|||
162168798|NCT00470704|585671424|FG001|Overall Study|toxicity|1|||
162168799|NCT04802967|585671426|FG000|Part B|Withdrawal by Subject|0|||
162168800|NCT04802967|585671427|FG001|Part B|Withdrawal by Subject|0|||
162168801|NCT04802967|585671428|FG002|Part B|Withdrawal by Subject|0|||
162168802|NCT04802967|585671429|FG003|Part B|Withdrawal by Subject|0|||
162168803|NCT04802967|585671430|FG004|Part B|Withdrawal by Subject|0|||
162168804|NCT04802967|585671431|FG005|Part B|Withdrawal by Subject|1|||
162168805|NCT04802967|585671432|FG006|Part B|Withdrawal by Subject|0|||
162168806|NCT04802967|585671433|FG007|Part B|Withdrawal by Subject|0|||
162168807|NCT04802967|585671434|FG008|Part B|Withdrawal by Subject|0|||
162168808|NCT04802967|585671435|FG009|Part B|Withdrawal by Subject|0|||
162168809|NCT03339713|585671440|FG000|Overall Study|Lost to Follow-up|2|||
162168810|NCT03339713|585671441|FG001|Overall Study|Lost to Follow-up|1|||
162168811|NCT03339713|585671440|FG000|Overall Study|Protocol Violation|1|||
162168812|NCT03339713|585671441|FG001|Overall Study|Protocol Violation|0|||
162168813|NCT03339713|585671440|FG000|Overall Study|Withdrawal by Subject|1|||
162168814|NCT03339713|585671441|FG001|Overall Study|Withdrawal by Subject|1|||
162168815|NCT05540665|585671445|FG000|Overall Study|Study terminated by sponsor|6|||
162168816|NCT05540665|585671446|FG001|Overall Study|Study terminated by sponsor|6|||
162168817|NCT05540665|585671447|FG002|Overall Study|Study terminated by sponsor|7|||
162168818|NCT03462030|585671448|FG000|Overall Study|Withdrawal by Subject|1|||
162168819|NCT03462030|585671449|FG001|Overall Study|Withdrawal by Subject|1|||
162168820|NCT03381196|585671450|FG000|Overall Study|Withdrawal by Subject|7|||
162168821|NCT03381196|585671451|FG001|Overall Study|Withdrawal by Subject|7|||
162168822|NCT03381196|585671450|FG000|Overall Study|Other|0|||
162168823|NCT03381196|585671451|FG001|Overall Study|Other|1|||
162168824|NCT03381196|585671450|FG000|Overall Study|Lost to Follow-up|5|||
162168825|NCT03381196|585671451|FG001|Overall Study|Lost to Follow-up|4|||
162168826|NCT03381196|585671450|FG000|Overall Study|Death|0|||
161921315|NCT02903914|584757197|FG004|Overall Study|Death|1|||
161921316|NCT02903914|584757198|FG005|Overall Study|Death|3|||
161921317|NCT02903914|584757199|FG006|Overall Study|Death|24|||
161921318|NCT02903914|584757200|FG007|Overall Study|Death|2|||
161921319|NCT02903914|584757193|FG000|Overall Study|Lost to Follow-up|0|||
161921320|NCT02903914|584757194|FG001|Overall Study|Lost to Follow-up|1|||
162168827|NCT03381196|585671451|FG001|Overall Study|Death|1|||
162168828|NCT03381196|585671450|FG000|Overall Study|Adverse Event|1|||
162168829|NCT03381196|585671451|FG001|Overall Study|Adverse Event|0|||
162168830|NCT03381196|585671450|FG000|Overall Study|Randomized, not treated|3|||
162168831|NCT03381196|585671451|FG001|Overall Study|Randomized, not treated|6|||
162168832|NCT03371381|585671452|FG000|Overall Study|Death|5|||
162168833|NCT03371381|585671452|FG000|Overall Study|Study terminated by sponsor|3|||
162168834|NCT03371381|585671452|FG000|Overall Study|Other|4|||
162168835|NCT03628924|585671454|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
162168836|NCT03628924|585671455|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
162168837|NCT03628924|585671456|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161921321|NCT02903914|584757195|FG002|Overall Study|Lost to Follow-up|0|||
161921322|NCT02903914|584757196|FG003|Overall Study|Lost to Follow-up|0|||
162168838|NCT03628924|585671457|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
162168839|NCT03628924|585671458|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
162168840|NCT03628924|585671459|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
162168841|NCT03628924|585671460|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
162168842|NCT03628924|585671454|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162168843|NCT03628924|585671455|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162168844|NCT03628924|585671456|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
162168845|NCT03628924|585671457|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162168846|NCT03628924|585671458|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162168847|NCT03628924|585671459|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162168848|NCT03628924|585671460|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
162168849|NCT03628924|585671454|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
162168850|NCT03628924|585671455|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
162168851|NCT03628924|585671456|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
162168852|NCT03628924|585671457|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
162168853|NCT03628924|585671458|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
162168854|NCT03628924|585671459|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
162168855|NCT03628924|585671460|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
162168856|NCT03628924|585671454|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162168857|NCT03628924|585671455|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
162168858|NCT03628924|585671456|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162168859|NCT03628924|585671457|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162168860|NCT03628924|585671458|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162168861|NCT03628924|585671459|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162168862|NCT03628924|585671460|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162168863|NCT03628924|585671454|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
162168864|NCT03628924|585671455|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
162168865|NCT03628924|585671456|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
162168866|NCT03628924|585671457|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
162168867|NCT03628924|585671458|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
162168868|NCT03628924|585671459|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
162168869|NCT03628924|585671460|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
162168870|NCT03628924|585671454|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
162168871|NCT03628924|585671455|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
162168872|NCT03628924|585671456|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
162168873|NCT03628924|585671457|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
162168874|NCT03628924|585671458|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
162168875|NCT03628924|585671459|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
162168876|NCT03628924|585671460|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
162168877|NCT03628924|585671454|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
162168878|NCT03628924|585671455|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
162168879|NCT03628924|585671456|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
162168880|NCT03628924|585671457|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
162168881|NCT03628924|585671458|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
162168882|NCT03628924|585671459|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
162168883|NCT03628924|585671460|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
162168884|NCT03628924|585671454|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
162168885|NCT03628924|585671455|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
162168886|NCT03628924|585671456|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
162168887|NCT03628924|585671457|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
162168888|NCT03628924|585671458|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
162168889|NCT03628924|585671459|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
162168890|NCT03628924|585671460|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
162168891|NCT03628924|585671454|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
162168892|NCT03628924|585671455|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
162168893|NCT03628924|585671456|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
162168894|NCT03628924|585671457|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
162168895|NCT03628924|585671458|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
162168896|NCT03628924|585671459|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
162168897|NCT03628924|585671460|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
162168898|NCT03628924|585671454|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
162168899|NCT03628924|585671455|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
162168900|NCT03628924|585671456|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
162168901|NCT03628924|585671457|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
162168902|NCT03628924|585671458|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
162168903|NCT03628924|585671459|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
162168904|NCT03628924|585671460|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
162168905|NCT03603600|585671463|FG000|Overall Study|Withdrawal by Subject|5|||
162168906|NCT03603600|585671464|FG001|Overall Study|Withdrawal by Subject|7|||
162168907|NCT03603600|585671463|FG000|Overall Study|Lost to Follow-up|2|||
162168908|NCT03603600|585671464|FG001|Overall Study|Lost to Follow-up|3|||
162168909|NCT03603600|585671463|FG000|Overall Study|Death|3|||
162168910|NCT03603600|585671464|FG001|Overall Study|Death|1|||
162168911|NCT03603600|585671463|FG000|Overall Study|Physician Decision|2|||
162168912|NCT03603600|585671464|FG001|Overall Study|Physician Decision|1|||
162168913|NCT03603600|585671463|FG000|Overall Study|Other reason|1|||
162168914|NCT03603600|585671464|FG001|Overall Study|Other reason|0|||
162168915|NCT03461276|585671465|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
162168916|NCT03461276|585671466|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
162168917|NCT03461276|585671465|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
162168918|NCT03461276|585671466|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
162168919|NCT03461276|585671465|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
162168920|NCT03461276|585671466|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
162168921|NCT03461276|585671465|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
162168922|NCT03461276|585671466|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
162168923|NCT03461276|585671465|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
162168924|NCT03461276|585671466|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
162168925|NCT03461276|585671465|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
162168926|NCT03461276|585671466|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
162168927|NCT03461276|585671465|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
162168928|NCT03461276|585671466|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
162168929|NCT03461276|585671465|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
162168930|NCT03461276|585671466|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
162168931|NCT03461276|585671465|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
162168932|NCT03461276|585671466|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
162168933|NCT03461276|585671465|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
162168934|NCT03461276|585671466|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
162168935|NCT02043678|585671471|FG000|Overall Study|Never treated|11|||
162168936|NCT02043678|585671472|FG001|Overall Study|Never treated|9|||
162168937|NCT02043678|585671471|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
162168938|NCT02043678|585671472|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
162168939|NCT02043678|585671471|FG000|Overall Study|AE without clinical PD|54|||
162168940|NCT02043678|585671472|FG001|Overall Study|AE without clinical PD|36|||
162168941|NCT02043678|585671471|FG000|Overall Study|Lost to Follow-up|1|||
162168942|NCT02043678|585671472|FG001|Overall Study|Lost to Follow-up|1|||
162168943|NCT02043678|585671471|FG000|Overall Study|Other|10|||
162168944|NCT02043678|585671472|FG001|Overall Study|Other|14|||
162168945|NCT02043678|585671471|FG000|Overall Study|Clinical PD|114|||
162168946|NCT02043678|585671472|FG001|Overall Study|Clinical PD|148|||
162168947|NCT02043678|585671471|FG000|Overall Study|Radiological PD|100|||
162168948|NCT02043678|585671472|FG001|Overall Study|Radiological PD|90|||
162168949|NCT02043678|585671471|FG000|Overall Study|Protocol-driven decision point|59|||
162168950|NCT02043678|585671472|FG001|Overall Study|Protocol-driven decision point|58|||
162168951|NCT02043678|585671471|FG000|Overall Study|Withdrawal by Subject|16|||
161816464|NCT00112437|584368817|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816465|NCT00112437|584368818|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816466|NCT00112437|584368819|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816467|NCT00112437|584368820|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816468|NCT00112437|584368821|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816469|NCT00112437|584368822|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816470|NCT00112437|584368823|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816471|NCT00112437|584368824|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816472|NCT00112437|584368825|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
162168952|NCT02043678|585671472|FG001|Overall Study|Withdrawal by Subject|20|||
162168953|NCT02043678|585671471|FG000|Overall Study|Protocol Violation|1|||
162168954|NCT02043678|585671472|FG001|Overall Study|Protocol Violation|0|||
162168955|NCT02043678|585671471|FG000|Overall Study|Deterioration of general conditions|1|||
161669614|NCT04796896|583843123|FG009|Overall Study|Adverse Event|1|||
161669615|NCT04796896|583843124|FG010|Overall Study|Adverse Event|1|||
161816473|NCT00112437|584368826|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
162168956|NCT02043678|585671472|FG001|Overall Study|Deterioration of general conditions|1|||
162168957|NCT02043678|585671471|FG000|Overall Study|Logistical difficulties|2|||
162168958|NCT02043678|585671472|FG001|Overall Study|Logistical difficulties|0|||
162168959|NCT02043678|585671471|FG000|Overall Study|Non-compliance with study drug|3|||
162168960|NCT02043678|585671472|FG001|Overall Study|Non-compliance with study drug|1|||
162168961|NCT02043678|585671471|FG000|Overall Study|Physician Decision|4|||
162168962|NCT02043678|585671472|FG001|Overall Study|Physician Decision|3|||
162168963|NCT02043678|585671471|FG000|Overall Study|Subject decision|0|||
162168964|NCT02043678|585671472|FG001|Overall Study|Subject decision|1|||
162168965|NCT02043678|585671471|FG000|Overall Study|Switching to other therapy|3|||
162168966|NCT02043678|585671472|FG001|Overall Study|Switching to other therapy|2|||
162168967|NCT02043678|585671471|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
162168968|NCT02043678|585671472|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
162168969|NCT02043678|585671471|FG000|Overall Study|Missing|1|||
162168970|NCT02043678|585671472|FG001|Overall Study|Missing|0|||
162168971|NCT02043678|585671471|FG000|Overall Study|Adverse Event|0|||
162168972|NCT02043678|585671472|FG001|Overall Study|Adverse Event|1|||
162168973|NCT04307355|585671480|FG000|Overall Study|Non-Compliance|3|||
162168974|NCT04307355|585671481|FG001|Overall Study|Non-Compliance|3|||
162168975|NCT04307355|585671482|FG002|Overall Study|Non-Compliance|0|||
162168976|NCT04065841|585671483|FG000|Overall Study|Adverse Event|4|||
162168977|NCT04065841|585671484|FG001|Overall Study|Adverse Event|2|||
162168978|NCT04065841|585671485|FG002|Overall Study|Adverse Event|10|||
162168979|NCT04065841|585671486|FG003|Overall Study|Adverse Event|1|||
162168980|NCT04065841|585671483|FG000|Overall Study|Lost to Follow-up|1|||
162168981|NCT04065841|585671484|FG001|Overall Study|Lost to Follow-up|2|||
162168982|NCT04065841|585671485|FG002|Overall Study|Lost to Follow-up|2|||
162168983|NCT04065841|585671486|FG003|Overall Study|Lost to Follow-up|2|||
162168984|NCT04065841|585671483|FG000|Overall Study|Physician Decision|1|||
162168985|NCT04065841|585671484|FG001|Overall Study|Physician Decision|0|||
162168986|NCT04065841|585671485|FG002|Overall Study|Physician Decision|0|||
162168987|NCT04065841|585671486|FG003|Overall Study|Physician Decision|0|||
162168988|NCT04065841|585671483|FG000|Overall Study|Protocol Violation|0|||
162168989|NCT04065841|585671484|FG001|Overall Study|Protocol Violation|1|||
162168990|NCT04065841|585671485|FG002|Overall Study|Protocol Violation|0|||
161921323|NCT02903914|584757197|FG004|Overall Study|Lost to Follow-up|2|||
161921324|NCT02903914|584757198|FG005|Overall Study|Lost to Follow-up|0|||
162168991|NCT04065841|585671486|FG003|Overall Study|Protocol Violation|0|||
162168992|NCT04065841|585671483|FG000|Overall Study|Study terminated by Sponsor|22|||
162168993|NCT04065841|585671484|FG001|Overall Study|Study terminated by Sponsor|16|||
162168994|NCT04065841|585671485|FG002|Overall Study|Study terminated by Sponsor|28|||
162168995|NCT04065841|585671486|FG003|Overall Study|Study terminated by Sponsor|17|||
162168996|NCT04065841|585671483|FG000|Overall Study|Withdrawal by Subject|1|||
162168997|NCT04065841|585671484|FG001|Overall Study|Withdrawal by Subject|1|||
161669616|NCT04796896|583843125|FG011|Overall Study|Adverse Event|0|||
161669617|NCT04796896|583843114|FG000|Overall Study|Lost to Follow-up|24|||
161669618|NCT04796896|583843115|FG001|Overall Study|Lost to Follow-up|15|||
161669619|NCT04796896|583843116|FG002|Overall Study|Lost to Follow-up|6|||
161669620|NCT04796896|583843117|FG003|Overall Study|Lost to Follow-up|4|||
161669621|NCT04796896|583843118|FG004|Overall Study|Lost to Follow-up|21|||
161669622|NCT04796896|583843119|FG005|Overall Study|Lost to Follow-up|55|||
161669623|NCT04796896|583843120|FG006|Overall Study|Lost to Follow-up|237|||
161669624|NCT04796896|583843121|FG007|Overall Study|Lost to Follow-up|52|||
161669625|NCT04796896|583843122|FG008|Overall Study|Lost to Follow-up|221|||
161669626|NCT04796896|583843123|FG009|Overall Study|Lost to Follow-up|43|||
161669627|NCT04796896|583843124|FG010|Overall Study|Lost to Follow-up|142|||
161669628|NCT04796896|583843125|FG011|Overall Study|Lost to Follow-up|18|||
161669629|NCT04796896|583843114|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
161669630|NCT04796896|583843115|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
161669631|NCT04796896|583843116|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
161669632|NCT04796896|583843117|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
161669633|NCT04796896|583843118|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
161669634|NCT04796896|583843119|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
161669635|NCT04796896|583843120|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
161669636|NCT04796896|583843121|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
161669637|NCT04796896|583843122|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
161669638|NCT04796896|583843123|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
161669639|NCT04796896|583843124|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
161669640|NCT04796896|583843125|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
161669641|NCT04796896|583843114|FG000|Overall Study|Physician Decision|1|||
161669642|NCT04796896|583843115|FG001|Overall Study|Physician Decision|0|||
161669643|NCT04796896|583843116|FG002|Overall Study|Physician Decision|0|||
161669644|NCT04796896|583843117|FG003|Overall Study|Physician Decision|0|||
161669645|NCT04796896|583843118|FG004|Overall Study|Physician Decision|0|||
161669646|NCT04796896|583843119|FG005|Overall Study|Physician Decision|3|||
161669647|NCT04796896|583843120|FG006|Overall Study|Physician Decision|18|||
161669648|NCT04796896|583843121|FG007|Overall Study|Physician Decision|1|||
161669649|NCT04796896|583843122|FG008|Overall Study|Physician Decision|7|||
161669650|NCT04796896|583843123|FG009|Overall Study|Physician Decision|0|||
161669651|NCT04796896|583843124|FG010|Overall Study|Physician Decision|5|||
161669652|NCT04796896|583843125|FG011|Overall Study|Physician Decision|0|||
161669653|NCT04796896|583843114|FG000|Overall Study|Withdrawal by Subject|36|||
161669654|NCT04796896|583843115|FG001|Overall Study|Withdrawal by Subject|31|||
161669655|NCT04796896|583843116|FG002|Overall Study|Withdrawal by Subject|11|||
161669656|NCT04796896|583843117|FG003|Overall Study|Withdrawal by Subject|8|||
161669657|NCT04796896|583843118|FG004|Overall Study|Withdrawal by Subject|16|||
161669658|NCT04796896|583843119|FG005|Overall Study|Withdrawal by Subject|162|||
161669659|NCT04796896|583843120|FG006|Overall Study|Withdrawal by Subject|299|||
161669660|NCT04796896|583843121|FG007|Overall Study|Withdrawal by Subject|149|||
161669661|NCT04796896|583843122|FG008|Overall Study|Withdrawal by Subject|303|||
161669662|NCT04796896|583843123|FG009|Overall Study|Withdrawal by Subject|94|||
161669663|NCT04796896|583843124|FG010|Overall Study|Withdrawal by Subject|192|||
161669664|NCT04796896|583843125|FG011|Overall Study|Withdrawal by Subject|16|||
161669665|NCT04796896|583843114|FG000|Overall Study|Other Than Specified|6|||
161669666|NCT04796896|583843115|FG001|Overall Study|Other Than Specified|5|||
161669667|NCT04796896|583843116|FG002|Overall Study|Other Than Specified|3|||
161669668|NCT04796896|583843117|FG003|Overall Study|Other Than Specified|2|||
161669669|NCT04796896|583843118|FG004|Overall Study|Other Than Specified|6|||
161669670|NCT04796896|583843119|FG005|Overall Study|Other Than Specified|31|||
161669671|NCT04796896|583843120|FG006|Overall Study|Other Than Specified|86|||
161669672|NCT04796896|583843121|FG007|Overall Study|Other Than Specified|66|||
161669673|NCT04796896|583843122|FG008|Overall Study|Other Than Specified|388|||
161669674|NCT04796896|583843123|FG009|Overall Study|Other Than Specified|48|||
161669675|NCT04796896|583843124|FG010|Overall Study|Other Than Specified|258|||
161669676|NCT04796896|583843125|FG011|Overall Study|Other Than Specified|4|||
161669677|NCT04796896|583843114|FG000|Overall Study|Protocol Deviation|0|||
161669678|NCT04796896|583843115|FG001|Overall Study|Protocol Deviation|0|||
161669679|NCT04796896|583843116|FG002|Overall Study|Protocol Deviation|0|||
161669680|NCT04796896|583843117|FG003|Overall Study|Protocol Deviation|1|||
161669681|NCT04796896|583843118|FG004|Overall Study|Protocol Deviation|1|||
161669682|NCT04796896|583843119|FG005|Overall Study|Protocol Deviation|2|||
161669683|NCT04796896|583843120|FG006|Overall Study|Protocol Deviation|2|||
161669684|NCT04796896|583843121|FG007|Overall Study|Protocol Deviation|2|||
161669685|NCT04796896|583843122|FG008|Overall Study|Protocol Deviation|2|||
161669686|NCT04796896|583843123|FG009|Overall Study|Protocol Deviation|1|||
161921325|NCT02903914|584757199|FG006|Overall Study|Lost to Follow-up|1|||
161669687|NCT04796896|583843124|FG010|Overall Study|Protocol Deviation|0|||
161669688|NCT04796896|583843125|FG011|Overall Study|Protocol Deviation|0|||
161669689|NCT04796896|583843114|FG000|Overall Study|Missing|0|||
161669690|NCT04796896|583843115|FG001|Overall Study|Missing|0|||
162168998|NCT04065841|585671485|FG002|Overall Study|Withdrawal by Subject|2|||
162168999|NCT04065841|585671486|FG003|Overall Study|Withdrawal by Subject|0|||
162169000|NCT01420237|585671490|FG000|Overall Study|Death|13|||
162169001|NCT01420237|585671490|FG000|Overall Study|Withdrawal by Subject|41|||
162169002|NCT01420237|585671490|FG000|Overall Study|Lost to Follow-up|32|||
162169003|NCT01420237|585671490|FG000|Overall Study|Adverse Event|10|||
162169004|NCT01420237|585671490|FG000|Overall Study|Investigative Site Termination|43|||
162169005|NCT01420237|585671490|FG000|Overall Study|Censored because study device not implanted|21|||
162169006|NCT01420237|585671490|FG000|Overall Study|Censored because surgery not performed|2|||
162169007|NCT01420237|585671490|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
162169008|NCT01420237|585671490|FG000|Overall Study|Sponsor terminated study early|127|||
162169009|NCT05269667|585671491|FG000|Overall Study|Study Terminated by Sponsor|4|||
162169010|NCT03768505|585671492|FG000|Overall Study|sponsor decision|76|||
161816474|NCT00112437|584368827|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816475|NCT00112437|584368828|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816476|NCT00112437|584368829|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161816477|NCT00112437|584368804|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
161921326|NCT02903914|584757200|FG007|Overall Study|Lost to Follow-up|0|||
161921327|NCT02903914|584757193|FG000|Overall Study|Physician Decision|0|||
161921328|NCT02903914|584757194|FG001|Overall Study|Physician Decision|0|||
161921329|NCT02903914|584757195|FG002|Overall Study|Physician Decision|1|||
161921330|NCT02903914|584757196|FG003|Overall Study|Physician Decision|0|||
161921331|NCT02903914|584757197|FG004|Overall Study|Physician Decision|0|||
161921332|NCT02903914|584757198|FG005|Overall Study|Physician Decision|0|||
161921333|NCT02903914|584757199|FG006|Overall Study|Physician Decision|1|||
161921334|NCT02903914|584757200|FG007|Overall Study|Physician Decision|0|||
161921335|NCT02903914|584757193|FG000|Overall Study|Symptomatic Deterioration|0|||
161921336|NCT02903914|584757194|FG001|Overall Study|Symptomatic Deterioration|0|||
161921337|NCT02903914|584757195|FG002|Overall Study|Symptomatic Deterioration|1|||
161921338|NCT02903914|584757196|FG003|Overall Study|Symptomatic Deterioration|0|||
161921339|NCT02903914|584757197|FG004|Overall Study|Symptomatic Deterioration|0|||
161921340|NCT02903914|584757198|FG005|Overall Study|Symptomatic Deterioration|0|||
161921341|NCT02903914|584757199|FG006|Overall Study|Symptomatic Deterioration|0|||
161921342|NCT02903914|584757200|FG007|Overall Study|Symptomatic Deterioration|0|||
161921343|NCT02903914|584757193|FG000|Overall Study|New Cancer Therapy|2|||
161921344|NCT02903914|584757194|FG001|Overall Study|New Cancer Therapy|2|||
162169011|NCT03768505|585671492|FG000|Overall Study|Death|35|||
162169012|NCT03768505|585671492|FG000|Overall Study|Other -Various|30|||
162169013|NCT03768505|585671492|FG000|Overall Study|Withdrawal by Subject|22|||
162169014|NCT03768505|585671492|FG000|Overall Study|Lost to Follow-up|6|||
162169015|NCT02861300|585671496|FG000|Overall Study|Death|0|||
162169016|NCT02861300|585671497|FG001|Overall Study|Death|0|||
162169017|NCT02861300|585671498|FG002|Overall Study|Death|0|||
162169018|NCT02861300|585671499|FG003|Overall Study|Death|0|||
162169019|NCT02861300|585671500|FG004|Overall Study|Death|0|||
162169020|NCT02861300|585671501|FG005|Overall Study|Death|0|||
162169021|NCT02861300|585671502|FG006|Overall Study|Death|24|||
162169022|NCT02861300|585671496|FG000|Overall Study|Delay in treatment|0|||
162169023|NCT02861300|585671497|FG001|Overall Study|Delay in treatment|0|||
162169024|NCT02861300|585671498|FG002|Overall Study|Delay in treatment|0|||
162169025|NCT02861300|585671499|FG003|Overall Study|Delay in treatment|0|||
162169026|NCT02861300|585671500|FG004|Overall Study|Delay in treatment|0|||
162169027|NCT02861300|585671501|FG005|Overall Study|Delay in treatment|1|||
162169028|NCT02861300|585671502|FG006|Overall Study|Delay in treatment|0|||
162169029|NCT02861300|585671496|FG000|Overall Study|Disease Progression|0|||
162169030|NCT02861300|585671497|FG001|Overall Study|Disease Progression|1|||
162169031|NCT02861300|585671498|FG002|Overall Study|Disease Progression|0|||
162169032|NCT02861300|585671499|FG003|Overall Study|Disease Progression|0|||
162169033|NCT02861300|585671500|FG004|Overall Study|Disease Progression|0|||
162169034|NCT02861300|585671501|FG005|Overall Study|Disease Progression|0|||
162169035|NCT02861300|585671502|FG006|Overall Study|Disease Progression|2|||
162169036|NCT02861300|585671496|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
162169037|NCT02861300|585671497|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
162169038|NCT02861300|585671498|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
162169039|NCT02861300|585671499|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
162169040|NCT02861300|585671500|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
162169041|NCT02861300|585671501|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
162169042|NCT02861300|585671502|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
162169043|NCT02861300|585671496|FG000|Overall Study|Clinical Complications|0|||
162169044|NCT02861300|585671497|FG001|Overall Study|Clinical Complications|0|||
162169045|NCT02861300|585671498|FG002|Overall Study|Clinical Complications|0|||
162169046|NCT02861300|585671499|FG003|Overall Study|Clinical Complications|0|||
162169047|NCT02861300|585671500|FG004|Overall Study|Clinical Complications|0|||
162169048|NCT02861300|585671501|FG005|Overall Study|Clinical Complications|0|||
162169049|NCT02861300|585671502|FG006|Overall Study|Clinical Complications|1|||
162169050|NCT03133546|585671508|FG000|Overall Study|Death|46|||
162169051|NCT03133546|585671509|FG001|Overall Study|Death|43|||
162169052|NCT03133546|585671508|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
162169053|NCT03133546|585671509|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
162169054|NCT02993159|585671510|FG000|Overall Study|Withdrawal by Subject|1|||
162169055|NCT02993159|585671511|FG001|Overall Study|Withdrawal by Subject|3|||
161921345|NCT02903914|584757195|FG002|Overall Study|New Cancer Therapy|21|||
161921346|NCT02903914|584757196|FG003|Overall Study|New Cancer Therapy|4|||
161921347|NCT02903914|584757197|FG004|Overall Study|New Cancer Therapy|3|||
161921348|NCT02903914|584757198|FG005|Overall Study|New Cancer Therapy|6|||
161921349|NCT02903914|584757199|FG006|Overall Study|New Cancer Therapy|56|||
161921350|NCT02903914|584757200|FG007|Overall Study|New Cancer Therapy|3|||
161921351|NCT02903914|584757193|FG000|Overall Study|Didn't Return to Site|1|||
162169056|NCT02993159|585671510|FG000|Overall Study|Protocol Violation|1|||
162169057|NCT02993159|585671511|FG001|Overall Study|Protocol Violation|0|||
162169058|NCT02993159|585671510|FG000|Overall Study|Opted out of surgery|2|||
162169059|NCT02993159|585671511|FG001|Overall Study|Opted out of surgery|0|||
162169060|NCT02993159|585671510|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
161921352|NCT02903914|584757194|FG001|Overall Study|Didn't Return to Site|0|||
161921353|NCT02903914|584757195|FG002|Overall Study|Didn't Return to Site|1|||
161921354|NCT02903914|584757196|FG003|Overall Study|Didn't Return to Site|1|||
161921355|NCT02903914|584757197|FG004|Overall Study|Didn't Return to Site|0|||
161921356|NCT02903914|584757198|FG005|Overall Study|Didn't Return to Site|0|||
161921357|NCT02903914|584757199|FG006|Overall Study|Didn't Return to Site|2|||
161921358|NCT02903914|584757200|FG007|Overall Study|Didn't Return to Site|0|||
161921359|NCT02903914|584757193|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
161921360|NCT02903914|584757194|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
161921361|NCT02903914|584757195|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
161921362|NCT02903914|584757196|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
162169061|NCT02993159|585671511|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
162169062|NCT02993159|585671510|FG000|Overall Study|Physician Decision|0|||
162169063|NCT02993159|585671511|FG001|Overall Study|Physician Decision|1|||
161921363|NCT02903914|584757197|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
161921364|NCT02903914|584757198|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
161921365|NCT02903914|584757199|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
162017347|NCT01958164|585117943|FG001|Overall Study|Lost to Follow-up|3|||
162169064|NCT05034328|585671512|FG000|Overall Study|Protocol Violation|1|||
162169065|NCT05034328|585671513|FG001|Overall Study|Protocol Violation|0|||
162169066|NCT05034328|585671512|FG000|Overall Study|Lost to Follow-up|0|||
162169067|NCT05034328|585671513|FG001|Overall Study|Lost to Follow-up|10|||
162169068|NCT03625167|585671516|FG000|Overall Study|Protocol Violation|5|||
162169069|NCT02231164|585671517|FG000|Overall Study|Adverse Event|1|||
162169070|NCT02231164|585671518|FG001|Overall Study|Adverse Event|1|||
162169071|NCT02231164|585671517|FG000|Overall Study|Lack of Efficacy|4|||
162169072|NCT02231164|585671518|FG001|Overall Study|Lack of Efficacy|3|||
162169073|NCT02231164|585671517|FG000|Overall Study|Withdrawal by Subject|1|||
162169074|NCT02231164|585671518|FG001|Overall Study|Withdrawal by Subject|2|||
162169075|NCT01210807|585671521|FG000|Overall Study|Lost to Follow-up|1|||
162169076|NCT01210807|585671522|FG001|Overall Study|Lost to Follow-up|2|||
162169077|NCT01210807|585671521|FG000|Overall Study|Not implanted bilaterally|2|||
162169078|NCT01210807|585671522|FG001|Overall Study|Not implanted bilaterally|1|||
162169079|NCT05281562|585671523|FG000|Overall Study|Ineligible patient|1|||
162169080|NCT05281562|585671524|FG001|Overall Study|Ineligible patient|0|||
162169081|NCT00324805|585671530|FG000|Overall Study|Adverse Event|62|||
162169082|NCT00324805|585671531|FG001|Overall Study|Adverse Event|203|||
162169083|NCT00324805|585671530|FG000|Overall Study|Progression|7|||
162169084|NCT00324805|585671531|FG001|Overall Study|Progression|35|||
162169085|NCT00324805|585671530|FG000|Overall Study|Withdrawal by Subject|51|||
162169086|NCT00324805|585671531|FG001|Overall Study|Withdrawal by Subject|174|||
162169087|NCT00324805|585671530|FG000|Overall Study|Death|6|||
162169088|NCT00324805|585671531|FG001|Overall Study|Death|9|||
162169089|NCT00324805|585671530|FG000|Overall Study|Alternative therapy|4|||
162169090|NCT00324805|585671531|FG001|Overall Study|Alternative therapy|8|||
162169091|NCT00324805|585671530|FG000|Overall Study|Other complicating disease|1|||
162169092|NCT00324805|585671531|FG001|Overall Study|Other complicating disease|9|||
162169093|NCT00324805|585671530|FG000|Overall Study|Other reasons|7|||
162169094|NCT00324805|585671531|FG001|Overall Study|Other reasons|26|||
162169095|NCT00324805|585671530|FG000|Overall Study|Other|0|||
162169096|NCT00324805|585671531|FG001|Overall Study|Other|2|||
162169097|NCT00324805|585671530|FG000|Overall Study|Did not start therapy|12|||
162169098|NCT00324805|585671531|FG001|Overall Study|Did not start therapy|17|||
162169099|NCT05792085|585671533|FG000|Overall Study|Death|0|||
162169100|NCT05792085|585671534|FG001|Overall Study|Death|0|||
162169101|NCT05792085|585671535|FG002|Overall Study|Death|0|||
162169102|NCT05792085|585671536|FG003|Overall Study|Death|0|||
162169103|NCT05792085|585671537|FG004|Overall Study|Death|1|||
162169104|NCT05977530|585671544|FG000|Overall Study|Withdrawal by Subject|1|||
162169105|NCT05977530|585671544|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
162169106|NCT04524442|585671545|FG000|Overall Study|Subject Decision|1|||
162169107|NCT04898673|585671553|FG000|Overall Study|Screenfail|1|||
162169108|NCT04898673|585671554|FG001|Overall Study|Screenfail|0|||
162169109|NCT04797897|585671555|FG000|Overall Study|Study Termination by Sponsor|1|||
162169110|NCT04797897|585671556|FG001|Overall Study|Study Termination by Sponsor|1|||
162169111|NCT05526430|585671561|FG000|Overall Study|Withdrawal by Subject|0|||
162169112|NCT05526430|585671562|FG001|Overall Study|Withdrawal by Subject|2|||
162169113|NCT05526430|585671563|FG002|Overall Study|Withdrawal by Subject|0|||
162169114|NCT05526430|585671564|FG003|Overall Study|Withdrawal by Subject|0|||
162169115|NCT03085810|585671565|FG000|Main Study|Withdrawal by Subject|77|||
162169116|NCT03085810|585671566|FG001|Main Study|Withdrawal by Subject|0|||
162169117|NCT03085810|585671567|FG002|Main Study|Withdrawal by Subject|0|||
162169118|NCT03085810|585671565|FG000|Main Study|Terminated By Sponsor|14|||
162169119|NCT03085810|585671566|FG001|Main Study|Terminated By Sponsor|0|||
162169120|NCT03085810|585671567|FG002|Main Study|Terminated By Sponsor|0|||
162169121|NCT03085810|585671565|FG000|Main Study|Protocol Violation|15|||
162169122|NCT03085810|585671566|FG001|Main Study|Protocol Violation|0|||
162169123|NCT03085810|585671567|FG002|Main Study|Protocol Violation|0|||
162169124|NCT03085810|585671565|FG000|Main Study|Physician Decision|13|||
162169125|NCT03085810|585671566|FG001|Main Study|Physician Decision|0|||
162169126|NCT03085810|585671567|FG002|Main Study|Physician Decision|0|||
162169127|NCT03085810|585671565|FG000|Main Study|Lost to Follow-up|17|||
161669691|NCT04796896|583843116|FG002|Overall Study|Missing|0|||
162169128|NCT03085810|585671566|FG001|Main Study|Lost to Follow-up|0|||
162169129|NCT03085810|585671567|FG002|Main Study|Lost to Follow-up|0|||
162169130|NCT03085810|585671565|FG000|Main Study|Adverse Event|25|||
162169131|NCT03085810|585671566|FG001|Main Study|Adverse Event|0|||
162169132|NCT03085810|585671567|FG002|Main Study|Adverse Event|0|||
161921366|NCT02903914|584757200|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
161921367|NCT02903914|584757193|FG000|Overall Study|Follow-up Did Not Occur|0|||
161921368|NCT02903914|584757194|FG001|Overall Study|Follow-up Did Not Occur|1|||
161921369|NCT02903914|584757195|FG002|Overall Study|Follow-up Did Not Occur|1|||
161921370|NCT02903914|584757196|FG003|Overall Study|Follow-up Did Not Occur|0|||
161921371|NCT02903914|584757197|FG004|Overall Study|Follow-up Did Not Occur|2|||
161921372|NCT02903914|584757198|FG005|Overall Study|Follow-up Did Not Occur|0|||
161921373|NCT02903914|584757199|FG006|Overall Study|Follow-up Did Not Occur|8|||
161921374|NCT02903914|584757200|FG007|Overall Study|Follow-up Did Not Occur|0|||
161921375|NCT02903914|584757193|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
161921376|NCT02903914|584757194|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
161921377|NCT02903914|584757195|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
161921378|NCT02903914|584757196|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
161921379|NCT02903914|584757197|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
161921380|NCT02903914|584757198|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
161921381|NCT02903914|584757199|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
161921382|NCT02903914|584757200|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
161921383|NCT02903914|584757193|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
161921384|NCT02903914|584757194|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
161921385|NCT02903914|584757195|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
161921386|NCT02903914|584757196|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
161921387|NCT02903914|584757197|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
161921388|NCT02903914|584757198|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
161921389|NCT02903914|584757199|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
161921390|NCT02903914|584757200|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
161921391|NCT02903914|584757193|FG000|Overall Study|Clinical Disease Progression|0|||
161921392|NCT02903914|584757194|FG001|Overall Study|Clinical Disease Progression|0|||
161921393|NCT02903914|584757195|FG002|Overall Study|Clinical Disease Progression|2|||
161921394|NCT02903914|584757196|FG003|Overall Study|Clinical Disease Progression|0|||
161921395|NCT02903914|584757197|FG004|Overall Study|Clinical Disease Progression|0|||
161921396|NCT02903914|584757198|FG005|Overall Study|Clinical Disease Progression|0|||
161921397|NCT02903914|584757199|FG006|Overall Study|Clinical Disease Progression|0|||
161921398|NCT02903914|584757200|FG007|Overall Study|Clinical Disease Progression|0|||
161921399|NCT02903914|584757193|FG000|Overall Study|Completed Follow-up Period|0|||
161921400|NCT02903914|584757194|FG001|Overall Study|Completed Follow-up Period|0|||
161921401|NCT02903914|584757195|FG002|Overall Study|Completed Follow-up Period|6|||
161921402|NCT02903914|584757196|FG003|Overall Study|Completed Follow-up Period|2|||
161921403|NCT02903914|584757197|FG004|Overall Study|Completed Follow-up Period|1|||
161921404|NCT02903914|584757198|FG005|Overall Study|Completed Follow-up Period|0|||
161921405|NCT02903914|584757199|FG006|Overall Study|Completed Follow-up Period|9|||
161921406|NCT02903914|584757200|FG007|Overall Study|Completed Follow-up Period|1|||
161921407|NCT02903914|584757193|FG000|Overall Study|Taken off Treatment per Protocol|0|||
161921408|NCT02903914|584757194|FG001|Overall Study|Taken off Treatment per Protocol|0|||
161921409|NCT02903914|584757195|FG002|Overall Study|Taken off Treatment per Protocol|0|||
161921410|NCT02903914|584757196|FG003|Overall Study|Taken off Treatment per Protocol|0|||
161921411|NCT02903914|584757197|FG004|Overall Study|Taken off Treatment per Protocol|0|||
161921412|NCT02903914|584757198|FG005|Overall Study|Taken off Treatment per Protocol|1|||
161921413|NCT02903914|584757199|FG006|Overall Study|Taken off Treatment per Protocol|0|||
161921414|NCT02903914|584757200|FG007|Overall Study|Taken off Treatment per Protocol|0|||
161921415|NCT02903914|584757193|FG000|Overall Study|Refused Further Treatment/Contact|0|||
161921416|NCT02903914|584757194|FG001|Overall Study|Refused Further Treatment/Contact|0|||
161921417|NCT02903914|584757195|FG002|Overall Study|Refused Further Treatment/Contact|0|||
161921418|NCT02903914|584757196|FG003|Overall Study|Refused Further Treatment/Contact|0|||
161921419|NCT02903914|584757197|FG004|Overall Study|Refused Further Treatment/Contact|0|||
161921420|NCT02903914|584757198|FG005|Overall Study|Refused Further Treatment/Contact|0|||
161921421|NCT02903914|584757199|FG006|Overall Study|Refused Further Treatment/Contact|1|||
161921422|NCT02903914|584757200|FG007|Overall Study|Refused Further Treatment/Contact|0|||
161921423|NCT02903914|584757193|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921424|NCT02903914|584757194|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921425|NCT02903914|584757195|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921426|NCT02903914|584757196|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921427|NCT02903914|584757197|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921428|NCT02903914|584757198|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921429|NCT02903914|584757199|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
161921430|NCT02903914|584757200|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161921431|NCT03487445|584757204|FG000|Randomization|Not treated for administrative reasons|1|||
161921432|NCT03487445|584757205|FG001|Randomization|Not treated for administrative reasons|0|||
161921433|NCT04225039|584757208|FG000|Overall Study|Withdrawal by Subject|1|||
161921434|NCT04225039|584757209|FG001|Overall Study|Withdrawal by Subject|0|||
161921435|NCT04225039|584757210|FG002|Overall Study|Withdrawal by Subject|0|||
161921436|NCT04225039|584757211|FG003|Overall Study|Withdrawal by Subject|1|||
161921437|NCT04225039|584757208|FG000|Overall Study|Currently active on study treatment|0|||
161921438|NCT04225039|584757209|FG001|Overall Study|Currently active on study treatment|1|||
161921439|NCT04225039|584757210|FG002|Overall Study|Currently active on study treatment|0|||
161921440|NCT04225039|584757211|FG003|Overall Study|Currently active on study treatment|0|||
161921441|NCT04225039|584757208|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
161921442|NCT04225039|584757209|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
161921443|NCT04225039|584757210|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
161921444|NCT04225039|584757211|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
161921445|NCT04225039|584757208|FG000|Overall Study|Ineligible for treatment|0|||
161921446|NCT04225039|584757209|FG001|Overall Study|Ineligible for treatment|0|||
161921447|NCT04225039|584757210|FG002|Overall Study|Ineligible for treatment|0|||
161921448|NCT04225039|584757211|FG003|Overall Study|Ineligible for treatment|4|||
161921449|NCT00975923|584757212|FG000|Overall Study|Withdrawal by Subject|0|||
161921450|NCT00975923|584757213|FG001|Overall Study|Withdrawal by Subject|1|||
161921451|NCT01964404|584757214|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
161921452|NCT01964404|584757215|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
161921453|NCT01964404|584757216|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
161921454|NCT01964404|584757217|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
161921455|NCT01964404|584757218|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
161921456|NCT01964404|584757219|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
161921457|NCT01964404|584757220|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
161921458|NCT01964404|584757221|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
161921459|NCT01964404|584757222|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
161921460|NCT01964404|584757223|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
161921461|NCT01964404|584757214|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
161921462|NCT01964404|584757215|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
162169133|NCT03085810|585671565|FG000|Main Study|Pregnancy|7|||
162169134|NCT03085810|585671566|FG001|Main Study|Pregnancy|0|||
162169135|NCT03085810|585671567|FG002|Main Study|Pregnancy|0|||
162169136|NCT03085810|585671565|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
162169137|NCT03085810|585671566|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
162169138|NCT03085810|585671567|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
162169139|NCT03085810|585671565|FG000|Main Study|Lack of Efficacy|10|||
162169140|NCT03085810|585671566|FG001|Main Study|Lack of Efficacy|0|||
162169141|NCT03085810|585671567|FG002|Main Study|Lack of Efficacy|0|||
162169142|NCT03085810|585671565|FG000|Main Study|Death|12|||
162169143|NCT03085810|585671566|FG001|Main Study|Death|0|||
162169144|NCT03085810|585671567|FG002|Main Study|Death|0|||
162169145|NCT03085810|585671565|FG000|Main Study|Disease progression|1|||
162169146|NCT03085810|585671566|FG001|Main Study|Disease progression|0|||
162169147|NCT03085810|585671567|FG002|Main Study|Disease progression|0|||
162169148|NCT03085810|585671565|FG000|Main Study|Site Closure|3|||
162169149|NCT03085810|585671566|FG001|Main Study|Site Closure|0|||
162169150|NCT03085810|585671567|FG002|Main Study|Site Closure|0|||
162169151|NCT03085810|585671565|FG000|Main Study|Planned pregnancy|17|||
162169152|NCT03085810|585671566|FG001|Main Study|Planned pregnancy|0|||
162169153|NCT03085810|585671567|FG002|Main Study|Planned pregnancy|0|||
162169154|NCT03085810|585671565|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
162169155|NCT03085810|585671566|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
162169156|NCT03085810|585671567|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
162169157|NCT03085810|585671565|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
162169158|NCT03085810|585671566|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
162169159|NCT03085810|585671567|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
162169160|NCT03085810|585671565|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
162169161|NCT03085810|585671566|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
162169162|NCT03085810|585671567|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
162169163|NCT03085810|585671565|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
162169164|NCT03085810|585671566|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
162169165|NCT03085810|585671567|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
162169166|NCT02601313|585671568|FG000|Overall Study|Death|2|||
162169167|NCT02601313|585671569|FG001|Overall Study|Death|41|||
162169168|NCT02601313|585671570|FG002|Overall Study|Death|6|||
162169169|NCT02601313|585671568|FG000|Overall Study|Enrolled but never treated|0|||
162169170|NCT02601313|585671569|FG001|Overall Study|Enrolled but never treated|6|||
162169171|NCT02601313|585671570|FG002|Overall Study|Enrolled but never treated|3|||
162169172|NCT02601313|585671568|FG000|Overall Study|Enrolled, did not initiate AC|4|||
162169173|NCT02601313|585671569|FG001|Overall Study|Enrolled, did not initiate AC|0|||
162169174|NCT02601313|585671570|FG002|Overall Study|Enrolled, did not initiate AC|0|||
162169175|NCT02601313|585671568|FG000|Overall Study|Full consent withdrawal|0|||
162169176|NCT02601313|585671569|FG001|Overall Study|Full consent withdrawal|3|||
162169177|NCT02601313|585671570|FG002|Overall Study|Full consent withdrawal|2|||
162169178|NCT02601313|585671568|FG000|Overall Study|Lost to Follow-up|0|||
162169179|NCT02601313|585671569|FG001|Overall Study|Lost to Follow-up|1|||
162169180|NCT02601313|585671570|FG002|Overall Study|Lost to Follow-up|1|||
161816478|NCT00112437|584368805|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816479|NCT00112437|584368806|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816480|NCT00112437|584368807|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816481|NCT00112437|584368808|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816482|NCT00112437|584368809|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816483|NCT00112437|584368810|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816484|NCT00112437|584368811|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816485|NCT00112437|584368812|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816486|NCT00112437|584368813|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816487|NCT00112437|584368814|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816488|NCT00112437|584368815|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816489|NCT00112437|584368816|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816490|NCT00112437|584368817|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816491|NCT00112437|584368818|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816492|NCT00112437|584368819|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816493|NCT00112437|584368820|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816494|NCT00112437|584368821|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816495|NCT00112437|584368822|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816496|NCT00112437|584368823|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816497|NCT00112437|584368824|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816498|NCT00112437|584368825|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
161816499|NCT00112437|584368826|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816500|NCT00112437|584368827|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816501|NCT00112437|584368828|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
161816502|NCT00112437|584368829|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
161921463|NCT01964404|584757216|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
161921464|NCT01964404|584757217|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
161921465|NCT01964404|584757218|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921466|NCT01964404|584757219|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921467|NCT01964404|584757220|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
162017348|NCT00740857|585117944|FG000|Overall Study|Withdrawal by Subject|1|||
162017349|NCT00740857|585117945|FG001|Overall Study|Withdrawal by Subject|0|||
162017350|NCT00740857|585117946|FG002|Overall Study|Withdrawal by Subject|0|||
162017351|NCT02963506|585117947|FG000|Double-Blind Period|Adverse Event|0|||
162017352|NCT02963506|585117948|FG001|Double-Blind Period|Adverse Event|0|||
162017353|NCT02963506|585117949|FG002|Double-Blind Period|Adverse Event|1|||
162017354|NCT02963506|585117950|FG003|Double-Blind Period|Adverse Event|0|||
162017355|NCT02963506|585117951|FG004|Double-Blind Period|Adverse Event|0|||
162017356|NCT02963506|585117952|FG005|Double-Blind Period|Adverse Event|0|||
162017357|NCT02963506|585117953|FG006|Double-Blind Period|Adverse Event|0|||
162017358|NCT02963506|585117954|FG007|Double-Blind Period|Adverse Event|0|||
161921468|NCT01964404|584757221|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921469|NCT01964404|584757222|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921470|NCT01964404|584757223|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921471|NCT01964404|584757214|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
162017359|NCT02963506|585117955|FG008|Double-Blind Period|Adverse Event|0|||
161921472|NCT01964404|584757215|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
162017360|NCT02963506|585117956|FG009|Double-Blind Period|Adverse Event|0|||
162017361|NCT02963506|585117957|FG010|Double-Blind Period|Adverse Event|0|||
162017362|NCT02963506|585117958|FG011|Double-Blind Period|Adverse Event|0|||
162017363|NCT02963506|585117959|FG012|Double-Blind Period|Adverse Event|0|||
162017364|NCT02963506|585117947|FG000|Double-Blind Period|Death|0|||
162017365|NCT02963506|585117948|FG001|Double-Blind Period|Death|0|||
162017366|NCT02963506|585117949|FG002|Double-Blind Period|Death|0|||
162017367|NCT02963506|585117950|FG003|Double-Blind Period|Death|1|||
162017368|NCT02963506|585117951|FG004|Double-Blind Period|Death|0|||
162017369|NCT02963506|585117952|FG005|Double-Blind Period|Death|0|||
162017370|NCT02963506|585117953|FG006|Double-Blind Period|Death|0|||
162017371|NCT02963506|585117954|FG007|Double-Blind Period|Death|0|||
162017372|NCT02963506|585117955|FG008|Double-Blind Period|Death|0|||
162017373|NCT02963506|585117956|FG009|Double-Blind Period|Death|0|||
162017374|NCT02963506|585117957|FG010|Double-Blind Period|Death|0|||
162017375|NCT02963506|585117958|FG011|Double-Blind Period|Death|0|||
162017376|NCT02963506|585117959|FG012|Double-Blind Period|Death|0|||
162017377|NCT02963506|585117947|FG000|Double-Blind Period|Lost to Follow-up|0|||
162017378|NCT02963506|585117948|FG001|Double-Blind Period|Lost to Follow-up|1|||
162017379|NCT02963506|585117949|FG002|Double-Blind Period|Lost to Follow-up|0|||
162017380|NCT02963506|585117950|FG003|Double-Blind Period|Lost to Follow-up|0|||
162017381|NCT02963506|585117951|FG004|Double-Blind Period|Lost to Follow-up|0|||
162017382|NCT02963506|585117952|FG005|Double-Blind Period|Lost to Follow-up|0|||
162017383|NCT02963506|585117953|FG006|Double-Blind Period|Lost to Follow-up|0|||
162017384|NCT02963506|585117954|FG007|Double-Blind Period|Lost to Follow-up|0|||
162017385|NCT02963506|585117955|FG008|Double-Blind Period|Lost to Follow-up|0|||
162017386|NCT02963506|585117956|FG009|Double-Blind Period|Lost to Follow-up|0|||
162017387|NCT02963506|585117957|FG010|Double-Blind Period|Lost to Follow-up|0|||
162017388|NCT02963506|585117958|FG011|Double-Blind Period|Lost to Follow-up|0|||
162017389|NCT02963506|585117959|FG012|Double-Blind Period|Lost to Follow-up|0|||
162017390|NCT02963506|585117947|FG000|Double-Blind Period|Withdrawal by Subject|0|||
162017391|NCT02963506|585117948|FG001|Double-Blind Period|Withdrawal by Subject|0|||
162017392|NCT02963506|585117949|FG002|Double-Blind Period|Withdrawal by Subject|1|||
162017393|NCT02963506|585117950|FG003|Double-Blind Period|Withdrawal by Subject|1|||
162017394|NCT02963506|585117951|FG004|Double-Blind Period|Withdrawal by Subject|0|||
162017395|NCT02963506|585117952|FG005|Double-Blind Period|Withdrawal by Subject|0|||
162017396|NCT02963506|585117953|FG006|Double-Blind Period|Withdrawal by Subject|0|||
162017397|NCT02963506|585117954|FG007|Double-Blind Period|Withdrawal by Subject|0|||
162017398|NCT02963506|585117955|FG008|Double-Blind Period|Withdrawal by Subject|0|||
162017399|NCT02963506|585117956|FG009|Double-Blind Period|Withdrawal by Subject|0|||
162017400|NCT02963506|585117957|FG010|Double-Blind Period|Withdrawal by Subject|0|||
162017401|NCT02963506|585117958|FG011|Double-Blind Period|Withdrawal by Subject|0|||
162017402|NCT02963506|585117959|FG012|Double-Blind Period|Withdrawal by Subject|0|||
162017403|NCT02963506|585117947|FG000|Double-Blind Period|No compliance|0|||
162017404|NCT02963506|585117948|FG001|Double-Blind Period|No compliance|1|||
162017405|NCT02963506|585117949|FG002|Double-Blind Period|No compliance|0|||
162017406|NCT02963506|585117950|FG003|Double-Blind Period|No compliance|0|||
162017407|NCT02963506|585117951|FG004|Double-Blind Period|No compliance|0|||
162017408|NCT02963506|585117952|FG005|Double-Blind Period|No compliance|0|||
162017409|NCT02963506|585117953|FG006|Double-Blind Period|No compliance|0|||
162017410|NCT02963506|585117954|FG007|Double-Blind Period|No compliance|0|||
161921473|NCT01964404|584757216|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
162017411|NCT02963506|585117955|FG008|Double-Blind Period|No compliance|0|||
162017412|NCT02963506|585117956|FG009|Double-Blind Period|No compliance|0|||
162017413|NCT02963506|585117957|FG010|Double-Blind Period|No compliance|0|||
162017414|NCT02963506|585117958|FG011|Double-Blind Period|No compliance|0|||
161921474|NCT01964404|584757217|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
161921475|NCT01964404|584757218|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921476|NCT01964404|584757219|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921477|NCT01964404|584757220|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921478|NCT01964404|584757221|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161669692|NCT04796896|583843117|FG003|Overall Study|Missing|0|||
161669693|NCT04796896|583843118|FG004|Overall Study|Missing|0|||
161669694|NCT04796896|583843119|FG005|Overall Study|Missing|0|||
161669695|NCT04796896|583843120|FG006|Overall Study|Missing|2|||
161669696|NCT04796896|583843121|FG007|Overall Study|Missing|1|||
161669697|NCT04796896|583843122|FG008|Overall Study|Missing|2|||
161669698|NCT04796896|583843123|FG009|Overall Study|Missing|1|||
161669699|NCT04796896|583843124|FG010|Overall Study|Missing|1|||
161669700|NCT04796896|583843125|FG011|Overall Study|Missing|0|||
161669701|NCT04796896|583843114|FG000|Overall Study|Death|0|||
161669702|NCT04796896|583843115|FG001|Overall Study|Death|0|||
161669703|NCT04796896|583843116|FG002|Overall Study|Death|0|||
161669704|NCT04796896|583843117|FG003|Overall Study|Death|0|||
161669705|NCT04796896|583843118|FG004|Overall Study|Death|0|||
161669706|NCT04796896|583843119|FG005|Overall Study|Death|0|||
161669707|NCT04796896|583843120|FG006|Overall Study|Death|0|||
161669708|NCT04796896|583843121|FG007|Overall Study|Death|0|||
161669709|NCT04796896|583843122|FG008|Overall Study|Death|1|||
161669710|NCT04796896|583843123|FG009|Overall Study|Death|0|||
161669711|NCT04796896|583843124|FG010|Overall Study|Death|0|||
161921479|NCT01964404|584757222|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921480|NCT01964404|584757223|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161921481|NCT00325416|584757226|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
161669712|NCT04796896|583843125|FG011|Overall Study|Death|0|||
161669713|NCT02021292|583843126|FG000|Overall Study|Physician Decision|0|||
161669714|NCT02021292|583843127|FG001|Overall Study|Physician Decision|1|||
161669715|NCT02021292|583843126|FG000|Overall Study|Lost to Follow-up|0|||
161669716|NCT02021292|583843127|FG001|Overall Study|Lost to Follow-up|1|||
161669717|NCT02021292|583843126|FG000|Overall Study|Death|0|||
161669718|NCT02021292|583843127|FG001|Overall Study|Death|1|||
161669719|NCT04356183|583843128|FG000|Overall Study|Lost to Follow-up|1|||
161669720|NCT04356183|583843129|FG001|Overall Study|Lost to Follow-up|0|||
161669721|NCT04356183|583843128|FG000|Overall Study|Withdrawal by Subject|1|||
161669722|NCT04356183|583843129|FG001|Overall Study|Withdrawal by Subject|1|||
161669723|NCT05972733|583843132|FG000|Overall Study|Lost to Follow-up|2|||
161669724|NCT05972733|583843132|FG000|Overall Study|Withdrawal by Subject|1|||
161669725|NCT01177787|583843133|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
161669726|NCT01177787|583843133|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
161669727|NCT01177787|583843133|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
161669728|NCT01637623|583843134|FG000|Overall Study|Lost to Follow-up|0|||
161669729|NCT01637623|583843135|FG001|Overall Study|Lost to Follow-up|0|||
161669730|NCT01637623|583843136|FG002|Overall Study|Lost to Follow-up|2|||
161669731|NCT01637623|583843134|FG000|Overall Study|Physician Decision|1|||
161669732|NCT01637623|583843135|FG001|Overall Study|Physician Decision|0|||
161669733|NCT01637623|583843136|FG002|Overall Study|Physician Decision|1|||
161669734|NCT02824263|583843141|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
161669735|NCT02824263|583843142|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
161669736|NCT02824263|583843141|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
161669737|NCT02824263|583843142|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
161921482|NCT00325416|584757227|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
161921483|NCT00325416|584757226|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
161921484|NCT00325416|584757227|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
161921485|NCT00325416|584757226|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
161921486|NCT00325416|584757227|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
162169181|NCT05239455|585671575|FG000|Overall Study|Adverse Event|1|||
162169182|NCT05239455|585671575|FG000|Overall Study|Sponsor Decision|5|||
162169183|NCT05239455|585671575|FG000|Overall Study|Incomplete Blood Collection|1|||
161921487|NCT00325416|584757226|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
161669756|NCT01676909|583843147|FG000|Overall Study|Withdrawal by Subject|3|||
161669757|NCT01676909|583843148|FG001|Overall Study|Withdrawal by Subject|5|||
161669758|NCT01676909|583843147|FG000|Overall Study|Lost to Follow-up|15|||
161669759|NCT01676909|583843148|FG001|Overall Study|Lost to Follow-up|9|||
161669760|NCT04615247|583843149|FG000|Overall Study|Adverse Event|0|||
161669761|NCT04615247|583843150|FG001|Overall Study|Adverse Event|2|||
161669762|NCT04615247|583843149|FG000|Overall Study|Withdrawal by Subject|1|||
161669763|NCT04615247|583843150|FG001|Overall Study|Withdrawal by Subject|1|||
161669764|NCT00823901|583843153|FG000|Overall Study|Adverse Event|1|||
161669765|NCT00823901|583843154|FG001|Overall Study|Adverse Event|1|||
161669766|NCT00823901|583843153|FG000|Overall Study|Lack of Efficacy|1|||
161669767|NCT00823901|583843154|FG001|Overall Study|Lack of Efficacy|0|||
161669768|NCT00823901|583843153|FG000|Overall Study|Lost to Follow-up|2|||
161669769|NCT00823901|583843154|FG001|Overall Study|Lost to Follow-up|1|||
161669770|NCT01369511|583843155|FG000|Overall Study|Adverse Event|1|||
161669771|NCT01369511|583843156|FG001|Overall Study|Adverse Event|1|||
161669772|NCT01369511|583843157|FG002|Overall Study|Adverse Event|5|||
161669773|NCT01369511|583843158|FG003|Overall Study|Adverse Event|0|||
161669774|NCT01369511|583843155|FG000|Overall Study|Entry criteria not met|2|||
161669775|NCT01369511|583843156|FG001|Overall Study|Entry criteria not met|0|||
161669776|NCT01369511|583843157|FG002|Overall Study|Entry criteria not met|0|||
161669777|NCT01369511|583843158|FG003|Overall Study|Entry criteria not met|1|||
161669778|NCT01369511|583843155|FG000|Overall Study|Lost to Follow-up|0|||
161669779|NCT01369511|583843156|FG001|Overall Study|Lost to Follow-up|1|||
161669780|NCT01369511|583843157|FG002|Overall Study|Lost to Follow-up|1|||
161669781|NCT01369511|583843158|FG003|Overall Study|Lost to Follow-up|2|||
161669782|NCT01369511|583843155|FG000|Overall Study|Protocol Violation|0|||
161669783|NCT01369511|583843156|FG001|Overall Study|Protocol Violation|1|||
161669784|NCT01369511|583843157|FG002|Overall Study|Protocol Violation|0|||
161669785|NCT01369511|583843158|FG003|Overall Study|Protocol Violation|2|||
161669786|NCT01369511|583843155|FG000|Overall Study|Physician Decision|3|||
161669787|NCT01369511|583843156|FG001|Overall Study|Physician Decision|4|||
161669788|NCT01369511|583843157|FG002|Overall Study|Physician Decision|0|||
161669789|NCT01369511|583843158|FG003|Overall Study|Physician Decision|0|||
161669790|NCT01369511|583843155|FG000|Overall Study|Sponsor decision|2|||
161669791|NCT01369511|583843156|FG001|Overall Study|Sponsor decision|0|||
161669792|NCT01369511|583843157|FG002|Overall Study|Sponsor decision|1|||
161669793|NCT01369511|583843158|FG003|Overall Study|Sponsor decision|0|||
161669794|NCT01369511|583843155|FG000|Overall Study|Withdrawal by Subject|5|||
161669795|NCT01369511|583843156|FG001|Overall Study|Withdrawal by Subject|6|||
161669796|NCT01369511|583843157|FG002|Overall Study|Withdrawal by Subject|4|||
161669797|NCT01369511|583843158|FG003|Overall Study|Withdrawal by Subject|6|||
161669798|NCT01376349|583843159|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
161669799|NCT01376349|583843160|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
161669800|NCT01376349|583843161|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
161669801|NCT01376349|583843159|FG000|Raondomized Treatment|Adverse Event|13|||
161669802|NCT01376349|583843160|FG001|Raondomized Treatment|Adverse Event|17|||
161669803|NCT01376349|583843161|FG002|Raondomized Treatment|Adverse Event|14|||
161669804|NCT01376349|583843159|FG000|Raondomized Treatment|Unkown|1|||
161669805|NCT01376349|583843160|FG001|Raondomized Treatment|Unkown|2|||
161669806|NCT01376349|583843161|FG002|Raondomized Treatment|Unkown|1|||
161669807|NCT01376349|583843159|FG000|Raondomized Treatment|Alternative Treatment|0|||
161669808|NCT01376349|583843160|FG001|Raondomized Treatment|Alternative Treatment|0|||
161669809|NCT01376349|583843161|FG002|Raondomized Treatment|Alternative Treatment|1|||
161669810|NCT00718640|583843162|FG000|Overall Study|Adverse Event|4|||
161669811|NCT00718640|583843162|FG000|Overall Study|Death|1|||
161921488|NCT00325416|584757227|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
161921489|NCT00325416|584757226|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
161921490|NCT00325416|584757227|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
161921491|NCT00325416|584757226|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
161921492|NCT00325416|584757227|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
161921493|NCT06239610|584757228|FG000|Overall Study|no usable migration data for minimum of one day|11|||
161669812|NCT00718640|583843162|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
161669813|NCT00818389|583843163|FG000|Overall Study|Death|1|||
161669814|NCT00818389|583843164|FG001|Overall Study|Death|3|||
161669815|NCT00818389|583843163|FG000|Overall Study|ALS Disease Progression|1|||
161921494|NCT02830087|584757231|FG000|Overall Study|No study staff to follow-up patients|4|||
161921495|NCT02830087|584757232|FG001|Overall Study|No study staff to follow-up patients|4|||
161669816|NCT00818389|583843164|FG001|Overall Study|ALS Disease Progression|0|||
161669817|NCT00818389|583843163|FG000|Overall Study|Withdrawal by Subject|2|||
161669818|NCT00818389|583843164|FG001|Overall Study|Withdrawal by Subject|2|||
161669819|NCT00818389|583843163|FG000|Overall Study|Adverse Event|0|||
161669820|NCT00818389|583843164|FG001|Overall Study|Adverse Event|1|||
161669821|NCT05193500|583843167|FG000|Overall Study|Withdrawal by Subject|7|||
161669822|NCT05193500|583843168|FG001|Overall Study|Withdrawal by Subject|4|||
162169184|NCT03701763|585671577|FG000|Placebo-controlled Phase|Adverse Event|1|||
162169185|NCT03701763|585671578|FG001|Placebo-controlled Phase|Adverse Event|5|||
162169186|NCT03701763|585671579|FG002|Placebo-controlled Phase|Adverse Event|0|||
162169187|NCT03701763|585671580|FG003|Placebo-controlled Phase|Adverse Event|0|||
162169188|NCT03701763|585671577|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
162169189|NCT03701763|585671578|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
162169190|NCT03701763|585671579|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
162169191|NCT03701763|585671580|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
162169192|NCT03701763|585671577|FG000|Placebo-controlled Phase|Miscellaneous|2|||
162169193|NCT03701763|585671578|FG001|Placebo-controlled Phase|Miscellaneous|0|||
162169194|NCT03701763|585671579|FG002|Placebo-controlled Phase|Miscellaneous|0|||
162169195|NCT03701763|585671580|FG003|Placebo-controlled Phase|Miscellaneous|0|||
162169196|NCT03701763|585671577|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
162169197|NCT03701763|585671578|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
162169198|NCT03701763|585671579|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
162169199|NCT03701763|585671580|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
162169200|NCT03701763|585671577|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
162169201|NCT03701763|585671578|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
162169202|NCT03701763|585671579|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
162169203|NCT03701763|585671580|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
162169204|NCT03701763|585671577|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
162169205|NCT03701763|585671578|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
162169206|NCT03701763|585671579|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
162169207|NCT03701763|585671580|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
162169208|NCT03701763|585671577|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
162169209|NCT03701763|585671578|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
162169210|NCT03701763|585671579|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
162169211|NCT03701763|585671580|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
162169212|NCT03701763|585671577|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
162169213|NCT03701763|585671578|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
162169214|NCT03701763|585671579|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
162169215|NCT03701763|585671580|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
162169216|NCT03701763|585671577|FG000|Apremilast Extension Phase|Adverse Event|0|||
162169217|NCT03701763|585671578|FG001|Apremilast Extension Phase|Adverse Event|0|||
162169218|NCT03701763|585671579|FG002|Apremilast Extension Phase|Adverse Event|3|||
162169219|NCT03701763|585671580|FG003|Apremilast Extension Phase|Adverse Event|1|||
162169220|NCT03701763|585671577|FG000|Apremilast Extension Phase|Miscellaneous|0|||
162169221|NCT03701763|585671578|FG001|Apremilast Extension Phase|Miscellaneous|0|||
162169222|NCT03701763|585671579|FG002|Apremilast Extension Phase|Miscellaneous|2|||
162169223|NCT03701763|585671580|FG003|Apremilast Extension Phase|Miscellaneous|1|||
162169224|NCT03701763|585671577|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
162169225|NCT03701763|585671578|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
162169226|NCT03701763|585671579|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
162169227|NCT03701763|585671580|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
162169228|NCT03701763|585671577|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
162169229|NCT03701763|585671578|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
162169230|NCT03701763|585671579|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
162169231|NCT03701763|585671580|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
162169232|NCT03701763|585671577|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
162169233|NCT03701763|585671578|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
162169234|NCT03701763|585671579|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
162169235|NCT03701763|585671580|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
162169236|NCT03701763|585671577|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
162169237|NCT03701763|585671578|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
162169238|NCT03701763|585671579|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
162169239|NCT03701763|585671580|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
162169240|NCT03701763|585671577|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
162169241|NCT03701763|585671578|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
162169242|NCT03701763|585671579|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
162169243|NCT03701763|585671580|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
162169244|NCT03701763|585671577|FG000|14-Week Observational Follow-up Phase|Other|0|||
162169245|NCT03701763|585671578|FG001|14-Week Observational Follow-up Phase|Other|0|||
162169246|NCT03701763|585671579|FG002|14-Week Observational Follow-up Phase|Other|1|||
162169247|NCT03701763|585671580|FG003|14-Week Observational Follow-up Phase|Other|0|||
162169248|NCT03701763|585671577|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
162169249|NCT03701763|585671578|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
162169250|NCT03701763|585671579|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
162169251|NCT03701763|585671580|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
162169252|NCT03701763|585671577|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
161669823|NCT05193500|583843169|FG002|Overall Study|Withdrawal by Subject|3|||
161669824|NCT05193500|583843170|FG003|Overall Study|Withdrawal by Subject|5|||
161669825|NCT05458479|583843171|FG000|Overall Study|Lost to Follow-up|1|||
162169253|NCT03701763|585671578|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
162169254|NCT03701763|585671579|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
162169255|NCT03701763|585671580|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
162169256|NCT03365882|585671587|FG000|Randomization|Still Receiving Protocol Treatment|2|||
162169257|NCT03365882|585671588|FG001|Randomization|Still Receiving Protocol Treatment|0|||
162169258|NCT03365882|585671587|FG000|Randomization|Adverse Event|1|||
162169259|NCT03365882|585671588|FG001|Randomization|Adverse Event|2|||
162169260|NCT03365882|585671587|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
162169261|NCT03365882|585671588|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
162169262|NCT03365882|585671587|FG000|Randomization|Progression/Relapse|21|||
162169263|NCT03365882|585671588|FG001|Randomization|Progression/Relapse|3|||
162169264|NCT03365882|585671587|FG000|Randomization|Death|1|||
162169265|NCT03365882|585671588|FG001|Randomization|Death|0|||
162169266|NCT03365882|585671587|FG000|Randomization|Other - Not Protocol Specified|1|||
162169267|NCT03365882|585671588|FG001|Randomization|Other - Not Protocol Specified|1|||
162169268|NCT03365882|585671587|FG000|Randomization|Major Protocol Deviation|0|||
162169269|NCT03365882|585671588|FG001|Randomization|Major Protocol Deviation|1|||
162169270|NCT03365882|585671587|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
162169271|NCT03365882|585671588|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
162169272|NCT03365882|585671587|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
162169273|NCT03365882|585671588|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
162169274|NCT03365882|585671587|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
162169275|NCT03365882|585671588|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
162169276|NCT03365882|585671587|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
162169277|NCT03365882|585671588|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
162169278|NCT04437615|585671589|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
162169279|NCT04828005|585671590|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
162169280|NCT04828005|585671591|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
162169281|NCT04828005|585671592|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
162169282|NCT04828005|585671593|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
162169283|NCT04828005|585671590|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
162169284|NCT04828005|585671591|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
162169285|NCT04828005|585671592|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
162169286|NCT04828005|585671593|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
162169287|NCT04828005|585671590|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
162169288|NCT04828005|585671591|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
162169289|NCT04828005|585671592|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
161669826|NCT01978262|583843172|FG000|Overall Study|Withdrawal by Subject|9|||
162169290|NCT04828005|585671593|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
162169291|NCT04828005|585671590|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
161669827|NCT01978262|583843172|FG000|Overall Study|Lost to Follow-up|2|||
162169292|NCT04828005|585671591|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
162169293|NCT04828005|585671592|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
161921496|NCT02830087|584757233|FG002|Overall Study|No study staff to follow-up patients|4|||
161921497|NCT02830087|584757234|FG003|Overall Study|No study staff to follow-up patients|3|||
161921498|NCT02830087|584757235|FG004|Overall Study|No study staff to follow-up patients|3|||
161921499|NCT02830087|584757236|FG005|Overall Study|No study staff to follow-up patients|3|||
161921500|NCT02916771|584757237|FG000|Overall Study|Withdrawal by Subject|9|||
162169294|NCT04828005|585671593|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
162169295|NCT04828005|585671590|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
162169296|NCT04828005|585671591|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
162169297|NCT04828005|585671592|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
162169298|NCT04828005|585671593|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
162169299|NCT04828005|585671590|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
162169300|NCT04828005|585671591|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
162169301|NCT04828005|585671592|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
162169302|NCT04828005|585671593|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
162169303|NCT04828005|585671590|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
162169304|NCT04828005|585671591|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
162169305|NCT04828005|585671592|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
162169306|NCT04828005|585671593|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
162169307|NCT04828005|585671590|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
162169308|NCT04828005|585671591|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
162169309|NCT04828005|585671592|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
162169310|NCT04828005|585671593|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
162169311|NCT04828005|585671590|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
162169312|NCT04828005|585671591|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
162169313|NCT04828005|585671592|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
162169314|NCT04828005|585671593|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
162169315|NCT02675751|585673068|FG000|Overall Study|Lost to Follow-up|16|||
162169316|NCT02359890|585673069|FG000|Overall Study|Not meeting eligibility|4|||
162169317|NCT02359890|585673069|FG000|Overall Study|Never treated with study catheter|6|||
162169318|NCT02268253|585673073|FG000|Stage 1|Withdrawal by Subject|1|||
162169319|NCT02268253|585673074|FG001|Stage 1|Withdrawal by Subject|0|||
162169320|NCT02268253|585673075|FG002|Stage 1|Withdrawal by Subject|0|||
162169321|NCT02268253|585673076|FG003|Stage 1|Withdrawal by Subject|0|||
162169322|NCT02268253|585673077|FG004|Stage 1|Withdrawal by Subject|0|||
162169323|NCT02268253|585673078|FG005|Stage 1|Withdrawal by Subject|0|||
162169324|NCT02268253|585673079|FG006|Stage 1|Withdrawal by Subject|0|||
162169325|NCT02268253|585673073|FG000|Stage 1|Death|0|||
162169326|NCT02268253|585673074|FG001|Stage 1|Death|2|||
162169327|NCT02268253|585673075|FG002|Stage 1|Death|2|||
162169328|NCT02268253|585673076|FG003|Stage 1|Death|2|||
162169329|NCT02268253|585673077|FG004|Stage 1|Death|1|||
162169330|NCT02268253|585673078|FG005|Stage 1|Death|1|||
162169331|NCT02268253|585673079|FG006|Stage 1|Death|0|||
162169332|NCT02268253|585673073|FG000|Stage 2|Disease Recurrence/ Progression|0|||
162169333|NCT02268253|585673074|FG001|Stage 2|Disease Recurrence/ Progression|0|||
162169334|NCT02268253|585673075|FG002|Stage 2|Disease Recurrence/ Progression|1|||
162169335|NCT02268253|585673076|FG003|Stage 2|Disease Recurrence/ Progression|0|||
162169336|NCT02268253|585673077|FG004|Stage 2|Disease Recurrence/ Progression|0|||
162169337|NCT02268253|585673078|FG005|Stage 2|Disease Recurrence/ Progression|0|||
162169338|NCT02268253|585673079|FG006|Stage 2|Disease Recurrence/ Progression|0|||
162169339|NCT02268253|585673073|FG000|Stage 2|Withdrawal by Subject|0|||
162169340|NCT02268253|585673074|FG001|Stage 2|Withdrawal by Subject|0|||
162169341|NCT02268253|585673075|FG002|Stage 2|Withdrawal by Subject|2|||
162169342|NCT02268253|585673076|FG003|Stage 2|Withdrawal by Subject|0|||
162169343|NCT02268253|585673077|FG004|Stage 2|Withdrawal by Subject|0|||
162169344|NCT02268253|585673078|FG005|Stage 2|Withdrawal by Subject|2|||
162169345|NCT02268253|585673079|FG006|Stage 2|Withdrawal by Subject|0|||
162169346|NCT02268253|585673073|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
162169347|NCT02268253|585673074|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
162169348|NCT02268253|585673075|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
162169349|NCT02268253|585673076|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
162169350|NCT02268253|585673077|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
162169351|NCT02268253|585673078|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
162169352|NCT02268253|585673079|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
162169353|NCT02268253|585673073|FG000|Stage 2|Death|0|||
162169354|NCT02268253|585673074|FG001|Stage 2|Death|0|||
162169355|NCT02268253|585673075|FG002|Stage 2|Death|19|||
162169356|NCT02268253|585673076|FG003|Stage 2|Death|0|||
161921501|NCT02916771|584757237|FG000|Overall Study|Physician Decision|1|||
162169357|NCT02268253|585673077|FG004|Stage 2|Death|0|||
162169358|NCT02268253|585673078|FG005|Stage 2|Death|20|||
162169359|NCT02268253|585673079|FG006|Stage 2|Death|1|||
162169360|NCT02268253|585673073|FG000|Stage 2|Lost to Follow-up|0|||
162017415|NCT02963506|585117959|FG012|Double-Blind Period|No compliance|0|||
161669828|NCT02202551|583843173|FG000|Overall Study|Adverse Event|8|||
161669829|NCT02202551|583843174|FG001|Overall Study|Adverse Event|19|||
161669830|NCT02202551|583843175|FG002|Overall Study|Adverse Event|5|||
161669831|NCT02202551|583843176|FG003|Overall Study|Adverse Event|9|||
161669832|NCT02202551|583843173|FG000|Overall Study|Death|3|||
161669833|NCT02202551|583843174|FG001|Overall Study|Death|2|||
161669834|NCT02202551|583843175|FG002|Overall Study|Death|1|||
161669835|NCT02202551|583843176|FG003|Overall Study|Death|1|||
161669836|NCT02202551|583843173|FG000|Overall Study|Lost to Follow-up|0|||
161669837|NCT02202551|583843174|FG001|Overall Study|Lost to Follow-up|1|||
161669838|NCT02202551|583843175|FG002|Overall Study|Lost to Follow-up|0|||
161669839|NCT02202551|583843176|FG003|Overall Study|Lost to Follow-up|1|||
161669840|NCT02202551|583843173|FG000|Overall Study|Needed to take excluded medication|0|||
161669841|NCT02202551|583843174|FG001|Overall Study|Needed to take excluded medication|2|||
161669842|NCT02202551|583843175|FG002|Overall Study|Needed to take excluded medication|0|||
161669843|NCT02202551|583843176|FG003|Overall Study|Needed to take excluded medication|1|||
161669844|NCT02202551|583843173|FG000|Overall Study|Subject moved away|0|||
161669845|NCT02202551|583843174|FG001|Overall Study|Subject moved away|1|||
161669846|NCT02202551|583843175|FG002|Overall Study|Subject moved away|0|||
161669847|NCT02202551|583843176|FG003|Overall Study|Subject moved away|0|||
161669848|NCT02202551|583843173|FG000|Overall Study|DBS surgery|3|||
161669849|NCT02202551|583843174|FG001|Overall Study|DBS surgery|0|||
161669850|NCT02202551|583843175|FG002|Overall Study|DBS surgery|0|||
161669851|NCT02202551|583843176|FG003|Overall Study|DBS surgery|0|||
161669852|NCT02202551|583843173|FG000|Overall Study|Dyskinesia upon taper|1|||
161669853|NCT02202551|583843174|FG001|Overall Study|Dyskinesia upon taper|0|||
161669854|NCT02202551|583843175|FG002|Overall Study|Dyskinesia upon taper|0|||
161669855|NCT02202551|583843176|FG003|Overall Study|Dyskinesia upon taper|0|||
161669856|NCT02202551|583843173|FG000|Overall Study|Lack of Efficacy|0|||
161669857|NCT02202551|583843174|FG001|Overall Study|Lack of Efficacy|1|||
161669858|NCT02202551|583843175|FG002|Overall Study|Lack of Efficacy|0|||
161669859|NCT02202551|583843176|FG003|Overall Study|Lack of Efficacy|0|||
161669860|NCT02202551|583843173|FG000|Overall Study|Physician Decision|1|||
161669861|NCT02202551|583843174|FG001|Overall Study|Physician Decision|0|||
161669862|NCT02202551|583843175|FG002|Overall Study|Physician Decision|0|||
161669863|NCT02202551|583843176|FG003|Overall Study|Physician Decision|0|||
161669864|NCT02202551|583843173|FG000|Overall Study|Site closure|3|||
161669865|NCT02202551|583843174|FG001|Overall Study|Site closure|0|||
161669866|NCT02202551|583843175|FG002|Overall Study|Site closure|0|||
161669867|NCT02202551|583843176|FG003|Overall Study|Site closure|1|||
161669868|NCT02202551|583843173|FG000|Overall Study|Unable to complete visits per protocol|1|||
161669869|NCT02202551|583843174|FG001|Overall Study|Unable to complete visits per protocol|0|||
161669870|NCT02202551|583843175|FG002|Overall Study|Unable to complete visits per protocol|0|||
161669871|NCT02202551|583843176|FG003|Overall Study|Unable to complete visits per protocol|0|||
161669872|NCT02202551|583843173|FG000|Overall Study|Worsening Dyskinesia|0|||
161669873|NCT02202551|583843174|FG001|Overall Study|Worsening Dyskinesia|0|||
161669874|NCT02202551|583843175|FG002|Overall Study|Worsening Dyskinesia|0|||
161669875|NCT02202551|583843176|FG003|Overall Study|Worsening Dyskinesia|1|||
161669876|NCT02202551|583843173|FG000|Overall Study|Protocol Violation|0|||
161669877|NCT02202551|583843174|FG001|Overall Study|Protocol Violation|1|||
161669878|NCT02202551|583843175|FG002|Overall Study|Protocol Violation|0|||
161669879|NCT02202551|583843176|FG003|Overall Study|Protocol Violation|0|||
161669880|NCT02202551|583843173|FG000|Overall Study|Sponsor's decision|2|||
161669881|NCT02202551|583843174|FG001|Overall Study|Sponsor's decision|0|||
161669882|NCT02202551|583843175|FG002|Overall Study|Sponsor's decision|0|||
161669883|NCT02202551|583843176|FG003|Overall Study|Sponsor's decision|0|||
161669884|NCT02202551|583843173|FG000|Overall Study|Subject unwilling to proceed|1|||
161669885|NCT02202551|583843174|FG001|Overall Study|Subject unwilling to proceed|5|||
161669886|NCT02202551|583843175|FG002|Overall Study|Subject unwilling to proceed|3|||
161669887|NCT02202551|583843176|FG003|Overall Study|Subject unwilling to proceed|5|||
161669888|NCT02202551|583843173|FG000|Overall Study|Subject consent withdrawn|0|||
161669889|NCT02202551|583843174|FG001|Overall Study|Subject consent withdrawn|3|||
161669890|NCT02202551|583843175|FG002|Overall Study|Subject consent withdrawn|1|||
161669891|NCT02202551|583843176|FG003|Overall Study|Subject consent withdrawn|2|||
161669892|NCT02202551|583843173|FG000|Overall Study|eGFR<50mL/min/m2|2|||
161669893|NCT02202551|583843174|FG001|Overall Study|eGFR<50mL/min/m2|2|||
161816503|NCT00112437|584368804|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
162017416|NCT02963506|585117947|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
161669894|NCT02202551|583843175|FG002|Overall Study|eGFR<50mL/min/m2|0|||
161669895|NCT02202551|583843176|FG003|Overall Study|eGFR<50mL/min/m2|1|||
161669896|NCT02121834|583843177|FG000|Overall Study|Protocol Violation|0|||
161669897|NCT02121834|583843178|FG001|Overall Study|Protocol Violation|1|||
161669898|NCT02121834|583843179|FG002|Overall Study|Protocol Violation|0|||
161669899|NCT02121834|583843180|FG003|Overall Study|Protocol Violation|0|||
161669900|NCT02121834|583843181|FG004|Overall Study|Protocol Violation|0|||
161669901|NCT02121834|583843182|FG005|Overall Study|Protocol Violation|0|||
161669902|NCT02121834|583843183|FG006|Overall Study|Protocol Violation|0|||
161669903|NCT02121834|583843177|FG000|Overall Study|Withdrawal by Subject|0|||
162169361|NCT02268253|585673074|FG001|Stage 2|Lost to Follow-up|0|||
162169362|NCT02268253|585673075|FG002|Stage 2|Lost to Follow-up|0|||
162169363|NCT02268253|585673076|FG003|Stage 2|Lost to Follow-up|0|||
162169364|NCT02268253|585673077|FG004|Stage 2|Lost to Follow-up|0|||
162169365|NCT02268253|585673078|FG005|Stage 2|Lost to Follow-up|4|||
162169366|NCT02268253|585673079|FG006|Stage 2|Lost to Follow-up|0|||
162169367|NCT02268253|585673073|FG000|Stage 2|Transferred to Hospice|0|||
162169368|NCT02268253|585673074|FG001|Stage 2|Transferred to Hospice|0|||
162169369|NCT02268253|585673075|FG002|Stage 2|Transferred to Hospice|0|||
162169370|NCT02268253|585673076|FG003|Stage 2|Transferred to Hospice|0|||
162169371|NCT02268253|585673077|FG004|Stage 2|Transferred to Hospice|0|||
162169372|NCT02268253|585673078|FG005|Stage 2|Transferred to Hospice|2|||
162169373|NCT02268253|585673079|FG006|Stage 2|Transferred to Hospice|0|||
162169374|NCT02268253|585673073|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
162169375|NCT02268253|585673074|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
162169376|NCT02268253|585673075|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
162169377|NCT02268253|585673076|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
162169378|NCT02268253|585673077|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
162169379|NCT02268253|585673078|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
162169380|NCT02268253|585673079|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
162169381|NCT02268253|585673073|FG000|Stage 3A|Withdrawal by Subject|0|||
162169382|NCT02268253|585673074|FG001|Stage 3A|Withdrawal by Subject|0|||
162169383|NCT02268253|585673075|FG002|Stage 3A|Withdrawal by Subject|2|||
162169384|NCT02268253|585673076|FG003|Stage 3A|Withdrawal by Subject|0|||
162169385|NCT02268253|585673077|FG004|Stage 3A|Withdrawal by Subject|0|||
162169386|NCT02268253|585673078|FG005|Stage 3A|Withdrawal by Subject|0|||
162169387|NCT02268253|585673079|FG006|Stage 3A|Withdrawal by Subject|0|||
162169388|NCT02268253|585673073|FG000|Stage 3A|Physician Decision|0|||
162169389|NCT02268253|585673074|FG001|Stage 3A|Physician Decision|0|||
162169390|NCT02268253|585673075|FG002|Stage 3A|Physician Decision|2|||
162169391|NCT02268253|585673076|FG003|Stage 3A|Physician Decision|0|||
162169392|NCT02268253|585673077|FG004|Stage 3A|Physician Decision|0|||
162169393|NCT02268253|585673078|FG005|Stage 3A|Physician Decision|0|||
162169394|NCT02268253|585673079|FG006|Stage 3A|Physician Decision|0|||
162169395|NCT02268253|585673073|FG000|Stage 3A|Study Terminated by Sponsor|0|||
162169396|NCT02268253|585673074|FG001|Stage 3A|Study Terminated by Sponsor|0|||
162169397|NCT02268253|585673075|FG002|Stage 3A|Study Terminated by Sponsor|2|||
162169398|NCT02268253|585673076|FG003|Stage 3A|Study Terminated by Sponsor|0|||
162169399|NCT02268253|585673077|FG004|Stage 3A|Study Terminated by Sponsor|0|||
162169400|NCT02268253|585673078|FG005|Stage 3A|Study Terminated by Sponsor|0|||
162169401|NCT02268253|585673079|FG006|Stage 3A|Study Terminated by Sponsor|0|||
162169402|NCT02268253|585673073|FG000|Stage 3A|Lost to Follow-up|0|||
162169403|NCT02268253|585673074|FG001|Stage 3A|Lost to Follow-up|0|||
162169404|NCT02268253|585673075|FG002|Stage 3A|Lost to Follow-up|1|||
162169405|NCT02268253|585673076|FG003|Stage 3A|Lost to Follow-up|0|||
162169406|NCT02268253|585673077|FG004|Stage 3A|Lost to Follow-up|0|||
162169407|NCT02268253|585673078|FG005|Stage 3A|Lost to Follow-up|0|||
162169408|NCT02268253|585673079|FG006|Stage 3A|Lost to Follow-up|0|||
162169409|NCT02268253|585673073|FG000|Stage 3A|Death|0|||
162169410|NCT02268253|585673074|FG001|Stage 3A|Death|0|||
162169411|NCT02268253|585673075|FG002|Stage 3A|Death|5|||
162169412|NCT02268253|585673076|FG003|Stage 3A|Death|0|||
162169413|NCT02268253|585673077|FG004|Stage 3A|Death|0|||
162169414|NCT02268253|585673078|FG005|Stage 3A|Death|0|||
162169415|NCT02268253|585673079|FG006|Stage 3A|Death|0|||
162169416|NCT05714761|585673080|FG000|Overall Study|Lost to Follow-up|3|||
162169417|NCT05714761|585673080|FG000|Overall Study|Withdrawal by Subject|3|||
162169418|NCT05714761|585673080|FG000|Overall Study|unblinding of sensor data|1|||
162169419|NCT05714761|585673080|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
162169420|NCT05714761|585673080|FG000|Overall Study|did not return second CGM sensor|4|||
162169421|NCT05672069|585673081|FG000|Overall Study|Implant removal|1|||
162169422|NCT05672069|585673081|FG000|Overall Study|Lost to Follow-up|2|||
162169423|NCT05949788|585673082|FG000|Overall Study|severe birth deformity|2|||
162169424|NCT05949788|585673083|FG001|Overall Study|severe birth deformity|7|||
162169425|NCT05949788|585673082|FG000|Overall Study|twin-twin transfusion syndrome|2|||
162169426|NCT05949788|585673083|FG001|Overall Study|twin-twin transfusion syndrome|7|||
162169427|NCT05949788|585673082|FG000|Overall Study|neonatal hemolytic disease|3|||
162169428|NCT05949788|585673083|FG001|Overall Study|neonatal hemolytic disease|8|||
162169429|NCT05949788|585673082|FG000|Overall Study|death within 14 days after birth|2|||
162169430|NCT05949788|585673083|FG001|Overall Study|death within 14 days after birth|6|||
162169431|NCT05949788|585673082|FG000|Overall Study|transfer to another hospital|2|||
162169432|NCT05949788|585673083|FG001|Overall Study|transfer to another hospital|6|||
162169433|NCT05213390|585673084|FG000|Overall Study|Withdrawal by Subject|2|||
162169434|NCT05213390|585673084|FG000|Overall Study|Lost to Follow-up|12|||
162169435|NCT05213390|585673084|FG000|Overall Study|Protocol Violation|9|||
162169436|NCT02191618|585673092|FG000|Overall Study|Withdrawal by Subject|3|||
162169437|NCT02191618|585673092|FG000|Overall Study|Missed Visit|4|||
162169438|NCT03031470|585673094|FG000|Overall Study|Adverse Event|3|||
162169439|NCT03031470|585673095|FG001|Overall Study|Adverse Event|0|||
162169440|NCT03031470|585673094|FG000|Overall Study|Death|3|||
162169441|NCT03031470|585673095|FG001|Overall Study|Death|1|||
162169442|NCT03031470|585673094|FG000|Overall Study|Lost to Follow-up|1|||
162169443|NCT03031470|585673095|FG001|Overall Study|Lost to Follow-up|1|||
162169444|NCT03031470|585673094|FG000|Overall Study|Withdrawal by Subject|1|||
162169445|NCT03031470|585673095|FG001|Overall Study|Withdrawal by Subject|0|||
162169446|NCT03031470|585673094|FG000|Overall Study|Protocol entry criteria not met|0|||
162169447|NCT03031470|585673095|FG001|Overall Study|Protocol entry criteria not met|1|||
162169448|NCT03031470|585673094|FG000|Overall Study|Cancel the operation|0|||
162169449|NCT03031470|585673095|FG001|Overall Study|Cancel the operation|1|||
162169450|NCT01593917|585673096|FG000|Overall Study|Death|67|||
162169451|NCT01593917|585673096|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
162169452|NCT01593917|585673096|FG000|Overall Study|Withdrawal by Subject|23|||
162169453|NCT01593917|585673096|FG000|Overall Study|Lost to Follow-up|12|||
162169454|NCT01593917|585673096|FG000|Overall Study|Protocol Violation|5|||
162169455|NCT01593917|585673096|FG000|Overall Study|Physician Decision|3|||
162169456|NCT02683447|585673100|FG000|Overall Study|Lost to Follow-up|2|||
162169457|NCT04663737|585673101|FG000|Overall Study|Withdrawal by Subject|2|||
162169458|NCT04663737|585673102|FG001|Overall Study|Withdrawal by Subject|0|||
162169459|NCT04016662|585673103|FG000|Run-In Phase|Death|1|||
162169460|NCT04016662|585673103|FG000|Run-In Phase|Withdrawal by Subject|11|||
162169461|NCT04016662|585673103|FG000|Run-In Phase|Not meeting screening eligibility|9|||
162169462|NCT04016662|585673103|FG000|Run-In Phase|Physician Decision|3|||
162169463|NCT04016662|585673103|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
162169464|NCT04016662|585673103|FG000|PLGS (12 Weeks)|Death|1|||
162169465|NCT04016662|585673103|FG000|SAP (12 Weeks)|Death|1|||
162169466|NCT01943409|585673107|FG000|Overall Study|resumed oral/entral|24|||
162169467|NCT01943409|585673108|FG001|Overall Study|resumed oral/entral|20|||
162169468|NCT01943409|585673107|FG000|Overall Study|Protocol Violation|14|||
162169469|NCT01943409|585673108|FG001|Overall Study|Protocol Violation|24|||
162169470|NCT01943409|585673107|FG000|Overall Study|Death|3|||
162169471|NCT01943409|585673108|FG001|Overall Study|Death|1|||
162169472|NCT01943409|585673107|FG000|Overall Study|Withdrawal by Subject|4|||
162169473|NCT01943409|585673108|FG001|Overall Study|Withdrawal by Subject|3|||
162169474|NCT03021096|585673109|FG000|Overall Study|Lost to Follow-up|4|||
162169475|NCT03021096|585673109|FG000|Overall Study|Protocol Violation|2|||
162169476|NCT03216057|585673110|FG000|Overall Study|Lost to Follow-up|2|||
162169477|NCT03216057|585673111|FG001|Overall Study|Lost to Follow-up|2|||
162169478|NCT05126433|585673112|FG000|Overall Study|Withdrawal by Subject|3|||
162169479|NCT05126433|585673113|FG001|Overall Study|Withdrawal by Subject|0|||
162169480|NCT05126433|585673114|FG002|Overall Study|Withdrawal by Subject|4|||
162169481|NCT05126433|585673112|FG000|Overall Study|Death|9|||
162169482|NCT05126433|585673113|FG001|Overall Study|Death|3|||
162169483|NCT05126433|585673114|FG002|Overall Study|Death|5|||
162169484|NCT05126433|585673112|FG000|Overall Study|Study Terminated by sponsor|0|||
162169485|NCT05126433|585673113|FG001|Overall Study|Study Terminated by sponsor|1|||
162169486|NCT05126433|585673114|FG002|Overall Study|Study Terminated by sponsor|2|||
162169487|NCT05126433|585673112|FG000|Overall Study|Progressive Disease|1|||
162169488|NCT05126433|585673113|FG001|Overall Study|Progressive Disease|4|||
162169489|NCT05126433|585673114|FG002|Overall Study|Progressive Disease|3|||
162169490|NCT05126433|585673112|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
162169491|NCT05126433|585673113|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
162169492|NCT05126433|585673114|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
162169493|NCT03907878|585673115|FG000|Treatment Period|Withdrawal by Subject|5|||
162169494|NCT03907878|585673115|FG000|Treatment Period|Adverse Event|4|||
162169495|NCT03907878|585673115|FG000|Treatment Period|Lack of Efficacy|1|||
162169496|NCT03907878|585673115|FG000|Treatment Period|Protocol Violation|1|||
162169497|NCT03907878|585673115|FG000|Follow-up Period|Adverse Event|3|||
162169498|NCT03907878|585673115|FG000|Follow-up Period|Withdrawal by Subject|3|||
162169499|NCT03904147|585673120|FG000|Overall Study|Death|15|||
162169500|NCT03904147|585673121|FG001|Overall Study|Death|13|||
162169501|NCT03904147|585673122|FG002|Overall Study|Death|15|||
162169502|NCT03904147|585673120|FG000|Overall Study|Withdrawal by Subject|7|||
162169503|NCT03904147|585673121|FG001|Overall Study|Withdrawal by Subject|12|||
162169504|NCT03904147|585673122|FG002|Overall Study|Withdrawal by Subject|1|||
162169505|NCT03904147|585673120|FG000|Overall Study|1Y visit completed after 365 days|1|||
162169506|NCT03904147|585673121|FG001|Overall Study|1Y visit completed after 365 days|1|||
162169507|NCT03904147|585673122|FG002|Overall Study|1Y visit completed after 365 days|0|||
162169508|NCT05399459|585673127|FG000|Overall Study|Randomized but not treated|29|||
162169509|NCT05399459|585673128|FG001|Overall Study|Randomized but not treated|30|||
162169510|NCT05399459|585673129|FG002|Overall Study|Randomized but not treated|38|||
162169511|NCT05399459|585673127|FG000|Overall Study|Lost to Follow-up|1|||
162169512|NCT05399459|585673128|FG001|Overall Study|Lost to Follow-up|0|||
162169513|NCT05399459|585673129|FG002|Overall Study|Lost to Follow-up|0|||
162169514|NCT04992520|585673130|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
162169515|NCT04992520|585673131|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
162169516|NCT04992520|585673132|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
162169517|NCT04992520|585673133|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
162169518|NCT04992520|585673134|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
162169519|NCT04992520|585673135|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
162169520|NCT04992520|585673130|FG000|Part A: First Challenge|Non-compliance|0|||
162169521|NCT04992520|585673131|FG001|Part A: First Challenge|Non-compliance|0|||
162169522|NCT04992520|585673132|FG002|Part A: First Challenge|Non-compliance|0|||
162169523|NCT04992520|585673133|FG003|Part A: First Challenge|Non-compliance|1|||
162169524|NCT04992520|585673134|FG004|Part A: First Challenge|Non-compliance|0|||
162169525|NCT04992520|585673135|FG005|Part A: First Challenge|Non-compliance|0|||
162169526|NCT04992520|585673130|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
162169527|NCT04992520|585673131|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
162169528|NCT04992520|585673132|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
162169529|NCT04992520|585673133|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
162169530|NCT04992520|585673134|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
162169531|NCT04992520|585673135|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
162169532|NCT04992520|585673130|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
162169533|NCT04992520|585673131|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
162169534|NCT04992520|585673132|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
162169535|NCT04992520|585673133|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
162169536|NCT04992520|585673134|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
162169537|NCT04992520|585673135|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
162169538|NCT06103188|585673137|FG000|Overall Study|Lost to Follow-up|1|||
162169539|NCT06103188|585673138|FG001|Overall Study|Lost to Follow-up|6|||
162017417|NCT02963506|585117948|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
162169540|NCT06103188|585673139|FG002|Overall Study|Lost to Follow-up|4|||
162169541|NCT02969707|585673140|FG000|Overall Study|Withdrawal by Subject|6|||
162169542|NCT02969707|585673141|FG001|Overall Study|Withdrawal by Subject|5|||
162169543|NCT02969707|585673140|FG000|Overall Study|Severe anxiety|0|||
162169544|NCT02969707|585673141|FG001|Overall Study|Severe anxiety|1|||
162169545|NCT02969707|585673140|FG000|Overall Study|Positive toxicology screen|0|||
162169546|NCT02969707|585673141|FG001|Overall Study|Positive toxicology screen|2|||
162169547|NCT02969707|585673140|FG000|Overall Study|Claustrophobia|2|||
162169548|NCT02969707|585673141|FG001|Overall Study|Claustrophobia|2|||
162169549|NCT02969707|585673140|FG000|Overall Study|Non-compliance|1|||
162169550|NCT02969707|585673141|FG001|Overall Study|Non-compliance|2|||
162169551|NCT01175356|585673142|FG000|Overall Study|Death|1|||
162169552|NCT01175356|585673142|FG000|Overall Study|Lack of Efficacy|12|||
162169553|NCT01175356|585673142|FG000|Overall Study|Lost to Follow-up|1|||
162169554|NCT01175356|585673142|FG000|Overall Study|Physician Decision|23|||
162169555|NCT01175356|585673142|FG000|Overall Study|Ineligible|1|||
162169556|NCT01175356|585673142|FG000|Overall Study|Treatment Slot Not Available|18|||
162169557|NCT01175356|585673142|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
162169558|NCT01175356|585673142|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
162169559|NCT01175356|585673142|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
162169560|NCT01175356|585673142|FG000|Overall Study|Inadequate stem cell for transplant|1|||
162169561|NCT01175356|585673142|FG000|Overall Study|Initiation other tx prior to completion|9|||
162169562|NCT05583578|585673145|FG000|Overall Study|Withdrawal by Subject|2|||
162169563|NCT05583578|585673146|FG001|Overall Study|Withdrawal by Subject|0|||
162169564|NCT05877976|585673149|FG000|Overall Study|Lost to Follow-up|31|||
162169565|NCT00248287|585673150|FG000|Overall Study|Adverse Event|11|||
162169566|NCT00248287|585673151|FG001|Overall Study|Adverse Event|10|||
162169567|NCT00248287|585673150|FG000|Overall Study|Death|1|||
162017418|NCT02963506|585117949|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
162169568|NCT00248287|585673151|FG001|Overall Study|Death|0|||
162169569|NCT00248287|585673150|FG000|Overall Study|Lost to Follow-up|0|||
162169570|NCT00248287|585673151|FG001|Overall Study|Lost to Follow-up|1|||
162169571|NCT00248287|585673150|FG000|Overall Study|Investigator Request|4|||
162169572|NCT00248287|585673151|FG001|Overall Study|Investigator Request|3|||
162169573|NCT00248287|585673150|FG000|Overall Study|Patient Request|5|||
162169574|NCT00248287|585673151|FG001|Overall Study|Patient Request|3|||
162169575|NCT00248287|585673150|FG000|Overall Study|Other|3|||
162169576|NCT00248287|585673151|FG001|Overall Study|Other|2|||
162017419|NCT02963506|585117950|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
162169577|NCT02714257|585673152|FG000|Overall Study|Withdrawal by Subject|6|||
162169578|NCT02714257|585673153|FG001|Overall Study|Withdrawal by Subject|11|||
162169579|NCT02714257|585673152|FG000|Overall Study|Death|3|||
162169580|NCT02714257|585673153|FG001|Overall Study|Death|4|||
162169581|NCT02714257|585673152|FG000|Overall Study|Lost to Follow-up|1|||
162169582|NCT02714257|585673153|FG001|Overall Study|Lost to Follow-up|6|||
162169583|NCT04103580|585673154|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
162169584|NCT04103580|585673155|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
162169585|NCT04103580|585673154|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
162169586|NCT04103580|585673155|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
162169587|NCT04103580|585673154|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
162169588|NCT04103580|585673155|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
162169589|NCT04103580|585673154|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
162169590|NCT04103580|585673155|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
162169591|NCT04103580|585673154|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
162169592|NCT04103580|585673155|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
162169593|NCT04103580|585673154|FG000|Phase 1 Active Caregiving|Other|3|||
162169594|NCT04103580|585673155|FG001|Phase 1 Active Caregiving|Other|3|||
162169595|NCT04103580|585673154|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
162169596|NCT04103580|585673155|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
162017420|NCT02963506|585117951|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
162169597|NCT04103580|585673154|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
161816504|NCT00112437|584368805|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816505|NCT00112437|584368806|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816506|NCT00112437|584368807|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816507|NCT00112437|584368808|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816508|NCT00112437|584368809|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816509|NCT00112437|584368810|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816510|NCT00112437|584368811|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816511|NCT00112437|584368812|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816512|NCT00112437|584368813|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816513|NCT00112437|584368814|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816514|NCT00112437|584368815|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816515|NCT00112437|584368816|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816516|NCT00112437|584368817|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816517|NCT00112437|584368818|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816518|NCT00112437|584368819|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816519|NCT00112437|584368820|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816520|NCT00112437|584368821|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816521|NCT00112437|584368822|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816522|NCT00112437|584368823|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816523|NCT00112437|584368824|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
161816524|NCT00112437|584368825|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
161816525|NCT00112437|584368826|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816526|NCT00112437|584368827|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816527|NCT00112437|584368828|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816528|NCT00112437|584368829|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161816529|NCT00112437|584368804|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816530|NCT00112437|584368805|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816531|NCT00112437|584368806|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816532|NCT00112437|584368807|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816533|NCT00112437|584368808|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816534|NCT00112437|584368809|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816535|NCT00112437|584368810|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816536|NCT00112437|584368811|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816537|NCT00112437|584368812|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816538|NCT00112437|584368813|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816539|NCT00112437|584368814|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816540|NCT00112437|584368815|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816541|NCT00112437|584368816|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816542|NCT00112437|584368817|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816543|NCT00112437|584368818|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816544|NCT00112437|584368819|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816545|NCT00112437|584368820|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816546|NCT00112437|584368821|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816547|NCT00112437|584368822|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816548|NCT00112437|584368823|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816549|NCT00112437|584368824|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816550|NCT00112437|584368825|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816551|NCT00112437|584368826|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
161816552|NCT00112437|584368827|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
162169598|NCT04103580|585673155|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
162169599|NCT04103580|585673154|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
162169600|NCT04103580|585673155|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
162169601|NCT04103580|585673154|FG000|Phase 2 Bereavement|Other|8|||
162169602|NCT04103580|585673155|FG001|Phase 2 Bereavement|Other|6|||
162169603|NCT04145440|585673156|FG000|Overall Study|Physician Decision|3|||
162169604|NCT04145440|585673157|FG001|Overall Study|Physician Decision|0|||
162169605|NCT04145440|585673156|FG000|Overall Study|Use of prohibited therapy|2|||
162169606|NCT04145440|585673157|FG001|Overall Study|Use of prohibited therapy|3|||
162017421|NCT02963506|585117952|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
162017422|NCT02963506|585117953|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
162017423|NCT02963506|585117954|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
162017424|NCT02963506|585117955|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
162017425|NCT02963506|585117956|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
162017426|NCT02963506|585117957|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
162017427|NCT02963506|585117958|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
162017428|NCT02963506|585117959|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
162017429|NCT02963506|585117947|FG000|Dose-Blind Period|Adverse Event|0|||
162017430|NCT02963506|585117948|FG001|Dose-Blind Period|Adverse Event|0|||
162017431|NCT02963506|585117949|FG002|Dose-Blind Period|Adverse Event|0|||
162017432|NCT02963506|585117950|FG003|Dose-Blind Period|Adverse Event|0|||
162017433|NCT02963506|585117951|FG004|Dose-Blind Period|Adverse Event|0|||
162017434|NCT02963506|585117952|FG005|Dose-Blind Period|Adverse Event|1|||
162017435|NCT02963506|585117953|FG006|Dose-Blind Period|Adverse Event|3|||
162017436|NCT02963506|585117954|FG007|Dose-Blind Period|Adverse Event|2|||
162017437|NCT02963506|585117955|FG008|Dose-Blind Period|Adverse Event|2|||
162017438|NCT02963506|585117956|FG009|Dose-Blind Period|Adverse Event|2|||
162017439|NCT02963506|585117957|FG010|Dose-Blind Period|Adverse Event|1|||
162017440|NCT02963506|585117958|FG011|Dose-Blind Period|Adverse Event|1|||
162017441|NCT02963506|585117959|FG012|Dose-Blind Period|Adverse Event|6|||
162017442|NCT02963506|585117947|FG000|Dose-Blind Period|Lack of Efficacy|0|||
162017443|NCT02963506|585117948|FG001|Dose-Blind Period|Lack of Efficacy|0|||
162017444|NCT02963506|585117949|FG002|Dose-Blind Period|Lack of Efficacy|0|||
162017445|NCT02963506|585117950|FG003|Dose-Blind Period|Lack of Efficacy|0|||
162017446|NCT02963506|585117951|FG004|Dose-Blind Period|Lack of Efficacy|0|||
162017447|NCT02963506|585117952|FG005|Dose-Blind Period|Lack of Efficacy|0|||
162017448|NCT02963506|585117953|FG006|Dose-Blind Period|Lack of Efficacy|0|||
162017449|NCT02963506|585117954|FG007|Dose-Blind Period|Lack of Efficacy|1|||
162017450|NCT02963506|585117955|FG008|Dose-Blind Period|Lack of Efficacy|0|||
162017451|NCT02963506|585117956|FG009|Dose-Blind Period|Lack of Efficacy|1|||
162017452|NCT02963506|585117957|FG010|Dose-Blind Period|Lack of Efficacy|0|||
162017453|NCT02963506|585117958|FG011|Dose-Blind Period|Lack of Efficacy|0|||
162017454|NCT02963506|585117959|FG012|Dose-Blind Period|Lack of Efficacy|0|||
162017455|NCT02963506|585117947|FG000|Dose-Blind Period|Lost to Follow-up|0|||
162017456|NCT02963506|585117948|FG001|Dose-Blind Period|Lost to Follow-up|0|||
162017457|NCT02963506|585117949|FG002|Dose-Blind Period|Lost to Follow-up|0|||
162017458|NCT02963506|585117950|FG003|Dose-Blind Period|Lost to Follow-up|0|||
162017459|NCT02963506|585117951|FG004|Dose-Blind Period|Lost to Follow-up|0|||
162017460|NCT02963506|585117952|FG005|Dose-Blind Period|Lost to Follow-up|1|||
162017461|NCT02963506|585117953|FG006|Dose-Blind Period|Lost to Follow-up|0|||
162017462|NCT02963506|585117954|FG007|Dose-Blind Period|Lost to Follow-up|0|||
162017463|NCT02963506|585117955|FG008|Dose-Blind Period|Lost to Follow-up|1|||
162017464|NCT02963506|585117956|FG009|Dose-Blind Period|Lost to Follow-up|0|||
162017465|NCT02963506|585117957|FG010|Dose-Blind Period|Lost to Follow-up|0|||
162017466|NCT02963506|585117958|FG011|Dose-Blind Period|Lost to Follow-up|1|||
162017467|NCT02963506|585117959|FG012|Dose-Blind Period|Lost to Follow-up|0|||
162169607|NCT05808257|585673160|FG000|Overall Study|Lost to Follow-up|8|||
162017468|NCT02963506|585117947|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
162017469|NCT02963506|585117948|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
162169608|NCT05808257|585673161|FG001|Overall Study|Lost to Follow-up|8|||
162169609|NCT04568486|585673162|FG000|Overall Study|Withdrawal by Subject|26|||
162169610|NCT04568486|585673162|FG000|Overall Study|Lost to Follow-up|7|||
162017470|NCT02963506|585117949|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
162017471|NCT02963506|585117950|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
162017472|NCT02963506|585117951|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
162017473|NCT02963506|585117952|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
162017474|NCT02963506|585117953|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
162017475|NCT02963506|585117954|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
162017476|NCT02963506|585117955|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
162017477|NCT02963506|585117956|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
162017478|NCT02963506|585117957|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
162017479|NCT02963506|585117958|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
162017480|NCT02963506|585117959|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
162017481|NCT02963506|585117947|FG000|Dose-Blind Period|Sponsor decision|0|||
162017482|NCT02963506|585117948|FG001|Dose-Blind Period|Sponsor decision|0|||
162017483|NCT02963506|585117949|FG002|Dose-Blind Period|Sponsor decision|0|||
162017484|NCT02963506|585117950|FG003|Dose-Blind Period|Sponsor decision|0|||
162017485|NCT02963506|585117951|FG004|Dose-Blind Period|Sponsor decision|0|||
162017486|NCT02963506|585117952|FG005|Dose-Blind Period|Sponsor decision|1|||
162017487|NCT02963506|585117953|FG006|Dose-Blind Period|Sponsor decision|0|||
162017488|NCT02963506|585117954|FG007|Dose-Blind Period|Sponsor decision|0|||
162017489|NCT02963506|585117955|FG008|Dose-Blind Period|Sponsor decision|0|||
162017490|NCT02963506|585117956|FG009|Dose-Blind Period|Sponsor decision|0|||
162017491|NCT02963506|585117957|FG010|Dose-Blind Period|Sponsor decision|0|||
162017492|NCT02963506|585117958|FG011|Dose-Blind Period|Sponsor decision|0|||
162017493|NCT02963506|585117959|FG012|Dose-Blind Period|Sponsor decision|0|||
162017494|NCT02963506|585117947|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162017495|NCT02963506|585117948|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162017496|NCT02963506|585117949|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162017497|NCT02963506|585117950|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162017498|NCT02963506|585117951|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162017499|NCT02963506|585117952|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162017500|NCT02963506|585117953|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162017501|NCT02963506|585117954|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162017502|NCT02963506|585117955|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162017503|NCT02963506|585117956|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162017504|NCT02963506|585117957|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162017505|NCT02963506|585117958|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
162017506|NCT02963506|585117959|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
162017507|NCT01724346|585117960|FG000|Overall Study|Death|42|||
162017508|NCT01724346|585117961|FG001|Overall Study|Death|42|||
162017509|NCT01724346|585117960|FG000|Overall Study|Lost to Follow-up|5|||
162017510|NCT01724346|585117961|FG001|Overall Study|Lost to Follow-up|1|||
162017511|NCT01724346|585117960|FG000|Overall Study|Withdrawal by Subject|27|||
162017512|NCT01724346|585117961|FG001|Overall Study|Withdrawal by Subject|19|||
162017513|NCT01724346|585117960|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
162017514|NCT01724346|585117961|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
162017515|NCT01006291|585119648|FG000|Overall Study|Adverse Event|2|||
162017516|NCT01006291|585119649|FG001|Overall Study|Adverse Event|1|||
162017517|NCT01006291|585119650|FG002|Overall Study|Adverse Event|2|||
162017518|NCT01006291|585119648|FG000|Overall Study|Lack of Efficacy|2|||
162017519|NCT01006291|585119649|FG001|Overall Study|Lack of Efficacy|2|||
162017520|NCT01006291|585119650|FG002|Overall Study|Lack of Efficacy|1|||
162017521|NCT01006291|585119648|FG000|Overall Study|Protocol Violation|3|||
162017522|NCT01006291|585119649|FG001|Overall Study|Protocol Violation|3|||
162017523|NCT01006291|585119650|FG002|Overall Study|Protocol Violation|3|||
162017524|NCT01006291|585119648|FG000|Overall Study|Withdrawal criteria|5|||
162017525|NCT01006291|585119649|FG001|Overall Study|Withdrawal criteria|4|||
162017526|NCT01006291|585119650|FG002|Overall Study|Withdrawal criteria|4|||
162017527|NCT01006291|585119648|FG000|Overall Study|Other|14|||
162017528|NCT01006291|585119649|FG001|Overall Study|Other|14|||
162017529|NCT01006291|585119650|FG002|Overall Study|Other|17|||
162017530|NCT01677377|585119651|FG000|Overall Study|Protocol Violation|1|||
162017531|NCT01677377|585119652|FG001|Overall Study|Protocol Violation|0|||
162017532|NCT01677377|585119653|FG002|Overall Study|Protocol Violation|0|||
162169611|NCT04042233|585673163|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
162017533|NCT01677377|585119651|FG000|Overall Study|Lost to Follow-up|0|||
162169612|NCT04042233|585673164|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
162017534|NCT01677377|585119652|FG001|Overall Study|Lost to Follow-up|1|||
162017535|NCT01677377|585119653|FG002|Overall Study|Lost to Follow-up|1|||
162017536|NCT01677377|585119651|FG000|Overall Study|Withdrawal by Subject|0|||
162017537|NCT01677377|585119652|FG001|Overall Study|Withdrawal by Subject|0|||
162017538|NCT01677377|585119653|FG002|Overall Study|Withdrawal by Subject|3|||
162017539|NCT01677377|585119651|FG000|Overall Study|Lack of Efficacy|0|||
162017540|NCT01677377|585119652|FG001|Overall Study|Lack of Efficacy|0|||
162017541|NCT01677377|585119653|FG002|Overall Study|Lack of Efficacy|1|||
162017542|NCT01677377|585119651|FG000|Overall Study|Pregnancy|0|||
162017543|NCT01677377|585119652|FG001|Overall Study|Pregnancy|0|||
162017544|NCT01677377|585119653|FG002|Overall Study|Pregnancy|1|||
162017545|NCT02260180|585119654|FG000|Overall Study|Adverse Event|2|||
162017546|NCT02260180|585119655|FG001|Overall Study|Adverse Event|0|||
162169613|NCT04042233|585673163|FG000|Overall Study|Protocol Violation|0|||
162169614|NCT04042233|585673164|FG001|Overall Study|Protocol Violation|2|||
162169615|NCT04907851|585673167|FG000|Overall Study|Consent withdrawn|1|||
162169616|NCT04907851|585673168|FG001|Overall Study|Consent withdrawn|2|||
162169617|NCT04907851|585673169|FG002|Overall Study|Consent withdrawn|0|||
162169618|NCT04907851|585673167|FG000|Overall Study|Death|5|||
162169619|NCT04907851|585673168|FG001|Overall Study|Death|15|||
162169620|NCT04907851|585673169|FG002|Overall Study|Death|10|||
162169621|NCT04248725|585673181|FG000|Post-Treatment|Lost to Follow-up|6|||
162169622|NCT04248725|585673182|FG001|Post-Treatment|Lost to Follow-up|5|||
162169623|NCT04248725|585673181|FG000|6-Month Follow Up|Lost to Follow-up|9|||
162169624|NCT04248725|585673182|FG001|6-Month Follow Up|Lost to Follow-up|8|||
162169625|NCT05496231|585673190|FG000|Overall Study|Adverse Event|1|||
162169626|NCT05496231|585673191|FG001|Overall Study|Adverse Event|1|||
162169627|NCT05496231|585673192|FG002|Overall Study|Adverse Event|0|||
162169628|NCT05496231|585673193|FG003|Overall Study|Adverse Event|4|||
162169629|NCT05496231|585673190|FG000|Overall Study|Withdrawal by Subject|5|||
162169630|NCT05496231|585673191|FG001|Overall Study|Withdrawal by Subject|5|||
162169631|NCT05496231|585673192|FG002|Overall Study|Withdrawal by Subject|4|||
162169632|NCT05496231|585673193|FG003|Overall Study|Withdrawal by Subject|11|||
162169633|NCT05496231|585673190|FG000|Overall Study|Migrated/moved from the study area|3|||
162169634|NCT05496231|585673191|FG001|Overall Study|Migrated/moved from the study area|5|||
162169635|NCT05496231|585673192|FG002|Overall Study|Migrated/moved from the study area|3|||
162169636|NCT05496231|585673193|FG003|Overall Study|Migrated/moved from the study area|3|||
162169637|NCT05496231|585673190|FG000|Overall Study|Lost to Follow-up|13|||
162169638|NCT05496231|585673191|FG001|Overall Study|Lost to Follow-up|6|||
162169639|NCT05496231|585673192|FG002|Overall Study|Lost to Follow-up|11|||
162169640|NCT05496231|585673193|FG003|Overall Study|Lost to Follow-up|6|||
162169641|NCT05496231|585673190|FG000|Overall Study|Other|9|||
162169642|NCT05496231|585673191|FG001|Overall Study|Other|7|||
162169643|NCT05496231|585673192|FG002|Overall Study|Other|7|||
162169644|NCT05496231|585673193|FG003|Overall Study|Other|8|||
162169645|NCT03819153|585673205|FG000|Overall Study|Withdrawal by Subject|20|||
162169646|NCT03819153|585673206|FG001|Overall Study|Withdrawal by Subject|28|||
162169647|NCT03819153|585673205|FG000|Overall Study|Lost to Follow-up|23|||
162169648|NCT03819153|585673206|FG001|Overall Study|Lost to Follow-up|30|||
162169649|NCT03058289|585673207|FG000|Overall Study|Radiographic Deterioration|0|||
162169650|NCT03058289|585673208|FG001|Overall Study|Radiographic Deterioration|3|||
162169651|NCT03058289|585673209|FG002|Overall Study|Radiographic Deterioration|1|||
162169652|NCT03058289|585673210|FG003|Overall Study|Radiographic Deterioration|2|||
162169653|NCT03058289|585673211|FG004|Overall Study|Radiographic Deterioration|6|||
162169654|NCT03058289|585673212|FG005|Overall Study|Radiographic Deterioration|3|||
162169655|NCT03058289|585673213|FG006|Overall Study|Radiographic Deterioration|0|||
162169656|NCT03058289|585673214|FG007|Overall Study|Radiographic Deterioration|4|||
162169657|NCT03058289|585673215|FG008|Overall Study|Radiographic Deterioration|2|||
162169658|NCT03058289|585673207|FG000|Overall Study|Adverse Event|2|||
162169659|NCT03058289|585673208|FG001|Overall Study|Adverse Event|0|||
162169660|NCT03058289|585673209|FG002|Overall Study|Adverse Event|1|||
162169661|NCT03058289|585673210|FG003|Overall Study|Adverse Event|3|||
162169662|NCT03058289|585673211|FG004|Overall Study|Adverse Event|1|||
162169663|NCT03058289|585673212|FG005|Overall Study|Adverse Event|0|||
162169664|NCT03058289|585673213|FG006|Overall Study|Adverse Event|1|||
162169665|NCT03058289|585673214|FG007|Overall Study|Adverse Event|3|||
162169666|NCT03058289|585673215|FG008|Overall Study|Adverse Event|0|||
162169667|NCT03058289|585673207|FG000|Overall Study|Withdrawal by Subject|0|||
162169668|NCT03058289|585673208|FG001|Overall Study|Withdrawal by Subject|0|||
162169669|NCT03058289|585673209|FG002|Overall Study|Withdrawal by Subject|0|||
162169670|NCT03058289|585673210|FG003|Overall Study|Withdrawal by Subject|2|||
162169671|NCT03058289|585673211|FG004|Overall Study|Withdrawal by Subject|0|||
162169672|NCT03058289|585673212|FG005|Overall Study|Withdrawal by Subject|2|||
162169673|NCT03058289|585673213|FG006|Overall Study|Withdrawal by Subject|0|||
162169674|NCT03058289|585673214|FG007|Overall Study|Withdrawal by Subject|4|||
162169675|NCT03058289|585673215|FG008|Overall Study|Withdrawal by Subject|1|||
162169676|NCT03058289|585673207|FG000|Overall Study|Physician Decision|1|||
162169677|NCT03058289|585673208|FG001|Overall Study|Physician Decision|0|||
162169678|NCT03058289|585673209|FG002|Overall Study|Physician Decision|0|||
162169679|NCT03058289|585673210|FG003|Overall Study|Physician Decision|2|||
162169680|NCT03058289|585673211|FG004|Overall Study|Physician Decision|1|||
162169681|NCT03058289|585673212|FG005|Overall Study|Physician Decision|0|||
162169682|NCT03058289|585673213|FG006|Overall Study|Physician Decision|2|||
162169683|NCT03058289|585673214|FG007|Overall Study|Physician Decision|3|||
162169684|NCT03058289|585673215|FG008|Overall Study|Physician Decision|0|||
162169685|NCT03058289|585673207|FG000|Overall Study|Clinical Deterioration|2|||
162169686|NCT03058289|585673208|FG001|Overall Study|Clinical Deterioration|0|||
162169687|NCT03058289|585673209|FG002|Overall Study|Clinical Deterioration|0|||
162169688|NCT03058289|585673210|FG003|Overall Study|Clinical Deterioration|2|||
162169689|NCT03058289|585673211|FG004|Overall Study|Clinical Deterioration|1|||
162169690|NCT03058289|585673212|FG005|Overall Study|Clinical Deterioration|1|||
162169691|NCT03058289|585673213|FG006|Overall Study|Clinical Deterioration|0|||
162169692|NCT03058289|585673214|FG007|Overall Study|Clinical Deterioration|3|||
162169693|NCT03058289|585673215|FG008|Overall Study|Clinical Deterioration|2|||
162169694|NCT03058289|585673207|FG000|Overall Study|Lost to Follow-up|0|||
162169695|NCT03058289|585673208|FG001|Overall Study|Lost to Follow-up|0|||
162169696|NCT03058289|585673209|FG002|Overall Study|Lost to Follow-up|0|||
162169697|NCT03058289|585673210|FG003|Overall Study|Lost to Follow-up|0|||
162169698|NCT03058289|585673211|FG004|Overall Study|Lost to Follow-up|1|||
162169699|NCT03058289|585673212|FG005|Overall Study|Lost to Follow-up|0|||
162169700|NCT03058289|585673213|FG006|Overall Study|Lost to Follow-up|0|||
162169701|NCT03058289|585673214|FG007|Overall Study|Lost to Follow-up|0|||
162169702|NCT03058289|585673215|FG008|Overall Study|Lost to Follow-up|0|||
162169703|NCT03058289|585673207|FG000|Overall Study|Refused Further Treatment|0|||
162169704|NCT03058289|585673208|FG001|Overall Study|Refused Further Treatment|0|||
162169705|NCT03058289|585673209|FG002|Overall Study|Refused Further Treatment|1|||
162169706|NCT03058289|585673210|FG003|Overall Study|Refused Further Treatment|0|||
162169707|NCT03058289|585673211|FG004|Overall Study|Refused Further Treatment|1|||
162169708|NCT03058289|585673212|FG005|Overall Study|Refused Further Treatment|0|||
162169709|NCT03058289|585673213|FG006|Overall Study|Refused Further Treatment|0|||
162169710|NCT03058289|585673214|FG007|Overall Study|Refused Further Treatment|0|||
162169711|NCT03058289|585673215|FG008|Overall Study|Refused Further Treatment|0|||
162169712|NCT03058289|585673207|FG000|Overall Study|Rapid Progression of Disease|0|||
162169713|NCT03058289|585673208|FG001|Overall Study|Rapid Progression of Disease|0|||
162169714|NCT03058289|585673209|FG002|Overall Study|Rapid Progression of Disease|0|||
162169715|NCT03058289|585673210|FG003|Overall Study|Rapid Progression of Disease|1|||
162169716|NCT03058289|585673211|FG004|Overall Study|Rapid Progression of Disease|0|||
162169717|NCT03058289|585673212|FG005|Overall Study|Rapid Progression of Disease|0|||
162169718|NCT03058289|585673213|FG006|Overall Study|Rapid Progression of Disease|0|||
162169719|NCT03058289|585673214|FG007|Overall Study|Rapid Progression of Disease|0|||
162169720|NCT03058289|585673215|FG008|Overall Study|Rapid Progression of Disease|0|||
162169721|NCT04049643|585673219|FG000|Overall Study|Lack of Efficacy|1|||
162169722|NCT04049643|585673220|FG001|Overall Study|Lack of Efficacy|1|||
162169723|NCT04049643|585673221|FG002|Overall Study|Lack of Efficacy|0|||
162169724|NCT04049643|585673219|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
162169725|NCT04049643|585673220|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
162169726|NCT04049643|585673221|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
162169727|NCT05623228|585673222|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
162169728|NCT05623228|585673223|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162169729|NCT05623228|585673224|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162169730|NCT05623228|585673225|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162169731|NCT05623228|585673226|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162169732|NCT05623228|585673227|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162169733|NCT05623228|585673228|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162169734|NCT05623228|585673229|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
162169735|NCT05623228|585673222|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
162169736|NCT05623228|585673223|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
162169737|NCT05623228|585673224|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
162169738|NCT05623228|585673225|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
162169739|NCT05623228|585673226|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
162169740|NCT05623228|585673227|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
162169741|NCT05623228|585673228|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
162169742|NCT05623228|585673229|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
162169743|NCT03023410|585676148|FG000|Overall Study|study termination|0|||
162169744|NCT03023410|585676149|FG001|Overall Study|study termination|1|||
162169745|NCT04799899|585676150|FG000|Overall Study|Lost to Follow-up|2|||
162169746|NCT04799899|585676151|FG001|Overall Study|Lost to Follow-up|4|||
162169747|NCT04987320|585676156|FG000|Overall Study|Withdrawal by Subject|0|||
162169748|NCT04987320|585676157|FG001|Overall Study|Withdrawal by Subject|1|||
162169749|NCT00085735|585676158|FG000|Overall Study|Adverse Event|1|||
162169750|NCT00085735|585676159|FG001|Overall Study|Adverse Event|0|||
162169751|NCT00085735|585676160|FG002|Overall Study|Adverse Event|0|||
162169752|NCT00085735|585676161|FG003|Overall Study|Adverse Event|0|||
162169753|NCT00085735|585676162|FG004|Overall Study|Adverse Event|0|||
162169754|NCT00085735|585676163|FG005|Overall Study|Adverse Event|0|||
162169755|NCT00085735|585676158|FG000|Overall Study|Lack of Efficacy|2|||
162169756|NCT00085735|585676159|FG001|Overall Study|Lack of Efficacy|4|||
162169757|NCT00085735|585676160|FG002|Overall Study|Lack of Efficacy|6|||
162169758|NCT00085735|585676161|FG003|Overall Study|Lack of Efficacy|3|||
162169759|NCT00085735|585676162|FG004|Overall Study|Lack of Efficacy|4|||
162169760|NCT00085735|585676163|FG005|Overall Study|Lack of Efficacy|3|||
162169761|NCT00085735|585676158|FG000|Overall Study|Lost to Follow-up|0|||
162169762|NCT00085735|585676159|FG001|Overall Study|Lost to Follow-up|1|||
162169763|NCT00085735|585676160|FG002|Overall Study|Lost to Follow-up|0|||
162169764|NCT00085735|585676161|FG003|Overall Study|Lost to Follow-up|0|||
162169765|NCT00085735|585676162|FG004|Overall Study|Lost to Follow-up|1|||
162169766|NCT00085735|585676163|FG005|Overall Study|Lost to Follow-up|0|||
162169767|NCT00085735|585676158|FG000|Overall Study|Physician Decision|2|||
162169768|NCT00085735|585676159|FG001|Overall Study|Physician Decision|3|||
162169769|NCT00085735|585676160|FG002|Overall Study|Physician Decision|2|||
162169770|NCT00085735|585676161|FG003|Overall Study|Physician Decision|3|||
162169771|NCT00085735|585676162|FG004|Overall Study|Physician Decision|11|||
162169772|NCT00085735|585676163|FG005|Overall Study|Physician Decision|8|||
162169773|NCT00085735|585676158|FG000|Overall Study|Protocol Violation|1|||
162169774|NCT00085735|585676159|FG001|Overall Study|Protocol Violation|0|||
162169775|NCT00085735|585676160|FG002|Overall Study|Protocol Violation|0|||
162169776|NCT00085735|585676161|FG003|Overall Study|Protocol Violation|0|||
162169777|NCT00085735|585676162|FG004|Overall Study|Protocol Violation|0|||
162169778|NCT00085735|585676163|FG005|Overall Study|Protocol Violation|0|||
162169779|NCT00085735|585676158|FG000|Overall Study|Withdrawal by Subject|1|||
162169780|NCT00085735|585676159|FG001|Overall Study|Withdrawal by Subject|0|||
162169781|NCT00085735|585676160|FG002|Overall Study|Withdrawal by Subject|4|||
162169782|NCT00085735|585676161|FG003|Overall Study|Withdrawal by Subject|5|||
162169783|NCT00085735|585676162|FG004|Overall Study|Withdrawal by Subject|7|||
162169784|NCT00085735|585676163|FG005|Overall Study|Withdrawal by Subject|8|||
162169785|NCT00085735|585676158|FG000|Overall Study|Patient ineligible|1|||
162169786|NCT00085735|585676159|FG001|Overall Study|Patient ineligible|0|||
162169787|NCT00085735|585676160|FG002|Overall Study|Patient ineligible|3|||
162169788|NCT00085735|585676161|FG003|Overall Study|Patient ineligible|7|||
162169789|NCT00085735|585676162|FG004|Overall Study|Patient ineligible|17|||
162169790|NCT00085735|585676163|FG005|Overall Study|Patient ineligible|8|||
162169791|NCT00085735|585676158|FG000|Overall Study|Excess residual disease|2|||
162169792|NCT00085735|585676159|FG001|Overall Study|Excess residual disease|2|||
162169793|NCT00085735|585676160|FG002|Overall Study|Excess residual disease|1|||
162169794|NCT00085735|585676161|FG003|Overall Study|Excess residual disease|1|||
162169795|NCT00085735|585676162|FG004|Overall Study|Excess residual disease|1|||
162169796|NCT00085735|585676163|FG005|Overall Study|Excess residual disease|4|||
162169797|NCT00085735|585676158|FG000|Overall Study|Reason not documented|1|||
162169798|NCT00085735|585676159|FG001|Overall Study|Reason not documented|0|||
162169799|NCT00085735|585676160|FG002|Overall Study|Reason not documented|1|||
162169800|NCT00085735|585676161|FG003|Overall Study|Reason not documented|0|||
162169801|NCT00085735|585676162|FG004|Overall Study|Reason not documented|1|||
162169802|NCT00085735|585676163|FG005|Overall Study|Reason not documented|0|||
162169803|NCT00085735|585676158|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
162169804|NCT00085735|585676159|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
162169805|NCT00085735|585676160|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
162169806|NCT00085735|585676161|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
162169807|NCT00085735|585676162|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
162169808|NCT00085735|585676163|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
162169809|NCT01824875|585676164|FG000|Overall Study|Disease progression|22|||
162169810|NCT01824875|585676165|FG001|Overall Study|Disease progression|15|||
162169811|NCT01824875|585676164|FG000|Overall Study|Withdrawal by Subject|5|||
162169812|NCT01824875|585676165|FG001|Overall Study|Withdrawal by Subject|4|||
162169813|NCT01824875|585676164|FG000|Overall Study|Adverse Event|4|||
162169814|NCT01824875|585676165|FG001|Overall Study|Adverse Event|10|||
162169815|NCT01824875|585676164|FG000|Overall Study|Alternative therapy|3|||
162169816|NCT01824875|585676165|FG001|Overall Study|Alternative therapy|0|||
162169817|NCT01824875|585676164|FG000|Overall Study|Complicating disease|1|||
162169818|NCT01824875|585676165|FG001|Overall Study|Complicating disease|0|||
162017547|NCT02260180|585119656|FG002|Overall Study|Adverse Event|1|||
162169819|NCT01824875|585676164|FG000|Overall Study|Physician Decision|0|||
162169820|NCT01824875|585676165|FG001|Overall Study|Physician Decision|1|||
162169821|NCT01824875|585676164|FG000|Overall Study|Non-compliance|1|||
162169822|NCT01824875|585676165|FG001|Overall Study|Non-compliance|1|||
162169823|NCT01824875|585676164|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
162169824|NCT01824875|585676165|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
162169825|NCT01824875|585676164|FG000|Overall Study|Administrative issues|0|||
162169826|NCT01824875|585676165|FG001|Overall Study|Administrative issues|2|||
162169827|NCT01824875|585676164|FG000|Overall Study|Ineligible or never started treatment|9|||
161816553|NCT00112437|584368828|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161816554|NCT00112437|584368829|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
162017548|NCT00943072|585119659|FG000|Overall Study|Adverse Event|0|||
162017549|NCT00943072|585119660|FG001|Overall Study|Adverse Event|3|||
162017550|NCT00943072|585119659|FG000|Overall Study|Death|0|||
162017551|NCT00943072|585119660|FG001|Overall Study|Death|2|||
162017552|NCT00943072|585119659|FG000|Overall Study|Withdrawal by Subject|3|||
162017553|NCT00943072|585119660|FG001|Overall Study|Withdrawal by Subject|1|||
162017554|NCT00943072|585119659|FG000|Overall Study|Protocol Violation|0|||
162017555|NCT00943072|585119660|FG001|Overall Study|Protocol Violation|1|||
162017556|NCT00943072|585119659|FG000|Overall Study|Lost to Follow-up|1|||
162017557|NCT00943072|585119660|FG001|Overall Study|Lost to Follow-up|2|||
162017558|NCT00943072|585119659|FG000|Overall Study|Lack of Efficacy|0|||
162017559|NCT00943072|585119660|FG001|Overall Study|Lack of Efficacy|4|||
162017560|NCT00943072|585119659|FG000|Overall Study|Other|1|||
162017561|NCT00943072|585119660|FG001|Overall Study|Other|1|||
162017562|NCT01193257|585119664|FG000|Overall Study|Death|202|||
162017563|NCT01193257|585119665|FG001|Overall Study|Death|391|||
162017564|NCT01193257|585119664|FG000|Overall Study|Study termination by sponsor|0|||
162017565|NCT01193257|585119665|FG001|Overall Study|Study termination by sponsor|3|||
162017566|NCT01193257|585119664|FG000|Overall Study|Withdrawal by Subject|26|||
162017567|NCT01193257|585119665|FG001|Overall Study|Withdrawal by Subject|86|||
162017568|NCT01193257|585119664|FG000|Overall Study|Lost to Follow-up|2|||
162017569|NCT01193257|585119665|FG001|Overall Study|Lost to Follow-up|3|||
162017570|NCT01193257|585119664|FG000|Overall Study|Unblinded due to futility|135|||
162017571|NCT01193257|585119665|FG001|Overall Study|Unblinded due to futility|251|||
162017572|NCT01330108|585119671|FG000|Overall Study|Withdrawal by Subject|4|||
162017573|NCT00423917|585119674|FG000|Overall Study|Cancel|2|||
162017574|NCT00423917|585119674|FG000|Overall Study|Ineligible|1|||
162017575|NCT00555061|585119675|FG000|Overall Study|Adverse Event|3|||
162017576|NCT00555061|585119675|FG000|Overall Study|Protocol Violation|1|||
162017577|NCT00555061|585119675|FG000|Overall Study|Lost to Follow-up|2|||
162017578|NCT00555061|585119675|FG000|Overall Study|Withdrawal by Subject|2|||
162017579|NCT00555061|585119675|FG000|Overall Study|Participant enrolled, but never treated|1|||
162017580|NCT01175083|585119676|FG000|Primary Epoch|Withdrawal by Subject|0|||
162017581|NCT01175083|585119677|FG001|Primary Epoch|Withdrawal by Subject|0|||
162017582|NCT01175083|585119678|FG002|Primary Epoch|Withdrawal by Subject|0|||
162017583|NCT01175083|585119679|FG003|Primary Epoch|Withdrawal by Subject|0|||
162017584|NCT01175083|585119680|FG004|Primary Epoch|Withdrawal by Subject|0|||
162017585|NCT01175083|585119681|FG005|Primary Epoch|Withdrawal by Subject|2|||
162017586|NCT01175083|585119676|FG000|Primary Epoch|Lost to Follow-up|0|||
162017587|NCT01175083|585119677|FG001|Primary Epoch|Lost to Follow-up|0|||
162017588|NCT01175083|585119678|FG002|Primary Epoch|Lost to Follow-up|0|||
162017589|NCT01175083|585119679|FG003|Primary Epoch|Lost to Follow-up|0|||
162017590|NCT01175083|585119680|FG004|Primary Epoch|Lost to Follow-up|0|||
162017591|NCT01175083|585119681|FG005|Primary Epoch|Lost to Follow-up|1|||
162017592|NCT01175083|585119676|FG000|Booster Epoch|Death|0|||
162017593|NCT01175083|585119677|FG001|Booster Epoch|Death|0|||
162017594|NCT01175083|585119678|FG002|Booster Epoch|Death|1|||
162017595|NCT01175083|585119679|FG003|Booster Epoch|Death|0|||
162017596|NCT01175083|585119680|FG004|Booster Epoch|Death|0|||
162017597|NCT01175083|585119681|FG005|Booster Epoch|Death|0|||
162017598|NCT01175083|585119676|FG000|Booster Epoch|Withdrawal by Subject|0|||
162017599|NCT01175083|585119677|FG001|Booster Epoch|Withdrawal by Subject|0|||
162017600|NCT01175083|585119678|FG002|Booster Epoch|Withdrawal by Subject|0|||
162017601|NCT01175083|585119679|FG003|Booster Epoch|Withdrawal by Subject|1|||
161816555|NCT00112437|584368804|FG000|Years 6-10 (60-Month Extension)|Death|0|||
162017602|NCT01175083|585119680|FG004|Booster Epoch|Withdrawal by Subject|0|||
162017603|NCT01175083|585119681|FG005|Booster Epoch|Withdrawal by Subject|0|||
162017604|NCT02881567|585119682|FG000|Overall Study|Adverse Event|1|||
162017605|NCT02881567|585119682|FG000|Overall Study|Lost to Follow-up|3|||
162017606|NCT02881567|585119682|FG000|Overall Study|Consent withdrawn|1|||
162017607|NCT02881567|585119682|FG000|Overall Study|Investigator decision|1|||
162017608|NCT02881567|585119682|FG000|Overall Study|Study terminated by sponsor|9|||
162017609|NCT02881567|585119682|FG000|Overall Study|Reason not Specified|3|||
162017610|NCT00373113|585119684|FG000|Overall Study|Death|1|||
162017611|NCT00373113|585119685|FG001|Overall Study|Death|7|||
162017612|NCT00373113|585119684|FG000|Overall Study|Adverse Event|38|||
162017613|NCT00373113|585119685|FG001|Overall Study|Adverse Event|24|||
162017614|NCT00373113|585119684|FG000|Overall Study|Study terminated by sponsor|9|||
162017615|NCT00373113|585119685|FG001|Overall Study|Study terminated by sponsor|1|||
161921502|NCT02916771|584757237|FG000|Overall Study|Began treatment for another active malignancy|1|||
161921503|NCT00479232|584758121|FG000|Overall Study|Adverse Event|0|||
161921504|NCT00479232|584758122|FG001|Overall Study|Adverse Event|0|||
161921505|NCT00479232|584758123|FG002|Overall Study|Adverse Event|5|||
162169828|NCT01824875|585676165|FG001|Overall Study|Ineligible or never started treatment|5|||
161921506|NCT00479232|584758124|FG003|Overall Study|Adverse Event|0|||
161921507|NCT00479232|584758125|FG004|Overall Study|Adverse Event|0|||
161921508|NCT00479232|584758126|FG005|Overall Study|Adverse Event|10|||
161921509|NCT00479232|584758121|FG000|Overall Study|Deviation from Protocol|0|||
161921510|NCT00479232|584758122|FG001|Overall Study|Deviation from Protocol|0|||
161921511|NCT00479232|584758123|FG002|Overall Study|Deviation from Protocol|1|||
161921512|NCT00479232|584758124|FG003|Overall Study|Deviation from Protocol|0|||
161921513|NCT00479232|584758125|FG004|Overall Study|Deviation from Protocol|0|||
161921514|NCT00479232|584758126|FG005|Overall Study|Deviation from Protocol|0|||
161921515|NCT00479232|584758121|FG000|Overall Study|Lack of Efficacy|0|||
161921516|NCT00479232|584758122|FG001|Overall Study|Lack of Efficacy|0|||
161921517|NCT00479232|584758123|FG002|Overall Study|Lack of Efficacy|2|||
161921518|NCT00479232|584758124|FG003|Overall Study|Lack of Efficacy|0|||
161921519|NCT00479232|584758125|FG004|Overall Study|Lack of Efficacy|0|||
161921520|NCT00479232|584758126|FG005|Overall Study|Lack of Efficacy|4|||
161921521|NCT00479232|584758121|FG000|Overall Study|Physician Decision|0|||
161921522|NCT00479232|584758122|FG001|Overall Study|Physician Decision|0|||
161921523|NCT00479232|584758123|FG002|Overall Study|Physician Decision|2|||
161921524|NCT00479232|584758124|FG003|Overall Study|Physician Decision|0|||
161921525|NCT00479232|584758125|FG004|Overall Study|Physician Decision|0|||
161921526|NCT00479232|584758126|FG005|Overall Study|Physician Decision|1|||
161921527|NCT00479232|584758121|FG000|Overall Study|Progressive Disease|3|||
161921528|NCT00479232|584758122|FG001|Overall Study|Progressive Disease|1|||
161921529|NCT00479232|584758123|FG002|Overall Study|Progressive Disease|12|||
161921530|NCT00479232|584758124|FG003|Overall Study|Progressive Disease|3|||
161921531|NCT00479232|584758125|FG004|Overall Study|Progressive Disease|3|||
161921532|NCT00479232|584758126|FG005|Overall Study|Progressive Disease|12|||
161921533|NCT00479232|584758121|FG000|Overall Study|Withdrew Consent|0|||
161921534|NCT00479232|584758122|FG001|Overall Study|Withdrew Consent|2|||
161921535|NCT00479232|584758123|FG002|Overall Study|Withdrew Consent|6|||
161921536|NCT00479232|584758124|FG003|Overall Study|Withdrew Consent|0|||
161921537|NCT00479232|584758125|FG004|Overall Study|Withdrew Consent|1|||
161921538|NCT00479232|584758126|FG005|Overall Study|Withdrew Consent|3|||
161921539|NCT02260986|584758127|FG000|Overall Study|Adverse Event|24|||
161921540|NCT02260986|584758128|FG001|Overall Study|Adverse Event|0|||
161921541|NCT02260986|584758129|FG002|Overall Study|Adverse Event|11|||
161921542|NCT02260986|584758127|FG000|Overall Study|Lack of Efficacy|27|||
161921543|NCT02260986|584758128|FG001|Overall Study|Lack of Efficacy|3|||
161921544|NCT02260986|584758129|FG002|Overall Study|Lack of Efficacy|0|||
161921545|NCT02260986|584758127|FG000|Overall Study|Protocol Violation|14|||
161921546|NCT02260986|584758128|FG001|Overall Study|Protocol Violation|5|||
161921547|NCT02260986|584758129|FG002|Overall Study|Protocol Violation|16|||
161921548|NCT02260986|584758127|FG000|Overall Study|Car accident|0|||
161921549|NCT02260986|584758128|FG001|Overall Study|Car accident|0|||
161921550|NCT02260986|584758129|FG002|Overall Study|Car accident|1|||
161921551|NCT02260986|584758127|FG000|Overall Study|Withdrawal by Subject|17|||
161921552|NCT02260986|584758128|FG001|Overall Study|Withdrawal by Subject|4|||
161921553|NCT02260986|584758129|FG002|Overall Study|Withdrawal by Subject|9|||
161921554|NCT02260986|584758127|FG000|Overall Study|Incorrect randomization|0|||
161921555|NCT02260986|584758128|FG001|Overall Study|Incorrect randomization|1|||
161921556|NCT02260986|584758129|FG002|Overall Study|Incorrect randomization|0|||
161921557|NCT02260986|584758127|FG000|Overall Study|Lack of investigation product supply|2|||
161921558|NCT02260986|584758128|FG001|Overall Study|Lack of investigation product supply|0|||
161921559|NCT02260986|584758129|FG002|Overall Study|Lack of investigation product supply|1|||
161921560|NCT02260986|584758127|FG000|Overall Study|Lost to Follow-up|4|||
161921561|NCT02260986|584758128|FG001|Overall Study|Lost to Follow-up|0|||
161921562|NCT02260986|584758129|FG002|Overall Study|Lost to Follow-up|3|||
161921563|NCT02260986|584758127|FG000|Overall Study|Pregnancy|2|||
162169829|NCT01824875|585676164|FG000|Overall Study|Other|0|||
161921564|NCT02260986|584758128|FG001|Overall Study|Pregnancy|0|||
161921565|NCT02260986|584758129|FG002|Overall Study|Pregnancy|0|||
161921566|NCT02536794|584758131|FG000|Reached 1st Response Assessment|Adverse Event|2|||
161921567|NCT02536794|584758131|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
161921568|NCT02536794|584758131|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
161921569|NCT02536794|584758131|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
161921570|NCT02536794|584758131|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
161921571|NCT02536794|584758131|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
161921572|NCT00313170|584758132|FG000|Overall Study|Death|2|||
161921573|NCT00313170|584758133|FG001|Overall Study|Death|4|||
161921574|NCT00313170|584758134|FG002|Overall Study|Death|2|||
161921575|NCT00313170|584758132|FG000|Overall Study|Adverse Event|1|||
161921576|NCT00313170|584758133|FG001|Overall Study|Adverse Event|2|||
161921577|NCT00313170|584758134|FG002|Overall Study|Adverse Event|0|||
162169830|NCT01824875|585676165|FG001|Overall Study|Other|2|||
162169831|NCT00433329|585676168|FG000|Overall Study|Adverse Event|9|||
162169832|NCT00433329|585676168|FG000|Overall Study|Death|4|||
162169833|NCT00433329|585676168|FG000|Overall Study|Withdrew consent|3|||
162169834|NCT00433329|585676168|FG000|Overall Study|Discontinued sildenafil|2|||
162169835|NCT00433329|585676168|FG000|Overall Study|Moved out of state|1|||
162169836|NCT00433329|585676168|FG000|Overall Study|Lost to Follow-up|1|||
162169837|NCT00433329|585676168|FG000|Overall Study|Physician Decision|1|||
162169838|NCT04195698|585676169|FG000|Overall Study|Adverse Event|4|||
162169839|NCT04195698|585676170|FG001|Overall Study|Adverse Event|11|||
162169840|NCT04195698|585676169|FG000|Overall Study|Withdrawal by Subject|9|||
162169841|NCT04195698|585676170|FG001|Overall Study|Withdrawal by Subject|10|||
162169842|NCT04195698|585676169|FG000|Overall Study|Lost to Follow-up|5|||
162169843|NCT04195698|585676170|FG001|Overall Study|Lost to Follow-up|4|||
162169844|NCT04195698|585676169|FG000|Overall Study|Lack of Efficacy|2|||
162169845|NCT04195698|585676170|FG001|Overall Study|Lack of Efficacy|10|||
162169846|NCT04195698|585676169|FG000|Overall Study|Other|5|||
162169847|NCT04195698|585676170|FG001|Overall Study|Other|4|||
162169848|NCT05459688|585676171|FG000|Overall Study|Lost to Follow-up|6|||
162169849|NCT05459688|585676171|FG000|Overall Study|Physician Decision|1|||
162169850|NCT05459688|585676171|FG000|Overall Study|Withdrawal by Subject|19|||
162169851|NCT05459688|585676171|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
162169852|NCT01129102|585676172|FG000|Overall Study|No study drug treatment|2|||
162169853|NCT01129102|585676173|FG001|Overall Study|No study drug treatment|3|||
162169854|NCT01129102|585676174|FG002|Overall Study|No study drug treatment|1|||
162169855|NCT01129102|585676172|FG000|Overall Study|Withdrawal by Subject|2|||
162169856|NCT01129102|585676173|FG001|Overall Study|Withdrawal by Subject|0|||
162169857|NCT01129102|585676174|FG002|Overall Study|Withdrawal by Subject|3|||
162169858|NCT01129102|585676172|FG000|Overall Study|Protocol Violation|0|||
162169859|NCT01129102|585676173|FG001|Overall Study|Protocol Violation|1|||
162169860|NCT01129102|585676174|FG002|Overall Study|Protocol Violation|1|||
162169861|NCT01129102|585676172|FG000|Overall Study|Pregnancy|0|||
162169862|NCT01129102|585676173|FG001|Overall Study|Pregnancy|0|||
162169863|NCT01129102|585676174|FG002|Overall Study|Pregnancy|1|||
162169864|NCT01129102|585676172|FG000|Overall Study|Adverse Event|2|||
162169865|NCT01129102|585676173|FG001|Overall Study|Adverse Event|2|||
162169866|NCT01129102|585676174|FG002|Overall Study|Adverse Event|1|||
162169867|NCT01129102|585676172|FG000|Overall Study|Lost to Follow-up|2|||
162169868|NCT01129102|585676173|FG001|Overall Study|Lost to Follow-up|0|||
161669904|NCT02121834|583843178|FG001|Overall Study|Withdrawal by Subject|1|||
161669905|NCT02121834|583843179|FG002|Overall Study|Withdrawal by Subject|1|||
161669906|NCT02121834|583843180|FG003|Overall Study|Withdrawal by Subject|0|||
161921578|NCT00313170|584758132|FG000|Overall Study|Disease progression|31|||
161921579|NCT00313170|584758133|FG001|Overall Study|Disease progression|26|||
162169869|NCT01129102|585676174|FG002|Overall Study|Lost to Follow-up|0|||
162169870|NCT03379675|585676177|FG000|Overall Study|Lost to Follow-up|0|||
162169871|NCT03379675|585676178|FG001|Overall Study|Lost to Follow-up|1|||
162169872|NCT03379675|585676179|FG002|Overall Study|Lost to Follow-up|0|||
162169873|NCT03379675|585676177|FG000|Overall Study|Adverse Event|2|||
162169874|NCT03379675|585676178|FG001|Overall Study|Adverse Event|0|||
162169875|NCT03379675|585676179|FG002|Overall Study|Adverse Event|0|||
162169876|NCT03379675|585676177|FG000|Overall Study|Withdrawal by Subject|2|||
161816556|NCT00112437|584368805|FG001|Years 6-10 (60-Month Extension)|Death|0|||
161816557|NCT00112437|584368806|FG002|Years 6-10 (60-Month Extension)|Death|0|||
161816558|NCT00112437|584368807|FG003|Years 6-10 (60-Month Extension)|Death|0|||
161816559|NCT00112437|584368808|FG004|Years 6-10 (60-Month Extension)|Death|0|||
161816560|NCT00112437|584368809|FG005|Years 6-10 (60-Month Extension)|Death|0|||
161816561|NCT00112437|584368810|FG006|Years 6-10 (60-Month Extension)|Death|0|||
161816562|NCT00112437|584368811|FG007|Years 6-10 (60-Month Extension)|Death|0|||
161816563|NCT00112437|584368812|FG008|Years 6-10 (60-Month Extension)|Death|0|||
161816564|NCT00112437|584368813|FG009|Years 6-10 (60-Month Extension)|Death|0|||
161816565|NCT00112437|584368814|FG010|Years 6-10 (60-Month Extension)|Death|0|||
161921580|NCT00313170|584758134|FG002|Overall Study|Disease progression|27|||
161921581|NCT00313170|584758132|FG000|Overall Study|Withdrawal by Subject|1|||
161921582|NCT00313170|584758133|FG001|Overall Study|Withdrawal by Subject|0|||
161921583|NCT00313170|584758134|FG002|Overall Study|Withdrawal by Subject|1|||
161921584|NCT00313170|584758132|FG000|Overall Study|Incorrect enrollment|0|||
161921585|NCT00313170|584758133|FG001|Overall Study|Incorrect enrollment|2|||
161921586|NCT00313170|584758134|FG002|Overall Study|Incorrect enrollment|1|||
161921587|NCT00313170|584758132|FG000|Overall Study|Lost to Follow-up|0|||
161921588|NCT00313170|584758133|FG001|Overall Study|Lost to Follow-up|0|||
161921589|NCT00313170|584758134|FG002|Overall Study|Lost to Follow-up|1|||
161921590|NCT00313170|584758132|FG000|Overall Study|Progression (investigators opinion)|1|||
161921591|NCT00313170|584758133|FG001|Overall Study|Progression (investigators opinion)|0|||
161921592|NCT00313170|584758134|FG002|Overall Study|Progression (investigators opinion)|0|||
161921593|NCT01521364|584758140|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
161921594|NCT01521364|584758140|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
161921595|NCT02447029|584758144|FG000|Overall Study|Withdrawal by Subject|3|||
161921596|NCT02447029|584758145|FG001|Overall Study|Withdrawal by Subject|2|||
161921597|NCT04132050|584758151|FG000|Period I (Double-blind Period)|Adverse Event|3|||
161921598|NCT04132050|584758152|FG001|Period I (Double-blind Period)|Adverse Event|0|||
161921599|NCT04132050|584758151|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
161921600|NCT04132050|584758152|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
161921601|NCT04132050|584758151|FG000|R788 Treatment Period|Adverse Event|5|||
161921602|NCT04132050|584758152|FG001|R788 Treatment Period|Adverse Event|0|||
161921603|NCT04132050|584758151|FG000|R788 Treatment Period|Lack of Efficacy|5|||
161921604|NCT04132050|584758152|FG001|R788 Treatment Period|Lack of Efficacy|0|||
162169877|NCT03379675|585676178|FG001|Overall Study|Withdrawal by Subject|1|||
162169878|NCT03379675|585676179|FG002|Overall Study|Withdrawal by Subject|2|||
162169879|NCT02817776|585676180|FG000|Overall Study|Excluded|33|||
162169880|NCT02817776|585676180|FG000|Overall Study|Lost to Follow-up|20|||
162169881|NCT02817776|585676180|FG000|Overall Study|Withdrawal by Subject|33|||
162169882|NCT02817776|585676180|FG000|Overall Study|Death|2|||
162169883|NCT02489903|585676185|FG000|Screening|Screen Failure|24|||
162169884|NCT02489903|585676186|FG001|Screening|Screen Failure|0|||
162169885|NCT02489903|585676187|FG002|Screening|Screen Failure|0|||
161921605|NCT04132050|584758151|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
161921606|NCT04132050|584758152|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
161921607|NCT02406612|584758163|FG000|Overall Study|Screening Failure|3|||
161921608|NCT02406612|584758164|FG001|Overall Study|Screening Failure|0|||
161921609|NCT02406612|584758163|FG000|Overall Study|Intra-procedural Exclusion|1|||
161921610|NCT02406612|584758164|FG001|Overall Study|Intra-procedural Exclusion|3|||
161921611|NCT02406612|584758163|FG000|Overall Study|Guidewire Failure|0|||
161921612|NCT02406612|584758164|FG001|Overall Study|Guidewire Failure|1|||
161921613|NCT03483012|584758168|FG000|Overall Study|Lack of Efficacy|6|||
161921614|NCT02900976|584758169|FG000|Overall Study|Adverse Event|0|||
161921615|NCT02900976|584758170|FG001|Overall Study|Adverse Event|1|||
161921616|NCT02900976|584758169|FG000|Overall Study|Physician Decision|0|||
161921617|NCT02900976|584758170|FG001|Overall Study|Physician Decision|2|||
161921618|NCT02900976|584758169|FG000|Overall Study|Progressive disease|0|||
161921619|NCT02900976|584758170|FG001|Overall Study|Progressive disease|6|||
161921620|NCT03611946|584758177|FG000|Overall Study|Withdrawal by Subject|0|||
161921621|NCT03611946|584758178|FG001|Overall Study|Withdrawal by Subject|0|||
161921622|NCT03611946|584758179|FG002|Overall Study|Withdrawal by Subject|1|||
161921623|NCT03611946|584758180|FG003|Overall Study|Withdrawal by Subject|0|||
161921624|NCT03069989|584758185|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
161921625|NCT03069989|584758186|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
161921626|NCT02872714|584758187|FG000|Overall Study|Progressive Disease|1|||
161921627|NCT02872714|584758188|FG001|Overall Study|Progressive Disease|2|||
161921628|NCT02872714|584758189|FG002|Overall Study|Progressive Disease|0|||
161921629|NCT02872714|584758190|FG003|Overall Study|Progressive Disease|0|||
161921630|NCT02872714|584758191|FG004|Overall Study|Progressive Disease|0|||
161921631|NCT02872714|584758187|FG000|Overall Study|Death|87|||
161921632|NCT02872714|584758188|FG001|Overall Study|Death|36|||
161921633|NCT02872714|584758189|FG002|Overall Study|Death|8|||
161921634|NCT02872714|584758190|FG003|Overall Study|Death|81|||
161921635|NCT02872714|584758191|FG004|Overall Study|Death|2|||
161921636|NCT02872714|584758187|FG000|Overall Study|Lost to Follow-up|2|||
161921637|NCT02872714|584758188|FG001|Overall Study|Lost to Follow-up|1|||
161921638|NCT02872714|584758189|FG002|Overall Study|Lost to Follow-up|0|||
161921639|NCT02872714|584758190|FG003|Overall Study|Lost to Follow-up|3|||
161921640|NCT02872714|584758191|FG004|Overall Study|Lost to Follow-up|0|||
161921641|NCT02872714|584758187|FG000|Overall Study|Physician Decision|0|||
161921642|NCT02872714|584758188|FG001|Overall Study|Physician Decision|0|||
161921643|NCT02872714|584758189|FG002|Overall Study|Physician Decision|0|||
161921644|NCT02872714|584758190|FG003|Overall Study|Physician Decision|1|||
161921645|NCT02872714|584758191|FG004|Overall Study|Physician Decision|0|||
161921646|NCT02872714|584758187|FG000|Overall Study|Withdrawal by Subject|1|||
161921647|NCT02872714|584758188|FG001|Overall Study|Withdrawal by Subject|3|||
162017616|NCT00373113|585119684|FG000|Overall Study|Global deterioration of health status|10|||
162169886|NCT02489903|585676188|FG003|Screening|Screen Failure|8|||
162169887|NCT02489903|585676185|FG000|Randomized and Received Treatment|Protocol Violation|0|||
161921648|NCT02872714|584758189|FG002|Overall Study|Withdrawal by Subject|0|||
161921649|NCT02872714|584758190|FG003|Overall Study|Withdrawal by Subject|2|||
161921650|NCT02872714|584758191|FG004|Overall Study|Withdrawal by Subject|0|||
161921651|NCT02872714|584758187|FG000|Overall Study|Captured as Other|2|||
161921652|NCT02872714|584758188|FG001|Overall Study|Captured as Other|0|||
161921653|NCT02872714|584758189|FG002|Overall Study|Captured as Other|0|||
161921654|NCT02872714|584758190|FG003|Overall Study|Captured as Other|1|||
161921655|NCT02872714|584758191|FG004|Overall Study|Captured as Other|0|||
161921656|NCT06717399|584758192|FG000|Overall Study|Death|1|||
161921657|NCT03043573|584758195|FG000|Overall Study|Lost to Follow-up|3|||
161921658|NCT03043573|584758196|FG001|Overall Study|Lost to Follow-up|3|||
161921659|NCT03043573|584758195|FG000|Overall Study|Physician Decision|0|||
162169888|NCT02489903|585676186|FG001|Randomized and Received Treatment|Protocol Violation|1|||
162169889|NCT02489903|585676187|FG002|Randomized and Received Treatment|Protocol Violation|0|||
162169890|NCT02489903|585676188|FG003|Randomized and Received Treatment|Protocol Violation|0|||
162169891|NCT02489903|585676185|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
162169892|NCT02489903|585676186|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
162169893|NCT02489903|585676187|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
162169894|NCT02489903|585676188|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
162169895|NCT02489903|585676185|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
162169896|NCT02489903|585676186|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
162169897|NCT02489903|585676187|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
162169898|NCT02489903|585676188|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
162169899|NCT02489903|585676185|FG000|Randomized and Received Treatment|Death|10|||
162169900|NCT02489903|585676186|FG001|Randomized and Received Treatment|Death|1|||
162169901|NCT02489903|585676187|FG002|Randomized and Received Treatment|Death|0|||
162169902|NCT02489903|585676188|FG003|Randomized and Received Treatment|Death|0|||
161921660|NCT03043573|584758196|FG001|Overall Study|Physician Decision|5|||
162169903|NCT04413708|585676189|FG000|Overall Study|Lost to Follow-up|1|||
162169904|NCT04413708|585676190|FG001|Overall Study|Lost to Follow-up|2|||
162169905|NCT04948697|585676191|FG000|Overall Study|Progressive disease|27|||
162169906|NCT04948697|585676192|FG001|Overall Study|Progressive disease|18|||
162169907|NCT04948697|585676191|FG000|Overall Study|Adverse Event|14|||
162169908|NCT04948697|585676192|FG001|Overall Study|Adverse Event|4|||
162169909|NCT04948697|585676191|FG000|Overall Study|Participant moved to long term extension study|7|||
162169910|NCT04948697|585676192|FG001|Overall Study|Participant moved to long term extension study|4|||
162169911|NCT04948697|585676191|FG000|Overall Study|Withdrawal by Subject|10|||
162169912|NCT04948697|585676192|FG001|Overall Study|Withdrawal by Subject|0|||
162169913|NCT04948697|585676191|FG000|Overall Study|Closed by Sponsor|3|||
162169914|NCT04948697|585676192|FG001|Overall Study|Closed by Sponsor|2|||
162169915|NCT04948697|585676191|FG000|Overall Study|Physician Decision|0|||
162169916|NCT04948697|585676192|FG001|Overall Study|Physician Decision|2|||
162169917|NCT04948697|585676191|FG000|Overall Study|Lost to Follow-up|0|||
162169918|NCT04948697|585676192|FG001|Overall Study|Lost to Follow-up|1|||
162169919|NCT04948697|585676191|FG000|Overall Study|Other-Miscellaneous|1|||
162169920|NCT04948697|585676192|FG001|Overall Study|Other-Miscellaneous|0|||
162169921|NCT04948697|585676191|FG000|Overall Study|Randomized but not treated|0|||
162169922|NCT04948697|585676192|FG001|Overall Study|Randomized but not treated|1|||
162169923|NCT04599062|585676193|FG000|Overall Study|Physician Decision|1|||
162169924|NCT04599062|585676194|FG001|Overall Study|Physician Decision|0|||
162169925|NCT04032704|585676195|FG000|Part A|Withdrawal by Subject|0|||
162169926|NCT04032704|585676196|FG001|Part A|Withdrawal by Subject|0|||
162169927|NCT04032704|585676197|FG002|Part A|Withdrawal by Subject|3|||
162169928|NCT04032704|585676198|FG003|Part A|Withdrawal by Subject|0|||
162169929|NCT04032704|585676199|FG004|Part A|Withdrawal by Subject|1|||
162169930|NCT04032704|585676200|FG005|Part A|Withdrawal by Subject|7|||
162169931|NCT04032704|585676201|FG006|Part A|Withdrawal by Subject|0|||
162169932|NCT04032704|585676202|FG007|Part A|Withdrawal by Subject|0|||
162169933|NCT04032704|585676203|FG008|Part A|Withdrawal by Subject|0|||
162169934|NCT04032704|585676204|FG009|Part A|Withdrawal by Subject|0|||
162169935|NCT04032704|585676205|FG010|Part A|Withdrawal by Subject|0|||
162169936|NCT04032704|585676206|FG011|Part A|Withdrawal by Subject|0|||
162169937|NCT04032704|585676207|FG012|Part A|Withdrawal by Subject|0|||
162169938|NCT04032704|585676208|FG013|Part A|Withdrawal by Subject|0|||
162169939|NCT04032704|585676209|FG014|Part A|Withdrawal by Subject|0|||
162169940|NCT04032704|585676210|FG015|Part A|Withdrawal by Subject|0|||
162169941|NCT04032704|585676211|FG016|Part A|Withdrawal by Subject|0|||
162169942|NCT04032704|585676212|FG017|Part A|Withdrawal by Subject|0|||
162169943|NCT04032704|585676195|FG000|Part A|Lost to Follow-up|1|||
161921661|NCT03043573|584758195|FG000|Overall Study|Withdrawal by Subject|0|||
162169944|NCT04032704|585676196|FG001|Part A|Lost to Follow-up|0|||
162169945|NCT04032704|585676197|FG002|Part A|Lost to Follow-up|0|||
162169946|NCT04032704|585676198|FG003|Part A|Lost to Follow-up|0|||
162169947|NCT04032704|585676199|FG004|Part A|Lost to Follow-up|0|||
162169948|NCT04032704|585676200|FG005|Part A|Lost to Follow-up|0|||
162169949|NCT04032704|585676201|FG006|Part A|Lost to Follow-up|0|||
162169950|NCT04032704|585676202|FG007|Part A|Lost to Follow-up|0|||
162169951|NCT04032704|585676203|FG008|Part A|Lost to Follow-up|0|||
162169952|NCT04032704|585676204|FG009|Part A|Lost to Follow-up|0|||
162169953|NCT04032704|585676205|FG010|Part A|Lost to Follow-up|0|||
161921662|NCT03043573|584758196|FG001|Overall Study|Withdrawal by Subject|4|||
162169954|NCT04032704|585676206|FG011|Part A|Lost to Follow-up|0|||
162169955|NCT04032704|585676207|FG012|Part A|Lost to Follow-up|0|||
162169956|NCT04032704|585676208|FG013|Part A|Lost to Follow-up|0|||
161921663|NCT03580928|584758197|FG000|Overall Study|Death|0|||
162169957|NCT04032704|585676209|FG014|Part A|Lost to Follow-up|0|||
162169958|NCT04032704|585676210|FG015|Part A|Lost to Follow-up|0|||
162169959|NCT04032704|585676211|FG016|Part A|Lost to Follow-up|0|||
162169960|NCT04032704|585676212|FG017|Part A|Lost to Follow-up|0|||
162169961|NCT04032704|585676195|FG000|Part A|Death|9|||
162169962|NCT04032704|585676196|FG001|Part A|Death|2|||
162169963|NCT04032704|585676197|FG002|Part A|Death|10|||
162169964|NCT04032704|585676198|FG003|Part A|Death|7|||
162169965|NCT04032704|585676199|FG004|Part A|Death|4|||
162169966|NCT04032704|585676200|FG005|Part A|Death|5|||
162169967|NCT04032704|585676201|FG006|Part A|Death|0|||
162169968|NCT04032704|585676202|FG007|Part A|Death|0|||
162169969|NCT04032704|585676203|FG008|Part A|Death|0|||
162169970|NCT04032704|585676204|FG009|Part A|Death|0|||
162169971|NCT04032704|585676205|FG010|Part A|Death|0|||
162169972|NCT04032704|585676206|FG011|Part A|Death|0|||
162169973|NCT04032704|585676207|FG012|Part A|Death|0|||
162169974|NCT04032704|585676208|FG013|Part A|Death|0|||
162169975|NCT04032704|585676209|FG014|Part A|Death|0|||
162169976|NCT04032704|585676210|FG015|Part A|Death|0|||
162169977|NCT04032704|585676211|FG016|Part A|Death|0|||
162169978|NCT04032704|585676212|FG017|Part A|Death|0|||
162169979|NCT04032704|585676195|FG000|Part B|Other|0|||
162169980|NCT04032704|585676196|FG001|Part B|Other|0|||
162169981|NCT04032704|585676197|FG002|Part B|Other|0|||
162169982|NCT04032704|585676198|FG003|Part B|Other|0|||
162169983|NCT04032704|585676199|FG004|Part B|Other|0|||
162169984|NCT04032704|585676200|FG005|Part B|Other|0|||
162169985|NCT04032704|585676201|FG006|Part B|Other|0|||
162169986|NCT04032704|585676202|FG007|Part B|Other|1|||
162169987|NCT04032704|585676203|FG008|Part B|Other|2|||
162169988|NCT04032704|585676204|FG009|Part B|Other|1|||
162169989|NCT04032704|585676205|FG010|Part B|Other|1|||
162169990|NCT04032704|585676206|FG011|Part B|Other|1|||
162169991|NCT04032704|585676207|FG012|Part B|Other|5|||
162169992|NCT04032704|585676208|FG013|Part B|Other|13|||
162169993|NCT04032704|585676209|FG014|Part B|Other|0|||
162169994|NCT04032704|585676210|FG015|Part B|Other|0|||
162169995|NCT04032704|585676211|FG016|Part B|Other|0|||
162169996|NCT04032704|585676212|FG017|Part B|Other|0|||
162169997|NCT04032704|585676195|FG000|Part B|Study termination by Sponsor|0|||
162169998|NCT04032704|585676196|FG001|Part B|Study termination by Sponsor|0|||
162169999|NCT04032704|585676197|FG002|Part B|Study termination by Sponsor|0|||
162170000|NCT04032704|585676198|FG003|Part B|Study termination by Sponsor|0|||
162170001|NCT04032704|585676199|FG004|Part B|Study termination by Sponsor|0|||
162170002|NCT04032704|585676200|FG005|Part B|Study termination by Sponsor|0|||
162170003|NCT04032704|585676201|FG006|Part B|Study termination by Sponsor|0|||
162170004|NCT04032704|585676202|FG007|Part B|Study termination by Sponsor|0|||
162170005|NCT04032704|585676203|FG008|Part B|Study termination by Sponsor|1|||
162170006|NCT04032704|585676204|FG009|Part B|Study termination by Sponsor|0|||
162170007|NCT04032704|585676205|FG010|Part B|Study termination by Sponsor|0|||
162170008|NCT04032704|585676206|FG011|Part B|Study termination by Sponsor|0|||
162170009|NCT04032704|585676207|FG012|Part B|Study termination by Sponsor|0|||
162170010|NCT04032704|585676208|FG013|Part B|Study termination by Sponsor|0|||
162170011|NCT04032704|585676209|FG014|Part B|Study termination by Sponsor|0|||
162170012|NCT04032704|585676210|FG015|Part B|Study termination by Sponsor|0|||
162170013|NCT04032704|585676211|FG016|Part B|Study termination by Sponsor|0|||
162170014|NCT04032704|585676212|FG017|Part B|Study termination by Sponsor|0|||
162170015|NCT04032704|585676195|FG000|Part B|Withdrawal by Subject|0|||
162170016|NCT04032704|585676196|FG001|Part B|Withdrawal by Subject|0|||
161816566|NCT00112437|584368815|FG011|Years 6-10 (60-Month Extension)|Death|0|||
162170017|NCT04032704|585676197|FG002|Part B|Withdrawal by Subject|0|||
162170018|NCT04032704|585676198|FG003|Part B|Withdrawal by Subject|0|||
162170019|NCT04032704|585676199|FG004|Part B|Withdrawal by Subject|0|||
162170020|NCT04032704|585676200|FG005|Part B|Withdrawal by Subject|0|||
161816567|NCT00112437|584368816|FG012|Years 6-10 (60-Month Extension)|Death|0|||
161816568|NCT00112437|584368817|FG013|Years 6-10 (60-Month Extension)|Death|0|||
161816569|NCT00112437|584368818|FG014|Years 6-10 (60-Month Extension)|Death|0|||
161816570|NCT00112437|584368819|FG015|Years 6-10 (60-Month Extension)|Death|0|||
162170021|NCT04032704|585676201|FG006|Part B|Withdrawal by Subject|3|||
161816571|NCT00112437|584368820|FG016|Years 6-10 (60-Month Extension)|Death|0|||
162170022|NCT04032704|585676202|FG007|Part B|Withdrawal by Subject|2|||
162170023|NCT04032704|585676203|FG008|Part B|Withdrawal by Subject|2|||
162170024|NCT04032704|585676204|FG009|Part B|Withdrawal by Subject|1|||
162170025|NCT04032704|585676205|FG010|Part B|Withdrawal by Subject|4|||
162170026|NCT04032704|585676206|FG011|Part B|Withdrawal by Subject|6|||
162170027|NCT04032704|585676207|FG012|Part B|Withdrawal by Subject|2|||
162170028|NCT04032704|585676208|FG013|Part B|Withdrawal by Subject|1|||
162170029|NCT04032704|585676209|FG014|Part B|Withdrawal by Subject|0|||
162170030|NCT04032704|585676210|FG015|Part B|Withdrawal by Subject|1|||
162170031|NCT04032704|585676211|FG016|Part B|Withdrawal by Subject|0|||
162170032|NCT04032704|585676212|FG017|Part B|Withdrawal by Subject|0|||
162170033|NCT04032704|585676195|FG000|Part B|Lost to Follow-up|0|||
162170034|NCT04032704|585676196|FG001|Part B|Lost to Follow-up|0|||
162170035|NCT04032704|585676197|FG002|Part B|Lost to Follow-up|0|||
162170036|NCT04032704|585676198|FG003|Part B|Lost to Follow-up|0|||
162170037|NCT04032704|585676199|FG004|Part B|Lost to Follow-up|0|||
162170038|NCT04032704|585676200|FG005|Part B|Lost to Follow-up|0|||
162170039|NCT04032704|585676201|FG006|Part B|Lost to Follow-up|0|||
162170040|NCT04032704|585676202|FG007|Part B|Lost to Follow-up|0|||
162170041|NCT04032704|585676203|FG008|Part B|Lost to Follow-up|0|||
162170042|NCT04032704|585676204|FG009|Part B|Lost to Follow-up|0|||
162170043|NCT04032704|585676205|FG010|Part B|Lost to Follow-up|0|||
162170044|NCT04032704|585676206|FG011|Part B|Lost to Follow-up|1|||
162170045|NCT04032704|585676207|FG012|Part B|Lost to Follow-up|0|||
162170046|NCT04032704|585676208|FG013|Part B|Lost to Follow-up|0|||
162170047|NCT04032704|585676209|FG014|Part B|Lost to Follow-up|0|||
162170048|NCT04032704|585676210|FG015|Part B|Lost to Follow-up|0|||
162170049|NCT04032704|585676211|FG016|Part B|Lost to Follow-up|0|||
162170050|NCT04032704|585676212|FG017|Part B|Lost to Follow-up|0|||
162170051|NCT04032704|585676195|FG000|Part B|Death|0|||
162170052|NCT04032704|585676196|FG001|Part B|Death|0|||
162170053|NCT04032704|585676197|FG002|Part B|Death|0|||
162170054|NCT04032704|585676198|FG003|Part B|Death|0|||
162170055|NCT04032704|585676199|FG004|Part B|Death|0|||
162170056|NCT04032704|585676200|FG005|Part B|Death|0|||
162170057|NCT04032704|585676201|FG006|Part B|Death|13|||
162170058|NCT04032704|585676202|FG007|Part B|Death|13|||
162170059|NCT04032704|585676203|FG008|Part B|Death|14|||
162170060|NCT04032704|585676204|FG009|Part B|Death|12|||
162170061|NCT04032704|585676205|FG010|Part B|Death|12|||
162170062|NCT04032704|585676206|FG011|Part B|Death|13|||
162170063|NCT04032704|585676207|FG012|Part B|Death|7|||
162170064|NCT04032704|585676208|FG013|Part B|Death|17|||
162170065|NCT04032704|585676209|FG014|Part B|Death|2|||
162170066|NCT04032704|585676210|FG015|Part B|Death|1|||
162170067|NCT04032704|585676211|FG016|Part B|Death|2|||
162170068|NCT04032704|585676212|FG017|Part B|Death|2|||
162170069|NCT03020199|585676219|FG000|Treatment Period|Adverse Event|0|||
162170070|NCT03020199|585676220|FG001|Treatment Period|Adverse Event|2|||
162170071|NCT03020199|585676219|FG000|Treatment Period|Lack of Efficacy|1|||
162170072|NCT03020199|585676220|FG001|Treatment Period|Lack of Efficacy|6|||
162170073|NCT03020199|585676219|FG000|Treatment Period|Lost to Follow-up|1|||
162170074|NCT03020199|585676220|FG001|Treatment Period|Lost to Follow-up|6|||
162170075|NCT03020199|585676219|FG000|Treatment Period|Physician Decision|0|||
162170076|NCT03020199|585676220|FG001|Treatment Period|Physician Decision|1|||
162170077|NCT03020199|585676219|FG000|Treatment Period|Subject/guardian decision|8|||
162170078|NCT03020199|585676220|FG001|Treatment Period|Subject/guardian decision|15|||
162170079|NCT03020199|585676219|FG000|Treatment Period|Subjects not treated|3|||
162170080|NCT03020199|585676220|FG001|Treatment Period|Subjects not treated|4|||
162170081|NCT03020199|585676219|FG000|Follow-up Period|Disease relapse|32|||
162170082|NCT03020199|585676220|FG001|Follow-up Period|Disease relapse|7|||
162170083|NCT03020199|585676219|FG000|Follow-up Period|Lack of Efficacy|1|||
162170084|NCT03020199|585676220|FG001|Follow-up Period|Lack of Efficacy|2|||
162170085|NCT03020199|585676219|FG000|Follow-up Period|Lost to Follow-up|4|||
162170086|NCT03020199|585676220|FG001|Follow-up Period|Lost to Follow-up|6|||
162170087|NCT03020199|585676219|FG000|Follow-up Period|Physician Decision|2|||
162170088|NCT03020199|585676220|FG001|Follow-up Period|Physician Decision|2|||
162170089|NCT03020199|585676219|FG000|Follow-up Period|Protocol Violation|1|||
162170090|NCT03020199|585676220|FG001|Follow-up Period|Protocol Violation|2|||
162170091|NCT03020199|585676219|FG000|Follow-up Period|Study terminated by Sponsor|6|||
162170092|NCT03020199|585676220|FG001|Follow-up Period|Study terminated by Sponsor|3|||
162170093|NCT03020199|585676219|FG000|Follow-up Period|Subject/guardian decision|14|||
162170094|NCT03020199|585676220|FG001|Follow-up Period|Subject/guardian decision|9|||
162170095|NCT04314713|585676221|FG000|Overall Study|Lost to Follow-up|0|||
162170096|NCT04314713|585676222|FG001|Overall Study|Lost to Follow-up|0|||
162170097|NCT04314713|585676223|FG002|Overall Study|Lost to Follow-up|0|||
161669907|NCT02121834|583843181|FG004|Overall Study|Withdrawal by Subject|0|||
161669908|NCT02121834|583843182|FG005|Overall Study|Withdrawal by Subject|0|||
161669909|NCT02121834|583843183|FG006|Overall Study|Withdrawal by Subject|0|||
162170098|NCT04314713|585676224|FG003|Overall Study|Lost to Follow-up|1|||
162170099|NCT04314713|585676225|FG004|Overall Study|Lost to Follow-up|0|||
162170100|NCT04314713|585676226|FG005|Overall Study|Lost to Follow-up|0|||
162170101|NCT04436276|585676234|FG000|Overall Study|Adverse Event|0|||
162170102|NCT04436276|585676235|FG001|Overall Study|Adverse Event|0|||
162170103|NCT04436276|585676236|FG002|Overall Study|Adverse Event|0|||
162170104|NCT04436276|585676237|FG003|Overall Study|Adverse Event|0|||
162170105|NCT04436276|585676238|FG004|Overall Study|Adverse Event|0|||
162170106|NCT04436276|585676239|FG005|Overall Study|Adverse Event|0|||
162170107|NCT04436276|585676240|FG006|Overall Study|Adverse Event|0|||
161669910|NCT02121834|583843177|FG000|Overall Study|Lost to Follow-up|0|||
162170108|NCT04436276|585676241|FG007|Overall Study|Adverse Event|0|||
162170109|NCT04436276|585676242|FG008|Overall Study|Adverse Event|0|||
162170110|NCT04436276|585676243|FG009|Overall Study|Adverse Event|0|||
162170111|NCT04436276|585676244|FG010|Overall Study|Adverse Event|0|||
162170112|NCT04436276|585676245|FG011|Overall Study|Adverse Event|0|||
162170113|NCT04436276|585676246|FG012|Overall Study|Adverse Event|0|||
162170114|NCT04436276|585676247|FG013|Overall Study|Adverse Event|0|||
162170115|NCT04436276|585676248|FG014|Overall Study|Adverse Event|0|||
162170116|NCT04436276|585676249|FG015|Overall Study|Adverse Event|0|||
162170117|NCT04436276|585676250|FG016|Overall Study|Adverse Event|1|||
162170118|NCT04436276|585676251|FG017|Overall Study|Adverse Event|0|||
162170119|NCT04436276|585676252|FG018|Overall Study|Adverse Event|0|||
162170120|NCT04436276|585676253|FG019|Overall Study|Adverse Event|0|||
162170121|NCT04436276|585676254|FG020|Overall Study|Adverse Event|0|||
162170122|NCT04436276|585676255|FG021|Overall Study|Adverse Event|0|||
162170123|NCT04436276|585676256|FG022|Overall Study|Adverse Event|0|||
162170124|NCT04436276|585676234|FG000|Overall Study|Death|0|||
162170125|NCT04436276|585676235|FG001|Overall Study|Death|0|||
162170126|NCT04436276|585676236|FG002|Overall Study|Death|0|||
162170127|NCT04436276|585676237|FG003|Overall Study|Death|0|||
162170128|NCT04436276|585676238|FG004|Overall Study|Death|0|||
162170129|NCT04436276|585676239|FG005|Overall Study|Death|0|||
162170130|NCT04436276|585676240|FG006|Overall Study|Death|0|||
162170131|NCT04436276|585676241|FG007|Overall Study|Death|0|||
162170132|NCT04436276|585676242|FG008|Overall Study|Death|0|||
162170133|NCT04436276|585676243|FG009|Overall Study|Death|0|||
162170134|NCT04436276|585676244|FG010|Overall Study|Death|0|||
162170135|NCT04436276|585676245|FG011|Overall Study|Death|0|||
162170136|NCT04436276|585676246|FG012|Overall Study|Death|1|||
161816572|NCT00112437|584368821|FG017|Years 6-10 (60-Month Extension)|Death|0|||
161816573|NCT00112437|584368822|FG018|Years 6-10 (60-Month Extension)|Death|0|||
162170137|NCT04436276|585676247|FG013|Overall Study|Death|0|||
162170138|NCT04436276|585676248|FG014|Overall Study|Death|1|||
162170139|NCT04436276|585676249|FG015|Overall Study|Death|0|||
162170140|NCT04436276|585676250|FG016|Overall Study|Death|0|||
162170141|NCT04436276|585676251|FG017|Overall Study|Death|0|||
162170142|NCT04436276|585676252|FG018|Overall Study|Death|0|||
162170143|NCT04436276|585676253|FG019|Overall Study|Death|2|||
162170144|NCT04436276|585676254|FG020|Overall Study|Death|0|||
162170145|NCT04436276|585676255|FG021|Overall Study|Death|1|||
162170146|NCT04436276|585676256|FG022|Overall Study|Death|0|||
162170147|NCT04436276|585676234|FG000|Overall Study|Lost to Follow-up|0|||
162170148|NCT04436276|585676235|FG001|Overall Study|Lost to Follow-up|2|||
162170149|NCT04436276|585676236|FG002|Overall Study|Lost to Follow-up|2|||
162170150|NCT04436276|585676237|FG003|Overall Study|Lost to Follow-up|1|||
162170151|NCT04436276|585676238|FG004|Overall Study|Lost to Follow-up|4|||
162170152|NCT04436276|585676239|FG005|Overall Study|Lost to Follow-up|1|||
162170153|NCT04436276|585676240|FG006|Overall Study|Lost to Follow-up|0|||
162170154|NCT04436276|585676241|FG007|Overall Study|Lost to Follow-up|0|||
162170155|NCT04436276|585676242|FG008|Overall Study|Lost to Follow-up|1|||
162170156|NCT04436276|585676243|FG009|Overall Study|Lost to Follow-up|0|||
162170157|NCT04436276|585676244|FG010|Overall Study|Lost to Follow-up|5|||
162170158|NCT04436276|585676245|FG011|Overall Study|Lost to Follow-up|5|||
162170159|NCT04436276|585676246|FG012|Overall Study|Lost to Follow-up|4|||
162170160|NCT04436276|585676247|FG013|Overall Study|Lost to Follow-up|1|||
162170161|NCT04436276|585676248|FG014|Overall Study|Lost to Follow-up|7|||
162170162|NCT04436276|585676249|FG015|Overall Study|Lost to Follow-up|7|||
162170163|NCT04436276|585676250|FG016|Overall Study|Lost to Follow-up|1|||
162170164|NCT04436276|585676251|FG017|Overall Study|Lost to Follow-up|0|||
162170165|NCT04436276|585676252|FG018|Overall Study|Lost to Follow-up|1|||
162170166|NCT04436276|585676253|FG019|Overall Study|Lost to Follow-up|1|||
162170167|NCT04436276|585676254|FG020|Overall Study|Lost to Follow-up|2|||
162170168|NCT04436276|585676255|FG021|Overall Study|Lost to Follow-up|1|||
162170169|NCT04436276|585676256|FG022|Overall Study|Lost to Follow-up|1|||
162170170|NCT04436276|585676234|FG000|Overall Study|Physician Decision|1|||
162170171|NCT04436276|585676235|FG001|Overall Study|Physician Decision|0|||
162170172|NCT04436276|585676236|FG002|Overall Study|Physician Decision|2|||
162170173|NCT04436276|585676237|FG003|Overall Study|Physician Decision|1|||
162170174|NCT04436276|585676238|FG004|Overall Study|Physician Decision|0|||
162170175|NCT04436276|585676239|FG005|Overall Study|Physician Decision|0|||
162170176|NCT04436276|585676240|FG006|Overall Study|Physician Decision|0|||
162170177|NCT04436276|585676241|FG007|Overall Study|Physician Decision|0|||
162170178|NCT04436276|585676242|FG008|Overall Study|Physician Decision|0|||
162170179|NCT04436276|585676243|FG009|Overall Study|Physician Decision|0|||
162170180|NCT04436276|585676244|FG010|Overall Study|Physician Decision|0|||
162170181|NCT04436276|585676245|FG011|Overall Study|Physician Decision|1|||
162170182|NCT04436276|585676246|FG012|Overall Study|Physician Decision|2|||
162170183|NCT04436276|585676247|FG013|Overall Study|Physician Decision|0|||
162170184|NCT04436276|585676248|FG014|Overall Study|Physician Decision|0|||
162170185|NCT04436276|585676249|FG015|Overall Study|Physician Decision|0|||
162170186|NCT04436276|585676250|FG016|Overall Study|Physician Decision|0|||
162170187|NCT04436276|585676251|FG017|Overall Study|Physician Decision|0|||
162170188|NCT04436276|585676252|FG018|Overall Study|Physician Decision|0|||
162170189|NCT04436276|585676253|FG019|Overall Study|Physician Decision|0|||
162170190|NCT04436276|585676254|FG020|Overall Study|Physician Decision|1|||
162170191|NCT04436276|585676255|FG021|Overall Study|Physician Decision|2|||
162170192|NCT04436276|585676256|FG022|Overall Study|Physician Decision|0|||
162170193|NCT04436276|585676234|FG000|Overall Study|Protocol Violation|0|||
161669911|NCT02121834|583843178|FG001|Overall Study|Lost to Follow-up|0|||
161669912|NCT02121834|583843179|FG002|Overall Study|Lost to Follow-up|1|||
161669913|NCT02121834|583843180|FG003|Overall Study|Lost to Follow-up|0|||
161669914|NCT02121834|583843181|FG004|Overall Study|Lost to Follow-up|0|||
161669915|NCT02121834|583843182|FG005|Overall Study|Lost to Follow-up|0|||
161669916|NCT02121834|583843183|FG006|Overall Study|Lost to Follow-up|0|||
161669917|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
161669918|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
161669919|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
161669920|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
161669921|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
161669922|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
161669923|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
161669924|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
161669925|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
161669926|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
161816574|NCT00112437|584368823|FG019|Years 6-10 (60-Month Extension)|Death|0|||
162017617|NCT00373113|585119685|FG001|Overall Study|Global deterioration of health status|7|||
161669927|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
161816575|NCT00112437|584368824|FG020|Years 6-10 (60-Month Extension)|Death|0|||
161816576|NCT00112437|584368825|FG021|Years 6-10 (60-Month Extension)|Death|0|||
162170194|NCT04436276|585676235|FG001|Overall Study|Protocol Violation|0|||
161816577|NCT00112437|584368826|FG022|Years 6-10 (60-Month Extension)|Death|0|||
161816578|NCT00112437|584368827|FG023|Years 6-10 (60-Month Extension)|Death|2|||
162170195|NCT04436276|585676236|FG002|Overall Study|Protocol Violation|0|||
162170196|NCT04436276|585676237|FG003|Overall Study|Protocol Violation|0|||
162170197|NCT04436276|585676238|FG004|Overall Study|Protocol Violation|0|||
162170198|NCT04436276|585676239|FG005|Overall Study|Protocol Violation|0|||
162170199|NCT04436276|585676240|FG006|Overall Study|Protocol Violation|0|||
162170200|NCT04436276|585676241|FG007|Overall Study|Protocol Violation|0|||
162170201|NCT04436276|585676242|FG008|Overall Study|Protocol Violation|0|||
162170202|NCT04436276|585676243|FG009|Overall Study|Protocol Violation|0|||
162170203|NCT04436276|585676244|FG010|Overall Study|Protocol Violation|0|||
162170204|NCT04436276|585676245|FG011|Overall Study|Protocol Violation|0|||
162170205|NCT04436276|585676246|FG012|Overall Study|Protocol Violation|0|||
162170206|NCT04436276|585676247|FG013|Overall Study|Protocol Violation|1|||
162170207|NCT04436276|585676248|FG014|Overall Study|Protocol Violation|0|||
162170208|NCT04436276|585676249|FG015|Overall Study|Protocol Violation|1|||
162170209|NCT04436276|585676250|FG016|Overall Study|Protocol Violation|0|||
162170210|NCT04436276|585676251|FG017|Overall Study|Protocol Violation|0|||
162170211|NCT04436276|585676252|FG018|Overall Study|Protocol Violation|0|||
162170212|NCT04436276|585676253|FG019|Overall Study|Protocol Violation|0|||
162170213|NCT04436276|585676254|FG020|Overall Study|Protocol Violation|0|||
162170214|NCT04436276|585676255|FG021|Overall Study|Protocol Violation|0|||
162170215|NCT04436276|585676256|FG022|Overall Study|Protocol Violation|0|||
162170216|NCT04436276|585676234|FG000|Overall Study|Withdrawal by Subject|25|||
162170217|NCT04436276|585676235|FG001|Overall Study|Withdrawal by Subject|22|||
162170218|NCT04436276|585676236|FG002|Overall Study|Withdrawal by Subject|24|||
162170219|NCT04436276|585676237|FG003|Overall Study|Withdrawal by Subject|23|||
162170220|NCT04436276|585676238|FG004|Overall Study|Withdrawal by Subject|14|||
162170221|NCT04436276|585676239|FG005|Overall Study|Withdrawal by Subject|0|||
162170222|NCT04436276|585676240|FG006|Overall Study|Withdrawal by Subject|0|||
162170223|NCT04436276|585676241|FG007|Overall Study|Withdrawal by Subject|1|||
162170224|NCT04436276|585676242|FG008|Overall Study|Withdrawal by Subject|0|||
162170225|NCT04436276|585676243|FG009|Overall Study|Withdrawal by Subject|1|||
162170226|NCT04436276|585676244|FG010|Overall Study|Withdrawal by Subject|17|||
162170227|NCT04436276|585676245|FG011|Overall Study|Withdrawal by Subject|7|||
162170228|NCT04436276|585676246|FG012|Overall Study|Withdrawal by Subject|10|||
162170229|NCT04436276|585676247|FG013|Overall Study|Withdrawal by Subject|6|||
162170230|NCT04436276|585676248|FG014|Overall Study|Withdrawal by Subject|20|||
162170231|NCT04436276|585676249|FG015|Overall Study|Withdrawal by Subject|6|||
162170232|NCT04436276|585676250|FG016|Overall Study|Withdrawal by Subject|11|||
162170233|NCT04436276|585676251|FG017|Overall Study|Withdrawal by Subject|4|||
162170234|NCT04436276|585676252|FG018|Overall Study|Withdrawal by Subject|14|||
162170235|NCT04436276|585676253|FG019|Overall Study|Withdrawal by Subject|24|||
162170236|NCT04436276|585676254|FG020|Overall Study|Withdrawal by Subject|24|||
162170237|NCT04436276|585676255|FG021|Overall Study|Withdrawal by Subject|16|||
162170238|NCT04436276|585676256|FG022|Overall Study|Withdrawal by Subject|14|||
162170239|NCT04436276|585676234|FG000|Overall Study|Other|3|||
162170240|NCT04436276|585676235|FG001|Overall Study|Other|2|||
162170241|NCT04436276|585676236|FG002|Overall Study|Other|5|||
162170242|NCT04436276|585676237|FG003|Overall Study|Other|9|||
162170243|NCT04436276|585676238|FG004|Overall Study|Other|23|||
162170244|NCT04436276|585676239|FG005|Overall Study|Other|1|||
162170245|NCT04436276|585676240|FG006|Overall Study|Other|0|||
162170246|NCT04436276|585676241|FG007|Overall Study|Other|0|||
162170247|NCT04436276|585676242|FG008|Overall Study|Other|0|||
162170248|NCT04436276|585676243|FG009|Overall Study|Other|0|||
162170249|NCT04436276|585676244|FG010|Overall Study|Other|3|||
162170250|NCT04436276|585676245|FG011|Overall Study|Other|1|||
162170251|NCT04436276|585676246|FG012|Overall Study|Other|1|||
162170252|NCT04436276|585676247|FG013|Overall Study|Other|2|||
162170253|NCT04436276|585676248|FG014|Overall Study|Other|3|||
162170254|NCT04436276|585676249|FG015|Overall Study|Other|0|||
162170255|NCT04436276|585676250|FG016|Overall Study|Other|0|||
162170256|NCT04436276|585676251|FG017|Overall Study|Other|6|||
162170257|NCT04436276|585676252|FG018|Overall Study|Other|1|||
162170258|NCT04436276|585676253|FG019|Overall Study|Other|0|||
162170259|NCT04436276|585676254|FG020|Overall Study|Other|2|||
162170260|NCT04436276|585676255|FG021|Overall Study|Other|2|||
162170261|NCT04436276|585676256|FG022|Overall Study|Other|60|||
162170262|NCT03656510|585676258|FG000|Overall Study|Lost to Follow-up|1|||
162170263|NCT03656510|585676259|FG001|Overall Study|Lost to Follow-up|0|||
162170264|NCT03656510|585676260|FG002|Overall Study|Lost to Follow-up|0|||
162170265|NCT03656510|585676261|FG003|Overall Study|Lost to Follow-up|0|||
162170266|NCT03656510|585676262|FG004|Overall Study|Lost to Follow-up|0|||
161669928|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
162017618|NCT00373113|585119684|FG000|Overall Study|Lost to Follow-up|1|||
162170267|NCT03656510|585676263|FG005|Overall Study|Lost to Follow-up|0|||
162170268|NCT03656510|585676258|FG000|Overall Study|Withdrawal by Subject|1|||
162170269|NCT03656510|585676259|FG001|Overall Study|Withdrawal by Subject|1|||
162170270|NCT03656510|585676260|FG002|Overall Study|Withdrawal by Subject|0|||
162170271|NCT03656510|585676261|FG003|Overall Study|Withdrawal by Subject|1|||
162170272|NCT03656510|585676262|FG004|Overall Study|Withdrawal by Subject|0|||
162170273|NCT03656510|585676263|FG005|Overall Study|Withdrawal by Subject|0|||
162170274|NCT06457802|585676270|FG000|Overall Study|Early termination of study prior to participant completion|2|||
162170275|NCT06457802|585676271|FG001|Overall Study|Early termination of study prior to participant completion|2|||
162170276|NCT03974178|585676274|FG000|Overall Study|Death|0|||
162170277|NCT03974178|585676275|FG001|Overall Study|Death|1|||
162170278|NCT03899259|585676276|FG000|Overall Study|Adverse Event|5|||
162170279|NCT03899259|585676277|FG001|Overall Study|Adverse Event|4|||
162170280|NCT03899259|585676278|FG002|Overall Study|Adverse Event|6|||
162170281|NCT03899259|585676276|FG000|Overall Study|Lack of Efficacy|5|||
162170282|NCT03899259|585676277|FG001|Overall Study|Lack of Efficacy|0|||
162170283|NCT03899259|585676278|FG002|Overall Study|Lack of Efficacy|2|||
162170284|NCT03899259|585676276|FG000|Overall Study|Pregnancy|3|||
162170285|NCT03899259|585676277|FG001|Overall Study|Pregnancy|0|||
162170286|NCT03899259|585676278|FG002|Overall Study|Pregnancy|1|||
162170287|NCT03899259|585676276|FG000|Overall Study|Physician Decision|0|||
162170288|NCT03899259|585676277|FG001|Overall Study|Physician Decision|1|||
162170289|NCT03899259|585676278|FG002|Overall Study|Physician Decision|0|||
162170290|NCT03899259|585676276|FG000|Overall Study|Protocol Deviation|1|||
162170291|NCT03899259|585676277|FG001|Overall Study|Protocol Deviation|1|||
162170292|NCT03899259|585676278|FG002|Overall Study|Protocol Deviation|1|||
162170293|NCT03899259|585676276|FG000|Overall Study|Withdrawal by Subject|8|||
162170294|NCT03899259|585676277|FG001|Overall Study|Withdrawal by Subject|10|||
162170295|NCT03899259|585676278|FG002|Overall Study|Withdrawal by Subject|12|||
162170296|NCT03899259|585676276|FG000|Overall Study|Lost to Follow-up|5|||
162170297|NCT03899259|585676277|FG001|Overall Study|Lost to Follow-up|6|||
162170298|NCT03899259|585676278|FG002|Overall Study|Lost to Follow-up|2|||
162170299|NCT03899259|585676276|FG000|Overall Study|Lack of Adherence|1|||
162170300|NCT03899259|585676277|FG001|Overall Study|Lack of Adherence|0|||
162170301|NCT03899259|585676278|FG002|Overall Study|Lack of Adherence|0|||
162170302|NCT03899259|585676276|FG000|Overall Study|Screen Failure|1|||
162170303|NCT03899259|585676277|FG001|Overall Study|Screen Failure|0|||
162170304|NCT03899259|585676278|FG002|Overall Study|Screen Failure|0|||
162170305|NCT03899259|585676276|FG000|Overall Study|Ongoing Study Participation|127|||
162170306|NCT03899259|585676277|FG001|Overall Study|Ongoing Study Participation|134|||
162170307|NCT03899259|585676278|FG002|Overall Study|Ongoing Study Participation|210|||
162170308|NCT01152450|585676279|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
162170309|NCT01152450|585676280|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
162170310|NCT01152450|585676281|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
162170311|NCT01152450|585676282|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
162170312|NCT01152450|585676283|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
162170313|NCT01152450|585676284|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
162170314|NCT01152450|585676279|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
162170315|NCT01152450|585676280|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
162170316|NCT01152450|585676281|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
162170317|NCT01152450|585676282|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
162170318|NCT01152450|585676283|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
162170319|NCT01152450|585676284|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
162170320|NCT01152450|585676279|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
162170321|NCT01152450|585676280|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
162170322|NCT01152450|585676281|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
162170323|NCT01152450|585676282|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
162170324|NCT01152450|585676283|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
162170325|NCT01152450|585676284|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
162170326|NCT01544114|585676289|FG000|Overall Study|Withdrawal by Subject|0|||
162170327|NCT01544114|585676290|FG001|Overall Study|Withdrawal by Subject|0|||
162170328|NCT01544114|585676291|FG002|Overall Study|Withdrawal by Subject|3|||
162170329|NCT01544114|585676289|FG000|Overall Study|Lost to Follow-up|0|||
162170330|NCT01544114|585676290|FG001|Overall Study|Lost to Follow-up|2|||
162170331|NCT01544114|585676291|FG002|Overall Study|Lost to Follow-up|0|||
162170332|NCT01544114|585676289|FG000|Overall Study|Adverse Event|1|||
162170333|NCT01544114|585676290|FG001|Overall Study|Adverse Event|1|||
161816579|NCT00112437|584368828|FG024|Years 6-10 (60-Month Extension)|Death|0|||
162170334|NCT01544114|585676291|FG002|Overall Study|Adverse Event|2|||
162170335|NCT01544114|585676289|FG000|Overall Study|Protocol Violation|0|||
162170336|NCT01544114|585676290|FG001|Overall Study|Protocol Violation|1|||
162170337|NCT01544114|585676291|FG002|Overall Study|Protocol Violation|0|||
162170338|NCT04508309|585676294|FG000|Overall Study|Death|0|||
162170339|NCT04508309|585676295|FG001|Overall Study|Death|0|||
162170340|NCT04508309|585676296|FG002|Overall Study|Death|0|||
162170341|NCT04508309|585676297|FG003|Overall Study|Death|0|||
162170342|NCT04508309|585676298|FG004|Overall Study|Death|1|||
161816580|NCT00112437|584368829|FG025|Years 6-10 (60-Month Extension)|Death|0|||
161816581|NCT00112437|584368804|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816582|NCT00112437|584368805|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816583|NCT00112437|584368806|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162170343|NCT04508309|585676294|FG000|Overall Study|Lost to Follow-up|0|||
162170344|NCT04508309|585676295|FG001|Overall Study|Lost to Follow-up|0|||
162170345|NCT04508309|585676296|FG002|Overall Study|Lost to Follow-up|1|||
162170346|NCT04508309|585676297|FG003|Overall Study|Lost to Follow-up|1|||
162170347|NCT04508309|585676298|FG004|Overall Study|Lost to Follow-up|0|||
162170348|NCT04508309|585676294|FG000|Overall Study|Withdrawal by Subject|0|||
162170349|NCT04508309|585676295|FG001|Overall Study|Withdrawal by Subject|0|||
162170350|NCT04508309|585676296|FG002|Overall Study|Withdrawal by Subject|0|||
161816584|NCT00112437|584368807|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816585|NCT00112437|584368808|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162170351|NCT04508309|585676297|FG003|Overall Study|Withdrawal by Subject|0|||
162170352|NCT04508309|585676298|FG004|Overall Study|Withdrawal by Subject|1|||
162170353|NCT05940194|585676299|FG000|Overall Study|Adverse Event|0|||
162170354|NCT05940194|585676300|FG001|Overall Study|Adverse Event|1|||
162170355|NCT05940194|585676301|FG002|Overall Study|Adverse Event|0|||
162170356|NCT05940194|585676299|FG000|Overall Study|Migrated/Moved from the study area|2|||
162170357|NCT05940194|585676300|FG001|Overall Study|Migrated/Moved from the study area|2|||
162170358|NCT05940194|585676301|FG002|Overall Study|Migrated/Moved from the study area|4|||
162170359|NCT03800654|585676302|FG000|Overall Study|Time constraints|3|||
162170360|NCT03800654|585676303|FG001|Overall Study|Time constraints|3|||
162170361|NCT03800654|585676304|FG002|Overall Study|Time constraints|3|||
162170362|NCT03800654|585676302|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
162170363|NCT03800654|585676303|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
162170364|NCT03800654|585676304|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
162170365|NCT03800654|585676302|FG000|Overall Study|Lost to Follow-up|2|||
162170366|NCT03800654|585676303|FG001|Overall Study|Lost to Follow-up|1|||
162170367|NCT03800654|585676304|FG002|Overall Study|Lost to Follow-up|6|||
162170368|NCT03800654|585676302|FG000|Overall Study|Medical Health Issue|0|||
162170369|NCT03800654|585676303|FG001|Overall Study|Medical Health Issue|0|||
162170370|NCT03800654|585676304|FG002|Overall Study|Medical Health Issue|1|||
162170371|NCT03800654|585676302|FG000|Overall Study|Personal Issues|0|||
162170372|NCT03800654|585676303|FG001|Overall Study|Personal Issues|2|||
162170373|NCT03800654|585676304|FG002|Overall Study|Personal Issues|0|||
162170374|NCT03800654|585676302|FG000|Overall Study|Protocol Violation|0|||
162170375|NCT03800654|585676303|FG001|Overall Study|Protocol Violation|1|||
162170376|NCT03800654|585676304|FG002|Overall Study|Protocol Violation|0|||
162170377|NCT03459729|585676305|FG000|Overall Study|Physician Decision|2|||
162170378|NCT06182033|585676306|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
162170379|NCT06182033|585676307|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
162170380|NCT06182033|585676306|FG000|Overall Study|Target child relocation|1|||
162170381|NCT06182033|585676307|FG001|Overall Study|Target child relocation|1|||
162170382|NCT06182033|585676306|FG000|Overall Study|Withdrawal by Subject|1|||
162170383|NCT06182033|585676307|FG001|Overall Study|Withdrawal by Subject|0|||
162170384|NCT02626533|585676309|FG000|Overall Study|Protocol Violation|14|||
162170385|NCT02626533|585676309|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
162170386|NCT02626533|585676309|FG000|Overall Study|Withdrawal by Subject|1|||
162170387|NCT02151981|585676310|FG000|Overall Study|Death|184|||
162170388|NCT02151981|585676311|FG001|Overall Study|Death|88|||
162170389|NCT02151981|585676310|FG000|Overall Study|Lost to Follow-up|7|||
162170390|NCT02151981|585676311|FG001|Overall Study|Lost to Follow-up|1|||
162170391|NCT02151981|585676310|FG000|Overall Study|Withdrawal by Subject|27|||
162170392|NCT02151981|585676311|FG001|Overall Study|Withdrawal by Subject|21|||
162170393|NCT02151981|585676310|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162170394|NCT02151981|585676311|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
162170395|NCT02151981|585676310|FG000|Overall Study|Other reasons|1|||
162170396|NCT02151981|585676311|FG001|Overall Study|Other reasons|2|||
162170397|NCT05645757|585676331|FG000|Overall Study|Enrolled but treatment not administered|0|||
162170398|NCT05645757|585676332|FG001|Overall Study|Enrolled but treatment not administered|0|||
162170399|NCT05645757|585676333|FG002|Overall Study|Enrolled but treatment not administered|0|||
162170400|NCT05645757|585676334|FG003|Overall Study|Enrolled but treatment not administered|0|||
162170401|NCT05645757|585676335|FG004|Overall Study|Enrolled but treatment not administered|1|||
162170402|NCT05645757|585676336|FG005|Overall Study|Enrolled but treatment not administered|1|||
162170403|NCT05645757|585676337|FG006|Overall Study|Enrolled but treatment not administered|0|||
162170404|NCT05645757|585676338|FG007|Overall Study|Enrolled but treatment not administered|0|||
162017619|NCT00373113|585119685|FG001|Overall Study|Lost to Follow-up|3|||
162017620|NCT00373113|585119684|FG000|Overall Study|Objective progression or relapse|150|||
162017621|NCT00373113|585119685|FG001|Overall Study|Objective progression or relapse|169|||
162017622|NCT00373113|585119684|FG000|Overall Study|Other|14|||
162017623|NCT00373113|585119685|FG001|Overall Study|Other|17|||
162017624|NCT00373113|585119684|FG000|Overall Study|Protocol Violation|5|||
162017625|NCT00373113|585119685|FG001|Overall Study|Protocol Violation|1|||
162017626|NCT00373113|585119684|FG000|Overall Study|Withdrawal by Subject|10|||
162017627|NCT00373113|585119685|FG001|Overall Study|Withdrawal by Subject|15|||
162170405|NCT04568434|585676343|FG000|Overall Study|Voluntary Withdrawal|0|||
161816586|NCT00112437|584368809|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816587|NCT00112437|584368810|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162017628|NCT03275350|585119686|FG000|Overall Study|Lost to Follow-up|4|||
162170406|NCT04568434|585676344|FG001|Overall Study|Voluntary Withdrawal|1|||
162170407|NCT04568434|585676345|FG002|Overall Study|Voluntary Withdrawal|1|||
162170408|NCT04568434|585676343|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
162170409|NCT04568434|585676344|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
162170410|NCT04568434|585676345|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
162170411|NCT04568434|585676343|FG000|Overall Study|Investigator Judgement|1|||
162170412|NCT04568434|585676344|FG001|Overall Study|Investigator Judgement|0|||
162170413|NCT04568434|585676345|FG002|Overall Study|Investigator Judgement|0|||
162017629|NCT03275350|585119687|FG001|Overall Study|Lost to Follow-up|6|||
162017630|NCT03275350|585119686|FG000|Overall Study|Death|2|||
162170414|NCT03463044|585676346|FG000|Overall Study|Lost to Follow-up|0|||
162170415|NCT03463044|585676347|FG001|Overall Study|Lost to Follow-up|0|||
162170416|NCT03463044|585676348|FG002|Overall Study|Lost to Follow-up|0|||
162170417|NCT03463044|585676349|FG003|Overall Study|Lost to Follow-up|0|||
162170418|NCT03463044|585676350|FG004|Overall Study|Lost to Follow-up|0|||
162170419|NCT03463044|585676351|FG005|Overall Study|Lost to Follow-up|0|||
162170420|NCT03463044|585676352|FG006|Overall Study|Lost to Follow-up|0|||
162170421|NCT03463044|585676353|FG007|Overall Study|Lost to Follow-up|1|||
162170422|NCT03463044|585676354|FG008|Overall Study|Lost to Follow-up|0|||
162170423|NCT05576155|585676355|FG000|Overall Study|Withdrawal by Subject|1|||
162170424|NCT05576155|585676356|FG001|Overall Study|Withdrawal by Subject|1|||
162170425|NCT04515849|585676357|FG000|Overall Study|Adverse Event|0|||
162170426|NCT04515849|585676358|FG001|Overall Study|Adverse Event|0|||
162170427|NCT04515849|585676359|FG002|Overall Study|Adverse Event|0|||
162170428|NCT04515849|585676360|FG003|Overall Study|Adverse Event|1|||
162170429|NCT04515849|585676361|FG004|Overall Study|Adverse Event|2|||
162170430|NCT04515849|585676357|FG000|Overall Study|Death|2|||
162170431|NCT04515849|585676358|FG001|Overall Study|Death|0|||
162170432|NCT04515849|585676359|FG002|Overall Study|Death|0|||
162170433|NCT04515849|585676360|FG003|Overall Study|Death|0|||
162170434|NCT04515849|585676361|FG004|Overall Study|Death|0|||
162170435|NCT04515849|585676357|FG000|Overall Study|Other:family emergency|0|||
162170436|NCT04515849|585676358|FG001|Overall Study|Other:family emergency|0|||
162170437|NCT04515849|585676359|FG002|Overall Study|Other:family emergency|0|||
162170438|NCT04515849|585676360|FG003|Overall Study|Other:family emergency|1|||
162170439|NCT04515849|585676361|FG004|Overall Study|Other:family emergency|0|||
162170440|NCT04515849|585676357|FG000|Overall Study|Other:randomised by error|0|||
162170441|NCT04515849|585676358|FG001|Overall Study|Other:randomised by error|1|||
162170442|NCT04515849|585676359|FG002|Overall Study|Other:randomised by error|0|||
162170443|NCT04515849|585676360|FG003|Overall Study|Other:randomised by error|0|||
162170444|NCT04515849|585676361|FG004|Overall Study|Other:randomised by error|0|||
162170445|NCT04515849|585676357|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
162170446|NCT04515849|585676358|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
162170447|NCT04515849|585676359|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
162170448|NCT04515849|585676360|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
162170449|NCT04515849|585676361|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
162170450|NCT04515849|585676357|FG000|Overall Study|Physician Decision|0|||
162170451|NCT04515849|585676358|FG001|Overall Study|Physician Decision|1|||
162170452|NCT04515849|585676359|FG002|Overall Study|Physician Decision|0|||
162170453|NCT04515849|585676360|FG003|Overall Study|Physician Decision|0|||
162170454|NCT04515849|585676361|FG004|Overall Study|Physician Decision|0|||
162170455|NCT04515849|585676357|FG000|Overall Study|Withdrawal by Subject|1|||
162170456|NCT04515849|585676358|FG001|Overall Study|Withdrawal by Subject|2|||
162170457|NCT04515849|585676359|FG002|Overall Study|Withdrawal by Subject|1|||
162170458|NCT04515849|585676360|FG003|Overall Study|Withdrawal by Subject|0|||
162170459|NCT04515849|585676361|FG004|Overall Study|Withdrawal by Subject|0|||
162170460|NCT04081103|585676370|FG000|Overall Study|Adverse Event|1|||
162170461|NCT04081103|585676371|FG001|Overall Study|Adverse Event|1|||
162170462|NCT04081103|585676372|FG002|Overall Study|Adverse Event|1|||
161816588|NCT00112437|584368811|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816589|NCT00112437|584368812|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816590|NCT00112437|584368813|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816591|NCT00112437|584368814|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816592|NCT00112437|584368815|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816593|NCT00112437|584368816|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816594|NCT00112437|584368817|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816595|NCT00112437|584368818|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816596|NCT00112437|584368819|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816597|NCT00112437|584368820|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816598|NCT00112437|584368821|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162170463|NCT04081103|585676370|FG000|Overall Study|Physician Decision|0|||
162170464|NCT04081103|585676371|FG001|Overall Study|Physician Decision|0|||
162170465|NCT04081103|585676372|FG002|Overall Study|Physician Decision|1|||
162170466|NCT05693935|585677673|FG000|Double-blind Period (8 Weeks)|Adverse Event|5|||
162170467|NCT05693935|585677674|FG001|Double-blind Period (8 Weeks)|Adverse Event|4|||
162170468|NCT05693935|585677675|FG002|Double-blind Period (8 Weeks)|Adverse Event|2|||
162170469|NCT05693935|585677676|FG003|Double-blind Period (8 Weeks)|Adverse Event|3|||
162170470|NCT05693935|585677677|FG004|Double-blind Period (8 Weeks)|Adverse Event|0|||
162170471|NCT05693935|585677678|FG005|Double-blind Period (8 Weeks)|Adverse Event|0|||
162170472|NCT05693935|585677679|FG006|Double-blind Period (8 Weeks)|Adverse Event|0|||
162170473|NCT05693935|585677673|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|26|||
162170474|NCT05693935|585677674|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|35|||
162170475|NCT05693935|585677675|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|31|||
162170476|NCT05693935|585677676|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|33|||
162170477|NCT05693935|585677677|FG004|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
162170478|NCT05693935|585677678|FG005|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
162170479|NCT05693935|585677679|FG006|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
162170480|NCT05693935|585677673|FG000|Double-blind Period (8 Weeks)|Lost to Follow-up|5|||
162170481|NCT05693935|585677674|FG001|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
162170482|NCT05693935|585677675|FG002|Double-blind Period (8 Weeks)|Lost to Follow-up|6|||
162170483|NCT05693935|585677676|FG003|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
162170484|NCT05693935|585677677|FG004|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
162170485|NCT05693935|585677678|FG005|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
162170486|NCT05693935|585677679|FG006|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
162170487|NCT05693935|585677673|FG000|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
162170488|NCT05693935|585677674|FG001|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
162170489|NCT05693935|585677675|FG002|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
162170490|NCT05693935|585677676|FG003|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
162170491|NCT05693935|585677677|FG004|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
162170492|NCT05693935|585677678|FG005|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
162170493|NCT05693935|585677679|FG006|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
162170494|NCT05693935|585677673|FG000|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
162170495|NCT05693935|585677674|FG001|Double-blind Period (8 Weeks)|Randomized But Not Treated|5|||
162170496|NCT05693935|585677675|FG002|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
162170497|NCT05693935|585677676|FG003|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
162170498|NCT05693935|585677677|FG004|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
162170499|NCT05693935|585677678|FG005|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
162170500|NCT05693935|585677679|FG006|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
162170501|NCT05693935|585677673|FG000|Double-blind Period (8 Weeks)|Other Than Specified|11|||
162170502|NCT05693935|585677674|FG001|Double-blind Period (8 Weeks)|Other Than Specified|5|||
162170503|NCT05693935|585677675|FG002|Double-blind Period (8 Weeks)|Other Than Specified|8|||
162170504|NCT05693935|585677676|FG003|Double-blind Period (8 Weeks)|Other Than Specified|7|||
162170505|NCT05693935|585677677|FG004|Double-blind Period (8 Weeks)|Other Than Specified|0|||
162170506|NCT05693935|585677678|FG005|Double-blind Period (8 Weeks)|Other Than Specified|0|||
162170507|NCT05693935|585677679|FG006|Double-blind Period (8 Weeks)|Other Than Specified|0|||
162170508|NCT05693935|585677673|FG000|Open-label Period (48 Weeks)|Adverse Event|0|||
162170509|NCT05693935|585677674|FG001|Open-label Period (48 Weeks)|Adverse Event|5|||
162170510|NCT05693935|585677675|FG002|Open-label Period (48 Weeks)|Adverse Event|6|||
162170511|NCT05693935|585677676|FG003|Open-label Period (48 Weeks)|Adverse Event|14|||
162170512|NCT05693935|585677677|FG004|Open-label Period (48 Weeks)|Adverse Event|4|||
162170513|NCT05693935|585677678|FG005|Open-label Period (48 Weeks)|Adverse Event|1|||
162170514|NCT05693935|585677679|FG006|Open-label Period (48 Weeks)|Adverse Event|3|||
161816599|NCT00112437|584368822|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
162170515|NCT05693935|585677673|FG000|Open-label Period (48 Weeks)|Withdrawal by Subject|0|||
162170516|NCT05693935|585677674|FG001|Open-label Period (48 Weeks)|Withdrawal by Subject|32|||
162170517|NCT05693935|585677675|FG002|Open-label Period (48 Weeks)|Withdrawal by Subject|29|||
162170518|NCT05693935|585677676|FG003|Open-label Period (48 Weeks)|Withdrawal by Subject|39|||
162170519|NCT05693935|585677677|FG004|Open-label Period (48 Weeks)|Withdrawal by Subject|14|||
162170520|NCT05693935|585677678|FG005|Open-label Period (48 Weeks)|Withdrawal by Subject|15|||
162170521|NCT05693935|585677679|FG006|Open-label Period (48 Weeks)|Withdrawal by Subject|8|||
162170522|NCT05693935|585677673|FG000|Open-label Period (48 Weeks)|Protocol Violation|0|||
161816600|NCT00112437|584368823|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816601|NCT00112437|584368824|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816602|NCT00112437|584368825|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816603|NCT00112437|584368826|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816604|NCT00112437|584368827|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816605|NCT00112437|584368828|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161816606|NCT00112437|584368829|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
161816607|NCT00112437|584368804|FG000|Years 6-10 (60-Month Extension)|Other|0|||
161816608|NCT00112437|584368805|FG001|Years 6-10 (60-Month Extension)|Other|0|||
161816609|NCT00112437|584368806|FG002|Years 6-10 (60-Month Extension)|Other|0|||
161816610|NCT00112437|584368807|FG003|Years 6-10 (60-Month Extension)|Other|0|||
161816611|NCT00112437|584368808|FG004|Years 6-10 (60-Month Extension)|Other|0|||
161816612|NCT00112437|584368809|FG005|Years 6-10 (60-Month Extension)|Other|0|||
161816613|NCT00112437|584368810|FG006|Years 6-10 (60-Month Extension)|Other|0|||
162170523|NCT05693935|585677674|FG001|Open-label Period (48 Weeks)|Protocol Violation|1|||
162170524|NCT05693935|585677675|FG002|Open-label Period (48 Weeks)|Protocol Violation|1|||
162170525|NCT05693935|585677676|FG003|Open-label Period (48 Weeks)|Protocol Violation|1|||
162170526|NCT05693935|585677677|FG004|Open-label Period (48 Weeks)|Protocol Violation|0|||
162170527|NCT05693935|585677678|FG005|Open-label Period (48 Weeks)|Protocol Violation|0|||
161669929|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
162170528|NCT05693935|585677679|FG006|Open-label Period (48 Weeks)|Protocol Violation|0|||
162170529|NCT05693935|585677673|FG000|Open-label Period (48 Weeks)|Lost to Follow-up|0|||
162170530|NCT05693935|585677674|FG001|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
162170531|NCT05693935|585677675|FG002|Open-label Period (48 Weeks)|Lost to Follow-up|19|||
162170532|NCT05693935|585677676|FG003|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
162170533|NCT05693935|585677677|FG004|Open-label Period (48 Weeks)|Lost to Follow-up|3|||
162170534|NCT05693935|585677678|FG005|Open-label Period (48 Weeks)|Lost to Follow-up|5|||
162170535|NCT05693935|585677679|FG006|Open-label Period (48 Weeks)|Lost to Follow-up|4|||
162170536|NCT05693935|585677673|FG000|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
162170537|NCT05693935|585677674|FG001|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
162170538|NCT05693935|585677675|FG002|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
162170539|NCT05693935|585677676|FG003|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
162170540|NCT05693935|585677677|FG004|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
162170541|NCT05693935|585677678|FG005|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
162170542|NCT05693935|585677679|FG006|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
162170543|NCT05693935|585677673|FG000|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
162170544|NCT05693935|585677674|FG001|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
162170545|NCT05693935|585677675|FG002|Open-label Period (48 Weeks)|Randomized But Not Treated|1|||
162170546|NCT05693935|585677676|FG003|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
162170547|NCT05693935|585677677|FG004|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
162170548|NCT05693935|585677678|FG005|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
162170549|NCT05693935|585677679|FG006|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
162170550|NCT05693935|585677673|FG000|Open-label Period (48 Weeks)|Other Than Specified|0|||
162170551|NCT05693935|585677674|FG001|Open-label Period (48 Weeks)|Other Than Specified|12|||
162170552|NCT05693935|585677675|FG002|Open-label Period (48 Weeks)|Other Than Specified|9|||
162170553|NCT05693935|585677676|FG003|Open-label Period (48 Weeks)|Other Than Specified|10|||
162170554|NCT05693935|585677677|FG004|Open-label Period (48 Weeks)|Other Than Specified|4|||
162170555|NCT05693935|585677678|FG005|Open-label Period (48 Weeks)|Other Than Specified|3|||
162170556|NCT05693935|585677679|FG006|Open-label Period (48 Weeks)|Other Than Specified|4|||
162170557|NCT05256017|585677685|FG000|Treatment Period|Withdrawal by Subject|1|||
162170558|NCT05256017|585677686|FG001|Treatment Period|Withdrawal by Subject|1|||
162170559|NCT05256017|585677685|FG000|Follow-up|Lost to Follow-up|7|||
162170560|NCT05256017|585677686|FG001|Follow-up|Lost to Follow-up|1|||
162170561|NCT05256017|585677685|FG000|Follow-up|Withdrawal by Subject|1|||
162170562|NCT05256017|585677686|FG001|Follow-up|Withdrawal by Subject|0|||
162170563|NCT05256017|585677685|FG000|Follow-up|Death|0|||
162170564|NCT05256017|585677686|FG001|Follow-up|Death|1|||
162170565|NCT05082025|585677687|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
162170566|NCT03854227|585677689|FG000|Overall Study|Adverse Event|0|||
162170567|NCT03854227|585677690|FG001|Overall Study|Adverse Event|0|||
162170568|NCT03854227|585677691|FG002|Overall Study|Adverse Event|0|||
162017631|NCT03275350|585119687|FG001|Overall Study|Death|1|||
162017632|NCT03275350|585119686|FG000|Overall Study|Physician Decision|1|||
162017633|NCT03275350|585119687|FG001|Overall Study|Physician Decision|0|||
162017634|NCT03275350|585119686|FG000|Overall Study|Incarcerated|1|||
162017635|NCT03275350|585119687|FG001|Overall Study|Incarcerated|1|||
162017636|NCT00905645|585119690|FG000|Overall Study|Death (not device related)|10|||
162170569|NCT03854227|585677692|FG003|Overall Study|Adverse Event|1|||
162170570|NCT03854227|585677693|FG004|Overall Study|Adverse Event|0|||
162170571|NCT03854227|585677694|FG005|Overall Study|Adverse Event|0|||
162170572|NCT03854227|585677695|FG006|Overall Study|Adverse Event|1|||
162170573|NCT03854227|585677696|FG007|Overall Study|Adverse Event|0|||
162170574|NCT03854227|585677697|FG008|Overall Study|Adverse Event|0|||
162170575|NCT03854227|585677698|FG009|Overall Study|Adverse Event|3|||
162170576|NCT03854227|585677699|FG010|Overall Study|Adverse Event|0|||
162170577|NCT03854227|585677700|FG011|Overall Study|Adverse Event|1|||
162170578|NCT03854227|585677689|FG000|Overall Study|Death|0|||
162170579|NCT03854227|585677690|FG001|Overall Study|Death|0|||
161816614|NCT00112437|584368811|FG007|Years 6-10 (60-Month Extension)|Other|0|||
161816615|NCT00112437|584368812|FG008|Years 6-10 (60-Month Extension)|Other|0|||
161816616|NCT00112437|584368813|FG009|Years 6-10 (60-Month Extension)|Other|0|||
161816617|NCT00112437|584368814|FG010|Years 6-10 (60-Month Extension)|Other|0|||
161816618|NCT00112437|584368815|FG011|Years 6-10 (60-Month Extension)|Other|0|||
161816619|NCT00112437|584368816|FG012|Years 6-10 (60-Month Extension)|Other|0|||
161816620|NCT00112437|584368817|FG013|Years 6-10 (60-Month Extension)|Other|0|||
162017637|NCT00905645|585119691|FG001|Overall Study|Death (not device related)|4|||
161816621|NCT00112437|584368818|FG014|Years 6-10 (60-Month Extension)|Other|0|||
161816622|NCT00112437|584368819|FG015|Years 6-10 (60-Month Extension)|Other|0|||
161816623|NCT00112437|584368820|FG016|Years 6-10 (60-Month Extension)|Other|0|||
162170580|NCT03854227|585677691|FG002|Overall Study|Death|0|||
162170581|NCT03854227|585677692|FG003|Overall Study|Death|0|||
162170582|NCT03854227|585677693|FG004|Overall Study|Death|0|||
162170583|NCT03854227|585677694|FG005|Overall Study|Death|1|||
162017638|NCT00905645|585119692|FG002|Overall Study|Death (not device related)|15|||
162017639|NCT00905645|585119693|FG003|Overall Study|Death (not device related)|8|||
162170584|NCT03854227|585677695|FG006|Overall Study|Death|0|||
162170585|NCT03854227|585677696|FG007|Overall Study|Death|0|||
162170586|NCT03854227|585677697|FG008|Overall Study|Death|0|||
162170587|NCT03854227|585677698|FG009|Overall Study|Death|1|||
162170588|NCT03854227|585677699|FG010|Overall Study|Death|0|||
162170589|NCT03854227|585677700|FG011|Overall Study|Death|1|||
162170590|NCT03854227|585677689|FG000|Overall Study|Physician Decision|0|||
162170591|NCT03854227|585677690|FG001|Overall Study|Physician Decision|0|||
162170592|NCT03854227|585677691|FG002|Overall Study|Physician Decision|0|||
162170593|NCT03854227|585677692|FG003|Overall Study|Physician Decision|0|||
162170594|NCT03854227|585677693|FG004|Overall Study|Physician Decision|0|||
162170595|NCT03854227|585677694|FG005|Overall Study|Physician Decision|1|||
162170596|NCT03854227|585677695|FG006|Overall Study|Physician Decision|0|||
162170597|NCT03854227|585677696|FG007|Overall Study|Physician Decision|0|||
162170598|NCT03854227|585677697|FG008|Overall Study|Physician Decision|1|||
162170599|NCT03854227|585677698|FG009|Overall Study|Physician Decision|1|||
162170600|NCT03854227|585677699|FG010|Overall Study|Physician Decision|0|||
162170601|NCT03854227|585677700|FG011|Overall Study|Physician Decision|1|||
162170602|NCT03854227|585677689|FG000|Overall Study|Progressive disease|1|||
162170603|NCT03854227|585677690|FG001|Overall Study|Progressive disease|1|||
162170604|NCT03854227|585677691|FG002|Overall Study|Progressive disease|1|||
162170605|NCT03854227|585677692|FG003|Overall Study|Progressive disease|2|||
162170606|NCT03854227|585677693|FG004|Overall Study|Progressive disease|3|||
162170607|NCT03854227|585677694|FG005|Overall Study|Progressive disease|1|||
162170608|NCT03854227|585677695|FG006|Overall Study|Progressive disease|2|||
162170609|NCT03854227|585677696|FG007|Overall Study|Progressive disease|5|||
162170610|NCT03854227|585677697|FG008|Overall Study|Progressive disease|2|||
162170611|NCT03854227|585677698|FG009|Overall Study|Progressive disease|5|||
162170612|NCT03854227|585677699|FG010|Overall Study|Progressive disease|1|||
162170613|NCT03854227|585677700|FG011|Overall Study|Progressive disease|6|||
162170614|NCT03854227|585677689|FG000|Overall Study|Study terminated by sponsor|0|||
162170615|NCT03854227|585677690|FG001|Overall Study|Study terminated by sponsor|0|||
162170616|NCT03854227|585677691|FG002|Overall Study|Study terminated by sponsor|0|||
162170617|NCT03854227|585677692|FG003|Overall Study|Study terminated by sponsor|0|||
161921664|NCT03580928|584758198|FG001|Overall Study|Death|3|||
162170618|NCT03854227|585677693|FG004|Overall Study|Study terminated by sponsor|0|||
162170619|NCT03854227|585677694|FG005|Overall Study|Study terminated by sponsor|0|||
161921665|NCT03580928|584758197|FG000|Overall Study|Withdrawal by Subject|2|||
161921666|NCT03580928|584758198|FG001|Overall Study|Withdrawal by Subject|1|||
162170620|NCT03854227|585677695|FG006|Overall Study|Study terminated by sponsor|0|||
162170621|NCT03854227|585677696|FG007|Overall Study|Study terminated by sponsor|0|||
162170622|NCT03854227|585677697|FG008|Overall Study|Study terminated by sponsor|0|||
162170623|NCT03854227|585677698|FG009|Overall Study|Study terminated by sponsor|1|||
162170624|NCT03854227|585677699|FG010|Overall Study|Study terminated by sponsor|0|||
161921667|NCT03580928|584758197|FG000|Overall Study|Lost to Follow-up|2|||
161921668|NCT03580928|584758198|FG001|Overall Study|Lost to Follow-up|0|||
161921669|NCT03580928|584758197|FG000|Overall Study|Progressive Disease|0|||
161921670|NCT03580928|584758198|FG001|Overall Study|Progressive Disease|1|||
161921671|NCT00484159|584759968|FG000|Overall Study|Lost to Follow-up|1|||
162170625|NCT03854227|585677700|FG011|Overall Study|Study terminated by sponsor|0|||
162170626|NCT03854227|585677689|FG000|Overall Study|Withdrawal by Subject|0|||
162170627|NCT03854227|585677690|FG001|Overall Study|Withdrawal by Subject|0|||
162170628|NCT03854227|585677691|FG002|Overall Study|Withdrawal by Subject|1|||
162170629|NCT03854227|585677692|FG003|Overall Study|Withdrawal by Subject|0|||
162170630|NCT03854227|585677693|FG004|Overall Study|Withdrawal by Subject|0|||
162170631|NCT03854227|585677694|FG005|Overall Study|Withdrawal by Subject|0|||
162170632|NCT03854227|585677695|FG006|Overall Study|Withdrawal by Subject|0|||
161921672|NCT00484159|584759969|FG001|Overall Study|Lost to Follow-up|1|||
162170633|NCT03854227|585677696|FG007|Overall Study|Withdrawal by Subject|0|||
162170634|NCT03854227|585677697|FG008|Overall Study|Withdrawal by Subject|0|||
162170635|NCT03854227|585677698|FG009|Overall Study|Withdrawal by Subject|1|||
162170636|NCT03854227|585677699|FG010|Overall Study|Withdrawal by Subject|1|||
162170637|NCT03854227|585677700|FG011|Overall Study|Withdrawal by Subject|0|||
162170638|NCT03854227|585677689|FG000|Overall Study|Disease relapse|0|||
162170639|NCT03854227|585677690|FG001|Overall Study|Disease relapse|0|||
162170640|NCT03854227|585677691|FG002|Overall Study|Disease relapse|0|||
162170641|NCT03854227|585677692|FG003|Overall Study|Disease relapse|0|||
162170642|NCT03854227|585677693|FG004|Overall Study|Disease relapse|0|||
162170643|NCT03854227|585677694|FG005|Overall Study|Disease relapse|0|||
161921673|NCT00484159|584759970|FG002|Overall Study|Lost to Follow-up|0|||
161921674|NCT03234881|584759971|FG000|Overall Study|Lost to Follow-up|9|||
161921675|NCT03234881|584759972|FG001|Overall Study|Lost to Follow-up|3|||
162170644|NCT03854227|585677695|FG006|Overall Study|Disease relapse|0|||
162170645|NCT03854227|585677696|FG007|Overall Study|Disease relapse|0|||
162170646|NCT03854227|585677697|FG008|Overall Study|Disease relapse|1|||
162170647|NCT03854227|585677698|FG009|Overall Study|Disease relapse|0|||
162170648|NCT03854227|585677699|FG010|Overall Study|Disease relapse|0|||
162170649|NCT03854227|585677700|FG011|Overall Study|Disease relapse|0|||
162170650|NCT03854227|585677689|FG000|Overall Study|Global deterioration of health status|0|||
162170651|NCT03854227|585677690|FG001|Overall Study|Global deterioration of health status|0|||
162170652|NCT03854227|585677691|FG002|Overall Study|Global deterioration of health status|0|||
162170653|NCT03854227|585677692|FG003|Overall Study|Global deterioration of health status|0|||
162170654|NCT03854227|585677693|FG004|Overall Study|Global deterioration of health status|0|||
162170655|NCT03854227|585677694|FG005|Overall Study|Global deterioration of health status|1|||
162170656|NCT03854227|585677695|FG006|Overall Study|Global deterioration of health status|0|||
162170657|NCT03854227|585677696|FG007|Overall Study|Global deterioration of health status|1|||
162170658|NCT03854227|585677697|FG008|Overall Study|Global deterioration of health status|0|||
162170659|NCT03854227|585677698|FG009|Overall Study|Global deterioration of health status|0|||
162170660|NCT03854227|585677699|FG010|Overall Study|Global deterioration of health status|0|||
162170661|NCT03854227|585677700|FG011|Overall Study|Global deterioration of health status|0|||
162170662|NCT03854227|585677689|FG000|Overall Study|Refused further treatment|0|||
162170663|NCT03854227|585677690|FG001|Overall Study|Refused further treatment|0|||
162170664|NCT03854227|585677691|FG002|Overall Study|Refused further treatment|0|||
162170665|NCT03854227|585677692|FG003|Overall Study|Refused further treatment|0|||
162170666|NCT03854227|585677693|FG004|Overall Study|Refused further treatment|0|||
162170667|NCT03854227|585677694|FG005|Overall Study|Refused further treatment|0|||
162170668|NCT03854227|585677695|FG006|Overall Study|Refused further treatment|0|||
161669930|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
162170669|NCT03854227|585677696|FG007|Overall Study|Refused further treatment|0|||
162170670|NCT03854227|585677697|FG008|Overall Study|Refused further treatment|0|||
162170671|NCT03854227|585677698|FG009|Overall Study|Refused further treatment|1|||
162170672|NCT03854227|585677699|FG010|Overall Study|Refused further treatment|0|||
161669931|NCT01294683|583843186|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
161669932|NCT01294683|583843187|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
161669933|NCT01294683|583843186|FG000|Post Crossover (Period III)|Adverse Event|6|||
161669934|NCT01294683|583843187|FG001|Post Crossover (Period III)|Adverse Event|6|||
161669935|NCT01294683|583843186|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
161669936|NCT01294683|583843187|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
161669937|NCT01294683|583843186|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
161669938|NCT01294683|583843187|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
161921676|NCT03807843|584759973|FG000|Overall Study|Lost to Follow-up|1|||
162170673|NCT03854227|585677700|FG011|Overall Study|Refused further treatment|1|||
162170674|NCT03854227|585677689|FG000|Overall Study|Other|0|||
162170675|NCT03854227|585677690|FG001|Overall Study|Other|0|||
162170676|NCT03854227|585677691|FG002|Overall Study|Other|0|||
162170677|NCT03854227|585677692|FG003|Overall Study|Other|0|||
162170678|NCT03854227|585677693|FG004|Overall Study|Other|0|||
162170679|NCT03854227|585677694|FG005|Overall Study|Other|0|||
162170680|NCT03854227|585677695|FG006|Overall Study|Other|0|||
162170681|NCT03854227|585677696|FG007|Overall Study|Other|0|||
162170682|NCT03854227|585677697|FG008|Overall Study|Other|1|||
162170683|NCT03854227|585677698|FG009|Overall Study|Other|1|||
162170684|NCT03854227|585677699|FG010|Overall Study|Other|0|||
162170685|NCT03854227|585677700|FG011|Overall Study|Other|0|||
162170686|NCT06504862|585677701|FG000|Transition period|Adverse Event|1|||
162170687|NCT06504862|585677702|FG001|Transition period|Adverse Event|0|||
162170688|NCT01574274|585677703|FG000|Overall Study|Ineligible|0|||
162170689|NCT01574274|585677704|FG001|Overall Study|Ineligible|1|||
162170690|NCT01574274|585677703|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
162170691|NCT01574274|585677704|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
162170692|NCT01574274|585677703|FG000|Overall Study|Ph+ B-ALL|3|||
162170693|NCT01574274|585677704|FG001|Overall Study|Ph+ B-ALL|4|||
162170694|NCT01574274|585677703|FG000|Overall Study|Induction Death|2|||
162170695|NCT01574274|585677704|FG001|Overall Study|Induction Death|0|||
161669939|NCT01294683|583843186|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
161669940|NCT01294683|583843187|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
161669941|NCT01794923|583843188|FG000|Overall Study|Adverse Event|0|||
161921677|NCT03807843|584759974|FG001|Overall Study|Lost to Follow-up|0|||
161921678|NCT01239680|584759979|FG000|Overall Study|Withdrawal by Subject|2|||
161921679|NCT01239680|584759980|FG001|Overall Study|Withdrawal by Subject|0|||
161921680|NCT00639379|584759981|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
161921681|NCT00639379|584759982|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
161921682|NCT00639379|584759981|FG000|Period 1 - 2 Weeks|lens issue|3|||
162170696|NCT01574274|585677703|FG000|Overall Study|Induction Failure|4|||
161669942|NCT01794923|583843189|FG001|Overall Study|Adverse Event|0|||
161669943|NCT01794923|583843190|FG002|Overall Study|Adverse Event|1|||
161921683|NCT00639379|584759982|FG001|Period 1 - 2 Weeks|lens issue|0|||
162170697|NCT01574274|585677704|FG001|Overall Study|Induction Failure|1|||
162170698|NCT01574274|585677703|FG000|Overall Study|Adverse Event|16|||
162170699|NCT01574274|585677704|FG001|Overall Study|Adverse Event|13|||
162170700|NCT01574274|585677703|FG000|Overall Study|Remission Death|1|||
162170701|NCT01574274|585677704|FG001|Overall Study|Remission Death|0|||
161921684|NCT01797185|584759983|FG000|Overall Study|Adverse Event|5|||
162170702|NCT01574274|585677703|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
162170703|NCT01574274|585677704|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
162170704|NCT01574274|585677703|FG000|Overall Study|Other, unknown|3|||
162170705|NCT01574274|585677704|FG001|Overall Study|Other, unknown|2|||
162170706|NCT04870515|585677711|FG000|Overall Study|Lost to Follow-up|0|||
162170707|NCT04870515|585677712|FG001|Overall Study|Lost to Follow-up|2|||
162170708|NCT04870515|585677711|FG000|Overall Study|Withdrawal by Subject|0|||
162170709|NCT04870515|585677712|FG001|Overall Study|Withdrawal by Subject|1|||
162170710|NCT04870515|585677711|FG000|Overall Study|Withdrawal due to complications with standard of care treatment|2|||
162170711|NCT04870515|585677712|FG001|Overall Study|Withdrawal due to complications with standard of care treatment|0|||
162170712|NCT03852472|585677715|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
162170713|NCT03852472|585677716|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
162170714|NCT03852472|585677717|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
162170715|NCT03852472|585677718|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
162170716|NCT03852472|585677719|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
162170717|NCT03852472|585677715|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
162170718|NCT03852472|585677716|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
162170719|NCT03852472|585677717|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
162170720|NCT03852472|585677718|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
162170721|NCT03852472|585677719|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
162170722|NCT03852472|585677715|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
162170723|NCT03852472|585677716|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
162170724|NCT03852472|585677717|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
162170725|NCT03852472|585677718|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
162170726|NCT03852472|585677719|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
162170727|NCT03852472|585677715|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
162170728|NCT03852472|585677716|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
162170729|NCT03852472|585677717|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
162170730|NCT03852472|585677718|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
162170731|NCT03852472|585677719|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
162170732|NCT03852472|585677715|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
162170733|NCT03852472|585677716|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
162170734|NCT03852472|585677717|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
162170735|NCT03852472|585677718|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
162170736|NCT03852472|585677719|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
162170737|NCT03852472|585677715|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
162170738|NCT03852472|585677716|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
162170739|NCT03852472|585677717|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
162170740|NCT03852472|585677718|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
162170741|NCT03852472|585677719|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
162170742|NCT03852472|585677715|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
162170743|NCT03852472|585677716|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
162170744|NCT03852472|585677717|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
162170745|NCT03852472|585677718|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
162170746|NCT03852472|585677719|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
162170747|NCT03852472|585677715|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
162170748|NCT03852472|585677716|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
162170749|NCT03852472|585677717|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
162170750|NCT03852472|585677718|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
162170751|NCT03852472|585677719|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
162170752|NCT03852472|585677715|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
162170753|NCT03852472|585677716|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
162170754|NCT03852472|585677717|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
162170755|NCT03852472|585677718|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
162170756|NCT03852472|585677719|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
162170757|NCT03852472|585677715|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
162170758|NCT03852472|585677716|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
162170759|NCT03852472|585677717|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
162170760|NCT03852472|585677718|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
162170761|NCT03852472|585677719|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
162170762|NCT03852472|585677715|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
162170763|NCT03852472|585677716|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
161816624|NCT00112437|584368821|FG017|Years 6-10 (60-Month Extension)|Other|0|||
161816625|NCT00112437|584368822|FG018|Years 6-10 (60-Month Extension)|Other|0|||
161816626|NCT00112437|584368823|FG019|Years 6-10 (60-Month Extension)|Other|0|||
162170764|NCT03852472|585677717|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
162170765|NCT03852472|585677718|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
162170766|NCT03852472|585677719|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
162170767|NCT03852472|585677715|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
161816627|NCT00112437|584368824|FG020|Years 6-10 (60-Month Extension)|Other|0|||
162170768|NCT03852472|585677716|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
162170769|NCT03852472|585677717|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
162170770|NCT03852472|585677718|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
162170771|NCT03852472|585677719|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
162170772|NCT03852472|585677715|FG000|Period 2 - Week 44|Adverse Event|0|||
162170773|NCT03852472|585677716|FG001|Period 2 - Week 44|Adverse Event|3|||
162170774|NCT03852472|585677717|FG002|Period 2 - Week 44|Adverse Event|1|||
162170775|NCT03852472|585677718|FG003|Period 2 - Week 44|Adverse Event|2|||
162170776|NCT03852472|585677719|FG004|Period 2 - Week 44|Adverse Event|2|||
162170777|NCT03852472|585677715|FG000|Period 2 - Week 44|COVID-19 Related|0|||
162170778|NCT03852472|585677716|FG001|Period 2 - Week 44|COVID-19 Related|0|||
162170779|NCT03852472|585677717|FG002|Period 2 - Week 44|COVID-19 Related|0|||
162170780|NCT03852472|585677718|FG003|Period 2 - Week 44|COVID-19 Related|1|||
162170781|NCT03852472|585677719|FG004|Period 2 - Week 44|COVID-19 Related|0|||
162170782|NCT03852472|585677715|FG000|Period 2 - Week 44|Reason not stated|0|||
162170783|NCT03852472|585677716|FG001|Period 2 - Week 44|Reason not stated|0|||
162170784|NCT03852472|585677717|FG002|Period 2 - Week 44|Reason not stated|0|||
162170785|NCT03852472|585677718|FG003|Period 2 - Week 44|Reason not stated|0|||
162170786|NCT03852472|585677719|FG004|Period 2 - Week 44|Reason not stated|1|||
162170787|NCT04880863|585677722|FG000|Overall Study|Adverse Event|1|||
162170788|NCT04880863|585677722|FG000|Overall Study|Patient decision|2|||
162170789|NCT04880863|585677722|FG000|Overall Study|Confirmed Disease Progression|15|||
162170790|NCT04880863|585677722|FG000|Overall Study|Death|3|||
162170791|NCT04880863|585677722|FG000|Overall Study|Physician Decision|4|||
162170792|NCT04880863|585677722|FG000|Overall Study|Unconfirmed Disease Progression|4|||
162170793|NCT04880863|585677722|FG000|Overall Study|Withdrawal by Subject|2|||
162170794|NCT04880863|585677722|FG000|Overall Study|Study discontinuation by the sponsor|4|||
162170795|NCT04880863|585677722|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
162170796|NCT04880863|585677722|FG000|Overall Study|Not received study drug NAP|2|||
162170797|NCT05670587|585677723|FG000|Overall Study|Withdrawal by Subject|3|||
162170798|NCT02305888|585677733|FG000|Overall Study|Lost to Follow-up|0|||
162170799|NCT02305888|585677734|FG001|Overall Study|Lost to Follow-up|0|||
162170800|NCT02305888|585677735|FG002|Overall Study|Lost to Follow-up|1|||
162170801|NCT02305888|585677733|FG000|Overall Study|Adverse Event|0|||
162170802|NCT02305888|585677734|FG001|Overall Study|Adverse Event|1|||
162170803|NCT02305888|585677735|FG002|Overall Study|Adverse Event|0|||
162170804|NCT05139810|585677736|FG000|Overall Study|Voluntary Withdrawal|2|||
162170805|NCT05139810|585677737|FG001|Overall Study|Voluntary Withdrawal|1|||
162170806|NCT05139810|585677738|FG002|Overall Study|Voluntary Withdrawal|0|||
162170807|NCT05139810|585677736|FG000|Overall Study|Pregnancy|1|||
162170808|NCT05139810|585677737|FG001|Overall Study|Pregnancy|0|||
162170809|NCT05139810|585677738|FG002|Overall Study|Pregnancy|0|||
162170810|NCT05139810|585677736|FG000|Overall Study|Roll Over to CS7|19|||
162170811|NCT05139810|585677737|FG001|Overall Study|Roll Over to CS7|44|||
162170812|NCT05139810|585677738|FG002|Overall Study|Roll Over to CS7|20|||
162170813|NCT03240016|585677745|FG000|Overall Study|Adverse Event|9|||
162170814|NCT03240016|585677745|FG000|Overall Study|Withdrawal by Subject|7|||
162170815|NCT03240016|585677745|FG000|Overall Study|Death|1|||
162170816|NCT03240016|585677745|FG000|Overall Study|Physician Decision|2|||
162170817|NCT05200403|585677746|FG000|Overall Study|Withdrawal by Subject|4|||
162170818|NCT05200403|585677747|FG001|Overall Study|Withdrawal by Subject|2|||
162170819|NCT05200403|585677748|FG002|Overall Study|Withdrawal by Subject|6|||
162170820|NCT05546411|585677749|FG000|Overall Study|Progressive Disease|1|||
162170821|NCT05546411|585677750|FG001|Overall Study|Progressive Disease|0|||
162017640|NCT00905645|585119690|FG000|Overall Study|Explantation of study device(s)|78|||
162017641|NCT00905645|585119691|FG001|Overall Study|Explantation of study device(s)|47|||
162017642|NCT00905645|585119692|FG002|Overall Study|Explantation of study device(s)|28|||
162017643|NCT00905645|585119693|FG003|Overall Study|Explantation of study device(s)|21|||
162017644|NCT00905645|585119690|FG000|Overall Study|Subject Request|41|||
162017645|NCT00905645|585119691|FG001|Overall Study|Subject Request|17|||
162170822|NCT05546411|585677749|FG000|Overall Study|Adverse Event|0|||
162170823|NCT05546411|585677750|FG001|Overall Study|Adverse Event|1|||
162170824|NCT05546411|585677749|FG000|Overall Study|Metastatic disease|1|||
162170825|NCT05546411|585677750|FG001|Overall Study|Metastatic disease|0|||
162170826|NCT04068181|585677758|FG000|Overall Study|Death|17|||
162170827|NCT04068181|585677759|FG001|Overall Study|Death|12|||
162170828|NCT04068181|585677760|FG002|Overall Study|Death|4|||
162170829|NCT04068181|585677761|FG003|Overall Study|Death|7|||
162170830|NCT04068181|585677758|FG000|Overall Study|Lost to Follow-up|1|||
162170831|NCT04068181|585677759|FG001|Overall Study|Lost to Follow-up|0|||
162170832|NCT04068181|585677760|FG002|Overall Study|Lost to Follow-up|0|||
162170833|NCT04068181|585677761|FG003|Overall Study|Lost to Follow-up|0|||
162170834|NCT04068181|585677758|FG000|Overall Study|Withdrawal of consent from study|3|||
162170835|NCT04068181|585677759|FG001|Overall Study|Withdrawal of consent from study|0|||
162170836|NCT04068181|585677760|FG002|Overall Study|Withdrawal of consent from study|0|||
162017646|NCT00905645|585119692|FG002|Overall Study|Subject Request|13|||
162170837|NCT04068181|585677761|FG003|Overall Study|Withdrawal of consent from study|0|||
162170838|NCT03785964|585677764|FG000|Overall Study|Adverse Event|14|||
162170839|NCT03785964|585677765|FG001|Overall Study|Adverse Event|1|||
162170840|NCT03785964|585677764|FG000|Overall Study|Unqualified Clinical Progression|1|||
162170841|NCT03785964|585677765|FG001|Overall Study|Unqualified Clinical Progression|1|||
162170842|NCT03785964|585677764|FG000|Overall Study|Participant non-compliance|1|||
162170843|NCT03785964|585677765|FG001|Overall Study|Participant non-compliance|1|||
162170844|NCT03785964|585677764|FG000|Overall Study|Not treated|1|||
162170845|NCT03785964|585677765|FG001|Overall Study|Not treated|0|||
162170846|NCT03785964|585677764|FG000|Overall Study|Other reason|5|||
162170847|NCT03785964|585677765|FG001|Overall Study|Other reason|11|||
162170848|NCT03785964|585677764|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
162170849|NCT03785964|585677765|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
162170850|NCT02723591|585677766|FG000|Overall Study|Adverse Event|48|||
162170851|NCT02723591|585677767|FG001|Overall Study|Adverse Event|40|||
162170852|NCT02723591|585677766|FG000|Overall Study|Death|2|||
162170853|NCT02723591|585677767|FG001|Overall Study|Death|2|||
162170854|NCT02723591|585677766|FG000|Overall Study|Lack of Efficacy|4|||
162170855|NCT02723591|585677767|FG001|Overall Study|Lack of Efficacy|3|||
162170856|NCT02723591|585677766|FG000|Overall Study|Lost to Follow-up|1|||
162170857|NCT02723591|585677767|FG001|Overall Study|Lost to Follow-up|7|||
162170858|NCT02723591|585677766|FG000|Overall Study|Protocol Violation|20|||
162170859|NCT02723591|585677767|FG001|Overall Study|Protocol Violation|23|||
162170860|NCT02723591|585677766|FG000|Overall Study|Withdrawal by Subject|4|||
162170861|NCT02723591|585677767|FG001|Overall Study|Withdrawal by Subject|8|||
162170862|NCT02723591|585677766|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
162170863|NCT02723591|585677767|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
162170864|NCT02723591|585677766|FG000|Overall Study|Miscellaneous|5|||
162170865|NCT02723591|585677767|FG001|Overall Study|Miscellaneous|6|||
162170866|NCT05070728|585677768|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
162170867|NCT05070728|585677769|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
161921685|NCT01797185|584759984|FG001|Overall Study|Adverse Event|15|||
161921686|NCT01797185|584759985|FG002|Overall Study|Adverse Event|6|||
161921687|NCT01797185|584759983|FG000|Overall Study|Withdrawal by Subject|6|||
161921688|NCT01797185|584759984|FG001|Overall Study|Withdrawal by Subject|9|||
161921689|NCT01797185|584759985|FG002|Overall Study|Withdrawal by Subject|5|||
161921690|NCT01797185|584759983|FG000|Overall Study|Site terminated|8|||
161921691|NCT01797185|584759984|FG001|Overall Study|Site terminated|4|||
161921692|NCT01797185|584759985|FG002|Overall Study|Site terminated|0|||
161921693|NCT01797185|584759983|FG000|Overall Study|Lost to Follow-up|2|||
162170868|NCT03334630|585677770|FG000|Overall Study|Withdrawal by Subject|7|||
162170869|NCT03334630|585677771|FG001|Overall Study|Withdrawal by Subject|7|||
162170870|NCT03334630|585677770|FG000|Overall Study|Lost to Follow-up|3|||
162170871|NCT03334630|585677771|FG001|Overall Study|Lost to Follow-up|1|||
162170872|NCT03334630|585677770|FG000|Overall Study|Adverse Event|0|||
162170873|NCT03334630|585677771|FG001|Overall Study|Adverse Event|1|||
162170874|NCT03334630|585677770|FG000|Overall Study|Physician Decision|1|||
162170875|NCT03334630|585677771|FG001|Overall Study|Physician Decision|1|||
162170876|NCT03334630|585677770|FG000|Overall Study|Enrollment closed|2|||
162170877|NCT03334630|585677771|FG001|Overall Study|Enrollment closed|1|||
162170878|NCT03334630|585677770|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
162170879|NCT03334630|585677771|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
162170880|NCT03334630|585677770|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
162170881|NCT03334630|585677771|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
162170882|NCT03697876|585677776|FG000|Overall Study|Lost to Follow-up|0|||
162170883|NCT03697876|585677777|FG001|Overall Study|Lost to Follow-up|1|||
162170884|NCT03697876|585677776|FG000|Overall Study|Adverse Event|1|||
162170885|NCT03697876|585677777|FG001|Overall Study|Adverse Event|0|||
162170886|NCT04721977|585677778|FG000|Overall Study|Death|15|||
162170887|NCT04721977|585677778|FG000|Overall Study|Ongoing|51|||
162017647|NCT00905645|585119693|FG003|Overall Study|Subject Request|11|||
162017648|NCT00905645|585119690|FG000|Overall Study|Lost to Follow-up|299|||
162017649|NCT00905645|585119691|FG001|Overall Study|Lost to Follow-up|103|||
162170888|NCT02670525|585677779|FG000|Overall Study|Death|94|||
162170889|NCT02670525|585677780|FG001|Overall Study|Death|14|||
162170890|NCT02670525|585677779|FG000|Overall Study|Lost to Follow-up|4|||
162170891|NCT02670525|585677780|FG001|Overall Study|Lost to Follow-up|1|||
162170892|NCT02670525|585677779|FG000|Overall Study|Subject withdrew consent|1|||
162170893|NCT02670525|585677780|FG001|Overall Study|Subject withdrew consent|0|||
162170894|NCT02670525|585677779|FG000|Overall Study|Unknown, data entry delayed|123|||
162170895|NCT02670525|585677780|FG001|Overall Study|Unknown, data entry delayed|78|||
161921694|NCT01797185|584759984|FG001|Overall Study|Lost to Follow-up|6|||
161921695|NCT01797185|584759985|FG002|Overall Study|Lost to Follow-up|1|||
161921696|NCT01797185|584759983|FG000|Overall Study|Withdrawn per sponsor|5|||
162017650|NCT00905645|585119692|FG002|Overall Study|Lost to Follow-up|51|||
162170896|NCT04304820|585678941|FG000|Overall Study|Death|1|||
162170897|NCT04304820|585678941|FG000|Overall Study|Lost to Follow-up|1|||
162170898|NCT04304820|585678941|FG000|Overall Study|Pursuing Stem Cell Transplant|4|||
162170899|NCT04304820|585678941|FG000|Overall Study|Pursuing Additional Immunosuppressive therapy|4|||
162170900|NCT04304820|585678941|FG000|Overall Study|Evolution to Myeloid Malignancy|1|||
162170901|NCT03873818|585678942|FG000|Overall Study|Death|9|||
162170902|NCT03873818|585678943|FG001|Overall Study|Death|3|||
162170903|NCT03873818|585678942|FG000|Overall Study|Lost to Follow-up|1|||
162170904|NCT03873818|585678943|FG001|Overall Study|Lost to Follow-up|0|||
162170905|NCT03474107|585678944|FG000|Overall Study|Adverse Event|42|||
162170906|NCT03474107|585678945|FG001|Overall Study|Adverse Event|46|||
162170907|NCT03474107|585678944|FG000|Overall Study|Death|2|||
162170908|NCT03474107|585678945|FG001|Overall Study|Death|2|||
162170909|NCT03474107|585678944|FG000|Overall Study|Lost to Follow-up|0|||
162170910|NCT03474107|585678945|FG001|Overall Study|Lost to Follow-up|1|||
162170911|NCT03474107|585678944|FG000|Overall Study|Progressive Disease|177|||
162170912|NCT03474107|585678945|FG001|Overall Study|Progressive Disease|180|||
162170913|NCT03474107|585678944|FG000|Overall Study|Protocol Violation|1|||
162170914|NCT03474107|585678945|FG001|Overall Study|Protocol Violation|1|||
162170915|NCT03474107|585678944|FG000|Overall Study|Withdrawal by Subject|15|||
162170916|NCT03474107|585678945|FG001|Overall Study|Withdrawal by Subject|27|||
162170917|NCT03474107|585678944|FG000|Overall Study|Physician Decision|7|||
162170918|NCT03474107|585678945|FG001|Overall Study|Physician Decision|22|||
162170919|NCT03474107|585678944|FG000|Overall Study|Miscellaneous|1|||
162170920|NCT03474107|585678945|FG001|Overall Study|Miscellaneous|6|||
162170921|NCT05171855|585678946|FG000|Overall Study|Death|1|||
162170922|NCT05171855|585678947|FG001|Overall Study|Death|0|||
162170923|NCT05171855|585678948|FG002|Overall Study|Death|0|||
162170924|NCT05171855|585678946|FG000|Overall Study|Withdrawal by Subject|2|||
162170925|NCT05171855|585678947|FG001|Overall Study|Withdrawal by Subject|0|||
162170926|NCT05171855|585678948|FG002|Overall Study|Withdrawal by Subject|5|||
162170927|NCT05171855|585678946|FG000|Overall Study|Physician Decision|1|||
161816628|NCT00112437|584368825|FG021|Years 6-10 (60-Month Extension)|Other|0|||
161816629|NCT00112437|584368826|FG022|Years 6-10 (60-Month Extension)|Other|0|||
161816630|NCT00112437|584368827|FG023|Years 6-10 (60-Month Extension)|Other|0|||
161816631|NCT00112437|584368828|FG024|Years 6-10 (60-Month Extension)|Other|1|||
161816632|NCT00112437|584368829|FG025|Years 6-10 (60-Month Extension)|Other|0|||
161816633|NCT00112437|584368804|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816634|NCT00112437|584368805|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816635|NCT00112437|584368806|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816636|NCT00112437|584368807|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816637|NCT00112437|584368808|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816638|NCT00112437|584368809|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816639|NCT00112437|584368810|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816640|NCT00112437|584368811|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816641|NCT00112437|584368812|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816642|NCT00112437|584368813|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816643|NCT00112437|584368814|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816644|NCT00112437|584368815|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816645|NCT00112437|584368816|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816646|NCT00112437|584368817|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816647|NCT00112437|584368818|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816648|NCT00112437|584368819|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816649|NCT00112437|584368820|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816650|NCT00112437|584368821|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816651|NCT00112437|584368822|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816652|NCT00112437|584368823|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816653|NCT00112437|584368824|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816654|NCT00112437|584368825|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816655|NCT00112437|584368826|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816656|NCT00112437|584368827|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
161816657|NCT00112437|584368828|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816658|NCT00112437|584368829|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161816659|NCT00112437|584368804|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816660|NCT00112437|584368805|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162170928|NCT05171855|585678947|FG001|Overall Study|Physician Decision|0|||
162170929|NCT05171855|585678948|FG002|Overall Study|Physician Decision|0|||
162170930|NCT05171855|585678946|FG000|Overall Study|Adverse Event|2|||
162170931|NCT05171855|585678947|FG001|Overall Study|Adverse Event|4|||
162170932|NCT05171855|585678948|FG002|Overall Study|Adverse Event|2|||
162170933|NCT05171855|585678946|FG000|Overall Study|Other|0|||
162170934|NCT05171855|585678947|FG001|Overall Study|Other|0|||
162170935|NCT05171855|585678948|FG002|Overall Study|Other|1|||
162170936|NCT05041257|585678949|FG000|Overall Study|Death|37|||
162170937|NCT05041257|585678949|FG000|Overall Study|Lost to Follow-up|3|||
162170938|NCT05041257|585678949|FG000|Overall Study|Sponsor decision|39|||
162170939|NCT03067480|585678950|FG000|Overall Study|Lost to Follow-up|2|||
162170940|NCT03067480|585678951|FG001|Overall Study|Lost to Follow-up|4|||
162170941|NCT03067480|585678950|FG000|Overall Study|started insulin|1|||
162170942|NCT03067480|585678951|FG001|Overall Study|started insulin|1|||
162170943|NCT05782816|585678954|FG000|Overall Study|Withdrawal by Subject|1|||
162170944|NCT05782816|585678955|FG001|Overall Study|Withdrawal by Subject|0|||
162170945|NCT04221490|585678956|FG000|At 30 Days Follow-up|Death|7|||
162170946|NCT04221490|585678956|FG000|At 30 Days Follow-up|Physician Decision|1|||
162170947|NCT04221490|585678956|FG000|At 30 Days Follow-up|Missed Visit|4|||
162170948|NCT04221490|585678956|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
162170949|NCT04221490|585678956|FG000|At 6 Months Follow-up|Death|9|||
162170950|NCT04221490|585678956|FG000|At 6 Months Follow-up|Missed Visit|8|||
162170951|NCT04221490|585678956|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
162170952|NCT04221490|585678956|FG000|At 1 Year Follow-up|Death|7|||
162170953|NCT04221490|585678956|FG000|At 1 Year Follow-up|Withdrawal by Subject|2|||
162170954|NCT04221490|585678956|FG000|At 1 Year Follow-up|Missed Visit|9|||
162170955|NCT04221490|585678956|FG000|At 1 Year Follow-up|Exited for Other Reasons|1|||
162170956|NCT02442349|585678957|FG000|Overall Study|Death|95|||
162170957|NCT02442349|585678957|FG000|Overall Study|Withdrawal by Subject|27|||
162170958|NCT02442349|585678957|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
162170959|NCT02442349|585678957|FG000|Overall Study|Lost to Follow-up|1|||
162170960|NCT02296125|585678958|FG000|Overall Study|Withdrawal by Subject|18|||
162170961|NCT02296125|585678959|FG001|Overall Study|Withdrawal by Subject|8|||
162170962|NCT02296125|585678960|FG002|Overall Study|Withdrawal by Subject|6|||
162170963|NCT02296125|585678961|FG003|Overall Study|Withdrawal by Subject|2|||
162170964|NCT02296125|585678958|FG000|Overall Study|Adverse Event|41|||
162170965|NCT02296125|585678959|FG001|Overall Study|Adverse Event|52|||
162170966|NCT02296125|585678960|FG002|Overall Study|Adverse Event|9|||
162170967|NCT02296125|585678961|FG003|Overall Study|Adverse Event|4|||
162170968|NCT02296125|585678958|FG000|Overall Study|Severe non-compliance to protocol|0|||
162170969|NCT02296125|585678959|FG001|Overall Study|Severe non-compliance to protocol|1|||
162170970|NCT02296125|585678960|FG002|Overall Study|Severe non-compliance to protocol|0|||
162170971|NCT02296125|585678961|FG003|Overall Study|Severe non-compliance to protocol|0|||
162170972|NCT02296125|585678958|FG000|Overall Study|Condition under investigation worsened|153|||
162170973|NCT02296125|585678959|FG001|Overall Study|Condition under investigation worsened|199|||
162170974|NCT02296125|585678960|FG002|Overall Study|Condition under investigation worsened|39|||
162170975|NCT02296125|585678961|FG003|Overall Study|Condition under investigation worsened|56|||
162170976|NCT02296125|585678958|FG000|Overall Study|Any reason not specifically recorded|6|||
162170977|NCT02296125|585678959|FG001|Overall Study|Any reason not specifically recorded|4|||
162170978|NCT02296125|585678960|FG002|Overall Study|Any reason not specifically recorded|2|||
162170979|NCT02296125|585678961|FG003|Overall Study|Any reason not specifically recorded|0|||
161816661|NCT00112437|584368806|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816662|NCT00112437|584368807|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816663|NCT00112437|584368808|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816664|NCT00112437|584368809|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816665|NCT00112437|584368810|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816666|NCT00112437|584368811|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816667|NCT00112437|584368812|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816668|NCT00112437|584368813|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816669|NCT00112437|584368814|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816670|NCT00112437|584368815|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816671|NCT00112437|584368816|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816672|NCT00112437|584368817|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816673|NCT00112437|584368818|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816674|NCT00112437|584368819|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816675|NCT00112437|584368820|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816676|NCT00112437|584368821|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816677|NCT00112437|584368822|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162017651|NCT00905645|585119693|FG003|Overall Study|Lost to Follow-up|12|||
161816678|NCT00112437|584368823|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816679|NCT00112437|584368824|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
162017652|NCT01386970|585119694|FG000|Overall Study|Withdrawal by Subject|0|||
162170980|NCT02998268|585678966|FG000|Overall Study|Adverse Event|0|||
162170981|NCT02998268|585678967|FG001|Overall Study|Adverse Event|2|||
161921697|NCT01797185|584759984|FG001|Overall Study|Withdrawn per sponsor|0|||
161921698|NCT01797185|584759985|FG002|Overall Study|Withdrawn per sponsor|0|||
161921699|NCT01797185|584759983|FG000|Overall Study|Physician Decision|1|||
161921700|NCT01797185|584759984|FG001|Overall Study|Physician Decision|3|||
161921701|NCT01797185|584759985|FG002|Overall Study|Physician Decision|0|||
161921702|NCT01797185|584759983|FG000|Overall Study|Protocol Violation|1|||
161921703|NCT01797185|584759984|FG001|Overall Study|Protocol Violation|1|||
161921704|NCT01797185|584759985|FG002|Overall Study|Protocol Violation|0|||
161921705|NCT01033942|584759986|FG000|Overall Study|Withdrawal by Subject|1|||
161921706|NCT01033942|584759987|FG001|Overall Study|Withdrawal by Subject|1|||
161921707|NCT01033942|584759988|FG002|Overall Study|Withdrawal by Subject|1|||
161921708|NCT01033942|584759986|FG000|Overall Study|Lost to Follow-up|1|||
161921709|NCT01033942|584759987|FG001|Overall Study|Lost to Follow-up|0|||
161921710|NCT01033942|584759988|FG002|Overall Study|Lost to Follow-up|0|||
161921711|NCT01033942|584759986|FG000|Overall Study|Enrolled in Extension Study|0|||
161921712|NCT01033942|584759987|FG001|Overall Study|Enrolled in Extension Study|3|||
162017653|NCT01386970|585119695|FG001|Overall Study|Withdrawal by Subject|1|||
161921713|NCT01033942|584759988|FG002|Overall Study|Enrolled in Extension Study|0|||
161921714|NCT05276804|584759996|FG000|Overall Study|screen failure|23|||
161921715|NCT05276804|584759997|FG001|Overall Study|screen failure|0|||
161921716|NCT02827708|584759998|FG000|Overall Study|Lost to Follow-up|3|||
161921717|NCT02827708|584759999|FG001|Overall Study|Lost to Follow-up|1|||
162170982|NCT02998268|585678966|FG000|Overall Study|Withdrawal by Subject|0|||
162170983|NCT02998268|585678967|FG001|Overall Study|Withdrawal by Subject|1|||
162170984|NCT04225273|585678968|FG000|Overall Study|Lost to Follow-up|3|||
162170985|NCT04192266|585678969|FG000|Overall Study|Withdrawal by Subject|3|||
162170986|NCT04192266|585678970|FG001|Overall Study|Withdrawal by Subject|2|||
162170987|NCT01501955|585678971|FG000|Overall Study|Withdrawal by Subject|1|||
162170988|NCT01501955|585678972|FG001|Overall Study|Withdrawal by Subject|0|||
162170989|NCT01501955|585678971|FG000|Overall Study|Adverse Event|1|||
162170990|NCT01501955|585678972|FG001|Overall Study|Adverse Event|3|||
162170991|NCT01733316|585678974|FG000|RP103 Phase|Non-compliance|1|||
162170992|NCT01733316|585678974|FG000|Long Term Extension Phase|Adverse Event|1|||
162170993|NCT01733316|585678974|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
162170994|NCT01733316|585678974|FG000|Long Term Extension Phase|Sponsor Decision|2|||
162170995|NCT02838420|585678975|FG000|Overall Study|Ongoing in Study|113|||
162170996|NCT02838420|585678976|FG001|Overall Study|Ongoing in Study|45|||
162170997|NCT02838420|585678975|FG000|Overall Study|Lost to Follow-up|1|||
162170998|NCT02838420|585678976|FG001|Overall Study|Lost to Follow-up|0|||
162170999|NCT02838420|585678975|FG000|Overall Study|Withdrawal by Subject|3|||
162171000|NCT02838420|585678976|FG001|Overall Study|Withdrawal by Subject|4|||
162171001|NCT02838420|585678975|FG000|Overall Study|Death|8|||
162171002|NCT02838420|585678976|FG001|Overall Study|Death|13|||
162171003|NCT04811040|585678977|FG000|Overall Study|Lost to Follow-up|2|||
162171004|NCT04811040|585678978|FG001|Overall Study|Lost to Follow-up|0|||
162171005|NCT04811040|585678979|FG002|Overall Study|Lost to Follow-up|0|||
162171006|NCT04811040|585678980|FG003|Overall Study|Lost to Follow-up|0|||
162171007|NCT04811040|585678977|FG000|Overall Study|Withdrew consent|1|||
162171008|NCT04811040|585678978|FG001|Overall Study|Withdrew consent|1|||
162171009|NCT04811040|585678979|FG002|Overall Study|Withdrew consent|0|||
162171010|NCT04811040|585678980|FG003|Overall Study|Withdrew consent|0|||
162171011|NCT05934942|585678983|FG000|Run-in Period|Not treated|1|||
162171012|NCT05934942|585678983|FG000|Run-in Period|Withdrawal by Subject|1|||
162171013|NCT05469464|585678984|FG000|Overall Study|Withdrawal by Subject|8|||
162171014|NCT05469464|585678985|FG001|Overall Study|Withdrawal by Subject|7|||
162171015|NCT05469464|585678986|FG002|Overall Study|Withdrawal by Subject|4|||
162171016|NCT05469464|585678987|FG003|Overall Study|Withdrawal by Subject|5|||
162171017|NCT05469464|585678984|FG000|Overall Study|Adverse Event|8|||
162171018|NCT05469464|585678985|FG001|Overall Study|Adverse Event|14|||
162171019|NCT05469464|585678986|FG002|Overall Study|Adverse Event|13|||
162171020|NCT05469464|585678987|FG003|Overall Study|Adverse Event|2|||
162171021|NCT05469464|585678984|FG000|Overall Study|Lost to Follow-up|2|||
162171022|NCT05469464|585678985|FG001|Overall Study|Lost to Follow-up|5|||
162171023|NCT05469464|585678986|FG002|Overall Study|Lost to Follow-up|3|||
162171024|NCT05469464|585678987|FG003|Overall Study|Lost to Follow-up|3|||
162171025|NCT05469464|585678984|FG000|Overall Study|Lack of Efficacy|4|||
162171026|NCT05469464|585678985|FG001|Overall Study|Lack of Efficacy|1|||
161921718|NCT02827708|584759998|FG000|Overall Study|Withdrawal by Subject|1|||
161921719|NCT02827708|584759999|FG001|Overall Study|Withdrawal by Subject|2|||
161921720|NCT02827708|584759998|FG000|Overall Study|Death|1|||
161921721|NCT02827708|584759999|FG001|Overall Study|Death|2|||
161921722|NCT00407511|584760001|FG000|Overall Study|Adverse Event|9|||
161921723|NCT00407511|584760001|FG000|Overall Study|Lost to Follow-up|4|||
161921724|NCT00407511|584760001|FG000|Overall Study|Other|5|||
161921725|NCT00407511|584760001|FG000|Overall Study|Withdrawal by Subject|4|||
162171027|NCT05469464|585678986|FG002|Overall Study|Lack of Efficacy|2|||
162171028|NCT05469464|585678987|FG003|Overall Study|Lack of Efficacy|2|||
162171029|NCT05469464|585678984|FG000|Overall Study|Physician Decision|0|||
162171030|NCT05469464|585678985|FG001|Overall Study|Physician Decision|0|||
162171031|NCT05469464|585678986|FG002|Overall Study|Physician Decision|0|||
161816680|NCT00112437|584368825|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161921726|NCT02115386|584760002|FG000|Overall Study|Protocol Violation|1|||
161921727|NCT02115386|584760002|FG000|Overall Study|Administrative - trial was terminated|6|||
161921728|NCT02493855|584760003|FG000|Overall Study|Non-compliance|1|||
161921729|NCT02493855|584760004|FG001|Overall Study|Non-compliance|0|||
161921730|NCT02493855|584760005|FG002|Overall Study|Non-compliance|0|||
161921731|NCT02493855|584760003|FG000|Overall Study|Adverse Event|0|||
161921732|NCT02493855|584760004|FG001|Overall Study|Adverse Event|1|||
161921733|NCT02493855|584760005|FG002|Overall Study|Adverse Event|0|||
161921734|NCT02493855|584760003|FG000|Overall Study|Withdrawal by Subject|1|||
161921735|NCT02493855|584760004|FG001|Overall Study|Withdrawal by Subject|0|||
161921736|NCT02493855|584760005|FG002|Overall Study|Withdrawal by Subject|0|||
161921737|NCT05059080|584760006|FG000|Overall Study|Withdrawal by Subject|3|||
161921738|NCT05059080|584760006|FG000|Overall Study|Study Terminated by Sponsor|64|||
161921739|NCT02299167|584760007|FG000|Overall Study|patients were excluded from the study|11|||
161921740|NCT03600428|584760009|FG000|Overall Study|Not eligible|0|||
161921741|NCT03600428|584760010|FG001|Overall Study|Not eligible|1|||
161921742|NCT03600428|584760009|FG000|Overall Study|Lost to Follow-up|5|||
161921743|NCT03600428|584760010|FG001|Overall Study|Lost to Follow-up|4|||
161921744|NCT00549328|584760011|FG000|Overall Study|Adverse Event|2|||
161921745|NCT00549328|584760011|FG000|Overall Study|Disease Progression|10|||
161921746|NCT00549328|584760011|FG000|Overall Study|Death|1|||
161921747|NCT00549328|584760011|FG000|Overall Study|Use of Prohibited Medication|1|||
161921748|NCT00770484|584760012|FG000|Overall Study|Withdrawal by Subject|1|||
161921749|NCT00770484|584760013|FG001|Overall Study|Withdrawal by Subject|0|||
161921750|NCT04868682|584760019|FG000|Post-treatment|Lost to Follow-up|1|||
161921751|NCT04868682|584760020|FG001|Post-treatment|Lost to Follow-up|1|||
161921752|NCT04868682|584760019|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
161921753|NCT04868682|584760020|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
161921754|NCT04868682|584760019|FG000|Six-month Assessment|Lost to Follow-up|1|||
161921755|NCT04868682|584760020|FG001|Six-month Assessment|Lost to Follow-up|0|||
161921756|NCT04868682|584760019|FG000|Six-month Assessment|Death|1|||
161921757|NCT04868682|584760020|FG001|Six-month Assessment|Death|0|||
161921758|NCT04868682|584760019|FG000|Six-month Assessment|Refused|0|||
161921759|NCT04868682|584760020|FG001|Six-month Assessment|Refused|1|||
161921760|NCT04868682|584760019|FG000|12-month Assessment|Lost to Follow-up|2|||
161921761|NCT04868682|584760020|FG001|12-month Assessment|Lost to Follow-up|1|||
161921762|NCT04868682|584760019|FG000|12-month Assessment|Death|0|||
161921763|NCT04868682|584760020|FG001|12-month Assessment|Death|1|||
161921764|NCT03880565|584760024|FG000|Overall Study|Withdrawal by Subject|1|||
161921765|NCT03880565|584760025|FG001|Overall Study|Withdrawal by Subject|0|||
161921766|NCT02202616|584760026|FG000|Overall Study|Screen failed|24|||
161921767|NCT02202616|584760026|FG000|Overall Study|Adverse Event|32|||
161921768|NCT02202616|584760026|FG000|Overall Study|Protocol deviation|18|||
161921769|NCT02202616|584760026|FG000|Overall Study|Patient withdrew consent|12|||
161921770|NCT02202616|584760026|FG000|Overall Study|Lost to Follow-up|6|||
161921771|NCT02202616|584760026|FG000|Overall Study|Administrative problems|6|||
161921772|NCT02202616|584760026|FG000|Overall Study|Abnormal test procedure result|1|||
161921773|NCT02202616|584760026|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161921774|NCT04327271|584760030|FG000|Overall Study|Death|1|||
161921775|NCT04327271|584760031|FG001|Overall Study|Death|0|||
161921776|NCT04327271|584760030|FG000|Overall Study|Withdrawal by Subject|1|||
161921777|NCT04327271|584760031|FG001|Overall Study|Withdrawal by Subject|0|||
161921778|NCT04327271|584760030|FG000|Overall Study|randomization error (data capture)|4|||
161921779|NCT04327271|584760031|FG001|Overall Study|randomization error (data capture)|3|||
161921780|NCT05696847|584760032|FG000|Overall Study|Withdrawal by Subject|1|||
161921781|NCT05696847|584760033|FG001|Overall Study|Withdrawal by Subject|0|||
161921782|NCT05696847|584760034|FG002|Overall Study|Withdrawal by Subject|0|||
161921783|NCT05696847|584760035|FG003|Overall Study|Withdrawal by Subject|0|||
161921784|NCT05696847|584760036|FG004|Overall Study|Withdrawal by Subject|0|||
161921785|NCT05696847|584760037|FG005|Overall Study|Withdrawal by Subject|0|||
161921786|NCT05696847|584760032|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161921787|NCT05696847|584760033|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161921788|NCT05696847|584760034|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161921789|NCT05696847|584760035|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161921790|NCT05696847|584760036|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161921791|NCT05696847|584760037|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161921792|NCT05696847|584760032|FG000|Overall Study|Adverse Event|0|||
161921793|NCT05696847|584760033|FG001|Overall Study|Adverse Event|0|||
161921794|NCT05696847|584760034|FG002|Overall Study|Adverse Event|0|||
161921795|NCT05696847|584760035|FG003|Overall Study|Adverse Event|0|||
161921796|NCT05696847|584760036|FG004|Overall Study|Adverse Event|0|||
161921797|NCT05696847|584760037|FG005|Overall Study|Adverse Event|1|||
161921798|NCT05696847|584760032|FG000|Overall Study|Sponsor Decision|0|||
161921799|NCT05696847|584760033|FG001|Overall Study|Sponsor Decision|0|||
161921800|NCT05696847|584760034|FG002|Overall Study|Sponsor Decision|0|||
161921801|NCT05696847|584760035|FG003|Overall Study|Sponsor Decision|1|||
161921802|NCT05696847|584760036|FG004|Overall Study|Sponsor Decision|0|||
161921803|NCT05696847|584760037|FG005|Overall Study|Sponsor Decision|0|||
161921804|NCT01695746|584760041|FG000|Overall Study|Adverse Event|1|||
161921805|NCT01695746|584760041|FG000|Overall Study|Non-compliance by the participant|3|||
161921806|NCT01695746|584760041|FG000|Overall Study|Protocol Violation|5|||
161921807|NCT01695746|584760041|FG000|Overall Study|Participant not willing to participate|3|||
161921808|NCT03506477|584760044|FG000|Overall Study|Withdrawal by Subject|1|||
161921809|NCT03506477|584760045|FG001|Overall Study|Withdrawal by Subject|0|||
161921810|NCT03462680|584760046|FG000|Overall Study|Withdrawal by Subject|3|||
161921811|NCT03462680|584760047|FG001|Overall Study|Withdrawal by Subject|5|||
161921812|NCT02516241|584760048|FG000|Overall Study|Death|255|||
161921813|NCT02516241|584760049|FG001|Overall Study|Death|262|||
161921814|NCT02516241|584760050|FG002|Overall Study|Death|270|||
161921815|NCT02516241|584760048|FG000|Overall Study|Lost to Follow-up|1|||
161921816|NCT02516241|584760049|FG001|Overall Study|Lost to Follow-up|1|||
161921817|NCT02516241|584760050|FG002|Overall Study|Lost to Follow-up|3|||
161921818|NCT02516241|584760048|FG000|Overall Study|Withdrawal by Subject|2|||
161921819|NCT02516241|584760049|FG001|Overall Study|Withdrawal by Subject|7|||
161921820|NCT02516241|584760050|FG002|Overall Study|Withdrawal by Subject|12|||
161921821|NCT02516241|584760048|FG000|Overall Study|participants ongoing at data cut-off|84|||
161921822|NCT02516241|584760049|FG001|Overall Study|participants ongoing at data cut-off|76|||
161921823|NCT02516241|584760050|FG002|Overall Study|participants ongoing at data cut-off|59|||
161921824|NCT00462462|584760051|FG000|Overall Study|Physician Decision|0|||
161921825|NCT00462462|584760052|FG001|Overall Study|Physician Decision|1|||
161921826|NCT01163617|584760053|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921827|NCT01163617|584760054|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
161921828|NCT01163617|584760055|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921829|NCT01163617|584760056|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921830|NCT01163617|584760057|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921831|NCT01163617|584760058|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921832|NCT01163617|584760059|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921833|NCT01163617|584760060|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161921834|NCT01163617|584760053|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921835|NCT01163617|584760054|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
161921836|NCT01163617|584760055|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921837|NCT01163617|584760056|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921838|NCT01163617|584760057|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921839|NCT01163617|584760058|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921840|NCT01163617|584760059|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921841|NCT01163617|584760060|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161921842|NCT01163617|584760053|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921843|NCT01163617|584760054|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921844|NCT01163617|584760055|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
161921845|NCT01163617|584760056|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921846|NCT01163617|584760057|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921847|NCT01163617|584760058|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921848|NCT01163617|584760059|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921849|NCT01163617|584760060|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161921850|NCT02875080|584760061|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
161921851|NCT02875080|584760062|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
161921852|NCT02875080|584760063|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
161921853|NCT02394756|584760064|FG000|Period 1|Lens Discomfort|0|||
161921854|NCT02394756|584760065|FG001|Period 1|Lens Discomfort|0|||
161921855|NCT02394756|584760066|FG002|Period 1|Lens Discomfort|0|||
161921856|NCT02394756|584760067|FG003|Period 1|Lens Discomfort|0|||
162171032|NCT05469464|585678987|FG003|Overall Study|Physician Decision|1|||
162171033|NCT03905798|585678988|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
162171034|NCT05374798|585678991|FG000|Overall Study|Lost to Follow-up|2|||
162171035|NCT05374798|585678991|FG000|Overall Study|Withdrawal by Subject|2|||
162171036|NCT05374798|585678991|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
162171037|NCT04498390|585678992|FG000|Overall Study|Adverse Event|0|||
162171038|NCT04498390|585678993|FG001|Overall Study|Adverse Event|0|||
162171039|NCT04498390|585678994|FG002|Overall Study|Adverse Event|1|||
162171040|NCT04498390|585678995|FG003|Overall Study|Adverse Event|0|||
162171041|NCT04498390|585678996|FG004|Overall Study|Adverse Event|0|||
162171042|NCT04498390|585678992|FG000|Overall Study|Withdrawal by Subject|0|||
162171043|NCT04498390|585678993|FG001|Overall Study|Withdrawal by Subject|0|||
162171044|NCT04498390|585678994|FG002|Overall Study|Withdrawal by Subject|0|||
162171045|NCT04498390|585678995|FG003|Overall Study|Withdrawal by Subject|1|||
162171046|NCT04498390|585678996|FG004|Overall Study|Withdrawal by Subject|0|||
162171047|NCT04585815|585678997|FG000|Sub-study A- Treatment Phase|Adverse Event|1|||
162171048|NCT04585815|585678998|FG001|Sub-study A- Treatment Phase|Adverse Event|4|||
162171049|NCT04585815|585678999|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
162171050|NCT04585815|585679000|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
162171051|NCT04585815|585679001|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
162171052|NCT04585815|585679002|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
161921857|NCT02394756|584760068|FG004|Period 1|Lens Discomfort|0|||
161921858|NCT02394756|584760069|FG005|Period 1|Lens Discomfort|1|||
161921859|NCT02394756|584760064|FG000|Period 1|Withdrawal by Subject|0|||
161921860|NCT02394756|584760065|FG001|Period 1|Withdrawal by Subject|1|||
162171053|NCT04585815|585679003|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
162171054|NCT04585815|585678997|FG000|Sub-study A- Treatment Phase|Death|0|||
162171055|NCT04585815|585678998|FG001|Sub-study A- Treatment Phase|Death|2|||
162171056|NCT04585815|585678999|FG002|Sub-study A- Treatment Phase|Death|0|||
162171057|NCT04585815|585679000|FG003|Sub-study A- Treatment Phase|Death|0|||
162171058|NCT04585815|585679001|FG004|Sub-study A- Treatment Phase|Death|0|||
162171059|NCT04585815|585679002|FG005|Sub-study A- Treatment Phase|Death|0|||
161921861|NCT02394756|584760066|FG002|Period 1|Withdrawal by Subject|1|||
162171060|NCT04585815|585679003|FG006|Sub-study A- Treatment Phase|Death|0|||
162171061|NCT04585815|585678997|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
162171062|NCT04585815|585678998|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
162171063|NCT04585815|585678999|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
162171064|NCT04585815|585679000|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
162171065|NCT04585815|585679001|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
162171066|NCT04585815|585679002|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
162171067|NCT04585815|585679003|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
162171068|NCT04585815|585678997|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
162171069|NCT04585815|585678998|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
162171070|NCT04585815|585678999|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161921862|NCT02394756|584760067|FG003|Period 1|Withdrawal by Subject|1|||
162171071|NCT04585815|585679000|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
162171072|NCT04585815|585679001|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161921863|NCT02394756|584760068|FG004|Period 1|Withdrawal by Subject|0|||
161921864|NCT02394756|584760069|FG005|Period 1|Withdrawal by Subject|0|||
161921865|NCT02394756|584760064|FG000|Period 2|Unsatisfactory Visual Response|0|||
161921866|NCT02394756|584760065|FG001|Period 2|Unsatisfactory Visual Response|0|||
161921867|NCT02394756|584760066|FG002|Period 2|Unsatisfactory Visual Response|0|||
161921868|NCT02394756|584760067|FG003|Period 2|Unsatisfactory Visual Response|0|||
162017654|NCT01386970|585119694|FG000|Overall Study|Adverse Event|4|||
162171073|NCT04585815|585679002|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
162171074|NCT04585815|585679003|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
162171075|NCT04585815|585678997|FG000|Sub-study A- Treatment Phase|Progressive disease|0|||
162171076|NCT04585815|585678998|FG001|Sub-study A- Treatment Phase|Progressive disease|1|||
162171077|NCT04585815|585678999|FG002|Sub-study A- Treatment Phase|Progressive disease|0|||
162171078|NCT04585815|585679000|FG003|Sub-study A- Treatment Phase|Progressive disease|0|||
162171079|NCT04585815|585679001|FG004|Sub-study A- Treatment Phase|Progressive disease|0|||
162171080|NCT04585815|585679002|FG005|Sub-study A- Treatment Phase|Progressive disease|0|||
162171081|NCT04585815|585679003|FG006|Sub-study A- Treatment Phase|Progressive disease|0|||
162171082|NCT04585815|585678997|FG000|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
162171083|NCT04585815|585678998|FG001|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
162171084|NCT04585815|585678999|FG002|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
162171085|NCT04585815|585679000|FG003|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
162171086|NCT04585815|585679001|FG004|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
162171087|NCT04585815|585679002|FG005|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
162171088|NCT04585815|585679003|FG006|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
162171089|NCT04585815|585678997|FG000|Sub-study A- Treatment Phase|Other|1|||
162171090|NCT04585815|585678998|FG001|Sub-study A- Treatment Phase|Other|0|||
162171091|NCT04585815|585678999|FG002|Sub-study A- Treatment Phase|Other|0|||
162171092|NCT04585815|585679000|FG003|Sub-study A- Treatment Phase|Other|0|||
161921869|NCT02394756|584760068|FG004|Period 2|Unsatisfactory Visual Response|1|||
161921870|NCT02394756|584760069|FG005|Period 2|Unsatisfactory Visual Response|0|||
161921871|NCT03018938|584760070|FG000|Overall Study|Death|0|||
161921872|NCT03018938|584760071|FG001|Overall Study|Death|1|||
161921873|NCT03018938|584760070|FG000|Overall Study|Lost to Follow-up|21|||
161921874|NCT03018938|584760071|FG001|Overall Study|Lost to Follow-up|32|||
161921875|NCT03018938|584760070|FG000|Overall Study|Withdrawal by Subject|38|||
161921876|NCT03018938|584760071|FG001|Overall Study|Withdrawal by Subject|45|||
161921877|NCT03018938|584760070|FG000|Overall Study|Physician Decision|3|||
161921878|NCT03018938|584760071|FG001|Overall Study|Physician Decision|2|||
161921879|NCT03018938|584760070|FG000|Overall Study|Sponsor Decision|0|||
161921880|NCT03018938|584760071|FG001|Overall Study|Sponsor Decision|1|||
161921881|NCT03018938|584760070|FG000|Overall Study|Screen failure-After randomization|4|||
161921882|NCT03018938|584760071|FG001|Overall Study|Screen failure-After randomization|2|||
161921883|NCT03018938|584760070|FG000|Overall Study|Not recorded|0|||
161921884|NCT03018938|584760071|FG001|Overall Study|Not recorded|2|||
161921885|NCT00191100|584760074|FG000|Overall Study|Adverse Event|18|||
161921886|NCT00191100|584760075|FG001|Overall Study|Adverse Event|1|||
161921887|NCT00191100|584760074|FG000|Overall Study|Lost to Follow-up|2|||
161921888|NCT00191100|584760075|FG001|Overall Study|Lost to Follow-up|0|||
161921889|NCT00191100|584760074|FG000|Overall Study|Patient Moved|0|||
161921890|NCT00191100|584760075|FG001|Overall Study|Patient Moved|1|||
161921891|NCT00191100|584760074|FG000|Overall Study|Withdrawal by Subject|9|||
161921892|NCT00191100|584760075|FG001|Overall Study|Withdrawal by Subject|3|||
161921893|NCT00191100|584760074|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
161921894|NCT00191100|584760075|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
161921895|NCT00191100|584760074|FG000|Overall Study|Clinical Relapse|2|||
161921896|NCT00191100|584760075|FG001|Overall Study|Clinical Relapse|1|||
161921897|NCT00191100|584760074|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
161921898|NCT00191100|584760075|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
161921899|NCT00191100|584760074|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
161921900|NCT00191100|584760075|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
161921901|NCT00191100|584760074|FG000|Overall Study|Physician Decision|3|||
161921902|NCT00191100|584760075|FG001|Overall Study|Physician Decision|1|||
161921903|NCT00191100|584760074|FG000|Overall Study|Death from Study Drug Toxicity|2|||
161921904|NCT00191100|584760075|FG001|Overall Study|Death from Study Drug Toxicity|0|||
161921905|NCT00191100|584760074|FG000|Overall Study|Protocol Violation|1|||
161921906|NCT00191100|584760075|FG001|Overall Study|Protocol Violation|1|||
161921907|NCT00191100|584760074|FG000|Overall Study|Death from Other Cause|1|||
161921908|NCT00191100|584760075|FG001|Overall Study|Death from Other Cause|0|||
161921909|NCT00191100|584760074|FG000|Overall Study|Reason Not Specified|0|||
161921910|NCT00191100|584760075|FG001|Overall Study|Reason Not Specified|1|||
161921911|NCT04766333|584760994|FG000|Overall Study|Lost to Follow-up|40|||
161921912|NCT04766333|584760995|FG001|Overall Study|Lost to Follow-up|826|||
161921913|NCT05177094|584760998|FG000|Overall Study|Adverse Event|5|||
161921914|NCT05177094|584760999|FG001|Overall Study|Adverse Event|5|||
161921915|NCT05177094|584760998|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
162171093|NCT04585815|585679001|FG004|Sub-study A- Treatment Phase|Other|0|||
162171094|NCT04585815|585679002|FG005|Sub-study A- Treatment Phase|Other|0|||
162171095|NCT04585815|585679003|FG006|Sub-study A- Treatment Phase|Other|0|||
162171096|NCT04585815|585678997|FG000|Sub-study A- Follow-up Phase|Death|0|||
162171097|NCT04585815|585678998|FG001|Sub-study A- Follow-up Phase|Death|1|||
162171098|NCT04585815|585678999|FG002|Sub-study A- Follow-up Phase|Death|0|||
162171099|NCT04585815|585679000|FG003|Sub-study A- Follow-up Phase|Death|0|||
162171100|NCT04585815|585679001|FG004|Sub-study A- Follow-up Phase|Death|0|||
161669944|NCT01881750|583843191|FG000|Overall Study|Changes in concomitant therapies|2|||
161669945|NCT01881750|583843192|FG001|Overall Study|Changes in concomitant therapies|3|||
161669946|NCT01881750|583843191|FG000|Overall Study|Lost to Follow-up|0|||
161669947|NCT01881750|583843192|FG001|Overall Study|Lost to Follow-up|1|||
161669948|NCT00051363|583843193|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
161669949|NCT00051363|583843194|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
161669950|NCT00051363|583843193|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
161669951|NCT00051363|583843194|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
161669952|NCT00051363|583843193|FG000|Overall Study|Death|2|||
161669953|NCT00051363|583843194|FG001|Overall Study|Death|2|||
161669954|NCT00051363|583843193|FG000|Overall Study|Excluded Pre-Randomization|2|||
161669955|NCT00051363|583843194|FG001|Overall Study|Excluded Pre-Randomization|5|||
161669956|NCT00026208|583843199|FG000|Overall Study|Complications of auto accident|1|||
161669957|NCT00026208|583843200|FG001|Overall Study|Complications of auto accident|0|||
161669958|NCT03282240|583843201|FG000|Overall Study|Adverse Event|2|||
161669959|NCT03282240|583843202|FG001|Overall Study|Adverse Event|2|||
161669960|NCT03282240|583843203|FG002|Overall Study|Adverse Event|0|||
161669961|NCT03282240|583843201|FG000|Overall Study|Lost to Follow-up|3|||
161669962|NCT03282240|583843202|FG001|Overall Study|Lost to Follow-up|0|||
161669963|NCT03282240|583843203|FG002|Overall Study|Lost to Follow-up|0|||
161669964|NCT03282240|583843201|FG000|Overall Study|Protocol Deviation|4|||
161669965|NCT03282240|583843202|FG001|Overall Study|Protocol Deviation|1|||
161669966|NCT03282240|583843203|FG002|Overall Study|Protocol Deviation|2|||
161669967|NCT03282240|583843201|FG000|Overall Study|Withdrawal by Subject|1|||
161669968|NCT03282240|583843202|FG001|Overall Study|Withdrawal by Subject|0|||
161669969|NCT03282240|583843203|FG002|Overall Study|Withdrawal by Subject|1|||
161669970|NCT01675479|583843204|FG000|Overall Study|Lost to Follow-up|11|||
161669971|NCT02910739|583843205|FG000|Overall Study|Adverse Event|1|||
162017655|NCT01386970|585119695|FG001|Overall Study|Adverse Event|1|||
162017656|NCT04439136|585119696|FG000|Overall Study|Ineligible|1|||
162017657|NCT04439136|585119696|FG000|Overall Study|Never Started Treatment|2|||
162017658|NCT04439136|585119696|FG000|Overall Study|Adverse Event|4|||
162017659|NCT04439136|585119696|FG000|Overall Study|Death|3|||
162017660|NCT04439136|585119696|FG000|Overall Study|Disease Progression|27|||
162017661|NCT04439136|585119696|FG000|Overall Study|Alternative Therapy|1|||
161669972|NCT02910739|583843206|FG001|Overall Study|Adverse Event|0|||
161669973|NCT02910739|583843207|FG002|Overall Study|Adverse Event|0|||
161669974|NCT02910739|583843208|FG003|Overall Study|Adverse Event|0|||
161669975|NCT01572922|583843211|FG000|Overall Study|Adverse Event|1|||
161669976|NCT01572922|583843211|FG000|Overall Study|Protocol Violation|1|||
161669977|NCT01572922|583843211|FG000|Overall Study|Death|1|||
161669978|NCT01103245|583845285|FG000|Overall Study|Withdrawal by Subject|1|||
161669979|NCT01103245|583845286|FG001|Overall Study|Withdrawal by Subject|0|||
161669980|NCT01103245|583845287|FG002|Overall Study|Withdrawal by Subject|3|||
161669981|NCT01103245|583845288|FG003|Overall Study|Withdrawal by Subject|0|||
161669982|NCT01103245|583845285|FG000|Overall Study|Inadequate IV access|1|||
161669983|NCT01103245|583845286|FG001|Overall Study|Inadequate IV access|0|||
161669984|NCT01103245|583845287|FG002|Overall Study|Inadequate IV access|0|||
161669985|NCT01103245|583845288|FG003|Overall Study|Inadequate IV access|0|||
162017662|NCT04439136|585119696|FG000|Overall Study|Increased Tumor Burden|1|||
162017663|NCT04439136|585119696|FG000|Overall Study|Symptomatic Detrioration|1|||
162017664|NCT00578292|585119697|FG000|Overall Study|Death|1|||
162171101|NCT04585815|585679002|FG005|Sub-study A- Follow-up Phase|Death|0|||
162171102|NCT04585815|585679003|FG006|Sub-study A- Follow-up Phase|Death|0|||
162171103|NCT04585815|585678997|FG000|Sub-study A- Follow-up Phase|Study terminated by sponsor|1|||
162171104|NCT04585815|585678998|FG001|Sub-study A- Follow-up Phase|Study terminated by sponsor|3|||
162171105|NCT04585815|585678999|FG002|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
162017665|NCT00578292|585119697|FG000|Overall Study|Graft failure|2|||
162017666|NCT04849559|585119698|FG000|Overall Study|Withdrawal by Subject|2|||
162171106|NCT04585815|585679000|FG003|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161669986|NCT01103245|583845285|FG000|Overall Study|Adverse Event|0|||
161669987|NCT01103245|583845286|FG001|Overall Study|Adverse Event|2|||
161669988|NCT01103245|583845287|FG002|Overall Study|Adverse Event|1|||
161669989|NCT01103245|583845288|FG003|Overall Study|Adverse Event|0|||
161669990|NCT01103245|583845285|FG000|Overall Study|Physician Decision|1|||
161669991|NCT01103245|583845286|FG001|Overall Study|Physician Decision|0|||
161669992|NCT01103245|583845287|FG002|Overall Study|Physician Decision|0|||
162017667|NCT04849559|585119699|FG001|Overall Study|Withdrawal by Subject|1|||
162171107|NCT04585815|585679001|FG004|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161921916|NCT05177094|584760999|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
161921917|NCT05177094|584760998|FG000|Overall Study|Protocol Deviation|3|||
161921918|NCT05177094|584760999|FG001|Overall Study|Protocol Deviation|0|||
161921919|NCT05177094|584760998|FG000|Overall Study|Withdrawal by Subject|6|||
161921920|NCT05177094|584760999|FG001|Overall Study|Withdrawal by Subject|3|||
161921921|NCT05177094|584760998|FG000|Overall Study|Participant could not tolerate long study visits|1|||
161921922|NCT05177094|584760999|FG001|Overall Study|Participant could not tolerate long study visits|0|||
161921923|NCT02737618|584761000|FG000|Overall Study|Withdrawal by Subject|9|||
161921924|NCT01047501|584761003|FG000|Overall Study|Adverse Event|7|||
161921925|NCT01047501|584761004|FG001|Overall Study|Adverse Event|8|||
161921926|NCT01047501|584761005|FG002|Overall Study|Adverse Event|5|||
161921927|NCT01047501|584761003|FG000|Overall Study|Withdrew Consent|6|||
161921928|NCT01047501|584761004|FG001|Overall Study|Withdrew Consent|2|||
161921929|NCT01047501|584761005|FG002|Overall Study|Withdrew Consent|4|||
161921930|NCT01047501|584761003|FG000|Overall Study|Lost to Follow-up|0|||
161921931|NCT01047501|584761004|FG001|Overall Study|Lost to Follow-up|1|||
161921932|NCT01047501|584761005|FG002|Overall Study|Lost to Follow-up|1|||
161921933|NCT01047501|584761003|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
161921934|NCT01047501|584761004|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
161921935|NCT01047501|584761005|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
161921936|NCT01047501|584761003|FG000|Overall Study|Death|1|||
161921937|NCT01047501|584761004|FG001|Overall Study|Death|0|||
161921938|NCT01047501|584761005|FG002|Overall Study|Death|0|||
161921939|NCT01047501|584761003|FG000|Overall Study|Other discontinuation|1|||
161921940|NCT01047501|584761004|FG001|Overall Study|Other discontinuation|0|||
161921941|NCT01047501|584761005|FG002|Overall Study|Other discontinuation|1|||
161921942|NCT01047501|584761003|FG000|Overall Study|Investigator judgement|0|||
161921943|NCT01047501|584761004|FG001|Overall Study|Investigator judgement|0|||
161921944|NCT01047501|584761005|FG002|Overall Study|Investigator judgement|1|||
161921945|NCT01257542|584761006|FG000|Overall Study|Protocol Violation|3|||
161921946|NCT01257542|584761007|FG001|Overall Study|Protocol Violation|5|||
161921947|NCT01257542|584761006|FG000|Overall Study|Withdrawal by Subject|0|||
161921948|NCT01257542|584761007|FG001|Overall Study|Withdrawal by Subject|2|||
161921949|NCT03097315|584761013|FG000|Overall Study|Withdrawal by Subject|1|||
161921950|NCT03384966|584761014|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
161921951|NCT03384966|584761015|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
161921952|NCT03384966|584761016|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
161921953|NCT03384966|584761014|FG000|Follow-up Period|Adverse Event|1|||
161921954|NCT03384966|584761015|FG001|Follow-up Period|Adverse Event|0|||
161921955|NCT03384966|584761016|FG002|Follow-up Period|Adverse Event|0|||
161921956|NCT02948400|584761018|FG000|Overall Study|Withdrawal by Subject|17|||
161921957|NCT02948400|584761019|FG001|Overall Study|Withdrawal by Subject|10|||
161921958|NCT02948400|584761018|FG000|Overall Study|failed to attend appointments|47|||
161921959|NCT02948400|584761019|FG001|Overall Study|failed to attend appointments|34|||
161921960|NCT02948400|584761018|FG000|Overall Study|COVID-related closure|6|||
161921961|NCT02948400|584761019|FG001|Overall Study|COVID-related closure|2|||
162171108|NCT04585815|585679002|FG005|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
162171109|NCT04585815|585679003|FG006|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
162171110|NCT04585815|585678997|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
162171111|NCT04585815|585678998|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
162171112|NCT04585815|585678999|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
162171113|NCT04585815|585679000|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
162171114|NCT04585815|585679001|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
162171115|NCT04585815|585679002|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
162171116|NCT04585815|585679003|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
162171117|NCT04585815|585678997|FG000|Sub-study B- Treatment Phase|Death|0|||
161921962|NCT02948400|584761018|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
162171118|NCT04585815|585678998|FG001|Sub-study B- Treatment Phase|Death|0|||
162171119|NCT04585815|585678999|FG002|Sub-study B- Treatment Phase|Death|0|||
162171120|NCT04585815|585679000|FG003|Sub-study B- Treatment Phase|Death|1|||
162171121|NCT04585815|585679001|FG004|Sub-study B- Treatment Phase|Death|0|||
162171122|NCT04585815|585679002|FG005|Sub-study B- Treatment Phase|Death|0|||
162171123|NCT04585815|585679003|FG006|Sub-study B- Treatment Phase|Death|0|||
162171124|NCT04585815|585678997|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
162171125|NCT04585815|585678998|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
162171126|NCT04585815|585678999|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
162171127|NCT04585815|585679000|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
162171128|NCT04585815|585679001|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
162171129|NCT04585815|585679002|FG005|Sub-study B- Treatment Phase|Progressive disease|1|||
162171130|NCT04585815|585679003|FG006|Sub-study B- Treatment Phase|Progressive disease|5|||
162171131|NCT04585815|585678997|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
162171132|NCT04585815|585678998|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
162171133|NCT04585815|585678999|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
162171134|NCT04585815|585679000|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
162171135|NCT04585815|585679001|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
162171136|NCT04585815|585679002|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
162171137|NCT04585815|585679003|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
162171138|NCT04585815|585678997|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
162171139|NCT04585815|585678998|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
162171140|NCT04585815|585678999|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
162171141|NCT04585815|585679000|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
162171142|NCT04585815|585679001|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
162171143|NCT04585815|585679002|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
162171144|NCT04585815|585679003|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
162171145|NCT04585815|585678997|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
162171146|NCT04585815|585678998|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
162171147|NCT04585815|585678999|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
162171148|NCT04585815|585679000|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
161669993|NCT01103245|583845288|FG003|Overall Study|Physician Decision|0|||
161921963|NCT02948400|584761019|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
161921964|NCT02948400|584761018|FG000|Overall Study|motion sickness in virtual reality|2|||
161921965|NCT02948400|584761019|FG001|Overall Study|motion sickness in virtual reality|0|||
161921966|NCT01716156|584761020|FG000|Overall Study|Protocol Violation|1|||
161921967|NCT01716156|584761021|FG001|Overall Study|Protocol Violation|0|||
161921968|NCT01716156|584761022|FG002|Overall Study|Protocol Violation|0|||
162017668|NCT03901469|585119700|FG000|Overall Study|Radiographic Progression|4|||
162017669|NCT03901469|585119701|FG001|Overall Study|Radiographic Progression|6|||
162017670|NCT03901469|585119702|FG002|Overall Study|Radiographic Progression|3|||
162017671|NCT03901469|585119703|FG003|Overall Study|Radiographic Progression|30|||
162017672|NCT03901469|585119704|FG004|Overall Study|Radiographic Progression|7|||
162017673|NCT03901469|585119705|FG005|Overall Study|Radiographic Progression|2|||
162017674|NCT03901469|585119706|FG006|Overall Study|Radiographic Progression|11|||
162017675|NCT03901469|585119700|FG000|Overall Study|Clinical Progression|0|||
162017676|NCT03901469|585119701|FG001|Overall Study|Clinical Progression|2|||
162017677|NCT03901469|585119702|FG002|Overall Study|Clinical Progression|0|||
162017678|NCT03901469|585119703|FG003|Overall Study|Clinical Progression|7|||
162017679|NCT03901469|585119704|FG004|Overall Study|Clinical Progression|6|||
162017680|NCT03901469|585119705|FG005|Overall Study|Clinical Progression|0|||
162017681|NCT03901469|585119706|FG006|Overall Study|Clinical Progression|2|||
162017682|NCT03901469|585119700|FG000|Overall Study|Adverse Event|1|||
162017683|NCT03901469|585119701|FG001|Overall Study|Adverse Event|0|||
162017684|NCT03901469|585119702|FG002|Overall Study|Adverse Event|0|||
162017685|NCT03901469|585119703|FG003|Overall Study|Adverse Event|0|||
162017686|NCT03901469|585119704|FG004|Overall Study|Adverse Event|0|||
162017687|NCT03901469|585119705|FG005|Overall Study|Adverse Event|0|||
162017688|NCT03901469|585119706|FG006|Overall Study|Adverse Event|9|||
162017689|NCT03901469|585119700|FG000|Overall Study|Physician Decision|0|||
162017690|NCT03901469|585119701|FG001|Overall Study|Physician Decision|0|||
162017691|NCT03901469|585119702|FG002|Overall Study|Physician Decision|0|||
162017692|NCT03901469|585119703|FG003|Overall Study|Physician Decision|1|||
162017693|NCT03901469|585119704|FG004|Overall Study|Physician Decision|0|||
162017694|NCT03901469|585119705|FG005|Overall Study|Physician Decision|0|||
162017695|NCT03901469|585119706|FG006|Overall Study|Physician Decision|0|||
162017696|NCT03901469|585119700|FG000|Overall Study|Withdrawal by Subject|0|||
162017697|NCT03901469|585119701|FG001|Overall Study|Withdrawal by Subject|0|||
162017698|NCT03901469|585119702|FG002|Overall Study|Withdrawal by Subject|0|||
162017699|NCT03901469|585119703|FG003|Overall Study|Withdrawal by Subject|0|||
162017700|NCT03901469|585119704|FG004|Overall Study|Withdrawal by Subject|2|||
162017701|NCT03901469|585119705|FG005|Overall Study|Withdrawal by Subject|0|||
162017702|NCT03901469|585119706|FG006|Overall Study|Withdrawal by Subject|8|||
162017703|NCT03901469|585119700|FG000|Overall Study|Death|0|||
162017704|NCT03901469|585119701|FG001|Overall Study|Death|0|||
162017705|NCT03901469|585119702|FG002|Overall Study|Death|0|||
162017706|NCT03901469|585119703|FG003|Overall Study|Death|3|||
162017707|NCT03901469|585119704|FG004|Overall Study|Death|5|||
162017708|NCT03901469|585119705|FG005|Overall Study|Death|0|||
162017709|NCT03901469|585119706|FG006|Overall Study|Death|1|||
162017710|NCT03901469|585119700|FG000|Overall Study|Termination of study by sponsor|0|||
162017711|NCT03901469|585119701|FG001|Overall Study|Termination of study by sponsor|0|||
162017712|NCT03901469|585119702|FG002|Overall Study|Termination of study by sponsor|0|||
162017713|NCT03901469|585119703|FG003|Overall Study|Termination of study by sponsor|0|||
162017714|NCT03901469|585119704|FG004|Overall Study|Termination of study by sponsor|1|||
162017715|NCT03901469|585119705|FG005|Overall Study|Termination of study by sponsor|1|||
162017716|NCT03901469|585119706|FG006|Overall Study|Termination of study by sponsor|0|||
162017717|NCT03901469|585119700|FG000|Overall Study|Not Reported|1|||
162017718|NCT03901469|585119701|FG001|Overall Study|Not Reported|0|||
162017719|NCT03901469|585119702|FG002|Overall Study|Not Reported|0|||
162017720|NCT03901469|585119703|FG003|Overall Study|Not Reported|1|||
162017721|NCT03901469|585119704|FG004|Overall Study|Not Reported|0|||
162017722|NCT03901469|585119705|FG005|Overall Study|Not Reported|0|||
162017723|NCT03901469|585119706|FG006|Overall Study|Not Reported|1|||
162017724|NCT01662102|585119707|FG000|Overall Study|Sponsor's decision|1|||
162017725|NCT01662102|585119708|FG001|Overall Study|Sponsor's decision|0|||
162017726|NCT02586207|585119709|FG000|Overall Study|Physician Decision|1|||
162017727|NCT02586207|585119709|FG000|Overall Study|Withdrawal by Subject|1|||
162017728|NCT00439517|585119710|FG000|Overall Study|Subject on treatment|1|||
162017729|NCT00439517|585119711|FG001|Overall Study|Subject on treatment|0|||
162017730|NCT00439517|585119710|FG000|Overall Study|Subject in survival follow-up|1|||
161669994|NCT03078907|583845293|FG000|Overall Study|Adverse Event|2|||
162017731|NCT00439517|585119711|FG001|Overall Study|Subject in survival follow-up|0|||
162017732|NCT00470275|585119714|FG000|Overall Study|Death|1|||
162017733|NCT00470275|585119714|FG000|Overall Study|Lack of Efficacy|7|||
162017734|NCT00470275|585119714|FG000|Overall Study|Withdrawal by Subject|2|||
162017735|NCT02207088|585119715|FG000|Overall Study|Adverse Event|2|||
162017736|NCT01077076|585119717|FG000|First Intervention|Withdrawal by Subject|1|||
162017737|NCT01077076|585119718|FG001|First Intervention|Withdrawal by Subject|0|||
162017738|NCT01077076|585119719|FG002|First Intervention|Withdrawal by Subject|0|||
162017739|NCT01077076|585119720|FG003|First Intervention|Withdrawal by Subject|0|||
162017740|NCT01077076|585119721|FG004|First Intervention|Withdrawal by Subject|0|||
162017741|NCT01077076|585119722|FG005|First Intervention|Withdrawal by Subject|0|||
162017742|NCT01077076|585119717|FG000|Third Intervention|Death in the participant's family|0|||
162017743|NCT01077076|585119718|FG001|Third Intervention|Death in the participant's family|0|||
162017744|NCT01077076|585119719|FG002|Third Intervention|Death in the participant's family|0|||
162017745|NCT01077076|585119720|FG003|Third Intervention|Death in the participant's family|0|||
162017746|NCT01077076|585119721|FG004|Third Intervention|Death in the participant's family|0|||
162017747|NCT01077076|585119722|FG005|Third Intervention|Death in the participant's family|1|||
162017748|NCT00060840|585119725|FG000|Overall Study|Change in surgical plan|2|||
162017749|NCT00060840|585119726|FG001|Overall Study|Change in surgical plan|6|||
162017750|NCT00060840|585119725|FG000|Overall Study|Death|0|||
162017751|NCT00060840|585119726|FG001|Overall Study|Death|1|||
162017752|NCT00060840|585119725|FG000|Overall Study|Withdrawal by Subject|0|||
162017753|NCT00060840|585119726|FG001|Overall Study|Withdrawal by Subject|1|||
162017754|NCT00060840|585119725|FG000|Overall Study|Subinvestigator unavailable|0|||
162017755|NCT00060840|585119726|FG001|Overall Study|Subinvestigator unavailable|1|||
162017756|NCT00060840|585119725|FG000|Overall Study|Physician Decision|1|||
162017757|NCT00060840|585119726|FG001|Overall Study|Physician Decision|0|||
162017758|NCT00060840|585119725|FG000|Overall Study|Other|1|||
162017759|NCT00060840|585119726|FG001|Overall Study|Other|0|||
162017760|NCT01388335|585119727|FG000|Period 1|Progressive Disease|1|||
162017761|NCT01388335|585119727|FG000|Period 2|Progressive Disease|2|||
162017762|NCT01388335|585119727|FG000|Period 2|Sponsor Decision|1|||
162017763|NCT01388335|585119727|FG000|Safety Extension|Progressive Disease|7|||
162017764|NCT01415882|585119728|FG000|Overall Study|Ineligible|1|||
162017765|NCT01415882|585119729|FG001|Overall Study|Ineligible|0|||
162017766|NCT01415882|585119730|FG002|Overall Study|Ineligible|0|||
162017767|NCT01415882|585119731|FG003|Overall Study|Ineligible|3|||
162017768|NCT01415882|585119732|FG004|Overall Study|Ineligible|0|||
162017769|NCT01415882|585119728|FG000|Overall Study|Withdrawal by Subject|0|||
162017770|NCT01415882|585119729|FG001|Overall Study|Withdrawal by Subject|1|||
162017771|NCT01415882|585119730|FG002|Overall Study|Withdrawal by Subject|0|||
162017772|NCT01415882|585119731|FG003|Overall Study|Withdrawal by Subject|1|||
162017773|NCT01415882|585119732|FG004|Overall Study|Withdrawal by Subject|0|||
162017774|NCT00976560|585119733|FG000|Overall Study|Adverse Event|5|||
162017775|NCT00976560|585119734|FG001|Overall Study|Adverse Event|5|||
162017776|NCT00976560|585119733|FG000|Overall Study|Lack of Efficacy|3|||
162017777|NCT00976560|585119734|FG001|Overall Study|Lack of Efficacy|5|||
162017778|NCT00976560|585119733|FG000|Overall Study|Protocol Violation|1|||
162017779|NCT00976560|585119734|FG001|Overall Study|Protocol Violation|0|||
162017780|NCT00976560|585119733|FG000|Overall Study|Lost to Follow-up|1|||
162017781|NCT00976560|585119734|FG001|Overall Study|Lost to Follow-up|0|||
162017782|NCT00976560|585119733|FG000|Overall Study|Physician Decision|2|||
162017783|NCT00976560|585119734|FG001|Overall Study|Physician Decision|0|||
162171149|NCT04585815|585679001|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
162171150|NCT04585815|585679002|FG005|Sub-study B- Treatment Phase|Physician Decision|0|||
162171151|NCT04585815|585679003|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
162171152|NCT04585815|585678997|FG000|Sub-study B- Follow-up Phase|Death|0|||
162171153|NCT04585815|585678998|FG001|Sub-study B- Follow-up Phase|Death|0|||
162171154|NCT04585815|585678999|FG002|Sub-study B- Follow-up Phase|Death|1|||
162171155|NCT04585815|585679000|FG003|Sub-study B- Follow-up Phase|Death|3|||
162171156|NCT04585815|585679001|FG004|Sub-study B- Follow-up Phase|Death|1|||
162171157|NCT04585815|585679002|FG005|Sub-study B- Follow-up Phase|Death|0|||
162171158|NCT04585815|585679003|FG006|Sub-study B- Follow-up Phase|Death|3|||
162171159|NCT04585815|585678997|FG000|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162171160|NCT04585815|585678998|FG001|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162171161|NCT04585815|585678999|FG002|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162171162|NCT04585815|585679000|FG003|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162171163|NCT04585815|585679001|FG004|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162171164|NCT04585815|585679002|FG005|Sub-study B- Follow-up Phase|Study terminated by sponsor|1|||
162171165|NCT04585815|585679003|FG006|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
162017784|NCT00976560|585119733|FG000|Overall Study|Withdrawal by Subject|2|||
162017785|NCT00976560|585119734|FG001|Overall Study|Withdrawal by Subject|3|||
162017786|NCT00125164|585119737|FG000|Overall Study|Adverse Event|0|||
162017787|NCT00125164|585119738|FG001|Overall Study|Adverse Event|0|||
162017788|NCT00125164|585119739|FG002|Overall Study|Adverse Event|2|||
162017789|NCT00125164|585119740|FG003|Overall Study|Adverse Event|4|||
162017790|NCT00125164|585119737|FG000|Overall Study|Lost to Follow-up|0|||
162017791|NCT00125164|585119738|FG001|Overall Study|Lost to Follow-up|0|||
162017792|NCT00125164|585119739|FG002|Overall Study|Lost to Follow-up|1|||
162171166|NCT01854775|585679004|FG000|Treatment Phase (48 Weeks)|Withdrew consent|1|||
162171167|NCT01854775|585679005|FG001|Treatment Phase (48 Weeks)|Withdrew consent|1|||
162017793|NCT00125164|585119740|FG003|Overall Study|Lost to Follow-up|1|||
162017794|NCT00125164|585119737|FG000|Overall Study|Withdrawal by Subject|2|||
162017795|NCT00125164|585119738|FG001|Overall Study|Withdrawal by Subject|0|||
161921969|NCT01716156|584761020|FG000|Overall Study|Withdrawal by Subject|0|||
161921970|NCT01716156|584761021|FG001|Overall Study|Withdrawal by Subject|1|||
161921971|NCT01716156|584761022|FG002|Overall Study|Withdrawal by Subject|2|||
161921972|NCT01716156|584761020|FG000|Overall Study|Lost to Follow-up|1|||
161921973|NCT01716156|584761021|FG001|Overall Study|Lost to Follow-up|0|||
161921974|NCT01716156|584761022|FG002|Overall Study|Lost to Follow-up|0|||
161921975|NCT05513950|584761025|FG000|Overall Study|Not treated due to technical reasons|0|||
161921976|NCT05513950|584761026|FG001|Overall Study|Not treated due to technical reasons|0|||
161921977|NCT05513950|584761027|FG002|Overall Study|Not treated due to technical reasons|1|||
161921978|NCT05513950|584761028|FG003|Overall Study|Not treated due to technical reasons|0|||
161921979|NCT05221866|584761029|FG000|Overall Study|Withdrawal by Subject|5|||
161921980|NCT05221866|584761030|FG001|Overall Study|Withdrawal by Subject|7|||
161921981|NCT05221866|584761031|FG002|Overall Study|Withdrawal by Subject|6|||
161921982|NCT05221866|584761032|FG003|Overall Study|Withdrawal by Subject|4|||
161921983|NCT05221866|584761029|FG000|Overall Study|Physician Decision|3|||
161921984|NCT05221866|584761030|FG001|Overall Study|Physician Decision|2|||
161921985|NCT05221866|584761031|FG002|Overall Study|Physician Decision|1|||
161921986|NCT05221866|584761032|FG003|Overall Study|Physician Decision|4|||
161921987|NCT05221866|584761029|FG000|Overall Study|Lost to Follow-up|12|||
161921988|NCT05221866|584761030|FG001|Overall Study|Lost to Follow-up|17|||
161921989|NCT05221866|584761031|FG002|Overall Study|Lost to Follow-up|14|||
161921990|NCT05221866|584761032|FG003|Overall Study|Lost to Follow-up|14|||
161921991|NCT05221866|584761029|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
161921992|NCT05221866|584761030|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
161921993|NCT05221866|584761031|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
161921994|NCT05221866|584761032|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
161921995|NCT05561140|584761033|FG000|Randomized Treatment Period|Adverse Event|1|||
161921996|NCT05561140|584761034|FG001|Randomized Treatment Period|Adverse Event|0|||
161921997|NCT05561140|584761033|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
161921998|NCT05561140|584761034|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
161921999|NCT05561140|584761033|FG000|Open Label Treatment Period|Adverse Event|6|||
161922000|NCT05561140|584761034|FG001|Open Label Treatment Period|Adverse Event|4|||
161922001|NCT05561140|584761033|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
161922002|NCT05561140|584761034|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
161922003|NCT05561140|584761033|FG000|Open Label Treatment Period|Physician Decision|0|||
161922004|NCT05561140|584761034|FG001|Open Label Treatment Period|Physician Decision|1|||
161922005|NCT05561140|584761033|FG000|Open Label Treatment Period|Pregnancy|1|||
161922006|NCT05561140|584761034|FG001|Open Label Treatment Period|Pregnancy|0|||
161922007|NCT05561140|584761033|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
161922008|NCT05561140|584761034|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
161922009|NCT05561140|584761033|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
161922010|NCT05561140|584761034|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
161922011|NCT05561140|584761033|FG000|Open Label Treatment Period|Other|1|||
161922012|NCT05561140|584761034|FG001|Open Label Treatment Period|Other|0|||
161922013|NCT00221104|584761037|FG000|Overall Study|Adverse Event|1|||
161922014|NCT00221104|584761038|FG001|Overall Study|Adverse Event|0|||
161922015|NCT00221104|584761037|FG000|Overall Study|Physician Decision|1|||
161922016|NCT00221104|584761038|FG001|Overall Study|Physician Decision|0|||
161922017|NCT00221104|584761037|FG000|Overall Study|Protocol Violation|2|||
161922018|NCT00221104|584761038|FG001|Overall Study|Protocol Violation|0|||
161922019|NCT00221104|584761037|FG000|Overall Study|Withdrawal by Subject|42|||
161922020|NCT00221104|584761038|FG001|Overall Study|Withdrawal by Subject|29|||
161922021|NCT00221104|584761037|FG000|Overall Study|Others|37|||
161922022|NCT00221104|584761038|FG001|Overall Study|Others|47|||
161922023|NCT02989389|584761039|FG000|Period 1|Lost to Follow-up|0|||
161922024|NCT02989389|584761040|FG001|Period 1|Lost to Follow-up|1|||
161922025|NCT02989389|584761041|FG002|Period 1|Lost to Follow-up|0|||
161922026|NCT02989389|584761042|FG003|Period 1|Lost to Follow-up|0|||
161922027|NCT02989389|584761043|FG004|Period 1|Lost to Follow-up|0|||
161922028|NCT02989389|584761044|FG005|Period 1|Lost to Follow-up|0|||
161922029|NCT02989389|584761045|FG006|Period 1|Lost to Follow-up|0|||
161922030|NCT02989389|584761046|FG007|Period 1|Lost to Follow-up|0|||
161922031|NCT02989389|584761047|FG008|Period 1|Lost to Follow-up|0|||
161922032|NCT02989389|584761048|FG009|Period 1|Lost to Follow-up|0|||
161816681|NCT00112437|584368826|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
161816682|NCT00112437|584368827|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
161816683|NCT00112437|584368828|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161816684|NCT00112437|584368829|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
161816685|NCT03218787|584368831|FG000|Overall Study|Lost to Follow-up|12|||
161816686|NCT03218787|584368831|FG000|Overall Study|Withdrawal by Subject|72|||
161816687|NCT03218787|584368831|FG000|Overall Study|Physician Decision|11|||
161816688|NCT03218787|584368831|FG000|Overall Study|Death|111|||
161669995|NCT03078907|583845294|FG001|Overall Study|Adverse Event|0|||
161669996|NCT03078907|583845293|FG000|Overall Study|Other|1|||
161669997|NCT03078907|583845294|FG001|Overall Study|Other|0|||
161816689|NCT02896296|584368832|FG000|Overall Study|Adverse Event|1|||
161816690|NCT02896296|584368832|FG000|Overall Study|Lost to Follow-up|19|||
161816691|NCT02896296|584368832|FG000|Overall Study|Pregnancy|1|||
162171168|NCT01854775|585679006|FG002|Treatment Phase (48 Weeks)|Withdrew consent|0|||
162171169|NCT01854775|585679004|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
162171170|NCT01854775|585679005|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
162171171|NCT01854775|585679006|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
162171172|NCT01854775|585679004|FG000|Extension Phase|Pregnancy|1|||
162171173|NCT01854775|585679005|FG001|Extension Phase|Pregnancy|0|||
162171174|NCT01854775|585679006|FG002|Extension Phase|Pregnancy|0|||
162171175|NCT01854775|585679004|FG000|Extension Phase|Investigator's Discretion|1|||
162171176|NCT01854775|585679005|FG001|Extension Phase|Investigator's Discretion|0|||
162171177|NCT01854775|585679006|FG002|Extension Phase|Investigator's Discretion|0|||
162171178|NCT01854775|585679004|FG000|Extension Phase|Non-Compliance with study drug|1|||
162171179|NCT01854775|585679005|FG001|Extension Phase|Non-Compliance with study drug|0|||
162171180|NCT01854775|585679006|FG002|Extension Phase|Non-Compliance with study drug|0|||
162171181|NCT01854775|585679004|FG000|Extension Phase|Lost to Follow-up|1|||
162171182|NCT01854775|585679005|FG001|Extension Phase|Lost to Follow-up|0|||
162171183|NCT01854775|585679006|FG002|Extension Phase|Lost to Follow-up|0|||
162171184|NCT01854775|585679004|FG000|Extension Phase|Withdrew consent|0|||
162171185|NCT01854775|585679005|FG001|Extension Phase|Withdrew consent|1|||
162171186|NCT01854775|585679006|FG002|Extension Phase|Withdrew consent|0|||
162171187|NCT04068311|585679007|FG000|Overall Study|Death|3|||
162171188|NCT04068311|585679008|FG001|Overall Study|Death|3|||
162171189|NCT04068311|585679007|FG000|Overall Study|Lost to Follow-up|24|||
162171190|NCT04068311|585679008|FG001|Overall Study|Lost to Follow-up|68|||
162171191|NCT04068311|585679007|FG000|Overall Study|Withdrawal by Subject|5|||
162171192|NCT04068311|585679008|FG001|Overall Study|Withdrawal by Subject|0|||
162171193|NCT02068885|585679009|FG000|Overall Study|Withdrew|3|||
162171194|NCT02068885|585679010|FG001|Overall Study|Withdrew|5|||
162171195|NCT02068885|585679011|FG002|Overall Study|Withdrew|8|||
162171196|NCT03100149|585679014|FG000|Overall Study|Adverse Event|0|||
162171197|NCT03100149|585679015|FG001|Overall Study|Adverse Event|1|||
162171198|NCT03100149|585679016|FG002|Overall Study|Adverse Event|0|||
162171199|NCT03100149|585679014|FG000|Overall Study|Participant Moved out of Country|0|||
162171200|NCT03100149|585679015|FG001|Overall Study|Participant Moved out of Country|0|||
162171201|NCT03100149|585679016|FG002|Overall Study|Participant Moved out of Country|1|||
162171202|NCT03100149|585679014|FG000|Overall Study|Withdrawal by Subject|0|||
162171203|NCT03100149|585679015|FG001|Overall Study|Withdrawal by Subject|3|||
162171204|NCT03100149|585679016|FG002|Overall Study|Withdrawal by Subject|1|||
162171205|NCT05321082|585679017|FG000|Overall Study|Other than listed|40|||
162171206|NCT05321082|585679018|FG001|Overall Study|Other than listed|26|||
162171207|NCT05321082|585679019|FG002|Overall Study|Other than listed|27|||
162171208|NCT05321082|585679017|FG000|Overall Study|Lost to Follow-up|0|||
162171209|NCT05321082|585679018|FG001|Overall Study|Lost to Follow-up|1|||
162171210|NCT05321082|585679019|FG002|Overall Study|Lost to Follow-up|0|||
162171211|NCT05321082|585679017|FG000|Overall Study|Withdrawal by Subject|30|||
162171212|NCT05321082|585679018|FG001|Overall Study|Withdrawal by Subject|34|||
162171213|NCT05321082|585679019|FG002|Overall Study|Withdrawal by Subject|42|||
162171214|NCT05321082|585679017|FG000|Overall Study|Protocol Violation|0|||
162171215|NCT05321082|585679018|FG001|Overall Study|Protocol Violation|0|||
162171216|NCT05321082|585679019|FG002|Overall Study|Protocol Violation|1|||
162171217|NCT05321082|585679017|FG000|Overall Study|Adverse Event|49|||
162171218|NCT05321082|585679018|FG001|Overall Study|Adverse Event|49|||
162171219|NCT05321082|585679019|FG002|Overall Study|Adverse Event|48|||
162171220|NCT05321082|585679017|FG000|Overall Study|Lack of Efficacy|2|||
162171221|NCT05321082|585679018|FG001|Overall Study|Lack of Efficacy|0|||
162171222|NCT05321082|585679019|FG002|Overall Study|Lack of Efficacy|1|||
162171223|NCT05321082|585679017|FG000|Overall Study|Not treated|1|||
162171224|NCT05321082|585679018|FG001|Overall Study|Not treated|0|||
162171225|NCT05321082|585679019|FG002|Overall Study|Not treated|1|||
162171226|NCT07147257|585679020|FG000|Overall Study|Pregnancy|1|||
162171227|NCT07147257|585679021|FG001|Overall Study|Pregnancy|0|||
162171228|NCT07147257|585679020|FG000|Overall Study|Physician Decision|0|||
162171229|NCT07147257|585679021|FG001|Overall Study|Physician Decision|1|||
162171230|NCT07147257|585679020|FG000|Overall Study|Withdrawal by Subject|0|||
162171231|NCT07147257|585679021|FG001|Overall Study|Withdrawal by Subject|1|||
162171232|NCT07147257|585679020|FG000|Overall Study|Drug administration failure|0|||
162171233|NCT07147257|585679021|FG001|Overall Study|Drug administration failure|1|||
161922033|NCT02989389|584761039|FG000|Period 1|Physician Decision|0|||
162171234|NCT03748953|585680348|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
162171235|NCT03748953|585680349|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
162171236|NCT03748953|585680348|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
162171237|NCT03748953|585680349|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
162171238|NCT03748953|585680348|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
162171239|NCT03748953|585680349|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
162171240|NCT03748953|585680348|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
162171241|NCT03748953|585680349|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
161922034|NCT02989389|584761040|FG001|Period 1|Physician Decision|0|||
161922035|NCT02989389|584761041|FG002|Period 1|Physician Decision|0|||
161922036|NCT02989389|584761042|FG003|Period 1|Physician Decision|0|||
161922037|NCT02989389|584761043|FG004|Period 1|Physician Decision|0|||
161922038|NCT02989389|584761044|FG005|Period 1|Physician Decision|0|||
161922039|NCT02989389|584761045|FG006|Period 1|Physician Decision|0|||
161922040|NCT02989389|584761046|FG007|Period 1|Physician Decision|0|||
161922041|NCT02989389|584761047|FG008|Period 1|Physician Decision|1|||
161922042|NCT02989389|584761048|FG009|Period 1|Physician Decision|0|||
161922043|NCT01666652|584761049|FG000|Overall Study|Serious Adverse Event|0|||
161922044|NCT01666652|584761050|FG001|Overall Study|Serious Adverse Event|0|||
161922045|NCT01666652|584761051|FG002|Overall Study|Serious Adverse Event|0|||
161922046|NCT01666652|584761052|FG003|Overall Study|Serious Adverse Event|1|||
161922047|NCT01666652|584761053|FG004|Overall Study|Serious Adverse Event|0|||
161922048|NCT01666652|584761049|FG000|Overall Study|Withdrawal by Subject|0|||
161922049|NCT01666652|584761050|FG001|Overall Study|Withdrawal by Subject|0|||
161922050|NCT01666652|584761051|FG002|Overall Study|Withdrawal by Subject|0|||
161922051|NCT01666652|584761052|FG003|Overall Study|Withdrawal by Subject|0|||
161922052|NCT01666652|584761053|FG004|Overall Study|Withdrawal by Subject|1|||
161922053|NCT01666652|584761049|FG000|Overall Study|Moved from study area|1|||
161922054|NCT01666652|584761050|FG001|Overall Study|Moved from study area|0|||
161922055|NCT01666652|584761051|FG002|Overall Study|Moved from study area|0|||
161922056|NCT01666652|584761052|FG003|Overall Study|Moved from study area|2|||
161922057|NCT01666652|584761053|FG004|Overall Study|Moved from study area|0|||
161922058|NCT01666652|584761049|FG000|Overall Study|Lost to Follow-up|1|||
161922059|NCT01666652|584761050|FG001|Overall Study|Lost to Follow-up|1|||
161922060|NCT01666652|584761051|FG002|Overall Study|Lost to Follow-up|1|||
161922061|NCT01666652|584761052|FG003|Overall Study|Lost to Follow-up|1|||
161922062|NCT01666652|584761053|FG004|Overall Study|Lost to Follow-up|0|||
161922063|NCT01018979|584761054|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
161922064|NCT01018979|584761055|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
161922065|NCT01018979|584761054|FG000|Overall Study|Not received at least one dose|0|||
161922066|NCT01018979|584761055|FG001|Overall Study|Not received at least one dose|1|||
161922067|NCT00088153|584761056|FG000|Overall Study|Physician Decision|3|||
161922068|NCT00088153|584761057|FG001|Overall Study|Physician Decision|3|||
161922069|NCT00088153|584761056|FG000|Overall Study|Withdrawal by Subject|10|||
162171242|NCT03748953|585680348|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
162171243|NCT03748953|585680349|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
162171244|NCT04298983|585680350|FG000|Overall Study|Adverse Event|4|||
162171245|NCT04298983|585680350|FG000|Overall Study|Lack of Efficacy|3|||
162171246|NCT02927236|585680351|FG000|Characterization Phase|Physician Decision|0|||
162171247|NCT02927236|585680352|FG001|Characterization Phase|Physician Decision|3|||
162171248|NCT02927236|585680353|FG002|Characterization Phase|Physician Decision|0|||
162171249|NCT02927236|585680354|FG003|Characterization Phase|Physician Decision|2|||
162171250|NCT02927236|585680351|FG000|Characterization Phase|Lost to Follow-up|0|||
162171251|NCT02927236|585680352|FG001|Characterization Phase|Lost to Follow-up|0|||
162171252|NCT02927236|585680353|FG002|Characterization Phase|Lost to Follow-up|0|||
162171253|NCT02927236|585680354|FG003|Characterization Phase|Lost to Follow-up|3|||
162171254|NCT02927236|585680351|FG000|Characterization Phase|Withdrawal by Subject|1|||
162171255|NCT02927236|585680352|FG001|Characterization Phase|Withdrawal by Subject|0|||
162171256|NCT02927236|585680353|FG002|Characterization Phase|Withdrawal by Subject|0|||
162171257|NCT02927236|585680354|FG003|Characterization Phase|Withdrawal by Subject|1|||
162171258|NCT02927236|585680351|FG000|Treatment Phase|Adverse Event|1|||
162171259|NCT02927236|585680352|FG001|Treatment Phase|Adverse Event|0|||
162171260|NCT02927236|585680353|FG002|Treatment Phase|Adverse Event|1|||
162171261|NCT02927236|585680354|FG003|Treatment Phase|Adverse Event|1|||
162171262|NCT02927236|585680351|FG000|Treatment Phase|Protocol Violation|3|||
162171263|NCT02927236|585680352|FG001|Treatment Phase|Protocol Violation|0|||
162171264|NCT02927236|585680353|FG002|Treatment Phase|Protocol Violation|0|||
162171265|NCT02927236|585680354|FG003|Treatment Phase|Protocol Violation|1|||
162171266|NCT02927236|585680351|FG000|Treatment Phase|Lost to Follow-up|1|||
162171267|NCT02927236|585680352|FG001|Treatment Phase|Lost to Follow-up|0|||
162171268|NCT02927236|585680353|FG002|Treatment Phase|Lost to Follow-up|0|||
162171269|NCT02927236|585680354|FG003|Treatment Phase|Lost to Follow-up|0|||
162171270|NCT02927236|585680351|FG000|Follow-up Phase|Lost to Follow-up|1|||
162171271|NCT02927236|585680352|FG001|Follow-up Phase|Lost to Follow-up|0|||
162171272|NCT02927236|585680353|FG002|Follow-up Phase|Lost to Follow-up|1|||
162171273|NCT02927236|585680354|FG003|Follow-up Phase|Lost to Follow-up|0|||
162171274|NCT05477186|585680355|FG000|Overall Study|Vaccine not administered|0|||
162171275|NCT05477186|585680356|FG001|Overall Study|Vaccine not administered|2|||
162171276|NCT05477186|585680357|FG002|Overall Study|Vaccine not administered|1|||
162171277|NCT05477186|585680358|FG003|Overall Study|Vaccine not administered|0|||
162171278|NCT05477186|585680359|FG004|Overall Study|Vaccine not administered|1|||
162171279|NCT05477186|585680360|FG005|Overall Study|Vaccine not administered|0|||
162171280|NCT05477186|585680361|FG006|Overall Study|Vaccine not administered|0|||
162171281|NCT05477186|585680355|FG000|Overall Study|Withdrawal by Subject|1|||
162171282|NCT05477186|585680356|FG001|Overall Study|Withdrawal by Subject|0|||
162171283|NCT05477186|585680357|FG002|Overall Study|Withdrawal by Subject|0|||
162171284|NCT05477186|585680358|FG003|Overall Study|Withdrawal by Subject|0|||
162171285|NCT05477186|585680359|FG004|Overall Study|Withdrawal by Subject|0|||
162171286|NCT05477186|585680360|FG005|Overall Study|Withdrawal by Subject|1|||
162171287|NCT05477186|585680361|FG006|Overall Study|Withdrawal by Subject|0|||
162171288|NCT05477186|585680355|FG000|Overall Study|Lost to Follow-up|1|||
162171289|NCT05477186|585680356|FG001|Overall Study|Lost to Follow-up|0|||
162171290|NCT05477186|585680357|FG002|Overall Study|Lost to Follow-up|2|||
162171291|NCT05477186|585680358|FG003|Overall Study|Lost to Follow-up|1|||
162171292|NCT05477186|585680359|FG004|Overall Study|Lost to Follow-up|1|||
162171293|NCT05477186|585680360|FG005|Overall Study|Lost to Follow-up|0|||
162171294|NCT05477186|585680361|FG006|Overall Study|Lost to Follow-up|2|||
161669998|NCT03078907|583845293|FG000|Overall Study|Protocol Violation|0|||
161669999|NCT03078907|583845294|FG001|Overall Study|Protocol Violation|1|||
161670000|NCT01955122|583845295|FG000|Overall Study|Physician Decision|5|||
161670001|NCT01955122|583845296|FG001|Overall Study|Physician Decision|5|||
161670002|NCT01672788|583845297|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
161670003|NCT01672788|583845298|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
161670004|NCT01672788|583845299|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
161670005|NCT01672788|583845300|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
161670006|NCT01128361|583845303|FG000|Overall Study|Lost to Follow-up|0|||
161670007|NCT01128361|583845304|FG001|Overall Study|Lost to Follow-up|1|||
161670008|NCT01128361|583845303|FG000|Overall Study|Withdrawal by Subject|5|||
161670009|NCT01128361|583845304|FG001|Overall Study|Withdrawal by Subject|2|||
161670010|NCT02464228|583845305|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
161670011|NCT02464228|583845306|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
161670012|NCT02464228|583845307|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
161670013|NCT02464228|583845308|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
161670014|NCT02464228|583845305|FG000|Overall Study|Physician Decision|2|||
161670015|NCT02464228|583845306|FG001|Overall Study|Physician Decision|0|||
161670016|NCT02464228|583845307|FG002|Overall Study|Physician Decision|1|||
161670017|NCT02464228|583845308|FG003|Overall Study|Physician Decision|0|||
161670018|NCT02464228|583845305|FG000|Overall Study|Miscellaneous|1|||
161670019|NCT02464228|583845306|FG001|Overall Study|Miscellaneous|0|||
161670020|NCT02464228|583845307|FG002|Overall Study|Miscellaneous|1|||
161670021|NCT02464228|583845308|FG003|Overall Study|Miscellaneous|0|||
161670022|NCT02464228|583845305|FG000|Overall Study|Adverse Event|9|||
161670023|NCT02464228|583845306|FG001|Overall Study|Adverse Event|0|||
161670024|NCT02464228|583845307|FG002|Overall Study|Adverse Event|3|||
161670025|NCT02464228|583845308|FG003|Overall Study|Adverse Event|0|||
161670026|NCT02464228|583845305|FG000|Overall Study|Withdrawal by Subject|1|||
161670027|NCT02464228|583845306|FG001|Overall Study|Withdrawal by Subject|1|||
161670028|NCT02464228|583845307|FG002|Overall Study|Withdrawal by Subject|1|||
161670029|NCT02464228|583845308|FG003|Overall Study|Withdrawal by Subject|0|||
161670030|NCT02464228|583845305|FG000|Overall Study|Disease Progression|22|||
161670031|NCT02464228|583845306|FG001|Overall Study|Disease Progression|12|||
161670032|NCT02464228|583845307|FG002|Overall Study|Disease Progression|5|||
161670033|NCT02464228|583845308|FG003|Overall Study|Disease Progression|2|||
161670034|NCT04658186|583845324|FG000|Overall Study|Adverse Event|4|||
161670035|NCT04658186|583845325|FG001|Overall Study|Adverse Event|18|||
161670036|NCT04658186|583845326|FG002|Overall Study|Adverse Event|15|||
161670037|NCT04658186|583845324|FG000|Overall Study|Lack of Efficacy|1|||
161670038|NCT04658186|583845325|FG001|Overall Study|Lack of Efficacy|1|||
161670039|NCT04658186|583845326|FG002|Overall Study|Lack of Efficacy|0|||
161670040|NCT04658186|583845324|FG000|Overall Study|Protocol Violation|0|||
161670041|NCT04658186|583845325|FG001|Overall Study|Protocol Violation|0|||
161670042|NCT04658186|583845326|FG002|Overall Study|Protocol Violation|1|||
161670043|NCT04658186|583845324|FG000|Overall Study|Lost to Follow-up|0|||
161670044|NCT04658186|583845325|FG001|Overall Study|Lost to Follow-up|0|||
161670045|NCT04658186|583845326|FG002|Overall Study|Lost to Follow-up|2|||
161670046|NCT04658186|583845324|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
161670047|NCT04658186|583845325|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
161670048|NCT04658186|583845326|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
161670049|NCT04658186|583845324|FG000|Overall Study|Participant is Moving in Another Province|0|||
161670050|NCT04658186|583845325|FG001|Overall Study|Participant is Moving in Another Province|1|||
161670051|NCT04658186|583845326|FG002|Overall Study|Participant is Moving in Another Province|0|||
161670052|NCT04658186|583845324|FG000|Overall Study|Non-Compliance|0|||
161670053|NCT04658186|583845325|FG001|Overall Study|Non-Compliance|1|||
161670054|NCT04658186|583845326|FG002|Overall Study|Non-Compliance|1|||
161670055|NCT04658186|583845324|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
161670056|NCT04658186|583845325|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
161922070|NCT00088153|584761057|FG001|Overall Study|Withdrawal by Subject|10|||
161922071|NCT00088153|584761056|FG000|Overall Study|Lost to Follow-up|11|||
161922072|NCT00088153|584761057|FG001|Overall Study|Lost to Follow-up|12|||
161922073|NCT01132755|584761058|FG000|Overall Study|Procedure not done due to medical reason|23|||
161922074|NCT01132755|584761058|FG000|Overall Study|Protocol Violation|15|||
161922075|NCT01132755|584761058|FG000|Overall Study|Withdrawal by Subject|4|||
161670057|NCT04658186|583845326|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
161922076|NCT01757847|584761059|FG000|Overall Study|Withdrawal by Subject|3|||
161922077|NCT01757847|584761060|FG001|Overall Study|Withdrawal by Subject|4|||
161670058|NCT04658186|583845324|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
161922078|NCT04057365|584761061|FG000|Overall Study|Withdrawal by Subject|2|||
161670059|NCT04658186|583845325|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
161670060|NCT04658186|583845326|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
161670061|NCT04658186|583845324|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
161670062|NCT04658186|583845325|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
161670063|NCT04658186|583845326|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
162171295|NCT01919554|585680363|FG000|Overall Study|Withdrawal by Subject|0|||
162171296|NCT01919554|585680364|FG001|Overall Study|Withdrawal by Subject|0|||
162171297|NCT01919554|585680365|FG002|Overall Study|Withdrawal by Subject|1|||
162171298|NCT01919554|585680366|FG003|Overall Study|Withdrawal by Subject|1|||
162171299|NCT03024437|585680367|FG000|Overall Study|Adverse Event|0|||
162171300|NCT03024437|585680368|FG001|Overall Study|Adverse Event|1|||
162171301|NCT03024437|585680369|FG002|Overall Study|Adverse Event|3|||
162171302|NCT03024437|585680370|FG003|Overall Study|Adverse Event|5|||
162171303|NCT03024437|585680371|FG004|Overall Study|Adverse Event|0|||
162171304|NCT03024437|585680367|FG000|Overall Study|Physician Decision|1|||
162171305|NCT03024437|585680368|FG001|Overall Study|Physician Decision|0|||
162171306|NCT03024437|585680369|FG002|Overall Study|Physician Decision|0|||
162171307|NCT03024437|585680370|FG003|Overall Study|Physician Decision|1|||
162171308|NCT03024437|585680371|FG004|Overall Study|Physician Decision|0|||
162171309|NCT03024437|585680367|FG000|Overall Study|Disease progression, relapse|1|||
162171310|NCT03024437|585680368|FG001|Overall Study|Disease progression, relapse|0|||
162171311|NCT03024437|585680369|FG002|Overall Study|Disease progression, relapse|0|||
162171312|NCT03024437|585680370|FG003|Overall Study|Disease progression, relapse|3|||
162171313|NCT03024437|585680371|FG004|Overall Study|Disease progression, relapse|0|||
162171314|NCT03024437|585680367|FG000|Overall Study|Disease progression, refractory disease|4|||
162171315|NCT03024437|585680368|FG001|Overall Study|Disease progression, refractory disease|4|||
162171316|NCT03024437|585680369|FG002|Overall Study|Disease progression, refractory disease|2|||
162171317|NCT03024437|585680370|FG003|Overall Study|Disease progression, refractory disease|2|||
162171318|NCT03024437|585680371|FG004|Overall Study|Disease progression, refractory disease|1|||
162171319|NCT03024437|585680367|FG000|Overall Study|Newly diagnosed cancer|0|||
162171320|NCT03024437|585680368|FG001|Overall Study|Newly diagnosed cancer|0|||
162171321|NCT03024437|585680369|FG002|Overall Study|Newly diagnosed cancer|0|||
162171322|NCT03024437|585680370|FG003|Overall Study|Newly diagnosed cancer|1|||
162171323|NCT03024437|585680371|FG004|Overall Study|Newly diagnosed cancer|0|||
162171324|NCT03024437|585680367|FG000|Overall Study|Moved out of state|0|||
162171325|NCT03024437|585680368|FG001|Overall Study|Moved out of state|1|||
162171326|NCT03024437|585680369|FG002|Overall Study|Moved out of state|0|||
162171327|NCT03024437|585680370|FG003|Overall Study|Moved out of state|0|||
162171328|NCT03024437|585680371|FG004|Overall Study|Moved out of state|0|||
162171329|NCT03024437|585680367|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
162171330|NCT03024437|585680368|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
162171331|NCT03024437|585680369|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
162171332|NCT03024437|585680370|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
162171333|NCT03024437|585680371|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
162171334|NCT02606422|585680372|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
162171335|NCT02606422|585680373|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
162171336|NCT02606422|585680372|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
162171337|NCT02606422|585680373|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
162171338|NCT02606422|585680372|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
162171339|NCT02606422|585680373|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
162171340|NCT02606422|585680372|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
162171341|NCT02606422|585680373|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
162171342|NCT04625465|585680374|FG000|Overall Study|Lost to Follow-up|2|||
162171343|NCT04625465|585680375|FG001|Overall Study|Lost to Follow-up|2|||
162171344|NCT04625465|585680376|FG002|Overall Study|Lost to Follow-up|1|||
162171345|NCT04625465|585680377|FG003|Overall Study|Lost to Follow-up|0|||
162171346|NCT04625465|585680378|FG004|Overall Study|Lost to Follow-up|0|||
162171347|NCT04625465|585680379|FG005|Overall Study|Lost to Follow-up|2|||
162171348|NCT04625465|585680380|FG006|Overall Study|Lost to Follow-up|0|||
162171349|NCT04625465|585680381|FG007|Overall Study|Lost to Follow-up|0|||
162171350|NCT04625465|585680374|FG000|Overall Study|Death|1|||
162171351|NCT04625465|585680375|FG001|Overall Study|Death|0|||
162171352|NCT04625465|585680376|FG002|Overall Study|Death|0|||
162171353|NCT04625465|585680377|FG003|Overall Study|Death|0|||
162171354|NCT04625465|585680378|FG004|Overall Study|Death|0|||
162171355|NCT04625465|585680379|FG005|Overall Study|Death|0|||
162171356|NCT04625465|585680380|FG006|Overall Study|Death|0|||
162171357|NCT04625465|585680381|FG007|Overall Study|Death|0|||
162171358|NCT04625465|585680374|FG000|Overall Study|Withdrawal by Subject|1|||
162171359|NCT04625465|585680375|FG001|Overall Study|Withdrawal by Subject|0|||
162171360|NCT04625465|585680376|FG002|Overall Study|Withdrawal by Subject|4|||
162171361|NCT04625465|585680377|FG003|Overall Study|Withdrawal by Subject|4|||
162171362|NCT04625465|585680378|FG004|Overall Study|Withdrawal by Subject|4|||
162171363|NCT04625465|585680379|FG005|Overall Study|Withdrawal by Subject|0|||
162171364|NCT04625465|585680380|FG006|Overall Study|Withdrawal by Subject|0|||
162171365|NCT04625465|585680381|FG007|Overall Study|Withdrawal by Subject|0|||
162171366|NCT05566639|585680385|FG000|Overall Study|Adverse Event|1|||
162171367|NCT05566639|585680386|FG001|Overall Study|Adverse Event|1|||
162171368|NCT05566639|585680385|FG000|Overall Study|Serious Adverse Event|1|||
162017796|NCT00125164|585119739|FG002|Overall Study|Withdrawal by Subject|1|||
162017797|NCT00125164|585119740|FG003|Overall Study|Withdrawal by Subject|1|||
162017798|NCT01339052|585119741|FG000|Overall Study|Disease progression|13|||
162017799|NCT01339052|585119742|FG001|Overall Study|Disease progression|46|||
162017800|NCT01339052|585119741|FG000|Overall Study|Adverse Event|1|||
162017801|NCT01339052|585119742|FG001|Overall Study|Adverse Event|1|||
162017802|NCT01339052|585119741|FG000|Overall Study|Withdrawal by Subject|0|||
162171369|NCT05566639|585680386|FG001|Overall Study|Serious Adverse Event|3|||
162171370|NCT05566639|585680385|FG000|Overall Study|Death|44|||
162171371|NCT05566639|585680386|FG001|Overall Study|Death|45|||
162171372|NCT05566639|585680385|FG000|Overall Study|Lost to Follow-up|467|||
162171373|NCT05566639|585680386|FG001|Overall Study|Lost to Follow-up|461|||
162171374|NCT05566639|585680385|FG000|Overall Study|Physician Decision|45|||
162171375|NCT05566639|585680386|FG001|Overall Study|Physician Decision|44|||
162171376|NCT05566639|585680385|FG000|Overall Study|Protocol Deviation|4|||
162171377|NCT05566639|585680386|FG001|Overall Study|Protocol Deviation|4|||
162171378|NCT05566639|585680385|FG000|Overall Study|Withdrawal by Subject|277|||
162171379|NCT05566639|585680386|FG001|Overall Study|Withdrawal by Subject|271|||
162171380|NCT05566639|585680385|FG000|Overall Study|Other Than Specified|52|||
162171381|NCT05566639|585680386|FG001|Overall Study|Other Than Specified|64|||
162171382|NCT04054193|585680394|FG000|Cycle 1|Physician Decision|1|||
162171383|NCT04054193|585680394|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
162171384|NCT04054193|585680394|FG000|Cycle 1|Allocated but not treated|3|||
162171385|NCT04054193|585680394|FG000|Cycles 2-3|Physician Decision|2|||
162171386|NCT04054193|585680394|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
162171387|NCT04054193|585680394|FG000|Cycles 2-3|Various reasons|17|||
162171388|NCT02966873|585680395|FG000|Overall Study|Lost to Follow-up|16|||
162171389|NCT02966873|585680396|FG001|Overall Study|Lost to Follow-up|15|||
162171390|NCT03235544|585680398|FG000|Overall Study|Death|11|||
162171391|NCT03235544|585680399|FG001|Overall Study|Death|31|||
162171392|NCT03235544|585680400|FG002|Overall Study|Death|19|||
162171393|NCT03235544|585680401|FG003|Overall Study|Death|34|||
162171394|NCT03235544|585680398|FG000|Overall Study|Lost to Follow-up|0|||
162171395|NCT03235544|585680399|FG001|Overall Study|Lost to Follow-up|1|||
162171396|NCT03235544|585680400|FG002|Overall Study|Lost to Follow-up|1|||
162171397|NCT03235544|585680401|FG003|Overall Study|Lost to Follow-up|1|||
162171398|NCT03235544|585680398|FG000|Overall Study|Withdrawal by Subject|0|||
162171399|NCT03235544|585680399|FG001|Overall Study|Withdrawal by Subject|3|||
162171400|NCT03235544|585680400|FG002|Overall Study|Withdrawal by Subject|1|||
162171401|NCT03235544|585680401|FG003|Overall Study|Withdrawal by Subject|5|||
162171402|NCT03235544|585680398|FG000|Overall Study|Disease Progression|0|||
162171403|NCT03235544|585680399|FG001|Overall Study|Disease Progression|1|||
162171404|NCT03235544|585680400|FG002|Overall Study|Disease Progression|0|||
162171405|NCT03235544|585680401|FG003|Overall Study|Disease Progression|2|||
162171406|NCT03235544|585680398|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
162171407|NCT03235544|585680399|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
162171408|NCT03235544|585680400|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
162171409|NCT03235544|585680401|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
162171410|NCT03235544|585680398|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
162171411|NCT03235544|585680399|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
162171412|NCT03235544|585680400|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
162171413|NCT03235544|585680401|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
162171414|NCT00950742|585680402|FG000|Overall Study|Other Adverse Event|1|||
162171415|NCT00950742|585680403|FG001|Overall Study|Other Adverse Event|0|||
162171416|NCT00950742|585680402|FG000|Overall Study|Withdrawal by Subject|3|||
162171417|NCT00950742|585680403|FG001|Overall Study|Withdrawal by Subject|0|||
162171418|NCT00950742|585680402|FG000|Overall Study|Progressive Disease|6|||
162171419|NCT00950742|585680403|FG001|Overall Study|Progressive Disease|2|||
162171420|NCT00950742|585680402|FG000|Overall Study|Dose limiting toxicity|6|||
162171421|NCT00950742|585680403|FG001|Overall Study|Dose limiting toxicity|0|||
162171422|NCT05436262|585680405|FG000|Pre-Randomization|Withdrawal by Subject|1|||
162171423|NCT05436262|585680406|FG001|Pre-Randomization|Withdrawal by Subject|0|||
162171424|NCT05436262|585680407|FG002|Pre-Randomization|Withdrawal by Subject|0|||
162017803|NCT01339052|585119742|FG001|Overall Study|Withdrawal by Subject|3|||
162171425|NCT05436262|585680405|FG000|Randomization|Withdrawal by Subject|0|||
162017804|NCT01339052|585119741|FG000|Overall Study|Physician Decision|1|||
162171426|NCT05436262|585680406|FG001|Randomization|Withdrawal by Subject|1|||
162171427|NCT05436262|585680407|FG002|Randomization|Withdrawal by Subject|0|||
162171428|NCT05299073|585680408|FG000|Overall Study|Withdrawal by Subject|0|||
162171429|NCT05299073|585680409|FG001|Overall Study|Withdrawal by Subject|0|||
162171430|NCT05299073|585680410|FG002|Overall Study|Withdrawal by Subject|1|||
162171431|NCT05299073|585680408|FG000|Overall Study|Adverse Event|0|||
162171432|NCT05299073|585680409|FG001|Overall Study|Adverse Event|1|||
162171433|NCT05299073|585680410|FG002|Overall Study|Adverse Event|0|||
162171434|NCT05299073|585680408|FG000|Overall Study|Lost to Follow-up|0|||
162171435|NCT05299073|585680409|FG001|Overall Study|Lost to Follow-up|1|||
162017805|NCT01339052|585119742|FG001|Overall Study|Physician Decision|0|||
162017806|NCT01301027|585119748|FG000|Overall Study|Physician Decision|2|||
162017807|NCT01301027|585119749|FG001|Overall Study|Physician Decision|0|||
162017808|NCT01301027|585119748|FG000|Overall Study|Withdrawal by Subject|2|||
162017809|NCT01301027|585119749|FG001|Overall Study|Withdrawal by Subject|3|||
162017810|NCT01301027|585119748|FG000|Overall Study|Adverse Event|0|||
162017811|NCT01301027|585119749|FG001|Overall Study|Adverse Event|2|||
162017812|NCT01301027|585119748|FG000|Overall Study|Fracture|1|||
162017813|NCT01301027|585119749|FG001|Overall Study|Fracture|3|||
162017814|NCT01301027|585119748|FG000|Overall Study|Transplant|0|||
162017815|NCT01301027|585119749|FG001|Overall Study|Transplant|2|||
162017816|NCT01301027|585119748|FG000|Overall Study|Volume Overload|3|||
162017817|NCT01301027|585119749|FG001|Overall Study|Volume Overload|0|||
162017818|NCT04625101|585119750|FG000|Overall Study|Withdrawal by Subject|0|||
162017819|NCT04625101|585119751|FG001|Overall Study|Withdrawal by Subject|1|||
162017820|NCT04625101|585119750|FG000|Overall Study|Protocol Deviation|1|||
162017821|NCT04625101|585119751|FG001|Overall Study|Protocol Deviation|0|||
162017822|NCT00467753|585119753|FG000|Overall Study|Lost to Follow-up|1|||
162017823|NCT00467753|585119754|FG001|Overall Study|Lost to Follow-up|2|||
162017824|NCT00467753|585119753|FG000|Overall Study|Adverse Event|2|||
162017825|NCT00467753|585119754|FG001|Overall Study|Adverse Event|0|||
162017826|NCT02533453|585119755|FG000|Overall Study|Adverse Event|6|||
162017827|NCT02533453|585119755|FG000|Overall Study|Protocol Violation|1|||
162017828|NCT02533453|585119755|FG000|Overall Study|Withdrawal by Subject|2|||
162017829|NCT00396253|585119756|FG000|Overall Study|Protocol Violation|1|||
162017830|NCT00396253|585119756|FG000|Overall Study|Withdrawal by Subject|7|||
162017831|NCT00396253|585119756|FG000|Overall Study|Death|3|||
162017832|NCT00396253|585119756|FG000|Overall Study|Physician Decision|1|||
162017833|NCT00396253|585119756|FG000|Overall Study|Change in eligibility status|1|||
162017834|NCT00092443|585119757|FG000|Overall Study|Adverse Event|9|||
162017835|NCT00092443|585119758|FG001|Overall Study|Adverse Event|13|||
162017836|NCT00092443|585119757|FG000|Overall Study|Lost to Follow-up|7|||
162017837|NCT00092443|585119758|FG001|Overall Study|Lost to Follow-up|3|||
162017838|NCT00092443|585119757|FG000|Overall Study|Protocol Violation|11|||
162017839|NCT00092443|585119758|FG001|Overall Study|Protocol Violation|9|||
162017840|NCT00092443|585119757|FG000|Overall Study|Withdrawal by Subject|9|||
162017841|NCT00092443|585119758|FG001|Overall Study|Withdrawal by Subject|11|||
162017842|NCT00092443|585119757|FG000|Overall Study|Moved|5|||
162017843|NCT00092443|585119758|FG001|Overall Study|Moved|5|||
162017844|NCT00092443|585119757|FG000|Overall Study|Other|17|||
162017845|NCT00092443|585119758|FG001|Overall Study|Other|13|||
162017846|NCT01500720|585119759|FG000|Overall Study|Randomized But Not Treated|1|||
162017847|NCT01500720|585119760|FG001|Overall Study|Randomized But Not Treated|1|||
162017848|NCT01500720|585119759|FG000|Overall Study|Other|4|||
162017849|NCT01500720|585119760|FG001|Overall Study|Other|8|||
162017850|NCT02624986|585119762|FG000|Overall Study|Death|0|||
162017851|NCT02624986|585119763|FG001|Overall Study|Death|1|||
162017852|NCT02624986|585119764|FG002|Overall Study|Death|2|||
162017853|NCT02624986|585119765|FG003|Overall Study|Death|2|||
161816692|NCT02896296|584368832|FG000|Overall Study|Physician Decision|2|||
161816693|NCT02896296|584368832|FG000|Overall Study|Withdrawal by Subject|10|||
161816694|NCT02896296|584368832|FG000|Overall Study|Site closing|7|||
161816695|NCT02896296|584368832|FG000|Overall Study|Incarceration|1|||
161816696|NCT02896296|584368832|FG000|Overall Study|Relocation|1|||
162017854|NCT02624986|585119766|FG004|Overall Study|Death|2|||
162017855|NCT02624986|585119767|FG005|Overall Study|Death|0|||
162017856|NCT02624986|585119768|FG006|Overall Study|Death|0|||
162017857|NCT02624986|585119769|FG007|Overall Study|Death|1|||
162017858|NCT02624986|585119762|FG000|Overall Study|Study Terminated by Sponsor|1|||
162017859|NCT02624986|585119763|FG001|Overall Study|Study Terminated by Sponsor|1|||
162017860|NCT02624986|585119764|FG002|Overall Study|Study Terminated by Sponsor|0|||
162017861|NCT02624986|585119765|FG003|Overall Study|Study Terminated by Sponsor|1|||
162017862|NCT02624986|585119766|FG004|Overall Study|Study Terminated by Sponsor|2|||
162017863|NCT02624986|585119767|FG005|Overall Study|Study Terminated by Sponsor|2|||
162017864|NCT02624986|585119768|FG006|Overall Study|Study Terminated by Sponsor|4|||
162017865|NCT02624986|585119769|FG007|Overall Study|Study Terminated by Sponsor|3|||
162017866|NCT02624986|585119762|FG000|Overall Study|Progressive Disease|0|||
162017867|NCT02624986|585119763|FG001|Overall Study|Progressive Disease|1|||
162017868|NCT02624986|585119764|FG002|Overall Study|Progressive Disease|0|||
162017869|NCT02624986|585119765|FG003|Overall Study|Progressive Disease|0|||
162017870|NCT02624986|585119766|FG004|Overall Study|Progressive Disease|0|||
162017871|NCT02624986|585119767|FG005|Overall Study|Progressive Disease|0|||
161816697|NCT04633564|584368833|FG000|Period 1|Adverse Event|28|||
162017872|NCT02624986|585119768|FG006|Overall Study|Progressive Disease|0|||
162017873|NCT02624986|585119769|FG007|Overall Study|Progressive Disease|0|||
162017874|NCT02624986|585119762|FG000|Overall Study|Protocol Violation|1|||
162017875|NCT02624986|585119763|FG001|Overall Study|Protocol Violation|0|||
162017876|NCT02624986|585119764|FG002|Overall Study|Protocol Violation|0|||
162017877|NCT02624986|585119765|FG003|Overall Study|Protocol Violation|0|||
162017878|NCT02624986|585119766|FG004|Overall Study|Protocol Violation|0|||
162017879|NCT02624986|585119767|FG005|Overall Study|Protocol Violation|0|||
161816698|NCT04633564|584368834|FG001|Period 1|Adverse Event|19|||
161816699|NCT04633564|584368833|FG000|Period 1|Death|8|||
161816700|NCT04633564|584368834|FG001|Period 1|Death|7|||
161816701|NCT04633564|584368833|FG000|Period 1|Lost to Follow-up|3|||
161816702|NCT04633564|584368834|FG001|Period 1|Lost to Follow-up|5|||
161816703|NCT04633564|584368833|FG000|Period 1|Physician Decision|4|||
161816704|NCT04633564|584368834|FG001|Period 1|Physician Decision|12|||
161816705|NCT04633564|584368833|FG000|Period 1|Protocol Violation|0|||
161816706|NCT04633564|584368834|FG001|Period 1|Protocol Violation|1|||
161816707|NCT04633564|584368833|FG000|Period 1|Withdrawal by Subject|10|||
161816708|NCT04633564|584368834|FG001|Period 1|Withdrawal by Subject|8|||
161816709|NCT04633564|584368833|FG000|Period 1|Progressive disease|47|||
161816710|NCT04633564|584368834|FG001|Period 1|Progressive disease|51|||
161816711|NCT04633564|584368833|FG000|Period 1|Terminated by Sponsor|8|||
161922079|NCT04057365|584761062|FG001|Overall Study|Withdrawal by Subject|0|||
161922080|NCT01063114|584761063|FG000|Overall Study|Lost to Follow-up|1|||
161922081|NCT04598828|584761066|FG000|Overall Study|Physician Decision|1|||
161922082|NCT04598828|584761067|FG001|Overall Study|Physician Decision|0|||
161922083|NCT04598828|584761066|FG000|Overall Study|Withdrawal by Subject|0|||
161922084|NCT04598828|584761067|FG001|Overall Study|Withdrawal by Subject|1|||
161922085|NCT04598828|584761066|FG000|Overall Study|Withdrawal by Subject|0|||
161922086|NCT04598828|584761067|FG001|Overall Study|Withdrawal by Subject|1|||
161922087|NCT02676973|584761068|FG000|Overall Study|Withdrawal by Subject|9|||
161922088|NCT02676973|584761069|FG001|Overall Study|Withdrawal by Subject|8|||
161922089|NCT02676973|584761070|FG002|Overall Study|Withdrawal by Subject|11|||
161922090|NCT02676973|584761068|FG000|Overall Study|Lost to Follow-up|8|||
161922091|NCT02676973|584761069|FG001|Overall Study|Lost to Follow-up|12|||
161922092|NCT02676973|584761070|FG002|Overall Study|Lost to Follow-up|8|||
161922093|NCT02676973|584761068|FG000|Overall Study|Death|2|||
161922094|NCT02676973|584761069|FG001|Overall Study|Death|1|||
161922095|NCT02676973|584761070|FG002|Overall Study|Death|5|||
161922096|NCT01078662|584761072|FG000|Overall Study|Death|41|||
161922097|NCT01078662|584761073|FG001|Overall Study|Death|103|||
161922098|NCT01078662|584761074|FG002|Overall Study|Death|18|||
161922099|NCT01078662|584761075|FG003|Overall Study|Death|5|||
161922100|NCT01078662|584761076|FG004|Overall Study|Death|8|||
161922101|NCT01078662|584761072|FG000|Overall Study|Patients reached data cut-off|12|||
161922102|NCT01078662|584761073|FG001|Overall Study|Patients reached data cut-off|53|||
161922103|NCT01078662|584761074|FG002|Overall Study|Patients reached data cut-off|2|||
161922104|NCT01078662|584761075|FG003|Overall Study|Patients reached data cut-off|2|||
161922105|NCT01078662|584761076|FG004|Overall Study|Patients reached data cut-off|3|||
161922106|NCT01078662|584761072|FG000|Overall Study|Withdrawal by Subject|4|||
161922107|NCT01078662|584761073|FG001|Overall Study|Withdrawal by Subject|11|||
162017880|NCT02624986|585119768|FG006|Overall Study|Protocol Violation|0|||
161922108|NCT01078662|584761074|FG002|Overall Study|Withdrawal by Subject|1|||
161922109|NCT01078662|584761075|FG003|Overall Study|Withdrawal by Subject|0|||
161922110|NCT01078662|584761076|FG004|Overall Study|Withdrawal by Subject|0|||
161922111|NCT01078662|584761072|FG000|Overall Study|Protocol Violation|0|||
161922112|NCT01078662|584761073|FG001|Overall Study|Protocol Violation|1|||
161922113|NCT01078662|584761074|FG002|Overall Study|Protocol Violation|0|||
161922114|NCT01078662|584761075|FG003|Overall Study|Protocol Violation|0|||
161922115|NCT01078662|584761076|FG004|Overall Study|Protocol Violation|0|||
161922116|NCT01078662|584761072|FG000|Overall Study|Lost to Follow-up|1|||
161922117|NCT01078662|584761073|FG001|Overall Study|Lost to Follow-up|0|||
161922118|NCT01078662|584761074|FG002|Overall Study|Lost to Follow-up|0|||
161922119|NCT01078662|584761075|FG003|Overall Study|Lost to Follow-up|0|||
161922120|NCT01078662|584761076|FG004|Overall Study|Lost to Follow-up|0|||
161922121|NCT01127061|584762232|FG000|Overall Study|Lost to Follow-up|7|||
161922122|NCT01127061|584762233|FG001|Overall Study|Lost to Follow-up|10|||
161922123|NCT01127061|584762232|FG000|Overall Study|Physician Decision|3|||
161922124|NCT01127061|584762233|FG001|Overall Study|Physician Decision|3|||
161922125|NCT03921541|584762238|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
161922126|NCT03921541|584762239|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
161922127|NCT00182637|584762240|FG000|Overall Study|Adverse Event|2|||
161922128|NCT00182637|584762240|FG000|Overall Study|Disease Progression|1|||
161922129|NCT00003456|584762241|FG000|Overall Study|Not evaluable|8|||
161922130|NCT00420407|584762243|FG000|Overall Study|Lost to Follow-up|0|||
161922131|NCT00420407|584762244|FG001|Overall Study|Lost to Follow-up|3|||
161922132|NCT00420407|584762243|FG000|Overall Study|Physician Decision|2|||
161922133|NCT00420407|584762244|FG001|Overall Study|Physician Decision|1|||
161922134|NCT00420407|584762243|FG000|Overall Study|subject identified as detainee|1|||
161922135|NCT00420407|584762244|FG001|Overall Study|subject identified as detainee|0|||
161922136|NCT00420407|584762243|FG000|Overall Study|subject identified as Jehovah's witness|1|||
161922137|NCT00420407|584762244|FG001|Overall Study|subject identified as Jehovah's witness|0|||
161922138|NCT00420407|584762243|FG000|Overall Study|Withdrawal by Subject|0|||
161922139|NCT00420407|584762244|FG001|Overall Study|Withdrawal by Subject|2|||
161922140|NCT04633447|584762247|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
161922141|NCT04633447|584762248|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
161922142|NCT04633447|584762247|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
161922143|NCT04633447|584762248|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
161922144|NCT04633447|584762247|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
161922145|NCT04633447|584762248|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
161922146|NCT04633447|584762247|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
162017881|NCT02624986|585119769|FG007|Overall Study|Protocol Violation|0|||
161670064|NCT04658186|583845324|FG000|Overall Study|PI Decision due to Participant Safety|0|||
161670065|NCT04658186|583845325|FG001|Overall Study|PI Decision due to Participant Safety|0|||
161816712|NCT04633564|584368834|FG001|Period 1|Terminated by Sponsor|6|||
161816713|NCT04633564|584368833|FG000|Period 2|Adverse Event|3|||
161816714|NCT04633564|584368834|FG001|Period 2|Adverse Event|4|||
161816715|NCT04633564|584368833|FG000|Period 2|Death|0|||
161816716|NCT04633564|584368834|FG001|Period 2|Death|2|||
161816717|NCT04633564|584368833|FG000|Period 2|Lost to Follow-up|0|||
162017882|NCT02624986|585119762|FG000|Overall Study|Withdrawal by Subject|0|||
162017883|NCT02624986|585119763|FG001|Overall Study|Withdrawal by Subject|0|||
162017884|NCT02624986|585119764|FG002|Overall Study|Withdrawal by Subject|0|||
162171436|NCT05299073|585680410|FG002|Overall Study|Lost to Follow-up|0|||
162171437|NCT03952338|585680411|FG000|Overall Study|Lost to Follow-up|11|||
162171438|NCT03952338|585680412|FG001|Overall Study|Lost to Follow-up|17|||
162171439|NCT03952338|585680411|FG000|Overall Study|Withdrawal by Subject|1|||
162171440|NCT03952338|585680412|FG001|Overall Study|Withdrawal by Subject|1|||
162171441|NCT03952338|585680411|FG000|Overall Study|Protocol Violation|1|||
162171442|NCT03952338|585680412|FG001|Overall Study|Protocol Violation|0|||
162171443|NCT01456949|585680413|FG000|Enrollment|PI death- incomplete data|6|||
162171444|NCT01456949|585680413|FG000|Enrollment|Death|1|||
162171445|NCT01456949|585680413|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
162171446|NCT01456949|585680413|FG000|Enrollment|Physician Decision|10|||
162171447|NCT01456949|585680413|FG000|Enrollment|Withdrawal by Subject|7|||
162171448|NCT01456949|585680413|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
162171449|NCT01456949|585680413|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
162171450|NCT01456949|585680413|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
162171451|NCT01456949|585680413|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
162171452|NCT01456949|585680413|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
162171453|NCT01456949|585680413|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
162171454|NCT01456949|585680413|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
162171455|NCT01456949|585680413|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
162171456|NCT04753697|585680414|FG000|Induction Phase|Withdrawal by Subject|12|||
162171457|NCT04753697|585680415|FG001|Induction Phase|Withdrawal by Subject|5|||
162171458|NCT04753697|585680416|FG002|Induction Phase|Withdrawal by Subject|6|||
162171459|NCT04753697|585680414|FG000|Induction Phase|Physician Decision|1|||
162171460|NCT04753697|585680415|FG001|Induction Phase|Physician Decision|0|||
162171461|NCT04753697|585680416|FG002|Induction Phase|Physician Decision|0|||
162171462|NCT04753697|585680414|FG000|Induction Phase|Lost to Follow-up|2|||
162171463|NCT04753697|585680415|FG001|Induction Phase|Lost to Follow-up|2|||
162171464|NCT04753697|585680416|FG002|Induction Phase|Lost to Follow-up|1|||
162171465|NCT04753697|585680414|FG000|Induction Phase|Lack of Efficacy|1|||
162171466|NCT04753697|585680415|FG001|Induction Phase|Lack of Efficacy|0|||
162171467|NCT04753697|585680416|FG002|Induction Phase|Lack of Efficacy|0|||
162171468|NCT04753697|585680414|FG000|Maintenance Phase|Physician Decision|0|||
162171469|NCT04753697|585680415|FG001|Maintenance Phase|Physician Decision|0|||
162171470|NCT04753697|585680416|FG002|Maintenance Phase|Physician Decision|1|||
162171471|NCT04753697|585680414|FG000|Maintenance Phase|Withdrawal by Subject|3|||
162171472|NCT04753697|585680415|FG001|Maintenance Phase|Withdrawal by Subject|4|||
162171473|NCT04753697|585680416|FG002|Maintenance Phase|Withdrawal by Subject|6|||
162171474|NCT04753697|585680414|FG000|Maintenance Phase|Lost to Follow-up|2|||
162171475|NCT04753697|585680415|FG001|Maintenance Phase|Lost to Follow-up|2|||
162171476|NCT04753697|585680416|FG002|Maintenance Phase|Lost to Follow-up|0|||
162171477|NCT04753697|585680414|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
162171478|NCT04753697|585680415|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
162171479|NCT04753697|585680416|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
162017885|NCT02624986|585119765|FG003|Overall Study|Withdrawal by Subject|0|||
162017886|NCT02624986|585119766|FG004|Overall Study|Withdrawal by Subject|0|||
162171480|NCT04753697|585680414|FG000|Maintenance Phase|Adverse Event|0|||
162171481|NCT04753697|585680415|FG001|Maintenance Phase|Adverse Event|1|||
162171482|NCT04753697|585680416|FG002|Maintenance Phase|Adverse Event|1|||
162171483|NCT04753697|585680414|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
162171484|NCT04753697|585680415|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
162171485|NCT04753697|585680416|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
162171486|NCT04200456|585680419|FG000|Overall Study|Physician Decision|0|||
162171487|NCT04200456|585680420|FG001|Overall Study|Physician Decision|1|||
162171488|NCT04200456|585680419|FG000|Overall Study|Withdrawal by Subject|2|||
162171489|NCT04200456|585680420|FG001|Overall Study|Withdrawal by Subject|2|||
162171490|NCT04200456|585680419|FG000|Overall Study|Lack of Efficacy|1|||
162171491|NCT04200456|585680420|FG001|Overall Study|Lack of Efficacy|1|||
162171492|NCT04200456|585680419|FG000|Overall Study|Adverse event, non-fatal|0|||
162171493|NCT04200456|585680420|FG001|Overall Study|Adverse event, non-fatal|1|||
162171494|NCT04200456|585680419|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
162171495|NCT04200456|585680420|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
162171496|NCT00592852|585680421|FG000|Overall Study|Non-compliance|1|||
162171497|NCT00592852|585680421|FG000|Overall Study|Adverse Event|3|||
162171498|NCT00592852|585680421|FG000|Overall Study|Found ineligible|1|||
162171499|NCT00592852|585680421|FG000|Overall Study|Withdrawal by Subject|1|||
162171500|NCT05002088|585680423|FG000|Overall Study|Withdrawal by Subject|9|||
162171501|NCT05002088|585680424|FG001|Overall Study|Withdrawal by Subject|0|||
162171502|NCT05002088|585680423|FG000|Overall Study|Lost to Follow-up|0|||
162171503|NCT05002088|585680424|FG001|Overall Study|Lost to Follow-up|1|||
162171504|NCT05002088|585680423|FG000|Overall Study|Death|16|||
162171505|NCT05002088|585680424|FG001|Overall Study|Death|2|||
162171506|NCT05002088|585680423|FG000|Overall Study|Protocol Violation|25|||
162171507|NCT05002088|585680424|FG001|Overall Study|Protocol Violation|7|||
162171508|NCT04770402|585680425|FG000|Overall Study|Lost to Follow-up|1|||
162171509|NCT04770402|585680426|FG001|Overall Study|Lost to Follow-up|2|||
162171510|NCT04770402|585680425|FG000|Overall Study|Non-compliance|1|||
162171511|NCT04770402|585680426|FG001|Overall Study|Non-compliance|0|||
162171512|NCT04770402|585680425|FG000|Overall Study|Withdrawal by Subject|0|||
162171513|NCT04770402|585680426|FG001|Overall Study|Withdrawal by Subject|1|||
162171514|NCT03599661|585680427|FG000|Overall Study|Lost to Follow-up|9|||
162171515|NCT05446168|585680428|FG000|Overall Study|Physician Decision|0|||
162171516|NCT05446168|585680429|FG001|Overall Study|Physician Decision|1|||
162171517|NCT01828099|585680430|FG000|Treatment Period|Adverse Event|24|||
162171518|NCT01828099|585680431|FG001|Treatment Period|Adverse Event|23|||
162171519|NCT01828099|585680430|FG000|Treatment Period|Death|10|||
162171520|NCT01828099|585680431|FG001|Treatment Period|Death|12|||
162171521|NCT01828099|585680430|FG000|Treatment Period|Lost to Follow-up|2|||
162171522|NCT01828099|585680431|FG001|Treatment Period|Lost to Follow-up|1|||
162171523|NCT01828099|585680430|FG000|Treatment Period|Non-compliance with study treatment|1|||
162171524|NCT01828099|585680431|FG001|Treatment Period|Non-compliance with study treatment|0|||
162171525|NCT01828099|585680430|FG000|Treatment Period|Physician Decision|17|||
162171526|NCT01828099|585680431|FG001|Treatment Period|Physician Decision|16|||
161922147|NCT04633447|584762248|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
162171527|NCT01828099|585680430|FG000|Treatment Period|Progressive disease|99|||
162171528|NCT01828099|585680431|FG001|Treatment Period|Progressive disease|107|||
162171529|NCT01828099|585680430|FG000|Treatment Period|Subject/guardian decision|22|||
162171530|NCT01828099|585680431|FG001|Treatment Period|Subject/guardian decision|26|||
162171531|NCT01828099|585680430|FG000|Treatment Period|Study terminated by Sponsor|13|||
162171532|NCT01828099|585680431|FG001|Treatment Period|Study terminated by Sponsor|1|||
162171533|NCT01828099|585680430|FG000|Treatment Period|Protocol deviation|1|||
162171534|NCT01828099|585680431|FG001|Treatment Period|Protocol deviation|0|||
162171535|NCT01828099|585680430|FG000|Treatment Period|No longer requires treatment|0|||
162171536|NCT01828099|585680431|FG001|Treatment Period|No longer requires treatment|1|||
162171537|NCT01828099|585680430|FG000|Extension-treatment Phase|Adverse Event|0|||
162171538|NCT01828099|585680431|FG001|Extension-treatment Phase|Adverse Event|17|||
162171539|NCT01828099|585680430|FG000|Extension-treatment Phase|Death|0|||
162171540|NCT01828099|585680431|FG001|Extension-treatment Phase|Death|11|||
162171541|NCT01828099|585680430|FG000|Extension-treatment Phase|Physician Decision|0|||
162171542|NCT01828099|585680431|FG001|Extension-treatment Phase|Physician Decision|5|||
162171543|NCT01828099|585680430|FG000|Extension-treatment Phase|Progressive disease|0|||
162171544|NCT01828099|585680431|FG001|Extension-treatment Phase|Progressive disease|54|||
161922148|NCT04633447|584762247|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
161922149|NCT04633447|584762248|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
161922150|NCT04633447|584762247|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
162171545|NCT01828099|585680430|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
162171546|NCT01828099|585680431|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
162171547|NCT01828099|585680430|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
162171548|NCT01828099|585680431|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
162171549|NCT03924635|585680434|FG000|Overall Study|Withdrawal by Subject|2|||
162171550|NCT03924635|585680435|FG001|Overall Study|Withdrawal by Subject|4|||
162171551|NCT06473662|585680436|FG000|Overall Study|Withdrawal by Subject|1|||
162171552|NCT06473662|585680437|FG001|Overall Study|Withdrawal by Subject|6|||
162171553|NCT06473662|585680438|FG002|Overall Study|Withdrawal by Subject|5|||
162171554|NCT06473662|585680436|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
162171555|NCT06473662|585680437|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
162171556|NCT06473662|585680438|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
162171557|NCT06473662|585680436|FG000|Overall Study|Starting HbA1c below 7%|0|||
162171558|NCT06473662|585680437|FG001|Overall Study|Starting HbA1c below 7%|1|||
162171559|NCT06473662|585680438|FG002|Overall Study|Starting HbA1c below 7%|1|||
162171560|NCT06473662|585680436|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
162171561|NCT06473662|585680437|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
162171562|NCT06473662|585680438|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
162171563|NCT06473662|585680436|FG000|Overall Study|Did not take medication|2|||
162171564|NCT06473662|585680437|FG001|Overall Study|Did not take medication|3|||
162171565|NCT06473662|585680438|FG002|Overall Study|Did not take medication|2|||
162171566|NCT04471246|585680443|FG000|Overall Study|Lost to Follow-up|2|||
162171567|NCT04471246|585680444|FG001|Overall Study|Lost to Follow-up|2|||
162171568|NCT04826471|585680445|FG000|Overall Study|Lost to Follow-up|2|||
162171569|NCT04826471|585680445|FG000|Overall Study|Protocol Violation|3|||
162171570|NCT04826471|585680445|FG000|Overall Study|Withdrawal by Subject|1|||
162171571|NCT05104463|585680460|FG000|Overall Study|Adverse Event|1|||
162171572|NCT05104463|585680461|FG001|Overall Study|Adverse Event|1|||
162171573|NCT05104463|585680460|FG000|Overall Study|Lost to Follow-up|1|||
161922151|NCT04633447|584762248|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
162171574|NCT05104463|585680461|FG001|Overall Study|Lost to Follow-up|1|||
162171575|NCT05104463|585680460|FG000|Overall Study|Physician Decision|1|||
162171576|NCT05104463|585680461|FG001|Overall Study|Physician Decision|0|||
162171577|NCT05104463|585680460|FG000|Overall Study|Protocol Violation|0|||
162171578|NCT05104463|585680461|FG001|Overall Study|Protocol Violation|2|||
162171579|NCT05104463|585680460|FG000|Overall Study|Withdrawal by Subject|1|||
162171580|NCT05104463|585680461|FG001|Overall Study|Withdrawal by Subject|1|||
162171581|NCT02823145|585680462|FG000|Enrollment|Other|1|||
162171582|NCT02823145|585680463|FG001|Enrollment|Other|0|||
162171583|NCT02823145|585680462|FG000|Treatment|Adverse Event|0|||
162171584|NCT02823145|585680463|FG001|Treatment|Adverse Event|11|||
162171585|NCT02823145|585680462|FG000|Treatment|Death|0|||
162171586|NCT02823145|585680463|FG001|Treatment|Death|3|||
162171587|NCT02823145|585680462|FG000|Treatment|Family Decision|0|||
162171588|NCT02823145|585680463|FG001|Treatment|Family Decision|1|||
162171589|NCT02823145|585680462|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
162171590|NCT02823145|585680463|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
162171591|NCT02823145|585680462|FG000|Treatment|Lack of Efficacy|0|||
162171592|NCT02823145|585680463|FG001|Treatment|Lack of Efficacy|48|||
162171593|NCT02823145|585680462|FG000|Treatment|Non-Compliance With E-Diary|0|||
162171594|NCT02823145|585680463|FG001|Treatment|Non-Compliance With E-Diary|1|||
162171595|NCT02823145|585680462|FG000|Treatment|Physician Decision|0|||
162171596|NCT02823145|585680463|FG001|Treatment|Physician Decision|2|||
162171597|NCT02823145|585680462|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
162171598|NCT02823145|585680463|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
162171599|NCT02823145|585680462|FG000|Treatment|Subject needed to take prohibited medication|0|||
162171600|NCT02823145|585680463|FG001|Treatment|Subject needed to take prohibited medication|1|||
162171601|NCT02823145|585680462|FG000|Treatment|Subject transferred to direct access programme|0|||
162171602|NCT02823145|585680463|FG001|Treatment|Subject transferred to direct access programme|1|||
162171603|NCT02823145|585680462|FG000|Treatment|Switching to commercially available drug|0|||
162171604|NCT02823145|585680463|FG001|Treatment|Switching to commercially available drug|11|||
162171605|NCT02823145|585680462|FG000|Treatment|Transitioned to commercial supply of medication|0|||
162171606|NCT02823145|585680463|FG001|Treatment|Transitioned to commercial supply of medication|1|||
162171607|NCT02823145|585680462|FG000|Treatment|Withdrawal By Caregiver|0|||
162171608|NCT02823145|585680463|FG001|Treatment|Withdrawal By Caregiver|1|||
162171609|NCT02823145|585680462|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
162171610|NCT02823145|585680463|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
162171611|NCT02823145|585680462|FG000|Treatment|Withdrawal by Subject|0|||
162171612|NCT02823145|585680463|FG001|Treatment|Withdrawal by Subject|16|||
162171613|NCT02823145|585680462|FG000|Treatment|Reason unknown|0|||
162171614|NCT02823145|585680463|FG001|Treatment|Reason unknown|1|||
162171615|NCT04622046|585680464|FG000|Intervention Period|Adverse Event|1|||
162171616|NCT04622046|585680464|FG000|Intervention Period|Withdrawal by Subject|2|||
162171617|NCT04622046|585680464|FG000|Extension Period|Ongoing in the Extension Period|21|||
161922152|NCT04333498|584762249|FG000|Overall Study|Lost to Follow-up|1|||
161922153|NCT04333498|584762250|FG001|Overall Study|Lost to Follow-up|0|||
162171618|NCT04676763|585682406|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
162171619|NCT04676763|585682407|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
162171620|NCT04676763|585682408|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
162171621|NCT04676763|585682406|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
162171622|NCT04676763|585682407|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
162171623|NCT04676763|585682408|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
162171624|NCT04676763|585682406|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
162171625|NCT04676763|585682407|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
162171626|NCT04676763|585682408|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
162171627|NCT04858451|585682409|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
162171628|NCT04858451|585682410|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161670066|NCT04658186|583845326|FG002|Overall Study|PI Decision due to Participant Safety|1|||
161670067|NCT04658186|583845324|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
161670068|NCT04658186|583845325|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
161670069|NCT04658186|583845326|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
161670070|NCT04098068|583845327|FG000|Overall Study|Disease Progression|7|||
161670071|NCT04098068|583845327|FG000|Overall Study|Withdrawal by Subject|2|||
161670072|NCT04098068|583845327|FG000|Overall Study|New Cancer Diagnosis|1|||
161670073|NCT03871829|583845328|FG000|Overall Study|Lost to Follow-up|0|||
161670074|NCT03871829|583845329|FG001|Overall Study|Lost to Follow-up|1|||
161670075|NCT03871829|583845328|FG000|Overall Study|Withdrawal by Subject|1|||
161670076|NCT03871829|583845329|FG001|Overall Study|Withdrawal by Subject|1|||
161670077|NCT03871829|583845328|FG000|Overall Study|Death|12|||
161670078|NCT03871829|583845329|FG001|Overall Study|Death|8|||
161670079|NCT03871829|583845328|FG000|Overall Study|Study terminated by sponsor|31|||
161670080|NCT03871829|583845329|FG001|Overall Study|Study terminated by sponsor|34|||
161670081|NCT02993523|583845330|FG000|Overall Study|Withdrew Consent|0|||
161670082|NCT02993523|583845331|FG001|Overall Study|Withdrew Consent|0|||
161670083|NCT02993523|583845332|FG002|Overall Study|Withdrew Consent|2|||
161670084|NCT02993523|583845333|FG003|Overall Study|Withdrew Consent|9|||
161670085|NCT02993523|583845334|FG004|Overall Study|Withdrew Consent|0|||
161670086|NCT02993523|583845330|FG000|Overall Study|Lost to Follow-up|0|||
161670087|NCT02993523|583845331|FG001|Overall Study|Lost to Follow-up|0|||
161670088|NCT02993523|583845332|FG002|Overall Study|Lost to Follow-up|3|||
161670089|NCT02993523|583845333|FG003|Overall Study|Lost to Follow-up|6|||
161670090|NCT02993523|583845334|FG004|Overall Study|Lost to Follow-up|0|||
161670091|NCT02993523|583845330|FG000|Overall Study|Death|1|||
161670092|NCT02993523|583845331|FG001|Overall Study|Death|1|||
161670093|NCT02993523|583845332|FG002|Overall Study|Death|138|||
161670094|NCT02993523|583845333|FG003|Overall Study|Death|222|||
161670095|NCT02993523|583845334|FG004|Overall Study|Death|6|||
161670096|NCT02993523|583845330|FG000|Overall Study|Reason not Specified|0|||
161670097|NCT02993523|583845331|FG001|Overall Study|Reason not Specified|0|||
161670098|NCT02993523|583845332|FG002|Overall Study|Reason not Specified|1|||
161670099|NCT02993523|583845333|FG003|Overall Study|Reason not Specified|1|||
161670100|NCT02993523|583845334|FG004|Overall Study|Reason not Specified|0|||
161670101|NCT03694418|583845335|FG000|Overall Study|Lost to Follow-up|115|||
161670102|NCT03694418|583845336|FG001|Overall Study|Lost to Follow-up|23|||
161670103|NCT03694418|583845337|FG002|Overall Study|Lost to Follow-up|12|||
161670104|NCT03694418|583845338|FG003|Overall Study|Lost to Follow-up|12|||
162171629|NCT04858451|585682411|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162171630|NCT04858451|585682412|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162171631|NCT04858451|585682413|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162171632|NCT04858451|585682414|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162171633|NCT04858451|585682415|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161670105|NCT03694418|583845339|FG004|Overall Study|Lost to Follow-up|13|||
161670106|NCT04288778|583845342|FG000|Overall Study|Withdrawal by Subject|2|||
161670107|NCT04288778|583845342|FG000|Overall Study|Adverse Event|5|||
162171634|NCT04858451|585682416|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162171635|NCT04858451|585682417|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
162171636|NCT04858451|585682409|FG000|Part 2|Discontinued|0|||
161670108|NCT04288778|583845342|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161670109|NCT04288778|583845342|FG000|Overall Study|Other|1|||
161670110|NCT04288778|583845342|FG000|Overall Study|Started but not treated|2|||
161670111|NCT04442737|583845343|FG000|Overall Study|Lost to Follow-up|1|||
161670112|NCT04442737|583845344|FG001|Overall Study|Lost to Follow-up|3|||
161670113|NCT04442737|583845343|FG000|Overall Study|Withdrawal by Subject|3|||
161670114|NCT04442737|583845344|FG001|Overall Study|Withdrawal by Subject|2|||
161670115|NCT04442737|583845343|FG000|Overall Study|Adverse Event|3|||
161670116|NCT04442737|583845344|FG001|Overall Study|Adverse Event|2|||
161670117|NCT04442737|583845343|FG000|Overall Study|Death|0|||
161670118|NCT04442737|583845344|FG001|Overall Study|Death|1|||
162171637|NCT04858451|585682410|FG001|Part 2|Discontinued|0|||
162171638|NCT04858451|585682411|FG002|Part 2|Discontinued|0|||
162171639|NCT04858451|585682412|FG003|Part 2|Discontinued|0|||
162171640|NCT04858451|585682413|FG004|Part 2|Discontinued|0|||
162171641|NCT04858451|585682414|FG005|Part 2|Discontinued|0|||
162171642|NCT04858451|585682415|FG006|Part 2|Discontinued|0|||
162171643|NCT04858451|585682416|FG007|Part 2|Discontinued|0|||
162171644|NCT04858451|585682417|FG008|Part 2|Discontinued|63|||
162171645|NCT04119843|585682418|FG000|Overall Study|Adverse Event|3|||
162171646|NCT04119843|585682418|FG000|Overall Study|Death|1|||
162171647|NCT03652389|585682420|FG000|Overall Study|Lost to Follow-up|1|||
162171648|NCT03652389|585682421|FG001|Overall Study|Lost to Follow-up|5|||
162171649|NCT03652389|585682420|FG000|Overall Study|Withdrawal by Subject|5|||
162171650|NCT03652389|585682421|FG001|Overall Study|Withdrawal by Subject|1|||
162171651|NCT03652389|585682420|FG000|Overall Study|New diagnosis|2|||
162171652|NCT03652389|585682421|FG001|Overall Study|New diagnosis|0|||
162171653|NCT04231149|585682422|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
162171654|NCT04231149|585682423|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
162171655|NCT04231149|585682424|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
162171656|NCT04231149|585682425|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
162171657|NCT04231149|585682426|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
162171658|NCT03252847|585682427|FG000|Overall Study|Withdrawal by Subject|0|||
162171659|NCT03252847|585682428|FG001|Overall Study|Withdrawal by Subject|0|||
162171660|NCT03252847|585682429|FG002|Overall Study|Withdrawal by Subject|1|||
162171661|NCT03252847|585682430|FG003|Overall Study|Withdrawal by Subject|0|||
162171662|NCT03252847|585682431|FG004|Overall Study|Withdrawal by Subject|0|||
162171663|NCT03252847|585682432|FG005|Overall Study|Withdrawal by Subject|0|||
162171664|NCT03252847|585682433|FG006|Overall Study|Withdrawal by Subject|0|||
162171665|NCT03252847|585682427|FG000|Overall Study|Other: Patient decision|0|||
162171666|NCT03252847|585682428|FG001|Overall Study|Other: Patient decision|0|||
162171667|NCT03252847|585682429|FG002|Overall Study|Other: Patient decision|0|||
162171668|NCT03252847|585682430|FG003|Overall Study|Other: Patient decision|0|||
162171669|NCT03252847|585682431|FG004|Overall Study|Other: Patient decision|1|||
162171670|NCT03252847|585682432|FG005|Overall Study|Other: Patient decision|0|||
162171671|NCT03252847|585682433|FG006|Overall Study|Other: Patient decision|0|||
162171672|NCT02116530|585682438|FG000|Overall Study|Withdrawal by Subject|1|||
162171673|NCT02116530|585682439|FG001|Overall Study|Withdrawal by Subject|2|||
162171674|NCT02116530|585682438|FG000|Overall Study|Adverse Event|4|||
162171675|NCT02116530|585682439|FG001|Overall Study|Adverse Event|0|||
162171676|NCT02116530|585682438|FG000|Overall Study|Physician Decision|1|||
162171677|NCT02116530|585682439|FG001|Overall Study|Physician Decision|0|||
162171678|NCT02116530|585682438|FG000|Overall Study|Lost to Follow-up|1|||
162171679|NCT02116530|585682439|FG001|Overall Study|Lost to Follow-up|0|||
162171680|NCT02116530|585682438|FG000|Overall Study|Other Medical Problems|2|||
162171681|NCT02116530|585682439|FG001|Overall Study|Other Medical Problems|2|||
162171682|NCT05297565|585682440|FG000|Overall Study|Other Reasons|0|||
162171683|NCT05297565|585682441|FG001|Overall Study|Other Reasons|1|||
162171684|NCT05297565|585682440|FG000|Overall Study|Physician Decision|0|||
162171685|NCT05297565|585682441|FG001|Overall Study|Physician Decision|1|||
162171686|NCT05297565|585682440|FG000|Overall Study|Disease recurrence|1|||
162171687|NCT05297565|585682441|FG001|Overall Study|Disease recurrence|0|||
161922154|NCT04333498|584762249|FG000|Overall Study|Lost to Follow-up|0|||
161922155|NCT04333498|584762250|FG001|Overall Study|Lost to Follow-up|1|||
162171688|NCT05671653|585682442|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
162171689|NCT05671653|585682443|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
162171690|NCT05671653|585682444|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
162171691|NCT05671653|585682445|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
162171692|NCT05671653|585682446|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
162171693|NCT05671653|585682447|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
162171694|NCT05671653|585682448|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
162171695|NCT05671653|585682449|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
162171696|NCT05671653|585682450|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
162171697|NCT05671653|585682451|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
162171698|NCT05671653|585682452|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
161922156|NCT01565694|584762251|FG000|Dose-Titration Period|Adverse Event|4|||
162171699|NCT05671653|585682453|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
162171700|NCT05671653|585682454|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
162171701|NCT05671653|585682442|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162171702|NCT05671653|585682443|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162171703|NCT05671653|585682444|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162171704|NCT05671653|585682445|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162171705|NCT05671653|585682446|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162171706|NCT05671653|585682447|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
162171707|NCT05671653|585682448|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162171708|NCT05671653|585682449|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162171709|NCT05671653|585682450|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162171710|NCT05671653|585682451|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161922157|NCT01565694|584762251|FG000|Dose-Titration Period|Protocol Violation|10|||
161922158|NCT01565694|584762251|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
161922159|NCT05399771|584762253|FG000|Overall Study|Physician Decision|3|||
161922160|NCT05399771|584762253|FG000|Overall Study|Adverse Event|1|||
161922161|NCT00541229|584762256|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
161922162|NCT00541229|584762257|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
161922163|NCT00541229|584762258|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
161922164|NCT00541229|584762259|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
161922165|NCT00541229|584762260|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
161922166|NCT00541229|584762261|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
161922167|NCT00541229|584762256|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
162171711|NCT05671653|585682452|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162171712|NCT05671653|585682453|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162171713|NCT05671653|585682454|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
162171714|NCT05671653|585682442|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162171715|NCT05671653|585682443|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162171716|NCT05671653|585682444|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162171717|NCT05671653|585682445|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162171718|NCT05671653|585682446|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162171719|NCT05671653|585682447|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
162171720|NCT05671653|585682448|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162171721|NCT05671653|585682449|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162171722|NCT05671653|585682450|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162171723|NCT05671653|585682451|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162171724|NCT05671653|585682452|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162171725|NCT05671653|585682453|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162171726|NCT05671653|585682454|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
162171727|NCT05671653|585682442|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162171728|NCT05671653|585682443|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162171729|NCT05671653|585682444|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162171730|NCT05671653|585682445|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162171731|NCT05671653|585682446|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162171732|NCT05671653|585682447|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162171733|NCT05671653|585682448|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162171734|NCT05671653|585682449|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162171735|NCT05671653|585682450|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
162171736|NCT05671653|585682451|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162171737|NCT05671653|585682452|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162171738|NCT05671653|585682453|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162171739|NCT05671653|585682454|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
162171740|NCT05671653|585682442|FG000|Cohort 2 Period 2|Adverse Event|0|||
162171741|NCT05671653|585682443|FG001|Cohort 2 Period 2|Adverse Event|0|||
162171742|NCT05671653|585682444|FG002|Cohort 2 Period 2|Adverse Event|0|||
162171743|NCT05671653|585682445|FG003|Cohort 2 Period 2|Adverse Event|0|||
162171744|NCT05671653|585682446|FG004|Cohort 2 Period 2|Adverse Event|0|||
162171745|NCT05671653|585682447|FG005|Cohort 2 Period 2|Adverse Event|0|||
162171746|NCT05671653|585682448|FG006|Cohort 2 Period 2|Adverse Event|0|||
162171747|NCT05671653|585682449|FG007|Cohort 2 Period 2|Adverse Event|0|||
162171748|NCT05671653|585682450|FG008|Cohort 2 Period 2|Adverse Event|0|||
162171749|NCT05671653|585682451|FG009|Cohort 2 Period 2|Adverse Event|0|||
162171750|NCT05671653|585682452|FG010|Cohort 2 Period 2|Adverse Event|1|||
162171751|NCT05671653|585682453|FG011|Cohort 2 Period 2|Adverse Event|0|||
162171752|NCT05671653|585682454|FG012|Cohort 2 Period 2|Adverse Event|0|||
162171753|NCT05671653|585682442|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
162171754|NCT05671653|585682443|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
162171755|NCT05671653|585682444|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
162171756|NCT05671653|585682445|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
162171757|NCT05671653|585682446|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
162171758|NCT05671653|585682447|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
162171759|NCT05671653|585682448|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
162171760|NCT05671653|585682449|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
162171761|NCT05671653|585682450|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
162171762|NCT05671653|585682451|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
162171763|NCT05671653|585682452|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
162171764|NCT05671653|585682453|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
162171765|NCT05671653|585682454|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
162171766|NCT05671653|585682442|FG000|Cohort 2 Period 2|Pregnancy|0|||
161922168|NCT00541229|584762257|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
161922169|NCT00541229|584762258|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
162171767|NCT05671653|585682443|FG001|Cohort 2 Period 2|Pregnancy|0|||
162171768|NCT05671653|585682444|FG002|Cohort 2 Period 2|Pregnancy|0|||
162171769|NCT05671653|585682445|FG003|Cohort 2 Period 2|Pregnancy|0|||
162171770|NCT05671653|585682446|FG004|Cohort 2 Period 2|Pregnancy|0|||
162171771|NCT05671653|585682447|FG005|Cohort 2 Period 2|Pregnancy|0|||
162171772|NCT05671653|585682448|FG006|Cohort 2 Period 2|Pregnancy|0|||
162171773|NCT05671653|585682449|FG007|Cohort 2 Period 2|Pregnancy|0|||
162171774|NCT05671653|585682450|FG008|Cohort 2 Period 2|Pregnancy|0|||
162171775|NCT05671653|585682451|FG009|Cohort 2 Period 2|Pregnancy|0|||
162171776|NCT05671653|585682452|FG010|Cohort 2 Period 2|Pregnancy|1|||
162171777|NCT05671653|585682453|FG011|Cohort 2 Period 2|Pregnancy|0|||
162171778|NCT05671653|585682454|FG012|Cohort 2 Period 2|Pregnancy|0|||
162171779|NCT05671653|585682442|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
162171780|NCT05671653|585682443|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
162171781|NCT05671653|585682444|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
162171782|NCT05671653|585682445|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
162171783|NCT05671653|585682446|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
162171784|NCT05671653|585682447|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
162171785|NCT05671653|585682448|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
162171786|NCT05671653|585682449|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
162171787|NCT05671653|585682450|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
162171788|NCT05671653|585682451|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
162171789|NCT05671653|585682452|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
162171790|NCT05671653|585682453|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
162171791|NCT05671653|585682454|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
162171792|NCT05671653|585682442|FG000|Cohort 2 Period 2|Other|0|||
162171793|NCT05671653|585682443|FG001|Cohort 2 Period 2|Other|0|||
162171794|NCT05671653|585682444|FG002|Cohort 2 Period 2|Other|0|||
162171795|NCT05671653|585682445|FG003|Cohort 2 Period 2|Other|0|||
162171796|NCT05671653|585682446|FG004|Cohort 2 Period 2|Other|0|||
162171797|NCT05671653|585682447|FG005|Cohort 2 Period 2|Other|0|||
162171798|NCT05671653|585682448|FG006|Cohort 2 Period 2|Other|0|||
162171799|NCT05671653|585682449|FG007|Cohort 2 Period 2|Other|0|||
162171800|NCT05671653|585682450|FG008|Cohort 2 Period 2|Other|0|||
162171801|NCT05671653|585682451|FG009|Cohort 2 Period 2|Other|0|||
162171802|NCT05671653|585682452|FG010|Cohort 2 Period 2|Other|1|||
162171803|NCT05671653|585682453|FG011|Cohort 2 Period 2|Other|0|||
162171804|NCT05671653|585682454|FG012|Cohort 2 Period 2|Other|0|||
162171805|NCT05671653|585682442|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162171806|NCT05671653|585682443|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162171807|NCT05671653|585682444|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162171808|NCT05671653|585682445|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162171809|NCT05671653|585682446|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162171810|NCT05671653|585682447|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162171811|NCT05671653|585682448|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162171812|NCT05671653|585682449|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162171813|NCT05671653|585682450|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162171814|NCT05671653|585682451|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162171815|NCT05671653|585682452|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162171816|NCT05671653|585682453|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
162171817|NCT05671653|585682454|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
162171818|NCT04914676|585682455|FG000|Overall Study|Study termination|3|||
162171819|NCT04914676|585682456|FG001|Overall Study|Study termination|0|||
162171820|NCT02433379|585682460|FG000|Overall Study|Screen Failures|55|||
162171821|NCT02433379|585682460|FG000|Overall Study|Death|57|||
162171822|NCT02433379|585682460|FG000|Overall Study|Total Withdrawals|209|||
162171823|NCT02505984|585682461|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
162171824|NCT02505984|585682462|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
162171825|NCT02505984|585682461|FG000|Overall Study|Unreliable self-report data|1|||
162171826|NCT02505984|585682462|FG001|Overall Study|Unreliable self-report data|0|||
162171827|NCT02505984|585682461|FG000|Overall Study|Study blind opened during assessment|0|||
162171828|NCT02505984|585682462|FG001|Overall Study|Study blind opened during assessment|1|||
162171829|NCT02505984|585682461|FG000|Overall Study|Noncompliance with study protocol|0|||
162171830|NCT02505984|585682462|FG001|Overall Study|Noncompliance with study protocol|1|||
161670119|NCT04442737|583845343|FG000|Overall Study|Protocol Violation|0|||
162171831|NCT04299464|585682472|FG000|Overall Study|Adverse Event|1|||
162171832|NCT04299464|585682473|FG001|Overall Study|Adverse Event|0|||
162171833|NCT04299464|585682474|FG002|Overall Study|Adverse Event|2|||
162171834|NCT04299464|585682472|FG000|Overall Study|Non-compliance with Study Drug|1|||
162171835|NCT04299464|585682473|FG001|Overall Study|Non-compliance with Study Drug|0|||
162171836|NCT04299464|585682474|FG002|Overall Study|Non-compliance with Study Drug|0|||
162171837|NCT04299464|585682472|FG000|Overall Study|Reason not Specified|0|||
162171838|NCT04299464|585682473|FG001|Overall Study|Reason not Specified|1|||
162171839|NCT04299464|585682474|FG002|Overall Study|Reason not Specified|3|||
162171840|NCT04299464|585682472|FG000|Overall Study|Physician Decision|0|||
162171841|NCT04299464|585682473|FG001|Overall Study|Physician Decision|1|||
162171842|NCT04299464|585682474|FG002|Overall Study|Physician Decision|1|||
162171843|NCT04299464|585682472|FG000|Overall Study|Withdrawal by Subject|0|||
162171844|NCT04299464|585682473|FG001|Overall Study|Withdrawal by Subject|2|||
162171845|NCT04299464|585682474|FG002|Overall Study|Withdrawal by Subject|1|||
162171846|NCT05764525|585682475|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
162171847|NCT05764525|585682476|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
162171848|NCT05764525|585682475|FG000|Overall Study|Withdrawal by Subject|4|||
162171849|NCT05764525|585682476|FG001|Overall Study|Withdrawal by Subject|8|||
162171850|NCT05764525|585682475|FG000|Overall Study|Physician Decision|1|||
162171851|NCT05764525|585682476|FG001|Overall Study|Physician Decision|0|||
162171852|NCT04079218|585682477|FG000|Overall Study|Death|1|||
162171853|NCT04079218|585682478|FG001|Overall Study|Death|0|||
162171854|NCT04079218|585682477|FG000|Overall Study|Withdrawal by Subject|3|||
162171855|NCT04079218|585682478|FG001|Overall Study|Withdrawal by Subject|0|||
162171856|NCT04079218|585682477|FG000|Overall Study|Physician Decision|4|||
162171857|NCT04079218|585682478|FG001|Overall Study|Physician Decision|0|||
162171858|NCT04079218|585682477|FG000|Overall Study|Lost to Follow-up|0|||
162171859|NCT04079218|585682478|FG001|Overall Study|Lost to Follow-up|1|||
162171860|NCT05907174|585682486|FG000|3-Month Assessment|Withdrawal by Subject|0|||
162171861|NCT05907174|585682487|FG001|3-Month Assessment|Withdrawal by Subject|0|||
162171862|NCT05907174|585682488|FG002|3-Month Assessment|Withdrawal by Subject|0|||
162171863|NCT05907174|585682489|FG003|3-Month Assessment|Withdrawal by Subject|1|||
162171864|NCT05907174|585682486|FG000|3-Month Assessment|Lost to Follow-up|1|||
162171865|NCT05907174|585682487|FG001|3-Month Assessment|Lost to Follow-up|1|||
162171866|NCT05907174|585682488|FG002|3-Month Assessment|Lost to Follow-up|1|||
162171867|NCT05907174|585682489|FG003|3-Month Assessment|Lost to Follow-up|1|||
162171868|NCT05907174|585682486|FG000|6-Month Assessment|Death|0|||
162171869|NCT05907174|585682487|FG001|6-Month Assessment|Death|0|||
162171870|NCT05907174|585682488|FG002|6-Month Assessment|Death|3|||
162171871|NCT05907174|585682489|FG003|6-Month Assessment|Death|0|||
162171872|NCT05907174|585682486|FG000|6-Month Assessment|Withdrawal by Subject|0|||
162171873|NCT05907174|585682487|FG001|6-Month Assessment|Withdrawal by Subject|0|||
162171874|NCT05907174|585682488|FG002|6-Month Assessment|Withdrawal by Subject|1|||
162171875|NCT05907174|585682489|FG003|6-Month Assessment|Withdrawal by Subject|1|||
162171876|NCT05907174|585682486|FG000|6-Month Assessment|Lost to Follow-up|0|||
162171877|NCT05907174|585682487|FG001|6-Month Assessment|Lost to Follow-up|1|||
162171878|NCT05907174|585682488|FG002|6-Month Assessment|Lost to Follow-up|1|||
162171879|NCT05907174|585682489|FG003|6-Month Assessment|Lost to Follow-up|1|||
162171880|NCT05093842|585682496|FG000|Overall Study|Pregnancy loss|1|||
162171881|NCT05093842|585682497|FG001|Overall Study|Pregnancy loss|1|||
162171882|NCT05093842|585682496|FG000|Overall Study|Lost to Follow-up|6|||
162171883|NCT05093842|585682497|FG001|Overall Study|Lost to Follow-up|0|||
162171884|NCT05093842|585682496|FG000|Overall Study|Physician Decision|0|||
162171885|NCT05093842|585682497|FG001|Overall Study|Physician Decision|1|||
162171886|NCT03910478|585682498|FG000|Overall Study|Death|13|||
162171887|NCT03910478|585682499|FG001|Overall Study|Death|6|||
162171888|NCT03910478|585682498|FG000|Overall Study|Withdrawal by Subject|23|||
162171889|NCT03910478|585682499|FG001|Overall Study|Withdrawal by Subject|2|||
162171890|NCT03910478|585682498|FG000|Overall Study|Physician Decision|5|||
162171891|NCT03910478|585682499|FG001|Overall Study|Physician Decision|0|||
162171892|NCT03910478|585682498|FG000|Overall Study|Protocol Violation|1|||
162171893|NCT03910478|585682499|FG001|Overall Study|Protocol Violation|0|||
162171894|NCT03910478|585682498|FG000|Overall Study|Failure to meet continuation criteria|2|||
161922170|NCT00541229|584762259|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
161922171|NCT00541229|584762260|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
161922172|NCT00541229|584762261|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
161922173|NCT00541229|584762256|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
161922174|NCT00541229|584762257|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
162171895|NCT03910478|585682499|FG001|Overall Study|Failure to meet continuation criteria|0|||
162171896|NCT03910478|585682498|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
162171897|NCT03910478|585682499|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
162171898|NCT05293171|585682501|FG000|Washout 5 to 7 Days|Adverse Event|1|||
162171899|NCT05293171|585682502|FG001|Washout 5 to 7 Days|Adverse Event|1|||
162171900|NCT05293171|585682503|FG002|Washout 5 to 7 Days|Adverse Event|0|||
161922175|NCT00541229|584762258|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
162171901|NCT05293171|585682504|FG003|Washout 5 to 7 Days|Adverse Event|0|||
162171902|NCT05293171|585682505|FG004|Washout 5 to 7 Days|Adverse Event|0|||
162171903|NCT05293171|585682506|FG005|Washout 5 to 7 Days|Adverse Event|0|||
162171904|NCT05293171|585682507|FG006|Washout 5 to 7 Days|Adverse Event|0|||
162171905|NCT05293171|585682508|FG007|Washout 5 to 7 Days|Adverse Event|0|||
162171906|NCT05293171|585682509|FG008|Washout 5 to 7 Days|Adverse Event|0|||
162171907|NCT05293171|585682510|FG009|Washout 5 to 7 Days|Adverse Event|0|||
162171908|NCT05293171|585682511|FG010|Washout 5 to 7 Days|Adverse Event|0|||
162171909|NCT05293171|585682512|FG011|Washout 5 to 7 Days|Adverse Event|0|||
162171910|NCT05293171|585682501|FG000|Washout 5 to 7 Days|Adverse Event|0|||
162171911|NCT05293171|585682502|FG001|Washout 5 to 7 Days|Adverse Event|0|||
162171912|NCT05293171|585682503|FG002|Washout 5 to 7 Days|Adverse Event|0|||
162171913|NCT05293171|585682504|FG003|Washout 5 to 7 Days|Adverse Event|0|||
162171914|NCT05293171|585682505|FG004|Washout 5 to 7 Days|Adverse Event|0|||
162171915|NCT05293171|585682506|FG005|Washout 5 to 7 Days|Adverse Event|1|||
162171916|NCT05293171|585682507|FG006|Washout 5 to 7 Days|Adverse Event|0|||
162171917|NCT05293171|585682508|FG007|Washout 5 to 7 Days|Adverse Event|0|||
162171918|NCT05293171|585682509|FG008|Washout 5 to 7 Days|Adverse Event|0|||
162171919|NCT05293171|585682510|FG009|Washout 5 to 7 Days|Adverse Event|0|||
162171920|NCT05293171|585682511|FG010|Washout 5 to 7 Days|Adverse Event|0|||
162171921|NCT05293171|585682512|FG011|Washout 5 to 7 Days|Adverse Event|0|||
162171922|NCT04066205|585682513|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
162171923|NCT04066205|585682514|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
162171924|NCT04066205|585682513|FG000|T2 Immediate Post-Intervention|did not respond|5|||
162171925|NCT04066205|585682514|FG001|T2 Immediate Post-Intervention|did not respond|3|||
162171926|NCT02052882|585682515|FG000|Overall Study|Not treated|11|||
162171927|NCT02052882|585682515|FG000|Overall Study|Protocol Violation|1|||
162171928|NCT02052882|585682515|FG000|Overall Study|Inadequate testing|1|||
162171929|NCT01275677|585682522|FG000|Overall Study|Not at risk for recurrence.|1|||
162171930|NCT01275677|585682523|FG001|Overall Study|Not at risk for recurrence.|1|||
162171931|NCT01275677|585682522|FG000|Overall Study|No follow-up|26|||
162171932|NCT01275677|585682523|FG001|Overall Study|No follow-up|37|||
162171933|NCT01275677|585682522|FG000|Overall Study|No clinical follow up.|1|||
162171934|NCT01275677|585682523|FG001|Overall Study|No clinical follow up.|4|||
162171935|NCT03478956|585682525|FG000|Randomized Treatment Period|Adverse Event|1|||
162171936|NCT03478956|585682526|FG001|Randomized Treatment Period|Adverse Event|0|||
162171937|NCT03478956|585682527|FG002|Randomized Treatment Period|Adverse Event|0|||
162171938|NCT03478956|585682528|FG003|Randomized Treatment Period|Adverse Event|0|||
162171939|NCT03478956|585682525|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
162171940|NCT03478956|585682526|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
162171941|NCT03478956|585682527|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
162171942|NCT03478956|585682528|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
162171943|NCT03478956|585682525|FG000|Open Label Extension Period|Adverse Event|0|||
162171944|NCT03478956|585682526|FG001|Open Label Extension Period|Adverse Event|0|||
162171945|NCT03478956|585682527|FG002|Open Label Extension Period|Adverse Event|4|||
162171946|NCT03478956|585682528|FG003|Open Label Extension Period|Adverse Event|0|||
162171947|NCT03478956|585682525|FG000|Open Label Extension Period|Lack of Efficacy|0|||
162171948|NCT03478956|585682526|FG001|Open Label Extension Period|Lack of Efficacy|0|||
162171949|NCT03478956|585682527|FG002|Open Label Extension Period|Lack of Efficacy|8|||
162171950|NCT03478956|585682528|FG003|Open Label Extension Period|Lack of Efficacy|0|||
162171951|NCT03478956|585682525|FG000|Open Label Extension Period|Reason Not Provided|0|||
162171952|NCT03478956|585682526|FG001|Open Label Extension Period|Reason Not Provided|0|||
162171953|NCT03478956|585682527|FG002|Open Label Extension Period|Reason Not Provided|1|||
162171954|NCT03478956|585682528|FG003|Open Label Extension Period|Reason Not Provided|0|||
162171955|NCT03478956|585682525|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
162171956|NCT03478956|585682526|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
162171957|NCT03478956|585682527|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
162171958|NCT03478956|585682528|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
162171959|NCT03478956|585682525|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
162171960|NCT03478956|585682526|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
162171961|NCT03478956|585682527|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
162171962|NCT03478956|585682528|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
162171963|NCT03478956|585682525|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
162171964|NCT03478956|585682526|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
162171965|NCT03478956|585682527|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
162171966|NCT03478956|585682528|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
162171967|NCT04800211|585682529|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
162171968|NCT04800211|585682530|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
162171969|NCT04800211|585682531|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
162171970|NCT04800211|585682529|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
162171971|NCT04800211|585682530|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
161670120|NCT04442737|583845344|FG001|Overall Study|Protocol Violation|2|||
162171972|NCT04800211|585682531|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
162171973|NCT04800211|585682529|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
162171974|NCT04800211|585682530|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
162171975|NCT04800211|585682531|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
162171976|NCT04800211|585682529|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
162171977|NCT04800211|585682530|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
162171978|NCT04800211|585682531|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
162171979|NCT04800211|585682529|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
162171980|NCT04800211|585682530|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
162171981|NCT04800211|585682531|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
162171982|NCT04800211|585682529|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
162171983|NCT04800211|585682530|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
162171984|NCT04800211|585682531|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
162171985|NCT04800211|585682529|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
162171986|NCT04800211|585682530|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
162171987|NCT04800211|585682531|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
162171988|NCT04800211|585682529|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
162171989|NCT04800211|585682530|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
162171990|NCT04800211|585682531|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
162171991|NCT04800211|585682529|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
162171992|NCT04800211|585682530|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
162171993|NCT04800211|585682531|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
162171994|NCT04800211|585682529|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
162171995|NCT04800211|585682530|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
162171996|NCT04800211|585682531|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
162171997|NCT04800211|585682529|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
161922176|NCT00541229|584762259|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
161922177|NCT00541229|584762260|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
161922178|NCT00541229|584762261|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
161922179|NCT00541229|584762256|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
161922180|NCT00541229|584762257|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
161922181|NCT00541229|584762258|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
161922182|NCT00541229|584762259|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
161922183|NCT00541229|584762260|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
161922184|NCT00541229|584762261|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
161922185|NCT00541229|584762256|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
161922186|NCT00541229|584762257|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
161922187|NCT00541229|584762258|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
161922188|NCT00541229|584762259|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
161922189|NCT00541229|584762260|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
161922190|NCT00541229|584762261|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
161922191|NCT00541229|584762256|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
162171998|NCT04800211|585682530|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
162171999|NCT04800211|585682531|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
162172000|NCT05170841|585682532|FG000|Single Dose Phase|Adverse Event|1|||
162172001|NCT05170841|585682533|FG001|Single Dose Phase|Adverse Event|2|||
162172002|NCT05170841|585682534|FG002|Single Dose Phase|Adverse Event|0|||
162172003|NCT05170841|585682535|FG003|Single Dose Phase|Adverse Event|2|||
162172004|NCT05170841|585682532|FG000|Multiple Dose Phase|Adverse Event|1|||
162172005|NCT05170841|585682533|FG001|Multiple Dose Phase|Adverse Event|2|||
162172006|NCT05170841|585682534|FG002|Multiple Dose Phase|Adverse Event|1|||
162172007|NCT05170841|585682535|FG003|Multiple Dose Phase|Adverse Event|4|||
162172008|NCT05170841|585682532|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
162172009|NCT05170841|585682533|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
161922192|NCT00541229|584762257|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
161922193|NCT00541229|584762258|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
161922194|NCT00541229|584762259|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
161922195|NCT00541229|584762260|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
161922196|NCT00541229|584762261|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
161922197|NCT00541229|584762256|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
161922198|NCT00541229|584762257|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
161922199|NCT00541229|584762258|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
161922200|NCT00541229|584762259|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
161922201|NCT00541229|584762260|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
161922202|NCT00541229|584762261|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
161922203|NCT00541229|584762256|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
161922204|NCT00541229|584762257|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
161922205|NCT00541229|584762258|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
161922206|NCT00541229|584762259|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
161922207|NCT00541229|584762260|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
161922208|NCT00541229|584762261|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
161922209|NCT00541229|584762256|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
161922210|NCT00541229|584762257|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
161922211|NCT00541229|584762258|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
161922212|NCT00541229|584762259|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
161922213|NCT00541229|584762260|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
161922214|NCT00541229|584762261|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
161922215|NCT00541229|584762256|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
161922216|NCT00541229|584762257|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
161922217|NCT00541229|584762258|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
161922218|NCT00541229|584762259|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
161922219|NCT00541229|584762260|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
161922220|NCT00541229|584762261|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
161922221|NCT00541229|584762256|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
161922222|NCT00541229|584762257|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
161922223|NCT00541229|584762258|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
162017887|NCT02624986|585119767|FG005|Overall Study|Withdrawal by Subject|0|||
162017888|NCT02624986|585119768|FG006|Overall Study|Withdrawal by Subject|0|||
162017889|NCT02624986|585119769|FG007|Overall Study|Withdrawal by Subject|1|||
161922224|NCT00541229|584762259|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
161922225|NCT00541229|584762260|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
161922226|NCT00541229|584762261|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
161922227|NCT00541229|584762256|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
161922228|NCT00541229|584762257|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
161922229|NCT00541229|584762258|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
161922230|NCT00541229|584762259|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
161922231|NCT00541229|584762260|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
161922232|NCT00541229|584762261|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
161922233|NCT00541229|584762256|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
161922234|NCT00541229|584762257|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
161922235|NCT00541229|584762258|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
161922236|NCT00541229|584762259|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
161922237|NCT00541229|584762260|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
161922238|NCT00541229|584762261|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
161922239|NCT00541229|584762256|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
161922240|NCT00541229|584762257|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
161922241|NCT00541229|584762258|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
161922242|NCT00541229|584762259|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
161922243|NCT00541229|584762260|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
161922244|NCT00541229|584762261|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
161922245|NCT00541229|584762256|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
161922246|NCT00541229|584762257|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
161922247|NCT00541229|584762258|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
161922248|NCT00541229|584762259|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
161922249|NCT00541229|584762260|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
161922250|NCT00541229|584762261|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
161922251|NCT00541229|584762256|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
161922252|NCT00541229|584762257|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
161922253|NCT00541229|584762258|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
161922254|NCT00541229|584762259|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
162172010|NCT05170841|585682534|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
162172011|NCT05170841|585682535|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
162172012|NCT03734679|585682552|FG000|Overall Study|Missed Visit|1|||
162172013|NCT02733159|585682563|FG000|Overall Study|Adverse Event|1|||
162172014|NCT02733159|585682563|FG000|Overall Study|Lack of disease progression|1|||
162172015|NCT06122194|585682566|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
162172016|NCT06122194|585682567|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
162172017|NCT06122194|585682568|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
162172018|NCT06122194|585682569|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
162172019|NCT05218096|585682570|FG000|Primary Evaluation|Withdrawal by Subject|0|||
162172020|NCT05218096|585682571|FG001|Primary Evaluation|Withdrawal by Subject|0|||
162172021|NCT05218096|585682572|FG002|Primary Evaluation|Withdrawal by Subject|2|||
162172022|NCT05218096|585682573|FG003|Primary Evaluation|Withdrawal by Subject|0|||
161816718|NCT04633564|584368834|FG001|Period 2|Lost to Follow-up|1|||
162172023|NCT05218096|585682574|FG004|Primary Evaluation|Withdrawal by Subject|0|||
162172024|NCT05218096|585682570|FG000|Primary Evaluation|Physician Decision|1|||
162172025|NCT05218096|585682571|FG001|Primary Evaluation|Physician Decision|0|||
162172026|NCT05218096|585682572|FG002|Primary Evaluation|Physician Decision|0|||
162172027|NCT05218096|585682573|FG003|Primary Evaluation|Physician Decision|0|||
161816719|NCT04633564|584368833|FG000|Period 2|Physician Decision|2|||
161816720|NCT04633564|584368834|FG001|Period 2|Physician Decision|4|||
161816721|NCT04633564|584368833|FG000|Period 2|Withdrawal by Subject|5|||
161816722|NCT04633564|584368834|FG001|Period 2|Withdrawal by Subject|1|||
161816723|NCT04633564|584368833|FG000|Period 2|Progressive Disease|74|||
161816724|NCT04633564|584368834|FG001|Period 2|Progressive Disease|82|||
161816725|NCT04633564|584368833|FG000|Period 2|Terminated by Sponsor|9|||
161816726|NCT04633564|584368834|FG001|Period 2|Terminated by Sponsor|3|||
161816727|NCT04198363|584368835|FG000|Overall Study|Adverse Event|1|||
161816728|NCT04198363|584368836|FG001|Overall Study|Adverse Event|1|||
161816729|NCT04198363|584368835|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
161816730|NCT04198363|584368836|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
161816731|NCT04198363|584368835|FG000|Overall Study|Reason not Specified|1|||
162172028|NCT05218096|585682574|FG004|Primary Evaluation|Physician Decision|0|||
162172029|NCT05218096|585682570|FG000|Extended Treatment|Clinical Deterioration|1|||
161816732|NCT04198363|584368836|FG001|Overall Study|Reason not Specified|0|||
161816733|NCT03500094|584368842|FG000|Overall Study|Withdrawal by Subject|1|||
161816734|NCT03500094|584368842|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
161922255|NCT00541229|584762260|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
161922256|NCT00541229|584762261|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
161922257|NCT01312129|584762262|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
161922258|NCT01312129|584762263|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
161922259|NCT02397837|584762266|FG000|Overall Study|Withdrawal by Subject|6|||
161922260|NCT02397837|584762267|FG001|Overall Study|Withdrawal by Subject|5|||
161922261|NCT02397837|584762266|FG000|Overall Study|Physician Decision|1|||
161922262|NCT02397837|584762267|FG001|Overall Study|Physician Decision|1|||
161922263|NCT01482221|584762275|FG000|Overall Study|Lack of Efficacy|1|||
161922264|NCT01482221|584762276|FG001|Overall Study|Lack of Efficacy|0|||
161922265|NCT01482221|584762277|FG002|Overall Study|Lack of Efficacy|1|||
161922266|NCT01482221|584762275|FG000|Overall Study|Lost to Follow-up|3|||
161922267|NCT01482221|584762276|FG001|Overall Study|Lost to Follow-up|2|||
161922268|NCT01482221|584762277|FG002|Overall Study|Lost to Follow-up|1|||
161922269|NCT01482221|584762275|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
161922270|NCT01482221|584762276|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
161922271|NCT01482221|584762277|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
161922272|NCT01482221|584762275|FG000|Overall Study|Condition under Investigation Worsened|3|||
161922273|NCT01482221|584762276|FG001|Overall Study|Condition under Investigation Worsened|2|||
161922274|NCT01482221|584762277|FG002|Overall Study|Condition under Investigation Worsened|4|||
162017890|NCT03532451|585119770|FG000|Overall Study|Withdrawal by Subject|0|||
162017891|NCT03532451|585119771|FG001|Overall Study|Withdrawal by Subject|1|||
162017892|NCT03532451|585119770|FG000|Overall Study|Did not undergo surgery|1|||
162017893|NCT03532451|585119771|FG001|Overall Study|Did not undergo surgery|1|||
162017894|NCT00525161|585119774|FG000|Overall Study|Adverse Event|1|||
162017895|NCT01076361|585119775|FG000|Overall Study|22 leads were excluded from analysis|21|||
162017896|NCT00630838|585119785|FG000|Overall Study|Death|0|||
162017897|NCT00630838|585119786|FG001|Overall Study|Death|1|||
162017898|NCT00630838|585119785|FG000|Overall Study|Lost to Follow-up|0|||
162017899|NCT00630838|585119786|FG001|Overall Study|Lost to Follow-up|1|||
162017900|NCT00928408|585119787|FG000|Overall Study|Other|2|||
162017901|NCT00928408|585119787|FG000|Overall Study|Withdrawal by Subject|4|||
162017902|NCT00928408|585119787|FG000|Overall Study|Death|5|||
162017903|NCT00928408|585119787|FG000|Overall Study|Lost to Follow-up|12|||
162017904|NCT01287741|585119794|FG000|Overall Study|Withdrawal by Subject|35|||
162017905|NCT01287741|585119795|FG001|Overall Study|Withdrawal by Subject|38|||
162017906|NCT01287741|585119794|FG000|Overall Study|Protocol Violation|2|||
162017907|NCT01287741|585119795|FG001|Overall Study|Protocol Violation|0|||
162017908|NCT01287741|585119794|FG000|Overall Study|Physician Decision|15|||
162017909|NCT01287741|585119795|FG001|Overall Study|Physician Decision|23|||
162017910|NCT01287741|585119794|FG000|Overall Study|Non-compliance|8|||
162017911|NCT01287741|585119795|FG001|Overall Study|Non-compliance|6|||
162017912|NCT01287741|585119794|FG000|Overall Study|Lost to Follow-up|10|||
162017913|NCT01287741|585119795|FG001|Overall Study|Lost to Follow-up|8|||
162017914|NCT01287741|585119794|FG000|Overall Study|Death|32|||
162017915|NCT01287741|585119795|FG001|Overall Study|Death|44|||
162017916|NCT01287741|585119794|FG000|Overall Study|Adverse Event|4|||
162017917|NCT01287741|585119795|FG001|Overall Study|Adverse Event|6|||
162017918|NCT01287741|585119794|FG000|Overall Study|Study terminated by Sponsor|307|||
162017919|NCT01287741|585119795|FG001|Overall Study|Study terminated by Sponsor|315|||
162017920|NCT01287741|585119794|FG000|Overall Study|Progressive disease|190|||
162017921|NCT01287741|585119795|FG001|Overall Study|Progressive disease|166|||
161670121|NCT04442737|583845343|FG000|Overall Study|Other|1|||
162017922|NCT01287741|585119794|FG000|Overall Study|Reason not specified|23|||
162017923|NCT01287741|585119795|FG001|Overall Study|Reason not specified|9|||
162017924|NCT02930018|585119797|FG000|Overall Study|Lost to Follow-up|1|||
162017925|NCT02930018|585119798|FG001|Overall Study|Lost to Follow-up|1|||
162172030|NCT05218096|585682571|FG001|Extended Treatment|Clinical Deterioration|1|||
162172031|NCT05218096|585682572|FG002|Extended Treatment|Clinical Deterioration|0|||
162172032|NCT05218096|585682573|FG003|Extended Treatment|Clinical Deterioration|0|||
162172033|NCT05218096|585682574|FG004|Extended Treatment|Clinical Deterioration|0|||
162172034|NCT05218096|585682570|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
162172035|NCT05218096|585682571|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
162172036|NCT05218096|585682572|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
162172037|NCT05218096|585682573|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
162172038|NCT05218096|585682574|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
162172039|NCT05218096|585682570|FG000|Extended Treatment|Withdrawal by Subject|1|||
162172040|NCT05218096|585682571|FG001|Extended Treatment|Withdrawal by Subject|3|||
162172041|NCT05218096|585682572|FG002|Extended Treatment|Withdrawal by Subject|0|||
162172042|NCT05218096|585682573|FG003|Extended Treatment|Withdrawal by Subject|2|||
161922275|NCT01482221|584762275|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
161922276|NCT01482221|584762276|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
161922277|NCT01482221|584762277|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
162017926|NCT02930018|585119797|FG000|Overall Study|Withdrawal by Subject|5|||
162017927|NCT02930018|585119798|FG001|Overall Study|Withdrawal by Subject|2|||
162017928|NCT02807402|585119799|FG000|Overall Study|Failure to Return|1|||
161816735|NCT03500094|584368842|FG000|Overall Study|Lost to Follow-up|1|||
161816736|NCT00640341|584370829|FG000|Overall Study|Adverse Event|0|||
161816737|NCT00640341|584370830|FG001|Overall Study|Adverse Event|0|||
161816738|NCT00640341|584370831|FG002|Overall Study|Adverse Event|1|||
161816739|NCT00640341|584370829|FG000|Overall Study|Positive Slit Lamp Findings|0|||
161816740|NCT00640341|584370830|FG001|Overall Study|Positive Slit Lamp Findings|0|||
161816741|NCT00640341|584370831|FG002|Overall Study|Positive Slit Lamp Findings|1|||
161816742|NCT00640341|584370829|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
161816743|NCT00640341|584370830|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
161816744|NCT00640341|584370831|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
161816745|NCT00640341|584370829|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
161816746|NCT00640341|584370830|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
161816747|NCT00640341|584370831|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
161816748|NCT00640341|584370829|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
161816749|NCT00640341|584370830|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
161816750|NCT00640341|584370831|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
161816751|NCT00640341|584370829|FG000|Overall Study|Lost to Follow-up|2|||
161816752|NCT00640341|584370830|FG001|Overall Study|Lost to Follow-up|0|||
161816753|NCT00640341|584370831|FG002|Overall Study|Lost to Follow-up|0|||
161816754|NCT00640341|584370829|FG000|Overall Study|Withdrawal by Subject|4|||
161816755|NCT00640341|584370830|FG001|Overall Study|Withdrawal by Subject|0|||
161816756|NCT00640341|584370831|FG002|Overall Study|Withdrawal by Subject|1|||
161816757|NCT00640341|584370829|FG000|Overall Study|Unacceptable Lens Movement|1|||
161816758|NCT00640341|584370830|FG001|Overall Study|Unacceptable Lens Movement|0|||
161816759|NCT00640341|584370831|FG002|Overall Study|Unacceptable Lens Movement|0|||
161816760|NCT00640341|584370829|FG000|Overall Study|Poor fit/Uncomfortable|4|||
161816761|NCT00640341|584370830|FG001|Overall Study|Poor fit/Uncomfortable|0|||
161816762|NCT00640341|584370831|FG002|Overall Study|Poor fit/Uncomfortable|0|||
161816763|NCT00640341|584370829|FG000|Overall Study|Ineligable at Baseline|5|||
161816764|NCT00640341|584370830|FG001|Overall Study|Ineligable at Baseline|3|||
161816765|NCT00640341|584370831|FG002|Overall Study|Ineligable at Baseline|2|||
161816766|NCT00640341|584370829|FG000|Overall Study|Adverse event and positive slit lamp|1|||
161816767|NCT00640341|584370830|FG001|Overall Study|Adverse event and positive slit lamp|0|||
161816768|NCT00640341|584370831|FG002|Overall Study|Adverse event and positive slit lamp|0|||
161816769|NCT01541215|584370834|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
161816770|NCT01541215|584370835|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
161816771|NCT01541215|584370834|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
161816772|NCT01541215|584370835|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
161816773|NCT01541215|584370834|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
161816774|NCT01541215|584370835|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
161816775|NCT01541215|584370834|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
161816776|NCT01541215|584370835|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
161816777|NCT01541215|584370834|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
161816778|NCT01541215|584370835|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
161816779|NCT01541215|584370834|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
161816780|NCT01541215|584370835|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
161816781|NCT02316223|584370839|FG000|Overall Study|Lack of Efficacy|0|||
161816782|NCT02316223|584370840|FG001|Overall Study|Lack of Efficacy|1|||
161816783|NCT02316223|584370841|FG002|Overall Study|Lack of Efficacy|1|||
161816784|NCT02316223|584370839|FG000|Overall Study|Lost to Follow-up|27|||
161816785|NCT02316223|584370840|FG001|Overall Study|Lost to Follow-up|34|||
161816786|NCT02316223|584370841|FG002|Overall Study|Lost to Follow-up|36|||
161922278|NCT01482221|584762275|FG000|Overall Study|Adverse Event|1|||
161816787|NCT02316223|584370839|FG000|Overall Study|COPD Diagnosis|3|||
161816788|NCT02316223|584370840|FG001|Overall Study|COPD Diagnosis|2|||
161816789|NCT02316223|584370841|FG002|Overall Study|COPD Diagnosis|3|||
161816790|NCT02316223|584370839|FG000|Overall Study|Reside outside study area|1|||
161816791|NCT02316223|584370840|FG001|Overall Study|Reside outside study area|1|||
161816792|NCT02316223|584370841|FG002|Overall Study|Reside outside study area|1|||
161816793|NCT02316223|584370839|FG000|Overall Study|No asthma|2|||
161816794|NCT02316223|584370840|FG001|Overall Study|No asthma|0|||
161816795|NCT02316223|584370841|FG002|Overall Study|No asthma|0|||
161922279|NCT01482221|584762276|FG001|Overall Study|Adverse Event|7|||
161922280|NCT01482221|584762277|FG002|Overall Study|Adverse Event|3|||
161922281|NCT01482221|584762275|FG000|Overall Study|Withdrawal by Subject|10|||
161922282|NCT01482221|584762276|FG001|Overall Study|Withdrawal by Subject|7|||
161922283|NCT01482221|584762277|FG002|Overall Study|Withdrawal by Subject|12|||
161922284|NCT01482221|584762275|FG000|Overall Study|Incorrect randomization|0|||
161922285|NCT01482221|584762276|FG001|Overall Study|Incorrect randomization|1|||
161922286|NCT01482221|584762277|FG002|Overall Study|Incorrect randomization|0|||
161922287|NCT01482221|584762275|FG000|Overall Study|Physician Decision|0|||
161922288|NCT01482221|584762276|FG001|Overall Study|Physician Decision|1|||
162172043|NCT05218096|585682574|FG004|Extended Treatment|Withdrawal by Subject|2|||
162172044|NCT05218096|585682570|FG000|Extended Treatment|Lack of Efficacy|3|||
162172045|NCT05218096|585682571|FG001|Extended Treatment|Lack of Efficacy|0|||
162172046|NCT05218096|585682572|FG002|Extended Treatment|Lack of Efficacy|0|||
162172047|NCT05218096|585682573|FG003|Extended Treatment|Lack of Efficacy|0|||
162172048|NCT05218096|585682574|FG004|Extended Treatment|Lack of Efficacy|0|||
162172049|NCT05218096|585682570|FG000|Extended Treatment|Physician Decision|0|||
162172050|NCT05218096|585682571|FG001|Extended Treatment|Physician Decision|1|||
162172051|NCT05218096|585682572|FG002|Extended Treatment|Physician Decision|0|||
162172052|NCT05218096|585682573|FG003|Extended Treatment|Physician Decision|0|||
162172053|NCT05218096|585682574|FG004|Extended Treatment|Physician Decision|0|||
162172054|NCT05218096|585682570|FG000|Open-label Extension|Adverse Event|1|||
162172055|NCT05218096|585682571|FG001|Open-label Extension|Adverse Event|0|||
162172056|NCT05218096|585682572|FG002|Open-label Extension|Adverse Event|0|||
162172057|NCT05218096|585682573|FG003|Open-label Extension|Adverse Event|0|||
162172058|NCT05218096|585682574|FG004|Open-label Extension|Adverse Event|1|||
162172059|NCT05218096|585682570|FG000|Open-label Extension|Pregnancy|0|||
162172060|NCT05218096|585682571|FG001|Open-label Extension|Pregnancy|0|||
162172061|NCT05218096|585682572|FG002|Open-label Extension|Pregnancy|0|||
162172062|NCT05218096|585682573|FG003|Open-label Extension|Pregnancy|0|||
162172063|NCT05218096|585682574|FG004|Open-label Extension|Pregnancy|1|||
162172064|NCT05218096|585682570|FG000|Open-label Extension|Lack of Efficacy|1|||
162172065|NCT05218096|585682571|FG001|Open-label Extension|Lack of Efficacy|2|||
162172066|NCT05218096|585682572|FG002|Open-label Extension|Lack of Efficacy|0|||
162172067|NCT05218096|585682573|FG003|Open-label Extension|Lack of Efficacy|0|||
162172068|NCT05218096|585682574|FG004|Open-label Extension|Lack of Efficacy|0|||
162172069|NCT05218096|585682570|FG000|Open-label Extension|Lost to Follow-up|1|||
162172070|NCT05218096|585682571|FG001|Open-label Extension|Lost to Follow-up|0|||
161922289|NCT01482221|584762277|FG002|Overall Study|Physician Decision|0|||
161922290|NCT00263562|584762278|FG000|Overall Study|Protocol Violation|3|||
162172071|NCT05218096|585682572|FG002|Open-label Extension|Lost to Follow-up|0|||
161922291|NCT00263562|584762279|FG001|Overall Study|Protocol Violation|0|||
161922292|NCT04602000|584762280|FG000|Overall Study|Withdrawal by Subject|3|||
161922293|NCT04602000|584762281|FG001|Overall Study|Withdrawal by Subject|6|||
161922294|NCT04602000|584762282|FG002|Overall Study|Withdrawal by Subject|3|||
161922295|NCT04602000|584762283|FG003|Overall Study|Withdrawal by Subject|27|||
161922296|NCT04602000|584762284|FG004|Overall Study|Withdrawal by Subject|39|||
161922297|NCT04602000|584762280|FG000|Overall Study|Physician Decision|1|||
161922298|NCT04602000|584762281|FG001|Overall Study|Physician Decision|0|||
161922299|NCT04602000|584762282|FG002|Overall Study|Physician Decision|0|||
161922300|NCT04602000|584762283|FG003|Overall Study|Physician Decision|2|||
161922301|NCT04602000|584762284|FG004|Overall Study|Physician Decision|2|||
161922302|NCT04602000|584762280|FG000|Overall Study|Death|0|||
161922303|NCT04602000|584762281|FG001|Overall Study|Death|1|||
161922304|NCT04602000|584762282|FG002|Overall Study|Death|0|||
161922305|NCT04602000|584762283|FG003|Overall Study|Death|1|||
161922306|NCT04602000|584762284|FG004|Overall Study|Death|2|||
161922307|NCT04602000|584762280|FG000|Overall Study|Lost to Follow-up|0|||
161922308|NCT04602000|584762281|FG001|Overall Study|Lost to Follow-up|0|||
161922309|NCT04602000|584762282|FG002|Overall Study|Lost to Follow-up|0|||
161922310|NCT04602000|584762283|FG003|Overall Study|Lost to Follow-up|3|||
161922311|NCT04602000|584762284|FG004|Overall Study|Lost to Follow-up|4|||
161922312|NCT04602000|584762280|FG000|Overall Study|Other|4|||
161922313|NCT04602000|584762281|FG001|Overall Study|Other|1|||
161922314|NCT04602000|584762282|FG002|Overall Study|Other|2|||
161922315|NCT04602000|584762283|FG003|Overall Study|Other|5|||
161922316|NCT04602000|584762284|FG004|Overall Study|Other|4|||
161922317|NCT04602000|584762280|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
161922318|NCT04602000|584762281|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
161922319|NCT04602000|584762282|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
161922320|NCT04602000|584762283|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
161922321|NCT04602000|584762284|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
161922322|NCT05607043|584762285|FG000|Overall Study|Lost to Follow-up|2|||
161922323|NCT00081458|584762289|FG000|Overall Study|Adverse Event|1|||
161922324|NCT00081458|584762290|FG001|Overall Study|Adverse Event|5|||
161922325|NCT00081458|584762291|FG002|Overall Study|Adverse Event|2|||
161922326|NCT00081458|584762289|FG000|Overall Study|Withdrawal by Subject|0|||
161922327|NCT00081458|584762290|FG001|Overall Study|Withdrawal by Subject|3|||
161922328|NCT00081458|584762291|FG002|Overall Study|Withdrawal by Subject|1|||
161922329|NCT00081458|584762289|FG000|Overall Study|Randomized but not dosed|0|||
161922330|NCT00081458|584762290|FG001|Overall Study|Randomized but not dosed|0|||
161922331|NCT00081458|584762291|FG002|Overall Study|Randomized but not dosed|1|||
161922332|NCT00195429|584762292|FG000|Overall Study|Adverse Event|2|||
161922333|NCT00195429|584762293|FG001|Overall Study|Adverse Event|4|||
161922334|NCT00195429|584762292|FG000|Overall Study|Lack of Efficacy|2|||
161922335|NCT00195429|584762293|FG001|Overall Study|Lack of Efficacy|1|||
161922336|NCT00195429|584762292|FG000|Overall Study|Lost to Follow-up|1|||
162017929|NCT02807402|585119799|FG000|Overall Study|Death|3|||
162172072|NCT05218096|585682573|FG003|Open-label Extension|Lost to Follow-up|0|||
162172073|NCT05218096|585682574|FG004|Open-label Extension|Lost to Follow-up|0|||
162172074|NCT05218096|585682570|FG000|Open-label Extension|Death|0|||
162172075|NCT05218096|585682571|FG001|Open-label Extension|Death|0|||
162172076|NCT05218096|585682572|FG002|Open-label Extension|Death|0|||
162172077|NCT05218096|585682573|FG003|Open-label Extension|Death|1|||
162172078|NCT05218096|585682574|FG004|Open-label Extension|Death|0|||
162172079|NCT05218096|585682570|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
162172080|NCT05218096|585682571|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
162172081|NCT05218096|585682572|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
162172082|NCT05218096|585682573|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
162172083|NCT05218096|585682574|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
162172084|NCT03088878|585682575|FG000|Overall Study|Adverse Event|0|||
162172085|NCT03088878|585682576|FG001|Overall Study|Adverse Event|0|||
162172086|NCT03088878|585682577|FG002|Overall Study|Adverse Event|0|||
162172087|NCT03088878|585682578|FG003|Overall Study|Adverse Event|0|||
162172088|NCT03088878|585682579|FG004|Overall Study|Adverse Event|4|||
162172089|NCT03088878|585682580|FG005|Overall Study|Adverse Event|2|||
162172090|NCT03088878|585682581|FG006|Overall Study|Adverse Event|1|||
162172091|NCT03088878|585682582|FG007|Overall Study|Adverse Event|0|||
162172092|NCT03088878|585682583|FG008|Overall Study|Adverse Event|0|||
162172093|NCT03088878|585682584|FG009|Overall Study|Adverse Event|0|||
161670122|NCT04442737|583845344|FG001|Overall Study|Other|1|||
161922337|NCT00195429|584762293|FG001|Overall Study|Lost to Follow-up|0|||
161922338|NCT00367458|584762294|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
161922339|NCT00367458|584762295|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
161922340|NCT01334515|584762298|FG000|Overall Study|Adverse Event|1|||
162017930|NCT02807402|585119799|FG000|Overall Study|Other|2|||
162172094|NCT03088878|585682585|FG010|Overall Study|Adverse Event|0|||
162172095|NCT03088878|585682586|FG011|Overall Study|Adverse Event|0|||
162172096|NCT03088878|585682587|FG012|Overall Study|Adverse Event|5|||
161922341|NCT01334515|584762299|FG001|Overall Study|Adverse Event|6|||
161922342|NCT01334515|584762298|FG000|Overall Study|Death|1|||
161922343|NCT01334515|584762299|FG001|Overall Study|Death|0|||
162172097|NCT03088878|585682588|FG013|Overall Study|Adverse Event|3|||
162172098|NCT03088878|585682575|FG000|Overall Study|Clinical Progression|0|||
161670123|NCT01139021|583845345|FG000|Overall Study|Adverse Event|0|||
161670124|NCT01139021|583845346|FG001|Overall Study|Adverse Event|0|||
161670125|NCT01139021|583845347|FG002|Overall Study|Adverse Event|0|||
161670126|NCT01139021|583845348|FG003|Overall Study|Adverse Event|0|||
161670127|NCT01139021|583845349|FG004|Overall Study|Adverse Event|1|||
161670128|NCT01139021|583845350|FG005|Overall Study|Adverse Event|0|||
161670129|NCT01139021|583845345|FG000|Overall Study|Lost to Follow-up|0|||
161670130|NCT01139021|583845346|FG001|Overall Study|Lost to Follow-up|0|||
161670131|NCT01139021|583845347|FG002|Overall Study|Lost to Follow-up|0|||
161670132|NCT01139021|583845348|FG003|Overall Study|Lost to Follow-up|0|||
161670133|NCT01139021|583845349|FG004|Overall Study|Lost to Follow-up|2|||
162172099|NCT03088878|585682576|FG001|Overall Study|Clinical Progression|0|||
162172100|NCT03088878|585682577|FG002|Overall Study|Clinical Progression|0|||
162172101|NCT03088878|585682578|FG003|Overall Study|Clinical Progression|0|||
161670134|NCT01139021|583845350|FG005|Overall Study|Lost to Follow-up|0|||
161670135|NCT01139021|583845345|FG000|Overall Study|Protocol Violation|1|||
161922344|NCT01334515|584762298|FG000|Overall Study|Lack of Efficacy|8|||
161922345|NCT01334515|584762299|FG001|Overall Study|Lack of Efficacy|21|||
161922346|NCT01334515|584762298|FG000|Overall Study|Physician Decision|1|||
161922347|NCT01334515|584762299|FG001|Overall Study|Physician Decision|1|||
161922348|NCT01334515|584762298|FG000|Overall Study|Withdrawal by Subject|1|||
161922349|NCT01334515|584762299|FG001|Overall Study|Withdrawal by Subject|1|||
161922350|NCT05774977|584762304|FG000|Overall Study|Withdrawal by Subject|2|||
161922351|NCT00374868|584762306|FG000|Overall Study|Adverse Event|12|||
161922352|NCT00374868|584762306|FG000|Overall Study|Progressive Disease|7|||
161922353|NCT00374868|584762306|FG000|Overall Study|Physician Decision|13|||
161922354|NCT00374868|584762306|FG000|Overall Study|Lost to Follow-up|1|||
161922355|NCT00374868|584762306|FG000|Overall Study|Death|2|||
161922356|NCT00374868|584762306|FG000|Overall Study|Other - Not Specified|1|||
161922357|NCT04470427|584762307|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
161922358|NCT04470427|584762308|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
161922359|NCT04470427|584762309|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
161922360|NCT04470427|584762310|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
161922361|NCT04470427|584762311|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
161922362|NCT04470427|584762312|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
161922363|NCT04470427|584762307|FG000|Part B :Open-label|Other than specified|0|||
161922364|NCT04470427|584762308|FG001|Part B :Open-label|Other than specified|0|||
161922365|NCT04470427|584762309|FG002|Part B :Open-label|Other than specified|788|||
161922366|NCT04470427|584762310|FG003|Part B :Open-label|Other than specified|0|||
161922367|NCT04470427|584762311|FG004|Part B :Open-label|Other than specified|523|||
161922368|NCT04470427|584762312|FG005|Part B :Open-label|Other than specified|0|||
161922369|NCT04470427|584762307|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
161922370|NCT04470427|584762308|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
161922371|NCT04470427|584762309|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
161922372|NCT04470427|584762310|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
161922373|NCT04470427|584762311|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
161922374|NCT04470427|584762312|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
161922375|NCT04470427|584762307|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
161922376|NCT04470427|584762308|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
161922377|NCT04470427|584762309|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
161922378|NCT04470427|584762310|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
161922379|NCT04470427|584762311|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
161922380|NCT04470427|584762312|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
161922381|NCT03188185|584762313|FG000|Stage 1|Adverse Event|4|||
161922382|NCT03188185|584762314|FG001|Stage 1|Adverse Event|12|||
161922383|NCT03188185|584762315|FG002|Stage 1|Adverse Event|0|||
161922384|NCT03188185|584762316|FG003|Stage 1|Adverse Event|0|||
161922385|NCT03188185|584762313|FG000|Stage 1|Lack of Efficacy|0|||
161922386|NCT03188185|584762314|FG001|Stage 1|Lack of Efficacy|2|||
161922387|NCT03188185|584762315|FG002|Stage 1|Lack of Efficacy|0|||
161922388|NCT03188185|584762316|FG003|Stage 1|Lack of Efficacy|0|||
161922389|NCT03188185|584762313|FG000|Stage 1|Lost to Follow-up|6|||
161922390|NCT03188185|584762314|FG001|Stage 1|Lost to Follow-up|1|||
161922391|NCT03188185|584762315|FG002|Stage 1|Lost to Follow-up|0|||
161922392|NCT03188185|584762316|FG003|Stage 1|Lost to Follow-up|0|||
161670136|NCT01139021|583845346|FG001|Overall Study|Protocol Violation|0|||
161670137|NCT01139021|583845347|FG002|Overall Study|Protocol Violation|0|||
161922393|NCT03188185|584762313|FG000|Stage 1|Withdrawal by Subject|9|||
161922394|NCT03188185|584762314|FG001|Stage 1|Withdrawal by Subject|0|||
161922395|NCT03188185|584762315|FG002|Stage 1|Withdrawal by Subject|0|||
161922396|NCT03188185|584762316|FG003|Stage 1|Withdrawal by Subject|0|||
161922397|NCT03188185|584762313|FG000|Stage 1|Identified as a professional patient|0|||
162017931|NCT01865552|585121840|FG000|Period 1|Adverse Event|1|||
161922398|NCT03188185|584762314|FG001|Stage 1|Identified as a professional patient|1|||
161922399|NCT03188185|584762315|FG002|Stage 1|Identified as a professional patient|0|||
161922400|NCT03188185|584762316|FG003|Stage 1|Identified as a professional patient|0|||
161922401|NCT03188185|584762313|FG000|Stage 2|Adverse Event|0|||
161922402|NCT03188185|584762314|FG001|Stage 2|Adverse Event|0|||
161922403|NCT03188185|584762315|FG002|Stage 2|Adverse Event|2|||
161922404|NCT03188185|584762316|FG003|Stage 2|Adverse Event|4|||
161922405|NCT03188185|584762313|FG000|Stage 2|Lack of Efficacy|0|||
161922406|NCT03188185|584762314|FG001|Stage 2|Lack of Efficacy|0|||
161922407|NCT03188185|584762315|FG002|Stage 2|Lack of Efficacy|3|||
161922408|NCT03188185|584762316|FG003|Stage 2|Lack of Efficacy|0|||
161922409|NCT03188185|584762313|FG000|Stage 2|Lost to Follow-up|0|||
161922410|NCT03188185|584762314|FG001|Stage 2|Lost to Follow-up|0|||
161922411|NCT03188185|584762315|FG002|Stage 2|Lost to Follow-up|1|||
161922412|NCT03188185|584762316|FG003|Stage 2|Lost to Follow-up|0|||
161922413|NCT03188185|584762313|FG000|Stage 2|Physician Decision|0|||
161922414|NCT03188185|584762314|FG001|Stage 2|Physician Decision|0|||
161922415|NCT03188185|584762315|FG002|Stage 2|Physician Decision|0|||
161922416|NCT03188185|584762316|FG003|Stage 2|Physician Decision|1|||
161922417|NCT03188185|584762313|FG000|Stage 2|Withdrawal by Subject|0|||
161922418|NCT03188185|584762314|FG001|Stage 2|Withdrawal by Subject|0|||
161922419|NCT03188185|584762315|FG002|Stage 2|Withdrawal by Subject|3|||
161922420|NCT03188185|584762316|FG003|Stage 2|Withdrawal by Subject|1|||
161922421|NCT02324153|584762319|FG000|Overall Study|Withdrawal by Subject|4|||
161922422|NCT02324153|584762320|FG001|Overall Study|Withdrawal by Subject|1|||
161922423|NCT02324153|584762319|FG000|Overall Study|Surgery postponed after randomization|3|||
161922424|NCT02324153|584762320|FG001|Overall Study|Surgery postponed after randomization|0|||
162017932|NCT01865552|585121841|FG001|Period 1|Adverse Event|0|||
162017933|NCT01865552|585121842|FG002|Period 1|Adverse Event|0|||
162017934|NCT01865552|585121843|FG003|Period 1|Adverse Event|1|||
162017935|NCT01865552|585121844|FG004|Period 1|Adverse Event|1|||
162017936|NCT01865552|585121845|FG005|Period 1|Adverse Event|1|||
162017937|NCT01865552|585121840|FG000|Period 1|Pathological lab|0|||
162017938|NCT01865552|585121841|FG001|Period 1|Pathological lab|0|||
162017939|NCT01865552|585121842|FG002|Period 1|Pathological lab|0|||
162017940|NCT01865552|585121843|FG003|Period 1|Pathological lab|0|||
162017941|NCT01865552|585121844|FG004|Period 1|Pathological lab|1|||
162017942|NCT01865552|585121845|FG005|Period 1|Pathological lab|0|||
162017943|NCT01865552|585121840|FG000|Period 1|Other|0|||
162017944|NCT01865552|585121841|FG001|Period 1|Other|0|||
162017945|NCT01865552|585121842|FG002|Period 1|Other|0|||
162017946|NCT01865552|585121843|FG003|Period 1|Other|0|||
162017947|NCT01865552|585121844|FG004|Period 1|Other|1|||
162017948|NCT01865552|585121845|FG005|Period 1|Other|0|||
162017949|NCT03079102|585121848|FG000|Overall Study|Physician Decision|0|||
162017950|NCT03079102|585121849|FG001|Overall Study|Physician Decision|1|||
162017951|NCT02923921|585121850|FG000|Overall Study|Sponsor Decision|39|||
162017952|NCT02923921|585121851|FG001|Overall Study|Sponsor Decision|38|||
162017953|NCT02923921|585121850|FG000|Overall Study|Lost to Follow-up|1|||
162017954|NCT02923921|585121851|FG001|Overall Study|Lost to Follow-up|0|||
162017955|NCT02923921|585121850|FG000|Overall Study|Withdrawal by Subject|6|||
162017956|NCT02923921|585121851|FG001|Overall Study|Withdrawal by Subject|13|||
162017957|NCT02923921|585121850|FG000|Overall Study|Unknown, Not Collected|7|||
162017958|NCT02923921|585121851|FG001|Overall Study|Unknown, Not Collected|6|||
162017959|NCT03083873|585121852|FG000|Overall Study|Death|6|||
162017960|NCT03083873|585121853|FG001|Overall Study|Death|15|||
162017961|NCT03083873|585121854|FG002|Overall Study|Death|13|||
162017962|NCT03083873|585121855|FG003|Overall Study|Death|9|||
162017963|NCT03083873|585121856|FG004|Overall Study|Death|0|||
162017964|NCT03083873|585121852|FG000|Overall Study|Sponsor Terminated Study|0|||
162017965|NCT03083873|585121853|FG001|Overall Study|Sponsor Terminated Study|1|||
162017966|NCT03083873|585121854|FG002|Overall Study|Sponsor Terminated Study|2|||
162017967|NCT03083873|585121855|FG003|Overall Study|Sponsor Terminated Study|3|||
162017968|NCT03083873|585121856|FG004|Overall Study|Sponsor Terminated Study|0|||
162017969|NCT03083873|585121852|FG000|Overall Study|Lost to Follow-up|0|||
162017970|NCT03083873|585121853|FG001|Overall Study|Lost to Follow-up|1|||
162017971|NCT03083873|585121854|FG002|Overall Study|Lost to Follow-up|1|||
162017972|NCT03083873|585121855|FG003|Overall Study|Lost to Follow-up|0|||
162017973|NCT03083873|585121856|FG004|Overall Study|Lost to Follow-up|0|||
162017974|NCT03083873|585121852|FG000|Overall Study|Withdrawal by Subject|2|||
162017975|NCT03083873|585121853|FG001|Overall Study|Withdrawal by Subject|0|||
162017976|NCT03083873|585121854|FG002|Overall Study|Withdrawal by Subject|0|||
162017977|NCT03083873|585121855|FG003|Overall Study|Withdrawal by Subject|0|||
161922425|NCT02324153|584762319|FG000|Overall Study|Developed delirium preoperatively|1|||
162017978|NCT03083873|585121856|FG004|Overall Study|Withdrawal by Subject|0|||
162017979|NCT03083873|585121852|FG000|Overall Study|Did Not Receive TIL|2|||
162017980|NCT03083873|585121853|FG001|Overall Study|Did Not Receive TIL|5|||
161922426|NCT02324153|584762320|FG001|Overall Study|Developed delirium preoperatively|0|||
162017981|NCT03083873|585121854|FG002|Overall Study|Did Not Receive TIL|3|||
162017982|NCT03083873|585121855|FG003|Overall Study|Did Not Receive TIL|1|||
162017983|NCT03083873|585121856|FG004|Overall Study|Did Not Receive TIL|0|||
162017984|NCT00854113|585121857|FG000|Overall Study|Adverse Event|0|||
162172102|NCT03088878|585682579|FG004|Overall Study|Clinical Progression|2|||
162172103|NCT03088878|585682580|FG005|Overall Study|Clinical Progression|0|||
162172104|NCT03088878|585682581|FG006|Overall Study|Clinical Progression|0|||
162172105|NCT03088878|585682582|FG007|Overall Study|Clinical Progression|0|||
162172106|NCT03088878|585682583|FG008|Overall Study|Clinical Progression|0|||
161922427|NCT01937299|584762321|FG000|Overall Study|Adverse Event|13|||
161922428|NCT01937299|584762322|FG001|Overall Study|Adverse Event|0|||
161922429|NCT01937299|584762321|FG000|Overall Study|Lack of Efficacy|0|||
161922430|NCT01937299|584762322|FG001|Overall Study|Lack of Efficacy|4|||
161922431|NCT01937299|584762321|FG000|Overall Study|Withdrawal by Subject|1|||
161922432|NCT01937299|584762322|FG001|Overall Study|Withdrawal by Subject|0|||
161922433|NCT01913353|584762323|FG000|Overall Study|Adverse Event|2|||
161922434|NCT01913353|584762324|FG001|Overall Study|Adverse Event|0|||
161922435|NCT01913353|584762323|FG000|Overall Study|Physician Decision|0|||
161922436|NCT01913353|584762324|FG001|Overall Study|Physician Decision|2|||
161922437|NCT01913353|584762323|FG000|Overall Study|Withdrawal by Subject|20|||
161922438|NCT01913353|584762324|FG001|Overall Study|Withdrawal by Subject|6|||
161922439|NCT01913353|584762323|FG000|Overall Study|multiple reasons|10|||
161922440|NCT01913353|584762324|FG001|Overall Study|multiple reasons|7|||
161922441|NCT00385840|584762325|FG000|Overall Study|Adverse Event|1|||
161922442|NCT00385840|584762326|FG001|Overall Study|Adverse Event|1|||
161922443|NCT00385840|584762325|FG000|Overall Study|Lost to Follow-up|3|||
161922444|NCT00385840|584762326|FG001|Overall Study|Lost to Follow-up|13|||
161922445|NCT04017962|584762327|FG000|Overall Study|Death|2|||
161922446|NCT04017962|584762328|FG001|Overall Study|Death|0|||
161922447|NCT04017962|584762327|FG000|Overall Study|Lost to Follow-up|2|||
161922448|NCT04017962|584762328|FG001|Overall Study|Lost to Follow-up|0|||
161922449|NCT04017962|584762327|FG000|Overall Study|Physician Decision|1|||
161922450|NCT04017962|584762328|FG001|Overall Study|Physician Decision|0|||
161922451|NCT04017962|584762327|FG000|Overall Study|Discontinued LTV|5|||
161922452|NCT04017962|584762328|FG001|Overall Study|Discontinued LTV|0|||
161922453|NCT00700635|584762329|FG000|Overall Study|Adverse Event|1|||
161922454|NCT00700635|584762330|FG001|Overall Study|Adverse Event|0|||
161922455|NCT00700635|584762331|FG002|Overall Study|Adverse Event|0|||
161922456|NCT00700635|584762329|FG000|Overall Study|Lost to Follow-up|1|||
161922457|NCT00700635|584762330|FG001|Overall Study|Lost to Follow-up|3|||
161922458|NCT00700635|584762331|FG002|Overall Study|Lost to Follow-up|0|||
161922459|NCT00700635|584762329|FG000|Overall Study|Protocol Violation|2|||
161922460|NCT00700635|584762330|FG001|Overall Study|Protocol Violation|2|||
161922461|NCT00700635|584762331|FG002|Overall Study|Protocol Violation|0|||
161922462|NCT00700635|584762329|FG000|Overall Study|Withdrawal by Subject|7|||
161922463|NCT00700635|584762330|FG001|Overall Study|Withdrawal by Subject|3|||
161922464|NCT00700635|584762331|FG002|Overall Study|Withdrawal by Subject|1|||
161922465|NCT05172570|584762332|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
161922466|NCT05172570|584762333|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
161922467|NCT05172570|584762334|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
161922468|NCT05172570|584762332|FG000|Overall Study|PI Decision due to equipment shortages|0|||
161922469|NCT05172570|584762333|FG001|Overall Study|PI Decision due to equipment shortages|0|||
161922470|NCT05172570|584762334|FG002|Overall Study|PI Decision due to equipment shortages|1|||
161922471|NCT01260948|584762335|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
161922472|NCT01260948|584762336|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
161922473|NCT01260948|584762335|FG000|Second Intervention|Emesis|0|||
161922474|NCT01260948|584762336|FG001|Second Intervention|Emesis|1|||
161922475|NCT00768053|584762337|FG000|Overall Study|Adverse Event|10|||
161922476|NCT00768053|584762337|FG000|Overall Study|Lost to Follow-up|1|||
161922477|NCT01202591|584762338|FG000|Overall Study|Adverse Event|2|||
161922478|NCT01202591|584762339|FG001|Overall Study|Adverse Event|1|||
161922479|NCT01202591|584762340|FG002|Overall Study|Adverse Event|4|||
161922480|NCT01202591|584762341|FG003|Overall Study|Adverse Event|4|||
161922481|NCT01202591|584762342|FG004|Overall Study|Adverse Event|0|||
161922482|NCT01202591|584762343|FG005|Overall Study|Adverse Event|0|||
161922483|NCT01202591|584762338|FG000|Overall Study|Other reason as per investigator|3|||
161922484|NCT01202591|584762339|FG001|Overall Study|Other reason as per investigator|4|||
161922485|NCT01202591|584762340|FG002|Overall Study|Other reason as per investigator|7|||
161922486|NCT01202591|584762341|FG003|Overall Study|Other reason as per investigator|3|||
161922487|NCT01202591|584762342|FG004|Overall Study|Other reason as per investigator|1|||
161922488|NCT01202591|584762343|FG005|Overall Study|Other reason as per investigator|3|||
161922489|NCT01202591|584762338|FG000|Overall Study|Withdrawal by Subject|0|||
161922490|NCT01202591|584762339|FG001|Overall Study|Withdrawal by Subject|0|||
161922491|NCT01202591|584762340|FG002|Overall Study|Withdrawal by Subject|0|||
162172107|NCT03088878|585682584|FG009|Overall Study|Clinical Progression|0|||
161922492|NCT01202591|584762341|FG003|Overall Study|Withdrawal by Subject|0|||
162172108|NCT03088878|585682585|FG010|Overall Study|Clinical Progression|0|||
161922493|NCT01202591|584762342|FG004|Overall Study|Withdrawal by Subject|2|||
161922494|NCT01202591|584762343|FG005|Overall Study|Withdrawal by Subject|1|||
161922495|NCT01202591|584762338|FG000|Overall Study|Objective Disease Progression|0|||
161922496|NCT01202591|584762339|FG001|Overall Study|Objective Disease Progression|0|||
161922497|NCT01202591|584762340|FG002|Overall Study|Objective Disease Progression|0|||
161922498|NCT01202591|584762341|FG003|Overall Study|Objective Disease Progression|0|||
161922499|NCT01202591|584762342|FG004|Overall Study|Objective Disease Progression|2|||
161922500|NCT01202591|584762343|FG005|Overall Study|Objective Disease Progression|0|||
161942208|NCT02082977|584838338|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161942209|NCT02082977|584838339|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
162172109|NCT03088878|585682586|FG011|Overall Study|Clinical Progression|0|||
162172110|NCT03088878|585682587|FG012|Overall Study|Clinical Progression|0|||
162172111|NCT03088878|585682588|FG013|Overall Study|Clinical Progression|0|||
162172112|NCT03088878|585682575|FG000|Overall Study|Death|0|||
162172113|NCT03088878|585682576|FG001|Overall Study|Death|0|||
162172114|NCT03088878|585682577|FG002|Overall Study|Death|0|||
162172115|NCT03088878|585682578|FG003|Overall Study|Death|0|||
162172116|NCT03088878|585682579|FG004|Overall Study|Death|2|||
161942210|NCT02082977|584838340|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
161942211|NCT02082977|584838341|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161942212|NCT02082977|584838342|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161942213|NCT03261505|584838351|FG000|Overall Study|Withdrawal by Subject|2|||
161942214|NCT03261505|584838352|FG001|Overall Study|Withdrawal by Subject|3|||
161942215|NCT03261505|584838353|FG002|Overall Study|Withdrawal by Subject|4|||
161942216|NCT03261505|584838354|FG003|Overall Study|Withdrawal by Subject|3|||
161942217|NCT03261505|584838351|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
161942218|NCT03261505|584838352|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
161942219|NCT03261505|584838353|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
161942220|NCT03261505|584838354|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
161942221|NCT03261505|584838351|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
161942222|NCT03261505|584838352|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
161942223|NCT03261505|584838353|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
161942224|NCT03261505|584838354|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
161942225|NCT03261505|584838351|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
162172117|NCT03088878|585682580|FG005|Overall Study|Death|0|||
162172118|NCT03088878|585682581|FG006|Overall Study|Death|0|||
162172119|NCT03088878|585682582|FG007|Overall Study|Death|0|||
162172120|NCT03088878|585682583|FG008|Overall Study|Death|0|||
162172121|NCT03088878|585682584|FG009|Overall Study|Death|0|||
162172122|NCT03088878|585682585|FG010|Overall Study|Death|0|||
162172123|NCT03088878|585682586|FG011|Overall Study|Death|1|||
162172124|NCT03088878|585682587|FG012|Overall Study|Death|0|||
162172125|NCT03088878|585682588|FG013|Overall Study|Death|0|||
162172126|NCT03088878|585682575|FG000|Overall Study|Disease Progression|1|||
162172127|NCT03088878|585682576|FG001|Overall Study|Disease Progression|2|||
162172128|NCT03088878|585682577|FG002|Overall Study|Disease Progression|3|||
162172129|NCT03088878|585682578|FG003|Overall Study|Disease Progression|0|||
162172130|NCT03088878|585682579|FG004|Overall Study|Disease Progression|3|||
162172131|NCT03088878|585682580|FG005|Overall Study|Disease Progression|0|||
162172132|NCT03088878|585682581|FG006|Overall Study|Disease Progression|0|||
162172133|NCT03088878|585682582|FG007|Overall Study|Disease Progression|0|||
162172134|NCT03088878|585682583|FG008|Overall Study|Disease Progression|0|||
162172135|NCT03088878|585682584|FG009|Overall Study|Disease Progression|0|||
162172136|NCT03088878|585682585|FG010|Overall Study|Disease Progression|0|||
161942226|NCT03261505|584838352|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
161942227|NCT03261505|584838353|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
162172137|NCT03088878|585682586|FG011|Overall Study|Disease Progression|0|||
161942228|NCT03261505|584838354|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
162172138|NCT03088878|585682587|FG012|Overall Study|Disease Progression|1|||
162172139|NCT03088878|585682588|FG013|Overall Study|Disease Progression|1|||
162172140|NCT03088878|585682575|FG000|Overall Study|Initiation of Alternative Treatment|0|||
162172141|NCT03088878|585682576|FG001|Overall Study|Initiation of Alternative Treatment|0|||
162172142|NCT03088878|585682577|FG002|Overall Study|Initiation of Alternative Treatment|0|||
162172143|NCT03088878|585682578|FG003|Overall Study|Initiation of Alternative Treatment|1|||
162172144|NCT03088878|585682579|FG004|Overall Study|Initiation of Alternative Treatment|0|||
162172145|NCT03088878|585682580|FG005|Overall Study|Initiation of Alternative Treatment|0|||
161922501|NCT04941898|584763156|FG000|Overall Study|Protocol Violation|1|||
161922502|NCT03641924|584763157|FG000|Overall Study|Withdrawal by Subject|26|||
161922503|NCT03641924|584763157|FG000|Overall Study|Lost to Follow-up|16|||
161922504|NCT03641924|584763157|FG000|Overall Study|Protocol Violation|10|||
161922505|NCT02068794|584763158|FG000|Overall Study|Withdrawal by Subject|0|||
161922506|NCT02068794|584763159|FG001|Overall Study|Withdrawal by Subject|1|||
161922507|NCT02068794|584763160|FG002|Overall Study|Withdrawal by Subject|2|||
161922508|NCT02068794|584763158|FG000|Overall Study|Early Progression|1|||
161922509|NCT02068794|584763159|FG001|Overall Study|Early Progression|0|||
161922510|NCT02068794|584763160|FG002|Overall Study|Early Progression|1|||
162172146|NCT03088878|585682581|FG006|Overall Study|Initiation of Alternative Treatment|0|||
161922511|NCT02068794|584763158|FG000|Overall Study|Ineligible|0|||
161922512|NCT02068794|584763159|FG001|Overall Study|Ineligible|0|||
162172147|NCT03088878|585682582|FG007|Overall Study|Initiation of Alternative Treatment|1|||
162172148|NCT03088878|585682583|FG008|Overall Study|Initiation of Alternative Treatment|1|||
162172149|NCT03088878|585682584|FG009|Overall Study|Initiation of Alternative Treatment|0|||
162172150|NCT03088878|585682585|FG010|Overall Study|Initiation of Alternative Treatment|0|||
162172151|NCT03088878|585682586|FG011|Overall Study|Initiation of Alternative Treatment|0|||
162172152|NCT03088878|585682587|FG012|Overall Study|Initiation of Alternative Treatment|0|||
162172153|NCT03088878|585682588|FG013|Overall Study|Initiation of Alternative Treatment|0|||
161922513|NCT02068794|584763160|FG002|Overall Study|Ineligible|1|||
161922514|NCT03720847|584763161|FG000|Washout|Physician Decision|1|||
161922515|NCT03720847|584763162|FG001|Washout|Physician Decision|2|||
161922516|NCT01500096|584763163|FG000|Overall Study|Lost to Follow-up|1|||
161922517|NCT01500096|584763164|FG001|Overall Study|Lost to Follow-up|0|||
161922518|NCT01500096|584763165|FG002|Overall Study|Lost to Follow-up|0|||
162017985|NCT00854113|585121858|FG001|Overall Study|Adverse Event|0|||
162017986|NCT00854113|585121859|FG002|Overall Study|Adverse Event|0|||
162017987|NCT00854113|585121860|FG003|Overall Study|Adverse Event|0|||
162017988|NCT00854113|585121861|FG004|Overall Study|Adverse Event|0|||
162017989|NCT00854113|585121862|FG005|Overall Study|Adverse Event|0|||
162017990|NCT00854113|585121863|FG006|Overall Study|Adverse Event|0|||
162017991|NCT00854113|585121864|FG007|Overall Study|Adverse Event|2|||
162017992|NCT00854113|585121865|FG008|Overall Study|Adverse Event|0|||
162017993|NCT00854113|585121866|FG009|Overall Study|Adverse Event|0|||
162017994|NCT00854113|585121867|FG010|Overall Study|Adverse Event|0|||
162017995|NCT00854113|585121857|FG000|Overall Study|Withdrawal by Subject|0|||
162017996|NCT00854113|585121858|FG001|Overall Study|Withdrawal by Subject|0|||
162017997|NCT00854113|585121859|FG002|Overall Study|Withdrawal by Subject|0|||
162017998|NCT00854113|585121860|FG003|Overall Study|Withdrawal by Subject|0|||
162017999|NCT00854113|585121861|FG004|Overall Study|Withdrawal by Subject|0|||
162172154|NCT03088878|585682575|FG000|Overall Study|Withdrawal by Subject|0|||
161922519|NCT01500096|584763166|FG003|Overall Study|Lost to Follow-up|2|||
161922520|NCT02506036|584763168|FG000|First Intervention (4-6 Weeks)|Death|1|||
161922521|NCT02506036|584763169|FG001|First Intervention (4-6 Weeks)|Death|0|||
162018000|NCT00854113|585121862|FG005|Overall Study|Withdrawal by Subject|0|||
161922522|NCT02506036|584763168|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
161922523|NCT02506036|584763169|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
161922524|NCT02506036|584763168|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
161922525|NCT02506036|584763169|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
162018001|NCT00854113|585121863|FG006|Overall Study|Withdrawal by Subject|0|||
162018002|NCT00854113|585121864|FG007|Overall Study|Withdrawal by Subject|1|||
162018003|NCT00854113|585121865|FG008|Overall Study|Withdrawal by Subject|1|||
162018004|NCT00854113|585121866|FG009|Overall Study|Withdrawal by Subject|0|||
162172155|NCT03088878|585682576|FG001|Overall Study|Withdrawal by Subject|0|||
161670138|NCT01139021|583845348|FG003|Overall Study|Protocol Violation|0|||
162172156|NCT03088878|585682577|FG002|Overall Study|Withdrawal by Subject|0|||
162172157|NCT03088878|585682578|FG003|Overall Study|Withdrawal by Subject|1|||
162172158|NCT03088878|585682579|FG004|Overall Study|Withdrawal by Subject|4|||
162172159|NCT03088878|585682580|FG005|Overall Study|Withdrawal by Subject|1|||
162172160|NCT03088878|585682581|FG006|Overall Study|Withdrawal by Subject|1|||
162172161|NCT03088878|585682582|FG007|Overall Study|Withdrawal by Subject|0|||
162172162|NCT03088878|585682583|FG008|Overall Study|Withdrawal by Subject|1|||
162172163|NCT03088878|585682584|FG009|Overall Study|Withdrawal by Subject|2|||
162172164|NCT03088878|585682585|FG010|Overall Study|Withdrawal by Subject|0|||
162172165|NCT03088878|585682586|FG011|Overall Study|Withdrawal by Subject|2|||
162172166|NCT03088878|585682587|FG012|Overall Study|Withdrawal by Subject|1|||
161922526|NCT00898807|584763170|FG000|Overall Study|Withdrawal by Subject|5|||
161922527|NCT00898807|584763171|FG001|Overall Study|Withdrawal by Subject|3|||
161922528|NCT00898807|584763170|FG000|Overall Study|Family pressure to discontinue|2|||
161922529|NCT00898807|584763171|FG001|Overall Study|Family pressure to discontinue|2|||
161922530|NCT00898807|584763170|FG000|Overall Study|Lost to Follow-up|1|||
161922531|NCT00898807|584763171|FG001|Overall Study|Lost to Follow-up|3|||
161922532|NCT00898807|584763170|FG000|Overall Study|Death|0|||
161922533|NCT00898807|584763171|FG001|Overall Study|Death|1|||
161922534|NCT05427916|584763177|FG000|Overall Study|Adverse Event|3|||
161922535|NCT05427916|584763178|FG001|Overall Study|Adverse Event|0|||
161922536|NCT05427916|584763177|FG000|Overall Study|Lack of Efficacy|6|||
161922537|NCT05427916|584763178|FG001|Overall Study|Lack of Efficacy|0|||
161922538|NCT05427916|584763177|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
161922539|NCT05427916|584763178|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
161922540|NCT00429299|584763181|FG000|Overall Study|Disease Progression|1|||
161922541|NCT00429299|584763182|FG001|Overall Study|Disease Progression|1|||
161922542|NCT00429299|584763183|FG002|Overall Study|Disease Progression|0|||
161922543|NCT00429299|584763181|FG000|Overall Study|Adverse Event|2|||
161922544|NCT00429299|584763182|FG001|Overall Study|Adverse Event|5|||
161922545|NCT00429299|584763183|FG002|Overall Study|Adverse Event|1|||
161922546|NCT00429299|584763181|FG000|Overall Study|Protocol Violation|1|||
161922547|NCT00429299|584763182|FG001|Overall Study|Protocol Violation|0|||
162018005|NCT00854113|585121867|FG010|Overall Study|Withdrawal by Subject|0|||
161922548|NCT00429299|584763183|FG002|Overall Study|Protocol Violation|0|||
161922549|NCT00429299|584763181|FG000|Overall Study|Withdrawal by Subject|0|||
161922550|NCT00429299|584763182|FG001|Overall Study|Withdrawal by Subject|1|||
162018006|NCT00539864|585121868|FG000|Overall Study|Lost to Follow-up|0|||
162172167|NCT03088878|585682588|FG013|Overall Study|Withdrawal by Subject|0|||
162172168|NCT03088878|585682575|FG000|Overall Study|Terminated by Sponsor|2|||
162018007|NCT00539864|585121869|FG001|Overall Study|Lost to Follow-up|1|||
162018008|NCT00539864|585121868|FG000|Overall Study|Withdrawal by Subject|1|||
162018009|NCT00539864|585121869|FG001|Overall Study|Withdrawal by Subject|1|||
162018010|NCT01250145|585121870|FG000|Overall Study|Adverse Event|2|||
162018011|NCT01250145|585121871|FG001|Overall Study|Adverse Event|1|||
162018012|NCT01250145|585121870|FG000|Overall Study|Withdrawal by Subject|0|||
162018013|NCT01250145|585121871|FG001|Overall Study|Withdrawal by Subject|4|||
162018014|NCT04661579|585121876|FG000|Overall Study|Lost to Follow-up|19|||
162018015|NCT04661579|585121877|FG001|Overall Study|Lost to Follow-up|10|||
162018016|NCT04661579|585121878|FG002|Overall Study|Lost to Follow-up|2|||
162018017|NCT04661579|585121879|FG003|Overall Study|Lost to Follow-up|7|||
162018018|NCT04661579|585121880|FG004|Overall Study|Lost to Follow-up|11|||
162018019|NCT04661579|585121876|FG000|Overall Study|Physician Decision|2|||
162018020|NCT04661579|585121877|FG001|Overall Study|Physician Decision|0|||
162018021|NCT04661579|585121878|FG002|Overall Study|Physician Decision|0|||
162018022|NCT04661579|585121879|FG003|Overall Study|Physician Decision|1|||
162018023|NCT04661579|585121880|FG004|Overall Study|Physician Decision|0|||
162018024|NCT04661579|585121876|FG000|Overall Study|Withdrawal by Subject|1|||
162018025|NCT04661579|585121877|FG001|Overall Study|Withdrawal by Subject|4|||
162018026|NCT04661579|585121878|FG002|Overall Study|Withdrawal by Subject|0|||
162018027|NCT04661579|585121879|FG003|Overall Study|Withdrawal by Subject|2|||
162018028|NCT04661579|585121880|FG004|Overall Study|Withdrawal by Subject|0|||
162018029|NCT04661579|585121876|FG000|Overall Study|Death|1|||
162018030|NCT04661579|585121877|FG001|Overall Study|Death|0|||
162018031|NCT04661579|585121878|FG002|Overall Study|Death|0|||
162018032|NCT04661579|585121879|FG003|Overall Study|Death|0|||
162018033|NCT04661579|585121880|FG004|Overall Study|Death|0|||
162018034|NCT04661579|585121876|FG000|Overall Study|Other|1|||
162018035|NCT04661579|585121877|FG001|Overall Study|Other|2|||
162018036|NCT04661579|585121878|FG002|Overall Study|Other|1|||
162018037|NCT04661579|585121879|FG003|Overall Study|Other|1|||
162018038|NCT04661579|585121880|FG004|Overall Study|Other|1|||
162018039|NCT04661579|585121876|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
162018040|NCT04661579|585121877|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
162018041|NCT04661579|585121878|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
162018042|NCT04661579|585121879|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
162018043|NCT04661579|585121880|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
162018044|NCT03656562|585121881|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
161670139|NCT01139021|583845349|FG004|Overall Study|Protocol Violation|2|||
161670140|NCT01139021|583845350|FG005|Overall Study|Protocol Violation|0|||
161922551|NCT00429299|584763183|FG002|Overall Study|Withdrawal by Subject|3|||
161922552|NCT04871113|584763184|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922553|NCT04871113|584763185|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922554|NCT04871113|584763186|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922555|NCT04871113|584763187|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922556|NCT04871113|584763188|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922557|NCT04871113|584763189|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
161922558|NCT04871113|584763190|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922559|NCT04871113|584763191|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922560|NCT04871113|584763192|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922561|NCT04871113|584763193|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
161922562|NCT04871113|584763184|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922563|NCT04871113|584763185|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922564|NCT04871113|584763186|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922565|NCT04871113|584763187|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922566|NCT04871113|584763188|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922567|NCT04871113|584763189|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922568|NCT04871113|584763190|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
161922569|NCT04871113|584763191|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
161922570|NCT04871113|584763192|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
162018045|NCT03656562|585121882|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
162018046|NCT03656562|585121883|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
162018047|NCT03656562|585121884|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
162018048|NCT03656562|585121881|FG000|Overall Study|Physician Decision|1|||
162018049|NCT03656562|585121882|FG001|Overall Study|Physician Decision|2|||
162018050|NCT03656562|585121883|FG002|Overall Study|Physician Decision|0|||
162018051|NCT03656562|585121884|FG003|Overall Study|Physician Decision|0|||
162018052|NCT03656562|585121881|FG000|Overall Study|Subject Decision|3|||
162018053|NCT03656562|585121882|FG001|Overall Study|Subject Decision|5|||
162018054|NCT03656562|585121883|FG002|Overall Study|Subject Decision|0|||
162018055|NCT03656562|585121884|FG003|Overall Study|Subject Decision|2|||
161670141|NCT01139021|583845345|FG000|Overall Study|Withdrawal by Subject|0|||
161922571|NCT04871113|584763193|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
161922572|NCT02143778|584763194|FG000|Overall Study|Withdrawal by Subject|2|||
161922573|NCT02143778|584763194|FG000|Overall Study|Device malfunction|1|||
161922574|NCT05630755|584763195|FG000|Overall Study|Lost to Follow-up|7|||
161922575|NCT05630755|584763196|FG001|Overall Study|Lost to Follow-up|0|||
161922576|NCT05630755|584763195|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
161922577|NCT05630755|584763196|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
161922578|NCT05630755|584763195|FG000|Overall Study|Withdrawal by Subject|9|||
162018056|NCT04335136|585121885|FG000|Overall Study|Death|8|||
162018057|NCT04335136|585121886|FG001|Overall Study|Death|4|||
162172169|NCT03088878|585682576|FG001|Overall Study|Terminated by Sponsor|1|||
162172170|NCT03088878|585682577|FG002|Overall Study|Terminated by Sponsor|0|||
162172171|NCT03088878|585682578|FG003|Overall Study|Terminated by Sponsor|1|||
162172172|NCT03088878|585682579|FG004|Overall Study|Terminated by Sponsor|6|||
162172173|NCT03088878|585682580|FG005|Overall Study|Terminated by Sponsor|0|||
162172174|NCT03088878|585682581|FG006|Overall Study|Terminated by Sponsor|0|||
162172175|NCT03088878|585682582|FG007|Overall Study|Terminated by Sponsor|0|||
162172176|NCT03088878|585682583|FG008|Overall Study|Terminated by Sponsor|0|||
162172177|NCT03088878|585682584|FG009|Overall Study|Terminated by Sponsor|0|||
162172178|NCT03088878|585682585|FG010|Overall Study|Terminated by Sponsor|3|||
162172179|NCT03088878|585682586|FG011|Overall Study|Terminated by Sponsor|13|||
162172180|NCT03088878|585682587|FG012|Overall Study|Terminated by Sponsor|2|||
162172181|NCT03088878|585682588|FG013|Overall Study|Terminated by Sponsor|1|||
162172182|NCT03088878|585682575|FG000|Overall Study|Completed 2 years of Treatment|0|||
162172183|NCT03088878|585682576|FG001|Overall Study|Completed 2 years of Treatment|0|||
162172184|NCT03088878|585682577|FG002|Overall Study|Completed 2 years of Treatment|0|||
162172185|NCT03088878|585682578|FG003|Overall Study|Completed 2 years of Treatment|0|||
162172186|NCT03088878|585682579|FG004|Overall Study|Completed 2 years of Treatment|0|||
162172187|NCT03088878|585682580|FG005|Overall Study|Completed 2 years of Treatment|0|||
162172188|NCT03088878|585682581|FG006|Overall Study|Completed 2 years of Treatment|1|||
162172189|NCT03088878|585682582|FG007|Overall Study|Completed 2 years of Treatment|0|||
162172190|NCT03088878|585682583|FG008|Overall Study|Completed 2 years of Treatment|0|||
162172191|NCT03088878|585682584|FG009|Overall Study|Completed 2 years of Treatment|1|||
162172192|NCT03088878|585682585|FG010|Overall Study|Completed 2 years of Treatment|0|||
162172193|NCT03088878|585682586|FG011|Overall Study|Completed 2 years of Treatment|0|||
162172194|NCT03088878|585682587|FG012|Overall Study|Completed 2 years of Treatment|8|||
162172195|NCT03088878|585682588|FG013|Overall Study|Completed 2 years of Treatment|3|||
162172196|NCT03088878|585682575|FG000|Overall Study|Physician Decision|0|||
162172197|NCT03088878|585682576|FG001|Overall Study|Physician Decision|0|||
162172198|NCT03088878|585682577|FG002|Overall Study|Physician Decision|0|||
162172199|NCT03088878|585682578|FG003|Overall Study|Physician Decision|0|||
162172200|NCT03088878|585682579|FG004|Overall Study|Physician Decision|0|||
162172201|NCT03088878|585682580|FG005|Overall Study|Physician Decision|0|||
162172202|NCT03088878|585682581|FG006|Overall Study|Physician Decision|0|||
162172203|NCT03088878|585682582|FG007|Overall Study|Physician Decision|2|||
162172204|NCT03088878|585682583|FG008|Overall Study|Physician Decision|1|||
162172205|NCT03088878|585682584|FG009|Overall Study|Physician Decision|0|||
162172206|NCT03088878|585682585|FG010|Overall Study|Physician Decision|0|||
162172207|NCT03088878|585682586|FG011|Overall Study|Physician Decision|0|||
162172208|NCT03088878|585682587|FG012|Overall Study|Physician Decision|0|||
162172209|NCT03088878|585682588|FG013|Overall Study|Physician Decision|1|||
162172210|NCT03088878|585682575|FG000|Overall Study|COVID Related noncompliance|0|||
162172211|NCT03088878|585682576|FG001|Overall Study|COVID Related noncompliance|0|||
162172212|NCT03088878|585682577|FG002|Overall Study|COVID Related noncompliance|0|||
162172213|NCT03088878|585682578|FG003|Overall Study|COVID Related noncompliance|0|||
162172214|NCT03088878|585682579|FG004|Overall Study|COVID Related noncompliance|0|||
162172215|NCT03088878|585682580|FG005|Overall Study|COVID Related noncompliance|0|||
162172216|NCT03088878|585682581|FG006|Overall Study|COVID Related noncompliance|0|||
162172217|NCT03088878|585682582|FG007|Overall Study|COVID Related noncompliance|0|||
162172218|NCT03088878|585682583|FG008|Overall Study|COVID Related noncompliance|0|||
162172219|NCT03088878|585682584|FG009|Overall Study|COVID Related noncompliance|0|||
162172220|NCT03088878|585682585|FG010|Overall Study|COVID Related noncompliance|0|||
162172221|NCT03088878|585682586|FG011|Overall Study|COVID Related noncompliance|0|||
162172222|NCT03088878|585682587|FG012|Overall Study|COVID Related noncompliance|0|||
162172223|NCT03088878|585682588|FG013|Overall Study|COVID Related noncompliance|1|||
161922579|NCT05630755|584763196|FG001|Overall Study|Withdrawal by Subject|3|||
162018058|NCT04335136|585121885|FG000|Overall Study|Lost to Follow-up|2|||
162172224|NCT03088878|585682575|FG000|Overall Study|Drug or Study Noncompliance|0|||
162172225|NCT03088878|585682576|FG001|Overall Study|Drug or Study Noncompliance|0|||
162172226|NCT03088878|585682577|FG002|Overall Study|Drug or Study Noncompliance|0|||
162172227|NCT03088878|585682578|FG003|Overall Study|Drug or Study Noncompliance|0|||
162172228|NCT03088878|585682579|FG004|Overall Study|Drug or Study Noncompliance|0|||
162172229|NCT03088878|585682580|FG005|Overall Study|Drug or Study Noncompliance|0|||
162172230|NCT03088878|585682581|FG006|Overall Study|Drug or Study Noncompliance|0|||
162172231|NCT03088878|585682582|FG007|Overall Study|Drug or Study Noncompliance|0|||
162018059|NCT04335136|585121886|FG001|Overall Study|Lost to Follow-up|0|||
162018060|NCT04335136|585121885|FG000|Overall Study|Protocol Violation|1|||
162018061|NCT04335136|585121886|FG001|Overall Study|Protocol Violation|0|||
162018062|NCT04335136|585121885|FG000|Overall Study|Withdrawal by Subject|1|||
162018063|NCT04335136|585121886|FG001|Overall Study|Withdrawal by Subject|1|||
162018064|NCT04335136|585121885|FG000|Overall Study|Health-threatening condition|0|||
162018065|NCT04335136|585121886|FG001|Overall Study|Health-threatening condition|1|||
162018066|NCT04335136|585121885|FG000|Overall Study|Adverse Event|0|||
162018067|NCT04335136|585121886|FG001|Overall Study|Adverse Event|1|||
162018068|NCT04335136|585121885|FG000|Overall Study|Erroneously randomized|2|||
162172232|NCT03088878|585682583|FG008|Overall Study|Drug or Study Noncompliance|0|||
162018069|NCT04335136|585121886|FG001|Overall Study|Erroneously randomized|0|||
162172233|NCT03088878|585682584|FG009|Overall Study|Drug or Study Noncompliance|0|||
162172234|NCT03088878|585682585|FG010|Overall Study|Drug or Study Noncompliance|0|||
162172235|NCT03088878|585682586|FG011|Overall Study|Drug or Study Noncompliance|0|||
162172236|NCT03088878|585682587|FG012|Overall Study|Drug or Study Noncompliance|1|||
162172237|NCT03088878|585682588|FG013|Overall Study|Drug or Study Noncompliance|0|||
162172238|NCT04032847|585682601|FG000|Overall Study|Study termination by sponsor|8|||
162172239|NCT04032847|585682602|FG001|Overall Study|Study termination by sponsor|0|||
162172240|NCT04032847|585682603|FG002|Overall Study|Study termination by sponsor|4|||
162172241|NCT04032847|585682601|FG000|Overall Study|Death|12|||
162172242|NCT04032847|585682602|FG001|Overall Study|Death|0|||
162172243|NCT04032847|585682603|FG002|Overall Study|Death|0|||
162172244|NCT04032847|585682601|FG000|Overall Study|Progressive disease|2|||
162172245|NCT04032847|585682602|FG001|Overall Study|Progressive disease|0|||
162172246|NCT04032847|585682603|FG002|Overall Study|Progressive disease|1|||
162172247|NCT03056573|585682604|FG000|Overall Study|Death|2|||
162172248|NCT03056573|585682605|FG001|Overall Study|Death|4|||
162172249|NCT03056573|585682604|FG000|Overall Study|Withdrawal by Subject|2|||
162172250|NCT03056573|585682605|FG001|Overall Study|Withdrawal by Subject|0|||
162172251|NCT03056573|585682604|FG000|Overall Study|Lost to Follow-up|1|||
162172252|NCT03056573|585682605|FG001|Overall Study|Lost to Follow-up|1|||
162172253|NCT05267470|585682606|FG000|Overall Study|Decision by sponsor|0|||
162172254|NCT05267470|585682607|FG001|Overall Study|Decision by sponsor|3|||
162172255|NCT05267470|585682608|FG002|Overall Study|Decision by sponsor|19|||
162172256|NCT05267470|585682609|FG003|Overall Study|Decision by sponsor|7|||
162172257|NCT05267470|585682610|FG004|Overall Study|Decision by sponsor|3|||
162172258|NCT05267470|585682606|FG000|Overall Study|Withdrawal by Subject|1|||
162172259|NCT05267470|585682607|FG001|Overall Study|Withdrawal by Subject|1|||
162172260|NCT05267470|585682608|FG002|Overall Study|Withdrawal by Subject|2|||
162172261|NCT05267470|585682609|FG003|Overall Study|Withdrawal by Subject|2|||
162172262|NCT05267470|585682610|FG004|Overall Study|Withdrawal by Subject|0|||
162172263|NCT05267470|585682606|FG000|Overall Study|Death|3|||
162172264|NCT05267470|585682607|FG001|Overall Study|Death|5|||
162172265|NCT05267470|585682608|FG002|Overall Study|Death|8|||
162172266|NCT05267470|585682609|FG003|Overall Study|Death|18|||
162172267|NCT05267470|585682610|FG004|Overall Study|Death|1|||
162172268|NCT05267470|585682606|FG000|Overall Study|Lost to Follow-up|0|||
162172269|NCT05267470|585682607|FG001|Overall Study|Lost to Follow-up|0|||
162172270|NCT05267470|585682608|FG002|Overall Study|Lost to Follow-up|0|||
162172271|NCT05267470|585682609|FG003|Overall Study|Lost to Follow-up|1|||
162172272|NCT05267470|585682610|FG004|Overall Study|Lost to Follow-up|0|||
162172273|NCT04428203|585682611|FG000|Overall Study|Adverse Event|1|||
162172274|NCT04428203|585682612|FG001|Overall Study|Adverse Event|0|||
162172275|NCT04428203|585682613|FG002|Overall Study|Adverse Event|0|||
162172276|NCT04428203|585682611|FG000|Overall Study|Withdrawal by Subject|1|||
162172277|NCT04428203|585682612|FG001|Overall Study|Withdrawal by Subject|0|||
162172278|NCT04428203|585682613|FG002|Overall Study|Withdrawal by Subject|1|||
162172279|NCT04171141|585684603|FG000|Overall Study|Adverse Event|0|||
162172280|NCT04171141|585684604|FG001|Overall Study|Adverse Event|0|||
162172281|NCT04171141|585684605|FG002|Overall Study|Adverse Event|2|||
162172282|NCT04171141|585684606|FG003|Overall Study|Adverse Event|0|||
162172283|NCT04171141|585684607|FG004|Overall Study|Adverse Event|0|||
162018070|NCT01396447|585121887|FG000|Overall Study|Did Not Receive Treatment|3|||
162018071|NCT01396447|585121888|FG001|Overall Study|Did Not Receive Treatment|2|||
162018072|NCT01396447|585121889|FG002|Overall Study|Did Not Receive Treatment|1|||
162018073|NCT01396447|585121890|FG003|Overall Study|Did Not Receive Treatment|0|||
162172284|NCT04171141|585684608|FG005|Overall Study|Adverse Event|0|||
162172285|NCT04171141|585684609|FG006|Overall Study|Adverse Event|0|||
162172286|NCT04171141|585684610|FG007|Overall Study|Adverse Event|0|||
162172287|NCT04171141|585684611|FG008|Overall Study|Adverse Event|0|||
162172288|NCT04171141|585684612|FG009|Overall Study|Adverse Event|0|||
162172289|NCT04171141|585684613|FG010|Overall Study|Adverse Event|0|||
162172290|NCT04171141|585684614|FG011|Overall Study|Adverse Event|0|||
162172291|NCT04171141|585684615|FG012|Overall Study|Adverse Event|0|||
162172292|NCT04171141|585684616|FG013|Overall Study|Adverse Event|2|||
162172293|NCT04171141|585684617|FG014|Overall Study|Adverse Event|0|||
162172294|NCT04171141|585684618|FG015|Overall Study|Adverse Event|0|||
162172295|NCT04171141|585684603|FG000|Overall Study|Physician Decision|0|||
162172296|NCT04171141|585684604|FG001|Overall Study|Physician Decision|0|||
162172297|NCT04171141|585684605|FG002|Overall Study|Physician Decision|0|||
162172298|NCT04171141|585684606|FG003|Overall Study|Physician Decision|0|||
161816796|NCT02316223|584370839|FG000|Overall Study|Discontinued by PI|11|||
161816797|NCT02316223|584370840|FG001|Overall Study|Discontinued by PI|19|||
161816798|NCT02316223|584370841|FG002|Overall Study|Discontinued by PI|3|||
161816799|NCT03234907|584370843|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
161816800|NCT03234907|584370844|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
161816801|NCT03234907|584370845|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
161816802|NCT03234907|584370846|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
161816803|NCT03234907|584370847|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
161816804|NCT03234907|584370848|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
161816805|NCT03234907|584370843|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
161816806|NCT03234907|584370844|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
161816807|NCT03234907|584370845|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
161816808|NCT03234907|584370846|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
161816809|NCT03234907|584370847|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
161816810|NCT03234907|584370848|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
161816811|NCT03234907|584370843|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
161816812|NCT03234907|584370844|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161816813|NCT03234907|584370845|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161816814|NCT03234907|584370846|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161816815|NCT03234907|584370847|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161816816|NCT03234907|584370848|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161816817|NCT03234907|584370843|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
161816818|NCT03234907|584370844|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
161816819|NCT03234907|584370845|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
161816820|NCT03234907|584370846|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
161816821|NCT03234907|584370847|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
161816822|NCT03234907|584370848|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
161816823|NCT03234907|584370843|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
161816824|NCT03234907|584370844|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
161816825|NCT03234907|584370845|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
161816826|NCT03234907|584370846|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
161816827|NCT03234907|584370847|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
161816828|NCT03234907|584370848|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
161816829|NCT03234907|584370843|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
161816830|NCT03234907|584370844|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
161816831|NCT03234907|584370845|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
161816832|NCT03234907|584370846|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
161816833|NCT03234907|584370847|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
161816834|NCT03234907|584370848|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
161816835|NCT03234907|584370843|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
161816836|NCT03234907|584370844|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
161816837|NCT03234907|584370845|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
161816838|NCT03234907|584370846|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
161816839|NCT03234907|584370847|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
161816840|NCT03234907|584370848|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
161816841|NCT02986139|584370851|FG000|Overall Study|Sponsor Decision|1|||
161816842|NCT02986139|584370852|FG001|Overall Study|Sponsor Decision|2|||
161816843|NCT02986139|584370851|FG000|Overall Study|Withdrawal by Subject|0|||
161816844|NCT02986139|584370852|FG001|Overall Study|Withdrawal by Subject|1|||
161816845|NCT02986139|584370851|FG000|Overall Study|Lost to Follow-up|0|||
161816846|NCT02986139|584370852|FG001|Overall Study|Lost to Follow-up|1|||
161816847|NCT02583048|584370853|FG000|Overall Study|Withdrawal by Subject|0|||
161816848|NCT02583048|584370854|FG001|Overall Study|Withdrawal by Subject|1|||
161816849|NCT02583048|584370855|FG002|Overall Study|Withdrawal by Subject|0|||
161816850|NCT02583048|584370853|FG000|Overall Study|Failed to meet eligibility criterion|0|||
161816851|NCT02583048|584370854|FG001|Overall Study|Failed to meet eligibility criterion|0|||
161816852|NCT02583048|584370855|FG002|Overall Study|Failed to meet eligibility criterion|1|||
161816853|NCT00414726|584370859|FG000|Overall Study|Withdrawal by Subject|0|||
161816854|NCT00414726|584370860|FG001|Overall Study|Withdrawal by Subject|1|||
161816855|NCT02107196|584370861|FG000|12-week Treatment Period|Adverse Event|6|||
161816856|NCT02107196|584370862|FG001|12-week Treatment Period|Adverse Event|3|||
161816857|NCT02107196|584370861|FG000|12-week Treatment Period|Lack of Efficacy|2|||
162172299|NCT04171141|585684607|FG004|Overall Study|Physician Decision|1|||
162172300|NCT04171141|585684608|FG005|Overall Study|Physician Decision|0|||
162172301|NCT04171141|585684609|FG006|Overall Study|Physician Decision|0|||
162172302|NCT04171141|585684610|FG007|Overall Study|Physician Decision|0|||
162172303|NCT04171141|585684611|FG008|Overall Study|Physician Decision|0|||
162172304|NCT04171141|585684612|FG009|Overall Study|Physician Decision|0|||
162172305|NCT04171141|585684613|FG010|Overall Study|Physician Decision|0|||
162172306|NCT04171141|585684614|FG011|Overall Study|Physician Decision|0|||
162172307|NCT04171141|585684615|FG012|Overall Study|Physician Decision|0|||
162172308|NCT04171141|585684616|FG013|Overall Study|Physician Decision|0|||
162172309|NCT04171141|585684617|FG014|Overall Study|Physician Decision|0|||
162172310|NCT04171141|585684618|FG015|Overall Study|Physician Decision|1|||
162172311|NCT04171141|585684603|FG000|Overall Study|Progressive disease|2|||
162172312|NCT04171141|585684604|FG001|Overall Study|Progressive disease|3|||
162172313|NCT04171141|585684605|FG002|Overall Study|Progressive disease|4|||
162172314|NCT04171141|585684606|FG003|Overall Study|Progressive disease|7|||
162172315|NCT04171141|585684607|FG004|Overall Study|Progressive disease|1|||
162172316|NCT04171141|585684608|FG005|Overall Study|Progressive disease|8|||
162172317|NCT04171141|585684609|FG006|Overall Study|Progressive disease|4|||
162172318|NCT04171141|585684610|FG007|Overall Study|Progressive disease|6|||
162172319|NCT04171141|585684611|FG008|Overall Study|Progressive disease|7|||
162172320|NCT04171141|585684612|FG009|Overall Study|Progressive disease|3|||
162172321|NCT04171141|585684613|FG010|Overall Study|Progressive disease|4|||
162172322|NCT04171141|585684614|FG011|Overall Study|Progressive disease|3|||
162172323|NCT04171141|585684615|FG012|Overall Study|Progressive disease|4|||
162172324|NCT04171141|585684616|FG013|Overall Study|Progressive disease|2|||
162172325|NCT04171141|585684617|FG014|Overall Study|Progressive disease|4|||
162172326|NCT04171141|585684618|FG015|Overall Study|Progressive disease|1|||
162172327|NCT04171141|585684603|FG000|Overall Study|Withdrawal by Subject|0|||
162172328|NCT04171141|585684604|FG001|Overall Study|Withdrawal by Subject|0|||
162172329|NCT04171141|585684605|FG002|Overall Study|Withdrawal by Subject|0|||
162172330|NCT04171141|585684606|FG003|Overall Study|Withdrawal by Subject|1|||
162172331|NCT04171141|585684607|FG004|Overall Study|Withdrawal by Subject|0|||
162172332|NCT04171141|585684608|FG005|Overall Study|Withdrawal by Subject|0|||
161816858|NCT02107196|584370862|FG001|12-week Treatment Period|Lack of Efficacy|1|||
161816859|NCT02107196|584370861|FG000|12-week Treatment Period|Lost to Follow-up|3|||
161816860|NCT02107196|584370862|FG001|12-week Treatment Period|Lost to Follow-up|6|||
161816861|NCT02107196|584370861|FG000|12-week Treatment Period|Physician Decision|0|||
161816862|NCT02107196|584370862|FG001|12-week Treatment Period|Physician Decision|1|||
161816863|NCT02107196|584370861|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
161816864|NCT02107196|584370862|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
161816865|NCT02107196|584370861|FG000|12-week Treatment Period|Protocol Violation|7|||
161816866|NCT02107196|584370862|FG001|12-week Treatment Period|Protocol Violation|8|||
161816867|NCT02107196|584370861|FG000|12-week Treatment Period|Reason Missing|11|||
161816868|NCT02107196|584370862|FG001|12-week Treatment Period|Reason Missing|8|||
161816869|NCT02107196|584370861|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
161816870|NCT02107196|584370862|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
161816871|NCT02107196|584370861|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
161816872|NCT02107196|584370862|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161816873|NCT02107196|584370861|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
161816874|NCT02107196|584370862|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
161816875|NCT02107196|584370861|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
161816876|NCT02107196|584370862|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
161816877|NCT00691704|584370865|FG000|Induction Therapy|Disease Progression|1|||
161816878|NCT00691704|584370865|FG000|Induction Therapy|Active Hepatitis|1|||
161816879|NCT00691704|584370865|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
161922580|NCT05630755|584763195|FG000|Overall Study|Participant moved away from trial site|0|||
162172333|NCT04171141|585684609|FG006|Overall Study|Withdrawal by Subject|1|||
161922581|NCT05630755|584763196|FG001|Overall Study|Participant moved away from trial site|1|||
162172334|NCT04171141|585684610|FG007|Overall Study|Withdrawal by Subject|0|||
162172335|NCT04171141|585684611|FG008|Overall Study|Withdrawal by Subject|0|||
162172336|NCT04171141|585684612|FG009|Overall Study|Withdrawal by Subject|1|||
162172337|NCT04171141|585684613|FG010|Overall Study|Withdrawal by Subject|0|||
162172338|NCT04171141|585684614|FG011|Overall Study|Withdrawal by Subject|0|||
162172339|NCT04171141|585684615|FG012|Overall Study|Withdrawal by Subject|0|||
162172340|NCT04171141|585684616|FG013|Overall Study|Withdrawal by Subject|0|||
162172341|NCT04171141|585684617|FG014|Overall Study|Withdrawal by Subject|0|||
162172342|NCT04171141|585684618|FG015|Overall Study|Withdrawal by Subject|0|||
162172343|NCT04171141|585684603|FG000|Overall Study|Global deterioration of health status|0|||
162172344|NCT04171141|585684604|FG001|Overall Study|Global deterioration of health status|0|||
162172345|NCT04171141|585684605|FG002|Overall Study|Global deterioration of health status|0|||
162172346|NCT04171141|585684606|FG003|Overall Study|Global deterioration of health status|1|||
162172347|NCT04171141|585684607|FG004|Overall Study|Global deterioration of health status|0|||
162172348|NCT04171141|585684608|FG005|Overall Study|Global deterioration of health status|2|||
162172349|NCT04171141|585684609|FG006|Overall Study|Global deterioration of health status|1|||
162172350|NCT04171141|585684610|FG007|Overall Study|Global deterioration of health status|0|||
162172351|NCT04171141|585684611|FG008|Overall Study|Global deterioration of health status|1|||
162172352|NCT04171141|585684612|FG009|Overall Study|Global deterioration of health status|0|||
162172353|NCT04171141|585684613|FG010|Overall Study|Global deterioration of health status|0|||
162172354|NCT04171141|585684614|FG011|Overall Study|Global deterioration of health status|0|||
162172355|NCT04171141|585684615|FG012|Overall Study|Global deterioration of health status|0|||
162172356|NCT04171141|585684616|FG013|Overall Study|Global deterioration of health status|0|||
162172357|NCT04171141|585684617|FG014|Overall Study|Global deterioration of health status|1|||
162172358|NCT04171141|585684618|FG015|Overall Study|Global deterioration of health status|1|||
162172359|NCT03314454|585684619|FG000|Overall Study|Protocol Violation|1|||
162172360|NCT02841579|585684627|FG000|Overall Study|Death|1|||
162172361|NCT02841579|585684627|FG000|Overall Study|Adverse Event|1|||
162172362|NCT02841579|585684627|FG000|Overall Study|Lack of Efficacy|9|||
162172363|NCT04233216|585684630|FG000|Overall Study|Lost to Follow-up|1|||
162172364|NCT04233216|585684631|FG001|Overall Study|Lost to Follow-up|0|||
162172365|NCT04233216|585684632|FG002|Overall Study|Lost to Follow-up|2|||
162172366|NCT04233216|585684633|FG003|Overall Study|Lost to Follow-up|0|||
162172367|NCT04233216|585684630|FG000|Overall Study|Physician Decision|0|||
162172368|NCT04233216|585684631|FG001|Overall Study|Physician Decision|3|||
162172369|NCT04233216|585684632|FG002|Overall Study|Physician Decision|0|||
162172370|NCT04233216|585684633|FG003|Overall Study|Physician Decision|2|||
162172371|NCT04233216|585684630|FG000|Overall Study|Withdrawal by Subject|0|||
162172372|NCT04233216|585684631|FG001|Overall Study|Withdrawal by Subject|2|||
162172373|NCT04233216|585684632|FG002|Overall Study|Withdrawal by Subject|1|||
162172374|NCT04233216|585684633|FG003|Overall Study|Withdrawal by Subject|0|||
162172375|NCT04979442|585684634|FG000|Overall Study|Death|43|||
162172376|NCT04979442|585684635|FG001|Overall Study|Death|30|||
162172377|NCT04979442|585684634|FG000|Overall Study|Withdrawal by Subject|8|||
162172378|NCT04979442|585684635|FG001|Overall Study|Withdrawal by Subject|13|||
162172379|NCT04979442|585684634|FG000|Overall Study|Physician Decision|1|||
162172380|NCT04979442|585684635|FG001|Overall Study|Physician Decision|1|||
162172381|NCT04979442|585684634|FG000|Overall Study|Lost to Follow-up|0|||
162172382|NCT04979442|585684635|FG001|Overall Study|Lost to Follow-up|2|||
162172383|NCT04979442|585684634|FG000|Overall Study|do not want to continue|0|||
162172384|NCT04979442|585684635|FG001|Overall Study|do not want to continue|1|||
162172385|NCT04005794|585684637|FG000|Overall Study|Lost to Follow-up|0|||
162172386|NCT04005794|585684638|FG001|Overall Study|Lost to Follow-up|4|||
162172387|NCT04005794|585684639|FG002|Overall Study|Lost to Follow-up|0|||
162172388|NCT05622812|585684643|FG000|Overall Study|Withdrawal by Subject|1|||
162172389|NCT05622812|585684644|FG001|Overall Study|Withdrawal by Subject|4|||
162172390|NCT05622812|585684643|FG000|Overall Study|Lost to Follow-up|2|||
162172391|NCT05622812|585684644|FG001|Overall Study|Lost to Follow-up|1|||
162172392|NCT03916185|585684645|FG000|Overall Study|Lost to Follow-up|0|||
162172393|NCT03916185|585684646|FG001|Overall Study|Lost to Follow-up|1|||
162172394|NCT03916185|585684647|FG002|Overall Study|Lost to Follow-up|0|||
162172395|NCT03916185|585684648|FG003|Overall Study|Lost to Follow-up|0|||
162172396|NCT03916185|585684645|FG000|Overall Study|Moved|1|||
162172397|NCT03916185|585684646|FG001|Overall Study|Moved|0|||
162172398|NCT03916185|585684647|FG002|Overall Study|Moved|0|||
162172399|NCT03916185|585684648|FG003|Overall Study|Moved|1|||
162172400|NCT03916185|585684645|FG000|Overall Study|Not Able to Get to Clinic|1|||
162172401|NCT03916185|585684646|FG001|Overall Study|Not Able to Get to Clinic|0|||
161922582|NCT05630755|584763195|FG000|Overall Study|Status not Recorded|316|||
161922583|NCT05630755|584763196|FG001|Overall Study|Status not Recorded|161|||
162172402|NCT03916185|585684647|FG002|Overall Study|Not Able to Get to Clinic|0|||
162172403|NCT03916185|585684648|FG003|Overall Study|Not Able to Get to Clinic|0|||
162172404|NCT03766685|585684649|FG000|Overall Study|Lost to Follow-up|1|||
162172405|NCT03766685|585684650|FG001|Overall Study|Lost to Follow-up|1|||
162172406|NCT03766685|585684651|FG002|Overall Study|Lost to Follow-up|0|||
162172407|NCT03766685|585684652|FG003|Overall Study|Lost to Follow-up|0|||
162172408|NCT03766685|585684649|FG000|Overall Study|Adverse Event, not fatal|0|||
162172409|NCT03766685|585684650|FG001|Overall Study|Adverse Event, not fatal|1|||
162172410|NCT03766685|585684651|FG002|Overall Study|Adverse Event, not fatal|0|||
162172411|NCT03766685|585684652|FG003|Overall Study|Adverse Event, not fatal|1|||
162172412|NCT03766685|585684649|FG000|Overall Study|Withdrawal by Subject|0|||
162172413|NCT03766685|585684650|FG001|Overall Study|Withdrawal by Subject|2|||
162172414|NCT03766685|585684651|FG002|Overall Study|Withdrawal by Subject|0|||
162172415|NCT03766685|585684652|FG003|Overall Study|Withdrawal by Subject|0|||
162172416|NCT03766685|585684649|FG000|Overall Study|Protocol Violation|0|||
162172417|NCT03766685|585684650|FG001|Overall Study|Protocol Violation|1|||
162172418|NCT03766685|585684651|FG002|Overall Study|Protocol Violation|0|||
162172419|NCT03766685|585684652|FG003|Overall Study|Protocol Violation|0|||
162172420|NCT03766685|585684649|FG000|Overall Study|Non-compliance|0|||
162172421|NCT03766685|585684650|FG001|Overall Study|Non-compliance|2|||
162172422|NCT03766685|585684651|FG002|Overall Study|Non-compliance|0|||
162172423|NCT03766685|585684652|FG003|Overall Study|Non-compliance|0|||
162172424|NCT02844465|585684657|FG000|Overall Study|Screen Failure|36|||
162172425|NCT02844465|585684657|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
162172426|NCT02844465|585684657|FG000|Overall Study|Withdrawal by Subject|5|||
162172427|NCT02844465|585684657|FG000|Overall Study|Lost to Follow-up|1|||
162172428|NCT02844465|585684657|FG000|Overall Study|Retreatment|1|||
162172429|NCT05029622|585684658|FG000|Overall Study|Lost to Follow-up|1|||
162172430|NCT01197378|585684662|FG000|Overall Study|Adverse Event|3|||
162172431|NCT01197378|585684662|FG000|Overall Study|Withdrawal by Subject|1|||
162172432|NCT01197378|585684662|FG000|Overall Study|Physician Decision|1|||
162172433|NCT01197378|585684662|FG000|Overall Study|Other|2|||
162172434|NCT06232590|585684663|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
162172435|NCT06232590|585684664|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
162172436|NCT05299723|585684665|FG000|Overall Study|Withdrawal by Subject|0|||
162172437|NCT05299723|585684666|FG001|Overall Study|Withdrawal by Subject|2|||
162172438|NCT05299723|585684667|FG002|Overall Study|Withdrawal by Subject|0|||
162172439|NCT01959607|585684668|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
162172440|NCT01959607|585684669|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
162172441|NCT01959607|585684670|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
162172442|NCT01959607|585684671|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
162172443|NCT03913442|585684672|FG000|Overall Study|Adverse Event|0|||
161922584|NCT04790201|584763199|FG000|Overall Study|Lost to Follow-up|0|||
161922585|NCT04790201|584763200|FG001|Overall Study|Lost to Follow-up|0|||
161922586|NCT04790201|584763201|FG002|Overall Study|Lost to Follow-up|2|||
162172444|NCT03913442|585684673|FG001|Overall Study|Adverse Event|3|||
162172445|NCT03913442|585684672|FG000|Overall Study|Withdrawal by Subject|5|||
161922587|NCT04790201|584763199|FG000|Overall Study|Death|0|||
161922588|NCT04790201|584763200|FG001|Overall Study|Death|1|||
162172446|NCT03913442|585684673|FG001|Overall Study|Withdrawal by Subject|5|||
162172447|NCT03913442|585684672|FG000|Overall Study|Terminations|2|||
162172448|NCT03913442|585684673|FG001|Overall Study|Terminations|1|||
162172449|NCT03913442|585684672|FG000|Overall Study|Lost to Follow-up|2|||
162172450|NCT03913442|585684673|FG001|Overall Study|Lost to Follow-up|2|||
162172451|NCT02460458|585684674|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
162172452|NCT02460458|585684674|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
162172453|NCT02460458|585684674|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
162172454|NCT02460458|585684674|FG000|First Prospective Phase|Lost to Follow-up|84|||
162172455|NCT02460458|585684674|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
162172456|NCT03710603|585684675|FG000|Overall Study|Adverse Event|1|||
162172457|NCT03710603|585684676|FG001|Overall Study|Adverse Event|0|||
162172458|NCT03710603|585684675|FG000|Overall Study|Death|44|||
162172459|NCT03710603|585684676|FG001|Overall Study|Death|34|||
162172460|NCT03710603|585684675|FG000|Overall Study|Lost to Follow-up|3|||
162172461|NCT03710603|585684676|FG001|Overall Study|Lost to Follow-up|5|||
162172462|NCT03710603|585684675|FG000|Overall Study|Withdrawal by Subject|11|||
162172463|NCT03710603|585684676|FG001|Overall Study|Withdrawal by Subject|10|||
161922589|NCT04790201|584763201|FG002|Overall Study|Death|0|||
161922590|NCT04790201|584763199|FG000|Overall Study|Protocol Violation|1|||
161922591|NCT04790201|584763200|FG001|Overall Study|Protocol Violation|0|||
161922592|NCT04790201|584763201|FG002|Overall Study|Protocol Violation|1|||
161922593|NCT03637374|584763202|FG000|Overall Study|Death|2|||
161922594|NCT03637374|584763203|FG001|Overall Study|Death|0|||
161922595|NCT02836769|584763207|FG000|Overall Study|Lost to Follow-up|10|||
161922596|NCT02836769|584763207|FG000|Overall Study|Medical withdrawal|2|||
161922597|NCT02836769|584763207|FG000|Overall Study|Withdrawal by Subject|3|||
161922598|NCT04339972|584763208|FG000|Overall Study|Scheduling Issues|3|||
161922599|NCT04339972|584763209|FG001|Overall Study|Scheduling Issues|3|||
161922600|NCT04339972|584763208|FG000|Overall Study|dropout|1|||
161922601|NCT04339972|584763209|FG001|Overall Study|dropout|1|||
161922602|NCT04339972|584763208|FG000|Overall Study|Technical issues|1|||
161922603|NCT04339972|584763209|FG001|Overall Study|Technical issues|0|||
161922604|NCT04339972|584763208|FG000|Overall Study|Claustraphobia|0|||
162172464|NCT02589795|585684680|FG000|Overall Study|Lost to Follow-up|1|||
162172465|NCT02589795|585684681|FG001|Overall Study|Lost to Follow-up|0|||
162172466|NCT02589795|585684682|FG002|Overall Study|Lost to Follow-up|0|||
162172467|NCT02589795|585684680|FG000|Overall Study|Withdrawal by Subject|0|||
162172468|NCT02589795|585684681|FG001|Overall Study|Withdrawal by Subject|0|||
161922605|NCT04339972|584763209|FG001|Overall Study|Claustraphobia|1|||
161922606|NCT00776997|584763211|FG000|Overall Study|Adverse Event|2|||
161922607|NCT00933166|584763212|FG000|Overall Study|Lost to Follow-up|4|||
161922608|NCT00933166|584763212|FG000|Overall Study|Lack of Efficacy|9|||
161922609|NCT00933166|584763212|FG000|Overall Study|Unavailable|4|||
161922610|NCT00933166|584763212|FG000|Overall Study|Withdrawal by Subject|1|||
161922611|NCT02403271|584763213|FG000|Period 1|Other varied reasons|1|||
161922612|NCT02403271|584763214|FG001|Period 1|Other varied reasons|0|||
161922613|NCT02403271|584763213|FG000|Period 2|Withdrawal by Subject|0|||
161922614|NCT02403271|584763214|FG001|Period 2|Withdrawal by Subject|14|||
161922615|NCT02403271|584763213|FG000|Period 2|Death|0|||
161922616|NCT02403271|584763214|FG001|Period 2|Death|84|||
161922617|NCT02403271|584763213|FG000|Period 2|Lost to Follow-up|0|||
161922618|NCT02403271|584763214|FG001|Period 2|Lost to Follow-up|2|||
161922619|NCT02403271|584763213|FG000|Period 2|Study Terminated by Sponsor|0|||
161922620|NCT02403271|584763214|FG001|Period 2|Study Terminated by Sponsor|14|||
161922621|NCT02403271|584763213|FG000|Period 2|Other varied reasons|0|||
161922622|NCT02403271|584763214|FG001|Period 2|Other varied reasons|10|||
161922623|NCT03925220|584763215|FG000|Overall Study|Withdrawal by Subject|4|||
161922624|NCT03925220|584763216|FG001|Overall Study|Withdrawal by Subject|4|||
161922625|NCT03925220|584763217|FG002|Overall Study|Withdrawal by Subject|4|||
162172469|NCT02589795|585684682|FG002|Overall Study|Withdrawal by Subject|2|||
162172470|NCT02589795|585684680|FG000|Overall Study|Protocol Violation|0|||
161922626|NCT03925220|584763218|FG003|Overall Study|Withdrawal by Subject|4|||
161922627|NCT03925220|584763215|FG000|Overall Study|Lost to Follow-up|40|||
161922628|NCT03925220|584763216|FG001|Overall Study|Lost to Follow-up|46|||
161922629|NCT03925220|584763217|FG002|Overall Study|Lost to Follow-up|37|||
161922630|NCT03925220|584763218|FG003|Overall Study|Lost to Follow-up|38|||
161922631|NCT03301714|584763219|FG000|Overall Study|Lost to Follow-up|10|||
161922632|NCT03301714|584763220|FG001|Overall Study|Lost to Follow-up|4|||
161922633|NCT03301714|584763221|FG002|Overall Study|Lost to Follow-up|4|||
162172471|NCT02589795|585684681|FG001|Overall Study|Protocol Violation|0|||
161922634|NCT03301714|584763219|FG000|Overall Study|Did not receive allocated intervention|0|||
161922635|NCT03301714|584763220|FG001|Overall Study|Did not receive allocated intervention|2|||
162172472|NCT02589795|585684682|FG002|Overall Study|Protocol Violation|1|||
162172473|NCT03691935|585684686|FG000|Overall Study|Physician Decision|2|||
162172474|NCT03691935|585684687|FG001|Overall Study|Physician Decision|1|||
162172475|NCT03691935|585684686|FG000|Overall Study|Adverse Event|3|||
162172476|NCT03691935|585684687|FG001|Overall Study|Adverse Event|0|||
162172477|NCT03511664|585684694|FG000|Overall Study|Death|457|||
162172478|NCT03511664|585684695|FG001|Overall Study|Death|201|||
162172479|NCT03511664|585684696|FG002|Overall Study|Death|21|||
162172480|NCT03511664|585684694|FG000|Overall Study|Withdrew consent|40|||
162172481|NCT03511664|585684695|FG001|Overall Study|Withdrew consent|63|||
162172482|NCT03511664|585684696|FG002|Overall Study|Withdrew consent|3|||
162172483|NCT03511664|585684694|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
162172484|NCT03511664|585684695|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
162172485|NCT03511664|585684696|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
162172486|NCT03511664|585684694|FG000|Overall Study|Lost to Follow-up|8|||
162172487|NCT03511664|585684695|FG001|Overall Study|Lost to Follow-up|5|||
162172488|NCT03511664|585684696|FG002|Overall Study|Lost to Follow-up|0|||
162172489|NCT03511664|585684694|FG000|Overall Study|Physician Decision|2|||
162172490|NCT03511664|585684695|FG001|Overall Study|Physician Decision|1|||
162172491|NCT03511664|585684696|FG002|Overall Study|Physician Decision|0|||
162172492|NCT03511664|585684694|FG000|Overall Study|Patient non-compliance|1|||
162172493|NCT03511664|585684695|FG001|Overall Study|Patient non-compliance|0|||
162172494|NCT03511664|585684696|FG002|Overall Study|Patient non-compliance|0|||
162172495|NCT01946789|585684697|FG000|Overall Study|Death|0|||
161816880|NCT00691704|584370865|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
161816881|NCT00691704|584370865|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
161816882|NCT01993186|584370866|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
161816883|NCT01993186|584370867|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
161816884|NCT01993186|584370866|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
161816885|NCT01993186|584370867|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
161816886|NCT01993186|584370866|FG000|Open-Label Extension Period|Other, Not Specified|0|||
161816887|NCT01993186|584370867|FG001|Open-Label Extension Period|Other, Not Specified|1|||
161816888|NCT01993186|584370866|FG000|Open-Label Extension Period|Adverse Event|1|||
161816889|NCT01993186|584370867|FG001|Open-Label Extension Period|Adverse Event|0|||
161816890|NCT01993186|584370866|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
161816891|NCT01993186|584370867|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
161816892|NCT01993186|584370866|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
161816893|NCT01993186|584370867|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
161816894|NCT01993186|584370866|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
161816895|NCT01993186|584370867|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
161816896|NCT02451696|584370868|FG000|Overall Study|Surgery postponed|1|||
161816897|NCT02451696|584370869|FG001|Overall Study|Surgery postponed|0|||
161816898|NCT00198133|584370870|FG000|Overall Study|Disease progression|2|||
161816899|NCT00198133|584370871|FG001|Overall Study|Disease progression|5|||
161816900|NCT00198133|584370870|FG000|Overall Study|Adverse Event|1|||
161816901|NCT00198133|584370871|FG001|Overall Study|Adverse Event|3|||
161816902|NCT00198133|584370870|FG000|Overall Study|Withdrawal by Subject|1|||
161816903|NCT00198133|584370871|FG001|Overall Study|Withdrawal by Subject|0|||
161816904|NCT00198133|584370870|FG000|Overall Study|Physician Decision|1|||
161816905|NCT00198133|584370871|FG001|Overall Study|Physician Decision|0|||
161816906|NCT01557751|584370872|FG000|Overall Study|Physician Decision|3|||
161816907|NCT02752074|584370873|FG000|Overall Study|Lost to Follow-up|1|||
161816908|NCT02752074|584370874|FG001|Overall Study|Lost to Follow-up|4|||
161816909|NCT02752074|584370873|FG000|Overall Study|Death|146|||
161816910|NCT02752074|584370874|FG001|Overall Study|Death|129|||
161816911|NCT02752074|584370873|FG000|Overall Study|Withdrawal by Subject|9|||
161816912|NCT02752074|584370874|FG001|Overall Study|Withdrawal by Subject|10|||
161816913|NCT00840216|584370875|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161816914|NCT00840216|584370876|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
161816915|NCT01380782|584370877|FG000|Overall Study|Adverse Event|0|||
161816916|NCT01380782|584370878|FG001|Overall Study|Adverse Event|1|||
161816917|NCT01380782|584370879|FG002|Overall Study|Adverse Event|0|||
162172496|NCT01946789|585684698|FG001|Overall Study|Death|2|||
162172497|NCT01946789|585684699|FG002|Overall Study|Death|1|||
162172498|NCT01946789|585684700|FG003|Overall Study|Death|1|||
162172499|NCT01946789|585684701|FG004|Overall Study|Death|1|||
161816918|NCT01380782|584370880|FG003|Overall Study|Adverse Event|0|||
161816919|NCT01380782|584370877|FG000|Overall Study|Death|1|||
161816920|NCT01380782|584370878|FG001|Overall Study|Death|0|||
161816921|NCT01380782|584370879|FG002|Overall Study|Death|0|||
161816922|NCT01380782|584370880|FG003|Overall Study|Death|0|||
161816923|NCT01380782|584370877|FG000|Overall Study|Lack of Efficacy|10|||
162172500|NCT01946789|585684702|FG005|Overall Study|Death|1|||
162172501|NCT01946789|585684703|FG006|Overall Study|Death|3|||
161922636|NCT03301714|584763221|FG002|Overall Study|Did not receive allocated intervention|3|||
161922637|NCT04465955|584763222|FG000|Overall Study|Withdrew consent|6|||
161922638|NCT04465955|584763223|FG001|Overall Study|Withdrew consent|10|||
161922639|NCT04465955|584763224|FG002|Overall Study|Withdrew consent|7|||
161922640|NCT04465955|584763222|FG000|Overall Study|Adverse Event|6|||
161922641|NCT04465955|584763223|FG001|Overall Study|Adverse Event|5|||
161922642|NCT04465955|584763224|FG002|Overall Study|Adverse Event|1|||
161922643|NCT04465955|584763222|FG000|Overall Study|Lost to Follow-up|2|||
161922644|NCT04465955|584763223|FG001|Overall Study|Lost to Follow-up|0|||
161922645|NCT04465955|584763224|FG002|Overall Study|Lost to Follow-up|3|||
161922646|NCT04465955|584763222|FG000|Overall Study|Other|1|||
161922647|NCT04465955|584763223|FG001|Overall Study|Other|1|||
161922648|NCT04465955|584763224|FG002|Overall Study|Other|3|||
161922649|NCT04738487|584763225|FG000|Overall Study|Participant Ongoing in Study|298|||
161922650|NCT04738487|584763226|FG001|Overall Study|Participant Ongoing in Study|297|||
161922651|NCT04738487|584763225|FG000|Overall Study|Withdrawal by Subject|7|||
161922652|NCT04738487|584763226|FG001|Overall Study|Withdrawal by Subject|9|||
161922653|NCT04738487|584763225|FG000|Overall Study|Lost to Follow-up|2|||
161922654|NCT04738487|584763226|FG001|Overall Study|Lost to Follow-up|0|||
161922655|NCT04738487|584763225|FG000|Overall Study|Death|287|||
161922656|NCT04738487|584763226|FG001|Overall Study|Death|306|||
161922657|NCT00632359|584763227|FG000|Overall Study|Withdrawal by Subject|2|||
161922658|NCT03599713|584763232|FG000|Overall Study|Death|38|||
161922659|NCT03599713|584763233|FG001|Overall Study|Death|3|||
161922660|NCT03599713|584763232|FG000|Overall Study|Withdrawal by Subject|17|||
161922661|NCT03599713|584763233|FG001|Overall Study|Withdrawal by Subject|0|||
161922662|NCT03599713|584763232|FG000|Overall Study|Lost to Follow-up|4|||
161922663|NCT03599713|584763233|FG001|Overall Study|Lost to Follow-up|0|||
161922664|NCT03599713|584763232|FG000|Overall Study|Discontinued Due to End of Study|42|||
161922665|NCT03599713|584763233|FG001|Overall Study|Discontinued Due to End of Study|3|||
161922666|NCT05578872|584763236|FG000|Overall Study|Withdrawal by Subject|2|||
161922667|NCT05578872|584763237|FG001|Overall Study|Withdrawal by Subject|1|||
161922668|NCT05578872|584763236|FG000|Overall Study|Adverse Event|1|||
161922669|NCT05578872|584763237|FG001|Overall Study|Adverse Event|1|||
161922670|NCT05578872|584763236|FG000|Overall Study|Physician Decision|1|||
161922671|NCT05578872|584763237|FG001|Overall Study|Physician Decision|2|||
161922672|NCT05578872|584763236|FG000|Overall Study|Progressive disease|10|||
161922673|NCT05578872|584763237|FG001|Overall Study|Progressive disease|9|||
161922674|NCT05578872|584763236|FG000|Overall Study|Sponsor decision|0|||
161922675|NCT05578872|584763237|FG001|Overall Study|Sponsor decision|1|||
162172502|NCT01946789|585684704|FG007|Overall Study|Death|1|||
162172503|NCT01946789|585684705|FG008|Overall Study|Death|2|||
162172504|NCT01946789|585684697|FG000|Overall Study|Progressive Disease|0|||
162172505|NCT01946789|585684698|FG001|Overall Study|Progressive Disease|0|||
162172506|NCT01946789|585684699|FG002|Overall Study|Progressive Disease|1|||
162172507|NCT01946789|585684700|FG003|Overall Study|Progressive Disease|0|||
162172508|NCT01946789|585684701|FG004|Overall Study|Progressive Disease|0|||
162172509|NCT01946789|585684702|FG005|Overall Study|Progressive Disease|2|||
162172510|NCT01946789|585684703|FG006|Overall Study|Progressive Disease|0|||
162172511|NCT01946789|585684704|FG007|Overall Study|Progressive Disease|0|||
162172512|NCT01946789|585684705|FG008|Overall Study|Progressive Disease|0|||
162172513|NCT01946789|585684697|FG000|Overall Study|Withdrawal by Subject|0|||
162172514|NCT01946789|585684698|FG001|Overall Study|Withdrawal by Subject|0|||
162172515|NCT01946789|585684699|FG002|Overall Study|Withdrawal by Subject|0|||
162172516|NCT01946789|585684700|FG003|Overall Study|Withdrawal by Subject|2|||
162172517|NCT01946789|585684701|FG004|Overall Study|Withdrawal by Subject|1|||
162172518|NCT01946789|585684702|FG005|Overall Study|Withdrawal by Subject|0|||
162172519|NCT01946789|585684703|FG006|Overall Study|Withdrawal by Subject|1|||
162172520|NCT01946789|585684704|FG007|Overall Study|Withdrawal by Subject|0|||
161922676|NCT05578872|584763236|FG000|Overall Study|Toxicity and Patient's decision|0|||
161922677|NCT05578872|584763237|FG001|Overall Study|Toxicity and Patient's decision|1|||
162172521|NCT01946789|585684705|FG008|Overall Study|Withdrawal by Subject|0|||
162172522|NCT04076618|585684706|FG000|Overall Study|Lost to Follow-up|2|||
162172523|NCT04076618|585684707|FG001|Overall Study|Lost to Follow-up|1|||
162172524|NCT04076618|585684708|FG002|Overall Study|Lost to Follow-up|3|||
162172525|NCT04076618|585684706|FG000|Overall Study|Withdrawal by Subject|3|||
161922678|NCT01022580|584764826|FG000|Overall Study|Death|18|||
161922679|NCT01022580|584764827|FG001|Overall Study|Death|22|||
161922680|NCT03439839|584764828|FG000|Overall Study|Death|3|||
161922681|NCT03439839|584764829|FG001|Overall Study|Death|0|||
161922682|NCT03033901|584764833|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
161922683|NCT03033901|584764833|FG000|Overall Study|Refused PSG|23|||
161922684|NCT03033901|584764833|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
161922685|NCT03033901|584764833|FG000|Overall Study|Missing Oximetry Data|3|||
161922686|NCT00924651|584764836|FG000|Overall Study|Chemo started too soon|2|||
162172526|NCT04076618|585684707|FG001|Overall Study|Withdrawal by Subject|1|||
162018074|NCT01396447|585121887|FG000|Overall Study|Adverse Event|15|||
162018075|NCT01396447|585121888|FG001|Overall Study|Adverse Event|12|||
162018076|NCT01396447|585121889|FG002|Overall Study|Adverse Event|12|||
162018077|NCT01396447|585121890|FG003|Overall Study|Adverse Event|17|||
162018078|NCT01396447|585121887|FG000|Overall Study|Insufficient Therapeutic Response|5|||
162018079|NCT01396447|585121888|FG001|Overall Study|Insufficient Therapeutic Response|5|||
162018080|NCT01396447|585121889|FG002|Overall Study|Insufficient Therapeutic Response|2|||
162018081|NCT01396447|585121890|FG003|Overall Study|Insufficient Therapeutic Response|4|||
162018082|NCT01396447|585121887|FG000|Overall Study|Protocol Violation|5|||
162018083|NCT01396447|585121888|FG001|Overall Study|Protocol Violation|2|||
162018084|NCT01396447|585121889|FG002|Overall Study|Protocol Violation|3|||
162018085|NCT01396447|585121890|FG003|Overall Study|Protocol Violation|7|||
162018086|NCT01396447|585121887|FG000|Overall Study|Withdrawal of Consent|11|||
162018087|NCT01396447|585121888|FG001|Overall Study|Withdrawal of Consent|9|||
161816924|NCT01380782|584370878|FG001|Overall Study|Lack of Efficacy|9|||
161816925|NCT01380782|584370879|FG002|Overall Study|Lack of Efficacy|10|||
161816926|NCT01380782|584370880|FG003|Overall Study|Lack of Efficacy|3|||
161816927|NCT01380782|584370877|FG000|Overall Study|Physician Decision|1|||
161816928|NCT01380782|584370878|FG001|Overall Study|Physician Decision|0|||
161816929|NCT01380782|584370879|FG002|Overall Study|Physician Decision|0|||
161816930|NCT01380782|584370880|FG003|Overall Study|Physician Decision|0|||
161816931|NCT01380782|584370877|FG000|Overall Study|Withdrawal by Subject|0|||
161816932|NCT01380782|584370878|FG001|Overall Study|Withdrawal by Subject|0|||
161816933|NCT01380782|584370879|FG002|Overall Study|Withdrawal by Subject|1|||
161816934|NCT01380782|584370880|FG003|Overall Study|Withdrawal by Subject|1|||
161816935|NCT01403194|584370884|FG000|Overall Study|Screen Failure|2|||
161816936|NCT01403194|584370884|FG000|Overall Study|Lost to Follow-up|8|||
161816937|NCT03428750|584370885|FG000|Overall Study|Withdrawal by Subject|11|||
161816938|NCT03428750|584370886|FG001|Overall Study|Withdrawal by Subject|10|||
161816939|NCT03428750|584370885|FG000|Overall Study|Lost to Follow-up|3|||
161816940|NCT03428750|584370886|FG001|Overall Study|Lost to Follow-up|9|||
161816941|NCT03428750|584370885|FG000|Overall Study|Adverse Event|9|||
161816942|NCT03428750|584370886|FG001|Overall Study|Adverse Event|1|||
161816943|NCT03428750|584370885|FG000|Overall Study|Protocol Violation|1|||
161816944|NCT03428750|584370886|FG001|Overall Study|Protocol Violation|0|||
161816945|NCT03428750|584370885|FG000|Overall Study|Administrative|0|||
161816946|NCT03428750|584370886|FG001|Overall Study|Administrative|1|||
161816947|NCT04474405|584370889|FG000|Overall Study|Withdrawal by Subject|0|||
161816948|NCT04474405|584370890|FG001|Overall Study|Withdrawal by Subject|0|||
161816949|NCT04474405|584370891|FG002|Overall Study|Withdrawal by Subject|1|||
161816950|NCT04474405|584370892|FG003|Overall Study|Withdrawal by Subject|0|||
161816951|NCT04474405|584370893|FG004|Overall Study|Withdrawal by Subject|1|||
161816952|NCT04474405|584370894|FG005|Overall Study|Withdrawal by Subject|0|||
161816953|NCT04474405|584370889|FG000|Overall Study|Other|0|||
161816954|NCT04474405|584370890|FG001|Overall Study|Other|0|||
161816955|NCT04474405|584370891|FG002|Overall Study|Other|0|||
161816956|NCT04474405|584370892|FG003|Overall Study|Other|0|||
161816957|NCT04474405|584370893|FG004|Overall Study|Other|3|||
161816958|NCT04474405|584370894|FG005|Overall Study|Other|0|||
161816959|NCT00274651|584370895|FG000|Overall Study|Adverse Event|6|||
162018088|NCT01396447|585121889|FG002|Overall Study|Withdrawal of Consent|4|||
162018089|NCT01396447|585121890|FG003|Overall Study|Withdrawal of Consent|15|||
162018090|NCT01396447|585121887|FG000|Overall Study|Lost to Follow-up|4|||
161816960|NCT00274651|584370896|FG001|Overall Study|Adverse Event|3|||
161816961|NCT00274651|584370895|FG000|Overall Study|Lack of Efficacy|13|||
161816962|NCT00274651|584370896|FG001|Overall Study|Lack of Efficacy|6|||
161816963|NCT00274651|584370895|FG000|Overall Study|Death|1|||
161816964|NCT00274651|584370896|FG001|Overall Study|Death|3|||
161816965|NCT00274651|584370895|FG000|Overall Study|Withdrawal by Subject|0|||
161816966|NCT00274651|584370896|FG001|Overall Study|Withdrawal by Subject|1|||
161816967|NCT00274651|584370895|FG000|Overall Study|Physician Decision|8|||
161922687|NCT00924651|584764837|FG001|Overall Study|Chemo started too soon|3|||
161922688|NCT00924651|584764836|FG000|Overall Study|No Reason|3|||
161922689|NCT00924651|584764837|FG001|Overall Study|No Reason|7|||
161922690|NCT00924651|584764836|FG000|Overall Study|Overwhelmed|6|||
162172527|NCT04076618|585684708|FG002|Overall Study|Withdrawal by Subject|2|||
162172528|NCT04076618|585684706|FG000|Overall Study|Relocated out of state|0|||
162172529|NCT04076618|585684707|FG001|Overall Study|Relocated out of state|2|||
162172530|NCT04076618|585684708|FG002|Overall Study|Relocated out of state|0|||
162172531|NCT04076618|585684706|FG000|Overall Study|COVID concerns|0|||
162172532|NCT04076618|585684707|FG001|Overall Study|COVID concerns|1|||
162172533|NCT04076618|585684708|FG002|Overall Study|COVID concerns|0|||
162172534|NCT04076618|585684706|FG000|Overall Study|Adverse Event|0|||
162172535|NCT04076618|585684707|FG001|Overall Study|Adverse Event|0|||
162172536|NCT04076618|585684708|FG002|Overall Study|Adverse Event|2|||
162172537|NCT01928394|585684709|FG000|Treatment Period|Disease progression|17|||
162172538|NCT01928394|585684710|FG001|Treatment Period|Disease progression|2|||
161670142|NCT01139021|583845346|FG001|Overall Study|Withdrawal by Subject|0|||
161670143|NCT01139021|583845347|FG002|Overall Study|Withdrawal by Subject|0|||
161670144|NCT01139021|583845348|FG003|Overall Study|Withdrawal by Subject|1|||
161670145|NCT01139021|583845349|FG004|Overall Study|Withdrawal by Subject|4|||
161670146|NCT01139021|583845350|FG005|Overall Study|Withdrawal by Subject|0|||
161670147|NCT00784693|583845355|FG000|Overall Study|Lost to Follow-up|0|||
161670148|NCT00784693|583845356|FG001|Overall Study|Lost to Follow-up|1|||
161670149|NCT00784693|583845355|FG000|Overall Study|Lack of Efficacy|1|||
161670150|NCT00784693|583845356|FG001|Overall Study|Lack of Efficacy|1|||
161670151|NCT00784693|583845355|FG000|Overall Study|Withdrawal by Subject|0|||
161670152|NCT00784693|583845356|FG001|Overall Study|Withdrawal by Subject|4|||
161670153|NCT00784693|583845355|FG000|Overall Study|Randomized but not Treated|1|||
161670154|NCT00784693|583845356|FG001|Overall Study|Randomized but not Treated|0|||
161670155|NCT00784693|583845355|FG000|Overall Study|Other|1|||
161816968|NCT00274651|584370896|FG001|Overall Study|Physician Decision|7|||
161816969|NCT03446768|584370897|FG000|Overall Study|Withdrawal by Subject|0|||
161816970|NCT03446768|584370898|FG001|Overall Study|Withdrawal by Subject|1|||
161816971|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
161670156|NCT00784693|583845356|FG001|Overall Study|Other|0|||
161670157|NCT02982187|583845357|FG000|Overall Study|Withdrawal by Subject|0|||
161816972|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
161816973|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
161816974|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
161816975|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
161816976|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
161816977|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
161816978|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
161816979|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
161816980|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
161816981|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
161816982|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
161816983|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
161816984|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
161816985|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
161922691|NCT00924651|584764837|FG001|Overall Study|Overwhelmed|6|||
162172539|NCT01928394|585684711|FG002|Treatment Period|Disease progression|12|||
162172540|NCT01928394|585684712|FG003|Treatment Period|Disease progression|48|||
162172541|NCT01928394|585684713|FG004|Treatment Period|Disease progression|3|||
162172542|NCT01928394|585684714|FG005|Treatment Period|Disease progression|25|||
162172543|NCT01928394|585684715|FG006|Treatment Period|Disease progression|38|||
162172544|NCT01928394|585684716|FG007|Treatment Period|Disease progression|16|||
162172545|NCT01928394|585684717|FG008|Treatment Period|Disease progression|3|||
162172546|NCT01928394|585684718|FG009|Treatment Period|Disease progression|11|||
162172547|NCT01928394|585684719|FG010|Treatment Period|Disease progression|22|||
162172548|NCT01928394|585684720|FG011|Treatment Period|Disease progression|73|||
162172549|NCT01928394|585684721|FG012|Treatment Period|Disease progression|38|||
162172550|NCT01928394|585684722|FG013|Treatment Period|Disease progression|118|||
162172551|NCT01928394|585684723|FG014|Treatment Period|Disease progression|59|||
162172552|NCT01928394|585684724|FG015|Treatment Period|Disease progression|1|||
161816986|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
161816987|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
161816988|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
161670158|NCT02982187|583845358|FG001|Overall Study|Withdrawal by Subject|0|||
161670159|NCT02982187|583845359|FG002|Overall Study|Withdrawal by Subject|0|||
162172553|NCT01928394|585684725|FG016|Treatment Period|Disease progression|43|||
162172554|NCT01928394|585684726|FG017|Treatment Period|Disease progression|56|||
162172555|NCT01928394|585684727|FG018|Treatment Period|Disease progression|50|||
162172556|NCT01928394|585684728|FG019|Treatment Period|Disease progression|71|||
162172557|NCT01928394|585684729|FG020|Treatment Period|Disease progression|30|||
162172558|NCT01928394|585684730|FG021|Treatment Period|Disease progression|31|||
162172559|NCT01928394|585684731|FG022|Treatment Period|Disease progression|31|||
162172560|NCT01928394|585684709|FG000|Treatment Period|Study drug toxicity|1|||
162172561|NCT01928394|585684710|FG001|Treatment Period|Study drug toxicity|1|||
162172562|NCT01928394|585684711|FG002|Treatment Period|Study drug toxicity|3|||
162172563|NCT01928394|585684712|FG003|Treatment Period|Study drug toxicity|3|||
162172564|NCT01928394|585684713|FG004|Treatment Period|Study drug toxicity|0|||
162172565|NCT01928394|585684714|FG005|Treatment Period|Study drug toxicity|9|||
162172566|NCT01928394|585684715|FG006|Treatment Period|Study drug toxicity|7|||
162172567|NCT01928394|585684716|FG007|Treatment Period|Study drug toxicity|1|||
162172568|NCT01928394|585684717|FG008|Treatment Period|Study drug toxicity|0|||
162172569|NCT01928394|585684718|FG009|Treatment Period|Study drug toxicity|5|||
162172570|NCT01928394|585684719|FG010|Treatment Period|Study drug toxicity|2|||
162172571|NCT01928394|585684720|FG011|Treatment Period|Study drug toxicity|3|||
162172572|NCT01928394|585684721|FG012|Treatment Period|Study drug toxicity|7|||
162172573|NCT01928394|585684722|FG013|Treatment Period|Study drug toxicity|5|||
162172574|NCT01928394|585684723|FG014|Treatment Period|Study drug toxicity|12|||
162172575|NCT01928394|585684724|FG015|Treatment Period|Study drug toxicity|0|||
162172576|NCT01928394|585684725|FG016|Treatment Period|Study drug toxicity|3|||
161670160|NCT02982187|583845360|FG003|Overall Study|Withdrawal by Subject|0|||
161670161|NCT02982187|583845361|FG004|Overall Study|Withdrawal by Subject|0|||
161670162|NCT02982187|583845362|FG005|Overall Study|Withdrawal by Subject|0|||
161670163|NCT02982187|583845363|FG006|Overall Study|Withdrawal by Subject|1|||
161670164|NCT02982187|583845364|FG007|Overall Study|Withdrawal by Subject|0|||
161670165|NCT02349451|583845368|FG000|Overall Study|Withdrawal by Subject|0|||
161670166|NCT02349451|583845369|FG001|Overall Study|Withdrawal by Subject|1|||
161670167|NCT02349451|583845370|FG002|Overall Study|Withdrawal by Subject|2|||
161670168|NCT02349451|583845371|FG003|Overall Study|Withdrawal by Subject|1|||
161670169|NCT02168842|583845372|FG000|Overall Study|Withdrawal by Subject|5|||
161670170|NCT02168842|583845373|FG001|Overall Study|Withdrawal by Subject|3|||
161670171|NCT02168842|583845372|FG000|Overall Study|Lost to Follow-up|0|||
161670172|NCT02168842|583845373|FG001|Overall Study|Lost to Follow-up|2|||
161670173|NCT02168842|583845372|FG000|Overall Study|Death|2|||
161670174|NCT02168842|583845373|FG001|Overall Study|Death|1|||
161670175|NCT02168842|583845372|FG000|Overall Study|Physician Decision|1|||
161670176|NCT02168842|583845373|FG001|Overall Study|Physician Decision|2|||
161670177|NCT02147353|583845374|FG000|Overall Study|Lost to Follow-up|2|||
162172577|NCT01928394|585684726|FG017|Treatment Period|Study drug toxicity|3|||
162172578|NCT01928394|585684727|FG018|Treatment Period|Study drug toxicity|12|||
162172579|NCT01928394|585684728|FG019|Treatment Period|Study drug toxicity|15|||
162172580|NCT01928394|585684729|FG020|Treatment Period|Study drug toxicity|4|||
162172581|NCT01928394|585684730|FG021|Treatment Period|Study drug toxicity|7|||
162172582|NCT01928394|585684731|FG022|Treatment Period|Study drug toxicity|4|||
162172583|NCT01928394|585684709|FG000|Treatment Period|AE unrelated to study drug|0|||
162172584|NCT01928394|585684710|FG001|Treatment Period|AE unrelated to study drug|0|||
162172585|NCT01928394|585684711|FG002|Treatment Period|AE unrelated to study drug|2|||
162172586|NCT01928394|585684712|FG003|Treatment Period|AE unrelated to study drug|3|||
161670178|NCT02147353|583845375|FG001|Overall Study|Lost to Follow-up|0|||
161670179|NCT02147353|583845374|FG000|Overall Study|unable to make visits|4|||
162172587|NCT01928394|585684713|FG004|Treatment Period|AE unrelated to study drug|0|||
161670180|NCT02147353|583845375|FG001|Overall Study|unable to make visits|0|||
161670181|NCT02147353|583845374|FG000|Overall Study|medication noncompliance|3|||
162172588|NCT01928394|585684714|FG005|Treatment Period|AE unrelated to study drug|5|||
162172589|NCT01928394|585684715|FG006|Treatment Period|AE unrelated to study drug|1|||
162172590|NCT01928394|585684716|FG007|Treatment Period|AE unrelated to study drug|0|||
162172591|NCT01928394|585684717|FG008|Treatment Period|AE unrelated to study drug|0|||
162172592|NCT01928394|585684718|FG009|Treatment Period|AE unrelated to study drug|2|||
161670182|NCT02147353|583845375|FG001|Overall Study|medication noncompliance|0|||
161816989|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
162172593|NCT01928394|585684719|FG010|Treatment Period|AE unrelated to study drug|0|||
162172594|NCT01928394|585684720|FG011|Treatment Period|AE unrelated to study drug|12|||
161670183|NCT02578862|583845383|FG000|Overall Study|Withdrawal by Subject|0|||
161670184|NCT02578862|583845384|FG001|Overall Study|Withdrawal by Subject|1|||
161816990|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
162172595|NCT01928394|585684721|FG012|Treatment Period|AE unrelated to study drug|6|||
162172596|NCT01928394|585684722|FG013|Treatment Period|AE unrelated to study drug|13|||
162172597|NCT01928394|585684723|FG014|Treatment Period|AE unrelated to study drug|6|||
162172598|NCT01928394|585684724|FG015|Treatment Period|AE unrelated to study drug|1|||
162172599|NCT01928394|585684725|FG016|Treatment Period|AE unrelated to study drug|1|||
161670185|NCT02578862|583845383|FG000|Overall Study|Unplanned unilateral procedure|0|||
161670186|NCT02578862|583845384|FG001|Overall Study|Unplanned unilateral procedure|1|||
161670187|NCT01230788|583845393|FG000|Overall Study|Prescribed exclusion drug|1|||
161670188|NCT01142596|583845394|FG000|Overall Study|Withdrawal by Subject|9|||
161670189|NCT01142596|583845395|FG001|Overall Study|Withdrawal by Subject|35|||
161670190|NCT01142596|583845394|FG000|Overall Study|Adverse Event|8|||
161670191|NCT01142596|583845395|FG001|Overall Study|Adverse Event|35|||
161670192|NCT01142596|583845394|FG000|Overall Study|Lack of Efficacy|5|||
161670193|NCT01142596|583845395|FG001|Overall Study|Lack of Efficacy|9|||
161670194|NCT01142596|583845394|FG000|Overall Study|Lost to Follow-up|2|||
161670195|NCT01142596|583845395|FG001|Overall Study|Lost to Follow-up|3|||
161670196|NCT01142596|583845394|FG000|Overall Study|Other reason (not specified)|5|||
161670197|NCT01142596|583845395|FG001|Overall Study|Other reason (not specified)|4|||
161670198|NCT01423253|583845396|FG000|Overall Study|Adverse Event|2|||
161670199|NCT01423253|583845396|FG000|Overall Study|Lack of Efficacy|2|||
161670200|NCT01423253|583845396|FG000|Overall Study|Lost to Follow-up|1|||
161670201|NCT01423253|583845396|FG000|Overall Study|Protocol Violation|2|||
161670202|NCT01423253|583845396|FG000|Overall Study|Withdrawal by Subject|2|||
161670203|NCT01290601|583845399|FG000|Overall Study|Adverse Event|0|||
161670204|NCT01290601|583845400|FG001|Overall Study|Adverse Event|2|||
161670205|NCT01290601|583845401|FG002|Overall Study|Adverse Event|0|||
161670206|NCT01290601|583845402|FG003|Overall Study|Adverse Event|0|||
161670207|NCT01290601|583845399|FG000|Overall Study|Lack of Efficacy|2|||
161670208|NCT01290601|583845400|FG001|Overall Study|Lack of Efficacy|1|||
161670209|NCT01290601|583845401|FG002|Overall Study|Lack of Efficacy|0|||
161670210|NCT01290601|583845402|FG003|Overall Study|Lack of Efficacy|0|||
161670211|NCT01290601|583845399|FG000|Overall Study|Lost to Follow-up|7|||
161670212|NCT01290601|583845400|FG001|Overall Study|Lost to Follow-up|2|||
161670213|NCT01290601|583845401|FG002|Overall Study|Lost to Follow-up|0|||
161670214|NCT01290601|583845402|FG003|Overall Study|Lost to Follow-up|0|||
161670215|NCT01290601|583845399|FG000|Overall Study|Other|1|||
161670216|NCT01290601|583845400|FG001|Overall Study|Other|0|||
161670217|NCT01290601|583845401|FG002|Overall Study|Other|0|||
161670218|NCT01290601|583845402|FG003|Overall Study|Other|0|||
161670219|NCT01290601|583845399|FG000|Overall Study|Protocol Violation|1|||
161670220|NCT01290601|583845400|FG001|Overall Study|Protocol Violation|0|||
161670221|NCT01290601|583845401|FG002|Overall Study|Protocol Violation|0|||
161670222|NCT01290601|583845402|FG003|Overall Study|Protocol Violation|0|||
161670223|NCT00775450|583845403|FG000|Overall Study|Serious Adverse Event|2|||
161670224|NCT00775450|583845404|FG001|Overall Study|Serious Adverse Event|0|||
161670225|NCT00775450|583845405|FG002|Overall Study|Serious Adverse Event|0|||
161670226|NCT00775450|583845406|FG003|Overall Study|Serious Adverse Event|0|||
161670227|NCT00775450|583845407|FG004|Overall Study|Serious Adverse Event|0|||
161670228|NCT00775450|583845403|FG000|Overall Study|Protocol Violation|0|||
161670229|NCT00775450|583845404|FG001|Overall Study|Protocol Violation|0|||
161670230|NCT00775450|583845405|FG002|Overall Study|Protocol Violation|0|||
161670231|NCT00775450|583845406|FG003|Overall Study|Protocol Violation|0|||
161670232|NCT00775450|583845407|FG004|Overall Study|Protocol Violation|1|||
161670233|NCT00775450|583845403|FG000|Overall Study|Withdrawal by Subject|1|||
161670234|NCT00775450|583845404|FG001|Overall Study|Withdrawal by Subject|0|||
161816991|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
162172600|NCT01928394|585684726|FG017|Treatment Period|AE unrelated to study drug|6|||
162172601|NCT01928394|585684727|FG018|Treatment Period|AE unrelated to study drug|3|||
162172602|NCT01928394|585684728|FG019|Treatment Period|AE unrelated to study drug|5|||
162172603|NCT01928394|585684729|FG020|Treatment Period|AE unrelated to study drug|1|||
162172604|NCT01928394|585684730|FG021|Treatment Period|AE unrelated to study drug|1|||
162172605|NCT01928394|585684731|FG022|Treatment Period|AE unrelated to study drug|0|||
162172606|NCT01928394|585684709|FG000|Treatment Period|Participant request to stop therapy|0|||
162172607|NCT01928394|585684710|FG001|Treatment Period|Participant request to stop therapy|0|||
162172608|NCT01928394|585684711|FG002|Treatment Period|Participant request to stop therapy|0|||
162172609|NCT01928394|585684712|FG003|Treatment Period|Participant request to stop therapy|0|||
162172610|NCT01928394|585684713|FG004|Treatment Period|Participant request to stop therapy|0|||
161670235|NCT00775450|583845405|FG002|Overall Study|Withdrawal by Subject|0|||
161670236|NCT00775450|583845406|FG003|Overall Study|Withdrawal by Subject|0|||
161670237|NCT00775450|583845407|FG004|Overall Study|Withdrawal by Subject|1|||
161670238|NCT01749540|583845415|FG000|Overall Study|Protocol Violation|0|||
161670239|NCT01749540|583845416|FG001|Overall Study|Protocol Violation|0|||
161670240|NCT01749540|583845417|FG002|Overall Study|Protocol Violation|0|||
161670241|NCT01749540|583845418|FG003|Overall Study|Protocol Violation|0|||
161670242|NCT01749540|583845419|FG004|Overall Study|Protocol Violation|0|||
161670243|NCT01749540|583845420|FG005|Overall Study|Protocol Violation|1|||
161816992|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
161670244|NCT01749540|583845421|FG006|Overall Study|Protocol Violation|1|||
161922692|NCT00924651|584764836|FG000|Overall Study|Noncompliant|1|||
162018091|NCT01396447|585121888|FG001|Overall Study|Lost to Follow-up|8|||
162018092|NCT01396447|585121889|FG002|Overall Study|Lost to Follow-up|7|||
162018093|NCT01396447|585121890|FG003|Overall Study|Lost to Follow-up|9|||
162018094|NCT01396447|585121887|FG000|Overall Study|Other Miscellaneous Reasons|0|||
162018095|NCT01396447|585121888|FG001|Overall Study|Other Miscellaneous Reasons|2|||
162018096|NCT01396447|585121889|FG002|Overall Study|Other Miscellaneous Reasons|1|||
162018097|NCT01396447|585121890|FG003|Overall Study|Other Miscellaneous Reasons|0|||
162018098|NCT01402102|585121891|FG000|Overall Study|Protocol Violation|1|||
162018099|NCT01402102|585121892|FG001|Overall Study|Protocol Violation|0|||
162018100|NCT01402102|585121891|FG000|Overall Study|Insufficiency of compliance|1|||
162018101|NCT01402102|585121892|FG001|Overall Study|Insufficiency of compliance|1|||
162018102|NCT01402102|585121891|FG000|Overall Study|Withdrawal by Subject|0|||
162018103|NCT01402102|585121892|FG001|Overall Study|Withdrawal by Subject|2|||
162018104|NCT04269265|585121893|FG000|Overall Study|Physician Decision|1|||
162018105|NCT04269265|585121893|FG000|Overall Study|Withdrawal by Subject|1|||
162018106|NCT04269265|585121893|FG000|Overall Study|Overenrolled (sample size reached)|4|||
162018107|NCT04693234|585121894|FG000|Overall Study|Death|79|||
162018108|NCT04693234|585121895|FG001|Overall Study|Death|19|||
162018109|NCT04693234|585121894|FG000|Overall Study|Sponsor Ended Study|47|||
162018110|NCT04693234|585121895|FG001|Overall Study|Sponsor Ended Study|18|||
162018111|NCT04693234|585121894|FG000|Overall Study|Withdrawal by Subject|10|||
162018112|NCT04693234|585121895|FG001|Overall Study|Withdrawal by Subject|2|||
162018113|NCT04693234|585121894|FG000|Overall Study|Lost to Follow-up|2|||
162018114|NCT04693234|585121895|FG001|Overall Study|Lost to Follow-up|1|||
162018115|NCT04838626|585121898|FG000|Overall Study|Adverse Event|2|||
162018116|NCT04838626|585121898|FG000|Overall Study|Physician Decision|6|||
162018117|NCT04838626|585121898|FG000|Overall Study|Protocol Violation|3|||
162018118|NCT04838626|585121898|FG000|Overall Study|Withdrawal by Subject|9|||
162018119|NCT04838626|585121898|FG000|Overall Study|Technical Problems|2|||
162018120|NCT02578706|585121901|FG000|Overall Study|Withdrawal by Subject|1|||
162018121|NCT02578706|585121902|FG001|Overall Study|Withdrawal by Subject|0|||
162018122|NCT02578706|585121903|FG002|Overall Study|Withdrawal by Subject|0|||
162018123|NCT02578706|585121901|FG000|Overall Study|Lost to Follow-up|0|||
162018124|NCT02578706|585121902|FG001|Overall Study|Lost to Follow-up|4|||
162018125|NCT02578706|585121903|FG002|Overall Study|Lost to Follow-up|0|||
162018126|NCT02578706|585121901|FG000|Overall Study|Physician Decision|0|||
161922693|NCT00924651|584764837|FG001|Overall Study|Noncompliant|4|||
161922694|NCT00924651|584764836|FG000|Overall Study|Medical|1|||
161922695|NCT00924651|584764837|FG001|Overall Study|Medical|3|||
161922696|NCT00924651|584764836|FG000|Overall Study|Changed Mind|10|||
161922697|NCT00924651|584764837|FG001|Overall Study|Changed Mind|1|||
161922698|NCT00924651|584764836|FG000|Overall Study|Incomplete Form|2|||
161922699|NCT00924651|584764837|FG001|Overall Study|Incomplete Form|1|||
161922700|NCT00723944|584764838|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
161922701|NCT00723944|584764839|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
161922702|NCT00723944|584764838|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
161922703|NCT00723944|584764839|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
161922704|NCT00723944|584764838|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
161922705|NCT00723944|584764839|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
161922706|NCT00835978|584764840|FG000|Overall Study|Death|33|||
161922707|NCT00835978|584764841|FG001|Overall Study|Death|40|||
161922708|NCT00835978|584764842|FG002|Overall Study|Death|49|||
161816993|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
162172611|NCT01928394|585684714|FG005|Treatment Period|Participant request to stop therapy|3|||
162172612|NCT01928394|585684715|FG006|Treatment Period|Participant request to stop therapy|3|||
162172613|NCT01928394|585684716|FG007|Treatment Period|Participant request to stop therapy|0|||
162172614|NCT01928394|585684717|FG008|Treatment Period|Participant request to stop therapy|0|||
162172615|NCT01928394|585684718|FG009|Treatment Period|Participant request to stop therapy|0|||
162172616|NCT01928394|585684719|FG010|Treatment Period|Participant request to stop therapy|3|||
162172617|NCT01928394|585684720|FG011|Treatment Period|Participant request to stop therapy|2|||
162172618|NCT01928394|585684721|FG012|Treatment Period|Participant request to stop therapy|1|||
162172619|NCT01928394|585684722|FG013|Treatment Period|Participant request to stop therapy|2|||
162172620|NCT01928394|585684723|FG014|Treatment Period|Participant request to stop therapy|4|||
161816994|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
161816995|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
162172621|NCT01928394|585684724|FG015|Treatment Period|Participant request to stop therapy|0|||
162172622|NCT01928394|585684725|FG016|Treatment Period|Participant request to stop therapy|1|||
162172623|NCT01928394|585684726|FG017|Treatment Period|Participant request to stop therapy|3|||
162172624|NCT01928394|585684727|FG018|Treatment Period|Participant request to stop therapy|1|||
162172625|NCT01928394|585684728|FG019|Treatment Period|Participant request to stop therapy|1|||
162172626|NCT01928394|585684729|FG020|Treatment Period|Participant request to stop therapy|3|||
162172627|NCT01928394|585684730|FG021|Treatment Period|Participant request to stop therapy|1|||
162172628|NCT01928394|585684731|FG022|Treatment Period|Participant request to stop therapy|3|||
162172629|NCT01928394|585684709|FG000|Treatment Period|Participant withdrew consent|0|||
162172630|NCT01928394|585684710|FG001|Treatment Period|Participant withdrew consent|0|||
162172631|NCT01928394|585684711|FG002|Treatment Period|Participant withdrew consent|1|||
162172632|NCT01928394|585684712|FG003|Treatment Period|Participant withdrew consent|1|||
162172633|NCT01928394|585684713|FG004|Treatment Period|Participant withdrew consent|0|||
162172634|NCT01928394|585684714|FG005|Treatment Period|Participant withdrew consent|1|||
162172635|NCT01928394|585684715|FG006|Treatment Period|Participant withdrew consent|0|||
162172636|NCT01928394|585684716|FG007|Treatment Period|Participant withdrew consent|1|||
162172637|NCT01928394|585684717|FG008|Treatment Period|Participant withdrew consent|0|||
162172638|NCT01928394|585684718|FG009|Treatment Period|Participant withdrew consent|0|||
162172639|NCT01928394|585684719|FG010|Treatment Period|Participant withdrew consent|1|||
162172640|NCT01928394|585684720|FG011|Treatment Period|Participant withdrew consent|1|||
162172641|NCT01928394|585684721|FG012|Treatment Period|Participant withdrew consent|1|||
162172642|NCT01928394|585684722|FG013|Treatment Period|Participant withdrew consent|0|||
162172643|NCT01928394|585684723|FG014|Treatment Period|Participant withdrew consent|2|||
162172644|NCT01928394|585684724|FG015|Treatment Period|Participant withdrew consent|0|||
162172645|NCT01928394|585684725|FG016|Treatment Period|Participant withdrew consent|2|||
162172646|NCT01928394|585684726|FG017|Treatment Period|Participant withdrew consent|1|||
162172647|NCT01928394|585684727|FG018|Treatment Period|Participant withdrew consent|1|||
162172648|NCT01928394|585684728|FG019|Treatment Period|Participant withdrew consent|1|||
162172649|NCT01928394|585684729|FG020|Treatment Period|Participant withdrew consent|0|||
162172650|NCT01928394|585684730|FG021|Treatment Period|Participant withdrew consent|2|||
162172651|NCT01928394|585684731|FG022|Treatment Period|Participant withdrew consent|0|||
162172652|NCT01928394|585684709|FG000|Treatment Period|Poor/non-compliance|0|||
162172653|NCT01928394|585684710|FG001|Treatment Period|Poor/non-compliance|0|||
162172654|NCT01928394|585684711|FG002|Treatment Period|Poor/non-compliance|0|||
162172655|NCT01928394|585684712|FG003|Treatment Period|Poor/non-compliance|1|||
162172656|NCT01928394|585684713|FG004|Treatment Period|Poor/non-compliance|0|||
162172657|NCT01928394|585684714|FG005|Treatment Period|Poor/non-compliance|0|||
162172658|NCT01928394|585684715|FG006|Treatment Period|Poor/non-compliance|0|||
162172659|NCT01928394|585684716|FG007|Treatment Period|Poor/non-compliance|0|||
162172660|NCT01928394|585684717|FG008|Treatment Period|Poor/non-compliance|0|||
162172661|NCT01928394|585684718|FG009|Treatment Period|Poor/non-compliance|0|||
162172662|NCT01928394|585684719|FG010|Treatment Period|Poor/non-compliance|0|||
162172663|NCT01928394|585684720|FG011|Treatment Period|Poor/non-compliance|0|||
162172664|NCT01928394|585684721|FG012|Treatment Period|Poor/non-compliance|1|||
162172665|NCT01928394|585684722|FG013|Treatment Period|Poor/non-compliance|0|||
162172666|NCT01928394|585684723|FG014|Treatment Period|Poor/non-compliance|1|||
162172667|NCT01928394|585684724|FG015|Treatment Period|Poor/non-compliance|0|||
162172668|NCT01928394|585684725|FG016|Treatment Period|Poor/non-compliance|0|||
162172669|NCT01928394|585684726|FG017|Treatment Period|Poor/non-compliance|1|||
162172670|NCT01928394|585684727|FG018|Treatment Period|Poor/non-compliance|0|||
162172671|NCT01928394|585684728|FG019|Treatment Period|Poor/non-compliance|1|||
162172672|NCT01928394|585684729|FG020|Treatment Period|Poor/non-compliance|0|||
162172673|NCT01928394|585684730|FG021|Treatment Period|Poor/non-compliance|0|||
162172674|NCT01928394|585684731|FG022|Treatment Period|Poor/non-compliance|0|||
162172675|NCT01928394|585684709|FG000|Treatment Period|other reason|0|||
162172676|NCT01928394|585684710|FG001|Treatment Period|other reason|0|||
162172677|NCT01928394|585684711|FG002|Treatment Period|other reason|0|||
162172678|NCT01928394|585684712|FG003|Treatment Period|other reason|0|||
161670245|NCT01749540|583845415|FG000|Overall Study|Withdrawal by Subject|0|||
161670246|NCT01749540|583845416|FG001|Overall Study|Withdrawal by Subject|0|||
161670247|NCT01749540|583845417|FG002|Overall Study|Withdrawal by Subject|0|||
161670248|NCT01749540|583845418|FG003|Overall Study|Withdrawal by Subject|1|||
161670249|NCT01749540|583845419|FG004|Overall Study|Withdrawal by Subject|0|||
161670250|NCT01749540|583845420|FG005|Overall Study|Withdrawal by Subject|0|||
161670251|NCT01749540|583845421|FG006|Overall Study|Withdrawal by Subject|0|||
161670252|NCT01749540|583845415|FG000|Overall Study|Initiated into extension study A536-06|0|||
161670253|NCT01749540|583845416|FG001|Overall Study|Initiated into extension study A536-06|0|||
161670254|NCT01749540|583845417|FG002|Overall Study|Initiated into extension study A536-06|0|||
161670255|NCT01749540|583845418|FG003|Overall Study|Initiated into extension study A536-06|0|||
161670256|NCT01749540|583845419|FG004|Overall Study|Initiated into extension study A536-06|0|||
161670257|NCT01749540|583845420|FG005|Overall Study|Initiated into extension study A536-06|2|||
161670258|NCT01749540|583845421|FG006|Overall Study|Initiated into extension study A536-06|24|||
161670259|NCT00752622|583845433|FG000|Induction Phase|Adverse Event|3|||
161670260|NCT00752622|583845433|FG000|Induction Phase|Other|3|||
161670261|NCT00752622|583845433|FG000|Induction Phase|Non-responder|14|||
162172679|NCT01928394|585684713|FG004|Treatment Period|other reason|0|||
161670262|NCT00752622|583845433|FG000|Induction Phase|Withdrawal by Subject|1|||
161670263|NCT00752622|583845433|FG000|Induction Phase|Premature study termination|14|||
161670264|NCT00752622|583845433|FG000|Observational Phase|Premature Study Termination|36|||
161670265|NCT00752622|583845433|FG000|Observational Phase|Non-responder|2|||
161670266|NCT00752622|583845433|FG000|Observational Phase|Withdrawal by Subject|2|||
161670267|NCT00752622|583845433|FG000|Observational Phase|Adverse Event|1|||
162172680|NCT01928394|585684714|FG005|Treatment Period|other reason|0|||
162172681|NCT01928394|585684715|FG006|Treatment Period|other reason|0|||
162172682|NCT01928394|585684716|FG007|Treatment Period|other reason|0|||
162172683|NCT01928394|585684717|FG008|Treatment Period|other reason|0|||
162172684|NCT01928394|585684718|FG009|Treatment Period|other reason|0|||
162172685|NCT01928394|585684719|FG010|Treatment Period|other reason|1|||
162172686|NCT01928394|585684720|FG011|Treatment Period|other reason|1|||
162172687|NCT01928394|585684721|FG012|Treatment Period|other reason|1|||
162172688|NCT01928394|585684722|FG013|Treatment Period|other reason|0|||
162172689|NCT01928394|585684723|FG014|Treatment Period|other reason|1|||
162172690|NCT01928394|585684724|FG015|Treatment Period|other reason|0|||
162172691|NCT01928394|585684725|FG016|Treatment Period|other reason|0|||
162172692|NCT01928394|585684726|FG017|Treatment Period|other reason|0|||
162172693|NCT01928394|585684727|FG018|Treatment Period|other reason|2|||
162172694|NCT01928394|585684728|FG019|Treatment Period|other reason|2|||
162172695|NCT01928394|585684729|FG020|Treatment Period|other reason|0|||
162172696|NCT01928394|585684730|FG021|Treatment Period|other reason|0|||
162172697|NCT01928394|585684731|FG022|Treatment Period|other reason|0|||
162172698|NCT01928394|585684709|FG000|Treatment Period|Maximum clinical benefit|0|||
162172699|NCT01928394|585684710|FG001|Treatment Period|Maximum clinical benefit|0|||
162172700|NCT01928394|585684711|FG002|Treatment Period|Maximum clinical benefit|0|||
162172701|NCT01928394|585684712|FG003|Treatment Period|Maximum clinical benefit|0|||
162172702|NCT01928394|585684713|FG004|Treatment Period|Maximum clinical benefit|0|||
162172703|NCT01928394|585684714|FG005|Treatment Period|Maximum clinical benefit|0|||
162172704|NCT01928394|585684715|FG006|Treatment Period|Maximum clinical benefit|0|||
162172705|NCT01928394|585684716|FG007|Treatment Period|Maximum clinical benefit|0|||
162172706|NCT01928394|585684717|FG008|Treatment Period|Maximum clinical benefit|0|||
162172707|NCT01928394|585684718|FG009|Treatment Period|Maximum clinical benefit|0|||
162172708|NCT01928394|585684719|FG010|Treatment Period|Maximum clinical benefit|1|||
162172709|NCT01928394|585684720|FG011|Treatment Period|Maximum clinical benefit|1|||
162172710|NCT01928394|585684721|FG012|Treatment Period|Maximum clinical benefit|0|||
162172711|NCT01928394|585684722|FG013|Treatment Period|Maximum clinical benefit|0|||
162172712|NCT01928394|585684723|FG014|Treatment Period|Maximum clinical benefit|1|||
162172713|NCT01928394|585684724|FG015|Treatment Period|Maximum clinical benefit|0|||
162172714|NCT01928394|585684725|FG016|Treatment Period|Maximum clinical benefit|0|||
162172715|NCT01928394|585684726|FG017|Treatment Period|Maximum clinical benefit|1|||
162172716|NCT01928394|585684727|FG018|Treatment Period|Maximum clinical benefit|1|||
162172717|NCT01928394|585684728|FG019|Treatment Period|Maximum clinical benefit|0|||
162172718|NCT01928394|585684729|FG020|Treatment Period|Maximum clinical benefit|2|||
162172719|NCT01928394|585684730|FG021|Treatment Period|Maximum clinical benefit|0|||
162172720|NCT01928394|585684731|FG022|Treatment Period|Maximum clinical benefit|0|||
162172721|NCT01928394|585684709|FG000|Treatment Period|Lost to Follow-up|0|||
162172722|NCT01928394|585684710|FG001|Treatment Period|Lost to Follow-up|0|||
162172723|NCT01928394|585684711|FG002|Treatment Period|Lost to Follow-up|0|||
162172724|NCT01928394|585684712|FG003|Treatment Period|Lost to Follow-up|0|||
162172725|NCT01928394|585684713|FG004|Treatment Period|Lost to Follow-up|0|||
162172726|NCT01928394|585684714|FG005|Treatment Period|Lost to Follow-up|0|||
162172727|NCT01928394|585684715|FG006|Treatment Period|Lost to Follow-up|0|||
162172728|NCT01928394|585684716|FG007|Treatment Period|Lost to Follow-up|0|||
162172729|NCT01928394|585684717|FG008|Treatment Period|Lost to Follow-up|0|||
162172730|NCT01928394|585684718|FG009|Treatment Period|Lost to Follow-up|0|||
162172731|NCT01928394|585684719|FG010|Treatment Period|Lost to Follow-up|0|||
161670268|NCT00752622|583845433|FG000|Observational Phase|Other|2|||
161670269|NCT00752622|583845433|FG000|Interventional Phase|Non-responder|2|||
161670270|NCT00752622|583845433|FG000|Interventional Phase|Physician Decision|1|||
161670271|NCT00752622|583845433|FG000|Interventional Phase|Premature Study Termination|5|||
161670272|NCT00576836|583845434|FG000|Overall Study|Death|0|||
161670273|NCT00576836|583845435|FG001|Overall Study|Death|1|||
161670274|NCT00576836|583845434|FG000|Overall Study|Physician Decision|0|||
161670275|NCT00576836|583845435|FG001|Overall Study|Physician Decision|1|||
161670276|NCT00392327|583845438|FG000|Overall Study|Death|1|||
161670277|NCT00392327|583845439|FG001|Overall Study|Death|0|||
161670278|NCT00392327|583845440|FG002|Overall Study|Death|1|||
161670279|NCT00392327|583845441|FG003|Overall Study|Death|0|||
161670280|NCT00392327|583845442|FG004|Overall Study|Death|0|||
161670281|NCT00392327|583845443|FG005|Overall Study|Death|0|||
161670282|NCT00392327|583845444|FG006|Overall Study|Death|0|||
161670283|NCT00392327|583845445|FG007|Overall Study|Death|0|||
161670284|NCT00392327|583845438|FG000|Overall Study|Lack of Efficacy|8|||
161670285|NCT00392327|583845439|FG001|Overall Study|Lack of Efficacy|8|||
161670286|NCT00392327|583845440|FG002|Overall Study|Lack of Efficacy|9|||
161670287|NCT00392327|583845441|FG003|Overall Study|Lack of Efficacy|6|||
161670288|NCT00392327|583845442|FG004|Overall Study|Lack of Efficacy|3|||
161670289|NCT00392327|583845443|FG005|Overall Study|Lack of Efficacy|3|||
161670290|NCT00392327|583845444|FG006|Overall Study|Lack of Efficacy|3|||
161670291|NCT00392327|583845445|FG007|Overall Study|Lack of Efficacy|3|||
161670292|NCT00392327|583845438|FG000|Overall Study|Physician Decision|3|||
161670293|NCT00392327|583845439|FG001|Overall Study|Physician Decision|5|||
161670294|NCT00392327|583845440|FG002|Overall Study|Physician Decision|2|||
161670295|NCT00392327|583845441|FG003|Overall Study|Physician Decision|2|||
161670296|NCT00392327|583845442|FG004|Overall Study|Physician Decision|0|||
161670297|NCT00392327|583845443|FG005|Overall Study|Physician Decision|1|||
161670298|NCT00392327|583845444|FG006|Overall Study|Physician Decision|5|||
161670299|NCT00392327|583845445|FG007|Overall Study|Physician Decision|3|||
161670300|NCT00392327|583845438|FG000|Overall Study|Protocol Violation|0|||
161670301|NCT00392327|583845439|FG001|Overall Study|Protocol Violation|0|||
161670302|NCT00392327|583845440|FG002|Overall Study|Protocol Violation|1|||
161670303|NCT00392327|583845441|FG003|Overall Study|Protocol Violation|0|||
161670304|NCT00392327|583845442|FG004|Overall Study|Protocol Violation|0|||
161670305|NCT00392327|583845443|FG005|Overall Study|Protocol Violation|0|||
161670306|NCT00392327|583845444|FG006|Overall Study|Protocol Violation|0|||
161670307|NCT00392327|583845445|FG007|Overall Study|Protocol Violation|0|||
161670308|NCT00392327|583845438|FG000|Overall Study|Withdrawal by Subject|3|||
161670309|NCT00392327|583845439|FG001|Overall Study|Withdrawal by Subject|2|||
161670310|NCT00392327|583845440|FG002|Overall Study|Withdrawal by Subject|4|||
161670311|NCT00392327|583845441|FG003|Overall Study|Withdrawal by Subject|6|||
161670312|NCT00392327|583845442|FG004|Overall Study|Withdrawal by Subject|0|||
161670313|NCT00392327|583845443|FG005|Overall Study|Withdrawal by Subject|1|||
161670314|NCT00392327|583845444|FG006|Overall Study|Withdrawal by Subject|1|||
161670315|NCT00392327|583845445|FG007|Overall Study|Withdrawal by Subject|5|||
161670316|NCT00392327|583845438|FG000|Overall Study|Ineligible|0|||
161670317|NCT00392327|583845439|FG001|Overall Study|Ineligible|4|||
161670318|NCT00392327|583845440|FG002|Overall Study|Ineligible|3|||
161670319|NCT00392327|583845441|FG003|Overall Study|Ineligible|2|||
161670320|NCT00392327|583845442|FG004|Overall Study|Ineligible|0|||
161670321|NCT00392327|583845443|FG005|Overall Study|Ineligible|0|||
161670322|NCT00392327|583845444|FG006|Overall Study|Ineligible|0|||
161670323|NCT00392327|583845445|FG007|Overall Study|Ineligible|0|||
161670324|NCT00894686|583845446|FG000|Overall Study|Withdrawal by Subject|50|||
161670325|NCT00894686|583845446|FG000|Overall Study|Physician Decision|1|||
161670326|NCT00894686|583845446|FG000|Overall Study|Other|5|||
161670327|NCT03267940|583845447|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
161670328|NCT03267940|583845448|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
161816996|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
161670329|NCT03267940|583845449|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
161670330|NCT03267940|583845450|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
161670331|NCT03267940|583845451|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
161670332|NCT03267940|583845452|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
161670333|NCT03267940|583845447|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161670334|NCT03267940|583845448|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
161670335|NCT03267940|583845449|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161670336|NCT03267940|583845450|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161670337|NCT03267940|583845451|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161670338|NCT03267940|583845452|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161670339|NCT03267940|583845447|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161670340|NCT03267940|583845448|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
161670341|NCT03267940|583845449|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161922709|NCT00835978|584764843|FG003|Overall Study|Death|4|||
161670342|NCT03267940|583845450|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161670343|NCT03267940|583845451|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161670344|NCT03267940|583845452|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161670345|NCT03267940|583845447|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
161670346|NCT03267940|583845448|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
161670347|NCT03267940|583845449|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
161670348|NCT03267940|583845450|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
161670349|NCT03267940|583845451|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
161670350|NCT03267940|583845452|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
161670351|NCT03267940|583845447|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
161670352|NCT03267940|583845448|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
161670353|NCT03267940|583845449|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
161670354|NCT03267940|583845450|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
161670355|NCT03267940|583845451|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
161670356|NCT03267940|583845452|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
161670357|NCT03267940|583845447|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
161670358|NCT03267940|583845448|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
161670359|NCT03267940|583845449|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
161670360|NCT03267940|583845450|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
161670361|NCT03267940|583845451|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
161670362|NCT03267940|583845452|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
161670363|NCT03267940|583845447|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
161670364|NCT03267940|583845448|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
161670365|NCT03267940|583845449|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
161670366|NCT03267940|583845450|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
161670367|NCT03267940|583845451|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
161670368|NCT03267940|583845452|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
161670369|NCT03267940|583845447|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
161670370|NCT03267940|583845448|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
161670371|NCT03267940|583845449|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
161670372|NCT03267940|583845450|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
161670373|NCT03267940|583845451|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
161670374|NCT03267940|583845452|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
161670375|NCT03267940|583845447|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
161670376|NCT03267940|583845448|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
161670377|NCT03267940|583845449|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
161670378|NCT03267940|583845450|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
162172732|NCT01928394|585684720|FG011|Treatment Period|Lost to Follow-up|0|||
162172733|NCT01928394|585684721|FG012|Treatment Period|Lost to Follow-up|0|||
162172734|NCT01928394|585684722|FG013|Treatment Period|Lost to Follow-up|0|||
162172735|NCT01928394|585684723|FG014|Treatment Period|Lost to Follow-up|0|||
162172736|NCT01928394|585684724|FG015|Treatment Period|Lost to Follow-up|0|||
162172737|NCT01928394|585684725|FG016|Treatment Period|Lost to Follow-up|0|||
162172738|NCT01928394|585684726|FG017|Treatment Period|Lost to Follow-up|0|||
162172739|NCT01928394|585684727|FG018|Treatment Period|Lost to Follow-up|0|||
162172740|NCT01928394|585684728|FG019|Treatment Period|Lost to Follow-up|0|||
162172741|NCT01928394|585684729|FG020|Treatment Period|Lost to Follow-up|0|||
162172742|NCT01928394|585684730|FG021|Treatment Period|Lost to Follow-up|0|||
162172743|NCT01928394|585684731|FG022|Treatment Period|Lost to Follow-up|1|||
162172744|NCT01928394|585684709|FG000|Treatment Period|Death|0|||
162172745|NCT01928394|585684710|FG001|Treatment Period|Death|0|||
162172746|NCT01928394|585684711|FG002|Treatment Period|Death|0|||
162172747|NCT01928394|585684712|FG003|Treatment Period|Death|0|||
162172748|NCT01928394|585684713|FG004|Treatment Period|Death|0|||
162172749|NCT01928394|585684714|FG005|Treatment Period|Death|0|||
162172750|NCT01928394|585684715|FG006|Treatment Period|Death|0|||
162172751|NCT01928394|585684716|FG007|Treatment Period|Death|0|||
162172752|NCT01928394|585684717|FG008|Treatment Period|Death|0|||
162172753|NCT01928394|585684718|FG009|Treatment Period|Death|0|||
162172754|NCT01928394|585684719|FG010|Treatment Period|Death|0|||
162172755|NCT01928394|585684720|FG011|Treatment Period|Death|0|||
162172756|NCT01928394|585684721|FG012|Treatment Period|Death|0|||
162172757|NCT01928394|585684722|FG013|Treatment Period|Death|1|||
162172758|NCT01928394|585684723|FG014|Treatment Period|Death|2|||
162172759|NCT01928394|585684724|FG015|Treatment Period|Death|0|||
162172760|NCT01928394|585684725|FG016|Treatment Period|Death|0|||
162172761|NCT01928394|585684726|FG017|Treatment Period|Death|0|||
162172762|NCT01928394|585684727|FG018|Treatment Period|Death|0|||
162172763|NCT01928394|585684728|FG019|Treatment Period|Death|0|||
162172764|NCT01928394|585684729|FG020|Treatment Period|Death|0|||
162172765|NCT01928394|585684730|FG021|Treatment Period|Death|0|||
161670379|NCT03267940|583845451|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
161670380|NCT03267940|583845452|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
161670381|NCT00178126|583845459|FG000|Overall Study|Lost to Follow-up|21|||
161670382|NCT00178126|583845460|FG001|Overall Study|Lost to Follow-up|21|||
161670383|NCT00178126|583845459|FG000|Overall Study|did not receive intervention|4|||
161670384|NCT00178126|583845460|FG001|Overall Study|did not receive intervention|6|||
161670385|NCT01074216|583845461|FG000|Overall Study|Physician Decision|1|||
161670386|NCT01074216|583845461|FG000|Overall Study|Not Treated|12|||
161670387|NCT01323634|583845462|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
161670388|NCT01323634|583845463|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
161670389|NCT01323634|583845464|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
161670390|NCT01323634|583845462|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
161670391|NCT01323634|583845463|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
161670392|NCT01323634|583845464|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
161670393|NCT01323634|583845462|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
161670394|NCT01323634|583845463|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161670395|NCT01323634|583845464|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161670396|NCT01323634|583845462|FG000|2-week Run-in Period|Physician Decision|5|||
161670397|NCT01323634|583845463|FG001|2-week Run-in Period|Physician Decision|0|||
161670398|NCT01323634|583845464|FG002|2-week Run-in Period|Physician Decision|0|||
161670399|NCT01323634|583845462|FG000|2-week Run-in Period|Protocol Violation|1|||
161670400|NCT01323634|583845463|FG001|2-week Run-in Period|Protocol Violation|0|||
161670401|NCT01323634|583845464|FG002|2-week Run-in Period|Protocol Violation|0|||
161670402|NCT01323634|583845462|FG000|2-week Run-in Period|Adverse Event|1|||
161670403|NCT01323634|583845463|FG001|2-week Run-in Period|Adverse Event|0|||
161670404|NCT01323634|583845464|FG002|2-week Run-in Period|Adverse Event|0|||
161670405|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161670406|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
161670407|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
161670408|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161670409|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161670410|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
161670411|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161670412|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
161670413|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
161670414|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161670415|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161670416|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161670417|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
161670418|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
161670419|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
161670420|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161670421|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
161670422|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
161670423|NCT01323634|583845462|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
161670424|NCT01323634|583845463|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
161670425|NCT01323634|583845464|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
161670426|NCT05056987|583845465|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
161670427|NCT05056987|583845466|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
161670428|NCT05056987|583845465|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
161670429|NCT05056987|583845466|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
161670430|NCT01182194|583845467|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
161670431|NCT01182194|583845468|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
161670432|NCT01948908|583845469|FG000|Overall Study|Protocol Violation|1|||
161670433|NCT01948908|583845470|FG001|Overall Study|Protocol Violation|0|||
161670434|NCT01948908|583845471|FG002|Overall Study|Protocol Violation|2|||
161670435|NCT01585987|583845472|FG000|Randomized|Withdrawal by Subject|0|||
161670436|NCT01585987|583845473|FG001|Randomized|Withdrawal by Subject|4|||
161670437|NCT01585987|583845472|FG000|Randomized|No longer met criteria|0|||
161670438|NCT01585987|583845473|FG001|Randomized|No longer met criteria|2|||
161670439|NCT01585987|583845472|FG000|Treated|Disease Progression|39|||
161670440|NCT01585987|583845473|FG001|Treated|Disease Progression|36|||
161670441|NCT01585987|583845472|FG000|Treated|Study Drug Toxicity|9|||
161670442|NCT01585987|583845473|FG001|Treated|Study Drug Toxicity|5|||
161816997|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
161816998|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
161816999|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
161670443|NCT01585987|583845472|FG000|Treated|Adverse Event|3|||
161670444|NCT01585987|583845473|FG001|Treated|Adverse Event|0|||
161670445|NCT01585987|583845472|FG000|Treated|Withdrawal by Subject|1|||
161817000|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
162172766|NCT01928394|585684731|FG022|Treatment Period|Death|0|||
162172767|NCT01928394|585684709|FG000|Follow-up Period|Participant withdrew consent|3|||
162172768|NCT01928394|585684710|FG001|Follow-up Period|Participant withdrew consent|0|||
162172769|NCT01928394|585684711|FG002|Follow-up Period|Participant withdrew consent|1|||
162172770|NCT01928394|585684712|FG003|Follow-up Period|Participant withdrew consent|4|||
162172771|NCT01928394|585684713|FG004|Follow-up Period|Participant withdrew consent|0|||
162172772|NCT01928394|585684714|FG005|Follow-up Period|Participant withdrew consent|2|||
162172773|NCT01928394|585684715|FG006|Follow-up Period|Participant withdrew consent|5|||
162172774|NCT01928394|585684716|FG007|Follow-up Period|Participant withdrew consent|1|||
162172775|NCT01928394|585684717|FG008|Follow-up Period|Participant withdrew consent|0|||
162172776|NCT01928394|585684718|FG009|Follow-up Period|Participant withdrew consent|0|||
162172777|NCT01928394|585684719|FG010|Follow-up Period|Participant withdrew consent|5|||
162172778|NCT01928394|585684720|FG011|Follow-up Period|Participant withdrew consent|8|||
162172779|NCT01928394|585684721|FG012|Follow-up Period|Participant withdrew consent|2|||
162172780|NCT01928394|585684722|FG013|Follow-up Period|Participant withdrew consent|12|||
162172781|NCT01928394|585684723|FG014|Follow-up Period|Participant withdrew consent|7|||
162172782|NCT01928394|585684724|FG015|Follow-up Period|Participant withdrew consent|0|||
162172783|NCT01928394|585684725|FG016|Follow-up Period|Participant withdrew consent|5|||
161670446|NCT01585987|583845473|FG001|Treated|Withdrawal by Subject|2|||
162172784|NCT01928394|585684726|FG017|Follow-up Period|Participant withdrew consent|3|||
162172785|NCT01928394|585684727|FG018|Follow-up Period|Participant withdrew consent|2|||
162172786|NCT01928394|585684728|FG019|Follow-up Period|Participant withdrew consent|7|||
162172787|NCT01928394|585684729|FG020|Follow-up Period|Participant withdrew consent|4|||
162172788|NCT01928394|585684730|FG021|Follow-up Period|Participant withdrew consent|6|||
162172789|NCT01928394|585684731|FG022|Follow-up Period|Participant withdrew consent|2|||
162172790|NCT01928394|585684709|FG000|Follow-up Period|Death|0|||
162172791|NCT01928394|585684710|FG001|Follow-up Period|Death|0|||
162172792|NCT01928394|585684711|FG002|Follow-up Period|Death|2|||
162172793|NCT01928394|585684712|FG003|Follow-up Period|Death|6|||
162172794|NCT01928394|585684713|FG004|Follow-up Period|Death|0|||
162172795|NCT01928394|585684714|FG005|Follow-up Period|Death|6|||
162172796|NCT01928394|585684715|FG006|Follow-up Period|Death|6|||
162172797|NCT01928394|585684716|FG007|Follow-up Period|Death|2|||
162172798|NCT01928394|585684717|FG008|Follow-up Period|Death|1|||
162172799|NCT01928394|585684718|FG009|Follow-up Period|Death|2|||
162172800|NCT01928394|585684719|FG010|Follow-up Period|Death|4|||
162172801|NCT01928394|585684720|FG011|Follow-up Period|Death|12|||
162172802|NCT01928394|585684721|FG012|Follow-up Period|Death|11|||
162172803|NCT01928394|585684722|FG013|Follow-up Period|Death|25|||
162172804|NCT01928394|585684723|FG014|Follow-up Period|Death|18|||
162172805|NCT01928394|585684724|FG015|Follow-up Period|Death|0|||
162172806|NCT01928394|585684725|FG016|Follow-up Period|Death|6|||
162172807|NCT01928394|585684726|FG017|Follow-up Period|Death|5|||
162172808|NCT01928394|585684727|FG018|Follow-up Period|Death|13|||
162172809|NCT01928394|585684728|FG019|Follow-up Period|Death|13|||
162172810|NCT01928394|585684729|FG020|Follow-up Period|Death|5|||
162172811|NCT01928394|585684730|FG021|Follow-up Period|Death|3|||
162172812|NCT01928394|585684731|FG022|Follow-up Period|Death|2|||
162172813|NCT01928394|585684709|FG000|Follow-up Period|other reason|0|||
162172814|NCT01928394|585684710|FG001|Follow-up Period|other reason|0|||
162172815|NCT01928394|585684711|FG002|Follow-up Period|other reason|0|||
162172816|NCT01928394|585684712|FG003|Follow-up Period|other reason|0|||
162172817|NCT01928394|585684713|FG004|Follow-up Period|other reason|0|||
162172818|NCT01928394|585684714|FG005|Follow-up Period|other reason|0|||
162172819|NCT01928394|585684715|FG006|Follow-up Period|other reason|1|||
162172820|NCT01928394|585684716|FG007|Follow-up Period|other reason|3|||
162172821|NCT01928394|585684717|FG008|Follow-up Period|other reason|0|||
162172822|NCT01928394|585684718|FG009|Follow-up Period|other reason|0|||
162172823|NCT01928394|585684719|FG010|Follow-up Period|other reason|2|||
162172824|NCT01928394|585684720|FG011|Follow-up Period|other reason|1|||
162172825|NCT01928394|585684721|FG012|Follow-up Period|other reason|0|||
162172826|NCT01928394|585684722|FG013|Follow-up Period|other reason|1|||
162172827|NCT01928394|585684723|FG014|Follow-up Period|other reason|4|||
162172828|NCT01928394|585684724|FG015|Follow-up Period|other reason|0|||
162172829|NCT01928394|585684725|FG016|Follow-up Period|other reason|2|||
162172830|NCT01928394|585684726|FG017|Follow-up Period|other reason|0|||
162172831|NCT01928394|585684727|FG018|Follow-up Period|other reason|1|||
162172832|NCT01928394|585684728|FG019|Follow-up Period|other reason|1|||
162172833|NCT01928394|585684729|FG020|Follow-up Period|other reason|0|||
162172834|NCT01928394|585684730|FG021|Follow-up Period|other reason|0|||
162172835|NCT01928394|585684731|FG022|Follow-up Period|other reason|1|||
162172836|NCT01928394|585684709|FG000|Follow-up Period|Lost to Follow-up|0|||
161670447|NCT01585987|583845472|FG000|Treated|Death|1|||
162172837|NCT01928394|585684710|FG001|Follow-up Period|Lost to Follow-up|0|||
162172838|NCT01928394|585684711|FG002|Follow-up Period|Lost to Follow-up|0|||
162172839|NCT01928394|585684712|FG003|Follow-up Period|Lost to Follow-up|0|||
162172840|NCT01928394|585684713|FG004|Follow-up Period|Lost to Follow-up|0|||
162172841|NCT01928394|585684714|FG005|Follow-up Period|Lost to Follow-up|0|||
162172842|NCT01928394|585684715|FG006|Follow-up Period|Lost to Follow-up|0|||
161670448|NCT01585987|583845473|FG001|Treated|Death|0|||
161670449|NCT01585987|583845472|FG000|Treated|Lost to Follow-up|0|||
161670450|NCT01585987|583845473|FG001|Treated|Lost to Follow-up|1|||
161670451|NCT01585987|583845472|FG000|Treated|Maximum Clinical Benefit|0|||
161670452|NCT01585987|583845473|FG001|Treated|Maximum Clinical Benefit|1|||
161670453|NCT01585987|583845472|FG000|Treated|Non-Specified|1|||
161670454|NCT01585987|583845473|FG001|Treated|Non-Specified|2|||
161670455|NCT01585987|583845472|FG000|Treated|Subject Request|0|||
161670456|NCT01585987|583845473|FG001|Treated|Subject Request|1|||
161670457|NCT01585987|583845472|FG000|Treated|Poor/Non-Compliance|0|||
161670458|NCT01585987|583845473|FG001|Treated|Poor/Non-Compliance|1|||
161670459|NCT03291587|583845474|FG000|Overall Study|Lost to Follow-up|62|||
161670460|NCT03291587|583845475|FG001|Overall Study|Lost to Follow-up|43|||
161670461|NCT03291587|583845474|FG000|Overall Study|Refused to Answer|5|||
161670462|NCT03291587|583845475|FG001|Overall Study|Refused to Answer|2|||
161670463|NCT03291587|583845474|FG000|Overall Study|Death|2|||
161670464|NCT03291587|583845475|FG001|Overall Study|Death|4|||
161670465|NCT03291587|583845474|FG000|Overall Study|Not interested in participating|8|||
161670466|NCT03291587|583845475|FG001|Overall Study|Not interested in participating|6|||
161670467|NCT03291587|583845474|FG000|Overall Study|Too busy to participate|4|||
161670468|NCT03291587|583845475|FG001|Overall Study|Too busy to participate|2|||
161670469|NCT00796120|583845476|FG000|Overall Study|Death|3|||
161670470|NCT00796120|583845477|FG001|Overall Study|Death|0|||
161670471|NCT00796120|583845476|FG000|Overall Study|Adverse Event|11|||
161670472|NCT00796120|583845477|FG001|Overall Study|Adverse Event|6|||
161670473|NCT00796120|583845476|FG000|Overall Study|Progressive disease|22|||
161670474|NCT00796120|583845477|FG001|Overall Study|Progressive disease|13|||
161670475|NCT00796120|583845476|FG000|Overall Study|Participant refusal|3|||
161670476|NCT00796120|583845477|FG001|Overall Study|Participant refusal|4|||
161670477|NCT00796120|583845476|FG000|Overall Study|Other|6|||
161670478|NCT00796120|583845477|FG001|Overall Study|Other|17|||
161670479|NCT00796120|583845476|FG000|Overall Study|Physician Decision|16|||
161670480|NCT00796120|583845477|FG001|Overall Study|Physician Decision|17|||
161670481|NCT00796120|583845476|FG000|Overall Study|Randomized but not treated|0|||
161670482|NCT00796120|583845477|FG001|Overall Study|Randomized but not treated|3|||
161670483|NCT01411839|583845482|FG000|Overall Study|Lost to Follow-up|4|||
161670484|NCT01411839|583845483|FG001|Overall Study|Lost to Follow-up|3|||
161670485|NCT04641299|583847204|FG000|Overall Study|Adverse Event|0|||
161670486|NCT04641299|583847205|FG001|Overall Study|Adverse Event|0|||
162018127|NCT02578706|585121902|FG001|Overall Study|Physician Decision|1|||
162018128|NCT02578706|585121903|FG002|Overall Study|Physician Decision|0|||
162018129|NCT00392769|585121910|FG000|Overall Study|Clinical Deterioration|9|||
162018130|NCT00392769|585121910|FG000|Overall Study|Adverse Event|1|||
162018131|NCT00670306|585121912|FG000|Overall Study|Adverse Event|8|||
162018132|NCT00670306|585121912|FG000|Overall Study|Lack of Efficacy|10|||
162018133|NCT00670306|585121912|FG000|Overall Study|Withdrawal by Subject|9|||
162018134|NCT00670306|585121912|FG000|Overall Study|Physician Decision|1|||
162018135|NCT00670306|585121912|FG000|Overall Study|Lost to Follow-up|8|||
162018136|NCT00670306|585121912|FG000|Overall Study|incl/excl criterias did not meet|19|||
162018137|NCT04939415|585121915|FG000|Overall Study|Withdrawal by Subject|1|||
162018138|NCT04939415|585121916|FG001|Overall Study|Withdrawal by Subject|3|||
162018139|NCT04939415|585121915|FG000|Overall Study|Lost to Follow-up|0|||
162018140|NCT04939415|585121916|FG001|Overall Study|Lost to Follow-up|2|||
162018141|NCT00067002|585121920|FG000|Overall Study|Early Death|1|||
162018142|NCT00067002|585121921|FG001|Overall Study|Early Death|2|||
162018143|NCT00067002|585121920|FG000|Overall Study|Delayed|1|||
162018144|NCT00067002|585121921|FG001|Overall Study|Delayed|1|||
162018145|NCT00067002|585121920|FG000|Overall Study|Graft Failure|5|||
161670487|NCT04641299|583847206|FG002|Overall Study|Adverse Event|2|||
161670488|NCT04641299|583847207|FG003|Overall Study|Adverse Event|0|||
161670489|NCT04641299|583847204|FG000|Overall Study|Lost to Follow-up|0|||
161670490|NCT04641299|583847205|FG001|Overall Study|Lost to Follow-up|1|||
162018146|NCT00067002|585121921|FG001|Overall Study|Graft Failure|6|||
162018147|NCT03350672|585121922|FG000|Overall Study|Withdrawal by Subject|7|||
162018148|NCT03350672|585121923|FG001|Overall Study|Withdrawal by Subject|0|||
162018149|NCT03350672|585121924|FG002|Overall Study|Withdrawal by Subject|0|||
161670491|NCT04641299|583847206|FG002|Overall Study|Lost to Follow-up|0|||
161670492|NCT04641299|583847207|FG003|Overall Study|Lost to Follow-up|0|||
161670493|NCT04641299|583847204|FG000|Overall Study|Withdrawal by Subject|1|||
161670494|NCT04641299|583847205|FG001|Overall Study|Withdrawal by Subject|0|||
161670495|NCT04641299|583847206|FG002|Overall Study|Withdrawal by Subject|0|||
161670496|NCT04641299|583847207|FG003|Overall Study|Withdrawal by Subject|0|||
162018150|NCT01354314|585121925|FG000|Overall Study|Lost to Follow-up|1|||
162018151|NCT01354314|585121926|FG001|Overall Study|Lost to Follow-up|0|||
162018152|NCT01354314|585121927|FG002|Overall Study|Lost to Follow-up|1|||
162018153|NCT01354314|585121928|FG003|Overall Study|Lost to Follow-up|1|||
162018154|NCT01354314|585121925|FG000|Overall Study|Withdrawal by Subject|0|||
161670497|NCT04641299|583847204|FG000|Overall Study|Reason not given|1|||
162018155|NCT01354314|585121926|FG001|Overall Study|Withdrawal by Subject|0|||
162018156|NCT01354314|585121927|FG002|Overall Study|Withdrawal by Subject|1|||
161670498|NCT04641299|583847205|FG001|Overall Study|Reason not given|0|||
161831518|NCT03135899|584424793|FG001|Overall Study|Withdrawal by Subject|0|||
161670499|NCT04641299|583847206|FG002|Overall Study|Reason not given|0|||
161831519|NCT03135899|584424794|FG002|Overall Study|Withdrawal by Subject|0|||
161831520|NCT03135899|584424795|FG003|Overall Study|Withdrawal by Subject|0|||
161670500|NCT04641299|583847207|FG003|Overall Study|Reason not given|0|||
161670501|NCT01890148|583847211|FG000|Overall Study|Adverse Event|1|||
161670502|NCT05736211|583847216|FG000|Overall Study|Lost to Follow-up|6|||
161670503|NCT05736211|583847217|FG001|Overall Study|Lost to Follow-up|0|||
161670504|NCT00323297|583847233|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
161670505|NCT00323297|583847234|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
161670506|NCT00323297|583847233|FG000|Part A (Double Blind Randomized)|Death|0|||
161670507|NCT00323297|583847234|FG001|Part A (Double Blind Randomized)|Death|1|||
161670508|NCT00323297|583847233|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
161670509|NCT00323297|583847234|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
161670510|NCT00323297|583847233|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
161670511|NCT00323297|583847234|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
161670512|NCT00323297|583847233|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
161670513|NCT00323297|583847234|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
161670514|NCT00323297|583847233|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
161670515|NCT00323297|583847234|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
161670516|NCT00323297|583847233|FG000|Part B (Open-label)|Death|0|||
161670517|NCT00323297|583847234|FG001|Part B (Open-label)|Death|1|||
161670518|NCT00323297|583847233|FG000|Part B (Open-label)|Reason unspecified|0|||
161670519|NCT00323297|583847234|FG001|Part B (Open-label)|Reason unspecified|1|||
161670520|NCT00323297|583847233|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
161670521|NCT00323297|583847234|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
161670522|NCT00323297|583847233|FG000|Part B (Open-label)|Lack of Efficacy|3|||
161670523|NCT00323297|583847234|FG001|Part B (Open-label)|Lack of Efficacy|1|||
161670524|NCT00323297|583847233|FG000|Part B (Open-label)|Adverse Event|5|||
161670525|NCT00323297|583847234|FG001|Part B (Open-label)|Adverse Event|5|||
161670526|NCT00323297|583847233|FG000|Part B (Open-label)|Protocol Violation|0|||
161670527|NCT00323297|583847234|FG001|Part B (Open-label)|Protocol Violation|1|||
161670528|NCT01176773|583847235|FG000|Overall Study|Screen Failure|2|||
161670529|NCT01176773|583847235|FG000|Overall Study|Withdrew consent|1|||
161670530|NCT01498289|583847240|FG000|Overall Study|Adverse Event|16|||
162172843|NCT01928394|585684716|FG007|Follow-up Period|Lost to Follow-up|0|||
162172844|NCT01928394|585684717|FG008|Follow-up Period|Lost to Follow-up|0|||
162172845|NCT01928394|585684718|FG009|Follow-up Period|Lost to Follow-up|0|||
162172846|NCT01928394|585684719|FG010|Follow-up Period|Lost to Follow-up|0|||
162172847|NCT01928394|585684720|FG011|Follow-up Period|Lost to Follow-up|1|||
162172848|NCT01928394|585684721|FG012|Follow-up Period|Lost to Follow-up|1|||
162172849|NCT01928394|585684722|FG013|Follow-up Period|Lost to Follow-up|0|||
162172850|NCT01928394|585684723|FG014|Follow-up Period|Lost to Follow-up|1|||
162172851|NCT01928394|585684724|FG015|Follow-up Period|Lost to Follow-up|0|||
162172852|NCT01928394|585684725|FG016|Follow-up Period|Lost to Follow-up|1|||
162172853|NCT01928394|585684726|FG017|Follow-up Period|Lost to Follow-up|0|||
162172854|NCT01928394|585684727|FG018|Follow-up Period|Lost to Follow-up|0|||
162172855|NCT01928394|585684728|FG019|Follow-up Period|Lost to Follow-up|0|||
162172856|NCT01928394|585684729|FG020|Follow-up Period|Lost to Follow-up|0|||
162172857|NCT01928394|585684730|FG021|Follow-up Period|Lost to Follow-up|0|||
162172858|NCT01928394|585684731|FG022|Follow-up Period|Lost to Follow-up|1|||
162172859|NCT00321048|585684732|FG000|Overall Study|Withdrawal by Subject|6|||
162172860|NCT00321048|585684733|FG001|Overall Study|Withdrawal by Subject|8|||
162172861|NCT03209973|585684737|FG000|Overall Study|Withdrawal by Subject|7|||
162172862|NCT03209973|585684737|FG000|Overall Study|Lost to Follow-up|2|||
162172863|NCT03209973|585684737|FG000|Overall Study|Death|8|||
162172864|NCT03209973|585684737|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
162172865|NCT03209973|585684737|FG000|Overall Study|Sponsor Decision|18|||
162172866|NCT03209973|585684737|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
162172867|NCT03209973|585684737|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
162172868|NCT05123586|585684742|FG000|Overall Study|Physician Decision|1|||
162172869|NCT05123586|585684743|FG001|Overall Study|Physician Decision|1|||
162172870|NCT05123586|585684742|FG000|Overall Study|Withdrawal by Subject|0|||
162172871|NCT05123586|585684743|FG001|Overall Study|Withdrawal by Subject|3|||
162172872|NCT04690582|585684749|FG000|Overall Study|Withdrawal by Subject|6|||
162172873|NCT04690582|585684750|FG001|Overall Study|Withdrawal by Subject|4|||
162172874|NCT04797195|585684751|FG000|Overall Study|Death|8|||
162172875|NCT04797195|585684752|FG001|Overall Study|Death|15|||
161670531|NCT01498289|583847241|FG001|Overall Study|Adverse Event|18|||
161670532|NCT01498289|583847240|FG000|Overall Study|Death|6|||
161670533|NCT01498289|583847241|FG001|Overall Study|Death|8|||
161670534|NCT01498289|583847240|FG000|Overall Study|Withdrawal unrelated to AE|16|||
161670535|NCT01498289|583847241|FG001|Overall Study|Withdrawal unrelated to AE|16|||
161922710|NCT00835978|584764840|FG000|Overall Study|Lost to Follow-up|3|||
161922711|NCT00835978|584764841|FG001|Overall Study|Lost to Follow-up|4|||
162172876|NCT04797195|585684751|FG000|Overall Study|Change from PD|15|||
162172877|NCT04797195|585684752|FG001|Overall Study|Change from PD|15|||
162172878|NCT04797195|585684751|FG000|Overall Study|Withdrawal by Subject|3|||
161670536|NCT01498289|583847240|FG000|Overall Study|Progression/relapse|53|||
162172879|NCT04797195|585684752|FG001|Overall Study|Withdrawal by Subject|2|||
162172880|NCT01236781|585684753|FG000|Overall Study|Ineligible|2|||
162172881|NCT01236781|585684754|FG001|Overall Study|Ineligible|1|||
162172882|NCT01236781|585684753|FG000|Overall Study|Did not complete study imaging|5|||
162172883|NCT01236781|585684754|FG001|Overall Study|Did not complete study imaging|0|||
162172884|NCT04862416|585684757|FG000|Overall Study|Withdrawal by Subject|0|||
162172885|NCT04862416|585684758|FG001|Overall Study|Withdrawal by Subject|1|||
162172886|NCT04862416|585684759|FG002|Overall Study|Withdrawal by Subject|0|||
162172887|NCT04862416|585684760|FG003|Overall Study|Withdrawal by Subject|1|||
162172888|NCT04862416|585684761|FG004|Overall Study|Withdrawal by Subject|0|||
162172889|NCT04862416|585684762|FG005|Overall Study|Withdrawal by Subject|0|||
162172890|NCT04862416|585684763|FG006|Overall Study|Withdrawal by Subject|0|||
162172891|NCT04862416|585684764|FG007|Overall Study|Withdrawal by Subject|0|||
162172892|NCT04059185|585684767|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
162172893|NCT04059185|585684768|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
162172894|NCT04059185|585684769|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
162172895|NCT04059185|585684767|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
162172896|NCT04059185|585684768|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
162172897|NCT04059185|585684769|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
162172898|NCT04059185|585684767|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
162172899|NCT04059185|585684768|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
162172900|NCT04059185|585684769|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
162172901|NCT04059185|585684767|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
162172902|NCT04059185|585684768|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
162172903|NCT04059185|585684769|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
162172904|NCT04059185|585684767|FG000|Longitudinal Assessment-Adults Only|Death|4|||
162172905|NCT04059185|585684768|FG001|Longitudinal Assessment-Adults Only|Death|4|||
162172906|NCT04059185|585684769|FG002|Longitudinal Assessment-Adults Only|Death|3|||
162172907|NCT04737330|585684784|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
162172908|NCT04737330|585684785|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
162172909|NCT04737330|585684784|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
162172910|NCT04737330|585684785|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
162172911|NCT04737330|585684784|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
162172912|NCT04737330|585684785|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
162172913|NCT04737330|585684784|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
162172914|NCT04737330|585684785|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
162172915|NCT04737330|585684784|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
162172916|NCT04737330|585684785|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
162172917|NCT04737330|585684784|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
162172918|NCT04737330|585684785|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
162172919|NCT04741776|585684788|FG000|Overall Study|Withdrawal by Subject|7|||
162172920|NCT04741776|585684789|FG001|Overall Study|Withdrawal by Subject|10|||
162172921|NCT04741776|585684790|FG002|Overall Study|Withdrawal by Subject|10|||
162172922|NCT04741776|585684791|FG003|Overall Study|Withdrawal by Subject|17|||
162172923|NCT04741776|585684788|FG000|Overall Study|Death|0|||
162172924|NCT04741776|585684789|FG001|Overall Study|Death|0|||
162172925|NCT04741776|585684790|FG002|Overall Study|Death|1|||
162172926|NCT04741776|585684791|FG003|Overall Study|Death|0|||
162172927|NCT02852655|585684807|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
162172928|NCT02852655|585684808|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
162172929|NCT02852655|585684809|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
162172930|NCT02852655|585684807|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
162172931|NCT02852655|585684808|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
162172932|NCT02852655|585684809|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
162172933|NCT02852655|585684807|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
162172934|NCT02852655|585684808|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
162172935|NCT02852655|585684809|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
162172936|NCT02852655|585684807|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
162172937|NCT02852655|585684808|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
162172938|NCT02852655|585684809|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
162172939|NCT02852655|585684807|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
162172940|NCT02852655|585684808|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
162172941|NCT02852655|585684809|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
162172942|NCT02852655|585684807|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
162172943|NCT02852655|585684808|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
162172944|NCT02852655|585684809|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
162172945|NCT02852655|585684807|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
162172946|NCT02852655|585684808|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
162172947|NCT02852655|585684809|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
162172948|NCT02852655|585684807|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
161670537|NCT01498289|583847241|FG001|Overall Study|Progression/relapse|59|||
161670538|NCT01498289|583847240|FG000|Overall Study|Not protocol specified|7|||
161670539|NCT01498289|583847241|FG001|Overall Study|Not protocol specified|2|||
161670540|NCT01498289|583847240|FG000|Overall Study|Reason under review|0|||
161670541|NCT01498289|583847241|FG001|Overall Study|Reason under review|1|||
161670542|NCT01575028|583847242|FG000|Overall Study|Physician Decision|0|||
161670543|NCT01575028|583847243|FG001|Overall Study|Physician Decision|1|||
161670544|NCT01759407|583847246|FG000|Overall Study|Protocol Violation|0|||
161670545|NCT01759407|583847247|FG001|Overall Study|Protocol Violation|2|||
161670546|NCT02520284|583847248|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
161670547|NCT02520284|583847249|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
161670548|NCT02520284|583847250|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
161670549|NCT02520284|583847248|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
161670550|NCT02520284|583847249|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
161670551|NCT02520284|583847250|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
161670552|NCT02520284|583847248|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
161670553|NCT02520284|583847249|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
161670554|NCT02520284|583847250|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
161670555|NCT02520284|583847248|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
161670556|NCT02520284|583847249|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
161670557|NCT02520284|583847250|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
161670558|NCT02520284|583847248|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
162172949|NCT02852655|585684808|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
162172950|NCT02852655|585684809|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
162172951|NCT02852655|585684807|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
162172952|NCT02852655|585684808|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
162172953|NCT02852655|585684809|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
162172954|NCT03257410|585686362|FG000|Overall Study|Adverse Event|2|||
162172955|NCT03257410|585686363|FG001|Overall Study|Adverse Event|3|||
162172956|NCT03257410|585686362|FG000|Overall Study|Protocol Violation|1|||
162172957|NCT03257410|585686363|FG001|Overall Study|Protocol Violation|2|||
162172958|NCT03257410|585686362|FG000|Overall Study|Lost to Follow-up|1|||
162172959|NCT03257410|585686363|FG001|Overall Study|Lost to Follow-up|0|||
162172960|NCT03257410|585686362|FG000|Overall Study|Withdrawal by Subject|1|||
162172961|NCT03257410|585686363|FG001|Overall Study|Withdrawal by Subject|2|||
162172962|NCT03257410|585686362|FG000|Overall Study|Physician Decision|1|||
162172963|NCT03257410|585686363|FG001|Overall Study|Physician Decision|1|||
162172964|NCT03257410|585686362|FG000|Overall Study|Renal transplantation|2|||
162172965|NCT03257410|585686363|FG001|Overall Study|Renal transplantation|0|||
162172966|NCT03257410|585686362|FG000|Overall Study|Switch to peritoneal dialysis|1|||
162172967|NCT03257410|585686363|FG001|Overall Study|Switch to peritoneal dialysis|0|||
162172968|NCT03257410|585686362|FG000|Overall Study|Death|3|||
162172969|NCT03257410|585686363|FG001|Overall Study|Death|2|||
162172970|NCT03257410|585686362|FG000|Overall Study|Change to another dialysis center|2|||
162172971|NCT03257410|585686363|FG001|Overall Study|Change to another dialysis center|2|||
162172972|NCT03257410|585686362|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
162172973|NCT03257410|585686363|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
162172974|NCT03257410|585686362|FG000|Overall Study|Miscellaneous|2|||
162172975|NCT03257410|585686363|FG001|Overall Study|Miscellaneous|2|||
162172976|NCT03257410|585686362|FG000|Overall Study|Other|0|||
162172977|NCT03257410|585686363|FG001|Overall Study|Other|1|||
162172978|NCT02598388|585686364|FG000|Overall Study|Lost to Follow-up|1|||
162172979|NCT02598388|585686365|FG001|Overall Study|Lost to Follow-up|0|||
162172980|NCT02598388|585686366|FG002|Overall Study|Lost to Follow-up|1|||
162172981|NCT02598388|585686367|FG003|Overall Study|Lost to Follow-up|0|||
162172982|NCT02598388|585686368|FG004|Overall Study|Lost to Follow-up|5|||
162172983|NCT02598388|585686369|FG005|Overall Study|Lost to Follow-up|1|||
162172984|NCT02598388|585686370|FG006|Overall Study|Lost to Follow-up|2|||
162172985|NCT02598388|585686371|FG007|Overall Study|Lost to Follow-up|1|||
162172986|NCT02598388|585686372|FG008|Overall Study|Lost to Follow-up|0|||
162172987|NCT02598388|585686373|FG009|Overall Study|Lost to Follow-up|0|||
162172988|NCT02598388|585686374|FG010|Overall Study|Lost to Follow-up|1|||
162172989|NCT02598388|585686375|FG011|Overall Study|Lost to Follow-up|0|||
161670559|NCT02520284|583847249|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
162172990|NCT02598388|585686364|FG000|Overall Study|Withdrawal by Subject|0|||
161670560|NCT02520284|583847250|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
161670561|NCT02520284|583847248|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
162172991|NCT02598388|585686365|FG001|Overall Study|Withdrawal by Subject|0|||
162172992|NCT02598388|585686366|FG002|Overall Study|Withdrawal by Subject|0|||
162172993|NCT02598388|585686367|FG003|Overall Study|Withdrawal by Subject|0|||
161670562|NCT02520284|583847249|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
162018157|NCT01354314|585121928|FG003|Overall Study|Withdrawal by Subject|0|||
162018158|NCT01354314|585121925|FG000|Overall Study|Adverse Event|0|||
162018159|NCT01354314|585121926|FG001|Overall Study|Adverse Event|0|||
162018160|NCT01354314|585121927|FG002|Overall Study|Adverse Event|0|||
162018161|NCT01354314|585121928|FG003|Overall Study|Adverse Event|1|||
162018162|NCT01354314|585121925|FG000|Overall Study|Protocol Violation|1|||
162018163|NCT01354314|585121926|FG001|Overall Study|Protocol Violation|1|||
162018164|NCT01354314|585121927|FG002|Overall Study|Protocol Violation|0|||
162018165|NCT01354314|585121928|FG003|Overall Study|Protocol Violation|0|||
162018166|NCT01354314|585121925|FG000|Overall Study|Less than 90% Adherence|4|||
162018167|NCT01354314|585121926|FG001|Overall Study|Less than 90% Adherence|2|||
162018168|NCT01354314|585121927|FG002|Overall Study|Less than 90% Adherence|6|||
162018169|NCT01354314|585121928|FG003|Overall Study|Less than 90% Adherence|4|||
162018170|NCT00478023|585121929|FG000|Overall Study|Adverse Event|11|||
162018171|NCT00478023|585121930|FG001|Overall Study|Adverse Event|7|||
162018172|NCT00478023|585121931|FG002|Overall Study|Adverse Event|8|||
162018173|NCT00478023|585121932|FG003|Overall Study|Adverse Event|14|||
162018174|NCT00478023|585121933|FG004|Overall Study|Adverse Event|6|||
162018175|NCT00478023|585121929|FG000|Overall Study|Death|1|||
162018176|NCT00478023|585121930|FG001|Overall Study|Death|0|||
162018177|NCT00478023|585121931|FG002|Overall Study|Death|0|||
162018178|NCT00478023|585121932|FG003|Overall Study|Death|0|||
162018179|NCT00478023|585121933|FG004|Overall Study|Death|0|||
162018180|NCT00478023|585121929|FG000|Overall Study|Lack of Efficacy|11|||
162018181|NCT00478023|585121930|FG001|Overall Study|Lack of Efficacy|10|||
162018182|NCT00478023|585121931|FG002|Overall Study|Lack of Efficacy|4|||
162018183|NCT00478023|585121932|FG003|Overall Study|Lack of Efficacy|5|||
162018184|NCT00478023|585121933|FG004|Overall Study|Lack of Efficacy|41|||
162018185|NCT00478023|585121929|FG000|Overall Study|Lost to Follow-up|3|||
162018186|NCT00478023|585121930|FG001|Overall Study|Lost to Follow-up|1|||
162018187|NCT00478023|585121931|FG002|Overall Study|Lost to Follow-up|1|||
162018188|NCT00478023|585121932|FG003|Overall Study|Lost to Follow-up|1|||
162018189|NCT00478023|585121933|FG004|Overall Study|Lost to Follow-up|0|||
162018190|NCT00478023|585121929|FG000|Overall Study|Withdrawal by Subject|2|||
162018191|NCT00478023|585121930|FG001|Overall Study|Withdrawal by Subject|3|||
162018192|NCT00478023|585121931|FG002|Overall Study|Withdrawal by Subject|2|||
162018193|NCT00478023|585121932|FG003|Overall Study|Withdrawal by Subject|4|||
162018194|NCT00478023|585121933|FG004|Overall Study|Withdrawal by Subject|5|||
162018195|NCT00478023|585121929|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
162018196|NCT00478023|585121930|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
162018197|NCT00478023|585121931|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
162018198|NCT00478023|585121932|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
162018199|NCT00478023|585121933|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
162018200|NCT00369265|585121935|FG000|Overall Study|Study terminated|4|||
162018201|NCT00369265|585121936|FG001|Overall Study|Study terminated|7|||
162018202|NCT03895840|585121937|FG000|Overall Study|Withdrawal by Subject|21|||
162018203|NCT01599637|585121940|FG000|Overall Study|administrative problems|0|||
162018204|NCT01599637|585121941|FG001|Overall Study|administrative problems|2|||
162018205|NCT01599637|585121942|FG002|Overall Study|administrative problems|0|||
162018206|NCT01599637|585121940|FG000|Overall Study|Adverse Event|1|||
162018207|NCT01599637|585121941|FG001|Overall Study|Adverse Event|0|||
162018208|NCT01599637|585121942|FG002|Overall Study|Adverse Event|0|||
162018209|NCT00611026|585121943|FG000|Randomized to Double-blind Treatment|Not treated|2|||
162018210|NCT00611026|585121944|FG001|Randomized to Double-blind Treatment|Not treated|1|||
162018211|NCT00611026|585121945|FG002|Randomized to Double-blind Treatment|Not treated|3|||
162018212|NCT00611026|585121943|FG000|Double-blind Treatment Period|Death|1|||
162018213|NCT00611026|585121944|FG001|Double-blind Treatment Period|Death|0|||
162018214|NCT00611026|585121945|FG002|Double-blind Treatment Period|Death|0|||
162018215|NCT00611026|585121943|FG000|Double-blind Treatment Period|Adverse Event|9|||
162018216|NCT00611026|585121944|FG001|Double-blind Treatment Period|Adverse Event|28|||
162018217|NCT00611026|585121945|FG002|Double-blind Treatment Period|Adverse Event|46|||
162018218|NCT00611026|585121943|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
162018219|NCT00611026|585121944|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
162018220|NCT00611026|585121945|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
162018221|NCT00611026|585121943|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
162018222|NCT00611026|585121944|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
162018223|NCT00611026|585121945|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
162018224|NCT00611026|585121943|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
162018225|NCT00611026|585121944|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
162018226|NCT00611026|585121945|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
162018227|NCT00611026|585121943|FG000|Double-blind Treatment Period|Other|13|||
162018228|NCT00611026|585121944|FG001|Double-blind Treatment Period|Other|20|||
162018229|NCT00611026|585121945|FG002|Double-blind Treatment Period|Other|18|||
162018230|NCT05019521|585121946|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
161670563|NCT02520284|583847250|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
161670564|NCT02520284|583847248|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
161670565|NCT02520284|583847249|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
161670566|NCT02520284|583847250|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
161670567|NCT02520284|583847248|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
161670568|NCT02520284|583847249|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
161670569|NCT02520284|583847250|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
161670570|NCT02520284|583847248|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
161670571|NCT02520284|583847249|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
161670572|NCT02520284|583847250|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
161670573|NCT02520284|583847248|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
161670574|NCT02520284|583847249|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
161670575|NCT02520284|583847250|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
161670576|NCT02520284|583847248|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
161670577|NCT02520284|583847249|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
161670578|NCT02520284|583847250|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
161670579|NCT03737474|583847251|FG000|Overall Study|Adverse Event|18|||
161670580|NCT03737474|583847252|FG001|Overall Study|Adverse Event|48|||
161670581|NCT03737474|583847251|FG000|Overall Study|Lack of Efficacy|1|||
161670582|NCT03737474|583847252|FG001|Overall Study|Lack of Efficacy|3|||
161670583|NCT03737474|583847251|FG000|Overall Study|Protocol Violation|0|||
161670584|NCT03737474|583847252|FG001|Overall Study|Protocol Violation|8|||
161670585|NCT03737474|583847251|FG000|Overall Study|Withdrawal by Subject|5|||
161670586|NCT03737474|583847252|FG001|Overall Study|Withdrawal by Subject|20|||
161670587|NCT03737474|583847251|FG000|Overall Study|Non-compliance With Study Drug|0|||
161670588|NCT03737474|583847252|FG001|Overall Study|Non-compliance With Study Drug|1|||
161670589|NCT03737474|583847251|FG000|Overall Study|Physician Decision|1|||
161670590|NCT03737474|583847252|FG001|Overall Study|Physician Decision|4|||
161670591|NCT02513745|583847255|FG000|Overall Study|Criteria at time of surgery not met.|3|||
161670592|NCT02513745|583847256|FG001|Overall Study|Criteria at time of surgery not met.|3|||
161670593|NCT04526197|583847257|FG000|Period 1|Adverse Event|0|||
161670594|NCT04526197|583847258|FG001|Period 1|Adverse Event|1|||
161670595|NCT04526197|583847257|FG000|Period 1|Withdrawal by Subject|1|||
161670596|NCT04526197|583847258|FG001|Period 1|Withdrawal by Subject|0|||
161670597|NCT04526197|583847257|FG000|Period 2|Adverse Event|0|||
161670598|NCT04526197|583847258|FG001|Period 2|Adverse Event|1|||
161670599|NCT04526197|583847257|FG000|Period 2|Withdrawal by Subject|0|||
161670600|NCT04526197|583847258|FG001|Period 2|Withdrawal by Subject|1|||
161670601|NCT01209143|583847259|FG000|Overall Study|Adverse Event|2|||
161670602|NCT01209143|583847260|FG001|Overall Study|Adverse Event|1|||
161670603|NCT01209143|583847259|FG000|Overall Study|Death|0|||
161670604|NCT01209143|583847260|FG001|Overall Study|Death|1|||
161670605|NCT01209143|583847259|FG000|Overall Study|Physician Decision|3|||
161670606|NCT01209143|583847260|FG001|Overall Study|Physician Decision|1|||
161670607|NCT01209143|583847259|FG000|Overall Study|Lost to Follow-up|1|||
161670608|NCT01209143|583847260|FG001|Overall Study|Lost to Follow-up|0|||
161670609|NCT01209143|583847259|FG000|Overall Study|Withdrawal by Subject|2|||
161670610|NCT01209143|583847260|FG001|Overall Study|Withdrawal by Subject|1|||
161670611|NCT01209143|583847259|FG000|Overall Study|Disease progression|11|||
161670612|NCT01209143|583847260|FG001|Overall Study|Disease progression|16|||
161670613|NCT00381303|583847261|FG000|Overall Study|Lost to Follow-up|25|||
161670614|NCT00381303|583847262|FG001|Overall Study|Lost to Follow-up|9|||
161670615|NCT00381303|583847261|FG000|Overall Study|AE/HIV-related event|22|||
161670616|NCT00381303|583847262|FG001|Overall Study|AE/HIV-related event|6|||
161670617|NCT00381303|583847261|FG000|Overall Study|Non-Adherence|13|||
161670618|NCT00381303|583847262|FG001|Overall Study|Non-Adherence|6|||
161670619|NCT00381303|583847261|FG000|Overall Study|Withdrawal by Subject|13|||
161670620|NCT00381303|583847262|FG001|Overall Study|Withdrawal by Subject|6|||
161670621|NCT00381303|583847261|FG000|Overall Study|Virologic failure|6|||
161670622|NCT00381303|583847262|FG001|Overall Study|Virologic failure|4|||
161670623|NCT00381303|583847261|FG000|Overall Study|Ineligible to continue the trial|2|||
161670624|NCT00381303|583847262|FG001|Overall Study|Ineligible to continue the trial|1|||
161670625|NCT00381303|583847261|FG000|Overall Study|Pregnancy|2|||
161670626|NCT00381303|583847262|FG001|Overall Study|Pregnancy|0|||
161670627|NCT00381303|583847261|FG000|Overall Study|Physician Decision|1|||
161670628|NCT00381303|583847262|FG001|Overall Study|Physician Decision|0|||
161670629|NCT00381303|583847261|FG000|Overall Study|Physician's decision to close the site|3|||
161670630|NCT00381303|583847262|FG001|Overall Study|Physician's decision to close the site|1|||
161670631|NCT00381303|583847261|FG000|Overall Study|Subject moved out of state|2|||
161670632|NCT00381303|583847262|FG001|Overall Study|Subject moved out of state|0|||
161670633|NCT00381303|583847261|FG000|Overall Study|Subject taking too many different meds|1|||
161670634|NCT00381303|583847262|FG001|Overall Study|Subject taking too many different meds|0|||
161670635|NCT00381303|583847261|FG000|Overall Study|No virologic response by week 12|1|||
161670636|NCT00381303|583847262|FG001|Overall Study|No virologic response by week 12|0|||
161670637|NCT00381303|583847261|FG000|Overall Study|Subject was too busy for appointments|1|||
161670638|NCT00381303|583847262|FG001|Overall Study|Subject was too busy for appointments|0|||
161670639|NCT00381303|583847261|FG000|Overall Study|Subject did not continue visits|1|||
161670640|NCT00381303|583847262|FG001|Overall Study|Subject did not continue visits|0|||
161670641|NCT00381303|583847261|FG000|Overall Study|Subject primary physician's decision|1|||
161670642|NCT00381303|583847262|FG001|Overall Study|Subject primary physician's decision|0|||
161670643|NCT01136811|583847263|FG000|Overall Study|Physician Decision|11|||
161670644|NCT01211522|583847265|FG000|Overall Study|Withdrawal by Subject|3|||
161670645|NCT01211522|583847266|FG001|Overall Study|Withdrawal by Subject|7|||
161670646|NCT01211522|583847267|FG002|Overall Study|Withdrawal by Subject|5|||
161670647|NCT01116882|583847273|FG000|30-day|Lost to Follow-up|50|||
161670648|NCT01116882|583847274|FG001|30-day|Lost to Follow-up|21|||
161670649|NCT01116882|583847273|FG000|30-day|Withdrawal by Subject|2|||
161670650|NCT01116882|583847274|FG001|30-day|Withdrawal by Subject|4|||
161670651|NCT01116882|583847273|FG000|30-day|Other Reasons|16|||
161670652|NCT01116882|583847274|FG001|30-day|Other Reasons|6|||
161670653|NCT01116882|583847273|FG000|12-month|Lost to Follow-up|111|||
161670654|NCT01116882|583847274|FG001|12-month|Lost to Follow-up|42|||
161670655|NCT01116882|583847273|FG000|12-month|Other Reasons|151|||
161670656|NCT01116882|583847274|FG001|12-month|Other Reasons|49|||
161670657|NCT01116882|583847273|FG000|12-month|Withdrawal by Subject|5|||
161670658|NCT01116882|583847274|FG001|12-month|Withdrawal by Subject|8|||
161670659|NCT00547365|583847275|FG000|Overall Study|Physician Decision|1|||
161670660|NCT00547365|583847275|FG000|Overall Study|Lost to Follow-up|1|||
161670661|NCT00547365|583847275|FG000|Overall Study|Protocol Violation|2|||
161670662|NCT00547365|583847275|FG000|Overall Study|death (not related to study)|4|||
161670663|NCT01139658|583847278|FG000|Overall Study|Adverse Event|10|||
161670664|NCT01139658|583847279|FG001|Overall Study|Adverse Event|27|||
161670665|NCT01139658|583847278|FG000|Overall Study|Lack of Efficacy|15|||
161670666|NCT01139658|583847279|FG001|Overall Study|Lack of Efficacy|7|||
161670667|NCT01139658|583847278|FG000|Overall Study|Withdrawal by Subject|2|||
161670668|NCT01139658|583847279|FG001|Overall Study|Withdrawal by Subject|4|||
161670669|NCT01139658|583847278|FG000|Overall Study|No documentation of treatment|1|||
161670670|NCT01139658|583847279|FG001|Overall Study|No documentation of treatment|0|||
161670671|NCT01139658|583847278|FG000|Overall Study|Other|28|||
161670672|NCT01139658|583847279|FG001|Overall Study|Other|75|||
161670673|NCT01777269|583847280|FG000|Overall Study|Adverse Event|24|||
161670674|NCT01777269|583847281|FG001|Overall Study|Adverse Event|33|||
161670675|NCT01777269|583847280|FG000|Overall Study|Lack of Efficacy|8|||
161670676|NCT01777269|583847281|FG001|Overall Study|Lack of Efficacy|10|||
161670677|NCT01777269|583847280|FG000|Overall Study|Protocol Violation|4|||
161670678|NCT01777269|583847281|FG001|Overall Study|Protocol Violation|4|||
161670679|NCT01777269|583847280|FG000|Overall Study|Participants reached stopping criteria|1|||
161670680|NCT01777269|583847281|FG001|Overall Study|Participants reached stopping criteria|1|||
161670681|NCT01777269|583847280|FG000|Overall Study|Lost to Follow-up|4|||
161670682|NCT01777269|583847281|FG001|Overall Study|Lost to Follow-up|0|||
161670683|NCT01777269|583847280|FG000|Overall Study|Physician Decision|5|||
161670684|NCT01777269|583847281|FG001|Overall Study|Physician Decision|2|||
161670685|NCT01777269|583847280|FG000|Overall Study|Withdrawal by Subject|9|||
161670686|NCT01777269|583847281|FG001|Overall Study|Withdrawal by Subject|9|||
161670687|NCT00504881|583847282|FG000|Overall Study|Lack of Efficacy|1|||
161670688|NCT00504881|583847283|FG001|Overall Study|Lack of Efficacy|5|||
161670689|NCT00504881|583847282|FG000|Overall Study|Lost to Follow-up|0|||
161670690|NCT00504881|583847283|FG001|Overall Study|Lost to Follow-up|2|||
161670691|NCT00504881|583847282|FG000|Overall Study|Withdrawal by Subject|1|||
162172994|NCT02598388|585686368|FG004|Overall Study|Withdrawal by Subject|2|||
162172995|NCT02598388|585686369|FG005|Overall Study|Withdrawal by Subject|0|||
162172996|NCT02598388|585686370|FG006|Overall Study|Withdrawal by Subject|2|||
162172997|NCT02598388|585686371|FG007|Overall Study|Withdrawal by Subject|0|||
162172998|NCT02598388|585686372|FG008|Overall Study|Withdrawal by Subject|0|||
162172999|NCT02598388|585686373|FG009|Overall Study|Withdrawal by Subject|1|||
162173000|NCT02598388|585686374|FG010|Overall Study|Withdrawal by Subject|0|||
162173001|NCT02598388|585686375|FG011|Overall Study|Withdrawal by Subject|0|||
162173002|NCT02598388|585686364|FG000|Overall Study|Other|0|||
162173003|NCT02598388|585686365|FG001|Overall Study|Other|0|||
162173004|NCT02598388|585686366|FG002|Overall Study|Other|1|||
162173005|NCT02598388|585686367|FG003|Overall Study|Other|0|||
162173006|NCT02598388|585686368|FG004|Overall Study|Other|3|||
162173007|NCT02598388|585686369|FG005|Overall Study|Other|0|||
162173008|NCT02598388|585686370|FG006|Overall Study|Other|1|||
162173009|NCT02598388|585686371|FG007|Overall Study|Other|0|||
162173010|NCT02598388|585686372|FG008|Overall Study|Other|0|||
162173011|NCT02598388|585686373|FG009|Overall Study|Other|0|||
162173012|NCT02598388|585686374|FG010|Overall Study|Other|0|||
162173013|NCT02598388|585686375|FG011|Overall Study|Other|0|||
162173014|NCT03668236|585686378|FG000|90-day Follow-up|Withdrawal by Subject|3|||
162173015|NCT03668236|585686379|FG001|90-day Follow-up|Withdrawal by Subject|2|||
162173016|NCT03668236|585686378|FG000|90-day Follow-up|Lost to Follow-up|3|||
162173017|NCT03668236|585686379|FG001|90-day Follow-up|Lost to Follow-up|1|||
162173018|NCT03668236|585686378|FG000|Baseline Characteristics|Lost to Follow-up|9|||
162173019|NCT03668236|585686379|FG001|Baseline Characteristics|Lost to Follow-up|5|||
162173020|NCT03668236|585686378|FG000|1-year Follow-up|Withdrawal by Subject|17|||
162173021|NCT03668236|585686379|FG001|1-year Follow-up|Withdrawal by Subject|15|||
162173022|NCT06132282|585686380|FG000|Overall Study|Lost to Follow-up|31|||
162173023|NCT00104676|585686381|FG000|Overall Study|Death|3|||
162173024|NCT00104676|585686382|FG001|Overall Study|Death|2|||
162173025|NCT00104676|585686381|FG000|Overall Study|Withdrawal by Subject|0|||
162173026|NCT00104676|585686382|FG001|Overall Study|Withdrawal by Subject|2|||
161670692|NCT00504881|583847283|FG001|Overall Study|Withdrawal by Subject|4|||
161670693|NCT00504881|583847282|FG000|Overall Study|Non-Compliance|1|||
161670694|NCT00504881|583847283|FG001|Overall Study|Non-Compliance|0|||
161670695|NCT00504881|583847282|FG000|Overall Study|No Birth Control|0|||
161670696|NCT00504881|583847283|FG001|Overall Study|No Birth Control|1|||
161670697|NCT00504881|583847282|FG000|Overall Study|Safety Visit not performed|0|||
161670698|NCT00504881|583847283|FG001|Overall Study|Safety Visit not performed|1|||
161670699|NCT00504881|583847282|FG000|Overall Study|AE, serious fatal|0|||
161670700|NCT00504881|583847283|FG001|Overall Study|AE, serious fatal|1|||
161670701|NCT00504881|583847282|FG000|Overall Study|SAE, non-fatal|2|||
161670702|NCT00504881|583847283|FG001|Overall Study|SAE, non-fatal|6|||
161670703|NCT00504881|583847282|FG000|Overall Study|AE, non-serious non-fatal|4|||
161670704|NCT00504881|583847283|FG001|Overall Study|AE, non-serious non-fatal|14|||
161670705|NCT00504881|583847282|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
161670706|NCT00504881|583847283|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
161670707|NCT00504881|583847282|FG000|Overall Study|AE of unknown type|1|||
161670708|NCT00504881|583847283|FG001|Overall Study|AE of unknown type|0|||
161670709|NCT00753272|583847291|FG000|Overall Study|Adverse Event|878|||
161670710|NCT00753272|583847292|FG001|Overall Study|Adverse Event|869|||
161670711|NCT00753272|583847291|FG000|Overall Study|Protocol Violation|28|||
161670712|NCT00753272|583847292|FG001|Overall Study|Protocol Violation|46|||
161670713|NCT00753272|583847291|FG000|Overall Study|Withdrawal by Subject|2481|||
161670714|NCT00753272|583847292|FG001|Overall Study|Withdrawal by Subject|2407|||
161670715|NCT00753272|583847291|FG000|Overall Study|Lost to Follow-up|491|||
161670716|NCT00753272|583847292|FG001|Overall Study|Lost to Follow-up|497|||
161670717|NCT00753272|583847291|FG000|Overall Study|Other|1104|||
161670718|NCT00753272|583847292|FG001|Overall Study|Other|1088|||
161670719|NCT00803270|583847293|FG000|Overall Study|Lost to Follow-up|1|||
161670720|NCT00803270|583847294|FG001|Overall Study|Lost to Follow-up|2|||
161670721|NCT01966471|583847295|FG000|Overall Study|Death|44|||
161670722|NCT01966471|583847296|FG001|Overall Study|Death|56|||
161817001|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
161817002|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
161922712|NCT00835978|584764842|FG002|Overall Study|Lost to Follow-up|2|||
161670723|NCT01966471|583847295|FG000|Overall Study|Lost to Follow-up|46|||
161670724|NCT01966471|583847296|FG001|Overall Study|Lost to Follow-up|39|||
161670725|NCT01966471|583847295|FG000|Overall Study|Various reasons|4|||
161922713|NCT00835978|584764843|FG003|Overall Study|Lost to Follow-up|1|||
161922714|NCT00835978|584764840|FG000|Overall Study|Other|5|||
161922715|NCT00835978|584764841|FG001|Overall Study|Other|1|||
161922716|NCT00835978|584764842|FG002|Overall Study|Other|8|||
161922717|NCT00835978|584764843|FG003|Overall Study|Other|0|||
161922718|NCT00835978|584764840|FG000|Overall Study|Objective progression or relapse|2|||
161922719|NCT00835978|584764841|FG001|Overall Study|Objective progression or relapse|0|||
161922720|NCT00835978|584764842|FG002|Overall Study|Objective progression or relapse|1|||
161922721|NCT00835978|584764843|FG003|Overall Study|Objective progression or relapse|0|||
161922722|NCT00835978|584764840|FG000|Overall Study|Adverse Event|1|||
161922723|NCT00835978|584764841|FG001|Overall Study|Adverse Event|0|||
161922724|NCT00835978|584764842|FG002|Overall Study|Adverse Event|1|||
161922725|NCT00835978|584764843|FG003|Overall Study|Adverse Event|0|||
161922726|NCT00835978|584764840|FG000|Overall Study|Withdrawal by Subject|0|||
161922727|NCT00835978|584764841|FG001|Overall Study|Withdrawal by Subject|3|||
161922728|NCT00835978|584764842|FG002|Overall Study|Withdrawal by Subject|0|||
161922729|NCT00835978|584764843|FG003|Overall Study|Withdrawal by Subject|5|||
161922730|NCT00835978|584764840|FG000|Overall Study|Study terminated by sponsor|12|||
161922731|NCT00835978|584764841|FG001|Overall Study|Study terminated by sponsor|8|||
161922732|NCT00835978|584764842|FG002|Overall Study|Study terminated by sponsor|30|||
161922733|NCT00835978|584764843|FG003|Overall Study|Study terminated by sponsor|0|||
161922734|NCT01410604|584764844|FG000|Overall Study|Adverse Event|2|||
161922735|NCT01410604|584764845|FG001|Overall Study|Adverse Event|1|||
161922736|NCT01410604|584764844|FG000|Overall Study|Lost to Follow-up|1|||
161922737|NCT01410604|584764845|FG001|Overall Study|Lost to Follow-up|0|||
161670726|NCT01966471|583847296|FG001|Overall Study|Various reasons|4|||
161670727|NCT01966471|583847295|FG000|Overall Study|Physician Decision|7|||
161670728|NCT01966471|583847296|FG001|Overall Study|Physician Decision|5|||
161670729|NCT01966471|583847295|FG000|Overall Study|Study Terminated By Sponsor|758|||
161670730|NCT01966471|583847296|FG001|Overall Study|Study Terminated By Sponsor|773|||
161670731|NCT01966471|583847295|FG000|Overall Study|Withdrawal by Subject|59|||
161670732|NCT01966471|583847296|FG001|Overall Study|Withdrawal by Subject|51|||
161670733|NCT02092220|583847301|FG000|Period 1|Unrelated Illness|0|||
161670734|NCT02092220|583847302|FG001|Period 1|Unrelated Illness|2|||
161670735|NCT02092220|583847301|FG000|Period 2|Severe Hypoglycaemia|1|||
161670736|NCT02092220|583847302|FG001|Period 2|Severe Hypoglycaemia|0|||
161670737|NCT02092220|583847301|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
161670738|NCT02092220|583847302|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
161670739|NCT00960531|583847303|FG000|Overall Study|Lack of Efficacy|1|||
161670740|NCT00960531|583847304|FG001|Overall Study|Lack of Efficacy|0|||
161670741|NCT00960531|583847305|FG002|Overall Study|Lack of Efficacy|0|||
161670742|NCT00960531|583847306|FG003|Overall Study|Lack of Efficacy|0|||
161670743|NCT00960531|583847307|FG004|Overall Study|Lack of Efficacy|0|||
161670744|NCT00960531|583847308|FG005|Overall Study|Lack of Efficacy|0|||
161670745|NCT00960531|583847309|FG006|Overall Study|Lack of Efficacy|0|||
161670746|NCT00960531|583847310|FG007|Overall Study|Lack of Efficacy|0|||
161670747|NCT00960531|583847311|FG008|Overall Study|Lack of Efficacy|0|||
161670748|NCT00960531|583847312|FG009|Overall Study|Lack of Efficacy|0|||
161670749|NCT00960531|583847303|FG000|Overall Study|Withdrawal by Subject|1|||
161670750|NCT00960531|583847304|FG001|Overall Study|Withdrawal by Subject|0|||
161670751|NCT00960531|583847305|FG002|Overall Study|Withdrawal by Subject|5|||
161670752|NCT00960531|583847306|FG003|Overall Study|Withdrawal by Subject|2|||
161670753|NCT00960531|583847307|FG004|Overall Study|Withdrawal by Subject|0|||
161670754|NCT00960531|583847308|FG005|Overall Study|Withdrawal by Subject|0|||
161670755|NCT00960531|583847309|FG006|Overall Study|Withdrawal by Subject|2|||
161670756|NCT00960531|583847310|FG007|Overall Study|Withdrawal by Subject|0|||
161670757|NCT00960531|583847311|FG008|Overall Study|Withdrawal by Subject|1|||
161670758|NCT00960531|583847312|FG009|Overall Study|Withdrawal by Subject|0|||
161670759|NCT00960531|583847303|FG000|Overall Study|Caregiver Request|2|||
162173027|NCT00104676|585686381|FG000|Overall Study|treatment interruption|4|||
162173028|NCT00104676|585686382|FG001|Overall Study|treatment interruption|10|||
162173029|NCT00696111|585686391|FG000|Overall Study|Withdrawal by Subject|17|||
162173030|NCT03687086|585686398|FG000|Overall Study|Withdrawal by Subject|3|||
162173031|NCT03687086|585686399|FG001|Overall Study|Withdrawal by Subject|4|||
162173032|NCT03687086|585686398|FG000|Overall Study|Lost to Follow-up|1|||
162173033|NCT03687086|585686399|FG001|Overall Study|Lost to Follow-up|1|||
162173034|NCT03687086|585686398|FG000|Overall Study|Death|1|||
162173035|NCT03687086|585686399|FG001|Overall Study|Death|0|||
162173036|NCT03687086|585686398|FG000|Overall Study|Incomplete assessment|0|||
162173037|NCT03687086|585686399|FG001|Overall Study|Incomplete assessment|2|||
162173038|NCT04362254|585686403|FG000|Overall Study|Adverse Event|1|||
162173039|NCT04362254|585686403|FG000|Overall Study|Protocol Violation|1|||
162173040|NCT04362254|585686403|FG000|Overall Study|Due to early termination of the trial|10|||
162173041|NCT04707625|585686404|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
162173042|NCT02038777|585686405|FG000|Overall Study|Death|0|||
162173043|NCT02038777|585686406|FG001|Overall Study|Death|2|||
162173044|NCT02038777|585686407|FG002|Overall Study|Death|0|||
162173045|NCT02038777|585686408|FG003|Overall Study|Death|1|||
162173046|NCT02038777|585686409|FG004|Overall Study|Death|2|||
162173047|NCT02038777|585686410|FG005|Overall Study|Death|4|||
162173048|NCT02038777|585686411|FG006|Overall Study|Death|0|||
162173049|NCT02038777|585686412|FG007|Overall Study|Death|11|||
162173050|NCT02038777|585686405|FG000|Overall Study|Lost to Follow-up|0|||
162173051|NCT02038777|585686406|FG001|Overall Study|Lost to Follow-up|0|||
161670760|NCT00960531|583847304|FG001|Overall Study|Caregiver Request|0|||
161670761|NCT00960531|583847305|FG002|Overall Study|Caregiver Request|6|||
161670762|NCT00960531|583847306|FG003|Overall Study|Caregiver Request|5|||
161670763|NCT00960531|583847307|FG004|Overall Study|Caregiver Request|0|||
161670764|NCT00960531|583847308|FG005|Overall Study|Caregiver Request|2|||
161922738|NCT01410604|584764844|FG000|Overall Study|Physician Decision|0|||
162173052|NCT02038777|585686407|FG002|Overall Study|Lost to Follow-up|0|||
162173053|NCT02038777|585686408|FG003|Overall Study|Lost to Follow-up|1|||
161670765|NCT00960531|583847309|FG006|Overall Study|Caregiver Request|3|||
161670766|NCT00960531|583847310|FG007|Overall Study|Caregiver Request|1|||
161670767|NCT00960531|583847311|FG008|Overall Study|Caregiver Request|3|||
162173054|NCT02038777|585686409|FG004|Overall Study|Lost to Follow-up|0|||
162173055|NCT02038777|585686410|FG005|Overall Study|Lost to Follow-up|0|||
162173056|NCT02038777|585686411|FG006|Overall Study|Lost to Follow-up|0|||
162173057|NCT02038777|585686412|FG007|Overall Study|Lost to Follow-up|0|||
161670768|NCT00960531|583847312|FG009|Overall Study|Caregiver Request|0|||
161670769|NCT00960531|583847303|FG000|Overall Study|Investigator Request|0|||
161670770|NCT00960531|583847304|FG001|Overall Study|Investigator Request|0|||
161670771|NCT00960531|583847305|FG002|Overall Study|Investigator Request|1|||
162173058|NCT02038777|585686405|FG000|Overall Study|Other|0|||
161817003|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
161817004|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
161817005|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
161817006|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
162173059|NCT02038777|585686406|FG001|Overall Study|Other|1|||
162173060|NCT02038777|585686407|FG002|Overall Study|Other|0|||
162173061|NCT02038777|585686408|FG003|Overall Study|Other|2|||
162173062|NCT02038777|585686409|FG004|Overall Study|Other|1|||
162173063|NCT02038777|585686410|FG005|Overall Study|Other|0|||
162173064|NCT02038777|585686411|FG006|Overall Study|Other|0|||
162173065|NCT02038777|585686412|FG007|Overall Study|Other|0|||
162173066|NCT02038777|585686405|FG000|Overall Study|Randomized but not treated|0|||
162173067|NCT02038777|585686406|FG001|Overall Study|Randomized but not treated|1|||
162173068|NCT02038777|585686407|FG002|Overall Study|Randomized but not treated|0|||
162173069|NCT02038777|585686408|FG003|Overall Study|Randomized but not treated|0|||
162173070|NCT02038777|585686409|FG004|Overall Study|Randomized but not treated|0|||
162173071|NCT02038777|585686410|FG005|Overall Study|Randomized but not treated|0|||
162173072|NCT02038777|585686411|FG006|Overall Study|Randomized but not treated|0|||
162173073|NCT02038777|585686412|FG007|Overall Study|Randomized but not treated|0|||
162173074|NCT02038777|585686405|FG000|Overall Study|Started Chemotherapy|1|||
162173075|NCT02038777|585686406|FG001|Overall Study|Started Chemotherapy|0|||
162173076|NCT02038777|585686407|FG002|Overall Study|Started Chemotherapy|3|||
162173077|NCT02038777|585686408|FG003|Overall Study|Started Chemotherapy|0|||
162173078|NCT02038777|585686409|FG004|Overall Study|Started Chemotherapy|0|||
162173079|NCT02038777|585686410|FG005|Overall Study|Started Chemotherapy|0|||
162173080|NCT02038777|585686411|FG006|Overall Study|Started Chemotherapy|0|||
162173081|NCT02038777|585686412|FG007|Overall Study|Started Chemotherapy|0|||
162173082|NCT02038777|585686405|FG000|Overall Study|participation terminated by sponsor|0|||
162173083|NCT02038777|585686406|FG001|Overall Study|participation terminated by sponsor|0|||
162173084|NCT02038777|585686407|FG002|Overall Study|participation terminated by sponsor|0|||
162173085|NCT02038777|585686408|FG003|Overall Study|participation terminated by sponsor|0|||
162173086|NCT02038777|585686409|FG004|Overall Study|participation terminated by sponsor|0|||
162173087|NCT02038777|585686410|FG005|Overall Study|participation terminated by sponsor|0|||
162173088|NCT02038777|585686411|FG006|Overall Study|participation terminated by sponsor|1|||
162173089|NCT02038777|585686412|FG007|Overall Study|participation terminated by sponsor|1|||
161670772|NCT00960531|583847306|FG003|Overall Study|Investigator Request|0|||
161670773|NCT00960531|583847307|FG004|Overall Study|Investigator Request|0|||
161670774|NCT00960531|583847308|FG005|Overall Study|Investigator Request|0|||
161670775|NCT00960531|583847309|FG006|Overall Study|Investigator Request|0|||
161670776|NCT00960531|583847310|FG007|Overall Study|Investigator Request|0|||
161670777|NCT00960531|583847311|FG008|Overall Study|Investigator Request|0|||
161670778|NCT00960531|583847312|FG009|Overall Study|Investigator Request|0|||
161670779|NCT00960531|583847303|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
161670780|NCT00960531|583847304|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161670781|NCT00960531|583847305|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
161670782|NCT00960531|583847306|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
161670783|NCT00960531|583847307|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
161670784|NCT00960531|583847308|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
161670785|NCT00960531|583847309|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
161670786|NCT00960531|583847310|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
161670787|NCT00960531|583847311|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
161670788|NCT00960531|583847312|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
161670789|NCT00960531|583847303|FG000|Overall Study|Lost to Follow-up|0|||
161670790|NCT00960531|583847304|FG001|Overall Study|Lost to Follow-up|0|||
161670791|NCT00960531|583847305|FG002|Overall Study|Lost to Follow-up|1|||
161670792|NCT00960531|583847306|FG003|Overall Study|Lost to Follow-up|0|||
161670793|NCT00960531|583847307|FG004|Overall Study|Lost to Follow-up|0|||
161670794|NCT00960531|583847308|FG005|Overall Study|Lost to Follow-up|0|||
161670795|NCT00960531|583847309|FG006|Overall Study|Lost to Follow-up|1|||
161670796|NCT00960531|583847310|FG007|Overall Study|Lost to Follow-up|0|||
161670797|NCT00960531|583847311|FG008|Overall Study|Lost to Follow-up|0|||
161670798|NCT00960531|583847312|FG009|Overall Study|Lost to Follow-up|0|||
161670799|NCT00960531|583847303|FG000|Overall Study|Failed to Return|2|||
161670800|NCT00960531|583847304|FG001|Overall Study|Failed to Return|0|||
161670801|NCT00960531|583847305|FG002|Overall Study|Failed to Return|0|||
161670802|NCT00960531|583847306|FG003|Overall Study|Failed to Return|0|||
161670803|NCT00960531|583847307|FG004|Overall Study|Failed to Return|0|||
161670804|NCT00960531|583847308|FG005|Overall Study|Failed to Return|0|||
161670805|NCT00960531|583847309|FG006|Overall Study|Failed to Return|0|||
161670806|NCT00960531|583847310|FG007|Overall Study|Failed to Return|2|||
161670807|NCT00960531|583847311|FG008|Overall Study|Failed to Return|0|||
161670808|NCT00960531|583847312|FG009|Overall Study|Failed to Return|0|||
161670809|NCT00960531|583847303|FG000|Overall Study|Adverse Event (AE)|2|||
161670810|NCT00960531|583847304|FG001|Overall Study|Adverse Event (AE)|0|||
161670811|NCT00960531|583847305|FG002|Overall Study|Adverse Event (AE)|0|||
161670812|NCT00960531|583847306|FG003|Overall Study|Adverse Event (AE)|0|||
161670813|NCT00960531|583847307|FG004|Overall Study|Adverse Event (AE)|0|||
161670814|NCT00960531|583847308|FG005|Overall Study|Adverse Event (AE)|1|||
161670815|NCT00960531|583847309|FG006|Overall Study|Adverse Event (AE)|2|||
161670816|NCT00960531|583847310|FG007|Overall Study|Adverse Event (AE)|0|||
161670817|NCT00960531|583847311|FG008|Overall Study|Adverse Event (AE)|2|||
161670818|NCT00960531|583847312|FG009|Overall Study|Adverse Event (AE)|0|||
161670819|NCT00960531|583847303|FG000|Overall Study|Reason not Specified|2|||
161670820|NCT00960531|583847304|FG001|Overall Study|Reason not Specified|1|||
161670821|NCT00960531|583847305|FG002|Overall Study|Reason not Specified|13|||
161670822|NCT00960531|583847306|FG003|Overall Study|Reason not Specified|1|||
161670823|NCT00960531|583847307|FG004|Overall Study|Reason not Specified|2|||
161670824|NCT00960531|583847308|FG005|Overall Study|Reason not Specified|0|||
161670825|NCT00960531|583847309|FG006|Overall Study|Reason not Specified|16|||
161670826|NCT00960531|583847310|FG007|Overall Study|Reason not Specified|0|||
161670827|NCT00960531|583847311|FG008|Overall Study|Reason not Specified|8|||
161670828|NCT00960531|583847312|FG009|Overall Study|Reason not Specified|1|||
161670829|NCT00593957|583847313|FG000|Overall Study|Physician Decision|0|||
161670830|NCT00593957|583847314|FG001|Overall Study|Physician Decision|1|||
161817007|NCT04194801|584370899|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
161670831|NCT00593957|583847315|FG002|Overall Study|Physician Decision|2|||
161670832|NCT02411578|583847318|FG000|Crossover Trial Phase|Pregnancy|0|||
161670833|NCT02411578|583847319|FG001|Crossover Trial Phase|Pregnancy|1|||
161670834|NCT00494481|583847320|FG000|Overall Study|Condition under investigation worsened|11|||
161670835|NCT00494481|583847321|FG001|Overall Study|Condition under investigation worsened|13|||
161670836|NCT00494481|583847320|FG000|Overall Study|Adverse Event|15|||
161670837|NCT00494481|583847321|FG001|Overall Study|Adverse Event|11|||
161670838|NCT00494481|583847320|FG000|Overall Study|Other|1|||
161670839|NCT00494481|583847321|FG001|Overall Study|Other|0|||
161670840|NCT00494481|583847320|FG000|Overall Study|Never received IP|2|||
161670841|NCT00494481|583847321|FG001|Overall Study|Never received IP|0|||
161670842|NCT01030198|583847322|FG000|Overall Study|Could not measure efficacy accurately|0|||
161670843|NCT01030198|583847323|FG001|Overall Study|Could not measure efficacy accurately|7|||
161817008|NCT04194801|584370900|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
161670844|NCT00332189|583847324|FG000|Overall Study|Adverse Event|3|||
161670845|NCT00332189|583847324|FG000|Overall Study|Uncooperative/Noncompliant|3|||
161670846|NCT00332189|583847324|FG000|Overall Study|Withdrawal by Subject|9|||
161817009|NCT04194801|584370901|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
161817010|NCT04194801|584370899|FG000|Part Ib/II End of Study|Death|2|||
161817011|NCT04194801|584370900|FG001|Part Ib/II End of Study|Death|3|||
161817012|NCT04194801|584370901|FG002|Part Ib/II End of Study|Death|3|||
162173090|NCT03386578|585686416|FG000|PK Component|Lost to Follow-up|0|||
162173091|NCT03386578|585686417|FG001|PK Component|Lost to Follow-up|1|||
162173092|NCT03386578|585686418|FG002|PK Component|Lost to Follow-up|0|||
162173093|NCT03386578|585686419|FG003|PK Component|Lost to Follow-up|0|||
162173094|NCT03386578|585686420|FG004|PK Component|Lost to Follow-up|0|||
162173095|NCT03386578|585686421|FG005|PK Component|Lost to Follow-up|0|||
162173096|NCT03386578|585686422|FG006|PK Component|Lost to Follow-up|1|||
162173097|NCT03386578|585686423|FG007|PK Component|Lost to Follow-up|0|||
162173098|NCT03386578|585686424|FG008|PK Component|Lost to Follow-up|0|||
162173099|NCT03386578|585686425|FG009|PK Component|Lost to Follow-up|0|||
162173100|NCT03386578|585686416|FG000|PK Component|Stillbirth/Abortion|0|||
162173101|NCT03386578|585686417|FG001|PK Component|Stillbirth/Abortion|0|||
162173102|NCT03386578|585686418|FG002|PK Component|Stillbirth/Abortion|0|||
162173103|NCT03386578|585686419|FG003|PK Component|Stillbirth/Abortion|0|||
162173104|NCT03386578|585686420|FG004|PK Component|Stillbirth/Abortion|0|||
162173105|NCT03386578|585686421|FG005|PK Component|Stillbirth/Abortion|2|||
162173106|NCT03386578|585686422|FG006|PK Component|Stillbirth/Abortion|0|||
162173107|NCT03386578|585686423|FG007|PK Component|Stillbirth/Abortion|0|||
162173108|NCT03386578|585686424|FG008|PK Component|Stillbirth/Abortion|0|||
162173109|NCT03386578|585686425|FG009|PK Component|Stillbirth/Abortion|0|||
162173110|NCT03386578|585686416|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
162173111|NCT03386578|585686417|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
162173112|NCT03386578|585686418|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
162173113|NCT03386578|585686419|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
162173114|NCT03386578|585686420|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
162173115|NCT03386578|585686421|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
162173116|NCT03386578|585686422|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
162173117|NCT03386578|585686423|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
162173118|NCT03386578|585686424|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
162173119|NCT03386578|585686425|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
162173120|NCT03386578|585686416|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
162173121|NCT03386578|585686417|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
162173122|NCT03386578|585686418|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
162173123|NCT03386578|585686419|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
162173124|NCT03386578|585686420|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
162173125|NCT03386578|585686421|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
162173126|NCT03386578|585686422|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
162173127|NCT03386578|585686423|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
162173128|NCT03386578|585686424|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
162173129|NCT03386578|585686425|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
162173130|NCT03386578|585686416|FG000|PrEP Comparison Component Step 1|Death|0|||
162173131|NCT03386578|585686417|FG001|PrEP Comparison Component Step 1|Death|0|||
162173132|NCT03386578|585686418|FG002|PrEP Comparison Component Step 1|Death|1|||
162173133|NCT03386578|585686419|FG003|PrEP Comparison Component Step 1|Death|0|||
162173134|NCT03386578|585686420|FG004|PrEP Comparison Component Step 1|Death|0|||
162173135|NCT03386578|585686421|FG005|PrEP Comparison Component Step 1|Death|0|||
162173136|NCT03386578|585686422|FG006|PrEP Comparison Component Step 1|Death|0|||
162173137|NCT03386578|585686423|FG007|PrEP Comparison Component Step 1|Death|9|||
162173138|NCT03386578|585686424|FG008|PrEP Comparison Component Step 1|Death|5|||
162173139|NCT03386578|585686425|FG009|PrEP Comparison Component Step 1|Death|0|||
162173140|NCT03386578|585686416|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162173141|NCT03386578|585686417|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162173142|NCT03386578|585686418|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162173143|NCT03386578|585686419|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
162173144|NCT03386578|585686420|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162173145|NCT03386578|585686421|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162173146|NCT03386578|585686422|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162173147|NCT03386578|585686423|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162173148|NCT03386578|585686424|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
162173149|NCT03386578|585686425|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
162173150|NCT03386578|585686416|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162173151|NCT03386578|585686417|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162173152|NCT03386578|585686418|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162173153|NCT03386578|585686419|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162173154|NCT03386578|585686420|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162173155|NCT03386578|585686421|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162173156|NCT03386578|585686422|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162173157|NCT03386578|585686423|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
161670847|NCT00332189|583847324|FG000|Overall Study|Lack of Efficacy|4|||
161670848|NCT00332189|583847324|FG000|Overall Study|Moved out of country|2|||
161670849|NCT02370043|583847325|FG000|Overall Study|Withdrawal by Subject|0|||
161670850|NCT02370043|583847326|FG001|Overall Study|Withdrawal by Subject|0|||
161670851|NCT02370043|583847327|FG002|Overall Study|Withdrawal by Subject|0|||
161670852|NCT02370043|583847328|FG003|Overall Study|Withdrawal by Subject|0|||
161670853|NCT02370043|583847329|FG004|Overall Study|Withdrawal by Subject|1|||
161670854|NCT02370043|583847330|FG005|Overall Study|Withdrawal by Subject|1|||
161670855|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
161670856|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
161670857|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
161670858|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
161670859|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
161670860|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
161922739|NCT01410604|584764845|FG001|Overall Study|Physician Decision|1|||
161922740|NCT02383173|584764850|FG000|Overall Study|Palliative Care Team withdrew|0|||
161922741|NCT02383173|584764851|FG001|Overall Study|Palliative Care Team withdrew|2|||
161922742|NCT00800540|584764852|FG000|Period One: 6 Weeks|Noncompliance|1|||
161922743|NCT00800540|584764853|FG001|Period One: 6 Weeks|Noncompliance|0|||
161922744|NCT00800540|584764852|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
161922745|NCT00800540|584764853|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
161922746|NCT00800540|584764852|FG000|Period 2: 6 Weeks|Adverse Event|0|||
161922747|NCT00800540|584764853|FG001|Period 2: 6 Weeks|Adverse Event|1|||
161922748|NCT00153920|584764854|FG000|Overall Study|Adverse Event|9|||
161922749|NCT00153920|584764854|FG000|Overall Study|Progressive Disease|9|||
161922750|NCT00153920|584764854|FG000|Overall Study|Physician Decision|3|||
161922751|NCT00153920|584764854|FG000|Overall Study|Lack of Response|3|||
161922752|NCT00153920|584764854|FG000|Overall Study|Death|2|||
161922753|NCT00153920|584764854|FG000|Overall Study|Withdrawal by Subject|1|||
161922754|NCT00153920|584764854|FG000|Overall Study|Non-Protocol Therapy|1|||
161922755|NCT00153920|584764854|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
161922756|NCT00153920|584764854|FG000|Overall Study|Progressive Disease before Trt|1|||
161922757|NCT04795323|584764855|FG000|Overall Study|Did not interact with TARA|1|||
161922758|NCT04795323|584764856|FG001|Overall Study|Did not interact with TARA|0|||
161922759|NCT00376506|584764857|FG000|Overall Study|Death|0|||
161922760|NCT00376506|584764858|FG001|Overall Study|Death|2|||
161922761|NCT01944774|584764860|FG000|Overall Study|Withdrawal by Subject|2|||
161922762|NCT01944774|584764861|FG001|Overall Study|Withdrawal by Subject|3|||
161922763|NCT01944774|584764862|FG002|Overall Study|Withdrawal by Subject|3|||
161922764|NCT01944774|584764860|FG000|Overall Study|Adverse Event|3|||
161922765|NCT01944774|584764861|FG001|Overall Study|Adverse Event|2|||
161922766|NCT01944774|584764862|FG002|Overall Study|Adverse Event|3|||
161922767|NCT01944774|584764860|FG000|Overall Study|Lack of Efficacy|1|||
161922768|NCT01944774|584764861|FG001|Overall Study|Lack of Efficacy|2|||
161922769|NCT01944774|584764862|FG002|Overall Study|Lack of Efficacy|2|||
161922770|NCT01944774|584764860|FG000|Overall Study|Lost to Follow-up|0|||
161922771|NCT01944774|584764861|FG001|Overall Study|Lost to Follow-up|1|||
161922772|NCT01944774|584764862|FG002|Overall Study|Lost to Follow-up|0|||
161922773|NCT02112552|584764865|FG000|Overall Study|Withdrawal by Subject|1|||
161922774|NCT02112552|584764865|FG000|Overall Study|Adverse Event|1|||
161922775|NCT00774748|584764866|FG000|Overall Study|Lost to Follow-up|3|||
161922776|NCT03349515|584764870|FG000|Overall Study|Lack of Efficacy|2|||
161922777|NCT03349515|584764871|FG001|Overall Study|Lack of Efficacy|0|||
161922778|NCT03349515|584764870|FG000|Overall Study|Physician Decision|3|||
161922779|NCT03349515|584764871|FG001|Overall Study|Physician Decision|1|||
161922780|NCT02965456|584764876|FG000|Overall Study|Lost to Follow-up|40|||
161922781|NCT02965456|584764877|FG001|Overall Study|Lost to Follow-up|18|||
161922782|NCT02965456|584764876|FG000|Overall Study|Subject Request|22|||
161922783|NCT02965456|584764877|FG001|Overall Study|Subject Request|13|||
161922784|NCT02965456|584764876|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
161922785|NCT02965456|584764877|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
161922786|NCT02965456|584764876|FG000|Overall Study|Adverse Event|3|||
161922787|NCT02965456|584764877|FG001|Overall Study|Adverse Event|0|||
161922788|NCT02965456|584764876|FG000|Overall Study|Noncompliance with Study Drug|1|||
161922789|NCT02965456|584764877|FG001|Overall Study|Noncompliance with Study Drug|1|||
161922790|NCT02965456|584764876|FG000|Overall Study|Worsening Condition|0|||
161922791|NCT02965456|584764877|FG001|Overall Study|Worsening Condition|2|||
161922792|NCT02965456|584764876|FG000|Overall Study|Lack of Efficacy|1|||
161922793|NCT02965456|584764877|FG001|Overall Study|Lack of Efficacy|0|||
161922794|NCT02965456|584764876|FG000|Overall Study|Physician Decision|0|||
161922795|NCT02965456|584764877|FG001|Overall Study|Physician Decision|1|||
161922796|NCT02965456|584764876|FG000|Overall Study|Pregnancy|1|||
161922797|NCT02965456|584764877|FG001|Overall Study|Pregnancy|0|||
161922798|NCT02965456|584764876|FG000|Overall Study|Protocol Violation|0|||
161922799|NCT02965456|584764877|FG001|Overall Study|Protocol Violation|1|||
162173158|NCT03386578|585686424|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
162173159|NCT03386578|585686425|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
162173160|NCT03386578|585686416|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162173161|NCT03386578|585686417|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162173162|NCT03386578|585686418|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162173163|NCT03386578|585686419|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162173164|NCT03386578|585686420|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162173165|NCT03386578|585686421|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162173166|NCT03386578|585686422|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162173167|NCT03386578|585686423|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
162173168|NCT03386578|585686424|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
162173169|NCT03386578|585686425|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
162173170|NCT01868997|585686428|FG000|Overall Study|Adverse Event|2|||
162173171|NCT01868997|585686429|FG001|Overall Study|Adverse Event|5|||
162173172|NCT01868997|585686428|FG000|Overall Study|Lack of Efficacy|2|||
162173173|NCT01868997|585686429|FG001|Overall Study|Lack of Efficacy|0|||
162173174|NCT01868997|585686428|FG000|Overall Study|Other|3|||
162173175|NCT01868997|585686429|FG001|Overall Study|Other|1|||
162173176|NCT04971109|585686432|FG000|Overall Study|Adverse Event|4|||
162173177|NCT04971109|585686433|FG001|Overall Study|Adverse Event|3|||
162173178|NCT04971109|585686432|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
162173179|NCT04971109|585686433|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
162173180|NCT04971109|585686432|FG000|Overall Study|Lost to Follow-up|8|||
162173181|NCT04971109|585686433|FG001|Overall Study|Lost to Follow-up|2|||
162173182|NCT04971109|585686432|FG000|Overall Study|Physician Decision|5|||
162173183|NCT04971109|585686433|FG001|Overall Study|Physician Decision|0|||
162173184|NCT04971109|585686432|FG000|Overall Study|Protocol Violation|0|||
162173185|NCT04971109|585686433|FG001|Overall Study|Protocol Violation|1|||
162173186|NCT04971109|585686432|FG000|Overall Study|Withdrawal by Subject|18|||
162173187|NCT04971109|585686433|FG001|Overall Study|Withdrawal by Subject|3|||
162173188|NCT04971109|585686432|FG000|Overall Study|Subject was randomized in error|1|||
162173189|NCT04971109|585686433|FG001|Overall Study|Subject was randomized in error|0|||
162173190|NCT03987022|585686435|FG000|Overall Study|Lost to Follow-up|2|||
162173191|NCT03987022|585686436|FG001|Overall Study|Lost to Follow-up|2|||
162173192|NCT03987022|585686435|FG000|Overall Study|Withdrawal by Subject|1|||
162173193|NCT03987022|585686436|FG001|Overall Study|Withdrawal by Subject|0|||
162173194|NCT01627574|585686439|FG000|Overall Study|Withdrawal by Subject|8|||
162173195|NCT01627574|585686440|FG001|Overall Study|Withdrawal by Subject|5|||
162173196|NCT01627574|585686439|FG000|Overall Study|Lost to Follow-up|13|||
162173197|NCT01627574|585686440|FG001|Overall Study|Lost to Follow-up|13|||
162173198|NCT04730739|585686441|FG000|Overall Study|Death|1|||
162173199|NCT05646355|585686451|FG000|Overall Study|Lost to Follow-up|1|||
162173200|NCT05646355|585686452|FG001|Overall Study|Lost to Follow-up|0|||
162173201|NCT05646355|585686451|FG000|Overall Study|translated materials not available for pilot|2|||
162173202|NCT05646355|585686452|FG001|Overall Study|translated materials not available for pilot|0|||
162173203|NCT05646355|585686451|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
162173204|NCT05646355|585686452|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
162173205|NCT01346540|585686453|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
162173206|NCT01346540|585686454|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
162173207|NCT01346540|585686453|FG000|Overall Study|Adverse Event|0|||
162173208|NCT01346540|585686454|FG001|Overall Study|Adverse Event|4|||
162173209|NCT05863156|585686455|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
162173210|NCT05863156|585686456|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
162173211|NCT05863156|585686457|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
162173212|NCT03362476|585686458|FG000|Overall Study|Withdrawal by Subject|0|||
162173213|NCT03362476|585686459|FG001|Overall Study|Withdrawal by Subject|1|||
162173214|NCT05216406|585686460|FG000|Overall Study|Lost to Follow-up|8|||
162173215|NCT05216406|585686461|FG001|Overall Study|Lost to Follow-up|9|||
162173216|NCT04270942|585686464|FG000|Overall Study|Death|1|||
162173217|NCT01009788|585686475|FG000|Overall Study|Withdrawal by Subject|1|||
162173218|NCT01009788|585686476|FG001|Overall Study|Withdrawal by Subject|0|||
162173219|NCT04587453|585686477|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
162173220|NCT04587453|585686478|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
162173221|NCT03571581|585686479|FG000|Overall Study|Death|2|||
162173222|NCT03571581|585686479|FG000|Overall Study|Withdrawal by Subject|2|||
162173223|NCT01309672|585686480|FG000|Overall Study|Lack of Efficacy|20|||
162173224|NCT01309672|585686480|FG000|Overall Study|Other|9|||
162173225|NCT01309672|585686480|FG000|Overall Study|Adverse Event|5|||
162173226|NCT01309672|585686480|FG000|Overall Study|Withdrawal by Subject|3|||
162173227|NCT03295721|585686486|FG000|Overall Study|Adverse Event|1|||
162173228|NCT03295721|585686487|FG001|Overall Study|Adverse Event|0|||
162173229|NCT03295721|585686488|FG002|Overall Study|Adverse Event|0|||
162173230|NCT03295721|585686486|FG000|Overall Study|Lost to Follow-up|1|||
162173231|NCT03295721|585686487|FG001|Overall Study|Lost to Follow-up|1|||
162173232|NCT03295721|585686488|FG002|Overall Study|Lost to Follow-up|1|||
162173233|NCT03295721|585686486|FG000|Overall Study|Withdrawal by Subject|1|||
162173234|NCT03295721|585686487|FG001|Overall Study|Withdrawal by Subject|0|||
162173235|NCT03295721|585686488|FG002|Overall Study|Withdrawal by Subject|1|||
162173236|NCT03295721|585686486|FG000|Overall Study|Death|0|||
162173237|NCT03295721|585686487|FG001|Overall Study|Death|0|||
162173238|NCT03295721|585686488|FG002|Overall Study|Death|1|||
162173239|NCT01651403|585686494|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
162173240|NCT01651403|585686495|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
162173241|NCT01651403|585686494|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
162173242|NCT01651403|585686495|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
162173243|NCT01651403|585686494|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
162173244|NCT01651403|585686495|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
162173245|NCT01651403|585686494|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
162173246|NCT01651403|585686495|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
162173247|NCT01651403|585686494|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
162173248|NCT01651403|585686495|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
162173249|NCT01651403|585686494|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
162173250|NCT01651403|585686495|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
162173251|NCT05090683|585686496|FG000|Overall Study|Lost to Follow-up|10|||
162173252|NCT05090683|585686497|FG001|Overall Study|Lost to Follow-up|2|||
162173253|NCT05090683|585686496|FG000|Overall Study|Withdrawal by Subject|15|||
162173254|NCT05090683|585686497|FG001|Overall Study|Withdrawal by Subject|0|||
162173255|NCT03325985|585686498|FG000|Overall Study|Lost to Follow-up|122|||
162173256|NCT03325985|585686499|FG001|Overall Study|Lost to Follow-up|26|||
162173257|NCT03325985|585686500|FG002|Overall Study|Lost to Follow-up|141|||
162173258|NCT03325985|585686501|FG003|Overall Study|Lost to Follow-up|28|||
162173259|NCT03325985|585686498|FG000|Overall Study|Death|99|||
162173260|NCT03325985|585686499|FG001|Overall Study|Death|36|||
162173261|NCT03325985|585686500|FG002|Overall Study|Death|94|||
162173262|NCT03325985|585686501|FG003|Overall Study|Death|32|||
162173263|NCT03213665|585686502|FG000|Overall Study|Adverse Event|1|||
162173264|NCT03213665|585686502|FG000|Overall Study|Physician Decision|2|||
162173265|NCT03213665|585686502|FG000|Overall Study|Withdrawal by Subject|3|||
162173266|NCT03213665|585686502|FG000|Overall Study|Progressive Disease|13|||
161670861|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
161670862|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
161670863|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
161670864|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
161670865|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
161670866|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
161670867|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
161670868|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
161670869|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
161670870|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
161670871|NCT01231516|583847331|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
161670872|NCT01231516|583847332|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
161670873|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
161670874|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
161670875|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
161670876|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
161670877|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
161670878|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
161670879|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
161670880|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
161670881|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
161670882|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
161670883|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
161670884|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
161670885|NCT01231516|583847331|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
161670886|NCT01231516|583847332|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
161670887|NCT05266586|583847335|FG000|Overall Study|Adverse Event|2|||
161670888|NCT05266586|583847336|FG001|Overall Study|Adverse Event|2|||
161670889|NCT05266586|583847337|FG002|Overall Study|Adverse Event|1|||
161670890|NCT05266586|583847335|FG000|Overall Study|Withdrawal by Subject|1|||
161670891|NCT05266586|583847336|FG001|Overall Study|Withdrawal by Subject|0|||
161670892|NCT05266586|583847337|FG002|Overall Study|Withdrawal by Subject|1|||
161670893|NCT05266586|583847335|FG000|Overall Study|Non-compliance with study drug|0|||
161670894|NCT05266586|583847336|FG001|Overall Study|Non-compliance with study drug|1|||
161670895|NCT05266586|583847337|FG002|Overall Study|Non-compliance with study drug|0|||
161670896|NCT05266586|583847335|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
161670897|NCT05266586|583847336|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
161670898|NCT05266586|583847337|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
161670899|NCT02225353|583847338|FG000|Overall Study|Lost to Follow-up|0|||
161670900|NCT02225353|583847339|FG001|Overall Study|Lost to Follow-up|1|||
161670901|NCT02225353|583847340|FG002|Overall Study|Lost to Follow-up|3|||
161670902|NCT02225353|583847338|FG000|Overall Study|Protocol Violation|4|||
161670903|NCT02225353|583847339|FG001|Overall Study|Protocol Violation|5|||
161670904|NCT02225353|583847340|FG002|Overall Study|Protocol Violation|12|||
161670905|NCT03707925|583847341|FG000|Overall Study|Inevaluable|1|||
161670906|NCT01193920|583847342|FG000|Overall Study|Withdrawal by Subject|1|||
161670907|NCT01193920|583847343|FG001|Overall Study|Withdrawal by Subject|0|||
161670908|NCT01193920|583847344|FG002|Overall Study|Withdrawal by Subject|5|||
161670909|NCT01193920|583847345|FG003|Overall Study|Withdrawal by Subject|1|||
161670910|NCT01193920|583847346|FG004|Overall Study|Withdrawal by Subject|3|||
161670911|NCT01193920|583847347|FG005|Overall Study|Withdrawal by Subject|1|||
161670912|NCT01193920|583847348|FG006|Overall Study|Withdrawal by Subject|3|||
161670913|NCT01193920|583847349|FG007|Overall Study|Withdrawal by Subject|0|||
161670914|NCT01193920|583847350|FG008|Overall Study|Withdrawal by Subject|1|||
161670915|NCT01193920|583847351|FG009|Overall Study|Withdrawal by Subject|0|||
161670916|NCT01193920|583847342|FG000|Overall Study|Lost to Follow-up|1|||
161670917|NCT01193920|583847343|FG001|Overall Study|Lost to Follow-up|0|||
161670918|NCT01193920|583847344|FG002|Overall Study|Lost to Follow-up|1|||
161670919|NCT01193920|583847345|FG003|Overall Study|Lost to Follow-up|1|||
161670920|NCT01193920|583847346|FG004|Overall Study|Lost to Follow-up|3|||
161670921|NCT01193920|583847347|FG005|Overall Study|Lost to Follow-up|3|||
161670922|NCT01193920|583847348|FG006|Overall Study|Lost to Follow-up|1|||
161670923|NCT01193920|583847349|FG007|Overall Study|Lost to Follow-up|0|||
161670924|NCT01193920|583847350|FG008|Overall Study|Lost to Follow-up|2|||
161670925|NCT01193920|583847351|FG009|Overall Study|Lost to Follow-up|3|||
161670926|NCT01193920|583847342|FG000|Overall Study|Protocol Violation|1|||
161670927|NCT01193920|583847343|FG001|Overall Study|Protocol Violation|0|||
161670928|NCT01193920|583847344|FG002|Overall Study|Protocol Violation|0|||
161670929|NCT01193920|583847345|FG003|Overall Study|Protocol Violation|0|||
161670930|NCT01193920|583847346|FG004|Overall Study|Protocol Violation|0|||
162173267|NCT03034356|585686503|FG000|Baseline|Lost to Follow-up|2|||
162173268|NCT03034356|585686504|FG001|Baseline|Lost to Follow-up|4|||
162173269|NCT03034356|585686503|FG000|Baseline|Withdrawal by Subject|2|||
162173270|NCT03034356|585686504|FG001|Baseline|Withdrawal by Subject|0|||
162173271|NCT03034356|585686503|FG000|Baseline|Physician Decision|0|||
162173272|NCT03034356|585686504|FG001|Baseline|Physician Decision|1|||
162173273|NCT03034356|585686503|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
162173274|NCT03034356|585686504|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
162173275|NCT03034356|585686503|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
162173276|NCT03034356|585686504|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
162173277|NCT03034356|585686503|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
162173278|NCT03034356|585686504|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
162173279|NCT03034356|585686503|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
162173280|NCT03034356|585686504|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
162173281|NCT02684227|585686505|FG000|Overall Study|Adverse Event|1|||
162173282|NCT02684227|585686506|FG001|Overall Study|Adverse Event|7|||
162173283|NCT02684227|585686505|FG000|Overall Study|Death|0|||
162173284|NCT02684227|585686506|FG001|Overall Study|Death|2|||
162173285|NCT02684227|585686505|FG000|Overall Study|Withdrawal by Subject|0|||
162173286|NCT02684227|585686506|FG001|Overall Study|Withdrawal by Subject|1|||
162173287|NCT02684227|585686505|FG000|Overall Study|Progressive Disease|0|||
162173288|NCT02684227|585686506|FG001|Overall Study|Progressive Disease|2|||
162173289|NCT04479761|585686511|FG000|Overall Study|could not perform the balance tasks|1|||
162173290|NCT04479761|585686512|FG001|Overall Study|could not perform the balance tasks|0|||
162173291|NCT04479761|585686513|FG002|Overall Study|could not perform the balance tasks|0|||
162173292|NCT04479761|585686511|FG000|Overall Study|Adverse Event|1|||
162173293|NCT04479761|585686512|FG001|Overall Study|Adverse Event|0|||
162173294|NCT04479761|585686513|FG002|Overall Study|Adverse Event|0|||
162173295|NCT04479761|585686511|FG000|Overall Study|one control did not meet screening criteria|0|||
162173296|NCT04479761|585686512|FG001|Overall Study|one control did not meet screening criteria|0|||
162173297|NCT04479761|585686513|FG002|Overall Study|one control did not meet screening criteria|1|||
162173298|NCT04479761|585686511|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
162173299|NCT04479761|585686512|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
162173300|NCT04479761|585686513|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
162173301|NCT05309291|585686514|FG000|Overall Study|Adverse Event|0|||
162173302|NCT05309291|585686515|FG001|Overall Study|Adverse Event|1|||
162173303|NCT05809453|585688045|FG000|Overall Study|Withdrawal by Subject|1|||
162173304|NCT05809453|585688046|FG001|Overall Study|Withdrawal by Subject|0|||
162173305|NCT05809453|585688047|FG002|Overall Study|Withdrawal by Subject|0|||
162173306|NCT05809453|585688048|FG003|Overall Study|Withdrawal by Subject|0|||
162173307|NCT04499924|585688051|FG000|Overall Study|Study termination by sponsor|4|||
162173308|NCT04499924|585688052|FG001|Overall Study|Study termination by sponsor|6|||
162173309|NCT04499924|585688051|FG000|Overall Study|Withdrawal by Subject|1|||
162173310|NCT04499924|585688052|FG001|Overall Study|Withdrawal by Subject|3|||
162173311|NCT03011333|585688053|FG000|Overall Study|Lost to Follow-up|0|||
162173312|NCT03011333|585688054|FG001|Overall Study|Lost to Follow-up|1|||
162173313|NCT03011333|585688055|FG002|Overall Study|Lost to Follow-up|0|||
162173314|NCT03011333|585688056|FG003|Overall Study|Lost to Follow-up|1|||
162173315|NCT03011333|585688057|FG004|Overall Study|Lost to Follow-up|4|||
162173316|NCT03011333|585688058|FG005|Overall Study|Lost to Follow-up|4|||
162173317|NCT03011333|585688059|FG006|Overall Study|Lost to Follow-up|5|||
162173318|NCT03663569|585688060|FG000|Overall Study|Discontinuation of study|11|||
162173319|NCT03663569|585688060|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
162173320|NCT03663569|585688060|FG000|Overall Study|Deceased patient|6|||
162173321|NCT03663569|585688060|FG000|Overall Study|Lost to Follow-up|18|||
162173322|NCT03663569|585688060|FG000|Overall Study|Withdrawal of consent|5|||
162173323|NCT03663569|585688060|FG000|Overall Study|Patient's request|11|||
162173324|NCT03663569|585688060|FG000|Overall Study|Adverse Event|4|||
162173325|NCT03663569|585688060|FG000|Overall Study|Not come to second visit|3|||
162173326|NCT03663569|585688060|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
162173327|NCT03663569|585688060|FG000|Overall Study|Serious adverse event|1|||
162173328|NCT04183283|585688061|FG000|Period 1|Withdrawal by Subject|0|||
162173329|NCT04183283|585688062|FG001|Period 1|Withdrawal by Subject|1|||
162173330|NCT04183283|585688063|FG002|Period 1|Withdrawal by Subject|0|||
162173331|NCT04183283|585688064|FG003|Period 1|Withdrawal by Subject|0|||
162173332|NCT04183283|585688061|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
161922800|NCT02965456|584764876|FG000|Overall Study|Participant ran out of study drug|0|||
162173333|NCT04183283|585688062|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
162173334|NCT04183283|585688063|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
162173335|NCT04183283|585688064|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
161922801|NCT02965456|584764877|FG001|Overall Study|Participant ran out of study drug|1|||
162173336|NCT04909801|585688072|FG000|Overall Study|Lack of Efficacy|2|||
162173337|NCT04909801|585688073|FG001|Overall Study|Lack of Efficacy|1|||
162173338|NCT04909801|585688072|FG000|Overall Study|Adverse Event|1|||
162173339|NCT04909801|585688073|FG001|Overall Study|Adverse Event|2|||
162173340|NCT04909801|585688072|FG000|Overall Study|Participant request to discontinue study treatment|1|||
162173341|NCT04909801|585688073|FG001|Overall Study|Participant request to discontinue study treatment|2|||
162173342|NCT04909801|585688072|FG000|Overall Study|Withdrawal by Subject|2|||
162173343|NCT04909801|585688073|FG001|Overall Study|Withdrawal by Subject|1|||
162173344|NCT04909801|585688072|FG000|Overall Study|other reasons|1|||
162173345|NCT04909801|585688073|FG001|Overall Study|other reasons|1|||
162173346|NCT05274074|585688074|FG000|Overall Study|Lost to Follow-up|2|||
162173347|NCT05274074|585688075|FG001|Overall Study|Lost to Follow-up|3|||
162173348|NCT05274074|585688074|FG000|Overall Study|Withdrawal by Subject|1|||
162173349|NCT05274074|585688075|FG001|Overall Study|Withdrawal by Subject|2|||
162173350|NCT04117347|585688076|FG000|Overall Study|Adverse Event|0|||
162173351|NCT04117347|585688077|FG001|Overall Study|Adverse Event|0|||
162173352|NCT04117347|585688078|FG002|Overall Study|Adverse Event|1|||
162173353|NCT04117347|585688076|FG000|Overall Study|No time for study|0|||
162173354|NCT04117347|585688077|FG001|Overall Study|No time for study|2|||
162173355|NCT04117347|585688078|FG002|Overall Study|No time for study|0|||
162173356|NCT04117347|585688076|FG000|Overall Study|Family emergency|1|||
162173357|NCT04117347|585688077|FG001|Overall Study|Family emergency|0|||
162173358|NCT04117347|585688078|FG002|Overall Study|Family emergency|0|||
162173359|NCT05194956|585688079|FG000|Washout Period|Withdrawal by Subject|0|||
162173360|NCT05194956|585688080|FG001|Washout Period|Withdrawal by Subject|2|||
162173361|NCT05485779|585688083|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
162173362|NCT05485779|585688084|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
162173363|NCT05485779|585688085|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
162173364|NCT05485779|585688086|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
162173365|NCT05485779|585688087|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
162173366|NCT05485779|585688088|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
162173367|NCT05485779|585688089|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
162173368|NCT05485779|585688090|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
162173369|NCT05485779|585688091|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
162173370|NCT05485779|585688092|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
162173371|NCT05485779|585688093|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
162173372|NCT05485779|585688083|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
162173373|NCT05485779|585688084|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
162173374|NCT05485779|585688085|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
162173375|NCT05485779|585688086|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
162173376|NCT05485779|585688087|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
162173377|NCT05485779|585688088|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
162173378|NCT05485779|585688089|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
162173379|NCT05485779|585688090|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
162173380|NCT05485779|585688091|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
162173381|NCT05485779|585688092|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
162173382|NCT05485779|585688093|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
162173383|NCT05485779|585688083|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162173384|NCT05485779|585688084|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162173385|NCT05485779|585688085|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162173386|NCT05485779|585688086|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
162173387|NCT05485779|585688087|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162173388|NCT05485779|585688088|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162173389|NCT05485779|585688089|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162173390|NCT05485779|585688090|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162173391|NCT05485779|585688091|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162173392|NCT05485779|585688092|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162173393|NCT05485779|585688093|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
162173394|NCT03676192|585688094|FG000|Induction Study Period|Adverse Event|21|||
162173395|NCT03676192|585688095|FG001|Induction Study Period|Adverse Event|20|||
162173396|NCT03676192|585688094|FG000|Induction Study Period|Death|23|||
162173397|NCT03676192|585688095|FG001|Induction Study Period|Death|20|||
162173398|NCT03676192|585688094|FG000|Induction Study Period|Lost to Follow-up|3|||
162173399|NCT03676192|585688095|FG001|Induction Study Period|Lost to Follow-up|3|||
162173400|NCT03676192|585688094|FG000|Induction Study Period|Physician Decision|6|||
162173401|NCT03676192|585688095|FG001|Induction Study Period|Physician Decision|3|||
162173402|NCT03676192|585688094|FG000|Induction Study Period|Progressive Disease|32|||
162173403|NCT03676192|585688095|FG001|Induction Study Period|Progressive Disease|21|||
162018231|NCT05019521|585121947|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
162018232|NCT05019521|585121948|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
162018233|NCT05019521|585121949|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
162018234|NCT05019521|585121950|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
161922802|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
162018235|NCT05019521|585121951|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
162018236|NCT05019521|585121952|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
162018237|NCT05019521|585121946|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
162018238|NCT05019521|585121947|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
162018239|NCT05019521|585121948|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
162018240|NCT05019521|585121949|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
162018241|NCT05019521|585121950|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
162018242|NCT05019521|585121951|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
162018243|NCT05019521|585121952|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
162018244|NCT05019521|585121946|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
162018245|NCT05019521|585121947|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
162018246|NCT05019521|585121948|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
162018247|NCT05019521|585121949|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
162018248|NCT05019521|585121950|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
162018249|NCT05019521|585121951|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
162018250|NCT05019521|585121952|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
162018251|NCT05019521|585121946|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
162018252|NCT05019521|585121947|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
162018253|NCT05019521|585121948|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
162018254|NCT05019521|585121949|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
162018255|NCT05019521|585121950|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
162018256|NCT05019521|585121951|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
161922803|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
161922804|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
161922805|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Death|1|||
161922806|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Death|0|||
161922807|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Death|0|||
161922808|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
161922809|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
161922810|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
161922811|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
161922812|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
161922813|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
161922814|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
161922815|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
161922816|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
161922817|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
161922818|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
161922819|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
161922820|NCT05073315|584764878|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
161922821|NCT05073315|584764879|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
161922822|NCT05073315|584764880|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
161922823|NCT05073315|584764878|FG000|Period 2|Adverse Event|0|||
161922824|NCT05073315|584764879|FG001|Period 2|Adverse Event|3|||
161922825|NCT05073315|584764880|FG002|Period 2|Adverse Event|6|||
161922826|NCT05073315|584764878|FG000|Period 2|Lost to Follow-up|0|||
161922827|NCT05073315|584764879|FG001|Period 2|Lost to Follow-up|5|||
161922828|NCT05073315|584764880|FG002|Period 2|Lost to Follow-up|5|||
161922829|NCT05073315|584764878|FG000|Period 2|Withdrawal by Subject|0|||
161922830|NCT05073315|584764879|FG001|Period 2|Withdrawal by Subject|4|||
161922831|NCT05073315|584764880|FG002|Period 2|Withdrawal by Subject|9|||
161922832|NCT05073315|584764878|FG000|Period 2|Protocol Violation|0|||
161922833|NCT05073315|584764879|FG001|Period 2|Protocol Violation|0|||
161922834|NCT05073315|584764880|FG002|Period 2|Protocol Violation|1|||
161922835|NCT01529268|584764881|FG000|Overall Study|Lost to Follow-up|9|||
161922836|NCT01529268|584764882|FG001|Overall Study|Lost to Follow-up|3|||
161922837|NCT01529268|584764881|FG000|Overall Study|Moved|3|||
161922838|NCT01529268|584764882|FG001|Overall Study|Moved|0|||
161922839|NCT00303953|584764883|FG000|Overall Study|Ineligible|1|||
162173404|NCT03676192|585688094|FG000|Induction Study Period|Protocol Violation|1|||
162173405|NCT03676192|585688095|FG001|Induction Study Period|Protocol Violation|2|||
162173406|NCT03676192|585688094|FG000|Induction Study Period|Withdrawal by Subject|20|||
162173407|NCT03676192|585688095|FG001|Induction Study Period|Withdrawal by Subject|15|||
162173408|NCT02424617|585688096|FG000|Overall Study|Adverse Event|0|||
162173409|NCT02424617|585688097|FG001|Overall Study|Adverse Event|1|||
162173410|NCT02424617|585688098|FG002|Overall Study|Adverse Event|0|||
162173411|NCT02424617|585688099|FG003|Overall Study|Adverse Event|0|||
162173412|NCT02424617|585688096|FG000|Overall Study|Investigator Decision|0|||
162173413|NCT02424617|585688097|FG001|Overall Study|Investigator Decision|0|||
162173414|NCT02424617|585688098|FG002|Overall Study|Investigator Decision|0|||
162173415|NCT02424617|585688099|FG003|Overall Study|Investigator Decision|1|||
162173416|NCT02424617|585688096|FG000|Overall Study|Withdrawal by Subject|1|||
162173417|NCT02424617|585688097|FG001|Overall Study|Withdrawal by Subject|1|||
162173418|NCT02424617|585688098|FG002|Overall Study|Withdrawal by Subject|0|||
162173419|NCT02424617|585688099|FG003|Overall Study|Withdrawal by Subject|1|||
162173420|NCT02424617|585688096|FG000|Overall Study|Progressive Disease|7|||
162173421|NCT02424617|585688097|FG001|Overall Study|Progressive Disease|6|||
162173422|NCT02424617|585688098|FG002|Overall Study|Progressive Disease|11|||
162173423|NCT02424617|585688099|FG003|Overall Study|Progressive Disease|10|||
162173424|NCT02424617|585688096|FG000|Overall Study|Other|0|||
162173425|NCT02424617|585688097|FG001|Overall Study|Other|0|||
162173426|NCT02424617|585688098|FG002|Overall Study|Other|0|||
162173427|NCT02424617|585688099|FG003|Overall Study|Other|1|||
162173428|NCT04778397|585688102|FG000|Overall Study|Death|59|||
162173429|NCT04778397|585688103|FG001|Overall Study|Death|54|||
162173430|NCT04778397|585688104|FG002|Overall Study|Death|11|||
162173431|NCT04778397|585688105|FG003|Overall Study|Death|9|||
162173432|NCT04778397|585688102|FG000|Overall Study|Study Terminated by Sponsor|34|||
162173433|NCT04778397|585688103|FG001|Overall Study|Study Terminated by Sponsor|42|||
162173434|NCT04778397|585688104|FG002|Overall Study|Study Terminated by Sponsor|15|||
162173435|NCT04778397|585688105|FG003|Overall Study|Study Terminated by Sponsor|12|||
162173436|NCT04778397|585688102|FG000|Overall Study|Withdrew Consent|5|||
162173437|NCT04778397|585688103|FG001|Overall Study|Withdrew Consent|4|||
162173438|NCT04778397|585688104|FG002|Overall Study|Withdrew Consent|1|||
162173439|NCT04778397|585688105|FG003|Overall Study|Withdrew Consent|1|||
162173440|NCT04778397|585688102|FG000|Overall Study|Reason Not Specified|1|||
162173441|NCT04778397|585688103|FG001|Overall Study|Reason Not Specified|3|||
162173442|NCT04778397|585688104|FG002|Overall Study|Reason Not Specified|0|||
162173443|NCT04778397|585688105|FG003|Overall Study|Reason Not Specified|2|||
162173444|NCT04778397|585688102|FG000|Overall Study|Lost to Follow-up|2|||
162173445|NCT04778397|585688103|FG001|Overall Study|Lost to Follow-up|1|||
162173446|NCT04778397|585688104|FG002|Overall Study|Lost to Follow-up|0|||
162173447|NCT04778397|585688105|FG003|Overall Study|Lost to Follow-up|1|||
162173448|NCT04294641|585688106|FG000|Overall Study|Screen failure|4|||
162018257|NCT05019521|585121952|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
162018258|NCT05019521|585121946|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
162018259|NCT05019521|585121947|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
162018260|NCT05019521|585121948|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
162018261|NCT05019521|585121949|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
162018262|NCT05019521|585121950|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
162018263|NCT05019521|585121951|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
162018264|NCT05019521|585121952|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
162018265|NCT05019521|585121946|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
162018266|NCT05019521|585121947|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
162018267|NCT05019521|585121948|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
162018268|NCT05019521|585121949|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
162018269|NCT05019521|585121950|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
162018270|NCT05019521|585121951|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
162018271|NCT05019521|585121952|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
162018272|NCT05019521|585121946|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
162018273|NCT05019521|585121947|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
162018274|NCT05019521|585121948|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
162018275|NCT05019521|585121949|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
162018276|NCT05019521|585121950|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
162018277|NCT05019521|585121951|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
162018278|NCT05019521|585121952|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
162018279|NCT05019521|585121946|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
162018280|NCT05019521|585121947|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
162018281|NCT05019521|585121948|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
162018282|NCT05019521|585121949|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
162018283|NCT05019521|585121950|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
162018284|NCT05019521|585121951|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
162018285|NCT05019521|585121952|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
162018286|NCT05019521|585121946|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
162018287|NCT05019521|585121947|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
162018288|NCT05019521|585121948|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
162018289|NCT05019521|585121949|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
162018290|NCT05019521|585121950|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
162018291|NCT05019521|585121951|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
162018292|NCT05019521|585121952|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
162018293|NCT05019521|585121946|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
162018294|NCT05019521|585121947|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
162018295|NCT05019521|585121948|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
162018296|NCT05019521|585121949|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
162018297|NCT05019521|585121950|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
162018298|NCT05019521|585121951|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
162018299|NCT05019521|585121952|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
162018300|NCT05019521|585121946|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
162018301|NCT05019521|585121947|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
162018302|NCT05019521|585121948|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
162018303|NCT05019521|585121949|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
162018304|NCT05019521|585121950|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
162018305|NCT05019521|585121951|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
162018306|NCT05019521|585121952|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
162018307|NCT05019521|585121946|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
162018308|NCT05019521|585121947|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
162018309|NCT05019521|585121948|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
162018310|NCT05019521|585121949|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
162018311|NCT05019521|585121950|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
162018312|NCT05019521|585121951|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
161670931|NCT01193920|583847347|FG005|Overall Study|Protocol Violation|0|||
161670932|NCT01193920|583847348|FG006|Overall Study|Protocol Violation|0|||
161670933|NCT01193920|583847349|FG007|Overall Study|Protocol Violation|0|||
161670934|NCT01193920|583847350|FG008|Overall Study|Protocol Violation|0|||
161670935|NCT01193920|583847351|FG009|Overall Study|Protocol Violation|0|||
161670936|NCT01193920|583847342|FG000|Overall Study|Death|0|||
161670937|NCT01193920|583847343|FG001|Overall Study|Death|0|||
161670938|NCT01193920|583847344|FG002|Overall Study|Death|0|||
161670939|NCT01193920|583847345|FG003|Overall Study|Death|1|||
161670940|NCT01193920|583847346|FG004|Overall Study|Death|0|||
161670941|NCT01193920|583847347|FG005|Overall Study|Death|0|||
161922840|NCT00303953|584764883|FG000|Overall Study|Death|1|||
161922841|NCT00303953|584764883|FG000|Overall Study|Adverse Event|4|||
161922842|NCT00303953|584764883|FG000|Overall Study|Lack of Efficacy|12|||
161670942|NCT01193920|583847348|FG006|Overall Study|Death|2|||
161670943|NCT01193920|583847349|FG007|Overall Study|Death|3|||
161670944|NCT01193920|583847350|FG008|Overall Study|Death|2|||
161670945|NCT01193920|583847351|FG009|Overall Study|Death|4|||
162173449|NCT05906784|585688108|FG000|Overall Study|Lost to Follow-up|2|||
162173450|NCT05906784|585688109|FG001|Overall Study|Lost to Follow-up|1|||
162173451|NCT05906784|585688110|FG002|Overall Study|Lost to Follow-up|1|||
162173452|NCT05906784|585688111|FG003|Overall Study|Lost to Follow-up|1|||
162173453|NCT03308877|585688112|FG000|Overall Study|Lost to Follow-up|32|||
162173454|NCT03308877|585688113|FG001|Overall Study|Lost to Follow-up|28|||
162173455|NCT03249090|585688121|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
162173456|NCT03249090|585688122|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
162173457|NCT03249090|585688121|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
162173458|NCT03249090|585688122|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
162173459|NCT03249090|585688121|FG000|3 Month Time Point|Voluntary withdrawal|6|||
162173460|NCT03249090|585688122|FG001|3 Month Time Point|Voluntary withdrawal|3|||
162173461|NCT03249090|585688121|FG000|3 Month Time Point|Changed oncology practice|4|||
162173462|NCT03249090|585688122|FG001|3 Month Time Point|Changed oncology practice|2|||
162173463|NCT03249090|585688121|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
162173464|NCT03249090|585688122|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
162173465|NCT03249090|585688121|FG000|12 Month Time Point|Voluntary withdrawal|35|||
162173466|NCT03249090|585688122|FG001|12 Month Time Point|Voluntary withdrawal|4|||
162173467|NCT03249090|585688121|FG000|12 Month Time Point|Changed oncology practice|20|||
162173468|NCT03249090|585688122|FG001|12 Month Time Point|Changed oncology practice|9|||
162173469|NCT04314778|585688128|FG000|Overall Study|Lost to Follow-up|5|||
162173470|NCT04314778|585688129|FG001|Overall Study|Lost to Follow-up|3|||
162173471|NCT02240238|585688132|FG000|Phase 1|Adverse Event|0|||
162173472|NCT02240238|585688133|FG001|Phase 1|Adverse Event|0|||
162173473|NCT02240238|585688134|FG002|Phase 1|Adverse Event|0|||
162173474|NCT02240238|585688135|FG003|Phase 1|Adverse Event|0|||
162173475|NCT02240238|585688136|FG004|Phase 1|Adverse Event|0|||
162173476|NCT02240238|585688137|FG005|Phase 1|Adverse Event|0|||
162173477|NCT02240238|585688138|FG006|Phase 1|Adverse Event|3|||
162173478|NCT02240238|585688139|FG007|Phase 1|Adverse Event|1|||
162173479|NCT02240238|585688140|FG008|Phase 1|Adverse Event|0|||
162173480|NCT02240238|585688141|FG009|Phase 1|Adverse Event|0|||
162173481|NCT02240238|585688142|FG010|Phase 1|Adverse Event|0|||
162173482|NCT02240238|585688143|FG011|Phase 1|Adverse Event|0|||
162173483|NCT02240238|585688132|FG000|Phase 1|Death|0|||
162173484|NCT02240238|585688133|FG001|Phase 1|Death|0|||
162173485|NCT02240238|585688134|FG002|Phase 1|Death|0|||
162173486|NCT02240238|585688135|FG003|Phase 1|Death|0|||
162173487|NCT02240238|585688136|FG004|Phase 1|Death|0|||
162173488|NCT02240238|585688137|FG005|Phase 1|Death|1|||
162173489|NCT02240238|585688138|FG006|Phase 1|Death|0|||
162173490|NCT02240238|585688139|FG007|Phase 1|Death|0|||
162173491|NCT02240238|585688140|FG008|Phase 1|Death|0|||
162173492|NCT02240238|585688141|FG009|Phase 1|Death|0|||
162173493|NCT02240238|585688142|FG010|Phase 1|Death|0|||
162173494|NCT02240238|585688143|FG011|Phase 1|Death|0|||
162173495|NCT02240238|585688132|FG000|Phase 1|Sponsor termination|0|||
162173496|NCT02240238|585688133|FG001|Phase 1|Sponsor termination|0|||
162173497|NCT02240238|585688134|FG002|Phase 1|Sponsor termination|0|||
162173498|NCT02240238|585688135|FG003|Phase 1|Sponsor termination|0|||
162173499|NCT02240238|585688136|FG004|Phase 1|Sponsor termination|0|||
162173500|NCT02240238|585688137|FG005|Phase 1|Sponsor termination|1|||
162173501|NCT02240238|585688138|FG006|Phase 1|Sponsor termination|0|||
162173502|NCT02240238|585688139|FG007|Phase 1|Sponsor termination|0|||
162173503|NCT02240238|585688140|FG008|Phase 1|Sponsor termination|0|||
162173504|NCT02240238|585688141|FG009|Phase 1|Sponsor termination|0|||
162173505|NCT02240238|585688142|FG010|Phase 1|Sponsor termination|0|||
162173506|NCT02240238|585688143|FG011|Phase 1|Sponsor termination|0|||
162173507|NCT02240238|585688132|FG000|Phase 1|Withdrawal by Subject|0|||
162173508|NCT02240238|585688133|FG001|Phase 1|Withdrawal by Subject|0|||
162173509|NCT02240238|585688134|FG002|Phase 1|Withdrawal by Subject|0|||
162173510|NCT02240238|585688135|FG003|Phase 1|Withdrawal by Subject|0|||
162173511|NCT02240238|585688136|FG004|Phase 1|Withdrawal by Subject|0|||
162173512|NCT02240238|585688137|FG005|Phase 1|Withdrawal by Subject|2|||
162173513|NCT02240238|585688138|FG006|Phase 1|Withdrawal by Subject|0|||
162173514|NCT02240238|585688139|FG007|Phase 1|Withdrawal by Subject|0|||
162173515|NCT02240238|585688140|FG008|Phase 1|Withdrawal by Subject|0|||
162173516|NCT02240238|585688141|FG009|Phase 1|Withdrawal by Subject|0|||
162173517|NCT02240238|585688142|FG010|Phase 1|Withdrawal by Subject|0|||
162173518|NCT02240238|585688143|FG011|Phase 1|Withdrawal by Subject|0|||
162173519|NCT02240238|585688132|FG000|Phase 1|Physician Decision|0|||
162173520|NCT02240238|585688133|FG001|Phase 1|Physician Decision|0|||
162173521|NCT02240238|585688134|FG002|Phase 1|Physician Decision|0|||
162173522|NCT02240238|585688135|FG003|Phase 1|Physician Decision|0|||
162173523|NCT02240238|585688136|FG004|Phase 1|Physician Decision|0|||
162173524|NCT02240238|585688137|FG005|Phase 1|Physician Decision|2|||
162173525|NCT02240238|585688138|FG006|Phase 1|Physician Decision|0|||
162173526|NCT02240238|585688139|FG007|Phase 1|Physician Decision|0|||
162173527|NCT02240238|585688140|FG008|Phase 1|Physician Decision|0|||
161817013|NCT04194801|584370899|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
161817014|NCT04194801|584370900|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
162173528|NCT02240238|585688141|FG009|Phase 1|Physician Decision|0|||
162173529|NCT02240238|585688142|FG010|Phase 1|Physician Decision|0|||
162173530|NCT02240238|585688143|FG011|Phase 1|Physician Decision|0|||
162173531|NCT02240238|585688132|FG000|Phase 2|Adverse Event|0|||
162173532|NCT02240238|585688133|FG001|Phase 2|Adverse Event|0|||
162173533|NCT02240238|585688134|FG002|Phase 2|Adverse Event|0|||
162173534|NCT02240238|585688135|FG003|Phase 2|Adverse Event|0|||
162173535|NCT02240238|585688136|FG004|Phase 2|Adverse Event|0|||
162173536|NCT02240238|585688137|FG005|Phase 2|Adverse Event|0|||
162173537|NCT02240238|585688138|FG006|Phase 2|Adverse Event|0|||
162173538|NCT02240238|585688139|FG007|Phase 2|Adverse Event|0|||
162173539|NCT02240238|585688140|FG008|Phase 2|Adverse Event|0|||
162173540|NCT02240238|585688141|FG009|Phase 2|Adverse Event|7|||
162173541|NCT02240238|585688142|FG010|Phase 2|Adverse Event|14|||
162173542|NCT02240238|585688143|FG011|Phase 2|Adverse Event|2|||
162173543|NCT02240238|585688132|FG000|Phase 2|Death|0|||
162173544|NCT02240238|585688133|FG001|Phase 2|Death|0|||
162173545|NCT02240238|585688134|FG002|Phase 2|Death|0|||
162173546|NCT02240238|585688135|FG003|Phase 2|Death|0|||
162173547|NCT02240238|585688136|FG004|Phase 2|Death|0|||
162173548|NCT02240238|585688137|FG005|Phase 2|Death|0|||
162173549|NCT02240238|585688138|FG006|Phase 2|Death|0|||
162173550|NCT02240238|585688139|FG007|Phase 2|Death|0|||
162173551|NCT02240238|585688140|FG008|Phase 2|Death|0|||
162173552|NCT02240238|585688141|FG009|Phase 2|Death|3|||
162173553|NCT02240238|585688142|FG010|Phase 2|Death|2|||
162173554|NCT02240238|585688143|FG011|Phase 2|Death|1|||
162173555|NCT02240238|585688132|FG000|Phase 2|Disease progression|0|||
162173556|NCT02240238|585688133|FG001|Phase 2|Disease progression|0|||
162173557|NCT02240238|585688134|FG002|Phase 2|Disease progression|0|||
162173558|NCT02240238|585688135|FG003|Phase 2|Disease progression|0|||
162173559|NCT02240238|585688136|FG004|Phase 2|Disease progression|0|||
162173560|NCT02240238|585688137|FG005|Phase 2|Disease progression|0|||
162173561|NCT02240238|585688138|FG006|Phase 2|Disease progression|0|||
162173562|NCT02240238|585688139|FG007|Phase 2|Disease progression|0|||
162173563|NCT02240238|585688140|FG008|Phase 2|Disease progression|0|||
162173564|NCT02240238|585688141|FG009|Phase 2|Disease progression|5|||
162173565|NCT02240238|585688142|FG010|Phase 2|Disease progression|11|||
162173566|NCT02240238|585688143|FG011|Phase 2|Disease progression|1|||
162173567|NCT02240238|585688132|FG000|Phase 2|Withdrawal by Subject|0|||
162173568|NCT02240238|585688133|FG001|Phase 2|Withdrawal by Subject|0|||
162173569|NCT02240238|585688134|FG002|Phase 2|Withdrawal by Subject|0|||
162173570|NCT02240238|585688135|FG003|Phase 2|Withdrawal by Subject|0|||
162173571|NCT02240238|585688136|FG004|Phase 2|Withdrawal by Subject|0|||
162173572|NCT02240238|585688137|FG005|Phase 2|Withdrawal by Subject|0|||
162173573|NCT02240238|585688138|FG006|Phase 2|Withdrawal by Subject|0|||
162173574|NCT02240238|585688139|FG007|Phase 2|Withdrawal by Subject|0|||
162173575|NCT02240238|585688140|FG008|Phase 2|Withdrawal by Subject|0|||
162173576|NCT02240238|585688141|FG009|Phase 2|Withdrawal by Subject|1|||
162173577|NCT02240238|585688142|FG010|Phase 2|Withdrawal by Subject|1|||
162173578|NCT02240238|585688143|FG011|Phase 2|Withdrawal by Subject|0|||
162173579|NCT02240238|585688132|FG000|Phase 2|Physician Decision|0|||
162173580|NCT02240238|585688133|FG001|Phase 2|Physician Decision|0|||
162173581|NCT02240238|585688134|FG002|Phase 2|Physician Decision|0|||
162173582|NCT02240238|585688135|FG003|Phase 2|Physician Decision|0|||
162173583|NCT02240238|585688136|FG004|Phase 2|Physician Decision|0|||
162173584|NCT02240238|585688137|FG005|Phase 2|Physician Decision|0|||
162173585|NCT02240238|585688138|FG006|Phase 2|Physician Decision|0|||
162173586|NCT02240238|585688139|FG007|Phase 2|Physician Decision|0|||
162173587|NCT02240238|585688140|FG008|Phase 2|Physician Decision|0|||
162173588|NCT02240238|585688141|FG009|Phase 2|Physician Decision|1|||
162173589|NCT02240238|585688142|FG010|Phase 2|Physician Decision|3|||
162173590|NCT02240238|585688143|FG011|Phase 2|Physician Decision|0|||
162173591|NCT02240238|585688132|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161670946|NCT01193920|583847342|FG000|Overall Study|Unable to classify|0|||
161670947|NCT01193920|583847343|FG001|Overall Study|Unable to classify|0|||
161670948|NCT01193920|583847344|FG002|Overall Study|Unable to classify|0|||
161670949|NCT01193920|583847345|FG003|Overall Study|Unable to classify|1|||
161670950|NCT01193920|583847346|FG004|Overall Study|Unable to classify|0|||
161670951|NCT01193920|583847347|FG005|Overall Study|Unable to classify|0|||
161670952|NCT01193920|583847348|FG006|Overall Study|Unable to classify|0|||
161670953|NCT01193920|583847349|FG007|Overall Study|Unable to classify|1|||
161670954|NCT01193920|583847350|FG008|Overall Study|Unable to classify|0|||
161670955|NCT01193920|583847351|FG009|Overall Study|Unable to classify|0|||
161670956|NCT01323621|583847352|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
161670957|NCT01323621|583847353|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
161670958|NCT01323621|583847354|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
161670959|NCT01323621|583847352|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
161670960|NCT01323621|583847353|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
161670961|NCT01323621|583847354|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
161670962|NCT01323621|583847352|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
161670963|NCT01323621|583847353|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
161670964|NCT01323621|583847354|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
161670965|NCT01323621|583847352|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
161670966|NCT01323621|583847353|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
161670967|NCT01323621|583847354|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
161670968|NCT01323621|583847352|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
161670969|NCT01323621|583847353|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
161670970|NCT01323621|583847354|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
161670971|NCT01323621|583847352|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
161670972|NCT01323621|583847353|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
161670973|NCT01323621|583847354|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
161817015|NCT04194801|584370901|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
161817016|NCT04194801|584370899|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
161817017|NCT04194801|584370900|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
162173592|NCT02240238|585688133|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162173593|NCT02240238|585688134|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162173594|NCT02240238|585688135|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162173595|NCT02240238|585688136|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162173596|NCT02240238|585688137|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162173597|NCT02240238|585688138|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162173598|NCT02240238|585688139|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162173599|NCT02240238|585688140|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162173600|NCT02240238|585688141|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
162173601|NCT02240238|585688142|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162173602|NCT02240238|585688143|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
162173603|NCT02240238|585688132|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162173604|NCT02240238|585688133|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162173605|NCT02240238|585688134|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162173606|NCT02240238|585688135|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162173607|NCT02240238|585688136|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162173608|NCT02240238|585688137|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162173609|NCT02240238|585688138|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162173610|NCT02240238|585688139|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162173611|NCT02240238|585688140|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162173612|NCT02240238|585688141|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
162173613|NCT02240238|585688142|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162173614|NCT02240238|585688143|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
162173615|NCT02240238|585688132|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162173616|NCT02240238|585688133|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162173617|NCT02240238|585688134|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162173618|NCT02240238|585688135|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162173619|NCT02240238|585688136|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162173620|NCT02240238|585688137|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162173621|NCT02240238|585688138|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162173622|NCT02240238|585688139|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162173623|NCT02240238|585688140|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162173624|NCT02240238|585688141|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162173625|NCT02240238|585688142|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
162173626|NCT02240238|585688143|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
162173627|NCT02240238|585688132|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162173628|NCT02240238|585688133|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162173629|NCT02240238|585688134|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162173630|NCT02240238|585688135|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162173631|NCT02240238|585688136|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162173632|NCT02240238|585688137|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162173633|NCT02240238|585688138|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162173634|NCT02240238|585688139|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162173635|NCT02240238|585688140|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162173636|NCT02240238|585688141|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162173637|NCT02240238|585688142|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
162173638|NCT02240238|585688143|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
162173639|NCT02240238|585688132|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162173640|NCT02240238|585688133|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162173641|NCT02240238|585688134|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162173642|NCT02240238|585688135|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162173643|NCT02240238|585688136|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162173644|NCT02240238|585688137|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162173645|NCT02240238|585688138|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162173646|NCT02240238|585688139|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162173647|NCT02240238|585688140|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162173648|NCT02240238|585688141|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
162173649|NCT02240238|585688142|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
162173650|NCT02240238|585688143|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161922843|NCT00303953|584764883|FG000|Overall Study|Physician Decision|1|||
162173651|NCT02240238|585688132|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162173652|NCT02240238|585688133|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162173653|NCT02240238|585688134|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162173654|NCT02240238|585688135|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162173655|NCT02240238|585688136|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162173656|NCT02240238|585688137|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162173657|NCT02240238|585688138|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162173658|NCT02240238|585688139|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162173659|NCT02240238|585688140|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162173660|NCT02240238|585688141|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
162173661|NCT02240238|585688142|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
162173662|NCT02240238|585688143|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161922844|NCT00021255|584764884|FG000|Overall Study|Death|1|||
162173663|NCT02240238|585688132|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161670974|NCT01323621|583847352|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
161670975|NCT01323621|583847353|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
161670976|NCT01323621|583847354|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
161670977|NCT01323621|583847352|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
161670978|NCT01323621|583847353|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
161670979|NCT01323621|583847354|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
161670980|NCT01323621|583847352|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
161670981|NCT01323621|583847353|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
161670982|NCT01323621|583847354|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
161670983|NCT01323621|583847352|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161670984|NCT01323621|583847353|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
161670985|NCT01323621|583847354|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161670986|NCT01323621|583847352|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
161670987|NCT01323621|583847353|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
161670988|NCT01323621|583847354|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
161670989|NCT01323621|583847352|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161670990|NCT01323621|583847353|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
161670991|NCT01323621|583847354|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
161670992|NCT00954421|583847355|FG000|Screening|screen failures|3|||
161670993|NCT00954421|583847355|FG000|6 Months of DBS|Withdrawal by Subject|1|||
161670994|NCT00954421|583847355|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
161670995|NCT04683731|583847358|FG000|Overall Study|Withdrawal by Subject|1|||
161670996|NCT04683731|583847359|FG001|Overall Study|Withdrawal by Subject|0|||
161670997|NCT04683731|583847360|FG002|Overall Study|Withdrawal by Subject|3|||
161670998|NCT04683731|583847361|FG003|Overall Study|Withdrawal by Subject|2|||
161670999|NCT04683731|583847358|FG000|Overall Study|Determined patient was not eligible|3|||
161671000|NCT04683731|583847359|FG001|Overall Study|Determined patient was not eligible|3|||
161671001|NCT04683731|583847360|FG002|Overall Study|Determined patient was not eligible|12|||
161671002|NCT04683731|583847361|FG003|Overall Study|Determined patient was not eligible|3|||
161671003|NCT00883051|583847362|FG000|Overall Study|Lost to Follow-up|0|||
161671004|NCT00883051|583847363|FG001|Overall Study|Lost to Follow-up|0|||
161671005|NCT00883051|583847364|FG002|Overall Study|Lost to Follow-up|0|||
161671006|NCT00883051|583847365|FG003|Overall Study|Lost to Follow-up|0|||
161671007|NCT00883051|583847366|FG004|Overall Study|Lost to Follow-up|1|||
161671008|NCT00883051|583847362|FG000|Overall Study|Did not use study medication|24|||
161671009|NCT00883051|583847363|FG001|Overall Study|Did not use study medication|22|||
161671010|NCT00883051|583847364|FG002|Overall Study|Did not use study medication|29|||
161671011|NCT00883051|583847365|FG003|Overall Study|Did not use study medication|29|||
161671012|NCT00883051|583847366|FG004|Overall Study|Did not use study medication|17|||
161671013|NCT03144804|583847367|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
161671014|NCT00959647|583847368|FG000|Overall Study|Adverse Event|2|||
161671015|NCT00959647|583847368|FG000|Overall Study|Progressive disease|6|||
161671016|NCT00959647|583847368|FG000|Overall Study|Study terminated by sponsor|4|||
161671017|NCT00959647|583847368|FG000|Overall Study|Withdrawal by Subject|7|||
161671018|NCT04223856|583847369|FG000|Overall Study|Progressive disease|153|||
161671019|NCT04223856|583847370|FG001|Overall Study|Progressive disease|73|||
161671020|NCT04223856|583847369|FG000|Overall Study|Adverse Event|97|||
161671021|NCT04223856|583847370|FG001|Overall Study|Adverse Event|62|||
161671022|NCT04223856|583847369|FG000|Overall Study|Physician Decision|9|||
161671023|NCT04223856|583847370|FG001|Overall Study|Physician Decision|28|||
161671024|NCT04223856|583847369|FG000|Overall Study|Withdrawal by Subject|22|||
161671025|NCT04223856|583847370|FG001|Overall Study|Withdrawal by Subject|24|||
161671026|NCT04223856|583847369|FG000|Overall Study|Other|7|||
161671027|NCT04223856|583847370|FG001|Overall Study|Other|2|||
161671028|NCT04223856|583847369|FG000|Overall Study|Randomized but not treated|2|||
161671029|NCT04223856|583847370|FG001|Overall Study|Randomized but not treated|11|||
161671030|NCT04223856|583847369|FG000|Overall Study|On-treatment|144|||
162173664|NCT02240238|585688133|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162173665|NCT02240238|585688134|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162173666|NCT02240238|585688135|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162173667|NCT02240238|585688136|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162173668|NCT02240238|585688137|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162173669|NCT02240238|585688138|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162173670|NCT02240238|585688139|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161671031|NCT04223856|583847370|FG001|Overall Study|On-treatment|0|||
162018313|NCT05019521|585121952|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
161671032|NCT06515483|583847373|FG000|Overall Study|Subject withdraw due to family issues|1|||
161671033|NCT06515483|583847374|FG001|Overall Study|Subject withdraw due to family issues|0|||
161671034|NCT05104476|583849022|FG000|Overall Study|Randomized But Not Treated|1|||
161671035|NCT05104476|583849023|FG001|Overall Study|Randomized But Not Treated|2|||
162173671|NCT02240238|585688140|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162173672|NCT02240238|585688141|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162173673|NCT02240238|585688142|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
162173674|NCT02240238|585688143|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
162173675|NCT02240238|585688132|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162173676|NCT02240238|585688133|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162173677|NCT02240238|585688134|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162173678|NCT02240238|585688135|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162173679|NCT02240238|585688136|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162173680|NCT02240238|585688137|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162173681|NCT02240238|585688138|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161671036|NCT05104476|583849022|FG000|Overall Study|Adverse Event|2|||
161671037|NCT05104476|583849023|FG001|Overall Study|Adverse Event|2|||
161671038|NCT05104476|583849022|FG000|Overall Study|Withdrawal by Subject|3|||
161817018|NCT04194801|584370901|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
162173682|NCT02240238|585688139|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162173683|NCT02240238|585688140|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162173684|NCT02240238|585688141|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162173685|NCT02240238|585688142|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
162173686|NCT02240238|585688143|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
162173687|NCT03625115|585688156|FG000|Overall Study|Withdrawal by Subject|4|||
162173688|NCT03625115|585688157|FG001|Overall Study|Withdrawal by Subject|7|||
162173689|NCT03625115|585688156|FG000|Overall Study|Lost to Follow-up|17|||
162173690|NCT03625115|585688157|FG001|Overall Study|Lost to Follow-up|24|||
162173691|NCT04197336|585688158|FG000|Overall Study|Withdrawal by Subject|1|||
162173692|NCT05868382|585688160|FG000|Overall Study|Lost to Follow-up|5|||
162173693|NCT05868382|585688161|FG001|Overall Study|Lost to Follow-up|0|||
162173694|NCT05868382|585688162|FG002|Overall Study|Lost to Follow-up|6|||
162173695|NCT05868382|585688163|FG003|Overall Study|Lost to Follow-up|4|||
162173696|NCT05868382|585688164|FG004|Overall Study|Lost to Follow-up|2|||
162173697|NCT05868382|585688165|FG005|Overall Study|Lost to Follow-up|6|||
162173698|NCT05868382|585688160|FG000|Overall Study|Withdrawal by Subject|1|||
162173699|NCT05868382|585688161|FG001|Overall Study|Withdrawal by Subject|0|||
162173700|NCT05868382|585688162|FG002|Overall Study|Withdrawal by Subject|0|||
162173701|NCT05868382|585688163|FG003|Overall Study|Withdrawal by Subject|0|||
162173702|NCT05868382|585688164|FG004|Overall Study|Withdrawal by Subject|1|||
162173703|NCT05868382|585688165|FG005|Overall Study|Withdrawal by Subject|0|||
162173704|NCT03655028|585688166|FG000|12-weeks Follow up|Death|1|||
162173705|NCT03655028|585688167|FG001|12-weeks Follow up|Death|0|||
162173706|NCT03655028|585688166|FG000|12-weeks Follow up|Physician Decision|3|||
162173707|NCT03655028|585688167|FG001|12-weeks Follow up|Physician Decision|3|||
162173708|NCT03655028|585688166|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
162173709|NCT03655028|585688167|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
162173710|NCT03655028|585688166|FG000|12-weeks Follow up|Lost to Follow-up|4|||
162173711|NCT03655028|585688167|FG001|12-weeks Follow up|Lost to Follow-up|4|||
162173712|NCT03655028|585688166|FG000|24-weeks|Lost to Follow-up|1|||
162173713|NCT03655028|585688167|FG001|24-weeks|Lost to Follow-up|1|||
161817019|NCT04194801|584370899|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
161817020|NCT04194801|584370900|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
162173714|NCT03655028|585688166|FG000|24-weeks|Death|0|||
161817021|NCT04194801|584370901|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
162173715|NCT03655028|585688167|FG001|24-weeks|Death|1|||
162173716|NCT03513302|585688168|FG000|First Intervention (14 Days)|Screen failure|15|||
162173717|NCT03513302|585688169|FG001|First Intervention (14 Days)|Screen failure|16|||
162173718|NCT04577963|585688170|FG000|Part 2|Death|0|||
162173719|NCT04577963|585688171|FG001|Part 2|Death|1|||
162173720|NCT04577963|585688172|FG002|Part 2|Death|8|||
162173721|NCT04577963|585688173|FG003|Part 2|Death|0|||
162173722|NCT04577963|585688174|FG004|Part 2|Death|20|||
162173723|NCT04577963|585688170|FG000|Part 2|Lost to Follow-up|0|||
162173724|NCT04577963|585688171|FG001|Part 2|Lost to Follow-up|0|||
162173725|NCT04577963|585688172|FG002|Part 2|Lost to Follow-up|0|||
162173726|NCT04577963|585688173|FG003|Part 2|Lost to Follow-up|0|||
162173727|NCT04577963|585688174|FG004|Part 2|Lost to Follow-up|2|||
162173728|NCT04577963|585688170|FG000|Part 2|Withdrawal by Subject|0|||
162173729|NCT04577963|585688171|FG001|Part 2|Withdrawal by Subject|0|||
162173730|NCT04577963|585688172|FG002|Part 2|Withdrawal by Subject|0|||
162173731|NCT04577963|585688173|FG003|Part 2|Withdrawal by Subject|0|||
162173732|NCT04577963|585688174|FG004|Part 2|Withdrawal by Subject|10|||
162173733|NCT04577963|585688170|FG000|Part 2|Progressive disease|0|||
162173734|NCT04577963|585688171|FG001|Part 2|Progressive disease|0|||
162173735|NCT04577963|585688172|FG002|Part 2|Progressive disease|0|||
162173736|NCT04577963|585688173|FG003|Part 2|Progressive disease|0|||
162173737|NCT04577963|585688174|FG004|Part 2|Progressive disease|2|||
162173738|NCT04577963|585688170|FG000|Part 2|Investigator decision|0|||
162173739|NCT04577963|585688171|FG001|Part 2|Investigator decision|0|||
162173740|NCT04577963|585688172|FG002|Part 2|Investigator decision|0|||
162173741|NCT04577963|585688173|FG003|Part 2|Investigator decision|0|||
162173742|NCT04577963|585688174|FG004|Part 2|Investigator decision|1|||
162173743|NCT04577963|585688170|FG000|Part 2|Sponsor terminated study|0|||
162173744|NCT04577963|585688171|FG001|Part 2|Sponsor terminated study|0|||
162173745|NCT04577963|585688172|FG002|Part 2|Sponsor terminated study|3|||
162173746|NCT04577963|585688173|FG003|Part 2|Sponsor terminated study|1|||
162173747|NCT04577963|585688174|FG004|Part 2|Sponsor terminated study|4|||
162173748|NCT05256654|585688175|FG000|Overall Study|Adverse Event|0|||
162173749|NCT05256654|585688176|FG001|Overall Study|Adverse Event|0|||
162173750|NCT05256654|585688177|FG002|Overall Study|Adverse Event|1|||
162173751|NCT05256654|585688178|FG003|Overall Study|Adverse Event|0|||
162173752|NCT05256654|585688175|FG000|Overall Study|Lost to Follow-up|0|||
162173753|NCT05256654|585688176|FG001|Overall Study|Lost to Follow-up|0|||
162173754|NCT05256654|585688177|FG002|Overall Study|Lost to Follow-up|0|||
162173755|NCT05256654|585688178|FG003|Overall Study|Lost to Follow-up|1|||
162173756|NCT05256654|585688175|FG000|Overall Study|Withdrawal by Subject|1|||
162173757|NCT05256654|585688176|FG001|Overall Study|Withdrawal by Subject|2|||
162173758|NCT05256654|585688177|FG002|Overall Study|Withdrawal by Subject|1|||
162173759|NCT05256654|585688178|FG003|Overall Study|Withdrawal by Subject|3|||
162173760|NCT05256654|585688175|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
162173761|NCT05256654|585688176|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
162173762|NCT05256654|585688177|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
162173763|NCT05256654|585688178|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
162173764|NCT05256654|585688175|FG000|Overall Study|Other|0|||
162173765|NCT05256654|585688176|FG001|Overall Study|Other|0|||
162173766|NCT05256654|585688177|FG002|Overall Study|Other|0|||
162173767|NCT05256654|585688178|FG003|Overall Study|Other|1|||
162173768|NCT02709161|585688179|FG000|Overall Study|Withdrawal by Subject|1|||
162173769|NCT02709161|585688180|FG001|Overall Study|Withdrawal by Subject|0|||
162173770|NCT01221948|585688183|FG000|Overall Study|Physician Decision|5|||
162173771|NCT01221948|585688183|FG000|Overall Study|Withdrawal by Subject|2|||
162173772|NCT01221948|585688183|FG000|Overall Study|not disclosed|2|||
162173773|NCT01221948|585688183|FG000|Overall Study|Death|1|||
162173774|NCT01221948|585688183|FG000|Overall Study|Protocol Violation|4|||
162173775|NCT00746096|585688184|FG000|Overall Study|Adverse Event|1|||
162173776|NCT00746096|585688185|FG001|Overall Study|Adverse Event|0|||
162173777|NCT00746096|585688184|FG000|Overall Study|Withdrawal by Subject|5|||
162173778|NCT00746096|585688185|FG001|Overall Study|Withdrawal by Subject|1|||
162173779|NCT00746096|585688184|FG000|Overall Study|Lost to Follow-up|2|||
162173780|NCT00746096|585688185|FG001|Overall Study|Lost to Follow-up|1|||
162173781|NCT00746096|585688184|FG000|Overall Study|Protocol Violation|1|||
162173782|NCT00746096|585688185|FG001|Overall Study|Protocol Violation|0|||
162173783|NCT00746096|585688184|FG000|Overall Study|No study drug treatment|1|||
162173784|NCT00746096|585688185|FG001|Overall Study|No study drug treatment|1|||
162173785|NCT03756662|585688186|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
162173786|NCT04295512|585688191|FG000|Overall Study|Lack of family response to schedule assessment|0|||
162173787|NCT04295512|585688192|FG001|Overall Study|Lack of family response to schedule assessment|0|||
162173788|NCT04295512|585688193|FG002|Overall Study|Lack of family response to schedule assessment|0|||
162173789|NCT04295512|585688194|FG003|Overall Study|Lack of family response to schedule assessment|2|||
162173790|NCT04295512|585688191|FG000|Overall Study|Therapist did not refer eligible family|7|||
162173791|NCT04295512|585688192|FG001|Overall Study|Therapist did not refer eligible family|7|||
162173792|NCT04295512|585688193|FG002|Overall Study|Therapist did not refer eligible family|0|||
162173793|NCT04295512|585688194|FG003|Overall Study|Therapist did not refer eligible family|0|||
162173794|NCT05207956|585688198|FG000|Overall Study|Lost to follow up|1|||
162173795|NCT05207956|585688199|FG001|Overall Study|Lost to follow up|2|||
161671039|NCT05104476|583849023|FG001|Overall Study|Withdrawal by Subject|3|||
161671040|NCT05104476|583849022|FG000|Overall Study|Other Than Specified|0|||
161671041|NCT05104476|583849023|FG001|Overall Study|Other Than Specified|3|||
161671042|NCT00992511|583849026|FG000|Overall Study|Migrated/moved from study area|1|||
161671043|NCT00992511|583849027|FG001|Overall Study|Migrated/moved from study area|0|||
161671044|NCT00992511|583849028|FG002|Overall Study|Migrated/moved from study area|1|||
162173796|NCT01254864|585688201|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
162173797|NCT01254864|585688202|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
162173798|NCT01254864|585688203|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
162173799|NCT01254864|585688201|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
162173800|NCT01254864|585688202|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
162173801|NCT01254864|585688203|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
162173802|NCT01254864|585688201|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
162173803|NCT01254864|585688202|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
162173804|NCT01254864|585688203|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
162173805|NCT01254864|585688201|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
162173806|NCT01254864|585688202|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
162173807|NCT01254864|585688203|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
162173808|NCT01254864|585688201|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
162173809|NCT01254864|585688202|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
161671045|NCT00992511|583849029|FG003|Overall Study|Migrated/moved from study area|2|||
162018314|NCT05019521|585121946|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
162173810|NCT01254864|585688203|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
162173811|NCT01254864|585688201|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
162173812|NCT01254864|585688202|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
162173813|NCT01254864|585688203|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
162173814|NCT01254864|585688201|FG000|Randomization Phase|Adverse Event|0|||
162173815|NCT01254864|585688202|FG001|Randomization Phase|Adverse Event|5|||
162173816|NCT01254864|585688203|FG002|Randomization Phase|Adverse Event|17|||
162173817|NCT01254864|585688201|FG000|Randomization Phase|Death|0|||
162173818|NCT01254864|585688202|FG001|Randomization Phase|Death|1|||
162173819|NCT01254864|585688203|FG002|Randomization Phase|Death|0|||
162173820|NCT01254864|585688201|FG000|Randomization Phase|Lost to Follow-up|0|||
162173821|NCT01254864|585688202|FG001|Randomization Phase|Lost to Follow-up|0|||
162173822|NCT01254864|585688203|FG002|Randomization Phase|Lost to Follow-up|1|||
162173823|NCT01254864|585688201|FG000|Randomization Phase|Physician Decision|0|||
162173824|NCT01254864|585688202|FG001|Randomization Phase|Physician Decision|20|||
162173825|NCT01254864|585688203|FG002|Randomization Phase|Physician Decision|25|||
162173826|NCT01254864|585688201|FG000|Randomization Phase|Withdrawal by Subject|0|||
162173827|NCT01254864|585688202|FG001|Randomization Phase|Withdrawal by Subject|4|||
162173828|NCT01254864|585688203|FG002|Randomization Phase|Withdrawal by Subject|2|||
162173829|NCT01254864|585688201|FG000|Randomization Phase|Non-Compliance|0|||
162173830|NCT01254864|585688202|FG001|Randomization Phase|Non-Compliance|1|||
162173831|NCT01254864|585688203|FG002|Randomization Phase|Non-Compliance|0|||
162173832|NCT01254864|585688201|FG000|Randomization Phase|Comorbidities|0|||
162173833|NCT01254864|585688202|FG001|Randomization Phase|Comorbidities|2|||
162173834|NCT01254864|585688203|FG002|Randomization Phase|Comorbidities|1|||
162173835|NCT04141891|585688205|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
162173836|NCT04141891|585688206|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
162173837|NCT04141891|585688205|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
162173838|NCT04141891|585688206|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
162173839|NCT04141891|585688205|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
162173840|NCT04141891|585688206|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
162173841|NCT04141891|585688205|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
162173842|NCT04141891|585688206|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
162173843|NCT04141891|585688205|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
162173844|NCT04141891|585688206|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
162173845|NCT04141891|585688205|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
162173846|NCT04141891|585688206|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
162173847|NCT04141891|585688205|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
162173848|NCT04141891|585688206|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
162173849|NCT04141891|585688205|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
162173850|NCT04141891|585688206|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
162173851|NCT04141891|585688205|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
162173852|NCT04141891|585688206|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
162173853|NCT04141891|585688205|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
162173854|NCT04141891|585688206|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
162173855|NCT04141891|585688205|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
162173856|NCT04141891|585688206|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
162173857|NCT04141891|585688205|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
162173858|NCT04141891|585688206|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
162173859|NCT04141891|585688205|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
162173860|NCT04141891|585688206|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
162173861|NCT04141891|585688205|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
162173862|NCT04141891|585688206|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
162173863|NCT03626220|585688207|FG000|Overall Study|Withdrawal by Subject|2|||
162173864|NCT03626220|585688208|FG001|Overall Study|Withdrawal by Subject|0|||
162173865|NCT04571619|585688209|FG000|Phase 1|Death|22|||
162173866|NCT04571619|585688210|FG001|Phase 1|Death|18|||
162173867|NCT04571619|585688209|FG000|Phase 1|Withdrawal by Subject|7|||
162173868|NCT04571619|585688210|FG001|Phase 1|Withdrawal by Subject|2|||
162173869|NCT04571619|585688209|FG000|Phase 2|Death|13|||
162173870|NCT04571619|585688210|FG001|Phase 2|Death|16|||
162173871|NCT04571619|585688209|FG000|Phase 2|Withdrawal by Subject|6|||
162173872|NCT04571619|585688210|FG001|Phase 2|Withdrawal by Subject|4|||
162173873|NCT05209152|585688212|FG000|Overall Study|Sponsor decision|1|||
162173874|NCT05209152|585688213|FG001|Overall Study|Sponsor decision|2|||
162173875|NCT05209152|585688212|FG000|Overall Study|Death|3|||
162173876|NCT05209152|585688213|FG001|Overall Study|Death|1|||
162173877|NCT04850898|585690449|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
162173878|NCT04850898|585690450|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
162173879|NCT04550221|585690457|FG000|Overall Study|Lost to Follow-up|0|||
162173880|NCT04550221|585690458|FG001|Overall Study|Lost to Follow-up|4|||
162173881|NCT04550221|585690457|FG000|Overall Study|Withdrawn|3|||
162173882|NCT04550221|585690458|FG001|Overall Study|Withdrawn|0|||
162173883|NCT04550221|585690457|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
162173884|NCT04550221|585690458|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
162173885|NCT05452460|585690459|FG000|Overall Study|Lost to Follow-up|3|||
162173886|NCT05452460|585690460|FG001|Overall Study|Lost to Follow-up|3|||
162173887|NCT05452460|585690459|FG000|Overall Study|Did not receive intervention|1|||
162173888|NCT05452460|585690460|FG001|Overall Study|Did not receive intervention|0|||
162173889|NCT04447040|585690462|FG000|Overall Study|Lost to Follow-up|2|||
162173890|NCT04447040|585690463|FG001|Overall Study|Lost to Follow-up|1|||
162173891|NCT04447040|585690464|FG002|Overall Study|Lost to Follow-up|3|||
162173892|NCT04447040|585690465|FG003|Overall Study|Lost to Follow-up|3|||
162173893|NCT04447040|585690466|FG004|Overall Study|Lost to Follow-up|1|||
162173894|NCT04447040|585690467|FG005|Overall Study|Lost to Follow-up|3|||
162173895|NCT04447040|585690462|FG000|Overall Study|Withdrawal by Subject|0|||
162173896|NCT04447040|585690463|FG001|Overall Study|Withdrawal by Subject|1|||
162173897|NCT04447040|585690464|FG002|Overall Study|Withdrawal by Subject|1|||
162173898|NCT04447040|585690465|FG003|Overall Study|Withdrawal by Subject|1|||
162173899|NCT04447040|585690466|FG004|Overall Study|Withdrawal by Subject|0|||
162173900|NCT04447040|585690467|FG005|Overall Study|Withdrawal by Subject|0|||
162173901|NCT01208662|585690468|FG000|Induction and Consolidation|Disease Progression|23|||
162173902|NCT01208662|585690469|FG001|Induction and Consolidation|Disease Progression|13|||
162173903|NCT01208662|585690470|FG002|Induction and Consolidation|Disease Progression|0|||
162173904|NCT01208662|585690468|FG000|Induction and Consolidation|Adverse Event|16|||
162173905|NCT01208662|585690469|FG001|Induction and Consolidation|Adverse Event|18|||
162173906|NCT01208662|585690470|FG002|Induction and Consolidation|Adverse Event|2|||
162173907|NCT01208662|585690468|FG000|Induction and Consolidation|MD or Participant Decision|16|||
162173908|NCT01208662|585690469|FG001|Induction and Consolidation|MD or Participant Decision|34|||
162173909|NCT01208662|585690470|FG002|Induction and Consolidation|MD or Participant Decision|4|||
162173910|NCT01208662|585690468|FG000|Induction and Consolidation|Death|1|||
162173911|NCT01208662|585690469|FG001|Induction and Consolidation|Death|3|||
162173912|NCT01208662|585690470|FG002|Induction and Consolidation|Death|1|||
162173913|NCT01208662|585690468|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
162173914|NCT01208662|585690469|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
162173915|NCT01208662|585690470|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
162173916|NCT01208662|585690468|FG000|Maintenance|Disease Progression|156|||
162173917|NCT01208662|585690469|FG001|Maintenance|Disease Progression|102|||
162173918|NCT01208662|585690470|FG002|Maintenance|Disease Progression|0|||
162173919|NCT01208662|585690468|FG000|Maintenance|Adverse Event|12|||
162173920|NCT01208662|585690469|FG001|Maintenance|Adverse Event|28|||
162173921|NCT01208662|585690470|FG002|Maintenance|Adverse Event|0|||
162173922|NCT01208662|585690468|FG000|Maintenance|MD or Participant Decision|24|||
162173923|NCT01208662|585690469|FG001|Maintenance|MD or Participant Decision|36|||
162173924|NCT01208662|585690470|FG002|Maintenance|MD or Participant Decision|0|||
162173925|NCT01208662|585690468|FG000|Maintenance|Death|0|||
162173926|NCT01208662|585690469|FG001|Maintenance|Death|3|||
162173927|NCT01208662|585690470|FG002|Maintenance|Death|0|||
162173928|NCT01208662|585690468|FG000|Maintenance|Discontinued for other reasons|21|||
162173929|NCT01208662|585690469|FG001|Maintenance|Discontinued for other reasons|31|||
162173930|NCT01208662|585690470|FG002|Maintenance|Discontinued for other reasons|0|||
162173931|NCT01208662|585690468|FG000|Maintenance|Still on Treatment|78|||
162173932|NCT01208662|585690469|FG001|Maintenance|Still on Treatment|89|||
162173933|NCT01208662|585690470|FG002|Maintenance|Still on Treatment|0|||
162173934|NCT04433208|585690471|FG000|Overall Study|Withdrawal by Subject|0|||
162173935|NCT04433208|585690472|FG001|Overall Study|Withdrawal by Subject|1|||
162173936|NCT04433208|585690473|FG002|Overall Study|Withdrawal by Subject|1|||
162173937|NCT04433208|585690474|FG003|Overall Study|Withdrawal by Subject|0|||
162173938|NCT04433208|585690475|FG004|Overall Study|Withdrawal by Subject|2|||
162173939|NCT04433208|585690476|FG005|Overall Study|Withdrawal by Subject|1|||
162173940|NCT04433208|585690471|FG000|Overall Study|Lost to Follow-up|0|||
162173941|NCT04433208|585690472|FG001|Overall Study|Lost to Follow-up|0|||
162173942|NCT04433208|585690473|FG002|Overall Study|Lost to Follow-up|0|||
162173943|NCT04433208|585690474|FG003|Overall Study|Lost to Follow-up|0|||
162173944|NCT04433208|585690475|FG004|Overall Study|Lost to Follow-up|0|||
162173945|NCT04433208|585690476|FG005|Overall Study|Lost to Follow-up|1|||
162173946|NCT02694822|585690479|FG000|Phase 1|Death|2|||
162173947|NCT02694822|585690480|FG001|Phase 1|Death|1|||
162173948|NCT02694822|585690481|FG002|Phase 1|Death|6|||
162173949|NCT02694822|585690482|FG003|Phase 1|Death|6|||
162173950|NCT02694822|585690483|FG004|Phase 1|Death|3|||
162173951|NCT02694822|585690484|FG005|Phase 1|Death|0|||
162173952|NCT02694822|585690479|FG000|Phase 1|Withdrawal by Subject|2|||
162173953|NCT02694822|585690480|FG001|Phase 1|Withdrawal by Subject|2|||
162173954|NCT02694822|585690481|FG002|Phase 1|Withdrawal by Subject|4|||
162173955|NCT02694822|585690482|FG003|Phase 1|Withdrawal by Subject|8|||
162173956|NCT02694822|585690483|FG004|Phase 1|Withdrawal by Subject|1|||
161671046|NCT00992511|583849026|FG000|Overall Study|Lost to Follow-up|1|||
161671047|NCT00992511|583849027|FG001|Overall Study|Lost to Follow-up|0|||
162026106|NCT04839562|585152888|FG000|Overall Study|Withdrawal by Subject|0|||
161671048|NCT00992511|583849028|FG002|Overall Study|Lost to Follow-up|0|||
161671049|NCT00992511|583849029|FG003|Overall Study|Lost to Follow-up|2|||
161671050|NCT00992511|583849026|FG000|Overall Study|Withdrawal by Subject|0|||
161671051|NCT00992511|583849027|FG001|Overall Study|Withdrawal by Subject|0|||
161671052|NCT00992511|583849028|FG002|Overall Study|Withdrawal by Subject|1|||
161671053|NCT00992511|583849029|FG003|Overall Study|Withdrawal by Subject|1|||
161671054|NCT01180998|583849030|FG000|Overall Study|Poor Vision|0|||
161671055|NCT01180998|583849031|FG001|Overall Study|Poor Vision|2|||
161671056|NCT01180998|583849032|FG002|Overall Study|Poor Vision|2|||
161671057|NCT01180998|583849030|FG000|Overall Study|Lost to Follow-up|0|||
161671058|NCT01180998|583849031|FG001|Overall Study|Lost to Follow-up|0|||
161671059|NCT01180998|583849032|FG002|Overall Study|Lost to Follow-up|1|||
161671060|NCT01180998|583849030|FG000|Overall Study|Protocol Violation|1|||
161671061|NCT01180998|583849031|FG001|Overall Study|Protocol Violation|2|||
161671062|NCT01180998|583849032|FG002|Overall Study|Protocol Violation|0|||
161671063|NCT01180998|583849030|FG000|Overall Study|Withdrawal by Subject|0|||
161671064|NCT01180998|583849031|FG001|Overall Study|Withdrawal by Subject|0|||
161671065|NCT01180998|583849032|FG002|Overall Study|Withdrawal by Subject|1|||
161671066|NCT01180998|583849030|FG000|Overall Study|Poor comfort|3|||
161671067|NCT01180998|583849031|FG001|Overall Study|Poor comfort|0|||
161671068|NCT01180998|583849032|FG002|Overall Study|Poor comfort|4|||
161671069|NCT01180998|583849030|FG000|Overall Study|Poor lens handling|0|||
161671070|NCT01180998|583849031|FG001|Overall Study|Poor lens handling|0|||
161671071|NCT01180998|583849032|FG002|Overall Study|Poor lens handling|2|||
161671072|NCT01176968|583849033|FG000|Overall Study|Adverse Event|10|||
161671073|NCT01176968|583849034|FG001|Overall Study|Adverse Event|11|||
161671074|NCT01176968|583849033|FG000|Overall Study|Death|2|||
161671075|NCT01176968|583849034|FG001|Overall Study|Death|3|||
161671076|NCT01176968|583849033|FG000|Overall Study|Lack of Efficacy|0|||
161671077|NCT01176968|583849034|FG001|Overall Study|Lack of Efficacy|1|||
161671078|NCT01176968|583849033|FG000|Overall Study|Lost to Follow-up|16|||
161671079|NCT01176968|583849034|FG001|Overall Study|Lost to Follow-up|14|||
161671080|NCT01176968|583849033|FG000|Overall Study|Withdrawal by Subject|48|||
161671081|NCT01176968|583849034|FG001|Overall Study|Withdrawal by Subject|48|||
161671082|NCT01176968|583849033|FG000|Overall Study|Protocol Violation|2|||
161671083|NCT01176968|583849034|FG001|Overall Study|Protocol Violation|1|||
161671084|NCT01176968|583849033|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
161671085|NCT01176968|583849034|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
161671086|NCT01176968|583849033|FG000|Overall Study|Study terminated by sponsor|0|||
161671087|NCT01176968|583849034|FG001|Overall Study|Study terminated by sponsor|1|||
161671088|NCT01176968|583849033|FG000|Overall Study|Reason not defined|5|||
161671089|NCT01176968|583849034|FG001|Overall Study|Reason not defined|3|||
161671090|NCT04485104|583849035|FG000|Overall Study|Physician Decision|2|||
161671091|NCT04485104|583849036|FG001|Overall Study|Physician Decision|0|||
161671092|NCT04485104|583849035|FG000|Overall Study|Decision by sponsor|0|||
161671093|NCT04485104|583849036|FG001|Overall Study|Decision by sponsor|1|||
161671094|NCT00744523|583849037|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
161671095|NCT00744523|583849038|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
161671096|NCT05057247|583849039|FG000|Overall Study|Death|4|||
161671097|NCT05057247|583849039|FG000|Overall Study|Physician Decision|3|||
161671098|NCT05057247|583849039|FG000|Overall Study|Progressive Disease|7|||
161671099|NCT05057247|583849039|FG000|Overall Study|Withdrawal by Subject|3|||
161671100|NCT05057247|583849039|FG000|Overall Study|Adverse Event|6|||
161671101|NCT05057247|583849039|FG000|Overall Study|Subject Non-Compliance|1|||
161671102|NCT05057247|583849039|FG000|Overall Study|On treatment|2|||
161671103|NCT03588728|583849043|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
161671104|NCT03588728|583849044|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
161671105|NCT03588728|583849045|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
161671106|NCT03588728|583849046|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
161671107|NCT03588728|583849043|FG000|Overall Study|Lab shut down due to COVID-19|0|||
161671108|NCT03588728|583849044|FG001|Overall Study|Lab shut down due to COVID-19|0|||
161671109|NCT03588728|583849045|FG002|Overall Study|Lab shut down due to COVID-19|0|||
161671110|NCT03588728|583849046|FG003|Overall Study|Lab shut down due to COVID-19|1|||
161671111|NCT03588728|583849043|FG000|Overall Study|multiple technical issues|1|||
161671112|NCT03588728|583849044|FG001|Overall Study|multiple technical issues|0|||
161817022|NCT04194801|584370899|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
161817023|NCT04194801|584370900|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
162018315|NCT05019521|585121947|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
161671113|NCT03588728|583849045|FG002|Overall Study|multiple technical issues|0|||
161671114|NCT03588728|583849046|FG003|Overall Study|multiple technical issues|0|||
161671115|NCT03588728|583849043|FG000|Overall Study|Hospitalized for COVID|1|||
161671116|NCT03588728|583849044|FG001|Overall Study|Hospitalized for COVID|0|||
161671117|NCT03588728|583849045|FG002|Overall Study|Hospitalized for COVID|0|||
161671118|NCT03588728|583849046|FG003|Overall Study|Hospitalized for COVID|0|||
161671119|NCT03588728|583849043|FG000|Overall Study|Schedule change unable to attend sessions|1|||
161671120|NCT03588728|583849044|FG001|Overall Study|Schedule change unable to attend sessions|0|||
161817024|NCT04194801|584370901|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
162173957|NCT02694822|585690484|FG005|Phase 1|Withdrawal by Subject|0|||
161817025|NCT01604941|584370905|FG000|Overall Study|Adverse Event|1|||
162173958|NCT02694822|585690479|FG000|Phase 2|Death|0|||
162173959|NCT02694822|585690480|FG001|Phase 2|Death|0|||
162173960|NCT02694822|585690481|FG002|Phase 2|Death|0|||
162173961|NCT02694822|585690482|FG003|Phase 2|Death|0|||
162173962|NCT02694822|585690483|FG004|Phase 2|Death|0|||
162173963|NCT02694822|585690484|FG005|Phase 2|Death|26|||
162173964|NCT02694822|585690479|FG000|Phase 2|Withdrawal by Subject|0|||
162173965|NCT02694822|585690480|FG001|Phase 2|Withdrawal by Subject|0|||
162173966|NCT02694822|585690481|FG002|Phase 2|Withdrawal by Subject|0|||
162173967|NCT02694822|585690482|FG003|Phase 2|Withdrawal by Subject|0|||
162173968|NCT02694822|585690483|FG004|Phase 2|Withdrawal by Subject|0|||
162173969|NCT02694822|585690484|FG005|Phase 2|Withdrawal by Subject|13|||
162173970|NCT02694822|585690479|FG000|Phase 2|Administrative Study Closure|0|||
162173971|NCT02694822|585690480|FG001|Phase 2|Administrative Study Closure|0|||
162173972|NCT02694822|585690481|FG002|Phase 2|Administrative Study Closure|0|||
162173973|NCT02694822|585690482|FG003|Phase 2|Administrative Study Closure|0|||
162173974|NCT02694822|585690483|FG004|Phase 2|Administrative Study Closure|0|||
162173975|NCT02694822|585690484|FG005|Phase 2|Administrative Study Closure|2|||
162173976|NCT02694822|585690479|FG000|Phase 2|Lost to Follow-up|0|||
162173977|NCT02694822|585690480|FG001|Phase 2|Lost to Follow-up|0|||
162173978|NCT02694822|585690481|FG002|Phase 2|Lost to Follow-up|0|||
162173979|NCT02694822|585690482|FG003|Phase 2|Lost to Follow-up|0|||
162173980|NCT02694822|585690483|FG004|Phase 2|Lost to Follow-up|0|||
162173981|NCT02694822|585690484|FG005|Phase 2|Lost to Follow-up|1|||
162173982|NCT02694822|585690479|FG000|Phase 2|Participant Transferred to Another Site|0|||
162173983|NCT02694822|585690480|FG001|Phase 2|Participant Transferred to Another Site|0|||
162173984|NCT02694822|585690481|FG002|Phase 2|Participant Transferred to Another Site|0|||
162173985|NCT02694822|585690482|FG003|Phase 2|Participant Transferred to Another Site|0|||
162173986|NCT02694822|585690483|FG004|Phase 2|Participant Transferred to Another Site|0|||
162173987|NCT02694822|585690484|FG005|Phase 2|Participant Transferred to Another Site|1|||
162173988|NCT05370040|585690485|FG000|Overall Study|Lost to Follow-up|0|||
162173989|NCT05370040|585690486|FG001|Overall Study|Lost to Follow-up|0|||
162173990|NCT05370040|585690487|FG002|Overall Study|Lost to Follow-up|1|||
162173991|NCT05370040|585690488|FG003|Overall Study|Lost to Follow-up|0|||
162173992|NCT05370040|585690489|FG004|Overall Study|Lost to Follow-up|1|||
162173993|NCT05370040|585690490|FG005|Overall Study|Lost to Follow-up|0|||
162173994|NCT03523572|585690493|FG000|Dose Escalation|Progressive disease|1|||
162173995|NCT03523572|585690494|FG001|Dose Escalation|Progressive disease|0|||
162173996|NCT03523572|585690495|FG002|Dose Escalation|Progressive disease|0|||
162173997|NCT03523572|585690496|FG003|Dose Escalation|Progressive disease|0|||
162173998|NCT03523572|585690497|FG004|Dose Escalation|Progressive disease|0|||
162173999|NCT03523572|585690498|FG005|Dose Escalation|Progressive disease|0|||
162174000|NCT03523572|585690493|FG000|Dose Escalation|Clinical Progression|0|||
162174001|NCT03523572|585690494|FG001|Dose Escalation|Clinical Progression|1|||
162174002|NCT03523572|585690495|FG002|Dose Escalation|Clinical Progression|0|||
162174003|NCT03523572|585690496|FG003|Dose Escalation|Clinical Progression|0|||
162174004|NCT03523572|585690497|FG004|Dose Escalation|Clinical Progression|0|||
162174005|NCT03523572|585690498|FG005|Dose Escalation|Clinical Progression|0|||
162174006|NCT03523572|585690493|FG000|Dose Escalation|Adverse Event|2|||
162174007|NCT03523572|585690494|FG001|Dose Escalation|Adverse Event|0|||
162174008|NCT03523572|585690495|FG002|Dose Escalation|Adverse Event|0|||
162174009|NCT03523572|585690496|FG003|Dose Escalation|Adverse Event|0|||
162174010|NCT03523572|585690497|FG004|Dose Escalation|Adverse Event|0|||
162174011|NCT03523572|585690498|FG005|Dose Escalation|Adverse Event|0|||
162174012|NCT03523572|585690493|FG000|Dose Escalation|Physician Decision|1|||
162174013|NCT03523572|585690494|FG001|Dose Escalation|Physician Decision|1|||
162174014|NCT03523572|585690495|FG002|Dose Escalation|Physician Decision|0|||
162174015|NCT03523572|585690496|FG003|Dose Escalation|Physician Decision|0|||
162174016|NCT03523572|585690497|FG004|Dose Escalation|Physician Decision|0|||
162174017|NCT03523572|585690498|FG005|Dose Escalation|Physician Decision|0|||
162174018|NCT03523572|585690493|FG000|Dose Expansion|Progressive Disease|0|||
162174019|NCT03523572|585690494|FG001|Dose Expansion|Progressive Disease|0|||
162174020|NCT03523572|585690495|FG002|Dose Expansion|Progressive Disease|9|||
162174021|NCT03523572|585690496|FG003|Dose Expansion|Progressive Disease|11|||
162174022|NCT03523572|585690497|FG004|Dose Expansion|Progressive Disease|15|||
162174023|NCT03523572|585690498|FG005|Dose Expansion|Progressive Disease|2|||
162174024|NCT03523572|585690493|FG000|Dose Expansion|Clinical Progression|0|||
162174025|NCT03523572|585690494|FG001|Dose Expansion|Clinical Progression|0|||
162174026|NCT03523572|585690495|FG002|Dose Expansion|Clinical Progression|2|||
162174027|NCT03523572|585690496|FG003|Dose Expansion|Clinical Progression|2|||
162174028|NCT03523572|585690497|FG004|Dose Expansion|Clinical Progression|2|||
162174029|NCT03523572|585690498|FG005|Dose Expansion|Clinical Progression|0|||
162174030|NCT03523572|585690493|FG000|Dose Expansion|Adverse Event|0|||
162174031|NCT03523572|585690494|FG001|Dose Expansion|Adverse Event|0|||
162174032|NCT03523572|585690495|FG002|Dose Expansion|Adverse Event|10|||
162174033|NCT03523572|585690496|FG003|Dose Expansion|Adverse Event|1|||
162174034|NCT03523572|585690497|FG004|Dose Expansion|Adverse Event|5|||
161671121|NCT03588728|583849045|FG002|Overall Study|Schedule change unable to attend sessions|0|||
161671122|NCT03588728|583849046|FG003|Overall Study|Schedule change unable to attend sessions|0|||
161671123|NCT01388790|583849047|FG000|Overall Study|Ongoing at data cut-off date|8|||
161671124|NCT03153137|583849048|FG000|Overall Study|Lost to Follow-up|1|||
162174035|NCT03523572|585690498|FG005|Dose Expansion|Adverse Event|2|||
162174036|NCT03523572|585690493|FG000|Dose Expansion|Withdrawal by Subject|0|||
162174037|NCT03523572|585690494|FG001|Dose Expansion|Withdrawal by Subject|0|||
162174038|NCT03523572|585690495|FG002|Dose Expansion|Withdrawal by Subject|1|||
162174039|NCT03523572|585690496|FG003|Dose Expansion|Withdrawal by Subject|1|||
162174040|NCT03523572|585690497|FG004|Dose Expansion|Withdrawal by Subject|0|||
161671125|NCT03153137|583849049|FG001|Overall Study|Lost to Follow-up|0|||
161671126|NCT03153137|583849048|FG000|Overall Study|Withdrawal by Subject|2|||
162174041|NCT03523572|585690498|FG005|Dose Expansion|Withdrawal by Subject|0|||
162174042|NCT03523572|585690493|FG000|Dose Expansion|Physician Decision|0|||
162174043|NCT03523572|585690494|FG001|Dose Expansion|Physician Decision|0|||
162174044|NCT03523572|585690495|FG002|Dose Expansion|Physician Decision|1|||
162174045|NCT03523572|585690496|FG003|Dose Expansion|Physician Decision|0|||
162174046|NCT03523572|585690497|FG004|Dose Expansion|Physician Decision|1|||
162174047|NCT03523572|585690498|FG005|Dose Expansion|Physician Decision|0|||
161671127|NCT03153137|583849049|FG001|Overall Study|Withdrawal by Subject|1|||
161671128|NCT03153137|583849048|FG000|Overall Study|Physician Decision|0|||
161671129|NCT03153137|583849049|FG001|Overall Study|Physician Decision|3|||
161671130|NCT00195507|583849050|FG000|Overall Study|Adverse Event|24|||
161671131|NCT00195507|583849051|FG001|Overall Study|Adverse Event|13|||
161671132|NCT00195507|583849050|FG000|Overall Study|Death|0|||
161671133|NCT00195507|583849051|FG001|Overall Study|Death|1|||
161671134|NCT00195507|583849050|FG000|Overall Study|Failed to Return|4|||
161671135|NCT00195507|583849051|FG001|Overall Study|Failed to Return|3|||
161671136|NCT00195507|583849050|FG000|Overall Study|Physician Decision|1|||
161671137|NCT00195507|583849051|FG001|Overall Study|Physician Decision|2|||
161671138|NCT00195507|583849050|FG000|Overall Study|Lost to Follow-up|3|||
161671139|NCT00195507|583849051|FG001|Overall Study|Lost to Follow-up|2|||
161671140|NCT00195507|583849050|FG000|Overall Study|Protocol Violation|5|||
161817026|NCT01604941|584370906|FG001|Overall Study|Adverse Event|2|||
161817027|NCT01604941|584370907|FG002|Overall Study|Adverse Event|0|||
162174048|NCT03523572|585690493|FG000|Dose Expansion|Miscellaneous|0|||
162174049|NCT03523572|585690494|FG001|Dose Expansion|Miscellaneous|0|||
162174050|NCT03523572|585690495|FG002|Dose Expansion|Miscellaneous|0|||
162174051|NCT03523572|585690496|FG003|Dose Expansion|Miscellaneous|0|||
162174052|NCT03523572|585690497|FG004|Dose Expansion|Miscellaneous|3|||
162174053|NCT03523572|585690498|FG005|Dose Expansion|Miscellaneous|0|||
162174054|NCT04685135|585690504|FG000|Overall Study|Death|126|||
162174055|NCT04685135|585690505|FG001|Overall Study|Death|53|||
161671141|NCT00195507|583849051|FG001|Overall Study|Protocol Violation|4|||
161671142|NCT00195507|583849050|FG000|Overall Study|Lack of Efficacy|40|||
161817028|NCT01604941|584370908|FG003|Overall Study|Adverse Event|0|||
162174056|NCT04685135|585690504|FG000|Overall Study|Withdrawal by Subject|12|||
162174057|NCT04685135|585690505|FG001|Overall Study|Withdrawal by Subject|16|||
162174058|NCT02315703|585690506|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
162174059|NCT02315703|585690507|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
162174060|NCT02315703|585690508|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
162174061|NCT02315703|585690509|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
162174062|NCT02315703|585690510|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
162174063|NCT02315703|585690511|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
162174064|NCT02315703|585690512|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
162174065|NCT02315703|585690513|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
162174066|NCT02315703|585690506|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
162174067|NCT02315703|585690507|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
162174068|NCT02315703|585690508|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
162174069|NCT02315703|585690509|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
162174070|NCT02315703|585690510|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
162174071|NCT02315703|585690511|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
162174072|NCT02315703|585690512|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
162174073|NCT02315703|585690513|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
162174074|NCT02315703|585690506|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
162174075|NCT02315703|585690507|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
162174076|NCT02315703|585690508|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
162174077|NCT02315703|585690509|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
162174078|NCT02315703|585690510|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
162174079|NCT02315703|585690511|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
162174080|NCT02315703|585690512|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
162174081|NCT02315703|585690513|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
162174082|NCT02315703|585690506|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162174083|NCT02315703|585690507|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162174084|NCT02315703|585690508|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162174085|NCT02315703|585690509|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162174086|NCT02315703|585690510|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162174087|NCT02315703|585690511|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162174088|NCT02315703|585690512|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
162174089|NCT02315703|585690513|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
162174090|NCT02315703|585690506|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
162174091|NCT02315703|585690507|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
162174092|NCT02315703|585690508|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
162174093|NCT02315703|585690509|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
162174094|NCT02315703|585690510|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
162174095|NCT02315703|585690511|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
162174096|NCT02315703|585690512|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
162174097|NCT02315703|585690513|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
161671143|NCT00195507|583849051|FG001|Overall Study|Lack of Efficacy|67|||
161671144|NCT00195507|583849050|FG000|Overall Study|Withdrawal by Subject|16|||
162174098|NCT02315703|585690506|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
162174099|NCT02315703|585690507|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
162174100|NCT02315703|585690508|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
162174101|NCT02315703|585690509|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
162174102|NCT02315703|585690510|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
162174103|NCT02315703|585690511|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
162174104|NCT02315703|585690512|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
162174105|NCT02315703|585690513|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
162174106|NCT02315703|585690506|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
162174107|NCT02315703|585690507|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
162174108|NCT02315703|585690508|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
162174109|NCT02315703|585690509|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
162174110|NCT02315703|585690510|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
162174111|NCT02315703|585690511|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
162174112|NCT02315703|585690512|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
162174113|NCT02315703|585690513|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
162174114|NCT02315703|585690506|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162174115|NCT02315703|585690507|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
162174116|NCT02315703|585690508|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162174117|NCT02315703|585690509|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162174118|NCT02315703|585690510|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162174119|NCT02315703|585690511|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161817029|NCT01604941|584370909|FG004|Overall Study|Adverse Event|1|||
161671145|NCT00195507|583849051|FG001|Overall Study|Withdrawal by Subject|23|||
161671146|NCT00195507|583849050|FG000|Overall Study|Protocol Deviation|6|||
161671147|NCT00195507|583849051|FG001|Overall Study|Protocol Deviation|3|||
161671148|NCT00528866|583849052|FG000|Overall Study|Protocol Violation|6|||
161671149|NCT00993915|583849053|FG000|Overall Study|Insufficient clinical response|3|||
161671150|NCT00993915|583849053|FG000|Overall Study|Withdrawal by Subject|2|||
161671151|NCT00993915|583849053|FG000|Overall Study|Other|1|||
161671152|NCT00993915|583849053|FG000|Overall Study|Ongoing|3|||
161671153|NCT01386658|583849054|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
161671154|NCT01386658|583849055|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
161671155|NCT01386658|583849054|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
161671156|NCT01386658|583849055|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
161671157|NCT02465463|583849056|FG000|Overall Study|Lost to Follow-up|2|||
161671158|NCT02465463|583849057|FG001|Overall Study|Lost to Follow-up|1|||
161671159|NCT02465463|583849056|FG000|Overall Study|Death|1|||
161671160|NCT02465463|583849057|FG001|Overall Study|Death|0|||
162174120|NCT02315703|585690512|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162174121|NCT02315703|585690513|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
162174122|NCT02315703|585690506|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
162174123|NCT02315703|585690507|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
162174124|NCT02315703|585690508|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
162174125|NCT02315703|585690509|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
162174126|NCT02315703|585690510|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
162174127|NCT02315703|585690511|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
162174128|NCT02315703|585690512|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
162174129|NCT02315703|585690513|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
162174130|NCT03476343|585690515|FG000|Overall Study|Clinical exam moved to another scanner|7|||
162174131|NCT03476343|585690515|FG000|Overall Study|Clinical order cancelled|4|||
162174132|NCT03476343|585690515|FG000|Overall Study|Neonate did not settle down for the scan|1|||
162174133|NCT02724969|585690516|FG000|Overall Study|Lost to Follow-up|12|||
162174134|NCT02724969|585690517|FG001|Overall Study|Lost to Follow-up|6|||
162174135|NCT02724969|585690516|FG000|Overall Study|Withdrawal by Subject|3|||
162174136|NCT02724969|585690517|FG001|Overall Study|Withdrawal by Subject|3|||
162174137|NCT02724969|585690516|FG000|Overall Study|Infant demise|0|||
162174138|NCT02724969|585690517|FG001|Overall Study|Infant demise|2|||
162174139|NCT05974501|585690518|FG000|Overall Study|Physician Decision|0|||
162174140|NCT05974501|585690519|FG001|Overall Study|Physician Decision|1|||
162174141|NCT05147116|585690521|FG000|Overall Study|Withdrawal by Subject|0|||
162174142|NCT05147116|585690522|FG001|Overall Study|Withdrawal by Subject|1|||
162174143|NCT03672916|585690523|FG000|Overall Study|Death|6|||
162174144|NCT03672916|585690523|FG000|Overall Study|Lost to Follow-up|29|||
162174145|NCT03672916|585690523|FG000|Overall Study|Adverse Event|6|||
162174146|NCT03672916|585690523|FG000|Overall Study|Withdrawal by Subject|11|||
162174147|NCT02497950|585690526|FG000|Overall Study|Death|209|||
162174148|NCT02497950|585690526|FG000|Overall Study|Transplanted|85|||
162174149|NCT02497950|585690526|FG000|Overall Study|Explanted|8|||
162174150|NCT02497950|585690526|FG000|Overall Study|Device Permanently Deactivated|4|||
162174151|NCT02497950|585690526|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
161671161|NCT02465463|583849056|FG000|Overall Study|Protocol Violation|1|||
161671162|NCT02465463|583849057|FG001|Overall Study|Protocol Violation|0|||
161671163|NCT01067326|583849062|FG000|Overall Study|Adverse Event|0|||
161671164|NCT01067326|583849063|FG001|Overall Study|Adverse Event|2|||
162174152|NCT02497950|585690526|FG000|Overall Study|Lost to Follow-up|6|||
162174153|NCT02497950|585690526|FG000|Overall Study|Withdrawal by Subject|2|||
162174154|NCT02497950|585690526|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
162174155|NCT02497950|585690526|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
162174156|NCT05167864|585690533|FG000|Overall Study|Lost to Follow-up|7|||
162174157|NCT05167864|585690534|FG001|Overall Study|Lost to Follow-up|6|||
162174158|NCT05167864|585690535|FG002|Overall Study|Lost to Follow-up|7|||
162174159|NCT05167864|585690536|FG003|Overall Study|Lost to Follow-up|9|||
162174160|NCT03852550|585690539|FG000|Overall Study|Lost to Follow-up|4|||
162174161|NCT03852550|585690540|FG001|Overall Study|Lost to Follow-up|3|||
161671165|NCT01067326|583849062|FG000|Overall Study|Withdrawal by Subject|1|||
161671166|NCT01067326|583849063|FG001|Overall Study|Withdrawal by Subject|0|||
161671167|NCT01067326|583849062|FG000|Overall Study|Early Study Termination|1|||
162174162|NCT03852550|585690539|FG000|Overall Study|Only parent outcomes completed|0|||
162174163|NCT03852550|585690540|FG001|Overall Study|Only parent outcomes completed|1|||
162174164|NCT03852550|585690539|FG000|Overall Study|Withdrawal by Subject|1|||
162174165|NCT03852550|585690540|FG001|Overall Study|Withdrawal by Subject|0|||
161671168|NCT01067326|583849063|FG001|Overall Study|Early Study Termination|1|||
162174166|NCT05204654|585690541|FG000|Overall Study|Study terminated due to time restraint|2|||
162174167|NCT05204654|585690542|FG001|Overall Study|Study terminated due to time restraint|2|||
162174168|NCT04625725|585690548|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
161671169|NCT03026127|583849072|FG000|CRISP R61|Adverse Event|5|||
161671170|NCT03026127|583849073|FG001|CRISP R61|Adverse Event|0|||
161671171|NCT03026127|583849074|FG002|CRISP R61|Adverse Event|0|||
162174169|NCT04625725|585690549|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
162174170|NCT04625725|585690550|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
162174171|NCT04625725|585690551|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
162174172|NCT04625725|585690552|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
162174173|NCT04625725|585690553|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
162174174|NCT04625725|585690548|FG000|Provent Main Study|Withdrawal by Subject|242|||
162174175|NCT04625725|585690549|FG001|Provent Main Study|Withdrawal by Subject|144|||
162174176|NCT04625725|585690550|FG002|Provent Main Study|Withdrawal by Subject|0|||
162174177|NCT04625725|585690551|FG003|Provent Main Study|Withdrawal by Subject|0|||
162174178|NCT04625725|585690552|FG004|Provent Main Study|Withdrawal by Subject|0|||
162174179|NCT04625725|585690553|FG005|Provent Main Study|Withdrawal by Subject|0|||
162174180|NCT04625725|585690548|FG000|Provent Main Study|Physician Decision|5|||
162174181|NCT04625725|585690549|FG001|Provent Main Study|Physician Decision|0|||
162174182|NCT04625725|585690550|FG002|Provent Main Study|Physician Decision|0|||
162174183|NCT04625725|585690551|FG003|Provent Main Study|Physician Decision|0|||
162174184|NCT04625725|585690552|FG004|Provent Main Study|Physician Decision|0|||
162174185|NCT04625725|585690553|FG005|Provent Main Study|Physician Decision|0|||
162174186|NCT04625725|585690548|FG000|Provent Main Study|Protocol Violation|1|||
162174187|NCT04625725|585690549|FG001|Provent Main Study|Protocol Violation|0|||
162174188|NCT04625725|585690550|FG002|Provent Main Study|Protocol Violation|0|||
162174189|NCT04625725|585690551|FG003|Provent Main Study|Protocol Violation|0|||
162174190|NCT04625725|585690552|FG004|Provent Main Study|Protocol Violation|0|||
162174191|NCT04625725|585690553|FG005|Provent Main Study|Protocol Violation|0|||
162174192|NCT04625725|585690548|FG000|Provent Main Study|Lost to Follow-up|357|||
162174193|NCT04625725|585690549|FG001|Provent Main Study|Lost to Follow-up|200|||
162174194|NCT04625725|585690550|FG002|Provent Main Study|Lost to Follow-up|0|||
162174195|NCT04625725|585690551|FG003|Provent Main Study|Lost to Follow-up|0|||
162174196|NCT04625725|585690552|FG004|Provent Main Study|Lost to Follow-up|0|||
162174197|NCT04625725|585690553|FG005|Provent Main Study|Lost to Follow-up|0|||
162174198|NCT04625725|585690548|FG000|Provent Main Study|Death|22|||
162174199|NCT04625725|585690549|FG001|Provent Main Study|Death|10|||
162174200|NCT04625725|585690550|FG002|Provent Main Study|Death|0|||
162174201|NCT04625725|585690551|FG003|Provent Main Study|Death|0|||
162174202|NCT04625725|585690552|FG004|Provent Main Study|Death|0|||
162174203|NCT04625725|585690553|FG005|Provent Main Study|Death|0|||
162174204|NCT04625725|585690548|FG000|Provent Main Study|Adverse Event|2|||
162174205|NCT04625725|585690549|FG001|Provent Main Study|Adverse Event|1|||
162174206|NCT04625725|585690550|FG002|Provent Main Study|Adverse Event|0|||
162174207|NCT04625725|585690551|FG003|Provent Main Study|Adverse Event|0|||
162174208|NCT04625725|585690552|FG004|Provent Main Study|Adverse Event|0|||
162174209|NCT04625725|585690553|FG005|Provent Main Study|Adverse Event|0|||
162174210|NCT04625725|585690548|FG000|Provent Main Study|Participants dosed in sub-study|310|||
162174211|NCT04625725|585690549|FG001|Provent Main Study|Participants dosed in sub-study|193|||
162174212|NCT04625725|585690550|FG002|Provent Main Study|Participants dosed in sub-study|0|||
162174213|NCT04625725|585690551|FG003|Provent Main Study|Participants dosed in sub-study|0|||
162174214|NCT04625725|585690552|FG004|Provent Main Study|Participants dosed in sub-study|0|||
162174215|NCT04625725|585690553|FG005|Provent Main Study|Participants dosed in sub-study|0|||
162174216|NCT04625725|585690548|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
162174217|NCT04625725|585690549|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
162174218|NCT04625725|585690550|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
162174219|NCT04625725|585690551|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
162174220|NCT04625725|585690552|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
162174221|NCT04625725|585690553|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
162174222|NCT04625725|585690548|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
162174223|NCT04625725|585690549|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
162174224|NCT04625725|585690550|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
162174225|NCT04625725|585690551|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
162174226|NCT04625725|585690552|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
162174227|NCT04625725|585690553|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
162174228|NCT04625725|585690548|FG000|Provent Main Study|INCARCERATION|3|||
162174229|NCT04625725|585690549|FG001|Provent Main Study|INCARCERATION|0|||
162174230|NCT04625725|585690550|FG002|Provent Main Study|INCARCERATION|0|||
162174231|NCT04625725|585690551|FG003|Provent Main Study|INCARCERATION|0|||
162174232|NCT04625725|585690552|FG004|Provent Main Study|INCARCERATION|0|||
162174233|NCT04625725|585690553|FG005|Provent Main Study|INCARCERATION|0|||
162174234|NCT04625725|585690548|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
162174235|NCT04625725|585690549|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
162174236|NCT04625725|585690550|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
162174237|NCT04625725|585690551|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
162174238|NCT04625725|585690552|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
162174239|NCT04625725|585690553|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
162174240|NCT04625725|585690548|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
162174241|NCT04625725|585690549|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
162174242|NCT04625725|585690550|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
162174243|NCT04625725|585690551|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
162174244|NCT04625725|585690552|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
162174245|NCT04625725|585690553|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
162174246|NCT04625725|585690548|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
162174247|NCT04625725|585690549|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
162174248|NCT04625725|585690550|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
162174249|NCT04625725|585690551|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
162174250|NCT04625725|585690552|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
162174251|NCT04625725|585690553|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
162174252|NCT04625725|585690548|FG000|Provent Main Study|MISSING REASON|0|||
162174253|NCT04625725|585690549|FG001|Provent Main Study|MISSING REASON|1|||
162174254|NCT04625725|585690550|FG002|Provent Main Study|MISSING REASON|0|||
162174255|NCT04625725|585690551|FG003|Provent Main Study|MISSING REASON|0|||
162174256|NCT04625725|585690552|FG004|Provent Main Study|MISSING REASON|0|||
162174257|NCT04625725|585690553|FG005|Provent Main Study|MISSING REASON|0|||
162174258|NCT04625725|585690548|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
162174259|NCT04625725|585690549|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
162174260|NCT04625725|585690550|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
162174261|NCT04625725|585690551|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
162174262|NCT04625725|585690552|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
162174263|NCT04625725|585690553|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
162174264|NCT04625725|585690548|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
162174265|NCT04625725|585690549|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
162174266|NCT04625725|585690550|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
162174267|NCT04625725|585690551|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
162174268|NCT04625725|585690552|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
161671172|NCT03026127|583849072|FG000|CRISP R61|Lost to Follow-up|2|||
162174269|NCT04625725|585690553|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
162174270|NCT04625725|585690548|FG000|Provent Sub Study|Lost to Follow-up|0|||
162174271|NCT04625725|585690549|FG001|Provent Sub Study|Lost to Follow-up|0|||
162174272|NCT04625725|585690550|FG002|Provent Sub Study|Lost to Follow-up|20|||
162174273|NCT04625725|585690551|FG003|Provent Sub Study|Lost to Follow-up|10|||
162174274|NCT04625725|585690552|FG004|Provent Sub Study|Lost to Follow-up|6|||
162174275|NCT04625725|585690553|FG005|Provent Sub Study|Lost to Follow-up|4|||
162174276|NCT04625725|585690548|FG000|Provent Sub Study|Death|0|||
162174277|NCT04625725|585690549|FG001|Provent Sub Study|Death|0|||
162174278|NCT04625725|585690550|FG002|Provent Sub Study|Death|8|||
162174279|NCT04625725|585690551|FG003|Provent Sub Study|Death|5|||
162174280|NCT04625725|585690552|FG004|Provent Sub Study|Death|0|||
162174281|NCT04625725|585690553|FG005|Provent Sub Study|Death|1|||
162174282|NCT04625725|585690548|FG000|Provent Sub Study|Adverse Event|0|||
162174283|NCT04625725|585690549|FG001|Provent Sub Study|Adverse Event|0|||
162174284|NCT04625725|585690550|FG002|Provent Sub Study|Adverse Event|0|||
162174285|NCT04625725|585690551|FG003|Provent Sub Study|Adverse Event|0|||
162174286|NCT04625725|585690552|FG004|Provent Sub Study|Adverse Event|0|||
162174287|NCT04625725|585690553|FG005|Provent Sub Study|Adverse Event|1|||
162174288|NCT04625725|585690548|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
162174289|NCT04625725|585690549|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
162174290|NCT04625725|585690550|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
162174291|NCT04625725|585690551|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
162174292|NCT04625725|585690552|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
162174293|NCT04625725|585690553|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
162174294|NCT04625725|585690548|FG000|Provent Sub Study|Withdrawal by Subject|0|||
162174295|NCT04625725|585690549|FG001|Provent Sub Study|Withdrawal by Subject|0|||
162174296|NCT04625725|585690550|FG002|Provent Sub Study|Withdrawal by Subject|11|||
162174297|NCT04625725|585690551|FG003|Provent Sub Study|Withdrawal by Subject|13|||
162174298|NCT04625725|585690552|FG004|Provent Sub Study|Withdrawal by Subject|5|||
162174299|NCT04625725|585690553|FG005|Provent Sub Study|Withdrawal by Subject|6|||
162174300|NCT04625725|585690548|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
162174301|NCT04625725|585690549|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
162174302|NCT04625725|585690550|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
162174303|NCT04625725|585690551|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
161671173|NCT03026127|583849073|FG001|CRISP R61|Lost to Follow-up|0|||
162174304|NCT04625725|585690552|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
162174305|NCT04625725|585690553|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
162174306|NCT04308681|585690564|FG000|Pre-Treatment|Not reported|1|||
162174307|NCT04308681|585690565|FG001|Pre-Treatment|Not reported|1|||
162174308|NCT04308681|585690566|FG002|Pre-Treatment|Not reported|0|||
162174309|NCT04308681|585690567|FG003|Pre-Treatment|Not reported|0|||
162174310|NCT04308681|585690568|FG004|Pre-Treatment|Not reported|0|||
162174311|NCT04308681|585690569|FG005|Pre-Treatment|Not reported|2|||
162174312|NCT04308681|585690570|FG006|Pre-Treatment|Not reported|0|||
162174313|NCT04308681|585690571|FG007|Pre-Treatment|Not reported|0|||
162174314|NCT04308681|585690564|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
162174315|NCT04308681|585690565|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
162174316|NCT04308681|585690566|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
162174317|NCT04308681|585690567|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
162174318|NCT04308681|585690568|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
162174319|NCT04308681|585690569|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
162174320|NCT04308681|585690570|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
162174321|NCT04308681|585690571|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
162174322|NCT04308681|585690564|FG000|Treatment up to Week 26|Other reasons|2|||
162174323|NCT04308681|585690565|FG001|Treatment up to Week 26|Other reasons|0|||
162174324|NCT04308681|585690566|FG002|Treatment up to Week 26|Other reasons|0|||
162174325|NCT04308681|585690567|FG003|Treatment up to Week 26|Other reasons|0|||
162174326|NCT04308681|585690568|FG004|Treatment up to Week 26|Other reasons|1|||
162174327|NCT04308681|585690569|FG005|Treatment up to Week 26|Other reasons|1|||
162174328|NCT04308681|585690570|FG006|Treatment up to Week 26|Other reasons|0|||
162174329|NCT04308681|585690571|FG007|Treatment up to Week 26|Other reasons|0|||
162174330|NCT04308681|585690564|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
162174331|NCT04308681|585690565|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
162174332|NCT04308681|585690566|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
162174333|NCT04308681|585690567|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
162174334|NCT04308681|585690568|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
162174335|NCT04308681|585690569|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
162174336|NCT04308681|585690570|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
162174337|NCT04308681|585690571|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
162174338|NCT04308681|585690564|FG000|Treatment up to Week 26|Adverse Event|6|||
162174339|NCT04308681|585690565|FG001|Treatment up to Week 26|Adverse Event|5|||
162174340|NCT04308681|585690566|FG002|Treatment up to Week 26|Adverse Event|5|||
162174341|NCT04308681|585690567|FG003|Treatment up to Week 26|Adverse Event|0|||
162174342|NCT04308681|585690568|FG004|Treatment up to Week 26|Adverse Event|6|||
162174343|NCT04308681|585690569|FG005|Treatment up to Week 26|Adverse Event|1|||
162174344|NCT04308681|585690570|FG006|Treatment up to Week 26|Adverse Event|0|||
162174345|NCT04308681|585690571|FG007|Treatment up to Week 26|Adverse Event|0|||
162174346|NCT04308681|585690564|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
162174347|NCT04308681|585690565|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
162174348|NCT04308681|585690566|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
162174349|NCT04308681|585690567|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
162174350|NCT04308681|585690568|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
162174351|NCT04308681|585690569|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
162174352|NCT04308681|585690570|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
162174353|NCT04308681|585690571|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
162174354|NCT04308681|585690564|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
162174355|NCT04308681|585690565|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
162174356|NCT04308681|585690566|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
162174357|NCT04308681|585690567|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
162174358|NCT04308681|585690568|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
162174359|NCT04308681|585690569|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
162174360|NCT04308681|585690570|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
162174361|NCT04308681|585690571|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
162174362|NCT04308681|585690564|FG000|OTE - 26 Weeks|Death|0|||
162174363|NCT04308681|585690565|FG001|OTE - 26 Weeks|Death|1|||
162174364|NCT04308681|585690566|FG002|OTE - 26 Weeks|Death|0|||
162174365|NCT04308681|585690567|FG003|OTE - 26 Weeks|Death|0|||
162174366|NCT04308681|585690568|FG004|OTE - 26 Weeks|Death|0|||
162174367|NCT04308681|585690569|FG005|OTE - 26 Weeks|Death|0|||
162174368|NCT04308681|585690570|FG006|OTE - 26 Weeks|Death|1|||
162174369|NCT04308681|585690571|FG007|OTE - 26 Weeks|Death|0|||
162174370|NCT04308681|585690564|FG000|OTE - 26 Weeks|Adverse Event|0|||
162174371|NCT04308681|585690565|FG001|OTE - 26 Weeks|Adverse Event|2|||
162174372|NCT04308681|585690566|FG002|OTE - 26 Weeks|Adverse Event|8|||
162174373|NCT04308681|585690567|FG003|OTE - 26 Weeks|Adverse Event|3|||
162174374|NCT04308681|585690568|FG004|OTE - 26 Weeks|Adverse Event|0|||
162174375|NCT04308681|585690569|FG005|OTE - 26 Weeks|Adverse Event|1|||
162174376|NCT04308681|585690570|FG006|OTE - 26 Weeks|Adverse Event|2|||
162018316|NCT05019521|585121948|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
162018317|NCT05019521|585121949|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
162018318|NCT05019521|585121950|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
162018319|NCT05019521|585121951|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
162018320|NCT05019521|585121952|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
162018321|NCT05019521|585121946|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
162018322|NCT05019521|585121947|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
162018323|NCT05019521|585121948|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
162018324|NCT05019521|585121949|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
162018325|NCT05019521|585121950|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
162018326|NCT05019521|585121951|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
162018327|NCT05019521|585121952|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
162018328|NCT05019521|585121946|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
162018329|NCT05019521|585121947|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
162018330|NCT05019521|585121948|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
162018331|NCT05019521|585121949|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
162018332|NCT05019521|585121950|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
162018333|NCT05019521|585121951|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
162018334|NCT05019521|585121952|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
162018335|NCT00760617|585121953|FG000|Overall Study|Adverse Event|5|||
162018336|NCT00760617|585121954|FG001|Overall Study|Adverse Event|2|||
162018337|NCT00760617|585121955|FG002|Overall Study|Adverse Event|0|||
162018338|NCT00760617|585121953|FG000|Overall Study|Lost to Follow-up|0|||
162018339|NCT00760617|585121954|FG001|Overall Study|Lost to Follow-up|0|||
162018340|NCT00760617|585121955|FG002|Overall Study|Lost to Follow-up|5|||
162018341|NCT01192191|585121956|FG000|Overall Study|Adverse Event|7|||
162018342|NCT01192191|585121957|FG001|Overall Study|Adverse Event|12|||
162018343|NCT01192191|585121956|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
162018344|NCT01192191|585121957|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
162018345|NCT01192191|585121956|FG000|Overall Study|Lost to Follow-up|0|||
162018346|NCT01192191|585121957|FG001|Overall Study|Lost to Follow-up|1|||
162018347|NCT01192191|585121956|FG000|Overall Study|Withdrawal by Subject|1|||
162018348|NCT01192191|585121957|FG001|Overall Study|Withdrawal by Subject|6|||
162018349|NCT01047553|585121958|FG000|Overall Study|Adverse Event|10|||
162018350|NCT01047553|585121959|FG001|Overall Study|Adverse Event|5|||
162018351|NCT01047553|585121958|FG000|Overall Study|Withdrawal by Subject|4|||
162018352|NCT01047553|585121959|FG001|Overall Study|Withdrawal by Subject|2|||
162018353|NCT01047553|585121958|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
162018354|NCT01047553|585121959|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
162018355|NCT01047553|585121958|FG000|Overall Study|Lost to Follow-up|1|||
162018356|NCT01047553|585121959|FG001|Overall Study|Lost to Follow-up|0|||
162018357|NCT01047553|585121958|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
162018358|NCT01047553|585121959|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
162018359|NCT01047553|585121958|FG000|Overall Study|PI's decision|0|||
162018360|NCT01047553|585121959|FG001|Overall Study|PI's decision|1|||
162018361|NCT02817464|585121961|FG000|Overall Study|Lost to Follow-up|1|||
162018362|NCT02817464|585121962|FG001|Overall Study|Lost to Follow-up|0|||
162018363|NCT02817464|585121961|FG000|Overall Study|Discontinued early due to personal decision|1|||
162018364|NCT02817464|585121962|FG001|Overall Study|Discontinued early due to personal decision|1|||
162018365|NCT04292899|585121964|FG000|Overall Study|Death|21|||
162018366|NCT04292899|585121965|FG001|Overall Study|Death|28|||
162018367|NCT04292899|585121966|FG002|Overall Study|Death|188|||
162018368|NCT04292899|585121967|FG003|Overall Study|Death|371|||
162018369|NCT04292899|585121964|FG000|Overall Study|Lost to Follow-up|8|||
162018370|NCT04292899|585121965|FG001|Overall Study|Lost to Follow-up|4|||
162018371|NCT04292899|585121966|FG002|Overall Study|Lost to Follow-up|22|||
162018372|NCT04292899|585121967|FG003|Overall Study|Lost to Follow-up|235|||
162018373|NCT04292899|585121964|FG000|Overall Study|Withdrew consent|1|||
162018374|NCT04292899|585121965|FG001|Overall Study|Withdrew consent|0|||
162018375|NCT04292899|585121966|FG002|Overall Study|Withdrew consent|11|||
162018376|NCT04292899|585121967|FG003|Overall Study|Withdrew consent|32|||
162018377|NCT04292899|585121964|FG000|Overall Study|Adverse Event|2|||
162018378|NCT04292899|585121965|FG001|Overall Study|Adverse Event|1|||
162174377|NCT04308681|585690571|FG007|OTE - 26 Weeks|Adverse Event|0|||
162174378|NCT04308681|585690564|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
162174379|NCT04308681|585690565|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
162018379|NCT04292899|585121966|FG002|Overall Study|Adverse Event|2|||
162018380|NCT04292899|585121967|FG003|Overall Study|Adverse Event|2|||
162018381|NCT04292899|585121964|FG000|Overall Study|Investigator's Discretion|0|||
162018382|NCT04292899|585121965|FG001|Overall Study|Investigator's Discretion|0|||
162018383|NCT04292899|585121966|FG002|Overall Study|Investigator's Discretion|0|||
162018384|NCT04292899|585121967|FG003|Overall Study|Investigator's Discretion|3|||
162018385|NCT04292899|585121964|FG000|Overall Study|Non-compliance With Study Drug|0|||
162018386|NCT04292899|585121965|FG001|Overall Study|Non-compliance With Study Drug|0|||
162018387|NCT04292899|585121966|FG002|Overall Study|Non-compliance With Study Drug|0|||
162018388|NCT04292899|585121967|FG003|Overall Study|Non-compliance With Study Drug|1|||
162018389|NCT04292899|585121964|FG000|Overall Study|Protocol Violation|0|||
162018390|NCT04292899|585121965|FG001|Overall Study|Protocol Violation|0|||
162018391|NCT04292899|585121966|FG002|Overall Study|Protocol Violation|0|||
162018392|NCT04292899|585121967|FG003|Overall Study|Protocol Violation|1|||
162018393|NCT00948441|585121968|FG000|Overall Study|no longer meet inclusion criteria|1|||
162018394|NCT00948441|585121969|FG001|Overall Study|no longer meet inclusion criteria|4|||
162018395|NCT01026324|585121970|FG000|Follow up/Survival|Withdrawal by Subject|1|||
162018396|NCT01026324|585121971|FG001|Follow up/Survival|Withdrawal by Subject|0|||
162018397|NCT01026324|585121972|FG002|Follow up/Survival|Withdrawal by Subject|0|||
162018398|NCT05340478|585121979|FG000|Overall Study|Scheduling Issues|10|||
162018399|NCT05340478|585121980|FG001|Overall Study|Scheduling Issues|4|||
162018400|NCT05340478|585121979|FG000|Overall Study|Neither member of dyad started treatment|2|||
162018401|NCT05340478|585121980|FG001|Overall Study|Neither member of dyad started treatment|2|||
162018402|NCT05340478|585121979|FG000|Overall Study|Withdrawn from study|2|||
162018403|NCT05340478|585121980|FG001|Overall Study|Withdrawn from study|2|||
162018404|NCT05340478|585121979|FG000|Overall Study|Lost to Follow-up|1|||
162018405|NCT05340478|585121980|FG001|Overall Study|Lost to Follow-up|4|||
162018406|NCT01032889|585121983|FG000|Overall Study|Adverse Event|2|||
162018407|NCT01032889|585121984|FG001|Overall Study|Adverse Event|2|||
162018408|NCT01032889|585121985|FG002|Overall Study|Adverse Event|0|||
162018409|NCT01032889|585121983|FG000|Overall Study|Withdrawal of Consent|1|||
162018410|NCT01032889|585121984|FG001|Overall Study|Withdrawal of Consent|2|||
162018411|NCT01032889|585121985|FG002|Overall Study|Withdrawal of Consent|1|||
162018412|NCT01032889|585121983|FG000|Overall Study|Patient Request|0|||
162174380|NCT04308681|585690566|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
162174381|NCT04308681|585690567|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
162174382|NCT04308681|585690568|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
162174383|NCT04308681|585690569|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
162174384|NCT04308681|585690570|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
162174385|NCT04308681|585690571|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
162174386|NCT00429364|585690574|FG000|Overall Study|Withdrawal by Subject|11|||
162174387|NCT00429364|585690575|FG001|Overall Study|Withdrawal by Subject|5|||
162174388|NCT00429364|585690574|FG000|Overall Study|Physician Decision|4|||
162174389|NCT00429364|585690575|FG001|Overall Study|Physician Decision|2|||
162174390|NCT00429364|585690574|FG000|Overall Study|Lost to Follow-up|7|||
162174391|NCT00429364|585690575|FG001|Overall Study|Lost to Follow-up|6|||
162174392|NCT00429364|585690574|FG000|Overall Study|Death|0|||
162174393|NCT00429364|585690575|FG001|Overall Study|Death|1|||
162174394|NCT00429364|585690574|FG000|Overall Study|Underwent aortic root surgery|10|||
162174395|NCT00429364|585690575|FG001|Overall Study|Underwent aortic root surgery|18|||
162174396|NCT00429364|585690574|FG000|Overall Study|Pregnancy|0|||
162174397|NCT00429364|585690575|FG001|Overall Study|Pregnancy|1|||
162174398|NCT05873556|585690576|FG000|Overall Study|Lost to Follow-up|4|||
162174399|NCT05873556|585690577|FG001|Overall Study|Lost to Follow-up|1|||
162174400|NCT03606408|585690579|FG000|Overall Study|Adverse Event|13|||
162174401|NCT03606408|585690579|FG000|Overall Study|Withdrawal by Subject|7|||
162174402|NCT03606408|585690579|FG000|Overall Study|Physician Decision|4|||
162174403|NCT03606408|585690579|FG000|Overall Study|Lack of Efficacy|2|||
162174404|NCT03606408|585690579|FG000|Overall Study|Death|1|||
162174405|NCT03606408|585690579|FG000|Overall Study|new therapy for study indication|1|||
162174406|NCT05425420|585690589|FG000|Overall Study|Physician Decision|1|||
162174407|NCT05425420|585690589|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
162174408|NCT03714815|585690590|FG000|Overall Study|Physician Decision|2|||
162174409|NCT03714815|585690590|FG000|Overall Study|Withdrawal by Subject|2|||
162174410|NCT03714815|585690590|FG000|Overall Study|Death|11|||
162174411|NCT02631746|585690599|FG000|Overall Study|Lack of Efficacy|3|||
162174412|NCT02361216|585690600|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
162174413|NCT02361216|585690601|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
162174414|NCT02361216|585690600|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
162174415|NCT02361216|585690601|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
162174416|NCT02361216|585690600|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
162174417|NCT02361216|585690601|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
162174418|NCT02361216|585690600|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
162174419|NCT02361216|585690601|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
162174420|NCT02361216|585690600|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
161922845|NCT00021255|584764885|FG001|Overall Study|Death|0|||
162174421|NCT02361216|585690601|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
162174422|NCT02361216|585690600|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
162174423|NCT02361216|585690601|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
162174424|NCT03505008|585690602|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
162174425|NCT03505008|585690603|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
161922846|NCT00021255|584764886|FG002|Overall Study|Death|2|||
162174426|NCT03505008|585690604|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
162174427|NCT03505008|585690605|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
162174428|NCT03505008|585690602|FG000|Before Week 24 Randomization|Adverse Event|10|||
162174429|NCT03505008|585690603|FG001|Before Week 24 Randomization|Adverse Event|0|||
162174430|NCT03505008|585690604|FG002|Before Week 24 Randomization|Adverse Event|0|||
162174431|NCT03505008|585690605|FG003|Before Week 24 Randomization|Adverse Event|0|||
162174432|NCT03505008|585690602|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
162174433|NCT03505008|585690603|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
162174434|NCT03505008|585690604|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
162174435|NCT03505008|585690605|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
162174436|NCT03505008|585690602|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
162174437|NCT03505008|585690603|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
162174438|NCT03505008|585690604|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
162174439|NCT03505008|585690605|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
162174440|NCT03505008|585690602|FG000|Before Week 24 Randomization|Physician Decision|2|||
162174441|NCT03505008|585690603|FG001|Before Week 24 Randomization|Physician Decision|0|||
162174442|NCT03505008|585690604|FG002|Before Week 24 Randomization|Physician Decision|0|||
162174443|NCT03505008|585690605|FG003|Before Week 24 Randomization|Physician Decision|0|||
162174444|NCT03505008|585690602|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
162174445|NCT03505008|585690603|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
162174446|NCT03505008|585690604|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
162174447|NCT03505008|585690605|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
162174448|NCT03505008|585690602|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
162174449|NCT03505008|585690603|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
162174450|NCT03505008|585690604|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
162174451|NCT03505008|585690605|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
162174452|NCT03505008|585690602|FG000|Before Week 24 Randomization|Complication|1|||
162174453|NCT03505008|585690603|FG001|Before Week 24 Randomization|Complication|0|||
162174454|NCT03505008|585690604|FG002|Before Week 24 Randomization|Complication|0|||
162174455|NCT03505008|585690605|FG003|Before Week 24 Randomization|Complication|0|||
162174456|NCT03505008|585690602|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
162174457|NCT03505008|585690603|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
162174458|NCT03505008|585690604|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
162174459|NCT03505008|585690605|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
162174460|NCT03505008|585690602|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
162174461|NCT03505008|585690603|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
162174462|NCT03505008|585690604|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
162174463|NCT03505008|585690605|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
162174464|NCT03505008|585690602|FG000|After Week 24 Randomization|Adverse Event|0|||
162174465|NCT03505008|585690603|FG001|After Week 24 Randomization|Adverse Event|1|||
162174466|NCT03505008|585690604|FG002|After Week 24 Randomization|Adverse Event|2|||
162174467|NCT03505008|585690605|FG003|After Week 24 Randomization|Adverse Event|2|||
162174468|NCT03505008|585690602|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
162174469|NCT03505008|585690603|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
162174470|NCT03505008|585690604|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
162174471|NCT03505008|585690605|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
162174472|NCT03505008|585690602|FG000|After Week 24 Randomization|Protocol Violation|0|||
162174473|NCT03505008|585690603|FG001|After Week 24 Randomization|Protocol Violation|0|||
162174474|NCT03505008|585690604|FG002|After Week 24 Randomization|Protocol Violation|1|||
162174475|NCT03505008|585690605|FG003|After Week 24 Randomization|Protocol Violation|0|||
162174476|NCT02437136|585690606|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
162174477|NCT02437136|585690607|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162174478|NCT02437136|585690608|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162174479|NCT02437136|585690609|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162174480|NCT02437136|585690610|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162174481|NCT02437136|585690611|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162174482|NCT02437136|585690612|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
162174483|NCT02437136|585690606|FG000|Expansion (Phase 2)|Death|0|||
162174484|NCT02437136|585690607|FG001|Expansion (Phase 2)|Death|0|||
162174485|NCT02437136|585690608|FG002|Expansion (Phase 2)|Death|0|||
162174486|NCT02437136|585690609|FG003|Expansion (Phase 2)|Death|6|||
162174487|NCT02437136|585690610|FG004|Expansion (Phase 2)|Death|37|||
162174488|NCT02437136|585690611|FG005|Expansion (Phase 2)|Death|29|||
162174489|NCT02437136|585690612|FG006|Expansion (Phase 2)|Death|24|||
162174490|NCT02437136|585690606|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
162174491|NCT02437136|585690607|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
162174492|NCT02437136|585690608|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
162174493|NCT02437136|585690609|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
162174494|NCT02437136|585690610|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
162174495|NCT02437136|585690611|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
162174496|NCT02437136|585690612|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
162174497|NCT02437136|585690606|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
162174498|NCT02437136|585690607|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
162174499|NCT02437136|585690608|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
162174500|NCT02437136|585690609|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
162174501|NCT02437136|585690610|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
162174502|NCT02437136|585690611|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
162174503|NCT02437136|585690612|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
162174504|NCT02056834|585690615|FG000|Overall Study|Lost to Follow-up|7|||
162174505|NCT00323856|585690616|FG000|Overall Study|Withdrawal by Subject|1|||
162174506|NCT00323856|585690616|FG000|Overall Study|Was uncooperative and noncompliant|1|||
162174507|NCT00323856|585690616|FG000|Overall Study|Reason not specified|1|||
162174508|NCT00323856|585690616|FG000|Overall Study|Missing|2|||
162174509|NCT04086121|585690617|FG000|Overall Study|Other than listed|8|||
162174510|NCT04086121|585690617|FG000|Overall Study|Withdrawal by Subject|3|||
162174511|NCT04086121|585690617|FG000|Overall Study|Lost to Follow-up|2|||
162174512|NCT04086121|585690617|FG000|Overall Study|Adverse Event|1|||
162174513|NCT04580914|585690622|FG000|Overall Study|Withdrawal by Subject|6|||
162174514|NCT04580914|585690622|FG000|Overall Study|Lost to Follow-up|2|||
162174515|NCT04167553|585690625|FG000|Overall Study|Withdrawal by Subject|1|||
162174516|NCT04167553|585690626|FG001|Overall Study|Withdrawal by Subject|0|||
162174517|NCT04167553|585690627|FG002|Overall Study|Withdrawal by Subject|1|||
162174518|NCT04167553|585690628|FG003|Overall Study|Withdrawal by Subject|2|||
162174519|NCT04167553|585690629|FG004|Overall Study|Withdrawal by Subject|1|||
162174520|NCT04167553|585690630|FG005|Overall Study|Withdrawal by Subject|0|||
162174521|NCT04167553|585690631|FG006|Overall Study|Withdrawal by Subject|0|||
162174522|NCT04167553|585690625|FG000|Overall Study|Physician Decision|0|||
162174523|NCT04167553|585690626|FG001|Overall Study|Physician Decision|0|||
162174524|NCT04167553|585690627|FG002|Overall Study|Physician Decision|0|||
162174525|NCT04167553|585690628|FG003|Overall Study|Physician Decision|0|||
162174526|NCT04167553|585690629|FG004|Overall Study|Physician Decision|2|||
162174527|NCT04167553|585690630|FG005|Overall Study|Physician Decision|2|||
162174528|NCT04167553|585690631|FG006|Overall Study|Physician Decision|0|||
162174529|NCT04167553|585690625|FG000|Overall Study|Lost to Follow-up|0|||
162174530|NCT04167553|585690626|FG001|Overall Study|Lost to Follow-up|0|||
162174531|NCT04167553|585690627|FG002|Overall Study|Lost to Follow-up|2|||
162174532|NCT04167553|585690628|FG003|Overall Study|Lost to Follow-up|0|||
162174533|NCT04167553|585690629|FG004|Overall Study|Lost to Follow-up|0|||
162174534|NCT04167553|585690630|FG005|Overall Study|Lost to Follow-up|0|||
162174535|NCT04167553|585690631|FG006|Overall Study|Lost to Follow-up|0|||
162174536|NCT02828358|585690632|FG000|Overall Study|Physician Decision|7|||
162174537|NCT02828358|585690633|FG001|Overall Study|Physician Decision|1|||
162174538|NCT02828358|585690632|FG000|Overall Study|Treatment Failure|6|||
162174539|NCT02828358|585690633|FG001|Overall Study|Treatment Failure|0|||
162174540|NCT02828358|585690632|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
162174541|NCT02828358|585690633|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
162174542|NCT02828358|585690632|FG000|Overall Study|Refusal of further protocol therapy|2|||
162174543|NCT02828358|585690633|FG001|Overall Study|Refusal of further protocol therapy|0|||
162174544|NCT02828358|585690632|FG000|Overall Study|Relapse|25|||
162174545|NCT02828358|585690633|FG001|Overall Study|Relapse|0|||
162174546|NCT02828358|585690632|FG000|Overall Study|Still on therapy|5|||
162174547|NCT02828358|585690633|FG001|Overall Study|Still on therapy|0|||
162174548|NCT05285137|585690648|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
162174549|NCT05285137|585690649|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
162174550|NCT05285137|585690650|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
162174551|NCT05285137|585690651|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
162174552|NCT05285137|585690652|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
162174553|NCT05285137|585690653|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
162174554|NCT05285137|585690654|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
162174555|NCT05285137|585690655|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
162174556|NCT05285137|585690656|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
162174557|NCT05285137|585690648|FG000|Overall Study|Lost to Follow-up|0|||
162174558|NCT05285137|585690649|FG001|Overall Study|Lost to Follow-up|0|||
162174559|NCT05285137|585690650|FG002|Overall Study|Lost to Follow-up|1|||
162174560|NCT05285137|585690651|FG003|Overall Study|Lost to Follow-up|3|||
162174561|NCT05285137|585690652|FG004|Overall Study|Lost to Follow-up|0|||
162174562|NCT05285137|585690653|FG005|Overall Study|Lost to Follow-up|0|||
162174563|NCT05285137|585690654|FG006|Overall Study|Lost to Follow-up|1|||
162174564|NCT05285137|585690655|FG007|Overall Study|Lost to Follow-up|0|||
162174565|NCT05285137|585690656|FG008|Overall Study|Lost to Follow-up|0|||
162174566|NCT05285137|585690648|FG000|Overall Study|Physician Decision|0|||
162174567|NCT05285137|585690649|FG001|Overall Study|Physician Decision|1|||
162174568|NCT05285137|585690650|FG002|Overall Study|Physician Decision|0|||
162174569|NCT05285137|585690651|FG003|Overall Study|Physician Decision|0|||
162174570|NCT05285137|585690652|FG004|Overall Study|Physician Decision|0|||
162174571|NCT05285137|585690653|FG005|Overall Study|Physician Decision|0|||
162174572|NCT05285137|585690654|FG006|Overall Study|Physician Decision|0|||
162174573|NCT05285137|585690655|FG007|Overall Study|Physician Decision|0|||
162174574|NCT05285137|585690656|FG008|Overall Study|Physician Decision|0|||
162174575|NCT05285137|585690648|FG000|Overall Study|Pregnancy|0|||
162174576|NCT05285137|585690649|FG001|Overall Study|Pregnancy|0|||
162174577|NCT05285137|585690650|FG002|Overall Study|Pregnancy|0|||
162174578|NCT05285137|585690651|FG003|Overall Study|Pregnancy|0|||
162174579|NCT05285137|585690652|FG004|Overall Study|Pregnancy|0|||
162174580|NCT05285137|585690653|FG005|Overall Study|Pregnancy|0|||
162174581|NCT05285137|585690654|FG006|Overall Study|Pregnancy|1|||
162174582|NCT05285137|585690655|FG007|Overall Study|Pregnancy|0|||
162174583|NCT05285137|585690656|FG008|Overall Study|Pregnancy|0|||
162174584|NCT05285137|585690648|FG000|Overall Study|Withdrawal by Subject|0|||
162174585|NCT05285137|585690649|FG001|Overall Study|Withdrawal by Subject|1|||
162174586|NCT05285137|585690650|FG002|Overall Study|Withdrawal by Subject|2|||
162174587|NCT05285137|585690651|FG003|Overall Study|Withdrawal by Subject|1|||
162174588|NCT05285137|585690652|FG004|Overall Study|Withdrawal by Subject|0|||
162174589|NCT05285137|585690653|FG005|Overall Study|Withdrawal by Subject|0|||
162174590|NCT05285137|585690654|FG006|Overall Study|Withdrawal by Subject|0|||
162174591|NCT05285137|585690655|FG007|Overall Study|Withdrawal by Subject|0|||
162174592|NCT05285137|585690656|FG008|Overall Study|Withdrawal by Subject|1|||
162174593|NCT03221426|585690657|FG000|Overall Study|Ongoing in study|212|||
162174594|NCT03221426|585690658|FG001|Overall Study|Ongoing in study|193|||
162174595|NCT03221426|585690659|FG002|Overall Study|Ongoing in study|61|||
162174596|NCT03221426|585690660|FG003|Overall Study|Ongoing in study|55|||
162174597|NCT03221426|585690657|FG000|Overall Study|Withdrawal by Subject|12|||
162174598|NCT03221426|585690658|FG001|Overall Study|Withdrawal by Subject|4|||
162174599|NCT03221426|585690659|FG002|Overall Study|Withdrawal by Subject|2|||
162174600|NCT03221426|585690660|FG003|Overall Study|Withdrawal by Subject|3|||
162174601|NCT03221426|585690657|FG000|Overall Study|Lost to Follow-up|4|||
162174602|NCT03221426|585690658|FG001|Overall Study|Lost to Follow-up|1|||
162174603|NCT03221426|585690659|FG002|Overall Study|Lost to Follow-up|1|||
162174604|NCT03221426|585690660|FG003|Overall Study|Lost to Follow-up|0|||
162174605|NCT03221426|585690657|FG000|Overall Study|Death|174|||
162174606|NCT03221426|585690658|FG001|Overall Study|Death|204|||
162174607|NCT03221426|585690659|FG002|Overall Study|Death|36|||
162174608|NCT03221426|585690660|FG003|Overall Study|Death|45|||
162174609|NCT06262477|585692246|FG000|Overall Study|Withdrawal by Subject|1|||
162174610|NCT06262477|585692247|FG001|Overall Study|Withdrawal by Subject|0|||
162174611|NCT06262477|585692246|FG000|Overall Study|Adverse Event|0|||
162174612|NCT06262477|585692247|FG001|Overall Study|Adverse Event|1|||
162174613|NCT06262477|585692246|FG000|Overall Study|Lost to Follow-up|0|||
162174614|NCT06262477|585692247|FG001|Overall Study|Lost to Follow-up|1|||
162174615|NCT02593773|585692251|FG000|Overall Study|Voluntary Withdrawal|3|||
162174616|NCT02593773|585692251|FG000|Overall Study|Study Terminated by Sponsor|31|||
162174617|NCT02593773|585692251|FG000|Overall Study|Death|1|||
162018413|NCT01032889|585121984|FG001|Overall Study|Patient Request|1|||
162018414|NCT01032889|585121985|FG002|Overall Study|Patient Request|0|||
162018415|NCT01032889|585121983|FG000|Overall Study|Lost to Follow-up|1|||
162018416|NCT01032889|585121984|FG001|Overall Study|Lost to Follow-up|1|||
162018417|NCT01032889|585121985|FG002|Overall Study|Lost to Follow-up|0|||
162018418|NCT01032889|585121983|FG000|Overall Study|Lack of Submental Fat|2|||
162018419|NCT01032889|585121984|FG001|Overall Study|Lack of Submental Fat|8|||
162018420|NCT01032889|585121985|FG002|Overall Study|Lack of Submental Fat|1|||
162018421|NCT01032889|585121983|FG000|Overall Study|Miscellaneous Reasons|2|||
162018422|NCT01032889|585121984|FG001|Overall Study|Miscellaneous Reasons|1|||
162018423|NCT01032889|585121985|FG002|Overall Study|Miscellaneous Reasons|1|||
162018424|NCT02116205|585121986|FG000|Overall Study|Withdrawal by Subject|2|||
162018425|NCT02116205|585121987|FG001|Overall Study|Withdrawal by Subject|4|||
162018426|NCT02116205|585121988|FG002|Overall Study|Withdrawal by Subject|1|||
162018427|NCT02116205|585121989|FG003|Overall Study|Withdrawal by Subject|3|||
162018428|NCT02116205|585121986|FG000|Overall Study|Lost to Follow-up|0|||
162018429|NCT02116205|585121987|FG001|Overall Study|Lost to Follow-up|2|||
162018430|NCT02116205|585121988|FG002|Overall Study|Lost to Follow-up|1|||
162018431|NCT02116205|585121989|FG003|Overall Study|Lost to Follow-up|2|||
162174618|NCT04024020|585692255|FG000|Overall Study|Withdrawal by Subject|2|||
162018432|NCT02116205|585121986|FG000|Overall Study|Physician Decision|0|||
162018433|NCT02116205|585121987|FG001|Overall Study|Physician Decision|1|||
162174619|NCT04024020|585692256|FG001|Overall Study|Withdrawal by Subject|2|||
162174620|NCT05269966|585692257|FG000|Overall Study|Adverse Event|4|||
162174621|NCT05269966|585692257|FG000|Overall Study|Withdrawal by Subject|1|||
162174622|NCT05269966|585692257|FG000|Overall Study|Lost to Follow-up|4|||
162174623|NCT05269966|585692257|FG000|Overall Study|Physician Decision|1|||
162174624|NCT06262347|585692260|FG000|Overall Study|Lost to Follow-up|4|||
162174625|NCT06262347|585692261|FG001|Overall Study|Lost to Follow-up|3|||
162174626|NCT06262347|585692260|FG000|Overall Study|Withdrawal by Subject|0|||
162174627|NCT06262347|585692261|FG001|Overall Study|Withdrawal by Subject|1|||
162174628|NCT04304144|585692274|FG000|DLT Observation Period|Physician Decision|0|||
162174629|NCT04304144|585692275|FG001|DLT Observation Period|Physician Decision|1|||
162174630|NCT04304144|585692276|FG002|DLT Observation Period|Physician Decision|0|||
162174631|NCT04304144|585692277|FG003|DLT Observation Period|Physician Decision|0|||
162174632|NCT04304144|585692274|FG000|Continued Treatment Period|Adverse Event|0|||
162174633|NCT04304144|585692275|FG001|Continued Treatment Period|Adverse Event|1|||
162174634|NCT04304144|585692276|FG002|Continued Treatment Period|Adverse Event|0|||
162174635|NCT04304144|585692277|FG003|Continued Treatment Period|Adverse Event|0|||
162174636|NCT04304144|585692274|FG000|Continued Treatment Period|Death|0|||
162174637|NCT04304144|585692275|FG001|Continued Treatment Period|Death|0|||
162174638|NCT04304144|585692276|FG002|Continued Treatment Period|Death|1|||
162174639|NCT04304144|585692277|FG003|Continued Treatment Period|Death|2|||
162174640|NCT04304144|585692274|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
162174641|NCT04304144|585692275|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
162174642|NCT04304144|585692276|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
162174643|NCT04304144|585692277|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
162174644|NCT04304144|585692274|FG000|Continued Treatment Period|Other than specified|2|||
162174645|NCT04304144|585692275|FG001|Continued Treatment Period|Other than specified|0|||
162174646|NCT04304144|585692276|FG002|Continued Treatment Period|Other than specified|1|||
162174647|NCT04304144|585692277|FG003|Continued Treatment Period|Other than specified|1|||
162174648|NCT04101357|585692278|FG000|Overall Study|Death|1|||
162174649|NCT04101357|585692279|FG001|Overall Study|Death|1|||
162174650|NCT04101357|585692280|FG002|Overall Study|Death|1|||
162174651|NCT04101357|585692281|FG003|Overall Study|Death|2|||
162174652|NCT04101357|585692282|FG004|Overall Study|Death|4|||
162174653|NCT04101357|585692283|FG005|Overall Study|Death|11|||
162174654|NCT04101357|585692284|FG006|Overall Study|Death|4|||
162174655|NCT04101357|585692285|FG007|Overall Study|Death|4|||
162174656|NCT04101357|585692286|FG008|Overall Study|Death|5|||
162174657|NCT04101357|585692287|FG009|Overall Study|Death|2|||
162174658|NCT04101357|585692288|FG010|Overall Study|Death|3|||
162174659|NCT04101357|585692278|FG000|Overall Study|Trial closure|0|||
162174660|NCT04101357|585692279|FG001|Overall Study|Trial closure|0|||
162174661|NCT04101357|585692280|FG002|Overall Study|Trial closure|0|||
162174662|NCT04101357|585692281|FG003|Overall Study|Trial closure|0|||
162174663|NCT04101357|585692282|FG004|Overall Study|Trial closure|0|||
162174664|NCT04101357|585692283|FG005|Overall Study|Trial closure|2|||
162174665|NCT04101357|585692284|FG006|Overall Study|Trial closure|2|||
161671174|NCT03026127|583849074|FG002|CRISP R61|Lost to Follow-up|0|||
161671175|NCT03026127|583849072|FG000|CRISP R61|Dropped before therapy|5|||
161671176|NCT03026127|583849073|FG001|CRISP R61|Dropped before therapy|0|||
161671177|NCT03026127|583849074|FG002|CRISP R61|Dropped before therapy|0|||
161671178|NCT03026127|583849072|FG000|CRISP R33|Lost to Follow-up|0|||
161671179|NCT03026127|583849073|FG001|CRISP R33|Lost to Follow-up|5|||
161671180|NCT03026127|583849074|FG002|CRISP R33|Lost to Follow-up|4|||
161671181|NCT03026127|583849072|FG000|CRISP R33|Adverse Event|0|||
161671182|NCT03026127|583849073|FG001|CRISP R33|Adverse Event|9|||
161671183|NCT03026127|583849074|FG002|CRISP R33|Adverse Event|5|||
162174666|NCT04101357|585692285|FG007|Overall Study|Trial closure|0|||
162174667|NCT04101357|585692286|FG008|Overall Study|Trial closure|0|||
161671184|NCT03026127|583849072|FG000|CRISP R33|Withdrawal by Subject|0|||
161671185|NCT03026127|583849073|FG001|CRISP R33|Withdrawal by Subject|9|||
161671186|NCT03026127|583849074|FG002|CRISP R33|Withdrawal by Subject|1|||
161671187|NCT03026127|583849072|FG000|CRISP R33|Lack of Efficacy|0|||
161671188|NCT03026127|583849073|FG001|CRISP R33|Lack of Efficacy|3|||
161671189|NCT03026127|583849074|FG002|CRISP R33|Lack of Efficacy|2|||
162174668|NCT04101357|585692287|FG009|Overall Study|Trial closure|0|||
162174669|NCT04101357|585692288|FG010|Overall Study|Trial closure|1|||
162174670|NCT04101357|585692278|FG000|Overall Study|Lost to Follow-up|0|||
162174671|NCT04101357|585692279|FG001|Overall Study|Lost to Follow-up|0|||
162174672|NCT04101357|585692280|FG002|Overall Study|Lost to Follow-up|0|||
162174673|NCT04101357|585692281|FG003|Overall Study|Lost to Follow-up|1|||
162174674|NCT04101357|585692282|FG004|Overall Study|Lost to Follow-up|0|||
161671190|NCT03026127|583849072|FG000|CRISP R33|Physician Decision|0|||
161671191|NCT03026127|583849073|FG001|CRISP R33|Physician Decision|3|||
161817030|NCT01604941|584370910|FG005|Overall Study|Adverse Event|5|||
161817031|NCT01604941|584370905|FG000|Overall Study|Non-compliance|1|||
161817032|NCT01604941|584370906|FG001|Overall Study|Non-compliance|0|||
162174675|NCT04101357|585692283|FG005|Overall Study|Lost to Follow-up|0|||
161671192|NCT03026127|583849074|FG002|CRISP R33|Physician Decision|1|||
162174676|NCT04101357|585692284|FG006|Overall Study|Lost to Follow-up|0|||
162174677|NCT04101357|585692285|FG007|Overall Study|Lost to Follow-up|1|||
162174678|NCT04101357|585692286|FG008|Overall Study|Lost to Follow-up|0|||
162174679|NCT04101357|585692287|FG009|Overall Study|Lost to Follow-up|0|||
162174680|NCT04101357|585692288|FG010|Overall Study|Lost to Follow-up|0|||
162174681|NCT04101357|585692278|FG000|Overall Study|Withdrawal by Subject|1|||
162174682|NCT04101357|585692279|FG001|Overall Study|Withdrawal by Subject|0|||
162174683|NCT04101357|585692280|FG002|Overall Study|Withdrawal by Subject|0|||
162174684|NCT04101357|585692281|FG003|Overall Study|Withdrawal by Subject|0|||
161671193|NCT03026127|583849072|FG000|CRISP R33|Transportation|0|||
161671194|NCT03026127|583849073|FG001|CRISP R33|Transportation|2|||
161671195|NCT03026127|583849074|FG002|CRISP R33|Transportation|1|||
161671196|NCT00132496|583849077|FG000|Overall Study|Withdrawal by Subject|1|||
162174685|NCT04101357|585692282|FG004|Overall Study|Withdrawal by Subject|0|||
162174686|NCT04101357|585692283|FG005|Overall Study|Withdrawal by Subject|0|||
162174687|NCT04101357|585692284|FG006|Overall Study|Withdrawal by Subject|0|||
162174688|NCT04101357|585692285|FG007|Overall Study|Withdrawal by Subject|0|||
162174689|NCT04101357|585692286|FG008|Overall Study|Withdrawal by Subject|1|||
162174690|NCT04101357|585692287|FG009|Overall Study|Withdrawal by Subject|1|||
162174691|NCT04101357|585692288|FG010|Overall Study|Withdrawal by Subject|0|||
162174692|NCT04101357|585692278|FG000|Overall Study|Other|0|||
162174693|NCT04101357|585692279|FG001|Overall Study|Other|0|||
162174694|NCT04101357|585692280|FG002|Overall Study|Other|0|||
161671197|NCT00132496|583849078|FG001|Overall Study|Withdrawal by Subject|2|||
161671198|NCT00132496|583849077|FG000|Overall Study|Physician Decision|1|||
161671199|NCT00132496|583849078|FG001|Overall Study|Physician Decision|0|||
161671200|NCT00564018|583849081|FG000|Overall Study|Withdrawal by Subject|2|||
161671201|NCT00564018|583849082|FG001|Overall Study|Withdrawal by Subject|3|||
161671202|NCT00564018|583849083|FG002|Overall Study|Withdrawal by Subject|1|||
161671203|NCT00986440|583849084|FG000|Overall Study|Progressive disease|27|||
161671204|NCT00986440|583849085|FG001|Overall Study|Progressive disease|37|||
161671205|NCT00986440|583849084|FG000|Overall Study|Serious adverse event or adverse event|9|||
161671206|NCT00986440|583849085|FG001|Overall Study|Serious adverse event or adverse event|2|||
161671207|NCT00986440|583849084|FG000|Overall Study|Withdrawal by Subject|1|||
161671208|NCT00986440|583849085|FG001|Overall Study|Withdrawal by Subject|2|||
161671209|NCT00986440|583849084|FG000|Overall Study|Screen failure (not dosed)|4|||
161671210|NCT00986440|583849085|FG001|Overall Study|Screen failure (not dosed)|2|||
161671211|NCT00388154|583849086|FG000|Overall Study|Withdrawal by Subject|1|||
161671212|NCT03431857|583849095|FG000|Overall Study|Death|6|||
161671213|NCT03431857|583849095|FG000|Overall Study|Lost to Follow-up|41|||
161671214|NCT03431857|583849095|FG000|Overall Study|Adverse Event|6|||
161671215|NCT03431857|583849095|FG000|Overall Study|Withdrawal by Subject|1|||
162174695|NCT04101357|585692281|FG003|Overall Study|Other|0|||
162174696|NCT04101357|585692282|FG004|Overall Study|Other|0|||
162174697|NCT04101357|585692283|FG005|Overall Study|Other|1|||
162174698|NCT04101357|585692284|FG006|Overall Study|Other|2|||
162174699|NCT04101357|585692285|FG007|Overall Study|Other|1|||
162174700|NCT04101357|585692286|FG008|Overall Study|Other|0|||
162174701|NCT04101357|585692287|FG009|Overall Study|Other|0|||
162174702|NCT04101357|585692288|FG010|Overall Study|Other|0|||
162174703|NCT04101357|585692278|FG000|Overall Study|Enrolled but not treated|0|||
162174704|NCT04101357|585692279|FG001|Overall Study|Enrolled but not treated|0|||
162174705|NCT04101357|585692280|FG002|Overall Study|Enrolled but not treated|0|||
162174706|NCT04101357|585692281|FG003|Overall Study|Enrolled but not treated|0|||
162174707|NCT04101357|585692282|FG004|Overall Study|Enrolled but not treated|0|||
162174708|NCT04101357|585692283|FG005|Overall Study|Enrolled but not treated|1|||
162174709|NCT04101357|585692284|FG006|Overall Study|Enrolled but not treated|1|||
162174710|NCT04101357|585692285|FG007|Overall Study|Enrolled but not treated|0|||
162174711|NCT04101357|585692286|FG008|Overall Study|Enrolled but not treated|0|||
162174712|NCT04101357|585692287|FG009|Overall Study|Enrolled but not treated|0|||
162174713|NCT04101357|585692288|FG010|Overall Study|Enrolled but not treated|0|||
162174714|NCT04660539|585692291|FG000|Overall Study|Adverse Event|10|||
162174715|NCT04660539|585692291|FG000|Overall Study|Lack of Efficacy|4|||
162174716|NCT04660539|585692291|FG000|Overall Study|Lost to Follow-up|5|||
162174717|NCT04660539|585692291|FG000|Overall Study|Non-Compliance With Study Drug|3|||
162174718|NCT04660539|585692291|FG000|Overall Study|Reason not Specified|12|||
162174719|NCT04660539|585692291|FG000|Overall Study|Pregnancy|2|||
162174720|NCT04660539|585692291|FG000|Overall Study|Protocol Violation|2|||
162174721|NCT04660539|585692291|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
162174722|NCT04660539|585692291|FG000|Overall Study|Withdrawal by Subject|21|||
162174723|NCT05618587|585692292|FG000|Overall Study|Lost to Follow-up|2|||
162174724|NCT05618587|585692293|FG001|Overall Study|Lost to Follow-up|0|||
162174725|NCT01828112|585692299|FG000|Treatment Phase|Adverse Event|7|||
162174726|NCT01828112|585692300|FG001|Treatment Phase|Adverse Event|8|||
162174727|NCT01828112|585692301|FG002|Treatment Phase|Adverse Event|0|||
162174728|NCT01828112|585692299|FG000|Treatment Phase|Death|9|||
162174729|NCT01828112|585692300|FG001|Treatment Phase|Death|5|||
162174730|NCT01828112|585692301|FG002|Treatment Phase|Death|0|||
162174731|NCT01828112|585692299|FG000|Treatment Phase|No longer required treatment|0|||
162174732|NCT01828112|585692300|FG001|Treatment Phase|No longer required treatment|1|||
161671216|NCT02876835|583849098|FG000|Treatment Period (51.1 Month)|Other|1|||
161671217|NCT02876835|583849099|FG001|Treatment Period (51.1 Month)|Other|0|||
161671218|NCT02876835|583849098|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
162174733|NCT01828112|585692301|FG002|Treatment Phase|No longer required treatment|0|||
162174734|NCT01828112|585692299|FG000|Treatment Phase|Physician Decision|6|||
162174735|NCT01828112|585692300|FG001|Treatment Phase|Physician Decision|7|||
162174736|NCT01828112|585692301|FG002|Treatment Phase|Physician Decision|0|||
162174737|NCT01828112|585692299|FG000|Treatment Phase|Pregnancy|1|||
162174738|NCT01828112|585692300|FG001|Treatment Phase|Pregnancy|0|||
162174739|NCT01828112|585692301|FG002|Treatment Phase|Pregnancy|0|||
162174740|NCT01828112|585692299|FG000|Treatment Phase|Progressive disease|79|||
162174741|NCT01828112|585692300|FG001|Treatment Phase|Progressive disease|87|||
162174742|NCT01828112|585692301|FG002|Treatment Phase|Progressive disease|0|||
162174743|NCT01828112|585692299|FG000|Treatment Phase|Study terminated by sponsor|1|||
162174744|NCT01828112|585692300|FG001|Treatment Phase|Study terminated by sponsor|0|||
162174745|NCT01828112|585692301|FG002|Treatment Phase|Study terminated by sponsor|0|||
162174746|NCT01828112|585692299|FG000|Treatment Phase|Subject/guardian decision|12|||
162174747|NCT01828112|585692300|FG001|Treatment Phase|Subject/guardian decision|8|||
162174748|NCT01828112|585692301|FG002|Treatment Phase|Subject/guardian decision|0|||
162174749|NCT01828112|585692299|FG000|Extension Treatment Phase|Adverse Event|0|||
162174750|NCT01828112|585692300|FG001|Extension Treatment Phase|Adverse Event|0|||
162174751|NCT01828112|585692301|FG002|Extension Treatment Phase|Adverse Event|6|||
162174752|NCT01828112|585692299|FG000|Extension Treatment Phase|Death|0|||
162174753|NCT01828112|585692300|FG001|Extension Treatment Phase|Death|0|||
162174754|NCT01828112|585692301|FG002|Extension Treatment Phase|Death|17|||
162174755|NCT01828112|585692299|FG000|Extension Treatment Phase|Physician Decision|0|||
162174756|NCT01828112|585692300|FG001|Extension Treatment Phase|Physician Decision|0|||
162174757|NCT01828112|585692301|FG002|Extension Treatment Phase|Physician Decision|5|||
162174758|NCT01828112|585692299|FG000|Extension Treatment Phase|Progressive disease|0|||
162174759|NCT01828112|585692300|FG001|Extension Treatment Phase|Progressive disease|0|||
162174760|NCT01828112|585692301|FG002|Extension Treatment Phase|Progressive disease|46|||
162174761|NCT01828112|585692299|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
162174762|NCT01828112|585692300|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
162174763|NCT01828112|585692301|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
162174764|NCT01828112|585692299|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
162174765|NCT01828112|585692300|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
162174766|NCT01828112|585692301|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
162174767|NCT05565820|585692305|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
162174768|NCT05565820|585692306|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
162174769|NCT05565820|585692305|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
162174770|NCT05565820|585692306|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
162174771|NCT04689256|585692307|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
162174772|NCT04689256|585692308|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
162174773|NCT04862234|585692311|FG000|Overall Study|Surgery cancellation|1|||
162174774|NCT04862234|585692312|FG001|Overall Study|Surgery cancellation|2|||
162174775|NCT04862234|585692311|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
162174776|NCT04862234|585692312|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
162174777|NCT04862234|585692311|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
162174778|NCT04862234|585692312|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
162174779|NCT05828017|585692313|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
162174780|NCT05012163|585692317|FG000|Overall Study|Protocol Violation|0|||
162174781|NCT05012163|585692318|FG001|Overall Study|Protocol Violation|0|||
162174782|NCT05012163|585692319|FG002|Overall Study|Protocol Violation|1|||
162174783|NCT05012163|585692320|FG003|Overall Study|Protocol Violation|1|||
162174784|NCT04132518|585692323|FG000|Overall Study|Prematurely withdrawn from the study|0|||
162174785|NCT04132518|585692324|FG001|Overall Study|Prematurely withdrawn from the study|9|||
162174786|NCT04132518|585692325|FG002|Overall Study|Prematurely withdrawn from the study|1|||
162174787|NCT03381586|585692326|FG000|Overall Study|Adverse Event|1|||
162174788|NCT03381586|585692327|FG001|Overall Study|Adverse Event|1|||
162174789|NCT03381586|585692326|FG000|Overall Study|Protocol Violation|1|||
162174790|NCT03381586|585692327|FG001|Overall Study|Protocol Violation|0|||
162174791|NCT03381586|585692326|FG000|Overall Study|Withdrawal by Subject|1|||
162174792|NCT03381586|585692327|FG001|Overall Study|Withdrawal by Subject|2|||
162174793|NCT04999111|585692328|FG000|Overall Study|Lost to Follow-up|21|||
162174794|NCT04999111|585692329|FG001|Overall Study|Lost to Follow-up|16|||
162174795|NCT04999111|585692330|FG002|Overall Study|Lost to Follow-up|2|||
162174796|NCT04999111|585692331|FG003|Overall Study|Lost to Follow-up|26|||
162174797|NCT04999111|585692332|FG004|Overall Study|Lost to Follow-up|30|||
162174798|NCT04999111|585692333|FG005|Overall Study|Lost to Follow-up|6|||
162174799|NCT04999111|585692328|FG000|Overall Study|Physician Decision|1|||
162174800|NCT04999111|585692329|FG001|Overall Study|Physician Decision|3|||
162174801|NCT04999111|585692330|FG002|Overall Study|Physician Decision|0|||
162174802|NCT04999111|585692331|FG003|Overall Study|Physician Decision|1|||
162174803|NCT04999111|585692332|FG004|Overall Study|Physician Decision|2|||
162174804|NCT04999111|585692333|FG005|Overall Study|Physician Decision|0|||
162174805|NCT04999111|585692328|FG000|Overall Study|Withdrawal by Subject|23|||
162174806|NCT04999111|585692329|FG001|Overall Study|Withdrawal by Subject|29|||
162174807|NCT04999111|585692330|FG002|Overall Study|Withdrawal by Subject|15|||
162174808|NCT04999111|585692331|FG003|Overall Study|Withdrawal by Subject|30|||
162174809|NCT04999111|585692332|FG004|Overall Study|Withdrawal by Subject|35|||
162174810|NCT04999111|585692333|FG005|Overall Study|Withdrawal by Subject|10|||
162174811|NCT04999111|585692328|FG000|Overall Study|Other|6|||
162174812|NCT04999111|585692329|FG001|Overall Study|Other|6|||
162174813|NCT04999111|585692330|FG002|Overall Study|Other|3|||
162174814|NCT04999111|585692331|FG003|Overall Study|Other|8|||
162174815|NCT04999111|585692332|FG004|Overall Study|Other|8|||
162174816|NCT04999111|585692333|FG005|Overall Study|Other|5|||
162174817|NCT04999111|585692328|FG000|Overall Study|Non-compliance with study schedule|1|||
162174818|NCT04999111|585692329|FG001|Overall Study|Non-compliance with study schedule|0|||
162174819|NCT04999111|585692330|FG002|Overall Study|Non-compliance with study schedule|0|||
162174820|NCT04999111|585692331|FG003|Overall Study|Non-compliance with study schedule|1|||
162174821|NCT04999111|585692332|FG004|Overall Study|Non-compliance with study schedule|1|||
162174822|NCT04999111|585692333|FG005|Overall Study|Non-compliance with study schedule|1|||
162174823|NCT04999111|585692328|FG000|Overall Study|Randomized but not vaccinated|1|||
162174824|NCT04999111|585692329|FG001|Overall Study|Randomized but not vaccinated|2|||
162174825|NCT04999111|585692330|FG002|Overall Study|Randomized but not vaccinated|0|||
162174826|NCT04999111|585692331|FG003|Overall Study|Randomized but not vaccinated|3|||
162174827|NCT04999111|585692332|FG004|Overall Study|Randomized but not vaccinated|3|||
162174828|NCT04999111|585692333|FG005|Overall Study|Randomized but not vaccinated|0|||
162174829|NCT04999111|585692328|FG000|Overall Study|Adverse Event|1|||
162174830|NCT04999111|585692329|FG001|Overall Study|Adverse Event|1|||
162174831|NCT04999111|585692330|FG002|Overall Study|Adverse Event|0|||
162174832|NCT04999111|585692331|FG003|Overall Study|Adverse Event|0|||
162174833|NCT04999111|585692332|FG004|Overall Study|Adverse Event|0|||
162174834|NCT04999111|585692333|FG005|Overall Study|Adverse Event|0|||
162174835|NCT04999111|585692328|FG000|Overall Study|Initiated prohibited medication|0|||
162174836|NCT04999111|585692329|FG001|Overall Study|Initiated prohibited medication|0|||
162174837|NCT04999111|585692330|FG002|Overall Study|Initiated prohibited medication|0|||
162174838|NCT04999111|585692331|FG003|Overall Study|Initiated prohibited medication|0|||
162174839|NCT04999111|585692332|FG004|Overall Study|Initiated prohibited medication|1|||
162174840|NCT04999111|585692333|FG005|Overall Study|Initiated prohibited medication|0|||
162174841|NCT04056611|585692337|FG000|Overall Study|Physician Decision|1|||
162174842|NCT03733925|585692340|FG000|Overall Study|Lost to Follow-up|1|||
162174843|NCT03733925|585692340|FG000|Overall Study|Withdrawal by Subject|2|||
162174844|NCT03733925|585692340|FG000|Overall Study|Adverse Event|2|||
162174845|NCT03733925|585692340|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162174846|NCT03213873|585692341|FG000|Overall Study|Withdrawal by Subject|8|||
162174847|NCT03213873|585692342|FG001|Overall Study|Withdrawal by Subject|9|||
162174848|NCT03213873|585692341|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
162174849|NCT03213873|585692342|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
162174850|NCT03213873|585692341|FG000|Overall Study|Lost to Follow-up|0|||
162174851|NCT03213873|585692342|FG001|Overall Study|Lost to Follow-up|2|||
162174852|NCT04709419|585692343|FG000|Overall Study|Physician Decision|1|||
162174853|NCT04709419|585692344|FG001|Overall Study|Physician Decision|0|||
162174854|NCT05683340|585692345|FG000|Overall Study|Adverse Event|1|||
162174855|NCT05683340|585692346|FG001|Overall Study|Adverse Event|1|||
162174856|NCT05683340|585692345|FG000|Overall Study|Protocol Violation|1|||
162174857|NCT05683340|585692346|FG001|Overall Study|Protocol Violation|0|||
162174858|NCT05683340|585692345|FG000|Overall Study|Withdrawal by Subject|0|||
162174859|NCT05683340|585692346|FG001|Overall Study|Withdrawal by Subject|2|||
162174860|NCT02224144|585692350|FG000|Overall Study|Lost to Follow-up|3|||
162174861|NCT02224144|585692351|FG001|Overall Study|Lost to Follow-up|1|||
162174862|NCT02224144|585692350|FG000|Overall Study|Death|2|||
162174863|NCT02224144|585692351|FG001|Overall Study|Death|0|||
162174864|NCT02224144|585692350|FG000|Overall Study|Withdrawal by Subject|0|||
162174865|NCT02224144|585692351|FG001|Overall Study|Withdrawal by Subject|1|||
162174866|NCT02780700|585692353|FG000|Overall Study|Progressive disease|1|||
162174867|NCT03824366|585692364|FG000|Overall Study|Death|1|||
162174868|NCT03824366|585692364|FG000|Overall Study|Previously unidentified metal artifact|1|||
162174869|NCT03824366|585692364|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
162174870|NCT03824366|585692364|FG000|Overall Study|Withdrawal by Subject|1|||
162174871|NCT03118518|585692365|FG000|Overall Study|Early Exit after treatment|2|||
162174872|NCT03118518|585692366|FG001|Overall Study|Early Exit after treatment|8|||
162174873|NCT03118518|585692365|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
162174874|NCT03118518|585692366|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
162174875|NCT02834390|585692367|FG000|Induction Phase|Progressive disease|0|||
162174876|NCT02834390|585692368|FG001|Induction Phase|Progressive disease|1|||
162174877|NCT02834390|585692367|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
162174878|NCT02834390|585692368|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
162174879|NCT02834390|585692367|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
162174880|NCT02834390|585692368|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
162174881|NCT02834390|585692367|FG000|Consolidation Phase|Physician Decision|1|||
162174882|NCT02834390|585692368|FG001|Consolidation Phase|Physician Decision|1|||
162174883|NCT05533190|585692373|FG000|Overall Study|Lost to Follow-up|19|||
162174884|NCT05533190|585692374|FG001|Overall Study|Lost to Follow-up|7|||
162174885|NCT05533190|585692373|FG000|Overall Study|Failed to download app|1|||
162174886|NCT05533190|585692374|FG001|Overall Study|Failed to download app|0|||
162174887|NCT05533190|585692373|FG000|Overall Study|Thought app was a scam|1|||
162174888|NCT05533190|585692374|FG001|Overall Study|Thought app was a scam|0|||
161671219|NCT02876835|583849099|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
161671220|NCT02876835|583849098|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
162174889|NCT05533190|585692373|FG000|Overall Study|Withdrawal by Subject|2|||
162174890|NCT05533190|585692374|FG001|Overall Study|Withdrawal by Subject|0|||
162174891|NCT01199133|585692379|FG000|Year 1|Adverse Event|16|||
161671221|NCT02876835|583849099|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
161671222|NCT02876835|583849098|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
161671223|NCT02876835|583849099|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
161671224|NCT01117857|583849100|FG000|Overall Study|Lost to Follow-up|4|||
161671225|NCT01117857|583849100|FG000|Overall Study|Withdrawal by Subject|4|||
161671226|NCT01117857|583849100|FG000|Overall Study|Physician Decision|1|||
161671227|NCT01119001|583849101|FG000|Overall Study|Withdrawal by Subject|2|||
161671228|NCT05245097|583849102|FG000|Overall Study|Adverse Event|13|||
161671229|NCT05245097|583849103|FG001|Overall Study|Adverse Event|2|||
161671230|NCT05245097|583849102|FG000|Overall Study|Protocol Violation|8|||
161671231|NCT05245097|583849103|FG001|Overall Study|Protocol Violation|6|||
161671232|NCT05245097|583849102|FG000|Overall Study|Withdrawal by Subject|18|||
162174892|NCT01199133|585692380|FG001|Year 1|Adverse Event|4|||
162174893|NCT01199133|585692379|FG000|Year 1|Withdrawal by Subject|8|||
162174894|NCT01199133|585692380|FG001|Year 1|Withdrawal by Subject|4|||
162174895|NCT01199133|585692379|FG000|Year 1|Any other reason not above-mentioned|6|||
162174896|NCT01199133|585692380|FG001|Year 1|Any other reason not above-mentioned|7|||
162174897|NCT01199133|585692379|FG000|Year 2|Adverse Event|1|||
162174898|NCT01199133|585692380|FG001|Year 2|Adverse Event|0|||
162174899|NCT01199133|585692379|FG000|Year 2|Withdrawal by Subject|1|||
162174900|NCT01199133|585692380|FG001|Year 2|Withdrawal by Subject|1|||
162174901|NCT01199133|585692379|FG000|Year 2|Any other reason not above-mentioned|1|||
162174902|NCT01199133|585692380|FG001|Year 2|Any other reason not above-mentioned|2|||
162174903|NCT02575950|585692381|FG000|Overall Study|Withdrawal by Subject|0|||
162174904|NCT02575950|585692382|FG001|Overall Study|Withdrawal by Subject|0|||
162174905|NCT02575950|585692383|FG002|Overall Study|Withdrawal by Subject|0|||
162174906|NCT02575950|585692384|FG003|Overall Study|Withdrawal by Subject|2|||
162174907|NCT02575950|585692381|FG000|Overall Study|Lost to Follow-up|0|||
162174908|NCT02575950|585692382|FG001|Overall Study|Lost to Follow-up|1|||
162174909|NCT02575950|585692383|FG002|Overall Study|Lost to Follow-up|0|||
162174910|NCT02575950|585692384|FG003|Overall Study|Lost to Follow-up|3|||
162174911|NCT03993392|585692386|FG000|Overall Study|Withdrawal by Subject|3|||
162174912|NCT03993392|585692386|FG000|Overall Study|Lost to Follow-up|2|||
162174913|NCT03993392|585692386|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
162174914|NCT05292391|585692389|FG000|Overall Study|Lost to Follow-up|0|||
162174915|NCT05292391|585692390|FG001|Overall Study|Lost to Follow-up|0|||
161671233|NCT05245097|583849103|FG001|Overall Study|Withdrawal by Subject|0|||
161671234|NCT05245097|583849102|FG000|Overall Study|Death|6|||
161671235|NCT05245097|583849103|FG001|Overall Study|Death|7|||
162174916|NCT05292391|585692391|FG002|Overall Study|Lost to Follow-up|0|||
162174917|NCT05292391|585692392|FG003|Overall Study|Lost to Follow-up|1|||
162174918|NCT05292391|585692393|FG004|Overall Study|Lost to Follow-up|0|||
162174919|NCT04857723|585692396|FG000|Overall Study|Withdrawal by Subject|2|||
162174920|NCT01064440|585693699|FG000|Overall Study|Lost to Follow-up|1|||
162174921|NCT01064440|585693700|FG001|Overall Study|Lost to Follow-up|1|||
162174922|NCT01064440|585693701|FG002|Overall Study|Lost to Follow-up|1|||
162174923|NCT01064440|585693699|FG000|Overall Study|Non-compliance|0|||
162174924|NCT01064440|585693700|FG001|Overall Study|Non-compliance|1|||
162174925|NCT01064440|585693701|FG002|Overall Study|Non-compliance|0|||
162174926|NCT01064440|585693699|FG000|Overall Study|Death|1|||
162174927|NCT01064440|585693700|FG001|Overall Study|Death|0|||
162174928|NCT01064440|585693701|FG002|Overall Study|Death|1|||
162174929|NCT01064440|585693699|FG000|Overall Study|Withdrawal by Subject|0|||
162174930|NCT01064440|585693700|FG001|Overall Study|Withdrawal by Subject|1|||
162174931|NCT01064440|585693701|FG002|Overall Study|Withdrawal by Subject|1|||
162174932|NCT01064440|585693699|FG000|Overall Study|Other: amputation|1|||
162174933|NCT01064440|585693700|FG001|Overall Study|Other: amputation|0|||
162174934|NCT01064440|585693701|FG002|Overall Study|Other: amputation|0|||
162174935|NCT03220035|585693703|FG000|Overall Study|Adverse Event|1|||
162174936|NCT03220035|585693703|FG000|Overall Study|Protocol Violation|1|||
162174937|NCT03220035|585693703|FG000|Overall Study|Progressive Disease|2|||
162174938|NCT04871529|585693707|FG000|Overall Study|Withdrawal by Subject|0|||
162174939|NCT04871529|585693708|FG001|Overall Study|Withdrawal by Subject|1|||
162174940|NCT04871529|585693707|FG000|Overall Study|Death|0|||
162174941|NCT04871529|585693708|FG001|Overall Study|Death|1|||
162174942|NCT04871529|585693707|FG000|Overall Study|Not protocol specified|0|||
162174943|NCT04871529|585693708|FG001|Overall Study|Not protocol specified|1|||
162174944|NCT05184452|585693709|FG000|Overall Study|Lost to Follow-up|0|||
161671236|NCT05245097|583849102|FG000|Overall Study|Physician Decision|6|||
162174945|NCT05184452|585693710|FG001|Overall Study|Lost to Follow-up|0|||
162174946|NCT05184452|585693711|FG002|Overall Study|Lost to Follow-up|0|||
162174947|NCT05184452|585693712|FG003|Overall Study|Lost to Follow-up|0|||
162174948|NCT05184452|585693713|FG004|Overall Study|Lost to Follow-up|0|||
162174949|NCT05184452|585693714|FG005|Overall Study|Lost to Follow-up|2|||
162174950|NCT05184452|585693715|FG006|Overall Study|Lost to Follow-up|0|||
161671237|NCT05245097|583849103|FG001|Overall Study|Physician Decision|0|||
162174951|NCT05184452|585693716|FG007|Overall Study|Lost to Follow-up|0|||
162174952|NCT05184452|585693717|FG008|Overall Study|Lost to Follow-up|0|||
162174953|NCT05184452|585693718|FG009|Overall Study|Lost to Follow-up|1|||
161671238|NCT05245097|583849102|FG000|Overall Study|Relocation|4|||
161671239|NCT05245097|583849103|FG001|Overall Study|Relocation|3|||
161671240|NCT03604523|583849108|FG000|Overall Study|Physician Decision|1|||
161671241|NCT03604523|583849109|FG001|Overall Study|Physician Decision|0|||
161671242|NCT00458341|583849110|FG000|Cycle 1|Adverse Event|1|||
162174954|NCT05184452|585693709|FG000|Overall Study|Withdrawal by Subject|0|||
162174955|NCT05184452|585693710|FG001|Overall Study|Withdrawal by Subject|0|||
162174956|NCT05184452|585693711|FG002|Overall Study|Withdrawal by Subject|0|||
162174957|NCT05184452|585693712|FG003|Overall Study|Withdrawal by Subject|0|||
162174958|NCT05184452|585693713|FG004|Overall Study|Withdrawal by Subject|0|||
162174959|NCT05184452|585693714|FG005|Overall Study|Withdrawal by Subject|1|||
162174960|NCT05184452|585693715|FG006|Overall Study|Withdrawal by Subject|0|||
162174961|NCT05184452|585693716|FG007|Overall Study|Withdrawal by Subject|0|||
162174962|NCT05184452|585693717|FG008|Overall Study|Withdrawal by Subject|0|||
162174963|NCT05184452|585693718|FG009|Overall Study|Withdrawal by Subject|1|||
162174964|NCT05586490|585693719|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
162174965|NCT05586490|585693720|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
162174966|NCT05586490|585693721|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
162174967|NCT05586490|585693722|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
162174968|NCT05586490|585693723|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
162174969|NCT05586490|585693719|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
162174970|NCT05586490|585693720|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
162174971|NCT05586490|585693721|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
162174972|NCT05586490|585693722|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
162174973|NCT05586490|585693723|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
162174974|NCT05586490|585693719|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
162174975|NCT05586490|585693720|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
161817033|NCT01604941|584370907|FG002|Overall Study|Non-compliance|0|||
162174976|NCT05586490|585693721|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
162174977|NCT05586490|585693722|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
162174978|NCT05586490|585693723|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
162174979|NCT04136912|585693726|FG000|Overall Study|Operational reasons|0|||
162174980|NCT04136912|585693727|FG001|Overall Study|Operational reasons|0|||
162174981|NCT04136912|585693728|FG002|Overall Study|Operational reasons|2|||
162174982|NCT03556293|585693729|FG000|Overall Study|Ineligible for analysis|1904|||
162174983|NCT03556293|585693730|FG001|Overall Study|Ineligible for analysis|1471|||
162174984|NCT03556293|585693731|FG002|Overall Study|Ineligible for analysis|1091|||
162174985|NCT03556293|585693732|FG003|Overall Study|Ineligible for analysis|1269|||
162174986|NCT03292484|585693738|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
162174987|NCT03292484|585693738|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
162174988|NCT03292484|585693738|FG000|Overall Study|Protocol Violation|2|||
162174989|NCT03292484|585693738|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
162174990|NCT03292484|585693738|FG000|Overall Study|Sponsor decision|349|||
162174991|NCT03292484|585693738|FG000|Overall Study|Lost to Follow-up|7|||
162174992|NCT03292484|585693738|FG000|Overall Study|Coronavirus Disease 2019|1|||
162174993|NCT03292484|585693738|FG000|Overall Study|Other|20|||
162174994|NCT05290493|585693739|FG000|Overall Study|Withdrawal by Subject|2|||
162174995|NCT05290493|585693740|FG001|Overall Study|Withdrawal by Subject|2|||
162174996|NCT05290493|585693739|FG000|Overall Study|Adverse Event|1|||
162174997|NCT05290493|585693740|FG001|Overall Study|Adverse Event|0|||
162174998|NCT05524402|585693748|FG000|Overall Study|Withdrawal by Subject|3|||
162174999|NCT05524402|585693749|FG001|Overall Study|Withdrawal by Subject|1|||
162175000|NCT05524402|585693748|FG000|Overall Study|Lost to Follow-up|2|||
162175001|NCT05524402|585693749|FG001|Overall Study|Lost to Follow-up|1|||
162175002|NCT05976334|585693750|FG000|Part B|Death|0|||
161817034|NCT01604941|584370908|FG003|Overall Study|Non-compliance|0|||
162175003|NCT05976334|585693751|FG001|Part B|Death|1|||
162175004|NCT05976334|585693750|FG000|Part B|Study Terminated by Sponsor|0|||
162175005|NCT05976334|585693751|FG001|Part B|Study Terminated by Sponsor|1|||
162175006|NCT05976334|585693750|FG000|Part B|Reason Not Specified|0|||
162175007|NCT05976334|585693751|FG001|Part B|Reason Not Specified|1|||
162175008|NCT05280574|585693757|FG000|Overall Study|Withdrawal by Subject|0|||
162175009|NCT05280574|585693758|FG001|Overall Study|Withdrawal by Subject|2|||
162175010|NCT05280574|585693759|FG002|Overall Study|Withdrawal by Subject|0|||
162175011|NCT05363163|585693760|FG000|Overall Study|Withdrawal by Subject|13|||
162175012|NCT03673501|585693766|FG000|Overall Study|Participants ongoing.|36|||
162175013|NCT03673501|585693767|FG001|Overall Study|Participants ongoing.|24|||
162175014|NCT05838027|585693768|FG000|Overall Study|Lost to Follow-up|5|||
162175015|NCT05838027|585693769|FG001|Overall Study|Lost to Follow-up|1|||
162175016|NCT05838027|585693768|FG000|Overall Study|Withdrawal by Subject|1|||
162175017|NCT05838027|585693769|FG001|Overall Study|Withdrawal by Subject|0|||
162175018|NCT05237284|585693770|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
162175019|NCT05237284|585693771|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
162175020|NCT05237284|585693772|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
162175021|NCT05237284|585693773|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
162175022|NCT05237284|585693770|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
162175023|NCT05237284|585693771|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
162175024|NCT05237284|585693772|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
162175025|NCT05237284|585693773|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
162175026|NCT05237284|585693770|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
162175027|NCT05237284|585693771|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
162175028|NCT05237284|585693772|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
162175029|NCT05237284|585693773|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
162175030|NCT05237284|585693770|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
162175031|NCT05237284|585693771|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
162175032|NCT05237284|585693772|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
162175033|NCT05237284|585693773|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
162175034|NCT05237284|585693770|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
162175035|NCT05237284|585693771|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
162175036|NCT05237284|585693772|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
162175037|NCT05237284|585693773|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
162175038|NCT05237284|585693770|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
162175039|NCT05237284|585693771|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
162175040|NCT05237284|585693772|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
162175041|NCT05237284|585693773|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
162175042|NCT05237284|585693770|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
162175043|NCT05237284|585693771|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
162175044|NCT05237284|585693772|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
162175045|NCT05237284|585693773|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
162175046|NCT05237284|585693770|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
162175047|NCT05237284|585693771|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
162175048|NCT05237284|585693772|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
162175049|NCT05237284|585693773|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
162175050|NCT05237284|585693770|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
162175051|NCT05237284|585693771|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
162175052|NCT05237284|585693772|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
162175053|NCT05237284|585693773|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
162175054|NCT04599634|585693774|FG000|Overall Study|Dose limiting toxicity|0|||
162175055|NCT04599634|585693775|FG001|Overall Study|Dose limiting toxicity|0|||
162175056|NCT04599634|585693776|FG002|Overall Study|Dose limiting toxicity|2|||
162175057|NCT04599634|585693777|FG003|Overall Study|Dose limiting toxicity|0|||
162175058|NCT04068831|585693793|FG000|Overall Study|Disease Progression|10|||
162175059|NCT04068831|585693794|FG001|Overall Study|Disease Progression|8|||
162175060|NCT03485729|585693803|FG000|Overall Study|Withdrawal by Subject|0|||
162175061|NCT03485729|585693804|FG001|Overall Study|Withdrawal by Subject|0|||
162175062|NCT03485729|585693805|FG002|Overall Study|Withdrawal by Subject|1|||
162175063|NCT03485729|585693803|FG000|Overall Study|Disease progression|8|||
162175064|NCT03485729|585693804|FG001|Overall Study|Disease progression|13|||
162175065|NCT03485729|585693805|FG002|Overall Study|Disease progression|1|||
162175066|NCT03485729|585693803|FG000|Overall Study|Hospice care|1|||
162175067|NCT03485729|585693804|FG001|Overall Study|Hospice care|0|||
162175068|NCT03485729|585693805|FG002|Overall Study|Hospice care|0|||
162175069|NCT03485729|585693803|FG000|Overall Study|Poor performance status|1|||
162175070|NCT03485729|585693804|FG001|Overall Study|Poor performance status|0|||
162175071|NCT03485729|585693805|FG002|Overall Study|Poor performance status|0|||
162175072|NCT03485729|585693803|FG000|Overall Study|Illness|0|||
162175073|NCT03485729|585693804|FG001|Overall Study|Illness|1|||
161671243|NCT00458341|583849111|FG001|Cycle 1|Adverse Event|0|||
162175074|NCT03485729|585693805|FG002|Overall Study|Illness|0|||
161671244|NCT05461794|583849112|FG000|Overall Study|Withdrawal by Subject|1|||
162175075|NCT05552508|585693806|FG000|Overall Study|Adverse Event|3|||
162175076|NCT04632225|585693809|FG000|Overall Study|Withdrawal by Subject|2|||
162175077|NCT04632225|585693810|FG001|Overall Study|Withdrawal by Subject|2|||
162175078|NCT05660434|585693811|FG000|Overall Study|Never obtained study materials|2|||
162175079|NCT05660434|585693812|FG001|Overall Study|Never obtained study materials|1|||
162175080|NCT03213678|585693814|FG000|Overall Study|Death|1|||
162175081|NCT03213678|585693814|FG000|Overall Study|Physician Decision|1|||
162175082|NCT03213678|585693814|FG000|Overall Study|Progressive disease|16|||
162175083|NCT02413489|585693815|FG000|Overall Study|Death|11|||
162175084|NCT02413489|585693816|FG001|Overall Study|Death|3|||
162175085|NCT02413489|585693817|FG002|Overall Study|Death|4|||
162175086|NCT02413489|585693815|FG000|Overall Study|Withdrawal by Subject|2|||
162175087|NCT02413489|585693816|FG001|Overall Study|Withdrawal by Subject|0|||
162175088|NCT02413489|585693817|FG002|Overall Study|Withdrawal by Subject|0|||
162175089|NCT02413489|585693815|FG000|Overall Study|Study Terminated By Sponsor|2|||
162175090|NCT02413489|585693816|FG001|Overall Study|Study Terminated By Sponsor|13|||
162175091|NCT02413489|585693817|FG002|Overall Study|Study Terminated By Sponsor|1|||
162175092|NCT03717935|585693818|FG000|Overall Study|Withdrawal by Subject|0|||
162175093|NCT03717935|585693819|FG001|Overall Study|Withdrawal by Subject|2|||
162175094|NCT04456296|585693820|FG000|Overall Study|Withdrawal by Subject|14|||
162175095|NCT04456296|585693821|FG001|Overall Study|Withdrawal by Subject|21|||
162175096|NCT04456296|585693822|FG002|Overall Study|Withdrawal by Subject|21|||
162175097|NCT04456296|585693820|FG000|Overall Study|Adverse Event|2|||
162175098|NCT04456296|585693821|FG001|Overall Study|Adverse Event|2|||
162175099|NCT04456296|585693822|FG002|Overall Study|Adverse Event|2|||
162175100|NCT04456296|585693820|FG000|Overall Study|Death|1|||
162175101|NCT04456296|585693821|FG001|Overall Study|Death|0|||
162175102|NCT04456296|585693822|FG002|Overall Study|Death|0|||
162175103|NCT04456296|585693820|FG000|Overall Study|Lost to Follow-up|3|||
162175104|NCT04456296|585693821|FG001|Overall Study|Lost to Follow-up|5|||
162175105|NCT04456296|585693822|FG002|Overall Study|Lost to Follow-up|6|||
162175106|NCT04456296|585693820|FG000|Overall Study|Other than specified|0|||
162175107|NCT04456296|585693821|FG001|Overall Study|Other than specified|1|||
162175108|NCT04456296|585693822|FG002|Overall Study|Other than specified|4|||
162175109|NCT04456296|585693820|FG000|Overall Study|Randomized, not treated|2|||
162175110|NCT04456296|585693821|FG001|Overall Study|Randomized, not treated|1|||
162175111|NCT04456296|585693822|FG002|Overall Study|Randomized, not treated|0|||
162175112|NCT04230681|585693829|FG000|Overall Study|Physician Decision|2|||
162175113|NCT04230681|585693830|FG001|Overall Study|Physician Decision|3|||
162175114|NCT04230681|585693829|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
162175115|NCT04230681|585693830|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
162175116|NCT04230681|585693829|FG000|Overall Study|IV inadvertently removed|0|||
162175117|NCT04230681|585693830|FG001|Overall Study|IV inadvertently removed|1|||
162175118|NCT03106740|585695197|FG000|Overall Study|Lost to Follow-up|2|||
162175119|NCT03106740|585695198|FG001|Overall Study|Lost to Follow-up|2|||
162175120|NCT03106740|585695197|FG000|Overall Study|Withdrawal by Subject|2|||
162175121|NCT03106740|585695198|FG001|Overall Study|Withdrawal by Subject|4|||
162175122|NCT03106740|585695197|FG000|Overall Study|Physician Decision|0|||
162175123|NCT03106740|585695198|FG001|Overall Study|Physician Decision|1|||
162175124|NCT03106740|585695197|FG000|Overall Study|Partial data|1|||
162175125|NCT03106740|585695198|FG001|Overall Study|Partial data|0|||
162175126|NCT04797858|585695199|FG000|Overall Study|Withdrawal by Subject|0|||
162175127|NCT04797858|585695200|FG001|Overall Study|Withdrawal by Subject|1|||
162175128|NCT04797858|585695199|FG000|Overall Study|Excluded due to administrative error|7|||
162175129|NCT04797858|585695200|FG001|Overall Study|Excluded due to administrative error|8|||
162175130|NCT01880515|585695204|FG000|Overall Study|Lost to Follow-up|3|||
162175131|NCT01880515|585695205|FG001|Overall Study|Lost to Follow-up|2|||
162175132|NCT01880515|585695204|FG000|Overall Study|Disease Progression|5|||
162175133|NCT01880515|585695205|FG001|Overall Study|Disease Progression|7|||
162175134|NCT03505710|585695206|FG000|Overall Study|Progressive Disease|24|||
162175135|NCT03505710|585695207|FG001|Overall Study|Progressive Disease|17|||
162175136|NCT03505710|585695208|FG002|Overall Study|Progressive Disease|43|||
162175137|NCT03505710|585695206|FG000|Overall Study|Clinical Progression|6|||
162175138|NCT03505710|585695207|FG001|Overall Study|Clinical Progression|8|||
162175139|NCT03505710|585695208|FG002|Overall Study|Clinical Progression|3|||
162175140|NCT03505710|585695206|FG000|Overall Study|Adverse Event|12|||
162175141|NCT03505710|585695207|FG001|Overall Study|Adverse Event|6|||
162175142|NCT03505710|585695208|FG002|Overall Study|Adverse Event|28|||
162175143|NCT03505710|585695206|FG000|Overall Study|Withdrawal by Subject|1|||
162175144|NCT03505710|585695207|FG001|Overall Study|Withdrawal by Subject|3|||
162175145|NCT03505710|585695208|FG002|Overall Study|Withdrawal by Subject|7|||
162175146|NCT03505710|585695206|FG000|Overall Study|Physician Decision|1|||
162175147|NCT03505710|585695207|FG001|Overall Study|Physician Decision|1|||
162175148|NCT03505710|585695208|FG002|Overall Study|Physician Decision|2|||
162175149|NCT03505710|585695206|FG000|Overall Study|Death|4|||
162175150|NCT03505710|585695207|FG001|Overall Study|Death|5|||
162175151|NCT03505710|585695208|FG002|Overall Study|Death|6|||
162175152|NCT03505710|585695206|FG000|Overall Study|Other Reasons|1|||
162175153|NCT03505710|585695207|FG001|Overall Study|Other Reasons|1|||
162175154|NCT03505710|585695208|FG002|Overall Study|Other Reasons|1|||
162175155|NCT03505710|585695206|FG000|Overall Study|Study Terminated by Sponsor|0|||
162175156|NCT03505710|585695207|FG001|Overall Study|Study Terminated by Sponsor|0|||
162175157|NCT03505710|585695208|FG002|Overall Study|Study Terminated by Sponsor|1|||
162175158|NCT04414722|585695209|FG000|Overall Study|Lost to Follow-up|3|||
162175159|NCT04414722|585695210|FG001|Overall Study|Lost to Follow-up|4|||
162175160|NCT04414722|585695211|FG002|Overall Study|Lost to Follow-up|3|||
162175161|NCT04414722|585695212|FG003|Overall Study|Lost to Follow-up|2|||
162175162|NCT04414722|585695213|FG004|Overall Study|Lost to Follow-up|3|||
162175163|NCT04414722|585695209|FG000|Overall Study|Withdrawal by Subject|6|||
162175164|NCT04414722|585695210|FG001|Overall Study|Withdrawal by Subject|3|||
162175165|NCT04414722|585695211|FG002|Overall Study|Withdrawal by Subject|1|||
162175166|NCT04414722|585695212|FG003|Overall Study|Withdrawal by Subject|5|||
162175167|NCT04414722|585695213|FG004|Overall Study|Withdrawal by Subject|1|||
162175168|NCT04414722|585695209|FG000|Overall Study|Physician Decision|0|||
162175169|NCT04414722|585695210|FG001|Overall Study|Physician Decision|1|||
162175170|NCT04414722|585695211|FG002|Overall Study|Physician Decision|2|||
162175171|NCT04414722|585695212|FG003|Overall Study|Physician Decision|0|||
162175172|NCT04414722|585695213|FG004|Overall Study|Physician Decision|0|||
162175173|NCT04414722|585695209|FG000|Overall Study|Non-participatory|0|||
162175174|NCT04414722|585695210|FG001|Overall Study|Non-participatory|1|||
162175175|NCT04414722|585695211|FG002|Overall Study|Non-participatory|1|||
162175176|NCT04414722|585695212|FG003|Overall Study|Non-participatory|0|||
162175177|NCT04414722|585695213|FG004|Overall Study|Non-participatory|0|||
162175178|NCT04766892|585695214|FG000|Overall Study|Withdrawal by Subject|1|||
162175179|NCT04766892|585695214|FG000|Overall Study|Lost to Follow-up|1|||
162175180|NCT04766892|585695214|FG000|Overall Study|Adverse Event|3|||
162175181|NCT04766892|585695214|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
162175182|NCT04359654|585695215|FG000|Overall Study|Withdrawal by Subject|1|||
162175183|NCT04359654|585695216|FG001|Overall Study|Withdrawal by Subject|0|||
162175184|NCT04359654|585695215|FG000|Overall Study|Adverse Event|0|||
162175185|NCT04359654|585695216|FG001|Overall Study|Adverse Event|1|||
162175186|NCT03711474|585695219|FG000|Overall Study|Physician Decision|2|||
162175187|NCT03711474|585695220|FG001|Overall Study|Physician Decision|0|||
162175188|NCT02446236|585695221|FG000|Overall Study|Screen Failure|1|||
162175189|NCT02446236|585695222|FG001|Overall Study|Screen Failure|0|||
162175190|NCT02446236|585695223|FG002|Overall Study|Screen Failure|1|||
162175191|NCT02446236|585695221|FG000|Overall Study|Actively Receiving Therapy|0|||
162175192|NCT02446236|585695222|FG001|Overall Study|Actively Receiving Therapy|0|||
162175193|NCT02446236|585695223|FG002|Overall Study|Actively Receiving Therapy|1|||
162175194|NCT03677141|585695224|FG000|Overall Study|Death|2|||
162175195|NCT03677141|585695225|FG001|Overall Study|Death|1|||
162175196|NCT03677141|585695226|FG002|Overall Study|Death|6|||
162175197|NCT03677141|585695227|FG003|Overall Study|Death|9|||
162175198|NCT03677141|585695228|FG004|Overall Study|Death|5|||
162175199|NCT03677141|585695229|FG005|Overall Study|Death|3|||
162175200|NCT03677141|585695224|FG000|Overall Study|Lost to Follow-up|0|||
162175201|NCT03677141|585695225|FG001|Overall Study|Lost to Follow-up|0|||
162175202|NCT03677141|585695226|FG002|Overall Study|Lost to Follow-up|0|||
162175203|NCT03677141|585695227|FG003|Overall Study|Lost to Follow-up|2|||
162175204|NCT03677141|585695228|FG004|Overall Study|Lost to Follow-up|0|||
162175205|NCT03677141|585695229|FG005|Overall Study|Lost to Follow-up|0|||
162175206|NCT03677141|585695224|FG000|Overall Study|Screen failure or enrolled in error|0|||
162175207|NCT03677141|585695225|FG001|Overall Study|Screen failure or enrolled in error|0|||
162175208|NCT03677141|585695226|FG002|Overall Study|Screen failure or enrolled in error|0|||
162175209|NCT03677141|585695227|FG003|Overall Study|Screen failure or enrolled in error|0|||
162175210|NCT03677141|585695228|FG004|Overall Study|Screen failure or enrolled in error|2|||
162175211|NCT03677141|585695229|FG005|Overall Study|Screen failure or enrolled in error|0|||
162175212|NCT03677141|585695224|FG000|Overall Study|Physician Decision|0|||
161671245|NCT05461794|583849113|FG001|Overall Study|Withdrawal by Subject|1|||
161671246|NCT05461794|583849114|FG002|Overall Study|Withdrawal by Subject|3|||
162175213|NCT03677141|585695225|FG001|Overall Study|Physician Decision|0|||
162175214|NCT03677141|585695226|FG002|Overall Study|Physician Decision|0|||
162175215|NCT03677141|585695227|FG003|Overall Study|Physician Decision|0|||
162175216|NCT03677141|585695228|FG004|Overall Study|Physician Decision|1|||
162175217|NCT03677141|585695229|FG005|Overall Study|Physician Decision|0|||
162175218|NCT03677141|585695224|FG000|Overall Study|Withdrawal by Subject|0|||
162175219|NCT03677141|585695225|FG001|Overall Study|Withdrawal by Subject|0|||
162175220|NCT03677141|585695226|FG002|Overall Study|Withdrawal by Subject|1|||
162175221|NCT03677141|585695227|FG003|Overall Study|Withdrawal by Subject|1|||
162175222|NCT03677141|585695228|FG004|Overall Study|Withdrawal by Subject|1|||
162175223|NCT03677141|585695229|FG005|Overall Study|Withdrawal by Subject|0|||
162175224|NCT04003246|585695233|FG000|Overall Study|Death|9|||
162175225|NCT04526886|585695235|FG000|Overall Study|Physician Decision|4|||
162175226|NCT03276676|585695238|FG000|Overall Study|Withdrawal by Subject|2|||
162175227|NCT03276676|585695239|FG001|Overall Study|Withdrawal by Subject|1|||
162175228|NCT02962076|585695241|FG000|Overall Study|MHED tracer not available|5|||
161671247|NCT05461794|583849112|FG000|Overall Study|Study Terminated By Sponsor|18|||
161671248|NCT05461794|583849113|FG001|Overall Study|Study Terminated By Sponsor|13|||
161671249|NCT05461794|583849114|FG002|Overall Study|Study Terminated By Sponsor|16|||
161671250|NCT05461794|583849112|FG000|Overall Study|Death|20|||
161671251|NCT05461794|583849113|FG001|Overall Study|Death|5|||
161671252|NCT05461794|583849114|FG002|Overall Study|Death|19|||
161671253|NCT02730598|583849117|FG000|Overall Study|Withdrawal by Subject|3|||
161671254|NCT02730598|583849118|FG001|Overall Study|Withdrawal by Subject|3|||
161671255|NCT02730598|583849117|FG000|Overall Study|Protocol Violation|0|||
161671256|NCT02730598|583849118|FG001|Overall Study|Protocol Violation|1|||
161671257|NCT02730598|583849117|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
161671258|NCT02730598|583849118|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
161671259|NCT00810394|583849119|FG000|Overall Study|Withdrawal by Subject|3|||
161671260|NCT00467285|583849122|FG000|Overall Study|Lost to Follow-up|4|||
161671261|NCT00467285|583849123|FG001|Overall Study|Lost to Follow-up|4|||
161671262|NCT03891524|583849124|FG000|Overall Study|Death|0|||
161671263|NCT03891524|583849125|FG001|Overall Study|Death|0|||
161671264|NCT03891524|583849126|FG002|Overall Study|Death|0|||
161671265|NCT03891524|583849127|FG003|Overall Study|Death|0|||
161671266|NCT03891524|583849128|FG004|Overall Study|Death|0|||
161671267|NCT03891524|583849129|FG005|Overall Study|Death|0|||
161671268|NCT03891524|583849130|FG006|Overall Study|Death|0|||
162018434|NCT02116205|585121988|FG002|Overall Study|Physician Decision|1|||
162018435|NCT02116205|585121989|FG003|Overall Study|Physician Decision|1|||
162018436|NCT02116205|585121986|FG000|Overall Study|Exclusion criteria|0|||
162018437|NCT02116205|585121987|FG001|Overall Study|Exclusion criteria|0|||
162018438|NCT02116205|585121988|FG002|Overall Study|Exclusion criteria|1|||
162018439|NCT02116205|585121989|FG003|Overall Study|Exclusion criteria|0|||
162018440|NCT00256997|585121990|FG000|Overall Study|Protocol Violation|1|||
162018441|NCT00256997|585121991|FG001|Overall Study|Protocol Violation|4|||
162018442|NCT00256997|585121990|FG000|Overall Study|Lack of Efficacy|1|||
162018443|NCT00256997|585121991|FG001|Overall Study|Lack of Efficacy|4|||
162018444|NCT00256997|585121990|FG000|Overall Study|Death|2|||
162018445|NCT00256997|585121991|FG001|Overall Study|Death|0|||
162018446|NCT00256997|585121990|FG000|Overall Study|Adverse Event|4|||
162018447|NCT00256997|585121991|FG001|Overall Study|Adverse Event|0|||
162018448|NCT00256997|585121990|FG000|Overall Study|Lost to Follow-up|3|||
162018449|NCT00256997|585121991|FG001|Overall Study|Lost to Follow-up|5|||
162018450|NCT00256997|585121990|FG000|Overall Study|Withdrawal by Subject|13|||
162018451|NCT00256997|585121991|FG001|Overall Study|Withdrawal by Subject|3|||
162018452|NCT00256997|585121990|FG000|Overall Study|Started but not treated|2|||
162018453|NCT00256997|585121991|FG001|Overall Study|Started but not treated|0|||
162018454|NCT00256997|585121990|FG000|Overall Study|Other|5|||
162018455|NCT00256997|585121991|FG001|Overall Study|Other|8|||
162018456|NCT00256997|585121990|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
162018457|NCT00256997|585121991|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
162018458|NCT00256997|585121990|FG000|Overall Study|Participant Non-compliant|3|||
162018459|NCT00256997|585121991|FG001|Overall Study|Participant Non-compliant|6|||
162018460|NCT00256997|585121990|FG000|Overall Study|Investigator Withdrew Participant|2|||
162018461|NCT00256997|585121991|FG001|Overall Study|Investigator Withdrew Participant|1|||
162018462|NCT04672655|585121994|FG000|Overall Study|Lost to Follow-up|12|||
162018463|NCT04672655|585121995|FG001|Overall Study|Lost to Follow-up|17|||
162018464|NCT04672655|585121994|FG000|Overall Study|Withdrawal by Subject|1|||
162018465|NCT04672655|585121995|FG001|Overall Study|Withdrawal by Subject|0|||
162018466|NCT04672655|585121994|FG000|Overall Study|Withdrawal by Study|1|||
162018467|NCT04672655|585121995|FG001|Overall Study|Withdrawal by Study|0|||
162018468|NCT01326104|585121996|FG000|Overall Study|progressed prior to vaccine|0|||
162018469|NCT01326104|585121997|FG001|Overall Study|progressed prior to vaccine|2|||
162018470|NCT01326104|585121996|FG000|Overall Study|unable to make vaccine|0|||
162018471|NCT01326104|585121997|FG001|Overall Study|unable to make vaccine|2|||
162018472|NCT03843541|585121998|FG000|Overall Study|Adverse Event|4|||
162018473|NCT03843541|585121999|FG001|Overall Study|Adverse Event|2|||
162018474|NCT03843541|585122000|FG002|Overall Study|Adverse Event|3|||
162018475|NCT03843541|585121998|FG000|Overall Study|Death|1|||
162018476|NCT03843541|585121999|FG001|Overall Study|Death|0|||
162018477|NCT03843541|585122000|FG002|Overall Study|Death|0|||
162018478|NCT03843541|585121998|FG000|Overall Study|Lack of adherence to study medication|0|||
162018479|NCT03843541|585121999|FG001|Overall Study|Lack of adherence to study medication|0|||
162018480|NCT03843541|585122000|FG002|Overall Study|Lack of adherence to study medication|1|||
162018481|NCT03843541|585121998|FG000|Overall Study|Physician Decision|1|||
162018482|NCT03843541|585121999|FG001|Overall Study|Physician Decision|2|||
162018483|NCT03843541|585122000|FG002|Overall Study|Physician Decision|2|||
162018484|NCT03843541|585121998|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
161671269|NCT03891524|583849131|FG007|Overall Study|Death|1|||
162018485|NCT03843541|585121999|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
162018486|NCT03843541|585122000|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
161671270|NCT03891524|583849124|FG000|Overall Study|Withdrawal by Subject|0|||
161671271|NCT03891524|583849125|FG001|Overall Study|Withdrawal by Subject|1|||
162175229|NCT02962076|585695241|FG000|Overall Study|Protocol Violation|1|||
162175230|NCT02962076|585695241|FG000|Overall Study|Physician Decision|1|||
162175231|NCT03583333|585695245|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
162175232|NCT03583333|585695246|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
162175233|NCT03583333|585695245|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
162175234|NCT03583333|585695246|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
162175235|NCT03583333|585695245|FG000|Overall Study|Withdrawal by Subject|9|||
162175236|NCT03583333|585695246|FG001|Overall Study|Withdrawal by Subject|5|||
162175237|NCT03583333|585695245|FG000|Overall Study|Physician Decision|3|||
162175238|NCT03583333|585695246|FG001|Overall Study|Physician Decision|2|||
162175239|NCT03583333|585695245|FG000|Overall Study|Death|12|||
162175240|NCT03583333|585695246|FG001|Overall Study|Death|7|||
162175241|NCT03926130|585695247|FG000|Overall Study|Adverse Event|9|||
162175242|NCT03926130|585695248|FG001|Overall Study|Adverse Event|11|||
162175243|NCT03926130|585695249|FG002|Overall Study|Adverse Event|2|||
162175244|NCT03926130|585695250|FG003|Overall Study|Adverse Event|0|||
162175245|NCT03926130|585695247|FG000|Overall Study|Death|2|||
162175246|NCT03926130|585695248|FG001|Overall Study|Death|0|||
162175247|NCT03926130|585695249|FG002|Overall Study|Death|1|||
162175248|NCT03926130|585695250|FG003|Overall Study|Death|0|||
162175249|NCT03926130|585695247|FG000|Overall Study|Lack of Efficacy|14|||
162175250|NCT03926130|585695248|FG001|Overall Study|Lack of Efficacy|11|||
162175251|NCT03926130|585695249|FG002|Overall Study|Lack of Efficacy|7|||
162175252|NCT03926130|585695250|FG003|Overall Study|Lack of Efficacy|1|||
162175253|NCT03926130|585695247|FG000|Overall Study|Lost to Follow-up|0|||
162175254|NCT03926130|585695248|FG001|Overall Study|Lost to Follow-up|7|||
162175255|NCT03926130|585695249|FG002|Overall Study|Lost to Follow-up|1|||
162175256|NCT03926130|585695250|FG003|Overall Study|Lost to Follow-up|0|||
162175257|NCT03926130|585695247|FG000|Overall Study|As Reported by Investigator|2|||
162175258|NCT03926130|585695248|FG001|Overall Study|As Reported by Investigator|6|||
162175259|NCT03926130|585695249|FG002|Overall Study|As Reported by Investigator|6|||
162175260|NCT03926130|585695250|FG003|Overall Study|As Reported by Investigator|0|||
162175261|NCT03926130|585695247|FG000|Overall Study|Physician Decision|3|||
162175262|NCT03926130|585695248|FG001|Overall Study|Physician Decision|2|||
162175263|NCT03926130|585695249|FG002|Overall Study|Physician Decision|1|||
162175264|NCT03926130|585695250|FG003|Overall Study|Physician Decision|0|||
162175265|NCT03926130|585695247|FG000|Overall Study|Pregnancy|2|||
162175266|NCT03926130|585695248|FG001|Overall Study|Pregnancy|2|||
162175267|NCT03926130|585695249|FG002|Overall Study|Pregnancy|1|||
162175268|NCT03926130|585695250|FG003|Overall Study|Pregnancy|0|||
162175269|NCT03926130|585695247|FG000|Overall Study|Withdrawal by Subject|20|||
162175270|NCT03926130|585695248|FG001|Overall Study|Withdrawal by Subject|28|||
162175271|NCT03926130|585695249|FG002|Overall Study|Withdrawal by Subject|18|||
162175272|NCT03926130|585695250|FG003|Overall Study|Withdrawal by Subject|1|||
162175273|NCT03926130|585695247|FG000|Overall Study|Non-Compliance|1|||
162175274|NCT03926130|585695248|FG001|Overall Study|Non-Compliance|1|||
162175275|NCT03926130|585695249|FG002|Overall Study|Non-Compliance|0|||
162175276|NCT03926130|585695250|FG003|Overall Study|Non-Compliance|0|||
162175277|NCT03926130|585695247|FG000|Overall Study|Disposition Not Captured|0|||
162175278|NCT03926130|585695248|FG001|Overall Study|Disposition Not Captured|2|||
162175279|NCT03926130|585695249|FG002|Overall Study|Disposition Not Captured|1|||
162175280|NCT03926130|585695250|FG003|Overall Study|Disposition Not Captured|0|||
162175281|NCT05069896|585695257|FG000|Overall Study|Adverse Event|0|||
162175282|NCT05069896|585695258|FG001|Overall Study|Adverse Event|1|||
161671272|NCT03891524|583849126|FG002|Overall Study|Withdrawal by Subject|2|||
162175283|NCT05069896|585695259|FG002|Overall Study|Adverse Event|1|||
162175284|NCT05069896|585695260|FG003|Overall Study|Adverse Event|0|||
162175285|NCT05069896|585695261|FG004|Overall Study|Adverse Event|0|||
162175286|NCT05069896|585695262|FG005|Overall Study|Adverse Event|0|||
162175287|NCT05069896|585695257|FG000|Overall Study|Lost to Follow-up|0|||
162175288|NCT05069896|585695258|FG001|Overall Study|Lost to Follow-up|0|||
162175289|NCT05069896|585695259|FG002|Overall Study|Lost to Follow-up|1|||
162175290|NCT05069896|585695260|FG003|Overall Study|Lost to Follow-up|0|||
162175291|NCT05069896|585695261|FG004|Overall Study|Lost to Follow-up|1|||
162175292|NCT05069896|585695262|FG005|Overall Study|Lost to Follow-up|2|||
162175293|NCT03580356|585695266|FG000|Treatment Period|Withdrawal by Subject|13|||
162175294|NCT03580356|585695267|FG001|Treatment Period|Withdrawal by Subject|0|||
162175295|NCT03580356|585695268|FG002|Treatment Period|Withdrawal by Subject|13|||
162175296|NCT03580356|585695269|FG003|Treatment Period|Withdrawal by Subject|1|||
162175297|NCT03580356|585695270|FG004|Treatment Period|Withdrawal by Subject|17|||
162175298|NCT03580356|585695271|FG005|Treatment Period|Withdrawal by Subject|0|||
162175299|NCT03580356|585695272|FG006|Treatment Period|Withdrawal by Subject|5|||
161671273|NCT03891524|583849127|FG003|Overall Study|Withdrawal by Subject|1|||
161671274|NCT03891524|583849128|FG004|Overall Study|Withdrawal by Subject|2|||
162175300|NCT03580356|585695273|FG007|Treatment Period|Withdrawal by Subject|0|||
162175301|NCT03580356|585695266|FG000|Treatment Period|Adverse Event|10|||
162175302|NCT03580356|585695267|FG001|Treatment Period|Adverse Event|0|||
161671275|NCT03891524|583849129|FG005|Overall Study|Withdrawal by Subject|2|||
161671276|NCT03891524|583849130|FG006|Overall Study|Withdrawal by Subject|2|||
161671277|NCT03891524|583849131|FG007|Overall Study|Withdrawal by Subject|1|||
161671278|NCT01210118|583849133|FG000|Overall Study|Lost to Follow-up|1|||
161671279|NCT01210118|583849134|FG001|Overall Study|Lost to Follow-up|1|||
161671280|NCT01210118|583849133|FG000|Overall Study|Protocol Violation|1|||
161671281|NCT01210118|583849134|FG001|Overall Study|Protocol Violation|1|||
161671282|NCT01210118|583849133|FG000|Overall Study|Spontaneous abortion|1|||
161671283|NCT01210118|583849134|FG001|Overall Study|Spontaneous abortion|3|||
161671284|NCT02958267|583849135|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
161671285|NCT02958267|583849136|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
161671286|NCT02958267|583849135|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
162175303|NCT03580356|585695268|FG002|Treatment Period|Adverse Event|13|||
162175304|NCT03580356|585695269|FG003|Treatment Period|Adverse Event|0|||
162175305|NCT03580356|585695270|FG004|Treatment Period|Adverse Event|5|||
162175306|NCT03580356|585695271|FG005|Treatment Period|Adverse Event|0|||
162175307|NCT03580356|585695272|FG006|Treatment Period|Adverse Event|8|||
162175308|NCT03580356|585695273|FG007|Treatment Period|Adverse Event|0|||
162175309|NCT03580356|585695266|FG000|Treatment Period|Protocol Violation|5|||
162175310|NCT03580356|585695267|FG001|Treatment Period|Protocol Violation|0|||
162175311|NCT03580356|585695268|FG002|Treatment Period|Protocol Violation|6|||
162175312|NCT03580356|585695269|FG003|Treatment Period|Protocol Violation|1|||
162175313|NCT03580356|585695270|FG004|Treatment Period|Protocol Violation|9|||
162175314|NCT03580356|585695271|FG005|Treatment Period|Protocol Violation|1|||
162175315|NCT03580356|585695272|FG006|Treatment Period|Protocol Violation|1|||
162175316|NCT03580356|585695273|FG007|Treatment Period|Protocol Violation|0|||
162175317|NCT03580356|585695266|FG000|Treatment Period|Lack of Efficacy|6|||
161671287|NCT02958267|583849136|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
161671288|NCT02958267|583849135|FG000|Follow-up Visits|Additional treatment pursued|2|||
161671289|NCT02958267|583849136|FG001|Follow-up Visits|Additional treatment pursued|1|||
161671290|NCT01079130|583849137|FG000|Overall Study|Adverse Event|1|||
161671291|NCT01079130|583849138|FG001|Overall Study|Adverse Event|1|||
161671292|NCT01079130|583849139|FG002|Overall Study|Adverse Event|0|||
161671293|NCT01079130|583849140|FG003|Overall Study|Adverse Event|1|||
161671294|NCT01079130|583849141|FG004|Overall Study|Adverse Event|5|||
161671295|NCT01079130|583849142|FG005|Overall Study|Adverse Event|1|||
161671296|NCT01079130|583849137|FG000|Overall Study|Administrative problems|1|||
162175318|NCT03580356|585695267|FG001|Treatment Period|Lack of Efficacy|0|||
162175319|NCT03580356|585695268|FG002|Treatment Period|Lack of Efficacy|2|||
162175320|NCT03580356|585695269|FG003|Treatment Period|Lack of Efficacy|0|||
162175321|NCT03580356|585695270|FG004|Treatment Period|Lack of Efficacy|3|||
162175322|NCT03580356|585695271|FG005|Treatment Period|Lack of Efficacy|0|||
162175323|NCT03580356|585695272|FG006|Treatment Period|Lack of Efficacy|3|||
162175324|NCT03580356|585695273|FG007|Treatment Period|Lack of Efficacy|0|||
162175325|NCT03580356|585695266|FG000|Treatment Period|Pregnancy|1|||
162175326|NCT03580356|585695267|FG001|Treatment Period|Pregnancy|0|||
162175327|NCT03580356|585695268|FG002|Treatment Period|Pregnancy|7|||
162175328|NCT03580356|585695269|FG003|Treatment Period|Pregnancy|0|||
162175329|NCT03580356|585695270|FG004|Treatment Period|Pregnancy|2|||
162175330|NCT03580356|585695271|FG005|Treatment Period|Pregnancy|0|||
162175331|NCT03580356|585695272|FG006|Treatment Period|Pregnancy|1|||
162175332|NCT03580356|585695273|FG007|Treatment Period|Pregnancy|0|||
162175333|NCT03580356|585695266|FG000|Treatment Period|Physician Decision|2|||
162175334|NCT03580356|585695267|FG001|Treatment Period|Physician Decision|0|||
161671297|NCT01079130|583849138|FG001|Overall Study|Administrative problems|3|||
161671298|NCT01079130|583849139|FG002|Overall Study|Administrative problems|0|||
161671299|NCT01079130|583849140|FG003|Overall Study|Administrative problems|0|||
161671300|NCT01079130|583849141|FG004|Overall Study|Administrative problems|0|||
161671301|NCT01079130|583849142|FG005|Overall Study|Administrative problems|1|||
161817035|NCT01604941|584370909|FG004|Overall Study|Non-compliance|0|||
162175335|NCT03580356|585695268|FG002|Treatment Period|Physician Decision|1|||
162175336|NCT03580356|585695269|FG003|Treatment Period|Physician Decision|0|||
162175337|NCT03580356|585695270|FG004|Treatment Period|Physician Decision|4|||
161671302|NCT01079130|583849137|FG000|Overall Study|Withdrawal by Subject|0|||
161671303|NCT01079130|583849138|FG001|Overall Study|Withdrawal by Subject|1|||
161817036|NCT01604941|584370910|FG005|Overall Study|Non-compliance|0|||
162175338|NCT03580356|585695271|FG005|Treatment Period|Physician Decision|0|||
162175339|NCT03580356|585695272|FG006|Treatment Period|Physician Decision|2|||
162175340|NCT03580356|585695273|FG007|Treatment Period|Physician Decision|0|||
162175341|NCT03580356|585695266|FG000|Treatment Period|Lost to Follow-up|1|||
162018487|NCT03843541|585121998|FG000|Overall Study|Withdrawal by Subject|6|||
162018488|NCT03843541|585121999|FG001|Overall Study|Withdrawal by Subject|9|||
162018489|NCT03843541|585122000|FG002|Overall Study|Withdrawal by Subject|7|||
162018490|NCT03843541|585121998|FG000|Overall Study|Administration of rescue mucolytic|0|||
162018491|NCT03843541|585121999|FG001|Overall Study|Administration of rescue mucolytic|0|||
162018492|NCT03843541|585122000|FG002|Overall Study|Administration of rescue mucolytic|1|||
162018493|NCT03843541|585121998|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
162018494|NCT03843541|585121999|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
162018495|NCT03843541|585122000|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
162018496|NCT04163016|585122001|FG000|Enrollment|Adverse Event|1|||
162018497|NCT04163016|585122002|FG001|Enrollment|Adverse Event|0|||
162018498|NCT04163016|585122003|FG002|Enrollment|Adverse Event|0|||
162018499|NCT04163016|585122004|FG003|Enrollment|Adverse Event|0|||
162018500|NCT04163016|585122001|FG000|Treatment|Adverse Event|0|||
162018501|NCT04163016|585122002|FG001|Treatment|Adverse Event|1|||
162018502|NCT04163016|585122003|FG002|Treatment|Adverse Event|0|||
162018503|NCT04163016|585122004|FG003|Treatment|Adverse Event|0|||
162018504|NCT04163016|585122001|FG000|Treatment|Withdrawal by Subject|0|||
162018505|NCT04163016|585122002|FG001|Treatment|Withdrawal by Subject|2|||
162018506|NCT04163016|585122003|FG002|Treatment|Withdrawal by Subject|0|||
162018507|NCT04163016|585122004|FG003|Treatment|Withdrawal by Subject|0|||
162018508|NCT04163016|585122001|FG000|Treatment|Indeterminate TB-test|0|||
162018509|NCT04163016|585122002|FG001|Treatment|Indeterminate TB-test|0|||
162018510|NCT04163016|585122003|FG002|Treatment|Indeterminate TB-test|0|||
162018511|NCT04163016|585122004|FG003|Treatment|Indeterminate TB-test|1|||
162018512|NCT04163016|585122001|FG000|Treatment|Participant did not want to continue in study|0|||
162018513|NCT04163016|585122002|FG001|Treatment|Participant did not want to continue in study|0|||
162018514|NCT04163016|585122003|FG002|Treatment|Participant did not want to continue in study|0|||
162018515|NCT04163016|585122004|FG003|Treatment|Participant did not want to continue in study|1|||
162018516|NCT04193189|585122015|FG000|Overall Study|Lost to Follow-up|9|||
162018517|NCT04193189|585122016|FG001|Overall Study|Lost to Follow-up|7|||
162018518|NCT04193189|585122017|FG002|Overall Study|Lost to Follow-up|9|||
162018519|NCT04193189|585122018|FG003|Overall Study|Lost to Follow-up|0|||
162018520|NCT04193189|585122015|FG000|Overall Study|Withdrawal by Subject|1|||
162018521|NCT04193189|585122016|FG001|Overall Study|Withdrawal by Subject|2|||
162018522|NCT04193189|585122017|FG002|Overall Study|Withdrawal by Subject|2|||
162018523|NCT04193189|585122018|FG003|Overall Study|Withdrawal by Subject|0|||
162018524|NCT04193189|585122015|FG000|Overall Study|Death|1|||
162018525|NCT04193189|585122016|FG001|Overall Study|Death|1|||
162018526|NCT04193189|585122017|FG002|Overall Study|Death|0|||
162018527|NCT04193189|585122018|FG003|Overall Study|Death|0|||
162018528|NCT04193189|585122015|FG000|Overall Study|Protocol Violation|0|||
162018529|NCT04193189|585122016|FG001|Overall Study|Protocol Violation|0|||
162018530|NCT04193189|585122017|FG002|Overall Study|Protocol Violation|0|||
162018531|NCT04193189|585122018|FG003|Overall Study|Protocol Violation|1|||
162018532|NCT00479687|585123132|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
162018533|NCT00479687|585123133|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
162018534|NCT00479687|585123134|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
162018535|NCT00479687|585123132|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
162018536|NCT00479687|585123133|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
162018537|NCT00479687|585123134|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
162018538|NCT00479687|585123132|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
162018539|NCT00479687|585123133|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
162018540|NCT00479687|585123134|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
162018541|NCT00479687|585123132|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
162018542|NCT00479687|585123133|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
162018543|NCT00479687|585123134|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
162018544|NCT00479687|585123132|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
162018545|NCT00479687|585123133|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
162018546|NCT00479687|585123134|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
162018547|NCT00479687|585123132|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
162018548|NCT00479687|585123133|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
162018549|NCT00479687|585123134|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
162018550|NCT00479687|585123132|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
162018551|NCT00479687|585123133|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
162018552|NCT00479687|585123134|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
162018553|NCT00479687|585123132|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
162018554|NCT00479687|585123133|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
162018555|NCT00479687|585123134|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
162018556|NCT00479687|585123132|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
162018557|NCT00479687|585123133|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
162175342|NCT03580356|585695267|FG001|Treatment Period|Lost to Follow-up|1|||
162175343|NCT03580356|585695268|FG002|Treatment Period|Lost to Follow-up|1|||
162175344|NCT03580356|585695269|FG003|Treatment Period|Lost to Follow-up|0|||
162175345|NCT03580356|585695270|FG004|Treatment Period|Lost to Follow-up|3|||
162175346|NCT03580356|585695271|FG005|Treatment Period|Lost to Follow-up|0|||
162175347|NCT03580356|585695272|FG006|Treatment Period|Lost to Follow-up|1|||
162175348|NCT03580356|585695273|FG007|Treatment Period|Lost to Follow-up|0|||
162175349|NCT03580356|585695266|FG000|Treatment Period|Death|0|||
162175350|NCT03580356|585695267|FG001|Treatment Period|Death|0|||
162175351|NCT03580356|585695268|FG002|Treatment Period|Death|1|||
162175352|NCT03580356|585695269|FG003|Treatment Period|Death|0|||
162175353|NCT03580356|585695270|FG004|Treatment Period|Death|0|||
162175354|NCT03580356|585695271|FG005|Treatment Period|Death|0|||
162175355|NCT03580356|585695272|FG006|Treatment Period|Death|0|||
162175356|NCT03580356|585695273|FG007|Treatment Period|Death|0|||
162175357|NCT03580356|585695266|FG000|Treatment Period|Technical problems|0|||
162175358|NCT03580356|585695267|FG001|Treatment Period|Technical problems|0|||
162175359|NCT03580356|585695268|FG002|Treatment Period|Technical problems|0|||
162175360|NCT03580356|585695269|FG003|Treatment Period|Technical problems|0|||
162175361|NCT03580356|585695270|FG004|Treatment Period|Technical problems|1|||
162175362|NCT03580356|585695271|FG005|Treatment Period|Technical problems|0|||
162175363|NCT03580356|585695272|FG006|Treatment Period|Technical problems|0|||
162175364|NCT03580356|585695273|FG007|Treatment Period|Technical problems|0|||
162175365|NCT03580356|585695266|FG000|Treatment Period|Misrandomized, no treatment|0|||
162175366|NCT03580356|585695267|FG001|Treatment Period|Misrandomized, no treatment|0|||
162175367|NCT03580356|585695268|FG002|Treatment Period|Misrandomized, no treatment|1|||
162175368|NCT03580356|585695269|FG003|Treatment Period|Misrandomized, no treatment|0|||
162175369|NCT03580356|585695270|FG004|Treatment Period|Misrandomized, no treatment|2|||
162175370|NCT03580356|585695271|FG005|Treatment Period|Misrandomized, no treatment|0|||
162175371|NCT03580356|585695272|FG006|Treatment Period|Misrandomized, no treatment|0|||
162175372|NCT03580356|585695273|FG007|Treatment Period|Misrandomized, no treatment|0|||
162175373|NCT03580356|585695266|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
162175374|NCT03580356|585695267|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
162175375|NCT03580356|585695268|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
162175376|NCT03580356|585695269|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
162175377|NCT03580356|585695270|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
162175378|NCT03580356|585695271|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
162175379|NCT03580356|585695272|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
162175380|NCT03580356|585695273|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
162175381|NCT03580356|585695266|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
162175382|NCT03580356|585695267|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
161671304|NCT01079130|583849139|FG002|Overall Study|Withdrawal by Subject|0|||
161671305|NCT01079130|583849140|FG003|Overall Study|Withdrawal by Subject|0|||
161671306|NCT01079130|583849141|FG004|Overall Study|Withdrawal by Subject|1|||
161671307|NCT01079130|583849142|FG005|Overall Study|Withdrawal by Subject|3|||
162175383|NCT03580356|585695268|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
162175384|NCT03580356|585695269|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
162175385|NCT03580356|585695270|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
161671308|NCT01079130|583849137|FG000|Overall Study|Protocol deviation|0|||
162175386|NCT03580356|585695271|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
162175387|NCT03580356|585695272|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
162175388|NCT03580356|585695273|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
162175389|NCT03580356|585695266|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
161671309|NCT01079130|583849138|FG001|Overall Study|Protocol deviation|2|||
162175390|NCT03580356|585695267|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
162175391|NCT03580356|585695268|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
162175392|NCT03580356|585695269|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
162175393|NCT03580356|585695270|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
162175394|NCT03580356|585695271|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
162175395|NCT03580356|585695272|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
162175396|NCT03580356|585695273|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
162175397|NCT03580356|585695266|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
162175398|NCT03580356|585695267|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
162175399|NCT03580356|585695268|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
162175400|NCT03580356|585695269|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
162175401|NCT03580356|585695270|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
162175402|NCT03580356|585695271|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
162175403|NCT03580356|585695272|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
162175404|NCT03580356|585695273|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
162175405|NCT03580356|585695266|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
162175406|NCT03580356|585695267|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
162175407|NCT03580356|585695268|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
162175408|NCT03580356|585695269|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
162175409|NCT03580356|585695270|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
162175410|NCT03580356|585695271|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
162175411|NCT03580356|585695272|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
162175412|NCT03580356|585695273|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
162175413|NCT03580356|585695266|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
162175414|NCT03580356|585695267|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
162175415|NCT03580356|585695268|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
162175416|NCT03580356|585695269|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
162175417|NCT03580356|585695270|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
162175418|NCT03580356|585695271|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
162175419|NCT03580356|585695272|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
162175420|NCT03580356|585695273|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
162175421|NCT03580356|585695266|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
162175422|NCT03580356|585695267|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
162175423|NCT03580356|585695268|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
162175424|NCT03580356|585695269|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
162175425|NCT03580356|585695270|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
162175426|NCT03580356|585695271|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
162175427|NCT03580356|585695272|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
162175428|NCT03580356|585695273|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
162175429|NCT05715528|585695274|FG000|Overall Study|Randomized but never treated|11|||
162175430|NCT05715528|585695275|FG001|Overall Study|Randomized but never treated|13|||
162175431|NCT05715528|585695274|FG000|Overall Study|Withdrew consent|7|||
162175432|NCT05715528|585695275|FG001|Overall Study|Withdrew consent|15|||
162175433|NCT05715528|585695274|FG000|Overall Study|Lost to Follow-up|5|||
162175434|NCT05715528|585695275|FG001|Overall Study|Lost to Follow-up|13|||
162175435|NCT05715528|585695274|FG000|Overall Study|Investigator's discretion|3|||
162175436|NCT05715528|585695275|FG001|Overall Study|Investigator's discretion|1|||
162175437|NCT05715528|585695274|FG000|Overall Study|Protocol Violation|2|||
162175438|NCT05715528|585695275|FG001|Overall Study|Protocol Violation|0|||
162175439|NCT05715528|585695274|FG000|Overall Study|Non-compliance with study drug|0|||
162175440|NCT05715528|585695275|FG001|Overall Study|Non-compliance with study drug|1|||
162175441|NCT05035654|585695278|FG000|Overall Study|Physician Decision|0|||
162175442|NCT05035654|585695279|FG001|Overall Study|Physician Decision|1|||
162175443|NCT05035654|585695280|FG002|Overall Study|Physician Decision|0|||
162175444|NCT05035654|585695278|FG000|Overall Study|Adverse Event|0|||
162175445|NCT05035654|585695279|FG001|Overall Study|Adverse Event|1|||
162175446|NCT05035654|585695280|FG002|Overall Study|Adverse Event|0|||
162175447|NCT05035654|585695278|FG000|Overall Study|Withdrawal by Subject|0|||
162175448|NCT05035654|585695279|FG001|Overall Study|Withdrawal by Subject|0|||
162175449|NCT05035654|585695280|FG002|Overall Study|Withdrawal by Subject|4|||
162175450|NCT05035654|585695278|FG000|Overall Study|Bilateral Dislodgement|1|||
162175451|NCT05035654|585695279|FG001|Overall Study|Bilateral Dislodgement|0|||
162018558|NCT00479687|585123134|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
162175452|NCT05035654|585695280|FG002|Overall Study|Bilateral Dislodgement|0|||
162175453|NCT04451772|585695283|FG000|Overall Study|Adverse Event|1|||
162175454|NCT04451772|585695284|FG001|Overall Study|Adverse Event|0|||
162175455|NCT04451772|585695285|FG002|Overall Study|Adverse Event|1|||
162175456|NCT04451772|585695286|FG003|Overall Study|Adverse Event|1|||
162175457|NCT04451772|585695287|FG004|Overall Study|Adverse Event|0|||
162175458|NCT04451772|585695288|FG005|Overall Study|Adverse Event|3|||
162175459|NCT04451772|585695283|FG000|Overall Study|Withdrawal by Subject|2|||
162175460|NCT04451772|585695284|FG001|Overall Study|Withdrawal by Subject|7|||
162175461|NCT04451772|585695285|FG002|Overall Study|Withdrawal by Subject|2|||
162175462|NCT04451772|585695286|FG003|Overall Study|Withdrawal by Subject|1|||
162175463|NCT04451772|585695287|FG004|Overall Study|Withdrawal by Subject|1|||
162175464|NCT04451772|585695288|FG005|Overall Study|Withdrawal by Subject|0|||
162175465|NCT04451772|585695283|FG000|Overall Study|Other, not specified|1|||
162175466|NCT04451772|585695284|FG001|Overall Study|Other, not specified|2|||
162175467|NCT04451772|585695285|FG002|Overall Study|Other, not specified|1|||
162175468|NCT04451772|585695286|FG003|Overall Study|Other, not specified|0|||
162175469|NCT04451772|585695287|FG004|Overall Study|Other, not specified|0|||
162175470|NCT04451772|585695288|FG005|Overall Study|Other, not specified|1|||
162175471|NCT04451772|585695283|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
162175472|NCT04451772|585695284|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
162175473|NCT04451772|585695285|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
162175474|NCT04451772|585695286|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
162175475|NCT04451772|585695287|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
162175476|NCT04451772|585695288|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
162175477|NCT04311632|585695289|FG000|Overall Study|Withdrawal by Subject|0|||
162175478|NCT04311632|585695290|FG001|Overall Study|Withdrawal by Subject|0|||
162175479|NCT04311632|585695291|FG002|Overall Study|Withdrawal by Subject|1|||
162175480|NCT05856435|585695292|FG000|Overall Study|Lost to Follow-up|6|||
162175481|NCT05736458|585695296|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
162175482|NCT05736458|585695297|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
162175483|NCT05736458|585695298|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
162175484|NCT05736458|585695296|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
162175485|NCT05736458|585695297|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
162175486|NCT05736458|585695298|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
162175487|NCT05736458|585695296|FG000|TMS/fMRI #1|Physician Decision|0|||
162175488|NCT05736458|585695297|FG001|TMS/fMRI #1|Physician Decision|0|||
162175489|NCT05736458|585695298|FG002|TMS/fMRI #1|Physician Decision|2|||
162175490|NCT05736458|585695296|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
162175491|NCT05736458|585695297|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
161671310|NCT01079130|583849139|FG002|Overall Study|Protocol deviation|1|||
161671311|NCT01079130|583849140|FG003|Overall Study|Protocol deviation|2|||
161671312|NCT01079130|583849141|FG004|Overall Study|Protocol deviation|0|||
161671313|NCT01079130|583849142|FG005|Overall Study|Protocol deviation|0|||
161671314|NCT01079130|583849137|FG000|Overall Study|Abnormal test procedure result(s)|0|||
162175492|NCT05736458|585695298|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
162175493|NCT05100628|585695299|FG000|Overall Study|Progressive Disease|1|||
162175494|NCT05100628|585695300|FG001|Overall Study|Progressive Disease|0|||
162175495|NCT05100628|585695301|FG002|Overall Study|Progressive Disease|0|||
162175496|NCT05100628|585695302|FG003|Overall Study|Progressive Disease|0|||
162175497|NCT05100628|585695299|FG000|Overall Study|Study Terminated by Sponsor|0|||
162175498|NCT05100628|585695300|FG001|Overall Study|Study Terminated by Sponsor|0|||
162175499|NCT05100628|585695301|FG002|Overall Study|Study Terminated by Sponsor|3|||
162175500|NCT05100628|585695302|FG003|Overall Study|Study Terminated by Sponsor|0|||
162175501|NCT05100628|585695299|FG000|Overall Study|unkown|0|||
162175502|NCT05100628|585695300|FG001|Overall Study|unkown|1|||
162175503|NCT05100628|585695301|FG002|Overall Study|unkown|0|||
162175504|NCT05100628|585695302|FG003|Overall Study|unkown|0|||
162175505|NCT03914469|585695305|FG000|Overall Study|Lost to Follow-up|1|||
162175506|NCT03914469|585695306|FG001|Overall Study|Lost to Follow-up|4|||
162175507|NCT00721149|585695310|FG000|Overall Study|Physician Decision|1|||
162175508|NCT04614948|585695313|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
162175509|NCT04614948|585695314|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
162175510|NCT04614948|585695315|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
162175511|NCT04614948|585695313|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
162175512|NCT04614948|585695314|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
162175513|NCT04614948|585695315|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
162175514|NCT04614948|585695313|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
162175515|NCT04614948|585695314|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
162175516|NCT04614948|585695315|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
162175517|NCT04614948|585695313|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
162175518|NCT04614948|585695314|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
162175519|NCT04614948|585695315|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
162175520|NCT04614948|585695313|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
162175521|NCT04614948|585695314|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
162175522|NCT04614948|585695315|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
162175523|NCT04614948|585695313|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
162175524|NCT04614948|585695314|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
162175525|NCT04614948|585695315|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
162175526|NCT04614948|585695313|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
162175527|NCT04614948|585695314|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
162175528|NCT04614948|585695315|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
162175529|NCT04614948|585695313|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
162175530|NCT04614948|585695314|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
162175531|NCT04614948|585695315|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
162175532|NCT04614948|585695313|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
162175533|NCT04614948|585695314|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
162175534|NCT04614948|585695315|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
162175535|NCT04614948|585695313|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
162175536|NCT04614948|585695314|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
162175537|NCT04614948|585695315|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
162175538|NCT04614948|585695313|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
162175539|NCT04614948|585695314|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
162175540|NCT04614948|585695315|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
162175541|NCT04614948|585695313|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
162175542|NCT04614948|585695314|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
162175543|NCT04614948|585695315|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
162175544|NCT04614948|585695313|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
162175545|NCT04614948|585695314|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
162175546|NCT04614948|585695315|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
162175547|NCT04614948|585695313|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
162175548|NCT04614948|585695314|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
162175549|NCT04614948|585695315|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
162175550|NCT04614948|585695313|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
162175551|NCT04614948|585695314|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
162175552|NCT04614948|585695315|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
162175553|NCT04614948|585695313|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
162175554|NCT04614948|585695314|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
162175555|NCT04614948|585695315|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
162175556|NCT04614948|585695313|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
162175557|NCT04614948|585695314|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
162175558|NCT04614948|585695315|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
162175559|NCT04614948|585695313|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
162175560|NCT04614948|585695314|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
162175561|NCT04614948|585695315|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
162175562|NCT04614948|585695313|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
162175563|NCT04614948|585695314|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
162175564|NCT04614948|585695315|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
162175565|NCT04614948|585695313|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
162175566|NCT04614948|585695314|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
162175567|NCT04614948|585695315|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
162175568|NCT04614948|585695313|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
162175569|NCT04614948|585695314|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
162175570|NCT04614948|585695315|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
162175571|NCT04614948|585695313|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
162175572|NCT04614948|585695314|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
162175573|NCT04614948|585695315|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
162175574|NCT04614948|585695313|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
162175575|NCT04614948|585695314|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
161922847|NCT00021255|584764884|FG000|Overall Study|Breast cancer relapse|5|||
162175576|NCT04614948|585695315|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
162175577|NCT04271046|585695316|FG000|Overall Study|Death|0|||
162175578|NCT04271046|585695317|FG001|Overall Study|Death|2|||
162175579|NCT04271046|585695318|FG002|Overall Study|Death|0|||
162175580|NCT04271046|585695319|FG003|Overall Study|Death|2|||
162175581|NCT04271046|585695316|FG000|Overall Study|Lost to Follow-up|12|||
162175582|NCT04271046|585695317|FG001|Overall Study|Lost to Follow-up|12|||
162175583|NCT04271046|585695318|FG002|Overall Study|Lost to Follow-up|11|||
162175584|NCT04271046|585695319|FG003|Overall Study|Lost to Follow-up|11|||
162175585|NCT04271046|585695316|FG000|Overall Study|Patient with Dementia Died|2|||
162175586|NCT04271046|585695317|FG001|Overall Study|Patient with Dementia Died|0|||
162175587|NCT04271046|585695318|FG002|Overall Study|Patient with Dementia Died|2|||
162175588|NCT04271046|585695319|FG003|Overall Study|Patient with Dementia Died|0|||
162175589|NCT04271046|585695316|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
162175590|NCT04271046|585695317|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
162175591|NCT04271046|585695318|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
162175592|NCT04271046|585695319|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
162175593|NCT04129554|585695320|FG000|Overall Study|Withdrawal by Subject|4|||
162175594|NCT04129554|585695321|FG001|Overall Study|Withdrawal by Subject|3|||
162175595|NCT04129554|585695320|FG000|Overall Study|Other|0|||
162175596|NCT04129554|585695321|FG001|Overall Study|Other|2|||
162175597|NCT01570361|585695322|FG000|Overall Study|Subject discontinued|1|||
162175598|NCT01570361|585695323|FG001|Overall Study|Subject discontinued|2|||
162175599|NCT01570361|585695322|FG000|Overall Study|Sponsor closing the study|51|||
162175600|NCT01570361|585695323|FG001|Overall Study|Sponsor closing the study|50|||
162175601|NCT01570361|585695322|FG000|Overall Study|Subject excluded|5|||
162175602|NCT01570361|585695323|FG001|Overall Study|Subject excluded|3|||
162175603|NCT01570361|585695322|FG000|Overall Study|Subject withdrew consent|14|||
162175604|NCT01570361|585695323|FG001|Overall Study|Subject withdrew consent|9|||
162175605|NCT01570361|585695322|FG000|Overall Study|Adverse Event|2|||
162175606|NCT01570361|585695323|FG001|Overall Study|Adverse Event|1|||
162175607|NCT01570361|585695322|FG000|Overall Study|Lost to Follow-up|4|||
162175608|NCT01570361|585695323|FG001|Overall Study|Lost to Follow-up|4|||
162175609|NCT01570361|585695322|FG000|Overall Study|Death|5|||
162175610|NCT01570361|585695323|FG001|Overall Study|Death|4|||
162175611|NCT01570361|585695322|FG000|Overall Study|Other|0|||
162175612|NCT01570361|585695323|FG001|Overall Study|Other|2|||
162175613|NCT05158504|585695326|FG000|Overall Study|Lost to Follow-up|2|||
162175614|NCT05158504|585695327|FG001|Overall Study|Lost to Follow-up|3|||
162175615|NCT03606512|585695328|FG000|Overall Study|Lost to Follow-up|0|||
162175616|NCT03606512|585695329|FG001|Overall Study|Lost to Follow-up|1|||
162175617|NCT03606512|585695328|FG000|Overall Study|'moved from study area|0|||
162175618|NCT03606512|585695329|FG001|Overall Study|'moved from study area|1|||
162175619|NCT05513937|585695330|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
162175620|NCT05513937|585695331|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
161817037|NCT01604941|584370905|FG000|Overall Study|Participant Decision|0|||
162175621|NCT05513937|585695332|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
162175622|NCT05513937|585695333|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
162175623|NCT05513937|585695330|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
162175624|NCT05513937|585695331|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
162175625|NCT05513937|585695332|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
162175626|NCT05513937|585695333|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
162175627|NCT05513937|585695330|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
162175628|NCT05513937|585695331|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
162175629|NCT05513937|585695332|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
162175630|NCT05513937|585695333|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
162175631|NCT05513937|585695330|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
162175632|NCT05513937|585695331|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
162175633|NCT05513937|585695332|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
162175634|NCT05513937|585695333|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
162175635|NCT05513937|585695330|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
162175636|NCT05513937|585695331|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
162175637|NCT05513937|585695332|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
162175638|NCT05513937|585695333|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
162175639|NCT05513937|585695330|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
162175640|NCT05513937|585695331|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
161671315|NCT01079130|583849138|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161817038|NCT01604941|584370906|FG001|Overall Study|Participant Decision|0|||
162175641|NCT05513937|585695332|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
162175642|NCT05513937|585695333|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
162175643|NCT02846545|585695334|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
162175644|NCT02846545|585695335|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
162175645|NCT02846545|585695334|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
162175646|NCT02846545|585695335|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
162175647|NCT02846545|585695334|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
162175648|NCT02846545|585695335|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
162175649|NCT02846545|585695334|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
162175650|NCT02846545|585695335|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
162175651|NCT02846545|585695334|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
162175652|NCT02846545|585695335|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
162175653|NCT04633538|585695340|FG000|Overall Study|Death|1|||
162175654|NCT04633538|585695340|FG000|Overall Study|Lost to Follow-up|3|||
162175655|NCT04633538|585695340|FG000|Overall Study|Withdrawal by Subject|1|||
162175656|NCT03582033|585695341|FG000|Part A|Other|0|||
162175657|NCT03582033|585695342|FG001|Part A|Other|0|||
162175658|NCT03582033|585695343|FG002|Part A|Other|0|||
162175659|NCT03582033|585695344|FG003|Part A|Other|0|||
162175660|NCT03582033|585695345|FG004|Part A|Other|2|||
162175661|NCT03582033|585695346|FG005|Part A|Other|0|||
162175662|NCT03582033|585695347|FG006|Part A|Other|0|||
162175663|NCT03582033|585695348|FG007|Part A|Other|0|||
162175664|NCT03582033|585695349|FG008|Part A|Other|0|||
162175665|NCT03582033|585695350|FG009|Part A|Other|0|||
162175666|NCT03582033|585695341|FG000|Part A|Death|1|||
162175667|NCT03582033|585695342|FG001|Part A|Death|1|||
162175668|NCT03582033|585695343|FG002|Part A|Death|2|||
162175669|NCT03582033|585695344|FG003|Part A|Death|4|||
162175670|NCT03582033|585695345|FG004|Part A|Death|11|||
162175671|NCT03582033|585695346|FG005|Part A|Death|0|||
162175672|NCT03582033|585695347|FG006|Part A|Death|0|||
162175673|NCT03582033|585695348|FG007|Part A|Death|0|||
162175674|NCT03582033|585695349|FG008|Part A|Death|0|||
162175675|NCT03582033|585695350|FG009|Part A|Death|0|||
162175676|NCT03582033|585695341|FG000|Part A|Lost to Follow-up|0|||
162175677|NCT03582033|585695342|FG001|Part A|Lost to Follow-up|0|||
162175678|NCT03582033|585695343|FG002|Part A|Lost to Follow-up|0|||
162175679|NCT03582033|585695344|FG003|Part A|Lost to Follow-up|0|||
162175680|NCT03582033|585695345|FG004|Part A|Lost to Follow-up|1|||
162175681|NCT03582033|585695346|FG005|Part A|Lost to Follow-up|0|||
162175682|NCT03582033|585695347|FG006|Part A|Lost to Follow-up|0|||
162175683|NCT03582033|585695348|FG007|Part A|Lost to Follow-up|0|||
162175684|NCT03582033|585695349|FG008|Part A|Lost to Follow-up|0|||
162175685|NCT03582033|585695350|FG009|Part A|Lost to Follow-up|0|||
162175686|NCT03582033|585695341|FG000|Part A|Study terminated by sponsor|0|||
162175687|NCT03582033|585695342|FG001|Part A|Study terminated by sponsor|0|||
162175688|NCT03582033|585695343|FG002|Part A|Study terminated by sponsor|0|||
162175689|NCT03582033|585695344|FG003|Part A|Study terminated by sponsor|2|||
162175690|NCT03582033|585695345|FG004|Part A|Study terminated by sponsor|1|||
162175691|NCT03582033|585695346|FG005|Part A|Study terminated by sponsor|0|||
162175692|NCT03582033|585695347|FG006|Part A|Study terminated by sponsor|0|||
162175693|NCT03582033|585695348|FG007|Part A|Study terminated by sponsor|0|||
162175694|NCT03582033|585695349|FG008|Part A|Study terminated by sponsor|0|||
162175695|NCT03582033|585695350|FG009|Part A|Study terminated by sponsor|0|||
162175696|NCT03582033|585695341|FG000|Part A|Withdrawal by Subject|1|||
162175697|NCT03582033|585695342|FG001|Part A|Withdrawal by Subject|1|||
162175698|NCT03582033|585695343|FG002|Part A|Withdrawal by Subject|0|||
162175699|NCT03582033|585695344|FG003|Part A|Withdrawal by Subject|1|||
162175700|NCT03582033|585695345|FG004|Part A|Withdrawal by Subject|7|||
162175701|NCT03582033|585695346|FG005|Part A|Withdrawal by Subject|0|||
162175702|NCT03582033|585695347|FG006|Part A|Withdrawal by Subject|0|||
162175703|NCT03582033|585695348|FG007|Part A|Withdrawal by Subject|0|||
162175704|NCT03582033|585695349|FG008|Part A|Withdrawal by Subject|0|||
162175705|NCT03582033|585695350|FG009|Part A|Withdrawal by Subject|0|||
162175706|NCT03582033|585695341|FG000|Part B|Death|0|||
162175707|NCT03582033|585695342|FG001|Part B|Death|0|||
162175708|NCT03582033|585695343|FG002|Part B|Death|0|||
161942229|NCT00663260|584838356|FG000|Overall Study|Lack of Efficacy|2|||
162175709|NCT03582033|585695344|FG003|Part B|Death|0|||
162175710|NCT03582033|585695345|FG004|Part B|Death|0|||
162175711|NCT03582033|585695346|FG005|Part B|Death|2|||
162175712|NCT03582033|585695347|FG006|Part B|Death|0|||
162175713|NCT03582033|585695348|FG007|Part B|Death|0|||
162175714|NCT03582033|585695349|FG008|Part B|Death|0|||
162175715|NCT03582033|585695350|FG009|Part B|Death|0|||
162175716|NCT03582033|585695341|FG000|Part B|Study terminated by sponsor|0|||
162175717|NCT03582033|585695342|FG001|Part B|Study terminated by sponsor|0|||
162175718|NCT03582033|585695343|FG002|Part B|Study terminated by sponsor|0|||
162175719|NCT03582033|585695344|FG003|Part B|Study terminated by sponsor|0|||
162175720|NCT03582033|585695345|FG004|Part B|Study terminated by sponsor|0|||
162175721|NCT03582033|585695346|FG005|Part B|Study terminated by sponsor|12|||
162175722|NCT03582033|585695347|FG006|Part B|Study terminated by sponsor|0|||
162175723|NCT03582033|585695348|FG007|Part B|Study terminated by sponsor|0|||
162175724|NCT03582033|585695349|FG008|Part B|Study terminated by sponsor|0|||
162175725|NCT03582033|585695350|FG009|Part B|Study terminated by sponsor|0|||
161671316|NCT01079130|583849139|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161671317|NCT01079130|583849140|FG003|Overall Study|Abnormal test procedure result(s)|0|||
161671318|NCT01079130|583849141|FG004|Overall Study|Abnormal test procedure result(s)|1|||
161671319|NCT01079130|583849142|FG005|Overall Study|Abnormal test procedure result(s)|0|||
161671320|NCT01079130|583849137|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161671321|NCT01079130|583849138|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161671322|NCT01079130|583849139|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161671323|NCT01079130|583849140|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
161671324|NCT01079130|583849141|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
161671325|NCT01079130|583849142|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
161671326|NCT01079130|583849137|FG000|Overall Study|Lost to Follow-up|0|||
161671327|NCT01079130|583849138|FG001|Overall Study|Lost to Follow-up|0|||
161671328|NCT01079130|583849139|FG002|Overall Study|Lost to Follow-up|0|||
161671329|NCT01079130|583849140|FG003|Overall Study|Lost to Follow-up|0|||
161671330|NCT01079130|583849141|FG004|Overall Study|Lost to Follow-up|1|||
161671331|NCT01079130|583849142|FG005|Overall Study|Lost to Follow-up|0|||
161671332|NCT00475033|583849147|FG000|Infant Series|Failed to return|3|||
161671333|NCT00475033|583849148|FG001|Infant Series|Failed to return|4|||
161671334|NCT00475033|583849147|FG000|Infant Series|Parent or legal guardian request|1|||
161671335|NCT00475033|583849148|FG001|Infant Series|Parent or legal guardian request|5|||
161671336|NCT00475033|583849147|FG000|Infant Series|Protocol Violation|1|||
161671337|NCT00475033|583849148|FG001|Infant Series|Protocol Violation|2|||
161671338|NCT00475033|583849147|FG000|Infant Series|Lost to Follow-up|2|||
161671339|NCT00475033|583849148|FG001|Infant Series|Lost to Follow-up|0|||
161671340|NCT00475033|583849147|FG000|Infant Series|Adverse Event|0|||
161671341|NCT00475033|583849148|FG001|Infant Series|Adverse Event|2|||
161671342|NCT00475033|583849147|FG000|After the Infant Series|Adverse Event|0|||
161671343|NCT00475033|583849148|FG001|After the Infant Series|Adverse Event|4|||
161671344|NCT00475033|583849147|FG000|After the Infant Series|Parent or legal guardian request|2|||
161671345|NCT00475033|583849148|FG001|After the Infant Series|Parent or legal guardian request|2|||
161671346|NCT00475033|583849147|FG000|After the Infant Series|Failed to return|2|||
161671347|NCT00475033|583849148|FG001|After the Infant Series|Failed to return|1|||
161671348|NCT00475033|583849147|FG000|After the Infant Series|Protocol Violation|1|||
161671349|NCT00475033|583849148|FG001|After the Infant Series|Protocol Violation|0|||
161671350|NCT00475033|583849147|FG000|After the Infant Series|Lost to Follow-up|1|||
161671351|NCT00475033|583849148|FG001|After the Infant Series|Lost to Follow-up|0|||
161671352|NCT00475033|583849147|FG000|After the Infant Series|Other|0|||
161671353|NCT00475033|583849148|FG001|After the Infant Series|Other|1|||
161671354|NCT00475033|583849147|FG000|Toddler Dose|Parent or legal guardian request|2|||
161671355|NCT00475033|583849148|FG001|Toddler Dose|Parent or legal guardian request|0|||
161671356|NCT00475033|583849147|FG000|Toddler Dose|Failed to return|1|||
161671357|NCT00475033|583849148|FG001|Toddler Dose|Failed to return|0|||
161671358|NCT00475033|583849147|FG000|Toddler Dose|Lost to Follow-up|1|||
161671359|NCT00475033|583849148|FG001|Toddler Dose|Lost to Follow-up|0|||
161671360|NCT01696942|583849153|FG000|Overall Study|Withdrawal by Subject|1|||
161671361|NCT01696942|583849154|FG001|Overall Study|Withdrawal by Subject|0|||
161671362|NCT01696942|583849153|FG000|Overall Study|Protocol Violation|1|||
161671363|NCT01696942|583849154|FG001|Overall Study|Protocol Violation|2|||
161671364|NCT01696942|583849153|FG000|Overall Study|screen failure|0|||
161671365|NCT01696942|583849154|FG001|Overall Study|screen failure|1|||
161671366|NCT01335009|583849155|FG000|Overall Study|Too ill to travel to study sites|1|||
161671367|NCT01335009|583849156|FG001|Overall Study|Too ill to travel to study sites|0|||
161671368|NCT01335009|583849155|FG000|Overall Study|Death|28|||
161671369|NCT01335009|583849156|FG001|Overall Study|Death|32|||
161671370|NCT01335009|583849155|FG000|Overall Study|Withdrawal by Subject|1|||
161671371|NCT01335009|583849156|FG001|Overall Study|Withdrawal by Subject|1|||
161671372|NCT01335009|583849155|FG000|Overall Study|Lost to Follow-up|1|||
161671373|NCT01335009|583849156|FG001|Overall Study|Lost to Follow-up|0|||
161671374|NCT04824521|583849157|FG000|Overall Study|Lost to Follow-up|1|||
161671375|NCT01598311|583849158|FG000|Overall Study|Physician Decision|4|||
161671376|NCT01598311|583849159|FG001|Overall Study|Physician Decision|5|||
161671377|NCT01598311|583849158|FG000|Overall Study|Adverse Event|9|||
161671378|NCT01598311|583849159|FG001|Overall Study|Adverse Event|13|||
161671379|NCT01598311|583849158|FG000|Overall Study|Lost to Follow-up|7|||
161671380|NCT01598311|583849159|FG001|Overall Study|Lost to Follow-up|12|||
161671381|NCT01598311|583849158|FG000|Overall Study|Withdrawal by Subject|9|||
161671382|NCT01598311|583849159|FG001|Overall Study|Withdrawal by Subject|13|||
162018559|NCT00295880|585123135|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
162018560|NCT00295880|585123135|FG000|Overall Study|Unit randomization did not occur|1|||
161671383|NCT01598311|583849158|FG000|Overall Study|No reason provided.|0|||
161671384|NCT01598311|583849159|FG001|Overall Study|No reason provided.|5|||
161671385|NCT01598311|583849158|FG000|Overall Study|Randomized but never treated|8|||
161671386|NCT01598311|583849159|FG001|Overall Study|Randomized but never treated|5|||
161671387|NCT01598311|583849158|FG000|Overall Study|Treated but no confirmed CDAD|9|||
161671388|NCT01598311|583849159|FG001|Overall Study|Treated but no confirmed CDAD|8|||
161671389|NCT01598311|583849158|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
162175726|NCT03582033|585695341|FG000|Part B|Withdrawal by Subject|0|||
162175727|NCT03582033|585695342|FG001|Part B|Withdrawal by Subject|0|||
162175728|NCT03582033|585695343|FG002|Part B|Withdrawal by Subject|0|||
162175729|NCT03582033|585695344|FG003|Part B|Withdrawal by Subject|0|||
162175730|NCT03582033|585695345|FG004|Part B|Withdrawal by Subject|0|||
162175731|NCT03582033|585695346|FG005|Part B|Withdrawal by Subject|6|||
162175732|NCT03582033|585695347|FG006|Part B|Withdrawal by Subject|0|||
162175733|NCT03582033|585695348|FG007|Part B|Withdrawal by Subject|0|||
162175734|NCT03582033|585695349|FG008|Part B|Withdrawal by Subject|0|||
162175735|NCT03582033|585695350|FG009|Part B|Withdrawal by Subject|0|||
162175736|NCT03582033|585695341|FG000|Part C|Other|0|||
162175737|NCT03582033|585695342|FG001|Part C|Other|0|||
162175738|NCT03582033|585695343|FG002|Part C|Other|0|||
162175739|NCT03582033|585695344|FG003|Part C|Other|0|||
162175740|NCT03582033|585695345|FG004|Part C|Other|0|||
162175741|NCT03582033|585695346|FG005|Part C|Other|0|||
162175742|NCT03582033|585695347|FG006|Part C|Other|2|||
162175743|NCT03582033|585695348|FG007|Part C|Other|0|||
162175744|NCT03582033|585695349|FG008|Part C|Other|0|||
162175745|NCT03582033|585695350|FG009|Part C|Other|0|||
162175746|NCT03582033|585695341|FG000|Part C|Death|0|||
162175747|NCT03582033|585695342|FG001|Part C|Death|0|||
162175748|NCT03582033|585695343|FG002|Part C|Death|0|||
162175749|NCT03582033|585695344|FG003|Part C|Death|0|||
162175750|NCT03582033|585695345|FG004|Part C|Death|0|||
162175751|NCT03582033|585695346|FG005|Part C|Death|0|||
162175752|NCT03582033|585695347|FG006|Part C|Death|6|||
162175753|NCT03582033|585695348|FG007|Part C|Death|1|||
162175754|NCT03582033|585695349|FG008|Part C|Death|2|||
162175755|NCT03582033|585695350|FG009|Part C|Death|0|||
162175756|NCT03582033|585695341|FG000|Part C|Study terminated by sponsor|0|||
162175757|NCT03582033|585695342|FG001|Part C|Study terminated by sponsor|0|||
162175758|NCT03582033|585695343|FG002|Part C|Study terminated by sponsor|0|||
162175759|NCT03582033|585695344|FG003|Part C|Study terminated by sponsor|0|||
162175760|NCT03582033|585695345|FG004|Part C|Study terminated by sponsor|0|||
162175761|NCT03582033|585695346|FG005|Part C|Study terminated by sponsor|0|||
162175762|NCT03582033|585695347|FG006|Part C|Study terminated by sponsor|3|||
162175763|NCT03582033|585695348|FG007|Part C|Study terminated by sponsor|3|||
162175764|NCT03582033|585695349|FG008|Part C|Study terminated by sponsor|2|||
162175765|NCT03582033|585695350|FG009|Part C|Study terminated by sponsor|0|||
162175766|NCT03582033|585695341|FG000|Part C|Withdrawal by Subject|0|||
162175767|NCT03582033|585695342|FG001|Part C|Withdrawal by Subject|0|||
162175768|NCT03582033|585695343|FG002|Part C|Withdrawal by Subject|0|||
162175769|NCT03582033|585695344|FG003|Part C|Withdrawal by Subject|0|||
162175770|NCT03582033|585695345|FG004|Part C|Withdrawal by Subject|0|||
162175771|NCT03582033|585695346|FG005|Part C|Withdrawal by Subject|0|||
162175772|NCT03582033|585695347|FG006|Part C|Withdrawal by Subject|1|||
162175773|NCT03582033|585695348|FG007|Part C|Withdrawal by Subject|2|||
162175774|NCT03582033|585695349|FG008|Part C|Withdrawal by Subject|1|||
162175775|NCT03582033|585695350|FG009|Part C|Withdrawal by Subject|0|||
162175776|NCT03582033|585695341|FG000|Part D|Death|0|||
162175777|NCT03582033|585695342|FG001|Part D|Death|0|||
162175778|NCT03582033|585695343|FG002|Part D|Death|0|||
162175779|NCT03582033|585695344|FG003|Part D|Death|0|||
162175780|NCT03582033|585695345|FG004|Part D|Death|0|||
162175781|NCT03582033|585695346|FG005|Part D|Death|0|||
162175782|NCT03582033|585695347|FG006|Part D|Death|0|||
162175783|NCT03582033|585695348|FG007|Part D|Death|0|||
162175784|NCT03582033|585695349|FG008|Part D|Death|0|||
162175785|NCT03582033|585695350|FG009|Part D|Death|1|||
162175786|NCT03582033|585695341|FG000|Part D|Study terminated by sponsor|0|||
162175787|NCT03582033|585695342|FG001|Part D|Study terminated by sponsor|0|||
162175788|NCT03582033|585695343|FG002|Part D|Study terminated by sponsor|0|||
162175789|NCT03582033|585695344|FG003|Part D|Study terminated by sponsor|0|||
162175790|NCT03582033|585695345|FG004|Part D|Study terminated by sponsor|0|||
162175791|NCT03582033|585695346|FG005|Part D|Study terminated by sponsor|0|||
162175792|NCT03582033|585695347|FG006|Part D|Study terminated by sponsor|0|||
162175793|NCT03582033|585695348|FG007|Part D|Study terminated by sponsor|0|||
162175794|NCT03582033|585695349|FG008|Part D|Study terminated by sponsor|0|||
162175795|NCT03582033|585695350|FG009|Part D|Study terminated by sponsor|4|||
162175796|NCT04505410|585695353|FG000|Overall Study|Adverse Event|2|||
162175797|NCT04505410|585695354|FG001|Overall Study|Adverse Event|0|||
162175798|NCT04505410|585695353|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
162175799|NCT04505410|585695354|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
162175800|NCT04505410|585695353|FG000|Overall Study|did not want to follow diet|1|||
162175801|NCT04505410|585695354|FG001|Overall Study|did not want to follow diet|0|||
162175802|NCT04505410|585695353|FG000|Overall Study|flare up of ulcerative colitis|0|||
162175803|NCT04505410|585695354|FG001|Overall Study|flare up of ulcerative colitis|1|||
162175804|NCT04505410|585695353|FG000|Overall Study|Lost to Follow-up|0|||
162175805|NCT04505410|585695354|FG001|Overall Study|Lost to Follow-up|2|||
162175806|NCT04505410|585695353|FG000|Overall Study|Lost to Follow-up|1|||
162175807|NCT04505410|585695354|FG001|Overall Study|Lost to Follow-up|0|||
162175808|NCT04505410|585695353|FG000|Overall Study|initiated another diet on their own|0|||
162175809|NCT04505410|585695354|FG001|Overall Study|initiated another diet on their own|2|||
162175810|NCT05654662|585695355|FG000|Overall Study|Withdrawal by Subject|1|||
162175811|NCT05654662|585695356|FG001|Overall Study|Withdrawal by Subject|0|||
162175812|NCT05654662|585695355|FG000|Overall Study|A death in the family|1|||
162175813|NCT05654662|585695356|FG001|Overall Study|A death in the family|0|||
162175814|NCT05962814|585695357|FG000|Overall Study|failed eligibility|1|||
162175815|NCT04565990|585697032|FG000|Overall Study|Death|5|||
162175816|NCT04565990|585697032|FG000|Overall Study|Lost to Follow-up|1|||
162175817|NCT04565990|585697032|FG000|Overall Study|Withdrawal by Subject|1|||
162175818|NCT05507333|585697033|FG000|Overall Study|Protocol Violation|1|||
162175819|NCT01960452|585697036|FG000|Overall Study|Withdrawal by Subject|2|||
162175820|NCT01960452|585697037|FG001|Overall Study|Withdrawal by Subject|1|||
162175821|NCT01960452|585697036|FG000|Overall Study|Sleep apnea in Night 1|1|||
162175822|NCT01960452|585697037|FG001|Overall Study|Sleep apnea in Night 1|0|||
162175823|NCT01960452|585697036|FG000|Overall Study|Poor Sleep in Night 1|0|||
162175824|NCT01960452|585697037|FG001|Overall Study|Poor Sleep in Night 1|2|||
162175825|NCT01960452|585697036|FG000|Overall Study|No Sex/Age Match Night 1|1|||
162175826|NCT01960452|585697037|FG001|Overall Study|No Sex/Age Match Night 1|0|||
162175827|NCT01960452|585697036|FG000|Overall Study|No Sex/Age Match Night 2|0|||
162175828|NCT01960452|585697037|FG001|Overall Study|No Sex/Age Match Night 2|2|||
162175829|NCT01960452|585697036|FG000|Overall Study|Technical Difficulties Night 2|2|||
162175830|NCT01960452|585697037|FG001|Overall Study|Technical Difficulties Night 2|0|||
162175831|NCT03981926|585697038|FG000|Overall Study|Lost to Follow-up|5|||
162175832|NCT03981926|585697039|FG001|Overall Study|Lost to Follow-up|9|||
162175833|NCT01314105|585697046|FG000|Overall Study|Progressive Disease|6|||
162175834|NCT01314105|585697047|FG001|Overall Study|Progressive Disease|10|||
162175835|NCT01314105|585697046|FG000|Overall Study|Refused to continue taking medication|0|||
162175836|NCT01314105|585697047|FG001|Overall Study|Refused to continue taking medication|1|||
162175837|NCT01314105|585697046|FG000|Overall Study|Other Adverse Event|1|||
162175838|NCT01314105|585697047|FG001|Overall Study|Other Adverse Event|1|||
162175839|NCT04820322|585697048|FG000|Overall Study|Adverse Event|1|||
162175840|NCT04820322|585697049|FG001|Overall Study|Adverse Event|0|||
162175841|NCT03156465|585697055|FG000|Overall Study|Withdrawal by Subject|2|||
162175842|NCT03640286|585697056|FG000|Overall Study|Adverse Event|6|||
161671390|NCT01598311|583849159|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
161671391|NCT00523718|583851252|FG000|Overall Study|Withdrawal by Subject|1|||
162175843|NCT03640286|585697057|FG001|Overall Study|Adverse Event|6|||
162175844|NCT03640286|585697056|FG000|Overall Study|Lost to Follow-up|3|||
162175845|NCT03640286|585697057|FG001|Overall Study|Lost to Follow-up|6|||
162175846|NCT03640286|585697056|FG000|Overall Study|Pregnancy|1|||
162175847|NCT03640286|585697057|FG001|Overall Study|Pregnancy|0|||
162175848|NCT03640286|585697056|FG000|Overall Study|Withdrawal by Subject|10|||
162175849|NCT03640286|585697057|FG001|Overall Study|Withdrawal by Subject|10|||
162175850|NCT03640286|585697056|FG000|Overall Study|Non-compliance|4|||
162175851|NCT03640286|585697057|FG001|Overall Study|Non-compliance|10|||
162175852|NCT03640286|585697056|FG000|Overall Study|Medication change|1|||
162175853|NCT03640286|585697057|FG001|Overall Study|Medication change|0|||
162175854|NCT03640286|585697056|FG000|Overall Study|Other|1|||
162175855|NCT03640286|585697057|FG001|Overall Study|Other|2|||
162175856|NCT03640286|585697056|FG000|Overall Study|Joined another lifestyle program|0|||
162175857|NCT03640286|585697057|FG001|Overall Study|Joined another lifestyle program|1|||
162175858|NCT03181516|585697059|FG000|Overall Study|Withdrawal by Subject|14|||
162175859|NCT03181516|585697060|FG001|Overall Study|Withdrawal by Subject|7|||
162175860|NCT03181516|585697059|FG000|Overall Study|Lost to Follow-up|2|||
162175861|NCT03181516|585697060|FG001|Overall Study|Lost to Follow-up|2|||
162175862|NCT04544007|585697066|FG000|Overall Study|Withdrawal by Subject|1|||
162175863|NCT04544007|585697066|FG000|Overall Study|Confirmed Progressive Disease|1|||
162175864|NCT05405985|585697072|FG000|Overall Study|Withdrawal by Subject|1|||
162175865|NCT05405985|585697073|FG001|Overall Study|Withdrawal by Subject|0|||
162175866|NCT02839265|585697074|FG000|Overall Study|Screen Failure|2|||
162175867|NCT02839265|585697074|FG000|Overall Study|Death|1|||
162175868|NCT02839265|585697074|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
162175869|NCT04605159|585697090|FG000|Overall Study|Adverse Event|6|||
162175870|NCT04605159|585697091|FG001|Overall Study|Adverse Event|3|||
162175871|NCT04605159|585697092|FG002|Overall Study|Adverse Event|21|||
162175872|NCT04605159|585697093|FG003|Overall Study|Adverse Event|4|||
162175873|NCT04605159|585697090|FG000|Overall Study|Lost to Follow-up|74|||
162175874|NCT04605159|585697091|FG001|Overall Study|Lost to Follow-up|45|||
162175875|NCT04605159|585697092|FG002|Overall Study|Lost to Follow-up|119|||
162175876|NCT04605159|585697093|FG003|Overall Study|Lost to Follow-up|80|||
162175877|NCT04605159|585697090|FG000|Overall Study|Protocol Violation|4|||
162175878|NCT04605159|585697091|FG001|Overall Study|Protocol Violation|5|||
162175879|NCT04605159|585697092|FG002|Overall Study|Protocol Violation|2|||
162175880|NCT04605159|585697093|FG003|Overall Study|Protocol Violation|0|||
162175881|NCT04605159|585697090|FG000|Overall Study|Withdrawal by Subject|66|||
161817039|NCT01604941|584370907|FG002|Overall Study|Participant Decision|0|||
161817040|NCT01604941|584370908|FG003|Overall Study|Participant Decision|0|||
161817041|NCT01604941|584370909|FG004|Overall Study|Participant Decision|0|||
161817042|NCT01604941|584370910|FG005|Overall Study|Participant Decision|2|||
162175882|NCT04605159|585697091|FG001|Overall Study|Withdrawal by Subject|37|||
162175883|NCT04605159|585697092|FG002|Overall Study|Withdrawal by Subject|68|||
162175884|NCT04605159|585697093|FG003|Overall Study|Withdrawal by Subject|50|||
162175885|NCT04605159|585697090|FG000|Overall Study|Migrated / moved from the study area|32|||
162175886|NCT04605159|585697091|FG001|Overall Study|Migrated / moved from the study area|22|||
162175887|NCT04605159|585697092|FG002|Overall Study|Migrated / moved from the study area|41|||
162175888|NCT04605159|585697093|FG003|Overall Study|Migrated / moved from the study area|21|||
162175889|NCT04605159|585697090|FG000|Overall Study|Other|1|||
162175890|NCT04605159|585697091|FG001|Overall Study|Other|2|||
162175891|NCT04605159|585697092|FG002|Overall Study|Other|7|||
161922848|NCT00021255|584764885|FG001|Overall Study|Breast cancer relapse|18|||
162175892|NCT04605159|585697093|FG003|Overall Study|Other|3|||
162175893|NCT02323880|585697094|FG000|Overall Study|Adverse Event|2|||
162175894|NCT02323880|585697095|FG001|Overall Study|Adverse Event|0|||
162175895|NCT02323880|585697096|FG002|Overall Study|Adverse Event|1|||
162175896|NCT02323880|585697097|FG003|Overall Study|Adverse Event|1|||
162175897|NCT02323880|585697098|FG004|Overall Study|Adverse Event|1|||
162175898|NCT02323880|585697099|FG005|Overall Study|Adverse Event|0|||
162175899|NCT02323880|585697100|FG006|Overall Study|Adverse Event|1|||
162175900|NCT02323880|585697101|FG007|Overall Study|Adverse Event|0|||
162175901|NCT02323880|585697094|FG000|Overall Study|Death|0|||
162175902|NCT02323880|585697095|FG001|Overall Study|Death|0|||
162175903|NCT02323880|585697096|FG002|Overall Study|Death|0|||
162175904|NCT02323880|585697097|FG003|Overall Study|Death|0|||
162175905|NCT02323880|585697098|FG004|Overall Study|Death|0|||
162175906|NCT02323880|585697099|FG005|Overall Study|Death|1|||
162175907|NCT02323880|585697100|FG006|Overall Study|Death|0|||
162175908|NCT02323880|585697101|FG007|Overall Study|Death|0|||
162175909|NCT02323880|585697094|FG000|Overall Study|Lack of Efficacy|4|||
162175910|NCT02323880|585697095|FG001|Overall Study|Lack of Efficacy|11|||
162175911|NCT02323880|585697096|FG002|Overall Study|Lack of Efficacy|5|||
162175912|NCT02323880|585697097|FG003|Overall Study|Lack of Efficacy|5|||
162175913|NCT02323880|585697098|FG004|Overall Study|Lack of Efficacy|4|||
162175914|NCT02323880|585697099|FG005|Overall Study|Lack of Efficacy|8|||
162175915|NCT02323880|585697100|FG006|Overall Study|Lack of Efficacy|4|||
162175916|NCT02323880|585697101|FG007|Overall Study|Lack of Efficacy|6|||
162175917|NCT02323880|585697094|FG000|Overall Study|Physician Decision|0|||
162175918|NCT02323880|585697095|FG001|Overall Study|Physician Decision|0|||
162175919|NCT02323880|585697096|FG002|Overall Study|Physician Decision|0|||
162175920|NCT02323880|585697097|FG003|Overall Study|Physician Decision|0|||
162175921|NCT02323880|585697098|FG004|Overall Study|Physician Decision|1|||
162175922|NCT02323880|585697099|FG005|Overall Study|Physician Decision|1|||
162175923|NCT02323880|585697100|FG006|Overall Study|Physician Decision|1|||
162175924|NCT02323880|585697101|FG007|Overall Study|Physician Decision|0|||
162175925|NCT02323880|585697094|FG000|Overall Study|Withdrawal by Subject|0|||
162175926|NCT02323880|585697095|FG001|Overall Study|Withdrawal by Subject|2|||
162175927|NCT02323880|585697096|FG002|Overall Study|Withdrawal by Subject|0|||
162175928|NCT02323880|585697097|FG003|Overall Study|Withdrawal by Subject|0|||
162175929|NCT02323880|585697098|FG004|Overall Study|Withdrawal by Subject|0|||
162175930|NCT02323880|585697099|FG005|Overall Study|Withdrawal by Subject|0|||
162175931|NCT02323880|585697100|FG006|Overall Study|Withdrawal by Subject|0|||
162175932|NCT02323880|585697101|FG007|Overall Study|Withdrawal by Subject|0|||
162175933|NCT04934072|585697103|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
162175934|NCT04934072|585697104|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
162175935|NCT04934072|585697105|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
162175936|NCT04934072|585697106|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
162175937|NCT04934072|585697107|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
162175938|NCT04934072|585697103|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
162175939|NCT04934072|585697104|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
162175940|NCT04934072|585697105|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
162175941|NCT04934072|585697106|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
161922849|NCT00021255|584764886|FG002|Overall Study|Breast cancer relapse|11|||
161922850|NCT00021255|584764884|FG000|Overall Study|Second primary malignancy|0|||
162175942|NCT04934072|585697107|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
162175943|NCT04934072|585697103|FG000|Day 0 to Week 52|Other|3|||
162175944|NCT04934072|585697104|FG001|Day 0 to Week 52|Other|1|||
162175945|NCT04934072|585697105|FG002|Day 0 to Week 52|Other|0|||
162175946|NCT04934072|585697106|FG003|Day 0 to Week 52|Other|0|||
162175947|NCT04934072|585697107|FG004|Day 0 to Week 52|Other|0|||
162175948|NCT04934072|585697103|FG000|Day 0 to Week 52|Adverse Event|1|||
162175949|NCT04934072|585697104|FG001|Day 0 to Week 52|Adverse Event|3|||
162175950|NCT04934072|585697105|FG002|Day 0 to Week 52|Adverse Event|0|||
162175951|NCT04934072|585697106|FG003|Day 0 to Week 52|Adverse Event|0|||
162175952|NCT04934072|585697107|FG004|Day 0 to Week 52|Adverse Event|0|||
162175953|NCT04934072|585697103|FG000|Week 52 to Week 78|Adverse Event|0|||
162175954|NCT04934072|585697104|FG001|Week 52 to Week 78|Adverse Event|0|||
162175955|NCT04934072|585697105|FG002|Week 52 to Week 78|Adverse Event|0|||
162175956|NCT04934072|585697106|FG003|Week 52 to Week 78|Adverse Event|1|||
162175957|NCT04934072|585697107|FG004|Week 52 to Week 78|Adverse Event|1|||
162175958|NCT04934072|585697103|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
162175959|NCT04934072|585697104|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
162175960|NCT04934072|585697105|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
162175961|NCT04934072|585697106|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
162175962|NCT04934072|585697107|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
162175963|NCT04934072|585697103|FG000|Week 52 to Week 78|Other|0|||
162175964|NCT04934072|585697104|FG001|Week 52 to Week 78|Other|0|||
162175965|NCT04934072|585697105|FG002|Week 52 to Week 78|Other|1|||
162175966|NCT04934072|585697106|FG003|Week 52 to Week 78|Other|0|||
162175967|NCT04934072|585697107|FG004|Week 52 to Week 78|Other|0|||
162175968|NCT05424380|585697112|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
162175969|NCT05424380|585697113|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
162175970|NCT05424380|585697114|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
162175971|NCT05424380|585697115|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
162175972|NCT05424380|585697116|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
162175973|NCT05424380|585697117|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
162175974|NCT05424380|585697112|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
162175975|NCT05424380|585697113|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
162175976|NCT05424380|585697114|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
162175977|NCT05424380|585697115|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
162175978|NCT05424380|585697116|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
162175979|NCT05424380|585697117|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
162175980|NCT05424380|585697112|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
162175981|NCT05424380|585697113|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
162175982|NCT05424380|585697114|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
162175983|NCT05424380|585697115|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
162175984|NCT05424380|585697116|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
162175985|NCT05424380|585697117|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
162175986|NCT05424380|585697112|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
162175987|NCT05424380|585697113|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
162175988|NCT05424380|585697114|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
162175989|NCT05424380|585697115|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
162175990|NCT05424380|585697116|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
162175991|NCT05424380|585697117|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
162175992|NCT05424380|585697112|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
162175993|NCT05424380|585697113|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
162175994|NCT05424380|585697114|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
162175995|NCT05424380|585697115|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
162175996|NCT05424380|585697116|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
162175997|NCT05424380|585697117|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
162175998|NCT05424380|585697112|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
162175999|NCT05424380|585697113|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
162176000|NCT05424380|585697114|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
162176001|NCT05424380|585697115|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
162176002|NCT05424380|585697116|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
162176003|NCT05424380|585697117|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
162176004|NCT05424380|585697112|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
162176005|NCT05424380|585697113|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
162176006|NCT05424380|585697114|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
162176007|NCT05424380|585697115|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
162176008|NCT05424380|585697116|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
162176009|NCT05424380|585697117|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
162176010|NCT05424380|585697112|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
162176011|NCT05424380|585697113|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
162176012|NCT05424380|585697114|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
162176013|NCT05424380|585697115|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
162176014|NCT05424380|585697116|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
162176015|NCT05424380|585697117|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
162176016|NCT05424380|585697112|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162176017|NCT05424380|585697113|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162176018|NCT05424380|585697114|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162176019|NCT05424380|585697115|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
162176020|NCT05424380|585697116|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162176021|NCT05424380|585697117|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162176022|NCT05424380|585697112|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
162176023|NCT05424380|585697113|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
162176024|NCT05424380|585697114|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
162176025|NCT05424380|585697115|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
162176026|NCT05424380|585697116|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
162176027|NCT05424380|585697117|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
162176028|NCT05424380|585697112|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
162176029|NCT05424380|585697113|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
162176030|NCT05424380|585697114|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
162176031|NCT05424380|585697115|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
162176032|NCT05424380|585697116|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
162176033|NCT05424380|585697117|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
162176034|NCT05424380|585697112|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
162176035|NCT05424380|585697113|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
162176036|NCT05424380|585697114|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
162176037|NCT05424380|585697115|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
162176038|NCT05424380|585697116|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
162176039|NCT05424380|585697117|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
162176040|NCT05424380|585697112|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162176041|NCT05424380|585697113|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162176042|NCT05424380|585697114|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162176043|NCT05424380|585697115|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162176044|NCT05424380|585697116|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
162176045|NCT05424380|585697117|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
162176046|NCT05424380|585697112|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
162176047|NCT05424380|585697113|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
162176048|NCT05424380|585697114|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
162176049|NCT05424380|585697115|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
162176050|NCT05424380|585697116|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
162176051|NCT05424380|585697117|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
162176052|NCT04218851|585697124|FG000|Overall Study|Death|1|||
162176053|NCT04218851|585697125|FG001|Overall Study|Death|3|||
162176054|NCT00844415|585697126|FG000|Overall Study|Withdrawal by Subject|1|||
162176055|NCT03174275|585697129|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
162176056|NCT03174275|585697129|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
162176057|NCT03174275|585697129|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
162176058|NCT03174275|585697129|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
162176059|NCT03174275|585697129|FG000|Adjuvant Chemotherapy|Progression|1|||
162176060|NCT03174275|585697129|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
162176061|NCT03174275|585697129|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
162176062|NCT03174275|585697129|FG000|Adjuvant Durvalumab|Progression|1|||
162176063|NCT03174275|585697129|FG000|Adjuvant Durvalumab|Adverse Event|3|||
162176064|NCT03174275|585697129|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
162176065|NCT03174275|585697129|FG000|Adjuvant Radiotherapy|Progression|1|||
162176066|NCT03174275|585697129|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
162176067|NCT05970861|585697130|FG000|Overall Study|Physician Decision|4|||
162176068|NCT05970861|585697131|FG001|Overall Study|Physician Decision|4|||
162176069|NCT05970861|585697130|FG000|Overall Study|Lost to Follow-up|4|||
162176070|NCT05970861|585697131|FG001|Overall Study|Lost to Follow-up|3|||
162176071|NCT02990338|585697132|FG000|Overall Study|Randomized and not treated|4|||
162176072|NCT02990338|585697133|FG001|Overall Study|Randomized and not treated|2|||
162176073|NCT02990338|585697132|FG000|Overall Study|Adverse Event|23|||
162176074|NCT02990338|585697133|FG001|Overall Study|Adverse Event|22|||
162176075|NCT02990338|585697132|FG000|Overall Study|Progressive disease|118|||
162176076|NCT02990338|585697133|FG001|Overall Study|Progressive disease|107|||
162176077|NCT02990338|585697132|FG000|Overall Study|Poor compliance to protocol|0|||
162176078|NCT02990338|585697133|FG001|Overall Study|Poor compliance to protocol|1|||
162176079|NCT02990338|585697132|FG000|Overall Study|Withdrawal by Subject|6|||
162176080|NCT02990338|585697133|FG001|Overall Study|Withdrawal by Subject|8|||
162176081|NCT02990338|585697132|FG000|Overall Study|Physician's decision|2|||
162176082|NCT02990338|585697133|FG001|Overall Study|Physician's decision|6|||
162176083|NCT02990338|585697132|FG000|Overall Study|Treatment extension study|0|||
162176084|NCT02990338|585697133|FG001|Overall Study|Treatment extension study|6|||
162176085|NCT02990338|585697132|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
162176086|NCT02990338|585697133|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
162176087|NCT02990338|585697132|FG000|Overall Study|Continue with therapy available commercially|0|||
162176088|NCT02990338|585697133|FG001|Overall Study|Continue with therapy available commercially|1|||
162176089|NCT04186819|585697135|FG000|Overall Study|Adverse Event|1|||
162176090|NCT04186819|585697135|FG000|Overall Study|Lost to Follow-up|1|||
162176091|NCT04186819|585697135|FG000|Overall Study|Opted for EBRT|1|||
162176092|NCT04186819|585697135|FG000|Overall Study|Opted SBRT|1|||
161922851|NCT00021255|584764885|FG001|Overall Study|Second primary malignancy|4|||
161922852|NCT00021255|584764886|FG002|Overall Study|Second primary malignancy|1|||
162018561|NCT01474239|585123136|FG000|Overall Study|Disease Progression|37|||
162018562|NCT01474239|585123137|FG001|Overall Study|Disease Progression|25|||
161922853|NCT00021255|584764884|FG000|Overall Study|Withdrawal by Subject|41|||
161922854|NCT00021255|584764885|FG001|Overall Study|Withdrawal by Subject|64|||
161922855|NCT00021255|584764886|FG002|Overall Study|Withdrawal by Subject|26|||
161922856|NCT00021255|584764884|FG000|Overall Study|Lost to Follow-up|0|||
161922857|NCT00021255|584764885|FG001|Overall Study|Lost to Follow-up|2|||
161922858|NCT00021255|584764886|FG002|Overall Study|Lost to Follow-up|3|||
161922859|NCT00021255|584764884|FG000|Overall Study|Cardiac toxicity|0|||
161922860|NCT00021255|584764885|FG001|Overall Study|Cardiac toxicity|61|||
161922861|NCT00021255|584764886|FG002|Overall Study|Cardiac toxicity|32|||
161922862|NCT00021255|584764884|FG000|Overall Study|Herceptin toxicity|0|||
161922863|NCT00021255|584764885|FG001|Overall Study|Herceptin toxicity|22|||
161922864|NCT00021255|584764886|FG002|Overall Study|Herceptin toxicity|6|||
161922865|NCT00021255|584764884|FG000|Overall Study|Adverse Event|46|||
161922866|NCT00021255|584764885|FG001|Overall Study|Adverse Event|30|||
161922867|NCT00021255|584764886|FG002|Overall Study|Adverse Event|18|||
161922868|NCT00021255|584764884|FG000|Overall Study|Protocol Violation|0|||
161922869|NCT00021255|584764885|FG001|Overall Study|Protocol Violation|2|||
161922870|NCT00021255|584764886|FG002|Overall Study|Protocol Violation|0|||
161922871|NCT00021255|584764884|FG000|Overall Study|Other than specified above|0|||
161922872|NCT00021255|584764885|FG001|Overall Study|Other than specified above|38|||
161922873|NCT00021255|584764886|FG002|Overall Study|Other than specified above|19|||
161922874|NCT00021255|584764884|FG000|Overall Study|Missing|0|||
161922875|NCT00021255|584764885|FG001|Overall Study|Missing|27|||
161922876|NCT00021255|584764886|FG002|Overall Study|Missing|13|||
162018563|NCT01474239|585123136|FG000|Overall Study|Adverse Event|12|||
162018564|NCT01474239|585123137|FG001|Overall Study|Adverse Event|3|||
162018565|NCT01474239|585123136|FG000|Overall Study|Withdrawal by Subject|1|||
162018566|NCT01474239|585123137|FG001|Overall Study|Withdrawal by Subject|2|||
162018567|NCT01474239|585123136|FG000|Overall Study|Death|1|||
162018568|NCT01474239|585123137|FG001|Overall Study|Death|1|||
162018569|NCT01474239|585123136|FG000|Overall Study|Clinical Disease Progression|7|||
162018570|NCT01474239|585123137|FG001|Overall Study|Clinical Disease Progression|1|||
162018571|NCT01474239|585123136|FG000|Overall Study|Withdrawal for Economic Reason|1|||
162018572|NCT01474239|585123137|FG001|Overall Study|Withdrawal for Economic Reason|0|||
162018573|NCT01243242|585123138|FG000|Overall Study|Adverse Event|1|||
162018574|NCT01243242|585123139|FG001|Overall Study|Adverse Event|1|||
162018575|NCT01243242|585123138|FG000|Overall Study|Withdrawal by Subject|1|||
162018576|NCT01243242|585123139|FG001|Overall Study|Withdrawal by Subject|1|||
162018577|NCT01243242|585123138|FG000|Overall Study|Physician Decision|0|||
162018578|NCT01243242|585123139|FG001|Overall Study|Physician Decision|1|||
162018579|NCT01243242|585123138|FG000|Overall Study|sponsor decision|0|||
162018580|NCT01243242|585123139|FG001|Overall Study|sponsor decision|1|||
162018581|NCT01243242|585123138|FG000|Overall Study|non compliance|1|||
162018582|NCT01243242|585123139|FG001|Overall Study|non compliance|0|||
162018583|NCT00796419|585123144|FG000|Overall Study|Death|0|||
162018584|NCT00796419|585123145|FG001|Overall Study|Death|1|||
162018585|NCT02840799|585123148|FG000|Phase 1|Physician Decision|1|||
162018586|NCT02840799|585123149|FG001|Phase 1|Physician Decision|3|||
162018587|NCT02840799|585123148|FG000|Phase 1|Withdrawal by Subject|4|||
162018588|NCT02840799|585123149|FG001|Phase 1|Withdrawal by Subject|0|||
162018589|NCT02840799|585123148|FG000|Phase 2 (Crossover)|Adverse Event|0|||
162018590|NCT02840799|585123149|FG001|Phase 2 (Crossover)|Adverse Event|1|||
162018591|NCT02840799|585123148|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
162018592|NCT02840799|585123149|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
162018593|NCT03983317|585123152|FG000|Overall Study|Physician Decision|5|||
162018594|NCT02687191|585123157|FG000|Overall Study|Death|0|||
162018595|NCT02687191|585123158|FG001|Overall Study|Death|1|||
162018596|NCT02687191|585123159|FG002|Overall Study|Death|1|||
162018597|NCT02687191|585123160|FG003|Overall Study|Death|0|||
162018598|NCT02687191|585123161|FG004|Overall Study|Death|1|||
162018599|NCT02687191|585123162|FG005|Overall Study|Death|1|||
162018600|NCT02687191|585123157|FG000|Overall Study|Withdrawal by Subject|0|||
162018601|NCT02687191|585123158|FG001|Overall Study|Withdrawal by Subject|0|||
162018602|NCT02687191|585123159|FG002|Overall Study|Withdrawal by Subject|0|||
162018603|NCT02687191|585123160|FG003|Overall Study|Withdrawal by Subject|1|||
162018604|NCT02687191|585123161|FG004|Overall Study|Withdrawal by Subject|0|||
161922877|NCT00021255|584764884|FG000|Overall Study|Randomized but not treated|28|||
161922878|NCT00021255|584764885|FG001|Overall Study|Randomized but not treated|2|||
161922879|NCT00021255|584764886|FG002|Overall Study|Randomized but not treated|18|||
161922880|NCT02232698|584764887|FG000|Overall Study|Pregnancy|1|||
161922881|NCT02232698|584764888|FG001|Overall Study|Pregnancy|1|||
161922882|NCT02232698|584764887|FG000|Overall Study|Met exclusion criteria|1|||
162018605|NCT02687191|585123162|FG005|Overall Study|Withdrawal by Subject|0|||
162018606|NCT01349049|585123163|FG000|Overall Study|Disease progression|3|||
162018607|NCT01349049|585123164|FG001|Overall Study|Disease progression|5|||
162176093|NCT04186819|585697135|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
162176094|NCT04186819|585697135|FG000|Overall Study|Physician Decision|1|||
162176095|NCT04186819|585697135|FG000|Overall Study|RP Delayed|1|||
162176096|NCT04186819|585697135|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
162176097|NCT04186819|585697135|FG000|Overall Study|Subject declined for financial reasons|1|||
162176098|NCT04186819|585697135|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
162176099|NCT04186819|585697135|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
162176100|NCT04186819|585697135|FG000|Overall Study|The subject opted for other treatment option|2|||
162176101|NCT04186819|585697135|FG000|Overall Study|The subject opted for other treatment options|1|||
162176102|NCT04186819|585697135|FG000|Overall Study|Withdrawal by Subject|3|||
162176103|NCT04186819|585697135|FG000|Overall Study|Reason not specified|1|||
162176104|NCT05013385|585697136|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
162176105|NCT00677365|585697137|FG000|Overall Study|Adverse Event|2|||
162176106|NCT00677365|585697138|FG001|Overall Study|Adverse Event|1|||
162176107|NCT00677365|585697139|FG002|Overall Study|Adverse Event|1|||
162176108|NCT00677365|585697140|FG003|Overall Study|Adverse Event|2|||
162176109|NCT00677365|585697137|FG000|Overall Study|Withdrawal by Subject|0|||
162176110|NCT00677365|585697138|FG001|Overall Study|Withdrawal by Subject|0|||
162176111|NCT00677365|585697139|FG002|Overall Study|Withdrawal by Subject|1|||
162176112|NCT00677365|585697140|FG003|Overall Study|Withdrawal by Subject|0|||
162176113|NCT00677365|585697137|FG000|Overall Study|Other reason|0|||
162176114|NCT00677365|585697138|FG001|Overall Study|Other reason|0|||
162176115|NCT00677365|585697139|FG002|Overall Study|Other reason|0|||
162176116|NCT00677365|585697140|FG003|Overall Study|Other reason|1|||
162176117|NCT05900154|585697141|FG000|Follow-Up Period|Lost to Follow-up|1|||
162176118|NCT05900154|585697142|FG001|Follow-Up Period|Lost to Follow-up|2|||
162176119|NCT05900154|585697143|FG002|Follow-Up Period|Lost to Follow-up|1|||
162176120|NCT05900154|585697144|FG003|Follow-Up Period|Lost to Follow-up|0|||
162176121|NCT05900154|585697145|FG004|Follow-Up Period|Lost to Follow-up|1|||
162176122|NCT05900154|585697146|FG005|Follow-Up Period|Lost to Follow-up|1|||
162176123|NCT04102111|585697155|FG000|Overall Study|Withdrawal by Subject|2|||
162176124|NCT04102111|585697156|FG001|Overall Study|Withdrawal by Subject|3|||
162176125|NCT04102111|585697155|FG000|Overall Study|Adverse Event|1|||
162176126|NCT04102111|585697156|FG001|Overall Study|Adverse Event|1|||
162176127|NCT04102111|585697155|FG000|Overall Study|Study terminated by sponsor|1|||
162176128|NCT04102111|585697156|FG001|Overall Study|Study terminated by sponsor|3|||
162176129|NCT03334695|585697157|FG000|Overall Study|Lost to Follow-up|3|||
162176130|NCT03334695|585697158|FG001|Overall Study|Lost to Follow-up|3|||
162176131|NCT03334695|585697157|FG000|Overall Study|Physician Decision|1|||
162176132|NCT03334695|585697158|FG001|Overall Study|Physician Decision|2|||
162176133|NCT03334695|585697157|FG000|Overall Study|Protocol Violation|0|||
162176134|NCT03334695|585697158|FG001|Overall Study|Protocol Violation|1|||
162176135|NCT02542631|585697159|FG000|Overall Study|Adverse Event|1|||
162176136|NCT02542631|585697160|FG001|Overall Study|Adverse Event|1|||
162176137|NCT02542631|585697159|FG000|Overall Study|Sponsor Termination|1|||
162176138|NCT02542631|585697160|FG001|Overall Study|Sponsor Termination|0|||
162176139|NCT02542631|585697159|FG000|Overall Study|Withdrawal by Subject|11|||
162176140|NCT02542631|585697160|FG001|Overall Study|Withdrawal by Subject|16|||
162176141|NCT02542631|585697159|FG000|Overall Study|Protocol Violation|1|||
162176142|NCT02542631|585697160|FG001|Overall Study|Protocol Violation|1|||
162176143|NCT02542631|585697159|FG000|Overall Study|Physician Decision|6|||
162176144|NCT02542631|585697160|FG001|Overall Study|Physician Decision|4|||
162176145|NCT02542631|585697159|FG000|Overall Study|Lost to Follow-up|6|||
162176146|NCT02542631|585697160|FG001|Overall Study|Lost to Follow-up|5|||
162176147|NCT02542631|585697159|FG000|Overall Study|Death|1|||
162176148|NCT02542631|585697160|FG001|Overall Study|Death|2|||
162176149|NCT02542631|585697159|FG000|Overall Study|Other|2|||
162176150|NCT02542631|585697160|FG001|Overall Study|Other|1|||
162176151|NCT02542631|585697159|FG000|Overall Study|Used Prohibited Medication|2|||
162176152|NCT02542631|585697160|FG001|Overall Study|Used Prohibited Medication|1|||
162176153|NCT02641730|585697161|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
162176154|NCT02641730|585697162|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162176155|NCT02641730|585697163|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
162176156|NCT02641730|585697164|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
162176157|NCT02641730|585697165|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
162176158|NCT02641730|585697161|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
162176159|NCT02641730|585697162|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
162176160|NCT02641730|585697163|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
162176161|NCT02641730|585697164|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
162176162|NCT02641730|585697165|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
162176163|NCT02641730|585697161|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
162176164|NCT02641730|585697162|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
162176165|NCT02641730|585697163|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
162176166|NCT02641730|585697164|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
162176167|NCT02641730|585697165|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
162176168|NCT02641730|585697161|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
162176169|NCT02641730|585697162|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
162176170|NCT02641730|585697163|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
162176171|NCT02641730|585697164|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
162176172|NCT02641730|585697165|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
162176173|NCT02641730|585697161|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
162176174|NCT02641730|585697162|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
162176175|NCT02641730|585697163|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
162176176|NCT02641730|585697164|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
162176177|NCT02641730|585697165|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
162176178|NCT02641730|585697161|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
162176179|NCT02641730|585697162|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
162176180|NCT02641730|585697163|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
162176181|NCT02641730|585697164|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
162176182|NCT02641730|585697165|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
162176183|NCT05460871|585697166|FG000|Overall Study|Withdrawal by Subject|1|||
162176184|NCT05460871|585697167|FG001|Overall Study|Withdrawal by Subject|2|||
162176185|NCT02938923|585697168|FG000|Overall Study|Death|1|||
162176186|NCT02938923|585697169|FG001|Overall Study|Death|0|||
162176187|NCT02938923|585697170|FG002|Overall Study|Death|0|||
162176188|NCT02938923|585697168|FG000|Overall Study|Physician Decision|0|||
162176189|NCT02938923|585697169|FG001|Overall Study|Physician Decision|2|||
162176190|NCT02938923|585697170|FG002|Overall Study|Physician Decision|0|||
162176191|NCT02938923|585697168|FG000|Overall Study|Withdrawal by Subject|0|||
162176192|NCT02938923|585697169|FG001|Overall Study|Withdrawal by Subject|1|||
162176193|NCT02938923|585697170|FG002|Overall Study|Withdrawal by Subject|1|||
162176194|NCT03663205|585697171|FG000|Overall Study|Death|144|||
162176195|NCT03663205|585697172|FG001|Overall Study|Death|69|||
162176196|NCT03663205|585697171|FG000|Overall Study|Sponsor decision|53|||
162176197|NCT03663205|585697172|FG001|Overall Study|Sponsor decision|19|||
162176198|NCT03663205|585697171|FG000|Overall Study|Withdrawal by Subject|8|||
162176199|NCT03663205|585697172|FG001|Overall Study|Withdrawal by Subject|11|||
162176200|NCT03663205|585697171|FG000|Overall Study|Lost to Follow-up|7|||
162176201|NCT03663205|585697172|FG001|Overall Study|Lost to Follow-up|9|||
162176202|NCT03663205|585697171|FG000|Overall Study|Transferred to long term extension study|11|||
162176203|NCT03663205|585697172|FG001|Overall Study|Transferred to long term extension study|3|||
162176204|NCT02326974|585697173|FG000|Overall Study|Withdrawal by Subject|2|||
162176205|NCT02326974|585697173|FG000|Overall Study|failed heterogenity evaluation|5|||
162176206|NCT04924400|585697177|FG000|Overall Study|Lost to Follow-up|3|||
162176207|NCT04924400|585697178|FG001|Overall Study|Lost to Follow-up|0|||
162176208|NCT06010836|585697179|FG000|Overall Study|Lost to Follow-up|2|||
162176209|NCT06010836|585697180|FG001|Overall Study|Lost to Follow-up|2|||
162176210|NCT06010836|585697179|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
162176211|NCT06010836|585697180|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
162176212|NCT06010836|585697179|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
162176213|NCT06010836|585697180|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
162176214|NCT06010836|585697179|FG000|Overall Study|Did not receive intervention discussion|0|||
162176215|NCT06010836|585697180|FG001|Overall Study|Did not receive intervention discussion|4|||
162176216|NCT03057054|585697182|FG000|Overall Study|Death|4|||
162176217|NCT03057054|585697183|FG001|Overall Study|Death|4|||
162176218|NCT03057054|585697182|FG000|Overall Study|Withdrawal by Subject|6|||
162176219|NCT03057054|585697183|FG001|Overall Study|Withdrawal by Subject|3|||
162176220|NCT03057054|585697182|FG000|Overall Study|Ineligible|1|||
162176221|NCT03057054|585697183|FG001|Overall Study|Ineligible|1|||
161671392|NCT00523718|583851253|FG001|Overall Study|Withdrawal by Subject|0|||
162176222|NCT04427007|585698478|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
162176223|NCT04427007|585698479|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
162176224|NCT05311176|585698482|FG000|Overall Study|Death|6|||
162176225|NCT05311176|585698482|FG000|Overall Study|Sponsor discontinued the study|1|||
162176226|NCT05247034|585698483|FG000|Overall Study|Lost to Follow-up|3|||
162176227|NCT05247034|585698484|FG001|Overall Study|Lost to Follow-up|2|||
162176228|NCT05247034|585698483|FG000|Overall Study|Organizational problems when attending appointments|1|||
161671393|NCT00523718|583851252|FG000|Overall Study|Protocol Violation|2|||
161922883|NCT02232698|584764888|FG001|Overall Study|Met exclusion criteria|1|||
161922884|NCT02232698|584764887|FG000|Overall Study|Had device-associated symptoms|7|||
161922885|NCT02232698|584764888|FG001|Overall Study|Had device-associated symptoms|0|||
161922886|NCT02232698|584764887|FG000|Overall Study|Non-compliance with study device|1|||
161922887|NCT02232698|584764888|FG001|Overall Study|Non-compliance with study device|4|||
161922888|NCT02232698|584764887|FG000|Overall Study|Allocated to control group|0|||
161922889|NCT02232698|584764888|FG001|Overall Study|Allocated to control group|3|||
161922890|NCT02232698|584764887|FG000|Overall Study|Withdrawal by Subject|0|||
161922891|NCT02232698|584764888|FG001|Overall Study|Withdrawal by Subject|11|||
161922892|NCT02393755|584764889|FG000|Overall Study|Withdrawal by Subject|0|||
161922893|NCT02393755|584764890|FG001|Overall Study|Withdrawal by Subject|3|||
161922894|NCT02393755|584764889|FG000|Overall Study|Adverse Event|0|||
161922895|NCT02393755|584764890|FG001|Overall Study|Adverse Event|2|||
161922896|NCT02393755|584764889|FG000|Overall Study|Physician Decision|0|||
161922897|NCT02393755|584764890|FG001|Overall Study|Physician Decision|2|||
161922898|NCT01327703|584764891|FG000|Second Treatment Period|Adverse Event|1|||
161922899|NCT01327703|584764892|FG001|Second Treatment Period|Adverse Event|1|||
161922900|NCT01327703|584764891|FG000|Second Treatment Period|Protocol Violation|0|||
161922901|NCT01327703|584764892|FG001|Second Treatment Period|Protocol Violation|1|||
161922902|NCT05324371|584764893|FG000|Overall Study|Withdrawal by Subject|1|||
161922903|NCT05324371|584764893|FG000|Overall Study|Death|1|||
161922904|NCT00812097|584764894|FG000|Overall Study|Death|3|||
161922905|NCT00812097|584764895|FG001|Overall Study|Death|10|||
162018608|NCT01349049|585123165|FG002|Overall Study|Disease progression|3|||
162018609|NCT01349049|585123166|FG003|Overall Study|Disease progression|2|||
162018610|NCT01349049|585123167|FG004|Overall Study|Disease progression|2|||
162018611|NCT01349049|585123168|FG005|Overall Study|Disease progression|2|||
162018612|NCT01349049|585123169|FG006|Overall Study|Disease progression|3|||
162018613|NCT01349049|585123170|FG007|Overall Study|Disease progression|2|||
162018614|NCT01349049|585123171|FG008|Overall Study|Disease progression|33|||
162018615|NCT01349049|585123163|FG000|Overall Study|Adverse Event|0|||
162018616|NCT01349049|585123164|FG001|Overall Study|Adverse Event|1|||
162018617|NCT01349049|585123165|FG002|Overall Study|Adverse Event|0|||
162018618|NCT01349049|585123166|FG003|Overall Study|Adverse Event|0|||
162018619|NCT01349049|585123167|FG004|Overall Study|Adverse Event|0|||
162018620|NCT01349049|585123168|FG005|Overall Study|Adverse Event|3|||
162018621|NCT01349049|585123169|FG006|Overall Study|Adverse Event|1|||
162018622|NCT01349049|585123170|FG007|Overall Study|Adverse Event|0|||
162018623|NCT01349049|585123171|FG008|Overall Study|Adverse Event|4|||
162018624|NCT01349049|585123163|FG000|Overall Study|Physician Decision|0|||
162018625|NCT01349049|585123164|FG001|Overall Study|Physician Decision|1|||
162018626|NCT01349049|585123165|FG002|Overall Study|Physician Decision|0|||
162018627|NCT01349049|585123166|FG003|Overall Study|Physician Decision|0|||
162018628|NCT01349049|585123167|FG004|Overall Study|Physician Decision|0|||
162018629|NCT01349049|585123168|FG005|Overall Study|Physician Decision|0|||
162018630|NCT01349049|585123169|FG006|Overall Study|Physician Decision|0|||
162018631|NCT01349049|585123170|FG007|Overall Study|Physician Decision|0|||
162018632|NCT01349049|585123171|FG008|Overall Study|Physician Decision|2|||
162018633|NCT01349049|585123163|FG000|Overall Study|Protocol Violation|0|||
162018634|NCT01349049|585123164|FG001|Overall Study|Protocol Violation|0|||
162018635|NCT01349049|585123165|FG002|Overall Study|Protocol Violation|0|||
162018636|NCT01349049|585123166|FG003|Overall Study|Protocol Violation|0|||
162018637|NCT01349049|585123167|FG004|Overall Study|Protocol Violation|0|||
162018638|NCT01349049|585123168|FG005|Overall Study|Protocol Violation|0|||
162018639|NCT01349049|585123169|FG006|Overall Study|Protocol Violation|0|||
162018640|NCT01349049|585123170|FG007|Overall Study|Protocol Violation|0|||
162018641|NCT01349049|585123171|FG008|Overall Study|Protocol Violation|1|||
162018642|NCT01349049|585123163|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
162018643|NCT01349049|585123164|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
162018644|NCT01349049|585123165|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
162018645|NCT01349049|585123166|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
162018646|NCT01349049|585123167|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
162018647|NCT01349049|585123168|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
162018648|NCT01349049|585123169|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
162018649|NCT01349049|585123170|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
162018650|NCT01349049|585123171|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
162018651|NCT01349049|585123163|FG000|Overall Study|Other|0|||
162018652|NCT01349049|585123164|FG001|Overall Study|Other|0|||
162018653|NCT01349049|585123165|FG002|Overall Study|Other|0|||
162018654|NCT01349049|585123166|FG003|Overall Study|Other|0|||
162018655|NCT01349049|585123167|FG004|Overall Study|Other|0|||
162018656|NCT01349049|585123168|FG005|Overall Study|Other|1|||
162018657|NCT01349049|585123169|FG006|Overall Study|Other|0|||
162018658|NCT01349049|585123170|FG007|Overall Study|Other|0|||
162018659|NCT01349049|585123171|FG008|Overall Study|Other|4|||
162018660|NCT01349049|585123163|FG000|Overall Study|Death|0|||
162018661|NCT01349049|585123164|FG001|Overall Study|Death|0|||
162018662|NCT01349049|585123165|FG002|Overall Study|Death|0|||
162176229|NCT05247034|585698484|FG001|Overall Study|Organizational problems when attending appointments|0|||
162176230|NCT03972150|585698487|FG000|Overall Study|Adverse Event|0|||
162176231|NCT03972150|585698488|FG001|Overall Study|Adverse Event|1|||
162176232|NCT03972150|585698489|FG002|Overall Study|Adverse Event|1|||
162176233|NCT03972150|585698490|FG003|Overall Study|Adverse Event|0|||
162176234|NCT03972150|585698491|FG004|Overall Study|Adverse Event|0|||
162176235|NCT03972150|585698487|FG000|Overall Study|Progressive disease|3|||
162176236|NCT03972150|585698488|FG001|Overall Study|Progressive disease|5|||
162176237|NCT03972150|585698489|FG002|Overall Study|Progressive disease|2|||
162176238|NCT03972150|585698490|FG003|Overall Study|Progressive disease|2|||
162176239|NCT03972150|585698491|FG004|Overall Study|Progressive disease|3|||
162176240|NCT02668692|585698492|FG000|Overall Study|Adverse Event|1|||
162176241|NCT02668692|585698493|FG001|Overall Study|Adverse Event|0|||
162176242|NCT03442309|585698495|FG000|Overall Study|Lost to Follow-up|1676|||
162176243|NCT03442309|585698496|FG001|Overall Study|Lost to Follow-up|1642|||
162176244|NCT04615273|585698502|FG000|Overall Study|Withdrawal by Subject|3|||
162176245|NCT04615273|585698503|FG001|Overall Study|Withdrawal by Subject|1|||
162176246|NCT04615273|585698504|FG002|Overall Study|Withdrawal by Subject|2|||
162176247|NCT04615273|585698502|FG000|Overall Study|Adverse Event|1|||
162176248|NCT04615273|585698503|FG001|Overall Study|Adverse Event|0|||
162176249|NCT04615273|585698504|FG002|Overall Study|Adverse Event|1|||
162176250|NCT04615273|585698502|FG000|Overall Study|Lost to Follow-up|0|||
162176251|NCT04615273|585698503|FG001|Overall Study|Lost to Follow-up|1|||
162176252|NCT04615273|585698504|FG002|Overall Study|Lost to Follow-up|0|||
162176253|NCT04615273|585698502|FG000|Overall Study|Physician Decision|0|||
162176254|NCT04615273|585698503|FG001|Overall Study|Physician Decision|0|||
162176255|NCT04615273|585698504|FG002|Overall Study|Physician Decision|1|||
162176256|NCT04615273|585698502|FG000|Overall Study|Other|0|||
162176257|NCT04615273|585698503|FG001|Overall Study|Other|1|||
162176258|NCT04615273|585698504|FG002|Overall Study|Other|0|||
162176259|NCT04615273|585698502|FG000|Overall Study|Randomized but not treated|1|||
162176260|NCT04615273|585698503|FG001|Overall Study|Randomized but not treated|3|||
162176261|NCT04615273|585698504|FG002|Overall Study|Randomized but not treated|1|||
162176262|NCT06106022|585698505|FG000|Overall Study|Lost to Follow-up|1|||
162176263|NCT06106022|585698506|FG001|Overall Study|Lost to Follow-up|0|||
162176264|NCT06106022|585698505|FG000|Overall Study|Voluntary Withdrawal|0|||
162176265|NCT06106022|585698506|FG001|Overall Study|Voluntary Withdrawal|2|||
161671394|NCT00523718|583851253|FG001|Overall Study|Protocol Violation|0|||
162176266|NCT05524116|585698518|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
162176267|NCT05524116|585698519|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
162176268|NCT05524116|585698518|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
162176269|NCT05524116|585698519|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
162176270|NCT05524116|585698518|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
162176271|NCT05524116|585698519|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
162176272|NCT05524116|585698518|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
162176273|NCT05524116|585698519|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
162176274|NCT05524116|585698518|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
162176275|NCT05524116|585698519|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
162176276|NCT01820611|585698526|FG000|Overall Study|Death|8|||
162176277|NCT01820611|585698526|FG000|Overall Study|Adverse Event|1|||
162176278|NCT01820611|585698526|FG000|Overall Study|Withdrawal by Subject|9|||
162176279|NCT03484819|585698527|FG000|Overall Study|Death|2|||
162176280|NCT03484819|585698527|FG000|Overall Study|Adverse Event|2|||
162176281|NCT03484819|585698527|FG000|Overall Study|Physician Decision|1|||
162176282|NCT03484819|585698527|FG000|Overall Study|Withdrawal by Subject|2|||
162176283|NCT03484819|585698527|FG000|Overall Study|Disease Progression|4|||
162176284|NCT03484819|585698527|FG000|Overall Study|Complicating Condition|1|||
162176285|NCT03015532|585698528|FG000|Overall Study|Adverse Event|0|||
162176286|NCT03015532|585698529|FG001|Overall Study|Adverse Event|0|||
162176287|NCT03015532|585698530|FG002|Overall Study|Adverse Event|0|||
162176288|NCT03015532|585698531|FG003|Overall Study|Adverse Event|0|||
162176289|NCT03015532|585698532|FG004|Overall Study|Adverse Event|0|||
162176290|NCT03015532|585698533|FG005|Overall Study|Adverse Event|2|||
162176291|NCT03015532|585698534|FG006|Overall Study|Adverse Event|1|||
162176292|NCT03015532|585698535|FG007|Overall Study|Adverse Event|0|||
162176293|NCT03015532|585698528|FG000|Overall Study|Withdrawal by Subject|0|||
162176294|NCT03015532|585698529|FG001|Overall Study|Withdrawal by Subject|0|||
162176295|NCT03015532|585698530|FG002|Overall Study|Withdrawal by Subject|0|||
162176296|NCT03015532|585698531|FG003|Overall Study|Withdrawal by Subject|0|||
162176297|NCT03015532|585698532|FG004|Overall Study|Withdrawal by Subject|0|||
162176298|NCT03015532|585698533|FG005|Overall Study|Withdrawal by Subject|0|||
162176299|NCT03015532|585698534|FG006|Overall Study|Withdrawal by Subject|1|||
162176300|NCT03015532|585698535|FG007|Overall Study|Withdrawal by Subject|0|||
162176301|NCT01447719|585698539|FG000|Overall Study|Image acquisition failure|2|||
162176302|NCT01447719|585698539|FG000|Overall Study|Invalid image or not imaged|3|||
162176303|NCT01447719|585698539|FG000|Overall Study|Subject still living at end of study|79|||
162176304|NCT01447719|585698539|FG000|Overall Study|Withdrawal by Subject|2|||
162176305|NCT01447719|585698539|FG000|Overall Study|Family withdrew autopsy consent|7|||
162176306|NCT03252288|585698540|FG000|Overall Study|Death|1|||
161817043|NCT01604941|584370905|FG000|Overall Study|Early Study Termination|9|||
161922906|NCT00812097|584764896|FG002|Overall Study|Death|3|||
161922907|NCT00812097|584764897|FG003|Overall Study|Death|3|||
161922908|NCT00812097|584764894|FG000|Overall Study|Withdrawal by Subject|14|||
161922909|NCT00812097|584764895|FG001|Overall Study|Withdrawal by Subject|12|||
161922910|NCT00812097|584764896|FG002|Overall Study|Withdrawal by Subject|8|||
161922911|NCT00812097|584764897|FG003|Overall Study|Withdrawal by Subject|2|||
161922912|NCT00812097|584764894|FG000|Overall Study|Lost to Follow-up|90|||
161922913|NCT00812097|584764895|FG001|Overall Study|Lost to Follow-up|14|||
161922914|NCT00812097|584764896|FG002|Overall Study|Lost to Follow-up|17|||
161922915|NCT00812097|584764897|FG003|Overall Study|Lost to Follow-up|5|||
161922916|NCT00812097|584764894|FG000|Overall Study|Explantation of study device(s)|27|||
161922917|NCT00812097|584764895|FG001|Overall Study|Explantation of study device(s)|29|||
161922918|NCT00812097|584764896|FG002|Overall Study|Explantation of study device(s)|14|||
161922919|NCT00812097|584764897|FG003|Overall Study|Explantation of study device(s)|20|||
161922920|NCT00812097|584764894|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
161922921|NCT00812097|584764895|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
161922922|NCT00812097|584764896|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
161922923|NCT00812097|584764897|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
161922924|NCT01786109|584764898|FG000|Overall Study|fail manometry barostat tube placement|1|||
161922925|NCT01786109|584764899|FG001|Overall Study|fail manometry barostat tube placement|0|||
161922926|NCT01786109|584764900|FG002|Overall Study|fail manometry barostat tube placement|0|||
161922927|NCT01786109|584764898|FG000|Overall Study|unrelated illness|0|||
161922928|NCT01786109|584764899|FG001|Overall Study|unrelated illness|0|||
162176307|NCT03252288|585698541|FG001|Overall Study|Death|0|||
162176308|NCT03252288|585698542|FG002|Overall Study|Death|0|||
162176309|NCT03252288|585698540|FG000|Overall Study|Death|11|||
162176310|NCT03252288|585698541|FG001|Overall Study|Death|0|||
162176311|NCT03252288|585698542|FG002|Overall Study|Death|0|||
162176312|NCT03252288|585698540|FG000|Overall Study|Withdrawal by Subject|2|||
162176313|NCT03252288|585698541|FG001|Overall Study|Withdrawal by Subject|0|||
162176314|NCT03252288|585698542|FG002|Overall Study|Withdrawal by Subject|0|||
162176315|NCT03252288|585698540|FG000|Overall Study|Lost to Follow-up|79|||
162176316|NCT03252288|585698541|FG001|Overall Study|Lost to Follow-up|0|||
162176317|NCT03252288|585698542|FG002|Overall Study|Lost to Follow-up|0|||
162176318|NCT03252288|585698540|FG000|Overall Study|Loss of baseline data on tablets|6|||
162176319|NCT03252288|585698541|FG001|Overall Study|Loss of baseline data on tablets|0|||
162176320|NCT03252288|585698542|FG002|Overall Study|Loss of baseline data on tablets|0|||
162176321|NCT02944968|585698543|FG000|Overall Study|Subject excluded before study procedure|1|||
162176322|NCT02944968|585698543|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
162176323|NCT03812614|585698546|FG000|Intervention|Withdrawal by Subject|7|||
162176324|NCT03812614|585698547|FG001|Intervention|Withdrawal by Subject|2|||
162176325|NCT03812614|585698548|FG002|Intervention|Withdrawal by Subject|7|||
162176326|NCT03812614|585698549|FG003|Intervention|Withdrawal by Subject|2|||
162176327|NCT03812614|585698546|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
162176328|NCT03812614|585698547|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
162176329|NCT03812614|585698548|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
162176330|NCT03812614|585698549|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
162176331|NCT03812614|585698546|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
162176332|NCT03812614|585698547|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
162176333|NCT03812614|585698548|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
162176334|NCT03812614|585698549|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
162176335|NCT03812614|585698546|FG000|6-month Follow-up|Lost to Follow-up|0|||
162176336|NCT03812614|585698547|FG001|6-month Follow-up|Lost to Follow-up|0|||
162176337|NCT03812614|585698548|FG002|6-month Follow-up|Lost to Follow-up|12|||
162176338|NCT03812614|585698549|FG003|6-month Follow-up|Lost to Follow-up|8|||
162176339|NCT03812614|585698546|FG000|12-month Follow-up|Lost to Follow-up|18|||
162176340|NCT03812614|585698547|FG001|12-month Follow-up|Lost to Follow-up|17|||
162176341|NCT03812614|585698548|FG002|12-month Follow-up|Lost to Follow-up|5|||
162176342|NCT03812614|585698549|FG003|12-month Follow-up|Lost to Follow-up|2|||
162176343|NCT05451693|585698551|FG000|Overall Study|Withdrawal by Subject|1|||
162176344|NCT05451693|585698552|FG001|Overall Study|Withdrawal by Subject|1|||
162176345|NCT03372057|585698563|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
162176346|NCT03372057|585698564|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
162176347|NCT03372057|585698565|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
162176348|NCT03372057|585698563|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
162176349|NCT03372057|585698564|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
162176350|NCT03372057|585698565|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
162176351|NCT03372057|585698563|FG000|Dose Optimization Phase|Death|16|||
162176352|NCT03372057|585698564|FG001|Dose Optimization Phase|Death|11|||
162176353|NCT03372057|585698565|FG002|Dose Optimization Phase|Death|0|||
162176354|NCT03372057|585698563|FG000|Expansion Phase|Withdrawal by Subject|0|||
162176355|NCT03372057|585698564|FG001|Expansion Phase|Withdrawal by Subject|0|||
162176356|NCT03372057|585698565|FG002|Expansion Phase|Withdrawal by Subject|4|||
162176357|NCT03372057|585698563|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
162176358|NCT03372057|585698564|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
162176359|NCT03372057|585698565|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
162176360|NCT03372057|585698563|FG000|Expansion Phase|Death|0|||
162176361|NCT03372057|585698564|FG001|Expansion Phase|Death|0|||
162176362|NCT03372057|585698565|FG002|Expansion Phase|Death|78|||
162176363|NCT03372057|585698563|FG000|Expansion Phase|Progressive Disease|0|||
162176364|NCT03372057|585698564|FG001|Expansion Phase|Progressive Disease|0|||
162176365|NCT03372057|585698565|FG002|Expansion Phase|Progressive Disease|1|||
162176366|NCT03372057|585698563|FG000|Expansion Phase|Adverse Event|0|||
162176367|NCT03372057|585698564|FG001|Expansion Phase|Adverse Event|0|||
162176368|NCT03372057|585698565|FG002|Expansion Phase|Adverse Event|1|||
162176369|NCT02518048|585698566|FG000|Overall Study|Withdrawal by Subject|1|||
162176370|NCT05890105|585698567|FG000|Overall Study|Adverse Event|1|||
162176371|NCT05890105|585698568|FG001|Overall Study|Adverse Event|0|||
162176372|NCT05890105|585698569|FG002|Overall Study|Adverse Event|0|||
162176373|NCT05890105|585698567|FG000|Overall Study|Other|1|||
162176374|NCT05890105|585698568|FG001|Overall Study|Other|2|||
162176375|NCT05890105|585698569|FG002|Overall Study|Other|0|||
162176376|NCT05123027|585698571|FG000|Overall Study|Lost to Follow-up|17|||
162176377|NCT05123027|585698572|FG001|Overall Study|Lost to Follow-up|22|||
162176378|NCT05123027|585698571|FG000|Overall Study|Incarceration|3|||
162176379|NCT05123027|585698572|FG001|Overall Study|Incarceration|4|||
162176380|NCT05123027|585698571|FG000|Overall Study|Death|2|||
162176381|NCT05123027|585698572|FG001|Overall Study|Death|2|||
162176382|NCT05123027|585698571|FG000|Overall Study|Other|2|||
162176383|NCT05123027|585698572|FG001|Overall Study|Other|0|||
162176384|NCT04330040|585698573|FG000|Overall Study|Other: Adverse event|5|||
162176385|NCT04330040|585698574|FG001|Overall Study|Other: Adverse event|0|||
162176386|NCT04330040|585698575|FG002|Overall Study|Other: Adverse event|0|||
162176387|NCT04330040|585698573|FG000|Overall Study|Disease progression|38|||
162176388|NCT04330040|585698574|FG001|Overall Study|Disease progression|10|||
162176389|NCT04330040|585698575|FG002|Overall Study|Disease progression|0|||
162176390|NCT04330040|585698573|FG000|Overall Study|Physician Decision|5|||
162176391|NCT04330040|585698574|FG001|Overall Study|Physician Decision|3|||
162176392|NCT04330040|585698575|FG002|Overall Study|Physician Decision|0|||
162176393|NCT04330040|585698573|FG000|Overall Study|Lost to Follow-up|1|||
162176394|NCT04330040|585698574|FG001|Overall Study|Lost to Follow-up|1|||
162176395|NCT04330040|585698575|FG002|Overall Study|Lost to Follow-up|0|||
162176396|NCT04330040|585698573|FG000|Overall Study|Death|2|||
162176397|NCT04330040|585698574|FG001|Overall Study|Death|1|||
162176398|NCT04330040|585698575|FG002|Overall Study|Death|0|||
162176399|NCT04330040|585698573|FG000|Overall Study|Withdrawal by Subject|3|||
162176400|NCT04330040|585698574|FG001|Overall Study|Withdrawal by Subject|3|||
162176401|NCT04330040|585698575|FG002|Overall Study|Withdrawal by Subject|0|||
162176402|NCT04330040|585698573|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
162176403|NCT04330040|585698574|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
162176404|NCT04330040|585698575|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
162176405|NCT04330040|585698573|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
162176406|NCT04330040|585698574|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
162176407|NCT04330040|585698575|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
162176408|NCT04330040|585698573|FG000|Overall Study|Other: Disease progression|1|||
162176409|NCT04330040|585698574|FG001|Overall Study|Other: Disease progression|0|||
162176410|NCT04330040|585698575|FG002|Overall Study|Other: Disease progression|0|||
162176411|NCT04330040|585698573|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
162176412|NCT04330040|585698574|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
162176413|NCT04330040|585698575|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
162176414|NCT04330040|585698573|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
162176415|NCT04330040|585698574|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
162176416|NCT04330040|585698575|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
162176417|NCT04330040|585698573|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
162176418|NCT04330040|585698574|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
162176419|NCT04330040|585698575|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
162176420|NCT04761198|585698576|FG000|Overall Study|Progressive Disease|1|||
162176421|NCT04761198|585698577|FG001|Overall Study|Progressive Disease|0|||
162176422|NCT04761198|585698578|FG002|Overall Study|Progressive Disease|0|||
162176423|NCT04761198|585698579|FG003|Overall Study|Progressive Disease|1|||
161671395|NCT01306890|583851254|FG000|Overall Study|Adverse Event|2|||
161671396|NCT01306890|583851254|FG000|Overall Study|Death|1223|||
161671397|NCT01306890|583851254|FG000|Overall Study|Lost to Follow-up|58|||
161671398|NCT01306890|583851254|FG000|Overall Study|Withdrawal by Subject|88|||
162176424|NCT04761198|585698580|FG004|Overall Study|Progressive Disease|4|||
162176425|NCT04761198|585698581|FG005|Overall Study|Progressive Disease|1|||
162176426|NCT04761198|585698582|FG006|Overall Study|Progressive Disease|2|||
162176427|NCT04761198|585698576|FG000|Overall Study|Protocol Violation|0|||
162176428|NCT04761198|585698577|FG001|Overall Study|Protocol Violation|0|||
162176429|NCT04761198|585698578|FG002|Overall Study|Protocol Violation|0|||
162176430|NCT04761198|585698579|FG003|Overall Study|Protocol Violation|0|||
162176431|NCT04761198|585698580|FG004|Overall Study|Protocol Violation|1|||
161671399|NCT01306890|583851254|FG000|Overall Study|Unspecified reasons|104|||
161671400|NCT01306890|583851254|FG000|Overall Study|Study Termination|3|||
161671401|NCT01306890|583851254|FG000|Overall Study|No discontinuation documentation|41|||
161671402|NCT02217436|583851255|FG000|Overall Study|Protocol Violation|1|||
161671403|NCT02217436|583851256|FG001|Overall Study|Protocol Violation|1|||
161671404|NCT02217436|583851255|FG000|Overall Study|Incomplete data|0|||
162176432|NCT04761198|585698581|FG005|Overall Study|Protocol Violation|0|||
162176433|NCT04761198|585698582|FG006|Overall Study|Protocol Violation|0|||
162176434|NCT04761198|585698576|FG000|Overall Study|Death|2|||
162176435|NCT04761198|585698577|FG001|Overall Study|Death|1|||
162176436|NCT04761198|585698578|FG002|Overall Study|Death|2|||
162176437|NCT04761198|585698579|FG003|Overall Study|Death|5|||
162176438|NCT04761198|585698580|FG004|Overall Study|Death|14|||
162176439|NCT04761198|585698581|FG005|Overall Study|Death|2|||
162176440|NCT04761198|585698582|FG006|Overall Study|Death|5|||
162176441|NCT04761198|585698576|FG000|Overall Study|Lost to Follow-up|0|||
162176442|NCT04761198|585698577|FG001|Overall Study|Lost to Follow-up|0|||
162176443|NCT04761198|585698578|FG002|Overall Study|Lost to Follow-up|0|||
162176444|NCT04761198|585698579|FG003|Overall Study|Lost to Follow-up|0|||
162176445|NCT04761198|585698580|FG004|Overall Study|Lost to Follow-up|1|||
162176446|NCT04761198|585698581|FG005|Overall Study|Lost to Follow-up|0|||
162176447|NCT04761198|585698582|FG006|Overall Study|Lost to Follow-up|0|||
162176448|NCT04761198|585698576|FG000|Overall Study|Withdrawal by Subject|2|||
162176449|NCT04761198|585698577|FG001|Overall Study|Withdrawal by Subject|0|||
162176450|NCT04761198|585698578|FG002|Overall Study|Withdrawal by Subject|1|||
162176451|NCT04761198|585698579|FG003|Overall Study|Withdrawal by Subject|0|||
162176452|NCT04761198|585698580|FG004|Overall Study|Withdrawal by Subject|2|||
161817044|NCT01604941|584370906|FG001|Overall Study|Early Study Termination|2|||
161817045|NCT01604941|584370907|FG002|Overall Study|Early Study Termination|3|||
162176453|NCT04761198|585698581|FG005|Overall Study|Withdrawal by Subject|0|||
162176454|NCT04761198|585698582|FG006|Overall Study|Withdrawal by Subject|1|||
162176455|NCT04761198|585698576|FG000|Overall Study|Study Terminated by Sponsor|6|||
162176456|NCT04761198|585698577|FG001|Overall Study|Study Terminated by Sponsor|0|||
162176457|NCT04761198|585698578|FG002|Overall Study|Study Terminated by Sponsor|5|||
162176458|NCT04761198|585698579|FG003|Overall Study|Study Terminated by Sponsor|3|||
162176459|NCT04761198|585698580|FG004|Overall Study|Study Terminated by Sponsor|10|||
162176460|NCT04761198|585698581|FG005|Overall Study|Study Terminated by Sponsor|1|||
162176461|NCT04761198|585698582|FG006|Overall Study|Study Terminated by Sponsor|2|||
162176462|NCT02994927|585698583|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162176463|NCT02994927|585698584|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162176464|NCT02994927|585698583|FG000|Overall Study|Did not meet eligibility criteria|0|||
162176465|NCT02994927|585698584|FG001|Overall Study|Did not meet eligibility criteria|1|||
162176466|NCT02994927|585698583|FG000|Overall Study|Physician Decision|4|||
162176467|NCT02994927|585698584|FG001|Overall Study|Physician Decision|3|||
162176468|NCT02994927|585698583|FG000|Overall Study|Death|4|||
162176469|NCT02994927|585698584|FG001|Overall Study|Death|2|||
162176470|NCT02994927|585698583|FG000|Overall Study|Adverse Event|2|||
162176471|NCT02994927|585698584|FG001|Overall Study|Adverse Event|1|||
162176472|NCT02994927|585698583|FG000|Overall Study|Withdrawal by Subject|3|||
162176473|NCT02994927|585698584|FG001|Overall Study|Withdrawal by Subject|6|||
162176474|NCT02994927|585698583|FG000|Overall Study|Lost to Follow-up|2|||
162176475|NCT02994927|585698584|FG001|Overall Study|Lost to Follow-up|1|||
162176476|NCT03533257|585698592|FG000|Overall Study|Adverse Event|4|||
162176477|NCT03533257|585698593|FG001|Overall Study|Adverse Event|2|||
162176478|NCT03533257|585698592|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
162176479|NCT03533257|585698593|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
162176480|NCT05525104|585698595|FG000|Overall Study|Failed caudal analgesia|1|||
162176481|NCT05525104|585698596|FG001|Overall Study|Failed caudal analgesia|3|||
162176482|NCT05525104|585698595|FG000|Overall Study|Premedication needed|0|||
162176483|NCT05525104|585698596|FG001|Overall Study|Premedication needed|1|||
162176484|NCT05525104|585698595|FG000|Overall Study|Protocol Violation|10|||
162176485|NCT05525104|585698596|FG001|Overall Study|Protocol Violation|0|||
162176486|NCT05525104|585698595|FG000|Overall Study|Cancelled operation|1|||
162176487|NCT05525104|585698596|FG001|Overall Study|Cancelled operation|0|||
162176488|NCT02039401|585698597|FG000|Overall Study|Adverse Event|0|||
162176489|NCT02039401|585698598|FG001|Overall Study|Adverse Event|1|||
162176490|NCT05464069|585699738|FG000|Overall Study|Protocol Violation|3|||
162176491|NCT05464069|585699739|FG001|Overall Study|Protocol Violation|2|||
162176492|NCT04389957|585699744|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
162176493|NCT04389957|585699745|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
162176494|NCT04389957|585699746|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
162176495|NCT04389957|585699747|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
162176496|NCT04389957|585699748|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
162176497|NCT03988621|585699750|FG000|Overall Study|Lost to Follow-up|16|||
162176498|NCT03988621|585699751|FG001|Overall Study|Lost to Follow-up|17|||
162176499|NCT03988621|585699750|FG000|Overall Study|Withdrawal by Subject|14|||
162176500|NCT03988621|585699751|FG001|Overall Study|Withdrawal by Subject|7|||
162176501|NCT03988621|585699750|FG000|Overall Study|Patient Lost to Follow Up|15|||
162176502|NCT03988621|585699751|FG001|Overall Study|Patient Lost to Follow Up|15|||
162176503|NCT03988621|585699750|FG000|Overall Study|Patient death|1|||
162176504|NCT03988621|585699751|FG001|Overall Study|Patient death|5|||
162176505|NCT02905331|585699752|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
162176506|NCT02905331|585699753|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
162176507|NCT02905331|585699754|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
162176508|NCT02905331|585699752|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
162176509|NCT02905331|585699753|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
162176510|NCT02905331|585699754|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
162176511|NCT02905331|585699752|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
161817046|NCT01604941|584370908|FG003|Overall Study|Early Study Termination|3|||
161922929|NCT01786109|584764900|FG002|Overall Study|unrelated illness|1|||
162176512|NCT02905331|585699753|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
162176513|NCT02905331|585699754|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
162176514|NCT02905331|585699752|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
162176515|NCT02905331|585699753|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
162176516|NCT02905331|585699754|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
162176517|NCT02905331|585699752|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
162176518|NCT02905331|585699753|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
162176519|NCT02905331|585699754|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
162176520|NCT02874742|585699756|FG000|Overall Study|Death|0|||
162176521|NCT02874742|585699757|FG001|Overall Study|Death|1|||
162176522|NCT02874742|585699758|FG002|Overall Study|Death|0|||
162176523|NCT02874742|585699756|FG000|Overall Study|Lost to Follow-up|5|||
162176524|NCT02874742|585699757|FG001|Overall Study|Lost to Follow-up|4|||
162176525|NCT02874742|585699758|FG002|Overall Study|Lost to Follow-up|1|||
162176526|NCT02874742|585699756|FG000|Overall Study|Withdrawal by Subject|17|||
162176527|NCT02874742|585699757|FG001|Overall Study|Withdrawal by Subject|8|||
162176528|NCT02874742|585699758|FG002|Overall Study|Withdrawal by Subject|0|||
162176529|NCT02874742|585699756|FG000|Overall Study|Other|4|||
162176530|NCT02874742|585699757|FG001|Overall Study|Other|1|||
162176531|NCT02874742|585699758|FG002|Overall Study|Other|0|||
162018663|NCT01349049|585123166|FG003|Overall Study|Death|0|||
162018664|NCT01349049|585123167|FG004|Overall Study|Death|0|||
162176532|NCT02874742|585699756|FG000|Overall Study|Progressive Disease|1|||
162176533|NCT02874742|585699757|FG001|Overall Study|Progressive Disease|0|||
162176534|NCT02874742|585699758|FG002|Overall Study|Progressive Disease|0|||
162176535|NCT02874742|585699756|FG000|Overall Study|Screen Failure|0|||
162176536|NCT02874742|585699757|FG001|Overall Study|Screen Failure|2|||
162176537|NCT02874742|585699758|FG002|Overall Study|Screen Failure|0|||
162176538|NCT03691298|585699763|FG000|Overall Study|Lost to Follow-up|8|||
162176539|NCT03691298|585699763|FG000|Overall Study|Sponsor terminated study|2|||
162176540|NCT04424316|585699766|FG000|Overall Study|Adverse Event|0|||
162176541|NCT04424316|585699767|FG001|Overall Study|Adverse Event|1|||
162176542|NCT04424316|585699768|FG002|Overall Study|Adverse Event|0|||
162176543|NCT04424316|585699769|FG003|Overall Study|Adverse Event|0|||
162176544|NCT04424316|585699766|FG000|Overall Study|Death|1|||
162176545|NCT04424316|585699767|FG001|Overall Study|Death|0|||
162176546|NCT04424316|585699768|FG002|Overall Study|Death|8|||
162176547|NCT04424316|585699769|FG003|Overall Study|Death|14|||
162176548|NCT04424316|585699766|FG000|Overall Study|Lost to Follow-up|93|||
162176549|NCT04424316|585699767|FG001|Overall Study|Lost to Follow-up|88|||
162176550|NCT04424316|585699768|FG002|Overall Study|Lost to Follow-up|224|||
162176551|NCT04424316|585699769|FG003|Overall Study|Lost to Follow-up|211|||
162176552|NCT04424316|585699766|FG000|Overall Study|No longer met eligibility criteria|1|||
162176553|NCT04424316|585699767|FG001|Overall Study|No longer met eligibility criteria|0|||
162176554|NCT04424316|585699768|FG002|Overall Study|No longer met eligibility criteria|0|||
162176555|NCT04424316|585699769|FG003|Overall Study|No longer met eligibility criteria|0|||
162176556|NCT04424316|585699766|FG000|Overall Study|Other|15|||
161817047|NCT01604941|584370909|FG004|Overall Study|Early Study Termination|0|||
162176557|NCT04424316|585699767|FG001|Overall Study|Other|11|||
162176558|NCT04424316|585699768|FG002|Overall Study|Other|34|||
162176559|NCT04424316|585699769|FG003|Overall Study|Other|45|||
162176560|NCT04424316|585699766|FG000|Overall Study|Physician Decision|1|||
162176561|NCT04424316|585699767|FG001|Overall Study|Physician Decision|0|||
162176562|NCT04424316|585699768|FG002|Overall Study|Physician Decision|1|||
162176563|NCT04424316|585699769|FG003|Overall Study|Physician Decision|1|||
162176564|NCT04424316|585699766|FG000|Overall Study|Protocol Violation|0|||
162176565|NCT04424316|585699767|FG001|Overall Study|Protocol Violation|1|||
162176566|NCT04424316|585699768|FG002|Overall Study|Protocol Violation|0|||
162176567|NCT04424316|585699769|FG003|Overall Study|Protocol Violation|0|||
162176568|NCT04424316|585699766|FG000|Overall Study|Withdrawal by Subject|71|||
162176569|NCT04424316|585699767|FG001|Overall Study|Withdrawal by Subject|77|||
162176570|NCT04424316|585699768|FG002|Overall Study|Withdrawal by Subject|0|||
162176571|NCT04424316|585699769|FG003|Overall Study|Withdrawal by Subject|0|||
162176572|NCT04424316|585699766|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162176573|NCT04424316|585699767|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162176574|NCT04424316|585699768|FG002|Overall Study|Withdrawal by parent/guardian|74|||
162176575|NCT04424316|585699769|FG003|Overall Study|Withdrawal by parent/guardian|81|||
162176576|NCT04424316|585699766|FG000|Overall Study|Randomized but not vaccinated|13|||
162176577|NCT04424316|585699767|FG001|Overall Study|Randomized but not vaccinated|21|||
161817048|NCT01604941|584370910|FG005|Overall Study|Early Study Termination|0|||
161671405|NCT02217436|583851256|FG001|Overall Study|Incomplete data|1|||
161671406|NCT00234494|583851261|FG000|Overall Study|Protocol Violation|2|||
162018665|NCT01349049|585123168|FG005|Overall Study|Death|0|||
162176578|NCT04424316|585699768|FG002|Overall Study|Randomized but not vaccinated|0|||
162176579|NCT04424316|585699769|FG003|Overall Study|Randomized but not vaccinated|0|||
162176580|NCT04424316|585699766|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
162176581|NCT04424316|585699767|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
162176582|NCT04424316|585699768|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
162176583|NCT04424316|585699769|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
162176584|NCT05070741|585699770|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
162176585|NCT03245840|585699771|FG000|Overall Study|Adverse Event|6|||
162176586|NCT03245840|585699772|FG001|Overall Study|Adverse Event|0|||
162176587|NCT03245840|585699771|FG000|Overall Study|Death|2|||
162176588|NCT03245840|585699772|FG001|Overall Study|Death|0|||
162176589|NCT03245840|585699771|FG000|Overall Study|Withdrawal by Subject|31|||
162176590|NCT03245840|585699772|FG001|Overall Study|Withdrawal by Subject|1|||
162176591|NCT03245840|585699771|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
162176592|NCT03245840|585699772|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162176593|NCT03245840|585699771|FG000|Overall Study|Physician Decision|4|||
162176594|NCT03245840|585699772|FG001|Overall Study|Physician Decision|1|||
162176595|NCT03245840|585699771|FG000|Overall Study|Study Terminated by Sponsor|56|||
162176596|NCT03245840|585699772|FG001|Overall Study|Study Terminated by Sponsor|6|||
162176597|NCT03245840|585699771|FG000|Overall Study|Site Terminated by Sponsor|4|||
162176598|NCT03245840|585699772|FG001|Overall Study|Site Terminated by Sponsor|0|||
162176599|NCT03245840|585699771|FG000|Overall Study|Lost to Follow-up|12|||
162176600|NCT03245840|585699772|FG001|Overall Study|Lost to Follow-up|2|||
162176601|NCT03245840|585699771|FG000|Overall Study|Pregnancy|2|||
162176602|NCT03245840|585699772|FG001|Overall Study|Pregnancy|0|||
162176603|NCT03245840|585699771|FG000|Overall Study|Non-Compliance with Study Drug|2|||
162176604|NCT03245840|585699772|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162176605|NCT03245840|585699771|FG000|Overall Study|Not treated|1|||
162176606|NCT03245840|585699772|FG001|Overall Study|Not treated|1|||
162176607|NCT05652010|585699779|FG000|First Intervention|Withdrawal by Subject|0|||
162176608|NCT05652010|585699780|FG001|First Intervention|Withdrawal by Subject|1|||
162176609|NCT05652010|585699779|FG000|Second Intervention|Withdrawal by Subject|1|||
162176610|NCT05652010|585699780|FG001|Second Intervention|Withdrawal by Subject|0|||
162176611|NCT03744676|585699785|FG000|Pre-Treatment Phase|Disease related complications|2|||
162176612|NCT03744676|585699785|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
162176613|NCT03744676|585699785|FG000|Pre-Treatment Phase|Death|7|||
162176614|NCT03744676|585699785|FG000|Pre-Treatment Phase|Other Reasons|7|||
162176615|NCT03744676|585699785|FG000|Treatment Phase|Participant withdrew consent|8|||
162176616|NCT03744676|585699785|FG000|Treatment Phase|Death|33|||
162176617|NCT03744676|585699785|FG000|Treatment Phase|other reasons|6|||
162176618|NCT04206787|585699787|FG000|Overall Study|Other than listed|2|||
162176619|NCT04206787|585699787|FG000|Overall Study|Investigator decision|1|||
162176620|NCT04206787|585699787|FG000|Overall Study|Death|25|||
162176621|NCT04206787|585699787|FG000|Overall Study|Lost to Follow-up|9|||
162176622|NCT04206787|585699787|FG000|Overall Study|Withdrawal of consent|9|||
162176623|NCT05008055|585699788|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
162176624|NCT05008055|585699789|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
162176625|NCT05008055|585699790|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
162176626|NCT03011034|585699798|FG000|Overall Study|Adverse Event|1|||
162176627|NCT03011034|585699799|FG001|Overall Study|Adverse Event|0|||
162176628|NCT03735979|585699808|FG000|Overall Study|Lost to Follow-up|1|||
162176629|NCT03735979|585699809|FG001|Overall Study|Lost to Follow-up|12|||
162176630|NCT03735979|585699810|FG002|Overall Study|Lost to Follow-up|14|||
162176631|NCT03735979|585699808|FG000|Overall Study|Withdrawal by Subject|1|||
162176632|NCT03735979|585699809|FG001|Overall Study|Withdrawal by Subject|5|||
161671407|NCT02634346|583851265|FG000|Overall Study|Withdrawal by Subject|8|||
161671408|NCT02634346|583851266|FG001|Overall Study|Withdrawal by Subject|9|||
161817049|NCT02213263|584370915|FG000|Overall Study|Insufficient clinical response|4|||
161817050|NCT02213263|584370916|FG001|Overall Study|Insufficient clinical response|3|||
162176633|NCT03735979|585699810|FG002|Overall Study|Withdrawal by Subject|2|||
162176634|NCT03735979|585699808|FG000|Overall Study|Not due to the above reasons|1|||
162176635|NCT03735979|585699809|FG001|Overall Study|Not due to the above reasons|0|||
162176636|NCT03735979|585699810|FG002|Overall Study|Not due to the above reasons|0|||
162176637|NCT00319111|585699813|FG000|Overall Study|Adverse Event|20|||
162176638|NCT00319111|585699813|FG000|Overall Study|Withdrawal of consent|11|||
162176639|NCT00319111|585699813|FG000|Overall Study|Death|9|||
161817051|NCT02213263|584370915|FG000|Overall Study|Lost to Follow-up|0|||
161671409|NCT02634346|583851267|FG002|Overall Study|Withdrawal by Subject|8|||
161671410|NCT02634346|583851265|FG000|Overall Study|Adverse Event|2|||
161671411|NCT02634346|583851266|FG001|Overall Study|Adverse Event|2|||
161671412|NCT02634346|583851267|FG002|Overall Study|Adverse Event|7|||
161671413|NCT02634346|583851265|FG000|Overall Study|Lack of Efficacy|1|||
161671414|NCT02634346|583851266|FG001|Overall Study|Lack of Efficacy|2|||
161671415|NCT02634346|583851267|FG002|Overall Study|Lack of Efficacy|8|||
161671416|NCT02634346|583851265|FG000|Overall Study|Lost to Follow-up|1|||
161671417|NCT02634346|583851266|FG001|Overall Study|Lost to Follow-up|0|||
161671418|NCT02634346|583851267|FG002|Overall Study|Lost to Follow-up|0|||
161671419|NCT02634346|583851265|FG000|Overall Study|Protocol Violation|0|||
161671420|NCT02634346|583851266|FG001|Overall Study|Protocol Violation|1|||
161671421|NCT02634346|583851267|FG002|Overall Study|Protocol Violation|0|||
161671422|NCT02170389|583851268|FG000|Overall Study|Study terminated prior to start of treat|1|||
161671423|NCT00908232|583851274|FG000|Cycle 1 to 4|Death|5|||
161671424|NCT00908232|583851275|FG001|Cycle 1 to 4|Death|0|||
161671425|NCT00908232|583851276|FG002|Cycle 1 to 4|Death|0|||
161671426|NCT00908232|583851277|FG003|Cycle 1 to 4|Death|0|||
161671427|NCT00908232|583851274|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
161671428|NCT00908232|583851275|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
161671429|NCT00908232|583851276|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
161671430|NCT00908232|583851277|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
161671431|NCT00908232|583851274|FG000|Cycle 1 to 4|Progressive Disease|6|||
161671432|NCT00908232|583851275|FG001|Cycle 1 to 4|Progressive Disease|0|||
161671433|NCT00908232|583851276|FG002|Cycle 1 to 4|Progressive Disease|0|||
161671434|NCT00908232|583851277|FG003|Cycle 1 to 4|Progressive Disease|0|||
161671435|NCT00908232|583851274|FG000|Cycle 1 to 4|Adverse Event|12|||
161671436|NCT00908232|583851275|FG001|Cycle 1 to 4|Adverse Event|0|||
161671437|NCT00908232|583851276|FG002|Cycle 1 to 4|Adverse Event|0|||
161671438|NCT00908232|583851277|FG003|Cycle 1 to 4|Adverse Event|0|||
161671439|NCT00908232|583851274|FG000|Cycle 1 to 4|Other|1|||
161671440|NCT00908232|583851275|FG001|Cycle 1 to 4|Other|0|||
161671441|NCT00908232|583851276|FG002|Cycle 1 to 4|Other|0|||
161671442|NCT00908232|583851277|FG003|Cycle 1 to 4|Other|0|||
161671443|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
161671444|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
161671445|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
161671446|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
161671447|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
161671448|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
161671449|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
161671450|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
161671451|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
161671452|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
161671453|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
161671454|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
161671455|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
161671456|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
161671457|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
161671458|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
161671459|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
161671460|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
161671461|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
161671462|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
161671463|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
161671464|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
161671465|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
161671466|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
161671467|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
161671468|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
161671469|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
161671470|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
161671471|NCT00908232|583851274|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
161817052|NCT02213263|584370916|FG001|Overall Study|Lost to Follow-up|1|||
161817053|NCT02213263|584370915|FG000|Overall Study|No longer willing to participate|3|||
161817054|NCT02213263|584370916|FG001|Overall Study|No longer willing to participate|4|||
161671472|NCT00908232|583851275|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
161671473|NCT00908232|583851276|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
161671474|NCT00908232|583851277|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
161671475|NCT00769860|583851286|FG000|Overall Study|Withdrawal by Subject|2|||
161671476|NCT00769860|583851287|FG001|Overall Study|Withdrawal by Subject|0|||
161671477|NCT00448435|583851290|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
161817055|NCT02213263|584370915|FG000|Overall Study|Progressive disease|20|||
161817056|NCT02213263|584370916|FG001|Overall Study|Progressive disease|14|||
162176640|NCT00319111|585699813|FG000|Overall Study|Lack of clinical improvement|4|||
162176641|NCT00319111|585699813|FG000|Overall Study|Administrative|2|||
162176642|NCT00319111|585699813|FG000|Overall Study|Treatment failure|1|||
162176643|NCT01475786|585699814|FG000|Overall Study|Adverse Event|0|||
162176644|NCT01475786|585699815|FG001|Overall Study|Adverse Event|1|||
162176645|NCT01475786|585699816|FG002|Overall Study|Adverse Event|0|||
162176646|NCT01475786|585699814|FG000|Overall Study|Lost to Follow-up|1|||
162176647|NCT01475786|585699815|FG001|Overall Study|Lost to Follow-up|2|||
162176648|NCT01475786|585699816|FG002|Overall Study|Lost to Follow-up|1|||
162176649|NCT01475786|585699814|FG000|Overall Study|Withdrawal by Subject|0|||
162176650|NCT01475786|585699815|FG001|Overall Study|Withdrawal by Subject|1|||
162176651|NCT01475786|585699816|FG002|Overall Study|Withdrawal by Subject|1|||
162176652|NCT01475786|585699814|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
162176653|NCT01475786|585699815|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
162176654|NCT01475786|585699816|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
162176655|NCT03165955|585699818|FG000|Treatment|Withdrawal by Subject|3|||
162176656|NCT03165955|585699818|FG000|Treatment|Death|1|||
162176657|NCT03165955|585699818|FG000|Treatment|Adverse Event|1|||
162176658|NCT03165955|585699818|FG000|Treatment|Progressive disease|3|||
162176659|NCT02865538|585699823|FG000|Overall Study|Withdrawal by Subject|0|||
162176660|NCT02865538|585699824|FG001|Overall Study|Withdrawal by Subject|0|||
162176661|NCT02865538|585699825|FG002|Overall Study|Withdrawal by Subject|1|||
162176662|NCT02865538|585699826|FG003|Overall Study|Withdrawal by Subject|0|||
162176663|NCT02865538|585699827|FG004|Overall Study|Withdrawal by Subject|0|||
162176664|NCT02865538|585699823|FG000|Overall Study|Lost to Follow-up|1|||
162176665|NCT02865538|585699824|FG001|Overall Study|Lost to Follow-up|0|||
162176666|NCT02865538|585699825|FG002|Overall Study|Lost to Follow-up|0|||
162176667|NCT02865538|585699826|FG003|Overall Study|Lost to Follow-up|0|||
162176668|NCT02865538|585699827|FG004|Overall Study|Lost to Follow-up|0|||
162176669|NCT03417284|585701543|FG000|Overall Study|Inadequate supply on study drug|1|||
162176670|NCT03417284|585701544|FG001|Overall Study|Inadequate supply on study drug|0|||
162176671|NCT03417284|585701545|FG002|Overall Study|Inadequate supply on study drug|0|||
162176672|NCT03417284|585701546|FG003|Overall Study|Inadequate supply on study drug|0|||
162176673|NCT03417284|585701543|FG000|Overall Study|Disease Progression|0|||
162176674|NCT03417284|585701544|FG001|Overall Study|Disease Progression|0|||
162176675|NCT03417284|585701545|FG002|Overall Study|Disease Progression|1|||
162176676|NCT03417284|585701546|FG003|Overall Study|Disease Progression|0|||
162176677|NCT04089865|585701553|FG000|Overall Study|Withdrawal by Subject|2|||
162176678|NCT04089865|585701554|FG001|Overall Study|Withdrawal by Subject|2|||
162176679|NCT04089865|585701555|FG002|Overall Study|Withdrawal by Subject|7|||
162176680|NCT04089865|585701556|FG003|Overall Study|Withdrawal by Subject|2|||
162176681|NCT04282980|585701559|FG000|Overall Study|Remained on treatment|6|||
162176682|NCT04282980|585701559|FG000|Overall Study|Survival follow-up|11|||
162176683|NCT04282980|585701559|FG000|Overall Study|Withdrawal of informed consent|1|||
162176684|NCT04282980|585701559|FG000|Overall Study|Lost to Follow-up|1|||
162176685|NCT01917084|585701561|FG000|Overall Study|Withdrawal by Subject|1|||
162176686|NCT03571386|585701562|FG000|Overall Study|scheduling conflict|4|||
162176687|NCT03571386|585701563|FG001|Overall Study|scheduling conflict|0|||
162176688|NCT03571386|585701562|FG000|Overall Study|Withdrawal by Subject|15|||
162176689|NCT03571386|585701563|FG001|Overall Study|Withdrawal by Subject|5|||
162176690|NCT06037668|585701570|FG000|Overall Study|Lost to Follow-up|1|||
162176691|NCT06037668|585701571|FG001|Overall Study|Lost to Follow-up|1|||
162176692|NCT06037668|585701570|FG000|Overall Study|Protocol Violation|1|||
162176693|NCT06037668|585701571|FG001|Overall Study|Protocol Violation|0|||
162176694|NCT06037668|585701570|FG000|Overall Study|Withdrawal by Subject|1|||
162176695|NCT06037668|585701571|FG001|Overall Study|Withdrawal by Subject|0|||
162176696|NCT06037668|585701570|FG000|Overall Study|Other Study Discontinuation Reason|1|||
162176697|NCT06037668|585701571|FG001|Overall Study|Other Study Discontinuation Reason|0|||
162176698|NCT02473445|585701572|FG000|Overall Study|Withdrawal by Subject|2|||
162176699|NCT02473445|585701572|FG000|Overall Study|Sponsor Decision|20|||
162176700|NCT04881461|585701573|FG000|Overall Study|Adverse Event|2|||
162176701|NCT04881461|585701574|FG001|Overall Study|Adverse Event|4|||
162176702|NCT04881461|585701573|FG000|Overall Study|Withdrawal by Subject|19|||
162176703|NCT04881461|585701574|FG001|Overall Study|Withdrawal by Subject|19|||
162176704|NCT04881461|585701573|FG000|Overall Study|Lost to Follow-up|4|||
162176705|NCT04881461|585701574|FG001|Overall Study|Lost to Follow-up|4|||
162176706|NCT04881461|585701573|FG000|Overall Study|Lack of Efficacy|1|||
162176707|NCT04881461|585701574|FG001|Overall Study|Lack of Efficacy|0|||
162176708|NCT04881461|585701573|FG000|Overall Study|"Reason stated as other in CRF"|1|||
162176709|NCT04881461|585701574|FG001|Overall Study|"Reason stated as other in CRF"|2|||
162176710|NCT04247802|585701575|FG000|Overall Study|Withdrawal by Subject|1|||
162176711|NCT04247802|585701576|FG001|Overall Study|Withdrawal by Subject|3|||
162176712|NCT04247802|585701575|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
162176713|NCT04247802|585701576|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
162176714|NCT04629339|585701582|FG000|Overall Study|Death|1|||
162176715|NCT04629339|585701583|FG001|Overall Study|Death|0|||
162176716|NCT04629339|585701584|FG002|Overall Study|Death|2|||
162176717|NCT04629339|585701585|FG003|Overall Study|Death|2|||
162176718|NCT04629339|585701586|FG004|Overall Study|Death|0|||
162176719|NCT04629339|585701582|FG000|Overall Study|Disease Progression|0|||
162176720|NCT04629339|585701583|FG001|Overall Study|Disease Progression|0|||
162176721|NCT04629339|585701584|FG002|Overall Study|Disease Progression|1|||
162176722|NCT04629339|585701585|FG003|Overall Study|Disease Progression|1|||
162176723|NCT04629339|585701586|FG004|Overall Study|Disease Progression|0|||
162176724|NCT04629339|585701582|FG000|Overall Study|Lost to Follow-up|0|||
162176725|NCT04629339|585701583|FG001|Overall Study|Lost to Follow-up|0|||
162176726|NCT04629339|585701584|FG002|Overall Study|Lost to Follow-up|0|||
162176727|NCT04629339|585701585|FG003|Overall Study|Lost to Follow-up|1|||
162176728|NCT04629339|585701586|FG004|Overall Study|Lost to Follow-up|0|||
162176729|NCT04629339|585701582|FG000|Overall Study|Physician Decision|0|||
162176730|NCT04629339|585701583|FG001|Overall Study|Physician Decision|1|||
162176731|NCT04629339|585701584|FG002|Overall Study|Physician Decision|0|||
162176732|NCT04629339|585701585|FG003|Overall Study|Physician Decision|0|||
162176733|NCT04629339|585701586|FG004|Overall Study|Physician Decision|0|||
162176734|NCT04629339|585701582|FG000|Overall Study|Study Terminated by Sponsor|0|||
162176735|NCT04629339|585701583|FG001|Overall Study|Study Terminated by Sponsor|0|||
162176736|NCT04629339|585701584|FG002|Overall Study|Study Terminated by Sponsor|0|||
162176737|NCT04629339|585701585|FG003|Overall Study|Study Terminated by Sponsor|1|||
162176738|NCT04629339|585701586|FG004|Overall Study|Study Terminated by Sponsor|0|||
162176739|NCT04629339|585701582|FG000|Overall Study|Withdrawal by Subject|0|||
162176740|NCT04629339|585701583|FG001|Overall Study|Withdrawal by Subject|0|||
162176741|NCT04629339|585701584|FG002|Overall Study|Withdrawal by Subject|2|||
162176742|NCT04629339|585701585|FG003|Overall Study|Withdrawal by Subject|2|||
162176743|NCT04629339|585701586|FG004|Overall Study|Withdrawal by Subject|0|||
162176744|NCT04158739|585701593|FG000|Overall Study|Adverse Event|1|||
162176745|NCT04158739|585701594|FG001|Overall Study|Adverse Event|0|||
162176746|NCT04158739|585701593|FG000|Overall Study|Death|0|||
162176747|NCT04158739|585701594|FG001|Overall Study|Death|1|||
162176748|NCT04158739|585701593|FG000|Overall Study|Lack of Efficacy|3|||
162176749|NCT04158739|585701594|FG001|Overall Study|Lack of Efficacy|7|||
162176750|NCT04158739|585701593|FG000|Overall Study|Physician Decision|0|||
162176751|NCT04158739|585701594|FG001|Overall Study|Physician Decision|1|||
162176752|NCT04158739|585701593|FG000|Overall Study|Withdrawal by Subject|3|||
162176753|NCT04158739|585701594|FG001|Overall Study|Withdrawal by Subject|0|||
162176754|NCT04778410|585701595|FG000|Safety Run-in Period|Death|5|||
162176755|NCT04778410|585701596|FG001|Safety Run-in Period|Death|6|||
162176756|NCT04778410|585701597|FG002|Safety Run-in Period|Death|0|||
162176757|NCT04778410|585701598|FG003|Safety Run-in Period|Death|0|||
162176758|NCT04778410|585701599|FG004|Safety Run-in Period|Death|0|||
162176759|NCT04778410|585701600|FG005|Safety Run-in Period|Death|0|||
162176760|NCT04778410|585701595|FG000|Phase 2 Period|Death|0|||
162176761|NCT04778410|585701596|FG001|Phase 2 Period|Death|0|||
162176762|NCT04778410|585701597|FG002|Phase 2 Period|Death|0|||
162176763|NCT04778410|585701598|FG003|Phase 2 Period|Death|5|||
162176764|NCT04778410|585701599|FG004|Phase 2 Period|Death|18|||
162176765|NCT04778410|585701600|FG005|Phase 2 Period|Death|0|||
162176766|NCT04778410|585701595|FG000|Phase 2 Period|Lost to Follow-up|0|||
162176767|NCT04778410|585701596|FG001|Phase 2 Period|Lost to Follow-up|0|||
162176768|NCT04778410|585701597|FG002|Phase 2 Period|Lost to Follow-up|0|||
162176769|NCT04778410|585701598|FG003|Phase 2 Period|Lost to Follow-up|1|||
162176770|NCT04778410|585701599|FG004|Phase 2 Period|Lost to Follow-up|1|||
162176771|NCT04778410|585701600|FG005|Phase 2 Period|Lost to Follow-up|0|||
162176772|NCT04778410|585701595|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
162176773|NCT04778410|585701596|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
162176774|NCT04778410|585701597|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
162176775|NCT04778410|585701598|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
162176776|NCT04778410|585701599|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
162176777|NCT04778410|585701600|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
162176778|NCT04778410|585701595|FG000|Phase 2 Period|Withdrew Consent|0|||
162176779|NCT04778410|585701596|FG001|Phase 2 Period|Withdrew Consent|0|||
162176780|NCT04778410|585701597|FG002|Phase 2 Period|Withdrew Consent|0|||
162176781|NCT04778410|585701598|FG003|Phase 2 Period|Withdrew Consent|0|||
162176782|NCT04778410|585701599|FG004|Phase 2 Period|Withdrew Consent|2|||
162176783|NCT04778410|585701600|FG005|Phase 2 Period|Withdrew Consent|0|||
162176784|NCT00942877|585701612|FG000|Overall Study|Refused further treatment|1|||
162176785|NCT00942877|585701613|FG001|Overall Study|Refused further treatment|1|||
162176786|NCT00942877|585701612|FG000|Overall Study|Patient was not treated|1|||
162176787|NCT00942877|585701613|FG001|Overall Study|Patient was not treated|0|||
162176788|NCT00942877|585701612|FG000|Overall Study|Adverse Event|1|||
162176789|NCT00942877|585701613|FG001|Overall Study|Adverse Event|0|||
162176790|NCT00942877|585701612|FG000|Overall Study|Progressive disease|42|||
162176791|NCT00942877|585701613|FG001|Overall Study|Progressive disease|3|||
162176792|NCT01385202|585701614|FG000|Overall Study|Lost to Follow-up|6|||
162176793|NCT01385202|585701614|FG000|Overall Study|Not Eligible|11|||
162176794|NCT01385202|585701614|FG000|Overall Study|Withdrawn|1|||
162176795|NCT02095691|585701615|FG000|Overall Study|Physician Decision|1|||
162176796|NCT05007080|585701617|FG000|Overall Study|Lost to Follow-up|0|||
162176797|NCT05007080|585701618|FG001|Overall Study|Lost to Follow-up|1|||
162176798|NCT05007080|585701619|FG002|Overall Study|Lost to Follow-up|0|||
162176799|NCT05007080|585701620|FG003|Overall Study|Lost to Follow-up|1|||
162176800|NCT05007080|585701621|FG004|Overall Study|Lost to Follow-up|1|||
162176801|NCT05007080|585701622|FG005|Overall Study|Lost to Follow-up|1|||
162176802|NCT05007080|585701617|FG000|Overall Study|Death|0|||
162176803|NCT05007080|585701618|FG001|Overall Study|Death|1|||
162176804|NCT05007080|585701619|FG002|Overall Study|Death|0|||
162176805|NCT05007080|585701620|FG003|Overall Study|Death|0|||
162176806|NCT05007080|585701621|FG004|Overall Study|Death|0|||
162176807|NCT05007080|585701622|FG005|Overall Study|Death|0|||
162176808|NCT05007080|585701617|FG000|Overall Study|Withdrawal by Subject|1|||
162176809|NCT05007080|585701618|FG001|Overall Study|Withdrawal by Subject|2|||
162176810|NCT05007080|585701619|FG002|Overall Study|Withdrawal by Subject|0|||
162176811|NCT05007080|585701620|FG003|Overall Study|Withdrawal by Subject|2|||
162176812|NCT05007080|585701621|FG004|Overall Study|Withdrawal by Subject|1|||
162176813|NCT05007080|585701622|FG005|Overall Study|Withdrawal by Subject|1|||
162176814|NCT05007080|585701617|FG000|Overall Study|Other|1|||
162176815|NCT05007080|585701618|FG001|Overall Study|Other|0|||
162176816|NCT05007080|585701619|FG002|Overall Study|Other|1|||
162176817|NCT05007080|585701620|FG003|Overall Study|Other|1|||
162176818|NCT05007080|585701621|FG004|Overall Study|Other|0|||
162176819|NCT05007080|585701622|FG005|Overall Study|Other|2|||
162176820|NCT05007080|585701617|FG000|Overall Study|Randomized not vaccinated|0|||
162176821|NCT05007080|585701618|FG001|Overall Study|Randomized not vaccinated|0|||
162176822|NCT05007080|585701619|FG002|Overall Study|Randomized not vaccinated|0|||
162176823|NCT05007080|585701620|FG003|Overall Study|Randomized not vaccinated|0|||
162176824|NCT05007080|585701621|FG004|Overall Study|Randomized not vaccinated|0|||
161671478|NCT00448435|583851291|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
162176825|NCT05007080|585701622|FG005|Overall Study|Randomized not vaccinated|1|||
162176826|NCT04583280|585701626|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
162176827|NCT04583280|585701627|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
161671479|NCT02804178|583851296|FG000|Overall Study|Adverse Event|1|||
161671480|NCT00412971|583851297|FG000|Overall Study|Lost to Follow-up|17|||
162176828|NCT00964392|585701628|FG000|Overall Study|Withdrawal by Subject|4|||
161671481|NCT00412971|583851298|FG001|Overall Study|Lost to Follow-up|9|||
162176829|NCT00964392|585701629|FG001|Overall Study|Withdrawal by Subject|6|||
162176830|NCT00964392|585701628|FG000|Overall Study|Lost to Follow-up|4|||
162176831|NCT00964392|585701629|FG001|Overall Study|Lost to Follow-up|10|||
162176832|NCT00964392|585701628|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
162176833|NCT00964392|585701629|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
162176834|NCT00964392|585701628|FG000|Overall Study|Not completed|44|||
161671482|NCT00412971|583851297|FG000|Overall Study|Protocol Violation|13|||
161671483|NCT00412971|583851298|FG001|Overall Study|Protocol Violation|1|||
161671484|NCT01106404|583851299|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
162176835|NCT00964392|585701629|FG001|Overall Study|Not completed|168|||
161671485|NCT01106404|583851300|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
162176836|NCT00631475|585701630|FG000|Overall Study|Death|18|||
162176837|NCT00631475|585701630|FG000|Overall Study|Adverse Event|14|||
162176838|NCT00631475|585701630|FG000|Overall Study|Withdrew consent|5|||
162176839|NCT00631475|585701630|FG000|Overall Study|Preparation for lung transplant|8|||
162176840|NCT02577354|585701636|FG000|Overall Study|Lack of Efficacy|4|||
162176841|NCT02577354|585701637|FG001|Overall Study|Lack of Efficacy|4|||
162176842|NCT02577354|585701636|FG000|Overall Study|Lost to Follow-up|3|||
162176843|NCT02577354|585701637|FG001|Overall Study|Lost to Follow-up|1|||
162176844|NCT02577354|585701636|FG000|Overall Study|Missed Visit|4|||
162176845|NCT02577354|585701637|FG001|Overall Study|Missed Visit|3|||
162176846|NCT02577354|585701636|FG000|Overall Study|Adverse Event|4|||
162176847|NCT02577354|585701637|FG001|Overall Study|Adverse Event|5|||
162176848|NCT04173247|585701638|FG000|Overall Study|Withdrawal by Subject|0|||
162176849|NCT04173247|585701639|FG001|Overall Study|Withdrawal by Subject|2|||
162176850|NCT04173247|585701638|FG000|Overall Study|Death|1|||
162176851|NCT04173247|585701639|FG001|Overall Study|Death|0|||
162176852|NCT04173247|585701638|FG000|Overall Study|Physician Decision|1|||
162176853|NCT04173247|585701639|FG001|Overall Study|Physician Decision|0|||
162176854|NCT04214834|585701647|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
162176855|NCT04214834|585701648|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
162176856|NCT04109066|585701657|FG000|Pre-treatment|Participant withdrew consent|2|||
162176857|NCT04109066|585701658|FG001|Pre-treatment|Participant withdrew consent|0|||
162176858|NCT04109066|585701657|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
162176859|NCT04109066|585701658|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
162176860|NCT04109066|585701657|FG000|Treatment|Lack of Efficacy|2|||
162176861|NCT04109066|585701658|FG001|Treatment|Lack of Efficacy|4|||
162176862|NCT04109066|585701657|FG000|Treatment|Adverse Event|23|||
162176863|NCT04109066|585701658|FG001|Treatment|Adverse Event|7|||
162176864|NCT04109066|585701657|FG000|Treatment|Participant request to discontinue Study treatment|15|||
162176865|NCT04109066|585701658|FG001|Treatment|Participant request to discontinue Study treatment|14|||
162176866|NCT04109066|585701657|FG000|Treatment|Withdrawal by Subject|8|||
162176867|NCT04109066|585701658|FG001|Treatment|Withdrawal by Subject|8|||
162176868|NCT04109066|585701657|FG000|Treatment|Death|3|||
162176869|NCT04109066|585701658|FG001|Treatment|Death|0|||
162176870|NCT04109066|585701657|FG000|Treatment|Participant no longer meets study criteria|2|||
162176871|NCT04109066|585701658|FG001|Treatment|Participant no longer meets study criteria|2|||
162176872|NCT04109066|585701657|FG000|Treatment|Administrative reasons by sponsor|2|||
162176873|NCT04109066|585701658|FG001|Treatment|Administrative reasons by sponsor|3|||
162176874|NCT04109066|585701657|FG000|Treatment|Other reasons|17|||
162176875|NCT04109066|585701658|FG001|Treatment|Other reasons|23|||
162176876|NCT04109066|585701657|FG000|Treatment|Disease Progression|4|||
162176877|NCT04109066|585701658|FG001|Treatment|Disease Progression|7|||
162176878|NCT04109066|585701657|FG000|Treatment|Study drug toxicity|12|||
162176879|NCT04109066|585701658|FG001|Treatment|Study drug toxicity|5|||
162176880|NCT04109066|585701657|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
162176881|NCT04109066|585701658|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
162176882|NCT04109066|585701657|FG000|Treatment|Disease Recurrence|0|||
162176883|NCT04109066|585701658|FG001|Treatment|Disease Recurrence|2|||
162176884|NCT04109066|585701657|FG000|Treatment|Not reported|4|||
162176885|NCT04109066|585701658|FG001|Treatment|Not reported|8|||
162176886|NCT05205161|585701659|FG000|Overall Study|Study terminated by sponsor|3|||
162176887|NCT05205161|585701660|FG001|Overall Study|Study terminated by sponsor|3|||
162176888|NCT05205161|585701661|FG002|Overall Study|Study terminated by sponsor|1|||
162176889|NCT04369911|585701663|FG000|Overall Study|Lost to Follow-up|3|||
162176890|NCT04369911|585701664|FG001|Overall Study|Lost to Follow-up|3|||
162176891|NCT04369911|585701663|FG000|Overall Study|Withdrawal by Subject|1|||
162176892|NCT04369911|585701664|FG001|Overall Study|Withdrawal by Subject|2|||
162176893|NCT05741294|585701665|FG000|Overall Study|Lost to Follow-up|3|||
162176894|NCT05741294|585701665|FG000|Overall Study|Protocol deviation|3|||
162176895|NCT05741294|585701665|FG000|Overall Study|Withdrawal by Subject|1|||
162176896|NCT04707768|585701668|FG000|Overall Study|Adverse Event|9|||
162176897|NCT04707768|585701669|FG001|Overall Study|Adverse Event|18|||
162176898|NCT04707768|585701670|FG002|Overall Study|Adverse Event|3|||
162176899|NCT04707768|585701668|FG000|Overall Study|Investigator's Discretion|8|||
162176900|NCT04707768|585701669|FG001|Overall Study|Investigator's Discretion|4|||
162176901|NCT04707768|585701670|FG002|Overall Study|Investigator's Discretion|3|||
162176902|NCT04707768|585701668|FG000|Overall Study|Withdrawal by Subject|6|||
162176903|NCT04707768|585701669|FG001|Overall Study|Withdrawal by Subject|8|||
162176904|NCT04707768|585701670|FG002|Overall Study|Withdrawal by Subject|2|||
162176905|NCT04707768|585701668|FG000|Overall Study|Lack of Efficacy|1|||
162176906|NCT04707768|585701669|FG001|Overall Study|Lack of Efficacy|3|||
162176907|NCT04707768|585701670|FG002|Overall Study|Lack of Efficacy|0|||
162176908|NCT04707768|585701668|FG000|Overall Study|Lost to Follow-up|0|||
162176909|NCT04707768|585701669|FG001|Overall Study|Lost to Follow-up|0|||
162176910|NCT04707768|585701670|FG002|Overall Study|Lost to Follow-up|3|||
162176911|NCT04707768|585701668|FG000|Overall Study|Death|13|||
162176912|NCT04707768|585701669|FG001|Overall Study|Death|11|||
162176913|NCT04707768|585701670|FG002|Overall Study|Death|13|||
161671486|NCT01106404|583851299|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
162176914|NCT04707768|585701668|FG000|Overall Study|Protocol Violation|2|||
162176915|NCT04707768|585701669|FG001|Overall Study|Protocol Violation|1|||
162176916|NCT04707768|585701670|FG002|Overall Study|Protocol Violation|0|||
162176917|NCT04707768|585701668|FG000|Overall Study|Non Compliance with Study Drug|1|||
162176918|NCT04707768|585701669|FG001|Overall Study|Non Compliance with Study Drug|0|||
162176919|NCT04707768|585701670|FG002|Overall Study|Non Compliance with Study Drug|0|||
162176920|NCT04707768|585701668|FG000|Overall Study|Transplant|4|||
162176921|NCT04707768|585701669|FG001|Overall Study|Transplant|4|||
162176922|NCT04707768|585701670|FG002|Overall Study|Transplant|8|||
161671487|NCT01106404|583851300|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
162176923|NCT04707768|585701668|FG000|Overall Study|Other|9|||
162176924|NCT04707768|585701669|FG001|Overall Study|Other|5|||
162176925|NCT04707768|585701670|FG002|Overall Study|Other|2|||
162176926|NCT04490109|585701671|FG000|Overall Study|Lost to Follow-up|3|||
162176927|NCT04490109|585701672|FG001|Overall Study|Lost to Follow-up|10|||
162176928|NCT04490109|585701673|FG002|Overall Study|Lost to Follow-up|4|||
162176929|NCT04490109|585701671|FG000|Overall Study|Withdrawal by Subject|8|||
162176930|NCT04490109|585701672|FG001|Overall Study|Withdrawal by Subject|6|||
162176931|NCT04490109|585701673|FG002|Overall Study|Withdrawal by Subject|9|||
162176932|NCT04490109|585701671|FG000|Overall Study|Physician Decision|0|||
162176933|NCT04490109|585701672|FG001|Overall Study|Physician Decision|2|||
162176934|NCT04490109|585701673|FG002|Overall Study|Physician Decision|3|||
162176935|NCT04490109|585701671|FG000|Overall Study|Adverse Event|2|||
162176936|NCT04490109|585701672|FG001|Overall Study|Adverse Event|1|||
162176937|NCT04490109|585701673|FG002|Overall Study|Adverse Event|0|||
162176938|NCT04490109|585701671|FG000|Overall Study|Significant Non-Compliance|2|||
162176939|NCT04490109|585701672|FG001|Overall Study|Significant Non-Compliance|4|||
162176940|NCT04490109|585701673|FG002|Overall Study|Significant Non-Compliance|4|||
162176941|NCT04490109|585701671|FG000|Overall Study|Significant Clinical Event|0|||
162176942|NCT04490109|585701672|FG001|Overall Study|Significant Clinical Event|1|||
162176943|NCT04490109|585701673|FG002|Overall Study|Significant Clinical Event|0|||
162176944|NCT04490109|585701671|FG000|Overall Study|Other Reason|4|||
162176945|NCT04490109|585701672|FG001|Overall Study|Other Reason|1|||
162176946|NCT04490109|585701673|FG002|Overall Study|Other Reason|1|||
162176947|NCT04163991|585701674|FG000|Overall Study|Adverse Event|0|||
162176948|NCT04163991|585701675|FG001|Overall Study|Adverse Event|0|||
162176949|NCT04163991|585701676|FG002|Overall Study|Adverse Event|0|||
162176950|NCT04163991|585701677|FG003|Overall Study|Adverse Event|1|||
162176951|NCT04163991|585701678|FG004|Overall Study|Adverse Event|0|||
162176952|NCT04163991|585701674|FG000|Overall Study|Death|0|||
162176953|NCT04163991|585701675|FG001|Overall Study|Death|0|||
162176954|NCT04163991|585701676|FG002|Overall Study|Death|1|||
162176955|NCT04163991|585701677|FG003|Overall Study|Death|0|||
162176956|NCT04163991|585701678|FG004|Overall Study|Death|0|||
162176957|NCT04163991|585701674|FG000|Overall Study|Lost to Follow-up|0|||
162176958|NCT04163991|585701675|FG001|Overall Study|Lost to Follow-up|1|||
162176959|NCT04163991|585701676|FG002|Overall Study|Lost to Follow-up|0|||
162176960|NCT04163991|585701677|FG003|Overall Study|Lost to Follow-up|0|||
162176961|NCT04163991|585701678|FG004|Overall Study|Lost to Follow-up|0|||
162176962|NCT04163991|585701674|FG000|Overall Study|Withdrawal by Subject|1|||
162176963|NCT04163991|585701675|FG001|Overall Study|Withdrawal by Subject|1|||
162176964|NCT04163991|585701676|FG002|Overall Study|Withdrawal by Subject|3|||
162176965|NCT04163991|585701677|FG003|Overall Study|Withdrawal by Subject|1|||
162176966|NCT04163991|585701678|FG004|Overall Study|Withdrawal by Subject|1|||
162176967|NCT04163991|585701674|FG000|Overall Study|Other, Not Specified|0|||
162176968|NCT04163991|585701675|FG001|Overall Study|Other, Not Specified|1|||
162176969|NCT04163991|585701676|FG002|Overall Study|Other, Not Specified|1|||
162176970|NCT04163991|585701677|FG003|Overall Study|Other, Not Specified|1|||
162176971|NCT04163991|585701678|FG004|Overall Study|Other, Not Specified|0|||
162176972|NCT05953740|585701679|FG000|Period 1|Physician Decision|0|||
162176973|NCT05953740|585701680|FG001|Period 1|Physician Decision|1|||
162176974|NCT05953740|585701681|FG002|Period 1|Physician Decision|0|||
162176975|NCT05953740|585701682|FG003|Period 1|Physician Decision|0|||
162176976|NCT05953740|585701683|FG004|Period 1|Physician Decision|0|||
161817057|NCT02213263|584370915|FG000|Overall Study|Protocol Violation|0|||
162176977|NCT05953740|585701684|FG005|Period 1|Physician Decision|0|||
162176978|NCT05953740|585701685|FG006|Period 1|Physician Decision|0|||
162176979|NCT05953740|585701686|FG007|Period 1|Physician Decision|0|||
162176980|NCT05953740|585701679|FG000|Period 2|Withdrawal by Subject|0|||
162176981|NCT05953740|585701680|FG001|Period 2|Withdrawal by Subject|1|||
162176982|NCT05953740|585701681|FG002|Period 2|Withdrawal by Subject|1|||
162176983|NCT05953740|585701682|FG003|Period 2|Withdrawal by Subject|0|||
162176984|NCT05953740|585701683|FG004|Period 2|Withdrawal by Subject|0|||
162176985|NCT05953740|585701684|FG005|Period 2|Withdrawal by Subject|0|||
162176986|NCT05953740|585701685|FG006|Period 2|Withdrawal by Subject|0|||
162176987|NCT05953740|585701686|FG007|Period 2|Withdrawal by Subject|0|||
162176988|NCT04108130|585702618|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
162176989|NCT04108130|585702619|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
162176990|NCT04108130|585702618|FG000|Overall Study|Consent Withdrawn|9|||
162176991|NCT04108130|585702619|FG001|Overall Study|Consent Withdrawn|6|||
162176992|NCT04108130|585702618|FG000|Overall Study|Surgery Cancelled|4|||
162176993|NCT04108130|585702619|FG001|Overall Study|Surgery Cancelled|4|||
162176994|NCT04108130|585702618|FG000|Overall Study|Found Ineligible for Study|4|||
162176995|NCT04108130|585702619|FG001|Overall Study|Found Ineligible for Study|3|||
162176996|NCT04108130|585702618|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
162176997|NCT04108130|585702619|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
162176998|NCT04108130|585702618|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
162176999|NCT04108130|585702619|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
162177000|NCT04244175|585702620|FG000|Overall Study|Adverse Event|3|||
162177001|NCT04244175|585702621|FG001|Overall Study|Adverse Event|2|||
162177002|NCT04244175|585702622|FG002|Overall Study|Adverse Event|5|||
162177003|NCT04244175|585702620|FG000|Overall Study|Lack of Efficacy|1|||
162177004|NCT04244175|585702621|FG001|Overall Study|Lack of Efficacy|0|||
162177005|NCT04244175|585702622|FG002|Overall Study|Lack of Efficacy|1|||
162177006|NCT04244175|585702620|FG000|Overall Study|Lost to Follow-up|1|||
162177007|NCT04244175|585702621|FG001|Overall Study|Lost to Follow-up|0|||
162177008|NCT04244175|585702622|FG002|Overall Study|Lost to Follow-up|0|||
162177009|NCT04244175|585702620|FG000|Overall Study|Non-compliance with study drug|1|||
162177010|NCT04244175|585702621|FG001|Overall Study|Non-compliance with study drug|0|||
162177011|NCT04244175|585702622|FG002|Overall Study|Non-compliance with study drug|1|||
162177012|NCT04244175|585702620|FG000|Overall Study|Protocol deviation|0|||
162177013|NCT04244175|585702621|FG001|Overall Study|Protocol deviation|1|||
162177014|NCT04244175|585702622|FG002|Overall Study|Protocol deviation|0|||
162177015|NCT04244175|585702620|FG000|Overall Study|Withdrawal by Subject|1|||
162177016|NCT04244175|585702621|FG001|Overall Study|Withdrawal by Subject|3|||
162177017|NCT04244175|585702622|FG002|Overall Study|Withdrawal by Subject|1|||
162177018|NCT04244175|585702620|FG000|Overall Study|Other, not specified|0|||
162177019|NCT04244175|585702621|FG001|Overall Study|Other, not specified|1|||
162177020|NCT04244175|585702622|FG002|Overall Study|Other, not specified|2|||
162177021|NCT03636490|585702623|FG000|Overall Study|Dropped out or incomplete data|141|||
162177022|NCT02909686|585702625|FG000|Overall Study|Physician Decision|3|||
162177023|NCT02909686|585702625|FG000|Overall Study|Withdrawal by Subject|2|||
162177024|NCT03858517|585702626|FG000|Overall Study|Adverse Event|1|||
162177025|NCT03858517|585702626|FG000|Overall Study|Lost to Follow-up|1|||
162177026|NCT03858517|585702626|FG000|Overall Study|removed for being incarcerated|1|||
162177027|NCT03858517|585702626|FG000|Overall Study|Sponsor Closure|48|||
162177028|NCT04804540|585702627|FG000|Overall Study|Adverse Event|26|||
162177029|NCT04804540|585702628|FG001|Overall Study|Adverse Event|13|||
162177030|NCT05172232|585702629|FG000|Overall Study|Lost to Follow-up|3|||
162177031|NCT02997202|585702630|FG000|Overall Study|Miscellaneous|2|||
162177032|NCT02997202|585702631|FG001|Overall Study|Miscellaneous|2|||
162177033|NCT02997202|585702630|FG000|Overall Study|Withdrawal by Subject|8|||
162177034|NCT02997202|585702631|FG001|Overall Study|Withdrawal by Subject|12|||
162177035|NCT02997202|585702630|FG000|Overall Study|Lost to Follow-up|5|||
162177036|NCT02997202|585702631|FG001|Overall Study|Lost to Follow-up|3|||
162177037|NCT02997202|585702630|FG000|Overall Study|Death|41|||
162177038|NCT02997202|585702631|FG001|Overall Study|Death|45|||
162177039|NCT05422885|585702632|FG000|Overall Study|Lost to Follow-up|1|||
162177040|NCT05422885|585702632|FG000|Overall Study|Withdrawal by Subject|2|||
162177041|NCT04084574|585702633|FG000|Overall Study|Lost to Follow-up|1|||
162177042|NCT04084574|585702634|FG001|Overall Study|Lost to Follow-up|0|||
162177043|NCT04084574|585702633|FG000|Overall Study|Physician Decision|1|||
162177044|NCT04084574|585702634|FG001|Overall Study|Physician Decision|0|||
162177045|NCT04084574|585702633|FG000|Overall Study|Relocated out of state|1|||
162177046|NCT04084574|585702634|FG001|Overall Study|Relocated out of state|0|||
162177047|NCT01121588|585702635|FG000|Overall Study|Death|5|||
162177048|NCT01121588|585702636|FG001|Overall Study|Death|3|||
162177049|NCT01121588|585702637|FG002|Overall Study|Death|13|||
162177050|NCT01121588|585702635|FG000|Overall Study|Study Terminated by Sponsor|1|||
162177051|NCT01121588|585702636|FG001|Overall Study|Study Terminated by Sponsor|1|||
162177052|NCT01121588|585702637|FG002|Overall Study|Study Terminated by Sponsor|0|||
162177053|NCT01121588|585702635|FG000|Overall Study|Participant Refused Further Followup|2|||
162177054|NCT01121588|585702636|FG001|Overall Study|Participant Refused Further Followup|0|||
162177055|NCT01121588|585702637|FG002|Overall Study|Participant Refused Further Followup|2|||
162177056|NCT01121588|585702635|FG000|Overall Study|Lost to Follow-up|0|||
162177057|NCT01121588|585702636|FG001|Overall Study|Lost to Follow-up|1|||
162177058|NCT01121588|585702637|FG002|Overall Study|Lost to Follow-up|1|||
162177059|NCT01121588|585702635|FG000|Overall Study|Non-Specified Reasons|9|||
162177060|NCT01121588|585702636|FG001|Overall Study|Non-Specified Reasons|4|||
162177061|NCT01121588|585702637|FG002|Overall Study|Non-Specified Reasons|2|||
162177062|NCT03681262|585702640|FG000|Overall Study|Continuing on study|3|||
162177063|NCT03681262|585702641|FG001|Overall Study|Continuing on study|3|||
162177064|NCT03681262|585702640|FG000|Overall Study|Lost to Follow-up|1|||
162177065|NCT03681262|585702641|FG001|Overall Study|Lost to Follow-up|0|||
161671488|NCT01106404|583851299|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
161671489|NCT01106404|583851300|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
161922930|NCT01786109|584764898|FG000|Overall Study|adverse effects colon preparation|0|||
161922931|NCT01786109|584764899|FG001|Overall Study|adverse effects colon preparation|0|||
161922932|NCT01786109|584764900|FG002|Overall Study|adverse effects colon preparation|1|||
161922933|NCT02513563|584764903|FG000|Overall Study|Death|4|||
161922934|NCT02513563|584764903|FG000|Overall Study|Withdrawal by Subject|4|||
162177066|NCT00887198|585702642|FG000|Randomized Period|Ongoing|42|||
162177067|NCT00887198|585702643|FG001|Randomized Period|Ongoing|0|||
162177068|NCT00887198|585702644|FG002|Randomized Period|Ongoing|0|||
161922935|NCT02513563|584764903|FG000|Overall Study|Physician Decision|1|||
161922936|NCT00317369|584764904|FG000|Overall Study|Adverse Event|2|||
161922937|NCT00317369|584764905|FG001|Overall Study|Adverse Event|1|||
161922938|NCT00317369|584764906|FG002|Overall Study|Adverse Event|0|||
161922939|NCT00317369|584764904|FG000|Overall Study|Lack of Efficacy|0|||
161922940|NCT00317369|584764905|FG001|Overall Study|Lack of Efficacy|1|||
161922941|NCT00317369|584764906|FG002|Overall Study|Lack of Efficacy|1|||
161922942|NCT00317369|584764904|FG000|Overall Study|Withdrawal by Subject|0|||
161922943|NCT00317369|584764905|FG001|Overall Study|Withdrawal by Subject|0|||
161922944|NCT00317369|584764906|FG002|Overall Study|Withdrawal by Subject|1|||
161922945|NCT04069520|584764907|FG000|Overall Study|Lost to Follow-up|0|||
161922946|NCT04069520|584764908|FG001|Overall Study|Lost to Follow-up|2|||
161922947|NCT04069520|584764907|FG000|Overall Study|Withdrawal by Subject|0|||
161922948|NCT04069520|584764908|FG001|Overall Study|Withdrawal by Subject|1|||
161922949|NCT04069520|584764907|FG000|Overall Study|Prior Injury|1|||
161922950|NCT04069520|584764908|FG001|Overall Study|Prior Injury|0|||
161922951|NCT04069520|584764907|FG000|Overall Study|Orthodontia|1|||
161922952|NCT04069520|584764908|FG001|Overall Study|Orthodontia|0|||
161922953|NCT04069520|584764907|FG000|Overall Study|Cut from team|0|||
161922954|NCT04069520|584764908|FG001|Overall Study|Cut from team|2|||
161922955|NCT01068912|584764909|FG000|Overall Study|Adverse Event|2|||
161922956|NCT01068912|584764910|FG001|Overall Study|Adverse Event|3|||
161922957|NCT01068912|584764911|FG002|Overall Study|Adverse Event|2|||
161922958|NCT01068912|584764909|FG000|Overall Study|Withdrawal by Subject|5|||
161922959|NCT01068912|584764910|FG001|Overall Study|Withdrawal by Subject|6|||
161922960|NCT01068912|584764911|FG002|Overall Study|Withdrawal by Subject|6|||
161922961|NCT01068912|584764909|FG000|Overall Study|Lost to Follow-up|3|||
161922962|NCT01068912|584764910|FG001|Overall Study|Lost to Follow-up|7|||
161922963|NCT01068912|584764911|FG002|Overall Study|Lost to Follow-up|3|||
161922964|NCT01068912|584764909|FG000|Overall Study|Protocol Violation|0|||
161922965|NCT01068912|584764910|FG001|Overall Study|Protocol Violation|2|||
161922966|NCT01068912|584764911|FG002|Overall Study|Protocol Violation|0|||
161922967|NCT01068912|584764909|FG000|Overall Study|aggravation influenza|1|||
161922968|NCT01068912|584764910|FG001|Overall Study|aggravation influenza|1|||
161922969|NCT01068912|584764911|FG002|Overall Study|aggravation influenza|1|||
161922970|NCT01068912|584764909|FG000|Overall Study|other underlying illness|0|||
161922971|NCT01068912|584764910|FG001|Overall Study|other underlying illness|3|||
161922972|NCT01068912|584764911|FG002|Overall Study|other underlying illness|3|||
161922973|NCT03998462|584764913|FG000|Overall Study|Withdrawal by Subject|10|||
161922974|NCT03998462|584764914|FG001|Overall Study|Withdrawal by Subject|4|||
161922975|NCT03998462|584764913|FG000|Overall Study|Lost to Follow-up|1|||
161922976|NCT03998462|584764914|FG001|Overall Study|Lost to Follow-up|0|||
161922977|NCT03998462|584764913|FG000|Overall Study|Technical Difficulties|1|||
161922978|NCT03998462|584764914|FG001|Overall Study|Technical Difficulties|2|||
161922979|NCT05710224|584764915|FG000|Overall Study|Death|1|||
161922980|NCT05710224|584764916|FG001|Overall Study|Death|0|||
161922981|NCT05710224|584764915|FG000|Overall Study|Lost to Follow-up|16|||
161922982|NCT05710224|584764916|FG001|Overall Study|Lost to Follow-up|7|||
161922983|NCT05710224|584764915|FG000|Overall Study|Withdrawal by Subject|4|||
161922984|NCT05710224|584764916|FG001|Overall Study|Withdrawal by Subject|6|||
161922985|NCT05710224|584764915|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161922986|NCT05710224|584764916|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
161922987|NCT05710224|584764915|FG000|Overall Study|Participants Left The City|0|||
161922988|NCT05710224|584764916|FG001|Overall Study|Participants Left The City|2|||
161922989|NCT04822194|584764919|FG000|Overall Study|Withdrawal by Subject|5|||
161922990|NCT04822194|584764920|FG001|Overall Study|Withdrawal by Subject|4|||
161922991|NCT04822194|584764919|FG000|Overall Study|Technical issues with MR scanner|1|||
161922992|NCT04822194|584764920|FG001|Overall Study|Technical issues with MR scanner|0|||
161922993|NCT04822194|584764919|FG000|Overall Study|Lost to Follow-up|5|||
161922994|NCT04822194|584764920|FG001|Overall Study|Lost to Follow-up|7|||
161922995|NCT03369223|584764921|FG000|Overall Study|Lost to Follow-up|0|||
161922996|NCT03369223|584764922|FG001|Overall Study|Lost to Follow-up|0|||
161922997|NCT03369223|584764923|FG002|Overall Study|Lost to Follow-up|0|||
161922998|NCT03369223|584764924|FG003|Overall Study|Lost to Follow-up|0|||
161922999|NCT03369223|584764925|FG004|Overall Study|Lost to Follow-up|0|||
161923000|NCT03369223|584764926|FG005|Overall Study|Lost to Follow-up|0|||
161923001|NCT03369223|584764927|FG006|Overall Study|Lost to Follow-up|0|||
161923002|NCT03369223|584764928|FG007|Overall Study|Lost to Follow-up|0|||
161923003|NCT03369223|584764929|FG008|Overall Study|Lost to Follow-up|0|||
161923004|NCT03369223|584764930|FG009|Overall Study|Lost to Follow-up|0|||
161923005|NCT03369223|584764931|FG010|Overall Study|Lost to Follow-up|0|||
161923006|NCT03369223|584764932|FG011|Overall Study|Lost to Follow-up|0|||
161923007|NCT03369223|584764933|FG012|Overall Study|Lost to Follow-up|0|||
161923008|NCT03369223|584764934|FG013|Overall Study|Lost to Follow-up|0|||
161923009|NCT03369223|584764935|FG014|Overall Study|Lost to Follow-up|0|||
161923010|NCT03369223|584764936|FG015|Overall Study|Lost to Follow-up|0|||
161923011|NCT03369223|584764937|FG016|Overall Study|Lost to Follow-up|0|||
161671490|NCT01106404|583851299|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
161671491|NCT01106404|583851300|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
161671492|NCT01774084|583851301|FG000|Overall Study|Personal reasons|1|||
162177069|NCT00887198|585702642|FG000|Randomized Period|Adverse Event|50|||
162177070|NCT00887198|585702643|FG001|Randomized Period|Adverse Event|33|||
162177071|NCT00887198|585702644|FG002|Randomized Period|Adverse Event|0|||
162177072|NCT00887198|585702642|FG000|Randomized Period|Lost to Follow-up|1|||
162177073|NCT00887198|585702643|FG001|Randomized Period|Lost to Follow-up|0|||
162177074|NCT00887198|585702644|FG002|Randomized Period|Lost to Follow-up|0|||
162177075|NCT00887198|585702642|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
162177076|NCT00887198|585702643|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
162177077|NCT00887198|585702644|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
162177078|NCT00887198|585702642|FG000|Randomized Period|Withdrawal by Subject|41|||
162177079|NCT00887198|585702643|FG001|Randomized Period|Withdrawal by Subject|56|||
162177080|NCT00887198|585702644|FG002|Randomized Period|Withdrawal by Subject|0|||
162177081|NCT00887198|585702642|FG000|Randomized Period|Progressive disease|366|||
162177082|NCT00887198|585702643|FG001|Randomized Period|Progressive disease|370|||
162177083|NCT00887198|585702644|FG002|Randomized Period|Progressive disease|0|||
162177084|NCT00887198|585702642|FG000|Randomized Period|Other|42|||
162177085|NCT00887198|585702643|FG001|Randomized Period|Other|30|||
162177086|NCT00887198|585702644|FG002|Randomized Period|Other|0|||
162177087|NCT00887198|585702642|FG000|Randomized Period|Randomized, Not treated|4|||
162177088|NCT00887198|585702643|FG001|Randomized Period|Randomized, Not treated|2|||
162177089|NCT00887198|585702644|FG002|Randomized Period|Randomized, Not treated|0|||
162177090|NCT00887198|585702642|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
162177091|NCT00887198|585702643|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
162177092|NCT00887198|585702644|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
161671493|NCT01774084|583851302|FG001|Overall Study|Personal reasons|0|||
161671494|NCT01387230|583851303|FG000|Overall Study|Adverse Event|0|||
161671495|NCT01387230|583851304|FG001|Overall Study|Adverse Event|1|||
161671496|NCT01387230|583851305|FG002|Overall Study|Adverse Event|3|||
161671497|NCT01387230|583851303|FG000|Overall Study|Lack of Efficacy|8|||
161671498|NCT01387230|583851304|FG001|Overall Study|Lack of Efficacy|5|||
161671499|NCT01387230|583851305|FG002|Overall Study|Lack of Efficacy|4|||
161671500|NCT01387230|583851303|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
161671501|NCT01387230|583851304|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
161671502|NCT01387230|583851305|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
161671503|NCT01387230|583851303|FG000|Overall Study|Lost to Follow-up|0|||
161671504|NCT01387230|583851304|FG001|Overall Study|Lost to Follow-up|0|||
161671505|NCT01387230|583851305|FG002|Overall Study|Lost to Follow-up|1|||
161671506|NCT01387230|583851303|FG000|Overall Study|Withdrawal by Subject|4|||
161671507|NCT01387230|583851304|FG001|Overall Study|Withdrawal by Subject|1|||
161671508|NCT01387230|583851305|FG002|Overall Study|Withdrawal by Subject|0|||
161671509|NCT01182766|583851309|FG000|Overall Study|Lost to Follow-up|32|||
161671510|NCT01182766|583851310|FG001|Overall Study|Lost to Follow-up|36|||
161671511|NCT01182766|583851311|FG002|Overall Study|Lost to Follow-up|29|||
161671512|NCT01182766|583851309|FG000|Overall Study|Withdrawal by Subject|14|||
161671513|NCT01182766|583851310|FG001|Overall Study|Withdrawal by Subject|3|||
162177093|NCT00887198|585702642|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
162177094|NCT00887198|585702643|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
162177095|NCT00887198|585702644|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
162177096|NCT00887198|585702642|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
162177097|NCT00887198|585702643|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
162177098|NCT00887198|585702644|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
161671514|NCT01182766|583851311|FG002|Overall Study|Withdrawal by Subject|6|||
161923012|NCT03369223|584764938|FG017|Overall Study|Lost to Follow-up|0|||
161671515|NCT01182766|583851309|FG000|Overall Study|Physician Decision|1|||
161671516|NCT01182766|583851310|FG001|Overall Study|Physician Decision|0|||
162177099|NCT00887198|585702642|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
162177100|NCT00887198|585702643|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
162177101|NCT00887198|585702644|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
162177102|NCT00887198|585702642|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
162177103|NCT00887198|585702643|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
162177104|NCT00887198|585702644|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
162177105|NCT00887198|585702642|FG000|Cross Over (Placebo to AA)|Other|0|||
162177106|NCT00887198|585702643|FG001|Cross Over (Placebo to AA)|Other|0|||
162177107|NCT00887198|585702644|FG002|Cross Over (Placebo to AA)|Other|19|||
162177108|NCT02782676|585702645|FG000|Overall Study|Lost to Follow-up|0|||
162177109|NCT02782676|585702646|FG001|Overall Study|Lost to Follow-up|1|||
162177110|NCT00303459|585702649|FG000|Overall Study|Death|33|||
162177111|NCT00303459|585702650|FG001|Overall Study|Death|44|||
162177112|NCT00303459|585702649|FG000|Overall Study|Withdrawal of consent|32|||
162177113|NCT00303459|585702650|FG001|Overall Study|Withdrawal of consent|26|||
162177114|NCT00303459|585702649|FG000|Overall Study|Lost to Follow-up|5|||
162177115|NCT00303459|585702650|FG001|Overall Study|Lost to Follow-up|4|||
162177116|NCT00303459|585702649|FG000|Overall Study|Administrative reason|7|||
162177117|NCT00303459|585702650|FG001|Overall Study|Administrative reason|7|||
162177118|NCT00303459|585702649|FG000|Overall Study|Decision by the investigator|5|||
162177119|NCT00303459|585702650|FG001|Overall Study|Decision by the investigator|7|||
162177120|NCT00303459|585702649|FG000|Overall Study|Lung transplantation|1|||
162177121|NCT00303459|585702650|FG001|Overall Study|Lung transplantation|1|||
162177122|NCT04631016|585702651|FG000|Overall Study|Adverse Event|3|||
162177123|NCT04631016|585702652|FG001|Overall Study|Adverse Event|0|||
162177124|NCT04631016|585702651|FG000|Overall Study|Withdrawal by Subject|5|||
162177125|NCT04631016|585702652|FG001|Overall Study|Withdrawal by Subject|4|||
162177126|NCT04631016|585702651|FG000|Overall Study|Reason unspecified|1|||
162177127|NCT04631016|585702652|FG001|Overall Study|Reason unspecified|0|||
162177128|NCT04631016|585702651|FG000|Overall Study|Failure to meet randomization criteria|2|||
162177129|NCT04631016|585702652|FG001|Overall Study|Failure to meet randomization criteria|1|||
162177130|NCT04967599|585702655|FG000|Overall Study|Lost to Follow-up|35|||
162177131|NCT04967599|585702656|FG001|Overall Study|Lost to Follow-up|19|||
162177132|NCT04967599|585702657|FG002|Overall Study|Lost to Follow-up|23|||
162177133|NCT03880955|585702660|FG000|Overall Study|Adverse Event|1|||
162177134|NCT03880955|585702660|FG000|Overall Study|Death|1|||
162177135|NCT03880955|585702660|FG000|Overall Study|Lost to Follow-up|12|||
162177136|NCT03880955|585702660|FG000|Overall Study|Withdrawal by Subject|4|||
162177137|NCT03880955|585702660|FG000|Overall Study|Missing- Study Site Closed|27|||
162177138|NCT03817983|585702661|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
162177139|NCT03817983|585702662|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
162177140|NCT03817983|585702663|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
162177141|NCT02510235|585702664|FG000|Overall Study|Withdrawal by Subject|1|||
162177142|NCT02510235|585702665|FG001|Overall Study|Withdrawal by Subject|0|||
162177143|NCT00450216|585702666|FG000|Overall Study|Adverse Event|38|||
162177144|NCT00450216|585702667|FG001|Overall Study|Adverse Event|23|||
162177145|NCT00450216|585702666|FG000|Overall Study|Withdrawal by Subject|48|||
162177146|NCT00450216|585702667|FG001|Overall Study|Withdrawal by Subject|26|||
162177147|NCT00450216|585702666|FG000|Overall Study|Lost to Follow-up|16|||
162177148|NCT00450216|585702667|FG001|Overall Study|Lost to Follow-up|9|||
162177149|NCT00450216|585702666|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
162177150|NCT00450216|585702667|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
162177151|NCT00450216|585702666|FG000|Overall Study|misc|21|||
162177152|NCT00450216|585702667|FG001|Overall Study|misc|20|||
162177153|NCT05541484|585702672|FG000|Overall Study|Withdrawal by Subject|1|||
162177154|NCT05541484|585702673|FG001|Overall Study|Withdrawal by Subject|0|||
162177155|NCT03418740|585702678|FG000|Overall Study|Lost to Follow-up|13|||
162177156|NCT03418740|585702678|FG000|Overall Study|Scheduling Issues|7|||
162177157|NCT03418740|585702678|FG000|Overall Study|Withdrawal by Subject|2|||
162177158|NCT03418740|585702678|FG000|Overall Study|Unable to Continue Consent|1|||
162177159|NCT04499521|585702679|FG000|Overall Study|Disease Progression|1|||
162177160|NCT04499521|585702680|FG001|Overall Study|Disease Progression|0|||
162177161|NCT02585323|585703345|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
162177162|NCT02585323|585703346|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
162177163|NCT02585323|585703345|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
162177164|NCT02585323|585703346|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
162177165|NCT02585323|585703345|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
162177166|NCT02585323|585703346|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
162177167|NCT02585323|585703345|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
162177168|NCT02585323|585703346|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
162177169|NCT01130883|585703347|FG000|Overall Study|Patient Noncompliance|6|||
162177170|NCT01130883|585703347|FG000|Overall Study|Reason Unknown|1|||
162177171|NCT01130883|585703347|FG000|Overall Study|Adverse Event|3|||
162177172|NCT04165213|585703357|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
162177173|NCT04165213|585703358|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
162177174|NCT04165213|585703357|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
162177175|NCT04165213|585703358|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
162177176|NCT04165213|585703357|FG000|Clinician Enrollment|Termination from site|0|||
162177177|NCT04165213|585703358|FG001|Clinician Enrollment|Termination from site|1|||
162177178|NCT04165213|585703357|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
162177179|NCT04165213|585703358|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
162177180|NCT04165213|585703357|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
161923013|NCT03369223|584764939|FG018|Overall Study|Lost to Follow-up|2|||
161923014|NCT03369223|584764940|FG019|Overall Study|Lost to Follow-up|1|||
161923015|NCT03369223|584764921|FG000|Overall Study|Participant no longer meets study criteria|0|||
161923016|NCT03369223|584764922|FG001|Overall Study|Participant no longer meets study criteria|0|||
161923017|NCT03369223|584764923|FG002|Overall Study|Participant no longer meets study criteria|0|||
161923018|NCT03369223|584764924|FG003|Overall Study|Participant no longer meets study criteria|0|||
161923019|NCT03369223|584764925|FG004|Overall Study|Participant no longer meets study criteria|0|||
161923020|NCT03369223|584764926|FG005|Overall Study|Participant no longer meets study criteria|0|||
161923021|NCT03369223|584764927|FG006|Overall Study|Participant no longer meets study criteria|0|||
161923022|NCT03369223|584764928|FG007|Overall Study|Participant no longer meets study criteria|0|||
161923023|NCT03369223|584764929|FG008|Overall Study|Participant no longer meets study criteria|0|||
162177181|NCT04165213|585703358|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
162177182|NCT04165213|585703357|FG000|Caregiver Enrollment|Physician Decision|1|||
162177183|NCT04165213|585703358|FG001|Caregiver Enrollment|Physician Decision|0|||
162177184|NCT04165213|585703357|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
162177185|NCT04165213|585703358|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
162177186|NCT04165213|585703357|FG000|Caregiver Enrollment|PLWD death|2|||
162177187|NCT04165213|585703358|FG001|Caregiver Enrollment|PLWD death|0|||
162177188|NCT04165213|585703357|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
162177189|NCT04165213|585703358|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
162177190|NCT04165213|585703357|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
162177191|NCT04165213|585703358|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
162177192|NCT04165213|585703357|FG000|PLWD Enrollment|Lost to Follow-up|1|||
162177193|NCT04165213|585703358|FG001|PLWD Enrollment|Lost to Follow-up|1|||
162177194|NCT04165213|585703357|FG000|PLWD Enrollment|Physician Decision|1|||
162177195|NCT04165213|585703358|FG001|PLWD Enrollment|Physician Decision|0|||
162177196|NCT04165213|585703357|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
162177197|NCT04165213|585703358|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
162177198|NCT04165213|585703357|FG000|PLWD Enrollment|Death|2|||
162177199|NCT04165213|585703358|FG001|PLWD Enrollment|Death|0|||
162177200|NCT04165213|585703357|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
162177201|NCT04165213|585703358|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
162177202|NCT04464564|585703359|FG000|Period A (Placebo lead-in)|Other|5|||
162177203|NCT04464564|585703360|FG001|Period A (Placebo lead-in)|Other|0|||
162177204|NCT04464564|585703361|FG002|Period A (Placebo lead-in)|Other|0|||
162177205|NCT04464564|585703362|FG003|Period A (Placebo lead-in)|Other|0|||
162177206|NCT04464564|585703359|FG000|Period B (Randomization Period)|Adverse Event|0|||
162177207|NCT04464564|585703360|FG001|Period B (Randomization Period)|Adverse Event|1|||
162177208|NCT04464564|585703361|FG002|Period B (Randomization Period)|Adverse Event|2|||
162177209|NCT04464564|585703362|FG003|Period B (Randomization Period)|Adverse Event|8|||
162177210|NCT04464564|585703359|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
162177211|NCT04464564|585703360|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
162177212|NCT04464564|585703361|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
162177213|NCT04464564|585703362|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
162177214|NCT04464564|585703359|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
162177215|NCT04464564|585703360|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
162177216|NCT04464564|585703361|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
162177217|NCT04464564|585703362|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
162177218|NCT04464564|585703359|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
162177219|NCT04464564|585703360|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
162177220|NCT04464564|585703361|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
162177221|NCT04464564|585703362|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
162177222|NCT04464564|585703359|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
162177223|NCT04464564|585703360|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
162177224|NCT04464564|585703361|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
162177225|NCT04464564|585703362|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
162177226|NCT04464564|585703359|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
162177227|NCT04464564|585703360|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
162177228|NCT04464564|585703361|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
162177229|NCT04464564|585703362|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
162177230|NCT04464564|585703359|FG000|Period B (Randomization Period)|Reason not Specified|0|||
162177231|NCT04464564|585703360|FG001|Period B (Randomization Period)|Reason not Specified|3|||
162177232|NCT04464564|585703361|FG002|Period B (Randomization Period)|Reason not Specified|3|||
162177233|NCT04464564|585703362|FG003|Period B (Randomization Period)|Reason not Specified|3|||
162177234|NCT02278211|585703370|FG000|Overall Study|Unable to analyse PET scan|2|||
162177235|NCT01828021|585703373|FG000|Overall Study|Adverse Event|5|||
162177236|NCT01828021|585703373|FG000|Overall Study|Lack of Efficacy|17|||
162177237|NCT01828021|585703373|FG000|Overall Study|Withdrawal by Subject|2|||
162177238|NCT01828021|585703373|FG000|Overall Study|Ileal obstruction, unrelated|1|||
162177239|NCT04055012|585703382|FG000|Overall Study|Withdrawal by Subject|1|||
162177240|NCT04055012|585703383|FG001|Overall Study|Withdrawal by Subject|3|||
162177241|NCT04055012|585703384|FG002|Overall Study|Withdrawal by Subject|1|||
162177242|NCT04055012|585703385|FG003|Overall Study|Withdrawal by Subject|0|||
162177243|NCT04055012|585703382|FG000|Overall Study|Metformin Recall|1|||
162177244|NCT04055012|585703383|FG001|Overall Study|Metformin Recall|1|||
162177245|NCT04055012|585703384|FG002|Overall Study|Metformin Recall|1|||
162177246|NCT04055012|585703385|FG003|Overall Study|Metformin Recall|0|||
162177247|NCT02492711|585703389|FG000|Overall Study|Adverse Event|9|||
162177248|NCT02492711|585703390|FG001|Overall Study|Adverse Event|9|||
162177249|NCT02492711|585703391|FG002|Overall Study|Adverse Event|2|||
162177250|NCT02492711|585703389|FG000|Overall Study|Death|3|||
162177251|NCT02492711|585703390|FG001|Overall Study|Death|3|||
162177252|NCT02492711|585703391|FG002|Overall Study|Death|0|||
162177253|NCT02492711|585703389|FG000|Overall Study|Withdrawal by Subject|10|||
162177254|NCT02492711|585703390|FG001|Overall Study|Withdrawal by Subject|16|||
161671517|NCT01182766|583851311|FG002|Overall Study|Physician Decision|0|||
161671518|NCT01182766|583851309|FG000|Overall Study|Non-compliance|1|||
162177255|NCT02492711|585703391|FG002|Overall Study|Withdrawal by Subject|5|||
162177256|NCT02492711|585703389|FG000|Overall Study|Physician Decision|10|||
162177257|NCT02492711|585703390|FG001|Overall Study|Physician Decision|6|||
162177258|NCT02492711|585703391|FG002|Overall Study|Physician Decision|4|||
162177259|NCT02492711|585703389|FG000|Overall Study|Lost to Follow-up|0|||
162177260|NCT02492711|585703390|FG001|Overall Study|Lost to Follow-up|0|||
162177261|NCT02492711|585703391|FG002|Overall Study|Lost to Follow-up|1|||
162177262|NCT02492711|585703389|FG000|Overall Study|study treatment delay|2|||
162177263|NCT02492711|585703390|FG001|Overall Study|study treatment delay|1|||
162177264|NCT02492711|585703391|FG002|Overall Study|study treatment delay|0|||
162177265|NCT02492711|585703389|FG000|Overall Study|change in chemotherapy|0|||
162177266|NCT02492711|585703390|FG001|Overall Study|change in chemotherapy|1|||
162177267|NCT02492711|585703391|FG002|Overall Study|change in chemotherapy|0|||
162177268|NCT02492711|585703389|FG000|Overall Study|never treated|2|||
162177269|NCT02492711|585703390|FG001|Overall Study|never treated|4|||
162177270|NCT02492711|585703391|FG002|Overall Study|never treated|0|||
162177271|NCT02492711|585703389|FG000|Overall Study|Other|0|||
162177272|NCT02492711|585703390|FG001|Overall Study|Other|0|||
162177273|NCT02492711|585703391|FG002|Overall Study|Other|1|||
162177274|NCT05830799|585703395|FG000|Overall Study|Withdrawal by Subject|1|||
162177275|NCT03652272|585703396|FG000|3 Month|Withdrawal by Subject|1|||
162177276|NCT03652272|585703397|FG001|3 Month|Withdrawal by Subject|1|||
162177277|NCT03652272|585703396|FG000|3 Month|Lost to Follow-up|16|||
162177278|NCT03652272|585703397|FG001|3 Month|Lost to Follow-up|14|||
162177279|NCT02163694|585703398|FG000|Overall Study|Adverse event- related to progression|4|||
162177280|NCT02163694|585703399|FG001|Overall Study|Adverse event- related to progression|10|||
162177281|NCT02163694|585703398|FG000|Overall Study|Adverse event- not related to progression|7|||
162177282|NCT02163694|585703399|FG001|Overall Study|Adverse event- not related to progression|22|||
162177283|NCT02163694|585703398|FG000|Overall Study|Withdrew consent|13|||
162177284|NCT02163694|585703399|FG001|Overall Study|Withdrew consent|28|||
162177285|NCT02163694|585703398|FG000|Overall Study|Lost to Follow-up|2|||
162177286|NCT02163694|585703399|FG001|Overall Study|Lost to Follow-up|2|||
162177287|NCT02163694|585703398|FG000|Overall Study|Sponsor discontinued study|3|||
162177288|NCT02163694|585703399|FG001|Overall Study|Sponsor discontinued study|29|||
162177289|NCT02163694|585703398|FG000|Overall Study|Progressive disease per protocol|125|||
162177290|NCT02163694|585703399|FG001|Overall Study|Progressive disease per protocol|224|||
162177291|NCT02163694|585703398|FG000|Overall Study|Other, not specified|17|||
162177292|NCT02163694|585703399|FG001|Overall Study|Other, not specified|22|||
162177293|NCT02163694|585703398|FG000|Overall Study|Randomized but Not Treated|1|||
162177294|NCT02163694|585703399|FG001|Overall Study|Randomized but Not Treated|0|||
162177295|NCT02163694|585703398|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
162177296|NCT02163694|585703399|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
162177297|NCT03884101|585703400|FG000|Overall Study|Participant Ongoing in Study|202|||
162177298|NCT03884101|585703401|FG001|Overall Study|Participant Ongoing in Study|186|||
162177299|NCT03884101|585703400|FG000|Overall Study|Death|212|||
162177300|NCT03884101|585703401|FG001|Overall Study|Death|224|||
162177301|NCT03884101|585703400|FG000|Overall Study|Lost to Follow-up|0|||
162177302|NCT03884101|585703401|FG001|Overall Study|Lost to Follow-up|1|||
162177303|NCT03884101|585703400|FG000|Overall Study|Withdrawal by Subject|6|||
162177304|NCT03884101|585703401|FG001|Overall Study|Withdrawal by Subject|11|||
162177305|NCT05112900|585703406|FG000|Overall Study|Withdrawal by Subject|960|||
162177306|NCT05112900|585703407|FG001|Overall Study|Withdrawal by Subject|921|||
162177307|NCT05112900|585703408|FG002|Overall Study|Withdrawal by Subject|968|||
162177308|NCT02919917|585703409|FG000|Overall Study|Withdrawal by Subject|4|||
162177309|NCT02919917|585703410|FG001|Overall Study|Withdrawal by Subject|8|||
162177310|NCT04743973|585703411|FG000|Overall Study|Withdrawal by Subject|5|||
162177311|NCT02461134|585703416|FG000|Overall Study|Adverse Event|1|||
162177312|NCT00626795|585703417|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
161671519|NCT01182766|583851310|FG001|Overall Study|Non-compliance|1|||
162177313|NCT00626795|585703418|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
162177314|NCT00626795|585703419|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
162177315|NCT00626795|585703417|FG000|Blinded Treatment|Lack of Efficacy|2|||
162177316|NCT00626795|585703418|FG001|Blinded Treatment|Lack of Efficacy|0|||
162177317|NCT00626795|585703419|FG002|Blinded Treatment|Lack of Efficacy|0|||
162177318|NCT00626795|585703417|FG000|Blinded Treatment|Unacceptable adverse event|0|||
162177319|NCT00626795|585703418|FG001|Blinded Treatment|Unacceptable adverse event|0|||
162177320|NCT00626795|585703419|FG002|Blinded Treatment|Unacceptable adverse event|1|||
162177321|NCT00626795|585703417|FG000|Blinded Treatment|Protocol Violation|0|||
162177322|NCT00626795|585703418|FG001|Blinded Treatment|Protocol Violation|1|||
162177323|NCT00626795|585703419|FG002|Blinded Treatment|Protocol Violation|1|||
162177324|NCT00626795|585703417|FG000|Blinded Treatment|Withdrawal by Subject|1|||
162177325|NCT00626795|585703418|FG001|Blinded Treatment|Withdrawal by Subject|1|||
162177326|NCT00626795|585703419|FG002|Blinded Treatment|Withdrawal by Subject|0|||
162177327|NCT00626795|585703417|FG000|Blinded Treatment|Other reasons|2|||
162177328|NCT00626795|585703418|FG001|Blinded Treatment|Other reasons|0|||
162177329|NCT00626795|585703419|FG002|Blinded Treatment|Other reasons|2|||
162177330|NCT00626795|585703417|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
162177331|NCT00626795|585703418|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
162177332|NCT00626795|585703419|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
162177333|NCT01651000|585703423|FG000|Overall Study|Adverse Event|2|||
162177334|NCT01651000|585703424|FG001|Overall Study|Adverse Event|8|||
162177335|NCT01651000|585703423|FG000|Overall Study|Lost to Follow-up|3|||
162177336|NCT01651000|585703424|FG001|Overall Study|Lost to Follow-up|2|||
162177337|NCT01651000|585703423|FG000|Overall Study|Protocol Violation|0|||
162177338|NCT01651000|585703424|FG001|Overall Study|Protocol Violation|3|||
162177339|NCT01651000|585703423|FG000|Overall Study|Withdrawal by Subject|2|||
162177340|NCT01651000|585703424|FG001|Overall Study|Withdrawal by Subject|10|||
162177341|NCT01651000|585703423|FG000|Overall Study|Subject noncompliance|0|||
162177342|NCT01651000|585703424|FG001|Overall Study|Subject noncompliance|3|||
162177343|NCT01651000|585703423|FG000|Overall Study|Lack of Efficacy|1|||
162177344|NCT01651000|585703424|FG001|Overall Study|Lack of Efficacy|1|||
162177345|NCT01651000|585703423|FG000|Overall Study|Physician Decision|1|||
162177346|NCT01651000|585703424|FG001|Overall Study|Physician Decision|0|||
162177347|NCT01651000|585703423|FG000|Overall Study|Administrative reason|1|||
162177348|NCT01651000|585703424|FG001|Overall Study|Administrative reason|0|||
162177349|NCT01651000|585703423|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
162177350|NCT01651000|585703424|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
162177351|NCT05412004|585704351|FG000|Overall Study|Adverse Event|0|||
162177352|NCT05412004|585704352|FG001|Overall Study|Adverse Event|2|||
162177353|NCT05412004|585704353|FG002|Overall Study|Adverse Event|1|||
162177354|NCT05412004|585704354|FG003|Overall Study|Adverse Event|5|||
162177355|NCT05412004|585704351|FG000|Overall Study|Assigned Treatment by Mistake|5|||
162177356|NCT05412004|585704352|FG001|Overall Study|Assigned Treatment by Mistake|10|||
162177357|NCT05412004|585704353|FG002|Overall Study|Assigned Treatment by Mistake|2|||
162177358|NCT05412004|585704354|FG003|Overall Study|Assigned Treatment by Mistake|5|||
162177359|NCT05412004|585704351|FG000|Overall Study|Lost to Follow-up|3|||
162177360|NCT05412004|585704352|FG001|Overall Study|Lost to Follow-up|0|||
162177361|NCT05412004|585704353|FG002|Overall Study|Lost to Follow-up|0|||
162177362|NCT05412004|585704354|FG003|Overall Study|Lost to Follow-up|0|||
162177363|NCT05412004|585704351|FG000|Overall Study|Patient could not travel to site|0|||
162177364|NCT05412004|585704352|FG001|Overall Study|Patient could not travel to site|1|||
162177365|NCT05412004|585704353|FG002|Overall Study|Patient could not travel to site|0|||
162177366|NCT05412004|585704354|FG003|Overall Study|Patient could not travel to site|0|||
162177367|NCT05412004|585704351|FG000|Overall Study|Physician Decision|0|||
162177368|NCT05412004|585704352|FG001|Overall Study|Physician Decision|1|||
162177369|NCT05412004|585704353|FG002|Overall Study|Physician Decision|0|||
162177370|NCT05412004|585704354|FG003|Overall Study|Physician Decision|0|||
162177371|NCT05412004|585704351|FG000|Overall Study|Pregnancy|0|||
162177372|NCT05412004|585704352|FG001|Overall Study|Pregnancy|1|||
162177373|NCT05412004|585704353|FG002|Overall Study|Pregnancy|0|||
162177374|NCT05412004|585704354|FG003|Overall Study|Pregnancy|0|||
162177375|NCT05412004|585704351|FG000|Overall Study|Protocol Violation|1|||
162177376|NCT05412004|585704352|FG001|Overall Study|Protocol Violation|0|||
162177377|NCT05412004|585704353|FG002|Overall Study|Protocol Violation|0|||
162177378|NCT05412004|585704354|FG003|Overall Study|Protocol Violation|0|||
162177379|NCT05412004|585704351|FG000|Overall Study|Withdrawal by Subject|4|||
162177380|NCT05412004|585704352|FG001|Overall Study|Withdrawal by Subject|19|||
162177381|NCT05412004|585704353|FG002|Overall Study|Withdrawal by Subject|4|||
161923024|NCT03369223|584764930|FG009|Overall Study|Participant no longer meets study criteria|0|||
161923025|NCT03369223|584764931|FG010|Overall Study|Participant no longer meets study criteria|0|||
162177382|NCT05412004|585704354|FG003|Overall Study|Withdrawal by Subject|14|||
162177383|NCT05412004|585704351|FG000|Overall Study|Screen Failure|0|||
162177384|NCT05412004|585704352|FG001|Overall Study|Screen Failure|0|||
162177385|NCT05412004|585704353|FG002|Overall Study|Screen Failure|0|||
162177386|NCT05412004|585704354|FG003|Overall Study|Screen Failure|1|||
162177387|NCT05412004|585704351|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
162177388|NCT05412004|585704352|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
162177389|NCT05412004|585704353|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
162177390|NCT05412004|585704354|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
162177391|NCT03781089|585704355|FG000|Overall Study|Constipation|1|||
162177392|NCT03781089|585704356|FG001|Overall Study|Constipation|0|||
162177393|NCT03781089|585704355|FG000|Overall Study|Positive pregnancy test|0|||
162177394|NCT03781089|585704356|FG001|Overall Study|Positive pregnancy test|1|||
162177395|NCT04644029|585704357|FG000|Overall Study|Death|1|||
162177396|NCT04644029|585704358|FG001|Overall Study|Death|0|||
162177397|NCT04644029|585704357|FG000|Overall Study|Physician Decision|1|||
162177398|NCT04644029|585704358|FG001|Overall Study|Physician Decision|2|||
162177399|NCT04644029|585704357|FG000|Overall Study|Withdrawal by Subject|21|||
162177400|NCT04644029|585704358|FG001|Overall Study|Withdrawal by Subject|19|||
162177401|NCT04644029|585704357|FG000|Overall Study|Lost to Follow-up|31|||
162177402|NCT04644029|585704358|FG001|Overall Study|Lost to Follow-up|34|||
162177403|NCT04644029|585704357|FG000|Overall Study|Study Terminated by Sponsor|308|||
162177404|NCT04644029|585704358|FG001|Overall Study|Study Terminated by Sponsor|309|||
162177405|NCT04644029|585704357|FG000|Overall Study|Randomized in Error|2|||
162177406|NCT04644029|585704358|FG001|Overall Study|Randomized in Error|1|||
162177407|NCT04644029|585704357|FG000|Overall Study|Other|0|||
162177408|NCT04644029|585704358|FG001|Overall Study|Other|1|||
162177409|NCT05132400|585704359|FG000|Overall Study|Withdrawal by Subject|14|||
162177410|NCT05132400|585704360|FG001|Overall Study|Withdrawal by Subject|8|||
162177411|NCT05132400|585704359|FG000|Overall Study|Lost to Follow-up|132|||
162177412|NCT05132400|585704360|FG001|Overall Study|Lost to Follow-up|121|||
162177413|NCT02611687|585704363|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
162177414|NCT02611687|585704364|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
162177415|NCT03934931|585704365|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
162177416|NCT03934931|585704366|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
162177417|NCT03934931|585704367|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
162177418|NCT02246127|585704368|FG000|First Course Treatment|Adverse Event|9|||
162177419|NCT02246127|585704369|FG001|First Course Treatment|Adverse Event|7|||
162177420|NCT02246127|585704368|FG000|First Course Treatment|Withdrawal by Subject|6|||
162177421|NCT02246127|585704369|FG001|First Course Treatment|Withdrawal by Subject|7|||
162177422|NCT02246127|585704368|FG000|First Course Treatment|Physician Decision|9|||
162177423|NCT02246127|585704369|FG001|First Course Treatment|Physician Decision|9|||
162177424|NCT02246127|585704368|FG000|First Course Treatment|Death|3|||
162177425|NCT02246127|585704369|FG001|First Course Treatment|Death|3|||
162177426|NCT02246127|585704368|FG000|First Course Treatment|Not reported reasons|6|||
162177427|NCT02246127|585704369|FG001|First Course Treatment|Not reported reasons|7|||
162177428|NCT02246127|585704368|FG000|First Course Treatment|Not treated|3|||
162177429|NCT02246127|585704369|FG001|First Course Treatment|Not treated|3|||
162177430|NCT03635567|585704372|FG000|Overall Study|Lost to Follow-up|4|||
162177431|NCT03635567|585704373|FG001|Overall Study|Lost to Follow-up|1|||
162177432|NCT03635567|585704372|FG000|Overall Study|Withdrawal by Subject|11|||
162177433|NCT03635567|585704373|FG001|Overall Study|Withdrawal by Subject|16|||
162177434|NCT03635567|585704372|FG000|Overall Study|Sponsor Decision|99|||
162177435|NCT03635567|585704373|FG001|Overall Study|Sponsor Decision|57|||
162177436|NCT03635567|585704372|FG000|Overall Study|Death|194|||
162177437|NCT03635567|585704373|FG001|Overall Study|Death|235|||
162177438|NCT00739908|585704374|FG000|Overall Study|Adverse Event|5|||
162177439|NCT00739908|585704375|FG001|Overall Study|Adverse Event|6|||
161671520|NCT01182766|583851311|FG002|Overall Study|Non-compliance|1|||
161671521|NCT03027557|583851312|FG000|Overall Study|Adverse Event|1|||
161671522|NCT03027557|583851313|FG001|Overall Study|Adverse Event|0|||
162177440|NCT00739908|585704374|FG000|Overall Study|Withdrawal by Subject|4|||
162177441|NCT00739908|585704375|FG001|Overall Study|Withdrawal by Subject|2|||
162177442|NCT00739908|585704374|FG000|Overall Study|Lost to Follow-up|14|||
162177443|NCT00739908|585704375|FG001|Overall Study|Lost to Follow-up|9|||
162177444|NCT00739908|585704374|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
162177445|NCT00739908|585704375|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
162177446|NCT00739908|585704374|FG000|Overall Study|Non-Compliance With Study Medication|0|||
162177447|NCT00739908|585704375|FG001|Overall Study|Non-Compliance With Study Medication|3|||
162177448|NCT00739908|585704374|FG000|Overall Study|Lack of Efficacy|0|||
162177449|NCT00739908|585704375|FG001|Overall Study|Lack of Efficacy|1|||
162177450|NCT00739908|585704374|FG000|Overall Study|Relocation|0|||
162177451|NCT00739908|585704375|FG001|Overall Study|Relocation|1|||
162177452|NCT05157841|585704376|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
162177453|NCT05157841|585704377|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
162177454|NCT05157841|585704378|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
162177455|NCT05157841|585704376|FG000|Part A (14 Days)|Adverse Event|1|||
162177456|NCT05157841|585704377|FG001|Part A (14 Days)|Adverse Event|0|||
162177457|NCT05157841|585704378|FG002|Part A (14 Days)|Adverse Event|0|||
162177458|NCT05157841|585704376|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
162177459|NCT05157841|585704377|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
162177460|NCT05157841|585704378|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
162177461|NCT02076009|585704380|FG000|Overall Study|Death|172|||
162177462|NCT02076009|585704381|FG001|Overall Study|Death|153|||
162177463|NCT02076009|585704380|FG000|Overall Study|Withdrawal by Subject|16|||
162177464|NCT02076009|585704381|FG001|Overall Study|Withdrawal by Subject|12|||
162177465|NCT02076009|585704380|FG000|Overall Study|Lost to Follow-up|4|||
162177466|NCT02076009|585704381|FG001|Overall Study|Lost to Follow-up|2|||
162177467|NCT02076009|585704380|FG000|Overall Study|Progressive Disease|1|||
162177468|NCT02076009|585704381|FG001|Overall Study|Progressive Disease|0|||
162177469|NCT02076009|585704380|FG000|Overall Study|Physician Decision|0|||
162177470|NCT02076009|585704381|FG001|Overall Study|Physician Decision|1|||
162177471|NCT02076009|585704380|FG000|Overall Study|End of data collection|90|||
162177472|NCT02076009|585704381|FG001|Overall Study|End of data collection|118|||
162177473|NCT03786926|585704382|FG000|Overall Study|Adverse Event|0|||
162177474|NCT03786926|585704383|FG001|Overall Study|Adverse Event|0|||
162177475|NCT03786926|585704384|FG002|Overall Study|Adverse Event|0|||
162177476|NCT03786926|585704385|FG003|Overall Study|Adverse Event|0|||
162177477|NCT03786926|585704386|FG004|Overall Study|Adverse Event|0|||
162177478|NCT03786926|585704387|FG005|Overall Study|Adverse Event|0|||
162177479|NCT03786926|585704388|FG006|Overall Study|Adverse Event|0|||
162177480|NCT03786926|585704389|FG007|Overall Study|Adverse Event|1|||
162177481|NCT03786926|585704390|FG008|Overall Study|Adverse Event|1|||
162177482|NCT03786926|585704391|FG009|Overall Study|Adverse Event|0|||
162177483|NCT03786926|585704392|FG010|Overall Study|Adverse Event|1|||
162177484|NCT03786926|585704382|FG000|Overall Study|Progressive disease|3|||
162177485|NCT03786926|585704383|FG001|Overall Study|Progressive disease|0|||
162177486|NCT03786926|585704384|FG002|Overall Study|Progressive disease|3|||
162177487|NCT03786926|585704385|FG003|Overall Study|Progressive disease|1|||
162177488|NCT03786926|585704386|FG004|Overall Study|Progressive disease|2|||
162177489|NCT03786926|585704387|FG005|Overall Study|Progressive disease|2|||
162177490|NCT03786926|585704388|FG006|Overall Study|Progressive disease|1|||
162177491|NCT03786926|585704389|FG007|Overall Study|Progressive disease|6|||
162177492|NCT03786926|585704390|FG008|Overall Study|Progressive disease|1|||
162177493|NCT03786926|585704391|FG009|Overall Study|Progressive disease|1|||
162177494|NCT03786926|585704392|FG010|Overall Study|Progressive disease|1|||
162177495|NCT03786926|585704382|FG000|Overall Study|Death|0|||
162177496|NCT03786926|585704383|FG001|Overall Study|Death|1|||
162177497|NCT03786926|585704384|FG002|Overall Study|Death|1|||
162177498|NCT03786926|585704385|FG003|Overall Study|Death|0|||
162177499|NCT03786926|585704386|FG004|Overall Study|Death|0|||
162177500|NCT03786926|585704387|FG005|Overall Study|Death|0|||
162177501|NCT03786926|585704388|FG006|Overall Study|Death|0|||
162177502|NCT03786926|585704389|FG007|Overall Study|Death|0|||
162177503|NCT03786926|585704390|FG008|Overall Study|Death|0|||
161817058|NCT02213263|584370916|FG001|Overall Study|Protocol Violation|1|||
161817059|NCT02213263|584370915|FG000|Overall Study|Adverse Event|1|||
162177504|NCT03786926|585704391|FG009|Overall Study|Death|1|||
162177505|NCT03786926|585704392|FG010|Overall Study|Death|2|||
162177506|NCT03786926|585704382|FG000|Overall Study|Physician Decision|0|||
162177507|NCT03786926|585704383|FG001|Overall Study|Physician Decision|1|||
162177508|NCT03786926|585704384|FG002|Overall Study|Physician Decision|0|||
162177509|NCT03786926|585704385|FG003|Overall Study|Physician Decision|1|||
162177510|NCT03786926|585704386|FG004|Overall Study|Physician Decision|2|||
161817060|NCT02213263|584370916|FG001|Overall Study|Adverse Event|3|||
161817061|NCT05752721|584370917|FG000|Overall Study|Lost to Follow-up|22|||
161817062|NCT05752721|584370918|FG001|Overall Study|Lost to Follow-up|20|||
161817063|NCT05752721|584370917|FG000|Overall Study|Withdrawal by Subject|15|||
161817064|NCT05752721|584370918|FG001|Overall Study|Withdrawal by Subject|12|||
162177511|NCT03786926|585704387|FG005|Overall Study|Physician Decision|0|||
162177512|NCT03786926|585704388|FG006|Overall Study|Physician Decision|0|||
162177513|NCT03786926|585704389|FG007|Overall Study|Physician Decision|2|||
162177514|NCT03786926|585704390|FG008|Overall Study|Physician Decision|1|||
162177515|NCT03786926|585704391|FG009|Overall Study|Physician Decision|1|||
162177516|NCT03786926|585704392|FG010|Overall Study|Physician Decision|0|||
162177517|NCT03786926|585704382|FG000|Overall Study|Withdrawal by Subject|0|||
162177518|NCT03786926|585704383|FG001|Overall Study|Withdrawal by Subject|1|||
162177519|NCT03786926|585704384|FG002|Overall Study|Withdrawal by Subject|1|||
161817065|NCT00263588|584370919|FG000|Overall Study|Death|54|||
162177520|NCT03786926|585704385|FG003|Overall Study|Withdrawal by Subject|0|||
162177521|NCT03786926|585704386|FG004|Overall Study|Withdrawal by Subject|0|||
162177522|NCT03786926|585704387|FG005|Overall Study|Withdrawal by Subject|0|||
162177523|NCT03786926|585704388|FG006|Overall Study|Withdrawal by Subject|1|||
162177524|NCT03786926|585704389|FG007|Overall Study|Withdrawal by Subject|0|||
162177525|NCT03786926|585704390|FG008|Overall Study|Withdrawal by Subject|1|||
162177526|NCT03786926|585704391|FG009|Overall Study|Withdrawal by Subject|0|||
162177527|NCT03786926|585704392|FG010|Overall Study|Withdrawal by Subject|1|||
162177528|NCT03786926|585704382|FG000|Overall Study|Study terminated by Sponsor|0|||
162177529|NCT03786926|585704383|FG001|Overall Study|Study terminated by Sponsor|0|||
162177530|NCT03786926|585704384|FG002|Overall Study|Study terminated by Sponsor|0|||
162177531|NCT03786926|585704385|FG003|Overall Study|Study terminated by Sponsor|0|||
162177532|NCT03786926|585704386|FG004|Overall Study|Study terminated by Sponsor|1|||
162177533|NCT03786926|585704387|FG005|Overall Study|Study terminated by Sponsor|0|||
162177534|NCT03786926|585704388|FG006|Overall Study|Study terminated by Sponsor|0|||
162177535|NCT03786926|585704389|FG007|Overall Study|Study terminated by Sponsor|4|||
162177536|NCT03786926|585704390|FG008|Overall Study|Study terminated by Sponsor|0|||
162177537|NCT03786926|585704391|FG009|Overall Study|Study terminated by Sponsor|0|||
162177538|NCT03786926|585704392|FG010|Overall Study|Study terminated by Sponsor|0|||
162177539|NCT03786926|585704382|FG000|Overall Study|Anti-neoplasm treatment|0|||
162177540|NCT03786926|585704383|FG001|Overall Study|Anti-neoplasm treatment|0|||
162177541|NCT03786926|585704384|FG002|Overall Study|Anti-neoplasm treatment|0|||
162177542|NCT03786926|585704385|FG003|Overall Study|Anti-neoplasm treatment|0|||
162177543|NCT03786926|585704386|FG004|Overall Study|Anti-neoplasm treatment|1|||
162177544|NCT03786926|585704387|FG005|Overall Study|Anti-neoplasm treatment|0|||
162177545|NCT03786926|585704388|FG006|Overall Study|Anti-neoplasm treatment|1|||
162177546|NCT03786926|585704389|FG007|Overall Study|Anti-neoplasm treatment|0|||
162177547|NCT03786926|585704390|FG008|Overall Study|Anti-neoplasm treatment|0|||
162177548|NCT03786926|585704391|FG009|Overall Study|Anti-neoplasm treatment|0|||
162177549|NCT03786926|585704392|FG010|Overall Study|Anti-neoplasm treatment|0|||
162177550|NCT03786926|585704382|FG000|Overall Study|Other|0|||
162177551|NCT03786926|585704383|FG001|Overall Study|Other|0|||
162177552|NCT03786926|585704384|FG002|Overall Study|Other|0|||
162177553|NCT03786926|585704385|FG003|Overall Study|Other|1|||
162177554|NCT03786926|585704386|FG004|Overall Study|Other|0|||
162177555|NCT03786926|585704387|FG005|Overall Study|Other|1|||
162177556|NCT03786926|585704388|FG006|Overall Study|Other|0|||
162177557|NCT03786926|585704389|FG007|Overall Study|Other|0|||
162177558|NCT03786926|585704390|FG008|Overall Study|Other|2|||
162177559|NCT03786926|585704391|FG009|Overall Study|Other|0|||
162177560|NCT03786926|585704392|FG010|Overall Study|Other|0|||
162177561|NCT04757753|585704393|FG000|Overall Study|Lost to Follow-up|7|||
162177562|NCT04757753|585704394|FG001|Overall Study|Lost to Follow-up|7|||
162177563|NCT04757753|585704393|FG000|Overall Study|Withdrawal by Subject|0|||
162177564|NCT04757753|585704394|FG001|Overall Study|Withdrawal by Subject|3|||
162177565|NCT04757753|585704393|FG000|Overall Study|Endodontic treatment failure|1|||
162177566|NCT04757753|585704394|FG001|Overall Study|Endodontic treatment failure|2|||
162177567|NCT04757753|585704393|FG000|Overall Study|Tooth fracture/extraction|3|||
162177568|NCT04757753|585704394|FG001|Overall Study|Tooth fracture/extraction|0|||
162177569|NCT05988398|585704399|FG000|Overall Study|Lack of time|21|||
162177570|NCT05988398|585704400|FG001|Overall Study|Lack of time|0|||
162177571|NCT05988398|585704399|FG000|Overall Study|Absent from school|0|||
162177572|NCT05988398|585704400|FG001|Overall Study|Absent from school|38|||
162177573|NCT05988398|585704399|FG000|Overall Study|Chose not to participate|0|||
162177574|NCT05988398|585704400|FG001|Overall Study|Chose not to participate|42|||
162177575|NCT05988398|585704399|FG000|Overall Study|Other commitments (e.g., sports)|0|||
162177576|NCT05988398|585704400|FG001|Overall Study|Other commitments (e.g., sports)|25|||
162177577|NCT00942734|585704402|FG000|Overall Study|Adverse Event|2|||
162177578|NCT00942734|585704402|FG000|Overall Study|Protocol Violation|3|||
162177579|NCT00942734|585704402|FG000|Overall Study|Disease Progression|2|||
162177580|NCT00942734|585704402|FG000|Overall Study|Physician Decision|1|||
162177581|NCT03733626|585704403|FG000|Overall Study|Physician Decision|4|||
162177582|NCT03733626|585704404|FG001|Overall Study|Physician Decision|4|||
162177583|NCT00319046|585704405|FG000|Overall Study|withdrawal of subject's consent|7|||
162177584|NCT00319046|585704405|FG000|Overall Study|administrative reason|1|||
162177585|NCT05147584|585704406|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
162177586|NCT04560179|585704413|FG000|Overall Study|Physician Decision|1|||
162177587|NCT04560179|585704414|FG001|Overall Study|Physician Decision|0|||
162177588|NCT04560179|585704415|FG002|Overall Study|Physician Decision|0|||
162177589|NCT04560179|585704416|FG003|Overall Study|Physician Decision|0|||
162177590|NCT04560179|585704417|FG004|Overall Study|Physician Decision|0|||
162177591|NCT04560179|585704413|FG000|Overall Study|Adverse Event|0|||
162177592|NCT04560179|585704414|FG001|Overall Study|Adverse Event|0|||
162177593|NCT04560179|585704415|FG002|Overall Study|Adverse Event|0|||
162177594|NCT04560179|585704416|FG003|Overall Study|Adverse Event|1|||
162177595|NCT04560179|585704417|FG004|Overall Study|Adverse Event|0|||
162177596|NCT05454514|585704418|FG000|Overall Study|Withdrawal by Subject|4|||
162177597|NCT01438853|585704421|FG000|Overall Study|Death|0|||
162177598|NCT01438853|585704422|FG001|Overall Study|Death|0|||
162177599|NCT01438853|585704423|FG002|Overall Study|Death|0|||
162177600|NCT01438853|585704424|FG003|Overall Study|Death|1|||
162177601|NCT01438853|585704421|FG000|Overall Study|Withdrawal by Subject|0|||
162177602|NCT01438853|585704422|FG001|Overall Study|Withdrawal by Subject|0|||
162177603|NCT01438853|585704423|FG002|Overall Study|Withdrawal by Subject|1|||
162177604|NCT01438853|585704424|FG003|Overall Study|Withdrawal by Subject|0|||
162177605|NCT03279978|585704426|FG000|Overall Study|Withdrawal by Subject|0|||
162177606|NCT03279978|585704427|FG001|Overall Study|Withdrawal by Subject|1|||
162177607|NCT03279978|585704428|FG002|Overall Study|Withdrawal by Subject|0|||
162177608|NCT03279978|585704429|FG003|Overall Study|Withdrawal by Subject|0|||
162177609|NCT03279978|585704430|FG004|Overall Study|Withdrawal by Subject|0|||
162177610|NCT03279978|585704431|FG005|Overall Study|Withdrawal by Subject|0|||
162177611|NCT03279978|585704432|FG006|Overall Study|Withdrawal by Subject|0|||
162177612|NCT03279978|585704433|FG007|Overall Study|Withdrawal by Subject|0|||
162177613|NCT03279978|585704434|FG008|Overall Study|Withdrawal by Subject|0|||
162177614|NCT03279978|585704435|FG009|Overall Study|Withdrawal by Subject|1|||
162177615|NCT03279978|585704426|FG000|Overall Study|Lost to Follow-up|1|||
162177616|NCT03279978|585704427|FG001|Overall Study|Lost to Follow-up|0|||
162177617|NCT03279978|585704428|FG002|Overall Study|Lost to Follow-up|1|||
162177618|NCT03279978|585704429|FG003|Overall Study|Lost to Follow-up|0|||
162177619|NCT03279978|585704430|FG004|Overall Study|Lost to Follow-up|0|||
162177620|NCT03279978|585704431|FG005|Overall Study|Lost to Follow-up|0|||
162177621|NCT03279978|585704432|FG006|Overall Study|Lost to Follow-up|0|||
162177622|NCT03279978|585704433|FG007|Overall Study|Lost to Follow-up|0|||
162177623|NCT03279978|585704434|FG008|Overall Study|Lost to Follow-up|0|||
162177624|NCT03279978|585704435|FG009|Overall Study|Lost to Follow-up|0|||
162177625|NCT03279978|585704426|FG000|Overall Study|Other than stated above|0|||
162177626|NCT03279978|585704427|FG001|Overall Study|Other than stated above|0|||
162177627|NCT03279978|585704428|FG002|Overall Study|Other than stated above|0|||
162177628|NCT03279978|585704429|FG003|Overall Study|Other than stated above|0|||
162177629|NCT03279978|585704430|FG004|Overall Study|Other than stated above|0|||
162177630|NCT03279978|585704431|FG005|Overall Study|Other than stated above|0|||
162177631|NCT03279978|585704432|FG006|Overall Study|Other than stated above|1|||
162177632|NCT03279978|585704433|FG007|Overall Study|Other than stated above|0|||
162177633|NCT03279978|585704434|FG008|Overall Study|Other than stated above|0|||
162177634|NCT03279978|585704435|FG009|Overall Study|Other than stated above|0|||
162177635|NCT04159519|585704436|FG000|Overall Study|Adverse Event|1|||
162177636|NCT04159519|585704437|FG001|Overall Study|Adverse Event|1|||
162177637|NCT04159519|585704436|FG000|Overall Study|Lack of Efficacy|1|||
162177638|NCT04159519|585704437|FG001|Overall Study|Lack of Efficacy|0|||
162177639|NCT04159519|585704436|FG000|Overall Study|Discontinued from study|1|||
162177640|NCT04159519|585704437|FG001|Overall Study|Discontinued from study|0|||
162177641|NCT04159519|585704436|FG000|Overall Study|Protocol Violation|1|||
162177642|NCT04159519|585704437|FG001|Overall Study|Protocol Violation|1|||
162177643|NCT04159519|585704436|FG000|Overall Study|Withdrawal by Subject|4|||
162177644|NCT04159519|585704437|FG001|Overall Study|Withdrawal by Subject|4|||
162177645|NCT03493542|585704440|FG000|Base Study|Withdrawal by Subject|0|||
162177646|NCT03493542|585704441|FG001|Base Study|Withdrawal by Subject|4|||
162177647|NCT03493542|585704442|FG002|Base Study|Withdrawal by Subject|0|||
162177648|NCT03493542|585704440|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
162177649|NCT03493542|585704441|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
162177650|NCT03493542|585704442|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
162177651|NCT03493542|585704440|FG000|Extension Study|Withdrawal by Subject|0|||
162177652|NCT03493542|585704441|FG001|Extension Study|Withdrawal by Subject|0|||
162177653|NCT03493542|585704442|FG002|Extension Study|Withdrawal by Subject|25|||
162177654|NCT03734029|585704443|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
162177655|NCT03734029|585704444|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
162177656|NCT03734029|585704443|FG000|Overall Study|Adverse Event|60|||
162177657|NCT03734029|585704444|FG001|Overall Study|Adverse Event|14|||
161671523|NCT03027557|583851314|FG002|Overall Study|Adverse Event|0|||
162177658|NCT03734029|585704443|FG000|Overall Study|Withdrawal by Subject|12|||
162177659|NCT03734029|585704444|FG001|Overall Study|Withdrawal by Subject|11|||
162177660|NCT03734029|585704443|FG000|Overall Study|Clinical progression by investigator|10|||
162177661|NCT03734029|585704444|FG001|Overall Study|Clinical progression by investigator|8|||
162177662|NCT03734029|585704443|FG000|Overall Study|Death|5|||
161817066|NCT00263588|584370920|FG001|Overall Study|Death|90|||
161671524|NCT02430051|583851317|FG000|Overall Study|Withdrawal by Subject|6|||
161671525|NCT02430051|583851318|FG001|Overall Study|Withdrawal by Subject|3|||
161671526|NCT02430051|583851317|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
161671527|NCT02430051|583851318|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
161671528|NCT02430051|583851317|FG000|Overall Study|Protocol Violation|1|||
161671529|NCT02430051|583851318|FG001|Overall Study|Protocol Violation|0|||
161671530|NCT02030405|583851322|FG000|Overall Study|Withdrawal by Subject|1|||
161671531|NCT02030405|583851322|FG000|Overall Study|Lost to Follow-up|1|||
161671532|NCT01145755|583851325|FG000|Overall Study|Adverse Event|2|||
161671533|NCT01145755|583851326|FG001|Overall Study|Adverse Event|4|||
161923026|NCT03369223|584764932|FG011|Overall Study|Participant no longer meets study criteria|0|||
161923027|NCT03369223|584764933|FG012|Overall Study|Participant no longer meets study criteria|0|||
161923028|NCT03369223|584764934|FG013|Overall Study|Participant no longer meets study criteria|0|||
161671534|NCT01145755|583851327|FG002|Overall Study|Adverse Event|2|||
161923029|NCT03369223|584764935|FG014|Overall Study|Participant no longer meets study criteria|2|||
161923030|NCT03369223|584764936|FG015|Overall Study|Participant no longer meets study criteria|0|||
161923031|NCT03369223|584764937|FG016|Overall Study|Participant no longer meets study criteria|2|||
161923032|NCT03369223|584764938|FG017|Overall Study|Participant no longer meets study criteria|0|||
161923033|NCT03369223|584764939|FG018|Overall Study|Participant no longer meets study criteria|0|||
161923034|NCT03369223|584764940|FG019|Overall Study|Participant no longer meets study criteria|0|||
161923035|NCT03369223|584764921|FG000|Overall Study|Other reasons|0|||
161923036|NCT03369223|584764922|FG001|Overall Study|Other reasons|0|||
161923037|NCT03369223|584764923|FG002|Overall Study|Other reasons|0|||
161923038|NCT03369223|584764924|FG003|Overall Study|Other reasons|0|||
161923039|NCT03369223|584764925|FG004|Overall Study|Other reasons|0|||
161923040|NCT03369223|584764926|FG005|Overall Study|Other reasons|0|||
161923041|NCT03369223|584764927|FG006|Overall Study|Other reasons|0|||
161923042|NCT03369223|584764928|FG007|Overall Study|Other reasons|0|||
161923043|NCT03369223|584764929|FG008|Overall Study|Other reasons|0|||
161923044|NCT03369223|584764930|FG009|Overall Study|Other reasons|0|||
161923045|NCT03369223|584764931|FG010|Overall Study|Other reasons|0|||
161923046|NCT03369223|584764932|FG011|Overall Study|Other reasons|0|||
161923047|NCT03369223|584764933|FG012|Overall Study|Other reasons|0|||
161923048|NCT03369223|584764934|FG013|Overall Study|Other reasons|1|||
161923049|NCT03369223|584764935|FG014|Overall Study|Other reasons|2|||
161923050|NCT03369223|584764936|FG015|Overall Study|Other reasons|0|||
161923051|NCT03369223|584764937|FG016|Overall Study|Other reasons|1|||
161923052|NCT03369223|584764938|FG017|Overall Study|Other reasons|0|||
161923053|NCT03369223|584764939|FG018|Overall Study|Other reasons|0|||
161923054|NCT03369223|584764940|FG019|Overall Study|Other reasons|2|||
161923055|NCT03369223|584764921|FG000|Overall Study|Death|0|||
161923056|NCT03369223|584764922|FG001|Overall Study|Death|0|||
161923057|NCT03369223|584764923|FG002|Overall Study|Death|0|||
161923058|NCT03369223|584764924|FG003|Overall Study|Death|0|||
161923059|NCT03369223|584764925|FG004|Overall Study|Death|0|||
161923060|NCT03369223|584764926|FG005|Overall Study|Death|0|||
161923061|NCT03369223|584764927|FG006|Overall Study|Death|0|||
161923062|NCT03369223|584764928|FG007|Overall Study|Death|0|||
161923063|NCT03369223|584764929|FG008|Overall Study|Death|0|||
161923064|NCT03369223|584764930|FG009|Overall Study|Death|0|||
161923065|NCT03369223|584764931|FG010|Overall Study|Death|0|||
161923066|NCT03369223|584764932|FG011|Overall Study|Death|0|||
161923067|NCT03369223|584764933|FG012|Overall Study|Death|0|||
161923068|NCT03369223|584764934|FG013|Overall Study|Death|1|||
161923069|NCT03369223|584764935|FG014|Overall Study|Death|0|||
161923070|NCT03369223|584764936|FG015|Overall Study|Death|0|||
161923071|NCT03369223|584764937|FG016|Overall Study|Death|0|||
161923072|NCT03369223|584764938|FG017|Overall Study|Death|0|||
161923073|NCT03369223|584764939|FG018|Overall Study|Death|1|||
161923074|NCT03369223|584764940|FG019|Overall Study|Death|0|||
161923075|NCT03369223|584764921|FG000|Overall Study|Adverse event unrelated to study drug|0|||
161923076|NCT03369223|584764922|FG001|Overall Study|Adverse event unrelated to study drug|0|||
161923077|NCT03369223|584764923|FG002|Overall Study|Adverse event unrelated to study drug|0|||
161923078|NCT03369223|584764924|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161923079|NCT03369223|584764925|FG004|Overall Study|Adverse event unrelated to study drug|0|||
161923080|NCT03369223|584764926|FG005|Overall Study|Adverse event unrelated to study drug|0|||
161923081|NCT03369223|584764927|FG006|Overall Study|Adverse event unrelated to study drug|1|||
161923082|NCT03369223|584764928|FG007|Overall Study|Adverse event unrelated to study drug|0|||
161923083|NCT03369223|584764929|FG008|Overall Study|Adverse event unrelated to study drug|0|||
161923084|NCT03369223|584764930|FG009|Overall Study|Adverse event unrelated to study drug|1|||
161923085|NCT03369223|584764931|FG010|Overall Study|Adverse event unrelated to study drug|0|||
161923086|NCT03369223|584764932|FG011|Overall Study|Adverse event unrelated to study drug|0|||
161923087|NCT03369223|584764933|FG012|Overall Study|Adverse event unrelated to study drug|0|||
161923088|NCT03369223|584764934|FG013|Overall Study|Adverse event unrelated to study drug|4|||
161923089|NCT03369223|584764935|FG014|Overall Study|Adverse event unrelated to study drug|2|||
161923090|NCT03369223|584764936|FG015|Overall Study|Adverse event unrelated to study drug|0|||
162177663|NCT03734029|585704444|FG001|Overall Study|Death|2|||
162177664|NCT03734029|585704443|FG000|Overall Study|Physician Decision|4|||
162177665|NCT03734029|585704444|FG001|Overall Study|Physician Decision|3|||
162177666|NCT03734029|585704443|FG000|Overall Study|Other|2|||
162177667|NCT03734029|585704444|FG001|Overall Study|Other|0|||
162177668|NCT03734029|585704443|FG000|Overall Study|Lost to Follow-up|0|||
162177669|NCT03734029|585704444|FG001|Overall Study|Lost to Follow-up|1|||
162177670|NCT03734029|585704443|FG000|Overall Study|Randomized, but not treated|2|||
162177671|NCT03734029|585704444|FG001|Overall Study|Randomized, but not treated|12|||
162177672|NCT06655818|585705088|FG000|Overall Study|Withdrawal by Subject|1|||
162177673|NCT03370913|585705092|FG000|Overall Study|Death|1|||
162177674|NCT03370913|585705092|FG000|Overall Study|Lost to Follow-up|1|||
162177675|NCT03816397|585705093|FG000|Overall Study|Censored at interim analysis date.|13|||
162177676|NCT03816397|585705094|FG001|Overall Study|Censored at interim analysis date.|6|||
161923091|NCT03369223|584764937|FG016|Overall Study|Adverse event unrelated to study drug|2|||
161923092|NCT03369223|584764938|FG017|Overall Study|Adverse event unrelated to study drug|1|||
161923093|NCT03369223|584764939|FG018|Overall Study|Adverse event unrelated to study drug|3|||
161923094|NCT03369223|584764940|FG019|Overall Study|Adverse event unrelated to study drug|2|||
161923095|NCT03369223|584764921|FG000|Overall Study|Disease progression|6|||
161923096|NCT03369223|584764922|FG001|Overall Study|Disease progression|8|||
161923097|NCT03369223|584764923|FG002|Overall Study|Disease progression|5|||
161923098|NCT03369223|584764924|FG003|Overall Study|Disease progression|1|||
161923099|NCT03369223|584764925|FG004|Overall Study|Disease progression|9|||
161923100|NCT03369223|584764926|FG005|Overall Study|Disease progression|9|||
161923101|NCT03369223|584764927|FG006|Overall Study|Disease progression|4|||
162177677|NCT03816397|585705093|FG000|Overall Study|Withdrawal by Subject|1|||
162177678|NCT03816397|585705094|FG001|Overall Study|Withdrawal by Subject|1|||
162177679|NCT04496752|585705095|FG000|Second Assessment|Lost to Follow-up|3|||
161923102|NCT03369223|584764928|FG007|Overall Study|Disease progression|6|||
161923103|NCT03369223|584764929|FG008|Overall Study|Disease progression|10|||
162177680|NCT04496752|585705096|FG001|Second Assessment|Lost to Follow-up|3|||
161923104|NCT03369223|584764930|FG009|Overall Study|Disease progression|7|||
161923105|NCT03369223|584764931|FG010|Overall Study|Disease progression|4|||
162177681|NCT04496752|585705095|FG000|Second Assessment|Adverse Event|2|||
162177682|NCT04496752|585705096|FG001|Second Assessment|Adverse Event|0|||
162177683|NCT04078152|585705097|FG000|Overall Study|Other|83|||
162177684|NCT04078152|585705098|FG001|Overall Study|Other|22|||
162177685|NCT04078152|585705099|FG002|Overall Study|Other|25|||
162177686|NCT04078152|585705097|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
162177687|NCT04078152|585705098|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
162177688|NCT04078152|585705099|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
162177689|NCT04078152|585705097|FG000|Overall Study|Withdrawal by Subject|5|||
162177690|NCT04078152|585705098|FG001|Overall Study|Withdrawal by Subject|0|||
162177691|NCT04078152|585705099|FG002|Overall Study|Withdrawal by Subject|1|||
162177692|NCT04078152|585705097|FG000|Overall Study|Death|10|||
162177693|NCT04078152|585705098|FG001|Overall Study|Death|2|||
162177694|NCT04078152|585705099|FG002|Overall Study|Death|12|||
162177695|NCT04078152|585705097|FG000|Overall Study|Adverse Event|1|||
162177696|NCT04078152|585705098|FG001|Overall Study|Adverse Event|0|||
162177697|NCT04078152|585705099|FG002|Overall Study|Adverse Event|0|||
162177698|NCT04908930|585705105|FG000|Overall Study|Lost to Follow-up|1|||
162177699|NCT04908930|585705106|FG001|Overall Study|Lost to Follow-up|1|||
162177700|NCT04908930|585705107|FG002|Overall Study|Lost to Follow-up|0|||
162177701|NCT04908930|585705108|FG003|Overall Study|Lost to Follow-up|0|||
162177702|NCT04908930|585705109|FG004|Overall Study|Lost to Follow-up|0|||
162177703|NCT04908930|585705105|FG000|Overall Study|hardware in mouth|1|||
162177704|NCT04908930|585705106|FG001|Overall Study|hardware in mouth|1|||
162177705|NCT04908930|585705107|FG002|Overall Study|hardware in mouth|0|||
162177706|NCT04908930|585705108|FG003|Overall Study|hardware in mouth|0|||
162177707|NCT04908930|585705109|FG004|Overall Study|hardware in mouth|0|||
162177708|NCT04908930|585705105|FG000|Overall Study|wrong team|1|||
162177709|NCT04908930|585705106|FG001|Overall Study|wrong team|0|||
162177710|NCT04908930|585705107|FG002|Overall Study|wrong team|0|||
162177711|NCT04908930|585705108|FG003|Overall Study|wrong team|0|||
162177712|NCT04908930|585705109|FG004|Overall Study|wrong team|0|||
162177713|NCT04908930|585705105|FG000|Overall Study|quit team|2|||
162177714|NCT04908930|585705106|FG001|Overall Study|quit team|4|||
162177715|NCT04908930|585705107|FG002|Overall Study|quit team|0|||
162177716|NCT04908930|585705108|FG003|Overall Study|quit team|0|||
162177717|NCT04908930|585705109|FG004|Overall Study|quit team|0|||
162177718|NCT04908930|585705105|FG000|Overall Study|Withdrawal by Subject|1|||
162177719|NCT04908930|585705106|FG001|Overall Study|Withdrawal by Subject|2|||
162177720|NCT04908930|585705107|FG002|Overall Study|Withdrawal by Subject|0|||
162177721|NCT04908930|585705108|FG003|Overall Study|Withdrawal by Subject|0|||
162177722|NCT04908930|585705109|FG004|Overall Study|Withdrawal by Subject|0|||
162177723|NCT04908930|585705105|FG000|Overall Study|parent not liking program|0|||
162177724|NCT04908930|585705106|FG001|Overall Study|parent not liking program|1|||
162177725|NCT04908930|585705107|FG002|Overall Study|parent not liking program|0|||
162177726|NCT04908930|585705108|FG003|Overall Study|parent not liking program|0|||
162177727|NCT04908930|585705109|FG004|Overall Study|parent not liking program|0|||
162177728|NCT04679389|585705110|FG000|Overall Study|Adverse Event|1|||
162177729|NCT04679389|585705111|FG001|Overall Study|Adverse Event|0|||
162177730|NCT04679389|585705110|FG000|Overall Study|Protocol Violation|2|||
161671535|NCT01145755|583851325|FG000|Overall Study|Withdrawal by Subject|2|||
161671536|NCT01145755|583851326|FG001|Overall Study|Withdrawal by Subject|2|||
161671537|NCT01145755|583851327|FG002|Overall Study|Withdrawal by Subject|2|||
161671538|NCT01145755|583851325|FG000|Overall Study|Lost to Follow-up|2|||
161671539|NCT01145755|583851326|FG001|Overall Study|Lost to Follow-up|3|||
161671540|NCT01145755|583851327|FG002|Overall Study|Lost to Follow-up|1|||
161671541|NCT01145755|583851325|FG000|Overall Study|Protocol Violation|0|||
161671542|NCT01145755|583851326|FG001|Overall Study|Protocol Violation|3|||
161671543|NCT01145755|583851327|FG002|Overall Study|Protocol Violation|1|||
161671544|NCT01145755|583851325|FG000|Overall Study|Study Closure|14|||
161671545|NCT01145755|583851326|FG001|Overall Study|Study Closure|14|||
161671546|NCT01145755|583851327|FG002|Overall Study|Study Closure|17|||
161671547|NCT01145755|583851325|FG000|Overall Study|Lack of Efficacy|0|||
161671548|NCT01145755|583851326|FG001|Overall Study|Lack of Efficacy|1|||
162177731|NCT04679389|585705111|FG001|Overall Study|Protocol Violation|0|||
162177732|NCT04679389|585705110|FG000|Overall Study|Physician Decision|3|||
162177733|NCT04679389|585705111|FG001|Overall Study|Physician Decision|5|||
162177734|NCT04679389|585705110|FG000|Overall Study|Withdrawal by Subject|5|||
161671549|NCT01145755|583851327|FG002|Overall Study|Lack of Efficacy|0|||
161671550|NCT01145755|583851325|FG000|Overall Study|Patient could not swollow medication|0|||
161671551|NCT01145755|583851326|FG001|Overall Study|Patient could not swollow medication|0|||
161671552|NCT01145755|583851327|FG002|Overall Study|Patient could not swollow medication|1|||
161671553|NCT01145755|583851325|FG000|Overall Study|Withdrawal by Subject|0|||
162177735|NCT04679389|585705111|FG001|Overall Study|Withdrawal by Subject|7|||
162177736|NCT02777593|585705114|FG000|Overall Study|Still in study|1|||
162177737|NCT02777593|585705115|FG001|Overall Study|Still in study|32|||
162177738|NCT02777593|585705116|FG002|Overall Study|Still in study|3|||
162177739|NCT02777593|585705117|FG003|Overall Study|Still in study|6|||
162177740|NCT02777593|585705118|FG004|Overall Study|Still in study|5|||
162177741|NCT02777593|585705114|FG000|Overall Study|Death|21|||
162177742|NCT02777593|585705115|FG001|Overall Study|Death|28|||
162177743|NCT02777593|585705116|FG002|Overall Study|Death|0|||
162177744|NCT02777593|585705117|FG003|Overall Study|Death|5|||
162177745|NCT02777593|585705118|FG004|Overall Study|Death|0|||
162177746|NCT02777593|585705114|FG000|Overall Study|Withdrawal by Subject|8|||
162177747|NCT02777593|585705115|FG001|Overall Study|Withdrawal by Subject|4|||
162177748|NCT02777593|585705116|FG002|Overall Study|Withdrawal by Subject|1|||
162177749|NCT02777593|585705117|FG003|Overall Study|Withdrawal by Subject|1|||
162177750|NCT02777593|585705118|FG004|Overall Study|Withdrawal by Subject|0|||
162177751|NCT02777593|585705114|FG000|Overall Study|Lost to Follow-up|8|||
162177752|NCT02777593|585705115|FG001|Overall Study|Lost to Follow-up|16|||
162177753|NCT02777593|585705116|FG002|Overall Study|Lost to Follow-up|5|||
162177754|NCT02777593|585705117|FG003|Overall Study|Lost to Follow-up|0|||
162177755|NCT02777593|585705118|FG004|Overall Study|Lost to Follow-up|1|||
162177756|NCT02777593|585705114|FG000|Overall Study|Physician Decision|2|||
162177757|NCT02777593|585705115|FG001|Overall Study|Physician Decision|2|||
162177758|NCT02777593|585705116|FG002|Overall Study|Physician Decision|0|||
162177759|NCT02777593|585705117|FG003|Overall Study|Physician Decision|0|||
162177760|NCT02777593|585705118|FG004|Overall Study|Physician Decision|0|||
162177761|NCT02777593|585705114|FG000|Overall Study|Discontinued due to Other|1|||
162177762|NCT02777593|585705115|FG001|Overall Study|Discontinued due to Other|0|||
162177763|NCT02777593|585705116|FG002|Overall Study|Discontinued due to Other|0|||
162177764|NCT02777593|585705117|FG003|Overall Study|Discontinued due to Other|0|||
162177765|NCT02777593|585705118|FG004|Overall Study|Discontinued due to Other|0|||
162177766|NCT02624050|585705122|FG000|Overall Study|Physician Decision|4|||
162177767|NCT02624050|585705123|FG001|Overall Study|Physician Decision|0|||
162177768|NCT02624050|585705122|FG000|Overall Study|Protocol Violation|2|||
162177769|NCT02624050|585705123|FG001|Overall Study|Protocol Violation|0|||
162177770|NCT03547271|585705124|FG000|Overall Study|Adverse Event|1|||
162177771|NCT03547271|585705125|FG001|Overall Study|Adverse Event|1|||
162177772|NCT03547271|585705126|FG002|Overall Study|Adverse Event|0|||
162177773|NCT03547271|585705127|FG003|Overall Study|Adverse Event|0|||
162177774|NCT03547271|585705124|FG000|Overall Study|Protocol deviation|5|||
162177775|NCT03547271|585705125|FG001|Overall Study|Protocol deviation|7|||
162177776|NCT03547271|585705126|FG002|Overall Study|Protocol deviation|3|||
162177777|NCT03547271|585705127|FG003|Overall Study|Protocol deviation|0|||
162177778|NCT03547271|585705124|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
162177779|NCT03547271|585705125|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
162177780|NCT03547271|585705126|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
162177781|NCT03547271|585705127|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
162177782|NCT03547271|585705124|FG000|Overall Study|Lost to Follow-up|3|||
162177783|NCT03547271|585705125|FG001|Overall Study|Lost to Follow-up|3|||
162177784|NCT03547271|585705126|FG002|Overall Study|Lost to Follow-up|1|||
162177785|NCT03547271|585705127|FG003|Overall Study|Lost to Follow-up|0|||
162177786|NCT04795245|585705136|FG000|Overall Study|Unkown reason|7|||
162177787|NCT04795245|585705136|FG000|Overall Study|Death|17|||
162177788|NCT04795245|585705136|FG000|Overall Study|Other than listed|19|||
162177789|NCT04795245|585705136|FG000|Overall Study|Adverse Event|143|||
162177790|NCT04795245|585705136|FG000|Overall Study|Progressive disease|512|||
162177791|NCT04795245|585705136|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
162177792|NCT04780581|585705137|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
162177793|NCT04780581|585705138|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
162177794|NCT04780581|585705137|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
162177795|NCT04780581|585705138|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
162177796|NCT01756300|585705139|FG000|Overall Study|Death|1|||
162177797|NCT01756300|585705139|FG000|Overall Study|Withdrawal by Subject|1|||
162177798|NCT02765412|585705140|FG000|Overall Study|Death|482|||
162177799|NCT02765412|585705141|FG001|Overall Study|Death|855|||
162177800|NCT03990883|585705142|FG000|Blinded Treatment Phase|Adverse Event|1|||
162177801|NCT03990883|585705143|FG001|Blinded Treatment Phase|Adverse Event|1|||
162177802|NCT03990883|585705144|FG002|Blinded Treatment Phase|Adverse Event|0|||
162177803|NCT03990883|585705142|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
162177804|NCT03990883|585705143|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
162177805|NCT03990883|585705144|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
162177806|NCT03990883|585705142|FG000|Blinded Treatment Phase|Physician Decision|1|||
162177807|NCT03990883|585705143|FG001|Blinded Treatment Phase|Physician Decision|0|||
162177808|NCT03990883|585705144|FG002|Blinded Treatment Phase|Physician Decision|0|||
162177809|NCT03990883|585705142|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
162177810|NCT03990883|585705143|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
162177811|NCT03990883|585705144|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
162177812|NCT03990883|585705142|FG000|Blinded Treatment Phase|COVID-19|3|||
162177813|NCT03990883|585705143|FG001|Blinded Treatment Phase|COVID-19|2|||
161671554|NCT01145755|583851326|FG001|Overall Study|Withdrawal by Subject|0|||
161671555|NCT01145755|583851327|FG002|Overall Study|Withdrawal by Subject|1|||
161671556|NCT01145755|583851325|FG000|Overall Study|Positive urine ethanol|0|||
161671557|NCT01145755|583851326|FG001|Overall Study|Positive urine ethanol|1|||
161671558|NCT01145755|583851327|FG002|Overall Study|Positive urine ethanol|0|||
161671559|NCT01009554|583851330|FG000|Overall Study|Adverse Event|1|||
161671560|NCT01009554|583851331|FG001|Overall Study|Adverse Event|1|||
162177814|NCT03990883|585705144|FG002|Blinded Treatment Phase|COVID-19|0|||
162177815|NCT03990883|585705142|FG000|Blinded Treatment Phase|Personal Reasons|6|||
162177816|NCT03990883|585705143|FG001|Blinded Treatment Phase|Personal Reasons|3|||
162177817|NCT03990883|585705144|FG002|Blinded Treatment Phase|Personal Reasons|0|||
162177818|NCT03990883|585705142|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
162177819|NCT03990883|585705143|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
162177820|NCT03990883|585705144|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
162177821|NCT03990883|585705142|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
162177822|NCT03990883|585705143|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
162177823|NCT03990883|585705144|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
162177824|NCT03990883|585705142|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
162177825|NCT03990883|585705143|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
162177826|NCT03990883|585705144|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
162177827|NCT04678856|585705145|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
162177828|NCT04678856|585705146|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
162177829|NCT04678856|585705145|FG000|Overall Study|Withdrawal by Subject|5|||
162177830|NCT04678856|585705146|FG001|Overall Study|Withdrawal by Subject|1|||
162177831|NCT04595331|585705911|FG000|Overall Study|Withdrawal by Subject|0|||
162177832|NCT04595331|585705912|FG001|Overall Study|Withdrawal by Subject|1|||
162177833|NCT04595331|585705911|FG000|Overall Study|Lost to Follow-up|0|||
162177834|NCT04595331|585705912|FG001|Overall Study|Lost to Follow-up|5|||
162177835|NCT04595331|585705911|FG000|Overall Study|Medical reason|0|||
162177836|NCT04595331|585705912|FG001|Overall Study|Medical reason|1|||
162177837|NCT05020353|585705915|FG000|Overall Study|Protocol Violation|7|||
162177838|NCT05020353|585705915|FG000|Overall Study|Withdrawal by Subject|33|||
162177839|NCT02075554|585705921|FG000|Overall Study|Lost to Follow-up|7|||
162177840|NCT02075554|585705921|FG000|Overall Study|Withdrawal by Subject|5|||
162177841|NCT02075554|585705921|FG000|Overall Study|Physician Decision|3|||
162177842|NCT04933474|585705927|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
162177843|NCT04933474|585705928|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
162177844|NCT04933474|585705927|FG000|Overall Study|Lost to Follow-up|19|||
161671561|NCT01009554|583851330|FG000|Overall Study|Withdrawal by Subject|1|||
161671562|NCT01009554|583851331|FG001|Overall Study|Withdrawal by Subject|3|||
161671563|NCT01009554|583851330|FG000|Overall Study|Noncompliant with Study Product|0|||
161671564|NCT01009554|583851331|FG001|Overall Study|Noncompliant with Study Product|3|||
161671565|NCT01605253|583851332|FG000|Overall Study|Physician Decision|3|||
161671566|NCT01605253|583851333|FG001|Overall Study|Physician Decision|2|||
161671567|NCT01605253|583851332|FG000|Overall Study|Lost to Follow-up|3|||
161671568|NCT01605253|583851333|FG001|Overall Study|Lost to Follow-up|1|||
161671569|NCT02973048|583851334|FG000|Overall Study|Epidural catheter insertion failure|1|||
161671570|NCT02973048|583851335|FG001|Overall Study|Epidural catheter insertion failure|0|||
161671571|NCT02973048|583851334|FG000|Overall Study|Withdrawal by Subject|0|||
161671572|NCT02973048|583851335|FG001|Overall Study|Withdrawal by Subject|3|||
161671573|NCT04427501|583851336|FG000|Overall Study|Death|0|||
161671574|NCT04427501|583851337|FG001|Overall Study|Death|0|||
161671575|NCT04427501|583851338|FG002|Overall Study|Death|0|||
161671576|NCT04427501|583851339|FG003|Overall Study|Death|0|||
161671577|NCT04427501|583851340|FG004|Overall Study|Death|0|||
161671578|NCT04427501|583851341|FG005|Overall Study|Death|15|||
161671579|NCT04427501|583851342|FG006|Overall Study|Death|0|||
161671580|NCT04427501|583851343|FG007|Overall Study|Death|0|||
161671581|NCT04427501|583851344|FG008|Overall Study|Death|0|||
161671582|NCT04427501|583851345|FG009|Overall Study|Death|0|||
161671583|NCT04427501|583851346|FG010|Overall Study|Death|0|||
161817067|NCT00263588|584370919|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
162177845|NCT04933474|585705928|FG001|Overall Study|Lost to Follow-up|9|||
162177846|NCT04933474|585705927|FG000|Overall Study|Life Burden - unable to participate|6|||
162177847|NCT04933474|585705928|FG001|Overall Study|Life Burden - unable to participate|2|||
161671584|NCT04427501|583851347|FG011|Overall Study|Death|0|||
162177848|NCT04933474|585705927|FG000|Overall Study|Disease Burden - unable to participate|4|||
162177849|NCT04933474|585705928|FG001|Overall Study|Disease Burden - unable to participate|1|||
162177850|NCT04933474|585705927|FG000|Overall Study|Surgery/Hospitalization|1|||
161671585|NCT04427501|583851336|FG000|Overall Study|Lost to Follow-up|5|||
161671586|NCT04427501|583851337|FG001|Overall Study|Lost to Follow-up|1|||
161671587|NCT04427501|583851338|FG002|Overall Study|Lost to Follow-up|2|||
161671588|NCT04427501|583851339|FG003|Overall Study|Lost to Follow-up|0|||
161671589|NCT04427501|583851340|FG004|Overall Study|Lost to Follow-up|2|||
161671590|NCT04427501|583851341|FG005|Overall Study|Lost to Follow-up|11|||
161671591|NCT04427501|583851342|FG006|Overall Study|Lost to Follow-up|10|||
161817068|NCT00263588|584370920|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
162177851|NCT04933474|585705928|FG001|Overall Study|Surgery/Hospitalization|2|||
162177852|NCT04933474|585705927|FG000|Overall Study|Dissatisfied with Intervention|1|||
162177853|NCT04933474|585705928|FG001|Overall Study|Dissatisfied with Intervention|1|||
162177854|NCT04933474|585705927|FG000|Overall Study|Withdrew interest in participation|1|||
162177855|NCT04933474|585705928|FG001|Overall Study|Withdrew interest in participation|0|||
162177856|NCT04933474|585705927|FG000|Overall Study|Had previously enrolled in the study|0|||
162177857|NCT04933474|585705928|FG001|Overall Study|Had previously enrolled in the study|1|||
162177858|NCT04214418|585705948|FG000|Overall Study|Withdrawal by Subject|1|||
162177859|NCT04214418|585705949|FG001|Overall Study|Withdrawal by Subject|0|||
162177860|NCT04214418|585705950|FG002|Overall Study|Withdrawal by Subject|0|||
162177861|NCT04214418|585705951|FG003|Overall Study|Withdrawal by Subject|0|||
162177862|NCT04214418|585705952|FG004|Overall Study|Withdrawal by Subject|0|||
162177863|NCT04214418|585705953|FG005|Overall Study|Withdrawal by Subject|0|||
162177864|NCT04214418|585705948|FG000|Overall Study|Adverse Event|0|||
162177865|NCT04214418|585705949|FG001|Overall Study|Adverse Event|2|||
162177866|NCT04214418|585705950|FG002|Overall Study|Adverse Event|0|||
162177867|NCT04214418|585705951|FG003|Overall Study|Adverse Event|0|||
162177868|NCT04214418|585705952|FG004|Overall Study|Adverse Event|0|||
162177869|NCT04214418|585705953|FG005|Overall Study|Adverse Event|0|||
162177870|NCT04214418|585705948|FG000|Overall Study|Death|1|||
161817069|NCT00263588|584370919|FG000|Overall Study|Lost to Follow-up|7|||
161817070|NCT00263588|584370920|FG001|Overall Study|Lost to Follow-up|10|||
161817071|NCT00263588|584370919|FG000|Overall Study|Withdrawal by Subject|3|||
161817072|NCT00263588|584370920|FG001|Overall Study|Withdrawal by Subject|4|||
161817073|NCT00263588|584370919|FG000|Overall Study|Protocol Violation|0|||
161817074|NCT00263588|584370920|FG001|Overall Study|Protocol Violation|1|||
161817075|NCT00263588|584370919|FG000|Overall Study|Investigator decision|7|||
161817076|NCT00263588|584370920|FG001|Overall Study|Investigator decision|15|||
161817077|NCT00263588|584370919|FG000|Overall Study|Sponsor terminated study|0|||
161817078|NCT00263588|584370920|FG001|Overall Study|Sponsor terminated study|1|||
161817079|NCT00463684|584370932|FG000|Overall Study|Withdrawal by Subject|1|||
161817080|NCT00463684|584370932|FG000|Overall Study|Lost to Follow-up|3|||
161817081|NCT01906372|584370933|FG000|Overall Study|Withdrawal by Subject|2|||
161817082|NCT03629054|584370934|FG000|Period 2 (4 Days)|Not treated|0|||
161817083|NCT03629054|584370935|FG001|Period 2 (4 Days)|Not treated|1|||
161817084|NCT02462837|584370936|FG000|Overall Study|pt developed hives|1|||
161923106|NCT03369223|584764932|FG011|Overall Study|Disease progression|1|||
161923107|NCT03369223|584764933|FG012|Overall Study|Disease progression|1|||
162177871|NCT04214418|585705949|FG001|Overall Study|Death|0|||
161923108|NCT03369223|584764934|FG013|Overall Study|Disease progression|25|||
161923109|NCT03369223|584764935|FG014|Overall Study|Disease progression|22|||
161923110|NCT03369223|584764936|FG015|Overall Study|Disease progression|2|||
161923111|NCT03369223|584764937|FG016|Overall Study|Disease progression|10|||
161923112|NCT03369223|584764938|FG017|Overall Study|Disease progression|1|||
161923113|NCT03369223|584764939|FG018|Overall Study|Disease progression|18|||
161923114|NCT03369223|584764940|FG019|Overall Study|Disease progression|28|||
161923115|NCT03369223|584764921|FG000|Overall Study|Study drug toxicity|0|||
161923116|NCT03369223|584764922|FG001|Overall Study|Study drug toxicity|1|||
161923117|NCT03369223|584764923|FG002|Overall Study|Study drug toxicity|4|||
161923118|NCT03369223|584764924|FG003|Overall Study|Study drug toxicity|0|||
161923119|NCT03369223|584764925|FG004|Overall Study|Study drug toxicity|1|||
161923120|NCT03369223|584764926|FG005|Overall Study|Study drug toxicity|2|||
161923121|NCT03369223|584764927|FG006|Overall Study|Study drug toxicity|4|||
161923122|NCT03369223|584764928|FG007|Overall Study|Study drug toxicity|2|||
161923123|NCT03369223|584764929|FG008|Overall Study|Study drug toxicity|2|||
161923124|NCT03369223|584764930|FG009|Overall Study|Study drug toxicity|0|||
161923125|NCT03369223|584764931|FG010|Overall Study|Study drug toxicity|6|||
161923126|NCT03369223|584764932|FG011|Overall Study|Study drug toxicity|1|||
162177872|NCT04214418|585705950|FG002|Overall Study|Death|0|||
162177873|NCT04214418|585705951|FG003|Overall Study|Death|0|||
161817085|NCT02462837|584370937|FG001|Overall Study|pt developed hives|0|||
161817086|NCT02462837|584370936|FG000|Overall Study|Withdrawal by Subject|1|||
161817087|NCT02462837|584370937|FG001|Overall Study|Withdrawal by Subject|0|||
161923127|NCT03369223|584764933|FG012|Overall Study|Study drug toxicity|2|||
161923128|NCT03369223|584764934|FG013|Overall Study|Study drug toxicity|19|||
161923129|NCT03369223|584764935|FG014|Overall Study|Study drug toxicity|19|||
162177874|NCT04214418|585705952|FG004|Overall Study|Death|0|||
162177875|NCT04214418|585705953|FG005|Overall Study|Death|0|||
161817088|NCT00924638|584370941|FG000|Overall Study|Death|3|||
161817089|NCT00924638|584370942|FG001|Overall Study|Death|2|||
162177876|NCT05836012|585705956|FG000|Overall Study|Lost to Follow-up|1|||
162177877|NCT05836012|585705957|FG001|Overall Study|Lost to Follow-up|0|||
161817090|NCT00924638|584370941|FG000|Overall Study|Lost to Follow-up|1|||
161817091|NCT00924638|584370942|FG001|Overall Study|Lost to Follow-up|1|||
161923130|NCT03369223|584764936|FG015|Overall Study|Study drug toxicity|0|||
161923131|NCT03369223|584764937|FG016|Overall Study|Study drug toxicity|18|||
161923132|NCT03369223|584764938|FG017|Overall Study|Study drug toxicity|3|||
161923133|NCT03369223|584764939|FG018|Overall Study|Study drug toxicity|11|||
162177878|NCT05836012|585705956|FG000|Overall Study|Withdrawal by Subject|1|||
162177879|NCT05836012|585705957|FG001|Overall Study|Withdrawal by Subject|3|||
162177880|NCT05836012|585705956|FG000|Overall Study|Reason not included in pre-specified categories|2|||
162177881|NCT05836012|585705957|FG001|Overall Study|Reason not included in pre-specified categories|1|||
162177882|NCT05785130|585705965|FG000|Overall Study|Withdrawal by Subject|1|||
162177883|NCT05785130|585705966|FG001|Overall Study|Withdrawal by Subject|0|||
162177884|NCT05785130|585705965|FG000|Overall Study|Lack of Efficacy|0|||
162177885|NCT05785130|585705966|FG001|Overall Study|Lack of Efficacy|1|||
162177886|NCT03904576|585705967|FG000|Washout Period|Protocol Violation|1|||
162177887|NCT03904576|585705968|FG001|Washout Period|Protocol Violation|1|||
162177888|NCT05718687|585705971|FG000|Overall Study|Withdrawal by Subject|3|||
162177889|NCT05215054|585705976|FG000|Overall Study|Lost to Follow-up|1|||
162177890|NCT05215054|585705977|FG001|Overall Study|Lost to Follow-up|1|||
162177891|NCT05215054|585705976|FG000|Overall Study|Protocol Violation|1|||
162177892|NCT05215054|585705977|FG001|Overall Study|Protocol Violation|1|||
162177893|NCT05215054|585705976|FG000|Overall Study|Withdrawal by Subject|4|||
162177894|NCT05215054|585705977|FG001|Overall Study|Withdrawal by Subject|4|||
162177895|NCT01897441|585705978|FG000|Overall Study|Lost to Follow-up|0|||
162177896|NCT01897441|585705979|FG001|Overall Study|Lost to Follow-up|0|||
162177897|NCT01897441|585705980|FG002|Overall Study|Lost to Follow-up|1|||
162177898|NCT01897441|585705981|FG003|Overall Study|Lost to Follow-up|0|||
162177899|NCT01897441|585705982|FG004|Overall Study|Lost to Follow-up|0|||
162177900|NCT01897441|585705983|FG005|Overall Study|Lost to Follow-up|0|||
162177901|NCT01897441|585705978|FG000|Overall Study|Withdrawal by Subject|0|||
162177902|NCT01897441|585705979|FG001|Overall Study|Withdrawal by Subject|0|||
162177903|NCT01897441|585705980|FG002|Overall Study|Withdrawal by Subject|0|||
162177904|NCT01897441|585705981|FG003|Overall Study|Withdrawal by Subject|0|||
162177905|NCT01897441|585705982|FG004|Overall Study|Withdrawal by Subject|1|||
162177906|NCT01897441|585705983|FG005|Overall Study|Withdrawal by Subject|0|||
162177907|NCT01897441|585705978|FG000|Overall Study|Withdrawn by Provider|0|||
162177908|NCT01897441|585705979|FG001|Overall Study|Withdrawn by Provider|2|||
162177909|NCT01897441|585705980|FG002|Overall Study|Withdrawn by Provider|0|||
162177910|NCT01897441|585705981|FG003|Overall Study|Withdrawn by Provider|0|||
162177911|NCT01897441|585705982|FG004|Overall Study|Withdrawn by Provider|0|||
162177912|NCT01897441|585705983|FG005|Overall Study|Withdrawn by Provider|0|||
162177913|NCT02933489|585705984|FG000|Overall Study|Ineligible|3|||
162177914|NCT02933489|585705985|FG001|Overall Study|Ineligible|3|||
162177915|NCT02933489|585705984|FG000|Overall Study|Withdrawal by Subject|27|||
162177916|NCT02933489|585705985|FG001|Overall Study|Withdrawal by Subject|18|||
162177917|NCT02933489|585705984|FG000|Overall Study|Unable to complete exams (other)|14|||
162177918|NCT02933489|585705985|FG001|Overall Study|Unable to complete exams (other)|7|||
162177919|NCT05485935|585705986|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
162177920|NCT05485935|585705987|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
162177921|NCT05485935|585705986|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
162177922|NCT05485935|585705987|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
162177923|NCT05485935|585705986|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
162177924|NCT05485935|585705987|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
162177925|NCT05485935|585705986|FG000|Period 2 (T2 and V3)|loss of contact|0|||
162177926|NCT05485935|585705987|FG001|Period 2 (T2 and V3)|loss of contact|1|||
162177927|NCT02325154|585705988|FG000|Overall Study|Physician Decision|1|||
162177928|NCT04633278|585706980|FG000|Overall Study|Adverse Event|1|||
162177929|NCT04633278|585706981|FG001|Overall Study|Adverse Event|0|||
162177930|NCT04633278|585706980|FG000|Overall Study|Withdrawal by Subject|1|||
162177931|NCT04633278|585706981|FG001|Overall Study|Withdrawal by Subject|0|||
162177932|NCT04633278|585706980|FG000|Overall Study|Death|11|||
162177933|NCT04633278|585706981|FG001|Overall Study|Death|7|||
162177934|NCT04633278|585706980|FG000|Overall Study|Sponsor Decision|3|||
162177935|NCT04633278|585706981|FG001|Overall Study|Sponsor Decision|0|||
162177936|NCT04633278|585706980|FG000|Overall Study|Not Listed|1|||
162177937|NCT04633278|585706981|FG001|Overall Study|Not Listed|0|||
162177938|NCT03705793|585706982|FG000|Overall Study|Lost to Follow-up|3|||
162177939|NCT03705793|585706983|FG001|Overall Study|Lost to Follow-up|4|||
162177940|NCT03705793|585706982|FG000|Overall Study|Withdrawal by Subject|2|||
162177941|NCT03705793|585706983|FG001|Overall Study|Withdrawal by Subject|1|||
162177942|NCT00447980|585706984|FG000|Overall Study|Withdrawal by Subject|1|||
162177943|NCT00447980|585706985|FG001|Overall Study|Withdrawal by Subject|1|||
162177944|NCT00447980|585706986|FG002|Overall Study|Withdrawal by Subject|4|||
162177945|NCT00447980|585706987|FG003|Overall Study|Withdrawal by Subject|4|||
162177946|NCT00447980|585706984|FG000|Overall Study|Lost to Follow-up|1|||
162177947|NCT00447980|585706985|FG001|Overall Study|Lost to Follow-up|1|||
162177948|NCT00447980|585706986|FG002|Overall Study|Lost to Follow-up|0|||
162177949|NCT00447980|585706987|FG003|Overall Study|Lost to Follow-up|0|||
162177950|NCT00447980|585706984|FG000|Overall Study|Did not proceed with surgery|3|||
162177951|NCT00447980|585706985|FG001|Overall Study|Did not proceed with surgery|3|||
162177952|NCT00447980|585706986|FG002|Overall Study|Did not proceed with surgery|2|||
162177953|NCT00447980|585706987|FG003|Overall Study|Did not proceed with surgery|2|||
162177954|NCT02720068|585706988|FG000|Overall Study|Adverse Event|0|||
162018666|NCT01349049|585123169|FG006|Overall Study|Death|0|||
162018667|NCT01349049|585123170|FG007|Overall Study|Death|1|||
162018668|NCT01349049|585123171|FG008|Overall Study|Death|5|||
162018669|NCT01349049|585123163|FG000|Overall Study|Non-compliance|0|||
162018670|NCT01349049|585123164|FG001|Overall Study|Non-compliance|0|||
162177955|NCT02720068|585706989|FG001|Overall Study|Adverse Event|0|||
162177956|NCT02720068|585706990|FG002|Overall Study|Adverse Event|0|||
162177957|NCT02720068|585706991|FG003|Overall Study|Adverse Event|0|||
162177958|NCT02720068|585706992|FG004|Overall Study|Adverse Event|0|||
162177959|NCT02720068|585706993|FG005|Overall Study|Adverse Event|0|||
162177960|NCT02720068|585706994|FG006|Overall Study|Adverse Event|0|||
162177961|NCT02720068|585706995|FG007|Overall Study|Adverse Event|0|||
162177962|NCT02720068|585706996|FG008|Overall Study|Adverse Event|0|||
162177963|NCT02720068|585706997|FG009|Overall Study|Adverse Event|0|||
162177964|NCT02720068|585706998|FG010|Overall Study|Adverse Event|0|||
162177965|NCT02720068|585706999|FG011|Overall Study|Adverse Event|1|||
162177966|NCT02720068|585707000|FG012|Overall Study|Adverse Event|0|||
162177967|NCT02720068|585707001|FG013|Overall Study|Adverse Event|0|||
162177968|NCT02720068|585707002|FG014|Overall Study|Adverse Event|0|||
162177969|NCT02720068|585707003|FG015|Overall Study|Adverse Event|0|||
162177970|NCT02720068|585707004|FG016|Overall Study|Adverse Event|0|||
162177971|NCT02720068|585707005|FG017|Overall Study|Adverse Event|0|||
162177972|NCT02720068|585706988|FG000|Overall Study|Death|1|||
162177973|NCT02720068|585706989|FG001|Overall Study|Death|3|||
162177974|NCT02720068|585706990|FG002|Overall Study|Death|2|||
162177975|NCT02720068|585706991|FG003|Overall Study|Death|1|||
162177976|NCT02720068|585706992|FG004|Overall Study|Death|2|||
162177977|NCT02720068|585706993|FG005|Overall Study|Death|1|||
162177978|NCT02720068|585706994|FG006|Overall Study|Death|2|||
162177979|NCT02720068|585706995|FG007|Overall Study|Death|2|||
162177980|NCT02720068|585706996|FG008|Overall Study|Death|3|||
162177981|NCT02720068|585706997|FG009|Overall Study|Death|1|||
162177982|NCT02720068|585706998|FG010|Overall Study|Death|20|||
162177983|NCT02720068|585706999|FG011|Overall Study|Death|166|||
162018671|NCT01349049|585123165|FG002|Overall Study|Non-compliance|0|||
162018672|NCT01349049|585123166|FG003|Overall Study|Non-compliance|1|||
162177984|NCT02720068|585707000|FG012|Overall Study|Death|34|||
162177985|NCT02720068|585707001|FG013|Overall Study|Death|30|||
162177986|NCT02720068|585707002|FG014|Overall Study|Death|45|||
162177987|NCT02720068|585707003|FG015|Overall Study|Death|16|||
162177988|NCT02720068|585707004|FG016|Overall Study|Death|20|||
162177989|NCT02720068|585707005|FG017|Overall Study|Death|28|||
162177990|NCT02720068|585706988|FG000|Overall Study|Lost to Follow-up|0|||
162177991|NCT02720068|585706989|FG001|Overall Study|Lost to Follow-up|0|||
162177992|NCT02720068|585706990|FG002|Overall Study|Lost to Follow-up|0|||
162177993|NCT02720068|585706991|FG003|Overall Study|Lost to Follow-up|0|||
162177994|NCT02720068|585706992|FG004|Overall Study|Lost to Follow-up|0|||
162177995|NCT02720068|585706993|FG005|Overall Study|Lost to Follow-up|0|||
162177996|NCT02720068|585706994|FG006|Overall Study|Lost to Follow-up|0|||
162177997|NCT02720068|585706995|FG007|Overall Study|Lost to Follow-up|0|||
162177998|NCT02720068|585706996|FG008|Overall Study|Lost to Follow-up|0|||
162177999|NCT02720068|585706997|FG009|Overall Study|Lost to Follow-up|0|||
162178000|NCT02720068|585706998|FG010|Overall Study|Lost to Follow-up|0|||
162178001|NCT02720068|585706999|FG011|Overall Study|Lost to Follow-up|1|||
162178002|NCT02720068|585707000|FG012|Overall Study|Lost to Follow-up|0|||
162178003|NCT02720068|585707001|FG013|Overall Study|Lost to Follow-up|1|||
162178004|NCT02720068|585707002|FG014|Overall Study|Lost to Follow-up|2|||
162178005|NCT02720068|585707003|FG015|Overall Study|Lost to Follow-up|0|||
162178006|NCT02720068|585707004|FG016|Overall Study|Lost to Follow-up|0|||
162178007|NCT02720068|585707005|FG017|Overall Study|Lost to Follow-up|1|||
162178008|NCT02720068|585706988|FG000|Overall Study|Physician Decision|0|||
162178009|NCT02720068|585706989|FG001|Overall Study|Physician Decision|0|||
162178010|NCT02720068|585706990|FG002|Overall Study|Physician Decision|0|||
162178011|NCT02720068|585706991|FG003|Overall Study|Physician Decision|1|||
162178012|NCT02720068|585706992|FG004|Overall Study|Physician Decision|0|||
162178013|NCT02720068|585706993|FG005|Overall Study|Physician Decision|0|||
162178014|NCT02720068|585706994|FG006|Overall Study|Physician Decision|0|||
162178015|NCT02720068|585706995|FG007|Overall Study|Physician Decision|0|||
162178016|NCT02720068|585706996|FG008|Overall Study|Physician Decision|0|||
162178017|NCT02720068|585706997|FG009|Overall Study|Physician Decision|0|||
162178018|NCT02720068|585706998|FG010|Overall Study|Physician Decision|0|||
162178019|NCT02720068|585706999|FG011|Overall Study|Physician Decision|1|||
162178020|NCT02720068|585707000|FG012|Overall Study|Physician Decision|0|||
162178021|NCT02720068|585707001|FG013|Overall Study|Physician Decision|0|||
162178022|NCT02720068|585707002|FG014|Overall Study|Physician Decision|0|||
162178023|NCT02720068|585707003|FG015|Overall Study|Physician Decision|0|||
162178024|NCT02720068|585707004|FG016|Overall Study|Physician Decision|0|||
162178025|NCT02720068|585707005|FG017|Overall Study|Physician Decision|1|||
162178026|NCT02720068|585706988|FG000|Overall Study|Progressive Disease|2|||
162178027|NCT02720068|585706989|FG001|Overall Study|Progressive Disease|3|||
162178028|NCT02720068|585706990|FG002|Overall Study|Progressive Disease|1|||
162178029|NCT02720068|585706991|FG003|Overall Study|Progressive Disease|1|||
162178030|NCT02720068|585706992|FG004|Overall Study|Progressive Disease|1|||
162178031|NCT02720068|585706993|FG005|Overall Study|Progressive Disease|2|||
162178032|NCT02720068|585706994|FG006|Overall Study|Progressive Disease|1|||
162178033|NCT02720068|585706995|FG007|Overall Study|Progressive Disease|1|||
162178034|NCT02720068|585706996|FG008|Overall Study|Progressive Disease|0|||
162178035|NCT02720068|585706997|FG009|Overall Study|Progressive Disease|1|||
162178036|NCT02720068|585706998|FG010|Overall Study|Progressive Disease|0|||
162178037|NCT02720068|585706999|FG011|Overall Study|Progressive Disease|4|||
162178038|NCT02720068|585707000|FG012|Overall Study|Progressive Disease|1|||
162178039|NCT02720068|585707001|FG013|Overall Study|Progressive Disease|0|||
162178040|NCT02720068|585707002|FG014|Overall Study|Progressive Disease|0|||
162178041|NCT02720068|585707003|FG015|Overall Study|Progressive Disease|0|||
162178042|NCT02720068|585707004|FG016|Overall Study|Progressive Disease|0|||
162178043|NCT02720068|585707005|FG017|Overall Study|Progressive Disease|0|||
162178044|NCT02720068|585706988|FG000|Overall Study|Sponsor Decision|0|||
162178045|NCT02720068|585706989|FG001|Overall Study|Sponsor Decision|0|||
162178046|NCT02720068|585706990|FG002|Overall Study|Sponsor Decision|0|||
162178047|NCT02720068|585706991|FG003|Overall Study|Sponsor Decision|0|||
162178048|NCT02720068|585706992|FG004|Overall Study|Sponsor Decision|0|||
162178049|NCT02720068|585706993|FG005|Overall Study|Sponsor Decision|0|||
162178050|NCT02720068|585706994|FG006|Overall Study|Sponsor Decision|0|||
162178051|NCT02720068|585706995|FG007|Overall Study|Sponsor Decision|0|||
162178052|NCT02720068|585706996|FG008|Overall Study|Sponsor Decision|0|||
162178053|NCT02720068|585706997|FG009|Overall Study|Sponsor Decision|0|||
162178054|NCT02720068|585706998|FG010|Overall Study|Sponsor Decision|0|||
162178055|NCT02720068|585706999|FG011|Overall Study|Sponsor Decision|6|||
162018673|NCT01349049|585123167|FG004|Overall Study|Non-compliance|0|||
162178056|NCT02720068|585707000|FG012|Overall Study|Sponsor Decision|3|||
162178057|NCT02720068|585707001|FG013|Overall Study|Sponsor Decision|2|||
162178058|NCT02720068|585707002|FG014|Overall Study|Sponsor Decision|4|||
162178059|NCT02720068|585707003|FG015|Overall Study|Sponsor Decision|4|||
162178060|NCT02720068|585707004|FG016|Overall Study|Sponsor Decision|0|||
162178061|NCT02720068|585707005|FG017|Overall Study|Sponsor Decision|8|||
162178062|NCT02720068|585706988|FG000|Overall Study|Withdrawal by Subject|0|||
162178063|NCT02720068|585706989|FG001|Overall Study|Withdrawal by Subject|0|||
162178064|NCT02720068|585706990|FG002|Overall Study|Withdrawal by Subject|0|||
162178065|NCT02720068|585706991|FG003|Overall Study|Withdrawal by Subject|0|||
162178066|NCT02720068|585706992|FG004|Overall Study|Withdrawal by Subject|0|||
162178067|NCT02720068|585706993|FG005|Overall Study|Withdrawal by Subject|0|||
162178068|NCT02720068|585706994|FG006|Overall Study|Withdrawal by Subject|0|||
162178069|NCT02720068|585706995|FG007|Overall Study|Withdrawal by Subject|0|||
162178070|NCT02720068|585706996|FG008|Overall Study|Withdrawal by Subject|0|||
162178071|NCT02720068|585706997|FG009|Overall Study|Withdrawal by Subject|1|||
162178072|NCT02720068|585706998|FG010|Overall Study|Withdrawal by Subject|0|||
162178073|NCT02720068|585706999|FG011|Overall Study|Withdrawal by Subject|27|||
161923134|NCT03369223|584764940|FG019|Overall Study|Study drug toxicity|7|||
161923135|NCT03369223|584764921|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161923136|NCT03369223|584764922|FG001|Overall Study|Participant request to discontinue study treatment|1|||
161923137|NCT03369223|584764923|FG002|Overall Study|Participant request to discontinue study treatment|0|||
161923138|NCT03369223|584764924|FG003|Overall Study|Participant request to discontinue study treatment|0|||
162178074|NCT02720068|585707000|FG012|Overall Study|Withdrawal by Subject|2|||
162178075|NCT02720068|585707001|FG013|Overall Study|Withdrawal by Subject|8|||
162178076|NCT02720068|585707002|FG014|Overall Study|Withdrawal by Subject|7|||
162178077|NCT02720068|585707003|FG015|Overall Study|Withdrawal by Subject|0|||
162178078|NCT02720068|585707004|FG016|Overall Study|Withdrawal by Subject|0|||
162178079|NCT02720068|585707005|FG017|Overall Study|Withdrawal by Subject|2|||
162178080|NCT02720068|585706988|FG000|Overall Study|Protocol Violation|0|||
162178081|NCT02720068|585706989|FG001|Overall Study|Protocol Violation|0|||
162178082|NCT02720068|585706990|FG002|Overall Study|Protocol Violation|0|||
162178083|NCT02720068|585706991|FG003|Overall Study|Protocol Violation|0|||
162178084|NCT02720068|585706992|FG004|Overall Study|Protocol Violation|0|||
162178085|NCT02720068|585706993|FG005|Overall Study|Protocol Violation|0|||
162178086|NCT02720068|585706994|FG006|Overall Study|Protocol Violation|0|||
162178087|NCT02720068|585706995|FG007|Overall Study|Protocol Violation|0|||
162178088|NCT02720068|585706996|FG008|Overall Study|Protocol Violation|0|||
162178089|NCT02720068|585706997|FG009|Overall Study|Protocol Violation|0|||
162178090|NCT02720068|585706998|FG010|Overall Study|Protocol Violation|1|||
162178091|NCT02720068|585706999|FG011|Overall Study|Protocol Violation|0|||
162178092|NCT02720068|585707000|FG012|Overall Study|Protocol Violation|0|||
162178093|NCT02720068|585707001|FG013|Overall Study|Protocol Violation|0|||
162178094|NCT02720068|585707002|FG014|Overall Study|Protocol Violation|1|||
162178095|NCT02720068|585707003|FG015|Overall Study|Protocol Violation|0|||
162178096|NCT02720068|585707004|FG016|Overall Study|Protocol Violation|1|||
162178097|NCT02720068|585707005|FG017|Overall Study|Protocol Violation|0|||
162178098|NCT01773993|585707007|FG000|Overall Study|No Visit After Treatment|35|||
162178099|NCT04664881|585707008|FG000|Overall Study|Withdrawal by Subject|1|||
162178100|NCT04664881|585707009|FG001|Overall Study|Withdrawal by Subject|8|||
162178101|NCT04664881|585707008|FG000|Overall Study|Physician Decision|0|||
162178102|NCT04664881|585707009|FG001|Overall Study|Physician Decision|5|||
162178103|NCT04664881|585707008|FG000|Overall Study|Lost to Follow-up|1|||
162178104|NCT04664881|585707009|FG001|Overall Study|Lost to Follow-up|0|||
162178105|NCT04408755|585707017|FG000|Period A (Placebo lead-in)|Other|11|||
162178106|NCT04408755|585707018|FG001|Period A (Placebo lead-in)|Other|0|||
162178107|NCT04408755|585707019|FG002|Period A (Placebo lead-in)|Other|0|||
162178108|NCT04408755|585707020|FG003|Period A (Placebo lead-in)|Other|0|||
162178109|NCT04408755|585707017|FG000|Period B (Randomization Period)|Adverse Event|0|||
162178110|NCT04408755|585707018|FG001|Period B (Randomization Period)|Adverse Event|3|||
162178111|NCT04408755|585707019|FG002|Period B (Randomization Period)|Adverse Event|0|||
162178112|NCT04408755|585707020|FG003|Period B (Randomization Period)|Adverse Event|1|||
162178113|NCT04408755|585707017|FG000|Period B (Randomization Period)|Death|0|||
162178114|NCT04408755|585707018|FG001|Period B (Randomization Period)|Death|0|||
162178115|NCT04408755|585707019|FG002|Period B (Randomization Period)|Death|1|||
162178116|NCT04408755|585707020|FG003|Period B (Randomization Period)|Death|0|||
162178117|NCT04408755|585707017|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
162178118|NCT04408755|585707018|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
162178119|NCT04408755|585707019|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
162178120|NCT04408755|585707020|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
162178121|NCT04408755|585707017|FG000|Period B (Randomization Period)|Physician Decision|0|||
162178122|NCT04408755|585707018|FG001|Period B (Randomization Period)|Physician Decision|0|||
162178123|NCT04408755|585707019|FG002|Period B (Randomization Period)|Physician Decision|1|||
162178124|NCT04408755|585707020|FG003|Period B (Randomization Period)|Physician Decision|0|||
162178125|NCT04408755|585707017|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
162178126|NCT04408755|585707018|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
162178127|NCT04408755|585707019|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
162178128|NCT04408755|585707020|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
162178129|NCT04408755|585707017|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
162178130|NCT04408755|585707018|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
162178131|NCT04408755|585707019|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
162178132|NCT04408755|585707020|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
162178133|NCT04408755|585707017|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
162178134|NCT04408755|585707018|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
162178135|NCT04408755|585707019|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
162178136|NCT04408755|585707020|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
162178137|NCT04408755|585707017|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
162178138|NCT04408755|585707018|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
162178139|NCT04408755|585707019|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
162178140|NCT04408755|585707020|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
162178141|NCT04408755|585707017|FG000|Period B (Randomization Period)|Reason not Specified|0|||
162178142|NCT04408755|585707018|FG001|Period B (Randomization Period)|Reason not Specified|1|||
162178143|NCT04408755|585707019|FG002|Period B (Randomization Period)|Reason not Specified|0|||
162178144|NCT04408755|585707020|FG003|Period B (Randomization Period)|Reason not Specified|2|||
162178145|NCT00308997|585707021|FG000|Overall Study|Subject feigned clinical data|0|||
162178146|NCT00308997|585707022|FG001|Overall Study|Subject feigned clinical data|1|||
162178147|NCT00308997|585707021|FG000|Overall Study|Unable to tolerate intervention|1|||
162178148|NCT00308997|585707022|FG001|Overall Study|Unable to tolerate intervention|0|||
162178149|NCT00412607|585707028|FG000|Overall Study|Withdrawal by Subject|9|||
162178150|NCT00412607|585707028|FG000|Overall Study|Lost to Follow-up|19|||
162178151|NCT00412607|585707028|FG000|Overall Study|Death|61|||
162178152|NCT00412607|585707028|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
162178153|NCT03248479|585707029|FG000|Overall Study|Death|12|||
162178154|NCT03248479|585707030|FG001|Overall Study|Death|44|||
162178155|NCT03248479|585707031|FG002|Overall Study|Death|1|||
162178156|NCT03248479|585707032|FG003|Overall Study|Death|72|||
162178157|NCT03248479|585707033|FG004|Overall Study|Death|17|||
162178158|NCT03248479|585707034|FG005|Overall Study|Death|6|||
162178159|NCT03248479|585707035|FG006|Overall Study|Death|1|||
162178160|NCT03248479|585707036|FG007|Overall Study|Death|14|||
162178161|NCT03248479|585707037|FG008|Overall Study|Death|3|||
162178162|NCT03248479|585707038|FG009|Overall Study|Death|7|||
162178163|NCT03248479|585707039|FG010|Overall Study|Death|3|||
162178164|NCT03248479|585707040|FG011|Overall Study|Death|1|||
162178165|NCT03248479|585707041|FG012|Overall Study|Death|1|||
162178166|NCT03248479|585707029|FG000|Overall Study|Study terminated by sponsor|12|||
162178167|NCT03248479|585707030|FG001|Overall Study|Study terminated by sponsor|15|||
162178168|NCT03248479|585707031|FG002|Overall Study|Study terminated by sponsor|0|||
162178169|NCT03248479|585707032|FG003|Overall Study|Study terminated by sponsor|5|||
162178170|NCT03248479|585707033|FG004|Overall Study|Study terminated by sponsor|0|||
162178171|NCT03248479|585707034|FG005|Overall Study|Study terminated by sponsor|0|||
162178172|NCT03248479|585707035|FG006|Overall Study|Study terminated by sponsor|0|||
162178173|NCT03248479|585707036|FG007|Overall Study|Study terminated by sponsor|1|||
162178174|NCT03248479|585707037|FG008|Overall Study|Study terminated by sponsor|1|||
162178175|NCT03248479|585707038|FG009|Overall Study|Study terminated by sponsor|0|||
162178176|NCT03248479|585707039|FG010|Overall Study|Study terminated by sponsor|5|||
162178177|NCT03248479|585707040|FG011|Overall Study|Study terminated by sponsor|4|||
162178178|NCT03248479|585707041|FG012|Overall Study|Study terminated by sponsor|0|||
162178179|NCT03248479|585707029|FG000|Overall Study|Consent withdrawn|6|||
162178180|NCT03248479|585707030|FG001|Overall Study|Consent withdrawn|3|||
162178181|NCT03248479|585707031|FG002|Overall Study|Consent withdrawn|0|||
162178182|NCT03248479|585707032|FG003|Overall Study|Consent withdrawn|9|||
162178183|NCT03248479|585707033|FG004|Overall Study|Consent withdrawn|1|||
162178184|NCT03248479|585707034|FG005|Overall Study|Consent withdrawn|0|||
162178185|NCT03248479|585707035|FG006|Overall Study|Consent withdrawn|0|||
162178186|NCT03248479|585707036|FG007|Overall Study|Consent withdrawn|1|||
162178187|NCT03248479|585707037|FG008|Overall Study|Consent withdrawn|0|||
162178188|NCT03248479|585707038|FG009|Overall Study|Consent withdrawn|3|||
162178189|NCT03248479|585707039|FG010|Overall Study|Consent withdrawn|1|||
162178190|NCT03248479|585707040|FG011|Overall Study|Consent withdrawn|0|||
162178191|NCT03248479|585707041|FG012|Overall Study|Consent withdrawn|1|||
162178192|NCT03248479|585707029|FG000|Overall Study|Lost to Follow-up|2|||
162178193|NCT03248479|585707030|FG001|Overall Study|Lost to Follow-up|1|||
162178194|NCT03248479|585707031|FG002|Overall Study|Lost to Follow-up|0|||
162178195|NCT03248479|585707032|FG003|Overall Study|Lost to Follow-up|0|||
162178196|NCT03248479|585707033|FG004|Overall Study|Lost to Follow-up|0|||
162178197|NCT03248479|585707034|FG005|Overall Study|Lost to Follow-up|0|||
162178198|NCT03248479|585707035|FG006|Overall Study|Lost to Follow-up|0|||
162178199|NCT03248479|585707036|FG007|Overall Study|Lost to Follow-up|0|||
162178200|NCT03248479|585707037|FG008|Overall Study|Lost to Follow-up|0|||
162178201|NCT03248479|585707038|FG009|Overall Study|Lost to Follow-up|0|||
162178202|NCT03248479|585707039|FG010|Overall Study|Lost to Follow-up|0|||
162178203|NCT03248479|585707040|FG011|Overall Study|Lost to Follow-up|0|||
162178204|NCT03248479|585707041|FG012|Overall Study|Lost to Follow-up|1|||
162178205|NCT03248479|585707029|FG000|Overall Study|Not reported|0|||
162178206|NCT03248479|585707030|FG001|Overall Study|Not reported|0|||
162178207|NCT03248479|585707031|FG002|Overall Study|Not reported|0|||
162178208|NCT03248479|585707032|FG003|Overall Study|Not reported|1|||
162178209|NCT03248479|585707033|FG004|Overall Study|Not reported|1|||
161817092|NCT00924638|584370941|FG000|Overall Study|Withdrawal by Subject|5|||
161817093|NCT00924638|584370942|FG001|Overall Study|Withdrawal by Subject|7|||
161817094|NCT00924638|584370941|FG000|Overall Study|Physician Decision|3|||
161817095|NCT00924638|584370942|FG001|Overall Study|Physician Decision|3|||
161817096|NCT01316055|584370943|FG000|Overall Study|Lost to Follow-up|1|||
161817097|NCT01316055|584370944|FG001|Overall Study|Lost to Follow-up|0|||
161817098|NCT01316055|584370945|FG002|Overall Study|Lost to Follow-up|0|||
161817099|NCT00989950|584370947|FG000|Randomized Phase|Protocol Violation|1|||
161817100|NCT00989950|584370948|FG001|Randomized Phase|Protocol Violation|0|||
161817101|NCT00989950|584370949|FG002|Randomized Phase|Protocol Violation|0|||
161817102|NCT00989950|584370950|FG003|Randomized Phase|Protocol Violation|0|||
161817103|NCT00989950|584370947|FG000|Randomized Phase|Adverse Event|0|||
161817104|NCT00989950|584370948|FG001|Randomized Phase|Adverse Event|1|||
161817105|NCT00989950|584370949|FG002|Randomized Phase|Adverse Event|0|||
161817106|NCT00989950|584370950|FG003|Randomized Phase|Adverse Event|0|||
161817107|NCT02845336|584370954|FG000|Overall Study|Lost to Follow-up|3|||
161817108|NCT02845336|584370955|FG001|Overall Study|Lost to Follow-up|1|||
161817109|NCT02845336|584370954|FG000|Overall Study|Inability to get medication|2|||
161817110|NCT02845336|584370955|FG001|Overall Study|Inability to get medication|0|||
161817111|NCT03488108|584370956|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
161817112|NCT03488108|584370957|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161817113|NCT03488108|584370956|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
161817114|NCT03488108|584370957|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
161817115|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Refused|1|||
161817116|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Refused|3|||
161817117|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Medical|0|||
161817118|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Medical|1|||
161817119|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
161817120|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
161817121|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
161817122|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
161817123|NCT02054715|584370959|FG000|Baseline/Follow-up 1|No Reason|0|||
161817124|NCT02054715|584370960|FG001|Baseline/Follow-up 1|No Reason|1|||
161817125|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
161817126|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
161817127|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Ineligible|3|||
161817128|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Ineligible|0|||
161817129|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Hospitalization|1|||
161817130|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Hospitalization|0|||
161817131|NCT02054715|584370959|FG000|Baseline/Follow-up 1|Changed Mind|1|||
161817132|NCT02054715|584370960|FG001|Baseline/Follow-up 1|Changed Mind|0|||
161817133|NCT02054715|584370959|FG000|Follow-up 2|Lost to Followup|3|||
161817134|NCT02054715|584370960|FG001|Follow-up 2|Lost to Followup|1|||
161817135|NCT02054715|584370959|FG000|Follow-up 2|Refused|3|||
161817136|NCT02054715|584370960|FG001|Follow-up 2|Refused|2|||
161817137|NCT02054715|584370959|FG000|Follow-up 2|Followup Not Completed|3|||
161817138|NCT02054715|584370960|FG001|Follow-up 2|Followup Not Completed|4|||
161817139|NCT02054715|584370959|FG000|Follow-up 2|Ineligible|4|||
161817140|NCT02054715|584370960|FG001|Follow-up 2|Ineligible|5|||
161817141|NCT02054715|584370959|FG000|Follow-up 2|Death|3|||
161817142|NCT02054715|584370960|FG001|Follow-up 2|Death|3|||
161817143|NCT02054715|584370959|FG000|Follow-up 2|Hospitalization|0|||
161817144|NCT02054715|584370960|FG001|Follow-up 2|Hospitalization|2|||
161817145|NCT02054715|584370959|FG000|Follow-up 2|Changed MD/Facility|0|||
161817146|NCT02054715|584370960|FG001|Follow-up 2|Changed MD/Facility|1|||
161817147|NCT02054715|584370959|FG000|Follow-up 2|Changed Mind|0|||
161817148|NCT02054715|584370960|FG001|Follow-up 2|Changed Mind|1|||
161817149|NCT02054715|584370959|FG000|Follow-up 2|No Reason|2|||
161817150|NCT02054715|584370960|FG001|Follow-up 2|No Reason|0|||
162018674|NCT01349049|585123168|FG005|Overall Study|Non-compliance|0|||
162178210|NCT03248479|585707034|FG005|Overall Study|Not reported|0|||
161817151|NCT02054715|584370959|FG000|Follow-up 2|Treatment Change or Delay|1|||
161817152|NCT02054715|584370960|FG001|Follow-up 2|Treatment Change or Delay|0|||
161817153|NCT00674128|584370961|FG000|Overall Study|Withdrawal by Subject|25|||
161817154|NCT00674128|584370962|FG001|Overall Study|Withdrawal by Subject|23|||
161817155|NCT01825798|584370965|FG000|Overall Study|Adverse Event|1|||
161817156|NCT01825798|584370966|FG001|Overall Study|Adverse Event|5|||
161817157|NCT01825798|584370965|FG000|Overall Study|Lost to Follow-up|1|||
162018675|NCT01349049|585123169|FG006|Overall Study|Non-compliance|0|||
161817158|NCT01825798|584370966|FG001|Overall Study|Lost to Follow-up|0|||
161817159|NCT02471807|584370976|FG000|Overall Study|Death|14|||
161817160|NCT02471807|584370976|FG000|Overall Study|Withdrawal by Subject|2|||
161817161|NCT02471807|584370976|FG000|Overall Study|Explant|5|||
161817162|NCT02471807|584370976|FG000|Overall Study|Lost to Follow-up|1|||
161817163|NCT01559363|584370977|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
161817164|NCT01559363|584370978|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
161817165|NCT01559363|584370979|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
162018676|NCT01349049|585123170|FG007|Overall Study|Non-compliance|0|||
162178211|NCT03248479|585707035|FG006|Overall Study|Not reported|0|||
161817166|NCT01559363|584370980|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
161817167|NCT01559363|584370981|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
161817168|NCT01559363|584370982|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
161817169|NCT01559363|584370977|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
161817170|NCT01559363|584370978|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
161817171|NCT01559363|584370979|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
161817172|NCT01559363|584370980|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
161817173|NCT01559363|584370981|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
161817174|NCT01559363|584370982|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
161817175|NCT01559363|584370977|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
161817176|NCT01559363|584370978|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
161817177|NCT01559363|584370979|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
161817178|NCT01559363|584370980|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
161817179|NCT01559363|584370981|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
161817180|NCT01559363|584370982|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
161817181|NCT01559363|584370977|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
161817182|NCT01559363|584370978|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
161817183|NCT01559363|584370979|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
161817184|NCT01559363|584370980|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
161817185|NCT01559363|584370981|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
161817186|NCT01559363|584370982|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
161817187|NCT01559363|584370977|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161817188|NCT01559363|584370978|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
161817189|NCT01559363|584370979|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161817190|NCT01559363|584370980|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161817191|NCT01559363|584370981|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161817192|NCT01559363|584370982|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
162178212|NCT03248479|585707036|FG007|Overall Study|Not reported|1|||
162178213|NCT03248479|585707037|FG008|Overall Study|Not reported|1|||
162178214|NCT03248479|585707038|FG009|Overall Study|Not reported|0|||
162178215|NCT03248479|585707039|FG010|Overall Study|Not reported|0|||
162178216|NCT03248479|585707040|FG011|Overall Study|Not reported|0|||
162178217|NCT03248479|585707041|FG012|Overall Study|Not reported|0|||
162178218|NCT06065735|585707048|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
162178219|NCT06065735|585707049|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
162178220|NCT06065735|585707050|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
161671592|NCT04427501|583851343|FG007|Overall Study|Lost to Follow-up|10|||
161671593|NCT04427501|583851344|FG008|Overall Study|Lost to Follow-up|2|||
161671594|NCT04427501|583851345|FG009|Overall Study|Lost to Follow-up|5|||
161671595|NCT04427501|583851346|FG010|Overall Study|Lost to Follow-up|2|||
161671596|NCT04427501|583851347|FG011|Overall Study|Lost to Follow-up|0|||
161671597|NCT04427501|583851336|FG000|Overall Study|Physician Decision|0|||
161671598|NCT04427501|583851337|FG001|Overall Study|Physician Decision|3|||
161671599|NCT04427501|583851338|FG002|Overall Study|Physician Decision|0|||
162178221|NCT06065735|585707048|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
162178222|NCT06065735|585707049|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
162178223|NCT06065735|585707050|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
162178224|NCT06065735|585707048|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
162178225|NCT06065735|585707049|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
162178226|NCT06065735|585707050|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
162178227|NCT06065735|585707048|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
162178228|NCT06065735|585707049|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
162178229|NCT06065735|585707050|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
162178230|NCT06065735|585707048|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
162178231|NCT06065735|585707049|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
162178232|NCT06065735|585707050|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
162178233|NCT03522298|585707051|FG000|Overall Study|Adverse Event|1|||
162178234|NCT03522298|585707052|FG001|Overall Study|Adverse Event|0|||
162178235|NCT03522298|585707053|FG002|Overall Study|Adverse Event|0|||
162178236|NCT03522298|585707054|FG003|Overall Study|Adverse Event|1|||
161671600|NCT04427501|583851339|FG003|Overall Study|Physician Decision|0|||
161671601|NCT04427501|583851340|FG004|Overall Study|Physician Decision|0|||
161671602|NCT04427501|583851341|FG005|Overall Study|Physician Decision|0|||
161671603|NCT04427501|583851342|FG006|Overall Study|Physician Decision|2|||
161671604|NCT04427501|583851343|FG007|Overall Study|Physician Decision|0|||
161671605|NCT04427501|583851344|FG008|Overall Study|Physician Decision|0|||
161817193|NCT01559363|584370977|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
161817194|NCT01559363|584370978|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
161817195|NCT01559363|584370979|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
161817196|NCT01559363|584370980|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
161817197|NCT01559363|584370981|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
161942230|NCT00663260|584838357|FG001|Overall Study|Lack of Efficacy|0|||
161817198|NCT01559363|584370982|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
161817199|NCT01559363|584370977|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
162178237|NCT03522298|585707051|FG000|Overall Study|Death|2|||
162178238|NCT03522298|585707052|FG001|Overall Study|Death|4|||
162178239|NCT03522298|585707053|FG002|Overall Study|Death|8|||
162178240|NCT03522298|585707054|FG003|Overall Study|Death|8|||
162178241|NCT03522298|585707051|FG000|Overall Study|Patient decision|0|||
162178242|NCT03522298|585707052|FG001|Overall Study|Patient decision|2|||
162178243|NCT03522298|585707053|FG002|Overall Study|Patient decision|2|||
162178244|NCT03522298|585707054|FG003|Overall Study|Patient decision|2|||
162178245|NCT04093869|585707055|FG000|Overall Study|Death|0|||
162178246|NCT04093869|585707056|FG001|Overall Study|Death|1|||
162178247|NCT04093869|585707055|FG000|Overall Study|Withdrawal by Subject|1|||
162178248|NCT04093869|585707056|FG001|Overall Study|Withdrawal by Subject|0|||
162178249|NCT03250676|585707057|FG000|Overall Study|Adverse Event|0|||
162178250|NCT03250676|585707058|FG001|Overall Study|Adverse Event|0|||
161817200|NCT01559363|584370978|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
161817201|NCT01559363|584370979|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
162178251|NCT03250676|585707059|FG002|Overall Study|Adverse Event|0|||
162178252|NCT03250676|585707060|FG003|Overall Study|Adverse Event|1|||
162178253|NCT03250676|585707061|FG004|Overall Study|Adverse Event|2|||
162178254|NCT03250676|585707062|FG005|Overall Study|Adverse Event|9|||
162178255|NCT03250676|585707057|FG000|Overall Study|Withdrawal by Subject|1|||
162178256|NCT03250676|585707058|FG001|Overall Study|Withdrawal by Subject|0|||
162178257|NCT03250676|585707059|FG002|Overall Study|Withdrawal by Subject|0|||
162178258|NCT03250676|585707060|FG003|Overall Study|Withdrawal by Subject|1|||
162178259|NCT03250676|585707061|FG004|Overall Study|Withdrawal by Subject|1|||
162178260|NCT03250676|585707062|FG005|Overall Study|Withdrawal by Subject|2|||
162178261|NCT03250676|585707057|FG000|Overall Study|Physician Decision|0|||
162178262|NCT03250676|585707058|FG001|Overall Study|Physician Decision|0|||
162178263|NCT03250676|585707059|FG002|Overall Study|Physician Decision|0|||
162178264|NCT03250676|585707060|FG003|Overall Study|Physician Decision|2|||
162178265|NCT03250676|585707061|FG004|Overall Study|Physician Decision|0|||
162178266|NCT03250676|585707062|FG005|Overall Study|Physician Decision|3|||
162178267|NCT03250676|585707057|FG000|Overall Study|Withdrawal of consent|0|||
162178268|NCT03250676|585707058|FG001|Overall Study|Withdrawal of consent|0|||
162178269|NCT03250676|585707059|FG002|Overall Study|Withdrawal of consent|2|||
162178270|NCT03250676|585707060|FG003|Overall Study|Withdrawal of consent|0|||
162178271|NCT03250676|585707061|FG004|Overall Study|Withdrawal of consent|0|||
162178272|NCT03250676|585707062|FG005|Overall Study|Withdrawal of consent|2|||
162178273|NCT03250676|585707057|FG000|Overall Study|Other|1|||
162178274|NCT03250676|585707058|FG001|Overall Study|Other|0|||
162018677|NCT01349049|585123171|FG008|Overall Study|Non-compliance|0|||
162178275|NCT03250676|585707059|FG002|Overall Study|Other|0|||
162178276|NCT03250676|585707060|FG003|Overall Study|Other|0|||
162178277|NCT03250676|585707061|FG004|Overall Study|Other|0|||
162178278|NCT03250676|585707062|FG005|Overall Study|Other|0|||
162178279|NCT03250676|585707057|FG000|Overall Study|Disease progression|4|||
162178280|NCT03250676|585707058|FG001|Overall Study|Disease progression|12|||
162178281|NCT03250676|585707059|FG002|Overall Study|Disease progression|9|||
162178282|NCT03250676|585707060|FG003|Overall Study|Disease progression|7|||
162178283|NCT03250676|585707061|FG004|Overall Study|Disease progression|4|||
162178284|NCT03250676|585707062|FG005|Overall Study|Disease progression|88|||
162178285|NCT01499368|585707063|FG000|Overall Study|Did not meet I/E criteria|8|||
162178286|NCT01499368|585707064|FG001|Overall Study|Did not meet I/E criteria|4|||
162178287|NCT01499368|585707065|FG002|Overall Study|Did not meet I/E criteria|4|||
162178288|NCT01499368|585707063|FG000|Overall Study|Prohibited Concomitant medication|1|||
162178289|NCT01499368|585707064|FG001|Overall Study|Prohibited Concomitant medication|1|||
162178290|NCT01499368|585707065|FG002|Overall Study|Prohibited Concomitant medication|0|||
162178291|NCT01499368|585707063|FG000|Overall Study|Withdrawal by Subject|11|||
162178292|NCT01499368|585707064|FG001|Overall Study|Withdrawal by Subject|10|||
162178293|NCT01499368|585707065|FG002|Overall Study|Withdrawal by Subject|8|||
162178294|NCT01499368|585707063|FG000|Overall Study|Lost to Follow-up|3|||
162178295|NCT01499368|585707064|FG001|Overall Study|Lost to Follow-up|2|||
162178296|NCT01499368|585707065|FG002|Overall Study|Lost to Follow-up|5|||
162178297|NCT01499368|585707063|FG000|Overall Study|Adverse Event|4|||
162178298|NCT01499368|585707064|FG001|Overall Study|Adverse Event|0|||
162178299|NCT01499368|585707065|FG002|Overall Study|Adverse Event|2|||
162178300|NCT01499368|585707063|FG000|Overall Study|Physician Decision|0|||
162178301|NCT01499368|585707064|FG001|Overall Study|Physician Decision|1|||
162178302|NCT01499368|585707065|FG002|Overall Study|Physician Decision|0|||
162178303|NCT01499368|585707063|FG000|Overall Study|Deviation from visit window|0|||
162178304|NCT01499368|585707064|FG001|Overall Study|Deviation from visit window|0|||
162178305|NCT01499368|585707065|FG002|Overall Study|Deviation from visit window|1|||
162178306|NCT01499368|585707063|FG000|Overall Study|Error of Prescriptions|0|||
162178307|NCT01499368|585707064|FG001|Overall Study|Error of Prescriptions|0|||
162178308|NCT01499368|585707065|FG002|Overall Study|Error of Prescriptions|1|||
162178309|NCT03092674|585707066|FG000|Overall Study|Adverse Event or Side Effects|1|||
162178310|NCT03092674|585707067|FG001|Overall Study|Adverse Event or Side Effects|4|||
162178311|NCT03092674|585707068|FG002|Overall Study|Adverse Event or Side Effects|4|||
162178312|NCT03092674|585707066|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
162178313|NCT03092674|585707067|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
162178314|NCT03092674|585707068|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
162178315|NCT03092674|585707066|FG000|Overall Study|Progression/Relapse|5|||
162178316|NCT03092674|585707067|FG001|Overall Study|Progression/Relapse|4|||
162178317|NCT03092674|585707068|FG002|Overall Study|Progression/Relapse|8|||
162018678|NCT01349049|585123163|FG000|Overall Study|Withdrawal by Subject|0|||
162178318|NCT03092674|585707066|FG000|Overall Study|Death|4|||
162178319|NCT03092674|585707067|FG001|Overall Study|Death|8|||
162178320|NCT03092674|585707068|FG002|Overall Study|Death|2|||
162178321|NCT03092674|585707066|FG000|Overall Study|Other - Not Protocol Specified|11|||
162178322|NCT03092674|585707067|FG001|Overall Study|Other - Not Protocol Specified|8|||
162178323|NCT03092674|585707068|FG002|Overall Study|Other - Not Protocol Specified|8|||
162178324|NCT01527188|585707069|FG000|Overall Study|Adverse Event|5|||
162178325|NCT01527188|585707070|FG001|Overall Study|Adverse Event|5|||
162178326|NCT01527188|585707071|FG002|Overall Study|Adverse Event|11|||
162178327|NCT01527188|585707072|FG003|Overall Study|Adverse Event|0|||
162178328|NCT01527188|585707069|FG000|Overall Study|Withdrawal by Subject|3|||
162178329|NCT01527188|585707070|FG001|Overall Study|Withdrawal by Subject|6|||
162178330|NCT01527188|585707071|FG002|Overall Study|Withdrawal by Subject|4|||
162178331|NCT01527188|585707072|FG003|Overall Study|Withdrawal by Subject|4|||
162178332|NCT01527188|585707069|FG000|Overall Study|Any other reason not above-mentioned|6|||
162178333|NCT01527188|585707070|FG001|Overall Study|Any other reason not above-mentioned|7|||
162178334|NCT01527188|585707071|FG002|Overall Study|Any other reason not above-mentioned|8|||
162178335|NCT01527188|585707072|FG003|Overall Study|Any other reason not above-mentioned|8|||
162178336|NCT04626427|585707073|FG000|Overall Study|Death|1|||
162178337|NCT04626427|585707073|FG000|Overall Study|Withdrawal by Subject|1|||
162178338|NCT04626427|585707073|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
162178339|NCT04626427|585707073|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
162178340|NCT01265537|585707074|FG000|Overall Study|Adverse Event|2|||
162178341|NCT01265537|585707075|FG001|Overall Study|Adverse Event|1|||
162178342|NCT01265537|585707074|FG000|Overall Study|Physician Decision|0|||
162178343|NCT01265537|585707075|FG001|Overall Study|Physician Decision|1|||
162178344|NCT04518943|585707686|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
162178345|NCT04518943|585707687|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
162178346|NCT04518943|585707688|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
162178347|NCT04518943|585707689|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
162178348|NCT04518943|585707690|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
162178349|NCT04518943|585707691|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
162178350|NCT04518943|585707692|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
162178351|NCT04518943|585707693|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
162178352|NCT04518943|585707694|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
162178353|NCT04518943|585707695|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
162178354|NCT04518943|585707696|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
162178355|NCT04518943|585707697|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
162178356|NCT04518943|585707698|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
162178357|NCT04518943|585707699|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
162178358|NCT04518943|585707700|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
162178359|NCT04518943|585707701|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
162178360|NCT06408870|585707705|FG000|Washout period|Withdrawal by Subject|1|||
162178361|NCT06408870|585707706|FG001|Washout period|Withdrawal by Subject|0|||
162178362|NCT06408870|585707705|FG000|Washout period|Adverse Event|2|||
162178363|NCT06408870|585707706|FG001|Washout period|Adverse Event|0|||
162178364|NCT04772534|585707711|FG000|Overall Study|Physician Decision|1|||
162178365|NCT04772534|585707712|FG001|Overall Study|Physician Decision|0|||
162178366|NCT04772534|585707713|FG002|Overall Study|Physician Decision|0|||
162178367|NCT04772534|585707711|FG000|Overall Study|Withdrawal by Subject|3|||
162178368|NCT04772534|585707712|FG001|Overall Study|Withdrawal by Subject|0|||
162178369|NCT04772534|585707713|FG002|Overall Study|Withdrawal by Subject|1|||
162178370|NCT04194450|585707714|FG000|Overall Study|not eligible|1|||
162178371|NCT04194450|585707715|FG001|Overall Study|not eligible|0|||
162178372|NCT05875701|585707724|FG000|Overall Study|Lost to Follow-up|2|||
162178373|NCT05875701|585707725|FG001|Overall Study|Lost to Follow-up|0|||
162178374|NCT05875701|585707724|FG000|Overall Study|Withdrawal by Subject|1|||
162178375|NCT05875701|585707725|FG001|Overall Study|Withdrawal by Subject|1|||
162178376|NCT04490356|585707731|FG000|Overall Study|Lost to Follow-up|1|||
162178377|NCT03662022|585707734|FG000|Year 1 2019|prevalent case|83|||
162178378|NCT03662022|585707735|FG001|Year 1 2019|prevalent case|116|||
162178379|NCT03662022|585707736|FG002|Year 1 2019|prevalent case|158|||
162178380|NCT03662022|585707737|FG003|Year 1 2019|prevalent case|99|||
162178381|NCT03662022|585707734|FG000|Year 2 2020|incident case|18|||
161923139|NCT03369223|584764925|FG004|Overall Study|Participant request to discontinue study treatment|1|||
161923140|NCT03369223|584764926|FG005|Overall Study|Participant request to discontinue study treatment|1|||
161923141|NCT03369223|584764927|FG006|Overall Study|Participant request to discontinue study treatment|1|||
162178382|NCT03662022|585707735|FG001|Year 2 2020|incident case|18|||
162178383|NCT03662022|585707736|FG002|Year 2 2020|incident case|16|||
162178384|NCT03662022|585707737|FG003|Year 2 2020|incident case|26|||
162178385|NCT03662022|585707734|FG000|Year 2 2020|other case|18|||
162178386|NCT03662022|585707735|FG001|Year 2 2020|other case|16|||
162178387|NCT03662022|585707736|FG002|Year 2 2020|other case|16|||
162178388|NCT03662022|585707737|FG003|Year 2 2020|other case|24|||
162178389|NCT03662022|585707734|FG000|Year 2 2020|Lost to Follow-up|1633|||
162178390|NCT03662022|585707735|FG001|Year 2 2020|Lost to Follow-up|1183|||
162178391|NCT03662022|585707736|FG002|Year 2 2020|Lost to Follow-up|1381|||
162178392|NCT03662022|585707737|FG003|Year 2 2020|Lost to Follow-up|2858|||
162178393|NCT03662022|585707734|FG000|Year 3 2021|incident case|24|||
162178394|NCT03662022|585707735|FG001|Year 3 2021|incident case|27|||
162178395|NCT03662022|585707736|FG002|Year 3 2021|incident case|24|||
162178396|NCT03662022|585707737|FG003|Year 3 2021|incident case|11|||
162178397|NCT03662022|585707734|FG000|Year 3 2021|other case|4|||
162178398|NCT03662022|585707735|FG001|Year 3 2021|other case|15|||
162178399|NCT03662022|585707736|FG002|Year 3 2021|other case|10|||
162178400|NCT03662022|585707737|FG003|Year 3 2021|other case|14|||
162178401|NCT03662022|585707734|FG000|Year 3 2021|Lost to Follow-up|179|||
162178402|NCT03662022|585707735|FG001|Year 3 2021|Lost to Follow-up|244|||
162178403|NCT03662022|585707736|FG002|Year 3 2021|Lost to Follow-up|480|||
162178404|NCT03662022|585707737|FG003|Year 3 2021|Lost to Follow-up|477|||
162178405|NCT03662022|585707734|FG000|Year 4 2022|incident case|25|||
162178406|NCT03662022|585707735|FG001|Year 4 2022|incident case|41|||
162178407|NCT03662022|585707736|FG002|Year 4 2022|incident case|28|||
162178408|NCT03662022|585707737|FG003|Year 4 2022|incident case|7|||
162178409|NCT03662022|585707734|FG000|Year 4 2022|other case|8|||
162178410|NCT03662022|585707735|FG001|Year 4 2022|other case|19|||
162178411|NCT03662022|585707736|FG002|Year 4 2022|other case|13|||
162178412|NCT03662022|585707737|FG003|Year 4 2022|other case|7|||
162178413|NCT03662022|585707734|FG000|Year 4 2022|Lost to Follow-up|986|||
162178414|NCT03662022|585707735|FG001|Year 4 2022|Lost to Follow-up|1079|||
162178415|NCT03662022|585707736|FG002|Year 4 2022|Lost to Follow-up|1236|||
162178416|NCT03662022|585707737|FG003|Year 4 2022|Lost to Follow-up|1826|||
162178417|NCT02806726|585707745|FG000|Overall Study|Lost to Follow-up|1|||
162178418|NCT05129501|585707749|FG000|Overall Study|Lost to Follow-up|54|||
162178419|NCT05129501|585707750|FG001|Overall Study|Lost to Follow-up|41|||
162178420|NCT03142009|585707753|FG000|Overall Study|Lost to Follow-up|45|||
162178421|NCT03142009|585707754|FG001|Overall Study|Lost to Follow-up|30|||
162178422|NCT01553149|585707755|FG000|Overall Study|Adverse Event|0|||
162178423|NCT01553149|585707756|FG001|Overall Study|Adverse Event|9|||
162178424|NCT01553149|585707755|FG000|Overall Study|Physician Decision|5|||
162178425|NCT01553149|585707756|FG001|Overall Study|Physician Decision|10|||
162178426|NCT01553149|585707755|FG000|Overall Study|Ineligible|0|||
162178427|NCT01553149|585707756|FG001|Overall Study|Ineligible|1|||
162178428|NCT03512301|585708614|FG000|Overall Study|Protocol Violation|2|||
162178429|NCT03512301|585708614|FG000|Overall Study|Did Not Qualify|3|||
162178430|NCT03512301|585708614|FG000|Overall Study|Age-ineligible|1|||
162178431|NCT03512301|585708614|FG000|Overall Study|Inadequate fluency with the English language|3|||
162178432|NCT04993677|585708618|FG000|Overall Study|Lost to Follow-up|1|||
162178433|NCT04993677|585708619|FG001|Overall Study|Lost to Follow-up|0|||
162178434|NCT04993677|585708620|FG002|Overall Study|Lost to Follow-up|0|||
162178435|NCT04993677|585708621|FG003|Overall Study|Lost to Follow-up|0|||
162178436|NCT04993677|585708618|FG000|Overall Study|Death|11|||
162178437|NCT04993677|585708619|FG001|Overall Study|Death|8|||
162178438|NCT04993677|585708620|FG002|Overall Study|Death|3|||
162178439|NCT04993677|585708621|FG003|Overall Study|Death|1|||
162178440|NCT04993677|585708618|FG000|Overall Study|Subject withdrawal of consent|4|||
162178441|NCT04993677|585708619|FG001|Overall Study|Subject withdrawal of consent|3|||
162178442|NCT04993677|585708620|FG002|Overall Study|Subject withdrawal of consent|0|||
162178443|NCT04993677|585708621|FG003|Overall Study|Subject withdrawal of consent|2|||
162178444|NCT04993677|585708618|FG000|Overall Study|Study termination by sponsor|3|||
162178445|NCT04993677|585708619|FG001|Overall Study|Study termination by sponsor|25|||
162178446|NCT04993677|585708620|FG002|Overall Study|Study termination by sponsor|3|||
162178447|NCT04993677|585708621|FG003|Overall Study|Study termination by sponsor|3|||
162178448|NCT04993677|585708618|FG000|Overall Study|Other|2|||
162178449|NCT04993677|585708619|FG001|Overall Study|Other|3|||
162178450|NCT04993677|585708620|FG002|Overall Study|Other|3|||
162178451|NCT04993677|585708621|FG003|Overall Study|Other|2|||
162178452|NCT04174170|585708622|FG000|Placebo Run-in Period|Not Randomized|38|||
162178453|NCT04174170|585708623|FG001|Placebo Run-in Period|Not Randomized|0|||
162178454|NCT04174170|585708624|FG002|Placebo Run-in Period|Not Randomized|0|||
162178455|NCT04174170|585708625|FG003|Placebo Run-in Period|Not Randomized|0|||
162178456|NCT04174170|585708622|FG000|Double Blind Treatment Period|Adverse Event|0|||
162178457|NCT04174170|585708623|FG001|Double Blind Treatment Period|Adverse Event|9|||
162178458|NCT04174170|585708624|FG002|Double Blind Treatment Period|Adverse Event|9|||
162178459|NCT04174170|585708625|FG003|Double Blind Treatment Period|Adverse Event|8|||
162178460|NCT04174170|585708622|FG000|Double Blind Treatment Period|Death|0|||
162178461|NCT04174170|585708623|FG001|Double Blind Treatment Period|Death|1|||
162178462|NCT04174170|585708624|FG002|Double Blind Treatment Period|Death|0|||
162178463|NCT04174170|585708625|FG003|Double Blind Treatment Period|Death|0|||
162178464|NCT04174170|585708622|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
162178465|NCT04174170|585708623|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
162178466|NCT04174170|585708624|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
162178467|NCT04174170|585708625|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
162178468|NCT04174170|585708622|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
162178469|NCT04174170|585708623|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
162178470|NCT04174170|585708624|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
162178471|NCT04174170|585708625|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
162178472|NCT04174170|585708622|FG000|Double Blind Treatment Period|Physician Decision|0|||
162178473|NCT04174170|585708623|FG001|Double Blind Treatment Period|Physician Decision|1|||
162178474|NCT04174170|585708624|FG002|Double Blind Treatment Period|Physician Decision|0|||
162178475|NCT04174170|585708625|FG003|Double Blind Treatment Period|Physician Decision|1|||
162178476|NCT04174170|585708622|FG000|Double Blind Treatment Period|Pregnancy|0|||
162178477|NCT04174170|585708623|FG001|Double Blind Treatment Period|Pregnancy|1|||
162178478|NCT04174170|585708624|FG002|Double Blind Treatment Period|Pregnancy|0|||
162178479|NCT04174170|585708625|FG003|Double Blind Treatment Period|Pregnancy|1|||
162178480|NCT04174170|585708622|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
162178481|NCT04174170|585708623|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
162178482|NCT04174170|585708624|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
162178483|NCT04174170|585708625|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
162178484|NCT04174170|585708622|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
162178485|NCT04174170|585708623|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
162178486|NCT04174170|585708624|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
162178487|NCT04174170|585708625|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
162178488|NCT04174170|585708622|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
162178489|NCT04174170|585708623|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
162178490|NCT04174170|585708624|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
162178491|NCT04174170|585708625|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
162178492|NCT04675034|585708641|FG000|Overall Study|Lost to Follow-up|1|||
162178493|NCT04675034|585708642|FG001|Overall Study|Lost to Follow-up|1|||
162178494|NCT04675034|585708643|FG002|Overall Study|Lost to Follow-up|0|||
162178495|NCT04675034|585708644|FG003|Overall Study|Lost to Follow-up|2|||
162178496|NCT04675034|585708645|FG004|Overall Study|Lost to Follow-up|0|||
162178497|NCT04675034|585708641|FG000|Overall Study|Protocol Violation|1|||
162178498|NCT04675034|585708642|FG001|Overall Study|Protocol Violation|0|||
162178499|NCT04675034|585708643|FG002|Overall Study|Protocol Violation|0|||
162178500|NCT04675034|585708644|FG003|Overall Study|Protocol Violation|1|||
162178501|NCT04675034|585708645|FG004|Overall Study|Protocol Violation|3|||
162178502|NCT04675034|585708641|FG000|Overall Study|Withdrawal by Subject|9|||
162178503|NCT04675034|585708642|FG001|Overall Study|Withdrawal by Subject|3|||
162178504|NCT04675034|585708643|FG002|Overall Study|Withdrawal by Subject|4|||
162178505|NCT04675034|585708644|FG003|Overall Study|Withdrawal by Subject|8|||
162178506|NCT04675034|585708645|FG004|Overall Study|Withdrawal by Subject|6|||
162178507|NCT03201939|585708650|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
162178508|NCT03201939|585708651|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
162178509|NCT03884439|585708652|FG000|Overall Study|No informed consent for publication of study results|38|||
162178510|NCT03884439|585708652|FG000|Overall Study|Contract violation/deficiency|7|||
162178511|NCT06059443|585708653|FG000|Overall Study|Withdrawal by Subject|2|||
162178512|NCT06059443|585708654|FG001|Overall Study|Withdrawal by Subject|0|||
162178513|NCT06059443|585708653|FG000|Overall Study|Lost to Follow-up|2|||
162178514|NCT06059443|585708654|FG001|Overall Study|Lost to Follow-up|2|||
162178515|NCT03587805|585708656|FG000|Overall Study|Adverse Event|72|||
162178516|NCT03587805|585708656|FG000|Overall Study|Death|1|||
162178517|NCT03587805|585708656|FG000|Overall Study|Lost to Follow-up|78|||
162178518|NCT03587805|585708656|FG000|Overall Study|Withdrawal by Subject|105|||
162178519|NCT03587805|585708656|FG000|Overall Study|Lack of Efficacy|119|||
162178520|NCT03587805|585708656|FG000|Overall Study|Reason unknown|26|||
162178521|NCT03587805|585708656|FG000|Overall Study|COVID_19 pandemic|4|||
162178522|NCT03587805|585708656|FG000|Overall Study|Various reasons|121|||
162178523|NCT03587805|585708656|FG000|Overall Study|Withdrawal by parent/guardian|3|||
162178524|NCT03982186|585708657|FG000|Overall Study|Lost to Follow-up|0|||
162178525|NCT03982186|585708658|FG001|Overall Study|Lost to Follow-up|1|||
162178526|NCT03982186|585708659|FG002|Overall Study|Lost to Follow-up|2|||
161817202|NCT01559363|584370980|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
162178527|NCT03982186|585708660|FG003|Overall Study|Lost to Follow-up|1|||
162178528|NCT03982186|585708661|FG004|Overall Study|Lost to Follow-up|1|||
162178529|NCT03982186|585708662|FG005|Overall Study|Lost to Follow-up|0|||
162178530|NCT03982186|585708657|FG000|Overall Study|Physician Decision|0|||
162178531|NCT03982186|585708658|FG001|Overall Study|Physician Decision|1|||
162178532|NCT03982186|585708659|FG002|Overall Study|Physician Decision|0|||
162178533|NCT03982186|585708660|FG003|Overall Study|Physician Decision|0|||
162178534|NCT03982186|585708661|FG004|Overall Study|Physician Decision|0|||
162178535|NCT03982186|585708662|FG005|Overall Study|Physician Decision|0|||
162178536|NCT03982186|585708657|FG000|Overall Study|Withdrawal by Subject|3|||
162178537|NCT03982186|585708658|FG001|Overall Study|Withdrawal by Subject|4|||
162178538|NCT03982186|585708659|FG002|Overall Study|Withdrawal by Subject|1|||
162178539|NCT03982186|585708660|FG003|Overall Study|Withdrawal by Subject|7|||
162178540|NCT03982186|585708661|FG004|Overall Study|Withdrawal by Subject|2|||
162178541|NCT03982186|585708662|FG005|Overall Study|Withdrawal by Subject|0|||
162178542|NCT03982186|585708657|FG000|Overall Study|Randomized and not treated|0|||
162178543|NCT03982186|585708658|FG001|Overall Study|Randomized and not treated|0|||
162178544|NCT03982186|585708659|FG002|Overall Study|Randomized and not treated|0|||
162178545|NCT03982186|585708660|FG003|Overall Study|Randomized and not treated|1|||
161671606|NCT04427501|583851345|FG009|Overall Study|Physician Decision|0|||
162178546|NCT03982186|585708661|FG004|Overall Study|Randomized and not treated|0|||
162178547|NCT03982186|585708662|FG005|Overall Study|Randomized and not treated|0|||
162178548|NCT03008382|585708664|FG000|Overall Study|Withdrawal by Subject|2|||
162178549|NCT03008382|585708665|FG001|Overall Study|Withdrawal by Subject|5|||
162178550|NCT03008382|585708666|FG002|Overall Study|Withdrawal by Subject|2|||
162178551|NCT03008382|585708667|FG003|Overall Study|Withdrawal by Subject|0|||
162178552|NCT03008382|585708664|FG000|Overall Study|Protocol Violation|1|||
162178553|NCT03008382|585708665|FG001|Overall Study|Protocol Violation|0|||
162178554|NCT03008382|585708666|FG002|Overall Study|Protocol Violation|0|||
162178555|NCT03008382|585708667|FG003|Overall Study|Protocol Violation|0|||
162178556|NCT03008382|585708664|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
162178557|NCT03008382|585708665|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
162178558|NCT03008382|585708666|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
162178559|NCT03008382|585708667|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
162178560|NCT03008382|585708664|FG000|Overall Study|Lost to Follow-up|0|||
162178561|NCT03008382|585708665|FG001|Overall Study|Lost to Follow-up|0|||
162178562|NCT03008382|585708666|FG002|Overall Study|Lost to Follow-up|1|||
162178563|NCT03008382|585708667|FG003|Overall Study|Lost to Follow-up|0|||
162178564|NCT03008382|585708664|FG000|Overall Study|Screenfail|0|||
162178565|NCT03008382|585708665|FG001|Overall Study|Screenfail|0|||
162178566|NCT03008382|585708666|FG002|Overall Study|Screenfail|2|||
162178567|NCT03008382|585708667|FG003|Overall Study|Screenfail|0|||
162178568|NCT05267639|585709450|FG000|Overall Study|Withdrawal by Subject|1|||
162178569|NCT05267639|585709451|FG001|Overall Study|Withdrawal by Subject|0|||
162178570|NCT04732871|585709452|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
162178571|NCT04732871|585709453|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
162178572|NCT04732871|585709454|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
162178573|NCT04732871|585709452|FG000|Overall Study|Lost to Follow-up|7|||
162178574|NCT04732871|585709453|FG001|Overall Study|Lost to Follow-up|4|||
162178575|NCT04732871|585709454|FG002|Overall Study|Lost to Follow-up|3|||
162178576|NCT04732871|585709452|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
162178577|NCT04732871|585709453|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
162178578|NCT04732871|585709454|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
162178579|NCT04732871|585709452|FG000|Overall Study|Migrated / moved from the study area|5|||
162178580|NCT04732871|585709453|FG001|Overall Study|Migrated / moved from the study area|0|||
162178581|NCT04732871|585709454|FG002|Overall Study|Migrated / moved from the study area|0|||
162178582|NCT04732871|585709452|FG000|Overall Study|Other|1|||
162178583|NCT04732871|585709453|FG001|Overall Study|Other|0|||
162178584|NCT04732871|585709454|FG002|Overall Study|Other|1|||
162178585|NCT04732871|585709452|FG000|Overall Study|Ongoing|6|||
162178586|NCT04732871|585709453|FG001|Overall Study|Ongoing|0|||
162178587|NCT04732871|585709454|FG002|Overall Study|Ongoing|1|||
162178588|NCT04732871|585709452|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
162178589|NCT04732871|585709453|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
162178590|NCT04732871|585709454|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
162178591|NCT05180539|585709466|FG000|Overall Study|Lost to Follow-up|27|||
162178592|NCT05180539|585709467|FG001|Overall Study|Lost to Follow-up|30|||
162178593|NCT00968149|585709470|FG000|Overall Study|Adverse Event|5|||
162178594|NCT00968149|585709471|FG001|Overall Study|Adverse Event|1|||
162178595|NCT00968149|585709470|FG000|Overall Study|Lack of Efficacy|0|||
162178596|NCT00968149|585709471|FG001|Overall Study|Lack of Efficacy|4|||
162178597|NCT00968149|585709470|FG000|Overall Study|Lost to Follow-up|0|||
162178598|NCT00968149|585709471|FG001|Overall Study|Lost to Follow-up|1|||
162178599|NCT00968149|585709470|FG000|Overall Study|Protocol Violation|4|||
162178600|NCT00968149|585709471|FG001|Overall Study|Protocol Violation|0|||
162178601|NCT00968149|585709470|FG000|Overall Study|Withdrawal by Subject|2|||
162178602|NCT00968149|585709471|FG001|Overall Study|Withdrawal by Subject|0|||
162178603|NCT02719574|585709472|FG000|Phase 1 (Dose Escalation)|Other|0|||
162178604|NCT02719574|585709473|FG001|Phase 1 (Dose Escalation)|Other|2|||
162178605|NCT02719574|585709474|FG002|Phase 1 (Dose Escalation)|Other|1|||
162178606|NCT02719574|585709475|FG003|Phase 1 (Dose Escalation)|Other|2|||
162178607|NCT02719574|585709476|FG004|Phase 1 (Dose Escalation)|Other|2|||
162178608|NCT02719574|585709477|FG005|Phase 1 (Dose Escalation)|Other|0|||
162178609|NCT02719574|585709478|FG006|Phase 1 (Dose Escalation)|Other|0|||
162178610|NCT02719574|585709479|FG007|Phase 1 (Dose Escalation)|Other|0|||
162178611|NCT02719574|585709480|FG008|Phase 1 (Dose Escalation)|Other|0|||
162178612|NCT02719574|585709481|FG009|Phase 1 (Dose Escalation)|Other|0|||
162178613|NCT02719574|585709482|FG010|Phase 1 (Dose Escalation)|Other|0|||
162178614|NCT02719574|585709483|FG011|Phase 1 (Dose Escalation)|Other|0|||
162178615|NCT02719574|585709484|FG012|Phase 1 (Dose Escalation)|Other|0|||
162178616|NCT02719574|585709485|FG013|Phase 1 (Dose Escalation)|Other|0|||
162178617|NCT02719574|585709486|FG014|Phase 1 (Dose Escalation)|Other|0|||
162178618|NCT02719574|585709487|FG015|Phase 1 (Dose Escalation)|Other|0|||
162178619|NCT02719574|585709488|FG016|Phase 1 (Dose Escalation)|Other|0|||
162178620|NCT02719574|585709472|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
162178621|NCT02719574|585709473|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
162178622|NCT02719574|585709474|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
162178623|NCT02719574|585709475|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
162178624|NCT02719574|585709476|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
162178625|NCT02719574|585709477|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
162178626|NCT02719574|585709478|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162178627|NCT02719574|585709479|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162178628|NCT02719574|585709480|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162178629|NCT02719574|585709481|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162178630|NCT02719574|585709482|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162178631|NCT02719574|585709483|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162178632|NCT02719574|585709484|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162178633|NCT02719574|585709485|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162178634|NCT02719574|585709486|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162178635|NCT02719574|585709487|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162178636|NCT02719574|585709488|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
162178637|NCT02719574|585709472|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162018679|NCT01349049|585123164|FG001|Overall Study|Withdrawal by Subject|0|||
162018680|NCT01349049|585123165|FG002|Overall Study|Withdrawal by Subject|0|||
162018681|NCT01349049|585123166|FG003|Overall Study|Withdrawal by Subject|0|||
162018682|NCT01349049|585123167|FG004|Overall Study|Withdrawal by Subject|0|||
162178638|NCT02719574|585709473|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
162178639|NCT02719574|585709474|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
162178640|NCT02719574|585709475|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162178641|NCT02719574|585709476|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
162178642|NCT02719574|585709477|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
162178643|NCT02719574|585709478|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162178644|NCT02719574|585709479|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162178645|NCT02719574|585709480|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162178646|NCT02719574|585709481|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162178647|NCT02719574|585709482|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162178648|NCT02719574|585709483|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162178649|NCT02719574|585709484|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162178650|NCT02719574|585709485|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162178651|NCT02719574|585709486|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162178652|NCT02719574|585709487|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162178653|NCT02719574|585709488|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
162178654|NCT02719574|585709472|FG000|Phase 1 (Dose Escalation)|Death|2|||
162178655|NCT02719574|585709473|FG001|Phase 1 (Dose Escalation)|Death|1|||
162178656|NCT02719574|585709474|FG002|Phase 1 (Dose Escalation)|Death|1|||
162178657|NCT02719574|585709475|FG003|Phase 1 (Dose Escalation)|Death|0|||
162178658|NCT02719574|585709476|FG004|Phase 1 (Dose Escalation)|Death|0|||
162178659|NCT02719574|585709477|FG005|Phase 1 (Dose Escalation)|Death|0|||
162178660|NCT02719574|585709478|FG006|Phase 1 (Dose Escalation)|Death|0|||
162178661|NCT02719574|585709479|FG007|Phase 1 (Dose Escalation)|Death|0|||
162178662|NCT02719574|585709480|FG008|Phase 1 (Dose Escalation)|Death|0|||
162178663|NCT02719574|585709481|FG009|Phase 1 (Dose Escalation)|Death|0|||
161671607|NCT04427501|583851346|FG010|Overall Study|Physician Decision|0|||
161671608|NCT04427501|583851347|FG011|Overall Study|Physician Decision|0|||
161671609|NCT04427501|583851336|FG000|Overall Study|Withdrawal by Subject|9|||
161671610|NCT04427501|583851337|FG001|Overall Study|Withdrawal by Subject|2|||
161817203|NCT01559363|584370981|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
161817204|NCT01559363|584370982|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
161817205|NCT00834873|584370983|FG000|First Intervention|Adverse Event|0|||
161817206|NCT00834873|584370984|FG001|First Intervention|Adverse Event|1|||
161817207|NCT02055547|584370989|FG000|Overall Study|Protocol Violation|0|||
161817208|NCT02055547|584370990|FG001|Overall Study|Protocol Violation|0|||
161817209|NCT02055547|584370991|FG002|Overall Study|Protocol Violation|1|||
162178664|NCT02719574|585709482|FG010|Phase 1 (Dose Escalation)|Death|0|||
162178665|NCT02719574|585709483|FG011|Phase 1 (Dose Escalation)|Death|0|||
162178666|NCT02719574|585709484|FG012|Phase 1 (Dose Escalation)|Death|0|||
162178667|NCT02719574|585709485|FG013|Phase 1 (Dose Escalation)|Death|0|||
162178668|NCT02719574|585709486|FG014|Phase 1 (Dose Escalation)|Death|0|||
162178669|NCT02719574|585709487|FG015|Phase 1 (Dose Escalation)|Death|0|||
162178670|NCT02719574|585709488|FG016|Phase 1 (Dose Escalation)|Death|0|||
162178671|NCT02719574|585709472|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178672|NCT02719574|585709473|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
162178673|NCT02719574|585709474|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178674|NCT02719574|585709475|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178675|NCT02719574|585709476|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
162178676|NCT02719574|585709477|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
162178677|NCT02719574|585709478|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178678|NCT02719574|585709479|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178679|NCT02719574|585709480|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178680|NCT02719574|585709481|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178681|NCT02719574|585709482|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178682|NCT02719574|585709483|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178683|NCT02719574|585709484|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178684|NCT02719574|585709485|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178685|NCT02719574|585709486|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178686|NCT02719574|585709487|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178687|NCT02719574|585709488|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
162178688|NCT02719574|585709472|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178689|NCT02719574|585709473|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178690|NCT02719574|585709474|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178691|NCT02719574|585709475|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178692|NCT02719574|585709476|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
162178693|NCT02719574|585709477|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
162178694|NCT02719574|585709478|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178695|NCT02719574|585709479|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178696|NCT02719574|585709480|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178697|NCT02719574|585709481|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178698|NCT02719574|585709482|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178699|NCT02719574|585709483|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178700|NCT02719574|585709484|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178701|NCT02719574|585709485|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178702|NCT02719574|585709486|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178703|NCT02719574|585709487|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178704|NCT02719574|585709488|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
162178705|NCT02719574|585709472|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178706|NCT02719574|585709473|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178707|NCT02719574|585709474|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
162178708|NCT02719574|585709475|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178709|NCT02719574|585709476|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178710|NCT02719574|585709477|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178711|NCT02719574|585709478|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178712|NCT02719574|585709479|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178713|NCT02719574|585709480|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178714|NCT02719574|585709481|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178715|NCT02719574|585709482|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178716|NCT02719574|585709483|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178717|NCT02719574|585709484|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178718|NCT02719574|585709485|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161817210|NCT02055547|584370992|FG003|Overall Study|Protocol Violation|0|||
161817211|NCT02055547|584370993|FG004|Overall Study|Protocol Violation|0|||
161817212|NCT02055547|584370994|FG005|Overall Study|Protocol Violation|0|||
161817213|NCT02055547|584370995|FG006|Overall Study|Protocol Violation|1|||
161817214|NCT02055547|584370996|FG007|Overall Study|Protocol Violation|0|||
161817215|NCT02055547|584370997|FG008|Overall Study|Protocol Violation|0|||
162178719|NCT02719574|585709486|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178720|NCT02719574|585709487|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178721|NCT02719574|585709488|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
162178722|NCT02719574|585709472|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178723|NCT02719574|585709473|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178724|NCT02719574|585709474|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178725|NCT02719574|585709475|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178726|NCT02719574|585709476|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178727|NCT02719574|585709477|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178728|NCT02719574|585709478|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
162178729|NCT02719574|585709479|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
162178730|NCT02719574|585709480|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
162178731|NCT02719574|585709481|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178732|NCT02719574|585709482|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178733|NCT02719574|585709483|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178734|NCT02719574|585709484|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178735|NCT02719574|585709485|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178736|NCT02719574|585709486|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178737|NCT02719574|585709487|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178738|NCT02719574|585709488|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
162178739|NCT02719574|585709472|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178740|NCT02719574|585709473|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178741|NCT02719574|585709474|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178742|NCT02719574|585709475|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178743|NCT02719574|585709476|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178744|NCT02719574|585709477|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178745|NCT02719574|585709478|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
162178746|NCT02719574|585709479|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
162178747|NCT02719574|585709480|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178748|NCT02719574|585709481|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178749|NCT02719574|585709482|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178750|NCT02719574|585709483|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178751|NCT02719574|585709484|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178752|NCT02719574|585709485|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178753|NCT02719574|585709486|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178754|NCT02719574|585709487|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178755|NCT02719574|585709488|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
162178756|NCT02719574|585709472|FG000|Phase 1 (Dose Expansion)|Death|0|||
162178757|NCT02719574|585709473|FG001|Phase 1 (Dose Expansion)|Death|0|||
162178758|NCT02719574|585709474|FG002|Phase 1 (Dose Expansion)|Death|0|||
162178759|NCT02719574|585709475|FG003|Phase 1 (Dose Expansion)|Death|0|||
162178760|NCT02719574|585709476|FG004|Phase 1 (Dose Expansion)|Death|0|||
162178761|NCT02719574|585709477|FG005|Phase 1 (Dose Expansion)|Death|0|||
162178762|NCT02719574|585709478|FG006|Phase 1 (Dose Expansion)|Death|1|||
162178763|NCT02719574|585709479|FG007|Phase 1 (Dose Expansion)|Death|6|||
162178764|NCT02719574|585709480|FG008|Phase 1 (Dose Expansion)|Death|0|||
162178765|NCT02719574|585709481|FG009|Phase 1 (Dose Expansion)|Death|0|||
162178766|NCT02719574|585709482|FG010|Phase 1 (Dose Expansion)|Death|0|||
162178767|NCT02719574|585709483|FG011|Phase 1 (Dose Expansion)|Death|0|||
161817216|NCT02055547|584370998|FG009|Overall Study|Protocol Violation|0|||
161817217|NCT02055547|584370999|FG010|Overall Study|Protocol Violation|0|||
161817218|NCT02055547|584371000|FG011|Overall Study|Protocol Violation|0|||
161817219|NCT02055547|584371001|FG012|Overall Study|Protocol Violation|0|||
161817220|NCT02055547|584371002|FG013|Overall Study|Protocol Violation|0|||
162178768|NCT02719574|585709484|FG012|Phase 1 (Dose Expansion)|Death|0|||
162178769|NCT02719574|585709485|FG013|Phase 1 (Dose Expansion)|Death|0|||
162178770|NCT02719574|585709486|FG014|Phase 1 (Dose Expansion)|Death|0|||
161671611|NCT04427501|583851338|FG002|Overall Study|Withdrawal by Subject|2|||
161817221|NCT02055547|584371003|FG014|Overall Study|Protocol Violation|0|||
162178771|NCT02719574|585709487|FG015|Phase 1 (Dose Expansion)|Death|0|||
162178772|NCT02719574|585709488|FG016|Phase 1 (Dose Expansion)|Death|0|||
162178773|NCT02719574|585709472|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
161817222|NCT02055547|584371004|FG015|Overall Study|Protocol Violation|0|||
161817223|NCT02055547|584371005|FG016|Overall Study|Protocol Violation|0|||
161817224|NCT02055547|584371006|FG017|Overall Study|Protocol Violation|0|||
161817225|NCT02055547|584371007|FG018|Overall Study|Protocol Violation|0|||
161817226|NCT02055547|584370989|FG000|Overall Study|Physician Decision|0|||
161817227|NCT02055547|584370990|FG001|Overall Study|Physician Decision|1|||
161817228|NCT02055547|584370991|FG002|Overall Study|Physician Decision|1|||
161817229|NCT02055547|584370992|FG003|Overall Study|Physician Decision|0|||
162178774|NCT02719574|585709473|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178775|NCT02719574|585709474|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178776|NCT02719574|585709475|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178777|NCT02719574|585709476|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
161923142|NCT03369223|584764928|FG007|Overall Study|Participant request to discontinue study treatment|0|||
162178778|NCT02719574|585709477|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178779|NCT02719574|585709478|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
162178780|NCT02719574|585709479|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
162178781|NCT02719574|585709480|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178782|NCT02719574|585709481|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178783|NCT02719574|585709482|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178784|NCT02719574|585709483|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178785|NCT02719574|585709484|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178786|NCT02719574|585709485|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178787|NCT02719574|585709486|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178788|NCT02719574|585709487|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178789|NCT02719574|585709488|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
162178790|NCT02719574|585709472|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178791|NCT02719574|585709473|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178792|NCT02719574|585709474|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178793|NCT02719574|585709475|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178794|NCT02719574|585709476|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178795|NCT02719574|585709477|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178796|NCT02719574|585709478|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
162178797|NCT02719574|585709479|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
162178798|NCT02719574|585709480|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178799|NCT02719574|585709481|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178800|NCT02719574|585709482|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178801|NCT02719574|585709483|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178802|NCT02719574|585709484|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178803|NCT02719574|585709485|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178804|NCT02719574|585709486|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178805|NCT02719574|585709487|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178806|NCT02719574|585709488|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
162178807|NCT02719574|585709472|FG000|Phase 1 (Dose Expansion)|Other|0|||
162178808|NCT02719574|585709473|FG001|Phase 1 (Dose Expansion)|Other|0|||
162178809|NCT02719574|585709474|FG002|Phase 1 (Dose Expansion)|Other|0|||
162178810|NCT02719574|585709475|FG003|Phase 1 (Dose Expansion)|Other|0|||
162178811|NCT02719574|585709476|FG004|Phase 1 (Dose Expansion)|Other|0|||
162178812|NCT02719574|585709477|FG005|Phase 1 (Dose Expansion)|Other|0|||
162178813|NCT02719574|585709478|FG006|Phase 1 (Dose Expansion)|Other|1|||
162178814|NCT02719574|585709479|FG007|Phase 1 (Dose Expansion)|Other|7|||
162178815|NCT02719574|585709480|FG008|Phase 1 (Dose Expansion)|Other|0|||
162178816|NCT02719574|585709481|FG009|Phase 1 (Dose Expansion)|Other|0|||
162178817|NCT02719574|585709482|FG010|Phase 1 (Dose Expansion)|Other|0|||
162178818|NCT02719574|585709483|FG011|Phase 1 (Dose Expansion)|Other|0|||
162178819|NCT02719574|585709484|FG012|Phase 1 (Dose Expansion)|Other|0|||
162178820|NCT02719574|585709485|FG013|Phase 1 (Dose Expansion)|Other|0|||
162178821|NCT02719574|585709486|FG014|Phase 1 (Dose Expansion)|Other|0|||
162178822|NCT02719574|585709487|FG015|Phase 1 (Dose Expansion)|Other|0|||
162178823|NCT02719574|585709488|FG016|Phase 1 (Dose Expansion)|Other|0|||
162178824|NCT02719574|585709472|FG000|Phase 2|Protocol Defined Disease Progression|0|||
162178825|NCT02719574|585709473|FG001|Phase 2|Protocol Defined Disease Progression|0|||
162178826|NCT02719574|585709474|FG002|Phase 2|Protocol Defined Disease Progression|0|||
162178827|NCT02719574|585709475|FG003|Phase 2|Protocol Defined Disease Progression|0|||
162178828|NCT02719574|585709476|FG004|Phase 2|Protocol Defined Disease Progression|0|||
162178829|NCT02719574|585709477|FG005|Phase 2|Protocol Defined Disease Progression|0|||
162178830|NCT02719574|585709478|FG006|Phase 2|Protocol Defined Disease Progression|0|||
162178831|NCT02719574|585709479|FG007|Phase 2|Protocol Defined Disease Progression|0|||
162178832|NCT02719574|585709480|FG008|Phase 2|Protocol Defined Disease Progression|0|||
162178833|NCT02719574|585709481|FG009|Phase 2|Protocol Defined Disease Progression|65|||
162178834|NCT02719574|585709482|FG010|Phase 2|Protocol Defined Disease Progression|8|||
162178835|NCT02719574|585709483|FG011|Phase 2|Protocol Defined Disease Progression|2|||
162178836|NCT02719574|585709484|FG012|Phase 2|Protocol Defined Disease Progression|4|||
162178837|NCT02719574|585709485|FG013|Phase 2|Protocol Defined Disease Progression|9|||
162178838|NCT02719574|585709486|FG014|Phase 2|Protocol Defined Disease Progression|11|||
162178839|NCT02719574|585709487|FG015|Phase 2|Protocol Defined Disease Progression|3|||
162178840|NCT02719574|585709488|FG016|Phase 2|Protocol Defined Disease Progression|4|||
162178841|NCT02719574|585709472|FG000|Phase 2|Adverse Event|0|||
162178842|NCT02719574|585709473|FG001|Phase 2|Adverse Event|0|||
162178843|NCT02719574|585709474|FG002|Phase 2|Adverse Event|0|||
162178844|NCT02719574|585709475|FG003|Phase 2|Adverse Event|0|||
162178845|NCT02719574|585709476|FG004|Phase 2|Adverse Event|0|||
162178846|NCT02719574|585709477|FG005|Phase 2|Adverse Event|0|||
162178847|NCT02719574|585709478|FG006|Phase 2|Adverse Event|0|||
162178848|NCT02719574|585709479|FG007|Phase 2|Adverse Event|0|||
162178849|NCT02719574|585709480|FG008|Phase 2|Adverse Event|0|||
162178850|NCT02719574|585709481|FG009|Phase 2|Adverse Event|27|||
162178851|NCT02719574|585709482|FG010|Phase 2|Adverse Event|0|||
162178852|NCT02719574|585709483|FG011|Phase 2|Adverse Event|1|||
162178853|NCT02719574|585709484|FG012|Phase 2|Adverse Event|1|||
162178854|NCT02719574|585709485|FG013|Phase 2|Adverse Event|1|||
162178855|NCT02719574|585709486|FG014|Phase 2|Adverse Event|2|||
162178856|NCT02719574|585709487|FG015|Phase 2|Adverse Event|2|||
162178857|NCT02719574|585709488|FG016|Phase 2|Adverse Event|3|||
162178858|NCT02719574|585709472|FG000|Phase 2|Other|0|||
162178859|NCT02719574|585709473|FG001|Phase 2|Other|0|||
162178860|NCT02719574|585709474|FG002|Phase 2|Other|0|||
162178861|NCT02719574|585709475|FG003|Phase 2|Other|0|||
162178862|NCT02719574|585709476|FG004|Phase 2|Other|0|||
162178863|NCT02719574|585709477|FG005|Phase 2|Other|0|||
162178864|NCT02719574|585709478|FG006|Phase 2|Other|0|||
162178865|NCT02719574|585709479|FG007|Phase 2|Other|0|||
162178866|NCT02719574|585709480|FG008|Phase 2|Other|0|||
162178867|NCT02719574|585709481|FG009|Phase 2|Other|20|||
162178868|NCT02719574|585709482|FG010|Phase 2|Other|7|||
162178869|NCT02719574|585709483|FG011|Phase 2|Other|0|||
162178870|NCT02719574|585709484|FG012|Phase 2|Other|5|||
162178871|NCT02719574|585709485|FG013|Phase 2|Other|7|||
162178872|NCT02719574|585709486|FG014|Phase 2|Other|0|||
162178873|NCT02719574|585709487|FG015|Phase 2|Other|1|||
162178874|NCT02719574|585709488|FG016|Phase 2|Other|4|||
162178875|NCT02719574|585709472|FG000|Phase 2|Transplant|0|||
162178876|NCT02719574|585709473|FG001|Phase 2|Transplant|0|||
162178877|NCT02719574|585709474|FG002|Phase 2|Transplant|0|||
162178878|NCT02719574|585709475|FG003|Phase 2|Transplant|0|||
162178879|NCT02719574|585709476|FG004|Phase 2|Transplant|0|||
162178880|NCT02719574|585709477|FG005|Phase 2|Transplant|0|||
162178881|NCT02719574|585709478|FG006|Phase 2|Transplant|0|||
162178882|NCT02719574|585709479|FG007|Phase 2|Transplant|0|||
162178883|NCT02719574|585709480|FG008|Phase 2|Transplant|0|||
162178884|NCT02719574|585709481|FG009|Phase 2|Transplant|15|||
162178885|NCT02719574|585709482|FG010|Phase 2|Transplant|2|||
162178886|NCT02719574|585709483|FG011|Phase 2|Transplant|0|||
162178887|NCT02719574|585709484|FG012|Phase 2|Transplant|6|||
162178888|NCT02719574|585709485|FG013|Phase 2|Transplant|1|||
162178889|NCT02719574|585709486|FG014|Phase 2|Transplant|1|||
162178890|NCT02719574|585709487|FG015|Phase 2|Transplant|0|||
162178891|NCT02719574|585709488|FG016|Phase 2|Transplant|0|||
162178892|NCT02719574|585709472|FG000|Phase 2|Death|0|||
162178893|NCT02719574|585709473|FG001|Phase 2|Death|0|||
161671612|NCT04427501|583851339|FG003|Overall Study|Withdrawal by Subject|3|||
161671613|NCT04427501|583851340|FG004|Overall Study|Withdrawal by Subject|7|||
161671614|NCT04427501|583851341|FG005|Overall Study|Withdrawal by Subject|25|||
162178894|NCT02719574|585709474|FG002|Phase 2|Death|0|||
162178895|NCT02719574|585709475|FG003|Phase 2|Death|0|||
162178896|NCT02719574|585709476|FG004|Phase 2|Death|0|||
162178897|NCT02719574|585709477|FG005|Phase 2|Death|0|||
162178898|NCT02719574|585709478|FG006|Phase 2|Death|0|||
162178899|NCT02719574|585709479|FG007|Phase 2|Death|0|||
161671615|NCT04427501|583851342|FG006|Overall Study|Withdrawal by Subject|15|||
161671616|NCT04427501|583851343|FG007|Overall Study|Withdrawal by Subject|7|||
162178900|NCT02719574|585709480|FG008|Phase 2|Death|0|||
162178901|NCT02719574|585709481|FG009|Phase 2|Death|14|||
162178902|NCT02719574|585709482|FG010|Phase 2|Death|0|||
162178903|NCT02719574|585709483|FG011|Phase 2|Death|0|||
162178904|NCT02719574|585709484|FG012|Phase 2|Death|1|||
162178905|NCT02719574|585709485|FG013|Phase 2|Death|1|||
162178906|NCT02719574|585709486|FG014|Phase 2|Death|2|||
162178907|NCT02719574|585709487|FG015|Phase 2|Death|0|||
162178908|NCT02719574|585709488|FG016|Phase 2|Death|0|||
162178909|NCT02719574|585709472|FG000|Phase 2|Investigator Decision|0|||
162178910|NCT02719574|585709473|FG001|Phase 2|Investigator Decision|0|||
162178911|NCT02719574|585709474|FG002|Phase 2|Investigator Decision|0|||
162178912|NCT02719574|585709475|FG003|Phase 2|Investigator Decision|0|||
162178913|NCT02719574|585709476|FG004|Phase 2|Investigator Decision|0|||
162178914|NCT02719574|585709477|FG005|Phase 2|Investigator Decision|0|||
162178915|NCT02719574|585709478|FG006|Phase 2|Investigator Decision|0|||
162178916|NCT02719574|585709479|FG007|Phase 2|Investigator Decision|0|||
162178917|NCT02719574|585709480|FG008|Phase 2|Investigator Decision|0|||
162178918|NCT02719574|585709481|FG009|Phase 2|Investigator Decision|6|||
162178919|NCT02719574|585709482|FG010|Phase 2|Investigator Decision|1|||
162178920|NCT02719574|585709483|FG011|Phase 2|Investigator Decision|2|||
162178921|NCT02719574|585709484|FG012|Phase 2|Investigator Decision|3|||
162178922|NCT02719574|585709485|FG013|Phase 2|Investigator Decision|1|||
162178923|NCT02719574|585709486|FG014|Phase 2|Investigator Decision|3|||
162178924|NCT02719574|585709487|FG015|Phase 2|Investigator Decision|2|||
162178925|NCT02719574|585709488|FG016|Phase 2|Investigator Decision|0|||
162178926|NCT02719574|585709472|FG000|Phase 2|Withdrawal by Subject|0|||
162178927|NCT02719574|585709473|FG001|Phase 2|Withdrawal by Subject|0|||
162178928|NCT02719574|585709474|FG002|Phase 2|Withdrawal by Subject|0|||
162178929|NCT02719574|585709475|FG003|Phase 2|Withdrawal by Subject|0|||
162178930|NCT02719574|585709476|FG004|Phase 2|Withdrawal by Subject|0|||
162178931|NCT02719574|585709477|FG005|Phase 2|Withdrawal by Subject|0|||
162178932|NCT02719574|585709478|FG006|Phase 2|Withdrawal by Subject|0|||
162178933|NCT02719574|585709479|FG007|Phase 2|Withdrawal by Subject|0|||
162178934|NCT02719574|585709480|FG008|Phase 2|Withdrawal by Subject|0|||
162178935|NCT02719574|585709481|FG009|Phase 2|Withdrawal by Subject|5|||
162178936|NCT02719574|585709482|FG010|Phase 2|Withdrawal by Subject|0|||
162178937|NCT02719574|585709483|FG011|Phase 2|Withdrawal by Subject|0|||
162178938|NCT02719574|585709484|FG012|Phase 2|Withdrawal by Subject|0|||
162178939|NCT02719574|585709485|FG013|Phase 2|Withdrawal by Subject|1|||
162178940|NCT02719574|585709486|FG014|Phase 2|Withdrawal by Subject|1|||
162178941|NCT02719574|585709487|FG015|Phase 2|Withdrawal by Subject|2|||
161817230|NCT02055547|584370993|FG004|Overall Study|Physician Decision|1|||
161817231|NCT02055547|584370994|FG005|Overall Study|Physician Decision|0|||
161817232|NCT02055547|584370995|FG006|Overall Study|Physician Decision|0|||
161817233|NCT02055547|584370996|FG007|Overall Study|Physician Decision|0|||
162178942|NCT02719574|585709488|FG016|Phase 2|Withdrawal by Subject|0|||
162178943|NCT02719574|585709472|FG000|Phase 2|Protocol Violation|0|||
162178944|NCT02719574|585709473|FG001|Phase 2|Protocol Violation|0|||
162178945|NCT02719574|585709474|FG002|Phase 2|Protocol Violation|0|||
162178946|NCT02719574|585709475|FG003|Phase 2|Protocol Violation|0|||
162178947|NCT02719574|585709476|FG004|Phase 2|Protocol Violation|0|||
161817234|NCT02055547|584370997|FG008|Overall Study|Physician Decision|0|||
161817235|NCT02055547|584370998|FG009|Overall Study|Physician Decision|1|||
161817236|NCT02055547|584370999|FG010|Overall Study|Physician Decision|1|||
161817237|NCT02055547|584371000|FG011|Overall Study|Physician Decision|0|||
161817238|NCT02055547|584371001|FG012|Overall Study|Physician Decision|0|||
161817239|NCT02055547|584371002|FG013|Overall Study|Physician Decision|0|||
161817240|NCT02055547|584371003|FG014|Overall Study|Physician Decision|0|||
161817241|NCT02055547|584371004|FG015|Overall Study|Physician Decision|0|||
161817242|NCT02055547|584371005|FG016|Overall Study|Physician Decision|0|||
161817243|NCT02055547|584371006|FG017|Overall Study|Physician Decision|0|||
161817244|NCT02055547|584371007|FG018|Overall Study|Physician Decision|0|||
161817245|NCT02055547|584370989|FG000|Overall Study|Adverse Event|0|||
161817246|NCT02055547|584370990|FG001|Overall Study|Adverse Event|0|||
161817247|NCT02055547|584370991|FG002|Overall Study|Adverse Event|0|||
161817248|NCT02055547|584370992|FG003|Overall Study|Adverse Event|0|||
161817249|NCT02055547|584370993|FG004|Overall Study|Adverse Event|0|||
161817250|NCT02055547|584370994|FG005|Overall Study|Adverse Event|0|||
161817251|NCT02055547|584370995|FG006|Overall Study|Adverse Event|1|||
162178948|NCT02719574|585709477|FG005|Phase 2|Protocol Violation|0|||
162178949|NCT02719574|585709478|FG006|Phase 2|Protocol Violation|0|||
162178950|NCT02719574|585709479|FG007|Phase 2|Protocol Violation|0|||
162178951|NCT02719574|585709480|FG008|Phase 2|Protocol Violation|0|||
162178952|NCT02719574|585709481|FG009|Phase 2|Protocol Violation|1|||
162178953|NCT02719574|585709482|FG010|Phase 2|Protocol Violation|0|||
162178954|NCT02719574|585709483|FG011|Phase 2|Protocol Violation|0|||
162178955|NCT02719574|585709484|FG012|Phase 2|Protocol Violation|0|||
162178956|NCT02719574|585709485|FG013|Phase 2|Protocol Violation|0|||
162178957|NCT02719574|585709486|FG014|Phase 2|Protocol Violation|0|||
162178958|NCT02719574|585709487|FG015|Phase 2|Protocol Violation|0|||
162178959|NCT02719574|585709488|FG016|Phase 2|Protocol Violation|0|||
162178960|NCT00113360|585709489|FG000|Overall Study|Adverse Event|3|||
162178961|NCT00113360|585709489|FG000|Overall Study|Subject required surgery|1|||
162178962|NCT00113360|585709489|FG000|Overall Study|Did not meet eligibility criteria|3|||
161671617|NCT04427501|583851344|FG008|Overall Study|Withdrawal by Subject|4|||
161817252|NCT02055547|584370996|FG007|Overall Study|Adverse Event|0|||
161817253|NCT02055547|584370997|FG008|Overall Study|Adverse Event|1|||
161817254|NCT02055547|584370998|FG009|Overall Study|Adverse Event|0|||
161817255|NCT02055547|584370999|FG010|Overall Study|Adverse Event|0|||
161817256|NCT02055547|584371000|FG011|Overall Study|Adverse Event|0|||
161817257|NCT02055547|584371001|FG012|Overall Study|Adverse Event|0|||
161817258|NCT02055547|584371002|FG013|Overall Study|Adverse Event|0|||
161817259|NCT02055547|584371003|FG014|Overall Study|Adverse Event|0|||
161817260|NCT02055547|584371004|FG015|Overall Study|Adverse Event|0|||
161817261|NCT02055547|584371005|FG016|Overall Study|Adverse Event|0|||
161817262|NCT02055547|584371006|FG017|Overall Study|Adverse Event|0|||
161817263|NCT02055547|584371007|FG018|Overall Study|Adverse Event|0|||
161817264|NCT02055547|584370989|FG000|Overall Study|Withdrawal by Subject|0|||
161817265|NCT02055547|584370990|FG001|Overall Study|Withdrawal by Subject|0|||
161817266|NCT02055547|584370991|FG002|Overall Study|Withdrawal by Subject|0|||
162178963|NCT02231749|585709504|FG000|Overall Study|Disease progression|229|||
162178964|NCT02231749|585709505|FG001|Overall Study|Disease progression|297|||
162178965|NCT02231749|585709504|FG000|Overall Study|Study Drug Toxicity|134|||
162178966|NCT02231749|585709505|FG001|Overall Study|Study Drug Toxicity|63|||
162178967|NCT02231749|585709504|FG000|Overall Study|Death|1|||
162178968|NCT02231749|585709505|FG001|Overall Study|Death|1|||
162178969|NCT02231749|585709504|FG000|Overall Study|AE unrelated to Study drug|32|||
162178970|NCT02231749|585709505|FG001|Overall Study|AE unrelated to Study drug|31|||
162178971|NCT02231749|585709504|FG000|Overall Study|Participant's request to discontinue|10|||
162178972|NCT02231749|585709505|FG001|Overall Study|Participant's request to discontinue|21|||
162178973|NCT02231749|585709504|FG000|Overall Study|Participant withdrew Consent|8|||
162178974|NCT02231749|585709505|FG001|Overall Study|Participant withdrew Consent|15|||
162178975|NCT02231749|585709504|FG000|Overall Study|Lost to Follow-up|1|||
162178976|NCT02231749|585709505|FG001|Overall Study|Lost to Follow-up|2|||
162178977|NCT02231749|585709504|FG000|Overall Study|Maximum Clinical Benefit|5|||
162178978|NCT02231749|585709505|FG001|Overall Study|Maximum Clinical Benefit|8|||
161817267|NCT02055547|584370992|FG003|Overall Study|Withdrawal by Subject|0|||
161817268|NCT02055547|584370993|FG004|Overall Study|Withdrawal by Subject|0|||
161817269|NCT02055547|584370994|FG005|Overall Study|Withdrawal by Subject|1|||
162178979|NCT02231749|585709504|FG000|Overall Study|Poor/Non-Compliance|0|||
162178980|NCT02231749|585709505|FG001|Overall Study|Poor/Non-Compliance|3|||
162178981|NCT02231749|585709504|FG000|Overall Study|Pregnancy|1|||
162178982|NCT02231749|585709505|FG001|Overall Study|Pregnancy|0|||
162178983|NCT02231749|585709504|FG000|Overall Study|other|0|||
162178984|NCT02231749|585709505|FG001|Overall Study|other|8|||
162178985|NCT02231749|585709504|FG000|Overall Study|No longer meets Study Criteria|1|||
162178986|NCT02231749|585709505|FG001|Overall Study|No longer meets Study Criteria|0|||
162178987|NCT02532621|585709508|FG000|Overall Study|Death|3|||
162178988|NCT02532621|585709508|FG000|Overall Study|Lost to Follow-up|3|||
162178989|NCT02532621|585709508|FG000|Overall Study|Withdrawal by Subject|6|||
162178990|NCT02532621|585709508|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
162178991|NCT02532621|585709508|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
162178992|NCT04281498|585709509|FG000|Overall Study|Progression of disease|1|||
162178993|NCT04281498|585709509|FG000|Overall Study|Planned SCT|1|||
162178994|NCT04281498|585709509|FG000|Overall Study|Alternative Treatment|1|||
162178995|NCT05771467|585709511|FG000|Overall Study|Lost to Follow-up|6|||
162178996|NCT05771467|585709512|FG001|Overall Study|Lost to Follow-up|3|||
162178997|NCT01220531|585709517|FG000|Overall Study|Death|7|||
162178998|NCT01220531|585709517|FG000|Overall Study|Lost to Follow-up|1|||
162178999|NCT05866926|585709518|FG000|Overall Study|Death|16|||
162179000|NCT05866926|585709519|FG001|Overall Study|Death|9|||
162179001|NCT05866926|585709518|FG000|Overall Study|Lost to Follow-up|0|||
162179002|NCT05866926|585709519|FG001|Overall Study|Lost to Follow-up|1|||
162179003|NCT05866926|585709518|FG000|Overall Study|Adverse Event|1|||
162179004|NCT05866926|585709519|FG001|Overall Study|Adverse Event|0|||
162179005|NCT05866926|585709518|FG000|Overall Study|Withdrawal by Subject|5|||
162179006|NCT05866926|585709519|FG001|Overall Study|Withdrawal by Subject|1|||
162179007|NCT05866926|585709518|FG000|Overall Study|Disease progression|1|||
162179008|NCT05866926|585709519|FG001|Overall Study|Disease progression|0|||
162179009|NCT05866926|585709518|FG000|Overall Study|other causes|2|||
162179010|NCT05866926|585709519|FG001|Overall Study|other causes|1|||
162179011|NCT00709956|585709520|FG000|Overall Study|Withdrawal by Subject|1|||
162179012|NCT00709956|585709521|FG001|Overall Study|Withdrawal by Subject|1|||
162179013|NCT00709956|585709520|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
162179014|NCT00709956|585709521|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
162179015|NCT01105091|585709522|FG000|Overall Study|Death|2|||
162179016|NCT01105091|585709523|FG001|Overall Study|Death|0|||
162179017|NCT04940624|585709526|FG000|Overall Study|Adverse Event|4|||
162179018|NCT04940624|585709527|FG001|Overall Study|Adverse Event|11|||
162179019|NCT04940624|585709526|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162179020|NCT04940624|585709527|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
162179021|NCT04940624|585709526|FG000|Overall Study|Physician Decision|1|||
162179022|NCT04940624|585709527|FG001|Overall Study|Physician Decision|0|||
162179023|NCT04940624|585709526|FG000|Overall Study|Lost to Follow-up|1|||
162179024|NCT04940624|585709527|FG001|Overall Study|Lost to Follow-up|0|||
162179025|NCT04940624|585709526|FG000|Overall Study|Reason Not Specified|1|||
162179026|NCT04940624|585709527|FG001|Overall Study|Reason Not Specified|0|||
162179027|NCT04479787|585709528|FG000|Through 6 Months|Withdrawal by Subject|16|||
162179028|NCT04479787|585709529|FG001|Through 6 Months|Withdrawal by Subject|14|||
162179029|NCT04479787|585709528|FG000|Through 6 Months|Unsuccessful Trial|17|||
162179030|NCT04479787|585709529|FG001|Through 6 Months|Unsuccessful Trial|0|||
162179031|NCT04479787|585709528|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
162179032|NCT04479787|585709529|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
162179033|NCT04479787|585709528|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
162179034|NCT04479787|585709529|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
162179035|NCT04479787|585709528|FG000|Through 6 Months|Lost to Follow-up|3|||
162179036|NCT04479787|585709529|FG001|Through 6 Months|Lost to Follow-up|2|||
162179037|NCT04479787|585709528|FG000|Through 6 Months|Death|3|||
162179038|NCT04479787|585709529|FG001|Through 6 Months|Death|0|||
162179039|NCT04479787|585709528|FG000|Through 6 Months|Inclusion/Exclusion|2|||
162179040|NCT04479787|585709529|FG001|Through 6 Months|Inclusion/Exclusion|1|||
162179041|NCT04479787|585709528|FG000|Through 6 Months|Subject Became Pregnant|1|||
162179042|NCT04479787|585709529|FG001|Through 6 Months|Subject Became Pregnant|1|||
162179043|NCT04479787|585709528|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
162179044|NCT04479787|585709529|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
162179045|NCT04479787|585709528|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
162179046|NCT04479787|585709529|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
162179047|NCT04479787|585709528|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
162179048|NCT04479787|585709529|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
162179049|NCT04479787|585709528|FG000|After 6 Months|Withdrawal by Subject|3|||
162179050|NCT04479787|585709529|FG001|After 6 Months|Withdrawal by Subject|13|||
162179051|NCT04479787|585709528|FG000|After 6 Months|Unsuccessful Trial|0|||
162179052|NCT04479787|585709529|FG001|After 6 Months|Unsuccessful Trial|7|||
162179053|NCT04479787|585709528|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
162179054|NCT04479787|585709529|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
162179055|NCT04479787|585709528|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
162179056|NCT04479787|585709529|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
162179057|NCT04479787|585709528|FG000|After 6 Months|Death|2|||
162179058|NCT04479787|585709529|FG001|After 6 Months|Death|0|||
162179059|NCT04479787|585709528|FG000|After 6 Months|Lost to Follow-up|1|||
162179060|NCT04479787|585709529|FG001|After 6 Months|Lost to Follow-up|1|||
162179061|NCT04479787|585709528|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
162179062|NCT04479787|585709529|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
162179063|NCT04479787|585709528|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
162179064|NCT04479787|585709529|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
162179065|NCT04479787|585709528|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
162179066|NCT04479787|585709529|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
162179067|NCT04479787|585709528|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
162179068|NCT04479787|585709529|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
162179069|NCT04039113|585709532|FG000|Overall Study|Withdrawal by Subject|8|||
162179070|NCT04039113|585709533|FG001|Overall Study|Withdrawal by Subject|11|||
162179071|NCT04039113|585709532|FG000|Overall Study|Lost to Follow-up|1|||
162179072|NCT04039113|585709533|FG001|Overall Study|Lost to Follow-up|1|||
162179073|NCT04039113|585709532|FG000|Overall Study|Adverse Event|2|||
162179074|NCT04039113|585709533|FG001|Overall Study|Adverse Event|2|||
162179075|NCT04039113|585709532|FG000|Overall Study|Death|2|||
162179076|NCT04039113|585709533|FG001|Overall Study|Death|4|||
162179077|NCT04039113|585709532|FG000|Overall Study|Site Closure|6|||
162179078|NCT04039113|585709533|FG001|Overall Study|Site Closure|0|||
162179079|NCT04039113|585709532|FG000|Overall Study|Failure to meet randomisation criteria|4|||
162179080|NCT04039113|585709533|FG001|Overall Study|Failure to meet randomisation criteria|0|||
162179081|NCT00353496|585709534|FG000|Overall Study|Adverse Event|1|||
162179082|NCT00353496|585709535|FG001|Overall Study|Adverse Event|0|||
162179083|NCT00353496|585709534|FG000|Overall Study|Protocol Violation|2|||
162179084|NCT00353496|585709535|FG001|Overall Study|Protocol Violation|2|||
162179085|NCT00353496|585709534|FG000|Overall Study|Withdrawal by Subject|3|||
162179086|NCT00353496|585709535|FG001|Overall Study|Withdrawal by Subject|4|||
162179087|NCT00353496|585709534|FG000|Overall Study|Physician Decision|6|||
162179088|NCT00353496|585709535|FG001|Overall Study|Physician Decision|9|||
162179089|NCT00353496|585709534|FG000|Overall Study|Not otherwise specified|4|||
162179090|NCT00353496|585709535|FG001|Overall Study|Not otherwise specified|2|||
162179091|NCT02180867|585709536|FG000|Overall Study|Adverse Event|3|||
162179092|NCT02180867|585709537|FG001|Overall Study|Adverse Event|4|||
162179093|NCT02180867|585709538|FG002|Overall Study|Adverse Event|1|||
162179094|NCT02180867|585709539|FG003|Overall Study|Adverse Event|5|||
162179095|NCT02180867|585709540|FG004|Overall Study|Adverse Event|0|||
162179096|NCT02180867|585709541|FG005|Overall Study|Adverse Event|0|||
162179097|NCT02180867|585709542|FG006|Overall Study|Adverse Event|0|||
162179098|NCT02180867|585709536|FG000|Overall Study|Death|0|||
162179099|NCT02180867|585709537|FG001|Overall Study|Death|0|||
162179100|NCT02180867|585709538|FG002|Overall Study|Death|0|||
162179101|NCT02180867|585709539|FG003|Overall Study|Death|0|||
161817270|NCT02055547|584370995|FG006|Overall Study|Withdrawal by Subject|0|||
161817271|NCT02055547|584370996|FG007|Overall Study|Withdrawal by Subject|0|||
162179102|NCT02180867|585709540|FG004|Overall Study|Death|1|||
162179103|NCT02180867|585709541|FG005|Overall Study|Death|0|||
162179104|NCT02180867|585709542|FG006|Overall Study|Death|0|||
162179105|NCT02180867|585709536|FG000|Overall Study|Lack of Efficacy|0|||
162179106|NCT02180867|585709537|FG001|Overall Study|Lack of Efficacy|2|||
162179107|NCT02180867|585709538|FG002|Overall Study|Lack of Efficacy|0|||
162179108|NCT02180867|585709539|FG003|Overall Study|Lack of Efficacy|1|||
162179109|NCT02180867|585709540|FG004|Overall Study|Lack of Efficacy|6|||
162179110|NCT02180867|585709541|FG005|Overall Study|Lack of Efficacy|0|||
162179111|NCT02180867|585709542|FG006|Overall Study|Lack of Efficacy|1|||
162179112|NCT02180867|585709536|FG000|Overall Study|Physician Decision|1|||
162179113|NCT02180867|585709537|FG001|Overall Study|Physician Decision|3|||
162179114|NCT02180867|585709538|FG002|Overall Study|Physician Decision|1|||
162179115|NCT02180867|585709539|FG003|Overall Study|Physician Decision|10|||
162179116|NCT02180867|585709540|FG004|Overall Study|Physician Decision|9|||
162179117|NCT02180867|585709541|FG005|Overall Study|Physician Decision|3|||
161817272|NCT02055547|584370997|FG008|Overall Study|Withdrawal by Subject|1|||
161817273|NCT02055547|584370998|FG009|Overall Study|Withdrawal by Subject|0|||
162179118|NCT02180867|585709542|FG006|Overall Study|Physician Decision|4|||
161817274|NCT02055547|584370999|FG010|Overall Study|Withdrawal by Subject|0|||
161817275|NCT02055547|584371000|FG011|Overall Study|Withdrawal by Subject|0|||
161817276|NCT02055547|584371001|FG012|Overall Study|Withdrawal by Subject|0|||
162179119|NCT02180867|585709536|FG000|Overall Study|Withdrawal by Subject|0|||
162179120|NCT02180867|585709537|FG001|Overall Study|Withdrawal by Subject|0|||
162179121|NCT02180867|585709538|FG002|Overall Study|Withdrawal by Subject|0|||
162179122|NCT02180867|585709539|FG003|Overall Study|Withdrawal by Subject|1|||
162179123|NCT02180867|585709540|FG004|Overall Study|Withdrawal by Subject|1|||
162179124|NCT02180867|585709541|FG005|Overall Study|Withdrawal by Subject|0|||
162179125|NCT02180867|585709542|FG006|Overall Study|Withdrawal by Subject|0|||
162179126|NCT02180867|585709536|FG000|Overall Study|Ineligible|1|||
162179127|NCT02180867|585709537|FG001|Overall Study|Ineligible|2|||
162179128|NCT02180867|585709538|FG002|Overall Study|Ineligible|0|||
162179129|NCT02180867|585709539|FG003|Overall Study|Ineligible|3|||
162179130|NCT02180867|585709540|FG004|Overall Study|Ineligible|5|||
162179131|NCT02180867|585709541|FG005|Overall Study|Ineligible|0|||
162179132|NCT02180867|585709542|FG006|Overall Study|Ineligible|0|||
162179133|NCT02180867|585709536|FG000|Overall Study|Repeat Eligibility Studies|0|||
162179134|NCT02180867|585709537|FG001|Overall Study|Repeat Eligibility Studies|0|||
162179135|NCT02180867|585709538|FG002|Overall Study|Repeat Eligibility Studies|0|||
162179136|NCT02180867|585709539|FG003|Overall Study|Repeat Eligibility Studies|0|||
162179137|NCT02180867|585709540|FG004|Overall Study|Repeat Eligibility Studies|1|||
162179138|NCT02180867|585709541|FG005|Overall Study|Repeat Eligibility Studies|0|||
162179139|NCT02180867|585709542|FG006|Overall Study|Repeat Eligibility Studies|0|||
162179140|NCT02180867|585709536|FG000|Overall Study|Refusal of further protocol therapy|1|||
162179141|NCT02180867|585709537|FG001|Overall Study|Refusal of further protocol therapy|0|||
162179142|NCT02180867|585709538|FG002|Overall Study|Refusal of further protocol therapy|2|||
162179143|NCT02180867|585709539|FG003|Overall Study|Refusal of further protocol therapy|6|||
162179144|NCT02180867|585709540|FG004|Overall Study|Refusal of further protocol therapy|4|||
162179145|NCT02180867|585709541|FG005|Overall Study|Refusal of further protocol therapy|0|||
162179146|NCT02180867|585709542|FG006|Overall Study|Refusal of further protocol therapy|0|||
162179147|NCT02502266|585710256|FG000|Overall Study|Adverse Event|0|||
162179148|NCT02502266|585710257|FG001|Overall Study|Adverse Event|0|||
162179149|NCT02502266|585710258|FG002|Overall Study|Adverse Event|0|||
162179150|NCT02502266|585710259|FG003|Overall Study|Adverse Event|0|||
162179151|NCT02502266|585710260|FG004|Overall Study|Adverse Event|1|||
162179152|NCT02502266|585710261|FG005|Overall Study|Adverse Event|1|||
162179153|NCT02502266|585710262|FG006|Overall Study|Adverse Event|1|||
162179154|NCT02502266|585710256|FG000|Overall Study|Withdrawal by Subject|30|||
162179155|NCT02502266|585710257|FG001|Overall Study|Withdrawal by Subject|15|||
162179156|NCT02502266|585710258|FG002|Overall Study|Withdrawal by Subject|16|||
162179157|NCT02502266|585710259|FG003|Overall Study|Withdrawal by Subject|0|||
162179158|NCT02502266|585710260|FG004|Overall Study|Withdrawal by Subject|0|||
162179159|NCT02502266|585710261|FG005|Overall Study|Withdrawal by Subject|0|||
162179160|NCT02502266|585710262|FG006|Overall Study|Withdrawal by Subject|0|||
162179161|NCT02502266|585710256|FG000|Overall Study|Still on Treatment|0|||
162179162|NCT02502266|585710257|FG001|Overall Study|Still on Treatment|0|||
162179163|NCT02502266|585710258|FG002|Overall Study|Still on Treatment|1|||
162179164|NCT02502266|585710259|FG003|Overall Study|Still on Treatment|0|||
162179165|NCT02502266|585710260|FG004|Overall Study|Still on Treatment|0|||
162179166|NCT02502266|585710261|FG005|Overall Study|Still on Treatment|0|||
162179167|NCT02502266|585710262|FG006|Overall Study|Still on Treatment|0|||
162179168|NCT02502266|585710256|FG000|Overall Study|Other Reasons|19|||
162179169|NCT02502266|585710257|FG001|Overall Study|Other Reasons|6|||
162179170|NCT02502266|585710258|FG002|Overall Study|Other Reasons|14|||
162179171|NCT02502266|585710259|FG003|Overall Study|Other Reasons|0|||
162179172|NCT02502266|585710260|FG004|Overall Study|Other Reasons|1|||
162179173|NCT02502266|585710261|FG005|Overall Study|Other Reasons|1|||
162179174|NCT02502266|585710262|FG006|Overall Study|Other Reasons|0|||
162179175|NCT02502266|585710256|FG000|Overall Study|Arm 4 Discontinued|0|||
162179176|NCT02502266|585710257|FG001|Overall Study|Arm 4 Discontinued|0|||
162179177|NCT02502266|585710258|FG002|Overall Study|Arm 4 Discontinued|0|||
162179178|NCT02502266|585710259|FG003|Overall Study|Arm 4 Discontinued|52|||
162179179|NCT02502266|585710260|FG004|Overall Study|Arm 4 Discontinued|0|||
162179180|NCT02502266|585710261|FG005|Overall Study|Arm 4 Discontinued|0|||
162179181|NCT02502266|585710262|FG006|Overall Study|Arm 4 Discontinued|0|||
162179182|NCT02502266|585710256|FG000|Overall Study|Never treated|0|||
162179183|NCT02502266|585710257|FG001|Overall Study|Never treated|0|||
162179184|NCT02502266|585710258|FG002|Overall Study|Never treated|0|||
162179185|NCT02502266|585710259|FG003|Overall Study|Never treated|0|||
162179186|NCT02502266|585710260|FG004|Overall Study|Never treated|0|||
162179187|NCT02502266|585710261|FG005|Overall Study|Never treated|1|||
162179188|NCT02502266|585710262|FG006|Overall Study|Never treated|0|||
162179189|NCT01976936|585710263|FG000|Overall Study|Did not receive at least 9 doses|9|||
162179190|NCT01976936|585710264|FG001|Overall Study|Did not receive at least 9 doses|4|||
162179191|NCT02467270|585710265|FG000|Overall Study|Participants Never Treated|0|||
162179192|NCT02467270|585710266|FG001|Overall Study|Participants Never Treated|1|||
162179193|NCT02467270|585710267|FG002|Overall Study|Participants Never Treated|0|||
162179194|NCT02467270|585710265|FG000|Overall Study|Ongoing|50|||
162179195|NCT02467270|585710266|FG001|Overall Study|Ongoing|41|||
162179196|NCT02467270|585710267|FG002|Overall Study|Ongoing|43|||
162179197|NCT02467270|585710265|FG000|Overall Study|Adverse Event|16|||
162179198|NCT02467270|585710266|FG001|Overall Study|Adverse Event|15|||
162179199|NCT02467270|585710267|FG002|Overall Study|Adverse Event|14|||
162179200|NCT02467270|585710265|FG000|Overall Study|Progressive Disease|7|||
162179201|NCT02467270|585710266|FG001|Overall Study|Progressive Disease|7|||
162179202|NCT02467270|585710267|FG002|Overall Study|Progressive Disease|4|||
162179203|NCT02467270|585710265|FG000|Overall Study|Death|2|||
162179204|NCT02467270|585710266|FG001|Overall Study|Death|0|||
162179205|NCT02467270|585710267|FG002|Overall Study|Death|2|||
162179206|NCT02467270|585710265|FG000|Overall Study|Lack of Efficacy|12|||
162179207|NCT02467270|585710266|FG001|Overall Study|Lack of Efficacy|18|||
162179208|NCT02467270|585710267|FG002|Overall Study|Lack of Efficacy|23|||
162179209|NCT02467270|585710265|FG000|Overall Study|Non-compliance With Study Drug|0|||
162179210|NCT02467270|585710266|FG001|Overall Study|Non-compliance With Study Drug|2|||
162179211|NCT02467270|585710267|FG002|Overall Study|Non-compliance With Study Drug|1|||
162179212|NCT02467270|585710265|FG000|Overall Study|Lost to Follow-up|2|||
162179213|NCT02467270|585710266|FG001|Overall Study|Lost to Follow-up|1|||
162179214|NCT02467270|585710267|FG002|Overall Study|Lost to Follow-up|0|||
162179215|NCT02467270|585710265|FG000|Overall Study|Pregnancy|0|||
162179216|NCT02467270|585710266|FG001|Overall Study|Pregnancy|1|||
162179217|NCT02467270|585710267|FG002|Overall Study|Pregnancy|0|||
162179218|NCT02467270|585710265|FG000|Overall Study|Physician Decision|0|||
162179219|NCT02467270|585710266|FG001|Overall Study|Physician Decision|4|||
162179220|NCT02467270|585710267|FG002|Overall Study|Physician Decision|1|||
162179221|NCT02467270|585710265|FG000|Overall Study|Withdrawal by Subject|4|||
162179222|NCT02467270|585710266|FG001|Overall Study|Withdrawal by Subject|3|||
162179223|NCT02467270|585710267|FG002|Overall Study|Withdrawal by Subject|5|||
162179224|NCT02467270|585710265|FG000|Overall Study|Reason not Specified|1|||
162179225|NCT02467270|585710266|FG001|Overall Study|Reason not Specified|2|||
162179226|NCT02467270|585710267|FG002|Overall Study|Reason not Specified|1|||
162179227|NCT00495677|585710269|FG000|Stage 1 (25 Days)|Adverse Event|0|||
162179228|NCT00495677|585710270|FG001|Stage 1 (25 Days)|Adverse Event|0|||
162179229|NCT00495677|585710271|FG002|Stage 1 (25 Days)|Adverse Event|1|||
162179230|NCT00495677|585710272|FG003|Stage 1 (25 Days)|Adverse Event|0|||
162179231|NCT00495677|585710273|FG004|Stage 1 (25 Days)|Adverse Event|0|||
162179232|NCT00495677|585710274|FG005|Stage 1 (25 Days)|Adverse Event|0|||
162179233|NCT00495677|585710275|FG006|Stage 1 (25 Days)|Adverse Event|0|||
162179234|NCT02306161|585710276|FG000|Overall Study|Death|1|||
162179235|NCT02306161|585710277|FG001|Overall Study|Death|3|||
162179236|NCT02306161|585710276|FG000|Overall Study|Lack of Efficacy|20|||
162179237|NCT02306161|585710277|FG001|Overall Study|Lack of Efficacy|43|||
162179238|NCT02306161|585710276|FG000|Overall Study|Physician Decision|30|||
162179239|NCT02306161|585710277|FG001|Overall Study|Physician Decision|18|||
162179240|NCT02306161|585710276|FG000|Overall Study|Withdrawal by Subject|4|||
162179241|NCT02306161|585710277|FG001|Overall Study|Withdrawal by Subject|0|||
162179242|NCT02306161|585710276|FG000|Overall Study|Ineligible|9|||
162179243|NCT02306161|585710277|FG001|Overall Study|Ineligible|5|||
162179244|NCT05162586|585710278|FG000|Overall Study|Other|0|||
162179245|NCT05162586|585710279|FG001|Overall Study|Other|0|||
162179246|NCT05162586|585710280|FG002|Overall Study|Other|0|||
162179247|NCT05162586|585710281|FG003|Overall Study|Other|0|||
162179248|NCT05162586|585710282|FG004|Overall Study|Other|1|||
162179249|NCT05162586|585710283|FG005|Overall Study|Other|0|||
162179250|NCT05162586|585710284|FG006|Overall Study|Other|2|||
162179251|NCT05162586|585710285|FG007|Overall Study|Other|2|||
162179252|NCT05162586|585710278|FG000|Overall Study|Lack of Efficacy|0|||
162179253|NCT05162586|585710279|FG001|Overall Study|Lack of Efficacy|0|||
162179254|NCT05162586|585710280|FG002|Overall Study|Lack of Efficacy|0|||
162179255|NCT05162586|585710281|FG003|Overall Study|Lack of Efficacy|0|||
162179256|NCT05162586|585710282|FG004|Overall Study|Lack of Efficacy|1|||
162179257|NCT05162586|585710283|FG005|Overall Study|Lack of Efficacy|0|||
162179258|NCT05162586|585710284|FG006|Overall Study|Lack of Efficacy|0|||
162179259|NCT05162586|585710285|FG007|Overall Study|Lack of Efficacy|1|||
162179260|NCT05162586|585710278|FG000|Overall Study|Lost to Follow-up|0|||
162179261|NCT05162586|585710279|FG001|Overall Study|Lost to Follow-up|0|||
162179262|NCT05162586|585710280|FG002|Overall Study|Lost to Follow-up|0|||
162179263|NCT05162586|585710281|FG003|Overall Study|Lost to Follow-up|0|||
162179264|NCT05162586|585710282|FG004|Overall Study|Lost to Follow-up|2|||
162179265|NCT05162586|585710283|FG005|Overall Study|Lost to Follow-up|0|||
162179266|NCT05162586|585710284|FG006|Overall Study|Lost to Follow-up|0|||
162179267|NCT05162586|585710285|FG007|Overall Study|Lost to Follow-up|2|||
162179268|NCT05162586|585710278|FG000|Overall Study|Non-Compliance|0|||
162179269|NCT05162586|585710279|FG001|Overall Study|Non-Compliance|1|||
162179270|NCT05162586|585710280|FG002|Overall Study|Non-Compliance|0|||
162179271|NCT05162586|585710281|FG003|Overall Study|Non-Compliance|0|||
162179272|NCT05162586|585710282|FG004|Overall Study|Non-Compliance|1|||
162179273|NCT05162586|585710283|FG005|Overall Study|Non-Compliance|0|||
162179274|NCT05162586|585710284|FG006|Overall Study|Non-Compliance|0|||
162179275|NCT05162586|585710285|FG007|Overall Study|Non-Compliance|1|||
162179276|NCT05162586|585710278|FG000|Overall Study|Withdrawal by Subject|2|||
162179277|NCT05162586|585710279|FG001|Overall Study|Withdrawal by Subject|0|||
162179278|NCT05162586|585710280|FG002|Overall Study|Withdrawal by Subject|0|||
162179279|NCT05162586|585710281|FG003|Overall Study|Withdrawal by Subject|0|||
162179280|NCT05162586|585710282|FG004|Overall Study|Withdrawal by Subject|7|||
162179281|NCT05162586|585710283|FG005|Overall Study|Withdrawal by Subject|6|||
162179282|NCT05162586|585710284|FG006|Overall Study|Withdrawal by Subject|2|||
162179283|NCT05162586|585710285|FG007|Overall Study|Withdrawal by Subject|2|||
162179284|NCT05162586|585710278|FG000|Overall Study|Adverse Event|2|||
162179285|NCT05162586|585710279|FG001|Overall Study|Adverse Event|0|||
162179286|NCT05162586|585710280|FG002|Overall Study|Adverse Event|1|||
162179287|NCT05162586|585710281|FG003|Overall Study|Adverse Event|2|||
162179288|NCT05162586|585710282|FG004|Overall Study|Adverse Event|4|||
162179289|NCT05162586|585710283|FG005|Overall Study|Adverse Event|1|||
162179290|NCT05162586|585710284|FG006|Overall Study|Adverse Event|5|||
162179291|NCT05162586|585710285|FG007|Overall Study|Adverse Event|2|||
162179292|NCT00982644|585710288|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
162179293|NCT00982644|585710289|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
162179294|NCT00982644|585710288|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
162179295|NCT00982644|585710289|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
162179296|NCT00982644|585710288|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
162179297|NCT00982644|585710289|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
162179298|NCT00982644|585710288|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
162179299|NCT00982644|585710289|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
162179300|NCT00982644|585710288|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
162179301|NCT00982644|585710289|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
162179302|NCT00982644|585710288|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
162179303|NCT00982644|585710289|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
162179304|NCT00982644|585710288|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
162179305|NCT00982644|585710289|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
162179306|NCT00982644|585710288|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
162179307|NCT00982644|585710289|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
162179308|NCT00982644|585710288|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
162179309|NCT00982644|585710289|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
162179310|NCT00982644|585710288|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
162179311|NCT00982644|585710289|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
162179312|NCT05030584|585710292|FG000|Overall Study|Adverse Event|17|||
162179313|NCT05030584|585710293|FG001|Overall Study|Adverse Event|2|||
162179314|NCT05030584|585710292|FG000|Overall Study|Lack of Efficacy|0|||
162179315|NCT05030584|585710293|FG001|Overall Study|Lack of Efficacy|6|||
162179316|NCT05030584|585710292|FG000|Overall Study|Lost to Follow-up|5|||
161671618|NCT04427501|583851345|FG009|Overall Study|Withdrawal by Subject|1|||
161671619|NCT04427501|583851346|FG010|Overall Study|Withdrawal by Subject|4|||
161671620|NCT04427501|583851347|FG011|Overall Study|Withdrawal by Subject|0|||
161671621|NCT04427501|583851336|FG000|Overall Study|Other - as reported by the investigator|1|||
161817277|NCT02055547|584371002|FG013|Overall Study|Withdrawal by Subject|1|||
162179317|NCT05030584|585710293|FG001|Overall Study|Lost to Follow-up|2|||
161817278|NCT02055547|584371003|FG014|Overall Study|Withdrawal by Subject|0|||
162179318|NCT05030584|585710292|FG000|Overall Study|Non-Compliance with Study Drug|2|||
162179319|NCT05030584|585710293|FG001|Overall Study|Non-Compliance with Study Drug|3|||
162179320|NCT05030584|585710292|FG000|Overall Study|Other reason|4|||
162179321|NCT05030584|585710293|FG001|Overall Study|Other reason|3|||
162179322|NCT05030584|585710292|FG000|Overall Study|Physician Decision|1|||
162179323|NCT05030584|585710293|FG001|Overall Study|Physician Decision|4|||
162179324|NCT05030584|585710292|FG000|Overall Study|Protocol Violation|0|||
162179325|NCT05030584|585710293|FG001|Overall Study|Protocol Violation|2|||
162179326|NCT05030584|585710292|FG000|Overall Study|Randomized by Mistake|0|||
161671622|NCT04427501|583851337|FG001|Overall Study|Other - as reported by the investigator|0|||
161942231|NCT00663260|584838358|FG002|Overall Study|Lack of Efficacy|0|||
161671623|NCT04427501|583851338|FG002|Overall Study|Other - as reported by the investigator|0|||
161817279|NCT02055547|584371004|FG015|Overall Study|Withdrawal by Subject|1|||
161817280|NCT02055547|584371005|FG016|Overall Study|Withdrawal by Subject|0|||
161817281|NCT02055547|584371006|FG017|Overall Study|Withdrawal by Subject|0|||
161817282|NCT02055547|584371007|FG018|Overall Study|Withdrawal by Subject|0|||
161817283|NCT02055547|584370989|FG000|Overall Study|Lost to Follow-up|0|||
161817284|NCT02055547|584370990|FG001|Overall Study|Lost to Follow-up|0|||
161817285|NCT02055547|584370991|FG002|Overall Study|Lost to Follow-up|1|||
161817286|NCT02055547|584370992|FG003|Overall Study|Lost to Follow-up|0|||
161817287|NCT02055547|584370993|FG004|Overall Study|Lost to Follow-up|0|||
161817288|NCT02055547|584370994|FG005|Overall Study|Lost to Follow-up|0|||
161817289|NCT02055547|584370995|FG006|Overall Study|Lost to Follow-up|0|||
161817290|NCT02055547|584370996|FG007|Overall Study|Lost to Follow-up|0|||
161817291|NCT02055547|584370997|FG008|Overall Study|Lost to Follow-up|0|||
161817292|NCT02055547|584370998|FG009|Overall Study|Lost to Follow-up|0|||
161817293|NCT02055547|584370999|FG010|Overall Study|Lost to Follow-up|0|||
161817294|NCT02055547|584371000|FG011|Overall Study|Lost to Follow-up|0|||
161817295|NCT02055547|584371001|FG012|Overall Study|Lost to Follow-up|0|||
161817296|NCT02055547|584371002|FG013|Overall Study|Lost to Follow-up|0|||
161817297|NCT02055547|584371003|FG014|Overall Study|Lost to Follow-up|0|||
161817298|NCT02055547|584371004|FG015|Overall Study|Lost to Follow-up|0|||
161817299|NCT02055547|584371005|FG016|Overall Study|Lost to Follow-up|0|||
161817300|NCT02055547|584371006|FG017|Overall Study|Lost to Follow-up|0|||
161817301|NCT02055547|584371007|FG018|Overall Study|Lost to Follow-up|0|||
161817302|NCT01653704|584371008|FG000|Overall Study|Technical failure during recording|1|||
161817303|NCT01653704|584371009|FG001|Overall Study|Technical failure during recording|1|||
161817304|NCT01653704|584371008|FG000|Overall Study|Performance not reflective of training|1|||
161817305|NCT01653704|584371009|FG001|Overall Study|Performance not reflective of training|0|||
161817306|NCT03966911|584371010|FG000|Overall Study|Adverse Event|1|||
161817307|NCT03966911|584371011|FG001|Overall Study|Adverse Event|1|||
161817308|NCT03966911|584371010|FG000|Overall Study|Withdrawal by Subject|8|||
161817309|NCT03966911|584371011|FG001|Overall Study|Withdrawal by Subject|2|||
162179327|NCT05030584|585710293|FG001|Overall Study|Randomized by Mistake|2|||
162179328|NCT05030584|585710292|FG000|Overall Study|Withdrawal by Subject|21|||
162179329|NCT05030584|585710293|FG001|Overall Study|Withdrawal by Subject|28|||
162179330|NCT05030584|585710292|FG000|Overall Study|Technical Problems|0|||
162179331|NCT05030584|585710293|FG001|Overall Study|Technical Problems|1|||
162179332|NCT05030584|585710292|FG000|Overall Study|Completed post-treatment/FU visits|41|||
162179333|NCT05030584|585710293|FG001|Overall Study|Completed post-treatment/FU visits|31|||
162179334|NCT03767335|585710298|FG000|Overall Study|Physician Decision|1|||
162179335|NCT03767335|585710299|FG001|Overall Study|Physician Decision|1|||
162179336|NCT03767335|585710300|FG002|Overall Study|Physician Decision|0|||
162179337|NCT03767335|585710298|FG000|Overall Study|Withdrawal by Subject|0|||
162179338|NCT03767335|585710299|FG001|Overall Study|Withdrawal by Subject|0|||
162179339|NCT03767335|585710300|FG002|Overall Study|Withdrawal by Subject|6|||
162179340|NCT03767335|585710298|FG000|Overall Study|Participant excluded from efficacy population|0|||
162179341|NCT03767335|585710299|FG001|Overall Study|Participant excluded from efficacy population|0|||
162179342|NCT03767335|585710300|FG002|Overall Study|Participant excluded from efficacy population|1|||
162179343|NCT03767335|585710298|FG000|Overall Study|Death|0|||
162179344|NCT03767335|585710299|FG001|Overall Study|Death|0|||
162179345|NCT03767335|585710300|FG002|Overall Study|Death|2|||
162179346|NCT03767335|585710298|FG000|Overall Study|Progressive Disease|2|||
162179347|NCT03767335|585710299|FG001|Overall Study|Progressive Disease|2|||
162179348|NCT03767335|585710300|FG002|Overall Study|Progressive Disease|2|||
162179349|NCT03767335|585710298|FG000|Overall Study|Disease progression needing additional medication|0|||
162179350|NCT03767335|585710299|FG001|Overall Study|Disease progression needing additional medication|0|||
162179351|NCT03767335|585710300|FG002|Overall Study|Disease progression needing additional medication|17|||
162179352|NCT03767335|585710298|FG000|Overall Study|Sponsor decision|0|||
162179353|NCT03767335|585710299|FG001|Overall Study|Sponsor decision|0|||
162179354|NCT03767335|585710300|FG002|Overall Study|Sponsor decision|2|||
162179355|NCT03767335|585710298|FG000|Overall Study|Other Medical Reasons|0|||
162179356|NCT03767335|585710299|FG001|Overall Study|Other Medical Reasons|0|||
162179357|NCT03767335|585710300|FG002|Overall Study|Other Medical Reasons|3|||
162179358|NCT03705390|585710301|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
162179359|NCT03705390|585710301|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
162179360|NCT03047213|585710302|FG000|Overall Study|Withdrawal by Subject|2|||
162179361|NCT03047213|585710303|FG001|Overall Study|Withdrawal by Subject|0|||
162179362|NCT03047213|585710302|FG000|Overall Study|Adverse Event|2|||
162179363|NCT03047213|585710303|FG001|Overall Study|Adverse Event|0|||
162179364|NCT00357682|585710309|FG000|Overall Study|Did not receive allocated Treatment|10|||
162179365|NCT00357682|585710310|FG001|Overall Study|Did not receive allocated Treatment|9|||
162179366|NCT00357682|585710311|FG002|Overall Study|Did not receive allocated Treatment|9|||
162179367|NCT00357682|585710312|FG003|Overall Study|Did not receive allocated Treatment|10|||
162179368|NCT00357682|585710309|FG000|Overall Study|Withdrew consent|6|||
162179369|NCT00357682|585710310|FG001|Overall Study|Withdrew consent|6|||
161817310|NCT03966911|584371010|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
161923143|NCT03369223|584764929|FG008|Overall Study|Participant request to discontinue study treatment|0|||
161923144|NCT03369223|584764930|FG009|Overall Study|Participant request to discontinue study treatment|0|||
162179370|NCT00357682|585710311|FG002|Overall Study|Withdrew consent|5|||
162179371|NCT00357682|585710312|FG003|Overall Study|Withdrew consent|5|||
162179372|NCT00357682|585710309|FG000|Overall Study|Lost to Follow-up|39|||
162179373|NCT00357682|585710310|FG001|Overall Study|Lost to Follow-up|33|||
162179374|NCT00357682|585710311|FG002|Overall Study|Lost to Follow-up|26|||
162179375|NCT00357682|585710312|FG003|Overall Study|Lost to Follow-up|35|||
162179376|NCT00357682|585710309|FG000|Overall Study|Adverse Event|24|||
162179377|NCT00357682|585710310|FG001|Overall Study|Adverse Event|32|||
162179378|NCT00357682|585710311|FG002|Overall Study|Adverse Event|22|||
162179379|NCT00357682|585710312|FG003|Overall Study|Adverse Event|27|||
162179380|NCT00357682|585710309|FG000|Overall Study|Physician Decision|32|||
162179381|NCT00357682|585710310|FG001|Overall Study|Physician Decision|20|||
162179382|NCT00357682|585710311|FG002|Overall Study|Physician Decision|24|||
162179383|NCT00357682|585710312|FG003|Overall Study|Physician Decision|30|||
162179384|NCT00357682|585710309|FG000|Overall Study|Patient decision|73|||
162179385|NCT00357682|585710310|FG001|Overall Study|Patient decision|80|||
162179386|NCT00357682|585710311|FG002|Overall Study|Patient decision|51|||
162179387|NCT00357682|585710312|FG003|Overall Study|Patient decision|59|||
162179388|NCT00357682|585710309|FG000|Overall Study|Other reason|157|||
162179389|NCT00357682|585710310|FG001|Overall Study|Other reason|130|||
162179390|NCT00357682|585710311|FG002|Overall Study|Other reason|114|||
162179391|NCT00357682|585710312|FG003|Overall Study|Other reason|99|||
162179392|NCT05424718|585710325|FG000|Overall Study|Lost to Follow-up|5|||
162179393|NCT05424718|585710326|FG001|Overall Study|Lost to Follow-up|4|||
162179394|NCT04046549|585710327|FG000|Overall Study|Adverse Event|1|||
162179395|NCT04046549|585710327|FG000|Overall Study|Physician Decision|1|||
162179396|NCT04046549|585710327|FG000|Overall Study|Withdrawal by Subject|3|||
162179397|NCT04046549|585710327|FG000|Overall Study|Other, Not Specified|5|||
162179398|NCT00945724|585710331|FG000|Overall Study|Withdrawal by Subject|2|||
162179399|NCT00945724|585710331|FG000|Overall Study|Physician Decision|1|||
162179400|NCT00945724|585710331|FG000|Overall Study|Adverse Event|5|||
162179401|NCT00945724|585710331|FG000|Overall Study|Second malignancy|1|||
162179402|NCT03699163|585710911|FG000|Overall Study|Physician Decision|12|||
162179403|NCT03699163|585710912|FG001|Overall Study|Physician Decision|0|||
162179404|NCT03699163|585710911|FG000|Overall Study|failed QC measures|205|||
162179405|NCT03699163|585710912|FG001|Overall Study|failed QC measures|206|||
162179406|NCT00557492|585710917|FG000|Overall Study|Change in health insurance|1|||
162179407|NCT03983382|585710927|FG000|Overall Study|Death|1|||
162179408|NCT03983382|585710927|FG000|Overall Study|Lost to Follow-up|3|||
162179409|NCT03983382|585710927|FG000|Overall Study|Physician Decision|2|||
161671624|NCT04427501|583851339|FG003|Overall Study|Other - as reported by the investigator|0|||
162179410|NCT03983382|585710927|FG000|Overall Study|Withdrawal by Subject|10|||
162179411|NCT03983382|585710927|FG000|Overall Study|Change in cancer treatment|2|||
162179412|NCT02567435|585710934|FG000|Overall Study|Death|1|||
162179413|NCT02567435|585710935|FG001|Overall Study|Death|1|||
162179414|NCT02567435|585710936|FG002|Overall Study|Death|0|||
162179415|NCT02567435|585710937|FG003|Overall Study|Death|0|||
162179416|NCT02567435|585710934|FG000|Overall Study|Ineligible|1|||
162179417|NCT02567435|585710935|FG001|Overall Study|Ineligible|3|||
162179418|NCT02567435|585710936|FG002|Overall Study|Ineligible|0|||
162179419|NCT02567435|585710937|FG003|Overall Study|Ineligible|0|||
162179420|NCT02567435|585710934|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
162179421|NCT02567435|585710935|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
162179422|NCT02567435|585710936|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
162179423|NCT02567435|585710937|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
162179424|NCT02166463|585710938|FG000|Overall Study|Lost to Follow-up|0|||
162179425|NCT02166463|585710939|FG001|Overall Study|Lost to Follow-up|1|||
162179426|NCT02166463|585710938|FG000|Overall Study|Physician Decision|10|||
162179427|NCT02166463|585710939|FG001|Overall Study|Physician Decision|10|||
162179428|NCT02166463|585710938|FG000|Overall Study|Ineligible|11|||
162179429|NCT02166463|585710939|FG001|Overall Study|Ineligible|2|||
162179430|NCT02166463|585710938|FG000|Overall Study|Progressive Disease|9|||
162179431|NCT02166463|585710939|FG001|Overall Study|Progressive Disease|6|||
162179432|NCT02166463|585710938|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
162179433|NCT02166463|585710939|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
162179434|NCT02166463|585710938|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
162179435|NCT02166463|585710939|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
162179436|NCT02166463|585710938|FG000|Overall Study|Refusal of further protocol therapy|5|||
162179437|NCT02166463|585710939|FG001|Overall Study|Refusal of further protocol therapy|6|||
162179438|NCT02989662|585710942|FG000|Overall Study|Lost to Follow-up|0|||
162179439|NCT02989662|585710943|FG001|Overall Study|Lost to Follow-up|0|||
162179440|NCT02989662|585710944|FG002|Overall Study|Lost to Follow-up|0|||
162179441|NCT02989662|585710945|FG003|Overall Study|Lost to Follow-up|2|||
162179442|NCT02989662|585710942|FG000|Overall Study|Physician Decision|3|||
162179443|NCT02989662|585710943|FG001|Overall Study|Physician Decision|0|||
162179444|NCT02989662|585710944|FG002|Overall Study|Physician Decision|0|||
162179445|NCT02989662|585710945|FG003|Overall Study|Physician Decision|0|||
162179446|NCT02989662|585710942|FG000|Overall Study|Withdrawal by Subject|1|||
162179447|NCT02989662|585710943|FG001|Overall Study|Withdrawal by Subject|0|||
162179448|NCT02989662|585710944|FG002|Overall Study|Withdrawal by Subject|0|||
162179449|NCT02989662|585710945|FG003|Overall Study|Withdrawal by Subject|0|||
162179450|NCT06393127|585710946|FG000|Washout period|Withdrawal by Subject|1|||
162179451|NCT06393127|585710947|FG001|Washout period|Withdrawal by Subject|0|||
162179452|NCT06393127|585710946|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
162179453|NCT06393127|585710947|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
162179454|NCT02446600|585710948|FG000|Overall Study|Never treated|20|||
162179455|NCT02446600|585710949|FG001|Overall Study|Never treated|2|||
162179456|NCT02446600|585710950|FG002|Overall Study|Never treated|6|||
162179457|NCT02446600|585710951|FG003|Overall Study|Never treated|0|||
162179458|NCT02446600|585710948|FG000|Overall Study|Withdrawal by Subject|19|||
162179459|NCT02446600|585710949|FG001|Overall Study|Withdrawal by Subject|5|||
162179460|NCT02446600|585710950|FG002|Overall Study|Withdrawal by Subject|17|||
162179461|NCT02446600|585710951|FG003|Overall Study|Withdrawal by Subject|0|||
162179462|NCT02446600|585710948|FG000|Overall Study|Ineligible|1|||
162179463|NCT02446600|585710949|FG001|Overall Study|Ineligible|4|||
162179464|NCT02446600|585710950|FG002|Overall Study|Ineligible|4|||
161671625|NCT04427501|583851340|FG004|Overall Study|Other - as reported by the investigator|0|||
161671626|NCT04427501|583851341|FG005|Overall Study|Other - as reported by the investigator|6|||
161671627|NCT04427501|583851342|FG006|Overall Study|Other - as reported by the investigator|6|||
161671628|NCT04427501|583851343|FG007|Overall Study|Other - as reported by the investigator|0|||
161671629|NCT04427501|583851344|FG008|Overall Study|Other - as reported by the investigator|0|||
161671630|NCT04427501|583851345|FG009|Overall Study|Other - as reported by the investigator|0|||
161671631|NCT04427501|583851346|FG010|Overall Study|Other - as reported by the investigator|0|||
161671632|NCT04427501|583851347|FG011|Overall Study|Other - as reported by the investigator|0|||
161671633|NCT04427501|583851336|FG000|Overall Study|Other|0|||
161671634|NCT04427501|583851337|FG001|Overall Study|Other|0|||
161671635|NCT04427501|583851338|FG002|Overall Study|Other|0|||
161817311|NCT03966911|584371011|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
161817312|NCT00985751|584371012|FG000|Overall Study|Adverse Event|0|||
162179465|NCT02446600|585710951|FG003|Overall Study|Ineligible|1|||
162179466|NCT02446600|585710948|FG000|Overall Study|Duplicate Enrollment|0|||
162179467|NCT02446600|585710949|FG001|Overall Study|Duplicate Enrollment|1|||
162179468|NCT02446600|585710950|FG002|Overall Study|Duplicate Enrollment|0|||
162179469|NCT02446600|585710951|FG003|Overall Study|Duplicate Enrollment|0|||
162179470|NCT00328783|585710952|FG000|Overall Study|Could not tolerate ABC|21|||
162179471|NCT00328783|585710952|FG000|Overall Study|No heart in RT field|4|||
162179472|NCT00328783|585710952|FG000|Overall Study|Withdrawal by Subject|1|||
161671636|NCT04427501|583851339|FG003|Overall Study|Other|0|||
162179473|NCT03660930|585710953|FG000|Overall Study|Adverse Event|0|||
162179474|NCT03660930|585710954|FG001|Overall Study|Adverse Event|0|||
162179475|NCT03660930|585710955|FG002|Overall Study|Adverse Event|0|||
162179476|NCT03660930|585710956|FG003|Overall Study|Adverse Event|2|||
162179477|NCT03660930|585710957|FG004|Overall Study|Adverse Event|0|||
162179478|NCT03660930|585710958|FG005|Overall Study|Adverse Event|1|||
162179479|NCT03660930|585710959|FG006|Overall Study|Adverse Event|0|||
162179480|NCT03660930|585710960|FG007|Overall Study|Adverse Event|0|||
162179481|NCT03660930|585710953|FG000|Overall Study|Withdrawal by Subject|0|||
162179482|NCT03660930|585710954|FG001|Overall Study|Withdrawal by Subject|0|||
162179483|NCT03660930|585710955|FG002|Overall Study|Withdrawal by Subject|0|||
162179484|NCT03660930|585710956|FG003|Overall Study|Withdrawal by Subject|0|||
162179485|NCT03660930|585710957|FG004|Overall Study|Withdrawal by Subject|0|||
162179486|NCT03660930|585710958|FG005|Overall Study|Withdrawal by Subject|1|||
162179487|NCT03660930|585710959|FG006|Overall Study|Withdrawal by Subject|0|||
162179488|NCT03660930|585710960|FG007|Overall Study|Withdrawal by Subject|0|||
162179489|NCT03725332|585710961|FG000|Overall Study|Adverse Event|5|||
162179490|NCT03725332|585710962|FG001|Overall Study|Adverse Event|10|||
162179491|NCT03725332|585710961|FG000|Overall Study|Death|1|||
162179492|NCT03725332|585710962|FG001|Overall Study|Death|3|||
162179493|NCT03725332|585710961|FG000|Overall Study|Lost to Follow-up|43|||
162179494|NCT03725332|585710962|FG001|Overall Study|Lost to Follow-up|122|||
162179495|NCT03725332|585710961|FG000|Overall Study|Withdrawal by Subject|0|||
162179496|NCT03725332|585710962|FG001|Overall Study|Withdrawal by Subject|1|||
162179497|NCT03725332|585710961|FG000|Overall Study|Duplicate enrollment|0|||
162179498|NCT03725332|585710962|FG001|Overall Study|Duplicate enrollment|1|||
162179499|NCT03725332|585710961|FG000|Overall Study|Did not consent|0|||
162179500|NCT03725332|585710962|FG001|Overall Study|Did not consent|1|||
162179501|NCT03242915|585710969|FG000|Overall Study|Adverse Event|5|||
162179502|NCT03242915|585710970|FG001|Overall Study|Adverse Event|1|||
162179503|NCT03242915|585710969|FG000|Overall Study|Withdrawal by Subject|0|||
162179504|NCT03242915|585710970|FG001|Overall Study|Withdrawal by Subject|2|||
162179505|NCT03242915|585710969|FG000|Overall Study|Physician Decision|4|||
162179506|NCT03242915|585710970|FG001|Overall Study|Physician Decision|1|||
162179507|NCT02726386|585710971|FG000|Overall Study|Adverse Event|17|||
162179508|NCT02726386|585710972|FG001|Overall Study|Adverse Event|20|||
162179509|NCT02726386|585710971|FG000|Overall Study|Withdrawal by Subject|14|||
161671637|NCT04427501|583851340|FG004|Overall Study|Other|0|||
161671638|NCT04427501|583851341|FG005|Overall Study|Other|0|||
161671639|NCT04427501|583851342|FG006|Overall Study|Other|0|||
161923145|NCT03369223|584764931|FG010|Overall Study|Participant request to discontinue study treatment|0|||
161923146|NCT03369223|584764932|FG011|Overall Study|Participant request to discontinue study treatment|0|||
162179510|NCT02726386|585710972|FG001|Overall Study|Withdrawal by Subject|28|||
162179511|NCT02726386|585710971|FG000|Overall Study|Other reasons|7|||
162179512|NCT02726386|585710972|FG001|Overall Study|Other reasons|8|||
162179513|NCT02101853|585710975|FG000|Block 1 Induction|Adverse Event|11|||
162179514|NCT02101853|585710976|FG001|Block 1 Induction|Adverse Event|0|||
162179515|NCT02101853|585710977|FG002|Block 1 Induction|Adverse Event|0|||
162179516|NCT02101853|585710978|FG003|Block 1 Induction|Adverse Event|0|||
162179517|NCT02101853|585710979|FG004|Block 1 Induction|Adverse Event|0|||
162179518|NCT02101853|585710980|FG005|Block 1 Induction|Adverse Event|0|||
162179519|NCT02101853|585710975|FG000|Block 1 Induction|Death|20|||
162179520|NCT02101853|585710976|FG001|Block 1 Induction|Death|0|||
161671640|NCT04427501|583851343|FG007|Overall Study|Other|0|||
161671641|NCT04427501|583851344|FG008|Overall Study|Other|0|||
161942232|NCT00663260|584838356|FG000|Overall Study|Adverse Event|12|||
161923147|NCT03369223|584764933|FG012|Overall Study|Participant request to discontinue study treatment|0|||
161923148|NCT03369223|584764934|FG013|Overall Study|Participant request to discontinue study treatment|1|||
161923149|NCT03369223|584764935|FG014|Overall Study|Participant request to discontinue study treatment|1|||
161923150|NCT03369223|584764936|FG015|Overall Study|Participant request to discontinue study treatment|0|||
161923151|NCT03369223|584764937|FG016|Overall Study|Participant request to discontinue study treatment|0|||
161923152|NCT03369223|584764938|FG017|Overall Study|Participant request to discontinue study treatment|0|||
161923153|NCT03369223|584764939|FG018|Overall Study|Participant request to discontinue study treatment|1|||
161923154|NCT03369223|584764940|FG019|Overall Study|Participant request to discontinue study treatment|0|||
161923155|NCT03369223|584764921|FG000|Overall Study|Participant withdrew consent|0|||
161923156|NCT03369223|584764922|FG001|Overall Study|Participant withdrew consent|1|||
161923157|NCT03369223|584764923|FG002|Overall Study|Participant withdrew consent|1|||
161923158|NCT03369223|584764924|FG003|Overall Study|Participant withdrew consent|0|||
161923159|NCT03369223|584764925|FG004|Overall Study|Participant withdrew consent|0|||
161923160|NCT03369223|584764926|FG005|Overall Study|Participant withdrew consent|0|||
161923161|NCT03369223|584764927|FG006|Overall Study|Participant withdrew consent|1|||
161923162|NCT03369223|584764928|FG007|Overall Study|Participant withdrew consent|1|||
161923163|NCT03369223|584764929|FG008|Overall Study|Participant withdrew consent|1|||
161923164|NCT03369223|584764930|FG009|Overall Study|Participant withdrew consent|0|||
161923165|NCT03369223|584764931|FG010|Overall Study|Participant withdrew consent|0|||
161923166|NCT03369223|584764932|FG011|Overall Study|Participant withdrew consent|1|||
161923167|NCT03369223|584764933|FG012|Overall Study|Participant withdrew consent|0|||
161923168|NCT03369223|584764934|FG013|Overall Study|Participant withdrew consent|0|||
161923169|NCT03369223|584764935|FG014|Overall Study|Participant withdrew consent|3|||
161923170|NCT03369223|584764936|FG015|Overall Study|Participant withdrew consent|0|||
161923171|NCT03369223|584764937|FG016|Overall Study|Participant withdrew consent|1|||
161923172|NCT03369223|584764938|FG017|Overall Study|Participant withdrew consent|0|||
161923173|NCT03369223|584764939|FG018|Overall Study|Participant withdrew consent|4|||
161923174|NCT03369223|584764940|FG019|Overall Study|Participant withdrew consent|2|||
161923175|NCT03369223|584764921|FG000|Overall Study|Randomized but not treated|0|||
161923176|NCT03369223|584764922|FG001|Overall Study|Randomized but not treated|0|||
161923177|NCT03369223|584764923|FG002|Overall Study|Randomized but not treated|0|||
161923178|NCT03369223|584764924|FG003|Overall Study|Randomized but not treated|0|||
161923179|NCT03369223|584764925|FG004|Overall Study|Randomized but not treated|0|||
161923180|NCT03369223|584764926|FG005|Overall Study|Randomized but not treated|0|||
161923181|NCT03369223|584764927|FG006|Overall Study|Randomized but not treated|0|||
161923182|NCT03369223|584764928|FG007|Overall Study|Randomized but not treated|0|||
161923183|NCT03369223|584764929|FG008|Overall Study|Randomized but not treated|0|||
161923184|NCT03369223|584764930|FG009|Overall Study|Randomized but not treated|0|||
161923185|NCT03369223|584764931|FG010|Overall Study|Randomized but not treated|0|||
161923186|NCT03369223|584764932|FG011|Overall Study|Randomized but not treated|0|||
161923187|NCT03369223|584764933|FG012|Overall Study|Randomized but not treated|0|||
161923188|NCT03369223|584764934|FG013|Overall Study|Randomized but not treated|1|||
161923189|NCT03369223|584764935|FG014|Overall Study|Randomized but not treated|1|||
161923190|NCT03369223|584764936|FG015|Overall Study|Randomized but not treated|0|||
161923191|NCT03369223|584764937|FG016|Overall Study|Randomized but not treated|0|||
161923192|NCT03369223|584764938|FG017|Overall Study|Randomized but not treated|0|||
161923193|NCT03369223|584764939|FG018|Overall Study|Randomized but not treated|0|||
161923194|NCT03369223|584764940|FG019|Overall Study|Randomized but not treated|0|||
161923195|NCT05182125|584764941|FG000|Overall Study|Withdrawal by Subject|0|||
161923196|NCT05182125|584764942|FG001|Overall Study|Withdrawal by Subject|0|||
161923197|NCT05182125|584764943|FG002|Overall Study|Withdrawal by Subject|0|||
161923198|NCT05182125|584764944|FG003|Overall Study|Withdrawal by Subject|0|||
161923199|NCT05182125|584764945|FG004|Overall Study|Withdrawal by Subject|2|||
162018683|NCT01349049|585123168|FG005|Overall Study|Withdrawal by Subject|0|||
162018684|NCT01349049|585123169|FG006|Overall Study|Withdrawal by Subject|0|||
162018685|NCT01349049|585123170|FG007|Overall Study|Withdrawal by Subject|0|||
162018686|NCT01349049|585123171|FG008|Overall Study|Withdrawal by Subject|6|||
162018687|NCT00552188|585123177|FG000|Overall Study|Adverse Event|0|||
162018688|NCT00552188|585123178|FG001|Overall Study|Adverse Event|2|||
161923200|NCT05182125|584764946|FG005|Overall Study|Withdrawal by Subject|0|||
161923201|NCT05182125|584764941|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
161923202|NCT05182125|584764942|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
161923203|NCT05182125|584764943|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
161923204|NCT05182125|584764944|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
161923205|NCT05182125|584764945|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
161923206|NCT05182125|584764946|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
161923207|NCT05182125|584764941|FG000|Overall Study|Death|0|||
161923208|NCT05182125|584764942|FG001|Overall Study|Death|0|||
161923209|NCT05182125|584764943|FG002|Overall Study|Death|0|||
161923210|NCT05182125|584764944|FG003|Overall Study|Death|0|||
161923211|NCT05182125|584764945|FG004|Overall Study|Death|1|||
162018689|NCT00552188|585123177|FG000|Overall Study|Lost to Follow-up|2|||
161923212|NCT05182125|584764946|FG005|Overall Study|Death|0|||
161923213|NCT02965833|584764951|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
161923214|NCT02965833|584764952|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
161923215|NCT02965833|584764951|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
161923216|NCT02965833|584764952|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
161923217|NCT02965833|584764951|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
161923218|NCT02965833|584764952|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
161923219|NCT02965833|584764951|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
161923220|NCT02965833|584764952|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
161923221|NCT02965833|584764951|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
161923222|NCT02965833|584764952|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
161923223|NCT03370302|584764953|FG000|Dose Escalation Phase|Other|0|||
161923224|NCT03370302|584764954|FG001|Dose Escalation Phase|Other|1|||
161923225|NCT03370302|584764955|FG002|Dose Escalation Phase|Other|1|||
161923226|NCT03370302|584764956|FG003|Dose Escalation Phase|Other|0|||
161817313|NCT00985751|584371013|FG001|Overall Study|Adverse Event|0|||
161817314|NCT00985751|584371014|FG002|Overall Study|Adverse Event|0|||
161817315|NCT00985751|584371015|FG003|Overall Study|Adverse Event|0|||
161817316|NCT00985751|584371016|FG004|Overall Study|Adverse Event|1|||
161817317|NCT01899053|584371017|FG000|Overall Study|Progressive Disease|4|||
161817318|NCT01899053|584371018|FG001|Overall Study|Progressive Disease|0|||
161817319|NCT01899053|584371019|FG002|Overall Study|Progressive Disease|3|||
161817320|NCT01899053|584371020|FG003|Overall Study|Progressive Disease|0|||
161817321|NCT01899053|584371021|FG004|Overall Study|Progressive Disease|3|||
161817322|NCT01899053|584371022|FG005|Overall Study|Progressive Disease|1|||
161817323|NCT01899053|584371023|FG006|Overall Study|Progressive Disease|1|||
161817324|NCT01899053|584371024|FG007|Overall Study|Progressive Disease|1|||
161817325|NCT01899053|584371025|FG008|Overall Study|Progressive Disease|4|||
161817326|NCT01899053|584371026|FG009|Overall Study|Progressive Disease|3|||
161817327|NCT01899053|584371027|FG010|Overall Study|Progressive Disease|12|||
161817328|NCT01899053|584371028|FG011|Overall Study|Progressive Disease|5|||
161817329|NCT01899053|584371029|FG012|Overall Study|Progressive Disease|8|||
161817330|NCT01899053|584371030|FG013|Overall Study|Progressive Disease|17|||
161817331|NCT01899053|584371017|FG000|Overall Study|Adverse Event|1|||
161817332|NCT01899053|584371018|FG001|Overall Study|Adverse Event|1|||
161817333|NCT01899053|584371019|FG002|Overall Study|Adverse Event|1|||
161817334|NCT01899053|584371020|FG003|Overall Study|Adverse Event|3|||
161817335|NCT01899053|584371021|FG004|Overall Study|Adverse Event|1|||
161817336|NCT01899053|584371022|FG005|Overall Study|Adverse Event|1|||
161817337|NCT01899053|584371023|FG006|Overall Study|Adverse Event|1|||
161817338|NCT01899053|584371024|FG007|Overall Study|Adverse Event|0|||
161817339|NCT01899053|584371025|FG008|Overall Study|Adverse Event|2|||
161817340|NCT01899053|584371026|FG009|Overall Study|Adverse Event|0|||
161817341|NCT01899053|584371027|FG010|Overall Study|Adverse Event|3|||
161817342|NCT01899053|584371028|FG011|Overall Study|Adverse Event|1|||
161817343|NCT01899053|584371029|FG012|Overall Study|Adverse Event|2|||
161817344|NCT01899053|584371030|FG013|Overall Study|Adverse Event|2|||
161817345|NCT01899053|584371017|FG000|Overall Study|Reason Not Specified|0|||
161817346|NCT01899053|584371018|FG001|Overall Study|Reason Not Specified|0|||
161817347|NCT01899053|584371019|FG002|Overall Study|Reason Not Specified|0|||
161817348|NCT01899053|584371020|FG003|Overall Study|Reason Not Specified|0|||
161817349|NCT01899053|584371021|FG004|Overall Study|Reason Not Specified|0|||
161817350|NCT01899053|584371022|FG005|Overall Study|Reason Not Specified|0|||
161817351|NCT01899053|584371023|FG006|Overall Study|Reason Not Specified|1|||
161817352|NCT01899053|584371024|FG007|Overall Study|Reason Not Specified|0|||
161817353|NCT01899053|584371025|FG008|Overall Study|Reason Not Specified|0|||
161817354|NCT01899053|584371026|FG009|Overall Study|Reason Not Specified|0|||
161817355|NCT01899053|584371027|FG010|Overall Study|Reason Not Specified|0|||
161817356|NCT01899053|584371028|FG011|Overall Study|Reason Not Specified|0|||
161817357|NCT01899053|584371029|FG012|Overall Study|Reason Not Specified|1|||
161817358|NCT01899053|584371030|FG013|Overall Study|Reason Not Specified|0|||
161817359|NCT01899053|584371017|FG000|Overall Study|Withdrawal by Subject|1|||
161817360|NCT01899053|584371018|FG001|Overall Study|Withdrawal by Subject|1|||
161817361|NCT01899053|584371019|FG002|Overall Study|Withdrawal by Subject|2|||
161817362|NCT01899053|584371020|FG003|Overall Study|Withdrawal by Subject|0|||
161817363|NCT01899053|584371021|FG004|Overall Study|Withdrawal by Subject|2|||
161817364|NCT01899053|584371022|FG005|Overall Study|Withdrawal by Subject|0|||
161817365|NCT01899053|584371023|FG006|Overall Study|Withdrawal by Subject|0|||
161817366|NCT01899053|584371024|FG007|Overall Study|Withdrawal by Subject|1|||
161817367|NCT01899053|584371025|FG008|Overall Study|Withdrawal by Subject|0|||
161817368|NCT01899053|584371026|FG009|Overall Study|Withdrawal by Subject|0|||
161817369|NCT01899053|584371027|FG010|Overall Study|Withdrawal by Subject|0|||
161817370|NCT01899053|584371028|FG011|Overall Study|Withdrawal by Subject|0|||
161817371|NCT01899053|584371029|FG012|Overall Study|Withdrawal by Subject|1|||
161817372|NCT01899053|584371030|FG013|Overall Study|Withdrawal by Subject|1|||
161817373|NCT01899053|584371017|FG000|Overall Study|Protocol Violation|0|||
161817374|NCT01899053|584371018|FG001|Overall Study|Protocol Violation|0|||
161817375|NCT01899053|584371019|FG002|Overall Study|Protocol Violation|1|||
161817376|NCT01899053|584371020|FG003|Overall Study|Protocol Violation|0|||
161817377|NCT01899053|584371021|FG004|Overall Study|Protocol Violation|0|||
161817378|NCT01899053|584371022|FG005|Overall Study|Protocol Violation|0|||
161817379|NCT01899053|584371023|FG006|Overall Study|Protocol Violation|0|||
161817380|NCT01899053|584371024|FG007|Overall Study|Protocol Violation|0|||
161817381|NCT01899053|584371025|FG008|Overall Study|Protocol Violation|0|||
161817382|NCT01899053|584371026|FG009|Overall Study|Protocol Violation|0|||
161817383|NCT01899053|584371027|FG010|Overall Study|Protocol Violation|0|||
161817384|NCT01899053|584371028|FG011|Overall Study|Protocol Violation|0|||
161817385|NCT01899053|584371029|FG012|Overall Study|Protocol Violation|0|||
161817386|NCT01899053|584371030|FG013|Overall Study|Protocol Violation|0|||
161817387|NCT01899053|584371017|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
161817388|NCT01899053|584371018|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
161817389|NCT01899053|584371019|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817390|NCT01899053|584371020|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817391|NCT01899053|584371021|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817392|NCT01899053|584371022|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817393|NCT01899053|584371023|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817394|NCT01899053|584371024|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817395|NCT01899053|584371025|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817396|NCT01899053|584371026|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817397|NCT01899053|584371027|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
161817398|NCT01899053|584371028|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817399|NCT01899053|584371029|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817400|NCT01899053|584371030|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
161817401|NCT01899053|584371017|FG000|Overall Study|Symptomatic Deterioration|0|||
161817402|NCT01899053|584371018|FG001|Overall Study|Symptomatic Deterioration|0|||
161817403|NCT01899053|584371019|FG002|Overall Study|Symptomatic Deterioration|0|||
161817404|NCT01899053|584371020|FG003|Overall Study|Symptomatic Deterioration|0|||
161817405|NCT01899053|584371021|FG004|Overall Study|Symptomatic Deterioration|0|||
161817406|NCT01899053|584371022|FG005|Overall Study|Symptomatic Deterioration|1|||
161817407|NCT01899053|584371023|FG006|Overall Study|Symptomatic Deterioration|0|||
161817408|NCT01899053|584371024|FG007|Overall Study|Symptomatic Deterioration|1|||
161817409|NCT01899053|584371025|FG008|Overall Study|Symptomatic Deterioration|0|||
161817410|NCT01899053|584371026|FG009|Overall Study|Symptomatic Deterioration|0|||
161817411|NCT01899053|584371027|FG010|Overall Study|Symptomatic Deterioration|0|||
161817412|NCT01899053|584371028|FG011|Overall Study|Symptomatic Deterioration|1|||
161817413|NCT01899053|584371029|FG012|Overall Study|Symptomatic Deterioration|2|||
161817414|NCT01899053|584371030|FG013|Overall Study|Symptomatic Deterioration|0|||
161817415|NCT01891357|584371031|FG000|Overall Study|Protocol Violation|3|||
161671642|NCT04427501|583851345|FG009|Overall Study|Other|0|||
161923227|NCT03370302|584764957|FG004|Dose Escalation Phase|Other|0|||
161923228|NCT03370302|584764958|FG005|Dose Escalation Phase|Other|0|||
161923229|NCT03370302|584764953|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
161923230|NCT03370302|584764954|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
161923231|NCT03370302|584764955|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
161923232|NCT03370302|584764956|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161923233|NCT03370302|584764957|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
161923234|NCT03370302|584764958|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
161923235|NCT03370302|584764953|FG000|Dose Escalation Phase|Adverse Event|1|||
161923236|NCT03370302|584764954|FG001|Dose Escalation Phase|Adverse Event|0|||
161923237|NCT03370302|584764955|FG002|Dose Escalation Phase|Adverse Event|2|||
161923238|NCT03370302|584764956|FG003|Dose Escalation Phase|Adverse Event|0|||
161923239|NCT03370302|584764957|FG004|Dose Escalation Phase|Adverse Event|0|||
161923240|NCT03370302|584764958|FG005|Dose Escalation Phase|Adverse Event|0|||
161923241|NCT03370302|584764953|FG000|Dose Escalation Phase|Progressive Disease|2|||
161923242|NCT03370302|584764954|FG001|Dose Escalation Phase|Progressive Disease|4|||
161923243|NCT03370302|584764955|FG002|Dose Escalation Phase|Progressive Disease|2|||
161923244|NCT03370302|584764956|FG003|Dose Escalation Phase|Progressive Disease|0|||
161923245|NCT03370302|584764957|FG004|Dose Escalation Phase|Progressive Disease|3|||
161923246|NCT03370302|584764958|FG005|Dose Escalation Phase|Progressive Disease|1|||
161923247|NCT03370302|584764953|FG000|Dose Expansion Phase|Progressive Disease|0|||
161923248|NCT03370302|584764954|FG001|Dose Expansion Phase|Progressive Disease|0|||
161923249|NCT03370302|584764955|FG002|Dose Expansion Phase|Progressive Disease|0|||
161923250|NCT03370302|584764956|FG003|Dose Expansion Phase|Progressive Disease|6|||
161923251|NCT03370302|584764957|FG004|Dose Expansion Phase|Progressive Disease|0|||
161923252|NCT03370302|584764958|FG005|Dose Expansion Phase|Progressive Disease|0|||
162179521|NCT02101853|585710977|FG002|Block 1 Induction|Death|0|||
162179522|NCT02101853|585710978|FG003|Block 1 Induction|Death|0|||
162179523|NCT02101853|585710979|FG004|Block 1 Induction|Death|0|||
162179524|NCT02101853|585710980|FG005|Block 1 Induction|Death|0|||
162179525|NCT02101853|585710975|FG000|Block 1 Induction|Lack of Efficacy|6|||
162179526|NCT02101853|585710976|FG001|Block 1 Induction|Lack of Efficacy|0|||
162179527|NCT02101853|585710977|FG002|Block 1 Induction|Lack of Efficacy|0|||
162179528|NCT02101853|585710978|FG003|Block 1 Induction|Lack of Efficacy|0|||
162179529|NCT02101853|585710979|FG004|Block 1 Induction|Lack of Efficacy|0|||
162179530|NCT02101853|585710980|FG005|Block 1 Induction|Lack of Efficacy|0|||
162179531|NCT02101853|585710975|FG000|Block 1 Induction|Physician Decision|61|||
162179532|NCT02101853|585710976|FG001|Block 1 Induction|Physician Decision|0|||
162179533|NCT02101853|585710977|FG002|Block 1 Induction|Physician Decision|0|||
162179534|NCT02101853|585710978|FG003|Block 1 Induction|Physician Decision|0|||
162179535|NCT02101853|585710979|FG004|Block 1 Induction|Physician Decision|0|||
161923253|NCT00118287|584764959|FG000|Overall Study|Intracranial haemorrhage|1|||
161923254|NCT00118287|584764959|FG000|Overall Study|Muscle pain|1|||
161923255|NCT03976375|584764960|FG000|Overall Study|Death|158|||
162179536|NCT02101853|585710980|FG005|Block 1 Induction|Physician Decision|0|||
161923256|NCT03976375|584764961|FG001|Overall Study|Death|160|||
161923257|NCT03976375|584764962|FG002|Overall Study|Death|42|||
161923258|NCT03976375|584764960|FG000|Overall Study|Lost to Follow-up|2|||
161923259|NCT03976375|584764961|FG001|Overall Study|Lost to Follow-up|1|||
161923260|NCT03976375|584764962|FG002|Overall Study|Lost to Follow-up|1|||
161923261|NCT03976375|584764960|FG000|Overall Study|Withdrawal by Subject|5|||
161923262|NCT03976375|584764961|FG001|Overall Study|Withdrawal by Subject|9|||
161923263|NCT03976375|584764962|FG002|Overall Study|Withdrawal by Subject|4|||
161923264|NCT03976375|584764960|FG000|Overall Study|Sponsor decision|20|||
161923265|NCT03976375|584764961|FG001|Overall Study|Sponsor decision|19|||
161923266|NCT03976375|584764962|FG002|Overall Study|Sponsor decision|1|||
161923267|NCT04818112|584764963|FG000|Overall Study|Withdrawal by Subject|54|||
161923268|NCT04818112|584764964|FG001|Overall Study|Withdrawal by Subject|12|||
161923269|NCT04818112|584764963|FG000|Overall Study|Lost to Follow-up|38|||
161923270|NCT04818112|584764964|FG001|Overall Study|Lost to Follow-up|10|||
161923271|NCT03091439|584764965|FG000|Overall Study|Study Terminated by the Sponsor|1|||
161923272|NCT03091439|584764966|FG001|Overall Study|Study Terminated by the Sponsor|0|||
161923273|NCT03122106|584764967|FG000|Overall Study|Not enough tissue|1|||
161923274|NCT03122106|584764967|FG000|Overall Study|Disease progression during screening|2|||
161923275|NCT03122106|584764967|FG000|Overall Study|Poor RNA quality for vaccine|1|||
161923276|NCT00640289|584764968|FG000|Overall Study|Death|3|||
161923277|NCT00640289|584764968|FG000|Overall Study|Withdrawal by Subject|1|||
161923278|NCT00640289|584764968|FG000|Overall Study|Lost to Follow-up|1|||
161923279|NCT00640289|584764968|FG000|Overall Study|Data collected under different amendment|2|||
161923280|NCT00640289|584764968|FG000|Overall Study|Transferred to another center|1|||
161923281|NCT00640289|584764968|FG000|Overall Study|Missing status|5|||
161923282|NCT03550209|584764970|FG000|Overall Study|Lost to Follow-up|1|||
161923283|NCT03550209|584764971|FG001|Overall Study|Lost to Follow-up|0|||
161923284|NCT03550209|584764972|FG002|Overall Study|Lost to Follow-up|1|||
161923285|NCT03550209|584764973|FG003|Overall Study|Lost to Follow-up|0|||
161923286|NCT03550209|584764970|FG000|Overall Study|Withdrawal by Subject|0|||
161923287|NCT03550209|584764971|FG001|Overall Study|Withdrawal by Subject|3|||
161923288|NCT03550209|584764972|FG002|Overall Study|Withdrawal by Subject|1|||
161923289|NCT03550209|584764973|FG003|Overall Study|Withdrawal by Subject|2|||
161923290|NCT03550209|584764970|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
161923291|NCT03550209|584764971|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
161923292|NCT03550209|584764972|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
161923293|NCT03550209|584764973|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
161923294|NCT06170827|584764976|FG000|Overall Study|Withdrawal by Subject|1|||
161923295|NCT06170827|584764977|FG001|Overall Study|Withdrawal by Subject|1|||
161923296|NCT02850406|584764982|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923297|NCT02850406|584764983|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923298|NCT02850406|584764984|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923299|NCT02850406|584764985|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
161923300|NCT02850406|584764986|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923301|NCT02850406|584764987|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923302|NCT02850406|584764988|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923303|NCT02850406|584764989|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
161923304|NCT02850406|584764982|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
161923305|NCT02850406|584764983|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
161923306|NCT02850406|584764984|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
161923307|NCT02850406|584764985|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
161923308|NCT02850406|584764986|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
161923309|NCT02850406|584764987|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
161923310|NCT02850406|584764988|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
161923311|NCT02850406|584764989|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
161923312|NCT02850406|584764982|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161923313|NCT02850406|584764983|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161923314|NCT02850406|584764984|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
161923315|NCT02850406|584764985|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161671643|NCT04427501|583851346|FG010|Overall Study|Other|0|||
161923316|NCT02850406|584764986|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161923317|NCT02850406|584764987|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161923318|NCT02850406|584764988|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161923319|NCT02850406|584764989|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
161923320|NCT02850406|584764982|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
161923321|NCT02850406|584764983|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
161923322|NCT02850406|584764984|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
161923323|NCT02850406|584764985|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
161923324|NCT02850406|584764986|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
161923325|NCT02850406|584764987|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
161923326|NCT02850406|584764988|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
161923327|NCT02850406|584764989|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
161923328|NCT02850406|584764982|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
161923329|NCT02850406|584764983|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
161923330|NCT02850406|584764984|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
161923331|NCT02850406|584764985|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
161923332|NCT02850406|584764986|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
161923333|NCT02850406|584764987|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
161923334|NCT02850406|584764988|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
161923335|NCT02850406|584764989|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
161923336|NCT02850406|584764982|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923337|NCT02850406|584764983|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923338|NCT02850406|584764984|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923339|NCT02850406|584764985|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923340|NCT02850406|584764986|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
161923341|NCT02850406|584764987|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
161923342|NCT02850406|584764988|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923343|NCT02850406|584764989|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923344|NCT02850406|584764982|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923345|NCT02850406|584764983|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923346|NCT02850406|584764984|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923347|NCT02850406|584764985|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923348|NCT02850406|584764986|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
161923349|NCT02850406|584764987|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923350|NCT02850406|584764988|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923351|NCT02850406|584764989|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
161923352|NCT02850406|584764982|FG000|Part C (Up to 52 Weeks)|Other|0|||
161923353|NCT02850406|584764983|FG001|Part C (Up to 52 Weeks)|Other|0|||
161923354|NCT02850406|584764984|FG002|Part C (Up to 52 Weeks)|Other|0|||
161923355|NCT02850406|584764985|FG003|Part C (Up to 52 Weeks)|Other|0|||
161923356|NCT02850406|584764986|FG004|Part C (Up to 52 Weeks)|Other|1|||
161923357|NCT02850406|584764987|FG005|Part C (Up to 52 Weeks)|Other|3|||
161923358|NCT02850406|584764988|FG006|Part C (Up to 52 Weeks)|Other|0|||
161923359|NCT02850406|584764989|FG007|Part C (Up to 52 Weeks)|Other|0|||
161923360|NCT02850406|584764982|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923361|NCT02850406|584764983|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923362|NCT02850406|584764984|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923363|NCT02850406|584764985|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923364|NCT02850406|584764986|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923365|NCT02850406|584764987|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923366|NCT02850406|584764988|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
161923367|NCT02850406|584764989|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
161923368|NCT02850406|584764982|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923369|NCT02850406|584764983|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923370|NCT02850406|584764984|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923371|NCT02850406|584764985|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923372|NCT02850406|584764986|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923373|NCT02850406|584764987|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923374|NCT02850406|584764988|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
161923375|NCT02850406|584764989|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
161923376|NCT02850406|584764982|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
161923377|NCT02850406|584764983|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
161923378|NCT02850406|584764984|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
161671644|NCT04427501|583851347|FG011|Overall Study|Other|1|||
161923379|NCT02850406|584764985|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
161923380|NCT02850406|584764986|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
161923381|NCT02850406|584764987|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
161923382|NCT02850406|584764988|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
161923383|NCT02850406|584764989|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
161923384|NCT02850406|584764982|FG000|Part D (Up to 52 Weeks)|Other|0|||
161923385|NCT02850406|584764983|FG001|Part D (Up to 52 Weeks)|Other|0|||
161923386|NCT02850406|584764984|FG002|Part D (Up to 52 Weeks)|Other|0|||
161923387|NCT02850406|584764985|FG003|Part D (Up to 52 Weeks)|Other|0|||
161923388|NCT02850406|584764986|FG004|Part D (Up to 52 Weeks)|Other|0|||
161923389|NCT02850406|584764987|FG005|Part D (Up to 52 Weeks)|Other|0|||
161923390|NCT02850406|584764988|FG006|Part D (Up to 52 Weeks)|Other|0|||
161923391|NCT02850406|584764989|FG007|Part D (Up to 52 Weeks)|Other|1|||
161923392|NCT05643794|584766481|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
161923393|NCT05643794|584766482|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
161923394|NCT05643794|584766483|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
161923395|NCT05643794|584766481|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
161923396|NCT05643794|584766482|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161923397|NCT05643794|584766483|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161923398|NCT05643794|584766481|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
161923399|NCT05643794|584766482|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
161923400|NCT05643794|584766483|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
161923401|NCT05643794|584766481|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
161923402|NCT05643794|584766482|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
161923403|NCT05643794|584766483|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
161923404|NCT05643794|584766481|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
161923405|NCT05643794|584766482|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
161923406|NCT05643794|584766483|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
161923407|NCT05643794|584766481|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
161923408|NCT05643794|584766482|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
161923409|NCT05643794|584766483|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
161923410|NCT04167670|584766486|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
161923411|NCT04167670|584766487|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
161923412|NCT04167670|584766488|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
161923413|NCT04167670|584766486|FG000|Overall Study|Significant protocol deviation|3|||
161923414|NCT04167670|584766487|FG001|Overall Study|Significant protocol deviation|1|||
161923415|NCT04167670|584766488|FG002|Overall Study|Significant protocol deviation|0|||
161923416|NCT04167670|584766486|FG000|Overall Study|Lost to Follow-up|0|||
161923417|NCT04167670|584766487|FG001|Overall Study|Lost to Follow-up|3|||
161923418|NCT04167670|584766488|FG002|Overall Study|Lost to Follow-up|3|||
161923419|NCT04167670|584766486|FG000|Overall Study|Voluntary Withdrawal|0|||
161923420|NCT04167670|584766487|FG001|Overall Study|Voluntary Withdrawal|1|||
161923421|NCT04167670|584766488|FG002|Overall Study|Voluntary Withdrawal|1|||
161923422|NCT04167670|584766486|FG000|Overall Study|Withdrawal of Consent|4|||
161923423|NCT04167670|584766487|FG001|Overall Study|Withdrawal of Consent|1|||
161923424|NCT04167670|584766488|FG002|Overall Study|Withdrawal of Consent|3|||
161923425|NCT04167670|584766486|FG000|Overall Study|Miscellaneous|7|||
161923426|NCT04167670|584766487|FG001|Overall Study|Miscellaneous|5|||
161923427|NCT04167670|584766488|FG002|Overall Study|Miscellaneous|3|||
161923428|NCT04706403|584766489|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
161923429|NCT04706403|584766490|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
161923430|NCT04706403|584766491|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
161923431|NCT04706403|584766492|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
161923432|NCT04706403|584766493|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
161923433|NCT01653262|584766494|FG000|Overall Study|Lack of Efficacy|1|||
161923434|NCT01653262|584766494|FG000|Overall Study|SAE, non-fatal|1|||
161923435|NCT01653262|584766494|FG000|Overall Study|AE, non-serious non-fatal|1|||
161923436|NCT01112267|584766496|FG000|Overall Study|Adverse Event|24|||
161923437|NCT01112267|584766497|FG001|Overall Study|Adverse Event|6|||
161923438|NCT01112267|584766496|FG000|Overall Study|Withdrawal by Subject|3|||
161923439|NCT01112267|584766497|FG001|Overall Study|Withdrawal by Subject|5|||
161923440|NCT01112267|584766496|FG000|Overall Study|Protocol Violation|5|||
161923441|NCT01112267|584766497|FG001|Overall Study|Protocol Violation|3|||
161923442|NCT01112267|584766496|FG000|Overall Study|Participants not compliant|1|||
161923443|NCT01112267|584766497|FG001|Overall Study|Participants not compliant|2|||
161923444|NCT01112267|584766496|FG000|Overall Study|Participants not receive any study drug|1|||
161923445|NCT01112267|584766497|FG001|Overall Study|Participants not receive any study drug|2|||
161923446|NCT01373229|584766498|FG000|Overall Study|Death|3|||
161671645|NCT03170154|583851348|FG000|Overall Study|Lost to Follow-up|4|||
161923447|NCT01373229|584766498|FG000|Overall Study|Physician Decision|3|||
162018690|NCT00552188|585123178|FG001|Overall Study|Lost to Follow-up|1|||
162018691|NCT00552188|585123177|FG000|Overall Study|Withdrawal of consent|0|||
162018692|NCT00552188|585123178|FG001|Overall Study|Withdrawal of consent|1|||
162018693|NCT00552188|585123177|FG000|Overall Study|Subject returned to home country|0|||
162018694|NCT00552188|585123178|FG001|Overall Study|Subject returned to home country|1|||
162018695|NCT01256294|585123179|FG000|Overall Study|Adverse Event|1|||
162018696|NCT01256294|585123180|FG001|Overall Study|Adverse Event|0|||
162018697|NCT01256294|585123179|FG000|Overall Study|Withdrawal by Subject|1|||
161923448|NCT00587457|584766499|FG000|Overall Study|Adverse Event|1|||
161923449|NCT00587457|584766500|FG001|Overall Study|Adverse Event|2|||
161923450|NCT00587457|584766501|FG002|Overall Study|Adverse Event|1|||
161923451|NCT00587457|584766499|FG000|Overall Study|Disease progression|2|||
161923452|NCT00587457|584766500|FG001|Overall Study|Disease progression|0|||
161923453|NCT00587457|584766501|FG002|Overall Study|Disease progression|2|||
161923454|NCT00587457|584766499|FG000|Overall Study|Initiation of alternative therapy|0|||
161923455|NCT00587457|584766500|FG001|Overall Study|Initiation of alternative therapy|1|||
161923456|NCT00587457|584766501|FG002|Overall Study|Initiation of alternative therapy|0|||
161923457|NCT00587457|584766499|FG000|Overall Study|Undefined|0|||
161923458|NCT00587457|584766500|FG001|Overall Study|Undefined|0|||
161923459|NCT00587457|584766501|FG002|Overall Study|Undefined|1|||
161923460|NCT00587457|584766499|FG000|Overall Study|Development of neutralizing Abs|0|||
162018698|NCT01256294|585123180|FG001|Overall Study|Withdrawal by Subject|1|||
162018699|NCT01256294|585123179|FG000|Overall Study|Protocol deviation|2|||
161923461|NCT00587457|584766500|FG001|Overall Study|Development of neutralizing Abs|0|||
161923462|NCT00587457|584766501|FG002|Overall Study|Development of neutralizing Abs|1|||
161923463|NCT04439175|584766502|FG000|Overall Study|Never started treatment|4|||
161923464|NCT04439175|584766502|FG000|Overall Study|Ineligible|5|||
161923465|NCT04439175|584766502|FG000|Overall Study|Adverse Event|6|||
161923466|NCT04439175|584766502|FG000|Overall Study|Death|4|||
162018700|NCT01256294|585123180|FG001|Overall Study|Protocol deviation|1|||
162018701|NCT03887702|585123181|FG000|Overall Study|Study terminated|0|||
162018702|NCT03887702|585123182|FG001|Overall Study|Study terminated|0|||
161923467|NCT04439175|584766502|FG000|Overall Study|Disease progression|44|||
162018703|NCT03887702|585123183|FG002|Overall Study|Study terminated|2|||
162018704|NCT03887702|585123184|FG003|Overall Study|Study terminated|2|||
162018705|NCT01643772|585123185|FG000|Overall Study|Protocol Violation|0|||
162018706|NCT01643772|585123186|FG001|Overall Study|Protocol Violation|0|||
161923468|NCT04439175|584766502|FG000|Overall Study|Withdrawal by Subject|4|||
161923469|NCT04439175|584766502|FG000|Overall Study|Alternative Therapy|1|||
161923470|NCT04439175|584766502|FG000|Overall Study|Other|2|||
161923471|NCT05417113|584766505|FG000|Overall Study|Lost to Follow-up|2|||
161923472|NCT05417113|584766506|FG001|Overall Study|Lost to Follow-up|2|||
161923473|NCT01847209|584766507|FG000|Overall Study|Withdrawal by Subject|1|||
161923474|NCT01847209|584766507|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
161923475|NCT00729586|584766508|FG000|Overall Study|Ineligible|0|||
161923476|NCT00729586|584766509|FG001|Overall Study|Ineligible|1|||
162018707|NCT01643772|585123187|FG002|Overall Study|Protocol Violation|0|||
162018708|NCT01643772|585123188|FG003|Overall Study|Protocol Violation|1|||
162018709|NCT01643772|585123185|FG000|Overall Study|Adverse Event|0|||
162018710|NCT01643772|585123186|FG001|Overall Study|Adverse Event|0|||
162018711|NCT01643772|585123187|FG002|Overall Study|Adverse Event|0|||
162018712|NCT01643772|585123188|FG003|Overall Study|Adverse Event|1|||
162018713|NCT03860818|585123189|FG000|Overall Study|Death|144|||
162018714|NCT03860818|585123190|FG001|Overall Study|Death|195|||
162018715|NCT03860818|585123189|FG000|Overall Study|Graft Loss|32|||
162018716|NCT03860818|585123190|FG001|Overall Study|Graft Loss|45|||
162018717|NCT00505778|585123191|FG000|Overall Study|Adverse Event|2|||
162018718|NCT00505778|585123192|FG001|Overall Study|Adverse Event|7|||
162018719|NCT00505778|585123191|FG000|Overall Study|Physician Decision|8|||
162018720|NCT00505778|585123192|FG001|Overall Study|Physician Decision|14|||
162018721|NCT00505778|585123191|FG000|Overall Study|Lost to Follow-up|17|||
162018722|NCT00505778|585123192|FG001|Overall Study|Lost to Follow-up|23|||
162018723|NCT00505778|585123191|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
162179537|NCT02101853|585710975|FG000|Block 1 Induction|Protocol Violation|2|||
162179538|NCT02101853|585710976|FG001|Block 1 Induction|Protocol Violation|0|||
162179539|NCT02101853|585710977|FG002|Block 1 Induction|Protocol Violation|0|||
162179540|NCT02101853|585710978|FG003|Block 1 Induction|Protocol Violation|0|||
162179541|NCT02101853|585710979|FG004|Block 1 Induction|Protocol Violation|0|||
161923477|NCT00729586|584766508|FG000|Overall Study|never treated|1|||
162179542|NCT02101853|585710980|FG005|Block 1 Induction|Protocol Violation|0|||
162018724|NCT00505778|585123192|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
162018725|NCT00505778|585123191|FG000|Overall Study|Protocol Violation|7|||
162018726|NCT00505778|585123192|FG001|Overall Study|Protocol Violation|9|||
162018727|NCT00505778|585123191|FG000|Overall Study|Withdrawal by Subject|29|||
161923478|NCT00729586|584766509|FG001|Overall Study|never treated|0|||
161923479|NCT02513199|584766512|FG000|Treatment|Death|1|||
162018728|NCT00505778|585123192|FG001|Overall Study|Withdrawal by Subject|14|||
162018729|NCT00505778|585123191|FG000|Overall Study|Relapse|65|||
162179543|NCT02101853|585710975|FG000|Block 1 Induction|Withdrawal by Subject|65|||
162179544|NCT02101853|585710976|FG001|Block 1 Induction|Withdrawal by Subject|0|||
162179545|NCT02101853|585710977|FG002|Block 1 Induction|Withdrawal by Subject|0|||
162179546|NCT02101853|585710978|FG003|Block 1 Induction|Withdrawal by Subject|0|||
162179547|NCT02101853|585710979|FG004|Block 1 Induction|Withdrawal by Subject|0|||
161923480|NCT02513199|584766512|FG000|Treatment|Lost to Follow-up|1|||
161923481|NCT02513199|584766512|FG000|Follow-Up|Death|11|||
161923482|NCT02927145|584766516|FG000|Initial Recruitment|Withdrawal by Subject|0|||
161923483|NCT02927145|584766517|FG001|Initial Recruitment|Withdrawal by Subject|1|||
161923484|NCT02927145|584766518|FG002|Initial Recruitment|Withdrawal by Subject|1|||
161923485|NCT02927145|584766519|FG003|Initial Recruitment|Withdrawal by Subject|4|||
161923486|NCT02927145|584766520|FG004|Initial Recruitment|Withdrawal by Subject|1|||
161923487|NCT02927145|584766521|FG005|Initial Recruitment|Withdrawal by Subject|1|||
161923488|NCT02927145|584766522|FG006|Initial Recruitment|Withdrawal by Subject|0|||
161923489|NCT02927145|584766523|FG007|Initial Recruitment|Withdrawal by Subject|0|||
161923490|NCT02927145|584766524|FG008|Initial Recruitment|Withdrawal by Subject|2|||
161923491|NCT02927145|584766516|FG000|Initial Recruitment|Adverse Event|0|||
161923492|NCT02927145|584766517|FG001|Initial Recruitment|Adverse Event|0|||
161923493|NCT02927145|584766518|FG002|Initial Recruitment|Adverse Event|0|||
161923494|NCT02927145|584766519|FG003|Initial Recruitment|Adverse Event|0|||
161923495|NCT02927145|584766520|FG004|Initial Recruitment|Adverse Event|2|||
161923496|NCT02927145|584766521|FG005|Initial Recruitment|Adverse Event|0|||
161923497|NCT02927145|584766522|FG006|Initial Recruitment|Adverse Event|0|||
161923498|NCT02927145|584766523|FG007|Initial Recruitment|Adverse Event|0|||
161923499|NCT02927145|584766524|FG008|Initial Recruitment|Adverse Event|0|||
161923500|NCT02927145|584766516|FG000|Invitation for Additional Challenge|Pregnancy|0|||
161923501|NCT02927145|584766517|FG001|Invitation for Additional Challenge|Pregnancy|0|||
161923502|NCT02927145|584766518|FG002|Invitation for Additional Challenge|Pregnancy|0|||
161923503|NCT02927145|584766519|FG003|Invitation for Additional Challenge|Pregnancy|0|||
161923504|NCT02927145|584766520|FG004|Invitation for Additional Challenge|Pregnancy|0|||
161923505|NCT02927145|584766521|FG005|Invitation for Additional Challenge|Pregnancy|0|||
161923506|NCT02927145|584766522|FG006|Invitation for Additional Challenge|Pregnancy|1|||
162018730|NCT00505778|585123192|FG001|Overall Study|Relapse|65|||
162018731|NCT00505778|585123191|FG000|Overall Study|Took No Study Drug|2|||
162018732|NCT00505778|585123192|FG001|Overall Study|Took No Study Drug|2|||
162179548|NCT02101853|585710980|FG005|Block 1 Induction|Withdrawal by Subject|0|||
162179549|NCT02101853|585710975|FG000|Block 1 Induction|Ineligible|8|||
162179550|NCT02101853|585710976|FG001|Block 1 Induction|Ineligible|0|||
162179551|NCT02101853|585710977|FG002|Block 1 Induction|Ineligible|0|||
162179552|NCT02101853|585710978|FG003|Block 1 Induction|Ineligible|0|||
162179553|NCT02101853|585710979|FG004|Block 1 Induction|Ineligible|0|||
162179554|NCT02101853|585710980|FG005|Block 1 Induction|Ineligible|0|||
162179555|NCT02101853|585710975|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
162179556|NCT02101853|585710976|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
162179557|NCT02101853|585710977|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
162179558|NCT02101853|585710978|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
162179559|NCT02101853|585710979|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
162179560|NCT02101853|585710980|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
162179561|NCT02101853|585710975|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
162179562|NCT02101853|585710976|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162179563|NCT02101853|585710977|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162179564|NCT02101853|585710978|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162179565|NCT02101853|585710979|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162179566|NCT02101853|585710980|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162179567|NCT02101853|585710975|FG000|Post Induction Randomization|Adverse Event|0|||
162179568|NCT02101853|585710976|FG001|Post Induction Randomization|Adverse Event|3|||
162179569|NCT02101853|585710977|FG002|Post Induction Randomization|Adverse Event|8|||
162179570|NCT02101853|585710978|FG003|Post Induction Randomization|Adverse Event|4|||
162179571|NCT02101853|585710979|FG004|Post Induction Randomization|Adverse Event|4|||
162179572|NCT02101853|585710980|FG005|Post Induction Randomization|Adverse Event|0|||
162179573|NCT02101853|585710975|FG000|Post Induction Randomization|Death|0|||
162179574|NCT02101853|585710976|FG001|Post Induction Randomization|Death|9|||
162179575|NCT02101853|585710977|FG002|Post Induction Randomization|Death|2|||
162179576|NCT02101853|585710978|FG003|Post Induction Randomization|Death|2|||
162179577|NCT02101853|585710979|FG004|Post Induction Randomization|Death|0|||
162179578|NCT02101853|585710980|FG005|Post Induction Randomization|Death|0|||
161923507|NCT02927145|584766523|FG007|Invitation for Additional Challenge|Pregnancy|0|||
161923508|NCT02927145|584766524|FG008|Invitation for Additional Challenge|Pregnancy|0|||
161923509|NCT03298061|584766525|FG000|Overall Study|Adverse Event|3|||
161923510|NCT03298061|584766525|FG000|Overall Study|Lack of Efficacy|6|||
161923511|NCT03298061|584766525|FG000|Overall Study|Protocol Violation|1|||
161923512|NCT03298061|584766525|FG000|Overall Study|Physician Decision|7|||
161923513|NCT03298061|584766525|FG000|Overall Study|Withdrawal by Subject|10|||
161923514|NCT04307394|584766527|FG000|Overall Study|Lost to Follow-up|3|||
161923515|NCT04307394|584766527|FG000|Overall Study|Withdrawal by Subject|2|||
161923516|NCT01166945|584766530|FG000|Randomized|diagnosed with Group A strep|4|||
161923517|NCT01166945|584766531|FG001|Randomized|diagnosed with Group A strep|4|||
161923518|NCT01166945|584766530|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
161923519|NCT01166945|584766531|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
161923520|NCT01166945|584766530|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
161923521|NCT01166945|584766531|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
161923522|NCT01166945|584766530|FG000|Day 30|Lost to Follow-up|4|||
161923523|NCT01166945|584766531|FG001|Day 30|Lost to Follow-up|3|||
161923524|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
161923525|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
161923526|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
161923527|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
161923528|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
161923529|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
161923530|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
161923531|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
161923532|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
161923533|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
161923534|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
161923535|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
161923536|NCT00447278|584766533|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
161923537|NCT00447278|584766534|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
161923538|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
161923539|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
161923540|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
161923541|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
161923542|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
161923543|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
161923544|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
161923545|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
161923546|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
161923547|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
161923548|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
161923549|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
161923550|NCT00447278|584766533|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
161923551|NCT00447278|584766534|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
161923552|NCT01239745|584766540|FG000|Overall Study|Study terminated by sponsor|45|||
161923553|NCT01239745|584766540|FG000|Overall Study|Adverse Event|1|||
161923554|NCT06262607|584766547|FG000|Overall Study|Physician Decision|0|||
161923555|NCT06262607|584766548|FG001|Overall Study|Physician Decision|1|||
161923556|NCT06262607|584766547|FG000|Overall Study|Withdrawal by Subject|2|||
161923557|NCT06262607|584766548|FG001|Overall Study|Withdrawal by Subject|0|||
161923558|NCT01946802|584766549|FG000|Overall Study|Death|1|||
161923559|NCT01946802|584766549|FG000|Overall Study|Withdrawal by Subject|2|||
161923560|NCT01946802|584766549|FG000|Overall Study|Combined septic shock|1|||
161923561|NCT01946802|584766549|FG000|Overall Study|Protocol Violation|1|||
161923562|NCT02541903|584766550|FG000|Overall Study|Death|1|||
161923563|NCT02969018|584766555|FG000|Overall Study|Adverse Event|2|||
161923564|NCT02969018|584766556|FG001|Overall Study|Adverse Event|4|||
161923565|NCT02969018|584766557|FG002|Overall Study|Adverse Event|1|||
161923566|NCT02969018|584766558|FG003|Overall Study|Adverse Event|2|||
161923567|NCT02969018|584766559|FG004|Overall Study|Adverse Event|0|||
161923568|NCT02969018|584766560|FG005|Overall Study|Adverse Event|1|||
161923569|NCT02969018|584766561|FG006|Overall Study|Adverse Event|2|||
162018733|NCT03436082|585123193|FG000|Overall Study|Did not undergo procedure|1|||
162179579|NCT02101853|585710975|FG000|Post Induction Randomization|Lack of Efficacy|0|||
162179580|NCT02101853|585710976|FG001|Post Induction Randomization|Lack of Efficacy|14|||
162179581|NCT02101853|585710977|FG002|Post Induction Randomization|Lack of Efficacy|23|||
162179582|NCT02101853|585710978|FG003|Post Induction Randomization|Lack of Efficacy|18|||
162179583|NCT02101853|585710979|FG004|Post Induction Randomization|Lack of Efficacy|21|||
161923570|NCT02969018|584766562|FG007|Overall Study|Adverse Event|0|||
161923571|NCT02969018|584766555|FG000|Overall Study|Lack of Efficacy|0|||
161923572|NCT02969018|584766556|FG001|Overall Study|Lack of Efficacy|1|||
161923573|NCT02969018|584766557|FG002|Overall Study|Lack of Efficacy|0|||
161923574|NCT02969018|584766558|FG003|Overall Study|Lack of Efficacy|0|||
161923575|NCT02969018|584766559|FG004|Overall Study|Lack of Efficacy|1|||
162179584|NCT02101853|585710980|FG005|Post Induction Randomization|Lack of Efficacy|0|||
162179585|NCT02101853|585710975|FG000|Post Induction Randomization|Physician Decision|0|||
162179586|NCT02101853|585710976|FG001|Post Induction Randomization|Physician Decision|43|||
162179587|NCT02101853|585710977|FG002|Post Induction Randomization|Physician Decision|23|||
162179588|NCT02101853|585710978|FG003|Post Induction Randomization|Physician Decision|14|||
162179589|NCT02101853|585710979|FG004|Post Induction Randomization|Physician Decision|14|||
162179590|NCT02101853|585710980|FG005|Post Induction Randomization|Physician Decision|0|||
162179591|NCT02101853|585710975|FG000|Post Induction Randomization|Protocol Violation|0|||
162179592|NCT02101853|585710976|FG001|Post Induction Randomization|Protocol Violation|3|||
162179593|NCT02101853|585710977|FG002|Post Induction Randomization|Protocol Violation|0|||
162179594|NCT02101853|585710978|FG003|Post Induction Randomization|Protocol Violation|0|||
162179595|NCT02101853|585710979|FG004|Post Induction Randomization|Protocol Violation|0|||
161817416|NCT00829764|584371032|FG000|First Intervention|Adverse Event|1|||
161817417|NCT00829764|584371033|FG001|First Intervention|Adverse Event|0|||
161817418|NCT00829764|584371032|FG000|First Intervention|Withdrawal by Subject|1|||
161817419|NCT00829764|584371033|FG001|First Intervention|Withdrawal by Subject|1|||
161817420|NCT00258856|584372808|FG000|Overall Study|Lost to Follow-up|1|||
161817421|NCT00258856|584372809|FG001|Overall Study|Lost to Follow-up|0|||
161817422|NCT00258856|584372810|FG002|Overall Study|Lost to Follow-up|2|||
161817423|NCT00258856|584372811|FG003|Overall Study|Lost to Follow-up|0|||
161817424|NCT00258856|584372808|FG000|Overall Study|Non-compliance|2|||
161817425|NCT00258856|584372809|FG001|Overall Study|Non-compliance|0|||
161817426|NCT00258856|584372810|FG002|Overall Study|Non-compliance|0|||
161817427|NCT00258856|584372811|FG003|Overall Study|Non-compliance|1|||
161817428|NCT02488109|584372817|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
161817429|NCT02488109|584372818|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
161817430|NCT02488109|584372817|FG000|12-month Follow-Up|Lost to Follow-up|4|||
161817431|NCT02488109|584372818|FG001|12-month Follow-Up|Lost to Follow-up|7|||
161817432|NCT03969641|584372819|FG000|Overall Study|Lost to Follow-up|5|||
161817433|NCT03969641|584372820|FG001|Overall Study|Lost to Follow-up|3|||
161817434|NCT03969641|584372819|FG000|Overall Study|Withdrawal by Subject|1|||
161817435|NCT03969641|584372820|FG001|Overall Study|Withdrawal by Subject|2|||
161817436|NCT03969641|584372819|FG000|Overall Study|Found to be ineligible|1|||
161817437|NCT03969641|584372820|FG001|Overall Study|Found to be ineligible|1|||
161817438|NCT03969641|584372819|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
161817439|NCT03969641|584372820|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
161817440|NCT03969641|584372819|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
161817441|NCT03969641|584372820|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
161817442|NCT03969641|584372819|FG000|Overall Study|Elective termination|0|||
161817443|NCT03969641|584372820|FG001|Overall Study|Elective termination|1|||
161817444|NCT02658019|584372836|FG000|Overall Study|Adverse Event|1|||
161817445|NCT00660660|584372837|FG000|Overall Study|Adverse Event|1|||
161817446|NCT00660660|584372838|FG001|Overall Study|Adverse Event|0|||
161817447|NCT00660660|584372837|FG000|Overall Study|Lost to Follow-up|0|||
161817448|NCT00660660|584372838|FG001|Overall Study|Lost to Follow-up|6|||
161817449|NCT00660660|584372837|FG000|Overall Study|Lack of Efficacy|0|||
161817450|NCT00660660|584372838|FG001|Overall Study|Lack of Efficacy|2|||
161817451|NCT00660660|584372837|FG000|Overall Study|Withdrawal by Subject|3|||
161817452|NCT00660660|584372838|FG001|Overall Study|Withdrawal by Subject|0|||
161817453|NCT00660660|584372837|FG000|Overall Study|Incorrect enrollment and other|0|||
161817454|NCT00660660|584372838|FG001|Overall Study|Incorrect enrollment and other|1|||
161817455|NCT00660660|584372837|FG000|Overall Study|New medication after randomization|1|||
161817456|NCT00660660|584372838|FG001|Overall Study|New medication after randomization|0|||
161671646|NCT03170154|583851348|FG000|Overall Study|Death|2|||
161817457|NCT01630616|584372839|FG000|Overall Study|Adverse Event|0|||
161817458|NCT01630616|584372840|FG001|Overall Study|Adverse Event|0|||
161817459|NCT01630616|584372841|FG002|Overall Study|Adverse Event|0|||
161817460|NCT01630616|584372842|FG003|Overall Study|Adverse Event|1|||
161817461|NCT01630616|584372843|FG004|Overall Study|Adverse Event|0|||
161817462|NCT01630616|584372844|FG005|Overall Study|Adverse Event|0|||
161817463|NCT01630616|584372839|FG000|Overall Study|Withdrawal by Subject|0|||
161817464|NCT01630616|584372840|FG001|Overall Study|Withdrawal by Subject|0|||
161817465|NCT01630616|584372841|FG002|Overall Study|Withdrawal by Subject|0|||
161817466|NCT01630616|584372842|FG003|Overall Study|Withdrawal by Subject|2|||
161817467|NCT01630616|584372843|FG004|Overall Study|Withdrawal by Subject|0|||
161817468|NCT01630616|584372844|FG005|Overall Study|Withdrawal by Subject|0|||
161817469|NCT00640393|584372846|FG000|Part 1|Lost to Follow-up|2|||
162179596|NCT02101853|585710980|FG005|Post Induction Randomization|Protocol Violation|0|||
162179597|NCT02101853|585710975|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
162179598|NCT02101853|585710976|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
162179599|NCT02101853|585710977|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
162179600|NCT02101853|585710978|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
162179601|NCT02101853|585710979|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
162179602|NCT02101853|585710980|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
162179603|NCT02101853|585710975|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162179604|NCT02101853|585710976|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162179605|NCT02101853|585710977|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162179606|NCT02101853|585710978|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
162179607|NCT02101853|585710979|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
162179608|NCT02101853|585710980|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161817470|NCT00640393|584372847|FG001|Part 1|Lost to Follow-up|0|||
161817471|NCT00640393|584372848|FG002|Part 1|Lost to Follow-up|0|||
161817472|NCT00640393|584372846|FG000|Part 1|Withdrawal by Subject|3|||
161817473|NCT00640393|584372847|FG001|Part 1|Withdrawal by Subject|0|||
161817474|NCT00640393|584372848|FG002|Part 1|Withdrawal by Subject|0|||
161817475|NCT00640393|584372846|FG000|Randomization|Withdrawn per protocol|17|||
161817476|NCT00640393|584372847|FG001|Randomization|Withdrawn per protocol|0|||
161817477|NCT00640393|584372848|FG002|Randomization|Withdrawn per protocol|0|||
161817478|NCT00640393|584372846|FG000|Randomization|Never randomized by site|2|||
161817479|NCT00640393|584372847|FG001|Randomization|Never randomized by site|0|||
161817480|NCT00640393|584372848|FG002|Randomization|Never randomized by site|0|||
161817481|NCT00640393|584372846|FG000|Part 2|Lost to Follow-up|0|||
161817482|NCT00640393|584372847|FG001|Part 2|Lost to Follow-up|2|||
161817483|NCT00640393|584372848|FG002|Part 2|Lost to Follow-up|2|||
161817484|NCT00640393|584372846|FG000|Part 2|Withdrawal by Subject|0|||
161817485|NCT00640393|584372847|FG001|Part 2|Withdrawal by Subject|6|||
161817486|NCT00640393|584372848|FG002|Part 2|Withdrawal by Subject|1|||
161817487|NCT00640393|584372846|FG000|Part 2|Non-adherence|0|||
161817488|NCT00640393|584372847|FG001|Part 2|Non-adherence|1|||
161817489|NCT00640393|584372848|FG002|Part 2|Non-adherence|0|||
161817490|NCT00640393|584372846|FG000|Part 2|Adverse Event|0|||
161817491|NCT00640393|584372847|FG001|Part 2|Adverse Event|1|||
161817492|NCT00640393|584372848|FG002|Part 2|Adverse Event|0|||
161817493|NCT00294047|584372850|FG000|Month 48|Adverse Event|28|||
161817494|NCT00294047|584372851|FG001|Month 48|Adverse Event|13|||
161817495|NCT00294047|584372850|FG000|Month 48|Protocol Violation|4|||
161817496|NCT00294047|584372851|FG001|Month 48|Protocol Violation|4|||
161817497|NCT00294047|584372850|FG000|Month 48|Withdrawal by Subject|111|||
161817498|NCT00294047|584372851|FG001|Month 48|Withdrawal by Subject|115|||
161817499|NCT00294047|584372850|FG000|Month 48|Lost to Follow-up|272|||
161817500|NCT00294047|584372851|FG001|Month 48|Lost to Follow-up|287|||
161817501|NCT00294047|584372850|FG000|Month 48|Other|10|||
161817502|NCT00294047|584372851|FG001|Month 48|Other|14|||
161817503|NCT00294047|584372850|FG000|Month 84|Adverse Event|4|||
161817504|NCT00294047|584372851|FG001|Month 84|Adverse Event|2|||
161817505|NCT00294047|584372850|FG000|Month 84|Protocol Violation|1|||
161817506|NCT00294047|584372851|FG001|Month 84|Protocol Violation|1|||
161817507|NCT00294047|584372850|FG000|Month 84|Withdrawal by Subject|33|||
161817508|NCT00294047|584372851|FG001|Month 84|Withdrawal by Subject|31|||
161817509|NCT00294047|584372850|FG000|Month 84|Lost to Follow-up|187|||
161817510|NCT00294047|584372851|FG001|Month 84|Lost to Follow-up|190|||
161817511|NCT00294047|584372850|FG000|Month 84|Absent Cervix|2|||
161817512|NCT00294047|584372851|FG001|Month 84|Absent Cervix|0|||
161817513|NCT00294047|584372850|FG000|Month 84|Work related reasons|4|||
161817514|NCT00294047|584372851|FG001|Month 84|Work related reasons|2|||
161817515|NCT00294047|584372850|FG000|Month 84|Center closed, subject did not transfer|1|||
161817516|NCT00294047|584372851|FG001|Month 84|Center closed, subject did not transfer|0|||
161817517|NCT00294047|584372850|FG000|Month 84|Family problems|2|||
161817518|NCT00294047|584372851|FG001|Month 84|Family problems|2|||
161817519|NCT00294047|584372850|FG000|Month 84|Lack of time|3|||
161817520|NCT00294047|584372851|FG001|Month 84|Lack of time|1|||
161817521|NCT00294047|584372850|FG000|Month 84|Personal reason|2|||
161817522|NCT00294047|584372851|FG001|Month 84|Personal reason|4|||
161817523|NCT00294047|584372850|FG000|Month 84|Subject does not want male physician|1|||
161817524|NCT00294047|584372851|FG001|Month 84|Subject does not want male physician|0|||
161817525|NCT00294047|584372850|FG000|Month 84|Transport reimbursement delayed|0|||
161817526|NCT00294047|584372851|FG001|Month 84|Transport reimbursement delayed|1|||
161817527|NCT00294047|584372850|FG000|Month 84|Unable to reach study site|1|||
161817528|NCT00294047|584372851|FG001|Month 84|Unable to reach study site|0|||
161817529|NCT00294047|584372850|FG000|Month 84|Under investigation locally|1|||
161817530|NCT00294047|584372851|FG001|Month 84|Under investigation locally|0|||
161817531|NCT00294047|584372850|FG000|Month 84|Visit missed|0|||
161671647|NCT03170154|583851348|FG000|Overall Study|Withdrawal by Subject|2|||
161671648|NCT01906346|583851351|FG000|Overall Study|AEs|1|||
161671649|NCT04936841|583851352|FG000|Overall Study|Death|1|||
161671650|NCT02279862|583851353|FG000|Overall Study|Study drug toxicity|3|||
161671651|NCT02279862|583851354|FG001|Overall Study|Study drug toxicity|6|||
161923576|NCT02969018|584766560|FG005|Overall Study|Lack of Efficacy|1|||
161923577|NCT02969018|584766561|FG006|Overall Study|Lack of Efficacy|1|||
161923578|NCT02969018|584766562|FG007|Overall Study|Lack of Efficacy|1|||
161923579|NCT02969018|584766555|FG000|Overall Study|Lost to Follow-up|1|||
161923580|NCT02969018|584766556|FG001|Overall Study|Lost to Follow-up|2|||
161923581|NCT02969018|584766557|FG002|Overall Study|Lost to Follow-up|2|||
161923582|NCT02969018|584766558|FG003|Overall Study|Lost to Follow-up|0|||
161923583|NCT02969018|584766559|FG004|Overall Study|Lost to Follow-up|1|||
161923584|NCT02969018|584766560|FG005|Overall Study|Lost to Follow-up|1|||
161923585|NCT02969018|584766561|FG006|Overall Study|Lost to Follow-up|0|||
161923586|NCT02969018|584766562|FG007|Overall Study|Lost to Follow-up|1|||
161923587|NCT02969018|584766555|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923588|NCT02969018|584766556|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923589|NCT02969018|584766557|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923590|NCT02969018|584766558|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923591|NCT02969018|584766559|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923592|NCT02969018|584766560|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923593|NCT02969018|584766561|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
161923594|NCT02969018|584766562|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
161923595|NCT02969018|584766555|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161923596|NCT02969018|584766556|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161923597|NCT02969018|584766557|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161923598|NCT02969018|584766558|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161923599|NCT02969018|584766559|FG004|Overall Study|Non-Compliance With Study Drug|0|||
161671652|NCT02279862|583851353|FG000|Overall Study|No longer meets criteria|0|||
161923600|NCT02969018|584766560|FG005|Overall Study|Non-Compliance With Study Drug|0|||
161923601|NCT02969018|584766561|FG006|Overall Study|Non-Compliance With Study Drug|0|||
161923602|NCT02969018|584766562|FG007|Overall Study|Non-Compliance With Study Drug|0|||
161923603|NCT02969018|584766555|FG000|Overall Study|Other|0|||
161923604|NCT02969018|584766556|FG001|Overall Study|Other|0|||
161923605|NCT02969018|584766557|FG002|Overall Study|Other|0|||
162179609|NCT02101853|585710975|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
162179610|NCT02101853|585710976|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
162179611|NCT02101853|585710977|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
162179612|NCT02101853|585710978|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
162179613|NCT02101853|585710979|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
162179614|NCT02101853|585710980|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
162179615|NCT02101853|585710975|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
162179616|NCT02101853|585710976|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
162179617|NCT02101853|585710977|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
162179618|NCT02101853|585710978|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
162179619|NCT02101853|585710979|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
162179620|NCT02101853|585710980|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
162179621|NCT02101853|585710975|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
162179622|NCT02101853|585710976|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
162179623|NCT02101853|585710977|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
162179624|NCT02101853|585710978|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
162179625|NCT02101853|585710979|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
162179626|NCT02101853|585710980|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
162179627|NCT02101853|585710975|FG000|Blinatumomab Salvage Therapy|Death|0|||
162179628|NCT02101853|585710976|FG001|Blinatumomab Salvage Therapy|Death|0|||
162179629|NCT02101853|585710977|FG002|Blinatumomab Salvage Therapy|Death|0|||
162179630|NCT02101853|585710978|FG003|Blinatumomab Salvage Therapy|Death|0|||
162179631|NCT02101853|585710979|FG004|Blinatumomab Salvage Therapy|Death|0|||
162179632|NCT02101853|585710980|FG005|Blinatumomab Salvage Therapy|Death|2|||
162179633|NCT02101853|585710975|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
162179634|NCT02101853|585710976|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
162179635|NCT02101853|585710977|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
161923606|NCT02969018|584766558|FG003|Overall Study|Other|1|||
161923607|NCT02969018|584766559|FG004|Overall Study|Other|0|||
161923608|NCT02969018|584766560|FG005|Overall Study|Other|0|||
161923609|NCT02969018|584766561|FG006|Overall Study|Other|0|||
161923610|NCT02969018|584766562|FG007|Overall Study|Other|2|||
161671653|NCT02279862|583851354|FG001|Overall Study|No longer meets criteria|1|||
161671654|NCT02279862|583851353|FG000|Overall Study|Administrative reason by sponsor|0|||
161923611|NCT02969018|584766555|FG000|Overall Study|Pregnancy|0|||
161923612|NCT02969018|584766556|FG001|Overall Study|Pregnancy|0|||
161923613|NCT02969018|584766557|FG002|Overall Study|Pregnancy|0|||
161923614|NCT02969018|584766558|FG003|Overall Study|Pregnancy|0|||
161923615|NCT02969018|584766559|FG004|Overall Study|Pregnancy|0|||
161923616|NCT02969018|584766560|FG005|Overall Study|Pregnancy|1|||
161923617|NCT02969018|584766561|FG006|Overall Study|Pregnancy|0|||
161923618|NCT02969018|584766562|FG007|Overall Study|Pregnancy|0|||
161923619|NCT02969018|584766555|FG000|Overall Study|Protocol Violation|0|||
161923620|NCT02969018|584766556|FG001|Overall Study|Protocol Violation|0|||
161923621|NCT02969018|584766557|FG002|Overall Study|Protocol Violation|1|||
161923622|NCT02969018|584766558|FG003|Overall Study|Protocol Violation|1|||
161923623|NCT02969018|584766559|FG004|Overall Study|Protocol Violation|0|||
161923624|NCT02969018|584766560|FG005|Overall Study|Protocol Violation|0|||
161923625|NCT02969018|584766561|FG006|Overall Study|Protocol Violation|0|||
161923626|NCT02969018|584766562|FG007|Overall Study|Protocol Violation|0|||
161923627|NCT02969018|584766555|FG000|Overall Study|Withdrawal by Subject|0|||
161923628|NCT02969018|584766556|FG001|Overall Study|Withdrawal by Subject|1|||
161923629|NCT02969018|584766557|FG002|Overall Study|Withdrawal by Subject|2|||
161923630|NCT02969018|584766558|FG003|Overall Study|Withdrawal by Subject|1|||
161923631|NCT02969018|584766559|FG004|Overall Study|Withdrawal by Subject|0|||
161923632|NCT02969018|584766560|FG005|Overall Study|Withdrawal by Subject|4|||
161923633|NCT02969018|584766561|FG006|Overall Study|Withdrawal by Subject|4|||
161923634|NCT02969018|584766562|FG007|Overall Study|Withdrawal by Subject|3|||
161923635|NCT00827242|584766564|FG000|Overall Study|Withdrawal by Subject|2|||
161923636|NCT00827242|584766565|FG001|Overall Study|Withdrawal by Subject|4|||
161923637|NCT00827242|584766564|FG000|Overall Study|Protocol Violation|1|||
161923638|NCT00827242|584766565|FG001|Overall Study|Protocol Violation|3|||
161923639|NCT00827242|584766564|FG000|Overall Study|Lost to Follow-up|0|||
161923640|NCT00827242|584766565|FG001|Overall Study|Lost to Follow-up|3|||
161923641|NCT00827242|584766564|FG000|Overall Study|Adverse Event Excluding Death|2|||
161923642|NCT00827242|584766565|FG001|Overall Study|Adverse Event Excluding Death|1|||
161923643|NCT00827242|584766564|FG000|Overall Study|Entry Criteria Not Met|4|||
161923644|NCT00827242|584766565|FG001|Overall Study|Entry Criteria Not Met|1|||
161923645|NCT00827242|584766564|FG000|Overall Study|Physician Decision|2|||
161923646|NCT00827242|584766565|FG001|Overall Study|Physician Decision|0|||
161923647|NCT00827242|584766564|FG000|Overall Study|Death|1|||
161923648|NCT00827242|584766565|FG001|Overall Study|Death|0|||
161923649|NCT00827242|584766564|FG000|Overall Study|Lack of Efficacy|1|||
161923650|NCT00827242|584766565|FG001|Overall Study|Lack of Efficacy|0|||
161923651|NCT05762679|584766566|FG000|Overall Study|Withdrawal by Subject|1|||
161923652|NCT05762679|584766566|FG000|Overall Study|No analyzable imaging data|1|||
161923653|NCT01479530|584766571|FG000|Overall Study|Adverse Event|5|||
161923654|NCT01479530|584766572|FG001|Overall Study|Adverse Event|6|||
161923655|NCT01479530|584766571|FG000|Overall Study|Lack of Efficacy|0|||
161923656|NCT01479530|584766572|FG001|Overall Study|Lack of Efficacy|1|||
161923657|NCT01479530|584766571|FG000|Overall Study|Protocol Violation|2|||
161923658|NCT01479530|584766572|FG001|Overall Study|Protocol Violation|3|||
161923659|NCT01479530|584766571|FG000|Overall Study|Withdrawal of Consent|3|||
161923660|NCT01479530|584766572|FG001|Overall Study|Withdrawal of Consent|2|||
161923661|NCT00927082|584766580|FG000|Overall Study|Lost to Follow-up|9|||
161923662|NCT00927082|584766581|FG001|Overall Study|Lost to Follow-up|8|||
161923663|NCT00927082|584766582|FG002|Overall Study|Lost to Follow-up|12|||
161923664|NCT00927082|584766583|FG003|Overall Study|Lost to Follow-up|16|||
161923665|NCT00927082|584766580|FG000|Overall Study|Withdrawal by Subject|3|||
161923666|NCT00927082|584766581|FG001|Overall Study|Withdrawal by Subject|2|||
161923667|NCT00927082|584766582|FG002|Overall Study|Withdrawal by Subject|7|||
161923668|NCT00927082|584766583|FG003|Overall Study|Withdrawal by Subject|2|||
161923669|NCT00927082|584766580|FG000|Overall Study|Death|0|||
161923670|NCT00927082|584766581|FG001|Overall Study|Death|0|||
162179636|NCT02101853|585710978|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
162179637|NCT02101853|585710979|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
162179638|NCT02101853|585710980|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
162179639|NCT02101853|585710975|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
162179640|NCT02101853|585710976|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
161923671|NCT00927082|584766582|FG002|Overall Study|Death|1|||
161923672|NCT00927082|584766583|FG003|Overall Study|Death|0|||
161923673|NCT00927082|584766580|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
161923674|NCT00927082|584766581|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
161923675|NCT00927082|584766582|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
161923676|NCT00927082|584766583|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
161923677|NCT00825175|584766589|FG000|Overall Study|Withdrawal by Subject|0|||
161923678|NCT00825175|584766590|FG001|Overall Study|Withdrawal by Subject|5|||
161923679|NCT04615507|584766593|FG000|Period 1|Covid-19 exposure|2|||
161923680|NCT04615507|584766594|FG001|Period 1|Covid-19 exposure|1|||
161923681|NCT04615507|584766593|FG000|Period 2|Covid-19 exposure|0|||
161923682|NCT04615507|584766594|FG001|Period 2|Covid-19 exposure|1|||
161923683|NCT04615507|584766593|FG000|Period 2|Protocol Violation|1|||
161817532|NCT00294047|584372851|FG001|Month 84|Visit missed|1|||
161817533|NCT00294047|584372850|FG000|Month 84|No consent for Month 84 Follow-up|731|||
161817534|NCT00294047|584372851|FG001|Month 84|No consent for Month 84 Follow-up|754|||
161817535|NCT00506831|584372852|FG000|Overall Study|Death|1|||
161817536|NCT00506831|584372852|FG000|Overall Study|Withdrawal by Subject|1|||
161817537|NCT01410227|584372856|FG000|Overall Study|Adverse Event|1|||
161817538|NCT01410227|584372857|FG001|Overall Study|Adverse Event|0|||
161817539|NCT01410227|584372858|FG002|Overall Study|Adverse Event|0|||
161817540|NCT01410227|584372859|FG003|Overall Study|Adverse Event|0|||
161817541|NCT01410227|584372856|FG000|Overall Study|Withdrawal by Subject|3|||
161817542|NCT01410227|584372857|FG001|Overall Study|Withdrawal by Subject|0|||
161817543|NCT01410227|584372858|FG002|Overall Study|Withdrawal by Subject|1|||
161817544|NCT01410227|584372859|FG003|Overall Study|Withdrawal by Subject|0|||
161817545|NCT01410227|584372856|FG000|Overall Study|Pregnancy|0|||
161817546|NCT01410227|584372857|FG001|Overall Study|Pregnancy|0|||
161817547|NCT01410227|584372858|FG002|Overall Study|Pregnancy|0|||
161817548|NCT01410227|584372859|FG003|Overall Study|Pregnancy|1|||
161817549|NCT01410227|584372856|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
161817550|NCT01410227|584372857|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
161817551|NCT01410227|584372858|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
161817552|NCT01410227|584372859|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
161817553|NCT00608322|584372862|FG000|Overall Study|Death|2|||
161817554|NCT00608322|584372863|FG001|Overall Study|Death|1|||
161817555|NCT04002648|584372864|FG000|Overall Study|Lost to Follow-up|2|||
161817556|NCT04002648|584372865|FG001|Overall Study|Lost to Follow-up|0|||
161817557|NCT00606281|584372869|FG000|Overall Study|Adverse Event|11|||
161817558|NCT00606281|584372870|FG001|Overall Study|Adverse Event|12|||
161817559|NCT00606281|584372869|FG000|Overall Study|Death|1|||
161817560|NCT00606281|584372870|FG001|Overall Study|Death|0|||
161817561|NCT00606281|584372869|FG000|Overall Study|Lack of Efficacy|28|||
161817562|NCT00606281|584372870|FG001|Overall Study|Lack of Efficacy|35|||
161817563|NCT00606281|584372869|FG000|Overall Study|Physician Decision|0|||
161817564|NCT00606281|584372870|FG001|Overall Study|Physician Decision|1|||
161817565|NCT00606281|584372869|FG000|Overall Study|Protocol Violation|3|||
161817566|NCT00606281|584372870|FG001|Overall Study|Protocol Violation|3|||
161817567|NCT00606281|584372869|FG000|Overall Study|Withdrawal by Subject|11|||
161817568|NCT00606281|584372870|FG001|Overall Study|Withdrawal by Subject|13|||
161817569|NCT00606281|584372869|FG000|Overall Study|Progression to depressive phase|1|||
161817570|NCT00606281|584372870|FG001|Overall Study|Progression to depressive phase|1|||
161817571|NCT00606281|584372869|FG000|Overall Study|Change of residence or other commitments|1|||
161817572|NCT00606281|584372870|FG001|Overall Study|Change of residence or other commitments|1|||
161817573|NCT00540423|584372872|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161817574|NCT00540423|584372873|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161817575|NCT00540423|584372874|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161817576|NCT00540423|584372872|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
161817577|NCT00540423|584372873|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
161817578|NCT00540423|584372874|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
161817579|NCT03131895|584372875|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
161817580|NCT03131895|584372876|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
161817581|NCT03131895|584372877|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
161817582|NCT03131895|584372878|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
161817583|NCT03131895|584372875|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
161817584|NCT03131895|584372876|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
161817585|NCT03131895|584372877|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
161817586|NCT03131895|584372878|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
161817587|NCT03131895|584372875|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161817588|NCT03131895|584372876|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
161817589|NCT03131895|584372877|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161817590|NCT03131895|584372878|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
161817591|NCT03131895|584372875|FG000|Washout Period (at Least 5 Days)|Other|0|||
161817592|NCT03131895|584372876|FG001|Washout Period (at Least 5 Days)|Other|0|||
161817593|NCT03131895|584372877|FG002|Washout Period (at Least 5 Days)|Other|2|||
161817594|NCT03131895|584372878|FG003|Washout Period (at Least 5 Days)|Other|0|||
161923684|NCT04615507|584766594|FG001|Period 2|Protocol Violation|0|||
161923685|NCT04615507|584766593|FG000|Period 2|Withdrawal by Subject|1|||
161923686|NCT04615507|584766594|FG001|Period 2|Withdrawal by Subject|0|||
161923687|NCT04615507|584766593|FG000|Period 2|Adverse Event|0|||
162179641|NCT02101853|585710977|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
162179642|NCT02101853|585710978|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
162179643|NCT02101853|585710979|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
162179644|NCT02101853|585710980|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
162179645|NCT02101853|585710975|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
162179646|NCT02101853|585710976|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
162179647|NCT02101853|585710977|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
162179648|NCT02101853|585710978|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
162179649|NCT02101853|585710979|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
162179650|NCT02101853|585710980|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
162179651|NCT02112916|585710984|FG000|Overall Study|Adverse Event|6|||
162179652|NCT02112916|585710985|FG001|Overall Study|Adverse Event|9|||
162179653|NCT02112916|585710986|FG002|Overall Study|Adverse Event|3|||
162179654|NCT02112916|585710987|FG003|Overall Study|Adverse Event|2|||
162179655|NCT02112916|585710984|FG000|Overall Study|Death|9|||
162179656|NCT02112916|585710985|FG001|Overall Study|Death|9|||
162179657|NCT02112916|585710986|FG002|Overall Study|Death|3|||
162179658|NCT02112916|585710987|FG003|Overall Study|Death|4|||
162179659|NCT02112916|585710984|FG000|Overall Study|Lost to Follow-up|1|||
162179660|NCT02112916|585710985|FG001|Overall Study|Lost to Follow-up|0|||
162179661|NCT02112916|585710986|FG002|Overall Study|Lost to Follow-up|0|||
162179662|NCT02112916|585710987|FG003|Overall Study|Lost to Follow-up|0|||
162179663|NCT02112916|585710984|FG000|Overall Study|Physician Decision|94|||
162179664|NCT02112916|585710985|FG001|Overall Study|Physician Decision|72|||
162179665|NCT02112916|585710986|FG002|Overall Study|Physician Decision|24|||
161817595|NCT03131895|584372875|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
161817596|NCT03131895|584372876|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
161817597|NCT03131895|584372877|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
161817598|NCT03131895|584372878|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
161817599|NCT03131895|584372875|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
162179666|NCT02112916|585710987|FG003|Overall Study|Physician Decision|15|||
162179667|NCT02112916|585710984|FG000|Overall Study|Withdrawal by Subject|5|||
162179668|NCT02112916|585710985|FG001|Overall Study|Withdrawal by Subject|3|||
161817600|NCT03131895|584372876|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
161817601|NCT03131895|584372877|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
161817602|NCT03131895|584372878|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
161817603|NCT00731939|584372884|FG000|Overall Study|Adverse Event|6|||
161817604|NCT00731939|584372884|FG000|Overall Study|Lost to Follow-up|15|||
161817605|NCT00731939|584372884|FG000|Overall Study|Not implanted with study device|9|||
161817606|NCT00731939|584372884|FG000|Overall Study|Withdrawal by Subject|2|||
161817607|NCT00731939|584372884|FG000|Overall Study|Did not meet enrollment criteria|2|||
161817608|NCT02280863|584372885|FG000|Integrated Platform|Met stopping criteria|0|||
161817609|NCT02280863|584372886|FG001|Integrated Platform|Met stopping criteria|1|||
161817610|NCT02622386|584372887|FG000|First Assignment|Withdrawal by Subject|3|||
161817611|NCT02622386|584372888|FG001|First Assignment|Withdrawal by Subject|2|||
161817612|NCT02622386|584372887|FG000|Washout|Withdrawal by Subject|4|||
161817613|NCT02622386|584372888|FG001|Washout|Withdrawal by Subject|4|||
161817614|NCT02622386|584372887|FG000|Second Assignment|Withdrawal by Subject|0|||
161817615|NCT02622386|584372888|FG001|Second Assignment|Withdrawal by Subject|2|||
161817616|NCT05274763|584372889|FG000|Overall Study|Lost to Follow-up|1|||
161817617|NCT01174186|584372890|FG000|Overall Study|Lost to Follow-up|0|||
161817618|NCT01174186|584372891|FG001|Overall Study|Lost to Follow-up|1|||
161817619|NCT01174186|584372890|FG000|Overall Study|Withdrawal by Subject|0|||
161817620|NCT01174186|584372891|FG001|Overall Study|Withdrawal by Subject|2|||
161817621|NCT00918684|584372892|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
161817622|NCT00918684|584372892|FG000|Treatment Phase|Lack of Efficacy|6|||
161817623|NCT00918684|584372892|FG000|Treatment Phase|Lost to Follow-up|2|||
162018734|NCT03436082|585123194|FG001|Overall Study|Did not undergo procedure|0|||
162018735|NCT01864603|585123201|FG000|Stage 2|DSMB design modification|86056|||
162179669|NCT02112916|585710986|FG002|Overall Study|Withdrawal by Subject|1|||
162179670|NCT02112916|585710987|FG003|Overall Study|Withdrawal by Subject|1|||
162179671|NCT02112916|585710984|FG000|Overall Study|Ineligible|4|||
162179672|NCT02112916|585710985|FG001|Overall Study|Ineligible|8|||
162179673|NCT02112916|585710986|FG002|Overall Study|Ineligible|3|||
162179674|NCT02112916|585710987|FG003|Overall Study|Ineligible|8|||
162179675|NCT02112916|585710984|FG000|Overall Study|Inevaluable|6|||
162179676|NCT02112916|585710985|FG001|Overall Study|Inevaluable|4|||
162179677|NCT02112916|585710986|FG002|Overall Study|Inevaluable|5|||
162179678|NCT02112916|585710987|FG003|Overall Study|Inevaluable|5|||
162179679|NCT02112916|585710984|FG000|Overall Study|Refusal of further protocol therapy|19|||
162179680|NCT02112916|585710985|FG001|Overall Study|Refusal of further protocol therapy|16|||
161817624|NCT00918684|584372892|FG000|Treatment Phase|Physician Decision|8|||
161817625|NCT00918684|584372892|FG000|Treatment Phase|Protocol Violation|1|||
161817626|NCT00918684|584372892|FG000|Treatment Phase|Withdrawal by Subject|8|||
161817627|NCT00402103|584372893|FG000|Overall Study|Adverse Event|60|||
161671655|NCT02279862|583851354|FG001|Overall Study|Administrative reason by sponsor|1|||
161671656|NCT02279862|583851353|FG000|Overall Study|Disease progression|5|||
161671657|NCT02279862|583851354|FG001|Overall Study|Disease progression|2|||
161671658|NCT02279862|583851353|FG000|Overall Study|Study closed by sponsor|16|||
161671659|NCT02279862|583851354|FG001|Overall Study|Study closed by sponsor|13|||
162179681|NCT02112916|585710986|FG002|Overall Study|Refusal of further protocol therapy|1|||
162179682|NCT02112916|585710987|FG003|Overall Study|Refusal of further protocol therapy|7|||
162179683|NCT02112916|585710984|FG000|Overall Study|Development of SMN|1|||
162179684|NCT02112916|585710985|FG001|Overall Study|Development of SMN|0|||
162179685|NCT02112916|585710986|FG002|Overall Study|Development of SMN|0|||
162179686|NCT02112916|585710987|FG003|Overall Study|Development of SMN|1|||
161671660|NCT02279862|583851353|FG000|Overall Study|Other|1|||
162179687|NCT02112916|585710984|FG000|Overall Study|Relapse/Progression|10|||
162179688|NCT02112916|585710985|FG001|Overall Study|Relapse/Progression|18|||
162179689|NCT02112916|585710986|FG002|Overall Study|Relapse/Progression|15|||
162179690|NCT02112916|585710987|FG003|Overall Study|Relapse/Progression|2|||
162179691|NCT02112916|585710984|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
162179692|NCT02112916|585710985|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
162179693|NCT02112916|585710986|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
162179694|NCT02112916|585710987|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
162179695|NCT02112916|585710984|FG000|Overall Study|Still on Therapy|44|||
161671661|NCT02279862|583851354|FG001|Overall Study|Other|2|||
161671662|NCT02279862|583851353|FG000|Overall Study|Withdrawal by Subject|1|||
161671663|NCT02279862|583851354|FG001|Overall Study|Withdrawal by Subject|0|||
161671664|NCT04226833|583851357|FG000|Overall Study|Death|0|||
161671665|NCT04226833|583851358|FG001|Overall Study|Death|0|||
161671666|NCT04226833|583851359|FG002|Overall Study|Death|1|||
161671667|NCT04226833|583851360|FG003|Overall Study|Death|0|||
161671668|NCT00403754|583851363|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
161671669|NCT00403754|583851364|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
161671670|NCT00403754|583851365|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
161671671|NCT00403754|583851366|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
161671672|NCT00403754|583851363|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
161671673|NCT00403754|583851364|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
161671674|NCT00403754|583851365|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
161671675|NCT00403754|583851366|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
161817628|NCT00402103|584372894|FG001|Overall Study|Adverse Event|7|||
161817629|NCT00402103|584372893|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161817630|NCT00402103|584372894|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161817631|NCT00402103|584372893|FG000|Overall Study|Condition no longer requires study drug|2|||
161817632|NCT00402103|584372894|FG001|Overall Study|Condition no longer requires study drug|0|||
161817633|NCT00402103|584372893|FG000|Overall Study|Protocol Deviation|8|||
161817634|NCT00402103|584372894|FG001|Overall Study|Protocol Deviation|0|||
161817635|NCT00402103|584372893|FG000|Overall Study|Patient withdrew consent|12|||
161817636|NCT00402103|584372894|FG001|Overall Study|Patient withdrew consent|1|||
161817637|NCT00402103|584372893|FG000|Overall Study|Lost to Follow-up|6|||
161817638|NCT00402103|584372894|FG001|Overall Study|Lost to Follow-up|3|||
161817639|NCT00402103|584372893|FG000|Overall Study|Administrative problems|2|||
161817640|NCT00402103|584372894|FG001|Overall Study|Administrative problems|0|||
161817641|NCT00484679|584372895|FG000|Overall Study|Withdrawal by Subject|3|||
161817642|NCT00418145|584372898|FG000|Overall Study|study terminated|6|||
162179696|NCT02112916|585710985|FG001|Overall Study|Still on Therapy|47|||
162179697|NCT02112916|585710986|FG002|Overall Study|Still on Therapy|3|||
161817643|NCT00472212|584372899|FG000|Overall Study|Lost to Follow-up|6|||
162018736|NCT01864603|585123202|FG001|Stage 2|DSMB design modification|92558|||
161671676|NCT04343248|583851367|FG000|Overall Study|Withdrawal by Subject|5|||
161817644|NCT00472212|584372900|FG001|Overall Study|Lost to Follow-up|4|||
161671677|NCT04343248|583851368|FG001|Overall Study|Withdrawal by Subject|6|||
161817645|NCT00425308|584372901|FG000|Overall Study|Adverse Event|2|||
161671678|NCT04343248|583851367|FG000|Overall Study|Death|1|||
161671679|NCT04343248|583851368|FG001|Overall Study|Death|2|||
161671680|NCT04343248|583851367|FG000|Overall Study|Lost to Follow-up|9|||
161671681|NCT04343248|583851368|FG001|Overall Study|Lost to Follow-up|6|||
161671682|NCT04343248|583851367|FG000|Overall Study|Physician Decision|0|||
161671683|NCT04343248|583851368|FG001|Overall Study|Physician Decision|1|||
161923688|NCT04615507|584766594|FG001|Period 2|Adverse Event|1|||
161923689|NCT04615507|584766593|FG000|Period 3|Covid-19 exposure|0|||
161923690|NCT04615507|584766594|FG001|Period 3|Covid-19 exposure|1|||
161923691|NCT03407482|584766595|FG000|Overall Study|Adverse Event|12|||
161923692|NCT03407482|584766595|FG000|Overall Study|Disease Relapse|1|||
161923693|NCT03407482|584766595|FG000|Overall Study|Lost to Follow-up|1|||
161923694|NCT03407482|584766595|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161923695|NCT03407482|584766595|FG000|Overall Study|Pregnancy|2|||
161923696|NCT03407482|584766595|FG000|Overall Study|Protocol Violation|1|||
161923697|NCT03407482|584766595|FG000|Overall Study|Study Terminated By Sponsor|106|||
161923698|NCT03407482|584766595|FG000|Overall Study|Withdrawal by Subject|6|||
161923699|NCT03407482|584766595|FG000|Overall Study|Data Entry Error|1|||
161923700|NCT05887401|584766599|FG000|Overall Study|Withdrawal by Subject|0|||
161923701|NCT05887401|584766600|FG001|Overall Study|Withdrawal by Subject|0|||
161923702|NCT05887401|584766601|FG002|Overall Study|Withdrawal by Subject|0|||
161923703|NCT05887401|584766602|FG003|Overall Study|Withdrawal by Subject|0|||
161923704|NCT05887401|584766603|FG004|Overall Study|Withdrawal by Subject|0|||
161923705|NCT05887401|584766604|FG005|Overall Study|Withdrawal by Subject|0|||
161923706|NCT05887401|584766605|FG006|Overall Study|Withdrawal by Subject|0|||
161923707|NCT05887401|584766606|FG007|Overall Study|Withdrawal by Subject|0|||
161923708|NCT05887401|584766607|FG008|Overall Study|Withdrawal by Subject|0|||
161923709|NCT05887401|584766608|FG009|Overall Study|Withdrawal by Subject|1|||
161923710|NCT05887401|584766609|FG010|Overall Study|Withdrawal by Subject|0|||
161923711|NCT05887401|584766610|FG011|Overall Study|Withdrawal by Subject|0|||
161923712|NCT05887401|584766611|FG012|Overall Study|Withdrawal by Subject|0|||
161923713|NCT05887401|584766612|FG013|Overall Study|Withdrawal by Subject|0|||
161923714|NCT05887401|584766613|FG014|Overall Study|Withdrawal by Subject|0|||
161923715|NCT05887401|584766614|FG015|Overall Study|Withdrawal by Subject|1|||
161923716|NCT05887401|584766599|FG000|Overall Study|Lost to Follow-up|0|||
161923717|NCT05887401|584766600|FG001|Overall Study|Lost to Follow-up|1|||
161923718|NCT05887401|584766601|FG002|Overall Study|Lost to Follow-up|1|||
161923719|NCT05887401|584766602|FG003|Overall Study|Lost to Follow-up|2|||
161923720|NCT05887401|584766603|FG004|Overall Study|Lost to Follow-up|0|||
161923721|NCT05887401|584766604|FG005|Overall Study|Lost to Follow-up|0|||
161923722|NCT05887401|584766605|FG006|Overall Study|Lost to Follow-up|0|||
161923723|NCT05887401|584766606|FG007|Overall Study|Lost to Follow-up|0|||
161923724|NCT05887401|584766607|FG008|Overall Study|Lost to Follow-up|1|||
161923725|NCT05887401|584766608|FG009|Overall Study|Lost to Follow-up|1|||
161923726|NCT05887401|584766609|FG010|Overall Study|Lost to Follow-up|2|||
161923727|NCT05887401|584766610|FG011|Overall Study|Lost to Follow-up|1|||
161923728|NCT05887401|584766611|FG012|Overall Study|Lost to Follow-up|0|||
161923729|NCT05887401|584766612|FG013|Overall Study|Lost to Follow-up|0|||
161923730|NCT05887401|584766613|FG014|Overall Study|Lost to Follow-up|0|||
161923731|NCT05887401|584766614|FG015|Overall Study|Lost to Follow-up|0|||
161923732|NCT03010501|584766618|FG000|Study Week 1|Withdrawal by Subject|2|||
161923733|NCT03010501|584766619|FG001|Study Week 1|Withdrawal by Subject|1|||
161923734|NCT03010501|584766620|FG002|Study Week 1|Withdrawal by Subject|0|||
161923735|NCT03010501|584766621|FG003|Study Week 1|Withdrawal by Subject|2|||
161923736|NCT03010501|584766622|FG004|Study Week 1|Withdrawal by Subject|0|||
161923737|NCT03010501|584766623|FG005|Study Week 1|Withdrawal by Subject|0|||
161923738|NCT03010501|584766618|FG000|Study Week 3|Withdrawal by Subject|0|||
161923739|NCT03010501|584766619|FG001|Study Week 3|Withdrawal by Subject|0|||
161923740|NCT03010501|584766620|FG002|Study Week 3|Withdrawal by Subject|0|||
161923741|NCT03010501|584766621|FG003|Study Week 3|Withdrawal by Subject|1|||
161923742|NCT03010501|584766622|FG004|Study Week 3|Withdrawal by Subject|0|||
161923743|NCT03010501|584766623|FG005|Study Week 3|Withdrawal by Subject|0|||
161923744|NCT02347787|584766626|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
161923745|NCT02347787|584766627|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
161923746|NCT02347787|584766626|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
161923747|NCT02347787|584766627|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
161923748|NCT02347787|584766626|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
161923749|NCT02347787|584766627|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
161923750|NCT02347787|584766626|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
161923751|NCT02347787|584766627|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
162018737|NCT02423902|585123204|FG000|Overall Study|Disease progression|1|||
161671684|NCT04343248|583851367|FG000|Overall Study|Adverse Event|1|||
161671685|NCT04343248|583851368|FG001|Overall Study|Adverse Event|0|||
161923752|NCT02369458|584766630|FG000|Overall Study|Determined to be not eligible|1|||
161923753|NCT02369458|584766631|FG001|Overall Study|Determined to be not eligible|0|||
161923754|NCT03853798|584766632|FG000|Overall Study|Death|0|||
161923755|NCT03853798|584766633|FG001|Overall Study|Death|0|||
161923756|NCT03853798|584766634|FG002|Overall Study|Death|0|||
162179698|NCT02112916|585710987|FG003|Overall Study|Still on Therapy|2|||
162179699|NCT02112916|585710984|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
162179700|NCT02112916|585710985|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
162179701|NCT02112916|585710986|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
162179702|NCT02112916|585710987|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
162179703|NCT02112916|585710984|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
162179704|NCT02112916|585710985|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
162179705|NCT02112916|585710986|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
162179706|NCT02112916|585710987|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
162179707|NCT03333915|585710989|FG000|Overall Study|Lost to Follow-up|0|||
162179708|NCT03333915|585710990|FG001|Overall Study|Lost to Follow-up|0|||
162179709|NCT03333915|585710991|FG002|Overall Study|Lost to Follow-up|1|||
162179710|NCT03333915|585710992|FG003|Overall Study|Lost to Follow-up|0|||
162179711|NCT03333915|585710993|FG004|Overall Study|Lost to Follow-up|0|||
162179712|NCT03333915|585710989|FG000|Overall Study|Disease Progression|0|||
162179713|NCT03333915|585710990|FG001|Overall Study|Disease Progression|1|||
162179714|NCT03333915|585710991|FG002|Overall Study|Disease Progression|0|||
162179715|NCT03333915|585710992|FG003|Overall Study|Disease Progression|0|||
162179716|NCT03333915|585710993|FG004|Overall Study|Disease Progression|0|||
162179717|NCT03333915|585710989|FG000|Overall Study|Death|0|||
162179718|NCT03333915|585710990|FG001|Overall Study|Death|0|||
162179719|NCT03333915|585710991|FG002|Overall Study|Death|0|||
162179720|NCT03333915|585710992|FG003|Overall Study|Death|37|||
162179721|NCT03333915|585710993|FG004|Overall Study|Death|18|||
162179722|NCT03333915|585710989|FG000|Overall Study|Sponsor's Decision|0|||
162179723|NCT03333915|585710990|FG001|Overall Study|Sponsor's Decision|0|||
162179724|NCT03333915|585710991|FG002|Overall Study|Sponsor's Decision|0|||
162179725|NCT03333915|585710992|FG003|Overall Study|Sponsor's Decision|48|||
162179726|NCT03333915|585710993|FG004|Overall Study|Sponsor's Decision|4|||
162179727|NCT03333915|585710989|FG000|Overall Study|Withdrawal by Subject|0|||
162179728|NCT03333915|585710990|FG001|Overall Study|Withdrawal by Subject|0|||
162179729|NCT03333915|585710991|FG002|Overall Study|Withdrawal by Subject|0|||
162179730|NCT03333915|585710992|FG003|Overall Study|Withdrawal by Subject|5|||
162179731|NCT03333915|585710993|FG004|Overall Study|Withdrawal by Subject|1|||
162179732|NCT02206828|585710994|FG000|Overall Study|Lost to Follow-up|7|||
162179733|NCT05039021|585711707|FG000|Overall Study|Death|1|||
162179734|NCT05039021|585711707|FG000|Overall Study|Lost to Follow-up|3|||
162179735|NCT00994643|585711708|FG000|Overall Study|Withdrawal by Subject|1|||
162179736|NCT02566889|585711709|FG000|Overall Study|Withdrawal by Subject|3|||
162179737|NCT02566889|585711710|FG001|Overall Study|Withdrawal by Subject|1|||
162179738|NCT02566889|585711709|FG000|Overall Study|Adverse Event|4|||
162179739|NCT02566889|585711710|FG001|Overall Study|Adverse Event|2|||
162179740|NCT02566889|585711709|FG000|Overall Study|Other|6|||
162179741|NCT02566889|585711710|FG001|Overall Study|Other|2|||
162179742|NCT03391466|585711712|FG000|Overall Study|Death|84|||
162179743|NCT03391466|585711713|FG001|Overall Study|Death|91|||
162179744|NCT03391466|585711712|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
162179745|NCT03391466|585711713|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
162179746|NCT03391466|585711712|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
162179747|NCT03391466|585711713|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
162179748|NCT03391466|585711712|FG000|Overall Study|Lost to Follow-up|9|||
162179749|NCT03391466|585711713|FG001|Overall Study|Lost to Follow-up|5|||
162179750|NCT03391466|585711712|FG000|Overall Study|Reason Not Specified|2|||
162179751|NCT03391466|585711713|FG001|Overall Study|Reason Not Specified|2|||
162179752|NCT03391466|585711712|FG000|Overall Study|Investigator Decision|0|||
162179753|NCT03391466|585711713|FG001|Overall Study|Investigator Decision|1|||
162179754|NCT03140670|585711714|FG000|Overall Study|Withdrawal by Subject|2|||
162179755|NCT03140670|585711714|FG000|Overall Study|Lost to Follow-up|1|||
162179756|NCT03140670|585711714|FG000|Overall Study|Physician Decision|1|||
162179757|NCT00220805|585711715|FG000|Overall Study|Adverse Event|1|||
162179758|NCT00220805|585711716|FG001|Overall Study|Adverse Event|3|||
162179759|NCT00220805|585711715|FG000|Overall Study|Withdrawal by Subject|3|||
162179760|NCT00220805|585711716|FG001|Overall Study|Withdrawal by Subject|0|||
162179761|NCT00220805|585711715|FG000|Overall Study|Lack of Efficacy|1|||
162179762|NCT00220805|585711716|FG001|Overall Study|Lack of Efficacy|0|||
162179763|NCT00220805|585711715|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
162179764|NCT00220805|585711716|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
162179765|NCT02325466|585711717|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
162179766|NCT02325466|585711718|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
162179767|NCT02325466|585711719|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
162179768|NCT02325466|585711717|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
162179769|NCT02325466|585711718|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
162179770|NCT02325466|585711719|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
162179771|NCT02325466|585711717|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
162179772|NCT02325466|585711718|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
162179773|NCT02325466|585711719|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
162179774|NCT02325466|585711717|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
162179775|NCT02325466|585711718|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
162179776|NCT02325466|585711719|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
162179777|NCT02325466|585711717|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
162179778|NCT02325466|585711718|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
162179779|NCT02325466|585711719|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
162179780|NCT02325466|585711717|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
162179781|NCT02325466|585711718|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
162179782|NCT02325466|585711719|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
162179783|NCT02325466|585711717|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
162179784|NCT02325466|585711718|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
162179785|NCT02325466|585711719|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
162179786|NCT02325466|585711717|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
162179787|NCT02325466|585711718|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
162179788|NCT02325466|585711719|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
162179789|NCT02325466|585711717|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
162179790|NCT02325466|585711718|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
162179791|NCT02325466|585711719|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
162179792|NCT04121546|585711740|FG000|Overall Study|Lost to Follow-up|1|||
162179793|NCT04121546|585711741|FG001|Overall Study|Lost to Follow-up|3|||
162179794|NCT04129164|585711742|FG000|Overall Study|Non-compliance with procedures|0|||
162179795|NCT04129164|585711743|FG001|Overall Study|Non-compliance with procedures|0|||
162179796|NCT04129164|585711744|FG002|Overall Study|Non-compliance with procedures|2|||
162179797|NCT04129164|585711745|FG003|Overall Study|Non-compliance with procedures|0|||
162179798|NCT04129164|585711742|FG000|Overall Study|Adverse Event|0|||
162179799|NCT04129164|585711743|FG001|Overall Study|Adverse Event|0|||
162179800|NCT04129164|585711744|FG002|Overall Study|Adverse Event|2|||
162179801|NCT04129164|585711745|FG003|Overall Study|Adverse Event|0|||
162179802|NCT04129164|585711742|FG000|Overall Study|Pregnancy|0|||
162179803|NCT04129164|585711743|FG001|Overall Study|Pregnancy|0|||
162179804|NCT04129164|585711744|FG002|Overall Study|Pregnancy|0|||
162179805|NCT04129164|585711745|FG003|Overall Study|Pregnancy|1|||
162179806|NCT04129164|585711742|FG000|Overall Study|Withdrawal by Subject|3|||
162179807|NCT04129164|585711743|FG001|Overall Study|Withdrawal by Subject|2|||
162179808|NCT04129164|585711744|FG002|Overall Study|Withdrawal by Subject|4|||
162179809|NCT04129164|585711745|FG003|Overall Study|Withdrawal by Subject|6|||
162179810|NCT04129164|585711742|FG000|Overall Study|Death|0|||
162179811|NCT04129164|585711743|FG001|Overall Study|Death|1|||
162179812|NCT04129164|585711744|FG002|Overall Study|Death|0|||
161671686|NCT03951220|583851373|FG000|Overall Study|Withdrawal by Subject|9|||
161923757|NCT03853798|584766635|FG003|Overall Study|Death|0|||
161923758|NCT03853798|584766636|FG004|Overall Study|Death|0|||
161923759|NCT03853798|584766637|FG005|Overall Study|Death|1|||
161923760|NCT03853798|584766638|FG006|Overall Study|Death|0|||
161923761|NCT03853798|584766639|FG007|Overall Study|Death|0|||
162179813|NCT04129164|585711745|FG003|Overall Study|Death|0|||
162179814|NCT04129164|585711742|FG000|Overall Study|Lost to Follow-up|0|||
162179815|NCT04129164|585711743|FG001|Overall Study|Lost to Follow-up|1|||
162179816|NCT04129164|585711744|FG002|Overall Study|Lost to Follow-up|0|||
162179817|NCT04129164|585711745|FG003|Overall Study|Lost to Follow-up|0|||
161671687|NCT03951220|583851374|FG001|Overall Study|Withdrawal by Subject|2|||
161671688|NCT03951220|583851375|FG002|Overall Study|Withdrawal by Subject|0|||
161923762|NCT03853798|584766640|FG008|Overall Study|Death|0|||
161923763|NCT03853798|584766632|FG000|Overall Study|Adverse Event|0|||
161923764|NCT03853798|584766633|FG001|Overall Study|Adverse Event|0|||
162179818|NCT03653364|585711746|FG000|Overall Study|Withdrawal by Subject|1|||
162179819|NCT03653364|585711746|FG000|Overall Study|Enrolled in Error|1|||
162179820|NCT03653364|585711746|FG000|Overall Study|Death|1|||
162179821|NCT01260896|585711749|FG000|First Intervention|Withdrawn Due to Emesis|2|||
162179822|NCT01260896|585711750|FG001|First Intervention|Withdrawn Due to Emesis|0|||
162179823|NCT02754596|585711764|FG000|Overall Study|Withdrawal by Subject|3|||
162179824|NCT02754596|585711765|FG001|Overall Study|Withdrawal by Subject|4|||
162179825|NCT02754596|585711766|FG002|Overall Study|Withdrawal by Subject|0|||
162179826|NCT02754596|585711764|FG000|Overall Study|Physician Decision|1|||
162179827|NCT02754596|585711765|FG001|Overall Study|Physician Decision|1|||
162179828|NCT02754596|585711766|FG002|Overall Study|Physician Decision|1|||
162179829|NCT02754596|585711764|FG000|Overall Study|Lost to Follow-up|1|||
162179830|NCT02754596|585711765|FG001|Overall Study|Lost to Follow-up|1|||
162179831|NCT02754596|585711766|FG002|Overall Study|Lost to Follow-up|2|||
162179832|NCT02754596|585711764|FG000|Overall Study|Death|0|||
162179833|NCT02754596|585711765|FG001|Overall Study|Death|2|||
162179834|NCT02754596|585711766|FG002|Overall Study|Death|0|||
162179835|NCT02754596|585711764|FG000|Overall Study|Adverse Event|1|||
162179836|NCT02754596|585711765|FG001|Overall Study|Adverse Event|0|||
162179837|NCT02754596|585711766|FG002|Overall Study|Adverse Event|1|||
162179838|NCT02754596|585711764|FG000|Overall Study|Other|1|||
162179839|NCT02754596|585711765|FG001|Overall Study|Other|0|||
162179840|NCT02754596|585711766|FG002|Overall Study|Other|0|||
162179841|NCT03782116|585711784|FG000|Completed Intervetion|Lost to Follow-up|11|||
162179842|NCT03782116|585711785|FG001|Completed Intervetion|Lost to Follow-up|7|||
162179843|NCT03782116|585711784|FG000|Completed Intervetion|Withdrawal by Subject|6|||
162179844|NCT03782116|585711785|FG001|Completed Intervetion|Withdrawal by Subject|5|||
162179845|NCT03782116|585711784|FG000|Included in Analysis|Protocol Violation|5|||
162179846|NCT03782116|585711785|FG001|Included in Analysis|Protocol Violation|5|||
162179847|NCT04908514|585711786|FG000|Overall Study|Lost to Follow-up|2|||
162179848|NCT04908514|585711786|FG000|Overall Study|Withdrawal by Subject|1|||
162179849|NCT02890355|585711787|FG000|Overall Study|Adverse Event|5|||
162179850|NCT02890355|585711788|FG001|Overall Study|Adverse Event|5|||
162179851|NCT02890355|585711787|FG000|Overall Study|Refusal unrelated to adverse event|5|||
162179852|NCT02890355|585711788|FG001|Overall Study|Refusal unrelated to adverse event|10|||
162179853|NCT02890355|585711787|FG000|Overall Study|Progression/relapse|46|||
162179854|NCT02890355|585711788|FG001|Overall Study|Progression/relapse|39|||
162179855|NCT02890355|585711787|FG000|Overall Study|Not protocol specified|3|||
162179856|NCT02890355|585711788|FG001|Overall Study|Not protocol specified|4|||
162179857|NCT01964300|585712391|FG000|Overall Study|Ineligible after enrollment|0|||
162179858|NCT01964300|585712392|FG001|Overall Study|Ineligible after enrollment|1|||
162179859|NCT01964300|585712391|FG000|Overall Study|Adverse Event|1|||
162179860|NCT01964300|585712392|FG001|Overall Study|Adverse Event|1|||
161817646|NCT00425308|584372902|FG001|Overall Study|Adverse Event|1|||
161817647|NCT00425308|584372901|FG000|Overall Study|Withdrawal by Subject|1|||
161817648|NCT00425308|584372902|FG001|Overall Study|Withdrawal by Subject|0|||
161817649|NCT00425308|584372901|FG000|Overall Study|Death|1|||
161817650|NCT00425308|584372902|FG001|Overall Study|Death|0|||
161817651|NCT01075282|584372903|FG000|Overall Study|Withdrawal by Subject|11|||
161817652|NCT01075282|584372904|FG001|Overall Study|Withdrawal by Subject|7|||
161817653|NCT01075282|584372905|FG002|Overall Study|Withdrawal by Subject|11|||
161817654|NCT01075282|584372903|FG000|Overall Study|Adverse Event|9|||
161817655|NCT01075282|584372904|FG001|Overall Study|Adverse Event|8|||
161817656|NCT01075282|584372905|FG002|Overall Study|Adverse Event|5|||
161817657|NCT01075282|584372903|FG000|Overall Study|Entry Criteria Not Met|3|||
161817658|NCT01075282|584372904|FG001|Overall Study|Entry Criteria Not Met|2|||
161817659|NCT01075282|584372905|FG002|Overall Study|Entry Criteria Not Met|0|||
161817660|NCT01075282|584372903|FG000|Overall Study|Lost to Follow-up|3|||
161817661|NCT01075282|584372904|FG001|Overall Study|Lost to Follow-up|3|||
161817662|NCT01075282|584372905|FG002|Overall Study|Lost to Follow-up|3|||
161817663|NCT01075282|584372903|FG000|Overall Study|Physician Decision|3|||
161817664|NCT01075282|584372904|FG001|Overall Study|Physician Decision|3|||
161817665|NCT01075282|584372905|FG002|Overall Study|Physician Decision|3|||
161817666|NCT01075282|584372903|FG000|Overall Study|Lack of Efficacy|1|||
161817667|NCT01075282|584372904|FG001|Overall Study|Lack of Efficacy|1|||
162179861|NCT01964300|585712391|FG000|Overall Study|Lack of Efficacy|3|||
162179862|NCT01964300|585712392|FG001|Overall Study|Lack of Efficacy|5|||
162179863|NCT01964300|585712391|FG000|Overall Study|Withdrawal by Subject|0|||
162179864|NCT01964300|585712392|FG001|Overall Study|Withdrawal by Subject|1|||
162179865|NCT01964300|585712391|FG000|Overall Study|To receive alternative therapy|1|||
162179866|NCT01964300|585712392|FG001|Overall Study|To receive alternative therapy|2|||
162179867|NCT01964300|585712391|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
161923765|NCT03853798|584766634|FG002|Overall Study|Adverse Event|2|||
161923766|NCT03853798|584766635|FG003|Overall Study|Adverse Event|0|||
162179868|NCT01964300|585712392|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
162179869|NCT01964300|585712391|FG000|Overall Study|Weight criteria not met|0|||
161817668|NCT01075282|584372905|FG002|Overall Study|Lack of Efficacy|0|||
162179870|NCT01964300|585712392|FG001|Overall Study|Weight criteria not met|1|||
162179871|NCT02285270|585712393|FG000|Overall Study|Lost to Follow-up|1|||
162179872|NCT02285270|585712393|FG000|Overall Study|Physician Decision|3|||
162179873|NCT02285270|585712393|FG000|Overall Study|Determined to be ineligible|1|||
162179874|NCT03286114|585712394|FG000|Overall Study|Adverse Event|6|||
162179875|NCT03286114|585712394|FG000|Overall Study|Death|3|||
162179876|NCT00943917|585712398|FG000|Stage I|Adverse Event|1|||
162179877|NCT00943917|585712399|FG001|Stage I|Adverse Event|2|||
162179878|NCT00943917|585712400|FG002|Stage I|Adverse Event|2|||
162179879|NCT00943917|585712401|FG003|Stage I|Adverse Event|0|||
162179880|NCT00943917|585712402|FG004|Stage I|Adverse Event|0|||
162179881|NCT00943917|585712403|FG005|Stage I|Adverse Event|0|||
162179882|NCT00943917|585712404|FG006|Stage I|Adverse Event|0|||
162179883|NCT00943917|585712405|FG007|Stage I|Adverse Event|0|||
162179884|NCT00943917|585712406|FG008|Stage I|Adverse Event|0|||
162179885|NCT00943917|585712407|FG009|Stage I|Adverse Event|0|||
162179886|NCT00943917|585712408|FG010|Stage I|Adverse Event|0|||
162179887|NCT00943917|585712409|FG011|Stage I|Adverse Event|0|||
162179888|NCT00943917|585712410|FG012|Stage I|Adverse Event|0|||
162179889|NCT00943917|585712411|FG013|Stage I|Adverse Event|0|||
162179890|NCT00943917|585712412|FG014|Stage I|Adverse Event|0|||
162179891|NCT00943917|585712398|FG000|Stage I|Lost to Follow-up|0|||
162179892|NCT00943917|585712399|FG001|Stage I|Lost to Follow-up|0|||
162179893|NCT00943917|585712400|FG002|Stage I|Lost to Follow-up|1|||
162179894|NCT00943917|585712401|FG003|Stage I|Lost to Follow-up|0|||
162179895|NCT00943917|585712402|FG004|Stage I|Lost to Follow-up|0|||
162179896|NCT00943917|585712403|FG005|Stage I|Lost to Follow-up|0|||
162179897|NCT00943917|585712404|FG006|Stage I|Lost to Follow-up|0|||
162179898|NCT00943917|585712405|FG007|Stage I|Lost to Follow-up|0|||
162179899|NCT00943917|585712406|FG008|Stage I|Lost to Follow-up|0|||
162179900|NCT00943917|585712407|FG009|Stage I|Lost to Follow-up|0|||
162179901|NCT00943917|585712408|FG010|Stage I|Lost to Follow-up|0|||
162179902|NCT00943917|585712409|FG011|Stage I|Lost to Follow-up|0|||
162179903|NCT00943917|585712410|FG012|Stage I|Lost to Follow-up|0|||
162179904|NCT00943917|585712411|FG013|Stage I|Lost to Follow-up|0|||
162179905|NCT00943917|585712412|FG014|Stage I|Lost to Follow-up|0|||
162179906|NCT00943917|585712398|FG000|Stage I|hyperglycemia|0|||
162179907|NCT00943917|585712399|FG001|Stage I|hyperglycemia|0|||
162179908|NCT00943917|585712400|FG002|Stage I|hyperglycemia|1|||
162179909|NCT00943917|585712401|FG003|Stage I|hyperglycemia|0|||
162179910|NCT00943917|585712402|FG004|Stage I|hyperglycemia|0|||
161817669|NCT01075282|584372903|FG000|Overall Study|Treatment Non-compliance|1|||
161817670|NCT01075282|584372904|FG001|Overall Study|Treatment Non-compliance|2|||
161817671|NCT01075282|584372905|FG002|Overall Study|Treatment Non-compliance|2|||
161817672|NCT01075282|584372903|FG000|Overall Study|Protocol Violation|0|||
161817673|NCT01075282|584372904|FG001|Overall Study|Protocol Violation|2|||
161817674|NCT01075282|584372905|FG002|Overall Study|Protocol Violation|1|||
161817675|NCT01075282|584372903|FG000|Overall Study|Death|0|||
161817676|NCT01075282|584372904|FG001|Overall Study|Death|1|||
161817677|NCT01075282|584372905|FG002|Overall Study|Death|2|||
161817678|NCT00367133|584372906|FG000|2 Years|Death|20|||
161817679|NCT00367133|584372907|FG001|2 Years|Death|12|||
161817680|NCT00367133|584372908|FG002|2 Years|Death|12|||
161817681|NCT00367133|584372906|FG000|2 Years|Dropped|34|||
161817682|NCT00367133|584372907|FG001|2 Years|Dropped|19|||
161817683|NCT00367133|584372908|FG002|2 Years|Dropped|33|||
161817684|NCT00367133|584372906|FG000|2 Years|Missed visit|4|||
161817685|NCT00367133|584372907|FG001|2 Years|Missed visit|5|||
161817686|NCT00367133|584372908|FG002|2 Years|Missed visit|4|||
161817687|NCT00847535|584372909|FG000|Overall Study|Withdrawal by Subject|2|||
161817688|NCT00847535|584372910|FG001|Overall Study|Withdrawal by Subject|1|||
161817689|NCT00847535|584372911|FG002|Overall Study|Withdrawal by Subject|1|||
161817690|NCT00847535|584372909|FG000|Overall Study|Lost to Follow-up|0|||
161817691|NCT00847535|584372910|FG001|Overall Study|Lost to Follow-up|1|||
161817692|NCT00847535|584372911|FG002|Overall Study|Lost to Follow-up|0|||
161817693|NCT01252953|584372912|FG000|Overall Study|Withdrawal by Subject|16|||
161671689|NCT04484831|583851382|FG000|Overall Study|Withdrawal by Subject|1|||
161671690|NCT04484831|583851383|FG001|Overall Study|Withdrawal by Subject|0|||
161817694|NCT01252953|584372913|FG001|Overall Study|Withdrawal by Subject|17|||
161817695|NCT01252953|584372912|FG000|Overall Study|Lost to Follow-up|22|||
161817696|NCT01252953|584372913|FG001|Overall Study|Lost to Follow-up|21|||
161817697|NCT00906399|584372916|FG000|Year 1|Randomized But Not Treated|0|||
161817698|NCT00906399|584372917|FG001|Year 1|Randomized But Not Treated|1|||
161817699|NCT00906399|584372918|FG002|Year 1|Randomized But Not Treated|3|||
161817700|NCT00906399|584372919|FG003|Year 1|Randomized But Not Treated|0|||
161817701|NCT00906399|584372920|FG004|Year 1|Randomized But Not Treated|0|||
161817702|NCT00906399|584372921|FG005|Year 1|Randomized But Not Treated|0|||
161817703|NCT00906399|584372922|FG006|Year 1|Randomized But Not Treated|0|||
162179911|NCT00943917|585712403|FG005|Stage I|hyperglycemia|0|||
162179912|NCT00943917|585712404|FG006|Stage I|hyperglycemia|0|||
162179913|NCT00943917|585712405|FG007|Stage I|hyperglycemia|0|||
162179914|NCT00943917|585712406|FG008|Stage I|hyperglycemia|0|||
162179915|NCT00943917|585712407|FG009|Stage I|hyperglycemia|0|||
162179916|NCT00943917|585712408|FG010|Stage I|hyperglycemia|0|||
162179917|NCT00943917|585712409|FG011|Stage I|hyperglycemia|0|||
162179918|NCT00943917|585712410|FG012|Stage I|hyperglycemia|0|||
162179919|NCT00943917|585712411|FG013|Stage I|hyperglycemia|0|||
162179920|NCT00943917|585712412|FG014|Stage I|hyperglycemia|0|||
162179921|NCT00943917|585712398|FG000|Stage I|A1C elevation|1|||
162179922|NCT00943917|585712399|FG001|Stage I|A1C elevation|0|||
162179923|NCT00943917|585712400|FG002|Stage I|A1C elevation|0|||
162179924|NCT00943917|585712401|FG003|Stage I|A1C elevation|0|||
162179925|NCT00943917|585712402|FG004|Stage I|A1C elevation|0|||
162179926|NCT00943917|585712403|FG005|Stage I|A1C elevation|0|||
162179927|NCT00943917|585712404|FG006|Stage I|A1C elevation|0|||
162179928|NCT00943917|585712405|FG007|Stage I|A1C elevation|0|||
162179929|NCT00943917|585712406|FG008|Stage I|A1C elevation|0|||
162179930|NCT00943917|585712407|FG009|Stage I|A1C elevation|0|||
162179931|NCT00943917|585712408|FG010|Stage I|A1C elevation|0|||
162179932|NCT00943917|585712409|FG011|Stage I|A1C elevation|0|||
162179933|NCT00943917|585712410|FG012|Stage I|A1C elevation|0|||
161923767|NCT03853798|584766636|FG004|Overall Study|Adverse Event|0|||
161923768|NCT03853798|584766637|FG005|Overall Study|Adverse Event|0|||
161923769|NCT03853798|584766638|FG006|Overall Study|Adverse Event|0|||
161923770|NCT03853798|584766639|FG007|Overall Study|Adverse Event|0|||
161923771|NCT03853798|584766640|FG008|Overall Study|Adverse Event|0|||
161923772|NCT03853798|584766632|FG000|Overall Study|Withdrawal by Subject|0|||
161923773|NCT03853798|584766633|FG001|Overall Study|Withdrawal by Subject|1|||
161923774|NCT03853798|584766634|FG002|Overall Study|Withdrawal by Subject|4|||
161923775|NCT03853798|584766635|FG003|Overall Study|Withdrawal by Subject|0|||
161923776|NCT03853798|584766636|FG004|Overall Study|Withdrawal by Subject|0|||
161923777|NCT03853798|584766637|FG005|Overall Study|Withdrawal by Subject|5|||
161923778|NCT03853798|584766638|FG006|Overall Study|Withdrawal by Subject|0|||
161923779|NCT03853798|584766639|FG007|Overall Study|Withdrawal by Subject|0|||
161923780|NCT03853798|584766640|FG008|Overall Study|Withdrawal by Subject|4|||
161923781|NCT03853798|584766632|FG000|Overall Study|Physician Decision|1|||
161923782|NCT03853798|584766633|FG001|Overall Study|Physician Decision|0|||
161923783|NCT03853798|584766634|FG002|Overall Study|Physician Decision|0|||
161923784|NCT03853798|584766635|FG003|Overall Study|Physician Decision|0|||
161923785|NCT03853798|584766636|FG004|Overall Study|Physician Decision|0|||
161923786|NCT03853798|584766637|FG005|Overall Study|Physician Decision|0|||
161923787|NCT03853798|584766638|FG006|Overall Study|Physician Decision|0|||
161923788|NCT03853798|584766639|FG007|Overall Study|Physician Decision|0|||
161923789|NCT03853798|584766640|FG008|Overall Study|Physician Decision|1|||
161923790|NCT03853798|584766632|FG000|Overall Study|Lack of Efficacy|0|||
161923791|NCT03853798|584766633|FG001|Overall Study|Lack of Efficacy|0|||
161923792|NCT03853798|584766634|FG002|Overall Study|Lack of Efficacy|2|||
161923793|NCT03853798|584766635|FG003|Overall Study|Lack of Efficacy|0|||
161923794|NCT03853798|584766636|FG004|Overall Study|Lack of Efficacy|0|||
161923795|NCT03853798|584766637|FG005|Overall Study|Lack of Efficacy|0|||
161923796|NCT03853798|584766638|FG006|Overall Study|Lack of Efficacy|0|||
161923797|NCT03853798|584766639|FG007|Overall Study|Lack of Efficacy|0|||
161923798|NCT03853798|584766640|FG008|Overall Study|Lack of Efficacy|1|||
161923799|NCT03853798|584766632|FG000|Overall Study|Approved Drug Available for Indication|0|||
161923800|NCT03853798|584766633|FG001|Overall Study|Approved Drug Available for Indication|0|||
161923801|NCT03853798|584766634|FG002|Overall Study|Approved Drug Available for Indication|1|||
161923802|NCT03853798|584766635|FG003|Overall Study|Approved Drug Available for Indication|0|||
161923803|NCT03853798|584766636|FG004|Overall Study|Approved Drug Available for Indication|0|||
161923804|NCT03853798|584766637|FG005|Overall Study|Approved Drug Available for Indication|1|||
161923805|NCT03853798|584766638|FG006|Overall Study|Approved Drug Available for Indication|0|||
161923806|NCT03853798|584766639|FG007|Overall Study|Approved Drug Available for Indication|0|||
161923807|NCT03853798|584766640|FG008|Overall Study|Approved Drug Available for Indication|0|||
161923808|NCT03853798|584766632|FG000|Overall Study|Other un-specified|0|||
161923809|NCT03853798|584766633|FG001|Overall Study|Other un-specified|0|||
162179934|NCT00943917|585712411|FG013|Stage I|A1C elevation|0|||
162179935|NCT00943917|585712412|FG014|Stage I|A1C elevation|0|||
162179936|NCT00943917|585712398|FG000|Stage I|Withdrawal by Subject|2|||
162179937|NCT00943917|585712399|FG001|Stage I|Withdrawal by Subject|1|||
162179938|NCT00943917|585712400|FG002|Stage I|Withdrawal by Subject|2|||
162179939|NCT00943917|585712401|FG003|Stage I|Withdrawal by Subject|0|||
161923810|NCT03853798|584766634|FG002|Overall Study|Other un-specified|2|||
161923811|NCT03853798|584766635|FG003|Overall Study|Other un-specified|0|||
161923812|NCT03853798|584766636|FG004|Overall Study|Other un-specified|0|||
161923813|NCT03853798|584766637|FG005|Overall Study|Other un-specified|1|||
161923814|NCT03853798|584766638|FG006|Overall Study|Other un-specified|0|||
161923815|NCT03853798|584766639|FG007|Overall Study|Other un-specified|0|||
161923816|NCT03853798|584766640|FG008|Overall Study|Other un-specified|0|||
161923817|NCT02743494|584766641|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
161923818|NCT02743494|584766642|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
162179940|NCT00943917|585712402|FG004|Stage I|Withdrawal by Subject|0|||
162179941|NCT00943917|585712403|FG005|Stage I|Withdrawal by Subject|0|||
162179942|NCT00943917|585712404|FG006|Stage I|Withdrawal by Subject|0|||
162179943|NCT00943917|585712405|FG007|Stage I|Withdrawal by Subject|0|||
162179944|NCT00943917|585712406|FG008|Stage I|Withdrawal by Subject|0|||
162179945|NCT00943917|585712407|FG009|Stage I|Withdrawal by Subject|0|||
161923819|NCT02743494|584766641|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
161923820|NCT02743494|584766642|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
161923821|NCT02743494|584766641|FG000|Treatment Period|Disease recurrence|152|||
161923822|NCT02743494|584766642|FG001|Treatment Period|Disease recurrence|115|||
161923823|NCT02743494|584766641|FG000|Treatment Period|Study drug toxicity|56|||
161923824|NCT02743494|584766642|FG001|Treatment Period|Study drug toxicity|8|||
161923825|NCT02743494|584766641|FG000|Treatment Period|Death|1|||
161923826|NCT02743494|584766642|FG001|Treatment Period|Death|1|||
162179946|NCT00943917|585712408|FG010|Stage I|Withdrawal by Subject|0|||
162179947|NCT00943917|585712409|FG011|Stage I|Withdrawal by Subject|0|||
162179948|NCT00943917|585712410|FG012|Stage I|Withdrawal by Subject|0|||
162179949|NCT00943917|585712411|FG013|Stage I|Withdrawal by Subject|0|||
162179950|NCT00943917|585712412|FG014|Stage I|Withdrawal by Subject|0|||
162179951|NCT00943917|585712398|FG000|Stage II|Adverse Event|0|||
162179952|NCT00943917|585712399|FG001|Stage II|Adverse Event|0|||
162179953|NCT00943917|585712400|FG002|Stage II|Adverse Event|0|||
162179954|NCT00943917|585712401|FG003|Stage II|Adverse Event|0|||
162179955|NCT00943917|585712402|FG004|Stage II|Adverse Event|0|||
162179956|NCT00943917|585712403|FG005|Stage II|Adverse Event|1|||
162179957|NCT00943917|585712404|FG006|Stage II|Adverse Event|3|||
162179958|NCT00943917|585712405|FG007|Stage II|Adverse Event|0|||
162179959|NCT00943917|585712406|FG008|Stage II|Adverse Event|1|||
162179960|NCT00943917|585712407|FG009|Stage II|Adverse Event|0|||
162179961|NCT00943917|585712408|FG010|Stage II|Adverse Event|0|||
162179962|NCT00943917|585712409|FG011|Stage II|Adverse Event|0|||
162179963|NCT00943917|585712410|FG012|Stage II|Adverse Event|0|||
162179964|NCT00943917|585712411|FG013|Stage II|Adverse Event|0|||
162179965|NCT00943917|585712412|FG014|Stage II|Adverse Event|0|||
162179966|NCT00943917|585712398|FG000|Stage II|Withdrawal by Subject|0|||
162179967|NCT00943917|585712399|FG001|Stage II|Withdrawal by Subject|0|||
162179968|NCT00943917|585712400|FG002|Stage II|Withdrawal by Subject|0|||
162179969|NCT00943917|585712401|FG003|Stage II|Withdrawal by Subject|0|||
162179970|NCT00943917|585712402|FG004|Stage II|Withdrawal by Subject|0|||
162179971|NCT00943917|585712403|FG005|Stage II|Withdrawal by Subject|1|||
162179972|NCT00943917|585712404|FG006|Stage II|Withdrawal by Subject|0|||
162179973|NCT00943917|585712405|FG007|Stage II|Withdrawal by Subject|0|||
162179974|NCT00943917|585712406|FG008|Stage II|Withdrawal by Subject|0|||
162179975|NCT00943917|585712407|FG009|Stage II|Withdrawal by Subject|0|||
162179976|NCT00943917|585712408|FG010|Stage II|Withdrawal by Subject|0|||
162179977|NCT00943917|585712409|FG011|Stage II|Withdrawal by Subject|0|||
161817704|NCT00906399|584372916|FG000|Year 1|Adverse Event|4|||
161817705|NCT00906399|584372917|FG001|Year 1|Adverse Event|22|||
161817706|NCT00906399|584372918|FG002|Year 1|Adverse Event|24|||
161817707|NCT00906399|584372919|FG003|Year 1|Adverse Event|0|||
161817708|NCT00906399|584372920|FG004|Year 1|Adverse Event|0|||
161817709|NCT00906399|584372921|FG005|Year 1|Adverse Event|0|||
161817710|NCT00906399|584372922|FG006|Year 1|Adverse Event|0|||
161817711|NCT00906399|584372916|FG000|Year 1|Lost to Follow-up|4|||
161817712|NCT00906399|584372917|FG001|Year 1|Lost to Follow-up|4|||
161817713|NCT00906399|584372918|FG002|Year 1|Lost to Follow-up|2|||
161817714|NCT00906399|584372919|FG003|Year 1|Lost to Follow-up|0|||
161817715|NCT00906399|584372920|FG004|Year 1|Lost to Follow-up|0|||
161817716|NCT00906399|584372921|FG005|Year 1|Lost to Follow-up|0|||
161817717|NCT00906399|584372922|FG006|Year 1|Lost to Follow-up|0|||
161817718|NCT00906399|584372916|FG000|Year 1|Withdrawal by Subject|30|||
161817719|NCT00906399|584372917|FG001|Year 1|Withdrawal by Subject|32|||
161817720|NCT00906399|584372918|FG002|Year 1|Withdrawal by Subject|36|||
161817721|NCT00906399|584372919|FG003|Year 1|Withdrawal by Subject|0|||
161817722|NCT00906399|584372920|FG004|Year 1|Withdrawal by Subject|0|||
161817723|NCT00906399|584372921|FG005|Year 1|Withdrawal by Subject|0|||
161817724|NCT00906399|584372922|FG006|Year 1|Withdrawal by Subject|0|||
161817725|NCT00906399|584372916|FG000|Year 1|Physician Decision|0|||
161817726|NCT00906399|584372917|FG001|Year 1|Physician Decision|1|||
161817727|NCT00906399|584372918|FG002|Year 1|Physician Decision|3|||
161817728|NCT00906399|584372919|FG003|Year 1|Physician Decision|0|||
161817729|NCT00906399|584372920|FG004|Year 1|Physician Decision|0|||
162179978|NCT00943917|585712410|FG012|Stage II|Withdrawal by Subject|0|||
162179979|NCT00943917|585712411|FG013|Stage II|Withdrawal by Subject|0|||
162179980|NCT00943917|585712412|FG014|Stage II|Withdrawal by Subject|0|||
162179981|NCT00943917|585712398|FG000|Stage II|Pregnancy|0|||
162179982|NCT00943917|585712399|FG001|Stage II|Pregnancy|0|||
162179983|NCT00943917|585712400|FG002|Stage II|Pregnancy|0|||
162179984|NCT00943917|585712401|FG003|Stage II|Pregnancy|0|||
162179985|NCT00943917|585712402|FG004|Stage II|Pregnancy|0|||
162179986|NCT00943917|585712403|FG005|Stage II|Pregnancy|1|||
162179987|NCT00943917|585712404|FG006|Stage II|Pregnancy|0|||
162179988|NCT00943917|585712405|FG007|Stage II|Pregnancy|0|||
161817730|NCT00906399|584372921|FG005|Year 1|Physician Decision|0|||
161817731|NCT00906399|584372922|FG006|Year 1|Physician Decision|0|||
162179989|NCT00943917|585712406|FG008|Stage II|Pregnancy|0|||
162179990|NCT00943917|585712407|FG009|Stage II|Pregnancy|0|||
162179991|NCT00943917|585712408|FG010|Stage II|Pregnancy|0|||
162179992|NCT00943917|585712409|FG011|Stage II|Pregnancy|0|||
162179993|NCT00943917|585712410|FG012|Stage II|Pregnancy|0|||
162179994|NCT00943917|585712411|FG013|Stage II|Pregnancy|0|||
162179995|NCT00943917|585712412|FG014|Stage II|Pregnancy|0|||
162179996|NCT00943917|585712398|FG000|Stage II Continuation|Adverse Event|0|||
162179997|NCT00943917|585712399|FG001|Stage II Continuation|Adverse Event|0|||
162179998|NCT00943917|585712400|FG002|Stage II Continuation|Adverse Event|0|||
162179999|NCT00943917|585712401|FG003|Stage II Continuation|Adverse Event|0|||
162180000|NCT00943917|585712402|FG004|Stage II Continuation|Adverse Event|0|||
162180001|NCT00943917|585712403|FG005|Stage II Continuation|Adverse Event|0|||
162180002|NCT00943917|585712404|FG006|Stage II Continuation|Adverse Event|0|||
162180003|NCT00943917|585712405|FG007|Stage II Continuation|Adverse Event|0|||
162180004|NCT00943917|585712406|FG008|Stage II Continuation|Adverse Event|0|||
162180005|NCT00943917|585712407|FG009|Stage II Continuation|Adverse Event|0|||
162180006|NCT00943917|585712408|FG010|Stage II Continuation|Adverse Event|0|||
162180007|NCT00943917|585712409|FG011|Stage II Continuation|Adverse Event|1|||
162180008|NCT00943917|585712410|FG012|Stage II Continuation|Adverse Event|2|||
162180009|NCT00943917|585712411|FG013|Stage II Continuation|Adverse Event|1|||
162180010|NCT00943917|585712412|FG014|Stage II Continuation|Adverse Event|1|||
162180011|NCT00943917|585712398|FG000|Stage II Continuation|Withdrawal by Subject|0|||
162180012|NCT00943917|585712399|FG001|Stage II Continuation|Withdrawal by Subject|0|||
162180013|NCT00943917|585712400|FG002|Stage II Continuation|Withdrawal by Subject|0|||
162180014|NCT00943917|585712401|FG003|Stage II Continuation|Withdrawal by Subject|0|||
162180015|NCT00943917|585712402|FG004|Stage II Continuation|Withdrawal by Subject|0|||
162180016|NCT00943917|585712403|FG005|Stage II Continuation|Withdrawal by Subject|0|||
162180017|NCT00943917|585712404|FG006|Stage II Continuation|Withdrawal by Subject|0|||
162180018|NCT00943917|585712405|FG007|Stage II Continuation|Withdrawal by Subject|0|||
162180019|NCT00943917|585712406|FG008|Stage II Continuation|Withdrawal by Subject|0|||
162180020|NCT00943917|585712407|FG009|Stage II Continuation|Withdrawal by Subject|0|||
162180021|NCT00943917|585712408|FG010|Stage II Continuation|Withdrawal by Subject|0|||
162180022|NCT00943917|585712409|FG011|Stage II Continuation|Withdrawal by Subject|0|||
162180023|NCT00943917|585712410|FG012|Stage II Continuation|Withdrawal by Subject|0|||
162180024|NCT00943917|585712411|FG013|Stage II Continuation|Withdrawal by Subject|1|||
162180025|NCT00943917|585712412|FG014|Stage II Continuation|Withdrawal by Subject|3|||
162180026|NCT00943917|585712398|FG000|Stage II Continuation|Protocol Violation|0|||
162180027|NCT00943917|585712399|FG001|Stage II Continuation|Protocol Violation|0|||
162180028|NCT00943917|585712400|FG002|Stage II Continuation|Protocol Violation|0|||
162180029|NCT00943917|585712401|FG003|Stage II Continuation|Protocol Violation|0|||
162180030|NCT00943917|585712402|FG004|Stage II Continuation|Protocol Violation|0|||
162180031|NCT00943917|585712403|FG005|Stage II Continuation|Protocol Violation|0|||
162180032|NCT00943917|585712404|FG006|Stage II Continuation|Protocol Violation|0|||
162180033|NCT00943917|585712405|FG007|Stage II Continuation|Protocol Violation|0|||
162180034|NCT00943917|585712406|FG008|Stage II Continuation|Protocol Violation|0|||
162180035|NCT00943917|585712407|FG009|Stage II Continuation|Protocol Violation|1|||
162180036|NCT00943917|585712408|FG010|Stage II Continuation|Protocol Violation|0|||
162180037|NCT00943917|585712409|FG011|Stage II Continuation|Protocol Violation|1|||
162180038|NCT00943917|585712410|FG012|Stage II Continuation|Protocol Violation|0|||
162180039|NCT00943917|585712411|FG013|Stage II Continuation|Protocol Violation|0|||
162018738|NCT02423902|585123205|FG001|Overall Study|Disease progression|4|||
162018739|NCT02136069|585123206|FG000|Overall Study|UC flare-up|1|||
162180040|NCT00943917|585712412|FG014|Stage II Continuation|Protocol Violation|0|||
162180041|NCT00943917|585712398|FG000|Stage II Continuation|hypoglycemia|0|||
162180042|NCT00943917|585712399|FG001|Stage II Continuation|hypoglycemia|0|||
162180043|NCT00943917|585712400|FG002|Stage II Continuation|hypoglycemia|0|||
162180044|NCT00943917|585712401|FG003|Stage II Continuation|hypoglycemia|0|||
162180045|NCT00943917|585712402|FG004|Stage II Continuation|hypoglycemia|0|||
162180046|NCT00943917|585712403|FG005|Stage II Continuation|hypoglycemia|0|||
162180047|NCT00943917|585712404|FG006|Stage II Continuation|hypoglycemia|0|||
162180048|NCT00943917|585712405|FG007|Stage II Continuation|hypoglycemia|0|||
162180049|NCT00943917|585712406|FG008|Stage II Continuation|hypoglycemia|0|||
162180050|NCT00943917|585712407|FG009|Stage II Continuation|hypoglycemia|0|||
162180051|NCT00943917|585712408|FG010|Stage II Continuation|hypoglycemia|0|||
162180052|NCT00943917|585712409|FG011|Stage II Continuation|hypoglycemia|0|||
162180053|NCT00943917|585712410|FG012|Stage II Continuation|hypoglycemia|1|||
162180054|NCT00943917|585712411|FG013|Stage II Continuation|hypoglycemia|0|||
162180055|NCT00943917|585712412|FG014|Stage II Continuation|hypoglycemia|0|||
162180056|NCT00943917|585712398|FG000|Stage II Continuation|A1C elevation|0|||
162180057|NCT00943917|585712399|FG001|Stage II Continuation|A1C elevation|0|||
162180058|NCT00943917|585712400|FG002|Stage II Continuation|A1C elevation|0|||
162180059|NCT00943917|585712401|FG003|Stage II Continuation|A1C elevation|0|||
162180060|NCT00943917|585712402|FG004|Stage II Continuation|A1C elevation|0|||
162180061|NCT00943917|585712403|FG005|Stage II Continuation|A1C elevation|0|||
162180062|NCT00943917|585712404|FG006|Stage II Continuation|A1C elevation|0|||
162018740|NCT02136069|585123207|FG001|Overall Study|UC flare-up|0|||
162180063|NCT00943917|585712405|FG007|Stage II Continuation|A1C elevation|0|||
162180064|NCT00943917|585712406|FG008|Stage II Continuation|A1C elevation|0|||
162180065|NCT00943917|585712407|FG009|Stage II Continuation|A1C elevation|0|||
162180066|NCT00943917|585712408|FG010|Stage II Continuation|A1C elevation|0|||
162180067|NCT00943917|585712409|FG011|Stage II Continuation|A1C elevation|0|||
162180068|NCT00943917|585712410|FG012|Stage II Continuation|A1C elevation|0|||
162180069|NCT00943917|585712411|FG013|Stage II Continuation|A1C elevation|1|||
161923827|NCT02743494|584766641|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
161923828|NCT02743494|584766642|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
161923829|NCT02743494|584766641|FG000|Treatment Period|Participant request to discontinue treatment|31|||
161923830|NCT02743494|584766642|FG001|Treatment Period|Participant request to discontinue treatment|5|||
161923831|NCT02743494|584766641|FG000|Treatment Period|Participant withdrew consent|11|||
161923832|NCT02743494|584766642|FG001|Treatment Period|Participant withdrew consent|4|||
161923833|NCT02743494|584766641|FG000|Treatment Period|Lost to Follow-up|0|||
161923834|NCT02743494|584766642|FG001|Treatment Period|Lost to Follow-up|1|||
161923835|NCT02743494|584766641|FG000|Treatment Period|Poor/Non-compliance|2|||
161923836|NCT02743494|584766642|FG001|Treatment Period|Poor/Non-compliance|0|||
161923837|NCT02743494|584766641|FG000|Treatment Period|Other reasons|4|||
161923838|NCT02743494|584766642|FG001|Treatment Period|Other reasons|1|||
161923839|NCT02207608|584766643|FG000|Overall Study|Adverse Event|1|||
161923840|NCT02207608|584766644|FG001|Overall Study|Adverse Event|0|||
161923841|NCT05399485|584768055|FG000|DBT Phase|Other|6|||
161923842|NCT05399485|584768056|FG001|DBT Phase|Other|5|||
161923843|NCT05399485|584768055|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
161923844|NCT05399485|584768056|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
161923845|NCT05399485|584768055|FG000|DBT Phase|Withdrawal by Subject|3|||
161923846|NCT05399485|584768056|FG001|DBT Phase|Withdrawal by Subject|2|||
161923847|NCT05399485|584768055|FG000|DBT Phase|Protocol Violation|2|||
161923848|NCT05399485|584768056|FG001|DBT Phase|Protocol Violation|1|||
161923849|NCT05399485|584768055|FG000|DBT Phase|Physician Decision|0|||
161923850|NCT05399485|584768056|FG001|DBT Phase|Physician Decision|1|||
161923851|NCT05399485|584768055|FG000|DBT Phase|Adverse Event|2|||
161923852|NCT05399485|584768056|FG001|DBT Phase|Adverse Event|1|||
161923853|NCT05399485|584768055|FG000|OLE Phase|Protocol deviation|1|||
161923854|NCT05399485|584768056|FG001|OLE Phase|Protocol deviation|0|||
161923855|NCT05399485|584768055|FG000|OLE Phase|Other|5|||
161923856|NCT05399485|584768056|FG001|OLE Phase|Other|5|||
161923857|NCT05399485|584768055|FG000|OLE Phase|Withdrawal by Subject|12|||
161923858|NCT05399485|584768056|FG001|OLE Phase|Withdrawal by Subject|7|||
161923859|NCT05399485|584768055|FG000|OLE Phase|Pregnancy|0|||
161923860|NCT05399485|584768056|FG001|OLE Phase|Pregnancy|2|||
161923861|NCT05399485|584768055|FG000|OLE Phase|Physician Decision|3|||
161923862|NCT05399485|584768056|FG001|OLE Phase|Physician Decision|0|||
161923863|NCT05399485|584768055|FG000|OLE Phase|Adverse Event|2|||
161923864|NCT05399485|584768056|FG001|OLE Phase|Adverse Event|2|||
161923865|NCT03554473|584768059|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
162180070|NCT00943917|585712412|FG014|Stage II Continuation|A1C elevation|0|||
162180071|NCT01171976|585712413|FG000|Overall Study|Protocol Violation|0|||
162180072|NCT01171976|585712414|FG001|Overall Study|Protocol Violation|0|||
162180073|NCT01171976|585712415|FG002|Overall Study|Protocol Violation|1|||
162180074|NCT01171976|585712413|FG000|Overall Study|Death|2|||
162180075|NCT01171976|585712414|FG001|Overall Study|Death|4|||
162180076|NCT01171976|585712415|FG002|Overall Study|Death|1|||
162180077|NCT01171976|585712413|FG000|Overall Study|Lost to Follow-up|4|||
162180078|NCT01171976|585712414|FG001|Overall Study|Lost to Follow-up|0|||
162180079|NCT01171976|585712415|FG002|Overall Study|Lost to Follow-up|2|||
162180080|NCT01171976|585712413|FG000|Overall Study|Withdrawal by Subject|1|||
162180081|NCT01171976|585712414|FG001|Overall Study|Withdrawal by Subject|5|||
162180082|NCT01171976|585712415|FG002|Overall Study|Withdrawal by Subject|6|||
162180083|NCT01171976|585712413|FG000|Overall Study|Abnormal test result|1|||
162180084|NCT01171976|585712414|FG001|Overall Study|Abnormal test result|0|||
162180085|NCT01171976|585712415|FG002|Overall Study|Abnormal test result|0|||
162180086|NCT01171976|585712413|FG000|Overall Study|Adverse Event|6|||
162180087|NCT01171976|585712414|FG001|Overall Study|Adverse Event|2|||
162180088|NCT01171976|585712415|FG002|Overall Study|Adverse Event|5|||
162180089|NCT00003222|585712416|FG000|Overall Study|Physician Decision|0|||
162180090|NCT00003222|585712417|FG001|Overall Study|Physician Decision|1|||
162180091|NCT01313559|585712419|FG000|Overall Study|Withdrawal by Subject|1|||
162180092|NCT01313559|585712420|FG001|Overall Study|Withdrawal by Subject|2|||
162180093|NCT01313559|585712419|FG000|Overall Study|Disease progression|1|||
162180094|NCT01313559|585712420|FG001|Overall Study|Disease progression|0|||
162180095|NCT01313559|585712419|FG000|Overall Study|Rising PSA|2|||
161923866|NCT03554473|584768060|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
161923867|NCT03554473|584768061|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
161942233|NCT00663260|584838357|FG001|Overall Study|Adverse Event|7|||
162180096|NCT01313559|585712420|FG001|Overall Study|Rising PSA|0|||
162180097|NCT02466971|585712423|FG000|Overall Study|eligible and never treated|14|||
161923868|NCT03554473|584768059|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
161923869|NCT03554473|584768060|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
161923870|NCT03554473|584768061|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
161923871|NCT03554473|584768059|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
161923872|NCT03554473|584768060|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
161923873|NCT03554473|584768061|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
161923874|NCT01363076|584768062|FG000|Overall Study|Withdrawal by Subject|0|||
161923875|NCT01363076|584768063|FG001|Overall Study|Withdrawal by Subject|1|||
161923876|NCT02642679|584768064|FG000|Overall Study|Withdrawal by Subject|1|||
161923877|NCT02642679|584768064|FG000|Overall Study|Physician Decision|1|||
161923878|NCT02642679|584768064|FG000|Overall Study|Physician Decision|1|||
161923879|NCT05206604|584768065|FG000|Overall Study|Non-compliance with study drug|0|||
161923880|NCT05206604|584768066|FG001|Overall Study|Non-compliance with study drug|0|||
161923881|NCT05206604|584768067|FG002|Overall Study|Non-compliance with study drug|0|||
161923882|NCT05206604|584768068|FG003|Overall Study|Non-compliance with study drug|0|||
161923883|NCT05206604|584768069|FG004|Overall Study|Non-compliance with study drug|0|||
161923884|NCT05206604|584768070|FG005|Overall Study|Non-compliance with study drug|1|||
161923885|NCT05206604|584768071|FG006|Overall Study|Non-compliance with study drug|0|||
161923886|NCT05206604|584768072|FG007|Overall Study|Non-compliance with study drug|0|||
161923887|NCT02014103|584768073|FG000|Overall Study|Protocol Violation|7|||
161923888|NCT02014103|584768074|FG001|Overall Study|Protocol Violation|7|||
161923889|NCT02014103|584768073|FG000|Overall Study|Adverse Event|1|||
161923890|NCT02014103|584768074|FG001|Overall Study|Adverse Event|0|||
161923891|NCT02014103|584768073|FG000|Overall Study|Lost venous access|1|||
161923892|NCT02014103|584768074|FG001|Overall Study|Lost venous access|0|||
161923893|NCT02014103|584768073|FG000|Overall Study|Withdrawal by Subject|0|||
161923894|NCT02014103|584768074|FG001|Overall Study|Withdrawal by Subject|2|||
161923895|NCT05638737|584768075|FG000|Overall Study|Withdrawal by Subject|4|||
161923896|NCT05638737|584768076|FG001|Overall Study|Withdrawal by Subject|7|||
161923897|NCT01617967|584768087|FG000|Overall Study|Protocol Violation|0|||
161923898|NCT01617967|584768088|FG001|Overall Study|Protocol Violation|0|||
161923899|NCT01617967|584768089|FG002|Overall Study|Protocol Violation|0|||
161923900|NCT01617967|584768090|FG003|Overall Study|Protocol Violation|1|||
161923901|NCT01617967|584768091|FG004|Overall Study|Protocol Violation|0|||
161923902|NCT01617967|584768092|FG005|Overall Study|Protocol Violation|0|||
161923903|NCT01617967|584768087|FG000|Overall Study|Withdrawal by Subject|0|||
161923904|NCT01617967|584768088|FG001|Overall Study|Withdrawal by Subject|0|||
161923905|NCT01617967|584768089|FG002|Overall Study|Withdrawal by Subject|0|||
161671691|NCT00174265|583851384|FG000|Overall Study|Adverse Event|7|||
161671692|NCT00174265|583851385|FG001|Overall Study|Adverse Event|4|||
161671693|NCT00174265|583851384|FG000|Overall Study|Lack of Efficacy|2|||
161671694|NCT00174265|583851385|FG001|Overall Study|Lack of Efficacy|2|||
161671695|NCT00174265|583851384|FG000|Overall Study|Withdrawal by Subject|3|||
161671696|NCT00174265|583851385|FG001|Overall Study|Withdrawal by Subject|5|||
161671697|NCT00174265|583851384|FG000|Overall Study|Lost to Follow-up|1|||
161671698|NCT00174265|583851385|FG001|Overall Study|Lost to Follow-up|0|||
161671699|NCT00174265|583851384|FG000|Overall Study|Other (Not specified)|16|||
161671700|NCT00174265|583851385|FG001|Overall Study|Other (Not specified)|10|||
161671701|NCT03231943|583851386|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671702|NCT03231943|583851387|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
161671703|NCT03231943|583851388|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
161671704|NCT03231943|583851389|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671705|NCT03231943|583851390|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671706|NCT03231943|583851391|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671707|NCT03231943|583851392|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161817732|NCT00906399|584372916|FG000|Year 1|Death|2|||
161817733|NCT00906399|584372917|FG001|Year 1|Death|1|||
161817734|NCT00906399|584372918|FG002|Year 1|Death|1|||
161817735|NCT00906399|584372919|FG003|Year 1|Death|0|||
161817736|NCT00906399|584372920|FG004|Year 1|Death|0|||
161817737|NCT00906399|584372921|FG005|Year 1|Death|0|||
161817738|NCT00906399|584372922|FG006|Year 1|Death|0|||
161817739|NCT00906399|584372916|FG000|Year 1|Other|4|||
161817740|NCT00906399|584372917|FG001|Year 1|Other|2|||
161817741|NCT00906399|584372918|FG002|Year 1|Other|7|||
161817742|NCT00906399|584372919|FG003|Year 1|Other|0|||
161817743|NCT00906399|584372920|FG004|Year 1|Other|0|||
161817744|NCT00906399|584372921|FG005|Year 1|Other|0|||
161817745|NCT00906399|584372922|FG006|Year 1|Other|0|||
161817746|NCT00906399|584372916|FG000|Year 2|Adverse Event|0|||
161817747|NCT00906399|584372917|FG001|Year 2|Adverse Event|0|||
161817748|NCT00906399|584372918|FG002|Year 2|Adverse Event|0|||
161817749|NCT00906399|584372919|FG003|Year 2|Adverse Event|9|||
161817750|NCT00906399|584372920|FG004|Year 2|Adverse Event|8|||
161817751|NCT00906399|584372921|FG005|Year 2|Adverse Event|11|||
161817752|NCT00906399|584372922|FG006|Year 2|Adverse Event|6|||
161817753|NCT00906399|584372916|FG000|Year 2|Lost to Follow-up|0|||
161817754|NCT00906399|584372917|FG001|Year 2|Lost to Follow-up|0|||
161817755|NCT00906399|584372918|FG002|Year 2|Lost to Follow-up|0|||
161817756|NCT00906399|584372919|FG003|Year 2|Lost to Follow-up|1|||
161817757|NCT00906399|584372920|FG004|Year 2|Lost to Follow-up|4|||
161817758|NCT00906399|584372921|FG005|Year 2|Lost to Follow-up|2|||
161817759|NCT00906399|584372922|FG006|Year 2|Lost to Follow-up|4|||
161817760|NCT00906399|584372916|FG000|Year 2|Withdrawal by Subject|0|||
161817761|NCT00906399|584372917|FG001|Year 2|Withdrawal by Subject|0|||
161817762|NCT00906399|584372918|FG002|Year 2|Withdrawal by Subject|0|||
161817763|NCT00906399|584372919|FG003|Year 2|Withdrawal by Subject|17|||
161817764|NCT00906399|584372920|FG004|Year 2|Withdrawal by Subject|18|||
161817765|NCT00906399|584372921|FG005|Year 2|Withdrawal by Subject|27|||
161817766|NCT00906399|584372922|FG006|Year 2|Withdrawal by Subject|13|||
161817767|NCT00906399|584372916|FG000|Year 2|Physician Decision|0|||
161817768|NCT00906399|584372917|FG001|Year 2|Physician Decision|0|||
161817769|NCT00906399|584372918|FG002|Year 2|Physician Decision|0|||
161817770|NCT00906399|584372919|FG003|Year 2|Physician Decision|0|||
161817771|NCT00906399|584372920|FG004|Year 2|Physician Decision|2|||
161817772|NCT00906399|584372921|FG005|Year 2|Physician Decision|6|||
161817773|NCT00906399|584372922|FG006|Year 2|Physician Decision|3|||
161817774|NCT00906399|584372916|FG000|Year 2|Death|0|||
161817775|NCT00906399|584372917|FG001|Year 2|Death|0|||
161817776|NCT00906399|584372918|FG002|Year 2|Death|0|||
161817777|NCT00906399|584372919|FG003|Year 2|Death|1|||
161817778|NCT00906399|584372920|FG004|Year 2|Death|0|||
161817779|NCT00906399|584372921|FG005|Year 2|Death|0|||
161817780|NCT00906399|584372922|FG006|Year 2|Death|3|||
161817781|NCT00906399|584372916|FG000|Year 2|Other|0|||
161817782|NCT00906399|584372917|FG001|Year 2|Other|0|||
161817783|NCT00906399|584372918|FG002|Year 2|Other|0|||
161817784|NCT00906399|584372919|FG003|Year 2|Other|2|||
161817785|NCT00906399|584372920|FG004|Year 2|Other|3|||
161817786|NCT00906399|584372921|FG005|Year 2|Other|1|||
161817787|NCT00906399|584372922|FG006|Year 2|Other|0|||
161817788|NCT01456221|584372925|FG000|Overall Study|Withdrawal by Subject|56|||
161817789|NCT01456221|584372926|FG001|Overall Study|Withdrawal by Subject|49|||
161817790|NCT01456221|584372925|FG000|Overall Study|Lost to Follow-up|1|||
161817791|NCT01456221|584372926|FG001|Overall Study|Lost to Follow-up|4|||
161817792|NCT01456221|584372925|FG000|Overall Study|Received medication|3|||
161817793|NCT01456221|584372926|FG001|Overall Study|Received medication|2|||
161817794|NCT01456221|584372925|FG000|Overall Study|Incomplete data|4|||
161817795|NCT01456221|584372926|FG001|Overall Study|Incomplete data|2|||
161817796|NCT01986647|584372928|FG000|Overall Study|Lost to Follow-up|4|||
161817797|NCT01986647|584372929|FG001|Overall Study|Lost to Follow-up|1|||
161923906|NCT01617967|584768090|FG003|Overall Study|Withdrawal by Subject|0|||
161817798|NCT01986647|584372930|FG002|Overall Study|Lost to Follow-up|4|||
161817799|NCT01986647|584372931|FG003|Overall Study|Lost to Follow-up|4|||
161817800|NCT01986647|584372928|FG000|Overall Study|Withdrawal by Subject|1|||
161817801|NCT01986647|584372929|FG001|Overall Study|Withdrawal by Subject|3|||
161817802|NCT01986647|584372930|FG002|Overall Study|Withdrawal by Subject|2|||
161817803|NCT01986647|584372931|FG003|Overall Study|Withdrawal by Subject|3|||
161817804|NCT01986647|584372928|FG000|Overall Study|Health|5|||
161817805|NCT01986647|584372929|FG001|Overall Study|Health|3|||
161817806|NCT01986647|584372930|FG002|Overall Study|Health|6|||
161817807|NCT01986647|584372931|FG003|Overall Study|Health|4|||
161817808|NCT01960296|584372932|FG000|Overall Study|Postponed surgery|1|||
161817809|NCT01960296|584372933|FG001|Overall Study|Postponed surgery|0|||
161817810|NCT01960296|584372932|FG000|Overall Study|Received different procedure|1|||
161817811|NCT01960296|584372933|FG001|Overall Study|Received different procedure|3|||
161817812|NCT02003391|584372934|FG000|Overall Study|Withdrawal by Subject|2|||
161817813|NCT02003391|584372935|FG001|Overall Study|Withdrawal by Subject|1|||
162180098|NCT02466971|585712424|FG001|Overall Study|eligible and never treated|20|||
162180099|NCT02466971|585712423|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
162180100|NCT02466971|585712424|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
162180101|NCT02466971|585712423|FG000|Overall Study|ineligible and treated|1|||
162180102|NCT02466971|585712424|FG001|Overall Study|ineligible and treated|0|||
162180103|NCT02466971|585712423|FG000|Overall Study|ineligible and never treated|0|||
162180104|NCT02466971|585712424|FG001|Overall Study|ineligible and never treated|1|||
162180105|NCT05707351|585712425|FG000|Overall Study|Withdrawal by Subject|2|||
162180106|NCT05707351|585712425|FG000|Overall Study|Reason Not Specified|1|||
162180107|NCT04174560|585712429|FG000|Overall Study|Lost to Follow-up|1|||
162180108|NCT04174560|585712430|FG001|Overall Study|Lost to Follow-up|0|||
162180109|NCT04174560|585712431|FG002|Overall Study|Lost to Follow-up|0|||
162180110|NCT04174560|585712432|FG003|Overall Study|Lost to Follow-up|0|||
162180111|NCT04174560|585712429|FG000|Overall Study|Withdrawal by Subject|0|||
161671708|NCT03231943|583851393|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671709|NCT03231943|583851394|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671710|NCT03231943|583851395|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671711|NCT03231943|583851396|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671712|NCT03231943|583851397|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671713|NCT03231943|583851398|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161671714|NCT03231943|583851386|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671715|NCT03231943|583851387|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
161671716|NCT03231943|583851388|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671717|NCT03231943|583851389|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671718|NCT03231943|583851390|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161923907|NCT01617967|584768091|FG004|Overall Study|Withdrawal by Subject|0|||
161923908|NCT01617967|584768092|FG005|Overall Study|Withdrawal by Subject|1|||
161923909|NCT01617967|584768087|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
161923910|NCT01617967|584768088|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
161923911|NCT01617967|584768089|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
161923912|NCT01617967|584768090|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
161923913|NCT01617967|584768091|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
161923914|NCT01617967|584768092|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
161923915|NCT00530075|584768093|FG000|Overall Study|Adverse Event|1|||
161923916|NCT00530075|584768093|FG000|Overall Study|Death|1|||
161923917|NCT00530075|584768093|FG000|Overall Study|Lack of Efficacy|3|||
161923918|NCT00530075|584768093|FG000|Overall Study|Protocol Violation|1|||
161923919|NCT00530075|584768093|FG000|Overall Study|Withdrawal by Subject|1|||
161923920|NCT03520569|584768098|FG000|Overall Study|Withdrawal by Subject|1|||
161923921|NCT01178411|584768099|FG000|Overall Study|Adverse Event|5|||
161923922|NCT01178411|584768099|FG000|Overall Study|Withdrawal by Subject|4|||
161923923|NCT01178411|584768099|FG000|Overall Study|Protocol Violation|1|||
161923924|NCT01178411|584768099|FG000|Overall Study|Progressive disease per RECIST|32|||
161923925|NCT01178411|584768099|FG000|Overall Study|Progressive disease per clinician|9|||
161923926|NCT01178411|584768099|FG000|Overall Study|Physician Decision|6|||
161923927|NCT01178411|584768099|FG000|Overall Study|Death|1|||
161923928|NCT01178411|584768099|FG000|Overall Study|No reason provided|1|||
161923929|NCT01178411|584768099|FG000|Overall Study|Drug manufacturing ended|1|||
161923930|NCT00784927|584768100|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
161923931|NCT00784927|584768100|FG000|Overall Study|Protocol Violation|1|||
161923932|NCT00784927|584768100|FG000|Overall Study|Ineligible|1|||
161923933|NCT02453048|584768103|FG000|Overall Study|Only part of initial 6 mo. study|0|||
161923934|NCT02453048|584768104|FG001|Overall Study|Only part of initial 6 mo. study|0|||
161923935|NCT02453048|584768105|FG002|Overall Study|Only part of initial 6 mo. study|0|||
161923936|NCT02453048|584768106|FG003|Overall Study|Only part of initial 6 mo. study|0|||
161923937|NCT02453048|584768107|FG004|Overall Study|Only part of initial 6 mo. study|6|||
161923938|NCT02453048|584768103|FG000|Overall Study|Lost to Follow-up|0|||
161923939|NCT02453048|584768104|FG001|Overall Study|Lost to Follow-up|1|||
161923940|NCT02453048|584768105|FG002|Overall Study|Lost to Follow-up|2|||
161923941|NCT02453048|584768106|FG003|Overall Study|Lost to Follow-up|0|||
161923942|NCT02453048|584768107|FG004|Overall Study|Lost to Follow-up|0|||
161923943|NCT03677401|584768110|FG000|Overall Study|Adverse Event|4|||
161923944|NCT03677401|584768111|FG001|Overall Study|Adverse Event|14|||
161923945|NCT03677401|584768110|FG000|Overall Study|Lack of Efficacy|3|||
161923946|NCT03677401|584768111|FG001|Overall Study|Lack of Efficacy|1|||
161923947|NCT03677401|584768110|FG000|Overall Study|Withdrawal by Subject|2|||
161923948|NCT03677401|584768111|FG001|Overall Study|Withdrawal by Subject|2|||
161923949|NCT03677401|584768110|FG000|Overall Study|Sponsor decision|0|||
161923950|NCT03677401|584768111|FG001|Overall Study|Sponsor decision|1|||
161923951|NCT03677401|584768110|FG000|Overall Study|Reason Unspecified|1|||
161923952|NCT03677401|584768111|FG001|Overall Study|Reason Unspecified|0|||
161923953|NCT00726557|584768112|FG000|Overall Study|Screening failure|4|||
161923954|NCT00726557|584768112|FG000|Overall Study|No end of treatment documentation|37|||
161923955|NCT00726557|584768112|FG000|Overall Study|No follow-up documentation available|55|||
161923956|NCT00726557|584768112|FG000|Overall Study|Treatment less than 3 months|17|||
161923957|NCT00726557|584768112|FG000|Overall Study|Inclusion criteria not met|15|||
162018741|NCT02136069|585123206|FG000|Overall Study|Adverse Event|6|||
161671719|NCT03231943|583851391|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671720|NCT03231943|583851392|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671721|NCT03231943|583851393|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671722|NCT03231943|583851394|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161923958|NCT00574951|584768113|FG000|Overall Study|Ineligible - improper prior treatment|1|||
161923959|NCT05161936|584768114|FG000|Overall Study|Study terminated by Sponsor|1|||
161923960|NCT05161936|584768115|FG001|Overall Study|Study terminated by Sponsor|0|||
161923961|NCT05161936|584768116|FG002|Overall Study|Study terminated by Sponsor|0|||
161923962|NCT05161936|584768114|FG000|Overall Study|Withdrawal by Subject|0|||
161923963|NCT05161936|584768115|FG001|Overall Study|Withdrawal by Subject|0|||
161923964|NCT05161936|584768116|FG002|Overall Study|Withdrawal by Subject|1|||
161671723|NCT03231943|583851395|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671724|NCT03231943|583851396|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671725|NCT03231943|583851397|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671726|NCT03231943|583851398|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161671727|NCT03231943|583851386|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
161671728|NCT03231943|583851387|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671729|NCT03231943|583851388|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671730|NCT03231943|583851389|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671731|NCT03231943|583851390|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671732|NCT03231943|583851391|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671733|NCT03231943|583851392|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671734|NCT03231943|583851393|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671735|NCT03231943|583851394|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671736|NCT03231943|583851395|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671737|NCT03231943|583851396|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671738|NCT03231943|583851397|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671739|NCT03231943|583851398|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161671740|NCT03231943|583851386|FG000|Part 2|Adverse Event|0|||
161671741|NCT03231943|583851387|FG001|Part 2|Adverse Event|0|||
161671742|NCT03231943|583851388|FG002|Part 2|Adverse Event|0|||
161671743|NCT03231943|583851389|FG003|Part 2|Adverse Event|0|||
161671744|NCT03231943|583851390|FG004|Part 2|Adverse Event|0|||
161671745|NCT03231943|583851391|FG005|Part 2|Adverse Event|0|||
161671746|NCT03231943|583851392|FG006|Part 2|Adverse Event|0|||
161671747|NCT03231943|583851393|FG007|Part 2|Adverse Event|0|||
161671748|NCT03231943|583851394|FG008|Part 2|Adverse Event|0|||
161671749|NCT03231943|583851395|FG009|Part 2|Adverse Event|0|||
161671750|NCT03231943|583851396|FG010|Part 2|Adverse Event|1|||
161671751|NCT03231943|583851397|FG011|Part 2|Adverse Event|0|||
161671752|NCT03231943|583851398|FG012|Part 2|Adverse Event|0|||
161671753|NCT03231943|583851386|FG000|Part 2|Withdrawal by Subject|0|||
161671754|NCT03231943|583851387|FG001|Part 2|Withdrawal by Subject|0|||
161671755|NCT03231943|583851388|FG002|Part 2|Withdrawal by Subject|0|||
161671756|NCT03231943|583851389|FG003|Part 2|Withdrawal by Subject|0|||
161671757|NCT03231943|583851390|FG004|Part 2|Withdrawal by Subject|0|||
161671758|NCT03231943|583851391|FG005|Part 2|Withdrawal by Subject|0|||
161671759|NCT03231943|583851392|FG006|Part 2|Withdrawal by Subject|0|||
161671760|NCT03231943|583851393|FG007|Part 2|Withdrawal by Subject|0|||
161671761|NCT03231943|583851394|FG008|Part 2|Withdrawal by Subject|0|||
161671762|NCT03231943|583851395|FG009|Part 2|Withdrawal by Subject|0|||
161671763|NCT03231943|583851396|FG010|Part 2|Withdrawal by Subject|0|||
161671764|NCT03231943|583851397|FG011|Part 2|Withdrawal by Subject|1|||
161671765|NCT03231943|583851398|FG012|Part 2|Withdrawal by Subject|0|||
161671766|NCT00047320|583851399|FG000|Overall Study|Lack of Efficacy|8|||
161671767|NCT00047320|583851399|FG000|Overall Study|Lost to Follow-up|1|||
161671768|NCT00047320|583851399|FG000|Overall Study|Physician Decision|8|||
161671769|NCT00047320|583851399|FG000|Overall Study|Withdrawal by Subject|9|||
161671770|NCT00047320|583851399|FG000|Overall Study|Ineligible|2|||
161671771|NCT03471871|583851400|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
161671772|NCT03471871|583851401|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
161671773|NCT03471871|583851402|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
161671774|NCT03471871|583851403|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
161671775|NCT03471871|583851404|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
162180112|NCT04174560|585712430|FG001|Overall Study|Withdrawal by Subject|0|||
162180113|NCT04174560|585712431|FG002|Overall Study|Withdrawal by Subject|2|||
162180114|NCT04174560|585712432|FG003|Overall Study|Withdrawal by Subject|0|||
162180115|NCT03872466|585712433|FG000|Overall Study|Withdrawal by Subject|1|||
162180116|NCT03872466|585712434|FG001|Overall Study|Withdrawal by Subject|0|||
162180117|NCT03872466|585712433|FG000|Overall Study|Physician Decision|2|||
162180118|NCT03872466|585712434|FG001|Overall Study|Physician Decision|0|||
162180119|NCT01778686|585712435|FG000|Overall Study|Adverse Event|0|||
162180120|NCT01778686|585712436|FG001|Overall Study|Adverse Event|0|||
162180121|NCT01778686|585712437|FG002|Overall Study|Adverse Event|1|||
162180122|NCT04012567|585712438|FG000|Overall Study|Lost to Follow-up|0|||
162180123|NCT04012567|585712439|FG001|Overall Study|Lost to Follow-up|1|||
162180124|NCT04012567|585712438|FG000|Overall Study|Withdrawal by Subject|1|||
161671776|NCT03471871|583851400|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
161671777|NCT03471871|583851401|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
161671778|NCT03471871|583851402|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
161671779|NCT03471871|583851403|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
161671780|NCT03471871|583851404|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
161671781|NCT03471871|583851400|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
161671782|NCT03471871|583851401|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
161671783|NCT03471871|583851402|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
162180125|NCT04012567|585712439|FG001|Overall Study|Withdrawal by Subject|0|||
161671784|NCT03471871|583851403|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
161671785|NCT03471871|583851404|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
161671786|NCT03471871|583851400|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
161671787|NCT03471871|583851401|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
161671788|NCT03471871|583851402|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
161671789|NCT03471871|583851403|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
161671790|NCT03471871|583851404|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
161671791|NCT03471871|583851400|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
161671792|NCT03471871|583851401|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
161671793|NCT03471871|583851402|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
161671794|NCT03471871|583851403|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
161671795|NCT03471871|583851404|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
161671796|NCT03040622|583851405|FG000|Overall Study|unable to implant device|3|||
161671797|NCT02818920|583851406|FG000|Overall Study|Unresectable|4|||
161671798|NCT02818920|583851406|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
161671799|NCT02818920|583851406|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
161671800|NCT02818920|583851406|FG000|Overall Study|Adverse Event|3|||
161671801|NCT02818920|583851406|FG000|Overall Study|Developed Other Disease|1|||
161671802|NCT02818920|583851406|FG000|Overall Study|Refused Further Treatment|1|||
161671803|NCT00445068|583851407|FG000|Overall Study|Disease progression|26|||
161671804|NCT00445068|583851407|FG000|Overall Study|Adverse Event|5|||
161671805|NCT00445068|583851407|FG000|Overall Study|Abnormal laboratory value|2|||
161671806|NCT00445068|583851407|FG000|Overall Study|Withdrawal by Subject|2|||
161671807|NCT00445068|583851407|FG000|Overall Study|Death|1|||
161671808|NCT02673619|583851408|FG000|Overall Study|Lost to Follow-up|1|||
161671809|NCT02673619|583851409|FG001|Overall Study|Lost to Follow-up|0|||
161671810|NCT02673619|583851410|FG002|Overall Study|Lost to Follow-up|0|||
161671811|NCT02673619|583851411|FG003|Overall Study|Lost to Follow-up|0|||
161671812|NCT02673619|583851408|FG000|Overall Study|Withdrawal by Subject|1|||
161671813|NCT02673619|583851409|FG001|Overall Study|Withdrawal by Subject|1|||
161671814|NCT02673619|583851410|FG002|Overall Study|Withdrawal by Subject|1|||
161671815|NCT02673619|583851411|FG003|Overall Study|Withdrawal by Subject|0|||
161671816|NCT02673619|583851408|FG000|Overall Study|Adverse Event|0|||
161671817|NCT02673619|583851409|FG001|Overall Study|Adverse Event|0|||
161671818|NCT02673619|583851410|FG002|Overall Study|Adverse Event|1|||
161671819|NCT02673619|583851411|FG003|Overall Study|Adverse Event|0|||
161671820|NCT02673619|583851408|FG000|Overall Study|Lack of Efficacy|0|||
161671821|NCT02673619|583851409|FG001|Overall Study|Lack of Efficacy|0|||
161671822|NCT02673619|583851410|FG002|Overall Study|Lack of Efficacy|1|||
161671823|NCT02673619|583851411|FG003|Overall Study|Lack of Efficacy|0|||
161671824|NCT03444324|583851412|FG000|Overall Study|Withdrawal by Subject|0|||
161671825|NCT03444324|583851413|FG001|Overall Study|Withdrawal by Subject|1|||
161671826|NCT03444324|583851412|FG000|Overall Study|Lost to Follow-up|4|||
161671827|NCT03444324|583851413|FG001|Overall Study|Lost to Follow-up|2|||
161671828|NCT03444324|583851412|FG000|Overall Study|Protocol Violation|0|||
161671829|NCT03444324|583851413|FG001|Overall Study|Protocol Violation|1|||
161671830|NCT03444324|583851412|FG000|Overall Study|Lack of Trial Compliance|1|||
161671831|NCT03444324|583851413|FG001|Overall Study|Lack of Trial Compliance|1|||
161671832|NCT03444324|583851412|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
161671833|NCT03444324|583851413|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
161671834|NCT00658684|583851415|FG000|Overall Study|Adverse Event|10|||
161671835|NCT00658684|583851416|FG001|Overall Study|Adverse Event|8|||
161671836|NCT00658684|583851417|FG002|Overall Study|Adverse Event|2|||
161671837|NCT00658684|583851418|FG003|Overall Study|Adverse Event|0|||
161671838|NCT00658684|583851415|FG000|Overall Study|Withdrawal by Subject|6|||
161671839|NCT00658684|583851416|FG001|Overall Study|Withdrawal by Subject|4|||
161671840|NCT00658684|583851417|FG002|Overall Study|Withdrawal by Subject|1|||
161671841|NCT00658684|583851418|FG003|Overall Study|Withdrawal by Subject|1|||
161671842|NCT00658684|583851415|FG000|Overall Study|Lack of Efficacy|1|||
161671843|NCT00658684|583851416|FG001|Overall Study|Lack of Efficacy|1|||
161671844|NCT00658684|583851417|FG002|Overall Study|Lack of Efficacy|0|||
161671845|NCT00658684|583851418|FG003|Overall Study|Lack of Efficacy|0|||
161671846|NCT00658684|583851415|FG000|Overall Study|Protocol Violation|1|||
161671847|NCT00658684|583851416|FG001|Overall Study|Protocol Violation|1|||
161671848|NCT00658684|583851417|FG002|Overall Study|Protocol Violation|0|||
161671849|NCT00658684|583851418|FG003|Overall Study|Protocol Violation|0|||
161671850|NCT00658684|583851415|FG000|Overall Study|Pregnancy|1|||
161671851|NCT00658684|583851416|FG001|Overall Study|Pregnancy|1|||
161671852|NCT00658684|583851417|FG002|Overall Study|Pregnancy|0|||
161671853|NCT00658684|583851418|FG003|Overall Study|Pregnancy|0|||
161671854|NCT00688103|583851419|FG000|Overall Study|Adverse Event|4|||
161671855|NCT00688103|583851420|FG001|Overall Study|Adverse Event|1|||
161671856|NCT00688103|583851419|FG000|Overall Study|Lack of Efficacy|11|||
161671857|NCT00688103|583851420|FG001|Overall Study|Lack of Efficacy|1|||
161671858|NCT00688103|583851419|FG000|Overall Study|Withdrawal by Subject|4|||
162180126|NCT04018495|585712445|FG000|Overall Study|Physician Decision|1|||
162180127|NCT05934292|585712454|FG000|Overall Study|Lost to Follow-up|0|||
162180128|NCT05934292|585712455|FG001|Overall Study|Lost to Follow-up|0|||
162180129|NCT05934292|585712456|FG002|Overall Study|Lost to Follow-up|1|||
162180130|NCT05934292|585712457|FG003|Overall Study|Lost to Follow-up|0|||
162180131|NCT05714059|585712460|FG000|Overall Study|Withdrawal by Subject|2|||
162180132|NCT05714059|585712461|FG001|Overall Study|Withdrawal by Subject|2|||
162180133|NCT05714059|585712460|FG000|Overall Study|Adverse Event|0|||
162180134|NCT05714059|585712461|FG001|Overall Study|Adverse Event|1|||
162180135|NCT05714059|585712460|FG000|Overall Study|Lost to Follow-up|0|||
162180136|NCT05714059|585712461|FG001|Overall Study|Lost to Follow-up|1|||
162180137|NCT05714059|585712460|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
162180138|NCT05714059|585712461|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
162180139|NCT05714059|585712460|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
162180140|NCT05714059|585712461|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
162180141|NCT04899674|585712462|FG000|Test|Adverse Event|1|||
162180142|NCT04129450|585712466|FG000|Overall Study|Lost to Follow-up|20|||
162180143|NCT04129450|585712467|FG001|Overall Study|Lost to Follow-up|10|||
162180144|NCT04129450|585712466|FG000|Overall Study|Withdrawal by Subject|9|||
162180145|NCT04129450|585712467|FG001|Overall Study|Withdrawal by Subject|5|||
162180146|NCT04129450|585712466|FG000|Overall Study|Work Family Obligations|2|||
162180147|NCT04129450|585712467|FG001|Overall Study|Work Family Obligations|0|||
162180148|NCT04129450|585712466|FG000|Overall Study|Other|3|||
162180149|NCT04129450|585712467|FG001|Overall Study|Other|0|||
162180150|NCT04974047|585713236|FG000|Overall Study|Sponsor Ended Study|20|||
162180151|NCT04974047|585713237|FG001|Overall Study|Sponsor Ended Study|22|||
162180152|NCT04974047|585713236|FG000|Overall Study|Death|8|||
162180153|NCT04974047|585713237|FG001|Overall Study|Death|17|||
162180154|NCT04974047|585713236|FG000|Overall Study|Lost to Follow-up|2|||
162180155|NCT04974047|585713237|FG001|Overall Study|Lost to Follow-up|0|||
162180156|NCT04974047|585713236|FG000|Overall Study|Withdrawal by Subject|0|||
162180157|NCT04974047|585713237|FG001|Overall Study|Withdrawal by Subject|1|||
162180158|NCT00655499|585713238|FG000|Overall Study|not eligible|4|||
162180159|NCT01596972|585713240|FG000|Overall Study|Physician Decision|1|||
162180160|NCT01596972|585713241|FG001|Overall Study|Physician Decision|9|||
161671859|NCT00688103|583851420|FG001|Overall Study|Withdrawal by Subject|2|||
161671860|NCT00688103|583851419|FG000|Overall Study|complex reasons|11|||
161671861|NCT00688103|583851420|FG001|Overall Study|complex reasons|9|||
161671862|NCT05959629|583851424|FG000|Overall Study|partially necrotic/technical issues|2|||
161671863|NCT05959629|583851425|FG001|Overall Study|partially necrotic/technical issues|2|||
161671864|NCT02076113|583852977|FG000|Overall Study|Lost to Follow-up|4|||
161671865|NCT02076113|583852978|FG001|Overall Study|Lost to Follow-up|1|||
161671866|NCT02076113|583852977|FG000|Overall Study|Withdrawal by Subject|2|||
161671867|NCT02076113|583852978|FG001|Overall Study|Withdrawal by Subject|3|||
161671868|NCT02076113|583852977|FG000|Overall Study|Death|1|||
161671869|NCT02076113|583852978|FG001|Overall Study|Death|3|||
161671870|NCT00833911|583852979|FG000|Titration|Adverse Event|18|||
161671871|NCT00833911|583852979|FG000|Titration|Withdrawal by Subject|3|||
161671872|NCT00833911|583852979|FG000|Maintenance Phase I|Adverse Event|73|||
161671873|NCT00833911|583852979|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
161671874|NCT00833911|583852979|FG000|Maintenance Phase I|Physician Decision|10|||
161671875|NCT00833911|583852979|FG000|Maintenance Phase I|Lack of Efficacy|4|||
162180161|NCT01596972|585713240|FG000|Overall Study|Lost to Follow-up|0|||
162180162|NCT01596972|585713241|FG001|Overall Study|Lost to Follow-up|4|||
162180163|NCT01596972|585713240|FG000|Overall Study|Withdrawal by Subject|0|||
161671876|NCT00833911|583852979|FG000|Maintenance Phase II|Adverse Event|6|||
162180164|NCT01596972|585713241|FG001|Overall Study|Withdrawal by Subject|1|||
162018742|NCT02136069|585123207|FG001|Overall Study|Adverse Event|8|||
162180165|NCT01639131|585713242|FG000|Overall Study|Disease Progression|6|||
162180166|NCT00945321|585713246|FG000|Period 1|Adverse Event|0|||
162180167|NCT00945321|585713247|FG001|Period 1|Adverse Event|0|||
162180168|NCT00945321|585713248|FG002|Period 1|Adverse Event|0|||
162180169|NCT00945321|585713249|FG003|Period 1|Adverse Event|0|||
162180170|NCT00945321|585713250|FG004|Period 1|Adverse Event|1|||
162180171|NCT00945321|585713251|FG005|Period 1|Adverse Event|0|||
162180172|NCT00945321|585713246|FG000|Period 4|Lost to Follow-up|0|||
162180173|NCT00945321|585713247|FG001|Period 4|Lost to Follow-up|0|||
162180174|NCT00945321|585713248|FG002|Period 4|Lost to Follow-up|0|||
162180175|NCT00945321|585713249|FG003|Period 4|Lost to Follow-up|0|||
162180176|NCT00945321|585713250|FG004|Period 4|Lost to Follow-up|0|||
162180177|NCT00945321|585713251|FG005|Period 4|Lost to Follow-up|1|||
162180178|NCT02438137|585713252|FG000|Overall Study|Lost to Follow-up|3|||
162180179|NCT02438137|585713253|FG001|Overall Study|Lost to Follow-up|2|||
162180180|NCT02438137|585713252|FG000|Overall Study|Adverse Event|1|||
162180181|NCT02438137|585713253|FG001|Overall Study|Adverse Event|0|||
162180182|NCT02438137|585713252|FG000|Overall Study|Withdrawal by Subject|4|||
162180183|NCT02438137|585713253|FG001|Overall Study|Withdrawal by Subject|3|||
162180184|NCT02438137|585713252|FG000|Overall Study|Physician Decision|0|||
162180185|NCT02438137|585713253|FG001|Overall Study|Physician Decision|1|||
162180186|NCT00692913|585713254|FG000|Overall Study|Adverse Event|8|||
162180187|NCT00692913|585713255|FG001|Overall Study|Adverse Event|4|||
162180188|NCT00692913|585713254|FG000|Overall Study|Lost to Follow-up|3|||
162180189|NCT00692913|585713255|FG001|Overall Study|Lost to Follow-up|5|||
162180190|NCT00692913|585713254|FG000|Overall Study|Physician Decision|2|||
162180191|NCT00692913|585713255|FG001|Overall Study|Physician Decision|0|||
162180192|NCT00692913|585713254|FG000|Overall Study|Protocol Violation|1|||
162180193|NCT00692913|585713255|FG001|Overall Study|Protocol Violation|1|||
162180194|NCT00692913|585713254|FG000|Overall Study|Withdrawal by Subject|15|||
162180195|NCT00692913|585713255|FG001|Overall Study|Withdrawal by Subject|20|||
162180196|NCT01637402|585713256|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
162180197|NCT01637402|585713257|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
162180198|NCT01637402|585713256|FG000|Standard Dose Regimen|Adverse Event|1|||
162180199|NCT01637402|585713257|FG001|Standard Dose Regimen|Adverse Event|0|||
161671877|NCT00833911|583852979|FG000|Maintenance Phase II|Physician Decision|2|||
161671878|NCT00833911|583852979|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
162180200|NCT01637402|585713256|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
162180201|NCT01637402|585713257|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
162180202|NCT01637402|585713256|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
162180203|NCT01637402|585713257|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
162180204|NCT01637402|585713256|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
161817814|NCT02003391|584372934|FG000|Overall Study|Protocol Violation|0|||
161817815|NCT02003391|584372935|FG001|Overall Study|Protocol Violation|1|||
161817816|NCT02003391|584372934|FG000|Overall Study|Adverse Event|1|||
161817817|NCT02003391|584372935|FG001|Overall Study|Adverse Event|0|||
161817818|NCT02272803|584372936|FG000|Overall Study|Disease progression|16|||
161817819|NCT02272803|584372937|FG001|Overall Study|Disease progression|8|||
161817820|NCT02272803|584372936|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
161817821|NCT02272803|584372937|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
161817822|NCT02272803|584372936|FG000|Overall Study|Study drug toxicity|4|||
161817823|NCT02272803|584372937|FG001|Overall Study|Study drug toxicity|9|||
161817824|NCT02272803|584372936|FG000|Overall Study|Participant request to discontinue study treatment|3|||
161817825|NCT02272803|584372937|FG001|Overall Study|Participant request to discontinue study treatment|7|||
161817826|NCT02272803|584372936|FG000|Overall Study|Maximum clinical benefit|4|||
161817827|NCT02272803|584372937|FG001|Overall Study|Maximum clinical benefit|2|||
161817828|NCT02272803|584372936|FG000|Overall Study|Poor/non-compliance|2|||
161817829|NCT02272803|584372937|FG001|Overall Study|Poor/non-compliance|2|||
161817830|NCT02272803|584372936|FG000|Overall Study|Withdrawal by Subject|2|||
161817831|NCT02272803|584372937|FG001|Overall Study|Withdrawal by Subject|1|||
161817832|NCT02272803|584372936|FG000|Overall Study|Death|0|||
161817833|NCT02272803|584372937|FG001|Overall Study|Death|1|||
161817834|NCT02272803|584372936|FG000|Overall Study|Other reasons|1|||
161817835|NCT02272803|584372937|FG001|Overall Study|Other reasons|3|||
161817836|NCT02272803|584372936|FG000|Overall Study|Administrative reason by sponsor|5|||
161817837|NCT02272803|584372937|FG001|Overall Study|Administrative reason by sponsor|4|||
161817838|NCT02611323|584372938|FG000|Overall Study|Death|3|||
161817839|NCT02611323|584372939|FG001|Overall Study|Death|1|||
161817840|NCT02611323|584372940|FG002|Overall Study|Death|0|||
161817841|NCT02611323|584372941|FG003|Overall Study|Death|0|||
161817842|NCT02611323|584372942|FG004|Overall Study|Death|1|||
161817843|NCT02611323|584372943|FG005|Overall Study|Death|1|||
161817844|NCT02611323|584372944|FG006|Overall Study|Death|8|||
161817845|NCT02611323|584372945|FG007|Overall Study|Death|0|||
161817846|NCT02611323|584372946|FG008|Overall Study|Death|4|||
161817847|NCT02611323|584372947|FG009|Overall Study|Death|6|||
161817848|NCT02611323|584372948|FG010|Overall Study|Death|26|||
161817849|NCT02611323|584372938|FG000|Overall Study|Lost to Follow-up|1|||
161817850|NCT02611323|584372939|FG001|Overall Study|Lost to Follow-up|0|||
161817851|NCT02611323|584372940|FG002|Overall Study|Lost to Follow-up|0|||
161817852|NCT02611323|584372941|FG003|Overall Study|Lost to Follow-up|0|||
161817853|NCT02611323|584372942|FG004|Overall Study|Lost to Follow-up|0|||
161817854|NCT02611323|584372943|FG005|Overall Study|Lost to Follow-up|0|||
161817855|NCT02611323|584372944|FG006|Overall Study|Lost to Follow-up|3|||
161817856|NCT02611323|584372945|FG007|Overall Study|Lost to Follow-up|0|||
161817857|NCT02611323|584372946|FG008|Overall Study|Lost to Follow-up|0|||
161817858|NCT02611323|584372947|FG009|Overall Study|Lost to Follow-up|0|||
161817859|NCT02611323|584372948|FG010|Overall Study|Lost to Follow-up|2|||
161817860|NCT02611323|584372938|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817861|NCT02611323|584372939|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817862|NCT02611323|584372940|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817863|NCT02611323|584372941|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817864|NCT02611323|584372942|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817865|NCT02611323|584372943|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817866|NCT02611323|584372944|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817867|NCT02611323|584372945|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817868|NCT02611323|584372946|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817869|NCT02611323|584372947|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
161923965|NCT04925934|584768117|FG000|Overall Study|Adverse Event|1|||
161923966|NCT04925934|584768118|FG001|Overall Study|Adverse Event|0|||
161671879|NCT00833911|583852979|FG000|Maintenance Phase II|Lack of Efficacy|1|||
161671880|NCT03942406|583852982|FG000|Overall Study|Lost to Follow-up|4|||
161671881|NCT03942406|583852983|FG001|Overall Study|Lost to Follow-up|5|||
161671882|NCT03942406|583852984|FG002|Overall Study|Lost to Follow-up|3|||
161671883|NCT03942406|583852985|FG003|Overall Study|Lost to Follow-up|7|||
161671884|NCT03942406|583852986|FG004|Overall Study|Lost to Follow-up|1|||
161671885|NCT03942406|583852987|FG005|Overall Study|Lost to Follow-up|0|||
161671886|NCT03942406|583852988|FG006|Overall Study|Lost to Follow-up|0|||
161671887|NCT03942406|583852982|FG000|Overall Study|Withdrawal by Subject|3|||
161671888|NCT03942406|583852983|FG001|Overall Study|Withdrawal by Subject|1|||
161671889|NCT03942406|583852984|FG002|Overall Study|Withdrawal by Subject|1|||
161671890|NCT03942406|583852985|FG003|Overall Study|Withdrawal by Subject|3|||
161671891|NCT03942406|583852986|FG004|Overall Study|Withdrawal by Subject|0|||
161671892|NCT03942406|583852987|FG005|Overall Study|Withdrawal by Subject|0|||
161671893|NCT03942406|583852988|FG006|Overall Study|Withdrawal by Subject|0|||
161671894|NCT03942406|583852982|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
161671895|NCT03942406|583852983|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
161671896|NCT03942406|583852984|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
161671897|NCT03942406|583852985|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
161671898|NCT03942406|583852986|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
161671899|NCT03942406|583852987|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
161671900|NCT03942406|583852988|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
161671901|NCT02616614|583852989|FG000|Overall Study|Withdrawal by Subject|10|||
161671902|NCT02616614|583852990|FG001|Overall Study|Withdrawal by Subject|5|||
161671903|NCT02616614|583852991|FG002|Overall Study|Withdrawal by Subject|6|||
161671904|NCT02616614|583852989|FG000|Overall Study|Physician Decision|2|||
161671905|NCT02616614|583852990|FG001|Overall Study|Physician Decision|1|||
161671906|NCT02616614|583852991|FG002|Overall Study|Physician Decision|0|||
161671907|NCT02616614|583852989|FG000|Overall Study|Adverse Event|1|||
161671908|NCT02616614|583852990|FG001|Overall Study|Adverse Event|4|||
161671909|NCT02616614|583852991|FG002|Overall Study|Adverse Event|1|||
161671910|NCT02616614|583852989|FG000|Overall Study|Protocol Violation|0|||
161671911|NCT02616614|583852990|FG001|Overall Study|Protocol Violation|3|||
161671912|NCT02616614|583852991|FG002|Overall Study|Protocol Violation|1|||
161671913|NCT02616614|583852989|FG000|Overall Study|Prohibited Medication|12|||
161671914|NCT02616614|583852990|FG001|Overall Study|Prohibited Medication|9|||
161671915|NCT02616614|583852991|FG002|Overall Study|Prohibited Medication|5|||
161671916|NCT02616614|583852989|FG000|Overall Study|More than 3 applications missed|6|||
161671917|NCT02616614|583852990|FG001|Overall Study|More than 3 applications missed|8|||
161671918|NCT02616614|583852991|FG002|Overall Study|More than 3 applications missed|1|||
161671919|NCT02616614|583852989|FG000|Overall Study|Lost to Follow-up|31|||
161671920|NCT02616614|583852990|FG001|Overall Study|Lost to Follow-up|28|||
161671921|NCT02616614|583852991|FG002|Overall Study|Lost to Follow-up|13|||
161671922|NCT02616614|583852989|FG000|Overall Study|Pregnancy|2|||
161671923|NCT02616614|583852990|FG001|Overall Study|Pregnancy|0|||
162180205|NCT01637402|585713257|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
162180206|NCT01637402|585713256|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
162180207|NCT01637402|585713257|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
162180208|NCT02111096|585713260|FG000|Overall Study|Adverse Event|4|||
162180209|NCT02111096|585713261|FG001|Overall Study|Adverse Event|1|||
162180210|NCT02111096|585713262|FG002|Overall Study|Adverse Event|2|||
162180211|NCT02111096|585713260|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162180212|NCT02111096|585713261|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162180213|NCT02111096|585713262|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162180214|NCT02111096|585713260|FG000|Overall Study|Lost to Follow Up|1|||
162180215|NCT02111096|585713261|FG001|Overall Study|Lost to Follow Up|1|||
162180216|NCT02111096|585713262|FG002|Overall Study|Lost to Follow Up|1|||
162180217|NCT02111096|585713260|FG000|Overall Study|Physician Decision|0|||
162180218|NCT02111096|585713261|FG001|Overall Study|Physician Decision|1|||
162180219|NCT02111096|585713262|FG002|Overall Study|Physician Decision|0|||
162180220|NCT02111096|585713260|FG000|Overall Study|Protocol Violation|1|||
162180221|NCT02111096|585713261|FG001|Overall Study|Protocol Violation|0|||
162180222|NCT02111096|585713262|FG002|Overall Study|Protocol Violation|1|||
161671924|NCT02616614|583852991|FG002|Overall Study|Pregnancy|1|||
161671925|NCT02616614|583852989|FG000|Overall Study|Other|1|||
161671926|NCT02616614|583852990|FG001|Overall Study|Other|2|||
161671927|NCT02616614|583852991|FG002|Overall Study|Other|1|||
161671928|NCT02748018|583852992|FG000|Study Period|Adverse Event|1|||
162180223|NCT02111096|585713260|FG000|Overall Study|Terminated by Sponsor|53|||
162180224|NCT02111096|585713261|FG001|Overall Study|Terminated by Sponsor|35|||
161671929|NCT02748018|583852993|FG001|Study Period|Adverse Event|3|||
161671930|NCT02748018|583852994|FG002|Study Period|Adverse Event|4|||
161671931|NCT02748018|583852995|FG003|Study Period|Adverse Event|0|||
161671932|NCT02748018|583852996|FG004|Study Period|Adverse Event|3|||
161671933|NCT02748018|583852997|FG005|Study Period|Adverse Event|3|||
161671934|NCT02748018|583852992|FG000|Study Period|Withdrawal by Subject|7|||
162180225|NCT02111096|585713262|FG002|Overall Study|Terminated by Sponsor|54|||
162180226|NCT02111096|585713260|FG000|Overall Study|Withdrawal by Subject|4|||
162180227|NCT02111096|585713261|FG001|Overall Study|Withdrawal by Subject|2|||
162180228|NCT02111096|585713262|FG002|Overall Study|Withdrawal by Subject|8|||
162180229|NCT00439270|585713265|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
162180230|NCT00439270|585713266|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
162180231|NCT00439270|585713267|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
162180232|NCT00439270|585713268|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
162180233|NCT00439270|585713269|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
162180234|NCT00439270|585713265|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
162180235|NCT00439270|585713266|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
162180236|NCT00439270|585713267|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
161671935|NCT02748018|583852993|FG001|Study Period|Withdrawal by Subject|4|||
161671936|NCT02748018|583852994|FG002|Study Period|Withdrawal by Subject|4|||
161671937|NCT02748018|583852995|FG003|Study Period|Withdrawal by Subject|11|||
161671938|NCT02748018|583852996|FG004|Study Period|Withdrawal by Subject|12|||
161671939|NCT02748018|583852997|FG005|Study Period|Withdrawal by Subject|10|||
161671940|NCT02748018|583852992|FG000|Study Period|Pregnancy|0|||
161671941|NCT02748018|583852993|FG001|Study Period|Pregnancy|1|||
161671942|NCT02748018|583852994|FG002|Study Period|Pregnancy|0|||
161671943|NCT02748018|583852995|FG003|Study Period|Pregnancy|0|||
161671944|NCT02748018|583852996|FG004|Study Period|Pregnancy|1|||
161671945|NCT02748018|583852997|FG005|Study Period|Pregnancy|0|||
161671946|NCT02748018|583852992|FG000|Study Period|Physician Decision|2|||
161671947|NCT02748018|583852993|FG001|Study Period|Physician Decision|2|||
161671948|NCT02748018|583852994|FG002|Study Period|Physician Decision|1|||
161671949|NCT02748018|583852995|FG003|Study Period|Physician Decision|0|||
161671950|NCT02748018|583852996|FG004|Study Period|Physician Decision|2|||
161671951|NCT02748018|583852997|FG005|Study Period|Physician Decision|0|||
161671952|NCT02748018|583852992|FG000|Study Period|Lost to Follow-up|0|||
161671953|NCT02748018|583852993|FG001|Study Period|Lost to Follow-up|0|||
161671954|NCT02748018|583852994|FG002|Study Period|Lost to Follow-up|0|||
161671955|NCT02748018|583852995|FG003|Study Period|Lost to Follow-up|2|||
161671956|NCT02748018|583852996|FG004|Study Period|Lost to Follow-up|0|||
161671957|NCT02748018|583852997|FG005|Study Period|Lost to Follow-up|1|||
161671958|NCT02748018|583852992|FG000|Continuation Period|Adverse Event|2|||
161671959|NCT02748018|583852993|FG001|Continuation Period|Adverse Event|0|||
161671960|NCT02748018|583852994|FG002|Continuation Period|Adverse Event|1|||
161671961|NCT02748018|583852995|FG003|Continuation Period|Adverse Event|1|||
161671962|NCT02748018|583852996|FG004|Continuation Period|Adverse Event|1|||
161671963|NCT02748018|583852997|FG005|Continuation Period|Adverse Event|4|||
161671964|NCT02748018|583852992|FG000|Continuation Period|Withdrawal by Subject|3|||
161671965|NCT02748018|583852993|FG001|Continuation Period|Withdrawal by Subject|5|||
161671966|NCT02748018|583852994|FG002|Continuation Period|Withdrawal by Subject|3|||
162180237|NCT00439270|585713268|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
162180238|NCT00439270|585713269|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
162180239|NCT00439270|585713265|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
162180240|NCT00439270|585713266|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
162180241|NCT00439270|585713267|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
161671967|NCT02748018|583852995|FG003|Continuation Period|Withdrawal by Subject|9|||
161671968|NCT02748018|583852996|FG004|Continuation Period|Withdrawal by Subject|11|||
161671969|NCT02748018|583852997|FG005|Continuation Period|Withdrawal by Subject|1|||
161671970|NCT02748018|583852992|FG000|Continuation Period|Lost to Follow-up|0|||
161671971|NCT02748018|583852993|FG001|Continuation Period|Lost to Follow-up|2|||
161671972|NCT02748018|583852994|FG002|Continuation Period|Lost to Follow-up|1|||
161671973|NCT02748018|583852995|FG003|Continuation Period|Lost to Follow-up|0|||
161671974|NCT02748018|583852996|FG004|Continuation Period|Lost to Follow-up|1|||
161671975|NCT02748018|583852997|FG005|Continuation Period|Lost to Follow-up|0|||
161671976|NCT02748018|583852992|FG000|Continuation Period|Pregnancy|1|||
161671977|NCT02748018|583852993|FG001|Continuation Period|Pregnancy|2|||
161671978|NCT02748018|583852994|FG002|Continuation Period|Pregnancy|0|||
161671979|NCT02748018|583852995|FG003|Continuation Period|Pregnancy|0|||
162018743|NCT02136069|585123206|FG000|Overall Study|Death|0|||
162018744|NCT02136069|585123207|FG001|Overall Study|Death|1|||
162180242|NCT00439270|585713268|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
162180243|NCT00439270|585713269|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
162180244|NCT00439270|585713265|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
162180245|NCT00439270|585713266|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
161671980|NCT02748018|583852996|FG004|Continuation Period|Pregnancy|0|||
161671981|NCT02748018|583852997|FG005|Continuation Period|Pregnancy|0|||
161671982|NCT02748018|583852992|FG000|Continuation Period|Physician Decision|0|||
161671983|NCT02748018|583852993|FG001|Continuation Period|Physician Decision|1|||
162180246|NCT00439270|585713267|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
161671984|NCT02748018|583852994|FG002|Continuation Period|Physician Decision|2|||
161671985|NCT02748018|583852995|FG003|Continuation Period|Physician Decision|0|||
161671986|NCT02748018|583852996|FG004|Continuation Period|Physician Decision|2|||
161671987|NCT02748018|583852997|FG005|Continuation Period|Physician Decision|1|||
161671988|NCT02748018|583852992|FG000|Continuation Period|Protocol Violation|0|||
162018745|NCT02136069|585123206|FG000|Overall Study|Lack of Efficacy|10|||
162180247|NCT00439270|585713268|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
162180248|NCT00439270|585713269|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
162180249|NCT00439270|585713265|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
162180250|NCT00439270|585713266|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
162180251|NCT00439270|585713267|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
162180252|NCT00439270|585713268|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
162180253|NCT00439270|585713269|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
162180254|NCT00439270|585713265|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
162180255|NCT00439270|585713266|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
162180256|NCT00439270|585713267|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
162180257|NCT00439270|585713268|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
162180258|NCT00439270|585713269|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
162180259|NCT00439270|585713265|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
162180260|NCT00439270|585713266|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
162180261|NCT00439270|585713267|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
162180262|NCT00439270|585713268|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
162180263|NCT00439270|585713269|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
162180264|NCT00439270|585713265|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
162180265|NCT00439270|585713266|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
162180266|NCT00439270|585713267|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
162180267|NCT00439270|585713268|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
162180268|NCT00439270|585713269|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
162180269|NCT00439270|585713265|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
162180270|NCT00439270|585713266|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
161817870|NCT02611323|584372948|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
161817871|NCT02611323|584372938|FG000|Overall Study|Progressive Disease|0|||
161817872|NCT02611323|584372939|FG001|Overall Study|Progressive Disease|0|||
161817873|NCT02611323|584372940|FG002|Overall Study|Progressive Disease|0|||
161817874|NCT02611323|584372941|FG003|Overall Study|Progressive Disease|0|||
161817875|NCT02611323|584372942|FG004|Overall Study|Progressive Disease|0|||
161817876|NCT02611323|584372943|FG005|Overall Study|Progressive Disease|0|||
161817877|NCT02611323|584372944|FG006|Overall Study|Progressive Disease|0|||
161817878|NCT02611323|584372945|FG007|Overall Study|Progressive Disease|0|||
161817879|NCT02611323|584372946|FG008|Overall Study|Progressive Disease|0|||
161817880|NCT02611323|584372947|FG009|Overall Study|Progressive Disease|0|||
161817881|NCT02611323|584372948|FG010|Overall Study|Progressive Disease|1|||
161817882|NCT02611323|584372938|FG000|Overall Study|Withdrawal by Subject|1|||
161817883|NCT02611323|584372939|FG001|Overall Study|Withdrawal by Subject|0|||
161817884|NCT02611323|584372940|FG002|Overall Study|Withdrawal by Subject|0|||
161817885|NCT02611323|584372941|FG003|Overall Study|Withdrawal by Subject|0|||
161817886|NCT02611323|584372942|FG004|Overall Study|Withdrawal by Subject|0|||
161817887|NCT02611323|584372943|FG005|Overall Study|Withdrawal by Subject|0|||
161817888|NCT02611323|584372944|FG006|Overall Study|Withdrawal by Subject|0|||
161817889|NCT02611323|584372945|FG007|Overall Study|Withdrawal by Subject|1|||
161817890|NCT02611323|584372946|FG008|Overall Study|Withdrawal by Subject|0|||
161817891|NCT02611323|584372947|FG009|Overall Study|Withdrawal by Subject|1|||
161817892|NCT02611323|584372948|FG010|Overall Study|Withdrawal by Subject|0|||
161817893|NCT00243347|584372949|FG000|Overall Study|Lack of Efficacy|4|||
161817894|NCT00243347|584372949|FG000|Overall Study|Adverse Event|2|||
161817895|NCT00243347|584372949|FG000|Overall Study|Death|1|||
161817896|NCT00243347|584372949|FG000|Overall Study|Withdrawal by Subject|5|||
161817897|NCT00243347|584372949|FG000|Overall Study|Condition worsened|7|||
161817898|NCT02011945|584372956|FG000|Overall Study|Participant requested to Discontinue|0|||
161817899|NCT02011945|584372957|FG001|Overall Study|Participant requested to Discontinue|1|||
161817900|NCT02011945|584372958|FG002|Overall Study|Participant requested to Discontinue|1|||
161817901|NCT02011945|584372956|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
161817902|NCT02011945|584372957|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
161817903|NCT02011945|584372958|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
161817904|NCT02011945|584372956|FG000|Overall Study|Study Drug Toxicity|0|||
161817905|NCT02011945|584372957|FG001|Overall Study|Study Drug Toxicity|0|||
161817906|NCT02011945|584372958|FG002|Overall Study|Study Drug Toxicity|1|||
161817907|NCT02011945|584372956|FG000|Overall Study|Treatment Failure|0|||
161817908|NCT02011945|584372957|FG001|Overall Study|Treatment Failure|7|||
162180271|NCT00439270|585713267|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
162180272|NCT00439270|585713268|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
162180273|NCT00439270|585713269|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
161817909|NCT02011945|584372958|FG002|Overall Study|Treatment Failure|6|||
161817910|NCT02011945|584372956|FG000|Overall Study|No Longer Meets Study Criteria|1|||
161817911|NCT02011945|584372957|FG001|Overall Study|No Longer Meets Study Criteria|0|||
161817912|NCT02011945|584372958|FG002|Overall Study|No Longer Meets Study Criteria|0|||
161817913|NCT02011945|584372956|FG000|Overall Study|Proceeded to stem cell transplant|0|||
161817914|NCT02011945|584372957|FG001|Overall Study|Proceeded to stem cell transplant|0|||
162180274|NCT00439270|585713265|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
162180275|NCT00439270|585713266|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
162180276|NCT00439270|585713267|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
162180277|NCT00439270|585713268|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
162180278|NCT00439270|585713269|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
162180279|NCT01268306|585713270|FG000|Overall Study|Lost to Follow-up|1|||
162180280|NCT03774472|585713285|FG000|Overall Study|Physician Decision|1|||
162180281|NCT03774472|585713286|FG001|Overall Study|Physician Decision|0|||
162180282|NCT03774472|585713287|FG002|Overall Study|Physician Decision|0|||
162180283|NCT03774472|585713285|FG000|Overall Study|Progression prior to 4 weeks|0|||
162180284|NCT03774472|585713286|FG001|Overall Study|Progression prior to 4 weeks|1|||
162180285|NCT03774472|585713287|FG002|Overall Study|Progression prior to 4 weeks|0|||
162180286|NCT03774472|585713285|FG000|Overall Study|Withdrawal by Subject|0|||
162180287|NCT03774472|585713286|FG001|Overall Study|Withdrawal by Subject|1|||
162180288|NCT03774472|585713287|FG002|Overall Study|Withdrawal by Subject|0|||
162180289|NCT04059406|585713288|FG000|Overall Study|Early Treatment Termination|5|||
162180290|NCT04059406|585713289|FG001|Overall Study|Early Treatment Termination|5|||
162180291|NCT04059406|585713290|FG002|Overall Study|Early Treatment Termination|15|||
162180292|NCT05155306|585713295|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
162180293|NCT05155306|585713296|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
162180294|NCT05155306|585713297|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
162180295|NCT05155306|585713298|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
162180296|NCT05155306|585713295|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
162180297|NCT05155306|585713296|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
161671989|NCT02748018|583852993|FG001|Continuation Period|Protocol Violation|1|||
161671990|NCT02748018|583852994|FG002|Continuation Period|Protocol Violation|0|||
161671991|NCT02748018|583852995|FG003|Continuation Period|Protocol Violation|0|||
161671992|NCT02748018|583852996|FG004|Continuation Period|Protocol Violation|0|||
161671993|NCT02748018|583852997|FG005|Continuation Period|Protocol Violation|0|||
161671994|NCT06069778|583852998|FG000|Overall Study|Withdrawal by Subject|1|||
161671995|NCT03801902|583852999|FG000|Overall Study|Did not receive protocol treatment.|1|||
161671996|NCT03801902|583853000|FG001|Overall Study|Did not receive protocol treatment.|0|||
161671997|NCT03801902|583853001|FG002|Overall Study|Did not receive protocol treatment.|0|||
161671998|NCT03801902|583853002|FG003|Overall Study|Did not receive protocol treatment.|0|||
161671999|NCT04704336|583853008|FG000|Overall Study|Death|2|||
161672000|NCT04704336|583853009|FG001|Overall Study|Death|2|||
161672001|NCT04704336|583853008|FG000|Overall Study|Lost to Follow-up|33|||
161672002|NCT04704336|583853009|FG001|Overall Study|Lost to Follow-up|40|||
161672003|NCT02260882|583853010|FG000|Overall Study|Protocol Violation|0|||
161672004|NCT02260882|583853011|FG001|Overall Study|Protocol Violation|1|||
161672005|NCT02119325|583853012|FG000|Washout Period 1|Adverse Event|0|||
161672006|NCT02119325|583853013|FG001|Washout Period 1|Adverse Event|1|||
161672007|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
161672008|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
161672009|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
161672010|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
161672011|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
161672012|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
161672013|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
161672014|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
161672015|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Death|1|||
161672016|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Death|1|||
161672017|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
161672018|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
161672019|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
161672020|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
161672021|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
161672022|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
161672023|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
161672024|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
161672025|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
161672026|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
161817915|NCT02011945|584372958|FG002|Overall Study|Proceeded to stem cell transplant|1|||
161817916|NCT02011945|584372956|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
161672027|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
161672028|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
161817917|NCT02011945|584372957|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
161817918|NCT02011945|584372958|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
161817919|NCT03531827|584372959|FG000|Overall Study|Adverse Event|2|||
162180298|NCT05155306|585713297|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
162180299|NCT05155306|585713298|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
162180300|NCT04158141|585713299|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
162180301|NCT04158141|585713300|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
162180302|NCT04158141|585713301|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
162180303|NCT04158141|585713299|FG000|Step 1: Registration|Adverse Event|1|||
162180304|NCT04158141|585713300|FG001|Step 1: Registration|Adverse Event|0|||
162180305|NCT04158141|585713301|FG002|Step 1: Registration|Adverse Event|0|||
162180306|NCT04158141|585713299|FG000|Step 1: Registration|Withdrawal by Subject|1|||
162180307|NCT04158141|585713300|FG001|Step 1: Registration|Withdrawal by Subject|0|||
162180308|NCT04158141|585713301|FG002|Step 1: Registration|Withdrawal by Subject|0|||
162180309|NCT04158141|585713299|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
162180310|NCT04158141|585713300|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
162180311|NCT04158141|585713301|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
162180312|NCT04121741|585713302|FG000|Overall Study|Protocol Violation|1|||
162180313|NCT04121741|585713303|FG001|Overall Study|Protocol Violation|0|||
162180314|NCT04121741|585713304|FG002|Overall Study|Protocol Violation|0|||
162180315|NCT04121741|585713305|FG003|Overall Study|Protocol Violation|0|||
162180316|NCT04121741|585713306|FG004|Overall Study|Protocol Violation|0|||
162180317|NCT04121741|585713307|FG005|Overall Study|Protocol Violation|0|||
162180318|NCT01084863|585713309|FG000|Main Study Treatment Period|Disease progression|11|||
162180319|NCT01084863|585713310|FG001|Main Study Treatment Period|Disease progression|7|||
162180320|NCT01084863|585713309|FG000|Main Study Treatment Period|Adverse Event|5|||
162180321|NCT01084863|585713310|FG001|Main Study Treatment Period|Adverse Event|3|||
162180322|NCT01084863|585713309|FG000|Main Study Treatment Period|Other Reason|0|||
162180323|NCT01084863|585713310|FG001|Main Study Treatment Period|Other Reason|1|||
162180324|NCT01084863|585713309|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
162180325|NCT01084863|585713310|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
162180326|NCT01084863|585713309|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
162180327|NCT01084863|585713310|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
162180328|NCT01084863|585713309|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
162180329|NCT01084863|585713310|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
162180330|NCT01084863|585713309|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
162180331|NCT01084863|585713310|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
162180332|NCT01084863|585713309|FG000|Treatment Period Beyond Cycle 8|Other|0|||
162180333|NCT01084863|585713310|FG001|Treatment Period Beyond Cycle 8|Other|1|||
162180334|NCT01084863|585713309|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
162180335|NCT01084863|585713310|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
162180336|NCT04505722|585713311|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
162180337|NCT04505722|585713312|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
162180338|NCT04505722|585713313|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
162180339|NCT04505722|585713311|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
162180340|NCT04505722|585713312|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
162180341|NCT04505722|585713313|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
162180342|NCT04505722|585713311|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
162180343|NCT04505722|585713312|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
162180344|NCT04505722|585713313|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
162180345|NCT04505722|585713311|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
162180346|NCT04505722|585713312|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
162180347|NCT04505722|585713313|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
162180348|NCT04505722|585713311|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
162180349|NCT04505722|585713312|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
162180350|NCT04505722|585713313|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
162180351|NCT04505722|585713311|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
162180352|NCT04505722|585713312|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
162180353|NCT04505722|585713313|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
162180354|NCT04505722|585713311|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
162180355|NCT04505722|585713312|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
162180356|NCT04505722|585713313|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
162180357|NCT04505722|585713311|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
162180358|NCT04505722|585713312|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
162180359|NCT04505722|585713313|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
162180360|NCT04505722|585713311|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
162180361|NCT04505722|585713312|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
162180362|NCT04505722|585713313|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
162180363|NCT04505722|585713311|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
162180364|NCT04505722|585713312|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
162180365|NCT04505722|585713313|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
162180366|NCT04505722|585713311|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
162180367|NCT04505722|585713312|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
162180368|NCT04505722|585713313|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
162180369|NCT04505722|585713311|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
162180370|NCT04505722|585713312|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
162180371|NCT04505722|585713313|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
162180372|NCT04505722|585713311|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
162180373|NCT04505722|585713312|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
162180374|NCT04505722|585713313|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
162180375|NCT04505722|585713311|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
162180376|NCT04505722|585713312|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
162180377|NCT04505722|585713313|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
162180378|NCT04505722|585713311|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
162180379|NCT04505722|585713312|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
162180380|NCT04505722|585713313|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
162180381|NCT04755595|585713314|FG000|Overall Study|Lost to Follow-up|1|||
162180382|NCT04305327|585713317|FG000|Overall Study|Study early termination|2|||
162180383|NCT04305327|585713318|FG001|Overall Study|Study early termination|5|||
162180384|NCT04305327|585713319|FG002|Overall Study|Study early termination|2|||
162180385|NCT04305327|585713320|FG003|Overall Study|Study early termination|2|||
162180386|NCT04305327|585713317|FG000|Overall Study|Withdrawal by Subject|0|||
161672029|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
162180387|NCT04305327|585713318|FG001|Overall Study|Withdrawal by Subject|1|||
162180388|NCT04305327|585713319|FG002|Overall Study|Withdrawal by Subject|0|||
162180389|NCT04305327|585713320|FG003|Overall Study|Withdrawal by Subject|0|||
162180390|NCT05864209|585714365|FG000|Overall Study|Lost to Follow-up|2|||
162180391|NCT05864209|585714366|FG001|Overall Study|Lost to Follow-up|3|||
162180392|NCT04530487|585714367|FG000|Overall Study|Death|1|||
162180393|NCT04977583|585714368|FG000|Overall Study|Lost to Follow-up|8|||
162180394|NCT04977583|585714369|FG001|Overall Study|Lost to Follow-up|4|||
162180395|NCT04977583|585714370|FG002|Overall Study|Lost to Follow-up|13|||
162180396|NCT04977583|585714368|FG000|Overall Study|Withdrawal by Subject|3|||
162180397|NCT04977583|585714369|FG001|Overall Study|Withdrawal by Subject|2|||
162180398|NCT04977583|585714370|FG002|Overall Study|Withdrawal by Subject|1|||
162180399|NCT00146172|585714375|FG000|Overall Study|Adverse Event|0|||
162180400|NCT00146172|585714376|FG001|Overall Study|Adverse Event|0|||
162180401|NCT00146172|585714377|FG002|Overall Study|Adverse Event|1|||
162180402|NCT00146172|585714378|FG003|Overall Study|Adverse Event|1|||
162180403|NCT00146172|585714379|FG004|Overall Study|Adverse Event|0|||
162180404|NCT00146172|585714380|FG005|Overall Study|Adverse Event|2|||
162180405|NCT00146172|585714381|FG006|Overall Study|Adverse Event|3|||
162180406|NCT00146172|585714382|FG007|Overall Study|Adverse Event|10|||
162180407|NCT00146172|585714375|FG000|Overall Study|Lost to Follow-up|0|||
162180408|NCT00146172|585714376|FG001|Overall Study|Lost to Follow-up|0|||
162180409|NCT00146172|585714377|FG002|Overall Study|Lost to Follow-up|0|||
162180410|NCT00146172|585714378|FG003|Overall Study|Lost to Follow-up|0|||
162180411|NCT00146172|585714379|FG004|Overall Study|Lost to Follow-up|0|||
162180412|NCT00146172|585714380|FG005|Overall Study|Lost to Follow-up|0|||
162180413|NCT00146172|585714381|FG006|Overall Study|Lost to Follow-up|0|||
162180414|NCT00146172|585714382|FG007|Overall Study|Lost to Follow-up|1|||
162180415|NCT00146172|585714375|FG000|Overall Study|Disease Progression|2|||
162180416|NCT00146172|585714376|FG001|Overall Study|Disease Progression|4|||
162180417|NCT00146172|585714377|FG002|Overall Study|Disease Progression|2|||
161672030|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
161672031|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
161672032|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
161672033|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
161672034|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
161672035|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
161672036|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
161672037|NCT00559585|583853016|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
161672038|NCT00559585|583853017|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
161672039|NCT00559585|583853016|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
161672040|NCT00559585|583853017|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
161672041|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
161672042|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
161672043|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
161672044|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
161672045|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
161672046|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
161672047|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
161672048|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
161672049|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
161672050|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
162018746|NCT02136069|585123207|FG001|Overall Study|Lack of Efficacy|4|||
162018747|NCT02136069|585123206|FG000|Overall Study|Lost to Follow-up|1|||
162018748|NCT02136069|585123207|FG001|Overall Study|Lost to Follow-up|0|||
162018749|NCT02136069|585123206|FG000|Overall Study|Non-Compliance|1|||
162018750|NCT02136069|585123207|FG001|Overall Study|Non-Compliance|0|||
162018751|NCT02136069|585123206|FG000|Overall Study|Physician Decision|5|||
161672051|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
161672052|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
161672053|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
161672054|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
161672055|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
161672056|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
161672057|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
161672058|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
161672059|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
161672060|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
161672061|NCT00559585|583853016|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
161672062|NCT00559585|583853017|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
161672063|NCT04209621|583853018|FG000|Overall Study|Death|1|||
161672064|NCT04209621|583853018|FG000|Overall Study|Study Terminated Early|2|||
161672065|NCT02249767|583853019|FG000|Overall Study|Did not use medication|8|||
161672066|NCT02249767|583853020|FG001|Overall Study|Did not use medication|9|||
161672067|NCT02249767|583853021|FG002|Overall Study|Did not use medication|8|||
161672068|NCT01372410|583853022|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
161672069|NCT01372410|583853023|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
161672070|NCT01372410|583853024|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161672071|NCT01372410|583853025|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161672072|NCT01372410|583853026|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
161672073|NCT01372410|583853027|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161923967|NCT04925934|584768119|FG002|Overall Study|Adverse Event|0|||
161672074|NCT01372410|583853028|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161672075|NCT01372410|583853029|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161672076|NCT01372410|583853022|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
161672077|NCT01372410|583853023|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
161672078|NCT01372410|583853024|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
161672079|NCT01372410|583853025|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
161672080|NCT01372410|583853026|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
161923968|NCT04925934|584768117|FG000|Overall Study|Lost to Follow-up|2|||
161923969|NCT04925934|584768118|FG001|Overall Study|Lost to Follow-up|0|||
161923970|NCT04925934|584768119|FG002|Overall Study|Lost to Follow-up|1|||
161923971|NCT04925934|584768117|FG000|Overall Study|Death|0|||
161923972|NCT04925934|584768118|FG001|Overall Study|Death|1|||
161923973|NCT04925934|584768119|FG002|Overall Study|Death|0|||
161923974|NCT04925934|584768117|FG000|Overall Study|Withdrawal by Subject|8|||
161923975|NCT04925934|584768118|FG001|Overall Study|Withdrawal by Subject|5|||
161923976|NCT04925934|584768119|FG002|Overall Study|Withdrawal by Subject|9|||
161923977|NCT04925934|584768117|FG000|Overall Study|Other|2|||
161923978|NCT04925934|584768118|FG001|Overall Study|Other|2|||
161923979|NCT04925934|584768119|FG002|Overall Study|Other|2|||
162018752|NCT02136069|585123207|FG001|Overall Study|Physician Decision|4|||
161923980|NCT04925934|584768117|FG000|Overall Study|Eastern European Conflict|7|||
161923981|NCT04925934|584768118|FG001|Overall Study|Eastern European Conflict|3|||
161923982|NCT04925934|584768119|FG002|Overall Study|Eastern European Conflict|2|||
161923983|NCT04425018|584768120|FG000|Overall Study|Withdrawal by Subject|1|||
161672081|NCT01372410|583853027|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
161672082|NCT01372410|583853028|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
161672083|NCT01372410|583853029|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
161672084|NCT01372410|583853022|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161672085|NCT01372410|583853023|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161923984|NCT04425018|584768121|FG001|Overall Study|Withdrawal by Subject|2|||
161923985|NCT02503865|584768122|FG000|Overall Study|Moved out of area|1|||
161923986|NCT02503865|584768123|FG001|Overall Study|Moved out of area|8|||
161923987|NCT02503865|584768124|FG002|Overall Study|Moved out of area|0|||
161923988|NCT02503865|584768122|FG000|Overall Study|Refused treatment|4|||
161923989|NCT02503865|584768123|FG001|Overall Study|Refused treatment|39|||
161923990|NCT02503865|584768124|FG002|Overall Study|Refused treatment|2|||
161923991|NCT00849472|584768133|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
161923992|NCT00849472|584768133|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
161923993|NCT00849472|584768133|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
161923994|NCT00849472|584768133|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
161923995|NCT00849472|584768133|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
161923996|NCT00849472|584768133|FG000|Weekly Paclitaxel|Disease Progression|1|||
161923997|NCT00849472|584768133|FG000|Weekly Paclitaxel|Adverse Event|11|||
161923998|NCT00849472|584768133|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
161923999|NCT00849472|584768133|FG000|Weekly Paclitaxel|Physician Decision|3|||
161924000|NCT00849472|584768133|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
161924001|NCT00849472|584768133|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
161924002|NCT00849472|584768133|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
161924003|NCT00849472|584768133|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
161924004|NCT00849472|584768133|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
161924005|NCT00849472|584768133|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
161924006|NCT00849472|584768133|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
161924007|NCT00849472|584768133|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
161924008|NCT05128942|584768134|FG000|Overall Study|Withdrawal by Subject|1|||
161924009|NCT05128942|584768135|FG001|Overall Study|Withdrawal by Subject|0|||
161924010|NCT05128942|584768136|FG002|Overall Study|Withdrawal by Subject|1|||
161924011|NCT05128942|584768137|FG003|Overall Study|Withdrawal by Subject|0|||
161924012|NCT05128942|584768138|FG004|Overall Study|Withdrawal by Subject|0|||
161924013|NCT05128942|584768139|FG005|Overall Study|Withdrawal by Subject|0|||
161924014|NCT05128942|584768140|FG006|Overall Study|Withdrawal by Subject|0|||
161924015|NCT05128942|584768141|FG007|Overall Study|Withdrawal by Subject|0|||
161924016|NCT05128942|584768142|FG008|Overall Study|Withdrawal by Subject|0|||
161924017|NCT05128942|584768134|FG000|Overall Study|Other|2|||
161924018|NCT05128942|584768135|FG001|Overall Study|Other|0|||
161924019|NCT05128942|584768136|FG002|Overall Study|Other|2|||
161924020|NCT05128942|584768137|FG003|Overall Study|Other|0|||
161924021|NCT05128942|584768138|FG004|Overall Study|Other|0|||
161924022|NCT05128942|584768139|FG005|Overall Study|Other|0|||
161924023|NCT05128942|584768140|FG006|Overall Study|Other|0|||
161924024|NCT05128942|584768141|FG007|Overall Study|Other|0|||
161924025|NCT05128942|584768142|FG008|Overall Study|Other|0|||
161924026|NCT05128942|584768134|FG000|Overall Study|Termination by Sponsor|2|||
161924027|NCT05128942|584768135|FG001|Overall Study|Termination by Sponsor|6|||
161924028|NCT05128942|584768136|FG002|Overall Study|Termination by Sponsor|14|||
161924029|NCT05128942|584768137|FG003|Overall Study|Termination by Sponsor|2|||
161924030|NCT05128942|584768138|FG004|Overall Study|Termination by Sponsor|4|||
161924031|NCT05128942|584768139|FG005|Overall Study|Termination by Sponsor|8|||
161924032|NCT05128942|584768140|FG006|Overall Study|Termination by Sponsor|11|||
161924033|NCT05128942|584768141|FG007|Overall Study|Termination by Sponsor|6|||
161924034|NCT05128942|584768142|FG008|Overall Study|Termination by Sponsor|0|||
161924035|NCT05128942|584768134|FG000|Overall Study|Adverse Event|0|||
161924036|NCT05128942|584768135|FG001|Overall Study|Adverse Event|0|||
161924037|NCT05128942|584768136|FG002|Overall Study|Adverse Event|0|||
161924038|NCT05128942|584768137|FG003|Overall Study|Adverse Event|0|||
161924039|NCT05128942|584768138|FG004|Overall Study|Adverse Event|0|||
161924040|NCT05128942|584768139|FG005|Overall Study|Adverse Event|0|||
161924041|NCT05128942|584768140|FG006|Overall Study|Adverse Event|1|||
161924042|NCT05128942|584768141|FG007|Overall Study|Adverse Event|1|||
161924043|NCT05128942|584768142|FG008|Overall Study|Adverse Event|0|||
161924044|NCT05128942|584768134|FG000|Overall Study|Lost to Follow-up|0|||
161924045|NCT05128942|584768135|FG001|Overall Study|Lost to Follow-up|0|||
161924046|NCT05128942|584768136|FG002|Overall Study|Lost to Follow-up|0|||
161924047|NCT05128942|584768137|FG003|Overall Study|Lost to Follow-up|0|||
161924048|NCT05128942|584768138|FG004|Overall Study|Lost to Follow-up|1|||
161924049|NCT05128942|584768139|FG005|Overall Study|Lost to Follow-up|0|||
161924050|NCT05128942|584768140|FG006|Overall Study|Lost to Follow-up|0|||
162180418|NCT00146172|585714378|FG003|Overall Study|Disease Progression|5|||
162180419|NCT00146172|585714379|FG004|Overall Study|Disease Progression|2|||
162180420|NCT00146172|585714380|FG005|Overall Study|Disease Progression|2|||
162180421|NCT00146172|585714381|FG006|Overall Study|Disease Progression|1|||
162180422|NCT00146172|585714382|FG007|Overall Study|Disease Progression|22|||
162180423|NCT00146172|585714375|FG000|Overall Study|Death|0|||
162180424|NCT00146172|585714376|FG001|Overall Study|Death|0|||
162180425|NCT00146172|585714377|FG002|Overall Study|Death|0|||
162180426|NCT00146172|585714378|FG003|Overall Study|Death|0|||
162180427|NCT00146172|585714379|FG004|Overall Study|Death|0|||
162180428|NCT00146172|585714380|FG005|Overall Study|Death|0|||
162180429|NCT00146172|585714381|FG006|Overall Study|Death|1|||
162180430|NCT00146172|585714382|FG007|Overall Study|Death|0|||
162180431|NCT00146172|585714375|FG000|Overall Study|Physician Decision|0|||
162180432|NCT00146172|585714376|FG001|Overall Study|Physician Decision|0|||
162180433|NCT00146172|585714377|FG002|Overall Study|Physician Decision|0|||
162180434|NCT00146172|585714378|FG003|Overall Study|Physician Decision|0|||
162180435|NCT00146172|585714379|FG004|Overall Study|Physician Decision|0|||
162180436|NCT00146172|585714380|FG005|Overall Study|Physician Decision|0|||
162180437|NCT00146172|585714381|FG006|Overall Study|Physician Decision|0|||
162180438|NCT00146172|585714382|FG007|Overall Study|Physician Decision|1|||
162180439|NCT00146172|585714375|FG000|Overall Study|Withdrawal by Subject|0|||
162180440|NCT00146172|585714376|FG001|Overall Study|Withdrawal by Subject|0|||
162180441|NCT00146172|585714377|FG002|Overall Study|Withdrawal by Subject|0|||
162180442|NCT00146172|585714378|FG003|Overall Study|Withdrawal by Subject|0|||
162180443|NCT00146172|585714379|FG004|Overall Study|Withdrawal by Subject|0|||
162180444|NCT00146172|585714380|FG005|Overall Study|Withdrawal by Subject|1|||
162180445|NCT00146172|585714381|FG006|Overall Study|Withdrawal by Subject|1|||
162180446|NCT00146172|585714382|FG007|Overall Study|Withdrawal by Subject|4|||
162180447|NCT00146172|585714375|FG000|Overall Study|Symptomatic Deterioration|1|||
162180448|NCT00146172|585714376|FG001|Overall Study|Symptomatic Deterioration|0|||
162180449|NCT00146172|585714377|FG002|Overall Study|Symptomatic Deterioration|1|||
162180450|NCT00146172|585714378|FG003|Overall Study|Symptomatic Deterioration|0|||
162180451|NCT00146172|585714379|FG004|Overall Study|Symptomatic Deterioration|1|||
162180452|NCT00146172|585714380|FG005|Overall Study|Symptomatic Deterioration|2|||
162180453|NCT00146172|585714381|FG006|Overall Study|Symptomatic Deterioration|0|||
162180454|NCT00146172|585714382|FG007|Overall Study|Symptomatic Deterioration|2|||
162180455|NCT00210106|585714383|FG000|Overall Study|Death|1|||
162180456|NCT00210106|585714383|FG000|Overall Study|Protocol Violation|13|||
162180457|NCT00786864|585714384|FG000|Overall Study|Lost to Follow-up|0|||
162180458|NCT00786864|585714385|FG001|Overall Study|Lost to Follow-up|1|||
162180459|NCT00786864|585714384|FG000|Overall Study|Sustained serious back injury|1|||
162180460|NCT00786864|585714385|FG001|Overall Study|Sustained serious back injury|0|||
162180461|NCT02422615|585714386|FG000|Treatment Period|Progressive disease|314|||
162180462|NCT02422615|585714387|FG001|Treatment Period|Progressive disease|200|||
162180463|NCT02422615|585714386|FG000|Treatment Period|Adverse Event|51|||
162180464|NCT02422615|585714387|FG001|Treatment Period|Adverse Event|9|||
162180465|NCT02422615|585714386|FG000|Treatment Period|Physician Decision|32|||
162180466|NCT02422615|585714387|FG001|Treatment Period|Physician Decision|8|||
162180467|NCT02422615|585714386|FG000|Treatment Period|Subject/guardian decision|38|||
162180468|NCT02422615|585714387|FG001|Treatment Period|Subject/guardian decision|8|||
162180469|NCT02422615|585714386|FG000|Treatment Period|Death|2|||
162180470|NCT02422615|585714387|FG001|Treatment Period|Death|1|||
162180471|NCT02422615|585714386|FG000|Treatment Period|Technical problems|0|||
162180472|NCT02422615|585714387|FG001|Treatment Period|Technical problems|1|||
162180473|NCT02422615|585714386|FG000|Treatment Period|Protocol deviation|1|||
162180474|NCT02422615|585714387|FG001|Treatment Period|Protocol deviation|1|||
162180475|NCT02422615|585714386|FG000|Treatment Period|Study terminated as per protocol|46|||
162180476|NCT02422615|585714387|FG001|Treatment Period|Study terminated as per protocol|14|||
162180477|NCT02422615|585714386|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
162180478|NCT02422615|585714387|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162180479|NCT02422615|585714386|FG000|Post-treatment Efficacy Follow-up|Death|2|||
162180480|NCT02422615|585714387|FG001|Post-treatment Efficacy Follow-up|Death|1|||
162180481|NCT02422615|585714386|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
162180482|NCT02422615|585714387|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
162180483|NCT02422615|585714386|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
162180484|NCT02422615|585714387|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
162180485|NCT02422615|585714386|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
162180486|NCT02422615|585714387|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
162180487|NCT02422615|585714386|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
161672086|NCT01372410|583853024|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162180488|NCT02422615|585714387|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
162180489|NCT01288443|585714388|FG000|Overall Study|Adverse Event|0|||
162180490|NCT01288443|585714389|FG001|Overall Study|Adverse Event|0|||
162180491|NCT01288443|585714390|FG002|Overall Study|Adverse Event|1|||
162180492|NCT01288443|585714391|FG003|Overall Study|Adverse Event|1|||
162180493|NCT01288443|585714392|FG004|Overall Study|Adverse Event|3|||
162180494|NCT01288443|585714393|FG005|Overall Study|Adverse Event|1|||
162180495|NCT01288443|585714388|FG000|Overall Study|Poor compliance to protocol|0|||
162180496|NCT01288443|585714389|FG001|Overall Study|Poor compliance to protocol|0|||
162180497|NCT01288443|585714390|FG002|Overall Study|Poor compliance to protocol|0|||
162180498|NCT01288443|585714391|FG003|Overall Study|Poor compliance to protocol|0|||
162180499|NCT01288443|585714392|FG004|Overall Study|Poor compliance to protocol|0|||
162180500|NCT01288443|585714393|FG005|Overall Study|Poor compliance to protocol|1|||
162180501|NCT01288443|585714388|FG000|Overall Study|Participant Moved|0|||
162180502|NCT01288443|585714389|FG001|Overall Study|Participant Moved|0|||
162180503|NCT01288443|585714390|FG002|Overall Study|Participant Moved|0|||
162180504|NCT01288443|585714391|FG003|Overall Study|Participant Moved|1|||
162180505|NCT01288443|585714392|FG004|Overall Study|Participant Moved|2|||
162180506|NCT01288443|585714393|FG005|Overall Study|Participant Moved|1|||
162180507|NCT01288443|585714388|FG000|Overall Study|Consent withdrawn by Participant|0|||
162180508|NCT01288443|585714389|FG001|Overall Study|Consent withdrawn by Participant|0|||
162180509|NCT01288443|585714390|FG002|Overall Study|Consent withdrawn by Participant|0|||
162180510|NCT01288443|585714391|FG003|Overall Study|Consent withdrawn by Participant|0|||
162180511|NCT01288443|585714392|FG004|Overall Study|Consent withdrawn by Participant|0|||
162180512|NCT01288443|585714393|FG005|Overall Study|Consent withdrawn by Participant|1|||
162180513|NCT01288443|585714388|FG000|Overall Study|Lost to Follow-up|0|||
162180514|NCT01288443|585714389|FG001|Overall Study|Lost to Follow-up|1|||
162180515|NCT01288443|585714390|FG002|Overall Study|Lost to Follow-up|0|||
162180516|NCT01288443|585714391|FG003|Overall Study|Lost to Follow-up|0|||
162180517|NCT01288443|585714392|FG004|Overall Study|Lost to Follow-up|0|||
162180518|NCT01288443|585714393|FG005|Overall Study|Lost to Follow-up|0|||
162180519|NCT01288443|585714388|FG000|Overall Study|Study drug auto-injector administration|0|||
162180520|NCT01288443|585714389|FG001|Overall Study|Study drug auto-injector administration|0|||
162180521|NCT01288443|585714390|FG002|Overall Study|Study drug auto-injector administration|0|||
162180522|NCT01288443|585714391|FG003|Overall Study|Study drug auto-injector administration|0|||
162180523|NCT01288443|585714392|FG004|Overall Study|Study drug auto-injector administration|1|||
162180524|NCT01288443|585714393|FG005|Overall Study|Study drug auto-injector administration|1|||
162180525|NCT01288443|585714388|FG000|Overall Study|Other than above|0|||
162180526|NCT01288443|585714389|FG001|Overall Study|Other than above|0|||
162180527|NCT01288443|585714390|FG002|Overall Study|Other than above|0|||
162180528|NCT01288443|585714391|FG003|Overall Study|Other than above|2|||
161817920|NCT03531827|584372960|FG001|Overall Study|Adverse Event|0|||
161817921|NCT03531827|584372959|FG000|Overall Study|Progressive disease|1|||
162180529|NCT01288443|585714392|FG004|Overall Study|Other than above|1|||
162180530|NCT01288443|585714393|FG005|Overall Study|Other than above|0|||
162180531|NCT02291913|585714395|FG000|Overall Study|Progressive Disease|32|||
162180532|NCT02291913|585714395|FG000|Overall Study|Adverse Event|11|||
162180533|NCT02291913|585714395|FG000|Overall Study|Death|2|||
162180534|NCT02291913|585714395|FG000|Overall Study|Physician Decision|1|||
162180535|NCT02291913|585714395|FG000|Overall Study|Withdrawal by Subject|1|||
162180536|NCT02291913|585714395|FG000|Overall Study|Protocol Violation|1|||
162180537|NCT04876417|585714396|FG000|Overall Study|Lost to Follow-up|5|||
162180538|NCT04876417|585714397|FG001|Overall Study|Lost to Follow-up|8|||
162180539|NCT04876417|585714398|FG002|Overall Study|Lost to Follow-up|0|||
162180540|NCT04876417|585714399|FG003|Overall Study|Lost to Follow-up|0|||
162180541|NCT04334317|585714400|FG000|Overall Study|Adverse Event|1|||
162180542|NCT04334317|585714401|FG001|Overall Study|Adverse Event|2|||
162180543|NCT04334317|585714402|FG002|Overall Study|Adverse Event|0|||
162180544|NCT04334317|585714403|FG003|Overall Study|Adverse Event|0|||
162180545|NCT04334317|585714400|FG000|Overall Study|Protocol Deviation|0|||
162180546|NCT04334317|585714401|FG001|Overall Study|Protocol Deviation|1|||
162180547|NCT04334317|585714402|FG002|Overall Study|Protocol Deviation|0|||
162180548|NCT04334317|585714403|FG003|Overall Study|Protocol Deviation|0|||
162180549|NCT04334317|585714400|FG000|Overall Study|Withdrawal by Subject|2|||
162180550|NCT04334317|585714401|FG001|Overall Study|Withdrawal by Subject|2|||
162180551|NCT04334317|585714402|FG002|Overall Study|Withdrawal by Subject|0|||
162180552|NCT04334317|585714403|FG003|Overall Study|Withdrawal by Subject|0|||
162180553|NCT03621735|585714404|FG000|Overall Study|Withdrawal by Subject|13|||
162180554|NCT03621735|585714405|FG001|Overall Study|Withdrawal by Subject|13|||
162180555|NCT00605306|585714408|FG000|Overall Study|Adverse Event|0|||
162180556|NCT00605306|585714409|FG001|Overall Study|Adverse Event|1|||
162180557|NCT03875313|585714412|FG000|Overall Study|Withdrawal by Subject|1|||
162180558|NCT03875313|585714413|FG001|Overall Study|Withdrawal by Subject|3|||
162180559|NCT03875313|585714414|FG002|Overall Study|Withdrawal by Subject|0|||
162180560|NCT03875313|585714415|FG003|Overall Study|Withdrawal by Subject|0|||
162180561|NCT03875313|585714416|FG004|Overall Study|Withdrawal by Subject|0|||
162180562|NCT03875313|585714412|FG000|Overall Study|Death|0|||
162180563|NCT03875313|585714413|FG001|Overall Study|Death|0|||
162180564|NCT03875313|585714414|FG002|Overall Study|Death|0|||
162180565|NCT03875313|585714415|FG003|Overall Study|Death|0|||
162180566|NCT03875313|585714416|FG004|Overall Study|Death|1|||
161817922|NCT03531827|584372960|FG001|Overall Study|Progressive disease|0|||
161817923|NCT03067987|584372961|FG000|Overall Study|Lost to Follow-up|7|||
162180567|NCT03875313|585714412|FG000|Overall Study|Lost to Follow-up|0|||
162180568|NCT03875313|585714413|FG001|Overall Study|Lost to Follow-up|0|||
162180569|NCT03875313|585714414|FG002|Overall Study|Lost to Follow-up|0|||
162180570|NCT03875313|585714415|FG003|Overall Study|Lost to Follow-up|0|||
162180571|NCT03875313|585714416|FG004|Overall Study|Lost to Follow-up|1|||
162180572|NCT03875313|585714412|FG000|Overall Study|Study Termination by Sponsor|0|||
162180573|NCT03875313|585714413|FG001|Overall Study|Study Termination by Sponsor|1|||
162180574|NCT03875313|585714414|FG002|Overall Study|Study Termination by Sponsor|1|||
162180575|NCT03875313|585714415|FG003|Overall Study|Study Termination by Sponsor|0|||
162180576|NCT03875313|585714416|FG004|Overall Study|Study Termination by Sponsor|1|||
162180577|NCT03875313|585714412|FG000|Overall Study|New Anticancer Treatment|0|||
162180578|NCT03875313|585714413|FG001|Overall Study|New Anticancer Treatment|1|||
162180579|NCT03875313|585714414|FG002|Overall Study|New Anticancer Treatment|2|||
162180580|NCT03875313|585714415|FG003|Overall Study|New Anticancer Treatment|1|||
162180581|NCT03875313|585714416|FG004|Overall Study|New Anticancer Treatment|0|||
162180582|NCT03875313|585714412|FG000|Overall Study|Other, Not Specified|2|||
162180583|NCT03875313|585714413|FG001|Overall Study|Other, Not Specified|11|||
162180584|NCT03875313|585714414|FG002|Overall Study|Other, Not Specified|3|||
162180585|NCT03875313|585714415|FG003|Overall Study|Other, Not Specified|3|||
162180586|NCT03875313|585714416|FG004|Overall Study|Other, Not Specified|1|||
162180587|NCT01092416|585714417|FG000|Enrollment|Atherectomy device not inserted|3|||
162180588|NCT01092416|585714417|FG000|30-Day Follow-up|Death|2|||
162180589|NCT01092416|585714417|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
162180590|NCT01092416|585714417|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
162180591|NCT01092416|585714417|FG000|12-Month Follow-up|Death|16|||
162180592|NCT01092416|585714417|FG000|12-Month Follow-up|Lost to Follow-up|4|||
162180593|NCT01092416|585714417|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
162180594|NCT01092416|585714417|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
162180595|NCT01092416|585714417|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
162180596|NCT03709706|585714418|FG000|Overall Study|Adverse Event|0|||
162180597|NCT03709706|585714419|FG001|Overall Study|Adverse Event|1|||
162180598|NCT03709706|585714418|FG000|Overall Study|Physician Decision|14|||
162180599|NCT03709706|585714419|FG001|Overall Study|Physician Decision|8|||
162180600|NCT03709706|585714418|FG000|Overall Study|Withdrawal by Subject|2|||
162180601|NCT03709706|585714419|FG001|Overall Study|Withdrawal by Subject|1|||
162180602|NCT03709706|585714418|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
162180603|NCT03709706|585714419|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
162180604|NCT01105975|585714420|FG000|Overall Study|Adverse Event|2|||
162180605|NCT01105975|585714421|FG001|Overall Study|Adverse Event|1|||
162180606|NCT01105975|585714422|FG002|Overall Study|Adverse Event|5|||
162180607|NCT01105975|585714423|FG003|Overall Study|Adverse Event|1|||
162180608|NCT01105975|585714424|FG004|Overall Study|Adverse Event|0|||
162180609|NCT01105975|585714425|FG005|Overall Study|Adverse Event|1|||
162180610|NCT01105975|585714426|FG006|Overall Study|Adverse Event|2|||
162180611|NCT01105975|585714427|FG007|Overall Study|Adverse Event|4|||
162180612|NCT01105975|585714428|FG008|Overall Study|Adverse Event|1|||
162180613|NCT01105975|585714429|FG009|Overall Study|Adverse Event|4|||
162180614|NCT01105975|585714420|FG000|Overall Study|Withdrawal by Subject|2|||
162180615|NCT01105975|585714421|FG001|Overall Study|Withdrawal by Subject|2|||
162180616|NCT01105975|585714422|FG002|Overall Study|Withdrawal by Subject|2|||
162180617|NCT01105975|585714423|FG003|Overall Study|Withdrawal by Subject|0|||
162180618|NCT01105975|585714424|FG004|Overall Study|Withdrawal by Subject|4|||
162180619|NCT01105975|585714425|FG005|Overall Study|Withdrawal by Subject|1|||
162180620|NCT01105975|585714426|FG006|Overall Study|Withdrawal by Subject|2|||
161817924|NCT03067987|584372962|FG001|Overall Study|Lost to Follow-up|10|||
162018753|NCT02136069|585123206|FG000|Overall Study|Withdrawal by Subject|10|||
162180621|NCT01105975|585714427|FG007|Overall Study|Withdrawal by Subject|1|||
162180622|NCT01105975|585714428|FG008|Overall Study|Withdrawal by Subject|0|||
162180623|NCT01105975|585714429|FG009|Overall Study|Withdrawal by Subject|3|||
162180624|NCT01105975|585714420|FG000|Overall Study|Lost to Follow-up|1|||
161817925|NCT03067987|584372961|FG000|Overall Study|Protocol Violation|1|||
162180625|NCT01105975|585714421|FG001|Overall Study|Lost to Follow-up|0|||
162180626|NCT01105975|585714422|FG002|Overall Study|Lost to Follow-up|0|||
162180627|NCT01105975|585714423|FG003|Overall Study|Lost to Follow-up|1|||
162180628|NCT01105975|585714424|FG004|Overall Study|Lost to Follow-up|1|||
162180629|NCT01105975|585714425|FG005|Overall Study|Lost to Follow-up|0|||
162180630|NCT01105975|585714426|FG006|Overall Study|Lost to Follow-up|0|||
162180631|NCT01105975|585714427|FG007|Overall Study|Lost to Follow-up|0|||
162180632|NCT01105975|585714428|FG008|Overall Study|Lost to Follow-up|1|||
162180633|NCT01105975|585714429|FG009|Overall Study|Lost to Follow-up|0|||
162180634|NCT01105975|585714420|FG000|Overall Study|Physician Decision|0|||
162180635|NCT01105975|585714421|FG001|Overall Study|Physician Decision|0|||
162180636|NCT01105975|585714422|FG002|Overall Study|Physician Decision|0|||
162180637|NCT01105975|585714423|FG003|Overall Study|Physician Decision|0|||
162180638|NCT01105975|585714424|FG004|Overall Study|Physician Decision|0|||
162180639|NCT01105975|585714425|FG005|Overall Study|Physician Decision|0|||
162180640|NCT01105975|585714426|FG006|Overall Study|Physician Decision|2|||
162180641|NCT01105975|585714427|FG007|Overall Study|Physician Decision|0|||
162180642|NCT01105975|585714428|FG008|Overall Study|Physician Decision|0|||
162180643|NCT01105975|585714429|FG009|Overall Study|Physician Decision|0|||
162180644|NCT01105975|585714420|FG000|Overall Study|Protocol Violation|0|||
162180645|NCT01105975|585714421|FG001|Overall Study|Protocol Violation|2|||
162180646|NCT01105975|585714422|FG002|Overall Study|Protocol Violation|2|||
162180647|NCT01105975|585714423|FG003|Overall Study|Protocol Violation|0|||
162180648|NCT01105975|585714424|FG004|Overall Study|Protocol Violation|1|||
162180649|NCT01105975|585714425|FG005|Overall Study|Protocol Violation|1|||
162180650|NCT01105975|585714426|FG006|Overall Study|Protocol Violation|1|||
162180651|NCT01105975|585714427|FG007|Overall Study|Protocol Violation|1|||
162180652|NCT01105975|585714428|FG008|Overall Study|Protocol Violation|2|||
162180653|NCT01105975|585714429|FG009|Overall Study|Protocol Violation|2|||
162180654|NCT01105975|585714420|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162180655|NCT01105975|585714421|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162180656|NCT01105975|585714422|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
162180657|NCT01105975|585714423|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162180658|NCT01105975|585714424|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162180659|NCT01105975|585714425|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
162180660|NCT01105975|585714426|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
162180661|NCT01105975|585714427|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
162180662|NCT01105975|585714428|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
162180663|NCT01105975|585714429|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162180664|NCT04868617|585714430|FG000|Overall Study|Death|1|||
162180665|NCT04868617|585714431|FG001|Overall Study|Death|0|||
162180666|NCT04868617|585714430|FG000|Overall Study|Adverse Event|1|||
162180667|NCT04868617|585714431|FG001|Overall Study|Adverse Event|0|||
162180668|NCT04868617|585714430|FG000|Overall Study|Withdrawal by Subject|1|||
162180669|NCT04868617|585714431|FG001|Overall Study|Withdrawal by Subject|0|||
162180670|NCT04868617|585714430|FG000|Overall Study|Device deficiency|1|||
162180671|NCT04868617|585714431|FG001|Overall Study|Device deficiency|0|||
162180672|NCT00686595|585714432|FG000|Overall Study|Adverse Event|3|||
162180673|NCT00686595|585714432|FG000|Overall Study|Protocol Violation|1|||
162180674|NCT00686595|585714432|FG000|Overall Study|Lost to Follow-up|1|||
162180675|NCT00686595|585714432|FG000|Overall Study|Lack of Efficacy|1|||
162180676|NCT00686595|585714432|FG000|Overall Study|Poor Compliance|1|||
162180677|NCT02502526|585714433|FG000|Overall Study|Lost to Follow-up|2|||
162180678|NCT02502526|585714434|FG001|Overall Study|Lost to Follow-up|2|||
161817926|NCT03067987|584372962|FG001|Overall Study|Protocol Violation|2|||
161817927|NCT03067987|584372961|FG000|Overall Study|Withdrawal by Subject|2|||
161817928|NCT03067987|584372962|FG001|Overall Study|Withdrawal by Subject|1|||
161817929|NCT03733145|584372963|FG000|Overall Study|screenfail|3|||
161817930|NCT03733145|584372964|FG001|Overall Study|screenfail|3|||
161817931|NCT03733145|584372965|FG002|Overall Study|screenfail|2|||
162018754|NCT02136069|585123207|FG001|Overall Study|Withdrawal by Subject|11|||
162180679|NCT02502526|585714435|FG002|Overall Study|Lost to Follow-up|3|||
162180680|NCT02502526|585714433|FG000|Overall Study|Withdrawal by Subject|0|||
162180681|NCT02502526|585714434|FG001|Overall Study|Withdrawal by Subject|1|||
162180682|NCT02502526|585714435|FG002|Overall Study|Withdrawal by Subject|1|||
162180683|NCT02502526|585714433|FG000|Overall Study|Disqualified due to cataract grading|0|||
161817932|NCT00754052|584374292|FG000|Overall Study|Study terminated by Sponsor|5|||
161817933|NCT00754052|584374293|FG001|Overall Study|Study terminated by Sponsor|3|||
162180684|NCT02502526|585714434|FG001|Overall Study|Disqualified due to cataract grading|0|||
162180685|NCT02502526|585714435|FG002|Overall Study|Disqualified due to cataract grading|1|||
162180686|NCT02502526|585714433|FG000|Overall Study|Enrollment suspension|4|||
162180687|NCT02502526|585714434|FG001|Overall Study|Enrollment suspension|1|||
162180688|NCT02502526|585714435|FG002|Overall Study|Enrollment suspension|1|||
162180689|NCT01074294|585714436|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
162180690|NCT01074294|585714437|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
162180691|NCT01074294|585714438|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
162180692|NCT01074294|585714439|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
162180693|NCT01074294|585714436|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
162180694|NCT01074294|585714437|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
162180695|NCT01074294|585714438|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
162180696|NCT01074294|585714439|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
162180697|NCT01074294|585714436|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
162180698|NCT01074294|585714437|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
162180699|NCT01074294|585714438|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
161672087|NCT01372410|583853025|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161672088|NCT01372410|583853026|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
161672089|NCT01372410|583853027|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161672090|NCT01372410|583853028|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161817934|NCT00557245|584374294|FG000|Overall Study|Lost to Follow-up|7|||
162180700|NCT01074294|585714439|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
162180701|NCT01074294|585714436|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
162180702|NCT01074294|585714437|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
162180703|NCT01074294|585714438|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
162180704|NCT01074294|585714439|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
162180705|NCT01074294|585714436|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
162180706|NCT01074294|585714437|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
162180707|NCT01074294|585714438|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
162180708|NCT01074294|585714439|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
162180709|NCT01074294|585714436|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
162180710|NCT01074294|585714437|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
162180711|NCT01074294|585714438|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
162180712|NCT01074294|585714439|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
162180713|NCT01074294|585714436|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
162180714|NCT01074294|585714437|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
162180715|NCT01074294|585714438|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
162180716|NCT01074294|585714439|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
162180717|NCT01074294|585714436|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
162180718|NCT01074294|585714437|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
162180719|NCT01074294|585714438|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
162180720|NCT01074294|585714439|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
162180721|NCT01074294|585714436|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
162180722|NCT01074294|585714437|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
162180723|NCT01074294|585714438|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
162180724|NCT01074294|585714439|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
162180725|NCT01074294|585714436|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
162180726|NCT01074294|585714437|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
162180727|NCT01074294|585714438|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
162180728|NCT01074294|585714439|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
162180729|NCT01074294|585714436|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
162180730|NCT01074294|585714437|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
162180731|NCT01074294|585714438|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
162180732|NCT01074294|585714439|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
162180733|NCT01074294|585714436|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
162180734|NCT01074294|585714437|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
162180735|NCT01074294|585714438|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
162180736|NCT01074294|585714439|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
162180737|NCT01074294|585714436|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
162180738|NCT01074294|585714437|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
162180739|NCT01074294|585714438|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
162180740|NCT01074294|585714439|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
162180741|NCT03248492|585714440|FG000|Overall Study|Progressive Disease|24|||
162180742|NCT03248492|585714441|FG001|Overall Study|Progressive Disease|23|||
162180743|NCT03248492|585714442|FG002|Overall Study|Progressive Disease|11|||
162180744|NCT03248492|585714443|FG003|Overall Study|Progressive Disease|66|||
162180745|NCT03248492|585714444|FG004|Overall Study|Progressive Disease|1|||
162180746|NCT03248492|585714440|FG000|Overall Study|Adverse Event|14|||
162180747|NCT03248492|585714441|FG001|Overall Study|Adverse Event|13|||
162180748|NCT03248492|585714442|FG002|Overall Study|Adverse Event|9|||
162180749|NCT03248492|585714443|FG003|Overall Study|Adverse Event|22|||
162180750|NCT03248492|585714444|FG004|Overall Study|Adverse Event|2|||
162180751|NCT03248492|585714440|FG000|Overall Study|Withdrawal by Subject|5|||
162180752|NCT03248492|585714441|FG001|Overall Study|Withdrawal by Subject|4|||
162180753|NCT03248492|585714442|FG002|Overall Study|Withdrawal by Subject|0|||
162180754|NCT03248492|585714443|FG003|Overall Study|Withdrawal by Subject|8|||
162180755|NCT03248492|585714444|FG004|Overall Study|Withdrawal by Subject|1|||
162180756|NCT03248492|585714440|FG000|Overall Study|Physician Decision|1|||
162180757|NCT03248492|585714441|FG001|Overall Study|Physician Decision|1|||
162180758|NCT03248492|585714442|FG002|Overall Study|Physician Decision|1|||
161817935|NCT00557245|584374295|FG001|Overall Study|Lost to Follow-up|8|||
161817936|NCT00557245|584374296|FG002|Overall Study|Lost to Follow-up|10|||
162018755|NCT02675634|585123208|FG000|Test Period 1|Adverse Event|0|||
162018756|NCT02675634|585123209|FG001|Test Period 1|Adverse Event|1|||
162180759|NCT03248492|585714443|FG003|Overall Study|Physician Decision|7|||
162180760|NCT03248492|585714444|FG004|Overall Study|Physician Decision|0|||
162180761|NCT03248492|585714440|FG000|Overall Study|Death|1|||
162180762|NCT03248492|585714441|FG001|Overall Study|Death|1|||
162180763|NCT03248492|585714442|FG002|Overall Study|Death|0|||
162180764|NCT03248492|585714443|FG003|Overall Study|Death|6|||
161817937|NCT00557245|584374294|FG000|Overall Study|Ineligible|5|||
161817938|NCT00557245|584374295|FG001|Overall Study|Ineligible|4|||
162180765|NCT03248492|585714444|FG004|Overall Study|Death|0|||
162180766|NCT03248492|585714440|FG000|Overall Study|Study Terminated by Sponsor|3|||
162180767|NCT03248492|585714441|FG001|Overall Study|Study Terminated by Sponsor|1|||
162180768|NCT03248492|585714442|FG002|Overall Study|Study Terminated by Sponsor|0|||
162180769|NCT03248492|585714443|FG003|Overall Study|Study Terminated by Sponsor|7|||
162180770|NCT03248492|585714444|FG004|Overall Study|Study Terminated by Sponsor|0|||
162180771|NCT03248492|585714440|FG000|Overall Study|Other|2|||
162180772|NCT03248492|585714441|FG001|Overall Study|Other|5|||
162180773|NCT03248492|585714442|FG002|Overall Study|Other|0|||
162180774|NCT03248492|585714443|FG003|Overall Study|Other|14|||
162180775|NCT03248492|585714444|FG004|Overall Study|Other|0|||
162180776|NCT04495621|585714445|FG000|Overall Study|Withdrawal by Subject|0|||
162180777|NCT04495621|585714446|FG001|Overall Study|Withdrawal by Subject|3|||
162180778|NCT04495621|585714445|FG000|Overall Study|Death|7|||
162180779|NCT04495621|585714446|FG001|Overall Study|Death|11|||
162180780|NCT04495621|585714445|FG000|Overall Study|Investigator Decision|0|||
162180781|NCT04495621|585714446|FG001|Overall Study|Investigator Decision|7|||
162180782|NCT04495621|585714445|FG000|Overall Study|Lost to Follow-up|0|||
162180783|NCT04495621|585714446|FG001|Overall Study|Lost to Follow-up|1|||
162180784|NCT03473223|585714452|FG000|Overall Study|Lost to Follow-up|1|||
162180785|NCT03473223|585714453|FG001|Overall Study|Lost to Follow-up|1|||
162180786|NCT03473223|585714452|FG000|Overall Study|Withdrawal by Subject|47|||
162180787|NCT03473223|585714453|FG001|Overall Study|Withdrawal by Subject|42|||
162180788|NCT03473223|585714452|FG000|Overall Study|Indirect contact|32|||
162180789|NCT03473223|585714453|FG001|Overall Study|Indirect contact|29|||
162180790|NCT03473223|585714452|FG000|Overall Study|Other (Not specified)|32|||
162180791|NCT03473223|585714453|FG001|Overall Study|Other (Not specified)|20|||
162180792|NCT00319696|585714454|FG000|Overall Study|Adverse Event|36|||
162180793|NCT00319696|585714454|FG000|Overall Study|withdrawal of consent|14|||
162180794|NCT00319696|585714454|FG000|Overall Study|administrative|7|||
162180795|NCT00319696|585714454|FG000|Overall Study|Lost to Follow-up|3|||
162180796|NCT03777657|585714456|FG000|Overall Study|Death|397|||
162180797|NCT03777657|585714457|FG001|Overall Study|Death|431|||
162180798|NCT03777657|585714456|FG000|Overall Study|Study Closed by Sponsor|77|||
162180799|NCT03777657|585714457|FG001|Overall Study|Study Closed by Sponsor|38|||
161817939|NCT00557245|584374296|FG002|Overall Study|Ineligible|2|||
161817940|NCT00516295|584374300|FG000|Overall Study|Lack of Efficacy|2|||
161817941|NCT00516295|584374301|FG001|Overall Study|Lack of Efficacy|0|||
161817942|NCT00516295|584374302|FG002|Overall Study|Lack of Efficacy|0|||
161817943|NCT00516295|584374300|FG000|Overall Study|Ineligible|1|||
161817944|NCT00516295|584374301|FG001|Overall Study|Ineligible|0|||
161817945|NCT00516295|584374302|FG002|Overall Study|Ineligible|0|||
161817946|NCT02651987|584374305|FG000|Overall Study|Adverse Event|2|||
161817947|NCT02651987|584374306|FG001|Overall Study|Adverse Event|2|||
161817948|NCT02651987|584374305|FG000|Overall Study|Consent Withdrawn|2|||
161817949|NCT02651987|584374306|FG001|Overall Study|Consent Withdrawn|0|||
162018757|NCT02675634|585123210|FG002|Test Period 1|Adverse Event|0|||
162180800|NCT03777657|585714456|FG000|Overall Study|Withdrawal by Subject|20|||
162180801|NCT03777657|585714457|FG001|Overall Study|Withdrawal by Subject|17|||
162180802|NCT03777657|585714456|FG000|Overall Study|Lost to Follow-up|6|||
162180803|NCT03777657|585714457|FG001|Overall Study|Lost to Follow-up|10|||
162180804|NCT02549352|585714460|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
162180805|NCT02549352|585714461|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
162180806|NCT02549352|585714460|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
162180807|NCT02549352|585714461|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
162180808|NCT02549352|585714460|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
162180809|NCT02549352|585714461|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
161817950|NCT02651987|584374305|FG000|Overall Study|Local PD|0|||
161817951|NCT02651987|584374306|FG001|Overall Study|Local PD|2|||
161817952|NCT02651987|584374305|FG000|Overall Study|Investigator Decision|1|||
161817953|NCT02651987|584374306|FG001|Overall Study|Investigator Decision|1|||
162180810|NCT02549352|585714460|FG000|12-month Follow-up|Withdrawal by Subject|4|||
162180811|NCT02549352|585714461|FG001|12-month Follow-up|Withdrawal by Subject|5|||
162180812|NCT02549352|585714460|FG000|12-month Follow-up|Lost to Follow-up|3|||
162180813|NCT02549352|585714461|FG001|12-month Follow-up|Lost to Follow-up|2|||
162180814|NCT02549352|585714460|FG000|12-month Follow-up|Death|0|||
162180815|NCT02549352|585714461|FG001|12-month Follow-up|Death|1|||
162180816|NCT02549352|585714460|FG000|12-month Follow-up|Protocol Violation|0|||
162180817|NCT02549352|585714461|FG001|12-month Follow-up|Protocol Violation|1|||
162180818|NCT02549352|585714460|FG000|12-month Follow-up|Other|1|||
162180819|NCT02549352|585714461|FG001|12-month Follow-up|Other|3|||
162180820|NCT04559698|585714916|FG000|Overall Study|Lost to Follow-up|14|||
162180821|NCT04559698|585714917|FG001|Overall Study|Lost to Follow-up|15|||
162180822|NCT04559698|585714916|FG000|Overall Study|Withdrawal by Subject|0|||
162180823|NCT04559698|585714917|FG001|Overall Study|Withdrawal by Subject|1|||
162180824|NCT01982682|585714918|FG000|Overall Study|Physician Decision|1|||
162180825|NCT02760654|585714919|FG000|Overall Study|Lost to Follow-up|3|||
162180826|NCT02760654|585714920|FG001|Overall Study|Lost to Follow-up|3|||
162180827|NCT02760654|585714919|FG000|Overall Study|Withdrawal by Subject|4|||
162180828|NCT02760654|585714920|FG001|Overall Study|Withdrawal by Subject|3|||
162180829|NCT01574716|585714921|FG000|Part 1|Death|3|||
162180830|NCT01574716|585714922|FG001|Part 1|Death|1|||
162180831|NCT01574716|585714923|FG002|Part 1|Death|8|||
162180832|NCT01574716|585714924|FG003|Part 1|Death|0|||
162180833|NCT01574716|585714925|FG004|Part 1|Death|0|||
162180834|NCT01574716|585714921|FG000|Part 1|Discontinuation of study by sponsor|0|||
162180835|NCT01574716|585714922|FG001|Part 1|Discontinuation of study by sponsor|0|||
162180836|NCT01574716|585714923|FG002|Part 1|Discontinuation of study by sponsor|1|||
162180837|NCT01574716|585714924|FG003|Part 1|Discontinuation of study by sponsor|0|||
162180838|NCT01574716|585714925|FG004|Part 1|Discontinuation of study by sponsor|0|||
162180839|NCT01574716|585714921|FG000|Part 1|Withdrawal by Subject|0|||
162180840|NCT01574716|585714922|FG001|Part 1|Withdrawal by Subject|2|||
162180841|NCT01574716|585714923|FG002|Part 1|Withdrawal by Subject|0|||
162180842|NCT01574716|585714924|FG003|Part 1|Withdrawal by Subject|0|||
162180843|NCT01574716|585714925|FG004|Part 1|Withdrawal by Subject|0|||
162180844|NCT01574716|585714921|FG000|Part 1|Lost to Follow-up|0|||
162180845|NCT01574716|585714922|FG001|Part 1|Lost to Follow-up|1|||
162180846|NCT01574716|585714923|FG002|Part 1|Lost to Follow-up|0|||
162180847|NCT01574716|585714924|FG003|Part 1|Lost to Follow-up|0|||
162180848|NCT01574716|585714925|FG004|Part 1|Lost to Follow-up|0|||
162180849|NCT01574716|585714921|FG000|Part 2|Progressive disease|0|||
162180850|NCT01574716|585714922|FG001|Part 2|Progressive disease|0|||
162180851|NCT01574716|585714923|FG002|Part 2|Progressive disease|0|||
162180852|NCT01574716|585714924|FG003|Part 2|Progressive disease|1|||
162180853|NCT01574716|585714925|FG004|Part 2|Progressive disease|0|||
162180854|NCT01574716|585714921|FG000|Part 2|Death|0|||
162180855|NCT01574716|585714922|FG001|Part 2|Death|0|||
162180856|NCT01574716|585714923|FG002|Part 2|Death|0|||
162180857|NCT01574716|585714924|FG003|Part 2|Death|76|||
162180858|NCT01574716|585714925|FG004|Part 2|Death|35|||
162180859|NCT01574716|585714921|FG000|Part 2|Discontinuation of study by sponsor|0|||
162180860|NCT01574716|585714922|FG001|Part 2|Discontinuation of study by sponsor|0|||
162180861|NCT01574716|585714923|FG002|Part 2|Discontinuation of study by sponsor|0|||
162180862|NCT01574716|585714924|FG003|Part 2|Discontinuation of study by sponsor|51|||
162180863|NCT01574716|585714925|FG004|Part 2|Discontinuation of study by sponsor|31|||
162180864|NCT01574716|585714921|FG000|Part 2|Withdrawal by Subject|0|||
162180865|NCT01574716|585714922|FG001|Part 2|Withdrawal by Subject|0|||
162180866|NCT01574716|585714923|FG002|Part 2|Withdrawal by Subject|0|||
162180867|NCT01574716|585714924|FG003|Part 2|Withdrawal by Subject|5|||
162180868|NCT01574716|585714925|FG004|Part 2|Withdrawal by Subject|4|||
162180869|NCT01574716|585714921|FG000|Part 2|Brain metastases|0|||
162180870|NCT01574716|585714922|FG001|Part 2|Brain metastases|0|||
162180871|NCT01574716|585714923|FG002|Part 2|Brain metastases|0|||
162180872|NCT01574716|585714924|FG003|Part 2|Brain metastases|1|||
162180873|NCT01574716|585714925|FG004|Part 2|Brain metastases|0|||
162180874|NCT01574716|585714921|FG000|Part 2|Lost to Follow-up|0|||
162180875|NCT01574716|585714922|FG001|Part 2|Lost to Follow-up|0|||
162180876|NCT01574716|585714923|FG002|Part 2|Lost to Follow-up|0|||
162180877|NCT01574716|585714924|FG003|Part 2|Lost to Follow-up|3|||
162180878|NCT01574716|585714925|FG004|Part 2|Lost to Follow-up|0|||
162180879|NCT03183050|585714927|FG000|Overall Study|Lost to Follow-up|23|||
162180880|NCT02797132|585714931|FG000|Part A (15 Days)|Adverse Event|1|||
162180881|NCT02797132|585714931|FG000|Part B (24 Weeks)|Adverse Event|3|||
161672091|NCT01372410|583853029|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162180882|NCT02964741|585714932|FG000|Overall Study|Protocol Violation|1|||
162180883|NCT02964741|585714933|FG001|Overall Study|Protocol Violation|0|||
162180884|NCT02964741|585714934|FG002|Overall Study|Protocol Violation|0|||
162180885|NCT02964741|585714932|FG000|Overall Study|Withdrawal by Subject|0|||
162180886|NCT02964741|585714933|FG001|Overall Study|Withdrawal by Subject|1|||
162180887|NCT02964741|585714934|FG002|Overall Study|Withdrawal by Subject|0|||
162180888|NCT02964741|585714932|FG000|Overall Study|claustrophobia|1|||
162180889|NCT02964741|585714933|FG001|Overall Study|claustrophobia|0|||
162180890|NCT02964741|585714934|FG002|Overall Study|claustrophobia|0|||
162180891|NCT00640159|585714938|FG000|Overall Study|Lost to Follow-up|2|||
162180892|NCT00112359|585714939|FG000|Overall Study|Unrelated adverse event|16|||
161817954|NCT02725515|584374307|FG000|Overall Study|Refused infusion (no study treatment)|1|||
161817955|NCT02725515|584374308|FG001|Overall Study|Refused infusion (no study treatment)|0|||
161817956|NCT02725515|584374307|FG000|Overall Study|Loss of Improvement per Protocol|14|||
161817957|NCT02725515|584374308|FG001|Overall Study|Loss of Improvement per Protocol|25|||
161817958|NCT02725515|584374307|FG000|Overall Study|Withdrawal by Subject|2|||
161817959|NCT02725515|584374308|FG001|Overall Study|Withdrawal by Subject|1|||
161817960|NCT02725515|584374307|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161817961|NCT02725515|584374308|FG001|Overall Study|Non-Compliance With Study Drug|3|||
161817962|NCT02725515|584374307|FG000|Overall Study|Lost to Follow-up|1|||
161817963|NCT02725515|584374308|FG001|Overall Study|Lost to Follow-up|1|||
161817964|NCT02725515|584374307|FG000|Overall Study|Adverse Event|7|||
161817965|NCT02725515|584374308|FG001|Overall Study|Adverse Event|2|||
161817966|NCT02725515|584374307|FG000|Overall Study|No Documented Disease Improvement|0|||
161817967|NCT02725515|584374308|FG001|Overall Study|No Documented Disease Improvement|1|||
161817968|NCT02725515|584374307|FG000|Overall Study|Completed Study Under Original Protocol|0|||
161817969|NCT02725515|584374308|FG001|Overall Study|Completed Study Under Original Protocol|1|||
161817970|NCT02725515|584374307|FG000|Overall Study|Lack of Response|0|||
161817971|NCT02725515|584374308|FG001|Overall Study|Lack of Response|1|||
161817972|NCT00183196|584374314|FG000|Overall Study|Withdrawal by Subject|18|||
161817973|NCT00183196|584374315|FG001|Overall Study|Withdrawal by Subject|11|||
161817974|NCT00183196|584374316|FG002|Overall Study|Withdrawal by Subject|13|||
161817975|NCT00183196|584374314|FG000|Overall Study|Adverse Event|1|||
161817976|NCT00183196|584374315|FG001|Overall Study|Adverse Event|2|||
161817977|NCT00183196|584374316|FG002|Overall Study|Adverse Event|2|||
161817978|NCT00183196|584374314|FG000|Overall Study|Legal event|1|||
161817979|NCT00183196|584374315|FG001|Overall Study|Legal event|1|||
161817980|NCT00183196|584374316|FG002|Overall Study|Legal event|1|||
161817981|NCT00183196|584374314|FG000|Overall Study|Required more intensive care|0|||
161817982|NCT00183196|584374315|FG001|Overall Study|Required more intensive care|1|||
161817983|NCT00183196|584374316|FG002|Overall Study|Required more intensive care|2|||
161817984|NCT00385736|584374317|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
161817985|NCT00385736|584374318|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
161817986|NCT00385736|584374319|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
161817987|NCT00385736|584374317|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
161817988|NCT00385736|584374318|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
161817989|NCT00385736|584374319|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
161817990|NCT00385736|584374317|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
161817991|NCT00385736|584374318|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
161817992|NCT00385736|584374319|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
161817993|NCT00385736|584374317|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
161817994|NCT00385736|584374318|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
161817995|NCT00385736|584374319|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
161817996|NCT00385736|584374317|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
161817997|NCT00385736|584374318|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
161817998|NCT00385736|584374319|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
161817999|NCT00385736|584374317|FG000|Efficacy Analysis Set - Induction|Other|0|||
161818000|NCT00385736|584374318|FG001|Efficacy Analysis Set - Induction|Other|0|||
162180893|NCT00112359|585714940|FG001|Overall Study|Unrelated adverse event|8|||
162180894|NCT00112359|585714939|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
162180895|NCT00112359|585714940|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
162180896|NCT00112359|585714939|FG000|Overall Study|Related adverse event|5|||
162180897|NCT00112359|585714940|FG001|Overall Study|Related adverse event|3|||
162180898|NCT00112359|585714939|FG000|Overall Study|Lost to Follow-up|0|||
162180899|NCT00112359|585714940|FG001|Overall Study|Lost to Follow-up|1|||
162180900|NCT00112359|585714939|FG000|Overall Study|Personal/administrative|1|||
162180901|NCT00112359|585714940|FG001|Overall Study|Personal/administrative|1|||
162180902|NCT00112359|585714939|FG000|Overall Study|Other|3|||
162180903|NCT00112359|585714940|FG001|Overall Study|Other|0|||
162180904|NCT00312208|585714941|FG000|Overall Study|Adverse Event|97|||
162180905|NCT00312208|585714942|FG001|Overall Study|Adverse Event|61|||
162180906|NCT00312208|585714941|FG000|Overall Study|Protocol Violation|5|||
162180907|NCT00312208|585714942|FG001|Overall Study|Protocol Violation|3|||
162180908|NCT00312208|585714941|FG000|Overall Study|Death|2|||
162180909|NCT00312208|585714942|FG001|Overall Study|Death|1|||
162180910|NCT00312208|585714941|FG000|Overall Study|Lack of Efficacy|7|||
162180911|NCT00312208|585714942|FG001|Overall Study|Lack of Efficacy|4|||
161818001|NCT00385736|584374319|FG002|Efficacy Analysis Set - Induction|Other|1|||
161818002|NCT00385736|584374317|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
161818003|NCT00385736|584374318|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
161818004|NCT00385736|584374319|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
161818005|NCT00385736|584374317|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
161818006|NCT00385736|584374318|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
161818007|NCT00385736|584374319|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
161818008|NCT00385736|584374317|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
161818009|NCT00385736|584374318|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
161818010|NCT00385736|584374319|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
161818011|NCT00385736|584374317|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
161818012|NCT00385736|584374318|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
161818013|NCT00385736|584374319|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
161818014|NCT00385736|584374317|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
161818015|NCT00385736|584374318|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
161818016|NCT00385736|584374319|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
161818017|NCT00385736|584374317|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
161818018|NCT00385736|584374318|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
161818019|NCT00385736|584374319|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
161818020|NCT00385736|584374317|FG000|Safety Analysis Set|Adverse Event|23|||
161818021|NCT00385736|584374318|FG001|Safety Analysis Set|Adverse Event|15|||
161818022|NCT00385736|584374319|FG002|Safety Analysis Set|Adverse Event|23|||
161818023|NCT00385736|584374317|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
161818024|NCT00385736|584374318|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
161818025|NCT00385736|584374319|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
161818026|NCT00385736|584374317|FG000|Safety Analysis Set|Lost to Follow-up|0|||
161818027|NCT00385736|584374318|FG001|Safety Analysis Set|Lost to Follow-up|2|||
161818028|NCT00385736|584374319|FG002|Safety Analysis Set|Lost to Follow-up|2|||
161818029|NCT00385736|584374317|FG000|Safety Analysis Set|Lack of Efficacy|38|||
161818030|NCT00385736|584374318|FG001|Safety Analysis Set|Lack of Efficacy|16|||
161818031|NCT00385736|584374319|FG002|Safety Analysis Set|Lack of Efficacy|31|||
161818032|NCT00385736|584374317|FG000|Safety Analysis Set|Protocol Violation|2|||
161818033|NCT00385736|584374318|FG001|Safety Analysis Set|Protocol Violation|1|||
161818034|NCT00385736|584374319|FG002|Safety Analysis Set|Protocol Violation|6|||
161818035|NCT00385736|584374317|FG000|Safety Analysis Set|Other|1|||
161818036|NCT00385736|584374318|FG001|Safety Analysis Set|Other|4|||
161818037|NCT00385736|584374319|FG002|Safety Analysis Set|Other|4|||
161818038|NCT01701063|584374326|FG000|Overall Study|Lost to Follow-up|0|||
161818039|NCT01701063|584374327|FG001|Overall Study|Lost to Follow-up|1|||
161818040|NCT01701063|584374328|FG002|Overall Study|Lost to Follow-up|0|||
161818041|NCT01701063|584374326|FG000|Overall Study|Withdrawal by Subject|0|||
161818042|NCT01701063|584374327|FG001|Overall Study|Withdrawal by Subject|0|||
161818043|NCT01701063|584374328|FG002|Overall Study|Withdrawal by Subject|1|||
161818044|NCT01701063|584374326|FG000|Overall Study|Other|0|||
161818045|NCT01701063|584374327|FG001|Overall Study|Other|0|||
161818046|NCT01701063|584374328|FG002|Overall Study|Other|1|||
161818047|NCT01919112|584374329|FG000|Secondary Analysis-day 30|Death|1|||
161818048|NCT01919112|584374330|FG001|Secondary Analysis-day 30|Death|1|||
161818049|NCT01919112|584374331|FG002|Secondary Analysis-day 30|Death|1|||
161818050|NCT01919112|584374329|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
161818051|NCT01919112|584374330|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
161818052|NCT01919112|584374331|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
161818053|NCT00835666|584374332|FG000|Washout|Protocol Violation|1|||
161818054|NCT00835666|584374333|FG001|Washout|Protocol Violation|0|||
161818055|NCT00835666|584374332|FG000|Washout|Withdrawal by Subject|1|||
161818056|NCT00835666|584374333|FG001|Washout|Withdrawal by Subject|0|||
161818057|NCT00635648|584374334|FG000|Overall Study|Adverse Event|12|||
161818058|NCT00635648|584374334|FG000|Overall Study|Withdrawal by Subject|9|||
161818059|NCT00635648|584374334|FG000|Overall Study|Physician Decision|4|||
161818060|NCT00635648|584374334|FG000|Overall Study|Rapid progression of baseline disease|4|||
161818061|NCT00635648|584374334|FG000|Overall Study|Use of other antifungal agent needed|1|||
161818062|NCT00635648|584374334|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
161818063|NCT00635648|584374334|FG000|Overall Study|Noncompliance with protocol|1|||
161818064|NCT00635648|584374334|FG000|Overall Study|Other reason|2|||
161818065|NCT03158727|584374339|FG000|Overall Study|Withdrawal by Subject|2|||
161818066|NCT03158727|584374340|FG001|Overall Study|Withdrawal by Subject|6|||
161818067|NCT03158727|584374339|FG000|Overall Study|Death|11|||
161818068|NCT03158727|584374340|FG001|Overall Study|Death|12|||
161818069|NCT03158727|584374339|FG000|Overall Study|Lost to Follow-up|1|||
161818070|NCT03158727|584374340|FG001|Overall Study|Lost to Follow-up|0|||
161818071|NCT03158727|584374339|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
161818072|NCT03158727|584374340|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
161924051|NCT05128942|584768141|FG007|Overall Study|Lost to Follow-up|0|||
161924052|NCT05128942|584768142|FG008|Overall Study|Lost to Follow-up|0|||
161924053|NCT05942040|584768143|FG000|Overall Study|No longer employed at study site.|0|||
161924054|NCT05942040|584768144|FG001|Overall Study|No longer employed at study site.|0|||
161924055|NCT05942040|584768145|FG002|Overall Study|No longer employed at study site.|3|||
161924056|NCT03442569|584768146|FG000|Overall Study|Subject was ineligible after enrollment|1|||
161924057|NCT06461455|584768147|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
161924058|NCT06461455|584768148|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
161924059|NCT06461455|584768147|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
162180912|NCT00312208|585714941|FG000|Overall Study|Lost to Follow-up|3|||
162180913|NCT00312208|585714942|FG001|Overall Study|Lost to Follow-up|5|||
162180914|NCT00312208|585714941|FG000|Overall Study|Withdrawal by Subject|53|||
162180915|NCT00312208|585714942|FG001|Overall Study|Withdrawal by Subject|42|||
162180916|NCT00312208|585714941|FG000|Overall Study|Other|5|||
162180917|NCT00312208|585714942|FG001|Overall Study|Other|7|||
162180918|NCT01324310|585714943|FG000|Overall Study|Adverse Event|1|||
162180919|NCT01324310|585714943|FG000|Overall Study|Disease Progression|1|||
162180920|NCT01315132|585714946|FG000|Overall Study|not treated due to disease progression|1|||
162180921|NCT00747565|585714952|FG000|Overall Study|Withdrawal by Subject|10|||
162180922|NCT00747565|585714953|FG001|Overall Study|Withdrawal by Subject|6|||
162180923|NCT00747565|585714952|FG000|Overall Study|Lost to Follow-up|4|||
162180924|NCT00747565|585714953|FG001|Overall Study|Lost to Follow-up|1|||
162180925|NCT01983683|585714958|FG000|Overall Study|Withdrawal by Subject|14|||
162180926|NCT01983683|585714959|FG001|Overall Study|Withdrawal by Subject|18|||
162180927|NCT01983683|585714958|FG000|Overall Study|Death|11|||
162180928|NCT01983683|585714959|FG001|Overall Study|Death|15|||
162180929|NCT01983683|585714958|FG000|Overall Study|Physician Decision|8|||
162180930|NCT01983683|585714959|FG001|Overall Study|Physician Decision|9|||
162180931|NCT01983683|585714958|FG000|Overall Study|Lost to Follow-up|4|||
162180932|NCT01983683|585714959|FG001|Overall Study|Lost to Follow-up|8|||
162180933|NCT01983683|585714958|FG000|Overall Study|Sponsor Decision|1|||
162180934|NCT01983683|585714959|FG001|Overall Study|Sponsor Decision|1|||
162180935|NCT03437733|585715693|FG000|Overall Study|Eligibility criteria not met|0|||
161924060|NCT06461455|584768148|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
161924061|NCT06461455|584768147|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
161924062|NCT06461455|584768148|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
161924063|NCT06142383|584768149|FG000|Overall Study|Mis-randomized|0|||
161924064|NCT06142383|584768150|FG001|Overall Study|Mis-randomized|0|||
161924065|NCT06142383|584768151|FG002|Overall Study|Mis-randomized|1|||
161924066|NCT06142383|584768152|FG003|Overall Study|Mis-randomized|0|||
162180936|NCT03437733|585715694|FG001|Overall Study|Eligibility criteria not met|3|||
162180937|NCT00246805|585715709|FG000|Phase 1|Lost to Follow-up|1|||
162180938|NCT00246805|585715710|FG001|Phase 1|Lost to Follow-up|0|||
162180939|NCT01342367|585715712|FG000|Overall Study|Death|1|||
162180940|NCT01342367|585715713|FG001|Overall Study|Death|0|||
162180941|NCT01342367|585715712|FG000|Overall Study|Withdrawal by Subject|1|||
162180942|NCT01342367|585715713|FG001|Overall Study|Withdrawal by Subject|2|||
162180943|NCT01500200|585715714|FG000|Stage 1|Adverse Event|1|||
162180944|NCT01500200|585715715|FG001|Stage 1|Adverse Event|4|||
162180945|NCT01500200|585715716|FG002|Stage 1|Adverse Event|5|||
162180946|NCT01500200|585715717|FG003|Stage 1|Adverse Event|0|||
162180947|NCT01500200|585715718|FG004|Stage 1|Adverse Event|0|||
162180948|NCT01500200|585715719|FG005|Stage 1|Adverse Event|0|||
162180949|NCT01500200|585715714|FG000|Stage 1|Lost to Follow-up|2|||
162180950|NCT01500200|585715715|FG001|Stage 1|Lost to Follow-up|2|||
162180951|NCT01500200|585715716|FG002|Stage 1|Lost to Follow-up|1|||
162180952|NCT01500200|585715717|FG003|Stage 1|Lost to Follow-up|0|||
162180953|NCT01500200|585715718|FG004|Stage 1|Lost to Follow-up|0|||
162180954|NCT01500200|585715719|FG005|Stage 1|Lost to Follow-up|0|||
162180955|NCT01500200|585715714|FG000|Stage 1|Withdrawal by Subject|3|||
162180956|NCT01500200|585715715|FG001|Stage 1|Withdrawal by Subject|0|||
162180957|NCT01500200|585715716|FG002|Stage 1|Withdrawal by Subject|0|||
162180958|NCT01500200|585715717|FG003|Stage 1|Withdrawal by Subject|0|||
162180959|NCT01500200|585715718|FG004|Stage 1|Withdrawal by Subject|0|||
162180960|NCT01500200|585715719|FG005|Stage 1|Withdrawal by Subject|0|||
162180961|NCT01500200|585715714|FG000|Stage 1|Noncompliance with Study Drug|1|||
162180962|NCT01500200|585715715|FG001|Stage 1|Noncompliance with Study Drug|0|||
162180963|NCT01500200|585715716|FG002|Stage 1|Noncompliance with Study Drug|0|||
162180964|NCT01500200|585715717|FG003|Stage 1|Noncompliance with Study Drug|0|||
162180965|NCT01500200|585715718|FG004|Stage 1|Noncompliance with Study Drug|0|||
162180966|NCT01500200|585715719|FG005|Stage 1|Noncompliance with Study Drug|0|||
162180967|NCT01500200|585715714|FG000|Stage 1|Physician Decision|1|||
162180968|NCT01500200|585715715|FG001|Stage 1|Physician Decision|0|||
162180969|NCT01500200|585715716|FG002|Stage 1|Physician Decision|0|||
162180970|NCT01500200|585715717|FG003|Stage 1|Physician Decision|0|||
162180971|NCT01500200|585715718|FG004|Stage 1|Physician Decision|0|||
162180972|NCT01500200|585715719|FG005|Stage 1|Physician Decision|0|||
162180973|NCT01500200|585715714|FG000|Stage 2|Adverse Event|0|||
161924067|NCT06142383|584768153|FG004|Overall Study|Mis-randomized|0|||
162180974|NCT01500200|585715715|FG001|Stage 2|Adverse Event|0|||
162180975|NCT01500200|585715716|FG002|Stage 2|Adverse Event|0|||
162180976|NCT01500200|585715717|FG003|Stage 2|Adverse Event|0|||
162180977|NCT01500200|585715718|FG004|Stage 2|Adverse Event|5|||
162180978|NCT01500200|585715719|FG005|Stage 2|Adverse Event|4|||
162180979|NCT01218659|585715721|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
162180980|NCT01218659|585715722|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
162180981|NCT01218659|585715723|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
162180982|NCT01218659|585715721|FG000|18-Month Randomized Period|Did not receive study drug|0|||
162180983|NCT01218659|585715722|FG001|18-Month Randomized Period|Did not receive study drug|3|||
162180984|NCT01218659|585715723|FG002|18-Month Randomized Period|Did not receive study drug|0|||
162180985|NCT01218659|585715721|FG000|12-Month OLE|Withdrawal by Subject|0|||
162180986|NCT01218659|585715722|FG001|12-Month OLE|Withdrawal by Subject|0|||
162180987|NCT01218659|585715723|FG002|12-Month OLE|Withdrawal by Subject|2|||
162180988|NCT01218659|585715721|FG000|12-Month OLE|Physician Decision|0|||
162180989|NCT01218659|585715722|FG001|12-Month OLE|Physician Decision|0|||
162180990|NCT01218659|585715723|FG002|12-Month OLE|Physician Decision|1|||
162180991|NCT01218659|585715721|FG000|12-Month OLE|Lost to Follow-up|0|||
162180992|NCT01218659|585715722|FG001|12-Month OLE|Lost to Follow-up|0|||
162180993|NCT01218659|585715723|FG002|12-Month OLE|Lost to Follow-up|1|||
162180994|NCT01218659|585715721|FG000|12-Month OLE|Pregnancy|0|||
162180995|NCT01218659|585715722|FG001|12-Month OLE|Pregnancy|0|||
162180996|NCT01218659|585715723|FG002|12-Month OLE|Pregnancy|1|||
162180997|NCT01218659|585715721|FG000|12-Month OLE|Lack of Efficacy|0|||
162180998|NCT01218659|585715722|FG001|12-Month OLE|Lack of Efficacy|0|||
162180999|NCT01218659|585715723|FG002|12-Month OLE|Lack of Efficacy|1|||
162181000|NCT01218659|585715721|FG000|12-Month OLE|Declined to participate in the OLE|0|||
162181001|NCT01218659|585715722|FG001|12-Month OLE|Declined to participate in the OLE|0|||
162181002|NCT01218659|585715723|FG002|12-Month OLE|Declined to participate in the OLE|4|||
162181003|NCT03066609|585715726|FG000|INDUCTION|Pregnancy|0|||
162181004|NCT03066609|585715727|FG001|INDUCTION|Pregnancy|0|||
162181005|NCT03066609|585715728|FG002|INDUCTION|Pregnancy|1|||
162181006|NCT03066609|585715729|FG003|INDUCTION|Pregnancy|0|||
162181007|NCT03066609|585715726|FG000|INDUCTION|Lack of Efficacy|0|||
162181008|NCT03066609|585715727|FG001|INDUCTION|Lack of Efficacy|0|||
162181009|NCT03066609|585715728|FG002|INDUCTION|Lack of Efficacy|1|||
162181010|NCT03066609|585715729|FG003|INDUCTION|Lack of Efficacy|0|||
162181011|NCT03066609|585715726|FG000|INDUCTION|Adverse Event|2|||
162181012|NCT03066609|585715727|FG001|INDUCTION|Adverse Event|2|||
162181013|NCT03066609|585715728|FG002|INDUCTION|Adverse Event|0|||
162181014|NCT03066609|585715729|FG003|INDUCTION|Adverse Event|0|||
162181015|NCT03066609|585715726|FG000|MAINTENANCE|Adverse Event|0|||
162181016|NCT03066609|585715727|FG001|MAINTENANCE|Adverse Event|0|||
162181017|NCT03066609|585715728|FG002|MAINTENANCE|Adverse Event|0|||
162181018|NCT03066609|585715729|FG003|MAINTENANCE|Adverse Event|1|||
162181019|NCT03066609|585715726|FG000|MAINTENANCE|Withdrawal by Subject|4|||
162181020|NCT03066609|585715727|FG001|MAINTENANCE|Withdrawal by Subject|2|||
162181021|NCT03066609|585715728|FG002|MAINTENANCE|Withdrawal by Subject|1|||
162181022|NCT03066609|585715729|FG003|MAINTENANCE|Withdrawal by Subject|1|||
162181023|NCT03066609|585715726|FG000|MAINTENANCE|Lost to Follow-up|0|||
162181024|NCT03066609|585715727|FG001|MAINTENANCE|Lost to Follow-up|1|||
162181025|NCT03066609|585715728|FG002|MAINTENANCE|Lost to Follow-up|1|||
162181026|NCT03066609|585715729|FG003|MAINTENANCE|Lost to Follow-up|0|||
162181027|NCT03066609|585715726|FG000|MAINTENANCE|Pregnancy|1|||
162181028|NCT03066609|585715727|FG001|MAINTENANCE|Pregnancy|0|||
162181029|NCT03066609|585715728|FG002|MAINTENANCE|Pregnancy|0|||
162181030|NCT03066609|585715729|FG003|MAINTENANCE|Pregnancy|0|||
162181031|NCT03066609|585715726|FG000|MAINTENANCE|Lack of Efficacy|2|||
162181032|NCT03066609|585715727|FG001|MAINTENANCE|Lack of Efficacy|1|||
162181033|NCT03066609|585715728|FG002|MAINTENANCE|Lack of Efficacy|0|||
162181034|NCT03066609|585715729|FG003|MAINTENANCE|Lack of Efficacy|1|||
162181035|NCT03066609|585715726|FG000|OVERALL STUDY|Adverse Event|2|||
162181036|NCT03066609|585715727|FG001|OVERALL STUDY|Adverse Event|2|||
162181037|NCT03066609|585715728|FG002|OVERALL STUDY|Adverse Event|0|||
162181038|NCT03066609|585715729|FG003|OVERALL STUDY|Adverse Event|1|||
162181039|NCT03066609|585715726|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
162181040|NCT03066609|585715727|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
162181041|NCT03066609|585715728|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
162181042|NCT03066609|585715729|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
162181043|NCT03066609|585715726|FG000|OVERALL STUDY|Lost to Follow-up|1|||
162181044|NCT03066609|585715727|FG001|OVERALL STUDY|Lost to Follow-up|1|||
161672092|NCT01372410|583853022|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161672093|NCT01372410|583853023|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
162181045|NCT03066609|585715728|FG002|OVERALL STUDY|Lost to Follow-up|1|||
162181046|NCT03066609|585715729|FG003|OVERALL STUDY|Lost to Follow-up|1|||
162181047|NCT03066609|585715726|FG000|OVERALL STUDY|Pregnancy|1|||
162181048|NCT03066609|585715727|FG001|OVERALL STUDY|Pregnancy|0|||
162181049|NCT03066609|585715728|FG002|OVERALL STUDY|Pregnancy|1|||
162181050|NCT03066609|585715729|FG003|OVERALL STUDY|Pregnancy|0|||
162181051|NCT03066609|585715726|FG000|OVERALL STUDY|Lack of Efficacy|2|||
162181052|NCT03066609|585715727|FG001|OVERALL STUDY|Lack of Efficacy|1|||
162181053|NCT03066609|585715728|FG002|OVERALL STUDY|Lack of Efficacy|1|||
162181054|NCT03066609|585715729|FG003|OVERALL STUDY|Lack of Efficacy|1|||
162181055|NCT03066609|585715726|FG000|OVERALL STUDY|discontinued follow up|0|||
162181056|NCT03066609|585715727|FG001|OVERALL STUDY|discontinued follow up|2|||
162181057|NCT03066609|585715728|FG002|OVERALL STUDY|discontinued follow up|0|||
161818073|NCT03158727|584374339|FG000|Overall Study|Visit 11 not done by mistake|0|||
161818074|NCT03158727|584374340|FG001|Overall Study|Visit 11 not done by mistake|1|||
161818075|NCT03158727|584374339|FG000|Overall Study|Enrolled, not treated|1|||
161818076|NCT03158727|584374340|FG001|Overall Study|Enrolled, not treated|0|||
161818077|NCT00985439|584374341|FG000|Overall Study|Adverse Event|0|||
161818078|NCT00985439|584374342|FG001|Overall Study|Adverse Event|0|||
161818079|NCT00985439|584374343|FG002|Overall Study|Adverse Event|1|||
161818080|NCT00985439|584374344|FG003|Overall Study|Adverse Event|0|||
161818081|NCT00101439|584374348|FG000|Period 2|Withdrawal by Subject|0|||
161818082|NCT00101439|584374349|FG001|Period 2|Withdrawal by Subject|2|||
161818083|NCT00863330|584374355|FG000|Overall Study|study terminated early due to administra|6|||
161818084|NCT02615249|584374356|FG000|Overall Study|Withdrawal by Subject|1|||
161818085|NCT05098743|584374357|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
161818086|NCT05098743|584374358|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
161818087|NCT05098743|584374357|FG000|Overall Study|Lost to Follow-up|1|||
161818088|NCT05098743|584374358|FG001|Overall Study|Lost to Follow-up|2|||
161818089|NCT00868998|584374359|FG000|Overall Study|Screen Failure|1|||
161818090|NCT00868998|584374359|FG000|Overall Study|Withdrawal by Subject|1|||
162181058|NCT03066609|585715729|FG003|OVERALL STUDY|discontinued follow up|0|||
162181059|NCT02284113|585715730|FG000|Overall Study|Adverse Event|1|||
162181060|NCT02284113|585715731|FG001|Overall Study|Adverse Event|0|||
162181061|NCT02284113|585715730|FG000|Overall Study|non-compliance|0|||
162181062|NCT02284113|585715731|FG001|Overall Study|non-compliance|1|||
162181063|NCT02284113|585715730|FG000|Overall Study|Withdrawal by Subject|0|||
162181064|NCT02284113|585715731|FG001|Overall Study|Withdrawal by Subject|1|||
162181065|NCT02284113|585715730|FG000|Overall Study|not provided|0|||
162181066|NCT02284113|585715731|FG001|Overall Study|not provided|1|||
162181067|NCT02284113|585715730|FG000|Overall Study|surgery cancelled|2|||
162181068|NCT02284113|585715731|FG001|Overall Study|surgery cancelled|0|||
162181069|NCT04191824|585715732|FG000|Overall Study|Death|13|||
162181070|NCT04191824|585715733|FG001|Overall Study|Death|12|||
162181071|NCT04191824|585715732|FG000|Overall Study|Lost to Follow-up|456|||
162181072|NCT04191824|585715733|FG001|Overall Study|Lost to Follow-up|435|||
162181073|NCT04191824|585715732|FG000|Overall Study|Physician Decision|2|||
162181074|NCT04191824|585715733|FG001|Overall Study|Physician Decision|1|||
162181075|NCT04191824|585715732|FG000|Overall Study|Protocol Violation|0|||
162181076|NCT04191824|585715733|FG001|Overall Study|Protocol Violation|2|||
162181077|NCT04191824|585715732|FG000|Overall Study|Withdrawal by Subject|16|||
162181078|NCT04191824|585715733|FG001|Overall Study|Withdrawal by Subject|18|||
162181079|NCT04191824|585715732|FG000|Overall Study|Early site closure|24|||
162181080|NCT04191824|585715733|FG001|Overall Study|Early site closure|22|||
162181081|NCT03170882|585715736|FG000|Overall Study|Death|17|||
162181082|NCT03170882|585715737|FG001|Overall Study|Death|29|||
162181083|NCT03170882|585715736|FG000|Overall Study|Lost to Follow-up|0|||
162181084|NCT03170882|585715737|FG001|Overall Study|Lost to Follow-up|1|||
162181085|NCT03170882|585715736|FG000|Overall Study|Withdrawal by Subject|4|||
162181086|NCT03170882|585715737|FG001|Overall Study|Withdrawal by Subject|7|||
162181087|NCT03170882|585715736|FG000|Overall Study|Reason not Specified|28|||
162181088|NCT03170882|585715737|FG001|Overall Study|Reason not Specified|36|||
162181089|NCT01371994|585715741|FG000|Overall Study|Adverse Event|3|||
162181090|NCT01371994|585715742|FG001|Overall Study|Adverse Event|6|||
162181091|NCT01371994|585715741|FG000|Overall Study|Lack of Efficacy|3|||
162181092|NCT01371994|585715742|FG001|Overall Study|Lack of Efficacy|0|||
162181093|NCT01371994|585715741|FG000|Overall Study|Withdrawal by Subject|13|||
162181094|NCT01371994|585715742|FG001|Overall Study|Withdrawal by Subject|7|||
162181095|NCT01371994|585715741|FG000|Overall Study|Lost to Follow-up|1|||
162181096|NCT01371994|585715742|FG001|Overall Study|Lost to Follow-up|1|||
162181097|NCT01371994|585715741|FG000|Overall Study|Protocol Violation|24|||
162181098|NCT01371994|585715742|FG001|Overall Study|Protocol Violation|17|||
162181099|NCT01371994|585715741|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
162181100|NCT01371994|585715742|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
162181101|NCT01371994|585715741|FG000|Overall Study|Physician Decision|1|||
162181102|NCT01371994|585715742|FG001|Overall Study|Physician Decision|1|||
161818091|NCT00868998|584374359|FG000|Overall Study|Progression of disease|2|||
161818092|NCT00868998|584374359|FG000|Overall Study|Death|1|||
161818093|NCT01483820|584374361|FG000|Overall Study|Lack of Efficacy|6|||
161818094|NCT01483820|584374361|FG000|Overall Study|Adverse Event|1|||
161818095|NCT01483820|584374361|FG000|Overall Study|Death|1|||
162181103|NCT01371994|585715741|FG000|Overall Study|Miscellaneous Reasons|6|||
162181104|NCT01371994|585715742|FG001|Overall Study|Miscellaneous Reasons|4|||
161818096|NCT00474188|584374365|FG000|Overall Study|Withdrawal by Subject|1|||
162181105|NCT00087685|585715743|FG000|Overall Study|Adverse Event|5|||
161818097|NCT00474188|584374365|FG000|Overall Study|Study discontinued by sponsor|5|||
161818098|NCT05412121|584374366|FG000|Overall Study|Withdrawal by Subject|4|||
161818099|NCT05412121|584374366|FG000|Overall Study|Physician Decision|1|||
162181106|NCT00087685|585715743|FG000|Overall Study|Non-Compliance|1|||
162181107|NCT00087685|585715743|FG000|Overall Study|Progressive Disease|5|||
162181108|NCT00087685|585715743|FG000|Overall Study|Withdrawal by Subject|3|||
162181109|NCT03213457|585715744|FG000|Screening Period|Withdrawal by Subject|0|||
162181110|NCT03213457|585715745|FG001|Screening Period|Withdrawal by Subject|1|||
162181111|NCT03213457|585715746|FG002|Screening Period|Withdrawal by Subject|0|||
162181112|NCT03213457|585715744|FG000|Screening Period|Other|1|||
162181113|NCT03213457|585715745|FG001|Screening Period|Other|0|||
162181114|NCT03213457|585715746|FG002|Screening Period|Other|0|||
161924068|NCT06142383|584768149|FG000|Overall Study|Adverse Event|0|||
161924069|NCT06142383|584768150|FG001|Overall Study|Adverse Event|1|||
162181115|NCT03213457|585715744|FG000|Double-Blind Period|Adverse Event|3|||
162181116|NCT03213457|585715745|FG001|Double-Blind Period|Adverse Event|2|||
162181117|NCT03213457|585715746|FG002|Double-Blind Period|Adverse Event|7|||
162181118|NCT03213457|585715744|FG000|Double-Blind Period|Withdrawal by Subject|14|||
162181119|NCT03213457|585715745|FG001|Double-Blind Period|Withdrawal by Subject|2|||
162181120|NCT03213457|585715746|FG002|Double-Blind Period|Withdrawal by Subject|14|||
162181121|NCT03213457|585715744|FG000|Double-Blind Period|Lost to Follow-up|2|||
162181122|NCT03213457|585715745|FG001|Double-Blind Period|Lost to Follow-up|3|||
162181123|NCT03213457|585715746|FG002|Double-Blind Period|Lost to Follow-up|9|||
162181124|NCT03213457|585715744|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
162181125|NCT03213457|585715745|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
162181126|NCT03213457|585715746|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
162181127|NCT03213457|585715744|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
162181128|NCT03213457|585715745|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
162181129|NCT03213457|585715746|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
162181130|NCT03213457|585715744|FG000|Double-Blind Period|Pregnancy|5|||
162181131|NCT03213457|585715745|FG001|Double-Blind Period|Pregnancy|0|||
161924070|NCT06142383|584768151|FG002|Overall Study|Adverse Event|1|||
161924071|NCT06142383|584768152|FG003|Overall Study|Adverse Event|0|||
161924072|NCT06142383|584768153|FG004|Overall Study|Adverse Event|0|||
161924073|NCT06142383|584768149|FG000|Overall Study|Death|0|||
161924074|NCT06142383|584768150|FG001|Overall Study|Death|1|||
161924075|NCT06142383|584768151|FG002|Overall Study|Death|3|||
161924076|NCT06142383|584768152|FG003|Overall Study|Death|0|||
161924077|NCT06142383|584768153|FG004|Overall Study|Death|1|||
161924078|NCT06142383|584768149|FG000|Overall Study|Study Terminated by Sponsor|20|||
161924079|NCT06142383|584768150|FG001|Overall Study|Study Terminated by Sponsor|17|||
161924080|NCT06142383|584768151|FG002|Overall Study|Study Terminated by Sponsor|33|||
162018758|NCT02675634|585123211|FG003|Test Period 1|Adverse Event|1|||
162181132|NCT03213457|585715746|FG002|Double-Blind Period|Pregnancy|0|||
162181133|NCT03213457|585715744|FG000|Double-Blind Period|Other|10|||
161924081|NCT06142383|584768152|FG003|Overall Study|Study Terminated by Sponsor|0|||
161924082|NCT06142383|584768153|FG004|Overall Study|Study Terminated by Sponsor|21|||
161924083|NCT06142383|584768149|FG000|Overall Study|Subject Decision|0|||
161924084|NCT06142383|584768150|FG001|Overall Study|Subject Decision|1|||
162181134|NCT03213457|585715745|FG001|Double-Blind Period|Other|3|||
162181135|NCT03213457|585715746|FG002|Double-Blind Period|Other|17|||
162181136|NCT03213457|585715744|FG000|Open-Label Period|Adverse Event|1|||
162181137|NCT03213457|585715745|FG001|Open-Label Period|Adverse Event|2|||
162181138|NCT03213457|585715746|FG002|Open-Label Period|Adverse Event|2|||
162181139|NCT03213457|585715744|FG000|Open-Label Period|Withdrawal by Subject|12|||
162181140|NCT03213457|585715745|FG001|Open-Label Period|Withdrawal by Subject|5|||
162181141|NCT03213457|585715746|FG002|Open-Label Period|Withdrawal by Subject|24|||
162181142|NCT03213457|585715744|FG000|Open-Label Period|Lost to Follow-up|1|||
162181143|NCT03213457|585715745|FG001|Open-Label Period|Lost to Follow-up|2|||
162181144|NCT03213457|585715746|FG002|Open-Label Period|Lost to Follow-up|8|||
162181145|NCT03213457|585715744|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
162181146|NCT03213457|585715745|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
162181147|NCT03213457|585715746|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
162181148|NCT03213457|585715744|FG000|Open-Label Period|Non-compliance with study procedures|1|||
162181149|NCT03213457|585715745|FG001|Open-Label Period|Non-compliance with study procedures|1|||
162181150|NCT03213457|585715746|FG002|Open-Label Period|Non-compliance with study procedures|2|||
162181151|NCT03213457|585715744|FG000|Open-Label Period|Exclusionary medications|0|||
162181152|NCT03213457|585715745|FG001|Open-Label Period|Exclusionary medications|0|||
162181153|NCT03213457|585715746|FG002|Open-Label Period|Exclusionary medications|1|||
162181154|NCT03213457|585715744|FG000|Open-Label Period|Other|1|||
162181155|NCT03213457|585715745|FG001|Open-Label Period|Other|1|||
162181156|NCT03213457|585715746|FG002|Open-Label Period|Other|6|||
162181157|NCT03213457|585715744|FG000|Follow-Up Period|Adverse Event|16|||
162181158|NCT03213457|585715745|FG001|Follow-Up Period|Adverse Event|8|||
162181159|NCT03213457|585715746|FG002|Follow-Up Period|Adverse Event|37|||
162181160|NCT03213457|585715744|FG000|Follow-Up Period|Withdrawal by Subject|18|||
162181161|NCT03213457|585715745|FG001|Follow-Up Period|Withdrawal by Subject|11|||
162181162|NCT03213457|585715746|FG002|Follow-Up Period|Withdrawal by Subject|55|||
162181163|NCT03213457|585715744|FG000|Follow-Up Period|Lost to Follow-up|28|||
162181164|NCT03213457|585715745|FG001|Follow-Up Period|Lost to Follow-up|15|||
162181165|NCT03213457|585715746|FG002|Follow-Up Period|Lost to Follow-up|50|||
162181166|NCT03213457|585715744|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
162181167|NCT03213457|585715745|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
162181168|NCT03213457|585715746|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
162181169|NCT03213457|585715744|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
162181170|NCT03213457|585715745|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
162181171|NCT03213457|585715746|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
162181172|NCT03213457|585715744|FG000|Follow-Up Period|Pregnancy|7|||
162181173|NCT03213457|585715745|FG001|Follow-Up Period|Pregnancy|0|||
162181174|NCT03213457|585715746|FG002|Follow-Up Period|Pregnancy|18|||
162181175|NCT03213457|585715744|FG000|Follow-Up Period|Exclusionary medications|1|||
162181176|NCT03213457|585715745|FG001|Follow-Up Period|Exclusionary medications|1|||
162181177|NCT03213457|585715746|FG002|Follow-Up Period|Exclusionary medications|5|||
162181178|NCT03213457|585715744|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
162181179|NCT03213457|585715745|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
162181180|NCT03213457|585715746|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
162181181|NCT03213457|585715744|FG000|Follow-Up Period|Other|14|||
162181182|NCT03213457|585715745|FG001|Follow-Up Period|Other|10|||
162181183|NCT03213457|585715746|FG002|Follow-Up Period|Other|31|||
162181184|NCT01830595|585715747|FG000|First Period|Withdrawal by Subject|1|||
162181185|NCT01830595|585715748|FG001|First Period|Withdrawal by Subject|3|||
162181186|NCT01830595|585715747|FG000|Washout|Withdrawal by Subject|2|||
162181187|NCT01830595|585715748|FG001|Washout|Withdrawal by Subject|2|||
162181188|NCT05116774|585715753|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
162181189|NCT05116774|585715754|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
162181190|NCT05116774|585715753|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
162181191|NCT05116774|585715754|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
162181192|NCT05116774|585715753|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
162181193|NCT05116774|585715754|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
162181194|NCT05116774|585715753|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
162181195|NCT05116774|585715754|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
162181196|NCT03150862|585715755|FG000|Overall Study|Death|2|||
162181197|NCT03150862|585715756|FG001|Overall Study|Death|7|||
162181198|NCT03150862|585715757|FG002|Overall Study|Death|8|||
162181199|NCT03150862|585715758|FG003|Overall Study|Death|27|||
162181200|NCT03150862|585715759|FG004|Overall Study|Death|4|||
162181201|NCT03150862|585715760|FG005|Overall Study|Death|8|||
162181202|NCT03150862|585715761|FG006|Overall Study|Death|6|||
162181203|NCT03150862|585715762|FG007|Overall Study|Death|21|||
162181204|NCT03150862|585715755|FG000|Overall Study|Withdrawal by Subject|1|||
162181205|NCT03150862|585715756|FG001|Overall Study|Withdrawal by Subject|1|||
162181206|NCT03150862|585715757|FG002|Overall Study|Withdrawal by Subject|0|||
162181207|NCT03150862|585715758|FG003|Overall Study|Withdrawal by Subject|3|||
162181208|NCT03150862|585715759|FG004|Overall Study|Withdrawal by Subject|1|||
162181209|NCT03150862|585715760|FG005|Overall Study|Withdrawal by Subject|1|||
162181210|NCT03150862|585715761|FG006|Overall Study|Withdrawal by Subject|1|||
162181211|NCT03150862|585715762|FG007|Overall Study|Withdrawal by Subject|3|||
162181212|NCT03150862|585715755|FG000|Overall Study|Lost to Follow-up|0|||
162181213|NCT03150862|585715756|FG001|Overall Study|Lost to Follow-up|0|||
162181214|NCT03150862|585715757|FG002|Overall Study|Lost to Follow-up|1|||
162181215|NCT03150862|585715758|FG003|Overall Study|Lost to Follow-up|0|||
162181216|NCT03150862|585715759|FG004|Overall Study|Lost to Follow-up|0|||
162181217|NCT03150862|585715760|FG005|Overall Study|Lost to Follow-up|0|||
162181218|NCT03150862|585715761|FG006|Overall Study|Lost to Follow-up|0|||
162181219|NCT03150862|585715762|FG007|Overall Study|Lost to Follow-up|2|||
162181220|NCT03150862|585715755|FG000|Overall Study|Sponsor's decision|0|||
162181221|NCT03150862|585715756|FG001|Overall Study|Sponsor's decision|0|||
162181222|NCT03150862|585715757|FG002|Overall Study|Sponsor's decision|0|||
162181223|NCT03150862|585715758|FG003|Overall Study|Sponsor's decision|10|||
162181224|NCT03150862|585715759|FG004|Overall Study|Sponsor's decision|3|||
162181225|NCT03150862|585715760|FG005|Overall Study|Sponsor's decision|0|||
162181226|NCT03150862|585715761|FG006|Overall Study|Sponsor's decision|1|||
162181227|NCT03150862|585715762|FG007|Overall Study|Sponsor's decision|1|||
162181228|NCT03150862|585715755|FG000|Overall Study|Change in Methylation status|0|||
162181229|NCT03150862|585715756|FG001|Overall Study|Change in Methylation status|0|||
162181230|NCT03150862|585715757|FG002|Overall Study|Change in Methylation status|0|||
162181231|NCT03150862|585715758|FG003|Overall Study|Change in Methylation status|0|||
162181232|NCT03150862|585715759|FG004|Overall Study|Change in Methylation status|1|||
162181233|NCT03150862|585715760|FG005|Overall Study|Change in Methylation status|0|||
162181234|NCT03150862|585715761|FG006|Overall Study|Change in Methylation status|0|||
162181235|NCT03150862|585715762|FG007|Overall Study|Change in Methylation status|0|||
162181236|NCT03150862|585715755|FG000|Overall Study|Roll over in to Long Term Extension|0|||
162181237|NCT03150862|585715756|FG001|Overall Study|Roll over in to Long Term Extension|0|||
162181238|NCT03150862|585715757|FG002|Overall Study|Roll over in to Long Term Extension|0|||
162181239|NCT03150862|585715758|FG003|Overall Study|Roll over in to Long Term Extension|0|||
162181240|NCT03150862|585715759|FG004|Overall Study|Roll over in to Long Term Extension|0|||
162181241|NCT03150862|585715760|FG005|Overall Study|Roll over in to Long Term Extension|0|||
162181242|NCT03150862|585715761|FG006|Overall Study|Roll over in to Long Term Extension|0|||
162181243|NCT03150862|585715762|FG007|Overall Study|Roll over in to Long Term Extension|1|||
162181244|NCT03150862|585715755|FG000|Overall Study|Progressive Disease|0|||
162181245|NCT03150862|585715756|FG001|Overall Study|Progressive Disease|0|||
162181246|NCT03150862|585715757|FG002|Overall Study|Progressive Disease|0|||
162181247|NCT03150862|585715758|FG003|Overall Study|Progressive Disease|0|||
162181248|NCT03150862|585715759|FG004|Overall Study|Progressive Disease|0|||
162181249|NCT03150862|585715760|FG005|Overall Study|Progressive Disease|0|||
162181250|NCT03150862|585715761|FG006|Overall Study|Progressive Disease|0|||
162181251|NCT03150862|585715762|FG007|Overall Study|Progressive Disease|2|||
162181252|NCT05139992|585715765|FG000|Overall Study|Withdrawal by Subject|12|||
162181253|NCT05139992|585715765|FG000|Overall Study|Lost to Follow-up|6|||
162181254|NCT05521516|585715766|FG000|Overall Study|Withdrawal by Subject|1|||
162181255|NCT05521516|585715767|FG001|Overall Study|Withdrawal by Subject|1|||
162181256|NCT04882917|585715769|FG000|Overall Study|Adverse Event|0|||
162181257|NCT04882917|585715770|FG001|Overall Study|Adverse Event|1|||
162181258|NCT04882917|585715771|FG002|Overall Study|Adverse Event|2|||
162181259|NCT04882917|585715772|FG003|Overall Study|Adverse Event|2|||
162181260|NCT04882917|585715769|FG000|Overall Study|Withdrawal by Subject|1|||
162181261|NCT04882917|585715770|FG001|Overall Study|Withdrawal by Subject|0|||
162181262|NCT04882917|585715771|FG002|Overall Study|Withdrawal by Subject|2|||
162181263|NCT04882917|585715772|FG003|Overall Study|Withdrawal by Subject|1|||
162181264|NCT04882917|585715769|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
162181265|NCT04882917|585715770|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
162181266|NCT04882917|585715771|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
162181267|NCT04882917|585715772|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
162181268|NCT00319020|585715773|FG000|Overall Study|Death|2|||
162181269|NCT00319020|585715774|FG001|Overall Study|Death|2|||
162181270|NCT00319020|585715773|FG000|Overall Study|Withdrawal by Subject|4|||
162181271|NCT00319020|585715774|FG001|Overall Study|Withdrawal by Subject|1|||
162181272|NCT00319020|585715773|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
162181273|NCT00319020|585715774|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
162181274|NCT00319020|585715773|FG000|Overall Study|Administrative reason|0|||
162181275|NCT00319020|585715774|FG001|Overall Study|Administrative reason|5|||
162181276|NCT00319020|585715773|FG000|Overall Study|Disease progression|0|||
162181277|NCT00319020|585715774|FG001|Overall Study|Disease progression|2|||
162181278|NCT00319020|585715773|FG000|Overall Study|Transplant|0|||
162181279|NCT00319020|585715774|FG001|Overall Study|Transplant|1|||
162181280|NCT00319020|585715773|FG000|Overall Study|Treatment failure|0|||
162181281|NCT00319020|585715774|FG001|Overall Study|Treatment failure|1|||
161924085|NCT06142383|584768151|FG002|Overall Study|Subject Decision|2|||
161924086|NCT06142383|584768152|FG003|Overall Study|Subject Decision|0|||
161924087|NCT06142383|584768153|FG004|Overall Study|Subject Decision|0|||
161924088|NCT00544882|584768157|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
161924089|NCT00544882|584768158|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
161924090|NCT00544882|584768159|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
161924091|NCT00544882|584768157|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
161924092|NCT00544882|584768158|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
162181282|NCT00319020|585715773|FG000|Overall Study|Adverse Event|0|||
162181283|NCT00319020|585715774|FG001|Overall Study|Adverse Event|1|||
162181284|NCT00593840|585715775|FG000|Overall Study|Withdrawal by Subject|1|||
162236512|NCT04874415|585916969|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236513|NCT04874415|585916970|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236514|NCT04874415|585916971|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236515|NCT04874415|585916972|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236516|NCT04874415|585916973|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236517|NCT04874415|585916974|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
162236518|NCT00881608|585916975|FG000|Overall Study|Study prematurely terminated|11|||
162236519|NCT00701220|585916976|FG000|Overall Study|Withdrawal by Subject|0|||
162236520|NCT00701220|585916977|FG001|Overall Study|Withdrawal by Subject|2|||
162236521|NCT00701220|585916976|FG000|Overall Study|Protocol Violation|2|||
162236522|NCT00701220|585916977|FG001|Overall Study|Protocol Violation|0|||
162236523|NCT00211185|585916978|FG000|Overall Study|Death|2|||
162236524|NCT00211185|585916978|FG000|Overall Study|Disease progression|7|||
162236525|NCT00211185|585916978|FG000|Overall Study|Withdrawal by Subject|6|||
162236526|NCT00211185|585916978|FG000|Overall Study|Physician Decision|5|||
162236527|NCT00069108|585916979|FG000|Overall Study|Withdrawal by Subject|5|||
162236528|NCT00069108|585916980|FG001|Overall Study|Withdrawal by Subject|9|||
162236529|NCT00069108|585916979|FG000|Overall Study|Adverse Event|64|||
162236530|NCT00069108|585916980|FG001|Overall Study|Adverse Event|42|||
162236531|NCT00069108|585916979|FG000|Overall Study|Death|6|||
162236532|NCT00069108|585916980|FG001|Overall Study|Death|6|||
162236533|NCT00069108|585916979|FG000|Overall Study|Administration|15|||
162236534|NCT00069108|585916980|FG001|Overall Study|Administration|4|||
162236535|NCT00069108|585916979|FG000|Overall Study|Insufficient therapy|117|||
162236536|NCT00069108|585916980|FG001|Overall Study|Insufficient therapy|144|||
162236537|NCT00069108|585916979|FG000|Overall Study|Violation criteria|1|||
162236538|NCT00069108|585916980|FG001|Overall Study|Violation criteria|4|||
162236539|NCT00069108|585916979|FG000|Overall Study|Refused treatment|5|||
162236540|NCT00069108|585916980|FG001|Overall Study|Refused treatment|10|||
162236541|NCT00903630|585916981|FG000|Phase 2|Adverse Event|0|||
162236542|NCT00903630|585916982|FG001|Phase 2|Adverse Event|0|||
162236543|NCT00903630|585916983|FG002|Phase 2|Adverse Event|1|||
162236544|NCT03658668|585916986|FG000|Overall Study|Time Commitment|1|||
162236545|NCT03658668|585916987|FG001|Overall Study|Time Commitment|1|||
161924093|NCT00544882|584768159|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
162236546|NCT03305731|585916988|FG000|Overall Study|Protocol Violation|1|||
162236547|NCT04634825|585916989|FG000|Overall Study|Death|10|||
162236548|NCT04634825|585916990|FG001|Overall Study|Death|3|||
162236549|NCT04634825|585916989|FG000|Overall Study|Lost to Follow-up|1|||
162236550|NCT04634825|585916990|FG001|Overall Study|Lost to Follow-up|0|||
162236551|NCT04634825|585916989|FG000|Overall Study|Study terminated by sponsor|35|||
162236552|NCT04634825|585916990|FG001|Overall Study|Study terminated by sponsor|11|||
162236553|NCT04634825|585916989|FG000|Overall Study|Withdrawal by Subject|2|||
162236554|NCT04634825|585916990|FG001|Overall Study|Withdrawal by Subject|0|||
162236555|NCT01127139|585916993|FG000|Overall Study|Adverse Event|40|||
162236556|NCT01127139|585916993|FG000|Overall Study|Incompliance|12|||
162236557|NCT01127139|585916993|FG000|Overall Study|Lack of Efficacy|4|||
162236558|NCT01127139|585916993|FG000|Overall Study|Reason not specified|1|||
162236559|NCT01136772|585916994|FG000|Overall Study|Adverse Event|15|||
162236560|NCT01136772|585916995|FG001|Overall Study|Adverse Event|14|||
162236561|NCT01136772|585916994|FG000|Overall Study|Lack of Efficacy|42|||
162236562|NCT01136772|585916995|FG001|Overall Study|Lack of Efficacy|39|||
162236563|NCT01136772|585916994|FG000|Overall Study|Administrative|14|||
162236564|NCT01136772|585916995|FG001|Overall Study|Administrative|12|||
162236565|NCT01136772|585916994|FG000|Overall Study|Withdrawal by Subject|33|||
162236566|NCT01136772|585916995|FG001|Overall Study|Withdrawal by Subject|36|||
162236567|NCT01136772|585916994|FG000|Overall Study|Did not receive injection|10|||
162236568|NCT01136772|585916995|FG001|Overall Study|Did not receive injection|7|||
162236569|NCT01136772|585916994|FG000|Overall Study|Did not follow up after first injection|2|||
162236570|NCT01136772|585916995|FG001|Overall Study|Did not follow up after first injection|2|||
162236571|NCT01718353|585917001|FG000|Overall Study|Lost to Follow-up|0|||
162236572|NCT01718353|585917002|FG001|Overall Study|Lost to Follow-up|1|||
162236573|NCT01718353|585917001|FG000|Overall Study|Principal Investigator's Decision|10|||
162236574|NCT01718353|585917002|FG001|Overall Study|Principal Investigator's Decision|4|||
162236575|NCT01718353|585917001|FG000|Overall Study|Randomized but not treated|2|||
162181285|NCT00536120|585717047|FG000|Overall Study|Lost to Follow-up|1|||
162181286|NCT00536120|585717048|FG001|Overall Study|Lost to Follow-up|0|||
162181287|NCT00536120|585717047|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
162181288|NCT00536120|585717048|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
162181289|NCT00536120|585717047|FG000|Overall Study|Non-compliance|1|||
162181290|NCT00536120|585717048|FG001|Overall Study|Non-compliance|0|||
162181291|NCT00536120|585717047|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
162181292|NCT00536120|585717048|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
162181293|NCT00536120|585717047|FG000|Overall Study|Steroid Use|0|||
162181294|NCT00536120|585717048|FG001|Overall Study|Steroid Use|2|||
162181295|NCT00536120|585717047|FG000|Overall Study|Missed Study Visit|0|||
162181296|NCT00536120|585717048|FG001|Overall Study|Missed Study Visit|1|||
162181297|NCT02722434|585717049|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
162181298|NCT02722434|585717050|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
162181299|NCT02722434|585717049|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
162181300|NCT02722434|585717050|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
162181301|NCT04989816|585717051|FG000|Overall Study|Death|77|||
162181302|NCT04989816|585717051|FG000|Overall Study|Lost to Follow-up|3|||
162181303|NCT03876457|585717056|FG000|Overall Study|Lost to Follow-up|1|||
162181304|NCT03876457|585717057|FG001|Overall Study|Lost to Follow-up|3|||
162181305|NCT01184326|585717058|FG000|Overall Study|Adverse Event|1|||
162181306|NCT01184326|585717059|FG001|Overall Study|Adverse Event|2|||
162181307|NCT01184326|585717060|FG002|Overall Study|Adverse Event|0|||
162181308|NCT01184326|585717058|FG000|Overall Study|Death|0|||
162181309|NCT01184326|585717059|FG001|Overall Study|Death|0|||
162181310|NCT01184326|585717060|FG002|Overall Study|Death|1|||
162181311|NCT01184326|585717058|FG000|Overall Study|Withdrawal by Subject|0|||
162181312|NCT01184326|585717059|FG001|Overall Study|Withdrawal by Subject|0|||
162181313|NCT01184326|585717060|FG002|Overall Study|Withdrawal by Subject|1|||
162181314|NCT01184326|585717058|FG000|Overall Study|Physician Decision|1|||
162181315|NCT01184326|585717059|FG001|Overall Study|Physician Decision|1|||
162181316|NCT01184326|585717060|FG002|Overall Study|Physician Decision|0|||
162181317|NCT01184326|585717058|FG000|Overall Study|Disease Progression|1|||
162181318|NCT01184326|585717059|FG001|Overall Study|Disease Progression|3|||
162181319|NCT01184326|585717060|FG002|Overall Study|Disease Progression|12|||
162181320|NCT01036724|585717061|FG000|Overall Study|Adverse Event|1|||
162181321|NCT01036724|585717062|FG001|Overall Study|Adverse Event|2|||
162181322|NCT01036724|585717061|FG000|Overall Study|Lack of Efficacy|1|||
162181323|NCT01036724|585717062|FG001|Overall Study|Lack of Efficacy|1|||
162181324|NCT01036724|585717061|FG000|Overall Study|Protocol Violation|4|||
162181325|NCT01036724|585717062|FG001|Overall Study|Protocol Violation|5|||
162181326|NCT01084694|585717064|FG000|Overall Study|Withdrawal by Subject|2|||
162181327|NCT01084694|585717065|FG001|Overall Study|Withdrawal by Subject|1|||
162181328|NCT01084694|585717064|FG000|Overall Study|Death|2|||
162181329|NCT01084694|585717065|FG001|Overall Study|Death|12|||
162181330|NCT01084694|585717064|FG000|Overall Study|eligibility not maintained|2|||
162181331|NCT01084694|585717065|FG001|Overall Study|eligibility not maintained|7|||
162181332|NCT04017611|585717072|FG000|Overall Study|Withdrawn prior to completion|1|||
162181333|NCT01128595|585717073|FG000|Treatment Period 3|Withdrawal by Subject|0|||
162181334|NCT01128595|585717074|FG001|Treatment Period 3|Withdrawal by Subject|1|||
162181335|NCT01128595|585717075|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162181336|NCT01128595|585717076|FG003|Treatment Period 3|Withdrawal by Subject|0|||
162181337|NCT02185794|585717078|FG000|Overall Study|Enrolled but Never Dosed|1|||
162181338|NCT02185794|585717079|FG001|Overall Study|Enrolled but Never Dosed|6|||
162181339|NCT02185794|585717080|FG002|Overall Study|Enrolled but Never Dosed|3|||
162181340|NCT02185794|585717081|FG003|Overall Study|Enrolled but Never Dosed|1|||
162181341|NCT02185794|585717082|FG004|Overall Study|Enrolled but Never Dosed|1|||
162181342|NCT02185794|585717083|FG005|Overall Study|Enrolled but Never Dosed|0|||
162181343|NCT02185794|585717078|FG000|Overall Study|Investigator's Discretion|1|||
162181344|NCT02185794|585717079|FG001|Overall Study|Investigator's Discretion|0|||
162181345|NCT02185794|585717080|FG002|Overall Study|Investigator's Discretion|1|||
162181346|NCT02185794|585717081|FG003|Overall Study|Investigator's Discretion|2|||
162181347|NCT02185794|585717082|FG004|Overall Study|Investigator's Discretion|2|||
162181348|NCT02185794|585717083|FG005|Overall Study|Investigator's Discretion|15|||
162181349|NCT02185794|585717078|FG000|Overall Study|Withdrew Consent|2|||
162181350|NCT02185794|585717079|FG001|Overall Study|Withdrew Consent|5|||
162181351|NCT02185794|585717080|FG002|Overall Study|Withdrew Consent|10|||
162181352|NCT02185794|585717081|FG003|Overall Study|Withdrew Consent|2|||
162181353|NCT02185794|585717082|FG004|Overall Study|Withdrew Consent|0|||
162181354|NCT02185794|585717083|FG005|Overall Study|Withdrew Consent|0|||
162181355|NCT02185794|585717078|FG000|Overall Study|Lost to Follow-up|1|||
162181356|NCT02185794|585717079|FG001|Overall Study|Lost to Follow-up|2|||
162181357|NCT02185794|585717080|FG002|Overall Study|Lost to Follow-up|2|||
162181358|NCT02185794|585717081|FG003|Overall Study|Lost to Follow-up|3|||
162181359|NCT02185794|585717082|FG004|Overall Study|Lost to Follow-up|0|||
162181360|NCT02185794|585717083|FG005|Overall Study|Lost to Follow-up|1|||
162181361|NCT00336505|585717084|FG000|Overall Study|Adverse Event|10|||
162181362|NCT00336505|585717085|FG001|Overall Study|Adverse Event|9|||
162181363|NCT00336505|585717084|FG000|Overall Study|Lack of Efficacy|8|||
162181364|NCT00336505|585717085|FG001|Overall Study|Lack of Efficacy|4|||
162181365|NCT00336505|585717084|FG000|Overall Study|Lost to Follow-up|7|||
162181366|NCT00336505|585717085|FG001|Overall Study|Lost to Follow-up|4|||
162181367|NCT00336505|585717084|FG000|Overall Study|Withdrawal by Subject|5|||
162181368|NCT00336505|585717085|FG001|Overall Study|Withdrawal by Subject|3|||
162181369|NCT00336505|585717084|FG000|Overall Study|Other|7|||
162181370|NCT00336505|585717085|FG001|Overall Study|Other|7|||
162181371|NCT00366249|585717086|FG000|Overall Study|Adverse Event|53|||
162181372|NCT00366249|585717087|FG001|Overall Study|Adverse Event|28|||
162181373|NCT00366249|585717086|FG000|Overall Study|Death|0|||
162181374|NCT00366249|585717087|FG001|Overall Study|Death|1|||
162181375|NCT00366249|585717086|FG000|Overall Study|Physician Decision|5|||
162181376|NCT00366249|585717087|FG001|Overall Study|Physician Decision|2|||
162181377|NCT00366249|585717086|FG000|Overall Study|Lost to Follow-up|2|||
162181378|NCT00366249|585717087|FG001|Overall Study|Lost to Follow-up|0|||
162181379|NCT00366249|585717086|FG000|Overall Study|Protocol Violation|1|||
162181380|NCT00366249|585717087|FG001|Overall Study|Protocol Violation|2|||
162181381|NCT00366249|585717086|FG000|Overall Study|Withdrawal by Subject|18|||
162181382|NCT00366249|585717087|FG001|Overall Study|Withdrawal by Subject|4|||
162181383|NCT00366249|585717086|FG000|Overall Study|Lack of Efficacy|21|||
162181384|NCT00366249|585717087|FG001|Overall Study|Lack of Efficacy|21|||
162181385|NCT00366249|585717086|FG000|Overall Study|Most due to osteomylitis status|31|||
162181386|NCT00366249|585717087|FG001|Overall Study|Most due to osteomylitis status|20|||
162181387|NCT00609869|585717088|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
162181388|NCT00609869|585717088|FG000|Overall Study|Severe hematologic toxicity|1|||
162181389|NCT00609869|585717088|FG000|Overall Study|Withdrawal by Subject|1|||
162181390|NCT00609869|585717088|FG000|Overall Study|Seizures|1|||
162181391|NCT00609869|585717088|FG000|Overall Study|Severe tumor flare reaction|1|||
162181392|NCT00609869|585717088|FG000|Overall Study|Hepatitis B infection|1|||
162181393|NCT00609869|585717088|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
162181394|NCT00609869|585717088|FG000|Overall Study|Mantle cell: not evaluable|4|||
162181395|NCT03478969|585717089|FG000|Overall Study|Withdrawal by Subject|4|||
162181396|NCT03478969|585717090|FG001|Overall Study|Withdrawal by Subject|7|||
162181397|NCT03478969|585717091|FG002|Overall Study|Withdrawal by Subject|6|||
162181398|NCT03478969|585717089|FG000|Overall Study|Adverse Event|2|||
162181399|NCT03478969|585717090|FG001|Overall Study|Adverse Event|0|||
162181400|NCT03478969|585717091|FG002|Overall Study|Adverse Event|1|||
162181401|NCT03478969|585717089|FG000|Overall Study|Pregnancy|1|||
162181402|NCT03478969|585717090|FG001|Overall Study|Pregnancy|0|||
162181403|NCT03478969|585717091|FG002|Overall Study|Pregnancy|0|||
162181404|NCT03478969|585717089|FG000|Overall Study|Personal Reasons|1|||
162181405|NCT03478969|585717090|FG001|Overall Study|Personal Reasons|0|||
162181406|NCT03478969|585717091|FG002|Overall Study|Personal Reasons|1|||
162181407|NCT03478969|585717089|FG000|Overall Study|Covid-19|1|||
162181408|NCT03478969|585717090|FG001|Overall Study|Covid-19|4|||
162181409|NCT03478969|585717091|FG002|Overall Study|Covid-19|3|||
162181410|NCT03478969|585717089|FG000|Overall Study|Multiple Reasons|0|||
162181411|NCT03478969|585717090|FG001|Overall Study|Multiple Reasons|1|||
162181412|NCT03478969|585717091|FG002|Overall Study|Multiple Reasons|1|||
162181413|NCT03478969|585717089|FG000|Overall Study|Eligibility Criteria|0|||
162181414|NCT03478969|585717090|FG001|Overall Study|Eligibility Criteria|0|||
162018759|NCT02675634|585123212|FG004|Test Period 1|Adverse Event|0|||
162018760|NCT02675634|585123213|FG005|Test Period 1|Adverse Event|0|||
162018761|NCT02675634|585123208|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
162018762|NCT02675634|585123209|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
162018763|NCT02675634|585123210|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
162018764|NCT02675634|585123211|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
162018765|NCT02675634|585123212|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
162018766|NCT02675634|585123213|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
162018767|NCT02675634|585123208|FG000|Test Period 2|Lack of Efficacy|1|||
162018768|NCT02675634|585123209|FG001|Test Period 2|Lack of Efficacy|0|||
162018769|NCT02675634|585123210|FG002|Test Period 2|Lack of Efficacy|0|||
162018770|NCT02675634|585123211|FG003|Test Period 2|Lack of Efficacy|0|||
162018771|NCT02675634|585123212|FG004|Test Period 2|Lack of Efficacy|0|||
162018772|NCT02675634|585123213|FG005|Test Period 2|Lack of Efficacy|0|||
162018773|NCT02675634|585123208|FG000|Test Period 2|Adverse Event|0|||
162018774|NCT02675634|585123209|FG001|Test Period 2|Adverse Event|0|||
162018775|NCT02675634|585123210|FG002|Test Period 2|Adverse Event|0|||
162018776|NCT02675634|585123211|FG003|Test Period 2|Adverse Event|0|||
162018777|NCT02675634|585123212|FG004|Test Period 2|Adverse Event|0|||
162181415|NCT03478969|585717091|FG002|Overall Study|Eligibility Criteria|5|||
162181416|NCT03478969|585717089|FG000|Overall Study|Lost to Follow-up|0|||
162181417|NCT03478969|585717090|FG001|Overall Study|Lost to Follow-up|0|||
161818100|NCT05412121|584374366|FG000|Overall Study|Lost to Follow-up|5|||
162018778|NCT02675634|585123213|FG005|Test Period 2|Adverse Event|1|||
162181418|NCT03478969|585717091|FG002|Overall Study|Lost to Follow-up|1|||
162181419|NCT01185600|585717092|FG000|Overall Study|Adverse Event|1|||
162181420|NCT01185600|585717093|FG001|Overall Study|Adverse Event|1|||
162181421|NCT01185600|585717092|FG000|Overall Study|Death|0|||
162181422|NCT01185600|585717093|FG001|Overall Study|Death|1|||
162181423|NCT01185600|585717092|FG000|Overall Study|Lost to Follow-up|0|||
162181424|NCT01185600|585717093|FG001|Overall Study|Lost to Follow-up|5|||
162181425|NCT01185600|585717092|FG000|Overall Study|Physician Decision|29|||
162181426|NCT01185600|585717093|FG001|Overall Study|Physician Decision|35|||
162181427|NCT01185600|585717092|FG000|Overall Study|Withdrawal by Subject|1|||
162181428|NCT01185600|585717093|FG001|Overall Study|Withdrawal by Subject|1|||
162181429|NCT01185600|585717092|FG000|Overall Study|Hold by DSMB|1|||
162181430|NCT01185600|585717093|FG001|Overall Study|Hold by DSMB|2|||
162181431|NCT05405244|585717094|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
162181432|NCT05405244|585717095|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
162181433|NCT05405244|585717094|FG000|Washout (2 Weeks)|Adverse Event|2|||
162181434|NCT05405244|585717095|FG001|Washout (2 Weeks)|Adverse Event|0|||
162181435|NCT05405244|585717094|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
162181436|NCT05405244|585717095|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
162181437|NCT00739934|585717096|FG000|Voriconazole IV|Adverse Event|6|||
162181438|NCT00739934|585717096|FG000|Voriconazole Oral|Other|3|||
162181439|NCT00754065|585717099|FG000|Overall Study|Never received treatment|12|||
161818101|NCT03541252|584374367|FG000|Overall Study|Withdrawal by Subject|1|||
161818102|NCT01576705|584374368|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
161818103|NCT01576705|584374369|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
161818104|NCT01576705|584374370|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
161942234|NCT00663260|584838358|FG002|Overall Study|Adverse Event|6|||
161672094|NCT01372410|583853024|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161672095|NCT01372410|583853025|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161672096|NCT01372410|583853026|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161672097|NCT01372410|583853027|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161672098|NCT01372410|583853028|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
161672099|NCT01372410|583853029|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161672100|NCT01372410|583853022|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
161672101|NCT01372410|583853023|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161672102|NCT01372410|583853024|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161672103|NCT01372410|583853025|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161672104|NCT01372410|583853026|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161672105|NCT01372410|583853027|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161672106|NCT01372410|583853028|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161672107|NCT01372410|583853029|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
161672108|NCT01372410|583853022|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672109|NCT01372410|583853023|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672110|NCT01372410|583853024|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672111|NCT01372410|583853025|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672112|NCT01372410|583853026|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
161672113|NCT01372410|583853027|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672114|NCT01372410|583853028|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672115|NCT01372410|583853029|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161672116|NCT01372410|583853022|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161672117|NCT01372410|583853023|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161672118|NCT01372410|583853024|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161672119|NCT01372410|583853025|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161672120|NCT01372410|583853026|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
161672121|NCT01372410|583853027|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161672122|NCT01372410|583853028|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
161672123|NCT01372410|583853029|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
161672124|NCT01372410|583853022|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672125|NCT01372410|583853023|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672126|NCT01372410|583853024|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672127|NCT01372410|583853025|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672128|NCT01372410|583853026|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672129|NCT01372410|583853027|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672130|NCT01372410|583853028|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161672131|NCT01372410|583853029|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
161672132|NCT01372410|583853022|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672133|NCT01372410|583853023|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672134|NCT01372410|583853024|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
161672135|NCT01372410|583853025|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672136|NCT01372410|583853026|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672137|NCT01372410|583853027|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672138|NCT01372410|583853028|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672139|NCT01372410|583853029|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
161672140|NCT01372410|583853022|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672141|NCT01372410|583853023|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672142|NCT01372410|583853024|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672143|NCT01372410|583853025|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672144|NCT01372410|583853026|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672145|NCT01372410|583853027|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
161672146|NCT01372410|583853028|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672147|NCT01372410|583853029|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161672148|NCT04585646|583853030|FG000|First Intervention|Physician Decision|1|||
161672149|NCT04585646|583853031|FG001|First Intervention|Physician Decision|0|||
161672150|NCT04585646|583853030|FG000|First Intervention|Lost to Follow-up|0|||
161672151|NCT04585646|583853031|FG001|First Intervention|Lost to Follow-up|3|||
161672152|NCT04585646|583853030|FG000|First Intervention|Withdrawal by Subject|0|||
161672153|NCT04585646|583853031|FG001|First Intervention|Withdrawal by Subject|1|||
161672154|NCT04614662|583853034|FG000|Overall Study|Withdrawal by Subject|0|||
161672155|NCT04614662|583853035|FG001|Overall Study|Withdrawal by Subject|1|||
161672156|NCT01862640|583853043|FG000|Overall Study|Adverse Event|4|||
161672157|NCT01862640|583853044|FG001|Overall Study|Adverse Event|10|||
161672158|NCT01862640|583853045|FG002|Overall Study|Adverse Event|6|||
161672159|NCT01862640|583853046|FG003|Overall Study|Adverse Event|8|||
161672160|NCT01862640|583853043|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
161672161|NCT01862640|583853044|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
161924094|NCT00544882|584768157|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
161672162|NCT01862640|583853045|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
161672163|NCT01862640|583853046|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
161672164|NCT01862640|583853043|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
161672165|NCT01862640|583853044|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
161672166|NCT01862640|583853045|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
161672167|NCT01862640|583853046|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
161672168|NCT01862640|583853043|FG000|Overall Study|Withdrawal by Subject|2|||
161672169|NCT01862640|583853044|FG001|Overall Study|Withdrawal by Subject|4|||
161672170|NCT01862640|583853045|FG002|Overall Study|Withdrawal by Subject|8|||
161672171|NCT01862640|583853046|FG003|Overall Study|Withdrawal by Subject|5|||
161672172|NCT01862640|583853043|FG000|Overall Study|Protocol Deviation|0|||
161924095|NCT00544882|584768158|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
161924096|NCT00544882|584768159|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
161924097|NCT00544882|584768157|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
161924098|NCT00544882|584768158|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
161924099|NCT00544882|584768159|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
161924100|NCT00544882|584768157|FG000|Cycle 3: Follow-up|Noncompliance|0|||
162181440|NCT00754065|585717100|FG001|Overall Study|Never received treatment|2|||
162181441|NCT00754065|585717099|FG000|Overall Study|Adverse Event|19|||
162181442|NCT00754065|585717100|FG001|Overall Study|Adverse Event|25|||
162181443|NCT00754065|585717099|FG000|Overall Study|Lost to Follow-up|7|||
162181444|NCT00754065|585717100|FG001|Overall Study|Lost to Follow-up|11|||
162181445|NCT00754065|585717099|FG000|Overall Study|Protocol Violation|12|||
162181446|NCT00754065|585717100|FG001|Overall Study|Protocol Violation|10|||
162181447|NCT00754065|585717099|FG000|Overall Study|Withdrawal by Subject|4|||
162181448|NCT00754065|585717100|FG001|Overall Study|Withdrawal by Subject|5|||
162181449|NCT00754065|585717099|FG000|Overall Study|Pregnancy|6|||
162181450|NCT00754065|585717100|FG001|Overall Study|Pregnancy|0|||
162181451|NCT00754065|585717099|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
162181452|NCT00754065|585717100|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
162181453|NCT04353492|585717103|FG000|Overall Study|Subject decision|24|||
162181454|NCT04353492|585717103|FG000|Overall Study|Physician Decision|5|||
162181455|NCT04353492|585717103|FG000|Overall Study|Adverse Event|3|||
162181456|NCT04353492|585717103|FG000|Overall Study|Pregnancy|3|||
162181457|NCT04353492|585717103|FG000|Overall Study|Lost to Follow-up|2|||
162181458|NCT04353492|585717103|FG000|Overall Study|Protocol deviation|1|||
162181459|NCT04353492|585717103|FG000|Overall Study|Technical problems|1|||
162181460|NCT01961609|585717104|FG000|Initiation|Missing|3|||
161672173|NCT01862640|583853044|FG001|Overall Study|Protocol Deviation|0|||
162181461|NCT01961609|585717105|FG001|Initiation|Missing|2|||
162181462|NCT01961609|585717106|FG002|Initiation|Missing|0|||
162181463|NCT01961609|585717107|FG003|Initiation|Missing|0|||
162181464|NCT01961609|585717104|FG000|Initiation|Protocol deviation|1|||
162181465|NCT01961609|585717105|FG001|Initiation|Protocol deviation|0|||
162181466|NCT01961609|585717106|FG002|Initiation|Protocol deviation|0|||
162181467|NCT01961609|585717107|FG003|Initiation|Protocol deviation|0|||
162181468|NCT01961609|585717104|FG000|Initiation|Death|0|||
162181469|NCT01961609|585717105|FG001|Initiation|Death|1|||
162181470|NCT01961609|585717106|FG002|Initiation|Death|0|||
162181471|NCT01961609|585717107|FG003|Initiation|Death|0|||
161672174|NCT01862640|583853045|FG002|Overall Study|Protocol Deviation|1|||
161672175|NCT01862640|583853046|FG003|Overall Study|Protocol Deviation|0|||
161924101|NCT00544882|584768158|FG001|Cycle 3: Follow-up|Noncompliance|1|||
162181472|NCT01961609|585717104|FG000|Initiation|Administrative problems|1|||
162181473|NCT01961609|585717105|FG001|Initiation|Administrative problems|0|||
162181474|NCT01961609|585717106|FG002|Initiation|Administrative problems|0|||
162181475|NCT01961609|585717107|FG003|Initiation|Administrative problems|0|||
162181476|NCT01961609|585717104|FG000|Initiation|Withdrawal by Subject|1|||
162181477|NCT01961609|585717105|FG001|Initiation|Withdrawal by Subject|2|||
162181478|NCT01961609|585717106|FG002|Initiation|Withdrawal by Subject|0|||
161672176|NCT02178553|583853049|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
161672177|NCT02178553|583853050|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
161818105|NCT01576705|584374371|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
162018779|NCT00811018|585123214|FG000|Overall Study|Additional Chronic Treatment|31|||
162018780|NCT00811018|585123214|FG000|Overall Study|Adverse Event|79|||
162018781|NCT00811018|585123214|FG000|Overall Study|Death|147|||
162018782|NCT00811018|585123214|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
162018783|NCT00811018|585123214|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
162018784|NCT00811018|585123214|FG000|Overall Study|Investigator Decision|57|||
162018785|NCT00811018|585123214|FG000|Overall Study|Lost to Follow-up|19|||
162018786|NCT00811018|585123214|FG000|Overall Study|Pregnancy|6|||
162018787|NCT00811018|585123214|FG000|Overall Study|Sponsor Decision|450|||
162181479|NCT01961609|585717107|FG003|Initiation|Withdrawal by Subject|0|||
162181480|NCT01961609|585717104|FG000|Initiation|Lack of Efficacy|2|||
162181481|NCT01961609|585717105|FG001|Initiation|Lack of Efficacy|1|||
162181482|NCT01961609|585717106|FG002|Initiation|Lack of Efficacy|0|||
162181483|NCT01961609|585717107|FG003|Initiation|Lack of Efficacy|0|||
162181484|NCT01961609|585717104|FG000|Initiation|Abnormal lab values|0|||
162181485|NCT01961609|585717105|FG001|Initiation|Abnormal lab values|1|||
162181486|NCT01961609|585717106|FG002|Initiation|Abnormal lab values|0|||
162181487|NCT01961609|585717107|FG003|Initiation|Abnormal lab values|0|||
162181488|NCT01961609|585717104|FG000|Initiation|Adverse Event|3|||
162181489|NCT01961609|585717105|FG001|Initiation|Adverse Event|5|||
162181490|NCT01961609|585717106|FG002|Initiation|Adverse Event|0|||
162181491|NCT01961609|585717107|FG003|Initiation|Adverse Event|0|||
162181492|NCT01961609|585717104|FG000|Initiation|Randomized but not treated|1|||
162181493|NCT01961609|585717105|FG001|Initiation|Randomized but not treated|1|||
162181494|NCT01961609|585717106|FG002|Initiation|Randomized but not treated|0|||
162181495|NCT01961609|585717107|FG003|Initiation|Randomized but not treated|0|||
162181496|NCT01961609|585717104|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
162181497|NCT01961609|585717105|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
162181498|NCT01961609|585717106|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
162181499|NCT01961609|585717107|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
162181500|NCT01961609|585717104|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
162181501|NCT01961609|585717105|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
162181502|NCT01961609|585717106|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
162181503|NCT01961609|585717107|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
162181504|NCT01961609|585717104|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
162181505|NCT01961609|585717105|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
162181506|NCT01961609|585717106|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
162181507|NCT01961609|585717107|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
162181508|NCT01961609|585717104|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
162181509|NCT01961609|585717105|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
162181510|NCT01961609|585717106|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
162181511|NCT01961609|585717107|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
162181512|NCT01961609|585717104|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
162181513|NCT01961609|585717105|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
162181514|NCT01961609|585717106|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
162181515|NCT01961609|585717107|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
162181516|NCT01961609|585717104|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
162181517|NCT01961609|585717105|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
162181518|NCT01961609|585717106|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
162181519|NCT01961609|585717107|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
162181520|NCT01961609|585717104|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
162181521|NCT01961609|585717105|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
162181522|NCT01961609|585717106|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
162181523|NCT01961609|585717107|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
162181524|NCT01961609|585717104|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
162181525|NCT01961609|585717105|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
162181526|NCT01961609|585717106|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
162181527|NCT01961609|585717107|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
162181528|NCT01961609|585717104|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
162181529|NCT01961609|585717105|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
162181530|NCT01961609|585717106|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
162181531|NCT01961609|585717107|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
162181532|NCT01961609|585717104|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
162181533|NCT01961609|585717105|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
162181534|NCT01961609|585717106|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
162181535|NCT01961609|585717107|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
162181536|NCT01961609|585717104|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
161672178|NCT02178553|583853049|FG000|Overall Study|Physician Decision|0|||
161672179|NCT02178553|583853050|FG001|Overall Study|Physician Decision|4|||
161672180|NCT02178553|583853049|FG000|Overall Study|Technical problem with injection|1|||
161818106|NCT01576705|584374368|FG000|Overall Study|invalid ICF|0|||
161672181|NCT02178553|583853050|FG001|Overall Study|Technical problem with injection|3|||
161818107|NCT01576705|584374369|FG001|Overall Study|invalid ICF|1|||
161818108|NCT01576705|584374370|FG002|Overall Study|invalid ICF|0|||
161818109|NCT01576705|584374371|FG003|Overall Study|invalid ICF|0|||
161818110|NCT00858403|584374372|FG000|Overall Study|Withdrawal by Subject|1|||
161818111|NCT00858403|584374372|FG000|Overall Study|Death|3|||
161818112|NCT00858403|584374372|FG000|Overall Study|Disease Progression|1|||
161818113|NCT00227370|584374376|FG000|Overall Study|Withdrawal by Subject|1|||
161818114|NCT00227370|584374377|FG001|Overall Study|Withdrawal by Subject|2|||
161818115|NCT00227370|584374376|FG000|Overall Study|Death|3|||
161818116|NCT00227370|584374377|FG001|Overall Study|Death|4|||
161818117|NCT00227370|584374376|FG000|Overall Study|Adverse Event|6|||
161818118|NCT00227370|584374377|FG001|Overall Study|Adverse Event|11|||
161818119|NCT00227370|584374376|FG000|Overall Study|Physician Decision|9|||
162181537|NCT01961609|585717105|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
162181538|NCT01961609|585717106|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
162181539|NCT01961609|585717107|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
162181540|NCT01961609|585717104|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
162181541|NCT01961609|585717105|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
162181542|NCT01961609|585717106|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
162181543|NCT01961609|585717107|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
162181544|NCT02167451|585717110|FG000|Overall Study|Withdrawal by Subject|1|||
162181545|NCT03355573|585717115|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
162181546|NCT03355573|585717115|FG000|Overall Study|Sponsor's decision|1|||
162181547|NCT03355573|585717115|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
162181548|NCT03355573|585717115|FG000|Overall Study|PI's decision|2|||
162181549|NCT03355573|585717115|FG000|Overall Study|Withdrawal by Subject|23|||
162181550|NCT03355573|585717115|FG000|Overall Study|Lost to Follow-up|4|||
162181551|NCT03355573|585717115|FG000|Overall Study|Lack of Efficacy|2|||
161818120|NCT00227370|584374377|FG001|Overall Study|Physician Decision|6|||
161818121|NCT00227370|584374376|FG000|Overall Study|Other reasons|2|||
162181552|NCT03355573|585717115|FG000|Overall Study|Adverse Event, non-fatal|17|||
162181553|NCT03355573|585717115|FG000|Overall Study|Adverse Event, serious fatal|2|||
161818122|NCT00227370|584374377|FG001|Overall Study|Other reasons|1|||
162181554|NCT01566890|585717116|FG000|Overall Study|Adverse Event|1|||
162181555|NCT01566890|585717117|FG001|Overall Study|Adverse Event|0|||
162181556|NCT01566890|585717118|FG002|Overall Study|Adverse Event|0|||
162181557|NCT01566890|585717119|FG003|Overall Study|Adverse Event|0|||
162181558|NCT01566890|585717120|FG004|Overall Study|Adverse Event|0|||
162181559|NCT01566890|585717116|FG000|Overall Study|Withdrawal by Subject|3|||
162181560|NCT01566890|585717117|FG001|Overall Study|Withdrawal by Subject|1|||
162181561|NCT01566890|585717118|FG002|Overall Study|Withdrawal by Subject|1|||
162181562|NCT01566890|585717119|FG003|Overall Study|Withdrawal by Subject|1|||
162181563|NCT01566890|585717120|FG004|Overall Study|Withdrawal by Subject|0|||
162181564|NCT01566890|585717116|FG000|Overall Study|Screen failure|6|||
162181565|NCT01566890|585717117|FG001|Overall Study|Screen failure|0|||
162181566|NCT01566890|585717118|FG002|Overall Study|Screen failure|1|||
162181567|NCT01566890|585717119|FG003|Overall Study|Screen failure|1|||
161818123|NCT03846193|584374378|FG000|Overall Study|Physician Decision|0|||
162181568|NCT01566890|585717120|FG004|Overall Study|Screen failure|0|||
162181569|NCT01566890|585717116|FG000|Overall Study|Incomplete CEU data|1|||
162181570|NCT01566890|585717117|FG001|Overall Study|Incomplete CEU data|3|||
161818124|NCT03846193|584374379|FG001|Overall Study|Physician Decision|0|||
161818125|NCT03846193|584374380|FG002|Overall Study|Physician Decision|1|||
161818126|NCT03846193|584374381|FG003|Overall Study|Physician Decision|0|||
162181571|NCT01566890|585717118|FG002|Overall Study|Incomplete CEU data|5|||
162181572|NCT01566890|585717119|FG003|Overall Study|Incomplete CEU data|8|||
162181573|NCT01566890|585717120|FG004|Overall Study|Incomplete CEU data|0|||
162181574|NCT01566890|585717116|FG000|Overall Study|Lost to Follow-up|0|||
162181575|NCT01566890|585717117|FG001|Overall Study|Lost to Follow-up|0|||
162181576|NCT01566890|585717118|FG002|Overall Study|Lost to Follow-up|4|||
162181577|NCT01566890|585717119|FG003|Overall Study|Lost to Follow-up|4|||
162181578|NCT01566890|585717120|FG004|Overall Study|Lost to Follow-up|0|||
162181579|NCT01566890|585717116|FG000|Overall Study|Other|0|||
162181580|NCT01566890|585717117|FG001|Overall Study|Other|0|||
162181581|NCT01566890|585717118|FG002|Overall Study|Other|0|||
162181582|NCT01566890|585717119|FG003|Overall Study|Other|0|||
162181583|NCT01566890|585717120|FG004|Overall Study|Other|7|||
162181584|NCT01218009|585717123|FG000|Overall Study|Protocol Violation|2|||
162181585|NCT01218009|585717124|FG001|Overall Study|Protocol Violation|1|||
162181586|NCT01218009|585717123|FG000|Overall Study|Withdrawal by Subject|3|||
162181587|NCT01218009|585717124|FG001|Overall Study|Withdrawal by Subject|1|||
162181588|NCT01218009|585717123|FG000|Overall Study|Sponsor terminated study|161|||
162181589|NCT01218009|585717124|FG001|Overall Study|Sponsor terminated study|163|||
162181590|NCT03280030|585717126|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
162181591|NCT03280030|585717127|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
162181592|NCT03280030|585717128|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
162181593|NCT03280030|585717126|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
162181594|NCT03280030|585717127|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
162181595|NCT03280030|585717128|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
162181596|NCT03280030|585717126|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
162181597|NCT03280030|585717127|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
162181598|NCT03280030|585717128|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
162181599|NCT03280030|585717126|FG000|Part 2 - Efficacy|Adverse Event|0|||
162181600|NCT03280030|585717127|FG001|Part 2 - Efficacy|Adverse Event|4|||
162181601|NCT03280030|585717128|FG002|Part 2 - Efficacy|Adverse Event|6|||
162181602|NCT03280030|585717126|FG000|Part 2 - Efficacy|Death|0|||
162181603|NCT03280030|585717127|FG001|Part 2 - Efficacy|Death|3|||
161818127|NCT03846193|584374382|FG004|Overall Study|Physician Decision|0|||
161818128|NCT03846193|584374378|FG000|Overall Study|Lost to Follow-up|0|||
161818129|NCT03846193|584374379|FG001|Overall Study|Lost to Follow-up|0|||
161818130|NCT03846193|584374380|FG002|Overall Study|Lost to Follow-up|0|||
161818131|NCT03846193|584374381|FG003|Overall Study|Lost to Follow-up|0|||
161818132|NCT03846193|584374382|FG004|Overall Study|Lost to Follow-up|1|||
161818133|NCT03846193|584374378|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
161818134|NCT03846193|584374379|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
161818135|NCT03846193|584374380|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
161818136|NCT03846193|584374381|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
162181604|NCT03280030|585717128|FG002|Part 2 - Efficacy|Death|0|||
162181605|NCT03280030|585717126|FG000|Part 2 - Efficacy|Physician Decision|0|||
162181606|NCT03280030|585717127|FG001|Part 2 - Efficacy|Physician Decision|10|||
162181607|NCT03280030|585717128|FG002|Part 2 - Efficacy|Physician Decision|16|||
161818137|NCT03846193|584374382|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
162181608|NCT03280030|585717126|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
162181609|NCT03280030|585717127|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
162181610|NCT03280030|585717128|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
162181611|NCT03280030|585717126|FG000|Part 2 - Efficacy|Progressive disease|0|||
162181612|NCT03280030|585717127|FG001|Part 2 - Efficacy|Progressive disease|7|||
162181613|NCT03280030|585717128|FG002|Part 2 - Efficacy|Progressive disease|5|||
162181614|NCT03275285|585717131|FG000|Overall Study|Ongoing|45|||
162181615|NCT03275285|585717132|FG001|Overall Study|Ongoing|69|||
162181616|NCT00115934|585717133|FG000|Overall Study|Lost to Follow-up|1|||
162181617|NCT00115934|585717134|FG001|Overall Study|Lost to Follow-up|0|||
162181618|NCT00115934|585717133|FG000|Overall Study|Did not receive intervention|3|||
162181619|NCT00115934|585717134|FG001|Overall Study|Did not receive intervention|2|||
162181620|NCT03789110|585717135|FG000|Overall Study|Adverse Event|2|||
162181621|NCT03789110|585717135|FG000|Overall Study|Physician Decision|1|||
162181622|NCT03789110|585717135|FG000|Overall Study|Withdrawal by Subject|2|||
162181623|NCT03789110|585717135|FG000|Overall Study|Lack of Efficacy|22|||
162181624|NCT03789110|585717135|FG000|Overall Study|still on treatment|3|||
162181625|NCT03959423|585717141|FG000|Overall Study|Withdrawal by Subject|2|||
162181626|NCT03959423|585717142|FG001|Overall Study|Withdrawal by Subject|3|||
162181627|NCT03959423|585717141|FG000|Overall Study|Physician Decision|0|||
162181628|NCT03959423|585717142|FG001|Overall Study|Physician Decision|1|||
162181629|NCT03959423|585717141|FG000|Overall Study|Lost to Follow-up|1|||
162181630|NCT03959423|585717142|FG001|Overall Study|Lost to Follow-up|0|||
162181631|NCT03959423|585717141|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
162181632|NCT03959423|585717142|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162181633|NCT04926740|585717145|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
162181634|NCT04926740|585717146|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
162181635|NCT04926740|585717145|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
162181636|NCT04926740|585717146|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
162181637|NCT04980300|585717147|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
162181638|NCT04980300|585717148|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
162181639|NCT04980300|585717147|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
162181640|NCT04980300|585717148|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
162181641|NCT04980300|585717147|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
162181642|NCT04980300|585717148|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
162181643|NCT04980300|585717147|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
162181644|NCT04980300|585717148|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
162181645|NCT06056310|585717999|FG000|Overall Study|Other Reasons|2|||
162181646|NCT06056310|585717999|FG000|Overall Study|Sponsor Request|16|||
162181647|NCT02866942|585718002|FG000|Overall Study|Invalid consent|1|||
162181648|NCT01750684|585718003|FG000|Overall Study|Death|1|||
162181649|NCT01750684|585718004|FG001|Overall Study|Death|0|||
162181650|NCT01750684|585718003|FG000|Overall Study|Non-compliance with Study Drug|0|||
162181651|NCT01750684|585718004|FG001|Overall Study|Non-compliance with Study Drug|1|||
162181652|NCT01750684|585718003|FG000|Overall Study|Withdrawn by Sponsor|0|||
162181653|NCT01750684|585718004|FG001|Overall Study|Withdrawn by Sponsor|1|||
162181654|NCT01750684|585718003|FG000|Overall Study|Protocol Violation|1|||
162181655|NCT01750684|585718004|FG001|Overall Study|Protocol Violation|0|||
162181656|NCT00372775|585718005|FG000|Overall Study|Adverse Event|8|||
162181657|NCT00372775|585718005|FG000|Overall Study|Death|15|||
162181658|NCT00372775|585718005|FG000|Overall Study|Objective progression or relapse|30|||
162181659|NCT00372775|585718005|FG000|Overall Study|Global deterioration of health status|6|||
162181660|NCT00372775|585718005|FG000|Overall Study|Withdrawal by Subject|1|||
162181661|NCT00372775|585718005|FG000|Overall Study|Other|1|||
162181662|NCT00372775|585718005|FG000|Overall Study|Not Treated|2|||
162181663|NCT01561300|585718006|FG000|Run in on Placebo|Adverse Event|1|||
162181664|NCT01561300|585718007|FG001|Run in on Placebo|Adverse Event|0|||
162181665|NCT00777049|585718008|FG000|Overall Study|Withdrawal by Subject|1|||
162181666|NCT00777049|585718009|FG001|Overall Study|Withdrawal by Subject|0|||
162181667|NCT00777049|585718008|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
162181668|NCT00777049|585718009|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
162181669|NCT01436175|585718010|FG000|Overall Study|Adverse Event|111|||
162181670|NCT01436175|585718010|FG000|Overall Study|Protocol Violation|49|||
162181671|NCT01436175|585718010|FG000|Overall Study|Withdrawal by Subject|108|||
162181672|NCT01436175|585718010|FG000|Overall Study|Lost to Follow-up|89|||
162181673|NCT01436175|585718010|FG000|Overall Study|Lack of Efficacy|24|||
162181674|NCT01436175|585718010|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
162181675|NCT01436175|585718010|FG000|Overall Study|Other|826|||
162181676|NCT04250194|585718015|FG000|Overall Study|Declined to schedule biopsy|6|||
161924102|NCT00544882|584768159|FG002|Cycle 3: Follow-up|Noncompliance|0|||
161924103|NCT00544882|584768157|FG000|Cycle 3: Follow-up|Pregnancy|0|||
162181677|NCT04250194|585718016|FG001|Overall Study|Declined to schedule biopsy|10|||
162181678|NCT04250194|585718015|FG000|Overall Study|Medically Unfit for Biopsy|2|||
162181679|NCT04250194|585718016|FG001|Overall Study|Medically Unfit for Biopsy|1|||
161924104|NCT00544882|584768158|FG001|Cycle 3: Follow-up|Pregnancy|1|||
162181680|NCT04250194|585718015|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
162181681|NCT04250194|585718016|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
162181682|NCT04250194|585718015|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
162181683|NCT04250194|585718016|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
162181684|NCT04250194|585718015|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
162181685|NCT04250194|585718016|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
162181686|NCT01952366|585718019|FG000|Overall Study|Death|22|||
162181687|NCT01952366|585718019|FG000|Overall Study|Withdrawal by Subject|9|||
162181688|NCT00623194|585718020|FG000|Overall Study|Lack of Efficacy|1|||
162181689|NCT00623194|585718020|FG000|Overall Study|Protocol Violation|3|||
162181690|NCT00623194|585718020|FG000|Overall Study|Unclassified|1|||
162181691|NCT00857766|585718021|FG000|Overall Study|Adverse Event|13|||
162181692|NCT00857766|585718022|FG001|Overall Study|Adverse Event|12|||
162181693|NCT00857766|585718021|FG000|Overall Study|Protocol Violation|11|||
162181694|NCT00857766|585718022|FG001|Overall Study|Protocol Violation|11|||
162181695|NCT00857766|585718021|FG000|Overall Study|Lost to Follow-up|1|||
162181696|NCT00857766|585718022|FG001|Overall Study|Lost to Follow-up|0|||
162181697|NCT00857766|585718021|FG000|Overall Study|Investigator Discretion|2|||
162181698|NCT00857766|585718022|FG001|Overall Study|Investigator Discretion|3|||
162181699|NCT00857766|585718021|FG000|Overall Study|Participant Withdrew Consent|4|||
162181700|NCT00857766|585718022|FG001|Overall Study|Participant Withdrew Consent|4|||
162181701|NCT01988402|585718023|FG000|Overall Study|Adverse Event|1|||
162181702|NCT01988402|585718024|FG001|Overall Study|Adverse Event|2|||
162181703|NCT01988402|585718023|FG000|Overall Study|Withdrawal by Subject|1|||
162181704|NCT01988402|585718024|FG001|Overall Study|Withdrawal by Subject|0|||
162181705|NCT01212744|585718025|FG000|Overall Study|Withdrawal by Subject|1|||
162181706|NCT00571649|585718026|FG000|Treatment Period|Adverse Event|438|||
162181707|NCT00571649|585718027|FG001|Treatment Period|Adverse Event|385|||
162181708|NCT00571649|585718026|FG000|Treatment Period|Clinical endpoint reached|50|||
162181709|NCT00571649|585718027|FG001|Treatment Period|Clinical endpoint reached|56|||
162181710|NCT00571649|585718026|FG000|Treatment Period|Withdrawal by Subject|285|||
162181711|NCT00571649|585718027|FG001|Treatment Period|Withdrawal by Subject|255|||
162181712|NCT00571649|585718026|FG000|Treatment Period|Death|76|||
162181713|NCT00571649|585718027|FG001|Treatment Period|Death|59|||
162181714|NCT00571649|585718026|FG000|Treatment Period|Physician Decision|8|||
162181715|NCT00571649|585718027|FG001|Treatment Period|Physician Decision|9|||
162181716|NCT00571649|585718026|FG000|Treatment Period|Lost to Follow-up|43|||
162181717|NCT00571649|585718027|FG001|Treatment Period|Lost to Follow-up|41|||
162181718|NCT00571649|585718026|FG000|Treatment Period|Non-compliant with study medication|88|||
162181719|NCT00571649|585718027|FG001|Treatment Period|Non-compliant with study medication|89|||
162181720|NCT00571649|585718026|FG000|Treatment Period|Patient convenience|11|||
162181721|NCT00571649|585718027|FG001|Treatment Period|Patient convenience|13|||
162181722|NCT00571649|585718026|FG000|Treatment Period|Protocol Violation|90|||
162181723|NCT00571649|585718027|FG001|Treatment Period|Protocol Violation|92|||
162181724|NCT00571649|585718026|FG000|Treatment Period|Technical problems|3|||
162181725|NCT00571649|585718027|FG001|Treatment Period|Technical problems|5|||
162181726|NCT00571649|585718026|FG000|Follow-up Period|Adverse Event|46|||
162181727|NCT00571649|585718027|FG001|Follow-up Period|Adverse Event|40|||
162181728|NCT00571649|585718026|FG000|Follow-up Period|Clinical endpoint reached|5|||
162181729|NCT00571649|585718027|FG001|Follow-up Period|Clinical endpoint reached|2|||
162181730|NCT00571649|585718026|FG000|Follow-up Period|Withdrawal by Subject|119|||
162181731|NCT00571649|585718027|FG001|Follow-up Period|Withdrawal by Subject|115|||
162181732|NCT00571649|585718026|FG000|Follow-up Period|Death|132|||
162181733|NCT00571649|585718027|FG001|Follow-up Period|Death|133|||
162181734|NCT00571649|585718026|FG000|Follow-up Period|Physician Decision|7|||
162181735|NCT00571649|585718027|FG001|Follow-up Period|Physician Decision|13|||
162181736|NCT00571649|585718026|FG000|Follow-up Period|Lost to Follow-up|95|||
162181737|NCT00571649|585718027|FG001|Follow-up Period|Lost to Follow-up|92|||
162181738|NCT00571649|585718026|FG000|Follow-up Period|Patient convenience|136|||
162181739|NCT00571649|585718027|FG001|Follow-up Period|Patient convenience|121|||
162181740|NCT00571649|585718026|FG000|Follow-up Period|Protocol Violation|5|||
162181741|NCT00571649|585718027|FG001|Follow-up Period|Protocol Violation|12|||
162181742|NCT02397096|585718028|FG000|Day 1 to Week 24|Adverse Event|7|||
162181743|NCT02397096|585718029|FG001|Day 1 to Week 24|Adverse Event|1|||
162181744|NCT02397096|585718028|FG000|Day 1 to Week 24|Death|1|||
162181745|NCT02397096|585718029|FG001|Day 1 to Week 24|Death|0|||
162181746|NCT02397096|585718028|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
162181747|NCT02397096|585718029|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
162181748|NCT02397096|585718028|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
162181749|NCT02397096|585718029|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
162181750|NCT02397096|585718028|FG000|Day 1 to Week 24|Physician Decision|2|||
162181751|NCT02397096|585718029|FG001|Day 1 to Week 24|Physician Decision|3|||
162181752|NCT02397096|585718028|FG000|Day 1 to Week 24|Protocol Violation|1|||
162181753|NCT02397096|585718029|FG001|Day 1 to Week 24|Protocol Violation|4|||
161924105|NCT00544882|584768159|FG002|Cycle 3: Follow-up|Pregnancy|0|||
161924106|NCT00308685|584768160|FG000|Overall Study|Lost to Follow-up|1|||
161924107|NCT00308685|584768161|FG001|Overall Study|Lost to Follow-up|0|||
161924108|NCT00308685|584768160|FG000|Overall Study|Need to administer prohibited medication|1|||
161924109|NCT00308685|584768161|FG001|Overall Study|Need to administer prohibited medication|2|||
161924110|NCT00308685|584768160|FG000|Overall Study|Other than specified|1|||
161924111|NCT00308685|584768161|FG001|Overall Study|Other than specified|3|||
161924112|NCT03770455|584768162|FG000|Overall Study|Screen failures|3|||
161924113|NCT01121575|584768163|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
161924114|NCT01121575|584768164|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
161924115|NCT01121575|584768165|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
161924116|NCT01121575|584768166|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
161924117|NCT01121575|584768167|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
161924118|NCT01121575|584768168|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
161924119|NCT01121575|584768163|FG000|Overall Study|Unspecified Reasons|8|||
161924120|NCT01121575|584768164|FG001|Overall Study|Unspecified Reasons|6|||
161924121|NCT01121575|584768165|FG002|Overall Study|Unspecified Reasons|7|||
161924122|NCT01121575|584768166|FG003|Overall Study|Unspecified Reasons|5|||
161924123|NCT01121575|584768167|FG004|Overall Study|Unspecified Reasons|13|||
161924124|NCT01121575|584768168|FG005|Overall Study|Unspecified Reasons|10|||
161924125|NCT01121575|584768163|FG000|Overall Study|Death|6|||
161924126|NCT01121575|584768164|FG001|Overall Study|Death|0|||
161924127|NCT01121575|584768165|FG002|Overall Study|Death|0|||
161924128|NCT01121575|584768166|FG003|Overall Study|Death|1|||
161924129|NCT01121575|584768167|FG004|Overall Study|Death|7|||
161924130|NCT01121575|584768168|FG005|Overall Study|Death|1|||
161924131|NCT02583269|584768169|FG000|Overall Study|Patient hospitalized prior to start|1|||
161924132|NCT02583269|584768170|FG001|Overall Study|Patient hospitalized prior to start|0|||
161924133|NCT02583269|584768171|FG002|Overall Study|Patient hospitalized prior to start|0|||
161924134|NCT02583269|584768172|FG003|Overall Study|Patient hospitalized prior to start|0|||
161924135|NCT02583269|584768173|FG004|Overall Study|Patient hospitalized prior to start|0|||
161924136|NCT03244189|584768175|FG000|Overall Study|Death|0|||
161924137|NCT03244189|584768176|FG001|Overall Study|Death|2|||
161924138|NCT03244189|584768175|FG000|Overall Study|Lost to Follow-up|92|||
161924139|NCT03244189|584768176|FG001|Overall Study|Lost to Follow-up|107|||
161924140|NCT03244189|584768175|FG000|Overall Study|Physician Decision|4|||
161924141|NCT03244189|584768176|FG001|Overall Study|Physician Decision|2|||
161924142|NCT03244189|584768175|FG000|Overall Study|Pregnancy|7|||
161924143|NCT03244189|584768176|FG001|Overall Study|Pregnancy|5|||
161924144|NCT03244189|584768175|FG000|Overall Study|Protocol Violation|0|||
161924145|NCT03244189|584768176|FG001|Overall Study|Protocol Violation|2|||
161924146|NCT03244189|584768175|FG000|Overall Study|Withdrawal by Subject|45|||
161924147|NCT03244189|584768176|FG001|Overall Study|Withdrawal by Subject|23|||
161924148|NCT03244189|584768175|FG000|Overall Study|Technical Problems|2|||
161924149|NCT03244189|584768176|FG001|Overall Study|Technical Problems|0|||
161924150|NCT03860584|584768184|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
161924151|NCT03860584|584768185|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
161924152|NCT03860584|584768184|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161924153|NCT03860584|584768185|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
161924154|NCT03860584|584768184|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
161924155|NCT03860584|584768185|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
161924156|NCT03860584|584768184|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
161924157|NCT03860584|584768185|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
161924158|NCT05800145|584768186|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
161924159|NCT05800145|584768187|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161924160|NCT05800145|584768188|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161924161|NCT05800145|584768189|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
161924162|NCT05800145|584768190|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161924163|NCT05800145|584768191|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161924164|NCT05800145|584768186|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
161924165|NCT05800145|584768187|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
161924166|NCT05800145|584768188|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
161924167|NCT05800145|584768189|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
161924168|NCT05800145|584768190|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
161924169|NCT05800145|584768191|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
161924170|NCT05800145|584768186|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
161924171|NCT05800145|584768187|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
161924172|NCT05800145|584768188|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
162181754|NCT02397096|585718028|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
162181755|NCT02397096|585718029|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
162181756|NCT02397096|585718028|FG000|Day 1 to Week 24|Randomized, not treated|3|||
162181757|NCT02397096|585718029|FG001|Day 1 to Week 24|Randomized, not treated|0|||
162181758|NCT02397096|585718028|FG000|Week 24 to Week 48|Adverse Event|6|||
162181759|NCT02397096|585718029|FG001|Week 24 to Week 48|Adverse Event|2|||
162181760|NCT02397096|585718028|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
162181761|NCT02397096|585718029|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
162181762|NCT02397096|585718028|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
162181763|NCT02397096|585718029|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
162181764|NCT02397096|585718028|FG000|Week 24 to Week 48|Physician Decision|2|||
162181765|NCT02397096|585718029|FG001|Week 24 to Week 48|Physician Decision|1|||
162181766|NCT02397096|585718028|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
162181767|NCT02397096|585718029|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
162181768|NCT02397096|585718028|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
162181769|NCT02397096|585718029|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
162181770|NCT02397096|585718028|FG000|Study Extension 1|Adverse Event|7|||
162181771|NCT02397096|585718029|FG001|Study Extension 1|Adverse Event|5|||
162181772|NCT02397096|585718028|FG000|Study Extension 1|Death|1|||
162181773|NCT02397096|585718029|FG001|Study Extension 1|Death|0|||
162181774|NCT02397096|585718028|FG000|Study Extension 1|Lack of Efficacy|2|||
162181775|NCT02397096|585718029|FG001|Study Extension 1|Lack of Efficacy|5|||
162181776|NCT02397096|585718028|FG000|Study Extension 1|Lost to Follow-up|2|||
162181777|NCT02397096|585718029|FG001|Study Extension 1|Lost to Follow-up|3|||
162181778|NCT02397096|585718028|FG000|Study Extension 1|Non-compliance with study drug|3|||
162181779|NCT02397096|585718029|FG001|Study Extension 1|Non-compliance with study drug|0|||
162181780|NCT02397096|585718028|FG000|Study Extension 1|Physician Decision|4|||
162181781|NCT02397096|585718029|FG001|Study Extension 1|Physician Decision|2|||
161672182|NCT05085665|583853051|FG000|Overall Study|Physician Decision|2|||
161672183|NCT03294109|583853052|FG000|Overall Study|Withdrawal by Subject|6|||
161672184|NCT03294109|583853053|FG001|Overall Study|Withdrawal by Subject|5|||
161672185|NCT01717768|583853054|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672186|NCT01717768|583853055|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
161672187|NCT01717768|583853056|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672188|NCT01717768|583853057|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672189|NCT01717768|583853058|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672190|NCT01717768|583853059|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672191|NCT01717768|583853060|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161818138|NCT03961204|584374383|FG000|Overall Study|Withdrawal by Subject|2|||
161818139|NCT03961204|584374383|FG000|Overall Study|Lost to Follow-up|3|||
161818140|NCT03961204|584374383|FG000|Overall Study|Other|1|||
161818141|NCT03961204|584374383|FG000|Overall Study|Missing|1|||
162018788|NCT00811018|585123214|FG000|Overall Study|Withdrawal by Subject|70|||
162181782|NCT02397096|585718028|FG000|Study Extension 1|Pregnancy|1|||
162181783|NCT02397096|585718029|FG001|Study Extension 1|Pregnancy|0|||
161672192|NCT01717768|583853061|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672193|NCT01717768|583853062|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672194|NCT01717768|583853063|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672195|NCT01717768|583853064|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672196|NCT01717768|583853065|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161672197|NCT01717768|583853054|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672198|NCT01717768|583853055|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672199|NCT01717768|583853056|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672200|NCT01717768|583853057|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672201|NCT01717768|583853058|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672202|NCT01717768|583853059|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672203|NCT01717768|583853060|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672204|NCT01717768|583853061|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672205|NCT01717768|583853062|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672206|NCT01717768|583853063|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672207|NCT01717768|583853064|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161672208|NCT01717768|583853065|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
161672209|NCT01717768|583853054|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672210|NCT01717768|583853055|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672211|NCT01717768|583853056|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672212|NCT01717768|583853057|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672213|NCT01717768|583853058|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672214|NCT01717768|583853059|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672215|NCT01717768|583853060|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672216|NCT01717768|583853061|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
161672217|NCT01717768|583853062|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672218|NCT01717768|583853063|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672219|NCT01717768|583853064|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672220|NCT01717768|583853065|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161672221|NCT01717768|583853054|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672222|NCT01717768|583853055|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672223|NCT01717768|583853056|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672224|NCT01717768|583853057|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672225|NCT01717768|583853058|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672226|NCT01717768|583853059|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672227|NCT01717768|583853060|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672228|NCT01717768|583853061|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672229|NCT01717768|583853062|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672230|NCT01717768|583853063|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
161672231|NCT01717768|583853064|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161672232|NCT01717768|583853065|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161924173|NCT05800145|584768189|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
161924174|NCT05800145|584768190|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
161924175|NCT05800145|584768191|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
161924176|NCT04827446|584769599|FG000|Overall Study|Lost to Follow-up|1|||
161924177|NCT04827446|584769600|FG001|Overall Study|Lost to Follow-up|1|||
161924178|NCT04827446|584769599|FG000|Overall Study|Death|2|||
162181784|NCT02397096|585718028|FG000|Study Extension 1|Protocol Violation|0|||
162181785|NCT02397096|585718029|FG001|Study Extension 1|Protocol Violation|1|||
162181786|NCT02397096|585718028|FG000|Study Extension 1|Withdrawal by Subject|21|||
162181787|NCT02397096|585718029|FG001|Study Extension 1|Withdrawal by Subject|7|||
162181788|NCT02397096|585718028|FG000|Study Extension 2|Adverse Event|3|||
162181789|NCT02397096|585718029|FG001|Study Extension 2|Adverse Event|3|||
162181790|NCT02397096|585718028|FG000|Study Extension 2|Availability of study medication locally|152|||
162181791|NCT02397096|585718029|FG001|Study Extension 2|Availability of study medication locally|64|||
162181792|NCT02397096|585718028|FG000|Study Extension 2|Death|2|||
162181793|NCT02397096|585718029|FG001|Study Extension 2|Death|0|||
162181794|NCT02397096|585718028|FG000|Study Extension 2|Lack of Efficacy|1|||
162181795|NCT02397096|585718029|FG001|Study Extension 2|Lack of Efficacy|0|||
162181796|NCT02397096|585718028|FG000|Study Extension 2|Lost to Follow-up|2|||
162181797|NCT02397096|585718029|FG001|Study Extension 2|Lost to Follow-up|1|||
162181798|NCT02397096|585718028|FG000|Study Extension 2|Non-compliance with study drug|1|||
162181799|NCT02397096|585718029|FG001|Study Extension 2|Non-compliance with study drug|0|||
162181800|NCT02397096|585718028|FG000|Study Extension 2|Physician Decision|2|||
162181801|NCT02397096|585718029|FG001|Study Extension 2|Physician Decision|5|||
162181802|NCT02397096|585718028|FG000|Study Extension 2|Pregnancy|1|||
162181803|NCT02397096|585718029|FG001|Study Extension 2|Pregnancy|0|||
162181804|NCT02397096|585718028|FG000|Study Extension 2|Withdrawal by Subject|10|||
162181805|NCT02397096|585718029|FG001|Study Extension 2|Withdrawal by Subject|3|||
161818142|NCT02218216|584374384|FG000|Overall Study|Study terminated before completed|6|||
161818143|NCT02218216|584374385|FG001|Overall Study|Study terminated before completed|0|||
161818144|NCT02218216|584374386|FG002|Overall Study|Study terminated before completed|0|||
161818145|NCT02452463|584374389|FG000|Overall Study|Death|1|||
161818146|NCT02452463|584374390|FG001|Overall Study|Death|0|||
161818147|NCT02452463|584374391|FG002|Overall Study|Death|0|||
161818148|NCT02452463|584374389|FG000|Overall Study|Study Suspended|1|||
161818149|NCT02452463|584374390|FG001|Overall Study|Study Suspended|0|||
162181806|NCT02397096|585718028|FG000|Study Extension 3|Adverse Event|1|||
162181807|NCT02397096|585718029|FG001|Study Extension 3|Adverse Event|0|||
162181808|NCT02397096|585718028|FG000|Study Extension 3|Availability of study medication locally|11|||
162181809|NCT02397096|585718029|FG001|Study Extension 3|Availability of study medication locally|3|||
162181810|NCT02397096|585718028|FG000|Study Extension 3|Lost to Follow-up|1|||
162181811|NCT02397096|585718029|FG001|Study Extension 3|Lost to Follow-up|0|||
162181812|NCT02397096|585718028|FG000|Study Extension 3|Withdrawal by Subject|2|||
162181813|NCT02397096|585718029|FG001|Study Extension 3|Withdrawal by Subject|1|||
162181814|NCT00274261|585718030|FG000|Overall Study|Adverse Event|19|||
162181815|NCT00274261|585718031|FG001|Overall Study|Adverse Event|11|||
162181816|NCT00274261|585718030|FG000|Overall Study|Pregnancy|114|||
162181817|NCT00274261|585718031|FG001|Overall Study|Pregnancy|83|||
162181818|NCT00274261|585718030|FG000|Overall Study|Withdrawal by Subject|179|||
162181819|NCT00274261|585718031|FG001|Overall Study|Withdrawal by Subject|126|||
162181820|NCT00274261|585718030|FG000|Overall Study|Protocol Violation|71|||
162181821|NCT00274261|585718031|FG001|Overall Study|Protocol Violation|42|||
162181822|NCT00274261|585718030|FG000|Overall Study|Lost to Follow-up|106|||
162181823|NCT00274261|585718031|FG001|Overall Study|Lost to Follow-up|75|||
162181824|NCT03500549|585718032|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
162181825|NCT03500549|585718033|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
162181826|NCT03500549|585718032|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
162181827|NCT03500549|585718033|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
162181828|NCT02016872|585718036|FG000|Overall Study|Withdrawal by Subject|10|||
162181829|NCT02016872|585718036|FG000|Overall Study|Death Progression|2|||
162181830|NCT02016872|585718036|FG000|Overall Study|No FMISO scan|1|||
162181831|NCT02016872|585718036|FG000|Overall Study|Ineligible|2|||
162181832|NCT05018143|585718037|FG000|Overall Study|Lost to Follow-up|5|||
161818150|NCT02452463|584374391|FG002|Overall Study|Study Suspended|0|||
161818151|NCT02452463|584374389|FG000|Overall Study|Recommended by DSMB|0|||
161818152|NCT02452463|584374390|FG001|Overall Study|Recommended by DSMB|1|||
161818153|NCT02452463|584374391|FG002|Overall Study|Recommended by DSMB|0|||
161818154|NCT02452463|584374389|FG000|Overall Study|Withdrawal by Subject|0|||
162181833|NCT05018143|585718038|FG001|Overall Study|Lost to Follow-up|4|||
162181834|NCT05018143|585718037|FG000|Overall Study|Withdrawal by Subject|0|||
162181835|NCT05018143|585718038|FG001|Overall Study|Withdrawal by Subject|1|||
162181836|NCT06688357|585718039|FG000|Overall Study|Adverse Event|0|||
162181837|NCT06688357|585718040|FG001|Overall Study|Adverse Event|1|||
162181838|NCT05601882|585718041|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
162181839|NCT05601882|585718042|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
162181840|NCT05601882|585718043|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
162181841|NCT05601882|585718044|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
162181842|NCT05601882|585718041|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
162181843|NCT05601882|585718042|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
162181844|NCT05601882|585718043|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
161818155|NCT02452463|584374390|FG001|Overall Study|Withdrawal by Subject|1|||
161924179|NCT04827446|584769600|FG001|Overall Study|Death|0|||
162181845|NCT05601882|585718044|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
162181846|NCT05601882|585718041|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
162181847|NCT05601882|585718042|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
162181848|NCT05601882|585718043|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
162181849|NCT05601882|585718044|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
162181850|NCT05601882|585718041|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
162181851|NCT05601882|585718042|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
162181852|NCT05601882|585718043|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
162181853|NCT05601882|585718044|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
162181854|NCT05601882|585718041|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
162181855|NCT05601882|585718042|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
162181856|NCT05601882|585718043|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
162181857|NCT05601882|585718044|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
162181858|NCT05601882|585718041|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
162181859|NCT05601882|585718042|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
162181860|NCT05601882|585718043|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
162181861|NCT05601882|585718044|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
162181862|NCT03222609|585718047|FG000|Overall Study|Withdrew consent|2|||
162181863|NCT03222609|585718048|FG001|Overall Study|Withdrew consent|3|||
162181864|NCT03222609|585718049|FG002|Overall Study|Withdrew consent|4|||
162181865|NCT03222609|585718050|FG003|Overall Study|Withdrew consent|2|||
162181866|NCT03222609|585718047|FG000|Overall Study|Lost to Follow-up|1|||
162181867|NCT03222609|585718048|FG001|Overall Study|Lost to Follow-up|0|||
162181868|NCT03222609|585718049|FG002|Overall Study|Lost to Follow-up|0|||
162181869|NCT03222609|585718050|FG003|Overall Study|Lost to Follow-up|0|||
162181870|NCT03222609|585718047|FG000|Overall Study|Death|16|||
162181871|NCT03222609|585718048|FG001|Overall Study|Death|13|||
162181872|NCT03222609|585718049|FG002|Overall Study|Death|9|||
162181873|NCT03222609|585718050|FG003|Overall Study|Death|6|||
162181874|NCT03222609|585718047|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
162181875|NCT03222609|585718048|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
162181876|NCT03222609|585718049|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
162181877|NCT03222609|585718050|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
162181878|NCT00545545|585718051|FG000|Overall Study|Progressive Neoplastic Disease|1|||
162181879|NCT00545545|585718052|FG001|Overall Study|Progressive Neoplastic Disease|5|||
162181880|NCT00545545|585718053|FG002|Overall Study|Progressive Neoplastic Disease|0|||
162181881|NCT00545545|585718054|FG003|Overall Study|Progressive Neoplastic Disease|4|||
161672233|NCT00372385|583853066|FG000|Overall Study|Adverse Event|6|||
161818156|NCT02452463|584374391|FG002|Overall Study|Withdrawal by Subject|0|||
162181882|NCT00545545|585718055|FG004|Overall Study|Progressive Neoplastic Disease|8|||
161924180|NCT04827446|584769599|FG000|Overall Study|Withdrawal by Subject|2|||
162181883|NCT00545545|585718056|FG005|Overall Study|Progressive Neoplastic Disease|7|||
162181884|NCT00545545|585718051|FG000|Overall Study|Withdrawal by Subject|0|||
162181885|NCT00545545|585718052|FG001|Overall Study|Withdrawal by Subject|1|||
162181886|NCT00545545|585718053|FG002|Overall Study|Withdrawal by Subject|0|||
162181887|NCT00545545|585718054|FG003|Overall Study|Withdrawal by Subject|0|||
162181888|NCT00545545|585718055|FG004|Overall Study|Withdrawal by Subject|0|||
162181889|NCT00545545|585718056|FG005|Overall Study|Withdrawal by Subject|0|||
162181890|NCT00545545|585718051|FG000|Overall Study|Physician Decision|1|||
162181891|NCT00545545|585718052|FG001|Overall Study|Physician Decision|0|||
162181892|NCT00545545|585718053|FG002|Overall Study|Physician Decision|0|||
162181893|NCT00545545|585718054|FG003|Overall Study|Physician Decision|0|||
162181894|NCT00545545|585718055|FG004|Overall Study|Physician Decision|0|||
162181895|NCT00545545|585718056|FG005|Overall Study|Physician Decision|1|||
162181896|NCT00545545|585718051|FG000|Overall Study|Irinotecan intolerance|1|||
162181897|NCT00545545|585718052|FG001|Overall Study|Irinotecan intolerance|1|||
162181898|NCT00545545|585718053|FG002|Overall Study|Irinotecan intolerance|0|||
162181899|NCT00545545|585718054|FG003|Overall Study|Irinotecan intolerance|0|||
162181900|NCT00545545|585718055|FG004|Overall Study|Irinotecan intolerance|0|||
162181901|NCT00545545|585718056|FG005|Overall Study|Irinotecan intolerance|0|||
162181902|NCT00545545|585718051|FG000|Overall Study|No target lesions to track post surgery|0|||
162181903|NCT00545545|585718052|FG001|Overall Study|No target lesions to track post surgery|0|||
162181904|NCT00545545|585718053|FG002|Overall Study|No target lesions to track post surgery|0|||
162181905|NCT00545545|585718054|FG003|Overall Study|No target lesions to track post surgery|0|||
162181906|NCT00545545|585718055|FG004|Overall Study|No target lesions to track post surgery|1|||
162181907|NCT00545545|585718056|FG005|Overall Study|No target lesions to track post surgery|1|||
162181908|NCT02761187|585718060|FG000|Overall Study|Too ill to Participate|13|||
162181909|NCT02761187|585718061|FG001|Overall Study|Too ill to Participate|8|||
162181910|NCT02761187|585718060|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
162181911|NCT02761187|585718061|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
162181912|NCT02761187|585718060|FG000|Overall Study|Patient withdrew consent|64|||
162181913|NCT02761187|585718061|FG001|Overall Study|Patient withdrew consent|58|||
162181914|NCT02761187|585718060|FG000|Overall Study|Physician discretion|4|||
162181915|NCT02761187|585718061|FG001|Overall Study|Physician discretion|8|||
162181916|NCT02761187|585718060|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
162181917|NCT02761187|585718061|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
162181918|NCT02761187|585718060|FG000|Overall Study|On Hospice|20|||
162181919|NCT02761187|585718061|FG001|Overall Study|On Hospice|26|||
162181920|NCT02761187|585718060|FG000|Overall Study|Deceased|474|||
162181921|NCT02761187|585718061|FG001|Overall Study|Deceased|642|||
162181922|NCT02761187|585718060|FG000|Overall Study|Lost to Follow-up|73|||
162181923|NCT02761187|585718061|FG001|Overall Study|Lost to Follow-up|63|||
162181924|NCT02761187|585718060|FG000|Overall Study|Due to study discontinued at site|100|||
162181925|NCT02761187|585718061|FG001|Overall Study|Due to study discontinued at site|85|||
162181926|NCT02761187|585718060|FG000|Overall Study|Reason not Specified|1484|||
162181927|NCT02761187|585718061|FG001|Overall Study|Reason not Specified|937|||
162181928|NCT05704725|585718063|FG000|Overall Study|Lost to Follow-up|0|||
162181929|NCT05704725|585718064|FG001|Overall Study|Lost to Follow-up|1|||
162181930|NCT05704725|585718063|FG000|Overall Study|Withdrawal by Subject|1|||
162181931|NCT05704725|585718064|FG001|Overall Study|Withdrawal by Subject|0|||
162181932|NCT01470144|585718065|FG000|Overall Study|Adverse Event|2|||
162181933|NCT01470144|585718065|FG000|Overall Study|Death|1|||
162181934|NCT01470144|585718065|FG000|Overall Study|Lung transplant|6|||
162181935|NCT01470144|585718065|FG000|Overall Study|Patient's and investigator's decision|1|||
162181936|NCT02798471|585718069|FG000|Overall Study|Adverse Event|7|||
161924181|NCT04827446|584769600|FG001|Overall Study|Withdrawal by Subject|2|||
161924182|NCT03735498|584769601|FG000|Overall Study|Withdrawal by Subject|3|||
161924183|NCT03735498|584769601|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
161924184|NCT00160615|584769602|FG000|Overall Study|Adverse Event|5|||
161924185|NCT00160615|584769603|FG001|Overall Study|Adverse Event|12|||
161924186|NCT00160615|584769602|FG000|Overall Study|Withdrawal by Subject|0|||
161924187|NCT00160615|584769603|FG001|Overall Study|Withdrawal by Subject|2|||
161924188|NCT00160615|584769602|FG000|Overall Study|Lack of Efficacy|11|||
161924189|NCT00160615|584769603|FG001|Overall Study|Lack of Efficacy|23|||
161924190|NCT00160615|584769602|FG000|Overall Study|Patient decision|1|||
162181937|NCT02798471|585718070|FG001|Overall Study|Adverse Event|2|||
162181938|NCT02798471|585718069|FG000|Overall Study|Physician Decision|3|||
162181939|NCT02798471|585718070|FG001|Overall Study|Physician Decision|7|||
162181940|NCT02798471|585718069|FG000|Overall Study|Death|2|||
162181941|NCT02798471|585718070|FG001|Overall Study|Death|3|||
162181942|NCT02798471|585718069|FG000|Overall Study|Lost to Follow-up|0|||
162181943|NCT02798471|585718070|FG001|Overall Study|Lost to Follow-up|1|||
162181944|NCT02798471|585718069|FG000|Overall Study|Other|5|||
162181945|NCT02798471|585718070|FG001|Overall Study|Other|3|||
162181946|NCT02798471|585718069|FG000|Overall Study|Subject withdrew consent|0|||
161818157|NCT01073631|584374392|FG000|Overall Study|Death|82|||
161818158|NCT01073631|584374392|FG000|Overall Study|Adverse Event|24|||
162181947|NCT02798471|585718070|FG001|Overall Study|Subject withdrew consent|6|||
162181948|NCT02798471|585718069|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
162181949|NCT02798471|585718070|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
162181950|NCT02798471|585718069|FG000|Overall Study|Randomized, but not treated|0|||
162181951|NCT02798471|585718070|FG001|Overall Study|Randomized, but not treated|2|||
162181952|NCT05802173|585719168|FG000|Overall Study|Withdrawal by Subject|2|||
162181953|NCT05802173|585719169|FG001|Overall Study|Withdrawal by Subject|0|||
162181954|NCT05802173|585719170|FG002|Overall Study|Withdrawal by Subject|0|||
162181955|NCT05802173|585719168|FG000|Overall Study|Protocol Violation|1|||
162181956|NCT05802173|585719169|FG001|Overall Study|Protocol Violation|0|||
162181957|NCT05802173|585719170|FG002|Overall Study|Protocol Violation|0|||
162181958|NCT05802173|585719168|FG000|Overall Study|Lost to Follow-up|0|||
162181959|NCT05802173|585719169|FG001|Overall Study|Lost to Follow-up|6|||
162181960|NCT05802173|585719170|FG002|Overall Study|Lost to Follow-up|4|||
162181961|NCT05802173|585719168|FG000|Overall Study|non-compliance|0|||
162181962|NCT05802173|585719169|FG001|Overall Study|non-compliance|1|||
162181963|NCT05802173|585719170|FG002|Overall Study|non-compliance|0|||
162181964|NCT04503681|585719171|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
162181965|NCT04503681|585719172|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
162181966|NCT03352713|585719173|FG000|Overall Study|Lost to Follow-up|8|||
162181967|NCT03352713|585719173|FG000|Overall Study|Withdrawn by investigator|5|||
162181968|NCT03352713|585719173|FG000|Overall Study|Completed 0 EMAs|8|||
162181969|NCT03352713|585719173|FG000|Overall Study|Device incompatible/stolen|5|||
162181970|NCT01812759|585719174|FG000|Overall Study|Physician Decision|0|||
162181971|NCT01812759|585719175|FG001|Overall Study|Physician Decision|0|||
162181972|NCT01812759|585719176|FG002|Overall Study|Physician Decision|1|||
162181973|NCT00360269|585719177|FG000|Overall Study|Lost to Follow-up|7|||
162181974|NCT00360269|585719178|FG001|Overall Study|Lost to Follow-up|9|||
162181975|NCT00360269|585719177|FG000|Overall Study|Physician Decision|1|||
162181976|NCT00360269|585719178|FG001|Overall Study|Physician Decision|2|||
162181977|NCT00360269|585719177|FG000|Overall Study|Adverse Event|1|||
162181978|NCT00360269|585719178|FG001|Overall Study|Adverse Event|0|||
162181979|NCT00360269|585719177|FG000|Overall Study|Withdrawal by Subject|1|||
162181980|NCT00360269|585719178|FG001|Overall Study|Withdrawal by Subject|1|||
162181981|NCT03758638|585719181|FG000|Overall Study|Pregnancy|17|||
162181982|NCT03758638|585719182|FG001|Overall Study|Pregnancy|25|||
162181983|NCT03758638|585719181|FG000|Overall Study|Lost to Follow-up|60|||
162181984|NCT03758638|585719182|FG001|Overall Study|Lost to Follow-up|54|||
162181985|NCT03758638|585719181|FG000|Overall Study|Protocol Violation|2|||
162181986|NCT03758638|585719182|FG001|Overall Study|Protocol Violation|0|||
162181987|NCT03758638|585719181|FG000|Overall Study|Withdrawal by Subject|8|||
162181988|NCT03758638|585719182|FG001|Overall Study|Withdrawal by Subject|2|||
162181989|NCT03758638|585719181|FG000|Overall Study|Providers not included in the primary outcome.|183|||
162181990|NCT03758638|585719182|FG001|Overall Study|Providers not included in the primary outcome.|128|||
162181991|NCT04213807|585719184|FG000|Overall Study|Physician Decision|0|||
162181992|NCT04213807|585719185|FG001|Overall Study|Physician Decision|0|||
162181993|NCT04213807|585719186|FG002|Overall Study|Physician Decision|1|||
162181994|NCT03442777|585719187|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
162181995|NCT03442777|585719188|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
162181996|NCT03442777|585719189|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
162181997|NCT00790569|585719190|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
162181998|NCT00790569|585719191|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
162181999|NCT00790569|585719192|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
162182000|NCT00790569|585719190|FG000|End of Treatment (6 Month Interview)|Death|0|||
162182001|NCT00790569|585719191|FG001|End of Treatment (6 Month Interview)|Death|2|||
162182002|NCT00790569|585719192|FG002|End of Treatment (6 Month Interview)|Death|1|||
162182003|NCT00790569|585719190|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
161818159|NCT01073631|584374392|FG000|Overall Study|Other|63|||
161818160|NCT01131260|584374393|FG000|Overall Study|Randomization error|5|||
161818161|NCT01131260|584374394|FG001|Overall Study|Randomization error|1|||
161818162|NCT01131260|584374393|FG000|Overall Study|Declined to continue participation|8|||
161818163|NCT01131260|584374394|FG001|Overall Study|Declined to continue participation|13|||
161818164|NCT01131260|584374393|FG000|Overall Study|Physician Decision|22|||
161818165|NCT01131260|584374394|FG001|Overall Study|Physician Decision|24|||
161818166|NCT01131260|584374393|FG000|Overall Study|Technical problems|7|||
161924191|NCT00160615|584769603|FG001|Overall Study|Patient decision|2|||
162182004|NCT00790569|585719191|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
162182005|NCT00790569|585719192|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
162182006|NCT00790569|585719190|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
162182007|NCT00790569|585719191|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
162182008|NCT00790569|585719192|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
161818167|NCT01131260|584374394|FG001|Overall Study|Technical problems|6|||
161818168|NCT01131260|584374393|FG000|Overall Study|Staff error|2|||
161818169|NCT01131260|584374394|FG001|Overall Study|Staff error|1|||
161818170|NCT01131260|584374393|FG000|Overall Study|Ineligible|0|||
161818171|NCT01131260|584374394|FG001|Overall Study|Ineligible|2|||
161818172|NCT01494532|584374399|FG000|Overall Study|Adverse Event|4|||
161818173|NCT01494532|584374400|FG001|Overall Study|Adverse Event|1|||
161924192|NCT00160615|584769602|FG000|Overall Study|Investigator decision|1|||
161924193|NCT00160615|584769603|FG001|Overall Study|Investigator decision|1|||
161924194|NCT00160615|584769602|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
161924195|NCT00160615|584769603|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
161924196|NCT00160615|584769602|FG000|Overall Study|Switch to surgical treatment|0|||
161924197|NCT00160615|584769603|FG001|Overall Study|Switch to surgical treatment|2|||
161924198|NCT00160615|584769602|FG000|Overall Study|Non-compliance was suspected|0|||
161924199|NCT00160615|584769603|FG001|Overall Study|Non-compliance was suspected|1|||
161924200|NCT00160615|584769602|FG000|Overall Study|Poor compliance|0|||
162018789|NCT00811018|585123214|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
162018790|NCT00811018|585123214|FG000|Overall Study|Other|26|||
162018791|NCT04154189|585123215|FG000|Overall Study|Withdrawal by Subject|4|||
162018792|NCT04154189|585123216|FG001|Overall Study|Withdrawal by Subject|6|||
162018793|NCT04154189|585123215|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
162018794|NCT04154189|585123216|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
162018795|NCT04154189|585123215|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
162018796|NCT04154189|585123216|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
162018797|NCT04154189|585123215|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
162018798|NCT04154189|585123216|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
162018799|NCT04154189|585123215|FG000|Overall Study|Death|25|||
162018800|NCT04154189|585123216|FG001|Overall Study|Death|25|||
162018801|NCT00845897|585123219|FG000|Overall Study|Lost to Follow-up|1|||
162018802|NCT00845897|585123220|FG001|Overall Study|Lost to Follow-up|1|||
162018803|NCT00845897|585123221|FG002|Overall Study|Lost to Follow-up|0|||
162018804|NCT00845897|585123219|FG000|Overall Study|Withdrawal by Subject|0|||
162018805|NCT00845897|585123220|FG001|Overall Study|Withdrawal by Subject|3|||
162018806|NCT00845897|585123221|FG002|Overall Study|Withdrawal by Subject|2|||
162018807|NCT00845897|585123219|FG000|Overall Study|Ulcer did not heal|1|||
162018808|NCT00845897|585123220|FG001|Overall Study|Ulcer did not heal|0|||
162018809|NCT00845897|585123221|FG002|Overall Study|Ulcer did not heal|1|||
162018810|NCT00845897|585123219|FG000|Overall Study|Too ill to participate|0|||
162018811|NCT00845897|585123220|FG001|Overall Study|Too ill to participate|1|||
162018812|NCT00845897|585123221|FG002|Overall Study|Too ill to participate|0|||
162018813|NCT02722499|585123223|FG000|Overall Study|Lost to Follow-up|2|||
162018814|NCT02722499|585123224|FG001|Overall Study|Lost to Follow-up|0|||
162018815|NCT02722499|585123225|FG002|Overall Study|Lost to Follow-up|1|||
162018816|NCT04999852|585123226|FG000|Overall Study|Withdrawal by Subject|11|||
162018817|NCT04999852|585123227|FG001|Overall Study|Withdrawal by Subject|1|||
162018818|NCT04999852|585123226|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
162018819|NCT04999852|585123227|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
162018820|NCT05626322|585123228|FG000|Overall Study|Death|2|||
162018821|NCT05626322|585123229|FG001|Overall Study|Death|0|||
162018822|NCT05626322|585123230|FG002|Overall Study|Death|0|||
162018823|NCT05626322|585123228|FG000|Overall Study|Physician Decision|1|||
162018824|NCT05626322|585123229|FG001|Overall Study|Physician Decision|0|||
162018825|NCT05626322|585123230|FG002|Overall Study|Physician Decision|0|||
162018826|NCT05626322|585123228|FG000|Overall Study|Progressive Disease|0|||
162018827|NCT05626322|585123229|FG001|Overall Study|Progressive Disease|1|||
162018828|NCT05626322|585123230|FG002|Overall Study|Progressive Disease|1|||
162018829|NCT05626322|585123228|FG000|Overall Study|Study terminated by sponsor|0|||
162018830|NCT05626322|585123229|FG001|Overall Study|Study terminated by sponsor|1|||
162018831|NCT05626322|585123230|FG002|Overall Study|Study terminated by sponsor|0|||
161924201|NCT00160615|584769603|FG001|Overall Study|Poor compliance|1|||
161924202|NCT03971422|584769605|FG000|Overall Study|Lost to Follow-up|0|||
161924203|NCT03971422|584769606|FG001|Overall Study|Lost to Follow-up|1|||
161924204|NCT03971422|584769607|FG002|Overall Study|Lost to Follow-up|0|||
161924205|NCT03971422|584769605|FG000|Overall Study|Lack of Efficacy|5|||
161924206|NCT03971422|584769606|FG001|Overall Study|Lack of Efficacy|1|||
161924207|NCT03971422|584769607|FG002|Overall Study|Lack of Efficacy|1|||
161924208|NCT03971422|584769605|FG000|Overall Study|Adverse event, not fatal|2|||
161924209|NCT03971422|584769606|FG001|Overall Study|Adverse event, not fatal|2|||
161924210|NCT03971422|584769607|FG002|Overall Study|Adverse event, not fatal|5|||
161924211|NCT03971422|584769605|FG000|Overall Study|Worsening of MG Symptoms|1|||
161924212|NCT03971422|584769606|FG001|Overall Study|Worsening of MG Symptoms|4|||
162018832|NCT04758637|585123231|FG000|Overall Study|Lost to Follow-up|0|||
162018833|NCT04758637|585123232|FG001|Overall Study|Lost to Follow-up|1|||
162018834|NCT04758637|585123233|FG002|Overall Study|Lost to Follow-up|0|||
161818174|NCT01494532|584374401|FG002|Overall Study|Adverse Event|8|||
161818175|NCT01494532|584374402|FG003|Overall Study|Adverse Event|6|||
162182009|NCT00790569|585719190|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
162182010|NCT00790569|585719191|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
162182011|NCT00790569|585719192|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
162182012|NCT00790569|585719190|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
162182013|NCT00790569|585719191|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
162182014|NCT00790569|585719192|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
162182015|NCT01627561|585719193|FG000|Overall Study|Lost to Follow-up|1|||
162182016|NCT01627561|585719194|FG001|Overall Study|Lost to Follow-up|0|||
162182017|NCT01627561|585719193|FG000|Overall Study|Withdrawal by Subject|0|||
162182018|NCT01627561|585719194|FG001|Overall Study|Withdrawal by Subject|1|||
162182019|NCT01627561|585719193|FG000|Overall Study|Migrated/moved from study area|0|||
162182020|NCT01627561|585719194|FG001|Overall Study|Migrated/moved from study area|2|||
162182021|NCT00724126|585719195|FG000|Overall Study|Adverse Event|2|||
162182022|NCT00724126|585719196|FG001|Overall Study|Adverse Event|0|||
162182023|NCT00724126|585719195|FG000|Overall Study|Withdrawal by Subject|8|||
162182024|NCT00724126|585719196|FG001|Overall Study|Withdrawal by Subject|6|||
162182025|NCT00724126|585719195|FG000|Overall Study|Lost to Follow-up|6|||
162182026|NCT00724126|585719196|FG001|Overall Study|Lost to Follow-up|6|||
162182027|NCT00724126|585719195|FG000|Overall Study|Noncompliance|2|||
162182028|NCT00724126|585719196|FG001|Overall Study|Noncompliance|1|||
162182029|NCT00724126|585719195|FG000|Overall Study|Subject randomized although ineligible|1|||
162182030|NCT00724126|585719196|FG001|Overall Study|Subject randomized although ineligible|1|||
162182031|NCT00724126|585719195|FG000|Overall Study|Subject had to leave vicinity of site|0|||
162182032|NCT00724126|585719196|FG001|Overall Study|Subject had to leave vicinity of site|1|||
162182033|NCT03577106|585719200|FG000|Overall Study|Withdrawal by Subject|3|||
162182034|NCT03451422|585719201|FG000|Overall Study|Lost to Follow-up|0|||
162182035|NCT03451422|585719202|FG001|Overall Study|Lost to Follow-up|0|||
162182036|NCT03451422|585719203|FG002|Overall Study|Lost to Follow-up|0|||
162182037|NCT03451422|585719204|FG003|Overall Study|Lost to Follow-up|0|||
162182038|NCT03451422|585719205|FG004|Overall Study|Lost to Follow-up|0|||
162182039|NCT03451422|585719206|FG005|Overall Study|Lost to Follow-up|1|||
162182040|NCT03451422|585719201|FG000|Overall Study|Decision by sponsor|1|||
162182041|NCT03451422|585719202|FG001|Overall Study|Decision by sponsor|0|||
162182042|NCT03451422|585719203|FG002|Overall Study|Decision by sponsor|1|||
162182043|NCT03451422|585719204|FG003|Overall Study|Decision by sponsor|0|||
162182044|NCT03451422|585719205|FG004|Overall Study|Decision by sponsor|0|||
162182045|NCT03451422|585719206|FG005|Overall Study|Decision by sponsor|0|||
162182046|NCT03451422|585719201|FG000|Overall Study|Withdrawal by Subject|0|||
162182047|NCT03451422|585719202|FG001|Overall Study|Withdrawal by Subject|0|||
162182048|NCT03451422|585719203|FG002|Overall Study|Withdrawal by Subject|2|||
162182049|NCT03451422|585719204|FG003|Overall Study|Withdrawal by Subject|3|||
162182050|NCT03451422|585719205|FG004|Overall Study|Withdrawal by Subject|2|||
162182051|NCT03451422|585719206|FG005|Overall Study|Withdrawal by Subject|1|||
162182052|NCT01579318|585719207|FG000|Overall Study|Disease Progression|1|||
162182053|NCT03601715|585719210|FG000|Second Intervention|Lost to Follow-up|1|||
162182054|NCT03601715|585719211|FG001|Second Intervention|Lost to Follow-up|1|||
162182055|NCT03601715|585719212|FG002|Second Intervention|Lost to Follow-up|0|||
162182056|NCT02347332|585719213|FG000|Overall Study|Not treated|5|||
162182057|NCT02347332|585719214|FG001|Overall Study|Not treated|2|||
162182058|NCT02347332|585719213|FG000|Overall Study|Progressive disease|141|||
161924213|NCT03971422|584769607|FG002|Overall Study|Worsening of MG Symptoms|2|||
161924214|NCT03971422|584769605|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
161924215|NCT03971422|584769606|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
161924216|NCT03971422|584769607|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
161924217|NCT03971422|584769605|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
161924218|NCT03971422|584769606|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
162182059|NCT02347332|585719214|FG001|Overall Study|Progressive disease|159|||
162182060|NCT02347332|585719213|FG000|Overall Study|Adverse Event|50|||
162182061|NCT02347332|585719214|FG001|Overall Study|Adverse Event|41|||
162182062|NCT02347332|585719213|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
161672234|NCT00372385|583853067|FG001|Overall Study|Adverse Event|11|||
161924219|NCT03971422|584769607|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
162018835|NCT04758637|585123234|FG003|Overall Study|Lost to Follow-up|0|||
162182063|NCT02347332|585719214|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
162182064|NCT02347332|585719213|FG000|Overall Study|Protocol Violation|1|||
162182065|NCT02347332|585719214|FG001|Overall Study|Protocol Violation|1|||
162182066|NCT02347332|585719213|FG000|Overall Study|Lost to Follow-up|2|||
161672235|NCT00372385|583853068|FG002|Overall Study|Adverse Event|9|||
162182067|NCT02347332|585719214|FG001|Overall Study|Lost to Follow-up|1|||
162182068|NCT02347332|585719213|FG000|Overall Study|Physician Decision|4|||
162182069|NCT02347332|585719214|FG001|Overall Study|Physician Decision|3|||
162182070|NCT02347332|585719213|FG000|Overall Study|Withdrawal by Subject|20|||
162182071|NCT02347332|585719214|FG001|Overall Study|Withdrawal by Subject|14|||
162182072|NCT02347332|585719213|FG000|Overall Study|Protocol requirement|1|||
162182073|NCT02347332|585719214|FG001|Overall Study|Protocol requirement|1|||
161672236|NCT00372385|583853069|FG003|Overall Study|Adverse Event|7|||
162018836|NCT03610269|585123235|FG000|Overall Study|Physician Decision|10|||
162018837|NCT03610269|585123235|FG000|Overall Study|Protocol Violation|1|||
162018838|NCT03610269|585123235|FG000|Overall Study|Unable to draw blood|1|||
162018839|NCT03610269|585123235|FG000|Overall Study|Screen fail|4|||
162018840|NCT02721966|585123236|FG000|Overall Study|Protocol Violation|1|||
162018841|NCT02721966|585123237|FG001|Overall Study|Protocol Violation|0|||
162018842|NCT02721966|585123238|FG002|Overall Study|Protocol Violation|0|||
162018843|NCT02721966|585123239|FG003|Overall Study|Protocol Violation|0|||
162018844|NCT02721966|585123240|FG004|Overall Study|Protocol Violation|0|||
162018845|NCT02721966|585123236|FG000|Overall Study|Withdrawal by Subject|9|||
162018846|NCT02721966|585123237|FG001|Overall Study|Withdrawal by Subject|2|||
162018847|NCT02721966|585123238|FG002|Overall Study|Withdrawal by Subject|3|||
162018848|NCT02721966|585123239|FG003|Overall Study|Withdrawal by Subject|7|||
162018849|NCT02721966|585123240|FG004|Overall Study|Withdrawal by Subject|0|||
162018850|NCT02721966|585123236|FG000|Overall Study|Adverse Event|4|||
162018851|NCT02721966|585123237|FG001|Overall Study|Adverse Event|4|||
162018852|NCT02721966|585123238|FG002|Overall Study|Adverse Event|3|||
162018853|NCT02721966|585123239|FG003|Overall Study|Adverse Event|0|||
162018854|NCT02721966|585123240|FG004|Overall Study|Adverse Event|0|||
162018855|NCT02721966|585123236|FG000|Overall Study|Death|1|||
162018856|NCT02721966|585123237|FG001|Overall Study|Death|0|||
162018857|NCT02721966|585123238|FG002|Overall Study|Death|0|||
162018858|NCT02721966|585123239|FG003|Overall Study|Death|0|||
162018859|NCT02721966|585123240|FG004|Overall Study|Death|0|||
162018860|NCT02721966|585123236|FG000|Overall Study|Lack of Efficacy|7|||
162018861|NCT02721966|585123237|FG001|Overall Study|Lack of Efficacy|4|||
162018862|NCT02721966|585123238|FG002|Overall Study|Lack of Efficacy|0|||
162018863|NCT02721966|585123239|FG003|Overall Study|Lack of Efficacy|0|||
162018864|NCT02721966|585123240|FG004|Overall Study|Lack of Efficacy|0|||
162018865|NCT02721966|585123236|FG000|Overall Study|Lost to Follow-up|0|||
162018866|NCT02721966|585123237|FG001|Overall Study|Lost to Follow-up|0|||
162018867|NCT02721966|585123238|FG002|Overall Study|Lost to Follow-up|3|||
162018868|NCT02721966|585123239|FG003|Overall Study|Lost to Follow-up|0|||
162018869|NCT02721966|585123240|FG004|Overall Study|Lost to Follow-up|0|||
162018870|NCT02721966|585123236|FG000|Overall Study|Physician Decision|1|||
162018871|NCT02721966|585123237|FG001|Overall Study|Physician Decision|1|||
162018872|NCT02721966|585123238|FG002|Overall Study|Physician Decision|0|||
162018873|NCT02721966|585123239|FG003|Overall Study|Physician Decision|0|||
162018874|NCT02721966|585123240|FG004|Overall Study|Physician Decision|0|||
162018875|NCT02721966|585123236|FG000|Overall Study|Pregnancy|1|||
162018876|NCT02721966|585123237|FG001|Overall Study|Pregnancy|0|||
162018877|NCT02721966|585123238|FG002|Overall Study|Pregnancy|0|||
162018878|NCT02721966|585123239|FG003|Overall Study|Pregnancy|0|||
162018879|NCT02721966|585123240|FG004|Overall Study|Pregnancy|0|||
162018880|NCT02721966|585123236|FG000|Overall Study|Did not continue to period 2|5|||
162018881|NCT02721966|585123237|FG001|Overall Study|Did not continue to period 2|12|||
162018882|NCT02721966|585123238|FG002|Overall Study|Did not continue to period 2|0|||
162018883|NCT02721966|585123239|FG003|Overall Study|Did not continue to period 2|0|||
162018884|NCT02721966|585123240|FG004|Overall Study|Did not continue to period 2|5|||
162018885|NCT00828204|585123241|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
162018886|NCT00828204|585123242|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
162018887|NCT00828204|585123241|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
162018888|NCT00828204|585123242|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
162018889|NCT00828204|585123241|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
162018890|NCT00828204|585123242|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
162018891|NCT00828204|585123241|FG000|Main Study: After Study Restart|Adverse Event|0|||
162018892|NCT00828204|585123242|FG001|Main Study: After Study Restart|Adverse Event|2|||
162018893|NCT00828204|585123241|FG000|Main Study: After Study Restart|Noncompliance|0|||
162018894|NCT00828204|585123242|FG001|Main Study: After Study Restart|Noncompliance|1|||
162018895|NCT00828204|585123241|FG000|Extension Study|Lost to Follow-up|0|||
162018896|NCT00828204|585123242|FG001|Extension Study|Lost to Follow-up|1|||
162018897|NCT00828204|585123241|FG000|Extension Study|Physician Decision|0|||
162018898|NCT00828204|585123242|FG001|Extension Study|Physician Decision|2|||
162018899|NCT02840461|585123243|FG000|Overall Study|Adverse Event|1|||
162018900|NCT02840461|585123244|FG001|Overall Study|Adverse Event|5|||
162018901|NCT02840461|585123245|FG002|Overall Study|Adverse Event|3|||
162018902|NCT02840461|585123243|FG000|Overall Study|Lost to Follow-up|10|||
162018903|NCT02840461|585123244|FG001|Overall Study|Lost to Follow-up|7|||
162018904|NCT02840461|585123245|FG002|Overall Study|Lost to Follow-up|6|||
162018905|NCT02840461|585123243|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
162018906|NCT02840461|585123244|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
162018907|NCT02840461|585123245|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
162018908|NCT02840461|585123243|FG000|Overall Study|Protocol Violation|2|||
162018909|NCT02840461|585123244|FG001|Overall Study|Protocol Violation|3|||
162018910|NCT02840461|585123245|FG002|Overall Study|Protocol Violation|1|||
162182074|NCT02347332|585719213|FG000|Overall Study|Switch Post-Trial program|0|||
162182075|NCT02347332|585719214|FG001|Overall Study|Switch Post-Trial program|1|||
162182076|NCT01478594|585719216|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
162182077|NCT01478594|585719217|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
162182078|NCT01478594|585719216|FG000|Overall Study|Death|45|||
162182079|NCT01478594|585719217|FG001|Overall Study|Death|18|||
162182080|NCT01478594|585719216|FG000|Overall Study|Lost to Follow-up|3|||
162182081|NCT01478594|585719217|FG001|Overall Study|Lost to Follow-up|1|||
162182082|NCT01478594|585719216|FG000|Overall Study|Withdrawal by Subject|9|||
162182083|NCT01478594|585719217|FG001|Overall Study|Withdrawal by Subject|3|||
162182084|NCT01478594|585719216|FG000|Overall Study|Study Closed by Sponsor|8|||
162182085|NCT01478594|585719217|FG001|Overall Study|Study Closed by Sponsor|5|||
162182086|NCT01313884|585719218|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
162182087|NCT01970007|585719219|FG000|Overall Study|Death|5|||
162182088|NCT01970007|585719219|FG000|Overall Study|Withdrawal by Subject|23|||
162182089|NCT01970007|585719219|FG000|Overall Study|Lost to Follow-up|24|||
162182090|NCT01970007|585719219|FG000|Overall Study|"Other endpoint"|3|||
162182091|NCT04384172|585719221|FG000|Overall Study|Lost to Follow-up|0|||
162182092|NCT04384172|585719222|FG001|Overall Study|Lost to Follow-up|2|||
162182093|NCT04384172|585719221|FG000|Overall Study|Pregnancy|1|||
162182094|NCT04384172|585719222|FG001|Overall Study|Pregnancy|0|||
162182095|NCT04384172|585719221|FG000|Overall Study|Withdrawal by Subject|0|||
162182096|NCT04384172|585719222|FG001|Overall Study|Withdrawal by Subject|1|||
162182097|NCT00523419|585719226|FG000|Overall Study|Adverse Event|1|||
162182098|NCT00523419|585719226|FG000|Overall Study|Withdrawal by Subject|1|||
162182099|NCT00523419|585719226|FG000|Overall Study|Physician Decision|2|||
162182100|NCT00523419|585719226|FG000|Overall Study|Progressive Disease|22|||
162182101|NCT00523419|585719226|FG000|Overall Study|Death due to Study Disease|4|||
162182102|NCT00523419|585719226|FG000|Overall Study|Death due to Adverse Event|2|||
162182103|NCT00822120|585719227|FG000|Initial Registration|Adverse Event|1|||
162182104|NCT00822120|585719228|FG001|Initial Registration|Adverse Event|0|||
162182105|NCT00822120|585719229|FG002|Initial Registration|Adverse Event|0|||
162182106|NCT00822120|585719230|FG003|Initial Registration|Adverse Event|0|||
162182107|NCT00822120|585719231|FG004|Initial Registration|Adverse Event|0|||
162182108|NCT00822120|585719232|FG005|Initial Registration|Adverse Event|0|||
162182109|NCT00822120|585719227|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
162182110|NCT00822120|585719228|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
162182111|NCT00822120|585719229|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
162182112|NCT00822120|585719230|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
162182113|NCT00822120|585719231|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
162182114|NCT00822120|585719232|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
162182115|NCT00822120|585719227|FG000|Initial Registration|Reasons not Protocol Specified|2|||
162182116|NCT00822120|585719228|FG001|Initial Registration|Reasons not Protocol Specified|0|||
162182117|NCT00822120|585719229|FG002|Initial Registration|Reasons not Protocol Specified|0|||
162182118|NCT00822120|585719230|FG003|Initial Registration|Reasons not Protocol Specified|0|||
162182119|NCT00822120|585719231|FG004|Initial Registration|Reasons not Protocol Specified|0|||
162182120|NCT00822120|585719232|FG005|Initial Registration|Reasons not Protocol Specified|0|||
162182121|NCT00822120|585719227|FG000|Initial Registration|Ineligible|22|||
162182122|NCT00822120|585719228|FG001|Initial Registration|Ineligible|1|||
162182123|NCT00822120|585719229|FG002|Initial Registration|Ineligible|0|||
162182124|NCT00822120|585719230|FG003|Initial Registration|Ineligible|0|||
162182125|NCT00822120|585719231|FG004|Initial Registration|Ineligible|0|||
162182126|NCT00822120|585719232|FG005|Initial Registration|Ineligible|0|||
162182127|NCT00822120|585719227|FG000|PET-directed Therapy|Adverse Event|0|||
162182128|NCT00822120|585719228|FG001|PET-directed Therapy|Adverse Event|0|||
162182129|NCT00822120|585719229|FG002|PET-directed Therapy|Adverse Event|0|||
162182130|NCT00822120|585719230|FG003|PET-directed Therapy|Adverse Event|1|||
162182131|NCT00822120|585719231|FG004|PET-directed Therapy|Adverse Event|0|||
162182132|NCT00822120|585719232|FG005|PET-directed Therapy|Adverse Event|0|||
161924220|NCT03971422|584769605|FG000|Overall Study|Due to COVID-19 pandemic|0|||
161924221|NCT03971422|584769606|FG001|Overall Study|Due to COVID-19 pandemic|1|||
161924222|NCT03971422|584769607|FG002|Overall Study|Due to COVID-19 pandemic|1|||
161924223|NCT03928704|584769610|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
162182133|NCT00822120|585719227|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
162182134|NCT00822120|585719228|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
162182135|NCT00822120|585719229|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
162182136|NCT00822120|585719230|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
162182137|NCT00822120|585719231|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
162182138|NCT00822120|585719232|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
162182139|NCT00822120|585719227|FG000|PET-directed Therapy|Death|0|||
162182140|NCT00822120|585719228|FG001|PET-directed Therapy|Death|0|||
162182141|NCT00822120|585719229|FG002|PET-directed Therapy|Death|0|||
162182142|NCT00822120|585719230|FG003|PET-directed Therapy|Death|2|||
162182143|NCT00822120|585719231|FG004|PET-directed Therapy|Death|0|||
161924224|NCT03928704|584769611|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
161924225|NCT03928704|584769612|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
161924226|NCT03928704|584769613|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
161924227|NCT03928704|584769614|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
161924228|NCT03928704|584769615|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
161924229|NCT03928704|584769610|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
161924230|NCT03928704|584769611|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
161924231|NCT03928704|584769612|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
161924232|NCT03928704|584769613|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
161924233|NCT03928704|584769614|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
161924234|NCT03928704|584769615|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
161924235|NCT03928704|584769610|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
161924236|NCT03928704|584769611|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
161924237|NCT03928704|584769612|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
161924238|NCT03928704|584769613|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
161924239|NCT03928704|584769614|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
161924240|NCT03928704|584769615|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
161924241|NCT03928704|584769610|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
161924242|NCT03928704|584769611|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
161924243|NCT03928704|584769612|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
161924244|NCT03928704|584769613|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
161924245|NCT03928704|584769614|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
161924246|NCT03928704|584769615|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
161924247|NCT03928704|584769610|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
161924248|NCT03928704|584769611|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
161924249|NCT03928704|584769612|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
162182144|NCT00822120|585719232|FG005|PET-directed Therapy|Death|0|||
162182145|NCT00822120|585719227|FG000|PET-directed Therapy|Protocol Violation|0|||
162182146|NCT00822120|585719228|FG001|PET-directed Therapy|Protocol Violation|0|||
162182147|NCT00822120|585719229|FG002|PET-directed Therapy|Protocol Violation|0|||
162182148|NCT00822120|585719230|FG003|PET-directed Therapy|Protocol Violation|6|||
161672237|NCT00372385|583853066|FG000|Overall Study|Noncompliance|0|||
161672238|NCT00372385|583853067|FG001|Overall Study|Noncompliance|1|||
162182149|NCT00822120|585719231|FG004|PET-directed Therapy|Protocol Violation|0|||
162182150|NCT00822120|585719232|FG005|PET-directed Therapy|Protocol Violation|0|||
162182151|NCT01759862|585719233|FG000|Overall Study|Physician Decision|3|||
162182152|NCT01759862|585719234|FG001|Overall Study|Physician Decision|1|||
162182153|NCT01759862|585719233|FG000|Overall Study|Adverse Event|0|||
162182154|NCT01759862|585719234|FG001|Overall Study|Adverse Event|1|||
162182155|NCT04060212|585719236|FG000|Overall Study|Withdrawal by Subject|7|||
162182156|NCT01437319|585719237|FG000|Phase I|Lost to Follow-up|2|||
162182157|NCT01437319|585719238|FG001|Phase I|Lost to Follow-up|0|||
162182158|NCT01437319|585719239|FG002|Phase I|Lost to Follow-up|0|||
161672239|NCT00372385|583853068|FG002|Overall Study|Noncompliance|1|||
162182159|NCT01437319|585719237|FG000|Phase I|Protocol Violation|1|||
162182160|NCT01437319|585719238|FG001|Phase I|Protocol Violation|0|||
162182161|NCT01437319|585719239|FG002|Phase I|Protocol Violation|0|||
162182162|NCT01437319|585719237|FG000|Phase I|Study related symptoms/complaints|27|||
162182163|NCT01437319|585719238|FG001|Phase I|Study related symptoms/complaints|0|||
162182164|NCT01437319|585719239|FG002|Phase I|Study related symptoms/complaints|0|||
162182165|NCT01437319|585719237|FG000|Phase I|Withdrawal by Subject|25|||
162182166|NCT01437319|585719238|FG001|Phase I|Withdrawal by Subject|0|||
162182167|NCT01437319|585719239|FG002|Phase I|Withdrawal by Subject|0|||
162182168|NCT01437319|585719237|FG000|Phase II|Withdrawal by Subject|0|||
162182169|NCT01437319|585719238|FG001|Phase II|Withdrawal by Subject|8|||
162182170|NCT01437319|585719239|FG002|Phase II|Withdrawal by Subject|16|||
162182171|NCT01437319|585719237|FG000|Phase II|Lost to Follow-up|0|||
162182172|NCT01437319|585719238|FG001|Phase II|Lost to Follow-up|7|||
162182173|NCT01437319|585719239|FG002|Phase II|Lost to Follow-up|2|||
162182174|NCT01437319|585719237|FG000|Phase II|Study related symptoms/complaints|0|||
162182175|NCT01437319|585719238|FG001|Phase II|Study related symptoms/complaints|28|||
162182176|NCT01437319|585719239|FG002|Phase II|Study related symptoms/complaints|19|||
162182177|NCT01437319|585719237|FG000|Phase II|Protocol Violation|0|||
162182178|NCT01437319|585719238|FG001|Phase II|Protocol Violation|1|||
162182179|NCT01437319|585719239|FG002|Phase II|Protocol Violation|0|||
162182180|NCT01499849|585719240|FG000|Overall Study|Adverse Event|28|||
162182181|NCT01499849|585719241|FG001|Overall Study|Adverse Event|32|||
162182182|NCT01499849|585719240|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
162182183|NCT01499849|585719241|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
162182184|NCT01499849|585719240|FG000|Overall Study|Withdrawal by Subject|43|||
162182185|NCT01499849|585719241|FG001|Overall Study|Withdrawal by Subject|43|||
162182186|NCT01499849|585719240|FG000|Overall Study|Death|5|||
162182187|NCT01499849|585719241|FG001|Overall Study|Death|7|||
162182188|NCT01499849|585719240|FG000|Overall Study|Disease Progression|11|||
162182189|NCT01499849|585719241|FG001|Overall Study|Disease Progression|10|||
162182190|NCT01499849|585719240|FG000|Overall Study|Protocol Violation|11|||
162182191|NCT01499849|585719241|FG001|Overall Study|Protocol Violation|11|||
162182192|NCT01499849|585719240|FG000|Overall Study|Physician Decision|20|||
162182193|NCT01499849|585719241|FG001|Overall Study|Physician Decision|19|||
162182194|NCT01499849|585719240|FG000|Overall Study|Lack of Efficacy|3|||
162182195|NCT01499849|585719241|FG001|Overall Study|Lack of Efficacy|4|||
162182196|NCT01499849|585719240|FG000|Overall Study|Lost to Follow-up|6|||
162182197|NCT01499849|585719241|FG001|Overall Study|Lost to Follow-up|3|||
162182198|NCT01499849|585719240|FG000|Overall Study|Other Reasons|27|||
162182199|NCT01499849|585719241|FG001|Overall Study|Other Reasons|30|||
162182200|NCT02646618|585719242|FG000|Overall Study|Lost to Follow-up|10|||
162182201|NCT02646618|585719243|FG001|Overall Study|Lost to Follow-up|14|||
162182202|NCT03885232|585719244|FG000|Overall Study|Lost to Follow-up|74|||
162182203|NCT03885232|585719245|FG001|Overall Study|Lost to Follow-up|32|||
162182204|NCT03885232|585719244|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
162182205|NCT03885232|585719245|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
162182206|NCT03834740|585719246|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
162182207|NCT03834740|585719247|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
162182208|NCT03834740|585719248|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
162182209|NCT01208974|585719249|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
162182210|NCT01208974|585719250|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
162182211|NCT01208974|585719251|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
162182212|NCT01208974|585719252|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
162182213|NCT01208974|585719249|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
162182214|NCT01208974|585719250|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
162182215|NCT01208974|585719251|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
162182216|NCT01208974|585719252|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
162182217|NCT01208974|585719249|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
162182218|NCT01208974|585719250|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
162182219|NCT01208974|585719251|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
162182220|NCT01208974|585719252|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
162182221|NCT03593226|585719253|FG000|Overall Study|Disease progression|6|||
162182222|NCT03593226|585719254|FG001|Overall Study|Disease progression|13|||
162182223|NCT03593226|585719255|FG002|Overall Study|Disease progression|5|||
162182224|NCT03593226|585719256|FG003|Overall Study|Disease progression|6|||
162182225|NCT03593226|585719253|FG000|Overall Study|Adverse Event|0|||
162182226|NCT03593226|585719254|FG001|Overall Study|Adverse Event|1|||
162182227|NCT03593226|585719255|FG002|Overall Study|Adverse Event|0|||
162182228|NCT03593226|585719256|FG003|Overall Study|Adverse Event|0|||
162182229|NCT03593226|585719253|FG000|Overall Study|Withdrawal by Subject|0|||
162182230|NCT03593226|585719254|FG001|Overall Study|Withdrawal by Subject|4|||
162182231|NCT03593226|585719255|FG002|Overall Study|Withdrawal by Subject|1|||
162182232|NCT03593226|585719256|FG003|Overall Study|Withdrawal by Subject|0|||
162182233|NCT03593226|585719253|FG000|Overall Study|Physician Decision|0|||
162182234|NCT03593226|585719254|FG001|Overall Study|Physician Decision|1|||
162018911|NCT02840461|585123243|FG000|Overall Study|Withdrawal by Subject|10|||
162018912|NCT02840461|585123244|FG001|Overall Study|Withdrawal by Subject|6|||
162018913|NCT02840461|585123245|FG002|Overall Study|Withdrawal by Subject|2|||
162018914|NCT02840461|585123243|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
162018915|NCT02840461|585123244|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
162018916|NCT02840461|585123245|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
162018917|NCT01104311|585123248|FG000|Overall Study|Withdrawal by Subject|6|||
162018918|NCT01104311|585123249|FG001|Overall Study|Withdrawal by Subject|6|||
162018919|NCT01104311|585123248|FG000|Overall Study|Protocol Violation|0|||
162018920|NCT01104311|585123249|FG001|Overall Study|Protocol Violation|1|||
162018921|NCT01104311|585123248|FG000|Overall Study|Physician Decision|2|||
162018922|NCT01104311|585123249|FG001|Overall Study|Physician Decision|2|||
162018923|NCT01104311|585123248|FG000|Overall Study|low compliance|1|||
162018924|NCT01104311|585123249|FG001|Overall Study|low compliance|1|||
162018925|NCT01104311|585123248|FG000|Overall Study|Adverse Event|1|||
162018926|NCT01104311|585123249|FG001|Overall Study|Adverse Event|2|||
162018927|NCT04434937|585123251|FG000|Overall Study|Death|4|||
162018928|NCT04434937|585123251|FG000|Overall Study|Withdrawal by Subject|1|||
162018929|NCT04434937|585123251|FG000|Overall Study|Transitioned to Rollover Study|19|||
162018930|NCT04434937|585123251|FG000|Overall Study|Progressive Disease|18|||
162018931|NCT04549545|585124802|FG000|Initial Period|Withdrawal by Subject|4|||
162018932|NCT04549545|585124803|FG001|Initial Period|Withdrawal by Subject|0|||
162018933|NCT04549545|585124802|FG000|Initial Period|Additional ENT Procedure|3|||
162018934|NCT04549545|585124803|FG001|Initial Period|Additional ENT Procedure|0|||
162018935|NCT04549545|585124802|FG000|Initial Period|Lost to Follow-up|3|||
162018936|NCT04549545|585124803|FG001|Initial Period|Lost to Follow-up|1|||
162018937|NCT04549545|585124802|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
162182235|NCT03593226|585719255|FG002|Overall Study|Physician Decision|0|||
162182236|NCT03593226|585719256|FG003|Overall Study|Physician Decision|0|||
162182237|NCT03593226|585719253|FG000|Overall Study|Clinical disease progression|0|||
162182238|NCT03593226|585719254|FG001|Overall Study|Clinical disease progression|0|||
162182239|NCT03593226|585719255|FG002|Overall Study|Clinical disease progression|1|||
162182240|NCT03593226|585719256|FG003|Overall Study|Clinical disease progression|0|||
162182241|NCT02500576|585719257|FG000|Overall Study|Adverse Event|0|||
162182242|NCT02500576|585719258|FG001|Overall Study|Adverse Event|1|||
162182243|NCT02500576|585719257|FG000|Overall Study|Death|2|||
162182244|NCT02500576|585719258|FG001|Overall Study|Death|1|||
162182245|NCT02500576|585719257|FG000|Overall Study|Lack of Efficacy|5|||
162182246|NCT02500576|585719258|FG001|Overall Study|Lack of Efficacy|5|||
162182247|NCT02500576|585719257|FG000|Overall Study|Withdrawal by Subject|1|||
162182248|NCT02500576|585719258|FG001|Overall Study|Withdrawal by Subject|1|||
162182249|NCT03691493|585719262|FG000|Overall Study|Withdrawal by Subject|1|||
162182250|NCT00227266|585719273|FG000|Overall Study|Withdrawal by Subject|0|||
162182251|NCT00227266|585719274|FG001|Overall Study|Withdrawal by Subject|0|||
162182252|NCT00227266|585719275|FG002|Overall Study|Withdrawal by Subject|1|||
162182253|NCT00227266|585719273|FG000|Overall Study|Protocol Violation|1|||
162182254|NCT00227266|585719274|FG001|Overall Study|Protocol Violation|0|||
162182255|NCT00227266|585719275|FG002|Overall Study|Protocol Violation|1|||
162182256|NCT00227266|585719273|FG000|Overall Study|Excessive weight gain|0|||
162182257|NCT00227266|585719274|FG001|Overall Study|Excessive weight gain|0|||
162182258|NCT00227266|585719275|FG002|Overall Study|Excessive weight gain|2|||
162182259|NCT02678689|585719278|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
162182260|NCT02678689|585719279|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
162182261|NCT05786612|585719284|FG000|Overall Study|Adverse Event|1|||
162182262|NCT05786612|585719285|FG001|Overall Study|Adverse Event|2|||
162182263|NCT05786612|585719284|FG000|Overall Study|one screening failure|0|||
162182264|NCT05786612|585719285|FG001|Overall Study|one screening failure|2|||
162018938|NCT04549545|585124803|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
162018939|NCT04549545|585124802|FG000|Crossover Period|Additional ENT Procedure|0|||
162018940|NCT04549545|585124803|FG001|Crossover Period|Additional ENT Procedure|6|||
162018941|NCT04549545|585124802|FG000|Crossover Period|Lost to Follow-up|0|||
162182265|NCT03459196|585721227|FG000|Overall Study|Subject didn't receive study catheter|2|||
162182266|NCT03367156|585721228|FG000|Overall Study|Lack of interest|3|||
162182267|NCT03367156|585721229|FG001|Overall Study|Lack of interest|1|||
162182268|NCT03367156|585721228|FG000|Overall Study|Death|2|||
162182269|NCT03367156|585721229|FG001|Overall Study|Death|0|||
162182270|NCT03367156|585721228|FG000|Overall Study|Lost to Follow-up|2|||
162182271|NCT03367156|585721229|FG001|Overall Study|Lost to Follow-up|1|||
162018942|NCT04549545|585124803|FG001|Crossover Period|Lost to Follow-up|1|||
162018943|NCT04549545|585124802|FG000|Crossover Period|Withdrawal by Subject|0|||
162018944|NCT04549545|585124803|FG001|Crossover Period|Withdrawal by Subject|4|||
162182272|NCT03367156|585721228|FG000|Overall Study|Became ineligible|1|||
162182273|NCT03367156|585721229|FG001|Overall Study|Became ineligible|2|||
162182274|NCT03367156|585721228|FG000|Overall Study|Hospitalization|1|||
162182275|NCT03367156|585721229|FG001|Overall Study|Hospitalization|0|||
162182276|NCT03367156|585721228|FG000|Overall Study|Concerned about Treatment|11|||
161672240|NCT00372385|583853069|FG003|Overall Study|Noncompliance|1|||
161672241|NCT00372385|583853066|FG000|Overall Study|Physician Decision|1|||
161672242|NCT00372385|583853067|FG001|Overall Study|Physician Decision|0|||
161672243|NCT00372385|583853068|FG002|Overall Study|Physician Decision|0|||
161672244|NCT00372385|583853069|FG003|Overall Study|Physician Decision|0|||
161672245|NCT00372385|583853066|FG000|Overall Study|Lost to Follow-up|2|||
161672246|NCT00372385|583853067|FG001|Overall Study|Lost to Follow-up|0|||
161672247|NCT00372385|583853068|FG002|Overall Study|Lost to Follow-up|0|||
161672248|NCT00372385|583853069|FG003|Overall Study|Lost to Follow-up|0|||
161672249|NCT00372385|583853066|FG000|Overall Study|Withdrawal by Subject|2|||
161672250|NCT00372385|583853067|FG001|Overall Study|Withdrawal by Subject|1|||
161672251|NCT00372385|583853068|FG002|Overall Study|Withdrawal by Subject|0|||
161672252|NCT00372385|583853069|FG003|Overall Study|Withdrawal by Subject|0|||
161672253|NCT00372385|583853066|FG000|Overall Study|Refusal of Treatment|3|||
161672254|NCT00372385|583853067|FG001|Overall Study|Refusal of Treatment|6|||
161672255|NCT00372385|583853068|FG002|Overall Study|Refusal of Treatment|0|||
161672256|NCT00372385|583853069|FG003|Overall Study|Refusal of Treatment|0|||
161672257|NCT00372385|583853066|FG000|Overall Study|No Response|1|||
161672258|NCT00372385|583853067|FG001|Overall Study|No Response|1|||
161672259|NCT00372385|583853068|FG002|Overall Study|No Response|0|||
161672260|NCT00372385|583853069|FG003|Overall Study|No Response|0|||
161672261|NCT00372385|583853066|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
161672262|NCT00372385|583853067|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
161672263|NCT00372385|583853068|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
161672264|NCT00372385|583853069|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
161672265|NCT00372385|583853066|FG000|Overall Study|Virologic Stopping Rule|17|||
161672266|NCT00372385|583853067|FG001|Overall Study|Virologic Stopping Rule|0|||
161672267|NCT00372385|583853068|FG002|Overall Study|Virologic Stopping Rule|0|||
161672268|NCT00372385|583853069|FG003|Overall Study|Virologic Stopping Rule|0|||
161672269|NCT02554903|583853070|FG000|Overall Study|Death|1|||
161672270|NCT02554903|583853071|FG001|Overall Study|Death|1|||
161672271|NCT02554903|583853070|FG000|Overall Study|Physician Decision|2|||
161672272|NCT02554903|583853071|FG001|Overall Study|Physician Decision|2|||
161672273|NCT02554903|583853070|FG000|Overall Study|Heart Transplant|1|||
161672274|NCT02554903|583853071|FG001|Overall Study|Heart Transplant|2|||
161672275|NCT01163721|583853079|FG000|Overall Study|Adverse Event|5|||
161672276|NCT01163721|583853080|FG001|Overall Study|Adverse Event|6|||
161672277|NCT01163721|583853079|FG000|Overall Study|Withdrawal by Subject|3|||
161672278|NCT01163721|583853080|FG001|Overall Study|Withdrawal by Subject|4|||
161672279|NCT01163721|583853079|FG000|Overall Study|Lost to Follow-up|0|||
161672280|NCT01163721|583853080|FG001|Overall Study|Lost to Follow-up|1|||
161672281|NCT01163721|583853079|FG000|Overall Study|Physician Decision|0|||
161672282|NCT01163721|583853080|FG001|Overall Study|Physician Decision|1|||
161672283|NCT00364156|583853086|FG000|Overall Study|Withdrawal by Subject|73|||
162182277|NCT03367156|585721229|FG001|Overall Study|Concerned about Treatment|3|||
162182278|NCT03367156|585721228|FG000|Overall Study|Started new treatment|4|||
162182279|NCT03367156|585721229|FG001|Overall Study|Started new treatment|1|||
162182280|NCT03762850|585721230|FG000|Overall Study|Death|0|||
161672284|NCT00364156|583853087|FG001|Overall Study|Withdrawal by Subject|80|||
161672285|NCT00364156|583853086|FG000|Overall Study|Protocol Violation|6|||
161672286|NCT00364156|583853087|FG001|Overall Study|Protocol Violation|1|||
161672287|NCT01050205|583853088|FG000|Overall Study|Lost to Follow-up|7|||
161672288|NCT01050205|583853089|FG001|Overall Study|Lost to Follow-up|1|||
161672289|NCT01050205|583853088|FG000|Overall Study|Withdrawal by Subject|1|||
161672290|NCT01050205|583853089|FG001|Overall Study|Withdrawal by Subject|1|||
161672291|NCT01050205|583853088|FG000|Overall Study|Relocated from area|1|||
161818176|NCT01494532|584374403|FG004|Overall Study|Adverse Event|5|||
162182281|NCT03762850|585721231|FG001|Overall Study|Death|1|||
161672292|NCT01050205|583853089|FG001|Overall Study|Relocated from area|2|||
161672293|NCT01050205|583853088|FG000|Overall Study|Discontinued Intervention|2|||
161672294|NCT01050205|583853089|FG001|Overall Study|Discontinued Intervention|0|||
161672295|NCT01472380|583853090|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
161818177|NCT01494532|584374404|FG005|Overall Study|Adverse Event|0|||
161818178|NCT01494532|584374399|FG000|Overall Study|Lack of Efficacy|0|||
161672296|NCT01472380|583853090|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
161672297|NCT02708095|583853091|FG000|Overall Study|Adverse Event|4|||
161672298|NCT02708095|583853092|FG001|Overall Study|Adverse Event|10|||
161672299|NCT02708095|583853093|FG002|Overall Study|Adverse Event|11|||
161672300|NCT02708095|583853091|FG000|Overall Study|Lack of Efficacy|9|||
161672301|NCT02708095|583853092|FG001|Overall Study|Lack of Efficacy|3|||
161672302|NCT02708095|583853093|FG002|Overall Study|Lack of Efficacy|0|||
161672303|NCT02708095|583853091|FG000|Overall Study|Lost to Follow-up|2|||
161672304|NCT02708095|583853092|FG001|Overall Study|Lost to Follow-up|0|||
161818179|NCT01494532|584374400|FG001|Overall Study|Lack of Efficacy|0|||
161818180|NCT01494532|584374401|FG002|Overall Study|Lack of Efficacy|0|||
162182282|NCT03762850|585721230|FG000|Overall Study|Lost to Follow-up|0|||
161672305|NCT02708095|583853093|FG002|Overall Study|Lost to Follow-up|0|||
161672306|NCT02708095|583853091|FG000|Overall Study|Physician Decision|2|||
161818181|NCT01494532|584374402|FG003|Overall Study|Lack of Efficacy|0|||
162182283|NCT03762850|585721231|FG001|Overall Study|Lost to Follow-up|1|||
162182284|NCT03762850|585721230|FG000|Overall Study|Physician Decision|0|||
162182285|NCT03762850|585721231|FG001|Overall Study|Physician Decision|1|||
162182286|NCT03762850|585721230|FG000|Overall Study|Withdrawal by Subject|4|||
162182287|NCT03762850|585721231|FG001|Overall Study|Withdrawal by Subject|9|||
162182288|NCT00092534|585721234|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
162182289|NCT00092534|585721235|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
162182290|NCT00092534|585721236|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
162182291|NCT00092534|585721237|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
162182292|NCT00092534|585721238|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
162182293|NCT00092534|585721234|FG000|Base Study Vaccination Period|Adverse Event|3|||
162182294|NCT00092534|585721235|FG001|Base Study Vaccination Period|Adverse Event|1|||
162182295|NCT00092534|585721236|FG002|Base Study Vaccination Period|Adverse Event|0|||
162182296|NCT00092534|585721237|FG003|Base Study Vaccination Period|Adverse Event|0|||
162182297|NCT00092534|585721238|FG004|Base Study Vaccination Period|Adverse Event|0|||
162182298|NCT00092534|585721234|FG000|Base Study Vaccination Period|Death|5|||
162182299|NCT00092534|585721235|FG001|Base Study Vaccination Period|Death|4|||
162182300|NCT00092534|585721236|FG002|Base Study Vaccination Period|Death|0|||
162182301|NCT00092534|585721237|FG003|Base Study Vaccination Period|Death|0|||
162182302|NCT00092534|585721238|FG004|Base Study Vaccination Period|Death|0|||
162182303|NCT00092534|585721234|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
162182304|NCT00092534|585721235|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
162182305|NCT00092534|585721236|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
162182306|NCT00092534|585721237|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
162182307|NCT00092534|585721238|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
162182308|NCT00092534|585721234|FG000|Base Study Vaccination Period|Physician Decision|1|||
162182309|NCT00092534|585721235|FG001|Base Study Vaccination Period|Physician Decision|0|||
162182310|NCT00092534|585721236|FG002|Base Study Vaccination Period|Physician Decision|0|||
162182311|NCT00092534|585721237|FG003|Base Study Vaccination Period|Physician Decision|0|||
162182312|NCT00092534|585721238|FG004|Base Study Vaccination Period|Physician Decision|0|||
162182313|NCT00092534|585721234|FG000|Base Study Vaccination Period|Pregnancy|9|||
162182314|NCT00092534|585721235|FG001|Base Study Vaccination Period|Pregnancy|7|||
162182315|NCT00092534|585721236|FG002|Base Study Vaccination Period|Pregnancy|0|||
162182316|NCT00092534|585721237|FG003|Base Study Vaccination Period|Pregnancy|0|||
162182317|NCT00092534|585721238|FG004|Base Study Vaccination Period|Pregnancy|0|||
162182318|NCT00092534|585721234|FG000|Base Study Vaccination Period|Protocol Violation|2|||
162182319|NCT00092534|585721235|FG001|Base Study Vaccination Period|Protocol Violation|1|||
162182320|NCT00092534|585721236|FG002|Base Study Vaccination Period|Protocol Violation|0|||
162182321|NCT00092534|585721237|FG003|Base Study Vaccination Period|Protocol Violation|0|||
162182322|NCT00092534|585721238|FG004|Base Study Vaccination Period|Protocol Violation|0|||
162182323|NCT00092534|585721234|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
162182324|NCT00092534|585721235|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
162182325|NCT00092534|585721236|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
162182326|NCT00092534|585721237|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
162182327|NCT00092534|585721238|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
162182328|NCT00092534|585721234|FG000|Base Study Vaccination Period|Moved|14|||
162182329|NCT00092534|585721235|FG001|Base Study Vaccination Period|Moved|12|||
162182330|NCT00092534|585721236|FG002|Base Study Vaccination Period|Moved|0|||
162182331|NCT00092534|585721237|FG003|Base Study Vaccination Period|Moved|0|||
162182332|NCT00092534|585721238|FG004|Base Study Vaccination Period|Moved|0|||
162182333|NCT00092534|585721234|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
162182334|NCT00092534|585721235|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
162182335|NCT00092534|585721236|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
162182336|NCT00092534|585721237|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
162182337|NCT00092534|585721238|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
162182338|NCT00092534|585721234|FG000|Base Study Vaccination Period|Travel|1|||
162182339|NCT00092534|585721235|FG001|Base Study Vaccination Period|Travel|0|||
162182340|NCT00092534|585721236|FG002|Base Study Vaccination Period|Travel|0|||
162182341|NCT00092534|585721237|FG003|Base Study Vaccination Period|Travel|0|||
162182342|NCT00092534|585721238|FG004|Base Study Vaccination Period|Travel|0|||
162182343|NCT00092534|585721234|FG000|Base Study Vaccination Period|Site Closed|0|||
162182344|NCT00092534|585721235|FG001|Base Study Vaccination Period|Site Closed|1|||
162182345|NCT00092534|585721236|FG002|Base Study Vaccination Period|Site Closed|0|||
162182346|NCT00092534|585721237|FG003|Base Study Vaccination Period|Site Closed|0|||
162182347|NCT00092534|585721238|FG004|Base Study Vaccination Period|Site Closed|0|||
162182348|NCT00092534|585721234|FG000|Base Study Follow-Up Period|Adverse Event|2|||
162182349|NCT00092534|585721235|FG001|Base Study Follow-Up Period|Adverse Event|4|||
162182350|NCT00092534|585721236|FG002|Base Study Follow-Up Period|Adverse Event|0|||
162182351|NCT00092534|585721237|FG003|Base Study Follow-Up Period|Adverse Event|0|||
162182352|NCT00092534|585721238|FG004|Base Study Follow-Up Period|Adverse Event|0|||
162182353|NCT00092534|585721234|FG000|Base Study Follow-Up Period|Death|2|||
162182354|NCT00092534|585721235|FG001|Base Study Follow-Up Period|Death|1|||
162182355|NCT00092534|585721236|FG002|Base Study Follow-Up Period|Death|0|||
162182356|NCT00092534|585721237|FG003|Base Study Follow-Up Period|Death|0|||
162182357|NCT00092534|585721238|FG004|Base Study Follow-Up Period|Death|0|||
162182358|NCT00092534|585721234|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
162182359|NCT00092534|585721235|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
162182360|NCT00092534|585721236|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
162182361|NCT00092534|585721237|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
162182362|NCT00092534|585721238|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
162182363|NCT00092534|585721234|FG000|Base Study Follow-Up Period|Pregnancy|6|||
162182364|NCT00092534|585721235|FG001|Base Study Follow-Up Period|Pregnancy|10|||
162182365|NCT00092534|585721236|FG002|Base Study Follow-Up Period|Pregnancy|0|||
162182366|NCT00092534|585721237|FG003|Base Study Follow-Up Period|Pregnancy|0|||
162182367|NCT00092534|585721238|FG004|Base Study Follow-Up Period|Pregnancy|0|||
162182368|NCT00092534|585721234|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
162182369|NCT00092534|585721235|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
162182370|NCT00092534|585721236|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
162182371|NCT00092534|585721237|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
162182372|NCT00092534|585721238|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
162182373|NCT00092534|585721234|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
162182374|NCT00092534|585721235|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
162182375|NCT00092534|585721236|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
162182376|NCT00092534|585721237|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
162182377|NCT00092534|585721238|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
162182378|NCT00092534|585721234|FG000|Base Study Follow-Up Period|Moved|62|||
162182379|NCT00092534|585721235|FG001|Base Study Follow-Up Period|Moved|58|||
162182380|NCT00092534|585721236|FG002|Base Study Follow-Up Period|Moved|0|||
161672307|NCT02708095|583853092|FG001|Overall Study|Physician Decision|3|||
161672308|NCT02708095|583853093|FG002|Overall Study|Physician Decision|2|||
161672309|NCT02708095|583853091|FG000|Overall Study|Protocol Violation|0|||
161672310|NCT02708095|583853092|FG001|Overall Study|Protocol Violation|0|||
161672311|NCT02708095|583853093|FG002|Overall Study|Protocol Violation|1|||
161672312|NCT02708095|583853091|FG000|Overall Study|Withdrawal by Subject|5|||
161672313|NCT02708095|583853092|FG001|Overall Study|Withdrawal by Subject|3|||
161672314|NCT02708095|583853093|FG002|Overall Study|Withdrawal by Subject|4|||
161672315|NCT03254485|583853106|FG000|Overall Study|Adverse Event|3|||
161672316|NCT03254485|583853107|FG001|Overall Study|Adverse Event|0|||
161672317|NCT03254485|583853108|FG002|Overall Study|Adverse Event|0|||
161672318|NCT03254485|583853109|FG003|Overall Study|Adverse Event|6|||
161672319|NCT03254485|583853106|FG000|Overall Study|Protocol Violation|6|||
161672320|NCT03254485|583853107|FG001|Overall Study|Protocol Violation|0|||
161672321|NCT03254485|583853108|FG002|Overall Study|Protocol Violation|0|||
161672322|NCT03254485|583853109|FG003|Overall Study|Protocol Violation|2|||
161672323|NCT03254485|583853106|FG000|Overall Study|Withdrawal by Subject|1|||
161672324|NCT03254485|583853107|FG001|Overall Study|Withdrawal by Subject|0|||
161672325|NCT03254485|583853108|FG002|Overall Study|Withdrawal by Subject|0|||
161672326|NCT03254485|583853109|FG003|Overall Study|Withdrawal by Subject|4|||
161672327|NCT03254485|583853106|FG000|Overall Study|Death|0|||
161672328|NCT03254485|583853107|FG001|Overall Study|Death|0|||
161672329|NCT03254485|583853108|FG002|Overall Study|Death|0|||
161672330|NCT03254485|583853109|FG003|Overall Study|Death|1|||
161672331|NCT03254485|583853106|FG000|Overall Study|Lost to Follow-up|1|||
161672332|NCT03254485|583853107|FG001|Overall Study|Lost to Follow-up|0|||
162182381|NCT00092534|585721237|FG003|Base Study Follow-Up Period|Moved|0|||
161924250|NCT03928704|584769613|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
161924251|NCT03928704|584769614|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
161924252|NCT03928704|584769615|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
161924253|NCT03928704|584769610|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
161924254|NCT03928704|584769611|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
161924255|NCT03928704|584769612|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
161924256|NCT03928704|584769613|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
162018945|NCT04681352|585124807|FG000|Overall Study|Lost to Follow-up|2|||
162182382|NCT00092534|585721238|FG004|Base Study Follow-Up Period|Moved|0|||
162182383|NCT00092534|585721234|FG000|Base Study Follow-Up Period|Travel|10|||
162182384|NCT00092534|585721235|FG001|Base Study Follow-Up Period|Travel|7|||
162182385|NCT00092534|585721236|FG002|Base Study Follow-Up Period|Travel|0|||
161672333|NCT03254485|583853108|FG002|Overall Study|Lost to Follow-up|0|||
161672334|NCT03254485|583853109|FG003|Overall Study|Lost to Follow-up|0|||
161672335|NCT03254485|583853106|FG000|Overall Study|Other|1|||
161672336|NCT03254485|583853107|FG001|Overall Study|Other|0|||
161672337|NCT03254485|583853108|FG002|Overall Study|Other|0|||
161672338|NCT03254485|583853109|FG003|Overall Study|Other|2|||
162182386|NCT00092534|585721237|FG003|Base Study Follow-Up Period|Travel|0|||
161672339|NCT03153111|583853110|FG000|Overall Study|Death|2|||
161672340|NCT03153111|583853111|FG001|Overall Study|Death|5|||
161672341|NCT03153111|583853110|FG000|Overall Study|Lost to Follow-up|1|||
161672342|NCT03153111|583853111|FG001|Overall Study|Lost to Follow-up|0|||
161818182|NCT01494532|584374403|FG004|Overall Study|Lack of Efficacy|2|||
161818183|NCT01494532|584374404|FG005|Overall Study|Lack of Efficacy|0|||
161818184|NCT01494532|584374399|FG000|Overall Study|Protocol deviation|2|||
161818185|NCT01494532|584374400|FG001|Overall Study|Protocol deviation|1|||
161818186|NCT01494532|584374401|FG002|Overall Study|Protocol deviation|3|||
161818187|NCT01494532|584374402|FG003|Overall Study|Protocol deviation|2|||
161818188|NCT01494532|584374403|FG004|Overall Study|Protocol deviation|3|||
161818189|NCT01494532|584374404|FG005|Overall Study|Protocol deviation|0|||
161818190|NCT01494532|584374399|FG000|Overall Study|Protocol-defined stopping criteria|0|||
161818191|NCT01494532|584374400|FG001|Overall Study|Protocol-defined stopping criteria|0|||
161818192|NCT01494532|584374401|FG002|Overall Study|Protocol-defined stopping criteria|1|||
161818193|NCT01494532|584374402|FG003|Overall Study|Protocol-defined stopping criteria|0|||
161818194|NCT01494532|584374403|FG004|Overall Study|Protocol-defined stopping criteria|0|||
161818195|NCT01494532|584374404|FG005|Overall Study|Protocol-defined stopping criteria|0|||
161818196|NCT01494532|584374399|FG000|Overall Study|Lost to Follow-up|1|||
161818197|NCT01494532|584374400|FG001|Overall Study|Lost to Follow-up|0|||
161818198|NCT01494532|584374401|FG002|Overall Study|Lost to Follow-up|0|||
161818199|NCT01494532|584374402|FG003|Overall Study|Lost to Follow-up|2|||
161818200|NCT01494532|584374403|FG004|Overall Study|Lost to Follow-up|0|||
161818201|NCT01494532|584374404|FG005|Overall Study|Lost to Follow-up|0|||
161818202|NCT01494532|584374399|FG000|Overall Study|Physician Decision|0|||
161818203|NCT01494532|584374400|FG001|Overall Study|Physician Decision|1|||
161818204|NCT01494532|584374401|FG002|Overall Study|Physician Decision|1|||
162018946|NCT04681352|585124807|FG000|Overall Study|Withdrawal by Subject|22|||
162018947|NCT01675544|585124810|FG000|Overall Study|Withdrawal by Subject|2|||
162018948|NCT00792571|585124811|FG000|Overall Study|Death|1|||
162018949|NCT00792571|585124811|FG000|Overall Study|Adverse Event|4|||
162018950|NCT00792571|585124811|FG000|Overall Study|Withdrawal by Subject|1|||
162018951|NCT00792571|585124811|FG000|Overall Study|Other|4|||
162018952|NCT02600819|585124812|FG000|GEN Phase|Adverse Event|2|||
162018953|NCT02600819|585124813|FG001|GEN Phase|Adverse Event|0|||
162018954|NCT02600819|585124812|FG000|GEN Phase|Death|2|||
162018955|NCT02600819|585124813|FG001|GEN Phase|Death|0|||
162018956|NCT02600819|585124812|FG000|GEN Phase|Investigator's Discretion|4|||
162018957|NCT02600819|585124813|FG001|GEN Phase|Investigator's Discretion|0|||
162018958|NCT02600819|585124812|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
162018959|NCT02600819|585124813|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
162018960|NCT02600819|585124812|FG000|GEN Phase|Withdrew Consent|5|||
162018961|NCT02600819|585124813|FG001|GEN Phase|Withdrew Consent|0|||
162018962|NCT02600819|585124812|FG000|GEN Phase|Lost to Follow-up|2|||
162018963|NCT02600819|585124813|FG001|GEN Phase|Lost to Follow-up|0|||
162018964|NCT01621802|585124815|FG000|Overall Study|Protocol Violation|0|||
162018965|NCT01621802|585124816|FG001|Overall Study|Protocol Violation|0|||
162018966|NCT01621802|585124817|FG002|Overall Study|Protocol Violation|0|||
162018967|NCT01621802|585124818|FG003|Overall Study|Protocol Violation|0|||
162018968|NCT01621802|585124819|FG004|Overall Study|Protocol Violation|0|||
162018969|NCT01621802|585124820|FG005|Overall Study|Protocol Violation|1|||
162018970|NCT01621802|585124815|FG000|Overall Study|Withdrawal by Subject|8|||
162018971|NCT01621802|585124816|FG001|Overall Study|Withdrawal by Subject|4|||
162018972|NCT01621802|585124817|FG002|Overall Study|Withdrawal by Subject|4|||
162018973|NCT01621802|585124818|FG003|Overall Study|Withdrawal by Subject|2|||
162018974|NCT01621802|585124819|FG004|Overall Study|Withdrawal by Subject|2|||
162018975|NCT01621802|585124820|FG005|Overall Study|Withdrawal by Subject|0|||
162018976|NCT01621802|585124815|FG000|Overall Study|Migrated/moved from study area|0|||
162018977|NCT01621802|585124816|FG001|Overall Study|Migrated/moved from study area|0|||
162018978|NCT01621802|585124817|FG002|Overall Study|Migrated/moved from study area|2|||
162018979|NCT01621802|585124818|FG003|Overall Study|Migrated/moved from study area|0|||
162018980|NCT01621802|585124819|FG004|Overall Study|Migrated/moved from study area|1|||
162018981|NCT01621802|585124820|FG005|Overall Study|Migrated/moved from study area|0|||
162018982|NCT01621802|585124815|FG000|Overall Study|Others|3|||
162018983|NCT01621802|585124816|FG001|Overall Study|Others|3|||
162018984|NCT01621802|585124817|FG002|Overall Study|Others|3|||
161818205|NCT01494532|584374402|FG003|Overall Study|Physician Decision|2|||
161818206|NCT01494532|584374403|FG004|Overall Study|Physician Decision|0|||
161818207|NCT01494532|584374404|FG005|Overall Study|Physician Decision|0|||
161818208|NCT01494532|584374399|FG000|Overall Study|Withdrawal by Subject|3|||
161818209|NCT01494532|584374400|FG001|Overall Study|Withdrawal by Subject|1|||
161818210|NCT01494532|584374401|FG002|Overall Study|Withdrawal by Subject|4|||
162018985|NCT01621802|585124818|FG003|Overall Study|Others|2|||
162018986|NCT01621802|585124819|FG004|Overall Study|Others|1|||
162018987|NCT01621802|585124820|FG005|Overall Study|Others|0|||
162018988|NCT01621802|585124815|FG000|Overall Study|Lost to Follow-up|36|||
162018989|NCT01621802|585124816|FG001|Overall Study|Lost to Follow-up|16|||
162018990|NCT01621802|585124817|FG002|Overall Study|Lost to Follow-up|24|||
162018991|NCT01621802|585124818|FG003|Overall Study|Lost to Follow-up|7|||
162018992|NCT01621802|585124819|FG004|Overall Study|Lost to Follow-up|31|||
162018993|NCT01621802|585124820|FG005|Overall Study|Lost to Follow-up|11|||
162018994|NCT03790696|585124822|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
162182387|NCT00092534|585721238|FG004|Base Study Follow-Up Period|Travel|0|||
162182388|NCT00092534|585721234|FG000|Base Study Follow-Up Period|Site Closed|0|||
162182389|NCT00092534|585721235|FG001|Base Study Follow-Up Period|Site Closed|2|||
162182390|NCT00092534|585721236|FG002|Base Study Follow-Up Period|Site Closed|0|||
162182391|NCT00092534|585721237|FG003|Base Study Follow-Up Period|Site Closed|0|||
162182392|NCT00092534|585721238|FG004|Base Study Follow-Up Period|Site Closed|0|||
162182393|NCT00092534|585721234|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
162182394|NCT00092534|585721235|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
162182395|NCT00092534|585721236|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
162182396|NCT00092534|585721237|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
162182397|NCT00092534|585721238|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
162182398|NCT00092534|585721234|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
162182399|NCT00092534|585721235|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
162182400|NCT00092534|585721236|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
162182401|NCT00092534|585721237|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
162182402|NCT00092534|585721238|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
162182403|NCT00092534|585721234|FG000|Base Study EXT|Lost to Follow-up|0|||
162182404|NCT00092534|585721235|FG001|Base Study EXT|Lost to Follow-up|0|||
162182405|NCT00092534|585721236|FG002|Base Study EXT|Lost to Follow-up|41|||
162182406|NCT00092534|585721237|FG003|Base Study EXT|Lost to Follow-up|0|||
162182407|NCT00092534|585721238|FG004|Base Study EXT|Lost to Follow-up|0|||
162182408|NCT00092534|585721234|FG000|Base Study EXT|Physician Decision|0|||
162182409|NCT00092534|585721235|FG001|Base Study EXT|Physician Decision|0|||
162182410|NCT00092534|585721236|FG002|Base Study EXT|Physician Decision|1|||
162182411|NCT00092534|585721237|FG003|Base Study EXT|Physician Decision|0|||
162182412|NCT00092534|585721238|FG004|Base Study EXT|Physician Decision|0|||
162182413|NCT00092534|585721234|FG000|Base Study EXT|Pregnancy|0|||
162182414|NCT00092534|585721235|FG001|Base Study EXT|Pregnancy|0|||
162182415|NCT00092534|585721236|FG002|Base Study EXT|Pregnancy|12|||
162182416|NCT00092534|585721237|FG003|Base Study EXT|Pregnancy|0|||
162182417|NCT00092534|585721238|FG004|Base Study EXT|Pregnancy|0|||
162182418|NCT00092534|585721234|FG000|Base Study EXT|Withdrawal by Subject|0|||
162182419|NCT00092534|585721235|FG001|Base Study EXT|Withdrawal by Subject|0|||
162182420|NCT00092534|585721236|FG002|Base Study EXT|Withdrawal by Subject|18|||
162182421|NCT00092534|585721237|FG003|Base Study EXT|Withdrawal by Subject|0|||
162182422|NCT00092534|585721238|FG004|Base Study EXT|Withdrawal by Subject|0|||
162182423|NCT00092534|585721234|FG000|Base Study EXT|Participant moved|0|||
162182424|NCT00092534|585721235|FG001|Base Study EXT|Participant moved|0|||
162182425|NCT00092534|585721236|FG002|Base Study EXT|Participant moved|6|||
162182426|NCT00092534|585721237|FG003|Base Study EXT|Participant moved|0|||
162182427|NCT00092534|585721238|FG004|Base Study EXT|Participant moved|0|||
162182428|NCT00092534|585721234|FG000|Base Study EXT|Travel|0|||
162182429|NCT00092534|585721235|FG001|Base Study EXT|Travel|0|||
162182430|NCT00092534|585721236|FG002|Base Study EXT|Travel|2|||
161924257|NCT03928704|584769614|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
161924258|NCT03928704|584769615|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
161924259|NCT03928704|584769610|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
161924260|NCT03928704|584769611|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
161924261|NCT03928704|584769612|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
161924262|NCT03928704|584769613|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
161924263|NCT03928704|584769614|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
161924264|NCT03928704|584769615|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
161924265|NCT03928704|584769610|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
161924266|NCT03928704|584769611|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
161924267|NCT03928704|584769612|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
161924268|NCT03928704|584769613|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
161924269|NCT03928704|584769614|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
161924270|NCT03928704|584769615|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
161924271|NCT03928704|584769610|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
162182431|NCT00092534|585721237|FG003|Base Study EXT|Travel|0|||
162182432|NCT00092534|585721238|FG004|Base Study EXT|Travel|0|||
162182433|NCT00092534|585721234|FG000|Base Study EXT|Site closed|0|||
162182434|NCT00092534|585721235|FG001|Base Study EXT|Site closed|0|||
162182435|NCT00092534|585721236|FG002|Base Study EXT|Site closed|21|||
161924272|NCT03928704|584769611|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
162182436|NCT00092534|585721237|FG003|Base Study EXT|Site closed|0|||
162182437|NCT00092534|585721238|FG004|Base Study EXT|Site closed|0|||
162182438|NCT00092534|585721234|FG000|Base Study EXT|Study ended|0|||
162182439|NCT00092534|585721235|FG001|Base Study EXT|Study ended|0|||
162182440|NCT00092534|585721236|FG002|Base Study EXT|Study ended|29|||
161924273|NCT03928704|584769612|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
161924274|NCT03928704|584769613|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
162182441|NCT00092534|585721237|FG003|Base Study EXT|Study ended|0|||
162182442|NCT00092534|585721238|FG004|Base Study EXT|Study ended|0|||
162182443|NCT00092534|585721234|FG000|Base Study EXT|Protocol Violation|0|||
162018995|NCT03790696|585124823|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
162018996|NCT01149148|585124824|FG000|Overall Study|Lost to Follow-up|1|||
162018997|NCT01149148|585124825|FG001|Overall Study|Lost to Follow-up|2|||
162018998|NCT01149148|585124824|FG000|Overall Study|Death|1|||
162018999|NCT01149148|585124825|FG001|Overall Study|Death|0|||
162019000|NCT04896086|585124826|FG000|Overall Study|Lost to Follow-up|0|||
162019001|NCT04896086|585124827|FG001|Overall Study|Lost to Follow-up|2|||
162019002|NCT04896086|585124828|FG002|Overall Study|Lost to Follow-up|1|||
162019003|NCT04896086|585124829|FG003|Overall Study|Lost to Follow-up|0|||
162019004|NCT04896086|585124830|FG004|Overall Study|Lost to Follow-up|0|||
162019005|NCT04896086|585124826|FG000|Overall Study|Physician Decision|0|||
162019006|NCT04896086|585124827|FG001|Overall Study|Physician Decision|1|||
162019007|NCT04896086|585124828|FG002|Overall Study|Physician Decision|0|||
162019008|NCT04896086|585124829|FG003|Overall Study|Physician Decision|0|||
162019009|NCT04896086|585124830|FG004|Overall Study|Physician Decision|0|||
162019010|NCT04896086|585124826|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
162019011|NCT04896086|585124827|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
162019012|NCT04896086|585124828|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
162019013|NCT04896086|585124829|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
162019014|NCT04896086|585124830|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
162019015|NCT04896086|585124826|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
162019016|NCT04896086|585124827|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
162019017|NCT04896086|585124828|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
162019018|NCT04896086|585124829|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
162019019|NCT04896086|585124830|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
162019020|NCT02249832|585124831|FG000|Overall Study|Withdrawal by Subject|3|||
162019021|NCT02249832|585124831|FG000|Overall Study|Lost to Follow-up|10|||
162019022|NCT00243269|585124832|FG000|Overall Study|Protocol Violation|2|||
162019023|NCT00243269|585124833|FG001|Overall Study|Protocol Violation|1|||
162019024|NCT00243269|585124834|FG002|Overall Study|Protocol Violation|0|||
162019025|NCT00243269|585124835|FG003|Overall Study|Protocol Violation|1|||
162019026|NCT00243269|585124832|FG000|Overall Study|Lost to Follow-up|1|||
162019027|NCT00243269|585124833|FG001|Overall Study|Lost to Follow-up|0|||
162019028|NCT00243269|585124834|FG002|Overall Study|Lost to Follow-up|1|||
162019029|NCT00243269|585124835|FG003|Overall Study|Lost to Follow-up|3|||
162019030|NCT00485134|585124841|FG000|Overall Study|Lost to Follow-up|1|||
162019031|NCT00485134|585124842|FG001|Overall Study|Lost to Follow-up|0|||
162019032|NCT00485134|585124843|FG002|Overall Study|Lost to Follow-up|0|||
162019033|NCT00485134|585124844|FG003|Overall Study|Lost to Follow-up|0|||
162019034|NCT00485134|585124845|FG004|Overall Study|Lost to Follow-up|0|||
162019035|NCT00485134|585124846|FG005|Overall Study|Lost to Follow-up|0|||
162019036|NCT00485134|585124847|FG006|Overall Study|Lost to Follow-up|0|||
162019037|NCT00485134|585124848|FG007|Overall Study|Lost to Follow-up|0|||
162019038|NCT00485134|585124841|FG000|Overall Study|Withdrawal by Subject|0|||
162019039|NCT00485134|585124842|FG001|Overall Study|Withdrawal by Subject|1|||
162019040|NCT00485134|585124843|FG002|Overall Study|Withdrawal by Subject|0|||
162019041|NCT00485134|585124844|FG003|Overall Study|Withdrawal by Subject|0|||
162019042|NCT00485134|585124845|FG004|Overall Study|Withdrawal by Subject|0|||
162019043|NCT00485134|585124846|FG005|Overall Study|Withdrawal by Subject|0|||
162019044|NCT00485134|585124847|FG006|Overall Study|Withdrawal by Subject|0|||
162019045|NCT00485134|585124848|FG007|Overall Study|Withdrawal by Subject|0|||
162019046|NCT00485134|585124841|FG000|Overall Study|Change in health status|0|||
162019047|NCT00485134|585124842|FG001|Overall Study|Change in health status|1|||
162019048|NCT00485134|585124843|FG002|Overall Study|Change in health status|2|||
162019049|NCT00485134|585124844|FG003|Overall Study|Change in health status|1|||
162019050|NCT00485134|585124845|FG004|Overall Study|Change in health status|0|||
161818211|NCT01494532|584374402|FG003|Overall Study|Withdrawal by Subject|3|||
161818212|NCT01494532|584374403|FG004|Overall Study|Withdrawal by Subject|2|||
162019051|NCT00485134|585124846|FG005|Overall Study|Change in health status|1|||
162019052|NCT00485134|585124847|FG006|Overall Study|Change in health status|0|||
162019053|NCT00485134|585124848|FG007|Overall Study|Change in health status|0|||
162019054|NCT00485134|585124841|FG000|Overall Study|Withdrew for adverse event|0|||
162019055|NCT00485134|585124842|FG001|Overall Study|Withdrew for adverse event|0|||
162019056|NCT00485134|585124843|FG002|Overall Study|Withdrew for adverse event|1|||
162019057|NCT00485134|585124844|FG003|Overall Study|Withdrew for adverse event|0|||
162182444|NCT00092534|585721235|FG001|Base Study EXT|Protocol Violation|0|||
162182445|NCT00092534|585721236|FG002|Base Study EXT|Protocol Violation|15|||
162182446|NCT00092534|585721237|FG003|Base Study EXT|Protocol Violation|0|||
162182447|NCT00092534|585721238|FG004|Base Study EXT|Protocol Violation|0|||
162182448|NCT00092534|585721234|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
162182449|NCT00092534|585721235|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
162182450|NCT00092534|585721236|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
162182451|NCT00092534|585721237|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
162182452|NCT00092534|585721238|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
162182453|NCT03083366|585721239|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
162182454|NCT03083366|585721240|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
162182455|NCT03083366|585721239|FG000|Enrollment Period|Lack of Efficacy|1|||
162182456|NCT03083366|585721240|FG001|Enrollment Period|Lack of Efficacy|0|||
162182457|NCT03752684|585721247|FG000|Overall Study|Lost to Follow-up|4|||
162182458|NCT00048932|585721250|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
162182459|NCT00048932|585721251|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
162182460|NCT00048932|585721252|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
162182461|NCT00048932|585721250|FG000|Double Blind Period (DB)|Adverse Event|51|||
162182462|NCT00048932|585721251|FG001|Double Blind Period (DB)|Adverse Event|19|||
162182463|NCT00048932|585721252|FG002|Double Blind Period (DB)|Adverse Event|0|||
162182464|NCT00048932|585721250|FG000|Double Blind Period (DB)|Death|5|||
162182465|NCT00048932|585721251|FG001|Double Blind Period (DB)|Death|3|||
162182466|NCT00048932|585721252|FG002|Double Blind Period (DB)|Death|0|||
162182467|NCT00048932|585721250|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
162182468|NCT00048932|585721251|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
161818213|NCT01494532|584374404|FG005|Overall Study|Withdrawal by Subject|0|||
161672343|NCT03153111|583853110|FG000|Overall Study|Physician Decision|5|||
161672344|NCT03153111|583853111|FG001|Overall Study|Physician Decision|1|||
161672345|NCT03153111|583853110|FG000|Overall Study|Withdrawal by Subject|3|||
161672346|NCT03153111|583853111|FG001|Overall Study|Withdrawal by Subject|3|||
161818214|NCT00679081|584374405|FG000|Overall Study|Lost to Follow-up|1|||
161818215|NCT01404988|584374410|FG000|Overall Study|Death|2|||
161818216|NCT01404988|584374411|FG001|Overall Study|Death|0|||
162182469|NCT00048932|585721252|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
162182470|NCT00048932|585721250|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
162182471|NCT00048932|585721251|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
161818217|NCT01404988|584374412|FG002|Overall Study|Death|2|||
161818218|NCT01404988|584374410|FG000|Overall Study|Adverse Event|1|||
161818219|NCT01404988|584374411|FG001|Overall Study|Adverse Event|0|||
161818220|NCT01404988|584374412|FG002|Overall Study|Adverse Event|0|||
161818221|NCT01404988|584374410|FG000|Overall Study|Withdrawal by Subject|2|||
161818222|NCT01404988|584374411|FG001|Overall Study|Withdrawal by Subject|2|||
161818223|NCT01404988|584374412|FG002|Overall Study|Withdrawal by Subject|0|||
161818224|NCT01404988|584374410|FG000|Overall Study|Lost to Follow-up|1|||
161818225|NCT01404988|584374411|FG001|Overall Study|Lost to Follow-up|2|||
162182472|NCT00048932|585721252|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
162182473|NCT00048932|585721250|FG000|Double Blind Period (DB)|Relocation|1|||
162182474|NCT00048932|585721251|FG001|Double Blind Period (DB)|Relocation|0|||
162182475|NCT00048932|585721252|FG002|Double Blind Period (DB)|Relocation|0|||
162182476|NCT00048932|585721250|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
162182477|NCT00048932|585721251|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
162182478|NCT00048932|585721252|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
162182479|NCT00048932|585721250|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
162182480|NCT00048932|585721251|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
162182481|NCT00048932|585721252|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
162182482|NCT00048932|585721250|FG000|Double Blind Period (DB)|Pregnancy|1|||
162182483|NCT00048932|585721251|FG001|Double Blind Period (DB)|Pregnancy|0|||
162182484|NCT00048932|585721252|FG002|Double Blind Period (DB)|Pregnancy|0|||
162182485|NCT00048932|585721250|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
162182486|NCT00048932|585721251|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
162182487|NCT00048932|585721252|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
162182488|NCT00048932|585721250|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
162182489|NCT00048932|585721251|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
162182490|NCT00048932|585721252|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
162182491|NCT00048932|585721250|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
162182492|NCT00048932|585721251|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
162182493|NCT00048932|585721252|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
162182494|NCT00048932|585721250|FG000|Open Label Period (OL)|Death|0|||
162182495|NCT00048932|585721251|FG001|Open Label Period (OL)|Death|0|||
162182496|NCT00048932|585721252|FG002|Open Label Period (OL)|Death|25|||
161818226|NCT01404988|584374412|FG002|Overall Study|Lost to Follow-up|1|||
161818227|NCT04594252|584374413|FG000|Overall Study|Adverse Event|0|||
161818228|NCT04594252|584374414|FG001|Overall Study|Adverse Event|2|||
161672347|NCT02684357|583853112|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
161672348|NCT02684357|583853113|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
161672349|NCT02684357|583853114|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
161672350|NCT02684357|583853115|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
161672351|NCT02684357|583853116|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
161672352|NCT02684357|583853117|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
161672353|NCT02684357|583853112|FG000|Part A|Lost to Follow-up|0|||
161818229|NCT01109849|584376003|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
161818230|NCT01109849|584376004|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
161818231|NCT01109849|584376005|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
161818232|NCT01109849|584376006|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
161818233|NCT01109849|584376007|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
161818234|NCT01109849|584376003|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
161818235|NCT01109849|584376004|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
161818236|NCT01109849|584376005|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
161818237|NCT01109849|584376006|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
161818238|NCT01109849|584376007|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
161818239|NCT01109849|584376003|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
161818240|NCT01109849|584376004|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
161818241|NCT01109849|584376005|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
161924275|NCT03928704|584769614|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
161924276|NCT03928704|584769615|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
161924277|NCT03928704|584769610|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
161924278|NCT03928704|584769611|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
161924279|NCT03928704|584769612|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
161924280|NCT03928704|584769613|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
161924281|NCT03928704|584769614|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
161924282|NCT03928704|584769615|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
161818242|NCT01109849|584376006|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
161672354|NCT02684357|583853113|FG001|Part A|Lost to Follow-up|2|||
161924283|NCT01631188|584769616|FG000|Overall Study|Physician Decision|75|||
161924284|NCT04575324|584769620|FG000|Overall Study|Lost to Follow-up|29|||
161924285|NCT04575324|584769621|FG001|Overall Study|Lost to Follow-up|25|||
161924286|NCT04575324|584769620|FG000|Overall Study|Death|1|||
161924287|NCT04575324|584769621|FG001|Overall Study|Death|2|||
161924288|NCT04575324|584769620|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
161924289|NCT04575324|584769621|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
161924290|NCT01105130|584769622|FG000|Overall Study|Withdrawal by Subject|4|||
161924291|NCT01105130|584769623|FG001|Overall Study|Withdrawal by Subject|6|||
161924292|NCT01105130|584769624|FG002|Overall Study|Withdrawal by Subject|2|||
161924293|NCT01105130|584769622|FG000|Overall Study|Never Started|2|||
161924294|NCT01105130|584769623|FG001|Overall Study|Never Started|2|||
161924295|NCT01105130|584769624|FG002|Overall Study|Never Started|4|||
161924296|NCT01105130|584769622|FG000|Overall Study|Toxicity|1|||
161924297|NCT01105130|584769623|FG001|Overall Study|Toxicity|3|||
161924298|NCT01105130|584769624|FG002|Overall Study|Toxicity|2|||
161924299|NCT01105130|584769622|FG000|Overall Study|Multiple Reasons|3|||
161924300|NCT01105130|584769623|FG001|Overall Study|Multiple Reasons|0|||
161924301|NCT01105130|584769624|FG002|Overall Study|Multiple Reasons|2|||
161924302|NCT02582632|584769626|FG000|Overall Study|Other|1|||
161924303|NCT02323334|584769627|FG000|Period 3|Lost to Follow-up|0|||
161924304|NCT02323334|584769628|FG001|Period 3|Lost to Follow-up|0|||
161924305|NCT02323334|584769629|FG002|Period 3|Lost to Follow-up|1|||
161924306|NCT02323334|584769630|FG003|Period 3|Lost to Follow-up|0|||
161924307|NCT02323334|584769631|FG004|Period 3|Lost to Follow-up|0|||
161924308|NCT02323334|584769632|FG005|Period 3|Lost to Follow-up|0|||
161924309|NCT02323334|584769633|FG006|Period 3|Lost to Follow-up|0|||
161924310|NCT02323334|584769634|FG007|Period 3|Lost to Follow-up|0|||
161924311|NCT02323334|584769635|FG008|Period 3|Lost to Follow-up|0|||
161924312|NCT02323334|584769636|FG009|Period 3|Lost to Follow-up|0|||
161924313|NCT02323334|584769637|FG010|Period 3|Lost to Follow-up|0|||
161924314|NCT02323334|584769638|FG011|Period 3|Lost to Follow-up|0|||
161924315|NCT02323334|584769639|FG012|Period 3|Lost to Follow-up|0|||
161924316|NCT02323334|584769640|FG013|Period 3|Lost to Follow-up|0|||
161924317|NCT02323334|584769641|FG014|Period 3|Lost to Follow-up|0|||
161924318|NCT02323334|584769642|FG015|Period 3|Lost to Follow-up|0|||
161924319|NCT02323334|584769643|FG016|Period 3|Lost to Follow-up|0|||
161924320|NCT02323334|584769627|FG000|Period 3|Withdrawal by Subject|1|||
161924321|NCT02323334|584769628|FG001|Period 3|Withdrawal by Subject|0|||
161924322|NCT02323334|584769629|FG002|Period 3|Withdrawal by Subject|0|||
161924323|NCT02323334|584769630|FG003|Period 3|Withdrawal by Subject|0|||
161924324|NCT02323334|584769631|FG004|Period 3|Withdrawal by Subject|0|||
161924325|NCT02323334|584769632|FG005|Period 3|Withdrawal by Subject|0|||
161672355|NCT02684357|583853114|FG002|Part A|Lost to Follow-up|2|||
161672356|NCT02684357|583853115|FG003|Part A|Lost to Follow-up|0|||
161672357|NCT02684357|583853116|FG004|Part A|Lost to Follow-up|0|||
161672358|NCT02684357|583853117|FG005|Part A|Lost to Follow-up|0|||
161672359|NCT02684357|583853112|FG000|Part A|Withdrawal by Subject|3|||
161672360|NCT02684357|583853113|FG001|Part A|Withdrawal by Subject|0|||
162019058|NCT00485134|585124845|FG004|Overall Study|Withdrew for adverse event|0|||
162019059|NCT00485134|585124846|FG005|Overall Study|Withdrew for adverse event|0|||
162019060|NCT00485134|585124847|FG006|Overall Study|Withdrew for adverse event|0|||
162019061|NCT00485134|585124848|FG007|Overall Study|Withdrew for adverse event|0|||
162019062|NCT00485134|585124841|FG000|Overall Study|Positive drug test|0|||
162019063|NCT00485134|585124842|FG001|Overall Study|Positive drug test|0|||
162019064|NCT00485134|585124843|FG002|Overall Study|Positive drug test|0|||
162019065|NCT00485134|585124844|FG003|Overall Study|Positive drug test|0|||
162019066|NCT00485134|585124845|FG004|Overall Study|Positive drug test|2|||
162019067|NCT00485134|585124846|FG005|Overall Study|Positive drug test|1|||
162019068|NCT00485134|585124847|FG006|Overall Study|Positive drug test|0|||
162019069|NCT00485134|585124848|FG007|Overall Study|Positive drug test|0|||
162019070|NCT00485134|585124841|FG000|Overall Study|Non-compliance|0|||
162019071|NCT00485134|585124842|FG001|Overall Study|Non-compliance|0|||
162019072|NCT00485134|585124843|FG002|Overall Study|Non-compliance|0|||
162019073|NCT00485134|585124844|FG003|Overall Study|Non-compliance|0|||
162019074|NCT00485134|585124845|FG004|Overall Study|Non-compliance|1|||
162019075|NCT00485134|585124846|FG005|Overall Study|Non-compliance|2|||
162019076|NCT00485134|585124847|FG006|Overall Study|Non-compliance|2|||
162019077|NCT00485134|585124848|FG007|Overall Study|Non-compliance|0|||
162019078|NCT00485134|585124841|FG000|Overall Study|Unable to comply with study schedule|0|||
162019079|NCT00485134|585124842|FG001|Overall Study|Unable to comply with study schedule|0|||
162019080|NCT00485134|585124843|FG002|Overall Study|Unable to comply with study schedule|0|||
162019081|NCT00485134|585124844|FG003|Overall Study|Unable to comply with study schedule|0|||
162019082|NCT00485134|585124845|FG004|Overall Study|Unable to comply with study schedule|0|||
162019083|NCT00485134|585124846|FG005|Overall Study|Unable to comply with study schedule|0|||
162019084|NCT00485134|585124847|FG006|Overall Study|Unable to comply with study schedule|0|||
162019085|NCT00485134|585124848|FG007|Overall Study|Unable to comply with study schedule|1|||
162019086|NCT00485134|585124841|FG000|Overall Study|Pregnancy|0|||
162019087|NCT00485134|585124842|FG001|Overall Study|Pregnancy|0|||
162019088|NCT00485134|585124843|FG002|Overall Study|Pregnancy|0|||
162019089|NCT00485134|585124844|FG003|Overall Study|Pregnancy|0|||
162019090|NCT00485134|585124845|FG004|Overall Study|Pregnancy|0|||
162019091|NCT00485134|585124846|FG005|Overall Study|Pregnancy|0|||
162019092|NCT00485134|585124847|FG006|Overall Study|Pregnancy|1|||
162019093|NCT00485134|585124848|FG007|Overall Study|Pregnancy|0|||
162019094|NCT00970684|585124849|FG000|Overall Study|Lack of Efficacy|5|||
162019095|NCT00970684|585124849|FG000|Overall Study|Adverse Event|4|||
162019096|NCT00970684|585124849|FG000|Overall Study|Withdrawal by Subject|1|||
162019097|NCT00481091|585124850|FG000|Overall Study|Withdrawal by Subject|0|||
162019098|NCT00481091|585124851|FG001|Overall Study|Withdrawal by Subject|1|||
162019099|NCT00481091|585124852|FG002|Overall Study|Withdrawal by Subject|1|||
162019100|NCT00481091|585124853|FG003|Overall Study|Withdrawal by Subject|0|||
162019101|NCT00481091|585124854|FG004|Overall Study|Withdrawal by Subject|0|||
162019102|NCT00481091|585124855|FG005|Overall Study|Withdrawal by Subject|0|||
162019103|NCT00481091|585124856|FG006|Overall Study|Withdrawal by Subject|0|||
162019104|NCT00481091|585124857|FG007|Overall Study|Withdrawal by Subject|0|||
162019105|NCT00481091|585124858|FG008|Overall Study|Withdrawal by Subject|1|||
162019106|NCT00481091|585124859|FG009|Overall Study|Withdrawal by Subject|6|||
162019107|NCT00481091|585124850|FG000|Overall Study|Other, Not Specified|0|||
162019108|NCT00481091|585124851|FG001|Overall Study|Other, Not Specified|1|||
162019109|NCT00481091|585124852|FG002|Overall Study|Other, Not Specified|1|||
162019110|NCT00481091|585124853|FG003|Overall Study|Other, Not Specified|0|||
162019111|NCT00481091|585124854|FG004|Overall Study|Other, Not Specified|0|||
162019112|NCT00481091|585124855|FG005|Overall Study|Other, Not Specified|1|||
162019113|NCT00481091|585124856|FG006|Overall Study|Other, Not Specified|0|||
162019114|NCT00481091|585124857|FG007|Overall Study|Other, Not Specified|0|||
162019115|NCT00481091|585124858|FG008|Overall Study|Other, Not Specified|0|||
162019116|NCT00481091|585124859|FG009|Overall Study|Other, Not Specified|4|||
162019117|NCT00481091|585124850|FG000|Overall Study|Adverse Event|1|||
162019118|NCT00481091|585124851|FG001|Overall Study|Adverse Event|2|||
162019119|NCT00481091|585124852|FG002|Overall Study|Adverse Event|0|||
162019120|NCT00481091|585124853|FG003|Overall Study|Adverse Event|1|||
162019121|NCT00481091|585124854|FG004|Overall Study|Adverse Event|1|||
162019122|NCT00481091|585124855|FG005|Overall Study|Adverse Event|1|||
162019123|NCT00481091|585124856|FG006|Overall Study|Adverse Event|2|||
162019124|NCT00481091|585124857|FG007|Overall Study|Adverse Event|1|||
162019125|NCT00481091|585124858|FG008|Overall Study|Adverse Event|1|||
162019126|NCT00481091|585124859|FG009|Overall Study|Adverse Event|6|||
162019127|NCT00481091|585124850|FG000|Overall Study|Progressive disease clinical|0|||
161672361|NCT02684357|583853114|FG002|Part A|Withdrawal by Subject|0|||
161672362|NCT02684357|583853115|FG003|Part A|Withdrawal by Subject|0|||
162182497|NCT00048932|585721250|FG000|Open Label Period (OL)|Adverse Event|0|||
162182498|NCT00048932|585721251|FG001|Open Label Period (OL)|Adverse Event|0|||
162182499|NCT00048932|585721252|FG002|Open Label Period (OL)|Adverse Event|103|||
162182500|NCT00048932|585721250|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
162182501|NCT00048932|585721251|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
162182502|NCT00048932|585721252|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
162182503|NCT00048932|585721250|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
162182504|NCT00048932|585721251|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
162182505|NCT00048932|585721252|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
162182506|NCT00048932|585721250|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
162182507|NCT00048932|585721251|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
162182508|NCT00048932|585721252|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
162182509|NCT00048932|585721250|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
162182510|NCT00048932|585721251|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
162182511|NCT00048932|585721252|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
162182512|NCT00048932|585721250|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
162182513|NCT00048932|585721251|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
162182514|NCT00048932|585721252|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
162182515|NCT00048932|585721250|FG000|Open Label Period (OL)|Pregnancy|0|||
162182516|NCT00048932|585721251|FG001|Open Label Period (OL)|Pregnancy|0|||
162182517|NCT00048932|585721252|FG002|Open Label Period (OL)|Pregnancy|6|||
162182518|NCT00048932|585721250|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
162182519|NCT00048932|585721251|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
162182520|NCT00048932|585721252|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
162182521|NCT00048932|585721250|FG000|Open Label Period (OL)|Investigator Retiring|0|||
162182522|NCT00048932|585721251|FG001|Open Label Period (OL)|Investigator Retiring|0|||
162182523|NCT00048932|585721252|FG002|Open Label Period (OL)|Investigator Retiring|2|||
162182524|NCT00048932|585721250|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
162182525|NCT00048932|585721251|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
162182526|NCT00048932|585721252|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
162182527|NCT00048932|585721250|FG000|Open Label Period (OL)|Participant Relocated|0|||
162182528|NCT00048932|585721251|FG001|Open Label Period (OL)|Participant Relocated|0|||
162182529|NCT00048932|585721252|FG002|Open Label Period (OL)|Participant Relocated|6|||
162182530|NCT00048932|585721250|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
162182531|NCT00048932|585721251|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
162182532|NCT00048932|585721252|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
162182533|NCT00048932|585721250|FG000|Open Label Period (OL)|Site Closure|0|||
162182534|NCT00048932|585721251|FG001|Open Label Period (OL)|Site Closure|0|||
162182535|NCT00048932|585721252|FG002|Open Label Period (OL)|Site Closure|3|||
162182536|NCT00048932|585721250|FG000|Open Label Period (OL)|Trial Terminated|0|||
162182537|NCT00048932|585721251|FG001|Open Label Period (OL)|Trial Terminated|0|||
162182538|NCT00048932|585721252|FG002|Open Label Period (OL)|Trial Terminated|1|||
162182539|NCT00048932|585721250|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
162182540|NCT00048932|585721251|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
162182541|NCT00048932|585721252|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
162182542|NCT00048932|585721250|FG000|Open Label Period (OL)|Patient Decision|0|||
162182543|NCT00048932|585721251|FG001|Open Label Period (OL)|Patient Decision|0|||
162182544|NCT00048932|585721252|FG002|Open Label Period (OL)|Patient Decision|4|||
162182545|NCT00048932|585721250|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
162182546|NCT00048932|585721251|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
162182547|NCT00048932|585721252|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
162182548|NCT00048932|585721250|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
162182549|NCT00048932|585721251|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
162182550|NCT00048932|585721252|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
162182551|NCT00048932|585721250|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
162182552|NCT00048932|585721251|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
162182553|NCT00048932|585721252|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
162182554|NCT00048932|585721250|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
162182555|NCT00048932|585721251|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
162182556|NCT00048932|585721252|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
162182557|NCT00048932|585721250|FG000|Open Label Period (OL)|Investigator Decision|0|||
162182558|NCT00048932|585721251|FG001|Open Label Period (OL)|Investigator Decision|0|||
161818243|NCT01109849|584376007|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
161818244|NCT01109849|584376003|FG000|Initial Randomization: ADHD Treatment|move away|2|||
161818245|NCT01109849|584376004|FG001|Initial Randomization: ADHD Treatment|move away|7|||
161818246|NCT01109849|584376005|FG002|Initial Randomization: ADHD Treatment|move away|0|||
162182559|NCT00048932|585721252|FG002|Open Label Period (OL)|Investigator Decision|4|||
161818247|NCT01109849|584376006|FG003|Initial Randomization: ADHD Treatment|move away|0|||
161818248|NCT01109849|584376007|FG004|Initial Randomization: ADHD Treatment|move away|0|||
162182560|NCT00048932|585721250|FG000|Open Label Period (OL)|Site Staff Issues|0|||
162182561|NCT00048932|585721251|FG001|Open Label Period (OL)|Site Staff Issues|0|||
162182562|NCT00048932|585721252|FG002|Open Label Period (OL)|Site Staff Issues|2|||
162182563|NCT00048932|585721250|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
162182564|NCT00048932|585721251|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
162182565|NCT00048932|585721252|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
162182566|NCT00048932|585721250|FG000|Open Label Period (OL)|Participant Surgery|0|||
162182567|NCT00048932|585721251|FG001|Open Label Period (OL)|Participant Surgery|0|||
162182568|NCT00048932|585721252|FG002|Open Label Period (OL)|Participant Surgery|1|||
162182569|NCT05250115|585721255|FG000|Overall Study|Premature study end|40|||
162182570|NCT05250115|585721255|FG000|Overall Study|Adverse Event|8|||
162182571|NCT05250115|585721255|FG000|Overall Study|Lost to Follow-up|7|||
162182572|NCT05250115|585721255|FG000|Overall Study|Withdrawal by Subject|6|||
162182573|NCT05250115|585721255|FG000|Overall Study|Withdrawal of informed consent|1|||
162182574|NCT05250115|585721255|FG000|Overall Study|Other|7|||
162182575|NCT03244800|585721257|FG000|Overall Study|Adverse Event|0|||
162182576|NCT03244800|585721258|FG001|Overall Study|Adverse Event|1|||
162182577|NCT03244800|585721259|FG002|Overall Study|Adverse Event|0|||
162182578|NCT03244800|585721260|FG003|Overall Study|Adverse Event|1|||
162182579|NCT03244800|585721257|FG000|Overall Study|Withdrew treatment|0|||
162182580|NCT03244800|585721258|FG001|Overall Study|Withdrew treatment|0|||
162182581|NCT03244800|585721259|FG002|Overall Study|Withdrew treatment|0|||
162182582|NCT03244800|585721260|FG003|Overall Study|Withdrew treatment|1|||
162182583|NCT03418922|585721262|FG000|Overall Study|Withdrawal by Subject|0|||
162182584|NCT03418922|585721263|FG001|Overall Study|Withdrawal by Subject|2|||
162182585|NCT03418922|585721262|FG000|Overall Study|Adverse Event|2|||
162182586|NCT03418922|585721263|FG001|Overall Study|Adverse Event|2|||
162182587|NCT03418922|585721262|FG000|Overall Study|Death|0|||
162182588|NCT03418922|585721263|FG001|Overall Study|Death|1|||
162182589|NCT03418922|585721262|FG000|Overall Study|Physician Decision|0|||
162182590|NCT03418922|585721263|FG001|Overall Study|Physician Decision|1|||
162182591|NCT04860505|585721264|FG000|Overall Study|Lost to Follow-up|2|||
162182592|NCT01640951|585721265|FG000|Overall Study|Adverse Event|8|||
162182593|NCT01640951|585721266|FG001|Overall Study|Adverse Event|3|||
162182594|NCT01640951|585721267|FG002|Overall Study|Adverse Event|10|||
162182595|NCT01640951|585721268|FG003|Overall Study|Adverse Event|6|||
162182596|NCT01640951|585721269|FG004|Overall Study|Adverse Event|1|||
162182597|NCT01640951|585721270|FG005|Overall Study|Adverse Event|11|||
162182598|NCT01640951|585721271|FG006|Overall Study|Adverse Event|1|||
162182599|NCT01640951|585721272|FG007|Overall Study|Adverse Event|3|||
162182600|NCT01640951|585721265|FG000|Overall Study|Lack of Efficacy|20|||
162182601|NCT01640951|585721266|FG001|Overall Study|Lack of Efficacy|1|||
162182602|NCT01640951|585721267|FG002|Overall Study|Lack of Efficacy|7|||
162182603|NCT01640951|585721268|FG003|Overall Study|Lack of Efficacy|14|||
162182604|NCT01640951|585721269|FG004|Overall Study|Lack of Efficacy|0|||
162182605|NCT01640951|585721270|FG005|Overall Study|Lack of Efficacy|6|||
162182606|NCT01640951|585721271|FG006|Overall Study|Lack of Efficacy|5|||
162182607|NCT01640951|585721272|FG007|Overall Study|Lack of Efficacy|6|||
162182608|NCT01640951|585721265|FG000|Overall Study|Lost to Follow-up|1|||
161818249|NCT01109849|584376003|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
161818250|NCT01109849|584376004|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
161818251|NCT01109849|584376005|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
161818252|NCT01109849|584376006|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
162182609|NCT01640951|585721266|FG001|Overall Study|Lost to Follow-up|0|||
161818253|NCT01109849|584376007|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
162182610|NCT01640951|585721267|FG002|Overall Study|Lost to Follow-up|6|||
162182611|NCT01640951|585721268|FG003|Overall Study|Lost to Follow-up|2|||
162182612|NCT01640951|585721269|FG004|Overall Study|Lost to Follow-up|2|||
162182613|NCT01640951|585721270|FG005|Overall Study|Lost to Follow-up|3|||
162182614|NCT01640951|585721271|FG006|Overall Study|Lost to Follow-up|1|||
162182615|NCT01640951|585721272|FG007|Overall Study|Lost to Follow-up|1|||
162182616|NCT01640951|585721265|FG000|Overall Study|Non-compliance with study treatment|0|||
162182617|NCT01640951|585721266|FG001|Overall Study|Non-compliance with study treatment|0|||
162182618|NCT01640951|585721267|FG002|Overall Study|Non-compliance with study treatment|1|||
162182619|NCT01640951|585721268|FG003|Overall Study|Non-compliance with study treatment|1|||
161818254|NCT01109849|584376003|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
161818255|NCT01109849|584376004|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
161818256|NCT01109849|584376005|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
161818257|NCT01109849|584376006|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
161818258|NCT01109849|584376007|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
161818259|NCT02485158|584376011|FG000|Overall Study|Withdrawal by Subject|3|||
161818260|NCT02485158|584376011|FG000|Overall Study|expected drug side effect|1|||
161818261|NCT01098851|584376012|FG000|Overall Study|Equipment failure|1|||
161818262|NCT01098851|584376013|FG001|Overall Study|Equipment failure|0|||
161818263|NCT03087786|584376014|FG000|Overall Study|Withdrawal by Subject|2|||
161818264|NCT03087786|584376015|FG001|Overall Study|Withdrawal by Subject|0|||
161818265|NCT04661202|584376016|FG000|Overall Study|Withdrawal by Subject|1|||
161818266|NCT04661202|584376017|FG001|Overall Study|Withdrawal by Subject|1|||
161818267|NCT04661202|584376016|FG000|Overall Study|Lack of Efficacy|2|||
161818268|NCT04661202|584376017|FG001|Overall Study|Lack of Efficacy|0|||
161818269|NCT02313558|584376018|FG000|Overall Study|Withdrawal by Subject|2|||
161818270|NCT02313558|584376019|FG001|Overall Study|Withdrawal by Subject|0|||
161818271|NCT02313558|584376018|FG000|Overall Study|Lost to Follow-up|4|||
161924326|NCT02323334|584769633|FG006|Period 3|Withdrawal by Subject|0|||
161924327|NCT02323334|584769634|FG007|Period 3|Withdrawal by Subject|0|||
161924328|NCT02323334|584769635|FG008|Period 3|Withdrawal by Subject|0|||
161924329|NCT02323334|584769636|FG009|Period 3|Withdrawal by Subject|0|||
161924330|NCT02323334|584769637|FG010|Period 3|Withdrawal by Subject|0|||
162182620|NCT01640951|585721269|FG004|Overall Study|Non-compliance with study treatment|1|||
162182621|NCT01640951|585721270|FG005|Overall Study|Non-compliance with study treatment|4|||
162182622|NCT01640951|585721271|FG006|Overall Study|Non-compliance with study treatment|1|||
162182623|NCT01640951|585721272|FG007|Overall Study|Non-compliance with study treatment|0|||
162182624|NCT01640951|585721265|FG000|Overall Study|Physician Decision|2|||
162182625|NCT01640951|585721266|FG001|Overall Study|Physician Decision|5|||
162182626|NCT01640951|585721267|FG002|Overall Study|Physician Decision|2|||
162182627|NCT01640951|585721268|FG003|Overall Study|Physician Decision|2|||
161818272|NCT02313558|584376019|FG001|Overall Study|Lost to Follow-up|4|||
161818273|NCT04158687|584376022|FG000|Overall Study|Adverse Event|2|||
161818274|NCT04158687|584376023|FG001|Overall Study|Adverse Event|3|||
161818275|NCT04158687|584376024|FG002|Overall Study|Adverse Event|0|||
161818276|NCT04158687|584376025|FG003|Overall Study|Adverse Event|3|||
161818277|NCT04158687|584376022|FG000|Overall Study|Lost to Follow-up|5|||
161818278|NCT04158687|584376023|FG001|Overall Study|Lost to Follow-up|12|||
161818279|NCT04158687|584376024|FG002|Overall Study|Lost to Follow-up|4|||
161818280|NCT04158687|584376025|FG003|Overall Study|Lost to Follow-up|5|||
161818281|NCT04158687|584376022|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
161818282|NCT04158687|584376023|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
161924331|NCT02323334|584769638|FG011|Period 3|Withdrawal by Subject|0|||
161924332|NCT02323334|584769639|FG012|Period 3|Withdrawal by Subject|0|||
161924333|NCT02323334|584769640|FG013|Period 3|Withdrawal by Subject|0|||
161924334|NCT02323334|584769641|FG014|Period 3|Withdrawal by Subject|0|||
161924335|NCT02323334|584769642|FG015|Period 3|Withdrawal by Subject|0|||
161924336|NCT02323334|584769643|FG016|Period 3|Withdrawal by Subject|0|||
161924337|NCT00266812|584769645|FG000|Overall Study|Disease Progression|9|||
161924338|NCT00266812|584769646|FG001|Overall Study|Disease Progression|3|||
161924339|NCT00266812|584769645|FG000|Overall Study|Death|5|||
161924340|NCT00266812|584769646|FG001|Overall Study|Death|4|||
161818283|NCT04158687|584376024|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
161818284|NCT04158687|584376025|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
161818285|NCT04158687|584376022|FG000|Overall Study|Non-Compliance with Study Medication|2|||
161818286|NCT04158687|584376023|FG001|Overall Study|Non-Compliance with Study Medication|2|||
161818287|NCT04158687|584376024|FG002|Overall Study|Non-Compliance with Study Medication|3|||
161924341|NCT00266812|584769645|FG000|Overall Study|Adverse Event|3|||
161924342|NCT00266812|584769646|FG001|Overall Study|Adverse Event|1|||
162182628|NCT01640951|585721269|FG004|Overall Study|Physician Decision|2|||
162182629|NCT01640951|585721270|FG005|Overall Study|Physician Decision|3|||
162182630|NCT01640951|585721271|FG006|Overall Study|Physician Decision|3|||
162182631|NCT01640951|585721272|FG007|Overall Study|Physician Decision|0|||
162182632|NCT01640951|585721265|FG000|Overall Study|Pregnancy|3|||
162182633|NCT01640951|585721266|FG001|Overall Study|Pregnancy|0|||
162182634|NCT01640951|585721267|FG002|Overall Study|Pregnancy|0|||
162182635|NCT01640951|585721268|FG003|Overall Study|Pregnancy|4|||
162182636|NCT01640951|585721269|FG004|Overall Study|Pregnancy|0|||
162182637|NCT01640951|585721270|FG005|Overall Study|Pregnancy|0|||
162182638|NCT01640951|585721271|FG006|Overall Study|Pregnancy|2|||
162182639|NCT01640951|585721272|FG007|Overall Study|Pregnancy|0|||
162182640|NCT01640951|585721265|FG000|Overall Study|Protocol Deviation|0|||
162182641|NCT01640951|585721266|FG001|Overall Study|Protocol Deviation|1|||
162182642|NCT01640951|585721267|FG002|Overall Study|Protocol Deviation|2|||
162182643|NCT01640951|585721268|FG003|Overall Study|Protocol Deviation|1|||
162182644|NCT01640951|585721269|FG004|Overall Study|Protocol Deviation|0|||
162182645|NCT01640951|585721270|FG005|Overall Study|Protocol Deviation|1|||
162182646|NCT01640951|585721271|FG006|Overall Study|Protocol Deviation|0|||
162182647|NCT01640951|585721272|FG007|Overall Study|Protocol Deviation|0|||
162182648|NCT01640951|585721265|FG000|Overall Study|Subject/Guardian decision|12|||
162182649|NCT01640951|585721266|FG001|Overall Study|Subject/Guardian decision|4|||
162182650|NCT01640951|585721267|FG002|Overall Study|Subject/Guardian decision|13|||
162182651|NCT01640951|585721268|FG003|Overall Study|Subject/Guardian decision|15|||
162182652|NCT01640951|585721269|FG004|Overall Study|Subject/Guardian decision|7|||
162182653|NCT01640951|585721270|FG005|Overall Study|Subject/Guardian decision|19|||
162182654|NCT01640951|585721271|FG006|Overall Study|Subject/Guardian decision|5|||
162182655|NCT01640951|585721272|FG007|Overall Study|Subject/Guardian decision|4|||
162182656|NCT01640951|585721265|FG000|Overall Study|Death|0|||
162182657|NCT01640951|585721266|FG001|Overall Study|Death|1|||
162182658|NCT01640951|585721267|FG002|Overall Study|Death|1|||
162182659|NCT01640951|585721268|FG003|Overall Study|Death|0|||
162182660|NCT01640951|585721269|FG004|Overall Study|Death|0|||
162182661|NCT01640951|585721270|FG005|Overall Study|Death|0|||
162182662|NCT01640951|585721271|FG006|Overall Study|Death|0|||
162182663|NCT01640951|585721272|FG007|Overall Study|Death|2|||
162182664|NCT00582972|585721273|FG000|Overall Study|Protocol Violation|2|||
162182665|NCT00293397|585721277|FG000|Overall Study|Death|2|||
162182666|NCT03631407|585721278|FG000|Overall Study|Withdrawal by Subject|3|||
162182667|NCT03631407|585721279|FG001|Overall Study|Withdrawal by Subject|2|||
162182668|NCT03631407|585721278|FG000|Overall Study|Sponsor Decision|0|||
162182669|NCT03631407|585721279|FG001|Overall Study|Sponsor Decision|2|||
162182670|NCT03631407|585721278|FG000|Overall Study|Death|16|||
162182671|NCT03631407|585721279|FG001|Overall Study|Death|16|||
162182672|NCT03631407|585721278|FG000|Overall Study|Randomized by mistake without study treatment|1|||
162182673|NCT03631407|585721279|FG001|Overall Study|Randomized by mistake without study treatment|0|||
162182674|NCT00811941|585721281|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
162182675|NCT00811941|585721282|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
162182676|NCT00811941|585721281|FG000|All Treated Patients|Adverse Event|2|||
162182677|NCT00811941|585721282|FG001|All Treated Patients|Adverse Event|43|||
162182678|NCT00811941|585721281|FG000|All Treated Patients|Lack of Efficacy|2|||
162182679|NCT00811941|585721282|FG001|All Treated Patients|Lack of Efficacy|3|||
162182680|NCT00811941|585721281|FG000|All Treated Patients|Non-compliance|1|||
162182681|NCT00811941|585721282|FG001|All Treated Patients|Non-compliance|8|||
162182682|NCT00811941|585721281|FG000|All Treated Patients|Protocol Violation|5|||
162182683|NCT00811941|585721282|FG001|All Treated Patients|Protocol Violation|17|||
162182684|NCT00811941|585721281|FG000|All Treated Patients|Withdrawal by Subject|35|||
162182685|NCT00811941|585721282|FG001|All Treated Patients|Withdrawal by Subject|94|||
162182686|NCT00811941|585721281|FG000|All Treated Patients|Lost to Follow-up|3|||
162182687|NCT00811941|585721282|FG001|All Treated Patients|Lost to Follow-up|12|||
162182688|NCT00811941|585721281|FG000|All Treated Patients|Other Reason|4|||
162182689|NCT00811941|585721282|FG001|All Treated Patients|Other Reason|14|||
162182690|NCT03802994|585721285|FG000|Overall Study|Lost to Follow-up|0|||
162182691|NCT03802994|585721286|FG001|Overall Study|Lost to Follow-up|2|||
162182692|NCT03802994|585721287|FG002|Overall Study|Lost to Follow-up|3|||
162182693|NCT03802994|585721288|FG003|Overall Study|Lost to Follow-up|2|||
162182694|NCT03802994|585721289|FG004|Overall Study|Lost to Follow-up|2|||
162182695|NCT00983294|585721295|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
162182696|NCT00983294|585721295|FG000|Colchicine With Azithromycin|Adverse Event|1|||
162182697|NCT00622700|585721296|FG000|Core Treatment Period|Randomized but Not Treated|0|||
162182698|NCT00622700|585721297|FG001|Core Treatment Period|Randomized but Not Treated|2|||
162182699|NCT00622700|585721298|FG002|Core Treatment Period|Randomized but Not Treated|2|||
162182700|NCT00622700|585721299|FG003|Core Treatment Period|Randomized but Not Treated|0|||
162182701|NCT00622700|585721300|FG004|Core Treatment Period|Randomized but Not Treated|0|||
162182702|NCT00622700|585721301|FG005|Core Treatment Period|Randomized but Not Treated|0|||
162182703|NCT00622700|585721302|FG006|Core Treatment Period|Randomized but Not Treated|0|||
162182704|NCT00622700|585721296|FG000|Core Treatment Period|Adverse Event|18|||
162182705|NCT00622700|585721297|FG001|Core Treatment Period|Adverse Event|25|||
162182706|NCT00622700|585721298|FG002|Core Treatment Period|Adverse Event|18|||
162182707|NCT00622700|585721299|FG003|Core Treatment Period|Adverse Event|0|||
162182708|NCT00622700|585721300|FG004|Core Treatment Period|Adverse Event|0|||
162182709|NCT00622700|585721301|FG005|Core Treatment Period|Adverse Event|0|||
162182710|NCT00622700|585721302|FG006|Core Treatment Period|Adverse Event|0|||
162182711|NCT00622700|585721296|FG000|Core Treatment Period|Lack of Efficacy|19|||
162182712|NCT00622700|585721297|FG001|Core Treatment Period|Lack of Efficacy|6|||
162182713|NCT00622700|585721298|FG002|Core Treatment Period|Lack of Efficacy|12|||
162182714|NCT00622700|585721299|FG003|Core Treatment Period|Lack of Efficacy|0|||
162182715|NCT00622700|585721300|FG004|Core Treatment Period|Lack of Efficacy|0|||
162182716|NCT00622700|585721301|FG005|Core Treatment Period|Lack of Efficacy|0|||
162182717|NCT00622700|585721302|FG006|Core Treatment Period|Lack of Efficacy|0|||
162182718|NCT00622700|585721296|FG000|Core Treatment Period|Lost to Follow-up|1|||
162182719|NCT00622700|585721297|FG001|Core Treatment Period|Lost to Follow-up|1|||
162182720|NCT00622700|585721298|FG002|Core Treatment Period|Lost to Follow-up|1|||
162182721|NCT00622700|585721299|FG003|Core Treatment Period|Lost to Follow-up|0|||
162182722|NCT00622700|585721300|FG004|Core Treatment Period|Lost to Follow-up|0|||
162182723|NCT00622700|585721301|FG005|Core Treatment Period|Lost to Follow-up|0|||
162182724|NCT00622700|585721302|FG006|Core Treatment Period|Lost to Follow-up|0|||
162182725|NCT00622700|585721296|FG000|Core Treatment Period|Death|1|||
162182726|NCT00622700|585721297|FG001|Core Treatment Period|Death|0|||
162182727|NCT00622700|585721298|FG002|Core Treatment Period|Death|0|||
162182728|NCT00622700|585721299|FG003|Core Treatment Period|Death|0|||
162182729|NCT00622700|585721300|FG004|Core Treatment Period|Death|0|||
162182730|NCT00622700|585721301|FG005|Core Treatment Period|Death|0|||
162182731|NCT00622700|585721302|FG006|Core Treatment Period|Death|0|||
162182732|NCT00622700|585721296|FG000|Core Treatment Period|Progressive Disease|3|||
162182733|NCT00622700|585721297|FG001|Core Treatment Period|Progressive Disease|1|||
162182734|NCT00622700|585721298|FG002|Core Treatment Period|Progressive Disease|0|||
162182735|NCT00622700|585721299|FG003|Core Treatment Period|Progressive Disease|0|||
162182736|NCT00622700|585721300|FG004|Core Treatment Period|Progressive Disease|0|||
162019128|NCT00481091|585124851|FG001|Overall Study|Progressive disease clinical|0|||
162019129|NCT00481091|585124852|FG002|Overall Study|Progressive disease clinical|0|||
162019130|NCT00481091|585124853|FG003|Overall Study|Progressive disease clinical|0|||
162019131|NCT00481091|585124854|FG004|Overall Study|Progressive disease clinical|0|||
162019132|NCT00481091|585124855|FG005|Overall Study|Progressive disease clinical|0|||
162019133|NCT00481091|585124856|FG006|Overall Study|Progressive disease clinical|0|||
162019134|NCT00481091|585124857|FG007|Overall Study|Progressive disease clinical|0|||
162019135|NCT00481091|585124858|FG008|Overall Study|Progressive disease clinical|1|||
162019136|NCT00481091|585124859|FG009|Overall Study|Progressive disease clinical|7|||
162019137|NCT00481091|585124850|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
162019138|NCT00481091|585124851|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
162019139|NCT00481091|585124852|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
162019140|NCT00481091|585124853|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
162019141|NCT00481091|585124854|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
162019142|NCT00481091|585124855|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
162019143|NCT00481091|585124856|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
162019144|NCT00481091|585124857|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
162019145|NCT00481091|585124858|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
162019146|NCT00481091|585124859|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
162019147|NCT00481091|585124850|FG000|Overall Study|Progressive disease other|1|||
162019148|NCT00481091|585124851|FG001|Overall Study|Progressive disease other|1|||
162019149|NCT00481091|585124852|FG002|Overall Study|Progressive disease other|0|||
162019150|NCT00481091|585124853|FG003|Overall Study|Progressive disease other|1|||
162019151|NCT00481091|585124854|FG004|Overall Study|Progressive disease other|1|||
162019152|NCT00481091|585124855|FG005|Overall Study|Progressive disease other|1|||
162019153|NCT00481091|585124856|FG006|Overall Study|Progressive disease other|0|||
162019154|NCT00481091|585124857|FG007|Overall Study|Progressive disease other|2|||
162019155|NCT00481091|585124858|FG008|Overall Study|Progressive disease other|0|||
162019156|NCT00481091|585124859|FG009|Overall Study|Progressive disease other|0|||
162019157|NCT00481091|585124850|FG000|Overall Study|No reason given|0|||
162019158|NCT00481091|585124851|FG001|Overall Study|No reason given|0|||
162182737|NCT00622700|585721301|FG005|Core Treatment Period|Progressive Disease|0|||
162182738|NCT00622700|585721302|FG006|Core Treatment Period|Progressive Disease|0|||
162182739|NCT00622700|585721296|FG000|Core Treatment Period|Withdrawal by Subject|12|||
162182740|NCT00622700|585721297|FG001|Core Treatment Period|Withdrawal by Subject|18|||
162182741|NCT00622700|585721298|FG002|Core Treatment Period|Withdrawal by Subject|15|||
162182742|NCT00622700|585721299|FG003|Core Treatment Period|Withdrawal by Subject|0|||
162182743|NCT00622700|585721300|FG004|Core Treatment Period|Withdrawal by Subject|0|||
162182744|NCT00622700|585721301|FG005|Core Treatment Period|Withdrawal by Subject|0|||
162182745|NCT00622700|585721302|FG006|Core Treatment Period|Withdrawal by Subject|0|||
162182746|NCT00622700|585721296|FG000|Core Treatment Period|Other than specified above|2|||
162182747|NCT00622700|585721297|FG001|Core Treatment Period|Other than specified above|2|||
162182748|NCT00622700|585721298|FG002|Core Treatment Period|Other than specified above|5|||
162182749|NCT00622700|585721299|FG003|Core Treatment Period|Other than specified above|0|||
162182750|NCT00622700|585721300|FG004|Core Treatment Period|Other than specified above|0|||
162182751|NCT00622700|585721301|FG005|Core Treatment Period|Other than specified above|0|||
162182752|NCT00622700|585721302|FG006|Core Treatment Period|Other than specified above|0|||
162182753|NCT00622700|585721296|FG000|Extension Treatment Period|Adverse Event|0|||
162182754|NCT00622700|585721297|FG001|Extension Treatment Period|Adverse Event|0|||
162182755|NCT00622700|585721298|FG002|Extension Treatment Period|Adverse Event|0|||
162182756|NCT00622700|585721299|FG003|Extension Treatment Period|Adverse Event|5|||
162182757|NCT00622700|585721300|FG004|Extension Treatment Period|Adverse Event|9|||
162182758|NCT00622700|585721301|FG005|Extension Treatment Period|Adverse Event|6|||
162182759|NCT00622700|585721302|FG006|Extension Treatment Period|Adverse Event|8|||
162182760|NCT00622700|585721296|FG000|Extension Treatment Period|Lack of Efficacy|0|||
162182761|NCT00622700|585721297|FG001|Extension Treatment Period|Lack of Efficacy|0|||
162182762|NCT00622700|585721298|FG002|Extension Treatment Period|Lack of Efficacy|0|||
162182763|NCT00622700|585721299|FG003|Extension Treatment Period|Lack of Efficacy|2|||
162182764|NCT00622700|585721300|FG004|Extension Treatment Period|Lack of Efficacy|8|||
162182765|NCT00622700|585721301|FG005|Extension Treatment Period|Lack of Efficacy|1|||
162182766|NCT00622700|585721302|FG006|Extension Treatment Period|Lack of Efficacy|9|||
162182767|NCT00622700|585721296|FG000|Extension Treatment Period|Protocol Violation|0|||
162182768|NCT00622700|585721297|FG001|Extension Treatment Period|Protocol Violation|0|||
162182769|NCT00622700|585721298|FG002|Extension Treatment Period|Protocol Violation|0|||
162182770|NCT00622700|585721299|FG003|Extension Treatment Period|Protocol Violation|0|||
162182771|NCT00622700|585721300|FG004|Extension Treatment Period|Protocol Violation|0|||
162182772|NCT00622700|585721301|FG005|Extension Treatment Period|Protocol Violation|2|||
162182773|NCT00622700|585721302|FG006|Extension Treatment Period|Protocol Violation|0|||
162182774|NCT00622700|585721296|FG000|Extension Treatment Period|Lost to Follow-up|0|||
162182775|NCT00622700|585721297|FG001|Extension Treatment Period|Lost to Follow-up|0|||
162182776|NCT00622700|585721298|FG002|Extension Treatment Period|Lost to Follow-up|0|||
162182777|NCT00622700|585721299|FG003|Extension Treatment Period|Lost to Follow-up|0|||
162182778|NCT00622700|585721300|FG004|Extension Treatment Period|Lost to Follow-up|1|||
162182779|NCT00622700|585721301|FG005|Extension Treatment Period|Lost to Follow-up|0|||
162182780|NCT00622700|585721302|FG006|Extension Treatment Period|Lost to Follow-up|0|||
162182781|NCT00622700|585721296|FG000|Extension Treatment Period|Progressive Disease|0|||
162182782|NCT00622700|585721297|FG001|Extension Treatment Period|Progressive Disease|0|||
161818288|NCT04158687|584376025|FG003|Overall Study|Non-Compliance with Study Medication|0|||
161818289|NCT04158687|584376022|FG000|Overall Study|Investigator Decision|0|||
161818290|NCT04158687|584376023|FG001|Overall Study|Investigator Decision|0|||
161818291|NCT04158687|584376024|FG002|Overall Study|Investigator Decision|2|||
161818292|NCT04158687|584376025|FG003|Overall Study|Investigator Decision|0|||
161818293|NCT04158687|584376022|FG000|Overall Study|Protocol Violation|0|||
161818294|NCT04158687|584376023|FG001|Overall Study|Protocol Violation|2|||
161818295|NCT04158687|584376024|FG002|Overall Study|Protocol Violation|1|||
161818296|NCT04158687|584376025|FG003|Overall Study|Protocol Violation|0|||
161818297|NCT04158687|584376022|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
161818298|NCT04158687|584376023|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
161818299|NCT04158687|584376024|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
161818300|NCT04158687|584376025|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
161818301|NCT04158687|584376022|FG000|Overall Study|Reason not Specified|3|||
161818302|NCT04158687|584376023|FG001|Overall Study|Reason not Specified|2|||
162182783|NCT00622700|585721298|FG002|Extension Treatment Period|Progressive Disease|0|||
162182784|NCT00622700|585721299|FG003|Extension Treatment Period|Progressive Disease|1|||
162182785|NCT00622700|585721300|FG004|Extension Treatment Period|Progressive Disease|2|||
162182786|NCT00622700|585721301|FG005|Extension Treatment Period|Progressive Disease|0|||
162182787|NCT00622700|585721302|FG006|Extension Treatment Period|Progressive Disease|2|||
162182788|NCT00622700|585721296|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
162182789|NCT00622700|585721297|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
162182790|NCT00622700|585721298|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
161818303|NCT04158687|584376024|FG002|Overall Study|Reason not Specified|4|||
161818304|NCT04158687|584376025|FG003|Overall Study|Reason not Specified|4|||
161818305|NCT02043132|584376033|FG000|Overall Study|Lost to Follow-up|1|||
161818306|NCT02043132|584376034|FG001|Overall Study|Lost to Follow-up|1|||
162182791|NCT00622700|585721299|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
162182792|NCT00622700|585721300|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
162182793|NCT00622700|585721301|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
162182794|NCT00622700|585721302|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
162182795|NCT00622700|585721296|FG000|Extension Treatment Period|Missing|0|||
162182796|NCT00622700|585721297|FG001|Extension Treatment Period|Missing|0|||
162182797|NCT00622700|585721298|FG002|Extension Treatment Period|Missing|0|||
162182798|NCT00622700|585721299|FG003|Extension Treatment Period|Missing|2|||
162182799|NCT00622700|585721300|FG004|Extension Treatment Period|Missing|3|||
162182800|NCT00622700|585721301|FG005|Extension Treatment Period|Missing|1|||
162182801|NCT00622700|585721302|FG006|Extension Treatment Period|Missing|0|||
162182802|NCT00622700|585721296|FG000|Extension Treatment Period|Other than specified above|0|||
162182803|NCT00622700|585721297|FG001|Extension Treatment Period|Other than specified above|0|||
162182804|NCT00622700|585721298|FG002|Extension Treatment Period|Other than specified above|0|||
162182805|NCT00622700|585721299|FG003|Extension Treatment Period|Other than specified above|0|||
162182806|NCT00622700|585721300|FG004|Extension Treatment Period|Other than specified above|0|||
162182807|NCT00622700|585721301|FG005|Extension Treatment Period|Other than specified above|1|||
162182808|NCT00622700|585721302|FG006|Extension Treatment Period|Other than specified above|1|||
162182809|NCT00942266|585721303|FG000|Overall Study|Withdrawal by Subject|1|||
162182810|NCT00942266|585721304|FG001|Overall Study|Withdrawal by Subject|0|||
162182811|NCT00942266|585721303|FG000|Overall Study|Adverse Event|2|||
162182812|NCT00942266|585721304|FG001|Overall Study|Adverse Event|1|||
162182813|NCT00942266|585721303|FG000|Overall Study|Disease Progression|38|||
162182814|NCT00942266|585721304|FG001|Overall Study|Disease Progression|11|||
162182815|NCT00942266|585721303|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
162182816|NCT00942266|585721304|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
162182817|NCT00942266|585721303|FG000|Overall Study|Intercurrent illness|0|||
162182818|NCT00942266|585721304|FG001|Overall Study|Intercurrent illness|1|||
162182819|NCT00942266|585721303|FG000|Overall Study|Physician Decision|2|||
162182820|NCT00942266|585721304|FG001|Overall Study|Physician Decision|0|||
162182821|NCT00942266|585721303|FG000|Overall Study|medical deterioration (pneumonia)|0|||
162182822|NCT00942266|585721304|FG001|Overall Study|medical deterioration (pneumonia)|1|||
162182823|NCT03611556|585721305|FG000|Overall Study|Death|7|||
162019159|NCT00481091|585124852|FG002|Overall Study|No reason given|1|||
162019160|NCT00481091|585124853|FG003|Overall Study|No reason given|1|||
162019161|NCT00481091|585124854|FG004|Overall Study|No reason given|1|||
162019162|NCT00481091|585124855|FG005|Overall Study|No reason given|0|||
162019163|NCT00481091|585124856|FG006|Overall Study|No reason given|1|||
162019164|NCT00481091|585124857|FG007|Overall Study|No reason given|1|||
162019165|NCT00481091|585124858|FG008|Overall Study|No reason given|1|||
162019166|NCT00481091|585124859|FG009|Overall Study|No reason given|4|||
162019167|NCT04294680|585124860|FG000|Overall Study|Withdrawal by Subject|2|||
162019168|NCT04294680|585124861|FG001|Overall Study|Withdrawal by Subject|1|||
162019169|NCT04294680|585124860|FG000|Overall Study|Follow-up visits completed outside of window|1|||
162019170|NCT04294680|585124861|FG001|Overall Study|Follow-up visits completed outside of window|0|||
162019171|NCT02078960|585124864|FG000|Treatment Period|Other|0|||
162019172|NCT02078960|585124865|FG001|Treatment Period|Other|0|||
162019173|NCT02078960|585124866|FG002|Treatment Period|Other|1|||
162019174|NCT02078960|585124864|FG000|Treatment Period|Lack of Efficacy|0|||
162019175|NCT02078960|585124865|FG001|Treatment Period|Lack of Efficacy|1|||
162019176|NCT02078960|585124866|FG002|Treatment Period|Lack of Efficacy|0|||
162019177|NCT02078960|585124864|FG000|Treatment Period|Disease progression - accelerated phase|0|||
162019178|NCT02078960|585124865|FG001|Treatment Period|Disease progression - accelerated phase|1|||
162019179|NCT02078960|585124866|FG002|Treatment Period|Disease progression - accelerated phase|0|||
162019180|NCT02078960|585124864|FG000|Treatment Period|Disease progression - blast phase|1|||
162019181|NCT02078960|585124865|FG001|Treatment Period|Disease progression - blast phase|0|||
162182824|NCT03611556|585721306|FG001|Overall Study|Death|7|||
162182825|NCT03611556|585721307|FG002|Overall Study|Death|3|||
162182826|NCT03611556|585721308|FG003|Overall Study|Death|8|||
162182827|NCT03611556|585721309|FG004|Overall Study|Death|47|||
162182828|NCT03611556|585721310|FG005|Overall Study|Death|32|||
162182829|NCT03611556|585721311|FG006|Overall Study|Death|53|||
162019182|NCT02078960|585124866|FG002|Treatment Period|Disease progression - blast phase|0|||
162182830|NCT03611556|585721305|FG000|Overall Study|Withdrawal by Subject|0|||
162182831|NCT03611556|585721306|FG001|Overall Study|Withdrawal by Subject|0|||
162182832|NCT03611556|585721307|FG002|Overall Study|Withdrawal by Subject|0|||
162019183|NCT02078960|585124864|FG000|Treatment Period|Withdrawal by Subject|0|||
162019184|NCT02078960|585124865|FG001|Treatment Period|Withdrawal by Subject|1|||
162019185|NCT02078960|585124866|FG002|Treatment Period|Withdrawal by Subject|1|||
162019186|NCT02078960|585124864|FG000|Treatment Period|Adverse Event|1|||
162019187|NCT02078960|585124865|FG001|Treatment Period|Adverse Event|0|||
162019188|NCT02078960|585124866|FG002|Treatment Period|Adverse Event|0|||
162182833|NCT03611556|585721308|FG003|Overall Study|Withdrawal by Subject|0|||
162182834|NCT03611556|585721309|FG004|Overall Study|Withdrawal by Subject|4|||
162182835|NCT03611556|585721310|FG005|Overall Study|Withdrawal by Subject|2|||
162182836|NCT03611556|585721311|FG006|Overall Study|Withdrawal by Subject|4|||
162182837|NCT03611556|585721305|FG000|Overall Study|Sponsor decision|0|||
162182838|NCT03611556|585721306|FG001|Overall Study|Sponsor decision|0|||
162182839|NCT03611556|585721307|FG002|Overall Study|Sponsor decision|0|||
162182840|NCT03611556|585721308|FG003|Overall Study|Sponsor decision|0|||
162182841|NCT03611556|585721309|FG004|Overall Study|Sponsor decision|9|||
162182842|NCT03611556|585721310|FG005|Overall Study|Sponsor decision|4|||
162182843|NCT03611556|585721311|FG006|Overall Study|Sponsor decision|12|||
162182844|NCT03611556|585721305|FG000|Overall Study|Reasons|0|||
162182845|NCT03611556|585721306|FG001|Overall Study|Reasons|0|||
162182846|NCT03611556|585721307|FG002|Overall Study|Reasons|0|||
162182847|NCT03611556|585721308|FG003|Overall Study|Reasons|0|||
162182848|NCT03611556|585721309|FG004|Overall Study|Reasons|2|||
162182849|NCT03611556|585721310|FG005|Overall Study|Reasons|0|||
162182850|NCT03611556|585721311|FG006|Overall Study|Reasons|1|||
162182851|NCT02844439|585721333|FG000|Overall Study|Withdrawal by Subject|1|||
162182852|NCT02844439|585721333|FG000|Overall Study|Lost to Follow-up|2|||
162182853|NCT02844439|585721333|FG000|Overall Study|Termination by Sponsor|4|||
162182854|NCT02844439|585721333|FG000|Overall Study|Death|28|||
162182855|NCT02844439|585721333|FG000|Overall Study|Other|5|||
162182856|NCT00390884|585721336|FG000|Overall Study|Withdrawal by Subject|2|||
162182857|NCT00390884|585721337|FG001|Overall Study|Withdrawal by Subject|2|||
162182858|NCT00756574|585721338|FG000|Overall Study|Withdrawal by Subject|9|||
162182859|NCT00756574|585721339|FG001|Overall Study|Withdrawal by Subject|7|||
162182860|NCT00756574|585721338|FG000|Overall Study|Lost to Follow-up|4|||
162182861|NCT00756574|585721339|FG001|Overall Study|Lost to Follow-up|4|||
162182862|NCT04035447|585721340|FG000|Treatment Period|Lost to Follow-up|6|||
162182863|NCT04035447|585721341|FG001|Treatment Period|Lost to Follow-up|5|||
162182864|NCT04035447|585721340|FG000|Treatment Period|Physician Decision|0|||
162182865|NCT04035447|585721341|FG001|Treatment Period|Physician Decision|2|||
162182866|NCT04622332|585721342|FG000|Overall Study|Withdrawal by Subject|4|||
162182867|NCT04622332|585721343|FG001|Overall Study|Withdrawal by Subject|2|||
162182868|NCT04622332|585721342|FG000|Overall Study|Physician Decision|1|||
162182869|NCT04622332|585721343|FG001|Overall Study|Physician Decision|1|||
162182870|NCT04622332|585721342|FG000|Overall Study|Adverse Event|0|||
162182871|NCT04622332|585721343|FG001|Overall Study|Adverse Event|2|||
162182872|NCT04622332|585721342|FG000|Overall Study|Protocol Violation|0|||
162182873|NCT04622332|585721343|FG001|Overall Study|Protocol Violation|1|||
162182874|NCT05966155|585721344|FG000|Overall Study|Death|1|||
162182875|NCT05966155|585721345|FG001|Overall Study|Death|2|||
162182876|NCT05966155|585721344|FG000|Overall Study|Lost to Follow-up|63|||
162182877|NCT05966155|585721345|FG001|Overall Study|Lost to Follow-up|67|||
162182878|NCT05966155|585721344|FG000|Overall Study|Protocol Violation|1|||
162182879|NCT05966155|585721345|FG001|Overall Study|Protocol Violation|0|||
162182880|NCT05966155|585721344|FG000|Overall Study|Withdrawal by Subject|8|||
162182881|NCT05966155|585721345|FG001|Overall Study|Withdrawal by Subject|9|||
162182882|NCT05966155|585721344|FG000|Overall Study|Enrolled Erroneously|0|||
162182883|NCT05966155|585721345|FG001|Overall Study|Enrolled Erroneously|1|||
162182884|NCT05966155|585721344|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
162182885|NCT05966155|585721345|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
162019189|NCT02078960|585124864|FG000|Treatment Period|Death|0|||
162019190|NCT02078960|585124865|FG001|Treatment Period|Death|0|||
162019191|NCT02078960|585124866|FG002|Treatment Period|Death|1|||
162019192|NCT02078960|585124864|FG000|Follow-up Period|Death|2|||
162019193|NCT02078960|585124865|FG001|Follow-up Period|Death|0|||
162019194|NCT02078960|585124866|FG002|Follow-up Period|Death|0|||
162019195|NCT02078960|585124864|FG000|Follow-up Period|Lost to Follow-up|0|||
162019196|NCT02078960|585124865|FG001|Follow-up Period|Lost to Follow-up|1|||
162019197|NCT02078960|585124866|FG002|Follow-up Period|Lost to Follow-up|0|||
162019198|NCT04605991|585124868|FG000|Overall Study|Adverse Event|5|||
162019199|NCT04605991|585124868|FG000|Overall Study|Lack of Efficacy|1|||
162019200|NCT04605991|585124868|FG000|Overall Study|Lost to Follow-up|8|||
162019201|NCT04605991|585124868|FG000|Overall Study|Physician Decision|4|||
162019202|NCT04605991|585124868|FG000|Overall Study|Withdrawal by Subject|14|||
162019203|NCT04605991|585124868|FG000|Overall Study|Non-compliance with study|1|||
162019204|NCT04881942|585124870|FG000|Overall Study|Adverse Event|0|||
162019205|NCT04881942|585124871|FG001|Overall Study|Adverse Event|0|||
162019206|NCT04881942|585124872|FG002|Overall Study|Adverse Event|0|||
162019207|NCT04881942|585124873|FG003|Overall Study|Adverse Event|0|||
162019208|NCT04881942|585124874|FG004|Overall Study|Adverse Event|1|||
162019209|NCT04881942|585124870|FG000|Overall Study|Alternates|0|||
162182886|NCT03304587|585721349|FG000|Overall Study|Headache after intervention|0|||
162182887|NCT03304587|585721350|FG001|Overall Study|Headache after intervention|1|||
162182888|NCT03304587|585721349|FG000|Overall Study|Withdrawal by Subject|1|||
162182889|NCT03304587|585721350|FG001|Overall Study|Withdrawal by Subject|0|||
162182890|NCT05036278|585721355|FG000|Overall Study|Withdrawal by Subject|1|||
162182891|NCT05036278|585721355|FG000|Overall Study|Adverse Event|1|||
162182892|NCT01458366|585721357|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
162182893|NCT01458366|585721358|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
162182894|NCT01458366|585721359|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
162182895|NCT01458366|585721360|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
162182896|NCT01458366|585721361|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
162182897|NCT01458366|585721357|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
161818307|NCT02043132|584376033|FG000|Overall Study|screen failures|4|||
162019210|NCT04881942|585124871|FG001|Overall Study|Alternates|0|||
162019211|NCT04881942|585124872|FG002|Overall Study|Alternates|0|||
162019212|NCT04881942|585124873|FG003|Overall Study|Alternates|0|||
162019213|NCT04881942|585124874|FG004|Overall Study|Alternates|2|||
162182898|NCT01458366|585721358|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
162182899|NCT01458366|585721359|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
161818308|NCT02043132|584376034|FG001|Overall Study|screen failures|8|||
162019214|NCT00859638|585124875|FG000|Overall Study|Lost to Follow-up|6|||
162182900|NCT01458366|585721360|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
162182901|NCT01458366|585721361|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
162182902|NCT04647487|585721364|FG000|Overall Study|Protocol Deviation|0|||
162182903|NCT04647487|585721365|FG001|Overall Study|Protocol Deviation|0|||
162182904|NCT04647487|585721366|FG002|Overall Study|Protocol Deviation|1|||
162182905|NCT04647487|585721364|FG000|Overall Study|Withdrawal by Subject|1|||
162182906|NCT04647487|585721365|FG001|Overall Study|Withdrawal by Subject|0|||
162182907|NCT04647487|585721366|FG002|Overall Study|Withdrawal by Subject|2|||
162182908|NCT02787005|585721367|FG000|Overall Study|Adverse Event|24|||
162182909|NCT02787005|585721368|FG001|Overall Study|Adverse Event|9|||
162182910|NCT02787005|585721369|FG002|Overall Study|Adverse Event|9|||
162182911|NCT02787005|585721370|FG003|Overall Study|Adverse Event|7|||
162182912|NCT02787005|585721371|FG004|Overall Study|Adverse Event|2|||
162182913|NCT02787005|585721367|FG000|Overall Study|Death|100|||
162182914|NCT02787005|585721368|FG001|Overall Study|Death|53|||
162182915|NCT02787005|585721369|FG002|Overall Study|Death|48|||
162182916|NCT02787005|585721370|FG003|Overall Study|Death|69|||
162182917|NCT02787005|585721371|FG004|Overall Study|Death|38|||
162182918|NCT02787005|585721367|FG000|Overall Study|Sponsor Decision|7|||
162182919|NCT02787005|585721368|FG001|Overall Study|Sponsor Decision|4|||
162182920|NCT02787005|585721369|FG002|Overall Study|Sponsor Decision|0|||
162182921|NCT02787005|585721370|FG003|Overall Study|Sponsor Decision|4|||
162182922|NCT02787005|585721371|FG004|Overall Study|Sponsor Decision|5|||
162182923|NCT02787005|585721367|FG000|Overall Study|Withdrawal by Subject|2|||
162182924|NCT02787005|585721368|FG001|Overall Study|Withdrawal by Subject|1|||
162182925|NCT02787005|585721369|FG002|Overall Study|Withdrawal by Subject|1|||
162182926|NCT02787005|585721370|FG003|Overall Study|Withdrawal by Subject|0|||
162182927|NCT02787005|585721371|FG004|Overall Study|Withdrawal by Subject|1|||
162182928|NCT02787005|585721367|FG000|Overall Study|Screen Failure|0|||
162182929|NCT02787005|585721368|FG001|Overall Study|Screen Failure|2|||
162182930|NCT02787005|585721369|FG002|Overall Study|Screen Failure|0|||
162182931|NCT02787005|585721370|FG003|Overall Study|Screen Failure|0|||
162182932|NCT02787005|585721371|FG004|Overall Study|Screen Failure|1|||
162182933|NCT02787005|585721367|FG000|Overall Study|Lost to Follow-up|0|||
162182934|NCT02787005|585721368|FG001|Overall Study|Lost to Follow-up|0|||
162182935|NCT02787005|585721369|FG002|Overall Study|Lost to Follow-up|0|||
162182936|NCT02787005|585721370|FG003|Overall Study|Lost to Follow-up|1|||
162182937|NCT02787005|585721371|FG004|Overall Study|Lost to Follow-up|0|||
162182938|NCT03890289|585721377|FG000|Overall Study|Adverse Event|1|||
162182939|NCT03890289|585721377|FG000|Overall Study|Physician Decision|1|||
162182940|NCT03890289|585721377|FG000|Overall Study|Lack of Efficacy|2|||
162182941|NCT00174252|585721384|FG000|Overall Study|Protocol Violation|2|||
162182942|NCT02744066|585721385|FG000|Overall Study|Withdrawal by parent|0|||
162182943|NCT02744066|585721386|FG001|Overall Study|Withdrawal by parent|1|||
162182944|NCT02744066|585721385|FG000|Overall Study|Discharged from NICU prior to completion|0|||
162182945|NCT02744066|585721386|FG001|Overall Study|Discharged from NICU prior to completion|4|||
162182946|NCT05509816|585721387|FG000|Overall Study|Lost to Follow-up|1|||
162182947|NCT02107261|585721394|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
162182948|NCT02107261|585721395|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
162182949|NCT02107261|585721394|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
162182950|NCT02107261|585721395|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
162182951|NCT04337931|585721397|FG000|Overall Study|Death|4|||
162182952|NCT04337931|585721398|FG001|Overall Study|Death|1|||
162182953|NCT04337931|585721399|FG002|Overall Study|Death|7|||
162182954|NCT04337931|585721397|FG000|Overall Study|Withdrawal by Subject|0|||
162182955|NCT04337931|585721398|FG001|Overall Study|Withdrawal by Subject|1|||
162182956|NCT04337931|585721399|FG002|Overall Study|Withdrawal by Subject|0|||
162182957|NCT04337931|585721397|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
162182958|NCT04337931|585721398|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
162182959|NCT04337931|585721399|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
162182960|NCT04337931|585721397|FG000|Overall Study|Study terminated by sponsor|3|||
162182961|NCT04337931|585721398|FG001|Overall Study|Study terminated by sponsor|6|||
162182962|NCT04337931|585721399|FG002|Overall Study|Study terminated by sponsor|2|||
162182963|NCT04337931|585721397|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
162182964|NCT04337931|585721398|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
162182965|NCT04337931|585721399|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
162182966|NCT04337931|585721397|FG000|Overall Study|Colorectal cancer treatment|1|||
162182967|NCT04337931|585721398|FG001|Overall Study|Colorectal cancer treatment|0|||
162182968|NCT04337931|585721399|FG002|Overall Study|Colorectal cancer treatment|0|||
162182969|NCT04337931|585721397|FG000|Overall Study|Participant decision|0|||
162182970|NCT04337931|585721398|FG001|Overall Study|Participant decision|1|||
162182971|NCT04337931|585721399|FG002|Overall Study|Participant decision|0|||
162182972|NCT01738438|585721401|FG000|Overall Study|Disease Progression|32|||
162182973|NCT01738438|585721401|FG000|Overall Study|Adverse Event|3|||
162182974|NCT02130557|585721403|FG000|Overall Study|Withdrawal by Subject|12|||
162182975|NCT02130557|585721404|FG001|Overall Study|Withdrawal by Subject|12|||
162182976|NCT02130557|585721403|FG000|Overall Study|Investigator Request|0|||
162182977|NCT02130557|585721404|FG001|Overall Study|Investigator Request|2|||
162182978|NCT02130557|585721403|FG000|Overall Study|Deceased|14|||
162182979|NCT02130557|585721404|FG001|Overall Study|Deceased|14|||
162182980|NCT02130557|585721403|FG000|Overall Study|Lost to Follow-up|6|||
162182981|NCT02130557|585721404|FG001|Overall Study|Lost to Follow-up|7|||
162182982|NCT02130557|585721403|FG000|Overall Study|Other|2|||
162182983|NCT02130557|585721404|FG001|Overall Study|Other|1|||
162182984|NCT02130557|585721403|FG000|Overall Study|Missing|2|||
162182985|NCT02130557|585721404|FG001|Overall Study|Missing|1|||
162182986|NCT02928172|585721405|FG000|Overall Study|Device did not record data|1|||
162182987|NCT01532999|585721406|FG000|Overall Study|Lost to Follow-up|14|||
162182988|NCT01532999|585721407|FG001|Overall Study|Lost to Follow-up|8|||
162182989|NCT01532999|585721406|FG000|Overall Study|Physician Decision|1|||
162182990|NCT01532999|585721407|FG001|Overall Study|Physician Decision|2|||
162182991|NCT01532999|585721406|FG000|Overall Study|Withdrawal by Subject|5|||
162182992|NCT01532999|585721407|FG001|Overall Study|Withdrawal by Subject|0|||
162182993|NCT01532999|585721406|FG000|Overall Study|Relocated|2|||
162182994|NCT01532999|585721407|FG001|Overall Study|Relocated|0|||
162182995|NCT01532999|585721406|FG000|Overall Study|should not have been randomized|1|||
162182996|NCT01532999|585721407|FG001|Overall Study|should not have been randomized|0|||
162182997|NCT01532999|585721406|FG000|Overall Study|substantial noncompliance|2|||
162182998|NCT01532999|585721407|FG001|Overall Study|substantial noncompliance|0|||
162182999|NCT01532999|585721406|FG000|Overall Study|no show for week 9 assessments|6|||
162183000|NCT01532999|585721407|FG001|Overall Study|no show for week 9 assessments|4|||
162183001|NCT01532999|585721406|FG000|Overall Study|Adverse Event|0|||
162183002|NCT01532999|585721407|FG001|Overall Study|Adverse Event|1|||
162183003|NCT01532999|585721406|FG000|Overall Study|incarcerated|0|||
162183004|NCT01532999|585721407|FG001|Overall Study|incarcerated|1|||
162183005|NCT01532999|585721406|FG000|Overall Study|New job|0|||
162183006|NCT01532999|585721407|FG001|Overall Study|New job|2|||
162183007|NCT02408887|585721408|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
162183008|NCT02408887|585721409|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
162183009|NCT02408887|585721408|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
162183010|NCT02408887|585721409|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
162183011|NCT03333109|585721411|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
162183012|NCT03333109|585721412|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
162183013|NCT03333109|585721413|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
162183014|NCT03333109|585721411|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
162183015|NCT03333109|585721412|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
162183016|NCT03333109|585721413|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
162183017|NCT03333109|585721411|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
162183018|NCT03333109|585721412|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
162183019|NCT03333109|585721413|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
162183020|NCT03333109|585721411|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
162183021|NCT03333109|585721412|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
162183022|NCT03333109|585721413|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
162183023|NCT03333109|585721411|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
162183024|NCT03333109|585721412|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
162183025|NCT03333109|585721413|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
162183026|NCT03333109|585721411|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
162183027|NCT03333109|585721412|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
162183028|NCT03333109|585721413|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
162183029|NCT03333109|585721411|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
162183030|NCT03333109|585721412|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
162183031|NCT03333109|585721413|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
162183032|NCT03333109|585721411|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
162183033|NCT03333109|585721412|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
162183034|NCT03333109|585721413|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
162183035|NCT00918203|585721414|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
162183036|NCT00918203|585721415|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
162183037|NCT00918203|585721416|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
162183038|NCT00918203|585721414|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
162183039|NCT00918203|585721415|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
162183040|NCT00918203|585721416|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
162183041|NCT00918203|585721414|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
162183042|NCT00918203|585721415|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
162183043|NCT00918203|585721416|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
162183044|NCT00918203|585721414|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
162183045|NCT00918203|585721415|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
162183046|NCT00918203|585721416|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
162183047|NCT04066075|585721419|FG000|Overall Study|Lost to Follow-up|3|||
162183048|NCT04066075|585721420|FG001|Overall Study|Lost to Follow-up|3|||
162183049|NCT04066075|585721419|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
162183050|NCT04066075|585721420|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
162183051|NCT04066075|585721419|FG000|Overall Study|Withdrawal by Subject|2|||
162183052|NCT04066075|585721420|FG001|Overall Study|Withdrawal by Subject|2|||
162183053|NCT00309166|585721421|FG000|Overall Study|Adverse event, non-fatal|1|||
162183054|NCT00309166|585721422|FG001|Overall Study|Adverse event, non-fatal|0|||
162183055|NCT00309166|585721421|FG000|Overall Study|Withdrawal by Subject|4|||
162183056|NCT00309166|585721422|FG001|Overall Study|Withdrawal by Subject|3|||
162183057|NCT00701701|585721425|FG000|Overall Study|Withdrawal by Subject|0|||
162183058|NCT00701701|585721426|FG001|Overall Study|Withdrawal by Subject|1|||
162183059|NCT00701701|585721425|FG000|Overall Study|Adverse Event|0|||
162183060|NCT00701701|585721426|FG001|Overall Study|Adverse Event|1|||
162183061|NCT03357952|585721427|FG000|Overall Study|Withdrawal by Subject|0|||
162183062|NCT03357952|585721428|FG001|Overall Study|Withdrawal by Subject|1|||
162183063|NCT03357952|585721427|FG000|Overall Study|Sponsor Decision|9|||
162183064|NCT03357952|585721428|FG001|Overall Study|Sponsor Decision|0|||
162183065|NCT02386098|585723021|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
162183066|NCT02386098|585723022|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
162183067|NCT02386098|585723023|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
162183068|NCT02386098|585723024|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
162183069|NCT02386098|585723025|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
162183070|NCT02386098|585723021|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
162183071|NCT02386098|585723022|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
162183072|NCT02386098|585723023|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
162183073|NCT02386098|585723024|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
162183074|NCT02386098|585723025|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
162183075|NCT02386098|585723021|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
162183076|NCT02386098|585723022|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
162183077|NCT02386098|585723023|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
162183078|NCT02386098|585723024|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
162183079|NCT02386098|585723025|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
162183080|NCT02386098|585723021|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
162183081|NCT02386098|585723022|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
162183082|NCT02386098|585723023|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
162183083|NCT02386098|585723024|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
162183084|NCT02386098|585723025|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
162183085|NCT02386098|585723021|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
162183086|NCT02386098|585723022|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
162183087|NCT02386098|585723023|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
162183088|NCT02386098|585723024|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
162183089|NCT02386098|585723025|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
162183090|NCT02386098|585723021|FG000|Stage 1 (96 Weeks)|Other|1|||
162183091|NCT02386098|585723022|FG001|Stage 1 (96 Weeks)|Other|0|||
162183092|NCT02386098|585723023|FG002|Stage 1 (96 Weeks)|Other|0|||
162183093|NCT02386098|585723024|FG003|Stage 1 (96 Weeks)|Other|0|||
162183094|NCT02386098|585723025|FG004|Stage 1 (96 Weeks)|Other|0|||
162183095|NCT02386098|585723021|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
162183096|NCT02386098|585723022|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
162183097|NCT02386098|585723023|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
162183098|NCT02386098|585723024|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
162183099|NCT02386098|585723025|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
162183100|NCT00890591|585723035|FG000|Overall Study|Lack of Efficacy|20|||
161672363|NCT02684357|583853116|FG004|Part A|Withdrawal by Subject|0|||
161672364|NCT02684357|583853117|FG005|Part A|Withdrawal by Subject|0|||
161672365|NCT02684357|583853112|FG000|Part A|Other|0|||
161672366|NCT02684357|583853113|FG001|Part A|Other|1|||
161672367|NCT02684357|583853114|FG002|Part A|Other|0|||
161672368|NCT02684357|583853115|FG003|Part A|Other|0|||
161672369|NCT02684357|583853116|FG004|Part A|Other|0|||
161672370|NCT02684357|583853117|FG005|Part A|Other|0|||
161672371|NCT02684357|583853112|FG000|Part B|Adverse Event (Other)|0|||
161818309|NCT03827395|584376035|FG000|Overall Study|Lost to Follow-up|1|||
162183101|NCT00776009|585723040|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
161818310|NCT03827395|584376036|FG001|Overall Study|Lost to Follow-up|0|||
162183102|NCT00776009|585723041|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
162183103|NCT00776009|585723042|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
161672372|NCT02684357|583853113|FG001|Part B|Adverse Event (Other)|0|||
161672373|NCT02684357|583853114|FG002|Part B|Adverse Event (Other)|0|||
161672374|NCT02684357|583853115|FG003|Part B|Adverse Event (Other)|1|||
161672375|NCT02684357|583853116|FG004|Part B|Adverse Event (Other)|1|||
162183104|NCT00776009|585723043|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
162183105|NCT00776009|585723044|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
162183106|NCT00776009|585723045|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
162183107|NCT00776009|585723040|FG000|Period 1: First Intervention|Protocol Violation|0|||
162183108|NCT00776009|585723041|FG001|Period 1: First Intervention|Protocol Violation|1|||
162183109|NCT00776009|585723042|FG002|Period 1: First Intervention|Protocol Violation|0|||
162183110|NCT00776009|585723043|FG003|Period 1: First Intervention|Protocol Violation|0|||
162183111|NCT00776009|585723044|FG004|Period 1: First Intervention|Protocol Violation|1|||
162183112|NCT00776009|585723045|FG005|Period 1: First Intervention|Protocol Violation|0|||
162183113|NCT00776009|585723040|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
162183114|NCT00776009|585723041|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
162183115|NCT00776009|585723042|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
162183116|NCT00776009|585723043|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
162183117|NCT00776009|585723044|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
162183118|NCT00776009|585723045|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
162183119|NCT00776009|585723040|FG000|Period 2: Second Intervention|Protocol Violation|1|||
162183120|NCT00776009|585723041|FG001|Period 2: Second Intervention|Protocol Violation|0|||
162183121|NCT00776009|585723042|FG002|Period 2: Second Intervention|Protocol Violation|1|||
162183122|NCT00776009|585723043|FG003|Period 2: Second Intervention|Protocol Violation|0|||
162183123|NCT00776009|585723044|FG004|Period 2: Second Intervention|Protocol Violation|0|||
162183124|NCT00776009|585723045|FG005|Period 2: Second Intervention|Protocol Violation|0|||
162183125|NCT00776009|585723040|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
162183126|NCT00776009|585723041|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
162183127|NCT00776009|585723042|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
162183128|NCT00776009|585723043|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
162183129|NCT00776009|585723044|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
162183130|NCT00776009|585723045|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
162183131|NCT01536093|585723048|FG000|Overall Study|Death|1|||
162183132|NCT01536093|585723049|FG001|Overall Study|Death|2|||
162183133|NCT01536093|585723048|FG000|Overall Study|absence of maternal colostrum|2|||
162183134|NCT01536093|585723049|FG001|Overall Study|absence of maternal colostrum|0|||
162183135|NCT01536093|585723048|FG000|Overall Study|Withdrawal by Subject|0|||
162183136|NCT01536093|585723049|FG001|Overall Study|Withdrawal by Subject|1|||
162183137|NCT02275611|585723052|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
162183138|NCT02275611|585723053|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
162183139|NCT02275611|585723054|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
162183140|NCT02275611|585723055|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
162183141|NCT01211184|585723061|FG000|Overall Study|Withdrawal by Subject|0|||
162183142|NCT01211184|585723062|FG001|Overall Study|Withdrawal by Subject|2|||
162183143|NCT01211184|585723063|FG002|Overall Study|Withdrawal by Subject|1|||
162183144|NCT01421667|585723064|FG000|Overall Study|Withdrawal by Subject|0|||
162183145|NCT01421667|585723065|FG001|Overall Study|Withdrawal by Subject|1|||
162183146|NCT01421667|585723066|FG002|Overall Study|Withdrawal by Subject|2|||
162183147|NCT01421667|585723067|FG003|Overall Study|Withdrawal by Subject|1|||
162183148|NCT01421667|585723064|FG000|Overall Study|Lost to Follow-up|0|||
162183149|NCT01421667|585723065|FG001|Overall Study|Lost to Follow-up|1|||
162183150|NCT01421667|585723066|FG002|Overall Study|Lost to Follow-up|0|||
162183151|NCT01421667|585723067|FG003|Overall Study|Lost to Follow-up|0|||
162183152|NCT00503906|585723068|FG000|Overall Study|Withdrawal by Subject|1|||
162183153|NCT05580003|585723071|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183154|NCT05580003|585723072|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183155|NCT05580003|585723073|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183156|NCT05580003|585723074|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183157|NCT05580003|585723075|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183158|NCT05580003|585723076|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183159|NCT05580003|585723077|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
162183160|NCT05580003|585723078|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183161|NCT05580003|585723079|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183162|NCT05580003|585723080|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183163|NCT05580003|585723081|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183164|NCT05580003|585723082|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183165|NCT05580003|585723083|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183166|NCT05580003|585723084|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183167|NCT05580003|585723085|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183168|NCT05580003|585723086|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183169|NCT05580003|585723087|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183170|NCT05580003|585723088|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183171|NCT05580003|585723089|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183172|NCT05580003|585723090|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183173|NCT05580003|585723091|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183174|NCT05580003|585723092|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183175|NCT05580003|585723093|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183176|NCT05580003|585723094|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183177|NCT05580003|585723095|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183178|NCT05580003|585723096|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183179|NCT05580003|585723097|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183180|NCT05580003|585723098|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
162183181|NCT05580003|585723071|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183182|NCT05580003|585723072|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183183|NCT05580003|585723073|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183184|NCT05580003|585723074|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183185|NCT05580003|585723075|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161818311|NCT03827395|584376035|FG000|Overall Study|Protocol Violation|1|||
161818312|NCT03827395|584376036|FG001|Overall Study|Protocol Violation|0|||
161818313|NCT03827395|584376035|FG000|Overall Study|Became ineligible after enrollment|1|||
161818314|NCT03827395|584376036|FG001|Overall Study|Became ineligible after enrollment|2|||
162183186|NCT05580003|585723076|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
162183187|NCT05580003|585723077|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183188|NCT05580003|585723078|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183189|NCT05580003|585723079|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161818315|NCT01370083|584376037|FG000|Overall Study|Lost to Follow-up|2|||
161818316|NCT01370083|584376038|FG001|Overall Study|Lost to Follow-up|0|||
161818317|NCT01370083|584376037|FG000|Overall Study|Adverse Event|0|||
161818318|NCT01370083|584376038|FG001|Overall Study|Adverse Event|1|||
161818319|NCT02450539|584376041|FG000|Overall Study|Withdrawal by Subject|12|||
161818320|NCT02450539|584376042|FG001|Overall Study|Withdrawal by Subject|6|||
161818321|NCT02450539|584376041|FG000|Overall Study|Lost to Follow-up|4|||
161818322|NCT02450539|584376042|FG001|Overall Study|Lost to Follow-up|1|||
161818323|NCT00585286|584376043|FG000|Overall Study|Lost to Follow-up|1|||
161818324|NCT03358147|584376045|FG000|Overall Study|Withdrawal by Subject|13|||
161818325|NCT03358147|584376046|FG001|Overall Study|Withdrawal by Subject|19|||
161818326|NCT03358147|584376047|FG002|Overall Study|Withdrawal by Subject|16|||
161818327|NCT03358147|584376048|FG003|Overall Study|Withdrawal by Subject|10|||
161818328|NCT03358147|584376049|FG004|Overall Study|Withdrawal by Subject|5|||
161818329|NCT03358147|584376045|FG000|Overall Study|Adverse Event|3|||
161818330|NCT03358147|584376046|FG001|Overall Study|Adverse Event|9|||
161818331|NCT03358147|584376047|FG002|Overall Study|Adverse Event|7|||
161818332|NCT03358147|584376048|FG003|Overall Study|Adverse Event|5|||
161818333|NCT03358147|584376049|FG004|Overall Study|Adverse Event|2|||
161818334|NCT03358147|584376045|FG000|Overall Study|Lost to Follow-up|4|||
161818335|NCT03358147|584376046|FG001|Overall Study|Lost to Follow-up|3|||
161818336|NCT03358147|584376047|FG002|Overall Study|Lost to Follow-up|7|||
161818337|NCT03358147|584376048|FG003|Overall Study|Lost to Follow-up|6|||
161818338|NCT03358147|584376049|FG004|Overall Study|Lost to Follow-up|4|||
161818339|NCT03358147|584376045|FG000|Overall Study|Major Protocol Deviation|11|||
161818340|NCT03358147|584376046|FG001|Overall Study|Major Protocol Deviation|3|||
161818341|NCT03358147|584376047|FG002|Overall Study|Major Protocol Deviation|2|||
161818342|NCT03358147|584376048|FG003|Overall Study|Major Protocol Deviation|3|||
161818343|NCT03358147|584376049|FG004|Overall Study|Major Protocol Deviation|1|||
161818344|NCT03358147|584376045|FG000|Overall Study|Protocol specified criteria|2|||
161818345|NCT03358147|584376046|FG001|Overall Study|Protocol specified criteria|3|||
161818346|NCT03358147|584376047|FG002|Overall Study|Protocol specified criteria|0|||
161818347|NCT03358147|584376048|FG003|Overall Study|Protocol specified criteria|3|||
161818348|NCT03358147|584376049|FG004|Overall Study|Protocol specified criteria|1|||
161818349|NCT03358147|584376045|FG000|Overall Study|Physician Decision|1|||
161818350|NCT03358147|584376046|FG001|Overall Study|Physician Decision|0|||
161818351|NCT03358147|584376047|FG002|Overall Study|Physician Decision|1|||
162183190|NCT05580003|585723080|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161818352|NCT03358147|584376048|FG003|Overall Study|Physician Decision|6|||
161818353|NCT03358147|584376049|FG004|Overall Study|Physician Decision|1|||
161818354|NCT03358147|584376045|FG000|Overall Study|Administrative reasons|0|||
161818355|NCT03358147|584376046|FG001|Overall Study|Administrative reasons|1|||
161818356|NCT03358147|584376047|FG002|Overall Study|Administrative reasons|0|||
161818357|NCT03358147|584376048|FG003|Overall Study|Administrative reasons|3|||
161818358|NCT03358147|584376049|FG004|Overall Study|Administrative reasons|0|||
161818359|NCT03358147|584376045|FG000|Overall Study|Lack of Efficacy|0|||
161818360|NCT03358147|584376046|FG001|Overall Study|Lack of Efficacy|1|||
161818361|NCT03358147|584376047|FG002|Overall Study|Lack of Efficacy|1|||
161818362|NCT03358147|584376048|FG003|Overall Study|Lack of Efficacy|0|||
161818363|NCT03358147|584376049|FG004|Overall Study|Lack of Efficacy|0|||
161818364|NCT03236311|584376050|FG000|Overall Study|Study terminated by sponsor|0|||
162183191|NCT05580003|585723081|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183192|NCT05580003|585723082|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183193|NCT05580003|585723083|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183194|NCT05580003|585723084|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183195|NCT05580003|585723085|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183196|NCT05580003|585723086|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183197|NCT05580003|585723087|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183198|NCT05580003|585723088|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183199|NCT05580003|585723089|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183200|NCT05580003|585723090|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183201|NCT05580003|585723091|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183202|NCT05580003|585723092|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183203|NCT05580003|585723093|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183204|NCT05580003|585723094|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183205|NCT05580003|585723095|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183206|NCT05580003|585723096|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183207|NCT05580003|585723097|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183208|NCT05580003|585723098|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
162183209|NCT05580003|585723071|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161924343|NCT00266812|584769645|FG000|Overall Study|Protocol Violation|0|||
161924344|NCT00266812|584769646|FG001|Overall Study|Protocol Violation|1|||
161924345|NCT00266812|584769645|FG000|Overall Study|Withdrawal by Subject|0|||
161924346|NCT00266812|584769646|FG001|Overall Study|Withdrawal by Subject|2|||
162183210|NCT05580003|585723072|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183211|NCT05580003|585723073|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183212|NCT05580003|585723074|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
162183213|NCT05580003|585723075|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183214|NCT05580003|585723076|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183215|NCT05580003|585723077|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183216|NCT05580003|585723078|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183217|NCT05580003|585723079|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183218|NCT05580003|585723080|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183219|NCT05580003|585723081|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183220|NCT05580003|585723082|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183221|NCT05580003|585723083|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183222|NCT05580003|585723084|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183223|NCT05580003|585723085|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183224|NCT05580003|585723086|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183225|NCT05580003|585723087|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183226|NCT05580003|585723088|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183227|NCT05580003|585723089|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183228|NCT05580003|585723090|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183229|NCT05580003|585723091|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183230|NCT05580003|585723092|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183231|NCT05580003|585723093|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183232|NCT05580003|585723094|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183233|NCT05580003|585723095|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183234|NCT05580003|585723096|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183235|NCT05580003|585723097|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183236|NCT05580003|585723098|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
162183237|NCT05580003|585723071|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183238|NCT05580003|585723072|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
162183239|NCT05580003|585723073|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183240|NCT05580003|585723074|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183241|NCT05580003|585723075|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183242|NCT05580003|585723076|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183243|NCT05580003|585723077|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183244|NCT05580003|585723078|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183245|NCT05580003|585723079|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183246|NCT05580003|585723080|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183247|NCT05580003|585723081|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183248|NCT05580003|585723082|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183249|NCT05580003|585723083|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183250|NCT05580003|585723084|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183251|NCT05580003|585723085|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183252|NCT05580003|585723086|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183253|NCT05580003|585723087|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183254|NCT05580003|585723088|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161924347|NCT00266812|584769645|FG000|Overall Study|Discontinued before starting study drug|4|||
161924348|NCT00266812|584769646|FG001|Overall Study|Discontinued before starting study drug|0|||
161818365|NCT03236311|584376051|FG001|Overall Study|Study terminated by sponsor|2|||
161818366|NCT03236311|584376050|FG000|Overall Study|Adverse Event|0|||
161818367|NCT03236311|584376051|FG001|Overall Study|Adverse Event|1|||
161818368|NCT00669162|584376052|FG000|Overall Study|Withdrawal by Subject|1|||
161818369|NCT02704091|584376053|FG000|Overall Study|Adverse Event|4|||
161818370|NCT02704091|584376054|FG001|Overall Study|Adverse Event|3|||
161818371|NCT02704091|584376053|FG000|Overall Study|Protocol Violation|5|||
161818372|NCT02704091|584376054|FG001|Overall Study|Protocol Violation|3|||
161818373|NCT02704091|584376053|FG000|Overall Study|Consent withdrawn|4|||
161818374|NCT02704091|584376054|FG001|Overall Study|Consent withdrawn|4|||
161924349|NCT00416949|584769647|FG000|Overall Study|Patients refused to participate|5|||
161924350|NCT01137812|584769648|FG000|Overall Study|Adverse Event|21|||
162183255|NCT05580003|585723089|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183256|NCT05580003|585723090|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183257|NCT05580003|585723091|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183258|NCT05580003|585723092|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183259|NCT05580003|585723093|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183260|NCT05580003|585723094|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183261|NCT05580003|585723095|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183262|NCT05580003|585723096|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183263|NCT05580003|585723097|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183264|NCT05580003|585723098|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
162183265|NCT05580003|585723071|FG000|Part 2 (up to 10 Days)|Other|0|||
162183266|NCT05580003|585723072|FG001|Part 2 (up to 10 Days)|Other|0|||
162183267|NCT05580003|585723073|FG002|Part 2 (up to 10 Days)|Other|0|||
162183268|NCT05580003|585723074|FG003|Part 2 (up to 10 Days)|Other|0|||
162183269|NCT05580003|585723075|FG004|Part 2 (up to 10 Days)|Other|0|||
162183270|NCT05580003|585723076|FG005|Part 2 (up to 10 Days)|Other|0|||
162183271|NCT05580003|585723077|FG006|Part 2 (up to 10 Days)|Other|0|||
162183272|NCT05580003|585723078|FG007|Part 2 (up to 10 Days)|Other|0|||
162183273|NCT05580003|585723079|FG008|Part 2 (up to 10 Days)|Other|0|||
162183274|NCT05580003|585723080|FG009|Part 2 (up to 10 Days)|Other|1|||
162183275|NCT05580003|585723081|FG010|Part 2 (up to 10 Days)|Other|0|||
162183276|NCT05580003|585723082|FG011|Part 2 (up to 10 Days)|Other|0|||
162183277|NCT05580003|585723083|FG012|Part 2 (up to 10 Days)|Other|0|||
162183278|NCT05580003|585723084|FG013|Part 2 (up to 10 Days)|Other|0|||
162183279|NCT05580003|585723085|FG014|Part 2 (up to 10 Days)|Other|0|||
162183280|NCT05580003|585723086|FG015|Part 2 (up to 10 Days)|Other|0|||
162183281|NCT05580003|585723087|FG016|Part 2 (up to 10 Days)|Other|0|||
162183282|NCT05580003|585723088|FG017|Part 2 (up to 10 Days)|Other|0|||
162183283|NCT05580003|585723089|FG018|Part 2 (up to 10 Days)|Other|0|||
162183284|NCT05580003|585723090|FG019|Part 2 (up to 10 Days)|Other|0|||
162183285|NCT05580003|585723091|FG020|Part 2 (up to 10 Days)|Other|0|||
162183286|NCT05580003|585723092|FG021|Part 2 (up to 10 Days)|Other|0|||
162183287|NCT05580003|585723093|FG022|Part 2 (up to 10 Days)|Other|0|||
162183288|NCT05580003|585723094|FG023|Part 2 (up to 10 Days)|Other|0|||
162183289|NCT05580003|585723095|FG024|Part 2 (up to 10 Days)|Other|0|||
162183290|NCT05580003|585723096|FG025|Part 2 (up to 10 Days)|Other|0|||
162183291|NCT05580003|585723097|FG026|Part 2 (up to 10 Days)|Other|0|||
162183292|NCT05580003|585723098|FG027|Part 2 (up to 10 Days)|Other|0|||
162183293|NCT05580003|585723071|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183294|NCT05580003|585723072|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183295|NCT05580003|585723073|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183296|NCT05580003|585723074|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183297|NCT05580003|585723075|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183298|NCT05580003|585723076|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183299|NCT05580003|585723077|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183300|NCT05580003|585723078|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161818375|NCT02704091|584376053|FG000|Overall Study|Lost to Follow-up|13|||
161818376|NCT02704091|584376054|FG001|Overall Study|Lost to Follow-up|5|||
161818377|NCT02704091|584376053|FG000|Overall Study|Other|2|||
161924351|NCT01137812|584769649|FG001|Overall Study|Adverse Event|14|||
161924352|NCT01137812|584769648|FG000|Overall Study|Lost to Follow-up|6|||
161924353|NCT01137812|584769649|FG001|Overall Study|Lost to Follow-up|8|||
161924354|NCT01137812|584769648|FG000|Overall Study|Physician Decision|25|||
162183301|NCT05580003|585723079|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183302|NCT05580003|585723080|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183303|NCT05580003|585723081|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183304|NCT05580003|585723082|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183305|NCT05580003|585723083|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183306|NCT05580003|585723084|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183307|NCT05580003|585723085|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183308|NCT05580003|585723086|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183309|NCT05580003|585723087|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161818378|NCT02704091|584376054|FG001|Overall Study|Other|8|||
161818379|NCT02412852|584376055|FG000|Overall Study|Withdrawal by Subject|0|||
161924355|NCT01137812|584769649|FG001|Overall Study|Physician Decision|17|||
162183310|NCT05580003|585723088|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183311|NCT05580003|585723089|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183312|NCT05580003|585723090|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
162183313|NCT05580003|585723091|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183314|NCT05580003|585723092|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183315|NCT05580003|585723093|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183316|NCT05580003|585723094|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183317|NCT05580003|585723095|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183318|NCT05580003|585723096|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183319|NCT05580003|585723097|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183320|NCT05580003|585723098|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
162183321|NCT05580003|585723071|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183322|NCT05580003|585723072|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183323|NCT05580003|585723073|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183324|NCT05580003|585723074|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183325|NCT05580003|585723075|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183326|NCT05580003|585723076|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183327|NCT05580003|585723077|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183328|NCT05580003|585723078|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183329|NCT05580003|585723079|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183330|NCT05580003|585723080|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183331|NCT05580003|585723081|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183332|NCT05580003|585723082|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183333|NCT05580003|585723083|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183334|NCT05580003|585723084|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183335|NCT05580003|585723085|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183336|NCT05580003|585723086|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183337|NCT05580003|585723087|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183338|NCT05580003|585723088|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183339|NCT05580003|585723089|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183340|NCT05580003|585723090|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183341|NCT05580003|585723091|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
161924356|NCT01137812|584769648|FG000|Overall Study|Protocol Violation|5|||
161924357|NCT01137812|584769649|FG001|Overall Study|Protocol Violation|4|||
161924358|NCT01137812|584769648|FG000|Overall Study|Withdrawal by Subject|5|||
161924359|NCT01137812|584769649|FG001|Overall Study|Withdrawal by Subject|13|||
161924360|NCT01137812|584769648|FG000|Overall Study|Death|2|||
161924361|NCT01137812|584769649|FG001|Overall Study|Death|0|||
161924362|NCT01137812|584769648|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
161924363|NCT01137812|584769649|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
161924364|NCT01137812|584769648|FG000|Overall Study|Other|19|||
161924365|NCT01137812|584769649|FG001|Overall Study|Other|27|||
161924366|NCT03927157|584769650|FG000|Overall Study|Adverse Event|1|||
161924367|NCT03927157|584769651|FG001|Overall Study|Adverse Event|3|||
162183342|NCT05580003|585723092|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183343|NCT05580003|585723093|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183344|NCT05580003|585723094|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183345|NCT05580003|585723095|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183346|NCT05580003|585723096|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183347|NCT05580003|585723097|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183348|NCT05580003|585723098|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
162183349|NCT05580003|585723071|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183350|NCT05580003|585723072|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183351|NCT05580003|585723073|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161818380|NCT02412852|584376056|FG001|Overall Study|Withdrawal by Subject|1|||
161818381|NCT02412852|584376057|FG002|Overall Study|Withdrawal by Subject|0|||
161818382|NCT02412852|584376058|FG003|Overall Study|Withdrawal by Subject|0|||
161818383|NCT02412852|584376055|FG000|Overall Study|Physician Decision|0|||
161818384|NCT02412852|584376056|FG001|Overall Study|Physician Decision|0|||
161818385|NCT02412852|584376057|FG002|Overall Study|Physician Decision|0|||
161818386|NCT02412852|584376058|FG003|Overall Study|Physician Decision|1|||
161818387|NCT01051349|584376059|FG000|Overall Study|Adverse Event|88|||
161818388|NCT01051349|584376059|FG000|Overall Study|Consent Withdrawn|54|||
161818389|NCT01051349|584376059|FG000|Overall Study|Investigator Decision|6|||
161818390|NCT01051349|584376059|FG000|Overall Study|Lost to Follow-up|6|||
161818391|NCT01051349|584376059|FG000|Overall Study|Subject non-compliance|7|||
161818392|NCT01051349|584376059|FG000|Overall Study|Reason not Specified|12|||
162019215|NCT00859638|585124876|FG001|Overall Study|Lost to Follow-up|1|||
161818393|NCT00840203|584376062|FG000|First Intervention|Protocol Violation|1|||
161924368|NCT03927157|584769650|FG000|Overall Study|Protocol Violation|1|||
161924369|NCT03927157|584769651|FG001|Overall Study|Protocol Violation|2|||
161924370|NCT03927157|584769650|FG000|Overall Study|Withdrawal by Subject|8|||
162183352|NCT05580003|585723074|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183353|NCT05580003|585723075|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183354|NCT05580003|585723076|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183355|NCT05580003|585723077|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183356|NCT05580003|585723078|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183357|NCT05580003|585723079|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183358|NCT05580003|585723080|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183359|NCT05580003|585723081|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183360|NCT05580003|585723082|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183361|NCT05580003|585723083|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183362|NCT05580003|585723084|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183363|NCT05580003|585723085|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183364|NCT05580003|585723086|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183365|NCT05580003|585723087|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183366|NCT05580003|585723088|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183367|NCT05580003|585723089|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183368|NCT05580003|585723090|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183369|NCT05580003|585723091|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183370|NCT05580003|585723092|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
162183371|NCT05580003|585723093|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183372|NCT05580003|585723094|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183373|NCT05580003|585723095|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161672376|NCT02684357|583853117|FG005|Part B|Adverse Event (Other)|1|||
161924371|NCT03927157|584769651|FG001|Overall Study|Withdrawal by Subject|21|||
161924372|NCT03927157|584769650|FG000|Overall Study|Due to COVID-19 pandemic|5|||
161924373|NCT03927157|584769651|FG001|Overall Study|Due to COVID-19 pandemic|2|||
161924374|NCT03927157|584769650|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
161924375|NCT03927157|584769651|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
161924376|NCT03927157|584769650|FG000|Overall Study|Other than above|0|||
161924377|NCT03927157|584769651|FG001|Overall Study|Other than above|1|||
161924378|NCT05558410|584769652|FG000|Overall Study|Adverse Event|1|||
161924379|NCT05558410|584769653|FG001|Overall Study|Adverse Event|2|||
161924380|NCT05558410|584769654|FG002|Overall Study|Adverse Event|0|||
161924381|NCT05558410|584769652|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
161924382|NCT05558410|584769653|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
161924383|NCT05558410|584769654|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
161672377|NCT02684357|583853112|FG000|Part B|Lost to Follow-up|0|||
161672378|NCT02684357|583853113|FG001|Part B|Lost to Follow-up|0|||
161672379|NCT02684357|583853114|FG002|Part B|Lost to Follow-up|0|||
161672380|NCT02684357|583853115|FG003|Part B|Lost to Follow-up|1|||
161672381|NCT02684357|583853116|FG004|Part B|Lost to Follow-up|1|||
161672382|NCT02684357|583853117|FG005|Part B|Lost to Follow-up|7|||
161672383|NCT02684357|583853112|FG000|Part B|Withdrawal by Subject|0|||
161672384|NCT02684357|583853113|FG001|Part B|Withdrawal by Subject|0|||
161672385|NCT02684357|583853114|FG002|Part B|Withdrawal by Subject|0|||
161672386|NCT02684357|583853115|FG003|Part B|Withdrawal by Subject|0|||
161672387|NCT02684357|583853116|FG004|Part B|Withdrawal by Subject|2|||
161672388|NCT02684357|583853117|FG005|Part B|Withdrawal by Subject|4|||
161672389|NCT02684357|583853112|FG000|Part B|Other|0|||
161672390|NCT02684357|583853113|FG001|Part B|Other|0|||
161672391|NCT02684357|583853114|FG002|Part B|Other|0|||
161672392|NCT02684357|583853115|FG003|Part B|Other|1|||
161672393|NCT02684357|583853116|FG004|Part B|Other|0|||
161672394|NCT02684357|583853117|FG005|Part B|Other|1|||
161672395|NCT01853982|583853118|FG000|Overall Study|Withdrawal by Subject|1|||
161672396|NCT01853982|583853119|FG001|Overall Study|Withdrawal by Subject|0|||
161672397|NCT01853982|583853118|FG000|Overall Study|Death|1|||
161672398|NCT01853982|583853119|FG001|Overall Study|Death|0|||
161672399|NCT01853982|583853118|FG000|Overall Study|Lost to Follow-up|0|||
161672400|NCT01853982|583853119|FG001|Overall Study|Lost to Follow-up|1|||
161672401|NCT00390910|583853120|FG000|Overall Study|Adverse Event|1|||
161924384|NCT05558410|584769652|FG000|Overall Study|Lost to Follow-up|10|||
161924385|NCT05558410|584769653|FG001|Overall Study|Lost to Follow-up|17|||
162183374|NCT05580003|585723096|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183375|NCT05580003|585723097|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183376|NCT05580003|585723098|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
162183377|NCT05580003|585723071|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161672402|NCT00390910|583853121|FG001|Overall Study|Adverse Event|0|||
161672403|NCT00390910|583853122|FG002|Overall Study|Adverse Event|0|||
161672404|NCT00390910|583853120|FG000|Overall Study|Lost to Follow-up|0|||
161672405|NCT00390910|583853121|FG001|Overall Study|Lost to Follow-up|1|||
161672406|NCT00390910|583853122|FG002|Overall Study|Lost to Follow-up|5|||
161672407|NCT00390910|583853120|FG000|Overall Study|Withdrawal by Subject|1|||
161672408|NCT00390910|583853121|FG001|Overall Study|Withdrawal by Subject|3|||
161924386|NCT05558410|584769654|FG002|Overall Study|Lost to Follow-up|19|||
161924387|NCT05558410|584769652|FG000|Overall Study|Death|1|||
161924388|NCT05558410|584769653|FG001|Overall Study|Death|0|||
161924389|NCT05558410|584769654|FG002|Overall Study|Death|0|||
161924390|NCT05558410|584769652|FG000|Overall Study|Other non-compliance|0|||
161924391|NCT05558410|584769653|FG001|Overall Study|Other non-compliance|1|||
161924392|NCT05558410|584769654|FG002|Overall Study|Other non-compliance|2|||
161924393|NCT05558410|584769652|FG000|Overall Study|Sponsor Decision|1|||
161924394|NCT05558410|584769653|FG001|Overall Study|Sponsor Decision|0|||
161924395|NCT05558410|584769654|FG002|Overall Study|Sponsor Decision|0|||
161924396|NCT05558410|584769652|FG000|Overall Study|Other|1|||
161924397|NCT05558410|584769653|FG001|Overall Study|Other|0|||
161924398|NCT05558410|584769654|FG002|Overall Study|Other|1|||
161924399|NCT02265744|584769657|FG000|Overall Study|Poor/Non-compliance|1|||
161924400|NCT02265744|584769658|FG001|Overall Study|Poor/Non-compliance|1|||
161924401|NCT02265744|584769659|FG002|Overall Study|Poor/Non-compliance|0|||
161924402|NCT02265744|584769660|FG003|Overall Study|Poor/Non-compliance|0|||
161924403|NCT02265744|584769661|FG004|Overall Study|Poor/Non-compliance|2|||
161924404|NCT02265744|584769657|FG000|Overall Study|Lost to Follow-up|0|||
161924405|NCT02265744|584769658|FG001|Overall Study|Lost to Follow-up|0|||
161924406|NCT02265744|584769659|FG002|Overall Study|Lost to Follow-up|0|||
161924407|NCT02265744|584769660|FG003|Overall Study|Lost to Follow-up|1|||
162019216|NCT00859638|585124875|FG000|Overall Study|Withdrawal by Subject|3|||
161672409|NCT00390910|583853122|FG002|Overall Study|Withdrawal by Subject|2|||
161672410|NCT00390910|583853120|FG000|Overall Study|Migrated/moved from study area|0|||
161672411|NCT00390910|583853121|FG001|Overall Study|Migrated/moved from study area|0|||
161672412|NCT00390910|583853122|FG002|Overall Study|Migrated/moved from study area|3|||
161672413|NCT05066724|583853124|FG000|Overall Study|Adverse Event|1|||
161672414|NCT05066724|583853124|FG000|Overall Study|Non-Compliance With Study Drug|5|||
161672415|NCT05066724|583853124|FG000|Overall Study|Withdrawal by Subject|6|||
161672416|NCT05066724|583853124|FG000|Overall Study|Physician Decision|2|||
161672417|NCT01422850|583853125|FG000|Overall Study|Physician Decision|3|||
161672418|NCT02244996|583853127|FG000|Overall Study|Lack of Efficacy|2|||
161672419|NCT02244996|583853128|FG001|Overall Study|Lack of Efficacy|6|||
161672420|NCT03602261|583853131|FG000|Overall Study|Adverse Event|5|||
161672421|NCT03602261|583853132|FG001|Overall Study|Adverse Event|1|||
161672422|NCT03602261|583853131|FG000|Overall Study|Physician Decision|1|||
161672423|NCT03602261|583853132|FG001|Overall Study|Physician Decision|0|||
161672424|NCT03602261|583853131|FG000|Overall Study|Withdrawal by Subject|1|||
161924408|NCT02265744|584769661|FG004|Overall Study|Lost to Follow-up|0|||
161924409|NCT02265744|584769657|FG000|Overall Study|Death|0|||
161672425|NCT03602261|583853132|FG001|Overall Study|Withdrawal by Subject|1|||
161672426|NCT03602261|583853131|FG000|Overall Study|Lack of Efficacy|0|||
161672427|NCT03602261|583853132|FG001|Overall Study|Lack of Efficacy|1|||
161924410|NCT02265744|584769658|FG001|Overall Study|Death|0|||
161924411|NCT02265744|584769659|FG002|Overall Study|Death|0|||
161924412|NCT02265744|584769660|FG003|Overall Study|Death|2|||
161924413|NCT02265744|584769661|FG004|Overall Study|Death|0|||
162183378|NCT05580003|585723072|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183379|NCT05580003|585723073|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183380|NCT05580003|585723074|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183381|NCT05580003|585723075|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183382|NCT05580003|585723076|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183383|NCT05580003|585723077|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183384|NCT05580003|585723078|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183385|NCT05580003|585723079|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183386|NCT05580003|585723080|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183387|NCT05580003|585723081|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161818394|NCT00840203|584376063|FG001|First Intervention|Protocol Violation|1|||
161818395|NCT00840203|584376062|FG000|Washout|Protocol Violation|1|||
161818396|NCT00840203|584376063|FG001|Washout|Protocol Violation|0|||
161818397|NCT01438060|584376071|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
161818398|NCT01438060|584376072|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
161818399|NCT01438060|584376071|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
161818400|NCT01438060|584376072|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
161818401|NCT01438060|584376071|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
161818402|NCT01438060|584376072|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
161818403|NCT01438060|584376071|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
161818404|NCT01438060|584376072|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
161818405|NCT01438060|584376071|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
161818406|NCT01438060|584376072|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
161818407|NCT01438060|584376071|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
161818408|NCT01438060|584376072|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
161818409|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
161818410|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
161818411|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
161818412|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
162183388|NCT05580003|585723082|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183389|NCT05580003|585723083|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183390|NCT05580003|585723084|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183391|NCT05580003|585723085|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183392|NCT05580003|585723086|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161818413|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
162183393|NCT05580003|585723087|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183394|NCT05580003|585723088|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183395|NCT05580003|585723089|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183396|NCT05580003|585723090|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183397|NCT05580003|585723091|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183398|NCT05580003|585723092|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183399|NCT05580003|585723093|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183400|NCT05580003|585723094|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183401|NCT05580003|585723095|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183402|NCT05580003|585723096|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183403|NCT05580003|585723097|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
162183404|NCT05580003|585723098|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
162183405|NCT05580003|585723071|FG000|Part 6 Period 2 (Day 1)|Other|0|||
162183406|NCT05580003|585723072|FG001|Part 6 Period 2 (Day 1)|Other|0|||
162183407|NCT05580003|585723073|FG002|Part 6 Period 2 (Day 1)|Other|0|||
162183408|NCT05580003|585723074|FG003|Part 6 Period 2 (Day 1)|Other|0|||
162183409|NCT05580003|585723075|FG004|Part 6 Period 2 (Day 1)|Other|0|||
162183410|NCT05580003|585723076|FG005|Part 6 Period 2 (Day 1)|Other|0|||
162183411|NCT05580003|585723077|FG006|Part 6 Period 2 (Day 1)|Other|0|||
162183412|NCT05580003|585723078|FG007|Part 6 Period 2 (Day 1)|Other|0|||
162183413|NCT05580003|585723079|FG008|Part 6 Period 2 (Day 1)|Other|0|||
162183414|NCT05580003|585723080|FG009|Part 6 Period 2 (Day 1)|Other|0|||
162183415|NCT05580003|585723081|FG010|Part 6 Period 2 (Day 1)|Other|0|||
162183416|NCT05580003|585723082|FG011|Part 6 Period 2 (Day 1)|Other|0|||
162183417|NCT05580003|585723083|FG012|Part 6 Period 2 (Day 1)|Other|0|||
162183418|NCT05580003|585723084|FG013|Part 6 Period 2 (Day 1)|Other|0|||
162183419|NCT05580003|585723085|FG014|Part 6 Period 2 (Day 1)|Other|0|||
162183420|NCT05580003|585723086|FG015|Part 6 Period 2 (Day 1)|Other|0|||
162183421|NCT05580003|585723087|FG016|Part 6 Period 2 (Day 1)|Other|0|||
162183422|NCT05580003|585723088|FG017|Part 6 Period 2 (Day 1)|Other|0|||
162183423|NCT05580003|585723089|FG018|Part 6 Period 2 (Day 1)|Other|0|||
162183424|NCT05580003|585723090|FG019|Part 6 Period 2 (Day 1)|Other|0|||
162183425|NCT05580003|585723091|FG020|Part 6 Period 2 (Day 1)|Other|0|||
162183426|NCT05580003|585723092|FG021|Part 6 Period 2 (Day 1)|Other|0|||
162183427|NCT05580003|585723093|FG022|Part 6 Period 2 (Day 1)|Other|0|||
162183428|NCT05580003|585723094|FG023|Part 6 Period 2 (Day 1)|Other|0|||
162183429|NCT05580003|585723095|FG024|Part 6 Period 2 (Day 1)|Other|1|||
162183430|NCT05580003|585723096|FG025|Part 6 Period 2 (Day 1)|Other|0|||
162183431|NCT05580003|585723097|FG026|Part 6 Period 2 (Day 1)|Other|0|||
162183432|NCT05580003|585723098|FG027|Part 6 Period 2 (Day 1)|Other|0|||
161924414|NCT02265744|584769657|FG000|Overall Study|Withdrawal by Subject|2|||
161924415|NCT02265744|584769658|FG001|Overall Study|Withdrawal by Subject|0|||
161924416|NCT02265744|584769659|FG002|Overall Study|Withdrawal by Subject|0|||
161924417|NCT02265744|584769660|FG003|Overall Study|Withdrawal by Subject|2|||
161924418|NCT02265744|584769661|FG004|Overall Study|Withdrawal by Subject|0|||
161924419|NCT02265744|584769657|FG000|Overall Study|Participant request to discontinue|2|||
161924420|NCT02265744|584769658|FG001|Overall Study|Participant request to discontinue|2|||
161924421|NCT02265744|584769659|FG002|Overall Study|Participant request to discontinue|2|||
161924422|NCT02265744|584769660|FG003|Overall Study|Participant request to discontinue|0|||
161924423|NCT02265744|584769661|FG004|Overall Study|Participant request to discontinue|0|||
161924424|NCT02265744|584769657|FG000|Overall Study|Adverse Event|8|||
161924425|NCT02265744|584769658|FG001|Overall Study|Adverse Event|4|||
161924426|NCT02265744|584769659|FG002|Overall Study|Adverse Event|9|||
161924427|NCT02265744|584769660|FG003|Overall Study|Adverse Event|8|||
161924428|NCT02265744|584769661|FG004|Overall Study|Adverse Event|2|||
161924429|NCT02265744|584769657|FG000|Overall Study|Lack of Efficacy|2|||
161924430|NCT02265744|584769658|FG001|Overall Study|Lack of Efficacy|4|||
161924431|NCT02265744|584769659|FG002|Overall Study|Lack of Efficacy|3|||
161924432|NCT02265744|584769660|FG003|Overall Study|Lack of Efficacy|4|||
161924433|NCT02265744|584769661|FG004|Overall Study|Lack of Efficacy|5|||
161924434|NCT02265744|584769657|FG000|Overall Study|Reason not provided by Investigator|1|||
161924435|NCT02265744|584769658|FG001|Overall Study|Reason not provided by Investigator|0|||
161924436|NCT02265744|584769659|FG002|Overall Study|Reason not provided by Investigator|0|||
161924437|NCT02265744|584769660|FG003|Overall Study|Reason not provided by Investigator|2|||
161924438|NCT02265744|584769661|FG004|Overall Study|Reason not provided by Investigator|0|||
161924439|NCT02265744|584769657|FG000|Overall Study|Administrative reason by sponsor|3|||
161924440|NCT02265744|584769658|FG001|Overall Study|Administrative reason by sponsor|2|||
161924441|NCT02265744|584769659|FG002|Overall Study|Administrative reason by sponsor|2|||
161924442|NCT02265744|584769660|FG003|Overall Study|Administrative reason by sponsor|3|||
161924443|NCT02265744|584769661|FG004|Overall Study|Administrative reason by sponsor|3|||
161924444|NCT02265744|584769657|FG000|Overall Study|Subject no longer meets study criteria|0|||
161924445|NCT02265744|584769658|FG001|Overall Study|Subject no longer meets study criteria|0|||
161924446|NCT02265744|584769659|FG002|Overall Study|Subject no longer meets study criteria|0|||
161924447|NCT02265744|584769660|FG003|Overall Study|Subject no longer meets study criteria|0|||
161924448|NCT02265744|584769661|FG004|Overall Study|Subject no longer meets study criteria|1|||
161924449|NCT02265744|584769657|FG000|Overall Study|Pregnancy|1|||
161924450|NCT02265744|584769658|FG001|Overall Study|Pregnancy|2|||
161924451|NCT02265744|584769659|FG002|Overall Study|Pregnancy|1|||
161924452|NCT02265744|584769660|FG003|Overall Study|Pregnancy|1|||
161924453|NCT02265744|584769661|FG004|Overall Study|Pregnancy|0|||
161924454|NCT00923702|584769662|FG000|Overall Study|Ongoing enrollment|0|||
161924455|NCT00923702|584769663|FG001|Overall Study|Ongoing enrollment|0|||
161924456|NCT00923702|584769664|FG002|Overall Study|Ongoing enrollment|0|||
161924457|NCT00923702|584769665|FG003|Overall Study|Ongoing enrollment|0|||
161924458|NCT00923702|584769666|FG004|Overall Study|Ongoing enrollment|354|||
161924459|NCT05950906|584769670|FG000|Overall Study|Adverse Event|0|||
161924460|NCT05950906|584769671|FG001|Overall Study|Adverse Event|0|||
161924461|NCT05950906|584769672|FG002|Overall Study|Adverse Event|0|||
161924462|NCT05950906|584769673|FG003|Overall Study|Adverse Event|0|||
161924463|NCT05950906|584769674|FG004|Overall Study|Adverse Event|0|||
161924464|NCT05950906|584769675|FG005|Overall Study|Adverse Event|0|||
161924465|NCT05950906|584769676|FG006|Overall Study|Adverse Event|0|||
161924466|NCT05950906|584769677|FG007|Overall Study|Adverse Event|0|||
161924467|NCT05950906|584769678|FG008|Overall Study|Adverse Event|0|||
161924468|NCT05950906|584769679|FG009|Overall Study|Adverse Event|0|||
161924469|NCT05950906|584769680|FG010|Overall Study|Adverse Event|0|||
161924470|NCT05950906|584769681|FG011|Overall Study|Adverse Event|0|||
161924471|NCT05950906|584769682|FG012|Overall Study|Adverse Event|1|||
161924472|NCT05950906|584769683|FG013|Overall Study|Adverse Event|0|||
161924473|NCT05950906|584769670|FG000|Overall Study|Physician Decision|0|||
161924474|NCT05950906|584769671|FG001|Overall Study|Physician Decision|0|||
161924475|NCT05950906|584769672|FG002|Overall Study|Physician Decision|0|||
161924476|NCT05950906|584769673|FG003|Overall Study|Physician Decision|0|||
161924477|NCT05950906|584769674|FG004|Overall Study|Physician Decision|0|||
161924478|NCT05950906|584769675|FG005|Overall Study|Physician Decision|0|||
161924479|NCT05950906|584769676|FG006|Overall Study|Physician Decision|0|||
161924480|NCT05950906|584769677|FG007|Overall Study|Physician Decision|0|||
161924481|NCT05950906|584769678|FG008|Overall Study|Physician Decision|0|||
161924482|NCT05950906|584769679|FG009|Overall Study|Physician Decision|0|||
161924483|NCT05950906|584769680|FG010|Overall Study|Physician Decision|0|||
161924484|NCT05950906|584769681|FG011|Overall Study|Physician Decision|0|||
161924485|NCT05950906|584769682|FG012|Overall Study|Physician Decision|1|||
161924486|NCT05950906|584769683|FG013|Overall Study|Physician Decision|0|||
161924487|NCT02448043|584769684|FG000|Overall Study|Withdrawal by Subject|2|||
161924488|NCT02448043|584769685|FG001|Overall Study|Withdrawal by Subject|2|||
161924489|NCT02448043|584769684|FG000|Overall Study|Protocol Violation|1|||
161924490|NCT02448043|584769685|FG001|Overall Study|Protocol Violation|2|||
162183433|NCT03516812|585723099|FG000|Overall Study|Adverse Event|4|||
162183434|NCT03516812|585723099|FG000|Overall Study|Lack of Efficacy|2|||
162183435|NCT04795167|585723100|FG000|Overall Study|Death|1|||
162183436|NCT04795167|585723101|FG001|Overall Study|Death|18|||
162183437|NCT04795167|585723102|FG002|Overall Study|Death|1|||
162183438|NCT04795167|585723100|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
161924491|NCT03142750|584769686|FG000|Overall Study|Lost to Follow-up|4|||
162183439|NCT04795167|585723101|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
162183440|NCT04795167|585723102|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
162183441|NCT01753999|585723103|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
162183442|NCT01753999|585723104|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
162183443|NCT01753999|585723103|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
162183444|NCT01753999|585723104|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
162183445|NCT01753999|585723103|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
162183446|NCT01753999|585723104|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
162183447|NCT01753999|585723103|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
162183448|NCT01753999|585723104|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
162183449|NCT01753999|585723103|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
162183450|NCT01753999|585723104|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
162183451|NCT01753999|585723103|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
162183452|NCT01753999|585723104|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
162183453|NCT03840902|585723105|FG000|Overall Study|Randomized but not treated|1|||
162183454|NCT03840902|585723106|FG001|Overall Study|Randomized but not treated|1|||
162183455|NCT02392234|585723107|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
162183456|NCT02392234|585723108|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
162183457|NCT02392234|585723109|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
162183458|NCT02392234|585723110|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
162183459|NCT02392234|585723111|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
162183460|NCT02392234|585723112|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
162183461|NCT02392234|585723107|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
162183462|NCT02392234|585723108|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
162183463|NCT02392234|585723109|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
162183464|NCT02392234|585723110|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
162183465|NCT02392234|585723111|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
162183466|NCT02392234|585723112|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
162183467|NCT02392234|585723107|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
162183468|NCT02392234|585723108|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
162183469|NCT02392234|585723109|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
162183470|NCT02392234|585723110|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
162183471|NCT02392234|585723111|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
162183472|NCT02392234|585723112|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
162183473|NCT02392234|585723107|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
162183474|NCT02392234|585723108|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
162183475|NCT02392234|585723109|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
162183476|NCT02392234|585723110|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
162183477|NCT02392234|585723111|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
162183478|NCT02392234|585723112|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
162183479|NCT02392234|585723107|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
162183480|NCT02392234|585723108|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
162183481|NCT02392234|585723109|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
162183482|NCT02392234|585723110|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
162183483|NCT02392234|585723111|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
162183484|NCT02392234|585723112|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
162183485|NCT02392234|585723107|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
162183486|NCT02392234|585723108|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
162183487|NCT02392234|585723109|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
162183488|NCT02392234|585723110|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
162183489|NCT02392234|585723111|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
162183490|NCT02392234|585723112|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
162183491|NCT02392234|585723107|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
162183492|NCT02392234|585723108|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
162183493|NCT02392234|585723109|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
162183494|NCT02392234|585723110|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
162183495|NCT02392234|585723111|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
162183496|NCT02392234|585723112|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
162183497|NCT02392234|585723107|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
162183498|NCT02392234|585723108|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
162183499|NCT02392234|585723109|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
162183500|NCT02392234|585723110|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
162183501|NCT02392234|585723111|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
162183502|NCT02392234|585723112|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
162183503|NCT02029235|585723114|FG000|Overall Study|Non-compliance with study meds or diary|4|||
162183504|NCT02029235|585723115|FG001|Overall Study|Non-compliance with study meds or diary|1|||
162183505|NCT02816398|585723120|FG000|Overall Study|Death|5|||
162183506|NCT02816398|585723120|FG000|Overall Study|Lack of Efficacy|8|||
162183507|NCT02816398|585723120|FG000|Overall Study|Lost to Follow-up|1|||
162183508|NCT03582475|585723121|FG000|Treatment Period|Withdrawal by Subject|0|||
162183509|NCT03582475|585723122|FG001|Treatment Period|Withdrawal by Subject|1|||
161924492|NCT03142750|584769687|FG001|Overall Study|Lost to Follow-up|1|||
161924493|NCT03158688|584769692|FG000|Overall Study|Withdrawal by Subject|14|||
161924494|NCT03158688|584769693|FG001|Overall Study|Withdrawal by Subject|28|||
161924495|NCT03158688|584769692|FG000|Overall Study|Decision by sponsor|13|||
161924496|NCT03158688|584769693|FG001|Overall Study|Decision by sponsor|37|||
161924497|NCT03158688|584769692|FG000|Overall Study|Lost to Follow-up|4|||
161924498|NCT03158688|584769693|FG001|Overall Study|Lost to Follow-up|3|||
161924499|NCT03158688|584769692|FG000|Overall Study|Death|74|||
161924500|NCT03158688|584769693|FG001|Overall Study|Death|142|||
161924501|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
161924502|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
161924503|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
161924504|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
161924505|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
161924506|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
161924507|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
161924508|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
161924509|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
161924510|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
161924511|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
161924512|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
161924513|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
161924514|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
161924515|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
161924516|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
161924517|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
161924518|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
161924519|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
161924520|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
161924521|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
161924522|NCT02337946|584769700|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
161924523|NCT02337946|584769701|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
161924524|NCT02337946|584769702|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
161924525|NCT02337946|584769700|FG000|In-between Period|Without Informed Consent|1|||
161924526|NCT02337946|584769701|FG001|In-between Period|Without Informed Consent|0|||
161924527|NCT02337946|584769702|FG002|In-between Period|Without Informed Consent|0|||
161924528|NCT02337946|584769700|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
161924529|NCT02337946|584769701|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
161924530|NCT02337946|584769702|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
161924531|NCT02337946|584769700|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
161924532|NCT02337946|584769701|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
161924533|NCT02337946|584769702|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
161924534|NCT02337946|584769700|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
161924535|NCT02337946|584769701|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
161924536|NCT02337946|584769702|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
161924537|NCT02337946|584769700|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
161924538|NCT02337946|584769701|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
161924539|NCT02337946|584769702|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
161924540|NCT02337946|584769700|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
161924541|NCT02337946|584769701|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
161924542|NCT02337946|584769702|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
161924543|NCT02337946|584769700|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
161924544|NCT02337946|584769701|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
162183510|NCT03582475|585723121|FG000|Follow-up Period|Withdrawal by Subject|0|||
162183511|NCT03582475|585723122|FG001|Follow-up Period|Withdrawal by Subject|1|||
162183512|NCT01400958|585723126|FG000|Overall Study|Physician Decision|0|||
162183513|NCT01400958|585723127|FG001|Overall Study|Physician Decision|1|||
162183514|NCT01400958|585723126|FG000|Overall Study|Withdrawal by Subject|0|||
162183515|NCT01400958|585723127|FG001|Overall Study|Withdrawal by Subject|1|||
162183516|NCT01400958|585723126|FG000|Overall Study|Adverse Event|1|||
162183517|NCT01400958|585723127|FG001|Overall Study|Adverse Event|0|||
161924545|NCT02337946|584769702|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
161924546|NCT01131585|584769703|FG000|Overall Study|Adverse Event|0|||
162183518|NCT04436289|585723128|FG000|Overall Study|Death prior to hospital discharge|8|||
162183519|NCT04436289|585723129|FG001|Overall Study|Death prior to hospital discharge|5|||
162183520|NCT04436289|585723130|FG002|Overall Study|Death prior to hospital discharge|0|||
162183521|NCT04436289|585723131|FG003|Overall Study|Death prior to hospital discharge|1|||
162183522|NCT04436289|585723128|FG000|Overall Study|Withdrawal by Subject|0|||
162183523|NCT04436289|585723129|FG001|Overall Study|Withdrawal by Subject|1|||
162183524|NCT04436289|585723130|FG002|Overall Study|Withdrawal by Subject|4|||
162183525|NCT04436289|585723131|FG003|Overall Study|Withdrawal by Subject|0|||
162183526|NCT04436289|585723128|FG000|Overall Study|Extended hospital stay|0|||
162183527|NCT04436289|585723129|FG001|Overall Study|Extended hospital stay|1|||
162183528|NCT04436289|585723130|FG002|Overall Study|Extended hospital stay|0|||
162183529|NCT04436289|585723131|FG003|Overall Study|Extended hospital stay|0|||
162183530|NCT04436289|585723128|FG000|Overall Study|Lost to Follow-up|0|||
162183531|NCT04436289|585723129|FG001|Overall Study|Lost to Follow-up|4|||
162183532|NCT04436289|585723130|FG002|Overall Study|Lost to Follow-up|1|||
162183533|NCT04436289|585723131|FG003|Overall Study|Lost to Follow-up|3|||
162183534|NCT00589875|585723132|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
162183535|NCT00589875|585723132|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
162183536|NCT03598907|585723139|FG000|Overall Study|Physician Decision|14|||
162183537|NCT03598907|585723140|FG001|Overall Study|Physician Decision|19|||
162183538|NCT01675492|585723143|FG000|Overall Study|study completed early - product approval|42|||
162183539|NCT04517435|585723160|FG000|Overall Study|Withdrawal by Subject|0|||
162183540|NCT04517435|585723161|FG001|Overall Study|Withdrawal by Subject|0|||
162183541|NCT04517435|585723162|FG002|Overall Study|Withdrawal by Subject|1|||
162183542|NCT04517435|585723160|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
162183543|NCT04517435|585723161|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
162183544|NCT04517435|585723162|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
162183545|NCT06191679|585723163|FG000|Baseline|Lost to Follow-up|1|||
162183546|NCT06191679|585723164|FG001|Baseline|Lost to Follow-up|0|||
162183547|NCT06191679|585723165|FG002|Baseline|Lost to Follow-up|1|||
162183548|NCT06191679|585723166|FG003|Baseline|Lost to Follow-up|0|||
162183549|NCT06191679|585723163|FG000|Allocation to Group|Withdrawal by Subject|0|||
162183550|NCT06191679|585723164|FG001|Allocation to Group|Withdrawal by Subject|1|||
162183551|NCT06191679|585723165|FG002|Allocation to Group|Withdrawal by Subject|2|||
162183552|NCT06191679|585723166|FG003|Allocation to Group|Withdrawal by Subject|0|||
162183553|NCT06191679|585723163|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
162183554|NCT06191679|585723164|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
162183555|NCT06191679|585723165|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
162183556|NCT06191679|585723166|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
162183557|NCT06191679|585723163|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
162183558|NCT06191679|585723164|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
162183559|NCT06191679|585723165|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
162183560|NCT06191679|585723166|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
162183561|NCT06191679|585723163|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
162183562|NCT06191679|585723164|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
162183563|NCT06191679|585723165|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
162183564|NCT06191679|585723166|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
162183565|NCT03656718|585723167|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
162183566|NCT03656718|585723168|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
162183567|NCT03656718|585723169|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
162183568|NCT03656718|585723170|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
162183569|NCT03656718|585723171|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
162183570|NCT03656718|585723172|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
162183571|NCT03656718|585723173|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
162183572|NCT03656718|585723167|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
162183573|NCT03656718|585723168|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
162183574|NCT03656718|585723169|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
162183575|NCT03656718|585723170|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
162183576|NCT03656718|585723171|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
162183577|NCT03656718|585723172|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
162183578|NCT03656718|585723173|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
162183579|NCT03656718|585723167|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
161818414|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
161818415|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
161818416|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
161818417|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
161818418|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
161818419|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
162183580|NCT03656718|585723168|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
162183581|NCT03656718|585723169|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
162183582|NCT03656718|585723170|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
162183583|NCT03656718|585723171|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
162183584|NCT03656718|585723172|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
162183585|NCT03656718|585723173|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
162183586|NCT03656718|585723167|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161924547|NCT01131585|584769704|FG001|Overall Study|Adverse Event|2|||
161924548|NCT01131585|584769703|FG000|Overall Study|Abnormal laboratory value|1|||
161924549|NCT01131585|584769704|FG001|Overall Study|Abnormal laboratory value|0|||
161924550|NCT01131585|584769703|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161924551|NCT01131585|584769704|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161924552|NCT01131585|584769703|FG000|Overall Study|Protocol Violation|2|||
161924553|NCT01131585|584769704|FG001|Overall Study|Protocol Violation|1|||
161924554|NCT01131585|584769703|FG000|Overall Study|Withdrawal by Subject|3|||
161924555|NCT01131585|584769704|FG001|Overall Study|Withdrawal by Subject|3|||
161924556|NCT01131585|584769703|FG000|Overall Study|Lost to Follow-up|0|||
161924557|NCT01131585|584769704|FG001|Overall Study|Lost to Follow-up|1|||
161924558|NCT01131585|584769703|FG000|Overall Study|Administrative problems|1|||
161924559|NCT01131585|584769704|FG001|Overall Study|Administrative problems|1|||
161924560|NCT01131585|584769703|FG000|Overall Study|Study termination|78|||
161924561|NCT01131585|584769704|FG001|Overall Study|Study termination|32|||
162019217|NCT00859638|585124876|FG001|Overall Study|Withdrawal by Subject|2|||
162019218|NCT00859638|585124875|FG000|Overall Study|Ill health|1|||
162019219|NCT00859638|585124876|FG001|Overall Study|Ill health|1|||
162019220|NCT00771953|585124880|FG000|Overall Study|Adverse Event|5|||
162019221|NCT00771953|585124881|FG001|Overall Study|Adverse Event|3|||
162019222|NCT00771953|585124880|FG000|Overall Study|Death|2|||
162019223|NCT00771953|585124881|FG001|Overall Study|Death|2|||
162183587|NCT03656718|585723168|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161924562|NCT02949934|584769705|FG000|Natural Drinking Period|Adverse Event|1|||
161924563|NCT02949934|584769706|FG001|Natural Drinking Period|Adverse Event|0|||
161924564|NCT02949934|584769707|FG002|Natural Drinking Period|Adverse Event|0|||
161924565|NCT02949934|584769708|FG003|Natural Drinking Period|Adverse Event|1|||
162019224|NCT00771953|585124880|FG000|Overall Study|Progression before active Tx|1|||
162183588|NCT03656718|585723169|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161924566|NCT02949934|584769709|FG004|Natural Drinking Period|Adverse Event|0|||
161924567|NCT02949934|584769710|FG005|Natural Drinking Period|Adverse Event|0|||
161924568|NCT02949934|584769705|FG000|Natural Drinking Period|Lost to Follow-up|0|||
162019225|NCT00771953|585124881|FG001|Overall Study|Progression before active Tx|2|||
161924569|NCT02949934|584769706|FG001|Natural Drinking Period|Lost to Follow-up|0|||
162019226|NCT00771953|585124880|FG000|Overall Study|Sponsor decision|1|||
162183589|NCT03656718|585723170|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
162183590|NCT03656718|585723171|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
162183591|NCT03656718|585723172|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
162183592|NCT03656718|585723173|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
162183593|NCT03656718|585723167|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
162183594|NCT03656718|585723168|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
162183595|NCT03656718|585723169|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
162183596|NCT03656718|585723170|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
162183597|NCT03656718|585723171|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
162183598|NCT03656718|585723172|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
162183599|NCT03656718|585723173|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
162183600|NCT03656718|585723167|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
162183601|NCT03656718|585723168|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
162183602|NCT03656718|585723169|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
162183603|NCT03656718|585723170|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
162183604|NCT03656718|585723171|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
162183605|NCT03656718|585723172|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
162183606|NCT03656718|585723173|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
162183607|NCT03656718|585723167|FG000|Treatment Period Part C|Disease progression|0|||
162183608|NCT03656718|585723168|FG001|Treatment Period Part C|Disease progression|0|||
162183609|NCT03656718|585723169|FG002|Treatment Period Part C|Disease progression|0|||
162183610|NCT03656718|585723170|FG003|Treatment Period Part C|Disease progression|0|||
162183611|NCT03656718|585723171|FG004|Treatment Period Part C|Disease progression|12|||
162183612|NCT03656718|585723172|FG005|Treatment Period Part C|Disease progression|0|||
162183613|NCT03656718|585723173|FG006|Treatment Period Part C|Disease progression|0|||
162183614|NCT03656718|585723167|FG000|Treatment Period Part C|Death|0|||
162183615|NCT03656718|585723168|FG001|Treatment Period Part C|Death|0|||
162183616|NCT03656718|585723169|FG002|Treatment Period Part C|Death|0|||
162183617|NCT03656718|585723170|FG003|Treatment Period Part C|Death|0|||
162183618|NCT03656718|585723171|FG004|Treatment Period Part C|Death|1|||
162183619|NCT03656718|585723172|FG005|Treatment Period Part C|Death|0|||
162183620|NCT03656718|585723173|FG006|Treatment Period Part C|Death|0|||
162183621|NCT03656718|585723167|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
162183622|NCT03656718|585723168|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
162183623|NCT03656718|585723169|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
162183624|NCT03656718|585723170|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
162183625|NCT03656718|585723171|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
162183626|NCT03656718|585723172|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
162183627|NCT03656718|585723173|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
162183628|NCT03656718|585723167|FG000|Treatment Period Part C|Other reasons|0|||
162183629|NCT03656718|585723168|FG001|Treatment Period Part C|Other reasons|0|||
162183630|NCT03656718|585723169|FG002|Treatment Period Part C|Other reasons|0|||
162183631|NCT03656718|585723170|FG003|Treatment Period Part C|Other reasons|0|||
162183632|NCT03656718|585723171|FG004|Treatment Period Part C|Other reasons|1|||
162183633|NCT03656718|585723172|FG005|Treatment Period Part C|Other reasons|0|||
162183634|NCT03656718|585723173|FG006|Treatment Period Part C|Other reasons|0|||
162183635|NCT03656718|585723167|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
162183636|NCT03656718|585723168|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
162183637|NCT03656718|585723169|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
162183638|NCT03656718|585723170|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
162183639|NCT03656718|585723171|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
162183640|NCT03656718|585723172|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
162183641|NCT03656718|585723173|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
162183642|NCT03211247|585723174|FG000|Overall Study|Adverse Event|8|||
162183643|NCT03211247|585723175|FG001|Overall Study|Adverse Event|0|||
162183644|NCT03211247|585723176|FG002|Overall Study|Adverse Event|1|||
162183645|NCT03211247|585723177|FG003|Overall Study|Adverse Event|0|||
162183646|NCT03211247|585723178|FG004|Overall Study|Adverse Event|0|||
162183647|NCT03211247|585723174|FG000|Overall Study|Lost to Follow-up|2|||
162183648|NCT03211247|585723175|FG001|Overall Study|Lost to Follow-up|1|||
162183649|NCT03211247|585723176|FG002|Overall Study|Lost to Follow-up|0|||
162183650|NCT03211247|585723177|FG003|Overall Study|Lost to Follow-up|0|||
162183651|NCT03211247|585723178|FG004|Overall Study|Lost to Follow-up|0|||
162183652|NCT03211247|585723174|FG000|Overall Study|Physician Decision|1|||
162183653|NCT03211247|585723175|FG001|Overall Study|Physician Decision|2|||
162183654|NCT03211247|585723176|FG002|Overall Study|Physician Decision|0|||
162183655|NCT03211247|585723177|FG003|Overall Study|Physician Decision|0|||
161672428|NCT03602261|583853131|FG000|Overall Study|Subject moving out of state|1|||
161672429|NCT03602261|583853132|FG001|Overall Study|Subject moving out of state|0|||
161672430|NCT06071754|583853133|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
161672431|NCT03226275|583853134|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
161672432|NCT03226275|583853135|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
161672433|NCT03226275|583853136|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
161672434|NCT03226275|583853137|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
161672435|NCT03226275|583853134|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
161672436|NCT03226275|583853135|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
161672437|NCT03226275|583853136|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
161672438|NCT03226275|583853137|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
161672439|NCT01436071|583854453|FG000|Overall Study|Adverse Event|1|||
161672440|NCT01436071|583854454|FG001|Overall Study|Adverse Event|0|||
162183656|NCT03211247|585723178|FG004|Overall Study|Physician Decision|0|||
162183657|NCT03211247|585723174|FG000|Overall Study|Non-compliance with study drug|2|||
162183658|NCT03211247|585723175|FG001|Overall Study|Non-compliance with study drug|0|||
162183659|NCT03211247|585723176|FG002|Overall Study|Non-compliance with study drug|0|||
162183660|NCT03211247|585723177|FG003|Overall Study|Non-compliance with study drug|0|||
162183661|NCT03211247|585723178|FG004|Overall Study|Non-compliance with study drug|0|||
162183662|NCT03211247|585723174|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
162183663|NCT03211247|585723175|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
162183664|NCT03211247|585723176|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
162183665|NCT03211247|585723177|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
162183666|NCT03211247|585723178|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
162183667|NCT03211247|585723174|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
162183668|NCT03211247|585723175|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
162183669|NCT03211247|585723176|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
162183670|NCT03211247|585723177|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
162183671|NCT03211247|585723178|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
162183672|NCT03211247|585723174|FG000|Overall Study|Protocol Violation|0|||
162183673|NCT03211247|585723175|FG001|Overall Study|Protocol Violation|1|||
162183674|NCT03211247|585723176|FG002|Overall Study|Protocol Violation|0|||
162183675|NCT03211247|585723177|FG003|Overall Study|Protocol Violation|0|||
162183676|NCT03211247|585723178|FG004|Overall Study|Protocol Violation|0|||
162183677|NCT02415127|585723179|FG000|Overall Study|Adverse Event|1|||
162183678|NCT02415127|585723180|FG001|Overall Study|Adverse Event|0|||
162183679|NCT05827068|585723181|FG000|Overall Study|Lost to Follow-up|1|||
162183680|NCT05827068|585723182|FG001|Overall Study|Lost to Follow-up|4|||
162183681|NCT05827068|585723183|FG002|Overall Study|Lost to Follow-up|1|||
162183682|NCT05827068|585723184|FG003|Overall Study|Lost to Follow-up|1|||
162183683|NCT05827068|585723185|FG004|Overall Study|Lost to Follow-up|2|||
162183684|NCT05827068|585723186|FG005|Overall Study|Lost to Follow-up|4|||
162183685|NCT05827068|585723187|FG006|Overall Study|Lost to Follow-up|1|||
162183686|NCT05827068|585723181|FG000|Overall Study|Withdrawal by Subject|4|||
161672441|NCT01436071|583854453|FG000|Overall Study|Lack of Efficacy|16|||
161672442|NCT01436071|583854454|FG001|Overall Study|Lack of Efficacy|7|||
161672443|NCT01436071|583854453|FG000|Overall Study|Protocol Violation|0|||
161672444|NCT01436071|583854454|FG001|Overall Study|Protocol Violation|1|||
161672445|NCT01436071|583854453|FG000|Overall Study|Lost to Follow-up|3|||
161672446|NCT01436071|583854454|FG001|Overall Study|Lost to Follow-up|1|||
161672447|NCT01436071|583854453|FG000|Overall Study|Physician Decision|1|||
162183687|NCT05827068|585723182|FG001|Overall Study|Withdrawal by Subject|0|||
162183688|NCT05827068|585723183|FG002|Overall Study|Withdrawal by Subject|1|||
162183689|NCT05827068|585723184|FG003|Overall Study|Withdrawal by Subject|2|||
162183690|NCT05827068|585723185|FG004|Overall Study|Withdrawal by Subject|3|||
161818420|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
161818421|NCT01438060|584376071|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
161818422|NCT01438060|584376072|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
161818423|NCT01438060|584376071|FG000|On Study Beyond Week 140|Adverse Event|0|||
161818424|NCT01438060|584376072|FG001|On Study Beyond Week 140|Adverse Event|2|||
161818425|NCT01438060|584376071|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
161818426|NCT01438060|584376072|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
161818427|NCT01438060|584376071|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
161818428|NCT01438060|584376072|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
161818429|NCT01438060|584376071|FG000|On Study Beyond Week 140|Death|0|||
161818430|NCT01438060|584376072|FG001|On Study Beyond Week 140|Death|1|||
161818431|NCT01438060|584376071|FG000|On Study Beyond Week 140|Other Reason|0|||
161818432|NCT01438060|584376072|FG001|On Study Beyond Week 140|Other Reason|3|||
161818433|NCT03602339|584376073|FG000|Overall Study|Withdrawal by Subject|9|||
162183691|NCT05827068|585723186|FG005|Overall Study|Withdrawal by Subject|0|||
162183692|NCT05827068|585723187|FG006|Overall Study|Withdrawal by Subject|1|||
162183693|NCT05827068|585723181|FG000|Overall Study|Physician Decision|0|||
162183694|NCT05827068|585723182|FG001|Overall Study|Physician Decision|0|||
162183695|NCT05827068|585723183|FG002|Overall Study|Physician Decision|0|||
162183696|NCT05827068|585723184|FG003|Overall Study|Physician Decision|0|||
162183697|NCT05827068|585723185|FG004|Overall Study|Physician Decision|1|||
162183698|NCT05827068|585723186|FG005|Overall Study|Physician Decision|0|||
162183699|NCT05827068|585723187|FG006|Overall Study|Physician Decision|1|||
162183700|NCT05827068|585723181|FG000|Overall Study|Other Than Specified|0|||
162183701|NCT05827068|585723182|FG001|Overall Study|Other Than Specified|1|||
162183702|NCT05827068|585723183|FG002|Overall Study|Other Than Specified|0|||
162183703|NCT05827068|585723184|FG003|Overall Study|Other Than Specified|0|||
162183704|NCT05827068|585723185|FG004|Overall Study|Other Than Specified|0|||
162183705|NCT05827068|585723186|FG005|Overall Study|Other Than Specified|0|||
162183706|NCT05827068|585723187|FG006|Overall Study|Other Than Specified|0|||
162183707|NCT05630833|585723190|FG000|Overall Study|Adverse Event|3|||
162183708|NCT05630833|585723191|FG001|Overall Study|Adverse Event|0|||
162183709|NCT05630833|585723190|FG000|Overall Study|Lack of Efficacy|0|||
162183710|NCT05630833|585723191|FG001|Overall Study|Lack of Efficacy|1|||
162183711|NCT05630833|585723190|FG000|Overall Study|Lost to Follow-up|1|||
162183712|NCT05630833|585723191|FG001|Overall Study|Lost to Follow-up|0|||
162183713|NCT05630833|585723190|FG000|Overall Study|Withdrawal by Subject|3|||
162183714|NCT05630833|585723191|FG001|Overall Study|Withdrawal by Subject|1|||
162183715|NCT05071430|585723192|FG000|Overall Study|Adverse Event|1|||
162183716|NCT05071430|585723193|FG001|Overall Study|Adverse Event|2|||
162183717|NCT05071430|585723192|FG000|Overall Study|Lost to Follow-up|4|||
162183718|NCT05071430|585723193|FG001|Overall Study|Lost to Follow-up|4|||
162183719|NCT05071430|585723192|FG000|Overall Study|Protocol Violation|1|||
162183720|NCT05071430|585723193|FG001|Overall Study|Protocol Violation|0|||
162183721|NCT05071430|585723192|FG000|Overall Study|Withdrawal by Subject|3|||
162183722|NCT05071430|585723193|FG001|Overall Study|Withdrawal by Subject|2|||
162183723|NCT05071430|585723192|FG000|Overall Study|Other|1|||
162183724|NCT05071430|585723193|FG001|Overall Study|Other|1|||
162183725|NCT01958021|585723194|FG000|Treatment|Progressive disease|206|||
162183726|NCT01958021|585723195|FG001|Treatment|Progressive disease|265|||
162183727|NCT01958021|585723194|FG000|Treatment|Adverse Event|38|||
162183728|NCT01958021|585723195|FG001|Treatment|Adverse Event|10|||
162183729|NCT01958021|585723194|FG000|Treatment|Subject/guardian decision|29|||
162183730|NCT01958021|585723195|FG001|Treatment|Subject/guardian decision|25|||
162183731|NCT01958021|585723194|FG000|Treatment|Physician Decision|28|||
162183732|NCT01958021|585723195|FG001|Treatment|Physician Decision|21|||
162183733|NCT01958021|585723194|FG000|Treatment|Death|6|||
162183734|NCT01958021|585723195|FG001|Treatment|Death|1|||
162183735|NCT01958021|585723194|FG000|Treatment|Protocol deviation|3|||
162183736|NCT01958021|585723195|FG001|Treatment|Protocol deviation|1|||
161818434|NCT03602339|584376073|FG000|Overall Study|Physician Decision|2|||
161818435|NCT03602339|584376073|FG000|Overall Study|Other reason|4|||
161924570|NCT02949934|584769707|FG002|Natural Drinking Period|Lost to Follow-up|0|||
161924571|NCT02949934|584769708|FG003|Natural Drinking Period|Lost to Follow-up|0|||
161924572|NCT02949934|584769709|FG004|Natural Drinking Period|Lost to Follow-up|1|||
161924573|NCT02949934|584769710|FG005|Natural Drinking Period|Lost to Follow-up|0|||
162183737|NCT01958021|585723194|FG000|Treatment|Sponsor decision|24|||
162183738|NCT01958021|585723195|FG001|Treatment|Sponsor decision|11|||
162183739|NCT01958021|585723194|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
162183740|NCT01958021|585723195|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162183741|NCT01958021|585723194|FG000|Post-treatment Efficacy Follow-up|Death|1|||
162183742|NCT01958021|585723195|FG001|Post-treatment Efficacy Follow-up|Death|0|||
162183743|NCT01958021|585723194|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
162183744|NCT01958021|585723195|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162183745|NCT01958021|585723194|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
162183746|NCT01958021|585723195|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
162183747|NCT01958021|585723194|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
161672448|NCT01436071|583854454|FG001|Overall Study|Physician Decision|0|||
161672449|NCT01436071|583854453|FG000|Overall Study|Withdrawal by Subject|2|||
161672450|NCT01436071|583854454|FG001|Overall Study|Withdrawal by Subject|2|||
161672451|NCT01436071|583854453|FG000|Overall Study|Did Not Receive Trial Medication|3|||
161672452|NCT01436071|583854454|FG001|Overall Study|Did Not Receive Trial Medication|3|||
161672453|NCT00352885|583854457|FG000|Overall Study|Withdrawal by Subject|0|||
161672454|NCT00352885|583854458|FG001|Overall Study|Withdrawal by Subject|3|||
161672455|NCT00352885|583854457|FG000|Overall Study|Development of major depression|0|||
161672456|NCT00352885|583854458|FG001|Overall Study|Development of major depression|1|||
162183748|NCT01958021|585723195|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
161672457|NCT00352885|583854457|FG000|Overall Study|Progression of metastatic melanoma|5|||
161672458|NCT00352885|583854458|FG001|Overall Study|Progression of metastatic melanoma|3|||
161672459|NCT00352885|583854457|FG000|Overall Study|Side effects of IL-2 administration|1|||
161672460|NCT00352885|583854458|FG001|Overall Study|Side effects of IL-2 administration|0|||
161672461|NCT01920594|583854459|FG000|Overall Study|Adverse Event|4|||
161672462|NCT01920594|583854460|FG001|Overall Study|Adverse Event|2|||
161672463|NCT01920594|583854459|FG000|Overall Study|Lost to Follow-up|1|||
161672464|NCT01920594|583854460|FG001|Overall Study|Lost to Follow-up|0|||
161672465|NCT01920594|583854459|FG000|Overall Study|Recovery|2|||
161672466|NCT01920594|583854460|FG001|Overall Study|Recovery|0|||
161672467|NCT01920594|583854459|FG000|Overall Study|Investigator discretion|0|||
161672468|NCT01920594|583854460|FG001|Overall Study|Investigator discretion|1|||
161672469|NCT01096342|583854461|FG000|Overall Study|Protocol Violation|1|||
161672470|NCT04906616|583854462|FG000|Overall Study|Divorce|3|||
161672471|NCT04906616|583854463|FG001|Overall Study|Divorce|2|||
161672472|NCT01521897|583854464|FG000|Overall Study|Protocol Violation|18|||
161672473|NCT01521897|583854464|FG000|Overall Study|Lost to Follow-up|5|||
161672474|NCT00385203|583854465|FG000|Overall Study|Adverse Event|5|||
161672475|NCT00385203|583854466|FG001|Overall Study|Adverse Event|4|||
161672476|NCT00385203|583854465|FG000|Overall Study|Death|1|||
161672477|NCT00385203|583854466|FG001|Overall Study|Death|0|||
161672478|NCT00385203|583854465|FG000|Overall Study|Condition under investigation worsened|18|||
161672479|NCT00385203|583854466|FG001|Overall Study|Condition under investigation worsened|3|||
161672480|NCT00385203|583854465|FG000|Overall Study|Incorrect enrollment|2|||
161672481|NCT00385203|583854466|FG001|Overall Study|Incorrect enrollment|0|||
161672482|NCT02194062|583854467|FG000|Overall Study|Lost to Follow-up|2|||
161672483|NCT02194062|583854468|FG001|Overall Study|Lost to Follow-up|2|||
161672484|NCT02194062|583854469|FG002|Overall Study|Lost to Follow-up|5|||
161672485|NCT03422172|583854470|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
161672486|NCT03422172|583854470|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
161672487|NCT03422172|583854470|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
161672488|NCT04147234|583854471|FG000|Overall Study|Clinical deterioration|0|||
161672489|NCT04147234|583854472|FG001|Overall Study|Clinical deterioration|0|||
161672490|NCT04147234|583854473|FG002|Overall Study|Clinical deterioration|1|||
161672491|NCT04147234|583854474|FG003|Overall Study|Clinical deterioration|0|||
161672492|NCT04147234|583854475|FG004|Overall Study|Clinical deterioration|0|||
162183749|NCT01958021|585723194|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
162183750|NCT01958021|585723195|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
162183751|NCT01958021|585723194|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
162183752|NCT01958021|585723195|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
162183753|NCT00490139|585723196|FG000|Overall Study|Lost to Follow-up|249|||
162183754|NCT00490139|585723197|FG001|Overall Study|Lost to Follow-up|216|||
162183755|NCT00490139|585723198|FG002|Overall Study|Lost to Follow-up|205|||
162183756|NCT00490139|585723199|FG003|Overall Study|Lost to Follow-up|229|||
162183757|NCT00490139|585723196|FG000|Overall Study|Withdrawal by Subject|333|||
162183758|NCT00490139|585723197|FG001|Overall Study|Withdrawal by Subject|322|||
161672493|NCT04147234|583854476|FG005|Overall Study|Clinical deterioration|0|||
162183759|NCT00490139|585723198|FG002|Overall Study|Withdrawal by Subject|396|||
161672494|NCT04147234|583854477|FG006|Overall Study|Clinical deterioration|0|||
161672495|NCT04147234|583854471|FG000|Overall Study|Withdrawal by Subject|0|||
161672496|NCT04147234|583854472|FG001|Overall Study|Withdrawal by Subject|1|||
161672497|NCT04147234|583854473|FG002|Overall Study|Withdrawal by Subject|1|||
161672498|NCT04147234|583854474|FG003|Overall Study|Withdrawal by Subject|0|||
161672499|NCT04147234|583854475|FG004|Overall Study|Withdrawal by Subject|0|||
162019227|NCT00771953|585124881|FG001|Overall Study|Sponsor decision|0|||
161672500|NCT04147234|583854476|FG005|Overall Study|Withdrawal by Subject|0|||
161672501|NCT04147234|583854477|FG006|Overall Study|Withdrawal by Subject|0|||
161672502|NCT04147234|583854471|FG000|Overall Study|Clinical disease progression|1|||
161672503|NCT04147234|583854472|FG001|Overall Study|Clinical disease progression|3|||
161672504|NCT04147234|583854473|FG002|Overall Study|Clinical disease progression|1|||
161672505|NCT04147234|583854474|FG003|Overall Study|Clinical disease progression|1|||
161672506|NCT04147234|583854475|FG004|Overall Study|Clinical disease progression|0|||
161672507|NCT04147234|583854476|FG005|Overall Study|Clinical disease progression|1|||
162183760|NCT00490139|585723199|FG003|Overall Study|Withdrawal by Subject|295|||
162183761|NCT00490139|585723196|FG000|Overall Study|Patient did not sign ICF 12|169|||
161672508|NCT04147234|583854477|FG006|Overall Study|Clinical disease progression|0|||
161672509|NCT04147234|583854471|FG000|Overall Study|Objective disease progression|6|||
161672510|NCT04147234|583854472|FG001|Overall Study|Objective disease progression|4|||
161672511|NCT04147234|583854473|FG002|Overall Study|Objective disease progression|3|||
161672512|NCT04147234|583854474|FG003|Overall Study|Objective disease progression|3|||
161672513|NCT04147234|583854475|FG004|Overall Study|Objective disease progression|5|||
161672514|NCT04147234|583854476|FG005|Overall Study|Objective disease progression|2|||
161672515|NCT04147234|583854477|FG006|Overall Study|Objective disease progression|3|||
161672516|NCT04147234|583854471|FG000|Overall Study|Adverse Event|0|||
161672517|NCT04147234|583854472|FG001|Overall Study|Adverse Event|0|||
161672518|NCT04147234|583854473|FG002|Overall Study|Adverse Event|0|||
161672519|NCT04147234|583854474|FG003|Overall Study|Adverse Event|0|||
161672520|NCT04147234|583854475|FG004|Overall Study|Adverse Event|1|||
161672521|NCT04147234|583854476|FG005|Overall Study|Adverse Event|0|||
161672522|NCT04147234|583854477|FG006|Overall Study|Adverse Event|0|||
161672523|NCT00293722|583854486|FG000|Overall Study|Other|427|||
161672524|NCT04498169|583854489|FG000|Study Completion|Adverse Event|1|||
161672525|NCT04498169|583854490|FG001|Study Completion|Adverse Event|1|||
161672526|NCT01754857|583854491|FG000|Overall Study|Adverse Event|7|||
161672527|NCT01754857|583854491|FG000|Overall Study|Disease progression|3|||
161672528|NCT01754857|583854491|FG000|Overall Study|Physician Decision|2|||
161672529|NCT01754857|583854491|FG000|Overall Study|Withdrawal by Subject|3|||
161672530|NCT01754857|583854491|FG000|Overall Study|other complicating disease|1|||
161672531|NCT01754857|583854491|FG000|Overall Study|ineligible to continue onto maintenance|1|||
161672532|NCT01754857|583854491|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
161672533|NCT01754857|583854491|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
161672534|NCT04964960|583854492|FG000|Overall Study|Withdrawal by Subject|1|||
161672535|NCT04964960|583854492|FG000|Overall Study|Did not complete cycles|1|||
161672536|NCT02960854|583854495|FG000|Overall Study|Not Disclosed|2|||
162183762|NCT00490139|585723197|FG001|Overall Study|Patient did not sign ICF 12|176|||
162183763|NCT00490139|585723198|FG002|Overall Study|Patient did not sign ICF 12|139|||
162183764|NCT00490139|585723199|FG003|Overall Study|Patient did not sign ICF 12|167|||
162183765|NCT00490139|585723196|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
162183766|NCT00490139|585723197|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
162183767|NCT00490139|585723198|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
162183768|NCT00490139|585723199|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
162183769|NCT00490139|585723196|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
162183770|NCT00490139|585723197|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
162183771|NCT00490139|585723198|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
162183772|NCT00490139|585723199|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
162183773|NCT00490139|585723196|FG000|Overall Study|Other reasons as defined per protocol|98|||
162183774|NCT00490139|585723197|FG001|Overall Study|Other reasons as defined per protocol|84|||
162183775|NCT00490139|585723198|FG002|Overall Study|Other reasons as defined per protocol|82|||
162183776|NCT00490139|585723199|FG003|Overall Study|Other reasons as defined per protocol|105|||
162183777|NCT02036970|585724496|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
162183778|NCT02036970|585724497|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
161672537|NCT02960854|583854496|FG001|Overall Study|Not Disclosed|2|||
161672538|NCT02960854|583854495|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
161672539|NCT02960854|583854496|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
161672540|NCT02960854|583854495|FG000|Overall Study|Subject Withdrew Consent|0|||
161672541|NCT02960854|583854496|FG001|Overall Study|Subject Withdrew Consent|1|||
161672542|NCT02960854|583854495|FG000|Overall Study|Death|4|||
161672543|NCT02960854|583854496|FG001|Overall Study|Death|6|||
161672544|NCT00221195|583854497|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
161672545|NCT00221195|583854498|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
161672546|NCT00221195|583854497|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
161672547|NCT00221195|583854498|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
162183779|NCT02036970|585724498|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
162183780|NCT02036970|585724499|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
162183781|NCT02036970|585724500|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
162183782|NCT02036970|585724501|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
161672548|NCT00221195|583854497|FG000|Washout Period (Months 7-9)|Death|0|||
161672549|NCT00221195|583854498|FG001|Washout Period (Months 7-9)|Death|1|||
161672550|NCT00221195|583854497|FG000|Therapy 2 (Months 10-15)|Death|1|||
161672551|NCT00221195|583854498|FG001|Therapy 2 (Months 10-15)|Death|0|||
161672552|NCT00221195|583854497|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
161672553|NCT00221195|583854498|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
161672554|NCT01383161|583854500|FG000|Overall Study|Adverse Event|5|||
161672555|NCT01383161|583854501|FG001|Overall Study|Adverse Event|1|||
161672556|NCT01383161|583854500|FG000|Overall Study|Withdrawal by Subject|0|||
162183783|NCT02036970|585724502|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
161672557|NCT01383161|583854501|FG001|Overall Study|Withdrawal by Subject|2|||
162183784|NCT02036970|585724503|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
162183785|NCT02036970|585724504|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
162183786|NCT02036970|585724505|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
162183787|NCT02036970|585724496|FG000|Part 1: Day 1 Through Week 16|Death|0|||
162183788|NCT02036970|585724497|FG001|Part 1: Day 1 Through Week 16|Death|0|||
162183789|NCT02036970|585724498|FG002|Part 1: Day 1 Through Week 16|Death|0|||
162183790|NCT02036970|585724499|FG003|Part 1: Day 1 Through Week 16|Death|0|||
162183791|NCT02036970|585724500|FG004|Part 1: Day 1 Through Week 16|Death|0|||
162183792|NCT02036970|585724501|FG005|Part 1: Day 1 Through Week 16|Death|0|||
162183793|NCT02036970|585724502|FG006|Part 1: Day 1 Through Week 16|Death|0|||
162183794|NCT02036970|585724503|FG007|Part 1: Day 1 Through Week 16|Death|0|||
162183795|NCT02036970|585724504|FG008|Part 1: Day 1 Through Week 16|Death|1|||
162183796|NCT02036970|585724505|FG009|Part 1: Day 1 Through Week 16|Death|0|||
162183797|NCT02036970|585724496|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
162183798|NCT02036970|585724497|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162183799|NCT02036970|585724498|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
162183800|NCT02036970|585724499|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162183801|NCT02036970|585724500|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162183802|NCT02036970|585724501|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162183803|NCT02036970|585724502|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162183804|NCT02036970|585724503|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162183805|NCT02036970|585724504|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
162183806|NCT02036970|585724505|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
162183807|NCT02036970|585724496|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162183808|NCT02036970|585724497|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162183809|NCT02036970|585724498|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162183810|NCT02036970|585724499|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162183811|NCT02036970|585724500|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
162183812|NCT02036970|585724501|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162183813|NCT02036970|585724502|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162183814|NCT02036970|585724503|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
162183815|NCT02036970|585724504|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
162183816|NCT02036970|585724505|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
162183817|NCT02036970|585724496|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162183818|NCT02036970|585724497|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162183819|NCT02036970|585724498|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162183820|NCT02036970|585724499|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
162183821|NCT02036970|585724500|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162183822|NCT02036970|585724501|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162183823|NCT02036970|585724502|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162183824|NCT02036970|585724503|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162183825|NCT02036970|585724504|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162183826|NCT02036970|585724505|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
162183827|NCT02036970|585724496|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
162183828|NCT02036970|585724497|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
162183829|NCT02036970|585724498|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
162183830|NCT02036970|585724499|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
162183831|NCT02036970|585724500|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
162183832|NCT02036970|585724501|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
162183833|NCT02036970|585724502|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
162183834|NCT02036970|585724503|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
162183835|NCT02036970|585724504|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
162183836|NCT02036970|585724505|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
162183837|NCT02036970|585724496|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
162183838|NCT02036970|585724497|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
162183839|NCT02036970|585724498|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
162183840|NCT02036970|585724499|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
162183841|NCT02036970|585724500|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
162183842|NCT02036970|585724501|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
162183843|NCT02036970|585724502|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
162183844|NCT02036970|585724503|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
162183845|NCT02036970|585724504|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
162183846|NCT02036970|585724505|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
162183847|NCT02036970|585724496|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162183848|NCT02036970|585724497|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
162183849|NCT02036970|585724498|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
162183850|NCT02036970|585724499|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161672558|NCT01383161|583854500|FG000|Overall Study|Lack of Efficacy|0|||
161672559|NCT01383161|583854501|FG001|Overall Study|Lack of Efficacy|1|||
161672560|NCT01423812|583854508|FG000|Overall Study|Lost to Follow-up|2|||
161672561|NCT01423812|583854509|FG001|Overall Study|Lost to Follow-up|2|||
161672562|NCT01423812|583854508|FG000|Overall Study|Withdrawal by Subject|1|||
161672563|NCT01423812|583854509|FG001|Overall Study|Withdrawal by Subject|2|||
161672564|NCT01699789|583854510|FG000|Overall Study|Withdrawal by Subject|18|||
161672565|NCT01699789|583854511|FG001|Overall Study|Withdrawal by Subject|23|||
162183851|NCT02036970|585724500|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162183852|NCT02036970|585724501|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162183853|NCT02036970|585724502|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162183854|NCT02036970|585724503|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162183855|NCT02036970|585724504|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
162183856|NCT02036970|585724505|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
162183857|NCT02036970|585724496|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
162183858|NCT02036970|585724497|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
162183859|NCT02036970|585724498|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
162183860|NCT02036970|585724499|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
162183861|NCT02036970|585724500|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
162183862|NCT02036970|585724501|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
162183863|NCT02036970|585724502|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
162183864|NCT02036970|585724503|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
162183865|NCT02036970|585724504|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
162183866|NCT02036970|585724505|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
162183867|NCT02702843|585724506|FG000|Overall Study|Insufficient data to analyze|15|||
162183868|NCT02702843|585724507|FG001|Overall Study|Insufficient data to analyze|23|||
162183869|NCT05029284|585724510|FG000|Overall Study|Lost to Follow-up|1|||
162183870|NCT03002194|585724512|FG000|Overall Study|Lost to Follow-up|6|||
162183871|NCT03002194|585724512|FG000|Overall Study|Adverse Event|1|||
162183872|NCT03002194|585724512|FG000|Overall Study|Lack of Efficacy|1|||
162183873|NCT03002194|585724512|FG000|Overall Study|Withdrawal by Subject|2|||
162183874|NCT02232737|585724513|FG000|Overall Study|Lost to Follow-up|18|||
162183875|NCT02232737|585724514|FG001|Overall Study|Lost to Follow-up|28|||
162183876|NCT02232737|585724515|FG002|Overall Study|Lost to Follow-up|33|||
162183877|NCT02232737|585724513|FG000|Overall Study|Personal reasons|7|||
162183878|NCT02232737|585724514|FG001|Overall Study|Personal reasons|8|||
162183879|NCT02232737|585724515|FG002|Overall Study|Personal reasons|14|||
162183880|NCT02232737|585724513|FG000|Overall Study|Adverse Event|6|||
162183881|NCT02232737|585724514|FG001|Overall Study|Adverse Event|3|||
162183882|NCT02232737|585724515|FG002|Overall Study|Adverse Event|8|||
162183883|NCT02232737|585724513|FG000|Overall Study|Incarcerated|2|||
162183884|NCT02232737|585724514|FG001|Overall Study|Incarcerated|1|||
161672566|NCT01699789|583854510|FG000|Overall Study|Death|1|||
161672567|NCT01699789|583854511|FG001|Overall Study|Death|2|||
161672568|NCT01699789|583854510|FG000|Overall Study|Lost to Follow-up|83|||
161672569|NCT01699789|583854511|FG001|Overall Study|Lost to Follow-up|101|||
161672570|NCT00639223|583854512|FG000|Overall Study|Lost to Follow-up|0|||
161672571|NCT00639223|583854513|FG001|Overall Study|Lost to Follow-up|2|||
162183885|NCT02232737|585724515|FG002|Overall Study|Incarcerated|2|||
162183886|NCT02232737|585724513|FG000|Overall Study|Withdrawal by Subject|0|||
162183887|NCT02232737|585724514|FG001|Overall Study|Withdrawal by Subject|1|||
162183888|NCT02232737|585724515|FG002|Overall Study|Withdrawal by Subject|2|||
162183889|NCT02232737|585724513|FG000|Overall Study|Death|0|||
161672572|NCT02511678|583854514|FG000|Overall Study|Withdrawal by Subject|2|||
161672573|NCT02511678|583854514|FG000|Overall Study|Lost to Follow-up|4|||
162183890|NCT02232737|585724514|FG001|Overall Study|Death|1|||
162183891|NCT02232737|585724515|FG002|Overall Study|Death|1|||
162183892|NCT02232737|585724513|FG000|Overall Study|Physician Decision|1|||
162183893|NCT02232737|585724514|FG001|Overall Study|Physician Decision|3|||
161672574|NCT02511678|583854514|FG000|Overall Study|Death|19|||
161672575|NCT02511678|583854514|FG000|Overall Study|Adverse Event|1|||
161672576|NCT02511678|583854514|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
161672577|NCT02511678|583854514|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
161672578|NCT02511678|583854514|FG000|Overall Study|Required Radiofrequency Ablation|1|||
161818436|NCT01190865|584376079|FG000|Overall Study|Withdrawal by Subject|1|||
161818437|NCT01190865|584376079|FG000|Overall Study|Non-compliance|2|||
161818438|NCT00875524|584376081|FG000|Overall Study|Serious adverse event|0|||
161818439|NCT00875524|584376082|FG001|Overall Study|Serious adverse event|1|||
161818440|NCT00875524|584376081|FG000|Overall Study|Protocol Violation|4|||
161818441|NCT00875524|584376082|FG001|Overall Study|Protocol Violation|0|||
161818442|NCT00875524|584376081|FG000|Overall Study|Lost to Follow-up|1|||
161818443|NCT00875524|584376082|FG001|Overall Study|Lost to Follow-up|0|||
161818444|NCT00875524|584376081|FG000|Overall Study|Withdrawal by Subject|3|||
161818445|NCT00875524|584376082|FG001|Overall Study|Withdrawal by Subject|5|||
161818446|NCT00829452|584376083|FG000|First Intervention|Withdrawal by Subject|0|||
161818447|NCT00829452|584376084|FG001|First Intervention|Withdrawal by Subject|1|||
161818448|NCT00829452|584376083|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
161818449|NCT00829452|584376084|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
161818450|NCT00829452|584376083|FG000|Second Intervention|Physician Decision|0|||
161818451|NCT00829452|584376084|FG001|Second Intervention|Physician Decision|1|||
161818452|NCT00574847|584376093|FG000|Overall Study|Adverse Event|2|||
161818453|NCT00574847|584376094|FG001|Overall Study|Adverse Event|0|||
161818454|NCT00574847|584376093|FG000|Overall Study|Death|1|||
161818455|NCT00574847|584376094|FG001|Overall Study|Death|0|||
161818456|NCT00574847|584376093|FG000|Overall Study|Withdrawal by Subject|2|||
162183894|NCT02232737|585724515|FG002|Overall Study|Physician Decision|1|||
161672579|NCT02511678|583854514|FG000|Overall Study|Biopsy was Negative|1|||
161672580|NCT02511678|583854514|FG000|Overall Study|Protocol Violation|1|||
161672581|NCT02511678|583854514|FG000|Overall Study|Received Radiation Treatment|1|||
161672582|NCT01295281|583854517|FG000|First Intervention (7 Days)|Death|0|||
161672583|NCT01295281|583854518|FG001|First Intervention (7 Days)|Death|1|||
161672584|NCT00292461|583854519|FG000|Overall Study|Adverse Event|4|||
161672585|NCT00292461|583854520|FG001|Overall Study|Adverse Event|2|||
161672586|NCT00292461|583854519|FG000|Overall Study|Lack of Efficacy|1|||
161672587|NCT00292461|583854520|FG001|Overall Study|Lack of Efficacy|0|||
161672588|NCT00292461|583854519|FG000|Overall Study|Withdrawal by Subject|0|||
161672589|NCT00292461|583854520|FG001|Overall Study|Withdrawal by Subject|1|||
161672590|NCT00292461|583854519|FG000|Overall Study|Protocol Violation|4|||
161672591|NCT00292461|583854520|FG001|Overall Study|Protocol Violation|3|||
161672592|NCT00292461|583854519|FG000|Overall Study|Lost to Follow-up|1|||
161672593|NCT00292461|583854520|FG001|Overall Study|Lost to Follow-up|0|||
161672594|NCT00633061|583854528|FG000|Overall Study|Study closed|86|||
161672595|NCT00633061|583854529|FG001|Overall Study|Study closed|0|||
161672596|NCT02000427|583854530|FG000|Overall Study|Death|22|||
161672597|NCT05125679|583854533|FG000|Overall Study|Study Terminated by Sponsor|2|||
161672598|NCT05125679|583854534|FG001|Overall Study|Study Terminated by Sponsor|5|||
161672599|NCT06268288|583854539|FG000|Overall Study|Withdrawal by Subject|1|||
161672600|NCT06268288|583854540|FG001|Overall Study|Withdrawal by Subject|2|||
161672601|NCT03049735|583854543|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
161672602|NCT03049735|583854544|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
161672603|NCT03049735|583854545|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
161672604|NCT03049735|583854543|FG000|Overall Study|Other|5|||
161672605|NCT03049735|583854544|FG001|Overall Study|Other|3|||
161672606|NCT03049735|583854545|FG002|Overall Study|Other|1|||
161672607|NCT03049735|583854543|FG000|Overall Study|Lack of Efficacy|4|||
161672608|NCT03049735|583854544|FG001|Overall Study|Lack of Efficacy|0|||
161672609|NCT03049735|583854545|FG002|Overall Study|Lack of Efficacy|3|||
161672610|NCT03049735|583854543|FG000|Overall Study|Protocol deviation|1|||
161672611|NCT03049735|583854544|FG001|Overall Study|Protocol deviation|0|||
161672612|NCT03049735|583854545|FG002|Overall Study|Protocol deviation|0|||
162183895|NCT02232737|585724513|FG000|Overall Study|Protocol Violation|1|||
161672613|NCT03049735|583854543|FG000|Overall Study|Pregnancy|0|||
161672614|NCT03049735|583854544|FG001|Overall Study|Pregnancy|0|||
161672615|NCT03049735|583854545|FG002|Overall Study|Pregnancy|1|||
161672616|NCT03049735|583854543|FG000|Overall Study|Adverse Event|7|||
161672617|NCT03049735|583854544|FG001|Overall Study|Adverse Event|18|||
161672618|NCT03049735|583854545|FG002|Overall Study|Adverse Event|5|||
161672619|NCT03049735|583854543|FG000|Overall Study|Withdrawal by Subject|10|||
161818457|NCT00574847|584376094|FG001|Overall Study|Withdrawal by Subject|2|||
161818458|NCT00574847|584376093|FG000|Overall Study|Physician Decision|1|||
161818459|NCT00574847|584376094|FG001|Overall Study|Physician Decision|0|||
162183896|NCT02232737|585724514|FG001|Overall Study|Protocol Violation|0|||
161672620|NCT03049735|583854544|FG001|Overall Study|Withdrawal by Subject|3|||
161672621|NCT03049735|583854545|FG002|Overall Study|Withdrawal by Subject|7|||
161672622|NCT03049735|583854543|FG000|Overall Study|Lost to Follow-up|1|||
161672623|NCT03049735|583854544|FG001|Overall Study|Lost to Follow-up|5|||
161818460|NCT00574847|584376093|FG000|Overall Study|Did not receive medication (declined)|2|||
161818461|NCT00574847|584376094|FG001|Overall Study|Did not receive medication (declined)|5|||
161818462|NCT00957021|584376097|FG000|Overall Study|Death|5|||
161818463|NCT00957021|584376097|FG000|Overall Study|Lost to Follow-up|8|||
162183897|NCT02232737|585724515|FG002|Overall Study|Protocol Violation|1|||
162183898|NCT02232737|585724513|FG000|Overall Study|Reason unknown|1|||
162183899|NCT02232737|585724514|FG001|Overall Study|Reason unknown|0|||
162183900|NCT02232737|585724515|FG002|Overall Study|Reason unknown|0|||
162183901|NCT02200705|585724518|FG000|Overall Study|Excluded|12|||
162183902|NCT02200705|585724518|FG000|Overall Study|Death|21|||
162183903|NCT02200705|585724518|FG000|Overall Study|Withdrawal by Subject|22|||
162183904|NCT02200705|585724518|FG000|Overall Study|Lost to Follow-up|13|||
162183905|NCT02200705|585724518|FG000|Overall Study|Physician Decision|5|||
162183906|NCT02200705|585724518|FG000|Overall Study|Adverse Event|2|||
162183907|NCT00065182|585724529|FG000|Overall Study|Adverse Event|24|||
162183908|NCT00065182|585724530|FG001|Overall Study|Adverse Event|17|||
162183909|NCT00065182|585724529|FG000|Overall Study|Lost to Follow-up|0|||
162183910|NCT00065182|585724530|FG001|Overall Study|Lost to Follow-up|4|||
162183911|NCT00065182|585724529|FG000|Overall Study|Protocol Violation|3|||
162183912|NCT00065182|585724530|FG001|Overall Study|Protocol Violation|4|||
162183913|NCT00065182|585724529|FG000|Overall Study|Serious adverse events (SAE)|1|||
162183914|NCT00065182|585724530|FG001|Overall Study|Serious adverse events (SAE)|0|||
162183915|NCT00065182|585724529|FG000|Overall Study|Sponsor Decision|11|||
162183916|NCT00065182|585724530|FG001|Overall Study|Sponsor Decision|7|||
162183917|NCT00065182|585724529|FG000|Overall Study|Withdrawal by Subject|8|||
162183918|NCT00065182|585724530|FG001|Overall Study|Withdrawal by Subject|3|||
162183919|NCT00065182|585724529|FG000|Overall Study|No clinical benefit|1|||
162183920|NCT00065182|585724530|FG001|Overall Study|No clinical benefit|0|||
162183921|NCT00065182|585724529|FG000|Overall Study|Death|0|||
162183922|NCT00065182|585724530|FG001|Overall Study|Death|1|||
162183923|NCT00065182|585724529|FG000|Overall Study|Decline in Status|0|||
162183924|NCT00065182|585724530|FG001|Overall Study|Decline in Status|1|||
162183925|NCT02633215|585724531|FG000|Overall Study|Lost to Follow-up|2|||
162183926|NCT02633215|585724532|FG001|Overall Study|Lost to Follow-up|3|||
162183927|NCT00754325|585724533|FG000|Initial Treatment|Continuing Active Treatment|4|||
162183928|NCT00754325|585724534|FG001|Initial Treatment|Continuing Active Treatment|5|||
162183929|NCT00754325|585724533|FG000|Initial Treatment|Adverse Event|7|||
162183930|NCT00754325|585724534|FG001|Initial Treatment|Adverse Event|6|||
162183931|NCT00754325|585724533|FG000|Initial Treatment|Withdrawal by Subject|2|||
162183932|NCT00754325|585724534|FG001|Initial Treatment|Withdrawal by Subject|2|||
162183933|NCT00754325|585724533|FG000|Initial Treatment|Physician Decision|2|||
162183934|NCT00754325|585724534|FG001|Initial Treatment|Physician Decision|0|||
162183935|NCT00754325|585724533|FG000|Initial Treatment|Sponsor Request|0|||
162183936|NCT00754325|585724534|FG001|Initial Treatment|Sponsor Request|1|||
161818464|NCT00957021|584376097|FG000|Overall Study|Withdrawal by Subject|34|||
161818465|NCT00957021|584376097|FG000|Overall Study|No 2 yr ROM data|35|||
161818466|NCT00957021|584376097|FG000|Overall Study|Revised study component by 2 yr visit|8|||
161818467|NCT00957021|584376097|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
161818468|NCT00957021|584376097|FG000|Overall Study|Surgery Cancelled|9|||
161818469|NCT00957021|584376097|FG000|Overall Study|Termination due to language issue|2|||
161818470|NCT04060251|584376109|FG000|Overall Study|Study terminated due to low enrollment.|7|||
161818471|NCT04060251|584376110|FG001|Overall Study|Study terminated due to low enrollment.|5|||
161818472|NCT04060251|584376111|FG002|Overall Study|Study terminated due to low enrollment.|7|||
161818473|NCT04060251|584376109|FG000|Overall Study|Adverse Event|1|||
161818474|NCT04060251|584376110|FG001|Overall Study|Adverse Event|1|||
161924574|NCT02949934|584769705|FG000|Neuroimaging|Protocol Violation|2|||
161924575|NCT02949934|584769706|FG001|Neuroimaging|Protocol Violation|0|||
161924576|NCT02949934|584769707|FG002|Neuroimaging|Protocol Violation|0|||
161924577|NCT02949934|584769708|FG003|Neuroimaging|Protocol Violation|0|||
161818475|NCT04060251|584376111|FG002|Overall Study|Adverse Event|0|||
161818476|NCT00487435|584376112|FG000|Overall Study|Adverse Event|146|||
161818477|NCT00487435|584376112|FG000|Overall Study|Death|2|||
161818478|NCT00487435|584376112|FG000|Overall Study|Lack of Efficacy|33|||
161818479|NCT00487435|584376112|FG000|Overall Study|Lost to Follow-up|54|||
161818480|NCT00487435|584376112|FG000|Overall Study|Pregnancy|2|||
161818481|NCT00487435|584376112|FG000|Overall Study|Withdrawal by Subject|132|||
161818482|NCT00487435|584376112|FG000|Overall Study|Resolution Of Pain|1|||
161818483|NCT00487435|584376112|FG000|Overall Study|Study Medication Non-Compliant|32|||
161818484|NCT00487435|584376112|FG000|Overall Study|Other|83|||
161818485|NCT01155531|584376119|FG000|Overall Study|Adverse Event|0|||
161818486|NCT01155531|584376120|FG001|Overall Study|Adverse Event|0|||
161924578|NCT02949934|584769709|FG004|Neuroimaging|Protocol Violation|1|||
161924579|NCT02949934|584769710|FG005|Neuroimaging|Protocol Violation|0|||
161924580|NCT02949934|584769705|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
161924581|NCT02949934|584769706|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
161924582|NCT02949934|584769707|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
161924583|NCT02949934|584769708|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
161924584|NCT02949934|584769709|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
161924585|NCT02949934|584769710|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
161924586|NCT02949934|584769705|FG000|Neuroimaging|Not scanned|0|||
161924587|NCT02949934|584769706|FG001|Neuroimaging|Not scanned|0|||
161924588|NCT02949934|584769707|FG002|Neuroimaging|Not scanned|1|||
161924589|NCT02949934|584769708|FG003|Neuroimaging|Not scanned|0|||
161924590|NCT02949934|584769709|FG004|Neuroimaging|Not scanned|0|||
161924591|NCT02949934|584769710|FG005|Neuroimaging|Not scanned|2|||
161924592|NCT02949934|584769705|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
161924593|NCT02949934|584769706|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
161924594|NCT02949934|584769707|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
161924595|NCT02949934|584769708|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
161924596|NCT02949934|584769709|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
161924597|NCT02949934|584769710|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
161924598|NCT02949934|584769705|FG000|Bar Laboratory|Adverse Event|1|||
161924599|NCT02949934|584769706|FG001|Bar Laboratory|Adverse Event|0|||
161924600|NCT02949934|584769707|FG002|Bar Laboratory|Adverse Event|2|||
161924601|NCT02949934|584769708|FG003|Bar Laboratory|Adverse Event|0|||
161924602|NCT02949934|584769709|FG004|Bar Laboratory|Adverse Event|1|||
161924603|NCT02949934|584769710|FG005|Bar Laboratory|Adverse Event|0|||
161924604|NCT02949934|584769705|FG000|Bar Laboratory|Protocol Violation|0|||
161924605|NCT02949934|584769706|FG001|Bar Laboratory|Protocol Violation|0|||
161924606|NCT02949934|584769707|FG002|Bar Laboratory|Protocol Violation|0|||
161924607|NCT02949934|584769708|FG003|Bar Laboratory|Protocol Violation|1|||
161924608|NCT02949934|584769709|FG004|Bar Laboratory|Protocol Violation|0|||
161924609|NCT02949934|584769710|FG005|Bar Laboratory|Protocol Violation|0|||
161924610|NCT02762604|584769711|FG000|Overall Study|Lost to Follow-up|2|||
161924611|NCT02762604|584769712|FG001|Overall Study|Lost to Follow-up|7|||
161924612|NCT02762604|584769711|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
161924613|NCT02762604|584769712|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
161924614|NCT04530526|584769716|FG000|Overall Study|Withdrawal by Subject|6|||
161924615|NCT04937387|584769717|FG000|Overall Study|Adverse Event|1|||
161924616|NCT04937387|584769718|FG001|Overall Study|Adverse Event|0|||
161924617|NCT04937387|584769719|FG002|Overall Study|Adverse Event|2|||
161924618|NCT04937387|584769720|FG003|Overall Study|Adverse Event|0|||
161818487|NCT01155531|584376121|FG002|Overall Study|Adverse Event|1|||
161818488|NCT01155531|584376122|FG003|Overall Study|Adverse Event|0|||
161818489|NCT01155531|584376119|FG000|Overall Study|Lost to Follow-up|0|||
161818490|NCT01155531|584376120|FG001|Overall Study|Lost to Follow-up|0|||
161818491|NCT01155531|584376121|FG002|Overall Study|Lost to Follow-up|0|||
161818492|NCT01155531|584376122|FG003|Overall Study|Lost to Follow-up|1|||
161924619|NCT04937387|584769717|FG000|Overall Study|Lack of Efficacy|1|||
161924620|NCT04937387|584769718|FG001|Overall Study|Lack of Efficacy|0|||
161672624|NCT03049735|583854545|FG002|Overall Study|Lost to Follow-up|5|||
161672625|NCT02146326|583854546|FG000|Overall Study|Lost to Follow-up|3|||
161672626|NCT02146326|583854547|FG001|Overall Study|Lost to Follow-up|3|||
161672627|NCT02146326|583854548|FG002|Overall Study|Lost to Follow-up|11|||
161672628|NCT02146326|583854549|FG003|Overall Study|Lost to Follow-up|19|||
161672629|NCT02146326|583854546|FG000|Overall Study|Withdrawal by Subject|2|||
161672630|NCT02146326|583854547|FG001|Overall Study|Withdrawal by Subject|1|||
161672631|NCT02146326|583854548|FG002|Overall Study|Withdrawal by Subject|15|||
161672632|NCT02146326|583854549|FG003|Overall Study|Withdrawal by Subject|11|||
161672633|NCT02146326|583854546|FG000|Overall Study|Separated from mental health center|23|||
161672634|NCT02146326|583854547|FG001|Overall Study|Separated from mental health center|33|||
161924621|NCT04937387|584769719|FG002|Overall Study|Lack of Efficacy|0|||
161924622|NCT04937387|584769720|FG003|Overall Study|Lack of Efficacy|1|||
161924623|NCT04937387|584769717|FG000|Overall Study|Withdrawal by Subject|1|||
161924624|NCT04937387|584769718|FG001|Overall Study|Withdrawal by Subject|0|||
161924625|NCT04937387|584769719|FG002|Overall Study|Withdrawal by Subject|1|||
161924626|NCT04937387|584769720|FG003|Overall Study|Withdrawal by Subject|1|||
161924627|NCT04937387|584769717|FG000|Overall Study|Randomized in error|0|||
161924628|NCT04937387|584769718|FG001|Overall Study|Randomized in error|0|||
161924629|NCT04937387|584769719|FG002|Overall Study|Randomized in error|0|||
161924630|NCT04937387|584769720|FG003|Overall Study|Randomized in error|1|||
161924631|NCT01658878|584770966|FG000|Treatment Period|Disease Progression|1|||
161924632|NCT01658878|584770967|FG001|Treatment Period|Disease Progression|3|||
162183937|NCT00754325|585724533|FG000|Initial Treatment|Disease Progression|35|||
162183938|NCT00754325|585724534|FG001|Initial Treatment|Disease Progression|35|||
162183939|NCT03738228|585724535|FG000|Overall Study|Never received study treatment|2|||
162183940|NCT03738228|585724536|FG001|Overall Study|Never received study treatment|2|||
162183941|NCT03801148|585724537|FG000|Period 1 (2 Days)|Adverse Event|1|||
162183942|NCT03801148|585724538|FG001|Period 1 (2 Days)|Adverse Event|1|||
162183943|NCT03801148|585724539|FG002|Period 1 (2 Days)|Adverse Event|0|||
162183944|NCT03801148|585724540|FG003|Period 1 (2 Days)|Adverse Event|0|||
162183945|NCT03801148|585724537|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
162183946|NCT03801148|585724538|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
162183947|NCT03801148|585724539|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
162183948|NCT03801148|585724540|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
162183949|NCT03801148|585724537|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162183950|NCT03801148|585724538|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162183951|NCT03801148|585724539|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
162183952|NCT03801148|585724540|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
162183953|NCT03801148|585724537|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
162183954|NCT03801148|585724538|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
162183955|NCT03801148|585724539|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
162183956|NCT03801148|585724540|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
162183957|NCT06212752|585724541|FG000|Overall Study|Death|5|||
162183958|NCT06212752|585724542|FG001|Overall Study|Death|3|||
162183959|NCT06212752|585724541|FG000|Overall Study|Participants ongoing|23|||
161672635|NCT02146326|583854548|FG002|Overall Study|Separated from mental health center|0|||
162183960|NCT06212752|585724542|FG001|Overall Study|Participants ongoing|8|||
162183961|NCT04162210|585724543|FG000|Overall Study|Lost to Follow-up|4|||
162183962|NCT04162210|585724544|FG001|Overall Study|Lost to Follow-up|1|||
162183963|NCT04162210|585724543|FG000|Overall Study|Withdrawal by Subject|17|||
162183964|NCT04162210|585724544|FG001|Overall Study|Withdrawal by Subject|9|||
162183965|NCT04162210|585724543|FG000|Overall Study|Ongoing|113|||
162183966|NCT04162210|585724544|FG001|Overall Study|Ongoing|59|||
162183967|NCT02568215|585724545|FG000|Overall Study|Death|1|||
162183968|NCT02568215|585724546|FG001|Overall Study|Death|2|||
162183969|NCT02568215|585724547|FG002|Overall Study|Death|0|||
162183970|NCT02568215|585724545|FG000|Overall Study|Physician Decision|2|||
162183971|NCT02568215|585724546|FG001|Overall Study|Physician Decision|2|||
162183972|NCT02568215|585724547|FG002|Overall Study|Physician Decision|2|||
162183973|NCT02568215|585724545|FG000|Overall Study|Lost to Follow-up|29|||
162183974|NCT02568215|585724546|FG001|Overall Study|Lost to Follow-up|32|||
162183975|NCT02568215|585724547|FG002|Overall Study|Lost to Follow-up|41|||
162183976|NCT02568215|585724545|FG000|Overall Study|Withdrawal by Subject|21|||
162183977|NCT02568215|585724546|FG001|Overall Study|Withdrawal by Subject|19|||
162183978|NCT02568215|585724547|FG002|Overall Study|Withdrawal by Subject|22|||
162183979|NCT02568215|585724545|FG000|Overall Study|Protocol Violation|1|||
162183980|NCT02568215|585724546|FG001|Overall Study|Protocol Violation|1|||
162183981|NCT02568215|585724547|FG002|Overall Study|Protocol Violation|0|||
162183982|NCT02568215|585724545|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
162183983|NCT02568215|585724546|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
162183984|NCT02568215|585724547|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
162183985|NCT02568215|585724545|FG000|Overall Study|Other|0|||
161672636|NCT02146326|583854549|FG003|Overall Study|Separated from mental health center|0|||
161672637|NCT02146326|583854546|FG000|Overall Study|Incarcerated|0|||
161672638|NCT02146326|583854547|FG001|Overall Study|Incarcerated|0|||
161672639|NCT02146326|583854548|FG002|Overall Study|Incarcerated|3|||
161672640|NCT02146326|583854549|FG003|Overall Study|Incarcerated|8|||
161672641|NCT02146326|583854546|FG000|Overall Study|Death|0|||
161672642|NCT02146326|583854547|FG001|Overall Study|Death|0|||
161672643|NCT02146326|583854548|FG002|Overall Study|Death|4|||
161672644|NCT02146326|583854549|FG003|Overall Study|Death|4|||
161672645|NCT02146326|583854546|FG000|Overall Study|Unable to complete interview|0|||
161672646|NCT02146326|583854547|FG001|Overall Study|Unable to complete interview|0|||
161672647|NCT02146326|583854548|FG002|Overall Study|Unable to complete interview|10|||
161672648|NCT02146326|583854549|FG003|Overall Study|Unable to complete interview|6|||
161672649|NCT00777946|583854552|FG000|Overall Study|Adverse Event|11|||
161672650|NCT00777946|583854553|FG001|Overall Study|Adverse Event|1|||
161672651|NCT00777946|583854554|FG002|Overall Study|Adverse Event|3|||
161672652|NCT00777946|583854552|FG000|Overall Study|Lack of Efficacy|0|||
161672653|NCT00777946|583854553|FG001|Overall Study|Lack of Efficacy|0|||
161672654|NCT00777946|583854554|FG002|Overall Study|Lack of Efficacy|9|||
161672655|NCT00777946|583854552|FG000|Overall Study|Condition no longer required study drug|1|||
161672656|NCT00777946|583854553|FG001|Overall Study|Condition no longer required study drug|0|||
161672657|NCT00777946|583854554|FG002|Overall Study|Condition no longer required study drug|0|||
161672658|NCT00777946|583854552|FG000|Overall Study|Patient withdrew consent|3|||
161924633|NCT01658878|584770968|FG002|Treatment Period|Disease Progression|2|||
161672659|NCT00777946|583854553|FG001|Overall Study|Patient withdrew consent|2|||
161672660|NCT00777946|583854554|FG002|Overall Study|Patient withdrew consent|3|||
162183986|NCT02568215|585724546|FG001|Overall Study|Other|1|||
162183987|NCT02568215|585724547|FG002|Overall Study|Other|4|||
162183988|NCT01641900|585724548|FG000|Overall Study|Withdrawal by Subject|2|||
162183989|NCT01641900|585724549|FG001|Overall Study|Withdrawal by Subject|2|||
162183990|NCT02941549|585724550|FG000|Overall Study|Adverse Event|1|||
162183991|NCT02941549|585724551|FG001|Overall Study|Adverse Event|0|||
162183992|NCT02941549|585724552|FG002|Overall Study|Adverse Event|0|||
162183993|NCT02941549|585724550|FG000|Overall Study|Withdrawal by Subject|2|||
162183994|NCT02941549|585724551|FG001|Overall Study|Withdrawal by Subject|1|||
162183995|NCT02941549|585724552|FG002|Overall Study|Withdrawal by Subject|2|||
162183996|NCT00263757|585724553|FG000|Overall Study|Withdrawal by Subject|5|||
162183997|NCT00263757|585724554|FG001|Overall Study|Withdrawal by Subject|4|||
162183998|NCT00263757|585724553|FG000|Overall Study|Screen failure|0|||
162183999|NCT00263757|585724554|FG001|Overall Study|Screen failure|1|||
162184000|NCT00263757|585724553|FG000|Overall Study|Adverse Event|3|||
162184001|NCT00263757|585724554|FG001|Overall Study|Adverse Event|3|||
162184002|NCT00713596|585724555|FG000|Overall Study|Study was terminated|2|||
162184003|NCT00713596|585724556|FG001|Overall Study|Study was terminated|3|||
162184004|NCT00713596|585724557|FG002|Overall Study|Study was terminated|2|||
162184005|NCT05464732|585724560|FG000|Overall Study|Lost to Follow-up|0|||
162184006|NCT05464732|585724561|FG001|Overall Study|Lost to Follow-up|1|||
162184007|NCT05464732|585724560|FG000|Overall Study|Adverse Event|1|||
162184008|NCT05464732|585724561|FG001|Overall Study|Adverse Event|0|||
162184009|NCT04153890|585724562|FG000|Overall Study|Lost to Follow-up|9|||
162184010|NCT04153890|585724563|FG001|Overall Study|Lost to Follow-up|0|||
162184011|NCT04153890|585724564|FG002|Overall Study|Lost to Follow-up|9|||
162184012|NCT04153890|585724565|FG003|Overall Study|Lost to Follow-up|0|||
162184013|NCT04153890|585724562|FG000|Overall Study|Death|0|||
162184014|NCT04153890|585724563|FG001|Overall Study|Death|2|||
162184015|NCT04153890|585724564|FG002|Overall Study|Death|0|||
162184016|NCT04153890|585724565|FG003|Overall Study|Death|0|||
162184017|NCT04153890|585724562|FG000|Overall Study|Withdrawal by Subject|0|||
162184018|NCT04153890|585724563|FG001|Overall Study|Withdrawal by Subject|0|||
162184019|NCT04153890|585724564|FG002|Overall Study|Withdrawal by Subject|0|||
162184020|NCT04153890|585724565|FG003|Overall Study|Withdrawal by Subject|2|||
162184021|NCT03610581|585724566|FG000|Overall Study|Study terminated by sponsor|2|||
162184022|NCT03610581|585724567|FG001|Overall Study|Study terminated by sponsor|0|||
162184023|NCT03610581|585724566|FG000|Overall Study|Other|0|||
162184024|NCT03610581|585724567|FG001|Overall Study|Other|1|||
162184025|NCT03610581|585724566|FG000|Overall Study|Withdrawal by Subject|1|||
162184026|NCT03610581|585724567|FG001|Overall Study|Withdrawal by Subject|0|||
162184027|NCT02307682|585724572|FG000|Overall Study|Adverse Event|9|||
162184028|NCT02307682|585724573|FG001|Overall Study|Adverse Event|8|||
162184029|NCT02307682|585724574|FG002|Overall Study|Adverse Event|12|||
162184030|NCT02307682|585724572|FG000|Overall Study|Lack of Efficacy|1|||
162184031|NCT02307682|585724573|FG001|Overall Study|Lack of Efficacy|0|||
162184032|NCT02307682|585724574|FG002|Overall Study|Lack of Efficacy|1|||
162184033|NCT02307682|585724572|FG000|Overall Study|Physician Decision|2|||
162184034|NCT02307682|585724573|FG001|Overall Study|Physician Decision|2|||
162184035|NCT02307682|585724574|FG002|Overall Study|Physician Decision|8|||
162184036|NCT02307682|585724572|FG000|Overall Study|Progressive Disease|1|||
162184037|NCT02307682|585724573|FG001|Overall Study|Progressive Disease|0|||
162184038|NCT02307682|585724574|FG002|Overall Study|Progressive Disease|0|||
162184039|NCT02307682|585724572|FG000|Overall Study|Withdrawal by Subject|26|||
162184040|NCT02307682|585724573|FG001|Overall Study|Withdrawal by Subject|34|||
162184041|NCT02307682|585724574|FG002|Overall Study|Withdrawal by Subject|23|||
162184042|NCT02307682|585724572|FG000|Overall Study|Death|9|||
162184043|NCT02307682|585724573|FG001|Overall Study|Death|7|||
162184044|NCT02307682|585724574|FG002|Overall Study|Death|12|||
162184045|NCT02307682|585724572|FG000|Overall Study|Lost to Follow-up|1|||
162184046|NCT02307682|585724573|FG001|Overall Study|Lost to Follow-up|5|||
162184047|NCT02307682|585724574|FG002|Overall Study|Lost to Follow-up|6|||
162184048|NCT02307682|585724572|FG000|Overall Study|Protocol Deviation|0|||
162184049|NCT02307682|585724573|FG001|Overall Study|Protocol Deviation|0|||
162184050|NCT02307682|585724574|FG002|Overall Study|Protocol Deviation|2|||
162184051|NCT02307682|585724572|FG000|Overall Study|Other|1|||
162184052|NCT02307682|585724573|FG001|Overall Study|Other|1|||
162184053|NCT02307682|585724574|FG002|Overall Study|Other|0|||
162184054|NCT03997474|585724576|FG000|Overall Study|Death|6|||
162184055|NCT03997474|585724577|FG001|Overall Study|Death|2|||
162184056|NCT03997474|585724578|FG002|Overall Study|Death|1|||
162184057|NCT03997474|585724576|FG000|Overall Study|Physician Decision|2|||
162184058|NCT03997474|585724577|FG001|Overall Study|Physician Decision|0|||
162184059|NCT03997474|585724578|FG002|Overall Study|Physician Decision|0|||
162184060|NCT03997474|585724576|FG000|Overall Study|study terminated by sponsor|1|||
162184061|NCT03997474|585724577|FG001|Overall Study|study terminated by sponsor|0|||
162184062|NCT03997474|585724578|FG002|Overall Study|study terminated by sponsor|1|||
162184063|NCT03277989|585724580|FG000|Overall Study|Lost to Follow-up|6|||
162184064|NCT03277989|585724580|FG000|Overall Study|Adverse Event|6|||
162184065|NCT03277989|585724580|FG000|Overall Study|Withdrawal by Subject|3|||
162184066|NCT03277989|585724580|FG000|Overall Study|Didn't Receive Study Device|7|||
162184067|NCT03277989|585724580|FG000|Overall Study|Site Closure|26|||
162184068|NCT03277989|585724580|FG000|Overall Study|Sponsor Closure|107|||
162184069|NCT04306367|585724581|FG000|Overall Study|Progression of Disease|9|||
162184070|NCT04306367|585724581|FG000|Overall Study|Adverse Event|3|||
162184071|NCT04306367|585724581|FG000|Overall Study|Withdrawal by Subject|1|||
162184072|NCT02751528|585724588|FG000|Overall Study|Withdrawal by Subject|1|||
162184073|NCT02751528|585724588|FG000|Overall Study|Adverse Event|1|||
162184074|NCT05485805|585724589|FG000|Overall Study|Withdrawal by Subject|1|||
162184075|NCT05485805|585724590|FG001|Overall Study|Withdrawal by Subject|2|||
162184076|NCT05485805|585724591|FG002|Overall Study|Withdrawal by Subject|2|||
162184077|NCT05485805|585724592|FG003|Overall Study|Withdrawal by Subject|0|||
162184078|NCT05485805|585724593|FG004|Overall Study|Withdrawal by Subject|2|||
162184079|NCT05485805|585724589|FG000|Overall Study|Adverse Event|0|||
161818493|NCT01155531|584376119|FG000|Overall Study|Withdrawal by Subject|1|||
161818494|NCT01155531|584376120|FG001|Overall Study|Withdrawal by Subject|0|||
162184080|NCT05485805|585724590|FG001|Overall Study|Adverse Event|1|||
162184081|NCT05485805|585724591|FG002|Overall Study|Adverse Event|0|||
162184082|NCT05485805|585724592|FG003|Overall Study|Adverse Event|0|||
162184083|NCT05485805|585724593|FG004|Overall Study|Adverse Event|0|||
162184084|NCT05485805|585724589|FG000|Overall Study|Lost to Follow-up|1|||
162184085|NCT05485805|585724590|FG001|Overall Study|Lost to Follow-up|1|||
162184086|NCT05485805|585724591|FG002|Overall Study|Lost to Follow-up|3|||
162184087|NCT05485805|585724592|FG003|Overall Study|Lost to Follow-up|1|||
162184088|NCT05485805|585724593|FG004|Overall Study|Lost to Follow-up|0|||
162184089|NCT04218357|585724594|FG000|1st Allocation|Withdrawal by Subject|1|||
162184090|NCT04218357|585724595|FG001|1st Allocation|Withdrawal by Subject|0|||
162184091|NCT05349838|585724596|FG000|Overall Study|Virological Failure|1|||
162184092|NCT05349838|585724597|FG001|Overall Study|Virological Failure|2|||
162184093|NCT05349838|585724596|FG000|Overall Study|Withdrawal by Subject|2|||
162184094|NCT05349838|585724597|FG001|Overall Study|Withdrawal by Subject|3|||
162184095|NCT05349838|585724596|FG000|Overall Study|Adverse Event|3|||
162184096|NCT05349838|585724597|FG001|Overall Study|Adverse Event|1|||
162184097|NCT05349838|585724596|FG000|Overall Study|Lost to Follow-up|1|||
162184098|NCT05349838|585724597|FG001|Overall Study|Lost to Follow-up|2|||
162184099|NCT05349838|585724596|FG000|Overall Study|Other reasons|5|||
162184100|NCT05349838|585724597|FG001|Overall Study|Other reasons|1|||
162184101|NCT05037513|585724602|FG000|Intervention Period|Lost to Follow-up|1|||
162184102|NCT05037513|585724603|FG001|Intervention Period|Lost to Follow-up|2|||
162184103|NCT05037513|585724602|FG000|Follow Up Period|Lost to Follow-up|16|||
162184104|NCT05037513|585724603|FG001|Follow Up Period|Lost to Follow-up|21|||
162184105|NCT05037513|585724602|FG000|Follow Up Period|Death|0|||
162184106|NCT05037513|585724603|FG001|Follow Up Period|Death|1|||
162184107|NCT05037513|585724602|FG000|Follow Up Period|Incarcerated|4|||
162184108|NCT05037513|585724603|FG001|Follow Up Period|Incarcerated|2|||
162184109|NCT03664804|585724605|FG000|Overall Study|Withdrawal by Subject|7|||
162184110|NCT05529992|585724606|FG000|Overall Study|Withdrawal by Subject|1|||
162184111|NCT06140290|585724607|FG000|Period 1|Adverse Event|1|||
162184112|NCT06140290|585724608|FG001|Period 1|Adverse Event|0|||
162184113|NCT06140290|585724607|FG000|Period 2|Assigned but not treated|0|||
162184114|NCT06140290|585724608|FG001|Period 2|Assigned but not treated|1|||
162184115|NCT06140290|585724607|FG000|Period 2|Withdrawal by Subject|0|||
162184116|NCT06140290|585724608|FG001|Period 2|Withdrawal by Subject|1|||
162184117|NCT03116464|585726000|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
162184118|NCT00371345|585726003|FG000|Overall Study|Disease Progression|21|||
162184119|NCT00371345|585726004|FG001|Overall Study|Disease Progression|35|||
162184120|NCT00371345|585726003|FG000|Overall Study|Study Drug Toxicity|1|||
162184121|NCT00371345|585726004|FG001|Overall Study|Study Drug Toxicity|7|||
162184122|NCT00371345|585726003|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
162184123|NCT00371345|585726004|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
162184124|NCT00371345|585726003|FG000|Overall Study|Participant Request|1|||
162184125|NCT00371345|585726004|FG001|Overall Study|Participant Request|1|||
162184126|NCT00371345|585726003|FG000|Overall Study|Participant Withdrew Consent|0|||
162184127|NCT00371345|585726004|FG001|Overall Study|Participant Withdrew Consent|1|||
162184128|NCT00705406|585726005|FG000|Overall Study|Lost to Follow-up|3|||
162184129|NCT00705406|585726006|FG001|Overall Study|Lost to Follow-up|3|||
162184130|NCT00705406|585726005|FG000|Overall Study|Did not receive study drug|1|||
162184131|NCT00705406|585726006|FG001|Overall Study|Did not receive study drug|2|||
162184132|NCT04545619|585726007|FG000|Overall Study|due to equipment challenges|1|||
162184133|NCT03712371|585726008|FG000|Overall Study|Lack of Efficacy|0|||
162184134|NCT03712371|585726009|FG001|Overall Study|Lack of Efficacy|0|||
162184135|NCT03712371|585726010|FG002|Overall Study|Lack of Efficacy|0|||
162184136|NCT03712371|585726011|FG003|Overall Study|Lack of Efficacy|1|||
162184137|NCT00683800|585726017|FG000|Overall Study|Adverse Event|195|||
161818495|NCT01155531|584376121|FG002|Overall Study|Withdrawal by Subject|1|||
161818496|NCT01155531|584376122|FG003|Overall Study|Withdrawal by Subject|0|||
162184138|NCT00683800|585726018|FG001|Overall Study|Adverse Event|102|||
162184139|NCT00683800|585726017|FG000|Overall Study|Death|0|||
162184140|NCT00683800|585726018|FG001|Overall Study|Death|1|||
162184141|NCT00683800|585726017|FG000|Overall Study|Lost to Follow-up|57|||
162184142|NCT00683800|585726018|FG001|Overall Study|Lost to Follow-up|44|||
162184143|NCT00683800|585726017|FG000|Overall Study|Other|5|||
162184144|NCT00683800|585726018|FG001|Overall Study|Other|2|||
162184145|NCT00683800|585726017|FG000|Overall Study|Protocol Violation|13|||
162184146|NCT00683800|585726018|FG001|Overall Study|Protocol Violation|16|||
162184147|NCT00683800|585726017|FG000|Overall Study|Withdrawal by Subject|66|||
162184148|NCT00683800|585726018|FG001|Overall Study|Withdrawal by Subject|64|||
162184149|NCT00683800|585726017|FG000|Overall Study|Lack of Efficacy|61|||
162184150|NCT00683800|585726018|FG001|Overall Study|Lack of Efficacy|104|||
162184151|NCT00683800|585726017|FG000|Overall Study|Randomized, not treated|35|||
162184152|NCT00683800|585726018|FG001|Overall Study|Randomized, not treated|33|||
162184153|NCT04949542|585726025|FG000|Overall Study|Lost to Follow-up|4|||
162184154|NCT04949542|585726026|FG001|Overall Study|Lost to Follow-up|1|||
162184155|NCT03021993|585726028|FG000|Overall Study|Withdrawal by Subject|4|||
162184156|NCT03021993|585726028|FG000|Overall Study|Physician Decision|1|||
162184157|NCT03021993|585726028|FG000|Overall Study|enrolled but were not treated|1|||
161672661|NCT00777946|583854552|FG000|Overall Study|Lost to Follow-up|3|||
161672662|NCT00777946|583854553|FG001|Overall Study|Lost to Follow-up|1|||
161672663|NCT00777946|583854554|FG002|Overall Study|Lost to Follow-up|0|||
161672664|NCT00777946|583854552|FG000|Overall Study|Protocol deviation|2|||
161672665|NCT00777946|583854553|FG001|Overall Study|Protocol deviation|1|||
161672666|NCT00777946|583854554|FG002|Overall Study|Protocol deviation|1|||
161672667|NCT00777946|583854552|FG000|Overall Study|Randomized in error|1|||
161672668|NCT00777946|583854553|FG001|Overall Study|Randomized in error|1|||
161672669|NCT00777946|583854554|FG002|Overall Study|Randomized in error|0|||
161672670|NCT04821869|583854566|FG000|Overall Study|Adverse Event|4|||
161672671|NCT04821869|583854566|FG000|Overall Study|Withdrawal by Subject|2|||
161672672|NCT04821869|583854566|FG000|Overall Study|Did not meet FEV1 criteria|1|||
161672673|NCT01313117|583854569|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
161672674|NCT01313117|583854569|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
161672675|NCT03442114|583854574|FG000|Overall Study|Lost to Follow-up|13|||
161672676|NCT03442114|583854575|FG001|Overall Study|Lost to Follow-up|13|||
161672677|NCT03442114|583854574|FG000|Overall Study|Physician Decision|2|||
161818497|NCT01087502|584376123|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
161818498|NCT01087502|584376124|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
161818499|NCT01087502|584376123|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
161818500|NCT01087502|584376124|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
161818501|NCT01087502|584376123|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
161818502|NCT01087502|584376124|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
161818503|NCT01087502|584376123|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
161818504|NCT01087502|584376124|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
161818505|NCT01087502|584376123|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
161818506|NCT01087502|584376124|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
162184158|NCT03021993|585726028|FG000|Overall Study|Death|3|||
162184159|NCT02101775|585726030|FG000|Overall Study|Adverse Event|4|||
162184160|NCT02101775|585726031|FG001|Overall Study|Adverse Event|0|||
162184161|NCT02101775|585726032|FG002|Overall Study|Adverse Event|0|||
162184162|NCT02101775|585726030|FG000|Overall Study|Admission to Hospital|0|||
162184163|NCT02101775|585726031|FG001|Overall Study|Admission to Hospital|1|||
162184164|NCT02101775|585726032|FG002|Overall Study|Admission to Hospital|0|||
162184165|NCT01387516|585726039|FG000|Overall Study|Lost to Follow-up|4|||
162184166|NCT01387516|585726040|FG001|Overall Study|Lost to Follow-up|4|||
162184167|NCT01387516|585726041|FG002|Overall Study|Lost to Follow-up|2|||
162184168|NCT01387516|585726042|FG003|Overall Study|Lost to Follow-up|3|||
162184169|NCT01387516|585726039|FG000|Overall Study|Withdrawal by Subject|1|||
162184170|NCT01387516|585726040|FG001|Overall Study|Withdrawal by Subject|1|||
162184171|NCT01387516|585726041|FG002|Overall Study|Withdrawal by Subject|2|||
162184172|NCT01387516|585726042|FG003|Overall Study|Withdrawal by Subject|0|||
162184173|NCT01387516|585726039|FG000|Overall Study|Death|0|||
162184174|NCT01387516|585726040|FG001|Overall Study|Death|0|||
162184175|NCT01387516|585726041|FG002|Overall Study|Death|0|||
162184176|NCT01387516|585726042|FG003|Overall Study|Death|1|||
162184177|NCT03509909|585726046|FG000|Overall Study|Withdrawal by Subject|16|||
162184178|NCT03509909|585726047|FG001|Overall Study|Withdrawal by Subject|9|||
162184179|NCT03509909|585726046|FG000|Overall Study|Lost to Follow-up|3|||
162184180|NCT03509909|585726047|FG001|Overall Study|Lost to Follow-up|4|||
162184181|NCT03509909|585726046|FG000|Overall Study|Adverse Event|2|||
162184182|NCT03509909|585726047|FG001|Overall Study|Adverse Event|0|||
162184183|NCT03683576|585726049|FG000|Overall Study|Withdrawal by Subject|2|||
162184184|NCT03683576|585726050|FG001|Overall Study|Withdrawal by Subject|0|||
162184185|NCT03683576|585726051|FG002|Overall Study|Withdrawal by Subject|8|||
162184186|NCT03683576|585726052|FG003|Overall Study|Withdrawal by Subject|3|||
162184187|NCT03683576|585726049|FG000|Overall Study|Adverse Event|3|||
162184188|NCT03683576|585726050|FG001|Overall Study|Adverse Event|0|||
162184189|NCT03683576|585726051|FG002|Overall Study|Adverse Event|0|||
162184190|NCT03683576|585726052|FG003|Overall Study|Adverse Event|4|||
162184191|NCT03683576|585726049|FG000|Overall Study|Lack of Efficacy|1|||
162184192|NCT03683576|585726050|FG001|Overall Study|Lack of Efficacy|0|||
162184193|NCT03683576|585726051|FG002|Overall Study|Lack of Efficacy|1|||
162184194|NCT03683576|585726052|FG003|Overall Study|Lack of Efficacy|1|||
162184195|NCT03683576|585726049|FG000|Overall Study|Lost to Follow-up|0|||
162184196|NCT03683576|585726050|FG001|Overall Study|Lost to Follow-up|1|||
162184197|NCT03683576|585726051|FG002|Overall Study|Lost to Follow-up|2|||
162184198|NCT03683576|585726052|FG003|Overall Study|Lost to Follow-up|0|||
162184199|NCT03683576|585726049|FG000|Overall Study|Other, Not Specified|0|||
162184200|NCT03683576|585726050|FG001|Overall Study|Other, Not Specified|2|||
162184201|NCT03683576|585726051|FG002|Overall Study|Other, Not Specified|0|||
162184202|NCT03683576|585726052|FG003|Overall Study|Other, Not Specified|0|||
162184203|NCT03683576|585726049|FG000|Overall Study|Protocol Violation|0|||
162184204|NCT03683576|585726050|FG001|Overall Study|Protocol Violation|1|||
161672678|NCT03442114|583854575|FG001|Overall Study|Physician Decision|2|||
161672679|NCT03442114|583854574|FG000|Overall Study|Protocol Violation|0|||
161672680|NCT03442114|583854575|FG001|Overall Study|Protocol Violation|2|||
161672681|NCT03442114|583854574|FG000|Overall Study|Withdrawal by Subject|1|||
161672682|NCT03442114|583854575|FG001|Overall Study|Withdrawal by Subject|3|||
161672683|NCT03442114|583854574|FG000|Overall Study|Guardianship Change|0|||
161672684|NCT03442114|583854575|FG001|Overall Study|Guardianship Change|1|||
161672685|NCT03808688|583856402|FG000|Overall Study|Adverse Event|13|||
161672686|NCT03808688|583856403|FG001|Overall Study|Adverse Event|17|||
161672687|NCT03808688|583856402|FG000|Overall Study|Lack of Efficacy|2|||
161672688|NCT03808688|583856403|FG001|Overall Study|Lack of Efficacy|0|||
161672689|NCT03808688|583856402|FG000|Overall Study|Lost to Follow-up|0|||
161672690|NCT03808688|583856403|FG001|Overall Study|Lost to Follow-up|2|||
161672691|NCT03808688|583856402|FG000|Overall Study|Withdrawal by Subject|1|||
161672692|NCT03808688|583856403|FG001|Overall Study|Withdrawal by Subject|0|||
161672693|NCT03808688|583856402|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
162184205|NCT03683576|585726051|FG002|Overall Study|Protocol Violation|1|||
162184206|NCT03683576|585726052|FG003|Overall Study|Protocol Violation|0|||
162184207|NCT01588951|585726053|FG000|Overall Study|Ineligible in retrospect|0|||
162184208|NCT01588951|585726054|FG001|Overall Study|Ineligible in retrospect|0|||
162184209|NCT01588951|585726055|FG002|Overall Study|Ineligible in retrospect|1|||
161672694|NCT03808688|583856403|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
161672695|NCT03808688|583856402|FG000|Overall Study|IOP Too High|1|||
161672696|NCT03808688|583856403|FG001|Overall Study|IOP Too High|1|||
161672697|NCT03808688|583856402|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
161672698|NCT03808688|583856403|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
161672699|NCT03808688|583856402|FG000|Overall Study|Visit Out of Window|0|||
162184210|NCT02454959|585726056|FG000|Overall Study|Protocol-Specified Criteria|3|||
162184211|NCT02454959|585726056|FG000|Overall Study|Physician Decision|1|||
162184212|NCT02454959|585726056|FG000|Overall Study|Withdrawal by Subject|3|||
162184213|NCT02454959|585726056|FG000|Overall Study|Adverse Event|2|||
162184214|NCT02350634|585726057|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
162184215|NCT02499328|585726066|FG000|Overall Study|Withdrawal by Subject|1|||
162184216|NCT02499328|585726067|FG001|Overall Study|Withdrawal by Subject|1|||
162184217|NCT02499328|585726068|FG002|Overall Study|Withdrawal by Subject|5|||
162184218|NCT02499328|585726069|FG003|Overall Study|Withdrawal by Subject|3|||
162184219|NCT02499328|585726070|FG004|Overall Study|Withdrawal by Subject|5|||
162184220|NCT02499328|585726071|FG005|Overall Study|Withdrawal by Subject|0|||
162184221|NCT02499328|585726072|FG006|Overall Study|Withdrawal by Subject|0|||
162184222|NCT02499328|585726073|FG007|Overall Study|Withdrawal by Subject|0|||
162184223|NCT02499328|585726074|FG008|Overall Study|Withdrawal by Subject|2|||
162184224|NCT02499328|585726075|FG009|Overall Study|Withdrawal by Subject|2|||
162184225|NCT02499328|585726076|FG010|Overall Study|Withdrawal by Subject|0|||
162184226|NCT02499328|585726077|FG011|Overall Study|Withdrawal by Subject|3|||
162184227|NCT02499328|585726078|FG012|Overall Study|Withdrawal by Subject|7|||
162184228|NCT02499328|585726079|FG013|Overall Study|Withdrawal by Subject|3|||
162184229|NCT02499328|585726080|FG014|Overall Study|Withdrawal by Subject|1|||
162184230|NCT02499328|585726081|FG015|Overall Study|Withdrawal by Subject|0|||
162184231|NCT02499328|585726082|FG016|Overall Study|Withdrawal by Subject|0|||
162184232|NCT02499328|585726083|FG017|Overall Study|Withdrawal by Subject|3|||
162184233|NCT02499328|585726084|FG018|Overall Study|Withdrawal by Subject|0|||
162184234|NCT02499328|585726066|FG000|Overall Study|Lost to Follow-up|0|||
162184235|NCT02499328|585726067|FG001|Overall Study|Lost to Follow-up|1|||
162184236|NCT02499328|585726068|FG002|Overall Study|Lost to Follow-up|1|||
162184237|NCT02499328|585726069|FG003|Overall Study|Lost to Follow-up|2|||
162184238|NCT02499328|585726070|FG004|Overall Study|Lost to Follow-up|0|||
162184239|NCT02499328|585726071|FG005|Overall Study|Lost to Follow-up|0|||
162184240|NCT02499328|585726072|FG006|Overall Study|Lost to Follow-up|0|||
162184241|NCT02499328|585726073|FG007|Overall Study|Lost to Follow-up|2|||
162184242|NCT02499328|585726074|FG008|Overall Study|Lost to Follow-up|3|||
162184243|NCT02499328|585726075|FG009|Overall Study|Lost to Follow-up|0|||
162184244|NCT02499328|585726076|FG010|Overall Study|Lost to Follow-up|0|||
162184245|NCT02499328|585726077|FG011|Overall Study|Lost to Follow-up|0|||
162184246|NCT02499328|585726078|FG012|Overall Study|Lost to Follow-up|0|||
162184247|NCT02499328|585726079|FG013|Overall Study|Lost to Follow-up|0|||
162184248|NCT02499328|585726080|FG014|Overall Study|Lost to Follow-up|0|||
162184249|NCT02499328|585726081|FG015|Overall Study|Lost to Follow-up|0|||
162184250|NCT02499328|585726082|FG016|Overall Study|Lost to Follow-up|0|||
162184251|NCT02499328|585726083|FG017|Overall Study|Lost to Follow-up|0|||
162184252|NCT02499328|585726084|FG018|Overall Study|Lost to Follow-up|1|||
162184253|NCT02499328|585726066|FG000|Overall Study|Death|0|||
162184254|NCT02499328|585726067|FG001|Overall Study|Death|3|||
162184255|NCT02499328|585726068|FG002|Overall Study|Death|3|||
162184256|NCT02499328|585726069|FG003|Overall Study|Death|2|||
161672700|NCT03808688|583856403|FG001|Overall Study|Visit Out of Window|1|||
161672701|NCT03808688|583856402|FG000|Overall Study|Medication Non-Compliance|0|||
161672702|NCT03808688|583856403|FG001|Overall Study|Medication Non-Compliance|1|||
161672703|NCT03335163|583856407|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
161672704|NCT03335163|583856407|FG000|Overall Study|Withdrawal by Subject|18|||
161672705|NCT01215175|583856409|FG000|Overall Study|Lost to Follow-up|0|||
161672706|NCT01215175|583856410|FG001|Overall Study|Lost to Follow-up|1|||
161672707|NCT01215175|583856411|FG002|Overall Study|Lost to Follow-up|0|||
161672708|NCT01215175|583856412|FG003|Overall Study|Lost to Follow-up|1|||
161672709|NCT01215175|583856413|FG004|Overall Study|Lost to Follow-up|0|||
161672710|NCT01016964|583856414|FG000|Overall Study|Lost to Follow-up|3|||
161672711|NCT01016964|583856415|FG001|Overall Study|Lost to Follow-up|3|||
161672712|NCT03872453|583856416|FG000|Overall Study|Adverse Event|1|||
161672713|NCT03872453|583856417|FG001|Overall Study|Adverse Event|1|||
161672714|NCT03872453|583856418|FG002|Overall Study|Adverse Event|0|||
161672715|NCT03872453|583856419|FG003|Overall Study|Adverse Event|0|||
161672716|NCT03872453|583856416|FG000|Overall Study|Lost to Follow-up|8|||
161672717|NCT03872453|583856417|FG001|Overall Study|Lost to Follow-up|7|||
161672718|NCT03872453|583856418|FG002|Overall Study|Lost to Follow-up|4|||
161672719|NCT03872453|583856419|FG003|Overall Study|Lost to Follow-up|4|||
161672720|NCT03872453|583856416|FG000|Overall Study|Never Treated Migraine|19|||
161672721|NCT03872453|583856417|FG001|Overall Study|Never Treated Migraine|17|||
162184257|NCT02499328|585726070|FG004|Overall Study|Death|4|||
162184258|NCT02499328|585726071|FG005|Overall Study|Death|7|||
162184259|NCT02499328|585726072|FG006|Overall Study|Death|3|||
162184260|NCT02499328|585726073|FG007|Overall Study|Death|0|||
162184261|NCT02499328|585726074|FG008|Overall Study|Death|2|||
162184262|NCT02499328|585726075|FG009|Overall Study|Death|6|||
162184263|NCT02499328|585726076|FG010|Overall Study|Death|6|||
161672722|NCT03872453|583856418|FG002|Overall Study|Never Treated Migraine|13|||
161672723|NCT03872453|583856419|FG003|Overall Study|Never Treated Migraine|12|||
161672724|NCT03872453|583856416|FG000|Overall Study|Pregnancy|1|||
161672725|NCT03872453|583856417|FG001|Overall Study|Pregnancy|0|||
161672726|NCT03872453|583856418|FG002|Overall Study|Pregnancy|0|||
162184264|NCT02499328|585726077|FG011|Overall Study|Death|20|||
162184265|NCT02499328|585726078|FG012|Overall Study|Death|9|||
162184266|NCT02499328|585726079|FG013|Overall Study|Death|7|||
162184267|NCT02499328|585726080|FG014|Overall Study|Death|3|||
162184268|NCT02499328|585726081|FG015|Overall Study|Death|1|||
162184269|NCT02499328|585726082|FG016|Overall Study|Death|1|||
162184270|NCT02499328|585726083|FG017|Overall Study|Death|16|||
162184271|NCT02499328|585726084|FG018|Overall Study|Death|5|||
162184272|NCT02499328|585726066|FG000|Overall Study|"Other"|2|||
162184273|NCT02499328|585726067|FG001|Overall Study|"Other"|2|||
162184274|NCT02499328|585726068|FG002|Overall Study|"Other"|1|||
162184275|NCT02499328|585726069|FG003|Overall Study|"Other"|3|||
162184276|NCT02499328|585726070|FG004|Overall Study|"Other"|6|||
162184277|NCT02499328|585726071|FG005|Overall Study|"Other"|2|||
162184278|NCT02499328|585726072|FG006|Overall Study|"Other"|3|||
162184279|NCT02499328|585726073|FG007|Overall Study|"Other"|4|||
162184280|NCT02499328|585726074|FG008|Overall Study|"Other"|6|||
162184281|NCT02499328|585726075|FG009|Overall Study|"Other"|16|||
162184282|NCT02499328|585726076|FG010|Overall Study|"Other"|13|||
162184283|NCT02499328|585726077|FG011|Overall Study|"Other"|31|||
162184284|NCT02499328|585726078|FG012|Overall Study|"Other"|8|||
162184285|NCT02499328|585726079|FG013|Overall Study|"Other"|7|||
162184286|NCT02499328|585726080|FG014|Overall Study|"Other"|6|||
162184287|NCT02499328|585726081|FG015|Overall Study|"Other"|0|||
162184288|NCT02499328|585726082|FG016|Overall Study|"Other"|0|||
162184289|NCT02499328|585726083|FG017|Overall Study|"Other"|34|||
162184290|NCT02499328|585726084|FG018|Overall Study|"Other"|43|||
162184291|NCT02499328|585726066|FG000|Overall Study|Disease Progression|0|||
162184292|NCT02499328|585726067|FG001|Overall Study|Disease Progression|0|||
162184293|NCT02499328|585726068|FG002|Overall Study|Disease Progression|0|||
162184294|NCT02499328|585726069|FG003|Overall Study|Disease Progression|0|||
162184295|NCT02499328|585726070|FG004|Overall Study|Disease Progression|0|||
162184296|NCT02499328|585726071|FG005|Overall Study|Disease Progression|0|||
162184297|NCT02499328|585726072|FG006|Overall Study|Disease Progression|1|||
162184298|NCT02499328|585726073|FG007|Overall Study|Disease Progression|0|||
162184299|NCT02499328|585726074|FG008|Overall Study|Disease Progression|1|||
162184300|NCT02499328|585726075|FG009|Overall Study|Disease Progression|0|||
162184301|NCT02499328|585726076|FG010|Overall Study|Disease Progression|1|||
162184302|NCT02499328|585726077|FG011|Overall Study|Disease Progression|0|||
162184303|NCT02499328|585726078|FG012|Overall Study|Disease Progression|0|||
162184304|NCT02499328|585726079|FG013|Overall Study|Disease Progression|0|||
162184305|NCT02499328|585726080|FG014|Overall Study|Disease Progression|0|||
162184306|NCT02499328|585726081|FG015|Overall Study|Disease Progression|0|||
162184307|NCT02499328|585726082|FG016|Overall Study|Disease Progression|0|||
162184308|NCT02499328|585726083|FG017|Overall Study|Disease Progression|2|||
162184309|NCT02499328|585726084|FG018|Overall Study|Disease Progression|0|||
162184310|NCT02499328|585726066|FG000|Overall Study|Adverse Event|1|||
162184311|NCT02499328|585726067|FG001|Overall Study|Adverse Event|0|||
162184312|NCT02499328|585726068|FG002|Overall Study|Adverse Event|0|||
162184313|NCT02499328|585726069|FG003|Overall Study|Adverse Event|1|||
162184314|NCT02499328|585726070|FG004|Overall Study|Adverse Event|0|||
162184315|NCT02499328|585726071|FG005|Overall Study|Adverse Event|0|||
162184316|NCT02499328|585726072|FG006|Overall Study|Adverse Event|0|||
162184317|NCT02499328|585726073|FG007|Overall Study|Adverse Event|0|||
162184318|NCT02499328|585726074|FG008|Overall Study|Adverse Event|0|||
162184319|NCT02499328|585726075|FG009|Overall Study|Adverse Event|0|||
162184320|NCT02499328|585726076|FG010|Overall Study|Adverse Event|0|||
162184321|NCT02499328|585726077|FG011|Overall Study|Adverse Event|0|||
162184322|NCT02499328|585726078|FG012|Overall Study|Adverse Event|1|||
162184323|NCT02499328|585726079|FG013|Overall Study|Adverse Event|0|||
162184324|NCT02499328|585726080|FG014|Overall Study|Adverse Event|0|||
162184325|NCT02499328|585726081|FG015|Overall Study|Adverse Event|0|||
162184326|NCT02499328|585726082|FG016|Overall Study|Adverse Event|0|||
162184327|NCT02499328|585726083|FG017|Overall Study|Adverse Event|0|||
162184328|NCT02499328|585726084|FG018|Overall Study|Adverse Event|0|||
162184329|NCT03488719|585726085|FG000|Overall Study|Adverse Event|0|||
162184330|NCT03488719|585726086|FG001|Overall Study|Adverse Event|4|||
162184331|NCT03488719|585726087|FG002|Overall Study|Adverse Event|2|||
162184332|NCT03488719|585726085|FG000|Overall Study|Other|0|||
162184333|NCT03488719|585726086|FG001|Overall Study|Other|0|||
162184334|NCT03488719|585726087|FG002|Overall Study|Other|5|||
162184335|NCT04801420|585726095|FG000|Overall Study|Other|1|||
162184336|NCT04801420|585726096|FG001|Overall Study|Other|2|||
162184337|NCT04801420|585726097|FG002|Overall Study|Other|1|||
162184338|NCT04801420|585726095|FG000|Overall Study|Lost to Follow-up|7|||
162184339|NCT04801420|585726096|FG001|Overall Study|Lost to Follow-up|9|||
162184340|NCT04801420|585726097|FG002|Overall Study|Lost to Follow-up|10|||
162184341|NCT04801420|585726095|FG000|Overall Study|Moved from study area|0|||
162184342|NCT04801420|585726096|FG001|Overall Study|Moved from study area|1|||
162184343|NCT04801420|585726097|FG002|Overall Study|Moved from study area|1|||
162184344|NCT04801420|585726095|FG000|Overall Study|Withdrawal by Subject|5|||
162184345|NCT04801420|585726096|FG001|Overall Study|Withdrawal by Subject|1|||
162184346|NCT04801420|585726097|FG002|Overall Study|Withdrawal by Subject|4|||
162184347|NCT04801420|585726095|FG000|Overall Study|Individual stopping criteria reached|0|||
161818507|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
161818508|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
161818509|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
161818510|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
161818511|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
161818512|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
161818513|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
161818514|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
161818515|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
161818516|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
161818517|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
161818518|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
161818519|NCT01087502|584376123|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
161818520|NCT01087502|584376124|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
161818521|NCT02705716|584376125|FG000|Overall Study|Adverse Event|0|||
161818522|NCT02705716|584376126|FG001|Overall Study|Adverse Event|1|||
161818523|NCT02705716|584376125|FG000|Overall Study|Protocol Violation|3|||
161818524|NCT02705716|584376126|FG001|Overall Study|Protocol Violation|0|||
161818525|NCT02705716|584376125|FG000|Overall Study|Withdrawal of Consent|1|||
161818526|NCT02705716|584376126|FG001|Overall Study|Withdrawal of Consent|1|||
161818527|NCT00562718|584376127|FG000|Overall Study|Death|1|||
161818528|NCT00562718|584376127|FG000|Overall Study|Withdrawal by Subject|3|||
161818529|NCT00562718|584376127|FG000|Overall Study|Adverse Event|4|||
161818530|NCT00562718|584376127|FG000|Overall Study|Lack of Efficacy|2|||
161818531|NCT00562718|584376127|FG000|Overall Study|not stated|1|||
161818532|NCT01151618|584376128|FG000|Overall Study|Adverse Event|2|||
161818533|NCT01151618|584376128|FG000|Overall Study|Withdrawal by Subject|7|||
161818534|NCT04025021|584376129|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
161818535|NCT04025021|584376130|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
161818536|NCT00842309|584376137|FG000|Overall Study|Withdrawal by Subject|3|||
161818537|NCT00842309|584376138|FG001|Overall Study|Withdrawal by Subject|1|||
161818538|NCT02670551|584376139|FG000|Overall Study|Adverse Event|4|||
162184348|NCT04801420|585726096|FG001|Overall Study|Individual stopping criteria reached|1|||
162184349|NCT04801420|585726097|FG002|Overall Study|Individual stopping criteria reached|0|||
162184350|NCT04801420|585726095|FG000|Overall Study|Ongoing in the study|195|||
162184351|NCT04801420|585726096|FG001|Overall Study|Ongoing in the study|195|||
162184352|NCT04801420|585726097|FG002|Overall Study|Ongoing in the study|192|||
162184353|NCT03414684|585726098|FG000|First-course Treatment|Complete response|0|||
161818539|NCT02670551|584376140|FG001|Overall Study|Adverse Event|7|||
161818540|NCT02670551|584376141|FG002|Overall Study|Adverse Event|9|||
161818541|NCT02670551|584376139|FG000|Overall Study|Lack of Efficacy|2|||
161818542|NCT02670551|584376140|FG001|Overall Study|Lack of Efficacy|0|||
161818543|NCT02670551|584376141|FG002|Overall Study|Lack of Efficacy|3|||
162184354|NCT03414684|585726099|FG001|First-course Treatment|Complete response|1|||
162184355|NCT03414684|585726098|FG000|First-course Treatment|Intercurrent illness|1|||
162184356|NCT03414684|585726099|FG001|First-course Treatment|Intercurrent illness|0|||
162184357|NCT03414684|585726098|FG000|First-course Treatment|Progressive Disease|31|||
162184358|NCT03414684|585726099|FG001|First-course Treatment|Progressive Disease|32|||
162184359|NCT03414684|585726098|FG000|First-course Treatment|Adverse Event|1|||
162184360|NCT03414684|585726099|FG001|First-course Treatment|Adverse Event|2|||
162184361|NCT03414684|585726098|FG000|First-course Treatment|Physician Decision|0|||
162184362|NCT03414684|585726099|FG001|First-course Treatment|Physician Decision|1|||
162184363|NCT03414684|585726098|FG000|First-course Treatment|Withdrawal by Subject|0|||
162184364|NCT03414684|585726099|FG001|First-course Treatment|Withdrawal by Subject|1|||
162184365|NCT03414684|585726098|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
162184366|NCT03414684|585726099|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
162184367|NCT03414684|585726098|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
162184368|NCT03414684|585726099|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
162184369|NCT03414684|585726098|FG000|First-course Treatment|Still on treatment|3|||
162184370|NCT03414684|585726099|FG001|First-course Treatment|Still on treatment|0|||
162184371|NCT03414684|585726098|FG000|First-course Treatment|Never started protocol therapy|2|||
162184372|NCT03414684|585726099|FG001|First-course Treatment|Never started protocol therapy|1|||
162184373|NCT03414684|585726098|FG000|Crossover Treatment|Progressive disease|0|||
162184374|NCT03414684|585726099|FG001|Crossover Treatment|Progressive disease|12|||
162184375|NCT03414684|585726098|FG000|Crossover Treatment|Adverse Event|0|||
162184376|NCT03414684|585726099|FG001|Crossover Treatment|Adverse Event|3|||
162184377|NCT03414684|585726098|FG000|Crossover Treatment|Physician Decision|0|||
162184378|NCT03414684|585726099|FG001|Crossover Treatment|Physician Decision|1|||
162184379|NCT03414684|585726098|FG000|Crossover Treatment|Still on treatment|0|||
162184380|NCT03414684|585726099|FG001|Crossover Treatment|Still on treatment|2|||
162184381|NCT04038580|585726100|FG000|Washout 1|Death|0|||
162184382|NCT04038580|585726101|FG001|Washout 1|Death|0|||
162184383|NCT04038580|585726102|FG002|Washout 1|Death|0|||
162184384|NCT04038580|585726103|FG003|Washout 1|Death|1|||
162184385|NCT04038580|585726104|FG004|Washout 1|Death|0|||
162184386|NCT04038580|585726105|FG005|Washout 1|Death|0|||
162184387|NCT04038580|585726100|FG000|Washout 1|Withdrawal by Subject|0|||
162184388|NCT04038580|585726101|FG001|Washout 1|Withdrawal by Subject|0|||
162184389|NCT04038580|585726102|FG002|Washout 1|Withdrawal by Subject|0|||
162184390|NCT04038580|585726103|FG003|Washout 1|Withdrawal by Subject|0|||
162184391|NCT04038580|585726104|FG004|Washout 1|Withdrawal by Subject|1|||
162184392|NCT04038580|585726105|FG005|Washout 1|Withdrawal by Subject|0|||
162184393|NCT04038580|585726100|FG000|Wash-out 2|Withdrawal by Subject|1|||
162184394|NCT04038580|585726101|FG001|Wash-out 2|Withdrawal by Subject|0|||
162184395|NCT04038580|585726102|FG002|Wash-out 2|Withdrawal by Subject|0|||
161672727|NCT03872453|583856419|FG003|Overall Study|Pregnancy|0|||
161672728|NCT03872453|583856416|FG000|Overall Study|Protocol Deviation|2|||
161672729|NCT03872453|583856417|FG001|Overall Study|Protocol Deviation|0|||
161672730|NCT03872453|583856418|FG002|Overall Study|Protocol Deviation|0|||
161672731|NCT03872453|583856419|FG003|Overall Study|Protocol Deviation|2|||
161672732|NCT03872453|583856416|FG000|Overall Study|Withdrawal by Subject|0|||
161672733|NCT03872453|583856417|FG001|Overall Study|Withdrawal by Subject|1|||
161672734|NCT03872453|583856418|FG002|Overall Study|Withdrawal by Subject|2|||
162184396|NCT04038580|585726103|FG003|Wash-out 2|Withdrawal by Subject|2|||
162184397|NCT04038580|585726104|FG004|Wash-out 2|Withdrawal by Subject|0|||
162184398|NCT04038580|585726105|FG005|Wash-out 2|Withdrawal by Subject|1|||
162184399|NCT04038580|585726100|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
162184400|NCT04038580|585726101|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
162184401|NCT04038580|585726102|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
162184402|NCT04038580|585726103|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
162184403|NCT04038580|585726104|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
162184404|NCT04038580|585726105|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
162184405|NCT04038580|585726100|FG000|Wash-out 3|Withdrawal by Subject|1|||
162184406|NCT04038580|585726101|FG001|Wash-out 3|Withdrawal by Subject|0|||
162184407|NCT04038580|585726102|FG002|Wash-out 3|Withdrawal by Subject|2|||
162184408|NCT04038580|585726103|FG003|Wash-out 3|Withdrawal by Subject|0|||
162184409|NCT04038580|585726104|FG004|Wash-out 3|Withdrawal by Subject|0|||
162184410|NCT04038580|585726105|FG005|Wash-out 3|Withdrawal by Subject|0|||
161672735|NCT03872453|583856419|FG003|Overall Study|Withdrawal by Subject|0|||
162184411|NCT03477175|585726106|FG000|Overall Study|Unable to travel due to COVID-19|0|||
162184412|NCT03477175|585726107|FG001|Overall Study|Unable to travel due to COVID-19|1|||
162184413|NCT03477175|585726106|FG000|Overall Study|Physician Decision|1|||
162184414|NCT03477175|585726107|FG001|Overall Study|Physician Decision|0|||
162184415|NCT03477175|585726106|FG000|Overall Study|Transitioned to commercial drug|6|||
161672736|NCT03872453|583856416|FG000|Overall Study|Other Than Specified|1|||
162184416|NCT03477175|585726107|FG001|Overall Study|Transitioned to commercial drug|6|||
162184417|NCT03477175|585726106|FG000|Overall Study|Lost to Follow-up|1|||
162184418|NCT03477175|585726107|FG001|Overall Study|Lost to Follow-up|1|||
162184419|NCT03477175|585726106|FG000|Overall Study|Withdrawal by Subject|3|||
161672737|NCT03872453|583856417|FG001|Overall Study|Other Than Specified|0|||
162019228|NCT00771953|585124880|FG000|Overall Study|Other complicating disease|1|||
161818544|NCT02670551|584376139|FG000|Overall Study|Withdrawal of Consent|6|||
161818545|NCT02670551|584376140|FG001|Overall Study|Withdrawal of Consent|3|||
161818546|NCT02670551|584376141|FG002|Overall Study|Withdrawal of Consent|8|||
161818547|NCT02670551|584376139|FG000|Overall Study|Lost to Follow-up|5|||
161818548|NCT02670551|584376140|FG001|Overall Study|Lost to Follow-up|7|||
162184420|NCT03477175|585726107|FG001|Overall Study|Withdrawal by Subject|1|||
162184421|NCT03477175|585726106|FG000|Overall Study|Adverse Event|1|||
162184422|NCT03477175|585726107|FG001|Overall Study|Adverse Event|5|||
162184423|NCT03477175|585726106|FG000|Overall Study|Disease Progression|7|||
162184424|NCT03477175|585726107|FG001|Overall Study|Disease Progression|7|||
162184425|NCT02078648|585726108|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
162184426|NCT02078648|585726109|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
162184427|NCT02078648|585726108|FG000|Overall Study|Adverse Event|0|||
162184428|NCT02078648|585726109|FG001|Overall Study|Adverse Event|1|||
162184429|NCT02078648|585726108|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
162184430|NCT02078648|585726109|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
161818549|NCT02670551|584376141|FG002|Overall Study|Lost to Follow-up|6|||
161818550|NCT02670551|584376139|FG000|Overall Study|Protocol Violation|1|||
162184431|NCT02078648|585726108|FG000|Overall Study|Withdrawal by Subject|3|||
162184432|NCT02078648|585726109|FG001|Overall Study|Withdrawal by Subject|1|||
162184433|NCT02078648|585726108|FG000|Overall Study|Investigator Decision|5|||
162184434|NCT02078648|585726109|FG001|Overall Study|Investigator Decision|7|||
162184435|NCT02078648|585726108|FG000|Overall Study|Death|1|||
162184436|NCT02078648|585726109|FG001|Overall Study|Death|1|||
162184437|NCT02078648|585726108|FG000|Overall Study|Undefined|0|||
162184438|NCT02078648|585726109|FG001|Overall Study|Undefined|1|||
162184439|NCT04088227|585726110|FG000|Overall Study|Withdrawal by Subject|1|||
162184440|NCT04088227|585726111|FG001|Overall Study|Withdrawal by Subject|0|||
162184441|NCT04088227|585726110|FG000|Overall Study|Surgery postponed >5weeks|1|||
162184442|NCT04088227|585726111|FG001|Overall Study|Surgery postponed >5weeks|0|||
162184443|NCT04021862|585726112|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
162184444|NCT04021862|585726113|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
162184445|NCT04021862|585726114|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
162184446|NCT04021862|585726115|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
162184447|NCT04021862|585726116|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
162184448|NCT04021862|585726117|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
162184449|NCT04021862|585726112|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
162184450|NCT04021862|585726113|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
162184451|NCT04021862|585726114|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
162184452|NCT04021862|585726115|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
162184453|NCT04021862|585726116|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
162184454|NCT04021862|585726117|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
162184455|NCT04021862|585726112|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
162184456|NCT04021862|585726113|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
162184457|NCT04021862|585726114|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
162184458|NCT04021862|585726115|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
162184459|NCT04021862|585726116|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
161818551|NCT02670551|584376140|FG001|Overall Study|Protocol Violation|0|||
161818552|NCT02670551|584376141|FG002|Overall Study|Protocol Violation|0|||
161818553|NCT02670551|584376139|FG000|Overall Study|Noncompliance with study drug|3|||
162184460|NCT04021862|585726117|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
162184461|NCT04021862|585726112|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
161818554|NCT02670551|584376140|FG001|Overall Study|Noncompliance with study drug|3|||
162184462|NCT04021862|585726113|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
162184463|NCT04021862|585726114|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
162184464|NCT04021862|585726115|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
162184465|NCT04021862|585726116|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
162184466|NCT04021862|585726117|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
162184467|NCT04021862|585726112|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
162184468|NCT04021862|585726113|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
162184469|NCT04021862|585726114|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
162184470|NCT04021862|585726115|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
162184471|NCT04021862|585726116|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
162184472|NCT04021862|585726117|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
162184473|NCT01855750|585726118|FG000|Overall Study|Death|78|||
162184474|NCT01855750|585726119|FG001|Overall Study|Death|78|||
162184475|NCT01855750|585726118|FG000|Overall Study|Lost to Follow-up|9|||
162184476|NCT01855750|585726119|FG001|Overall Study|Lost to Follow-up|23|||
162184477|NCT01855750|585726118|FG000|Overall Study|Withdrawal by Subject|35|||
162184478|NCT01855750|585726119|FG001|Overall Study|Withdrawal by Subject|28|||
162184479|NCT01855750|585726118|FG000|Overall Study|Sponsor ends the study|297|||
162184480|NCT01855750|585726119|FG001|Overall Study|Sponsor ends the study|290|||
162184481|NCT05379270|585726120|FG000|Overall Study|Withdrawal by Subject|1|||
162184482|NCT05379270|585726121|FG001|Overall Study|Withdrawal by Subject|1|||
162184483|NCT03160885|585726122|FG000|Initial Treatment Period|Not dosed|2|||
162184484|NCT03160885|585726123|FG001|Initial Treatment Period|Not dosed|0|||
162184485|NCT03160885|585726124|FG002|Initial Treatment Period|Not dosed|0|||
162184486|NCT03160885|585726125|FG003|Initial Treatment Period|Not dosed|0|||
162184487|NCT03160885|585726126|FG004|Initial Treatment Period|Not dosed|0|||
162184488|NCT03160885|585726127|FG005|Initial Treatment Period|Not dosed|0|||
162184489|NCT03160885|585726128|FG006|Initial Treatment Period|Not dosed|0|||
162184490|NCT03160885|585726122|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
162184491|NCT03160885|585726123|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
162184492|NCT03160885|585726124|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162184493|NCT03160885|585726125|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162184494|NCT03160885|585726126|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162184495|NCT03160885|585726127|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162184496|NCT03160885|585726128|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
162184497|NCT03160885|585726122|FG000|Open-label Treatment|Not dosed|0|||
162184498|NCT03160885|585726123|FG001|Open-label Treatment|Not dosed|0|||
162184499|NCT03160885|585726124|FG002|Open-label Treatment|Not dosed|0|||
162184500|NCT03160885|585726125|FG003|Open-label Treatment|Not dosed|0|||
161818555|NCT02670551|584376141|FG002|Overall Study|Noncompliance with study drug|2|||
161818556|NCT02670551|584376139|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161818557|NCT02670551|584376140|FG001|Overall Study|Other Miscellaneous Reasons|3|||
161818558|NCT02670551|584376141|FG002|Overall Study|Other Miscellaneous Reasons|3|||
161818559|NCT02670551|584376139|FG000|Overall Study|Did Not Receive Treatment|5|||
162184501|NCT03160885|585726126|FG004|Open-label Treatment|Not dosed|0|||
162184502|NCT03160885|585726127|FG005|Open-label Treatment|Not dosed|0|||
162184503|NCT03160885|585726128|FG006|Open-label Treatment|Not dosed|2|||
162184504|NCT03160885|585726122|FG000|Open-label Treatment|Discontinued IMP|0|||
162184505|NCT03160885|585726123|FG001|Open-label Treatment|Discontinued IMP|0|||
162184506|NCT03160885|585726124|FG002|Open-label Treatment|Discontinued IMP|0|||
162184507|NCT03160885|585726125|FG003|Open-label Treatment|Discontinued IMP|0|||
162184508|NCT03160885|585726126|FG004|Open-label Treatment|Discontinued IMP|0|||
162184509|NCT03160885|585726127|FG005|Open-label Treatment|Discontinued IMP|0|||
162184510|NCT03160885|585726128|FG006|Open-label Treatment|Discontinued IMP|131|||
162184511|NCT03160885|585726122|FG000|Open-label Treatment|Completed Week 50|0|||
162184512|NCT03160885|585726123|FG001|Open-label Treatment|Completed Week 50|0|||
162184513|NCT03160885|585726124|FG002|Open-label Treatment|Completed Week 50|0|||
161818560|NCT02670551|584376140|FG001|Overall Study|Did Not Receive Treatment|3|||
161818561|NCT02670551|584376141|FG002|Overall Study|Did Not Receive Treatment|0|||
161818562|NCT04476277|584376142|FG000|Overall Study|Withdrawal by Subject|0|||
162184514|NCT03160885|585726125|FG003|Open-label Treatment|Completed Week 50|0|||
162184515|NCT03160885|585726126|FG004|Open-label Treatment|Completed Week 50|0|||
162184516|NCT03160885|585726127|FG005|Open-label Treatment|Completed Week 50|0|||
161818563|NCT04476277|584376143|FG001|Overall Study|Withdrawal by Subject|0|||
161818564|NCT04476277|584376144|FG002|Overall Study|Withdrawal by Subject|1|||
162019229|NCT00771953|585124881|FG001|Overall Study|Other complicating disease|0|||
162184517|NCT03160885|585726128|FG006|Open-label Treatment|Completed Week 50|4|||
162184518|NCT03160885|585726122|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
162184519|NCT03160885|585726123|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
162184520|NCT03160885|585726124|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
162184521|NCT03160885|585726125|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
161818565|NCT04476277|584376145|FG003|Overall Study|Withdrawal by Subject|0|||
162184522|NCT03160885|585726126|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
162184523|NCT03160885|585726127|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
162184524|NCT03160885|585726128|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
162184525|NCT03160885|585726122|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
162184526|NCT03160885|585726123|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
162184527|NCT03160885|585726124|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
162184528|NCT03160885|585726125|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
162184529|NCT03160885|585726126|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
162184530|NCT03160885|585726127|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
162184531|NCT03160885|585726128|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
162184532|NCT03160885|585726122|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162184533|NCT03160885|585726123|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162184534|NCT03160885|585726124|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
162184535|NCT03160885|585726125|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
162184536|NCT03160885|585726126|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
162184537|NCT03160885|585726127|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
162184538|NCT03160885|585726128|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
162184539|NCT03160885|585726122|FG000|Maintenance Treatment Period|Completed Week 50|0|||
162184540|NCT03160885|585726123|FG001|Maintenance Treatment Period|Completed Week 50|0|||
162184541|NCT03160885|585726124|FG002|Maintenance Treatment Period|Completed Week 50|1|||
162184542|NCT03160885|585726125|FG003|Maintenance Treatment Period|Completed Week 50|0|||
162184543|NCT03160885|585726126|FG004|Maintenance Treatment Period|Completed Week 50|0|||
162184544|NCT03160885|585726127|FG005|Maintenance Treatment Period|Completed Week 50|0|||
162184545|NCT03160885|585726128|FG006|Maintenance Treatment Period|Completed Week 50|0|||
162184546|NCT03425682|585726129|FG000|Overall Study|Lost to Follow-up|2|||
162184547|NCT03425682|585726130|FG001|Overall Study|Lost to Follow-up|4|||
162184548|NCT03425682|585726129|FG000|Overall Study|Withdrawal by Subject|0|||
162184549|NCT03425682|585726130|FG001|Overall Study|Withdrawal by Subject|3|||
162184550|NCT03425682|585726129|FG000|Overall Study|Subject did not meet I/E|4|||
162184551|NCT03425682|585726130|FG001|Overall Study|Subject did not meet I/E|10|||
162184552|NCT01779700|585727227|FG000|Overall Study|Adverse Event|4|||
162184553|NCT01779700|585727228|FG001|Overall Study|Adverse Event|3|||
162184554|NCT01779700|585727227|FG000|Overall Study|Withdrawal by Subject|0|||
162184555|NCT01779700|585727228|FG001|Overall Study|Withdrawal by Subject|2|||
162184556|NCT00442104|585727229|FG000|Overall Study|Adverse Event|5|||
162184557|NCT00442104|585727229|FG000|Overall Study|Death|2|||
162184558|NCT00442104|585727229|FG000|Overall Study|Lost to Follow-up|3|||
162184559|NCT00442104|585727229|FG000|Overall Study|Withdrawal by Subject|5|||
162184560|NCT00442104|585727229|FG000|Overall Study|Insufficient Clinical Response|10|||
162184561|NCT00442104|585727229|FG000|Overall Study|Other|21|||
162184562|NCT00442104|585727229|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
162184563|NCT00918333|585727233|FG000|Overall Study|Drug not taken per protocol|1|||
162184564|NCT00918333|585727234|FG001|Overall Study|Drug not taken per protocol|0|||
161672738|NCT03872453|583856418|FG002|Overall Study|Other Than Specified|0|||
161672739|NCT03872453|583856419|FG003|Overall Study|Other Than Specified|0|||
161672740|NCT01678209|583856420|FG000|Overall Study|could not scan twice|1|||
161672741|NCT01678209|583856421|FG001|Overall Study|could not scan twice|1|||
161672742|NCT01678209|583856422|FG002|Overall Study|could not scan twice|1|||
161924634|NCT01658878|584770969|FG003|Treatment Period|Disease Progression|1|||
161924635|NCT01658878|584770970|FG004|Treatment Period|Disease Progression|13|||
161924636|NCT01658878|584770971|FG005|Treatment Period|Disease Progression|3|||
161924637|NCT01658878|584770972|FG006|Treatment Period|Disease Progression|4|||
162184565|NCT00918333|585727233|FG000|Overall Study|Inadequate amount of drugs provided|1|||
162184566|NCT00918333|585727234|FG001|Overall Study|Inadequate amount of drugs provided|4|||
162184567|NCT00918333|585727233|FG000|Overall Study|Ineligible|1|||
162184568|NCT00918333|585727234|FG001|Overall Study|Ineligible|0|||
162184569|NCT00918333|585727233|FG000|Overall Study|Withdrawal by Subject|0|||
162184570|NCT00918333|585727234|FG001|Overall Study|Withdrawal by Subject|1|||
162184571|NCT04497415|585727238|FG000|Overall Study|Lost to Follow-up|43|||
162184572|NCT04497415|585727239|FG001|Overall Study|Lost to Follow-up|27|||
162184573|NCT02463448|585727243|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
162184574|NCT02463448|585727243|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
162184575|NCT02463448|585727243|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
162184576|NCT02463448|585727243|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
161924638|NCT01658878|584770973|FG007|Treatment Period|Disease Progression|3|||
162184577|NCT00975585|585727244|FG000|Overall Study|Adverse Event|0|||
162184578|NCT00975585|585727245|FG001|Overall Study|Adverse Event|4|||
162184579|NCT00975585|585727244|FG000|Overall Study|Lost to Follow-up|3|||
161672743|NCT01678209|583856420|FG000|Overall Study|scheduling conflicts|0|||
161924639|NCT01658878|584770974|FG008|Treatment Period|Disease Progression|5|||
161924640|NCT01658878|584770975|FG009|Treatment Period|Disease Progression|3|||
161924641|NCT01658878|584770976|FG010|Treatment Period|Disease Progression|3|||
162184580|NCT00975585|585727245|FG001|Overall Study|Lost to Follow-up|5|||
161818566|NCT01962298|584376146|FG000|Overall Study|Protocol Violation|1|||
161818567|NCT01962298|584376147|FG001|Overall Study|Protocol Violation|0|||
161818568|NCT01962298|584376148|FG002|Overall Study|Protocol Violation|1|||
161818569|NCT01962298|584376149|FG003|Overall Study|Protocol Violation|1|||
162184581|NCT00975585|585727244|FG000|Overall Study|Withdrawal by Subject|2|||
162184582|NCT00975585|585727245|FG001|Overall Study|Withdrawal by Subject|1|||
162184583|NCT00975585|585727244|FG000|Overall Study|Lens issue|2|||
161818570|NCT01962298|584376150|FG004|Overall Study|Protocol Violation|0|||
161818571|NCT01962298|584376146|FG000|Overall Study|Data quality insufficient|2|||
161818572|NCT01962298|584376147|FG001|Overall Study|Data quality insufficient|0|||
161818573|NCT01962298|584376148|FG002|Overall Study|Data quality insufficient|3|||
161818574|NCT01962298|584376149|FG003|Overall Study|Data quality insufficient|1|||
161818575|NCT01962298|584376150|FG004|Overall Study|Data quality insufficient|4|||
161818576|NCT01962298|584376146|FG000|Overall Study|Insufficient data|0|||
161818577|NCT01962298|584376147|FG001|Overall Study|Insufficient data|2|||
161818578|NCT01962298|584376148|FG002|Overall Study|Insufficient data|1|||
161818579|NCT01962298|584376149|FG003|Overall Study|Insufficient data|0|||
161818580|NCT01962298|584376150|FG004|Overall Study|Insufficient data|1|||
161818581|NCT01962298|584376146|FG000|Overall Study|Incorrect data recorded|0|||
161818582|NCT01962298|584376147|FG001|Overall Study|Incorrect data recorded|1|||
161818583|NCT01962298|584376148|FG002|Overall Study|Incorrect data recorded|0|||
161818584|NCT01962298|584376149|FG003|Overall Study|Incorrect data recorded|0|||
162184584|NCT00975585|585727245|FG001|Overall Study|Lens issue|2|||
162184585|NCT00205179|585727246|FG000|Overall Study|Death|0|||
162184586|NCT00205179|585727247|FG001|Overall Study|Death|2|||
161818585|NCT01962298|584376150|FG004|Overall Study|Incorrect data recorded|0|||
161818586|NCT01962298|584376146|FG000|Overall Study|Physician Decision|0|||
161818587|NCT01962298|584376147|FG001|Overall Study|Physician Decision|1|||
161818588|NCT01962298|584376148|FG002|Overall Study|Physician Decision|0|||
161818589|NCT01962298|584376149|FG003|Overall Study|Physician Decision|0|||
161818590|NCT01962298|584376150|FG004|Overall Study|Physician Decision|1|||
161818591|NCT03727139|584376151|FG000|Overall Study|Protocol Violation|60|||
161818592|NCT00566722|584376152|FG000|Overall Study|Adverse Event|0|||
161818593|NCT00566722|584376153|FG001|Overall Study|Adverse Event|1|||
161818594|NCT00566722|584376154|FG002|Overall Study|Adverse Event|0|||
161818595|NCT00566722|584376152|FG000|Overall Study|Withdrawal by Subject|0|||
161818596|NCT00566722|584376153|FG001|Overall Study|Withdrawal by Subject|0|||
161818597|NCT00566722|584376154|FG002|Overall Study|Withdrawal by Subject|1|||
161818598|NCT00566722|584376152|FG000|Overall Study|Lost to Follow-up|1|||
161818599|NCT00566722|584376153|FG001|Overall Study|Lost to Follow-up|1|||
161818600|NCT00566722|584376154|FG002|Overall Study|Lost to Follow-up|1|||
161818601|NCT00566722|584376152|FG000|Overall Study|Lack of Efficacy|1|||
161818602|NCT00566722|584376153|FG001|Overall Study|Lack of Efficacy|2|||
161818603|NCT00566722|584376154|FG002|Overall Study|Lack of Efficacy|4|||
161818604|NCT00566722|584376152|FG000|Overall Study|Did not meet exclusion criteria|0|||
161818605|NCT00566722|584376153|FG001|Overall Study|Did not meet exclusion criteria|0|||
161818606|NCT00566722|584376154|FG002|Overall Study|Did not meet exclusion criteria|2|||
161818607|NCT00566722|584376152|FG000|Overall Study|Serious adverse event|0|||
161818608|NCT00566722|584376153|FG001|Overall Study|Serious adverse event|1|||
161818609|NCT00566722|584376154|FG002|Overall Study|Serious adverse event|0|||
161818610|NCT00566722|584376152|FG000|Overall Study|Noncompliant with drug administration|0|||
161818611|NCT00566722|584376153|FG001|Overall Study|Noncompliant with drug administration|0|||
161818612|NCT00566722|584376154|FG002|Overall Study|Noncompliant with drug administration|1|||
161818613|NCT02264977|584376155|FG000|Overall Study|Death|3|||
161818614|NCT02264977|584376155|FG000|Overall Study|Physician Decision|1|||
161818615|NCT02264977|584376155|FG000|Overall Study|Refuse to return|1|||
161818616|NCT03573544|584376156|FG000|Overall Study|Adverse Event|0|||
161818617|NCT03573544|584376157|FG001|Overall Study|Adverse Event|0|||
161818618|NCT03573544|584376158|FG002|Overall Study|Adverse Event|0|||
161818619|NCT03573544|584376159|FG003|Overall Study|Adverse Event|3|||
161818620|NCT03573544|584376160|FG004|Overall Study|Adverse Event|1|||
161818621|NCT03573544|584376161|FG005|Overall Study|Adverse Event|0|||
161818622|NCT03573544|584376162|FG006|Overall Study|Adverse Event|2|||
161924642|NCT01658878|584770977|FG011|Treatment Period|Disease Progression|4|||
161818623|NCT03573544|584376163|FG007|Overall Study|Adverse Event|0|||
161818624|NCT03573544|584376156|FG000|Overall Study|Physician Decision|0|||
161818625|NCT03573544|584376157|FG001|Overall Study|Physician Decision|0|||
161924643|NCT01658878|584770978|FG012|Treatment Period|Disease Progression|43|||
161818626|NCT03573544|584376158|FG002|Overall Study|Physician Decision|0|||
161818627|NCT03573544|584376159|FG003|Overall Study|Physician Decision|0|||
161818628|NCT03573544|584376160|FG004|Overall Study|Physician Decision|0|||
161818629|NCT03573544|584376161|FG005|Overall Study|Physician Decision|0|||
161818630|NCT03573544|584376162|FG006|Overall Study|Physician Decision|1|||
161818631|NCT03573544|584376163|FG007|Overall Study|Physician Decision|0|||
161818632|NCT03573544|584376156|FG000|Overall Study|Withdrawal by Subject|2|||
161818633|NCT03573544|584376157|FG001|Overall Study|Withdrawal by Subject|0|||
161818634|NCT03573544|584376158|FG002|Overall Study|Withdrawal by Subject|0|||
161924644|NCT01658878|584770979|FG013|Treatment Period|Disease Progression|48|||
162184587|NCT00205179|585727246|FG000|Overall Study|Physician Decision|1|||
162184588|NCT00205179|585727247|FG001|Overall Study|Physician Decision|1|||
162184589|NCT00205179|585727246|FG000|Overall Study|Adverse Event|1|||
162184590|NCT00205179|585727247|FG001|Overall Study|Adverse Event|1|||
162184591|NCT01619059|585727252|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
161672744|NCT01678209|583856421|FG001|Overall Study|scheduling conflicts|0|||
161672745|NCT01678209|583856422|FG002|Overall Study|scheduling conflicts|1|||
161924645|NCT01658878|584770980|FG014|Treatment Period|Disease Progression|33|||
161924646|NCT01658878|584770981|FG015|Treatment Period|Disease Progression|46|||
161924647|NCT01658878|584770982|FG016|Treatment Period|Disease Progression|41|||
161924648|NCT01658878|584770983|FG017|Treatment Period|Disease Progression|42|||
161924649|NCT01658878|584770984|FG018|Treatment Period|Disease Progression|28|||
161924650|NCT01658878|584770985|FG019|Treatment Period|Disease Progression|37|||
161924651|NCT01658878|584770986|FG020|Treatment Period|Disease Progression|37|||
161924652|NCT01658878|584770987|FG021|Treatment Period|Disease Progression|39|||
161924653|NCT01658878|584770988|FG022|Treatment Period|Disease Progression|27|||
161924654|NCT01658878|584770989|FG023|Treatment Period|Disease Progression|19|||
161924655|NCT01658878|584770966|FG000|Treatment Period|Study Drug Toxicity|0|||
161924656|NCT01658878|584770967|FG001|Treatment Period|Study Drug Toxicity|0|||
161672746|NCT01678209|583856420|FG000|Overall Study|screen fail|16|||
161672747|NCT01678209|583856421|FG001|Overall Study|screen fail|17|||
161672748|NCT01678209|583856422|FG002|Overall Study|screen fail|16|||
161672749|NCT03756350|583856427|FG000|Overall Study|Lost to Follow-up|1|||
161672750|NCT00702845|583856431|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
161672751|NCT00702845|583856432|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
161672752|NCT00702845|583856431|FG000|Overall Study|Too high ovarian response|5|||
161672753|NCT00702845|583856432|FG001|Overall Study|Too high ovarian response|1|||
161672754|NCT00702845|583856431|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
161672755|NCT00702845|583856432|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
161672756|NCT00702845|583856431|FG000|Overall Study|Insufficient ovarian response|1|||
161672757|NCT00702845|583856432|FG001|Overall Study|Insufficient ovarian response|0|||
161672758|NCT00702845|583856431|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
161672759|NCT00702845|583856432|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
161672760|NCT00702845|583856431|FG000|Overall Study|No or abnormal fertilization|4|||
161672761|NCT00702845|583856432|FG001|Overall Study|No or abnormal fertilization|2|||
161672762|NCT00702845|583856431|FG000|Overall Study|Patient's decision|2|||
161672763|NCT00702845|583856432|FG001|Overall Study|Patient's decision|1|||
161924657|NCT01658878|584770968|FG002|Treatment Period|Study Drug Toxicity|0|||
161924658|NCT01658878|584770969|FG003|Treatment Period|Study Drug Toxicity|1|||
161672764|NCT00702845|583856431|FG000|Overall Study|Not randomized|0|||
161672765|NCT00702845|583856432|FG001|Overall Study|Not randomized|1|||
161924659|NCT01658878|584770970|FG004|Treatment Period|Study Drug Toxicity|0|||
161924660|NCT01658878|584770971|FG005|Treatment Period|Study Drug Toxicity|0|||
161924661|NCT01658878|584770972|FG006|Treatment Period|Study Drug Toxicity|0|||
161924662|NCT01658878|584770973|FG007|Treatment Period|Study Drug Toxicity|0|||
161924663|NCT01658878|584770974|FG008|Treatment Period|Study Drug Toxicity|0|||
161924664|NCT01658878|584770975|FG009|Treatment Period|Study Drug Toxicity|0|||
161924665|NCT01658878|584770976|FG010|Treatment Period|Study Drug Toxicity|0|||
161924666|NCT01658878|584770977|FG011|Treatment Period|Study Drug Toxicity|0|||
161924667|NCT01658878|584770978|FG012|Treatment Period|Study Drug Toxicity|7|||
161924668|NCT01658878|584770979|FG013|Treatment Period|Study Drug Toxicity|1|||
161924669|NCT01658878|584770980|FG014|Treatment Period|Study Drug Toxicity|5|||
161924670|NCT01658878|584770981|FG015|Treatment Period|Study Drug Toxicity|0|||
162184592|NCT01619059|585727253|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
161672766|NCT00440700|583856433|FG000|Overall Study|Withdrawal by Subject|8|||
161672767|NCT00440700|583856434|FG001|Overall Study|Withdrawal by Subject|8|||
161672768|NCT00440700|583856435|FG002|Overall Study|Withdrawal by Subject|4|||
161672769|NCT00928564|583856436|FG000|Overall Study|Lost to Follow-up|6|||
161672770|NCT00928564|583856437|FG001|Overall Study|Lost to Follow-up|0|||
161672771|NCT03434353|583856444|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
161672772|NCT03434353|583856445|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
161672773|NCT03434353|583856446|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
161672774|NCT03434353|583856447|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
161672775|NCT03434353|583856448|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
162184593|NCT01619059|585727252|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
161672776|NCT03434353|583856444|FG000|Overall Study|Withdrew consent|1|||
161672777|NCT03434353|583856445|FG001|Overall Study|Withdrew consent|0|||
161672778|NCT03434353|583856446|FG002|Overall Study|Withdrew consent|3|||
161672779|NCT03434353|583856447|FG003|Overall Study|Withdrew consent|0|||
161672780|NCT03434353|583856448|FG004|Overall Study|Withdrew consent|0|||
161924671|NCT01658878|584770982|FG016|Treatment Period|Study Drug Toxicity|5|||
161924672|NCT01658878|584770983|FG017|Treatment Period|Study Drug Toxicity|10|||
161924673|NCT01658878|584770984|FG018|Treatment Period|Study Drug Toxicity|12|||
161924674|NCT01658878|584770985|FG019|Treatment Period|Study Drug Toxicity|4|||
161818635|NCT03573544|584376159|FG003|Overall Study|Withdrawal by Subject|1|||
161818636|NCT03573544|584376160|FG004|Overall Study|Withdrawal by Subject|1|||
161818637|NCT03573544|584376161|FG005|Overall Study|Withdrawal by Subject|1|||
161818638|NCT03573544|584376162|FG006|Overall Study|Withdrawal by Subject|0|||
161818639|NCT03573544|584376163|FG007|Overall Study|Withdrawal by Subject|1|||
161818640|NCT03573544|584376156|FG000|Overall Study|Disease progression|3|||
161818641|NCT03573544|584376157|FG001|Overall Study|Disease progression|3|||
161818642|NCT03573544|584376158|FG002|Overall Study|Disease progression|6|||
161818643|NCT03573544|584376159|FG003|Overall Study|Disease progression|4|||
161924675|NCT01658878|584770986|FG020|Treatment Period|Study Drug Toxicity|2|||
161924676|NCT01658878|584770987|FG021|Treatment Period|Study Drug Toxicity|3|||
161924677|NCT01658878|584770988|FG022|Treatment Period|Study Drug Toxicity|2|||
161924678|NCT01658878|584770989|FG023|Treatment Period|Study Drug Toxicity|6|||
161924679|NCT01658878|584770966|FG000|Treatment Period|Maximum Clinical Benefit|0|||
161924680|NCT01658878|584770967|FG001|Treatment Period|Maximum Clinical Benefit|0|||
161924681|NCT01658878|584770968|FG002|Treatment Period|Maximum Clinical Benefit|1|||
161924682|NCT01658878|584770969|FG003|Treatment Period|Maximum Clinical Benefit|0|||
161924683|NCT01658878|584770970|FG004|Treatment Period|Maximum Clinical Benefit|0|||
162019230|NCT00771953|585124880|FG000|Overall Study|Withdrawal by Subject|0|||
162019231|NCT00771953|585124881|FG001|Overall Study|Withdrawal by Subject|3|||
162019232|NCT00947193|585124884|FG000|Overall Study|Lost to Follow-up|1|||
162019233|NCT00947193|585124885|FG001|Overall Study|Lost to Follow-up|0|||
162019234|NCT00947193|585124884|FG000|Overall Study|Withdrawal by Subject|1|||
162019235|NCT00947193|585124885|FG001|Overall Study|Withdrawal by Subject|0|||
162019236|NCT00947193|585124884|FG000|Overall Study|Factor VIII >1%|1|||
162019237|NCT00947193|585124885|FG001|Overall Study|Factor VIII >1%|0|||
162019238|NCT04364984|585124886|FG000|Overall Study|Death|2|||
162019239|NCT04364984|585124887|FG001|Overall Study|Death|2|||
162019240|NCT04364984|585124888|FG002|Overall Study|Death|0|||
162019241|NCT01349959|585124889|FG000|Overall Study|Adverse Event|7|||
162019242|NCT01652534|585124890|FG000|Overall Study|Lack of Efficacy|1|||
162019243|NCT01652534|585124891|FG001|Overall Study|Lack of Efficacy|0|||
162019244|NCT02722304|585124892|FG000|Overall Study|Study Terminated by Sponsor|1|||
162019245|NCT02722304|585124893|FG001|Overall Study|Study Terminated by Sponsor|0|||
162019246|NCT02722304|585124894|FG002|Overall Study|Study Terminated by Sponsor|2|||
162019247|NCT02722304|585124895|FG003|Overall Study|Study Terminated by Sponsor|1|||
162019248|NCT02722304|585124896|FG004|Overall Study|Study Terminated by Sponsor|1|||
162019249|NCT02722304|585124892|FG000|Overall Study|Other|0|||
162019250|NCT02722304|585124893|FG001|Overall Study|Other|0|||
162019251|NCT02722304|585124894|FG002|Overall Study|Other|0|||
161818644|NCT03573544|584376160|FG004|Overall Study|Disease progression|5|||
161818645|NCT03573544|584376161|FG005|Overall Study|Disease progression|7|||
161924684|NCT01658878|584770971|FG005|Treatment Period|Maximum Clinical Benefit|0|||
162019252|NCT02722304|585124895|FG003|Overall Study|Other|1|||
162019253|NCT02722304|585124896|FG004|Overall Study|Other|1|||
162184594|NCT01619059|585727253|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
162184595|NCT01619059|585727252|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
162184596|NCT01619059|585727253|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
162184597|NCT01619059|585727252|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
162184598|NCT01619059|585727253|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
162184599|NCT01619059|585727252|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
162184600|NCT01619059|585727253|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
161672781|NCT03434353|583856444|FG000|Overall Study|Adverse Event|1|||
161672782|NCT03434353|583856445|FG001|Overall Study|Adverse Event|0|||
161672783|NCT03434353|583856446|FG002|Overall Study|Adverse Event|0|||
161672784|NCT03434353|583856447|FG003|Overall Study|Adverse Event|0|||
161672785|NCT03434353|583856448|FG004|Overall Study|Adverse Event|1|||
161672786|NCT03434353|583856444|FG000|Overall Study|Lost to Follow-up|2|||
161672787|NCT03434353|583856445|FG001|Overall Study|Lost to Follow-up|0|||
161672788|NCT03434353|583856446|FG002|Overall Study|Lost to Follow-up|0|||
161672789|NCT03434353|583856447|FG003|Overall Study|Lost to Follow-up|0|||
161672790|NCT03434353|583856448|FG004|Overall Study|Lost to Follow-up|0|||
161672791|NCT03739762|583856449|FG000|Overall Study|Lost to Follow-up|1|||
161672792|NCT03739762|583856450|FG001|Overall Study|Lost to Follow-up|1|||
161672793|NCT03739762|583856449|FG000|Overall Study|Withdrawal by Subject|2|||
161672794|NCT03739762|583856450|FG001|Overall Study|Withdrawal by Subject|6|||
161672795|NCT00929656|583856451|FG000|Overall Study|Lost to Follow-up|0|||
161672796|NCT00929656|583856452|FG001|Overall Study|Lost to Follow-up|1|||
161672797|NCT00607880|583856453|FG000|Overall Study|Unable to place port due to occlusion|1|||
161672798|NCT00607880|583856454|FG001|Overall Study|Unable to place port due to occlusion|0|||
161672799|NCT04606771|583856455|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
161672800|NCT04606771|583856456|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
161672801|NCT04606771|583856455|FG000|Overall Study|Death|5|||
161672802|NCT04606771|583856456|FG001|Overall Study|Death|6|||
161672803|NCT04606771|583856455|FG000|Overall Study|Wrong randomisation|0|||
161672804|NCT04606771|583856456|FG001|Overall Study|Wrong randomisation|1|||
161672805|NCT01008696|583856458|FG000|Overall Study|Participant's evasion of hospital visit|5|||
161672806|NCT01008696|583856459|FG001|Overall Study|Participant's evasion of hospital visit|4|||
161672807|NCT01008696|583856458|FG000|Overall Study|Withdrawal by Subject|2|||
161818646|NCT03573544|584376162|FG006|Overall Study|Disease progression|6|||
161818647|NCT03573544|584376163|FG007|Overall Study|Disease progression|7|||
161818648|NCT03105297|584376164|FG000|Baseline Phase (Day 1)|Other|21|||
161818649|NCT03105297|584376164|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
161818650|NCT03105297|584376164|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
161818651|NCT00714051|584376165|FG000|Overall Study|Withdrawal by Subject|1|||
161818652|NCT00714051|584376166|FG001|Overall Study|Withdrawal by Subject|0|||
161818653|NCT00714051|584376165|FG000|Overall Study|Death|0|||
161818654|NCT00714051|584376166|FG001|Overall Study|Death|1|||
161818655|NCT01390948|584376167|FG000|Overall Study|End of Study|1|||
161818656|NCT01390948|584376168|FG001|Overall Study|End of Study|0|||
161818657|NCT01390948|584376169|FG002|Overall Study|End of Study|0|||
161818658|NCT01390948|584376167|FG000|Overall Study|Withdrew consent|2|||
161818659|NCT01390948|584376168|FG001|Overall Study|Withdrew consent|2|||
161818660|NCT01390948|584376169|FG002|Overall Study|Withdrew consent|0|||
161818661|NCT01390948|584376167|FG000|Overall Study|Progressive Disease|2|||
161818662|NCT01390948|584376168|FG001|Overall Study|Progressive Disease|5|||
161818663|NCT01390948|584376169|FG002|Overall Study|Progressive Disease|0|||
161818664|NCT01390948|584376167|FG000|Overall Study|Death during follow-up|10|||
161818665|NCT01390948|584376168|FG001|Overall Study|Death during follow-up|11|||
161818666|NCT01390948|584376169|FG002|Overall Study|Death during follow-up|1|||
161818667|NCT05740098|584376172|FG000|Overall Study|Lost to Follow-up|26|||
161818668|NCT05740098|584376173|FG001|Overall Study|Lost to Follow-up|17|||
161818669|NCT05740098|584376174|FG002|Overall Study|Lost to Follow-up|21|||
161818670|NCT00849797|584376179|FG000|First Intervention|bad veins|1|||
161818671|NCT00849797|584376180|FG001|First Intervention|bad veins|0|||
161818672|NCT00849797|584376179|FG000|First Intervention|Adverse Event|0|||
161818673|NCT00849797|584376180|FG001|First Intervention|Adverse Event|1|||
161818674|NCT00849797|584376179|FG000|Washout: One Week|Withdrawal by Subject|0|||
161818675|NCT00849797|584376180|FG001|Washout: One Week|Withdrawal by Subject|2|||
161818676|NCT01018862|584376188|FG000|Overall Study|Adverse Event|2|||
161818677|NCT01018862|584376189|FG001|Overall Study|Adverse Event|0|||
161818678|NCT01018862|584376190|FG002|Overall Study|Adverse Event|6|||
161818679|NCT01018862|584376188|FG000|Overall Study|Lack of Efficacy|1|||
161818680|NCT01018862|584376189|FG001|Overall Study|Lack of Efficacy|0|||
161672808|NCT01008696|583856459|FG001|Overall Study|Withdrawal by Subject|4|||
161672809|NCT01008696|583856458|FG000|Overall Study|Physician Decision|5|||
161672810|NCT01008696|583856459|FG001|Overall Study|Physician Decision|1|||
161672811|NCT01008696|583856458|FG000|Overall Study|Adverse Event|1|||
161672812|NCT01008696|583856459|FG001|Overall Study|Adverse Event|0|||
161672813|NCT01008696|583856458|FG000|Overall Study|Participants' non-cooperation|2|||
161672814|NCT01008696|583856459|FG001|Overall Study|Participants' non-cooperation|3|||
161818681|NCT01018862|584376190|FG002|Overall Study|Lack of Efficacy|2|||
162184601|NCT01619059|585727252|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
162184602|NCT01619059|585727253|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
162184603|NCT01619059|585727252|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
162184604|NCT01619059|585727253|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
162184605|NCT01619059|585727252|FG000|Long-Term (LT) Treatment Period|Death|1|||
162184606|NCT01619059|585727253|FG001|Long-Term (LT) Treatment Period|Death|0|||
162184607|NCT01619059|585727252|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
162184608|NCT01619059|585727253|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
162184609|NCT01619059|585727252|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
162184610|NCT01619059|585727253|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
162184611|NCT03041233|585727254|FG000|Overall Study|Death|5|||
161672815|NCT01008696|583856458|FG000|Overall Study|Other|2|||
161672816|NCT01008696|583856459|FG001|Overall Study|Other|3|||
161672817|NCT01008696|583856458|FG000|Overall Study|Other|0|||
161672818|NCT01008696|583856459|FG001|Overall Study|Other|2|||
161672819|NCT01207596|583856460|FG000|Overall Study|Physician Decision|4|||
161672820|NCT01207596|583856460|FG000|Overall Study|Lack of Efficacy|1|||
161672821|NCT01207596|583856460|FG000|Overall Study|Adverse Event|3|||
161672822|NCT01207596|583856460|FG000|Overall Study|Withdrawal by Subject|1|||
161672823|NCT03083847|583856461|FG000|Main|Physician Decision|0|||
161672824|NCT03083847|583856462|FG001|Main|Physician Decision|0|||
161672825|NCT03083847|583856463|FG002|Main|Physician Decision|0|||
161672826|NCT03083847|583856464|FG003|Main|Physician Decision|0|||
161672827|NCT03083847|583856465|FG004|Main|Physician Decision|0|||
161672828|NCT03083847|583856466|FG005|Main|Physician Decision|1|||
161672829|NCT03083847|583856467|FG006|Main|Physician Decision|0|||
161672830|NCT03083847|583856468|FG007|Main|Physician Decision|0|||
161672831|NCT03083847|583856469|FG008|Main|Physician Decision|0|||
161672832|NCT03083847|583856470|FG009|Main|Physician Decision|0|||
161818682|NCT01018862|584376188|FG000|Overall Study|Lost to Follow-up|3|||
161818683|NCT01018862|584376189|FG001|Overall Study|Lost to Follow-up|1|||
162184612|NCT03041233|585727254|FG000|Overall Study|Physician Decision|1|||
162184613|NCT03041233|585727254|FG000|Overall Study|Lost to Follow-up|16|||
161818684|NCT01018862|584376190|FG002|Overall Study|Lost to Follow-up|0|||
161818685|NCT01018862|584376188|FG000|Overall Study|Protocol Violation|1|||
162184614|NCT03041233|585727254|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
162184615|NCT03041233|585727254|FG000|Overall Study|Sponsor Request|1|||
162184616|NCT03041233|585727254|FG000|Overall Study|Duplicate subject|1|||
162184617|NCT03041233|585727254|FG000|Overall Study|Re-ablation|1|||
162184618|NCT00853593|585727258|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
162184619|NCT00853593|585727258|FG000|Overall Study|Model 4396 lead not attempted|29|||
162184620|NCT00853593|585727258|FG000|Overall Study|Implant not attempted|4|||
162184621|NCT03229408|585727261|FG000|Overall Study|Withdrawal by Subject|4|||
162184622|NCT03229408|585727262|FG001|Overall Study|Withdrawal by Subject|1|||
162184623|NCT03229408|585727261|FG000|Overall Study|Adverse Event|2|||
162184624|NCT03229408|585727262|FG001|Overall Study|Adverse Event|0|||
162184625|NCT03229408|585727261|FG000|Overall Study|Pregnancy|0|||
162184626|NCT03229408|585727262|FG001|Overall Study|Pregnancy|1|||
162184627|NCT03229408|585727261|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
162184628|NCT03229408|585727262|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
162184629|NCT03745313|585727267|FG000|At 30 Days Follow-up|Death|2|||
162184630|NCT03745313|585727267|FG000|At 6 Months Follow-up|Death|1|||
162184631|NCT03745313|585727267|FG000|At 6 Months Follow-up|Missed Visit|1|||
162184632|NCT03745313|585727267|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
162184633|NCT03745313|585727267|FG000|At 1 Year Follow-up|Death|2|||
162184634|NCT03745313|585727267|FG000|At 1 Year Follow-up|Missed Visit|2|||
162184635|NCT03745313|585727267|FG000|At 2 Year Follow-up|Missed Visit|1|||
162184636|NCT03170648|585727271|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
162184637|NCT03170648|585727271|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
162184638|NCT02052440|585727272|FG000|Overall Study|Withdrawal by Subject|0|||
162184639|NCT02052440|585727273|FG001|Overall Study|Withdrawal by Subject|1|||
162184640|NCT01367236|585727277|FG000|Overall Study|Withdrawal by Subject|3|||
162184641|NCT01367236|585727278|FG001|Overall Study|Withdrawal by Subject|1|||
162184642|NCT02628626|585727283|FG000|Overall Study|Withdrawal by Subject|2|||
162184643|NCT02628626|585727284|FG001|Overall Study|Withdrawal by Subject|2|||
162184644|NCT01593020|585727285|FG000|Overall Study|Adverse Event|1|||
162184645|NCT01593020|585727286|FG001|Overall Study|Adverse Event|1|||
161672833|NCT03083847|583856461|FG000|Main|Pregnancy|0|||
161672834|NCT03083847|583856462|FG001|Main|Pregnancy|0|||
161672835|NCT03083847|583856463|FG002|Main|Pregnancy|0|||
161672836|NCT03083847|583856464|FG003|Main|Pregnancy|0|||
161672837|NCT03083847|583856465|FG004|Main|Pregnancy|0|||
161672838|NCT03083847|583856466|FG005|Main|Pregnancy|0|||
161672839|NCT03083847|583856467|FG006|Main|Pregnancy|0|||
161818686|NCT01018862|584376189|FG001|Overall Study|Protocol Violation|3|||
161818687|NCT01018862|584376190|FG002|Overall Study|Protocol Violation|3|||
161818688|NCT01018862|584376188|FG000|Overall Study|Withdrawal by Subject|1|||
161818689|NCT01018862|584376189|FG001|Overall Study|Withdrawal by Subject|2|||
161672840|NCT03083847|583856468|FG007|Main|Pregnancy|1|||
161672841|NCT03083847|583856469|FG008|Main|Pregnancy|0|||
161672842|NCT03083847|583856470|FG009|Main|Pregnancy|0|||
161672843|NCT03083847|583856461|FG000|Main|Adverse Event|0|||
161672844|NCT03083847|583856462|FG001|Main|Adverse Event|0|||
161672845|NCT03083847|583856463|FG002|Main|Adverse Event|0|||
161672846|NCT03083847|583856464|FG003|Main|Adverse Event|0|||
161672847|NCT03083847|583856465|FG004|Main|Adverse Event|0|||
161672848|NCT03083847|583856466|FG005|Main|Adverse Event|0|||
161672849|NCT03083847|583856467|FG006|Main|Adverse Event|0|||
161672850|NCT03083847|583856468|FG007|Main|Adverse Event|2|||
161672851|NCT03083847|583856469|FG008|Main|Adverse Event|0|||
161672852|NCT03083847|583856470|FG009|Main|Adverse Event|0|||
161672853|NCT03083847|583856461|FG000|Main|Withdrawal by Subject|0|||
161672854|NCT03083847|583856462|FG001|Main|Withdrawal by Subject|0|||
161672855|NCT03083847|583856463|FG002|Main|Withdrawal by Subject|0|||
161672856|NCT03083847|583856464|FG003|Main|Withdrawal by Subject|0|||
161672857|NCT03083847|583856465|FG004|Main|Withdrawal by Subject|0|||
161672858|NCT03083847|583856466|FG005|Main|Withdrawal by Subject|0|||
161672859|NCT03083847|583856467|FG006|Main|Withdrawal by Subject|1|||
161672860|NCT03083847|583856468|FG007|Main|Withdrawal by Subject|1|||
161672861|NCT03083847|583856469|FG008|Main|Withdrawal by Subject|0|||
161672862|NCT03083847|583856470|FG009|Main|Withdrawal by Subject|0|||
161672863|NCT00216203|583856471|FG000|Overall Study|Withdrawal by Subject|2|||
162184646|NCT01593020|585727285|FG000|Overall Study|Death|0|||
162184647|NCT01593020|585727286|FG001|Overall Study|Death|1|||
162184648|NCT01593020|585727285|FG000|Overall Study|Ineligible|1|||
162184649|NCT01593020|585727286|FG001|Overall Study|Ineligible|0|||
162184650|NCT03611075|585727291|FG000|Overall Study|Physician Decision|0|||
162184651|NCT03611075|585727292|FG001|Overall Study|Physician Decision|1|||
162184652|NCT03611075|585727293|FG002|Overall Study|Physician Decision|1|||
162184653|NCT03611075|585727294|FG003|Overall Study|Physician Decision|0|||
162184654|NCT03611075|585727295|FG004|Overall Study|Physician Decision|0|||
162184655|NCT03611075|585727296|FG005|Overall Study|Physician Decision|0|||
162184656|NCT03611075|585727297|FG006|Overall Study|Physician Decision|0|||
162184657|NCT03611075|585727298|FG007|Overall Study|Physician Decision|0|||
162184658|NCT03611075|585727299|FG008|Overall Study|Physician Decision|0|||
162184659|NCT03611075|585727291|FG000|Overall Study|Lost to Follow-up|1|||
162184660|NCT03611075|585727292|FG001|Overall Study|Lost to Follow-up|0|||
162184661|NCT03611075|585727293|FG002|Overall Study|Lost to Follow-up|0|||
162184662|NCT03611075|585727294|FG003|Overall Study|Lost to Follow-up|2|||
162184663|NCT03611075|585727295|FG004|Overall Study|Lost to Follow-up|0|||
162184664|NCT03611075|585727296|FG005|Overall Study|Lost to Follow-up|0|||
162184665|NCT03611075|585727297|FG006|Overall Study|Lost to Follow-up|0|||
162184666|NCT03611075|585727298|FG007|Overall Study|Lost to Follow-up|0|||
162184667|NCT03611075|585727299|FG008|Overall Study|Lost to Follow-up|0|||
161672864|NCT02596620|583856474|FG000|Overall Study|Lost to Follow-up|1|||
161672865|NCT02596620|583856475|FG001|Overall Study|Lost to Follow-up|1|||
161924685|NCT01658878|584770972|FG006|Treatment Period|Maximum Clinical Benefit|0|||
161924686|NCT01658878|584770973|FG007|Treatment Period|Maximum Clinical Benefit|0|||
162184668|NCT03611075|585727291|FG000|Overall Study|Withdrawal by Subject|0|||
162184669|NCT03611075|585727292|FG001|Overall Study|Withdrawal by Subject|1|||
162184670|NCT03611075|585727293|FG002|Overall Study|Withdrawal by Subject|1|||
162184671|NCT03611075|585727294|FG003|Overall Study|Withdrawal by Subject|1|||
161672866|NCT03155373|583856485|FG000|Overall Study|No longer required surgery|1|||
161672867|NCT03155373|583856485|FG000|Overall Study|Protocol Violation|1|||
161672868|NCT03155373|583856485|FG000|Overall Study|Death|2|||
161672869|NCT03155373|583856485|FG000|Overall Study|Withdrawal by Subject|3|||
161672870|NCT01054144|583856486|FG000|Overall Study|Death|2|||
161672871|NCT02856893|583856487|FG000|Overall Study|Lack of Efficacy|27|||
161672872|NCT02856893|583856488|FG001|Overall Study|Lack of Efficacy|15|||
162184672|NCT03611075|585727295|FG004|Overall Study|Withdrawal by Subject|0|||
162184673|NCT03611075|585727296|FG005|Overall Study|Withdrawal by Subject|0|||
161672873|NCT02856893|583856489|FG002|Overall Study|Lack of Efficacy|19|||
161672874|NCT02856893|583856487|FG000|Overall Study|Death|1|||
161672875|NCT02856893|583856488|FG001|Overall Study|Death|0|||
161672876|NCT02856893|583856489|FG002|Overall Study|Death|0|||
161672877|NCT02856893|583856487|FG000|Overall Study|Adverse Event|2|||
161672878|NCT02856893|583856488|FG001|Overall Study|Adverse Event|0|||
161672879|NCT02856893|583856489|FG002|Overall Study|Adverse Event|0|||
161672880|NCT02856893|583856487|FG000|Overall Study|Physician Decision|0|||
161672881|NCT02856893|583856488|FG001|Overall Study|Physician Decision|2|||
161672882|NCT02856893|583856489|FG002|Overall Study|Physician Decision|3|||
161672883|NCT02856893|583856487|FG000|Overall Study|Withdrawal by Subject|1|||
161672884|NCT02856893|583856488|FG001|Overall Study|Withdrawal by Subject|1|||
161672885|NCT02856893|583856489|FG002|Overall Study|Withdrawal by Subject|0|||
161672886|NCT02856893|583856487|FG000|Overall Study|Other reasons|2|||
161672887|NCT02856893|583856488|FG001|Overall Study|Other reasons|1|||
161672888|NCT02856893|583856489|FG002|Overall Study|Other reasons|2|||
161672889|NCT02310672|583856490|FG000|Overall Study|Death|1|||
161672890|NCT02310672|583856490|FG000|Overall Study|Lost to Follow-up|1|||
161672891|NCT02310672|583856490|FG000|Overall Study|Withdrawal by Subject|1|||
161672892|NCT02310672|583856490|FG000|Overall Study|Sponsor's decision|12|||
161672893|NCT01214187|583856494|FG000|Overall Study|Adverse Event|6|||
161672894|NCT01214187|583856495|FG001|Overall Study|Adverse Event|2|||
161672895|NCT01214187|583856494|FG000|Overall Study|Death|1|||
161672896|NCT01214187|583856495|FG001|Overall Study|Death|1|||
161672897|NCT01214187|583856494|FG000|Overall Study|Withdrawal by Subject|0|||
161672898|NCT01214187|583856495|FG001|Overall Study|Withdrawal by Subject|3|||
161672899|NCT02308007|583856504|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
161672900|NCT02308007|583856505|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
161672901|NCT02308007|583856506|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
161672902|NCT02308007|583856504|FG000|Overall Study|Positive for STD at Baseline|7|||
161672903|NCT02308007|583856505|FG001|Overall Study|Positive for STD at Baseline|11|||
161672904|NCT02308007|583856506|FG002|Overall Study|Positive for STD at Baseline|7|||
161672905|NCT02308007|583856504|FG000|Overall Study|Lost to Follow-up|3|||
161672906|NCT02308007|583856505|FG001|Overall Study|Lost to Follow-up|0|||
161672907|NCT02308007|583856506|FG002|Overall Study|Lost to Follow-up|1|||
161672908|NCT03118674|583856507|FG000|Overall Study|Lost to Follow-up|2|||
161672909|NCT03118674|583856507|FG000|Overall Study|Screen Faliure|8|||
161672910|NCT03118674|583856507|FG000|Overall Study|Withdrawal by Subject|5|||
161672911|NCT01233869|583856508|FG000|Initial Treatment Period (24 Months)|Death|1|||
161672912|NCT01233869|583856509|FG001|Initial Treatment Period (24 Months)|Death|0|||
161672913|NCT01233869|583856510|FG002|Initial Treatment Period (24 Months)|Death|0|||
161672914|NCT01233869|583856511|FG003|Initial Treatment Period (24 Months)|Death|0|||
161672915|NCT01233869|583856508|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
161672916|NCT01233869|583856509|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
161672917|NCT01233869|583856510|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
161672918|NCT01233869|583856511|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
161672919|NCT01233869|583856508|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
161672920|NCT01233869|583856509|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
161672921|NCT01233869|583856510|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
161672922|NCT01233869|583856511|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
161672923|NCT01233869|583856508|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
161672924|NCT01233869|583856509|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
161672925|NCT01233869|583856510|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
161672926|NCT01233869|583856511|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
161672927|NCT01233869|583856508|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
161672928|NCT01233869|583856509|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
161672929|NCT01233869|583856510|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
161672930|NCT01233869|583856511|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
162019254|NCT01727024|585124899|FG000|Period 1|Lost to Follow-up|1|||
161672931|NCT01233869|583856508|FG000|Extended Treatment Period (46 Months)|Other|3|||
161672932|NCT01233869|583856509|FG001|Extended Treatment Period (46 Months)|Other|0|||
161672933|NCT01233869|583856510|FG002|Extended Treatment Period (46 Months)|Other|0|||
161672934|NCT01233869|583856511|FG003|Extended Treatment Period (46 Months)|Other|3|||
162184674|NCT03611075|585727297|FG006|Overall Study|Withdrawal by Subject|1|||
162184675|NCT03611075|585727298|FG007|Overall Study|Withdrawal by Subject|0|||
162184676|NCT03611075|585727299|FG008|Overall Study|Withdrawal by Subject|0|||
162184677|NCT03611075|585727291|FG000|Overall Study|Reason unknown|0|||
162184678|NCT03611075|585727292|FG001|Overall Study|Reason unknown|0|||
162184679|NCT03611075|585727293|FG002|Overall Study|Reason unknown|0|||
161924687|NCT01658878|584770974|FG008|Treatment Period|Maximum Clinical Benefit|0|||
162184680|NCT03611075|585727294|FG003|Overall Study|Reason unknown|1|||
162184681|NCT03611075|585727295|FG004|Overall Study|Reason unknown|0|||
162184682|NCT03611075|585727296|FG005|Overall Study|Reason unknown|0|||
162184683|NCT03611075|585727297|FG006|Overall Study|Reason unknown|1|||
162184684|NCT03611075|585727298|FG007|Overall Study|Reason unknown|0|||
162184685|NCT03611075|585727299|FG008|Overall Study|Reason unknown|0|||
162184686|NCT02972359|585727300|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
162184687|NCT02972359|585727300|FG000|Overall Study|Lack of Efficacy|1|||
162184688|NCT02972359|585727300|FG000|Overall Study|Adverse Event|4|||
161924688|NCT01658878|584770975|FG009|Treatment Period|Maximum Clinical Benefit|0|||
162184689|NCT02972359|585727300|FG000|Overall Study|Death|1|||
162184690|NCT02972359|585727300|FG000|Overall Study|Withdrawal by Subject|30|||
162184691|NCT02972359|585727300|FG000|Overall Study|Protocol Violation|1|||
162184692|NCT02972359|585727300|FG000|Overall Study|Lost to Follow-up|26|||
162184693|NCT02972359|585727300|FG000|Overall Study|Other reasons|5|||
162184694|NCT02972359|585727300|FG000|Overall Study|Missing|1|||
162184695|NCT05525572|585727304|FG000|Overall Study|Lost to Follow-up|2|||
162184696|NCT05025384|585727311|FG000|Overall Study|Physician Decision|5|||
162184697|NCT05025384|585727312|FG001|Overall Study|Physician Decision|6|||
162184698|NCT03835754|585727313|FG000|Overall Study|Death|4|||
162184699|NCT02517268|585727314|FG000|Overall Study|Withdrawal by Subject|1|||
161672935|NCT01233869|583856508|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
161672936|NCT01233869|583856509|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
161672937|NCT01233869|583856510|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
161672938|NCT01233869|583856511|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
161672939|NCT01324323|583856512|FG000|Overall Study|Withdrawal by Subject|1|||
161672940|NCT00537485|583856513|FG000|Overall Study|Adverse Event|10|||
161672941|NCT00537485|583856514|FG001|Overall Study|Adverse Event|5|||
161672942|NCT00537485|583856513|FG000|Overall Study|Withdrawal by Subject|3|||
161672943|NCT00537485|583856514|FG001|Overall Study|Withdrawal by Subject|2|||
161672944|NCT00537485|583856513|FG000|Overall Study|Withdrawal by Subject|1|||
161672945|NCT00537485|583856514|FG001|Overall Study|Withdrawal by Subject|3|||
161672946|NCT00537485|583856513|FG000|Overall Study|Physician Decision|1|||
161672947|NCT00537485|583856514|FG001|Overall Study|Physician Decision|0|||
161672948|NCT01601847|583856523|FG000|Overall Study|Death|1|||
161672949|NCT01601847|583856524|FG001|Overall Study|Death|0|||
161672950|NCT01601847|583856523|FG000|Overall Study|Withdrawal by Subject|11|||
162019255|NCT01727024|585124900|FG001|Period 1|Lost to Follow-up|1|||
162184700|NCT02517268|585727315|FG001|Overall Study|Withdrawal by Subject|0|||
162184701|NCT03227861|585727318|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
162184702|NCT03227861|585727318|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
162184703|NCT03227861|585727318|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
162184704|NCT03227861|585727318|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
162184705|NCT03227861|585727318|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
162184706|NCT03227861|585727318|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
162184707|NCT03227861|585727318|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
162184708|NCT03227861|585727318|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
162184709|NCT03227861|585727318|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
162184710|NCT03227861|585727318|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
162184711|NCT05810285|585727319|FG000|Overall Study|Death|4|||
162184712|NCT05810285|585727320|FG001|Overall Study|Death|21|||
162184713|NCT05810285|585727319|FG000|Overall Study|Adverse Event|18|||
162184714|NCT05810285|585727320|FG001|Overall Study|Adverse Event|16|||
162184715|NCT05886777|585727321|FG000|Overall Study|Lost to Follow-up|1|||
162184716|NCT05886777|585727322|FG001|Overall Study|Lost to Follow-up|0|||
162184717|NCT05886777|585727323|FG002|Overall Study|Lost to Follow-up|2|||
162184718|NCT05886777|585727324|FG003|Overall Study|Lost to Follow-up|1|||
162184719|NCT05886777|585727325|FG004|Overall Study|Lost to Follow-up|0|||
162184720|NCT05886777|585727326|FG005|Overall Study|Lost to Follow-up|2|||
162184721|NCT05886777|585727327|FG006|Overall Study|Lost to Follow-up|0|||
162184722|NCT05886777|585727321|FG000|Overall Study|Other|0|||
162184723|NCT05886777|585727322|FG001|Overall Study|Other|2|||
162184724|NCT05886777|585727323|FG002|Overall Study|Other|1|||
162184725|NCT05886777|585727324|FG003|Overall Study|Other|0|||
162184726|NCT05886777|585727325|FG004|Overall Study|Other|0|||
162184727|NCT05886777|585727326|FG005|Overall Study|Other|0|||
162184728|NCT05886777|585727327|FG006|Overall Study|Other|0|||
162184729|NCT05886777|585727321|FG000|Overall Study|Withdrawal by Subject|1|||
162184730|NCT05886777|585727322|FG001|Overall Study|Withdrawal by Subject|0|||
162184731|NCT05886777|585727323|FG002|Overall Study|Withdrawal by Subject|1|||
162184732|NCT05886777|585727324|FG003|Overall Study|Withdrawal by Subject|4|||
162184733|NCT05886777|585727325|FG004|Overall Study|Withdrawal by Subject|3|||
162184734|NCT05886777|585727326|FG005|Overall Study|Withdrawal by Subject|1|||
162184735|NCT05886777|585727327|FG006|Overall Study|Withdrawal by Subject|1|||
161672951|NCT01601847|583856524|FG001|Overall Study|Withdrawal by Subject|7|||
162184736|NCT05886777|585727321|FG000|Overall Study|Protocol Violation|0|||
162184737|NCT05886777|585727322|FG001|Overall Study|Protocol Violation|0|||
162184738|NCT05886777|585727323|FG002|Overall Study|Protocol Violation|1|||
161672952|NCT01601847|583856523|FG000|Overall Study|Lost to Follow-up|1|||
161672953|NCT01601847|583856524|FG001|Overall Study|Lost to Follow-up|3|||
161818690|NCT01018862|584376190|FG002|Overall Study|Withdrawal by Subject|1|||
161818691|NCT01018862|584376188|FG000|Overall Study|administrative problems|5|||
162019256|NCT01727024|585124899|FG000|Period 1|Withdrawal by Subject|2|||
162184739|NCT05886777|585727324|FG003|Overall Study|Protocol Violation|0|||
162184740|NCT05886777|585727325|FG004|Overall Study|Protocol Violation|0|||
162184741|NCT05886777|585727326|FG005|Overall Study|Protocol Violation|0|||
162184742|NCT05886777|585727327|FG006|Overall Study|Protocol Violation|0|||
162184743|NCT05886777|585727321|FG000|Overall Study|No longer met eligibility criteria|0|||
162184744|NCT05886777|585727322|FG001|Overall Study|No longer met eligibility criteria|1|||
162184745|NCT05886777|585727323|FG002|Overall Study|No longer met eligibility criteria|0|||
162184746|NCT05886777|585727324|FG003|Overall Study|No longer met eligibility criteria|0|||
162184747|NCT05886777|585727325|FG004|Overall Study|No longer met eligibility criteria|0|||
162184748|NCT05886777|585727326|FG005|Overall Study|No longer met eligibility criteria|0|||
162184749|NCT05886777|585727327|FG006|Overall Study|No longer met eligibility criteria|0|||
162184750|NCT03773107|585727328|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
162184751|NCT03773107|585727329|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
162184752|NCT03773107|585727330|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
162184753|NCT03773107|585727331|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
162184754|NCT07204444|585727333|FG000|Overall Study|Medical/Hospitalization|6|||
162184755|NCT07204444|585727334|FG001|Overall Study|Medical/Hospitalization|9|||
162184756|NCT07204444|585727335|FG002|Overall Study|Medical/Hospitalization|6|||
162184757|NCT07204444|585727333|FG000|Overall Study|Treatment Provider Issue|1|||
162184758|NCT07204444|585727334|FG001|Overall Study|Treatment Provider Issue|3|||
162184759|NCT07204444|585727335|FG002|Overall Study|Treatment Provider Issue|0|||
162184760|NCT07204444|585727333|FG000|Overall Study|Withdrawal by Subject|11|||
162184761|NCT07204444|585727334|FG001|Overall Study|Withdrawal by Subject|5|||
162184762|NCT07204444|585727335|FG002|Overall Study|Withdrawal by Subject|5|||
162184763|NCT07204444|585727333|FG000|Overall Study|Death|3|||
162184764|NCT07204444|585727334|FG001|Overall Study|Death|6|||
162184765|NCT07204444|585727335|FG002|Overall Study|Death|1|||
162184766|NCT07204444|585727333|FG000|Overall Study|Unable To Reach|29|||
162184767|NCT07204444|585727334|FG001|Overall Study|Unable To Reach|26|||
162184768|NCT07204444|585727335|FG002|Overall Study|Unable To Reach|17|||
162184769|NCT07204444|585727333|FG000|Overall Study|Protocol Deviation|3|||
162184770|NCT07204444|585727334|FG001|Overall Study|Protocol Deviation|2|||
162184771|NCT07204444|585727335|FG002|Overall Study|Protocol Deviation|0|||
162184772|NCT00345046|585728642|FG000|Overall Study|Protocol Violation|1|||
162184773|NCT00345046|585728643|FG001|Overall Study|Protocol Violation|1|||
162184774|NCT00345046|585728644|FG002|Overall Study|Protocol Violation|2|||
162184775|NCT02157116|585728660|FG000|Overall Study|Withdrawal by Subject|4|||
162184776|NCT02157116|585728660|FG000|Overall Study|Physician Decision|3|||
162184777|NCT02157116|585728660|FG000|Overall Study|Failed Screening|2|||
162184778|NCT00463229|585728661|FG000|Overall Study|Lost to Follow-up|5|||
162184779|NCT00463229|585728662|FG001|Overall Study|Lost to Follow-up|7|||
162184780|NCT00463229|585728661|FG000|Overall Study|Death|4|||
162184781|NCT00463229|585728662|FG001|Overall Study|Death|3|||
162184782|NCT01359150|585728669|FG000|Overall Study|Lack of Efficacy|1|||
162184783|NCT01359150|585728670|FG001|Overall Study|Lack of Efficacy|1|||
162184784|NCT01359150|585728669|FG000|Overall Study|Withdrawal by Subject|1|||
162184785|NCT01359150|585728670|FG001|Overall Study|Withdrawal by Subject|1|||
162184786|NCT01359150|585728669|FG000|Overall Study|Adverse Event|4|||
162184787|NCT01359150|585728670|FG001|Overall Study|Adverse Event|3|||
162184788|NCT01359150|585728669|FG000|Overall Study|Other|1|||
162184789|NCT01359150|585728670|FG001|Overall Study|Other|0|||
162184790|NCT01728324|585728671|FG000|Termination of DBV|Adverse Event|14|||
162184791|NCT01728324|585728672|FG001|Termination of DBV|Adverse Event|13|||
162184792|NCT01728324|585728673|FG002|Termination of DBV|Adverse Event|4|||
162184793|NCT01728324|585728671|FG000|Termination of DBV|Lack of Efficacy|14|||
162184794|NCT01728324|585728672|FG001|Termination of DBV|Lack of Efficacy|12|||
162184795|NCT01728324|585728673|FG002|Termination of DBV|Lack of Efficacy|8|||
162184796|NCT01728324|585728671|FG000|Termination of DBV|Withdrawal by Subject|9|||
162184797|NCT01728324|585728672|FG001|Termination of DBV|Withdrawal by Subject|6|||
162184798|NCT01728324|585728673|FG002|Termination of DBV|Withdrawal by Subject|2|||
162184799|NCT01728324|585728671|FG000|Termination of DBV|Other than stated|1|||
162184800|NCT01728324|585728672|FG001|Termination of DBV|Other than stated|3|||
162184801|NCT01728324|585728673|FG002|Termination of DBV|Other than stated|0|||
162184802|NCT01728324|585728671|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
162184803|NCT01728324|585728672|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
162184804|NCT01728324|585728673|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
162184805|NCT01728324|585728671|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
162184806|NCT01728324|585728672|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
161818692|NCT01018862|584376189|FG001|Overall Study|administrative problems|4|||
161818693|NCT01018862|584376190|FG002|Overall Study|administrative problems|4|||
162184807|NCT01728324|585728673|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
162184808|NCT01728324|585728671|FG000|Termination of FDV|Adverse Event|14|||
162184809|NCT01728324|585728672|FG001|Termination of FDV|Adverse Event|13|||
162184810|NCT01728324|585728673|FG002|Termination of FDV|Adverse Event|4|||
162184811|NCT01728324|585728671|FG000|Termination of FDV|Lack of Efficacy|14|||
162184812|NCT01728324|585728672|FG001|Termination of FDV|Lack of Efficacy|12|||
162184813|NCT01728324|585728673|FG002|Termination of FDV|Lack of Efficacy|8|||
161818694|NCT01968031|584376194|FG000|Overall Study|Adverse Event|13|||
162184814|NCT01728324|585728671|FG000|Termination of FDV|Withdrawal by Subject|9|||
162184815|NCT01728324|585728672|FG001|Termination of FDV|Withdrawal by Subject|6|||
161672954|NCT00631189|583856525|FG000|Initial Phase|Protocol Violation|347|||
161672955|NCT00631189|583856526|FG001|Initial Phase|Protocol Violation|0|||
161672956|NCT00631189|583856527|FG002|Initial Phase|Protocol Violation|0|||
161672957|NCT00631189|583856528|FG003|Initial Phase|Protocol Violation|0|||
161672958|NCT00631189|583856525|FG000|Initial Phase|Withdrawal by Subject|4|||
161672959|NCT00631189|583856526|FG001|Initial Phase|Withdrawal by Subject|0|||
161672960|NCT00631189|583856527|FG002|Initial Phase|Withdrawal by Subject|0|||
161672961|NCT00631189|583856528|FG003|Initial Phase|Withdrawal by Subject|0|||
161672962|NCT00631189|583856525|FG000|Treatment Phase|Withdrawal by Subject|0|||
161672963|NCT00631189|583856526|FG001|Treatment Phase|Withdrawal by Subject|2|||
161672964|NCT00631189|583856527|FG002|Treatment Phase|Withdrawal by Subject|1|||
162019257|NCT01727024|585124900|FG001|Period 1|Withdrawal by Subject|3|||
162019258|NCT02920242|585124901|FG000|Overall Study|Withdrawal by Subject|1|||
162019259|NCT02920242|585124902|FG001|Overall Study|Withdrawal by Subject|0|||
162019260|NCT02920242|585124903|FG002|Overall Study|Withdrawal by Subject|1|||
162019261|NCT02920242|585124901|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
162184816|NCT01728324|585728673|FG002|Termination of FDV|Withdrawal by Subject|2|||
162184817|NCT01728324|585728671|FG000|Termination of FDV|Other than stated|1|||
162184818|NCT01728324|585728672|FG001|Termination of FDV|Other than stated|3|||
162184819|NCT01728324|585728673|FG002|Termination of FDV|Other than stated|0|||
162184820|NCT01728324|585728671|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
162184821|NCT01728324|585728672|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
162184822|NCT01728324|585728673|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
162184823|NCT01728324|585728671|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
162184824|NCT01728324|585728672|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
162184825|NCT01728324|585728673|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
162184826|NCT01728324|585728671|FG000|Termination of RBV|Adverse Event|15|||
162184827|NCT01728324|585728672|FG001|Termination of RBV|Adverse Event|16|||
162184828|NCT01728324|585728673|FG002|Termination of RBV|Adverse Event|5|||
162184829|NCT01728324|585728671|FG000|Termination of RBV|Lack of Efficacy|14|||
162184830|NCT01728324|585728672|FG001|Termination of RBV|Lack of Efficacy|11|||
162184831|NCT01728324|585728673|FG002|Termination of RBV|Lack of Efficacy|7|||
162184832|NCT01728324|585728671|FG000|Termination of RBV|Withdrawal by Subject|9|||
162184833|NCT01728324|585728672|FG001|Termination of RBV|Withdrawal by Subject|5|||
162184834|NCT01728324|585728673|FG002|Termination of RBV|Withdrawal by Subject|2|||
162184835|NCT01728324|585728671|FG000|Termination of RBV|Other than stated|1|||
162184836|NCT01728324|585728672|FG001|Termination of RBV|Other than stated|3|||
162184837|NCT01728324|585728673|FG002|Termination of RBV|Other than stated|1|||
162184838|NCT01728324|585728671|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
162184839|NCT01728324|585728672|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
161672965|NCT00631189|583856528|FG003|Treatment Phase|Withdrawal by Subject|1|||
161818695|NCT01968031|584376195|FG001|Overall Study|Adverse Event|10|||
162184840|NCT01728324|585728673|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
162184841|NCT01728324|585728671|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
161672966|NCT00631189|583856525|FG000|Treatment Phase|Protocol Violation|0|||
161818696|NCT01968031|584376196|FG002|Overall Study|Adverse Event|22|||
161672967|NCT00631189|583856526|FG001|Treatment Phase|Protocol Violation|1|||
161672968|NCT00631189|583856527|FG002|Treatment Phase|Protocol Violation|6|||
161672969|NCT00631189|583856528|FG003|Treatment Phase|Protocol Violation|2|||
162184842|NCT01728324|585728672|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
162184843|NCT01728324|585728673|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
162184844|NCT01787032|585728676|FG000|Overall Study|Protocol Violation|0|||
162184845|NCT01787032|585728677|FG001|Overall Study|Protocol Violation|0|||
162184846|NCT01787032|585728678|FG002|Overall Study|Protocol Violation|0|||
162184847|NCT01787032|585728679|FG003|Overall Study|Protocol Violation|0|||
162184848|NCT01787032|585728680|FG004|Overall Study|Protocol Violation|1|||
162184849|NCT01787032|585728681|FG005|Overall Study|Protocol Violation|1|||
162184850|NCT02040870|585728682|FG000|Overall Study|Completed treatment phase|6|||
162184851|NCT02040870|585728682|FG000|Overall Study|Adverse Event|7|||
162184852|NCT02040870|585728682|FG000|Overall Study|Progressive disease|58|||
162184853|NCT02040870|585728682|FG000|Overall Study|Physician Decision|6|||
162184854|NCT02040870|585728682|FG000|Overall Study|Subject/guardian decision|10|||
162184855|NCT02040870|585728682|FG000|Overall Study|Lost to Follow-up|3|||
162184856|NCT02040870|585728682|FG000|Overall Study|Death|13|||
161672970|NCT00631189|583856525|FG000|Treatment Phase|Adverse Event|0|||
162184857|NCT00388726|585728685|FG000|Overall Study|Adverse Event|50|||
162184858|NCT00388726|585728686|FG001|Overall Study|Adverse Event|24|||
162184859|NCT00388726|585728685|FG000|Overall Study|Progressive Disease|336|||
162184860|NCT00388726|585728686|FG001|Overall Study|Progressive Disease|153|||
162184861|NCT00388726|585728685|FG000|Overall Study|Clinical Progression|61|||
162184862|NCT00388726|585728686|FG001|Overall Study|Clinical Progression|36|||
162184863|NCT00388726|585728685|FG000|Overall Study|Withdrawal by Subject|10|||
162184864|NCT00388726|585728686|FG001|Overall Study|Withdrawal by Subject|7|||
162184865|NCT00388726|585728685|FG000|Overall Study|Administrative|6|||
162184866|NCT00388726|585728686|FG001|Overall Study|Administrative|9|||
162184867|NCT00388726|585728685|FG000|Overall Study|Physician Decision|18|||
162184868|NCT00388726|585728686|FG001|Overall Study|Physician Decision|13|||
162184869|NCT00388726|585728685|FG000|Overall Study|Death|3|||
162184870|NCT00388726|585728686|FG001|Overall Study|Death|2|||
162184871|NCT02406092|585728692|FG000|Overall Study|Screen failure|10|||
162184872|NCT02406092|585728693|FG001|Overall Study|Screen failure|7|||
162184873|NCT02406092|585728692|FG000|Overall Study|Death|22|||
162184874|NCT02406092|585728693|FG001|Overall Study|Death|5|||
162184875|NCT02406092|585728692|FG000|Overall Study|Lost to Follow-up|4|||
162184876|NCT02406092|585728693|FG001|Overall Study|Lost to Follow-up|1|||
162184877|NCT02406092|585728692|FG000|Overall Study|Adverse Event|1|||
162184878|NCT02406092|585728693|FG001|Overall Study|Adverse Event|0|||
162184879|NCT02406092|585728692|FG000|Overall Study|Withdrawal by Subject|1|||
161672971|NCT00631189|583856526|FG001|Treatment Phase|Adverse Event|3|||
161672972|NCT00631189|583856527|FG002|Treatment Phase|Adverse Event|2|||
161672973|NCT00631189|583856528|FG003|Treatment Phase|Adverse Event|4|||
161672974|NCT00631189|583856525|FG000|Treatment Phase|Lost to Follow-up|0|||
161672975|NCT00631189|583856526|FG001|Treatment Phase|Lost to Follow-up|1|||
161672976|NCT00631189|583856527|FG002|Treatment Phase|Lost to Follow-up|0|||
161672977|NCT00631189|583856528|FG003|Treatment Phase|Lost to Follow-up|0|||
161672978|NCT00631189|583856525|FG000|Treatment Phase|Pregnancy|0|||
161672979|NCT00631189|583856526|FG001|Treatment Phase|Pregnancy|0|||
161672980|NCT00631189|583856527|FG002|Treatment Phase|Pregnancy|1|||
161672981|NCT00631189|583856528|FG003|Treatment Phase|Pregnancy|0|||
161672982|NCT00631189|583856525|FG000|Treatment Phase|patient did not take pravastatin|0|||
161672983|NCT00631189|583856526|FG001|Treatment Phase|patient did not take pravastatin|0|||
161672984|NCT00631189|583856527|FG002|Treatment Phase|patient did not take pravastatin|1|||
161672985|NCT00631189|583856528|FG003|Treatment Phase|patient did not take pravastatin|0|||
162184880|NCT02406092|585728693|FG001|Overall Study|Withdrawal by Subject|0|||
161672986|NCT04464265|583856529|FG000|Overall Study|Physician Decision|2|||
161672987|NCT00954174|583856536|FG000|Overall Study|Adverse Event|28|||
161672988|NCT00954174|583856537|FG001|Overall Study|Adverse Event|23|||
161672989|NCT00954174|583856538|FG002|Overall Study|Adverse Event|4|||
161672990|NCT00954174|583856539|FG003|Overall Study|Adverse Event|9|||
162184881|NCT00641537|585728694|FG000|96-week Period|Adverse Event|0|||
161672991|NCT00954174|583856536|FG000|Overall Study|Death|4|||
161672992|NCT00954174|583856537|FG001|Overall Study|Death|2|||
161672993|NCT00954174|583856538|FG002|Overall Study|Death|0|||
161672994|NCT00954174|583856539|FG003|Overall Study|Death|0|||
161672995|NCT00954174|583856536|FG000|Overall Study|Lack of Efficacy|32|||
162184882|NCT00641537|585728695|FG001|96-week Period|Adverse Event|1|||
162184883|NCT00641537|585728696|FG002|96-week Period|Adverse Event|3|||
162184884|NCT00641537|585728697|FG003|96-week Period|Adverse Event|0|||
162184885|NCT00641537|585728698|FG004|96-week Period|Adverse Event|2|||
162184886|NCT00641537|585728699|FG005|96-week Period|Adverse Event|0|||
162184887|NCT00641537|585728700|FG006|96-week Period|Adverse Event|0|||
162184888|NCT00641537|585728701|FG007|96-week Period|Adverse Event|0|||
162184889|NCT00641537|585728694|FG000|96-week Period|Lost to Follow-up|3|||
161672996|NCT00954174|583856537|FG001|Overall Study|Lack of Efficacy|22|||
161672997|NCT00954174|583856538|FG002|Overall Study|Lack of Efficacy|8|||
162184890|NCT00641537|585728695|FG001|96-week Period|Lost to Follow-up|1|||
161672998|NCT00954174|583856539|FG003|Overall Study|Lack of Efficacy|6|||
161672999|NCT00954174|583856536|FG000|Overall Study|Withdrawal by Subject|14|||
161673000|NCT00954174|583856537|FG001|Overall Study|Withdrawal by Subject|10|||
161673001|NCT00954174|583856538|FG002|Overall Study|Withdrawal by Subject|4|||
161673002|NCT00954174|583856539|FG003|Overall Study|Withdrawal by Subject|3|||
161673003|NCT00954174|583856536|FG000|Overall Study|Medical Reason|4|||
161673004|NCT00954174|583856537|FG001|Overall Study|Medical Reason|2|||
161673005|NCT00954174|583856538|FG002|Overall Study|Medical Reason|1|||
161673006|NCT00954174|583856539|FG003|Overall Study|Medical Reason|0|||
161673007|NCT00954174|583856536|FG000|Overall Study|Ineligible|40|||
162184891|NCT00641537|585728696|FG002|96-week Period|Lost to Follow-up|2|||
162184892|NCT00641537|585728697|FG003|96-week Period|Lost to Follow-up|2|||
162184893|NCT00641537|585728698|FG004|96-week Period|Lost to Follow-up|4|||
162184894|NCT00641537|585728699|FG005|96-week Period|Lost to Follow-up|0|||
162184895|NCT00641537|585728700|FG006|96-week Period|Lost to Follow-up|1|||
162184896|NCT00641537|585728701|FG007|96-week Period|Lost to Follow-up|0|||
162184897|NCT00641537|585728694|FG000|96-week Period|Protocol Violation|0|||
162184898|NCT00641537|585728695|FG001|96-week Period|Protocol Violation|1|||
162184899|NCT00641537|585728696|FG002|96-week Period|Protocol Violation|0|||
162184900|NCT00641537|585728697|FG003|96-week Period|Protocol Violation|1|||
162184901|NCT00641537|585728698|FG004|96-week Period|Protocol Violation|0|||
162184902|NCT00641537|585728699|FG005|96-week Period|Protocol Violation|1|||
162184903|NCT00641537|585728700|FG006|96-week Period|Protocol Violation|0|||
162184904|NCT00641537|585728701|FG007|96-week Period|Protocol Violation|0|||
162184905|NCT00641537|585728694|FG000|96-week Period|Death|2|||
162184906|NCT00641537|585728695|FG001|96-week Period|Death|0|||
162184907|NCT00641537|585728696|FG002|96-week Period|Death|1|||
162184908|NCT00641537|585728697|FG003|96-week Period|Death|0|||
162184909|NCT00641537|585728698|FG004|96-week Period|Death|0|||
162184910|NCT00641537|585728699|FG005|96-week Period|Death|0|||
162184911|NCT00641537|585728700|FG006|96-week Period|Death|0|||
162184912|NCT00641537|585728701|FG007|96-week Period|Death|0|||
162184913|NCT00641537|585728694|FG000|96-week Period|Other|4|||
162184914|NCT00641537|585728695|FG001|96-week Period|Other|7|||
162184915|NCT00641537|585728696|FG002|96-week Period|Other|14|||
162184916|NCT00641537|585728697|FG003|96-week Period|Other|9|||
162184917|NCT00641537|585728698|FG004|96-week Period|Other|11|||
162184918|NCT00641537|585728699|FG005|96-week Period|Other|6|||
162184919|NCT00641537|585728700|FG006|96-week Period|Other|4|||
162184920|NCT00641537|585728701|FG007|96-week Period|Other|6|||
162184921|NCT00641537|585728694|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
162184922|NCT00641537|585728695|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
162184923|NCT00641537|585728696|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
162184924|NCT00641537|585728697|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
162184925|NCT00641537|585728698|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
161673008|NCT00954174|583856537|FG001|Overall Study|Ineligible|47|||
162019262|NCT02920242|585124902|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
162184926|NCT00641537|585728699|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
162184927|NCT00641537|585728700|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
162184928|NCT00641537|585728701|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
162184929|NCT00641537|585728694|FG000|24-Week Supplemental Follow-up Period|Other|0|||
162184930|NCT00641537|585728695|FG001|24-Week Supplemental Follow-up Period|Other|2|||
162184931|NCT00641537|585728696|FG002|24-Week Supplemental Follow-up Period|Other|2|||
162184932|NCT00641537|585728697|FG003|24-Week Supplemental Follow-up Period|Other|1|||
162184933|NCT00641537|585728698|FG004|24-Week Supplemental Follow-up Period|Other|3|||
162184934|NCT00641537|585728699|FG005|24-Week Supplemental Follow-up Period|Other|0|||
162184935|NCT00641537|585728700|FG006|24-Week Supplemental Follow-up Period|Other|1|||
162184936|NCT00641537|585728701|FG007|24-Week Supplemental Follow-up Period|Other|1|||
162184937|NCT01706159|585728702|FG000|Overall Study|Withdrawal Criteria|2|||
162184938|NCT01706159|585728703|FG001|Overall Study|Withdrawal Criteria|1|||
162184939|NCT01706159|585728702|FG000|Overall Study|Unclassified|6|||
162184940|NCT01706159|585728703|FG001|Overall Study|Unclassified|1|||
162184941|NCT02235298|585728704|FG000|Overall Study|Lost to Follow-up|6|||
161673009|NCT00954174|583856538|FG002|Overall Study|Ineligible|7|||
161673010|NCT00954174|583856539|FG003|Overall Study|Ineligible|4|||
161673011|NCT00954174|583856536|FG000|Overall Study|Never Treated|4|||
161818697|NCT01968031|584376194|FG000|Overall Study|Withdrawal by Subject|3|||
161673012|NCT00954174|583856537|FG001|Overall Study|Never Treated|17|||
162184942|NCT02235298|585728705|FG001|Overall Study|Lost to Follow-up|5|||
162184943|NCT02235298|585728704|FG000|Overall Study|Adverse Event|2|||
162184944|NCT02235298|585728705|FG001|Overall Study|Adverse Event|2|||
162184945|NCT02235298|585728704|FG000|Overall Study|Withdrawal by Subject|0|||
162184946|NCT02235298|585728705|FG001|Overall Study|Withdrawal by Subject|1|||
162184947|NCT03371017|585728707|FG000|Overall Study|Physician Decision|0|||
162184948|NCT03371017|585728708|FG001|Overall Study|Physician Decision|1|||
162184949|NCT03371017|585728707|FG000|Overall Study|Reason not Specified|0|||
162184950|NCT03371017|585728708|FG001|Overall Study|Reason not Specified|1|||
162184951|NCT03371017|585728707|FG000|Overall Study|Lost to Follow-up|13|||
162184952|NCT03371017|585728708|FG001|Overall Study|Lost to Follow-up|16|||
162184953|NCT03371017|585728707|FG000|Overall Study|Death|228|||
162184954|NCT03371017|585728708|FG001|Overall Study|Death|215|||
162184955|NCT03371017|585728707|FG000|Overall Study|Withdrawal by Subject|20|||
162184956|NCT03371017|585728708|FG001|Overall Study|Withdrawal by Subject|25|||
162184957|NCT03371017|585728707|FG000|Overall Study|Study Ended by Sponsor|37|||
162184958|NCT03371017|585728708|FG001|Overall Study|Study Ended by Sponsor|38|||
162184959|NCT03371017|585728707|FG000|Overall Study|Protocol Deviation|0|||
162184960|NCT03371017|585728708|FG001|Overall Study|Protocol Deviation|1|||
162184961|NCT04300023|585728709|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
162184962|NCT04300023|585728710|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
162184963|NCT04057131|585728711|FG000|Overall Study|Protocol Violation|24|||
162184964|NCT05251363|585728712|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
162184965|NCT05251363|585728712|FG000|Overall Study After Implant Period|Death|9|||
162184966|NCT05251363|585728712|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
162184967|NCT05251363|585728712|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
162184968|NCT05251363|585728712|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
162184969|NCT05251363|585728712|FG000|Overall Study After Implant Period|Physician Decision|1|||
162184970|NCT05251363|585728712|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
162184971|NCT00489307|585728713|FG000|Overall Study|Death|1|||
162184972|NCT00489307|585728714|FG001|Overall Study|Death|1|||
162184973|NCT00489307|585728713|FG000|Overall Study|Lost to Follow-up|2|||
162184974|NCT00489307|585728714|FG001|Overall Study|Lost to Follow-up|2|||
162184975|NCT00489307|585728713|FG000|Overall Study|Physician Decision|1|||
162184976|NCT00489307|585728714|FG001|Overall Study|Physician Decision|0|||
162184977|NCT00489307|585728713|FG000|Overall Study|Withdrawal by Subject|2|||
162184978|NCT00489307|585728714|FG001|Overall Study|Withdrawal by Subject|4|||
162184979|NCT00489307|585728713|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
162184980|NCT00489307|585728714|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
162184981|NCT00489307|585728713|FG000|Overall Study|Surgery after assignment|1|||
162184982|NCT00489307|585728714|FG001|Overall Study|Surgery after assignment|0|||
162184983|NCT00489307|585728713|FG000|Overall Study|Did not fill up the forms|2|||
162184984|NCT00489307|585728714|FG001|Overall Study|Did not fill up the forms|1|||
162184985|NCT00489307|585728713|FG000|Overall Study|Patient or family refusal|5|||
162184986|NCT00489307|585728714|FG001|Overall Study|Patient or family refusal|9|||
162184987|NCT02830204|585728715|FG000|Overall Study|Death|9|||
162184988|NCT02830204|585728715|FG000|Overall Study|Withdrawal by Subject|1|||
162184989|NCT04686266|585728720|FG000|Overall Study|Withdrawal by Subject|0|||
162184990|NCT04686266|585728721|FG001|Overall Study|Withdrawal by Subject|1|||
162184991|NCT02401815|585728726|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162184992|NCT02401815|585728727|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162184993|NCT02401815|585728728|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162184994|NCT02401815|585728729|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
162184995|NCT02401815|585728730|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162184996|NCT02401815|585728731|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162184997|NCT02401815|585728732|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162184998|NCT02401815|585728733|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162184999|NCT02401815|585728734|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162185000|NCT02401815|585728735|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
162185001|NCT02401815|585728726|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
162185002|NCT02401815|585728727|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162185003|NCT02401815|585728728|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162185004|NCT02401815|585728729|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
162185005|NCT02401815|585728730|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162185006|NCT02401815|585728731|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162185007|NCT02401815|585728732|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162185008|NCT02401815|585728733|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162185009|NCT02401815|585728734|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162185010|NCT02401815|585728735|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
162185011|NCT02401815|585728726|FG000|Dose Escalation (up to 670 Days)|Death|1|||
162185012|NCT02401815|585728727|FG001|Dose Escalation (up to 670 Days)|Death|2|||
162185013|NCT02401815|585728728|FG002|Dose Escalation (up to 670 Days)|Death|3|||
162185014|NCT02401815|585728729|FG003|Dose Escalation (up to 670 Days)|Death|5|||
162185015|NCT02401815|585728730|FG004|Dose Escalation (up to 670 Days)|Death|4|||
162185016|NCT02401815|585728731|FG005|Dose Escalation (up to 670 Days)|Death|0|||
162185017|NCT02401815|585728732|FG006|Dose Escalation (up to 670 Days)|Death|0|||
162185018|NCT02401815|585728733|FG007|Dose Escalation (up to 670 Days)|Death|0|||
162185019|NCT02401815|585728734|FG008|Dose Escalation (up to 670 Days)|Death|0|||
162185020|NCT02401815|585728735|FG009|Dose Escalation (up to 670 Days)|Death|0|||
162185021|NCT02401815|585728726|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162185022|NCT02401815|585728727|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
162185023|NCT02401815|585728728|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161673013|NCT00954174|583856538|FG002|Overall Study|Never Treated|0|||
162185024|NCT02401815|585728729|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162185025|NCT02401815|585728730|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
161673014|NCT00954174|583856539|FG003|Overall Study|Never Treated|3|||
161673015|NCT02234323|583856540|FG000|All Enrolled|Not Treated: Completed study in database|2|||
161673016|NCT02234323|583856540|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
161673017|NCT02234323|583856540|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
161673018|NCT02234323|583856540|FG000|All Treated|Death|1|||
161673019|NCT02234323|583856540|FG000|All Treated|Physician Decision|5|||
161673020|NCT02234323|583856540|FG000|All Treated|Lack of Efficacy|3|||
161673021|NCT02234323|583856540|FG000|All Treated|Exceeded lab value limit|2|||
161673022|NCT02234323|583856540|FG000|All Treated|Other|7|||
161673023|NCT02644941|583856541|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
161673024|NCT02644941|583856542|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
161673025|NCT00867113|583856543|FG000|Treatment Period|Adverse Event|15|||
161673026|NCT00867113|583856543|FG000|Treatment Period|Death|2|||
161673027|NCT00867113|583856543|FG000|Treatment Period|Withdrawal by Subject|19|||
161673028|NCT00867113|583856543|FG000|Treatment Period|Lost to Follow-up|3|||
161673029|NCT00867113|583856543|FG000|Treatment Period|Administrative problems|1|||
162185026|NCT02401815|585728731|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162185027|NCT02401815|585728732|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162185028|NCT02401815|585728733|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162185029|NCT02401815|585728734|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162185030|NCT02401815|585728735|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
162185031|NCT02401815|585728726|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
162185032|NCT02401815|585728727|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162185033|NCT02401815|585728728|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162185034|NCT02401815|585728729|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162185035|NCT02401815|585728730|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
162185036|NCT02401815|585728731|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162185037|NCT02401815|585728732|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162185038|NCT02401815|585728733|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162185039|NCT02401815|585728734|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162185040|NCT02401815|585728735|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
162185041|NCT02401815|585728726|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162185042|NCT02401815|585728727|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162185043|NCT02401815|585728728|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162185044|NCT02401815|585728729|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162185045|NCT02401815|585728730|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162185046|NCT02401815|585728731|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
162185047|NCT02401815|585728732|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162185048|NCT02401815|585728733|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162185049|NCT02401815|585728734|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162185050|NCT02401815|585728735|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
162185051|NCT02401815|585728726|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185052|NCT02401815|585728727|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185053|NCT02401815|585728728|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185054|NCT02401815|585728729|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185055|NCT02401815|585728730|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185056|NCT02401815|585728731|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185057|NCT02401815|585728732|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
161673030|NCT00867113|583856543|FG000|Treatment Period|Disease progression/relapse|1|||
161673031|NCT00867113|583856543|FG000|Treatment Period|Protocol Violation|4|||
161673032|NCT00867113|583856543|FG000|Post Treatment After Survival Follow-up|Death|1|||
161673033|NCT00867113|583856543|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
162185058|NCT02401815|585728733|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185059|NCT02401815|585728734|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185060|NCT02401815|585728735|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185061|NCT02401815|585728726|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161673034|NCT00867113|583856543|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
161673035|NCT00867113|583856543|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
161673036|NCT01145495|583856544|FG000|Overall Study|Adverse Event|6|||
161673037|NCT01145495|583856544|FG000|Overall Study|Withdrawal by Subject|6|||
161673038|NCT01145495|583856544|FG000|Overall Study|Disease progression after respone|2|||
161818698|NCT01968031|584376195|FG001|Overall Study|Withdrawal by Subject|7|||
161818699|NCT01968031|584376196|FG002|Overall Study|Withdrawal by Subject|3|||
161818700|NCT01968031|584376194|FG000|Overall Study|Did not meet entry criteria|1|||
162185062|NCT02401815|585728727|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162185063|NCT02401815|585728728|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162185064|NCT02401815|585728729|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162185065|NCT02401815|585728730|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162185066|NCT02401815|585728731|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
162185067|NCT02401815|585728732|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
162185068|NCT02401815|585728733|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162185069|NCT02401815|585728734|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162185070|NCT02401815|585728735|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
162185071|NCT02401815|585728726|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162185072|NCT02401815|585728727|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162185073|NCT02401815|585728728|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162185074|NCT02401815|585728729|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162185075|NCT02401815|585728730|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162185076|NCT02401815|585728731|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
162185077|NCT02401815|585728732|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162185078|NCT02401815|585728733|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162185079|NCT02401815|585728734|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162185080|NCT02401815|585728735|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
162185081|NCT02401815|585728726|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162185082|NCT02401815|585728727|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162185083|NCT02401815|585728728|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162185084|NCT02401815|585728729|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162185085|NCT02401815|585728730|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162185086|NCT02401815|585728731|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162185087|NCT02401815|585728732|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
162185088|NCT02401815|585728733|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
162185089|NCT02401815|585728734|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
162185090|NCT02401815|585728735|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
162185091|NCT02401815|585728726|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185092|NCT02401815|585728727|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185093|NCT02401815|585728728|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185094|NCT02401815|585728729|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185095|NCT02401815|585728730|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185096|NCT02401815|585728731|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185097|NCT02401815|585728732|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185098|NCT02401815|585728733|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
162185099|NCT02401815|585728734|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
162185100|NCT02401815|585728735|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
161818701|NCT01968031|584376195|FG001|Overall Study|Did not meet entry criteria|1|||
161818702|NCT01968031|584376196|FG002|Overall Study|Did not meet entry criteria|1|||
161673039|NCT01886313|583856547|FG000|Overall Study|Adverse Event|1|||
161673040|NCT01886313|583856548|FG001|Overall Study|Adverse Event|1|||
162185101|NCT02401815|585728726|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162185102|NCT02401815|585728727|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162185103|NCT02401815|585728728|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162185104|NCT02401815|585728729|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162185105|NCT02401815|585728730|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162185106|NCT02401815|585728731|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162185107|NCT02401815|585728732|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162185108|NCT02401815|585728733|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162185109|NCT02401815|585728734|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
162185110|NCT02401815|585728735|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
162185111|NCT02401815|585728726|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162185112|NCT02401815|585728727|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162185113|NCT02401815|585728728|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162185114|NCT02401815|585728729|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161673041|NCT01603082|583856553|FG000|Overall Study|Adverse Event|0|||
161673042|NCT01603082|583856554|FG001|Overall Study|Adverse Event|1|||
161673043|NCT01603082|583856553|FG000|Overall Study|Withdrawal by Subject|1|||
161818703|NCT01968031|584376194|FG000|Overall Study|Noncompliance|0|||
161818704|NCT01968031|584376195|FG001|Overall Study|Noncompliance|0|||
161818705|NCT01968031|584376196|FG002|Overall Study|Noncompliance|2|||
161818706|NCT01968031|584376194|FG000|Overall Study|Failed inclusion criteria|0|||
162185115|NCT02401815|585728730|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162185116|NCT02401815|585728731|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162185117|NCT02401815|585728732|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162185118|NCT02401815|585728733|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162185119|NCT02401815|585728734|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
162185120|NCT02401815|585728735|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
162185121|NCT02401815|585728726|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162185122|NCT02401815|585728727|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162185123|NCT02401815|585728728|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162185124|NCT02401815|585728729|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162185125|NCT02401815|585728730|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162185126|NCT02401815|585728731|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162185127|NCT02401815|585728732|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162185128|NCT02401815|585728733|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
162185129|NCT02401815|585728734|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
162185130|NCT02401815|585728735|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
162185131|NCT05613907|585728736|FG000|Overall Study|Lost to Follow-up|5|||
162185132|NCT05613907|585728736|FG000|Overall Study|Death|3|||
162185133|NCT05613907|585728736|FG000|Overall Study|Withdrawal by Subject|2|||
162185134|NCT00748709|585728746|FG000|Overall Study|Progressive disease|15|||
162185135|NCT00748709|585728746|FG000|Overall Study|Drug reducing Toxity|2|||
162185136|NCT00748709|585728746|FG000|Overall Study|Other Adverse Event|1|||
162185137|NCT00748709|585728746|FG000|Overall Study|Withdrawal by Subject|1|||
162185138|NCT00748709|585728746|FG000|Overall Study|Other Reasons|1|||
162185139|NCT03789656|585728747|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
162185140|NCT03789656|585728748|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
162185141|NCT03789656|585728749|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
162185142|NCT03789656|585728750|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
162185143|NCT03789656|585728751|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
162185144|NCT03789656|585728747|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
162185145|NCT03789656|585728748|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
162185146|NCT03789656|585728749|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
162185147|NCT03789656|585728750|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
162185148|NCT03789656|585728751|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
162185149|NCT03789656|585728747|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
162185150|NCT03789656|585728748|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
162185151|NCT03789656|585728749|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
162185152|NCT03789656|585728750|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
162185153|NCT03789656|585728751|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
162185154|NCT03789656|585728747|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
162185155|NCT03789656|585728748|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
162185156|NCT03789656|585728749|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
162185157|NCT03789656|585728750|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
162185158|NCT03789656|585728751|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
162185159|NCT04484623|585728759|FG000|Overall Study|Lost to Follow-up|0|||
162185160|NCT04484623|585728760|FG001|Overall Study|Lost to Follow-up|1|||
162185161|NCT04484623|585728759|FG000|Overall Study|Protocol Deviation|1|||
162185162|NCT04484623|585728760|FG001|Overall Study|Protocol Deviation|0|||
162185163|NCT04484623|585728759|FG000|Overall Study|Physician Decision|1|||
162185164|NCT04484623|585728760|FG001|Overall Study|Physician Decision|0|||
162185165|NCT04484623|585728759|FG000|Overall Study|Withdrawal by Subject|11|||
162185166|NCT04484623|585728760|FG001|Overall Study|Withdrawal by Subject|8|||
162185167|NCT04484623|585728759|FG000|Overall Study|Ongoing|94|||
162185168|NCT04484623|585728760|FG001|Overall Study|Ongoing|84|||
162185169|NCT05470114|585728761|FG000|Overall Study|Withdrawal by Subject|1|||
162185170|NCT05470114|585728762|FG001|Overall Study|Withdrawal by Subject|0|||
162185171|NCT05470114|585728761|FG000|Overall Study|Lost to Follow-up|1|||
162185172|NCT05470114|585728762|FG001|Overall Study|Lost to Follow-up|0|||
162185173|NCT05325294|585728767|FG000|Overall Study|Adverse Event|3|||
162185174|NCT05325294|585728768|FG001|Overall Study|Adverse Event|3|||
162185175|NCT05325294|585728767|FG000|Overall Study|Physician Decision|0|||
162185176|NCT05325294|585728768|FG001|Overall Study|Physician Decision|1|||
161673044|NCT01603082|583856554|FG001|Overall Study|Withdrawal by Subject|0|||
162185177|NCT05325294|585728767|FG000|Overall Study|Withdrawal by Subject|0|||
162185178|NCT05325294|585728768|FG001|Overall Study|Withdrawal by Subject|3|||
162185179|NCT05325294|585728767|FG000|Overall Study|Lost to Follow-up|1|||
162185180|NCT05325294|585728768|FG001|Overall Study|Lost to Follow-up|0|||
162185181|NCT05325294|585728767|FG000|Overall Study|Sponsor Request|0|||
162185182|NCT05325294|585728768|FG001|Overall Study|Sponsor Request|2|||
162185183|NCT04649047|585728769|FG000|Overall Study|Withdrawal by Subject|3|||
162185184|NCT02488408|585728770|FG000|Part A|Adverse Event|2|||
162185185|NCT02488408|585728771|FG001|Part A|Adverse Event|0|||
162185186|NCT02488408|585728772|FG002|Part A|Adverse Event|0|||
162185187|NCT02488408|585728773|FG003|Part A|Adverse Event|0|||
162185188|NCT02488408|585728774|FG004|Part A|Adverse Event|0|||
162185189|NCT02488408|585728775|FG005|Part A|Adverse Event|0|||
162185190|NCT02488408|585728776|FG006|Part A|Adverse Event|0|||
162185191|NCT02488408|585728777|FG007|Part A|Adverse Event|0|||
162185192|NCT02488408|585728778|FG008|Part A|Adverse Event|0|||
162185193|NCT02488408|585728779|FG009|Part A|Adverse Event|0|||
162185194|NCT02488408|585728770|FG000|Part A|Death|1|||
162185195|NCT02488408|585728771|FG001|Part A|Death|5|||
162185196|NCT02488408|585728772|FG002|Part A|Death|0|||
162185197|NCT02488408|585728773|FG003|Part A|Death|0|||
162185198|NCT02488408|585728774|FG004|Part A|Death|3|||
162185199|NCT02488408|585728775|FG005|Part A|Death|0|||
162185200|NCT02488408|585728776|FG006|Part A|Death|0|||
162185201|NCT02488408|585728777|FG007|Part A|Death|0|||
162185202|NCT02488408|585728778|FG008|Part A|Death|0|||
162185203|NCT02488408|585728779|FG009|Part A|Death|0|||
162185204|NCT02488408|585728770|FG000|Part A|Disease Progression|2|||
162185205|NCT02488408|585728771|FG001|Part A|Disease Progression|8|||
162185206|NCT02488408|585728772|FG002|Part A|Disease Progression|2|||
162185207|NCT02488408|585728773|FG003|Part A|Disease Progression|3|||
162185208|NCT02488408|585728774|FG004|Part A|Disease Progression|4|||
162185209|NCT02488408|585728775|FG005|Part A|Disease Progression|0|||
162185210|NCT02488408|585728776|FG006|Part A|Disease Progression|0|||
162185211|NCT02488408|585728777|FG007|Part A|Disease Progression|0|||
162185212|NCT02488408|585728778|FG008|Part A|Disease Progression|0|||
162185213|NCT02488408|585728779|FG009|Part A|Disease Progression|0|||
162185214|NCT02488408|585728770|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
162185215|NCT02488408|585728771|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
162185216|NCT02488408|585728772|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
162185217|NCT02488408|585728773|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
162185218|NCT02488408|585728774|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
162185219|NCT02488408|585728775|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
162185220|NCT02488408|585728776|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
162185221|NCT02488408|585728777|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
162185222|NCT02488408|585728778|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
162185223|NCT02488408|585728779|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
162185224|NCT02488408|585728770|FG000|Part A|Investigator Decision|0|||
162185225|NCT02488408|585728771|FG001|Part A|Investigator Decision|1|||
162185226|NCT02488408|585728772|FG002|Part A|Investigator Decision|1|||
162185227|NCT02488408|585728773|FG003|Part A|Investigator Decision|0|||
162185228|NCT02488408|585728774|FG004|Part A|Investigator Decision|0|||
162185229|NCT02488408|585728775|FG005|Part A|Investigator Decision|0|||
162185230|NCT02488408|585728776|FG006|Part A|Investigator Decision|0|||
162185231|NCT02488408|585728777|FG007|Part A|Investigator Decision|0|||
162185232|NCT02488408|585728778|FG008|Part A|Investigator Decision|0|||
162185233|NCT02488408|585728779|FG009|Part A|Investigator Decision|0|||
162185234|NCT02488408|585728770|FG000|Part A|Withdrawal by Subject|0|||
162185235|NCT02488408|585728771|FG001|Part A|Withdrawal by Subject|0|||
162185236|NCT02488408|585728772|FG002|Part A|Withdrawal by Subject|2|||
162185237|NCT02488408|585728773|FG003|Part A|Withdrawal by Subject|0|||
162185238|NCT02488408|585728774|FG004|Part A|Withdrawal by Subject|0|||
162185239|NCT02488408|585728775|FG005|Part A|Withdrawal by Subject|0|||
162185240|NCT02488408|585728776|FG006|Part A|Withdrawal by Subject|0|||
162185241|NCT02488408|585728777|FG007|Part A|Withdrawal by Subject|0|||
161673045|NCT01603082|583856553|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
161673046|NCT01603082|583856554|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
161673047|NCT01641809|583856558|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
161673048|NCT01641809|583856559|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
161673049|NCT01641809|583856560|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
162185242|NCT02488408|585728778|FG008|Part A|Withdrawal by Subject|0|||
161673050|NCT01641809|583856561|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
161818707|NCT01968031|584376195|FG001|Overall Study|Failed inclusion criteria|2|||
162185243|NCT02488408|585728779|FG009|Part A|Withdrawal by Subject|0|||
162185244|NCT02488408|585728770|FG000|Part A|Other|1|||
162185245|NCT02488408|585728771|FG001|Part A|Other|0|||
162185246|NCT02488408|585728772|FG002|Part A|Other|0|||
162185247|NCT02488408|585728773|FG003|Part A|Other|0|||
162185248|NCT02488408|585728774|FG004|Part A|Other|0|||
162185249|NCT02488408|585728775|FG005|Part A|Other|0|||
162185250|NCT02488408|585728776|FG006|Part A|Other|0|||
162185251|NCT02488408|585728777|FG007|Part A|Other|0|||
162185252|NCT02488408|585728778|FG008|Part A|Other|0|||
162185253|NCT02488408|585728779|FG009|Part A|Other|0|||
162185254|NCT02488408|585728770|FG000|Part B|Adverse Event|0|||
162185255|NCT02488408|585728771|FG001|Part B|Adverse Event|0|||
162185256|NCT02488408|585728772|FG002|Part B|Adverse Event|0|||
162185257|NCT02488408|585728773|FG003|Part B|Adverse Event|0|||
162185258|NCT02488408|585728774|FG004|Part B|Adverse Event|0|||
162185259|NCT02488408|585728775|FG005|Part B|Adverse Event|2|||
162185260|NCT02488408|585728776|FG006|Part B|Adverse Event|2|||
161924689|NCT01658878|584770976|FG010|Treatment Period|Maximum Clinical Benefit|0|||
161924690|NCT01658878|584770977|FG011|Treatment Period|Maximum Clinical Benefit|0|||
161924691|NCT01658878|584770978|FG012|Treatment Period|Maximum Clinical Benefit|0|||
161924692|NCT01658878|584770979|FG013|Treatment Period|Maximum Clinical Benefit|0|||
161924693|NCT01658878|584770980|FG014|Treatment Period|Maximum Clinical Benefit|0|||
161924694|NCT01658878|584770981|FG015|Treatment Period|Maximum Clinical Benefit|0|||
161924695|NCT01658878|584770982|FG016|Treatment Period|Maximum Clinical Benefit|0|||
161924696|NCT01658878|584770983|FG017|Treatment Period|Maximum Clinical Benefit|0|||
161924697|NCT01658878|584770984|FG018|Treatment Period|Maximum Clinical Benefit|1|||
161924698|NCT01658878|584770985|FG019|Treatment Period|Maximum Clinical Benefit|1|||
161924699|NCT01658878|584770986|FG020|Treatment Period|Maximum Clinical Benefit|0|||
162019263|NCT02920242|585124903|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
162019264|NCT04995419|585124909|FG000|Overall Study|Withdrawal by Subject|3|||
162019265|NCT04995419|585124909|FG000|Overall Study|Progressive Disease|19|||
162019266|NCT04995419|585124909|FG000|Overall Study|Adverse Event|2|||
162019267|NCT04995419|585124909|FG000|Overall Study|Ongoing|16|||
162185261|NCT02488408|585728777|FG007|Part B|Adverse Event|7|||
162185262|NCT02488408|585728778|FG008|Part B|Adverse Event|2|||
162185263|NCT02488408|585728779|FG009|Part B|Adverse Event|2|||
162185264|NCT02488408|585728770|FG000|Part B|Death|0|||
162185265|NCT02488408|585728771|FG001|Part B|Death|0|||
162185266|NCT02488408|585728772|FG002|Part B|Death|0|||
162185267|NCT02488408|585728773|FG003|Part B|Death|0|||
162185268|NCT02488408|585728774|FG004|Part B|Death|0|||
162185269|NCT02488408|585728775|FG005|Part B|Death|3|||
162185270|NCT02488408|585728776|FG006|Part B|Death|1|||
162185271|NCT02488408|585728777|FG007|Part B|Death|2|||
162185272|NCT02488408|585728778|FG008|Part B|Death|2|||
162185273|NCT02488408|585728779|FG009|Part B|Death|2|||
162185274|NCT02488408|585728770|FG000|Part B|Death due to Disease Progression|0|||
162185275|NCT02488408|585728771|FG001|Part B|Death due to Disease Progression|0|||
162185276|NCT02488408|585728772|FG002|Part B|Death due to Disease Progression|0|||
162185277|NCT02488408|585728773|FG003|Part B|Death due to Disease Progression|0|||
162185278|NCT02488408|585728774|FG004|Part B|Death due to Disease Progression|0|||
162185279|NCT02488408|585728775|FG005|Part B|Death due to Disease Progression|2|||
162185280|NCT02488408|585728776|FG006|Part B|Death due to Disease Progression|2|||
162185281|NCT02488408|585728777|FG007|Part B|Death due to Disease Progression|1|||
162185282|NCT02488408|585728778|FG008|Part B|Death due to Disease Progression|1|||
162185283|NCT02488408|585728779|FG009|Part B|Death due to Disease Progression|1|||
162185284|NCT02488408|585728770|FG000|Part B|Disease Progression|0|||
162185285|NCT02488408|585728771|FG001|Part B|Disease Progression|0|||
162185286|NCT02488408|585728772|FG002|Part B|Disease Progression|0|||
162185287|NCT02488408|585728773|FG003|Part B|Disease Progression|0|||
162185288|NCT02488408|585728774|FG004|Part B|Disease Progression|0|||
161673051|NCT01641809|583856558|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
161924700|NCT01658878|584770987|FG021|Treatment Period|Maximum Clinical Benefit|0|||
162019268|NCT02948088|585124910|FG000|Overall Study|Lost to Follow-up|8|||
162019269|NCT02948088|585124910|FG000|Overall Study|Death|1|||
162019270|NCT02948088|585124910|FG000|Overall Study|Withdrawal by Subject|4|||
162019271|NCT02948088|585124910|FG000|Overall Study|Other|2|||
162019272|NCT00634101|585124911|FG000|Overall Study|Study Terminated|3|||
162019273|NCT00634101|585124912|FG001|Overall Study|Study Terminated|3|||
162019274|NCT00634101|585124911|FG000|Overall Study|Lost to Follow-up|2|||
162019275|NCT00634101|585124912|FG001|Overall Study|Lost to Follow-up|0|||
162019276|NCT00139477|585124913|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
162019277|NCT00139477|585124914|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
162019278|NCT00139477|585124913|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
162019279|NCT00139477|585124914|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
162019280|NCT00139477|585124913|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
162019281|NCT00139477|585124914|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
162019282|NCT00139477|585124913|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
162019283|NCT00139477|585124914|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
162019284|NCT00139477|585124913|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
162019285|NCT00139477|585124914|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
162019286|NCT00139477|585124913|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
162185289|NCT02488408|585728775|FG005|Part B|Disease Progression|6|||
161924701|NCT01658878|584770988|FG022|Treatment Period|Maximum Clinical Benefit|0|||
161924702|NCT01658878|584770989|FG023|Treatment Period|Maximum Clinical Benefit|0|||
161924703|NCT01658878|584770966|FG000|Treatment Period|Other Reasons|0|||
162185290|NCT02488408|585728776|FG006|Part B|Disease Progression|9|||
161924704|NCT01658878|584770967|FG001|Treatment Period|Other Reasons|0|||
161924705|NCT01658878|584770968|FG002|Treatment Period|Other Reasons|0|||
162185291|NCT02488408|585728777|FG007|Part B|Disease Progression|7|||
162185292|NCT02488408|585728778|FG008|Part B|Disease Progression|9|||
162185293|NCT02488408|585728779|FG009|Part B|Disease Progression|11|||
162185294|NCT02488408|585728770|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
162185295|NCT02488408|585728771|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
161818708|NCT01968031|584376196|FG002|Overall Study|Failed inclusion criteria|0|||
161818709|NCT01968031|584376194|FG000|Overall Study|Death|0|||
161818710|NCT01968031|584376195|FG001|Overall Study|Death|0|||
161818711|NCT01968031|584376196|FG002|Overall Study|Death|1|||
161818712|NCT01968031|584376194|FG000|Overall Study|Prohibited concomitant medication|1|||
161818713|NCT01968031|584376195|FG001|Overall Study|Prohibited concomitant medication|0|||
161818714|NCT01968031|584376196|FG002|Overall Study|Prohibited concomitant medication|0|||
161818715|NCT00477594|584376197|FG000|Year 1 and Year 2|Adverse Event|4|||
161818716|NCT00477594|584376198|FG001|Year 1 and Year 2|Adverse Event|2|||
161818717|NCT00477594|584376197|FG000|Year 1 and Year 2|Physician Decision|2|||
161818718|NCT00477594|584376198|FG001|Year 1 and Year 2|Physician Decision|1|||
161818719|NCT00477594|584376197|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
161818720|NCT00477594|584376198|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
161818721|NCT00477594|584376197|FG000|Year 1 and Year 2|Other|1|||
161818722|NCT00477594|584376198|FG001|Year 1 and Year 2|Other|0|||
161818723|NCT00477594|584376197|FG000|Year 3|Adverse Event|1|||
161818724|NCT00477594|584376198|FG001|Year 3|Adverse Event|0|||
161818725|NCT00477594|584376197|FG000|Year 3|Withdrawal by Subject|1|||
161818726|NCT00477594|584376198|FG001|Year 3|Withdrawal by Subject|0|||
161818727|NCT00477594|584376197|FG000|Follow-up Period|Withdrawal by Subject|2|||
161818728|NCT00477594|584376198|FG001|Follow-up Period|Withdrawal by Subject|1|||
161818729|NCT00477594|584376197|FG000|Follow-up Period|Other|1|||
161818730|NCT00477594|584376198|FG001|Follow-up Period|Other|0|||
161818731|NCT04573309|584378103|FG000|Overall Study|Protocol Violation|1|||
161818732|NCT04573309|584378104|FG001|Overall Study|Protocol Violation|0|||
161818733|NCT01691430|584378105|FG000|Overall Study|Death|17|||
161818734|NCT01691430|584378106|FG001|Overall Study|Death|16|||
161818735|NCT01691430|584378105|FG000|Overall Study|Withdrawal by Subject|5|||
161818736|NCT01691430|584378106|FG001|Overall Study|Withdrawal by Subject|1|||
161818737|NCT01691430|584378105|FG000|Overall Study|Lost to Follow-up|0|||
161818738|NCT01691430|584378106|FG001|Overall Study|Lost to Follow-up|3|||
161818739|NCT02998541|584378108|FG000|Overall Study|Adverse Event|4|||
161818740|NCT02998541|584378109|FG001|Overall Study|Adverse Event|5|||
161818741|NCT02998541|584378110|FG002|Overall Study|Adverse Event|1|||
161818742|NCT02998541|584378108|FG000|Overall Study|Protocol Violation|1|||
161818743|NCT02998541|584378109|FG001|Overall Study|Protocol Violation|0|||
161818744|NCT02998541|584378110|FG002|Overall Study|Protocol Violation|0|||
161818745|NCT02998541|584378108|FG000|Overall Study|Withdrawal by Subject|3|||
161818746|NCT02998541|584378109|FG001|Overall Study|Withdrawal by Subject|1|||
161818747|NCT02998541|584378110|FG002|Overall Study|Withdrawal by Subject|0|||
161818748|NCT02998541|584378108|FG000|Overall Study|Lost to Follow-up|0|||
161818749|NCT02998541|584378109|FG001|Overall Study|Lost to Follow-up|3|||
161818750|NCT02998541|584378110|FG002|Overall Study|Lost to Follow-up|1|||
161818751|NCT02998541|584378108|FG000|Overall Study|Physician Decision|0|||
161818752|NCT02998541|584378109|FG001|Overall Study|Physician Decision|0|||
161818753|NCT02998541|584378110|FG002|Overall Study|Physician Decision|3|||
161818754|NCT02998541|584378108|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161818755|NCT02998541|584378109|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161818756|NCT02998541|584378110|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
161818757|NCT03540160|584378114|FG000|Overall Study|Protocol Violation|1|||
161818758|NCT03540160|584378114|FG000|Overall Study|Physician Decision|8|||
161818759|NCT03540160|584378114|FG000|Overall Study|Lack of Efficacy|60|||
161818760|NCT03540160|584378114|FG000|Overall Study|Pregnancy|1|||
161818761|NCT03540160|584378114|FG000|Overall Study|Adverse Event|20|||
161818762|NCT03540160|584378114|FG000|Overall Study|Withdrawal by Subject|68|||
161673052|NCT01641809|583856559|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
161818763|NCT03540160|584378114|FG000|Overall Study|COVID-19|2|||
161818764|NCT03540160|584378114|FG000|Overall Study|Study Closure|10|||
161818765|NCT03540160|584378114|FG000|Overall Study|Lost to Follow-up|18|||
161818766|NCT03540160|584378114|FG000|Overall Study|Sponsor decision|191|||
161818767|NCT01944722|584378115|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
161818768|NCT01944722|584378115|FG000|Overall Study|Specimen Shipping Issues|34|||
161818769|NCT01944722|584378115|FG000|Overall Study|Improper Storage/Transport|5|||
161818770|NCT01944722|584378115|FG000|Overall Study|Insufficient Volume for Test|1|||
161818771|NCT01944722|584378115|FG000|Overall Study|Missing Specimens|3|||
161818772|NCT01944722|584378115|FG000|Overall Study|Specimens Mislabeled|2|||
161818773|NCT01944722|584378115|FG000|Overall Study|Withdrawal by Subject|8|||
161673053|NCT01641809|583856560|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
161673054|NCT01641809|583856561|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
161673055|NCT01641809|583856558|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
161673056|NCT01641809|583856559|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
161673057|NCT01641809|583856560|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
161673058|NCT01641809|583856561|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
161673059|NCT01641809|583856558|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
161673060|NCT01641809|583856559|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
161924706|NCT01658878|584770969|FG003|Treatment Period|Other Reasons|1|||
161924707|NCT01658878|584770970|FG004|Treatment Period|Other Reasons|0|||
161924708|NCT01658878|584770971|FG005|Treatment Period|Other Reasons|0|||
161924709|NCT01658878|584770972|FG006|Treatment Period|Other Reasons|0|||
161924710|NCT01658878|584770973|FG007|Treatment Period|Other Reasons|0|||
161924711|NCT01658878|584770974|FG008|Treatment Period|Other Reasons|0|||
161924712|NCT01658878|584770975|FG009|Treatment Period|Other Reasons|0|||
161924713|NCT01658878|584770976|FG010|Treatment Period|Other Reasons|0|||
161924714|NCT01658878|584770977|FG011|Treatment Period|Other Reasons|0|||
161924715|NCT01658878|584770978|FG012|Treatment Period|Other Reasons|2|||
161924716|NCT01658878|584770979|FG013|Treatment Period|Other Reasons|0|||
161924717|NCT01658878|584770980|FG014|Treatment Period|Other Reasons|0|||
161924718|NCT01658878|584770981|FG015|Treatment Period|Other Reasons|2|||
161924719|NCT01658878|584770982|FG016|Treatment Period|Other Reasons|1|||
161924720|NCT01658878|584770983|FG017|Treatment Period|Other Reasons|1|||
161924721|NCT01658878|584770984|FG018|Treatment Period|Other Reasons|3|||
161924722|NCT01658878|584770985|FG019|Treatment Period|Other Reasons|1|||
161673061|NCT01641809|583856560|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
161924723|NCT01658878|584770986|FG020|Treatment Period|Other Reasons|4|||
161924724|NCT01658878|584770987|FG021|Treatment Period|Other Reasons|0|||
161924725|NCT01658878|584770988|FG022|Treatment Period|Other Reasons|0|||
161924726|NCT01658878|584770989|FG023|Treatment Period|Other Reasons|4|||
161924727|NCT01658878|584770966|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924728|NCT01658878|584770967|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
162019287|NCT00139477|585124914|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
162185296|NCT02488408|585728772|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
161673062|NCT01641809|583856561|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
162185297|NCT02488408|585728773|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
162185298|NCT02488408|585728774|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
161673063|NCT01641809|583856558|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
161673064|NCT01641809|583856559|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
161673065|NCT01641809|583856560|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
162185299|NCT02488408|585728775|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
162185300|NCT02488408|585728776|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
162185301|NCT02488408|585728777|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
162185302|NCT02488408|585728778|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
162185303|NCT02488408|585728779|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
162185304|NCT02488408|585728770|FG000|Part B|Investigator Decision|0|||
162185305|NCT02488408|585728771|FG001|Part B|Investigator Decision|0|||
162185306|NCT02488408|585728772|FG002|Part B|Investigator Decision|0|||
162185307|NCT02488408|585728773|FG003|Part B|Investigator Decision|0|||
161818774|NCT01944722|584378115|FG000|Overall Study|NILM Subjects <30 years old|8106|||
161818775|NCT01944722|584378115|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
161818776|NCT01944722|584378115|FG000|Overall Study|>ASCUS Cytology|1122|||
161818777|NCT02906917|584378118|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
161818778|NCT02906917|584378119|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
161818779|NCT02906917|584378118|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
161818780|NCT02906917|584378119|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
161818781|NCT02906917|584378118|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
161818782|NCT02906917|584378119|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
161818783|NCT02906917|584378118|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
161818784|NCT02906917|584378119|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
161818785|NCT02906917|584378118|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
161818786|NCT02906917|584378119|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
161818787|NCT02906917|584378118|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
161818788|NCT02906917|584378119|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
161818789|NCT02906917|584378118|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
161818790|NCT02906917|584378119|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
161818791|NCT02906917|584378118|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
161818792|NCT02906917|584378119|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
161818793|NCT00687739|584378120|FG000|Overall Study|Lost to Follow-up|2|||
161818794|NCT00687739|584378121|FG001|Overall Study|Lost to Follow-up|2|||
161818795|NCT00687739|584378122|FG002|Overall Study|Lost to Follow-up|1|||
161818796|NCT00687739|584378123|FG003|Overall Study|Lost to Follow-up|2|||
161818797|NCT00687739|584378120|FG000|Overall Study|Adverse Event|0|||
161818798|NCT00687739|584378121|FG001|Overall Study|Adverse Event|1|||
162019288|NCT00139477|585124913|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
162185308|NCT02488408|585728774|FG004|Part B|Investigator Decision|0|||
162185309|NCT02488408|585728775|FG005|Part B|Investigator Decision|0|||
162185310|NCT02488408|585728776|FG006|Part B|Investigator Decision|1|||
161673066|NCT01641809|583856561|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
161673067|NCT01641809|583856558|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
162185311|NCT02488408|585728777|FG007|Part B|Investigator Decision|0|||
161673068|NCT01641809|583856559|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
161673069|NCT01641809|583856560|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
161673070|NCT01641809|583856561|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
161818799|NCT00687739|584378122|FG002|Overall Study|Adverse Event|1|||
161818800|NCT00687739|584378123|FG003|Overall Study|Adverse Event|0|||
161818801|NCT02554877|584378124|FG000|Overall Study|Adverse Event|2|||
161818802|NCT02554877|584378125|FG001|Overall Study|Adverse Event|0|||
161818803|NCT02554877|584378126|FG002|Overall Study|Adverse Event|0|||
161818804|NCT02554877|584378127|FG003|Overall Study|Adverse Event|1|||
161818805|NCT02554877|584378124|FG000|Overall Study|Lost to Follow-up|1|||
161818806|NCT02554877|584378125|FG001|Overall Study|Lost to Follow-up|1|||
161818807|NCT02554877|584378126|FG002|Overall Study|Lost to Follow-up|1|||
161924729|NCT01658878|584770968|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924730|NCT01658878|584770969|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
162185312|NCT02488408|585728778|FG008|Part B|Investigator Decision|2|||
162185313|NCT02488408|585728779|FG009|Part B|Investigator Decision|1|||
162185314|NCT00719888|585728780|FG000|Overall Study|Death|24|||
162185315|NCT00719888|585728781|FG001|Overall Study|Death|9|||
162185316|NCT00719888|585728780|FG000|Overall Study|Relapse|8|||
162185317|NCT00719888|585728781|FG001|Overall Study|Relapse|3|||
162185318|NCT00719888|585728780|FG000|Overall Study|Physician Decision|1|||
162185319|NCT00719888|585728781|FG001|Overall Study|Physician Decision|0|||
162185320|NCT00719888|585728780|FG000|Overall Study|Withdrawal by Subject|1|||
162185321|NCT00719888|585728781|FG001|Overall Study|Withdrawal by Subject|0|||
162185322|NCT00491894|585728782|FG000|Overall Study|Adverse Event|14|||
162185323|NCT00491894|585728782|FG000|Overall Study|Withdrawal by Subject|5|||
162185324|NCT00491894|585728782|FG000|Overall Study|Death|3|||
162185325|NCT00491894|585728782|FG000|Overall Study|Lost to Follow-up|3|||
162185326|NCT00491894|585728782|FG000|Overall Study|Lack of Efficacy|2|||
162185327|NCT00491894|585728782|FG000|Overall Study|Other-Failed to meet any criteria|2|||
162185328|NCT00491894|585728782|FG000|Overall Study|Physician Decision|2|||
162185329|NCT00491894|585728782|FG000|Overall Study|Protocol Violation|2|||
162185330|NCT00491894|585728782|FG000|Overall Study|Other-Intake of prohibited medication|1|||
162185331|NCT04172675|585730154|FG000|Overall Study|Withdrawal by Subject|7|||
162185332|NCT04172675|585730155|FG001|Overall Study|Withdrawal by Subject|5|||
162185333|NCT04172675|585730156|FG002|Overall Study|Withdrawal by Subject|1|||
162185334|NCT04172675|585730157|FG003|Overall Study|Withdrawal by Subject|4|||
161673071|NCT01641809|583856558|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
161673072|NCT01641809|583856559|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
161673073|NCT01641809|583856560|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
161673074|NCT01641809|583856561|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
161673075|NCT01641809|583856558|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
161673076|NCT01641809|583856559|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
161673077|NCT01641809|583856560|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
161673078|NCT01641809|583856561|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
161673079|NCT01641809|583856558|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
161673080|NCT01641809|583856559|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
161673081|NCT01641809|583856560|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
161673082|NCT01641809|583856561|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
161673083|NCT01641809|583856558|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
161673084|NCT01641809|583856559|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
161673085|NCT01641809|583856560|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
161673086|NCT01641809|583856561|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
161673087|NCT01641809|583856558|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
161673088|NCT01641809|583856559|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
161673089|NCT01641809|583856560|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
161673090|NCT01641809|583856561|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
161673091|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
161673092|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
161673093|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
162185335|NCT02972034|585730158|FG000|Overall Study|Death|11|||
162185336|NCT02972034|585730159|FG001|Overall Study|Death|1|||
162185337|NCT02972034|585730160|FG002|Overall Study|Death|3|||
162185338|NCT02972034|585730161|FG003|Overall Study|Death|3|||
162185339|NCT02972034|585730162|FG004|Overall Study|Death|2|||
162185340|NCT02972034|585730163|FG005|Overall Study|Death|2|||
162185341|NCT02972034|585730164|FG006|Overall Study|Death|3|||
162185342|NCT02972034|585730165|FG007|Overall Study|Death|4|||
162185343|NCT02972034|585730166|FG008|Overall Study|Death|8|||
162185344|NCT02972034|585730167|FG009|Overall Study|Death|11|||
162185345|NCT02972034|585730168|FG010|Overall Study|Death|3|||
162185346|NCT02972034|585730169|FG011|Overall Study|Death|2|||
162185347|NCT02972034|585730170|FG012|Overall Study|Death|11|||
162185348|NCT02972034|585730171|FG013|Overall Study|Death|10|||
162185349|NCT02972034|585730172|FG014|Overall Study|Death|9|||
162185350|NCT02972034|585730158|FG000|Overall Study|Lost to Follow-up|0|||
162185351|NCT02972034|585730159|FG001|Overall Study|Lost to Follow-up|0|||
162185352|NCT02972034|585730160|FG002|Overall Study|Lost to Follow-up|0|||
162185353|NCT02972034|585730161|FG003|Overall Study|Lost to Follow-up|0|||
162185354|NCT02972034|585730162|FG004|Overall Study|Lost to Follow-up|1|||
161673094|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
161818808|NCT02554877|584378127|FG003|Overall Study|Lost to Follow-up|2|||
162185355|NCT02972034|585730163|FG005|Overall Study|Lost to Follow-up|0|||
162185356|NCT02972034|585730164|FG006|Overall Study|Lost to Follow-up|0|||
162185357|NCT02972034|585730165|FG007|Overall Study|Lost to Follow-up|1|||
162185358|NCT02972034|585730166|FG008|Overall Study|Lost to Follow-up|0|||
162185359|NCT02972034|585730167|FG009|Overall Study|Lost to Follow-up|0|||
162185360|NCT02972034|585730168|FG010|Overall Study|Lost to Follow-up|0|||
162185361|NCT02972034|585730169|FG011|Overall Study|Lost to Follow-up|0|||
162185362|NCT02972034|585730170|FG012|Overall Study|Lost to Follow-up|0|||
162185363|NCT02972034|585730171|FG013|Overall Study|Lost to Follow-up|0|||
162185364|NCT02972034|585730172|FG014|Overall Study|Lost to Follow-up|1|||
162185365|NCT02972034|585730158|FG000|Overall Study|Physician Decision|0|||
162185366|NCT02972034|585730159|FG001|Overall Study|Physician Decision|0|||
162185367|NCT02972034|585730160|FG002|Overall Study|Physician Decision|0|||
162185368|NCT02972034|585730161|FG003|Overall Study|Physician Decision|0|||
162185369|NCT02972034|585730162|FG004|Overall Study|Physician Decision|0|||
162185370|NCT02972034|585730163|FG005|Overall Study|Physician Decision|0|||
162185371|NCT02972034|585730164|FG006|Overall Study|Physician Decision|0|||
162185372|NCT02972034|585730165|FG007|Overall Study|Physician Decision|1|||
162185373|NCT02972034|585730166|FG008|Overall Study|Physician Decision|0|||
162185374|NCT02972034|585730167|FG009|Overall Study|Physician Decision|0|||
162185375|NCT02972034|585730168|FG010|Overall Study|Physician Decision|1|||
162185376|NCT02972034|585730169|FG011|Overall Study|Physician Decision|0|||
162185377|NCT02972034|585730170|FG012|Overall Study|Physician Decision|0|||
162185378|NCT02972034|585730171|FG013|Overall Study|Physician Decision|0|||
162185379|NCT02972034|585730172|FG014|Overall Study|Physician Decision|0|||
162185380|NCT02972034|585730158|FG000|Overall Study|Sponsor Decision|0|||
162185381|NCT02972034|585730159|FG001|Overall Study|Sponsor Decision|0|||
162185382|NCT02972034|585730160|FG002|Overall Study|Sponsor Decision|0|||
162185383|NCT02972034|585730161|FG003|Overall Study|Sponsor Decision|1|||
162185384|NCT02972034|585730162|FG004|Overall Study|Sponsor Decision|0|||
162185385|NCT02972034|585730163|FG005|Overall Study|Sponsor Decision|0|||
162185386|NCT02972034|585730164|FG006|Overall Study|Sponsor Decision|1|||
162185387|NCT02972034|585730165|FG007|Overall Study|Sponsor Decision|1|||
162185388|NCT02972034|585730166|FG008|Overall Study|Sponsor Decision|1|||
162185389|NCT02972034|585730167|FG009|Overall Study|Sponsor Decision|2|||
162185390|NCT02972034|585730168|FG010|Overall Study|Sponsor Decision|2|||
162185391|NCT02972034|585730169|FG011|Overall Study|Sponsor Decision|0|||
162185392|NCT02972034|585730170|FG012|Overall Study|Sponsor Decision|1|||
162185393|NCT02972034|585730171|FG013|Overall Study|Sponsor Decision|0|||
162185394|NCT02972034|585730172|FG014|Overall Study|Sponsor Decision|1|||
162185395|NCT02972034|585730158|FG000|Overall Study|Withdrawal by Subject|3|||
162185396|NCT02972034|585730159|FG001|Overall Study|Withdrawal by Subject|0|||
162185397|NCT02972034|585730160|FG002|Overall Study|Withdrawal by Subject|0|||
162185398|NCT02972034|585730161|FG003|Overall Study|Withdrawal by Subject|0|||
162185399|NCT02972034|585730162|FG004|Overall Study|Withdrawal by Subject|1|||
162185400|NCT02972034|585730163|FG005|Overall Study|Withdrawal by Subject|1|||
162185401|NCT02972034|585730164|FG006|Overall Study|Withdrawal by Subject|0|||
162185402|NCT02972034|585730165|FG007|Overall Study|Withdrawal by Subject|0|||
162185403|NCT02972034|585730166|FG008|Overall Study|Withdrawal by Subject|1|||
162185404|NCT02972034|585730167|FG009|Overall Study|Withdrawal by Subject|1|||
162185405|NCT02972034|585730168|FG010|Overall Study|Withdrawal by Subject|2|||
162185406|NCT02972034|585730169|FG011|Overall Study|Withdrawal by Subject|1|||
162185407|NCT02972034|585730170|FG012|Overall Study|Withdrawal by Subject|1|||
162185408|NCT02972034|585730171|FG013|Overall Study|Withdrawal by Subject|1|||
162185409|NCT02972034|585730172|FG014|Overall Study|Withdrawal by Subject|0|||
162185410|NCT02972034|585730158|FG000|Overall Study|Screen Failure|0|||
162185411|NCT02972034|585730159|FG001|Overall Study|Screen Failure|0|||
162185412|NCT02972034|585730160|FG002|Overall Study|Screen Failure|0|||
162185413|NCT02972034|585730161|FG003|Overall Study|Screen Failure|0|||
162185414|NCT02972034|585730162|FG004|Overall Study|Screen Failure|0|||
162185415|NCT02972034|585730163|FG005|Overall Study|Screen Failure|0|||
162185416|NCT02972034|585730164|FG006|Overall Study|Screen Failure|0|||
162185417|NCT02972034|585730165|FG007|Overall Study|Screen Failure|0|||
162185418|NCT02972034|585730166|FG008|Overall Study|Screen Failure|0|||
162185419|NCT02972034|585730167|FG009|Overall Study|Screen Failure|0|||
162185420|NCT02972034|585730168|FG010|Overall Study|Screen Failure|0|||
162185421|NCT02972034|585730169|FG011|Overall Study|Screen Failure|0|||
162185422|NCT02972034|585730170|FG012|Overall Study|Screen Failure|1|||
162185423|NCT02972034|585730171|FG013|Overall Study|Screen Failure|0|||
162185424|NCT02972034|585730172|FG014|Overall Study|Screen Failure|0|||
162185425|NCT03861052|585730173|FG000|Overall Study|Adverse Event|1|||
162185426|NCT03861052|585730174|FG001|Overall Study|Adverse Event|1|||
162185427|NCT03861052|585730175|FG002|Overall Study|Adverse Event|2|||
162185428|NCT03861052|585730176|FG003|Overall Study|Adverse Event|4|||
162185429|NCT03861052|585730173|FG000|Overall Study|Lost to Follow-up|0|||
162185430|NCT03861052|585730174|FG001|Overall Study|Lost to Follow-up|0|||
162185431|NCT03861052|585730175|FG002|Overall Study|Lost to Follow-up|0|||
162185432|NCT03861052|585730176|FG003|Overall Study|Lost to Follow-up|1|||
162185433|NCT03861052|585730173|FG000|Overall Study|Physician Decision|0|||
162185434|NCT03861052|585730174|FG001|Overall Study|Physician Decision|1|||
162185435|NCT03861052|585730175|FG002|Overall Study|Physician Decision|0|||
162185436|NCT03861052|585730176|FG003|Overall Study|Physician Decision|0|||
162185437|NCT03861052|585730173|FG000|Overall Study|Withdrawal by Subject|2|||
162185438|NCT03861052|585730174|FG001|Overall Study|Withdrawal by Subject|5|||
162185439|NCT03861052|585730175|FG002|Overall Study|Withdrawal by Subject|3|||
162185440|NCT03861052|585730176|FG003|Overall Study|Withdrawal by Subject|0|||
162185441|NCT03861052|585730173|FG000|Overall Study|Relocation to other city|1|||
162185442|NCT03861052|585730174|FG001|Overall Study|Relocation to other city|0|||
162185443|NCT03861052|585730175|FG002|Overall Study|Relocation to other city|0|||
162185444|NCT03861052|585730176|FG003|Overall Study|Relocation to other city|0|||
162185445|NCT03009344|585730177|FG000|Overall Study|Lack of Efficacy|5|||
162185446|NCT03009344|585730177|FG000|Overall Study|Withdrawal by Subject|1|||
162185447|NCT03009344|585730177|FG000|Overall Study|Adverse Event|1|||
162185448|NCT00378898|585730178|FG000|Overall Study|Withdrawal by Subject|10|||
162185449|NCT00378898|585730179|FG001|Overall Study|Withdrawal by Subject|5|||
162185450|NCT00378898|585730178|FG000|Overall Study|Protocol Violation|1|||
162185451|NCT00378898|585730179|FG001|Overall Study|Protocol Violation|1|||
162185452|NCT00551421|585730180|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
162185453|NCT01278030|585730181|FG000|Overall Study|Withdrawal by Subject|8|||
162185454|NCT01278030|585730182|FG001|Overall Study|Withdrawal by Subject|4|||
162185455|NCT05815342|585730187|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
162185456|NCT05815342|585730187|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
162185457|NCT05815342|585730187|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
162185458|NCT05815342|585730187|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
162185459|NCT05815342|585730187|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
162185460|NCT00745875|585730192|FG000|Overall Study|Continuing study treatment|4|||
162185461|NCT00745875|585730193|FG001|Overall Study|Continuing study treatment|4|||
162185462|NCT03689946|585730198|FG000|Overall Study|Withdrawal by Subject|3|||
162185463|NCT03689946|585730198|FG000|Overall Study|Lost to Follow-up|3|||
162185464|NCT03689946|585730198|FG000|Overall Study|Data corruption|2|||
162185465|NCT01555138|585730199|FG000|Overall Study|Death|0|||
162185466|NCT01555138|585730200|FG001|Overall Study|Death|1|||
162185467|NCT01555138|585730199|FG000|Overall Study|Lost to Follow-up|1|||
162185468|NCT01555138|585730200|FG001|Overall Study|Lost to Follow-up|0|||
162185469|NCT01555138|585730199|FG000|Overall Study|Abnormal Lab reults|1|||
162185470|NCT01555138|585730200|FG001|Overall Study|Abnormal Lab reults|3|||
162185471|NCT01555138|585730199|FG000|Overall Study|Lack of Efficacy|2|||
162185472|NCT01555138|585730200|FG001|Overall Study|Lack of Efficacy|2|||
162185473|NCT01555138|585730199|FG000|Overall Study|Protocol Violation|5|||
162185474|NCT01555138|585730200|FG001|Overall Study|Protocol Violation|3|||
162185475|NCT01555138|585730199|FG000|Overall Study|Administrative problems|8|||
162185476|NCT01555138|585730200|FG001|Overall Study|Administrative problems|0|||
162185477|NCT01555138|585730199|FG000|Overall Study|Withdrawal by Subject|16|||
162185478|NCT01555138|585730200|FG001|Overall Study|Withdrawal by Subject|15|||
162185479|NCT01555138|585730199|FG000|Overall Study|Adverse Event|14|||
162185480|NCT01555138|585730200|FG001|Overall Study|Adverse Event|14|||
162185481|NCT03220724|585730204|FG000|Overall Study|Lost to Follow-up|2|||
162185482|NCT03220724|585730205|FG001|Overall Study|Lost to Follow-up|2|||
162185483|NCT03220724|585730206|FG002|Overall Study|Lost to Follow-up|0|||
162185484|NCT03220724|585730207|FG003|Overall Study|Lost to Follow-up|3|||
162185485|NCT03220724|585730208|FG004|Overall Study|Lost to Follow-up|1|||
162185486|NCT03220724|585730209|FG005|Overall Study|Lost to Follow-up|0|||
162185487|NCT03220724|585730210|FG006|Overall Study|Lost to Follow-up|2|||
162185488|NCT03220724|585730211|FG007|Overall Study|Lost to Follow-up|1|||
162185489|NCT03220724|585730212|FG008|Overall Study|Lost to Follow-up|0|||
162185490|NCT03220724|585730204|FG000|Overall Study|Withdrawal by Subject|1|||
162185491|NCT03220724|585730205|FG001|Overall Study|Withdrawal by Subject|0|||
162185492|NCT03220724|585730206|FG002|Overall Study|Withdrawal by Subject|1|||
162185493|NCT03220724|585730207|FG003|Overall Study|Withdrawal by Subject|0|||
162185494|NCT03220724|585730208|FG004|Overall Study|Withdrawal by Subject|0|||
162185495|NCT03220724|585730209|FG005|Overall Study|Withdrawal by Subject|0|||
162185496|NCT03220724|585730210|FG006|Overall Study|Withdrawal by Subject|0|||
162185497|NCT03220724|585730211|FG007|Overall Study|Withdrawal by Subject|0|||
162185498|NCT03220724|585730212|FG008|Overall Study|Withdrawal by Subject|0|||
162185499|NCT01613417|585730213|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
162185500|NCT01613417|585730214|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
162185501|NCT02000752|585730217|FG000|Overall Study|Dystocic delivery|19|||
162185502|NCT02000752|585730218|FG001|Overall Study|Dystocic delivery|8|||
162185503|NCT02000752|585730217|FG000|Overall Study|Shift Changes|12|||
162185504|NCT02000752|585730218|FG001|Overall Study|Shift Changes|5|||
161924731|NCT01658878|584770970|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924732|NCT01658878|584770971|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924733|NCT01658878|584770972|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924734|NCT01658878|584770973|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924735|NCT01658878|584770974|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
162185505|NCT00512252|585730220|FG000|Overall Study|Lost to Follow-up|0|||
162185506|NCT00512252|585730221|FG001|Overall Study|Lost to Follow-up|0|||
162185507|NCT00512252|585730222|FG002|Overall Study|Lost to Follow-up|1|||
162185508|NCT00512252|585730220|FG000|Overall Study|Protocol Violation|0|||
162185509|NCT00512252|585730221|FG001|Overall Study|Protocol Violation|0|||
162185510|NCT00512252|585730222|FG002|Overall Study|Protocol Violation|1|||
162185511|NCT00512252|585730220|FG000|Overall Study|Death|0|||
162185512|NCT00512252|585730221|FG001|Overall Study|Death|0|||
162185513|NCT00512252|585730222|FG002|Overall Study|Death|1|||
162185514|NCT02357966|585730223|FG000|Overall Study|Death|0|||
162185515|NCT02357966|585730224|FG001|Overall Study|Death|0|||
162185516|NCT02357966|585730225|FG002|Overall Study|Death|1|||
162185517|NCT02357966|585730226|FG003|Overall Study|Death|0|||
162185518|NCT02357966|585730227|FG004|Overall Study|Death|2|||
162185519|NCT02357966|585730228|FG005|Overall Study|Death|0|||
162185520|NCT02357966|585730223|FG000|Overall Study|Physician Decision|1|||
162185521|NCT02357966|585730224|FG001|Overall Study|Physician Decision|0|||
162185522|NCT02357966|585730225|FG002|Overall Study|Physician Decision|0|||
162185523|NCT02357966|585730226|FG003|Overall Study|Physician Decision|0|||
162185524|NCT02357966|585730227|FG004|Overall Study|Physician Decision|1|||
162185525|NCT02357966|585730228|FG005|Overall Study|Physician Decision|0|||
162185526|NCT00019604|585730229|FG000|Overall Study|Death|1|||
162185527|NCT00019604|585730229|FG000|Overall Study|Progressive disease|23|||
162185528|NCT00019604|585730229|FG000|Overall Study|Refused treatment|1|||
162185529|NCT00019604|585730229|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
162185530|NCT00019604|585730229|FG000|Overall Study|Going to have liver transplant|1|||
162185531|NCT00019604|585730229|FG000|Overall Study|Move to a different study|1|||
162185532|NCT00019604|585730229|FG000|Overall Study|Non compliant on systemic CH|1|||
162185533|NCT00019604|585730229|FG000|Overall Study|Non compliant|1|||
162185534|NCT00019604|585730229|FG000|Overall Study|Resectable disease|1|||
162185535|NCT00019604|585730229|FG000|Overall Study|Started new chemo regimen|1|||
162185536|NCT00019604|585730229|FG000|Overall Study|Pt going to immunotherapy study|1|||
162185537|NCT00019604|585730229|FG000|Overall Study|Too much disease|1|||
162185538|NCT00019604|585730229|FG000|Overall Study|Unable to evaluate|1|||
162185539|NCT00019604|585730229|FG000|Overall Study|Details for other not available|4|||
162185540|NCT04608409|585730233|FG000|Overall Study|Physician Decision|1|||
162185541|NCT04608409|585730234|FG001|Overall Study|Physician Decision|1|||
162185542|NCT04608409|585730235|FG002|Overall Study|Physician Decision|2|||
162185543|NCT03392194|585730237|FG000|Overall Study|Withdrawal by Subject|1|||
162185544|NCT03392194|585730238|FG001|Overall Study|Withdrawal by Subject|2|||
162185545|NCT03392194|585730237|FG000|Overall Study|Conflicts with personal schedule|1|||
162185546|NCT03392194|585730238|FG001|Overall Study|Conflicts with personal schedule|0|||
162185547|NCT00454194|585730241|FG000|Overall Study|Adverse Event|7|||
162185548|NCT00454194|585730242|FG001|Overall Study|Adverse Event|2|||
162185549|NCT00454194|585730241|FG000|Overall Study|Withdrawal by Subject|12|||
162185550|NCT00454194|585730242|FG001|Overall Study|Withdrawal by Subject|8|||
162185551|NCT00454194|585730241|FG000|Overall Study|Other Medical Problems|1|||
162185552|NCT00454194|585730242|FG001|Overall Study|Other Medical Problems|2|||
162185553|NCT00454194|585730241|FG000|Overall Study|Other Unspecified Reason|2|||
162185554|NCT00454194|585730242|FG001|Overall Study|Other Unspecified Reason|2|||
162185555|NCT00620854|585730243|FG000|Washout 1|Withdrawal by Subject|0|||
161924736|NCT01658878|584770975|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924737|NCT01658878|584770976|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924738|NCT01658878|584770977|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
162185556|NCT00620854|585730244|FG001|Washout 1|Withdrawal by Subject|0|||
162185557|NCT00620854|585730245|FG002|Washout 1|Withdrawal by Subject|1|||
162185558|NCT00620854|585730246|FG003|Washout 1|Withdrawal by Subject|1|||
162185559|NCT00620854|585730247|FG004|Washout 1|Withdrawal by Subject|0|||
162185560|NCT00620854|585730248|FG005|Washout 1|Withdrawal by Subject|0|||
162185561|NCT00229658|585730252|FG000|Overall Study|Administrative|2|||
162185562|NCT00229658|585730253|FG001|Overall Study|Administrative|1|||
162185563|NCT00229658|585730252|FG000|Overall Study|Investigator decision|13|||
162185564|NCT00229658|585730253|FG001|Overall Study|Investigator decision|10|||
162185565|NCT00229658|585730252|FG000|Overall Study|Other|80|||
162185566|NCT00229658|585730253|FG001|Overall Study|Other|60|||
162185567|NCT00229658|585730252|FG000|Overall Study|Lost to Follow-up|82|||
162185568|NCT00229658|585730253|FG001|Overall Study|Lost to Follow-up|55|||
162185569|NCT00229658|585730252|FG000|Overall Study|Serious Adverse Event|2|||
162185570|NCT00229658|585730253|FG001|Overall Study|Serious Adverse Event|2|||
161673095|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
161924739|NCT01658878|584770978|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924740|NCT01658878|584770979|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924741|NCT01658878|584770980|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
161924742|NCT01658878|584770981|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924743|NCT01658878|584770982|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924744|NCT01658878|584770983|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
161924745|NCT01658878|584770984|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924746|NCT01658878|584770985|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924747|NCT01658878|584770986|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924748|NCT01658878|584770987|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161673096|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
161673097|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
161673098|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
161673099|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
161673100|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
161673101|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
161673102|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
161673103|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
161673104|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
161673105|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
161673106|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
161673107|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
161673108|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
161673109|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
161673110|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
162185571|NCT00229658|585730252|FG000|Overall Study|Withdrawal of consent|46|||
162185572|NCT00229658|585730253|FG001|Overall Study|Withdrawal of consent|39|||
162185573|NCT00093496|585730254|FG000|Overall Study|Protocol Violation|1|||
162185574|NCT00093496|585730255|FG001|Overall Study|Protocol Violation|3|||
162185575|NCT01953224|585730256|FG000|Overall Study|Lost to Follow-up|1|||
162185576|NCT01953224|585730257|FG001|Overall Study|Lost to Follow-up|1|||
162185577|NCT01953224|585730256|FG000|Overall Study|Withdrawal by Subject|1|||
162185578|NCT01953224|585730257|FG001|Overall Study|Withdrawal by Subject|2|||
162185579|NCT00586313|585730258|FG000|Overall Study|Lack of Efficacy|2|||
162185580|NCT03205566|585730263|FG000|Phase 1|Protocol Violation|1|||
162185581|NCT03205566|585730264|FG001|Phase 1|Protocol Violation|1|||
162185582|NCT01700205|585730265|FG000|Overall Study|Withdrawal by Subject|13|||
162185583|NCT01700205|585730266|FG001|Overall Study|Withdrawal by Subject|13|||
162185584|NCT01700205|585730265|FG000|Overall Study|Protocol Violation|2|||
162185585|NCT01700205|585730266|FG001|Overall Study|Protocol Violation|2|||
162185586|NCT01170208|585730269|FG000|Overall Study|Withdrawal by Subject|5|||
162185587|NCT01170208|585730270|FG001|Overall Study|Withdrawal by Subject|0|||
162185588|NCT01170208|585730271|FG002|Overall Study|Withdrawal by Subject|1|||
162185589|NCT01170208|585730269|FG000|Overall Study|Protocol Violation|1|||
162185590|NCT01170208|585730270|FG001|Overall Study|Protocol Violation|0|||
162185591|NCT01170208|585730271|FG002|Overall Study|Protocol Violation|1|||
162185592|NCT03113409|585730272|FG000|Overall Study|Withdrawal by Subject|5|||
161673111|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
161673112|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
161673113|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
161924749|NCT01658878|584770988|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161924750|NCT01658878|584770989|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
162185593|NCT03113409|585730273|FG001|Overall Study|Withdrawal by Subject|0|||
162185594|NCT03113409|585730274|FG002|Overall Study|Withdrawal by Subject|0|||
162185595|NCT03335488|585730275|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
162185596|NCT03335488|585730276|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
161673114|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
161924751|NCT01658878|584770966|FG000|Treatment Period|Poor/Non-compliance|0|||
162185597|NCT03335488|585730275|FG000|Safety Extension Period|Adverse Event|1|||
161673115|NCT01641809|583856558|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
161673116|NCT01641809|583856559|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
161924752|NCT01658878|584770967|FG001|Treatment Period|Poor/Non-compliance|0|||
162185598|NCT03335488|585730276|FG001|Safety Extension Period|Adverse Event|0|||
162185599|NCT03335488|585730275|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
162185600|NCT03335488|585730276|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
161818809|NCT02554877|584378124|FG000|Overall Study|Did not meet entrance criteria|0|||
161818810|NCT02554877|584378125|FG001|Overall Study|Did not meet entrance criteria|0|||
161818811|NCT02554877|584378126|FG002|Overall Study|Did not meet entrance criteria|1|||
162185601|NCT04971733|585730277|FG000|Overall Study|Adverse Event|1|||
162185602|NCT04971733|585730278|FG001|Overall Study|Adverse Event|1|||
162185603|NCT04971733|585730277|FG000|Overall Study|Subject choice|2|||
162185604|NCT04971733|585730278|FG001|Overall Study|Subject choice|0|||
162185605|NCT04971733|585730277|FG000|Overall Study|Withdrawal by Subject|1|||
162185606|NCT04971733|585730278|FG001|Overall Study|Withdrawal by Subject|0|||
162185607|NCT04971733|585730277|FG000|Overall Study|Other|1|||
162185608|NCT04971733|585730278|FG001|Overall Study|Other|0|||
162185609|NCT01160354|585730279|FG000|Overall Study|Death|0|||
162185610|NCT01160354|585730280|FG001|Overall Study|Death|1|||
162185611|NCT01160354|585730281|FG002|Overall Study|Death|1|||
162185612|NCT01801007|585730285|FG000|Overall Study|Adverse Event|2|||
162185613|NCT01801007|585730285|FG000|Overall Study|Lost to Follow-up|4|||
162185614|NCT01801007|585730285|FG000|Overall Study|Withdrawal by Subject|5|||
162185615|NCT00600353|585730286|FG000|Overall Study|history of malignancy within 5 years|1|||
162185616|NCT00600353|585730287|FG001|Overall Study|history of malignancy within 5 years|0|||
162185617|NCT00600353|585730286|FG000|Overall Study|History of prepartive regimen|0|||
161818812|NCT02554877|584378127|FG003|Overall Study|Did not meet entrance criteria|0|||
161818813|NCT02554877|584378124|FG000|Overall Study|No longer met eligibility criteria|1|||
161818814|NCT02554877|584378125|FG001|Overall Study|No longer met eligibility criteria|0|||
162185618|NCT00600353|585730287|FG001|Overall Study|History of prepartive regimen|1|||
162185619|NCT04941482|585730288|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
162185620|NCT04941482|585730289|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
162185621|NCT02743819|585730290|FG000|Overall Study|Lack of Efficacy|5|||
162185622|NCT02743819|585730290|FG000|Overall Study|Death|2|||
162185623|NCT02743819|585730290|FG000|Overall Study|Adverse Event|1|||
162185624|NCT04200664|585730291|FG000|Overall Study|Withdrawal by Subject|1|||
162185625|NCT04200664|585730292|FG001|Overall Study|Withdrawal by Subject|0|||
162185626|NCT04200664|585730293|FG002|Overall Study|Withdrawal by Subject|0|||
162185627|NCT03362190|585730296|FG000|Overall Study|Adverse Event|0|||
162185628|NCT03362190|585730297|FG001|Overall Study|Adverse Event|0|||
162185629|NCT03362190|585730298|FG002|Overall Study|Adverse Event|0|||
162185630|NCT03362190|585730299|FG003|Overall Study|Adverse Event|1|||
162185631|NCT03362190|585730296|FG000|Overall Study|Withdrawal by Subject|0|||
162185632|NCT03362190|585730297|FG001|Overall Study|Withdrawal by Subject|0|||
162185633|NCT03362190|585730298|FG002|Overall Study|Withdrawal by Subject|0|||
162185634|NCT03362190|585730299|FG003|Overall Study|Withdrawal by Subject|1|||
162185635|NCT00687219|585730300|FG000|Overall Study|Adverse Event|8|||
162185636|NCT00687219|585730300|FG000|Overall Study|Discontinuance criteria met|7|||
162185637|NCT00687219|585730300|FG000|Overall Study|HCV-RNA positive conversion|34|||
162185638|NCT00687219|585730300|FG000|Overall Study|Withdrawal by Subject|1|||
162185639|NCT00687219|585730300|FG000|Overall Study|Lack of Efficacy|1|||
162185640|NCT05422339|585731863|FG000|Overall Study|Withdrawal by Subject|17|||
162185641|NCT05422339|585731864|FG001|Overall Study|Withdrawal by Subject|15|||
162185642|NCT03070392|585731871|FG000|Overall Study|Not Treated|7|||
162185643|NCT03070392|585731872|FG001|Overall Study|Not Treated|0|||
162185644|NCT03070392|585731873|FG002|Overall Study|Not Treated|3|||
162185645|NCT03070392|585731874|FG003|Overall Study|Not Treated|12|||
162185646|NCT03070392|585731871|FG000|Overall Study|Death|3|||
161818815|NCT02554877|584378126|FG002|Overall Study|No longer met eligibility criteria|1|||
161818816|NCT02554877|584378127|FG003|Overall Study|No longer met eligibility criteria|1|||
161818817|NCT02554877|584378124|FG000|Overall Study|Protocol Violation|3|||
161818818|NCT02554877|584378125|FG001|Overall Study|Protocol Violation|1|||
161924753|NCT01658878|584770968|FG002|Treatment Period|Poor/Non-compliance|0|||
161924754|NCT01658878|584770969|FG003|Treatment Period|Poor/Non-compliance|0|||
161924755|NCT01658878|584770970|FG004|Treatment Period|Poor/Non-compliance|0|||
161924756|NCT01658878|584770971|FG005|Treatment Period|Poor/Non-compliance|0|||
161924757|NCT01658878|584770972|FG006|Treatment Period|Poor/Non-compliance|0|||
161924758|NCT01658878|584770973|FG007|Treatment Period|Poor/Non-compliance|0|||
162185647|NCT03070392|585731872|FG001|Overall Study|Death|0|||
162185648|NCT03070392|585731873|FG002|Overall Study|Death|0|||
162185649|NCT03070392|585731874|FG003|Overall Study|Death|1|||
162185650|NCT03070392|585731871|FG000|Overall Study|Withdrawal by Subject|7|||
162185651|NCT03070392|585731872|FG001|Overall Study|Withdrawal by Subject|0|||
162185652|NCT03070392|585731873|FG002|Overall Study|Withdrawal by Subject|0|||
162185653|NCT03070392|585731874|FG003|Overall Study|Withdrawal by Subject|3|||
162185654|NCT03070392|585731871|FG000|Overall Study|Physician Decision|1|||
162185655|NCT03070392|585731872|FG001|Overall Study|Physician Decision|0|||
161818819|NCT02554877|584378126|FG002|Overall Study|Protocol Violation|1|||
162185656|NCT03070392|585731873|FG002|Overall Study|Physician Decision|0|||
162185657|NCT03070392|585731874|FG003|Overall Study|Physician Decision|2|||
162185658|NCT03070392|585731871|FG000|Overall Study|Progressive Disease|154|||
162185659|NCT03070392|585731872|FG001|Overall Study|Progressive Disease|6|||
162185660|NCT03070392|585731873|FG002|Overall Study|Progressive Disease|2|||
162185661|NCT03070392|585731874|FG003|Overall Study|Progressive Disease|70|||
162185662|NCT03070392|585731871|FG000|Overall Study|Adverse Event|6|||
162185663|NCT03070392|585731872|FG001|Overall Study|Adverse Event|1|||
162185664|NCT03070392|585731873|FG002|Overall Study|Adverse Event|1|||
162185665|NCT03070392|585731874|FG003|Overall Study|Adverse Event|3|||
162185666|NCT03070392|585731871|FG000|Overall Study|Alternate anticancer treatment|1|||
162185667|NCT03070392|585731872|FG001|Overall Study|Alternate anticancer treatment|0|||
162185668|NCT03070392|585731873|FG002|Overall Study|Alternate anticancer treatment|0|||
162185669|NCT03070392|585731874|FG003|Overall Study|Alternate anticancer treatment|1|||
162185670|NCT03070392|585731871|FG000|Overall Study|Ongoing|73|||
162185671|NCT03070392|585731872|FG001|Overall Study|Ongoing|0|||
162185672|NCT03070392|585731873|FG002|Overall Study|Ongoing|0|||
162185673|NCT03070392|585731874|FG003|Overall Study|Ongoing|11|||
162185674|NCT03678688|585731875|FG000|Overall Study|Reason not Specified|0|||
162185675|NCT03678688|585731876|FG001|Overall Study|Reason not Specified|0|||
162185676|NCT03678688|585731877|FG002|Overall Study|Reason not Specified|3|||
162185677|NCT03678688|585731878|FG003|Overall Study|Reason not Specified|0|||
162185678|NCT03678688|585731879|FG004|Overall Study|Reason not Specified|1|||
162185679|NCT03678688|585731880|FG005|Overall Study|Reason not Specified|0|||
162185680|NCT03678688|585731881|FG006|Overall Study|Reason not Specified|0|||
162185681|NCT03678688|585731882|FG007|Overall Study|Reason not Specified|0|||
162185682|NCT03678688|585731883|FG008|Overall Study|Reason not Specified|0|||
162185683|NCT03678688|585731875|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
162185684|NCT03678688|585731876|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
162185685|NCT03678688|585731877|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
162185686|NCT03678688|585731878|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
162185687|NCT03678688|585731879|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
162185688|NCT03678688|585731880|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
162185689|NCT03678688|585731881|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
162185690|NCT03678688|585731882|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
162185691|NCT03678688|585731883|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
162185692|NCT03678688|585731875|FG000|Overall Study|Covid Related Adverse Event|0|||
162185693|NCT03678688|585731876|FG001|Overall Study|Covid Related Adverse Event|0|||
162185694|NCT03678688|585731877|FG002|Overall Study|Covid Related Adverse Event|0|||
162185695|NCT03678688|585731878|FG003|Overall Study|Covid Related Adverse Event|0|||
162185696|NCT03678688|585731879|FG004|Overall Study|Covid Related Adverse Event|0|||
162185697|NCT03678688|585731880|FG005|Overall Study|Covid Related Adverse Event|3|||
162185698|NCT03678688|585731881|FG006|Overall Study|Covid Related Adverse Event|1|||
161818820|NCT02554877|584378127|FG003|Overall Study|Protocol Violation|0|||
162185699|NCT03678688|585731882|FG007|Overall Study|Covid Related Adverse Event|1|||
162185700|NCT03678688|585731883|FG008|Overall Study|Covid Related Adverse Event|0|||
162185701|NCT03678688|585731875|FG000|Overall Study|Physician Decision|0|||
162185702|NCT03678688|585731876|FG001|Overall Study|Physician Decision|0|||
162185703|NCT03678688|585731877|FG002|Overall Study|Physician Decision|0|||
162185704|NCT03678688|585731878|FG003|Overall Study|Physician Decision|0|||
162185705|NCT03678688|585731879|FG004|Overall Study|Physician Decision|0|||
162185706|NCT03678688|585731880|FG005|Overall Study|Physician Decision|1|||
162185707|NCT03678688|585731881|FG006|Overall Study|Physician Decision|0|||
162185708|NCT03678688|585731882|FG007|Overall Study|Physician Decision|0|||
162185709|NCT03678688|585731883|FG008|Overall Study|Physician Decision|0|||
162185710|NCT03678688|585731875|FG000|Overall Study|Withdrawal by Subject|0|||
162185711|NCT03678688|585731876|FG001|Overall Study|Withdrawal by Subject|0|||
162185712|NCT03678688|585731877|FG002|Overall Study|Withdrawal by Subject|0|||
162185713|NCT03678688|585731878|FG003|Overall Study|Withdrawal by Subject|0|||
162185714|NCT03678688|585731879|FG004|Overall Study|Withdrawal by Subject|0|||
162185715|NCT03678688|585731880|FG005|Overall Study|Withdrawal by Subject|0|||
162185716|NCT03678688|585731881|FG006|Overall Study|Withdrawal by Subject|2|||
162185717|NCT03678688|585731882|FG007|Overall Study|Withdrawal by Subject|1|||
162185718|NCT03678688|585731883|FG008|Overall Study|Withdrawal by Subject|0|||
162185719|NCT02534233|585731886|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
162185720|NCT03136159|585731890|FG000|Overall Study|chorioamnionitis|2|||
162185721|NCT03136159|585731891|FG001|Overall Study|chorioamnionitis|0|||
162185722|NCT03136159|585731890|FG000|Overall Study|vertical skin incision|1|||
162185723|NCT03136159|585731891|FG001|Overall Study|vertical skin incision|0|||
162185724|NCT03136159|585731890|FG000|Overall Study|additional dressing|1|||
162185725|NCT03136159|585731891|FG001|Overall Study|additional dressing|0|||
162185726|NCT03136159|585731890|FG000|Overall Study|never got dressing placed|1|||
162185727|NCT03136159|585731891|FG001|Overall Study|never got dressing placed|0|||
162185728|NCT03823703|585731892|FG000|Overall Study|Sponsor request|0|||
162185729|NCT03823703|585731893|FG001|Overall Study|Sponsor request|3|||
162185730|NCT03823703|585731894|FG002|Overall Study|Sponsor request|4|||
162185731|NCT03823703|585731892|FG000|Overall Study|Adverse Event|3|||
162185732|NCT03823703|585731893|FG001|Overall Study|Adverse Event|1|||
162185733|NCT03823703|585731894|FG002|Overall Study|Adverse Event|0|||
162185734|NCT03823703|585731892|FG000|Overall Study|Withdrawal by Subject|0|||
162185735|NCT03823703|585731893|FG001|Overall Study|Withdrawal by Subject|1|||
162185736|NCT03823703|585731894|FG002|Overall Study|Withdrawal by Subject|0|||
162185737|NCT00925548|585731895|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
162185738|NCT00925548|585731896|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
162185739|NCT00458783|585731898|FG000|Overall Study|Protocol Violation|1228|||
162185740|NCT00458783|585731899|FG001|Overall Study|Protocol Violation|1220|||
162185741|NCT01737398|585731900|FG000|Overall Study|Adverse event or SAE|16|||
162185742|NCT01737398|585731901|FG001|Overall Study|Adverse event or SAE|1|||
162185743|NCT01737398|585731900|FG000|Overall Study|Stopping rule met|2|||
162185744|NCT01737398|585731901|FG001|Overall Study|Stopping rule met|1|||
162185745|NCT01737398|585731900|FG000|Overall Study|Voluntary withdrawal|2|||
162185746|NCT01737398|585731901|FG001|Overall Study|Voluntary withdrawal|3|||
162185747|NCT01737398|585731900|FG000|Overall Study|Ineligibility|1|||
162185748|NCT01737398|585731901|FG001|Overall Study|Ineligibility|0|||
162185749|NCT01737398|585731900|FG000|Overall Study|Liver transplant|1|||
162185750|NCT01737398|585731901|FG001|Overall Study|Liver transplant|0|||
162185751|NCT01737398|585731900|FG000|Overall Study|Disease progression|2|||
162185752|NCT01737398|585731901|FG001|Overall Study|Disease progression|3|||
162185753|NCT01737398|585731900|FG000|Overall Study|Sponsor's decision|2|||
162185754|NCT01737398|585731901|FG001|Overall Study|Sponsor's decision|0|||
162185755|NCT00089609|585731902|FG000|Overall Study|Withdrawal by Subject|3|||
162185756|NCT00089609|585731903|FG001|Overall Study|Withdrawal by Subject|1|||
162185757|NCT00357994|585731904|FG000|Overall Study|Adverse Event|1|||
162185758|NCT00357994|585731905|FG001|Overall Study|Adverse Event|2|||
162185759|NCT00357994|585731904|FG000|Overall Study|Lack of Efficacy|0|||
162185760|NCT00357994|585731905|FG001|Overall Study|Lack of Efficacy|1|||
162185761|NCT00357994|585731904|FG000|Overall Study|Protocol Violation|1|||
162185762|NCT00357994|585731905|FG001|Overall Study|Protocol Violation|0|||
162185763|NCT01833455|585731906|FG000|Overall Study|Withdrawal by Subject|1|||
162185764|NCT01833455|585731907|FG001|Overall Study|Withdrawal by Subject|0|||
162185765|NCT00047385|585731908|FG000|Overall Study|Death before any screening|2|||
162185766|NCT00047385|585731909|FG001|Overall Study|Death before any screening|5|||
162185767|NCT00047385|585731908|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
162185768|NCT00047385|585731909|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
162185769|NCT00047385|585731908|FG000|Overall Study|Eligible for screening but had no screen|260|||
162185770|NCT00047385|585731909|FG001|Overall Study|Eligible for screening but had no screen|492|||
162185771|NCT03865732|585731910|FG000|Overall Study|Adverse Event|0|||
162185772|NCT03865732|585731911|FG001|Overall Study|Adverse Event|1|||
162185773|NCT02095145|585731914|FG000|Overall Study|Withdrawal by Subject|1|||
162185774|NCT02095145|585731915|FG001|Overall Study|Withdrawal by Subject|0|||
162185775|NCT02085941|585731916|FG000|Overall Study|Lack of Efficacy|1|||
162185776|NCT02085941|585731917|FG001|Overall Study|Lack of Efficacy|0|||
162185777|NCT02085941|585731916|FG000|Overall Study|Death|6|||
162185778|NCT02085941|585731917|FG001|Overall Study|Death|1|||
162185779|NCT02085941|585731916|FG000|Overall Study|Lost to Follow-up|1|||
162185780|NCT02085941|585731917|FG001|Overall Study|Lost to Follow-up|0|||
162185781|NCT02085941|585731916|FG000|Overall Study|Physician Decision|0|||
162185782|NCT02085941|585731917|FG001|Overall Study|Physician Decision|2|||
162185783|NCT03184987|585731920|FG000|Overall Study|Withdrawal by Subject|0|||
162185784|NCT03184987|585731921|FG001|Overall Study|Withdrawal by Subject|1|||
162185785|NCT03184987|585731922|FG002|Overall Study|Withdrawal by Subject|2|||
162185786|NCT03184987|585731920|FG000|Overall Study|Physician Decision|0|||
162185787|NCT03184987|585731921|FG001|Overall Study|Physician Decision|0|||
162185788|NCT03184987|585731922|FG002|Overall Study|Physician Decision|1|||
162185789|NCT03184987|585731920|FG000|Overall Study|Adverse Event|1|||
162185790|NCT03184987|585731921|FG001|Overall Study|Adverse Event|0|||
162185791|NCT03184987|585731922|FG002|Overall Study|Adverse Event|1|||
162185792|NCT00853580|585731923|FG000|Overall Study|Lost to Follow-up|3|||
162185793|NCT00853580|585731924|FG001|Overall Study|Lost to Follow-up|5|||
161673117|NCT01641809|583856560|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
161673118|NCT01641809|583856561|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
161673119|NCT04195581|583856562|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
162185794|NCT00853580|585731923|FG000|Overall Study|Protocol Violation|2|||
162185795|NCT00853580|585731924|FG001|Overall Study|Protocol Violation|1|||
162185796|NCT00853580|585731923|FG000|Overall Study|Withdrawal by Subject|2|||
162185797|NCT00853580|585731924|FG001|Overall Study|Withdrawal by Subject|8|||
162185798|NCT00853580|585731923|FG000|Overall Study|Commenced contraindicated therapy|0|||
162185799|NCT00853580|585731924|FG001|Overall Study|Commenced contraindicated therapy|2|||
162185800|NCT01767467|585731925|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
162185801|NCT01767467|585731926|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
162185802|NCT01767467|585731925|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
162185803|NCT01767467|585731926|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
162185804|NCT01767467|585731925|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
162185805|NCT01767467|585731926|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
162185806|NCT01767467|585731925|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
162185807|NCT01767467|585731926|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
162185808|NCT01767467|585731925|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
162185809|NCT01767467|585731926|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
162185810|NCT01767467|585731925|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
162185811|NCT01767467|585731926|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
162185812|NCT01767467|585731925|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
161673120|NCT04195581|583856562|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
161673121|NCT04195581|583856562|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
161673122|NCT04195581|583856562|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
161673123|NCT04195581|583856562|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
161673124|NCT04195581|583856562|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
161673125|NCT00821431|583856563|FG000|Overall Study|Adverse Event|6|||
161673126|NCT00821431|583856564|FG001|Overall Study|Adverse Event|3|||
161673127|NCT00821431|583856563|FG000|Overall Study|Withdrawal by Subject|5|||
161673128|NCT00821431|583856564|FG001|Overall Study|Withdrawal by Subject|0|||
161673129|NCT00821431|583856563|FG000|Overall Study|Lost to Follow-up|1|||
161673130|NCT00821431|583856564|FG001|Overall Study|Lost to Follow-up|0|||
161673131|NCT00821431|583856563|FG000|Overall Study|Protocol Violation|3|||
161673132|NCT00821431|583856564|FG001|Overall Study|Protocol Violation|1|||
161673133|NCT00821431|583856563|FG000|Overall Study|Physician Decision|0|||
161673134|NCT00821431|583856564|FG001|Overall Study|Physician Decision|1|||
161673135|NCT04890054|583857890|FG000|Overall Study|Lost to Follow-up|202|||
161673136|NCT04890054|583857891|FG001|Overall Study|Lost to Follow-up|219|||
161673137|NCT04313153|583857892|FG000|Overall Study|Adverse Event (includes Death)|14|||
161673138|NCT04313153|583857893|FG001|Overall Study|Adverse Event (includes Death)|19|||
161673139|NCT04313153|583857894|FG002|Overall Study|Adverse Event (includes Death)|10|||
161673140|NCT04313153|583857892|FG000|Overall Study|Physician Decision|4|||
161673141|NCT04313153|583857893|FG001|Overall Study|Physician Decision|2|||
161673142|NCT04313153|583857894|FG002|Overall Study|Physician Decision|1|||
161673143|NCT04313153|583857892|FG000|Overall Study|Withdrawal by Subject|7|||
161673144|NCT04313153|583857893|FG001|Overall Study|Withdrawal by Subject|6|||
161673145|NCT04313153|583857894|FG002|Overall Study|Withdrawal by Subject|2|||
161673146|NCT04313153|583857892|FG000|Overall Study|Lack of Efficacy|3|||
161673147|NCT04313153|583857893|FG001|Overall Study|Lack of Efficacy|3|||
161673148|NCT04313153|583857894|FG002|Overall Study|Lack of Efficacy|0|||
161673149|NCT04313153|583857892|FG000|Overall Study|Lost to Follow-up|1|||
161924759|NCT01658878|584770974|FG008|Treatment Period|Poor/Non-compliance|0|||
161924760|NCT01658878|584770975|FG009|Treatment Period|Poor/Non-compliance|0|||
161924761|NCT01658878|584770976|FG010|Treatment Period|Poor/Non-compliance|0|||
161924762|NCT01658878|584770977|FG011|Treatment Period|Poor/Non-compliance|0|||
161924763|NCT01658878|584770978|FG012|Treatment Period|Poor/Non-compliance|0|||
161924764|NCT01658878|584770979|FG013|Treatment Period|Poor/Non-compliance|0|||
161924765|NCT01658878|584770980|FG014|Treatment Period|Poor/Non-compliance|0|||
161924766|NCT01658878|584770981|FG015|Treatment Period|Poor/Non-compliance|1|||
161924767|NCT01658878|584770982|FG016|Treatment Period|Poor/Non-compliance|0|||
161924768|NCT01658878|584770983|FG017|Treatment Period|Poor/Non-compliance|0|||
161924769|NCT01658878|584770984|FG018|Treatment Period|Poor/Non-compliance|0|||
161924770|NCT01658878|584770985|FG019|Treatment Period|Poor/Non-compliance|0|||
161924771|NCT01658878|584770986|FG020|Treatment Period|Poor/Non-compliance|0|||
161924772|NCT01658878|584770987|FG021|Treatment Period|Poor/Non-compliance|0|||
161924773|NCT01658878|584770988|FG022|Treatment Period|Poor/Non-compliance|0|||
161924774|NCT01658878|584770989|FG023|Treatment Period|Poor/Non-compliance|0|||
161924775|NCT01658878|584770966|FG000|Treatment Period|Participant Withdrew Consent|0|||
161924776|NCT01658878|584770967|FG001|Treatment Period|Participant Withdrew Consent|0|||
161924777|NCT01658878|584770968|FG002|Treatment Period|Participant Withdrew Consent|0|||
161924778|NCT01658878|584770969|FG003|Treatment Period|Participant Withdrew Consent|0|||
161924779|NCT01658878|584770970|FG004|Treatment Period|Participant Withdrew Consent|0|||
161924780|NCT01658878|584770971|FG005|Treatment Period|Participant Withdrew Consent|0|||
162185813|NCT01767467|585731926|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
162185814|NCT01767467|585731925|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
162185815|NCT01767467|585731926|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
162185816|NCT01767467|585731925|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
161673150|NCT04313153|583857893|FG001|Overall Study|Lost to Follow-up|0|||
161673151|NCT04313153|583857894|FG002|Overall Study|Lost to Follow-up|2|||
161673152|NCT04313153|583857892|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
161673153|NCT04313153|583857893|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
161924781|NCT01658878|584770972|FG006|Treatment Period|Participant Withdrew Consent|0|||
161924782|NCT01658878|584770973|FG007|Treatment Period|Participant Withdrew Consent|0|||
162185817|NCT01767467|585731926|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
161673154|NCT04313153|583857894|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
161924783|NCT01658878|584770974|FG008|Treatment Period|Participant Withdrew Consent|0|||
161924784|NCT01658878|584770975|FG009|Treatment Period|Participant Withdrew Consent|0|||
161924785|NCT01658878|584770976|FG010|Treatment Period|Participant Withdrew Consent|0|||
161924786|NCT01658878|584770977|FG011|Treatment Period|Participant Withdrew Consent|0|||
161924787|NCT01658878|584770978|FG012|Treatment Period|Participant Withdrew Consent|1|||
162185818|NCT01767467|585731925|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
162185819|NCT01767467|585731926|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
162185820|NCT01767467|585731925|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
162185821|NCT01767467|585731926|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
162185822|NCT01767467|585731925|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
162185823|NCT01767467|585731926|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
162185824|NCT01767467|585731925|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
162185825|NCT01767467|585731926|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
162185826|NCT01767467|585731925|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
162185827|NCT01767467|585731926|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
162185828|NCT02203799|585731933|FG000|Overall Study|Withdrawal by Subject|3|||
162185829|NCT01065779|585731938|FG000|Overall Study|Duplicate Investigation|1|||
162019289|NCT00139477|585124914|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
162185830|NCT01065779|585731938|FG000|Overall Study|Investigation Before Contract Date|37|||
162185831|NCT01065779|585731938|FG000|Overall Study|Non-enrollment Period Administration|10|||
162185832|NCT01065779|585731938|FG000|Overall Study|Not Administered With Study Drug|17|||
162185833|NCT01065779|585731938|FG000|Overall Study|Failed to Follow-up|10|||
162185834|NCT01065779|585731938|FG000|Overall Study|Inclusion Criteria Violation|7|||
162185835|NCT01683409|585731939|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
162185836|NCT01683409|585731940|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
162185837|NCT01683409|585731941|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
162185838|NCT01683409|585731942|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
162185839|NCT01683409|585731943|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
162185840|NCT01683409|585731939|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
162185841|NCT01683409|585731940|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
162185842|NCT01683409|585731941|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
162185843|NCT01683409|585731942|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
162185844|NCT01683409|585731943|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
162185845|NCT01683409|585731939|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
162185846|NCT01683409|585731940|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
162185847|NCT01683409|585731941|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
162185848|NCT01683409|585731942|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
162185849|NCT01683409|585731943|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
162185850|NCT01683409|585731939|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
162185851|NCT01683409|585731940|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
162185852|NCT01683409|585731941|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
162185853|NCT01683409|585731942|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
162185854|NCT01683409|585731943|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
162185855|NCT01683409|585731939|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
162185856|NCT01683409|585731940|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
162185857|NCT01683409|585731941|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
162185858|NCT01683409|585731942|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
161924788|NCT01658878|584770979|FG013|Treatment Period|Participant Withdrew Consent|0|||
161924789|NCT01658878|584770980|FG014|Treatment Period|Participant Withdrew Consent|2|||
161924790|NCT01658878|584770981|FG015|Treatment Period|Participant Withdrew Consent|0|||
161924791|NCT01658878|584770982|FG016|Treatment Period|Participant Withdrew Consent|0|||
161924792|NCT01658878|584770983|FG017|Treatment Period|Participant Withdrew Consent|2|||
161924793|NCT01658878|584770984|FG018|Treatment Period|Participant Withdrew Consent|1|||
162019290|NCT03776812|585124915|FG000|Overall Study|Death|53|||
162185859|NCT01683409|585731943|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
162185860|NCT01683409|585731939|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
162185861|NCT01683409|585731940|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
161924794|NCT01658878|584770985|FG019|Treatment Period|Participant Withdrew Consent|2|||
162019291|NCT03776812|585124916|FG001|Overall Study|Death|49|||
162019292|NCT03776812|585124917|FG002|Overall Study|Death|56|||
161924795|NCT01658878|584770986|FG020|Treatment Period|Participant Withdrew Consent|1|||
161924796|NCT01658878|584770987|FG021|Treatment Period|Participant Withdrew Consent|0|||
161924797|NCT01658878|584770988|FG022|Treatment Period|Participant Withdrew Consent|2|||
161924798|NCT01658878|584770989|FG023|Treatment Period|Participant Withdrew Consent|2|||
161924799|NCT01658878|584770966|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924800|NCT01658878|584770967|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924801|NCT01658878|584770968|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924802|NCT01658878|584770969|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924803|NCT01658878|584770970|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924804|NCT01658878|584770971|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924805|NCT01658878|584770972|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924806|NCT01658878|584770973|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924807|NCT01658878|584770974|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924808|NCT01658878|584770975|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
162185862|NCT01683409|585731941|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
162185863|NCT01683409|585731942|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
162185864|NCT01683409|585731943|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
162185865|NCT01683409|585731939|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
162185866|NCT01683409|585731940|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
162185867|NCT01683409|585731941|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
162185868|NCT01683409|585731942|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
162185869|NCT01683409|585731943|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
162185870|NCT01683409|585731939|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
162185871|NCT01683409|585731940|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
162185872|NCT01683409|585731941|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
162185873|NCT01683409|585731942|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
162185874|NCT01683409|585731943|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
162185875|NCT01683409|585731939|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
162185876|NCT01683409|585731940|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
162185877|NCT01683409|585731941|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
161924809|NCT01658878|584770976|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924810|NCT01658878|584770977|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
162185878|NCT01683409|585731942|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
162185879|NCT01683409|585731943|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
162185880|NCT01683409|585731939|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
162185881|NCT01683409|585731940|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
162185882|NCT01683409|585731941|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
162185883|NCT01683409|585731942|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
162185884|NCT01683409|585731943|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
162185885|NCT01683409|585731939|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
162185886|NCT01683409|585731940|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
162185887|NCT01683409|585731941|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
162185888|NCT01683409|585731942|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
162185889|NCT01683409|585731943|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
162185890|NCT00553332|585731944|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
162185891|NCT04745676|585731954|FG000|Overall Study|Death|1|||
162185892|NCT04745676|585731955|FG001|Overall Study|Death|0|||
162185893|NCT04745676|585731956|FG002|Overall Study|Death|0|||
162185894|NCT03102034|585731959|FG000|Overall Study|Withdrawal by Subject|1|||
162185895|NCT03102034|585731960|FG001|Overall Study|Withdrawal by Subject|0|||
162185896|NCT00145470|585731961|FG000|Overall Study|Adverse Event|19|||
162185897|NCT00145470|585731962|FG001|Overall Study|Adverse Event|25|||
162185898|NCT00145470|585731961|FG000|Overall Study|Lack of Efficacy|27|||
162185899|NCT00145470|585731962|FG001|Overall Study|Lack of Efficacy|13|||
162185900|NCT00145470|585731961|FG000|Overall Study|Withdrawal by Subject|36|||
161924811|NCT01658878|584770978|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
161924812|NCT01658878|584770979|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
161924813|NCT01658878|584770980|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
161924814|NCT01658878|584770981|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
161924815|NCT01658878|584770982|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
162185901|NCT00145470|585731962|FG001|Overall Study|Withdrawal by Subject|34|||
162185902|NCT00145470|585731961|FG000|Overall Study|Lost to Follow-up|21|||
162185903|NCT00145470|585731962|FG001|Overall Study|Lost to Follow-up|17|||
162185904|NCT00145470|585731961|FG000|Overall Study|Reason Not Reported|9|||
162185905|NCT00145470|585731962|FG001|Overall Study|Reason Not Reported|9|||
162185906|NCT00676091|585731964|FG000|Infant Series|Parent or legal guardian request|10|||
162185907|NCT00676091|585731965|FG001|Infant Series|Parent or legal guardian request|8|||
162185908|NCT00676091|585731964|FG000|Infant Series|Protocol Violation|6|||
162185909|NCT00676091|585731965|FG001|Infant Series|Protocol Violation|3|||
162185910|NCT00676091|585731964|FG000|Infant Series|Adverse Event|2|||
162185911|NCT00676091|585731965|FG001|Infant Series|Adverse Event|3|||
162185912|NCT00676091|585731964|FG000|Infant Series|Failed to return|1|||
162185913|NCT00676091|585731965|FG001|Infant Series|Failed to return|3|||
162185914|NCT00676091|585731964|FG000|Infant Series|Lost to Follow-up|1|||
162185915|NCT00676091|585731965|FG001|Infant Series|Lost to Follow-up|0|||
162185916|NCT00676091|585731964|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
162185917|NCT00676091|585731965|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
162185918|NCT00676091|585731964|FG000|After Infant Series|Adverse Event|0|||
162185919|NCT00676091|585731965|FG001|After Infant Series|Adverse Event|1|||
162185920|NCT00676091|585731964|FG000|After Infant Series|Protocol Violation|0|||
162185921|NCT00676091|585731965|FG001|After Infant Series|Protocol Violation|1|||
162185922|NCT00676091|585731964|FG000|After Infant Series|Failed to return|1|||
162185923|NCT00676091|585731965|FG001|After Infant Series|Failed to return|1|||
162185924|NCT00676091|585731964|FG000|Toddler Dose|Failed to return|2|||
162185925|NCT00676091|585731965|FG001|Toddler Dose|Failed to return|0|||
162185926|NCT00676091|585731964|FG000|Toddler Dose|Parent or legal guardian request|1|||
162185927|NCT00676091|585731965|FG001|Toddler Dose|Parent or legal guardian request|0|||
162185928|NCT02063659|585731971|FG000|Double-Blind Treatment Period|Adverse Event|1|||
162185929|NCT02063659|585731972|FG001|Double-Blind Treatment Period|Adverse Event|2|||
162185930|NCT02063659|585731973|FG002|Double-Blind Treatment Period|Adverse Event|0|||
162185931|NCT02063659|585731974|FG003|Double-Blind Treatment Period|Adverse Event|0|||
162185932|NCT02063659|585731971|FG000|Double-Blind Treatment Period|Physician Decision|1|||
162185933|NCT02063659|585731972|FG001|Double-Blind Treatment Period|Physician Decision|0|||
162185934|NCT02063659|585731973|FG002|Double-Blind Treatment Period|Physician Decision|0|||
162185935|NCT02063659|585731974|FG003|Double-Blind Treatment Period|Physician Decision|0|||
162185936|NCT02063659|585731971|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
162185937|NCT02063659|585731972|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
162185938|NCT02063659|585731973|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
162185939|NCT02063659|585731974|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
162185940|NCT02063659|585731971|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
162185941|NCT02063659|585731972|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
162185942|NCT02063659|585731973|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
162185943|NCT02063659|585731974|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
162185944|NCT02063659|585731971|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
162185945|NCT02063659|585731972|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
162185946|NCT02063659|585731973|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
162185947|NCT02063659|585731974|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
162185948|NCT02063659|585731971|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
162185949|NCT02063659|585731972|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
162185950|NCT02063659|585731973|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
162185951|NCT02063659|585731974|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
162185952|NCT02063659|585731971|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
162185953|NCT02063659|585731972|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
162185954|NCT02063659|585731973|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
162185955|NCT02063659|585731974|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
162185956|NCT02063659|585731971|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
162185957|NCT02063659|585731972|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
162185958|NCT02063659|585731973|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
162185959|NCT02063659|585731974|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
161818821|NCT02554877|584378124|FG000|Overall Study|Other|1|||
161818822|NCT02554877|584378125|FG001|Overall Study|Other|3|||
161818823|NCT02554877|584378126|FG002|Overall Study|Other|0|||
161818824|NCT02554877|584378127|FG003|Overall Study|Other|3|||
161818825|NCT02554877|584378124|FG000|Overall Study|Insufficient clinical response|4|||
161818826|NCT02554877|584378125|FG001|Overall Study|Insufficient clinical response|0|||
161818827|NCT02554877|584378126|FG002|Overall Study|Insufficient clinical response|0|||
161818828|NCT02554877|584378127|FG003|Overall Study|Insufficient clinical response|0|||
161818829|NCT02554877|584378124|FG000|Overall Study|No longer willing to participate|0|||
161818830|NCT02554877|584378125|FG001|Overall Study|No longer willing to participate|2|||
162185960|NCT00989196|585731975|FG000|Treatment Period|Lost to Follow-up|1|||
162185961|NCT00989196|585731976|FG001|Treatment Period|Lost to Follow-up|0|||
162185962|NCT04762277|585731979|FG000|Overall Study|Withdrawal by Subject|0|||
162185963|NCT04762277|585731980|FG001|Overall Study|Withdrawal by Subject|2|||
162185964|NCT04762277|585731979|FG000|Overall Study|Protocol Violation|0|||
162185965|NCT04762277|585731980|FG001|Overall Study|Protocol Violation|1|||
161818831|NCT02554877|584378126|FG002|Overall Study|No longer willing to participate|2|||
162185966|NCT04762277|585731979|FG000|Overall Study|Adverse Event|1|||
162185967|NCT04762277|585731980|FG001|Overall Study|Adverse Event|0|||
162185968|NCT02556918|585733378|FG000|Overall Study|Protocol Violation|5|||
162185969|NCT02556918|585733379|FG001|Overall Study|Protocol Violation|6|||
162185970|NCT02556918|585733378|FG000|Overall Study|Withdrawal by Subject|4|||
162185971|NCT02556918|585733379|FG001|Overall Study|Withdrawal by Subject|4|||
162185972|NCT04511702|585733389|FG000|Overall Study|Lost to Follow-up|3|||
162185973|NCT04511702|585733390|FG001|Overall Study|Lost to Follow-up|0|||
162185974|NCT04511702|585733391|FG002|Overall Study|Lost to Follow-up|4|||
162185975|NCT04511702|585733389|FG000|Overall Study|Withdrawal by Subject|17|||
161924816|NCT01658878|584770983|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
162185976|NCT04511702|585733390|FG001|Overall Study|Withdrawal by Subject|1|||
162185977|NCT04511702|585733391|FG002|Overall Study|Withdrawal by Subject|8|||
162185978|NCT05349721|585733392|FG000|Part A (24 Weeks)|Adverse Event|9|||
162185979|NCT05349721|585733393|FG001|Part A (24 Weeks)|Adverse Event|2|||
162185980|NCT05349721|585733392|FG000|Part A (24 Weeks)|Death|8|||
162185981|NCT05349721|585733393|FG001|Part A (24 Weeks)|Death|3|||
162185982|NCT05349721|585733392|FG000|Part A (24 Weeks)|Disease Progression|1|||
162185983|NCT05349721|585733393|FG001|Part A (24 Weeks)|Disease Progression|1|||
162185984|NCT05349721|585733392|FG000|Part A (24 Weeks)|Screen Failure|2|||
161818832|NCT02554877|584378127|FG003|Overall Study|No longer willing to participate|0|||
161818833|NCT01537887|584378128|FG000|Period 1|Physician Decision|0|||
161818834|NCT01537887|584378129|FG001|Period 1|Physician Decision|0|||
161818835|NCT01537887|584378130|FG002|Period 1|Physician Decision|0|||
161924817|NCT01658878|584770984|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924818|NCT01658878|584770985|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
162019293|NCT03776812|585124915|FG000|Overall Study|Withdrawal by Subject|1|||
162019294|NCT03776812|585124916|FG001|Overall Study|Withdrawal by Subject|7|||
162019295|NCT03776812|585124917|FG002|Overall Study|Withdrawal by Subject|2|||
162019296|NCT03776812|585124915|FG000|Overall Study|Lost to Follow-up|1|||
162019297|NCT03776812|585124916|FG001|Overall Study|Lost to Follow-up|1|||
162019298|NCT03776812|585124917|FG002|Overall Study|Lost to Follow-up|0|||
162019299|NCT03776812|585124915|FG000|Overall Study|Did not enter long-term follow-up|3|||
162019300|NCT03776812|585124916|FG001|Overall Study|Did not enter long-term follow-up|3|||
162019301|NCT03776812|585124917|FG002|Overall Study|Did not enter long-term follow-up|2|||
162019302|NCT04476797|585124922|FG000|Overall Study|Withdrawal by Subject|1|||
162019303|NCT04476797|585124923|FG001|Overall Study|Withdrawal by Subject|0|||
162019304|NCT04476797|585124924|FG002|Overall Study|Withdrawal by Subject|0|||
162019305|NCT04476797|585124922|FG000|Overall Study|Death|0|||
162019306|NCT04476797|585124923|FG001|Overall Study|Death|1|||
161924819|NCT01658878|584770986|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
161924820|NCT01658878|584770987|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
161924821|NCT01658878|584770988|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
161924822|NCT01658878|584770989|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
161924823|NCT01658878|584770966|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
161924824|NCT01658878|584770967|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
161924825|NCT01658878|584770968|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
161924826|NCT01658878|584770969|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
161924827|NCT01658878|584770970|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
161924828|NCT01658878|584770971|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
161924829|NCT01658878|584770972|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
161924830|NCT01658878|584770973|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
161924831|NCT01658878|584770974|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
161924832|NCT01658878|584770975|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
161924833|NCT01658878|584770976|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
161924834|NCT01658878|584770977|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
161924835|NCT01658878|584770978|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
162019307|NCT04476797|585124924|FG002|Overall Study|Death|2|||
162185985|NCT05349721|585733393|FG001|Part A (24 Weeks)|Screen Failure|0|||
161818836|NCT01537887|584378131|FG003|Period 1|Physician Decision|0|||
161818837|NCT01537887|584378132|FG004|Period 1|Physician Decision|1|||
162019308|NCT04476797|585124922|FG000|Overall Study|Sponsor Terminated Study|0|||
162019309|NCT04476797|585124923|FG001|Overall Study|Sponsor Terminated Study|18|||
162019310|NCT04476797|585124924|FG002|Overall Study|Sponsor Terminated Study|17|||
162019311|NCT02395081|585124925|FG000|Overall Study|Withdrawal by Subject|1|||
162185986|NCT05349721|585733392|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
162185987|NCT05349721|585733393|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
161818838|NCT01537887|584378133|FG005|Period 1|Physician Decision|1|||
161818839|NCT01537887|584378128|FG000|Period 1|Did not receive treatment|0|||
161818840|NCT01537887|584378129|FG001|Period 1|Did not receive treatment|0|||
161818841|NCT01537887|584378130|FG002|Period 1|Did not receive treatment|1|||
162019312|NCT02395081|585124926|FG001|Overall Study|Withdrawal by Subject|1|||
162185988|NCT05349721|585733392|FG000|Part A (24 Weeks)|Other Than Specified|5|||
162185989|NCT05349721|585733393|FG001|Part A (24 Weeks)|Other Than Specified|1|||
162019313|NCT02395081|585124927|FG002|Overall Study|Withdrawal by Subject|0|||
162019314|NCT02395081|585124925|FG000|Overall Study|Moved where blood couldn't be collected|4|||
162019315|NCT02395081|585124926|FG001|Overall Study|Moved where blood couldn't be collected|1|||
162019316|NCT02395081|585124927|FG002|Overall Study|Moved where blood couldn't be collected|3|||
162019317|NCT02395081|585124925|FG000|Overall Study|Fetal Loss|2|||
162019318|NCT02395081|585124926|FG001|Overall Study|Fetal Loss|3|||
162019319|NCT02395081|585124927|FG002|Overall Study|Fetal Loss|1|||
162019320|NCT02442804|585124929|FG000|Overall Study|Withdrawal by Subject|0|||
162019321|NCT02442804|585124930|FG001|Overall Study|Withdrawal by Subject|1|||
162019322|NCT02442804|585124929|FG000|Overall Study|Adverse Event|1|||
162019323|NCT02442804|585124930|FG001|Overall Study|Adverse Event|0|||
162019324|NCT02527421|585124934|FG000|Overall Study|Withdrawal by Subject|1|||
162019325|NCT02527421|585124935|FG001|Overall Study|Withdrawal by Subject|0|||
162019326|NCT04200352|585124936|FG000|Overall Study|Death|1|||
162019327|NCT04200352|585124936|FG000|Overall Study|Adverse Event|6|||
162019328|NCT04200352|585124936|FG000|Overall Study|Withdrawal by parent/guardian|6|||
162019329|NCT04200352|585124936|FG000|Overall Study|Lack of Efficacy|1|||
162019330|NCT04200352|585124936|FG000|Overall Study|Other than specified|6|||
162019331|NCT02541604|585124937|FG000|Overall Study|Death|6|||
162019332|NCT02541604|585124938|FG001|Overall Study|Death|5|||
162019333|NCT02541604|585124939|FG002|Overall Study|Death|7|||
162019334|NCT02541604|585124940|FG003|Overall Study|Death|2|||
162019335|NCT02541604|585124941|FG004|Overall Study|Death|9|||
162019336|NCT02541604|585124942|FG005|Overall Study|Death|8|||
162019337|NCT02541604|585124943|FG006|Overall Study|Death|9|||
162019338|NCT02541604|585124944|FG007|Overall Study|Death|9|||
162019339|NCT02541604|585124945|FG008|Overall Study|Death|3|||
162019340|NCT02541604|585124946|FG009|Overall Study|Death|4|||
162019341|NCT02541604|585124947|FG010|Overall Study|Death|2|||
162019342|NCT02541604|585124948|FG011|Overall Study|Death|3|||
162019343|NCT02541604|585124937|FG000|Overall Study|Lost to Follow-up|2|||
162019344|NCT02541604|585124938|FG001|Overall Study|Lost to Follow-up|0|||
162019345|NCT02541604|585124939|FG002|Overall Study|Lost to Follow-up|1|||
162019346|NCT02541604|585124940|FG003|Overall Study|Lost to Follow-up|0|||
162019347|NCT02541604|585124941|FG004|Overall Study|Lost to Follow-up|0|||
162019348|NCT02541604|585124942|FG005|Overall Study|Lost to Follow-up|1|||
162019349|NCT02541604|585124943|FG006|Overall Study|Lost to Follow-up|1|||
162019350|NCT02541604|585124944|FG007|Overall Study|Lost to Follow-up|0|||
162019351|NCT02541604|585124945|FG008|Overall Study|Lost to Follow-up|0|||
162019352|NCT02541604|585124946|FG009|Overall Study|Lost to Follow-up|0|||
162019353|NCT02541604|585124947|FG010|Overall Study|Lost to Follow-up|0|||
162019354|NCT02541604|585124948|FG011|Overall Study|Lost to Follow-up|0|||
162019355|NCT02541604|585124937|FG000|Overall Study|Withdrawal by Subject|2|||
162019356|NCT02541604|585124938|FG001|Overall Study|Withdrawal by Subject|0|||
162019357|NCT02541604|585124939|FG002|Overall Study|Withdrawal by Subject|1|||
162019358|NCT02541604|585124940|FG003|Overall Study|Withdrawal by Subject|0|||
162019359|NCT02541604|585124941|FG004|Overall Study|Withdrawal by Subject|1|||
162019360|NCT02541604|585124942|FG005|Overall Study|Withdrawal by Subject|1|||
162019361|NCT02541604|585124943|FG006|Overall Study|Withdrawal by Subject|0|||
162019362|NCT02541604|585124944|FG007|Overall Study|Withdrawal by Subject|0|||
162019363|NCT02541604|585124945|FG008|Overall Study|Withdrawal by Subject|1|||
162019364|NCT02541604|585124946|FG009|Overall Study|Withdrawal by Subject|0|||
162019365|NCT02541604|585124947|FG010|Overall Study|Withdrawal by Subject|0|||
162019366|NCT02541604|585124948|FG011|Overall Study|Withdrawal by Subject|0|||
162019367|NCT02541604|585124937|FG000|Overall Study|Study Terminated by Sponsor|1|||
162019368|NCT02541604|585124938|FG001|Overall Study|Study Terminated by Sponsor|4|||
162019369|NCT02541604|585124939|FG002|Overall Study|Study Terminated by Sponsor|2|||
162019370|NCT02541604|585124940|FG003|Overall Study|Study Terminated by Sponsor|1|||
162019371|NCT02541604|585124941|FG004|Overall Study|Study Terminated by Sponsor|0|||
162019372|NCT02541604|585124942|FG005|Overall Study|Study Terminated by Sponsor|0|||
162019373|NCT02541604|585124943|FG006|Overall Study|Study Terminated by Sponsor|0|||
162019374|NCT02541604|585124944|FG007|Overall Study|Study Terminated by Sponsor|0|||
162019375|NCT02541604|585124945|FG008|Overall Study|Study Terminated by Sponsor|0|||
162019376|NCT02541604|585124946|FG009|Overall Study|Study Terminated by Sponsor|0|||
162019377|NCT02541604|585124947|FG010|Overall Study|Study Terminated by Sponsor|0|||
162019378|NCT02541604|585124948|FG011|Overall Study|Study Terminated by Sponsor|0|||
162019379|NCT02541604|585124937|FG000|Overall Study|Medical condition may jeopardize safety|0|||
162019380|NCT02541604|585124938|FG001|Overall Study|Medical condition may jeopardize safety|0|||
162019381|NCT02541604|585124939|FG002|Overall Study|Medical condition may jeopardize safety|0|||
162019382|NCT02541604|585124940|FG003|Overall Study|Medical condition may jeopardize safety|0|||
162019383|NCT02541604|585124941|FG004|Overall Study|Medical condition may jeopardize safety|0|||
162019384|NCT02541604|585124942|FG005|Overall Study|Medical condition may jeopardize safety|0|||
162019385|NCT02541604|585124943|FG006|Overall Study|Medical condition may jeopardize safety|0|||
162019386|NCT02541604|585124944|FG007|Overall Study|Medical condition may jeopardize safety|1|||
162019387|NCT02541604|585124945|FG008|Overall Study|Medical condition may jeopardize safety|0|||
162019388|NCT02541604|585124946|FG009|Overall Study|Medical condition may jeopardize safety|0|||
161924836|NCT01658878|584770979|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
161924837|NCT01658878|584770980|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
161924838|NCT01658878|584770981|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
161924839|NCT01658878|584770982|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
161924840|NCT01658878|584770983|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
161924841|NCT01658878|584770984|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
161924842|NCT01658878|584770985|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
161924843|NCT01658878|584770986|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
161924844|NCT01658878|584770987|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
161924845|NCT01658878|584770988|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
161924846|NCT01658878|584770989|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
161924847|NCT01658878|584770966|FG000|Treatment Period|Death|0|||
161924848|NCT01658878|584770967|FG001|Treatment Period|Death|0|||
161924849|NCT01658878|584770968|FG002|Treatment Period|Death|0|||
161924850|NCT01658878|584770969|FG003|Treatment Period|Death|0|||
161924851|NCT01658878|584770970|FG004|Treatment Period|Death|0|||
161924852|NCT01658878|584770971|FG005|Treatment Period|Death|0|||
161924853|NCT01658878|584770972|FG006|Treatment Period|Death|0|||
161924854|NCT01658878|584770973|FG007|Treatment Period|Death|0|||
161924855|NCT01658878|584770974|FG008|Treatment Period|Death|0|||
161924856|NCT01658878|584770975|FG009|Treatment Period|Death|0|||
161924857|NCT01658878|584770976|FG010|Treatment Period|Death|0|||
161924858|NCT01658878|584770977|FG011|Treatment Period|Death|0|||
161924859|NCT01658878|584770978|FG012|Treatment Period|Death|1|||
161924860|NCT01658878|584770979|FG013|Treatment Period|Death|0|||
161924861|NCT01658878|584770980|FG014|Treatment Period|Death|0|||
161924862|NCT01658878|584770981|FG015|Treatment Period|Death|0|||
161924863|NCT01658878|584770982|FG016|Treatment Period|Death|1|||
161924864|NCT01658878|584770983|FG017|Treatment Period|Death|1|||
161924865|NCT01658878|584770984|FG018|Treatment Period|Death|0|||
161924866|NCT01658878|584770985|FG019|Treatment Period|Death|0|||
161924867|NCT01658878|584770986|FG020|Treatment Period|Death|0|||
161924868|NCT01658878|584770987|FG021|Treatment Period|Death|2|||
161924869|NCT01658878|584770988|FG022|Treatment Period|Death|0|||
161924870|NCT01658878|584770989|FG023|Treatment Period|Death|0|||
161924871|NCT01658878|584770966|FG000|Treatment Period|Adverse Event|0|||
161924872|NCT01658878|584770967|FG001|Treatment Period|Adverse Event|0|||
161924873|NCT01658878|584770968|FG002|Treatment Period|Adverse Event|0|||
161924874|NCT01658878|584770969|FG003|Treatment Period|Adverse Event|0|||
161924875|NCT01658878|584770970|FG004|Treatment Period|Adverse Event|0|||
161924876|NCT01658878|584770971|FG005|Treatment Period|Adverse Event|0|||
161924877|NCT01658878|584770972|FG006|Treatment Period|Adverse Event|0|||
161924878|NCT01658878|584770973|FG007|Treatment Period|Adverse Event|0|||
161924879|NCT01658878|584770974|FG008|Treatment Period|Adverse Event|0|||
161924880|NCT01658878|584770975|FG009|Treatment Period|Adverse Event|0|||
161924881|NCT01658878|584770976|FG010|Treatment Period|Adverse Event|0|||
161924882|NCT01658878|584770977|FG011|Treatment Period|Adverse Event|0|||
161924883|NCT01658878|584770978|FG012|Treatment Period|Adverse Event|0|||
161924884|NCT01658878|584770979|FG013|Treatment Period|Adverse Event|0|||
161924885|NCT01658878|584770980|FG014|Treatment Period|Adverse Event|0|||
161924886|NCT01658878|584770981|FG015|Treatment Period|Adverse Event|0|||
161924887|NCT01658878|584770982|FG016|Treatment Period|Adverse Event|10|||
161924888|NCT01658878|584770983|FG017|Treatment Period|Adverse Event|3|||
161924889|NCT01658878|584770984|FG018|Treatment Period|Adverse Event|3|||
161924890|NCT01658878|584770985|FG019|Treatment Period|Adverse Event|2|||
161924891|NCT01658878|584770986|FG020|Treatment Period|Adverse Event|3|||
161924892|NCT01658878|584770987|FG021|Treatment Period|Adverse Event|3|||
161924893|NCT01658878|584770988|FG022|Treatment Period|Adverse Event|4|||
161924894|NCT01658878|584770989|FG023|Treatment Period|Adverse Event|3|||
161924895|NCT01658878|584770966|FG000|Treatment Period|Lost to Follow-up|0|||
161924896|NCT01658878|584770967|FG001|Treatment Period|Lost to Follow-up|0|||
161924897|NCT01658878|584770968|FG002|Treatment Period|Lost to Follow-up|0|||
161924898|NCT01658878|584770969|FG003|Treatment Period|Lost to Follow-up|0|||
161924899|NCT01658878|584770970|FG004|Treatment Period|Lost to Follow-up|0|||
161924900|NCT01658878|584770971|FG005|Treatment Period|Lost to Follow-up|0|||
161924901|NCT01658878|584770972|FG006|Treatment Period|Lost to Follow-up|0|||
161924902|NCT01658878|584770973|FG007|Treatment Period|Lost to Follow-up|0|||
161924903|NCT01658878|584770974|FG008|Treatment Period|Lost to Follow-up|0|||
161924904|NCT01658878|584770975|FG009|Treatment Period|Lost to Follow-up|0|||
161924905|NCT01658878|584770976|FG010|Treatment Period|Lost to Follow-up|0|||
161924906|NCT01658878|584770977|FG011|Treatment Period|Lost to Follow-up|0|||
162019389|NCT02541604|585124947|FG010|Overall Study|Medical condition may jeopardize safety|0|||
161924907|NCT01658878|584770978|FG012|Treatment Period|Lost to Follow-up|0|||
161924908|NCT01658878|584770979|FG013|Treatment Period|Lost to Follow-up|0|||
161924909|NCT01658878|584770980|FG014|Treatment Period|Lost to Follow-up|0|||
161924910|NCT01658878|584770981|FG015|Treatment Period|Lost to Follow-up|0|||
161924911|NCT01658878|584770982|FG016|Treatment Period|Lost to Follow-up|1|||
161924912|NCT01658878|584770983|FG017|Treatment Period|Lost to Follow-up|0|||
162019390|NCT02541604|585124948|FG011|Overall Study|Medical condition may jeopardize safety|0|||
161924913|NCT01658878|584770984|FG018|Treatment Period|Lost to Follow-up|1|||
161924914|NCT01658878|584770985|FG019|Treatment Period|Lost to Follow-up|1|||
161924915|NCT01658878|584770986|FG020|Treatment Period|Lost to Follow-up|0|||
161924916|NCT01658878|584770987|FG021|Treatment Period|Lost to Follow-up|0|||
161924917|NCT01658878|584770988|FG022|Treatment Period|Lost to Follow-up|1|||
161924918|NCT01658878|584770989|FG023|Treatment Period|Lost to Follow-up|0|||
161924919|NCT03600350|584770990|FG000|Overall Study|Death|1|||
161924920|NCT03600350|584770990|FG000|Overall Study|On Follow Up|18|||
161924921|NCT02400736|584770993|FG000|Overall Study|Lost to Follow-up|6|||
161924922|NCT02400736|584770994|FG001|Overall Study|Lost to Follow-up|6|||
161924923|NCT02400736|584770993|FG000|Overall Study|Withdrawal by Subject|2|||
161924924|NCT02400736|584770994|FG001|Overall Study|Withdrawal by Subject|1|||
161924925|NCT02400736|584770993|FG000|Overall Study|Moved from the area|3|||
161924926|NCT02400736|584770994|FG001|Overall Study|Moved from the area|1|||
161924927|NCT00327171|584770995|FG000|Overall Study|Did not receive study medication|3|||
161924928|NCT00327171|584770996|FG001|Overall Study|Did not receive study medication|0|||
161924929|NCT00327171|584770995|FG000|Overall Study|Adverse Event|23|||
161924930|NCT00327171|584770996|FG001|Overall Study|Adverse Event|23|||
161924931|NCT00327171|584770995|FG000|Overall Study|Disease progression/lack of efficacy|68|||
161924932|NCT00327171|584770996|FG001|Overall Study|Disease progression/lack of efficacy|69|||
161924933|NCT00327171|584770995|FG000|Overall Study|Investigator/participant request|1|||
161924934|NCT00327171|584770996|FG001|Overall Study|Investigator/participant request|8|||
161924935|NCT00327171|584770995|FG000|Overall Study|Clinical progression|12|||
161924936|NCT00327171|584770996|FG001|Overall Study|Clinical progression|8|||
161924937|NCT00327171|584770995|FG000|Overall Study|Undisclosed history of ischemia|0|||
161924938|NCT00327171|584770996|FG001|Overall Study|Undisclosed history of ischemia|1|||
161924939|NCT00327171|584770995|FG000|Overall Study|Other|1|||
161924940|NCT00327171|584770996|FG001|Overall Study|Other|0|||
161924941|NCT01363440|584770997|FG000|Overall Study|Adverse Event|5|||
161924942|NCT01363440|584770998|FG001|Overall Study|Adverse Event|4|||
161924943|NCT01363440|584770999|FG002|Overall Study|Adverse Event|4|||
161924944|NCT01363440|584770997|FG000|Overall Study|Death|3|||
161924945|NCT01363440|584770998|FG001|Overall Study|Death|7|||
161924946|NCT01363440|584770999|FG002|Overall Study|Death|5|||
161924947|NCT01363440|584770997|FG000|Overall Study|Withdrawal by Subject|9|||
161924948|NCT01363440|584770998|FG001|Overall Study|Withdrawal by Subject|11|||
161924949|NCT01363440|584770999|FG002|Overall Study|Withdrawal by Subject|11|||
161924950|NCT01363440|584770997|FG000|Overall Study|Lost to Follow-up|2|||
161924951|NCT01363440|584770998|FG001|Overall Study|Lost to Follow-up|4|||
161924952|NCT01363440|584770999|FG002|Overall Study|Lost to Follow-up|5|||
161924953|NCT01363440|584770997|FG000|Overall Study|Other|4|||
161924954|NCT01363440|584770998|FG001|Overall Study|Other|5|||
161924955|NCT01363440|584770999|FG002|Overall Study|Other|2|||
161924956|NCT01771913|584771000|FG000|Overall Study|Withdrawal by Subject|1|||
161924957|NCT01771913|584771001|FG001|Overall Study|Withdrawal by Subject|0|||
161924958|NCT00992836|584771002|FG000|Overall Study|Lost to Follow-up|1|||
161924959|NCT00992836|584771002|FG000|Overall Study|Withdrawal by Subject|2|||
161924960|NCT00992836|584771002|FG000|Overall Study|Protocol Violation|2|||
161924961|NCT03695094|584771003|FG000|Overall Study|Adverse Event|1|||
161924962|NCT03695094|584771004|FG001|Overall Study|Adverse Event|1|||
161924963|NCT03695094|584771003|FG000|Overall Study|Withdrawal by Subject|1|||
161924964|NCT03695094|584771004|FG001|Overall Study|Withdrawal by Subject|0|||
161924965|NCT01471574|584771009|FG000|Treatment Period|Lack of Efficacy|12|||
161924966|NCT01471574|584771010|FG001|Treatment Period|Lack of Efficacy|4|||
161924967|NCT01471574|584771011|FG002|Treatment Period|Lack of Efficacy|14|||
161924968|NCT01471574|584771012|FG003|Treatment Period|Lack of Efficacy|1|||
161924969|NCT01471574|584771009|FG000|Treatment Period|Adverse Event|7|||
161924970|NCT01471574|584771010|FG001|Treatment Period|Adverse Event|3|||
161924971|NCT01471574|584771011|FG002|Treatment Period|Adverse Event|6|||
161924972|NCT01471574|584771012|FG003|Treatment Period|Adverse Event|1|||
161924973|NCT01471574|584771009|FG000|Treatment Period|Withdrawal by Subject|5|||
162185990|NCT05349721|585733392|FG000|Part B (28 Weeks)|Adverse Event|3|||
161683059|NCT02554019|583891223|FG002|Overall Study|Withdrawal by Subject|2|||
161924974|NCT01471574|584771010|FG001|Treatment Period|Withdrawal by Subject|1|||
161924975|NCT01471574|584771011|FG002|Treatment Period|Withdrawal by Subject|1|||
161924976|NCT01471574|584771012|FG003|Treatment Period|Withdrawal by Subject|0|||
161924977|NCT01471574|584771009|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
161924978|NCT01471574|584771010|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
161924979|NCT01471574|584771011|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
161924980|NCT01471574|584771012|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
162019391|NCT00993148|585124949|FG000|Overall Study|Lost to Follow-up|2|||
161924981|NCT01471574|584771009|FG000|Treatment Period|Lost to Follow-up|1|||
161924982|NCT01471574|584771010|FG001|Treatment Period|Lost to Follow-up|2|||
161924983|NCT01471574|584771011|FG002|Treatment Period|Lost to Follow-up|2|||
161924984|NCT01471574|584771012|FG003|Treatment Period|Lost to Follow-up|0|||
161924985|NCT01471574|584771009|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
162019392|NCT00993148|585124949|FG000|Overall Study|never initiated treatment|1|||
161924986|NCT01471574|584771010|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
162185991|NCT05349721|585733393|FG001|Part B (28 Weeks)|Adverse Event|0|||
162185992|NCT05349721|585733392|FG000|Part B (28 Weeks)|Death|21|||
162185993|NCT05349721|585733393|FG001|Part B (28 Weeks)|Death|11|||
162185994|NCT05349721|585733392|FG000|Part B (28 Weeks)|Disease Progression|2|||
162185995|NCT05349721|585733393|FG001|Part B (28 Weeks)|Disease Progression|1|||
162185996|NCT05349721|585733392|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
162185997|NCT05349721|585733393|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
162185998|NCT05349721|585733392|FG000|Part B (28 Weeks)|Physician Decision|1|||
162185999|NCT05349721|585733393|FG001|Part B (28 Weeks)|Physician Decision|0|||
162186000|NCT05349721|585733392|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
162186001|NCT05349721|585733393|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
162186002|NCT05349721|585733392|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
162186003|NCT05349721|585733393|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
162186004|NCT05349721|585733392|FG000|Part B (28 Weeks)|Other Than Specified|4|||
162186005|NCT05349721|585733393|FG001|Part B (28 Weeks)|Other Than Specified|2|||
162186006|NCT05349721|585733392|FG000|Part C (108 Weeks)|Death|0|||
162186007|NCT05349721|585733393|FG001|Part C (108 Weeks)|Death|1|||
162186008|NCT05349721|585733392|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
162186009|NCT05349721|585733393|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
162186010|NCT05349721|585733392|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
162186011|NCT05349721|585733393|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
162186012|NCT05349721|585733392|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
162186013|NCT05349721|585733393|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
162186014|NCT00799409|585733396|FG000|Overall Study|Withdrawal by Subject|1|||
162186015|NCT00799409|585733397|FG001|Overall Study|Withdrawal by Subject|0|||
162186016|NCT00799409|585733398|FG002|Overall Study|Withdrawal by Subject|0|||
162186017|NCT00799409|585733396|FG000|Overall Study|Lost to Follow-up|1|||
162186018|NCT00799409|585733397|FG001|Overall Study|Lost to Follow-up|0|||
162186019|NCT00799409|585733398|FG002|Overall Study|Lost to Follow-up|0|||
162186020|NCT00799409|585733396|FG000|Overall Study|Optimal Dose Not Achieved|2|||
162186021|NCT00799409|585733397|FG001|Overall Study|Optimal Dose Not Achieved|0|||
162186022|NCT00799409|585733398|FG002|Overall Study|Optimal Dose Not Achieved|0|||
162186023|NCT00799409|585733396|FG000|Overall Study|Failure to follow study protocol)|1|||
162186024|NCT00799409|585733397|FG001|Overall Study|Failure to follow study protocol)|0|||
162186025|NCT00799409|585733398|FG002|Overall Study|Failure to follow study protocol)|0|||
162186026|NCT00799409|585733396|FG000|Overall Study|Did not attend lab school day 1|1|||
162186027|NCT00799409|585733397|FG001|Overall Study|Did not attend lab school day 1|0|||
162186028|NCT00799409|585733398|FG002|Overall Study|Did not attend lab school day 1|0|||
162186029|NCT00799409|585733396|FG000|Overall Study|medication compliance|1|||
161924987|NCT01471574|584771011|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
161924988|NCT01471574|584771012|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
161924989|NCT01471574|584771009|FG000|Treatment Period|Other|1|||
161924990|NCT01471574|584771010|FG001|Treatment Period|Other|0|||
161924991|NCT01471574|584771011|FG002|Treatment Period|Other|0|||
161924992|NCT01471574|584771012|FG003|Treatment Period|Other|0|||
161924993|NCT01471574|584771009|FG000|Follow-up Period|Withdrawal by Subject|3|||
161924994|NCT01471574|584771010|FG001|Follow-up Period|Withdrawal by Subject|0|||
161924995|NCT01471574|584771011|FG002|Follow-up Period|Withdrawal by Subject|3|||
161924996|NCT01471574|584771012|FG003|Follow-up Period|Withdrawal by Subject|1|||
161924997|NCT01471574|584771009|FG000|Follow-up Period|Lost to Follow-up|4|||
161924998|NCT01471574|584771010|FG001|Follow-up Period|Lost to Follow-up|1|||
161924999|NCT01471574|584771011|FG002|Follow-up Period|Lost to Follow-up|3|||
161925000|NCT01471574|584771012|FG003|Follow-up Period|Lost to Follow-up|2|||
161925001|NCT01471574|584771009|FG000|Follow-up Period|Death|0|||
161925002|NCT01471574|584771010|FG001|Follow-up Period|Death|0|||
161925003|NCT01471574|584771011|FG002|Follow-up Period|Death|1|||
161925004|NCT01471574|584771012|FG003|Follow-up Period|Death|0|||
161925005|NCT01471574|584771009|FG000|Follow-up Period|Follow-up no longer required|0|||
161925006|NCT01471574|584771010|FG001|Follow-up Period|Follow-up no longer required|1|||
161925007|NCT01471574|584771011|FG002|Follow-up Period|Follow-up no longer required|0|||
161925008|NCT01471574|584771012|FG003|Follow-up Period|Follow-up no longer required|0|||
161925009|NCT01795937|584771013|FG000|Overall Study|Withdrawal by Subject|1|||
162186030|NCT00799409|585733397|FG001|Overall Study|medication compliance|0|||
161925010|NCT01795937|584771014|FG001|Overall Study|Withdrawal by Subject|0|||
162186031|NCT00799409|585733398|FG002|Overall Study|medication compliance|0|||
162186032|NCT04323800|585733399|FG000|Overall Study|Withdrawal by Subject|4|||
162186033|NCT04323800|585733400|FG001|Overall Study|Withdrawal by Subject|4|||
162186034|NCT04323800|585733399|FG000|Overall Study|Incomplete transfusion|1|||
161925011|NCT01795937|584771015|FG002|Overall Study|Withdrawal by Subject|0|||
161925012|NCT01795937|584771013|FG000|Overall Study|Physician Decision|0|||
162186035|NCT04323800|585733400|FG001|Overall Study|Incomplete transfusion|0|||
162186036|NCT04323800|585733399|FG000|Overall Study|Other|0|||
162186037|NCT04323800|585733400|FG001|Overall Study|Other|1|||
162186038|NCT04323800|585733399|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
162186039|NCT04323800|585733400|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
161925013|NCT01795937|584771014|FG001|Overall Study|Physician Decision|1|||
161925014|NCT01795937|584771015|FG002|Overall Study|Physician Decision|0|||
161925015|NCT01177410|584771016|FG000|Overall Study|Adverse Event|0|||
161925016|NCT01177410|584771017|FG001|Overall Study|Adverse Event|2|||
161925017|NCT01177410|584771018|FG002|Overall Study|Adverse Event|2|||
161925018|NCT01177410|584771016|FG000|Overall Study|Withdrawal by Subject|1|||
161925019|NCT01177410|584771017|FG001|Overall Study|Withdrawal by Subject|4|||
161925020|NCT01177410|584771018|FG002|Overall Study|Withdrawal by Subject|3|||
161925021|NCT01177410|584771016|FG000|Overall Study|Lost to Follow-up|0|||
161925022|NCT01177410|584771017|FG001|Overall Study|Lost to Follow-up|1|||
161925023|NCT01177410|584771018|FG002|Overall Study|Lost to Follow-up|0|||
161925024|NCT02965716|584771020|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
161925025|NCT02965716|584771021|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
161925026|NCT02965716|584771020|FG000|Overall Study|Progression/Relapse|8|||
161925027|NCT02965716|584771021|FG001|Overall Study|Progression/Relapse|16|||
161925028|NCT02965716|584771020|FG000|Overall Study|Death|1|||
161925029|NCT02965716|584771021|FG001|Overall Study|Death|0|||
161925030|NCT02965716|584771020|FG000|Overall Study|Not Protocol Specified|1|||
161925031|NCT02965716|584771021|FG001|Overall Study|Not Protocol Specified|3|||
161925032|NCT02691663|584771026|FG000|Overall Study|Screen failure after baseline|2|||
161925033|NCT02691663|584771027|FG001|Overall Study|Screen failure after baseline|2|||
161925034|NCT02691663|584771026|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
161925035|NCT02691663|584771027|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
161925036|NCT02691663|584771026|FG000|Overall Study|Withdrawn after Follow up 2|1|||
161925037|NCT02691663|584771027|FG001|Overall Study|Withdrawn after Follow up 2|1|||
161925038|NCT02691663|584771026|FG000|Overall Study|Lost to Follow-up|3|||
161925039|NCT02691663|584771027|FG001|Overall Study|Lost to Follow-up|2|||
161925040|NCT00303628|584771028|FG000|Overall Study|Disease progression|0|||
161925041|NCT00303628|584771029|FG001|Overall Study|Disease progression|1|||
161925042|NCT00303628|584771028|FG000|Overall Study|Adverse Event|26|||
162019393|NCT00806819|585124950|FG000|Overall Study|progressive disease (modified RECIST )|217|||
162186040|NCT00489554|585733401|FG000|Overall Study|Adverse Event|2|||
162186041|NCT00489554|585733401|FG000|Overall Study|Withdrawal by Subject|1|||
162186042|NCT00489554|585733401|FG000|Overall Study|Lost to Follow-up|1|||
162186043|NCT01732757|585733402|FG000|Overall Study|Lost to Follow-up|1|||
162186044|NCT01732757|585733403|FG001|Overall Study|Lost to Follow-up|0|||
162186045|NCT01732757|585733404|FG002|Overall Study|Lost to Follow-up|0|||
162186046|NCT00731692|585733405|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
162186047|NCT00731692|585733406|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
162186048|NCT00731692|585733407|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
162186049|NCT00731692|585733405|FG000|Core Study (36 Months)|Physician Decision|1|||
162186050|NCT00731692|585733406|FG001|Core Study (36 Months)|Physician Decision|0|||
162186051|NCT00731692|585733407|FG002|Core Study (36 Months)|Physician Decision|2|||
162186052|NCT00731692|585733405|FG000|Core Study (36 Months)|Death|2|||
162186053|NCT00731692|585733406|FG001|Core Study (36 Months)|Death|1|||
162186054|NCT00731692|585733407|FG002|Core Study (36 Months)|Death|2|||
162186055|NCT00731692|585733405|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
162186056|NCT00731692|585733406|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
162186057|NCT00731692|585733407|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
161925043|NCT00303628|584771029|FG001|Overall Study|Adverse Event|36|||
161925044|NCT00303628|584771028|FG000|Overall Study|Death|0|||
161925045|NCT00303628|584771029|FG001|Overall Study|Death|1|||
161925046|NCT00303628|584771028|FG000|Overall Study|Withdrawal by Subject|11|||
161925047|NCT00303628|584771029|FG001|Overall Study|Withdrawal by Subject|20|||
161925048|NCT00303628|584771028|FG000|Overall Study|Alternative therapy|2|||
161925049|NCT00303628|584771029|FG001|Overall Study|Alternative therapy|0|||
161925050|NCT00303628|584771028|FG000|Overall Study|Other complicating disease|0|||
161925051|NCT00303628|584771029|FG001|Overall Study|Other complicating disease|1|||
161925052|NCT00303628|584771028|FG000|Overall Study|Not start protocol therapy|3|||
161925053|NCT00303628|584771029|FG001|Overall Study|Not start protocol therapy|5|||
161925054|NCT00303628|584771028|FG000|Overall Study|Other|8|||
161925055|NCT00303628|584771029|FG001|Overall Study|Other|9|||
161925056|NCT02942407|584771030|FG000|Overall Study|Lost to Follow-up|3|||
161925057|NCT02942407|584771031|FG001|Overall Study|Lost to Follow-up|2|||
161925058|NCT02942407|584771030|FG000|Overall Study|Withdrawal by Subject|7|||
161925059|NCT02942407|584771031|FG001|Overall Study|Withdrawal by Subject|9|||
161925060|NCT02942407|584771030|FG000|Overall Study|Death|16|||
161925061|NCT02942407|584771031|FG001|Overall Study|Death|13|||
162186058|NCT00731692|585733405|FG000|Core Study (36 Months)|Administrative|2|||
162186059|NCT00731692|585733406|FG001|Core Study (36 Months)|Administrative|2|||
162186060|NCT00731692|585733407|FG002|Core Study (36 Months)|Administrative|6|||
161925062|NCT05887908|584771032|FG000|Overall Study|Adverse Event|6|||
161925063|NCT05887908|584771033|FG001|Overall Study|Adverse Event|1|||
161925064|NCT05887908|584771034|FG002|Overall Study|Adverse Event|1|||
161925065|NCT05887908|584771032|FG000|Overall Study|Physician Decision|4|||
161925066|NCT05887908|584771033|FG001|Overall Study|Physician Decision|1|||
161925067|NCT05887908|584771034|FG002|Overall Study|Physician Decision|0|||
161925068|NCT05887908|584771032|FG000|Overall Study|Withdrawal by Subject|3|||
162186061|NCT00731692|585733405|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
162186062|NCT00731692|585733406|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
162186063|NCT00731692|585733407|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
162186064|NCT00731692|585733405|FG000|Core Study (36 Months)|Protocol Violation|4|||
162186065|NCT00731692|585733406|FG001|Core Study (36 Months)|Protocol Violation|5|||
162186066|NCT00731692|585733407|FG002|Core Study (36 Months)|Protocol Violation|8|||
162186067|NCT00731692|585733405|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
162186068|NCT00731692|585733406|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
162186069|NCT00731692|585733407|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
162186070|NCT00731692|585733405|FG000|Core Study (36 Months)|Adverse Event|25|||
162186071|NCT00731692|585733406|FG001|Core Study (36 Months)|Adverse Event|28|||
162186072|NCT00731692|585733407|FG002|Core Study (36 Months)|Adverse Event|29|||
162186073|NCT00731692|585733405|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
162186074|NCT00731692|585733406|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
162186075|NCT00731692|585733407|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
162186076|NCT00731692|585733405|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
162186077|NCT00731692|585733406|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
162186078|NCT00731692|585733407|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
162186079|NCT00731692|585733405|FG000|Extension Phase|Abnormal test procedure|0|||
162186080|NCT00731692|585733406|FG001|Extension Phase|Abnormal test procedure|0|||
162186081|NCT00731692|585733407|FG002|Extension Phase|Abnormal test procedure|1|||
162186082|NCT00731692|585733405|FG000|Extension Phase|Abnormal lab values|0|||
162186083|NCT00731692|585733406|FG001|Extension Phase|Abnormal lab values|0|||
162186084|NCT00731692|585733407|FG002|Extension Phase|Abnormal lab values|1|||
162186085|NCT00731692|585733405|FG000|Extension Phase|Lost to Follow-up|0|||
162186086|NCT00731692|585733406|FG001|Extension Phase|Lost to Follow-up|1|||
162186087|NCT00731692|585733407|FG002|Extension Phase|Lost to Follow-up|4|||
162186088|NCT00731692|585733405|FG000|Extension Phase|Withdrawal by Subject|4|||
162186089|NCT00731692|585733406|FG001|Extension Phase|Withdrawal by Subject|5|||
162186090|NCT00731692|585733407|FG002|Extension Phase|Withdrawal by Subject|3|||
162186091|NCT00731692|585733405|FG000|Extension Phase|Adverse Event|1|||
162186092|NCT00731692|585733406|FG001|Extension Phase|Adverse Event|1|||
162186093|NCT00731692|585733407|FG002|Extension Phase|Adverse Event|15|||
162186094|NCT02372799|585733408|FG000|Treatment Period|Adverse Event|3|||
162186095|NCT02372799|585733409|FG001|Treatment Period|Adverse Event|10|||
162186096|NCT02372799|585733410|FG002|Treatment Period|Adverse Event|6|||
162186097|NCT02372799|585733408|FG000|Treatment Period|Insufficient therapeutic response|2|||
162186098|NCT02372799|585733409|FG001|Treatment Period|Insufficient therapeutic response|2|||
161818842|NCT01537887|584378131|FG003|Period 1|Did not receive treatment|0|||
161818843|NCT01537887|584378132|FG004|Period 1|Did not receive treatment|0|||
162186099|NCT02372799|585733410|FG002|Treatment Period|Insufficient therapeutic response|0|||
162186100|NCT02372799|585733408|FG000|Treatment Period|Withdrawal by Subject|10|||
162186101|NCT02372799|585733409|FG001|Treatment Period|Withdrawal by Subject|10|||
162186102|NCT02372799|585733410|FG002|Treatment Period|Withdrawal by Subject|2|||
162186103|NCT02372799|585733408|FG000|Treatment Period|Lost to Follow-up|11|||
162186104|NCT02372799|585733409|FG001|Treatment Period|Lost to Follow-up|5|||
162186105|NCT02372799|585733410|FG002|Treatment Period|Lost to Follow-up|3|||
162186106|NCT02372799|585733408|FG000|Treatment Period|Protocol Violation|3|||
162186107|NCT02372799|585733409|FG001|Treatment Period|Protocol Violation|0|||
162186108|NCT02372799|585733410|FG002|Treatment Period|Protocol Violation|0|||
162186109|NCT02372799|585733408|FG000|Treatment Period|Non-compliance with study drug|4|||
162186110|NCT02372799|585733409|FG001|Treatment Period|Non-compliance with study drug|4|||
162186111|NCT02372799|585733410|FG002|Treatment Period|Non-compliance with study drug|4|||
162186112|NCT02372799|585733408|FG000|Treatment Period|Miscellaneous Reasons|1|||
162186113|NCT02372799|585733409|FG001|Treatment Period|Miscellaneous Reasons|1|||
162186114|NCT02372799|585733410|FG002|Treatment Period|Miscellaneous Reasons|0|||
162186115|NCT02372799|585733408|FG000|Down-taper Period|Lost to Follow-up|1|||
162186116|NCT02372799|585733409|FG001|Down-taper Period|Lost to Follow-up|2|||
161818844|NCT01537887|584378133|FG005|Period 1|Did not receive treatment|0|||
161818845|NCT01537887|584378128|FG000|Period 2|Withdrawal by Subject|0|||
161818846|NCT01537887|584378129|FG001|Period 2|Withdrawal by Subject|1|||
161818847|NCT01537887|584378130|FG002|Period 2|Withdrawal by Subject|0|||
161818848|NCT01537887|584378131|FG003|Period 2|Withdrawal by Subject|0|||
161818849|NCT01537887|584378132|FG004|Period 2|Withdrawal by Subject|0|||
162186117|NCT02372799|585733410|FG002|Down-taper Period|Lost to Follow-up|2|||
162186118|NCT00747006|585733411|FG000|Overall Study|Adverse Event|1|||
162186119|NCT00747006|585733412|FG001|Overall Study|Adverse Event|0|||
162186120|NCT00747006|585733413|FG002|Overall Study|Adverse Event|0|||
162186121|NCT00747006|585733411|FG000|Overall Study|Lost to Follow-up|0|||
162186122|NCT00747006|585733412|FG001|Overall Study|Lost to Follow-up|1|||
162186123|NCT00747006|585733413|FG002|Overall Study|Lost to Follow-up|0|||
162186124|NCT00747006|585733411|FG000|Overall Study|Physician Decision|2|||
162186125|NCT00747006|585733412|FG001|Overall Study|Physician Decision|0|||
162186126|NCT00747006|585733413|FG002|Overall Study|Physician Decision|1|||
162186127|NCT02132949|585733418|FG000|Overall Study|Death|7|||
162186128|NCT02132949|585733419|FG001|Overall Study|Death|13|||
162186129|NCT02132949|585733418|FG000|Overall Study|Lost to Follow-up|14|||
162186130|NCT02132949|585733419|FG001|Overall Study|Lost to Follow-up|4|||
162186131|NCT02132949|585733418|FG000|Overall Study|Withdrawal by Subject|6|||
162186132|NCT02132949|585733419|FG001|Overall Study|Withdrawal by Subject|5|||
162186133|NCT02132949|585733418|FG000|Overall Study|Noncompliance|5|||
162186134|NCT02132949|585733419|FG001|Overall Study|Noncompliance|1|||
162186135|NCT02132949|585733418|FG000|Overall Study|Physician Decision|3|||
162186136|NCT02132949|585733419|FG001|Overall Study|Physician Decision|1|||
162186137|NCT02132949|585733418|FG000|Overall Study|Disease Progression|3|||
162186138|NCT02132949|585733419|FG001|Overall Study|Disease Progression|0|||
162186139|NCT02132949|585733418|FG000|Overall Study|Adverse Event|2|||
162186140|NCT02132949|585733419|FG001|Overall Study|Adverse Event|1|||
162186141|NCT02132949|585733418|FG000|Overall Study|Withdrew Prior to Treatment|1|||
162186142|NCT02132949|585733419|FG001|Overall Study|Withdrew Prior to Treatment|2|||
162186143|NCT02132949|585733418|FG000|Overall Study|Reason Unspecified|0|||
162186144|NCT02132949|585733419|FG001|Overall Study|Reason Unspecified|1|||
162186145|NCT01583166|585733422|FG000|Overall Study|Withdrawal by Subject|4|||
162186146|NCT01583166|585733423|FG001|Overall Study|Withdrawal by Subject|6|||
162186147|NCT04652869|585733426|FG000|Overall Study|Withdrawal by Subject|0|||
162186148|NCT04652869|585733427|FG001|Overall Study|Withdrawal by Subject|2|||
162186149|NCT04652869|585733428|FG002|Overall Study|Withdrawal by Subject|0|||
162186150|NCT01372085|585733429|FG000|Washout Period 2|Physician Decision|0|||
162186151|NCT01372085|585733430|FG001|Washout Period 2|Physician Decision|0|||
162186152|NCT01372085|585733431|FG002|Washout Period 2|Physician Decision|0|||
162186153|NCT01372085|585733432|FG003|Washout Period 2|Physician Decision|0|||
162186154|NCT01372085|585733433|FG004|Washout Period 2|Physician Decision|1|||
162186155|NCT01372085|585733434|FG005|Washout Period 2|Physician Decision|0|||
162186156|NCT01372085|585733435|FG006|Washout Period 2|Physician Decision|0|||
162186157|NCT01372085|585733436|FG007|Washout Period 2|Physician Decision|0|||
162186158|NCT01372085|585733437|FG008|Washout Period 2|Physician Decision|0|||
162186159|NCT01372085|585733438|FG009|Washout Period 2|Physician Decision|0|||
162186160|NCT01372085|585733429|FG000|Washout Period 3|Withdrawal by Subject|0|||
162186161|NCT01372085|585733430|FG001|Washout Period 3|Withdrawal by Subject|0|||
162186162|NCT01372085|585733431|FG002|Washout Period 3|Withdrawal by Subject|0|||
161925069|NCT05887908|584771033|FG001|Overall Study|Withdrawal by Subject|2|||
161925070|NCT05887908|584771034|FG002|Overall Study|Withdrawal by Subject|3|||
161925071|NCT05887908|584771032|FG000|Overall Study|Ineligibility after the start of the study|4|||
161925072|NCT05887908|584771033|FG001|Overall Study|Ineligibility after the start of the study|1|||
161925073|NCT05887908|584771034|FG002|Overall Study|Ineligibility after the start of the study|0|||
162186163|NCT01372085|585733432|FG003|Washout Period 3|Withdrawal by Subject|0|||
162186164|NCT01372085|585733433|FG004|Washout Period 3|Withdrawal by Subject|0|||
162186165|NCT01372085|585733434|FG005|Washout Period 3|Withdrawal by Subject|2|||
162186166|NCT01372085|585733435|FG006|Washout Period 3|Withdrawal by Subject|0|||
162186167|NCT01372085|585733436|FG007|Washout Period 3|Withdrawal by Subject|0|||
162186168|NCT01372085|585733437|FG008|Washout Period 3|Withdrawal by Subject|0|||
162186169|NCT01372085|585733438|FG009|Washout Period 3|Withdrawal by Subject|0|||
162186170|NCT00562094|585733439|FG000|Overall Study|Lost to Follow-up|62|||
162186171|NCT03960645|585733440|FG000|Overall Study|Protocol Violation|1|||
162186172|NCT03960645|585733441|FG001|Overall Study|Protocol Violation|0|||
161673155|NCT04313153|583857892|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
161673156|NCT04313153|583857893|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
161818850|NCT01537887|584378133|FG005|Period 2|Withdrawal by Subject|0|||
161818851|NCT01537887|584378128|FG000|Period 3|Adverse Event|0|||
161818852|NCT01537887|584378129|FG001|Period 3|Adverse Event|0|||
161818853|NCT01537887|584378130|FG002|Period 3|Adverse Event|1|||
161818854|NCT01537887|584378131|FG003|Period 3|Adverse Event|0|||
161818855|NCT01537887|584378132|FG004|Period 3|Adverse Event|0|||
161818856|NCT01537887|584378133|FG005|Period 3|Adverse Event|0|||
161818857|NCT01537887|584378128|FG000|Period 3|Withdrawal by Subject|0|||
161818858|NCT01537887|584378129|FG001|Period 3|Withdrawal by Subject|1|||
161818859|NCT01537887|584378130|FG002|Period 3|Withdrawal by Subject|0|||
161818860|NCT01537887|584378131|FG003|Period 3|Withdrawal by Subject|0|||
161818861|NCT01537887|584378132|FG004|Period 3|Withdrawal by Subject|0|||
161818862|NCT01537887|584378133|FG005|Period 3|Withdrawal by Subject|0|||
161818863|NCT02072096|584378136|FG000|Overall Study|Lack of Efficacy|18|||
161818864|NCT02072096|584378137|FG001|Overall Study|Lack of Efficacy|29|||
161818865|NCT02072096|584378136|FG000|Overall Study|Protocol Violation|7|||
161818866|NCT02072096|584378137|FG001|Overall Study|Protocol Violation|7|||
161818867|NCT02072096|584378136|FG000|Overall Study|Withdrawal by Subject|5|||
161818868|NCT02072096|584378137|FG001|Overall Study|Withdrawal by Subject|7|||
161818869|NCT02072096|584378136|FG000|Overall Study|Adverse Event|5|||
161818870|NCT02072096|584378137|FG001|Overall Study|Adverse Event|2|||
161818871|NCT02072096|584378136|FG000|Overall Study|No Reason Provided|4|||
161818872|NCT02072096|584378137|FG001|Overall Study|No Reason Provided|2|||
161818873|NCT02072096|584378136|FG000|Overall Study|Death|2|||
161818874|NCT02072096|584378137|FG001|Overall Study|Death|0|||
161818875|NCT02072096|584378136|FG000|Overall Study|Physician Decision|0|||
161818876|NCT02072096|584378137|FG001|Overall Study|Physician Decision|1|||
161818877|NCT02072096|584378136|FG000|Overall Study|Study Terminated by Sponsor|43|||
161818878|NCT02072096|584378137|FG001|Overall Study|Study Terminated by Sponsor|30|||
161818879|NCT02072096|584378136|FG000|Overall Study|Lost to Follow-up|1|||
161818880|NCT02072096|584378137|FG001|Overall Study|Lost to Follow-up|0|||
161818881|NCT02336074|584378144|FG000|Overall Study|Adverse Event|0|||
161818882|NCT02336074|584378145|FG001|Overall Study|Adverse Event|2|||
161818883|NCT05604014|584378165|FG000|Overall Study|Lost to Follow-up|13|||
161818884|NCT01266902|584378167|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
161818885|NCT01266902|584378168|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
161818886|NCT01266902|584378169|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
161818887|NCT01266902|584378167|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
161818888|NCT01266902|584378168|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
161818889|NCT01266902|584378169|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
161818890|NCT01266902|584378167|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
161818891|NCT01266902|584378168|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
161818892|NCT01266902|584378169|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
161818893|NCT01266902|584378167|FG000|Period 1 (Main Study)|Adverse Event|3|||
161818894|NCT01266902|584378168|FG001|Period 1 (Main Study)|Adverse Event|11|||
161818895|NCT01266902|584378169|FG002|Period 1 (Main Study)|Adverse Event|0|||
161818896|NCT01266902|584378167|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
161818897|NCT01266902|584378168|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
161818898|NCT01266902|584378169|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
161818899|NCT01266902|584378167|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
161818900|NCT01266902|584378168|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
161818901|NCT01266902|584378169|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
161818902|NCT01266902|584378167|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
161818903|NCT01266902|584378168|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
161818904|NCT01266902|584378169|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
161818905|NCT01266902|584378167|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
161818906|NCT01266902|584378168|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
161818907|NCT01266902|584378169|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
161818908|NCT01266902|584378167|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
161818909|NCT01266902|584378168|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
161818910|NCT01266902|584378169|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
161818911|NCT01266902|584378167|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
161818912|NCT01266902|584378168|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
161818913|NCT01266902|584378169|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
161818914|NCT02121184|584378170|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
161818915|NCT02121184|584378171|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
161818916|NCT02121184|584378170|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
161818917|NCT02121184|584378171|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
161818918|NCT02121184|584378170|FG000|Overall Study|Emergency cesarean section required|0|||
161818919|NCT02121184|584378171|FG001|Overall Study|Emergency cesarean section required|2|||
162019394|NCT00806819|585124951|FG001|Overall Study|progressive disease (modified RECIST )|216|||
162019395|NCT00806819|585124950|FG000|Overall Study|Worsening or AE of underlying disease|18|||
162019396|NCT00806819|585124951|FG001|Overall Study|Worsening or AE of underlying disease|25|||
162186173|NCT03732807|585733446|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
162186174|NCT03732807|585733447|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
162186175|NCT03732807|585733448|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
162186176|NCT03732807|585733449|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
162186177|NCT03732807|585733450|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
162186178|NCT03732807|585733451|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
162186179|NCT03732807|585733452|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
162186180|NCT03732807|585733446|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
162186181|NCT03732807|585733447|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
162186182|NCT03732807|585733448|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
162186183|NCT03732807|585733449|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
162186184|NCT03732807|585733450|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
162186185|NCT03732807|585733451|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
162186186|NCT03732807|585733452|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
162186187|NCT03732807|585733446|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
162186188|NCT03732807|585733447|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
162186189|NCT03732807|585733448|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
162186190|NCT03732807|585733449|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
162186191|NCT03732807|585733450|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
162186192|NCT03732807|585733451|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
162186193|NCT03732807|585733452|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
162186194|NCT03732807|585733446|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
162186195|NCT03732807|585733447|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
162186196|NCT03732807|585733448|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
162186197|NCT03732807|585733449|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
162186198|NCT03732807|585733450|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
162186199|NCT03732807|585733451|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
162186200|NCT03732807|585733452|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
162186201|NCT03732807|585733446|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
162186202|NCT03732807|585733447|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
162186203|NCT03732807|585733448|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
162186204|NCT03732807|585733449|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
162186205|NCT03732807|585733450|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
162186206|NCT03732807|585733451|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
162186207|NCT03732807|585733452|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
162186208|NCT03732807|585733446|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
162186209|NCT03732807|585733447|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
162186210|NCT03732807|585733448|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
162186211|NCT03732807|585733449|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
161818920|NCT02121184|584378170|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
161818921|NCT02121184|584378171|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
162019397|NCT00806819|585124950|FG000|Overall Study|Other AE|38|||
162019398|NCT00806819|585124951|FG001|Overall Study|Other AE|40|||
162019399|NCT00806819|585124950|FG000|Overall Study|Protocol Violation|9|||
162186212|NCT03732807|585733450|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
162186213|NCT03732807|585733451|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
162186214|NCT03732807|585733452|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
162186215|NCT03732807|585733446|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162186216|NCT03732807|585733447|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162186217|NCT03732807|585733448|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162186218|NCT03732807|585733449|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161818922|NCT04567329|584378174|FG000|Overall Study|Withdrawal by Subject|5|||
161818923|NCT04567329|584378175|FG001|Overall Study|Withdrawal by Subject|6|||
161818924|NCT04567329|584378174|FG000|Overall Study|Protocol Violation|2|||
161818925|NCT04567329|584378175|FG001|Overall Study|Protocol Violation|3|||
161818926|NCT04567329|584378174|FG000|Overall Study|Discontinued|2|||
161818927|NCT04567329|584378175|FG001|Overall Study|Discontinued|2|||
161818928|NCT04567329|584378174|FG000|Overall Study|Lost to Follow-up|0|||
161818929|NCT04567329|584378175|FG001|Overall Study|Lost to Follow-up|1|||
161818930|NCT04567329|584378174|FG000|Overall Study|Lack of Efficacy|0|||
161818931|NCT04567329|584378175|FG001|Overall Study|Lack of Efficacy|1|||
161818932|NCT02933060|584378176|FG000|Overall Study|Withdrawal by Subject|0|||
161818933|NCT02933060|584378177|FG001|Overall Study|Withdrawal by Subject|1|||
161818934|NCT01945580|584378178|FG000|Overall Study|Withdrawal by Subject|13|||
161818935|NCT01945580|584378179|FG001|Overall Study|Withdrawal by Subject|35|||
162019400|NCT00806819|585124951|FG001|Overall Study|Protocol Violation|4|||
162186219|NCT03732807|585733450|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162186220|NCT03732807|585733451|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
162186221|NCT03732807|585733452|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162186222|NCT03732807|585733446|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
162186223|NCT03732807|585733447|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
162186224|NCT03732807|585733448|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
162186225|NCT03732807|585733449|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
162186226|NCT03732807|585733450|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
162186227|NCT03732807|585733451|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
162186228|NCT03732807|585733452|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
162186229|NCT03732807|585733446|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
162186230|NCT03732807|585733447|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
162186231|NCT03732807|585733448|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
162186232|NCT03732807|585733449|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
162186233|NCT03732807|585733450|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
162186234|NCT03732807|585733451|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
162186235|NCT03732807|585733452|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
162186236|NCT03732807|585733446|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
162186237|NCT03732807|585733447|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
162186238|NCT03732807|585733448|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
162186239|NCT03732807|585733449|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
162186240|NCT03732807|585733450|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
162186241|NCT03732807|585733451|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
162186242|NCT03732807|585733452|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
162186243|NCT03732807|585733446|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
162186244|NCT03732807|585733447|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
162186245|NCT03732807|585733448|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
162186246|NCT03732807|585733449|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
162186247|NCT03732807|585733450|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
162186248|NCT03732807|585733451|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
162186249|NCT03732807|585733452|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
162186250|NCT03732807|585733446|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
162186251|NCT03732807|585733447|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
162186252|NCT03732807|585733448|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
162186253|NCT03732807|585733449|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
162186254|NCT03732807|585733450|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
162186255|NCT03732807|585733451|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
162186256|NCT03732807|585733452|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
162186257|NCT03732807|585733446|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
162186258|NCT03732807|585733447|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
162186259|NCT03732807|585733448|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
162186260|NCT03732807|585733449|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
162186261|NCT03732807|585733450|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
162186262|NCT03732807|585733451|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
162186263|NCT03732807|585733452|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
162186264|NCT03732807|585733446|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
162186265|NCT03732807|585733447|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
162186266|NCT03732807|585733448|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
162186267|NCT03732807|585733449|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
161925074|NCT05887908|584771032|FG000|Overall Study|Subject non-compliance|4|||
162186268|NCT03732807|585733450|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
162186269|NCT03732807|585733451|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
162186270|NCT03732807|585733452|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
162186271|NCT03345979|585733453|FG000|Overall Study|Withdrawal by Subject|20|||
162186272|NCT03345979|585733454|FG001|Overall Study|Withdrawal by Subject|31|||
162186273|NCT03345979|585733453|FG000|Overall Study|Adverse Event|10|||
162186274|NCT03345979|585733454|FG001|Overall Study|Adverse Event|11|||
162186275|NCT03345979|585733453|FG000|Overall Study|Lost to Follow-up|8|||
162186276|NCT03345979|585733454|FG001|Overall Study|Lost to Follow-up|9|||
162186277|NCT03345979|585733453|FG000|Overall Study|Lack of Efficacy|4|||
162186278|NCT03345979|585733454|FG001|Overall Study|Lack of Efficacy|2|||
162186279|NCT03345979|585733453|FG000|Overall Study|Protocol Violation|1|||
162186280|NCT03345979|585733454|FG001|Overall Study|Protocol Violation|3|||
162186281|NCT03345979|585733453|FG000|Overall Study|Physician Decision|0|||
162186282|NCT03345979|585733454|FG001|Overall Study|Physician Decision|2|||
162186283|NCT00734578|585733456|FG000|Overall Study|Adverse Event|4|||
161925075|NCT05887908|584771033|FG001|Overall Study|Subject non-compliance|0|||
162186284|NCT00734578|585733457|FG001|Overall Study|Adverse Event|6|||
162186285|NCT00734578|585733458|FG002|Overall Study|Adverse Event|1|||
162186286|NCT00734578|585733456|FG000|Overall Study|Protocol Violation|8|||
162186287|NCT00734578|585733457|FG001|Overall Study|Protocol Violation|6|||
162186288|NCT00734578|585733458|FG002|Overall Study|Protocol Violation|3|||
162186289|NCT00734578|585733456|FG000|Overall Study|Withdrawal by Subject|7|||
162186290|NCT00734578|585733457|FG001|Overall Study|Withdrawal by Subject|8|||
162186291|NCT00734578|585733458|FG002|Overall Study|Withdrawal by Subject|11|||
162186292|NCT00734578|585733456|FG000|Overall Study|Lost to Follow-up|9|||
162186293|NCT00734578|585733457|FG001|Overall Study|Lost to Follow-up|3|||
162186294|NCT00734578|585733458|FG002|Overall Study|Lost to Follow-up|5|||
162186295|NCT00734578|585733456|FG000|Overall Study|Lack of Efficacy|3|||
162186296|NCT00734578|585733457|FG001|Overall Study|Lack of Efficacy|2|||
162186297|NCT00734578|585733458|FG002|Overall Study|Lack of Efficacy|5|||
162186298|NCT00734578|585733456|FG000|Overall Study|Randomized in error|1|||
162186299|NCT00734578|585733457|FG001|Overall Study|Randomized in error|0|||
161925076|NCT05887908|584771034|FG002|Overall Study|Subject non-compliance|4|||
161925077|NCT05887908|584771032|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
161925078|NCT05887908|584771033|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
161925079|NCT05887908|584771034|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
162186300|NCT00734578|585733458|FG002|Overall Study|Randomized in error|0|||
162186301|NCT00734578|585733456|FG000|Overall Study|Exclusion criteria|1|||
162186302|NCT00734578|585733457|FG001|Overall Study|Exclusion criteria|0|||
162186303|NCT00734578|585733458|FG002|Overall Study|Exclusion criteria|0|||
162186304|NCT00999596|585733459|FG000|Overall Study|Statistical population not required|101|||
162186305|NCT02384382|585733460|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
162186306|NCT02384382|585733460|FG000|Overall Study|Death|1|||
162186307|NCT02384382|585733460|FG000|Overall Study|Adverse Event|1|||
162186308|NCT02384382|585733460|FG000|Overall Study|Disease progression|16|||
162186309|NCT01953692|585733461|FG000|Overall Study|Adverse Event|5|||
162186310|NCT01953692|585733462|FG001|Overall Study|Adverse Event|2|||
162186311|NCT01953692|585733463|FG002|Overall Study|Adverse Event|4|||
162186312|NCT01953692|585733464|FG003|Overall Study|Adverse Event|2|||
162186313|NCT01953692|585733465|FG004|Overall Study|Adverse Event|1|||
162186314|NCT01953692|585733466|FG005|Overall Study|Adverse Event|2|||
162186315|NCT01953692|585733467|FG006|Overall Study|Adverse Event|0|||
162186316|NCT01953692|585733468|FG007|Overall Study|Adverse Event|0|||
162186317|NCT01953692|585733469|FG008|Overall Study|Adverse Event|0|||
162186318|NCT01953692|585733461|FG000|Overall Study|Clinical Progression|0|||
162186319|NCT01953692|585733462|FG001|Overall Study|Clinical Progression|15|||
162186320|NCT01953692|585733463|FG002|Overall Study|Clinical Progression|7|||
162186321|NCT01953692|585733464|FG003|Overall Study|Clinical Progression|5|||
162186322|NCT01953692|585733465|FG004|Overall Study|Clinical Progression|0|||
162186323|NCT01953692|585733466|FG005|Overall Study|Clinical Progression|7|||
162186324|NCT01953692|585733467|FG006|Overall Study|Clinical Progression|20|||
162186325|NCT01953692|585733468|FG007|Overall Study|Clinical Progression|3|||
162186326|NCT01953692|585733469|FG008|Overall Study|Clinical Progression|3|||
162186327|NCT01953692|585733461|FG000|Overall Study|Death|5|||
162186328|NCT01953692|585733462|FG001|Overall Study|Death|0|||
162186329|NCT01953692|585733463|FG002|Overall Study|Death|2|||
162186330|NCT01953692|585733464|FG003|Overall Study|Death|2|||
162186331|NCT01953692|585733465|FG004|Overall Study|Death|1|||
162186332|NCT01953692|585733466|FG005|Overall Study|Death|3|||
162186333|NCT01953692|585733467|FG006|Overall Study|Death|6|||
162186334|NCT01953692|585733468|FG007|Overall Study|Death|2|||
162186335|NCT01953692|585733469|FG008|Overall Study|Death|1|||
162186336|NCT01953692|585733461|FG000|Overall Study|Excluded Medication|1|||
162186337|NCT01953692|585733462|FG001|Overall Study|Excluded Medication|0|||
162186338|NCT01953692|585733463|FG002|Overall Study|Excluded Medication|0|||
162186339|NCT01953692|585733464|FG003|Overall Study|Excluded Medication|0|||
162186340|NCT01953692|585733465|FG004|Overall Study|Excluded Medication|0|||
162186341|NCT01953692|585733466|FG005|Overall Study|Excluded Medication|0|||
162186342|NCT01953692|585733467|FG006|Overall Study|Excluded Medication|0|||
162186343|NCT01953692|585733468|FG007|Overall Study|Excluded Medication|0|||
162186344|NCT01953692|585733469|FG008|Overall Study|Excluded Medication|0|||
162186345|NCT01953692|585733461|FG000|Overall Study|Lost to Follow-up|1|||
162186346|NCT01953692|585733462|FG001|Overall Study|Lost to Follow-up|0|||
162186347|NCT01953692|585733463|FG002|Overall Study|Lost to Follow-up|3|||
162186348|NCT01953692|585733464|FG003|Overall Study|Lost to Follow-up|1|||
162186349|NCT01953692|585733465|FG004|Overall Study|Lost to Follow-up|0|||
162186350|NCT01953692|585733466|FG005|Overall Study|Lost to Follow-up|1|||
162186351|NCT01953692|585733467|FG006|Overall Study|Lost to Follow-up|0|||
162186352|NCT01953692|585733468|FG007|Overall Study|Lost to Follow-up|0|||
162186353|NCT01953692|585733469|FG008|Overall Study|Lost to Follow-up|0|||
162186354|NCT01953692|585733461|FG000|Overall Study|Physician Decision|11|||
162186355|NCT01953692|585733462|FG001|Overall Study|Physician Decision|4|||
162186356|NCT01953692|585733463|FG002|Overall Study|Physician Decision|2|||
162186357|NCT01953692|585733464|FG003|Overall Study|Physician Decision|2|||
162186358|NCT01953692|585733465|FG004|Overall Study|Physician Decision|1|||
162186359|NCT01953692|585733466|FG005|Overall Study|Physician Decision|2|||
162019401|NCT00806819|585124950|FG000|Overall Study|Lost to Follow-up|1|||
162019402|NCT00806819|585124951|FG001|Overall Study|Lost to Follow-up|0|||
162019403|NCT00806819|585124950|FG000|Overall Study|Withdrawal by Subject|32|||
162186360|NCT01953692|585733467|FG006|Overall Study|Physician Decision|4|||
162186361|NCT01953692|585733468|FG007|Overall Study|Physician Decision|1|||
162186362|NCT01953692|585733469|FG008|Overall Study|Physician Decision|0|||
162186363|NCT01953692|585733461|FG000|Overall Study|Protocol Violation|0|||
162186364|NCT01953692|585733462|FG001|Overall Study|Protocol Violation|2|||
162186365|NCT01953692|585733463|FG002|Overall Study|Protocol Violation|1|||
162186366|NCT01953692|585733464|FG003|Overall Study|Protocol Violation|0|||
162186367|NCT01953692|585733465|FG004|Overall Study|Protocol Violation|0|||
162186368|NCT01953692|585733466|FG005|Overall Study|Protocol Violation|0|||
162186369|NCT01953692|585733467|FG006|Overall Study|Protocol Violation|0|||
162186370|NCT01953692|585733468|FG007|Overall Study|Protocol Violation|1|||
162186371|NCT01953692|585733469|FG008|Overall Study|Protocol Violation|0|||
162186372|NCT01953692|585733461|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162186373|NCT01953692|585733462|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162186374|NCT01953692|585733463|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162186375|NCT01953692|585733464|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162186376|NCT01953692|585733465|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162186377|NCT01953692|585733466|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162186378|NCT01953692|585733467|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162186379|NCT01953692|585733468|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
162186380|NCT01953692|585733469|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
162186381|NCT01953692|585733461|FG000|Overall Study|Withdrawal by Subject|4|||
162186382|NCT01953692|585733462|FG001|Overall Study|Withdrawal by Subject|2|||
162186383|NCT01953692|585733463|FG002|Overall Study|Withdrawal by Subject|1|||
162186384|NCT01953692|585733464|FG003|Overall Study|Withdrawal by Subject|2|||
162186385|NCT01953692|585733465|FG004|Overall Study|Withdrawal by Subject|0|||
162186386|NCT01953692|585733466|FG005|Overall Study|Withdrawal by Subject|3|||
162186387|NCT01953692|585733467|FG006|Overall Study|Withdrawal by Subject|2|||
162186388|NCT01953692|585733468|FG007|Overall Study|Withdrawal by Subject|1|||
162186389|NCT01953692|585733469|FG008|Overall Study|Withdrawal by Subject|1|||
162186390|NCT01822756|585733472|FG000|Overall Study|Adverse Event|0|||
162186391|NCT01822756|585733473|FG001|Overall Study|Adverse Event|0|||
162186392|NCT01822756|585733474|FG002|Overall Study|Adverse Event|0|||
162186393|NCT01822756|585733475|FG003|Overall Study|Adverse Event|2|||
162186394|NCT01822756|585733476|FG004|Overall Study|Adverse Event|0|||
162186395|NCT01822756|585733472|FG000|Overall Study|Disease progression|11|||
162186396|NCT01822756|585733473|FG001|Overall Study|Disease progression|1|||
162186397|NCT01822756|585733474|FG002|Overall Study|Disease progression|7|||
162186398|NCT01822756|585733475|FG003|Overall Study|Disease progression|2|||
162186399|NCT01822756|585733476|FG004|Overall Study|Disease progression|6|||
162186400|NCT01822756|585733472|FG000|Overall Study|Death|2|||
162186401|NCT01822756|585733473|FG001|Overall Study|Death|2|||
162186402|NCT01822756|585733474|FG002|Overall Study|Death|1|||
162186403|NCT01822756|585733475|FG003|Overall Study|Death|0|||
162186404|NCT01822756|585733476|FG004|Overall Study|Death|0|||
162186405|NCT01822756|585733472|FG000|Overall Study|Lost to Follow-up|1|||
162186406|NCT01822756|585733473|FG001|Overall Study|Lost to Follow-up|0|||
162186407|NCT01822756|585733474|FG002|Overall Study|Lost to Follow-up|1|||
162186408|NCT01822756|585733475|FG003|Overall Study|Lost to Follow-up|0|||
162186409|NCT01822756|585733476|FG004|Overall Study|Lost to Follow-up|1|||
162186410|NCT01822756|585733472|FG000|Overall Study|Physician Decision|0|||
162186411|NCT01822756|585733473|FG001|Overall Study|Physician Decision|1|||
162186412|NCT01822756|585733474|FG002|Overall Study|Physician Decision|0|||
162186413|NCT01822756|585733475|FG003|Overall Study|Physician Decision|0|||
162186414|NCT01822756|585733476|FG004|Overall Study|Physician Decision|0|||
162186415|NCT01822756|585733472|FG000|Overall Study|disease progression & patient preference|2|||
162186416|NCT01822756|585733473|FG001|Overall Study|disease progression & patient preference|0|||
162186417|NCT01822756|585733474|FG002|Overall Study|disease progression & patient preference|1|||
162186418|NCT01822756|585733475|FG003|Overall Study|disease progression & patient preference|0|||
161673157|NCT04313153|583857894|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
161673158|NCT04313153|583857892|FG000|Overall Study|Change in Dialysis Modality|0|||
161673159|NCT04313153|583857893|FG001|Overall Study|Change in Dialysis Modality|1|||
161673160|NCT04313153|583857894|FG002|Overall Study|Change in Dialysis Modality|2|||
161673161|NCT04313153|583857892|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
161673162|NCT04313153|583857893|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
161673163|NCT04313153|583857894|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
161673164|NCT04313153|583857892|FG000|Overall Study|Other|5|||
161673165|NCT04313153|583857893|FG001|Overall Study|Other|3|||
161673166|NCT04313153|583857894|FG002|Overall Study|Other|2|||
161673167|NCT05586269|583857895|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
161673168|NCT05586269|583857896|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
161673169|NCT05586269|583857897|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
161673170|NCT05586269|583857898|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
161673171|NCT05586269|583857895|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
161673172|NCT05586269|583857896|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
161673173|NCT05586269|583857897|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
161673174|NCT05586269|583857898|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
161673175|NCT01990534|583857902|FG000|Overall Study|Death|22|||
161818936|NCT01945580|584378178|FG000|Overall Study|Physician Decision|3|||
161818937|NCT01945580|584378179|FG001|Overall Study|Physician Decision|2|||
161818938|NCT01945580|584378178|FG000|Overall Study|Lost to Follow-up|26|||
161818939|NCT01945580|584378179|FG001|Overall Study|Lost to Follow-up|39|||
161818940|NCT01945580|584378178|FG000|Overall Study|Death|7|||
161818941|NCT01945580|584378179|FG001|Overall Study|Death|2|||
161818942|NCT01945580|584378178|FG000|Overall Study|Patient moved out of state|0|||
161818943|NCT01945580|584378179|FG001|Overall Study|Patient moved out of state|1|||
161818944|NCT01945580|584378178|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
161818945|NCT01945580|584378179|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
161818946|NCT01945580|584378178|FG000|Overall Study|Family illness - unable to return|0|||
161925080|NCT05887908|584771032|FG000|Overall Study|Pregnancy|0|||
161673176|NCT01990534|583857902|FG000|Overall Study|Progressive disease|3|||
161673177|NCT01990534|583857902|FG000|Overall Study|Protocol Violation|1|||
161673178|NCT01990534|583857902|FG000|Overall Study|Withdrawal of Informed Consent|2|||
161673179|NCT01990534|583857902|FG000|Overall Study|Symptomatic Deterioration|1|||
161673180|NCT01990534|583857902|FG000|Overall Study|Withdrawal by Subject|3|||
161673181|NCT01990534|583857902|FG000|Overall Study|Reason not Specified|2|||
161673182|NCT01990534|583857902|FG000|Overall Study|Lost to Follow-up|1|||
161673183|NCT01831544|583857903|FG000|Overall Study|Death|1|||
161673184|NCT01831544|583857903|FG000|Overall Study|Still on original MVAD device|2|||
161673185|NCT03308942|583857906|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
161673186|NCT03308942|583857907|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
161673187|NCT03308942|583857908|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
161673188|NCT03308942|583857909|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
161673189|NCT03308942|583857910|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
161673190|NCT03308942|583857906|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
161673191|NCT03308942|583857907|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
161673192|NCT03308942|583857908|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
161673193|NCT03308942|583857909|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
161673194|NCT03308942|583857910|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
161673195|NCT03308942|583857906|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
161673196|NCT03308942|583857907|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
161673197|NCT03308942|583857908|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
161673198|NCT03308942|583857909|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
161673199|NCT03308942|583857910|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
161673200|NCT03308942|583857906|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
161673201|NCT03308942|583857907|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
161673202|NCT03308942|583857908|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
161673203|NCT03308942|583857909|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
161673204|NCT03308942|583857910|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
161673205|NCT03308942|583857906|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
161673206|NCT03308942|583857907|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
161673207|NCT03308942|583857908|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
161673208|NCT03308942|583857909|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
161673209|NCT03308942|583857910|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
161673210|NCT03308942|583857906|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
161673211|NCT03308942|583857907|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
161673212|NCT03308942|583857908|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
161673213|NCT03308942|583857909|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
161673214|NCT03308942|583857910|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
161673215|NCT03308942|583857906|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
161673216|NCT03308942|583857907|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
161673217|NCT03308942|583857908|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
161673218|NCT03308942|583857909|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
161673219|NCT03308942|583857910|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
161673220|NCT01131351|583857911|FG000|Overall Study|Adverse Event|0|||
161673221|NCT01131351|583857912|FG001|Overall Study|Adverse Event|2|||
161673222|NCT01131351|583857911|FG000|Overall Study|Protocol Deviation|0|||
161673223|NCT01131351|583857912|FG001|Overall Study|Protocol Deviation|1|||
161673224|NCT01284062|583857919|FG000|Overall Study|Adverse Event|4|||
161673225|NCT01284062|583857920|FG001|Overall Study|Adverse Event|5|||
161673226|NCT01284062|583857921|FG002|Overall Study|Adverse Event|0|||
161673227|NCT01284062|583857922|FG003|Overall Study|Adverse Event|5|||
161673228|NCT01284062|583857919|FG000|Overall Study|Lack of Efficacy|3|||
161673229|NCT01284062|583857920|FG001|Overall Study|Lack of Efficacy|2|||
161673230|NCT01284062|583857921|FG002|Overall Study|Lack of Efficacy|2|||
161673231|NCT01284062|583857922|FG003|Overall Study|Lack of Efficacy|1|||
161673232|NCT01284062|583857919|FG000|Overall Study|Medication error without adverse event|0|||
161673233|NCT01284062|583857920|FG001|Overall Study|Medication error without adverse event|0|||
161673234|NCT01284062|583857921|FG002|Overall Study|Medication error without adverse event|1|||
161673235|NCT01284062|583857922|FG003|Overall Study|Medication error without adverse event|0|||
161673236|NCT01284062|583857919|FG000|Overall Study|Protocol Violation|1|||
161818947|NCT01945580|584378179|FG001|Overall Study|Family illness - unable to return|1|||
161818948|NCT01945580|584378178|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
161818949|NCT01945580|584378179|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
161818950|NCT01945580|584378178|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
161818951|NCT01945580|584378179|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
161818952|NCT01945580|584378178|FG000|Overall Study|Noncompliance with 36 month visit|1|||
161673237|NCT01284062|583857920|FG001|Overall Study|Protocol Violation|0|||
161673238|NCT01284062|583857921|FG002|Overall Study|Protocol Violation|0|||
162186419|NCT01822756|585733476|FG004|Overall Study|disease progression & patient preference|0|||
162186420|NCT02157948|585733477|FG000|Overall Study|Withdrawal by Subject|4|||
162186421|NCT02157948|585733478|FG001|Overall Study|Withdrawal by Subject|5|||
162186422|NCT02157948|585733477|FG000|Overall Study|Lost to Follow-up|3|||
162186423|NCT02157948|585733478|FG001|Overall Study|Lost to Follow-up|2|||
162186424|NCT02157948|585733477|FG000|Overall Study|Protocol Specified Criteria|2|||
161818953|NCT01945580|584378179|FG001|Overall Study|Noncompliance with 36 month visit|0|||
161818954|NCT01945580|584378178|FG000|Overall Study|The patient moved.|1|||
162186425|NCT02157948|585733478|FG001|Overall Study|Protocol Specified Criteria|1|||
162186426|NCT02157948|585733477|FG000|Overall Study|Decision by Sponsor|0|||
162186427|NCT02157948|585733478|FG001|Overall Study|Decision by Sponsor|1|||
162186428|NCT00467272|585733482|FG000|Overall Study|Pneumonia|2|||
162186429|NCT00467272|585733482|FG000|Overall Study|Thrombophlebitis|1|||
162186430|NCT01701401|585733483|FG000|Overall Study|Randomized But Not Treated|3|||
162186431|NCT01701401|585733484|FG001|Overall Study|Randomized But Not Treated|1|||
162186432|NCT01701401|585733485|FG002|Overall Study|Randomized But Not Treated|0|||
162186433|NCT01701401|585733486|FG003|Overall Study|Randomized But Not Treated|1|||
162186434|NCT01701401|585733483|FG000|Overall Study|Lost to Follow-up|5|||
162186435|NCT01701401|585733484|FG001|Overall Study|Lost to Follow-up|5|||
162186436|NCT01701401|585733485|FG002|Overall Study|Lost to Follow-up|1|||
162186437|NCT01701401|585733486|FG003|Overall Study|Lost to Follow-up|3|||
162186438|NCT01701401|585733483|FG000|Overall Study|Withdrew Consent|0|||
162186439|NCT01701401|585733484|FG001|Overall Study|Withdrew Consent|3|||
162186440|NCT01701401|585733485|FG002|Overall Study|Withdrew Consent|1|||
162186441|NCT01701401|585733486|FG003|Overall Study|Withdrew Consent|2|||
162186442|NCT01701401|585733483|FG000|Overall Study|Lack of Efficacy|1|||
162186443|NCT01701401|585733484|FG001|Overall Study|Lack of Efficacy|0|||
162186444|NCT01701401|585733485|FG002|Overall Study|Lack of Efficacy|2|||
162186445|NCT01701401|585733486|FG003|Overall Study|Lack of Efficacy|0|||
162186446|NCT01701401|585733483|FG000|Overall Study|Adverse Event|1|||
162186447|NCT01701401|585733484|FG001|Overall Study|Adverse Event|0|||
162186448|NCT01701401|585733485|FG002|Overall Study|Adverse Event|0|||
162186449|NCT01701401|585733486|FG003|Overall Study|Adverse Event|0|||
162186450|NCT01701401|585733483|FG000|Overall Study|Protocol Violation|0|||
162186451|NCT01701401|585733484|FG001|Overall Study|Protocol Violation|0|||
162186452|NCT01701401|585733485|FG002|Overall Study|Protocol Violation|1|||
162186453|NCT01701401|585733486|FG003|Overall Study|Protocol Violation|0|||
162186454|NCT00914966|585733487|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
162186455|NCT00914966|585733487|FG000|Step 1: 1500 Units|Physician Decision|1|||
162186456|NCT00914966|585733487|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
162186457|NCT04827732|585733491|FG000|Overall Study|Did not start treatment|0|||
162186458|NCT04827732|585733492|FG001|Overall Study|Did not start treatment|1|||
162186459|NCT04827732|585733493|FG002|Overall Study|Did not start treatment|0|||
162186460|NCT04827732|585733494|FG003|Overall Study|Did not start treatment|1|||
162186461|NCT04577651|585733501|FG000|Overall Study|Screen Failure|7|||
162186462|NCT04577651|585733501|FG000|Overall Study|Adverse Event|1|||
162186463|NCT04577651|585733501|FG000|Overall Study|Death|1|||
162186464|NCT04577651|585733501|FG000|Overall Study|Physician Decision|1|||
162186465|NCT04577651|585733501|FG000|Overall Study|Withdrawal by Subject|3|||
162186466|NCT05293717|585733503|FG000|Overall Study|Physician Decision|1|||
162186467|NCT03147287|585733504|FG000|Overall Study|Randomized Not Treated|2|||
162186468|NCT03147287|585733505|FG001|Overall Study|Randomized Not Treated|1|||
162186469|NCT03147287|585733506|FG002|Overall Study|Randomized Not Treated|1|||
162186470|NCT03147287|585733504|FG000|Overall Study|Progressive Disease RECIST|31|||
162186471|NCT03147287|585733505|FG001|Overall Study|Progressive Disease RECIST|72|||
162186472|NCT03147287|585733506|FG002|Overall Study|Progressive Disease RECIST|32|||
162186473|NCT03147287|585733504|FG000|Overall Study|Progressive Disease not RECIST|13|||
162186474|NCT03147287|585733505|FG001|Overall Study|Progressive Disease not RECIST|21|||
162186475|NCT03147287|585733506|FG002|Overall Study|Progressive Disease not RECIST|13|||
161818955|NCT01945580|584378179|FG001|Overall Study|The patient moved.|0|||
162186476|NCT03147287|585733504|FG000|Overall Study|Physician Decision|1|||
162186477|NCT03147287|585733505|FG001|Overall Study|Physician Decision|2|||
162186478|NCT03147287|585733506|FG002|Overall Study|Physician Decision|1|||
162186479|NCT03147287|585733504|FG000|Overall Study|Intercurrent illness|0|||
162186480|NCT03147287|585733505|FG001|Overall Study|Intercurrent illness|1|||
162186481|NCT03147287|585733506|FG002|Overall Study|Intercurrent illness|0|||
162186482|NCT03147287|585733504|FG000|Overall Study|Withdrawal by Subject|2|||
162186483|NCT03147287|585733505|FG001|Overall Study|Withdrawal by Subject|3|||
162186484|NCT03147287|585733506|FG002|Overall Study|Withdrawal by Subject|2|||
162186485|NCT03147287|585733504|FG000|Overall Study|Patient Non-Compliance|0|||
162186486|NCT03147287|585733505|FG001|Overall Study|Patient Non-Compliance|2|||
162186487|NCT03147287|585733506|FG002|Overall Study|Patient Non-Compliance|0|||
162186488|NCT03147287|585733504|FG000|Overall Study|Patient moved|0|||
162186489|NCT03147287|585733505|FG001|Overall Study|Patient moved|1|||
162186490|NCT03147287|585733506|FG002|Overall Study|Patient moved|0|||
162186491|NCT03147287|585733504|FG000|Overall Study|Arm A crossover without PD|1|||
162186492|NCT03147287|585733505|FG001|Overall Study|Arm A crossover without PD|0|||
162186493|NCT03147287|585733506|FG002|Overall Study|Arm A crossover without PD|0|||
162186494|NCT03147287|585733504|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
162186495|NCT03147287|585733505|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
162186496|NCT03147287|585733506|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
162186497|NCT06571695|585735082|FG000|Overall Study|Lost to Follow-up|1|||
162186498|NCT06571695|585735083|FG001|Overall Study|Lost to Follow-up|6|||
162186499|NCT00108355|585735084|FG000|Overall Study|Peritonitis at index paracentesis|1|||
162186500|NCT00108355|585735085|FG001|Overall Study|Peritonitis at index paracentesis|1|||
162186501|NCT00108355|585735084|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
162186502|NCT00108355|585735085|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
162186503|NCT01629589|585735092|FG000|Overall Study|Protocol Violation|4|||
162186504|NCT01629589|585735093|FG001|Overall Study|Protocol Violation|2|||
162186505|NCT01629589|585735092|FG000|Overall Study|Lost to Follow-up|2|||
162186506|NCT01629589|585735093|FG001|Overall Study|Lost to Follow-up|1|||
162186507|NCT01629589|585735092|FG000|Overall Study|Withdrawal by Subject|2|||
162186508|NCT01629589|585735093|FG001|Overall Study|Withdrawal by Subject|3|||
162186509|NCT01629589|585735092|FG000|Overall Study|Did not receive study vaccine|0|||
162186510|NCT01629589|585735093|FG001|Overall Study|Did not receive study vaccine|1|||
162186511|NCT02079649|585735094|FG000|Overall Study|Lost to Follow-up|0|||
162186512|NCT02079649|585735095|FG001|Overall Study|Lost to Follow-up|0|||
162186513|NCT02079649|585735096|FG002|Overall Study|Lost to Follow-up|0|||
162186514|NCT02079649|585735097|FG003|Overall Study|Lost to Follow-up|1|||
162186515|NCT02079649|585735094|FG000|Overall Study|Withdrawal by Subject|0|||
162186516|NCT02079649|585735095|FG001|Overall Study|Withdrawal by Subject|0|||
162186517|NCT02079649|585735096|FG002|Overall Study|Withdrawal by Subject|0|||
162186518|NCT02079649|585735097|FG003|Overall Study|Withdrawal by Subject|1|||
162186519|NCT02079649|585735094|FG000|Overall Study|Randomization error (prior to treatment)|1|||
162186520|NCT02079649|585735095|FG001|Overall Study|Randomization error (prior to treatment)|0|||
162186521|NCT02079649|585735096|FG002|Overall Study|Randomization error (prior to treatment)|1|||
162186522|NCT02079649|585735097|FG003|Overall Study|Randomization error (prior to treatment)|0|||
162186523|NCT01932970|585735119|FG000|Overall Study|Withdrawal by Subject|5|||
162186524|NCT01932970|585735119|FG000|Overall Study|Death|1|||
162186525|NCT01932970|585735119|FG000|Overall Study|Lost to Follow-up|2|||
162186526|NCT01932970|585735119|FG000|Overall Study|Protocol Specified Criteria|10|||
162186527|NCT03739866|585735123|FG000|Overall Study|Lost to Follow-up|0|||
162186528|NCT03739866|585735124|FG001|Overall Study|Lost to Follow-up|0|||
162186529|NCT03739866|585735125|FG002|Overall Study|Lost to Follow-up|0|||
162186530|NCT03739866|585735126|FG003|Overall Study|Lost to Follow-up|1|||
162186531|NCT03739866|585735127|FG004|Overall Study|Lost to Follow-up|0|||
162186532|NCT03739866|585735128|FG005|Overall Study|Lost to Follow-up|0|||
162186533|NCT03739866|585735129|FG006|Overall Study|Lost to Follow-up|0|||
162186534|NCT03739866|585735130|FG007|Overall Study|Lost to Follow-up|0|||
162186535|NCT03739866|585735123|FG000|Overall Study|Enrolled but not treated|0|||
161925081|NCT05887908|584771033|FG001|Overall Study|Pregnancy|1|||
162186536|NCT03739866|585735124|FG001|Overall Study|Enrolled but not treated|0|||
162186537|NCT03739866|585735125|FG002|Overall Study|Enrolled but not treated|1|||
162186538|NCT03739866|585735126|FG003|Overall Study|Enrolled but not treated|0|||
162186539|NCT03739866|585735127|FG004|Overall Study|Enrolled but not treated|1|||
162186540|NCT03739866|585735128|FG005|Overall Study|Enrolled but not treated|0|||
162186541|NCT03739866|585735129|FG006|Overall Study|Enrolled but not treated|0|||
162186542|NCT03739866|585735130|FG007|Overall Study|Enrolled but not treated|0|||
162186543|NCT00836498|585735131|FG000|Overall Study|Adverse Event|1|||
162186544|NCT00836498|585735132|FG001|Overall Study|Adverse Event|0|||
162186545|NCT00836498|585735131|FG000|Overall Study|Lost to Follow-up|1|||
162186546|NCT00836498|585735132|FG001|Overall Study|Lost to Follow-up|0|||
162186547|NCT00836498|585735131|FG000|Overall Study|Withdrawal by Subject|2|||
162186548|NCT00836498|585735132|FG001|Overall Study|Withdrawal by Subject|1|||
161925082|NCT05887908|584771034|FG002|Overall Study|Pregnancy|0|||
161925083|NCT05887908|584771032|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
161925084|NCT05887908|584771033|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
161925085|NCT05887908|584771034|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
162186549|NCT01034306|585735133|FG000|Overall Study|Adverse Event|1|||
162186550|NCT01034306|585735134|FG001|Overall Study|Adverse Event|0|||
162186551|NCT01034306|585735133|FG000|Overall Study|Lost to Follow-up|0|||
162186552|NCT01034306|585735134|FG001|Overall Study|Lost to Follow-up|1|||
162186553|NCT01034306|585735133|FG000|Overall Study|Withdrawal by Subject|2|||
162186554|NCT01034306|585735134|FG001|Overall Study|Withdrawal by Subject|2|||
162186555|NCT01034306|585735133|FG000|Overall Study|hospitalized and decided to stop|1|||
162186556|NCT01034306|585735134|FG001|Overall Study|hospitalized and decided to stop|0|||
162186557|NCT01034306|585735133|FG000|Overall Study|Noncomplience|1|||
162186558|NCT01034306|585735134|FG001|Overall Study|Noncomplience|0|||
162186559|NCT03057600|585735135|FG000|Overall Study|Adverse Event|0|||
162186560|NCT03057600|585735136|FG001|Overall Study|Adverse Event|0|||
162186561|NCT03057600|585735137|FG002|Overall Study|Adverse Event|4|||
162186562|NCT03057600|585735138|FG003|Overall Study|Adverse Event|0|||
162186563|NCT03057600|585735135|FG000|Overall Study|Radiologic Disease Progression|8|||
162186564|NCT03057600|585735136|FG001|Overall Study|Radiologic Disease Progression|7|||
162186565|NCT03057600|585735137|FG002|Overall Study|Radiologic Disease Progression|13|||
162186566|NCT03057600|585735138|FG003|Overall Study|Radiologic Disease Progression|10|||
162186567|NCT03057600|585735135|FG000|Overall Study|Symptomatic Deterioration|0|||
162186568|NCT03057600|585735136|FG001|Overall Study|Symptomatic Deterioration|1|||
162186569|NCT03057600|585735137|FG002|Overall Study|Symptomatic Deterioration|1|||
162186570|NCT03057600|585735138|FG003|Overall Study|Symptomatic Deterioration|0|||
162186571|NCT03057600|585735135|FG000|Overall Study|Investigator Decision|0|||
162186572|NCT03057600|585735136|FG001|Overall Study|Investigator Decision|0|||
162186573|NCT03057600|585735137|FG002|Overall Study|Investigator Decision|1|||
162186574|NCT03057600|585735138|FG003|Overall Study|Investigator Decision|0|||
162186575|NCT03057600|585735135|FG000|Overall Study|Study Termination by Sponsor|0|||
162186576|NCT03057600|585735136|FG001|Overall Study|Study Termination by Sponsor|0|||
162186577|NCT03057600|585735137|FG002|Overall Study|Study Termination by Sponsor|0|||
162186578|NCT03057600|585735138|FG003|Overall Study|Study Termination by Sponsor|2|||
162186579|NCT03057600|585735135|FG000|Overall Study|Withdrawal by Subject|0|||
162186580|NCT03057600|585735136|FG001|Overall Study|Withdrawal by Subject|1|||
162186581|NCT03057600|585735137|FG002|Overall Study|Withdrawal by Subject|0|||
162186582|NCT03057600|585735138|FG003|Overall Study|Withdrawal by Subject|0|||
162186583|NCT03057600|585735135|FG000|Overall Study|Other, Not Specified|1|||
162186584|NCT03057600|585735136|FG001|Overall Study|Other, Not Specified|1|||
162186585|NCT03057600|585735137|FG002|Overall Study|Other, Not Specified|1|||
162186586|NCT03057600|585735138|FG003|Overall Study|Other, Not Specified|1|||
162186587|NCT01604824|585735145|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
162186588|NCT01604824|585735146|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
162186589|NCT01604824|585735147|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
162186590|NCT01604824|585735148|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
162186591|NCT01604824|585735149|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
162186592|NCT01604824|585735150|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
162186593|NCT01604824|585735145|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
162186594|NCT01604824|585735146|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
162186595|NCT01604824|585735147|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
162186596|NCT01604824|585735148|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
162186597|NCT01604824|585735149|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
162186598|NCT01604824|585735150|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
162186599|NCT02630966|585735151|FG000|Overall Study|Adverse Event|1|||
162186600|NCT02630966|585735152|FG001|Overall Study|Adverse Event|3|||
162186601|NCT02630966|585735151|FG000|Overall Study|Significant Protocol Deviation|0|||
162186602|NCT02630966|585735152|FG001|Overall Study|Significant Protocol Deviation|2|||
162186603|NCT02630966|585735151|FG000|Overall Study|Voluntary Withdrawal|1|||
162186604|NCT02630966|585735152|FG001|Overall Study|Voluntary Withdrawal|1|||
162186605|NCT02630966|585735151|FG000|Overall Study|Lack of Efficacy|0|||
162186606|NCT02630966|585735152|FG001|Overall Study|Lack of Efficacy|2|||
162186607|NCT03389802|585735176|FG000|Overall Study|Lack of Efficacy|3|||
162186608|NCT03389802|585735177|FG001|Overall Study|Lack of Efficacy|3|||
162186609|NCT03389802|585735178|FG002|Overall Study|Lack of Efficacy|13|||
162186610|NCT03389802|585735179|FG003|Overall Study|Lack of Efficacy|6|||
162186611|NCT03389802|585735180|FG004|Overall Study|Lack of Efficacy|1|||
162186612|NCT03389802|585735176|FG000|Overall Study|Adverse Event|0|||
162186613|NCT03389802|585735177|FG001|Overall Study|Adverse Event|0|||
162186614|NCT03389802|585735178|FG002|Overall Study|Adverse Event|1|||
162186615|NCT03389802|585735179|FG003|Overall Study|Adverse Event|0|||
162186616|NCT03389802|585735180|FG004|Overall Study|Adverse Event|4|||
162186617|NCT03389802|585735176|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
162186618|NCT03389802|585735177|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
162186619|NCT03389802|585735178|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
162186620|NCT03389802|585735179|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
162186621|NCT03389802|585735180|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
162186622|NCT02426138|585735181|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
162186623|NCT02426138|585735182|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
162186624|NCT04677738|585735183|FG000|Overall Study|Withdrawal by Subject|4|||
162186625|NCT04677738|585735184|FG001|Overall Study|Withdrawal by Subject|2|||
162186626|NCT02409680|585735192|FG000|Overall Study|Lost to Follow-up|15|||
162186627|NCT02409680|585735193|FG001|Overall Study|Lost to Follow-up|30|||
162186628|NCT05366751|585735194|FG000|Overall Study|Adverse Event|25|||
162186629|NCT05366751|585735194|FG000|Overall Study|Physician Decision|3|||
161818956|NCT01945580|584378178|FG000|Overall Study|No data available|0|||
161818957|NCT01945580|584378179|FG001|Overall Study|No data available|2|||
161818958|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
161818959|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
162019404|NCT00806819|585124951|FG001|Overall Study|Withdrawal by Subject|29|||
162019405|NCT00806819|585124950|FG000|Overall Study|Not treated|6|||
162186630|NCT05366751|585735194|FG000|Overall Study|Lost to Follow-up|2|||
162186631|NCT05366751|585735194|FG000|Overall Study|Withdrawal by Subject|14|||
162186632|NCT05366751|585735194|FG000|Overall Study|Study Terminated by Sponsor|50|||
162186633|NCT05366751|585735194|FG000|Overall Study|Site Terminated by Sponsor|3|||
162186634|NCT01690624|585735195|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
162186635|NCT01690624|585735196|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
162186636|NCT01690624|585735197|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
162186637|NCT01690624|585735198|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
162186638|NCT01690624|585735195|FG000|Overall Study|Adverse event (other than DLT)|3|||
162186639|NCT01690624|585735196|FG001|Overall Study|Adverse event (other than DLT)|1|||
162186640|NCT01690624|585735197|FG002|Overall Study|Adverse event (other than DLT)|1|||
162186641|NCT01690624|585735198|FG003|Overall Study|Adverse event (other than DLT)|1|||
162186642|NCT01690624|585735195|FG000|Overall Study|Withdrawal by Subject|0|||
162186643|NCT01690624|585735196|FG001|Overall Study|Withdrawal by Subject|0|||
162186644|NCT01690624|585735197|FG002|Overall Study|Withdrawal by Subject|1|||
162186645|NCT01690624|585735198|FG003|Overall Study|Withdrawal by Subject|0|||
162186646|NCT01690624|585735195|FG000|Overall Study|Sponsor is ending trial|0|||
162186647|NCT01690624|585735196|FG001|Overall Study|Sponsor is ending trial|0|||
162186648|NCT01690624|585735197|FG002|Overall Study|Sponsor is ending trial|0|||
162186649|NCT01690624|585735198|FG003|Overall Study|Sponsor is ending trial|1|||
162186650|NCT01690624|585735195|FG000|Overall Study|Physician Decision|0|||
162186651|NCT01690624|585735196|FG001|Overall Study|Physician Decision|0|||
162186652|NCT01690624|585735197|FG002|Overall Study|Physician Decision|0|||
162186653|NCT01690624|585735198|FG003|Overall Study|Physician Decision|1|||
162186654|NCT01690624|585735195|FG000|Overall Study|Withdrawal by Subject|0|||
162186655|NCT01690624|585735196|FG001|Overall Study|Withdrawal by Subject|1|||
162186656|NCT01690624|585735197|FG002|Overall Study|Withdrawal by Subject|0|||
162186657|NCT01690624|585735198|FG003|Overall Study|Withdrawal by Subject|0|||
162186658|NCT01690624|585735195|FG000|Overall Study|Lack of Efficacy|1|||
162186659|NCT01690624|585735196|FG001|Overall Study|Lack of Efficacy|1|||
162186660|NCT01690624|585735197|FG002|Overall Study|Lack of Efficacy|3|||
162186661|NCT01690624|585735198|FG003|Overall Study|Lack of Efficacy|0|||
162186662|NCT04445831|585735202|FG000|Overall Study|Withdrawal by Subject|2|||
162186663|NCT04445831|585735203|FG001|Overall Study|Withdrawal by Subject|1|||
162186664|NCT04445831|585735204|FG002|Overall Study|Withdrawal by Subject|1|||
162186665|NCT04445831|585735205|FG003|Overall Study|Withdrawal by Subject|0|||
162186666|NCT04445831|585735206|FG004|Overall Study|Withdrawal by Subject|0|||
162186667|NCT04445831|585735207|FG005|Overall Study|Withdrawal by Subject|0|||
162186668|NCT04445831|585735208|FG006|Overall Study|Withdrawal by Subject|0|||
162186669|NCT04445831|585735202|FG000|Overall Study|Subject withdrawal by caregiver|0|||
162186670|NCT04445831|585735203|FG001|Overall Study|Subject withdrawal by caregiver|1|||
162186671|NCT04445831|585735204|FG002|Overall Study|Subject withdrawal by caregiver|0|||
162186672|NCT04445831|585735205|FG003|Overall Study|Subject withdrawal by caregiver|0|||
162186673|NCT04445831|585735206|FG004|Overall Study|Subject withdrawal by caregiver|0|||
162186674|NCT04445831|585735207|FG005|Overall Study|Subject withdrawal by caregiver|0|||
162186675|NCT04445831|585735208|FG006|Overall Study|Subject withdrawal by caregiver|0|||
162186676|NCT04912856|585735212|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
162186677|NCT04912856|585735213|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
162186678|NCT04912856|585735212|FG000|Overall Study|Not reported in synoptic CSR.|0|||
162186679|NCT04912856|585735213|FG001|Overall Study|Not reported in synoptic CSR.|1|||
162186680|NCT04701203|585735214|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
162186681|NCT04701203|585735215|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
162186682|NCT04701203|585735216|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
162186683|NCT04701203|585735214|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
162186684|NCT04701203|585735215|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
162186685|NCT04701203|585735216|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
162186686|NCT04701203|585735214|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
162186687|NCT04701203|585735215|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
162186688|NCT04701203|585735216|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
162186689|NCT04701203|585735214|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
162186690|NCT04701203|585735215|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
162186691|NCT04701203|585735216|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
162186692|NCT02434328|585735219|FG000|Overall Study|Adverse Event|9|||
162186693|NCT02434328|585735220|FG001|Overall Study|Adverse Event|4|||
162186694|NCT02434328|585735219|FG000|Overall Study|Lack of Efficacy|0|||
162186695|NCT02434328|585735220|FG001|Overall Study|Lack of Efficacy|2|||
162186696|NCT02434328|585735219|FG000|Overall Study|Physician Decision|0|||
162186697|NCT02434328|585735220|FG001|Overall Study|Physician Decision|1|||
162186698|NCT02434328|585735219|FG000|Overall Study|Withdrawal by Subject|12|||
162186699|NCT02434328|585735220|FG001|Overall Study|Withdrawal by Subject|21|||
162186700|NCT02434328|585735219|FG000|Overall Study|Death|4|||
162186701|NCT02434328|585735220|FG001|Overall Study|Death|7|||
162186702|NCT02434328|585735219|FG000|Overall Study|Lost to Follow-up|1|||
162186703|NCT02434328|585735220|FG001|Overall Study|Lost to Follow-up|6|||
162186704|NCT02434328|585735219|FG000|Overall Study|Other|4|||
162186705|NCT02434328|585735220|FG001|Overall Study|Other|1|||
162186706|NCT01563185|585735221|FG000|Overall Study|Withdrawal by Subject|1|||
162186707|NCT01563185|585735221|FG000|Overall Study|Non-Compliance with study drug|1|||
162186708|NCT00647387|585735224|FG000|Overall Study|Lost to Follow-up|6|||
162186709|NCT00647387|585735224|FG000|Overall Study|Unsuccessful implant|5|||
162186710|NCT00647387|585735224|FG000|Overall Study|Device explanted|3|||
162186711|NCT00647387|585735224|FG000|Overall Study|Other Reason|3|||
162186712|NCT00647387|585735224|FG000|Overall Study|Death|2|||
162186713|NCT00302211|585735225|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
162186714|NCT00302211|585735226|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
162186715|NCT00302211|585735227|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
162186716|NCT00302211|585735228|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
162186717|NCT00302211|585735229|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
162186718|NCT00302211|585735225|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
162186719|NCT00302211|585735226|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
162186720|NCT00302211|585735227|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
162186721|NCT00302211|585735228|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
162186722|NCT00302211|585735229|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
162186723|NCT00302211|585735225|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
162186724|NCT00302211|585735226|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
162186725|NCT00302211|585735227|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
162186726|NCT00302211|585735228|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
162186727|NCT00302211|585735229|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
162186728|NCT00302211|585735225|FG000|Double Blind Period (New Patients)|Disease progression|0|||
162186729|NCT00302211|585735226|FG001|Double Blind Period (New Patients)|Disease progression|1|||
162186730|NCT00302211|585735227|FG002|Double Blind Period (New Patients)|Disease progression|1|||
162186731|NCT00302211|585735228|FG003|Double Blind Period (New Patients)|Disease progression|0|||
162186732|NCT00302211|585735229|FG004|Double Blind Period (New Patients)|Disease progression|0|||
162186733|NCT00302211|585735225|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
162186734|NCT00302211|585735226|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
162186735|NCT00302211|585735227|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
162186736|NCT00302211|585735228|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
162186737|NCT00302211|585735229|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
162186738|NCT00302211|585735225|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
162186739|NCT00302211|585735226|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
162186740|NCT00302211|585735227|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
162186741|NCT00302211|585735228|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
162186742|NCT00302211|585735229|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
162186743|NCT00302211|585735225|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
162186744|NCT00302211|585735226|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
162186745|NCT00302211|585735227|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
162186746|NCT00302211|585735228|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
162186747|NCT00302211|585735229|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
162186748|NCT00302211|585735225|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
162186749|NCT00302211|585735226|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
162186750|NCT00302211|585735227|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
162186751|NCT00302211|585735228|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
162186752|NCT00302211|585735229|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
162186753|NCT00302211|585735225|FG000|Open Label-Patients From Double-Blind|Death|0|||
162186754|NCT00302211|585735226|FG001|Open Label-Patients From Double-Blind|Death|0|||
162186755|NCT00302211|585735227|FG002|Open Label-Patients From Double-Blind|Death|0|||
162186756|NCT00302211|585735228|FG003|Open Label-Patients From Double-Blind|Death|1|||
162186757|NCT00302211|585735229|FG004|Open Label-Patients From Double-Blind|Death|1|||
162186758|NCT00302211|585735225|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
162186759|NCT00302211|585735226|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
162186760|NCT00302211|585735227|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
162186761|NCT00302211|585735228|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
162186762|NCT00302211|585735229|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
162186763|NCT00302211|585735225|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
162186764|NCT00302211|585735226|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
162186765|NCT00302211|585735227|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
162186766|NCT00302211|585735228|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
162186767|NCT00302211|585735229|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
162186768|NCT00302211|585735225|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
162186769|NCT00302211|585735226|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
162186770|NCT00302211|585735227|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
162186771|NCT00302211|585735228|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
162186772|NCT00302211|585735229|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
162186773|NCT04921358|585737198|FG000|Overall Study|Withdrawal by Subject|6|||
162186774|NCT04921358|585737199|FG001|Overall Study|Withdrawal by Subject|13|||
162186775|NCT04921358|585737198|FG000|Overall Study|Lost to Follow-up|3|||
162186776|NCT04921358|585737199|FG001|Overall Study|Lost to Follow-up|6|||
162186777|NCT04921358|585737198|FG000|Overall Study|Study Terminated by Sponsor|86|||
162186778|NCT04921358|585737199|FG001|Overall Study|Study Terminated by Sponsor|89|||
162186779|NCT04921358|585737198|FG000|Overall Study|Death|92|||
162186780|NCT04921358|585737199|FG001|Overall Study|Death|82|||
162186781|NCT02278796|585737200|FG000|Overall Study|Death|2|||
162186782|NCT02278796|585737201|FG001|Overall Study|Death|3|||
162186783|NCT04926857|585737202|FG000|Overall Study|Withdrawal by Subject|40|||
162186784|NCT04926857|585737202|FG000|Overall Study|Death|9|||
162186785|NCT04926857|585737202|FG000|Overall Study|Study product no longer in use|44|||
162186786|NCT04926857|585737202|FG000|Overall Study|Inadequate data to address primary objective|16|||
162186787|NCT01256359|585737206|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
162186788|NCT01256359|585737207|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
162186789|NCT01256359|585737206|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
162186790|NCT01256359|585737207|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
162186791|NCT03737110|585737212|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
162186792|NCT03737110|585737213|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
162186793|NCT03737110|585737214|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
162186794|NCT03737110|585737215|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
162186795|NCT03737110|585737216|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
162186796|NCT03737110|585737217|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
162186797|NCT03737110|585737212|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
162186798|NCT03737110|585737213|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
162186799|NCT03737110|585737214|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
162186800|NCT03737110|585737215|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
162186801|NCT03737110|585737216|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
162186802|NCT03737110|585737217|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
162186803|NCT03737110|585737212|FG000|Run-in (RI) Period|Adverse Event|4|||
162186804|NCT03737110|585737213|FG001|Run-in (RI) Period|Adverse Event|0|||
162186805|NCT03737110|585737214|FG002|Run-in (RI) Period|Adverse Event|0|||
162186806|NCT03737110|585737215|FG003|Run-in (RI) Period|Adverse Event|0|||
162186807|NCT03737110|585737216|FG004|Run-in (RI) Period|Adverse Event|0|||
162186808|NCT03737110|585737217|FG005|Run-in (RI) Period|Adverse Event|0|||
162186809|NCT03737110|585737212|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
162186810|NCT03737110|585737213|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
162186811|NCT03737110|585737214|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
162186812|NCT03737110|585737215|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
162186813|NCT03737110|585737216|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
162186814|NCT03737110|585737217|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
162186815|NCT03737110|585737212|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
162186816|NCT03737110|585737213|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
162186817|NCT03737110|585737214|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
162186818|NCT03737110|585737215|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
162186819|NCT03737110|585737216|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
162186820|NCT03737110|585737217|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
162186821|NCT03737110|585737212|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
162186822|NCT03737110|585737213|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
162186823|NCT03737110|585737214|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
162186824|NCT03737110|585737215|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
162186825|NCT03737110|585737216|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
162186826|NCT03737110|585737217|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
162186827|NCT03737110|585737212|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
162186828|NCT03737110|585737213|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
162186829|NCT03737110|585737214|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
162186830|NCT03737110|585737215|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
162186831|NCT03737110|585737216|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
161673239|NCT01284062|583857922|FG003|Overall Study|Protocol Violation|2|||
162019406|NCT00806819|585124951|FG001|Overall Study|Not treated|3|||
162186832|NCT03737110|585737217|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
162186833|NCT03737110|585737212|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
162186834|NCT03737110|585737213|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
162186835|NCT03737110|585737214|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
162186836|NCT03737110|585737215|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
162186837|NCT03737110|585737216|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
162186838|NCT03737110|585737217|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
162186839|NCT00599196|585737222|FG000|Overall Study|Lack of Efficacy|22|||
162186840|NCT00599196|585737222|FG000|Overall Study|Adverse Event|93|||
162186841|NCT00599196|585737222|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
162186842|NCT00599196|585737222|FG000|Overall Study|Subject withdrew consent|43|||
162186843|NCT00599196|585737222|FG000|Overall Study|Study ended per sponsor|197|||
162186844|NCT00599196|585737222|FG000|Overall Study|Lost to Follow-up|17|||
162186845|NCT00599196|585737222|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
162186846|NCT00599196|585737222|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
162186847|NCT00599196|585737222|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
162186848|NCT00599196|585737222|FG000|Overall Study|Other: Pt Moved To Australia|1|||
162186849|NCT00599196|585737222|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
162186850|NCT00599196|585737222|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
162186851|NCT01009645|585737236|FG000|Overall Study|Lost to Follow-up|2|||
162186852|NCT01009645|585737237|FG001|Overall Study|Lost to Follow-up|8|||
162186853|NCT01009645|585737238|FG002|Overall Study|Lost to Follow-up|4|||
162186854|NCT01009645|585737239|FG003|Overall Study|Lost to Follow-up|5|||
162186855|NCT04237792|585737240|FG000|Treatment (Day 1)|Adverse Event|1|||
162186856|NCT04237792|585737241|FG001|Treatment (Day 1)|Adverse Event|0|||
162186857|NCT04237792|585737242|FG002|Treatment (Day 1)|Adverse Event|0|||
162186858|NCT04237792|585737243|FG003|Treatment (Day 1)|Adverse Event|0|||
162186859|NCT04237792|585737244|FG004|Treatment (Day 1)|Adverse Event|1|||
162186860|NCT04237792|585737245|FG005|Treatment (Day 1)|Adverse Event|1|||
162186861|NCT04237792|585737240|FG000|Treatment (Day 1)|Other|0|||
162186862|NCT04237792|585737241|FG001|Treatment (Day 1)|Other|0|||
162186863|NCT04237792|585737242|FG002|Treatment (Day 1)|Other|1|||
162186864|NCT04237792|585737243|FG003|Treatment (Day 1)|Other|0|||
162186865|NCT04237792|585737244|FG004|Treatment (Day 1)|Other|0|||
162186866|NCT04237792|585737245|FG005|Treatment (Day 1)|Other|1|||
162186867|NCT04237792|585737240|FG000|Treatment (Day 1)|Not treated|1|||
162186868|NCT04237792|585737241|FG001|Treatment (Day 1)|Not treated|1|||
161925086|NCT05887908|584771032|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
162186869|NCT04237792|585737242|FG002|Treatment (Day 1)|Not treated|2|||
162186870|NCT04237792|585737243|FG003|Treatment (Day 1)|Not treated|1|||
162186871|NCT04237792|585737244|FG004|Treatment (Day 1)|Not treated|0|||
162186872|NCT04237792|585737245|FG005|Treatment (Day 1)|Not treated|1|||
162186873|NCT04693637|585737246|FG000|Overall Study|Death|4|||
162186874|NCT04693637|585737246|FG000|Overall Study|Withdrawal by Subject|3|||
162186875|NCT04693637|585737246|FG000|Overall Study|Physician Decision|2|||
162186876|NCT04693637|585737246|FG000|Overall Study|Lost to Follow-up|1|||
162186877|NCT03052517|585737247|FG000|Overall Study|Study Terminated By Sponsor|928|||
162186878|NCT03052517|585737248|FG001|Overall Study|Study Terminated By Sponsor|938|||
162186879|NCT03052517|585737249|FG002|Overall Study|Study Terminated By Sponsor|296|||
162186880|NCT03052517|585737247|FG000|Overall Study|Subject/Guardian Decision|50|||
162186881|NCT03052517|585737248|FG001|Overall Study|Subject/Guardian Decision|45|||
162186882|NCT03052517|585737249|FG002|Overall Study|Subject/Guardian Decision|22|||
162186883|NCT03052517|585737247|FG000|Overall Study|Lack of Efficacy|23|||
162186884|NCT03052517|585737248|FG001|Overall Study|Lack of Efficacy|14|||
162186885|NCT03052517|585737249|FG002|Overall Study|Lack of Efficacy|7|||
162186886|NCT03052517|585737247|FG000|Overall Study|Adverse Event|6|||
162186887|NCT03052517|585737248|FG001|Overall Study|Adverse Event|5|||
161925087|NCT05887908|584771033|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
161925088|NCT05887908|584771034|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
161925089|NCT05887908|584771032|FG000|Overall Study|Other Reason|3|||
161925090|NCT05887908|584771033|FG001|Overall Study|Other Reason|3|||
162186888|NCT03052517|585737249|FG002|Overall Study|Adverse Event|0|||
162186889|NCT03052517|585737247|FG000|Overall Study|Physician Decision|4|||
162186890|NCT03052517|585737248|FG001|Overall Study|Physician Decision|5|||
162186891|NCT03052517|585737249|FG002|Overall Study|Physician Decision|1|||
161925091|NCT05887908|584771034|FG002|Overall Study|Other Reason|3|||
161925092|NCT03928743|584771035|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
162186892|NCT03052517|585737247|FG000|Overall Study|Death|3|||
162186893|NCT03052517|585737248|FG001|Overall Study|Death|0|||
162186894|NCT03052517|585737249|FG002|Overall Study|Death|1|||
162186895|NCT03052517|585737247|FG000|Overall Study|Lost to Follow-up|2|||
162186896|NCT03052517|585737248|FG001|Overall Study|Lost to Follow-up|4|||
162186897|NCT03052517|585737249|FG002|Overall Study|Lost to Follow-up|0|||
162186898|NCT03052517|585737247|FG000|Overall Study|Pregnancy|1|||
162186899|NCT03052517|585737248|FG001|Overall Study|Pregnancy|0|||
162186900|NCT03052517|585737249|FG002|Overall Study|Pregnancy|1|||
162186901|NCT03052517|585737247|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
162186902|NCT03052517|585737248|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
162186903|NCT03052517|585737249|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
162186904|NCT03052517|585737247|FG000|Overall Study|Technical Problems|0|||
162186905|NCT03052517|585737248|FG001|Overall Study|Technical Problems|1|||
162186906|NCT03052517|585737249|FG002|Overall Study|Technical Problems|0|||
162186907|NCT04885998|585737252|FG000|Overall Study|Withdrawal by Subject|0|||
162186908|NCT04885998|585737253|FG001|Overall Study|Withdrawal by Subject|2|||
162186909|NCT04885998|585737254|FG002|Overall Study|Withdrawal by Subject|0|||
162186910|NCT04885998|585737255|FG003|Overall Study|Withdrawal by Subject|3|||
162186911|NCT04885998|585737252|FG000|Overall Study|Lost to Follow-up|1|||
162186912|NCT04885998|585737253|FG001|Overall Study|Lost to Follow-up|1|||
162186913|NCT04885998|585737254|FG002|Overall Study|Lost to Follow-up|0|||
162186914|NCT04885998|585737255|FG003|Overall Study|Lost to Follow-up|0|||
162186915|NCT04885998|585737252|FG000|Overall Study|Death|2|||
162186916|NCT04885998|585737253|FG001|Overall Study|Death|1|||
162186917|NCT04885998|585737254|FG002|Overall Study|Death|2|||
162186918|NCT04885998|585737255|FG003|Overall Study|Death|2|||
162186919|NCT04885998|585737252|FG000|Overall Study|Decision by sponsor|1|||
162186920|NCT04885998|585737253|FG001|Overall Study|Decision by sponsor|1|||
162186921|NCT04885998|585737254|FG002|Overall Study|Decision by sponsor|0|||
162186922|NCT04885998|585737255|FG003|Overall Study|Decision by sponsor|0|||
162186923|NCT05260437|585737257|FG000|Overall Study|Lost to Follow-up|5|||
162186924|NCT05260437|585737258|FG001|Overall Study|Lost to Follow-up|2|||
162186925|NCT05260437|585737259|FG002|Overall Study|Lost to Follow-up|1|||
162186926|NCT05260437|585737260|FG003|Overall Study|Lost to Follow-up|2|||
162186927|NCT05260437|585737261|FG004|Overall Study|Lost to Follow-up|2|||
162186928|NCT05260437|585737257|FG000|Overall Study|Withdrawal by Subject|3|||
162186929|NCT05260437|585737258|FG001|Overall Study|Withdrawal by Subject|0|||
162186930|NCT05260437|585737259|FG002|Overall Study|Withdrawal by Subject|4|||
162186931|NCT05260437|585737260|FG003|Overall Study|Withdrawal by Subject|5|||
162186932|NCT05260437|585737261|FG004|Overall Study|Withdrawal by Subject|0|||
162186933|NCT05260437|585737257|FG000|Overall Study|Vaccine Not Administered|0|||
162186934|NCT05260437|585737258|FG001|Overall Study|Vaccine Not Administered|1|||
162186935|NCT05260437|585737259|FG002|Overall Study|Vaccine Not Administered|0|||
162186936|NCT05260437|585737260|FG003|Overall Study|Vaccine Not Administered|0|||
162186937|NCT05260437|585737261|FG004|Overall Study|Vaccine Not Administered|0|||
162186938|NCT00910962|585737262|FG000|Overall Study|Adverse Event|5|||
162186939|NCT00910962|585737263|FG001|Overall Study|Adverse Event|20|||
162186940|NCT00910962|585737264|FG002|Overall Study|Adverse Event|17|||
162186941|NCT00910962|585737262|FG000|Overall Study|Protocol Violation|1|||
162186942|NCT00910962|585737263|FG001|Overall Study|Protocol Violation|3|||
162186943|NCT00910962|585737264|FG002|Overall Study|Protocol Violation|3|||
162186944|NCT00910962|585737262|FG000|Overall Study|Lost to Follow-up|0|||
162186945|NCT00910962|585737263|FG001|Overall Study|Lost to Follow-up|3|||
162186946|NCT00910962|585737264|FG002|Overall Study|Lost to Follow-up|1|||
162186947|NCT00910962|585737262|FG000|Overall Study|Physician Decision|0|||
161673240|NCT01284062|583857919|FG000|Overall Study|Withdrawal by Subject|3|||
161673241|NCT01284062|583857920|FG001|Overall Study|Withdrawal by Subject|1|||
161673242|NCT01284062|583857921|FG002|Overall Study|Withdrawal by Subject|2|||
161925093|NCT03928743|584771036|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
161925094|NCT03928743|584771037|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
161925095|NCT03928743|584771035|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
161673243|NCT01284062|583857922|FG003|Overall Study|Withdrawal by Subject|5|||
161673244|NCT01284062|583857919|FG000|Overall Study|Other|0|||
161673245|NCT01284062|583857920|FG001|Overall Study|Other|0|||
161673246|NCT01284062|583857921|FG002|Overall Study|Other|0|||
161925096|NCT03928743|584771036|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
161925097|NCT03928743|584771037|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
161925098|NCT03928743|584771035|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
161925099|NCT03928743|584771036|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
162186948|NCT00910962|585737263|FG001|Overall Study|Physician Decision|6|||
162186949|NCT00910962|585737264|FG002|Overall Study|Physician Decision|6|||
162186950|NCT00910962|585737262|FG000|Overall Study|Withdrawal by Subject|25|||
162186951|NCT00910962|585737263|FG001|Overall Study|Withdrawal by Subject|32|||
162186952|NCT00910962|585737264|FG002|Overall Study|Withdrawal by Subject|32|||
162186953|NCT00910962|585737262|FG000|Overall Study|Reached defined stopping criteria|12|||
162186954|NCT00910962|585737263|FG001|Overall Study|Reached defined stopping criteria|14|||
162186955|NCT00910962|585737264|FG002|Overall Study|Reached defined stopping criteria|17|||
162186956|NCT00195819|585737265|FG000|Double-Blind|Withdrawal by Subject|1|||
162186957|NCT00195819|585737266|FG001|Double-Blind|Withdrawal by Subject|0|||
162186958|NCT00195819|585737265|FG000|Double-Blind|Moved|1|||
161673247|NCT01284062|583857922|FG003|Overall Study|Other|1|||
161673248|NCT01284062|583857919|FG000|Overall Study|Site Closed|0|||
162019407|NCT00806819|585124950|FG000|Overall Study|Reasons other than stated above|25|||
162019408|NCT00806819|585124951|FG001|Overall Study|Reasons other than stated above|41|||
162019409|NCT01737502|585124955|FG000|Phase I|Disease progression|2|||
162019410|NCT01737502|585124956|FG001|Phase I|Disease progression|3|||
162019411|NCT01737502|585124955|FG000|Phase I|Complicating disease|1|||
162019412|NCT01737502|585124956|FG001|Phase I|Complicating disease|0|||
162019413|NCT01737502|585124955|FG000|Phase II|Adverse Event|0|||
162019414|NCT01737502|585124956|FG001|Phase II|Adverse Event|3|||
162019415|NCT01737502|585124955|FG000|Phase II|Disease progression|0|||
162019416|NCT01737502|585124956|FG001|Phase II|Disease progression|18|||
162019417|NCT01737502|585124955|FG000|Phase II|Death|0|||
162019418|NCT01737502|585124956|FG001|Phase II|Death|1|||
162019419|NCT01737502|585124955|FG000|Phase II|Transition to hospice care|0|||
162019420|NCT01737502|585124956|FG001|Phase II|Transition to hospice care|1|||
162019421|NCT01368562|585126049|FG000|Overall Study|Adverse Event|1|||
162019422|NCT01368562|585126049|FG000|Overall Study|Disease progression|1|||
161818960|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
161818961|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
161818962|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
161818963|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
161818964|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
161818965|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
161818966|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
161818967|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
161818968|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
161818969|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
161818970|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
161818971|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
161818972|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
161818973|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
161818974|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
161818975|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
161818976|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
161818977|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
161818978|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
161818979|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
161818980|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
161818981|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
161818982|NCT00073307|584378187|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
161818983|NCT00073307|584378188|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
161818984|NCT00073307|584378189|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
161818985|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
161818986|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
161818987|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
161818988|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
161818989|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
161818990|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
161818991|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
161818992|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
161818993|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
161818994|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
161818995|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
161818996|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
161818997|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
161818998|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
161818999|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
161819000|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
161819001|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
161819002|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
161819003|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
161819004|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
162019423|NCT01368562|585126049|FG000|Overall Study|Lost to Follow-up|1|||
162019424|NCT01368562|585126049|FG000|Overall Study|Death|6|||
162019425|NCT01368562|585126049|FG000|Overall Study|Unresponsive to treatment|5|||
162186959|NCT00195819|585737266|FG001|Double-Blind|Moved|0|||
162186960|NCT00195819|585737265|FG000|Open-label|Adverse Event|0|||
161925100|NCT03928743|584771037|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
162186961|NCT00195819|585737266|FG001|Open-label|Adverse Event|9|||
162186962|NCT00195819|585737265|FG000|Open-label|Lack of Efficacy|0|||
162186963|NCT00195819|585737266|FG001|Open-label|Lack of Efficacy|2|||
162186964|NCT00195819|585737265|FG000|Open-label|Pregnancy|0|||
162186965|NCT00195819|585737266|FG001|Open-label|Pregnancy|1|||
162186966|NCT00195819|585737265|FG000|Open-label|Protocol Violation|0|||
162186967|NCT00195819|585737266|FG001|Open-label|Protocol Violation|2|||
162186968|NCT00195819|585737265|FG000|Open-label|Moved|0|||
162186969|NCT00195819|585737266|FG001|Open-label|Moved|1|||
162186970|NCT00195819|585737265|FG000|Open-label|Withdrawal by Subject|0|||
162186971|NCT00195819|585737266|FG001|Open-label|Withdrawal by Subject|5|||
162186972|NCT00787176|585737267|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
162186973|NCT00787176|585737268|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
162186974|NCT00787176|585737269|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
162186975|NCT00787176|585737270|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
162186976|NCT01124045|585737271|FG000|Overall Study|Lost to Follow-up|0|||
162186977|NCT01124045|585737272|FG001|Overall Study|Lost to Follow-up|1|||
162186978|NCT01124045|585737271|FG000|Overall Study|Physician Decision|0|||
162186979|NCT01124045|585737272|FG001|Overall Study|Physician Decision|2|||
162186980|NCT03298087|585737278|FG000|Overall Study|Withdrawal by Subject|4|||
162186981|NCT01079806|585737279|FG000|Day 1 to Week 96|Adverse Event|0|||
162186982|NCT01079806|585737280|FG001|Day 1 to Week 96|Adverse Event|3|||
161925101|NCT03928743|584771035|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
161925102|NCT03928743|584771036|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
161925103|NCT03928743|584771037|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
162186983|NCT01079806|585737279|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
162186984|NCT01079806|585737280|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
162186985|NCT01079806|585737279|FG000|Day 1 to Week 96|Pregnancy|0|||
162186986|NCT01079806|585737280|FG001|Day 1 to Week 96|Pregnancy|1|||
162186987|NCT01079806|585737279|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
162186988|NCT01079806|585737280|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
162186989|NCT01079806|585737279|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
162186990|NCT01079806|585737280|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
162186991|NCT01079806|585737279|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
162186992|NCT01079806|585737280|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
162186993|NCT01079806|585737279|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
162186994|NCT01079806|585737280|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
162186995|NCT01079806|585737279|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
162186996|NCT01079806|585737280|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
162186997|NCT01079806|585737279|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
162186998|NCT01079806|585737280|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
162186999|NCT01079806|585737279|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
161925104|NCT03928743|584771035|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
161925105|NCT03928743|584771036|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
161925106|NCT03928743|584771037|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
161925107|NCT03928743|584771035|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
161925108|NCT03928743|584771036|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
161925109|NCT03928743|584771037|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
161925110|NCT03928743|584771035|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
161925111|NCT03928743|584771036|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
161925112|NCT03928743|584771037|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
161925113|NCT03928743|584771035|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
161925114|NCT03928743|584771036|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
161925115|NCT03928743|584771037|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
161925116|NCT03928743|584771035|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
162019426|NCT01368562|585126049|FG000|Overall Study|Other|3|||
162019427|NCT01368562|585126049|FG000|Overall Study|Other than specified|2|||
162019428|NCT01296672|585126054|FG000|Overall Study|Lost to Follow-up|73|||
162019429|NCT01296672|585126055|FG001|Overall Study|Lost to Follow-up|18|||
162187000|NCT01079806|585737280|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
162187001|NCT00249769|585737285|FG000|Overall Study|Withdrawal by Subject|1|||
162187002|NCT00249769|585737286|FG001|Overall Study|Withdrawal by Subject|10|||
161925117|NCT03928743|584771036|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
161925118|NCT03928743|584771037|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
162187003|NCT00249769|585737287|FG002|Overall Study|Withdrawal by Subject|6|||
162187004|NCT00249769|585737285|FG000|Overall Study|Migration from Study Area|1|||
162187005|NCT00249769|585737286|FG001|Overall Study|Migration from Study Area|3|||
162187006|NCT00249769|585737287|FG002|Overall Study|Migration from Study Area|14|||
162187007|NCT00249769|585737285|FG000|Overall Study|Miscellaneous|0|||
161925119|NCT03928743|584771035|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
161925120|NCT03928743|584771036|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
161925121|NCT03928743|584771037|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
161925122|NCT03928743|584771035|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
161925123|NCT03928743|584771036|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
161925124|NCT03928743|584771037|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
161925125|NCT04828486|584771042|FG000|Overall Study|Adverse Event|2|||
161925126|NCT04828486|584771042|FG000|Overall Study|Death|1|||
161925127|NCT04828486|584771042|FG000|Overall Study|Disease Progression|8|||
161925128|NCT04828486|584771042|FG000|Overall Study|Other Complicating Disease|1|||
161925129|NCT04828486|584771042|FG000|Overall Study|Withdrawal by Subject|1|||
161925130|NCT03325439|584771043|FG000|Overall Study|Ineligibility|3|||
161925131|NCT02315625|584771044|FG000|First Intervention|Disease Progression|1|||
161925132|NCT02315625|584771045|FG001|First Intervention|Disease Progression|0|||
161925133|NCT02315625|584771044|FG000|Second Intervention|Physician Decision|2|||
161925134|NCT02315625|584771045|FG001|Second Intervention|Physician Decision|1|||
161925135|NCT02315625|584771044|FG000|Second Intervention|Study closure|1|||
161925136|NCT02315625|584771045|FG001|Second Intervention|Study closure|0|||
161925137|NCT02315625|584771044|FG000|Second Intervention|Disease Progression|1|||
161925138|NCT02315625|584771045|FG001|Second Intervention|Disease Progression|0|||
162187008|NCT00249769|585737286|FG001|Overall Study|Miscellaneous|2|||
162187009|NCT00249769|585737287|FG002|Overall Study|Miscellaneous|2|||
162187010|NCT00249769|585737285|FG000|Overall Study|Adverse Event|0|||
162187011|NCT00249769|585737286|FG001|Overall Study|Adverse Event|0|||
162187012|NCT00249769|585737287|FG002|Overall Study|Adverse Event|1|||
162187013|NCT00249769|585737285|FG000|Overall Study|Physician Decision|0|||
162187014|NCT00249769|585737286|FG001|Overall Study|Physician Decision|0|||
162187015|NCT00249769|585737287|FG002|Overall Study|Physician Decision|2|||
162187016|NCT00249769|585737285|FG000|Overall Study|Lost to Follow-up|0|||
162187017|NCT00249769|585737286|FG001|Overall Study|Lost to Follow-up|0|||
162187018|NCT00249769|585737287|FG002|Overall Study|Lost to Follow-up|3|||
162187019|NCT03274076|585737292|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
162187020|NCT03274076|585737293|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
162187021|NCT03274076|585737294|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
162187022|NCT03274076|585737295|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
162187023|NCT03274076|585737292|FG000|24 Weeks Open Label|Adverse Event|0|||
162187024|NCT03274076|585737293|FG001|24 Weeks Open Label|Adverse Event|0|||
162187025|NCT03274076|585737294|FG002|24 Weeks Open Label|Adverse Event|2|||
162187026|NCT03274076|585737295|FG003|24 Weeks Open Label|Adverse Event|0|||
162187027|NCT03274076|585737292|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
162187028|NCT03274076|585737293|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
162187029|NCT03274076|585737294|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
162187030|NCT03274076|585737295|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
162187031|NCT03781375|585737296|FG000|Double-blind Phase|Adverse Event|0|||
162187032|NCT03781375|585737297|FG001|Double-blind Phase|Adverse Event|1|||
162187033|NCT03781375|585737296|FG000|Double-blind Phase|Lack of Response|6|||
162187034|NCT03781375|585737297|FG001|Double-blind Phase|Lack of Response|2|||
162187035|NCT03781375|585737296|FG000|Double-blind Phase|Other|1|||
162187036|NCT03781375|585737297|FG001|Double-blind Phase|Other|3|||
162187037|NCT03781375|585737296|FG000|Open-label Phase|Protocol Issues|0|||
162187038|NCT03781375|585737297|FG001|Open-label Phase|Protocol Issues|1|||
161925139|NCT06132386|584771049|FG000|Overall Study|ineligble laboratory|1|||
161925140|NCT06132386|584771050|FG001|Overall Study|ineligble laboratory|0|||
161925141|NCT06132386|584771051|FG002|Overall Study|ineligble laboratory|0|||
161925142|NCT06132386|584771052|FG003|Overall Study|ineligble laboratory|0|||
162187039|NCT03781375|585737296|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
162187040|NCT03781375|585737297|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
162187041|NCT03781375|585737296|FG000|Open-label Phase|Other|2|||
161819005|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
161819006|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
161819007|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
161819008|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
161819009|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
161819010|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
161819011|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
161819012|NCT00073307|584378187|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
161819013|NCT00073307|584378188|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
161819014|NCT00073307|584378189|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
161925143|NCT06132386|584771053|FG004|Overall Study|ineligble laboratory|1|||
162187042|NCT03781375|585737297|FG001|Open-label Phase|Other|2|||
162187043|NCT01530334|585737298|FG000|Overall Study|Adverse Event|3|||
162187044|NCT01530334|585737298|FG000|Overall Study|unknown reason|1|||
162187045|NCT01530334|585737298|FG000|Overall Study|Progressive disease|47|||
162187046|NCT01303510|585737300|FG000|Overall Study|Lost to Follow-up|1|||
162187047|NCT01303510|585737301|FG001|Overall Study|Lost to Follow-up|0|||
162187048|NCT00822900|585737303|FG000|Overall Study|Withdrawal by Subject|14|||
162187049|NCT00822900|585737304|FG001|Overall Study|Withdrawal by Subject|14|||
162187050|NCT00822900|585737303|FG000|Overall Study|Lost to Follow-up|9|||
162187051|NCT00822900|585737304|FG001|Overall Study|Lost to Follow-up|9|||
162187052|NCT00822900|585737303|FG000|Overall Study|Death|83|||
162187053|NCT00822900|585737304|FG001|Overall Study|Death|69|||
162187054|NCT00822900|585737303|FG000|Overall Study|Became a ward of the state|2|||
162187055|NCT00822900|585737304|FG001|Overall Study|Became a ward of the state|1|||
162187056|NCT03489369|585737305|FG000|Overall Study|Documented Progressive Disease|3|||
162187057|NCT03489369|585737306|FG001|Overall Study|Documented Progressive Disease|2|||
161673249|NCT01284062|583857920|FG001|Overall Study|Site Closed|0|||
161673250|NCT01284062|583857921|FG002|Overall Study|Site Closed|1|||
161819015|NCT00858780|584378190|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
161819016|NCT00858780|584378191|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
161819017|NCT00858780|584378192|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
161819018|NCT00858780|584378193|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
161819019|NCT00858780|584378194|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
161819020|NCT00858780|584378190|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
161819021|NCT00858780|584378191|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
161819022|NCT00858780|584378192|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
161819023|NCT00858780|584378193|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
161819024|NCT00858780|584378194|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
161819025|NCT00858780|584378190|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
161819026|NCT00858780|584378191|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
161819027|NCT00858780|584378192|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
161819028|NCT00858780|584378193|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
161819029|NCT00858780|584378194|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
161819030|NCT00858780|584378190|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
161819031|NCT00858780|584378191|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
161819032|NCT00858780|584378192|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
161819033|NCT00858780|584378193|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
161819034|NCT00858780|584378194|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
161819035|NCT00858780|584378190|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
161819036|NCT00858780|584378191|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
161819037|NCT00858780|584378192|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
161819038|NCT00858780|584378193|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
161819039|NCT00858780|584378194|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
161819040|NCT00858780|584378190|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
161819041|NCT00858780|584378191|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
161925144|NCT06132386|584771054|FG005|Overall Study|ineligble laboratory|0|||
161925145|NCT06132386|584771049|FG000|Overall Study|ineligible vital signs|0|||
161925146|NCT06132386|584771050|FG001|Overall Study|ineligible vital signs|1|||
162187058|NCT03489369|585737307|FG002|Overall Study|Documented Progressive Disease|3|||
162187059|NCT03489369|585737308|FG003|Overall Study|Documented Progressive Disease|6|||
162187060|NCT03489369|585737305|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
162187061|NCT03489369|585737306|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
161673251|NCT01284062|583857922|FG003|Overall Study|Site Closed|0|||
162187062|NCT03489369|585737307|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
162187063|NCT03489369|585737308|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
162187064|NCT01968967|585737309|FG000|Treatment Period|Other|22|||
162187065|NCT01968967|585737310|FG001|Treatment Period|Other|22|||
162187066|NCT01968967|585737311|FG002|Treatment Period|Other|0|||
162187067|NCT01968967|585737312|FG003|Treatment Period|Other|0|||
162187068|NCT01968967|585737313|FG004|Treatment Period|Other|0|||
162187069|NCT01968967|585737309|FG000|Treatment Period|Withdrawal by Subject|71|||
162187070|NCT01968967|585737310|FG001|Treatment Period|Withdrawal by Subject|61|||
162187071|NCT01968967|585737311|FG002|Treatment Period|Withdrawal by Subject|0|||
162187072|NCT01968967|585737312|FG003|Treatment Period|Withdrawal by Subject|0|||
162019430|NCT01311024|585126056|FG000|Overall Study|Protocol Violation|35|||
161819042|NCT00858780|584378192|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
161819043|NCT00858780|584378193|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
161819044|NCT00858780|584378194|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
161819045|NCT01964950|584378195|FG000|Overall Study|Protocol Violation|25|||
161819046|NCT00819169|584378203|FG000|Overall Study|Withdrawal by Subject|2|||
161819047|NCT00819169|584378204|FG001|Overall Study|Withdrawal by Subject|0|||
161819048|NCT00819169|584378205|FG002|Overall Study|Withdrawal by Subject|0|||
161819049|NCT00819169|584378206|FG003|Overall Study|Withdrawal by Subject|1|||
161819050|NCT00819169|584378207|FG004|Overall Study|Withdrawal by Subject|1|||
161819051|NCT00819169|584378208|FG005|Overall Study|Withdrawal by Subject|1|||
161819052|NCT00819169|584378209|FG006|Overall Study|Withdrawal by Subject|5|||
162187073|NCT01968967|585737313|FG004|Treatment Period|Withdrawal by Subject|0|||
162187074|NCT01968967|585737309|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
162187075|NCT01968967|585737310|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
162187076|NCT01968967|585737311|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
162187077|NCT01968967|585737312|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
162187078|NCT01968967|585737313|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
162187079|NCT01968967|585737309|FG000|Treatment Period|Lost to Follow-up|26|||
162187080|NCT01968967|585737310|FG001|Treatment Period|Lost to Follow-up|31|||
162187081|NCT01968967|585737311|FG002|Treatment Period|Lost to Follow-up|0|||
162187082|NCT01968967|585737312|FG003|Treatment Period|Lost to Follow-up|0|||
162187083|NCT01968967|585737313|FG004|Treatment Period|Lost to Follow-up|0|||
162187084|NCT01968967|585737309|FG000|Treatment Period|Protocol Violation|1|||
162187085|NCT01968967|585737310|FG001|Treatment Period|Protocol Violation|2|||
162187086|NCT01968967|585737311|FG002|Treatment Period|Protocol Violation|0|||
162187087|NCT01968967|585737312|FG003|Treatment Period|Protocol Violation|0|||
162187088|NCT01968967|585737313|FG004|Treatment Period|Protocol Violation|0|||
162187089|NCT01968967|585737309|FG000|Treatment Period|Adverse Event|9|||
162187090|NCT01968967|585737310|FG001|Treatment Period|Adverse Event|8|||
162187091|NCT01968967|585737311|FG002|Treatment Period|Adverse Event|0|||
162187092|NCT01968967|585737312|FG003|Treatment Period|Adverse Event|0|||
162187093|NCT01968967|585737313|FG004|Treatment Period|Adverse Event|0|||
162187094|NCT01968967|585737309|FG000|Treatment Period|Death|9|||
162187095|NCT01968967|585737310|FG001|Treatment Period|Death|2|||
162187096|NCT01968967|585737311|FG002|Treatment Period|Death|0|||
162187097|NCT01968967|585737312|FG003|Treatment Period|Death|0|||
162187098|NCT01968967|585737313|FG004|Treatment Period|Death|0|||
162187099|NCT01968967|585737309|FG000|Treatment Period|Randomized Not Treated|6|||
162187100|NCT01968967|585737310|FG001|Treatment Period|Randomized Not Treated|5|||
162187101|NCT01968967|585737311|FG002|Treatment Period|Randomized Not Treated|0|||
162187102|NCT01968967|585737312|FG003|Treatment Period|Randomized Not Treated|0|||
162187103|NCT01968967|585737313|FG004|Treatment Period|Randomized Not Treated|0|||
162187104|NCT01968967|585737309|FG000|Extension Period|Withdrew Consent|0|||
162187105|NCT01968967|585737310|FG001|Extension Period|Withdrew Consent|0|||
162187106|NCT01968967|585737311|FG002|Extension Period|Withdrew Consent|2|||
162187107|NCT01968967|585737312|FG003|Extension Period|Withdrew Consent|0|||
162187108|NCT01968967|585737313|FG004|Extension Period|Withdrew Consent|5|||
162187109|NCT00701415|585737316|FG000|Overall Study|Adverse Event|0|||
162187110|NCT00701415|585737317|FG001|Overall Study|Adverse Event|1|||
162187111|NCT00701415|585737316|FG000|Overall Study|Social/family issues and needle phobia|1|||
162187112|NCT00701415|585737317|FG001|Overall Study|Social/family issues and needle phobia|0|||
162187113|NCT02106884|585737318|FG000|Overall Study|Change of diagnosis/exclusion|0|||
162187114|NCT02106884|585737319|FG001|Overall Study|Change of diagnosis/exclusion|1|||
162187115|NCT02022670|585737322|FG000|Overall Study|Adverse Event|1|||
162187116|NCT02022670|585737323|FG001|Overall Study|Adverse Event|0|||
162187117|NCT02022670|585737324|FG002|Overall Study|Adverse Event|1|||
162187118|NCT02113449|585737325|FG000|Overall Study|Adverse Event|4|||
162187119|NCT00109031|585737326|FG000|Overall Study|Adverse Event|0|||
162187120|NCT00109031|585737327|FG001|Overall Study|Adverse Event|0|||
162187121|NCT00109031|585737328|FG002|Overall Study|Adverse Event|1|||
161819053|NCT00819169|584378210|FG007|Overall Study|Withdrawal by Subject|1|||
161819054|NCT00819169|584378211|FG008|Overall Study|Withdrawal by Subject|4|||
162187122|NCT00109031|585737329|FG003|Overall Study|Adverse Event|0|||
162187123|NCT00109031|585737326|FG000|Overall Study|Withdrawal by Subject|0|||
162187124|NCT00109031|585737327|FG001|Overall Study|Withdrawal by Subject|1|||
162187125|NCT00109031|585737328|FG002|Overall Study|Withdrawal by Subject|0|||
162187126|NCT00109031|585737329|FG003|Overall Study|Withdrawal by Subject|0|||
162187127|NCT00109031|585737326|FG000|Overall Study|Physician Decision|0|||
162187128|NCT00109031|585737327|FG001|Overall Study|Physician Decision|1|||
162187129|NCT00109031|585737328|FG002|Overall Study|Physician Decision|0|||
162187130|NCT00109031|585737329|FG003|Overall Study|Physician Decision|0|||
162187131|NCT00109031|585737326|FG000|Overall Study|Protocol Violation|0|||
162187132|NCT00109031|585737327|FG001|Overall Study|Protocol Violation|0|||
162187133|NCT00109031|585737328|FG002|Overall Study|Protocol Violation|1|||
162187134|NCT00109031|585737329|FG003|Overall Study|Protocol Violation|0|||
162187135|NCT02091752|585737332|FG000|Overall Study|Study terminated by Sponsor|2|||
162187136|NCT02091752|585737332|FG000|Overall Study|Adverse Event|1|||
162187137|NCT00665392|585737333|FG000|Overall Study|not treated|1|||
162187138|NCT00243867|585737339|FG000|Overall Study|Adverse Event|24|||
162187139|NCT00243867|585737340|FG001|Overall Study|Adverse Event|34|||
162187140|NCT00243867|585737339|FG000|Overall Study|Lack of Efficacy|115|||
162187141|NCT00243867|585737340|FG001|Overall Study|Lack of Efficacy|78|||
162187142|NCT00243867|585737339|FG000|Overall Study|Withdrawal by Subject|11|||
162187143|NCT00243867|585737340|FG001|Overall Study|Withdrawal by Subject|23|||
162187144|NCT00243867|585737339|FG000|Overall Study|Lost to Follow-up|2|||
162187145|NCT00243867|585737340|FG001|Overall Study|Lost to Follow-up|1|||
162187146|NCT00243867|585737339|FG000|Overall Study|Physician Decision|2|||
162187147|NCT00243867|585737340|FG001|Overall Study|Physician Decision|7|||
162187148|NCT00243867|585737339|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
162187149|NCT00243867|585737340|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
162187150|NCT02060487|585737341|FG000|Overall Study|Other|1|||
162187151|NCT02060487|585737342|FG001|Overall Study|Other|2|||
162187152|NCT02060487|585737343|FG002|Overall Study|Other|1|||
162187153|NCT02060487|585737341|FG000|Overall Study|Lack of Efficacy|0|||
162187154|NCT02060487|585737342|FG001|Overall Study|Lack of Efficacy|1|||
162187155|NCT02060487|585737343|FG002|Overall Study|Lack of Efficacy|0|||
162187156|NCT02060487|585737341|FG000|Overall Study|Withdrawal by Subject|3|||
162187157|NCT02060487|585737342|FG001|Overall Study|Withdrawal by Subject|10|||
162187158|NCT02060487|585737343|FG002|Overall Study|Withdrawal by Subject|4|||
162187159|NCT02060487|585737341|FG000|Overall Study|Study Terminated By Sponsor|87|||
162187160|NCT02060487|585737342|FG001|Overall Study|Study Terminated By Sponsor|89|||
162187161|NCT02060487|585737343|FG002|Overall Study|Study Terminated By Sponsor|100|||
162187162|NCT02060487|585737341|FG000|Overall Study|Randomized in error|1|||
162187163|NCT02060487|585737342|FG001|Overall Study|Randomized in error|0|||
162187164|NCT02060487|585737343|FG002|Overall Study|Randomized in error|0|||
162187165|NCT02060487|585737341|FG000|Overall Study|Protocol Violation|0|||
162187166|NCT02060487|585737342|FG001|Overall Study|Protocol Violation|1|||
162187167|NCT02060487|585737343|FG002|Overall Study|Protocol Violation|1|||
162187168|NCT02060487|585737341|FG000|Overall Study|Lost to Follow-up|3|||
162187169|NCT02060487|585737342|FG001|Overall Study|Lost to Follow-up|0|||
162187170|NCT02060487|585737343|FG002|Overall Study|Lost to Follow-up|2|||
162187171|NCT02060487|585737341|FG000|Overall Study|Death|34|||
161673252|NCT03189862|583857923|FG000|Overall Study|Withdrawal by Subject|1|||
161673253|NCT03189862|583857924|FG001|Overall Study|Withdrawal by Subject|0|||
161673254|NCT03189862|583857923|FG000|Overall Study|Lost to Follow-up|54|||
161673255|NCT03189862|583857924|FG001|Overall Study|Lost to Follow-up|62|||
162187172|NCT02060487|585737342|FG001|Overall Study|Death|25|||
162187173|NCT02060487|585737343|FG002|Overall Study|Death|19|||
162187174|NCT02060487|585737341|FG000|Overall Study|Adverse Event|0|||
162187175|NCT02060487|585737342|FG001|Overall Study|Adverse Event|0|||
162187176|NCT02060487|585737343|FG002|Overall Study|Adverse Event|1|||
162187177|NCT03697603|585737348|FG000|Overall Study|Adverse Event|3|||
162187178|NCT03697603|585737349|FG001|Overall Study|Adverse Event|18|||
162187179|NCT03697603|585737350|FG002|Overall Study|Adverse Event|3|||
162187180|NCT03697603|585737348|FG000|Overall Study|Physician Decision|1|||
162187181|NCT03697603|585737349|FG001|Overall Study|Physician Decision|0|||
162187182|NCT03697603|585737350|FG002|Overall Study|Physician Decision|2|||
162187183|NCT03697603|585737348|FG000|Overall Study|Protocol Violation|3|||
162187184|NCT03697603|585737349|FG001|Overall Study|Protocol Violation|8|||
162187185|NCT03697603|585737350|FG002|Overall Study|Protocol Violation|5|||
162187186|NCT03697603|585737348|FG000|Overall Study|Withdrawal by Subject|5|||
162187187|NCT03697603|585737349|FG001|Overall Study|Withdrawal by Subject|1|||
162187188|NCT03697603|585737350|FG002|Overall Study|Withdrawal by Subject|1|||
162187189|NCT03697603|585737348|FG000|Overall Study|Protocol Violation|0|||
161673256|NCT00931944|583857926|FG000|Overall Study|Adverse Event|4|||
162187190|NCT03697603|585737349|FG001|Overall Study|Protocol Violation|0|||
162187191|NCT03697603|585737350|FG002|Overall Study|Protocol Violation|1|||
162187192|NCT04218864|585737351|FG000|Overall Study|Lost to Follow-up|8|||
162187193|NCT04218864|585737352|FG001|Overall Study|Lost to Follow-up|4|||
162187194|NCT04218864|585737351|FG000|Overall Study|Withdrawal by Subject|1|||
162187195|NCT04218864|585737352|FG001|Overall Study|Withdrawal by Subject|3|||
162187196|NCT03683030|585737353|FG000|Overall Study|Enrolled but screen failures|12|||
162187197|NCT03683030|585737354|FG001|Overall Study|Enrolled but screen failures|7|||
162187198|NCT03683030|585737353|FG000|Overall Study|Enrolled but no catheter inserted|11|||
162187199|NCT03683030|585737354|FG001|Overall Study|Enrolled but no catheter inserted|13|||
162187200|NCT03683030|585737353|FG000|Overall Study|Withdrawal by Subject|0|||
162187201|NCT03683030|585737354|FG001|Overall Study|Withdrawal by Subject|2|||
162187202|NCT03683030|585737353|FG000|Overall Study|Early termination by subject|1|||
162187203|NCT03683030|585737354|FG001|Overall Study|Early termination by subject|0|||
162187204|NCT03683030|585737353|FG000|Overall Study|Lost to Follow-up|0|||
162187205|NCT03683030|585737354|FG001|Overall Study|Lost to Follow-up|6|||
162187206|NCT03683030|585737353|FG000|Overall Study|Death|0|||
162187207|NCT03683030|585737354|FG001|Overall Study|Death|2|||
162187208|NCT03683030|585737353|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
162187209|NCT03683030|585737354|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
162187210|NCT02222493|585737355|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
162187211|NCT02222493|585737356|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
162187212|NCT02222493|585737355|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
162187213|NCT02222493|585737356|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
162187214|NCT02222493|585737355|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
162187215|NCT02222493|585737356|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
162187216|NCT02222493|585737355|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
162187217|NCT02222493|585737356|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
162187218|NCT02222493|585737355|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
162187219|NCT02222493|585737356|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
162187220|NCT02222493|585737355|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
162187221|NCT02222493|585737356|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
162187222|NCT02222493|585737355|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
162187223|NCT02222493|585737356|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
162187224|NCT02222493|585737355|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
162187225|NCT02222493|585737356|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
162187226|NCT02222493|585737355|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
162187227|NCT02222493|585737356|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
162187228|NCT02222493|585737355|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
162187229|NCT02222493|585737356|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
162187230|NCT02222493|585737355|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
162187231|NCT02222493|585737356|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
162187232|NCT02222493|585737355|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
162187233|NCT02222493|585737356|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
162187234|NCT02222493|585737355|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
162187235|NCT02222493|585737356|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
162187236|NCT02222493|585737355|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
162187237|NCT02222493|585737356|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
162187238|NCT02222493|585737355|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
162187239|NCT02222493|585737356|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
162187240|NCT02222493|585737355|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
162187241|NCT02222493|585737356|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
162187242|NCT02222493|585737355|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
162187243|NCT02222493|585737356|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
162187244|NCT02222493|585737355|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
162187245|NCT02222493|585737356|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
162187246|NCT02222493|585737355|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
162187247|NCT02222493|585737356|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
162187248|NCT02222493|585737355|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
162187249|NCT02222493|585737356|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
162187250|NCT02222493|585737355|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
162187251|NCT02222493|585737356|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
162187252|NCT02222493|585737355|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
162187253|NCT02222493|585737356|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
162187254|NCT00933270|585737359|FG000|Overall Study|Withdrawal by Subject|26|||
162187255|NCT00933270|585737359|FG000|Overall Study|Insufficient Follow-up|10|||
162187256|NCT00933270|585737359|FG000|Overall Study|Lost to Follow-up|14|||
162187257|NCT00933270|585737359|FG000|Overall Study|Adverse Event|1|||
162187258|NCT00933270|585737359|FG000|Overall Study|Missed Visit|2|||
162187259|NCT00933270|585737359|FG000|Overall Study|Death|24|||
162187260|NCT00933270|585737359|FG000|Overall Study|Moved or would not return|10|||
162187261|NCT02542943|585737360|FG000|Overall Study|Lost to Follow-up|1|||
162187262|NCT02542943|585737361|FG001|Overall Study|Lost to Follow-up|0|||
162187263|NCT02542943|585737362|FG002|Overall Study|Lost to Follow-up|0|||
162187264|NCT02542943|585737360|FG000|Overall Study|Withdrawal by Subject|0|||
162187265|NCT02542943|585737361|FG001|Overall Study|Withdrawal by Subject|1|||
162187266|NCT02542943|585737362|FG002|Overall Study|Withdrawal by Subject|0|||
162187267|NCT05824559|585737365|FG000|Overall Study|Adverse Event|2|||
162187268|NCT05824559|585737365|FG000|Overall Study|Physician Decision|2|||
162187269|NCT05824559|585737365|FG000|Overall Study|Progressive Disease|16|||
162187270|NCT05824559|585737365|FG000|Overall Study|Study Terminated by Sponsor|1|||
162187271|NCT05824559|585737365|FG000|Overall Study|Withdrawal by Subject|2|||
162187272|NCT03137459|585739114|FG000|2-month Assessment|Withdrawal by Subject|13|||
162187273|NCT03137459|585739115|FG001|2-month Assessment|Withdrawal by Subject|3|||
162187274|NCT03137459|585739114|FG000|2-month Assessment|Unable to reach|42|||
162187275|NCT03137459|585739115|FG001|2-month Assessment|Unable to reach|32|||
162187276|NCT03137459|585739114|FG000|2-month Assessment|Refused assessment|7|||
162187277|NCT03137459|585739115|FG001|2-month Assessment|Refused assessment|5|||
162187278|NCT03137459|585739114|FG000|2-month Assessment|Acutely ill|6|||
162187279|NCT03137459|585739115|FG001|2-month Assessment|Acutely ill|2|||
162187280|NCT03137459|585739114|FG000|4-month Assessment|Death|4|||
162187281|NCT03137459|585739115|FG001|4-month Assessment|Death|2|||
162187282|NCT03137459|585739114|FG000|4-month Assessment|Withdrawal by Subject|4|||
162187283|NCT03137459|585739115|FG001|4-month Assessment|Withdrawal by Subject|2|||
162187284|NCT03137459|585739114|FG000|4-month Assessment|Unable to reach|44|||
162187285|NCT03137459|585739115|FG001|4-month Assessment|Unable to reach|29|||
162187286|NCT03137459|585739114|FG000|4-month Assessment|Refused assessment|24|||
162187287|NCT03137459|585739115|FG001|4-month Assessment|Refused assessment|10|||
162187288|NCT03137459|585739114|FG000|4-month Assessment|Acutely ill|2|||
162187289|NCT03137459|585739115|FG001|4-month Assessment|Acutely ill|3|||
162187290|NCT03137459|585739114|FG000|6-months|Lost to Follow-up|14|||
162187291|NCT03137459|585739115|FG001|6-months|Lost to Follow-up|11|||
162187292|NCT03137459|585739114|FG000|6-months|Death|0|||
162187293|NCT03137459|585739115|FG001|6-months|Death|2|||
162187294|NCT03137459|585739114|FG000|6-months|Refused assessment|6|||
162187295|NCT03137459|585739115|FG001|6-months|Refused assessment|3|||
162187296|NCT03137459|585739114|FG000|6-months|Acutely ill|1|||
162187297|NCT03137459|585739115|FG001|6-months|Acutely ill|1|||
162187298|NCT00985088|585739116|FG000|Overall Study|Serious Adverse Event|1|||
162187299|NCT00985088|585739117|FG001|Overall Study|Serious Adverse Event|1|||
162187300|NCT00985088|585739118|FG002|Overall Study|Serious Adverse Event|0|||
162187301|NCT00985088|585739119|FG003|Overall Study|Serious Adverse Event|0|||
162187302|NCT00985088|585739120|FG004|Overall Study|Serious Adverse Event|0|||
162187303|NCT00985088|585739121|FG005|Overall Study|Serious Adverse Event|0|||
162187304|NCT00985088|585739122|FG006|Overall Study|Serious Adverse Event|0|||
162187305|NCT00985088|585739123|FG007|Overall Study|Serious Adverse Event|1|||
162187306|NCT00985088|585739116|FG000|Overall Study|Adverse Event|0|||
162187307|NCT00985088|585739117|FG001|Overall Study|Adverse Event|0|||
162187308|NCT00985088|585739118|FG002|Overall Study|Adverse Event|1|||
162187309|NCT00985088|585739119|FG003|Overall Study|Adverse Event|0|||
162187310|NCT00985088|585739120|FG004|Overall Study|Adverse Event|0|||
162187311|NCT00985088|585739121|FG005|Overall Study|Adverse Event|0|||
162187312|NCT00985088|585739122|FG006|Overall Study|Adverse Event|0|||
162187313|NCT00985088|585739123|FG007|Overall Study|Adverse Event|0|||
162187314|NCT00985088|585739116|FG000|Overall Study|Withdrawal by Subject|4|||
162187315|NCT00985088|585739117|FG001|Overall Study|Withdrawal by Subject|0|||
162187316|NCT00985088|585739118|FG002|Overall Study|Withdrawal by Subject|0|||
162187317|NCT00985088|585739119|FG003|Overall Study|Withdrawal by Subject|1|||
162187318|NCT00985088|585739120|FG004|Overall Study|Withdrawal by Subject|3|||
162187319|NCT00985088|585739121|FG005|Overall Study|Withdrawal by Subject|2|||
162187320|NCT00985088|585739122|FG006|Overall Study|Withdrawal by Subject|1|||
162187321|NCT00985088|585739123|FG007|Overall Study|Withdrawal by Subject|2|||
162187322|NCT00985088|585739116|FG000|Overall Study|Migrated/moved from study area|0|||
162187323|NCT00985088|585739117|FG001|Overall Study|Migrated/moved from study area|0|||
162187324|NCT00985088|585739118|FG002|Overall Study|Migrated/moved from study area|1|||
162187325|NCT00985088|585739119|FG003|Overall Study|Migrated/moved from study area|0|||
161673257|NCT00931944|583857926|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
161819055|NCT00819169|584378203|FG000|Overall Study|Lost to Follow-up|0|||
161819056|NCT00819169|584378204|FG001|Overall Study|Lost to Follow-up|2|||
161819057|NCT00819169|584378205|FG002|Overall Study|Lost to Follow-up|0|||
162187326|NCT00985088|585739120|FG004|Overall Study|Migrated/moved from study area|0|||
162187327|NCT00985088|585739121|FG005|Overall Study|Migrated/moved from study area|0|||
162187328|NCT00985088|585739122|FG006|Overall Study|Migrated/moved from study area|0|||
162187329|NCT00985088|585739123|FG007|Overall Study|Migrated/moved from study area|1|||
162187330|NCT00985088|585739116|FG000|Overall Study|Lost to Follow-up|6|||
162187331|NCT00985088|585739117|FG001|Overall Study|Lost to Follow-up|1|||
162187332|NCT00985088|585739118|FG002|Overall Study|Lost to Follow-up|2|||
162187333|NCT00985088|585739119|FG003|Overall Study|Lost to Follow-up|6|||
162187334|NCT00985088|585739120|FG004|Overall Study|Lost to Follow-up|6|||
162187335|NCT00985088|585739121|FG005|Overall Study|Lost to Follow-up|5|||
162187336|NCT00985088|585739122|FG006|Overall Study|Lost to Follow-up|3|||
162187337|NCT00985088|585739123|FG007|Overall Study|Lost to Follow-up|2|||
162187338|NCT01970878|585739124|FG000|Overall Study|Withdrawal by Subject|11|||
161925147|NCT06132386|584771051|FG002|Overall Study|ineligible vital signs|0|||
161925148|NCT06132386|584771052|FG003|Overall Study|ineligible vital signs|0|||
161925149|NCT06132386|584771053|FG004|Overall Study|ineligible vital signs|0|||
161925150|NCT06132386|584771054|FG005|Overall Study|ineligible vital signs|0|||
161925151|NCT05179603|584771055|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
161925152|NCT05179603|584771055|FG000|Overall Study|Withdrawal by Subject|1|||
161925153|NCT05179603|584771055|FG000|Overall Study|Progressive disease|4|||
161925154|NCT05179603|584771055|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
161925155|NCT05937373|584771056|FG000|Overall Study|Out of Window|2|||
161925156|NCT05937373|584771057|FG001|Overall Study|Out of Window|0|||
161925157|NCT05937373|584771056|FG000|Overall Study|Device fell off prior to date of surgery|0|||
161925158|NCT05937373|584771057|FG001|Overall Study|Device fell off prior to date of surgery|2|||
161925159|NCT06061952|584771059|FG000|Overall Study|Withdrawal by Subject|1|||
161925160|NCT06061952|584771060|FG001|Overall Study|Withdrawal by Subject|2|||
161925161|NCT06061952|584771059|FG000|Overall Study|Lost to Follow-up|2|||
161925162|NCT06061952|584771060|FG001|Overall Study|Lost to Follow-up|2|||
161925163|NCT01405911|584771061|FG000|Overall Study|Pre-treatment lab AE|0|||
161925164|NCT01405911|584771062|FG001|Overall Study|Pre-treatment lab AE|1|||
161925165|NCT01405911|584771063|FG002|Overall Study|Pre-treatment lab AE|0|||
161925166|NCT01405911|584771061|FG000|Overall Study|Lost to Follow-up|0|||
161925167|NCT01405911|584771062|FG001|Overall Study|Lost to Follow-up|1|||
161925168|NCT01405911|584771063|FG002|Overall Study|Lost to Follow-up|0|||
161925169|NCT01405911|584771061|FG000|Overall Study|Protocol Violation|1|||
161925170|NCT01405911|584771062|FG001|Overall Study|Protocol Violation|0|||
161925171|NCT01405911|584771063|FG002|Overall Study|Protocol Violation|0|||
161925172|NCT01405911|584771061|FG000|Overall Study|Withdrawal by Subject|3|||
161925173|NCT01405911|584771062|FG001|Overall Study|Withdrawal by Subject|1|||
161925174|NCT01405911|584771063|FG002|Overall Study|Withdrawal by Subject|1|||
161925175|NCT06375655|584771064|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
161925176|NCT06375655|584771065|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
161925177|NCT01685437|584771068|FG000|Overall Study|Withdrawal by Subject|22|||
161925178|NCT01685437|584771068|FG000|Overall Study|Lost to Follow-up|3|||
161925179|NCT01685437|584771068|FG000|Overall Study|Adverse Event|1|||
161925180|NCT01685437|584771068|FG000|Overall Study|Protocol Violation|4|||
161925181|NCT01685437|584771068|FG000|Overall Study|Unable to make visits due to work|1|||
161925182|NCT01039675|584771075|FG000|Overall Study|Adverse Event|0|||
161925183|NCT01039675|584771076|FG001|Overall Study|Adverse Event|2|||
161925184|NCT01039675|584771075|FG000|Overall Study|Lack of Efficacy|0|||
161925185|NCT01039675|584771076|FG001|Overall Study|Lack of Efficacy|2|||
161925186|NCT01039675|584771075|FG000|Overall Study|Withdrawal by Subject|0|||
161925187|NCT01039675|584771076|FG001|Overall Study|Withdrawal by Subject|1|||
161925188|NCT01039675|584771075|FG000|Overall Study|Lost to Follow-up|0|||
161925189|NCT01039675|584771076|FG001|Overall Study|Lost to Follow-up|1|||
161925190|NCT01039675|584771075|FG000|Overall Study|Physician Decision|0|||
161925191|NCT01039675|584771076|FG001|Overall Study|Physician Decision|1|||
161925192|NCT03514017|584771081|FG000|Overall Study|Death|1|||
161925193|NCT03514017|584771081|FG000|Overall Study|Adverse Event|1|||
161925194|NCT01807520|584771803|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
161925195|NCT01807520|584771804|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
161925196|NCT01807520|584771805|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
161925197|NCT01807520|584771806|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
161925198|NCT01807520|584771807|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
161925199|NCT01807520|584771808|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
161925200|NCT01807520|584771809|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
161925201|NCT01807520|584771803|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
161925202|NCT01807520|584771804|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
161925203|NCT01807520|584771805|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
161925204|NCT01807520|584771806|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
161925205|NCT01807520|584771807|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
161925206|NCT01807520|584771808|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
161925207|NCT01807520|584771809|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
161925208|NCT01807520|584771803|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
161925209|NCT01807520|584771804|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
161925210|NCT01807520|584771805|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
161925211|NCT01807520|584771806|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
161925212|NCT01807520|584771807|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
162019431|NCT01311024|585126057|FG001|Overall Study|Protocol Violation|22|||
161925213|NCT01807520|584771808|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
161925214|NCT01807520|584771809|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
161925215|NCT01807520|584771803|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
161925216|NCT01807520|584771804|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
161925217|NCT01807520|584771805|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
162019432|NCT00856518|585126058|FG000|Overall Study|Lost to Follow-up|4|||
162187339|NCT01970878|585739125|FG001|Overall Study|Withdrawal by Subject|10|||
162187340|NCT01970878|585739126|FG002|Overall Study|Withdrawal by Subject|14|||
162187341|NCT01970878|585739127|FG003|Overall Study|Withdrawal by Subject|7|||
162187342|NCT01970878|585739124|FG000|Overall Study|Lost to Follow-up|1|||
162187343|NCT01970878|585739125|FG001|Overall Study|Lost to Follow-up|3|||
162187344|NCT01970878|585739126|FG002|Overall Study|Lost to Follow-up|2|||
162187345|NCT01970878|585739127|FG003|Overall Study|Lost to Follow-up|4|||
162187346|NCT01970878|585739124|FG000|Overall Study|Administrative Reasons|1|||
162187347|NCT01970878|585739125|FG001|Overall Study|Administrative Reasons|0|||
162187348|NCT01970878|585739126|FG002|Overall Study|Administrative Reasons|0|||
162187349|NCT01970878|585739127|FG003|Overall Study|Administrative Reasons|4|||
162187350|NCT01970878|585739124|FG000|Overall Study|Lack of Efficacy|2|||
162187351|NCT01970878|585739125|FG001|Overall Study|Lack of Efficacy|1|||
162187352|NCT01970878|585739126|FG002|Overall Study|Lack of Efficacy|2|||
162187353|NCT01970878|585739127|FG003|Overall Study|Lack of Efficacy|0|||
162187354|NCT01970878|585739124|FG000|Overall Study|Adverse Event|12|||
162187355|NCT01970878|585739125|FG001|Overall Study|Adverse Event|7|||
162187356|NCT01970878|585739126|FG002|Overall Study|Adverse Event|4|||
162187357|NCT01970878|585739127|FG003|Overall Study|Adverse Event|3|||
162187358|NCT01970878|585739124|FG000|Overall Study|Protocol Specified Criteria|10|||
161819058|NCT00819169|584378206|FG003|Overall Study|Lost to Follow-up|1|||
161819059|NCT00819169|584378207|FG004|Overall Study|Lost to Follow-up|0|||
161819060|NCT00819169|584378208|FG005|Overall Study|Lost to Follow-up|6|||
161819061|NCT00819169|584378209|FG006|Overall Study|Lost to Follow-up|2|||
161819062|NCT00819169|584378210|FG007|Overall Study|Lost to Follow-up|2|||
161819063|NCT00819169|584378211|FG008|Overall Study|Lost to Follow-up|1|||
161819064|NCT00819169|584378203|FG000|Overall Study|Death|1|||
161819065|NCT00819169|584378204|FG001|Overall Study|Death|1|||
161819066|NCT00819169|584378205|FG002|Overall Study|Death|3|||
161819067|NCT00819169|584378206|FG003|Overall Study|Death|8|||
161819068|NCT00819169|584378207|FG004|Overall Study|Death|5|||
161819069|NCT00819169|584378208|FG005|Overall Study|Death|7|||
161819070|NCT00819169|584378209|FG006|Overall Study|Death|9|||
161819071|NCT00819169|584378210|FG007|Overall Study|Death|4|||
161819072|NCT00819169|584378211|FG008|Overall Study|Death|7|||
161819073|NCT00819169|584378203|FG000|Overall Study|Ineligibility determined|0|||
161819074|NCT00819169|584378204|FG001|Overall Study|Ineligibility determined|0|||
161819075|NCT00819169|584378205|FG002|Overall Study|Ineligibility determined|0|||
161819076|NCT00819169|584378206|FG003|Overall Study|Ineligibility determined|2|||
161819077|NCT00819169|584378207|FG004|Overall Study|Ineligibility determined|0|||
161819078|NCT00819169|584378208|FG005|Overall Study|Ineligibility determined|0|||
161819079|NCT00819169|584378209|FG006|Overall Study|Ineligibility determined|0|||
161819080|NCT00819169|584378210|FG007|Overall Study|Ineligibility determined|0|||
161819081|NCT00819169|584378211|FG008|Overall Study|Ineligibility determined|1|||
161819082|NCT00819169|584378203|FG000|Overall Study|Adverse Event|0|||
161819083|NCT00819169|584378204|FG001|Overall Study|Adverse Event|0|||
161819084|NCT00819169|584378205|FG002|Overall Study|Adverse Event|0|||
161819085|NCT00819169|584378206|FG003|Overall Study|Adverse Event|0|||
161819086|NCT00819169|584378207|FG004|Overall Study|Adverse Event|1|||
161819087|NCT00819169|584378208|FG005|Overall Study|Adverse Event|0|||
161819088|NCT00819169|584378209|FG006|Overall Study|Adverse Event|0|||
161819089|NCT00819169|584378210|FG007|Overall Study|Adverse Event|0|||
161819090|NCT00819169|584378211|FG008|Overall Study|Adverse Event|0|||
161819091|NCT00819169|584378203|FG000|Overall Study|Administrative Decision|0|||
161819092|NCT00819169|584378204|FG001|Overall Study|Administrative Decision|0|||
161819093|NCT00819169|584378205|FG002|Overall Study|Administrative Decision|0|||
161819094|NCT00819169|584378206|FG003|Overall Study|Administrative Decision|0|||
161819095|NCT00819169|584378207|FG004|Overall Study|Administrative Decision|1|||
161819096|NCT00819169|584378208|FG005|Overall Study|Administrative Decision|2|||
161819097|NCT00819169|584378209|FG006|Overall Study|Administrative Decision|0|||
161819098|NCT00819169|584378210|FG007|Overall Study|Administrative Decision|2|||
161819099|NCT00819169|584378211|FG008|Overall Study|Administrative Decision|0|||
161819100|NCT02637141|584378215|FG000|Overall Study|Adverse Event|1|||
161819101|NCT02637141|584378216|FG001|Overall Study|Adverse Event|1|||
161819102|NCT02637141|584378217|FG002|Overall Study|Adverse Event|0|||
161819103|NCT02637141|584378215|FG000|Overall Study|Withdrawal by Subject|1|||
161819104|NCT02637141|584378216|FG001|Overall Study|Withdrawal by Subject|1|||
161819105|NCT02637141|584378217|FG002|Overall Study|Withdrawal by Subject|1|||
161819106|NCT03885934|584378221|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
161819107|NCT03885934|584378222|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
161819108|NCT03885934|584378223|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
162187359|NCT01970878|585739125|FG001|Overall Study|Protocol Specified Criteria|4|||
162187360|NCT01970878|585739126|FG002|Overall Study|Protocol Specified Criteria|3|||
162187361|NCT01970878|585739127|FG003|Overall Study|Protocol Specified Criteria|6|||
162187362|NCT01970878|585739124|FG000|Overall Study|Physician Decision|0|||
161819109|NCT03885934|584378224|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
161819110|NCT03885934|584378225|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
161819111|NCT03885934|584378226|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
162187363|NCT01970878|585739125|FG001|Overall Study|Physician Decision|1|||
162187364|NCT01970878|585739126|FG002|Overall Study|Physician Decision|1|||
162187365|NCT01970878|585739127|FG003|Overall Study|Physician Decision|0|||
162187366|NCT01970878|585739124|FG000|Overall Study|No Completion Status|0|||
162187367|NCT01970878|585739125|FG001|Overall Study|No Completion Status|1|||
162187368|NCT01970878|585739126|FG002|Overall Study|No Completion Status|0|||
162187369|NCT01970878|585739127|FG003|Overall Study|No Completion Status|0|||
162187370|NCT04992273|585739132|FG000|Overall Study|Lost to Follow-up|0|||
162187371|NCT04992273|585739133|FG001|Overall Study|Lost to Follow-up|1|||
162187372|NCT01364597|585739134|FG000|Overall Study|Adverse Event|4|||
162187373|NCT01364597|585739135|FG001|Overall Study|Adverse Event|5|||
162187374|NCT01364597|585739136|FG002|Overall Study|Adverse Event|16|||
162187375|NCT01364597|585739137|FG003|Overall Study|Adverse Event|7|||
162187376|NCT01364597|585739134|FG000|Overall Study|Lack of Efficacy|4|||
162187377|NCT01364597|585739135|FG001|Overall Study|Lack of Efficacy|4|||
162187378|NCT01364597|585739136|FG002|Overall Study|Lack of Efficacy|23|||
162187379|NCT01364597|585739137|FG003|Overall Study|Lack of Efficacy|8|||
162187380|NCT01364597|585739134|FG000|Overall Study|Protocol Violation|0|||
162187381|NCT01364597|585739135|FG001|Overall Study|Protocol Violation|0|||
162187382|NCT01364597|585739136|FG002|Overall Study|Protocol Violation|2|||
162187383|NCT01364597|585739137|FG003|Overall Study|Protocol Violation|0|||
162187384|NCT01364597|585739134|FG000|Overall Study|Lost to Follow-up|0|||
162187385|NCT01364597|585739135|FG001|Overall Study|Lost to Follow-up|0|||
162187386|NCT01364597|585739136|FG002|Overall Study|Lost to Follow-up|5|||
162187387|NCT01364597|585739137|FG003|Overall Study|Lost to Follow-up|3|||
162187388|NCT01364597|585739134|FG000|Overall Study|Withdrawal by Subject|4|||
162187389|NCT01364597|585739135|FG001|Overall Study|Withdrawal by Subject|1|||
162187390|NCT01364597|585739136|FG002|Overall Study|Withdrawal by Subject|18|||
162187391|NCT01364597|585739137|FG003|Overall Study|Withdrawal by Subject|6|||
162187392|NCT01364597|585739134|FG000|Overall Study|Non compliance|1|||
162187393|NCT01364597|585739135|FG001|Overall Study|Non compliance|0|||
162187394|NCT01364597|585739136|FG002|Overall Study|Non compliance|1|||
162187395|NCT01364597|585739137|FG003|Overall Study|Non compliance|0|||
162187396|NCT01364597|585739134|FG000|Overall Study|Lack of compliance|1|||
162187397|NCT01364597|585739135|FG001|Overall Study|Lack of compliance|0|||
162187398|NCT01364597|585739136|FG002|Overall Study|Lack of compliance|0|||
162187399|NCT01364597|585739137|FG003|Overall Study|Lack of compliance|0|||
162187400|NCT01364597|585739134|FG000|Overall Study|End of treatment epilepsy|1|||
162187401|NCT01364597|585739135|FG001|Overall Study|End of treatment epilepsy|0|||
162187402|NCT01364597|585739136|FG002|Overall Study|End of treatment epilepsy|0|||
162187403|NCT01364597|585739137|FG003|Overall Study|End of treatment epilepsy|0|||
162187404|NCT01364597|585739134|FG000|Overall Study|No Seizures|1|||
162187405|NCT01364597|585739135|FG001|Overall Study|No Seizures|0|||
162187406|NCT01364597|585739136|FG002|Overall Study|No Seizures|0|||
162187407|NCT01364597|585739137|FG003|Overall Study|No Seizures|0|||
162187408|NCT01364597|585739134|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
162187409|NCT01364597|585739135|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
162187410|NCT01364597|585739136|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
162187411|NCT01364597|585739137|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
162187412|NCT01364597|585739134|FG000|Overall Study|Cure|1|||
162187413|NCT01364597|585739135|FG001|Overall Study|Cure|0|||
162187414|NCT01364597|585739136|FG002|Overall Study|Cure|0|||
162187415|NCT01364597|585739137|FG003|Overall Study|Cure|0|||
162187416|NCT01364597|585739134|FG000|Overall Study|Patient was moving|0|||
162187417|NCT01364597|585739135|FG001|Overall Study|Patient was moving|1|||
162187418|NCT01364597|585739136|FG002|Overall Study|Patient was moving|0|||
162187419|NCT01364597|585739137|FG003|Overall Study|Patient was moving|0|||
162187420|NCT01364597|585739134|FG000|Overall Study|Seizures resolved|0|||
162187421|NCT01364597|585739135|FG001|Overall Study|Seizures resolved|0|||
162187422|NCT01364597|585739136|FG002|Overall Study|Seizures resolved|1|||
162187423|NCT01364597|585739137|FG003|Overall Study|Seizures resolved|0|||
162019433|NCT00856518|585126059|FG001|Overall Study|Lost to Follow-up|2|||
162187424|NCT01364597|585739134|FG000|Overall Study|Patient became seizure-free after surgery|0|||
162187425|NCT01364597|585739135|FG001|Overall Study|Patient became seizure-free after surgery|0|||
162187426|NCT01364597|585739136|FG002|Overall Study|Patient became seizure-free after surgery|1|||
162187427|NCT01364597|585739137|FG003|Overall Study|Patient became seizure-free after surgery|0|||
162187428|NCT01364597|585739134|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
162187429|NCT01364597|585739135|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
162187430|NCT01364597|585739136|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
162187431|NCT01364597|585739137|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
162187432|NCT01364597|585739134|FG000|Overall Study|Patient cured from Epilepsy|0|||
162187433|NCT01364597|585739135|FG001|Overall Study|Patient cured from Epilepsy|0|||
162187434|NCT01364597|585739136|FG002|Overall Study|Patient cured from Epilepsy|1|||
162187435|NCT01364597|585739137|FG003|Overall Study|Patient cured from Epilepsy|0|||
162187436|NCT01364597|585739134|FG000|Overall Study|Investigator decision|0|||
162187437|NCT01364597|585739135|FG001|Overall Study|Investigator decision|0|||
162187438|NCT01364597|585739136|FG002|Overall Study|Investigator decision|1|||
162187439|NCT01364597|585739137|FG003|Overall Study|Investigator decision|0|||
162187440|NCT01364597|585739134|FG000|Overall Study|Sponsor recommended discontinuation|0|||
162187441|NCT01364597|585739135|FG001|Overall Study|Sponsor recommended discontinuation|0|||
162187442|NCT01364597|585739136|FG002|Overall Study|Sponsor recommended discontinuation|0|||
162187443|NCT01364597|585739137|FG003|Overall Study|Sponsor recommended discontinuation|1|||
162187444|NCT01364597|585739134|FG000|Overall Study|Parents went abroad with the patient|0|||
162187445|NCT01364597|585739135|FG001|Overall Study|Parents went abroad with the patient|0|||
162187446|NCT01364597|585739136|FG002|Overall Study|Parents went abroad with the patient|1|||
162187447|NCT01364597|585739137|FG003|Overall Study|Parents went abroad with the patient|0|||
162187448|NCT01364597|585739134|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
162187449|NCT01364597|585739135|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
162187450|NCT01364597|585739136|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
162187451|NCT01364597|585739137|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
162187452|NCT01364597|585739134|FG000|Overall Study|BRV administration dropout|0|||
162187453|NCT01364597|585739135|FG001|Overall Study|BRV administration dropout|0|||
162187454|NCT01364597|585739136|FG002|Overall Study|BRV administration dropout|1|||
162187455|NCT01364597|585739137|FG003|Overall Study|BRV administration dropout|0|||
162187456|NCT01364597|585739134|FG000|Overall Study|Dropout|0|||
162187457|NCT01364597|585739135|FG001|Overall Study|Dropout|0|||
162187458|NCT01364597|585739136|FG002|Overall Study|Dropout|3|||
162187459|NCT01364597|585739137|FG003|Overall Study|Dropout|1|||
162187460|NCT01364597|585739134|FG000|Overall Study|Unreliable subject|0|||
162187461|NCT01364597|585739135|FG001|Overall Study|Unreliable subject|0|||
162187462|NCT01364597|585739136|FG002|Overall Study|Unreliable subject|0|||
162187463|NCT01364597|585739137|FG003|Overall Study|Unreliable subject|1|||
162187464|NCT01364597|585739134|FG000|Overall Study|Other|0|||
162187465|NCT01364597|585739135|FG001|Overall Study|Other|0|||
162187466|NCT01364597|585739136|FG002|Overall Study|Other|0|||
162187467|NCT01364597|585739137|FG003|Overall Study|Other|1|||
162187468|NCT03214081|585739138|FG000|Overall Study|Case Report Forms Uncollected|9|||
162187469|NCT03214081|585739138|FG000|Overall Study|Protocol Deviation|54|||
162187470|NCT02962284|585739139|FG000|Overall Study|Death|2|||
162187471|NCT02962284|585739140|FG001|Overall Study|Death|0|||
162187472|NCT02962284|585739139|FG000|Overall Study|Progressive disease|2|||
162187473|NCT02962284|585739140|FG001|Overall Study|Progressive disease|3|||
162187474|NCT02962284|585739139|FG000|Overall Study|Withdrawal by Subject|1|||
162187475|NCT02962284|585739140|FG001|Overall Study|Withdrawal by Subject|0|||
162187476|NCT03493282|585739144|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
162187477|NCT03493282|585739145|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
162187478|NCT03493282|585739146|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
162187479|NCT03493282|585739144|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
162187480|NCT03493282|585739145|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
162187481|NCT03493282|585739146|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
162187482|NCT02637063|585739147|FG000|Overall Study|Lost to Follow-up|3|||
162187483|NCT02637063|585739148|FG001|Overall Study|Lost to Follow-up|2|||
162187484|NCT02637063|585739149|FG002|Overall Study|Lost to Follow-up|3|||
162187485|NCT02637063|585739147|FG000|Overall Study|Withdrawal by Subject|2|||
162187486|NCT02637063|585739148|FG001|Overall Study|Withdrawal by Subject|2|||
162187487|NCT02637063|585739149|FG002|Overall Study|Withdrawal by Subject|3|||
162187488|NCT00491400|585739150|FG000|Overall Study|Withdrawal by Subject|5|||
162187489|NCT00491400|585739151|FG001|Overall Study|Withdrawal by Subject|4|||
162187490|NCT00597376|585739152|FG000|Overall Study|Withdrawal by Subject|4|||
162187491|NCT00597376|585739153|FG001|Overall Study|Withdrawal by Subject|3|||
162187492|NCT00597376|585739152|FG000|Overall Study|Adverse Event|4|||
162187493|NCT00597376|585739153|FG001|Overall Study|Adverse Event|1|||
161819112|NCT00406393|584378227|FG000|Overall Study|Did not undergo transplantation|2|||
161819113|NCT00406393|584378228|FG001|Overall Study|Did not undergo transplantation|1|||
161819114|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
161819115|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
161819116|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
162187494|NCT01380145|585739154|FG000|Overall Study|Progressive disease|4|||
161819117|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
161819118|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
161819119|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
161819120|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
161819121|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
162187495|NCT02634307|585739155|FG000|Overall Study|Adverse Event|50|||
162187496|NCT02634307|585739156|FG001|Overall Study|Adverse Event|24|||
162187497|NCT02634307|585739157|FG002|Overall Study|Adverse Event|14|||
162187498|NCT02634307|585739155|FG000|Overall Study|Lost to Follow-up|21|||
162187499|NCT02634307|585739156|FG001|Overall Study|Lost to Follow-up|5|||
161683060|NCT02554019|583891221|FG000|Overall Study|Adverse Event|1|||
161819122|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
161819123|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
162187500|NCT02634307|585739157|FG002|Overall Study|Lost to Follow-up|6|||
162187501|NCT02634307|585739155|FG000|Overall Study|Pregnancy|5|||
162187502|NCT02634307|585739156|FG001|Overall Study|Pregnancy|1|||
162187503|NCT02634307|585739157|FG002|Overall Study|Pregnancy|3|||
162187504|NCT02634307|585739155|FG000|Overall Study|Withdrawal by Subject|38|||
162187505|NCT02634307|585739156|FG001|Overall Study|Withdrawal by Subject|24|||
162187506|NCT02634307|585739157|FG002|Overall Study|Withdrawal by Subject|18|||
162187507|NCT02634307|585739155|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162187508|NCT02634307|585739156|FG001|Overall Study|Non-Compliance with Study Drug|2|||
162187509|NCT02634307|585739157|FG002|Overall Study|Non-Compliance with Study Drug|2|||
162187510|NCT02634307|585739155|FG000|Overall Study|Lack of Efficacy|1|||
162187511|NCT02634307|585739156|FG001|Overall Study|Lack of Efficacy|5|||
162187512|NCT02634307|585739157|FG002|Overall Study|Lack of Efficacy|3|||
162187513|NCT02634307|585739155|FG000|Overall Study|Physician Decision|7|||
162187514|NCT02634307|585739156|FG001|Overall Study|Physician Decision|5|||
162187515|NCT02634307|585739157|FG002|Overall Study|Physician Decision|5|||
162187516|NCT02634307|585739155|FG000|Overall Study|Reason not Specified|3|||
162187517|NCT02634307|585739156|FG001|Overall Study|Reason not Specified|5|||
162187518|NCT02634307|585739157|FG002|Overall Study|Reason not Specified|10|||
162187519|NCT02698475|585739158|FG000|Main Study Period|Lack of Efficacy|1|||
162187520|NCT02698475|585739158|FG000|Main Study Period|Protocol Violation|2|||
162187521|NCT02698475|585739158|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
162187522|NCT02698475|585739158|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
162187523|NCT02698475|585739158|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
162187524|NCT02698475|585739158|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
162187525|NCT02698475|585739158|FG000|Long-Term Extension Period|Other|1|||
162187526|NCT02038049|585739159|FG000|Overall Study|Lost to Follow-up|1|||
162187527|NCT02038049|585739160|FG001|Overall Study|Lost to Follow-up|0|||
162187528|NCT00413283|585739165|FG000|Overall Study|Withdrawal by Subject|1|||
162187529|NCT00413283|585739166|FG001|Overall Study|Withdrawal by Subject|0|||
162187530|NCT00413283|585739167|FG002|Overall Study|Withdrawal by Subject|0|||
162187531|NCT00413283|585739168|FG003|Overall Study|Withdrawal by Subject|1|||
162187532|NCT00413283|585739165|FG000|Overall Study|Death|0|||
162187533|NCT00413283|585739166|FG001|Overall Study|Death|0|||
162187534|NCT00413283|585739167|FG002|Overall Study|Death|1|||
162187535|NCT00413283|585739168|FG003|Overall Study|Death|1|||
162187536|NCT00413283|585739165|FG000|Overall Study|Adverse Event|0|||
162187537|NCT00413283|585739166|FG001|Overall Study|Adverse Event|0|||
162187538|NCT00413283|585739167|FG002|Overall Study|Adverse Event|0|||
162187539|NCT00413283|585739168|FG003|Overall Study|Adverse Event|1|||
162187540|NCT00413283|585739165|FG000|Overall Study|Ineligibility determined|0|||
162187541|NCT00413283|585739166|FG001|Overall Study|Ineligibility determined|0|||
162187542|NCT00413283|585739167|FG002|Overall Study|Ineligibility determined|0|||
162187543|NCT00413283|585739168|FG003|Overall Study|Ineligibility determined|1|||
162187544|NCT00413283|585739165|FG000|Overall Study|Protocol deviation|0|||
162187545|NCT00413283|585739166|FG001|Overall Study|Protocol deviation|1|||
162187546|NCT00413283|585739167|FG002|Overall Study|Protocol deviation|0|||
162187547|NCT00413283|585739168|FG003|Overall Study|Protocol deviation|0|||
162187548|NCT00413283|585739165|FG000|Overall Study|Requirement for alternative therapy|0|||
162187549|NCT00413283|585739166|FG001|Overall Study|Requirement for alternative therapy|2|||
162187550|NCT00413283|585739167|FG002|Overall Study|Requirement for alternative therapy|0|||
162187551|NCT00413283|585739168|FG003|Overall Study|Requirement for alternative therapy|0|||
162187552|NCT00413283|585739165|FG000|Overall Study|Other|0|||
162187553|NCT00413283|585739166|FG001|Overall Study|Other|0|||
162187554|NCT00413283|585739167|FG002|Overall Study|Other|1|||
162187555|NCT00413283|585739168|FG003|Overall Study|Other|0|||
162187556|NCT02310581|585739180|FG000|Overall Study|Adverse Event|1|||
162187557|NCT02310581|585739181|FG001|Overall Study|Adverse Event|1|||
162187558|NCT02310581|585739182|FG002|Overall Study|Adverse Event|1|||
162187559|NCT02310581|585739183|FG003|Overall Study|Adverse Event|0|||
162187560|NCT02310581|585739180|FG000|Overall Study|Withdrawal by Subject|2|||
162187561|NCT02310581|585739181|FG001|Overall Study|Withdrawal by Subject|1|||
162187562|NCT02310581|585739182|FG002|Overall Study|Withdrawal by Subject|0|||
161819124|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
161819125|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
162187563|NCT02310581|585739183|FG003|Overall Study|Withdrawal by Subject|1|||
162187564|NCT00887224|585739184|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
161819126|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
161819127|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
162187565|NCT00887224|585739185|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
162187566|NCT00887224|585739186|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
162187567|NCT00887224|585739184|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
162187568|NCT00887224|585739185|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
162187569|NCT00887224|585739186|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
162187570|NCT00887224|585739184|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
162187571|NCT00887224|585739185|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
162187572|NCT00887224|585739186|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
162187573|NCT00887224|585739184|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
162187574|NCT00887224|585739185|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
162187575|NCT00887224|585739186|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
162187576|NCT00887224|585739184|FG000|Open-label Response (OLR) Phase|Other|1|||
162187577|NCT00887224|585739185|FG001|Open-label Response (OLR) Phase|Other|0|||
162187578|NCT00887224|585739186|FG002|Open-label Response (OLR) Phase|Other|0|||
162187579|NCT00887224|585739184|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
162187580|NCT00887224|585739185|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
162187581|NCT00887224|585739186|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
162187582|NCT00887224|585739184|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
162187583|NCT00887224|585739185|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
162187584|NCT00887224|585739186|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
162187585|NCT00887224|585739184|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
162187586|NCT00887224|585739185|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
162187587|NCT00887224|585739186|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
162187588|NCT00887224|585739184|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
162187589|NCT00887224|585739185|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
162187590|NCT00887224|585739186|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
162187591|NCT00887224|585739184|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
162187592|NCT00887224|585739185|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
162187593|NCT00887224|585739186|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
162187594|NCT00887224|585739184|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
162187595|NCT00887224|585739185|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
162187596|NCT00887224|585739186|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
162187597|NCT00887224|585739184|FG000|Open-label Stability (OLS) Phase|Other|1|||
162187598|NCT00887224|585739185|FG001|Open-label Stability (OLS) Phase|Other|0|||
162187599|NCT00887224|585739186|FG002|Open-label Stability (OLS) Phase|Other|0|||
162187600|NCT00887224|585739184|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
162187601|NCT00887224|585739185|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
162187602|NCT00887224|585739186|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
162187603|NCT00887224|585739184|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
162187604|NCT00887224|585739185|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
162187605|NCT00887224|585739186|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
162187606|NCT00887224|585739184|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
161819128|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
161819129|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
161819130|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
161819131|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
161819132|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
161819133|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
161819134|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
161819135|NCT02227238|584378229|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
161819136|NCT02227238|584378230|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
161819137|NCT02227238|584378231|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
161819138|NCT02227238|584378229|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
161819139|NCT02227238|584378230|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
161819140|NCT02227238|584378231|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
161819141|NCT02227238|584378229|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
161819142|NCT02227238|584378230|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
161819143|NCT02227238|584378231|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
161819144|NCT02227238|584378229|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
161819145|NCT02227238|584378230|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
161819146|NCT02227238|584378231|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
161819147|NCT02227238|584378229|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
161819148|NCT02227238|584378230|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
161819149|NCT02227238|584378231|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
161819150|NCT02227238|584378229|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
161819151|NCT02227238|584378230|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
161819152|NCT02227238|584378231|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
161819153|NCT02227238|584378229|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
161819154|NCT02227238|584378230|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
161819155|NCT02227238|584378231|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
161819156|NCT00380588|584378232|FG000|Overall Study|Unequivocal Disease Progression|25|||
162019434|NCT02867384|585126060|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
162019435|NCT02867384|585126061|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
162187607|NCT00887224|585739185|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
162187608|NCT00887224|585739186|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
162187609|NCT00887224|585739184|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
162187610|NCT00887224|585739185|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
162187611|NCT00887224|585739186|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
162187612|NCT00887224|585739184|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
162187613|NCT00887224|585739185|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
162187614|NCT00887224|585739186|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
162187615|NCT00887224|585739184|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
162187616|NCT00887224|585739185|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
162187617|NCT00887224|585739186|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
162187618|NCT00887224|585739184|FG000|OL Taper Phase / OL Follow Up|Other|30|||
162187619|NCT00887224|585739185|FG001|OL Taper Phase / OL Follow Up|Other|0|||
162187620|NCT00887224|585739186|FG002|OL Taper Phase / OL Follow Up|Other|0|||
162187621|NCT00887224|585739184|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
162187622|NCT00887224|585739185|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
162187623|NCT00887224|585739186|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
162187624|NCT00887224|585739184|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
162187625|NCT00887224|585739185|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
162187626|NCT00887224|585739186|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
162187627|NCT00887224|585739184|FG000|Double-blind (DB) Phase|Adverse Event|0|||
162187628|NCT00887224|585739185|FG001|Double-blind (DB) Phase|Adverse Event|7|||
162187629|NCT00887224|585739186|FG002|Double-blind (DB) Phase|Adverse Event|2|||
162187630|NCT00887224|585739184|FG000|Double-blind (DB) Phase|Failed to return|0|||
162187631|NCT00887224|585739185|FG001|Double-blind (DB) Phase|Failed to return|2|||
162187632|NCT00887224|585739186|FG002|Double-blind (DB) Phase|Failed to return|2|||
162187633|NCT00887224|585739184|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
162187634|NCT00887224|585739185|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
162187635|NCT00887224|585739186|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
162187636|NCT00887224|585739184|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
162187637|NCT00887224|585739185|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
162187638|NCT00887224|585739186|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
162187639|NCT00887224|585739184|FG000|Double-blind (DB) Phase|Other|0|||
162187640|NCT00887224|585739185|FG001|Double-blind (DB) Phase|Other|2|||
162187641|NCT00887224|585739186|FG002|Double-blind (DB) Phase|Other|0|||
162187642|NCT00887224|585739184|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
162187643|NCT00887224|585739185|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
162187644|NCT00887224|585739186|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
162187645|NCT00887224|585739184|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
162187646|NCT00887224|585739185|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
162187647|NCT00887224|585739186|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
161819157|NCT00380588|584378233|FG001|Overall Study|Unequivocal Disease Progression|34|||
161819158|NCT00380588|584378232|FG000|Overall Study|Next Cycle Not Started|4|||
161925218|NCT01807520|584771806|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
161925219|NCT01807520|584771807|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
161925220|NCT01807520|584771808|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
161925221|NCT01807520|584771809|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
161925222|NCT01807520|584771803|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
162187648|NCT00887224|585739184|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
161819159|NCT00380588|584378233|FG001|Overall Study|Next Cycle Not Started|0|||
161819160|NCT00380588|584378232|FG000|Overall Study|Adverse Event|7|||
161819161|NCT00380588|584378233|FG001|Overall Study|Adverse Event|3|||
161819162|NCT00380588|584378232|FG000|Overall Study|Withdrawal by Subject|1|||
161819163|NCT00380588|584378233|FG001|Overall Study|Withdrawal by Subject|3|||
161819164|NCT00380588|584378232|FG000|Overall Study|Physician Decision|2|||
161819165|NCT00380588|584378233|FG001|Overall Study|Physician Decision|0|||
161819166|NCT02096705|584378234|FG000|Treatment|Adverse Event|6|||
161819167|NCT02096705|584378235|FG001|Treatment|Adverse Event|3|||
161819168|NCT02096705|584378234|FG000|Treatment|Subject request to discontinue treatment|1|||
161819169|NCT02096705|584378235|FG001|Treatment|Subject request to discontinue treatment|1|||
161819170|NCT02096705|584378234|FG000|Treatment|Withdrawal by Subject|1|||
162187649|NCT00887224|585739185|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
162187650|NCT00887224|585739186|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
162187651|NCT00887224|585739184|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
162187652|NCT00887224|585739185|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
162187653|NCT00887224|585739186|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
162187654|NCT00887224|585739184|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
161819171|NCT02096705|584378235|FG001|Treatment|Withdrawal by Subject|0|||
161819172|NCT02096705|584378234|FG000|Treatment|Other|1|||
162187655|NCT00887224|585739185|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
162187656|NCT00887224|585739186|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
162187657|NCT00887224|585739184|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
161819173|NCT02096705|584378235|FG001|Treatment|Other|1|||
161819174|NCT02096705|584378234|FG000|Follow-up|Withdrawal by Subject|1|||
161819175|NCT02096705|584378235|FG001|Follow-up|Withdrawal by Subject|0|||
161819176|NCT02096705|584378234|FG000|Follow-up|Adverse Event|2|||
161819177|NCT02096705|584378235|FG001|Follow-up|Adverse Event|2|||
161819178|NCT02096705|584378234|FG000|Follow-up|Subjects not reporting status|1|||
161819179|NCT02096705|584378235|FG001|Follow-up|Subjects not reporting status|2|||
161819180|NCT02905435|584378236|FG000|Overall Study|Death|2|||
161819181|NCT02905435|584378236|FG000|Overall Study|Physician Decision|1|||
161819182|NCT02905435|584378236|FG000|Overall Study|Lost to Follow-up|4|||
161819183|NCT02377349|584378240|FG000|Overall Study|Serious Adverse Event|1|||
161819184|NCT02377349|584378241|FG001|Overall Study|Serious Adverse Event|0|||
161819185|NCT02377349|584378240|FG000|Overall Study|Protocol Violation|3|||
161819186|NCT02377349|584378241|FG001|Overall Study|Protocol Violation|2|||
161819187|NCT02377349|584378240|FG000|Overall Study|Withdrawal by Subject|5|||
161819188|NCT02377349|584378241|FG001|Overall Study|Withdrawal by Subject|3|||
161819189|NCT02377349|584378240|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
161819190|NCT02377349|584378241|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
161819191|NCT02377349|584378240|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
161819192|NCT02377349|584378241|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
161819193|NCT02377349|584378240|FG000|Overall Study|Other|0|||
161819194|NCT02377349|584378241|FG001|Overall Study|Other|1|||
161819195|NCT01663896|584378254|FG000|Overall Study|Various reasons|43|||
161819196|NCT00999687|584378258|FG000|First Intervention|Withdrawal by Subject|1|||
161819197|NCT00999687|584378258|FG000|Second Intervention|Withdrawal by Subject|2|||
161819198|NCT00999687|584378258|FG000|Second Intervention|Lack of Efficacy|1|||
161819199|NCT03614728|584378261|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
162019436|NCT02867384|585126062|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
162019437|NCT02867384|585126060|FG000|Overall Study|Progression/ Relapse|15|||
162019438|NCT02867384|585126061|FG001|Overall Study|Progression/ Relapse|19|||
162019439|NCT02867384|585126062|FG002|Overall Study|Progression/ Relapse|0|||
162019440|NCT02867384|585126060|FG000|Overall Study|Adverse Event|13|||
162019441|NCT02867384|585126061|FG001|Overall Study|Adverse Event|1|||
162019442|NCT02867384|585126062|FG002|Overall Study|Adverse Event|0|||
162019443|NCT02867384|585126060|FG000|Overall Study|Withdrawal by Subject|6|||
162019444|NCT02867384|585126061|FG001|Overall Study|Withdrawal by Subject|5|||
162019445|NCT02867384|585126062|FG002|Overall Study|Withdrawal by Subject|0|||
162019446|NCT02867384|585126060|FG000|Overall Study|Physician Decision|1|||
162019447|NCT02867384|585126061|FG001|Overall Study|Physician Decision|2|||
162019448|NCT02867384|585126062|FG002|Overall Study|Physician Decision|0|||
162019449|NCT02867384|585126060|FG000|Overall Study|Patient compliance|1|||
162019450|NCT02867384|585126061|FG001|Overall Study|Patient compliance|0|||
162019451|NCT02867384|585126062|FG002|Overall Study|Patient compliance|0|||
162019452|NCT02867384|585126060|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
162019453|NCT02867384|585126061|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
162019454|NCT02867384|585126062|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
162019455|NCT02867384|585126060|FG000|Overall Study|Never start treatment|3|||
162019456|NCT02867384|585126061|FG001|Overall Study|Never start treatment|0|||
162019457|NCT02867384|585126062|FG002|Overall Study|Never start treatment|0|||
162019458|NCT01941186|585126063|FG000|Follow-up|Lost to Follow-up|1|||
162019459|NCT01941186|585126064|FG001|Follow-up|Lost to Follow-up|0|||
162019460|NCT02105961|585126065|FG000|Overall Study|Adverse Event|18|||
162019461|NCT02105961|585126066|FG001|Overall Study|Adverse Event|7|||
162019462|NCT02105961|585126067|FG002|Overall Study|Adverse Event|13|||
162019463|NCT02105961|585126065|FG000|Overall Study|Lack of Efficacy|3|||
162019464|NCT02105961|585126066|FG001|Overall Study|Lack of Efficacy|0|||
162019465|NCT02105961|585126067|FG002|Overall Study|Lack of Efficacy|3|||
162019466|NCT02105961|585126065|FG000|Overall Study|Lost to Follow-up|2|||
162019467|NCT02105961|585126066|FG001|Overall Study|Lost to Follow-up|0|||
162019468|NCT02105961|585126067|FG002|Overall Study|Lost to Follow-up|1|||
162019469|NCT02105961|585126065|FG000|Overall Study|Physician Decision|3|||
162019470|NCT02105961|585126066|FG001|Overall Study|Physician Decision|3|||
162019471|NCT02105961|585126067|FG002|Overall Study|Physician Decision|2|||
162019472|NCT02105961|585126065|FG000|Overall Study|Withdrawal by Subject|15|||
162019473|NCT02105961|585126066|FG001|Overall Study|Withdrawal by Subject|7|||
162019474|NCT02105961|585126067|FG002|Overall Study|Withdrawal by Subject|11|||
162019475|NCT00934362|585126071|FG000|Overall Study|Adverse Event|1|||
162019476|NCT00934362|585126072|FG001|Overall Study|Adverse Event|0|||
162019477|NCT01092117|585126075|FG000|Index Procedure to 1 Month|Death|1|||
162019478|NCT01092117|585126075|FG000|1 Month|Death|1|||
162019479|NCT01092117|585126075|FG000|1 Month|Withdrawal by Subject|1|||
162019480|NCT01092117|585126075|FG000|1 Month|Lost to Follow-up|1|||
161819200|NCT03614728|584378262|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
161819201|NCT03614728|584378263|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
161819202|NCT03614728|584378264|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
162019481|NCT01092117|585126075|FG000|6 Months|Death|2|||
162019482|NCT01092117|585126075|FG000|6 Months|Withdrawal by Subject|3|||
162187658|NCT00887224|585739185|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
162187659|NCT00887224|585739186|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
162187660|NCT00887224|585739184|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
162187661|NCT00887224|585739185|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
162187662|NCT00887224|585739186|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
162187663|NCT00887224|585739184|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
162187664|NCT00887224|585739185|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
162187665|NCT00887224|585739186|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
162187666|NCT00887224|585739184|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
162187667|NCT00887224|585739185|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
162187668|NCT00887224|585739186|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
162187669|NCT03883828|585739187|FG000|Overall Study|Did not start radiotherapy|1|||
162187670|NCT03883828|585739188|FG001|Overall Study|Did not start radiotherapy|2|||
162187671|NCT00878189|585739192|FG000|Overall Study|Death|0|||
162187672|NCT00878189|585739193|FG001|Overall Study|Death|1|||
162187673|NCT00878189|585739194|FG002|Overall Study|Death|0|||
162187674|NCT00878189|585739195|FG003|Overall Study|Death|1|||
162187675|NCT00878189|585739196|FG004|Overall Study|Death|0|||
162187676|NCT00878189|585739197|FG005|Overall Study|Death|0|||
162187677|NCT00878189|585739198|FG006|Overall Study|Death|0|||
162187678|NCT00878189|585739199|FG007|Overall Study|Death|0|||
162187679|NCT00878189|585739200|FG008|Overall Study|Death|1|||
162187680|NCT00878189|585739192|FG000|Overall Study|Participant Refused to Follow-up|0|||
161819203|NCT03614728|584378261|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
161819204|NCT03614728|584378262|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
161819205|NCT03614728|584378263|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
161819206|NCT03614728|584378264|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
161819207|NCT01401062|584378269|FG000|Overall Study|Death|9|||
161819208|NCT01401062|584378270|FG001|Overall Study|Death|7|||
161819209|NCT01401062|584378269|FG000|Overall Study|Physician Decision|1|||
161819210|NCT01401062|584378270|FG001|Overall Study|Physician Decision|0|||
161819211|NCT01401062|584378269|FG000|Overall Study|Withdrawal by Subject|1|||
161819212|NCT01401062|584378270|FG001|Overall Study|Withdrawal by Subject|1|||
161819213|NCT03684928|584378273|FG000|First Intervention|Lost to Follow-up|0|||
161819214|NCT03684928|584378274|FG001|First Intervention|Lost to Follow-up|1|||
161819215|NCT03684928|584378273|FG000|First Intervention|Withdrawal by Subject|0|||
161819216|NCT03684928|584378274|FG001|First Intervention|Withdrawal by Subject|2|||
161819217|NCT03684928|584378273|FG000|Second Intervention|Soft Tissue Injury|1|||
161819218|NCT03684928|584378274|FG001|Second Intervention|Soft Tissue Injury|0|||
161819219|NCT03193021|584378275|FG000|Overall Study|Lost to Follow-up|1|||
161819220|NCT03193021|584378276|FG001|Overall Study|Lost to Follow-up|1|||
161819221|NCT02286466|584378277|FG000|Overall Study|Death|1|||
161819222|NCT02286466|584378278|FG001|Overall Study|Death|3|||
161819223|NCT02286466|584378277|FG000|Overall Study|Withdrawal by Subject|5|||
161819224|NCT02286466|584378278|FG001|Overall Study|Withdrawal by Subject|2|||
161819225|NCT02286466|584378277|FG000|Overall Study|Lost to Follow-up|1|||
161819226|NCT02286466|584378278|FG001|Overall Study|Lost to Follow-up|4|||
161819227|NCT02286466|584378277|FG000|Overall Study|Declined Clinician Assessment|0|||
161819228|NCT02286466|584378278|FG001|Overall Study|Declined Clinician Assessment|1|||
161819229|NCT00835081|584378279|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161819230|NCT00835081|584378280|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161819231|NCT01139762|584378281|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
161819232|NCT01139762|584378282|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
161819233|NCT01139762|584378283|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
161819234|NCT01139762|584378281|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
161819235|NCT01139762|584378282|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
161819236|NCT01139762|584378283|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
161819237|NCT01139762|584378281|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
161819238|NCT01139762|584378282|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
161819239|NCT01139762|584378283|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
161819240|NCT01139762|584378281|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
161819241|NCT01139762|584378282|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
161819242|NCT01139762|584378283|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
161819243|NCT01139762|584378281|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
161819244|NCT01139762|584378282|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
161819245|NCT01139762|584378283|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
161819246|NCT01139762|584378281|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
162187681|NCT00878189|585739193|FG001|Overall Study|Participant Refused to Follow-up|0|||
162187682|NCT00878189|585739194|FG002|Overall Study|Participant Refused to Follow-up|0|||
162187683|NCT00878189|585739195|FG003|Overall Study|Participant Refused to Follow-up|0|||
162187684|NCT00878189|585739196|FG004|Overall Study|Participant Refused to Follow-up|0|||
162187685|NCT00878189|585739197|FG005|Overall Study|Participant Refused to Follow-up|4|||
161683061|NCT02554019|583891222|FG001|Overall Study|Adverse Event|0|||
162187686|NCT00878189|585739198|FG006|Overall Study|Participant Refused to Follow-up|0|||
162187687|NCT00878189|585739199|FG007|Overall Study|Participant Refused to Follow-up|0|||
162187688|NCT00878189|585739200|FG008|Overall Study|Participant Refused to Follow-up|0|||
162187689|NCT00878189|585739192|FG000|Overall Study|Other|3|||
162187690|NCT00878189|585739193|FG001|Overall Study|Other|2|||
162187691|NCT00878189|585739194|FG002|Overall Study|Other|4|||
162187692|NCT00878189|585739195|FG003|Overall Study|Other|7|||
162187693|NCT00878189|585739196|FG004|Overall Study|Other|4|||
162187694|NCT00878189|585739197|FG005|Overall Study|Other|18|||
162187695|NCT00878189|585739198|FG006|Overall Study|Other|15|||
162187696|NCT00878189|585739199|FG007|Overall Study|Other|3|||
162187697|NCT00878189|585739200|FG008|Overall Study|Other|4|||
162187698|NCT00878189|585739192|FG000|Overall Study|Lost to Follow-up|0|||
162187699|NCT00878189|585739193|FG001|Overall Study|Lost to Follow-up|0|||
162187700|NCT00878189|585739194|FG002|Overall Study|Lost to Follow-up|0|||
162187701|NCT00878189|585739195|FG003|Overall Study|Lost to Follow-up|0|||
162187702|NCT00878189|585739196|FG004|Overall Study|Lost to Follow-up|0|||
162187703|NCT00878189|585739197|FG005|Overall Study|Lost to Follow-up|1|||
162187704|NCT00878189|585739198|FG006|Overall Study|Lost to Follow-up|1|||
161925223|NCT01807520|584771804|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
161925224|NCT01807520|584771805|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
161925225|NCT01807520|584771806|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
161925226|NCT01807520|584771807|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
161925227|NCT01807520|584771808|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
161925228|NCT01807520|584771809|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
161925229|NCT01807520|584771803|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
161925230|NCT01807520|584771804|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
161925231|NCT01807520|584771805|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
161925232|NCT01807520|584771806|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
161925233|NCT01807520|584771807|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
161925234|NCT01807520|584771808|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
161925235|NCT01807520|584771809|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
161925236|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
161925237|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
161925238|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
161925239|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
161925240|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
161925241|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
161925242|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
161925243|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
161925244|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
161925245|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
161925246|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
161925247|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
161925248|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
161925249|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
161925250|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
161925251|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
161925252|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
161925253|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
161925254|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
161925255|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
161925256|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
161925257|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
161925258|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
161925259|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
161925260|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
161925261|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
161925262|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
161925263|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
161925264|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
162187705|NCT00878189|585739199|FG007|Overall Study|Lost to Follow-up|0|||
162187706|NCT00878189|585739200|FG008|Overall Study|Lost to Follow-up|0|||
162187707|NCT00878189|585739192|FG000|Overall Study|Objection Progression or Relapse|0|||
162187708|NCT00878189|585739193|FG001|Overall Study|Objection Progression or Relapse|0|||
162187709|NCT00878189|585739194|FG002|Overall Study|Objection Progression or Relapse|0|||
161925265|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
161925266|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
162187710|NCT00878189|585739195|FG003|Overall Study|Objection Progression or Relapse|0|||
162187711|NCT00878189|585739196|FG004|Overall Study|Objection Progression or Relapse|0|||
162019483|NCT01092117|585126075|FG000|12 Month|Death|11|||
162019484|NCT01092117|585126075|FG000|12 Month|Withdrawal by Subject|2|||
162019485|NCT01092117|585126075|FG000|12 Month|Lost to Follow-up|1|||
162019486|NCT01092117|585126075|FG000|Year 2|Death|5|||
162019487|NCT01092117|585126075|FG000|Year 2|Withdrawal by Subject|4|||
162019488|NCT01092117|585126075|FG000|Year 2|Lost to Follow-up|1|||
162019489|NCT01092117|585126075|FG000|Year 3|Death|7|||
162019490|NCT01092117|585126075|FG000|Year 3|Withdrawal by Subject|9|||
162019491|NCT01092117|585126075|FG000|Year 3|Lost to Follow-up|3|||
162019492|NCT01092117|585126075|FG000|Year 4|Death|8|||
162019493|NCT01092117|585126075|FG000|Year 4|Withdrawal by Subject|4|||
162019494|NCT01092117|585126075|FG000|Year 4|Lost to Follow-up|4|||
162019495|NCT04380519|585126076|FG000|Overall Study|Withdrawal by Subject|4|||
162019496|NCT04380519|585126077|FG001|Overall Study|Withdrawal by Subject|0|||
162019497|NCT04380519|585126078|FG002|Overall Study|Withdrawal by Subject|1|||
162019498|NCT04380519|585126076|FG000|Overall Study|Death|14|||
162019499|NCT04380519|585126077|FG001|Overall Study|Death|9|||
162019500|NCT04380519|585126078|FG002|Overall Study|Death|6|||
162019501|NCT04380519|585126076|FG000|Overall Study|Adverse Event|0|||
162019502|NCT04380519|585126077|FG001|Overall Study|Adverse Event|1|||
162019503|NCT04380519|585126078|FG002|Overall Study|Adverse Event|0|||
162019504|NCT04380519|585126076|FG000|Overall Study|relatives' decision|0|||
162019505|NCT04380519|585126077|FG001|Overall Study|relatives' decision|1|||
162019506|NCT04380519|585126078|FG002|Overall Study|relatives' decision|0|||
162019507|NCT04173494|585126079|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
162019508|NCT04173494|585126080|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
162019509|NCT04173494|585126079|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
162019510|NCT04173494|585126080|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
162019511|NCT04173494|585126079|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
162019512|NCT04173494|585126080|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
162019513|NCT04173494|585126079|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
162019514|NCT04173494|585126080|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
162019515|NCT04173494|585126079|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
162019516|NCT04173494|585126080|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
162019517|NCT04173494|585126079|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
162019518|NCT04173494|585126080|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
162019519|NCT04173494|585126079|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
162019520|NCT04173494|585126080|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
162019521|NCT04173494|585126079|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
162019522|NCT04173494|585126080|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
162019523|NCT04173494|585126079|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
162019524|NCT04173494|585126080|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
162187712|NCT00878189|585739197|FG005|Overall Study|Objection Progression or Relapse|0|||
162187713|NCT00878189|585739198|FG006|Overall Study|Objection Progression or Relapse|0|||
162187714|NCT00878189|585739199|FG007|Overall Study|Objection Progression or Relapse|0|||
162187715|NCT00878189|585739200|FG008|Overall Study|Objection Progression or Relapse|3|||
162187716|NCT02708498|585739201|FG000|Overall Study|Death|20|||
162187717|NCT02708498|585739202|FG001|Overall Study|Death|19|||
162187718|NCT02708498|585739203|FG002|Overall Study|Death|0|||
162187719|NCT02708498|585739204|FG003|Overall Study|Death|0|||
162187720|NCT02708498|585739205|FG004|Overall Study|Death|1|||
162187721|NCT02708498|585739206|FG005|Overall Study|Death|0|||
162187722|NCT02708498|585739207|FG006|Overall Study|Death|0|||
162187723|NCT02708498|585739208|FG007|Overall Study|Death|0|||
162187724|NCT02708498|585739201|FG000|Overall Study|Unknown reason, missing data|0|||
162187725|NCT02708498|585739202|FG001|Overall Study|Unknown reason, missing data|0|||
162187726|NCT02708498|585739203|FG002|Overall Study|Unknown reason, missing data|62|||
162187727|NCT02708498|585739204|FG003|Overall Study|Unknown reason, missing data|51|||
162187728|NCT02708498|585739205|FG004|Overall Study|Unknown reason, missing data|195|||
162187729|NCT02708498|585739206|FG005|Overall Study|Unknown reason, missing data|132|||
162187730|NCT02708498|585739207|FG006|Overall Study|Unknown reason, missing data|0|||
161683062|NCT02554019|583891223|FG002|Overall Study|Adverse Event|0|||
162019525|NCT04173494|585126079|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
162019526|NCT04173494|585126080|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
162019527|NCT04173494|585126079|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
162019528|NCT04173494|585126080|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
162019529|NCT04173494|585126079|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
162019530|NCT04173494|585126080|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
162019531|NCT04173494|585126079|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
162019532|NCT04173494|585126080|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
162187731|NCT02708498|585739208|FG007|Overall Study|Unknown reason, missing data|0|||
162187732|NCT01858688|585739209|FG000|Overall Study|Withdrawal by Subject|8|||
162187733|NCT01858688|585739209|FG000|Overall Study|Participant began another therapy|3|||
162187734|NCT01858688|585739209|FG000|Overall Study|Physician Decision|2|||
162187735|NCT01858688|585739209|FG000|Overall Study|Progressive Disease|2|||
162187736|NCT01858688|585739209|FG000|Overall Study|Reason not reproted|5|||
162187737|NCT02788981|585739210|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
162187738|NCT02788981|585739211|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
162187739|NCT05553366|585739212|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
162187740|NCT05553366|585739213|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
162187741|NCT05553366|585739214|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
162187742|NCT05553366|585739212|FG000|Overall Study|Lost to Follow-up|3|||
162187743|NCT05553366|585739213|FG001|Overall Study|Lost to Follow-up|3|||
162187744|NCT05553366|585739214|FG002|Overall Study|Lost to Follow-up|3|||
162187745|NCT05553366|585739212|FG000|Overall Study|Other non-compliance|1|||
162187746|NCT05553366|585739213|FG001|Overall Study|Other non-compliance|1|||
162187747|NCT05553366|585739214|FG002|Overall Study|Other non-compliance|0|||
162187748|NCT05553366|585739212|FG000|Overall Study|Randomized but not dosed|0|||
162187749|NCT05553366|585739213|FG001|Overall Study|Randomized but not dosed|0|||
162187750|NCT05553366|585739214|FG002|Overall Study|Randomized but not dosed|2|||
162187751|NCT02022657|585739215|FG000|Overall Study|Withdrawal by Subject|2|||
162187752|NCT02022657|585739216|FG001|Overall Study|Withdrawal by Subject|0|||
162187753|NCT02022657|585739217|FG002|Overall Study|Withdrawal by Subject|1|||
162187754|NCT02022657|585739218|FG003|Overall Study|Withdrawal by Subject|0|||
162187755|NCT02022657|585739219|FG004|Overall Study|Withdrawal by Subject|0|||
161819247|NCT01139762|584378282|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
161819248|NCT01139762|584378283|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
161819249|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
161819250|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
161819251|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
161819252|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Death|0|||
161819253|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Death|1|||
161819254|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Death|1|||
161819255|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
161819256|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
161819257|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
161819258|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
161819259|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
161819260|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
161819261|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
161819262|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
161819263|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
161819264|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
161819265|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
161819266|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
161819267|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
161819268|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
161819269|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
161819270|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
161819271|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
161819272|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
161819273|NCT01139762|584378281|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
161819274|NCT01139762|584378282|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
161819275|NCT01139762|584378283|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
161819276|NCT01675596|584378284|FG000|Overall Study|Death|6|||
161819277|NCT01675596|584378284|FG000|Overall Study|Exit with other reason|1|||
161819278|NCT01675596|584378284|FG000|Overall Study|Missed Visit|1|||
161819279|NCT00840879|584378285|FG000|Second Intervention|Withdrawal by Subject|1|||
161819280|NCT00840879|584378286|FG001|Second Intervention|Withdrawal by Subject|0|||
161819281|NCT01894230|584379599|FG000|Overall Study|Lost to Follow-up|2|||
161819282|NCT01894230|584379600|FG001|Overall Study|Lost to Follow-up|2|||
161819283|NCT01894230|584379599|FG000|Overall Study|Withdrawal by Subject|4|||
161819284|NCT01894230|584379600|FG001|Overall Study|Withdrawal by Subject|4|||
161819285|NCT01894230|584379599|FG000|Overall Study|Non-adherent|0|||
161819286|NCT01894230|584379600|FG001|Overall Study|Non-adherent|1|||
161819287|NCT01894230|584379599|FG000|Overall Study|Death|1|||
161819288|NCT01894230|584379600|FG001|Overall Study|Death|0|||
161819289|NCT02219009|584379601|FG000|Overall Study|Withdrawal by Subject|5|||
161819290|NCT02219009|584379602|FG001|Overall Study|Withdrawal by Subject|1|||
162187756|NCT02022657|585739220|FG005|Overall Study|Withdrawal by Subject|0|||
162187757|NCT02022657|585739215|FG000|Overall Study|Physician Decision|0|||
162187758|NCT02022657|585739216|FG001|Overall Study|Physician Decision|0|||
162187759|NCT02022657|585739217|FG002|Overall Study|Physician Decision|0|||
162187760|NCT02022657|585739218|FG003|Overall Study|Physician Decision|0|||
162187761|NCT02022657|585739219|FG004|Overall Study|Physician Decision|0|||
162187762|NCT02022657|585739220|FG005|Overall Study|Physician Decision|1|||
162187763|NCT00795184|585739222|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
162187764|NCT00795184|585739223|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
162187765|NCT00659373|585739241|FG000|Overall Study|Withdrawal by Subject|3|||
162187766|NCT00659373|585739242|FG001|Overall Study|Withdrawal by Subject|5|||
162187767|NCT00659373|585739241|FG000|Overall Study|Assessment Missed|2|||
161925267|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
161925268|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
161925269|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
161925270|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
161925271|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
161925272|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
161925273|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
161925274|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
161925275|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
161925276|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
161925277|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
161925278|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
161925279|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
161925280|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
161925281|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
161925282|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
161925283|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
161925284|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
161925285|NCT01807520|584771803|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
161925286|NCT01807520|584771804|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
161925287|NCT01807520|584771805|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
161925288|NCT01807520|584771806|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
161925289|NCT01807520|584771807|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
161925290|NCT01807520|584771808|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
162187768|NCT00659373|585739242|FG001|Overall Study|Assessment Missed|2|||
162187769|NCT03042767|585739245|FG000|Overall Study|Lost to Follow-up|1|||
162187770|NCT03042767|585739246|FG001|Overall Study|Lost to Follow-up|2|||
162187771|NCT04638816|585739248|FG000|Overall Study|Withdrawal by Subject|0|||
162187772|NCT04638816|585739249|FG001|Overall Study|Withdrawal by Subject|1|||
162187773|NCT04638816|585739248|FG000|Overall Study|Lost to Follow-up|0|||
162187774|NCT04638816|585739249|FG001|Overall Study|Lost to Follow-up|1|||
162187775|NCT01328496|585739252|FG000|Overall Study|Significant Change in Health Status|1|||
162187776|NCT01328496|585739253|FG001|Overall Study|Significant Change in Health Status|0|||
162187777|NCT02208843|585739254|FG000|Overall Study|Clinical symptoms of progression|2|||
162187778|NCT02208843|585739254|FG000|Overall Study|Progression disease according to RECIST|24|||
162187779|NCT02208843|585739254|FG000|Overall Study|Adverse Event|12|||
162187780|NCT02208843|585739254|FG000|Overall Study|Protocol Violation|1|||
162187781|NCT02208843|585739254|FG000|Overall Study|Withdrawal by Subject|1|||
162187782|NCT02208843|585739254|FG000|Overall Study|Switched to commercial afatinib|20|||
162187783|NCT04399837|585739256|FG000|Overall Study|Other than listed|0|||
162187784|NCT04399837|585739257|FG001|Overall Study|Other than listed|2|||
162187785|NCT04399837|585739258|FG002|Overall Study|Other than listed|2|||
162187786|NCT04399837|585739259|FG003|Overall Study|Other than listed|3|||
162187787|NCT04399837|585739256|FG000|Overall Study|Withdrawal by Subject|1|||
162187788|NCT04399837|585739257|FG001|Overall Study|Withdrawal by Subject|2|||
162187789|NCT04399837|585739258|FG002|Overall Study|Withdrawal by Subject|1|||
162187790|NCT04399837|585739259|FG003|Overall Study|Withdrawal by Subject|1|||
162187791|NCT02686658|585739264|FG000|Overall Study|Adverse Event|0|||
162187792|NCT02686658|585739265|FG001|Overall Study|Adverse Event|0|||
161925291|NCT01807520|584771809|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
161925292|NCT01807520|584771803|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
161925293|NCT01807520|584771804|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
162187793|NCT02686658|585739266|FG002|Overall Study|Adverse Event|1|||
161925294|NCT01807520|584771805|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
161925295|NCT01807520|584771806|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
161925296|NCT01807520|584771807|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
162019533|NCT04173494|585126079|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
162187794|NCT02686658|585739267|FG003|Overall Study|Adverse Event|1|||
162187795|NCT02686658|585739268|FG004|Overall Study|Adverse Event|2|||
162187796|NCT02686658|585739269|FG005|Overall Study|Adverse Event|1|||
162187797|NCT02686658|585739264|FG000|Overall Study|Investigator decision|0|||
162187798|NCT02686658|585739265|FG001|Overall Study|Investigator decision|0|||
162187799|NCT02686658|585739266|FG002|Overall Study|Investigator decision|0|||
162187800|NCT02686658|585739267|FG003|Overall Study|Investigator decision|1|||
162187801|NCT02686658|585739268|FG004|Overall Study|Investigator decision|2|||
162187802|NCT02686658|585739269|FG005|Overall Study|Investigator decision|1|||
162187803|NCT02686658|585739264|FG000|Overall Study|Sponsor decision|1|||
162187804|NCT02686658|585739265|FG001|Overall Study|Sponsor decision|2|||
162187805|NCT02686658|585739266|FG002|Overall Study|Sponsor decision|1|||
162187806|NCT02686658|585739267|FG003|Overall Study|Sponsor decision|5|||
162187807|NCT02686658|585739268|FG004|Overall Study|Sponsor decision|13|||
162187808|NCT02686658|585739269|FG005|Overall Study|Sponsor decision|2|||
162187809|NCT02686658|585739264|FG000|Overall Study|Lost to Follow-up|0|||
162187810|NCT02686658|585739265|FG001|Overall Study|Lost to Follow-up|0|||
162187811|NCT02686658|585739266|FG002|Overall Study|Lost to Follow-up|2|||
162187812|NCT02686658|585739267|FG003|Overall Study|Lost to Follow-up|0|||
162187813|NCT02686658|585739268|FG004|Overall Study|Lost to Follow-up|0|||
162187814|NCT02686658|585739269|FG005|Overall Study|Lost to Follow-up|1|||
162187815|NCT02686658|585739264|FG000|Overall Study|Death|1|||
162187816|NCT02686658|585739265|FG001|Overall Study|Death|0|||
162187817|NCT02686658|585739266|FG002|Overall Study|Death|0|||
162187818|NCT02686658|585739267|FG003|Overall Study|Death|1|||
162187819|NCT02686658|585739268|FG004|Overall Study|Death|1|||
162187820|NCT02686658|585739269|FG005|Overall Study|Death|1|||
162187821|NCT02686658|585739264|FG000|Overall Study|Withdrawal by Subject|2|||
162187822|NCT02686658|585739265|FG001|Overall Study|Withdrawal by Subject|5|||
162187823|NCT02686658|585739266|FG002|Overall Study|Withdrawal by Subject|4|||
162187824|NCT02686658|585739267|FG003|Overall Study|Withdrawal by Subject|4|||
162187825|NCT02686658|585739268|FG004|Overall Study|Withdrawal by Subject|17|||
162187826|NCT02686658|585739269|FG005|Overall Study|Withdrawal by Subject|8|||
162187827|NCT02686658|585739264|FG000|Overall Study|Placed in hospice care|0|||
162187828|NCT02686658|585739265|FG001|Overall Study|Placed in hospice care|0|||
162187829|NCT02686658|585739266|FG002|Overall Study|Placed in hospice care|1|||
162187830|NCT02686658|585739267|FG003|Overall Study|Placed in hospice care|0|||
162187831|NCT02686658|585739268|FG004|Overall Study|Placed in hospice care|0|||
162187832|NCT02686658|585739269|FG005|Overall Study|Placed in hospice care|0|||
162187833|NCT02686658|585739264|FG000|Overall Study|Participant non-compliance|0|||
162187834|NCT02686658|585739265|FG001|Overall Study|Participant non-compliance|0|||
162187835|NCT02686658|585739266|FG002|Overall Study|Participant non-compliance|0|||
162187836|NCT02686658|585739267|FG003|Overall Study|Participant non-compliance|0|||
162187837|NCT02686658|585739268|FG004|Overall Study|Participant non-compliance|0|||
162187838|NCT02686658|585739269|FG005|Overall Study|Participant non-compliance|1|||
162187839|NCT02686658|585739264|FG000|Overall Study|Concern over coronavirus disease care|0|||
162187840|NCT02686658|585739265|FG001|Overall Study|Concern over coronavirus disease care|0|||
162187841|NCT02686658|585739266|FG002|Overall Study|Concern over coronavirus disease care|0|||
162187842|NCT02686658|585739267|FG003|Overall Study|Concern over coronavirus disease care|0|||
162187843|NCT02686658|585739268|FG004|Overall Study|Concern over coronavirus disease care|2|||
162187844|NCT02686658|585739269|FG005|Overall Study|Concern over coronavirus disease care|1|||
162187845|NCT03476798|585739273|FG000|Overall Study|Death|1|||
162187846|NCT03476798|585739273|FG000|Overall Study|Withdrawal by Subject|2|||
162187847|NCT03476798|585739273|FG000|Overall Study|Protocol Violation|2|||
162187848|NCT06269003|585739274|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
162187849|NCT06269003|585739275|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
162187850|NCT06269003|585739276|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
162187851|NCT06269003|585739277|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
162187852|NCT04224272|585739281|FG000|Part 1 - Dose Finding|Death|4|||
162187853|NCT04224272|585739281|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
162187854|NCT04224272|585739281|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
161819291|NCT02219009|584379601|FG000|Overall Study|Adverse Event|2|||
161819292|NCT02219009|584379602|FG001|Overall Study|Adverse Event|4|||
161819293|NCT02219009|584379601|FG000|Overall Study|Lost to Follow-up|2|||
161819294|NCT02219009|584379602|FG001|Overall Study|Lost to Follow-up|2|||
161819295|NCT02219009|584379601|FG000|Overall Study|Protocol deviation|1|||
161819296|NCT02219009|584379602|FG001|Overall Study|Protocol deviation|0|||
162187855|NCT04224272|585739281|FG000|Part 2 - Dose Expansion|Death|10|||
162187856|NCT04224272|585739281|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
162187857|NCT02609048|585739282|FG000|Overall Study|Adverse Event|3|||
162187858|NCT02609048|585739283|FG001|Overall Study|Adverse Event|0|||
162187859|NCT02609048|585739284|FG002|Overall Study|Adverse Event|0|||
162187860|NCT02609048|585739282|FG000|Overall Study|Randomized but never treated|1|||
162187861|NCT02609048|585739283|FG001|Overall Study|Randomized but never treated|1|||
162187862|NCT02609048|585739284|FG002|Overall Study|Randomized but never treated|1|||
162187863|NCT02609048|585739282|FG000|Overall Study|Withdrawal of informed consent|1|||
162187864|NCT02609048|585739283|FG001|Overall Study|Withdrawal of informed consent|0|||
161819297|NCT02219009|584379601|FG000|Overall Study|Physician Decision|0|||
161819298|NCT02219009|584379602|FG001|Overall Study|Physician Decision|1|||
162019534|NCT04173494|585126080|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
162187865|NCT02609048|585739284|FG002|Overall Study|Withdrawal of informed consent|0|||
162187866|NCT02609048|585739282|FG000|Overall Study|Reason not specified|6|||
162187867|NCT02609048|585739283|FG001|Overall Study|Reason not specified|9|||
162187868|NCT02609048|585739284|FG002|Overall Study|Reason not specified|9|||
162187869|NCT01276509|585740601|FG000|Overall Study|Adverse Event|9|||
162187870|NCT01276509|585740602|FG001|Overall Study|Adverse Event|8|||
162187871|NCT01276509|585740603|FG002|Overall Study|Adverse Event|4|||
162187872|NCT01276509|585740604|FG003|Overall Study|Adverse Event|3|||
162187873|NCT01276509|585740601|FG000|Overall Study|Lack of Efficacy|2|||
162187874|NCT01276509|585740602|FG001|Overall Study|Lack of Efficacy|1|||
162187875|NCT01276509|585740603|FG002|Overall Study|Lack of Efficacy|1|||
162187876|NCT01276509|585740604|FG003|Overall Study|Lack of Efficacy|2|||
162187877|NCT01276509|585740601|FG000|Overall Study|Pregnancy|1|||
162187878|NCT01276509|585740602|FG001|Overall Study|Pregnancy|0|||
162187879|NCT01276509|585740603|FG002|Overall Study|Pregnancy|0|||
162187880|NCT01276509|585740604|FG003|Overall Study|Pregnancy|0|||
162187881|NCT01276509|585740601|FG000|Overall Study|Withdrawal by Subject|1|||
162187882|NCT01276509|585740602|FG001|Overall Study|Withdrawal by Subject|2|||
162187883|NCT01276509|585740603|FG002|Overall Study|Withdrawal by Subject|0|||
162187884|NCT01276509|585740604|FG003|Overall Study|Withdrawal by Subject|0|||
162187885|NCT01276509|585740601|FG000|Overall Study|Other|0|||
162187886|NCT01276509|585740602|FG001|Overall Study|Other|1|||
162187887|NCT01276509|585740603|FG002|Overall Study|Other|0|||
162187888|NCT01276509|585740604|FG003|Overall Study|Other|0|||
162187889|NCT00949117|585740606|FG000|Overall Study|Lack of Efficacy|2|||
162187890|NCT00949117|585740607|FG001|Overall Study|Lack of Efficacy|3|||
162187891|NCT00949117|585740606|FG000|Overall Study|Protocol Violation|1|||
162187892|NCT00949117|585740607|FG001|Overall Study|Protocol Violation|1|||
162187893|NCT00949117|585740606|FG000|Overall Study|Adverse Event|0|||
162187894|NCT00949117|585740607|FG001|Overall Study|Adverse Event|1|||
162187895|NCT03964974|585740608|FG000|Overall Study|Lost to Follow-up|3|||
162187896|NCT03964974|585740609|FG001|Overall Study|Lost to Follow-up|2|||
162187897|NCT03964974|585740608|FG000|Overall Study|Withdrawal by Subject|0|||
162187898|NCT03964974|585740609|FG001|Overall Study|Withdrawal by Subject|3|||
162187899|NCT02014402|585740613|FG000|Overall Study|Adverse Event|1|||
162187900|NCT02014402|585740614|FG001|Overall Study|Adverse Event|0|||
162187901|NCT02014402|585740615|FG002|Overall Study|Adverse Event|0|||
162187902|NCT02014402|585740616|FG003|Overall Study|Adverse Event|0|||
162187903|NCT02014402|585740613|FG000|Overall Study|Withdrawal by Subject|1|||
162187904|NCT02014402|585740614|FG001|Overall Study|Withdrawal by Subject|2|||
161819299|NCT02259348|584379603|FG000|Overall Study|Donors|6|||
161819300|NCT02259348|584379603|FG000|Overall Study|Death|4|||
161819301|NCT01622660|584379604|FG000|Overall Study|Adverse Event|1|||
161819302|NCT04211766|584379605|FG000|Overall Study|Withdrawal by Subject|5|||
161819303|NCT04211766|584379606|FG001|Overall Study|Withdrawal by Subject|1|||
161819304|NCT00642993|584379607|FG000|Overall Study|Adverse Event|85|||
161819305|NCT00642993|584379608|FG001|Overall Study|Adverse Event|4|||
161819306|NCT00642993|584379607|FG000|Overall Study|Lost to Follow-up|8|||
161819307|NCT00642993|584379608|FG001|Overall Study|Lost to Follow-up|4|||
161819308|NCT00642993|584379607|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
161819309|NCT00642993|584379608|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
161819310|NCT00642993|584379607|FG000|Overall Study|Protocol Violation|1|||
161819311|NCT00642993|584379608|FG001|Overall Study|Protocol Violation|4|||
161819312|NCT00642993|584379607|FG000|Overall Study|Did not meet protocol eligibility|0|||
161819313|NCT00642993|584379608|FG001|Overall Study|Did not meet protocol eligibility|1|||
161819314|NCT00642993|584379607|FG000|Overall Study|Administrative|1|||
161819315|NCT00642993|584379608|FG001|Overall Study|Administrative|0|||
161819316|NCT02664415|584379609|FG000|Overall Study|Adverse Event|1|||
161819317|NCT02664415|584379610|FG001|Overall Study|Adverse Event|0|||
161819318|NCT02034513|584379611|FG000|Overall Study|Adverse Event|11|||
161819319|NCT02034513|584379612|FG001|Overall Study|Adverse Event|10|||
161819320|NCT02034513|584379611|FG000|Overall Study|Lack of Efficacy|0|||
162187905|NCT02014402|585740615|FG002|Overall Study|Withdrawal by Subject|2|||
162187906|NCT02014402|585740616|FG003|Overall Study|Withdrawal by Subject|1|||
161819321|NCT02034513|584379612|FG001|Overall Study|Lack of Efficacy|1|||
162187907|NCT02014402|585740613|FG000|Overall Study|Subject did not have transportation|0|||
162187908|NCT02014402|585740614|FG001|Overall Study|Subject did not have transportation|1|||
162187909|NCT02014402|585740615|FG002|Overall Study|Subject did not have transportation|0|||
162187910|NCT02014402|585740616|FG003|Overall Study|Subject did not have transportation|0|||
162187911|NCT02014402|585740613|FG000|Overall Study|Lost to Follow-up|0|||
162187912|NCT02014402|585740614|FG001|Overall Study|Lost to Follow-up|0|||
162187913|NCT02014402|585740615|FG002|Overall Study|Lost to Follow-up|1|||
162187914|NCT02014402|585740616|FG003|Overall Study|Lost to Follow-up|2|||
161819322|NCT02034513|584379611|FG000|Overall Study|Lost to Follow-up|6|||
161819323|NCT02034513|584379612|FG001|Overall Study|Lost to Follow-up|7|||
161819324|NCT02034513|584379611|FG000|Overall Study|Pregnancy|0|||
162187915|NCT00670449|585740617|FG000|Overall Study|Adverse Event|6|||
162187916|NCT00670449|585740618|FG001|Overall Study|Adverse Event|2|||
162187917|NCT00670449|585740619|FG002|Overall Study|Adverse Event|8|||
162187918|NCT00670449|585740620|FG003|Overall Study|Adverse Event|5|||
162187919|NCT00670449|585740617|FG000|Overall Study|Protocol Deviation|1|||
162187920|NCT00670449|585740618|FG001|Overall Study|Protocol Deviation|2|||
162187921|NCT00670449|585740619|FG002|Overall Study|Protocol Deviation|0|||
162187922|NCT00670449|585740620|FG003|Overall Study|Protocol Deviation|1|||
162019535|NCT04173494|585126079|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
162019536|NCT04173494|585126080|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
162019537|NCT04173494|585126079|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
162019538|NCT04173494|585126080|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
162019539|NCT01623050|585126081|FG000|Overall Study|Lost to Follow-up|9|||
162019540|NCT00526071|585126084|FG000|Overall Study|Adverse Event|1|||
162019541|NCT00526071|585126084|FG000|Overall Study|Withdrawal by Subject|1|||
162019542|NCT00526071|585126084|FG000|Overall Study|Lack of Response to Study Drug|4|||
162019543|NCT01191762|585126085|FG000|Overall Study|Adverse Event|1|||
162019544|NCT01191762|585126086|FG001|Overall Study|Adverse Event|0|||
162019545|NCT00393861|585126089|FG000|Overall Study|Adverse Event|2|||
162019546|NCT00393861|585126089|FG000|Overall Study|Disease Progression|24|||
162019547|NCT05300763|585126090|FG000|Overall Study|Adverse Event|0|||
162019548|NCT05300763|585126091|FG001|Overall Study|Adverse Event|1|||
162019549|NCT05300763|585126090|FG000|Overall Study|Major Protocol Deviation|1|||
162019550|NCT05300763|585126091|FG001|Overall Study|Major Protocol Deviation|0|||
162019551|NCT05300763|585126090|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
162019552|NCT05300763|585126091|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
162019553|NCT01485172|585126092|FG000|Overall Study|Adverse Event|2|||
162019554|NCT01485172|585126093|FG001|Overall Study|Adverse Event|1|||
162019555|NCT01485172|585126094|FG002|Overall Study|Adverse Event|2|||
162019556|NCT01485172|585126095|FG003|Overall Study|Adverse Event|2|||
162019557|NCT01485172|585126096|FG004|Overall Study|Adverse Event|1|||
162187923|NCT00670449|585740617|FG000|Overall Study|Administrative Problems|0|||
162187924|NCT00670449|585740618|FG001|Overall Study|Administrative Problems|2|||
162187925|NCT00670449|585740619|FG002|Overall Study|Administrative Problems|0|||
162187926|NCT00670449|585740620|FG003|Overall Study|Administrative Problems|1|||
161925297|NCT01807520|584771808|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
161925298|NCT01807520|584771809|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
161925299|NCT01807520|584771803|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161925300|NCT01807520|584771804|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161925301|NCT01807520|584771805|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161925302|NCT01807520|584771806|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161925303|NCT01807520|584771807|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161925304|NCT01807520|584771808|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
161925305|NCT01807520|584771809|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161925306|NCT01807520|584771803|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
161925307|NCT01807520|584771804|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
161925308|NCT01807520|584771805|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
161925309|NCT01807520|584771806|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
161925310|NCT01807520|584771807|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
161925311|NCT01807520|584771808|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
161925312|NCT01807520|584771809|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
161925313|NCT01002105|584771813|FG000|Overall Study|Lost to Follow-up|10|||
161925314|NCT01002105|584771814|FG001|Overall Study|Lost to Follow-up|16|||
161925315|NCT01002105|584771813|FG000|Overall Study|non compliance|5|||
161925316|NCT01002105|584771814|FG001|Overall Study|non compliance|3|||
161925317|NCT01002105|584771813|FG000|Overall Study|condition worsened|4|||
161925318|NCT01002105|584771814|FG001|Overall Study|condition worsened|2|||
161925319|NCT00552058|584771815|FG000|Overall Study|Adverse Event|8|||
161925320|NCT00552058|584771816|FG001|Overall Study|Adverse Event|7|||
161925321|NCT00552058|584771815|FG000|Overall Study|Lack of Efficacy|1|||
161925322|NCT00552058|584771816|FG001|Overall Study|Lack of Efficacy|5|||
161925323|NCT00552058|584771815|FG000|Overall Study|Lost to Follow-up|1|||
161925324|NCT00552058|584771816|FG001|Overall Study|Lost to Follow-up|0|||
161925325|NCT00552058|584771815|FG000|Overall Study|Withdrawal by Subject|4|||
161925326|NCT00552058|584771816|FG001|Overall Study|Withdrawal by Subject|4|||
161925327|NCT00552058|584771815|FG000|Overall Study|Other: Protocol Violation|0|||
162019558|NCT01485172|585126097|FG005|Overall Study|Adverse Event|2|||
162019559|NCT01485172|585126092|FG000|Overall Study|Lack of Efficacy|2|||
162187927|NCT00670449|585740617|FG000|Overall Study|Subject Withdrew Consent|0|||
162187928|NCT00670449|585740618|FG001|Overall Study|Subject Withdrew Consent|2|||
162187929|NCT00670449|585740619|FG002|Overall Study|Subject Withdrew Consent|0|||
162187930|NCT00670449|585740620|FG003|Overall Study|Subject Withdrew Consent|1|||
162187931|NCT00670449|585740617|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
161925328|NCT00552058|584771816|FG001|Overall Study|Other: Protocol Violation|1|||
161925329|NCT00552058|584771815|FG000|Overall Study|Other: Non Compliance|1|||
161925330|NCT00552058|584771816|FG001|Overall Study|Other: Non Compliance|2|||
162187932|NCT00670449|585740618|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162187933|NCT00670449|585740619|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
162187934|NCT00670449|585740620|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162187935|NCT00670449|585740617|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
162187936|NCT00670449|585740618|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
162187937|NCT00670449|585740619|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
162187938|NCT00670449|585740620|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
161925331|NCT00552058|584771815|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
161925332|NCT00552058|584771816|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
161925333|NCT00552058|584771815|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
161925334|NCT00552058|584771816|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
161925335|NCT00552058|584771815|FG000|Overall Study|Other: Positive Stool Result|0|||
161925336|NCT00552058|584771816|FG001|Overall Study|Other: Positive Stool Result|1|||
161925337|NCT00552058|584771815|FG000|Overall Study|Other: Randomized in error|0|||
161925338|NCT00552058|584771816|FG001|Overall Study|Other: Randomized in error|1|||
161925339|NCT00552058|584771815|FG000|Overall Study|Other: Sponsors Decision|0|||
161925340|NCT00552058|584771816|FG001|Overall Study|Other: Sponsors Decision|1|||
161925341|NCT00552058|584771815|FG000|Overall Study|Other: Early Roll Over|1|||
161925342|NCT00552058|584771816|FG001|Overall Study|Other: Early Roll Over|0|||
161925343|NCT01028053|584771819|FG000|Overall Study|Screen Failure|113|||
161925344|NCT01028053|584771819|FG000|Overall Study|Patient Request|11|||
161925345|NCT01028053|584771819|FG000|Overall Study|Protocol Violation|1|||
161925346|NCT01028053|584771819|FG000|Overall Study|Physician Decision|2|||
161925347|NCT01028053|584771819|FG000|Overall Study|Technical Problem|1|||
161925348|NCT01028053|584771819|FG000|Overall Study|Terminated by Sponsor|1|||
161925349|NCT01028053|584771819|FG000|Overall Study|Various reasons|4|||
161925350|NCT00471354|584771820|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
161925351|NCT00471354|584771820|FG000|Overall Study|Adverse Event|13|||
161925352|NCT00471354|584771820|FG000|Overall Study|Protocol Violation|12|||
162187939|NCT02660086|585740621|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
162187940|NCT02660086|585740622|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
161925353|NCT00471354|584771820|FG000|Overall Study|Withdrawal by Subject|1|||
161925354|NCT00471354|584771820|FG000|Overall Study|Physician Decision|4|||
161925355|NCT00471354|584771820|FG000|Overall Study|Sponsor Decision|1|||
161925356|NCT00471354|584771820|FG000|Overall Study|Lost to Follow-up|3|||
161925357|NCT00471354|584771820|FG000|Overall Study|Lack of Efficacy|5|||
161925358|NCT00471354|584771820|FG000|Overall Study|Patient/Caregiver Decision|12|||
161925359|NCT05141357|584771821|FG000|Overall Study|Adverse Event|3|||
161925360|NCT05141357|584771821|FG000|Overall Study|Lack of Efficacy|2|||
161925361|NCT01336972|584771825|FG000|Overall Study|Adverse Event|1|||
161925362|NCT01336972|584771826|FG001|Overall Study|Adverse Event|1|||
162187941|NCT02660086|585740621|FG000|Overall Study- 12-month|Left full-time employment|12|||
162187942|NCT02660086|585740622|FG001|Overall Study- 12-month|Left full-time employment|20|||
162187943|NCT02660086|585740621|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
162187944|NCT02660086|585740622|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
162187945|NCT02660086|585740621|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
162187946|NCT02660086|585740622|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
162187947|NCT02660086|585740621|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
162187948|NCT02660086|585740622|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
162187949|NCT02660086|585740621|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
162187950|NCT02660086|585740622|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
162187951|NCT01377844|585740623|FG000|Overall Study|Withdrawal by Subject|25|||
162187952|NCT01377844|585740624|FG001|Overall Study|Withdrawal by Subject|28|||
162187953|NCT01377844|585740623|FG000|Overall Study|Protocol Violation|2|||
162187954|NCT01377844|585740624|FG001|Overall Study|Protocol Violation|3|||
162187955|NCT01377844|585740623|FG000|Overall Study|Adverse Event|3|||
162187956|NCT01377844|585740624|FG001|Overall Study|Adverse Event|0|||
162187957|NCT01377844|585740623|FG000|Overall Study|Physician Decision|6|||
162187958|NCT01377844|585740624|FG001|Overall Study|Physician Decision|3|||
162187959|NCT01377844|585740623|FG000|Overall Study|Study terminated by Sponsor|0|||
162187960|NCT01377844|585740624|FG001|Overall Study|Study terminated by Sponsor|1|||
162187961|NCT01214200|585740628|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
162187962|NCT01214200|585740628|FG000|Overall Study|Withdrawal by Subject|2|||
162187963|NCT00667017|585740629|FG000|Overall Study|Withdrawal by Subject|1|||
162187964|NCT01823224|585740630|FG000|Overall Study|Lost to Follow-up|5|||
162019560|NCT01485172|585126093|FG001|Overall Study|Lack of Efficacy|0|||
162187965|NCT01823224|585740631|FG001|Overall Study|Lost to Follow-up|6|||
162187966|NCT01823224|585740630|FG000|Overall Study|didn't qualify|1|||
161925363|NCT01336972|584771827|FG002|Overall Study|Adverse Event|0|||
161925364|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
161925365|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
161925366|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
161925367|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
161925368|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
161925369|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
161925370|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
161925371|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
161925372|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
161925373|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
161925374|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
161925375|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
161925376|NCT03446573|584771828|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
161925377|NCT03446573|584771829|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
161925378|NCT03446573|584771828|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
161925379|NCT03446573|584771829|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
162187967|NCT01823224|585740631|FG001|Overall Study|didn't qualify|2|||
162187968|NCT01823224|585740630|FG000|Overall Study|pharmacy error|0|||
162187969|NCT01823224|585740631|FG001|Overall Study|pharmacy error|1|||
162187970|NCT01823224|585740630|FG000|Overall Study|missed med dose|0|||
162187971|NCT01823224|585740631|FG001|Overall Study|missed med dose|1|||
162187972|NCT01823224|585740630|FG000|Overall Study|Withdrawal by Subject|0|||
162187973|NCT01823224|585740631|FG001|Overall Study|Withdrawal by Subject|1|||
162187974|NCT00587171|585740632|FG000|Overall Study|Lost to Follow-up|1|||
162187975|NCT00587171|585740633|FG001|Overall Study|Lost to Follow-up|1|||
162187976|NCT01532648|585740634|FG000|Overall Study|Lost to Follow-up|3|||
162187977|NCT01532648|585740635|FG001|Overall Study|Lost to Follow-up|4|||
162187978|NCT01532648|585740634|FG000|Overall Study|Lack of Efficacy|4|||
162187979|NCT01532648|585740635|FG001|Overall Study|Lack of Efficacy|1|||
162187980|NCT01532648|585740634|FG000|Overall Study|Protocol Violation|1|||
162187981|NCT01532648|585740635|FG001|Overall Study|Protocol Violation|1|||
162187982|NCT01532648|585740634|FG000|Overall Study|Adverse Event|12|||
162187983|NCT01532648|585740635|FG001|Overall Study|Adverse Event|9|||
162187984|NCT01532648|585740634|FG000|Overall Study|Withdrawal by Subject|16|||
162187985|NCT01532648|585740635|FG001|Overall Study|Withdrawal by Subject|2|||
162187986|NCT02148705|585740636|FG000|Overall Study|Death|2|||
162187987|NCT02148705|585740637|FG001|Overall Study|Death|0|||
162187988|NCT02148705|585740638|FG002|Overall Study|Death|0|||
162187989|NCT02148705|585740636|FG000|Overall Study|Lost to Follow-up|13|||
162187990|NCT02148705|585740637|FG001|Overall Study|Lost to Follow-up|4|||
161925380|NCT03446573|584771828|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
161925381|NCT03446573|584771829|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
161925382|NCT03446573|584771828|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
161925383|NCT03446573|584771829|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
161925384|NCT03446573|584771828|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
161925385|NCT03446573|584771829|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
161925386|NCT03446573|584771828|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
161925387|NCT03446573|584771829|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
161925388|NCT03446573|584771828|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
161925389|NCT03446573|584771829|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
161925390|NCT02639559|584771830|FG000|Overall Study|Mobilization failure|0|||
161925391|NCT02639559|584771831|FG001|Overall Study|Mobilization failure|3|||
161925392|NCT02639559|584771830|FG000|Overall Study|Issues with vascular acess|1|||
162019561|NCT01485172|585126094|FG002|Overall Study|Lack of Efficacy|0|||
162019562|NCT01485172|585126095|FG003|Overall Study|Lack of Efficacy|0|||
162019563|NCT01485172|585126096|FG004|Overall Study|Lack of Efficacy|0|||
162019564|NCT01485172|585126097|FG005|Overall Study|Lack of Efficacy|0|||
162019565|NCT01485172|585126092|FG000|Overall Study|Protocol Violation|0|||
162019566|NCT01485172|585126093|FG001|Overall Study|Protocol Violation|0|||
162019567|NCT01485172|585126094|FG002|Overall Study|Protocol Violation|4|||
162019568|NCT01485172|585126095|FG003|Overall Study|Protocol Violation|5|||
162019569|NCT01485172|585126096|FG004|Overall Study|Protocol Violation|1|||
162019570|NCT01485172|585126097|FG005|Overall Study|Protocol Violation|0|||
162019571|NCT01485172|585126092|FG000|Overall Study|Protocol defined stopping criteria|1|||
162019572|NCT01485172|585126093|FG001|Overall Study|Protocol defined stopping criteria|0|||
162019573|NCT01485172|585126094|FG002|Overall Study|Protocol defined stopping criteria|0|||
162019574|NCT01485172|585126095|FG003|Overall Study|Protocol defined stopping criteria|0|||
162019575|NCT01485172|585126096|FG004|Overall Study|Protocol defined stopping criteria|1|||
162187991|NCT02148705|585740638|FG002|Overall Study|Lost to Follow-up|10|||
162187992|NCT02148705|585740636|FG000|Overall Study|Withdrawal by Subject|3|||
162187993|NCT02148705|585740637|FG001|Overall Study|Withdrawal by Subject|0|||
162187994|NCT02148705|585740638|FG002|Overall Study|Withdrawal by Subject|2|||
162187995|NCT02148705|585740636|FG000|Overall Study|Not Treated|0|||
162187996|NCT02148705|585740637|FG001|Overall Study|Not Treated|1|||
162019576|NCT01485172|585126097|FG005|Overall Study|Protocol defined stopping criteria|0|||
162019577|NCT01485172|585126092|FG000|Overall Study|Lost to Follow-up|0|||
162187997|NCT02148705|585740638|FG002|Overall Study|Not Treated|5|||
162187998|NCT01737021|585740639|FG000|Overall Study|Lost to Follow-up|5|||
162187999|NCT01737021|585740640|FG001|Overall Study|Lost to Follow-up|3|||
162188000|NCT01673594|585740641|FG000|Overall Study|Adverse Event|3|||
162188001|NCT01673594|585740642|FG001|Overall Study|Adverse Event|1|||
162188002|NCT01673594|585740641|FG000|Overall Study|Lost to Follow-up|1|||
162188003|NCT01673594|585740642|FG001|Overall Study|Lost to Follow-up|0|||
162188004|NCT01673594|585740641|FG000|Overall Study|Physician Decision|2|||
161925393|NCT02639559|584771831|FG001|Overall Study|Issues with vascular acess|0|||
162188005|NCT01673594|585740642|FG001|Overall Study|Physician Decision|4|||
162188006|NCT01673594|585740641|FG000|Overall Study|Withdrawal by Subject|0|||
162188007|NCT01673594|585740642|FG001|Overall Study|Withdrawal by Subject|1|||
162188008|NCT02824198|585740643|FG000|Overall Study|Non-compliance with the protocol|5|||
162188009|NCT02824198|585740644|FG001|Overall Study|Non-compliance with the protocol|1|||
162188010|NCT02824198|585740643|FG000|Overall Study|Lost to Follow-up|5|||
162188011|NCT02824198|585740644|FG001|Overall Study|Lost to Follow-up|2|||
162188012|NCT02824198|585740643|FG000|Overall Study|Withdrawal by Subject|5|||
162188013|NCT02824198|585740644|FG001|Overall Study|Withdrawal by Subject|0|||
162188014|NCT01353274|585740645|FG000|Overall Study|No case report form (CRF) collected|28|||
162188015|NCT00403494|585740646|FG000|Overall Study|Adverse Event|10|||
161925394|NCT00471107|584771834|FG000|Overall Study|Technical problems/data loss|3|||
161925395|NCT00471107|584771835|FG001|Overall Study|Technical problems/data loss|1|||
161925396|NCT00471107|584771836|FG002|Overall Study|Technical problems/data loss|3|||
161925397|NCT04740567|584771840|FG000|Overall Study|Death|31|||
161925398|NCT04740567|584771841|FG001|Overall Study|Death|43|||
161925399|NCT04740567|584771840|FG000|Overall Study|Lost to Follow-up|2|||
161925400|NCT04740567|584771841|FG001|Overall Study|Lost to Follow-up|11|||
161819325|NCT02034513|584379612|FG001|Overall Study|Pregnancy|3|||
161819326|NCT02034513|584379611|FG000|Overall Study|Protocol Violation|7|||
161819327|NCT02034513|584379612|FG001|Overall Study|Protocol Violation|10|||
161819328|NCT02034513|584379611|FG000|Overall Study|Withdrawal by Subject|25|||
161819329|NCT02034513|584379612|FG001|Overall Study|Withdrawal by Subject|25|||
161819330|NCT02034513|584379611|FG000|Overall Study|Unclassified|0|||
161819331|NCT02034513|584379612|FG001|Overall Study|Unclassified|1|||
161819332|NCT00960154|584379613|FG000|Overall Study|Study termination|25|||
161819333|NCT00960154|584379614|FG001|Overall Study|Study termination|25|||
161819334|NCT00757705|584379615|FG000|Overall Study|Adverse Event|19|||
161819335|NCT00757705|584379615|FG000|Overall Study|Lost to Follow-up|16|||
161819336|NCT00757705|584379615|FG000|Overall Study|Withdrawal by Subject|25|||
161819337|NCT00757705|584379615|FG000|Overall Study|Insufficient Response|26|||
161819338|NCT00757705|584379615|FG000|Overall Study|Ineligible to continue|8|||
161819339|NCT00757705|584379615|FG000|Overall Study|Non-compliant|9|||
161819340|NCT00757705|584379615|FG000|Overall Study|Other|18|||
161819341|NCT04408924|584379619|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
161819342|NCT04408924|584379619|FG000|Overall Study|Lost to Follow-up|3|||
161819343|NCT04408924|584379619|FG000|Overall Study|Withdrawal by Subject|5|||
161819344|NCT04408924|584379619|FG000|Overall Study|Sponsor Decision|2|||
161819345|NCT00486434|584379620|FG000|Overall Study|Withdrawal by Subject|34|||
161819346|NCT00486434|584379621|FG001|Overall Study|Withdrawal by Subject|39|||
161819347|NCT00486434|584379620|FG000|Overall Study|Adverse Event|118|||
161819348|NCT00486434|584379621|FG001|Overall Study|Adverse Event|44|||
161819349|NCT00486434|584379620|FG000|Overall Study|Protocol Violation|22|||
161819350|NCT00486434|584379621|FG001|Overall Study|Protocol Violation|21|||
161819351|NCT00486434|584379620|FG000|Overall Study|Lack of Efficacy|12|||
161819352|NCT00486434|584379621|FG001|Overall Study|Lack of Efficacy|19|||
161819353|NCT00486434|584379620|FG000|Overall Study|Lost to Follow-up|2|||
161819354|NCT00486434|584379621|FG001|Overall Study|Lost to Follow-up|3|||
161819355|NCT00486434|584379620|FG000|Overall Study|Death|1|||
161819356|NCT00486434|584379621|FG001|Overall Study|Death|2|||
161819357|NCT00486434|584379620|FG000|Overall Study|Personal reasons|5|||
162188016|NCT00403494|585740647|FG001|Overall Study|Adverse Event|8|||
162188017|NCT00403494|585740646|FG000|Overall Study|Withdrew Consent|3|||
162188018|NCT00403494|585740647|FG001|Overall Study|Withdrew Consent|2|||
161819358|NCT00486434|584379621|FG001|Overall Study|Personal reasons|6|||
161819359|NCT02218541|584379622|FG000|Overall Study|Lost to Follow-up|2|||
161819360|NCT02218541|584379623|FG001|Overall Study|Lost to Follow-up|1|||
161819361|NCT02218541|584379622|FG000|Overall Study|Implant Failure|4|||
161819362|NCT02218541|584379623|FG001|Overall Study|Implant Failure|1|||
161925401|NCT04740567|584771840|FG000|Overall Study|Patient declined to participate|13|||
162188019|NCT00403494|585740646|FG000|Overall Study|Inappropriately enrolled|0|||
162188020|NCT00403494|585740647|FG001|Overall Study|Inappropriately enrolled|1|||
162188021|NCT00403494|585740646|FG000|Overall Study|Lost to Follow-up|0|||
162188022|NCT00403494|585740647|FG001|Overall Study|Lost to Follow-up|2|||
162188023|NCT00403494|585740646|FG000|Overall Study|Protocol noncompliance|0|||
162188024|NCT00403494|585740647|FG001|Overall Study|Protocol noncompliance|1|||
162188025|NCT00403494|585740646|FG000|Overall Study|Death|1|||
162188026|NCT00403494|585740647|FG001|Overall Study|Death|0|||
162188027|NCT00403494|585740646|FG000|Overall Study|Sponsor Request|1|||
162188028|NCT00403494|585740647|FG001|Overall Study|Sponsor Request|0|||
162188029|NCT05005247|585740648|FG000|Overall Study|Withdrawal by Subject|0|||
162188030|NCT05005247|585740649|FG001|Overall Study|Withdrawal by Subject|1|||
162188031|NCT05005247|585740650|FG002|Overall Study|Withdrawal by Subject|0|||
162188032|NCT02575365|585740651|FG000|Overall Study|Lost to Follow-up|4|||
162188033|NCT00487240|585740656|FG000|Overall Study|Withdrawal by Subject|12|||
162188034|NCT00487240|585740657|FG001|Overall Study|Withdrawal by Subject|6|||
162188035|NCT00487240|585740656|FG000|Overall Study|Lost to Follow-up|7|||
162188036|NCT00487240|585740657|FG001|Overall Study|Lost to Follow-up|6|||
162188037|NCT00487240|585740656|FG000|Overall Study|Adverse Event|0|||
162188038|NCT00487240|585740657|FG001|Overall Study|Adverse Event|4|||
162188039|NCT00487240|585740656|FG000|Overall Study|Protocol Violation|5|||
162188040|NCT00487240|585740657|FG001|Overall Study|Protocol Violation|5|||
162188041|NCT00487240|585740656|FG000|Overall Study|Entry Criteria Not Met|3|||
162188042|NCT00487240|585740657|FG001|Overall Study|Entry Criteria Not Met|4|||
162188043|NCT00487240|585740656|FG000|Overall Study|Sponsor Decision|2|||
162188044|NCT00487240|585740657|FG001|Overall Study|Sponsor Decision|1|||
162188045|NCT00487240|585740656|FG000|Overall Study|Physician Decision|2|||
162188046|NCT00487240|585740657|FG001|Overall Study|Physician Decision|0|||
162188047|NCT02736188|585740658|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
162188048|NCT02736188|585740658|FG000|Overall Study|Adverse Event|1|||
162188049|NCT02736188|585740658|FG000|Overall Study|Withdrawal by Subject|1|||
162188050|NCT02736188|585740658|FG000|Overall Study|Other|6|||
162188051|NCT01698918|585740659|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
162188052|NCT01698918|585740659|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
162188053|NCT01698918|585740659|FG000|First Line Treatment (Core+Extension)|Death|2|||
162188054|NCT01698918|585740659|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
162188055|NCT01698918|585740659|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
162188056|NCT01698918|585740659|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
162188057|NCT01698918|585740659|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
162188058|NCT01698918|585740659|FG000|Second Line Treatment (Core+Extension)|Death|1|||
162188059|NCT01698918|585740659|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
161819363|NCT00856349|584379624|FG000|Overall Study|Death|418|||
161819364|NCT00856349|584379624|FG000|Overall Study|Withdrawal by Subject|116|||
161819365|NCT00856349|584379624|FG000|Overall Study|Lost to Follow-up|91|||
161819366|NCT00856349|584379624|FG000|Overall Study|Protocol Violation|38|||
161819367|NCT00856349|584379624|FG000|Overall Study|Physician Decision|13|||
161819368|NCT00856349|584379624|FG000|Overall Study|Subject relocation|104|||
161819369|NCT00856349|584379624|FG000|Overall Study|Device explant|33|||
161819370|NCT00856349|584379624|FG000|Overall Study|Site closure|78|||
161819371|NCT00856349|584379624|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
161819372|NCT01923740|584379627|FG000|Overall Study|Lost to Follow-up|4|||
161819373|NCT01923740|584379628|FG001|Overall Study|Lost to Follow-up|9|||
161819374|NCT01923740|584379627|FG000|Overall Study|Withdrawal by Subject|2|||
161819375|NCT01923740|584379628|FG001|Overall Study|Withdrawal by Subject|0|||
161819376|NCT03345420|584379631|FG000|Overall Study|Withdrawal by Subject|1|||
161819377|NCT00834444|584379632|FG000|First Intervention|Adverse Event|1|||
161819378|NCT00834444|584379633|FG001|First Intervention|Adverse Event|0|||
161819379|NCT00834444|584379632|FG000|First Intervention|Intolerance to Venopuncture|0|||
161819380|NCT00834444|584379633|FG001|First Intervention|Intolerance to Venopuncture|1|||
161819381|NCT00834444|584379632|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
161819382|NCT00834444|584379633|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161819383|NCT00834444|584379632|FG000|Second Intervention|Adverse Event|1|||
161819384|NCT00834444|584379633|FG001|Second Intervention|Adverse Event|0|||
161819385|NCT02890992|584379637|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819386|NCT02890992|584379638|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
161819387|NCT02890992|584379639|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819388|NCT02890992|584379640|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819389|NCT02890992|584379641|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819390|NCT02890992|584379642|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819391|NCT02890992|584379643|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819392|NCT02890992|584379644|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161819393|NCT02890992|584379637|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161819394|NCT02890992|584379638|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162188060|NCT01698918|585740659|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
162188061|NCT03176407|585740660|FG000|Overall Study|Protocol Violation|1|||
162188062|NCT03176407|585740660|FG000|Overall Study|human failure|1|||
162188063|NCT03176407|585740660|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
162188064|NCT01428583|585740662|FG000|Overall Study|Adverse Event|75|||
162188065|NCT01428583|585740662|FG000|Overall Study|Withdrawal by Subject|51|||
162188066|NCT01428583|585740662|FG000|Overall Study|Lack of Efficacy|37|||
162188067|NCT01428583|585740662|FG000|Overall Study|Lost to Follow-up|17|||
162188068|NCT01428583|585740662|FG000|Overall Study|Death|1|||
162188069|NCT01428583|585740662|FG000|Overall Study|Pregnancy|1|||
162188070|NCT01428583|585740662|FG000|Overall Study|Protocol Violation|1|||
162188071|NCT01428583|585740662|FG000|Overall Study|Physician Decision|12|||
162188072|NCT01428583|585740662|FG000|Overall Study|Non-compliant|25|||
162188073|NCT01428583|585740662|FG000|Overall Study|Confirmed positive urine drug test|8|||
162188074|NCT01428583|585740662|FG000|Overall Study|Sponsor's request|3|||
162188075|NCT01428583|585740662|FG000|Overall Study|Other|6|||
162188076|NCT00768755|585740666|FG000|Phase 1|Death|6|||
162188077|NCT00768755|585740667|FG001|Phase 1|Death|0|||
162188078|NCT00768755|585740668|FG002|Phase 1|Death|0|||
162188079|NCT00768755|585740669|FG003|Phase 1|Death|0|||
162188080|NCT00768755|585740666|FG000|Phase 1|Other|4|||
162188081|NCT00768755|585740667|FG001|Phase 1|Other|0|||
162188082|NCT00768755|585740668|FG002|Phase 1|Other|0|||
162188083|NCT00768755|585740669|FG003|Phase 1|Other|0|||
162188084|NCT00768755|585740666|FG000|Phase 2|Death|0|||
162188085|NCT00768755|585740667|FG001|Phase 2|Death|37|||
162188086|NCT00768755|585740668|FG002|Phase 2|Death|48|||
162188087|NCT00768755|585740669|FG003|Phase 2|Death|31|||
162188088|NCT00768755|585740666|FG000|Phase 2|Protocol Violation|0|||
162188089|NCT00768755|585740667|FG001|Phase 2|Protocol Violation|2|||
162188090|NCT00768755|585740668|FG002|Phase 2|Protocol Violation|0|||
162188091|NCT00768755|585740669|FG003|Phase 2|Protocol Violation|1|||
162188092|NCT00768755|585740666|FG000|Phase 2|Lost to Follow-up|0|||
162188093|NCT00768755|585740667|FG001|Phase 2|Lost to Follow-up|1|||
162188094|NCT00768755|585740668|FG002|Phase 2|Lost to Follow-up|1|||
162188095|NCT00768755|585740669|FG003|Phase 2|Lost to Follow-up|4|||
162188096|NCT00768755|585740666|FG000|Phase 2|Withdrawal by Subject|0|||
162188097|NCT00768755|585740667|FG001|Phase 2|Withdrawal by Subject|1|||
162188098|NCT00768755|585740668|FG002|Phase 2|Withdrawal by Subject|0|||
162188099|NCT00768755|585740669|FG003|Phase 2|Withdrawal by Subject|1|||
162188100|NCT00768755|585740666|FG000|Phase 2|Other|0|||
162188101|NCT00768755|585740667|FG001|Phase 2|Other|1|||
162188102|NCT00768755|585740668|FG002|Phase 2|Other|2|||
162188103|NCT00768755|585740669|FG003|Phase 2|Other|4|||
162188104|NCT00768755|585740666|FG000|Phase 2|Study Terminated by Sponsor|0|||
162188105|NCT00768755|585740667|FG001|Phase 2|Study Terminated by Sponsor|13|||
162188106|NCT00768755|585740668|FG002|Phase 2|Study Terminated by Sponsor|7|||
162188107|NCT00768755|585740669|FG003|Phase 2|Study Terminated by Sponsor|14|||
162188108|NCT00768755|585740666|FG000|Phase 2|Randomized but not treated|0|||
162188109|NCT00768755|585740667|FG001|Phase 2|Randomized but not treated|0|||
162188110|NCT00768755|585740668|FG002|Phase 2|Randomized but not treated|0|||
162188111|NCT00768755|585740669|FG003|Phase 2|Randomized but not treated|2|||
162188112|NCT00670488|585740670|FG000|Overall Study|Adverse Event|0|||
162188113|NCT00670488|585740671|FG001|Overall Study|Adverse Event|7|||
162188114|NCT00670488|585740672|FG002|Overall Study|Adverse Event|0|||
162188115|NCT00670488|585740673|FG003|Overall Study|Adverse Event|3|||
162188116|NCT00670488|585740674|FG004|Overall Study|Adverse Event|1|||
162188117|NCT00670488|585740675|FG005|Overall Study|Adverse Event|1|||
162188118|NCT00670488|585740676|FG006|Overall Study|Adverse Event|5|||
162188119|NCT00670488|585740677|FG007|Overall Study|Adverse Event|1|||
162188120|NCT00670488|585740678|FG008|Overall Study|Adverse Event|0|||
162188121|NCT00670488|585740679|FG009|Overall Study|Adverse Event|1|||
162188122|NCT00670488|585740670|FG000|Overall Study|Physician Decision|1|||
162188123|NCT00670488|585740671|FG001|Overall Study|Physician Decision|9|||
162188124|NCT00670488|585740672|FG002|Overall Study|Physician Decision|0|||
162188125|NCT00670488|585740673|FG003|Overall Study|Physician Decision|1|||
162188126|NCT00670488|585740674|FG004|Overall Study|Physician Decision|0|||
162188127|NCT00670488|585740675|FG005|Overall Study|Physician Decision|0|||
162188128|NCT00670488|585740676|FG006|Overall Study|Physician Decision|0|||
162188129|NCT00670488|585740677|FG007|Overall Study|Physician Decision|0|||
162188130|NCT00670488|585740678|FG008|Overall Study|Physician Decision|0|||
162188131|NCT00670488|585740679|FG009|Overall Study|Physician Decision|0|||
162188132|NCT00670488|585740670|FG000|Overall Study|Progressive Disease|2|||
162188133|NCT00670488|585740671|FG001|Overall Study|Progressive Disease|41|||
162188134|NCT00670488|585740672|FG002|Overall Study|Progressive Disease|3|||
162188135|NCT00670488|585740673|FG003|Overall Study|Progressive Disease|2|||
162188136|NCT00670488|585740674|FG004|Overall Study|Progressive Disease|2|||
162188137|NCT00670488|585740675|FG005|Overall Study|Progressive Disease|4|||
162188138|NCT00670488|585740676|FG006|Overall Study|Progressive Disease|11|||
162188139|NCT00670488|585740677|FG007|Overall Study|Progressive Disease|2|||
162188140|NCT00670488|585740678|FG008|Overall Study|Progressive Disease|2|||
162019578|NCT01485172|585126093|FG001|Overall Study|Lost to Follow-up|0|||
162188141|NCT00670488|585740679|FG009|Overall Study|Progressive Disease|1|||
162188142|NCT00670488|585740670|FG000|Overall Study|Withdrawal by Subject|0|||
162188143|NCT00670488|585740671|FG001|Overall Study|Withdrawal by Subject|1|||
162188144|NCT00670488|585740672|FG002|Overall Study|Withdrawal by Subject|0|||
162188145|NCT00670488|585740673|FG003|Overall Study|Withdrawal by Subject|1|||
162188146|NCT00670488|585740674|FG004|Overall Study|Withdrawal by Subject|0|||
162188147|NCT00670488|585740675|FG005|Overall Study|Withdrawal by Subject|0|||
162188148|NCT00670488|585740676|FG006|Overall Study|Withdrawal by Subject|1|||
162188149|NCT00670488|585740677|FG007|Overall Study|Withdrawal by Subject|0|||
162188150|NCT00670488|585740678|FG008|Overall Study|Withdrawal by Subject|1|||
162188151|NCT00670488|585740679|FG009|Overall Study|Withdrawal by Subject|0|||
162188152|NCT01829711|585740680|FG000|Overall Study|Lost to Follow-up|2|||
162188153|NCT01829711|585740680|FG000|Overall Study|Withdrawal by Subject|3|||
162188154|NCT01829711|585740680|FG000|Overall Study|Death|4|||
162188155|NCT01829711|585740680|FG000|Overall Study|Started new therapies|17|||
161925402|NCT04740567|584771841|FG001|Overall Study|Patient declined to participate|26|||
161925403|NCT04740567|584771840|FG000|Overall Study|Patient was physically incapable|1|||
161925404|NCT04740567|584771841|FG001|Overall Study|Patient was physically incapable|3|||
161925405|NCT04740567|584771840|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
161925406|NCT04740567|584771841|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
161925407|NCT06204887|584771842|FG000|Overall Study|Lost to Follow-up|3|||
161925408|NCT06204887|584771843|FG001|Overall Study|Lost to Follow-up|4|||
161925409|NCT06204887|584771844|FG002|Overall Study|Lost to Follow-up|1|||
161925410|NCT06204887|584771845|FG003|Overall Study|Lost to Follow-up|6|||
161925411|NCT03833167|584771846|FG000|Overall Study|Withdrawal by Subject|4|||
161925412|NCT03833167|584771847|FG001|Overall Study|Withdrawal by Subject|6|||
161925413|NCT03833167|584771846|FG000|Overall Study|Ongoing|186|||
161925414|NCT03833167|584771847|FG001|Overall Study|Ongoing|194|||
161925415|NCT03833167|584771846|FG000|Overall Study|Lost to Follow-up|1|||
161925416|NCT03833167|584771847|FG001|Overall Study|Lost to Follow-up|1|||
161925417|NCT03833167|584771846|FG000|Overall Study|Physician Decision|0|||
161925418|NCT03833167|584771847|FG001|Overall Study|Physician Decision|2|||
161925419|NCT03833167|584771846|FG000|Overall Study|Death|34|||
161925420|NCT03833167|584771847|FG001|Overall Study|Death|22|||
161925421|NCT02227199|584771849|FG000|Overall Study|Physician Decision|0|||
161925422|NCT02227199|584771850|FG001|Overall Study|Physician Decision|0|||
161925423|NCT02227199|584771851|FG002|Overall Study|Physician Decision|1|||
162019579|NCT01485172|585126094|FG002|Overall Study|Lost to Follow-up|1|||
162019580|NCT01485172|585126095|FG003|Overall Study|Lost to Follow-up|0|||
162188156|NCT01829711|585740680|FG000|Overall Study|Adverse Event|3|||
162188157|NCT01829711|585740680|FG000|Overall Study|Due to progression of disease|13|||
162188158|NCT01829711|585740680|FG000|Overall Study|Due to lack of response|1|||
162188159|NCT01480258|585740681|FG000|Infant Series|Protocol Violation|2|||
162188160|NCT01480258|585740682|FG001|Infant Series|Protocol Violation|0|||
162188161|NCT01480258|585740681|FG000|Infant Series|Physician Decision|0|||
162188162|NCT01480258|585740682|FG001|Infant Series|Physician Decision|1|||
162188163|NCT01480258|585740681|FG000|Infant Series|Not Vaccinated|3|||
162188164|NCT01480258|585740682|FG001|Infant Series|Not Vaccinated|0|||
162188165|NCT01480258|585740681|FG000|Infant Series|Adverse Event|1|||
162188166|NCT01480258|585740682|FG001|Infant Series|Adverse Event|1|||
162188167|NCT01480258|585740681|FG000|Infant Series|Withdrawal by Subject|1|||
162188168|NCT01480258|585740682|FG001|Infant Series|Withdrawal by Subject|6|||
162188169|NCT01480258|585740681|FG000|Interim Period|Lost to Follow-up|0|||
162188170|NCT01480258|585740682|FG001|Interim Period|Lost to Follow-up|2|||
162188171|NCT01480258|585740681|FG000|Interim Period|Physician Decision|1|||
162188172|NCT01480258|585740682|FG001|Interim Period|Physician Decision|0|||
162188173|NCT01480258|585740681|FG000|Interim Period|Protocol Violation|0|||
162188174|NCT01480258|585740682|FG001|Interim Period|Protocol Violation|1|||
162188175|NCT01480258|585740681|FG000|Interim Period|Withdrawal by Subject|9|||
162188176|NCT01480258|585740682|FG001|Interim Period|Withdrawal by Subject|6|||
162188177|NCT04248868|585740683|FG000|Overall Study|Death|1|||
162188178|NCT04248868|585740683|FG000|Overall Study|Lost to Follow-up|3|||
162019581|NCT01485172|585126096|FG004|Overall Study|Lost to Follow-up|0|||
162188179|NCT04248868|585740683|FG000|Overall Study|Protocol Violation|2|||
162188180|NCT01543204|585740686|FG000|Overall Study|Non-compliance|1|||
162188181|NCT01543204|585740686|FG000|Overall Study|Adverse Event|1|||
162188182|NCT01543204|585740686|FG000|Overall Study|Withdrawal by Subject|4|||
162188183|NCT01543204|585740686|FG000|Overall Study|Requirement for Alternative Therapy|1|||
162188184|NCT01543204|585740686|FG000|Overall Study|Lost to Follow-up|1|||
162188185|NCT02309294|585740692|FG000|Overall Study|Withdrawal by Subject|2|||
162188186|NCT01227421|585740693|FG000|Overall Study|Lost to Follow-up|6|||
161925424|NCT02227199|584771849|FG000|Overall Study|Adverse Event|0|||
161925425|NCT02227199|584771850|FG001|Overall Study|Adverse Event|0|||
161925426|NCT02227199|584771851|FG002|Overall Study|Adverse Event|3|||
161925427|NCT01428128|584771852|FG000|Overall Study|Withdrawal by Subject|4|||
161925428|NCT01428128|584771852|FG000|Overall Study|Screen failure by p53|10|||
161925429|NCT01428128|584771852|FG000|Overall Study|Received Neulasta in one cycle|2|||
162019582|NCT01485172|585126097|FG005|Overall Study|Lost to Follow-up|1|||
162188187|NCT01227421|585740694|FG001|Overall Study|Lost to Follow-up|7|||
162188188|NCT01227421|585740695|FG002|Overall Study|Lost to Follow-up|5|||
162188189|NCT01227421|585740693|FG000|Overall Study|Adverse Event|2|||
162188190|NCT01227421|585740694|FG001|Overall Study|Adverse Event|7|||
161819395|NCT02890992|584379639|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
162188191|NCT01227421|585740695|FG002|Overall Study|Adverse Event|2|||
162188192|NCT01227421|585740693|FG000|Overall Study|Withdrawal by Subject|1|||
162188193|NCT01227421|585740694|FG001|Overall Study|Withdrawal by Subject|2|||
162188194|NCT01227421|585740695|FG002|Overall Study|Withdrawal by Subject|1|||
162188195|NCT01227421|585740693|FG000|Overall Study|Protocol Violation|1|||
162188196|NCT01227421|585740694|FG001|Overall Study|Protocol Violation|1|||
162188197|NCT01227421|585740695|FG002|Overall Study|Protocol Violation|2|||
162188198|NCT01227421|585740693|FG000|Overall Study|Randomized in error|1|||
162188199|NCT01227421|585740694|FG001|Overall Study|Randomized in error|1|||
162188200|NCT01227421|585740695|FG002|Overall Study|Randomized in error|0|||
162188201|NCT03343704|585740701|FG000|Overall Study|Refused to complete follow up|0|||
161819396|NCT02890992|584379640|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161819397|NCT02890992|584379641|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161819398|NCT02890992|584379642|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161819399|NCT02890992|584379643|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
161819400|NCT02890992|584379644|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
161819401|NCT02890992|584379637|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819402|NCT02890992|584379638|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
161819403|NCT02890992|584379639|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819404|NCT02890992|584379640|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819405|NCT02890992|584379641|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819406|NCT02890992|584379642|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819407|NCT02890992|584379643|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819408|NCT02890992|584379644|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
161819409|NCT00958724|584379647|FG000|Overall Study|Disease Progression|6|||
161819410|NCT01496118|584379648|FG000|Overall Study|Disease progression|3|||
161819411|NCT01496118|584379649|FG001|Overall Study|Disease progression|2|||
161819412|NCT01496118|584379650|FG002|Overall Study|Disease progression|3|||
161819413|NCT01496118|584379651|FG003|Overall Study|Disease progression|1|||
161819414|NCT01496118|584379652|FG004|Overall Study|Disease progression|2|||
161819415|NCT01496118|584379653|FG005|Overall Study|Disease progression|2|||
161819416|NCT01496118|584379654|FG006|Overall Study|Disease progression|14|||
161819417|NCT01496118|584379655|FG007|Overall Study|Disease progression|10|||
161819418|NCT01496118|584379648|FG000|Overall Study|Physician Decision|0|||
161819419|NCT01496118|584379649|FG001|Overall Study|Physician Decision|0|||
161819420|NCT01496118|584379650|FG002|Overall Study|Physician Decision|0|||
161819421|NCT01496118|584379651|FG003|Overall Study|Physician Decision|0|||
161819422|NCT01496118|584379652|FG004|Overall Study|Physician Decision|1|||
161819423|NCT01496118|584379653|FG005|Overall Study|Physician Decision|0|||
161819424|NCT01496118|584379654|FG006|Overall Study|Physician Decision|3|||
161819425|NCT01496118|584379655|FG007|Overall Study|Physician Decision|6|||
161925430|NCT01428128|584771852|FG000|Overall Study|Adverse Event|1|||
162188202|NCT03343704|585740702|FG001|Overall Study|Refused to complete follow up|1|||
162188203|NCT03343704|585740701|FG000|Overall Study|Death|0|||
162188204|NCT03343704|585740702|FG001|Overall Study|Death|1|||
161819426|NCT01496118|584379648|FG000|Overall Study|Adverse Event|1|||
161819427|NCT01496118|584379649|FG001|Overall Study|Adverse Event|1|||
162188205|NCT03343704|585740701|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
162188206|NCT03343704|585740702|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
162188207|NCT02969356|585740707|FG000|Overall Study|Adverse Event|7|||
162188208|NCT02969356|585740707|FG000|Overall Study|Consent withdrawn|2|||
162188209|NCT02969356|585740707|FG000|Overall Study|Lost to Follow-up|3|||
162188210|NCT02969356|585740707|FG000|Overall Study|Did not need to be reinjected|6|||
162188211|NCT02969356|585740707|FG000|Overall Study|Personal reasons|5|||
161925431|NCT03003962|584771853|FG000|Overall Study|Withdrawal by Subject|5|||
161925432|NCT03003962|584771854|FG001|Overall Study|Withdrawal by Subject|17|||
162188212|NCT05432986|585740720|FG000|Overall Study|Withdrawal by Subject|2|||
162188213|NCT05432986|585740720|FG000|Overall Study|incomplete measurement|7|||
162188214|NCT03332589|585742289|FG000|Overall Study|Lack of Efficacy|2|||
162188215|NCT03332589|585742290|FG001|Overall Study|Lack of Efficacy|0|||
162188216|NCT03332589|585742291|FG002|Overall Study|Lack of Efficacy|0|||
162188217|NCT03332589|585742289|FG000|Overall Study|Adverse Event|1|||
162188218|NCT03332589|585742290|FG001|Overall Study|Adverse Event|0|||
162188219|NCT03332589|585742291|FG002|Overall Study|Adverse Event|0|||
162188220|NCT03332589|585742289|FG000|Overall Study|Death|1|||
162188221|NCT03332589|585742290|FG001|Overall Study|Death|0|||
162188222|NCT03332589|585742291|FG002|Overall Study|Death|0|||
162188223|NCT02713594|585742292|FG000|Overall Study|Withdrawal by Subject|32|||
162188224|NCT02713594|585742293|FG001|Overall Study|Withdrawal by Subject|22|||
162188225|NCT02713594|585742292|FG000|Overall Study|Lost to Follow-up|358|||
162188226|NCT02713594|585742293|FG001|Overall Study|Lost to Follow-up|374|||
161819428|NCT01496118|584379650|FG002|Overall Study|Adverse Event|0|||
161819429|NCT01496118|584379651|FG003|Overall Study|Adverse Event|0|||
161819430|NCT01496118|584379652|FG004|Overall Study|Adverse Event|0|||
161819431|NCT01496118|584379653|FG005|Overall Study|Adverse Event|0|||
161819432|NCT01496118|584379654|FG006|Overall Study|Adverse Event|6|||
161819433|NCT01496118|584379655|FG007|Overall Study|Adverse Event|10|||
161819434|NCT01496118|584379648|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819435|NCT01496118|584379649|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819436|NCT01496118|584379650|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819437|NCT01496118|584379651|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819438|NCT01496118|584379652|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819439|NCT01496118|584379653|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819440|NCT01496118|584379654|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
161819441|NCT01496118|584379655|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161819442|NCT01496118|584379648|FG000|Overall Study|Death|0|||
161819443|NCT01496118|584379649|FG001|Overall Study|Death|0|||
161819444|NCT01496118|584379650|FG002|Overall Study|Death|0|||
161819445|NCT01496118|584379651|FG003|Overall Study|Death|0|||
161819446|NCT01496118|584379652|FG004|Overall Study|Death|0|||
161925433|NCT03003962|584771853|FG000|Overall Study|Death|274|||
161925434|NCT03003962|584771854|FG001|Overall Study|Death|277|||
161925435|NCT03003962|584771853|FG000|Overall Study|Participants ongoing at DCO|55|||
161925436|NCT03003962|584771854|FG001|Overall Study|Participants ongoing at DCO|40|||
161925437|NCT04337021|584771855|FG000|Overall Study|Lost to Follow-up|54|||
162188227|NCT01185340|585742294|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
162188228|NCT01185340|585742295|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162188229|NCT01185340|585742296|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162188230|NCT01185340|585742297|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162188231|NCT01185340|585742294|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
162188232|NCT01185340|585742295|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162188233|NCT01185340|585742296|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162188234|NCT01185340|585742297|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162188235|NCT01185340|585742294|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
162188236|NCT01185340|585742295|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162188237|NCT01185340|585742296|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162188238|NCT01185340|585742297|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162188239|NCT01185340|585742294|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
162188240|NCT01185340|585742295|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161925438|NCT04337021|584771856|FG001|Overall Study|Lost to Follow-up|66|||
162188241|NCT01185340|585742296|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162188242|NCT01185340|585742297|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162188243|NCT01185340|585742294|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
161673258|NCT00931944|583857926|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
161925439|NCT06394323|584771857|FG000|Overall Study|Death|0|||
161819447|NCT01496118|584379653|FG005|Overall Study|Death|0|||
161819448|NCT01496118|584379654|FG006|Overall Study|Death|1|||
162188244|NCT01185340|585742295|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161925440|NCT06394323|584771858|FG001|Overall Study|Death|1|||
161925441|NCT06394323|584771859|FG002|Overall Study|Death|0|||
161925442|NCT06394323|584771860|FG003|Overall Study|Death|0|||
162188245|NCT01185340|585742296|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162188246|NCT01185340|585742297|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162188247|NCT01185340|585742294|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
162188248|NCT01185340|585742295|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162188249|NCT01185340|585742296|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162188250|NCT01185340|585742297|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162188251|NCT01185340|585742294|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
162188252|NCT01185340|585742295|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162188253|NCT01185340|585742296|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162188254|NCT01185340|585742297|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162188255|NCT01185340|585742294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
162188256|NCT01185340|585742295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
162188257|NCT01185340|585742296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
162188258|NCT01185340|585742297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
162188259|NCT01185340|585742294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
162188260|NCT01185340|585742295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
162188261|NCT01185340|585742296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
162188262|NCT01185340|585742297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
162188263|NCT01185340|585742294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
162188264|NCT01185340|585742295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
162188265|NCT01185340|585742296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
162188266|NCT01185340|585742297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
162188267|NCT01185340|585742294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
162188268|NCT01185340|585742295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
162188269|NCT01185340|585742296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
162188270|NCT01185340|585742297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
162188271|NCT01185340|585742294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
162188272|NCT01185340|585742295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
162188273|NCT01185340|585742296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
162188274|NCT01185340|585742297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
162188275|NCT01185340|585742294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
162188276|NCT01185340|585742295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
162188277|NCT01185340|585742296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
162188278|NCT01185340|585742297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
162188279|NCT01185340|585742294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
162188280|NCT01185340|585742295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
162188281|NCT01185340|585742296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
162188282|NCT01185340|585742297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
162188283|NCT00246129|585742300|FG000|Overall Study|Lost to Follow-up|1|||
162188284|NCT00246129|585742301|FG001|Overall Study|Lost to Follow-up|0|||
162188285|NCT00246129|585742300|FG000|Overall Study|Death|2|||
162188286|NCT00246129|585742301|FG001|Overall Study|Death|1|||
162188287|NCT00246129|585742300|FG000|Overall Study|suffered primary non-function|1|||
162188288|NCT00246129|585742301|FG001|Overall Study|suffered primary non-function|0|||
162188289|NCT00246129|585742300|FG000|Overall Study|grafts failed|3|||
162188290|NCT00246129|585742301|FG001|Overall Study|grafts failed|1|||
162188291|NCT03469258|585742302|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
162188292|NCT02605174|585742309|FG000|Overall Study|Adverse Event|0|||
162188293|NCT02605174|585742310|FG001|Overall Study|Adverse Event|0|||
162188294|NCT02605174|585742311|FG002|Overall Study|Adverse Event|1|||
162188295|NCT02605174|585742312|FG003|Overall Study|Adverse Event|0|||
162188296|NCT02605174|585742313|FG004|Overall Study|Adverse Event|4|||
162188297|NCT02605174|585742314|FG005|Overall Study|Adverse Event|0|||
162188298|NCT02605174|585742315|FG006|Overall Study|Adverse Event|0|||
162188299|NCT02605174|585742309|FG000|Overall Study|Lost to Follow-up|20|||
162188300|NCT02605174|585742310|FG001|Overall Study|Lost to Follow-up|7|||
161925443|NCT06394323|584771857|FG000|Overall Study|Physician Decision|0|||
161925444|NCT06394323|584771858|FG001|Overall Study|Physician Decision|2|||
161925445|NCT06394323|584771859|FG002|Overall Study|Physician Decision|0|||
161925446|NCT06394323|584771860|FG003|Overall Study|Physician Decision|0|||
161925447|NCT06394323|584771857|FG000|Overall Study|Withdrawal by Subject|4|||
161925448|NCT06394323|584771858|FG001|Overall Study|Withdrawal by Subject|4|||
161925449|NCT06394323|584771859|FG002|Overall Study|Withdrawal by Subject|0|||
162188301|NCT02605174|585742311|FG002|Overall Study|Lost to Follow-up|27|||
162188302|NCT02605174|585742312|FG003|Overall Study|Lost to Follow-up|10|||
161925450|NCT06394323|584771860|FG003|Overall Study|Withdrawal by Subject|0|||
161925451|NCT00567580|584773183|FG000|Overall Study|Protocol Violation|28|||
161925452|NCT00567580|584773184|FG001|Overall Study|Protocol Violation|24|||
161925453|NCT00567580|584773185|FG002|Overall Study|Protocol Violation|24|||
161925454|NCT00134719|584773186|FG000|Primary Vaccination Phase|Adverse Event|4|||
161925455|NCT00134719|584773187|FG001|Primary Vaccination Phase|Adverse Event|0|||
161925456|NCT00134719|584773188|FG002|Primary Vaccination Phase|Adverse Event|0|||
161925457|NCT00134719|584773186|FG000|Primary Vaccination Phase|Protocol Violation|1|||
161925458|NCT00134719|584773187|FG001|Primary Vaccination Phase|Protocol Violation|0|||
161925459|NCT00134719|584773188|FG002|Primary Vaccination Phase|Protocol Violation|0|||
161925460|NCT00134719|584773186|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
161925461|NCT00134719|584773187|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
161925462|NCT00134719|584773188|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
161925463|NCT00134719|584773186|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
161925464|NCT00134719|584773187|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
161925465|NCT00134719|584773188|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
161925466|NCT00134719|584773186|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
161925467|NCT00134719|584773187|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
161925468|NCT00134719|584773188|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
161925469|NCT00134719|584773186|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
161925470|NCT00134719|584773187|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
161925471|NCT00134719|584773188|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
161925472|NCT00620035|584773189|FG000|Overall Study|Adverse Event|106|||
161925473|NCT00620035|584773189|FG000|Overall Study|Withdrawal of Informed Consent|1|||
161925474|NCT00620035|584773189|FG000|Overall Study|Other Reason|38|||
161925475|NCT00145327|584773190|FG000|Overall Study|Withdrawal by Subject|77|||
161925476|NCT00145327|584773191|FG001|Overall Study|Withdrawal by Subject|72|||
161925477|NCT00145327|584773192|FG002|Overall Study|Withdrawal by Subject|164|||
161925478|NCT00145327|584773190|FG000|Overall Study|Death|26|||
161925479|NCT00145327|584773191|FG001|Overall Study|Death|18|||
161925480|NCT00145327|584773192|FG002|Overall Study|Death|30|||
161925481|NCT00145327|584773190|FG000|Overall Study|Adverse Event|14|||
162188303|NCT02605174|585742313|FG004|Overall Study|Lost to Follow-up|20|||
162188304|NCT02605174|585742314|FG005|Overall Study|Lost to Follow-up|10|||
162188305|NCT02605174|585742315|FG006|Overall Study|Lost to Follow-up|29|||
162188306|NCT02605174|585742309|FG000|Overall Study|Protocol Violation|10|||
162188307|NCT02605174|585742310|FG001|Overall Study|Protocol Violation|4|||
162188308|NCT02605174|585742311|FG002|Overall Study|Protocol Violation|14|||
162188309|NCT02605174|585742312|FG003|Overall Study|Protocol Violation|6|||
162188310|NCT02605174|585742313|FG004|Overall Study|Protocol Violation|7|||
162188311|NCT02605174|585742314|FG005|Overall Study|Protocol Violation|7|||
162188312|NCT02605174|585742315|FG006|Overall Study|Protocol Violation|12|||
162188313|NCT02605174|585742309|FG000|Overall Study|Pregnancy|1|||
162188314|NCT02605174|585742310|FG001|Overall Study|Pregnancy|0|||
162188315|NCT02605174|585742311|FG002|Overall Study|Pregnancy|0|||
162188316|NCT02605174|585742312|FG003|Overall Study|Pregnancy|2|||
162188317|NCT02605174|585742313|FG004|Overall Study|Pregnancy|0|||
162188318|NCT02605174|585742314|FG005|Overall Study|Pregnancy|0|||
162188319|NCT02605174|585742315|FG006|Overall Study|Pregnancy|0|||
162188320|NCT02605174|585742309|FG000|Overall Study|Withdrawal by Subject|9|||
162188321|NCT02605174|585742310|FG001|Overall Study|Withdrawal by Subject|6|||
162188322|NCT02605174|585742311|FG002|Overall Study|Withdrawal by Subject|14|||
162188323|NCT02605174|585742312|FG003|Overall Study|Withdrawal by Subject|11|||
162188324|NCT02605174|585742313|FG004|Overall Study|Withdrawal by Subject|6|||
162188325|NCT02605174|585742314|FG005|Overall Study|Withdrawal by Subject|4|||
162188326|NCT02605174|585742315|FG006|Overall Study|Withdrawal by Subject|15|||
162188327|NCT02605174|585742309|FG000|Overall Study|Physician Decision|2|||
162188328|NCT02605174|585742310|FG001|Overall Study|Physician Decision|0|||
162188329|NCT02605174|585742311|FG002|Overall Study|Physician Decision|0|||
162188330|NCT02605174|585742312|FG003|Overall Study|Physician Decision|0|||
162188331|NCT02605174|585742313|FG004|Overall Study|Physician Decision|0|||
162188332|NCT02605174|585742314|FG005|Overall Study|Physician Decision|0|||
162188333|NCT02605174|585742315|FG006|Overall Study|Physician Decision|3|||
162188334|NCT02605174|585742309|FG000|Overall Study|Randomization Failure|22|||
161673259|NCT00931944|583857926|FG000|Overall Study|Death|28|||
162188335|NCT02605174|585742310|FG001|Overall Study|Randomization Failure|6|||
162188336|NCT02605174|585742311|FG002|Overall Study|Randomization Failure|20|||
161673260|NCT00931944|583857926|FG000|Overall Study|Other|2|||
161673261|NCT01026142|583857931|FG000|Overall Study|Death|136|||
161673262|NCT01026142|583857932|FG001|Overall Study|Death|134|||
161673263|NCT01026142|583857931|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
161673264|NCT01026142|583857932|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
161673265|NCT00634010|583857933|FG000|Overall Study|Adverse Event|2|||
161673266|NCT00634010|583857934|FG001|Overall Study|Adverse Event|5|||
161925482|NCT00145327|584773191|FG001|Overall Study|Adverse Event|11|||
161925483|NCT00145327|584773192|FG002|Overall Study|Adverse Event|22|||
161925484|NCT00145327|584773190|FG000|Overall Study|Lost to Follow-up|9|||
161925485|NCT00145327|584773191|FG001|Overall Study|Lost to Follow-up|14|||
162188337|NCT02605174|585742312|FG003|Overall Study|Randomization Failure|7|||
162188338|NCT02605174|585742313|FG004|Overall Study|Randomization Failure|16|||
162188339|NCT02605174|585742314|FG005|Overall Study|Randomization Failure|11|||
162188340|NCT02605174|585742315|FG006|Overall Study|Randomization Failure|30|||
162188341|NCT04250636|585742318|FG000|Overall Study|Lost to Follow-up|2|||
162188342|NCT01779050|585742319|FG000|Overall Study|Withdrawal by Subject|1|||
162188343|NCT01779050|585742320|FG001|Overall Study|Withdrawal by Subject|0|||
162188344|NCT03403036|585742321|FG000|Overall Study|Lack of Efficacy|5|||
162188345|NCT01128959|585742322|FG000|Lead in Period|Adverse Event|3|||
162188346|NCT01128959|585742322|FG000|Treatment Period|Adverse Event|3|||
162188347|NCT01128959|585742322|FG000|Treatment Period|Withdrawal by Subject|1|||
162188348|NCT01409837|585742325|FG000|Overall Study|Withdrawal by Subject|2|||
162188349|NCT01409837|585742326|FG001|Overall Study|Withdrawal by Subject|1|||
162188350|NCT01409837|585742325|FG000|Overall Study|Lost to Follow-up|1|||
162188351|NCT01409837|585742326|FG001|Overall Study|Lost to Follow-up|0|||
162188352|NCT01409837|585742325|FG000|Overall Study|Physician Decision|0|||
162188353|NCT01409837|585742326|FG001|Overall Study|Physician Decision|1|||
162188354|NCT04938453|585742327|FG000|Washout Period 1|Adverse Event|1|||
162188355|NCT04938453|585742328|FG001|Washout Period 1|Adverse Event|0|||
162188356|NCT04938453|585742327|FG000|Washout Period 1|Physician Decision|0|||
162188357|NCT04938453|585742328|FG001|Washout Period 1|Physician Decision|1|||
162188358|NCT03292406|585742330|FG000|Overall Study|Progressive Disease|6|||
162188359|NCT03292406|585742331|FG001|Overall Study|Progressive Disease|3|||
162188360|NCT03292406|585742332|FG002|Overall Study|Progressive Disease|4|||
162188361|NCT03292406|585742330|FG000|Overall Study|Adverse Event|7|||
162188362|NCT03292406|585742331|FG001|Overall Study|Adverse Event|1|||
162188363|NCT03292406|585742332|FG002|Overall Study|Adverse Event|4|||
162188364|NCT03292406|585742330|FG000|Overall Study|Withdrawal by Subject|0|||
162188365|NCT03292406|585742331|FG001|Overall Study|Withdrawal by Subject|7|||
162188366|NCT03292406|585742332|FG002|Overall Study|Withdrawal by Subject|2|||
162188367|NCT03292406|585742330|FG000|Overall Study|Protocol Violation|0|||
162188368|NCT03292406|585742331|FG001|Overall Study|Protocol Violation|1|||
162188369|NCT03292406|585742332|FG002|Overall Study|Protocol Violation|1|||
162188370|NCT03292406|585742330|FG000|Overall Study|Other|0|||
162188371|NCT03292406|585742331|FG001|Overall Study|Other|1|||
162188372|NCT03292406|585742332|FG002|Overall Study|Other|2|||
162188373|NCT00022672|585742334|FG000|Main Phase: 24 Months|Adverse Event|6|||
162188374|NCT00022672|585742335|FG001|Main Phase: 24 Months|Adverse Event|0|||
162188375|NCT00022672|585742334|FG000|Main Phase: 24 Months|Death|0|||
162188376|NCT00022672|585742335|FG001|Main Phase: 24 Months|Death|3|||
162188377|NCT00022672|585742334|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
162188378|NCT00022672|585742335|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
162188379|NCT00022672|585742334|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
162188380|NCT00022672|585742335|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
162188381|NCT00022672|585742334|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
162188382|NCT00022672|585742335|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
162188383|NCT00022672|585742334|FG000|Main Phase: 24 Months|Refused Treatment|3|||
162188384|NCT00022672|585742335|FG001|Main Phase: 24 Months|Refused Treatment|4|||
162188385|NCT00022672|585742334|FG000|Main Phase: 24 Months|Failure to Return|1|||
162188386|NCT00022672|585742335|FG001|Main Phase: 24 Months|Failure to Return|1|||
162188387|NCT00022672|585742334|FG000|Main Phase: 24 Months|Other|1|||
162188388|NCT00022672|585742335|FG001|Main Phase: 24 Months|Other|0|||
162188389|NCT00022672|585742334|FG000|Extension Phase|Adverse Event|1|||
162188390|NCT00022672|585742335|FG001|Extension Phase|Adverse Event|3|||
162188391|NCT00022672|585742334|FG000|Extension Phase|Death|0|||
162188392|NCT00022672|585742335|FG001|Extension Phase|Death|1|||
162188393|NCT00022672|585742334|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
162188394|NCT00022672|585742335|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
162188395|NCT00022672|585742334|FG000|Extension Phase|Refused Treatment|0|||
162188396|NCT00022672|585742335|FG001|Extension Phase|Refused Treatment|2|||
162188397|NCT00022672|585742334|FG000|Extension Phase|Other|1|||
162188398|NCT00022672|585742335|FG001|Extension Phase|Other|1|||
162188399|NCT03648541|585742339|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
162188400|NCT03648541|585742340|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
162188401|NCT03648541|585742339|FG000|Re-induction Period Only|Lack of Efficacy|7|||
162188402|NCT03648541|585742340|FG001|Re-induction Period Only|Lack of Efficacy|0|||
162188403|NCT03648541|585742339|FG000|Maintenance Period Only|Missing|0|||
162188404|NCT03648541|585742340|FG001|Maintenance Period Only|Missing|1|||
162188405|NCT03648541|585742339|FG000|Maintenance Period Only|Other not listed below|0|||
162188406|NCT03648541|585742340|FG001|Maintenance Period Only|Other not listed below|4|||
162188407|NCT03648541|585742339|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
162188408|NCT03648541|585742340|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
162188409|NCT03648541|585742339|FG000|Maintenance Period Only|Protocol Violation|0|||
162188410|NCT03648541|585742340|FG001|Maintenance Period Only|Protocol Violation|1|||
162188411|NCT03648541|585742339|FG000|Maintenance Period Only|Lack of Efficacy|0|||
162188412|NCT03648541|585742340|FG001|Maintenance Period Only|Lack of Efficacy|18|||
162188413|NCT03648541|585742339|FG000|Maintenance Period Only|Adverse Event|0|||
162188414|NCT03648541|585742340|FG001|Maintenance Period Only|Adverse Event|4|||
162188415|NCT03648541|585742339|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
162188416|NCT03648541|585742340|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
162188417|NCT03490032|585742341|FG000|Overall Study|family issue (child custody)|1|||
162188418|NCT03490032|585742342|FG001|Overall Study|family issue (child custody)|0|||
162188419|NCT03490032|585742343|FG002|Overall Study|family issue (child custody)|0|||
162188420|NCT00308308|585742344|FG000|Overall Study|Adverse Event|17|||
162188421|NCT00308308|585742345|FG001|Overall Study|Adverse Event|2|||
162188422|NCT00308308|585742344|FG000|Overall Study|Lost to Follow-up|5|||
162188423|NCT00308308|585742345|FG001|Overall Study|Lost to Follow-up|5|||
162188424|NCT00308308|585742344|FG000|Overall Study|Physician Decision|15|||
162188425|NCT00308308|585742345|FG001|Overall Study|Physician Decision|7|||
162188426|NCT00308308|585742344|FG000|Overall Study|Protocol Violation|3|||
162188427|NCT00308308|585742345|FG001|Overall Study|Protocol Violation|14|||
162188428|NCT00308308|585742344|FG000|Overall Study|Withdrawal by Subject|47|||
162188429|NCT00308308|585742345|FG001|Overall Study|Withdrawal by Subject|19|||
162188430|NCT00308308|585742344|FG000|Overall Study|Various|7|||
162188431|NCT00308308|585742345|FG001|Overall Study|Various|5|||
161819449|NCT01496118|584379655|FG007|Overall Study|Death|1|||
161819450|NCT01496118|584379648|FG000|Overall Study|Withdrawal by Subject|0|||
162188432|NCT00308308|585742344|FG000|Overall Study|Randomized but not dosed|8|||
162188433|NCT00308308|585742345|FG001|Overall Study|Randomized but not dosed|16|||
162188434|NCT00308308|585742344|FG000|Overall Study|Other|1|||
162188435|NCT00308308|585742345|FG001|Overall Study|Other|0|||
162188436|NCT01951703|585742348|FG000|First Intervention|Withdrawal by Subject|1|||
162188437|NCT01951703|585742349|FG001|First Intervention|Withdrawal by Subject|0|||
162188438|NCT01951703|585742348|FG000|First Intervention|Subject was not compliant|1|||
162188439|NCT01951703|585742349|FG001|First Intervention|Subject was not compliant|1|||
162188440|NCT01951703|585742348|FG000|First Intervention|Physician Decision|1|||
162188441|NCT01951703|585742349|FG001|First Intervention|Physician Decision|0|||
162188442|NCT01951703|585742348|FG000|Second Intervention|Protocol Violation|0|||
162188443|NCT01951703|585742349|FG001|Second Intervention|Protocol Violation|1|||
162188444|NCT01951703|585742348|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
162188445|NCT01951703|585742349|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
162188446|NCT01852045|585742350|FG000|Overall Study|Adverse Event|1|||
162188447|NCT01852045|585742351|FG001|Overall Study|Adverse Event|0|||
162188448|NCT01852045|585742352|FG002|Overall Study|Adverse Event|0|||
162188449|NCT01852045|585742350|FG000|Overall Study|Lack of Efficacy|3|||
162188450|NCT01852045|585742351|FG001|Overall Study|Lack of Efficacy|0|||
162188451|NCT01852045|585742352|FG002|Overall Study|Lack of Efficacy|0|||
161673267|NCT00634010|583857933|FG000|Overall Study|Withdrawal by Subject|5|||
161673268|NCT00634010|583857934|FG001|Overall Study|Withdrawal by Subject|6|||
161819451|NCT01496118|584379649|FG001|Overall Study|Withdrawal by Subject|0|||
161819452|NCT01496118|584379650|FG002|Overall Study|Withdrawal by Subject|0|||
162019583|NCT01485172|585126092|FG000|Overall Study|Physician Decision|0|||
162019584|NCT01485172|585126093|FG001|Overall Study|Physician Decision|0|||
162188452|NCT01852045|585742350|FG000|Overall Study|Lost to Follow-up|0|||
162188453|NCT01852045|585742351|FG001|Overall Study|Lost to Follow-up|1|||
162188454|NCT01852045|585742352|FG002|Overall Study|Lost to Follow-up|1|||
162188455|NCT01852045|585742350|FG000|Overall Study|Withdrawal by Subject|1|||
162188456|NCT01852045|585742351|FG001|Overall Study|Withdrawal by Subject|0|||
162188457|NCT01852045|585742352|FG002|Overall Study|Withdrawal by Subject|1|||
162188458|NCT01852045|585742350|FG000|Overall Study|Other Miscellaneous Reasons|1|||
162188459|NCT01852045|585742351|FG001|Overall Study|Other Miscellaneous Reasons|3|||
162188460|NCT01852045|585742352|FG002|Overall Study|Other Miscellaneous Reasons|2|||
162188461|NCT02827201|585742353|FG000|Overall Study|Death|1|||
162188462|NCT02827201|585742354|FG001|Overall Study|Death|2|||
162188463|NCT02827201|585742353|FG000|Overall Study|Patients not treated|1|||
162188464|NCT02827201|585742354|FG001|Overall Study|Patients not treated|1|||
162188465|NCT02128269|585742355|FG000|Treatment Period|Adverse Event|1|||
162188466|NCT02128269|585742355|FG000|Treatment Period|Physician Decision|1|||
162188467|NCT01640288|585742356|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
162188468|NCT01640288|585742357|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
162188469|NCT01640288|585742356|FG000|Overall Study|Screen Failure|20|||
162188470|NCT01640288|585742357|FG001|Overall Study|Screen Failure|18|||
162188471|NCT01640288|585742356|FG000|Overall Study|Withdrawn by PI|5|||
162188472|NCT01640288|585742357|FG001|Overall Study|Withdrawn by PI|0|||
162188473|NCT01640288|585742356|FG000|Overall Study|Withdrawal by Subject|1|||
161673269|NCT00634010|583857933|FG000|Overall Study|Physician Decision|1|||
161673270|NCT00634010|583857934|FG001|Overall Study|Physician Decision|1|||
161673271|NCT00634010|583857933|FG000|Overall Study|Disease Progression|1|||
161673272|NCT00634010|583857934|FG001|Overall Study|Disease Progression|1|||
162188474|NCT01640288|585742357|FG001|Overall Study|Withdrawal by Subject|0|||
162188475|NCT01972776|585742358|FG000|Part 1|Withdrawal by Subject|0|||
162188476|NCT01972776|585742359|FG001|Part 1|Withdrawal by Subject|0|||
162188477|NCT01972776|585742360|FG002|Part 1|Withdrawal by Subject|1|||
162188478|NCT01972776|585742361|FG003|Part 1|Withdrawal by Subject|0|||
162188479|NCT01972776|585742362|FG004|Part 1|Withdrawal by Subject|0|||
162188480|NCT01972776|585742363|FG005|Part 1|Withdrawal by Subject|0|||
162188481|NCT01972776|585742358|FG000|Part 1|Adverse Event|0|||
162188482|NCT01972776|585742359|FG001|Part 1|Adverse Event|0|||
162188483|NCT01972776|585742360|FG002|Part 1|Adverse Event|1|||
161673273|NCT00634010|583857933|FG000|Overall Study|Non-Compliant|1|||
161673274|NCT00634010|583857934|FG001|Overall Study|Non-Compliant|1|||
161673275|NCT00882310|583857935|FG000|Overall Study|Screen Failure|10|||
161673276|NCT00882310|583857935|FG000|Overall Study|Never received treatment|1|||
161673277|NCT00882310|583857935|FG000|Overall Study|Death|6|||
161673278|NCT00882310|583857935|FG000|Overall Study|Progression of disease|4|||
162188484|NCT01972776|585742361|FG003|Part 1|Adverse Event|1|||
162188485|NCT01972776|585742362|FG004|Part 1|Adverse Event|0|||
161673279|NCT00882310|583857935|FG000|Overall Study|Adverse Event|1|||
161673280|NCT04233164|583857940|FG000|Overall Study|Unable to obtain specimen|0|||
161673281|NCT04233164|583857941|FG001|Overall Study|Unable to obtain specimen|1|||
161673282|NCT04201821|583857944|FG000|Overall Study|Withdrawal by Subject|2|||
161673283|NCT00651157|583857945|FG000|Overall Study|Death|1|||
161673284|NCT00651157|583857945|FG000|Overall Study|Protocol Violation|1|||
161673285|NCT00688181|583857947|FG000|Overall Study|Lost to Follow-up|17|||
161673286|NCT00688181|583857947|FG000|Overall Study|Unknown Reason|4|||
161673287|NCT00688181|583857947|FG000|Overall Study|Non-clinical Reason|2|||
161673288|NCT01891721|583857948|FG000|Overall Study|Lost to Follow-up|10|||
161673289|NCT01891721|583857949|FG001|Overall Study|Lost to Follow-up|5|||
161673290|NCT01891721|583857950|FG002|Overall Study|Lost to Follow-up|1|||
161673291|NCT03829319|583857951|FG000|Overall Study|Sponsor's Decision|4|||
161673292|NCT03829319|583857952|FG001|Overall Study|Sponsor's Decision|90|||
161673293|NCT03829319|583857953|FG002|Overall Study|Sponsor's Decision|102|||
161673294|NCT03829319|583857951|FG000|Overall Study|Withdrawal by Subject|1|||
161673295|NCT03829319|583857952|FG001|Overall Study|Withdrawal by Subject|5|||
161673296|NCT03829319|583857953|FG002|Overall Study|Withdrawal by Subject|4|||
161673297|NCT03829319|583857951|FG000|Overall Study|Physician Decision|0|||
161673298|NCT03829319|583857952|FG001|Overall Study|Physician Decision|3|||
161673299|NCT03829319|583857953|FG002|Overall Study|Physician Decision|0|||
162188486|NCT01972776|585742363|FG005|Part 1|Adverse Event|0|||
162188487|NCT01972776|585742358|FG000|Part 2|Adverse Event|0|||
162188488|NCT01972776|585742359|FG001|Part 2|Adverse Event|0|||
162188489|NCT01972776|585742360|FG002|Part 2|Adverse Event|0|||
161673300|NCT03829319|583857951|FG000|Overall Study|Lost to Follow-up|0|||
161673301|NCT03829319|583857952|FG001|Overall Study|Lost to Follow-up|0|||
161673302|NCT03829319|583857953|FG002|Overall Study|Lost to Follow-up|1|||
161673303|NCT03829319|583857951|FG000|Overall Study|Death|8|||
161673304|NCT03829319|583857952|FG001|Overall Study|Death|277|||
161673305|NCT03829319|583857953|FG002|Overall Study|Death|266|||
161673306|NCT04484259|583857954|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
161673307|NCT04484259|583857955|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
161673308|NCT04484259|583857956|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
162188490|NCT01972776|585742361|FG003|Part 2|Adverse Event|0|||
162188491|NCT01972776|585742362|FG004|Part 2|Adverse Event|3|||
162188492|NCT01972776|585742363|FG005|Part 2|Adverse Event|0|||
162188493|NCT01972776|585742358|FG000|Part 2|Administrative problems|0|||
162188494|NCT01972776|585742359|FG001|Part 2|Administrative problems|0|||
161673309|NCT04484259|583857957|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
161673310|NCT04484259|583857958|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
161673311|NCT04484259|583857954|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
162188495|NCT01972776|585742360|FG002|Part 2|Administrative problems|0|||
162188496|NCT01972776|585742361|FG003|Part 2|Administrative problems|0|||
162188497|NCT01972776|585742362|FG004|Part 2|Administrative problems|10|||
162188498|NCT01972776|585742363|FG005|Part 2|Administrative problems|7|||
162188499|NCT01228734|585742364|FG000|Overall Study|Randomized, but not treated|0|||
162188500|NCT01228734|585742365|FG001|Overall Study|Randomized, but not treated|4|||
162188501|NCT02449902|585742366|FG000|Overall Study|Adverse Event|0|||
162188502|NCT02449902|585742367|FG001|Overall Study|Adverse Event|1|||
162188503|NCT02449902|585742366|FG000|Overall Study|Withdrawal by Subject|0|||
162188504|NCT02449902|585742367|FG001|Overall Study|Withdrawal by Subject|1|||
162188505|NCT01365546|585742368|FG000|Overall Study|Withdrawal by Subject|1|||
162188506|NCT01365546|585742368|FG000|Overall Study|Screen failure|9|||
162188507|NCT01365546|585742368|FG000|Overall Study|Study termination|1|||
162188508|NCT03326856|585742369|FG000|Overall Study|Lost to Follow-up|1|||
162188509|NCT03326856|585742370|FG001|Overall Study|Lost to Follow-up|1|||
162188510|NCT03326856|585742371|FG002|Overall Study|Lost to Follow-up|0|||
162188511|NCT03326856|585742372|FG003|Overall Study|Lost to Follow-up|0|||
162188512|NCT03326856|585742373|FG004|Overall Study|Lost to Follow-up|0|||
162188513|NCT03162614|585742374|FG000|Overall Study|Lost to Follow-up|2|||
162188514|NCT03162614|585742375|FG001|Overall Study|Lost to Follow-up|1|||
162188515|NCT03162614|585742376|FG002|Overall Study|Lost to Follow-up|1|||
162188516|NCT03162614|585742377|FG003|Overall Study|Lost to Follow-up|1|||
162188517|NCT03162614|585742378|FG004|Overall Study|Lost to Follow-up|2|||
162188518|NCT03162614|585742379|FG005|Overall Study|Lost to Follow-up|0|||
162188519|NCT03162614|585742374|FG000|Overall Study|Protocol Violation|0|||
162188520|NCT03162614|585742375|FG001|Overall Study|Protocol Violation|1|||
162188521|NCT03162614|585742376|FG002|Overall Study|Protocol Violation|0|||
162188522|NCT03162614|585742377|FG003|Overall Study|Protocol Violation|1|||
162188523|NCT03162614|585742378|FG004|Overall Study|Protocol Violation|0|||
162188524|NCT03162614|585742379|FG005|Overall Study|Protocol Violation|0|||
162188525|NCT03162614|585742374|FG000|Overall Study|Withdrawal by Subject|2|||
162188526|NCT03162614|585742375|FG001|Overall Study|Withdrawal by Subject|1|||
162188527|NCT03162614|585742376|FG002|Overall Study|Withdrawal by Subject|1|||
162188528|NCT03162614|585742377|FG003|Overall Study|Withdrawal by Subject|1|||
162188529|NCT03162614|585742378|FG004|Overall Study|Withdrawal by Subject|0|||
162188530|NCT03162614|585742379|FG005|Overall Study|Withdrawal by Subject|0|||
162188531|NCT03162614|585742374|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
162188532|NCT03162614|585742375|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
162188533|NCT03162614|585742376|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
162188534|NCT03162614|585742377|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
162188535|NCT03162614|585742378|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
162188536|NCT03162614|585742379|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
162188537|NCT00621842|585742380|FG000|Overall Study|Adverse Event|6|||
162188538|NCT00621842|585742380|FG000|Overall Study|Withdrawal by Subject|7|||
162188539|NCT00621842|585742380|FG000|Overall Study|Protocol Violation|4|||
162188540|NCT00621842|585742380|FG000|Overall Study|Lack of Efficacy|2|||
162188541|NCT01074242|585742383|FG000|Overall Study|Case report before date of contract|40|||
162188542|NCT01074242|585742383|FG000|Overall Study|Lost to Follow-up|1|||
162188543|NCT01074242|585742383|FG000|Overall Study|Case report unclear|6|||
162188544|NCT01074242|585742383|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
162188545|NCT01074242|585742383|FG000|Overall Study|Duplicate Case Report Form|5|||
162188546|NCT01957163|585742384|FG000|Overall Study|Adverse Event|5|||
162188547|NCT01957163|585742385|FG001|Overall Study|Adverse Event|2|||
162188548|NCT01957163|585742386|FG002|Overall Study|Adverse Event|4|||
162188549|NCT01957163|585742384|FG000|Overall Study|Lack of Efficacy|5|||
162188550|NCT01957163|585742385|FG001|Overall Study|Lack of Efficacy|4|||
162188551|NCT01957163|585742386|FG002|Overall Study|Lack of Efficacy|9|||
162188552|NCT01957163|585742384|FG000|Overall Study|Protocol Violation|1|||
162188553|NCT01957163|585742385|FG001|Overall Study|Protocol Violation|2|||
162188554|NCT01957163|585742386|FG002|Overall Study|Protocol Violation|0|||
162188555|NCT01957163|585742384|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
162188556|NCT01957163|585742385|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
162188557|NCT01957163|585742386|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
162188558|NCT01957163|585742384|FG000|Overall Study|Lost to Follow-up|0|||
162188559|NCT01957163|585742385|FG001|Overall Study|Lost to Follow-up|1|||
162188560|NCT01957163|585742386|FG002|Overall Study|Lost to Follow-up|0|||
162188561|NCT01957163|585742384|FG000|Overall Study|Withdrawal by Subject|4|||
162188562|NCT01957163|585742385|FG001|Overall Study|Withdrawal by Subject|2|||
162188563|NCT01957163|585742386|FG002|Overall Study|Withdrawal by Subject|4|||
162188564|NCT03822832|585742391|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
162188565|NCT03822832|585742392|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
162188566|NCT03822832|585742391|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
162188567|NCT03822832|585742392|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
162188568|NCT03822832|585742391|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
162188569|NCT03822832|585742392|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
162188570|NCT03822832|585742391|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
162188571|NCT03822832|585742392|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
162188572|NCT03822832|585742391|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
162188573|NCT03822832|585742392|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
162188574|NCT03822832|585742391|FG000|Re-allocation|Not re-allocated to open label period|2|||
162188575|NCT03822832|585742392|FG001|Re-allocation|Not re-allocated to open label period|6|||
162188576|NCT03822832|585742391|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
162188577|NCT03822832|585742392|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
162188578|NCT03822832|585742391|FG000|Period 2 - Open Label Period|Adverse Event|0|||
162188579|NCT03822832|585742392|FG001|Period 2 - Open Label Period|Adverse Event|3|||
162188580|NCT01668719|585742393|FG000|Phase I|On treatment|1|||
162188581|NCT01668719|585742394|FG001|Phase I|On treatment|0|||
162188582|NCT01668719|585742395|FG002|Phase I|On treatment|0|||
162188583|NCT01668719|585742393|FG000|Phase I|Adverse Event|2|||
162188584|NCT01668719|585742394|FG001|Phase I|Adverse Event|0|||
162188585|NCT01668719|585742395|FG002|Phase I|Adverse Event|0|||
162188586|NCT01668719|585742393|FG000|Phase I|Progression/relapse|1|||
162188587|NCT01668719|585742394|FG001|Phase I|Progression/relapse|0|||
162188588|NCT01668719|585742395|FG002|Phase I|Progression/relapse|0|||
162188589|NCT01668719|585742393|FG000|Phase I|not protocol specified|2|||
162188590|NCT01668719|585742394|FG001|Phase I|not protocol specified|0|||
162188591|NCT01668719|585742395|FG002|Phase I|not protocol specified|0|||
162188592|NCT01668719|585742393|FG000|Phase II|On treatment|0|||
162188593|NCT01668719|585742394|FG001|Phase II|On treatment|4|||
162188594|NCT01668719|585742395|FG002|Phase II|On treatment|3|||
162188595|NCT01668719|585742393|FG000|Phase II|Adverse Event|0|||
162188596|NCT01668719|585742394|FG001|Phase II|Adverse Event|18|||
162188597|NCT01668719|585742395|FG002|Phase II|Adverse Event|18|||
162188598|NCT01668719|585742393|FG000|Phase II|Refusal unrelated to adverse event|0|||
162188599|NCT01668719|585742394|FG001|Phase II|Refusal unrelated to adverse event|4|||
162188600|NCT01668719|585742395|FG002|Phase II|Refusal unrelated to adverse event|1|||
162188601|NCT01668719|585742393|FG000|Phase II|Progression/relapse|0|||
162188602|NCT01668719|585742394|FG001|Phase II|Progression/relapse|13|||
162188603|NCT01668719|585742395|FG002|Phase II|Progression/relapse|17|||
162188604|NCT01668719|585742393|FG000|Phase II|Death|0|||
162188605|NCT01668719|585742394|FG001|Phase II|Death|0|||
162188606|NCT01668719|585742395|FG002|Phase II|Death|2|||
162188607|NCT01668719|585742393|FG000|Phase II|not protocol specified|0|||
162188608|NCT01668719|585742394|FG001|Phase II|not protocol specified|13|||
162188609|NCT01668719|585742395|FG002|Phase II|not protocol specified|7|||
162188610|NCT03539055|585742396|FG000|Overall Study|Death|4|||
162188611|NCT03539055|585742396|FG000|Overall Study|Lost to Follow-up|1|||
162188612|NCT03539055|585742396|FG000|Overall Study|Withdrawal by Subject|2|||
162188613|NCT03539055|585742396|FG000|Overall Study|Screen Fail|7|||
162188614|NCT03539055|585742396|FG000|Overall Study|Drug Intolerance|2|||
162188615|NCT01321073|585742398|FG000|Overall Study|Did not attempt implant|4|||
162188616|NCT01321073|585742398|FG000|Overall Study|Death|3|||
162188617|NCT01638000|585742399|FG000|Overall Study|Randomized but Never Received Drug|7|||
162188618|NCT01638000|585742400|FG001|Overall Study|Randomized but Never Received Drug|10|||
162188619|NCT01638000|585742399|FG000|Overall Study|Adverse Event|14|||
162188620|NCT01638000|585742400|FG001|Overall Study|Adverse Event|16|||
162188621|NCT01638000|585742399|FG000|Overall Study|Lack of Efficacy|5|||
162188622|NCT01638000|585742400|FG001|Overall Study|Lack of Efficacy|6|||
162188623|NCT01638000|585742399|FG000|Overall Study|Protocol Violation|11|||
162188624|NCT01638000|585742400|FG001|Overall Study|Protocol Violation|13|||
162188625|NCT01638000|585742399|FG000|Overall Study|Withdrawal by Subject|21|||
162188626|NCT01638000|585742400|FG001|Overall Study|Withdrawal by Subject|24|||
162188627|NCT01638000|585742399|FG000|Overall Study|Miscellaneous|2|||
162188628|NCT01638000|585742400|FG001|Overall Study|Miscellaneous|2|||
162188629|NCT04248803|585742401|FG000|Overall Study|Lost to Follow-up|7|||
162188630|NCT04248803|585742402|FG001|Overall Study|Lost to Follow-up|7|||
162188631|NCT04248803|585742403|FG002|Overall Study|Lost to Follow-up|7|||
162188632|NCT04248803|585742404|FG003|Overall Study|Lost to Follow-up|7|||
162188633|NCT04248803|585742405|FG004|Overall Study|Lost to Follow-up|7|||
162188634|NCT04248803|585742406|FG005|Overall Study|Lost to Follow-up|7|||
162188635|NCT05352230|585742407|FG000|First Intervention (3 Months)|study terminated|2|||
162188636|NCT05352230|585742408|FG001|First Intervention (3 Months)|study terminated|2|||
162188637|NCT00875706|585742410|FG000|Overall Study|Withdrawal by Subject|1|||
162188638|NCT00875706|585742411|FG001|Overall Study|Withdrawal by Subject|0|||
162188639|NCT00875706|585742412|FG002|Overall Study|Withdrawal by Subject|0|||
162188640|NCT03775213|585742413|FG000|Overall Study|Withdrawal by Subject|51|||
162188641|NCT03775213|585742414|FG001|Overall Study|Withdrawal by Subject|53|||
162188642|NCT03775213|585742413|FG000|Overall Study|Incomplete Survey|7|||
162188643|NCT03775213|585742414|FG001|Overall Study|Incomplete Survey|7|||
162188644|NCT00786188|585742415|FG000|Overall Study|Adverse Event|3|||
162188645|NCT00786188|585742416|FG001|Overall Study|Adverse Event|1|||
162188646|NCT00786188|585742415|FG000|Overall Study|Withdrawal by Subject|2|||
162188647|NCT00786188|585742416|FG001|Overall Study|Withdrawal by Subject|0|||
162188648|NCT00326183|585742417|FG000|Overall Study|Lost to Follow-up|104|||
162188649|NCT00326183|585742418|FG001|Overall Study|Lost to Follow-up|56|||
162188650|NCT00326183|585742417|FG000|Overall Study|Protocol Violation|6|||
162188651|NCT00326183|585742418|FG001|Overall Study|Protocol Violation|3|||
162188652|NCT00326183|585742417|FG000|Overall Study|Withdrawal by Subject|35|||
162188653|NCT00326183|585742418|FG001|Overall Study|Withdrawal by Subject|7|||
162188654|NCT00326183|585742417|FG000|Overall Study|Subject Moved|7|||
162188655|NCT00326183|585742418|FG001|Overall Study|Subject Moved|4|||
162188656|NCT00326183|585742417|FG000|Overall Study|Other|47|||
162188657|NCT00326183|585742418|FG001|Overall Study|Other|13|||
162188658|NCT00326183|585742417|FG000|Overall Study|Adverse Event|1|||
162188659|NCT00326183|585742418|FG001|Overall Study|Adverse Event|0|||
162188660|NCT01827839|585742422|FG000|Overall Study|Adverse Event|1|||
162188661|NCT01827839|585742422|FG000|Overall Study|Consent Withdrawal|2|||
162188662|NCT00570505|585742423|FG000|Overall Study|Adverse Event|7|||
162188663|NCT00570505|585742423|FG000|Overall Study|Withdrawal by Subject|7|||
162188664|NCT00570505|585742423|FG000|Overall Study|Lost to Follow-up|23|||
162188665|NCT00570505|585742423|FG000|Overall Study|Other loss to follow-up|4|||
162188666|NCT00614614|585742424|FG000|Primary Vaccination Phase|Adverse Event|6|||
162188667|NCT00614614|585742425|FG001|Primary Vaccination Phase|Adverse Event|0|||
162188668|NCT00614614|585742426|FG002|Primary Vaccination Phase|Adverse Event|0|||
162188669|NCT00614614|585742427|FG003|Primary Vaccination Phase|Adverse Event|0|||
162188670|NCT00614614|585742428|FG004|Primary Vaccination Phase|Adverse Event|0|||
162188671|NCT00614614|585742424|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
162188672|NCT00614614|585742425|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
162188673|NCT00614614|585742426|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
162188674|NCT00614614|585742427|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
162188675|NCT00614614|585742428|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
162188676|NCT00614614|585742424|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
162188677|NCT00614614|585742425|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
162188678|NCT00614614|585742426|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
162188679|NCT00614614|585742427|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
162188680|NCT00614614|585742428|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
162188681|NCT00614614|585742424|FG000|Primary Vaccination Phase|Protocol Violation|9|||
162188682|NCT00614614|585742425|FG001|Primary Vaccination Phase|Protocol Violation|3|||
162188683|NCT00614614|585742426|FG002|Primary Vaccination Phase|Protocol Violation|0|||
162188684|NCT00614614|585742427|FG003|Primary Vaccination Phase|Protocol Violation|0|||
162188685|NCT00614614|585742428|FG004|Primary Vaccination Phase|Protocol Violation|0|||
162188686|NCT00614614|585742424|FG000|Primary Vaccination Phase|Other|4|||
162188687|NCT00614614|585742425|FG001|Primary Vaccination Phase|Other|0|||
162188688|NCT00614614|585742426|FG002|Primary Vaccination Phase|Other|0|||
162188689|NCT00614614|585742427|FG003|Primary Vaccination Phase|Other|0|||
162188690|NCT00614614|585742428|FG004|Primary Vaccination Phase|Other|0|||
162188691|NCT00614614|585742424|FG000|Booster Vaccination Phase|Adverse Event|0|||
162188692|NCT00614614|585742425|FG001|Booster Vaccination Phase|Adverse Event|0|||
162188693|NCT00614614|585742426|FG002|Booster Vaccination Phase|Adverse Event|1|||
162188694|NCT00614614|585742427|FG003|Booster Vaccination Phase|Adverse Event|1|||
162188695|NCT00614614|585742428|FG004|Booster Vaccination Phase|Adverse Event|0|||
162188696|NCT00614614|585742424|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
162188697|NCT00614614|585742425|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
162188698|NCT00614614|585742426|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
162188699|NCT00614614|585742427|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
162188700|NCT00614614|585742428|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
162188701|NCT00614614|585742424|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
162188702|NCT00614614|585742425|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
162188703|NCT00614614|585742426|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
162188704|NCT00614614|585742427|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
162188705|NCT00614614|585742428|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
162188706|NCT00614614|585742424|FG000|Booster Vaccination Phase|Protocol Violation|0|||
162188707|NCT00614614|585742425|FG001|Booster Vaccination Phase|Protocol Violation|0|||
162188708|NCT00614614|585742426|FG002|Booster Vaccination Phase|Protocol Violation|2|||
162188709|NCT00614614|585742427|FG003|Booster Vaccination Phase|Protocol Violation|3|||
162188710|NCT00614614|585742428|FG004|Booster Vaccination Phase|Protocol Violation|0|||
162188711|NCT00614614|585742424|FG000|Booster Vaccination Phase|Other|0|||
162188712|NCT00614614|585742425|FG001|Booster Vaccination Phase|Other|1|||
162188713|NCT00614614|585742426|FG002|Booster Vaccination Phase|Other|3|||
162188714|NCT00614614|585742427|FG003|Booster Vaccination Phase|Other|2|||
162188715|NCT00614614|585742428|FG004|Booster Vaccination Phase|Other|1|||
162188716|NCT05426109|585742429|FG000|Overall Study|Withdrawal by Subject|0|||
162188717|NCT05426109|585742430|FG001|Overall Study|Withdrawal by Subject|1|||
162188718|NCT05212285|585742431|FG000|Overall Study|Lack of Efficacy|12|||
162188719|NCT05212285|585742432|FG001|Overall Study|Lack of Efficacy|8|||
162188720|NCT05212285|585742431|FG000|Overall Study|Withdrawal by Subject|8|||
162188721|NCT05212285|585742432|FG001|Overall Study|Withdrawal by Subject|1|||
162188722|NCT05212285|585742431|FG000|Overall Study|Lost to Follow-up|13|||
162188723|NCT05212285|585742432|FG001|Overall Study|Lost to Follow-up|1|||
162188724|NCT05212285|585742431|FG000|Overall Study|miss data|21|||
162188725|NCT05212285|585742432|FG001|Overall Study|miss data|2|||
162188726|NCT01000805|585742433|FG000|Overall Study|Adverse Event|21|||
162188727|NCT01000805|585742434|FG001|Overall Study|Adverse Event|9|||
162188728|NCT01000805|585742433|FG000|Overall Study|Lack of Efficacy|5|||
162188729|NCT01000805|585742434|FG001|Overall Study|Lack of Efficacy|16|||
162188730|NCT01000805|585742433|FG000|Overall Study|Lost to Follow-up|16|||
162188731|NCT01000805|585742434|FG001|Overall Study|Lost to Follow-up|21|||
162188732|NCT01000805|585742433|FG000|Overall Study|Physician Decision|0|||
162188733|NCT01000805|585742434|FG001|Overall Study|Physician Decision|1|||
162188734|NCT01000805|585742433|FG000|Overall Study|Protocol Violation|12|||
162188735|NCT01000805|585742434|FG001|Overall Study|Protocol Violation|8|||
162188736|NCT01000805|585742433|FG000|Overall Study|Withdrawal by Subject|16|||
162188737|NCT01000805|585742434|FG001|Overall Study|Withdrawal by Subject|6|||
162188738|NCT01000805|585742433|FG000|Overall Study|Sponsor Decision|0|||
162188739|NCT01000805|585742434|FG001|Overall Study|Sponsor Decision|1|||
162188740|NCT04118894|585742435|FG000|Overall Study|Lost to Follow-up|21|||
162188741|NCT04118894|585742435|FG000|Overall Study|Withdrawal by Subject|10|||
162188742|NCT04118894|585742435|FG000|Overall Study|Adverse Event|4|||
162188743|NCT04493424|585743856|FG000|Overall Study|Termination of the trial by the sponsor|89|||
162188744|NCT04493424|585743856|FG000|Overall Study|Withdrawal by Subject|9|||
162188745|NCT04493424|585743856|FG000|Overall Study|Lost to Follow-up|2|||
162188746|NCT04493424|585743856|FG000|Overall Study|Lack of Efficacy|3|||
162188747|NCT04493424|585743856|FG000|Overall Study|Adverse Event|5|||
162188748|NCT03769090|585743858|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
162188749|NCT03769090|585743859|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
162188750|NCT03769090|585743860|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
162188751|NCT03769090|585743858|FG000|Overall Study|Withdrawal by Subject|52|||
162188752|NCT03769090|585743859|FG001|Overall Study|Withdrawal by Subject|62|||
162188753|NCT03769090|585743860|FG002|Overall Study|Withdrawal by Subject|74|||
162188754|NCT03769090|585743858|FG000|Overall Study|Death|4|||
162188755|NCT03769090|585743859|FG001|Overall Study|Death|2|||
162188756|NCT03769090|585743860|FG002|Overall Study|Death|2|||
162188757|NCT03769090|585743858|FG000|Overall Study|Adverse Event|7|||
161673312|NCT04484259|583857955|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
161673313|NCT04484259|583857956|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
161673314|NCT04484259|583857957|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
161673315|NCT04484259|583857958|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
161673316|NCT04484259|583857954|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
161673317|NCT04484259|583857955|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
161673318|NCT04484259|583857956|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
161673319|NCT04484259|583857957|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
161673320|NCT04484259|583857958|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
161673321|NCT04484259|583857954|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
161673322|NCT04484259|583857955|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
161673323|NCT04484259|583857956|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
161673324|NCT04484259|583857957|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
161673325|NCT04484259|583857958|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
161673326|NCT04484259|583857954|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
161673327|NCT04484259|583857955|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
161673328|NCT04484259|583857956|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
161673329|NCT04484259|583857957|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
161819453|NCT01496118|584379651|FG003|Overall Study|Withdrawal by Subject|2|||
162188758|NCT03769090|585743859|FG001|Overall Study|Adverse Event|7|||
162188759|NCT03769090|585743860|FG002|Overall Study|Adverse Event|8|||
162188760|NCT03769090|585743858|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
162188761|NCT03769090|585743859|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
162188762|NCT03769090|585743860|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
162188763|NCT03769090|585743858|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
162188764|NCT03769090|585743859|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
162188765|NCT03769090|585743860|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
162188766|NCT03769090|585743858|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
162188767|NCT03769090|585743859|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
162188768|NCT03769090|585743860|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
162188769|NCT03769090|585743858|FG000|Overall Study|Protocol Violation|5|||
162188770|NCT03769090|585743859|FG001|Overall Study|Protocol Violation|6|||
162188771|NCT03769090|585743860|FG002|Overall Study|Protocol Violation|8|||
162188772|NCT03769090|585743858|FG000|Overall Study|Pregnancy|1|||
162188773|NCT03769090|585743859|FG001|Overall Study|Pregnancy|0|||
162188774|NCT03769090|585743860|FG002|Overall Study|Pregnancy|3|||
162188775|NCT03769090|585743858|FG000|Overall Study|Lost to Follow-up|19|||
162188776|NCT03769090|585743859|FG001|Overall Study|Lost to Follow-up|25|||
162188777|NCT03769090|585743860|FG002|Overall Study|Lost to Follow-up|21|||
162188778|NCT03769090|585743858|FG000|Overall Study|Condition under investigation worsened|2|||
161673330|NCT04484259|583857958|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
161819454|NCT01496118|584379652|FG004|Overall Study|Withdrawal by Subject|0|||
161819455|NCT01496118|584379653|FG005|Overall Study|Withdrawal by Subject|1|||
161819456|NCT01496118|584379654|FG006|Overall Study|Withdrawal by Subject|6|||
161819457|NCT01496118|584379655|FG007|Overall Study|Withdrawal by Subject|3|||
161819458|NCT00841659|584379656|FG000|Washout: 2 Weeks|Protocol Violation|1|||
161819459|NCT00841659|584379657|FG001|Washout: 2 Weeks|Protocol Violation|0|||
161819460|NCT01149057|584379661|FG000|Overall Study|Lack of Efficacy|16|||
161819461|NCT01149057|584379661|FG000|Overall Study|Adverse Event|13|||
161819462|NCT01149057|584379661|FG000|Overall Study|Withdrawal by Subject|9|||
161819463|NCT01149057|584379661|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
161819464|NCT01149057|584379661|FG000|Overall Study|B Cell Depletion|4|||
161819465|NCT01149057|584379661|FG000|Overall Study|Participant Non-Compliance|2|||
161819466|NCT01149057|584379661|FG000|Overall Study|Lost to Follow-up|1|||
161819467|NCT01149057|584379661|FG000|Overall Study|High Parathyroid Hormone Value|1|||
161819468|NCT01149057|584379661|FG000|Overall Study|Other|6|||
161673331|NCT04484259|583857954|FG000|Randomized Treatment|Withdrawal by Subject|1|||
161673332|NCT04484259|583857955|FG001|Randomized Treatment|Withdrawal by Subject|0|||
161673333|NCT04484259|583857956|FG002|Randomized Treatment|Withdrawal by Subject|0|||
161673334|NCT04484259|583857957|FG003|Randomized Treatment|Withdrawal by Subject|0|||
161673335|NCT04484259|583857958|FG004|Randomized Treatment|Withdrawal by Subject|0|||
161673336|NCT04498832|583857959|FG000|Overall Study|Adverse Event|1|||
161673337|NCT04498832|583857960|FG001|Overall Study|Adverse Event|3|||
161673338|NCT04498832|583857959|FG000|Overall Study|Withdrawal by Subject|0|||
161673339|NCT04498832|583857960|FG001|Overall Study|Withdrawal by Subject|1|||
161673340|NCT01313650|583857962|FG000|Overall Study|Adverse Event|9|||
161673341|NCT01313650|583857963|FG001|Overall Study|Adverse Event|34|||
161673342|NCT01313650|583857964|FG002|Overall Study|Adverse Event|24|||
161673343|NCT01313650|583857965|FG003|Overall Study|Adverse Event|23|||
161673344|NCT01313650|583857962|FG000|Overall Study|Lack of Efficacy|37|||
161673345|NCT01313650|583857963|FG001|Overall Study|Lack of Efficacy|20|||
161673346|NCT01313650|583857964|FG002|Overall Study|Lack of Efficacy|32|||
161673347|NCT01313650|583857965|FG003|Overall Study|Lack of Efficacy|20|||
161673348|NCT01313650|583857962|FG000|Overall Study|Lost to Follow-up|1|||
161673349|NCT01313650|583857963|FG001|Overall Study|Lost to Follow-up|0|||
161673350|NCT01313650|583857964|FG002|Overall Study|Lost to Follow-up|3|||
161673351|NCT01313650|583857965|FG003|Overall Study|Lost to Follow-up|2|||
161673352|NCT01313650|583857962|FG000|Overall Study|Withdrawal by Subject|16|||
161673353|NCT01313650|583857963|FG001|Overall Study|Withdrawal by Subject|20|||
161673354|NCT01313650|583857964|FG002|Overall Study|Withdrawal by Subject|15|||
161673355|NCT01313650|583857965|FG003|Overall Study|Withdrawal by Subject|15|||
161673356|NCT01313650|583857962|FG000|Overall Study|Protocol Violation|4|||
161673357|NCT01313650|583857963|FG001|Overall Study|Protocol Violation|7|||
161673358|NCT01313650|583857964|FG002|Overall Study|Protocol Violation|5|||
161673359|NCT01313650|583857965|FG003|Overall Study|Protocol Violation|6|||
161673360|NCT01313650|583857962|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
161819469|NCT04608448|584379662|FG000|Overall Study|Withdrawal by Subject|1|||
161819470|NCT04608448|584379662|FG000|Overall Study|Adverse Event|1|||
161925486|NCT00145327|584773192|FG002|Overall Study|Lost to Follow-up|14|||
161925487|NCT00145327|584773190|FG000|Overall Study|Administrative problems|12|||
161925488|NCT00145327|584773191|FG001|Overall Study|Administrative problems|9|||
161925489|NCT00145327|584773192|FG002|Overall Study|Administrative problems|13|||
161925490|NCT00145327|584773190|FG000|Overall Study|Protocol Violation|2|||
161925491|NCT00145327|584773191|FG001|Overall Study|Protocol Violation|0|||
161925492|NCT00145327|584773192|FG002|Overall Study|Protocol Violation|2|||
161925493|NCT00145327|584773190|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161925494|NCT00145327|584773191|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161925495|NCT00145327|584773192|FG002|Overall Study|Abnormal laboratory value(s)|2|||
161925496|NCT00145327|584773190|FG000|Overall Study|Missing - not stated|1|||
161925497|NCT00145327|584773191|FG001|Overall Study|Missing - not stated|0|||
161673361|NCT01313650|583857963|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
161819471|NCT03499873|584379663|FG000|Overall Study|Withdrawal by Subject|4|||
161925498|NCT00145327|584773192|FG002|Overall Study|Missing - not stated|1|||
161925499|NCT00845182|584773193|FG000|Overall Study|Lost to Follow-up|3|||
161673362|NCT01313650|583857964|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
161673363|NCT01313650|583857965|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
161673364|NCT04029480|583857966|FG000|Overall Study|Physician Decision|0|||
161673365|NCT04029480|583857967|FG001|Overall Study|Physician Decision|0|||
161925500|NCT00845182|584773194|FG001|Overall Study|Lost to Follow-up|3|||
161925501|NCT00845182|584773195|FG002|Overall Study|Lost to Follow-up|4|||
161925502|NCT00845182|584773193|FG000|Overall Study|Adverse Event|0|||
161925503|NCT00845182|584773194|FG001|Overall Study|Adverse Event|1|||
161673366|NCT04029480|583857968|FG002|Overall Study|Physician Decision|2|||
161673367|NCT04029480|583857969|FG003|Overall Study|Physician Decision|1|||
161673368|NCT04029480|583857966|FG000|Overall Study|Withdrawal by Subject|2|||
161673369|NCT04029480|583857967|FG001|Overall Study|Withdrawal by Subject|0|||
161673370|NCT04029480|583857968|FG002|Overall Study|Withdrawal by Subject|1|||
161673371|NCT04029480|583857969|FG003|Overall Study|Withdrawal by Subject|1|||
161673372|NCT02593786|583857970|FG000|Overall Study|Disease progression|12|||
161673373|NCT02593786|583857971|FG001|Overall Study|Disease progression|16|||
161673374|NCT02593786|583857972|FG002|Overall Study|Disease progression|10|||
161673375|NCT02593786|583857973|FG003|Overall Study|Disease progression|7|||
161673376|NCT02593786|583857970|FG000|Overall Study|Study drug toxicity|1|||
161673377|NCT02593786|583857971|FG001|Overall Study|Study drug toxicity|0|||
161673378|NCT02593786|583857972|FG002|Overall Study|Study drug toxicity|0|||
162188779|NCT03769090|585743859|FG001|Overall Study|Condition under investigation worsened|0|||
162188780|NCT03769090|585743860|FG002|Overall Study|Condition under investigation worsened|1|||
162188781|NCT03769090|585743858|FG000|Overall Study|Lack of Efficacy|1|||
162188782|NCT03769090|585743859|FG001|Overall Study|Lack of Efficacy|2|||
161673379|NCT02593786|583857973|FG003|Overall Study|Study drug toxicity|0|||
161819472|NCT03499873|584379664|FG001|Overall Study|Withdrawal by Subject|6|||
161819473|NCT03499873|584379665|FG002|Overall Study|Withdrawal by Subject|1|||
161819474|NCT03499873|584379663|FG000|Overall Study|Subjects condition worsened|0|||
161819475|NCT03499873|584379664|FG001|Overall Study|Subjects condition worsened|3|||
161819476|NCT03499873|584379665|FG002|Overall Study|Subjects condition worsened|11|||
161819477|NCT03499873|584379663|FG000|Overall Study|Adverse Event|8|||
161819478|NCT03499873|584379664|FG001|Overall Study|Adverse Event|3|||
161819479|NCT03499873|584379665|FG002|Overall Study|Adverse Event|6|||
161819480|NCT03499873|584379663|FG000|Overall Study|Physician Decision|1|||
161819481|NCT03499873|584379664|FG001|Overall Study|Physician Decision|0|||
161819482|NCT03499873|584379665|FG002|Overall Study|Physician Decision|0|||
161819483|NCT03499873|584379663|FG000|Overall Study|Administrative reasons|0|||
161819484|NCT03499873|584379664|FG001|Overall Study|Administrative reasons|1|||
161819485|NCT03499873|584379665|FG002|Overall Study|Administrative reasons|0|||
161819486|NCT03499873|584379663|FG000|Overall Study|Concomitant therapy|5|||
161819487|NCT03499873|584379664|FG001|Overall Study|Concomitant therapy|4|||
161819488|NCT03499873|584379665|FG002|Overall Study|Concomitant therapy|7|||
161819489|NCT03499873|584379663|FG000|Overall Study|Miscellaneous|1|||
161819490|NCT03499873|584379664|FG001|Overall Study|Miscellaneous|2|||
161819491|NCT03499873|584379665|FG002|Overall Study|Miscellaneous|2|||
161819492|NCT03499873|584379663|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
161819493|NCT03499873|584379664|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
161819494|NCT03499873|584379665|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
161819495|NCT01297504|584379666|FG000|Overall Study|Invalid Consent|1|||
161819496|NCT01297504|584379666|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
161819497|NCT01297504|584379666|FG000|Overall Study|No Study Visits|4|||
161819498|NCT01297504|584379666|FG000|Overall Study|Death|3|||
161819499|NCT01297504|584379666|FG000|Overall Study|Lost to Follow-up|43|||
161819500|NCT01297504|584379666|FG000|Overall Study|Withdrawal by Subject|9|||
161819501|NCT01297504|584379666|FG000|Overall Study|Site Closure|3|||
161819502|NCT01297504|584379666|FG000|Overall Study|Protocol Violation|3|||
161819503|NCT00654186|584379667|FG000|Overall Study|Withdrawal by Subject|5|||
161819504|NCT01024855|584379670|FG000|Overall Study|Inclusion/exclusion criteria|1|||
161819505|NCT00577655|584379671|FG000|Overall Study|Patient Request|0|||
161819506|NCT00577655|584379672|FG001|Overall Study|Patient Request|2|||
161819507|NCT00577655|584379671|FG000|Overall Study|Protocol Violation|0|||
161819508|NCT00577655|584379672|FG001|Overall Study|Protocol Violation|1|||
161819509|NCT00577655|584379671|FG000|Overall Study|Lost to Follow-up|1|||
161819510|NCT00577655|584379672|FG001|Overall Study|Lost to Follow-up|1|||
161819511|NCT03306277|584379676|FG000|Overall Study|Death|1|||
161819512|NCT03306277|584379676|FG000|Overall Study|Adverse Event|1|||
161819513|NCT03306277|584379676|FG000|Overall Study|Withdrawal by Subject|1|||
162188783|NCT03769090|585743860|FG002|Overall Study|Lack of Efficacy|2|||
162188784|NCT03769090|585743858|FG000|Overall Study|Other reasons|8|||
161819514|NCT01370863|584379680|FG000|Overall Study|Adverse Event|1|||
161819515|NCT01370863|584379681|FG001|Overall Study|Adverse Event|1|||
161819516|NCT01370863|584379680|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
161819517|NCT01370863|584379681|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
161819518|NCT01370863|584379680|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161819519|NCT01370863|584379681|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161673380|NCT02593786|583857970|FG000|Overall Study|Adverse event unrelated to study drug|1|||
161819520|NCT00881751|584379682|FG000|Overall Study|Physician Decision|0|||
161819521|NCT00881751|584379683|FG001|Overall Study|Physician Decision|1|||
161673381|NCT02593786|583857971|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161673382|NCT02593786|583857972|FG002|Overall Study|Adverse event unrelated to study drug|1|||
162188785|NCT03769090|585743859|FG001|Overall Study|Other reasons|12|||
162188786|NCT03769090|585743860|FG002|Overall Study|Other reasons|15|||
162188787|NCT02830893|585743866|FG000|Overall Study|Relocation to out of the country|1|||
162188788|NCT02830893|585743867|FG001|Overall Study|Relocation to out of the country|0|||
162188789|NCT02830893|585743866|FG000|Overall Study|Lost to Follow-up|0|||
162188790|NCT02830893|585743867|FG001|Overall Study|Lost to Follow-up|2|||
162188791|NCT02830893|585743866|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
162188792|NCT02830893|585743867|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
162188793|NCT01277302|585743868|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
162188794|NCT01277302|585743869|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
162188795|NCT01277302|585743870|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
161673383|NCT02593786|583857973|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161673384|NCT02593786|583857970|FG000|Overall Study|Participant request to discontinue study therapy|0|||
161673385|NCT02593786|583857971|FG001|Overall Study|Participant request to discontinue study therapy|2|||
161673386|NCT02593786|583857972|FG002|Overall Study|Participant request to discontinue study therapy|0|||
162188796|NCT01277302|585743868|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
162188797|NCT01277302|585743869|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
162188798|NCT01277302|585743870|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
162188799|NCT01277302|585743868|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
162188800|NCT01277302|585743869|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
162188801|NCT01277302|585743870|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
162188802|NCT01277302|585743868|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
162188803|NCT01277302|585743869|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
161673387|NCT02593786|583857973|FG003|Overall Study|Participant request to discontinue study therapy|0|||
161673388|NCT02593786|583857970|FG000|Overall Study|Other reasons|1|||
161673389|NCT02593786|583857971|FG001|Overall Study|Other reasons|1|||
161673390|NCT02593786|583857972|FG002|Overall Study|Other reasons|0|||
161673391|NCT02593786|583857973|FG003|Overall Study|Other reasons|5|||
161673392|NCT01839487|583857974|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
161673393|NCT01839487|583857975|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161673394|NCT01839487|583857976|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161673395|NCT01839487|583857977|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161673396|NCT01839487|583857978|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161673397|NCT01839487|583857979|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161673398|NCT01839487|583857974|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
161673399|NCT01839487|583857975|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
161673400|NCT01839487|583857976|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
161673401|NCT01839487|583857977|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
161673402|NCT01839487|583857978|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
161673403|NCT01839487|583857979|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
161673404|NCT01839487|583857974|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161673405|NCT01839487|583857975|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
161673406|NCT01839487|583857976|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161673407|NCT01839487|583857977|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161673408|NCT01839487|583857978|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161673409|NCT01839487|583857979|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161673410|NCT01839487|583857974|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
161673411|NCT01839487|583857975|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161673412|NCT01839487|583857976|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161673413|NCT01839487|583857977|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161673414|NCT01839487|583857978|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161673415|NCT01839487|583857979|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161673416|NCT01839487|583857974|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
161673417|NCT01839487|583857975|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
161673418|NCT01839487|583857976|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
161925504|NCT00845182|584773195|FG002|Overall Study|Adverse Event|1|||
161925505|NCT00845182|584773193|FG000|Overall Study|Physician Decision|0|||
162188804|NCT01277302|585743870|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
162188805|NCT01277302|585743868|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
162188806|NCT01277302|585743869|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
162188807|NCT01277302|585743870|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
162188808|NCT01277302|585743868|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
162188809|NCT01277302|585743869|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
162188810|NCT01277302|585743870|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
162188811|NCT01277302|585743868|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
162188812|NCT01277302|585743869|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
162188813|NCT01277302|585743870|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
162188814|NCT01277302|585743868|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
162188815|NCT01277302|585743869|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
162188816|NCT01277302|585743870|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
162019585|NCT01485172|585126094|FG002|Overall Study|Physician Decision|0|||
162019586|NCT01485172|585126095|FG003|Overall Study|Physician Decision|0|||
162019587|NCT01485172|585126096|FG004|Overall Study|Physician Decision|1|||
162019588|NCT01485172|585126097|FG005|Overall Study|Physician Decision|0|||
162019589|NCT01485172|585126092|FG000|Overall Study|Withdrawal by Subject|2|||
162019590|NCT01485172|585126093|FG001|Overall Study|Withdrawal by Subject|0|||
162019591|NCT01485172|585126094|FG002|Overall Study|Withdrawal by Subject|0|||
162019592|NCT01485172|585126095|FG003|Overall Study|Withdrawal by Subject|1|||
162019593|NCT01485172|585126096|FG004|Overall Study|Withdrawal by Subject|1|||
162019594|NCT01485172|585126097|FG005|Overall Study|Withdrawal by Subject|1|||
162019595|NCT01587014|585126098|FG000|Overall Study|Death|2|||
162019596|NCT01409811|585126099|FG000|Overall Study|Insurance denial|1|||
162019597|NCT00441064|585126100|FG000|Overall Study|Adverse Event|1|||
162019598|NCT00441064|585126101|FG001|Overall Study|Adverse Event|0|||
162019599|NCT00441064|585126100|FG000|Overall Study|Abnormal laboratory values|0|||
162019600|NCT00441064|585126101|FG001|Overall Study|Abnormal laboratory values|2|||
162019601|NCT00441064|585126100|FG000|Overall Study|Abnormal test procedure results|0|||
162019602|NCT00441064|585126101|FG001|Overall Study|Abnormal test procedure results|1|||
162019603|NCT00441064|585126100|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162019604|NCT00441064|585126101|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162188817|NCT01277302|585743868|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
162188818|NCT01277302|585743869|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
162188819|NCT01277302|585743870|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
162188820|NCT02710669|585743871|FG000|Overall Study|Physician Decision|2|||
162188821|NCT02710669|585743872|FG001|Overall Study|Physician Decision|1|||
162188822|NCT02710669|585743873|FG002|Overall Study|Physician Decision|0|||
162188823|NCT02710669|585743871|FG000|Overall Study|Institutional delays (including COVID)|2|||
162188824|NCT02710669|585743872|FG001|Overall Study|Institutional delays (including COVID)|2|||
162188825|NCT02710669|585743873|FG002|Overall Study|Institutional delays (including COVID)|0|||
162188826|NCT02710669|585743871|FG000|Overall Study|arrived in afib/aflutter|10|||
162188827|NCT02710669|585743872|FG001|Overall Study|arrived in afib/aflutter|8|||
162188828|NCT02710669|585743873|FG002|Overall Study|arrived in afib/aflutter|2|||
162188829|NCT01567852|585743876|FG000|Overall Study|Withdrawal by Subject|3|||
162188830|NCT01567852|585743877|FG001|Overall Study|Withdrawal by Subject|6|||
162188831|NCT01567852|585743876|FG000|Overall Study|ECT discontinued|1|||
162188832|NCT01567852|585743877|FG001|Overall Study|ECT discontinued|1|||
162188833|NCT01190124|585743879|FG000|Overall Study|Death|3|||
162188834|NCT01190124|585743880|FG001|Overall Study|Death|0|||
162188835|NCT01190124|585743881|FG002|Overall Study|Death|0|||
162188836|NCT01190124|585743879|FG000|Overall Study|Therapeutic Failure|12|||
162188837|NCT01190124|585743880|FG001|Overall Study|Therapeutic Failure|0|||
162188838|NCT01190124|585743881|FG002|Overall Study|Therapeutic Failure|1|||
162188839|NCT01190124|585743879|FG000|Overall Study|Lost to Follow-up|2|||
162188840|NCT01190124|585743880|FG001|Overall Study|Lost to Follow-up|0|||
162188841|NCT01190124|585743881|FG002|Overall Study|Lost to Follow-up|0|||
162188842|NCT03690219|585743882|FG000|Overall Study|no injuries|9|||
162188843|NCT03690219|585743883|FG001|Overall Study|no injuries|20|||
162188844|NCT03690219|585743882|FG000|Overall Study|missing information|7|||
162188845|NCT03690219|585743883|FG001|Overall Study|missing information|7|||
162188846|NCT01523392|585743884|FG000|Treatment Period 1|Withdrawal by Subject|2|||
162019605|NCT00441064|585126100|FG000|Overall Study|Protocol Deviation|3|||
162188847|NCT01523392|585743885|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162188848|NCT01523392|585743884|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
162188849|NCT01523392|585743885|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
162188850|NCT01523392|585743884|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
162188851|NCT01523392|585743885|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
162188852|NCT02771366|585743886|FG000|Period 1|Withdrawal by Subject|0|||
162188853|NCT02771366|585743887|FG001|Period 1|Withdrawal by Subject|2|||
162188854|NCT02771366|585743886|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
162188855|NCT02771366|585743887|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
162019606|NCT00441064|585126101|FG001|Overall Study|Protocol Deviation|2|||
162019607|NCT00441064|585126100|FG000|Overall Study|Patient withdrew consent|5|||
161673419|NCT01839487|583857977|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
161673420|NCT01839487|583857978|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
161673421|NCT01839487|583857979|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
161673422|NCT01839487|583857974|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
161673423|NCT01839487|583857975|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
161673424|NCT01839487|583857976|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
161673425|NCT01839487|583857977|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
161673426|NCT01839487|583857978|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
161673427|NCT01839487|583857979|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
161673428|NCT01839487|583857974|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
161673429|NCT01839487|583857975|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
161673430|NCT01839487|583857976|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
161673431|NCT01839487|583857977|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
161673432|NCT01839487|583857978|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
161673433|NCT01839487|583857979|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
161673434|NCT01839487|583857974|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
161673435|NCT01839487|583857975|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
161673436|NCT01839487|583857976|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
161673437|NCT01839487|583857977|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
161673438|NCT01839487|583857978|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
161673439|NCT01839487|583857979|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
161673440|NCT01839487|583857974|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
161673441|NCT01839487|583857975|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
161925506|NCT00845182|584773194|FG001|Overall Study|Physician Decision|0|||
161925507|NCT00845182|584773195|FG002|Overall Study|Physician Decision|1|||
162188856|NCT02092285|585743889|FG000|Induction Phase|Adverse Event|7|||
162188857|NCT02092285|585743889|FG000|Induction Phase|Physician Decision|4|||
162188858|NCT02092285|585743889|FG000|Induction Phase|Pregnancy|1|||
162188859|NCT02092285|585743889|FG000|Induction Phase|Relapse/Recurrence|7|||
162188860|NCT02092285|585743889|FG000|Induction Phase|Withdrawal by Subject|2|||
162188861|NCT02092285|585743889|FG000|Induction Phase|Lack of Efficacy|14|||
162188862|NCT02092285|585743889|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
162188863|NCT02092285|585743889|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
162188864|NCT02092285|585743889|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
162188865|NCT02092285|585743889|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
161925508|NCT04621760|584773196|FG000|Overall Study|Lost to Follow-up|2|||
162188866|NCT02092285|585743889|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
162188867|NCT02092285|585743889|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
162188868|NCT02092285|585743889|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
162188869|NCT02092285|585743889|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
162188870|NCT02092285|585743889|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
162188871|NCT01719172|585743892|FG000|Overall Study|Lost to Follow-up|1|||
162188872|NCT01719172|585743892|FG000|Overall Study|Death|1|||
162188873|NCT00087516|585743893|FG000|Overall Study|Adverse Event|10|||
162188874|NCT00087516|585743894|FG001|Overall Study|Adverse Event|10|||
162188875|NCT00087516|585743895|FG002|Overall Study|Adverse Event|3|||
162188876|NCT00087516|585743896|FG003|Overall Study|Adverse Event|6|||
162188877|NCT00087516|585743893|FG000|Overall Study|Lack of Efficacy|82|||
162188878|NCT00087516|585743894|FG001|Overall Study|Lack of Efficacy|80|||
162188879|NCT00087516|585743895|FG002|Overall Study|Lack of Efficacy|39|||
162188880|NCT00087516|585743896|FG003|Overall Study|Lack of Efficacy|29|||
162188881|NCT00087516|585743893|FG000|Overall Study|Lost to Follow-up|8|||
162188882|NCT00087516|585743894|FG001|Overall Study|Lost to Follow-up|6|||
162188883|NCT00087516|585743895|FG002|Overall Study|Lost to Follow-up|5|||
162188884|NCT00087516|585743896|FG003|Overall Study|Lost to Follow-up|5|||
162188885|NCT00087516|585743893|FG000|Overall Study|Protocol Violation|4|||
162188886|NCT00087516|585743894|FG001|Overall Study|Protocol Violation|8|||
162188887|NCT00087516|585743895|FG002|Overall Study|Protocol Violation|3|||
162188888|NCT00087516|585743896|FG003|Overall Study|Protocol Violation|6|||
161673442|NCT01839487|583857976|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
161673443|NCT01839487|583857977|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
161673444|NCT01839487|583857978|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
161673445|NCT01839487|583857979|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
161673446|NCT01658826|583857983|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
161673447|NCT01658826|583857984|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
161673448|NCT01658826|583857983|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
161673449|NCT01658826|583857984|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
161673450|NCT01658826|583857983|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
161673451|NCT01658826|583857984|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
161673452|NCT01658826|583857983|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
161925509|NCT04621760|584773197|FG001|Overall Study|Lost to Follow-up|4|||
162188889|NCT00087516|585743893|FG000|Overall Study|Withdrawal by Subject|16|||
162188890|NCT00087516|585743894|FG001|Overall Study|Withdrawal by Subject|27|||
162188891|NCT00087516|585743895|FG002|Overall Study|Withdrawal by Subject|11|||
162188892|NCT00087516|585743896|FG003|Overall Study|Withdrawal by Subject|12|||
162188893|NCT00087516|585743893|FG000|Overall Study|Site terminated|0|||
162188894|NCT00087516|585743894|FG001|Overall Study|Site terminated|2|||
162188895|NCT00087516|585743895|FG002|Overall Study|Site terminated|1|||
162188896|NCT00087516|585743896|FG003|Overall Study|Site terminated|0|||
162188897|NCT00087516|585743893|FG000|Overall Study|Protocol specified discontinuation|35|||
162188898|NCT00087516|585743894|FG001|Overall Study|Protocol specified discontinuation|33|||
162188899|NCT00087516|585743895|FG002|Overall Study|Protocol specified discontinuation|33|||
162188900|NCT00087516|585743896|FG003|Overall Study|Protocol specified discontinuation|26|||
162188901|NCT00087516|585743893|FG000|Overall Study|Patient moved|3|||
162188902|NCT00087516|585743894|FG001|Overall Study|Patient moved|2|||
162188903|NCT00087516|585743895|FG002|Overall Study|Patient moved|1|||
162188904|NCT00087516|585743896|FG003|Overall Study|Patient moved|0|||
162188905|NCT00087516|585743893|FG000|Overall Study|Patient was non-compliant|3|||
162188906|NCT00087516|585743894|FG001|Overall Study|Patient was non-compliant|1|||
162188907|NCT00087516|585743895|FG002|Overall Study|Patient was non-compliant|0|||
162188908|NCT00087516|585743896|FG003|Overall Study|Patient was non-compliant|0|||
162188909|NCT00087516|585743893|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
162188910|NCT00087516|585743894|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
162188911|NCT00087516|585743895|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
162188912|NCT00087516|585743896|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
162188913|NCT00087516|585743893|FG000|Overall Study|Other|0|||
162188914|NCT00087516|585743894|FG001|Overall Study|Other|0|||
162188915|NCT00087516|585743895|FG002|Overall Study|Other|1|||
162188916|NCT00087516|585743896|FG003|Overall Study|Other|0|||
162188917|NCT02392507|585743897|FG000|Induction Regimen|Death|3|||
162188918|NCT02392507|585743897|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
162188919|NCT02392507|585743897|FG000|Induction Regimen|Physician Decision|1|||
162188920|NCT02392507|585743897|FG000|Induction Regimen|Withdrawal by Subject|2|||
162188921|NCT02392507|585743897|FG000|Maintenance Regimen|Death|1|||
162188922|NCT02392507|585743897|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
162188923|NCT00273052|585743898|FG000|Overall Study|Withdrawal by Subject|16|||
162188924|NCT00273052|585743899|FG001|Overall Study|Withdrawal by Subject|19|||
162188925|NCT00273052|585743898|FG000|Overall Study|Adverse Event|21|||
162188926|NCT00273052|585743899|FG001|Overall Study|Adverse Event|19|||
162188927|NCT00273052|585743898|FG000|Overall Study|Protocol Violation|14|||
162188928|NCT00273052|585743899|FG001|Overall Study|Protocol Violation|18|||
161673453|NCT01658826|583857984|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
161819522|NCT00881751|584379682|FG000|Overall Study|Adverse Event|0|||
162188929|NCT00273052|585743898|FG000|Overall Study|Lost to Follow-up|7|||
162188930|NCT00273052|585743899|FG001|Overall Study|Lost to Follow-up|25|||
162188931|NCT00273052|585743898|FG000|Overall Study|Lack of Efficacy|6|||
162188932|NCT00273052|585743899|FG001|Overall Study|Lack of Efficacy|4|||
162188933|NCT00273052|585743898|FG000|Overall Study|Non-Compliance|3|||
161673454|NCT01658826|583857983|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
161819523|NCT00881751|584379683|FG001|Overall Study|Adverse Event|2|||
161819524|NCT00881751|584379682|FG000|Overall Study|Withdrawal by Subject|0|||
161819525|NCT00881751|584379683|FG001|Overall Study|Withdrawal by Subject|2|||
161819526|NCT01926119|584379684|FG000|Overall Study|Withdrawal by Subject|1|||
161819527|NCT01968551|584379685|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
161819528|NCT01968551|584379686|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
161819529|NCT01968551|584379687|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
161819530|NCT01968551|584379685|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
161819531|NCT01968551|584379686|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
161819532|NCT01968551|584379687|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
161819533|NCT01968551|584379685|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
161819534|NCT01968551|584379686|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
161819535|NCT01968551|584379687|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
161819536|NCT01968551|584379685|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
161819537|NCT01968551|584379686|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
161819538|NCT01968551|584379687|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
161819539|NCT01968551|584379685|FG000|Extension Phase|Adverse Event|0|||
161819540|NCT01968551|584379686|FG001|Extension Phase|Adverse Event|0|||
161819541|NCT01968551|584379687|FG002|Extension Phase|Adverse Event|2|||
161819542|NCT01968551|584379685|FG000|Extension Phase|Death|0|||
161819543|NCT01968551|584379686|FG001|Extension Phase|Death|1|||
162188934|NCT00273052|585743899|FG001|Overall Study|Non-Compliance|1|||
161673455|NCT01658826|583857984|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
162188935|NCT00273052|585743898|FG000|Overall Study|Other|2|||
162188936|NCT00273052|585743899|FG001|Overall Study|Other|0|||
162188937|NCT00273052|585743898|FG000|Overall Study|Worsening serum lipid levels|0|||
162188938|NCT00273052|585743899|FG001|Overall Study|Worsening serum lipid levels|2|||
161673456|NCT01658826|583857983|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
161673457|NCT01658826|583857984|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
161673458|NCT01658826|583857983|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
161673459|NCT01658826|583857984|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
161673460|NCT01658826|583857983|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
161673461|NCT01658826|583857984|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
161673462|NCT01658826|583857983|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
161673463|NCT01658826|583857984|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
161673464|NCT01019980|583857988|FG000|Overall Study|Drug not available.|2|||
161673465|NCT01019980|583857989|FG001|Overall Study|Drug not available.|0|||
161925510|NCT04621760|584773196|FG000|Overall Study|Withdrawal by Subject|1|||
161925511|NCT04621760|584773197|FG001|Overall Study|Withdrawal by Subject|0|||
161925512|NCT01028560|584773198|FG000|Overall Study|Lack of Efficacy|3|||
161925513|NCT01028560|584773199|FG001|Overall Study|Lack of Efficacy|6|||
162188939|NCT00240994|585743900|FG000|Overall Study|Lost to Follow-up|1|||
162188940|NCT00240994|585743900|FG000|Overall Study|Protocol Violation|1|||
161673466|NCT02038920|583857999|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
161673467|NCT02038920|583858000|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
161673468|NCT02038920|583858001|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
161673469|NCT02038920|583858002|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
161673470|NCT02038920|583858003|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
161673471|NCT02038920|583858004|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
161673472|NCT02038920|583857999|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
161673473|NCT02038920|583858000|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161673474|NCT02038920|583858001|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161673475|NCT02038920|583858002|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161673476|NCT02038920|583858003|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161673477|NCT02038920|583858004|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161673478|NCT02038920|583857999|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
161673479|NCT02038920|583858000|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
161673480|NCT02038920|583858001|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
162188941|NCT00240994|585743900|FG000|Overall Study|Graft failure|1|||
162188942|NCT02630186|585743902|FG000|Overall Study|Withdrawal by Subject|1|||
162188943|NCT00439218|585743903|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
162188944|NCT03142932|585743906|FG000|Overall Study|Lost to Follow-up|2|||
162188945|NCT03142932|585743907|FG001|Overall Study|Lost to Follow-up|11|||
162188946|NCT01021748|585743908|FG000|Overall Study|Adverse Event|2|||
162188947|NCT01021748|585743909|FG001|Overall Study|Adverse Event|1|||
162188948|NCT01021748|585743910|FG002|Overall Study|Adverse Event|2|||
162188949|NCT01021748|585743911|FG003|Overall Study|Adverse Event|0|||
162188950|NCT01021748|585743912|FG004|Overall Study|Adverse Event|2|||
162188951|NCT01021748|585743913|FG005|Overall Study|Adverse Event|0|||
161673481|NCT02038920|583858002|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
161673482|NCT02038920|583858003|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
161673483|NCT02038920|583858004|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
161819544|NCT01968551|584379687|FG002|Extension Phase|Death|0|||
161819545|NCT01968551|584379685|FG000|Extension Phase|Withdrew Consent|0|||
161819546|NCT01968551|584379686|FG001|Extension Phase|Withdrew Consent|0|||
161819547|NCT01968551|584379687|FG002|Extension Phase|Withdrew Consent|1|||
161819548|NCT01968551|584379685|FG000|Extension Phase|Lost to Follow-up|1|||
161819549|NCT01968551|584379686|FG001|Extension Phase|Lost to Follow-up|0|||
161819550|NCT01968551|584379687|FG002|Extension Phase|Lost to Follow-up|1|||
161819551|NCT00645853|584379688|FG000|Overall Study|Adverse Event|18|||
161819552|NCT00645853|584379689|FG001|Overall Study|Adverse Event|7|||
161819553|NCT00645853|584379688|FG000|Overall Study|AZ study closure in Hungary|60|||
161819554|NCT00645853|584379689|FG001|Overall Study|AZ study closure in Hungary|40|||
161819555|NCT00645853|584379688|FG000|Overall Study|Withdrawal by Subject|5|||
161819556|NCT00645853|584379689|FG001|Overall Study|Withdrawal by Subject|2|||
161819557|NCT00645853|584379688|FG000|Overall Study|Protocol Violation|0|||
161819558|NCT00645853|584379689|FG001|Overall Study|Protocol Violation|2|||
161819559|NCT00645853|584379688|FG000|Overall Study|Discontinuation criteria|2|||
161673484|NCT02038920|583857999|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
161673485|NCT02038920|583858000|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
161673486|NCT02038920|583858001|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
161673487|NCT02038920|583858002|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
161819560|NCT00645853|584379689|FG001|Overall Study|Discontinuation criteria|2|||
162188952|NCT01021748|585743914|FG006|Overall Study|Adverse Event|1|||
162188953|NCT01021748|585743915|FG007|Overall Study|Adverse Event|0|||
162188954|NCT01021748|585743916|FG008|Overall Study|Adverse Event|7|||
162188955|NCT01021748|585743908|FG000|Overall Study|Physician Decision|1|||
161673488|NCT02038920|583858003|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
161673489|NCT02038920|583858004|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
161673490|NCT02038920|583857999|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161673491|NCT02038920|583858000|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161673492|NCT02038920|583858001|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
161673493|NCT02038920|583858002|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161673494|NCT02038920|583858003|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161673495|NCT02038920|583858004|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161673496|NCT02038920|583857999|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
161673497|NCT02038920|583858000|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
161673498|NCT02038920|583858001|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
161673499|NCT02038920|583858002|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
161673500|NCT02038920|583858003|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
161673501|NCT02038920|583858004|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
161673502|NCT02038920|583857999|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161925514|NCT01028560|584773198|FG000|Overall Study|Withdrawal by Subject|7|||
161925515|NCT01028560|584773199|FG001|Overall Study|Withdrawal by Subject|12|||
161925516|NCT01960842|584773202|FG000|Overall Study|Adverse Event|1|||
161925517|NCT01960842|584773202|FG000|Overall Study|Withdrawal by Subject|2|||
161925518|NCT02029443|584773204|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
161925519|NCT02029443|584773205|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
162188956|NCT01021748|585743909|FG001|Overall Study|Physician Decision|0|||
162188957|NCT01021748|585743910|FG002|Overall Study|Physician Decision|1|||
162188958|NCT01021748|585743911|FG003|Overall Study|Physician Decision|1|||
162188959|NCT01021748|585743912|FG004|Overall Study|Physician Decision|0|||
162188960|NCT01021748|585743913|FG005|Overall Study|Physician Decision|0|||
162188961|NCT01021748|585743914|FG006|Overall Study|Physician Decision|1|||
162188962|NCT01021748|585743915|FG007|Overall Study|Physician Decision|1|||
162188963|NCT01021748|585743916|FG008|Overall Study|Physician Decision|2|||
162188964|NCT01021748|585743908|FG000|Overall Study|Progressive Disease|3|||
162188965|NCT01021748|585743909|FG001|Overall Study|Progressive Disease|3|||
162188966|NCT01021748|585743910|FG002|Overall Study|Progressive Disease|4|||
162188967|NCT01021748|585743911|FG003|Overall Study|Progressive Disease|6|||
162188968|NCT01021748|585743912|FG004|Overall Study|Progressive Disease|7|||
162188969|NCT01021748|585743913|FG005|Overall Study|Progressive Disease|3|||
162188970|NCT01021748|585743914|FG006|Overall Study|Progressive Disease|0|||
162188971|NCT01021748|585743915|FG007|Overall Study|Progressive Disease|5|||
162188972|NCT01021748|585743916|FG008|Overall Study|Progressive Disease|6|||
162188973|NCT01021748|585743908|FG000|Overall Study|Withdrawal by Subject|0|||
162188974|NCT01021748|585743909|FG001|Overall Study|Withdrawal by Subject|0|||
162188975|NCT01021748|585743910|FG002|Overall Study|Withdrawal by Subject|0|||
162188976|NCT01021748|585743911|FG003|Overall Study|Withdrawal by Subject|0|||
162188977|NCT01021748|585743912|FG004|Overall Study|Withdrawal by Subject|0|||
162188978|NCT01021748|585743913|FG005|Overall Study|Withdrawal by Subject|0|||
162188979|NCT01021748|585743914|FG006|Overall Study|Withdrawal by Subject|1|||
162188980|NCT01021748|585743915|FG007|Overall Study|Withdrawal by Subject|0|||
162188981|NCT01021748|585743916|FG008|Overall Study|Withdrawal by Subject|1|||
162188982|NCT01021748|585743908|FG000|Overall Study|Not Treated|0|||
162188983|NCT01021748|585743909|FG001|Overall Study|Not Treated|1|||
162188984|NCT01021748|585743910|FG002|Overall Study|Not Treated|0|||
162188985|NCT01021748|585743911|FG003|Overall Study|Not Treated|0|||
162188986|NCT01021748|585743912|FG004|Overall Study|Not Treated|0|||
162188987|NCT01021748|585743913|FG005|Overall Study|Not Treated|0|||
162188988|NCT01021748|585743914|FG006|Overall Study|Not Treated|0|||
162188989|NCT01021748|585743915|FG007|Overall Study|Not Treated|0|||
162188990|NCT01021748|585743916|FG008|Overall Study|Not Treated|0|||
162188991|NCT01485887|585743921|FG000|Overall Study|Withdrawal by Subject|2|||
162188992|NCT01485887|585743921|FG000|Overall Study|Adverse Event|8|||
162188993|NCT01485887|585743921|FG000|Overall Study|Deterioration of primary disease|1|||
162188994|NCT01485887|585743921|FG000|Overall Study|Primary disease markedly improved|1|||
162188995|NCT02234141|585743922|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
162188996|NCT02234141|585743923|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
162188997|NCT02234141|585743924|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
162188998|NCT02234141|585743925|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
162188999|NCT02234141|585743926|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
162189000|NCT02234141|585743927|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
162189001|NCT02234141|585743928|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
162189002|NCT02234141|585743922|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
162189003|NCT02234141|585743923|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
161673503|NCT02038920|583858000|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161673504|NCT02038920|583858001|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161925520|NCT02029443|584773206|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
162189004|NCT02234141|585743924|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
162189005|NCT02234141|585743925|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
162189006|NCT02234141|585743926|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
162189007|NCT02234141|585743927|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
162189008|NCT02234141|585743928|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
162189009|NCT02234141|585743922|FG000|Treatment Period (24 Weeks)|Death|1|||
162189010|NCT02234141|585743923|FG001|Treatment Period (24 Weeks)|Death|2|||
162189011|NCT02234141|585743924|FG002|Treatment Period (24 Weeks)|Death|0|||
162189012|NCT02234141|585743925|FG003|Treatment Period (24 Weeks)|Death|1|||
162189013|NCT02234141|585743926|FG004|Treatment Period (24 Weeks)|Death|0|||
162189014|NCT02234141|585743927|FG005|Treatment Period (24 Weeks)|Death|0|||
162189015|NCT02234141|585743928|FG006|Treatment Period (24 Weeks)|Death|0|||
162189016|NCT02234141|585743922|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
162189017|NCT02234141|585743923|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
162189018|NCT02234141|585743924|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
162189019|NCT02234141|585743925|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
162189020|NCT02234141|585743926|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
162189021|NCT02234141|585743927|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
162189022|NCT02234141|585743928|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
162189023|NCT02234141|585743922|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
162189024|NCT02234141|585743923|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
162189025|NCT02234141|585743924|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
162189026|NCT02234141|585743925|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
162189027|NCT02234141|585743926|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
162189028|NCT02234141|585743927|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
162189029|NCT02234141|585743928|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
162189030|NCT02234141|585743922|FG000|Long-Term Treatment Period|Death|0|||
162189031|NCT02234141|585743923|FG001|Long-Term Treatment Period|Death|0|||
162189032|NCT02234141|585743924|FG002|Long-Term Treatment Period|Death|0|||
162189033|NCT02234141|585743925|FG003|Long-Term Treatment Period|Death|0|||
162189034|NCT02234141|585743926|FG004|Long-Term Treatment Period|Death|0|||
162189035|NCT02234141|585743927|FG005|Long-Term Treatment Period|Death|1|||
162189036|NCT02234141|585743928|FG006|Long-Term Treatment Period|Death|0|||
162189037|NCT02234141|585743922|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
162189038|NCT02234141|585743923|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
162189039|NCT02234141|585743924|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
162189040|NCT02234141|585743925|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
162189041|NCT02234141|585743926|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
162189042|NCT02234141|585743927|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
162189043|NCT02234141|585743928|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
162189044|NCT02234141|585743922|FG000|Long-Term Treatment Period|Adverse Event|4|||
162189045|NCT02234141|585743923|FG001|Long-Term Treatment Period|Adverse Event|0|||
162189046|NCT02234141|585743924|FG002|Long-Term Treatment Period|Adverse Event|5|||
162189047|NCT02234141|585743925|FG003|Long-Term Treatment Period|Adverse Event|0|||
162189048|NCT02234141|585743926|FG004|Long-Term Treatment Period|Adverse Event|1|||
162189049|NCT02234141|585743927|FG005|Long-Term Treatment Period|Adverse Event|1|||
162189050|NCT02234141|585743928|FG006|Long-Term Treatment Period|Adverse Event|1|||
162189051|NCT02234141|585743922|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
162189052|NCT02234141|585743923|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
162189053|NCT02234141|585743924|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
162189054|NCT02234141|585743925|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
162189055|NCT02234141|585743926|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
162189056|NCT02234141|585743927|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
162189057|NCT02234141|585743928|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
162189058|NCT02234141|585743922|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
162189059|NCT02234141|585743923|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
162189060|NCT02234141|585743924|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
162189061|NCT02234141|585743925|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
162189062|NCT02234141|585743926|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
162189063|NCT02234141|585743927|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
162189064|NCT02234141|585743928|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
162189065|NCT00895245|585743929|FG000|Overall Study|Lack of Efficacy|6|||
162189066|NCT02095678|585743930|FG000|Overall Study|Withdrawal by Subject|0|||
161819561|NCT00645853|584379688|FG000|Overall Study|recall of ICF, planned operation, death|7|||
161819562|NCT00645853|584379689|FG001|Overall Study|recall of ICF, planned operation, death|4|||
162019608|NCT00441064|585126101|FG001|Overall Study|Patient withdrew consent|2|||
162019609|NCT03051178|585126102|FG000|Overall Study|Withdrawal by Subject|5|||
162019610|NCT00953056|585126103|FG000|Overall Study|Withdrew Consent|0|||
162019611|NCT00953056|585126104|FG001|Overall Study|Withdrew Consent|0|||
162019612|NCT00953056|585126105|FG002|Overall Study|Withdrew Consent|0|||
162019613|NCT00953056|585126106|FG003|Overall Study|Withdrew Consent|0|||
162019614|NCT00953056|585126107|FG004|Overall Study|Withdrew Consent|2|||
162019615|NCT00953056|585126108|FG005|Overall Study|Withdrew Consent|3|||
162019616|NCT00953056|585126103|FG000|Overall Study|Serious Adverse Event|0|||
162019617|NCT00953056|585126104|FG001|Overall Study|Serious Adverse Event|0|||
162019618|NCT00953056|585126105|FG002|Overall Study|Serious Adverse Event|0|||
162019619|NCT00953056|585126106|FG003|Overall Study|Serious Adverse Event|0|||
162019620|NCT00953056|585126107|FG004|Overall Study|Serious Adverse Event|0|||
162019621|NCT00953056|585126108|FG005|Overall Study|Serious Adverse Event|1|||
162019622|NCT00048074|585126110|FG000|Overall Study|Adverse Event|46|||
162019623|NCT00048074|585126111|FG001|Overall Study|Adverse Event|41|||
162019624|NCT00048074|585126112|FG002|Overall Study|Adverse Event|53|||
162019625|NCT00048074|585126110|FG000|Overall Study|Death|3|||
162019626|NCT00048074|585126111|FG001|Overall Study|Death|3|||
162019627|NCT00048074|585126112|FG002|Overall Study|Death|2|||
162019628|NCT00048074|585126110|FG000|Overall Study|Lost to Follow-up|2|||
162019629|NCT00048074|585126111|FG001|Overall Study|Lost to Follow-up|6|||
162019630|NCT00048074|585126112|FG002|Overall Study|Lost to Follow-up|6|||
162019631|NCT00048074|585126110|FG000|Overall Study|Withdrawal by Subject|28|||
162019632|NCT00048074|585126111|FG001|Overall Study|Withdrawal by Subject|30|||
162019633|NCT00048074|585126112|FG002|Overall Study|Withdrawal by Subject|35|||
162019634|NCT00048074|585126110|FG000|Overall Study|Protocol Violation|1|||
162019635|NCT00048074|585126111|FG001|Overall Study|Protocol Violation|3|||
162019636|NCT00048074|585126112|FG002|Overall Study|Protocol Violation|0|||
162019637|NCT00048074|585126110|FG000|Overall Study|Study participation was terminated|0|||
162019638|NCT00048074|585126111|FG001|Overall Study|Study participation was terminated|1|||
162019639|NCT00048074|585126112|FG002|Overall Study|Study participation was terminated|0|||
162019640|NCT00048074|585126110|FG000|Overall Study|Husband ill|0|||
162019641|NCT00048074|585126111|FG001|Overall Study|Husband ill|1|||
162019642|NCT00048074|585126112|FG002|Overall Study|Husband ill|0|||
162019643|NCT00048074|585126110|FG000|Overall Study|Poor compliance|0|||
162019644|NCT00048074|585126111|FG001|Overall Study|Poor compliance|1|||
162019645|NCT00048074|585126112|FG002|Overall Study|Poor compliance|0|||
162019646|NCT00048074|585126110|FG000|Overall Study|Out of station|0|||
162019647|NCT00048074|585126111|FG001|Overall Study|Out of station|1|||
162019648|NCT00048074|585126112|FG002|Overall Study|Out of station|1|||
162019649|NCT00048074|585126110|FG000|Overall Study|Social reasons|1|||
162019650|NCT00048074|585126111|FG001|Overall Study|Social reasons|0|||
162019651|NCT00048074|585126112|FG002|Overall Study|Social reasons|0|||
162019652|NCT01583296|585126113|FG000|Overall Study|Withdrawal by Subject|11|||
162019653|NCT01583296|585126114|FG001|Overall Study|Withdrawal by Subject|10|||
162019654|NCT01063283|585126115|FG000|Cycle 1|Adverse Event|2|||
162019655|NCT01063283|585126116|FG001|Cycle 1|Adverse Event|0|||
162019656|NCT01063283|585126117|FG002|Cycle 1|Adverse Event|0|||
162019657|NCT01063283|585126115|FG000|Cycle 1|Technical failure in data collection|1|||
162019658|NCT01063283|585126116|FG001|Cycle 1|Technical failure in data collection|0|||
162019659|NCT01063283|585126117|FG002|Cycle 1|Technical failure in data collection|0|||
162019660|NCT02504216|585126120|FG000|Overall Study|Lost to Follow-up|3|||
162019661|NCT02504216|585126121|FG001|Overall Study|Lost to Follow-up|3|||
162019662|NCT02504216|585126120|FG000|Overall Study|Withdrawal by Subject|8|||
162019663|NCT02504216|585126121|FG001|Overall Study|Withdrawal by Subject|12|||
162019664|NCT00223080|585126122|FG000|Overall Study|Withdrawal by Subject|253|||
162019665|NCT00223080|585126123|FG001|Overall Study|Withdrawal by Subject|232|||
162019666|NCT00223080|585126122|FG000|Overall Study|Required contraindicated med|0|||
162019667|NCT00223080|585126123|FG001|Overall Study|Required contraindicated med|1|||
162019668|NCT00223080|585126122|FG000|Overall Study|Non-compliant|7|||
162019669|NCT00223080|585126123|FG001|Overall Study|Non-compliant|7|||
162189067|NCT02095678|585743931|FG001|Overall Study|Withdrawal by Subject|1|||
162019670|NCT00223080|585126122|FG000|Overall Study|Moved from study area|37|||
162019671|NCT00223080|585126123|FG001|Overall Study|Moved from study area|47|||
162019672|NCT00223080|585126122|FG000|Overall Study|Lost to Follow-up|259|||
162019673|NCT00223080|585126123|FG001|Overall Study|Lost to Follow-up|284|||
162019674|NCT00223080|585126122|FG000|Overall Study|Death|85|||
162019675|NCT00223080|585126123|FG001|Overall Study|Death|74|||
162019676|NCT00223080|585126122|FG000|Overall Study|Other|14|||
162019677|NCT00223080|585126123|FG001|Overall Study|Other|11|||
161673505|NCT02038920|583858002|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161673506|NCT02038920|583858003|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161673507|NCT02038920|583858004|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
161673508|NCT02038920|583857999|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161673509|NCT02038920|583858000|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161673510|NCT02038920|583858001|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161673511|NCT02038920|583858002|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161819563|NCT01507662|584379690|FG000|Overall Study|Death|26|||
161819564|NCT01507662|584379691|FG001|Overall Study|Death|18|||
161819565|NCT01507662|584379690|FG000|Overall Study|Withdrawal by Subject|290|||
161819566|NCT01507662|584379691|FG001|Overall Study|Withdrawal by Subject|287|||
161819567|NCT01507662|584379690|FG000|Overall Study|Lost to Follow-up|498|||
161819568|NCT01507662|584379691|FG001|Overall Study|Lost to Follow-up|523|||
161819569|NCT01507662|584379690|FG000|Overall Study|Proxy interview done|2|||
161819570|NCT01507662|584379691|FG001|Overall Study|Proxy interview done|3|||
161819571|NCT01395017|584379692|FG000|Overall Study|Lost to Follow-up|1|||
161819572|NCT01395017|584379693|FG001|Overall Study|Lost to Follow-up|0|||
161819573|NCT01395017|584379692|FG000|Overall Study|Adverse Event|26|||
161819574|NCT01395017|584379693|FG001|Overall Study|Adverse Event|12|||
161819575|NCT01395017|584379692|FG000|Overall Study|Physician Decision|11|||
161819576|NCT01395017|584379693|FG001|Overall Study|Physician Decision|15|||
161819577|NCT01395017|584379692|FG000|Overall Study|Withdrawal by Subject|14|||
161819578|NCT01395017|584379693|FG001|Overall Study|Withdrawal by Subject|8|||
161819579|NCT01395017|584379692|FG000|Overall Study|Protocol deviation|1|||
161819580|NCT01395017|584379693|FG001|Overall Study|Protocol deviation|2|||
161819581|NCT01395017|584379692|FG000|Overall Study|Death|4|||
161819582|NCT01395017|584379693|FG001|Overall Study|Death|3|||
161819583|NCT01395017|584379692|FG000|Overall Study|Disease progression|42|||
161819584|NCT01395017|584379693|FG001|Overall Study|Disease progression|58|||
161819585|NCT01395017|584379692|FG000|Overall Study|Sponsor discontinued study|1|||
161819586|NCT01395017|584379693|FG001|Overall Study|Sponsor discontinued study|4|||
161819587|NCT03366428|584379694|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
161819588|NCT03366428|584379694|FG000|Overall Study|Adverse Event|12|||
161819589|NCT03366428|584379694|FG000|Overall Study|Clinical progression|2|||
161819590|NCT03366428|584379694|FG000|Overall Study|Withdrawal by Subject|4|||
161819591|NCT01958476|584379695|FG000|Overall Study|Parent requested exclusion from analysis|1|||
161819592|NCT01958476|584379696|FG001|Overall Study|Parent requested exclusion from analysis|0|||
161819593|NCT02943096|584379699|FG000|Overall Study|Lack of Efficacy|0|||
161819594|NCT02943096|584379700|FG001|Overall Study|Lack of Efficacy|1|||
161819595|NCT03867760|584379706|FG000|Overall Study|Lost to Follow-up|2|||
161819596|NCT03867760|584379707|FG001|Overall Study|Lost to Follow-up|3|||
161819597|NCT03867760|584379706|FG000|Overall Study|Withdrawal by Subject|1|||
161819598|NCT03867760|584379707|FG001|Overall Study|Withdrawal by Subject|2|||
161819599|NCT03867760|584379706|FG000|Overall Study|subject could not meet study logistics|3|||
161819600|NCT03867760|584379707|FG001|Overall Study|subject could not meet study logistics|3|||
161819601|NCT04203823|584379708|FG000|Overall Study|Withdrawal by Subject|2|||
161819602|NCT04203823|584379709|FG001|Overall Study|Withdrawal by Subject|2|||
161819603|NCT04203823|584379708|FG000|Overall Study|Adverse Event|1|||
161819604|NCT04203823|584379709|FG001|Overall Study|Adverse Event|1|||
161819605|NCT04203823|584379708|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161819606|NCT04203823|584379709|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
161673512|NCT02038920|583858003|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161673513|NCT02038920|583858004|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
161673514|NCT02038920|583857999|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161673515|NCT02038920|583858000|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161673516|NCT02038920|583858001|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161673517|NCT02038920|583858002|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
162189068|NCT02095678|585743930|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
162189069|NCT02095678|585743931|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
162189070|NCT02095678|585743930|FG000|Overall Study|lesion impacted by previous treatment|1|||
162189071|NCT02095678|585743931|FG001|Overall Study|lesion impacted by previous treatment|1|||
161673518|NCT02038920|583858003|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161673519|NCT02038920|583858004|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
161673520|NCT02038920|583857999|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161673521|NCT02038920|583858000|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161673522|NCT02038920|583858001|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161673523|NCT02038920|583858002|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161673524|NCT02038920|583858003|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161673525|NCT02038920|583858004|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
161673526|NCT02038920|583857999|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161673527|NCT02038920|583858000|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161673528|NCT02038920|583858001|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161673529|NCT02038920|583858002|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161673530|NCT02038920|583858003|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161673531|NCT02038920|583858004|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
161673532|NCT02038920|583857999|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161673533|NCT02038920|583858000|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161673534|NCT02038920|583858001|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161673535|NCT02038920|583858002|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161673536|NCT02038920|583858003|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161673537|NCT02038920|583858004|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
161673538|NCT02383589|583858006|FG000|Treatment Period|Adverse Event|1|||
161673539|NCT02383589|583858007|FG001|Treatment Period|Adverse Event|3|||
161673540|NCT02383589|583858006|FG000|Treatment Period|Lost to Follow-up|0|||
161673541|NCT02383589|583858007|FG001|Treatment Period|Lost to Follow-up|1|||
161673542|NCT02383589|583858006|FG000|Treatment Period|Withdrawal by Subject|0|||
161673543|NCT02383589|583858007|FG001|Treatment Period|Withdrawal by Subject|5|||
161673544|NCT02383589|583858006|FG000|Treatment Period|Non-compliance with study drug|0|||
161673545|NCT02383589|583858007|FG001|Treatment Period|Non-compliance with study drug|1|||
161673546|NCT02383589|583858006|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
161673547|NCT02383589|583858007|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
161673548|NCT02383589|583858006|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
161673549|NCT02383589|583858007|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
161673550|NCT02383589|583858006|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
161673551|NCT02383589|583858007|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
161673552|NCT00866697|583858008|FG000|Overall Study|Study closed/terminated|156|||
161673553|NCT00866697|583858009|FG001|Overall Study|Study closed/terminated|138|||
161673554|NCT00866697|583858008|FG000|Overall Study|Lost to Follow-up|22|||
161673555|NCT00866697|583858009|FG001|Overall Study|Lost to Follow-up|28|||
161925521|NCT02029443|584773207|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
161925522|NCT02029443|584773208|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
161925523|NCT02029443|584773204|FG000|Overall Study|Death|13|||
161925524|NCT02029443|584773205|FG001|Overall Study|Death|2|||
161925525|NCT02029443|584773206|FG002|Overall Study|Death|2|||
161925526|NCT02029443|584773207|FG003|Overall Study|Death|11|||
161925527|NCT02029443|584773208|FG004|Overall Study|Death|2|||
161925528|NCT02029443|584773204|FG000|Overall Study|Lost to Follow-up|1|||
161925529|NCT02029443|584773205|FG001|Overall Study|Lost to Follow-up|0|||
161925530|NCT02029443|584773206|FG002|Overall Study|Lost to Follow-up|1|||
161925531|NCT02029443|584773207|FG003|Overall Study|Lost to Follow-up|1|||
161925532|NCT02029443|584773208|FG004|Overall Study|Lost to Follow-up|0|||
161925533|NCT02029443|584773204|FG000|Overall Study|Started other anti-cancer therapy|17|||
161925534|NCT02029443|584773205|FG001|Overall Study|Started other anti-cancer therapy|4|||
161925535|NCT02029443|584773206|FG002|Overall Study|Started other anti-cancer therapy|7|||
161925536|NCT02029443|584773207|FG003|Overall Study|Started other anti-cancer therapy|9|||
161673556|NCT00866697|583858008|FG000|Overall Study|Physician Decision|3|||
161673557|NCT00866697|583858009|FG001|Overall Study|Physician Decision|5|||
161673558|NCT00866697|583858008|FG000|Overall Study|Withdrawal by Subject|33|||
161673559|NCT00866697|583858009|FG001|Overall Study|Withdrawal by Subject|57|||
161925537|NCT02029443|584773208|FG004|Overall Study|Started other anti-cancer therapy|3|||
161925538|NCT02029443|584773204|FG000|Overall Study|Withdrawal by Subject|3|||
162019678|NCT00223080|585126122|FG000|Overall Study|Reason not provided|141|||
162019679|NCT00223080|585126123|FG001|Overall Study|Reason not provided|140|||
162019680|NCT00223080|585126122|FG000|Overall Study|Adverse Event|0|||
162019681|NCT00223080|585126123|FG001|Overall Study|Adverse Event|1|||
162019682|NCT02598583|585126124|FG000|Extension Period|Withdrawal by Subject|1|||
162019683|NCT02598583|585126125|FG001|Extension Period|Withdrawal by Subject|0|||
162019684|NCT03237286|585126126|FG000|Overall Study|Withdrawal by Subject|1|||
162019685|NCT03237286|585126127|FG001|Overall Study|Withdrawal by Subject|0|||
162019686|NCT03237286|585126128|FG002|Overall Study|Withdrawal by Subject|2|||
162019687|NCT03237286|585126126|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
162019688|NCT03237286|585126127|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
162019689|NCT03237286|585126128|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
162019690|NCT02792829|585126136|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
162019691|NCT02792829|585126137|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
162019692|NCT02792829|585126138|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
162019693|NCT02792829|585126139|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
162019694|NCT02792829|585126140|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
162019695|NCT02792829|585126141|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
162019696|NCT02792829|585126142|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
162019697|NCT02792829|585126143|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
162019698|NCT02792829|585126136|FG000|Treatment Period 2|Adverse Event|0|||
162019699|NCT02792829|585126137|FG001|Treatment Period 2|Adverse Event|0|||
162019700|NCT02792829|585126138|FG002|Treatment Period 2|Adverse Event|0|||
162019701|NCT02792829|585126139|FG003|Treatment Period 2|Adverse Event|0|||
162019702|NCT02792829|585126140|FG004|Treatment Period 2|Adverse Event|1|||
162019703|NCT02792829|585126141|FG005|Treatment Period 2|Adverse Event|0|||
162019704|NCT02792829|585126142|FG006|Treatment Period 2|Adverse Event|1|||
162019705|NCT02792829|585126143|FG007|Treatment Period 2|Adverse Event|1|||
162019706|NCT02792829|585126136|FG000|Treatment Period 2|Use of proscribed medications|0|||
162019707|NCT02792829|585126137|FG001|Treatment Period 2|Use of proscribed medications|0|||
162019708|NCT02792829|585126138|FG002|Treatment Period 2|Use of proscribed medications|0|||
162019709|NCT02792829|585126139|FG003|Treatment Period 2|Use of proscribed medications|0|||
162189072|NCT02095678|585743930|FG000|Overall Study|No Confirmed Diagnosis|0|||
162189073|NCT02095678|585743931|FG001|Overall Study|No Confirmed Diagnosis|3|||
162189074|NCT02095678|585743930|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
162189075|NCT02095678|585743931|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
162189076|NCT02095678|585743930|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
162189077|NCT02095678|585743931|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
162189078|NCT03418545|585743932|FG000|Overall Study|Withdrawal by Participant|2|||
162189079|NCT03418545|585743933|FG001|Overall Study|Withdrawal by Participant|4|||
162189080|NCT03418545|585743932|FG000|Overall Study|Lost to Follow-up|3|||
162189081|NCT03418545|585743933|FG001|Overall Study|Lost to Follow-up|5|||
162189082|NCT03418545|585743932|FG000|Overall Study|Reason Not Specified|0|||
162189083|NCT03418545|585743933|FG001|Overall Study|Reason Not Specified|1|||
162189084|NCT03418545|585743932|FG000|Overall Study|Missing Completion Status|0|||
162189085|NCT03418545|585743933|FG001|Overall Study|Missing Completion Status|1|||
162189086|NCT04660799|585743934|FG000|Overall Study|Progressive Disease|1|||
162189087|NCT04660799|585743935|FG001|Overall Study|Progressive Disease|1|||
162189088|NCT04660799|585743934|FG000|Overall Study|Death|2|||
162189089|NCT04660799|585743935|FG001|Overall Study|Death|1|||
162189090|NCT04660799|585743934|FG000|Overall Study|Adverse Event|2|||
162189091|NCT04660799|585743935|FG001|Overall Study|Adverse Event|1|||
162189092|NCT04660799|585743934|FG000|Overall Study|Withdrawal by Subject|2|||
162189093|NCT04660799|585743935|FG001|Overall Study|Withdrawal by Subject|5|||
162189094|NCT02706483|585743936|FG000|Overall Study|Adverse Event|97|||
162189095|NCT02706483|585743936|FG000|Overall Study|Death|1|||
162189096|NCT02706483|585743936|FG000|Overall Study|Lack of Efficacy|39|||
162189097|NCT02706483|585743936|FG000|Overall Study|Lost to Follow-up|101|||
162189098|NCT02706483|585743936|FG000|Overall Study|Non-compliance with study drug|15|||
162189099|NCT02706483|585743936|FG000|Overall Study|Physician Decision|6|||
162189100|NCT02706483|585743936|FG000|Overall Study|Pregnancy|6|||
162019710|NCT02792829|585126140|FG004|Treatment Period 2|Use of proscribed medications|0|||
162019711|NCT02792829|585126141|FG005|Treatment Period 2|Use of proscribed medications|0|||
162189101|NCT02706483|585743936|FG000|Overall Study|Protocol Violation|18|||
162189102|NCT02706483|585743936|FG000|Overall Study|Withdrawal by Subject|136|||
162189103|NCT02706483|585743936|FG000|Overall Study|Non-compliance with visits|6|||
162189104|NCT02706483|585743936|FG000|Overall Study|Site closure|4|||
162189105|NCT02706483|585743936|FG000|Overall Study|Subject moved|1|||
162189106|NCT03131713|585743937|FG000|Overall Study|Lost to Follow-up|5|||
162019712|NCT02792829|585126142|FG006|Treatment Period 2|Use of proscribed medications|0|||
162019713|NCT02792829|585126143|FG007|Treatment Period 2|Use of proscribed medications|1|||
162019714|NCT01262820|585126144|FG000|Overall Study|Adverse Event|5|||
162019715|NCT01262820|585126144|FG000|Overall Study|Lack of Efficacy|9|||
162019716|NCT01262820|585126144|FG000|Overall Study|Drug held for 21+ days|1|||
162189107|NCT03131713|585743938|FG001|Overall Study|Lost to Follow-up|0|||
162189108|NCT02382640|585743947|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
162189109|NCT02382640|585743948|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
162189110|NCT02382640|585743949|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
162189111|NCT02382640|585743950|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
162189112|NCT01220999|585743951|FG000|Overall Study|Progressive disease|0|||
162189113|NCT01220999|585743952|FG001|Overall Study|Progressive disease|0|||
162189114|NCT01220999|585743953|FG002|Overall Study|Progressive disease|1|||
162189115|NCT01220999|585743954|FG003|Overall Study|Progressive disease|0|||
162189116|NCT01220999|585743955|FG004|Overall Study|Progressive disease|0|||
162189117|NCT01560429|585743958|FG000|Overall Study|Protocol Violation|3|||
162189118|NCT01560429|585743959|FG001|Overall Study|Protocol Violation|6|||
162189119|NCT03861234|585743960|FG000|Overall Study|Not treated|0|||
162189120|NCT03861234|585743961|FG001|Overall Study|Not treated|0|||
162189121|NCT03861234|585743962|FG002|Overall Study|Not treated|0|||
162189122|NCT03861234|585743963|FG003|Overall Study|Not treated|0|||
162189123|NCT03861234|585743964|FG004|Overall Study|Not treated|0|||
162189124|NCT03861234|585743965|FG005|Overall Study|Not treated|1|||
162189125|NCT03861234|585743966|FG006|Overall Study|Not treated|0|||
162189126|NCT03861234|585743967|FG007|Overall Study|Not treated|0|||
162189127|NCT03861234|585743960|FG000|Overall Study|Adverse Event|0|||
162189128|NCT03861234|585743961|FG001|Overall Study|Adverse Event|0|||
162189129|NCT03861234|585743962|FG002|Overall Study|Adverse Event|0|||
162189130|NCT03861234|585743963|FG003|Overall Study|Adverse Event|0|||
162189131|NCT03861234|585743964|FG004|Overall Study|Adverse Event|0|||
162189132|NCT03861234|585743965|FG005|Overall Study|Adverse Event|1|||
162189133|NCT03861234|585743966|FG006|Overall Study|Adverse Event|0|||
162189134|NCT03861234|585743967|FG007|Overall Study|Adverse Event|0|||
162189135|NCT03861234|585743960|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
162189136|NCT03861234|585743961|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
162189137|NCT03861234|585743962|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
162189138|NCT03861234|585743963|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
162189139|NCT03861234|585743964|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
162189140|NCT03861234|585743965|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
162189141|NCT03861234|585743966|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
162189142|NCT03861234|585743967|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
162189143|NCT03861234|585743960|FG000|Overall Study|As per sponsor decision|0|||
162189144|NCT03861234|585743961|FG001|Overall Study|As per sponsor decision|0|||
162189145|NCT03861234|585743962|FG002|Overall Study|As per sponsor decision|0|||
162189146|NCT03861234|585743963|FG003|Overall Study|As per sponsor decision|0|||
162189147|NCT03861234|585743964|FG004|Overall Study|As per sponsor decision|0|||
162189148|NCT03861234|585743965|FG005|Overall Study|As per sponsor decision|0|||
162189149|NCT03861234|585743966|FG006|Overall Study|As per sponsor decision|1|||
162189150|NCT03861234|585743967|FG007|Overall Study|As per sponsor decision|0|||
162189151|NCT03861234|585743960|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
162189152|NCT03861234|585743961|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
162189153|NCT03861234|585743962|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
162189154|NCT03861234|585743963|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
162189155|NCT03861234|585743964|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
162189156|NCT03861234|585743965|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
162189157|NCT03861234|585743966|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
161673560|NCT02906787|583858012|FG000|Overall Study|Withdrawal by Subject|12|||
161673561|NCT02906787|583858013|FG001|Overall Study|Withdrawal by Subject|10|||
161673562|NCT02906787|583858012|FG000|Overall Study|Missed|24|||
161673563|NCT02906787|583858013|FG001|Overall Study|Missed|22|||
161673564|NCT00447382|583858014|FG000|Overall Study|Adverse Event|1|||
161673565|NCT00447382|583858015|FG001|Overall Study|Adverse Event|1|||
161673566|NCT00447382|583858014|FG000|Overall Study|Lack of Efficacy|1|||
161673567|NCT00447382|583858015|FG001|Overall Study|Lack of Efficacy|0|||
161673568|NCT00447382|583858014|FG000|Overall Study|Protocol Violation|2|||
161925539|NCT02029443|584773205|FG001|Overall Study|Withdrawal by Subject|1|||
161925540|NCT02029443|584773206|FG002|Overall Study|Withdrawal by Subject|1|||
161673569|NCT00447382|583858015|FG001|Overall Study|Protocol Violation|0|||
161673570|NCT00447382|583858014|FG000|Overall Study|Unclassified|2|||
161673571|NCT00447382|583858015|FG001|Overall Study|Unclassified|5|||
161673572|NCT03901053|583858020|FG000|Overall Study|Lost to Follow-up|6|||
161673573|NCT03901053|583858021|FG001|Overall Study|Lost to Follow-up|2|||
161673574|NCT03901053|583858020|FG000|Overall Study|Withdrawal by Subject|4|||
161673575|NCT03901053|583858021|FG001|Overall Study|Withdrawal by Subject|3|||
161673576|NCT03901053|583858020|FG000|Overall Study|Unsatisfactory Device|1|||
161673577|NCT03901053|583858021|FG001|Overall Study|Unsatisfactory Device|2|||
161673578|NCT03901053|583858020|FG000|Overall Study|No longer meets study criteria|1|||
161925541|NCT02029443|584773207|FG003|Overall Study|Withdrawal by Subject|1|||
161925542|NCT02029443|584773208|FG004|Overall Study|Withdrawal by Subject|0|||
162189158|NCT03861234|585743967|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
161925543|NCT02029443|584773204|FG000|Overall Study|Other|6|||
161925544|NCT02029443|584773205|FG001|Overall Study|Other|6|||
161925545|NCT02029443|584773206|FG002|Overall Study|Other|4|||
161925546|NCT02029443|584773207|FG003|Overall Study|Other|2|||
161925547|NCT02029443|584773208|FG004|Overall Study|Other|0|||
161925548|NCT03123588|584773209|FG000|Overall Study|Study Terminated by Sponsor|2|||
161925549|NCT03123588|584773210|FG001|Overall Study|Study Terminated by Sponsor|5|||
161925550|NCT03123588|584773209|FG000|Overall Study|Withdrawal by Subject|1|||
161925551|NCT03123588|584773210|FG001|Overall Study|Withdrawal by Subject|0|||
161925552|NCT03123588|584773209|FG000|Overall Study|Adverse Event|1|||
161925553|NCT03123588|584773210|FG001|Overall Study|Adverse Event|0|||
162189159|NCT05169684|585743973|FG000|Overall Study|Adverse Event|1|||
162189160|NCT05169684|585743974|FG001|Overall Study|Adverse Event|3|||
162189161|NCT05169684|585743973|FG000|Overall Study|Physician Decision|0|||
162189162|NCT05169684|585743974|FG001|Overall Study|Physician Decision|1|||
162189163|NCT05169684|585743973|FG000|Overall Study|Progressive Disease|1|||
162189164|NCT05169684|585743974|FG001|Overall Study|Progressive Disease|1|||
162189165|NCT05169684|585743973|FG000|Overall Study|Participant request to discontinue treatment|0|||
162189166|NCT05169684|585743974|FG001|Overall Study|Participant request to discontinue treatment|1|||
162189167|NCT05169684|585743973|FG000|Overall Study|Other Reason|0|||
162189168|NCT05169684|585743974|FG001|Overall Study|Other Reason|1|||
162189169|NCT04748341|585743980|FG000|Overall Study|Lost to Follow-up|1|||
162189170|NCT04748341|585743981|FG001|Overall Study|Lost to Follow-up|1|||
162189171|NCT02334215|585743982|FG000|Overall Study|Death|1|||
161925554|NCT03123588|584773209|FG000|Overall Study|Physician Decision|2|||
162189172|NCT02334215|585743983|FG001|Overall Study|Death|1|||
162189173|NCT02334215|585743984|FG002|Overall Study|Death|0|||
162189174|NCT02334215|585743982|FG000|Overall Study|Lost to Follow-up|1|||
162189175|NCT02334215|585743983|FG001|Overall Study|Lost to Follow-up|0|||
162189176|NCT02334215|585743984|FG002|Overall Study|Lost to Follow-up|4|||
162189177|NCT02334215|585743982|FG000|Overall Study|Withdrawal by Subject|2|||
162189178|NCT02334215|585743983|FG001|Overall Study|Withdrawal by Subject|2|||
162189179|NCT02334215|585743984|FG002|Overall Study|Withdrawal by Subject|1|||
162189180|NCT02334215|585743982|FG000|Overall Study|Not released from incarceration on time|3|||
162189181|NCT02334215|585743983|FG001|Overall Study|Not released from incarceration on time|3|||
162189182|NCT02334215|585743984|FG002|Overall Study|Not released from incarceration on time|3|||
162189183|NCT02334215|585743982|FG000|Overall Study|Incarcerated|0|||
162189184|NCT02334215|585743983|FG001|Overall Study|Incarcerated|0|||
162189185|NCT02334215|585743984|FG002|Overall Study|Incarcerated|7|||
162189186|NCT05865392|585743987|FG000|Overall Study|Withdrawal by Subject|4|||
162189187|NCT05865392|585743988|FG001|Overall Study|Withdrawal by Subject|0|||
162189188|NCT05865392|585743987|FG000|Overall Study|Didn't meet inclusion criteria|4|||
162189189|NCT05865392|585743988|FG001|Overall Study|Didn't meet inclusion criteria|0|||
162189190|NCT02159989|585743989|FG000|Overall Study|Adverse Event|1|||
162189191|NCT02159989|585743990|FG001|Overall Study|Adverse Event|0|||
162189192|NCT02159989|585743991|FG002|Overall Study|Adverse Event|0|||
162189193|NCT02159989|585743992|FG003|Overall Study|Adverse Event|0|||
162189194|NCT02159989|585743993|FG004|Overall Study|Adverse Event|1|||
162189195|NCT02159989|585743994|FG005|Overall Study|Adverse Event|0|||
162189196|NCT02159989|585743995|FG006|Overall Study|Adverse Event|1|||
162189197|NCT02159989|585743996|FG007|Overall Study|Adverse Event|2|||
162189198|NCT02159989|585743997|FG008|Overall Study|Adverse Event|0|||
162189199|NCT02159989|585743998|FG009|Overall Study|Adverse Event|2|||
162189200|NCT02159989|585743999|FG010|Overall Study|Adverse Event|1|||
162189201|NCT02159989|585743989|FG000|Overall Study|Death|0|||
162189202|NCT02159989|585743990|FG001|Overall Study|Death|0|||
162189203|NCT02159989|585743991|FG002|Overall Study|Death|0|||
162189204|NCT02159989|585743992|FG003|Overall Study|Death|0|||
162189205|NCT02159989|585743993|FG004|Overall Study|Death|0|||
161925555|NCT03123588|584773210|FG001|Overall Study|Physician Decision|1|||
161925556|NCT02063724|584773211|FG000|Overall Study|Disease progression|1|||
162019717|NCT00104520|585126145|FG000|Overall Study|Unrelated adverse event|34|||
162189206|NCT02159989|585743994|FG005|Overall Study|Death|0|||
161925557|NCT00896233|584773212|FG000|Overall Study|Claustrophobia during MRI|1|||
161925558|NCT02697422|584773216|FG000|Overall Study|Declined exit survey|9|||
161925559|NCT02697422|584773217|FG001|Overall Study|Declined exit survey|2|||
161925560|NCT02697422|584773216|FG000|Overall Study|Lost to Follow-up|13|||
162189207|NCT02159989|585743995|FG006|Overall Study|Death|0|||
162189208|NCT02159989|585743996|FG007|Overall Study|Death|0|||
162189209|NCT02159989|585743997|FG008|Overall Study|Death|0|||
162189210|NCT02159989|585743998|FG009|Overall Study|Death|0|||
162189211|NCT02159989|585743999|FG010|Overall Study|Death|1|||
162189212|NCT02159989|585743989|FG000|Overall Study|Lack of Efficacy|2|||
162189213|NCT02159989|585743990|FG001|Overall Study|Lack of Efficacy|3|||
162189214|NCT02159989|585743991|FG002|Overall Study|Lack of Efficacy|3|||
162189215|NCT02159989|585743992|FG003|Overall Study|Lack of Efficacy|0|||
162189216|NCT02159989|585743993|FG004|Overall Study|Lack of Efficacy|2|||
162189217|NCT02159989|585743994|FG005|Overall Study|Lack of Efficacy|3|||
162189218|NCT02159989|585743995|FG006|Overall Study|Lack of Efficacy|3|||
162189219|NCT02159989|585743996|FG007|Overall Study|Lack of Efficacy|1|||
162189220|NCT02159989|585743997|FG008|Overall Study|Lack of Efficacy|3|||
162189221|NCT02159989|585743998|FG009|Overall Study|Lack of Efficacy|6|||
162189222|NCT02159989|585743999|FG010|Overall Study|Lack of Efficacy|7|||
162189223|NCT02159989|585743989|FG000|Overall Study|Lost to Follow-up|0|||
162189224|NCT02159989|585743990|FG001|Overall Study|Lost to Follow-up|0|||
162189225|NCT02159989|585743991|FG002|Overall Study|Lost to Follow-up|0|||
162189226|NCT02159989|585743992|FG003|Overall Study|Lost to Follow-up|1|||
162189227|NCT02159989|585743993|FG004|Overall Study|Lost to Follow-up|0|||
162189228|NCT02159989|585743994|FG005|Overall Study|Lost to Follow-up|0|||
162189229|NCT02159989|585743995|FG006|Overall Study|Lost to Follow-up|0|||
162189230|NCT02159989|585743996|FG007|Overall Study|Lost to Follow-up|0|||
162189231|NCT02159989|585743997|FG008|Overall Study|Lost to Follow-up|0|||
162189232|NCT02159989|585743998|FG009|Overall Study|Lost to Follow-up|0|||
162189233|NCT02159989|585743999|FG010|Overall Study|Lost to Follow-up|1|||
162189234|NCT02159989|585743989|FG000|Overall Study|Withdrawal by Subject|2|||
162189235|NCT02159989|585743990|FG001|Overall Study|Withdrawal by Subject|0|||
162189236|NCT02159989|585743991|FG002|Overall Study|Withdrawal by Subject|0|||
162189237|NCT02159989|585743992|FG003|Overall Study|Withdrawal by Subject|2|||
162189238|NCT02159989|585743993|FG004|Overall Study|Withdrawal by Subject|1|||
162189239|NCT02159989|585743994|FG005|Overall Study|Withdrawal by Subject|0|||
162189240|NCT02159989|585743995|FG006|Overall Study|Withdrawal by Subject|3|||
162189241|NCT02159989|585743996|FG007|Overall Study|Withdrawal by Subject|1|||
162189242|NCT02159989|585743997|FG008|Overall Study|Withdrawal by Subject|0|||
162189243|NCT02159989|585743998|FG009|Overall Study|Withdrawal by Subject|0|||
162189244|NCT02159989|585743999|FG010|Overall Study|Withdrawal by Subject|0|||
162189245|NCT02159989|585743989|FG000|Overall Study|New treatment|0|||
162189246|NCT02159989|585743990|FG001|Overall Study|New treatment|1|||
162189247|NCT02159989|585743991|FG002|Overall Study|New treatment|0|||
162189248|NCT02159989|585743992|FG003|Overall Study|New treatment|0|||
162189249|NCT02159989|585743993|FG004|Overall Study|New treatment|0|||
162189250|NCT02159989|585743994|FG005|Overall Study|New treatment|0|||
162189251|NCT02159989|585743995|FG006|Overall Study|New treatment|0|||
162189252|NCT02159989|585743996|FG007|Overall Study|New treatment|0|||
162189253|NCT02159989|585743997|FG008|Overall Study|New treatment|0|||
162189254|NCT02159989|585743998|FG009|Overall Study|New treatment|0|||
162189255|NCT02159989|585743999|FG010|Overall Study|New treatment|0|||
162189256|NCT02159989|585743989|FG000|Overall Study|Insurance Issues|0|||
162189257|NCT02159989|585743990|FG001|Overall Study|Insurance Issues|0|||
162189258|NCT02159989|585743991|FG002|Overall Study|Insurance Issues|0|||
162189259|NCT02159989|585743992|FG003|Overall Study|Insurance Issues|0|||
162189260|NCT02159989|585743993|FG004|Overall Study|Insurance Issues|0|||
161925561|NCT02697422|584773217|FG001|Overall Study|Lost to Follow-up|8|||
161925562|NCT02697422|584773216|FG000|Overall Study|Death|2|||
161925563|NCT02697422|584773217|FG001|Overall Study|Death|1|||
161925564|NCT02697422|584773216|FG000|Overall Study|Withdrawal by Subject|0|||
161925565|NCT02697422|584773217|FG001|Overall Study|Withdrawal by Subject|1|||
161925566|NCT02697422|584773216|FG000|Overall Study|Physician Decision|1|||
162189261|NCT02159989|585743994|FG005|Overall Study|Insurance Issues|0|||
162189262|NCT02159989|585743995|FG006|Overall Study|Insurance Issues|0|||
162189263|NCT02159989|585743996|FG007|Overall Study|Insurance Issues|0|||
162189264|NCT02159989|585743997|FG008|Overall Study|Insurance Issues|0|||
162189265|NCT02159989|585743998|FG009|Overall Study|Insurance Issues|1|||
162189266|NCT02159989|585743999|FG010|Overall Study|Insurance Issues|0|||
162189267|NCT04447027|585744001|FG000|Dose Escalation|Withdrawal by Subject|1|||
162189268|NCT04447027|585744002|FG001|Dose Escalation|Withdrawal by Subject|4|||
162189269|NCT04447027|585744003|FG002|Dose Escalation|Withdrawal by Subject|3|||
162189270|NCT04447027|585744004|FG003|Dose Escalation|Withdrawal by Subject|3|||
162189271|NCT04447027|585744005|FG004|Dose Escalation|Withdrawal by Subject|1|||
162189272|NCT04447027|585744006|FG005|Dose Escalation|Withdrawal by Subject|0|||
162189273|NCT04447027|585744007|FG006|Dose Escalation|Withdrawal by Subject|0|||
162189274|NCT04447027|585744008|FG007|Dose Escalation|Withdrawal by Subject|0|||
162189275|NCT04447027|585744009|FG008|Dose Escalation|Withdrawal by Subject|0|||
162189276|NCT04447027|585744001|FG000|Dose Escalation|Refused further treatment|0|||
161925567|NCT02697422|584773217|FG001|Overall Study|Physician Decision|1|||
162189277|NCT04447027|585744002|FG001|Dose Escalation|Refused further treatment|1|||
162189278|NCT04447027|585744003|FG002|Dose Escalation|Refused further treatment|1|||
162019718|NCT00104520|585126146|FG001|Overall Study|Unrelated adverse event|47|||
162019719|NCT00104520|585126145|FG000|Overall Study|Study drug intolerance|0|||
162019720|NCT00104520|585126146|FG001|Overall Study|Study drug intolerance|1|||
162019721|NCT00104520|585126145|FG000|Overall Study|Related adverse event|13|||
162019722|NCT00104520|585126146|FG001|Overall Study|Related adverse event|15|||
162019723|NCT00104520|585126145|FG000|Overall Study|Lost to Follow-up|1|||
162019724|NCT00104520|585126146|FG001|Overall Study|Lost to Follow-up|0|||
162019725|NCT00104520|585126145|FG000|Overall Study|Noncompliance|0|||
162019726|NCT00104520|585126146|FG001|Overall Study|Noncompliance|2|||
162019727|NCT00104520|585126145|FG000|Overall Study|Personal/administrative|1|||
162019728|NCT00104520|585126146|FG001|Overall Study|Personal/administrative|1|||
162019729|NCT00104520|585126145|FG000|Overall Study|Other|1|||
162019730|NCT00104520|585126146|FG001|Overall Study|Other|5|||
162019731|NCT00912197|585126151|FG000|Overall Study|Withdrawal by Subject|3|||
162019732|NCT00912197|585126152|FG001|Overall Study|Withdrawal by Subject|3|||
162019733|NCT03304249|585126157|FG000|Overall Study|Lost to Follow-up|8|||
162019734|NCT03304249|585126158|FG001|Overall Study|Lost to Follow-up|10|||
162019735|NCT03304249|585126157|FG000|Overall Study|Withdrawal by Subject|12|||
162019736|NCT03304249|585126158|FG001|Overall Study|Withdrawal by Subject|2|||
162019737|NCT03304249|585126157|FG000|Overall Study|Moved Out of District|4|||
162019738|NCT03304249|585126158|FG001|Overall Study|Moved Out of District|2|||
162019739|NCT00560352|585126175|FG000|Overall Study|Adverse event unrelated to study drug|2|||
162019740|NCT00560352|585126176|FG001|Overall Study|Adverse event unrelated to study drug|1|||
162019741|NCT00560352|585126177|FG002|Overall Study|Adverse event unrelated to study drug|1|||
162019742|NCT00560352|585126175|FG000|Overall Study|Study drug toxicity|3|||
162019743|NCT00560352|585126176|FG001|Overall Study|Study drug toxicity|0|||
162189279|NCT04447027|585744004|FG003|Dose Escalation|Refused further treatment|0|||
162189280|NCT04447027|585744005|FG004|Dose Escalation|Refused further treatment|0|||
162189281|NCT04447027|585744006|FG005|Dose Escalation|Refused further treatment|0|||
162189282|NCT04447027|585744007|FG006|Dose Escalation|Refused further treatment|0|||
162189283|NCT04447027|585744008|FG007|Dose Escalation|Refused further treatment|0|||
162189284|NCT04447027|585744009|FG008|Dose Escalation|Refused further treatment|0|||
162189285|NCT04447027|585744001|FG000|Dose Expansion|Withdrawal by Subject|0|||
162189286|NCT04447027|585744002|FG001|Dose Expansion|Withdrawal by Subject|0|||
162189287|NCT04447027|585744003|FG002|Dose Expansion|Withdrawal by Subject|0|||
162189288|NCT04447027|585744004|FG003|Dose Expansion|Withdrawal by Subject|0|||
162189289|NCT04447027|585744005|FG004|Dose Expansion|Withdrawal by Subject|0|||
162189290|NCT04447027|585744006|FG005|Dose Expansion|Withdrawal by Subject|2|||
162189291|NCT04447027|585744007|FG006|Dose Expansion|Withdrawal by Subject|0|||
162189292|NCT04447027|585744008|FG007|Dose Expansion|Withdrawal by Subject|2|||
162189293|NCT04447027|585744009|FG008|Dose Expansion|Withdrawal by Subject|0|||
162189294|NCT02485925|585744012|FG000|Overall Study|Withdrawal by Subject|3|||
162189295|NCT02485925|585744012|FG000|Overall Study|Death|1|||
162189296|NCT02485925|585744012|FG000|Overall Study|Lost to Follow-up|11|||
162189297|NCT04937504|585744013|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
162189298|NCT04937504|585744014|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
162189299|NCT04937504|585744013|FG000|9 Months Assessment|Lost to Follow-up|3|||
162189300|NCT04937504|585744014|FG001|9 Months Assessment|Lost to Follow-up|2|||
162189301|NCT03662659|585744015|FG000|Pre-treatment|Participant no longer met study criteria|1|||
162189302|NCT03662659|585744016|FG001|Pre-treatment|Participant no longer met study criteria|1|||
162189303|NCT03662659|585744015|FG000|Pre-treatment|Other reasons|1|||
162189304|NCT03662659|585744016|FG001|Pre-treatment|Other reasons|0|||
162189305|NCT03662659|585744015|FG000|Treatment|Completed Treatment|0|||
162189306|NCT03662659|585744016|FG001|Treatment|Completed Treatment|2|||
162189307|NCT03662659|585744015|FG000|Treatment|Disease Progression|85|||
162189308|NCT03662659|585744016|FG001|Treatment|Disease Progression|97|||
162189309|NCT03662659|585744015|FG000|Treatment|Study Drug Toxicity|19|||
162189310|NCT03662659|585744016|FG001|Treatment|Study Drug Toxicity|9|||
162189311|NCT03662659|585744015|FG000|Treatment|Death|11|||
162189312|NCT03662659|585744016|FG001|Treatment|Death|9|||
161673579|NCT03901053|583858021|FG001|Overall Study|No longer meets study criteria|3|||
161673580|NCT03901053|583858020|FG000|Overall Study|Subject's Medical Status|0|||
161673581|NCT03901053|583858021|FG001|Overall Study|Subject's Medical Status|1|||
161673582|NCT03901053|583858020|FG000|Overall Study|Screening Failure|1|||
161925568|NCT02697422|584773216|FG000|Overall Study|Exit survey data lost|1|||
162189313|NCT03662659|585744015|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
162189314|NCT03662659|585744016|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
162189315|NCT03662659|585744015|FG000|Treatment|Withdrawal by Subject|1|||
162189316|NCT03662659|585744016|FG001|Treatment|Withdrawal by Subject|1|||
162189317|NCT03662659|585744015|FG000|Treatment|Poor/Non-compliance|1|||
162189318|NCT03662659|585744016|FG001|Treatment|Poor/Non-compliance|0|||
162189319|NCT03662659|585744015|FG000|Treatment|Participant no longer meets study criteria|1|||
162189320|NCT03662659|585744016|FG001|Treatment|Participant no longer meets study criteria|0|||
162189321|NCT03662659|585744015|FG000|Treatment|Other reasons|10|||
162189322|NCT03662659|585744016|FG001|Treatment|Other reasons|8|||
162189323|NCT03662659|585744015|FG000|Treatment|Administrative reasons by sponsor|1|||
162189324|NCT03662659|585744016|FG001|Treatment|Administrative reasons by sponsor|0|||
162189325|NCT03662659|585744015|FG000|Treatment|maximum clinical benefit|0|||
162189326|NCT03662659|585744016|FG001|Treatment|maximum clinical benefit|2|||
162189327|NCT04369664|585745366|FG000|Overall Study|Physician Decision|1|||
162019744|NCT00560352|585126177|FG002|Overall Study|Study drug toxicity|1|||
162189328|NCT04369664|585745367|FG001|Overall Study|Physician Decision|0|||
162189329|NCT03840200|585745368|FG000|Overall Study|Death|6|||
162189330|NCT03840200|585745369|FG001|Overall Study|Death|3|||
162189331|NCT03840200|585745370|FG002|Overall Study|Death|6|||
162189332|NCT03840200|585745371|FG003|Overall Study|Death|10|||
162189333|NCT03840200|585745368|FG000|Overall Study|Reason Not Specified|2|||
162189334|NCT03840200|585745369|FG001|Overall Study|Reason Not Specified|2|||
162189335|NCT03840200|585745370|FG002|Overall Study|Reason Not Specified|1|||
162189336|NCT03840200|585745371|FG003|Overall Study|Reason Not Specified|15|||
162019745|NCT00560352|585126175|FG000|Overall Study|Disease progression|0|||
162019746|NCT00560352|585126176|FG001|Overall Study|Disease progression|1|||
162019747|NCT00560352|585126177|FG002|Overall Study|Disease progression|1|||
162019748|NCT00560352|585126175|FG000|Overall Study|Withdrawal by Subject|1|||
162019749|NCT00560352|585126176|FG001|Overall Study|Withdrawal by Subject|1|||
162019750|NCT00560352|585126177|FG002|Overall Study|Withdrawal by Subject|1|||
162019751|NCT00560352|585126175|FG000|Overall Study|Maximum clinical benefit|1|||
162019752|NCT00560352|585126176|FG001|Overall Study|Maximum clinical benefit|0|||
162019753|NCT00560352|585126177|FG002|Overall Study|Maximum clinical benefit|0|||
162019754|NCT03892967|585126178|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
162019755|NCT03892967|585126179|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
162019756|NCT03892967|585126180|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
162019757|NCT03892967|585126181|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
162019758|NCT03892967|585126182|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
162019759|NCT03892967|585126178|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
162019760|NCT03892967|585126179|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
162019761|NCT03892967|585126180|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
162019762|NCT03892967|585126181|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
162019763|NCT03892967|585126182|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
162019764|NCT03892967|585126178|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
162019765|NCT03892967|585126179|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
162019766|NCT03892967|585126180|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
162019767|NCT03892967|585126181|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
162019768|NCT03892967|585126182|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
162019769|NCT03892967|585126178|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
162019770|NCT03892967|585126179|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
162019771|NCT03892967|585126180|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
162019772|NCT03892967|585126181|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
162019773|NCT03892967|585126182|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
162019774|NCT03892967|585126178|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
162019775|NCT03892967|585126179|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
162019776|NCT03892967|585126180|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
162019777|NCT03892967|585126181|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
162019778|NCT03892967|585126182|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
162019779|NCT03892967|585126178|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
162019780|NCT03892967|585126179|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
162019781|NCT03892967|585126180|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
162019782|NCT03892967|585126181|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
162019783|NCT03892967|585126182|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
162019784|NCT03568461|585126186|FG000|Overall Study|Death|7|||
162019785|NCT03568461|585126186|FG000|Overall Study|Physician Decision|5|||
162019786|NCT03568461|585126186|FG000|Overall Study|Subject decision|5|||
162019787|NCT03568461|585126186|FG000|Overall Study|Lost to Follow-up|1|||
162019788|NCT03387085|585126190|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
162019789|NCT01395524|585128458|FG000|Overall Study|Non-compliance with study schedule|1|||
162019790|NCT01395524|585128459|FG001|Overall Study|Non-compliance with study schedule|0|||
162019791|NCT01395524|585128460|FG002|Overall Study|Non-compliance with study schedule|1|||
162019792|NCT01395524|585128458|FG000|Overall Study|Lost to Follow-up|3|||
162019793|NCT01395524|585128459|FG001|Overall Study|Lost to Follow-up|1|||
162189337|NCT03840200|585745368|FG000|Overall Study|Physician Decision|0|||
162189338|NCT03840200|585745369|FG001|Overall Study|Physician Decision|0|||
162189339|NCT03840200|585745370|FG002|Overall Study|Physician Decision|0|||
162189340|NCT03840200|585745371|FG003|Overall Study|Physician Decision|2|||
162189341|NCT03840200|585745368|FG000|Overall Study|Progressive Disease|0|||
162189342|NCT03840200|585745369|FG001|Overall Study|Progressive Disease|0|||
162189343|NCT03840200|585745370|FG002|Overall Study|Progressive Disease|0|||
162189344|NCT03840200|585745371|FG003|Overall Study|Progressive Disease|1|||
162189345|NCT03840200|585745368|FG000|Overall Study|Withdrawal by Subject|0|||
162189346|NCT03840200|585745369|FG001|Overall Study|Withdrawal by Subject|1|||
162189347|NCT03840200|585745370|FG002|Overall Study|Withdrawal by Subject|0|||
162189348|NCT03840200|585745371|FG003|Overall Study|Withdrawal by Subject|2|||
162189349|NCT01450007|585745373|FG000|Overall Study|Late exclusion before treatment|2|||
162189350|NCT01450007|585745374|FG001|Overall Study|Late exclusion before treatment|3|||
162189351|NCT01450007|585745375|FG002|Overall Study|Late exclusion before treatment|2|||
162189352|NCT01450007|585745373|FG000|Overall Study|Protocol Violation|0|||
162189353|NCT01450007|585745374|FG001|Overall Study|Protocol Violation|1|||
162189354|NCT01450007|585745375|FG002|Overall Study|Protocol Violation|1|||
162189355|NCT01450007|585745373|FG000|Overall Study|Adverse Event|0|||
162189356|NCT01450007|585745374|FG001|Overall Study|Adverse Event|1|||
162189357|NCT01450007|585745375|FG002|Overall Study|Adverse Event|0|||
162189358|NCT03851094|585745376|FG000|Overall Study|Withdrawal by Subject|0|||
162189359|NCT03851094|585745377|FG001|Overall Study|Withdrawal by Subject|1|||
162189360|NCT03851094|585745376|FG000|Overall Study|Participant lost device|0|||
162189361|NCT03851094|585745377|FG001|Overall Study|Participant lost device|1|||
162189362|NCT03851094|585745376|FG000|Overall Study|Participant returned device|0|||
162189363|NCT03851094|585745377|FG001|Overall Study|Participant returned device|2|||
162189364|NCT00484198|585745378|FG000|Overall Study|Participant Withdrew Consent|12|||
162189365|NCT00484198|585745379|FG001|Overall Study|Participant Withdrew Consent|21|||
162189366|NCT00484198|585745380|FG002|Overall Study|Participant Withdrew Consent|47|||
162189367|NCT00484198|585745381|FG003|Overall Study|Participant Withdrew Consent|59|||
162189368|NCT00484198|585745378|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
162189369|NCT00484198|585745379|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
162189370|NCT00484198|585745380|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
162189371|NCT00484198|585745381|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
162189372|NCT00484198|585745378|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
162189373|NCT00484198|585745379|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
162189374|NCT00484198|585745380|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
162189375|NCT00484198|585745381|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
162189376|NCT00484198|585745378|FG000|Overall Study|Adverse Event|3|||
162189377|NCT00484198|585745379|FG001|Overall Study|Adverse Event|11|||
162189378|NCT00484198|585745380|FG002|Overall Study|Adverse Event|32|||
162189379|NCT00484198|585745381|FG003|Overall Study|Adverse Event|31|||
162189380|NCT00484198|585745378|FG000|Overall Study|Protocol Violation|0|||
162189381|NCT00484198|585745379|FG001|Overall Study|Protocol Violation|5|||
162189382|NCT00484198|585745380|FG002|Overall Study|Protocol Violation|6|||
162189383|NCT00484198|585745381|FG003|Overall Study|Protocol Violation|8|||
162189384|NCT00484198|585745378|FG000|Overall Study|Other|7|||
162189385|NCT00484198|585745379|FG001|Overall Study|Other|10|||
162189386|NCT00484198|585745380|FG002|Overall Study|Other|31|||
162189387|NCT00484198|585745381|FG003|Overall Study|Other|28|||
162189388|NCT01536704|585745382|FG000|Washout Period 1|Withdrawal by Subject|1|||
162189389|NCT01536704|585745383|FG001|Washout Period 1|Withdrawal by Subject|2|||
162189390|NCT01536704|585745384|FG002|Washout Period 1|Withdrawal by Subject|0|||
162189391|NCT01536704|585745385|FG003|Washout Period 1|Withdrawal by Subject|0|||
162189392|NCT01536704|585745382|FG000|Washout Period 2|Adverse Event|1|||
161819607|NCT00874276|584379710|FG000|Overall Study|Withdrawal by Subject|1|||
161819608|NCT00874276|584379711|FG001|Overall Study|Withdrawal by Subject|1|||
161819609|NCT04236596|584379712|FG000|Overall Study|Withdrawal by Subject|1|||
161819610|NCT04236596|584379712|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
161819611|NCT04236596|584379712|FG000|Overall Study|Participants did not receive implant at all|4|||
161819612|NCT02588339|584379714|FG000|Overall Study|Withdrawal by Subject|1|||
161819613|NCT02588339|584379714|FG000|Overall Study|GVHD Progression prior to treatment|2|||
162189393|NCT01536704|585745383|FG001|Washout Period 2|Adverse Event|0|||
162189394|NCT01536704|585745384|FG002|Washout Period 2|Adverse Event|0|||
162189395|NCT01536704|585745385|FG003|Washout Period 2|Adverse Event|0|||
162189396|NCT01536704|585745382|FG000|Washout Period 2|Withdrawal by Subject|0|||
162189397|NCT01536704|585745383|FG001|Washout Period 2|Withdrawal by Subject|0|||
162189398|NCT01536704|585745384|FG002|Washout Period 2|Withdrawal by Subject|0|||
162189399|NCT01536704|585745385|FG003|Washout Period 2|Withdrawal by Subject|1|||
162189400|NCT01536704|585745382|FG000|Period 3|Adverse Event|0|||
162189401|NCT01536704|585745383|FG001|Period 3|Adverse Event|0|||
162189402|NCT01536704|585745384|FG002|Period 3|Adverse Event|0|||
162189403|NCT01536704|585745385|FG003|Period 3|Adverse Event|1|||
162189404|NCT01536704|585745382|FG000|Washout Period 3|Adverse Event|0|||
161819614|NCT02300987|584381114|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
162189405|NCT01536704|585745383|FG001|Washout Period 3|Adverse Event|0|||
162189406|NCT01536704|585745384|FG002|Washout Period 3|Adverse Event|1|||
162189407|NCT01536704|585745385|FG003|Washout Period 3|Adverse Event|0|||
162189408|NCT04658784|585745386|FG000|6-month Follow-up|Lost to Follow-up|2|||
162189409|NCT04658784|585745387|FG001|6-month Follow-up|Lost to Follow-up|5|||
162189410|NCT02958553|585745388|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
162189411|NCT02958553|585745388|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
162189412|NCT00704340|585745396|FG000|Overall Study|Lost to Follow-up|2|||
162189413|NCT00704340|585745397|FG001|Overall Study|Lost to Follow-up|1|||
162189414|NCT00704340|585745396|FG000|Overall Study|Death|0|||
162189415|NCT00704340|585745397|FG001|Overall Study|Death|1|||
162189416|NCT00703092|585745401|FG000|Overall Study|Withdrawal by Subject|2|||
162189417|NCT02007070|585745402|FG000|Overall Study|Adverse Event|4|||
162189418|NCT02007070|585745402|FG000|Overall Study|Clinical Progression|4|||
162189419|NCT02007070|585745402|FG000|Overall Study|Death|1|||
162189420|NCT02007070|585745402|FG000|Overall Study|Protocol Violation|2|||
162189421|NCT02007070|585745402|FG000|Overall Study|Physician Decision|1|||
162189422|NCT02007070|585745402|FG000|Overall Study|Progressive Disease|21|||
162189423|NCT00403845|585745406|FG000|Treatment Period 1|Subject withdrew consent|1|||
162189424|NCT00403845|585745407|FG001|Treatment Period 1|Subject withdrew consent|0|||
162189425|NCT00403845|585745408|FG002|Treatment Period 1|Subject withdrew consent|0|||
162189426|NCT00403845|585745409|FG003|Treatment Period 1|Subject withdrew consent|0|||
162189427|NCT00403845|585745406|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
162189428|NCT00403845|585745407|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
162189429|NCT00403845|585745408|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
162189430|NCT00403845|585745409|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
162189431|NCT00403845|585745406|FG000|Treatment Period 2|Subject withdrew consent|1|||
162189432|NCT00403845|585745407|FG001|Treatment Period 2|Subject withdrew consent|0|||
162189433|NCT00403845|585745408|FG002|Treatment Period 2|Subject withdrew consent|0|||
162189434|NCT00403845|585745409|FG003|Treatment Period 2|Subject withdrew consent|0|||
162189435|NCT00403845|585745406|FG000|Treatment Period 3|Subject withdrew consent|0|||
162189436|NCT00403845|585745407|FG001|Treatment Period 3|Subject withdrew consent|0|||
162189437|NCT00403845|585745408|FG002|Treatment Period 3|Subject withdrew consent|0|||
162189438|NCT00403845|585745409|FG003|Treatment Period 3|Subject withdrew consent|1|||
162189439|NCT00403845|585745406|FG000|Treatment Period 3|Adverse Event|0|||
162189440|NCT00403845|585745407|FG001|Treatment Period 3|Adverse Event|0|||
162189441|NCT00403845|585745408|FG002|Treatment Period 3|Adverse Event|0|||
162189442|NCT00403845|585745409|FG003|Treatment Period 3|Adverse Event|1|||
162189443|NCT03316170|585745410|FG000|Overall Study|Death|1|||
162189444|NCT03316170|585745411|FG001|Overall Study|Death|0|||
162189445|NCT03316170|585745410|FG000|Overall Study|Lost to Follow-up|6|||
162189446|NCT03316170|585745411|FG001|Overall Study|Lost to Follow-up|7|||
162189447|NCT02935673|585745412|FG000|Overall Study|Adverse Event|0|||
162189448|NCT02935673|585745413|FG001|Overall Study|Adverse Event|1|||
162189449|NCT02935673|585745414|FG002|Overall Study|Adverse Event|0|||
162189450|NCT02935673|585745412|FG000|Overall Study|Withdrawal by Subject|1|||
162189451|NCT02935673|585745413|FG001|Overall Study|Withdrawal by Subject|2|||
162189452|NCT02935673|585745414|FG002|Overall Study|Withdrawal by Subject|0|||
162189453|NCT01836523|585745415|FG000|Overall Study|Adverse Event|15|||
162189454|NCT01836523|585745416|FG001|Overall Study|Adverse Event|41|||
162189455|NCT01836523|585745417|FG002|Overall Study|Adverse Event|49|||
161819615|NCT02300987|584381115|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
161819616|NCT02300987|584381114|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
161819617|NCT02300987|584381115|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
161819618|NCT02300987|584381114|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
161819619|NCT02300987|584381115|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
161819620|NCT02300987|584381114|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
162189456|NCT01836523|585745418|FG003|Overall Study|Adverse Event|14|||
162189457|NCT01836523|585745415|FG000|Overall Study|Protocol Violation|6|||
162189458|NCT01836523|585745416|FG001|Overall Study|Protocol Violation|3|||
162189459|NCT01836523|585745417|FG002|Overall Study|Protocol Violation|2|||
162189460|NCT01836523|585745418|FG003|Overall Study|Protocol Violation|4|||
162189461|NCT01836523|585745415|FG000|Overall Study|Met Withdrawal Criteria|13|||
162189462|NCT01836523|585745416|FG001|Overall Study|Met Withdrawal Criteria|13|||
162189463|NCT01836523|585745417|FG002|Overall Study|Met Withdrawal Criteria|21|||
162189464|NCT01836523|585745418|FG003|Overall Study|Met Withdrawal Criteria|27|||
161819621|NCT02300987|584381115|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
161819622|NCT02300987|584381114|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
161819623|NCT02300987|584381115|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
161819624|NCT05330975|584381116|FG000|Primary|Lost to Follow-up|12|||
162019794|NCT01395524|585128460|FG002|Overall Study|Lost to Follow-up|1|||
162019795|NCT01395524|585128458|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
162019796|NCT01395524|585128459|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
162019797|NCT01395524|585128460|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
162019798|NCT01395524|585128458|FG000|Overall Study|Severe noncompliance with protocol|1|||
162019799|NCT01395524|585128459|FG001|Overall Study|Severe noncompliance with protocol|0|||
162019800|NCT01395524|585128460|FG002|Overall Study|Severe noncompliance with protocol|0|||
162019801|NCT01395524|585128458|FG000|Overall Study|Adverse Event|4|||
162019802|NCT01395524|585128459|FG001|Overall Study|Adverse Event|4|||
162019803|NCT01395524|585128460|FG002|Overall Study|Adverse Event|3|||
162019804|NCT01395524|585128458|FG000|Overall Study|Death|1|||
162019805|NCT01395524|585128459|FG001|Overall Study|Death|0|||
162019806|NCT01395524|585128460|FG002|Overall Study|Death|0|||
162019807|NCT01395524|585128458|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
162019808|NCT01395524|585128459|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
162019809|NCT01395524|585128460|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
162019810|NCT01395524|585128458|FG000|Overall Study|Withdrawal by Subject|4|||
162019811|NCT01395524|585128459|FG001|Overall Study|Withdrawal by Subject|8|||
162019812|NCT01395524|585128460|FG002|Overall Study|Withdrawal by Subject|8|||
162019813|NCT01395524|585128458|FG000|Overall Study|Did not receive treatment|1|||
162019814|NCT01395524|585128459|FG001|Overall Study|Did not receive treatment|1|||
162019815|NCT01395524|585128460|FG002|Overall Study|Did not receive treatment|3|||
162019816|NCT01395524|585128458|FG000|Overall Study|Subject had spinal surgery|0|||
162019817|NCT01395524|585128459|FG001|Overall Study|Subject had spinal surgery|0|||
162019818|NCT01395524|585128460|FG002|Overall Study|Subject had spinal surgery|1|||
162019819|NCT00122980|585128471|FG000|Overall Study|Death|0|||
162019820|NCT00122980|585128472|FG001|Overall Study|Death|1|||
162019821|NCT00122980|585128471|FG000|Overall Study|Physician Decision|2|||
162019822|NCT00122980|585128472|FG001|Overall Study|Physician Decision|0|||
162019823|NCT00122980|585128471|FG000|Overall Study|Protocol Violation|5|||
162019824|NCT00122980|585128472|FG001|Overall Study|Protocol Violation|1|||
162019825|NCT00122980|585128471|FG000|Overall Study|Withdrawal by Subject|2|||
162019826|NCT00122980|585128472|FG001|Overall Study|Withdrawal by Subject|3|||
162019827|NCT00122980|585128471|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
162019828|NCT00122980|585128472|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
162019829|NCT00122980|585128471|FG000|Overall Study|Study termination|27|||
162019830|NCT00122980|585128472|FG001|Overall Study|Study termination|35|||
162019831|NCT02175199|585128473|FG000|Overall Study|Withdrawal by Subject|1|||
162019832|NCT02175199|585128474|FG001|Overall Study|Withdrawal by Subject|5|||
162019833|NCT02175199|585128473|FG000|Overall Study|Randomized in Error|1|||
162019834|NCT02175199|585128474|FG001|Overall Study|Randomized in Error|0|||
162019835|NCT02175199|585128473|FG000|Overall Study|Sponsor Decision|1|||
162019836|NCT02175199|585128474|FG001|Overall Study|Sponsor Decision|0|||
162019837|NCT01124864|585128477|FG000|Overall Study|Follow up phase competed as per protocol|18|||
162019838|NCT01124864|585128478|FG001|Overall Study|Follow up phase competed as per protocol|22|||
162019839|NCT01124864|585128479|FG002|Overall Study|Follow up phase competed as per protocol|24|||
162019840|NCT01124864|585128480|FG003|Overall Study|Follow up phase competed as per protocol|18|||
162019841|NCT01124864|585128481|FG004|Overall Study|Follow up phase competed as per protocol|26|||
162189465|NCT01836523|585745415|FG000|Overall Study|Unclassified|17|||
161819625|NCT05330975|584381117|FG001|Primary|Lost to Follow-up|21|||
161819626|NCT05330975|584381118|FG002|Primary|Lost to Follow-up|38|||
161819627|NCT05330975|584381119|FG003|Primary|Lost to Follow-up|30|||
161819628|NCT05330975|584381120|FG004|Primary|Lost to Follow-up|25|||
161819629|NCT05330975|584381121|FG005|Primary|Lost to Follow-up|28|||
161819630|NCT05330975|584381122|FG006|Primary|Lost to Follow-up|0|||
161819631|NCT05330975|584381116|FG000|Primary|Withdrawal by Subject|4|||
161819632|NCT05330975|584381117|FG001|Primary|Withdrawal by Subject|11|||
161819633|NCT05330975|584381118|FG002|Primary|Withdrawal by Subject|8|||
161819634|NCT05330975|584381119|FG003|Primary|Withdrawal by Subject|23|||
161819635|NCT05330975|584381120|FG004|Primary|Withdrawal by Subject|20|||
161819636|NCT05330975|584381121|FG005|Primary|Withdrawal by Subject|19|||
161819637|NCT05330975|584381122|FG006|Primary|Withdrawal by Subject|0|||
162019842|NCT01124864|585128482|FG005|Overall Study|Follow up phase competed as per protocol|2|||
162019843|NCT01124864|585128477|FG000|Overall Study|Death|6|||
162019844|NCT01124864|585128478|FG001|Overall Study|Death|9|||
162019845|NCT01124864|585128479|FG002|Overall Study|Death|6|||
162019846|NCT01124864|585128480|FG003|Overall Study|Death|2|||
162019847|NCT01124864|585128481|FG004|Overall Study|Death|1|||
161819638|NCT05330975|584381116|FG000|Primary|Protocol Violation|0|||
162019848|NCT01124864|585128482|FG005|Overall Study|Death|0|||
161819639|NCT05330975|584381117|FG001|Primary|Protocol Violation|2|||
162019849|NCT01124864|585128477|FG000|Overall Study|Withdrawal by Subject|2|||
161819640|NCT05330975|584381118|FG002|Primary|Protocol Violation|0|||
162189466|NCT01836523|585745416|FG001|Overall Study|Unclassified|28|||
162189467|NCT01836523|585745417|FG002|Overall Study|Unclassified|19|||
162189468|NCT01836523|585745418|FG003|Overall Study|Unclassified|29|||
162189469|NCT00749944|585745419|FG000|Overall Study|Lost to Follow-up|2|||
162189470|NCT00749944|585745420|FG001|Overall Study|Lost to Follow-up|1|||
162189471|NCT00749944|585745419|FG000|Overall Study|Other|1|||
162189472|NCT00749944|585745420|FG001|Overall Study|Other|0|||
162189473|NCT00749944|585745419|FG000|Overall Study|Withdrawal by Subject|2|||
162189474|NCT00749944|585745420|FG001|Overall Study|Withdrawal by Subject|0|||
162189475|NCT00624377|585745421|FG000|Overall Study|Lost to Follow-up|355|||
162189476|NCT00624377|585745421|FG000|Overall Study|Withdrawal by Subject|100|||
162189477|NCT00624377|585745421|FG000|Overall Study|Adverse Event|14|||
162189478|NCT00624377|585745421|FG000|Overall Study|Other|91|||
162189479|NCT00624377|585745421|FG000|Overall Study|Non-evaluable population|84|||
162189480|NCT00681109|585745422|FG000|Overall Study|Lost to Follow-up|2|||
162189481|NCT00681109|585745423|FG001|Overall Study|Lost to Follow-up|6|||
162189482|NCT00681109|585745424|FG002|Overall Study|Lost to Follow-up|0|||
162189483|NCT03128099|585745428|FG000|Overall Study|High dose task was too long|0|||
162189484|NCT03128099|585745429|FG001|Overall Study|High dose task was too long|4|||
162189485|NCT03128099|585745430|FG002|Overall Study|High dose task was too long|0|||
162189486|NCT03128099|585745428|FG000|Overall Study|Participant got a full time job.|1|||
162189487|NCT03128099|585745429|FG001|Overall Study|Participant got a full time job.|0|||
162189488|NCT03128099|585745430|FG002|Overall Study|Participant got a full time job.|0|||
162189489|NCT03128099|585745428|FG000|Overall Study|Became homeless and lost contact|1|||
162189490|NCT03128099|585745429|FG001|Overall Study|Became homeless and lost contact|0|||
162189491|NCT03128099|585745430|FG002|Overall Study|Became homeless and lost contact|0|||
162189492|NCT03128099|585745428|FG000|Overall Study|Did not complete all the assessments|0|||
162189493|NCT03128099|585745429|FG001|Overall Study|Did not complete all the assessments|0|||
162189494|NCT03128099|585745430|FG002|Overall Study|Did not complete all the assessments|1|||
162189495|NCT00148122|585745431|FG000|Overall Study|Withdrawal by Subject|2|||
162189496|NCT02362789|585745434|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
162189497|NCT02362789|585745435|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
162189498|NCT02362789|585745436|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
162189499|NCT02362789|585745434|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
162189500|NCT02362789|585745435|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
162189501|NCT02362789|585745436|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
162189502|NCT02362789|585745434|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
162189503|NCT02362789|585745435|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
162189504|NCT02362789|585745436|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
162189505|NCT02362789|585745434|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
162189506|NCT02362789|585745435|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
162189507|NCT02362789|585745436|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
162189508|NCT02362789|585745434|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
162189509|NCT02362789|585745435|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
162189510|NCT02362789|585745436|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
162189511|NCT02037568|585745437|FG000|Overall Study|Withdrawal by Subject|17|||
162189512|NCT02037568|585745438|FG001|Overall Study|Withdrawal by Subject|24|||
162189513|NCT02037568|585745437|FG000|Overall Study|Lost to Follow-up|16|||
162189514|NCT02037568|585745438|FG001|Overall Study|Lost to Follow-up|13|||
162189515|NCT02037568|585745437|FG000|Overall Study|Screen Failure|3|||
162189516|NCT02037568|585745438|FG001|Overall Study|Screen Failure|1|||
162189517|NCT02037568|585745437|FG000|Overall Study|Patient did not receive transplant|0|||
162189518|NCT02037568|585745438|FG001|Overall Study|Patient did not receive transplant|1|||
162189519|NCT00721734|585745439|FG000|Overall Study|Progressive Disease|3|||
162189520|NCT00721734|585745440|FG001|Overall Study|Progressive Disease|10|||
162189521|NCT00721734|585745441|FG002|Overall Study|Progressive Disease|4|||
162019850|NCT01124864|585128478|FG001|Overall Study|Withdrawal by Subject|3|||
161673583|NCT03901053|583858021|FG001|Overall Study|Screening Failure|0|||
161673584|NCT02408861|583858022|FG000|Overall Study|Death|0|||
161673585|NCT02408861|583858023|FG001|Overall Study|Death|3|||
161673586|NCT02408861|583858024|FG002|Overall Study|Death|1|||
162189522|NCT00721734|585745442|FG003|Overall Study|Progressive Disease|5|||
162189523|NCT00721734|585745443|FG004|Overall Study|Progressive Disease|2|||
161673587|NCT02408861|583858025|FG003|Overall Study|Death|2|||
161673588|NCT02408861|583858026|FG004|Overall Study|Death|4|||
162189524|NCT00721734|585745439|FG000|Overall Study|Adverse Event|3|||
162189525|NCT00721734|585745440|FG001|Overall Study|Adverse Event|1|||
162189526|NCT00721734|585745441|FG002|Overall Study|Adverse Event|4|||
162189527|NCT00721734|585745442|FG003|Overall Study|Adverse Event|0|||
162189528|NCT00721734|585745443|FG004|Overall Study|Adverse Event|3|||
162189529|NCT00721734|585745439|FG000|Overall Study|Withdrawal by Subject|2|||
161673589|NCT02408861|583858027|FG005|Overall Study|Death|1|||
161673590|NCT02408861|583858028|FG006|Overall Study|Death|0|||
162189530|NCT00721734|585745440|FG001|Overall Study|Withdrawal by Subject|1|||
162189531|NCT00721734|585745441|FG002|Overall Study|Withdrawal by Subject|0|||
162189532|NCT00721734|585745442|FG003|Overall Study|Withdrawal by Subject|0|||
162189533|NCT00721734|585745443|FG004|Overall Study|Withdrawal by Subject|1|||
162189534|NCT00721734|585745439|FG000|Overall Study|Other|0|||
162189535|NCT00721734|585745440|FG001|Overall Study|Other|0|||
162189536|NCT00721734|585745441|FG002|Overall Study|Other|0|||
162189537|NCT00721734|585745442|FG003|Overall Study|Other|1|||
162189538|NCT00721734|585745443|FG004|Overall Study|Other|0|||
162189539|NCT05270460|585745446|FG000|Overall Study|Adverse Event|0|||
162189540|NCT05270460|585745447|FG001|Overall Study|Adverse Event|1|||
162189541|NCT05270460|585745448|FG002|Overall Study|Adverse Event|0|||
162189542|NCT05270460|585745446|FG000|Overall Study|Early Termination|0|||
162189543|NCT05270460|585745447|FG001|Overall Study|Early Termination|1|||
162189544|NCT05270460|585745448|FG002|Overall Study|Early Termination|0|||
162189545|NCT00380250|585745449|FG000|Overall Study|Withdrawal by Subject|39|||
162189546|NCT00380250|585745450|FG001|Overall Study|Withdrawal by Subject|28|||
162189547|NCT00380250|585745449|FG000|Overall Study|Adverse Event|20|||
162189548|NCT00380250|585745450|FG001|Overall Study|Adverse Event|9|||
162189549|NCT00380250|585745449|FG000|Overall Study|Lack of Efficacy|10|||
162189550|NCT00380250|585745450|FG001|Overall Study|Lack of Efficacy|8|||
162189551|NCT00380250|585745449|FG000|Overall Study|Protocol Violation|15|||
162189552|NCT00380250|585745450|FG001|Overall Study|Protocol Violation|5|||
162189553|NCT00380250|585745449|FG000|Overall Study|Lost to Follow-up|14|||
162189554|NCT00380250|585745450|FG001|Overall Study|Lost to Follow-up|5|||
162189555|NCT00380250|585745449|FG000|Overall Study|Physician Decision|1|||
162189556|NCT00380250|585745450|FG001|Overall Study|Physician Decision|0|||
162189557|NCT05484661|585745456|FG000|Overall Study|Withdrawal by Subject|1|||
162189558|NCT05484661|585745457|FG001|Overall Study|Withdrawal by Subject|0|||
162189559|NCT03205488|585745458|FG000|Overall Study|Adverse Event|1|||
162189560|NCT03205488|585745459|FG001|Overall Study|Adverse Event|2|||
162189561|NCT03205488|585745460|FG002|Overall Study|Adverse Event|4|||
162189562|NCT03205488|585745458|FG000|Overall Study|Protocol Violation|0|||
162189563|NCT03205488|585745459|FG001|Overall Study|Protocol Violation|0|||
162189564|NCT03205488|585745460|FG002|Overall Study|Protocol Violation|1|||
162189565|NCT03652610|585745461|FG000|Overall Study|Lost to Follow-up|1|||
162189566|NCT03652610|585745462|FG001|Overall Study|Lost to Follow-up|0|||
162189567|NCT03652610|585745461|FG000|Overall Study|Withdrawal by Subject|3|||
162189568|NCT03652610|585745462|FG001|Overall Study|Withdrawal by Subject|5|||
162189569|NCT05615363|585745468|FG000|Overall Study|Adverse Event|0|||
162189570|NCT05615363|585745469|FG001|Overall Study|Adverse Event|4|||
162189571|NCT05615363|585745470|FG002|Overall Study|Adverse Event|4|||
162189572|NCT05615363|585745471|FG003|Overall Study|Adverse Event|3|||
162189573|NCT05615363|585745472|FG004|Overall Study|Adverse Event|1|||
162189574|NCT05615363|585745468|FG000|Overall Study|Physician Decision|2|||
162189575|NCT05615363|585745469|FG001|Overall Study|Physician Decision|0|||
162189576|NCT05615363|585745470|FG002|Overall Study|Physician Decision|4|||
161673591|NCT02408861|583858022|FG000|Overall Study|Lost to Follow-up|0|||
161673592|NCT02408861|583858023|FG001|Overall Study|Lost to Follow-up|0|||
161673593|NCT02408861|583858024|FG002|Overall Study|Lost to Follow-up|1|||
161673594|NCT02408861|583858025|FG003|Overall Study|Lost to Follow-up|1|||
161673595|NCT02408861|583858026|FG004|Overall Study|Lost to Follow-up|4|||
161673596|NCT02408861|583858027|FG005|Overall Study|Lost to Follow-up|2|||
162189577|NCT05615363|585745471|FG003|Overall Study|Physician Decision|1|||
162189578|NCT05615363|585745472|FG004|Overall Study|Physician Decision|3|||
162189579|NCT05615363|585745468|FG000|Overall Study|Protocol Violation|2|||
162189580|NCT05615363|585745469|FG001|Overall Study|Protocol Violation|0|||
162189581|NCT05615363|585745470|FG002|Overall Study|Protocol Violation|0|||
162189582|NCT05615363|585745471|FG003|Overall Study|Protocol Violation|0|||
162189583|NCT05615363|585745472|FG004|Overall Study|Protocol Violation|1|||
162189584|NCT05615363|585745468|FG000|Overall Study|Withdrawal by Subject|0|||
162189585|NCT05615363|585745469|FG001|Overall Study|Withdrawal by Subject|0|||
161673597|NCT02408861|583858028|FG006|Overall Study|Lost to Follow-up|1|||
161673598|NCT02408861|583858022|FG000|Overall Study|Disease Progression|0|||
161673599|NCT02408861|583858023|FG001|Overall Study|Disease Progression|0|||
162189586|NCT05615363|585745470|FG002|Overall Study|Withdrawal by Subject|1|||
162189587|NCT05615363|585745471|FG003|Overall Study|Withdrawal by Subject|0|||
162189588|NCT05615363|585745472|FG004|Overall Study|Withdrawal by Subject|0|||
162189589|NCT03905642|585745473|FG000|Overall Study|Withdrawal by Subject|3|||
162189590|NCT03905642|585745473|FG000|Overall Study|Pregnancy|1|||
162189591|NCT03905642|585745473|FG000|Overall Study|Adverse Event|1|||
161673600|NCT02408861|583858024|FG002|Overall Study|Disease Progression|1|||
161673601|NCT02408861|583858025|FG003|Overall Study|Disease Progression|0|||
161673602|NCT02408861|583858026|FG004|Overall Study|Disease Progression|3|||
162189592|NCT03905642|585745473|FG000|Overall Study|Lack of Efficacy|1|||
162189593|NCT03905642|585745473|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
162189594|NCT05995977|585745478|FG000|Overall Study|Withdrawal by Subject|1|||
162189595|NCT05995977|585745479|FG001|Overall Study|Withdrawal by Subject|4|||
162189596|NCT05995977|585745478|FG000|Overall Study|Lost to Follow-up|2|||
162189597|NCT05995977|585745479|FG001|Overall Study|Lost to Follow-up|0|||
161673603|NCT02408861|583858027|FG005|Overall Study|Disease Progression|1|||
162189598|NCT04181788|585745480|FG000|TREATMENT|Adverse Event|0|||
162189599|NCT04181788|585745481|FG001|TREATMENT|Adverse Event|2|||
162189600|NCT04181788|585745482|FG002|TREATMENT|Adverse Event|1|||
162189601|NCT04181788|585745483|FG003|TREATMENT|Adverse Event|0|||
162189602|NCT04181788|585745484|FG004|TREATMENT|Adverse Event|1|||
162189603|NCT04181788|585745485|FG005|TREATMENT|Adverse Event|3|||
162189604|NCT04181788|585745480|FG000|TREATMENT|Death|0|||
162189605|NCT04181788|585745481|FG001|TREATMENT|Death|0|||
162189606|NCT04181788|585745482|FG002|TREATMENT|Death|0|||
162189607|NCT04181788|585745483|FG003|TREATMENT|Death|0|||
162189608|NCT04181788|585745484|FG004|TREATMENT|Death|8|||
162189609|NCT04181788|585745485|FG005|TREATMENT|Death|8|||
162189610|NCT04181788|585745480|FG000|TREATMENT|Physician Decision|0|||
162189611|NCT04181788|585745481|FG001|TREATMENT|Physician Decision|0|||
162189612|NCT04181788|585745482|FG002|TREATMENT|Physician Decision|0|||
162189613|NCT04181788|585745483|FG003|TREATMENT|Physician Decision|0|||
162189614|NCT04181788|585745484|FG004|TREATMENT|Physician Decision|0|||
162189615|NCT04181788|585745485|FG005|TREATMENT|Physician Decision|1|||
162189616|NCT04181788|585745480|FG000|TREATMENT|Progressive disease|3|||
162189617|NCT04181788|585745481|FG001|TREATMENT|Progressive disease|3|||
162189618|NCT04181788|585745482|FG002|TREATMENT|Progressive disease|5|||
162189619|NCT04181788|585745483|FG003|TREATMENT|Progressive disease|7|||
162189620|NCT04181788|585745484|FG004|TREATMENT|Progressive disease|20|||
162189621|NCT04181788|585745485|FG005|TREATMENT|Progressive disease|38|||
162189622|NCT04181788|585745480|FG000|TREATMENT|Global deterioration of health status|0|||
162189623|NCT04181788|585745481|FG001|TREATMENT|Global deterioration of health status|2|||
162189624|NCT04181788|585745482|FG002|TREATMENT|Global deterioration of health status|0|||
162189625|NCT04181788|585745483|FG003|TREATMENT|Global deterioration of health status|0|||
162189626|NCT04181788|585745484|FG004|TREATMENT|Global deterioration of health status|2|||
162189627|NCT04181788|585745485|FG005|TREATMENT|Global deterioration of health status|8|||
162189628|NCT04181788|585745480|FG000|TREATMENT|Withdrawal by Subject|1|||
162189629|NCT04181788|585745481|FG001|TREATMENT|Withdrawal by Subject|2|||
162189630|NCT04181788|585745482|FG002|TREATMENT|Withdrawal by Subject|0|||
162189631|NCT04181788|585745483|FG003|TREATMENT|Withdrawal by Subject|0|||
162189632|NCT04181788|585745484|FG004|TREATMENT|Withdrawal by Subject|3|||
162189633|NCT04181788|585745485|FG005|TREATMENT|Withdrawal by Subject|5|||
162189634|NCT04181788|585745480|FG000|TREATMENT|Other unspecified|0|||
162189635|NCT04181788|585745481|FG001|TREATMENT|Other unspecified|0|||
162189636|NCT04181788|585745482|FG002|TREATMENT|Other unspecified|0|||
162189637|NCT04181788|585745483|FG003|TREATMENT|Other unspecified|0|||
162189638|NCT04181788|585745484|FG004|TREATMENT|Other unspecified|0|||
162189639|NCT04181788|585745485|FG005|TREATMENT|Other unspecified|2|||
162189640|NCT04181788|585745480|FG000|TREATMENT|Ongoing|0|||
162189641|NCT04181788|585745481|FG001|TREATMENT|Ongoing|3|||
162189642|NCT04181788|585745482|FG002|TREATMENT|Ongoing|0|||
162189643|NCT04181788|585745483|FG003|TREATMENT|Ongoing|5|||
162189644|NCT04181788|585745484|FG004|TREATMENT|Ongoing|7|||
162189645|NCT04181788|585745485|FG005|TREATMENT|Ongoing|15|||
162189646|NCT04181788|585745480|FG000|FOLLOW-UP|Death|0|||
162189647|NCT04181788|585745481|FG001|FOLLOW-UP|Death|0|||
162189648|NCT04181788|585745482|FG002|FOLLOW-UP|Death|1|||
162189649|NCT04181788|585745483|FG003|FOLLOW-UP|Death|2|||
162189650|NCT04181788|585745484|FG004|FOLLOW-UP|Death|8|||
162189651|NCT04181788|585745485|FG005|FOLLOW-UP|Death|20|||
162189652|NCT04181788|585745480|FG000|FOLLOW-UP|Lost to Follow-up|0|||
162189653|NCT04181788|585745481|FG001|FOLLOW-UP|Lost to Follow-up|0|||
162189654|NCT04181788|585745482|FG002|FOLLOW-UP|Lost to Follow-up|0|||
162189655|NCT04181788|585745483|FG003|FOLLOW-UP|Lost to Follow-up|0|||
161819641|NCT05330975|584381119|FG003|Primary|Protocol Violation|4|||
161819642|NCT05330975|584381120|FG004|Primary|Protocol Violation|0|||
162189656|NCT04181788|585745484|FG004|FOLLOW-UP|Lost to Follow-up|0|||
162189657|NCT04181788|585745485|FG005|FOLLOW-UP|Lost to Follow-up|2|||
162189658|NCT04181788|585745480|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
162189659|NCT04181788|585745481|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
162189660|NCT04181788|585745482|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
162189661|NCT04181788|585745483|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
162189662|NCT04181788|585745484|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
162189663|NCT04181788|585745485|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
162189664|NCT04181788|585745480|FG000|FOLLOW-UP|Other unspecified|0|||
162189665|NCT04181788|585745481|FG001|FOLLOW-UP|Other unspecified|1|||
162189666|NCT04181788|585745482|FG002|FOLLOW-UP|Other unspecified|0|||
162189667|NCT04181788|585745483|FG003|FOLLOW-UP|Other unspecified|0|||
162189668|NCT04181788|585745484|FG004|FOLLOW-UP|Other unspecified|0|||
162189669|NCT04181788|585745485|FG005|FOLLOW-UP|Other unspecified|3|||
162189670|NCT04181788|585745480|FG000|FOLLOW-UP|Ongoing|0|||
162189671|NCT04181788|585745481|FG001|FOLLOW-UP|Ongoing|0|||
162189672|NCT04181788|585745482|FG002|FOLLOW-UP|Ongoing|1|||
162189673|NCT04181788|585745483|FG003|FOLLOW-UP|Ongoing|3|||
162189674|NCT04181788|585745484|FG004|FOLLOW-UP|Ongoing|2|||
162189675|NCT04181788|585745485|FG005|FOLLOW-UP|Ongoing|2|||
162189676|NCT04535414|585745486|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
161673604|NCT02408861|583858028|FG006|Overall Study|Disease Progression|1|||
161673605|NCT02408861|583858022|FG000|Overall Study|Adverse Event|1|||
161673606|NCT02408861|583858023|FG001|Overall Study|Adverse Event|0|||
161673607|NCT02408861|583858024|FG002|Overall Study|Adverse Event|1|||
161673608|NCT02408861|583858025|FG003|Overall Study|Adverse Event|0|||
161925569|NCT02697422|584773217|FG001|Overall Study|Exit survey data lost|0|||
161925570|NCT02068599|584773222|FG000|Overall Study|Adverse Event|4|||
161925571|NCT02068599|584773223|FG001|Overall Study|Adverse Event|1|||
161925572|NCT02068599|584773224|FG002|Overall Study|Adverse Event|1|||
161925573|NCT02068599|584773222|FG000|Overall Study|Withdrawal by Subject|2|||
161925574|NCT02068599|584773223|FG001|Overall Study|Withdrawal by Subject|7|||
161925575|NCT02068599|584773224|FG002|Overall Study|Withdrawal by Subject|5|||
161925576|NCT02068599|584773222|FG000|Overall Study|Protocol Violation|4|||
162019851|NCT01124864|585128479|FG002|Overall Study|Withdrawal by Subject|4|||
162019852|NCT01124864|585128480|FG003|Overall Study|Withdrawal by Subject|0|||
161673609|NCT02408861|583858026|FG004|Overall Study|Adverse Event|2|||
161673610|NCT02408861|583858027|FG005|Overall Study|Adverse Event|0|||
161673611|NCT02408861|583858028|FG006|Overall Study|Adverse Event|0|||
161673612|NCT02408861|583858022|FG000|Overall Study|Physician Decision|1|||
161673613|NCT02408861|583858023|FG001|Overall Study|Physician Decision|1|||
161673614|NCT02408861|583858024|FG002|Overall Study|Physician Decision|1|||
161673615|NCT02408861|583858025|FG003|Overall Study|Physician Decision|0|||
161673616|NCT02408861|583858026|FG004|Overall Study|Physician Decision|0|||
161673617|NCT02408861|583858027|FG005|Overall Study|Physician Decision|1|||
161673618|NCT02408861|583858028|FG006|Overall Study|Physician Decision|0|||
161673619|NCT02408861|583858022|FG000|Overall Study|Protocol Violation|1|||
161673620|NCT02408861|583858023|FG001|Overall Study|Protocol Violation|0|||
161673621|NCT02408861|583858024|FG002|Overall Study|Protocol Violation|0|||
161673622|NCT02408861|583858025|FG003|Overall Study|Protocol Violation|0|||
161673623|NCT02408861|583858026|FG004|Overall Study|Protocol Violation|0|||
161673624|NCT02408861|583858027|FG005|Overall Study|Protocol Violation|0|||
162019853|NCT01124864|585128481|FG004|Overall Study|Withdrawal by Subject|2|||
162019854|NCT01124864|585128482|FG005|Overall Study|Withdrawal by Subject|1|||
162019855|NCT01124864|585128477|FG000|Overall Study|Lost to Follow-up|1|||
162019856|NCT01124864|585128478|FG001|Overall Study|Lost to Follow-up|1|||
162019857|NCT01124864|585128479|FG002|Overall Study|Lost to Follow-up|0|||
162019858|NCT01124864|585128480|FG003|Overall Study|Lost to Follow-up|1|||
162019859|NCT01124864|585128481|FG004|Overall Study|Lost to Follow-up|0|||
162019860|NCT01124864|585128482|FG005|Overall Study|Lost to Follow-up|0|||
162019861|NCT01124864|585128477|FG000|Overall Study|Protocol Violation|1|||
162019862|NCT01124864|585128478|FG001|Overall Study|Protocol Violation|0|||
162019863|NCT01124864|585128479|FG002|Overall Study|Protocol Violation|0|||
162019864|NCT01124864|585128480|FG003|Overall Study|Protocol Violation|0|||
162019865|NCT01124864|585128481|FG004|Overall Study|Protocol Violation|1|||
162019866|NCT01124864|585128482|FG005|Overall Study|Protocol Violation|0|||
162019867|NCT00798759|585128485|FG000|Overall Study|Adverse Event|3|||
162019868|NCT00798759|585128486|FG001|Overall Study|Adverse Event|3|||
162019869|NCT00798759|585128485|FG000|Overall Study|Lost to Follow-up|1|||
162019870|NCT00798759|585128486|FG001|Overall Study|Lost to Follow-up|1|||
162019871|NCT00798759|585128485|FG000|Overall Study|Protocol Violation|4|||
162019872|NCT00798759|585128486|FG001|Overall Study|Protocol Violation|8|||
162019873|NCT00798759|585128485|FG000|Overall Study|Other|0|||
162019874|NCT00798759|585128486|FG001|Overall Study|Other|1|||
162019875|NCT00724711|585128487|FG000|Overall Study|Adverse Event|7|||
162019876|NCT00724711|585128488|FG001|Overall Study|Adverse Event|3|||
162019877|NCT00724711|585128487|FG000|Overall Study|Pregnancy|0|||
162019878|NCT00724711|585128488|FG001|Overall Study|Pregnancy|1|||
162019879|NCT00724711|585128487|FG000|Overall Study|Lack of Efficacy|0|||
162019880|NCT00724711|585128488|FG001|Overall Study|Lack of Efficacy|1|||
162019881|NCT00724711|585128487|FG000|Overall Study|Physician Decision|0|||
162019882|NCT00724711|585128488|FG001|Overall Study|Physician Decision|3|||
162019883|NCT00724711|585128487|FG000|Overall Study|Withdrawal by Subject|5|||
162019884|NCT00724711|585128488|FG001|Overall Study|Withdrawal by Subject|4|||
162019885|NCT00724711|585128487|FG000|Overall Study|Lost to Follow-up|4|||
162019886|NCT00724711|585128488|FG001|Overall Study|Lost to Follow-up|5|||
162019887|NCT00724711|585128487|FG000|Overall Study|Protocol Violation|1|||
162019888|NCT00724711|585128488|FG001|Overall Study|Protocol Violation|0|||
162019889|NCT03387111|585128489|FG000|Overall Study|Progressive Disease|3|||
162019890|NCT03387111|585128489|FG000|Overall Study|Other|1|||
162019891|NCT00727441|585128493|FG000|Overall Study|Disease Progression|11|||
162019892|NCT00727441|585128494|FG001|Overall Study|Disease Progression|14|||
161673625|NCT02408861|583858028|FG006|Overall Study|Protocol Violation|0|||
161673626|NCT02408861|583858022|FG000|Overall Study|Withdrawal by Subject|0|||
162019893|NCT00727441|585128495|FG002|Overall Study|Disease Progression|17|||
162019894|NCT00727441|585128493|FG000|Overall Study|Eligibility|7|||
162019895|NCT00727441|585128494|FG001|Overall Study|Eligibility|5|||
161673627|NCT02408861|583858023|FG001|Overall Study|Withdrawal by Subject|0|||
161925577|NCT02068599|584773223|FG001|Overall Study|Protocol Violation|2|||
161925578|NCT02068599|584773224|FG002|Overall Study|Protocol Violation|3|||
162019896|NCT00727441|585128495|FG002|Overall Study|Eligibility|7|||
162019897|NCT00727441|585128493|FG000|Overall Study|Death|0|||
162019898|NCT00727441|585128494|FG001|Overall Study|Death|1|||
162019899|NCT00727441|585128495|FG002|Overall Study|Death|1|||
162019900|NCT00727441|585128493|FG000|Overall Study|Physician Decision|0|||
162019901|NCT00727441|585128494|FG001|Overall Study|Physician Decision|1|||
162019902|NCT00727441|585128495|FG002|Overall Study|Physician Decision|0|||
162019903|NCT00727441|585128493|FG000|Overall Study|Withdrawal by Subject|0|||
162019904|NCT00727441|585128494|FG001|Overall Study|Withdrawal by Subject|1|||
162019905|NCT00727441|585128495|FG002|Overall Study|Withdrawal by Subject|0|||
162019906|NCT01239992|585128496|FG000|Overall Study|Withdrawal by Subject|2|||
162019907|NCT00535288|585128497|FG000|Overall Study|Adverse Event|20|||
162019908|NCT00535288|585128498|FG001|Overall Study|Adverse Event|19|||
162019909|NCT00535288|585128499|FG002|Overall Study|Adverse Event|25|||
162019910|NCT00535288|585128500|FG003|Overall Study|Adverse Event|20|||
162019911|NCT00535288|585128501|FG004|Overall Study|Adverse Event|30|||
162019912|NCT00535288|585128497|FG000|Overall Study|Lost to Follow-up|0|||
162019913|NCT00535288|585128498|FG001|Overall Study|Lost to Follow-up|3|||
162019914|NCT00535288|585128499|FG002|Overall Study|Lost to Follow-up|0|||
162019915|NCT00535288|585128500|FG003|Overall Study|Lost to Follow-up|0|||
162019916|NCT00535288|585128501|FG004|Overall Study|Lost to Follow-up|0|||
162019917|NCT00535288|585128497|FG000|Overall Study|Lack of Efficacy|26|||
162019918|NCT00535288|585128498|FG001|Overall Study|Lack of Efficacy|3|||
161673628|NCT02408861|583858024|FG002|Overall Study|Withdrawal by Subject|0|||
161673629|NCT02408861|583858025|FG003|Overall Study|Withdrawal by Subject|0|||
161673630|NCT02408861|583858026|FG004|Overall Study|Withdrawal by Subject|1|||
161673631|NCT02408861|583858027|FG005|Overall Study|Withdrawal by Subject|1|||
161673632|NCT02408861|583858028|FG006|Overall Study|Withdrawal by Subject|0|||
161673633|NCT02408861|583858022|FG000|Overall Study|Other Treatment|0|||
161673634|NCT02408861|583858023|FG001|Overall Study|Other Treatment|0|||
161673635|NCT02408861|583858024|FG002|Overall Study|Other Treatment|0|||
161673636|NCT02408861|583858025|FG003|Overall Study|Other Treatment|0|||
161673637|NCT02408861|583858026|FG004|Overall Study|Other Treatment|0|||
161673638|NCT02408861|583858027|FG005|Overall Study|Other Treatment|1|||
161673639|NCT02408861|583858028|FG006|Overall Study|Other Treatment|1|||
161673640|NCT04752475|583859841|FG000|Overall Study|Withdrawal by Subject|1|||
161673641|NCT04752475|583859842|FG001|Overall Study|Withdrawal by Subject|1|||
161673642|NCT01310803|583859848|FG000|Overall Study|Subject terminated by Sponsor|1|||
161673643|NCT01310803|583859849|FG001|Overall Study|Subject terminated by Sponsor|0|||
161673644|NCT02113579|583859852|FG000|Overall Study|Adverse Event|1|||
161673645|NCT02113579|583859853|FG001|Overall Study|Adverse Event|0|||
161673646|NCT02113579|583859852|FG000|Overall Study|Withdrawal by Subject|3|||
161673647|NCT02113579|583859853|FG001|Overall Study|Withdrawal by Subject|2|||
161673648|NCT02113579|583859852|FG000|Overall Study|Lost to Follow-up|6|||
161673649|NCT02113579|583859853|FG001|Overall Study|Lost to Follow-up|2|||
161673650|NCT03047551|583859854|FG000|Overall Study|Did not receive TAS|1|||
161673651|NCT03047551|583859855|FG001|Overall Study|Did not receive TAS|0|||
161673652|NCT03047551|583859854|FG000|Overall Study|Physician Decision|1|||
161673653|NCT03047551|583859855|FG001|Overall Study|Physician Decision|0|||
161673654|NCT03047551|583859854|FG000|Overall Study|Withdrawal by Subject|0|||
161673655|NCT03047551|583859855|FG001|Overall Study|Withdrawal by Subject|1|||
161673656|NCT03047551|583859854|FG000|Overall Study|Probe malfunction|0|||
161673657|NCT03047551|583859855|FG001|Overall Study|Probe malfunction|1|||
161673658|NCT03047551|583859854|FG000|Overall Study|Ineligible|0|||
161673659|NCT03047551|583859855|FG001|Overall Study|Ineligible|1|||
161673660|NCT00726622|583859856|FG000|Overall Study|Withdrawal by Subject|16|||
161673661|NCT00726622|583859857|FG001|Overall Study|Withdrawal by Subject|2|||
162019919|NCT00535288|585128499|FG002|Overall Study|Lack of Efficacy|4|||
162019920|NCT00535288|585128500|FG003|Overall Study|Lack of Efficacy|4|||
162189677|NCT04535414|585745487|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
162189678|NCT04535414|585745486|FG000|Overall Study|Cancelled appointment|1|||
162189679|NCT04535414|585745487|FG001|Overall Study|Cancelled appointment|0|||
162189680|NCT04535414|585745486|FG000|Overall Study|cancelled - food in stomach|2|||
161673662|NCT00726622|583859856|FG000|Overall Study|Physician Decision|0|||
161673663|NCT00726622|583859857|FG001|Overall Study|Physician Decision|1|||
161673664|NCT00726622|583859856|FG000|Overall Study|Metastasis|2|||
161673665|NCT00726622|583859857|FG001|Overall Study|Metastasis|0|||
161673666|NCT02462928|583859859|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
161673667|NCT02462928|583859860|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
161673668|NCT02462928|583859861|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
161673669|NCT02462928|583859859|FG000|Overall Study|Adverse Event|47|||
161673670|NCT02462928|583859860|FG001|Overall Study|Adverse Event|51|||
162019921|NCT00535288|585128501|FG004|Overall Study|Lack of Efficacy|7|||
162019922|NCT00535288|585128497|FG000|Overall Study|Unwilling to cooperate|6|||
162189681|NCT04535414|585745487|FG001|Overall Study|cancelled - food in stomach|0|||
161673671|NCT02462928|583859861|FG002|Overall Study|Adverse Event|25|||
161673672|NCT02462928|583859859|FG000|Overall Study|Lack of Efficacy|3|||
161673673|NCT02462928|583859860|FG001|Overall Study|Lack of Efficacy|8|||
161673674|NCT02462928|583859861|FG002|Overall Study|Lack of Efficacy|3|||
162019923|NCT00535288|585128498|FG001|Overall Study|Unwilling to cooperate|6|||
161673675|NCT02462928|583859859|FG000|Overall Study|Lost to Follow-up|4|||
161673676|NCT02462928|583859860|FG001|Overall Study|Lost to Follow-up|4|||
161673677|NCT02462928|583859861|FG002|Overall Study|Lost to Follow-up|1|||
161673678|NCT02462928|583859859|FG000|Overall Study|Withdrawal by Patient|31|||
161673679|NCT02462928|583859860|FG001|Overall Study|Withdrawal by Patient|21|||
161673680|NCT02462928|583859861|FG002|Overall Study|Withdrawal by Patient|21|||
161673681|NCT02462928|583859859|FG000|Overall Study|Protocol Violation|0|||
161673682|NCT02462928|583859860|FG001|Overall Study|Protocol Violation|1|||
161673683|NCT02462928|583859861|FG002|Overall Study|Protocol Violation|0|||
161673684|NCT02462928|583859859|FG000|Overall Study|Reason not Specified|4|||
161673685|NCT02462928|583859860|FG001|Overall Study|Reason not Specified|6|||
161673686|NCT02462928|583859861|FG002|Overall Study|Reason not Specified|5|||
161673687|NCT00395863|583859862|FG000|Overall Study|Patients did not complete both exams|2|||
161673688|NCT00395863|583859863|FG001|Overall Study|Patients did not complete both exams|3|||
161673689|NCT01940354|583859864|FG000|Overall Study|Withdrawal by Subject|4|||
161673690|NCT01940354|583859865|FG001|Overall Study|Withdrawal by Subject|2|||
161673691|NCT02020863|583859866|FG000|Overall Study|Discovery of Metastatic disease|4|||
161673692|NCT02020863|583859866|FG000|Overall Study|Team chose not to place an a line|1|||
161673693|NCT03873493|583859867|FG000|Overall Study|Withdrawal by Subject|1|||
161673694|NCT03873493|583859867|FG000|Overall Study|Death|9|||
161673695|NCT03873493|583859867|FG000|Overall Study|Lost to Follow-up|1|||
161673696|NCT03873493|583859867|FG000|Overall Study|Study Terminated by Sponsor|1|||
161673697|NCT03873493|583859867|FG000|Overall Study|Other|2|||
161673698|NCT00909792|583859874|FG000|Period 1|Did not meet inclusion criteria|0|||
161925579|NCT02068599|584773222|FG000|Overall Study|Lost to Follow-up|1|||
161925580|NCT02068599|584773223|FG001|Overall Study|Lost to Follow-up|0|||
161925581|NCT02068599|584773224|FG002|Overall Study|Lost to Follow-up|0|||
161925582|NCT02068599|584773222|FG000|Overall Study|Lack of Efficacy|0|||
161925583|NCT02068599|584773223|FG001|Overall Study|Lack of Efficacy|0|||
161925584|NCT02068599|584773224|FG002|Overall Study|Lack of Efficacy|3|||
161925585|NCT02068599|584773222|FG000|Overall Study|Noncompliance|0|||
161673699|NCT00909792|583859875|FG001|Period 1|Did not meet inclusion criteria|1|||
161673700|NCT00909792|583859874|FG000|Period 2|Biomicroscopy|1|||
161673701|NCT00909792|583859875|FG001|Period 2|Biomicroscopy|0|||
161673702|NCT00909792|583859874|FG000|Period 2|Lost to Follow-up|0|||
161673703|NCT00909792|583859875|FG001|Period 2|Lost to Follow-up|1|||
161673704|NCT01448213|583859876|FG000|Overall Study|Lost to Follow-up|12|||
161673705|NCT01448213|583859877|FG001|Overall Study|Lost to Follow-up|10|||
161673706|NCT01448213|583859876|FG000|Overall Study|Adverse Event|4|||
161673707|NCT01448213|583859877|FG001|Overall Study|Adverse Event|10|||
161673708|NCT01448213|583859876|FG000|Overall Study|Protocol Violation|1|||
161673709|NCT01448213|583859877|FG001|Overall Study|Protocol Violation|2|||
161673710|NCT03503513|583859878|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
161673711|NCT03503513|583859878|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
161925586|NCT02068599|584773223|FG001|Overall Study|Noncompliance|0|||
161925587|NCT02068599|584773224|FG002|Overall Study|Noncompliance|1|||
161925588|NCT01263028|584773225|FG000|Overall Study|Withdrawal by Subject|1|||
161925589|NCT01263028|584773225|FG000|Overall Study|Adverse Event|1|||
161925590|NCT01263028|584773225|FG000|Overall Study|Study terminated due to low enrollment.|4|||
161925591|NCT03019588|584773226|FG000|Overall Study|Death|44|||
161925592|NCT03019588|584773227|FG001|Overall Study|Death|46|||
161925593|NCT03019588|584773226|FG000|Overall Study|Study terminated by Sponsor|3|||
161925594|NCT03019588|584773227|FG001|Overall Study|Study terminated by Sponsor|1|||
161925595|NCT00366535|584773228|FG000|First Phase: 12 Weeks|Adverse Event|1|||
161925596|NCT00366535|584773229|FG001|First Phase: 12 Weeks|Adverse Event|3|||
161925597|NCT00366535|584773228|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
161925598|NCT00366535|584773229|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
161925599|NCT00366535|584773228|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
161925600|NCT00366535|584773229|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
161925601|NCT00366535|584773228|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
161925602|NCT00366535|584773229|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
161925603|NCT02958527|584773234|FG000|Overall Study|Not collected CRFs|12|||
161925604|NCT06042855|584773237|FG000|Overall Study|No Receipt of Study Drug|48|||
161925605|NCT06042855|584773238|FG001|Overall Study|No Receipt of Study Drug|57|||
161925606|NCT06042855|584773237|FG000|Overall Study|Administratively Withdrawn|59|||
161925607|NCT06042855|584773238|FG001|Overall Study|Administratively Withdrawn|59|||
161925608|NCT02939781|584773244|FG000|Overall Study|Protocol Violation|8|||
161925609|NCT02939781|584773244|FG000|Overall Study|Withdrawal by Subject|1|||
161925610|NCT06100250|584773245|FG000|Overall Study|Lost to Follow-up|5|||
161925611|NCT05259033|584773248|FG000|Overall Study|Withdrawal by Subject|10|||
161925612|NCT05259033|584773249|FG001|Overall Study|Withdrawal by Subject|5|||
161673712|NCT03503513|583859878|FG000|Overall Study|Physician Decision|3|||
161673713|NCT03503513|583859878|FG000|Overall Study|Withdrawal by Subject|2|||
161673714|NCT03503513|583859878|FG000|Overall Study|Lost to Follow-up|1|||
161673715|NCT01170039|583859883|FG000|Overall Study|Withdrawal by Subject|5|||
161925613|NCT05259033|584773248|FG000|Overall Study|Lost to Follow-up|1|||
161673716|NCT01170039|583859884|FG001|Overall Study|Withdrawal by Subject|3|||
161673717|NCT01170039|583859883|FG000|Overall Study|Lack of funding, drug not available|3|||
161673718|NCT01170039|583859884|FG001|Overall Study|Lack of funding, drug not available|3|||
161673719|NCT01205438|583859885|FG000|Overall Study|Adverse Event|19|||
161673720|NCT01205438|583859886|FG001|Overall Study|Adverse Event|17|||
161673721|NCT01205438|583859887|FG002|Overall Study|Adverse Event|24|||
161673722|NCT01205438|583859885|FG000|Overall Study|Death|1|||
162019924|NCT00535288|585128499|FG002|Overall Study|Unwilling to cooperate|3|||
162019925|NCT00535288|585128500|FG003|Overall Study|Unwilling to cooperate|3|||
162019926|NCT00535288|585128501|FG004|Overall Study|Unwilling to cooperate|4|||
162019927|NCT00535288|585128497|FG000|Overall Study|Other|2|||
162019928|NCT00535288|585128498|FG001|Overall Study|Other|1|||
162019929|NCT00535288|585128499|FG002|Overall Study|Other|1|||
162019930|NCT00535288|585128500|FG003|Overall Study|Other|2|||
162019931|NCT00535288|585128501|FG004|Overall Study|Other|1|||
162019932|NCT02810444|585128502|FG000|Overall Study|Screen Failures|14|||
162019933|NCT02810444|585128502|FG000|Overall Study|Withdrawal by Subject|4|||
162019934|NCT02810444|585128502|FG000|Overall Study|Adverse Event|3|||
162019935|NCT04643158|585128509|FG000|Overall Study|Study terminated by sponsor|0|||
162019936|NCT04643158|585128510|FG001|Overall Study|Study terminated by sponsor|0|||
162019937|NCT04643158|585128511|FG002|Overall Study|Study terminated by sponsor|1|||
162019938|NCT04643158|585128512|FG003|Overall Study|Study terminated by sponsor|0|||
162019939|NCT04643158|585128513|FG004|Overall Study|Study terminated by sponsor|0|||
162019940|NCT04643158|585128514|FG005|Overall Study|Study terminated by sponsor|1|||
162019941|NCT04643158|585128515|FG006|Overall Study|Study terminated by sponsor|0|||
162019942|NCT04643158|585128509|FG000|Overall Study|Global/country situation|0|||
162019943|NCT04643158|585128510|FG001|Overall Study|Global/country situation|0|||
162019944|NCT04643158|585128511|FG002|Overall Study|Global/country situation|1|||
162019945|NCT04643158|585128512|FG003|Overall Study|Global/country situation|0|||
162019946|NCT04643158|585128513|FG004|Overall Study|Global/country situation|0|||
162019947|NCT04643158|585128514|FG005|Overall Study|Global/country situation|0|||
162019948|NCT04643158|585128515|FG006|Overall Study|Global/country situation|0|||
162019949|NCT04643158|585128509|FG000|Overall Study|Withdrawal by Subject|0|||
162019950|NCT04643158|585128510|FG001|Overall Study|Withdrawal by Subject|0|||
162019951|NCT04643158|585128511|FG002|Overall Study|Withdrawal by Subject|0|||
162019952|NCT04643158|585128512|FG003|Overall Study|Withdrawal by Subject|0|||
162019953|NCT04643158|585128513|FG004|Overall Study|Withdrawal by Subject|0|||
162019954|NCT04643158|585128514|FG005|Overall Study|Withdrawal by Subject|1|||
162019955|NCT04643158|585128515|FG006|Overall Study|Withdrawal by Subject|0|||
162019956|NCT04329806|585128516|FG000|Overall Study|Physician Decision|3|||
162019957|NCT04329806|585128517|FG001|Overall Study|Physician Decision|4|||
162019958|NCT00622440|585128530|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
162019959|NCT00622440|585128531|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
162019960|NCT00622440|585128530|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
162019961|NCT00622440|585128531|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
162019962|NCT00622440|585128530|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
162019963|NCT00622440|585128531|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
162019964|NCT00622440|585128530|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
162019965|NCT00622440|585128531|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
162019966|NCT02147561|585128537|FG000|Overall Study|Lost to Follow-up|3|||
162019967|NCT02147561|585128537|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
162019968|NCT03023813|585128540|FG000|Overall Study|Lost to Follow-up|1|||
162019969|NCT03023813|585128541|FG001|Overall Study|Lost to Follow-up|2|||
162019970|NCT03023813|585128542|FG002|Overall Study|Lost to Follow-up|0|||
162019971|NCT03710083|585128543|FG000|Overall Study|Withdrawal by Subject|2|||
162019972|NCT03710083|585128543|FG000|Overall Study|Unsuccessful Procedure|1|||
162019973|NCT02283762|585128544|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
162019974|NCT02283762|585128545|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
162019975|NCT02283762|585128544|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
162019976|NCT02283762|585128545|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
162019977|NCT02283762|585128544|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
162019978|NCT02283762|585128545|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
162019979|NCT02283762|585128544|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
162019980|NCT02283762|585128545|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
162019981|NCT02283762|585128544|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
162019982|NCT02283762|585128545|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
162019983|NCT02283762|585128544|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
162019984|NCT02283762|585128545|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
162019985|NCT02283762|585128544|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
162019986|NCT02283762|585128545|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
161673723|NCT01205438|583859886|FG001|Overall Study|Death|1|||
161673724|NCT01205438|583859887|FG002|Overall Study|Death|3|||
162019987|NCT02283762|585128544|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
161673725|NCT01205438|583859885|FG000|Overall Study|Entry Criteria Not Met|16|||
162189682|NCT04535414|585745486|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
162189683|NCT04535414|585745487|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
162189684|NCT04535414|585745486|FG000|Overall Study|Withdrawal by Subject|0|||
162189685|NCT04535414|585745487|FG001|Overall Study|Withdrawal by Subject|1|||
162189686|NCT04809623|585747772|FG000|Overall Study|Study Terminated by Sponsor|1|||
162189687|NCT04809623|585747773|FG001|Overall Study|Study Terminated by Sponsor|0|||
162189688|NCT00671853|585747774|FG000|Overall Study|Lack of Efficacy|3|||
162189689|NCT00671853|585747775|FG001|Overall Study|Lack of Efficacy|7|||
162189690|NCT00671853|585747774|FG000|Overall Study|Adverse Event|7|||
162189691|NCT00671853|585747775|FG001|Overall Study|Adverse Event|1|||
162189692|NCT00671853|585747774|FG000|Overall Study|Withdrawal by Subject|1|||
162189693|NCT00671853|585747775|FG001|Overall Study|Withdrawal by Subject|5|||
162189694|NCT00671853|585747774|FG000|Overall Study|Lost to Follow-up|8|||
162189695|NCT00671853|585747775|FG001|Overall Study|Lost to Follow-up|8|||
162189696|NCT00671853|585747774|FG000|Overall Study|Physician Decision|0|||
162189697|NCT00671853|585747775|FG001|Overall Study|Physician Decision|2|||
162189698|NCT00671853|585747774|FG000|Overall Study|Non-adherence with study procedures|1|||
162189699|NCT00671853|585747775|FG001|Overall Study|Non-adherence with study procedures|4|||
162189700|NCT02354417|585747776|FG000|Overall Study|Physician Decision|1|||
162189701|NCT01848483|585747777|FG000|Overall Study|Death|2|||
162189702|NCT01848483|585747778|FG001|Overall Study|Death|1|||
162189703|NCT01848483|585747777|FG000|Overall Study|Lost to Follow-up|6|||
162189704|NCT01848483|585747778|FG001|Overall Study|Lost to Follow-up|8|||
162189705|NCT01848483|585747777|FG000|Overall Study|Withdrawal by Subject|1|||
162189706|NCT01848483|585747778|FG001|Overall Study|Withdrawal by Subject|0|||
162189707|NCT01848483|585747777|FG000|Overall Study|Incarceration|2|||
162189708|NCT01848483|585747778|FG001|Overall Study|Incarceration|2|||
162189709|NCT02236611|585747781|FG000|Overall Study|Adverse Event|10|||
162189710|NCT02236611|585747782|FG001|Overall Study|Adverse Event|16|||
162189711|NCT02236611|585747781|FG000|Overall Study|Lack of Efficacy|4|||
162189712|NCT02236611|585747782|FG001|Overall Study|Lack of Efficacy|7|||
162189713|NCT02236611|585747781|FG000|Overall Study|Lost to Follow-up|0|||
162189714|NCT02236611|585747782|FG001|Overall Study|Lost to Follow-up|2|||
162189715|NCT02236611|585747781|FG000|Overall Study|Protocol deviation|3|||
162189716|NCT02236611|585747782|FG001|Overall Study|Protocol deviation|5|||
162189717|NCT02236611|585747781|FG000|Overall Study|Withdrew consent|9|||
162189718|NCT02236611|585747782|FG001|Overall Study|Withdrew consent|4|||
162189719|NCT03041090|585747783|FG000|Overall Study|technical error|0|||
162189720|NCT03041090|585747784|FG001|Overall Study|technical error|3|||
162189721|NCT02202317|585747785|FG000|Overall Study|Lost to Follow-up|1|||
162189722|NCT02338999|585747786|FG000|First Intervention|Withdrawal by Subject|3|||
162189723|NCT02338999|585747787|FG001|First Intervention|Withdrawal by Subject|1|||
162189724|NCT02338999|585747786|FG000|Washout Period|Withdrawal by Subject|0|||
162189725|NCT02338999|585747787|FG001|Washout Period|Withdrawal by Subject|2|||
162189726|NCT02338999|585747786|FG000|Second Intervention|Withdrawal by Subject|0|||
162189727|NCT02338999|585747787|FG001|Second Intervention|Withdrawal by Subject|2|||
161925614|NCT05259033|584773249|FG001|Overall Study|Lost to Follow-up|0|||
161925615|NCT05259033|584773248|FG000|Overall Study|Death|2|||
161925616|NCT05259033|584773249|FG001|Overall Study|Death|0|||
161925617|NCT05537571|584773250|FG000|Overall Study|Withdrawal by Subject|1|||
161925618|NCT05537571|584773251|FG001|Overall Study|Withdrawal by Subject|1|||
161673726|NCT01205438|583859886|FG001|Overall Study|Entry Criteria Not Met|15|||
161673727|NCT01205438|583859887|FG002|Overall Study|Entry Criteria Not Met|13|||
161925619|NCT05537571|584773252|FG002|Overall Study|Withdrawal by Subject|0|||
161925620|NCT05537571|584773253|FG003|Overall Study|Withdrawal by Subject|0|||
161925621|NCT05537571|584773254|FG004|Overall Study|Withdrawal by Subject|0|||
161925622|NCT05537571|584773250|FG000|Overall Study|Adverse Event|2|||
161925623|NCT05537571|584773251|FG001|Overall Study|Adverse Event|0|||
161925624|NCT05537571|584773252|FG002|Overall Study|Adverse Event|0|||
161925625|NCT05537571|584773253|FG003|Overall Study|Adverse Event|0|||
162189728|NCT02701296|585747788|FG000|Overall Study|Incomplete Data|0|||
162189729|NCT02701296|585747789|FG001|Overall Study|Incomplete Data|2|||
162189730|NCT01332266|585747790|FG000|Phase 1b|Death|3|||
162189731|NCT01332266|585747791|FG001|Phase 1b|Death|3|||
162189732|NCT01332266|585747792|FG002|Phase 1b|Death|2|||
162189733|NCT01332266|585747793|FG003|Phase 1b|Death|0|||
161925626|NCT05537571|584773254|FG004|Overall Study|Adverse Event|0|||
161925627|NCT05537571|584773250|FG000|Overall Study|Hepatitis A screening result|2|||
162189734|NCT01332266|585747794|FG004|Phase 1b|Death|0|||
162189735|NCT01332266|585747790|FG000|Phase 1b|Lost to Follow-up|0|||
162189736|NCT01332266|585747791|FG001|Phase 1b|Lost to Follow-up|1|||
162189737|NCT01332266|585747792|FG002|Phase 1b|Lost to Follow-up|0|||
162189738|NCT01332266|585747793|FG003|Phase 1b|Lost to Follow-up|0|||
162189739|NCT01332266|585747794|FG004|Phase 1b|Lost to Follow-up|0|||
162189740|NCT01332266|585747790|FG000|Phase 1b|Withdrawal by Subject|1|||
162189741|NCT01332266|585747791|FG001|Phase 1b|Withdrawal by Subject|1|||
162189742|NCT01332266|585747792|FG002|Phase 1b|Withdrawal by Subject|1|||
162189743|NCT01332266|585747793|FG003|Phase 1b|Withdrawal by Subject|0|||
162189744|NCT01332266|585747794|FG004|Phase 1b|Withdrawal by Subject|0|||
162189745|NCT01332266|585747790|FG000|Phase 2|Death|0|||
162189746|NCT01332266|585747791|FG001|Phase 2|Death|0|||
162189747|NCT01332266|585747792|FG002|Phase 2|Death|0|||
162189748|NCT01332266|585747793|FG003|Phase 2|Death|33|||
162189749|NCT01332266|585747794|FG004|Phase 2|Death|36|||
162189750|NCT01332266|585747790|FG000|Phase 2|Lost to Follow-up|0|||
162189751|NCT01332266|585747791|FG001|Phase 2|Lost to Follow-up|0|||
162189752|NCT01332266|585747792|FG002|Phase 2|Lost to Follow-up|0|||
162189753|NCT01332266|585747793|FG003|Phase 2|Lost to Follow-up|2|||
162189754|NCT01332266|585747794|FG004|Phase 2|Lost to Follow-up|0|||
162189755|NCT01332266|585747790|FG000|Phase 2|Physician Decision|0|||
162189756|NCT01332266|585747791|FG001|Phase 2|Physician Decision|0|||
162189757|NCT01332266|585747792|FG002|Phase 2|Physician Decision|0|||
162189758|NCT01332266|585747793|FG003|Phase 2|Physician Decision|3|||
162189759|NCT01332266|585747794|FG004|Phase 2|Physician Decision|1|||
162189760|NCT01332266|585747790|FG000|Phase 2|Symptomatic deterioration|0|||
162189761|NCT01332266|585747791|FG001|Phase 2|Symptomatic deterioration|0|||
162189762|NCT01332266|585747792|FG002|Phase 2|Symptomatic deterioration|0|||
162189763|NCT01332266|585747793|FG003|Phase 2|Symptomatic deterioration|0|||
162189764|NCT01332266|585747794|FG004|Phase 2|Symptomatic deterioration|1|||
162189765|NCT01332266|585747790|FG000|Phase 2|Progression Disease|0|||
162189766|NCT01332266|585747791|FG001|Phase 2|Progression Disease|0|||
162189767|NCT01332266|585747792|FG002|Phase 2|Progression Disease|0|||
162189768|NCT01332266|585747793|FG003|Phase 2|Progression Disease|2|||
162189769|NCT01332266|585747794|FG004|Phase 2|Progression Disease|1|||
162189770|NCT01332266|585747790|FG000|Phase 2|Withdrawal by Subject|0|||
162189771|NCT01332266|585747791|FG001|Phase 2|Withdrawal by Subject|0|||
162189772|NCT01332266|585747792|FG002|Phase 2|Withdrawal by Subject|0|||
162189773|NCT01332266|585747793|FG003|Phase 2|Withdrawal by Subject|2|||
162189774|NCT01332266|585747794|FG004|Phase 2|Withdrawal by Subject|2|||
162189775|NCT01686152|585747797|FG000|Overall Study|Withdrawal by Subject|11|||
162189776|NCT01686152|585747798|FG001|Overall Study|Withdrawal by Subject|11|||
162189777|NCT01686152|585747799|FG002|Overall Study|Withdrawal by Subject|3|||
162189778|NCT01686152|585747797|FG000|Overall Study|Drug Code Unblinded|0|||
162189779|NCT01686152|585747798|FG001|Overall Study|Drug Code Unblinded|1|||
162189780|NCT01686152|585747799|FG002|Overall Study|Drug Code Unblinded|0|||
162189781|NCT01686152|585747797|FG000|Overall Study|Protocol Violation|6|||
162189782|NCT01686152|585747798|FG001|Overall Study|Protocol Violation|1|||
162189783|NCT01686152|585747799|FG002|Overall Study|Protocol Violation|0|||
162189784|NCT01686152|585747797|FG000|Overall Study|Adverse Event|12|||
162189785|NCT01686152|585747798|FG001|Overall Study|Adverse Event|11|||
162189786|NCT01686152|585747799|FG002|Overall Study|Adverse Event|0|||
162189787|NCT01686152|585747797|FG000|Overall Study|Lack of Efficacy|0|||
162189788|NCT01686152|585747798|FG001|Overall Study|Lack of Efficacy|0|||
162189789|NCT01686152|585747799|FG002|Overall Study|Lack of Efficacy|1|||
162189790|NCT01686152|585747797|FG000|Overall Study|IP Non-compliance|5|||
162189791|NCT01686152|585747798|FG001|Overall Study|IP Non-compliance|5|||
162189792|NCT01686152|585747799|FG002|Overall Study|IP Non-compliance|0|||
162189793|NCT01686152|585747797|FG000|Overall Study|Lost to Follow-up|7|||
162189794|NCT01686152|585747798|FG001|Overall Study|Lost to Follow-up|6|||
162189795|NCT01686152|585747799|FG002|Overall Study|Lost to Follow-up|5|||
162189796|NCT01802333|585747800|FG000|Overall Study|Ineligible|2|||
162189797|NCT01802333|585747801|FG001|Overall Study|Ineligible|6|||
162189798|NCT01802333|585747802|FG002|Overall Study|Ineligible|8|||
162189799|NCT01802333|585747800|FG000|Overall Study|Adverse Event|1|||
162189800|NCT01802333|585747801|FG001|Overall Study|Adverse Event|8|||
162189801|NCT01802333|585747802|FG002|Overall Study|Adverse Event|8|||
162189802|NCT01802333|585747800|FG000|Overall Study|Withdrawal by Subject|6|||
162189803|NCT01802333|585747801|FG001|Overall Study|Withdrawal by Subject|6|||
162189804|NCT01802333|585747802|FG002|Overall Study|Withdrawal by Subject|5|||
162189805|NCT01802333|585747800|FG000|Overall Study|Progression/relapse|1|||
162189806|NCT01802333|585747801|FG001|Overall Study|Progression/relapse|3|||
162189807|NCT01802333|585747802|FG002|Overall Study|Progression/relapse|0|||
161819643|NCT05330975|584381121|FG005|Primary|Protocol Violation|3|||
162189808|NCT01802333|585747800|FG000|Overall Study|Death|7|||
162189809|NCT01802333|585747801|FG001|Overall Study|Death|14|||
162189810|NCT01802333|585747802|FG002|Overall Study|Death|13|||
162189811|NCT01802333|585747800|FG000|Overall Study|Other - not protocol specified|32|||
161819644|NCT05330975|584381122|FG006|Primary|Protocol Violation|0|||
162189812|NCT01802333|585747801|FG001|Overall Study|Other - not protocol specified|22|||
162189813|NCT01802333|585747802|FG002|Overall Study|Other - not protocol specified|24|||
162189814|NCT01802333|585747800|FG000|Overall Study|Did not start treatment|0|||
162189815|NCT01802333|585747801|FG001|Overall Study|Did not start treatment|2|||
162189816|NCT01802333|585747802|FG002|Overall Study|Did not start treatment|5|||
162189817|NCT01947491|585747806|FG000|Overall Study|Lost to Follow-up|5|||
162189818|NCT01947491|585747807|FG001|Overall Study|Lost to Follow-up|3|||
162189819|NCT01947491|585747808|FG002|Overall Study|Lost to Follow-up|1|||
162189820|NCT01947491|585747809|FG003|Overall Study|Lost to Follow-up|2|||
162189821|NCT01947491|585747806|FG000|Overall Study|Lack of Efficacy|1|||
162189822|NCT01947491|585747807|FG001|Overall Study|Lack of Efficacy|0|||
162189823|NCT01947491|585747808|FG002|Overall Study|Lack of Efficacy|0|||
162189824|NCT01947491|585747809|FG003|Overall Study|Lack of Efficacy|1|||
162189825|NCT01947491|585747806|FG000|Overall Study|Protocol Violation|1|||
162189826|NCT01947491|585747807|FG001|Overall Study|Protocol Violation|0|||
162189827|NCT01947491|585747808|FG002|Overall Study|Protocol Violation|0|||
162189828|NCT01947491|585747809|FG003|Overall Study|Protocol Violation|0|||
162189829|NCT01947491|585747806|FG000|Overall Study|Withdrawal by Subject|1|||
162189830|NCT01947491|585747807|FG001|Overall Study|Withdrawal by Subject|1|||
162189831|NCT01947491|585747808|FG002|Overall Study|Withdrawal by Subject|1|||
162189832|NCT01947491|585747809|FG003|Overall Study|Withdrawal by Subject|0|||
162189833|NCT01947491|585747806|FG000|Overall Study|Worsening of condition|0|||
162189834|NCT01947491|585747807|FG001|Overall Study|Worsening of condition|1|||
162189835|NCT01947491|585747808|FG002|Overall Study|Worsening of condition|0|||
162189836|NCT01947491|585747809|FG003|Overall Study|Worsening of condition|0|||
162189837|NCT01947491|585747806|FG000|Overall Study|Adverse Event|0|||
162189838|NCT01947491|585747807|FG001|Overall Study|Adverse Event|1|||
162189839|NCT01947491|585747808|FG002|Overall Study|Adverse Event|0|||
162189840|NCT01947491|585747809|FG003|Overall Study|Adverse Event|2|||
162189841|NCT02224755|585747810|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
162189842|NCT02224755|585747811|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
162189843|NCT02224755|585747810|FG000|Two Year Follow up Post-implant|Death|103|||
162189844|NCT02224755|585747811|FG001|Two Year Follow up Post-implant|Death|98|||
162189845|NCT02224755|585747810|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
162189846|NCT02224755|585747811|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
162189847|NCT02224755|585747810|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
162189848|NCT02224755|585747811|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
162189849|NCT02224755|585747810|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
162189850|NCT02224755|585747811|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
162189851|NCT02067663|585747812|FG000|Overall Study|Lost to Follow-up|13|||
162189852|NCT02067663|585747813|FG001|Overall Study|Lost to Follow-up|14|||
162189853|NCT04311983|585747814|FG000|Overall Study|Lost to Follow-up|421|||
162189854|NCT04311983|585747815|FG001|Overall Study|Lost to Follow-up|456|||
162189855|NCT04311983|585747814|FG000|Overall Study|Incomplete survey|7|||
162189856|NCT04311983|585747815|FG001|Overall Study|Incomplete survey|9|||
162189857|NCT04311983|585747814|FG000|Overall Study|Death|1|||
162189858|NCT04311983|585747815|FG001|Overall Study|Death|0|||
162189859|NCT04070105|585747818|FG000|Overall Study|Lost to Follow-up|0|||
162189860|NCT04070105|585747819|FG001|Overall Study|Lost to Follow-up|0|||
162189861|NCT04070105|585747820|FG002|Overall Study|Lost to Follow-up|0|||
162189862|NCT04070105|585747821|FG003|Overall Study|Lost to Follow-up|0|||
162189863|NCT04070105|585747822|FG004|Overall Study|Lost to Follow-up|0|||
162189864|NCT04070105|585747823|FG005|Overall Study|Lost to Follow-up|1|||
162189865|NCT01768572|585747824|FG000|Overall Study|Adverse Event|7|||
162189866|NCT01768572|585747825|FG001|Overall Study|Adverse Event|8|||
162189867|NCT01768572|585747826|FG002|Overall Study|Adverse Event|4|||
162189868|NCT01768572|585747824|FG000|Overall Study|Lack of Efficacy|1|||
162189869|NCT01768572|585747825|FG001|Overall Study|Lack of Efficacy|3|||
162189870|NCT01768572|585747826|FG002|Overall Study|Lack of Efficacy|1|||
162189871|NCT01768572|585747824|FG000|Overall Study|Other, Not due to an adverse event|1|||
162189872|NCT01768572|585747825|FG001|Overall Study|Other, Not due to an adverse event|1|||
162189873|NCT01768572|585747826|FG002|Overall Study|Other, Not due to an adverse event|1|||
162189874|NCT03265132|585747837|FG000|Overall Study|Adverse Event|0|||
162189875|NCT03265132|585747838|FG001|Overall Study|Adverse Event|1|||
162189876|NCT03265132|585747837|FG000|Overall Study|Lack of Efficacy|0|||
162189877|NCT03265132|585747838|FG001|Overall Study|Lack of Efficacy|2|||
162189878|NCT03265132|585747837|FG000|Overall Study|Progressive disease|0|||
162189879|NCT03265132|585747838|FG001|Overall Study|Progressive disease|2|||
162189880|NCT03265132|585747837|FG000|Overall Study|Withdrawal by Subject|0|||
162189881|NCT03265132|585747838|FG001|Overall Study|Withdrawal by Subject|1|||
162189882|NCT03259568|585747844|FG000|Overall Study|Participant performance was low|3|||
162189883|NCT00089791|585747845|FG000|Overall Study|Physician Decision|6|||
162189884|NCT00089791|585747846|FG001|Overall Study|Physician Decision|3|||
162189885|NCT00089791|585747845|FG000|Overall Study|Adverse Event|81|||
161819645|NCT05330975|584381116|FG000|Primary|Death|0|||
161819646|NCT05330975|584381117|FG001|Primary|Death|3|||
162189886|NCT00089791|585747846|FG001|Overall Study|Adverse Event|93|||
162189887|NCT00089791|585747845|FG000|Overall Study|Withdrawal by Subject|403|||
162189888|NCT00089791|585747846|FG001|Overall Study|Withdrawal by Subject|344|||
162189889|NCT00089791|585747845|FG000|Overall Study|Death|78|||
162189890|NCT00089791|585747846|FG001|Overall Study|Death|62|||
162189891|NCT00089791|585747845|FG000|Overall Study|Disease progression|7|||
162189892|NCT00089791|585747846|FG001|Overall Study|Disease progression|3|||
162189893|NCT00089791|585747845|FG000|Overall Study|Ineligibility determined|12|||
162189894|NCT00089791|585747846|FG001|Overall Study|Ineligibility determined|9|||
162189895|NCT00089791|585747845|FG000|Overall Study|Lost to Follow-up|57|||
162189896|NCT00089791|585747846|FG001|Overall Study|Lost to Follow-up|57|||
162189897|NCT00089791|585747845|FG000|Overall Study|Noncompliance|17|||
162189898|NCT00089791|585747846|FG001|Overall Study|Noncompliance|13|||
161673728|NCT01205438|583859885|FG000|Overall Study|Lack of Efficacy|14|||
162189899|NCT00089791|585747845|FG000|Overall Study|Other|20|||
162189900|NCT00089791|585747846|FG001|Overall Study|Other|32|||
162189901|NCT00089791|585747845|FG000|Overall Study|Protocol deviation|12|||
162189902|NCT00089791|585747846|FG001|Overall Study|Protocol deviation|10|||
162189903|NCT00089791|585747845|FG000|Overall Study|Requirement for alternative therapy|7|||
162189904|NCT00089791|585747846|FG001|Overall Study|Requirement for alternative therapy|4|||
162189905|NCT02161458|585747847|FG000|Overall Study|Withdrawal by Subject|0|||
162189906|NCT02161458|585747848|FG001|Overall Study|Withdrawal by Subject|4|||
162189907|NCT02161458|585747849|FG002|Overall Study|Withdrawal by Subject|4|||
162189908|NCT02161458|585747850|FG003|Overall Study|Withdrawal by Subject|0|||
162189909|NCT02161458|585747847|FG000|Overall Study|Lost to Follow-up|0|||
162189910|NCT02161458|585747848|FG001|Overall Study|Lost to Follow-up|2|||
161819647|NCT05330975|584381118|FG002|Primary|Death|1|||
161819648|NCT05330975|584381119|FG003|Primary|Death|1|||
161819649|NCT05330975|584381120|FG004|Primary|Death|0|||
161819650|NCT05330975|584381121|FG005|Primary|Death|0|||
161819651|NCT05330975|584381122|FG006|Primary|Death|0|||
161819652|NCT05330975|584381116|FG000|Primary|Other Than Specified|0|||
161819653|NCT05330975|584381117|FG001|Primary|Other Than Specified|1|||
161819654|NCT05330975|584381118|FG002|Primary|Other Than Specified|2|||
161819655|NCT05330975|584381119|FG003|Primary|Other Than Specified|1|||
161819656|NCT05330975|584381120|FG004|Primary|Other Than Specified|2|||
161819657|NCT05330975|584381121|FG005|Primary|Other Than Specified|2|||
161819658|NCT05330975|584381122|FG006|Primary|Other Than Specified|0|||
161819659|NCT05330975|584381116|FG000|Primary|Adverse Event|0|||
161819660|NCT05330975|584381117|FG001|Primary|Adverse Event|0|||
161819661|NCT05330975|584381118|FG002|Primary|Adverse Event|0|||
161819662|NCT05330975|584381119|FG003|Primary|Adverse Event|1|||
161819663|NCT05330975|584381120|FG004|Primary|Adverse Event|0|||
161819664|NCT05330975|584381121|FG005|Primary|Adverse Event|0|||
161819665|NCT05330975|584381122|FG006|Primary|Adverse Event|0|||
161819666|NCT05330975|584381116|FG000|Primary|Physician Decision|0|||
161819667|NCT05330975|584381117|FG001|Primary|Physician Decision|0|||
162019988|NCT02283762|585128545|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
161819668|NCT05330975|584381118|FG002|Primary|Physician Decision|0|||
162019989|NCT02283762|585128544|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
162019990|NCT02283762|585128545|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
162019991|NCT02283762|585128544|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
162019992|NCT02283762|585128545|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
162019993|NCT02283762|585128544|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
162019994|NCT02283762|585128545|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
162019995|NCT02283762|585128544|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
162019996|NCT02283762|585128545|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
162019997|NCT00202878|585128549|FG000|Overall Study|Death|964|||
162019998|NCT00202878|585128550|FG001|Overall Study|Death|968|||
162019999|NCT00202878|585128549|FG000|Overall Study|Only Vital Status Known|357|||
162020000|NCT00202878|585128550|FG001|Overall Study|Only Vital Status Known|356|||
162020001|NCT00202878|585128549|FG000|Overall Study|Lost to Follow-up|44|||
162020002|NCT00202878|585128550|FG001|Overall Study|Lost to Follow-up|49|||
162020003|NCT00202878|585128549|FG000|Overall Study|Site Closure|39|||
162020004|NCT00202878|585128550|FG001|Overall Study|Site Closure|36|||
162020005|NCT00202878|585128549|FG000|Overall Study|Withdrawal by Subject|795|||
162020006|NCT00202878|585128550|FG001|Overall Study|Withdrawal by Subject|808|||
162020007|NCT02123472|585128551|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
162020008|NCT02123472|585128552|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
162020009|NCT00918736|585128553|FG000|Overall Study|Withdrawal by Subject|4|||
162020010|NCT00838513|585128554|FG000|Screening Period|Screen Failure|3|||
162189911|NCT02161458|585747849|FG002|Overall Study|Lost to Follow-up|1|||
162189912|NCT02161458|585747850|FG003|Overall Study|Lost to Follow-up|0|||
162189913|NCT05074433|585747860|FG000|Overall Study|Adverse Event|0|||
162189914|NCT05074433|585747861|FG001|Overall Study|Adverse Event|2|||
162189915|NCT05074433|585747862|FG002|Overall Study|Adverse Event|0|||
162189916|NCT05074433|585747863|FG003|Overall Study|Adverse Event|1|||
162189917|NCT05074433|585747860|FG000|Overall Study|Sponsor Request|0|||
162189918|NCT05074433|585747861|FG001|Overall Study|Sponsor Request|1|||
162189919|NCT05074433|585747862|FG002|Overall Study|Sponsor Request|1|||
162189920|NCT05074433|585747863|FG003|Overall Study|Sponsor Request|0|||
162189921|NCT05074433|585747860|FG000|Overall Study|Death|1|||
162189922|NCT05074433|585747861|FG001|Overall Study|Death|0|||
162189923|NCT05074433|585747862|FG002|Overall Study|Death|0|||
162189924|NCT05074433|585747863|FG003|Overall Study|Death|0|||
162189925|NCT05074433|585747860|FG000|Overall Study|Lost to Follow-up|0|||
162189926|NCT05074433|585747861|FG001|Overall Study|Lost to Follow-up|0|||
162189927|NCT05074433|585747862|FG002|Overall Study|Lost to Follow-up|2|||
162189928|NCT05074433|585747863|FG003|Overall Study|Lost to Follow-up|0|||
162189929|NCT05074433|585747860|FG000|Overall Study|Subject Decision|8|||
162189930|NCT05074433|585747861|FG001|Overall Study|Subject Decision|6|||
162189931|NCT05074433|585747862|FG002|Overall Study|Subject Decision|4|||
162189932|NCT05074433|585747863|FG003|Overall Study|Subject Decision|5|||
162189933|NCT04397263|585747864|FG000|Overall Study|Withdrawal by Subject|2|||
162189934|NCT02251652|585747865|FG000|Overall Study|Withdrawal by Subject|1|||
161673729|NCT01205438|583859886|FG001|Overall Study|Lack of Efficacy|11|||
161673730|NCT01205438|583859887|FG002|Overall Study|Lack of Efficacy|14|||
161673731|NCT01205438|583859885|FG000|Overall Study|Lost to Follow-up|6|||
161673732|NCT01205438|583859886|FG001|Overall Study|Lost to Follow-up|7|||
161673733|NCT01205438|583859887|FG002|Overall Study|Lost to Follow-up|8|||
161673734|NCT01205438|583859885|FG000|Overall Study|Withdrawal by Subject|19|||
161673735|NCT01205438|583859886|FG001|Overall Study|Withdrawal by Subject|25|||
161673736|NCT01205438|583859887|FG002|Overall Study|Withdrawal by Subject|19|||
161673737|NCT01205438|583859885|FG000|Overall Study|Physician Decision|0|||
161673738|NCT01205438|583859886|FG001|Overall Study|Physician Decision|3|||
161673739|NCT01205438|583859887|FG002|Overall Study|Physician Decision|2|||
162189935|NCT01989689|585747866|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
162189936|NCT01989689|585747867|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
162189937|NCT01989689|585747866|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
162189938|NCT01989689|585747867|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
162189939|NCT04492475|585747868|FG000|Overall Study|Enrolled but not treated|8|||
162189940|NCT04492475|585747869|FG001|Overall Study|Enrolled but not treated|8|||
162189941|NCT04492475|585747868|FG000|Overall Study|Withdrawal by Subject|4|||
162189942|NCT04492475|585747869|FG001|Overall Study|Withdrawal by Subject|0|||
162189943|NCT04492475|585747868|FG000|Overall Study|Became ineligible after enrollment|2|||
162189944|NCT04492475|585747869|FG001|Overall Study|Became ineligible after enrollment|0|||
162189945|NCT02066636|585747870|FG000|Overall Study|Disease progression|51|||
162189946|NCT02066636|585747871|FG001|Overall Study|Disease progression|60|||
162189947|NCT02066636|585747872|FG002|Overall Study|Disease progression|700|||
162189948|NCT02066636|585747870|FG000|Overall Study|Study drug toxicity|13|||
162189949|NCT02066636|585747871|FG001|Overall Study|Study drug toxicity|2|||
162189950|NCT02066636|585747872|FG002|Overall Study|Study drug toxicity|58|||
162189951|NCT02066636|585747870|FG000|Overall Study|Death|4|||
162189952|NCT02066636|585747871|FG001|Overall Study|Death|2|||
162189953|NCT02066636|585747872|FG002|Overall Study|Death|158|||
162189954|NCT02066636|585747870|FG000|Overall Study|Adverse event unrelated to study drug|6|||
162189955|NCT02066636|585747871|FG001|Overall Study|Adverse event unrelated to study drug|4|||
162189956|NCT02066636|585747872|FG002|Overall Study|Adverse event unrelated to study drug|45|||
162189957|NCT02066636|585747870|FG000|Overall Study|Participant request to discontinue treatment|12|||
162189958|NCT02066636|585747871|FG001|Overall Study|Participant request to discontinue treatment|12|||
162189959|NCT02066636|585747872|FG002|Overall Study|Participant request to discontinue treatment|70|||
162189960|NCT02066636|585747870|FG000|Overall Study|Participant withdrew consent|10|||
162189961|NCT02066636|585747871|FG001|Overall Study|Participant withdrew consent|18|||
162189962|NCT02066636|585747872|FG002|Overall Study|Participant withdrew consent|61|||
162189963|NCT02066636|585747870|FG000|Overall Study|Lost to Follow-up|0|||
162189964|NCT02066636|585747871|FG001|Overall Study|Lost to Follow-up|2|||
162189965|NCT02066636|585747872|FG002|Overall Study|Lost to Follow-up|2|||
162189966|NCT02066636|585747870|FG000|Overall Study|Maximum clinical benefit|2|||
162189967|NCT02066636|585747871|FG001|Overall Study|Maximum clinical benefit|2|||
162189968|NCT02066636|585747872|FG002|Overall Study|Maximum clinical benefit|3|||
162189969|NCT02066636|585747870|FG000|Overall Study|Poor/non-compliance|2|||
162189970|NCT02066636|585747871|FG001|Overall Study|Poor/non-compliance|1|||
162189971|NCT02066636|585747872|FG002|Overall Study|Poor/non-compliance|1|||
162189972|NCT02066636|585747870|FG000|Overall Study|Participant no loner meets study criteria|3|||
162189973|NCT02066636|585747871|FG001|Overall Study|Participant no loner meets study criteria|2|||
162189974|NCT02066636|585747872|FG002|Overall Study|Participant no loner meets study criteria|28|||
162189975|NCT02066636|585747870|FG000|Overall Study|Administrative reasons by sponsor|8|||
162189976|NCT02066636|585747871|FG001|Overall Study|Administrative reasons by sponsor|5|||
162189977|NCT02066636|585747872|FG002|Overall Study|Administrative reasons by sponsor|0|||
162189978|NCT02066636|585747870|FG000|Overall Study|Other reasons|16|||
162189979|NCT02066636|585747871|FG001|Overall Study|Other reasons|15|||
162189980|NCT02066636|585747872|FG002|Overall Study|Other reasons|50|||
162189981|NCT00391170|585747879|FG000|Overall Study|Withdrawal by Subject|1|||
161673740|NCT01205438|583859885|FG000|Overall Study|Protocol Violation|2|||
161673741|NCT01205438|583859886|FG001|Overall Study|Protocol Violation|7|||
161673742|NCT01205438|583859887|FG002|Overall Study|Protocol Violation|4|||
161819669|NCT05330975|584381119|FG003|Primary|Physician Decision|0|||
161819670|NCT05330975|584381120|FG004|Primary|Physician Decision|1|||
162189982|NCT00391170|585747880|FG001|Overall Study|Withdrawal by Subject|0|||
162189983|NCT00391170|585747879|FG000|Overall Study|Adverse Event|3|||
162189984|NCT00391170|585747880|FG001|Overall Study|Adverse Event|2|||
162189985|NCT00391170|585747879|FG000|Overall Study|Physician Decision|2|||
162189986|NCT00391170|585747880|FG001|Overall Study|Physician Decision|2|||
162189987|NCT03567616|585747885|FG000|Overall Study|Disease progression|4|||
162189988|NCT03567616|585747885|FG000|Overall Study|Withdrawal by Subject|1|||
162189989|NCT03567616|585747885|FG000|Overall Study|Physician Decision|1|||
162189990|NCT03567616|585747885|FG000|Overall Study|Death|1|||
161673743|NCT01205438|583859885|FG000|Overall Study|Sponsor Decision|0|||
162189991|NCT03567616|585747885|FG000|Overall Study|Adverse Event|1|||
162189992|NCT03035942|585747887|FG000|Overall Study|Adverse Event|8|||
162189993|NCT03035942|585747888|FG001|Overall Study|Adverse Event|4|||
162189994|NCT03035942|585747889|FG002|Overall Study|Adverse Event|5|||
162189995|NCT01989104|585747890|FG000|Overall Study|Withdrawal by Subject|3|||
162189996|NCT01989104|585747891|FG001|Overall Study|Withdrawal by Subject|0|||
162189997|NCT01989104|585747892|FG002|Overall Study|Withdrawal by Subject|0|||
162189998|NCT01989104|585747893|FG003|Overall Study|Withdrawal by Subject|0|||
162189999|NCT01989104|585747894|FG004|Overall Study|Withdrawal by Subject|0|||
162190000|NCT02833948|585747895|FG000|Overall Study|Death|2|||
162190001|NCT02833948|585747896|FG001|Overall Study|Death|3|||
162190002|NCT02833948|585747895|FG000|Overall Study|were not scanned|8|||
162190003|NCT02833948|585747896|FG001|Overall Study|were not scanned|13|||
162190004|NCT02833948|585747895|FG000|Overall Study|scans could not be evaluated|5|||
162190005|NCT02833948|585747896|FG001|Overall Study|scans could not be evaluated|2|||
162190006|NCT00680771|585747899|FG000|Overall Study|Withdrawal by Subject|1|||
162190007|NCT00680771|585747900|FG001|Overall Study|Withdrawal by Subject|0|||
162190008|NCT00680771|585747899|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
162190009|NCT00680771|585747900|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
162190010|NCT00680771|585747899|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
162190011|NCT00680771|585747900|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
162190012|NCT02691702|585747901|FG000|Overall Study|Adverse Event|1|||
162190013|NCT02691702|585747902|FG001|Overall Study|Adverse Event|0|||
162190014|NCT02691702|585747903|FG002|Overall Study|Adverse Event|0|||
162190015|NCT02691702|585747904|FG003|Overall Study|Adverse Event|0|||
162190016|NCT02691702|585747905|FG004|Overall Study|Adverse Event|0|||
162190017|NCT02691702|585747906|FG005|Overall Study|Adverse Event|0|||
162190018|NCT02691702|585747907|FG006|Overall Study|Adverse Event|0|||
162190019|NCT02691702|585747908|FG007|Overall Study|Adverse Event|0|||
162190020|NCT02691702|585747909|FG008|Overall Study|Adverse Event|1|||
162190021|NCT02691702|585747910|FG009|Overall Study|Adverse Event|0|||
162190022|NCT02691702|585747911|FG010|Overall Study|Adverse Event|1|||
162190023|NCT02691702|585747901|FG000|Overall Study|Lost to Follow-up|0|||
162190024|NCT02691702|585747902|FG001|Overall Study|Lost to Follow-up|0|||
162190025|NCT02691702|585747903|FG002|Overall Study|Lost to Follow-up|1|||
162190026|NCT02691702|585747904|FG003|Overall Study|Lost to Follow-up|0|||
162190027|NCT02691702|585747905|FG004|Overall Study|Lost to Follow-up|0|||
162190028|NCT02691702|585747906|FG005|Overall Study|Lost to Follow-up|2|||
162190029|NCT02691702|585747907|FG006|Overall Study|Lost to Follow-up|0|||
162190030|NCT02691702|585747908|FG007|Overall Study|Lost to Follow-up|0|||
162190031|NCT02691702|585747909|FG008|Overall Study|Lost to Follow-up|0|||
162190032|NCT02691702|585747910|FG009|Overall Study|Lost to Follow-up|0|||
162190033|NCT02691702|585747911|FG010|Overall Study|Lost to Follow-up|1|||
162190034|NCT02691702|585747901|FG000|Overall Study|Withdrawal by Subject|1|||
162190035|NCT02691702|585747902|FG001|Overall Study|Withdrawal by Subject|1|||
162190036|NCT02691702|585747903|FG002|Overall Study|Withdrawal by Subject|0|||
162190037|NCT02691702|585747904|FG003|Overall Study|Withdrawal by Subject|0|||
162190038|NCT02691702|585747905|FG004|Overall Study|Withdrawal by Subject|0|||
162190039|NCT02691702|585747906|FG005|Overall Study|Withdrawal by Subject|1|||
162190040|NCT02691702|585747907|FG006|Overall Study|Withdrawal by Subject|2|||
162190041|NCT02691702|585747908|FG007|Overall Study|Withdrawal by Subject|0|||
162190042|NCT02691702|585747909|FG008|Overall Study|Withdrawal by Subject|0|||
162190043|NCT02691702|585747910|FG009|Overall Study|Withdrawal by Subject|0|||
162190044|NCT02691702|585747911|FG010|Overall Study|Withdrawal by Subject|0|||
161819671|NCT05330975|584381121|FG005|Primary|Physician Decision|0|||
161819672|NCT05330975|584381122|FG006|Primary|Physician Decision|0|||
161819673|NCT05330975|584381116|FG000|Revaccination|Adverse Event|0|||
161819674|NCT05330975|584381117|FG001|Revaccination|Adverse Event|0|||
161819675|NCT05330975|584381118|FG002|Revaccination|Adverse Event|0|||
161819676|NCT05330975|584381119|FG003|Revaccination|Adverse Event|0|||
161819677|NCT05330975|584381120|FG004|Revaccination|Adverse Event|0|||
162190045|NCT02691702|585747901|FG000|Overall Study|Other|0|||
161819678|NCT05330975|584381121|FG005|Revaccination|Adverse Event|0|||
162020011|NCT00838513|585128554|FG000|Extension Treatment Period|Death|1|||
162190046|NCT02691702|585747902|FG001|Overall Study|Other|0|||
162190047|NCT02691702|585747903|FG002|Overall Study|Other|0|||
162190048|NCT02691702|585747904|FG003|Overall Study|Other|0|||
162190049|NCT02691702|585747905|FG004|Overall Study|Other|0|||
162190050|NCT02691702|585747906|FG005|Overall Study|Other|0|||
162190051|NCT02691702|585747907|FG006|Overall Study|Other|1|||
162190052|NCT02691702|585747908|FG007|Overall Study|Other|0|||
162190053|NCT02691702|585747909|FG008|Overall Study|Other|1|||
162190054|NCT02691702|585747910|FG009|Overall Study|Other|0|||
162190055|NCT02691702|585747911|FG010|Overall Study|Other|0|||
162190056|NCT02691702|585747901|FG000|Overall Study|Protocol Violation|0|||
162190057|NCT02691702|585747902|FG001|Overall Study|Protocol Violation|0|||
162190058|NCT02691702|585747903|FG002|Overall Study|Protocol Violation|0|||
162190059|NCT02691702|585747904|FG003|Overall Study|Protocol Violation|0|||
162190060|NCT02691702|585747905|FG004|Overall Study|Protocol Violation|0|||
162190061|NCT02691702|585747906|FG005|Overall Study|Protocol Violation|0|||
162190062|NCT02691702|585747907|FG006|Overall Study|Protocol Violation|0|||
162190063|NCT02691702|585747908|FG007|Overall Study|Protocol Violation|0|||
162190064|NCT02691702|585747909|FG008|Overall Study|Protocol Violation|0|||
162190065|NCT02691702|585747910|FG009|Overall Study|Protocol Violation|2|||
162190066|NCT02691702|585747911|FG010|Overall Study|Protocol Violation|0|||
162190067|NCT05613088|585747912|FG000|Treatment|Ongoing Study Treatment|9|||
162190068|NCT05613088|585747913|FG001|Treatment|Ongoing Study Treatment|2|||
162190069|NCT05613088|585747912|FG000|Treatment|Adverse Event|3|||
162190070|NCT05613088|585747913|FG001|Treatment|Adverse Event|1|||
162190071|NCT05613088|585747912|FG000|Treatment|Other Reasons|0|||
162190072|NCT05613088|585747913|FG001|Treatment|Other Reasons|1|||
162190073|NCT05613088|585747912|FG000|Treatment|Progressive Disease|58|||
162190074|NCT05613088|585747913|FG001|Treatment|Progressive Disease|26|||
162190075|NCT05613088|585747912|FG000|Treatment|Withdrawal by Subject|0|||
162190076|NCT05613088|585747913|FG001|Treatment|Withdrawal by Subject|4|||
162190077|NCT05163353|585747916|FG000|Overall Study|Adverse Event|1|||
162190078|NCT05163353|585747917|FG001|Overall Study|Adverse Event|0|||
162190079|NCT05163353|585747916|FG000|Overall Study|Withdrawal by Subject|21|||
162190080|NCT05163353|585747917|FG001|Overall Study|Withdrawal by Subject|6|||
162190081|NCT05163353|585747916|FG000|Overall Study|Protocol Violation|0|||
162190082|NCT05163353|585747917|FG001|Overall Study|Protocol Violation|1|||
161925628|NCT05537571|584773251|FG001|Overall Study|Hepatitis A screening result|0|||
161925629|NCT05537571|584773252|FG002|Overall Study|Hepatitis A screening result|0|||
161925630|NCT05537571|584773253|FG003|Overall Study|Hepatitis A screening result|0|||
161925631|NCT05537571|584773254|FG004|Overall Study|Hepatitis A screening result|0|||
161925632|NCT05537571|584773250|FG000|Overall Study|Lost to Follow-up|0|||
161925633|NCT05537571|584773251|FG001|Overall Study|Lost to Follow-up|0|||
161925634|NCT05537571|584773252|FG002|Overall Study|Lost to Follow-up|1|||
161925635|NCT05537571|584773253|FG003|Overall Study|Lost to Follow-up|0|||
161925636|NCT05537571|584773254|FG004|Overall Study|Lost to Follow-up|1|||
161925637|NCT00424008|584773255|FG000|Overall Study|Adverse Event|8|||
161925638|NCT00424008|584773256|FG001|Overall Study|Adverse Event|6|||
161925639|NCT00424008|584773255|FG000|Overall Study|Lack of Efficacy|40|||
161925640|NCT00424008|584773256|FG001|Overall Study|Lack of Efficacy|34|||
161925641|NCT00424008|584773255|FG000|Overall Study|Lost to Follow-up|1|||
161925642|NCT00424008|584773256|FG001|Overall Study|Lost to Follow-up|2|||
161925643|NCT00424008|584773255|FG000|Overall Study|Withdrawal by Subject|5|||
161925644|NCT00424008|584773256|FG001|Overall Study|Withdrawal by Subject|8|||
161925645|NCT00424008|584773255|FG000|Overall Study|Noncompliance with protocol|13|||
161925646|NCT00424008|584773256|FG001|Overall Study|Noncompliance with protocol|7|||
161925647|NCT00424008|584773255|FG000|Overall Study|Did not meet protocol eligibility|16|||
162190083|NCT05163353|585747916|FG000|Overall Study|Lost to Follow-up|13|||
162190084|NCT05163353|585747917|FG001|Overall Study|Lost to Follow-up|2|||
162190085|NCT06086028|585747919|FG000|Overall Study|Withdrawal by Subject|1|||
162190086|NCT06086028|585747920|FG001|Overall Study|Withdrawal by Subject|1|||
162190087|NCT06086028|585747919|FG000|Overall Study|Lost to Follow-up|2|||
162190088|NCT06086028|585747920|FG001|Overall Study|Lost to Follow-up|3|||
162190089|NCT00824408|585747921|FG000|Run-in Phase|Progressive disease|4|||
162190090|NCT00824408|585747922|FG001|Run-in Phase|Progressive disease|4|||
162190091|NCT00824408|585747923|FG002|Run-in Phase|Progressive disease|0|||
162190092|NCT00824408|585747924|FG003|Run-in Phase|Progressive disease|0|||
162190093|NCT00824408|585747925|FG004|Run-in Phase|Progressive disease|0|||
162190094|NCT00824408|585747921|FG000|Run-in Phase|Adverse Event|1|||
162190095|NCT00824408|585747922|FG001|Run-in Phase|Adverse Event|1|||
162190096|NCT00824408|585747923|FG002|Run-in Phase|Adverse Event|0|||
162190097|NCT00824408|585747924|FG003|Run-in Phase|Adverse Event|0|||
162190098|NCT00824408|585747925|FG004|Run-in Phase|Adverse Event|0|||
162190099|NCT00824408|585747921|FG000|Run-in Phase|Refused to continue medication|1|||
162190100|NCT00824408|585747922|FG001|Run-in Phase|Refused to continue medication|0|||
161673744|NCT01205438|583859886|FG001|Overall Study|Sponsor Decision|1|||
161673745|NCT01205438|583859887|FG002|Overall Study|Sponsor Decision|1|||
161673746|NCT00733304|583859891|FG000|Overall Study|Adverse Event|3|||
161673747|NCT00733304|583859892|FG001|Overall Study|Adverse Event|0|||
161673748|NCT00733304|583859893|FG002|Overall Study|Adverse Event|0|||
161673749|NCT00733304|583859891|FG000|Overall Study|Lack of Efficacy|0|||
161673750|NCT00733304|583859892|FG001|Overall Study|Lack of Efficacy|0|||
161673751|NCT00733304|583859893|FG002|Overall Study|Lack of Efficacy|2|||
161673752|NCT00733304|583859891|FG000|Overall Study|Lost to Follow-up|0|||
161673753|NCT00733304|583859892|FG001|Overall Study|Lost to Follow-up|1|||
161673754|NCT00733304|583859893|FG002|Overall Study|Lost to Follow-up|0|||
161673755|NCT00733304|583859891|FG000|Overall Study|Physician Decision|3|||
162020012|NCT00838513|585128554|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
162020013|NCT00975780|585128563|FG000|Follow Up|Death|88|||
162020014|NCT00975780|585128564|FG001|Follow Up|Death|122|||
162020015|NCT00975780|585128563|FG000|Follow Up|Facility Withdrawal|7|||
162020016|NCT00975780|585128564|FG001|Follow Up|Facility Withdrawal|23|||
162020017|NCT00975780|585128563|FG000|Follow Up|Discharged from Facility|7|||
162020018|NCT00975780|585128564|FG001|Follow Up|Discharged from Facility|12|||
162020019|NCT03962504|585128565|FG000|Overall Study|Other|11|||
162020020|NCT03962504|585128566|FG001|Overall Study|Other|32|||
162020021|NCT02813577|585128567|FG000|Overall Study|Study terminated|4|||
162020022|NCT00035932|585128568|FG000|Overall Study|Adverse Event|10|||
162020023|NCT00035932|585128569|FG001|Overall Study|Adverse Event|9|||
162020024|NCT00035932|585128570|FG002|Overall Study|Adverse Event|9|||
162020025|NCT00035932|585128568|FG000|Overall Study|Death|0|||
162020026|NCT00035932|585128569|FG001|Overall Study|Death|0|||
162020027|NCT00035932|585128570|FG002|Overall Study|Death|1|||
162020028|NCT00035932|585128568|FG000|Overall Study|Disease Progression / Relapse|1|||
162020029|NCT00035932|585128569|FG001|Overall Study|Disease Progression / Relapse|1|||
162020030|NCT00035932|585128570|FG002|Overall Study|Disease Progression / Relapse|0|||
162020031|NCT00035932|585128568|FG000|Overall Study|Lost to Follow-up|4|||
162020032|NCT00035932|585128569|FG001|Overall Study|Lost to Follow-up|4|||
162020033|NCT00035932|585128570|FG002|Overall Study|Lost to Follow-up|3|||
162020034|NCT00035932|585128568|FG000|Overall Study|Noncompliance|6|||
162020035|NCT00035932|585128569|FG001|Overall Study|Noncompliance|7|||
162020036|NCT00035932|585128570|FG002|Overall Study|Noncompliance|6|||
162020037|NCT00035932|585128568|FG000|Overall Study|Protocol Violation While on Study|0|||
162020038|NCT00035932|585128569|FG001|Overall Study|Protocol Violation While on Study|1|||
162020039|NCT00035932|585128570|FG002|Overall Study|Protocol Violation While on Study|2|||
162020040|NCT00035932|585128568|FG000|Overall Study|Withdrawal by Subject|1|||
162020041|NCT00035932|585128569|FG001|Overall Study|Withdrawal by Subject|5|||
162020042|NCT00035932|585128570|FG002|Overall Study|Withdrawal by Subject|0|||
162020043|NCT00035932|585128568|FG000|Overall Study|Study Termination by Sponsor|1|||
162020044|NCT00035932|585128569|FG001|Overall Study|Study Termination by Sponsor|0|||
162190101|NCT00824408|585747923|FG002|Run-in Phase|Refused to continue medication|0|||
162190102|NCT00824408|585747924|FG003|Run-in Phase|Refused to continue medication|0|||
162190103|NCT00824408|585747925|FG004|Run-in Phase|Refused to continue medication|0|||
162190104|NCT00824408|585747921|FG000|Run-in Phase|Other reason not defined above|0|||
162190105|NCT00824408|585747922|FG001|Run-in Phase|Other reason not defined above|1|||
162190106|NCT00824408|585747923|FG002|Run-in Phase|Other reason not defined above|0|||
162190107|NCT00824408|585747924|FG003|Run-in Phase|Other reason not defined above|0|||
162190108|NCT00824408|585747925|FG004|Run-in Phase|Other reason not defined above|0|||
162190109|NCT00824408|585747921|FG000|Randomized Phase|Not treated|0|||
162190110|NCT00824408|585747922|FG001|Randomized Phase|Not treated|0|||
162190111|NCT00824408|585747923|FG002|Randomized Phase|Not treated|1|||
162190112|NCT00824408|585747924|FG003|Randomized Phase|Not treated|1|||
162190113|NCT00824408|585747925|FG004|Randomized Phase|Not treated|1|||
162190114|NCT00824408|585747921|FG000|Randomized Phase|Progressive disease|0|||
162190115|NCT00824408|585747922|FG001|Randomized Phase|Progressive disease|0|||
162190116|NCT00824408|585747923|FG002|Randomized Phase|Progressive disease|25|||
162190117|NCT00824408|585747924|FG003|Randomized Phase|Progressive disease|36|||
162190118|NCT00824408|585747925|FG004|Randomized Phase|Progressive disease|34|||
162190119|NCT00824408|585747921|FG000|Randomized Phase|Adverse Event|0|||
162190120|NCT00824408|585747922|FG001|Randomized Phase|Adverse Event|0|||
162190121|NCT00824408|585747923|FG002|Randomized Phase|Adverse Event|4|||
162190122|NCT00824408|585747924|FG003|Randomized Phase|Adverse Event|5|||
162190123|NCT00824408|585747925|FG004|Randomized Phase|Adverse Event|5|||
162020045|NCT00035932|585128570|FG002|Overall Study|Study Termination by Sponsor|0|||
162190124|NCT00824408|585747921|FG000|Randomized Phase|Refused to continue medication|0|||
162190125|NCT00824408|585747922|FG001|Randomized Phase|Refused to continue medication|0|||
162190126|NCT00824408|585747923|FG002|Randomized Phase|Refused to continue medication|2|||
162190127|NCT00824408|585747924|FG003|Randomized Phase|Refused to continue medication|2|||
162020046|NCT00035932|585128568|FG000|Overall Study|Lack of Efficacy|33|||
162020047|NCT00035932|585128569|FG001|Overall Study|Lack of Efficacy|33|||
161673756|NCT00733304|583859892|FG001|Overall Study|Physician Decision|1|||
161673757|NCT00733304|583859893|FG002|Overall Study|Physician Decision|3|||
162020048|NCT00035932|585128570|FG002|Overall Study|Lack of Efficacy|28|||
162190128|NCT00824408|585747925|FG004|Randomized Phase|Refused to continue medication|2|||
162190129|NCT00824408|585747921|FG000|Randomized Phase|Other reason not defined above|0|||
162190130|NCT00824408|585747922|FG001|Randomized Phase|Other reason not defined above|0|||
162190131|NCT00824408|585747923|FG002|Randomized Phase|Other reason not defined above|4|||
162190132|NCT00824408|585747924|FG003|Randomized Phase|Other reason not defined above|2|||
162190133|NCT00824408|585747925|FG004|Randomized Phase|Other reason not defined above|4|||
162190134|NCT01263496|585747931|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
162190135|NCT01263496|585747932|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162190136|NCT01263496|585747933|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162190137|NCT01263496|585747934|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162190138|NCT01263496|585747935|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162190139|NCT01263496|585747936|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162190140|NCT01263496|585747937|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162190141|NCT01263496|585747938|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162190142|NCT01263496|585747939|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
162190143|NCT01263496|585747931|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162190144|NCT01263496|585747932|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161673758|NCT00733304|583859891|FG000|Overall Study|Withdrawal by Subject|1|||
162190145|NCT01263496|585747933|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162190146|NCT01263496|585747934|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
162190147|NCT01263496|585747935|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
162190148|NCT01263496|585747936|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162190149|NCT01263496|585747937|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162190150|NCT01263496|585747938|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162190151|NCT01263496|585747939|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162190152|NCT01263496|585747931|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
162190153|NCT01263496|585747932|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
162190154|NCT01263496|585747933|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
162190155|NCT01263496|585747934|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
162190156|NCT01263496|585747935|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
162190157|NCT01263496|585747936|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
162190158|NCT01263496|585747937|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
162190159|NCT01263496|585747938|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
162190160|NCT01263496|585747939|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
162190161|NCT01263496|585747931|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162190162|NCT01263496|585747932|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
162190163|NCT01263496|585747933|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162190164|NCT01263496|585747934|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162190165|NCT01263496|585747935|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162190166|NCT01263496|585747936|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162190167|NCT01263496|585747937|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162190168|NCT01263496|585747938|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162190169|NCT01263496|585747939|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
162190170|NCT01263496|585747931|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
162190171|NCT01263496|585747932|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
162190172|NCT01263496|585747933|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
162190173|NCT01263496|585747934|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
162190174|NCT01263496|585747935|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
162190175|NCT01263496|585747936|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
162190176|NCT01263496|585747937|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
162190177|NCT01263496|585747938|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
162190178|NCT01263496|585747939|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
162190179|NCT01263496|585747931|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
162190180|NCT01263496|585747932|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
162190181|NCT01263496|585747933|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
162190182|NCT01263496|585747934|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
162190183|NCT01263496|585747935|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
162190184|NCT01263496|585747936|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
162190185|NCT01263496|585747937|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
162190186|NCT01263496|585747938|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
162190187|NCT01263496|585747939|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
162190188|NCT01263496|585747931|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162190189|NCT01263496|585747932|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162190190|NCT01263496|585747933|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161673759|NCT00733304|583859892|FG001|Overall Study|Withdrawal by Subject|1|||
161673760|NCT00733304|583859893|FG002|Overall Study|Withdrawal by Subject|0|||
161673761|NCT00528567|583859894|FG000|Overall Study|Death|4|||
161673762|NCT00528567|583859895|FG001|Overall Study|Death|5|||
161673763|NCT00528567|583859894|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
161673764|NCT00528567|583859895|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
161673765|NCT00528567|583859894|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
161673766|NCT00528567|583859895|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
161673767|NCT00528567|583859894|FG000|Overall Study|Violation Criteria at Entry|3|||
161673768|NCT00528567|583859895|FG001|Overall Study|Violation Criteria at Entry|17|||
161673769|NCT00528567|583859894|FG000|Overall Study|Withdrew Consent|59|||
161673770|NCT00528567|583859895|FG001|Overall Study|Withdrew Consent|55|||
161673771|NCT00528567|583859894|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
161673772|NCT00528567|583859895|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
161673773|NCT00528567|583859894|FG000|Overall Study|Failure to Return|1|||
161673774|NCT00528567|583859895|FG001|Overall Study|Failure to Return|4|||
161673775|NCT00528567|583859894|FG000|Overall Study|Other Protocol Violation|5|||
161673776|NCT00528567|583859895|FG001|Overall Study|Other Protocol Violation|21|||
161673777|NCT00528567|583859894|FG000|Overall Study|Administrative/Other|22|||
161673778|NCT00528567|583859895|FG001|Overall Study|Administrative/Other|75|||
161925648|NCT00424008|584773256|FG001|Overall Study|Did not meet protocol eligibility|21|||
161925649|NCT00424008|584773255|FG000|Overall Study|Administrative|266|||
161925650|NCT00424008|584773256|FG001|Overall Study|Administrative|257|||
161925651|NCT02530242|584773260|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
161925652|NCT02530242|584773261|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
161925653|NCT00283959|584773262|FG000|Extension Period|Low Compliance|1|||
161925654|NCT02665455|584773265|FG000|Overall Study|Withdrawal by Subject|6|||
161673779|NCT01122576|583859898|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
161673780|NCT01122576|583859899|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
161673781|NCT01122576|583859900|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
161673782|NCT01122576|583859898|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
161673783|NCT01122576|583859899|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
161673784|NCT01122576|583859900|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
162020049|NCT01976741|585128571|FG000|Overall Study|Withdrawal by Subject|1|||
162020050|NCT01976741|585128572|FG001|Overall Study|Withdrawal by Subject|0|||
162020051|NCT01976741|585128573|FG002|Overall Study|Withdrawal by Subject|1|||
162020052|NCT01976741|585128574|FG003|Overall Study|Withdrawal by Subject|1|||
162020053|NCT01976741|585128575|FG004|Overall Study|Withdrawal by Subject|0|||
162020054|NCT01976741|585128576|FG005|Overall Study|Withdrawal by Subject|0|||
162020055|NCT01976741|585128577|FG006|Overall Study|Withdrawal by Subject|1|||
162020056|NCT01976741|585128578|FG007|Overall Study|Withdrawal by Subject|4|||
162190191|NCT01263496|585747934|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161673785|NCT01122576|583859898|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
161925655|NCT02665455|584773265|FG000|Overall Study|Lost to Follow-up|1|||
161925656|NCT02665455|584773265|FG000|Overall Study|Adverse Event|1|||
161925657|NCT02665455|584773265|FG000|Overall Study|Protocol Violation|1|||
161925658|NCT06991803|584773266|FG000|Overall Study|Lost to Follow-up|0|||
161925659|NCT06991803|584773267|FG001|Overall Study|Lost to Follow-up|4|||
161925660|NCT06991803|584773268|FG002|Overall Study|Lost to Follow-up|0|||
161925661|NCT06991803|584773269|FG003|Overall Study|Lost to Follow-up|3|||
161925662|NCT06991803|584773270|FG004|Overall Study|Lost to Follow-up|2|||
161925663|NCT06991803|584773271|FG005|Overall Study|Lost to Follow-up|5|||
161925664|NCT05865886|584773272|FG000|Overall Study|Serious adverse event|0|||
161925665|NCT05865886|584773273|FG001|Overall Study|Serious adverse event|1|||
161925666|NCT01671059|584773274|FG000|Overall Study|Adverse Event|4|||
161925667|NCT01671059|584773274|FG000|Overall Study|Lack of Efficacy|1|||
161925668|NCT02564978|584773277|FG000|Overall Study|Adverse Event|8|||
161925669|NCT02564978|584773277|FG000|Overall Study|Death|1|||
161925670|NCT02564978|584773277|FG000|Overall Study|Lost to Follow-up|1|||
161925671|NCT02564978|584773277|FG000|Overall Study|Withdrawal by Subject|15|||
161925672|NCT02564978|584773277|FG000|Overall Study|Early Study Closure|2|||
161925673|NCT02564978|584773277|FG000|Overall Study|Other Reason|5|||
161925674|NCT04971837|584774565|FG000|Overall Study|Long Term Illness|1|||
161925675|NCT04971837|584774565|FG000|Overall Study|BMI too low|9|||
161925676|NCT04971837|584774565|FG000|Overall Study|geographic location|1|||
161925677|NCT04971837|584774565|FG000|Overall Study|Discontinued scheduling conflict|1|||
161925678|NCT03166631|584774566|FG000|Overall Study|Progressive disease|2|||
161925679|NCT03166631|584774567|FG001|Overall Study|Progressive disease|1|||
161925680|NCT03166631|584774568|FG002|Overall Study|Progressive disease|3|||
161925681|NCT03166631|584774569|FG003|Overall Study|Progressive disease|4|||
162020057|NCT01976741|585128579|FG008|Overall Study|Withdrawal by Subject|0|||
161673786|NCT01122576|583859899|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
161673787|NCT01122576|583859900|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
161925682|NCT03166631|584774570|FG004|Overall Study|Progressive disease|2|||
161925683|NCT03166631|584774571|FG005|Overall Study|Progressive disease|2|||
161925684|NCT03166631|584774572|FG006|Overall Study|Progressive disease|5|||
161925685|NCT03166631|584774573|FG007|Overall Study|Progressive disease|6|||
161925686|NCT03166631|584774574|FG008|Overall Study|Progressive disease|11|||
162190192|NCT01263496|585747935|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162190193|NCT01263496|585747936|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162190194|NCT01263496|585747937|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162190195|NCT01263496|585747938|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
162190196|NCT01263496|585747939|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162190197|NCT01218594|585747940|FG000|Overall Study|Death|1|||
162190198|NCT01218594|585747940|FG000|Overall Study|Withdrawal by Subject|3|||
162190199|NCT01218594|585747940|FG000|Overall Study|Adverse Event|2|||
162190200|NCT01218594|585747940|FG000|Overall Study|Physician Decision|6|||
162190201|NCT02203032|585747941|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
162190202|NCT02203032|585747942|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
162190203|NCT02203032|585747943|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
162190204|NCT02203032|585747944|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
162190205|NCT02203032|585747941|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
162190206|NCT02203032|585747942|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
162190207|NCT02203032|585747943|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
162190208|NCT02203032|585747944|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
162190209|NCT02203032|585747941|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
162190210|NCT02203032|585747942|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
162190211|NCT02203032|585747943|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
162190212|NCT02203032|585747944|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
162190213|NCT02203032|585747941|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
162190214|NCT02203032|585747942|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
162190215|NCT02203032|585747943|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
162190216|NCT02203032|585747944|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
162190217|NCT02203032|585747941|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
162190218|NCT02203032|585747942|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
162190219|NCT02203032|585747943|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
162190220|NCT02203032|585747944|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
162190221|NCT02203032|585747941|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
162190222|NCT02203032|585747942|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
162190223|NCT02203032|585747943|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
162190224|NCT02203032|585747944|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
162190225|NCT02203032|585747941|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
162190226|NCT02203032|585747942|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
162190227|NCT02203032|585747943|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
162190228|NCT02203032|585747944|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
162190229|NCT02203032|585747941|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
162190230|NCT02203032|585747942|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
162190231|NCT02203032|585747943|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
162190232|NCT02203032|585747944|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
162190233|NCT02203032|585747941|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
162190234|NCT02203032|585747942|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
162190235|NCT02203032|585747943|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
162190236|NCT02203032|585747944|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
162190237|NCT02203032|585747941|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
162190238|NCT02203032|585747942|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
162190239|NCT02203032|585747943|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
162190240|NCT02203032|585747944|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
162190241|NCT02203032|585747941|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
162190242|NCT02203032|585747942|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
162190243|NCT02203032|585747943|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
162190244|NCT02203032|585747944|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
162190245|NCT02203032|585747941|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
162190246|NCT02203032|585747942|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
162190247|NCT02203032|585747943|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
162190248|NCT02203032|585747944|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
162190249|NCT02241785|585747947|FG000|Overall Study|Sponsor Termination|43|||
162190250|NCT02241785|585747947|FG000|Overall Study|Withdrawal by Subject|1|||
162190251|NCT02241785|585747947|FG000|Overall Study|Lost to Follow-up|2|||
162190252|NCT02241785|585747947|FG000|Overall Study|Adverse Event|1|||
162190253|NCT04852978|585747950|FG000|Overall Study|Physician Decision|0|||
162190254|NCT04852978|585747951|FG001|Overall Study|Physician Decision|1|||
162190255|NCT04852978|585747952|FG002|Overall Study|Physician Decision|0|||
162190256|NCT04852978|585747953|FG003|Overall Study|Physician Decision|0|||
162190257|NCT04852978|585747954|FG004|Overall Study|Physician Decision|0|||
162190258|NCT04852978|585747955|FG005|Overall Study|Physician Decision|0|||
162190259|NCT04852978|585747956|FG006|Overall Study|Physician Decision|0|||
162190260|NCT04852978|585747957|FG007|Overall Study|Physician Decision|2|||
162190261|NCT04852978|585747958|FG008|Overall Study|Physician Decision|0|||
162190262|NCT04852978|585747950|FG000|Overall Study|Sponsor request|0|||
162190263|NCT04852978|585747951|FG001|Overall Study|Sponsor request|0|||
162190264|NCT04852978|585747952|FG002|Overall Study|Sponsor request|1|||
162190265|NCT04852978|585747953|FG003|Overall Study|Sponsor request|0|||
162190266|NCT04852978|585747954|FG004|Overall Study|Sponsor request|0|||
162190267|NCT04852978|585747955|FG005|Overall Study|Sponsor request|0|||
162190268|NCT04852978|585747956|FG006|Overall Study|Sponsor request|0|||
162190269|NCT04852978|585747957|FG007|Overall Study|Sponsor request|0|||
162190270|NCT04852978|585747958|FG008|Overall Study|Sponsor request|0|||
162190271|NCT04852978|585747950|FG000|Overall Study|Death|0|||
162190272|NCT04852978|585747951|FG001|Overall Study|Death|0|||
162190273|NCT04852978|585747952|FG002|Overall Study|Death|0|||
162190274|NCT04852978|585747953|FG003|Overall Study|Death|0|||
162190275|NCT04852978|585747954|FG004|Overall Study|Death|0|||
162190276|NCT04852978|585747955|FG005|Overall Study|Death|0|||
162190277|NCT04852978|585747956|FG006|Overall Study|Death|1|||
162190278|NCT04852978|585747957|FG007|Overall Study|Death|0|||
162190279|NCT04852978|585747958|FG008|Overall Study|Death|0|||
162190280|NCT04852978|585747950|FG000|Overall Study|Lost to Follow-up|3|||
162190281|NCT04852978|585747951|FG001|Overall Study|Lost to Follow-up|2|||
162190282|NCT04852978|585747952|FG002|Overall Study|Lost to Follow-up|2|||
162190283|NCT04852978|585747953|FG003|Overall Study|Lost to Follow-up|0|||
162190284|NCT04852978|585747954|FG004|Overall Study|Lost to Follow-up|2|||
162190285|NCT04852978|585747955|FG005|Overall Study|Lost to Follow-up|4|||
162190286|NCT04852978|585747956|FG006|Overall Study|Lost to Follow-up|1|||
162190287|NCT04852978|585747957|FG007|Overall Study|Lost to Follow-up|2|||
162190288|NCT04852978|585747958|FG008|Overall Study|Lost to Follow-up|2|||
162190289|NCT04852978|585747950|FG000|Overall Study|Withdrawal by Subject|4|||
162190290|NCT04852978|585747951|FG001|Overall Study|Withdrawal by Subject|2|||
162190291|NCT04852978|585747952|FG002|Overall Study|Withdrawal by Subject|2|||
162190292|NCT04852978|585747953|FG003|Overall Study|Withdrawal by Subject|1|||
162190293|NCT04852978|585747954|FG004|Overall Study|Withdrawal by Subject|5|||
162190294|NCT04852978|585747955|FG005|Overall Study|Withdrawal by Subject|3|||
162190295|NCT04852978|585747956|FG006|Overall Study|Withdrawal by Subject|2|||
162190296|NCT04852978|585747957|FG007|Overall Study|Withdrawal by Subject|2|||
162190297|NCT04852978|585747958|FG008|Overall Study|Withdrawal by Subject|1|||
162190298|NCT02196259|585749898|FG000|Overall Study|Researcher choice|0|||
162190299|NCT02196259|585749899|FG001|Overall Study|Researcher choice|0|||
162190300|NCT02196259|585749900|FG002|Overall Study|Researcher choice|1|||
162190301|NCT02196259|585749898|FG000|Overall Study|Partial data analysis|0|||
162190302|NCT02196259|585749899|FG001|Overall Study|Partial data analysis|3|||
162190303|NCT02196259|585749900|FG002|Overall Study|Partial data analysis|0|||
162190304|NCT01668355|585749902|FG000|Overall Study|Death|3|||
162190305|NCT01668355|585749903|FG001|Overall Study|Death|1|||
162190306|NCT01668355|585749902|FG000|Overall Study|Withdrawal by Subject|6|||
162190307|NCT01668355|585749903|FG001|Overall Study|Withdrawal by Subject|1|||
162190308|NCT00535626|585749904|FG000|Overall Study|Death|15|||
162190309|NCT00535626|585749904|FG000|Overall Study|Lost to Follow-up|29|||
162190310|NCT00535626|585749904|FG000|Overall Study|Withdrawal by Subject|20|||
162190311|NCT00535626|585749904|FG000|Overall Study|Removal/revision of study component|8|||
162190312|NCT00535626|585749904|FG000|Overall Study|Subject terminated|31|||
162190313|NCT00535626|585749904|FG000|Overall Study|Unable to return|2|||
162190314|NCT04633200|585749905|FG000|Overall Study|Lost to Follow-up|3|||
162190315|NCT04633200|585749906|FG001|Overall Study|Lost to Follow-up|5|||
162190316|NCT01808534|585749907|FG000|Overall Study|Disease progression|3|||
162190317|NCT01808534|585749907|FG000|Overall Study|Physician Decision|1|||
162190318|NCT01019135|585749911|FG000|Overall Study|Did not receive allocated intervention|12|||
161673788|NCT05696236|583859901|FG000|Overall Study|Lost to Follow-up|1|||
161673789|NCT05696236|583859902|FG001|Overall Study|Lost to Follow-up|0|||
161673790|NCT05696236|583859901|FG000|Overall Study|Later determined to not be eligible for participation|0|||
161673791|NCT05696236|583859902|FG001|Overall Study|Later determined to not be eligible for participation|1|||
162190319|NCT01019135|585749912|FG001|Overall Study|Did not receive allocated intervention|6|||
162190320|NCT01019135|585749913|FG002|Overall Study|Did not receive allocated intervention|25|||
162190321|NCT01019135|585749911|FG000|Overall Study|Did not attend CR|8|||
162190322|NCT01019135|585749912|FG001|Overall Study|Did not attend CR|13|||
161673792|NCT05696236|583859901|FG000|Overall Study|Withdrawal by Subject|2|||
161673793|NCT05696236|583859902|FG001|Overall Study|Withdrawal by Subject|2|||
162190323|NCT01019135|585749913|FG002|Overall Study|Did not attend CR|6|||
162190324|NCT01205126|585749914|FG000|Titration Phase|Adverse Event|5|||
162190325|NCT01205126|585749915|FG001|Titration Phase|Adverse Event|3|||
162190326|NCT01205126|585749914|FG000|Titration Phase|Withdrawal by Subject|5|||
162190327|NCT01205126|585749915|FG001|Titration Phase|Withdrawal by Subject|5|||
162190328|NCT01205126|585749914|FG000|Titration Phase|Lost to Follow-up|2|||
162190329|NCT01205126|585749915|FG001|Titration Phase|Lost to Follow-up|2|||
162190330|NCT01205126|585749914|FG000|Titration Phase|No stable titration dose|1|||
161673794|NCT01829360|583859905|FG000|Overall Study|Protocol Violation|0|||
162190331|NCT01205126|585749915|FG001|Titration Phase|No stable titration dose|0|||
162190332|NCT01205126|585749914|FG000|Titration Phase|More than maximum dosage required|2|||
162190333|NCT01205126|585749915|FG001|Titration Phase|More than maximum dosage required|3|||
162190334|NCT01205126|585749914|FG000|Titration Phase|Other|8|||
162190335|NCT01205126|585749915|FG001|Titration Phase|Other|6|||
162190336|NCT01205126|585749914|FG000|Between Titration & Maintenance Phase|Other|0|||
162190337|NCT01205126|585749915|FG001|Between Titration & Maintenance Phase|Other|4|||
162190338|NCT01205126|585749914|FG000|Maintenance Phase|Adverse Event|3|||
162190339|NCT01205126|585749915|FG001|Maintenance Phase|Adverse Event|7|||
162190340|NCT01205126|585749914|FG000|Maintenance Phase|Death|4|||
162190341|NCT01205126|585749915|FG001|Maintenance Phase|Death|4|||
162190342|NCT01205126|585749914|FG000|Maintenance Phase|More than the maximum dosage required|5|||
162190343|NCT01205126|585749915|FG001|Maintenance Phase|More than the maximum dosage required|5|||
162190344|NCT01205126|585749914|FG000|Maintenance Phase|Prohibited drugs used|1|||
162190345|NCT01205126|585749915|FG001|Maintenance Phase|Prohibited drugs used|0|||
162190346|NCT01205126|585749914|FG000|Maintenance Phase|Other|11|||
162190347|NCT01205126|585749915|FG001|Maintenance Phase|Other|8|||
162190348|NCT01205126|585749914|FG000|Maintenance Phase|Lost to Follow-up|5|||
162190349|NCT01205126|585749915|FG001|Maintenance Phase|Lost to Follow-up|5|||
162190350|NCT01205126|585749914|FG000|Maintenance Phase|Withdrawal by Subject|8|||
162190351|NCT01205126|585749915|FG001|Maintenance Phase|Withdrawal by Subject|11|||
162190352|NCT00486954|585749916|FG000|Pilot Part|Adverse Event|4|||
162190353|NCT00486954|585749917|FG001|Pilot Part|Adverse Event|0|||
162190354|NCT00486954|585749918|FG002|Pilot Part|Adverse Event|5|||
162190355|NCT00486954|585749919|FG003|Pilot Part|Adverse Event|0|||
162190356|NCT00486954|585749920|FG004|Pilot Part|Adverse Event|0|||
162190357|NCT00486954|585749916|FG000|Pilot Part|Disease Progression|2|||
162190358|NCT00486954|585749917|FG001|Pilot Part|Disease Progression|0|||
162190359|NCT00486954|585749918|FG002|Pilot Part|Disease Progression|1|||
162190360|NCT00486954|585749919|FG003|Pilot Part|Disease Progression|0|||
162190361|NCT00486954|585749920|FG004|Pilot Part|Disease Progression|0|||
162190362|NCT00486954|585749916|FG000|Randomized Part|Lost to Follow-up|0|||
162190363|NCT00486954|585749917|FG001|Randomized Part|Lost to Follow-up|0|||
162190364|NCT00486954|585749918|FG002|Randomized Part|Lost to Follow-up|0|||
162190365|NCT00486954|585749919|FG003|Randomized Part|Lost to Follow-up|0|||
162190366|NCT00486954|585749920|FG004|Randomized Part|Lost to Follow-up|1|||
162190367|NCT00486954|585749916|FG000|Randomized Part|Withdrawal by Subject|0|||
162190368|NCT00486954|585749917|FG001|Randomized Part|Withdrawal by Subject|0|||
162190369|NCT00486954|585749918|FG002|Randomized Part|Withdrawal by Subject|0|||
162190370|NCT00486954|585749919|FG003|Randomized Part|Withdrawal by Subject|1|||
162190371|NCT00486954|585749920|FG004|Randomized Part|Withdrawal by Subject|0|||
162190372|NCT00486954|585749916|FG000|Randomized Part|Sponsor Terminated Study|0|||
162190373|NCT00486954|585749917|FG001|Randomized Part|Sponsor Terminated Study|0|||
162190374|NCT00486954|585749918|FG002|Randomized Part|Sponsor Terminated Study|0|||
162190375|NCT00486954|585749919|FG003|Randomized Part|Sponsor Terminated Study|19|||
162190376|NCT00486954|585749920|FG004|Randomized Part|Sponsor Terminated Study|13|||
162190377|NCT05124210|585749921|FG000|Overall Study|Lost to Follow-up|1|||
162190378|NCT05124210|585749922|FG001|Overall Study|Lost to Follow-up|0|||
162190379|NCT05124210|585749921|FG000|Overall Study|Withdrawal by Subject|1|||
162190380|NCT05124210|585749922|FG001|Overall Study|Withdrawal by Subject|0|||
162190381|NCT00638456|585749925|FG000|Overall Study|Withdrawal by Subject|6|||
162190382|NCT00638456|585749926|FG001|Overall Study|Withdrawal by Subject|2|||
162190383|NCT03236779|585749927|FG000|Overall Study|Lost to Follow-up|13|||
162190384|NCT03236779|585749928|FG001|Overall Study|Lost to Follow-up|21|||
161673795|NCT01829360|583859906|FG001|Overall Study|Protocol Violation|0|||
161673796|NCT01829360|583859907|FG002|Overall Study|Protocol Violation|1|||
161673797|NCT01829360|583859908|FG003|Overall Study|Protocol Violation|0|||
161673798|NCT02545322|583859909|FG000|Overall Study|Withdrawal by Subject|3|||
161673799|NCT00041067|583859910|FG000|Overall Study|Adverse Event|20|||
161673800|NCT00041067|583859910|FG000|Overall Study|Progression|19|||
161673801|NCT00041067|583859910|FG000|Overall Study|Patient refusal|12|||
161673802|NCT00041067|583859910|FG000|Overall Study|Other reasons|23|||
162190385|NCT00929526|585749930|FG000|Overall Study|Withdrawal by Subject|1|||
162190386|NCT00929526|585749931|FG001|Overall Study|Withdrawal by Subject|11|||
162190387|NCT00929526|585749930|FG000|Overall Study|Lost to Follow-up|8|||
162190388|NCT00929526|585749931|FG001|Overall Study|Lost to Follow-up|12|||
161673803|NCT00041067|583859910|FG000|Overall Study|Ineligible|2|||
162190389|NCT00929526|585749930|FG000|Overall Study|Other|8|||
162190390|NCT00929526|585749931|FG001|Overall Study|Other|6|||
162190391|NCT00578344|585749932|FG000|Overall Study|Insurance problems|1|||
162190392|NCT00578344|585749932|FG000|Overall Study|Graft failure|1|||
162190393|NCT02169414|585749933|FG000|Overall Study|Withdrawal by Subject|1|||
162190394|NCT02169414|585749934|FG001|Overall Study|Withdrawal by Subject|0|||
162190395|NCT02169414|585749935|FG002|Overall Study|Withdrawal by Subject|0|||
162190396|NCT02169414|585749936|FG003|Overall Study|Withdrawal by Subject|0|||
162190397|NCT02169414|585749933|FG000|Overall Study|Adverse Event|0|||
162190398|NCT02169414|585749934|FG001|Overall Study|Adverse Event|1|||
162190399|NCT02169414|585749935|FG002|Overall Study|Adverse Event|0|||
161673804|NCT00778622|583859911|FG000|Overall Study|Adverse Event|5|||
161673805|NCT00778622|583859912|FG001|Overall Study|Adverse Event|4|||
161673806|NCT00778622|583859913|FG002|Overall Study|Adverse Event|7|||
162190400|NCT02169414|585749936|FG003|Overall Study|Adverse Event|0|||
162190401|NCT02309515|585749940|FG000|Overall Study|Withdrawal by Subject|0|||
162190402|NCT02309515|585749941|FG001|Overall Study|Withdrawal by Subject|1|||
162190403|NCT02547974|585749944|FG000|Overall Study|Withdrawal by Subject|1|||
162190404|NCT02547974|585749945|FG001|Overall Study|Withdrawal by Subject|0|||
162190405|NCT02547974|585749946|FG002|Overall Study|Withdrawal by Subject|0|||
162190406|NCT02547974|585749947|FG003|Overall Study|Withdrawal by Subject|0|||
162190407|NCT00923078|585749951|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
162190408|NCT00923078|585749952|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
162190409|NCT00923078|585749953|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
162190410|NCT00923078|585749951|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
162190411|NCT00923078|585749952|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
162190412|NCT00923078|585749953|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
162190413|NCT01072149|585749957|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190414|NCT01072149|585749958|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190415|NCT01072149|585749959|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
162190416|NCT01072149|585749960|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190417|NCT01072149|585749961|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190418|NCT01072149|585749962|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190419|NCT01072149|585749963|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190420|NCT01072149|585749964|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190421|NCT01072149|585749965|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190422|NCT01072149|585749966|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190423|NCT01072149|585749967|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190424|NCT01072149|585749968|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190425|NCT01072149|585749969|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190426|NCT01072149|585749970|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190427|NCT01072149|585749971|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190428|NCT01072149|585749972|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190429|NCT01072149|585749973|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190430|NCT01072149|585749974|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
162190431|NCT01072149|585749957|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190432|NCT01072149|585749958|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190433|NCT01072149|585749959|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190434|NCT01072149|585749960|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190435|NCT01072149|585749961|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190436|NCT01072149|585749962|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190437|NCT01072149|585749963|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190438|NCT01072149|585749964|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190439|NCT01072149|585749965|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190440|NCT01072149|585749966|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190441|NCT01072149|585749967|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190442|NCT01072149|585749968|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190443|NCT01072149|585749969|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190444|NCT01072149|585749970|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190445|NCT01072149|585749971|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190446|NCT01072149|585749972|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190447|NCT01072149|585749973|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
162190448|NCT01072149|585749974|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
162190449|NCT01072149|585749957|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190450|NCT01072149|585749958|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190451|NCT01072149|585749959|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190452|NCT01072149|585749960|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190453|NCT01072149|585749961|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190454|NCT01072149|585749962|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190455|NCT01072149|585749963|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190456|NCT01072149|585749964|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190457|NCT01072149|585749965|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190458|NCT01072149|585749966|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190459|NCT01072149|585749967|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
162190460|NCT01072149|585749968|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190461|NCT01072149|585749969|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190462|NCT01072149|585749970|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190463|NCT01072149|585749971|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161819679|NCT05330975|584381122|FG006|Revaccination|Adverse Event|3|||
161819680|NCT05330975|584381116|FG000|Revaccination|Lost to Follow-up|0|||
162190464|NCT01072149|585749972|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190465|NCT01072149|585749973|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161819681|NCT05330975|584381117|FG001|Revaccination|Lost to Follow-up|0|||
162190466|NCT01072149|585749974|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162190467|NCT01072149|585749957|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190468|NCT01072149|585749958|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
162190469|NCT01072149|585749959|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190470|NCT01072149|585749960|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190471|NCT01072149|585749961|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190472|NCT01072149|585749962|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190473|NCT01072149|585749963|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190474|NCT01072149|585749964|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190475|NCT01072149|585749965|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190476|NCT01072149|585749966|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190477|NCT01072149|585749967|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190478|NCT01072149|585749968|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190479|NCT01072149|585749969|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190480|NCT01072149|585749970|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190481|NCT01072149|585749971|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190482|NCT01072149|585749972|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190483|NCT01072149|585749973|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190484|NCT01072149|585749974|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162190485|NCT01072149|585749957|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190486|NCT01072149|585749958|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190487|NCT01072149|585749959|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
162190488|NCT01072149|585749960|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190489|NCT01072149|585749961|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190490|NCT01072149|585749962|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190491|NCT01072149|585749963|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190492|NCT01072149|585749964|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190493|NCT01072149|585749965|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190494|NCT01072149|585749966|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190495|NCT01072149|585749967|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190496|NCT01072149|585749968|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190497|NCT01072149|585749969|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190498|NCT01072149|585749970|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190499|NCT01072149|585749971|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190500|NCT01072149|585749972|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190501|NCT01072149|585749973|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190502|NCT01072149|585749974|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
162190503|NCT01072149|585749957|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190504|NCT01072149|585749958|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190505|NCT01072149|585749959|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190506|NCT01072149|585749960|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190507|NCT01072149|585749961|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190508|NCT01072149|585749962|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190509|NCT01072149|585749963|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190510|NCT01072149|585749964|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
162190511|NCT01072149|585749965|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190512|NCT01072149|585749966|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190513|NCT01072149|585749967|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190514|NCT01072149|585749968|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190515|NCT01072149|585749969|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190516|NCT01072149|585749970|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190517|NCT01072149|585749971|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190518|NCT01072149|585749972|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190519|NCT01072149|585749973|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190520|NCT01072149|585749974|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
162190521|NCT01072149|585749957|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
162190522|NCT01072149|585749958|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
162190523|NCT01072149|585749959|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
162190524|NCT01072149|585749960|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
162190525|NCT01072149|585749961|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
162190526|NCT01072149|585749962|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
162190527|NCT01072149|585749963|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
162190528|NCT01072149|585749964|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
162190529|NCT01072149|585749965|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
162190530|NCT01072149|585749966|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
162190531|NCT01072149|585749967|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
162190532|NCT01072149|585749968|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
162190533|NCT01072149|585749969|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
162190534|NCT01072149|585749970|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
162190535|NCT01072149|585749971|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
162190536|NCT01072149|585749972|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
162190537|NCT01072149|585749973|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
162190538|NCT01072149|585749974|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
162190539|NCT01072149|585749957|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190540|NCT01072149|585749958|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190541|NCT01072149|585749959|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190542|NCT01072149|585749960|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190543|NCT01072149|585749961|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190544|NCT01072149|585749962|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190545|NCT01072149|585749963|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190546|NCT01072149|585749964|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190547|NCT01072149|585749965|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190548|NCT01072149|585749966|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190549|NCT01072149|585749967|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161673807|NCT00778622|583859911|FG000|Overall Study|Withdrawal by Subject|4|||
162190550|NCT01072149|585749968|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190551|NCT01072149|585749969|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190552|NCT01072149|585749970|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190553|NCT01072149|585749971|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190554|NCT01072149|585749972|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
162190555|NCT01072149|585749973|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190556|NCT01072149|585749974|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
162190557|NCT01072149|585749957|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
162190558|NCT01072149|585749958|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
161673808|NCT00778622|583859912|FG001|Overall Study|Withdrawal by Subject|5|||
161673809|NCT00778622|583859913|FG002|Overall Study|Withdrawal by Subject|5|||
161673810|NCT00778622|583859911|FG000|Overall Study|Lost to Follow-up|3|||
161673811|NCT00778622|583859912|FG001|Overall Study|Lost to Follow-up|3|||
161673812|NCT00778622|583859913|FG002|Overall Study|Lost to Follow-up|2|||
161673813|NCT00778622|583859911|FG000|Overall Study|Protocol Violation|0|||
161673814|NCT00778622|583859912|FG001|Overall Study|Protocol Violation|3|||
161673815|NCT00778622|583859913|FG002|Overall Study|Protocol Violation|0|||
161673816|NCT00778622|583859911|FG000|Overall Study|Lack of Efficacy|2|||
161673817|NCT00778622|583859912|FG001|Overall Study|Lack of Efficacy|0|||
161673818|NCT00778622|583859913|FG002|Overall Study|Lack of Efficacy|0|||
161673819|NCT00778622|583859911|FG000|Overall Study|immigration|1|||
161673820|NCT00778622|583859912|FG001|Overall Study|immigration|0|||
161673821|NCT00778622|583859913|FG002|Overall Study|immigration|0|||
162190559|NCT01072149|585749959|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
162190560|NCT01072149|585749960|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
162190561|NCT01072149|585749961|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
162190562|NCT01072149|585749962|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
162190563|NCT01072149|585749963|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
161673822|NCT00778622|583859911|FG000|Overall Study|Other|1|||
161673823|NCT00778622|583859912|FG001|Overall Study|Other|0|||
161673824|NCT00778622|583859913|FG002|Overall Study|Other|1|||
162190564|NCT01072149|585749964|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
162190565|NCT01072149|585749965|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
162190566|NCT01072149|585749966|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
162190567|NCT01072149|585749967|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
162190568|NCT01072149|585749968|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
162190569|NCT01072149|585749969|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
162190570|NCT01072149|585749970|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
161673825|NCT01251120|583859915|FG000|Overall Study|Lack of Efficacy|0|||
161673826|NCT01251120|583859916|FG001|Overall Study|Lack of Efficacy|1|||
162190571|NCT01072149|585749971|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
162190572|NCT01072149|585749972|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
162190573|NCT01072149|585749973|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
161673827|NCT01968070|583859917|FG000|Period 1|Withdrawal by Subject|0|||
161673828|NCT01968070|583859918|FG001|Period 1|Withdrawal by Subject|1|||
161673829|NCT01968070|583859919|FG002|Period 1|Withdrawal by Subject|0|||
161673830|NCT01968070|583859920|FG003|Period 1|Withdrawal by Subject|0|||
161673831|NCT01968070|583859921|FG004|Period 1|Withdrawal by Subject|0|||
161673832|NCT01968070|583859922|FG005|Period 1|Withdrawal by Subject|0|||
161673833|NCT01968070|583859923|FG006|Period 1|Withdrawal by Subject|1|||
161673834|NCT01968070|583859924|FG007|Period 1|Withdrawal by Subject|0|||
161673835|NCT01968070|583859925|FG008|Period 1|Withdrawal by Subject|0|||
161673836|NCT01968070|583859926|FG009|Period 1|Withdrawal by Subject|0|||
162190574|NCT01072149|585749974|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
162190575|NCT01072149|585749957|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161673837|NCT01968070|583859927|FG010|Period 1|Withdrawal by Subject|0|||
161673838|NCT01968070|583859928|FG011|Period 1|Withdrawal by Subject|0|||
161673839|NCT01968070|583859929|FG012|Period 1|Withdrawal by Subject|0|||
161673840|NCT01968070|583859930|FG013|Period 1|Withdrawal by Subject|0|||
161673841|NCT01968070|583859931|FG014|Period 1|Withdrawal by Subject|0|||
161673842|NCT01968070|583859932|FG015|Period 1|Withdrawal by Subject|1|||
161673843|NCT01968070|583859933|FG016|Period 1|Withdrawal by Subject|0|||
161673844|NCT01968070|583859934|FG017|Period 1|Withdrawal by Subject|0|||
162020058|NCT01976741|585128580|FG009|Overall Study|Withdrawal by Subject|0|||
162020059|NCT01976741|585128571|FG000|Overall Study|Adverse Event|0|||
162190576|NCT01072149|585749958|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190577|NCT01072149|585749959|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190578|NCT01072149|585749960|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190579|NCT01072149|585749961|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190580|NCT01072149|585749962|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190581|NCT01072149|585749963|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190582|NCT01072149|585749964|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190583|NCT01072149|585749965|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190584|NCT01072149|585749966|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190585|NCT01072149|585749967|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190586|NCT01072149|585749968|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190587|NCT01072149|585749969|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
162190588|NCT01072149|585749970|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190589|NCT01072149|585749971|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190590|NCT01072149|585749972|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190591|NCT01072149|585749973|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190592|NCT01072149|585749974|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
162190593|NCT01072149|585749957|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190594|NCT01072149|585749958|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190595|NCT01072149|585749959|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
162190596|NCT01072149|585749960|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190597|NCT01072149|585749961|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190598|NCT01072149|585749962|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190599|NCT01072149|585749963|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190600|NCT01072149|585749964|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162020060|NCT01976741|585128572|FG001|Overall Study|Adverse Event|0|||
162020061|NCT01976741|585128573|FG002|Overall Study|Adverse Event|2|||
162020062|NCT01976741|585128574|FG003|Overall Study|Adverse Event|0|||
162190601|NCT01072149|585749965|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190602|NCT01072149|585749966|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190603|NCT01072149|585749967|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162020063|NCT01976741|585128575|FG004|Overall Study|Adverse Event|0|||
162020064|NCT01976741|585128576|FG005|Overall Study|Adverse Event|0|||
162190604|NCT01072149|585749968|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190605|NCT01072149|585749969|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190606|NCT01072149|585749970|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
162190607|NCT01072149|585749971|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190608|NCT01072149|585749972|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190609|NCT01072149|585749973|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190610|NCT01072149|585749974|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
162190611|NCT04766996|585749977|FG000|Overall Study|Withdrawal by Subject|1|||
162190612|NCT04766996|585749978|FG001|Overall Study|Withdrawal by Subject|0|||
161673845|NCT01968070|583859917|FG000|Period 1|Protocol Violation|0|||
162190613|NCT04766996|585749979|FG002|Overall Study|Withdrawal by Subject|13|||
161673846|NCT01968070|583859918|FG001|Period 1|Protocol Violation|0|||
161673847|NCT01968070|583859919|FG002|Period 1|Protocol Violation|0|||
161673848|NCT01968070|583859920|FG003|Period 1|Protocol Violation|1|||
162190614|NCT01322386|585749980|FG000|Overall Study|Protocol Violation|0|||
162190615|NCT01322386|585749981|FG001|Overall Study|Protocol Violation|1|||
162190616|NCT01322386|585749980|FG000|Overall Study|Physician Decision|0|||
162190617|NCT01322386|585749981|FG001|Overall Study|Physician Decision|1|||
162190618|NCT01102426|585749982|FG000|Overall Study|Randomized but not treated|4|||
161673849|NCT01968070|583859921|FG004|Period 1|Protocol Violation|1|||
161673850|NCT01968070|583859922|FG005|Period 1|Protocol Violation|0|||
161819682|NCT05330975|584381118|FG002|Revaccination|Lost to Follow-up|0|||
162020065|NCT01976741|585128577|FG006|Overall Study|Adverse Event|3|||
162190619|NCT01102426|585749983|FG001|Overall Study|Randomized but not treated|1|||
161673851|NCT01968070|583859923|FG006|Period 1|Protocol Violation|0|||
162190620|NCT01102426|585749982|FG000|Overall Study|Adverse Events (treatment-related)|15|||
162190621|NCT01102426|585749983|FG001|Overall Study|Adverse Events (treatment-related)|8|||
162190622|NCT01102426|585749982|FG000|Overall Study|Physician Decision|9|||
162190623|NCT01102426|585749983|FG001|Overall Study|Physician Decision|6|||
162190624|NCT01102426|585749982|FG000|Overall Study|Progressive Disease|85|||
162190625|NCT01102426|585749983|FG001|Overall Study|Progressive Disease|44|||
162190626|NCT01102426|585749982|FG000|Overall Study|Adverse Events (unrelated to|9|||
162190627|NCT01102426|585749983|FG001|Overall Study|Adverse Events (unrelated to|1|||
162190628|NCT01102426|585749982|FG000|Overall Study|Patient Refusal|24|||
162190629|NCT01102426|585749983|FG001|Overall Study|Patient Refusal|12|||
162190630|NCT01102426|585749982|FG000|Overall Study|Death (due to adverse events|0|||
162190631|NCT01102426|585749983|FG001|Overall Study|Death (due to adverse events|1|||
162190632|NCT01102426|585749982|FG000|Overall Study|Death (non-related to the study|19|||
162190633|NCT01102426|585749983|FG001|Overall Study|Death (non-related to the study|8|||
162190634|NCT00871494|585749984|FG000|Overall Study|Protocol Violation|5|||
162190635|NCT00871494|585749984|FG000|Overall Study|Lack of Efficacy|4|||
162190636|NCT00871494|585749984|FG000|Overall Study|Adverse Event|4|||
162190637|NCT00871494|585749984|FG000|Overall Study|Lost to Follow-up|1|||
162190638|NCT02988713|585749990|FG000|Overall Study|Withdrawal by Subject|1|||
162190639|NCT02988713|585749990|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
162190640|NCT00088166|585749991|FG000|Overall Study|Adverse Event|11|||
162190641|NCT00088166|585749992|FG001|Overall Study|Adverse Event|9|||
162190642|NCT00088166|585749991|FG000|Overall Study|Death|3|||
162190643|NCT00088166|585749992|FG001|Overall Study|Death|1|||
161673852|NCT01968070|583859924|FG007|Period 1|Protocol Violation|0|||
161673853|NCT01968070|583859925|FG008|Period 1|Protocol Violation|0|||
161673854|NCT01968070|583859926|FG009|Period 1|Protocol Violation|0|||
162190644|NCT00088166|585749991|FG000|Overall Study|Lost to Follow-up|0|||
162190645|NCT00088166|585749992|FG001|Overall Study|Lost to Follow-up|1|||
162190646|NCT00088166|585749991|FG000|Overall Study|Physician Decision|4|||
162190647|NCT00088166|585749992|FG001|Overall Study|Physician Decision|1|||
162190648|NCT00088166|585749991|FG000|Overall Study|Protocol Violation|1|||
162190649|NCT00088166|585749992|FG001|Overall Study|Protocol Violation|5|||
162190650|NCT00088166|585749991|FG000|Overall Study|Patient deterioration|29|||
162190651|NCT00088166|585749992|FG001|Overall Study|Patient deterioration|39|||
162190652|NCT00088166|585749991|FG000|Overall Study|Withdrawal by Subject|5|||
162190653|NCT00088166|585749992|FG001|Overall Study|Withdrawal by Subject|5|||
162190654|NCT00666705|585749993|FG000|Overall Study|Withdrawal by Subject|1|||
162190655|NCT01976507|585749994|FG000|Overall Study|Adverse Event|6|||
162190656|NCT01976507|585749994|FG000|Overall Study|ablation not done, drug not given|1|||
162190657|NCT01029704|585749996|FG000|Overall Study|Adverse Event|0|||
162190658|NCT01029704|585749997|FG001|Overall Study|Adverse Event|0|||
162190659|NCT01029704|585749998|FG002|Overall Study|Adverse Event|0|||
162190660|NCT01029704|585749999|FG003|Overall Study|Adverse Event|0|||
162190661|NCT01029704|585750000|FG004|Overall Study|Adverse Event|0|||
162190662|NCT01029704|585750001|FG005|Overall Study|Adverse Event|0|||
162190663|NCT01029704|585750002|FG006|Overall Study|Adverse Event|1|||
162190664|NCT01029704|585750003|FG007|Overall Study|Adverse Event|1|||
162190665|NCT01029704|585750004|FG008|Overall Study|Adverse Event|0|||
162190666|NCT01029704|585749996|FG000|Overall Study|Withdrawal by Subject|0|||
162190667|NCT01029704|585749997|FG001|Overall Study|Withdrawal by Subject|0|||
162190668|NCT01029704|585749998|FG002|Overall Study|Withdrawal by Subject|0|||
162190669|NCT01029704|585749999|FG003|Overall Study|Withdrawal by Subject|0|||
162190670|NCT01029704|585750000|FG004|Overall Study|Withdrawal by Subject|2|||
161673855|NCT01968070|583859927|FG010|Period 1|Protocol Violation|0|||
162190671|NCT01029704|585750001|FG005|Overall Study|Withdrawal by Subject|1|||
162190672|NCT01029704|585750002|FG006|Overall Study|Withdrawal by Subject|1|||
162190673|NCT01029704|585750003|FG007|Overall Study|Withdrawal by Subject|1|||
162190674|NCT01029704|585750004|FG008|Overall Study|Withdrawal by Subject|0|||
162190675|NCT01029704|585749996|FG000|Overall Study|Lost to Follow-up|0|||
162190676|NCT01029704|585749997|FG001|Overall Study|Lost to Follow-up|0|||
162190677|NCT01029704|585749998|FG002|Overall Study|Lost to Follow-up|0|||
162190678|NCT01029704|585749999|FG003|Overall Study|Lost to Follow-up|0|||
161673856|NCT01968070|583859928|FG011|Period 1|Protocol Violation|0|||
161673857|NCT01968070|583859929|FG012|Period 1|Protocol Violation|0|||
162190679|NCT01029704|585750000|FG004|Overall Study|Lost to Follow-up|0|||
162190680|NCT01029704|585750001|FG005|Overall Study|Lost to Follow-up|0|||
162190681|NCT01029704|585750002|FG006|Overall Study|Lost to Follow-up|1|||
162190682|NCT01029704|585750003|FG007|Overall Study|Lost to Follow-up|1|||
162190683|NCT01029704|585750004|FG008|Overall Study|Lost to Follow-up|1|||
162190684|NCT01029704|585749996|FG000|Overall Study|Lack of Efficacy|0|||
162190685|NCT01029704|585749997|FG001|Overall Study|Lack of Efficacy|0|||
162190686|NCT01029704|585749998|FG002|Overall Study|Lack of Efficacy|0|||
162190687|NCT01029704|585749999|FG003|Overall Study|Lack of Efficacy|0|||
161673858|NCT01968070|583859930|FG013|Period 1|Protocol Violation|0|||
161673859|NCT01968070|583859931|FG014|Period 1|Protocol Violation|0|||
162190688|NCT01029704|585750000|FG004|Overall Study|Lack of Efficacy|2|||
162190689|NCT01029704|585750001|FG005|Overall Study|Lack of Efficacy|3|||
162190690|NCT01029704|585750002|FG006|Overall Study|Lack of Efficacy|1|||
162190691|NCT01029704|585750003|FG007|Overall Study|Lack of Efficacy|2|||
162190692|NCT01029704|585750004|FG008|Overall Study|Lack of Efficacy|0|||
162190693|NCT01029704|585749996|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
162190694|NCT01029704|585749997|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
162190695|NCT01029704|585749998|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
162190696|NCT01029704|585749999|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
162190697|NCT01029704|585750000|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
162190698|NCT01029704|585750001|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
162190699|NCT01029704|585750002|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
162190700|NCT01029704|585750003|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
162190701|NCT01029704|585750004|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
162190702|NCT03845517|585750005|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
162190703|NCT03845517|585750006|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
162190704|NCT03845517|585750007|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
162190705|NCT03845517|585750008|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
162190706|NCT03845517|585750005|FG000|Treatment Period (52 Weeks)|Death|0|||
162190707|NCT03845517|585750006|FG001|Treatment Period (52 Weeks)|Death|0|||
162190708|NCT03845517|585750007|FG002|Treatment Period (52 Weeks)|Death|1|||
162190709|NCT03845517|585750008|FG003|Treatment Period (52 Weeks)|Death|0|||
162190710|NCT03845517|585750005|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
162190711|NCT03845517|585750006|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
162190712|NCT03845517|585750007|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
162190713|NCT03845517|585750008|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
162190714|NCT03845517|585750005|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
162190715|NCT03845517|585750006|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
162190716|NCT03845517|585750007|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
162190717|NCT03845517|585750008|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
162190718|NCT03845517|585750005|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
162190719|NCT03845517|585750006|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
162190720|NCT03845517|585750007|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
162190721|NCT03845517|585750008|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
162190722|NCT03845517|585750005|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
162190723|NCT03845517|585750006|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
162190724|NCT03845517|585750007|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
162190725|NCT03845517|585750008|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
162190726|NCT03845517|585750005|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
162190727|NCT03845517|585750006|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
162190728|NCT03845517|585750007|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
162190729|NCT03845517|585750008|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
162190730|NCT03845517|585750005|FG000|Treatment Period (52 Weeks)|Other|2|||
162190731|NCT03845517|585750006|FG001|Treatment Period (52 Weeks)|Other|0|||
162190732|NCT03845517|585750007|FG002|Treatment Period (52 Weeks)|Other|0|||
162190733|NCT03845517|585750008|FG003|Treatment Period (52 Weeks)|Other|0|||
162190734|NCT03845517|585750005|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
162190735|NCT03845517|585750006|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
162190736|NCT03845517|585750007|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
162190737|NCT03845517|585750008|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
162190738|NCT03845517|585750005|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
162190739|NCT03845517|585750006|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
162190740|NCT03845517|585750007|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
162190741|NCT03845517|585750008|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
162190742|NCT03845517|585750005|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
162190743|NCT03845517|585750006|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
162190744|NCT03845517|585750007|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
162190745|NCT03845517|585750008|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
162190746|NCT03845517|585750005|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
162190747|NCT03845517|585750006|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
162190748|NCT03845517|585750007|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
162190749|NCT03845517|585750008|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
162190750|NCT03845517|585750005|FG000|Follow-up Period (4 Weeks)|Death|0|||
162190751|NCT03845517|585750006|FG001|Follow-up Period (4 Weeks)|Death|0|||
161819683|NCT05330975|584381119|FG003|Revaccination|Lost to Follow-up|0|||
161819684|NCT05330975|584381120|FG004|Revaccination|Lost to Follow-up|0|||
161819685|NCT05330975|584381121|FG005|Revaccination|Lost to Follow-up|0|||
161819686|NCT05330975|584381122|FG006|Revaccination|Lost to Follow-up|10|||
161819687|NCT05330975|584381116|FG000|Revaccination|Withdrawal by Subject|0|||
161819688|NCT05330975|584381117|FG001|Revaccination|Withdrawal by Subject|0|||
161819689|NCT05330975|584381118|FG002|Revaccination|Withdrawal by Subject|0|||
161819690|NCT05330975|584381119|FG003|Revaccination|Withdrawal by Subject|0|||
162190752|NCT03845517|585750007|FG002|Follow-up Period (4 Weeks)|Death|1|||
162190753|NCT03845517|585750008|FG003|Follow-up Period (4 Weeks)|Death|1|||
162190754|NCT03845517|585750005|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
162190755|NCT03845517|585750006|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
162190756|NCT03845517|585750007|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
162190757|NCT03845517|585750008|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
162190758|NCT03845517|585750005|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
162190759|NCT03845517|585750006|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
162190760|NCT03845517|585750007|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
162190761|NCT03845517|585750008|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
162190762|NCT03845517|585750005|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
162190763|NCT03845517|585750006|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
162190764|NCT03845517|585750007|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
162190765|NCT03845517|585750008|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
162190766|NCT03845517|585750005|FG000|Follow-up Period (4 Weeks)|Other|1|||
162190767|NCT03845517|585750006|FG001|Follow-up Period (4 Weeks)|Other|0|||
162190768|NCT03845517|585750007|FG002|Follow-up Period (4 Weeks)|Other|1|||
162190769|NCT03845517|585750008|FG003|Follow-up Period (4 Weeks)|Other|0|||
162190770|NCT03845517|585750005|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
162190771|NCT03845517|585750006|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
162190772|NCT03845517|585750007|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
162190773|NCT03845517|585750008|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
162190774|NCT03845517|585750005|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
162190775|NCT03845517|585750006|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
162190776|NCT03845517|585750007|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
162190777|NCT03845517|585750008|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
162190778|NCT03845517|585750005|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
162190779|NCT03845517|585750006|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
162190780|NCT03845517|585750007|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
162190781|NCT03845517|585750008|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
162190782|NCT01109979|585750009|FG000|Overall Study|Physician Decision|2|||
162190783|NCT01109979|585750010|FG001|Overall Study|Physician Decision|0|||
162190784|NCT01109979|585750009|FG000|Overall Study|Withdrawal by Subject|0|||
162190785|NCT01109979|585750010|FG001|Overall Study|Withdrawal by Subject|1|||
162190786|NCT03136861|585750013|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
162190787|NCT03136861|585750014|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
162190788|NCT03136861|585750015|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
161819691|NCT05330975|584381120|FG004|Revaccination|Withdrawal by Subject|0|||
161819692|NCT05330975|584381121|FG005|Revaccination|Withdrawal by Subject|0|||
162190789|NCT03136861|585750016|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
162190790|NCT03136861|585750017|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
162190791|NCT03136861|585750018|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
162190792|NCT03136861|585750019|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
162190793|NCT03136861|585750013|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
161819693|NCT05330975|584381122|FG006|Revaccination|Withdrawal by Subject|2|||
161819694|NCT05330975|584381116|FG000|Revaccination|Death|0|||
161819695|NCT05330975|584381117|FG001|Revaccination|Death|0|||
161819696|NCT05330975|584381118|FG002|Revaccination|Death|0|||
161819697|NCT05330975|584381119|FG003|Revaccination|Death|0|||
161819698|NCT05330975|584381120|FG004|Revaccination|Death|0|||
161819699|NCT05330975|584381121|FG005|Revaccination|Death|0|||
161819700|NCT05330975|584381122|FG006|Revaccination|Death|3|||
161819701|NCT05267106|584381123|FG000|Overall Study|Death|50|||
161819702|NCT05267106|584381124|FG001|Overall Study|Death|2|||
161819703|NCT05267106|584381123|FG000|Overall Study|Study terminated by Sponsor|24|||
161819704|NCT05267106|584381124|FG001|Overall Study|Study terminated by Sponsor|6|||
161819705|NCT05267106|584381123|FG000|Overall Study|Withdrawal by Subject|0|||
161819706|NCT05267106|584381124|FG001|Overall Study|Withdrawal by Subject|1|||
161819707|NCT04165824|584381125|FG000|Overall Study|Adverse Event|23|||
161819708|NCT04165824|584381125|FG000|Overall Study|Physician Decision|1|||
161819709|NCT04165824|584381125|FG000|Overall Study|Withdrawal by Subject|17|||
161819710|NCT04165824|584381125|FG000|Overall Study|Other|5|||
161819711|NCT03036930|584381128|FG000|Overall Study|Lost to Follow-up|7|||
161819712|NCT03036930|584381128|FG000|Overall Study|Withdrawal by Subject|3|||
161819713|NCT03036930|584381128|FG000|Overall Study|Not eligible to receive transplant within 12 months|15|||
162190794|NCT03136861|585750014|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
161819714|NCT01513239|584381133|FG000|Period 1: Main Phase|Adverse Event|1|||
161819715|NCT01513239|584381134|FG001|Period 1: Main Phase|Adverse Event|1|||
161819716|NCT01513239|584381135|FG002|Period 1: Main Phase|Adverse Event|2|||
161819717|NCT01513239|584381136|FG003|Period 1: Main Phase|Adverse Event|0|||
161819718|NCT01513239|584381137|FG004|Period 1: Main Phase|Adverse Event|0|||
161819719|NCT01513239|584381138|FG005|Period 1: Main Phase|Adverse Event|0|||
161819720|NCT01513239|584381133|FG000|Period 1: Main Phase|Death|29|||
161819721|NCT01513239|584381134|FG001|Period 1: Main Phase|Death|22|||
162190795|NCT03136861|585750015|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
162190796|NCT03136861|585750016|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
162190797|NCT03136861|585750017|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
162190798|NCT03136861|585750018|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
162190799|NCT03136861|585750019|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
162190800|NCT03136861|585750013|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
162190801|NCT03136861|585750014|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
162190802|NCT03136861|585750015|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
162190803|NCT03136861|585750016|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
162190804|NCT03136861|585750017|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
162190805|NCT03136861|585750018|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
162190806|NCT03136861|585750019|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
162190807|NCT03136861|585750013|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
162190808|NCT03136861|585750014|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
162190809|NCT03136861|585750015|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
162190810|NCT03136861|585750016|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
162190811|NCT03136861|585750017|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
162190812|NCT03136861|585750018|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
162190813|NCT03136861|585750019|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
162190814|NCT03136861|585750013|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
162190815|NCT03136861|585750014|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
162190816|NCT03136861|585750015|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
162190817|NCT03136861|585750016|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
162190818|NCT03136861|585750017|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
162190819|NCT03136861|585750018|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
162190820|NCT03136861|585750019|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
162190821|NCT03136861|585750013|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
162190822|NCT03136861|585750014|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
162190823|NCT03136861|585750015|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
162190824|NCT03136861|585750016|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
162190825|NCT03136861|585750017|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
162190826|NCT03136861|585750018|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
162190827|NCT03136861|585750019|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
162190828|NCT03136861|585750013|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
162190829|NCT03136861|585750014|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
162190830|NCT03136861|585750015|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
162190831|NCT03136861|585750016|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
162190832|NCT03136861|585750017|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
162190833|NCT03136861|585750018|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
162190834|NCT03136861|585750019|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
162190835|NCT03136861|585750013|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
162190836|NCT03136861|585750014|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
162190837|NCT03136861|585750015|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
162190838|NCT03136861|585750016|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
162190839|NCT03136861|585750017|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
162190840|NCT03136861|585750018|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
162190841|NCT03136861|585750019|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
162190842|NCT03200574|585750021|FG000|Overall Study|Death|4|||
161673860|NCT01968070|583859932|FG015|Period 1|Protocol Violation|0|||
162190843|NCT03200574|585750021|FG000|Overall Study|Withdrawal by Subject|8|||
162190844|NCT03200574|585750021|FG000|Overall Study|Long-Term need for anticoagulation|1|||
162190845|NCT03200574|585750021|FG000|Overall Study|Relocation|2|||
162190846|NCT03200574|585750021|FG000|Overall Study|Lost to Follow-up|2|||
162190847|NCT03026166|585750025|FG000|Overall Study|Death|22|||
162190848|NCT03026166|585750026|FG001|Overall Study|Death|7|||
162190849|NCT03026166|585750025|FG000|Overall Study|Physician Decision|2|||
162190850|NCT03026166|585750026|FG001|Overall Study|Physician Decision|0|||
161673861|NCT01968070|583859933|FG016|Period 1|Protocol Violation|0|||
161673862|NCT01968070|583859934|FG017|Period 1|Protocol Violation|0|||
161673863|NCT01968070|583859917|FG000|Period 1|Lost to Follow-up|0|||
161673864|NCT01968070|583859918|FG001|Period 1|Lost to Follow-up|0|||
161673865|NCT01968070|583859919|FG002|Period 1|Lost to Follow-up|0|||
161673866|NCT01968070|583859920|FG003|Period 1|Lost to Follow-up|1|||
161673867|NCT01968070|583859921|FG004|Period 1|Lost to Follow-up|0|||
161673868|NCT01968070|583859922|FG005|Period 1|Lost to Follow-up|0|||
161673869|NCT01968070|583859923|FG006|Period 1|Lost to Follow-up|0|||
162190851|NCT03026166|585750025|FG000|Overall Study|Withdrawal by Subject|1|||
162190852|NCT03026166|585750026|FG001|Overall Study|Withdrawal by Subject|2|||
162190853|NCT03026166|585750025|FG000|Overall Study|Lost to Follow-up|1|||
162190854|NCT03026166|585750026|FG001|Overall Study|Lost to Follow-up|0|||
162190855|NCT03026166|585750025|FG000|Overall Study|Study Terminated by Sponsor|3|||
162190856|NCT03026166|585750026|FG001|Overall Study|Study Terminated by Sponsor|3|||
162190857|NCT03026166|585750025|FG000|Overall Study|Other|1|||
162190858|NCT03026166|585750026|FG001|Overall Study|Other|0|||
162190859|NCT01262456|585750027|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
162190860|NCT01262456|585750028|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
162190861|NCT01262456|585750029|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
162190862|NCT01262456|585750027|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
162190863|NCT01262456|585750028|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
162190864|NCT01262456|585750029|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
162190865|NCT01262456|585750027|FG000|3-Month Double-Blind Period|Adverse Event|6|||
162190866|NCT01262456|585750028|FG001|3-Month Double-Blind Period|Adverse Event|4|||
162190867|NCT01262456|585750029|FG002|3-Month Double-Blind Period|Adverse Event|8|||
162190868|NCT01262456|585750027|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
162190869|NCT01262456|585750028|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
162190870|NCT01262456|585750029|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
162190871|NCT01262456|585750027|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
162190872|NCT01262456|585750028|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
162190873|NCT01262456|585750029|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
162190874|NCT01262456|585750027|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
162190875|NCT01262456|585750028|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
162190876|NCT01262456|585750029|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
162190877|NCT01262456|585750027|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
162190878|NCT01262456|585750028|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
162190879|NCT01262456|585750029|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
162190880|NCT01262456|585750027|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
162190881|NCT01262456|585750028|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
162190882|NCT01262456|585750029|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
162190883|NCT01262456|585750027|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
162190884|NCT01262456|585750028|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
162190885|NCT01262456|585750029|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
162190886|NCT03938272|585750030|FG000|Overall Study|Withdrawal by Subject|1|||
162190887|NCT03938272|585750031|FG001|Overall Study|Withdrawal by Subject|0|||
162190888|NCT03938272|585750030|FG000|Overall Study|Physician Decision|0|||
162190889|NCT03938272|585750031|FG001|Overall Study|Physician Decision|2|||
162190890|NCT03938272|585750030|FG000|Overall Study|Study termination by sponsor|10|||
161819722|NCT01513239|584381135|FG002|Period 1: Main Phase|Death|32|||
161819723|NCT01513239|584381136|FG003|Period 1: Main Phase|Death|0|||
161819724|NCT01513239|584381137|FG004|Period 1: Main Phase|Death|0|||
161819725|NCT01513239|584381138|FG005|Period 1: Main Phase|Death|0|||
161819726|NCT01513239|584381133|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
161819727|NCT01513239|584381134|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
161819728|NCT01513239|584381135|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
161819729|NCT01513239|584381136|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
161819730|NCT01513239|584381137|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
161819731|NCT01513239|584381138|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
161819732|NCT01513239|584381133|FG000|Period 1: Main Phase|Physician Decision|4|||
161819733|NCT01513239|584381134|FG001|Period 1: Main Phase|Physician Decision|4|||
161819734|NCT01513239|584381135|FG002|Period 1: Main Phase|Physician Decision|4|||
161819735|NCT01513239|584381136|FG003|Period 1: Main Phase|Physician Decision|0|||
161819736|NCT01513239|584381137|FG004|Period 1: Main Phase|Physician Decision|0|||
161819737|NCT01513239|584381138|FG005|Period 1: Main Phase|Physician Decision|0|||
161819738|NCT01513239|584381133|FG000|Period 1: Main Phase|Protocol Violation|2|||
161819739|NCT01513239|584381134|FG001|Period 1: Main Phase|Protocol Violation|2|||
161819740|NCT01513239|584381135|FG002|Period 1: Main Phase|Protocol Violation|2|||
161819741|NCT01513239|584381136|FG003|Period 1: Main Phase|Protocol Violation|0|||
161819742|NCT01513239|584381137|FG004|Period 1: Main Phase|Protocol Violation|0|||
161819743|NCT01513239|584381138|FG005|Period 1: Main Phase|Protocol Violation|0|||
161819744|NCT01513239|584381133|FG000|Period 1: Main Phase|Technical Problems|1|||
161819745|NCT01513239|584381134|FG001|Period 1: Main Phase|Technical Problems|2|||
161819746|NCT01513239|584381135|FG002|Period 1: Main Phase|Technical Problems|0|||
161819747|NCT01513239|584381136|FG003|Period 1: Main Phase|Technical Problems|0|||
161819748|NCT01513239|584381137|FG004|Period 1: Main Phase|Technical Problems|0|||
161819749|NCT01513239|584381138|FG005|Period 1: Main Phase|Technical Problems|0|||
161819750|NCT01513239|584381133|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
161819751|NCT01513239|584381134|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
162190891|NCT03938272|585750031|FG001|Overall Study|Study termination by sponsor|8|||
162190892|NCT00266656|585750037|FG000|Overall Study|Death|1|||
162190893|NCT00266656|585750038|FG001|Overall Study|Death|0|||
162190894|NCT00266656|585750037|FG000|Overall Study|Lost to Follow-up|4|||
162190895|NCT00266656|585750038|FG001|Overall Study|Lost to Follow-up|1|||
162190896|NCT00266656|585750037|FG000|Overall Study|Withdrawal by Subject|4|||
162190897|NCT00266656|585750038|FG001|Overall Study|Withdrawal by Subject|2|||
162190898|NCT00266656|585750037|FG000|Overall Study|Did Not Reach Final Height|4|||
162190899|NCT00266656|585750038|FG001|Overall Study|Did Not Reach Final Height|8|||
162190900|NCT00266656|585750037|FG000|Overall Study|Parent/Caregiver Decision|1|||
162190901|NCT00266656|585750038|FG001|Overall Study|Parent/Caregiver Decision|2|||
162190902|NCT00667732|585750040|FG000|Run -In (8 Weeks)|Adverse Event|4|||
162190903|NCT00667732|585750041|FG001|Run -In (8 Weeks)|Adverse Event|0|||
162190904|NCT00667732|585750042|FG002|Run -In (8 Weeks)|Adverse Event|0|||
162190905|NCT00667732|585750040|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
162190906|NCT00667732|585750041|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
162190907|NCT00667732|585750042|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
162190908|NCT00667732|585750040|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
162190909|NCT00667732|585750041|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
162190910|NCT00667732|585750042|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
162190911|NCT02106325|585750043|FG000|Phase 1|Lost to Follow-up|2|||
162190912|NCT02106325|585750044|FG001|Phase 1|Lost to Follow-up|2|||
162190913|NCT02106325|585750043|FG000|Phase 2|Lost to Follow-up|2|||
162190914|NCT02106325|585750044|FG001|Phase 2|Lost to Follow-up|3|||
162190915|NCT02106325|585750043|FG000|Phase 3|Lost to Follow-up|2|||
162190916|NCT02106325|585750044|FG001|Phase 3|Lost to Follow-up|1|||
162190917|NCT03242863|585750045|FG000|Study Week 1|Withdrawal by Subject|0|||
162190918|NCT03242863|585750046|FG001|Study Week 1|Withdrawal by Subject|1|||
162190919|NCT03242863|585750047|FG002|Study Week 1|Withdrawal by Subject|0|||
162190920|NCT03242863|585750048|FG003|Study Week 1|Withdrawal by Subject|0|||
162190921|NCT03242863|585750049|FG004|Study Week 1|Withdrawal by Subject|3|||
162190922|NCT03242863|585750050|FG005|Study Week 1|Withdrawal by Subject|0|||
162190923|NCT05289037|585750054|FG000|Overall Study|Withdrawal by Subject|7|||
162190924|NCT05289037|585750055|FG001|Overall Study|Withdrawal by Subject|0|||
162190925|NCT05289037|585750056|FG002|Overall Study|Withdrawal by Subject|3|||
162190926|NCT05289037|585750057|FG003|Overall Study|Withdrawal by Subject|3|||
162190927|NCT05289037|585750058|FG004|Overall Study|Withdrawal by Subject|1|||
162190928|NCT05289037|585750059|FG005|Overall Study|Withdrawal by Subject|5|||
162190929|NCT05289037|585750060|FG006|Overall Study|Withdrawal by Subject|2|||
162190930|NCT05289037|585750061|FG007|Overall Study|Withdrawal by Subject|1|||
162190931|NCT05289037|585750062|FG008|Overall Study|Withdrawal by Subject|2|||
162190932|NCT05289037|585750063|FG009|Overall Study|Withdrawal by Subject|2|||
162190933|NCT05289037|585750064|FG010|Overall Study|Withdrawal by Subject|1|||
162190934|NCT05289037|585750065|FG011|Overall Study|Withdrawal by Subject|0|||
162190935|NCT05289037|585750066|FG012|Overall Study|Withdrawal by Subject|1|||
162190936|NCT05289037|585750067|FG013|Overall Study|Withdrawal by Subject|2|||
162190937|NCT05289037|585750068|FG014|Overall Study|Withdrawal by Subject|0|||
162190938|NCT05289037|585750069|FG015|Overall Study|Withdrawal by Subject|3|||
162190939|NCT05289037|585750070|FG016|Overall Study|Withdrawal by Subject|3|||
162190940|NCT05289037|585750054|FG000|Overall Study|Lost to Follow-up|1|||
162190941|NCT05289037|585750055|FG001|Overall Study|Lost to Follow-up|4|||
162190942|NCT05289037|585750056|FG002|Overall Study|Lost to Follow-up|3|||
162190943|NCT05289037|585750057|FG003|Overall Study|Lost to Follow-up|3|||
162190944|NCT05289037|585750058|FG004|Overall Study|Lost to Follow-up|3|||
162190945|NCT05289037|585750059|FG005|Overall Study|Lost to Follow-up|2|||
162190946|NCT05289037|585750060|FG006|Overall Study|Lost to Follow-up|3|||
162190947|NCT05289037|585750061|FG007|Overall Study|Lost to Follow-up|2|||
162190948|NCT05289037|585750062|FG008|Overall Study|Lost to Follow-up|2|||
162190949|NCT05289037|585750063|FG009|Overall Study|Lost to Follow-up|1|||
162190950|NCT05289037|585750064|FG010|Overall Study|Lost to Follow-up|3|||
161673870|NCT01968070|583859924|FG007|Period 1|Lost to Follow-up|0|||
161673871|NCT01968070|583859925|FG008|Period 1|Lost to Follow-up|0|||
162190951|NCT05289037|585750065|FG011|Overall Study|Lost to Follow-up|4|||
162190952|NCT05289037|585750066|FG012|Overall Study|Lost to Follow-up|2|||
162190953|NCT05289037|585750067|FG013|Overall Study|Lost to Follow-up|7|||
162190954|NCT05289037|585750068|FG014|Overall Study|Lost to Follow-up|4|||
162190955|NCT05289037|585750069|FG015|Overall Study|Lost to Follow-up|6|||
161673872|NCT01968070|583859926|FG009|Period 1|Lost to Follow-up|0|||
162190956|NCT05289037|585750070|FG016|Overall Study|Lost to Follow-up|4|||
162190957|NCT05289037|585750054|FG000|Overall Study|Death|0|||
161819752|NCT01513239|584381135|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
161673873|NCT01968070|583859927|FG010|Period 1|Lost to Follow-up|0|||
161819753|NCT01513239|584381136|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
161819754|NCT01513239|584381137|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
162020066|NCT01976741|585128578|FG007|Overall Study|Adverse Event|8|||
162190958|NCT05289037|585750055|FG001|Overall Study|Death|0|||
162190959|NCT05289037|585750056|FG002|Overall Study|Death|0|||
161673874|NCT01968070|583859928|FG011|Period 1|Lost to Follow-up|0|||
162190960|NCT05289037|585750057|FG003|Overall Study|Death|0|||
162190961|NCT05289037|585750058|FG004|Overall Study|Death|0|||
162190962|NCT05289037|585750059|FG005|Overall Study|Death|1|||
162190963|NCT05289037|585750060|FG006|Overall Study|Death|0|||
162190964|NCT05289037|585750061|FG007|Overall Study|Death|0|||
162190965|NCT05289037|585750062|FG008|Overall Study|Death|0|||
162190966|NCT05289037|585750063|FG009|Overall Study|Death|0|||
162190967|NCT05289037|585750064|FG010|Overall Study|Death|0|||
162190968|NCT05289037|585750065|FG011|Overall Study|Death|0|||
162190969|NCT05289037|585750066|FG012|Overall Study|Death|0|||
162190970|NCT05289037|585750067|FG013|Overall Study|Death|0|||
162190971|NCT05289037|585750068|FG014|Overall Study|Death|1|||
162190972|NCT05289037|585750069|FG015|Overall Study|Death|0|||
161819755|NCT01513239|584381138|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
161819756|NCT01513239|584381133|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
161819757|NCT01513239|584381134|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
161819758|NCT01513239|584381135|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
161819759|NCT01513239|584381136|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
161819760|NCT01513239|584381137|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
161819761|NCT01513239|584381138|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
161819762|NCT01513239|584381133|FG000|Period 2: 9 Month Extension Phase|Death|0|||
161819763|NCT01513239|584381134|FG001|Period 2: 9 Month Extension Phase|Death|0|||
161819764|NCT01513239|584381135|FG002|Period 2: 9 Month Extension Phase|Death|0|||
161819765|NCT01513239|584381136|FG003|Period 2: 9 Month Extension Phase|Death|2|||
161819766|NCT01513239|584381137|FG004|Period 2: 9 Month Extension Phase|Death|5|||
162190973|NCT05289037|585750070|FG016|Overall Study|Death|0|||
162190974|NCT05289037|585750054|FG000|Overall Study|Did not receive vaccine|0|||
162190975|NCT05289037|585750055|FG001|Overall Study|Did not receive vaccine|3|||
162190976|NCT05289037|585750056|FG002|Overall Study|Did not receive vaccine|0|||
162190977|NCT05289037|585750057|FG003|Overall Study|Did not receive vaccine|0|||
162190978|NCT05289037|585750058|FG004|Overall Study|Did not receive vaccine|1|||
162190979|NCT05289037|585750059|FG005|Overall Study|Did not receive vaccine|1|||
162190980|NCT05289037|585750060|FG006|Overall Study|Did not receive vaccine|1|||
162190981|NCT05289037|585750061|FG007|Overall Study|Did not receive vaccine|0|||
162190982|NCT05289037|585750062|FG008|Overall Study|Did not receive vaccine|0|||
162190983|NCT05289037|585750063|FG009|Overall Study|Did not receive vaccine|0|||
162190984|NCT05289037|585750064|FG010|Overall Study|Did not receive vaccine|0|||
162190985|NCT05289037|585750065|FG011|Overall Study|Did not receive vaccine|0|||
162190986|NCT05289037|585750066|FG012|Overall Study|Did not receive vaccine|0|||
162190987|NCT05289037|585750067|FG013|Overall Study|Did not receive vaccine|0|||
162190988|NCT05289037|585750068|FG014|Overall Study|Did not receive vaccine|1|||
162190989|NCT05289037|585750069|FG015|Overall Study|Did not receive vaccine|0|||
162190990|NCT05289037|585750070|FG016|Overall Study|Did not receive vaccine|0|||
162190991|NCT05289037|585750054|FG000|Overall Study|Unable to make last visit|0|||
162190992|NCT05289037|585750055|FG001|Overall Study|Unable to make last visit|0|||
162190993|NCT05289037|585750056|FG002|Overall Study|Unable to make last visit|1|||
162190994|NCT05289037|585750057|FG003|Overall Study|Unable to make last visit|0|||
162190995|NCT05289037|585750058|FG004|Overall Study|Unable to make last visit|0|||
162190996|NCT05289037|585750059|FG005|Overall Study|Unable to make last visit|0|||
162190997|NCT05289037|585750060|FG006|Overall Study|Unable to make last visit|0|||
162190998|NCT05289037|585750061|FG007|Overall Study|Unable to make last visit|0|||
162190999|NCT05289037|585750062|FG008|Overall Study|Unable to make last visit|0|||
162191000|NCT05289037|585750063|FG009|Overall Study|Unable to make last visit|0|||
162191001|NCT05289037|585750064|FG010|Overall Study|Unable to make last visit|0|||
162191002|NCT05289037|585750065|FG011|Overall Study|Unable to make last visit|0|||
162191003|NCT05289037|585750066|FG012|Overall Study|Unable to make last visit|0|||
162191004|NCT05289037|585750067|FG013|Overall Study|Unable to make last visit|0|||
162191005|NCT05289037|585750068|FG014|Overall Study|Unable to make last visit|0|||
162191006|NCT05289037|585750069|FG015|Overall Study|Unable to make last visit|0|||
162191007|NCT05289037|585750070|FG016|Overall Study|Unable to make last visit|0|||
162191008|NCT05289037|585750054|FG000|Overall Study|Protocol deviation|0|||
162191009|NCT05289037|585750055|FG001|Overall Study|Protocol deviation|0|||
162191010|NCT05289037|585750056|FG002|Overall Study|Protocol deviation|0|||
161673875|NCT01968070|583859929|FG012|Period 1|Lost to Follow-up|0|||
161819767|NCT01513239|584381138|FG005|Period 2: 9 Month Extension Phase|Death|2|||
161819768|NCT01513239|584381133|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
161819769|NCT01513239|584381134|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
161819770|NCT01513239|584381135|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
161819771|NCT01513239|584381136|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
161819772|NCT01513239|584381137|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
161819773|NCT01513239|584381138|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
161819774|NCT01513239|584381133|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161819775|NCT01513239|584381134|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161819776|NCT01513239|584381135|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
162191011|NCT05289037|585750057|FG003|Overall Study|Protocol deviation|0|||
162191012|NCT05289037|585750058|FG004|Overall Study|Protocol deviation|0|||
162191013|NCT05289037|585750059|FG005|Overall Study|Protocol deviation|0|||
162191014|NCT05289037|585750060|FG006|Overall Study|Protocol deviation|0|||
162191015|NCT05289037|585750061|FG007|Overall Study|Protocol deviation|0|||
162191016|NCT05289037|585750062|FG008|Overall Study|Protocol deviation|0|||
162191017|NCT05289037|585750063|FG009|Overall Study|Protocol deviation|0|||
162191018|NCT05289037|585750064|FG010|Overall Study|Protocol deviation|0|||
162191019|NCT05289037|585750065|FG011|Overall Study|Protocol deviation|0|||
162191020|NCT05289037|585750066|FG012|Overall Study|Protocol deviation|0|||
161673876|NCT01968070|583859930|FG013|Period 1|Lost to Follow-up|0|||
162191021|NCT05289037|585750067|FG013|Overall Study|Protocol deviation|0|||
162191022|NCT05289037|585750068|FG014|Overall Study|Protocol deviation|0|||
162191023|NCT05289037|585750069|FG015|Overall Study|Protocol deviation|1|||
162191024|NCT05289037|585750070|FG016|Overall Study|Protocol deviation|0|||
162191025|NCT02831049|585750071|FG000|Overall Study|Lost to Follow-up|0|||
162191026|NCT02831049|585750072|FG001|Overall Study|Lost to Follow-up|0|||
162191027|NCT02831049|585750073|FG002|Overall Study|Lost to Follow-up|1|||
162191028|NCT02831049|585750071|FG000|Overall Study|Withdrawal by Subject|0|||
162191029|NCT02831049|585750072|FG001|Overall Study|Withdrawal by Subject|1|||
162191030|NCT02831049|585750073|FG002|Overall Study|Withdrawal by Subject|1|||
162191031|NCT02831049|585750071|FG000|Overall Study|Pandemic shutdown|1|||
162191032|NCT02831049|585750072|FG001|Overall Study|Pandemic shutdown|0|||
162191033|NCT02831049|585750073|FG002|Overall Study|Pandemic shutdown|0|||
162191034|NCT04186247|585750074|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
162191035|NCT04186247|585750075|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
162191036|NCT04186247|585750076|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
162191037|NCT04186247|585750077|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
162191038|NCT04186247|585750078|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
162191039|NCT05006703|585751345|FG000|Overall Study|Withdrawal by Subject|1|||
162191040|NCT05006703|585751346|FG001|Overall Study|Withdrawal by Subject|0|||
162191041|NCT05006703|585751345|FG000|Overall Study|Lost to Follow-up|13|||
162191042|NCT05006703|585751346|FG001|Overall Study|Lost to Follow-up|5|||
162191043|NCT00264576|585751351|FG000|Overall Study|Lost to Follow-up|1|||
162191044|NCT00264576|585751352|FG001|Overall Study|Lost to Follow-up|1|||
162191045|NCT02659059|585751353|FG000|Overall Study|Other reasons|6|||
162191046|NCT02659059|585751354|FG001|Overall Study|Other reasons|1|||
162191047|NCT02659059|585751353|FG000|Overall Study|Disease Progression|143|||
162191048|NCT02659059|585751354|FG001|Overall Study|Disease Progression|16|||
162191049|NCT02659059|585751353|FG000|Overall Study|Study Drug toxicity|56|||
162191050|NCT02659059|585751354|FG001|Overall Study|Study Drug toxicity|9|||
162191051|NCT02659059|585751353|FG000|Overall Study|Death|3|||
162191052|NCT02659059|585751354|FG001|Overall Study|Death|1|||
162191053|NCT02659059|585751353|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
162191054|NCT02659059|585751354|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
162191055|NCT02659059|585751353|FG000|Overall Study|Participant request to discontinue study treatment|5|||
162191056|NCT02659059|585751354|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162191057|NCT02659059|585751353|FG000|Overall Study|Participant withdrew consent|6|||
162191058|NCT02659059|585751354|FG001|Overall Study|Participant withdrew consent|1|||
162191059|NCT02002689|585751357|FG000|Overall Study|Disease Progression|7|||
162191060|NCT02002689|585751357|FG000|Overall Study|Adverse Event|3|||
162191061|NCT00278395|585751360|FG000|Overall Study|Adverse Event|2|||
162191062|NCT00278395|585751360|FG000|Overall Study|Nonevaluable|1|||
162191063|NCT01148017|585751361|FG000|Overall Study|Withdrawal by Subject|31|||
162191064|NCT01148017|585751362|FG001|Overall Study|Withdrawal by Subject|14|||
162191065|NCT01148017|585751363|FG002|Overall Study|Withdrawal by Subject|0|||
161673877|NCT01968070|583859931|FG014|Period 1|Lost to Follow-up|0|||
161673878|NCT01968070|583859932|FG015|Period 1|Lost to Follow-up|0|||
161673879|NCT01968070|583859933|FG016|Period 1|Lost to Follow-up|0|||
161673880|NCT01968070|583859934|FG017|Period 1|Lost to Follow-up|0|||
161673881|NCT01968070|583859917|FG000|Period 1|Adverse Event|0|||
161673882|NCT01968070|583859918|FG001|Period 1|Adverse Event|0|||
161673883|NCT01968070|583859919|FG002|Period 1|Adverse Event|0|||
161673884|NCT01968070|583859920|FG003|Period 1|Adverse Event|0|||
161673885|NCT01968070|583859921|FG004|Period 1|Adverse Event|0|||
161673886|NCT01968070|583859922|FG005|Period 1|Adverse Event|0|||
161673887|NCT01968070|583859923|FG006|Period 1|Adverse Event|1|||
162191066|NCT01148017|585751364|FG003|Overall Study|Withdrawal by Subject|0|||
162191067|NCT01148017|585751361|FG000|Overall Study|Lost to Follow-up|23|||
162191068|NCT01148017|585751362|FG001|Overall Study|Lost to Follow-up|10|||
162191069|NCT01148017|585751363|FG002|Overall Study|Lost to Follow-up|0|||
162191070|NCT01148017|585751364|FG003|Overall Study|Lost to Follow-up|0|||
162191071|NCT01148017|585751361|FG000|Overall Study|Inappropriate enrollment|1|||
162191072|NCT01148017|585751362|FG001|Overall Study|Inappropriate enrollment|0|||
162191073|NCT01148017|585751363|FG002|Overall Study|Inappropriate enrollment|0|||
162191074|NCT01148017|585751364|FG003|Overall Study|Inappropriate enrollment|0|||
162191075|NCT01148017|585751361|FG000|Overall Study|Administrative reason|22|||
162191076|NCT01148017|585751362|FG001|Overall Study|Administrative reason|9|||
162191077|NCT01148017|585751363|FG002|Overall Study|Administrative reason|0|||
161925687|NCT03166631|584774575|FG009|Overall Study|Progressive disease|5|||
161673888|NCT01968070|583859924|FG007|Period 1|Adverse Event|0|||
161673889|NCT01968070|583859925|FG008|Period 1|Adverse Event|0|||
161673890|NCT01968070|583859926|FG009|Period 1|Adverse Event|0|||
161673891|NCT01968070|583859927|FG010|Period 1|Adverse Event|0|||
161673892|NCT01968070|583859928|FG011|Period 1|Adverse Event|0|||
162191078|NCT01148017|585751364|FG003|Overall Study|Administrative reason|0|||
162191079|NCT01148017|585751361|FG000|Overall Study|Unable to classify|3|||
162191080|NCT01148017|585751362|FG001|Overall Study|Unable to classify|1|||
162191081|NCT01148017|585751363|FG002|Overall Study|Unable to classify|0|||
162191082|NCT01148017|585751364|FG003|Overall Study|Unable to classify|0|||
162191083|NCT00569166|585751367|FG000|Overall Study|Withdrawal by Subject|7|||
162191084|NCT00569166|585751368|FG001|Overall Study|Withdrawal by Subject|5|||
162191085|NCT00569166|585751369|FG002|Overall Study|Withdrawal by Subject|3|||
161819777|NCT01513239|584381136|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
162191086|NCT00569166|585751367|FG000|Overall Study|Lost to Follow-up|2|||
162191087|NCT00569166|585751368|FG001|Overall Study|Lost to Follow-up|1|||
162191088|NCT00569166|585751369|FG002|Overall Study|Lost to Follow-up|1|||
162191089|NCT01853384|585751370|FG000|Randomized|Adverse Event|5|||
162191090|NCT01853384|585751371|FG001|Randomized|Adverse Event|3|||
162191091|NCT01853384|585751370|FG000|Randomized|Death|1|||
162191092|NCT01853384|585751371|FG001|Randomized|Death|2|||
162191093|NCT01853384|585751370|FG000|Randomized|Lost to Follow-up|1|||
162191094|NCT01853384|585751371|FG001|Randomized|Lost to Follow-up|1|||
162191095|NCT01853384|585751370|FG000|Randomized|Withdrawal by Subject|5|||
162191096|NCT01853384|585751371|FG001|Randomized|Withdrawal by Subject|3|||
162191097|NCT01853384|585751370|FG000|Randomized|Sponsor Decision|47|||
162191098|NCT01853384|585751371|FG001|Randomized|Sponsor Decision|34|||
162191099|NCT01853384|585751370|FG000|Randomized|Other|3|||
162191100|NCT01853384|585751371|FG001|Randomized|Other|3|||
162191101|NCT01853384|585751370|FG000|Completed Follow up Visit 1|Early Termination|13|||
162191102|NCT01853384|585751371|FG001|Completed Follow up Visit 1|Early Termination|9|||
162191103|NCT01853384|585751370|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
162191104|NCT01853384|585751371|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
162191105|NCT01853384|585751370|FG000|Completed Follow up Visit 2|Adverse Event|1|||
162191106|NCT01853384|585751371|FG001|Completed Follow up Visit 2|Adverse Event|0|||
162191107|NCT01853384|585751370|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
162191108|NCT01853384|585751371|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
162191109|NCT01853384|585751370|FG000|Completed Follow up Visit 2|Death|1|||
162191110|NCT01853384|585751371|FG001|Completed Follow up Visit 2|Death|0|||
162191111|NCT01853384|585751370|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
162191112|NCT01853384|585751371|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
162191113|NCT03374254|585751372|FG000|Overall Study|Death|5|||
162191114|NCT03374254|585751373|FG001|Overall Study|Death|16|||
162191115|NCT03374254|585751374|FG002|Overall Study|Death|13|||
162191116|NCT03374254|585751375|FG003|Overall Study|Death|11|||
162191117|NCT03374254|585751376|FG004|Overall Study|Death|9|||
162191118|NCT03374254|585751377|FG005|Overall Study|Death|12|||
162191119|NCT03374254|585751378|FG006|Overall Study|Death|11|||
162191120|NCT03374254|585751379|FG007|Overall Study|Death|6|||
162191121|NCT03374254|585751380|FG008|Overall Study|Death|7|||
162191122|NCT03374254|585751372|FG000|Overall Study|Lost to Follow-up|0|||
162191123|NCT03374254|585751373|FG001|Overall Study|Lost to Follow-up|0|||
162191124|NCT03374254|585751374|FG002|Overall Study|Lost to Follow-up|0|||
162191125|NCT03374254|585751375|FG003|Overall Study|Lost to Follow-up|0|||
162191126|NCT03374254|585751376|FG004|Overall Study|Lost to Follow-up|0|||
162191127|NCT03374254|585751377|FG005|Overall Study|Lost to Follow-up|0|||
162191128|NCT03374254|585751378|FG006|Overall Study|Lost to Follow-up|2|||
162191129|NCT03374254|585751379|FG007|Overall Study|Lost to Follow-up|0|||
162191130|NCT03374254|585751380|FG008|Overall Study|Lost to Follow-up|0|||
162191131|NCT03374254|585751372|FG000|Overall Study|Sponsor Decision|1|||
162191132|NCT03374254|585751373|FG001|Overall Study|Sponsor Decision|0|||
162191133|NCT03374254|585751374|FG002|Overall Study|Sponsor Decision|2|||
162191134|NCT03374254|585751375|FG003|Overall Study|Sponsor Decision|3|||
161819778|NCT01513239|584381137|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161819779|NCT01513239|584381138|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161925688|NCT03166631|584774576|FG010|Overall Study|Progressive disease|7|||
162191135|NCT03374254|585751376|FG004|Overall Study|Sponsor Decision|2|||
162191136|NCT03374254|585751377|FG005|Overall Study|Sponsor Decision|3|||
162191137|NCT03374254|585751378|FG006|Overall Study|Sponsor Decision|3|||
162191138|NCT03374254|585751379|FG007|Overall Study|Sponsor Decision|3|||
162191139|NCT03374254|585751380|FG008|Overall Study|Sponsor Decision|4|||
162191140|NCT03374254|585751372|FG000|Overall Study|Withdrawal by Subject|0|||
162191141|NCT03374254|585751373|FG001|Overall Study|Withdrawal by Subject|0|||
162191142|NCT03374254|585751374|FG002|Overall Study|Withdrawal by Subject|0|||
162191143|NCT03374254|585751375|FG003|Overall Study|Withdrawal by Subject|2|||
162191144|NCT03374254|585751376|FG004|Overall Study|Withdrawal by Subject|0|||
162191145|NCT03374254|585751377|FG005|Overall Study|Withdrawal by Subject|1|||
162191146|NCT03374254|585751378|FG006|Overall Study|Withdrawal by Subject|0|||
162191147|NCT03374254|585751379|FG007|Overall Study|Withdrawal by Subject|0|||
162191148|NCT03374254|585751380|FG008|Overall Study|Withdrawal by Subject|0|||
162191149|NCT02784834|585751382|FG000|Overall Study|Lack of Efficacy|1|||
162191150|NCT02245620|585751383|FG000|Overall Study|Physician Decision|1|||
162191151|NCT02245620|585751384|FG001|Overall Study|Physician Decision|1|||
162191152|NCT01090739|585751393|FG000|Enrollment|Withdrawal by Subject|24|||
162191153|NCT01090739|585751393|FG000|Enrollment|Protocol Violation|14|||
162191154|NCT01090739|585751393|FG000|Enrollment|Lost to Follow-up|5|||
162191155|NCT01090739|585751393|FG000|Enrollment|Physician Decision|5|||
162191156|NCT01090739|585751393|FG000|Enrollment|Sponsor termination of site|4|||
162191157|NCT01090739|585751393|FG000|Enrollment|Study implant limit reached|2|||
162191158|NCT01090739|585751393|FG000|Enrollment|Adverse Event|1|||
162191159|NCT01090739|585751393|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
162191160|NCT01090739|585751393|FG000|12 Month Follow-up|Lost to Follow-up|1|||
162191161|NCT01090739|585751393|FG000|12 Month Follow-up|Physician Decision|1|||
162191162|NCT01090739|585751393|FG000|12 Month Follow-up|Death|1|||
162191163|NCT01090739|585751393|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
162191164|NCT01090739|585751393|FG000|24 Month Follow-up|Lost to Follow-up|1|||
162191165|NCT01090739|585751393|FG000|24 Month Follow-up|Death|1|||
162191166|NCT01090739|585751393|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
162191167|NCT01090739|585751393|FG000|36 Month Follow-up|Visit still pending|17|||
162191168|NCT00441168|585751394|FG000|Treatment Period|Death|3|||
162191169|NCT00441168|585751395|FG001|Treatment Period|Death|0|||
162191170|NCT00441168|585751394|FG000|Treatment Period|Adverse Event|1|||
162191171|NCT00441168|585751395|FG001|Treatment Period|Adverse Event|2|||
162191172|NCT00441168|585751394|FG000|Treatment Period|Progressive Disease|0|||
162191173|NCT00441168|585751395|FG001|Treatment Period|Progressive Disease|2|||
162191174|NCT00441168|585751394|FG000|Treatment Period|Protocol Violation|0|||
162191175|NCT00441168|585751395|FG001|Treatment Period|Protocol Violation|1|||
162191176|NCT00441168|585751394|FG000|Treatment Period|Lost to Follow-up|0|||
162191177|NCT00441168|585751395|FG001|Treatment Period|Lost to Follow-up|1|||
162191178|NCT00441168|585751394|FG000|Treatment Period|Withdrawal by Subject|3|||
162191179|NCT00441168|585751395|FG001|Treatment Period|Withdrawal by Subject|0|||
162191180|NCT00441168|585751394|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
162191181|NCT00441168|585751395|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
162191182|NCT00441168|585751394|FG000|Treatment Period|refractory disease|1|||
162191183|NCT00441168|585751395|FG001|Treatment Period|refractory disease|0|||
162191184|NCT00441168|585751394|FG000|Follow-up Period|Death|3|||
162191185|NCT00441168|585751395|FG001|Follow-up Period|Death|0|||
162191186|NCT00441168|585751394|FG000|Follow-up Period|Lost to Follow-up|5|||
162191187|NCT00441168|585751395|FG001|Follow-up Period|Lost to Follow-up|6|||
162191188|NCT00441168|585751394|FG000|Follow-up Period|Withdrawal by Subject|3|||
162191189|NCT00441168|585751395|FG001|Follow-up Period|Withdrawal by Subject|0|||
162191190|NCT00441168|585751394|FG000|Follow-up Period|Other|1|||
162191191|NCT00441168|585751395|FG001|Follow-up Period|Other|3|||
162191192|NCT02291861|585751397|FG000|Overall Study|Adverse Event|2|||
162191193|NCT02291861|585751398|FG001|Overall Study|Adverse Event|4|||
162191194|NCT02291861|585751399|FG002|Overall Study|Adverse Event|1|||
162191195|NCT02291861|585751400|FG003|Overall Study|Adverse Event|2|||
162191196|NCT02291861|585751397|FG000|Overall Study|Death|0|||
162191197|NCT02291861|585751398|FG001|Overall Study|Death|0|||
162191198|NCT02291861|585751399|FG002|Overall Study|Death|1|||
162191199|NCT02291861|585751400|FG003|Overall Study|Death|1|||
162191200|NCT02291861|585751397|FG000|Overall Study|Protocol Violation|1|||
162191201|NCT02291861|585751398|FG001|Overall Study|Protocol Violation|0|||
162191202|NCT02291861|585751399|FG002|Overall Study|Protocol Violation|0|||
162191203|NCT02291861|585751400|FG003|Overall Study|Protocol Violation|1|||
162191204|NCT02291861|585751397|FG000|Overall Study|Withdrawal by Subject|1|||
162191205|NCT02291861|585751398|FG001|Overall Study|Withdrawal by Subject|2|||
162191206|NCT02291861|585751399|FG002|Overall Study|Withdrawal by Subject|1|||
162191207|NCT02291861|585751400|FG003|Overall Study|Withdrawal by Subject|4|||
162191208|NCT02291861|585751397|FG000|Overall Study|Noncompliance|1|||
162191209|NCT02291861|585751398|FG001|Overall Study|Noncompliance|1|||
162191210|NCT02291861|585751399|FG002|Overall Study|Noncompliance|2|||
162191211|NCT02291861|585751400|FG003|Overall Study|Noncompliance|1|||
162191212|NCT02291861|585751397|FG000|Overall Study|Lost to Follow-up|2|||
162191213|NCT02291861|585751398|FG001|Overall Study|Lost to Follow-up|1|||
162191214|NCT02291861|585751399|FG002|Overall Study|Lost to Follow-up|4|||
162191215|NCT02291861|585751400|FG003|Overall Study|Lost to Follow-up|0|||
162191216|NCT02291861|585751397|FG000|Overall Study|Other|0|||
162191217|NCT02291861|585751398|FG001|Overall Study|Other|0|||
162191218|NCT02291861|585751399|FG002|Overall Study|Other|0|||
162191219|NCT02291861|585751400|FG003|Overall Study|Other|1|||
162191220|NCT03547154|585751404|FG000|Overall Study|Disease Progression/Recurrence|6|||
162191221|NCT03547154|585751405|FG001|Overall Study|Disease Progression/Recurrence|14|||
162191222|NCT03547154|585751404|FG000|Overall Study|Adverse Event|26|||
162191223|NCT03547154|585751405|FG001|Overall Study|Adverse Event|31|||
162191224|NCT03547154|585751404|FG000|Overall Study|Protocol Violation|6|||
162191225|NCT03547154|585751405|FG001|Overall Study|Protocol Violation|1|||
162191226|NCT03547154|585751404|FG000|Overall Study|Physician Decision|4|||
162191227|NCT03547154|585751405|FG001|Overall Study|Physician Decision|3|||
162191228|NCT03547154|585751404|FG000|Overall Study|Insufficient Therapeutic Response|13|||
162191229|NCT03547154|585751405|FG001|Overall Study|Insufficient Therapeutic Response|10|||
162191230|NCT03547154|585751404|FG000|Overall Study|Withdrawal by Subject|10|||
162191231|NCT03547154|585751405|FG001|Overall Study|Withdrawal by Subject|6|||
162191232|NCT03547154|585751404|FG000|Overall Study|Not Selected|0|||
162191233|NCT03547154|585751405|FG001|Overall Study|Not Selected|1|||
162191234|NCT03547154|585751404|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
162191235|NCT03547154|585751405|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
162191236|NCT02404441|585751406|FG000|Phase 1 Part|Adverse Event|1|||
162191237|NCT02404441|585751407|FG001|Phase 1 Part|Adverse Event|0|||
162191238|NCT02404441|585751408|FG002|Phase 1 Part|Adverse Event|0|||
162191239|NCT02404441|585751409|FG003|Phase 1 Part|Adverse Event|0|||
162191240|NCT02404441|585751410|FG004|Phase 1 Part|Adverse Event|0|||
162191241|NCT02404441|585751411|FG005|Phase 1 Part|Adverse Event|0|||
162191242|NCT02404441|585751412|FG006|Phase 1 Part|Adverse Event|0|||
162191243|NCT02404441|585751413|FG007|Phase 1 Part|Adverse Event|0|||
162191244|NCT02404441|585751414|FG008|Phase 1 Part|Adverse Event|0|||
162191245|NCT02404441|585751415|FG009|Phase 1 Part|Adverse Event|0|||
162191246|NCT02404441|585751406|FG000|Phase 1 Part|Physician Decision|0|||
162191247|NCT02404441|585751407|FG001|Phase 1 Part|Physician Decision|1|||
162191248|NCT02404441|585751408|FG002|Phase 1 Part|Physician Decision|0|||
162191249|NCT02404441|585751409|FG003|Phase 1 Part|Physician Decision|0|||
162191250|NCT02404441|585751410|FG004|Phase 1 Part|Physician Decision|0|||
162191251|NCT02404441|585751411|FG005|Phase 1 Part|Physician Decision|0|||
162191252|NCT02404441|585751412|FG006|Phase 1 Part|Physician Decision|0|||
162191253|NCT02404441|585751413|FG007|Phase 1 Part|Physician Decision|0|||
162191254|NCT02404441|585751414|FG008|Phase 1 Part|Physician Decision|0|||
162191255|NCT02404441|585751415|FG009|Phase 1 Part|Physician Decision|0|||
162191256|NCT02404441|585751406|FG000|Phase 1 Part|Progressive Disease|14|||
162191257|NCT02404441|585751407|FG001|Phase 1 Part|Progressive Disease|11|||
162191258|NCT02404441|585751408|FG002|Phase 1 Part|Progressive Disease|7|||
162191259|NCT02404441|585751409|FG003|Phase 1 Part|Progressive Disease|6|||
162191260|NCT02404441|585751410|FG004|Phase 1 Part|Progressive Disease|9|||
162191261|NCT02404441|585751411|FG005|Phase 1 Part|Progressive Disease|0|||
162191262|NCT02404441|585751412|FG006|Phase 1 Part|Progressive Disease|0|||
162191263|NCT02404441|585751413|FG007|Phase 1 Part|Progressive Disease|0|||
162191264|NCT02404441|585751414|FG008|Phase 1 Part|Progressive Disease|0|||
162191265|NCT02404441|585751415|FG009|Phase 1 Part|Progressive Disease|0|||
162191266|NCT02404441|585751406|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
162191267|NCT02404441|585751407|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
162191268|NCT02404441|585751408|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
162191269|NCT02404441|585751409|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
162191270|NCT02404441|585751410|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
162191271|NCT02404441|585751411|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
162191272|NCT02404441|585751412|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
162191273|NCT02404441|585751413|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
162191274|NCT02404441|585751414|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
162191275|NCT02404441|585751415|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
162191276|NCT02404441|585751406|FG000|Phase 1 Part|Death|1|||
162191277|NCT02404441|585751407|FG001|Phase 1 Part|Death|1|||
162191278|NCT02404441|585751408|FG002|Phase 1 Part|Death|1|||
162191279|NCT02404441|585751409|FG003|Phase 1 Part|Death|0|||
162191280|NCT02404441|585751410|FG004|Phase 1 Part|Death|1|||
162191281|NCT02404441|585751411|FG005|Phase 1 Part|Death|0|||
162191282|NCT02404441|585751412|FG006|Phase 1 Part|Death|0|||
162191283|NCT02404441|585751413|FG007|Phase 1 Part|Death|0|||
162191284|NCT02404441|585751414|FG008|Phase 1 Part|Death|0|||
162191285|NCT02404441|585751415|FG009|Phase 1 Part|Death|0|||
162191286|NCT02404441|585751406|FG000|Phase 2 Part|Adverse Event|0|||
162191287|NCT02404441|585751407|FG001|Phase 2 Part|Adverse Event|0|||
162191288|NCT02404441|585751408|FG002|Phase 2 Part|Adverse Event|0|||
162191289|NCT02404441|585751409|FG003|Phase 2 Part|Adverse Event|0|||
162191290|NCT02404441|585751410|FG004|Phase 2 Part|Adverse Event|0|||
162191291|NCT02404441|585751411|FG005|Phase 2 Part|Adverse Event|2|||
162191292|NCT02404441|585751412|FG006|Phase 2 Part|Adverse Event|3|||
162191293|NCT02404441|585751413|FG007|Phase 2 Part|Adverse Event|3|||
162191294|NCT02404441|585751414|FG008|Phase 2 Part|Adverse Event|6|||
162191295|NCT02404441|585751415|FG009|Phase 2 Part|Adverse Event|1|||
162191296|NCT02404441|585751406|FG000|Phase 2 Part|Physician Decision|0|||
162191297|NCT02404441|585751407|FG001|Phase 2 Part|Physician Decision|0|||
162191298|NCT02404441|585751408|FG002|Phase 2 Part|Physician Decision|0|||
162191299|NCT02404441|585751409|FG003|Phase 2 Part|Physician Decision|0|||
162191300|NCT02404441|585751410|FG004|Phase 2 Part|Physician Decision|0|||
162191301|NCT02404441|585751411|FG005|Phase 2 Part|Physician Decision|7|||
162191302|NCT02404441|585751412|FG006|Phase 2 Part|Physician Decision|9|||
162191303|NCT02404441|585751413|FG007|Phase 2 Part|Physician Decision|2|||
162191304|NCT02404441|585751414|FG008|Phase 2 Part|Physician Decision|1|||
162191305|NCT02404441|585751415|FG009|Phase 2 Part|Physician Decision|3|||
162191306|NCT02404441|585751406|FG000|Phase 2 Part|Progressive disease|0|||
162191307|NCT02404441|585751407|FG001|Phase 2 Part|Progressive disease|0|||
162191308|NCT02404441|585751408|FG002|Phase 2 Part|Progressive disease|0|||
162191309|NCT02404441|585751409|FG003|Phase 2 Part|Progressive disease|0|||
162191310|NCT02404441|585751410|FG004|Phase 2 Part|Progressive disease|0|||
162191311|NCT02404441|585751411|FG005|Phase 2 Part|Progressive disease|43|||
162191312|NCT02404441|585751412|FG006|Phase 2 Part|Progressive disease|32|||
162191313|NCT02404441|585751413|FG007|Phase 2 Part|Progressive disease|31|||
162191314|NCT02404441|585751414|FG008|Phase 2 Part|Progressive disease|39|||
162191315|NCT02404441|585751415|FG009|Phase 2 Part|Progressive disease|27|||
162191316|NCT02404441|585751406|FG000|Phase 2 Part|Subject/guardian decision|0|||
162191317|NCT02404441|585751407|FG001|Phase 2 Part|Subject/guardian decision|0|||
162191318|NCT02404441|585751408|FG002|Phase 2 Part|Subject/guardian decision|0|||
162191319|NCT02404441|585751409|FG003|Phase 2 Part|Subject/guardian decision|0|||
162191320|NCT02404441|585751410|FG004|Phase 2 Part|Subject/guardian decision|0|||
162191321|NCT02404441|585751411|FG005|Phase 2 Part|Subject/guardian decision|3|||
162191322|NCT02404441|585751412|FG006|Phase 2 Part|Subject/guardian decision|9|||
162191323|NCT02404441|585751413|FG007|Phase 2 Part|Subject/guardian decision|0|||
162191324|NCT02404441|585751414|FG008|Phase 2 Part|Subject/guardian decision|3|||
162191325|NCT02404441|585751415|FG009|Phase 2 Part|Subject/guardian decision|2|||
162191326|NCT02404441|585751406|FG000|Phase 2 Part|Death|0|||
162191327|NCT02404441|585751407|FG001|Phase 2 Part|Death|0|||
162191328|NCT02404441|585751408|FG002|Phase 2 Part|Death|0|||
162191329|NCT02404441|585751409|FG003|Phase 2 Part|Death|0|||
162191330|NCT02404441|585751410|FG004|Phase 2 Part|Death|0|||
162191331|NCT02404441|585751411|FG005|Phase 2 Part|Death|4|||
162191332|NCT02404441|585751412|FG006|Phase 2 Part|Death|8|||
162191333|NCT02404441|585751413|FG007|Phase 2 Part|Death|4|||
162191334|NCT02404441|585751414|FG008|Phase 2 Part|Death|10|||
162191335|NCT02404441|585751415|FG009|Phase 2 Part|Death|9|||
162191336|NCT02671266|585751416|FG000|Overall Study|Withdrawal by Subject|1|||
162191337|NCT02671266|585751417|FG001|Overall Study|Withdrawal by Subject|1|||
162191338|NCT03390166|585751420|FG000|Overall Study|Death|0|||
162191339|NCT03390166|585751421|FG001|Overall Study|Death|1|||
162191340|NCT03390166|585751420|FG000|Overall Study|Lost to Follow-up|6|||
162191341|NCT03390166|585751421|FG001|Overall Study|Lost to Follow-up|4|||
162191342|NCT03390166|585751420|FG000|Overall Study|Physician Decision|2|||
162191343|NCT03390166|585751421|FG001|Overall Study|Physician Decision|1|||
162191344|NCT03390166|585751420|FG000|Overall Study|Move from study area|3|||
162191345|NCT03390166|585751421|FG001|Overall Study|Move from study area|2|||
162191346|NCT03390166|585751420|FG000|Overall Study|To militarycamp for conscript|1|||
162191347|NCT03390166|585751421|FG001|Overall Study|To militarycamp for conscript|0|||
162191348|NCT03390166|585751420|FG000|Overall Study|To drug therapy course|0|||
162191349|NCT03390166|585751421|FG001|Overall Study|To drug therapy course|1|||
162191350|NCT03390166|585751420|FG000|Overall Study|Move to work oversea|0|||
162191351|NCT03390166|585751421|FG001|Overall Study|Move to work oversea|1|||
162191352|NCT01328756|585751425|FG000|Overall Study|Protocol Violation|4|||
162191353|NCT01328756|585751425|FG000|Overall Study|Adverse Event|39|||
162191354|NCT01328756|585751425|FG000|Overall Study|Lack of Efficacy|5|||
162191355|NCT01328756|585751425|FG000|Overall Study|Withdrawal by Subject|41|||
162191356|NCT01328756|585751425|FG000|Overall Study|Lost to Follow-up|5|||
162191357|NCT01328756|585751425|FG000|Overall Study|Other|29|||
162191358|NCT00705159|585751439|FG000|Overall Study|Withdrawal by Subject|0|||
162191359|NCT00705159|585751440|FG001|Overall Study|Withdrawal by Subject|1|||
162191360|NCT00705159|585751441|FG002|Overall Study|Withdrawal by Subject|1|||
162191361|NCT00705159|585751442|FG003|Overall Study|Withdrawal by Subject|1|||
162191362|NCT00705159|585751439|FG000|Overall Study|Protocol Violation|0|||
162191363|NCT00705159|585751440|FG001|Overall Study|Protocol Violation|1|||
162191364|NCT00705159|585751441|FG002|Overall Study|Protocol Violation|0|||
162191365|NCT00705159|585751442|FG003|Overall Study|Protocol Violation|0|||
162191366|NCT00705159|585751439|FG000|Overall Study|Adverse Event|0|||
162191367|NCT00705159|585751440|FG001|Overall Study|Adverse Event|0|||
162191368|NCT00705159|585751441|FG002|Overall Study|Adverse Event|1|||
162191369|NCT00705159|585751442|FG003|Overall Study|Adverse Event|0|||
162191370|NCT00705159|585751439|FG000|Overall Study|Lost to Follow-up|0|||
162191371|NCT00705159|585751440|FG001|Overall Study|Lost to Follow-up|0|||
162191372|NCT00705159|585751441|FG002|Overall Study|Lost to Follow-up|3|||
162191373|NCT00705159|585751442|FG003|Overall Study|Lost to Follow-up|2|||
161673893|NCT01968070|583859929|FG012|Period 1|Adverse Event|0|||
161673894|NCT01968070|583859930|FG013|Period 1|Adverse Event|0|||
161673895|NCT01968070|583859931|FG014|Period 1|Adverse Event|0|||
162191374|NCT00705159|585751439|FG000|Overall Study|Screen Failure|0|||
162191375|NCT00705159|585751440|FG001|Overall Study|Screen Failure|0|||
162191376|NCT00705159|585751441|FG002|Overall Study|Screen Failure|0|||
161673896|NCT01968070|583859932|FG015|Period 1|Adverse Event|0|||
161673897|NCT01968070|583859933|FG016|Period 1|Adverse Event|0|||
162191377|NCT00705159|585751442|FG003|Overall Study|Screen Failure|1|||
162191378|NCT00526994|585751443|FG000|Overall Study|Lost to Follow-up|98|||
162191379|NCT00526994|585751444|FG001|Overall Study|Lost to Follow-up|108|||
162191380|NCT00526994|585751445|FG002|Overall Study|Lost to Follow-up|96|||
162191381|NCT00526994|585751443|FG000|Overall Study|Death|4|||
162191382|NCT00526994|585751444|FG001|Overall Study|Death|3|||
162191383|NCT00526994|585751445|FG002|Overall Study|Death|3|||
162191384|NCT00526994|585751443|FG000|Overall Study|Withdrawal by Subject|2|||
161819780|NCT01513239|584381133|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
162191385|NCT00526994|585751444|FG001|Overall Study|Withdrawal by Subject|7|||
162191386|NCT00526994|585751445|FG002|Overall Study|Withdrawal by Subject|5|||
162191387|NCT00526994|585751443|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
162191388|NCT00526994|585751444|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
161819781|NCT01513239|584381134|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
161819782|NCT01513239|584381135|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
162191389|NCT00526994|585751445|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
162191390|NCT04821271|585751449|FG000|Period 1|Withdrawal by Subject|2|||
162191391|NCT04821271|585751450|FG001|Period 1|Withdrawal by Subject|0|||
162191392|NCT02521493|585751453|FG000|Overall Study|Death|3|||
162191393|NCT02521493|585751454|FG001|Overall Study|Death|4|||
162191394|NCT02521493|585751455|FG002|Overall Study|Death|1|||
162191395|NCT02521493|585751453|FG000|Overall Study|Physician Decision|19|||
162191396|NCT02521493|585751454|FG001|Overall Study|Physician Decision|1|||
162191397|NCT02521493|585751455|FG002|Overall Study|Physician Decision|2|||
162191398|NCT02521493|585751453|FG000|Overall Study|Withdrawal by Subject|3|||
162191399|NCT02521493|585751454|FG001|Overall Study|Withdrawal by Subject|0|||
162191400|NCT02521493|585751455|FG002|Overall Study|Withdrawal by Subject|0|||
162191401|NCT02521493|585751453|FG000|Overall Study|Ineligible|0|||
162191402|NCT02521493|585751454|FG001|Overall Study|Ineligible|1|||
162191403|NCT02521493|585751455|FG002|Overall Study|Ineligible|0|||
162191404|NCT02521493|585751453|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
162191405|NCT02521493|585751454|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
162191406|NCT02521493|585751455|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
162191407|NCT02521493|585751453|FG000|Overall Study|No MRD result|0|||
162191408|NCT02521493|585751454|FG001|Overall Study|No MRD result|0|||
162191409|NCT02521493|585751455|FG002|Overall Study|No MRD result|4|||
162191410|NCT01880736|585751456|FG000|Overall Study|Adverse Event|0|||
162191411|NCT01880736|585751457|FG001|Overall Study|Adverse Event|0|||
162191412|NCT01880736|585751458|FG002|Overall Study|Adverse Event|0|||
162191413|NCT01880736|585751459|FG003|Overall Study|Adverse Event|1|||
162191414|NCT01880736|585751456|FG000|Overall Study|Withdrawal Criteria|1|||
162191415|NCT01880736|585751457|FG001|Overall Study|Withdrawal Criteria|2|||
162191416|NCT01880736|585751458|FG002|Overall Study|Withdrawal Criteria|1|||
162191417|NCT01880736|585751459|FG003|Overall Study|Withdrawal Criteria|5|||
162191418|NCT00428714|585751462|FG000|Overall Study|Progressive Disease|28|||
162191419|NCT00428714|585751463|FG001|Overall Study|Progressive Disease|36|||
162191420|NCT00428714|585751462|FG000|Overall Study|Withdrawal by Subject|0|||
162191421|NCT00428714|585751463|FG001|Overall Study|Withdrawal by Subject|3|||
162191422|NCT00428714|585751462|FG000|Overall Study|Adverse Event|0|||
162191423|NCT00428714|585751463|FG001|Overall Study|Adverse Event|2|||
162191424|NCT00428714|585751462|FG000|Overall Study|Physician Decision|1|||
161819783|NCT01513239|584381136|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
162191425|NCT00428714|585751463|FG001|Overall Study|Physician Decision|1|||
162191426|NCT00428714|585751462|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
162191427|NCT00428714|585751463|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
162191428|NCT00428714|585751462|FG000|Overall Study|Death due to other then PD|1|||
162191429|NCT00428714|585751463|FG001|Overall Study|Death due to other then PD|0|||
162191430|NCT00513071|585751465|FG000|Overall Study|Adverse Event|1|||
162191431|NCT00513071|585751465|FG000|Overall Study|Withdrawal by Subject|1|||
162191432|NCT00513071|585751465|FG000|Overall Study|Physician Decision|3|||
162191433|NCT00452114|585751468|FG000|Overall Study|Physician Decision|3|||
162191434|NCT00452114|585751469|FG001|Overall Study|Physician Decision|3|||
162191435|NCT04602728|585751471|FG000|Overall Study|Lost to Follow-up|4|||
162191436|NCT04602728|585751472|FG001|Overall Study|Lost to Follow-up|4|||
162191437|NCT03786471|585751478|FG000|Overall Study|Death|254|||
162191438|NCT03786471|585751479|FG001|Overall Study|Death|223|||
161819784|NCT01513239|584381137|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
162191439|NCT03786471|585751480|FG002|Overall Study|Death|37|||
162191440|NCT03786471|585751478|FG000|Overall Study|Lost to Follow-up|63|||
161819785|NCT01513239|584381138|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
161819786|NCT00396162|584381139|FG000|Overall Study|Withdrawal by Subject|2|||
161819787|NCT00396162|584381140|FG001|Overall Study|Withdrawal by Subject|3|||
161819788|NCT02694536|584381141|FG000|Overall Study|Progressive Disease|40|||
161819789|NCT02694536|584381141|FG000|Overall Study|Lost to Follow-up|1|||
162191441|NCT03786471|585751479|FG001|Overall Study|Lost to Follow-up|50|||
162191442|NCT03786471|585751480|FG002|Overall Study|Lost to Follow-up|15|||
162191443|NCT03786471|585751478|FG000|Overall Study|Withdrawal by Subject|99|||
162191444|NCT03786471|585751479|FG001|Overall Study|Withdrawal by Subject|81|||
162191445|NCT03786471|585751480|FG002|Overall Study|Withdrawal by Subject|11|||
162191446|NCT00747149|585753046|FG000|Overall Study|Adverse Event|0|||
162191447|NCT00747149|585753047|FG001|Overall Study|Adverse Event|15|||
162191448|NCT00747149|585753046|FG000|Overall Study|Lost to Follow-up|0|||
162191449|NCT00747149|585753047|FG001|Overall Study|Lost to Follow-up|10|||
162191450|NCT00747149|585753046|FG000|Overall Study|Withdrawal by Subject|0|||
162191451|NCT00747149|585753047|FG001|Overall Study|Withdrawal by Subject|6|||
162191452|NCT00747149|585753046|FG000|Overall Study|Did not receive treatment|0|||
162191453|NCT00747149|585753047|FG001|Overall Study|Did not receive treatment|1|||
162191454|NCT00747149|585753046|FG000|Overall Study|Incorrect enrollment|0|||
162191455|NCT00747149|585753047|FG001|Overall Study|Incorrect enrollment|6|||
162191456|NCT00747149|585753046|FG000|Overall Study|Severe non-compliance to protocol|0|||
162191457|NCT00747149|585753047|FG001|Overall Study|Severe non-compliance to protocol|1|||
162191458|NCT00747149|585753046|FG000|Overall Study|Not reported|1|||
162191459|NCT00747149|585753047|FG001|Overall Study|Not reported|4|||
162191460|NCT03141177|585753050|FG000|Overall Study|Death|62|||
162191461|NCT03141177|585753051|FG001|Overall Study|Death|13|||
162191462|NCT03141177|585753052|FG002|Overall Study|Death|84|||
162191463|NCT03141177|585753050|FG000|Overall Study|Participant withdrew consent|9|||
162191464|NCT03141177|585753051|FG001|Overall Study|Participant withdrew consent|2|||
162020067|NCT01976741|585128579|FG008|Overall Study|Adverse Event|1|||
162020068|NCT01976741|585128580|FG009|Overall Study|Adverse Event|4|||
162191465|NCT03141177|585753052|FG002|Overall Study|Participant withdrew consent|13|||
162191466|NCT03141177|585753050|FG000|Overall Study|Not reported|1|||
162191467|NCT03141177|585753051|FG001|Overall Study|Not reported|0|||
162191468|NCT03141177|585753052|FG002|Overall Study|Not reported|1|||
162191469|NCT03141177|585753050|FG000|Overall Study|Lost to Follow-up|2|||
162191470|NCT03141177|585753051|FG001|Overall Study|Lost to Follow-up|1|||
162191471|NCT03141177|585753052|FG002|Overall Study|Lost to Follow-up|1|||
162191472|NCT03141177|585753050|FG000|Overall Study|Other reasons|4|||
162191473|NCT03141177|585753051|FG001|Overall Study|Other reasons|0|||
162191474|NCT03141177|585753052|FG002|Overall Study|Other reasons|11|||
162191475|NCT03141177|585753050|FG000|Overall Study|Participants did not start treatment period|3|||
162191476|NCT03141177|585753051|FG001|Overall Study|Participants did not start treatment period|0|||
162191477|NCT03141177|585753052|FG002|Overall Study|Participants did not start treatment period|8|||
162191478|NCT00092456|585753053|FG000|Overall Study|Adverse Event|0|||
162191479|NCT00092456|585753054|FG001|Overall Study|Adverse Event|0|||
162191480|NCT00092456|585753055|FG002|Overall Study|Adverse Event|1|||
162191481|NCT00092456|585753056|FG003|Overall Study|Adverse Event|1|||
162191482|NCT00092456|585753053|FG000|Overall Study|Lost to Follow-up|2|||
162191483|NCT00092456|585753054|FG001|Overall Study|Lost to Follow-up|2|||
162191484|NCT00092456|585753055|FG002|Overall Study|Lost to Follow-up|1|||
162191485|NCT00092456|585753056|FG003|Overall Study|Lost to Follow-up|2|||
162191486|NCT00092456|585753053|FG000|Overall Study|Protocol Violation|5|||
162191487|NCT00092456|585753054|FG001|Overall Study|Protocol Violation|7|||
162191488|NCT00092456|585753055|FG002|Overall Study|Protocol Violation|8|||
162191489|NCT00092456|585753056|FG003|Overall Study|Protocol Violation|6|||
162191490|NCT00092456|585753053|FG000|Overall Study|Withdrawal by Subject|13|||
162191491|NCT00092456|585753054|FG001|Overall Study|Withdrawal by Subject|5|||
162191492|NCT00092456|585753055|FG002|Overall Study|Withdrawal by Subject|16|||
162191493|NCT00092456|585753056|FG003|Overall Study|Withdrawal by Subject|6|||
162191494|NCT00092456|585753053|FG000|Overall Study|Moved|1|||
162191495|NCT00092456|585753054|FG001|Overall Study|Moved|1|||
162191496|NCT00092456|585753055|FG002|Overall Study|Moved|0|||
162191497|NCT00092456|585753056|FG003|Overall Study|Moved|1|||
162191498|NCT00092456|585753053|FG000|Overall Study|Other|4|||
162191499|NCT00092456|585753054|FG001|Overall Study|Other|2|||
162191500|NCT00092456|585753055|FG002|Overall Study|Other|3|||
162191501|NCT00092456|585753056|FG003|Overall Study|Other|0|||
162191502|NCT00215943|585753057|FG000|Overall Study|Disease Progression|3|||
162191503|NCT00215943|585753058|FG001|Overall Study|Disease Progression|5|||
162191504|NCT00215943|585753057|FG000|Overall Study|Alternate therapy|0|||
162191505|NCT00215943|585753058|FG001|Overall Study|Alternate therapy|1|||
162191506|NCT00215943|585753057|FG000|Overall Study|Adverse Event|3|||
162191507|NCT00215943|585753058|FG001|Overall Study|Adverse Event|6|||
162191508|NCT00215943|585753057|FG000|Overall Study|Other disease|0|||
162191509|NCT00215943|585753058|FG001|Overall Study|Other disease|1|||
162191510|NCT00215943|585753057|FG000|Overall Study|Other complications|3|||
162191511|NCT00215943|585753058|FG001|Overall Study|Other complications|1|||
162191512|NCT00443820|585753059|FG000|Overall Study|Adverse Event|1|||
162191513|NCT00443820|585753060|FG001|Overall Study|Adverse Event|1|||
162191514|NCT00443820|585753061|FG002|Overall Study|Adverse Event|0|||
162191515|NCT00443820|585753062|FG003|Overall Study|Adverse Event|0|||
162191516|NCT00443820|585753059|FG000|Overall Study|Lack of Efficacy|3|||
162020069|NCT00889720|585128583|FG000|Overall Study|Withdrawal by Subject|4|||
162191517|NCT00443820|585753060|FG001|Overall Study|Lack of Efficacy|2|||
162191518|NCT00443820|585753061|FG002|Overall Study|Lack of Efficacy|1|||
162191519|NCT00443820|585753062|FG003|Overall Study|Lack of Efficacy|1|||
162191520|NCT00443820|585753059|FG000|Overall Study|Protocol Violation|2|||
162191521|NCT00443820|585753060|FG001|Overall Study|Protocol Violation|1|||
162191522|NCT00443820|585753061|FG002|Overall Study|Protocol Violation|2|||
162191523|NCT00443820|585753062|FG003|Overall Study|Protocol Violation|1|||
162191524|NCT00443820|585753059|FG000|Overall Study|Withdrawal by Subject|6|||
162191525|NCT00443820|585753060|FG001|Overall Study|Withdrawal by Subject|7|||
162191526|NCT00443820|585753061|FG002|Overall Study|Withdrawal by Subject|8|||
162191527|NCT00443820|585753062|FG003|Overall Study|Withdrawal by Subject|9|||
162191528|NCT00443820|585753059|FG000|Overall Study|Lost to Follow-up|9|||
162020070|NCT00889720|585128583|FG000|Overall Study|Other|4|||
162020071|NCT04080167|585128584|FG000|Overall Study|Lost to Follow-up-Patients|7|||
162020072|NCT04080167|585128585|FG001|Overall Study|Lost to Follow-up-Patients|14|||
162020073|NCT04080167|585128586|FG002|Overall Study|Lost to Follow-up-Patients|0|||
162020074|NCT04080167|585128584|FG000|Overall Study|Lost to Follow-up-Providers|2|||
162020075|NCT04080167|585128585|FG001|Overall Study|Lost to Follow-up-Providers|2|||
162020076|NCT04080167|585128586|FG002|Overall Study|Lost to Follow-up-Providers|0|||
162020077|NCT04080167|585128584|FG000|Overall Study|Withdrawal by Subject|1|||
162020078|NCT04080167|585128585|FG001|Overall Study|Withdrawal by Subject|2|||
162020079|NCT04080167|585128586|FG002|Overall Study|Withdrawal by Subject|0|||
162020080|NCT04080167|585128584|FG000|Overall Study|Withdrawal by Provider|0|||
162020081|NCT04080167|585128585|FG001|Overall Study|Withdrawal by Provider|0|||
162020082|NCT04080167|585128586|FG002|Overall Study|Withdrawal by Provider|4|||
162020083|NCT04080167|585128584|FG000|Overall Study|Death-Patient|2|||
162020084|NCT04080167|585128585|FG001|Overall Study|Death-Patient|1|||
162020085|NCT04080167|585128586|FG002|Overall Study|Death-Patient|0|||
162020086|NCT04080167|585128584|FG000|Overall Study|Hydroxyurea New Starts|0|||
162020087|NCT04080167|585128585|FG001|Overall Study|Hydroxyurea New Starts|0|||
162020088|NCT04080167|585128586|FG002|Overall Study|Hydroxyurea New Starts|1|||
162020089|NCT04080167|585128584|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
162020090|NCT04080167|585128585|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
162020091|NCT04080167|585128586|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
162020092|NCT02100696|585128587|FG000|Induction Phase|Adverse Event|0|||
162020093|NCT02100696|585128588|FG001|Induction Phase|Adverse Event|0|||
162020094|NCT02100696|585128589|FG002|Induction Phase|Adverse Event|1|||
162020095|NCT02100696|585128590|FG003|Induction Phase|Adverse Event|0|||
162020096|NCT02100696|585128591|FG004|Induction Phase|Adverse Event|0|||
162020097|NCT02100696|585128592|FG005|Induction Phase|Adverse Event|0|||
162020098|NCT02100696|585128587|FG000|Induction Phase|Lost to Follow-up|1|||
162020099|NCT02100696|585128588|FG001|Induction Phase|Lost to Follow-up|0|||
162020100|NCT02100696|585128589|FG002|Induction Phase|Lost to Follow-up|1|||
162020101|NCT02100696|585128590|FG003|Induction Phase|Lost to Follow-up|0|||
162020102|NCT02100696|585128591|FG004|Induction Phase|Lost to Follow-up|0|||
162020103|NCT02100696|585128592|FG005|Induction Phase|Lost to Follow-up|0|||
162020104|NCT02100696|585128587|FG000|Induction Phase|Protocol Violation|0|||
162020105|NCT02100696|585128588|FG001|Induction Phase|Protocol Violation|1|||
162020106|NCT02100696|585128589|FG002|Induction Phase|Protocol Violation|1|||
162020107|NCT02100696|585128590|FG003|Induction Phase|Protocol Violation|0|||
162020108|NCT02100696|585128591|FG004|Induction Phase|Protocol Violation|0|||
162020109|NCT02100696|585128592|FG005|Induction Phase|Protocol Violation|0|||
162020110|NCT02100696|585128587|FG000|Induction Phase|Withdrawal by Subject|8|||
162191529|NCT00443820|585753060|FG001|Overall Study|Lost to Follow-up|8|||
162191530|NCT00443820|585753061|FG002|Overall Study|Lost to Follow-up|6|||
162191531|NCT00443820|585753062|FG003|Overall Study|Lost to Follow-up|5|||
162191532|NCT00443820|585753059|FG000|Overall Study|Administrative problems|0|||
162191533|NCT00443820|585753060|FG001|Overall Study|Administrative problems|0|||
162191534|NCT00443820|585753061|FG002|Overall Study|Administrative problems|0|||
162191535|NCT00443820|585753062|FG003|Overall Study|Administrative problems|1|||
162191536|NCT00443820|585753059|FG000|Overall Study|Death|0|||
162191537|NCT00443820|585753060|FG001|Overall Study|Death|0|||
162191538|NCT00443820|585753061|FG002|Overall Study|Death|1|||
162191539|NCT00443820|585753062|FG003|Overall Study|Death|0|||
162191540|NCT02121808|585753063|FG000|Overall Study|Technical problem|3|||
162191541|NCT03924193|585753064|FG000|Overall Study|Adverse Event|10|||
162191542|NCT03924193|585753065|FG001|Overall Study|Adverse Event|0|||
161819790|NCT02694536|584381141|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
161819791|NCT02694536|584381141|FG000|Overall Study|Withdrawal by Subject|8|||
162020111|NCT02100696|585128588|FG001|Induction Phase|Withdrawal by Subject|2|||
162020112|NCT02100696|585128589|FG002|Induction Phase|Withdrawal by Subject|13|||
162020113|NCT02100696|585128590|FG003|Induction Phase|Withdrawal by Subject|0|||
162020114|NCT02100696|585128591|FG004|Induction Phase|Withdrawal by Subject|0|||
162020115|NCT02100696|585128592|FG005|Induction Phase|Withdrawal by Subject|0|||
162020116|NCT02100696|585128587|FG000|Induction Phase|Physician Decision|1|||
162020117|NCT02100696|585128588|FG001|Induction Phase|Physician Decision|0|||
162020118|NCT02100696|585128589|FG002|Induction Phase|Physician Decision|2|||
162020119|NCT02100696|585128590|FG003|Induction Phase|Physician Decision|0|||
162020120|NCT02100696|585128591|FG004|Induction Phase|Physician Decision|0|||
162191543|NCT03924193|585753066|FG002|Overall Study|Adverse Event|10|||
162191544|NCT03924193|585753064|FG000|Overall Study|Withdrawal by Subject|5|||
162191545|NCT03924193|585753065|FG001|Overall Study|Withdrawal by Subject|10|||
162191546|NCT03924193|585753066|FG002|Overall Study|Withdrawal by Subject|2|||
162191547|NCT02489799|585753067|FG000|Overall Study|Lost to Follow-up|4|||
162191548|NCT02489799|585753068|FG001|Overall Study|Lost to Follow-up|1|||
162191549|NCT02489799|585753067|FG000|Overall Study|Failure to Maintain Eligibility|4|||
162191550|NCT02489799|585753068|FG001|Overall Study|Failure to Maintain Eligibility|6|||
162191551|NCT02489799|585753067|FG000|Overall Study|Withdrawal by Subject|1|||
162191552|NCT02489799|585753068|FG001|Overall Study|Withdrawal by Subject|1|||
162191553|NCT02489799|585753067|FG000|Overall Study|Death|0|||
162191554|NCT02489799|585753068|FG001|Overall Study|Death|1|||
162191555|NCT00515112|585753070|FG000|Overall Study|Death|0|||
162191556|NCT00515112|585753071|FG001|Overall Study|Death|1|||
162191557|NCT00515112|585753070|FG000|Overall Study|The study was terminated|3|||
162191558|NCT00515112|585753071|FG001|Overall Study|The study was terminated|2|||
162191559|NCT02753075|585753077|FG000|Overall Study|Adverse Event|2|||
162191560|NCT02753075|585753078|FG001|Overall Study|Adverse Event|1|||
162191561|NCT02753075|585753079|FG002|Overall Study|Adverse Event|0|||
162191562|NCT02753075|585753077|FG000|Overall Study|Lost to Follow-up|2|||
161673898|NCT01968070|583859934|FG017|Period 1|Adverse Event|0|||
161673899|NCT01968070|583859917|FG000|Period 1|Physician Decision|0|||
161673900|NCT01968070|583859918|FG001|Period 1|Physician Decision|0|||
161673901|NCT01968070|583859919|FG002|Period 1|Physician Decision|0|||
161673902|NCT01968070|583859920|FG003|Period 1|Physician Decision|0|||
161673903|NCT01968070|583859921|FG004|Period 1|Physician Decision|0|||
161673904|NCT01968070|583859922|FG005|Period 1|Physician Decision|0|||
161673905|NCT01968070|583859923|FG006|Period 1|Physician Decision|0|||
161673906|NCT01968070|583859924|FG007|Period 1|Physician Decision|0|||
161819792|NCT02694536|584381141|FG000|Overall Study|Death|8|||
161819793|NCT02694536|584381141|FG000|Overall Study|Other|22|||
161819794|NCT01911429|584381142|FG000|Overall Study|Adverse Event|5|||
162191563|NCT02753075|585753078|FG001|Overall Study|Lost to Follow-up|0|||
162191564|NCT02753075|585753079|FG002|Overall Study|Lost to Follow-up|0|||
162191565|NCT02753075|585753077|FG000|Overall Study|Withdrawal of Consent|1|||
162191566|NCT02753075|585753078|FG001|Overall Study|Withdrawal of Consent|1|||
162191567|NCT02753075|585753079|FG002|Overall Study|Withdrawal of Consent|3|||
162191568|NCT02753075|585753077|FG000|Overall Study|Physician Decision|3|||
162191569|NCT02753075|585753078|FG001|Overall Study|Physician Decision|1|||
162191570|NCT02753075|585753079|FG002|Overall Study|Physician Decision|0|||
162191571|NCT02143713|585753080|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
162191572|NCT02143713|585753081|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
162191573|NCT02143713|585753082|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
162191574|NCT02143713|585753083|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
162191575|NCT02143713|585753080|FG000|Treatment Period (6 Months)|Adverse Event|7|||
162191576|NCT02143713|585753081|FG001|Treatment Period (6 Months)|Adverse Event|8|||
162191577|NCT02143713|585753082|FG002|Treatment Period (6 Months)|Adverse Event|8|||
162191578|NCT02143713|585753083|FG003|Treatment Period (6 Months)|Adverse Event|9|||
162191579|NCT02143713|585753080|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
162191580|NCT02143713|585753081|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
162191581|NCT02143713|585753082|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
162191582|NCT02143713|585753083|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
162191583|NCT02143713|585753080|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
162191584|NCT02143713|585753081|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
162191585|NCT02143713|585753082|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
162191586|NCT02143713|585753083|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
162191587|NCT02143713|585753080|FG000|Treatment Period (6 Months)|Pregnancy|0|||
162191588|NCT02143713|585753081|FG001|Treatment Period (6 Months)|Pregnancy|2|||
162191589|NCT02143713|585753082|FG002|Treatment Period (6 Months)|Pregnancy|2|||
162191590|NCT02143713|585753083|FG003|Treatment Period (6 Months)|Pregnancy|0|||
162191591|NCT02143713|585753080|FG000|Treatment Period (6 Months)|Non-compliance|1|||
162191592|NCT02143713|585753081|FG001|Treatment Period (6 Months)|Non-compliance|0|||
162191593|NCT02143713|585753082|FG002|Treatment Period (6 Months)|Non-compliance|0|||
162191594|NCT02143713|585753083|FG003|Treatment Period (6 Months)|Non-compliance|3|||
162191595|NCT02143713|585753080|FG000|Treatment Period (6 Months)|Other|3|||
162191596|NCT02143713|585753081|FG001|Treatment Period (6 Months)|Other|0|||
162191597|NCT02143713|585753082|FG002|Treatment Period (6 Months)|Other|3|||
162191598|NCT02143713|585753083|FG003|Treatment Period (6 Months)|Other|2|||
162191599|NCT02143713|585753080|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
162191600|NCT02143713|585753081|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
162191601|NCT02143713|585753082|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
162191602|NCT02143713|585753083|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
162191603|NCT02143713|585753080|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
162191604|NCT02143713|585753081|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
162191605|NCT02143713|585753082|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
161819795|NCT01911429|584381143|FG001|Overall Study|Adverse Event|3|||
162191606|NCT02143713|585753083|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
162191607|NCT02143713|585753080|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
162191608|NCT02143713|585753081|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
162191609|NCT02143713|585753082|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
161673907|NCT01968070|583859925|FG008|Period 1|Physician Decision|0|||
161673908|NCT01968070|583859926|FG009|Period 1|Physician Decision|0|||
161819796|NCT01911429|584381144|FG002|Overall Study|Adverse Event|9|||
161819797|NCT01911429|584381142|FG000|Overall Study|Lack of Efficacy|1|||
161819798|NCT01911429|584381143|FG001|Overall Study|Lack of Efficacy|2|||
162191610|NCT02143713|585753083|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
162191611|NCT02143713|585753080|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
162191612|NCT02143713|585753081|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
162191613|NCT02143713|585753082|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
162191614|NCT02143713|585753083|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
162191615|NCT02143713|585753080|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
162191616|NCT02143713|585753081|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
162191617|NCT02143713|585753082|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
162191618|NCT02143713|585753083|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
162191619|NCT02143713|585753080|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
162191620|NCT02143713|585753081|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
162191621|NCT02143713|585753082|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
162191622|NCT02143713|585753083|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
162191623|NCT02143713|585753080|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
162191624|NCT02143713|585753081|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
162191625|NCT02143713|585753082|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
162191626|NCT02143713|585753083|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
162191627|NCT02143713|585753080|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
162191628|NCT02143713|585753081|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
162191629|NCT02143713|585753082|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
162191630|NCT02143713|585753083|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
162191631|NCT02143713|585753080|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
162191632|NCT02143713|585753081|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
162191633|NCT02143713|585753082|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
162191634|NCT02143713|585753083|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
162191635|NCT01999335|585753084|FG000|Overall Study|Discontinued before receiving treatment|0|||
162191636|NCT01999335|585753085|FG001|Overall Study|Discontinued before receiving treatment|0|||
162191637|NCT01999335|585753086|FG002|Overall Study|Discontinued before receiving treatment|0|||
162191638|NCT01999335|585753087|FG003|Overall Study|Discontinued before receiving treatment|0|||
162191639|NCT01999335|585753088|FG004|Overall Study|Discontinued before receiving treatment|2|||
162191640|NCT01215253|585753089|FG000|Overall Study|Withdrawal by Subject|57|||
162191641|NCT01215253|585753090|FG001|Overall Study|Withdrawal by Subject|35|||
162191642|NCT01215253|585753089|FG000|Overall Study|Physician Decision|9|||
162191643|NCT01215253|585753090|FG001|Overall Study|Physician Decision|12|||
162191644|NCT01215253|585753089|FG000|Overall Study|Lost to Follow-up|6|||
162191645|NCT01215253|585753090|FG001|Overall Study|Lost to Follow-up|4|||
162191646|NCT01215253|585753089|FG000|Overall Study|Other|14|||
162191647|NCT01215253|585753090|FG001|Overall Study|Other|12|||
162191648|NCT00080119|585753091|FG000|Overall Study|Discontinued because of study closure|0|||
162191649|NCT00080119|585753092|FG001|Overall Study|Discontinued because of study closure|0|||
162191650|NCT00080119|585753093|FG002|Overall Study|Discontinued because of study closure|130|||
162191651|NCT00080119|585753094|FG003|Overall Study|Discontinued because of study closure|141|||
162191652|NCT00080119|585753091|FG000|Overall Study|Unable to get to clinic|24|||
162191653|NCT00080119|585753092|FG001|Overall Study|Unable to get to clinic|24|||
162191654|NCT00080119|585753093|FG002|Overall Study|Unable to get to clinic|7|||
162191655|NCT00080119|585753094|FG003|Overall Study|Unable to get to clinic|1|||
162191656|NCT00080119|585753091|FG000|Overall Study|Consent withdrawn|13|||
162191657|NCT00080119|585753092|FG001|Overall Study|Consent withdrawn|17|||
162191658|NCT00080119|585753093|FG002|Overall Study|Consent withdrawn|4|||
161673909|NCT01968070|583859927|FG010|Period 1|Physician Decision|0|||
161673910|NCT01968070|583859928|FG011|Period 1|Physician Decision|1|||
161819799|NCT01911429|584381144|FG002|Overall Study|Lack of Efficacy|4|||
161819800|NCT01911429|584381142|FG000|Overall Study|Lost to Follow-up|0|||
161819801|NCT01911429|584381143|FG001|Overall Study|Lost to Follow-up|0|||
162191659|NCT00080119|585753094|FG003|Overall Study|Consent withdrawn|6|||
162191660|NCT00080119|585753091|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
162191661|NCT00080119|585753092|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
161819802|NCT01911429|584381144|FG002|Overall Study|Lost to Follow-up|1|||
161819803|NCT01911429|584381142|FG000|Overall Study|Protocol Violation|0|||
161819804|NCT01911429|584381143|FG001|Overall Study|Protocol Violation|0|||
161819805|NCT01911429|584381144|FG002|Overall Study|Protocol Violation|1|||
161819806|NCT01911429|584381142|FG000|Overall Study|Withdrawal by Subject|5|||
161819807|NCT01911429|584381143|FG001|Overall Study|Withdrawal by Subject|5|||
161819808|NCT01911429|584381144|FG002|Overall Study|Withdrawal by Subject|4|||
161819809|NCT01911429|584381142|FG000|Overall Study|Accidental randomization|0|||
161819810|NCT01911429|584381143|FG001|Overall Study|Accidental randomization|0|||
161819811|NCT01911429|584381144|FG002|Overall Study|Accidental randomization|1|||
161819812|NCT01911429|584381142|FG000|Overall Study|subject left study|1|||
161819813|NCT01911429|584381143|FG001|Overall Study|subject left study|0|||
161819814|NCT01911429|584381144|FG002|Overall Study|subject left study|0|||
161819815|NCT04569032|584381146|FG000|Overall Study|Death|10|||
161819816|NCT04569032|584381147|FG001|Overall Study|Death|13|||
161819817|NCT04569032|584381146|FG000|Overall Study|Withdrawal by Subject|2|||
161819818|NCT04569032|584381147|FG001|Overall Study|Withdrawal by Subject|0|||
161819819|NCT04569032|584381146|FG000|Overall Study|Lost to Follow-up|0|||
161819820|NCT04569032|584381147|FG001|Overall Study|Lost to Follow-up|1|||
161819821|NCT04569032|584381146|FG000|Overall Study|In long term follow up|22|||
161819822|NCT04569032|584381147|FG001|Overall Study|In long term follow up|34|||
161819823|NCT03599362|584381153|FG000|Overall Study|Screen Failure|3|||
161819824|NCT03707587|584381154|FG000|Overall Study|Death|0|||
161819825|NCT03707587|584381155|FG001|Overall Study|Death|1|||
161819826|NCT01634139|584381157|FG000|Overall Study|Non compliant with protocol|1|||
161819827|NCT01634139|584381158|FG001|Overall Study|Non compliant with protocol|0|||
161819828|NCT01634139|584381159|FG002|Overall Study|Non compliant with protocol|0|||
161819829|NCT01634139|584381157|FG000|Overall Study|Consent withdrawn not due to AE|4|||
161819830|NCT01634139|584381158|FG001|Overall Study|Consent withdrawn not due to AE|3|||
161819831|NCT01634139|584381159|FG002|Overall Study|Consent withdrawn not due to AE|2|||
161819832|NCT01634139|584381157|FG000|Overall Study|Other|4|||
161819833|NCT01634139|584381158|FG001|Overall Study|Other|0|||
161819834|NCT01634139|584381159|FG002|Overall Study|Other|3|||
161819835|NCT01634139|584381157|FG000|Overall Study|Lost to Follow-up|0|||
161819836|NCT01634139|584381158|FG001|Overall Study|Lost to Follow-up|2|||
161819837|NCT01634139|584381159|FG002|Overall Study|Lost to Follow-up|0|||
161819838|NCT01634139|584381157|FG000|Overall Study|Not treated|1|||
161819839|NCT01634139|584381158|FG001|Overall Study|Not treated|1|||
161819840|NCT01634139|584381159|FG002|Overall Study|Not treated|0|||
161819841|NCT01168856|584381167|FG000|Overall Study|Lost to Follow-up|4|||
161819842|NCT01168856|584381168|FG001|Overall Study|Lost to Follow-up|34|||
161819843|NCT01168856|584381167|FG000|Overall Study|Withdrawal by Subject|6|||
161819844|NCT01168856|584381168|FG001|Overall Study|Withdrawal by Subject|8|||
161819845|NCT01168856|584381167|FG000|Overall Study|Physician Decision|2|||
161819846|NCT01168856|584381168|FG001|Overall Study|Physician Decision|1|||
161819847|NCT01168856|584381167|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
161819848|NCT01168856|584381168|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
161819849|NCT01168856|584381167|FG000|Overall Study|Participant received anti-HCV treatment|1|||
161819850|NCT01168856|584381168|FG001|Overall Study|Participant received anti-HCV treatment|0|||
161819851|NCT01168856|584381167|FG000|Overall Study|Death|0|||
161819852|NCT01168856|584381168|FG001|Overall Study|Death|2|||
161819853|NCT01168856|584381167|FG000|Overall Study|Other|1|||
161819854|NCT01168856|584381168|FG001|Overall Study|Other|291|||
161819855|NCT01168856|584381167|FG000|Overall Study|Protocol Violation|4|||
161819856|NCT01168856|584381168|FG001|Overall Study|Protocol Violation|6|||
161819857|NCT04442503|584381169|FG000|Overall Study|Adverse Event|1|||
161819858|NCT04442503|584381170|FG001|Overall Study|Adverse Event|1|||
161819859|NCT04442503|584381169|FG000|Overall Study|Lost to Follow-up|8|||
161819860|NCT04442503|584381170|FG001|Overall Study|Lost to Follow-up|6|||
161819861|NCT04442503|584381169|FG000|Overall Study|Physician Decision|0|||
161819862|NCT04442503|584381170|FG001|Overall Study|Physician Decision|2|||
161819863|NCT04442503|584381169|FG000|Overall Study|Withdrawal by Subject|3|||
162191662|NCT00080119|585753093|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
162191663|NCT00080119|585753094|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
162191664|NCT00080119|585753091|FG000|Overall Study|Lost to Follow-up|16|||
162191665|NCT00080119|585753092|FG001|Overall Study|Lost to Follow-up|19|||
162191666|NCT00080119|585753093|FG002|Overall Study|Lost to Follow-up|19|||
161819864|NCT04442503|584381170|FG001|Overall Study|Withdrawal by Subject|4|||
161819865|NCT04442503|584381169|FG000|Overall Study|Reason not Specified|0|||
161819866|NCT04442503|584381170|FG001|Overall Study|Reason not Specified|1|||
161819867|NCT04442503|584381169|FG000|Overall Study|Randomized but not Treated|3|||
161819868|NCT04442503|584381170|FG001|Overall Study|Randomized but not Treated|1|||
161819869|NCT05562011|584381177|FG000|Overall Study|Withdrawal by Subject|3|||
161819870|NCT05562011|584381177|FG000|Overall Study|Lost to Follow-up|1|||
161819871|NCT05562011|584381177|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
161819872|NCT05562011|584381177|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
161819873|NCT05562011|584381177|FG000|Overall Study|Device malfunction|13|||
162191667|NCT00080119|585753094|FG003|Overall Study|Lost to Follow-up|14|||
162191668|NCT00889863|585753096|FG000|Part I: Open Label|Death|1|||
162191669|NCT00889863|585753097|FG001|Part I: Open Label|Death|0|||
162191670|NCT00889863|585753096|FG000|Part I: Open Label|Adverse Event|4|||
162191671|NCT00889863|585753097|FG001|Part I: Open Label|Adverse Event|0|||
162191672|NCT00889863|585753096|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
162191673|NCT00889863|585753097|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
162191674|NCT00889863|585753096|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
162191675|NCT00889863|585753097|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
162191676|NCT00889863|585753096|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
162191677|NCT00889863|585753097|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
162191678|NCT00889863|585753096|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
162191679|NCT00889863|585753097|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
162191680|NCT00889863|585753096|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
162191681|NCT00889863|585753097|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
162191682|NCT04410445|585753098|FG000|Overall Study|Lost to Follow-up|3|||
162191683|NCT04410445|585753099|FG001|Overall Study|Lost to Follow-up|9|||
162191684|NCT04410445|585753098|FG000|Overall Study|Withdrawal by Subject|27|||
162191685|NCT04410445|585753099|FG001|Overall Study|Withdrawal by Subject|15|||
162191686|NCT01320683|585753100|FG000|Overall Study|Positive antibody response|1|||
162191687|NCT02005484|585753103|FG000|Overall Study|Death|1|||
162191688|NCT02005484|585753103|FG000|Overall Study|Disease progression|1|||
162191689|NCT02005484|585753103|FG000|Overall Study|Changed to a Different Study|1|||
162191690|NCT02005484|585753103|FG000|Overall Study|Sponsor decision|1|||
162191691|NCT03909100|585753107|FG000|Overall Study|Protocol Deviation|2|||
162191692|NCT03909100|585753107|FG000|Overall Study|Technical Problems|4|||
162191693|NCT03909100|585753107|FG000|Overall Study|Withdrawal by Subject|4|||
162191694|NCT03909100|585753107|FG000|Overall Study|Lost to Follow-up|1|||
162191695|NCT03909100|585753107|FG000|Overall Study|Reason not Specified|4|||
162191696|NCT01794299|585753109|FG000|Overall Study|ATIR manufacturing not possible|1|||
162191697|NCT01794299|585753109|FG000|Overall Study|Death|14|||
162191698|NCT01794299|585753109|FG000|Overall Study|Graft failure|1|||
162191699|NCT01794299|585753109|FG000|Overall Study|ATIR batch rejected|2|||
162191700|NCT01794299|585753109|FG000|Overall Study|Relapse|2|||
162191701|NCT01794299|585753109|FG000|Overall Study|Discontinued from active follow-up|1|||
162191702|NCT01794299|585753109|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
162191703|NCT03006393|585753110|FG000|Overall Study|Withdrawal by Subject|1|||
162191704|NCT03006393|585753111|FG001|Overall Study|Withdrawal by Subject|1|||
162191705|NCT03006393|585753110|FG000|Overall Study|Pregnancy|0|||
162191706|NCT03006393|585753111|FG001|Overall Study|Pregnancy|1|||
162191707|NCT03006393|585753110|FG000|Overall Study|Lost to Follow-up|0|||
162191708|NCT03006393|585753111|FG001|Overall Study|Lost to Follow-up|1|||
162191709|NCT00807599|585753114|FG000|Overall Study|Not treated on protocol study|0|||
162191710|NCT00807599|585753115|FG001|Overall Study|Not treated on protocol study|0|||
162191711|NCT00807599|585753116|FG002|Overall Study|Not treated on protocol study|2|||
162191712|NCT00807599|585753114|FG000|Overall Study|Adverse Event|0|||
162191713|NCT00807599|585753115|FG001|Overall Study|Adverse Event|0|||
162191714|NCT00807599|585753116|FG002|Overall Study|Adverse Event|5|||
162191715|NCT00807599|585753114|FG000|Overall Study|Inadequate response to induction|0|||
162191716|NCT00807599|585753115|FG001|Overall Study|Inadequate response to induction|0|||
162191717|NCT00807599|585753116|FG002|Overall Study|Inadequate response to induction|9|||
162191718|NCT00807599|585753114|FG000|Overall Study|Withdrawal by Subject|0|||
162191719|NCT00807599|585753115|FG001|Overall Study|Withdrawal by Subject|0|||
162191720|NCT00807599|585753116|FG002|Overall Study|Withdrawal by Subject|1|||
162191721|NCT03695185|585753117|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
162191722|NCT03695185|585753117|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
162191723|NCT03695185|585753117|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
162191724|NCT03695185|585753117|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
162191725|NCT03695185|585753117|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
162191726|NCT03695185|585753117|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
162191727|NCT00274287|585753120|FG000|Overall Study|Withdrawal by Subject|1|||
162191728|NCT00274287|585753120|FG000|Overall Study|subject non-compliance|1|||
162191729|NCT04183491|585753125|FG000|Overall Study|Withdrawal by Subject|0|||
162191730|NCT04183491|585753126|FG001|Overall Study|Withdrawal by Subject|0|||
162191731|NCT04183491|585753127|FG002|Overall Study|Withdrawal by Subject|1|||
162191732|NCT04183491|585753128|FG003|Overall Study|Withdrawal by Subject|0|||
162191733|NCT04183491|585753129|FG004|Overall Study|Withdrawal by Subject|0|||
162191734|NCT04183491|585753130|FG005|Overall Study|Withdrawal by Subject|1|||
162191735|NCT04183491|585753131|FG006|Overall Study|Withdrawal by Subject|0|||
162191736|NCT02538094|585753132|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
162191737|NCT02538094|585753133|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
162191738|NCT02538094|585753132|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
162191739|NCT02538094|585753133|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
162191740|NCT03288506|585753134|FG000|Overall Study|Withdrawal by Subject|52|||
162191741|NCT03692871|585753135|FG000|Overall Study|Death|1|||
162191742|NCT03692871|585753136|FG001|Overall Study|Death|1|||
162191743|NCT03692871|585753135|FG000|Overall Study|Lost to Follow-up|24|||
162191744|NCT03692871|585753136|FG001|Overall Study|Lost to Follow-up|9|||
162191745|NCT03692871|585753135|FG000|Overall Study|Physician Decision|22|||
162191746|NCT03692871|585753136|FG001|Overall Study|Physician Decision|7|||
162191747|NCT03692871|585753135|FG000|Overall Study|Protocol Deviation|1|||
162191748|NCT03692871|585753136|FG001|Overall Study|Protocol Deviation|0|||
162191749|NCT03692871|585753135|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
162191750|NCT03692871|585753136|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
162191751|NCT02852824|585753140|FG000|Overall Study|Withdrawal by Subject|1|||
162191752|NCT02852824|585753141|FG001|Overall Study|Withdrawal by Subject|0|||
162191753|NCT02852824|585753142|FG002|Overall Study|Withdrawal by Subject|0|||
162191754|NCT02852824|585753143|FG003|Overall Study|Withdrawal by Subject|0|||
162191755|NCT02852824|585753144|FG004|Overall Study|Withdrawal by Subject|0|||
162191756|NCT02852824|585753145|FG005|Overall Study|Withdrawal by Subject|0|||
162191757|NCT02852824|585753146|FG006|Overall Study|Withdrawal by Subject|0|||
162191758|NCT02852824|585753140|FG000|Overall Study|Adverse Event|0|||
162191759|NCT02852824|585753141|FG001|Overall Study|Adverse Event|0|||
162191760|NCT02852824|585753142|FG002|Overall Study|Adverse Event|0|||
162191761|NCT02852824|585753143|FG003|Overall Study|Adverse Event|0|||
162191762|NCT02852824|585753144|FG004|Overall Study|Adverse Event|2|||
162191763|NCT02852824|585753145|FG005|Overall Study|Adverse Event|0|||
162191764|NCT02852824|585753146|FG006|Overall Study|Adverse Event|0|||
162191765|NCT01316913|585753147|FG000|Overall Study|Adverse Event|17|||
162191766|NCT01316913|585753148|FG001|Overall Study|Adverse Event|20|||
162191767|NCT01316913|585753149|FG002|Overall Study|Adverse Event|15|||
162191768|NCT01316913|585753150|FG003|Overall Study|Adverse Event|11|||
162191769|NCT01316913|585753147|FG000|Overall Study|Lack of Efficacy|22|||
162191770|NCT01316913|585753148|FG001|Overall Study|Lack of Efficacy|12|||
162191771|NCT01316913|585753149|FG002|Overall Study|Lack of Efficacy|9|||
162191772|NCT01316913|585753150|FG003|Overall Study|Lack of Efficacy|13|||
162191773|NCT01316913|585753147|FG000|Overall Study|Protocol Violation|1|||
162191774|NCT01316913|585753148|FG001|Overall Study|Protocol Violation|4|||
162191775|NCT01316913|585753149|FG002|Overall Study|Protocol Violation|4|||
162191776|NCT01316913|585753150|FG003|Overall Study|Protocol Violation|1|||
162191777|NCT01316913|585753147|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
162191778|NCT01316913|585753148|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
162191779|NCT01316913|585753149|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
162191780|NCT01316913|585753150|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
162191781|NCT01316913|585753147|FG000|Overall Study|Lost to Follow-up|0|||
162191782|NCT01316913|585753148|FG001|Overall Study|Lost to Follow-up|1|||
162191783|NCT01316913|585753149|FG002|Overall Study|Lost to Follow-up|0|||
161673911|NCT01968070|583859929|FG012|Period 1|Physician Decision|0|||
162191784|NCT01316913|585753150|FG003|Overall Study|Lost to Follow-up|2|||
162191785|NCT01316913|585753147|FG000|Overall Study|Withdrawal by Subject|10|||
162191786|NCT01316913|585753148|FG001|Overall Study|Withdrawal by Subject|9|||
162191787|NCT01316913|585753149|FG002|Overall Study|Withdrawal by Subject|10|||
162191788|NCT01316913|585753150|FG003|Overall Study|Withdrawal by Subject|6|||
162191789|NCT01860079|585753151|FG000|Overall Study|Physician Decision|14|||
162191790|NCT01860079|585753152|FG001|Overall Study|Physician Decision|22|||
162191791|NCT02102724|585753153|FG000|Overall Study|Lost to Follow-up|1|||
162191792|NCT02102724|585753154|FG001|Overall Study|Lost to Follow-up|0|||
162191793|NCT02102724|585753153|FG000|Overall Study|surgery for brain aneurysm|1|||
161673912|NCT01968070|583859930|FG013|Period 1|Physician Decision|0|||
161673913|NCT01968070|583859931|FG014|Period 1|Physician Decision|0|||
161673914|NCT01968070|583859932|FG015|Period 1|Physician Decision|0|||
161673915|NCT01968070|583859933|FG016|Period 1|Physician Decision|0|||
161673916|NCT01968070|583859934|FG017|Period 1|Physician Decision|0|||
161673917|NCT01968070|583859917|FG000|Period 2|Withdrawal by Subject|0|||
162191794|NCT02102724|585753154|FG001|Overall Study|surgery for brain aneurysm|1|||
162191795|NCT02008916|585753155|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
162191796|NCT02008916|585753156|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
162191797|NCT02008916|585753157|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
162191798|NCT02008916|585753155|FG000|Week 16 - 156|Adverse Event|4|||
162191799|NCT02008916|585753156|FG001|Week 16 - 156|Adverse Event|2|||
162191800|NCT02008916|585753157|FG002|Week 16 - 156|Adverse Event|3|||
162191801|NCT02008916|585753155|FG000|Week 16 - 156|Withdrawal by Subject|7|||
162191802|NCT02008916|585753156|FG001|Week 16 - 156|Withdrawal by Subject|3|||
162191803|NCT02008916|585753157|FG002|Week 16 - 156|Withdrawal by Subject|5|||
162191804|NCT02008916|585753155|FG000|Week 16 - 156|No longer requires treatment|0|||
162191805|NCT02008916|585753156|FG001|Week 16 - 156|No longer requires treatment|1|||
162191806|NCT02008916|585753157|FG002|Week 16 - 156|No longer requires treatment|0|||
161673918|NCT01968070|583859918|FG001|Period 2|Withdrawal by Subject|0|||
161673919|NCT01968070|583859919|FG002|Period 2|Withdrawal by Subject|0|||
162191807|NCT02008916|585753155|FG000|Week 16 - 156|Lost to Follow-up|5|||
162191808|NCT02008916|585753156|FG001|Week 16 - 156|Lost to Follow-up|0|||
162191809|NCT02008916|585753157|FG002|Week 16 - 156|Lost to Follow-up|0|||
162191810|NCT02008916|585753155|FG000|Week 16 - 156|Lack of Efficacy|3|||
162191811|NCT02008916|585753156|FG001|Week 16 - 156|Lack of Efficacy|5|||
162191812|NCT02008916|585753157|FG002|Week 16 - 156|Lack of Efficacy|2|||
162191813|NCT02008916|585753155|FG000|Week 16 - 156|Pregnancy|0|||
162191814|NCT02008916|585753156|FG001|Week 16 - 156|Pregnancy|1|||
162191815|NCT02008916|585753157|FG002|Week 16 - 156|Pregnancy|0|||
162191816|NCT02008916|585753155|FG000|Week 16 - 156|Physician Decision|0|||
162191817|NCT02008916|585753156|FG001|Week 16 - 156|Physician Decision|1|||
162191818|NCT02008916|585753157|FG002|Week 16 - 156|Physician Decision|0|||
162191819|NCT03803475|585753158|FG000|Overall Study|Physician Decision|1|||
162191820|NCT02915783|585753165|FG000|Overall Study|Death|21|||
162191821|NCT02915783|585753165|FG000|Overall Study|Lost to Follow-up|1|||
162191822|NCT02915783|585753165|FG000|Overall Study|Withdrawal by Subject|2|||
162191823|NCT02950961|585753167|FG000|Overall Study|Study had to stop due to COVID.|7|||
162191824|NCT01915914|585753168|FG000|Acute Phase|Withdrawal by Subject|4|||
162191825|NCT01915914|585753169|FG001|Acute Phase|Withdrawal by Subject|0|||
162191826|NCT01915914|585753170|FG002|Acute Phase|Withdrawal by Subject|0|||
162191827|NCT01915914|585753171|FG003|Acute Phase|Withdrawal by Subject|0|||
162191828|NCT01915914|585753168|FG000|Acute Phase|Lost to Follow-up|4|||
162191829|NCT01915914|585753169|FG001|Acute Phase|Lost to Follow-up|0|||
162191830|NCT01915914|585753170|FG002|Acute Phase|Lost to Follow-up|0|||
162191831|NCT01915914|585753171|FG003|Acute Phase|Lost to Follow-up|0|||
162191832|NCT01915914|585753168|FG000|Acute Phase|Physician Decision|1|||
162191833|NCT01915914|585753169|FG001|Acute Phase|Physician Decision|0|||
162191834|NCT01915914|585753170|FG002|Acute Phase|Physician Decision|0|||
162191835|NCT01915914|585753171|FG003|Acute Phase|Physician Decision|0|||
162191836|NCT01915914|585753168|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
162191837|NCT01915914|585753169|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
162191838|NCT01915914|585753170|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
162191839|NCT01915914|585753171|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
162191840|NCT01915914|585753168|FG000|Acute Phase|"Not Achieved treatment success"|1|||
162191841|NCT01915914|585753169|FG001|Acute Phase|"Not Achieved treatment success"|0|||
162191842|NCT01915914|585753170|FG002|Acute Phase|"Not Achieved treatment success"|0|||
162191843|NCT01915914|585753171|FG003|Acute Phase|"Not Achieved treatment success"|0|||
162191844|NCT01915914|585753168|FG000|Acute Phase|Missing|1|||
162191845|NCT01915914|585753169|FG001|Acute Phase|Missing|0|||
162191846|NCT01915914|585753170|FG002|Acute Phase|Missing|0|||
162191847|NCT01915914|585753171|FG003|Acute Phase|Missing|0|||
162191848|NCT01915914|585753168|FG000|Maintenance Phase|Withdrawal by Subject|0|||
162191849|NCT01915914|585753169|FG001|Maintenance Phase|Withdrawal by Subject|1|||
162191850|NCT01915914|585753170|FG002|Maintenance Phase|Withdrawal by Subject|1|||
162191851|NCT01915914|585753171|FG003|Maintenance Phase|Withdrawal by Subject|0|||
162191852|NCT01915914|585753168|FG000|Maintenance Phase|Lost to Follow-up|0|||
162191853|NCT01915914|585753169|FG001|Maintenance Phase|Lost to Follow-up|4|||
162191854|NCT01915914|585753170|FG002|Maintenance Phase|Lost to Follow-up|1|||
162191855|NCT01915914|585753171|FG003|Maintenance Phase|Lost to Follow-up|0|||
162191856|NCT01915914|585753168|FG000|Maintenance Phase|Missing|0|||
162191857|NCT01915914|585753169|FG001|Maintenance Phase|Missing|1|||
162191858|NCT01915914|585753170|FG002|Maintenance Phase|Missing|0|||
162191859|NCT01915914|585753171|FG003|Maintenance Phase|Missing|0|||
162191860|NCT01915914|585753168|FG000|Follow-up Phase|Withdrawal by Subject|0|||
162191861|NCT01915914|585753169|FG001|Follow-up Phase|Withdrawal by Subject|0|||
162191862|NCT01915914|585753170|FG002|Follow-up Phase|Withdrawal by Subject|0|||
162191863|NCT01915914|585753171|FG003|Follow-up Phase|Withdrawal by Subject|1|||
162191864|NCT01915914|585753168|FG000|Follow-up Phase|Physician Decision|0|||
161819874|NCT00387153|584381178|FG000|Overall Study|Adverse Event|1|||
162191865|NCT01915914|585753169|FG001|Follow-up Phase|Physician Decision|0|||
162191866|NCT01915914|585753170|FG002|Follow-up Phase|Physician Decision|0|||
162191867|NCT01915914|585753171|FG003|Follow-up Phase|Physician Decision|1|||
162191868|NCT02432274|585753173|FG000|Overall Study|Death|2|||
162191869|NCT02432274|585753174|FG001|Overall Study|Death|6|||
162191870|NCT02432274|585753175|FG002|Overall Study|Death|7|||
162191871|NCT02432274|585753176|FG003|Overall Study|Death|0|||
162191872|NCT02432274|585753177|FG004|Overall Study|Death|27|||
162191873|NCT02432274|585753178|FG005|Overall Study|Death|7|||
162191874|NCT02432274|585753179|FG006|Overall Study|Death|9|||
162191875|NCT02432274|585753180|FG007|Overall Study|Death|14|||
162191876|NCT02432274|585753173|FG000|Overall Study|Withdrawal of Consent|0|||
162191877|NCT02432274|585753174|FG001|Overall Study|Withdrawal of Consent|0|||
162191878|NCT02432274|585753175|FG002|Overall Study|Withdrawal of Consent|0|||
162191879|NCT02432274|585753176|FG003|Overall Study|Withdrawal of Consent|0|||
162191880|NCT02432274|585753177|FG004|Overall Study|Withdrawal of Consent|2|||
162191881|NCT02432274|585753178|FG005|Overall Study|Withdrawal of Consent|0|||
161673920|NCT01968070|583859920|FG003|Period 2|Withdrawal by Subject|0|||
162191882|NCT02432274|585753179|FG006|Overall Study|Withdrawal of Consent|1|||
162191883|NCT02432274|585753180|FG007|Overall Study|Withdrawal of Consent|2|||
162191884|NCT02807857|585753183|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
162191885|NCT02807857|585753183|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
162191886|NCT02807857|585753183|FG000|Follow-Up Set|Withdrawal by Subject|8|||
162191887|NCT02807857|585753183|FG000|Follow-Up Set|Lost to Follow-up|7|||
162191888|NCT02807857|585753183|FG000|Follow-Up Set|Physician Decision|6|||
162191889|NCT02807857|585753183|FG000|Follow-Up Set|Adverse Event|3|||
162191890|NCT02807857|585753183|FG000|Follow-Up Set|Death|27|||
162191891|NCT02807857|585753183|FG000|Follow-Up Set|Relocation|2|||
162191892|NCT02114515|585753184|FG000|Overall Study|Lost to Follow-up|52|||
162191893|NCT02114515|585753185|FG001|Overall Study|Lost to Follow-up|55|||
162191894|NCT02114515|585753184|FG000|Overall Study|Death|12|||
162191895|NCT02114515|585753185|FG001|Overall Study|Death|12|||
162191896|NCT02114515|585753184|FG000|Overall Study|Withdrawal by Subject|4|||
162191897|NCT02114515|585753185|FG001|Overall Study|Withdrawal by Subject|22|||
162191898|NCT02114515|585753184|FG000|Overall Study|Other|65|||
162191899|NCT02114515|585753185|FG001|Overall Study|Other|61|||
162191900|NCT04197713|585753186|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
162191901|NCT04197713|585753187|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
161819875|NCT00387153|584381178|FG000|Overall Study|Disease Progression|3|||
161819876|NCT00387153|584381178|FG000|Overall Study|Lack of Response|4|||
162191902|NCT05338476|585753197|FG000|Period 2|Adverse Event|0|||
162191903|NCT05338476|585753198|FG001|Period 2|Adverse Event|1|||
162191904|NCT05522777|585754663|FG000|Overall Study|Lack of Efficacy|1|||
162191905|NCT05522777|585754663|FG000|Overall Study|Withdrawal by Subject|1|||
162191906|NCT05487300|585754664|FG000|Overall Study|Withdrawal by Subject|1|||
162191907|NCT05487300|585754665|FG001|Overall Study|Withdrawal by Subject|0|||
162191908|NCT01241448|585754670|FG000|Overall Study|Adverse Event|1|||
162191909|NCT01241448|585754671|FG001|Overall Study|Adverse Event|0|||
162191910|NCT01241448|585754672|FG002|Overall Study|Adverse Event|2|||
162191911|NCT01241448|585754673|FG003|Overall Study|Adverse Event|2|||
162191912|NCT01241448|585754670|FG000|Overall Study|Lost to Follow-up|2|||
162191913|NCT01241448|585754671|FG001|Overall Study|Lost to Follow-up|1|||
162191914|NCT01241448|585754672|FG002|Overall Study|Lost to Follow-up|1|||
162191915|NCT01241448|585754673|FG003|Overall Study|Lost to Follow-up|1|||
162191916|NCT01241448|585754670|FG000|Overall Study|Physician Decision|0|||
162191917|NCT01241448|585754671|FG001|Overall Study|Physician Decision|2|||
162191918|NCT01241448|585754672|FG002|Overall Study|Physician Decision|0|||
162191919|NCT01241448|585754673|FG003|Overall Study|Physician Decision|0|||
162191920|NCT01241448|585754670|FG000|Overall Study|Protocol Violation|10|||
162191921|NCT01241448|585754671|FG001|Overall Study|Protocol Violation|5|||
162191922|NCT01241448|585754672|FG002|Overall Study|Protocol Violation|3|||
162191923|NCT01241448|585754673|FG003|Overall Study|Protocol Violation|6|||
162191924|NCT01241448|585754670|FG000|Overall Study|Sponsor Decision|17|||
162191925|NCT01241448|585754671|FG001|Overall Study|Sponsor Decision|14|||
162191926|NCT01241448|585754672|FG002|Overall Study|Sponsor Decision|12|||
162191927|NCT01241448|585754673|FG003|Overall Study|Sponsor Decision|6|||
162191928|NCT01241448|585754670|FG000|Overall Study|Withdrawal by Subject|4|||
162191929|NCT01241448|585754671|FG001|Overall Study|Withdrawal by Subject|5|||
162191930|NCT01241448|585754672|FG002|Overall Study|Withdrawal by Subject|3|||
162191931|NCT01241448|585754673|FG003|Overall Study|Withdrawal by Subject|6|||
162191932|NCT01241448|585754670|FG000|Overall Study|Excluded due to data integrity issues|3|||
162191933|NCT01241448|585754671|FG001|Overall Study|Excluded due to data integrity issues|2|||
162191934|NCT01241448|585754672|FG002|Overall Study|Excluded due to data integrity issues|2|||
162191935|NCT01241448|585754673|FG003|Overall Study|Excluded due to data integrity issues|2|||
162191936|NCT00304278|585754675|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
162191937|NCT00304278|585754675|FG000|Overall Study|PT had medical condition preventing TX|1|||
162191938|NCT01304940|585754676|FG000|Overall Study|not meet symptom severity requirement|3|||
162191939|NCT01304940|585754677|FG001|Overall Study|not meet symptom severity requirement|0|||
162191940|NCT02065895|585754680|FG000|Overall Study|Protocol Violation|1|||
162191941|NCT02065895|585754681|FG001|Overall Study|Protocol Violation|0|||
162191942|NCT02065895|585754682|FG002|Overall Study|Protocol Violation|0|||
162191943|NCT02065895|585754683|FG003|Overall Study|Protocol Violation|1|||
162191944|NCT02065895|585754684|FG004|Overall Study|Protocol Violation|0|||
162191945|NCT02065895|585754685|FG005|Overall Study|Protocol Violation|0|||
162191946|NCT02065895|585754680|FG000|Overall Study|Scheduling conflicts|0|||
162191947|NCT02065895|585754681|FG001|Overall Study|Scheduling conflicts|1|||
162191948|NCT02065895|585754682|FG002|Overall Study|Scheduling conflicts|0|||
162191949|NCT02065895|585754683|FG003|Overall Study|Scheduling conflicts|0|||
162191950|NCT02065895|585754684|FG004|Overall Study|Scheduling conflicts|0|||
162191951|NCT02065895|585754685|FG005|Overall Study|Scheduling conflicts|0|||
162191952|NCT03740737|585754686|FG000|Overall Study|Protocol deviation|13|||
162191953|NCT03740737|585754687|FG001|Overall Study|Protocol deviation|0|||
162191954|NCT03740737|585754686|FG000|Overall Study|Adverse Event|2|||
162191955|NCT03740737|585754687|FG001|Overall Study|Adverse Event|0|||
162191956|NCT03740737|585754686|FG000|Overall Study|Lost to Follow-up|1|||
162191957|NCT03740737|585754687|FG001|Overall Study|Lost to Follow-up|0|||
162191958|NCT03740737|585754686|FG000|Overall Study|Randomization failure|1|||
162191959|NCT03740737|585754687|FG001|Overall Study|Randomization failure|0|||
162191960|NCT03740737|585754686|FG000|Overall Study|Participant withdrew consent|1|||
162191961|NCT03740737|585754687|FG001|Overall Study|Participant withdrew consent|0|||
162191962|NCT03740737|585754686|FG000|Overall Study|Participant withdrew from trial|2|||
162191963|NCT03740737|585754687|FG001|Overall Study|Participant withdrew from trial|1|||
162191964|NCT00507429|585754688|FG000|Treatment Phase|Disease Progression|12|||
162191965|NCT00507429|585754689|FG001|Treatment Phase|Disease Progression|5|||
162191966|NCT00507429|585754688|FG000|Treatment Phase|Adverse Event|12|||
162191967|NCT00507429|585754689|FG001|Treatment Phase|Adverse Event|5|||
162191968|NCT00507429|585754688|FG000|Treatment Phase|Withdrawal by Subject|3|||
162191969|NCT00507429|585754689|FG001|Treatment Phase|Withdrawal by Subject|3|||
162191970|NCT00507429|585754688|FG000|Treatment Phase|Physician Decision|4|||
162191971|NCT00507429|585754689|FG001|Treatment Phase|Physician Decision|2|||
162191972|NCT00507429|585754688|FG000|Treatment Phase|Other|6|||
162191973|NCT00507429|585754689|FG001|Treatment Phase|Other|3|||
162191974|NCT00507429|585754688|FG000|Maintenance Phase|Progressive Disease|14|||
162191975|NCT00507429|585754689|FG001|Maintenance Phase|Progressive Disease|0|||
162191976|NCT04025762|585754692|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
162191977|NCT04025762|585754693|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
162191978|NCT03340961|585754698|FG000|Overall Study|Adverse Event|1|||
162191979|NCT03340961|585754699|FG001|Overall Study|Adverse Event|3|||
162191980|NCT03340961|585754700|FG002|Overall Study|Adverse Event|2|||
162191981|NCT03340961|585754701|FG003|Overall Study|Adverse Event|4|||
162191982|NCT03340961|585754698|FG000|Overall Study|Lost to Follow-up|0|||
162191983|NCT03340961|585754699|FG001|Overall Study|Lost to Follow-up|1|||
162191984|NCT03340961|585754700|FG002|Overall Study|Lost to Follow-up|0|||
162191985|NCT03340961|585754701|FG003|Overall Study|Lost to Follow-up|1|||
162191986|NCT03340961|585754698|FG000|Overall Study|Withdrawal by Subject|3|||
162191987|NCT03340961|585754699|FG001|Overall Study|Withdrawal by Subject|2|||
162191988|NCT03340961|585754700|FG002|Overall Study|Withdrawal by Subject|4|||
162191989|NCT03340961|585754701|FG003|Overall Study|Withdrawal by Subject|7|||
162191990|NCT03340961|585754698|FG000|Overall Study|Use of prohibited treatment|0|||
162191991|NCT03340961|585754699|FG001|Overall Study|Use of prohibited treatment|3|||
162191992|NCT03340961|585754700|FG002|Overall Study|Use of prohibited treatment|2|||
162191993|NCT03340961|585754701|FG003|Overall Study|Use of prohibited treatment|4|||
162191994|NCT03340961|585754698|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
162191995|NCT03340961|585754699|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
162191996|NCT03340961|585754700|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
162191997|NCT03340961|585754701|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
162191998|NCT03340961|585754698|FG000|Overall Study|Subject developed an exclusion criterion|0|||
162191999|NCT03340961|585754699|FG001|Overall Study|Subject developed an exclusion criterion|1|||
162192000|NCT03340961|585754700|FG002|Overall Study|Subject developed an exclusion criterion|0|||
162192001|NCT03340961|585754701|FG003|Overall Study|Subject developed an exclusion criterion|0|||
162192002|NCT03340961|585754698|FG000|Overall Study|Protocol Violation|1|||
162192003|NCT03340961|585754699|FG001|Overall Study|Protocol Violation|0|||
162192004|NCT03340961|585754700|FG002|Overall Study|Protocol Violation|1|||
162192005|NCT03340961|585754701|FG003|Overall Study|Protocol Violation|0|||
162192006|NCT03340961|585754698|FG000|Overall Study|Adverse Event|1|||
162192007|NCT03340961|585754699|FG001|Overall Study|Adverse Event|1|||
162192008|NCT03340961|585754700|FG002|Overall Study|Adverse Event|0|||
162192009|NCT03340961|585754701|FG003|Overall Study|Adverse Event|0|||
162192010|NCT03340961|585754698|FG000|Overall Study|Lack of Efficacy|0|||
162192011|NCT03340961|585754699|FG001|Overall Study|Lack of Efficacy|0|||
162192012|NCT03340961|585754700|FG002|Overall Study|Lack of Efficacy|0|||
162192013|NCT03340961|585754701|FG003|Overall Study|Lack of Efficacy|1|||
162192014|NCT03137784|585754704|FG000|Overall Study|Adverse Event|1|||
162192015|NCT03137784|585754705|FG001|Overall Study|Adverse Event|1|||
162192016|NCT03137784|585754706|FG002|Overall Study|Adverse Event|0|||
162192017|NCT03137784|585754707|FG003|Overall Study|Adverse Event|0|||
162192018|NCT03137784|585754708|FG004|Overall Study|Adverse Event|0|||
162192019|NCT03137784|585754709|FG005|Overall Study|Adverse Event|0|||
162192020|NCT03137784|585754704|FG000|Overall Study|Subject/guardian decision|1|||
162192021|NCT03137784|585754705|FG001|Overall Study|Subject/guardian decision|0|||
162192022|NCT03137784|585754706|FG002|Overall Study|Subject/guardian decision|0|||
162192023|NCT03137784|585754707|FG003|Overall Study|Subject/guardian decision|0|||
162192024|NCT03137784|585754708|FG004|Overall Study|Subject/guardian decision|0|||
162192025|NCT03137784|585754709|FG005|Overall Study|Subject/guardian decision|0|||
162192026|NCT03137784|585754704|FG000|Overall Study|Non-compliance with study treatment|0|||
162192027|NCT03137784|585754705|FG001|Overall Study|Non-compliance with study treatment|0|||
162192028|NCT03137784|585754706|FG002|Overall Study|Non-compliance with study treatment|0|||
162192029|NCT03137784|585754707|FG003|Overall Study|Non-compliance with study treatment|0|||
162192030|NCT03137784|585754708|FG004|Overall Study|Non-compliance with study treatment|1|||
162192031|NCT03137784|585754709|FG005|Overall Study|Non-compliance with study treatment|0|||
162192032|NCT04803734|585754715|FG000|Overall Study|Withdrawal by Subject|0|||
162192033|NCT04803734|585754716|FG001|Overall Study|Withdrawal by Subject|1|||
162192034|NCT04803734|585754715|FG000|Overall Study|Protocol Violation|0|||
162192035|NCT04803734|585754716|FG001|Overall Study|Protocol Violation|1|||
162192036|NCT02152384|585754730|FG000|Period 1|Withdrawal by Subject|0|||
162192037|NCT02152384|585754731|FG001|Period 1|Withdrawal by Subject|1|||
162192038|NCT02152384|585754730|FG000|Period 1|Adverse Event|1|||
162192039|NCT02152384|585754731|FG001|Period 1|Adverse Event|1|||
162192040|NCT01393600|585754733|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
162192041|NCT01393600|585754734|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
162192042|NCT01393600|585754735|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
162192043|NCT01393600|585754736|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
162192044|NCT01393600|585754733|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
162192045|NCT01393600|585754734|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
162192046|NCT01393600|585754735|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
162192047|NCT01393600|585754736|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
162192048|NCT01393600|585754733|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
162192049|NCT01393600|585754734|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
161819877|NCT04411680|584381179|FG000|Treatment Period|Adverse Event|3|||
161819878|NCT04411680|584381180|FG001|Treatment Period|Adverse Event|0|||
161819879|NCT04411680|584381179|FG000|Treatment Period|Discharged from hospital|18|||
161819880|NCT04411680|584381180|FG001|Treatment Period|Discharged from hospital|7|||
161819881|NCT04411680|584381179|FG000|Treatment Period|Missed 1 or more doses|8|||
161819882|NCT04411680|584381180|FG001|Treatment Period|Missed 1 or more doses|0|||
161819883|NCT04411680|584381179|FG000|Treatment Period|Transferred to another hospital|0|||
161819884|NCT04411680|584381180|FG001|Treatment Period|Transferred to another hospital|1|||
161819885|NCT04411680|584381179|FG000|Follow up Period|Withdrawal by Subject|2|||
161819886|NCT04411680|584381180|FG001|Follow up Period|Withdrawal by Subject|0|||
161819887|NCT04411680|584381179|FG000|Follow up Period|Lost to Follow-up|5|||
161819888|NCT04411680|584381180|FG001|Follow up Period|Lost to Follow-up|6|||
161819889|NCT04411680|584381179|FG000|Follow up Period|Death|11|||
161819890|NCT04411680|584381180|FG001|Follow up Period|Death|8|||
161819891|NCT05034874|584381181|FG000|Overall Study|Withdrawal by Subject|6|||
161819892|NCT05034874|584381182|FG001|Overall Study|Withdrawal by Subject|6|||
161819893|NCT05034874|584381181|FG000|Overall Study|Lost to Follow-up|18|||
161819894|NCT05034874|584381182|FG001|Overall Study|Lost to Follow-up|8|||
161819895|NCT05034874|584381181|FG000|Overall Study|Physician Decision|0|||
161819896|NCT05034874|584381182|FG001|Overall Study|Physician Decision|1|||
161819897|NCT05034874|584381181|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
162192050|NCT01393600|585754735|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
161819898|NCT05034874|584381182|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
161819899|NCT01867658|584381183|FG000|Overall Study|Withdrawal by Subject|6|||
161819900|NCT01867658|584381183|FG000|Overall Study|Death|2|||
161819901|NCT01867658|584381183|FG000|Overall Study|Subject could not be contacted|1|||
162192051|NCT01393600|585754736|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
162192052|NCT01393600|585754733|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
162192053|NCT01393600|585754734|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
162192054|NCT01393600|585754735|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
162192055|NCT01393600|585754736|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
162192056|NCT01393600|585754733|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
162192057|NCT01393600|585754734|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
162192058|NCT01393600|585754735|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
162192059|NCT01393600|585754736|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
162192060|NCT01393600|585754733|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
162192061|NCT01393600|585754734|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
162192062|NCT01393600|585754735|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
162192063|NCT01393600|585754736|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
162192064|NCT01393600|585754733|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
162192065|NCT01393600|585754734|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
162192066|NCT01393600|585754735|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
162192067|NCT01393600|585754736|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
162192068|NCT00603798|585754737|FG000|Overall Study|Adverse Event|4|||
162192069|NCT00603798|585754738|FG001|Overall Study|Adverse Event|2|||
162192070|NCT00603798|585754739|FG002|Overall Study|Adverse Event|1|||
162192071|NCT00603798|585754737|FG000|Overall Study|Withdrawal by Subject|4|||
162192072|NCT00603798|585754738|FG001|Overall Study|Withdrawal by Subject|3|||
162192073|NCT00603798|585754739|FG002|Overall Study|Withdrawal by Subject|4|||
162192074|NCT00603798|585754737|FG000|Overall Study|Lost to Follow-up|1|||
162192075|NCT00603798|585754738|FG001|Overall Study|Lost to Follow-up|0|||
162192076|NCT00603798|585754739|FG002|Overall Study|Lost to Follow-up|1|||
162192077|NCT00603798|585754737|FG000|Overall Study|Non-compliance with study procedures|0|||
162192078|NCT00603798|585754738|FG001|Overall Study|Non-compliance with study procedures|1|||
162192079|NCT00603798|585754739|FG002|Overall Study|Non-compliance with study procedures|0|||
162192080|NCT00603798|585754737|FG000|Overall Study|Not due to AE|1|||
162192081|NCT00603798|585754738|FG001|Overall Study|Not due to AE|1|||
162192082|NCT00603798|585754739|FG002|Overall Study|Not due to AE|4|||
162192083|NCT02964234|585754745|FG000|Overall Study|Lost to Follow-up|22|||
162192084|NCT02964234|585754746|FG001|Overall Study|Lost to Follow-up|13|||
162192085|NCT01799993|585754747|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
162192086|NCT01799993|585754748|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
162192087|NCT01799993|585754747|FG000|Overall Study|Death|61|||
162192088|NCT01799993|585754748|FG001|Overall Study|Death|45|||
162192089|NCT01799993|585754747|FG000|Overall Study|Withdrawal by Subject|23|||
162192090|NCT01799993|585754748|FG001|Overall Study|Withdrawal by Subject|24|||
162192091|NCT01799993|585754747|FG000|Overall Study|Lost to Follow-up|5|||
162192092|NCT01799993|585754748|FG001|Overall Study|Lost to Follow-up|8|||
162192093|NCT01799993|585754747|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
162192094|NCT01799993|585754748|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
162192095|NCT01799993|585754747|FG000|Overall Study|Protocol driven decision point|0|||
162192096|NCT01799993|585754748|FG001|Overall Study|Protocol driven decision point|3|||
162192097|NCT01799993|585754747|FG000|Overall Study|Protocol Violation|1|||
162192098|NCT01799993|585754748|FG001|Overall Study|Protocol Violation|1|||
162192099|NCT01799993|585754747|FG000|Overall Study|Deterioration of general conditions|2|||
162192100|NCT01799993|585754748|FG001|Overall Study|Deterioration of general conditions|0|||
162192101|NCT01799993|585754747|FG000|Overall Study|Screen failure|0|||
162192102|NCT01799993|585754748|FG001|Overall Study|Screen failure|1|||
162192103|NCT01799993|585754747|FG000|Overall Study|Adverse Event|1|||
162192104|NCT01799993|585754748|FG001|Overall Study|Adverse Event|0|||
162192105|NCT01799993|585754747|FG000|Overall Study|Lack of Efficacy|1|||
162192106|NCT01799993|585754748|FG001|Overall Study|Lack of Efficacy|0|||
162192107|NCT01799993|585754747|FG000|Overall Study|Recovery|0|||
162192108|NCT01799993|585754748|FG001|Overall Study|Recovery|1|||
162192109|NCT01799993|585754747|FG000|Overall Study|Logistical difficulties|1|||
162192110|NCT01799993|585754748|FG001|Overall Study|Logistical difficulties|0|||
162192111|NCT01799993|585754747|FG000|Overall Study|Protocol deviation|1|||
162192112|NCT01799993|585754748|FG001|Overall Study|Protocol deviation|0|||
162192113|NCT01799993|585754747|FG000|Overall Study|Non-compliance with medical device|1|||
162192114|NCT01799993|585754748|FG001|Overall Study|Non-compliance with medical device|0|||
162192115|NCT01799993|585754747|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161673921|NCT01968070|583859921|FG004|Period 2|Withdrawal by Subject|1|||
161673922|NCT01968070|583859922|FG005|Period 2|Withdrawal by Subject|0|||
162020121|NCT02100696|585128592|FG005|Induction Phase|Physician Decision|0|||
162192116|NCT01799993|585754748|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162192117|NCT01799993|585754747|FG000|Overall Study|Other|1|||
162192118|NCT01799993|585754748|FG001|Overall Study|Other|0|||
162192119|NCT01799993|585754747|FG000|Overall Study|Subject didn't return for follow-up|0|||
162192120|NCT01799993|585754748|FG001|Overall Study|Subject didn't return for follow-up|1|||
162192121|NCT04361617|585754749|FG000|Overall Study|Withdrawal by Subject|0|||
162192122|NCT04361617|585754750|FG001|Overall Study|Withdrawal by Subject|1|||
162192123|NCT01263223|585754751|FG000|Period 2|Withdrawal by Subject|0|||
162192124|NCT01263223|585754752|FG001|Period 2|Withdrawal by Subject|1|||
162192125|NCT01263223|585754751|FG000|7-day Follow-up|Withdrawal by Subject|0|||
162192126|NCT01263223|585754752|FG001|7-day Follow-up|Withdrawal by Subject|1|||
162192127|NCT01263223|585754751|FG000|7-day Follow-up|Lost to Follow-up|1|||
162192128|NCT01263223|585754752|FG001|7-day Follow-up|Lost to Follow-up|0|||
162192129|NCT02246647|585754753|FG000|Overall Study|Withdrawal by Subject|1|||
162192130|NCT02246647|585754754|FG001|Overall Study|Withdrawal by Subject|1|||
162192131|NCT01113541|585754756|FG000|Overall Study|Withdrawal by Subject|1|||
162192132|NCT01113541|585754756|FG000|Overall Study|Protocol Violation|1|||
162192133|NCT01113541|585754756|FG000|Overall Study|Study Terminated by Sponsor|7|||
162192134|NCT01113541|585754756|FG000|Overall Study|Adverse Event|4|||
162192135|NCT01918033|585754760|FG000|Overall Study|Adverse Event|1|||
162192136|NCT01918033|585754761|FG001|Overall Study|Adverse Event|0|||
162192137|NCT01918033|585754762|FG002|Overall Study|Adverse Event|2|||
162192138|NCT01918033|585754760|FG000|Overall Study|Lost to Follow-up|0|||
162192139|NCT01918033|585754761|FG001|Overall Study|Lost to Follow-up|1|||
162192140|NCT01918033|585754762|FG002|Overall Study|Lost to Follow-up|0|||
162192141|NCT01918033|585754760|FG000|Overall Study|Protocol Violation|2|||
162192142|NCT01918033|585754761|FG001|Overall Study|Protocol Violation|0|||
162192143|NCT01918033|585754762|FG002|Overall Study|Protocol Violation|1|||
162192144|NCT01918033|585754760|FG000|Overall Study|Withdrawal by Subject|2|||
162192145|NCT01918033|585754761|FG001|Overall Study|Withdrawal by Subject|1|||
162192146|NCT01918033|585754762|FG002|Overall Study|Withdrawal by Subject|0|||
162192147|NCT04679675|585754763|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
162192148|NCT04679675|585754764|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
162192149|NCT04679675|585754765|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
162192150|NCT04679675|585754766|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
162192151|NCT04679675|585754763|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
162192152|NCT04679675|585754764|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
162192153|NCT04679675|585754765|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
162192154|NCT04679675|585754766|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
162192155|NCT02525744|585754773|FG000|Period 1|Physician Decision|0|||
162192156|NCT02525744|585754774|FG001|Period 1|Physician Decision|0|||
162192157|NCT02525744|585754775|FG002|Period 1|Physician Decision|1|||
162192158|NCT02525744|585754776|FG003|Period 1|Physician Decision|0|||
162192159|NCT02525744|585754773|FG000|Period 3|Adverse Event|0|||
162192160|NCT02525744|585754774|FG001|Period 3|Adverse Event|1|||
162192161|NCT02525744|585754775|FG002|Period 3|Adverse Event|0|||
162192162|NCT02525744|585754776|FG003|Period 3|Adverse Event|0|||
162192163|NCT02525744|585754773|FG000|Period 4|Withdrawal by Subject|1|||
162192164|NCT02525744|585754774|FG001|Period 4|Withdrawal by Subject|0|||
162192165|NCT02525744|585754775|FG002|Period 4|Withdrawal by Subject|0|||
162192166|NCT02525744|585754776|FG003|Period 4|Withdrawal by Subject|0|||
162192167|NCT02525744|585754773|FG000|Period 5|Physician Decision|1|||
162192168|NCT02525744|585754774|FG001|Period 5|Physician Decision|0|||
162192169|NCT02525744|585754775|FG002|Period 5|Physician Decision|0|||
162192170|NCT02525744|585754776|FG003|Period 5|Physician Decision|0|||
162192171|NCT01182285|585754777|FG000|First Intervention Week 1-10|Disease progression|1|||
162192172|NCT01182285|585754778|FG001|First Intervention Week 1-10|Disease progression|0|||
162192173|NCT01182285|585754779|FG002|First Intervention Week 1-10|Disease progression|0|||
162192174|NCT01182285|585754777|FG000|First Intervention Week 1-10|Adverse Event|1|||
162192175|NCT01182285|585754778|FG001|First Intervention Week 1-10|Adverse Event|0|||
162192176|NCT01182285|585754779|FG002|First Intervention Week 1-10|Adverse Event|0|||
162192177|NCT01182285|585754777|FG000|First Intervention Week 1-10|Non-compliance|1|||
162192178|NCT01182285|585754778|FG001|First Intervention Week 1-10|Non-compliance|0|||
162192179|NCT01182285|585754779|FG002|First Intervention Week 1-10|Non-compliance|0|||
162192180|NCT01182285|585754777|FG000|Third Intervention Week 11-52|Disease Progression|0|||
162192181|NCT01182285|585754778|FG001|Third Intervention Week 11-52|Disease Progression|0|||
162192182|NCT01182285|585754779|FG002|Third Intervention Week 11-52|Disease Progression|6|||
162192183|NCT01182285|585754777|FG000|Third Intervention Week 11-52|Other|0|||
162192184|NCT01182285|585754778|FG001|Third Intervention Week 11-52|Other|0|||
162192185|NCT01182285|585754779|FG002|Third Intervention Week 11-52|Other|2|||
162192186|NCT00472082|585754780|FG000|Overall Study|Study prematurely terminated|5|||
162192187|NCT02069379|585754781|FG000|Baseline Measurements|Lost to Follow-up|1|||
162192188|NCT02069379|585754782|FG001|Baseline Measurements|Lost to Follow-up|0|||
162192189|NCT02069379|585754783|FG002|Baseline Measurements|Lost to Follow-up|0|||
162192190|NCT02069379|585754784|FG003|Baseline Measurements|Lost to Follow-up|0|||
162192191|NCT02069379|585754781|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
162192192|NCT02069379|585754782|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
162192193|NCT02069379|585754783|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
162192194|NCT02069379|585754784|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
162020122|NCT02100696|585128587|FG000|Induction Phase|Multiple Reasons|5|||
162020123|NCT02100696|585128588|FG001|Induction Phase|Multiple Reasons|2|||
162020124|NCT02100696|585128589|FG002|Induction Phase|Multiple Reasons|8|||
162020125|NCT02100696|585128590|FG003|Induction Phase|Multiple Reasons|0|||
162020126|NCT02100696|585128591|FG004|Induction Phase|Multiple Reasons|0|||
162020127|NCT02100696|585128592|FG005|Induction Phase|Multiple Reasons|0|||
162020128|NCT02100696|585128587|FG000|Maintenance Phase|Adverse Event|0|||
162020129|NCT02100696|585128588|FG001|Maintenance Phase|Adverse Event|0|||
162020130|NCT02100696|585128589|FG002|Maintenance Phase|Adverse Event|0|||
162020131|NCT02100696|585128590|FG003|Maintenance Phase|Adverse Event|0|||
162020132|NCT02100696|585128591|FG004|Maintenance Phase|Adverse Event|0|||
162020133|NCT02100696|585128592|FG005|Maintenance Phase|Adverse Event|2|||
162020134|NCT02100696|585128587|FG000|Maintenance Phase|Lost to Follow-up|0|||
162020135|NCT02100696|585128588|FG001|Maintenance Phase|Lost to Follow-up|0|||
162020136|NCT02100696|585128589|FG002|Maintenance Phase|Lost to Follow-up|0|||
162192195|NCT02069379|585754781|FG000|First Treatment Arm|Lost to Follow-up|0|||
162192196|NCT02069379|585754782|FG001|First Treatment Arm|Lost to Follow-up|1|||
162192197|NCT02069379|585754783|FG002|First Treatment Arm|Lost to Follow-up|1|||
162192198|NCT02069379|585754784|FG003|First Treatment Arm|Lost to Follow-up|0|||
162192199|NCT02069379|585754781|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
162192200|NCT02069379|585754782|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
162192201|NCT02069379|585754783|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
162192202|NCT02069379|585754784|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
162192203|NCT02069379|585754781|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
162192204|NCT02069379|585754782|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
162192205|NCT02069379|585754783|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
162192206|NCT02069379|585754784|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
162192207|NCT02069379|585754781|FG000|Second Treatment Arm|Lost to Follow-up|0|||
162192208|NCT02069379|585754782|FG001|Second Treatment Arm|Lost to Follow-up|0|||
162192209|NCT02069379|585754783|FG002|Second Treatment Arm|Lost to Follow-up|1|||
162192210|NCT02069379|585754784|FG003|Second Treatment Arm|Lost to Follow-up|0|||
162192211|NCT04617847|585754787|FG000|Overall Study|Withdrawal by Subject|1|||
162192212|NCT04617847|585754788|FG001|Overall Study|Withdrawal by Subject|0|||
162192213|NCT04617847|585754787|FG000|Overall Study|Adverse Event|0|||
162192214|NCT04617847|585754788|FG001|Overall Study|Adverse Event|2|||
162192215|NCT04617847|585754787|FG000|Overall Study|Death|0|||
162192216|NCT04617847|585754788|FG001|Overall Study|Death|1|||
162192217|NCT04617847|585754787|FG000|Overall Study|Termination of Study by Sponsor|2|||
162192218|NCT04617847|585754788|FG001|Overall Study|Termination of Study by Sponsor|21|||
162192219|NCT01525875|585754789|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
162192220|NCT01525875|585754790|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
162192221|NCT01525875|585754789|FG000|Open-label Period|Lost to Follow-up|0|||
162020137|NCT02100696|585128590|FG003|Maintenance Phase|Lost to Follow-up|0|||
162020138|NCT02100696|585128591|FG004|Maintenance Phase|Lost to Follow-up|1|||
162192222|NCT01525875|585754790|FG001|Open-label Period|Lost to Follow-up|2|||
162192223|NCT00700999|585754791|FG000|Overall Study|Lost to Follow-up|7|||
162192224|NCT00700999|585754792|FG001|Overall Study|Lost to Follow-up|7|||
162192225|NCT00700999|585754791|FG000|Overall Study|Excluded - did not meet study criteria|0|||
162192226|NCT00700999|585754792|FG001|Overall Study|Excluded - did not meet study criteria|1|||
162192227|NCT00700999|585754791|FG000|Overall Study|Withdrawal by Subject|8|||
162192228|NCT00700999|585754792|FG001|Overall Study|Withdrawal by Subject|1|||
162192229|NCT00244751|585754793|FG000|Overall Study|Adverse Event|7|||
162192230|NCT00244751|585754794|FG001|Overall Study|Adverse Event|7|||
162192231|NCT00244751|585754795|FG002|Overall Study|Adverse Event|5|||
162192232|NCT00244751|585754793|FG000|Overall Study|Lost to Follow-up|0|||
161819902|NCT00474058|584381184|FG000|Overall Study|Adverse Event|11|||
162020139|NCT02100696|585128592|FG005|Maintenance Phase|Lost to Follow-up|0|||
162020140|NCT02100696|585128587|FG000|Maintenance Phase|Protocol Violation|0|||
162020141|NCT02100696|585128588|FG001|Maintenance Phase|Protocol Violation|0|||
162192233|NCT00244751|585754794|FG001|Overall Study|Lost to Follow-up|1|||
162192234|NCT00244751|585754795|FG002|Overall Study|Lost to Follow-up|0|||
162020142|NCT02100696|585128589|FG002|Maintenance Phase|Protocol Violation|0|||
162192235|NCT00244751|585754793|FG000|Overall Study|Protocol Violation|1|||
162192236|NCT00244751|585754794|FG001|Overall Study|Protocol Violation|0|||
162020143|NCT02100696|585128590|FG003|Maintenance Phase|Protocol Violation|0|||
162020144|NCT02100696|585128591|FG004|Maintenance Phase|Protocol Violation|1|||
162020145|NCT02100696|585128592|FG005|Maintenance Phase|Protocol Violation|0|||
162020146|NCT02100696|585128587|FG000|Maintenance Phase|Withdrawal by Subject|0|||
162020147|NCT02100696|585128588|FG001|Maintenance Phase|Withdrawal by Subject|0|||
162192237|NCT00244751|585754795|FG002|Overall Study|Protocol Violation|1|||
162192238|NCT00244751|585754793|FG000|Overall Study|Withdrawal by Subject|7|||
162192239|NCT00244751|585754794|FG001|Overall Study|Withdrawal by Subject|5|||
162192240|NCT00244751|585754795|FG002|Overall Study|Withdrawal by Subject|3|||
162192241|NCT00244751|585754793|FG000|Overall Study|Elevated liver enzymes|1|||
162192242|NCT00244751|585754794|FG001|Overall Study|Elevated liver enzymes|0|||
162192243|NCT00244751|585754795|FG002|Overall Study|Elevated liver enzymes|0|||
162192244|NCT00244751|585754793|FG000|Overall Study|Lack of compliance with protocol|0|||
162192245|NCT00244751|585754794|FG001|Overall Study|Lack of compliance with protocol|1|||
162192246|NCT00244751|585754795|FG002|Overall Study|Lack of compliance with protocol|0|||
162192247|NCT00244751|585754793|FG000|Overall Study|Safety reasons|0|||
162192248|NCT00244751|585754794|FG001|Overall Study|Safety reasons|1|||
162192249|NCT00244751|585754795|FG002|Overall Study|Safety reasons|0|||
162192250|NCT00244751|585754793|FG000|Overall Study|Participant randomized by mistake|0|||
162192251|NCT00244751|585754794|FG001|Overall Study|Participant randomized by mistake|0|||
162192252|NCT00244751|585754795|FG002|Overall Study|Participant randomized by mistake|1|||
162192253|NCT03031782|585754798|FG000|Treatment Period 1|Lack of Efficacy|3|||
162192254|NCT03031782|585754799|FG001|Treatment Period 1|Lack of Efficacy|0|||
162192255|NCT03031782|585754800|FG002|Treatment Period 1|Lack of Efficacy|0|||
162192256|NCT03031782|585754801|FG003|Treatment Period 1|Lack of Efficacy|0|||
162192257|NCT03031782|585754802|FG004|Treatment Period 1|Lack of Efficacy|0|||
162192258|NCT03031782|585754798|FG000|Treatment Period 2|Physician Decision|0|||
162192259|NCT03031782|585754799|FG001|Treatment Period 2|Physician Decision|1|||
162192260|NCT03031782|585754800|FG002|Treatment Period 2|Physician Decision|0|||
162192261|NCT03031782|585754801|FG003|Treatment Period 2|Physician Decision|0|||
161925689|NCT03166631|584774566|FG000|Overall Study|Physician Decision|0|||
161925690|NCT03166631|584774567|FG001|Overall Study|Physician Decision|0|||
161925691|NCT03166631|584774568|FG002|Overall Study|Physician Decision|0|||
161925692|NCT03166631|584774569|FG003|Overall Study|Physician Decision|0|||
161925693|NCT03166631|584774570|FG004|Overall Study|Physician Decision|0|||
161925694|NCT03166631|584774571|FG005|Overall Study|Physician Decision|0|||
161925695|NCT03166631|584774572|FG006|Overall Study|Physician Decision|1|||
161925696|NCT03166631|584774573|FG007|Overall Study|Physician Decision|0|||
161925697|NCT03166631|584774574|FG008|Overall Study|Physician Decision|1|||
161925698|NCT03166631|584774575|FG009|Overall Study|Physician Decision|0|||
162020148|NCT02100696|585128589|FG002|Maintenance Phase|Withdrawal by Subject|0|||
162020149|NCT02100696|585128590|FG003|Maintenance Phase|Withdrawal by Subject|1|||
162192262|NCT03031782|585754802|FG004|Treatment Period 2|Physician Decision|3|||
162192263|NCT03031782|585754798|FG000|Treatment Period 2|Lack of Efficacy|0|||
162192264|NCT03031782|585754799|FG001|Treatment Period 2|Lack of Efficacy|1|||
162192265|NCT03031782|585754800|FG002|Treatment Period 2|Lack of Efficacy|0|||
162192266|NCT03031782|585754801|FG003|Treatment Period 2|Lack of Efficacy|0|||
162192267|NCT03031782|585754802|FG004|Treatment Period 2|Lack of Efficacy|1|||
162192268|NCT03031782|585754798|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162192269|NCT03031782|585754799|FG001|Treatment Period 2|Withdrawal by Subject|3|||
162192270|NCT03031782|585754800|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162192271|NCT03031782|585754801|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161925699|NCT03166631|584774576|FG010|Overall Study|Physician Decision|1|||
161925700|NCT03166631|584774566|FG000|Overall Study|Death|0|||
162192272|NCT03031782|585754802|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161925701|NCT03166631|584774567|FG001|Overall Study|Death|0|||
161925702|NCT03166631|584774568|FG002|Overall Study|Death|0|||
161925703|NCT03166631|584774569|FG003|Overall Study|Death|0|||
161925704|NCT03166631|584774570|FG004|Overall Study|Death|1|||
161925705|NCT03166631|584774571|FG005|Overall Study|Death|0|||
161925706|NCT03166631|584774572|FG006|Overall Study|Death|1|||
161925707|NCT03166631|584774573|FG007|Overall Study|Death|0|||
161819903|NCT00474058|584381185|FG001|Overall Study|Adverse Event|6|||
161819904|NCT00474058|584381184|FG000|Overall Study|Lack of Efficacy|0|||
161819905|NCT00474058|584381185|FG001|Overall Study|Lack of Efficacy|4|||
161819906|NCT00474058|584381184|FG000|Overall Study|Withdrawal by Subject|11|||
161925708|NCT03166631|584774574|FG008|Overall Study|Death|0|||
161925709|NCT03166631|584774575|FG009|Overall Study|Death|0|||
161819907|NCT00474058|584381185|FG001|Overall Study|Withdrawal by Subject|7|||
161819908|NCT00474058|584381184|FG000|Overall Study|Other|2|||
161819909|NCT00474058|584381185|FG001|Overall Study|Other|0|||
161819910|NCT03101358|584381186|FG000|Overall Study|Non-compliance with study schedule|1|||
161819911|NCT03101358|584381187|FG001|Overall Study|Non-compliance with study schedule|0|||
161819912|NCT03101358|584381188|FG002|Overall Study|Non-compliance with study schedule|0|||
161819913|NCT03101358|584381189|FG003|Overall Study|Non-compliance with study schedule|1|||
161819914|NCT03101358|584381186|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
161819915|NCT03101358|584381187|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
161819916|NCT03101358|584381188|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
161819917|NCT03101358|584381189|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
161819918|NCT03101358|584381186|FG000|Overall Study|Physician Decision|1|||
162192273|NCT03031782|585754798|FG000|Treatment Period 2|Adverse Event|0|||
161819919|NCT03101358|584381187|FG001|Overall Study|Physician Decision|0|||
161819920|NCT03101358|584381188|FG002|Overall Study|Physician Decision|0|||
161819921|NCT03101358|584381189|FG003|Overall Study|Physician Decision|3|||
161819922|NCT03101358|584381186|FG000|Overall Study|Adverse Event|0|||
161819923|NCT03101358|584381187|FG001|Overall Study|Adverse Event|0|||
161819924|NCT03101358|584381188|FG002|Overall Study|Adverse Event|1|||
161819925|NCT03101358|584381189|FG003|Overall Study|Adverse Event|0|||
161819926|NCT03101358|584381186|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
161819927|NCT03101358|584381187|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
161819928|NCT03101358|584381188|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
161819929|NCT03101358|584381189|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
161819930|NCT03101358|584381186|FG000|Overall Study|Lost to Follow-up|1|||
161819931|NCT03101358|584381187|FG001|Overall Study|Lost to Follow-up|0|||
161819932|NCT03101358|584381188|FG002|Overall Study|Lost to Follow-up|0|||
161819933|NCT03101358|584381189|FG003|Overall Study|Lost to Follow-up|1|||
161819934|NCT02640235|584381190|FG000|Overall Study|Withdrawal by Subject|7|||
161819935|NCT02640235|584381191|FG001|Overall Study|Withdrawal by Subject|6|||
161819936|NCT02640235|584381190|FG000|Overall Study|Lost to Follow-up|4|||
161819937|NCT02640235|584381191|FG001|Overall Study|Lost to Follow-up|3|||
161819938|NCT02640235|584381190|FG000|Overall Study|Death|2|||
161819939|NCT02640235|584381191|FG001|Overall Study|Death|3|||
161819940|NCT02640235|584381190|FG000|Overall Study|Other|1|||
161819941|NCT02640235|584381191|FG001|Overall Study|Other|2|||
161819942|NCT02426918|584381192|FG000|Overall Study|Adverse Event|2|||
161819943|NCT02426918|584381193|FG001|Overall Study|Adverse Event|2|||
161819944|NCT02426918|584381194|FG002|Overall Study|Adverse Event|0|||
161925710|NCT03166631|584774576|FG010|Overall Study|Death|0|||
161925711|NCT03166631|584774566|FG000|Overall Study|Adverse Event|1|||
161925712|NCT03166631|584774567|FG001|Overall Study|Adverse Event|0|||
161925713|NCT03166631|584774568|FG002|Overall Study|Adverse Event|0|||
162192274|NCT03031782|585754799|FG001|Treatment Period 2|Adverse Event|1|||
162192275|NCT03031782|585754800|FG002|Treatment Period 2|Adverse Event|2|||
162192276|NCT03031782|585754801|FG003|Treatment Period 2|Adverse Event|0|||
162192277|NCT03031782|585754802|FG004|Treatment Period 2|Adverse Event|0|||
162192278|NCT03031782|585754798|FG000|Treatment Period 3|Withdrawal by Subject|0|||
162192279|NCT03031782|585754799|FG001|Treatment Period 3|Withdrawal by Subject|0|||
162192280|NCT03031782|585754800|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162192281|NCT03031782|585754801|FG003|Treatment Period 3|Withdrawal by Subject|1|||
162192282|NCT03031782|585754802|FG004|Treatment Period 3|Withdrawal by Subject|0|||
162192283|NCT04867382|585754805|FG000|Overall Study|Did not complete the survey|2|||
162192284|NCT04867382|585754806|FG001|Overall Study|Did not complete the survey|1|||
162192285|NCT05445557|585754807|FG000|Double Blind Part|Lost to Follow-up|1|||
162192286|NCT01323790|585754808|FG000|Overall Study|Other|3|||
162192287|NCT01323790|585754809|FG001|Overall Study|Other|2|||
162192288|NCT01323790|585754810|FG002|Overall Study|Other|1|||
161925714|NCT03166631|584774569|FG003|Overall Study|Adverse Event|0|||
162192289|NCT01323790|585754808|FG000|Overall Study|Lost to Follow-up|11|||
162192290|NCT01323790|585754809|FG001|Overall Study|Lost to Follow-up|9|||
162192291|NCT01323790|585754810|FG002|Overall Study|Lost to Follow-up|9|||
162192292|NCT01323790|585754808|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
162192293|NCT01323790|585754809|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
162192294|NCT01323790|585754810|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
162192295|NCT01323790|585754808|FG000|Overall Study|Lack of Efficacy|3|||
162192296|NCT01323790|585754809|FG001|Overall Study|Lack of Efficacy|0|||
162192297|NCT01323790|585754810|FG002|Overall Study|Lack of Efficacy|3|||
162192298|NCT01323790|585754808|FG000|Overall Study|Adverse Event|11|||
162192299|NCT01323790|585754809|FG001|Overall Study|Adverse Event|24|||
162192300|NCT01323790|585754810|FG002|Overall Study|Adverse Event|12|||
162192301|NCT01323790|585754808|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
162192302|NCT01323790|585754809|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
162192303|NCT01323790|585754810|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
162192304|NCT01323790|585754808|FG000|Overall Study|Withdrawal by Subject|23|||
162192305|NCT01323790|585754809|FG001|Overall Study|Withdrawal by Subject|20|||
162192306|NCT01323790|585754810|FG002|Overall Study|Withdrawal by Subject|13|||
162192307|NCT01323790|585754808|FG000|Overall Study|Did Not Receive Treatment|2|||
162192308|NCT01323790|585754809|FG001|Overall Study|Did Not Receive Treatment|0|||
162192309|NCT01323790|585754810|FG002|Overall Study|Did Not Receive Treatment|1|||
162192310|NCT01323790|585754808|FG000|Overall Study|Severe non-compliance with protocol|2|||
162192311|NCT01323790|585754809|FG001|Overall Study|Severe non-compliance with protocol|2|||
162192312|NCT01323790|585754810|FG002|Overall Study|Severe non-compliance with protocol|2|||
162192313|NCT01736475|585754811|FG000|Overall Study|Adverse Event|4|||
162192314|NCT01736475|585754812|FG001|Overall Study|Adverse Event|0|||
162192315|NCT01736475|585754811|FG000|Overall Study|Withdrawal by Subject|2|||
162192316|NCT01736475|585754812|FG001|Overall Study|Withdrawal by Subject|0|||
162192317|NCT01736475|585754811|FG000|Overall Study|Protocol Violation|4|||
162192318|NCT01736475|585754812|FG001|Overall Study|Protocol Violation|0|||
162192319|NCT01736475|585754811|FG000|Overall Study|Other - Screen failure|1|||
162192320|NCT01736475|585754812|FG001|Overall Study|Other - Screen failure|0|||
162192321|NCT01736475|585754811|FG000|Overall Study|Other - Surgical procedure|1|||
162192322|NCT01736475|585754812|FG001|Overall Study|Other - Surgical procedure|0|||
162192323|NCT02144285|585754814|FG000|Overall Study|Withdrawal by Subject|0|||
162192324|NCT02144285|585754815|FG001|Overall Study|Withdrawal by Subject|0|||
162192325|NCT02144285|585754816|FG002|Overall Study|Withdrawal by Subject|0|||
162192326|NCT02144285|585754817|FG003|Overall Study|Withdrawal by Subject|0|||
162192327|NCT02144285|585754818|FG004|Overall Study|Withdrawal by Subject|1|||
162192328|NCT02144285|585754819|FG005|Overall Study|Withdrawal by Subject|0|||
162192329|NCT02144285|585754820|FG006|Overall Study|Withdrawal by Subject|0|||
162192330|NCT02144285|585754821|FG007|Overall Study|Withdrawal by Subject|0|||
162192331|NCT02144285|585754822|FG008|Overall Study|Withdrawal by Subject|0|||
162192332|NCT02144285|585754823|FG009|Overall Study|Withdrawal by Subject|0|||
162192333|NCT01529632|585754824|FG000|Overall Study|Administrative problem|2|||
162192334|NCT01529632|585754825|FG001|Overall Study|Administrative problem|1|||
162192335|NCT01529632|585754824|FG000|Overall Study|Protocol Violation|0|||
162192336|NCT01529632|585754825|FG001|Overall Study|Protocol Violation|1|||
162192337|NCT01529632|585754824|FG000|Overall Study|Adverse Event|1|||
162192338|NCT01529632|585754825|FG001|Overall Study|Adverse Event|1|||
162192339|NCT05184062|585754827|FG000|Overall Study|Lost to Follow-up|5|||
162192340|NCT05184062|585754828|FG001|Overall Study|Lost to Follow-up|1|||
162192341|NCT05184062|585754827|FG000|Overall Study|Withdrawal by Subject|1|||
162192342|NCT05184062|585754828|FG001|Overall Study|Withdrawal by Subject|0|||
162192343|NCT00711555|585756763|FG000|Overall Study|Adverse Event|3|||
162192344|NCT04914897|585756768|FG000|Overall Study|Withdrawal by Subject|3|||
162192345|NCT04914897|585756769|FG001|Overall Study|Withdrawal by Subject|1|||
161819945|NCT02426918|584381192|FG000|Overall Study|Physician Decision|1|||
162192346|NCT04914897|585756770|FG002|Overall Study|Withdrawal by Subject|1|||
162192347|NCT04914897|585756771|FG003|Overall Study|Withdrawal by Subject|1|||
162192348|NCT04914897|585756768|FG000|Overall Study|Poor compliance to protocol|0|||
162192349|NCT04914897|585756769|FG001|Overall Study|Poor compliance to protocol|0|||
162192350|NCT04914897|585756770|FG002|Overall Study|Poor compliance to protocol|1|||
162192351|NCT04914897|585756771|FG003|Overall Study|Poor compliance to protocol|0|||
161673923|NCT01968070|583859923|FG006|Period 2|Withdrawal by Subject|0|||
161673924|NCT01968070|583859924|FG007|Period 2|Withdrawal by Subject|0|||
161673925|NCT01968070|583859925|FG008|Period 2|Withdrawal by Subject|0|||
161673926|NCT01968070|583859926|FG009|Period 2|Withdrawal by Subject|0|||
161673927|NCT01968070|583859927|FG010|Period 2|Withdrawal by Subject|0|||
162192352|NCT04914897|585756768|FG000|Overall Study|Progressive disease|5|||
162192353|NCT04914897|585756769|FG001|Overall Study|Progressive disease|14|||
162192354|NCT04914897|585756770|FG002|Overall Study|Progressive disease|30|||
162192355|NCT04914897|585756771|FG003|Overall Study|Progressive disease|21|||
162192356|NCT04914897|585756768|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
162192357|NCT04914897|585756769|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
162192358|NCT04914897|585756770|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
162192359|NCT04914897|585756771|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
162192360|NCT04914897|585756768|FG000|Overall Study|Other|1|||
162192361|NCT04914897|585756769|FG001|Overall Study|Other|0|||
162192362|NCT04914897|585756770|FG002|Overall Study|Other|0|||
162192363|NCT04914897|585756771|FG003|Overall Study|Other|1|||
162192364|NCT04783389|585756781|FG000|Overall Study|Withdrawal by Subject|2|||
162192365|NCT04783389|585756782|FG001|Overall Study|Withdrawal by Subject|0|||
162192366|NCT04783389|585756783|FG002|Overall Study|Withdrawal by Subject|0|||
162192367|NCT04783389|585756781|FG000|Overall Study|Termination of Study by Sponsor|10|||
162192368|NCT04783389|585756782|FG001|Overall Study|Termination of Study by Sponsor|12|||
162192369|NCT04783389|585756783|FG002|Overall Study|Termination of Study by Sponsor|14|||
162192370|NCT02164578|585756785|FG000|Treatment Period|Withdrawal by Subject|3|||
162192371|NCT02164578|585756786|FG001|Treatment Period|Withdrawal by Subject|3|||
162192372|NCT02164578|585756785|FG000|Treatment Period|Adverse Event|13|||
162192373|NCT02164578|585756786|FG001|Treatment Period|Adverse Event|6|||
162192374|NCT02164578|585756785|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
162192375|NCT02164578|585756786|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
162192376|NCT02164578|585756785|FG000|Treatment Period|Protocol Violation|0|||
162192377|NCT02164578|585756786|FG001|Treatment Period|Protocol Violation|2|||
162192378|NCT02164578|585756785|FG000|Extension Period|Withdrawal by Subject|2|||
162192379|NCT02164578|585756786|FG001|Extension Period|Withdrawal by Subject|0|||
162192380|NCT02164578|585756785|FG000|Extension Period|Adverse Event|4|||
162192381|NCT02164578|585756786|FG001|Extension Period|Adverse Event|0|||
162192382|NCT02164578|585756785|FG000|Extension Period|Expiry of study medication|1|||
162192383|NCT02164578|585756786|FG001|Extension Period|Expiry of study medication|0|||
162192384|NCT02164578|585756785|FG000|Extension Period|Protocol Violation|0|||
162192385|NCT02164578|585756786|FG001|Extension Period|Protocol Violation|1|||
162192386|NCT02507297|585756792|FG000|Overall Study|Withdrawal by Subject|1|||
162192387|NCT02507297|585756793|FG001|Overall Study|Withdrawal by Subject|0|||
162192388|NCT02507297|585756792|FG000|Overall Study|Lost to Follow-up|0|||
162192389|NCT02507297|585756793|FG001|Overall Study|Lost to Follow-up|1|||
162192390|NCT01562275|585756794|FG000|Stage 1|Adverse Event|0|||
162192391|NCT01562275|585756795|FG001|Stage 1|Adverse Event|0|||
162192392|NCT01562275|585756796|FG002|Stage 1|Adverse Event|0|||
162192393|NCT01562275|585756797|FG003|Stage 1|Adverse Event|1|||
162192394|NCT01562275|585756798|FG004|Stage 1|Adverse Event|1|||
162192395|NCT01562275|585756799|FG005|Stage 1|Adverse Event|0|||
162192396|NCT01562275|585756800|FG006|Stage 1|Adverse Event|0|||
162192397|NCT01562275|585756801|FG007|Stage 1|Adverse Event|0|||
162192398|NCT01562275|585756802|FG008|Stage 1|Adverse Event|0|||
162192399|NCT01562275|585756803|FG009|Stage 1|Adverse Event|1|||
162192400|NCT01562275|585756804|FG010|Stage 1|Adverse Event|0|||
162192401|NCT01562275|585756805|FG011|Stage 1|Adverse Event|0|||
162192402|NCT01562275|585756806|FG012|Stage 1|Adverse Event|0|||
162192403|NCT01562275|585756794|FG000|Stage 1|Death|1|||
162192404|NCT01562275|585756795|FG001|Stage 1|Death|0|||
162192405|NCT01562275|585756796|FG002|Stage 1|Death|0|||
161673928|NCT01968070|583859928|FG011|Period 2|Withdrawal by Subject|0|||
161673929|NCT01968070|583859929|FG012|Period 2|Withdrawal by Subject|0|||
161673930|NCT01968070|583859930|FG013|Period 2|Withdrawal by Subject|0|||
161673931|NCT01968070|583859931|FG014|Period 2|Withdrawal by Subject|0|||
161673932|NCT01968070|583859932|FG015|Period 2|Withdrawal by Subject|0|||
161673933|NCT01968070|583859933|FG016|Period 2|Withdrawal by Subject|0|||
162192406|NCT01562275|585756797|FG003|Stage 1|Death|0|||
162192407|NCT01562275|585756798|FG004|Stage 1|Death|0|||
162192408|NCT01562275|585756799|FG005|Stage 1|Death|0|||
162192409|NCT01562275|585756800|FG006|Stage 1|Death|0|||
162192410|NCT01562275|585756801|FG007|Stage 1|Death|0|||
162192411|NCT01562275|585756802|FG008|Stage 1|Death|0|||
162192412|NCT01562275|585756803|FG009|Stage 1|Death|0|||
161673934|NCT01968070|583859934|FG017|Period 2|Withdrawal by Subject|0|||
161673935|NCT01822522|583859937|FG000|Overall Study|Adverse Event|1|||
162192413|NCT01562275|585756804|FG010|Stage 1|Death|0|||
162192414|NCT01562275|585756805|FG011|Stage 1|Death|0|||
162192415|NCT01562275|585756806|FG012|Stage 1|Death|0|||
162192416|NCT01562275|585756794|FG000|Stage 1|Non Compliance|0|||
162192417|NCT01562275|585756795|FG001|Stage 1|Non Compliance|0|||
162192418|NCT01562275|585756796|FG002|Stage 1|Non Compliance|1|||
162192419|NCT01562275|585756797|FG003|Stage 1|Non Compliance|0|||
162192420|NCT01562275|585756798|FG004|Stage 1|Non Compliance|0|||
162192421|NCT01562275|585756799|FG005|Stage 1|Non Compliance|0|||
162192422|NCT01562275|585756800|FG006|Stage 1|Non Compliance|0|||
162192423|NCT01562275|585756801|FG007|Stage 1|Non Compliance|0|||
162192424|NCT01562275|585756802|FG008|Stage 1|Non Compliance|0|||
162192425|NCT01562275|585756803|FG009|Stage 1|Non Compliance|0|||
162192426|NCT01562275|585756804|FG010|Stage 1|Non Compliance|0|||
162192427|NCT01562275|585756805|FG011|Stage 1|Non Compliance|0|||
162192428|NCT01562275|585756806|FG012|Stage 1|Non Compliance|0|||
162192429|NCT01562275|585756794|FG000|Stage 1|Physician Decision|0|||
162192430|NCT01562275|585756795|FG001|Stage 1|Physician Decision|0|||
162192431|NCT01562275|585756796|FG002|Stage 1|Physician Decision|0|||
162192432|NCT01562275|585756797|FG003|Stage 1|Physician Decision|0|||
162192433|NCT01562275|585756798|FG004|Stage 1|Physician Decision|1|||
162192434|NCT01562275|585756799|FG005|Stage 1|Physician Decision|0|||
162192435|NCT01562275|585756800|FG006|Stage 1|Physician Decision|1|||
162192436|NCT01562275|585756801|FG007|Stage 1|Physician Decision|0|||
162192437|NCT01562275|585756802|FG008|Stage 1|Physician Decision|1|||
162192438|NCT01562275|585756803|FG009|Stage 1|Physician Decision|0|||
162192439|NCT01562275|585756804|FG010|Stage 1|Physician Decision|0|||
162192440|NCT01562275|585756805|FG011|Stage 1|Physician Decision|0|||
162192441|NCT01562275|585756806|FG012|Stage 1|Physician Decision|0|||
162192442|NCT01562275|585756794|FG000|Stage 1|Progression of Disease|2|||
162192443|NCT01562275|585756795|FG001|Stage 1|Progression of Disease|6|||
162192444|NCT01562275|585756796|FG002|Stage 1|Progression of Disease|2|||
162192445|NCT01562275|585756797|FG003|Stage 1|Progression of Disease|1|||
162192446|NCT01562275|585756798|FG004|Stage 1|Progression of Disease|2|||
162192447|NCT01562275|585756799|FG005|Stage 1|Progression of Disease|4|||
162192448|NCT01562275|585756800|FG006|Stage 1|Progression of Disease|1|||
162192449|NCT01562275|585756801|FG007|Stage 1|Progression of Disease|7|||
162192450|NCT01562275|585756802|FG008|Stage 1|Progression of Disease|2|||
162192451|NCT01562275|585756803|FG009|Stage 1|Progression of Disease|5|||
162192452|NCT01562275|585756804|FG010|Stage 1|Progression of Disease|3|||
162192453|NCT01562275|585756805|FG011|Stage 1|Progression of Disease|0|||
162192454|NCT01562275|585756806|FG012|Stage 1|Progression of Disease|0|||
162192455|NCT01562275|585756794|FG000|Stage 1|Withdrawal by Subject|0|||
162192456|NCT01562275|585756795|FG001|Stage 1|Withdrawal by Subject|1|||
162192457|NCT01562275|585756796|FG002|Stage 1|Withdrawal by Subject|0|||
162192458|NCT01562275|585756797|FG003|Stage 1|Withdrawal by Subject|2|||
162192459|NCT01562275|585756798|FG004|Stage 1|Withdrawal by Subject|0|||
162192460|NCT01562275|585756799|FG005|Stage 1|Withdrawal by Subject|0|||
162192461|NCT01562275|585756800|FG006|Stage 1|Withdrawal by Subject|1|||
162192462|NCT01562275|585756801|FG007|Stage 1|Withdrawal by Subject|0|||
162192463|NCT01562275|585756802|FG008|Stage 1|Withdrawal by Subject|0|||
162192464|NCT01562275|585756803|FG009|Stage 1|Withdrawal by Subject|1|||
162192465|NCT01562275|585756804|FG010|Stage 1|Withdrawal by Subject|0|||
162192466|NCT01562275|585756805|FG011|Stage 1|Withdrawal by Subject|0|||
162192467|NCT01562275|585756806|FG012|Stage 1|Withdrawal by Subject|0|||
162192468|NCT01562275|585756794|FG000|Stage 2|Death|0|||
162192469|NCT01562275|585756795|FG001|Stage 2|Death|0|||
162192470|NCT01562275|585756796|FG002|Stage 2|Death|0|||
162192471|NCT01562275|585756797|FG003|Stage 2|Death|0|||
162192472|NCT01562275|585756798|FG004|Stage 2|Death|0|||
162192473|NCT01562275|585756799|FG005|Stage 2|Death|0|||
162192474|NCT01562275|585756800|FG006|Stage 2|Death|0|||
162192475|NCT01562275|585756801|FG007|Stage 2|Death|0|||
162192476|NCT01562275|585756802|FG008|Stage 2|Death|0|||
162192477|NCT01562275|585756803|FG009|Stage 2|Death|0|||
162192478|NCT01562275|585756804|FG010|Stage 2|Death|0|||
162192479|NCT01562275|585756805|FG011|Stage 2|Death|2|||
162192480|NCT01562275|585756806|FG012|Stage 2|Death|1|||
162192481|NCT01562275|585756794|FG000|Stage 2|Progression of Disease|0|||
162192482|NCT01562275|585756795|FG001|Stage 2|Progression of Disease|0|||
162192483|NCT01562275|585756796|FG002|Stage 2|Progression of Disease|0|||
162192484|NCT01562275|585756797|FG003|Stage 2|Progression of Disease|0|||
162192485|NCT01562275|585756798|FG004|Stage 2|Progression of Disease|0|||
162192486|NCT01562275|585756799|FG005|Stage 2|Progression of Disease|0|||
162192487|NCT01562275|585756800|FG006|Stage 2|Progression of Disease|0|||
162192488|NCT01562275|585756801|FG007|Stage 2|Progression of Disease|0|||
161673936|NCT01822522|583859938|FG001|Overall Study|Adverse Event|1|||
162192489|NCT01562275|585756802|FG008|Stage 2|Progression of Disease|0|||
162192490|NCT01562275|585756803|FG009|Stage 2|Progression of Disease|0|||
162192491|NCT01562275|585756804|FG010|Stage 2|Progression of Disease|0|||
162192492|NCT01562275|585756805|FG011|Stage 2|Progression of Disease|12|||
162192493|NCT01562275|585756806|FG012|Stage 2|Progression of Disease|4|||
162192494|NCT01863368|585756807|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
162192495|NCT01863368|585756808|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
162192496|NCT01863368|585756807|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
162192497|NCT01863368|585756808|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
162192498|NCT01863368|585756807|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
162192499|NCT01863368|585756808|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
162192500|NCT01863368|585756807|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
162192501|NCT01863368|585756808|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
162192502|NCT01863368|585756807|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
162192503|NCT01863368|585756808|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
162192504|NCT01863368|585756807|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
162192505|NCT01863368|585756808|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
162192506|NCT00070707|585756809|FG000|Overall Study|Adverse Event|1|||
162192507|NCT00070707|585756810|FG001|Overall Study|Adverse Event|2|||
162192508|NCT00070707|585756809|FG000|Overall Study|Lack of Efficacy|4|||
162192509|NCT00070707|585756810|FG001|Overall Study|Lack of Efficacy|1|||
162192510|NCT00070707|585756809|FG000|Overall Study|Protocol Violation|8|||
162192511|NCT00070707|585756810|FG001|Overall Study|Protocol Violation|4|||
162192512|NCT00070707|585756809|FG000|Overall Study|Unrelated to Study Medication|1|||
162192513|NCT00070707|585756810|FG001|Overall Study|Unrelated to Study Medication|0|||
162192514|NCT00647699|585756811|FG000|Overall Study|Lost to Follow-up|5|||
162192515|NCT00647699|585756812|FG001|Overall Study|Lost to Follow-up|4|||
162192516|NCT00647699|585756811|FG000|Overall Study|Withdrawal by Subject|3|||
162192517|NCT00647699|585756812|FG001|Overall Study|Withdrawal by Subject|8|||
162192518|NCT04909593|585756813|FG000|Overall Study|Withdrawal by Subject|1|||
162192519|NCT01018992|585756814|FG000|Overall Study|Adverse Event|8|||
162192520|NCT01018992|585756815|FG001|Overall Study|Adverse Event|3|||
162192521|NCT01018992|585756814|FG000|Overall Study|Withdrawal by Subject|3|||
162192522|NCT01018992|585756815|FG001|Overall Study|Withdrawal by Subject|8|||
162192523|NCT01018992|585756814|FG000|Overall Study|Protocol Violation|0|||
162192524|NCT01018992|585756815|FG001|Overall Study|Protocol Violation|4|||
162192525|NCT01018992|585756814|FG000|Overall Study|Lost to Follow-up|5|||
162192526|NCT01018992|585756815|FG001|Overall Study|Lost to Follow-up|1|||
162192527|NCT03029585|585756818|FG000|Overall Study|Death|1|||
162192528|NCT03029585|585756819|FG001|Overall Study|Death|1|||
162192529|NCT03029585|585756818|FG000|Overall Study|Withdrawal by Subject|1|||
162192530|NCT03029585|585756819|FG001|Overall Study|Withdrawal by Subject|0|||
162192531|NCT02400749|585756820|FG000|Week 0 -16|Withdrawal by Subject|5|||
162192532|NCT02400749|585756821|FG001|Week 0 -16|Withdrawal by Subject|5|||
162192533|NCT02400749|585756820|FG000|Week 0 -16|Adverse Event|3|||
162192534|NCT02400749|585756821|FG001|Week 0 -16|Adverse Event|1|||
162192535|NCT02400749|585756820|FG000|Week 0 -16|Lost to Follow-up|2|||
162192536|NCT02400749|585756821|FG001|Week 0 -16|Lost to Follow-up|0|||
162192537|NCT02400749|585756820|FG000|Week 0 -16|Protocol Violation|1|||
162192538|NCT02400749|585756821|FG001|Week 0 -16|Protocol Violation|0|||
162192539|NCT02400749|585756820|FG000|Week 17 - 32|Withdrawal by Subject|3|||
162192540|NCT02400749|585756821|FG001|Week 17 - 32|Withdrawal by Subject|2|||
162192541|NCT02400749|585756820|FG000|Week 17 - 32|Adverse Event|2|||
162192542|NCT02400749|585756821|FG001|Week 17 - 32|Adverse Event|1|||
162192543|NCT00307489|585756822|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
162192544|NCT00307489|585756823|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
162192545|NCT00307489|585756822|FG000|Baseline Through Week 48|Physician Decision|1|||
162192546|NCT00307489|585756823|FG001|Baseline Through Week 48|Physician Decision|0|||
162192547|NCT00307489|585756822|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
162192548|NCT00307489|585756823|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
162192549|NCT00307489|585756822|FG000|Week 48 Through Week 168|Adverse Event|1|||
162192550|NCT00307489|585756823|FG001|Week 48 Through Week 168|Adverse Event|0|||
162192551|NCT00307489|585756822|FG000|Week 48 Through Week 168|Physician Decision|1|||
161673937|NCT01822522|583859939|FG002|Overall Study|Adverse Event|1|||
161673938|NCT01822522|583859940|FG003|Overall Study|Adverse Event|0|||
161673939|NCT01822522|583859941|FG004|Overall Study|Adverse Event|0|||
161673940|NCT01822522|583859942|FG005|Overall Study|Adverse Event|1|||
161673941|NCT01822522|583859937|FG000|Overall Study|Death|3|||
161673942|NCT01822522|583859938|FG001|Overall Study|Death|0|||
161673943|NCT01822522|583859939|FG002|Overall Study|Death|2|||
162192552|NCT00307489|585756823|FG001|Week 48 Through Week 168|Physician Decision|0|||
162192553|NCT00307489|585756822|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
162192554|NCT00307489|585756823|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
162192555|NCT00307489|585756822|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
162192556|NCT00307489|585756823|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
162192557|NCT00307489|585756822|FG000|Week 48 Through Week 168|Death|0|||
162192558|NCT00307489|585756823|FG001|Week 48 Through Week 168|Death|1|||
161673944|NCT01822522|583859940|FG003|Overall Study|Death|0|||
162192559|NCT00307489|585756822|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
161673945|NCT01822522|583859941|FG004|Overall Study|Death|0|||
162192560|NCT00307489|585756823|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
162192561|NCT00307489|585756822|FG000|Week 48 Through Week 168|Seroconversion|1|||
162192562|NCT00307489|585756823|FG001|Week 48 Through Week 168|Seroconversion|0|||
162192563|NCT04425252|585756824|FG000|Overall Study|Withdrawal by Subject|2|||
162192564|NCT04425252|585756825|FG001|Overall Study|Withdrawal by Subject|1|||
162192565|NCT04425252|585756824|FG000|Overall Study|Lost to Follow-up|1|||
162192566|NCT04425252|585756825|FG001|Overall Study|Lost to Follow-up|0|||
162192567|NCT04425252|585756824|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
162192568|NCT04425252|585756825|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
162192569|NCT01825785|585756826|FG000|Overall Study|Adverse Event|0|||
162192570|NCT01825785|585756827|FG001|Overall Study|Adverse Event|0|||
162192571|NCT01825785|585756828|FG002|Overall Study|Adverse Event|0|||
161673946|NCT01822522|583859942|FG005|Overall Study|Death|0|||
161673947|NCT01822522|583859937|FG000|Overall Study|Lost to Follow-up|0|||
161673948|NCT01822522|583859938|FG001|Overall Study|Lost to Follow-up|0|||
161673949|NCT01822522|583859939|FG002|Overall Study|Lost to Follow-up|1|||
161673950|NCT01822522|583859940|FG003|Overall Study|Lost to Follow-up|1|||
161673951|NCT01822522|583859941|FG004|Overall Study|Lost to Follow-up|0|||
161673952|NCT01822522|583859942|FG005|Overall Study|Lost to Follow-up|1|||
161673953|NCT01822522|583859937|FG000|Overall Study|Withdrawal by Subject|0|||
161673954|NCT01822522|583859938|FG001|Overall Study|Withdrawal by Subject|0|||
161673955|NCT01822522|583859939|FG002|Overall Study|Withdrawal by Subject|0|||
162192572|NCT01825785|585756829|FG003|Overall Study|Adverse Event|0|||
162192573|NCT01825785|585756830|FG004|Overall Study|Adverse Event|1|||
162192574|NCT01825785|585756831|FG005|Overall Study|Adverse Event|0|||
162192575|NCT01825785|585756832|FG006|Overall Study|Adverse Event|0|||
162192576|NCT01825785|585756826|FG000|Overall Study|Withdrawal by Subject|0|||
162192577|NCT01825785|585756827|FG001|Overall Study|Withdrawal by Subject|0|||
162192578|NCT01825785|585756828|FG002|Overall Study|Withdrawal by Subject|0|||
162192579|NCT01825785|585756829|FG003|Overall Study|Withdrawal by Subject|0|||
162192580|NCT01825785|585756830|FG004|Overall Study|Withdrawal by Subject|1|||
162192581|NCT01825785|585756831|FG005|Overall Study|Withdrawal by Subject|1|||
162192582|NCT01825785|585756832|FG006|Overall Study|Withdrawal by Subject|0|||
162192583|NCT01286311|585756834|FG000|Overall Study|Physician did not want outreach sent|14|||
162192584|NCT01286311|585756835|FG001|Overall Study|Physician did not want outreach sent|0|||
162192585|NCT01437540|585756836|FG000|Overall Study|Not listed below|7|||
162192586|NCT01437540|585756837|FG001|Overall Study|Not listed below|6|||
162192587|NCT01437540|585756836|FG000|Overall Study|COPD exacerbation|13|||
162192588|NCT01437540|585756837|FG001|Overall Study|COPD exacerbation|3|||
162192589|NCT01437540|585756836|FG000|Overall Study|Lost to Follow-up|3|||
162192590|NCT01437540|585756837|FG001|Overall Study|Lost to Follow-up|5|||
162192591|NCT01437540|585756836|FG000|Overall Study|Lack of Efficacy|23|||
162192592|NCT01437540|585756837|FG001|Overall Study|Lack of Efficacy|11|||
162192593|NCT01437540|585756836|FG000|Overall Study|Protocol Violation|24|||
162192594|NCT01437540|585756837|FG001|Overall Study|Protocol Violation|12|||
161673956|NCT01822522|583859940|FG003|Overall Study|Withdrawal by Subject|1|||
161673957|NCT01822522|583859941|FG004|Overall Study|Withdrawal by Subject|0|||
161673958|NCT01822522|583859942|FG005|Overall Study|Withdrawal by Subject|0|||
161673959|NCT01822522|583859937|FG000|Overall Study|Lack of Efficacy|0|||
161673960|NCT01822522|583859938|FG001|Overall Study|Lack of Efficacy|0|||
161673961|NCT01822522|583859939|FG002|Overall Study|Lack of Efficacy|0|||
161673962|NCT01822522|583859940|FG003|Overall Study|Lack of Efficacy|0|||
161673963|NCT01822522|583859941|FG004|Overall Study|Lack of Efficacy|0|||
162192595|NCT01437540|585756836|FG000|Overall Study|Adverse Event|26|||
162192596|NCT01437540|585756837|FG001|Overall Study|Adverse Event|13|||
162192597|NCT01437540|585756836|FG000|Overall Study|Withdrawal by Subject|31|||
162192598|NCT01437540|585756837|FG001|Overall Study|Withdrawal by Subject|15|||
162192599|NCT01381549|585756838|FG000|Overall Study|Ineligible: No organisms isolated|0|||
162192600|NCT01381549|585756839|FG001|Overall Study|Ineligible: No organisms isolated|0|||
162192601|NCT01381549|585756840|FG002|Overall Study|Ineligible: No organisms isolated|1|||
162192602|NCT02981953|585756841|FG000|Overall Study|Death|9|||
162192603|NCT02981953|585756841|FG000|Overall Study|Withdrawal by Subject|1|||
162192604|NCT02981953|585756841|FG000|Overall Study|Withdrawal to non-compliance|1|||
162192605|NCT01655498|585756846|FG000|Overall Study|Unrelated health issue|2|||
162192606|NCT01655498|585756846|FG000|Overall Study|Protocol Violation|2|||
162192607|NCT01655498|585756846|FG000|Overall Study|Withdrawal by Subject|1|||
162192608|NCT02446015|585756849|FG000|Overall Study|Adverse Event|0|||
162192609|NCT02446015|585756850|FG001|Overall Study|Adverse Event|1|||
161673964|NCT01822522|583859942|FG005|Overall Study|Lack of Efficacy|2|||
161673965|NCT00890929|583859943|FG000|Overall Study|Death before treatment|2|||
161673966|NCT00890929|583859943|FG000|Overall Study|Withdrawal by Subject|3|||
161673967|NCT00890929|583859943|FG000|Overall Study|Physician Decision|1|||
162020150|NCT02100696|585128591|FG004|Maintenance Phase|Withdrawal by Subject|4|||
161673968|NCT00108069|583859944|FG000|Overall Study|Never rec'd study drug|0|||
162020151|NCT02100696|585128592|FG005|Maintenance Phase|Withdrawal by Subject|2|||
162192610|NCT02446015|585756849|FG000|Overall Study|Withdrawal by Subject|1|||
161673969|NCT00108069|583859945|FG001|Overall Study|Never rec'd study drug|1|||
161673970|NCT00108069|583859944|FG000|Overall Study|Adverse Event|1|||
162192611|NCT02446015|585756850|FG001|Overall Study|Withdrawal by Subject|0|||
162192612|NCT00988429|585756851|FG000|Overall Study|Adverse Event|9|||
162192613|NCT00988429|585756852|FG001|Overall Study|Adverse Event|21|||
162192614|NCT00988429|585756853|FG002|Overall Study|Adverse Event|45|||
162192615|NCT00988429|585756851|FG000|Overall Study|Lack of Efficacy|0|||
162192616|NCT00988429|585756852|FG001|Overall Study|Lack of Efficacy|0|||
162192617|NCT00988429|585756853|FG002|Overall Study|Lack of Efficacy|1|||
162192618|NCT00988429|585756851|FG000|Overall Study|Non-Compliance with Study Drug|5|||
162192619|NCT00988429|585756852|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162192620|NCT00988429|585756853|FG002|Overall Study|Non-Compliance with Study Drug|3|||
162192621|NCT00988429|585756851|FG000|Overall Study|Physician Decision|1|||
162192622|NCT00988429|585756852|FG001|Overall Study|Physician Decision|0|||
162192623|NCT00988429|585756853|FG002|Overall Study|Physician Decision|3|||
162192624|NCT00988429|585756851|FG000|Overall Study|Pregnancy|2|||
162192625|NCT00988429|585756852|FG001|Overall Study|Pregnancy|1|||
162192626|NCT00988429|585756853|FG002|Overall Study|Pregnancy|0|||
162192627|NCT00988429|585756851|FG000|Overall Study|Protocol Violation|4|||
162192628|NCT00988429|585756852|FG001|Overall Study|Protocol Violation|3|||
162192629|NCT00988429|585756853|FG002|Overall Study|Protocol Violation|3|||
162192630|NCT00988429|585756851|FG000|Overall Study|Withdrawal by Subject|7|||
162192631|NCT00988429|585756852|FG001|Overall Study|Withdrawal by Subject|7|||
162192632|NCT00988429|585756853|FG002|Overall Study|Withdrawal by Subject|12|||
162192633|NCT00988429|585756851|FG000|Overall Study|Administrative Reasons|1|||
162192634|NCT00988429|585756852|FG001|Overall Study|Administrative Reasons|2|||
162192635|NCT00988429|585756853|FG002|Overall Study|Administrative Reasons|1|||
162192636|NCT00988429|585756851|FG000|Overall Study|other reasons|8|||
162192637|NCT00988429|585756852|FG001|Overall Study|other reasons|8|||
162192638|NCT00988429|585756853|FG002|Overall Study|other reasons|1|||
162192639|NCT01714947|585756854|FG000|Part B|Progressive Disease|3|||
162192640|NCT01123356|585756855|FG000|Overall Study|Adverse Event|2|||
162192641|NCT01123356|585756855|FG000|Overall Study|Lack of Efficacy|4|||
162192642|NCT01123356|585756855|FG000|Overall Study|Withdrawal by Subject|1|||
162192643|NCT00376259|585756858|FG000|Overall Study|Sponsor request - study termination|21|||
162192644|NCT00376259|585756859|FG001|Overall Study|Sponsor request - study termination|21|||
162192645|NCT00376259|585756858|FG000|Overall Study|Patient request|1|||
162192646|NCT00376259|585756859|FG001|Overall Study|Patient request|0|||
162192647|NCT01877720|585756861|FG000|Overall Study|Adverse Event|1|||
161819946|NCT02426918|584381193|FG001|Overall Study|Physician Decision|1|||
161819947|NCT02426918|584381194|FG002|Overall Study|Physician Decision|1|||
161819948|NCT02426918|584381192|FG000|Overall Study|Withdrawal by Subject|5|||
161819949|NCT02426918|584381193|FG001|Overall Study|Withdrawal by Subject|5|||
161819950|NCT02426918|584381194|FG002|Overall Study|Withdrawal by Subject|4|||
161819951|NCT02426918|584381192|FG000|Overall Study|Other|9|||
161819952|NCT02426918|584381193|FG001|Overall Study|Other|11|||
161819953|NCT02426918|584381194|FG002|Overall Study|Other|9|||
161819954|NCT02420353|584381195|FG000|Overall Study|Withdrawal by Subject|0|||
161819955|NCT02420353|584381196|FG001|Overall Study|Withdrawal by Subject|1|||
161819956|NCT00503867|584381197|FG000|Overall Study|Lost to Follow-up|1|||
161819957|NCT00503867|584381197|FG000|Overall Study|Adverse Event|1|||
161819958|NCT05616728|584381198|FG000|Overall Study|Lost to Follow-up|0|||
161819959|NCT05616728|584381199|FG001|Overall Study|Lost to Follow-up|0|||
161819960|NCT05616728|584381200|FG002|Overall Study|Lost to Follow-up|1|||
161819961|NCT05616728|584381198|FG000|Overall Study|Withdrawal by Subject|1|||
161819962|NCT05616728|584381199|FG001|Overall Study|Withdrawal by Subject|1|||
161819963|NCT05616728|584381200|FG002|Overall Study|Withdrawal by Subject|0|||
161819964|NCT05616728|584381198|FG000|Overall Study|Physician Decision|1|||
161819965|NCT05616728|584381199|FG001|Overall Study|Physician Decision|1|||
161819966|NCT05616728|584381200|FG002|Overall Study|Physician Decision|1|||
161819967|NCT05616728|584381198|FG000|Overall Study|Other|0|||
161819968|NCT05616728|584381199|FG001|Overall Study|Other|2|||
161819969|NCT05616728|584381200|FG002|Overall Study|Other|0|||
161819970|NCT05004649|584381207|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
161819971|NCT05004649|584381207|FG000|Overall Study|Lost to Follow-up|1|||
161819972|NCT05004649|584381207|FG000|Overall Study|Withdrawal by Subject|2|||
161819973|NCT05004649|584381207|FG000|Overall Study|COVID-19|1|||
161819974|NCT00301964|584381208|FG000|Overall Study|Second primary|2|||
161819975|NCT00301964|584381208|FG000|Overall Study|Wrong primary|1|||
161819976|NCT00301964|584381208|FG000|Overall Study|Inadequate pathology|1|||
161819977|NCT02385708|584381210|FG000|Overall Study|Withdrawal by Subject|0|||
161819978|NCT02385708|584381211|FG001|Overall Study|Withdrawal by Subject|2|||
161819979|NCT02385708|584381210|FG000|Overall Study|Withdrawn - surgery canceled|2|||
161819980|NCT02385708|584381211|FG001|Overall Study|Withdrawn - surgery canceled|5|||
161819981|NCT02385708|584381210|FG000|Overall Study|Investigator decision|5|||
161819982|NCT02385708|584381211|FG001|Overall Study|Investigator decision|7|||
161819983|NCT02385708|584381210|FG000|Overall Study|Protocol Violation|1|||
162192648|NCT01877720|585756862|FG001|Overall Study|Adverse Event|0|||
162192649|NCT00267956|585756865|FG000|Controlled Period|Adverse Event|4|||
162192650|NCT00267956|585756866|FG001|Controlled Period|Adverse Event|1|||
162192651|NCT00267956|585756867|FG002|Controlled Period|Adverse Event|0|||
162192652|NCT00267956|585756868|FG003|Controlled Period|Adverse Event|0|||
162192653|NCT00267956|585756865|FG000|Controlled Period|Lack of Efficacy|4|||
162192654|NCT00267956|585756866|FG001|Controlled Period|Lack of Efficacy|2|||
162192655|NCT00267956|585756867|FG002|Controlled Period|Lack of Efficacy|0|||
162192656|NCT00267956|585756868|FG003|Controlled Period|Lack of Efficacy|0|||
162192657|NCT00267956|585756865|FG000|Controlled Period|Lost to Follow-up|2|||
162192658|NCT00267956|585756866|FG001|Controlled Period|Lost to Follow-up|0|||
162192659|NCT00267956|585756867|FG002|Controlled Period|Lost to Follow-up|0|||
162192660|NCT00267956|585756868|FG003|Controlled Period|Lost to Follow-up|0|||
162192661|NCT00267956|585756865|FG000|Controlled Period|Withdrew consent|3|||
162192662|NCT00267956|585756866|FG001|Controlled Period|Withdrew consent|1|||
162192663|NCT00267956|585756867|FG002|Controlled Period|Withdrew consent|0|||
162192664|NCT00267956|585756868|FG003|Controlled Period|Withdrew consent|0|||
162192665|NCT00267956|585756865|FG000|After Controlled Period|Adverse Event|0|||
162192666|NCT00267956|585756866|FG001|After Controlled Period|Adverse Event|0|||
162192667|NCT00267956|585756867|FG002|After Controlled Period|Adverse Event|2|||
162192668|NCT00267956|585756868|FG003|After Controlled Period|Adverse Event|1|||
162192669|NCT00267956|585756865|FG000|After Controlled Period|Lack of Efficacy|0|||
162192670|NCT00267956|585756866|FG001|After Controlled Period|Lack of Efficacy|0|||
162192671|NCT00267956|585756867|FG002|After Controlled Period|Lack of Efficacy|1|||
162192672|NCT00267956|585756868|FG003|After Controlled Period|Lack of Efficacy|1|||
162192673|NCT00267956|585756865|FG000|After Controlled Period|Lost to Follow-up|0|||
162192674|NCT00267956|585756866|FG001|After Controlled Period|Lost to Follow-up|0|||
162192675|NCT00267956|585756867|FG002|After Controlled Period|Lost to Follow-up|1|||
162192676|NCT00267956|585756868|FG003|After Controlled Period|Lost to Follow-up|0|||
162192677|NCT00267956|585756865|FG000|After Controlled Period|Withdrew consent|0|||
162192678|NCT00267956|585756866|FG001|After Controlled Period|Withdrew consent|0|||
162192679|NCT00267956|585756867|FG002|After Controlled Period|Withdrew consent|1|||
162192680|NCT00267956|585756868|FG003|After Controlled Period|Withdrew consent|0|||
162192681|NCT01393964|585756873|FG000|Overall Study|Disease Progression|4|||
162192682|NCT01393964|585756874|FG001|Overall Study|Disease Progression|3|||
162192683|NCT01393964|585756875|FG002|Overall Study|Disease Progression|5|||
162192684|NCT01393964|585756873|FG000|Overall Study|Study drug toxicity|1|||
162192685|NCT01393964|585756874|FG001|Overall Study|Study drug toxicity|0|||
162192686|NCT01393964|585756875|FG002|Overall Study|Study drug toxicity|0|||
162192687|NCT01393964|585756873|FG000|Overall Study|Withdrawal by Subject|0|||
162192688|NCT01393964|585756874|FG001|Overall Study|Withdrawal by Subject|0|||
162192689|NCT01393964|585756875|FG002|Overall Study|Withdrawal by Subject|1|||
162192690|NCT01393964|585756873|FG000|Overall Study|Adverse event unrelated to study drug|0|||
162192691|NCT01393964|585756874|FG001|Overall Study|Adverse event unrelated to study drug|3|||
162192692|NCT01393964|585756875|FG002|Overall Study|Adverse event unrelated to study drug|0|||
162192693|NCT01393964|585756873|FG000|Overall Study|Subject request stop study treatment|0|||
162192694|NCT01393964|585756874|FG001|Overall Study|Subject request stop study treatment|1|||
162192695|NCT01393964|585756875|FG002|Overall Study|Subject request stop study treatment|0|||
162192696|NCT01393964|585756873|FG000|Overall Study|Subject decided to move to transplant|1|||
162192697|NCT01393964|585756874|FG001|Overall Study|Subject decided to move to transplant|0|||
162192698|NCT01393964|585756875|FG002|Overall Study|Subject decided to move to transplant|0|||
162192699|NCT01393964|585756873|FG000|Overall Study|Subject switched to commercial supply|1|||
162192700|NCT01393964|585756874|FG001|Overall Study|Subject switched to commercial supply|0|||
162192701|NCT01393964|585756875|FG002|Overall Study|Subject switched to commercial supply|2|||
162192702|NCT01393964|585756873|FG000|Overall Study|Subject plateaued in terms of effect|1|||
162192703|NCT01393964|585756874|FG001|Overall Study|Subject plateaued in terms of effect|0|||
162192704|NCT01393964|585756875|FG002|Overall Study|Subject plateaued in terms of effect|0|||
162192705|NCT01393964|585756873|FG000|Overall Study|Investigator removed subject from study|0|||
162192706|NCT01393964|585756874|FG001|Overall Study|Investigator removed subject from study|1|||
162192707|NCT01393964|585756875|FG002|Overall Study|Investigator removed subject from study|0|||
162192708|NCT01393964|585756873|FG000|Overall Study|Subject converted to roll-over study|0|||
161819984|NCT02385708|584381211|FG001|Overall Study|Protocol Violation|1|||
161819985|NCT02436200|584381212|FG000|Overall Study|Significant outlier|1|||
161819986|NCT02761915|584381213|FG000|Overall Study|Death|3|||
161819987|NCT02761915|584381214|FG001|Overall Study|Death|1|||
161819988|NCT02761915|584381215|FG002|Overall Study|Death|1|||
161819989|NCT02761915|584381216|FG003|Overall Study|Death|1|||
161819990|NCT02761915|584381217|FG004|Overall Study|Death|0|||
161819991|NCT02761915|584381218|FG005|Overall Study|Death|1|||
161819992|NCT02761915|584381213|FG000|Overall Study|Withdrawal by Subject|1|||
161819993|NCT02761915|584381214|FG001|Overall Study|Withdrawal by Subject|0|||
162020152|NCT02100696|585128587|FG000|Maintenance Phase|Physician Decision|0|||
162192709|NCT01393964|585756874|FG001|Overall Study|Subject converted to roll-over study|1|||
162192710|NCT01393964|585756875|FG002|Overall Study|Subject converted to roll-over study|0|||
162192711|NCT01393964|585756873|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
162192712|NCT01393964|585756874|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
161819994|NCT02761915|584381215|FG002|Overall Study|Withdrawal by Subject|0|||
162192713|NCT01393964|585756875|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
162192714|NCT00687297|585756881|FG000|Randomization|Withdrawal by Subject|2|||
162192715|NCT00687297|585756882|FG001|Randomization|Withdrawal by Subject|0|||
162192716|NCT00687297|585756881|FG000|Randomization|Withdrew before treatment, ineligible|1|||
162192717|NCT00687297|585756882|FG001|Randomization|Withdrew before treatment, ineligible|1|||
162192718|NCT00687297|585756881|FG000|Induction|Withdrawal by Subject|4|||
162192719|NCT00687297|585756882|FG001|Induction|Withdrawal by Subject|4|||
162192720|NCT00687297|585756881|FG000|Induction|Adverse Event|16|||
162192721|NCT00687297|585756882|FG001|Induction|Adverse Event|15|||
162192722|NCT00687297|585756881|FG000|Induction|Death|7|||
162192723|NCT00687297|585756882|FG001|Induction|Death|11|||
162192724|NCT00687297|585756881|FG000|Induction|Lack of Efficacy|17|||
162192725|NCT00687297|585756882|FG001|Induction|Lack of Efficacy|21|||
162192726|NCT00687297|585756881|FG000|Induction|Ineligible|0|||
162192727|NCT00687297|585756882|FG001|Induction|Ineligible|1|||
162192728|NCT00687297|585756881|FG000|Induction|Patient Noncompliance|1|||
162192729|NCT00687297|585756882|FG001|Induction|Patient Noncompliance|0|||
162192730|NCT00687297|585756881|FG000|Induction|Physician Decision|0|||
162192731|NCT00687297|585756882|FG001|Induction|Physician Decision|2|||
162192732|NCT00687297|585756881|FG000|Induction|Other|0|||
162192733|NCT00687297|585756882|FG001|Induction|Other|1|||
162192734|NCT01494467|585756885|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
162192735|NCT01494467|585756886|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
162192736|NCT01494467|585756885|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
162192737|NCT01494467|585756886|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
162192738|NCT01494467|585756885|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
162192739|NCT01494467|585756886|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
162192740|NCT01494467|585756885|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
162192741|NCT01494467|585756886|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
162192742|NCT01494467|585756885|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
162192743|NCT01494467|585756886|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
162192744|NCT01494467|585756885|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
162192745|NCT01494467|585756886|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
162192746|NCT01494467|585756885|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
162192747|NCT01494467|585756886|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
162192748|NCT01494467|585756885|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
162192749|NCT01494467|585756886|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
162192750|NCT01494467|585756885|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
162192751|NCT01494467|585756886|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
162192752|NCT01494467|585756885|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
162192753|NCT01494467|585756886|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
162192754|NCT01494467|585756885|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
162192755|NCT01494467|585756886|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
162192756|NCT01494467|585756885|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
162192757|NCT01494467|585756886|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
162192758|NCT01494467|585756885|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
162192759|NCT01494467|585756886|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
162192760|NCT01494467|585756885|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
162192761|NCT01494467|585756886|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
162192762|NCT02077374|585756889|FG000|Overall Study|Withdrawal by Subject|0|||
162192763|NCT02077374|585756890|FG001|Overall Study|Withdrawal by Subject|1|||
162192764|NCT02077374|585756889|FG000|Overall Study|Protocol Violation|0|||
162192765|NCT02077374|585756890|FG001|Overall Study|Protocol Violation|1|||
162192766|NCT01777932|585756891|FG000|Overall Study|Disease progression|136|||
162192767|NCT01777932|585756891|FG000|Overall Study|Death|3|||
161673971|NCT00108069|583859945|FG001|Overall Study|Adverse Event|1|||
161673972|NCT00108069|583859944|FG000|Overall Study|Withdrawal by Subject|1|||
162192768|NCT01777932|585756891|FG000|Overall Study|Adverse Event|34|||
162192769|NCT01777932|585756891|FG000|Overall Study|Lost to Follow-up|3|||
161673973|NCT00108069|583859945|FG001|Overall Study|Withdrawal by Subject|0|||
162192770|NCT01777932|585756891|FG000|Overall Study|Investigator decision|10|||
162192771|NCT01777932|585756891|FG000|Overall Study|Reimbursement limit|9|||
162192772|NCT01777932|585756891|FG000|Overall Study|Patient refused further treatment|10|||
161673974|NCT00108069|583859944|FG000|Overall Study|Death|1|||
162192773|NCT00068107|585756895|FG000|Overall Study|end-stage renal disease|6|||
162192774|NCT00068107|585756895|FG000|Overall Study|Death|2|||
162192775|NCT00068107|585756895|FG000|Overall Study|Withdrawal by Subject|1|||
162192776|NCT03989232|585756902|FG000|Overall Study|Lost to Follow-up|3|||
161673975|NCT00108069|583859945|FG001|Overall Study|Death|0|||
162192777|NCT03989232|585756903|FG001|Overall Study|Lost to Follow-up|10|||
162192778|NCT03989232|585756902|FG000|Overall Study|Withdrawal by Subject|6|||
162192779|NCT03989232|585756903|FG001|Overall Study|Withdrawal by Subject|6|||
162192780|NCT03989232|585756902|FG000|Overall Study|Death|1|||
162192781|NCT03989232|585756903|FG001|Overall Study|Death|2|||
162192782|NCT02644122|585756906|FG000|Overall Study|Withdrawal by Subject|1|||
162192783|NCT00424476|585756907|FG000|Overall Study|Withdrawal by Subject|7|||
162192784|NCT00424476|585756908|FG001|Overall Study|Withdrawal by Subject|6|||
162192785|NCT00424476|585756909|FG002|Overall Study|Withdrawal by Subject|3|||
162192786|NCT00424476|585756907|FG000|Overall Study|Adverse Event|19|||
162192787|NCT00424476|585756908|FG001|Overall Study|Adverse Event|16|||
162192788|NCT00424476|585756909|FG002|Overall Study|Adverse Event|15|||
162192789|NCT00424476|585756907|FG000|Overall Study|Lack of Efficacy|16|||
162192790|NCT00424476|585756908|FG001|Overall Study|Lack of Efficacy|12|||
162192791|NCT00424476|585756909|FG002|Overall Study|Lack of Efficacy|12|||
162192792|NCT00424476|585756907|FG000|Overall Study|Lack of Compliance|1|||
162192793|NCT00424476|585756908|FG001|Overall Study|Lack of Compliance|1|||
162192794|NCT00424476|585756909|FG002|Overall Study|Lack of Compliance|1|||
162192795|NCT00424476|585756907|FG000|Overall Study|Lost to Follow-up|4|||
162192796|NCT00424476|585756908|FG001|Overall Study|Lost to Follow-up|6|||
162192797|NCT00424476|585756909|FG002|Overall Study|Lost to Follow-up|3|||
162192798|NCT00424476|585756907|FG000|Overall Study|Protocol Violation|7|||
162192799|NCT00424476|585756908|FG001|Overall Study|Protocol Violation|2|||
162192800|NCT00424476|585756909|FG002|Overall Study|Protocol Violation|3|||
162192801|NCT00424476|585756907|FG000|Overall Study|Physician Decision|3|||
162192802|NCT00424476|585756908|FG001|Overall Study|Physician Decision|2|||
162192803|NCT00424476|585756909|FG002|Overall Study|Physician Decision|3|||
162192804|NCT00424476|585756907|FG000|Overall Study|Other|4|||
162192805|NCT00424476|585756908|FG001|Overall Study|Other|3|||
162192806|NCT00424476|585756909|FG002|Overall Study|Other|9|||
162192807|NCT01930188|585756910|FG000|Overall Study|unclassified|4|||
162192808|NCT01930188|585756911|FG001|Overall Study|unclassified|5|||
162192809|NCT01930188|585756912|FG002|Overall Study|unclassified|3|||
162192810|NCT01930188|585756910|FG000|Overall Study|Missing follow-up information|2|||
162192811|NCT01930188|585756911|FG001|Overall Study|Missing follow-up information|2|||
162192812|NCT01930188|585756912|FG002|Overall Study|Missing follow-up information|3|||
162192813|NCT01930188|585756910|FG000|Overall Study|Lost to Follow-up|5|||
162192814|NCT01930188|585756911|FG001|Overall Study|Lost to Follow-up|2|||
162192815|NCT01930188|585756912|FG002|Overall Study|Lost to Follow-up|2|||
162192816|NCT01930188|585756910|FG000|Overall Study|Death|2|||
162192817|NCT01930188|585756911|FG001|Overall Study|Death|1|||
162192818|NCT01930188|585756912|FG002|Overall Study|Death|3|||
162192819|NCT01930188|585756910|FG000|Overall Study|Withdrawal by Subject|9|||
162192820|NCT01930188|585756911|FG001|Overall Study|Withdrawal by Subject|11|||
162192821|NCT01930188|585756912|FG002|Overall Study|Withdrawal by Subject|8|||
162192822|NCT02399449|585756913|FG000|Overall Study|Withdrawal by Subject|3|||
162192823|NCT02399449|585756914|FG001|Overall Study|Withdrawal by Subject|9|||
162192824|NCT02399449|585756913|FG000|Overall Study|Physician Decision|0|||
162192825|NCT02399449|585756914|FG001|Overall Study|Physician Decision|1|||
162192826|NCT01020435|585756915|FG000|Overall Study|Lost to Follow-up|0|||
162192827|NCT01020435|585756916|FG001|Overall Study|Lost to Follow-up|1|||
162192828|NCT00346398|585756917|FG000|Overall Study|Lost to Follow-up|3|||
162192829|NCT00346398|585756918|FG001|Overall Study|Lost to Follow-up|0|||
162192830|NCT00346398|585756917|FG000|Overall Study|Withdrawal by Subject|0|||
162192831|NCT00346398|585756918|FG001|Overall Study|Withdrawal by Subject|2|||
162192832|NCT02607956|585756919|FG000|Double-Blinded Phase|Withdrew Consent|17|||
162192833|NCT02607956|585756920|FG001|Double-Blinded Phase|Withdrew Consent|19|||
162192834|NCT02607956|585756921|FG002|Double-Blinded Phase|Withdrew Consent|0|||
162192835|NCT02607956|585756922|FG003|Double-Blinded Phase|Withdrew Consent|0|||
162192836|NCT02607956|585756919|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
162192837|NCT02607956|585756920|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
162192838|NCT02607956|585756921|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
162192839|NCT02607956|585756922|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
162192840|NCT02607956|585756919|FG000|Double-Blinded Phase|Randomized but never treated|7|||
162192841|NCT02607956|585756920|FG001|Double-Blinded Phase|Randomized but never treated|5|||
162192842|NCT02607956|585756921|FG002|Double-Blinded Phase|Randomized but never treated|0|||
162192843|NCT02607956|585756922|FG003|Double-Blinded Phase|Randomized but never treated|0|||
162192844|NCT02607956|585756919|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
162192845|NCT02607956|585756920|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
162192846|NCT02607956|585756921|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
162192847|NCT02607956|585756922|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
162192848|NCT02607956|585756919|FG000|Double-Blinded Phase|Death|4|||
162192849|NCT02607956|585756920|FG001|Double-Blinded Phase|Death|4|||
162192850|NCT02607956|585756921|FG002|Double-Blinded Phase|Death|0|||
162192851|NCT02607956|585756922|FG003|Double-Blinded Phase|Death|0|||
162192852|NCT02607956|585756919|FG000|Double-Blinded Phase|Adverse Event|4|||
162192853|NCT02607956|585756920|FG001|Double-Blinded Phase|Adverse Event|3|||
162020153|NCT02100696|585128588|FG001|Maintenance Phase|Physician Decision|0|||
162020154|NCT02100696|585128589|FG002|Maintenance Phase|Physician Decision|0|||
162020155|NCT02100696|585128590|FG003|Maintenance Phase|Physician Decision|0|||
162020156|NCT02100696|585128591|FG004|Maintenance Phase|Physician Decision|1|||
162020157|NCT02100696|585128592|FG005|Maintenance Phase|Physician Decision|0|||
162020158|NCT02100696|585128587|FG000|Maintenance Phase|Multiple Reasons|0|||
162020159|NCT02100696|585128588|FG001|Maintenance Phase|Multiple Reasons|0|||
162192854|NCT02607956|585756921|FG002|Double-Blinded Phase|Adverse Event|0|||
162192855|NCT02607956|585756922|FG003|Double-Blinded Phase|Adverse Event|0|||
162192856|NCT02607956|585756919|FG000|Double-Blinded Phase|Protocol Violation|3|||
162192857|NCT02607956|585756920|FG001|Double-Blinded Phase|Protocol Violation|1|||
162192858|NCT02607956|585756921|FG002|Double-Blinded Phase|Protocol Violation|0|||
162192859|NCT02607956|585756922|FG003|Double-Blinded Phase|Protocol Violation|0|||
162192860|NCT02607956|585756919|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
162192861|NCT02607956|585756920|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
162192862|NCT02607956|585756921|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
162192863|NCT02607956|585756922|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
162192864|NCT02607956|585756919|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
162192865|NCT02607956|585756920|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
162192866|NCT02607956|585756921|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
162192867|NCT02607956|585756922|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
162192868|NCT02607956|585756919|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
162192869|NCT02607956|585756920|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
162192870|NCT02607956|585756921|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
162192871|NCT02607956|585756922|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
162192872|NCT02607956|585756919|FG000|Open-Label Extension Phase|Death|0|||
162192873|NCT02607956|585756920|FG001|Open-Label Extension Phase|Death|0|||
162192874|NCT02607956|585756921|FG002|Open-Label Extension Phase|Death|1|||
162192875|NCT02607956|585756922|FG003|Open-Label Extension Phase|Death|3|||
162192876|NCT02607956|585756919|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
162192877|NCT02607956|585756920|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
162192878|NCT02607956|585756921|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
162192879|NCT02607956|585756922|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
162192880|NCT02607956|585756919|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
162192881|NCT02607956|585756920|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
162192882|NCT02607956|585756921|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
162192883|NCT02607956|585756922|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
162192884|NCT02607956|585756919|FG000|Open-Label Extension Phase|Protocol Violation|0|||
162192885|NCT02607956|585756920|FG001|Open-Label Extension Phase|Protocol Violation|0|||
162192886|NCT02607956|585756921|FG002|Open-Label Extension Phase|Protocol Violation|0|||
162192887|NCT02607956|585756922|FG003|Open-Label Extension Phase|Protocol Violation|2|||
162192888|NCT02607956|585756919|FG000|Open-Label Extension Phase|Pregnancy|0|||
162192889|NCT02607956|585756920|FG001|Open-Label Extension Phase|Pregnancy|0|||
162192890|NCT02607956|585756921|FG002|Open-Label Extension Phase|Pregnancy|0|||
162192891|NCT02607956|585756922|FG003|Open-Label Extension Phase|Pregnancy|1|||
162192892|NCT00960206|585756929|FG000|Overall Study|Death|7|||
162192893|NCT00960206|585756930|FG001|Overall Study|Death|4|||
162192894|NCT00960206|585756931|FG002|Overall Study|Death|1|||
162192895|NCT00960206|585756929|FG000|Overall Study|Unwilling/Unable to return|1|||
162192896|NCT00960206|585756930|FG001|Overall Study|Unwilling/Unable to return|2|||
162192897|NCT00960206|585756931|FG002|Overall Study|Unwilling/Unable to return|0|||
162192898|NCT00960206|585756929|FG000|Overall Study|Lost to Follow-up|8|||
162192899|NCT00960206|585756930|FG001|Overall Study|Lost to Follow-up|14|||
162192900|NCT00960206|585756931|FG002|Overall Study|Lost to Follow-up|8|||
162192901|NCT00960206|585756929|FG000|Overall Study|Withdrawal by Subject|2|||
162192902|NCT00960206|585756930|FG001|Overall Study|Withdrawal by Subject|4|||
162192903|NCT00960206|585756931|FG002|Overall Study|Withdrawal by Subject|0|||
162192904|NCT00960206|585756929|FG000|Overall Study|Revision of study component|2|||
162192905|NCT00960206|585756930|FG001|Overall Study|Revision of study component|2|||
162192906|NCT00960206|585756931|FG002|Overall Study|Revision of study component|2|||
162192907|NCT00960206|585756929|FG000|Overall Study|Missing 10 year data|20|||
162192908|NCT00960206|585756930|FG001|Overall Study|Missing 10 year data|1|||
162192909|NCT00960206|585756931|FG002|Overall Study|Missing 10 year data|1|||
162192910|NCT01240590|585756934|FG000|Phase I|Refused further treatment|0|||
162192911|NCT01240590|585756935|FG001|Phase I|Refused further treatment|0|||
162192912|NCT01240590|585756936|FG002|Phase I|Refused further treatment|3|||
162192913|NCT01240590|585756937|FG003|Phase I|Refused further treatment|0|||
162192914|NCT01240590|585756938|FG004|Phase I|Refused further treatment|0|||
162192915|NCT01240590|585756934|FG000|Phase II|Refused further treatment|0|||
162192916|NCT01240590|585756935|FG001|Phase II|Refused further treatment|0|||
162020160|NCT02100696|585128589|FG002|Maintenance Phase|Multiple Reasons|0|||
162020161|NCT02100696|585128590|FG003|Maintenance Phase|Multiple Reasons|0|||
162020162|NCT02100696|585128591|FG004|Maintenance Phase|Multiple Reasons|2|||
162020163|NCT02100696|585128592|FG005|Maintenance Phase|Multiple Reasons|1|||
161819995|NCT02761915|584381216|FG003|Overall Study|Withdrawal by Subject|0|||
162192917|NCT01240590|585756936|FG002|Phase II|Refused further treatment|0|||
162192918|NCT01240590|585756937|FG003|Phase II|Refused further treatment|2|||
162192919|NCT01240590|585756938|FG004|Phase II|Refused further treatment|1|||
162192920|NCT02548585|585756939|FG000|Overall Study|Withdrawal by Subject|0|||
162192921|NCT02548585|585756940|FG001|Overall Study|Withdrawal by Subject|0|||
162192922|NCT02548585|585756941|FG002|Overall Study|Withdrawal by Subject|0|||
162192923|NCT02548585|585756942|FG003|Overall Study|Withdrawal by Subject|0|||
162192924|NCT02548585|585756943|FG004|Overall Study|Withdrawal by Subject|0|||
162192925|NCT02548585|585756944|FG005|Overall Study|Withdrawal by Subject|1|||
162192926|NCT02548585|585756945|FG006|Overall Study|Withdrawal by Subject|0|||
162192927|NCT02548585|585756939|FG000|Overall Study|Lost to Follow-up|1|||
162192928|NCT02548585|585756940|FG001|Overall Study|Lost to Follow-up|0|||
162192929|NCT02548585|585756941|FG002|Overall Study|Lost to Follow-up|0|||
162192930|NCT02548585|585756942|FG003|Overall Study|Lost to Follow-up|0|||
162192931|NCT02548585|585756943|FG004|Overall Study|Lost to Follow-up|0|||
162192932|NCT02548585|585756944|FG005|Overall Study|Lost to Follow-up|0|||
162192933|NCT02548585|585756945|FG006|Overall Study|Lost to Follow-up|0|||
162192934|NCT02548585|585756939|FG000|Overall Study|Other|1|||
162192935|NCT02548585|585756940|FG001|Overall Study|Other|0|||
162192936|NCT02548585|585756941|FG002|Overall Study|Other|0|||
162192937|NCT02548585|585756942|FG003|Overall Study|Other|2|||
162192938|NCT02548585|585756943|FG004|Overall Study|Other|3|||
162192939|NCT02548585|585756944|FG005|Overall Study|Other|0|||
162192940|NCT02548585|585756945|FG006|Overall Study|Other|1|||
162192941|NCT02548585|585756939|FG000|Overall Study|Randomized but not treated|0|||
162192942|NCT02548585|585756940|FG001|Overall Study|Randomized but not treated|0|||
162192943|NCT02548585|585756941|FG002|Overall Study|Randomized but not treated|0|||
162192944|NCT02548585|585756942|FG003|Overall Study|Randomized but not treated|0|||
162192945|NCT02548585|585756943|FG004|Overall Study|Randomized but not treated|0|||
162192946|NCT02548585|585756944|FG005|Overall Study|Randomized but not treated|1|||
162192947|NCT02548585|585756945|FG006|Overall Study|Randomized but not treated|0|||
162192948|NCT01075152|585756946|FG000|Overall Study|Withdrawal by Subject|1|||
162192949|NCT01075152|585756947|FG001|Overall Study|Withdrawal by Subject|0|||
162192950|NCT01079949|585756950|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
162192951|NCT01079949|585756951|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
162192952|NCT01079949|585756950|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
162192953|NCT01079949|585756951|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
162192954|NCT01079949|585756950|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
162192955|NCT01079949|585756951|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
162192956|NCT01079949|585756950|FG000|Overall Study|Randomized but not treated|1|||
162192957|NCT01079949|585756951|FG001|Overall Study|Randomized but not treated|0|||
162192958|NCT05066230|585758503|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
162192959|NCT05066230|585758504|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
162192960|NCT05066230|585758503|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
162192961|NCT05066230|585758504|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
162192962|NCT05066230|585758503|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
162192963|NCT05066230|585758504|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
162192964|NCT05066230|585758503|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
162192965|NCT05066230|585758504|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
162192966|NCT05066230|585758503|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
162192967|NCT05066230|585758504|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
162192968|NCT05066230|585758503|FG000|After Week 48|Adverse Event|1|||
162192969|NCT05066230|585758504|FG001|After Week 48|Adverse Event|0|||
162192970|NCT05066230|585758503|FG000|After Week 48|Non-compliance with study schedule|1|||
162192971|NCT05066230|585758504|FG001|After Week 48|Non-compliance with study schedule|0|||
162192972|NCT05066230|585758503|FG000|After Week 48|Withdrawal by Subject|0|||
162192973|NCT05066230|585758504|FG001|After Week 48|Withdrawal by Subject|1|||
162192974|NCT05066230|585758503|FG000|After Week 48|Lost to Follow-up|3|||
161819996|NCT02761915|584381217|FG004|Overall Study|Withdrawal by Subject|1|||
161819997|NCT02761915|584381218|FG005|Overall Study|Withdrawal by Subject|2|||
161819998|NCT02761915|584381213|FG000|Overall Study|Disease Progression|0|||
161819999|NCT02761915|584381214|FG001|Overall Study|Disease Progression|0|||
161820000|NCT02761915|584381215|FG002|Overall Study|Disease Progression|0|||
161820001|NCT02761915|584381216|FG003|Overall Study|Disease Progression|2|||
162192975|NCT05066230|585758504|FG001|After Week 48|Lost to Follow-up|3|||
162192976|NCT05066230|585758503|FG000|After Week 48|Sponsor Request|115|||
162192977|NCT05066230|585758504|FG001|After Week 48|Sponsor Request|111|||
162192978|NCT00805792|585758505|FG000|Overall Study|Death|3|||
162192979|NCT00805792|585758505|FG000|Overall Study|Lost to Follow-up|2|||
162192980|NCT02165202|585758510|FG000|Oral Phase|Refused further participation|5|||
162192981|NCT02165202|585758511|FG001|Oral Phase|Refused further participation|1|||
162192982|NCT02165202|585758510|FG000|Oral Phase|Study product Related Toxicity|1|||
162192983|NCT02165202|585758511|FG001|Oral Phase|Study product Related Toxicity|0|||
162192984|NCT02165202|585758510|FG000|Oral Phase|Unable to contact Participant|1|||
162192985|NCT02165202|585758511|FG001|Oral Phase|Unable to contact Participant|1|||
162192986|NCT02165202|585758510|FG000|Oral Phase|Clinical reasons|1|||
162192987|NCT02165202|585758511|FG001|Oral Phase|Clinical reasons|0|||
162192988|NCT02165202|585758510|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
162192989|NCT02165202|585758511|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
162192990|NCT02165202|585758510|FG000|Oral Phase|CMC advised termination|1|||
162192991|NCT02165202|585758511|FG001|Oral Phase|CMC advised termination|0|||
162192992|NCT02165202|585758510|FG000|Oral Phase|Relocated, no follow-up planned|1|||
162192993|NCT02165202|585758511|FG001|Oral Phase|Relocated, no follow-up planned|0|||
162192994|NCT02165202|585758510|FG000|Oral Phase|Abnormal EKG|0|||
162192995|NCT02165202|585758511|FG001|Oral Phase|Abnormal EKG|1|||
162192996|NCT02165202|585758510|FG000|Injection Phase|Abnormal Lab Value|5|||
162192997|NCT02165202|585758511|FG001|Injection Phase|Abnormal Lab Value|1|||
162192998|NCT02165202|585758510|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
162192999|NCT02165202|585758511|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
162193000|NCT02165202|585758510|FG000|Injection Phase|Unable to attend within Visit Window|1|||
162193001|NCT02165202|585758511|FG001|Injection Phase|Unable to attend within Visit Window|0|||
162193002|NCT02165202|585758510|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
162193003|NCT02165202|585758511|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
162193004|NCT02165202|585758510|FG000|Injection Phase|End of Study|2|||
162193005|NCT02165202|585758511|FG001|Injection Phase|End of Study|1|||
162193006|NCT02165202|585758510|FG000|Injection Phase|Study Product related Toxicity|1|||
162193007|NCT02165202|585758511|FG001|Injection Phase|Study Product related Toxicity|0|||
162193008|NCT02165202|585758510|FG000|Injection Phase|No longer interested|0|||
162193009|NCT02165202|585758511|FG001|Injection Phase|No longer interested|1|||
162193010|NCT02165202|585758510|FG000|Injection Phase|Participant unwilling to comply|1|||
162193011|NCT02165202|585758511|FG001|Injection Phase|Participant unwilling to comply|0|||
162193012|NCT04328467|585758521|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
162193013|NCT04328467|585758522|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
162193014|NCT04328467|585758523|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
162193015|NCT00990184|585758524|FG000|Overall Study|Physician Decision|1|||
162193016|NCT01975701|585758525|FG000|Overall Study|Lost to Follow-up|1|||
162193017|NCT01975701|585758525|FG000|Overall Study|Death|23|||
162193018|NCT01975701|585758525|FG000|Overall Study|Physician Decision|1|||
162193019|NCT00813709|585758526|FG000|Double Blind Period|Adverse Event|4|||
162193020|NCT00813709|585758527|FG001|Double Blind Period|Adverse Event|1|||
162193021|NCT00813709|585758528|FG002|Double Blind Period|Adverse Event|4|||
162193022|NCT00813709|585758529|FG003|Double Blind Period|Adverse Event|0|||
162193023|NCT00813709|585758530|FG004|Double Blind Period|Adverse Event|0|||
162193024|NCT00813709|585758531|FG005|Double Blind Period|Adverse Event|0|||
162193025|NCT00813709|585758526|FG000|Double Blind Period|Lost to Follow-up|3|||
162193026|NCT00813709|585758527|FG001|Double Blind Period|Lost to Follow-up|2|||
162193027|NCT00813709|585758528|FG002|Double Blind Period|Lost to Follow-up|2|||
162193028|NCT00813709|585758529|FG003|Double Blind Period|Lost to Follow-up|0|||
162193029|NCT00813709|585758530|FG004|Double Blind Period|Lost to Follow-up|0|||
162193030|NCT00813709|585758531|FG005|Double Blind Period|Lost to Follow-up|0|||
162193031|NCT00813709|585758526|FG000|Double Blind Period|Switched to open label phase|9|||
162193032|NCT00813709|585758527|FG001|Double Blind Period|Switched to open label phase|26|||
162193033|NCT00813709|585758528|FG002|Double Blind Period|Switched to open label phase|18|||
162193034|NCT00813709|585758529|FG003|Double Blind Period|Switched to open label phase|0|||
162193035|NCT00813709|585758530|FG004|Double Blind Period|Switched to open label phase|0|||
162193036|NCT00813709|585758531|FG005|Double Blind Period|Switched to open label phase|0|||
162193037|NCT00813709|585758526|FG000|Double Blind Period|Randomized but not treated|1|||
162193038|NCT00813709|585758527|FG001|Double Blind Period|Randomized but not treated|3|||
161673976|NCT00108069|583859944|FG000|Overall Study|Progessive disease|27|||
161673977|NCT00108069|583859945|FG001|Overall Study|Progessive disease|11|||
161673978|NCT04029116|583859946|FG000|Overall Study|Adverse Event|0|||
161673979|NCT04029116|583859947|FG001|Overall Study|Adverse Event|2|||
161673980|NCT04029116|583859946|FG000|Overall Study|Lost to Follow-up|3|||
162193039|NCT00813709|585758528|FG002|Double Blind Period|Randomized but not treated|1|||
162193040|NCT00813709|585758529|FG003|Double Blind Period|Randomized but not treated|0|||
162193041|NCT00813709|585758530|FG004|Double Blind Period|Randomized but not treated|0|||
162193042|NCT00813709|585758531|FG005|Double Blind Period|Randomized but not treated|0|||
162193043|NCT00813709|585758526|FG000|Double Blind Period|Other|14|||
162193044|NCT00813709|585758527|FG001|Double Blind Period|Other|9|||
161673981|NCT04029116|583859947|FG001|Overall Study|Lost to Follow-up|5|||
161673982|NCT04029116|583859946|FG000|Overall Study|Physician Decision|2|||
161673983|NCT04029116|583859947|FG001|Overall Study|Physician Decision|0|||
161673984|NCT04029116|583859946|FG000|Overall Study|Pregnancy|1|||
162193045|NCT00813709|585758528|FG002|Double Blind Period|Other|6|||
162193046|NCT00813709|585758529|FG003|Double Blind Period|Other|0|||
162193047|NCT00813709|585758530|FG004|Double Blind Period|Other|0|||
162193048|NCT00813709|585758531|FG005|Double Blind Period|Other|0|||
162193049|NCT00813709|585758526|FG000|Open Label Period|Adverse Event|0|||
162193050|NCT00813709|585758527|FG001|Open Label Period|Adverse Event|0|||
162193051|NCT00813709|585758528|FG002|Open Label Period|Adverse Event|0|||
162193052|NCT00813709|585758529|FG003|Open Label Period|Adverse Event|5|||
162193053|NCT00813709|585758530|FG004|Open Label Period|Adverse Event|4|||
162193054|NCT00813709|585758531|FG005|Open Label Period|Adverse Event|3|||
162193055|NCT00813709|585758526|FG000|Open Label Period|Lack of Efficacy|0|||
162193056|NCT00813709|585758527|FG001|Open Label Period|Lack of Efficacy|0|||
162193057|NCT00813709|585758528|FG002|Open Label Period|Lack of Efficacy|0|||
162193058|NCT00813709|585758529|FG003|Open Label Period|Lack of Efficacy|3|||
162193059|NCT00813709|585758530|FG004|Open Label Period|Lack of Efficacy|1|||
162193060|NCT00813709|585758531|FG005|Open Label Period|Lack of Efficacy|1|||
162193061|NCT00813709|585758526|FG000|Open Label Period|Randomized but not treated|0|||
162193062|NCT00813709|585758527|FG001|Open Label Period|Randomized but not treated|0|||
162193063|NCT00813709|585758528|FG002|Open Label Period|Randomized but not treated|0|||
162193064|NCT00813709|585758529|FG003|Open Label Period|Randomized but not treated|1|||
162193065|NCT00813709|585758530|FG004|Open Label Period|Randomized but not treated|0|||
162193066|NCT00813709|585758531|FG005|Open Label Period|Randomized but not treated|1|||
162193067|NCT00813709|585758526|FG000|Open Label Period|Other|0|||
162193068|NCT00813709|585758527|FG001|Open Label Period|Other|0|||
162193069|NCT00813709|585758528|FG002|Open Label Period|Other|0|||
162193070|NCT00813709|585758529|FG003|Open Label Period|Other|11|||
162193071|NCT00813709|585758530|FG004|Open Label Period|Other|5|||
162193072|NCT00813709|585758531|FG005|Open Label Period|Other|6|||
162193073|NCT00759681|585758532|FG000|Overall Study|Death|2|||
162193074|NCT00759681|585758533|FG001|Overall Study|Death|5|||
162193075|NCT00759681|585758532|FG000|Overall Study|Lost to Follow-up|8|||
162193076|NCT00759681|585758533|FG001|Overall Study|Lost to Follow-up|5|||
162193077|NCT01012999|585758534|FG000|Overall Study|Protocol Violation|1|||
162193078|NCT02410278|585758535|FG000|Run-in Period|Adverse Event|5|||
162193079|NCT02410278|585758536|FG001|Run-in Period|Adverse Event|0|||
162193080|NCT02410278|585758537|FG002|Run-in Period|Adverse Event|0|||
162193081|NCT02410278|585758535|FG000|Run-in Period|GSRS Threshold Not Met|30|||
162193082|NCT02410278|585758536|FG001|Run-in Period|GSRS Threshold Not Met|0|||
162193083|NCT02410278|585758537|FG002|Run-in Period|GSRS Threshold Not Met|0|||
162193084|NCT02410278|585758535|FG000|Run-in Period|Lost to Follow-up|1|||
162193085|NCT02410278|585758536|FG001|Run-in Period|Lost to Follow-up|0|||
162193086|NCT02410278|585758537|FG002|Run-in Period|Lost to Follow-up|0|||
162193087|NCT02410278|585758535|FG000|Run-in Period|Withdrawal by Subject|1|||
162193088|NCT02410278|585758536|FG001|Run-in Period|Withdrawal by Subject|0|||
162193089|NCT02410278|585758537|FG002|Run-in Period|Withdrawal by Subject|0|||
162193090|NCT02410278|585758535|FG000|Run-in Period|Pregnancy|1|||
162193091|NCT02410278|585758536|FG001|Run-in Period|Pregnancy|0|||
162193092|NCT02410278|585758537|FG002|Run-in Period|Pregnancy|0|||
162193093|NCT02410278|585758535|FG000|Study Treatment Period|Adverse Event|0|||
162193094|NCT02410278|585758536|FG001|Study Treatment Period|Adverse Event|6|||
162193095|NCT02410278|585758537|FG002|Study Treatment Period|Adverse Event|3|||
162193096|NCT02410278|585758535|FG000|Study Treatment Period|Physician Decision|0|||
162193097|NCT02410278|585758536|FG001|Study Treatment Period|Physician Decision|0|||
162193098|NCT02410278|585758537|FG002|Study Treatment Period|Physician Decision|1|||
162193099|NCT02410278|585758535|FG000|Study Treatment Period|Withdrawal by Subject|0|||
162193100|NCT02410278|585758536|FG001|Study Treatment Period|Withdrawal by Subject|1|||
162193101|NCT02410278|585758537|FG002|Study Treatment Period|Withdrawal by Subject|0|||
162193102|NCT02410278|585758535|FG000|Study Treatment Period|Other|0|||
162193103|NCT02410278|585758536|FG001|Study Treatment Period|Other|3|||
162193104|NCT02410278|585758537|FG002|Study Treatment Period|Other|0|||
161673985|NCT04029116|583859947|FG001|Overall Study|Pregnancy|2|||
161673986|NCT04029116|583859946|FG000|Overall Study|Withdrawal by Subject|4|||
161673987|NCT04029116|583859947|FG001|Overall Study|Withdrawal by Subject|6|||
162193105|NCT02410278|585758535|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
162193106|NCT02410278|585758536|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
162193107|NCT02410278|585758537|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
162193108|NCT02584257|585758538|FG000|Period 1|Withdrawal by Subject|0|||
162193109|NCT02584257|585758539|FG001|Period 1|Withdrawal by Subject|0|||
162193110|NCT02584257|585758540|FG002|Period 1|Withdrawal by Subject|0|||
162193111|NCT02584257|585758541|FG003|Period 1|Withdrawal by Subject|0|||
162193112|NCT02584257|585758542|FG004|Period 1|Withdrawal by Subject|0|||
162193113|NCT02584257|585758543|FG005|Period 1|Withdrawal by Subject|0|||
162193114|NCT02584257|585758544|FG006|Period 1|Withdrawal by Subject|1|||
162193115|NCT02584257|585758545|FG007|Period 1|Withdrawal by Subject|0|||
162193116|NCT02584257|585758546|FG008|Period 1|Withdrawal by Subject|0|||
162193117|NCT02584257|585758538|FG000|Period 2|Physician Decision|1|||
162193118|NCT02584257|585758539|FG001|Period 2|Physician Decision|0|||
162193119|NCT02584257|585758540|FG002|Period 2|Physician Decision|0|||
162193120|NCT02584257|585758541|FG003|Period 2|Physician Decision|0|||
162193121|NCT02584257|585758542|FG004|Period 2|Physician Decision|0|||
162193122|NCT02584257|585758543|FG005|Period 2|Physician Decision|0|||
162193123|NCT02584257|585758544|FG006|Period 2|Physician Decision|0|||
162193124|NCT02584257|585758545|FG007|Period 2|Physician Decision|0|||
162193125|NCT02584257|585758546|FG008|Period 2|Physician Decision|0|||
162193126|NCT02584257|585758538|FG000|Period 2|Adverse Event|0|||
161673988|NCT04029116|583859946|FG000|Overall Study|Other|2|||
161673989|NCT04029116|583859947|FG001|Overall Study|Other|1|||
161673990|NCT02469896|583859948|FG000|Overall Study|Withdrawal by Subject|2|||
162193127|NCT02584257|585758539|FG001|Period 2|Adverse Event|1|||
162193128|NCT02584257|585758540|FG002|Period 2|Adverse Event|0|||
162193129|NCT02584257|585758541|FG003|Period 2|Adverse Event|0|||
162193130|NCT02584257|585758542|FG004|Period 2|Adverse Event|0|||
162193131|NCT02584257|585758543|FG005|Period 2|Adverse Event|0|||
162193132|NCT02584257|585758544|FG006|Period 2|Adverse Event|0|||
162193133|NCT02584257|585758545|FG007|Period 2|Adverse Event|0|||
162193134|NCT02584257|585758546|FG008|Period 2|Adverse Event|0|||
162193135|NCT01670877|585758547|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
162193136|NCT01670877|585758548|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
162193137|NCT01670877|585758549|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
162193138|NCT01670877|585758550|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
162193139|NCT01670877|585758551|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
162193140|NCT01670877|585758552|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
162193141|NCT01670877|585758547|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
162193142|NCT01670877|585758548|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
162193143|NCT01670877|585758549|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
162193144|NCT01670877|585758550|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
162193145|NCT01670877|585758551|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
162193146|NCT01670877|585758552|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
162193147|NCT01670877|585758547|FG000|Part I and Part 2|Grade 2 vomiting|0|||
162193148|NCT01670877|585758548|FG001|Part I and Part 2|Grade 2 vomiting|0|||
162193149|NCT01670877|585758549|FG002|Part I and Part 2|Grade 2 vomiting|0|||
162193150|NCT01670877|585758550|FG003|Part I and Part 2|Grade 2 vomiting|1|||
162193151|NCT01670877|585758551|FG004|Part I and Part 2|Grade 2 vomiting|0|||
162193152|NCT01670877|585758552|FG005|Part I and Part 2|Grade 2 vomiting|0|||
162193153|NCT01670877|585758547|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
162193154|NCT01670877|585758548|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
162193155|NCT01670877|585758549|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
162193156|NCT01670877|585758550|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
162193157|NCT01670877|585758551|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
162193158|NCT01670877|585758552|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
162193159|NCT01670877|585758547|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
162193160|NCT01670877|585758548|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
162193161|NCT01670877|585758549|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
162193162|NCT01670877|585758550|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
162193163|NCT01670877|585758551|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
162193164|NCT01670877|585758552|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
162193165|NCT02309892|585758553|FG000|Overall Study|Physician Decision|1|||
162193166|NCT02309892|585758554|FG001|Overall Study|Physician Decision|0|||
162193167|NCT02309892|585758555|FG002|Overall Study|Physician Decision|0|||
162193168|NCT02309892|585758556|FG003|Overall Study|Physician Decision|0|||
162193169|NCT02309892|585758557|FG004|Overall Study|Physician Decision|0|||
161673991|NCT02469896|583859949|FG001|Overall Study|Withdrawal by Subject|0|||
161673992|NCT02510560|583859950|FG000|Overall Study|Discontinued from Treatment|27|||
162193170|NCT02309892|585758558|FG005|Overall Study|Physician Decision|0|||
162193171|NCT02309892|585758559|FG006|Overall Study|Physician Decision|0|||
162193172|NCT02309892|585758553|FG000|Overall Study|Adverse Event|1|||
162193173|NCT02309892|585758554|FG001|Overall Study|Adverse Event|0|||
162193174|NCT02309892|585758555|FG002|Overall Study|Adverse Event|1|||
162193175|NCT02309892|585758556|FG003|Overall Study|Adverse Event|0|||
162193176|NCT02309892|585758557|FG004|Overall Study|Adverse Event|0|||
162193177|NCT02309892|585758558|FG005|Overall Study|Adverse Event|0|||
162193178|NCT02309892|585758559|FG006|Overall Study|Adverse Event|0|||
162193179|NCT02309892|585758553|FG000|Overall Study|Progressive Disease|0|||
162193180|NCT02309892|585758554|FG001|Overall Study|Progressive Disease|1|||
162193181|NCT02309892|585758555|FG002|Overall Study|Progressive Disease|0|||
162193182|NCT02309892|585758556|FG003|Overall Study|Progressive Disease|0|||
162193183|NCT02309892|585758557|FG004|Overall Study|Progressive Disease|1|||
162193184|NCT02309892|585758558|FG005|Overall Study|Progressive Disease|0|||
162193185|NCT02309892|585758559|FG006|Overall Study|Progressive Disease|0|||
162193186|NCT02309892|585758553|FG000|Overall Study|Death|0|||
162193187|NCT02309892|585758554|FG001|Overall Study|Death|0|||
161673993|NCT02510560|583859951|FG001|Overall Study|Discontinued from Treatment|18|||
161673994|NCT02510560|583859952|FG002|Overall Study|Discontinued from Treatment|19|||
161673995|NCT02510560|583859950|FG000|Overall Study|Other|4|||
162193188|NCT02309892|585758555|FG002|Overall Study|Death|0|||
162193189|NCT02309892|585758556|FG003|Overall Study|Death|0|||
162193190|NCT02309892|585758557|FG004|Overall Study|Death|0|||
162193191|NCT02309892|585758558|FG005|Overall Study|Death|1|||
162193192|NCT02309892|585758559|FG006|Overall Study|Death|0|||
162193193|NCT05376397|585758562|FG000|Overall Study|Lost to Follow-up|1|||
162193194|NCT02721147|585758563|FG000|Overall Study|Lost to Follow-up|2|||
162193195|NCT02721147|585758564|FG001|Overall Study|Lost to Follow-up|0|||
162193196|NCT02721147|585758565|FG002|Overall Study|Lost to Follow-up|0|||
162193197|NCT01722097|585758566|FG000|Overall Study|Patient sheets not returned|6|||
162193198|NCT01722097|585758567|FG001|Overall Study|Patient sheets not returned|5|||
162193199|NCT01535261|585758571|FG000|Overall Study|Physician Decision|8|||
162193200|NCT01535261|585758571|FG000|Overall Study|Protocol Violation|3|||
162193201|NCT01535261|585758571|FG000|Overall Study|Death|5|||
162193202|NCT01535261|585758571|FG000|Overall Study|Lost to Follow-up|8|||
162193203|NCT01535261|585758571|FG000|Overall Study|Withdrawal by Subject|14|||
162193204|NCT01535261|585758571|FG000|Overall Study|Adverse Event|12|||
162193205|NCT01137682|585758574|FG000|Overall Study|Adverse Event-CORE|2|||
162193206|NCT01137682|585758575|FG001|Overall Study|Adverse Event-CORE|4|||
162193207|NCT01137682|585758576|FG002|Overall Study|Adverse Event-CORE|0|||
162193208|NCT01137682|585758574|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
162193209|NCT01137682|585758575|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
162193210|NCT01137682|585758576|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
162193211|NCT01137682|585758574|FG000|Overall Study|Administrative problems-CORE|2|||
162193212|NCT01137682|585758575|FG001|Overall Study|Administrative problems-CORE|1|||
162193213|NCT01137682|585758576|FG002|Overall Study|Administrative problems-CORE|0|||
162193214|NCT01137682|585758574|FG000|Overall Study|Protocol Violation-CORE|0|||
162193215|NCT01137682|585758575|FG001|Overall Study|Protocol Violation-CORE|1|||
162193216|NCT01137682|585758576|FG002|Overall Study|Protocol Violation-CORE|1|||
162193217|NCT01137682|585758574|FG000|Overall Study|Adverse Event-Extension|4|||
162193218|NCT01137682|585758575|FG001|Overall Study|Adverse Event-Extension|8|||
162193219|NCT01137682|585758576|FG002|Overall Study|Adverse Event-Extension|7|||
162193220|NCT01137682|585758574|FG000|Overall Study|Lack of Efficacy-Extension|15|||
162193221|NCT01137682|585758575|FG001|Overall Study|Lack of Efficacy-Extension|9|||
162193222|NCT01137682|585758576|FG002|Overall Study|Lack of Efficacy-Extension|13|||
162193223|NCT01137682|585758574|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
162193224|NCT01137682|585758575|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
162193225|NCT01137682|585758576|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
162193226|NCT01137682|585758574|FG000|Overall Study|Lost to Follow Up-Extension|0|||
162193227|NCT01137682|585758575|FG001|Overall Study|Lost to Follow Up-Extension|1|||
162193228|NCT01137682|585758576|FG002|Overall Study|Lost to Follow Up-Extension|0|||
162193229|NCT01137682|585758574|FG000|Overall Study|Administrative problems-Extension|0|||
162193230|NCT01137682|585758575|FG001|Overall Study|Administrative problems-Extension|2|||
162193231|NCT01137682|585758576|FG002|Overall Study|Administrative problems-Extension|0|||
162193232|NCT01137682|585758574|FG000|Overall Study|Death-Extension|2|||
162193233|NCT01137682|585758575|FG001|Overall Study|Death-Extension|0|||
162193234|NCT01137682|585758576|FG002|Overall Study|Death-Extension|0|||
162193235|NCT01137682|585758574|FG000|Overall Study|Protocol Violation-Extension|2|||
162193236|NCT01137682|585758575|FG001|Overall Study|Protocol Violation-Extension|1|||
162193237|NCT01137682|585758576|FG002|Overall Study|Protocol Violation-Extension|0|||
162193238|NCT01137682|585758574|FG000|Overall Study|Did not enter extension|2|||
162193239|NCT01137682|585758575|FG001|Overall Study|Did not enter extension|3|||
162193240|NCT01137682|585758576|FG002|Overall Study|Did not enter extension|2|||
162193241|NCT01137682|585758574|FG000|Overall Study|Did not receive treatment in extension|0|||
162193242|NCT01137682|585758575|FG001|Overall Study|Did not receive treatment in extension|0|||
162193243|NCT01137682|585758576|FG002|Overall Study|Did not receive treatment in extension|1|||
162193244|NCT02009332|585758577|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
162193245|NCT02009332|585758578|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
162193246|NCT02009332|585758579|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
162193247|NCT02009332|585758580|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
162193248|NCT02009332|585758581|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
162193249|NCT02009332|585758582|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
162193250|NCT02009332|585758577|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
162193251|NCT02009332|585758578|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
162193252|NCT02009332|585758579|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
162193253|NCT02009332|585758580|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
162193254|NCT02009332|585758581|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
162193255|NCT02009332|585758582|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
162193256|NCT02009332|585758577|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
162193257|NCT02009332|585758578|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
162193258|NCT02009332|585758579|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
162193259|NCT02009332|585758580|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
162193260|NCT02009332|585758581|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
162193261|NCT02009332|585758582|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
161673996|NCT02510560|583859951|FG001|Overall Study|Other|4|||
161673997|NCT02510560|583859952|FG002|Overall Study|Other|3|||
162193262|NCT01912599|585758584|FG000|Overall Study|Withdrawal by Subject|0|||
162193263|NCT01912599|585758585|FG001|Overall Study|Withdrawal by Subject|1|||
162193264|NCT01757288|585758586|FG000|Overall Study|Consent withdrawal|0|||
162193265|NCT01757288|585758587|FG001|Overall Study|Consent withdrawal|4|||
162193266|NCT01757288|585758588|FG002|Overall Study|Consent withdrawal|4|||
162193267|NCT01757288|585758586|FG000|Overall Study|Patient off study, IRB hold.|0|||
162193268|NCT01757288|585758587|FG001|Overall Study|Patient off study, IRB hold.|0|||
162193269|NCT01757288|585758588|FG002|Overall Study|Patient off study, IRB hold.|1|||
162193270|NCT01757288|585758586|FG000|Overall Study|Patient death prior to starting treatment|0|||
162193271|NCT01757288|585758587|FG001|Overall Study|Patient death prior to starting treatment|0|||
162193272|NCT01757288|585758588|FG002|Overall Study|Patient death prior to starting treatment|1|||
162193273|NCT01757288|585758586|FG000|Overall Study|Wrong medication administered|0|||
162193274|NCT01757288|585758587|FG001|Overall Study|Wrong medication administered|1|||
162193275|NCT01757288|585758588|FG002|Overall Study|Wrong medication administered|0|||
162193276|NCT01757288|585758586|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
162193277|NCT01757288|585758587|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
162193278|NCT01757288|585758588|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
162193279|NCT01757288|585758586|FG000|Overall Study|Not meeting protocol constraints|0|||
162193280|NCT01757288|585758587|FG001|Overall Study|Not meeting protocol constraints|1|||
162193281|NCT01757288|585758588|FG002|Overall Study|Not meeting protocol constraints|1|||
162193282|NCT01757288|585758586|FG000|Overall Study|Multiple missed appointments|0|||
162193283|NCT01757288|585758587|FG001|Overall Study|Multiple missed appointments|1|||
162193284|NCT01757288|585758588|FG002|Overall Study|Multiple missed appointments|0|||
162193285|NCT01757288|585758586|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
162193286|NCT01757288|585758587|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
162193287|NCT01757288|585758588|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
162193288|NCT01757288|585758586|FG000|Overall Study|>2 weeks treatment break|0|||
162193289|NCT01757288|585758587|FG001|Overall Study|>2 weeks treatment break|0|||
162193290|NCT01757288|585758588|FG002|Overall Study|>2 weeks treatment break|1|||
162193291|NCT02825550|585758590|FG000|Overall Study|Physician Decision|1|||
162193292|NCT03386344|585758591|FG000|Overall Study|Adverse Event|6|||
162193293|NCT03386344|585758592|FG001|Overall Study|Adverse Event|3|||
162193294|NCT03386344|585758593|FG002|Overall Study|Adverse Event|1|||
162193295|NCT03386344|585758591|FG000|Overall Study|Poor Compliance to Protocol|0|||
162193296|NCT03386344|585758592|FG001|Overall Study|Poor Compliance to Protocol|1|||
162193297|NCT03386344|585758593|FG002|Overall Study|Poor Compliance to Protocol|0|||
162193298|NCT03386344|585758591|FG000|Overall Study|Study Terminated by Sponsor|101|||
162193299|NCT03386344|585758592|FG001|Overall Study|Study Terminated by Sponsor|102|||
162193300|NCT03386344|585758593|FG002|Overall Study|Study Terminated by Sponsor|106|||
162193301|NCT03386344|585758591|FG000|Overall Study|Lost to Follow-up|3|||
162193302|NCT03386344|585758592|FG001|Overall Study|Lost to Follow-up|2|||
162193303|NCT03386344|585758593|FG002|Overall Study|Lost to Follow-up|1|||
162193304|NCT03386344|585758591|FG000|Overall Study|At the Participant's own Request|7|||
162193305|NCT03386344|585758592|FG001|Overall Study|At the Participant's own Request|7|||
162193306|NCT03386344|585758593|FG002|Overall Study|At the Participant's own Request|8|||
162193307|NCT03386344|585758591|FG000|Overall Study|Reason not Specified|0|||
162193308|NCT03386344|585758592|FG001|Overall Study|Reason not Specified|1|||
162193309|NCT03386344|585758593|FG002|Overall Study|Reason not Specified|0|||
162193310|NCT01077284|585758594|FG000|Overall Study|Adverse Event|2|||
162193311|NCT01077284|585758595|FG001|Overall Study|Adverse Event|0|||
162193312|NCT01077284|585758596|FG002|Overall Study|Adverse Event|1|||
162193313|NCT01077284|585758594|FG000|Overall Study|Lost to Follow-up|1|||
162193314|NCT01077284|585758595|FG001|Overall Study|Lost to Follow-up|2|||
162193315|NCT01077284|585758596|FG002|Overall Study|Lost to Follow-up|0|||
162193316|NCT01077284|585758594|FG000|Overall Study|Withdrawal by Subject|2|||
162193317|NCT01077284|585758595|FG001|Overall Study|Withdrawal by Subject|3|||
162193318|NCT01077284|585758596|FG002|Overall Study|Withdrawal by Subject|1|||
162193319|NCT01077284|585758594|FG000|Overall Study|Other|0|||
162193320|NCT01077284|585758595|FG001|Overall Study|Other|0|||
162193321|NCT01077284|585758596|FG002|Overall Study|Other|1|||
162193322|NCT01280721|585758600|FG000|Overall Study|Adverse Event|4|||
162193323|NCT01280721|585758600|FG000|Overall Study|Physician Decision|3|||
162193324|NCT01280721|585758600|FG000|Overall Study|Withdrawal by Subject|6|||
162193325|NCT01280721|585758600|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
162193326|NCT01280721|585758600|FG000|Overall Study|No tolerability for the lowest dose|2|||
162193327|NCT01180400|585758601|FG000|Overall Study|Withdrawal by Subject|5|||
162193328|NCT01180400|585758602|FG001|Overall Study|Withdrawal by Subject|6|||
162193329|NCT01180400|585758601|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161673998|NCT02401412|583859953|FG000|Overall Study|Lost to Follow-up|1|||
162193330|NCT01180400|585758602|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
162193331|NCT01180400|585758601|FG000|Overall Study|Adverse Event|12|||
162193332|NCT01180400|585758602|FG001|Overall Study|Adverse Event|10|||
161673999|NCT02401412|583859954|FG001|Overall Study|Lost to Follow-up|0|||
162193333|NCT01180400|585758601|FG000|Overall Study|Severe non-compliance to protocol|1|||
162193334|NCT01180400|585758602|FG001|Overall Study|Severe non-compliance to protocol|2|||
162193335|NCT01180400|585758601|FG000|Overall Study|Condition under investigation worsened|2|||
162193336|NCT01180400|585758602|FG001|Overall Study|Condition under investigation worsened|1|||
162193337|NCT01180400|585758601|FG000|Overall Study|Lack of Efficacy|2|||
162193338|NCT01180400|585758602|FG001|Overall Study|Lack of Efficacy|0|||
162193339|NCT01180400|585758601|FG000|Overall Study|Study-specific withdrawal criteria|1|||
162193340|NCT01180400|585758602|FG001|Overall Study|Study-specific withdrawal criteria|2|||
162193341|NCT01180400|585758601|FG000|Overall Study|Lost to Follow-up|2|||
162193342|NCT01180400|585758602|FG001|Overall Study|Lost to Follow-up|3|||
162193343|NCT01180400|585758601|FG000|Overall Study|Other|0|||
162193344|NCT01180400|585758602|FG001|Overall Study|Other|1|||
162193345|NCT00042939|585758604|FG000|Overall Study|Adverse Event|6|||
162193346|NCT00042939|585758605|FG001|Overall Study|Adverse Event|7|||
162193347|NCT00042939|585758604|FG000|Overall Study|Death|3|||
162193348|NCT00042939|585758605|FG001|Overall Study|Death|2|||
162193349|NCT00042939|585758604|FG000|Overall Study|Withdrawal by Subject|3|||
162193350|NCT00042939|585758605|FG001|Overall Study|Withdrawal by Subject|4|||
162193351|NCT00042939|585758604|FG000|Overall Study|Other disease|1|||
162193352|NCT00042939|585758605|FG001|Overall Study|Other disease|0|||
162193353|NCT00042939|585758604|FG000|Overall Study|Ineligible|2|||
162193354|NCT00042939|585758605|FG001|Overall Study|Ineligible|2|||
162193355|NCT00042939|585758604|FG000|Overall Study|Deterioration of health|3|||
162193356|NCT00042939|585758605|FG001|Overall Study|Deterioration of health|4|||
162193357|NCT00042939|585758604|FG000|Overall Study|QOL diminished|1|||
162193358|NCT00042939|585758605|FG001|Overall Study|QOL diminished|0|||
162193359|NCT00042939|585758604|FG000|Overall Study|Rising ca 19-9|1|||
162193360|NCT00042939|585758605|FG001|Overall Study|Rising ca 19-9|0|||
162193361|NCT00042939|585758604|FG000|Overall Study|Patient non-compliance|1|||
162193362|NCT00042939|585758605|FG001|Overall Study|Patient non-compliance|0|||
162193363|NCT00042939|585758604|FG000|Overall Study|Still on treatment|1|||
162193364|NCT00042939|585758605|FG001|Overall Study|Still on treatment|0|||
162193365|NCT00042939|585758604|FG000|Overall Study|Treatment break > 4 weeks|0|||
162193366|NCT00042939|585758605|FG001|Overall Study|Treatment break > 4 weeks|1|||
162193367|NCT00042939|585758604|FG000|Overall Study|Did not start treatment|2|||
162193368|NCT00042939|585758605|FG001|Overall Study|Did not start treatment|1|||
162193369|NCT00795639|585758606|FG000|Overall Study|Death|1|||
162193370|NCT00795639|585758607|FG001|Overall Study|Death|6|||
162193371|NCT00795639|585758606|FG000|Overall Study|Withdrawal by Subject|1|||
162193372|NCT00795639|585758607|FG001|Overall Study|Withdrawal by Subject|3|||
162193373|NCT00795639|585758606|FG000|Overall Study|Pregnancy|1|||
162193374|NCT00795639|585758607|FG001|Overall Study|Pregnancy|0|||
162193375|NCT00795639|585758606|FG000|Overall Study|Adverse Event|5|||
162193376|NCT00795639|585758607|FG001|Overall Study|Adverse Event|2|||
162193377|NCT00795639|585758606|FG000|Overall Study|Other|0|||
162193378|NCT00795639|585758607|FG001|Overall Study|Other|2|||
162193379|NCT00795639|585758606|FG000|Overall Study|Terminated by sponsor|13|||
162193380|NCT00795639|585758607|FG001|Overall Study|Terminated by sponsor|12|||
162193381|NCT00795639|585758606|FG000|Overall Study|Randomized and not treated|0|||
162193382|NCT00795639|585758607|FG001|Overall Study|Randomized and not treated|1|||
162193383|NCT03349476|585758608|FG000|Overall Study|Physician Decision|3|||
162193384|NCT04626128|585758609|FG000|Overall Study|Withdrawal by Subject|0|||
162193385|NCT04626128|585758610|FG001|Overall Study|Withdrawal by Subject|1|||
162193386|NCT04626128|585758611|FG002|Overall Study|Withdrawal by Subject|0|||
162193387|NCT04626128|585758612|FG003|Overall Study|Withdrawal by Subject|0|||
162193388|NCT03449979|585758615|FG000|Overall Study|Technical difficulty|0|||
162193389|NCT03449979|585758616|FG001|Overall Study|Technical difficulty|0|||
162193390|NCT03449979|585758617|FG002|Overall Study|Technical difficulty|0|||
162193391|NCT03449979|585758618|FG003|Overall Study|Technical difficulty|1|||
162193392|NCT01762345|585758619|FG000|Overall Study|Adverse Event|5|||
161820002|NCT02761915|584381217|FG004|Overall Study|Disease Progression|2|||
162193393|NCT01762345|585758619|FG000|Overall Study|Protocol Violation|2|||
162193394|NCT02379078|585758620|FG000|Overall Study|Lost to Follow-up|33|||
162193395|NCT02379078|585758621|FG001|Overall Study|Lost to Follow-up|30|||
162193396|NCT02379078|585758620|FG000|Overall Study|Withdrawal by Subject|6|||
161820003|NCT02761915|584381218|FG005|Overall Study|Disease Progression|2|||
162193397|NCT02379078|585758621|FG001|Overall Study|Withdrawal by Subject|5|||
162193398|NCT03481725|585758622|FG000|Overall Study|Withdrawal by Subject|1|||
162193399|NCT03481725|585758623|FG001|Overall Study|Withdrawal by Subject|0|||
162193400|NCT03444155|585758626|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
161674000|NCT02401412|583859953|FG000|Overall Study|Discontinued Intervention|15|||
162193401|NCT03444155|585758627|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
162193402|NCT02877680|585758628|FG000|Overall Study|Lost to Follow-up|1|||
162193403|NCT02877680|585758629|FG001|Overall Study|Lost to Follow-up|1|||
162193404|NCT01133678|585758630|FG000|Overall Study|Death|1|||
162193405|NCT01133678|585758631|FG001|Overall Study|Death|1|||
162193406|NCT01864200|585758638|FG000|Overall Study|Lost to Follow-up|1|||
162193407|NCT01864200|585758639|FG001|Overall Study|Lost to Follow-up|3|||
162193408|NCT01864200|585758638|FG000|Overall Study|Protocol Violation|1|||
162193409|NCT01864200|585758639|FG001|Overall Study|Protocol Violation|0|||
162193410|NCT01419184|585758646|FG000|Overall Study|Site data not available|3|||
162193411|NCT01419184|585758647|FG001|Overall Study|Site data not available|2|||
162193412|NCT01419184|585758646|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
162193413|NCT01419184|585758647|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
162193414|NCT01419184|585758646|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
162193415|NCT01419184|585758647|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
162193416|NCT01419184|585758646|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
162193417|NCT01419184|585758647|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
162193418|NCT01419184|585758646|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
162193419|NCT01419184|585758647|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
162193420|NCT01419184|585758646|FG000|Overall Study|Participant randomized, not treated|1|||
162193421|NCT01419184|585758647|FG001|Overall Study|Participant randomized, not treated|0|||
162193422|NCT02514824|585758648|FG000|Overall Study|Withdrawal by Subject|1|||
162193423|NCT02514824|585758649|FG001|Overall Study|Withdrawal by Subject|0|||
162193424|NCT02514824|585758650|FG002|Overall Study|Withdrawal by Subject|0|||
162193425|NCT02514824|585758651|FG003|Overall Study|Withdrawal by Subject|0|||
162193426|NCT02514824|585758648|FG000|Overall Study|Dose-Limiting Toxicity|0|||
162193427|NCT02514824|585758649|FG001|Overall Study|Dose-Limiting Toxicity|1|||
162193428|NCT02514824|585758650|FG002|Overall Study|Dose-Limiting Toxicity|0|||
162193429|NCT02514824|585758651|FG003|Overall Study|Dose-Limiting Toxicity|0|||
162193430|NCT02170207|585758654|FG000|Overall Study|Case report forms unavailable|5|||
162193431|NCT00657709|585758655|FG000|Overall Study|AE or Death|7|||
162193432|NCT00657709|585758656|FG001|Overall Study|AE or Death|7|||
162193433|NCT00657709|585758657|FG002|Overall Study|AE or Death|6|||
162193434|NCT00657709|585758658|FG003|Overall Study|AE or Death|7|||
162193435|NCT00657709|585758659|FG004|Overall Study|AE or Death|1|||
162193436|NCT00657709|585758655|FG000|Overall Study|Withdrawal by Subject|7|||
162193437|NCT00657709|585758656|FG001|Overall Study|Withdrawal by Subject|15|||
162193438|NCT00657709|585758657|FG002|Overall Study|Withdrawal by Subject|15|||
162193439|NCT00657709|585758658|FG003|Overall Study|Withdrawal by Subject|5|||
162193440|NCT00657709|585758659|FG004|Overall Study|Withdrawal by Subject|9|||
162193441|NCT00657709|585758655|FG000|Overall Study|Lost to Follow-up|9|||
162193442|NCT00657709|585758656|FG001|Overall Study|Lost to Follow-up|9|||
162193443|NCT00657709|585758657|FG002|Overall Study|Lost to Follow-up|7|||
162193444|NCT00657709|585758658|FG003|Overall Study|Lost to Follow-up|1|||
162193445|NCT00657709|585758659|FG004|Overall Study|Lost to Follow-up|21|||
162193446|NCT00657709|585758655|FG000|Overall Study|Protocol Violation|0|||
162193447|NCT00657709|585758656|FG001|Overall Study|Protocol Violation|2|||
162193448|NCT00657709|585758657|FG002|Overall Study|Protocol Violation|0|||
162193449|NCT00657709|585758658|FG003|Overall Study|Protocol Violation|1|||
162193450|NCT00657709|585758659|FG004|Overall Study|Protocol Violation|2|||
162193451|NCT03122860|585758660|FG000|Overall Study|Discontinued Before Treatment|1|||
162193452|NCT03122860|585758661|FG001|Overall Study|Discontinued Before Treatment|1|||
162193453|NCT03122860|585758662|FG002|Overall Study|Discontinued Before Treatment|2|||
162193454|NCT03122860|585758663|FG003|Overall Study|Discontinued Before Treatment|0|||
162193455|NCT03122860|585758664|FG004|Overall Study|Discontinued Before Treatment|1|||
162193456|NCT03122860|585758665|FG005|Overall Study|Discontinued Before Treatment|0|||
162193457|NCT03122860|585758660|FG000|Overall Study|Adverse Event|1|||
162193458|NCT03122860|585758661|FG001|Overall Study|Adverse Event|0|||
162193459|NCT03122860|585758662|FG002|Overall Study|Adverse Event|1|||
162193460|NCT03122860|585758663|FG003|Overall Study|Adverse Event|1|||
162193461|NCT03122860|585758664|FG004|Overall Study|Adverse Event|0|||
162193462|NCT03122860|585758665|FG005|Overall Study|Adverse Event|0|||
162193463|NCT03122860|585758660|FG000|Overall Study|Lost to Follow-up|5|||
162193464|NCT03122860|585758661|FG001|Overall Study|Lost to Follow-up|2|||
162193465|NCT03122860|585758662|FG002|Overall Study|Lost to Follow-up|3|||
162193466|NCT03122860|585758663|FG003|Overall Study|Lost to Follow-up|3|||
162193467|NCT03122860|585758664|FG004|Overall Study|Lost to Follow-up|5|||
162193468|NCT03122860|585758665|FG005|Overall Study|Lost to Follow-up|4|||
162193469|NCT03122860|585758660|FG000|Overall Study|Subject Non-Compliance|0|||
162193470|NCT03122860|585758661|FG001|Overall Study|Subject Non-Compliance|0|||
162193471|NCT03122860|585758662|FG002|Overall Study|Subject Non-Compliance|1|||
162193472|NCT03122860|585758663|FG003|Overall Study|Subject Non-Compliance|0|||
161820004|NCT02654145|584381225|FG000|Overall Study|Lack of Efficacy|1|||
162193473|NCT03122860|585758664|FG004|Overall Study|Subject Non-Compliance|0|||
162193474|NCT03122860|585758665|FG005|Overall Study|Subject Non-Compliance|0|||
162193475|NCT03122860|585758660|FG000|Overall Study|Withdrawal by Subject|3|||
162193476|NCT03122860|585758661|FG001|Overall Study|Withdrawal by Subject|2|||
162193477|NCT03122860|585758662|FG002|Overall Study|Withdrawal by Subject|5|||
162193478|NCT03122860|585758663|FG003|Overall Study|Withdrawal by Subject|7|||
162193479|NCT03122860|585758664|FG004|Overall Study|Withdrawal by Subject|9|||
162193480|NCT03122860|585758665|FG005|Overall Study|Withdrawal by Subject|8|||
162193481|NCT01138657|585758666|FG000|Overall Study|Adverse Event|3|||
162193482|NCT01138657|585758667|FG001|Overall Study|Adverse Event|10|||
162193483|NCT01138657|585758666|FG000|Overall Study|Lack of Efficacy|2|||
161674001|NCT02401412|583859954|FG001|Overall Study|Discontinued Intervention|21|||
161674002|NCT02401412|583859953|FG000|Overall Study|Withdrawal by Subject|4|||
161674003|NCT02401412|583859954|FG001|Overall Study|Withdrawal by Subject|4|||
161674004|NCT02401412|583859953|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
161674005|NCT02401412|583859954|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
161674006|NCT02401412|583859953|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
161674007|NCT02401412|583859954|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
161674008|NCT03684642|583859961|FG000|Overall Study|Adverse Event|6|||
161674009|NCT03684642|583859962|FG001|Overall Study|Adverse Event|15|||
161674010|NCT03684642|583859963|FG002|Overall Study|Adverse Event|11|||
161674011|NCT03684642|583859961|FG000|Overall Study|Withdrawal by Subject|35|||
161674012|NCT03684642|583859962|FG001|Overall Study|Withdrawal by Subject|53|||
161674013|NCT03684642|583859963|FG002|Overall Study|Withdrawal by Subject|23|||
161674014|NCT03684642|583859961|FG000|Overall Study|Lack of Efficacy|0|||
161674015|NCT03684642|583859962|FG001|Overall Study|Lack of Efficacy|0|||
161674016|NCT03684642|583859963|FG002|Overall Study|Lack of Efficacy|1|||
161674017|NCT03684642|583859961|FG000|Overall Study|Poor compliance to protocol|0|||
161674018|NCT03684642|583859962|FG001|Overall Study|Poor compliance to protocol|4|||
161674019|NCT03684642|583859963|FG002|Overall Study|Poor compliance to protocol|1|||
161674020|NCT03684642|583859961|FG000|Overall Study|Other than specified|62|||
161674021|NCT03684642|583859962|FG001|Overall Study|Other than specified|60|||
161674022|NCT03684642|583859963|FG002|Overall Study|Other than specified|67|||
161674023|NCT03684642|583859961|FG000|Overall Study|Randomized and not treated|0|||
161674024|NCT03684642|583859962|FG001|Overall Study|Randomized and not treated|0|||
161674025|NCT03684642|583859963|FG002|Overall Study|Randomized and not treated|1|||
161674026|NCT03684642|583859961|FG000|Overall Study|Missing completion status but alive at last contact|0|||
161674027|NCT03684642|583859962|FG001|Overall Study|Missing completion status but alive at last contact|1|||
161674028|NCT03684642|583859963|FG002|Overall Study|Missing completion status but alive at last contact|2|||
161674029|NCT01843218|583859966|FG000|Overall Study|Withdrawal by Subject|5|||
161674030|NCT01431534|583859967|FG000|Treatment Phase|Adverse Event|0|||
161674031|NCT01431534|583859968|FG001|Treatment Phase|Adverse Event|0|||
161674032|NCT01431534|583859969|FG002|Treatment Phase|Adverse Event|1|||
161674033|NCT01431534|583859967|FG000|Treatment Phase|Progressive Disease|4|||
161925715|NCT03166631|584774570|FG004|Overall Study|Adverse Event|0|||
161925716|NCT03166631|584774571|FG005|Overall Study|Adverse Event|1|||
161925717|NCT03166631|584774572|FG006|Overall Study|Adverse Event|1|||
161925718|NCT03166631|584774573|FG007|Overall Study|Adverse Event|0|||
161925719|NCT03166631|584774574|FG008|Overall Study|Adverse Event|1|||
161925720|NCT03166631|584774575|FG009|Overall Study|Adverse Event|2|||
161925721|NCT03166631|584774576|FG010|Overall Study|Adverse Event|1|||
161925722|NCT03166631|584774566|FG000|Overall Study|Withdrawal by Subject|0|||
161925723|NCT03166631|584774567|FG001|Overall Study|Withdrawal by Subject|0|||
161925724|NCT03166631|584774568|FG002|Overall Study|Withdrawal by Subject|0|||
161925725|NCT03166631|584774569|FG003|Overall Study|Withdrawal by Subject|0|||
161925726|NCT03166631|584774570|FG004|Overall Study|Withdrawal by Subject|0|||
161925727|NCT03166631|584774571|FG005|Overall Study|Withdrawal by Subject|0|||
161925728|NCT03166631|584774572|FG006|Overall Study|Withdrawal by Subject|0|||
161925729|NCT03166631|584774573|FG007|Overall Study|Withdrawal by Subject|0|||
161674034|NCT01431534|583859968|FG001|Treatment Phase|Progressive Disease|3|||
161674035|NCT01431534|583859969|FG002|Treatment Phase|Progressive Disease|10|||
161674036|NCT02742766|583859973|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674037|NCT02742766|583859974|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674038|NCT02742766|583859975|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674039|NCT02742766|583859976|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674040|NCT02742766|583859977|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674041|NCT02742766|583859978|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674042|NCT02742766|583859979|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674043|NCT02742766|583859980|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674044|NCT02742766|583859981|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674045|NCT02742766|583859982|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674046|NCT02742766|583859983|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674047|NCT02742766|583859984|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674048|NCT02742766|583859985|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674049|NCT02742766|583859986|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
161674050|NCT02742766|583859987|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674051|NCT02742766|583859988|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674052|NCT02742766|583859989|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674053|NCT02742766|583859990|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674054|NCT02742766|583859991|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161674055|NCT02742766|583859973|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
161925730|NCT03166631|584774574|FG008|Overall Study|Withdrawal by Subject|1|||
161925731|NCT03166631|584774575|FG009|Overall Study|Withdrawal by Subject|1|||
161925732|NCT03166631|584774576|FG010|Overall Study|Withdrawal by Subject|0|||
161925733|NCT03787212|584774580|FG000|Period 1|Study Termination|2|||
162193484|NCT01138657|585758667|FG001|Overall Study|Lack of Efficacy|1|||
162193485|NCT01138657|585758666|FG000|Overall Study|Lost to Follow-up|0|||
162193486|NCT01138657|585758667|FG001|Overall Study|Lost to Follow-up|3|||
162193487|NCT01138657|585758666|FG000|Overall Study|Miscellaneous Reasons|3|||
162193488|NCT01138657|585758667|FG001|Overall Study|Miscellaneous Reasons|4|||
162193489|NCT02574286|585758668|FG000|Overall Study|Adverse Event|3|||
162193490|NCT02574286|585758668|FG000|Overall Study|Withdrawal by Subject|2|||
162193491|NCT03979040|585758669|FG000|Overall Study|Withdrawal by Subject|24|||
162193492|NCT03979040|585758670|FG001|Overall Study|Withdrawal by Subject|32|||
162193493|NCT03979040|585758669|FG000|Overall Study|randomized but never started treatment|32|||
162193494|NCT03979040|585758670|FG001|Overall Study|randomized but never started treatment|39|||
162193495|NCT03979040|585758669|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
162193496|NCT03979040|585758670|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
162193497|NCT00090519|585758671|FG000|Overall Study|Adverse Event|5|||
162193498|NCT00090519|585758672|FG001|Overall Study|Adverse Event|4|||
162193499|NCT00090519|585758671|FG000|Overall Study|Death|9|||
162193500|NCT00090519|585758672|FG001|Overall Study|Death|9|||
162193501|NCT00090519|585758671|FG000|Overall Study|Lost to Follow-up|26|||
162193502|NCT00090519|585758672|FG001|Overall Study|Lost to Follow-up|29|||
162193503|NCT00090519|585758671|FG000|Overall Study|Withdrawal by Subject|28|||
162193504|NCT00090519|585758672|FG001|Overall Study|Withdrawal by Subject|29|||
162193505|NCT00090519|585758671|FG000|Overall Study|Physician Decision|2|||
162193506|NCT00090519|585758672|FG001|Overall Study|Physician Decision|3|||
162193507|NCT00090519|585758671|FG000|Overall Study|Sponsor Decision|3|||
162193508|NCT00090519|585758672|FG001|Overall Study|Sponsor Decision|1|||
162193509|NCT02659540|585758677|FG000|Overall Study|Adverse Event|3|||
162193510|NCT02659540|585758678|FG001|Overall Study|Adverse Event|2|||
162193511|NCT02659540|585758677|FG000|Overall Study|Death|1|||
162193512|NCT02659540|585758678|FG001|Overall Study|Death|0|||
162193513|NCT02659540|585758677|FG000|Overall Study|Progressive disease|2|||
162193514|NCT02659540|585758678|FG001|Overall Study|Progressive disease|6|||
162193515|NCT00824850|585758679|FG000|Overall Study|Withdrawal by Subject|0|||
162193516|NCT00824850|585758680|FG001|Overall Study|Withdrawal by Subject|1|||
162193517|NCT03659136|585758683|FG000|Overall Study|Not treated|2|||
162193518|NCT03659136|585758684|FG001|Overall Study|Not treated|0|||
162193519|NCT03659136|585758683|FG000|Overall Study|Covid-19 related|1|||
162193520|NCT03659136|585758684|FG001|Overall Study|Covid-19 related|1|||
162193521|NCT03659136|585758683|FG000|Overall Study|Withdrawal by Subject|1|||
162193522|NCT03659136|585758684|FG001|Overall Study|Withdrawal by Subject|6|||
162193523|NCT03659136|585758683|FG000|Overall Study|Adverse Event|4|||
162193524|NCT03659136|585758684|FG001|Overall Study|Adverse Event|6|||
162193525|NCT03659136|585758683|FG000|Overall Study|Progressive disease|37|||
162193526|NCT03659136|585758684|FG001|Overall Study|Progressive disease|31|||
162193527|NCT03659136|585758683|FG000|Overall Study|Study closure|2|||
162193528|NCT03659136|585758684|FG001|Overall Study|Study closure|2|||
162193529|NCT03659136|585758683|FG000|Overall Study|Sponsor decision/recommendation|3|||
162193530|NCT03659136|585758684|FG001|Overall Study|Sponsor decision/recommendation|2|||
162193531|NCT03659136|585758683|FG000|Overall Study|Switched to other drug/therapy|2|||
162193532|NCT03659136|585758684|FG001|Overall Study|Switched to other drug/therapy|2|||
162193533|NCT03659136|585758683|FG000|Overall Study|Lack of clinical benefit|0|||
162193534|NCT03659136|585758684|FG001|Overall Study|Lack of clinical benefit|1|||
162193535|NCT03020914|585760166|FG000|Overall Study|Surgery Cancelled|1|||
162193536|NCT03020914|585760167|FG001|Overall Study|Surgery Cancelled|0|||
162193537|NCT04620733|585760168|FG000|Overall Study|Adverse Event|4|||
162193538|NCT04620733|585760169|FG001|Overall Study|Adverse Event|3|||
161674056|NCT02742766|583859974|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
162020164|NCT03865381|585128605|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
162193539|NCT04620733|585760168|FG000|Overall Study|Withdrawal by Subject|2|||
162193540|NCT04620733|585760169|FG001|Overall Study|Withdrawal by Subject|5|||
162020165|NCT03865381|585128605|FG000|Overall Study|Withdrawal by Subject|2|||
162193541|NCT04620733|585760168|FG000|Overall Study|Lost to Follow-up|1|||
162193542|NCT04620733|585760169|FG001|Overall Study|Lost to Follow-up|1|||
162193543|NCT04620733|585760168|FG000|Overall Study|Protocol Deviation|1|||
162193544|NCT04620733|585760169|FG001|Overall Study|Protocol Deviation|1|||
162193545|NCT04620733|585760168|FG000|Overall Study|Reason Not Specified|0|||
162193546|NCT04620733|585760169|FG001|Overall Study|Reason Not Specified|1|||
162193547|NCT03976102|585760173|FG000|Overall Study|Withdrawal by Subject|4|||
162193548|NCT03976102|585760174|FG001|Overall Study|Withdrawal by Subject|4|||
162193549|NCT03976102|585760173|FG000|Overall Study|Adverse Event|2|||
162193550|NCT03976102|585760174|FG001|Overall Study|Adverse Event|4|||
162193551|NCT03976102|585760173|FG000|Overall Study|Not related to Covid-19|9|||
162193552|NCT03976102|585760174|FG001|Overall Study|Not related to Covid-19|13|||
162193553|NCT03976102|585760173|FG000|Overall Study|Lost to Follow-up|0|||
162193554|NCT03976102|585760174|FG001|Overall Study|Lost to Follow-up|2|||
162193555|NCT03976102|585760173|FG000|Overall Study|Death|3|||
162193556|NCT03976102|585760174|FG001|Overall Study|Death|2|||
162193557|NCT03976102|585760173|FG000|Overall Study|Physician Decision|1|||
162193558|NCT03976102|585760174|FG001|Overall Study|Physician Decision|1|||
162193559|NCT00451906|585760176|FG000|Overall Study|Adverse Event|515|||
162193560|NCT00451906|585760176|FG000|Overall Study|Lost to Follow-up|31|||
162193561|NCT00451906|585760176|FG000|Overall Study|Withdrawal by Subject|111|||
162193562|NCT00451906|585760176|FG000|Overall Study|Protocol Violation|21|||
162193563|NCT00451906|585760176|FG000|Overall Study|Progressive disease|1328|||
162193564|NCT00451906|585760176|FG000|Overall Study|Termination of the study|108|||
162193565|NCT00451906|585760176|FG000|Overall Study|Other Reasons|121|||
162193566|NCT00451906|585760176|FG000|Overall Study|Did not complete final visit|4|||
162193567|NCT03072238|585760181|FG000|Overall Study|Withdrawal by Subject|44|||
162193568|NCT03072238|585760182|FG001|Overall Study|Withdrawal by Subject|64|||
162193569|NCT03072238|585760181|FG000|Overall Study|Lost to Follow-up|14|||
162193570|NCT03072238|585760182|FG001|Overall Study|Lost to Follow-up|5|||
162193571|NCT03072238|585760181|FG000|Overall Study|Physician Decision|4|||
162193572|NCT03072238|585760182|FG001|Overall Study|Physician Decision|6|||
162193573|NCT03072238|585760181|FG000|Overall Study|Death|351|||
162193574|NCT03072238|585760182|FG001|Overall Study|Death|318|||
162193575|NCT03072238|585760181|FG000|Overall Study|Progressive Disease|3|||
162193576|NCT03072238|585760182|FG001|Overall Study|Progressive Disease|4|||
162193577|NCT03072238|585760181|FG000|Overall Study|Reason Not Specified|138|||
162193578|NCT03072238|585760182|FG001|Overall Study|Reason Not Specified|150|||
162193579|NCT02889900|585760188|FG000|Overall Study|Adverse Event|11|||
162193580|NCT02889900|585760188|FG000|Overall Study|Condition under investigation worsened|32|||
162193581|NCT02889900|585760188|FG000|Overall Study|Other|5|||
162193582|NCT02889900|585760188|FG000|Overall Study|Withdrawal by Subject|7|||
162193583|NCT02889900|585760188|FG000|Overall Study|Not treated|2|||
162193584|NCT00608959|585760189|FG000|Part 1|Did not meet eligibility criteria|1|||
162193585|NCT01416285|585760190|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
162193586|NCT01416285|585760191|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
162193587|NCT01005602|585760192|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
162193588|NCT01005602|585760193|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
162193589|NCT01248715|585760194|FG000|Overall Study|Not influenza positive|501|||
162193590|NCT01248715|585760195|FG001|Overall Study|Not influenza positive|510|||
162193591|NCT01807234|585760196|FG000|Overall Study|Lost to Follow-up|2|||
162193592|NCT01807234|585760197|FG001|Overall Study|Lost to Follow-up|5|||
162193593|NCT01807234|585760198|FG002|Overall Study|Lost to Follow-up|1|||
162193594|NCT01807234|585760199|FG003|Overall Study|Lost to Follow-up|1|||
162193595|NCT01807234|585760200|FG004|Overall Study|Lost to Follow-up|1|||
162193596|NCT01807234|585760201|FG005|Overall Study|Lost to Follow-up|2|||
162193597|NCT01807234|585760196|FG000|Overall Study|Withdrawal by Subject|3|||
162193598|NCT01807234|585760197|FG001|Overall Study|Withdrawal by Subject|1|||
162193599|NCT01807234|585760198|FG002|Overall Study|Withdrawal by Subject|1|||
162193600|NCT01807234|585760199|FG003|Overall Study|Withdrawal by Subject|1|||
162193601|NCT01807234|585760200|FG004|Overall Study|Withdrawal by Subject|2|||
162193602|NCT01807234|585760201|FG005|Overall Study|Withdrawal by Subject|1|||
162193603|NCT01807234|585760196|FG000|Overall Study|Lack of Efficacy|0|||
162193604|NCT01807234|585760197|FG001|Overall Study|Lack of Efficacy|0|||
162193605|NCT01807234|585760198|FG002|Overall Study|Lack of Efficacy|0|||
162193606|NCT01807234|585760199|FG003|Overall Study|Lack of Efficacy|0|||
162193607|NCT01807234|585760200|FG004|Overall Study|Lack of Efficacy|1|||
162193608|NCT01807234|585760201|FG005|Overall Study|Lack of Efficacy|1|||
162193609|NCT01540474|585760202|FG000|Vaccination Period|Lost to Follow-up|0|||
162193610|NCT01540474|585760203|FG001|Vaccination Period|Lost to Follow-up|1|||
162193611|NCT01540474|585760204|FG002|Vaccination Period|Lost to Follow-up|0|||
162193612|NCT01540474|585760205|FG003|Vaccination Period|Lost to Follow-up|0|||
162193613|NCT00857311|585760206|FG000|Overall Study|Lost to Follow-up|1|||
162193614|NCT00857311|585760207|FG001|Overall Study|Lost to Follow-up|0|||
162193615|NCT00857311|585760208|FG002|Overall Study|Lost to Follow-up|0|||
162193616|NCT00857311|585760209|FG003|Overall Study|Lost to Follow-up|0|||
162193617|NCT01345253|585760213|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
162193618|NCT01345253|585760214|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
162193619|NCT01345253|585760213|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
162193620|NCT01345253|585760214|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
162193621|NCT01345253|585760213|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
162193622|NCT01345253|585760214|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
162193623|NCT01345253|585760213|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
162193624|NCT01345253|585760214|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
162193625|NCT01345253|585760213|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
162193626|NCT01345253|585760214|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
162193627|NCT01345253|585760213|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
162193628|NCT01345253|585760214|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
162193629|NCT01345253|585760213|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
162193630|NCT01345253|585760214|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
162193631|NCT01345253|585760213|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
162193632|NCT01345253|585760214|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
162193633|NCT01345253|585760213|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
162193634|NCT01345253|585760214|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
162193635|NCT01345253|585760213|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
162193636|NCT01345253|585760214|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
162193637|NCT01345253|585760213|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
162193638|NCT01345253|585760214|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
162193639|NCT01345253|585760213|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
162193640|NCT01345253|585760214|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
162193641|NCT01345253|585760213|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
162193642|NCT01345253|585760214|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
162193643|NCT01345253|585760213|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
162193644|NCT01345253|585760214|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
162193645|NCT01345253|585760213|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
162193646|NCT01345253|585760214|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
162193647|NCT00930644|585760215|FG000|Overall Study|Withdrawal by Subject|4|||
162193648|NCT00930644|585760215|FG000|Overall Study|Physician Decision|2|||
162193649|NCT00930644|585760215|FG000|Overall Study|Death|1|||
162193650|NCT00930644|585760215|FG000|Overall Study|Adverse Event|16|||
162193651|NCT01129011|585760216|FG000|Overall Study|Adverse Event|20|||
162193652|NCT01129011|585760217|FG001|Overall Study|Adverse Event|30|||
162193653|NCT01129011|585760216|FG000|Overall Study|Withdrawal by Subject|24|||
162193654|NCT01129011|585760217|FG001|Overall Study|Withdrawal by Subject|8|||
162193655|NCT01129011|585760216|FG000|Overall Study|Lost to Follow-up|6|||
162193656|NCT01129011|585760217|FG001|Overall Study|Lost to Follow-up|7|||
162193657|NCT01129011|585760216|FG000|Overall Study|Duodenal Ulcer|2|||
162193658|NCT01129011|585760217|FG001|Overall Study|Duodenal Ulcer|8|||
162193659|NCT01129011|585760216|FG000|Overall Study|misc|7|||
162193660|NCT01129011|585760217|FG001|Overall Study|misc|4|||
162193661|NCT00417885|585760218|FG000|Overall Study|Adverse Event|1|||
162193662|NCT00417885|585760218|FG000|Overall Study|Objective Progression or Relapse|3|||
162193663|NCT00417885|585760218|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
162193664|NCT00248794|585760221|FG000|Overall Study|Lost to Follow-up|6|||
162193665|NCT00248794|585760222|FG001|Overall Study|Lost to Follow-up|8|||
162193666|NCT00248794|585760223|FG002|Overall Study|Lost to Follow-up|3|||
162193667|NCT01894620|585760226|FG000|Overall Study|Withdrawal by Subject|0|||
162193668|NCT01894620|585760227|FG001|Overall Study|Withdrawal by Subject|1|||
162193669|NCT01124916|585760228|FG000|Overall Study|Lost to Follow-up|3|||
162193670|NCT01124916|585760229|FG001|Overall Study|Lost to Follow-up|2|||
161674057|NCT02742766|583859975|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674058|NCT02742766|583859976|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
162193671|NCT02206607|585760230|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
162193672|NCT02206607|585760231|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
162193673|NCT02206607|585760232|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
162193674|NCT02206607|585760233|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
161674059|NCT02742766|583859977|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
162020166|NCT03566485|585128606|FG000|Overall Study|Disease progression|5|||
162020167|NCT03566485|585128607|FG001|Overall Study|Disease progression|4|||
162020168|NCT03566485|585128606|FG000|Overall Study|Clinical progression|0|||
162020169|NCT03566485|585128607|FG001|Overall Study|Clinical progression|1|||
161820005|NCT02654145|584381225|FG000|Overall Study|Protocol Violation|1|||
162020170|NCT03566485|585128606|FG000|Overall Study|Toxicity|0|||
162020171|NCT03566485|585128607|FG001|Overall Study|Toxicity|2|||
162020172|NCT02873377|585128611|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
162020173|NCT02873377|585128612|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
162020174|NCT02873377|585128611|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
162020175|NCT02873377|585128612|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
162020176|NCT00452361|585128613|FG000|Overall Study|Adverse Event|8|||
162020177|NCT00452361|585128614|FG001|Overall Study|Adverse Event|0|||
162020178|NCT00452361|585128613|FG000|Overall Study|Withdrawal by Subject|0|||
162020179|NCT00452361|585128614|FG001|Overall Study|Withdrawal by Subject|1|||
162020180|NCT00452361|585128613|FG000|Overall Study|Premature termination|13|||
162020181|NCT00452361|585128614|FG001|Overall Study|Premature termination|9|||
162020182|NCT02954172|585128615|FG000|Overall Study|Protocol Violation|3|||
162020183|NCT02954172|585128616|FG001|Overall Study|Protocol Violation|0|||
162020184|NCT02954172|585128615|FG000|Overall Study|allergic reaction|2|||
162020185|NCT02954172|585128616|FG001|Overall Study|allergic reaction|1|||
162020186|NCT02954172|585128615|FG000|Overall Study|non-measurable lesions at baseline|1|||
161674060|NCT02742766|583859978|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674061|NCT02742766|583859979|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674062|NCT02742766|583859980|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674063|NCT02742766|583859981|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674064|NCT02742766|583859982|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
161820006|NCT02654145|584381225|FG000|Overall Study|Withdrawal by Subject|5|||
161820007|NCT00354835|584381226|FG000|Overall Study|Death|1|||
161820008|NCT00354835|584381227|FG001|Overall Study|Death|1|||
161820009|NCT00354835|584381226|FG000|Overall Study|Physician Decision|8|||
161820010|NCT00354835|584381227|FG001|Overall Study|Physician Decision|13|||
161820011|NCT00354835|584381226|FG000|Overall Study|Withdrawal by Subject|2|||
161820012|NCT00354835|584381227|FG001|Overall Study|Withdrawal by Subject|1|||
161820013|NCT00354835|584381226|FG000|Overall Study|Ineligible|17|||
161820014|NCT00354835|584381227|FG001|Overall Study|Ineligible|16|||
161820015|NCT00354835|584381226|FG000|Overall Study|Disease progression or relapse|15|||
161820016|NCT00354835|584381227|FG001|Overall Study|Disease progression or relapse|22|||
161820017|NCT00354835|584381226|FG000|Overall Study|Adverse Event|6|||
161820018|NCT00354835|584381227|FG001|Overall Study|Adverse Event|0|||
161820019|NCT00354835|584381226|FG000|Overall Study|Refusal of further therapy|3|||
161820020|NCT00354835|584381227|FG001|Overall Study|Refusal of further therapy|8|||
161820021|NCT06475729|584381228|FG000|Overall Study|Withdrawal by Subject|2|||
161820022|NCT06475729|584381229|FG001|Overall Study|Withdrawal by Subject|1|||
161820023|NCT06475729|584381228|FG000|Overall Study|Randomized but did not receive any dose|3|||
161674065|NCT02742766|583859983|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674066|NCT02742766|583859984|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674067|NCT02742766|583859985|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
161674068|NCT02742766|583859986|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
161674069|NCT02742766|583859987|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674070|NCT02742766|583859988|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
161674071|NCT02742766|583859989|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674072|NCT02742766|583859990|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674073|NCT02742766|583859991|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
161674074|NCT03739437|583859992|FG000|Overall Study|Lost to Follow-up|2|||
161674075|NCT03739437|583859993|FG001|Overall Study|Lost to Follow-up|5|||
161674076|NCT01395316|583859995|FG000|Overall Study|Lost to Follow-up|2|||
161674077|NCT01395316|583859995|FG000|Overall Study|poor MRI quality|1|||
161674078|NCT03359590|583859996|FG000|First Intervention|Withdrawal by Subject|1|||
161674079|NCT03359590|583859997|FG001|First Intervention|Withdrawal by Subject|1|||
161674080|NCT03359590|583859996|FG000|First Intervention|Protocol Violation|0|||
161674081|NCT03359590|583859997|FG001|First Intervention|Protocol Violation|1|||
161674082|NCT02540538|583859998|FG000|Overall Study|Pregnancy|0|||
161674083|NCT02540538|583859999|FG001|Overall Study|Pregnancy|1|||
161674084|NCT02540538|583860000|FG002|Overall Study|Pregnancy|0|||
161674085|NCT02846532|583860001|FG000|Overall Study|Lost to Follow-up|0|||
161674086|NCT02846532|583860002|FG001|Overall Study|Lost to Follow-up|1|||
161820024|NCT06475729|584381229|FG001|Overall Study|Randomized but did not receive any dose|2|||
161820025|NCT06475729|584381228|FG000|Overall Study|Lost to Follow-up|1|||
161820026|NCT06475729|584381229|FG001|Overall Study|Lost to Follow-up|2|||
161820027|NCT06475729|584381228|FG000|Overall Study|Physician Decision|5|||
162020187|NCT02954172|585128616|FG001|Overall Study|non-measurable lesions at baseline|2|||
162020188|NCT00233064|585128617|FG000|Overall Study|Lost to Follow-up|7|||
162020189|NCT00233064|585128618|FG001|Overall Study|Lost to Follow-up|7|||
162020190|NCT00233064|585128617|FG000|Overall Study|Withdrawal by Subject|5|||
162020191|NCT00233064|585128618|FG001|Overall Study|Withdrawal by Subject|3|||
162020192|NCT00233064|585128617|FG000|Overall Study|Death|0|||
161820028|NCT06475729|584381229|FG001|Overall Study|Physician Decision|2|||
161820029|NCT06475729|584381228|FG000|Overall Study|Adverse Event|1|||
161820030|NCT06475729|584381229|FG001|Overall Study|Adverse Event|1|||
161820031|NCT03922750|584381236|FG000|Overall Study|Unclassified|0|||
161674087|NCT02846532|583860003|FG002|Overall Study|Lost to Follow-up|1|||
161674088|NCT02846532|583860001|FG000|Overall Study|Withdrawal by Subject|1|||
161674089|NCT02846532|583860002|FG001|Overall Study|Withdrawal by Subject|2|||
162020193|NCT00233064|585128618|FG001|Overall Study|Death|1|||
162020194|NCT00233064|585128617|FG000|Overall Study|Relocation|0|||
162020195|NCT00233064|585128618|FG001|Overall Study|Relocation|1|||
162020196|NCT00233064|585128617|FG000|Overall Study|Protocol Violation|1|||
162020197|NCT00233064|585128618|FG001|Overall Study|Protocol Violation|0|||
162020198|NCT00233064|585128617|FG000|Overall Study|Moved to Dom. Republic|1|||
162020199|NCT00233064|585128618|FG001|Overall Study|Moved to Dom. Republic|0|||
162020200|NCT01120964|585128620|FG000|Overall Study|Did not receive full treatment|1|||
161820032|NCT03922750|584381237|FG001|Overall Study|Unclassified|0|||
161674090|NCT02846532|583860003|FG002|Overall Study|Withdrawal by Subject|0|||
161674091|NCT04908189|583860005|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
161674092|NCT04908189|583860006|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
161674093|NCT04908189|583860007|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
161674094|NCT04908189|583860005|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
161674095|NCT04908189|583860006|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
161674096|NCT04908189|583860007|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
161674097|NCT04908189|583860005|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
161674098|NCT04908189|583860006|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
161674099|NCT04908189|583860007|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
161674100|NCT04908189|583860005|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
161820033|NCT03922750|584381238|FG002|Overall Study|Unclassified|1|||
161820034|NCT03922750|584381236|FG000|Overall Study|Adverse Event|0|||
161820035|NCT03922750|584381237|FG001|Overall Study|Adverse Event|1|||
161820036|NCT03922750|584381238|FG002|Overall Study|Adverse Event|0|||
161820037|NCT01046084|584381242|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
161820038|NCT01046084|584381243|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
161820039|NCT02166606|584381244|FG000|Overall Study|Adverse Event|3|||
161820040|NCT02166606|584381244|FG000|Overall Study|Death|31|||
161820041|NCT02166606|584381244|FG000|Overall Study|Protocol Violation|7|||
161820042|NCT02166606|584381244|FG000|Overall Study|Lost to Follow-up|30|||
161820043|NCT02166606|584381244|FG000|Overall Study|Withdrawal by Subject|1|||
161820044|NCT02166606|584381244|FG000|Overall Study|Physician Decision|1|||
161820045|NCT02166606|584381244|FG000|Overall Study|Device upgrade|1|||
161820046|NCT02166606|584381244|FG000|Overall Study|Enrolled after End of Enrollment|4|||
161820047|NCT01971645|584381245|FG000|Overall Study|Adverse Event|1|||
161820048|NCT01971645|584381246|FG001|Overall Study|Adverse Event|0|||
161820049|NCT01971645|584381247|FG002|Overall Study|Adverse Event|0|||
161820050|NCT01971645|584381245|FG000|Overall Study|Lost to Follow-up|1|||
161820051|NCT01971645|584381246|FG001|Overall Study|Lost to Follow-up|0|||
161820052|NCT01971645|584381247|FG002|Overall Study|Lost to Follow-up|1|||
161820053|NCT01971645|584381245|FG000|Overall Study|Protocol Violation|0|||
161820054|NCT01971645|584381246|FG001|Overall Study|Protocol Violation|0|||
161820055|NCT01971645|584381247|FG002|Overall Study|Protocol Violation|1|||
161820056|NCT03868631|584381249|FG000|Baseline to Week 6|Adverse Event|0|||
162020201|NCT01120964|585128621|FG001|Overall Study|Did not receive full treatment|0|||
162020202|NCT05064358|585128622|FG000|Overall Study|Death|23|||
162020203|NCT05064358|585128623|FG001|Overall Study|Death|23|||
162020204|NCT05064358|585128624|FG002|Overall Study|Death|25|||
162020205|NCT05064358|585128625|FG003|Overall Study|Death|21|||
161674101|NCT04908189|583860006|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
161674102|NCT04908189|583860007|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
161674103|NCT04908189|583860005|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
161674104|NCT04908189|583860006|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
161674105|NCT04908189|583860007|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
161925734|NCT03787212|584774581|FG001|Period 1|Study Termination|2|||
162193675|NCT02206607|585760234|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
162193676|NCT02206607|585760230|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
162193677|NCT02206607|585760231|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
162193678|NCT02206607|585760232|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
162193679|NCT02206607|585760233|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
162193680|NCT02206607|585760234|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
162193681|NCT00879710|585760235|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
162193682|NCT00879710|585760236|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
162193683|NCT00879710|585760237|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
162193684|NCT00879710|585760238|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
162193685|NCT00879710|585760235|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
162193686|NCT00879710|585760236|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
162193687|NCT00879710|585760237|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
162193688|NCT00879710|585760238|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
162193689|NCT00761267|585760239|FG000|Overall Study|Death|1|||
162193690|NCT00761267|585760240|FG001|Overall Study|Death|2|||
162193691|NCT00761267|585760241|FG002|Overall Study|Death|5|||
162193692|NCT00761267|585760239|FG000|Overall Study|Lost to Follow-up|0|||
162193693|NCT00761267|585760240|FG001|Overall Study|Lost to Follow-up|0|||
162193694|NCT00761267|585760241|FG002|Overall Study|Lost to Follow-up|1|||
162193695|NCT00761267|585760239|FG000|Overall Study|Randomized but not treated|1|||
162193696|NCT00761267|585760240|FG001|Overall Study|Randomized but not treated|1|||
162193697|NCT00761267|585760241|FG002|Overall Study|Randomized but not treated|0|||
162193698|NCT00761267|585760239|FG000|Overall Study|Withdrawal by Subject|0|||
162193699|NCT00761267|585760240|FG001|Overall Study|Withdrawal by Subject|1|||
162193700|NCT00761267|585760241|FG002|Overall Study|Withdrawal by Subject|0|||
162193701|NCT00963924|585760244|FG000|Overall Study|Adverse Event|1|||
162193702|NCT00963924|585760245|FG001|Overall Study|Adverse Event|0|||
162193703|NCT00963924|585760244|FG000|Overall Study|Withdrawal by Subject|0|||
162193704|NCT00963924|585760245|FG001|Overall Study|Withdrawal by Subject|1|||
162193705|NCT00963924|585760244|FG000|Overall Study|Changed antipsychotic|0|||
162193706|NCT00963924|585760245|FG001|Overall Study|Changed antipsychotic|1|||
162193707|NCT00963924|585760244|FG000|Overall Study|Lost to Follow-up|0|||
162193708|NCT00963924|585760245|FG001|Overall Study|Lost to Follow-up|1|||
162193709|NCT00446095|585760247|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
162193710|NCT00446095|585760248|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
162193711|NCT00446095|585760249|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
162193712|NCT00446095|585760250|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
162193713|NCT00446095|585760251|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
162193714|NCT00446095|585760247|FG000|Phase II (8 Weeks)|Adverse Event|0|||
162193715|NCT00446095|585760248|FG001|Phase II (8 Weeks)|Adverse Event|1|||
162193716|NCT00446095|585760249|FG002|Phase II (8 Weeks)|Adverse Event|1|||
162193717|NCT00446095|585760250|FG003|Phase II (8 Weeks)|Adverse Event|0|||
162193718|NCT00446095|585760251|FG004|Phase II (8 Weeks)|Adverse Event|0|||
162193719|NCT00446095|585760247|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
162193720|NCT00446095|585760248|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
162193721|NCT00446095|585760249|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
162193722|NCT00446095|585760250|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
162193723|NCT00446095|585760251|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
162193724|NCT00446095|585760247|FG000|Phase II (8 Weeks)|Physician Decision|1|||
162193725|NCT00446095|585760248|FG001|Phase II (8 Weeks)|Physician Decision|0|||
162193726|NCT00446095|585760249|FG002|Phase II (8 Weeks)|Physician Decision|0|||
162193727|NCT00446095|585760250|FG003|Phase II (8 Weeks)|Physician Decision|0|||
162193728|NCT00446095|585760251|FG004|Phase II (8 Weeks)|Physician Decision|0|||
161925735|NCT04289298|584774584|FG000|Overall Study|Lost to Follow-up|5|||
162193729|NCT00446095|585760247|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
162193730|NCT00446095|585760248|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
162193731|NCT00446095|585760249|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
162193732|NCT00446095|585760250|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
162193733|NCT00446095|585760251|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
162193734|NCT00446095|585760247|FG000|Phase II (8 Weeks)|Ongoing|0|||
162193735|NCT00446095|585760248|FG001|Phase II (8 Weeks)|Ongoing|0|||
161674106|NCT04908189|583860005|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
161674107|NCT04908189|583860006|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
162193736|NCT00446095|585760249|FG002|Phase II (8 Weeks)|Ongoing|1|||
162193737|NCT00446095|585760250|FG003|Phase II (8 Weeks)|Ongoing|0|||
162193738|NCT00446095|585760251|FG004|Phase II (8 Weeks)|Ongoing|0|||
162193739|NCT00446095|585760247|FG000|Phase I (28 Days)|Adverse Event|0|||
162193740|NCT00446095|585760248|FG001|Phase I (28 Days)|Adverse Event|0|||
162193741|NCT00446095|585760249|FG002|Phase I (28 Days)|Adverse Event|0|||
162193742|NCT00446095|585760250|FG003|Phase I (28 Days)|Adverse Event|1|||
162193743|NCT00446095|585760251|FG004|Phase I (28 Days)|Adverse Event|0|||
162193744|NCT00446095|585760247|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
162193745|NCT00446095|585760248|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
162193746|NCT00446095|585760249|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
162193747|NCT00446095|585760250|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
162193748|NCT00446095|585760251|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
162193749|NCT02159352|585760254|FG000|Overall Study|Adverse Event|3|||
162193750|NCT02159352|585760255|FG001|Overall Study|Adverse Event|1|||
162193751|NCT02159352|585760254|FG000|Overall Study|Withdrawal by Subject|0|||
162193752|NCT02159352|585760255|FG001|Overall Study|Withdrawal by Subject|1|||
162193753|NCT00529529|585760256|FG000|Overall Study|Adverse Event|12|||
162193754|NCT00529529|585760257|FG001|Overall Study|Adverse Event|17|||
162193755|NCT00529529|585760258|FG002|Overall Study|Adverse Event|8|||
162193756|NCT00529529|585760256|FG000|Overall Study|Subject withdrew consent|12|||
162193757|NCT00529529|585760257|FG001|Overall Study|Subject withdrew consent|9|||
162193758|NCT00529529|585760258|FG002|Overall Study|Subject withdrew consent|12|||
162193759|NCT00529529|585760256|FG000|Overall Study|Protocol deviation|8|||
162193760|NCT00529529|585760257|FG001|Overall Study|Protocol deviation|12|||
162193761|NCT00529529|585760258|FG002|Overall Study|Protocol deviation|5|||
162193762|NCT00529529|585760256|FG000|Overall Study|Lost to Follow-up|5|||
162193763|NCT00529529|585760257|FG001|Overall Study|Lost to Follow-up|3|||
162193764|NCT00529529|585760258|FG002|Overall Study|Lost to Follow-up|1|||
162193765|NCT00529529|585760256|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162193766|NCT00529529|585760257|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162193767|NCT00529529|585760258|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
162193768|NCT00529529|585760256|FG000|Overall Study|Death|2|||
162193769|NCT00529529|585760257|FG001|Overall Study|Death|0|||
162193770|NCT00529529|585760258|FG002|Overall Study|Death|0|||
162193771|NCT00529529|585760256|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162193772|NCT00529529|585760257|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162193773|NCT00529529|585760258|FG002|Overall Study|Abnormal test procedure result(s)|0|||
162193774|NCT00529529|585760256|FG000|Overall Study|Administrative problems|1|||
162193775|NCT00529529|585760257|FG001|Overall Study|Administrative problems|0|||
162193776|NCT00529529|585760258|FG002|Overall Study|Administrative problems|3|||
162193777|NCT00337610|585760259|FG000|Overall Study|Adverse Event|2|||
162193778|NCT00337610|585760260|FG001|Overall Study|Adverse Event|2|||
162193779|NCT00337610|585760259|FG000|Overall Study|Death|0|||
162193780|NCT00337610|585760260|FG001|Overall Study|Death|1|||
162193781|NCT00337610|585760259|FG000|Overall Study|Lack of Efficacy|6|||
162193782|NCT00337610|585760260|FG001|Overall Study|Lack of Efficacy|3|||
162193783|NCT00337610|585760259|FG000|Overall Study|Lost to Follow-up|3|||
162193784|NCT00337610|585760260|FG001|Overall Study|Lost to Follow-up|3|||
162193785|NCT00337610|585760259|FG000|Overall Study|Withdrawal by Subject|6|||
162193786|NCT00337610|585760260|FG001|Overall Study|Withdrawal by Subject|5|||
162193787|NCT02279732|585760267|FG000|Overall Study|Death|23|||
162193788|NCT02279732|585760268|FG001|Overall Study|Death|20|||
162193789|NCT02279732|585760267|FG000|Overall Study|Disease Progression|13|||
162193790|NCT02279732|585760268|FG001|Overall Study|Disease Progression|3|||
162193791|NCT02279732|585760267|FG000|Overall Study|Withdrawal by Subject|2|||
162193792|NCT02279732|585760268|FG001|Overall Study|Withdrawal by Subject|7|||
162193793|NCT02279732|585760267|FG000|Overall Study|Adverse Event|1|||
162193794|NCT02279732|585760268|FG001|Overall Study|Adverse Event|2|||
162193795|NCT02279732|585760267|FG000|Overall Study|Administrative Reason By Sponsor|0|||
162193796|NCT02279732|585760268|FG001|Overall Study|Administrative Reason By Sponsor|2|||
162193797|NCT02279732|585760267|FG000|Overall Study|Study Drug Toxicity|2|||
162193798|NCT02279732|585760268|FG001|Overall Study|Study Drug Toxicity|0|||
162193799|NCT02279732|585760267|FG000|Overall Study|Lost to Follow-up|0|||
162193800|NCT02279732|585760268|FG001|Overall Study|Lost to Follow-up|1|||
162193801|NCT02279732|585760267|FG000|Overall Study|Maximum Clinical Benefit|1|||
162193802|NCT02279732|585760268|FG001|Overall Study|Maximum Clinical Benefit|0|||
162193803|NCT02279732|585760267|FG000|Overall Study|Subject Requested to Discontinue|0|||
162193804|NCT02279732|585760268|FG001|Overall Study|Subject Requested to Discontinue|1|||
162193805|NCT02279732|585760267|FG000|Overall Study|Other|53|||
162193806|NCT02279732|585760268|FG001|Overall Study|Other|67|||
162193807|NCT02279732|585760267|FG000|Overall Study|Other|3|||
162193808|NCT02279732|585760268|FG001|Overall Study|Other|3|||
162193809|NCT02203513|585760272|FG000|Overall Study|Refused further treatment|2|||
162193810|NCT02203513|585760273|FG001|Overall Study|Refused further treatment|0|||
162193811|NCT02203513|585760274|FG002|Overall Study|Refused further treatment|1|||
162193812|NCT02203513|585760275|FG003|Overall Study|Refused further treatment|0|||
162193813|NCT02203513|585760276|FG004|Overall Study|Refused further treatment|0|||
162193814|NCT02203513|585760272|FG000|Overall Study|Switched to alternative treatment|3|||
162193815|NCT02203513|585760273|FG001|Overall Study|Switched to alternative treatment|4|||
162193816|NCT02203513|585760274|FG002|Overall Study|Switched to alternative treatment|0|||
162193817|NCT02203513|585760275|FG003|Overall Study|Switched to alternative treatment|0|||
162193818|NCT02203513|585760276|FG004|Overall Study|Switched to alternative treatment|4|||
162193819|NCT02203513|585760272|FG000|Overall Study|Did not receive investigational product (IP)|0|||
162193820|NCT02203513|585760273|FG001|Overall Study|Did not receive investigational product (IP)|1|||
162193821|NCT02203513|585760274|FG002|Overall Study|Did not receive investigational product (IP)|0|||
162193822|NCT02203513|585760275|FG003|Overall Study|Did not receive investigational product (IP)|0|||
162193823|NCT02203513|585760276|FG004|Overall Study|Did not receive investigational product (IP)|0|||
162193824|NCT02203513|585760272|FG000|Overall Study|Death (unrelated to study therapy)|1|||
162193825|NCT02203513|585760273|FG001|Overall Study|Death (unrelated to study therapy)|3|||
162193826|NCT02203513|585760274|FG002|Overall Study|Death (unrelated to study therapy)|1|||
162193827|NCT02203513|585760275|FG003|Overall Study|Death (unrelated to study therapy)|0|||
162193828|NCT02203513|585760276|FG004|Overall Study|Death (unrelated to study therapy)|2|||
162193829|NCT02203513|585760272|FG000|Overall Study|Lost to Follow-up|0|||
162193830|NCT02203513|585760273|FG001|Overall Study|Lost to Follow-up|0|||
162193831|NCT02203513|585760274|FG002|Overall Study|Lost to Follow-up|1|||
162193832|NCT02203513|585760275|FG003|Overall Study|Lost to Follow-up|1|||
162193833|NCT02203513|585760276|FG004|Overall Study|Lost to Follow-up|0|||
162193834|NCT01441596|585760277|FG000|Overall Study|Other reason not defined below|0|||
162193835|NCT01441596|585760278|FG001|Overall Study|Other reason not defined below|2|||
162193836|NCT01441596|585760279|FG002|Overall Study|Other reason not defined below|1|||
162193837|NCT01441596|585760277|FG000|Overall Study|Withdrawal by Subject|4|||
162193838|NCT01441596|585760278|FG001|Overall Study|Withdrawal by Subject|0|||
162193839|NCT01441596|585760279|FG002|Overall Study|Withdrawal by Subject|2|||
162193840|NCT01441596|585760277|FG000|Overall Study|Not treated|0|||
162193841|NCT01441596|585760278|FG001|Overall Study|Not treated|1|||
162193842|NCT01441596|585760279|FG002|Overall Study|Not treated|1|||
162193843|NCT03055988|585760280|FG000|Period 1|Adverse Event|0|||
162193844|NCT03055988|585760281|FG001|Period 1|Adverse Event|1|||
162193845|NCT03055988|585760280|FG000|Period 1|Lost to Follow-up|1|||
162193846|NCT03055988|585760281|FG001|Period 1|Lost to Follow-up|0|||
162193847|NCT03055988|585760280|FG000|Period 1|Withdrawal by Subject|0|||
162193848|NCT03055988|585760281|FG001|Period 1|Withdrawal by Subject|4|||
162193849|NCT03055988|585760280|FG000|Period 2|Adverse Event|0|||
162193850|NCT03055988|585760281|FG001|Period 2|Adverse Event|1|||
162193851|NCT03055988|585760280|FG000|Period 2|Other than listed|1|||
162193852|NCT03055988|585760281|FG001|Period 2|Other than listed|1|||
162193853|NCT01681511|585760282|FG000|Overall Study|No Treatment Received|1|||
162193854|NCT01681511|585760283|FG001|Overall Study|No Treatment Received|3|||
162193855|NCT01681511|585760282|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
162193856|NCT01681511|585760283|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
162193857|NCT01681511|585760282|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
162193858|NCT01681511|585760283|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
162193859|NCT01681511|585760282|FG000|Overall Study|No Daily Urine Sample Collected|0|||
162193860|NCT01681511|585760283|FG001|Overall Study|No Daily Urine Sample Collected|1|||
162193861|NCT01681511|585760282|FG000|Overall Study|No post-catheter sample collected|11|||
162193862|NCT01681511|585760283|FG001|Overall Study|No post-catheter sample collected|4|||
162193863|NCT01156675|585760284|FG000|Overall Study|Death|5|||
162193864|NCT01156675|585760285|FG001|Overall Study|Death|3|||
161820057|NCT03868631|584381250|FG001|Baseline to Week 6|Adverse Event|3|||
161820058|NCT03868631|584381249|FG000|Baseline to Week 6|Protocol Violation|1|||
161820059|NCT03868631|584381250|FG001|Baseline to Week 6|Protocol Violation|1|||
161820060|NCT03868631|584381249|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
161820061|NCT03868631|584381250|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
161820062|NCT03868631|584381249|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
161820063|NCT03868631|584381250|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
161820064|NCT03868631|584381249|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
161925736|NCT04289298|584774585|FG001|Overall Study|Lost to Follow-up|0|||
162020206|NCT05064358|585128626|FG004|Overall Study|Death|5|||
162193865|NCT01156675|585760286|FG002|Overall Study|Death|0|||
162193866|NCT01156675|585760284|FG000|Overall Study|No data|29|||
162193867|NCT01156675|585760285|FG001|Overall Study|No data|22|||
162193868|NCT01156675|585760286|FG002|Overall Study|No data|2|||
162193869|NCT00116649|585760300|FG000|Overall Study|Adverse Event|20|||
162193870|NCT00116649|585760300|FG000|Overall Study|Lack of Efficacy|1|||
161925737|NCT04289298|584774584|FG000|Overall Study|Withdrawal by Subject|2|||
161925738|NCT04289298|584774585|FG001|Overall Study|Withdrawal by Subject|0|||
161925739|NCT01778985|584774589|FG000|Overall Study|Lost to Follow-up|1|||
161925740|NCT01778985|584774590|FG001|Overall Study|Lost to Follow-up|0|||
161925741|NCT01778985|584774589|FG000|Overall Study|Physician Decision|2|||
161925742|NCT01778985|584774590|FG001|Overall Study|Physician Decision|2|||
161925743|NCT01778985|584774589|FG000|Overall Study|Protocol Violation|4|||
161925744|NCT01778985|584774590|FG001|Overall Study|Protocol Violation|1|||
161925745|NCT00504231|584774591|FG000|Overall Study|Discrepant chart documentation re route|0|||
161925746|NCT00504231|584774592|FG001|Overall Study|Discrepant chart documentation re route|0|||
161925747|NCT00504231|584774593|FG002|Overall Study|Discrepant chart documentation re route|1|||
162193871|NCT00116649|585760300|FG000|Overall Study|Lost to Follow-up|32|||
162193872|NCT00116649|585760300|FG000|Overall Study|Withdrawal by Subject|68|||
162193873|NCT00116649|585760300|FG000|Overall Study|Local Skin Reaction|9|||
162193874|NCT00116649|585760300|FG000|Overall Study|Various Reasons|18|||
162193875|NCT00116649|585760300|FG000|Overall Study|Protocol Specified|7|||
162193876|NCT02161146|585760301|FG000|Overall Study|Adverse Event|1|||
162193877|NCT02161146|585760302|FG001|Overall Study|Adverse Event|1|||
162193878|NCT02161146|585760303|FG002|Overall Study|Adverse Event|0|||
162193879|NCT02161146|585760304|FG003|Overall Study|Adverse Event|1|||
162193880|NCT02161146|585760305|FG004|Overall Study|Adverse Event|0|||
162193881|NCT02161146|585760301|FG000|Overall Study|Lost to Follow-up|0|||
162193882|NCT02161146|585760302|FG001|Overall Study|Lost to Follow-up|1|||
162193883|NCT02161146|585760303|FG002|Overall Study|Lost to Follow-up|0|||
162193884|NCT02161146|585760304|FG003|Overall Study|Lost to Follow-up|0|||
162020207|NCT05064358|585128622|FG000|Overall Study|Lost to Follow-up|1|||
162193885|NCT02161146|585760305|FG004|Overall Study|Lost to Follow-up|0|||
162020208|NCT05064358|585128623|FG001|Overall Study|Lost to Follow-up|2|||
162193886|NCT02161146|585760301|FG000|Overall Study|Personal Reasons|0|||
162193887|NCT02161146|585760302|FG001|Overall Study|Personal Reasons|1|||
162193888|NCT02161146|585760303|FG002|Overall Study|Personal Reasons|0|||
162193889|NCT02161146|585760304|FG003|Overall Study|Personal Reasons|2|||
162193890|NCT02161146|585760305|FG004|Overall Study|Personal Reasons|1|||
162193891|NCT02161146|585760301|FG000|Overall Study|Other Miscellaneous Reasons|0|||
162193892|NCT02161146|585760302|FG001|Overall Study|Other Miscellaneous Reasons|1|||
162193893|NCT02161146|585760303|FG002|Overall Study|Other Miscellaneous Reasons|0|||
162193894|NCT02161146|585760304|FG003|Overall Study|Other Miscellaneous Reasons|0|||
162193895|NCT02161146|585760305|FG004|Overall Study|Other Miscellaneous Reasons|0|||
162193896|NCT00845520|585760306|FG000|Overall Study|Death|1|||
162193897|NCT00845520|585760307|FG001|Overall Study|Death|2|||
162193898|NCT00845520|585760308|FG002|Overall Study|Death|0|||
162193899|NCT00845520|585760306|FG000|Overall Study|Lost to Follow-up|1|||
162193900|NCT00845520|585760307|FG001|Overall Study|Lost to Follow-up|0|||
162193901|NCT00845520|585760308|FG002|Overall Study|Lost to Follow-up|0|||
162193902|NCT00845520|585760306|FG000|Overall Study|Adverse Event|0|||
162193903|NCT00845520|585760307|FG001|Overall Study|Adverse Event|0|||
162193904|NCT00845520|585760308|FG002|Overall Study|Adverse Event|1|||
162193905|NCT02613403|585760309|FG000|Overall Study|Lost to Follow-up|0|||
162193906|NCT02613403|585760310|FG001|Overall Study|Lost to Follow-up|1|||
162193907|NCT02613403|585760311|FG002|Overall Study|Lost to Follow-up|0|||
162193908|NCT02613403|585760312|FG003|Overall Study|Lost to Follow-up|0|||
162193909|NCT02613403|585760313|FG004|Overall Study|Lost to Follow-up|0|||
161820065|NCT03868631|584381250|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
161820066|NCT03868631|584381249|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
161820067|NCT03868631|584381250|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
161820068|NCT01717040|584381252|FG000|Overall Study|Lost to Follow-up|2|||
161820069|NCT01717040|584381253|FG001|Overall Study|Lost to Follow-up|3|||
161820070|NCT01717040|584381252|FG000|Overall Study|Lack of Efficacy|1|||
161820071|NCT01717040|584381253|FG001|Overall Study|Lack of Efficacy|1|||
162193910|NCT02613403|585760309|FG000|Overall Study|Withdrawal by Subject|2|||
162193911|NCT02613403|585760310|FG001|Overall Study|Withdrawal by Subject|0|||
162193912|NCT02613403|585760311|FG002|Overall Study|Withdrawal by Subject|0|||
162193913|NCT02613403|585760312|FG003|Overall Study|Withdrawal by Subject|0|||
162193914|NCT02613403|585760313|FG004|Overall Study|Withdrawal by Subject|0|||
162193915|NCT00800176|585760314|FG000|Overall Study|Adverse Event|2|||
162193916|NCT00800176|585760315|FG001|Overall Study|Adverse Event|1|||
162193917|NCT00800176|585760316|FG002|Overall Study|Adverse Event|0|||
162193918|NCT00800176|585760317|FG003|Overall Study|Adverse Event|2|||
162193919|NCT00800176|585760318|FG004|Overall Study|Adverse Event|1|||
162193920|NCT00800176|585760319|FG005|Overall Study|Adverse Event|1|||
162193921|NCT00800176|585760314|FG000|Overall Study|Refused treatment|3|||
162193922|NCT00800176|585760315|FG001|Overall Study|Refused treatment|2|||
162193923|NCT00800176|585760316|FG002|Overall Study|Refused treatment|0|||
162193924|NCT00800176|585760317|FG003|Overall Study|Refused treatment|0|||
162193925|NCT00800176|585760318|FG004|Overall Study|Refused treatment|1|||
162193926|NCT00800176|585760319|FG005|Overall Study|Refused treatment|4|||
162193927|NCT00800176|585760314|FG000|Overall Study|Failure to return|3|||
162193928|NCT00800176|585760315|FG001|Overall Study|Failure to return|3|||
162193929|NCT00800176|585760316|FG002|Overall Study|Failure to return|0|||
162193930|NCT00800176|585760317|FG003|Overall Study|Failure to return|2|||
162193931|NCT00800176|585760318|FG004|Overall Study|Failure to return|0|||
162193932|NCT00800176|585760319|FG005|Overall Study|Failure to return|0|||
162193933|NCT00800176|585760314|FG000|Overall Study|Other|1|||
162193934|NCT00800176|585760315|FG001|Overall Study|Other|0|||
162193935|NCT00800176|585760316|FG002|Overall Study|Other|0|||
162193936|NCT00800176|585760317|FG003|Overall Study|Other|0|||
162193937|NCT00800176|585760318|FG004|Overall Study|Other|2|||
162193938|NCT00800176|585760319|FG005|Overall Study|Other|0|||
162193939|NCT02326220|585760322|FG000|Double-blind Treatment Period|Adverse Event|1|||
162193940|NCT02326220|585760323|FG001|Double-blind Treatment Period|Adverse Event|2|||
162193941|NCT02326220|585760324|FG002|Double-blind Treatment Period|Adverse Event|0|||
162193942|NCT02326220|585760322|FG000|Double-blind Treatment Period|Protocol Violation|0|||
162193943|NCT02326220|585760323|FG001|Double-blind Treatment Period|Protocol Violation|1|||
162193944|NCT02326220|585760324|FG002|Double-blind Treatment Period|Protocol Violation|0|||
162193945|NCT02326220|585760322|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
161820072|NCT01717040|584381252|FG000|Overall Study|Adverse Event|1|||
162193946|NCT02326220|585760323|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
162193947|NCT02326220|585760324|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
162193948|NCT02326220|585760322|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
162193949|NCT02326220|585760323|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
162193950|NCT02326220|585760324|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
162193951|NCT02326220|585760322|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
162193952|NCT02326220|585760323|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
162193953|NCT02326220|585760324|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
161820073|NCT01717040|584381253|FG001|Overall Study|Adverse Event|0|||
161674108|NCT04908189|583860007|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
161674109|NCT04908189|583860005|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
161674110|NCT04908189|583860006|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
161674111|NCT04908189|583860007|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
162193954|NCT02699099|585760325|FG000|Overall Study|Adverse Event|1|||
162193955|NCT02699099|585760326|FG001|Overall Study|Adverse Event|0|||
162193956|NCT02699099|585760327|FG002|Overall Study|Adverse Event|2|||
162193957|NCT02699099|585760325|FG000|Overall Study|Lost to Follow-up|0|||
162193958|NCT02699099|585760326|FG001|Overall Study|Lost to Follow-up|1|||
162193959|NCT02699099|585760327|FG002|Overall Study|Lost to Follow-up|0|||
162193960|NCT02699099|585760325|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
162193961|NCT02699099|585760326|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
162193962|NCT02699099|585760327|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
161674112|NCT04908189|583860005|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
161674113|NCT04908189|583860006|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
161674114|NCT04908189|583860007|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
161683063|NCT02463409|583891224|FG000|Overall Study|Withdrawal by Subject|1|||
162193963|NCT04820491|585760332|FG000|Overall Study|Withdrawal by Subject|1|||
162193964|NCT04820491|585760333|FG001|Overall Study|Withdrawal by Subject|0|||
162193965|NCT00452452|585760334|FG000|Overall Study|Protocol Violation|0|||
162193966|NCT00452452|585760335|FG001|Overall Study|Protocol Violation|0|||
162193967|NCT00452452|585760336|FG002|Overall Study|Protocol Violation|1|||
162193968|NCT00452452|585760334|FG000|Overall Study|Withdrawal by Subject|1|||
162193969|NCT00452452|585760335|FG001|Overall Study|Withdrawal by Subject|0|||
162193970|NCT00452452|585760336|FG002|Overall Study|Withdrawal by Subject|0|||
162193971|NCT00452452|585760334|FG000|Overall Study|Lost to Follow-up|1|||
162193972|NCT00452452|585760335|FG001|Overall Study|Lost to Follow-up|0|||
162193973|NCT00452452|585760336|FG002|Overall Study|Lost to Follow-up|0|||
162193974|NCT01919489|585762183|FG000|Overall Study|Rejected the need of injections|4|||
162193975|NCT01919489|585762184|FG001|Overall Study|Rejected the need of injections|7|||
162193976|NCT01919489|585762183|FG000|Overall Study|Adverse Event|10|||
162193977|NCT01919489|585762184|FG001|Overall Study|Adverse Event|0|||
162193978|NCT01919489|585762183|FG000|Overall Study|Hospital readmission|2|||
162193979|NCT01919489|585762184|FG001|Overall Study|Hospital readmission|9|||
162193980|NCT01919489|585762183|FG000|Overall Study|Death|2|||
162193981|NCT01919489|585762184|FG001|Overall Study|Death|1|||
162193982|NCT01919489|585762183|FG000|Overall Study|Lost to Follow-up|38|||
162193983|NCT01919489|585762184|FG001|Overall Study|Lost to Follow-up|27|||
162193984|NCT03884478|585762185|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
162193985|NCT03884478|585762186|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
162193986|NCT03884478|585762187|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
162193987|NCT03884478|585762185|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
162193988|NCT03884478|585762186|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
162193989|NCT03884478|585762187|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
162193990|NCT03884478|585762185|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
162193991|NCT03884478|585762186|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
162193992|NCT03884478|585762187|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
162193993|NCT03884478|585762185|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
162193994|NCT03884478|585762186|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
162193995|NCT03884478|585762187|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
162193996|NCT01587703|585762188|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
162193997|NCT01587703|585762189|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162193998|NCT01587703|585762190|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162193999|NCT01587703|585762191|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194000|NCT01587703|585762192|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194001|NCT01587703|585762193|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194002|NCT01587703|585762194|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194003|NCT01587703|585762195|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194004|NCT01587703|585762196|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194005|NCT01587703|585762197|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194006|NCT01587703|585762198|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194007|NCT01587703|585762199|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194008|NCT01587703|585762200|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194009|NCT01587703|585762201|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194010|NCT01587703|585762202|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194011|NCT01587703|585762203|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194012|NCT01587703|585762204|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194013|NCT01587703|585762205|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
162194014|NCT01587703|585762206|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161674115|NCT04908189|583860005|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
161674116|NCT04908189|583860006|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
161674117|NCT04908189|583860007|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
161674118|NCT04908189|583860005|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
161674119|NCT04908189|583860006|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
161674120|NCT04908189|583860007|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
161674121|NCT04908189|583860005|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
161674122|NCT04908189|583860006|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
161674123|NCT04908189|583860007|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
161674124|NCT04908189|583860005|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
161674125|NCT04908189|583860006|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
161674126|NCT04908189|583860007|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
162194015|NCT01587703|585762188|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194016|NCT01587703|585762189|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194017|NCT01587703|585762190|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194018|NCT01587703|585762191|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194019|NCT01587703|585762192|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194020|NCT01587703|585762193|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
162194021|NCT01587703|585762194|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194022|NCT01587703|585762195|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
162194023|NCT01587703|585762196|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194024|NCT01587703|585762197|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161674127|NCT04598477|583860008|FG000|Overall Study|Adverse Event|2|||
161674128|NCT04598477|583860009|FG001|Overall Study|Adverse Event|0|||
161674129|NCT04598477|583860008|FG000|Overall Study|Death|0|||
161674130|NCT04598477|583860009|FG001|Overall Study|Death|1|||
162194025|NCT01587703|585762198|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194026|NCT01587703|585762199|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194027|NCT01587703|585762200|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194028|NCT01587703|585762201|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194029|NCT01587703|585762202|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194030|NCT01587703|585762203|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194031|NCT01587703|585762204|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194032|NCT01587703|585762205|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194033|NCT01587703|585762206|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
162194034|NCT01587703|585762188|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194035|NCT01587703|585762189|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194036|NCT01587703|585762190|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194037|NCT01587703|585762191|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194038|NCT01587703|585762192|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194039|NCT01587703|585762193|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194040|NCT01587703|585762194|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
162194041|NCT01587703|585762195|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194042|NCT01587703|585762196|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194043|NCT01587703|585762197|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161674131|NCT04598477|583860008|FG000|Overall Study|Lost to Follow-up|1|||
161674132|NCT04598477|583860009|FG001|Overall Study|Lost to Follow-up|0|||
161674133|NCT04598477|583860008|FG000|Overall Study|Physician Decision|7|||
161674134|NCT04598477|583860009|FG001|Overall Study|Physician Decision|2|||
161674135|NCT04598477|583860008|FG000|Overall Study|Pregnancy|0|||
161674136|NCT04598477|583860009|FG001|Overall Study|Pregnancy|1|||
161674137|NCT04598477|583860008|FG000|Overall Study|Requires Prohibited Medication|0|||
161674138|NCT04598477|583860009|FG001|Overall Study|Requires Prohibited Medication|1|||
161674139|NCT04598477|583860008|FG000|Overall Study|Study Terminated by Sponsor|18|||
162194044|NCT01587703|585762198|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161674140|NCT04598477|583860009|FG001|Overall Study|Study Terminated by Sponsor|12|||
162194045|NCT01587703|585762199|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194046|NCT01587703|585762200|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194047|NCT01587703|585762201|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194048|NCT01587703|585762202|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194049|NCT01587703|585762203|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194050|NCT01587703|585762204|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194051|NCT01587703|585762205|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194052|NCT01587703|585762206|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
162194053|NCT01587703|585762188|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
162194054|NCT01587703|585762189|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
162194055|NCT01587703|585762190|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
162194056|NCT01587703|585762191|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
162194057|NCT01587703|585762192|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
162194058|NCT01587703|585762193|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
162194059|NCT01587703|585762194|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
162194060|NCT01587703|585762195|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
162194061|NCT01587703|585762196|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162194062|NCT01587703|585762197|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162194063|NCT01587703|585762198|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162194064|NCT01587703|585762199|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162194065|NCT01587703|585762200|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162194066|NCT01587703|585762201|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162194067|NCT01587703|585762202|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162194068|NCT01587703|585762203|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162194069|NCT01587703|585762204|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162194070|NCT01587703|585762205|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162194071|NCT01587703|585762206|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
162194072|NCT01587703|585762188|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194073|NCT01587703|585762189|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194074|NCT01587703|585762190|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194075|NCT01587703|585762191|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194076|NCT01587703|585762192|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194077|NCT01587703|585762193|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194078|NCT01587703|585762194|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194079|NCT01587703|585762195|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194080|NCT01587703|585762196|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
162194081|NCT01587703|585762197|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
161820074|NCT01717040|584381252|FG000|Overall Study|Required Medication Change|0|||
161820075|NCT01717040|584381253|FG001|Overall Study|Required Medication Change|1|||
161820076|NCT01717040|584381252|FG000|Overall Study|New Substance Use Disorder|1|||
161820077|NCT01717040|584381253|FG001|Overall Study|New Substance Use Disorder|0|||
161820078|NCT02957331|584381256|FG000|Overall Study|Protocol Violation|1|||
161820079|NCT02957331|584381257|FG001|Overall Study|Protocol Violation|0|||
161820080|NCT05568615|584382702|FG000|Overall Study|Death|1|||
161820081|NCT05568615|584382702|FG000|Overall Study|Physician Decision|1|||
161820082|NCT00565851|584382703|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
161820083|NCT00565851|584382704|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
161820084|NCT00565851|584382705|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
161820085|NCT00565851|584382706|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
161820086|NCT00565851|584382707|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
161820087|NCT00565851|584382708|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
161820088|NCT00565851|584382709|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
161820089|NCT00565851|584382710|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
161820090|NCT00565851|584382703|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
161820091|NCT00565851|584382704|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
161820092|NCT00565851|584382705|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
161820093|NCT00565851|584382706|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
161820094|NCT00565851|584382707|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
161820095|NCT00565851|584382708|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
161820096|NCT00565851|584382709|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
161820097|NCT00565851|584382710|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
161820098|NCT03291067|584382711|FG000|Overall Study|Adverse Event|0|||
161820099|NCT03291067|584382712|FG001|Overall Study|Adverse Event|2|||
161820100|NCT03291067|584382713|FG002|Overall Study|Adverse Event|17|||
161820101|NCT03291067|584382714|FG003|Overall Study|Adverse Event|3|||
161820102|NCT03291067|584382711|FG000|Overall Study|Lost to Follow-up|2|||
161820103|NCT03291067|584382712|FG001|Overall Study|Lost to Follow-up|1|||
161820104|NCT03291067|584382713|FG002|Overall Study|Lost to Follow-up|0|||
162194082|NCT01587703|585762198|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
161820105|NCT03291067|584382714|FG003|Overall Study|Lost to Follow-up|1|||
161820106|NCT03291067|584382711|FG000|Overall Study|Physician Decision|0|||
162194083|NCT01587703|585762199|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194084|NCT01587703|585762200|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194085|NCT01587703|585762201|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194086|NCT01587703|585762202|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194087|NCT01587703|585762203|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194088|NCT01587703|585762204|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194089|NCT01587703|585762205|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194090|NCT01587703|585762206|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
162194091|NCT01587703|585762188|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194092|NCT01587703|585762189|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194093|NCT01587703|585762190|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194094|NCT01587703|585762191|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194095|NCT01587703|585762192|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194096|NCT01587703|585762193|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194097|NCT01587703|585762194|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194098|NCT01587703|585762195|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194099|NCT01587703|585762196|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
162194100|NCT01587703|585762197|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194101|NCT01587703|585762198|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
162194102|NCT01587703|585762199|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194103|NCT01587703|585762200|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194104|NCT01587703|585762201|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194105|NCT01587703|585762202|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194106|NCT01587703|585762203|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194107|NCT01587703|585762204|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194108|NCT01587703|585762205|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194109|NCT01587703|585762206|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
162194110|NCT01587703|585762188|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194111|NCT01587703|585762189|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194112|NCT01587703|585762190|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194113|NCT01587703|585762191|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161674141|NCT04598477|583860008|FG000|Overall Study|Withdrawal by Subject|16|||
161674142|NCT04598477|583860009|FG001|Overall Study|Withdrawal by Subject|12|||
161674143|NCT04598477|583860008|FG000|Overall Study|Other|15|||
162194114|NCT01587703|585762192|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194115|NCT01587703|585762193|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194116|NCT01587703|585762194|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194117|NCT01587703|585762195|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194118|NCT01587703|585762196|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194119|NCT01587703|585762197|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
162194120|NCT01587703|585762198|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
162194121|NCT01587703|585762199|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194122|NCT01587703|585762200|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194123|NCT01587703|585762201|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194124|NCT01587703|585762202|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194125|NCT01587703|585762203|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194126|NCT01587703|585762204|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194127|NCT01587703|585762205|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194128|NCT01587703|585762206|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
162194129|NCT01587703|585762188|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194130|NCT01587703|585762189|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194131|NCT01587703|585762190|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194132|NCT01587703|585762191|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194133|NCT01587703|585762192|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194134|NCT01587703|585762193|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194135|NCT01587703|585762194|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194136|NCT01587703|585762195|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194137|NCT01587703|585762196|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
162194138|NCT01587703|585762197|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194139|NCT01587703|585762198|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194140|NCT01587703|585762199|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194141|NCT01587703|585762200|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194142|NCT01587703|585762201|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194143|NCT01587703|585762202|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194144|NCT01587703|585762203|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194145|NCT01587703|585762204|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194146|NCT01587703|585762205|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194147|NCT01587703|585762206|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
162194148|NCT01587703|585762188|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194149|NCT01587703|585762189|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194150|NCT01587703|585762190|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194151|NCT01587703|585762191|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194152|NCT01587703|585762192|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194153|NCT01587703|585762193|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194154|NCT01587703|585762194|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194155|NCT01587703|585762195|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194156|NCT01587703|585762196|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194157|NCT01587703|585762197|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194158|NCT01587703|585762198|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194159|NCT01587703|585762199|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194160|NCT01587703|585762200|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194161|NCT01587703|585762201|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194162|NCT01587703|585762202|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194163|NCT01587703|585762203|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194164|NCT01587703|585762204|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194165|NCT01587703|585762205|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
162194166|NCT01587703|585762206|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
162194167|NCT01587703|585762188|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194168|NCT01587703|585762189|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194169|NCT01587703|585762190|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194170|NCT01587703|585762191|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194171|NCT01587703|585762192|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194172|NCT01587703|585762193|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194173|NCT01587703|585762194|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194174|NCT01587703|585762195|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161674144|NCT04598477|583860009|FG001|Overall Study|Other|8|||
161674145|NCT05579990|583860017|FG000|Overall Study|Lost to Follow-up|3|||
161674146|NCT00607022|583860018|FG000|Overall Study|Withdrawal by Subject|1|||
162194175|NCT01587703|585762196|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194176|NCT01587703|585762197|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194177|NCT01587703|585762198|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194178|NCT01587703|585762199|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194179|NCT01587703|585762200|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194180|NCT01587703|585762201|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194181|NCT01587703|585762202|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194182|NCT01587703|585762203|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194183|NCT01587703|585762204|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
162194184|NCT01587703|585762205|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
162194185|NCT01587703|585762206|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
162194186|NCT01587703|585762188|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194187|NCT01587703|585762189|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194188|NCT01587703|585762190|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194189|NCT01587703|585762191|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161674147|NCT00607022|583860019|FG001|Overall Study|Withdrawal by Subject|0|||
162194190|NCT01587703|585762192|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194191|NCT01587703|585762193|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194192|NCT01587703|585762194|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194193|NCT01587703|585762195|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194194|NCT01587703|585762196|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161674148|NCT00607022|583860020|FG002|Overall Study|Withdrawal by Subject|0|||
161674149|NCT04786119|583860021|FG000|Overall Study|Withdrawal by Subject|4|||
161674150|NCT04786119|583860022|FG001|Overall Study|Withdrawal by Subject|5|||
161674151|NCT04786119|583860021|FG000|Overall Study|Lost to Follow-up|5|||
162194195|NCT01587703|585762197|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194196|NCT01587703|585762198|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194197|NCT01587703|585762199|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194198|NCT01587703|585762200|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194199|NCT01587703|585762201|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194200|NCT01587703|585762202|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194201|NCT01587703|585762203|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
162194202|NCT01587703|585762204|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194203|NCT01587703|585762205|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194204|NCT01587703|585762206|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
162194205|NCT01587703|585762188|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194206|NCT01587703|585762189|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194207|NCT01587703|585762190|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194208|NCT01587703|585762191|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194209|NCT01587703|585762192|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194210|NCT01587703|585762193|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194211|NCT01587703|585762194|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161674152|NCT04786119|583860022|FG001|Overall Study|Lost to Follow-up|5|||
161674153|NCT04786119|583860021|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
161683064|NCT02463409|583891224|FG000|Overall Study|Screen failure|1|||
162194212|NCT01587703|585762195|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194213|NCT01587703|585762196|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194214|NCT01587703|585762197|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194215|NCT01587703|585762198|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194216|NCT01587703|585762199|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
162194217|NCT01587703|585762200|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194218|NCT01587703|585762201|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194219|NCT01587703|585762202|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
162194220|NCT01587703|585762203|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194221|NCT01587703|585762204|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194222|NCT01587703|585762205|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194223|NCT01587703|585762206|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
162194224|NCT01587703|585762188|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194225|NCT01587703|585762189|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194226|NCT01587703|585762190|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194227|NCT01587703|585762191|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194228|NCT01587703|585762192|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194229|NCT01587703|585762193|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194230|NCT01587703|585762194|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194231|NCT01587703|585762195|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194232|NCT01587703|585762196|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194233|NCT01587703|585762197|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194234|NCT01587703|585762198|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194235|NCT01587703|585762199|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
162194236|NCT01587703|585762200|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
162194237|NCT01587703|585762201|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
162194238|NCT01587703|585762202|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
162194239|NCT01587703|585762203|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
162194240|NCT01587703|585762204|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
162194241|NCT01587703|585762205|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194242|NCT01587703|585762206|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
162194243|NCT01587703|585762188|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194244|NCT01587703|585762189|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194245|NCT01587703|585762190|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194246|NCT01587703|585762191|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194247|NCT01587703|585762192|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194248|NCT01587703|585762193|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194249|NCT01587703|585762194|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194250|NCT01587703|585762195|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194251|NCT01587703|585762196|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194252|NCT01587703|585762197|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194253|NCT01587703|585762198|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194254|NCT01587703|585762199|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
162194255|NCT01587703|585762200|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
162194256|NCT01587703|585762201|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
162194257|NCT01587703|585762202|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
162194258|NCT01587703|585762203|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
162194259|NCT01587703|585762204|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
162194260|NCT01587703|585762205|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194261|NCT01587703|585762206|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
162194262|NCT01587703|585762188|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194263|NCT01587703|585762189|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194264|NCT01587703|585762190|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194265|NCT01587703|585762191|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194266|NCT01587703|585762192|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194267|NCT01587703|585762193|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194268|NCT01587703|585762194|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194269|NCT01587703|585762195|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194270|NCT01587703|585762196|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194271|NCT01587703|585762197|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194272|NCT01587703|585762198|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194273|NCT01587703|585762199|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
162194274|NCT01587703|585762200|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194275|NCT01587703|585762201|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194276|NCT01587703|585762202|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194277|NCT01587703|585762203|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194278|NCT01587703|585762204|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194279|NCT01587703|585762205|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161674154|NCT04786119|583860022|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
161674155|NCT01130051|583860027|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
161674156|NCT01130051|583860028|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
161674157|NCT01130051|583860027|FG000|Washout Period of 14 Days|Protocol Violation|1|||
161674158|NCT01130051|583860028|FG001|Washout Period of 14 Days|Protocol Violation|1|||
161674159|NCT00835120|583860032|FG000|Overall Study|Lack of Efficacy|1|||
161674160|NCT00835120|583860032|FG000|Overall Study|Lost to Follow-up|3|||
161674161|NCT00835120|583860032|FG000|Overall Study|Adverse Event|2|||
161674162|NCT00835120|583860032|FG000|Overall Study|Withdrawal by Subject|2|||
161674163|NCT03610165|583860033|FG000|Overall Study|Device didn't work|0|||
161674164|NCT03610165|583860034|FG001|Overall Study|Device didn't work|1|||
161674165|NCT04223791|583860037|FG000|Overall Study|Lost to Follow-up|0|||
161674166|NCT04223791|583860038|FG001|Overall Study|Lost to Follow-up|4|||
161674167|NCT04223791|583860037|FG000|Overall Study|Physician Decision|5|||
161674168|NCT04223791|583860038|FG001|Overall Study|Physician Decision|1|||
161674169|NCT04223791|583860037|FG000|Overall Study|Protocol Violation|1|||
161674170|NCT04223791|583860038|FG001|Overall Study|Protocol Violation|1|||
161674171|NCT04223791|583860037|FG000|Overall Study|Withdrawal by Subject|10|||
161674172|NCT04223791|583860038|FG001|Overall Study|Withdrawal by Subject|12|||
161674173|NCT04223791|583860037|FG000|Overall Study|Pregnancy|1|||
161674174|NCT04223791|583860038|FG001|Overall Study|Pregnancy|1|||
161674175|NCT04223791|583860037|FG000|Overall Study|Ongoing in Study|305|||
161674176|NCT04223791|583860038|FG001|Overall Study|Ongoing in Study|302|||
161674177|NCT00594516|583861847|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
161674178|NCT00594516|583861848|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
161674179|NCT00594516|583861849|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
161674180|NCT00594516|583861847|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
162194280|NCT01587703|585762206|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
162194281|NCT00828139|585762207|FG000|Overall Study|Adverse Event|8|||
162194282|NCT00828139|585762208|FG001|Overall Study|Adverse Event|1|||
162194283|NCT00828139|585762209|FG002|Overall Study|Adverse Event|10|||
162194284|NCT00828139|585762210|FG003|Overall Study|Adverse Event|5|||
162194285|NCT00828139|585762207|FG000|Overall Study|Death|2|||
162194286|NCT00828139|585762208|FG001|Overall Study|Death|1|||
162194287|NCT00828139|585762209|FG002|Overall Study|Death|0|||
162194288|NCT00828139|585762210|FG003|Overall Study|Death|2|||
162194289|NCT00828139|585762207|FG000|Overall Study|Refusal unrelated to toxicity|3|||
162194290|NCT00828139|585762208|FG001|Overall Study|Refusal unrelated to toxicity|4|||
162194291|NCT00828139|585762209|FG002|Overall Study|Refusal unrelated to toxicity|5|||
162194292|NCT00828139|585762210|FG003|Overall Study|Refusal unrelated to toxicity|3|||
162194293|NCT00828139|585762207|FG000|Overall Study|Disease Progression|24|||
162194294|NCT00828139|585762208|FG001|Overall Study|Disease Progression|33|||
162194295|NCT00828139|585762209|FG002|Overall Study|Disease Progression|35|||
162194296|NCT00828139|585762210|FG003|Overall Study|Disease Progression|39|||
162194297|NCT00828139|585762207|FG000|Overall Study|Other|4|||
162194298|NCT00828139|585762208|FG001|Overall Study|Other|2|||
162194299|NCT00828139|585762209|FG002|Overall Study|Other|5|||
162194300|NCT00828139|585762210|FG003|Overall Study|Other|2|||
162194301|NCT04271254|585762211|FG000|Overall Study|Withdrawal by Subject|3|||
162194302|NCT04751929|585762212|FG000|Overall Study|Withdrawal by Subject|2|||
162194303|NCT04751929|585762213|FG001|Overall Study|Withdrawal by Subject|0|||
162194304|NCT04751929|585762214|FG002|Overall Study|Withdrawal by Subject|0|||
162194305|NCT04751929|585762215|FG003|Overall Study|Withdrawal by Subject|0|||
162194306|NCT04751929|585762212|FG000|Overall Study|Rising PSA|0|||
162194307|NCT04751929|585762213|FG001|Overall Study|Rising PSA|1|||
162194308|NCT04751929|585762214|FG002|Overall Study|Rising PSA|0|||
162194309|NCT04751929|585762215|FG003|Overall Study|Rising PSA|0|||
162194310|NCT04751929|585762212|FG000|Overall Study|Adverse Event|1|||
162194311|NCT04751929|585762213|FG001|Overall Study|Adverse Event|2|||
162194312|NCT04751929|585762214|FG002|Overall Study|Adverse Event|0|||
162194313|NCT04751929|585762215|FG003|Overall Study|Adverse Event|0|||
162194314|NCT04751929|585762212|FG000|Overall Study|Progressive Disease|3|||
162194315|NCT04751929|585762213|FG001|Overall Study|Progressive Disease|4|||
162194316|NCT04751929|585762214|FG002|Overall Study|Progressive Disease|4|||
162194317|NCT04751929|585762215|FG003|Overall Study|Progressive Disease|0|||
162194318|NCT04751929|585762212|FG000|Overall Study|Death|1|||
162194319|NCT04751929|585762213|FG001|Overall Study|Death|1|||
162194320|NCT04751929|585762214|FG002|Overall Study|Death|0|||
162194321|NCT04751929|585762215|FG003|Overall Study|Death|0|||
161674181|NCT00594516|583861848|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
161674182|NCT00594516|583861849|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
162194322|NCT00473512|585762220|FG000|Period 1 (Phase 1)|Adverse Event|0|||
162194323|NCT00473512|585762221|FG001|Period 1 (Phase 1)|Adverse Event|0|||
162194324|NCT00473512|585762222|FG002|Period 1 (Phase 1)|Adverse Event|0|||
162194325|NCT00473512|585762223|FG003|Period 1 (Phase 1)|Adverse Event|5|||
162194326|NCT00473512|585762224|FG004|Period 1 (Phase 1)|Adverse Event|0|||
161674183|NCT00594516|583861847|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
161674184|NCT00594516|583861848|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
162194327|NCT00473512|585762220|FG000|Period 1 (Phase 1)|Death|0|||
162194328|NCT00473512|585762221|FG001|Period 1 (Phase 1)|Death|0|||
162194329|NCT00473512|585762222|FG002|Period 1 (Phase 1)|Death|0|||
162194330|NCT00473512|585762223|FG003|Period 1 (Phase 1)|Death|1|||
162194331|NCT00473512|585762224|FG004|Period 1 (Phase 1)|Death|0|||
162194332|NCT00473512|585762220|FG000|Period 1 (Phase 1)|Disease Progression|1|||
162194333|NCT00473512|585762221|FG001|Period 1 (Phase 1)|Disease Progression|1|||
162194334|NCT00473512|585762222|FG002|Period 1 (Phase 1)|Disease Progression|0|||
162194335|NCT00473512|585762223|FG003|Period 1 (Phase 1)|Disease Progression|10|||
162194336|NCT00473512|585762224|FG004|Period 1 (Phase 1)|Disease Progression|1|||
162194337|NCT00473512|585762220|FG000|Period 1 (Phase 1)|Other|0|||
162194338|NCT00473512|585762221|FG001|Period 1 (Phase 1)|Other|0|||
162194339|NCT00473512|585762222|FG002|Period 1 (Phase 1)|Other|0|||
162194340|NCT00473512|585762223|FG003|Period 1 (Phase 1)|Other|1|||
162194341|NCT00473512|585762224|FG004|Period 1 (Phase 1)|Other|0|||
162194342|NCT00473512|585762220|FG000|Period 2 (Phase 2)|Adverse Event|0|||
162194343|NCT00473512|585762221|FG001|Period 2 (Phase 2)|Adverse Event|0|||
162194344|NCT00473512|585762222|FG002|Period 2 (Phase 2)|Adverse Event|0|||
162194345|NCT00473512|585762223|FG003|Period 2 (Phase 2)|Adverse Event|1|||
162194346|NCT00473512|585762224|FG004|Period 2 (Phase 2)|Adverse Event|0|||
162194347|NCT00473512|585762220|FG000|Period 2 (Phase 2)|Death|0|||
162194348|NCT00473512|585762221|FG001|Period 2 (Phase 2)|Death|0|||
162194349|NCT00473512|585762222|FG002|Period 2 (Phase 2)|Death|0|||
162194350|NCT00473512|585762223|FG003|Period 2 (Phase 2)|Death|1|||
162194351|NCT00473512|585762224|FG004|Period 2 (Phase 2)|Death|1|||
162194352|NCT00473512|585762220|FG000|Period 2 (Phase 2)|Disease Progression|0|||
162194353|NCT00473512|585762221|FG001|Period 2 (Phase 2)|Disease Progression|2|||
162194354|NCT00473512|585762222|FG002|Period 2 (Phase 2)|Disease Progression|2|||
162194355|NCT00473512|585762223|FG003|Period 2 (Phase 2)|Disease Progression|17|||
162194356|NCT00473512|585762224|FG004|Period 2 (Phase 2)|Disease Progression|1|||
162194357|NCT00473512|585762220|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
162194358|NCT00473512|585762221|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
162194359|NCT00473512|585762222|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
162194360|NCT00473512|585762223|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
162194361|NCT00473512|585762224|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
162194362|NCT00473512|585762220|FG000|Period 2 (Phase 2)|Other|1|||
162194363|NCT00473512|585762221|FG001|Period 2 (Phase 2)|Other|0|||
162194364|NCT00473512|585762222|FG002|Period 2 (Phase 2)|Other|0|||
162194365|NCT00473512|585762223|FG003|Period 2 (Phase 2)|Other|3|||
162194366|NCT00473512|585762224|FG004|Period 2 (Phase 2)|Other|0|||
162194367|NCT01369147|585762229|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
162194368|NCT01369147|585762230|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
161820107|NCT03291067|584382712|FG001|Overall Study|Physician Decision|0|||
161820108|NCT03291067|584382713|FG002|Overall Study|Physician Decision|1|||
161820109|NCT03291067|584382714|FG003|Overall Study|Physician Decision|0|||
162194369|NCT01369147|585762231|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
162194370|NCT01052272|585762234|FG000|Overall Study|Death|0|||
162194371|NCT01052272|585762235|FG001|Overall Study|Death|0|||
162194372|NCT01052272|585762236|FG002|Overall Study|Death|1|||
162194373|NCT01052272|585762237|FG003|Overall Study|Death|1|||
162194374|NCT01052272|585762234|FG000|Overall Study|Physician Decision|0|||
162194375|NCT01052272|585762235|FG001|Overall Study|Physician Decision|1|||
162194376|NCT01052272|585762236|FG002|Overall Study|Physician Decision|0|||
162194377|NCT01052272|585762237|FG003|Overall Study|Physician Decision|0|||
162194378|NCT01052272|585762234|FG000|Overall Study|patient refuses follow-up|5|||
162194379|NCT01052272|585762235|FG001|Overall Study|patient refuses follow-up|4|||
162194380|NCT01052272|585762236|FG002|Overall Study|patient refuses follow-up|2|||
162194381|NCT01052272|585762237|FG003|Overall Study|patient refuses follow-up|4|||
162194382|NCT01052272|585762234|FG000|Overall Study|Withdrawal by Subject|0|||
162194383|NCT01052272|585762235|FG001|Overall Study|Withdrawal by Subject|2|||
162194384|NCT01052272|585762236|FG002|Overall Study|Withdrawal by Subject|3|||
162194385|NCT01052272|585762237|FG003|Overall Study|Withdrawal by Subject|2|||
162194386|NCT01052272|585762234|FG000|Overall Study|placed in long-term care|0|||
162194387|NCT01052272|585762235|FG001|Overall Study|placed in long-term care|0|||
162194388|NCT01052272|585762236|FG002|Overall Study|placed in long-term care|1|||
161820110|NCT03291067|584382711|FG000|Overall Study|Protocol Violation|5|||
162194389|NCT01052272|585762237|FG003|Overall Study|placed in long-term care|0|||
162194390|NCT01052272|585762234|FG000|Overall Study|decline in health|0|||
162194391|NCT01052272|585762235|FG001|Overall Study|decline in health|0|||
162194392|NCT01052272|585762236|FG002|Overall Study|decline in health|1|||
162194393|NCT01052272|585762237|FG003|Overall Study|decline in health|0|||
162194394|NCT00113529|585762238|FG000|Overall Study|Adverse Event|4|||
162194395|NCT00113529|585762238|FG000|Overall Study|Lack of Efficacy|20|||
162194396|NCT00113529|585762238|FG000|Overall Study|Decision of sponsor|6|||
162194397|NCT00113529|585762238|FG000|Overall Study|Withdrawal by Subject|4|||
162194398|NCT00648895|585762240|FG000|Overall Study|Lack of Efficacy|0|||
161820111|NCT03291067|584382712|FG001|Overall Study|Protocol Violation|3|||
162194399|NCT00648895|585762241|FG001|Overall Study|Lack of Efficacy|1|||
162194400|NCT00841321|585762246|FG000|Overall Study|Lost to Follow-up|1|||
162194401|NCT00841321|585762247|FG001|Overall Study|Lost to Follow-up|1|||
162194402|NCT00841321|585762246|FG000|Overall Study|Adverse Event|0|||
162194403|NCT00841321|585762247|FG001|Overall Study|Adverse Event|2|||
162194404|NCT02632747|585762250|FG000|Wash-out Period|Adverse Event|1|||
162194405|NCT02632747|585762251|FG001|Wash-out Period|Adverse Event|0|||
162194406|NCT04421456|585762252|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
162194407|NCT04421456|585762253|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
162194408|NCT04421456|585762254|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
162194409|NCT04421456|585762252|FG000|Randomized Treatment Period|Adverse Event|0|||
162194410|NCT04421456|585762253|FG001|Randomized Treatment Period|Adverse Event|1|||
162194411|NCT04421456|585762254|FG002|Randomized Treatment Period|Adverse Event|0|||
162194412|NCT04421456|585762252|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
162194413|NCT04421456|585762253|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
162194414|NCT04421456|585762254|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
162194415|NCT04421456|585762252|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
162194416|NCT04421456|585762253|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
162194417|NCT04421456|585762254|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
162194418|NCT04421456|585762252|FG000|Randomized Treatment Period|Participant non-compliance|1|||
162194419|NCT04421456|585762253|FG001|Randomized Treatment Period|Participant non-compliance|1|||
162194420|NCT04421456|585762254|FG002|Randomized Treatment Period|Participant non-compliance|2|||
162194421|NCT04421456|585762252|FG000|Randomized Treatment Period|Other|0|||
162194422|NCT04421456|585762253|FG001|Randomized Treatment Period|Other|1|||
162194423|NCT04421456|585762254|FG002|Randomized Treatment Period|Other|3|||
162194424|NCT00379210|585762255|FG000|Overall Study|Withdrawal by Subject|10|||
162194425|NCT00379210|585762256|FG001|Overall Study|Withdrawal by Subject|7|||
162194426|NCT03209492|585762257|FG000|Overall Study|Case Report Forms Uncollected|5|||
162194427|NCT01358175|585762258|FG000|Overall Study|Death|1|||
162194428|NCT01358175|585762259|FG001|Overall Study|Death|0|||
162194429|NCT01358175|585762260|FG002|Overall Study|Death|1|||
162194430|NCT01358175|585762258|FG000|Overall Study|Withdrawal by Subject|9|||
162194431|NCT01358175|585762259|FG001|Overall Study|Withdrawal by Subject|5|||
162194432|NCT01358175|585762260|FG002|Overall Study|Withdrawal by Subject|10|||
162194433|NCT01358175|585762258|FG000|Overall Study|Technical issues|0|||
162194434|NCT01358175|585762259|FG001|Overall Study|Technical issues|1|||
162194435|NCT01358175|585762260|FG002|Overall Study|Technical issues|0|||
162194436|NCT01358175|585762258|FG000|Overall Study|Pregnancy|0|||
162194437|NCT01358175|585762259|FG001|Overall Study|Pregnancy|1|||
162194438|NCT01358175|585762260|FG002|Overall Study|Pregnancy|0|||
162194439|NCT01358175|585762258|FG000|Overall Study|Physician Decision|1|||
162194440|NCT01358175|585762259|FG001|Overall Study|Physician Decision|0|||
162194441|NCT01358175|585762260|FG002|Overall Study|Physician Decision|0|||
162194442|NCT01358175|585762258|FG000|Overall Study|Non Compliance with Study Treatment|0|||
162194443|NCT01358175|585762259|FG001|Overall Study|Non Compliance with Study Treatment|1|||
162194444|NCT01358175|585762260|FG002|Overall Study|Non Compliance with Study Treatment|1|||
162194445|NCT01358175|585762258|FG000|Overall Study|Lost to Follow-up|1|||
162194446|NCT01358175|585762259|FG001|Overall Study|Lost to Follow-up|1|||
162194447|NCT01358175|585762260|FG002|Overall Study|Lost to Follow-up|3|||
162194448|NCT01358175|585762258|FG000|Overall Study|Lack of Efficacy|3|||
162194449|NCT01358175|585762259|FG001|Overall Study|Lack of Efficacy|8|||
162194450|NCT01358175|585762260|FG002|Overall Study|Lack of Efficacy|6|||
162194451|NCT01358175|585762258|FG000|Overall Study|Adverse Event|6|||
162194452|NCT01358175|585762259|FG001|Overall Study|Adverse Event|11|||
162194453|NCT01358175|585762260|FG002|Overall Study|Adverse Event|11|||
162194454|NCT04908488|585762261|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
162194455|NCT04908488|585762262|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
162194456|NCT04908488|585762261|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
162194457|NCT04908488|585762262|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
162194458|NCT01107912|585762263|FG000|Period 1|Adverse Event|0|||
162194459|NCT01107912|585762264|FG001|Period 1|Adverse Event|0|||
161674185|NCT00594516|583861849|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
162194460|NCT01107912|585762265|FG002|Period 1|Adverse Event|0|||
162194461|NCT01107912|585762266|FG003|Period 1|Adverse Event|0|||
162194462|NCT01107912|585762267|FG004|Period 1|Adverse Event|2|||
162194463|NCT01107912|585762268|FG005|Period 1|Adverse Event|0|||
161674186|NCT00594516|583861847|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
161674187|NCT00594516|583861848|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
161674188|NCT00594516|583861849|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
162194464|NCT01107912|585762263|FG000|Period 1|Physician Decision|0|||
162194465|NCT01107912|585762264|FG001|Period 1|Physician Decision|0|||
162194466|NCT01107912|585762265|FG002|Period 1|Physician Decision|0|||
162194467|NCT01107912|585762266|FG003|Period 1|Physician Decision|0|||
162194468|NCT01107912|585762267|FG004|Period 1|Physician Decision|1|||
162194469|NCT01107912|585762268|FG005|Period 1|Physician Decision|0|||
162194470|NCT01107912|585762263|FG000|Period 1|Withdrawal by Subject|1|||
162194471|NCT01107912|585762264|FG001|Period 1|Withdrawal by Subject|0|||
162194472|NCT01107912|585762265|FG002|Period 1|Withdrawal by Subject|0|||
161674189|NCT00594516|583861847|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
161674190|NCT00594516|583861848|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
161674191|NCT00594516|583861849|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
161674192|NCT00594516|583861847|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
161674193|NCT00594516|583861848|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
161674194|NCT00594516|583861849|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
161674195|NCT00594516|583861847|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
161674196|NCT00594516|583861848|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
161674197|NCT00594516|583861849|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
161674198|NCT00594516|583861847|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
161674199|NCT00594516|583861848|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
161674200|NCT00594516|583861849|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
161925748|NCT00504231|584774594|FG003|Overall Study|Discrepant chart documentation re route|0|||
161925749|NCT02316613|584774598|FG000|Overall Study|Death|63|||
161925750|NCT02316613|584774598|FG000|Overall Study|Lost to Follow-up|9|||
161925751|NCT02316613|584774598|FG000|Overall Study|Lymphoma transformation|2|||
161925752|NCT02316613|584774598|FG000|Overall Study|Participant moved/changed medical team|11|||
161925753|NCT02316613|584774598|FG000|Overall Study|No data and duplicate cases|5|||
161925754|NCT02316613|584774598|FG000|Overall Study|Did not met selection criteria|14|||
161925755|NCT05788328|584774606|FG000|Treatment Period 4 (5 Days)|Other|1|||
161925756|NCT05788328|584774606|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
161925757|NCT02082483|584774607|FG000|Overall Study|Lost to Follow-up|1|||
161925758|NCT02082483|584774608|FG001|Overall Study|Lost to Follow-up|1|||
161925759|NCT02082483|584774607|FG000|Overall Study|Withdrawal by Subject|2|||
162194473|NCT01107912|585762266|FG003|Period 1|Withdrawal by Subject|0|||
162194474|NCT01107912|585762267|FG004|Period 1|Withdrawal by Subject|0|||
162194475|NCT01107912|585762268|FG005|Period 1|Withdrawal by Subject|0|||
162194476|NCT01107912|585762263|FG000|Period 2|Physician Decision|0|||
162194477|NCT01107912|585762264|FG001|Period 2|Physician Decision|0|||
162194478|NCT01107912|585762265|FG002|Period 2|Physician Decision|1|||
162194479|NCT01107912|585762266|FG003|Period 2|Physician Decision|0|||
162194480|NCT01107912|585762267|FG004|Period 2|Physician Decision|0|||
162194481|NCT01107912|585762268|FG005|Period 2|Physician Decision|0|||
162194482|NCT01107912|585762263|FG000|Period 3|Adverse Event|0|||
162194483|NCT01107912|585762264|FG001|Period 3|Adverse Event|1|||
161674201|NCT00594516|583861847|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
161674202|NCT00594516|583861848|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
161925760|NCT02082483|584774608|FG001|Overall Study|Withdrawal by Subject|1|||
161925761|NCT02082483|584774607|FG000|Overall Study|Physician Decision|1|||
161925762|NCT02082483|584774608|FG001|Overall Study|Physician Decision|1|||
161925763|NCT02082483|584774607|FG000|Overall Study|Death|2|||
161925764|NCT02082483|584774608|FG001|Overall Study|Death|3|||
161925765|NCT00422461|584774609|FG000|Overall Study|Adverse Event|1|||
162194484|NCT01107912|585762265|FG002|Period 3|Adverse Event|1|||
162194485|NCT01107912|585762266|FG003|Period 3|Adverse Event|0|||
162194486|NCT01107912|585762267|FG004|Period 3|Adverse Event|0|||
162194487|NCT01107912|585762268|FG005|Period 3|Adverse Event|0|||
162194488|NCT01107912|585762263|FG000|Period 3|Withdrawal by Subject|0|||
162194489|NCT01107912|585762264|FG001|Period 3|Withdrawal by Subject|0|||
162194490|NCT01107912|585762265|FG002|Period 3|Withdrawal by Subject|0|||
162194491|NCT01107912|585762266|FG003|Period 3|Withdrawal by Subject|1|||
162194492|NCT01107912|585762267|FG004|Period 3|Withdrawal by Subject|0|||
162194493|NCT01107912|585762268|FG005|Period 3|Withdrawal by Subject|0|||
162194494|NCT03875729|585762273|FG000|Overall Study|Adverse Event|0|||
161683065|NCT01444742|583891225|FG000|Overall Study|Death|1|||
161925766|NCT00422461|584774610|FG001|Overall Study|Adverse Event|2|||
161925767|NCT00422461|584774611|FG002|Overall Study|Adverse Event|1|||
161925768|NCT00422461|584774612|FG003|Overall Study|Adverse Event|1|||
162194495|NCT03875729|585762274|FG001|Overall Study|Adverse Event|5|||
162194496|NCT03875729|585762273|FG000|Overall Study|Withdrawal by Subject|8|||
162194497|NCT03875729|585762274|FG001|Overall Study|Withdrawal by Subject|11|||
161925769|NCT00422461|584774609|FG000|Overall Study|Other|0|||
161925770|NCT00422461|584774610|FG001|Overall Study|Other|0|||
162194498|NCT03875729|585762273|FG000|Overall Study|Pregnancy|0|||
162194499|NCT03875729|585762274|FG001|Overall Study|Pregnancy|1|||
162194500|NCT03875729|585762273|FG000|Overall Study|Lost to Follow-up|0|||
162194501|NCT03875729|585762274|FG001|Overall Study|Lost to Follow-up|5|||
162194502|NCT03875729|585762273|FG000|Overall Study|Personal reasons|2|||
162194503|NCT03875729|585762274|FG001|Overall Study|Personal reasons|0|||
162194504|NCT00753896|585762275|FG000|Overall Study|Adverse Event|4|||
162194505|NCT00753896|585762275|FG000|Overall Study|Death|1|||
162194506|NCT00753896|585762275|FG000|Overall Study|Lost to Follow-up|2|||
162194507|NCT00753896|585762275|FG000|Overall Study|Protocol Violation|1|||
162194508|NCT00753896|585762275|FG000|Overall Study|Withdrawal by Subject|4|||
162194509|NCT00753896|585762275|FG000|Overall Study|Entry Criteria Not Met|4|||
162194510|NCT01280656|585762276|FG000|Overall Study|Adverse Event|1|||
162194511|NCT01280656|585762277|FG001|Overall Study|Adverse Event|14|||
162194512|NCT01280656|585762278|FG002|Overall Study|Adverse Event|13|||
162194513|NCT01280656|585762276|FG000|Overall Study|Lack of Efficacy|1|||
162194514|NCT01280656|585762277|FG001|Overall Study|Lack of Efficacy|22|||
162194515|NCT01280656|585762278|FG002|Overall Study|Lack of Efficacy|38|||
162194516|NCT01280656|585762276|FG000|Overall Study|Treatment shortening (RGT)|0|||
162194517|NCT01280656|585762277|FG001|Overall Study|Treatment shortening (RGT)|4|||
162194518|NCT01280656|585762278|FG002|Overall Study|Treatment shortening (RGT)|5|||
162194519|NCT01280656|585762276|FG000|Overall Study|Other|1|||
162194520|NCT01280656|585762277|FG001|Overall Study|Other|7|||
162194521|NCT01280656|585762278|FG002|Overall Study|Other|7|||
161925771|NCT00422461|584774611|FG002|Overall Study|Other|0|||
162194522|NCT00952523|585762279|FG000|Overall Study|Withdrawal by Subject|7|||
162194523|NCT01029925|585762280|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
162194524|NCT01029925|585762280|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
162194525|NCT01029925|585762280|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
162194526|NCT05265247|585762281|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
162194527|NCT05265247|585762282|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
162194528|NCT05265247|585762281|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
162194529|NCT05265247|585762282|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
162194530|NCT05265247|585762281|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
162194531|NCT05265247|585762282|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
162194532|NCT00476957|585762283|FG000|Overall Study|Lost to Follow-up|176|||
162194533|NCT00476957|585762284|FG001|Overall Study|Lost to Follow-up|193|||
162194534|NCT02516202|585762285|FG000|Overall Study|Withdrawal by Subject|1|||
162194535|NCT02516202|585762286|FG001|Overall Study|Withdrawal by Subject|0|||
162194536|NCT02516202|585762287|FG002|Overall Study|Withdrawal by Subject|1|||
162194537|NCT02516202|585762285|FG000|Overall Study|Lost to Follow-up|1|||
162194538|NCT02516202|585762286|FG001|Overall Study|Lost to Follow-up|1|||
162194539|NCT02516202|585762287|FG002|Overall Study|Lost to Follow-up|1|||
162194540|NCT02516202|585762285|FG000|Overall Study|Stopped Follow-up|0|||
162194541|NCT02516202|585762286|FG001|Overall Study|Stopped Follow-up|0|||
162194542|NCT02516202|585762287|FG002|Overall Study|Stopped Follow-up|1|||
162194543|NCT01000649|585762290|FG000|Overall Study|Adverse Event|5|||
162194544|NCT01000649|585762291|FG001|Overall Study|Adverse Event|1|||
162194545|NCT01000649|585762292|FG002|Overall Study|Adverse Event|2|||
162194546|NCT01000649|585762293|FG003|Overall Study|Adverse Event|4|||
162194547|NCT01000649|585762290|FG000|Overall Study|Lost to Follow-up|0|||
162194548|NCT01000649|585762291|FG001|Overall Study|Lost to Follow-up|2|||
162194549|NCT01000649|585762292|FG002|Overall Study|Lost to Follow-up|0|||
162194550|NCT01000649|585762293|FG003|Overall Study|Lost to Follow-up|2|||
162194551|NCT01916109|585762294|FG000|Overall Study|Withdrawal by Subject|1|||
162194552|NCT00103857|585762295|FG000|54-Week Base Study|Adverse Event|12|||
162194553|NCT00103857|585762296|FG001|54-Week Base Study|Adverse Event|9|||
162194554|NCT00103857|585762297|FG002|54-Week Base Study|Adverse Event|11|||
162194555|NCT00103857|585762298|FG003|54-Week Base Study|Adverse Event|6|||
162194556|NCT00103857|585762299|FG004|54-Week Base Study|Adverse Event|5|||
162194557|NCT00103857|585762300|FG005|54-Week Base Study|Adverse Event|11|||
161925772|NCT00422461|584774612|FG003|Overall Study|Other|2|||
161925773|NCT00422461|584774609|FG000|Overall Study|Participants no longer willing to participate in study|1|||
162194558|NCT00103857|585762301|FG006|54-Week Base Study|Adverse Event|3|||
162194559|NCT00103857|585762295|FG000|54-Week Base Study|Death|0|||
162194560|NCT00103857|585762296|FG001|54-Week Base Study|Death|0|||
162194561|NCT00103857|585762297|FG002|54-Week Base Study|Death|0|||
162194562|NCT00103857|585762298|FG003|54-Week Base Study|Death|0|||
162194563|NCT00103857|585762299|FG004|54-Week Base Study|Death|1|||
162194564|NCT00103857|585762300|FG005|54-Week Base Study|Death|1|||
162194565|NCT00103857|585762301|FG006|54-Week Base Study|Death|0|||
162194566|NCT00103857|585762295|FG000|54-Week Base Study|Lack of Efficacy|11|||
161674203|NCT00594516|583861849|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
161674204|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
162194567|NCT00103857|585762296|FG001|54-Week Base Study|Lack of Efficacy|14|||
162194568|NCT00103857|585762297|FG002|54-Week Base Study|Lack of Efficacy|8|||
162194569|NCT00103857|585762298|FG003|54-Week Base Study|Lack of Efficacy|4|||
162194570|NCT00103857|585762299|FG004|54-Week Base Study|Lack of Efficacy|3|||
162194571|NCT00103857|585762300|FG005|54-Week Base Study|Lack of Efficacy|14|||
162194572|NCT00103857|585762301|FG006|54-Week Base Study|Lack of Efficacy|19|||
162194573|NCT00103857|585762295|FG000|54-Week Base Study|Lost to Follow-up|5|||
162194574|NCT00103857|585762296|FG001|54-Week Base Study|Lost to Follow-up|4|||
162194575|NCT00103857|585762297|FG002|54-Week Base Study|Lost to Follow-up|7|||
161674205|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
161674206|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
161674207|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
161674208|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
161674209|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
161674210|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
161674211|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
161674212|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
161674213|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
161674214|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
161674215|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
161674216|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
161674217|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
161674218|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
161674219|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
161674220|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
161674221|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
162194576|NCT00103857|585762298|FG003|54-Week Base Study|Lost to Follow-up|5|||
161674222|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Early termination|0|||
161674223|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Early termination|0|||
161674224|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Early termination|34|||
161674225|NCT01493557|583861850|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
161674226|NCT01493557|583861851|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
161674227|NCT01493557|583861852|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
161674228|NCT01493557|583861850|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
161674229|NCT01493557|583861851|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
161674230|NCT01493557|583861852|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
161674231|NCT01493557|583861850|FG000|Randomized to Management Strategies|Other adverse event|8|||
161674232|NCT01493557|583861851|FG001|Randomized to Management Strategies|Other adverse event|5|||
161674233|NCT01493557|583861852|FG002|Randomized to Management Strategies|Other adverse event|0|||
161674234|NCT01493557|583861850|FG000|Randomized to Management Strategies|Protocol Violation|3|||
161674235|NCT01493557|583861851|FG001|Randomized to Management Strategies|Protocol Violation|0|||
161674236|NCT01493557|583861852|FG002|Randomized to Management Strategies|Protocol Violation|0|||
161674237|NCT01493557|583861850|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
161674238|NCT01493557|583861851|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
161674239|NCT01493557|583861852|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
161674240|NCT01493557|583861850|FG000|Randomized to Management Strategies|Other than stated above|1|||
161674241|NCT01493557|583861851|FG001|Randomized to Management Strategies|Other than stated above|3|||
161674242|NCT01493557|583861852|FG002|Randomized to Management Strategies|Other than stated above|0|||
161674243|NCT01493557|583861850|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
161674244|NCT01493557|583861851|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
161674245|NCT01493557|583861852|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
161674246|NCT01493557|583861850|FG000|Adding the Second Strategy|Other adverse event|1|||
161674247|NCT01493557|583861851|FG001|Adding the Second Strategy|Other adverse event|2|||
161674248|NCT01493557|583861852|FG002|Adding the Second Strategy|Other adverse event|0|||
161674249|NCT01493557|583861850|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
161674250|NCT01493557|583861851|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
161820112|NCT03291067|584382713|FG002|Overall Study|Protocol Violation|4|||
161820113|NCT03291067|584382714|FG003|Overall Study|Protocol Violation|2|||
161820114|NCT03291067|584382711|FG000|Overall Study|Withdrawal by Subject|3|||
161820115|NCT03291067|584382712|FG001|Overall Study|Withdrawal by Subject|4|||
161820116|NCT03291067|584382713|FG002|Overall Study|Withdrawal by Subject|7|||
161820117|NCT03291067|584382714|FG003|Overall Study|Withdrawal by Subject|5|||
161820118|NCT03291067|584382711|FG000|Overall Study|Other|0|||
161674251|NCT01493557|583861852|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
161674252|NCT02973425|583861853|FG000|Overall Study|Lost to Follow-up|49|||
161674253|NCT02973425|583861854|FG001|Overall Study|Lost to Follow-up|53|||
161674254|NCT03823404|583861855|FG000|Overall Study|Lost to Follow-up|1|||
161674255|NCT03823404|583861856|FG001|Overall Study|Lost to Follow-up|2|||
161674256|NCT03823404|583861857|FG002|Overall Study|Lost to Follow-up|3|||
161674257|NCT03823404|583861855|FG000|Overall Study|Protocol Violation|2|||
161674258|NCT03823404|583861856|FG001|Overall Study|Protocol Violation|0|||
161674259|NCT03823404|583861857|FG002|Overall Study|Protocol Violation|2|||
161674260|NCT03823404|583861855|FG000|Overall Study|Adverse Event|35|||
161674261|NCT03823404|583861856|FG001|Overall Study|Adverse Event|38|||
161674262|NCT03823404|583861857|FG002|Overall Study|Adverse Event|8|||
161674263|NCT03823404|583861855|FG000|Overall Study|Withdrawal by Subject|38|||
161674264|NCT03823404|583861856|FG001|Overall Study|Withdrawal by Subject|40|||
161674265|NCT03823404|583861857|FG002|Overall Study|Withdrawal by Subject|35|||
161674266|NCT03823404|583861855|FG000|Overall Study|Death|4|||
161674267|NCT03823404|583861856|FG001|Overall Study|Death|0|||
161674268|NCT03823404|583861857|FG002|Overall Study|Death|0|||
162020209|NCT05064358|585128624|FG002|Overall Study|Lost to Follow-up|0|||
161674269|NCT03823404|583861855|FG000|Overall Study|Other: Various reasons provided|5|||
161674270|NCT03823404|583861856|FG001|Overall Study|Other: Various reasons provided|5|||
161674271|NCT03823404|583861857|FG002|Overall Study|Other: Various reasons provided|6|||
161820119|NCT03291067|584382712|FG001|Overall Study|Other|4|||
161820120|NCT03291067|584382713|FG002|Overall Study|Other|4|||
161820121|NCT03291067|584382714|FG003|Overall Study|Other|6|||
161820122|NCT01520987|584382722|FG000|Overall Study|Withdrawal by Subject|1|||
161820123|NCT01520987|584382723|FG001|Overall Study|Withdrawal by Subject|0|||
161820124|NCT01520987|584382724|FG002|Overall Study|Withdrawal by Subject|0|||
161820125|NCT01520987|584382725|FG003|Overall Study|Withdrawal by Subject|0|||
161820126|NCT01520987|584382726|FG004|Overall Study|Withdrawal by Subject|0|||
161820127|NCT01520987|584382727|FG005|Overall Study|Withdrawal by Subject|1|||
161820128|NCT01520987|584382728|FG006|Overall Study|Withdrawal by Subject|0|||
161820129|NCT01520987|584382729|FG007|Overall Study|Withdrawal by Subject|0|||
161820130|NCT02005562|584382730|FG000|Overall Study|Death|2|||
161820131|NCT02005562|584382731|FG001|Overall Study|Death|2|||
161820132|NCT02005562|584382730|FG000|Overall Study|Graft loss|7|||
161820133|NCT02005562|584382731|FG001|Overall Study|Graft loss|6|||
161820134|NCT02005562|584382730|FG000|Overall Study|Withdrawal by Subject|2|||
161820135|NCT02005562|584382731|FG001|Overall Study|Withdrawal by Subject|2|||
161820136|NCT02005562|584382730|FG000|Overall Study|No transplant|1|||
161820137|NCT02005562|584382731|FG001|Overall Study|No transplant|4|||
161820138|NCT02005562|584382730|FG000|Overall Study|Physician Decision|0|||
161820139|NCT02005562|584382731|FG001|Overall Study|Physician Decision|1|||
161820140|NCT00660387|584382732|FG000|Overall Study|Adverse Event|1|||
161820141|NCT00660387|584382733|FG001|Overall Study|Adverse Event|2|||
161820142|NCT00660387|584382732|FG000|Overall Study|Lack of Efficacy|0|||
161820143|NCT00660387|584382733|FG001|Overall Study|Lack of Efficacy|1|||
161820144|NCT00660387|584382732|FG000|Overall Study|Protocol Violation|1|||
161820145|NCT00660387|584382733|FG001|Overall Study|Protocol Violation|0|||
161820146|NCT03086135|584382734|FG000|Overall Study|Adverse Event|1|||
161820147|NCT03086135|584382734|FG000|Overall Study|Lost to Follow-up|2|||
161820148|NCT01023061|584382735|FG000|Overall Study|Withdrawal prior to treatment|2|||
161820149|NCT02966340|584382736|FG000|Overall Study|Adverse Event|0|||
161820150|NCT02966340|584382737|FG001|Overall Study|Adverse Event|1|||
161820151|NCT02966340|584382736|FG000|Overall Study|Lost to Follow-up|0|||
161820152|NCT02966340|584382737|FG001|Overall Study|Lost to Follow-up|1|||
161820153|NCT02966340|584382736|FG000|Overall Study|Withdrawal by Subject|1|||
161820154|NCT02966340|584382737|FG001|Overall Study|Withdrawal by Subject|0|||
161820155|NCT02966340|584382736|FG000|Overall Study|data acquisition error|1|||
161820156|NCT02966340|584382737|FG001|Overall Study|data acquisition error|0|||
161820157|NCT02966340|584382736|FG000|Overall Study|startle non-responder|1|||
161820158|NCT02966340|584382737|FG001|Overall Study|startle non-responder|1|||
161820159|NCT04768296|584382739|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
161820160|NCT04768296|584382740|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
162194577|NCT00103857|585762299|FG004|54-Week Base Study|Lost to Follow-up|10|||
162194578|NCT00103857|585762300|FG005|54-Week Base Study|Lost to Follow-up|9|||
162194579|NCT00103857|585762301|FG006|54-Week Base Study|Lost to Follow-up|3|||
162194580|NCT00103857|585762295|FG000|54-Week Base Study|Physician Decision|1|||
162194581|NCT00103857|585762296|FG001|54-Week Base Study|Physician Decision|1|||
162194582|NCT00103857|585762297|FG002|54-Week Base Study|Physician Decision|0|||
162194583|NCT00103857|585762298|FG003|54-Week Base Study|Physician Decision|0|||
162194584|NCT00103857|585762299|FG004|54-Week Base Study|Physician Decision|1|||
162194585|NCT00103857|585762300|FG005|54-Week Base Study|Physician Decision|0|||
162194586|NCT00103857|585762301|FG006|54-Week Base Study|Physician Decision|0|||
161820161|NCT00255346|584382747|FG000|Overall Study|Adverse Event|1|||
161820162|NCT00255346|584382748|FG001|Overall Study|Adverse Event|0|||
161820163|NCT00255346|584382749|FG002|Overall Study|Adverse Event|0|||
161820164|NCT00255346|584382750|FG003|Overall Study|Adverse Event|0|||
161820165|NCT00255346|584382751|FG004|Overall Study|Adverse Event|0|||
161820166|NCT04402489|584382757|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
161820167|NCT04402489|584382758|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
161820168|NCT04402489|584382759|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
161820169|NCT04402489|584382760|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
161820170|NCT04402489|584382761|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
161820171|NCT04402489|584382757|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
161820172|NCT04402489|584382758|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
161820173|NCT04402489|584382759|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
161820174|NCT04402489|584382760|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
162020210|NCT05064358|585128625|FG003|Overall Study|Lost to Follow-up|2|||
161820175|NCT04402489|584382761|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
161820176|NCT04402489|584382757|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
161820177|NCT04402489|584382758|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
161820178|NCT04402489|584382759|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
161820179|NCT04402489|584382760|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
161820180|NCT04402489|584382761|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
162194587|NCT00103857|585762295|FG000|54-Week Base Study|Pregnancy|1|||
161674272|NCT01524133|583861860|FG000|Treatment Phase|Withdrawal by Subject|13|||
161674273|NCT01524133|583861861|FG001|Treatment Phase|Withdrawal by Subject|28|||
161674274|NCT01524133|583861862|FG002|Treatment Phase|Withdrawal by Subject|31|||
161674275|NCT01524133|583861860|FG000|Treatment Phase|Physician Decision|6|||
162194588|NCT00103857|585762296|FG001|54-Week Base Study|Pregnancy|0|||
162194589|NCT00103857|585762297|FG002|54-Week Base Study|Pregnancy|0|||
162194590|NCT00103857|585762298|FG003|54-Week Base Study|Pregnancy|0|||
162194591|NCT00103857|585762299|FG004|54-Week Base Study|Pregnancy|1|||
162194592|NCT00103857|585762300|FG005|54-Week Base Study|Pregnancy|0|||
162194593|NCT00103857|585762301|FG006|54-Week Base Study|Pregnancy|1|||
162194594|NCT00103857|585762295|FG000|54-Week Base Study|Protocol Violation|6|||
162194595|NCT00103857|585762296|FG001|54-Week Base Study|Protocol Violation|4|||
162194596|NCT00103857|585762297|FG002|54-Week Base Study|Protocol Violation|2|||
162194597|NCT00103857|585762298|FG003|54-Week Base Study|Protocol Violation|4|||
162194598|NCT00103857|585762299|FG004|54-Week Base Study|Protocol Violation|0|||
162194599|NCT00103857|585762300|FG005|54-Week Base Study|Protocol Violation|3|||
162194600|NCT00103857|585762301|FG006|54-Week Base Study|Protocol Violation|3|||
162194601|NCT00103857|585762295|FG000|54-Week Base Study|Withdrawal by Subject|17|||
162194602|NCT00103857|585762296|FG001|54-Week Base Study|Withdrawal by Subject|16|||
162194603|NCT00103857|585762297|FG002|54-Week Base Study|Withdrawal by Subject|16|||
162194604|NCT00103857|585762298|FG003|54-Week Base Study|Withdrawal by Subject|15|||
162194605|NCT00103857|585762299|FG004|54-Week Base Study|Withdrawal by Subject|10|||
162194606|NCT00103857|585762300|FG005|54-Week Base Study|Withdrawal by Subject|15|||
162194607|NCT00103857|585762301|FG006|54-Week Base Study|Withdrawal by Subject|4|||
162194608|NCT00103857|585762295|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
162194609|NCT00103857|585762296|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
162194610|NCT00103857|585762297|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
162194611|NCT00103857|585762298|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
162194612|NCT00103857|585762299|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
162194613|NCT00103857|585762300|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
162194614|NCT00103857|585762301|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
162194615|NCT00103857|585762295|FG000|54-Week Base Study|patient moved|0|||
162194616|NCT00103857|585762296|FG001|54-Week Base Study|patient moved|1|||
162194617|NCT00103857|585762297|FG002|54-Week Base Study|patient moved|1|||
162194618|NCT00103857|585762298|FG003|54-Week Base Study|patient moved|2|||
162194619|NCT00103857|585762299|FG004|54-Week Base Study|patient moved|3|||
162194620|NCT00103857|585762300|FG005|54-Week Base Study|patient moved|1|||
162194621|NCT00103857|585762301|FG006|54-Week Base Study|patient moved|0|||
162194622|NCT00103857|585762295|FG000|54-Week Base Study|non-compliance with study procedures|1|||
162194623|NCT00103857|585762296|FG001|54-Week Base Study|non-compliance with study procedures|2|||
162194624|NCT00103857|585762297|FG002|54-Week Base Study|non-compliance with study procedures|0|||
162194625|NCT00103857|585762298|FG003|54-Week Base Study|non-compliance with study procedures|0|||
162194626|NCT00103857|585762299|FG004|54-Week Base Study|non-compliance with study procedures|0|||
162194627|NCT00103857|585762300|FG005|54-Week Base Study|non-compliance with study procedures|2|||
162194628|NCT00103857|585762301|FG006|54-Week Base Study|non-compliance with study procedures|0|||
162194629|NCT00103857|585762295|FG000|54-Week Base Study|patient incarcerated|0|||
162194630|NCT00103857|585762296|FG001|54-Week Base Study|patient incarcerated|0|||
162194631|NCT00103857|585762297|FG002|54-Week Base Study|patient incarcerated|0|||
162194632|NCT00103857|585762298|FG003|54-Week Base Study|patient incarcerated|0|||
162194633|NCT00103857|585762299|FG004|54-Week Base Study|patient incarcerated|1|||
162194634|NCT00103857|585762300|FG005|54-Week Base Study|patient incarcerated|1|||
162194635|NCT00103857|585762301|FG006|54-Week Base Study|patient incarcerated|0|||
162194636|NCT00103857|585762295|FG000|54-Week Base Study|laboratory reporting error|0|||
162194637|NCT00103857|585762296|FG001|54-Week Base Study|laboratory reporting error|0|||
162194638|NCT00103857|585762297|FG002|54-Week Base Study|laboratory reporting error|0|||
162194639|NCT00103857|585762298|FG003|54-Week Base Study|laboratory reporting error|0|||
162194640|NCT00103857|585762299|FG004|54-Week Base Study|laboratory reporting error|1|||
162194641|NCT00103857|585762300|FG005|54-Week Base Study|laboratory reporting error|0|||
162194642|NCT00103857|585762301|FG006|54-Week Base Study|laboratory reporting error|0|||
162194643|NCT00103857|585762295|FG000|54-Week Base Study|site error|0|||
162194644|NCT00103857|585762296|FG001|54-Week Base Study|site error|0|||
162194645|NCT00103857|585762297|FG002|54-Week Base Study|site error|0|||
161674276|NCT01524133|583861861|FG001|Treatment Phase|Physician Decision|3|||
162194646|NCT00103857|585762298|FG003|54-Week Base Study|site error|0|||
162194647|NCT00103857|585762299|FG004|54-Week Base Study|site error|0|||
161674277|NCT01524133|583861862|FG002|Treatment Phase|Physician Decision|3|||
162194648|NCT00103857|585762300|FG005|54-Week Base Study|site error|1|||
162194649|NCT00103857|585762301|FG006|54-Week Base Study|site error|0|||
162194650|NCT00103857|585762295|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
162194651|NCT00103857|585762296|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
162194652|NCT00103857|585762297|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
162194653|NCT00103857|585762298|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
161674278|NCT01524133|583861860|FG000|Treatment Phase|Lost to Follow-up|0|||
162194654|NCT00103857|585762299|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
162194655|NCT00103857|585762300|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
162194656|NCT00103857|585762301|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
162194657|NCT00103857|585762295|FG000|50-Week Extension Study|Adverse Event|2|||
162194658|NCT00103857|585762296|FG001|50-Week Extension Study|Adverse Event|3|||
162194659|NCT00103857|585762297|FG002|50-Week Extension Study|Adverse Event|2|||
162194660|NCT00103857|585762298|FG003|50-Week Extension Study|Adverse Event|0|||
162194661|NCT00103857|585762299|FG004|50-Week Extension Study|Adverse Event|1|||
162194662|NCT00103857|585762300|FG005|50-Week Extension Study|Adverse Event|1|||
162194663|NCT00103857|585762301|FG006|50-Week Extension Study|Adverse Event|0|||
162194664|NCT00103857|585762295|FG000|50-Week Extension Study|Death|0|||
162194665|NCT00103857|585762296|FG001|50-Week Extension Study|Death|0|||
162194666|NCT00103857|585762297|FG002|50-Week Extension Study|Death|0|||
162194667|NCT00103857|585762298|FG003|50-Week Extension Study|Death|1|||
162194668|NCT00103857|585762299|FG004|50-Week Extension Study|Death|0|||
162194669|NCT00103857|585762300|FG005|50-Week Extension Study|Death|1|||
162194670|NCT00103857|585762301|FG006|50-Week Extension Study|Death|0|||
162194671|NCT00103857|585762295|FG000|50-Week Extension Study|Lack of Efficacy|26|||
162194672|NCT00103857|585762296|FG001|50-Week Extension Study|Lack of Efficacy|15|||
162194673|NCT00103857|585762297|FG002|50-Week Extension Study|Lack of Efficacy|13|||
162194674|NCT00103857|585762298|FG003|50-Week Extension Study|Lack of Efficacy|16|||
162194675|NCT00103857|585762299|FG004|50-Week Extension Study|Lack of Efficacy|8|||
162194676|NCT00103857|585762300|FG005|50-Week Extension Study|Lack of Efficacy|8|||
162194677|NCT00103857|585762301|FG006|50-Week Extension Study|Lack of Efficacy|0|||
162194678|NCT00103857|585762295|FG000|50-Week Extension Study|Lost to Follow-up|4|||
162194679|NCT00103857|585762296|FG001|50-Week Extension Study|Lost to Follow-up|0|||
162194680|NCT00103857|585762297|FG002|50-Week Extension Study|Lost to Follow-up|1|||
161820181|NCT04402489|584382757|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
162194681|NCT00103857|585762298|FG003|50-Week Extension Study|Lost to Follow-up|4|||
162194682|NCT00103857|585762299|FG004|50-Week Extension Study|Lost to Follow-up|3|||
162194683|NCT00103857|585762300|FG005|50-Week Extension Study|Lost to Follow-up|3|||
161820182|NCT04402489|584382758|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
162194684|NCT00103857|585762301|FG006|50-Week Extension Study|Lost to Follow-up|0|||
162194685|NCT00103857|585762295|FG000|50-Week Extension Study|Physician Decision|0|||
162194686|NCT00103857|585762296|FG001|50-Week Extension Study|Physician Decision|1|||
162194687|NCT00103857|585762297|FG002|50-Week Extension Study|Physician Decision|1|||
162194688|NCT00103857|585762298|FG003|50-Week Extension Study|Physician Decision|0|||
162194689|NCT00103857|585762299|FG004|50-Week Extension Study|Physician Decision|0|||
162194690|NCT00103857|585762300|FG005|50-Week Extension Study|Physician Decision|0|||
162194691|NCT00103857|585762301|FG006|50-Week Extension Study|Physician Decision|0|||
162194692|NCT00103857|585762295|FG000|50-Week Extension Study|Pregnancy|0|||
162194693|NCT00103857|585762296|FG001|50-Week Extension Study|Pregnancy|0|||
162194694|NCT00103857|585762297|FG002|50-Week Extension Study|Pregnancy|1|||
162194695|NCT00103857|585762298|FG003|50-Week Extension Study|Pregnancy|0|||
162194696|NCT00103857|585762299|FG004|50-Week Extension Study|Pregnancy|1|||
162194697|NCT00103857|585762300|FG005|50-Week Extension Study|Pregnancy|0|||
162194698|NCT00103857|585762301|FG006|50-Week Extension Study|Pregnancy|0|||
162194699|NCT00103857|585762295|FG000|50-Week Extension Study|Protocol Violation|1|||
162194700|NCT00103857|585762296|FG001|50-Week Extension Study|Protocol Violation|1|||
162194701|NCT00103857|585762297|FG002|50-Week Extension Study|Protocol Violation|1|||
162194702|NCT00103857|585762298|FG003|50-Week Extension Study|Protocol Violation|2|||
162194703|NCT00103857|585762299|FG004|50-Week Extension Study|Protocol Violation|0|||
162194704|NCT00103857|585762300|FG005|50-Week Extension Study|Protocol Violation|1|||
162194705|NCT00103857|585762301|FG006|50-Week Extension Study|Protocol Violation|0|||
162194706|NCT00103857|585762295|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
162194707|NCT00103857|585762296|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
162194708|NCT00103857|585762297|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
162194709|NCT00103857|585762298|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
162194710|NCT00103857|585762299|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
162194711|NCT00103857|585762300|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
162194712|NCT00103857|585762301|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
162194713|NCT00103857|585762295|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
162194714|NCT00103857|585762296|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
162194715|NCT00103857|585762297|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
162194716|NCT00103857|585762298|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
162194717|NCT00103857|585762299|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
162194718|NCT00103857|585762300|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
162194719|NCT00103857|585762301|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
162194720|NCT00103857|585762295|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
162194721|NCT00103857|585762296|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
162194722|NCT00103857|585762297|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
161674279|NCT01524133|583861861|FG001|Treatment Phase|Lost to Follow-up|1|||
161674280|NCT01524133|583861862|FG002|Treatment Phase|Lost to Follow-up|2|||
161674281|NCT01524133|583861860|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
161674282|NCT01524133|583861861|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
161674283|NCT01524133|583861862|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
161674284|NCT01524133|583861860|FG000|Overall Study 52 Weeks|Physician Decision|1|||
161674285|NCT01524133|583861861|FG001|Overall Study 52 Weeks|Physician Decision|0|||
161674286|NCT01524133|583861862|FG002|Overall Study 52 Weeks|Physician Decision|2|||
161674287|NCT01524133|583861860|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
161674288|NCT01524133|583861861|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
161674289|NCT01524133|583861862|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
161674290|NCT01087957|583861863|FG000|Overall Study|Death|2|||
161674291|NCT01087957|583861864|FG001|Overall Study|Death|2|||
161674292|NCT01087957|583861863|FG000|Overall Study|Lost to Follow-up|3|||
161674293|NCT01087957|583861864|FG001|Overall Study|Lost to Follow-up|4|||
161674294|NCT01087957|583861863|FG000|Overall Study|Protocol Violation|13|||
161674295|NCT01087957|583861864|FG001|Overall Study|Protocol Violation|25|||
161674296|NCT01087957|583861863|FG000|Overall Study|Withdrawal by Subject|18|||
161674297|NCT01087957|583861864|FG001|Overall Study|Withdrawal by Subject|15|||
161674298|NCT01087957|583861863|FG000|Overall Study|Physician Decision|5|||
161674299|NCT01087957|583861864|FG001|Overall Study|Physician Decision|9|||
161674300|NCT02366728|583861865|FG000|Overall Study|Death|0|||
161674301|NCT02366728|583861866|FG001|Overall Study|Death|0|||
161674302|NCT02366728|583861867|FG002|Overall Study|Death|1|||
161674303|NCT02366728|583861865|FG000|Overall Study|Adverse Event|1|||
161674304|NCT02366728|583861866|FG001|Overall Study|Adverse Event|0|||
162194723|NCT00103857|585762298|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
162194724|NCT00103857|585762299|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
161674305|NCT02366728|583861867|FG002|Overall Study|Adverse Event|0|||
161674306|NCT02366728|583861865|FG000|Overall Study|Screen Failure|2|||
161674307|NCT02366728|583861866|FG001|Overall Study|Screen Failure|1|||
161674308|NCT02366728|583861867|FG002|Overall Study|Screen Failure|0|||
161674309|NCT02366728|583861865|FG000|Overall Study|Only yielded 2 vaccines|1|||
161674310|NCT02366728|583861866|FG001|Overall Study|Only yielded 2 vaccines|0|||
161674311|NCT02366728|583861867|FG002|Overall Study|Only yielded 2 vaccines|0|||
161674312|NCT00059839|583861869|FG000|Overall Study|Death|1|||
161674313|NCT00059839|583861870|FG001|Overall Study|Death|1|||
161674314|NCT00059839|583861869|FG000|Overall Study|Lack of Efficacy|6|||
161674315|NCT00059839|583861870|FG001|Overall Study|Lack of Efficacy|5|||
161674316|NCT00059839|583861869|FG000|Overall Study|Lost to Follow-up|2|||
161674317|NCT00059839|583861870|FG001|Overall Study|Lost to Follow-up|0|||
161674318|NCT00059839|583861869|FG000|Overall Study|Physician Decision|1|||
161674319|NCT00059839|583861870|FG001|Overall Study|Physician Decision|2|||
161674320|NCT00059839|583861869|FG000|Overall Study|Withdrawal by Subject|1|||
161674321|NCT00059839|583861870|FG001|Overall Study|Withdrawal by Subject|6|||
161674322|NCT00059839|583861869|FG000|Overall Study|Ineligible|1|||
161674323|NCT00059839|583861870|FG001|Overall Study|Ineligible|3|||
161674324|NCT03842163|583861871|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
161674325|NCT03842163|583861871|FG000|Overall Study|Scintigraphy was not performed|44|||
161674326|NCT03829241|583861875|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
161674327|NCT03829241|583861876|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
161674328|NCT03829241|583861875|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
161674329|NCT03829241|583861876|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
161674330|NCT03829241|583861875|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
161674331|NCT03829241|583861876|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
161674332|NCT03829241|583861875|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
161674333|NCT03829241|583861876|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
161674334|NCT03829241|583861875|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
161674335|NCT03829241|583861876|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
161674336|NCT03829241|583861875|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
161674337|NCT03829241|583861876|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
161674338|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
161674339|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
161674340|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
161674341|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
161674342|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
161674343|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
161674344|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
161674345|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
161674346|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
161674347|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
161674348|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
161674349|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
161674350|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
161674351|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
161674352|NCT03829241|583861875|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
161674353|NCT03829241|583861876|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
161674354|NCT00698451|583861877|FG000|Overall Study|Adverse Event|22|||
161674355|NCT00698451|583861877|FG000|Overall Study|Physician Decision|2|||
161674356|NCT00698451|583861877|FG000|Overall Study|Protocol Violation|6|||
161674357|NCT00698451|583861877|FG000|Overall Study|Withdrawal by Subject|6|||
161820183|NCT04402489|584382759|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
161820184|NCT04402489|584382760|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
161820185|NCT04402489|584382761|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
161820186|NCT04402489|584382757|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
161820187|NCT04402489|584382758|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
161820188|NCT04402489|584382759|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
161820189|NCT04402489|584382760|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
161820190|NCT04402489|584382761|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
161820191|NCT04402489|584382757|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
161820192|NCT04402489|584382758|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
161820193|NCT04402489|584382759|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
161820194|NCT04402489|584382760|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
161820195|NCT04402489|584382761|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
161820196|NCT03192891|584382762|FG000|Overall Study|Lost to Follow-up|55|||
161820197|NCT05223868|584382763|FG000|Overall Study|Lost to Follow-up|1|||
161820198|NCT05223868|584382764|FG001|Overall Study|Lost to Follow-up|3|||
161820199|NCT05223868|584382765|FG002|Overall Study|Lost to Follow-up|0|||
161820200|NCT05223868|584382766|FG003|Overall Study|Lost to Follow-up|0|||
161820201|NCT05223868|584382767|FG004|Overall Study|Lost to Follow-up|0|||
161820202|NCT05223868|584382768|FG005|Overall Study|Lost to Follow-up|1|||
161820203|NCT05223868|584382763|FG000|Overall Study|Withdrawal by Subject|6|||
161820204|NCT05223868|584382764|FG001|Overall Study|Withdrawal by Subject|2|||
161820205|NCT05223868|584382765|FG002|Overall Study|Withdrawal by Subject|3|||
161820206|NCT05223868|584382766|FG003|Overall Study|Withdrawal by Subject|1|||
161820207|NCT05223868|584382767|FG004|Overall Study|Withdrawal by Subject|1|||
161820208|NCT05223868|584382768|FG005|Overall Study|Withdrawal by Subject|2|||
161820209|NCT05223868|584382763|FG000|Overall Study|Other|0|||
161820210|NCT05223868|584382764|FG001|Overall Study|Other|2|||
161820211|NCT05223868|584382765|FG002|Overall Study|Other|0|||
161820212|NCT05223868|584382766|FG003|Overall Study|Other|0|||
161820213|NCT05223868|584382767|FG004|Overall Study|Other|1|||
161820214|NCT05223868|584382768|FG005|Overall Study|Other|1|||
162194725|NCT00103857|585762300|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
162194726|NCT00103857|585762301|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
162194727|NCT00103857|585762295|FG000|50-Week Extension Study|patient moved|0|||
162194728|NCT00103857|585762296|FG001|50-Week Extension Study|patient moved|0|||
162194729|NCT00103857|585762297|FG002|50-Week Extension Study|patient moved|1|||
161674358|NCT00698451|583861877|FG000|Overall Study|Disease progression|3|||
161674359|NCT02224599|583861880|FG000|Overall Study|Physician Decision|1|||
161674360|NCT02224599|583861880|FG000|Overall Study|Progression of Disease|1|||
161674361|NCT01330914|583861881|FG000|Overall Study|Withdrawal by Subject|4|||
161674362|NCT01330914|583861881|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
161674363|NCT05352048|583861886|FG000|Overall Study|Lost to Follow-up|1|||
161674364|NCT05352048|583861886|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
161674365|NCT03085758|583861887|FG000|Overall Study|Death|26|||
161674366|NCT03085758|583861888|FG001|Overall Study|Death|24|||
161674367|NCT03085758|583861889|FG002|Overall Study|Death|53|||
161674368|NCT03085758|583861887|FG000|Overall Study|Lost to Follow-up|1|||
161674369|NCT03085758|583861888|FG001|Overall Study|Lost to Follow-up|1|||
161674370|NCT03085758|583861889|FG002|Overall Study|Lost to Follow-up|1|||
161674371|NCT03085758|583861887|FG000|Overall Study|Withdrawal by Subject|2|||
161674372|NCT03085758|583861888|FG001|Overall Study|Withdrawal by Subject|2|||
161674373|NCT03085758|583861889|FG002|Overall Study|Withdrawal by Subject|1|||
161674374|NCT03085758|583861887|FG000|Overall Study|Refusal to recall it up to day 90|0|||
161674375|NCT03085758|583861888|FG001|Overall Study|Refusal to recall it up to day 90|0|||
161674376|NCT03085758|583861889|FG002|Overall Study|Refusal to recall it up to day 90|1|||
161674377|NCT03085758|583861887|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
161674378|NCT03085758|583861888|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
161820215|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161820216|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161820217|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161820218|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
161820219|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161820220|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161820221|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
161820222|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
161820223|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
162020211|NCT05064358|585128626|FG004|Overall Study|Lost to Follow-up|0|||
162194730|NCT00103857|585762298|FG003|50-Week Extension Study|patient moved|2|||
162194731|NCT00103857|585762299|FG004|50-Week Extension Study|patient moved|0|||
162194732|NCT00103857|585762300|FG005|50-Week Extension Study|patient moved|0|||
162194733|NCT00103857|585762301|FG006|50-Week Extension Study|patient moved|0|||
161674379|NCT03085758|583861889|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
161674380|NCT03974334|583861893|FG000|Overall Study|Lost to Follow-up|1|||
161674381|NCT00024167|583861894|FG000|Overall Study|Death|53|||
161674382|NCT00024167|583861895|FG001|Overall Study|Death|47|||
161674383|NCT01109173|583861896|FG000|Overall Study|Adverse Event|15|||
161674384|NCT01109173|583861897|FG001|Overall Study|Adverse Event|17|||
161674385|NCT01109173|583861898|FG002|Overall Study|Adverse Event|9|||
161674386|NCT01109173|583861899|FG003|Overall Study|Adverse Event|6|||
161674387|NCT01109173|583861896|FG000|Overall Study|Lost to Follow-up|0|||
161674388|NCT01109173|583861897|FG001|Overall Study|Lost to Follow-up|1|||
161674389|NCT01109173|583861898|FG002|Overall Study|Lost to Follow-up|0|||
161674390|NCT01109173|583861899|FG003|Overall Study|Lost to Follow-up|0|||
161674391|NCT01109173|583861896|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
161674392|NCT01109173|583861897|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
161674393|NCT01109173|583861898|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
161674394|NCT01109173|583861899|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
161674395|NCT01109173|583861896|FG000|Overall Study|Noncompliance|0|||
161674396|NCT01109173|583861897|FG001|Overall Study|Noncompliance|1|||
161674397|NCT01109173|583861898|FG002|Overall Study|Noncompliance|0|||
161674398|NCT01109173|583861899|FG003|Overall Study|Noncompliance|0|||
161674399|NCT01109173|583861896|FG000|Overall Study|Treatment Failure|25|||
161674400|NCT01109173|583861897|FG001|Overall Study|Treatment Failure|32|||
161674401|NCT01109173|583861898|FG002|Overall Study|Treatment Failure|69|||
161674402|NCT01109173|583861899|FG003|Overall Study|Treatment Failure|64|||
161674403|NCT01109173|583861896|FG000|Overall Study|Protocol Violation|4|||
161674404|NCT01109173|583861897|FG001|Overall Study|Protocol Violation|5|||
161674405|NCT01109173|583861898|FG002|Overall Study|Protocol Violation|1|||
161674406|NCT01109173|583861899|FG003|Overall Study|Protocol Violation|2|||
161674407|NCT01109173|583861896|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
161674408|NCT01109173|583861897|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
161674409|NCT01109173|583861898|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
161674410|NCT01109173|583861899|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
161674411|NCT01109173|583861896|FG000|Overall Study|Not Specifiied|5|||
161674412|NCT01109173|583861897|FG001|Overall Study|Not Specifiied|4|||
161674413|NCT01109173|583861898|FG002|Overall Study|Not Specifiied|9|||
161674414|NCT01109173|583861899|FG003|Overall Study|Not Specifiied|14|||
161674415|NCT01438151|583861901|FG000|Overall Study|study terminated|8|||
161674416|NCT00006392|583861908|FG000|Overall Study|Ineligible|11|||
161820224|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
161820225|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
161820226|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
161820227|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161820228|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161820229|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
161820230|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161820231|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161820232|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161820233|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
161820234|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
161820235|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
161820236|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
161820237|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
161820238|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
161820239|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
161820240|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
161820241|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
161820242|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
161820243|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
161820244|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
161820245|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
161674417|NCT00006392|583861909|FG001|Overall Study|Ineligible|3|||
161674418|NCT00006392|583861910|FG002|Overall Study|Ineligible|5|||
161674419|NCT00006392|583861911|FG003|Overall Study|Ineligible|5|||
161674420|NCT00006392|583861908|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
161674421|NCT00006392|583861909|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
161674422|NCT00006392|583861910|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
161674423|NCT00006392|583861911|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
161674424|NCT02459769|583861913|FG000|Overall Study|Withdrawal by Subject|7|||
161674425|NCT02459769|583861914|FG001|Overall Study|Withdrawal by Subject|4|||
161674426|NCT02459769|583861915|FG002|Overall Study|Withdrawal by Subject|8|||
161674427|NCT02459769|583861916|FG003|Overall Study|Withdrawal by Subject|5|||
161674428|NCT02459769|583861913|FG000|Overall Study|Lost to Follow-up|1|||
161674429|NCT02459769|583861914|FG001|Overall Study|Lost to Follow-up|0|||
161674430|NCT02459769|583861915|FG002|Overall Study|Lost to Follow-up|1|||
161674431|NCT02459769|583861916|FG003|Overall Study|Lost to Follow-up|0|||
161674432|NCT01186796|583861917|FG000|Overall Study|Adverse Event|3|||
161674433|NCT01186796|583861918|FG001|Overall Study|Adverse Event|0|||
161674434|NCT01186796|583861917|FG000|Overall Study|Withdrawal by Subject|1|||
161674435|NCT01186796|583861918|FG001|Overall Study|Withdrawal by Subject|1|||
161674436|NCT01186796|583861917|FG000|Overall Study|Protocol Violation|0|||
161674437|NCT01186796|583861918|FG001|Overall Study|Protocol Violation|1|||
161674438|NCT03838198|583861919|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
161674439|NCT03838198|583861920|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
161674440|NCT03838198|583861921|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
162194734|NCT00103857|585762295|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
162194735|NCT00103857|585762296|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
162194736|NCT00103857|585762297|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
162194737|NCT00103857|585762298|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
162194738|NCT00103857|585762299|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
162194739|NCT00103857|585762300|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
162194740|NCT00103857|585762301|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
162194741|NCT00103857|585762295|FG000|50-Week Extension Study|reason unspecified|0|||
162194742|NCT00103857|585762296|FG001|50-Week Extension Study|reason unspecified|0|||
162194743|NCT00103857|585762297|FG002|50-Week Extension Study|reason unspecified|0|||
162194744|NCT00103857|585762298|FG003|50-Week Extension Study|reason unspecified|0|||
162194745|NCT00103857|585762299|FG004|50-Week Extension Study|reason unspecified|1|||
162194746|NCT00103857|585762300|FG005|50-Week Extension Study|reason unspecified|0|||
162194747|NCT00103857|585762301|FG006|50-Week Extension Study|reason unspecified|0|||
162194748|NCT02707952|585762304|FG000|Overall Study|Adverse Event|1|||
162194749|NCT02707952|585762305|FG001|Overall Study|Adverse Event|0|||
162194750|NCT02707952|585762306|FG002|Overall Study|Adverse Event|0|||
162194751|NCT02707952|585762307|FG003|Overall Study|Adverse Event|0|||
162194752|NCT02707952|585762304|FG000|Overall Study|Lost to Follow-up|1|||
162194753|NCT02707952|585762305|FG001|Overall Study|Lost to Follow-up|0|||
162194754|NCT02707952|585762306|FG002|Overall Study|Lost to Follow-up|0|||
162194755|NCT02707952|585762307|FG003|Overall Study|Lost to Follow-up|0|||
162194756|NCT02707952|585762304|FG000|Overall Study|Withdrawal by Subject|0|||
162194757|NCT02707952|585762305|FG001|Overall Study|Withdrawal by Subject|1|||
162194758|NCT02707952|585762306|FG002|Overall Study|Withdrawal by Subject|2|||
162194759|NCT02707952|585762307|FG003|Overall Study|Withdrawal by Subject|0|||
162194760|NCT01287832|585762309|FG000|Overall Study|Adverse Event|1|||
162194761|NCT01287832|585762310|FG001|Overall Study|Adverse Event|0|||
162194762|NCT01287832|585762309|FG000|Overall Study|Death|0|||
162194763|NCT01287832|585762310|FG001|Overall Study|Death|1|||
162194764|NCT03065400|585762313|FG000|Overall Study|Adverse Event|1|||
162194765|NCT03065400|585762313|FG000|Overall Study|Physician Decision|3|||
162194766|NCT03065400|585762313|FG000|Overall Study|Withdrawal by Subject|1|||
162194767|NCT03065400|585762313|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
162194768|NCT03072862|585762314|FG000|Overall Study|Withdrawal by Subject|4|||
162194769|NCT03072862|585762314|FG000|Overall Study|Lost to Follow-up|6|||
162194770|NCT03072862|585762314|FG000|Overall Study|Protocol Violation|4|||
162194771|NCT03072862|585762314|FG000|Overall Study|Physician Decision|2|||
162194772|NCT03072862|585762314|FG000|Overall Study|Death|1|||
162194773|NCT03072862|585762314|FG000|Overall Study|Adverse Event|1|||
162194774|NCT00632736|585762315|FG000|Overall Study|Adverse Event|104|||
162194775|NCT00632736|585762315|FG000|Overall Study|Lost to Follow-up|15|||
162194776|NCT00632736|585762315|FG000|Overall Study|Protocol Violation|14|||
162194777|NCT00632736|585762315|FG000|Overall Study|Withdrawal by Subject|99|||
161674441|NCT03838198|583861922|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
162194778|NCT00632736|585762315|FG000|Overall Study|Lack of Efficacy|5|||
162194779|NCT00632736|585762315|FG000|Overall Study|Sponsor terminated study|5|||
162194780|NCT00632736|585762315|FG000|Overall Study|Non-compliance|10|||
162194781|NCT00632736|585762315|FG000|Overall Study|Other|16|||
162194782|NCT03347396|585762316|FG000|Part A (26 Weeks)|Adverse Event|1|||
161674442|NCT03838198|583861919|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
162194783|NCT03347396|585762317|FG001|Part A (26 Weeks)|Adverse Event|0|||
162194784|NCT03347396|585762316|FG000|Part A (26 Weeks)|Death|0|||
162194785|NCT03347396|585762317|FG001|Part A (26 Weeks)|Death|1|||
162194786|NCT03347396|585762316|FG000|Part B (149 Weeks)|Adverse Event|1|||
162194787|NCT03347396|585762317|FG001|Part B (149 Weeks)|Adverse Event|1|||
162194788|NCT03347396|585762316|FG000|Part B (149 Weeks)|Death|1|||
162194789|NCT03347396|585762317|FG001|Part B (149 Weeks)|Death|0|||
162194790|NCT03015220|585762319|FG000|Overall Study|Withdrawal by Subject|3|||
162194791|NCT03015220|585762320|FG001|Overall Study|Withdrawal by Subject|2|||
162194792|NCT03015220|585762321|FG002|Overall Study|Withdrawal by Subject|2|||
162194793|NCT03015220|585762322|FG003|Overall Study|Withdrawal by Subject|2|||
162194794|NCT03015220|585762319|FG000|Overall Study|Lost to Follow-up|0|||
162194795|NCT03015220|585762320|FG001|Overall Study|Lost to Follow-up|0|||
162194796|NCT03015220|585762321|FG002|Overall Study|Lost to Follow-up|1|||
162194797|NCT03015220|585762322|FG003|Overall Study|Lost to Follow-up|0|||
162194798|NCT01670526|585762324|FG000|Overall Study|Withdrawal by Subject|3|||
162194799|NCT01670526|585762325|FG001|Overall Study|Withdrawal by Subject|1|||
162194800|NCT01670526|585762324|FG000|Overall Study|Lost to Follow-up|9|||
162194801|NCT01670526|585762325|FG001|Overall Study|Lost to Follow-up|5|||
162194802|NCT00392197|585762326|FG000|Overall Study|Adverse Event|4|||
162194803|NCT00392197|585762327|FG001|Overall Study|Adverse Event|12|||
162194804|NCT00392197|585762326|FG000|Overall Study|Lack of Efficacy|3|||
162194805|NCT00392197|585762327|FG001|Overall Study|Lack of Efficacy|4|||
162194806|NCT00392197|585762326|FG000|Overall Study|Lost to Follow-up|0|||
162194807|NCT00392197|585762327|FG001|Overall Study|Lost to Follow-up|1|||
162194808|NCT00392197|585762326|FG000|Overall Study|Physician Decision|3|||
162194809|NCT00392197|585762327|FG001|Overall Study|Physician Decision|2|||
162194810|NCT00392197|585762326|FG000|Overall Study|Protocol Violation|7|||
162194811|NCT00392197|585762327|FG001|Overall Study|Protocol Violation|5|||
162194812|NCT00392197|585762326|FG000|Overall Study|Withdrawal by Subject|4|||
162194813|NCT00392197|585762327|FG001|Overall Study|Withdrawal by Subject|6|||
162194814|NCT01794689|585762328|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
162194815|NCT01794689|585762329|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
162194816|NCT01794689|585762330|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
162194817|NCT01794689|585762331|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
162194818|NCT01794689|585762328|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
162194819|NCT01794689|585762329|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
162194820|NCT01794689|585762330|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
162194821|NCT01794689|585762331|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
162194822|NCT01794689|585762328|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
162194823|NCT01794689|585762329|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
162194824|NCT01794689|585762330|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
162194825|NCT01794689|585762331|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
162194826|NCT01794689|585762328|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
162194827|NCT01794689|585762329|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
162194828|NCT01794689|585762330|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
162194829|NCT01794689|585762331|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
162194830|NCT02312258|585762332|FG000|Overall Study|Lost to Follow-up|8|||
162194831|NCT02312258|585762333|FG001|Overall Study|Lost to Follow-up|8|||
162194832|NCT02312258|585762332|FG000|Overall Study|Withdrawal by Patient|49|||
162194833|NCT02312258|585762333|FG001|Overall Study|Withdrawal by Patient|76|||
162194834|NCT02312258|585762332|FG000|Overall Study|Reason not Specified|107|||
162194835|NCT02312258|585762333|FG001|Overall Study|Reason not Specified|159|||
162194836|NCT02312258|585762332|FG000|Overall Study|Missing|2|||
162194837|NCT02312258|585762333|FG001|Overall Study|Missing|1|||
162194838|NCT02312258|585762332|FG000|Overall Study|Death|115|||
162194839|NCT02312258|585762333|FG001|Overall Study|Death|181|||
162194840|NCT01697956|585762334|FG000|Overall Study|Protocol Violation|1|||
162194841|NCT01697956|585762335|FG001|Overall Study|Protocol Violation|1|||
162194842|NCT01528605|585762336|FG000|Overall Study|Lost to Follow-up|1|||
162194843|NCT01528605|585762337|FG001|Overall Study|Lost to Follow-up|0|||
162194844|NCT01528605|585762338|FG002|Overall Study|Lost to Follow-up|1|||
162194845|NCT01528605|585762339|FG003|Overall Study|Lost to Follow-up|1|||
162194846|NCT01528605|585762340|FG004|Overall Study|Lost to Follow-up|0|||
162194847|NCT01528605|585762341|FG005|Overall Study|Lost to Follow-up|0|||
162194848|NCT01528605|585762336|FG000|Overall Study|Death|1|||
162194849|NCT01528605|585762337|FG001|Overall Study|Death|0|||
162194850|NCT01528605|585762338|FG002|Overall Study|Death|0|||
162194851|NCT01528605|585762339|FG003|Overall Study|Death|0|||
162194852|NCT01528605|585762340|FG004|Overall Study|Death|0|||
162194853|NCT01528605|585762341|FG005|Overall Study|Death|0|||
162194854|NCT01970527|585762343|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
162194855|NCT01970527|585762344|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
162194856|NCT01970527|585762343|FG000|Treatment|Disease progression|0|||
162194857|NCT01970527|585762344|FG001|Treatment|Disease progression|1|||
162194858|NCT01970527|585762343|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
162194859|NCT01970527|585762344|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
162194860|NCT01970527|585762343|FG000|Treatment|Death|0|||
162194861|NCT01970527|585762344|FG001|Treatment|Death|1|||
162194862|NCT01970527|585762343|FG000|Follow-up Clinic Visit|Disease progression|1|||
162194863|NCT01970527|585762344|FG001|Follow-up Clinic Visit|Disease progression|1|||
162194864|NCT01970527|585762343|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
161674443|NCT03838198|583861920|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
161674444|NCT03838198|583861921|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
161674445|NCT03838198|583861922|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
161674446|NCT00578786|583861927|FG000|Overall Study|Adverse Event|27|||
161674447|NCT00578786|583861928|FG001|Overall Study|Adverse Event|37|||
161674448|NCT00578786|583861929|FG002|Overall Study|Adverse Event|17|||
161674449|NCT00578786|583861927|FG000|Overall Study|Lack of Efficacy|2|||
161674450|NCT00578786|583861928|FG001|Overall Study|Lack of Efficacy|5|||
161674451|NCT00578786|583861929|FG002|Overall Study|Lack of Efficacy|2|||
161674452|NCT00578786|583861927|FG000|Overall Study|Early Escape from Prior Study|2|||
161674453|NCT00578786|583861928|FG001|Overall Study|Early Escape from Prior Study|1|||
161674454|NCT00578786|583861929|FG002|Overall Study|Early Escape from Prior Study|2|||
161674455|NCT00578786|583861927|FG000|Overall Study|Withdrawal by Subject|7|||
161674456|NCT00578786|583861928|FG001|Overall Study|Withdrawal by Subject|8|||
161674457|NCT00578786|583861929|FG002|Overall Study|Withdrawal by Subject|5|||
161674458|NCT00578786|583861927|FG000|Overall Study|Protocol Violation|0|||
161674459|NCT00578786|583861928|FG001|Overall Study|Protocol Violation|3|||
161674460|NCT00578786|583861929|FG002|Overall Study|Protocol Violation|1|||
161674461|NCT00578786|583861927|FG000|Overall Study|Physician Decision|1|||
161674462|NCT00578786|583861928|FG001|Overall Study|Physician Decision|0|||
161674463|NCT00578786|583861929|FG002|Overall Study|Physician Decision|1|||
161674464|NCT00578786|583861927|FG000|Overall Study|Sponsor Decision|0|||
161674465|NCT00578786|583861928|FG001|Overall Study|Sponsor Decision|0|||
161674466|NCT00578786|583861929|FG002|Overall Study|Sponsor Decision|1|||
161674467|NCT00578786|583861927|FG000|Overall Study|Lost to Follow-up|0|||
161674468|NCT00578786|583861928|FG001|Overall Study|Lost to Follow-up|4|||
161674469|NCT00578786|583861929|FG002|Overall Study|Lost to Follow-up|0|||
161674470|NCT00578786|583861927|FG000|Overall Study|Pregnancy|0|||
161674471|NCT00578786|583861928|FG001|Overall Study|Pregnancy|1|||
161674472|NCT00578786|583861929|FG002|Overall Study|Pregnancy|0|||
161674473|NCT00578786|583861927|FG000|Overall Study|Not Otherwise Specified|0|||
161674474|NCT00578786|583861928|FG001|Overall Study|Not Otherwise Specified|4|||
161674475|NCT00578786|583861929|FG002|Overall Study|Not Otherwise Specified|1|||
161674476|NCT00578786|583861927|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
161674477|NCT00578786|583861928|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
161674478|NCT00578786|583861929|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
161674479|NCT00312221|583861930|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
161674480|NCT00312221|583861931|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
161674481|NCT00312221|583861932|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
161674482|NCT00312221|583861933|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
161674483|NCT00312221|583861930|FG000|Open-label Run-in Period|Adverse Event|74|||
161674484|NCT00312221|583861931|FG001|Open-label Run-in Period|Adverse Event|0|||
161674485|NCT00312221|583861932|FG002|Open-label Run-in Period|Adverse Event|0|||
161674486|NCT00312221|583861933|FG003|Open-label Run-in Period|Adverse Event|0|||
161674487|NCT00312221|583861930|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
161674488|NCT00312221|583861931|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
161674489|NCT00312221|583861932|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
161674490|NCT00312221|583861933|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
161674491|NCT00312221|583861930|FG000|Open-label Run-in Period|Administrative|42|||
161674492|NCT00312221|583861931|FG001|Open-label Run-in Period|Administrative|0|||
161674493|NCT00312221|583861932|FG002|Open-label Run-in Period|Administrative|0|||
161674494|NCT00312221|583861933|FG003|Open-label Run-in Period|Administrative|0|||
161674495|NCT00312221|583861930|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
161674496|NCT00312221|583861931|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
161674497|NCT00312221|583861932|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
161674498|NCT00312221|583861933|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
161674499|NCT00312221|583861930|FG000|Open-label Run-in Period|Did not qualify|5|||
161674500|NCT00312221|583861931|FG001|Open-label Run-in Period|Did not qualify|0|||
161674501|NCT00312221|583861932|FG002|Open-label Run-in Period|Did not qualify|0|||
161674502|NCT00312221|583861933|FG003|Open-label Run-in Period|Did not qualify|0|||
161674503|NCT00312221|583861930|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161674504|NCT00312221|583861931|FG001|Double-blind Phase|Withdrawal by Subject|6|||
161674505|NCT00312221|583861932|FG002|Double-blind Phase|Withdrawal by Subject|8|||
161674506|NCT00312221|583861933|FG003|Double-blind Phase|Withdrawal by Subject|7|||
161674507|NCT00312221|583861930|FG000|Double-blind Phase|Adverse Event|0|||
161674508|NCT00312221|583861931|FG001|Double-blind Phase|Adverse Event|10|||
161674509|NCT00312221|583861932|FG002|Double-blind Phase|Adverse Event|19|||
161674510|NCT00312221|583861933|FG003|Double-blind Phase|Adverse Event|18|||
161674511|NCT00312221|583861930|FG000|Double-blind Phase|Lost to Follow-up|0|||
161674512|NCT00312221|583861931|FG001|Double-blind Phase|Lost to Follow-up|0|||
161674513|NCT00312221|583861932|FG002|Double-blind Phase|Lost to Follow-up|2|||
161674514|NCT00312221|583861933|FG003|Double-blind Phase|Lost to Follow-up|2|||
161674515|NCT00312221|583861930|FG000|Double-blind Phase|Administrative|0|||
161674516|NCT00312221|583861931|FG001|Double-blind Phase|Administrative|26|||
161674517|NCT00312221|583861932|FG002|Double-blind Phase|Administrative|37|||
161674518|NCT00312221|583861933|FG003|Double-blind Phase|Administrative|33|||
161674519|NCT00312221|583861930|FG000|Double-blind Phase|Lack of Efficacy|0|||
161674520|NCT00312221|583861931|FG001|Double-blind Phase|Lack of Efficacy|17|||
161674521|NCT00312221|583861932|FG002|Double-blind Phase|Lack of Efficacy|6|||
161674522|NCT00312221|583861933|FG003|Double-blind Phase|Lack of Efficacy|10|||
161674523|NCT01019317|583861934|FG000|Overall Study|Not Eligible|4|||
161674524|NCT01807923|583861936|FG000|Overall Study|Adverse Event|2|||
161674525|NCT01807923|583861937|FG001|Overall Study|Adverse Event|1|||
161674526|NCT01807923|583861938|FG002|Overall Study|Adverse Event|2|||
161674527|NCT01807923|583861936|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161674528|NCT01807923|583861937|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
161674529|NCT01807923|583861938|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
161674530|NCT01807923|583861936|FG000|Overall Study|Physician Decision|0|||
161674531|NCT01807923|583861937|FG001|Overall Study|Physician Decision|0|||
161674532|NCT01807923|583861938|FG002|Overall Study|Physician Decision|1|||
161674533|NCT01807923|583861936|FG000|Overall Study|Not Eligible (Genotype)|0|||
161674534|NCT01807923|583861937|FG001|Overall Study|Not Eligible (Genotype)|0|||
161674535|NCT01807923|583861938|FG002|Overall Study|Not Eligible (Genotype)|1|||
161674536|NCT01807923|583861936|FG000|Overall Study|Randomized But Not Treated|3|||
161674537|NCT01807923|583861937|FG001|Overall Study|Randomized But Not Treated|2|||
161674538|NCT01807923|583861938|FG002|Overall Study|Randomized But Not Treated|5|||
161674539|NCT01237340|583861944|FG000|Overall Study|Adverse Event|3|||
161674540|NCT01237340|583861944|FG000|Overall Study|Withdrawal by Subject|1|||
161674541|NCT01237340|583861944|FG000|Overall Study|Early termination of the trial|36|||
161674542|NCT03836807|583861945|FG000|Overall Study|Physician Decision|1|||
161674543|NCT03836807|583861946|FG001|Overall Study|Physician Decision|0|||
161674544|NCT00685685|583861947|FG000|Washout Period of 7 Days|Adverse Event|2|||
161674545|NCT00685685|583861948|FG001|Washout Period of 7 Days|Adverse Event|0|||
161674546|NCT00685685|583861947|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161674547|NCT00685685|583861948|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161674548|NCT01272947|583861949|FG000|Overall Study|Abnormal Laboratory Value|2|||
161674549|NCT01272947|583861950|FG001|Overall Study|Abnormal Laboratory Value|2|||
161674550|NCT02019420|583861953|FG000|Overall Study|Did not receive study drug|2|||
161674551|NCT02019420|583861954|FG001|Overall Study|Did not receive study drug|2|||
161674552|NCT02019420|583861953|FG000|Overall Study|Withdrawal by Subject|1|||
161674553|NCT02019420|583861954|FG001|Overall Study|Withdrawal by Subject|3|||
161674554|NCT02019420|583861953|FG000|Overall Study|At request of sponsor or investigator|0|||
161674555|NCT02019420|583861954|FG001|Overall Study|At request of sponsor or investigator|1|||
162194865|NCT01970527|585762344|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
162194866|NCT01970527|585762343|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
162194867|NCT01970527|585762344|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
162194868|NCT00882050|585762350|FG000|Overall Study|Physician Decision|1|||
162194869|NCT00882050|585762351|FG001|Overall Study|Physician Decision|0|||
162194870|NCT00882050|585762352|FG002|Overall Study|Physician Decision|0|||
162194871|NCT01131325|585764502|FG000|Overall Study|Adverse Event|1|||
162194872|NCT01131325|585764502|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
162194873|NCT03761849|585764503|FG000|Overall Study|transferred to OpenLabelExtension|35|||
162194874|NCT03761849|585764504|FG001|Overall Study|transferred to OpenLabelExtension|34|||
162194875|NCT03761849|585764505|FG002|Overall Study|transferred to OpenLabelExtension|36|||
162194876|NCT03761849|585764506|FG003|Overall Study|transferred to OpenLabelExtension|0|||
162194877|NCT03761849|585764507|FG004|Overall Study|transferred to OpenLabelExtension|0|||
162194878|NCT03761849|585764508|FG005|Overall Study|transferred to OpenLabelExtension|0|||
161820246|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
161820247|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
161820248|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
161820249|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
161820250|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
161820251|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
161820252|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
161820253|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
161820254|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
161820255|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
161820256|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
161820257|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
161820258|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
162194879|NCT03761849|585764503|FG000|Overall Study|Adverse Event|1|||
162194880|NCT03761849|585764504|FG001|Overall Study|Adverse Event|0|||
161674556|NCT02019420|583861953|FG000|Overall Study|Death|104|||
161674557|NCT02019420|583861954|FG001|Overall Study|Death|99|||
161674558|NCT02019420|583861953|FG000|Overall Study|Transferred to other care facility|1|||
161820259|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
161674559|NCT02019420|583861954|FG001|Overall Study|Transferred to other care facility|1|||
161674560|NCT02014740|583861955|FG000|Overall Study|Lost to Follow-up|4|||
161674561|NCT02014740|583861956|FG001|Overall Study|Lost to Follow-up|4|||
161674562|NCT02014740|583861955|FG000|Overall Study|Withdrawal by Subject|2|||
161674563|NCT02014740|583861956|FG001|Overall Study|Withdrawal by Subject|1|||
161674564|NCT01130974|583861957|FG000|Overall Study|Protocol Violation|10|||
161925774|NCT00422461|584774610|FG001|Overall Study|Participants no longer willing to participate in study|0|||
161925775|NCT00422461|584774611|FG002|Overall Study|Participants no longer willing to participate in study|0|||
161925776|NCT00422461|584774612|FG003|Overall Study|Participants no longer willing to participate in study|0|||
161925777|NCT00422461|584774609|FG000|Overall Study|Randomized but not treated|1|||
161925778|NCT00422461|584774610|FG001|Overall Study|Randomized but not treated|1|||
161925779|NCT00422461|584774611|FG002|Overall Study|Randomized but not treated|0|||
161925780|NCT00422461|584774612|FG003|Overall Study|Randomized but not treated|0|||
161925781|NCT02181621|584774614|FG000|Overall Study|Adverse Event|1|||
161925782|NCT02181621|584774615|FG001|Overall Study|Adverse Event|0|||
161925783|NCT02181621|584774614|FG000|Overall Study|Previously Enrolled|0|||
161925784|NCT02181621|584774615|FG001|Overall Study|Previously Enrolled|1|||
161925785|NCT02181621|584774614|FG000|Overall Study|Enrollment Hold|1|||
161925786|NCT02181621|584774615|FG001|Overall Study|Enrollment Hold|1|||
161925787|NCT01875237|584774620|FG000|Overall Study|GVDH before DLI|1|||
161925788|NCT01875237|584774621|FG001|Overall Study|GVDH before DLI|0|||
161925789|NCT01875237|584774620|FG000|Overall Study|DLI cells could not be produced|1|||
161925790|NCT01875237|584774621|FG001|Overall Study|DLI cells could not be produced|0|||
161925791|NCT02441114|584774622|FG000|Washout2|Withdrawal by Subject|4|||
161925792|NCT05278065|584774623|FG000|Overall Study|Withdrawal by Subject|1|||
161925793|NCT05278065|584774624|FG001|Overall Study|Withdrawal by Subject|0|||
161925794|NCT02070991|584774630|FG000|Overall Study|Death|2|||
161925795|NCT02070991|584774631|FG001|Overall Study|Death|0|||
161925796|NCT02070991|584774630|FG000|Overall Study|Withdrawal by Subject|1|||
161925797|NCT02070991|584774631|FG001|Overall Study|Withdrawal by Subject|0|||
161925798|NCT04999020|584774632|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
161925799|NCT04999020|584774633|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
161925800|NCT04999020|584774634|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
161925801|NCT04999020|584774635|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
161925802|NCT04999020|584774632|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
161925803|NCT04999020|584774633|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
161925804|NCT04999020|584774634|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
161925805|NCT04999020|584774635|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
161925806|NCT04999020|584774632|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
161925807|NCT04999020|584774633|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
161925808|NCT04999020|584774634|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
161925809|NCT04999020|584774635|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
161925810|NCT04999020|584774632|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161925811|NCT04999020|584774633|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161925812|NCT04999020|584774634|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
161925813|NCT04999020|584774635|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
161925814|NCT04999020|584774632|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
161925815|NCT04999020|584774633|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
161925816|NCT04999020|584774634|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
161925817|NCT04999020|584774635|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
161925818|NCT04999020|584774632|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
161925819|NCT04999020|584774633|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
161925820|NCT04999020|584774634|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
161925821|NCT04999020|584774635|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
161925822|NCT04999020|584774632|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161925823|NCT04999020|584774633|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161925824|NCT04999020|584774634|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
161925825|NCT04999020|584774635|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161925826|NCT04999020|584774632|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
161925827|NCT04999020|584774633|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
161925828|NCT04999020|584774634|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
161925829|NCT04999020|584774635|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
162020212|NCT05064358|585128622|FG000|Overall Study|Physician Decision|1|||
161925830|NCT00866320|584774641|FG000|Overall Study|Withdrawal by Subject|4|||
162020213|NCT05064358|585128623|FG001|Overall Study|Physician Decision|1|||
162020214|NCT05064358|585128624|FG002|Overall Study|Physician Decision|2|||
162020215|NCT05064358|585128625|FG003|Overall Study|Physician Decision|0|||
162020216|NCT05064358|585128626|FG004|Overall Study|Physician Decision|0|||
162020217|NCT05064358|585128622|FG000|Overall Study|Withdrawal by Subject|4|||
161674565|NCT01130974|583861958|FG001|Overall Study|Protocol Violation|10|||
161674566|NCT01130974|583861957|FG000|Overall Study|Withdrawal by Subject|0|||
161674567|NCT01130974|583861958|FG001|Overall Study|Withdrawal by Subject|1|||
161674568|NCT01130974|583861957|FG000|Overall Study|Ineligibility criteria|5|||
161674569|NCT01130974|583861958|FG001|Overall Study|Ineligibility criteria|2|||
161674570|NCT05118204|583861963|FG000|Overall Study|Lost to Follow-up|3|||
161674571|NCT05118204|583861964|FG001|Overall Study|Lost to Follow-up|2|||
161674572|NCT05118204|583861963|FG000|Overall Study|Withdrawal by Subject|0|||
161674573|NCT05118204|583861964|FG001|Overall Study|Withdrawal by Subject|2|||
161674574|NCT05393037|583861966|FG000|Part A|Death|1|||
161674575|NCT05393037|583861967|FG001|Part A|Death|0|||
161674576|NCT05393037|583861966|FG000|Part A|Lost to Follow-up|1|||
161674577|NCT05393037|583861967|FG001|Part A|Lost to Follow-up|1|||
161674578|NCT05393037|583861966|FG000|Part A|Withdrawal by Subject|2|||
161674579|NCT05393037|583861967|FG001|Part A|Withdrawal by Subject|4|||
161674580|NCT05393037|583861966|FG000|Part B|Lost to Follow-up|1|||
161674581|NCT05393037|583861967|FG001|Part B|Lost to Follow-up|0|||
161674582|NCT04409353|583861968|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
161674583|NCT04409353|583861969|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
161674584|NCT04409353|583861970|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
161674585|NCT04409353|583861968|FG000|Overall Study|Lost to Follow-up|6|||
161674586|NCT04409353|583861969|FG001|Overall Study|Lost to Follow-up|8|||
161674587|NCT04409353|583861970|FG002|Overall Study|Lost to Follow-up|7|||
161674588|NCT04409353|583861968|FG000|Overall Study|Major surgery during participation window|4|||
161674589|NCT04409353|583861969|FG001|Overall Study|Major surgery during participation window|3|||
161674590|NCT04409353|583861970|FG002|Overall Study|Major surgery during participation window|3|||
161674591|NCT04409353|583861968|FG000|Overall Study|Life event occurred during participation window|3|||
161674592|NCT04409353|583861969|FG001|Overall Study|Life event occurred during participation window|2|||
161674593|NCT04409353|583861970|FG002|Overall Study|Life event occurred during participation window|4|||
161674594|NCT04409353|583861968|FG000|Overall Study|Lack of Efficacy|4|||
161674595|NCT04409353|583861969|FG001|Overall Study|Lack of Efficacy|1|||
161674596|NCT04409353|583861970|FG002|Overall Study|Lack of Efficacy|3|||
161674597|NCT04409353|583861968|FG000|Overall Study|Adverse Event|2|||
161674598|NCT04409353|583861969|FG001|Overall Study|Adverse Event|1|||
161674599|NCT04409353|583861970|FG002|Overall Study|Adverse Event|1|||
161674600|NCT04409353|583861968|FG000|Overall Study|Disease burden - unable to participate|0|||
161674601|NCT04409353|583861969|FG001|Overall Study|Disease burden - unable to participate|1|||
161674602|NCT04409353|583861970|FG002|Overall Study|Disease burden - unable to participate|1|||
161674603|NCT04409353|583861968|FG000|Overall Study|Intervention too complicated|1|||
161674604|NCT04409353|583861969|FG001|Overall Study|Intervention too complicated|0|||
161674605|NCT04409353|583861970|FG002|Overall Study|Intervention too complicated|1|||
161674606|NCT01012739|583861971|FG000|Treatment Period 1|Adverse Event|0|||
161674607|NCT01012739|583861972|FG001|Treatment Period 1|Adverse Event|0|||
161674608|NCT01012739|583861973|FG002|Treatment Period 1|Adverse Event|0|||
161674609|NCT01012739|583861974|FG003|Treatment Period 1|Adverse Event|1|||
161674610|NCT01012739|583861971|FG000|Treatment Period 2|Abnormal test procedure results|0|||
161674611|NCT01012739|583861972|FG001|Treatment Period 2|Abnormal test procedure results|0|||
161674612|NCT01012739|583861973|FG002|Treatment Period 2|Abnormal test procedure results|0|||
161674613|NCT01012739|583861974|FG003|Treatment Period 2|Abnormal test procedure results|1|||
161674614|NCT04540133|583861975|FG000|Overall Study|Lost to Follow-up|1|||
161674615|NCT04540133|583861976|FG001|Overall Study|Lost to Follow-up|0|||
161674616|NCT04014361|583861977|FG000|Period 2|Physician Decision|0|||
161674617|NCT04014361|583861978|FG001|Period 2|Physician Decision|0|||
161674618|NCT04014361|583861979|FG002|Period 2|Physician Decision|0|||
161674619|NCT04014361|583861980|FG003|Period 2|Physician Decision|1|||
161674620|NCT04014361|583861981|FG004|Period 2|Physician Decision|0|||
161674621|NCT04014361|583861982|FG005|Period 2|Physician Decision|0|||
161674622|NCT04014361|583861983|FG006|Period 2|Physician Decision|0|||
161674623|NCT04014361|583861984|FG007|Period 2|Physician Decision|0|||
161674624|NCT06308666|583861985|FG000|Overall Study|Withdrawal by Subject|1|||
161674625|NCT06308666|583861985|FG000|Overall Study|Protocol Violation|2|||
161820260|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
161820261|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
162194881|NCT03761849|585764505|FG002|Overall Study|Adverse Event|0|||
162194882|NCT03761849|585764506|FG003|Overall Study|Adverse Event|0|||
162194883|NCT03761849|585764507|FG004|Overall Study|Adverse Event|2|||
162194884|NCT03761849|585764508|FG005|Overall Study|Adverse Event|3|||
162194885|NCT03761849|585764503|FG000|Overall Study|Withdrawal by Subject|0|||
161674626|NCT04252287|583861987|FG000|Overall Study|Death|5|||
161674627|NCT04252287|583861988|FG001|Overall Study|Death|3|||
161674628|NCT04252287|583861987|FG000|Overall Study|Lost to Follow-up|4|||
161674629|NCT04252287|583861988|FG001|Overall Study|Lost to Follow-up|6|||
161674630|NCT04252287|583861987|FG000|Overall Study|Withdrawal by Subject|19|||
161674631|NCT04252287|583861988|FG001|Overall Study|Withdrawal by Subject|16|||
161674632|NCT04252287|583861987|FG000|Overall Study|Protocol Violation|3|||
161674633|NCT04252287|583861988|FG001|Overall Study|Protocol Violation|4|||
161674634|NCT00671554|583861996|FG000|Overall Study|Disease progression|3|||
161674635|NCT04600336|583862004|FG000|Initial Treatment|Withdrawal by Subject|1|||
162194886|NCT03761849|585764504|FG001|Overall Study|Withdrawal by Subject|0|||
162194887|NCT03761849|585764505|FG002|Overall Study|Withdrawal by Subject|0|||
162194888|NCT03761849|585764506|FG003|Overall Study|Withdrawal by Subject|41|||
162194889|NCT03761849|585764507|FG004|Overall Study|Withdrawal by Subject|43|||
162194890|NCT03761849|585764508|FG005|Overall Study|Withdrawal by Subject|35|||
162194891|NCT03761849|585764503|FG000|Overall Study|Lost to Follow-up|0|||
162194892|NCT03761849|585764504|FG001|Overall Study|Lost to Follow-up|1|||
162194893|NCT03761849|585764505|FG002|Overall Study|Lost to Follow-up|0|||
162194894|NCT03761849|585764506|FG003|Overall Study|Lost to Follow-up|2|||
162194895|NCT03761849|585764507|FG004|Overall Study|Lost to Follow-up|4|||
162194896|NCT03761849|585764508|FG005|Overall Study|Lost to Follow-up|5|||
162194897|NCT03761849|585764503|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
162194898|NCT03761849|585764504|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
162194899|NCT03761849|585764505|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
162194900|NCT03761849|585764506|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
162194901|NCT03761849|585764507|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
162194902|NCT03761849|585764508|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
162194903|NCT03761849|585764503|FG000|Overall Study|Physician Decision|0|||
162194904|NCT03761849|585764504|FG001|Overall Study|Physician Decision|0|||
162194905|NCT03761849|585764505|FG002|Overall Study|Physician Decision|0|||
162194906|NCT03761849|585764506|FG003|Overall Study|Physician Decision|1|||
162194907|NCT03761849|585764507|FG004|Overall Study|Physician Decision|4|||
162194908|NCT03761849|585764508|FG005|Overall Study|Physician Decision|4|||
162194909|NCT03761849|585764503|FG000|Overall Study|Death|0|||
162194910|NCT03761849|585764504|FG001|Overall Study|Death|0|||
161674636|NCT04600336|583862005|FG001|Initial Treatment|Withdrawal by Subject|2|||
161674637|NCT04600336|583862006|FG002|Initial Treatment|Withdrawal by Subject|0|||
161674638|NCT04600336|583862007|FG003|Initial Treatment|Withdrawal by Subject|0|||
161674639|NCT04600336|583862004|FG000|Initial Treatment|Adverse Event|0|||
161674640|NCT04600336|583862005|FG001|Initial Treatment|Adverse Event|2|||
162194911|NCT03761849|585764505|FG002|Overall Study|Death|0|||
162194912|NCT03761849|585764506|FG003|Overall Study|Death|1|||
162194913|NCT03761849|585764507|FG004|Overall Study|Death|1|||
161820262|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
162194914|NCT03761849|585764508|FG005|Overall Study|Death|3|||
162194915|NCT03761849|585764503|FG000|Overall Study|Protocol Violation|0|||
161674641|NCT04600336|583862006|FG002|Initial Treatment|Adverse Event|0|||
161674642|NCT04600336|583862007|FG003|Initial Treatment|Adverse Event|0|||
161674643|NCT04600336|583862004|FG000|Initial Treatment|Other complicating disease|0|||
161674644|NCT04600336|583862005|FG001|Initial Treatment|Other complicating disease|0|||
161674645|NCT04600336|583862006|FG002|Initial Treatment|Other complicating disease|1|||
161674646|NCT04600336|583862007|FG003|Initial Treatment|Other complicating disease|0|||
161674647|NCT04600336|583862004|FG000|Crossover Treatment|Withdrawal by Subject|0|||
161674648|NCT04600336|583862005|FG001|Crossover Treatment|Withdrawal by Subject|0|||
161674649|NCT04600336|583862006|FG002|Crossover Treatment|Withdrawal by Subject|2|||
161674650|NCT04600336|583862007|FG003|Crossover Treatment|Withdrawal by Subject|1|||
161674651|NCT04600336|583862004|FG000|Crossover Treatment|Adverse Event|0|||
161674652|NCT04600336|583862005|FG001|Crossover Treatment|Adverse Event|0|||
161674653|NCT04600336|583862006|FG002|Crossover Treatment|Adverse Event|1|||
161674654|NCT04600336|583862007|FG003|Crossover Treatment|Adverse Event|1|||
161674655|NCT03672461|583862008|FG000|Overall Study|COVID Related|4|||
161674656|NCT03672461|583862009|FG001|Overall Study|COVID Related|2|||
161674657|NCT03672461|583862008|FG000|Overall Study|Adverse Event|2|||
161674658|NCT03672461|583862009|FG001|Overall Study|Adverse Event|0|||
161925831|NCT00866320|584774641|FG000|Overall Study|Death|2|||
161925832|NCT06038643|584774643|FG000|Overall Study|Withdrawal by Subject|9|||
161674659|NCT03672461|583862008|FG000|Overall Study|Serious Adverse Event|0|||
161674660|NCT03672461|583862009|FG001|Overall Study|Serious Adverse Event|1|||
161674661|NCT03672461|583862008|FG000|Overall Study|Too Busy|3|||
161674662|NCT03672461|583862009|FG001|Overall Study|Too Busy|1|||
161674663|NCT03672461|583862008|FG000|Overall Study|Lost to Follow-up|1|||
161674664|NCT03672461|583862009|FG001|Overall Study|Lost to Follow-up|2|||
161674665|NCT03672461|583862008|FG000|Overall Study|Family|2|||
161674666|NCT03672461|583862009|FG001|Overall Study|Family|2|||
161674667|NCT03672461|583862008|FG000|Overall Study|No remote technology access|0|||
161674668|NCT03672461|583862009|FG001|Overall Study|No remote technology access|1|||
161674669|NCT03672461|583862008|FG000|Overall Study|Withdrawal by Subject|1|||
161674670|NCT03672461|583862009|FG001|Overall Study|Withdrawal by Subject|0|||
161674671|NCT03672461|583862008|FG000|Overall Study|Cannot tolerate intervention|1|||
161674672|NCT03672461|583862009|FG001|Overall Study|Cannot tolerate intervention|0|||
161674673|NCT03672461|583862008|FG000|Overall Study|Incomplete outcome data|6|||
161674674|NCT03672461|583862009|FG001|Overall Study|Incomplete outcome data|1|||
161674675|NCT00977574|583862010|FG000|Overall Study|Never Treated|4|||
161674676|NCT00977574|583862011|FG001|Overall Study|Never Treated|2|||
161674677|NCT00977574|583862012|FG002|Overall Study|Never Treated|4|||
161674678|NCT00332839|583862944|FG000|Core (Months 0 - 12)|Administrative problems|1|||
161674679|NCT00332839|583862945|FG001|Core (Months 0 - 12)|Administrative problems|1|||
161674680|NCT00332839|583862944|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
161674681|NCT00332839|583862945|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
161674682|NCT00332839|583862944|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
161674683|NCT00332839|583862945|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
161674684|NCT00332839|583862944|FG000|Core (Months 0 - 12)|Adverse Event|5|||
161674685|NCT00332839|583862945|FG001|Core (Months 0 - 12)|Adverse Event|15|||
161674686|NCT00332839|583862944|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
161674687|NCT00332839|583862945|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
161674688|NCT00332839|583862944|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
161674689|NCT00332839|583862945|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
161674690|NCT00332839|583862944|FG000|Follow-up (Months 12 - 60)|Death|1|||
161674691|NCT00332839|583862945|FG001|Follow-up (Months 12 - 60)|Death|1|||
161674692|NCT01399190|583862946|FG000|Overall Study|Not Eligible for Final Analysis|5|||
161674693|NCT01399190|583862946|FG000|Overall Study|Adverse Event|8|||
161674694|NCT01399190|583862946|FG000|Overall Study|Participant's Request|5|||
161674695|NCT01399190|583862946|FG000|Overall Study|Physician Decision|2|||
161674696|NCT01187550|583862948|FG000|Overall Study|Protocol Violation|3|||
161674697|NCT01187550|583862949|FG001|Overall Study|Protocol Violation|1|||
161674698|NCT01187550|583862948|FG000|Overall Study|Other|3|||
161674699|NCT01187550|583862949|FG001|Overall Study|Other|0|||
161674700|NCT01187550|583862948|FG000|Overall Study|Randomized but not treated|8|||
161674701|NCT01187550|583862949|FG001|Overall Study|Randomized but not treated|0|||
161925833|NCT06038643|584774644|FG001|Overall Study|Withdrawal by Subject|4|||
161925834|NCT06038643|584774643|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
161925835|NCT06038643|584774644|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
161674702|NCT00129623|583862950|FG000|Overall Study|Adverse Event|3|||
161674703|NCT00129623|583862951|FG001|Overall Study|Adverse Event|7|||
161674704|NCT00129623|583862950|FG000|Overall Study|Refused Treatment|5|||
161674705|NCT00129623|583862951|FG001|Overall Study|Refused Treatment|3|||
161674706|NCT00129623|583862950|FG000|Overall Study|Failure to Return|1|||
161674707|NCT00129623|583862951|FG001|Overall Study|Failure to Return|1|||
161674708|NCT00129623|583862950|FG000|Overall Study|Relocated job out of state|1|||
161674709|NCT00129623|583862951|FG001|Overall Study|Relocated job out of state|0|||
161674710|NCT00129623|583862950|FG000|Overall Study|Uncertainty to return|0|||
161674711|NCT00129623|583862951|FG001|Overall Study|Uncertainty to return|1|||
161674712|NCT00596934|583862954|FG000|Overall Study|Protocol Violation|1|||
162020218|NCT05064358|585128623|FG001|Overall Study|Withdrawal by Subject|5|||
162020219|NCT05064358|585128624|FG002|Overall Study|Withdrawal by Subject|3|||
162194916|NCT03761849|585764504|FG001|Overall Study|Protocol Violation|0|||
162194917|NCT03761849|585764505|FG002|Overall Study|Protocol Violation|0|||
162194918|NCT03761849|585764506|FG003|Overall Study|Protocol Violation|2|||
162194919|NCT03761849|585764507|FG004|Overall Study|Protocol Violation|2|||
162194920|NCT03761849|585764508|FG005|Overall Study|Protocol Violation|1|||
162194921|NCT03761849|585764503|FG000|Overall Study|Participant could not come to site|0|||
162194922|NCT03761849|585764504|FG001|Overall Study|Participant could not come to site|0|||
162194923|NCT03761849|585764505|FG002|Overall Study|Participant could not come to site|0|||
162194924|NCT03761849|585764506|FG003|Overall Study|Participant could not come to site|0|||
162194925|NCT03761849|585764507|FG004|Overall Study|Participant could not come to site|1|||
162194926|NCT03761849|585764508|FG005|Overall Study|Participant could not come to site|0|||
162194927|NCT03761849|585764503|FG000|Overall Study|SF- safety Finding|0|||
162194928|NCT03761849|585764504|FG001|Overall Study|SF- safety Finding|0|||
162194929|NCT03761849|585764505|FG002|Overall Study|SF- safety Finding|0|||
162194930|NCT03761849|585764506|FG003|Overall Study|SF- safety Finding|0|||
162194931|NCT03761849|585764507|FG004|Overall Study|SF- safety Finding|0|||
162194932|NCT03761849|585764508|FG005|Overall Study|SF- safety Finding|1|||
162194933|NCT03761849|585764503|FG000|Overall Study|Patient did not attend visit|0|||
162194934|NCT03761849|585764504|FG001|Overall Study|Patient did not attend visit|0|||
162194935|NCT03761849|585764505|FG002|Overall Study|Patient did not attend visit|0|||
162194936|NCT03761849|585764506|FG003|Overall Study|Patient did not attend visit|0|||
162194937|NCT03761849|585764507|FG004|Overall Study|Patient did not attend visit|0|||
162194938|NCT03761849|585764508|FG005|Overall Study|Patient did not attend visit|1|||
162194939|NCT02213094|585764511|FG000|Overall Study|Adverse Event|1|||
162194940|NCT02213094|585764512|FG001|Overall Study|Adverse Event|0|||
162194941|NCT02163499|585764513|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
162194942|NCT02163499|585764513|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
162194943|NCT02163499|585764513|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
162194944|NCT02163499|585764513|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
161674713|NCT00596934|583862954|FG000|Overall Study|Withdrawal by Subject|1|||
161674714|NCT02315898|583862955|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
161674715|NCT02315898|583862956|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
161674716|NCT02315898|583862957|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
161674717|NCT02315898|583862958|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
161674718|NCT02445755|583862959|FG000|Overall Study|Withdrawal by Subject|2|||
161674719|NCT02445755|583862959|FG000|Overall Study|Protocol Violation|6|||
161674720|NCT02445755|583862959|FG000|Overall Study|Screen Failure|5|||
161674721|NCT03239483|583862960|FG000|Overall Study|Lost to Follow-up|1|||
161674722|NCT03239483|583862961|FG001|Overall Study|Lost to Follow-up|0|||
161674723|NCT03239483|583862960|FG000|Overall Study|Withdrawal by Subject|1|||
161674724|NCT03239483|583862961|FG001|Overall Study|Withdrawal by Subject|0|||
161674725|NCT03678103|583862971|FG000|Overall Study|Withdrawn prior to completion|4|||
161674726|NCT01296035|583862973|FG000|Overall Study|Withdrawal by Subject|1|||
161674727|NCT01674712|583862976|FG000|Overall Study|Adverse Event|5|||
161674728|NCT01674712|583862977|FG001|Overall Study|Adverse Event|6|||
161674729|NCT01674712|583862978|FG002|Overall Study|Adverse Event|3|||
161674730|NCT01674712|583862979|FG003|Overall Study|Adverse Event|4|||
161674731|NCT01674712|583862980|FG004|Overall Study|Adverse Event|6|||
162194945|NCT02163499|585764513|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
162194946|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
162194947|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
161674732|NCT01674712|583862976|FG000|Overall Study|Lost to Follow-up|1|||
161674733|NCT01674712|583862977|FG001|Overall Study|Lost to Follow-up|0|||
161674734|NCT01674712|583862978|FG002|Overall Study|Lost to Follow-up|0|||
161674735|NCT01674712|583862979|FG003|Overall Study|Lost to Follow-up|0|||
162194948|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
162194949|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
162194950|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
161674736|NCT01674712|583862980|FG004|Overall Study|Lost to Follow-up|0|||
161674737|NCT01674712|583862976|FG000|Overall Study|Protocol Violation|2|||
161674738|NCT01674712|583862977|FG001|Overall Study|Protocol Violation|0|||
162194951|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
162194952|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
162194953|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
162194954|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
162194955|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Death|8|||
162194956|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
162194957|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
162194958|NCT02163499|585764513|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
162194959|NCT00555620|585764517|FG000|Overall Study|Death|0|||
162194960|NCT00555620|585764518|FG001|Overall Study|Death|1|||
162194961|NCT00555620|585764519|FG002|Overall Study|Death|0|||
162194962|NCT00555620|585764520|FG003|Overall Study|Death|0|||
162194963|NCT00555620|585764521|FG004|Overall Study|Death|0|||
162194964|NCT00555620|585764522|FG005|Overall Study|Death|1|||
162194965|NCT00555620|585764517|FG000|Overall Study|Study terminated by sponsor|0|||
162194966|NCT00555620|585764518|FG001|Overall Study|Study terminated by sponsor|0|||
162194967|NCT00555620|585764519|FG002|Overall Study|Study terminated by sponsor|1|||
162194968|NCT00555620|585764520|FG003|Overall Study|Study terminated by sponsor|0|||
162194969|NCT00555620|585764521|FG004|Overall Study|Study terminated by sponsor|0|||
162194970|NCT00555620|585764522|FG005|Overall Study|Study terminated by sponsor|0|||
162194971|NCT00555620|585764517|FG000|Overall Study|Adverse Event|0|||
162194972|NCT00555620|585764518|FG001|Overall Study|Adverse Event|0|||
162194973|NCT00555620|585764519|FG002|Overall Study|Adverse Event|1|||
162194974|NCT00555620|585764520|FG003|Overall Study|Adverse Event|5|||
162194975|NCT00555620|585764521|FG004|Overall Study|Adverse Event|0|||
162194976|NCT00555620|585764522|FG005|Overall Study|Adverse Event|1|||
162194977|NCT00555620|585764517|FG000|Overall Study|Objective progression or relapse|6|||
162194978|NCT00555620|585764518|FG001|Overall Study|Objective progression or relapse|5|||
162194979|NCT00555620|585764519|FG002|Overall Study|Objective progression or relapse|12|||
162194980|NCT00555620|585764520|FG003|Overall Study|Objective progression or relapse|17|||
162194981|NCT00555620|585764521|FG004|Overall Study|Objective progression or relapse|3|||
162194982|NCT00555620|585764522|FG005|Overall Study|Objective progression or relapse|16|||
162194983|NCT00555620|585764517|FG000|Overall Study|Participant refused treatment|0|||
162194984|NCT00555620|585764518|FG001|Overall Study|Participant refused treatment|1|||
162194985|NCT00555620|585764519|FG002|Overall Study|Participant refused treatment|1|||
162194986|NCT00555620|585764520|FG003|Overall Study|Participant refused treatment|0|||
162194987|NCT00555620|585764521|FG004|Overall Study|Participant refused treatment|0|||
162194988|NCT00555620|585764522|FG005|Overall Study|Participant refused treatment|1|||
162194989|NCT00555620|585764517|FG000|Overall Study|Other|0|||
162194990|NCT00555620|585764518|FG001|Overall Study|Other|0|||
162194991|NCT00555620|585764519|FG002|Overall Study|Other|0|||
162194992|NCT00555620|585764520|FG003|Overall Study|Other|1|||
162194993|NCT00555620|585764521|FG004|Overall Study|Other|0|||
162194994|NCT00555620|585764522|FG005|Overall Study|Other|3|||
162194995|NCT00476151|585764523|FG000|Overall Study|Adverse Event|0|||
162194996|NCT00476151|585764524|FG001|Overall Study|Adverse Event|2|||
161820263|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
161820264|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
161820265|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
161820266|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
161820267|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
161820268|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
161820269|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
161820270|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
161820271|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
161820272|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
161820273|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
161820274|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
161820275|NCT03395197|584382769|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
161820276|NCT03395197|584382770|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
161820277|NCT03395197|584382771|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
161820278|NCT03395197|584382772|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
161820279|NCT03395197|584382773|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
161820280|NCT03395197|584382774|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
161820281|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Death|0|||
161820282|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Death|0|||
161820283|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Death|0|||
161820284|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Death|0|||
161820285|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Death|1|||
162194997|NCT00476151|585764523|FG000|Overall Study|Protocol Violation|1|||
162194998|NCT00476151|585764524|FG001|Overall Study|Protocol Violation|3|||
162194999|NCT00476151|585764523|FG000|Overall Study|Withdrawal by Subject|2|||
162195000|NCT00476151|585764524|FG001|Overall Study|Withdrawal by Subject|0|||
162195001|NCT00476151|585764523|FG000|Overall Study|Physician Decision|0|||
162195002|NCT00476151|585764524|FG001|Overall Study|Physician Decision|2|||
162195003|NCT02068352|585764526|FG000|Overall Study|Lost to Follow-up|0|||
162195004|NCT02068352|585764527|FG001|Overall Study|Lost to Follow-up|2|||
162195005|NCT02068352|585764528|FG002|Overall Study|Lost to Follow-up|0|||
162195006|NCT02068352|585764526|FG000|Overall Study|Adverse Event|4|||
162195007|NCT02068352|585764527|FG001|Overall Study|Adverse Event|2|||
162195008|NCT02068352|585764528|FG002|Overall Study|Adverse Event|7|||
162195009|NCT02068352|585764526|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
162195010|NCT02068352|585764527|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
162195011|NCT02068352|585764528|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
162195012|NCT02068352|585764526|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
162195013|NCT02068352|585764527|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
162195014|NCT02068352|585764528|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
162195015|NCT02068352|585764526|FG000|Overall Study|Protocol Deviation|0|||
162195016|NCT02068352|585764527|FG001|Overall Study|Protocol Deviation|0|||
162195017|NCT02068352|585764528|FG002|Overall Study|Protocol Deviation|1|||
162195018|NCT01767376|585764532|FG000|Overall Study|Lost to Follow-up|3|||
162195019|NCT01767376|585764533|FG001|Overall Study|Lost to Follow-up|2|||
162195020|NCT01767376|585764534|FG002|Overall Study|Lost to Follow-up|0|||
162195021|NCT01767376|585764532|FG000|Overall Study|Withdrawal by Subject|1|||
162195022|NCT01767376|585764533|FG001|Overall Study|Withdrawal by Subject|1|||
162195023|NCT01767376|585764534|FG002|Overall Study|Withdrawal by Subject|0|||
162195024|NCT03557307|585764535|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
162195025|NCT03557307|585764535|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
162195026|NCT03557307|585764535|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
162195027|NCT03557307|585764535|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
162195028|NCT03557307|585764535|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
162195029|NCT03557307|585764535|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
162195030|NCT03557307|585764535|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
162195031|NCT03557307|585764535|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
162195032|NCT03557307|585764535|FG000|Period 2: Maintenance Phase|Death|3|||
162195033|NCT03557307|585764535|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
161820286|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Death|4|||
161820287|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
161820288|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
161820289|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
161820290|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
161820291|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
162195034|NCT03557307|585764535|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
162195035|NCT03557307|585764535|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
161674739|NCT01674712|583862978|FG002|Overall Study|Protocol Violation|0|||
161925836|NCT03573882|584774645|FG000|Overall Study|Study Terminated by Sponsor|22|||
161925837|NCT03573882|584774646|FG001|Overall Study|Study Terminated by Sponsor|17|||
161925838|NCT03573882|584774647|FG002|Overall Study|Study Terminated by Sponsor|18|||
162195036|NCT03557307|585764535|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
162195037|NCT03557307|585764535|FG000|Period 2: Maintenance Phase|other|3|||
162195038|NCT03745651|585764536|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
162195039|NCT03745651|585764537|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
162195040|NCT03745651|585764538|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
162195041|NCT03745651|585764539|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
162195042|NCT03745651|585764540|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
162195043|NCT03745651|585764541|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
162195044|NCT03745651|585764542|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
162195045|NCT03745651|585764536|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
162195046|NCT03745651|585764537|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
162195047|NCT03745651|585764538|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
162195048|NCT03745651|585764539|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162195049|NCT03745651|585764540|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162195050|NCT03745651|585764541|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162195051|NCT03745651|585764542|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162195052|NCT03745651|585764536|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
162195053|NCT03745651|585764537|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
162195054|NCT03745651|585764538|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
162195055|NCT03745651|585764539|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
162195056|NCT03745651|585764540|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
162195057|NCT03745651|585764541|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
162195058|NCT03745651|585764542|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
162195059|NCT03745651|585764536|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
162195060|NCT03745651|585764537|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
162195061|NCT03745651|585764538|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
162195062|NCT03745651|585764539|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161925839|NCT03573882|584774645|FG000|Overall Study|Withdrawal by Subject|6|||
161925840|NCT03573882|584774646|FG001|Overall Study|Withdrawal by Subject|11|||
161925841|NCT03573882|584774647|FG002|Overall Study|Withdrawal by Subject|7|||
161925842|NCT03573882|584774645|FG000|Overall Study|Adverse Event|7|||
161925843|NCT03573882|584774646|FG001|Overall Study|Adverse Event|5|||
161925844|NCT03573882|584774647|FG002|Overall Study|Adverse Event|6|||
161925845|NCT03573882|584774645|FG000|Overall Study|Lost to Follow-up|2|||
161925846|NCT03573882|584774646|FG001|Overall Study|Lost to Follow-up|5|||
161925847|NCT03573882|584774647|FG002|Overall Study|Lost to Follow-up|3|||
161925848|NCT03573882|584774645|FG000|Overall Study|Physician Decision|4|||
161925849|NCT03573882|584774646|FG001|Overall Study|Physician Decision|3|||
161925850|NCT03573882|584774647|FG002|Overall Study|Physician Decision|2|||
161925851|NCT03573882|584774645|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
161925852|NCT03573882|584774646|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
161925853|NCT03573882|584774647|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
161925854|NCT03573882|584774645|FG000|Overall Study|Pregnancy|1|||
161925855|NCT03573882|584774646|FG001|Overall Study|Pregnancy|2|||
161925856|NCT03573882|584774647|FG002|Overall Study|Pregnancy|0|||
161925857|NCT03573882|584774645|FG000|Overall Study|Other|4|||
161925858|NCT03573882|584774646|FG001|Overall Study|Other|2|||
161925859|NCT03573882|584774647|FG002|Overall Study|Other|2|||
161925860|NCT02691572|584774648|FG000|Overall Study|Withdrawal by Subject|1|||
161925861|NCT02691572|584774649|FG001|Overall Study|Withdrawal by Subject|0|||
161925862|NCT02691572|584774648|FG000|Overall Study|Protocol Violation|0|||
161925863|NCT02691572|584774649|FG001|Overall Study|Protocol Violation|1|||
161925864|NCT00699751|584774650|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
161925865|NCT00699751|584774651|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
161925866|NCT00699751|584774650|FG000|Period 1: Without/Before Drug Switch|Death|28|||
161925867|NCT00699751|584774651|FG001|Period 1: Without/Before Drug Switch|Death|29|||
161925868|NCT00699751|584774650|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
161925869|NCT00699751|584774651|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
161925870|NCT00699751|584774650|FG000|Period 1: Without/Before Drug Switch|Other|30|||
162195063|NCT03745651|585764540|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
162195064|NCT03745651|585764541|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
162195065|NCT03745651|585764542|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
162195066|NCT03745651|585764536|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
162195067|NCT03745651|585764537|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
162195068|NCT03745651|585764538|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
162195069|NCT03745651|585764539|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162195070|NCT03745651|585764540|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162195071|NCT03745651|585764541|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162195072|NCT03745651|585764542|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162195073|NCT03745651|585764536|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
162195074|NCT03745651|585764537|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
162195075|NCT03745651|585764538|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
162195076|NCT03745651|585764539|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
162195077|NCT03745651|585764540|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
162195078|NCT03745651|585764541|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
162195079|NCT03745651|585764542|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
162195080|NCT03745651|585764536|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
162195081|NCT03745651|585764537|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
162195082|NCT03745651|585764538|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
162195083|NCT03745651|585764539|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
162195084|NCT03745651|585764540|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
162195085|NCT03745651|585764541|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
162195086|NCT03745651|585764542|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
162195087|NCT03745651|585764536|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162195088|NCT03745651|585764537|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162195089|NCT03745651|585764538|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162195090|NCT03745651|585764539|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
162195091|NCT03745651|585764540|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162195092|NCT03745651|585764541|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
162195093|NCT03745651|585764542|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
162195094|NCT03745651|585764536|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
162195095|NCT03745651|585764537|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
162195096|NCT03745651|585764538|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
162195097|NCT03745651|585764539|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
162195098|NCT03745651|585764540|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
162195099|NCT03745651|585764541|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
161674740|NCT01674712|583862979|FG003|Overall Study|Protocol Violation|0|||
161674741|NCT01674712|583862980|FG004|Overall Study|Protocol Violation|0|||
161674742|NCT01674712|583862976|FG000|Overall Study|Withdrawal by Subject|2|||
161674743|NCT01674712|583862977|FG001|Overall Study|Withdrawal by Subject|2|||
161674744|NCT01674712|583862978|FG002|Overall Study|Withdrawal by Subject|5|||
161674745|NCT01674712|583862979|FG003|Overall Study|Withdrawal by Subject|4|||
161674746|NCT01674712|583862980|FG004|Overall Study|Withdrawal by Subject|3|||
161674747|NCT01674712|583862976|FG000|Overall Study|Administrative|0|||
162195100|NCT03745651|585764542|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
162195101|NCT03745651|585764536|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161925871|NCT00699751|584774651|FG001|Period 1: Without/Before Drug Switch|Other|20|||
161925872|NCT00699751|584774650|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
162195102|NCT03745651|585764537|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
162195103|NCT03745651|585764538|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
162195104|NCT03745651|585764539|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
162195105|NCT03745651|585764540|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161674748|NCT01674712|583862977|FG001|Overall Study|Administrative|1|||
161674749|NCT01674712|583862978|FG002|Overall Study|Administrative|0|||
161674750|NCT01674712|583862979|FG003|Overall Study|Administrative|0|||
161674751|NCT01674712|583862980|FG004|Overall Study|Administrative|1|||
161674752|NCT01674712|583862976|FG000|Overall Study|Lack of Efficacy|0|||
161925873|NCT00699751|584774651|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
161674753|NCT01674712|583862977|FG001|Overall Study|Lack of Efficacy|0|||
161674754|NCT01674712|583862978|FG002|Overall Study|Lack of Efficacy|1|||
161674755|NCT01674712|583862979|FG003|Overall Study|Lack of Efficacy|0|||
162195106|NCT03745651|585764541|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
162195107|NCT03745651|585764542|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
162195108|NCT03745651|585764536|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
162195109|NCT03745651|585764537|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
162195110|NCT03745651|585764538|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
162195111|NCT03745651|585764539|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
162195112|NCT03745651|585764540|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
162195113|NCT03745651|585764541|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
162195114|NCT03745651|585764542|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
162195115|NCT03745651|585764536|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
162195116|NCT03745651|585764537|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
162195117|NCT03745651|585764538|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
162195118|NCT03745651|585764539|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
162195119|NCT03745651|585764540|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
162195120|NCT03745651|585764541|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
162195121|NCT03745651|585764542|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
162195122|NCT03745651|585764536|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
162195123|NCT03745651|585764537|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
162195124|NCT03745651|585764538|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
162195125|NCT03745651|585764539|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
162195126|NCT03745651|585764540|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
162195127|NCT03745651|585764541|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
162195128|NCT03745651|585764542|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
162195129|NCT03745651|585764536|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
162195130|NCT03745651|585764537|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
162195131|NCT03745651|585764538|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
162195132|NCT03745651|585764539|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
162195133|NCT03745651|585764540|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
162195134|NCT03745651|585764541|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
162195135|NCT03745651|585764542|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
162195136|NCT04175834|585764543|FG000|Overall Study|Withdrawal by Subject|1|||
162195137|NCT04175834|585764544|FG001|Overall Study|Withdrawal by Subject|0|||
162195138|NCT00946088|585764545|FG000|Overall Study|Withdrawal by Subject|0|||
162195139|NCT00946088|585764546|FG001|Overall Study|Withdrawal by Subject|1|||
162195140|NCT01322347|585764550|FG000|Overall Study|Adverse Event|7|||
162195141|NCT01322347|585764551|FG001|Overall Study|Adverse Event|2|||
162195142|NCT01322347|585764550|FG000|Overall Study|Death|5|||
162195143|NCT01322347|585764551|FG001|Overall Study|Death|3|||
162195144|NCT01322347|585764550|FG000|Overall Study|Physician Decision|2|||
162195145|NCT01322347|585764551|FG001|Overall Study|Physician Decision|1|||
162195146|NCT01322347|585764550|FG000|Overall Study|Protocol Violation|5|||
162195147|NCT01322347|585764551|FG001|Overall Study|Protocol Violation|2|||
162195148|NCT01322347|585764550|FG000|Overall Study|Withdrawal by Subject|1|||
162195149|NCT01322347|585764551|FG001|Overall Study|Withdrawal by Subject|4|||
162195150|NCT01322347|585764550|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
162195151|NCT01322347|585764551|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
162195152|NCT01322347|585764550|FG000|Overall Study|blood transfusion|5|||
162195153|NCT01322347|585764551|FG001|Overall Study|blood transfusion|5|||
162195154|NCT01322347|585764550|FG000|Overall Study|sponsor decision|1|||
162195155|NCT01322347|585764551|FG001|Overall Study|sponsor decision|3|||
162195156|NCT01322347|585764550|FG000|Overall Study|ineligible|6|||
162195157|NCT01322347|585764551|FG001|Overall Study|ineligible|3|||
162195158|NCT01322347|585764550|FG000|Overall Study|kidney transplant|3|||
162195159|NCT01322347|585764551|FG001|Overall Study|kidney transplant|1|||
162195160|NCT01322347|585764550|FG000|Overall Study|study drug withheld > 12 wks|0|||
161674756|NCT01674712|583862980|FG004|Overall Study|Lack of Efficacy|1|||
161674757|NCT00056862|583862981|FG000|Overall Study|Protocol Violation|1|||
162020220|NCT05064358|585128625|FG003|Overall Study|Withdrawal by Subject|6|||
162020221|NCT05064358|585128626|FG004|Overall Study|Withdrawal by Subject|3|||
162020222|NCT05064358|585128622|FG000|Overall Study|Ongoing at the time of analysis|1|||
162195161|NCT01322347|585764551|FG001|Overall Study|study drug withheld > 12 wks|1|||
162195162|NCT01322347|585764550|FG000|Overall Study|moved/changed dialysis|2|||
162195163|NCT01322347|585764551|FG001|Overall Study|moved/changed dialysis|4|||
162195164|NCT01193283|585764552|FG000|Overall Study|Death|1|||
162195165|NCT04883541|585764553|FG000|Overall Study|Not attending regular yoga class|16|||
162195166|NCT04883541|585764554|FG001|Overall Study|Not attending regular yoga class|0|||
162195167|NCT04883541|585764553|FG000|Overall Study|Not attending the pregnancy school|0|||
162195168|NCT04883541|585764554|FG001|Overall Study|Not attending the pregnancy school|9|||
161674758|NCT00056862|583862982|FG001|Overall Study|Protocol Violation|0|||
162020223|NCT05064358|585128623|FG001|Overall Study|Ongoing at the time of analysis|2|||
162195169|NCT04239911|585764555|FG000|Overall Study|Lost to Follow-up|2|||
162195170|NCT04239911|585764556|FG001|Overall Study|Lost to Follow-up|1|||
162195171|NCT02137785|585764557|FG000|Overall Study|Lost to Follow-up|1|||
162195172|NCT02137785|585764558|FG001|Overall Study|Lost to Follow-up|0|||
162195173|NCT02137785|585764557|FG000|Overall Study|Withdrawal by Subject|1|||
162195174|NCT02137785|585764558|FG001|Overall Study|Withdrawal by Subject|4|||
162195175|NCT02137785|585764557|FG000|Overall Study|subject moved out of state|1|||
162195176|NCT02137785|585764558|FG001|Overall Study|subject moved out of state|0|||
162195177|NCT03345407|585764560|FG000|Overall Study|Withdrawal by Subject|11|||
162195178|NCT03345407|585764561|FG001|Overall Study|Withdrawal by Subject|1|||
162195179|NCT03345407|585764562|FG002|Overall Study|Withdrawal by Subject|5|||
162195180|NCT03345407|585764563|FG003|Overall Study|Withdrawal by Subject|6|||
162195181|NCT03345407|585764564|FG004|Overall Study|Withdrawal by Subject|3|||
162195182|NCT03345407|585764565|FG005|Overall Study|Withdrawal by Subject|6|||
162195183|NCT03345407|585764566|FG006|Overall Study|Withdrawal by Subject|16|||
162195184|NCT03345407|585764560|FG000|Overall Study|Physician Decision|3|||
162195185|NCT03345407|585764561|FG001|Overall Study|Physician Decision|1|||
162195186|NCT03345407|585764562|FG002|Overall Study|Physician Decision|0|||
162195187|NCT03345407|585764563|FG003|Overall Study|Physician Decision|0|||
162195188|NCT03345407|585764564|FG004|Overall Study|Physician Decision|1|||
162195189|NCT03345407|585764565|FG005|Overall Study|Physician Decision|2|||
162195190|NCT03345407|585764566|FG006|Overall Study|Physician Decision|3|||
162195191|NCT03345407|585764560|FG000|Overall Study|Lost to Follow-up|2|||
162195192|NCT03345407|585764561|FG001|Overall Study|Lost to Follow-up|0|||
162195193|NCT03345407|585764562|FG002|Overall Study|Lost to Follow-up|1|||
162195194|NCT03345407|585764563|FG003|Overall Study|Lost to Follow-up|0|||
162195195|NCT03345407|585764564|FG004|Overall Study|Lost to Follow-up|1|||
162195196|NCT03345407|585764565|FG005|Overall Study|Lost to Follow-up|2|||
162195197|NCT03345407|585764566|FG006|Overall Study|Lost to Follow-up|3|||
162195198|NCT03345407|585764560|FG000|Overall Study|Protocol-defined stopping criteria|9|||
162195199|NCT03345407|585764561|FG001|Overall Study|Protocol-defined stopping criteria|0|||
162195200|NCT03345407|585764562|FG002|Overall Study|Protocol-defined stopping criteria|0|||
162195201|NCT03345407|585764563|FG003|Overall Study|Protocol-defined stopping criteria|0|||
162195202|NCT03345407|585764564|FG004|Overall Study|Protocol-defined stopping criteria|2|||
162195203|NCT03345407|585764565|FG005|Overall Study|Protocol-defined stopping criteria|1|||
162195204|NCT03345407|585764566|FG006|Overall Study|Protocol-defined stopping criteria|1|||
162195205|NCT03345407|585764560|FG000|Overall Study|Protocol Violation|2|||
162195206|NCT03345407|585764561|FG001|Overall Study|Protocol Violation|0|||
162195207|NCT03345407|585764562|FG002|Overall Study|Protocol Violation|0|||
162195208|NCT03345407|585764563|FG003|Overall Study|Protocol Violation|0|||
162195209|NCT03345407|585764564|FG004|Overall Study|Protocol Violation|1|||
162195210|NCT03345407|585764565|FG005|Overall Study|Protocol Violation|0|||
162195211|NCT03345407|585764566|FG006|Overall Study|Protocol Violation|3|||
162195212|NCT03345407|585764560|FG000|Overall Study|Lack of Efficacy|1|||
162195213|NCT03345407|585764561|FG001|Overall Study|Lack of Efficacy|1|||
162195214|NCT03345407|585764562|FG002|Overall Study|Lack of Efficacy|1|||
162195215|NCT03345407|585764563|FG003|Overall Study|Lack of Efficacy|1|||
162195216|NCT03345407|585764564|FG004|Overall Study|Lack of Efficacy|1|||
162195217|NCT03345407|585764565|FG005|Overall Study|Lack of Efficacy|0|||
162195218|NCT03345407|585764566|FG006|Overall Study|Lack of Efficacy|3|||
162195219|NCT03345407|585764560|FG000|Overall Study|Adverse Event|4|||
162195220|NCT03345407|585764561|FG001|Overall Study|Adverse Event|0|||
162195221|NCT03345407|585764562|FG002|Overall Study|Adverse Event|5|||
162195222|NCT03345407|585764563|FG003|Overall Study|Adverse Event|4|||
162195223|NCT03345407|585764564|FG004|Overall Study|Adverse Event|6|||
162195224|NCT03345407|585764565|FG005|Overall Study|Adverse Event|5|||
162195225|NCT03345407|585764566|FG006|Overall Study|Adverse Event|16|||
162195226|NCT01584648|585764567|FG000|Overall Study|Death|136|||
162195227|NCT01584648|585764568|FG001|Overall Study|Death|146|||
162195228|NCT01584648|585764567|FG000|Overall Study|Lost to Follow-up|9|||
162195229|NCT01584648|585764568|FG001|Overall Study|Lost to Follow-up|9|||
162195230|NCT01584648|585764567|FG000|Overall Study|Investigator discretion|3|||
162195231|NCT01584648|585764568|FG001|Overall Study|Investigator discretion|2|||
162195232|NCT01584648|585764567|FG000|Overall Study|Withdrew consent|13|||
162195233|NCT01584648|585764568|FG001|Overall Study|Withdrew consent|4|||
162195234|NCT01584648|585764567|FG000|Overall Study|Study closed/terminated|50|||
162195235|NCT01584648|585764568|FG001|Overall Study|Study closed/terminated|23|||
162195236|NCT01584648|585764567|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
162195237|NCT01584648|585764568|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
162020224|NCT05064358|585128624|FG002|Overall Study|Ongoing at the time of analysis|2|||
162020225|NCT05064358|585128625|FG003|Overall Study|Ongoing at the time of analysis|2|||
162195238|NCT03693989|585764571|FG000|Overall Study|Protocol Violation|3|||
162195239|NCT03693989|585764572|FG001|Overall Study|Protocol Violation|4|||
162195240|NCT01190436|585764573|FG000|Overall Study|Lost to Follow-up|35|||
162195241|NCT01190436|585764573|FG000|Overall Study|Other|4|||
162195242|NCT03146845|585764574|FG000|Overall Study|Reference ulcer healed|1|||
162195243|NCT03146845|585764575|FG001|Overall Study|Reference ulcer healed|0|||
161925874|NCT00699751|584774650|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
161925875|NCT00699751|584774651|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
161925876|NCT00699751|584774650|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
161925877|NCT00699751|584774651|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
161925878|NCT00699751|584774650|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
161925879|NCT00699751|584774651|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
161925880|NCT01947933|584774652|FG000|Overall Study|Withdrawal by Subject|0|||
161925881|NCT01947933|584774653|FG001|Overall Study|Withdrawal by Subject|0|||
161925882|NCT01947933|584774654|FG002|Overall Study|Withdrawal by Subject|1|||
161925883|NCT01947933|584774655|FG003|Overall Study|Withdrawal by Subject|0|||
162195244|NCT03146845|585764574|FG000|Overall Study|Physician Decision|1|||
162195245|NCT03146845|585764575|FG001|Overall Study|Physician Decision|0|||
162195246|NCT03146845|585764574|FG000|Overall Study|Adverse Event|1|||
162195247|NCT03146845|585764575|FG001|Overall Study|Adverse Event|0|||
162195248|NCT03146845|585764574|FG000|Overall Study|Withdrawal by Subject|2|||
162195249|NCT03146845|585764575|FG001|Overall Study|Withdrawal by Subject|0|||
162195250|NCT03146845|585764574|FG000|Overall Study|Noncompliance|0|||
162195251|NCT03146845|585764575|FG001|Overall Study|Noncompliance|1|||
162195252|NCT03146845|585764574|FG000|Overall Study|Protocol Violation|0|||
162195253|NCT03146845|585764575|FG001|Overall Study|Protocol Violation|2|||
162195254|NCT03146845|585764574|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
162195255|NCT03146845|585764575|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
162195256|NCT00595959|585764580|FG000|Overall Study|Withdrawal by Subject|1|||
162195257|NCT00595959|585764580|FG000|Overall Study|Lost to Follow-up|1|||
162195258|NCT00886834|585764581|FG000|Overall Study|Protocol Violation|0|||
162195259|NCT00886834|585764582|FG001|Overall Study|Protocol Violation|3|||
162195260|NCT04085614|585764583|FG000|Overall Study|Protocol Violation|9|||
162195261|NCT04085614|585764584|FG001|Overall Study|Protocol Violation|6|||
162195262|NCT01405508|585764585|FG000|Overall Study|AE, non-serious non-fatal|1|||
162195263|NCT01405508|585764586|FG001|Overall Study|AE, non-serious non-fatal|1|||
162195264|NCT01405508|585764587|FG002|Overall Study|AE, non-serious non-fatal|0|||
162195265|NCT01405508|585764588|FG003|Overall Study|AE, non-serious non-fatal|0|||
162195266|NCT00409747|585764589|FG000|Overall Study|Withdrawal by Subject|1|||
162195267|NCT03060525|585764592|FG000|Overall Study|moved out of state|1|||
162195268|NCT03060525|585764593|FG001|Overall Study|moved out of state|1|||
162195269|NCT03060525|585764594|FG002|Overall Study|moved out of state|1|||
162195270|NCT03060525|585764595|FG003|Overall Study|moved out of state|1|||
162195271|NCT03060525|585764592|FG000|Overall Study|unable to meet time commitment required of study|2|||
162195272|NCT03060525|585764593|FG001|Overall Study|unable to meet time commitment required of study|3|||
162195273|NCT03060525|585764594|FG002|Overall Study|unable to meet time commitment required of study|3|||
162195274|NCT03060525|585764595|FG003|Overall Study|unable to meet time commitment required of study|1|||
162195275|NCT03060525|585764592|FG000|Overall Study|no longer interested in doing intervention|0|||
162195276|NCT03060525|585764593|FG001|Overall Study|no longer interested in doing intervention|0|||
162195277|NCT03060525|585764594|FG002|Overall Study|no longer interested in doing intervention|0|||
161674759|NCT00381563|583862986|FG000|Overall Study|Withdrawal by Subject|5|||
161674760|NCT00381563|583862987|FG001|Overall Study|Withdrawal by Subject|5|||
161674761|NCT00381563|583862986|FG000|Overall Study|Lost to Follow-up|2|||
161674762|NCT00381563|583862987|FG001|Overall Study|Lost to Follow-up|0|||
161674763|NCT00381563|583862986|FG000|Overall Study|Protocol Violation|0|||
161674764|NCT00381563|583862987|FG001|Overall Study|Protocol Violation|1|||
161674765|NCT01132612|583862991|FG000|Overall Study|Death|0|||
161674766|NCT01132612|583862992|FG001|Overall Study|Death|0|||
161674767|NCT01132612|583862993|FG002|Overall Study|Death|1|||
161674768|NCT01132612|583862991|FG000|Overall Study|Protocol deviation|0|||
161674769|NCT01132612|583862992|FG001|Overall Study|Protocol deviation|0|||
161674770|NCT01132612|583862993|FG002|Overall Study|Protocol deviation|3|||
161674771|NCT01132612|583862991|FG000|Overall Study|Lost to Follow-up|2|||
161674772|NCT01132612|583862992|FG001|Overall Study|Lost to Follow-up|2|||
161674773|NCT01132612|583862993|FG002|Overall Study|Lost to Follow-up|7|||
161674774|NCT01132612|583862991|FG000|Overall Study|Adverse Event|5|||
161674775|NCT01132612|583862992|FG001|Overall Study|Adverse Event|2|||
161674776|NCT01132612|583862993|FG002|Overall Study|Adverse Event|15|||
161674777|NCT01132612|583862991|FG000|Overall Study|Withdrawal by Subject|5|||
161674778|NCT01132612|583862992|FG001|Overall Study|Withdrawal by Subject|8|||
161674779|NCT01132612|583862993|FG002|Overall Study|Withdrawal by Subject|19|||
161674780|NCT01132612|583862991|FG000|Overall Study|Administrative problems|5|||
161674781|NCT01132612|583862992|FG001|Overall Study|Administrative problems|1|||
161674782|NCT01132612|583862993|FG002|Overall Study|Administrative problems|52|||
161674783|NCT01132612|583862991|FG000|Overall Study|Lack of Efficacy|23|||
161674784|NCT01132612|583862992|FG001|Overall Study|Lack of Efficacy|22|||
161674785|NCT01132612|583862993|FG002|Overall Study|Lack of Efficacy|73|||
161674786|NCT02252536|583862994|FG000|Overall Study|Lost to Follow-up|5|||
161674787|NCT02252536|583862995|FG001|Overall Study|Lost to Follow-up|3|||
161674788|NCT02378220|583862998|FG000|Overall Study|Death|6|||
161674789|NCT02378220|583862999|FG001|Overall Study|Death|1|||
161674790|NCT02060721|583863004|FG000|Overall Study|Lost to Follow-up|1|||
161674791|NCT02060721|583863004|FG000|Overall Study|Physician Decision|2|||
161674792|NCT02060721|583863004|FG000|Overall Study|Death|14|||
161674793|NCT02060721|583863004|FG000|Overall Study|Withdrawal by Subject|2|||
161674794|NCT02060721|583863004|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
161674795|NCT05105789|583863005|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
161674796|NCT00728481|583863009|FG000|Overall Study|Withdrawal by Subject|0|||
161674797|NCT00728481|583863010|FG001|Overall Study|Withdrawal by Subject|1|||
161674798|NCT00728481|583863009|FG000|Overall Study|Adverse Event|0|||
161674799|NCT00728481|583863010|FG001|Overall Study|Adverse Event|1|||
161674800|NCT00728481|583863009|FG000|Overall Study|Study medication non-compliance|0|||
161674801|NCT00728481|583863010|FG001|Overall Study|Study medication non-compliance|2|||
161674802|NCT00728481|583863009|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
161674803|NCT00728481|583863010|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
161674804|NCT03690141|583863011|FG000|Overall Study|Adverse Event|5|||
161674805|NCT03690141|583863011|FG000|Overall Study|Withdrawal by Subject|3|||
161674806|NCT03690141|583863011|FG000|Overall Study|Physician Decision|4|||
161674807|NCT03690141|583863011|FG000|Overall Study|Disease progression|4|||
161674808|NCT01505010|583863012|FG000|Overall Study|Protocol Violation|0|||
161674809|NCT01505010|583863013|FG001|Overall Study|Protocol Violation|1|||
161820292|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
161820293|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
161820294|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
161820295|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
161820296|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
161820297|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
161820298|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
161820299|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
161820300|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
161820301|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
161674810|NCT01505010|583863012|FG000|Overall Study|Lost to Follow-up|0|||
161674811|NCT01505010|583863013|FG001|Overall Study|Lost to Follow-up|1|||
161674812|NCT04744285|583863014|FG000|Overall Study|Withdrawal by Subject|1|||
161674813|NCT04744285|583863015|FG001|Overall Study|Withdrawal by Subject|1|||
161674814|NCT04744285|583863016|FG002|Overall Study|Withdrawal by Subject|2|||
161674815|NCT04744285|583863017|FG003|Overall Study|Withdrawal by Subject|1|||
161674816|NCT02558231|583863024|FG000|Overall Study|Death|4|||
161674817|NCT02558231|583863025|FG001|Overall Study|Death|12|||
161674818|NCT02558231|583863024|FG000|Overall Study|Lost to Follow-up|7|||
161674819|NCT02558231|583863025|FG001|Overall Study|Lost to Follow-up|4|||
161674820|NCT02558231|583863024|FG000|Overall Study|Withdrawal by Subject|7|||
161674821|NCT02558231|583863025|FG001|Overall Study|Withdrawal by Subject|4|||
161674822|NCT02558231|583863024|FG000|Overall Study|Physician Decision|7|||
161674823|NCT02558231|583863025|FG001|Overall Study|Physician Decision|5|||
161674824|NCT02558231|583863024|FG000|Overall Study|Sponsor Decision|0|||
161674825|NCT02558231|583863025|FG001|Overall Study|Sponsor Decision|1|||
161674826|NCT00995007|583863026|FG000|Overall Study|Withdrew consent|1|||
161674827|NCT00995007|583863027|FG001|Overall Study|Withdrew consent|0|||
161674828|NCT00995007|583863026|FG000|Overall Study|Refused further treatment|8|||
161674829|NCT00995007|583863027|FG001|Overall Study|Refused further treatment|2|||
161674830|NCT00995007|583863026|FG000|Overall Study|Toxicity|8|||
161674831|NCT00995007|583863027|FG001|Overall Study|Toxicity|0|||
161674832|NCT03933397|583863028|FG000|Overall Study|No emergency department visit|65|||
161674833|NCT03933397|583863029|FG001|Overall Study|No emergency department visit|71|||
161674834|NCT03933397|583863028|FG000|Overall Study|Missed emergency department visit|25|||
161674835|NCT03933397|583863029|FG001|Overall Study|Missed emergency department visit|30|||
161674836|NCT03933397|583863028|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
161674837|NCT03933397|583863029|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
161674838|NCT03933397|583863028|FG000|Overall Study|Withdrawal by Subject|1|||
161674839|NCT03933397|583863029|FG001|Overall Study|Withdrawal by Subject|0|||
161674840|NCT03933397|583863028|FG000|Overall Study|Physician Decision|1|||
161674841|NCT03933397|583863029|FG001|Overall Study|Physician Decision|1|||
161674842|NCT03933397|583863028|FG000|Overall Study|missing pain score|1|||
161674843|NCT03933397|583863029|FG001|Overall Study|missing pain score|1|||
161674844|NCT03933397|583863028|FG000|Overall Study|Confirmed COVID-19|1|||
161674845|NCT03933397|583863029|FG001|Overall Study|Confirmed COVID-19|2|||
161674846|NCT02066051|583863031|FG000|Overall Study|Subject developed active GVHD|1|||
161674847|NCT01610687|583863034|FG000|Overall Study|Lack of Efficacy|26|||
161674848|NCT01610687|583863034|FG000|Overall Study|Adverse Event|18|||
161674849|NCT01610687|583863034|FG000|Overall Study|Moved out of area|6|||
161674850|NCT01610687|583863034|FG000|Overall Study|Withdrawal by Subject|7|||
161925884|NCT01947933|584774656|FG004|Overall Study|Withdrawal by Subject|0|||
161925885|NCT01947933|584774657|FG005|Overall Study|Withdrawal by Subject|0|||
161674851|NCT01610687|583863034|FG000|Overall Study|Lost to Follow-up|4|||
161674852|NCT01610687|583863034|FG000|Overall Study|Symptom control without study medication|2|||
161674853|NCT01610687|583863034|FG000|Overall Study|Unable to make journey|1|||
161674854|NCT01610687|583863034|FG000|Overall Study|Death|1|||
161925886|NCT01947933|584774658|FG006|Overall Study|Withdrawal by Subject|0|||
161925887|NCT01947933|584774659|FG007|Overall Study|Withdrawal by Subject|0|||
161674855|NCT01610687|583863034|FG000|Overall Study|Cannabis affecting job|1|||
161674856|NCT01610687|583863034|FG000|Overall Study|Felt more alter without study medication|1|||
161674857|NCT01294150|583863037|FG000|Overall Study|Physician Decision|2|||
161674858|NCT01294150|583863038|FG001|Overall Study|Physician Decision|2|||
161674859|NCT03675776|583863039|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
161674860|NCT03675776|583863040|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
161674861|NCT03675776|583863041|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
161674862|NCT03675776|583863039|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
161674863|NCT03675776|583863040|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
161674864|NCT03675776|583863041|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
161674865|NCT01093625|583863042|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
161674866|NCT01093625|583863043|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
161674867|NCT01093625|583863042|FG000|2-Week Visit|Withdrawal by Subject|1|||
161674868|NCT01093625|583863043|FG001|2-Week Visit|Withdrawal by Subject|0|||
161925888|NCT01947933|584774660|FG008|Overall Study|Withdrawal by Subject|0|||
161925889|NCT01947933|584774652|FG000|Overall Study|Lost to Follow-up|0|||
161925890|NCT01947933|584774653|FG001|Overall Study|Lost to Follow-up|0|||
161925891|NCT01947933|584774654|FG002|Overall Study|Lost to Follow-up|0|||
161925892|NCT01947933|584774655|FG003|Overall Study|Lost to Follow-up|0|||
161925893|NCT01947933|584774656|FG004|Overall Study|Lost to Follow-up|0|||
161674869|NCT01093625|583863042|FG000|1-Month Visit|Lost to Follow-up|2|||
161674870|NCT01093625|583863043|FG001|1-Month Visit|Lost to Follow-up|0|||
161674871|NCT01093625|583863042|FG000|3-Month Visit|Lost to Follow-up|2|||
161674872|NCT01093625|583863043|FG001|3-Month Visit|Lost to Follow-up|0|||
161674873|NCT01093625|583863042|FG000|6-Month Visit|Withdrawal by Subject|6|||
161925894|NCT01947933|584774657|FG005|Overall Study|Lost to Follow-up|0|||
161925895|NCT01947933|584774658|FG006|Overall Study|Lost to Follow-up|0|||
161925896|NCT01947933|584774659|FG007|Overall Study|Lost to Follow-up|0|||
161925897|NCT01947933|584774660|FG008|Overall Study|Lost to Follow-up|1|||
161925898|NCT00294398|584774661|FG000|Overall Study|Lost to Follow-up|21|||
161925899|NCT00294398|584774662|FG001|Overall Study|Lost to Follow-up|26|||
161925900|NCT00250718|584774665|FG000|Overall Study|Death|1|||
162195278|NCT03060525|585764595|FG003|Overall Study|no longer interested in doing intervention|1|||
162195279|NCT01964547|585764596|FG000|Overall Study|Adverse Event|8|||
162195280|NCT01964547|585764597|FG001|Overall Study|Adverse Event|2|||
162195281|NCT01964547|585764596|FG000|Overall Study|Withdrawal by Subject|4|||
161925901|NCT00250718|584774665|FG000|Overall Study|Adverse Event|1|||
161925902|NCT00250718|584774665|FG000|Overall Study|Withdrawal by Subject|1|||
161925903|NCT04439123|584774668|FG000|Overall Study|Adverse Event|11|||
161925904|NCT04439123|584774668|FG000|Overall Study|Death|1|||
161925905|NCT04439123|584774668|FG000|Overall Study|Disease progression|19|||
161925906|NCT04439123|584774668|FG000|Overall Study|Withdrawal by Subject|2|||
161925907|NCT04439123|584774668|FG000|Overall Study|Still on treatment|2|||
161925908|NCT02593864|584774670|FG000|Overall Study|Withdrawal by Subject|3|||
161925909|NCT02593864|584774670|FG000|Overall Study|Lost to Follow-up|3|||
161925910|NCT02114684|584774676|FG000|Overall Study|Death|6|||
161925911|NCT02114684|584774677|FG001|Overall Study|Death|4|||
161925912|NCT02114684|584774676|FG000|Overall Study|Lost to Follow-up|1|||
161925913|NCT02114684|584774677|FG001|Overall Study|Lost to Follow-up|2|||
161925914|NCT02114684|584774676|FG000|Overall Study|Withdrawal by Subject|1|||
161925915|NCT02114684|584774677|FG001|Overall Study|Withdrawal by Subject|2|||
161925916|NCT02114684|584774676|FG000|Overall Study|Relocation|3|||
161925917|NCT02114684|584774677|FG001|Overall Study|Relocation|1|||
161925918|NCT02114684|584774676|FG000|Overall Study|Rifampicin resistant on culture|0|||
161925919|NCT02114684|584774677|FG001|Overall Study|Rifampicin resistant on culture|1|||
161925920|NCT02114684|584774676|FG000|Overall Study|Patient Incarcerated|1|||
161925921|NCT02114684|584774677|FG001|Overall Study|Patient Incarcerated|0|||
161925922|NCT03828383|584774680|FG000|Overall Study|Lost to Follow-up|3|||
161925923|NCT03828383|584774681|FG001|Overall Study|Lost to Follow-up|2|||
161925924|NCT03828383|584774680|FG000|Overall Study|Withdrawal by Subject|4|||
161925925|NCT03828383|584774681|FG001|Overall Study|Withdrawal by Subject|5|||
161925926|NCT03345095|584774682|FG000|Overall Study|Lack of Efficacy|184|||
161925927|NCT03345095|584774683|FG001|Overall Study|Lack of Efficacy|156|||
161925928|NCT03345095|584774682|FG000|Overall Study|Adverse Event|36|||
161925929|NCT03345095|584774683|FG001|Overall Study|Adverse Event|118|||
161925930|NCT03345095|584774682|FG000|Overall Study|Withdrawal by Subject|22|||
161925931|NCT03345095|584774683|FG001|Overall Study|Withdrawal by Subject|59|||
161925932|NCT03345095|584774682|FG000|Overall Study|Physician Decision|3|||
161925933|NCT03345095|584774683|FG001|Overall Study|Physician Decision|18|||
161925934|NCT03345095|584774682|FG000|Overall Study|Death|2|||
161925935|NCT03345095|584774683|FG001|Overall Study|Death|4|||
161925936|NCT03345095|584774682|FG000|Overall Study|Other reasons|2|||
161925937|NCT03345095|584774683|FG001|Overall Study|Other reasons|11|||
161925938|NCT03345095|584774682|FG000|Overall Study|Protocol Violation|0|||
161925939|NCT03345095|584774683|FG001|Overall Study|Protocol Violation|1|||
161925940|NCT03022630|584777014|FG000|Overall Study|Death|9|||
161925941|NCT03022630|584777015|FG001|Overall Study|Death|7|||
161925942|NCT03022630|584777014|FG000|Overall Study|Withdrawal by Subject|0|||
161925943|NCT03022630|584777015|FG001|Overall Study|Withdrawal by Subject|5|||
161925944|NCT00382070|584777016|FG000|Overall Study|No follow up data mapped to Other|17|||
161925945|NCT00382070|584777017|FG001|Overall Study|No follow up data mapped to Other|19|||
161925946|NCT00382070|584777016|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
161925947|NCT00382070|584777017|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
161925948|NCT00382070|584777016|FG000|Overall Study|No clinical assessment|9|||
161925949|NCT00382070|584777017|FG001|Overall Study|No clinical assessment|11|||
161925950|NCT01734928|584777018|FG000|Randomization|Physician Decision|0|||
161925951|NCT01734928|584777019|FG001|Randomization|Physician Decision|1|||
161925952|NCT01734928|584777018|FG000|Randomization|clinical progression|0|||
161925953|NCT01734928|584777019|FG001|Randomization|clinical progression|1|||
161925954|NCT01734928|584777018|FG000|Randomization|progressive disease|0|||
161925955|NCT01734928|584777019|FG001|Randomization|progressive disease|2|||
161925956|NCT01734928|584777018|FG000|Randomization|Withdrew informed consent|0|||
161925957|NCT01734928|584777019|FG001|Randomization|Withdrew informed consent|4|||
161925958|NCT01734928|584777018|FG000|Randomization|Death|1|||
161925959|NCT01734928|584777019|FG001|Randomization|Death|0|||
161925960|NCT01734928|584777018|FG000|Randomization|Randomization error|1|||
161925961|NCT01734928|584777019|FG001|Randomization|Randomization error|0|||
161925962|NCT01734928|584777018|FG000|Randomization|Lost to Follow-up|1|||
161925963|NCT01734928|584777019|FG001|Randomization|Lost to Follow-up|0|||
161925964|NCT01734928|584777018|FG000|Treatment Period|Lost to Follow-up|0|||
161925965|NCT01734928|584777019|FG001|Treatment Period|Lost to Follow-up|2|||
162195282|NCT01964547|585764597|FG001|Overall Study|Withdrawal by Subject|7|||
161925966|NCT01734928|584777018|FG000|Treatment Period|Progressive Disease|167|||
161925967|NCT01734928|584777019|FG001|Treatment Period|Progressive Disease|165|||
161925968|NCT01734928|584777018|FG000|Treatment Period|Adverse Event|39|||
161925969|NCT01734928|584777019|FG001|Treatment Period|Adverse Event|52|||
161925970|NCT01734928|584777018|FG000|Treatment Period|Withdrawal of Consent|25|||
161925971|NCT01734928|584777019|FG001|Treatment Period|Withdrawal of Consent|22|||
161925972|NCT01734928|584777018|FG000|Treatment Period|Death|20|||
162195283|NCT01964547|585764596|FG000|Overall Study|Lost to Follow-up|0|||
161674874|NCT01093625|583863043|FG001|6-Month Visit|Withdrawal by Subject|7|||
161925973|NCT01734928|584777019|FG001|Treatment Period|Death|9|||
161925974|NCT01734928|584777018|FG000|Treatment Period|Other Reasons|27|||
161925975|NCT01734928|584777019|FG001|Treatment Period|Other Reasons|19|||
161925976|NCT01734928|584777018|FG000|Treatment Period|Pregnancy|0|||
161925977|NCT01734928|584777019|FG001|Treatment Period|Pregnancy|1|||
161925978|NCT01629563|584777020|FG000|Overall Study|Adverse Event|16|||
161925979|NCT01629563|584777021|FG001|Overall Study|Adverse Event|16|||
161925980|NCT01629563|584777020|FG000|Overall Study|Death|2|||
161925981|NCT01629563|584777021|FG001|Overall Study|Death|0|||
161925982|NCT01629563|584777020|FG000|Overall Study|Lack of Efficacy|2|||
161674875|NCT01093625|583863042|FG000|6-Month Visit|Lost to Follow-up|2|||
161674876|NCT01093625|583863043|FG001|6-Month Visit|Lost to Follow-up|2|||
161674877|NCT01093625|583863042|FG000|1-Year Visit|Lost to Follow-up|5|||
161925983|NCT01629563|584777021|FG001|Overall Study|Lack of Efficacy|3|||
161925984|NCT01629563|584777020|FG000|Overall Study|Lost to Follow-up|1|||
161925985|NCT01629563|584777021|FG001|Overall Study|Lost to Follow-up|0|||
161925986|NCT01629563|584777020|FG000|Overall Study|Pregnancy|1|||
161925987|NCT01629563|584777021|FG001|Overall Study|Pregnancy|2|||
161925988|NCT01629563|584777020|FG000|Overall Study|Protocol Violation|0|||
161925989|NCT01629563|584777021|FG001|Overall Study|Protocol Violation|1|||
161925990|NCT01629563|584777020|FG000|Overall Study|Withdrawal by Subject|27|||
161925991|NCT01629563|584777021|FG001|Overall Study|Withdrawal by Subject|20|||
161925992|NCT01629563|584777020|FG000|Overall Study|surgery|0|||
161925993|NCT01629563|584777021|FG001|Overall Study|surgery|3|||
161674878|NCT01093625|583863043|FG001|1-Year Visit|Lost to Follow-up|3|||
161674879|NCT00698932|583863044|FG000|Overall Study|Adverse Event|0|||
161674880|NCT00698932|583863045|FG001|Overall Study|Adverse Event|2|||
161674881|NCT00698932|583863044|FG000|Overall Study|Incorrect enrollment|0|||
161674882|NCT00698932|583863045|FG001|Overall Study|Incorrect enrollment|2|||
161674883|NCT00698932|583863044|FG000|Overall Study|Study specific discontinuation criteria|3|||
161674884|NCT00698932|583863045|FG001|Overall Study|Study specific discontinuation criteria|4|||
161674885|NCT00698932|583863044|FG000|Overall Study|Withdrawal by Subject|11|||
161674886|NCT00698932|583863045|FG001|Overall Study|Withdrawal by Subject|23|||
161674887|NCT00698932|583863044|FG000|Overall Study|Lost to Follow-up|6|||
161674888|NCT00698932|583863045|FG001|Overall Study|Lost to Follow-up|1|||
161674889|NCT00698932|583863044|FG000|Overall Study|Severe non-compliance to protocol|1|||
161674890|NCT00698932|583863045|FG001|Overall Study|Severe non-compliance to protocol|2|||
161674891|NCT00698932|583863044|FG000|Overall Study|Safety reasons|0|||
161674892|NCT00698932|583863045|FG001|Overall Study|Safety reasons|2|||
162195284|NCT01964547|585764597|FG001|Overall Study|Lost to Follow-up|1|||
162195285|NCT01964547|585764596|FG000|Overall Study|Withdrawal by Investigator|0|||
162195286|NCT01964547|585764597|FG001|Overall Study|Withdrawal by Investigator|1|||
162195287|NCT01115309|585764598|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
162195288|NCT01115309|585764598|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
162195289|NCT01115309|585764598|FG000|Long-term Follow-up|Lost to Follow-up|6|||
162195290|NCT04447287|585764599|FG000|Period 1: Run-in Period|Adverse Event|3|||
162195291|NCT04447287|585764600|FG001|Period 1: Run-in Period|Adverse Event|0|||
162195292|NCT04447287|585764601|FG002|Period 1: Run-in Period|Adverse Event|0|||
162195293|NCT04447287|585764599|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
161674893|NCT00698932|583863044|FG000|Overall Study|Death|1|||
161674894|NCT00698932|583863045|FG001|Overall Study|Death|0|||
161674895|NCT06132425|583863046|FG000|Overall Study|Withdrawal by Subject|3|||
161674896|NCT06132425|583863047|FG001|Overall Study|Withdrawal by Subject|0|||
161674897|NCT06132425|583863046|FG000|Overall Study|Did not follow study instructions|0|||
161674898|NCT06132425|583863047|FG001|Overall Study|Did not follow study instructions|2|||
161674899|NCT06132425|583863046|FG000|Overall Study|Lost to Follow-up|3|||
161674900|NCT06132425|583863047|FG001|Overall Study|Lost to Follow-up|5|||
161674901|NCT00708175|583863048|FG000|Overall Study|Adverse Event|4|||
161674902|NCT00708175|583863049|FG001|Overall Study|Adverse Event|5|||
161674903|NCT00708175|583863048|FG000|Overall Study|Protocol Violation|2|||
161674904|NCT00708175|583863049|FG001|Overall Study|Protocol Violation|3|||
161674905|NCT00708175|583863048|FG000|Overall Study|Lost to Follow-up|5|||
161674906|NCT00708175|583863049|FG001|Overall Study|Lost to Follow-up|3|||
161674907|NCT00708175|583863048|FG000|Overall Study|Withdrawal by Subject|5|||
161674908|NCT00708175|583863049|FG001|Overall Study|Withdrawal by Subject|7|||
161674909|NCT00708175|583863048|FG000|Overall Study|BMD loss >7%|2|||
161674910|NCT00708175|583863049|FG001|Overall Study|BMD loss >7%|3|||
161674911|NCT04435782|583863051|FG000|Overall Study|Study terminated by sponsor|4|||
161674912|NCT04667247|583863052|FG000|Overall Study|Withdrawal by Subject|0|||
161674913|NCT04667247|583863053|FG001|Overall Study|Withdrawal by Subject|1|||
161674914|NCT01876251|583865370|FG000|Overall Study|Clinical progression|1|||
161674915|NCT01876251|583865371|FG001|Overall Study|Clinical progression|0|||
161925994|NCT01629563|584777020|FG000|Overall Study|Lack of return of menses|12|||
161925995|NCT01629563|584777021|FG001|Overall Study|Lack of return of menses|7|||
161674916|NCT01876251|583865372|FG002|Overall Study|Clinical progression|0|||
161925996|NCT01629563|584777020|FG000|Overall Study|Protocol Violation|0|||
161925997|NCT01629563|584777021|FG001|Overall Study|Protocol Violation|1|||
162020226|NCT05064358|585128626|FG004|Overall Study|Ongoing at the time of analysis|2|||
162020227|NCT04421027|585128627|FG000|Treatment Period|Adverse Event|5|||
162020228|NCT04421027|585128628|FG001|Treatment Period|Adverse Event|3|||
162020229|NCT04421027|585128629|FG002|Treatment Period|Adverse Event|0|||
162020230|NCT04421027|585128630|FG003|Treatment Period|Adverse Event|0|||
162020231|NCT04421027|585128627|FG000|Treatment Period|Death|98|||
162020232|NCT04421027|585128628|FG001|Treatment Period|Death|61|||
162020233|NCT04421027|585128629|FG002|Treatment Period|Death|0|||
162020234|NCT04421027|585128630|FG003|Treatment Period|Death|0|||
162020235|NCT04421027|585128627|FG000|Treatment Period|Lost to Follow-up|22|||
162195294|NCT04447287|585764600|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
162195295|NCT04447287|585764601|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
162195296|NCT04447287|585764599|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
162195297|NCT04447287|585764600|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
162195298|NCT04447287|585764601|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
162195299|NCT05700851|585764602|FG000|Overall Study|Received a kidney transplant|1|||
162195300|NCT05700851|585764602|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
161674917|NCT01876251|583865370|FG000|Overall Study|Death|2|||
161674918|NCT01876251|583865371|FG001|Overall Study|Death|0|||
161674919|NCT01876251|583865372|FG002|Overall Study|Death|1|||
161674920|NCT01876251|583865370|FG000|Overall Study|Participant started new treatment|1|||
161674921|NCT01876251|583865371|FG001|Overall Study|Participant started new treatment|0|||
161674922|NCT01876251|583865372|FG002|Overall Study|Participant started new treatment|1|||
161674923|NCT01876251|583865370|FG000|Overall Study|Participant refused further follow-up|0|||
161674924|NCT01876251|583865371|FG001|Overall Study|Participant refused further follow-up|0|||
161674925|NCT01876251|583865372|FG002|Overall Study|Participant refused further follow-up|1|||
161674926|NCT01876251|583865370|FG000|Overall Study|Study terminated|1|||
161674927|NCT01876251|583865371|FG001|Overall Study|Study terminated|0|||
161674928|NCT01876251|583865372|FG002|Overall Study|Study terminated|0|||
162020236|NCT04421027|585128628|FG001|Treatment Period|Lost to Follow-up|20|||
162020237|NCT04421027|585128629|FG002|Treatment Period|Lost to Follow-up|0|||
162020238|NCT04421027|585128630|FG003|Treatment Period|Lost to Follow-up|0|||
162020239|NCT04421027|585128627|FG000|Treatment Period|Other-Unknown|15|||
162020240|NCT04421027|585128628|FG001|Treatment Period|Other-Unknown|9|||
162020241|NCT04421027|585128629|FG002|Treatment Period|Other-Unknown|0|||
162020242|NCT04421027|585128630|FG003|Treatment Period|Other-Unknown|0|||
162020243|NCT04421027|585128627|FG000|Treatment Period|Physician Decision|1|||
162020244|NCT04421027|585128628|FG001|Treatment Period|Physician Decision|1|||
162020245|NCT04421027|585128629|FG002|Treatment Period|Physician Decision|0|||
162020246|NCT04421027|585128630|FG003|Treatment Period|Physician Decision|0|||
162020247|NCT04421027|585128627|FG000|Treatment Period|Withdrawal by Subject|7|||
162020248|NCT04421027|585128628|FG001|Treatment Period|Withdrawal by Subject|12|||
162020249|NCT04421027|585128629|FG002|Treatment Period|Withdrawal by Subject|0|||
162020250|NCT04421027|585128630|FG003|Treatment Period|Withdrawal by Subject|0|||
162020251|NCT04421027|585128627|FG000|Treatment Period|Randomized Not Dosed|9|||
161674929|NCT01876251|583865370|FG000|Overall Study|Objective progression or relapse|10|||
162020252|NCT04421027|585128628|FG001|Treatment Period|Randomized Not Dosed|14|||
162020253|NCT04421027|585128629|FG002|Treatment Period|Randomized Not Dosed|0|||
162020254|NCT04421027|585128630|FG003|Treatment Period|Randomized Not Dosed|0|||
162020255|NCT04421027|585128627|FG000|Follow-Up Period|Adverse Event|0|||
162020256|NCT04421027|585128628|FG001|Follow-Up Period|Adverse Event|0|||
162020257|NCT04421027|585128629|FG002|Follow-Up Period|Adverse Event|0|||
162020258|NCT04421027|585128630|FG003|Follow-Up Period|Adverse Event|3|||
162020259|NCT04421027|585128627|FG000|Follow-Up Period|Death|0|||
162020260|NCT04421027|585128628|FG001|Follow-Up Period|Death|0|||
162020261|NCT04421027|585128629|FG002|Follow-Up Period|Death|16|||
162020262|NCT04421027|585128630|FG003|Follow-Up Period|Death|17|||
162020263|NCT04421027|585128627|FG000|Follow-Up Period|Lost to Follow-up|0|||
162020264|NCT04421027|585128628|FG001|Follow-Up Period|Lost to Follow-up|0|||
162020265|NCT04421027|585128629|FG002|Follow-Up Period|Lost to Follow-up|7|||
162020266|NCT04421027|585128630|FG003|Follow-Up Period|Lost to Follow-up|7|||
162020267|NCT04421027|585128627|FG000|Follow-Up Period|Protocol Deviation|0|||
162020268|NCT04421027|585128628|FG001|Follow-Up Period|Protocol Deviation|0|||
161674930|NCT01876251|583865371|FG001|Overall Study|Objective progression or relapse|3|||
161674931|NCT01876251|583865372|FG002|Overall Study|Objective progression or relapse|8|||
162020269|NCT04421027|585128629|FG002|Follow-Up Period|Protocol Deviation|1|||
162020270|NCT04421027|585128630|FG003|Follow-Up Period|Protocol Deviation|0|||
162020271|NCT04421027|585128627|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
162020272|NCT04421027|585128628|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
162020273|NCT04421027|585128629|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
162020274|NCT04421027|585128630|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
162020275|NCT04421027|585128627|FG000|Follow-Up Period|Left message, participant did not call back|0|||
161925998|NCT00088881|584777023|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
161925999|NCT00088881|584777023|FG000|Step 1 - R-CHOP|Adverse Event|1|||
162195301|NCT05700851|585764602|FG000|Overall Study|Withdrawal by Subject|1|||
162195302|NCT02147093|585764603|FG000|Period 1|Lost to Follow-up|0|||
162195303|NCT02147093|585764604|FG001|Period 1|Lost to Follow-up|1|||
162195304|NCT02147093|585764603|FG000|Period 2|Protocol Violation|2|||
162195305|NCT02147093|585764604|FG001|Period 2|Protocol Violation|0|||
162195306|NCT03246724|585764605|FG000|Overall Study|Withdrawal by Subject|5|||
162195307|NCT03246724|585764606|FG001|Overall Study|Withdrawal by Subject|2|||
162195308|NCT03246724|585764607|FG002|Overall Study|Withdrawal by Subject|4|||
162195309|NCT03246724|585764608|FG003|Overall Study|Withdrawal by Subject|2|||
162195310|NCT03246724|585764605|FG000|Overall Study|Ineligible on day of surgery|7|||
162195311|NCT03246724|585764606|FG001|Overall Study|Ineligible on day of surgery|2|||
162195312|NCT03246724|585764607|FG002|Overall Study|Ineligible on day of surgery|0|||
162195313|NCT03246724|585764608|FG003|Overall Study|Ineligible on day of surgery|3|||
162195314|NCT03246724|585764605|FG000|Overall Study|Study completed before surgical date|2|||
162195315|NCT03246724|585764606|FG001|Overall Study|Study completed before surgical date|1|||
162195316|NCT03246724|585764607|FG002|Overall Study|Study completed before surgical date|8|||
162195317|NCT03246724|585764608|FG003|Overall Study|Study completed before surgical date|1|||
162195318|NCT03246724|585764605|FG000|Overall Study|Transferred to other arm|0|||
162195319|NCT03246724|585764606|FG001|Overall Study|Transferred to other arm|0|||
162195320|NCT03246724|585764607|FG002|Overall Study|Transferred to other arm|1|||
162195321|NCT03246724|585764608|FG003|Overall Study|Transferred to other arm|0|||
161926000|NCT00088881|584777023|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
161926001|NCT00088881|584777023|FG000|Step 1 - R-CHOP|Physician Decision|1|||
162195322|NCT03246724|585764605|FG000|Overall Study|Unable to obtain medication timely|0|||
162195323|NCT03246724|585764606|FG001|Overall Study|Unable to obtain medication timely|2|||
161674932|NCT02012296|583865379|FG000|Overall Study|Lack of Efficacy|0|||
161674933|NCT02012296|583865380|FG001|Overall Study|Lack of Efficacy|0|||
161674934|NCT02012296|583865381|FG002|Overall Study|Lack of Efficacy|15|||
161674935|NCT02012296|583865379|FG000|Overall Study|Adverse Event|0|||
161674936|NCT02012296|583865380|FG001|Overall Study|Adverse Event|0|||
161674937|NCT02012296|583865381|FG002|Overall Study|Adverse Event|2|||
161674938|NCT02012296|583865379|FG000|Overall Study|Early study closure|0|||
161674939|NCT02012296|583865380|FG001|Overall Study|Early study closure|0|||
161674940|NCT02012296|583865381|FG002|Overall Study|Early study closure|5|||
161674941|NCT02012296|583865379|FG000|Overall Study|Protocol Violation|0|||
162020276|NCT04421027|585128628|FG001|Follow-Up Period|Left message, participant did not call back|0|||
161674942|NCT02012296|583865380|FG001|Overall Study|Protocol Violation|1|||
161674943|NCT02012296|583865381|FG002|Overall Study|Protocol Violation|0|||
162195324|NCT03246724|585764607|FG002|Overall Study|Unable to obtain medication timely|2|||
162195325|NCT03246724|585764608|FG003|Overall Study|Unable to obtain medication timely|1|||
162195326|NCT03246724|585764605|FG000|Overall Study|Re-consented to participate|0|||
162195327|NCT03246724|585764606|FG001|Overall Study|Re-consented to participate|0|||
162195328|NCT03246724|585764607|FG002|Overall Study|Re-consented to participate|0|||
162195329|NCT03246724|585764608|FG003|Overall Study|Re-consented to participate|1|||
162195330|NCT00655824|585764609|FG000|Overall Study|Adverse Event|3|||
162195331|NCT00655824|585764609|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
162195332|NCT00655824|585764609|FG000|Overall Study|Protocol Violation|1|||
161674944|NCT03876171|583865382|FG000|Overall Study|Withdrawal by Subject|3|||
162020277|NCT04421027|585128629|FG002|Follow-Up Period|Left message, participant did not call back|0|||
162195333|NCT00655824|585764609|FG000|Overall Study|Withdrawal by Subject|4|||
162195334|NCT00655824|585764609|FG000|Overall Study|Deterioration of Trial Disease|2|||
162195335|NCT02978716|585764610|FG000|Overall Study|Death|25|||
162195336|NCT02978716|585764611|FG001|Overall Study|Death|13|||
162195337|NCT02978716|585764612|FG002|Overall Study|Death|20|||
162195338|NCT02978716|585764610|FG000|Overall Study|Lost to Follow-up|0|||
162195339|NCT02978716|585764611|FG001|Overall Study|Lost to Follow-up|0|||
162195340|NCT02978716|585764612|FG002|Overall Study|Lost to Follow-up|1|||
162195341|NCT02978716|585764610|FG000|Overall Study|Withdrawal by Subject|6|||
162195342|NCT02978716|585764611|FG001|Overall Study|Withdrawal by Subject|4|||
162195343|NCT02978716|585764612|FG002|Overall Study|Withdrawal by Subject|5|||
162195344|NCT02978716|585764610|FG000|Overall Study|Sponsor terminated|2|||
162195345|NCT02978716|585764611|FG001|Overall Study|Sponsor terminated|13|||
162195346|NCT02978716|585764612|FG002|Overall Study|Sponsor terminated|9|||
161820302|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
161820303|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
161820304|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
161820305|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
161820306|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
161820307|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
161820308|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
161820309|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
161820310|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
161820311|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
161820312|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
161820313|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
161820314|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
161820315|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
161820316|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
161820317|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
161820318|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
161820319|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
161820320|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
161820321|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
161820322|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
161820323|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Other|0|||
161820324|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Other|0|||
161820325|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Other|0|||
161820326|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Other|0|||
162195347|NCT02978716|585764610|FG000|Overall Study|Other|1|||
162195348|NCT02978716|585764611|FG001|Overall Study|Other|3|||
161674945|NCT03876171|583865383|FG001|Overall Study|Withdrawal by Subject|3|||
161674946|NCT03876171|583865382|FG000|Overall Study|Re-arrest|0|||
161674947|NCT03876171|583865383|FG001|Overall Study|Re-arrest|4|||
162195349|NCT02978716|585764612|FG002|Overall Study|Other|0|||
162195350|NCT00589628|585764613|FG000|Overall Study|Lost to Follow-up|0|||
161674948|NCT00727649|583865386|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
162195351|NCT00589628|585764614|FG001|Overall Study|Lost to Follow-up|1|||
162195352|NCT02189759|585764625|FG000|Overall Study|Lost to Follow-up|0|||
162195353|NCT02189759|585764626|FG001|Overall Study|Lost to Follow-up|0|||
162195354|NCT02189759|585764627|FG002|Overall Study|Lost to Follow-up|2|||
162195355|NCT02189759|585764628|FG003|Overall Study|Lost to Follow-up|5|||
162195356|NCT03032198|585764629|FG000|Overall Study|Screen Fail|1|||
162195357|NCT02470806|585764630|FG000|Overall Study|Lost to Follow-up|1|||
162195358|NCT02470806|585764631|FG001|Overall Study|Lost to Follow-up|1|||
162195359|NCT02470806|585764630|FG000|Overall Study|Adverse Event|5|||
162195360|NCT02470806|585764631|FG001|Overall Study|Adverse Event|2|||
162195361|NCT02470806|585764630|FG000|Overall Study|Protocol Violation|4|||
162195362|NCT02470806|585764631|FG001|Overall Study|Protocol Violation|11|||
162195363|NCT02470806|585764630|FG000|Overall Study|Physician Decision|0|||
162195364|NCT02470806|585764631|FG001|Overall Study|Physician Decision|3|||
162195365|NCT02470806|585764630|FG000|Overall Study|Withdrawal by Subject|3|||
162195366|NCT02470806|585764631|FG001|Overall Study|Withdrawal by Subject|10|||
162195367|NCT02470806|585764630|FG000|Overall Study|Lack of Efficacy|5|||
161674949|NCT00727649|583865387|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
161674950|NCT00727649|583865386|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
161674951|NCT00727649|583865387|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
161674952|NCT00727649|583865386|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
161674953|NCT00727649|583865387|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
161674954|NCT00727649|583865386|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
161926002|NCT00088881|584777023|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
161926003|NCT00088881|584777023|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
161926004|NCT00088881|584777023|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
161926005|NCT02370394|584777031|FG000|Overall Study|Lost to Follow-up|2|||
161926006|NCT02370394|584777032|FG001|Overall Study|Lost to Follow-up|1|||
161926007|NCT02370394|584777031|FG000|Overall Study|Withdrawal by Subject|0|||
161926008|NCT02370394|584777032|FG001|Overall Study|Withdrawal by Subject|1|||
161926009|NCT00456612|584777033|FG000|Overall Study|Withdrawal by Subject|3|||
161926010|NCT01108796|584777034|FG000|Overall Study|Adverse Event|0|||
161926011|NCT01108796|584777035|FG001|Overall Study|Adverse Event|1|||
161926012|NCT01108796|584777034|FG000|Overall Study|Lost to Follow-up|7|||
161926013|NCT01108796|584777035|FG001|Overall Study|Lost to Follow-up|6|||
161926014|NCT02545127|584777040|FG000|Overall Study|Lost to Follow-up|1|||
162195368|NCT02470806|585764631|FG001|Overall Study|Lack of Efficacy|15|||
161674955|NCT00727649|583865387|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
161674956|NCT00727649|583865386|FG000|Second Intervention (4-weeks)|Death|1|||
161674957|NCT00727649|583865387|FG001|Second Intervention (4-weeks)|Death|0|||
161674958|NCT00727649|583865386|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
161674959|NCT00727649|583865387|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
161674960|NCT00727649|583865386|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
161674961|NCT00727649|583865387|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
161674962|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
161674963|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
161674964|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
161674965|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
161674966|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
161674967|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
161674968|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
161674969|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
162195369|NCT00866619|585764632|FG000|Overall Study|Adverse Event|112|||
162195370|NCT00866619|585764633|FG001|Overall Study|Adverse Event|106|||
161820327|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Other|3|||
161820328|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Other|3|||
161820329|NCT03395197|584382769|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
161820330|NCT03395197|584382770|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
161820331|NCT03395197|584382771|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
161820332|NCT03395197|584382772|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
161820333|NCT03395197|584382773|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
161820334|NCT03395197|584382774|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
161820335|NCT02308241|584382780|FG000|Overall Study|Withdrawal by Subject|3|||
161820336|NCT03609944|584382781|FG000|Overall Study|Lost to Follow-up|1|||
161820337|NCT03609944|584382782|FG001|Overall Study|Lost to Follow-up|5|||
161820338|NCT03609944|584382781|FG000|Overall Study|Withdrawal by Subject|1|||
161820339|NCT03609944|584382782|FG001|Overall Study|Withdrawal by Subject|1|||
161820340|NCT00659815|584382783|FG000|Overall Study|Study related symptoms and complaints|2|||
161820341|NCT00659815|584382784|FG001|Overall Study|Study related symptoms and complaints|1|||
161820342|NCT00659815|584382783|FG000|Overall Study|Inability to maintain wearing schedule|1|||
161820343|NCT00659815|584382784|FG001|Overall Study|Inability to maintain wearing schedule|2|||
161926015|NCT02545127|584777041|FG001|Overall Study|Lost to Follow-up|0|||
162195371|NCT00866619|585764634|FG002|Overall Study|Adverse Event|47|||
162195372|NCT00866619|585764635|FG003|Overall Study|Adverse Event|44|||
162195373|NCT00866619|585764632|FG000|Overall Study|Protocol Violation|2|||
162195374|NCT00866619|585764633|FG001|Overall Study|Protocol Violation|39|||
162195375|NCT00866619|585764634|FG002|Overall Study|Protocol Violation|2|||
162195376|NCT00866619|585764635|FG003|Overall Study|Protocol Violation|17|||
162195377|NCT00866619|585764632|FG000|Overall Study|Withdrawal by Subject|587|||
162195378|NCT00866619|585764633|FG001|Overall Study|Withdrawal by Subject|295|||
162195379|NCT00866619|585764634|FG002|Overall Study|Withdrawal by Subject|272|||
162195380|NCT00866619|585764635|FG003|Overall Study|Withdrawal by Subject|144|||
162195381|NCT00866619|585764632|FG000|Overall Study|Lost to Follow-up|1145|||
162195382|NCT00866619|585764633|FG001|Overall Study|Lost to Follow-up|830|||
162195383|NCT00866619|585764634|FG002|Overall Study|Lost to Follow-up|568|||
161674970|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
161674971|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
161674972|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
161674973|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
161674974|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
161674975|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
161674976|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
161674977|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
161674978|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
161674979|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
161674980|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
161674981|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
161674982|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
161674983|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
161674984|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
161674985|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
161674986|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
161674987|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
161674988|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
161926016|NCT03309605|584777046|FG000|Overall Study|Adverse Event|0|||
161926017|NCT03309605|584777047|FG001|Overall Study|Adverse Event|0|||
161926018|NCT03309605|584777048|FG002|Overall Study|Adverse Event|0|||
161926019|NCT03309605|584777049|FG003|Overall Study|Adverse Event|1|||
161926020|NCT03309605|584777050|FG004|Overall Study|Adverse Event|0|||
161926021|NCT03309605|584777051|FG005|Overall Study|Adverse Event|0|||
161926022|NCT03309605|584777052|FG006|Overall Study|Adverse Event|2|||
161926023|NCT03309605|584777053|FG007|Overall Study|Adverse Event|1|||
161926024|NCT03309605|584777046|FG000|Overall Study|Withdrawal by Subject|0|||
161926025|NCT03309605|584777047|FG001|Overall Study|Withdrawal by Subject|0|||
161926026|NCT03309605|584777048|FG002|Overall Study|Withdrawal by Subject|0|||
161926027|NCT03309605|584777049|FG003|Overall Study|Withdrawal by Subject|0|||
161926028|NCT03309605|584777050|FG004|Overall Study|Withdrawal by Subject|1|||
161926029|NCT03309605|584777051|FG005|Overall Study|Withdrawal by Subject|0|||
161926030|NCT03309605|584777052|FG006|Overall Study|Withdrawal by Subject|1|||
161926031|NCT03309605|584777053|FG007|Overall Study|Withdrawal by Subject|1|||
161926032|NCT01129284|584777054|FG000|Overall Study|Adverse Event|2|||
161926033|NCT01129284|584777055|FG001|Overall Study|Adverse Event|0|||
161926034|NCT01129284|584777056|FG002|Overall Study|Adverse Event|1|||
161926035|NCT00960856|584777057|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161926036|NCT00960856|584777058|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
161926037|NCT00960856|584777059|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
161926038|NCT00960856|584777060|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
162020278|NCT04421027|585128630|FG003|Follow-Up Period|Left message, participant did not call back|1|||
162020279|NCT04421027|585128627|FG000|Follow-Up Period|Participant died|0|||
162020280|NCT04421027|585128628|FG001|Follow-Up Period|Participant died|0|||
162020281|NCT04421027|585128629|FG002|Follow-Up Period|Participant died|0|||
161674989|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
162195384|NCT00866619|585764635|FG003|Overall Study|Lost to Follow-up|425|||
161674990|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
161674991|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
161674992|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
161674993|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
161674994|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
161683066|NCT01148537|583891233|FG000|Overall Study|Withdrawal by Subject|1|||
161926039|NCT00960856|584777057|FG000|Washout Period of 7 Days|Adverse Event|0|||
161926040|NCT00960856|584777058|FG001|Washout Period of 7 Days|Adverse Event|0|||
161926041|NCT00960856|584777059|FG002|Washout Period of 7 Days|Adverse Event|1|||
161926042|NCT00960856|584777060|FG003|Washout Period of 7 Days|Adverse Event|0|||
161926043|NCT04027946|584777062|FG000|Overall Study|Screen failures|3|||
161926044|NCT05938010|584777063|FG000|Overall Study|Lost to Follow-up|2|||
162020282|NCT04421027|585128630|FG003|Follow-Up Period|Participant died|1|||
162020283|NCT04421027|585128627|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
162020284|NCT04421027|585128628|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
162020285|NCT04421027|585128629|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
162020286|NCT04421027|585128630|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
162020287|NCT04976192|585128631|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
161820344|NCT00659815|584382783|FG000|Overall Study|Withdrawal by Subject|1|||
161820345|NCT00659815|584382784|FG001|Overall Study|Withdrawal by Subject|1|||
161820346|NCT02578641|584382785|FG000|Overall Study|Adverse Event|5|||
161820347|NCT02578641|584382786|FG001|Overall Study|Adverse Event|15|||
161820348|NCT02578641|584382785|FG000|Overall Study|Death|16|||
161820349|NCT02578641|584382786|FG001|Overall Study|Death|8|||
161820350|NCT02578641|584382785|FG000|Overall Study|Lost to Follow-up|0|||
161820351|NCT02578641|584382786|FG001|Overall Study|Lost to Follow-up|1|||
162020288|NCT04976192|585128632|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
161820352|NCT02578641|584382785|FG000|Overall Study|Withdrawal by Subject|14|||
162195385|NCT02892019|585764638|FG000|Overall Study|randomized but not treated|0|||
162195386|NCT02892019|585764639|FG001|Overall Study|randomized but not treated|1|||
162195387|NCT02892019|585764638|FG000|Overall Study|Withdrawal by Subject|0|||
162195388|NCT02892019|585764639|FG001|Overall Study|Withdrawal by Subject|1|||
162195389|NCT02892019|585764638|FG000|Overall Study|Adverse Event|1|||
162195390|NCT02892019|585764639|FG001|Overall Study|Adverse Event|1|||
161820353|NCT02578641|584382786|FG001|Overall Study|Withdrawal by Subject|7|||
161820354|NCT02578641|584382785|FG000|Overall Study|Progressive Disease|69|||
161820355|NCT02578641|584382786|FG001|Overall Study|Progressive Disease|21|||
161820356|NCT02578641|584382785|FG000|Overall Study|No Study Drug|2|||
161820357|NCT02578641|584382786|FG001|Overall Study|No Study Drug|0|||
161820358|NCT02578641|584382785|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
161820359|NCT02578641|584382786|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
161820360|NCT02578641|584382785|FG000|Overall Study|Non-compliance with Study Schedule|1|||
161820361|NCT02578641|584382786|FG001|Overall Study|Non-compliance with Study Schedule|0|||
161820362|NCT02578641|584382785|FG000|Overall Study|Other|1|||
162195391|NCT03890484|585764640|FG000|Overall Study|Lost to Follow-up|1|||
162195392|NCT03890484|585764641|FG001|Overall Study|Lost to Follow-up|1|||
162195393|NCT00518206|585764642|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
162195394|NCT00518206|585764643|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
162195395|NCT00518206|585764642|FG000|Overall Study|Withdrawal by Subject|2|||
162195396|NCT00518206|585764643|FG001|Overall Study|Withdrawal by Subject|0|||
162195397|NCT00518206|585764642|FG000|Overall Study|Drug Supply Issue|1|||
162195398|NCT00518206|585764643|FG001|Overall Study|Drug Supply Issue|0|||
162195399|NCT00518206|585764642|FG000|Overall Study|Reason Unknown|1|||
162195400|NCT00518206|585764643|FG001|Overall Study|Reason Unknown|0|||
162195401|NCT00518206|585764642|FG000|Overall Study|Completion Status Unknown|1|||
162195402|NCT00518206|585764643|FG001|Overall Study|Completion Status Unknown|0|||
162195403|NCT03075878|585764644|FG000|Overall Study|Physician Decision|1|||
162195404|NCT00805441|585764645|FG000|Overall Study|Adverse Event|5|||
161820363|NCT02578641|584382786|FG001|Overall Study|Other|10|||
161820364|NCT02578641|584382785|FG000|Overall Study|Not treated|1|||
162195405|NCT00805441|585764646|FG001|Overall Study|Adverse Event|2|||
162195406|NCT00805441|585764645|FG000|Overall Study|Lack of Efficacy|0|||
162195407|NCT00805441|585764646|FG001|Overall Study|Lack of Efficacy|2|||
161820365|NCT02578641|584382786|FG001|Overall Study|Not treated|4|||
161820366|NCT02655224|584382789|FG000|Overall Study|Adverse Event|1|||
162195408|NCT00805441|585764645|FG000|Overall Study|Protocol Violation|4|||
161820367|NCT02655224|584382790|FG001|Overall Study|Adverse Event|1|||
161820368|NCT04227899|584382797|FG000|Overall Study|Withdrawal by Subject|6|||
161820369|NCT04227899|584382798|FG001|Overall Study|Withdrawal by Subject|3|||
161820370|NCT04227899|584382797|FG000|Overall Study|Death|12|||
161820371|NCT04227899|584382798|FG001|Overall Study|Death|6|||
161820372|NCT04227899|584382797|FG000|Overall Study|Lost to Follow-up|2|||
161820373|NCT04227899|584382798|FG001|Overall Study|Lost to Follow-up|1|||
161820374|NCT05151471|584382799|FG000|Overall Study|Adverse Event|21|||
161820375|NCT05151471|584382800|FG001|Overall Study|Adverse Event|16|||
161820376|NCT05151471|584382799|FG000|Overall Study|Death|1|||
161820377|NCT05151471|584382800|FG001|Overall Study|Death|0|||
161820378|NCT05151471|584382799|FG000|Overall Study|Lost to Follow-up|0|||
161820379|NCT05151471|584382800|FG001|Overall Study|Lost to Follow-up|1|||
161820380|NCT05151471|584382799|FG000|Overall Study|Withdrawal by Subject|7|||
161820381|NCT05151471|584382800|FG001|Overall Study|Withdrawal by Subject|9|||
161820382|NCT05151471|584382799|FG000|Overall Study|Study terminated by sponsor|49|||
161820383|NCT05151471|584382800|FG001|Overall Study|Study terminated by sponsor|47|||
161820384|NCT05151471|584382799|FG000|Overall Study|Other|2|||
161820385|NCT05151471|584382800|FG001|Overall Study|Other|1|||
161820386|NCT03292458|584382806|FG000|Period 1|Adverse Event|2|||
161820387|NCT03292458|584382807|FG001|Period 1|Adverse Event|0|||
161820388|NCT01741545|584382808|FG000|Treatment Period|Lack of Efficacy|0|||
161926045|NCT00985192|584777064|FG000|Overall Study|Withdrawal by Subject|1|||
161926046|NCT00985192|584777064|FG000|Overall Study|Disease Progression|1|||
161926047|NCT00985192|584777064|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
161926048|NCT01454063|584777065|FG000|Randomized|Adverse Event|1|||
161926049|NCT01454063|584777066|FG001|Randomized|Adverse Event|1|||
161926050|NCT01454063|584777065|FG000|Randomized|Protocol Violation|0|||
161926051|NCT01454063|584777066|FG001|Randomized|Protocol Violation|1|||
161926052|NCT01562444|584777070|FG000|Overall Study|Did not meet entry criteria|2|||
161926053|NCT01562444|584777071|FG001|Overall Study|Did not meet entry criteria|0|||
161926054|NCT01562444|584777072|FG002|Overall Study|Did not meet entry criteria|3|||
161926055|NCT01562444|584777070|FG000|Overall Study|Did not comply with blood draw schedule|1|||
161926056|NCT01562444|584777071|FG001|Overall Study|Did not comply with blood draw schedule|0|||
161926057|NCT01562444|584777072|FG002|Overall Study|Did not comply with blood draw schedule|1|||
161926058|NCT01562444|584777070|FG000|Overall Study|Unavailable serological results|0|||
161926059|NCT01562444|584777071|FG001|Overall Study|Unavailable serological results|2|||
161926060|NCT01562444|584777072|FG002|Overall Study|Unavailable serological results|2|||
161926061|NCT01562444|584777070|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
161926062|NCT01562444|584777071|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
161926063|NCT01562444|584777072|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
161926064|NCT01562444|584777070|FG000|Overall Study|Protocol forbidden medication|1|||
161926065|NCT01562444|584777071|FG001|Overall Study|Protocol forbidden medication|0|||
161926066|NCT01562444|584777072|FG002|Overall Study|Protocol forbidden medication|0|||
161926067|NCT03055195|584777074|FG000|Overall Study|Lack of Efficacy|1|||
161926068|NCT03055195|584777075|FG001|Overall Study|Lack of Efficacy|0|||
161926069|NCT03055195|584777074|FG000|Overall Study|Withdrawal by Subject|6|||
161926070|NCT03055195|584777075|FG001|Overall Study|Withdrawal by Subject|7|||
161926071|NCT03055195|584777074|FG000|Overall Study|Study Terminated by Sponsor|2|||
161926072|NCT03055195|584777075|FG001|Overall Study|Study Terminated by Sponsor|6|||
161926073|NCT03055195|584777074|FG000|Overall Study|Protocol Violation|2|||
161926074|NCT03055195|584777075|FG001|Overall Study|Protocol Violation|1|||
161926075|NCT03055195|584777074|FG000|Overall Study|Physician Decision|1|||
161926076|NCT03055195|584777075|FG001|Overall Study|Physician Decision|0|||
161926077|NCT00421733|584777079|FG000|Overall Study|Adverse Event|4|||
161926078|NCT00421733|584777080|FG001|Overall Study|Adverse Event|9|||
162020289|NCT04976192|585128633|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
162020290|NCT04976192|585128634|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
162020291|NCT04976192|585128635|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
162020292|NCT04976192|585128636|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
162020293|NCT04976192|585128637|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
162020294|NCT04976192|585128638|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
162020295|NCT04976192|585128639|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
162020296|NCT04976192|585128640|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
162020297|NCT04976192|585128631|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
162020298|NCT04976192|585128632|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
162020299|NCT04976192|585128633|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
162020300|NCT04976192|585128634|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
162020301|NCT04976192|585128635|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162020302|NCT04976192|585128636|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162020303|NCT04976192|585128637|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162020304|NCT04976192|585128638|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162020305|NCT04976192|585128639|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162020306|NCT04976192|585128640|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162020307|NCT04976192|585128631|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
162020308|NCT04976192|585128632|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
162020309|NCT04976192|585128633|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
162020310|NCT04976192|585128634|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
162020311|NCT04976192|585128635|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
162020312|NCT04976192|585128636|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
162020313|NCT04976192|585128637|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
162020314|NCT04976192|585128638|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
162020315|NCT04976192|585128639|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
162020316|NCT04976192|585128640|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
162020317|NCT04976192|585128631|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162020318|NCT04976192|585128632|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162020319|NCT04976192|585128633|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162020320|NCT04976192|585128634|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162020321|NCT04976192|585128635|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
162020322|NCT04976192|585128636|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
162020323|NCT04976192|585128637|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
162195409|NCT00805441|585764646|FG001|Overall Study|Protocol Violation|8|||
162195410|NCT00805441|585764645|FG000|Overall Study|Lost to Follow-up|10|||
162195411|NCT00805441|585764646|FG001|Overall Study|Lost to Follow-up|13|||
162195412|NCT00805441|585764645|FG000|Overall Study|Withdrawal by Subject|15|||
162195413|NCT00805441|585764646|FG001|Overall Study|Withdrawal by Subject|9|||
162195414|NCT00805441|585764645|FG000|Overall Study|Physician Decision|0|||
162195415|NCT00805441|585764646|FG001|Overall Study|Physician Decision|1|||
162195416|NCT00805441|585764645|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
161926079|NCT00421733|584777081|FG002|Overall Study|Adverse Event|2|||
162195417|NCT00805441|585764646|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
161926080|NCT00421733|584777079|FG000|Overall Study|Lost to Follow-up|1|||
161926081|NCT00421733|584777080|FG001|Overall Study|Lost to Follow-up|2|||
162195418|NCT00946998|585766246|FG000|Overall Study|Exited prior to first outcome assessment|5|||
162195419|NCT00946998|585766247|FG001|Overall Study|Exited prior to first outcome assessment|3|||
162195420|NCT01945593|585766248|FG000|Overall Study|Adverse Event|0|||
162195421|NCT01945593|585766249|FG001|Overall Study|Adverse Event|0|||
162195422|NCT01945593|585766250|FG002|Overall Study|Adverse Event|0|||
162195423|NCT01945593|585766251|FG003|Overall Study|Adverse Event|5|||
162195424|NCT01945593|585766248|FG000|Overall Study|Physician Decision|0|||
162195425|NCT01945593|585766249|FG001|Overall Study|Physician Decision|0|||
162195426|NCT01945593|585766250|FG002|Overall Study|Physician Decision|1|||
162195427|NCT01945593|585766251|FG003|Overall Study|Physician Decision|1|||
162195428|NCT01945593|585766248|FG000|Overall Study|Withdrawal by Subject|0|||
162195429|NCT01945593|585766249|FG001|Overall Study|Withdrawal by Subject|2|||
162195430|NCT01945593|585766250|FG002|Overall Study|Withdrawal by Subject|0|||
162195431|NCT01945593|585766251|FG003|Overall Study|Withdrawal by Subject|4|||
161674995|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
161674996|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
161674997|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
161674998|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
161674999|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
161675000|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
161675001|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
161675002|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
161675003|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
161675004|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
161675005|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
161675006|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
161675007|NCT03627767|583865391|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
161675008|NCT03627767|583865392|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
161675009|NCT03627767|583865393|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
161675010|NCT03627767|583865394|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
161675011|NCT03627767|583865395|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
161675012|NCT03627767|583865391|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
161675013|NCT03627767|583865392|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
161675014|NCT03627767|583865393|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
161675015|NCT03627767|583865394|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
161675016|NCT03627767|583865395|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
161675017|NCT03627767|583865391|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
161675018|NCT03627767|583865392|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
161675019|NCT03627767|583865393|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
161675020|NCT03627767|583865394|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
161675021|NCT03627767|583865395|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
161675022|NCT03627767|583865391|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
161675023|NCT03627767|583865392|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
161675024|NCT03627767|583865393|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
161675025|NCT03627767|583865394|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
161675026|NCT03627767|583865395|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
161675027|NCT03627767|583865391|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
161675028|NCT03627767|583865392|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
161675029|NCT03627767|583865393|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
161675030|NCT03627767|583865394|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
161675031|NCT03627767|583865395|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
161675032|NCT03627767|583865391|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
161675033|NCT03627767|583865392|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
161675034|NCT03627767|583865393|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
161675035|NCT03627767|583865394|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
161675036|NCT03627767|583865395|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
161675037|NCT03627767|583865391|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
161675038|NCT03627767|583865392|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
161675039|NCT03627767|583865393|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
161675040|NCT03627767|583865394|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
161675041|NCT03627767|583865395|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
161675042|NCT03627767|583865391|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
161675043|NCT03627767|583865392|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
161675044|NCT03627767|583865393|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
161675045|NCT03627767|583865394|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
161675046|NCT03627767|583865395|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
161675047|NCT03627767|583865391|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
161675048|NCT03627767|583865392|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
161675049|NCT03627767|583865393|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
161926082|NCT00421733|584777081|FG002|Overall Study|Lost to Follow-up|4|||
161926083|NCT00421733|584777079|FG000|Overall Study|Withdrawal by Subject|1|||
161926084|NCT00421733|584777080|FG001|Overall Study|Withdrawal by Subject|2|||
161926085|NCT00421733|584777081|FG002|Overall Study|Withdrawal by Subject|7|||
161926086|NCT00421733|584777079|FG000|Overall Study|Death|0|||
161926087|NCT00421733|584777080|FG001|Overall Study|Death|3|||
162195432|NCT01945593|585766248|FG000|Overall Study|Protocol Violation|0|||
162195433|NCT01945593|585766249|FG001|Overall Study|Protocol Violation|2|||
162195434|NCT01945593|585766250|FG002|Overall Study|Protocol Violation|1|||
162195435|NCT01945593|585766251|FG003|Overall Study|Protocol Violation|3|||
161926088|NCT00421733|584777081|FG002|Overall Study|Death|0|||
161926089|NCT00421733|584777079|FG000|Overall Study|Required dialysis|1|||
162020324|NCT04976192|585128638|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
162020325|NCT04976192|585128639|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
162020326|NCT04976192|585128640|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
161926090|NCT00421733|584777080|FG001|Overall Study|Required dialysis|0|||
161926091|NCT00421733|584777081|FG002|Overall Study|Required dialysis|0|||
161926092|NCT00421733|584777079|FG000|Overall Study|Administrative|2|||
161926093|NCT00421733|584777080|FG001|Overall Study|Administrative|0|||
161926094|NCT00421733|584777081|FG002|Overall Study|Administrative|0|||
161926095|NCT00421733|584777079|FG000|Overall Study|Did not satisfy entry criteria|1|||
161926096|NCT00421733|584777080|FG001|Overall Study|Did not satisfy entry criteria|3|||
161926097|NCT00421733|584777081|FG002|Overall Study|Did not satisfy entry criteria|2|||
161926098|NCT00421733|584777079|FG000|Overall Study|Sponsor request|1|||
161926099|NCT00421733|584777080|FG001|Overall Study|Sponsor request|0|||
161926100|NCT00421733|584777081|FG002|Overall Study|Sponsor request|3|||
161926101|NCT00421733|584777079|FG000|Overall Study|Protocol deviation|4|||
161926102|NCT00421733|584777080|FG001|Overall Study|Protocol deviation|7|||
161926103|NCT00421733|584777081|FG002|Overall Study|Protocol deviation|2|||
161926104|NCT00790933|584777082|FG000|Overall Study|Adverse Event|94|||
161926105|NCT00790933|584777083|FG001|Overall Study|Adverse Event|119|||
161926106|NCT00790933|584777084|FG002|Overall Study|Adverse Event|65|||
161926107|NCT00790933|584777085|FG003|Overall Study|Adverse Event|5|||
161926108|NCT00790933|584777086|FG004|Overall Study|Adverse Event|69|||
161926109|NCT00790933|584777082|FG000|Overall Study|Protocol Violation(s)|8|||
161926110|NCT00790933|584777083|FG001|Overall Study|Protocol Violation(s)|18|||
161926111|NCT00790933|584777084|FG002|Overall Study|Protocol Violation(s)|7|||
161926112|NCT00790933|584777085|FG003|Overall Study|Protocol Violation(s)|0|||
161926113|NCT00790933|584777086|FG004|Overall Study|Protocol Violation(s)|12|||
161926114|NCT00790933|584777082|FG000|Overall Study|Lack of Efficacy|192|||
162020327|NCT04976192|585128631|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
162020328|NCT04976192|585128632|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
162020329|NCT04976192|585128633|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161926115|NCT00790933|584777083|FG001|Overall Study|Lack of Efficacy|176|||
161926116|NCT00790933|584777084|FG002|Overall Study|Lack of Efficacy|130|||
162020330|NCT04976192|585128634|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
162020331|NCT04976192|585128635|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
162020332|NCT04976192|585128636|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161926117|NCT00790933|584777085|FG003|Overall Study|Lack of Efficacy|1|||
161926118|NCT00790933|584777086|FG004|Overall Study|Lack of Efficacy|121|||
161926119|NCT00790933|584777082|FG000|Overall Study|Study Terminated by Sponsor|0|||
161926120|NCT00790933|584777083|FG001|Overall Study|Study Terminated by Sponsor|0|||
161926121|NCT00790933|584777084|FG002|Overall Study|Study Terminated by Sponsor|1|||
161926122|NCT00790933|584777085|FG003|Overall Study|Study Terminated by Sponsor|0|||
161926123|NCT00790933|584777086|FG004|Overall Study|Study Terminated by Sponsor|0|||
161926124|NCT00790933|584777082|FG000|Overall Study|Withdrawal by Subject|123|||
161926125|NCT00790933|584777083|FG001|Overall Study|Withdrawal by Subject|120|||
161926126|NCT00790933|584777084|FG002|Overall Study|Withdrawal by Subject|52|||
161926127|NCT00790933|584777085|FG003|Overall Study|Withdrawal by Subject|6|||
161926128|NCT00790933|584777086|FG004|Overall Study|Withdrawal by Subject|50|||
161926129|NCT00790933|584777082|FG000|Overall Study|Lost to Follow-up|13|||
161926130|NCT00790933|584777083|FG001|Overall Study|Lost to Follow-up|31|||
161926131|NCT00790933|584777084|FG002|Overall Study|Lost to Follow-up|10|||
161926132|NCT00790933|584777085|FG003|Overall Study|Lost to Follow-up|1|||
161926133|NCT00790933|584777086|FG004|Overall Study|Lost to Follow-up|15|||
161926134|NCT00790933|584777082|FG000|Overall Study|Reason Not Specified|8|||
161926135|NCT00790933|584777083|FG001|Overall Study|Reason Not Specified|16|||
161926136|NCT00790933|584777084|FG002|Overall Study|Reason Not Specified|4|||
161926137|NCT00790933|584777085|FG003|Overall Study|Reason Not Specified|1|||
161926138|NCT00790933|584777086|FG004|Overall Study|Reason Not Specified|9|||
161926139|NCT00720083|584777089|FG000|Overall Study|Ineligible|1|||
161926140|NCT00720083|584777090|FG001|Overall Study|Ineligible|2|||
161926141|NCT00894647|584777091|FG000|Overall Study|Adverse Event|5|||
161926142|NCT00894647|584777092|FG001|Overall Study|Adverse Event|4|||
161926143|NCT00894647|584777091|FG000|Overall Study|Withdrawal by Subject|4|||
161926144|NCT00894647|584777092|FG001|Overall Study|Withdrawal by Subject|4|||
161926145|NCT00894647|584777091|FG000|Overall Study|Lost to Follow-up|0|||
161926146|NCT00894647|584777092|FG001|Overall Study|Lost to Follow-up|2|||
161926147|NCT00894647|584777091|FG000|Overall Study|Non-compliance with study procedures|0|||
161926148|NCT00894647|584777092|FG001|Overall Study|Non-compliance with study procedures|2|||
161926149|NCT00894647|584777091|FG000|Overall Study|Other, not due to AE|1|||
161926150|NCT00894647|584777092|FG001|Overall Study|Other, not due to AE|2|||
161926151|NCT00245570|584777099|FG000|Washout Between Periods III and IV|Adverse Event|0|||
161926152|NCT00245570|584777100|FG001|Washout Between Periods III and IV|Adverse Event|1|||
161926153|NCT00245570|584777101|FG002|Washout Between Periods III and IV|Adverse Event|0|||
161926154|NCT00245570|584777102|FG003|Washout Between Periods III and IV|Adverse Event|0|||
161926155|NCT00245570|584777103|FG004|Washout Between Periods III and IV|Adverse Event|0|||
161926156|NCT00245570|584777104|FG005|Washout Between Periods III and IV|Adverse Event|0|||
161926157|NCT01913470|584777105|FG000|Overall Study|Lost to Follow-up|0|||
161926158|NCT01913470|584777106|FG001|Overall Study|Lost to Follow-up|1|||
161926159|NCT01913470|584777105|FG000|Overall Study|Physician Decision|0|||
161926160|NCT01913470|584777106|FG001|Overall Study|Physician Decision|1|||
161926161|NCT01913470|584777105|FG000|Overall Study|Withdrawal by Subject|0|||
161926162|NCT01913470|584777106|FG001|Overall Study|Withdrawal by Subject|1|||
161926163|NCT01524705|584777111|FG000|Overall Study|Adverse Event|2|||
161926164|NCT01524705|584777112|FG001|Overall Study|Adverse Event|0|||
161926165|NCT01524705|584777111|FG000|Overall Study|Death|1|||
161926166|NCT01524705|584777112|FG001|Overall Study|Death|0|||
161926167|NCT01524705|584777111|FG000|Overall Study|Lost to Follow-up|0|||
161926168|NCT01524705|584777112|FG001|Overall Study|Lost to Follow-up|1|||
161926169|NCT01524705|584777111|FG000|Overall Study|Withdrawal by Subject|0|||
161926170|NCT01524705|584777112|FG001|Overall Study|Withdrawal by Subject|1|||
161926171|NCT01524705|584777111|FG000|Overall Study|Pancreatic Cancer|0|||
161926172|NCT01524705|584777112|FG001|Overall Study|Pancreatic Cancer|1|||
161926173|NCT01829165|584777118|FG000|Overall Study|Did not complete intervention|2|||
161926174|NCT01829165|584777119|FG001|Overall Study|Did not complete intervention|0|||
161926175|NCT02573467|584777120|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
161926176|NCT02573467|584777121|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
162195436|NCT01945593|585766248|FG000|Overall Study|Death|0|||
162195437|NCT01945593|585766249|FG001|Overall Study|Death|0|||
162195438|NCT01945593|585766250|FG002|Overall Study|Death|1|||
162195439|NCT01945593|585766251|FG003|Overall Study|Death|0|||
162195440|NCT01945593|585766248|FG000|Overall Study|Other: Terminated|0|||
162195441|NCT01945593|585766249|FG001|Overall Study|Other: Terminated|0|||
162195442|NCT01945593|585766250|FG002|Overall Study|Other: Terminated|0|||
162195443|NCT01945593|585766251|FG003|Overall Study|Other: Terminated|1|||
162195444|NCT01945593|585766248|FG000|Overall Study|Other: Surgical Procedure|0|||
162195445|NCT01945593|585766249|FG001|Overall Study|Other: Surgical Procedure|2|||
162195446|NCT01945593|585766250|FG002|Overall Study|Other: Surgical Procedure|0|||
162195447|NCT01945593|585766251|FG003|Overall Study|Other: Surgical Procedure|6|||
161926177|NCT02573467|584777122|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
161926178|NCT02573467|584777123|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
161926179|NCT02573467|584777120|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
161926180|NCT02573467|584777121|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
161926181|NCT02573467|584777122|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
161926182|NCT02573467|584777123|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
161926183|NCT02573467|584777120|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
161926184|NCT02573467|584777121|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
161926185|NCT02573467|584777122|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
161926186|NCT02573467|584777123|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
162195448|NCT01945593|585766248|FG000|Overall Study|Other: Screen Failure|0|||
162020333|NCT04976192|585128637|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
162020334|NCT04976192|585128638|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
162195449|NCT01945593|585766249|FG001|Overall Study|Other: Screen Failure|2|||
162195450|NCT01945593|585766250|FG002|Overall Study|Other: Screen Failure|0|||
162195451|NCT01945593|585766251|FG003|Overall Study|Other: Screen Failure|0|||
162195452|NCT00228813|585766252|FG000|Overall Study|Death|4|||
162195453|NCT03456856|585766253|FG000|Overall Study|Lost to Follow-up|2|||
162195454|NCT03456856|585766253|FG000|Overall Study|Withdrawal by Subject|1|||
162195455|NCT02542696|585766255|FG000|Overall Study|Adverse Event|167|||
162195456|NCT02542696|585766255|FG000|Overall Study|Lack of Efficacy|26|||
162195457|NCT02542696|585766255|FG000|Overall Study|Lost to Follow-up|6|||
162195458|NCT02542696|585766255|FG000|Overall Study|Withdrawal by Subject|104|||
162195459|NCT02542696|585766255|FG000|Overall Study|Protocol Violation|5|||
162195460|NCT02542696|585766255|FG000|Overall Study|Death|8|||
162195461|NCT02542696|585766255|FG000|Overall Study|DECREASED OFF TIME|1|||
162195462|NCT02542696|585766255|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
162195463|NCT02542696|585766255|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
162195464|NCT02542696|585766255|FG000|Overall Study|MEDICAL HISTORY|1|||
162195465|NCT02542696|585766255|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
162195466|NCT02542696|585766255|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
162195467|NCT02542696|585766255|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
162195468|NCT02542696|585766255|FG000|Overall Study|SPONSOR DECISION|3|||
162195469|NCT02542696|585766255|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
162195470|NCT02542696|585766255|FG000|Overall Study|SUBJECT DECISION|2|||
162195471|NCT03262389|585766256|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
162195472|NCT03262389|585766256|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
162195473|NCT03262389|585766256|FG000|Overall Study|opted out of PET/MR|1|||
162195474|NCT02256553|585766258|FG000|Period I|Adverse Event|5|||
162195475|NCT02256553|585766258|FG000|Period I|Protocol Violation|1|||
162195476|NCT02256553|585766258|FG000|Period II|Adverse Event|1|||
162195477|NCT02256553|585766258|FG000|Period II|Subject Moved|1|||
161820389|NCT01741545|584382809|FG001|Treatment Period|Lack of Efficacy|1|||
161820390|NCT01741545|584382808|FG000|Treatment Period|Adverse event, non-fatal|1|||
161820391|NCT01741545|584382809|FG001|Treatment Period|Adverse event, non-fatal|3|||
161820392|NCT01741545|584382808|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
161820393|NCT01741545|584382809|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
161820394|NCT01741545|584382808|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
161820395|NCT01741545|584382809|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
161820396|NCT01664039|584382812|FG000|Overall Study|Adverse Event|3|||
161820397|NCT01664039|584382813|FG001|Overall Study|Adverse Event|4|||
161820398|NCT01664039|584382812|FG000|Overall Study|Lost to Follow-up|1|||
161820399|NCT01664039|584382813|FG001|Overall Study|Lost to Follow-up|1|||
161820400|NCT01664039|584382812|FG000|Overall Study|Withdrawal by Subject|1|||
161820401|NCT01664039|584382813|FG001|Overall Study|Withdrawal by Subject|3|||
161820402|NCT01664039|584382812|FG000|Overall Study|Noncompliance|1|||
162195478|NCT02256553|585766258|FG000|Period III|Adverse Event|3|||
162195479|NCT03651271|585766259|FG000|Overall Study|Death|4|||
162195480|NCT03651271|585766260|FG001|Overall Study|Death|37|||
161820403|NCT01664039|584382813|FG001|Overall Study|Noncompliance|1|||
161820404|NCT01853176|584382814|FG000|Overall Study|Study terminated|4|||
161820405|NCT01853176|584382815|FG001|Overall Study|Study terminated|0|||
162195481|NCT03651271|585766261|FG002|Overall Study|Death|0|||
162195482|NCT03651271|585766262|FG003|Overall Study|Death|2|||
161926187|NCT02573467|584777120|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
161926188|NCT02573467|584777121|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
161926189|NCT02573467|584777122|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
161926190|NCT02573467|584777123|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
162195483|NCT03651271|585766263|FG004|Overall Study|Death|6|||
162195484|NCT03651271|585766259|FG000|Overall Study|Lost to Follow-up|1|||
162195485|NCT03651271|585766260|FG001|Overall Study|Lost to Follow-up|5|||
162195486|NCT03651271|585766261|FG002|Overall Study|Lost to Follow-up|0|||
162195487|NCT03651271|585766262|FG003|Overall Study|Lost to Follow-up|1|||
162195488|NCT03651271|585766263|FG004|Overall Study|Lost to Follow-up|0|||
162195489|NCT03651271|585766259|FG000|Overall Study|Physician Decision|0|||
162195490|NCT03651271|585766260|FG001|Overall Study|Physician Decision|2|||
161926191|NCT02573467|584777120|FG000|Post-treatment Follow up Epoch|Death|1|||
161926192|NCT02573467|584777121|FG001|Post-treatment Follow up Epoch|Death|1|||
161926193|NCT02573467|584777122|FG002|Post-treatment Follow up Epoch|Death|0|||
161926194|NCT02573467|584777123|FG003|Post-treatment Follow up Epoch|Death|1|||
161926195|NCT02573467|584777120|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
161926196|NCT02573467|584777121|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
161926197|NCT02573467|584777122|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
161926198|NCT02573467|584777123|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
161926199|NCT02573467|584777120|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
161926200|NCT02573467|584777121|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
161926201|NCT02573467|584777122|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
161926202|NCT02573467|584777123|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
161926203|NCT00103506|584777124|FG000|Overall Study|Study closed by sponsor|34|||
161926204|NCT00103506|584777125|FG001|Overall Study|Study closed by sponsor|37|||
161926205|NCT00103506|584777124|FG000|Overall Study|Death|257|||
161926206|NCT00103506|584777125|FG001|Overall Study|Death|253|||
161926207|NCT00103506|584777124|FG000|Overall Study|Lost to Follow-up|13|||
161926208|NCT00103506|584777125|FG001|Overall Study|Lost to Follow-up|13|||
161926209|NCT00103506|584777124|FG000|Overall Study|Withdrawal by Subject|18|||
162195491|NCT03651271|585766261|FG002|Overall Study|Physician Decision|0|||
162195492|NCT03651271|585766262|FG003|Overall Study|Physician Decision|0|||
161926210|NCT00103506|584777125|FG001|Overall Study|Withdrawal by Subject|21|||
161926211|NCT00710970|584777128|FG000|Overall Study|Never took drug|3|||
161926212|NCT02153827|584777129|FG000|Overall Study|Lost to Follow-up|3|||
161926213|NCT02153827|584777130|FG001|Overall Study|Lost to Follow-up|9|||
162195493|NCT03651271|585766263|FG004|Overall Study|Physician Decision|0|||
161675050|NCT03627767|583865394|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
161675051|NCT03627767|583865395|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
161675052|NCT03627767|583865391|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
161675053|NCT03627767|583865392|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
161675054|NCT03627767|583865393|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
161675055|NCT03627767|583865394|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
161675056|NCT03627767|583865395|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
161675057|NCT03627767|583865391|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
161675058|NCT03627767|583865392|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
161675059|NCT03627767|583865393|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
161675060|NCT03627767|583865394|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
161675061|NCT03627767|583865395|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
161675062|NCT00283049|583865396|FG000|Overall Study|Adverse Event|6|||
161675063|NCT00283049|583865397|FG001|Overall Study|Adverse Event|1|||
161675064|NCT00283049|583865398|FG002|Overall Study|Adverse Event|4|||
161675065|NCT00283049|583865396|FG000|Overall Study|Protocol Violation|3|||
161675066|NCT00283049|583865397|FG001|Overall Study|Protocol Violation|0|||
161675067|NCT00283049|583865398|FG002|Overall Study|Protocol Violation|3|||
161675068|NCT00283049|583865396|FG000|Overall Study|Death|1|||
161675069|NCT00283049|583865397|FG001|Overall Study|Death|1|||
161675070|NCT00283049|583865398|FG002|Overall Study|Death|1|||
161675071|NCT00283049|583865396|FG000|Overall Study|Lack of Efficacy|0|||
161675072|NCT00283049|583865397|FG001|Overall Study|Lack of Efficacy|1|||
161675073|NCT00283049|583865398|FG002|Overall Study|Lack of Efficacy|1|||
161675074|NCT00283049|583865396|FG000|Overall Study|Lost to Follow-up|4|||
161675075|NCT00283049|583865397|FG001|Overall Study|Lost to Follow-up|2|||
161675076|NCT00283049|583865398|FG002|Overall Study|Lost to Follow-up|5|||
161675077|NCT00283049|583865396|FG000|Overall Study|Withdrawal by Subject|26|||
161675078|NCT00283049|583865397|FG001|Overall Study|Withdrawal by Subject|24|||
161675079|NCT00283049|583865398|FG002|Overall Study|Withdrawal by Subject|19|||
161675080|NCT00283049|583865396|FG000|Overall Study|Discontinuation of Study|18|||
161675081|NCT00283049|583865397|FG001|Overall Study|Discontinuation of Study|16|||
161675082|NCT00283049|583865398|FG002|Overall Study|Discontinuation of Study|20|||
161675083|NCT00283049|583865396|FG000|Overall Study|No longer requires study treatment|0|||
161675084|NCT00283049|583865397|FG001|Overall Study|No longer requires study treatment|0|||
161675085|NCT00283049|583865398|FG002|Overall Study|No longer requires study treatment|1|||
161675086|NCT02953639|583865399|FG000|Overall Study|Adverse Event|2|||
161675087|NCT02953639|583865400|FG001|Overall Study|Adverse Event|0|||
161675088|NCT02953639|583865401|FG002|Overall Study|Adverse Event|1|||
161675089|NCT02953639|583865399|FG000|Overall Study|Lost to Follow-up|8|||
161675090|NCT02953639|583865400|FG001|Overall Study|Lost to Follow-up|4|||
161675091|NCT02953639|583865401|FG002|Overall Study|Lost to Follow-up|3|||
161675092|NCT02953639|583865399|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161675093|NCT02953639|583865400|FG001|Overall Study|Non-Compliance With Study Drug|2|||
161675094|NCT02953639|583865401|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161675095|NCT02953639|583865399|FG000|Overall Study|Multiple Reasons|1|||
161675096|NCT02953639|583865400|FG001|Overall Study|Multiple Reasons|0|||
161675097|NCT02953639|583865401|FG002|Overall Study|Multiple Reasons|1|||
161675098|NCT02953639|583865399|FG000|Overall Study|Physician Decision|1|||
161675099|NCT02953639|583865400|FG001|Overall Study|Physician Decision|0|||
161675100|NCT02953639|583865401|FG002|Overall Study|Physician Decision|0|||
161675101|NCT02953639|583865399|FG000|Overall Study|Withdrawal by Subject|7|||
161675102|NCT02953639|583865400|FG001|Overall Study|Withdrawal by Subject|8|||
161675103|NCT02953639|583865401|FG002|Overall Study|Withdrawal by Subject|10|||
161675104|NCT02953639|583865399|FG000|Overall Study|Completed or Discontinued information is missing|1|||
161675105|NCT02953639|583865400|FG001|Overall Study|Completed or Discontinued information is missing|0|||
161675106|NCT02953639|583865401|FG002|Overall Study|Completed or Discontinued information is missing|0|||
161675107|NCT01667081|583865402|FG000|Overall Study|Death|43|||
161675108|NCT01667081|583865403|FG001|Overall Study|Death|3|||
161675109|NCT01667081|583865402|FG000|Overall Study|Lost to Follow-up|99|||
161675110|NCT01667081|583865403|FG001|Overall Study|Lost to Follow-up|48|||
161675111|NCT01667081|583865402|FG000|Overall Study|Physician Decision|16|||
161675112|NCT01667081|583865403|FG001|Overall Study|Physician Decision|2|||
161820406|NCT02276885|584382816|FG000|Overall Study|Withdrawal by Subject|2|||
161820407|NCT02276885|584382817|FG001|Overall Study|Withdrawal by Subject|0|||
161820408|NCT02276885|584382816|FG000|Overall Study|Lost to Follow-up|5|||
161675113|NCT01667081|583865402|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
161675114|NCT01667081|583865403|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
161675115|NCT01667081|583865402|FG000|Overall Study|Withdrawal by Subject|90|||
161675116|NCT01667081|583865403|FG001|Overall Study|Withdrawal by Subject|35|||
161675117|NCT03034460|583865404|FG000|Overall Study|Adverse Event|0|||
161675118|NCT03034460|583865405|FG001|Overall Study|Adverse Event|1|||
162020335|NCT04976192|585128639|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161675119|NCT03034460|583865404|FG000|Overall Study|Withdrawal by Subject|2|||
162020336|NCT04976192|585128640|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
162020337|NCT04976192|585128631|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162020338|NCT04976192|585128632|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162020339|NCT04976192|585128633|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162020340|NCT04976192|585128634|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162020341|NCT04976192|585128635|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162020342|NCT04976192|585128636|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
162020343|NCT04976192|585128637|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162020344|NCT04976192|585128638|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162020345|NCT04976192|585128639|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162020346|NCT04976192|585128640|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162020347|NCT02529553|585128646|FG000|Overall Study|Progressive Disease|1|||
162020348|NCT02529553|585128647|FG001|Overall Study|Progressive Disease|0|||
162020349|NCT02529553|585128648|FG002|Overall Study|Progressive Disease|1|||
162020350|NCT02529553|585128649|FG003|Overall Study|Progressive Disease|3|||
162020351|NCT02529553|585128650|FG004|Overall Study|Progressive Disease|2|||
162020352|NCT02529553|585128651|FG005|Overall Study|Progressive Disease|3|||
162020353|NCT02529553|585128652|FG006|Overall Study|Progressive Disease|3|||
162020354|NCT02529553|585128653|FG007|Overall Study|Progressive Disease|5|||
162020355|NCT02529553|585128654|FG008|Overall Study|Progressive Disease|3|||
162020356|NCT02529553|585128646|FG000|Overall Study|Physician Decision|0|||
162020357|NCT02529553|585128647|FG001|Overall Study|Physician Decision|1|||
162020358|NCT02529553|585128648|FG002|Overall Study|Physician Decision|0|||
162020359|NCT02529553|585128649|FG003|Overall Study|Physician Decision|0|||
161675120|NCT03034460|583865405|FG001|Overall Study|Withdrawal by Subject|2|||
161675121|NCT03034460|583865404|FG000|Overall Study|Personal Reasons|1|||
161675122|NCT03034460|583865405|FG001|Overall Study|Personal Reasons|0|||
161675123|NCT01798992|583865408|FG000|Overall Study|Administrative withdrawal|0|||
161675124|NCT01798992|583865409|FG001|Overall Study|Administrative withdrawal|1|||
161675125|NCT01798992|583865410|FG002|Overall Study|Administrative withdrawal|0|||
161675126|NCT01798992|583865411|FG003|Overall Study|Administrative withdrawal|1|||
161675127|NCT01798992|583865408|FG000|Overall Study|Lost to Follow-up|0|||
161675128|NCT01798992|583865409|FG001|Overall Study|Lost to Follow-up|1|||
161675129|NCT01798992|583865410|FG002|Overall Study|Lost to Follow-up|1|||
161675130|NCT01798992|583865411|FG003|Overall Study|Lost to Follow-up|0|||
161675131|NCT01798992|583865408|FG000|Overall Study|Insufficient biopsy tissue|0|||
161675132|NCT01798992|583865409|FG001|Overall Study|Insufficient biopsy tissue|0|||
161675133|NCT01798992|583865410|FG002|Overall Study|Insufficient biopsy tissue|1|||
161675134|NCT01798992|583865411|FG003|Overall Study|Insufficient biopsy tissue|0|||
161675135|NCT01069120|583865412|FG000|Overall Study|Study prematurely terminated|27|||
161675136|NCT02294682|583865413|FG000|Overall Study|Could not swallow pills|1|||
161675137|NCT02294682|583865414|FG001|Overall Study|Could not swallow pills|0|||
161675138|NCT01516970|583865415|FG000|Overall Study|Lost to Follow-up|7|||
161675139|NCT01516970|583865416|FG001|Overall Study|Lost to Follow-up|8|||
161675140|NCT01516970|583865415|FG000|Overall Study|Adverse Event|1|||
161675141|NCT01516970|583865416|FG001|Overall Study|Adverse Event|5|||
161675142|NCT01516970|583865415|FG000|Overall Study|Withdrawal by Subject|1|||
161675143|NCT01516970|583865416|FG001|Overall Study|Withdrawal by Subject|1|||
161675144|NCT01516970|583865415|FG000|Overall Study|Other|9|||
161675145|NCT01516970|583865416|FG001|Overall Study|Other|7|||
161675146|NCT00434421|583865417|FG000|Overall Study|Withdrawal by Subject|1|||
161675147|NCT00434421|583865417|FG000|Overall Study|Non-compliance with study treatment|1|||
161675148|NCT01301456|583865418|FG000|Stage 1|Withdrawal by Subject|0|||
161675149|NCT01301456|583865419|FG001|Stage 1|Withdrawal by Subject|0|||
161675150|NCT01301456|583865420|FG002|Stage 1|Withdrawal by Subject|1|||
161675151|NCT01301456|583865421|FG003|Stage 1|Withdrawal by Subject|0|||
161675152|NCT01301456|583865422|FG004|Stage 1|Withdrawal by Subject|1|||
161675153|NCT01301456|583865423|FG005|Stage 1|Withdrawal by Subject|0|||
162020360|NCT02529553|585128650|FG004|Overall Study|Physician Decision|1|||
162020361|NCT02529553|585128651|FG005|Overall Study|Physician Decision|0|||
162020362|NCT02529553|585128652|FG006|Overall Study|Physician Decision|0|||
162020363|NCT02529553|585128653|FG007|Overall Study|Physician Decision|0|||
162020364|NCT02529553|585128654|FG008|Overall Study|Physician Decision|0|||
161675154|NCT01301456|583865424|FG006|Stage 1|Withdrawal by Subject|0|||
161675155|NCT01301456|583865425|FG007|Stage 1|Withdrawal by Subject|0|||
161675156|NCT01301456|583865426|FG008|Stage 1|Withdrawal by Subject|0|||
161675157|NCT01301456|583865427|FG009|Stage 1|Withdrawal by Subject|0|||
162020365|NCT02529553|585128646|FG000|Overall Study|Withdrawal by Subject|0|||
162020366|NCT02529553|585128647|FG001|Overall Study|Withdrawal by Subject|0|||
162020367|NCT02529553|585128648|FG002|Overall Study|Withdrawal by Subject|0|||
161675158|NCT01301456|583865428|FG010|Stage 1|Withdrawal by Subject|0|||
161675159|NCT01301456|583865429|FG011|Stage 1|Withdrawal by Subject|0|||
161675160|NCT01301456|583865418|FG000|Stage 1|Randomized but not treated|0|||
161675161|NCT01301456|583865419|FG001|Stage 1|Randomized but not treated|0|||
162020368|NCT02529553|585128649|FG003|Overall Study|Withdrawal by Subject|0|||
161675162|NCT01301456|583865420|FG002|Stage 1|Randomized but not treated|0|||
162020369|NCT02529553|585128650|FG004|Overall Study|Withdrawal by Subject|0|||
162020370|NCT02529553|585128651|FG005|Overall Study|Withdrawal by Subject|1|||
162020371|NCT02529553|585128652|FG006|Overall Study|Withdrawal by Subject|0|||
162020372|NCT02529553|585128653|FG007|Overall Study|Withdrawal by Subject|1|||
162020373|NCT02529553|585128654|FG008|Overall Study|Withdrawal by Subject|0|||
162020374|NCT05767749|585128655|FG000|Overall Study|Withdrawal by Subject|0|||
162020375|NCT05767749|585128656|FG001|Overall Study|Withdrawal by Subject|0|||
162020376|NCT05767749|585128657|FG002|Overall Study|Withdrawal by Subject|2|||
162020377|NCT05767749|585128658|FG003|Overall Study|Withdrawal by Subject|2|||
162020378|NCT05767749|585128659|FG004|Overall Study|Withdrawal by Subject|2|||
162020379|NCT05767749|585128660|FG005|Overall Study|Withdrawal by Subject|2|||
162020380|NCT00114517|585128661|FG000|Overall Study|Adverse Event|6|||
162020381|NCT00114517|585128662|FG001|Overall Study|Adverse Event|1|||
162020382|NCT00114517|585128663|FG002|Overall Study|Adverse Event|6|||
162020383|NCT00114517|585128664|FG003|Overall Study|Adverse Event|3|||
162020384|NCT00114517|585128661|FG000|Overall Study|Lost to Follow-up|2|||
162020385|NCT00114517|585128662|FG001|Overall Study|Lost to Follow-up|2|||
162020386|NCT00114517|585128663|FG002|Overall Study|Lost to Follow-up|2|||
162020387|NCT00114517|585128664|FG003|Overall Study|Lost to Follow-up|1|||
162020388|NCT00114517|585128661|FG000|Overall Study|Too busy|3|||
162020389|NCT00114517|585128662|FG001|Overall Study|Too busy|1|||
162020390|NCT00114517|585128663|FG002|Overall Study|Too busy|1|||
162020391|NCT00114517|585128664|FG003|Overall Study|Too busy|2|||
162020392|NCT00114517|585128661|FG000|Overall Study|Moved from area|0|||
162020393|NCT00114517|585128662|FG001|Overall Study|Moved from area|3|||
162020394|NCT00114517|585128663|FG002|Overall Study|Moved from area|2|||
162020395|NCT00114517|585128664|FG003|Overall Study|Moved from area|1|||
162020396|NCT00114517|585128661|FG000|Overall Study|Did not want estradiol|1|||
162020397|NCT00114517|585128662|FG001|Overall Study|Did not want estradiol|1|||
162020398|NCT00114517|585128663|FG002|Overall Study|Did not want estradiol|0|||
162020399|NCT00114517|585128664|FG003|Overall Study|Did not want estradiol|0|||
162020400|NCT00114517|585128661|FG000|Overall Study|Armed-services duty|0|||
162020401|NCT00114517|585128662|FG001|Overall Study|Armed-services duty|1|||
162020402|NCT00114517|585128663|FG002|Overall Study|Armed-services duty|0|||
162020403|NCT00114517|585128664|FG003|Overall Study|Armed-services duty|1|||
162020404|NCT00114517|585128661|FG000|Overall Study|Competing family issue|0|||
162020405|NCT00114517|585128662|FG001|Overall Study|Competing family issue|1|||
162020406|NCT00114517|585128663|FG002|Overall Study|Competing family issue|0|||
162020407|NCT00114517|585128664|FG003|Overall Study|Competing family issue|1|||
162020408|NCT00114517|585128661|FG000|Overall Study|Physician Decision|0|||
162020409|NCT00114517|585128662|FG001|Overall Study|Physician Decision|1|||
162020410|NCT00114517|585128663|FG002|Overall Study|Physician Decision|0|||
162020411|NCT00114517|585128664|FG003|Overall Study|Physician Decision|0|||
162020412|NCT00114517|585128661|FG000|Overall Study|Lost interest|0|||
162020413|NCT00114517|585128662|FG001|Overall Study|Lost interest|0|||
162020414|NCT00114517|585128663|FG002|Overall Study|Lost interest|1|||
162020415|NCT00114517|585128664|FG003|Overall Study|Lost interest|0|||
162020416|NCT00114517|585128661|FG000|Overall Study|Weight increase|0|||
162020417|NCT00114517|585128662|FG001|Overall Study|Weight increase|0|||
162020418|NCT00114517|585128663|FG002|Overall Study|Weight increase|1|||
162020419|NCT00114517|585128664|FG003|Overall Study|Weight increase|0|||
162020420|NCT00114517|585128661|FG000|Overall Study|Concern about blood clots|0|||
162020421|NCT00114517|585128662|FG001|Overall Study|Concern about blood clots|0|||
162020422|NCT00114517|585128663|FG002|Overall Study|Concern about blood clots|1|||
162020423|NCT00114517|585128664|FG003|Overall Study|Concern about blood clots|0|||
162020424|NCT00114517|585128661|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
162020425|NCT00114517|585128662|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
162020426|NCT00114517|585128663|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
162195494|NCT03651271|585766259|FG000|Overall Study|Withdrawal by Subject|1|||
162195495|NCT03651271|585766260|FG001|Overall Study|Withdrawal by Subject|15|||
162195496|NCT03651271|585766261|FG002|Overall Study|Withdrawal by Subject|0|||
162020427|NCT00114517|585128664|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
162020428|NCT00924027|585128665|FG000|Overall Study|Lost to Further Follow-Up|4|||
162020429|NCT00924027|585128666|FG001|Overall Study|Lost to Further Follow-Up|0|||
162020430|NCT00924027|585128667|FG002|Overall Study|Lost to Further Follow-Up|0|||
162020431|NCT00924027|585128668|FG003|Overall Study|Lost to Further Follow-Up|0|||
162020432|NCT00924027|585128665|FG000|Overall Study|Physician Decision|1|||
162020433|NCT00924027|585128666|FG001|Overall Study|Physician Decision|0|||
162020434|NCT00924027|585128667|FG002|Overall Study|Physician Decision|0|||
162195497|NCT03651271|585766262|FG003|Overall Study|Withdrawal by Subject|0|||
162195498|NCT03651271|585766263|FG004|Overall Study|Withdrawal by Subject|1|||
161675163|NCT01301456|583865421|FG003|Stage 1|Randomized but not treated|0|||
162195499|NCT03651271|585766259|FG000|Overall Study|Patient medically unable to continue|0|||
162020435|NCT00924027|585128668|FG003|Overall Study|Physician Decision|1|||
162020436|NCT00924027|585128665|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
162020437|NCT00924027|585128666|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
162195500|NCT03651271|585766260|FG001|Overall Study|Patient medically unable to continue|0|||
162195501|NCT03651271|585766261|FG002|Overall Study|Patient medically unable to continue|0|||
162195502|NCT03651271|585766262|FG003|Overall Study|Patient medically unable to continue|1|||
162195503|NCT03651271|585766263|FG004|Overall Study|Patient medically unable to continue|0|||
162195504|NCT00821093|585766264|FG000|Overall Study|Adverse Event|20|||
162195505|NCT00821093|585766265|FG001|Overall Study|Adverse Event|12|||
162195506|NCT00821093|585766264|FG000|Overall Study|Withdrawal by Subject|9|||
162195507|NCT00821093|585766265|FG001|Overall Study|Withdrawal by Subject|13|||
162195508|NCT00821093|585766264|FG000|Overall Study|Lost to Follow-up|9|||
162195509|NCT00821093|585766265|FG001|Overall Study|Lost to Follow-up|3|||
162195510|NCT00821093|585766264|FG000|Overall Study|Protocol deviation|3|||
162195511|NCT00821093|585766265|FG001|Overall Study|Protocol deviation|6|||
162195512|NCT00821093|585766264|FG000|Overall Study|Abnormal laboratory value(s)|2|||
162195513|NCT00821093|585766265|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162195514|NCT00821093|585766264|FG000|Overall Study|Lack of Efficacy|2|||
162195515|NCT00821093|585766265|FG001|Overall Study|Lack of Efficacy|2|||
162195516|NCT00821093|585766264|FG000|Overall Study|Death|2|||
162195517|NCT00821093|585766265|FG001|Overall Study|Death|1|||
162195518|NCT00821093|585766264|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162195519|NCT00821093|585766265|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162195520|NCT00821093|585766264|FG000|Overall Study|Administrative problems|1|||
161675164|NCT01301456|583865422|FG004|Stage 1|Randomized but not treated|0|||
161675165|NCT01301456|583865423|FG005|Stage 1|Randomized but not treated|0|||
161675166|NCT01301456|583865424|FG006|Stage 1|Randomized but not treated|1|||
161675167|NCT01301456|583865425|FG007|Stage 1|Randomized but not treated|0|||
161675168|NCT01301456|583865426|FG008|Stage 1|Randomized but not treated|0|||
161675169|NCT01301456|583865427|FG009|Stage 1|Randomized but not treated|0|||
161926214|NCT00625378|584777137|FG000|Overall Study|Adverse Event|22|||
161926215|NCT00625378|584777138|FG001|Overall Study|Adverse Event|0|||
161926216|NCT00625378|584777137|FG000|Overall Study|Withdrawal by Subject|16|||
161926217|NCT00625378|584777138|FG001|Overall Study|Withdrawal by Subject|0|||
161926218|NCT00625378|584777137|FG000|Overall Study|Death|38|||
161926219|NCT00625378|584777138|FG001|Overall Study|Death|0|||
161926220|NCT00625378|584777137|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
161926221|NCT00625378|584777138|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
161926222|NCT00625378|584777137|FG000|Overall Study|Lost to Follow-up|17|||
161926223|NCT00625378|584777138|FG001|Overall Study|Lost to Follow-up|0|||
161926224|NCT00625378|584777137|FG000|Overall Study|Non-compliant with study medication|3|||
161926225|NCT00625378|584777138|FG001|Overall Study|Non-compliant with study medication|0|||
161926226|NCT00625378|584777137|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
161926227|NCT00625378|584777138|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
161926228|NCT00625378|584777137|FG000|Overall Study|Medical decision|1|||
161926229|NCT00625378|584777138|FG001|Overall Study|Medical decision|0|||
161926230|NCT00625378|584777137|FG000|Overall Study|Multiple toxicities|1|||
161926231|NCT00625378|584777138|FG001|Overall Study|Multiple toxicities|0|||
161926232|NCT00625378|584777137|FG000|Overall Study|New cancer|1|||
161926233|NCT00625378|584777138|FG001|Overall Study|New cancer|0|||
161926234|NCT00625378|584777137|FG000|Overall Study|PTA program|2|||
161926235|NCT00625378|584777138|FG001|Overall Study|PTA program|0|||
161926236|NCT00625378|584777137|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
161926237|NCT00625378|584777138|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
161926238|NCT00625378|584777137|FG000|Overall Study|Sponsor decision|1|||
161926239|NCT00625378|584777138|FG001|Overall Study|Sponsor decision|0|||
161926240|NCT00625378|584777137|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
161926241|NCT00625378|584777138|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
161926242|NCT00625378|584777137|FG000|Overall Study|Switch to commercial drug|6|||
161926243|NCT00625378|584777138|FG001|Overall Study|Switch to commercial drug|1|||
161926244|NCT00625378|584777137|FG000|Overall Study|Missing|2|||
161926245|NCT00625378|584777138|FG001|Overall Study|Missing|0|||
161926246|NCT00625378|584777137|FG000|Overall Study|End of treatment not available|2|||
161926247|NCT00625378|584777138|FG001|Overall Study|End of treatment not available|0|||
161926248|NCT00625378|584777137|FG000|Overall Study|Never treated|2|||
161926249|NCT00625378|584777138|FG001|Overall Study|Never treated|0|||
162195521|NCT00821093|585766265|FG001|Overall Study|Administrative problems|2|||
161675170|NCT01301456|583865428|FG010|Stage 1|Randomized but not treated|0|||
161675171|NCT01301456|583865429|FG011|Stage 1|Randomized but not treated|0|||
161675172|NCT01301456|583865418|FG000|Stage 2|Adverse Event|0|||
161675173|NCT01301456|583865419|FG001|Stage 2|Adverse Event|0|||
161675174|NCT01301456|583865420|FG002|Stage 2|Adverse Event|0|||
161675175|NCT01301456|583865421|FG003|Stage 2|Adverse Event|0|||
161675176|NCT01301456|583865422|FG004|Stage 2|Adverse Event|0|||
161675177|NCT01301456|583865423|FG005|Stage 2|Adverse Event|0|||
161675178|NCT01301456|583865424|FG006|Stage 2|Adverse Event|0|||
161675179|NCT01301456|583865425|FG007|Stage 2|Adverse Event|0|||
161675180|NCT01301456|583865426|FG008|Stage 2|Adverse Event|0|||
161675181|NCT01301456|583865427|FG009|Stage 2|Adverse Event|0|||
161675182|NCT01301456|583865428|FG010|Stage 2|Adverse Event|1|||
161675183|NCT01301456|583865429|FG011|Stage 2|Adverse Event|0|||
161675184|NCT05372653|583865437|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
161675185|NCT05372653|583865438|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
161675186|NCT05372653|583865437|FG000|Overall Study|Adverse Event|0|||
161675187|NCT05372653|583865438|FG001|Overall Study|Adverse Event|1|||
161675188|NCT00117507|583865439|FG000|Overall Study|Adverse Event|4|||
161675189|NCT00117507|583865439|FG000|Overall Study|Abnormal laboratory values|3|||
161675190|NCT00117507|583865439|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161675191|NCT00117507|583865439|FG000|Overall Study|Patient withdrew consent|4|||
161675192|NCT00117507|583865439|FG000|Overall Study|Death|3|||
161675193|NCT00866723|583865440|FG000|Overall Study|Withdrawal by Subject|1|||
161675194|NCT00866723|583865440|FG000|Overall Study|Disease Progression|4|||
161675195|NCT00711529|583865441|FG000|Overall Study|Protocol Violation|2|||
161675196|NCT00711529|583865442|FG001|Overall Study|Protocol Violation|0|||
161675197|NCT00711529|583865441|FG000|Overall Study|Withdrawal by Subject|2|||
161675198|NCT00711529|583865442|FG001|Overall Study|Withdrawal by Subject|6|||
161675199|NCT03740997|583865445|FG000|Overall Study|Withdrawal by Subject|1|||
161675200|NCT03740997|583865446|FG001|Overall Study|Withdrawal by Subject|0|||
161675201|NCT03740997|583865445|FG000|Overall Study|Participant was unable to complete study procedures|1|||
161675202|NCT03740997|583865446|FG001|Overall Study|Participant was unable to complete study procedures|0|||
161675203|NCT01003990|583865447|FG000|Overall Study|Adverse Event|8|||
161675204|NCT01003990|583865448|FG001|Overall Study|Adverse Event|5|||
161675205|NCT01003990|583865449|FG002|Overall Study|Adverse Event|11|||
161675206|NCT01003990|583865447|FG000|Overall Study|Death|0|||
161675207|NCT01003990|583865448|FG001|Overall Study|Death|8|||
161675208|NCT01003990|583865449|FG002|Overall Study|Death|1|||
161675209|NCT01003990|583865447|FG000|Overall Study|Lack of Efficacy|10|||
161675210|NCT01003990|583865448|FG001|Overall Study|Lack of Efficacy|2|||
161675211|NCT01003990|583865449|FG002|Overall Study|Lack of Efficacy|3|||
161675212|NCT01003990|583865447|FG000|Overall Study|Lost to Follow-up|30|||
161675213|NCT01003990|583865448|FG001|Overall Study|Lost to Follow-up|12|||
161675214|NCT01003990|583865449|FG002|Overall Study|Lost to Follow-up|7|||
161675215|NCT01003990|583865447|FG000|Overall Study|Reasons Not Identified|14|||
161675216|NCT01003990|583865448|FG001|Overall Study|Reasons Not Identified|13|||
161675217|NCT01003990|583865449|FG002|Overall Study|Reasons Not Identified|8|||
161675218|NCT01003990|583865447|FG000|Overall Study|Poor/Non-compliance|4|||
161675219|NCT01003990|583865448|FG001|Overall Study|Poor/Non-compliance|3|||
161675220|NCT01003990|583865449|FG002|Overall Study|Poor/Non-compliance|2|||
161675221|NCT01003990|583865447|FG000|Overall Study|Pregnancy|10|||
161675222|NCT01003990|583865448|FG001|Overall Study|Pregnancy|2|||
161675223|NCT01003990|583865449|FG002|Overall Study|Pregnancy|4|||
161675224|NCT01003990|583865447|FG000|Overall Study|No Longer Met Study Criteria|4|||
161675225|NCT01003990|583865448|FG001|Overall Study|No Longer Met Study Criteria|1|||
161675226|NCT01003990|583865449|FG002|Overall Study|No Longer Met Study Criteria|0|||
162020438|NCT00924027|585128667|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
162195522|NCT05104242|585766266|FG000|Overall Study|Withdrawal by Subject|1|||
162195523|NCT05104242|585766267|FG001|Overall Study|Withdrawal by Subject|5|||
162195524|NCT05104242|585766266|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
162195525|NCT05104242|585766267|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
162195526|NCT02469155|585766272|FG000|Overall Study|Adverse Event|6|||
162195527|NCT02469155|585766273|FG001|Overall Study|Adverse Event|0|||
161675227|NCT01003990|583865447|FG000|Overall Study|Subject Withdrew Consent|12|||
161675228|NCT01003990|583865448|FG001|Overall Study|Subject Withdrew Consent|5|||
161675229|NCT01003990|583865449|FG002|Overall Study|Subject Withdrew Consent|7|||
162195528|NCT02469155|585766274|FG002|Overall Study|Adverse Event|1|||
162195529|NCT02469155|585766275|FG003|Overall Study|Adverse Event|10|||
161675230|NCT01271803|583865450|FG000|Overall Study|Progressive disease|0|||
161675231|NCT01271803|583865451|FG001|Overall Study|Progressive disease|0|||
161675232|NCT01271803|583865452|FG002|Overall Study|Progressive disease|2|||
161675233|NCT01271803|583865450|FG000|Overall Study|Death|53|||
162195530|NCT02469155|585766272|FG000|Overall Study|Lack of Efficacy|13|||
161675234|NCT01271803|583865451|FG001|Overall Study|Death|34|||
161675235|NCT01271803|583865452|FG002|Overall Study|Death|0|||
161675236|NCT01271803|583865450|FG000|Overall Study|Withdrawal by Subject|1|||
161675237|NCT01271803|583865451|FG001|Overall Study|Withdrawal by Subject|5|||
161675238|NCT01271803|583865452|FG002|Overall Study|Withdrawal by Subject|0|||
161675239|NCT01271803|583865450|FG000|Overall Study|Lost to Follow-up|1|||
161675240|NCT01271803|583865451|FG001|Overall Study|Lost to Follow-up|0|||
161675241|NCT01271803|583865452|FG002|Overall Study|Lost to Follow-up|0|||
161675242|NCT04178967|583865453|FG000|Induction Period|Adverse Event|4|||
161675243|NCT04178967|583865454|FG001|Induction Period|Adverse Event|6|||
161675244|NCT04178967|583865455|FG002|Induction Period|Adverse Event|0|||
161675245|NCT04178967|583865456|FG003|Induction Period|Adverse Event|0|||
161675246|NCT04178967|583865457|FG004|Induction Period|Adverse Event|0|||
161675247|NCT04178967|583865458|FG005|Induction Period|Adverse Event|0|||
161675248|NCT04178967|583865459|FG006|Induction Period|Adverse Event|0|||
161675249|NCT04178967|583865460|FG007|Induction Period|Adverse Event|0|||
161675250|NCT04178967|583865461|FG008|Induction Period|Adverse Event|0|||
161675251|NCT04178967|583865462|FG009|Induction Period|Adverse Event|0|||
161675252|NCT04178967|583865463|FG010|Induction Period|Adverse Event|0|||
161675253|NCT04178967|583865453|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
161675254|NCT04178967|583865454|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
161675255|NCT04178967|583865455|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
161675256|NCT04178967|583865456|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
161675257|NCT04178967|583865457|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
161675258|NCT04178967|583865458|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
161675259|NCT04178967|583865459|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
161675260|NCT04178967|583865460|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
161675261|NCT04178967|583865461|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
161675262|NCT04178967|583865462|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
161675263|NCT04178967|583865463|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
161675264|NCT04178967|583865453|FG000|Induction Period|Lack of Efficacy|4|||
161675265|NCT04178967|583865454|FG001|Induction Period|Lack of Efficacy|1|||
161675266|NCT04178967|583865455|FG002|Induction Period|Lack of Efficacy|0|||
161675267|NCT04178967|583865456|FG003|Induction Period|Lack of Efficacy|0|||
161675268|NCT04178967|583865457|FG004|Induction Period|Lack of Efficacy|0|||
161675269|NCT04178967|583865458|FG005|Induction Period|Lack of Efficacy|0|||
161675270|NCT04178967|583865459|FG006|Induction Period|Lack of Efficacy|0|||
161675271|NCT04178967|583865460|FG007|Induction Period|Lack of Efficacy|0|||
161926250|NCT02609633|584777141|FG000|Overall Study|Consent Withdrawn|0|||
161926251|NCT02609633|584777142|FG001|Overall Study|Consent Withdrawn|1|||
161926252|NCT02609633|584777141|FG000|Overall Study|Protocol Deviation|1|||
161926253|NCT02609633|584777142|FG001|Overall Study|Protocol Deviation|0|||
161926254|NCT02609633|584777141|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
161926255|NCT02609633|584777142|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
161926256|NCT02609633|584777141|FG000|Overall Study|Reason not Specified|2|||
161926257|NCT02609633|584777142|FG001|Overall Study|Reason not Specified|1|||
161926258|NCT01769443|584777145|FG000|Overall Study|Study closure|1|||
161926259|NCT01769443|584777146|FG001|Overall Study|Study closure|0|||
161926260|NCT02583477|584777147|FG000|Overall Study|Adverse Event|0|||
161926261|NCT02583477|584777148|FG001|Overall Study|Adverse Event|2|||
161926262|NCT02583477|584777147|FG000|Overall Study|Death|1|||
161926263|NCT02583477|584777148|FG001|Overall Study|Death|16|||
161926264|NCT02583477|584777147|FG000|Overall Study|Study terminated|2|||
161926265|NCT02583477|584777148|FG001|Overall Study|Study terminated|2|||
161926266|NCT05507450|584777149|FG000|Overall Study|Death|0|||
161926267|NCT05507450|584777150|FG001|Overall Study|Death|0|||
161926268|NCT05507450|584777151|FG002|Overall Study|Death|1|||
161926269|NCT05507450|584777152|FG003|Overall Study|Death|0|||
161926270|NCT05507450|584777149|FG000|Overall Study|Lost to Follow-up|22|||
161926271|NCT05507450|584777150|FG001|Overall Study|Lost to Follow-up|20|||
161926272|NCT05507450|584777151|FG002|Overall Study|Lost to Follow-up|20|||
162195531|NCT02469155|585766273|FG001|Overall Study|Lack of Efficacy|10|||
162195532|NCT02469155|585766274|FG002|Overall Study|Lack of Efficacy|10|||
162195533|NCT02469155|585766275|FG003|Overall Study|Lack of Efficacy|8|||
162195534|NCT02469155|585766272|FG000|Overall Study|Death|0|||
162195535|NCT02469155|585766273|FG001|Overall Study|Death|0|||
162195536|NCT02469155|585766274|FG002|Overall Study|Death|0|||
162195537|NCT02469155|585766275|FG003|Overall Study|Death|1|||
162195538|NCT02469155|585766272|FG000|Overall Study|Lost to Follow-up|5|||
162195539|NCT02469155|585766273|FG001|Overall Study|Lost to Follow-up|2|||
161675272|NCT04178967|583865461|FG008|Induction Period|Lack of Efficacy|0|||
162195540|NCT02469155|585766274|FG002|Overall Study|Lost to Follow-up|7|||
162195541|NCT02469155|585766275|FG003|Overall Study|Lost to Follow-up|2|||
162195542|NCT02469155|585766272|FG000|Overall Study|Physician Decision|0|||
161675273|NCT04178967|583865462|FG009|Induction Period|Lack of Efficacy|0|||
161675274|NCT04178967|583865463|FG010|Induction Period|Lack of Efficacy|0|||
161675275|NCT04178967|583865453|FG000|Induction Period|Protocol Violation|0|||
161675276|NCT04178967|583865454|FG001|Induction Period|Protocol Violation|6|||
161926273|NCT05507450|584777152|FG003|Overall Study|Lost to Follow-up|7|||
161926274|NCT05507450|584777149|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161926275|NCT05507450|584777150|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
161926276|NCT05507450|584777151|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161675277|NCT04178967|583865455|FG002|Induction Period|Protocol Violation|0|||
162195543|NCT02469155|585766273|FG001|Overall Study|Physician Decision|0|||
162195544|NCT02469155|585766274|FG002|Overall Study|Physician Decision|1|||
162195545|NCT02469155|585766275|FG003|Overall Study|Physician Decision|0|||
162195546|NCT02469155|585766272|FG000|Overall Study|Withdrawal by Subject|34|||
162195547|NCT02469155|585766273|FG001|Overall Study|Withdrawal by Subject|30|||
162195548|NCT02469155|585766274|FG002|Overall Study|Withdrawal by Subject|20|||
162195549|NCT02469155|585766275|FG003|Overall Study|Withdrawal by Subject|37|||
162195550|NCT02469155|585766272|FG000|Overall Study|Other|3|||
162195551|NCT02469155|585766273|FG001|Overall Study|Other|3|||
162195552|NCT02469155|585766274|FG002|Overall Study|Other|2|||
162195553|NCT02469155|585766275|FG003|Overall Study|Other|10|||
162195554|NCT02469155|585766272|FG000|Overall Study|Protocol Violation|0|||
162195555|NCT02469155|585766273|FG001|Overall Study|Protocol Violation|1|||
162195556|NCT02469155|585766274|FG002|Overall Study|Protocol Violation|0|||
162195557|NCT02469155|585766275|FG003|Overall Study|Protocol Violation|1|||
162195558|NCT02991118|585766276|FG000|Overall Study|Death|3|||
162195559|NCT02991118|585766277|FG001|Overall Study|Death|8|||
162020439|NCT00924027|585128668|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
162020440|NCT00924027|585128665|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
162020441|NCT00924027|585128666|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
162020442|NCT00924027|585128667|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
162020443|NCT00924027|585128668|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
162020444|NCT00924027|585128665|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
162020445|NCT00924027|585128666|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
162020446|NCT00924027|585128667|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
162020447|NCT00924027|585128668|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
162020448|NCT02848729|585130473|FG000|Overall Study|Withdrawal by Subject|1|||
162020449|NCT02848729|585130474|FG001|Overall Study|Withdrawal by Subject|0|||
162020450|NCT02848729|585130473|FG000|Overall Study|Emesis|15|||
162020451|NCT02848729|585130474|FG001|Overall Study|Emesis|11|||
162020452|NCT03390101|585130475|FG000|Weeks 0-12|Withdrawal by Subject|0|||
162020453|NCT03390101|585130476|FG001|Weeks 0-12|Withdrawal by Subject|1|||
162020454|NCT03390101|585130477|FG002|Weeks 0-12|Withdrawal by Subject|1|||
162020455|NCT03390101|585130475|FG000|Weeks 0-12|Lost to Follow-up|0|||
162020456|NCT03390101|585130476|FG001|Weeks 0-12|Lost to Follow-up|1|||
162020457|NCT03390101|585130477|FG002|Weeks 0-12|Lost to Follow-up|0|||
162020458|NCT03390101|585130475|FG000|Weeks 12-54|Withdrawal by Subject|0|||
162020459|NCT03390101|585130476|FG001|Weeks 12-54|Withdrawal by Subject|3|||
162020460|NCT03390101|585130477|FG002|Weeks 12-54|Withdrawal by Subject|1|||
162020461|NCT03390101|585130475|FG000|Weeks 12-54|Pregnancy|1|||
162020462|NCT03390101|585130476|FG001|Weeks 12-54|Pregnancy|0|||
162020463|NCT03390101|585130477|FG002|Weeks 12-54|Pregnancy|0|||
162020464|NCT03390101|585130475|FG000|Weeks 12-54|Adverse Event|2|||
162020465|NCT03390101|585130476|FG001|Weeks 12-54|Adverse Event|1|||
162020466|NCT03390101|585130477|FG002|Weeks 12-54|Adverse Event|1|||
162020467|NCT04838977|585130478|FG000|Overall Study|Lost to Follow-up|2|||
162020468|NCT04838977|585130479|FG001|Overall Study|Lost to Follow-up|3|||
162020469|NCT04838977|585130478|FG000|Overall Study|Withdrawal by Subject|1|||
162020470|NCT04838977|585130479|FG001|Overall Study|Withdrawal by Subject|1|||
162020471|NCT05367492|585130480|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
162020472|NCT05367492|585130481|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
162020473|NCT05367492|585130482|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
162020474|NCT05367492|585130480|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
162020475|NCT05367492|585130481|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
162020476|NCT05367492|585130482|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
162020477|NCT05367492|585130480|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
162195560|NCT02991118|585766276|FG000|Overall Study|Protocol Violation|0|||
162195561|NCT02991118|585766277|FG001|Overall Study|Protocol Violation|3|||
161820409|NCT02276885|584382817|FG001|Overall Study|Lost to Follow-up|2|||
161820410|NCT03837626|584382818|FG000|Overall Study|Adverse Event|3|||
162195562|NCT02991118|585766276|FG000|Overall Study|Physician Decision|0|||
162195563|NCT02991118|585766277|FG001|Overall Study|Physician Decision|1|||
161820411|NCT03837626|584382819|FG001|Overall Study|Adverse Event|3|||
162020478|NCT05367492|585130481|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
162020479|NCT05367492|585130482|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
162195564|NCT02991118|585766276|FG000|Overall Study|Moved out of the country|0|||
162195565|NCT02991118|585766277|FG001|Overall Study|Moved out of the country|1|||
162195566|NCT02991118|585766276|FG000|Overall Study|Adverse Event|2|||
162195567|NCT02991118|585766277|FG001|Overall Study|Adverse Event|2|||
162020480|NCT05367492|585130480|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
162020481|NCT05367492|585130481|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
162020482|NCT05367492|585130482|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
162020483|NCT00950859|585130486|FG000|Overall Study|Adverse Event|3|||
162020484|NCT00950859|585130487|FG001|Overall Study|Adverse Event|3|||
162020485|NCT00950859|585130486|FG000|Overall Study|Insufficient Viral Load Response|12|||
162195568|NCT02991118|585766276|FG000|Overall Study|Withdrawal by Subject|1|||
162195569|NCT02991118|585766277|FG001|Overall Study|Withdrawal by Subject|7|||
162195570|NCT02991118|585766276|FG000|Overall Study|Could not attend study visits|0|||
162195571|NCT02991118|585766277|FG001|Overall Study|Could not attend study visits|1|||
162195572|NCT02991118|585766276|FG000|Overall Study|Lost to Follow-up|1|||
162195573|NCT02991118|585766277|FG001|Overall Study|Lost to Follow-up|9|||
162195574|NCT02764320|585766285|FG000|Overall Study|Withdrawal by Subject|35|||
162195575|NCT02764320|585766286|FG001|Overall Study|Withdrawal by Subject|38|||
162195576|NCT02764320|585766285|FG000|Overall Study|Protocol Violation|11|||
162195577|NCT02764320|585766286|FG001|Overall Study|Protocol Violation|6|||
162195578|NCT02764320|585766285|FG000|Overall Study|Adverse Event|2|||
162195579|NCT02764320|585766286|FG001|Overall Study|Adverse Event|0|||
162195580|NCT02764320|585766285|FG000|Overall Study|Health Issues unable to continue|2|||
162195581|NCT02764320|585766286|FG001|Overall Study|Health Issues unable to continue|0|||
162195582|NCT02764320|585766285|FG000|Overall Study|Did not meet inclusion criteria|1|||
162195583|NCT02764320|585766286|FG001|Overall Study|Did not meet inclusion criteria|0|||
162195584|NCT02764320|585766285|FG000|Overall Study|Subject moved|0|||
162195585|NCT02764320|585766286|FG001|Overall Study|Subject moved|2|||
161820412|NCT03837626|584382818|FG000|Overall Study|Withdrawal by Subject|2|||
161820413|NCT03837626|584382819|FG001|Overall Study|Withdrawal by Subject|4|||
161820414|NCT03837626|584382818|FG000|Overall Study|Physician Decision|2|||
161820415|NCT03837626|584382819|FG001|Overall Study|Physician Decision|3|||
161820416|NCT03837626|584382818|FG000|Overall Study|Lost to Follow-up|3|||
161820417|NCT03837626|584382819|FG001|Overall Study|Lost to Follow-up|1|||
161820418|NCT05740371|584382820|FG000|Overall Study|Death|1|||
161820419|NCT00874822|584382821|FG000|Overall Study|excluded by criteria|8|||
161820420|NCT02627963|584382822|FG000|Overall Study|Randomized but not treated|2|||
161820421|NCT02627963|584382823|FG001|Overall Study|Randomized but not treated|6|||
161820422|NCT03073798|584382824|FG000|Overall Study|Adverse Event|1|||
161820423|NCT03073798|584382824|FG000|Overall Study|Withdrawal by Subject|1|||
161820424|NCT05278858|584382827|FG000|Overall Study|Withdrawal by Subject|1|||
161820425|NCT00840658|584382828|FG000|Overall Study|Death|2|||
161820426|NCT00840658|584382829|FG001|Overall Study|Death|2|||
161820427|NCT00840658|584382830|FG002|Overall Study|Death|3|||
161820428|NCT00840658|584382831|FG003|Overall Study|Death|3|||
161820429|NCT00840658|584382828|FG000|Overall Study|Lost to Follow-up|3|||
161820430|NCT00840658|584382829|FG001|Overall Study|Lost to Follow-up|1|||
161820431|NCT00840658|584382830|FG002|Overall Study|Lost to Follow-up|2|||
161820432|NCT00840658|584382831|FG003|Overall Study|Lost to Follow-up|1|||
161820433|NCT00728754|584382836|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
161820434|NCT00728754|584382837|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
161820435|NCT00728754|584382836|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
161820436|NCT00728754|584382837|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
161820437|NCT00728754|584382836|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
161820438|NCT00728754|584382837|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
161820439|NCT00573313|584382842|FG000|Overall Study|Protocol Violation|5|||
162195586|NCT02764320|585766285|FG000|Overall Study|Overused medication unavailable|0|||
162195587|NCT02764320|585766286|FG001|Overall Study|Overused medication unavailable|1|||
162195588|NCT02764320|585766285|FG000|Overall Study|Seeking care outside site|0|||
162195589|NCT02764320|585766286|FG001|Overall Study|Seeking care outside site|1|||
162195590|NCT02764320|585766285|FG000|Overall Study|Technology barriers|0|||
162195591|NCT02764320|585766286|FG001|Overall Study|Technology barriers|1|||
162195592|NCT04765046|585766287|FG000|Overall Study|Screen Failure|2|||
162195593|NCT04765046|585766287|FG000|Overall Study|Withdrawal by Subject|4|||
162195594|NCT04765046|585766287|FG000|Overall Study|Physician Decision|4|||
162195595|NCT04765046|585766287|FG000|Overall Study|Surgery Cancelled|8|||
162195596|NCT03150589|585766289|FG000|Overall Study|Withdrawal by Subject|16|||
162195597|NCT03150589|585766290|FG001|Overall Study|Withdrawal by Subject|9|||
162195598|NCT03150589|585766289|FG000|Overall Study|Adverse Event|7|||
162195599|NCT03150589|585766290|FG001|Overall Study|Adverse Event|6|||
162195600|NCT03150589|585766289|FG000|Overall Study|Protocol Violation|4|||
162195601|NCT03150589|585766290|FG001|Overall Study|Protocol Violation|3|||
162195602|NCT03150589|585766289|FG000|Overall Study|Lost to Follow-up|3|||
162195603|NCT03150589|585766290|FG001|Overall Study|Lost to Follow-up|3|||
162195604|NCT03150589|585766289|FG000|Overall Study|Death|2|||
162195605|NCT03150589|585766290|FG001|Overall Study|Death|3|||
162195606|NCT03150589|585766289|FG000|Overall Study|IP non-compliance and other reasons|12|||
162195607|NCT03150589|585766290|FG001|Overall Study|IP non-compliance and other reasons|3|||
162195608|NCT03529942|585766291|FG000|Overall Study|Withdrawal by Subject|13|||
162195609|NCT03529942|585766291|FG000|Overall Study|Physician Decision|1|||
162195610|NCT03529942|585766291|FG000|Overall Study|Lost to Follow-up|7|||
161820440|NCT00573313|584382843|FG001|Overall Study|Protocol Violation|0|||
161820441|NCT00573313|584382844|FG002|Overall Study|Protocol Violation|6|||
161820442|NCT00573313|584382845|FG003|Overall Study|Protocol Violation|0|||
161820443|NCT00295490|584382848|FG000|Overall Study|Protocol Violation|0|||
161820444|NCT00295490|584382849|FG001|Overall Study|Protocol Violation|0|||
161820445|NCT00295490|584382850|FG002|Overall Study|Protocol Violation|3|||
162195611|NCT03529942|585766291|FG000|Overall Study|Needle inserted but no drug administered|1|||
162195612|NCT03529942|585766291|FG000|Overall Study|Personal reasons|1|||
161820446|NCT00295490|584382851|FG003|Overall Study|Protocol Violation|3|||
162195613|NCT01989156|585766304|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
162195614|NCT01989156|585766305|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
162195615|NCT01989156|585766306|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
162195616|NCT01989156|585766304|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
162195617|NCT01989156|585766305|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
162195618|NCT01989156|585766306|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
162195619|NCT01989156|585766304|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
162195620|NCT01989156|585766305|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
161926277|NCT05507450|584777152|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161926278|NCT05507450|584777149|FG000|Overall Study|Withdrawal by Subject|4|||
161926279|NCT05507450|584777150|FG001|Overall Study|Withdrawal by Subject|11|||
161926280|NCT05507450|584777151|FG002|Overall Study|Withdrawal by Subject|7|||
161926281|NCT05507450|584777152|FG003|Overall Study|Withdrawal by Subject|3|||
161926282|NCT05507450|584777149|FG000|Overall Study|Participant left the country|0|||
161926283|NCT05507450|584777150|FG001|Overall Study|Participant left the country|0|||
161926284|NCT05507450|584777151|FG002|Overall Study|Participant left the country|1|||
161926285|NCT05507450|584777152|FG003|Overall Study|Participant left the country|0|||
161926286|NCT05436288|584777153|FG000|Overall Study|Lost to Follow-up|1|||
161926287|NCT05436288|584777153|FG000|Overall Study|Adverse Event|1|||
161926288|NCT03767894|584777156|FG000|Overall Study|Withdrawal by Subject|1|||
161926289|NCT00387127|584777157|FG000|Overall Study|Lost to Follow-up|0|||
161926290|NCT00387127|584777158|FG001|Overall Study|Lost to Follow-up|4|||
161926291|NCT00387127|584777157|FG000|Overall Study|Death|16|||
161926292|NCT00387127|584777158|FG001|Overall Study|Death|16|||
161926293|NCT00387127|584777157|FG000|Overall Study|Physician Decision|0|||
161926294|NCT00387127|584777158|FG001|Overall Study|Physician Decision|1|||
161926295|NCT00387127|584777157|FG000|Overall Study|Withdrawal by Subject|3|||
161926296|NCT00387127|584777158|FG001|Overall Study|Withdrawal by Subject|2|||
161926297|NCT00387127|584777157|FG000|Overall Study|Required by Protocol Amendment #4|12|||
161926298|NCT00387127|584777158|FG001|Overall Study|Required by Protocol Amendment #4|10|||
161926299|NCT00387127|584777157|FG000|Overall Study|Serious Adverse Event|1|||
161926300|NCT00387127|584777158|FG001|Overall Study|Serious Adverse Event|1|||
161926301|NCT00387127|584777157|FG000|Overall Study|Sponsor Unblinded|1|||
161926302|NCT00387127|584777158|FG001|Overall Study|Sponsor Unblinded|0|||
161926303|NCT04149353|584777159|FG000|Overall Study|Study terminated|1|||
161926304|NCT01871727|584777160|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
161926305|NCT01871727|584777161|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
161926306|NCT01871727|584777162|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
161926307|NCT01871727|584777163|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
161926308|NCT01871727|584777164|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
161926309|NCT01871727|584777160|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
161926310|NCT01871727|584777161|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
161926311|NCT01871727|584777162|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
161926312|NCT01871727|584777163|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
161926313|NCT01871727|584777164|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
161926314|NCT01871727|584777160|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
161926315|NCT01871727|584777161|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
161926316|NCT01871727|584777162|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
161926317|NCT01871727|584777163|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
161926318|NCT01871727|584777164|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
162020486|NCT00950859|585130487|FG001|Overall Study|Insufficient Viral Load Response|3|||
162195621|NCT01989156|585766306|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
162195622|NCT01989156|585766304|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
161926319|NCT01871727|584777160|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
161926320|NCT01871727|584777161|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
161675278|NCT04178967|583865456|FG003|Induction Period|Protocol Violation|0|||
161675279|NCT04178967|583865457|FG004|Induction Period|Protocol Violation|0|||
161675280|NCT04178967|583865458|FG005|Induction Period|Protocol Violation|0|||
161675281|NCT04178967|583865459|FG006|Induction Period|Protocol Violation|0|||
161675282|NCT04178967|583865460|FG007|Induction Period|Protocol Violation|0|||
161675283|NCT04178967|583865461|FG008|Induction Period|Protocol Violation|0|||
161675284|NCT04178967|583865462|FG009|Induction Period|Protocol Violation|0|||
161675285|NCT04178967|583865463|FG010|Induction Period|Protocol Violation|0|||
161675286|NCT04178967|583865453|FG000|Induction Period|Withdrawal by Subject|6|||
161675287|NCT04178967|583865454|FG001|Induction Period|Withdrawal by Subject|4|||
161675288|NCT04178967|583865455|FG002|Induction Period|Withdrawal by Subject|0|||
161675289|NCT04178967|583865456|FG003|Induction Period|Withdrawal by Subject|0|||
161675290|NCT04178967|583865457|FG004|Induction Period|Withdrawal by Subject|0|||
161675291|NCT04178967|583865458|FG005|Induction Period|Withdrawal by Subject|0|||
161675292|NCT04178967|583865459|FG006|Induction Period|Withdrawal by Subject|0|||
161675293|NCT04178967|583865460|FG007|Induction Period|Withdrawal by Subject|0|||
161675294|NCT04178967|583865461|FG008|Induction Period|Withdrawal by Subject|0|||
161675295|NCT04178967|583865462|FG009|Induction Period|Withdrawal by Subject|0|||
161675296|NCT04178967|583865463|FG010|Induction Period|Withdrawal by Subject|0|||
161675297|NCT04178967|583865453|FG000|Induction Period|Lost to Follow-up|2|||
161675298|NCT04178967|583865454|FG001|Induction Period|Lost to Follow-up|0|||
161675299|NCT04178967|583865455|FG002|Induction Period|Lost to Follow-up|0|||
161675300|NCT04178967|583865456|FG003|Induction Period|Lost to Follow-up|0|||
161675301|NCT04178967|583865457|FG004|Induction Period|Lost to Follow-up|0|||
161675302|NCT04178967|583865458|FG005|Induction Period|Lost to Follow-up|0|||
161675303|NCT04178967|583865459|FG006|Induction Period|Lost to Follow-up|0|||
161675304|NCT04178967|583865460|FG007|Induction Period|Lost to Follow-up|0|||
161675305|NCT04178967|583865461|FG008|Induction Period|Lost to Follow-up|0|||
161675306|NCT04178967|583865462|FG009|Induction Period|Lost to Follow-up|0|||
161675307|NCT04178967|583865463|FG010|Induction Period|Lost to Follow-up|0|||
161675308|NCT04178967|583865453|FG000|Induction Period|Participant Missed Study Visits|0|||
161675309|NCT04178967|583865454|FG001|Induction Period|Participant Missed Study Visits|1|||
161675310|NCT04178967|583865455|FG002|Induction Period|Participant Missed Study Visits|0|||
161675311|NCT04178967|583865456|FG003|Induction Period|Participant Missed Study Visits|0|||
161675312|NCT04178967|583865457|FG004|Induction Period|Participant Missed Study Visits|0|||
161675313|NCT04178967|583865458|FG005|Induction Period|Participant Missed Study Visits|0|||
161675314|NCT04178967|583865459|FG006|Induction Period|Participant Missed Study Visits|0|||
161675315|NCT04178967|583865460|FG007|Induction Period|Participant Missed Study Visits|0|||
161675316|NCT04178967|583865461|FG008|Induction Period|Participant Missed Study Visits|0|||
161675317|NCT04178967|583865462|FG009|Induction Period|Participant Missed Study Visits|0|||
161675318|NCT04178967|583865463|FG010|Induction Period|Participant Missed Study Visits|0|||
161675319|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675320|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675321|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675322|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675323|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675324|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
161675325|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
161675326|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
161675327|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675328|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675329|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
161675330|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675331|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675332|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675333|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675334|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675335|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
161675336|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161820447|NCT00295490|584382848|FG000|Overall Study|Withdrawal by Subject|0|||
161675337|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675338|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675339|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675340|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161675341|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675342|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675343|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675344|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
161675345|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675346|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675347|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675348|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675349|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675350|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675351|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161675352|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675353|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675354|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
162020487|NCT00950859|585130486|FG000|Overall Study|Protocol Violation|1|||
161675355|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675356|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675357|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675358|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
161675359|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675360|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675361|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675362|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
161675363|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675364|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675365|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675366|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675367|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
161675368|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
161675369|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675370|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
161675371|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675372|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675373|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161675374|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161675375|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161675376|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
161675377|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
161675378|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
161675379|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
161675380|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
161675381|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
161675382|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161675383|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161675384|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161675385|NCT04178967|583865453|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675386|NCT04178967|583865454|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675387|NCT04178967|583865455|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675388|NCT04178967|583865456|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
161675389|NCT04178967|583865457|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675390|NCT04178967|583865458|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
161675391|NCT04178967|583865459|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
161675392|NCT04178967|583865460|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
161675393|NCT04178967|583865461|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675394|NCT04178967|583865462|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675395|NCT04178967|583865463|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161675396|NCT04178967|583865453|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675397|NCT04178967|583865454|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675398|NCT04178967|583865455|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
161820448|NCT00295490|584382849|FG001|Overall Study|Withdrawal by Subject|2|||
161820449|NCT00295490|584382850|FG002|Overall Study|Withdrawal by Subject|0|||
161820450|NCT00295490|584382851|FG003|Overall Study|Withdrawal by Subject|1|||
161820451|NCT00295490|584382848|FG000|Overall Study|Lost to Follow-up|0|||
161820452|NCT00295490|584382849|FG001|Overall Study|Lost to Follow-up|0|||
161820453|NCT00295490|584382850|FG002|Overall Study|Lost to Follow-up|1|||
161820454|NCT00295490|584382851|FG003|Overall Study|Lost to Follow-up|0|||
161820455|NCT00295490|584382848|FG000|Overall Study|Adverse Event|1|||
161675399|NCT04178967|583865456|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675400|NCT04178967|583865457|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
161820456|NCT00295490|584382849|FG001|Overall Study|Adverse Event|0|||
161820457|NCT00295490|584382850|FG002|Overall Study|Adverse Event|0|||
161820458|NCT00295490|584382851|FG003|Overall Study|Adverse Event|0|||
162195623|NCT01989156|585766305|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
161675401|NCT04178967|583865458|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675402|NCT04178967|583865459|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675403|NCT04178967|583865460|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675404|NCT04178967|583865461|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
161675405|NCT04178967|583865462|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
161675406|NCT04178967|583865463|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
161675407|NCT04178967|583865453|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675408|NCT04178967|583865454|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675409|NCT04178967|583865455|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675410|NCT04178967|583865456|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675411|NCT04178967|583865457|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675412|NCT04178967|583865458|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675413|NCT04178967|583865459|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675414|NCT04178967|583865460|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161675415|NCT04178967|583865461|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
161675416|NCT04178967|583865462|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
161675417|NCT04178967|583865463|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
161675418|NCT04178967|583865453|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675419|NCT04178967|583865454|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675420|NCT04178967|583865455|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675421|NCT04178967|583865456|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675422|NCT04178967|583865457|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675423|NCT04178967|583865458|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675424|NCT04178967|583865459|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675425|NCT04178967|583865460|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675426|NCT04178967|583865461|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675427|NCT04178967|583865462|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
161675428|NCT04178967|583865463|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161675429|NCT04178967|583865453|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675430|NCT04178967|583865454|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675431|NCT04178967|583865455|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675432|NCT04178967|583865456|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675433|NCT04178967|583865457|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675434|NCT04178967|583865458|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675435|NCT04178967|583865459|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161820459|NCT00295490|584382848|FG000|Overall Study|Other|0|||
161820460|NCT00295490|584382849|FG001|Overall Study|Other|2|||
161820461|NCT00295490|584382850|FG002|Overall Study|Other|0|||
161820462|NCT00295490|584382851|FG003|Overall Study|Other|1|||
161820463|NCT03255980|584382852|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
161820464|NCT03255980|584382853|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
161820465|NCT03255980|584382854|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
161820466|NCT03255980|584382855|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
161820467|NCT03255980|584382852|FG000|Overall Study|Adverse Event|1|||
162020488|NCT00950859|585130487|FG001|Overall Study|Protocol Violation|1|||
162195624|NCT01989156|585766306|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
162195625|NCT01989156|585766304|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
162195626|NCT01989156|585766305|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
162195627|NCT01989156|585766306|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
162195628|NCT01989156|585766304|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
162195629|NCT01989156|585766305|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
162195630|NCT01989156|585766306|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
162195631|NCT01989156|585766304|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
162195632|NCT01989156|585766305|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
162195633|NCT01989156|585766306|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
162195634|NCT01989156|585766304|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
162195635|NCT01989156|585766305|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
162195636|NCT01989156|585766306|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
162195637|NCT03839355|585766307|FG000|Overall Study|Withdrawal by Subject|1|||
161820468|NCT03255980|584382853|FG001|Overall Study|Adverse Event|1|||
161820469|NCT03255980|584382854|FG002|Overall Study|Adverse Event|0|||
161820470|NCT03255980|584382855|FG003|Overall Study|Adverse Event|1|||
161820471|NCT03255980|584382852|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
161820472|NCT03255980|584382853|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
161820473|NCT03255980|584382854|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
161820474|NCT03255980|584382855|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
161820475|NCT03255980|584382852|FG000|Overall Study|Lost to Follow-up|1|||
161820476|NCT03255980|584382853|FG001|Overall Study|Lost to Follow-up|1|||
161820477|NCT03255980|584382854|FG002|Overall Study|Lost to Follow-up|0|||
161820478|NCT03255980|584382855|FG003|Overall Study|Lost to Follow-up|3|||
161820479|NCT03255980|584382852|FG000|Overall Study|Withdrawal by Subject|0|||
161820480|NCT03255980|584382853|FG001|Overall Study|Withdrawal by Subject|1|||
161820481|NCT03255980|584382854|FG002|Overall Study|Withdrawal by Subject|0|||
161820482|NCT03255980|584382855|FG003|Overall Study|Withdrawal by Subject|3|||
161820483|NCT02611362|584382856|FG000|Overall Study|Withdrawal by Subject|7|||
161820484|NCT02611362|584382857|FG001|Overall Study|Withdrawal by Subject|2|||
161820485|NCT02611362|584382856|FG000|Overall Study|Lost to Follow-up|2|||
161820486|NCT02611362|584382857|FG001|Overall Study|Lost to Follow-up|4|||
161820487|NCT01559116|584382865|FG000|Overall Study|Adverse Event|10|||
161820488|NCT01559116|584382865|FG000|Overall Study|Lack of Efficacy|1|||
161820489|NCT01559116|584382865|FG000|Overall Study|Lost to Follow-up|1|||
161820490|NCT01559116|584382865|FG000|Overall Study|Protocol Violation|1|||
161820491|NCT01559116|584382865|FG000|Overall Study|Withdrawal by Subject|4|||
161820492|NCT01559116|584382865|FG000|Overall Study|other than stated above|9|||
161820493|NCT05468320|584382868|FG000|Overall Study|Other|1|||
161820494|NCT05468320|584382868|FG000|Overall Study|Adverse Event|1|||
161820495|NCT03921554|584382869|FG000|Overall Study|Adverse Event|2|||
161820496|NCT03921554|584382869|FG000|Overall Study|Withdrawal by Subject|1|||
161820497|NCT03921554|584382869|FG000|Overall Study|Death|3|||
161820498|NCT04440592|584382870|FG000|Overall Study|Adverse Event|8|||
161820499|NCT04440592|584382871|FG001|Overall Study|Adverse Event|0|||
161820500|NCT04440592|584382870|FG000|Overall Study|Lost to Follow-up|1|||
161820501|NCT04440592|584382871|FG001|Overall Study|Lost to Follow-up|0|||
161820502|NCT04440592|584382870|FG000|Overall Study|Withdrawal by Subject|1|||
161820503|NCT04440592|584382871|FG001|Overall Study|Withdrawal by Subject|1|||
161820504|NCT04440592|584382870|FG000|Overall Study|Other therapy needed|0|||
161926321|NCT01871727|584777162|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
161926322|NCT01871727|584777163|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
161926323|NCT01871727|584777164|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
161926324|NCT01871727|584777160|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
161926325|NCT01871727|584777161|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
161926326|NCT01871727|584777162|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
161926327|NCT01871727|584777163|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
161926328|NCT01871727|584777164|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
161926329|NCT01871727|584777160|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
161926330|NCT01871727|584777161|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
161926331|NCT01871727|584777162|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
161926332|NCT01871727|584777163|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
162020489|NCT00950859|585130486|FG000|Overall Study|Lost to Follow-up|0|||
162195638|NCT03839355|585766308|FG001|Overall Study|Withdrawal by Subject|0|||
162195639|NCT03541369|585766310|FG000|Overall Study|Death|0|||
162195640|NCT03541369|585766311|FG001|Overall Study|Death|0|||
162195641|NCT03541369|585766312|FG002|Overall Study|Death|0|||
162195642|NCT03541369|585766313|FG003|Overall Study|Death|0|||
162195643|NCT03541369|585766314|FG004|Overall Study|Death|1|||
162195644|NCT03541369|585766315|FG005|Overall Study|Death|1|||
162195645|NCT03541369|585766316|FG006|Overall Study|Death|0|||
162195646|NCT03541369|585766317|FG007|Overall Study|Death|2|||
162195647|NCT03541369|585766318|FG008|Overall Study|Death|1|||
162195648|NCT03541369|585766319|FG009|Overall Study|Death|2|||
162195649|NCT03541369|585766320|FG010|Overall Study|Death|1|||
162195650|NCT03541369|585766321|FG011|Overall Study|Death|0|||
162195651|NCT03541369|585766322|FG012|Overall Study|Death|2|||
162195652|NCT03541369|585766323|FG013|Overall Study|Death|1|||
162195653|NCT03541369|585766324|FG014|Overall Study|Death|1|||
162195654|NCT03541369|585766325|FG015|Overall Study|Death|1|||
162195655|NCT03541369|585766326|FG016|Overall Study|Death|0|||
162195656|NCT03541369|585766327|FG017|Overall Study|Death|1|||
162195657|NCT03541369|585766310|FG000|Overall Study|Decision by sponsor|0|||
162195658|NCT03541369|585766311|FG001|Overall Study|Decision by sponsor|0|||
162195659|NCT03541369|585766312|FG002|Overall Study|Decision by sponsor|0|||
162195660|NCT03541369|585766313|FG003|Overall Study|Decision by sponsor|1|||
162195661|NCT03541369|585766314|FG004|Overall Study|Decision by sponsor|0|||
162195662|NCT03541369|585766315|FG005|Overall Study|Decision by sponsor|2|||
162195663|NCT03541369|585766316|FG006|Overall Study|Decision by sponsor|0|||
162195664|NCT03541369|585766317|FG007|Overall Study|Decision by sponsor|1|||
162195665|NCT03541369|585766318|FG008|Overall Study|Decision by sponsor|2|||
162195666|NCT03541369|585766319|FG009|Overall Study|Decision by sponsor|0|||
162195667|NCT03541369|585766320|FG010|Overall Study|Decision by sponsor|0|||
162195668|NCT03541369|585766321|FG011|Overall Study|Decision by sponsor|0|||
162195669|NCT03541369|585766322|FG012|Overall Study|Decision by sponsor|2|||
162195670|NCT03541369|585766323|FG013|Overall Study|Decision by sponsor|2|||
162195671|NCT03541369|585766324|FG014|Overall Study|Decision by sponsor|0|||
162195672|NCT03541369|585766325|FG015|Overall Study|Decision by sponsor|1|||
162195673|NCT03541369|585766326|FG016|Overall Study|Decision by sponsor|1|||
162195674|NCT03541369|585766327|FG017|Overall Study|Decision by sponsor|1|||
162195675|NCT03541369|585766310|FG000|Overall Study|Withdrawal by Subject|0|||
162195676|NCT03541369|585766311|FG001|Overall Study|Withdrawal by Subject|0|||
162195677|NCT03541369|585766312|FG002|Overall Study|Withdrawal by Subject|0|||
162195678|NCT03541369|585766313|FG003|Overall Study|Withdrawal by Subject|0|||
162195679|NCT03541369|585766314|FG004|Overall Study|Withdrawal by Subject|0|||
162195680|NCT03541369|585766315|FG005|Overall Study|Withdrawal by Subject|0|||
162195681|NCT03541369|585766316|FG006|Overall Study|Withdrawal by Subject|1|||
162195682|NCT03541369|585766317|FG007|Overall Study|Withdrawal by Subject|0|||
161820505|NCT04440592|584382871|FG001|Overall Study|Other therapy needed|1|||
162020490|NCT00950859|585130487|FG001|Overall Study|Lost to Follow-up|3|||
162195683|NCT03541369|585766318|FG008|Overall Study|Withdrawal by Subject|0|||
162195684|NCT03541369|585766319|FG009|Overall Study|Withdrawal by Subject|0|||
162195685|NCT03541369|585766320|FG010|Overall Study|Withdrawal by Subject|0|||
162195686|NCT03541369|585766321|FG011|Overall Study|Withdrawal by Subject|1|||
162195687|NCT03541369|585766322|FG012|Overall Study|Withdrawal by Subject|0|||
162195688|NCT03541369|585766323|FG013|Overall Study|Withdrawal by Subject|0|||
162195689|NCT03541369|585766324|FG014|Overall Study|Withdrawal by Subject|3|||
162195690|NCT03541369|585766325|FG015|Overall Study|Withdrawal by Subject|0|||
162195691|NCT03541369|585766326|FG016|Overall Study|Withdrawal by Subject|4|||
162195692|NCT03541369|585766327|FG017|Overall Study|Withdrawal by Subject|2|||
162195693|NCT03541369|585766310|FG000|Overall Study|Lost to Follow-up|0|||
162195694|NCT03541369|585766311|FG001|Overall Study|Lost to Follow-up|0|||
162195695|NCT03541369|585766312|FG002|Overall Study|Lost to Follow-up|0|||
162195696|NCT03541369|585766313|FG003|Overall Study|Lost to Follow-up|0|||
162195697|NCT03541369|585766314|FG004|Overall Study|Lost to Follow-up|1|||
162195698|NCT03541369|585766315|FG005|Overall Study|Lost to Follow-up|0|||
162195699|NCT03541369|585766316|FG006|Overall Study|Lost to Follow-up|0|||
162195700|NCT03541369|585766317|FG007|Overall Study|Lost to Follow-up|0|||
162195701|NCT03541369|585766318|FG008|Overall Study|Lost to Follow-up|1|||
162195702|NCT03541369|585766319|FG009|Overall Study|Lost to Follow-up|0|||
162195703|NCT03541369|585766320|FG010|Overall Study|Lost to Follow-up|0|||
162195704|NCT03541369|585766321|FG011|Overall Study|Lost to Follow-up|0|||
162195705|NCT03541369|585766322|FG012|Overall Study|Lost to Follow-up|1|||
162195706|NCT03541369|585766323|FG013|Overall Study|Lost to Follow-up|0|||
162195707|NCT03541369|585766324|FG014|Overall Study|Lost to Follow-up|0|||
162195708|NCT03541369|585766325|FG015|Overall Study|Lost to Follow-up|0|||
162195709|NCT03541369|585766326|FG016|Overall Study|Lost to Follow-up|0|||
162195710|NCT03541369|585766327|FG017|Overall Study|Lost to Follow-up|0|||
162195711|NCT01856569|585766328|FG000|Overall Study|Other|1|||
162195712|NCT01856569|585766328|FG000|Overall Study|Changed Site/Structure|1|||
162195713|NCT01856569|585766328|FG000|Overall Study|Lost to Follow-up|3|||
162195714|NCT01856569|585766328|FG000|Overall Study|Did not met inclusion criteria|8|||
162195715|NCT00696241|585766329|FG000|Overall Study|Adverse Event|11|||
162195716|NCT00696241|585766330|FG001|Overall Study|Adverse Event|3|||
162195717|NCT00696241|585766331|FG002|Overall Study|Adverse Event|6|||
162195718|NCT00696241|585766332|FG003|Overall Study|Adverse Event|4|||
162195719|NCT00696241|585766333|FG004|Overall Study|Adverse Event|5|||
162195720|NCT00696241|585766329|FG000|Overall Study|Protocol Violation|1|||
162195721|NCT00696241|585766330|FG001|Overall Study|Protocol Violation|1|||
162195722|NCT00696241|585766331|FG002|Overall Study|Protocol Violation|2|||
162195723|NCT00696241|585766332|FG003|Overall Study|Protocol Violation|0|||
162195724|NCT00696241|585766333|FG004|Overall Study|Protocol Violation|3|||
162195725|NCT00696241|585766329|FG000|Overall Study|Lost to Follow-up|1|||
162195726|NCT00696241|585766330|FG001|Overall Study|Lost to Follow-up|4|||
162195727|NCT00696241|585766331|FG002|Overall Study|Lost to Follow-up|1|||
162195728|NCT00696241|585766332|FG003|Overall Study|Lost to Follow-up|2|||
162195729|NCT00696241|585766333|FG004|Overall Study|Lost to Follow-up|0|||
162195730|NCT00696241|585766329|FG000|Overall Study|Withdrawal by Subject|4|||
162195731|NCT00696241|585766330|FG001|Overall Study|Withdrawal by Subject|8|||
162195732|NCT00696241|585766331|FG002|Overall Study|Withdrawal by Subject|6|||
162195733|NCT00696241|585766332|FG003|Overall Study|Withdrawal by Subject|1|||
162195734|NCT00696241|585766333|FG004|Overall Study|Withdrawal by Subject|0|||
162195735|NCT00696241|585766329|FG000|Overall Study|Lack of Efficacy|1|||
162195736|NCT00696241|585766330|FG001|Overall Study|Lack of Efficacy|5|||
162195737|NCT00696241|585766331|FG002|Overall Study|Lack of Efficacy|4|||
162195738|NCT00696241|585766332|FG003|Overall Study|Lack of Efficacy|5|||
162195739|NCT00696241|585766333|FG004|Overall Study|Lack of Efficacy|3|||
162195740|NCT00696241|585766329|FG000|Overall Study|Other|6|||
162195741|NCT00696241|585766330|FG001|Overall Study|Other|1|||
162195742|NCT00696241|585766331|FG002|Overall Study|Other|5|||
162195743|NCT00696241|585766332|FG003|Overall Study|Other|2|||
162195744|NCT00696241|585766333|FG004|Overall Study|Other|1|||
162195745|NCT01613599|585766334|FG000|Overall Study|Death|9|||
162195746|NCT01613599|585766334|FG000|Overall Study|Lost to Follow-up|5|||
162195747|NCT01613599|585766334|FG000|Overall Study|Withdrawal by Subject|8|||
162195748|NCT01613599|585766334|FG000|Overall Study|Reason not specified|3|||
161820506|NCT00762411|584384531|FG000|Initial Treatment|Death|7|||
162195749|NCT04749797|585766339|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
162195750|NCT04749797|585766340|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
162195751|NCT04749797|585766341|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
161820507|NCT00762411|584384532|FG001|Initial Treatment|Death|6|||
161820508|NCT00762411|584384531|FG000|Initial Treatment|Adverse Event|132|||
161820509|NCT00762411|584384532|FG001|Initial Treatment|Adverse Event|40|||
161820510|NCT00762411|584384531|FG000|Initial Treatment|Protocol Violation|4|||
162020491|NCT01463007|585130489|FG000|Overall Study|Physician Decision|1|||
162020492|NCT03583385|585130490|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162020493|NCT03583385|585130491|FG001|Treatment Period 1|Withdrawal by Subject|1|||
162020494|NCT03583385|585130490|FG000|Treatment Period 2|Adverse Event|1|||
162020495|NCT03583385|585130491|FG001|Treatment Period 2|Adverse Event|0|||
162020496|NCT00545272|585130493|FG000|Overall Study|Protocol deviation|0|||
162020497|NCT00545272|585130494|FG001|Overall Study|Protocol deviation|1|||
162020498|NCT00545272|585130495|FG002|Overall Study|Protocol deviation|0|||
162020499|NCT00545272|585130496|FG003|Overall Study|Protocol deviation|1|||
162195752|NCT02513667|585766342|FG000|Overall Study|Withdrawal by Subject|0|||
162195753|NCT02513667|585766343|FG001|Overall Study|Withdrawal by Subject|1|||
162195754|NCT00871715|585766352|FG000|Overall Study|Withdrawal by Subject|6|||
161820511|NCT00762411|584384532|FG001|Initial Treatment|Protocol Violation|1|||
161820512|NCT00762411|584384531|FG000|Initial Treatment|Withdrawal by Subject|65|||
161820513|NCT00762411|584384532|FG001|Initial Treatment|Withdrawal by Subject|52|||
161820514|NCT00762411|584384531|FG000|Initial Treatment|Physician Decision|1|||
161820515|NCT00762411|584384532|FG001|Initial Treatment|Physician Decision|0|||
161820516|NCT00762411|584384531|FG000|Initial Treatment|Sponsor Decision|293|||
161820517|NCT00762411|584384532|FG001|Initial Treatment|Sponsor Decision|401|||
161820518|NCT00762411|584384531|FG000|Initial Treatment|Lost to Follow-up|5|||
161820519|NCT00762411|584384532|FG001|Initial Treatment|Lost to Follow-up|0|||
162195755|NCT00871715|585766353|FG001|Overall Study|Withdrawal by Subject|10|||
162195756|NCT00871715|585766354|FG002|Overall Study|Withdrawal by Subject|15|||
162195757|NCT00871715|585766352|FG000|Overall Study|Physician Decision|6|||
162195758|NCT00871715|585766353|FG001|Overall Study|Physician Decision|0|||
162195759|NCT00871715|585766354|FG002|Overall Study|Physician Decision|2|||
162195760|NCT00871715|585766352|FG000|Overall Study|Lost to Follow-up|3|||
162195761|NCT00871715|585766353|FG001|Overall Study|Lost to Follow-up|6|||
162195762|NCT00871715|585766354|FG002|Overall Study|Lost to Follow-up|9|||
162195763|NCT02291549|585766357|FG000|Overall Study|Lost to Follow-up|1|||
162195764|NCT02291549|585766358|FG001|Overall Study|Lost to Follow-up|0|||
162195765|NCT02291549|585766357|FG000|Overall Study|Withdrawal by Subject|0|||
162195766|NCT02291549|585766358|FG001|Overall Study|Withdrawal by Subject|1|||
162195767|NCT00537914|585766359|FG000|Overall Study|Death|1|||
162195768|NCT00537914|585766359|FG000|Overall Study|Adverse Event|7|||
162195769|NCT00537914|585766359|FG000|Overall Study|Treatment failure|10|||
162195770|NCT00537914|585766359|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
162195771|NCT00537914|585766359|FG000|Overall Study|Lost to Follow-up|19|||
162195772|NCT00537914|585766359|FG000|Overall Study|Withdrawal of informed consent|59|||
162195773|NCT01147471|585766365|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
162195774|NCT01147471|585766366|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
162195775|NCT01147471|585766365|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
162195776|NCT01147471|585766366|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
162195777|NCT01147471|585766365|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
161820520|NCT00762411|584384531|FG000|Initial Treatment|Caregiver Decision|21|||
161820521|NCT00762411|584384532|FG001|Initial Treatment|Caregiver Decision|16|||
161820522|NCT00762411|584384531|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
161820523|NCT00762411|584384532|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
161820524|NCT00762411|584384531|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
162020500|NCT00545272|585130497|FG004|Overall Study|Protocol deviation|0|||
162195778|NCT01147471|585766366|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
162195779|NCT01147471|585766365|FG000|3 Month Follow Up|Lost to Follow-up|1|||
162195780|NCT01147471|585766366|FG001|3 Month Follow Up|Lost to Follow-up|1|||
162195781|NCT01147471|585766365|FG000|3 Month Follow Up|Physician Decision|0|||
162195782|NCT01147471|585766366|FG001|3 Month Follow Up|Physician Decision|1|||
162195783|NCT01147471|585766365|FG000|6 Month Follow Up|Lost to Follow-up|4|||
162195784|NCT01147471|585766366|FG001|6 Month Follow Up|Lost to Follow-up|2|||
162195785|NCT01307800|585766371|FG000|Overall Study|Adverse Event|9|||
162195786|NCT01307800|585766372|FG001|Overall Study|Adverse Event|8|||
161820525|NCT00762411|584384532|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
161820526|NCT00762411|584384531|FG000|Delayed Start|Adverse Event|0|||
161820527|NCT00762411|584384532|FG001|Delayed Start|Adverse Event|4|||
161820528|NCT00762411|584384531|FG000|Delayed Start|Protocol Violation|0|||
161820529|NCT00762411|584384532|FG001|Delayed Start|Protocol Violation|1|||
161820530|NCT00762411|584384531|FG000|Delayed Start|Sponsor Decision|16|||
162020501|NCT00545272|585130498|FG005|Overall Study|Protocol deviation|1|||
162195787|NCT01307800|585766373|FG002|Overall Study|Adverse Event|10|||
162195788|NCT01307800|585766374|FG003|Overall Study|Adverse Event|14|||
162195789|NCT01307800|585766371|FG000|Overall Study|Entry Criteria Not Met|0|||
162195790|NCT01307800|585766372|FG001|Overall Study|Entry Criteria Not Met|0|||
162195791|NCT01307800|585766373|FG002|Overall Study|Entry Criteria Not Met|0|||
162195792|NCT01307800|585766374|FG003|Overall Study|Entry Criteria Not Met|2|||
162195793|NCT01307800|585766371|FG000|Overall Study|Lost to Follow-up|5|||
162195794|NCT01307800|585766372|FG001|Overall Study|Lost to Follow-up|6|||
162195795|NCT01307800|585766373|FG002|Overall Study|Lost to Follow-up|2|||
162195796|NCT01307800|585766374|FG003|Overall Study|Lost to Follow-up|8|||
162195797|NCT01307800|585766371|FG000|Overall Study|Perceived Lack of Efficacy|24|||
161675436|NCT04178967|583865460|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161675437|NCT04178967|583865461|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
161675438|NCT04178967|583865462|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
161675439|NCT04178967|583865463|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
161675440|NCT04178967|583865453|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675441|NCT04178967|583865454|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675442|NCT04178967|583865455|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675443|NCT04178967|583865456|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675444|NCT04178967|583865457|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675445|NCT04178967|583865458|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675446|NCT04178967|583865459|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675447|NCT04178967|583865460|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675448|NCT04178967|583865461|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675449|NCT04178967|583865462|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
161675450|NCT04178967|583865463|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161675451|NCT04178967|583865453|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675452|NCT04178967|583865454|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675453|NCT04178967|583865455|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675454|NCT04178967|583865456|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675455|NCT04178967|583865457|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675456|NCT04178967|583865458|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675457|NCT04178967|583865459|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675458|NCT04178967|583865460|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675459|NCT04178967|583865461|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675460|NCT04178967|583865462|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
161675461|NCT04178967|583865463|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161675462|NCT05211739|583865464|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
161675463|NCT05211739|583865465|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
161675464|NCT05211739|583865464|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
161675465|NCT05211739|583865465|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
161675466|NCT05211739|583865464|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
161675467|NCT05211739|583865465|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
161675468|NCT05211739|583865464|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
161675469|NCT05211739|583865465|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
161675470|NCT01975428|583865469|FG000|Overall Study|Lost to Follow-up|17|||
161675471|NCT01975428|583865470|FG001|Overall Study|Lost to Follow-up|4|||
161675472|NCT01975428|583865469|FG000|Overall Study|Withdrawal by Subject|3|||
161675473|NCT01975428|583865470|FG001|Overall Study|Withdrawal by Subject|10|||
161675474|NCT02187809|583865471|FG000|Overall Study|The study was terminated|3|||
161675475|NCT00628251|583865472|FG000|Randomised Part|Withdrawal by Subject|0|||
161675476|NCT00628251|583865473|FG001|Randomised Part|Withdrawal by Subject|0|||
161675477|NCT00628251|583865474|FG002|Randomised Part|Withdrawal by Subject|1|||
161820531|NCT00762411|584384532|FG001|Delayed Start|Sponsor Decision|20|||
162195798|NCT01307800|585766372|FG001|Overall Study|Perceived Lack of Efficacy|23|||
162195799|NCT01307800|585766373|FG002|Overall Study|Perceived Lack of Efficacy|20|||
162195800|NCT01307800|585766374|FG003|Overall Study|Perceived Lack of Efficacy|33|||
162195801|NCT01307800|585766371|FG000|Overall Study|Protocol Violation|0|||
162195802|NCT01307800|585766372|FG001|Overall Study|Protocol Violation|3|||
162195803|NCT01307800|585766373|FG002|Overall Study|Protocol Violation|4|||
162195804|NCT01307800|585766374|FG003|Overall Study|Protocol Violation|5|||
162195805|NCT01307800|585766371|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
162195806|NCT01307800|585766372|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
162195807|NCT01307800|585766373|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
162195808|NCT01307800|585766374|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
162195809|NCT01307800|585766371|FG000|Overall Study|Sponsor Decision|6|||
162195810|NCT01307800|585766372|FG001|Overall Study|Sponsor Decision|9|||
162195811|NCT01307800|585766373|FG002|Overall Study|Sponsor Decision|12|||
162195812|NCT01307800|585766374|FG003|Overall Study|Sponsor Decision|28|||
162195813|NCT01307800|585766371|FG000|Overall Study|Withdrawal by Subject|10|||
162195814|NCT01307800|585766372|FG001|Overall Study|Withdrawal by Subject|11|||
162195815|NCT01307800|585766373|FG002|Overall Study|Withdrawal by Subject|8|||
162195816|NCT01307800|585766374|FG003|Overall Study|Withdrawal by Subject|15|||
161675478|NCT00628251|583865472|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
161675479|NCT00628251|583865473|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
161675480|NCT00628251|583865474|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
161675481|NCT00628251|583865472|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
161675482|NCT00628251|583865473|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
161675483|NCT00628251|583865474|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
161675484|NCT00628251|583865472|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
161675485|NCT00628251|583865473|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
161675486|NCT00628251|583865474|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
161675487|NCT00628251|583865472|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
161675488|NCT00628251|583865473|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
161675489|NCT00628251|583865474|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
161675490|NCT00628251|583865472|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
161675491|NCT00628251|583865473|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
161675492|NCT00628251|583865474|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
161675493|NCT01245387|583865475|FG000|Overall Study|Lost to Follow-up|106|||
161675494|NCT01245387|583865475|FG000|Overall Study|Lack of Efficacy|195|||
161675495|NCT01245387|583865475|FG000|Overall Study|Adverse Event|9|||
161675496|NCT01245387|583865475|FG000|Overall Study|Death|3|||
161675497|NCT01245387|583865475|FG000|Overall Study|Other|131|||
161675498|NCT01245387|583865475|FG000|Overall Study|Missing discontinuation status|369|||
161675499|NCT00601705|583865476|FG000|Overall Study|Withdrawal by Subject|1|||
161675500|NCT04513665|583865477|FG000|Overall Study|Adverse Event|2|||
161675501|NCT04513665|583865478|FG001|Overall Study|Adverse Event|0|||
161675502|NCT04513665|583865477|FG000|Overall Study|Lack of Efficacy|14|||
161675503|NCT04513665|583865478|FG001|Overall Study|Lack of Efficacy|0|||
161675504|NCT02608879|583865482|FG000|Overall Study|Lost to Follow-up|1|||
161675505|NCT02608879|583865483|FG001|Overall Study|Lost to Follow-up|0|||
161675506|NCT02608879|583865484|FG002|Overall Study|Lost to Follow-up|0|||
161675507|NCT02608879|583865482|FG000|Overall Study|Did not meet continuation criteria|0|||
161675508|NCT02608879|583865483|FG001|Overall Study|Did not meet continuation criteria|0|||
161675509|NCT02608879|583865484|FG002|Overall Study|Did not meet continuation criteria|3|||
161675510|NCT04246801|583865485|FG000|Overall Study|Adverse Event|1|||
161675511|NCT04246801|583865486|FG001|Overall Study|Adverse Event|1|||
161675512|NCT04246801|583865485|FG000|Overall Study|Protocol Violation|1|||
161675513|NCT04246801|583865486|FG001|Overall Study|Protocol Violation|1|||
161675514|NCT04246801|583865485|FG000|Overall Study|Lack of Efficacy|0|||
161675515|NCT04246801|583865486|FG001|Overall Study|Lack of Efficacy|2|||
161675516|NCT04246801|583865485|FG000|Overall Study|Lost to Follow-up|1|||
161675517|NCT04246801|583865486|FG001|Overall Study|Lost to Follow-up|1|||
161675518|NCT04246801|583865485|FG000|Overall Study|Withdrawal by Subject|2|||
161675519|NCT04246801|583865486|FG001|Overall Study|Withdrawal by Subject|1|||
161675520|NCT01368042|583865490|FG000|Overall Study|Death|14|||
161675521|NCT01368042|583865490|FG000|Overall Study|Protocol Violation|11|||
161675522|NCT01368042|583865490|FG000|Overall Study|Lost to Follow-up|4|||
161675523|NCT01368042|583865490|FG000|Overall Study|Transplanted|1|||
161675524|NCT01621542|583865491|FG000|Overall Study|Adverse Event|0|||
161675525|NCT01621542|583865492|FG001|Overall Study|Adverse Event|0|||
161675526|NCT01621542|583865493|FG002|Overall Study|Adverse Event|1|||
161675527|NCT01621542|583865494|FG003|Overall Study|Adverse Event|3|||
161675528|NCT01621542|583865495|FG004|Overall Study|Adverse Event|0|||
161675529|NCT01621542|583865496|FG005|Overall Study|Adverse Event|0|||
161675530|NCT01621542|583865491|FG000|Overall Study|Death|0|||
161675531|NCT01621542|583865492|FG001|Overall Study|Death|1|||
161675532|NCT01621542|583865493|FG002|Overall Study|Death|0|||
161675533|NCT01621542|583865494|FG003|Overall Study|Death|0|||
161675534|NCT01621542|583865495|FG004|Overall Study|Death|0|||
161675535|NCT01621542|583865496|FG005|Overall Study|Death|0|||
161675536|NCT01621542|583865491|FG000|Overall Study|Physician Decision|1|||
162195817|NCT01307800|585766371|FG000|Overall Study|Participant Moved|0|||
162195818|NCT01307800|585766372|FG001|Overall Study|Participant Moved|2|||
162195819|NCT01307800|585766373|FG002|Overall Study|Participant Moved|1|||
161675537|NCT01621542|583865492|FG001|Overall Study|Physician Decision|0|||
161675538|NCT01621542|583865493|FG002|Overall Study|Physician Decision|1|||
162195820|NCT01307800|585766374|FG003|Overall Study|Participant Moved|3|||
162195821|NCT00689351|585766375|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
162195822|NCT00689351|585766376|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
161675539|NCT01621542|583865494|FG003|Overall Study|Physician Decision|13|||
162195823|NCT00689351|585766375|FG000|Infant Series of Dosing|Adverse Event|1|||
162195824|NCT00689351|585766376|FG001|Infant Series of Dosing|Adverse Event|0|||
162195825|NCT00689351|585766375|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
161675540|NCT01621542|583865495|FG004|Overall Study|Physician Decision|3|||
161675541|NCT01621542|583865496|FG005|Overall Study|Physician Decision|1|||
161675542|NCT01621542|583865491|FG000|Overall Study|Withdrawal by Subject|2|||
161675543|NCT01621542|583865492|FG001|Overall Study|Withdrawal by Subject|0|||
161675544|NCT01621542|583865493|FG002|Overall Study|Withdrawal by Subject|1|||
162195826|NCT00689351|585766376|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
162195827|NCT00689351|585766375|FG000|After Infant Series|Parent/legal guardian request|1|||
162195828|NCT00689351|585766376|FG001|After Infant Series|Parent/legal guardian request|0|||
162195829|NCT01766206|585766377|FG000|Overall Study|Withdrawal by Subject|22|||
162195830|NCT01766206|585766377|FG000|Overall Study|Lost to Follow-up|10|||
162195831|NCT01766206|585766377|FG000|Overall Study|Inappropriate enrollment|18|||
162195832|NCT01766206|585766377|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
162195833|NCT01662505|585766378|FG000|Overall Study|Progressive disease|6|||
162195834|NCT01662505|585766379|FG001|Overall Study|Progressive disease|1|||
162195835|NCT01662505|585766380|FG002|Overall Study|Progressive disease|5|||
162195836|NCT01662505|585766378|FG000|Overall Study|Refused cont. medication|0|||
162195837|NCT01662505|585766379|FG001|Overall Study|Refused cont. medication|0|||
162195838|NCT01662505|585766380|FG002|Overall Study|Refused cont. medication|1|||
162195839|NCT01662505|585766378|FG000|Overall Study|Not specified above|1|||
162195840|NCT01662505|585766379|FG001|Overall Study|Not specified above|3|||
162195841|NCT01662505|585766380|FG002|Overall Study|Not specified above|2|||
162195842|NCT01313663|585766381|FG000|Overall Study|Study Closed/Terminated|2|||
162195843|NCT01313663|585766382|FG001|Overall Study|Study Closed/Terminated|4|||
162195844|NCT01313663|585766381|FG000|Overall Study|Lost to Follow-up|0|||
162195845|NCT01313663|585766382|FG001|Overall Study|Lost to Follow-up|1|||
162195846|NCT01313663|585766381|FG000|Overall Study|Physician Decision|0|||
162195847|NCT01313663|585766382|FG001|Overall Study|Physician Decision|2|||
162195848|NCT01313663|585766381|FG000|Overall Study|Withdrawal by Subject|2|||
162195849|NCT01313663|585766382|FG001|Overall Study|Withdrawal by Subject|1|||
162195850|NCT01229176|585766383|FG000|Overall Study|Withdrawal by Subject|0|||
162195851|NCT01229176|585766384|FG001|Overall Study|Withdrawal by Subject|0|||
162195852|NCT01229176|585766385|FG002|Overall Study|Withdrawal by Subject|0|||
162195853|NCT01229176|585766386|FG003|Overall Study|Withdrawal by Subject|1|||
162195854|NCT01229176|585766387|FG004|Overall Study|Withdrawal by Subject|1|||
162195855|NCT01229176|585766388|FG005|Overall Study|Withdrawal by Subject|1|||
162195856|NCT01229176|585766389|FG006|Overall Study|Withdrawal by Subject|0|||
162195857|NCT01229176|585766390|FG007|Overall Study|Withdrawal by Subject|1|||
162195858|NCT01229176|585766383|FG000|Overall Study|Lost to Follow-up|0|||
162195859|NCT01229176|585766384|FG001|Overall Study|Lost to Follow-up|3|||
162195860|NCT01229176|585766385|FG002|Overall Study|Lost to Follow-up|0|||
162195861|NCT01229176|585766386|FG003|Overall Study|Lost to Follow-up|0|||
162195862|NCT01229176|585766387|FG004|Overall Study|Lost to Follow-up|1|||
162195863|NCT01229176|585766388|FG005|Overall Study|Lost to Follow-up|1|||
162195864|NCT01229176|585766389|FG006|Overall Study|Lost to Follow-up|0|||
162195865|NCT01229176|585766390|FG007|Overall Study|Lost to Follow-up|2|||
162195866|NCT02188459|585766396|FG000|Overall Study|Lost to Follow-up|3|||
162195867|NCT02188459|585766397|FG001|Overall Study|Lost to Follow-up|4|||
162195868|NCT02188459|585766396|FG000|Overall Study|Early Termination|0|||
162195869|NCT02188459|585766397|FG001|Overall Study|Early Termination|3|||
162195870|NCT02612285|585766402|FG000|Overall Study|Withdrawal by Subject|1|||
162195871|NCT02935894|585766403|FG000|Overall Study|Subject dismissed|1|||
162195872|NCT04895085|585766406|FG000|Overall Study|Death|1|||
162195873|NCT04895085|585766406|FG000|Overall Study|Withdrawal by Subject|1|||
162195874|NCT04895085|585766406|FG000|Overall Study|No longer eligible: Moved from area|1|||
162195875|NCT04919499|585766411|FG000|Overall Study|Adverse Event|0|||
162195876|NCT04919499|585766412|FG001|Overall Study|Adverse Event|0|||
162195877|NCT04919499|585766413|FG002|Overall Study|Adverse Event|0|||
162195878|NCT04919499|585766414|FG003|Overall Study|Adverse Event|0|||
162195879|NCT04919499|585766415|FG004|Overall Study|Adverse Event|2|||
162195880|NCT04919499|585766411|FG000|Overall Study|Not treated|0|||
162195881|NCT04919499|585766412|FG001|Overall Study|Not treated|0|||
162195882|NCT04919499|585766413|FG002|Overall Study|Not treated|0|||
162195883|NCT04919499|585766414|FG003|Overall Study|Not treated|1|||
162195884|NCT04919499|585766415|FG004|Overall Study|Not treated|0|||
162195885|NCT05356130|585767713|FG000|Overall Study|Withdrawal by Subject|0|||
162195886|NCT05356130|585767714|FG001|Overall Study|Withdrawal by Subject|0|||
162195887|NCT05356130|585767715|FG002|Overall Study|Withdrawal by Subject|3|||
162195888|NCT04820023|585767718|FG000|Overall Study|Death|0|||
162195889|NCT04820023|585767719|FG001|Overall Study|Death|0|||
162195890|NCT04820023|585767720|FG002|Overall Study|Death|0|||
162195891|NCT04820023|585767721|FG003|Overall Study|Death|0|||
162195892|NCT04820023|585767722|FG004|Overall Study|Death|0|||
162195893|NCT04820023|585767723|FG005|Overall Study|Death|0|||
162195894|NCT04820023|585767724|FG006|Overall Study|Death|1|||
162195895|NCT04820023|585767725|FG007|Overall Study|Death|0|||
162195896|NCT04820023|585767726|FG008|Overall Study|Death|1|||
162195897|NCT04820023|585767718|FG000|Overall Study|Withdrawal by Subject|1|||
162195898|NCT04820023|585767719|FG001|Overall Study|Withdrawal by Subject|2|||
162195899|NCT04820023|585767720|FG002|Overall Study|Withdrawal by Subject|2|||
162195900|NCT04820023|585767721|FG003|Overall Study|Withdrawal by Subject|1|||
162195901|NCT04820023|585767722|FG004|Overall Study|Withdrawal by Subject|4|||
162195902|NCT04820023|585767723|FG005|Overall Study|Withdrawal by Subject|3|||
162195903|NCT04820023|585767724|FG006|Overall Study|Withdrawal by Subject|3|||
162195904|NCT04820023|585767725|FG007|Overall Study|Withdrawal by Subject|6|||
162195905|NCT04820023|585767726|FG008|Overall Study|Withdrawal by Subject|5|||
162195906|NCT04820023|585767718|FG000|Overall Study|Progressive Disease|3|||
162195907|NCT04820023|585767719|FG001|Overall Study|Progressive Disease|0|||
162195908|NCT04820023|585767720|FG002|Overall Study|Progressive Disease|2|||
162195909|NCT04820023|585767721|FG003|Overall Study|Progressive Disease|2|||
162195910|NCT04820023|585767722|FG004|Overall Study|Progressive Disease|2|||
162195911|NCT04820023|585767723|FG005|Overall Study|Progressive Disease|0|||
162195912|NCT04820023|585767724|FG006|Overall Study|Progressive Disease|1|||
162195913|NCT04820023|585767725|FG007|Overall Study|Progressive Disease|1|||
162195914|NCT04820023|585767726|FG008|Overall Study|Progressive Disease|0|||
162195915|NCT04820023|585767718|FG000|Overall Study|New anti-cancer therapy|0|||
162195916|NCT04820023|585767719|FG001|Overall Study|New anti-cancer therapy|0|||
162195917|NCT04820023|585767720|FG002|Overall Study|New anti-cancer therapy|0|||
162195918|NCT04820023|585767721|FG003|Overall Study|New anti-cancer therapy|0|||
162195919|NCT04820023|585767722|FG004|Overall Study|New anti-cancer therapy|2|||
162195920|NCT04820023|585767723|FG005|Overall Study|New anti-cancer therapy|0|||
162195921|NCT04820023|585767724|FG006|Overall Study|New anti-cancer therapy|0|||
162195922|NCT04820023|585767725|FG007|Overall Study|New anti-cancer therapy|0|||
162195923|NCT04820023|585767726|FG008|Overall Study|New anti-cancer therapy|0|||
162195924|NCT04820023|585767718|FG000|Overall Study|Other|0|||
162195925|NCT04820023|585767719|FG001|Overall Study|Other|1|||
162195926|NCT04820023|585767720|FG002|Overall Study|Other|0|||
162195927|NCT04820023|585767721|FG003|Overall Study|Other|0|||
162195928|NCT04820023|585767722|FG004|Overall Study|Other|0|||
162195929|NCT04820023|585767723|FG005|Overall Study|Other|0|||
162195930|NCT04820023|585767724|FG006|Overall Study|Other|0|||
162195931|NCT04820023|585767725|FG007|Overall Study|Other|2|||
162195932|NCT04820023|585767726|FG008|Overall Study|Other|0|||
162195933|NCT02109172|585767737|FG000|Overall Study|Withdrawal by Subject|1|||
162195934|NCT02109172|585767738|FG001|Overall Study|Withdrawal by Subject|0|||
162195935|NCT02109172|585767739|FG002|Overall Study|Withdrawal by Subject|0|||
162195936|NCT02109172|585767740|FG003|Overall Study|Withdrawal by Subject|1|||
162195937|NCT02109172|585767741|FG004|Overall Study|Withdrawal by Subject|0|||
162195938|NCT02109172|585767742|FG005|Overall Study|Withdrawal by Subject|0|||
162195939|NCT02109172|585767737|FG000|Overall Study|Adverse Event|0|||
162195940|NCT02109172|585767738|FG001|Overall Study|Adverse Event|0|||
162195941|NCT02109172|585767739|FG002|Overall Study|Adverse Event|1|||
162195942|NCT02109172|585767740|FG003|Overall Study|Adverse Event|0|||
162195943|NCT02109172|585767741|FG004|Overall Study|Adverse Event|0|||
162195944|NCT02109172|585767742|FG005|Overall Study|Adverse Event|1|||
162195945|NCT02109172|585767737|FG000|Overall Study|Death|0|||
162195946|NCT02109172|585767738|FG001|Overall Study|Death|0|||
162195947|NCT02109172|585767739|FG002|Overall Study|Death|0|||
162195948|NCT02109172|585767740|FG003|Overall Study|Death|0|||
162195949|NCT02109172|585767741|FG004|Overall Study|Death|1|||
162195950|NCT02109172|585767742|FG005|Overall Study|Death|0|||
162195951|NCT00538629|585767745|FG000|Overall Study|At subject's request|1|||
162195952|NCT00538629|585767745|FG000|Overall Study|Adverse Event|2|||
162195953|NCT00538629|585767745|FG000|Overall Study|Lack of Efficacy|12|||
162195954|NCT00538629|585767745|FG000|Overall Study|Lost to Follow-up|6|||
162195955|NCT00538629|585767745|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
162195956|NCT04454125|585767746|FG000|Overall Study|Lost to Follow-up|0|||
162195957|NCT04454125|585767747|FG001|Overall Study|Lost to Follow-up|1|||
162195958|NCT01922102|585767748|FG000|Overall Study|Withdrawal by Subject|7|||
162195959|NCT01922102|585767749|FG001|Overall Study|Withdrawal by Subject|3|||
162195960|NCT01922102|585767750|FG002|Overall Study|Withdrawal by Subject|7|||
162195961|NCT01922102|585767748|FG000|Overall Study|Physician Decision|0|||
162195962|NCT01922102|585767749|FG001|Overall Study|Physician Decision|2|||
162195963|NCT01922102|585767750|FG002|Overall Study|Physician Decision|1|||
162195964|NCT01922102|585767748|FG000|Overall Study|Adverse Event|1|||
162195965|NCT01922102|585767749|FG001|Overall Study|Adverse Event|2|||
162195966|NCT01922102|585767750|FG002|Overall Study|Adverse Event|0|||
162195967|NCT01922102|585767748|FG000|Overall Study|Lost to Follow-up|1|||
162195968|NCT01922102|585767749|FG001|Overall Study|Lost to Follow-up|0|||
162195969|NCT01922102|585767750|FG002|Overall Study|Lost to Follow-up|0|||
162195970|NCT01922102|585767748|FG000|Overall Study|Administrative problems|0|||
162195971|NCT01922102|585767749|FG001|Overall Study|Administrative problems|2|||
162195972|NCT01922102|585767750|FG002|Overall Study|Administrative problems|0|||
162195973|NCT05203822|585767751|FG000|Overall Study|Adverse Event|1|||
162195974|NCT05203822|585767751|FG000|Overall Study|Withdrawal by Subject|1|||
162195975|NCT01816165|585767758|FG000|Overall Study|Adverse Event|1|||
162195976|NCT01816165|585767759|FG001|Overall Study|Adverse Event|0|||
162195977|NCT01816165|585767760|FG002|Overall Study|Adverse Event|0|||
162195978|NCT01816165|585767761|FG003|Overall Study|Adverse Event|0|||
162195979|NCT00447499|585767762|FG000|Overall Study|Adverse Event|1|||
162195980|NCT00447499|585767762|FG000|Overall Study|Patient Decision|4|||
162195981|NCT00447499|585767762|FG000|Overall Study|Sponsor Decision|1|||
162195982|NCT00447499|585767762|FG000|Overall Study|Physician Decision|1|||
162195983|NCT03360071|585767764|FG000|Overall Study|Lost to Follow-up|1|||
162195984|NCT03360071|585767765|FG001|Overall Study|Lost to Follow-up|0|||
162195985|NCT03184519|585767774|FG000|Overall Study|Lost to Follow-up|6|||
162195986|NCT03184519|585767774|FG000|Overall Study|Physician Decision|21|||
162195987|NCT02823574|585767778|FG000|Randomization|Disease Progression|0|||
162195988|NCT02823574|585767779|FG001|Randomization|Disease Progression|0|||
162195989|NCT02823574|585767780|FG002|Randomization|Disease Progression|1|||
162195990|NCT02823574|585767781|FG003|Randomization|Disease Progression|0|||
162195991|NCT02823574|585767778|FG000|Randomization|AE unrelated to Study Drug|1|||
162195992|NCT02823574|585767779|FG001|Randomization|AE unrelated to Study Drug|0|||
162195993|NCT02823574|585767780|FG002|Randomization|AE unrelated to Study Drug|0|||
162195994|NCT02823574|585767781|FG003|Randomization|AE unrelated to Study Drug|0|||
162195995|NCT02823574|585767778|FG000|Treatment Period|Poor/Non Compliance|1|||
162195996|NCT02823574|585767779|FG001|Treatment Period|Poor/Non Compliance|0|||
162195997|NCT02823574|585767780|FG002|Treatment Period|Poor/Non Compliance|0|||
162195998|NCT02823574|585767781|FG003|Treatment Period|Poor/Non Compliance|1|||
162195999|NCT02823574|585767778|FG000|Treatment Period|Maximum Clinical Benefit|8|||
162196000|NCT02823574|585767779|FG001|Treatment Period|Maximum Clinical Benefit|4|||
162196001|NCT02823574|585767780|FG002|Treatment Period|Maximum Clinical Benefit|7|||
162196002|NCT02823574|585767781|FG003|Treatment Period|Maximum Clinical Benefit|1|||
162196003|NCT02823574|585767778|FG000|Treatment Period|Lost to Follow-up|1|||
162196004|NCT02823574|585767779|FG001|Treatment Period|Lost to Follow-up|1|||
162196005|NCT02823574|585767780|FG002|Treatment Period|Lost to Follow-up|0|||
162196006|NCT02823574|585767781|FG003|Treatment Period|Lost to Follow-up|0|||
162196007|NCT02823574|585767778|FG000|Treatment Period|Participant withdrew consent|4|||
162196008|NCT02823574|585767779|FG001|Treatment Period|Participant withdrew consent|0|||
161926333|NCT01871727|584777164|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
162196009|NCT02823574|585767780|FG002|Treatment Period|Participant withdrew consent|0|||
162196010|NCT02823574|585767781|FG003|Treatment Period|Participant withdrew consent|1|||
162196011|NCT02823574|585767778|FG000|Treatment Period|Participant request to discontinue|5|||
162196012|NCT02823574|585767779|FG001|Treatment Period|Participant request to discontinue|0|||
162196013|NCT02823574|585767780|FG002|Treatment Period|Participant request to discontinue|3|||
162196014|NCT02823574|585767781|FG003|Treatment Period|Participant request to discontinue|2|||
162196015|NCT02823574|585767778|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
162196016|NCT02823574|585767779|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
162196017|NCT02823574|585767780|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
162196018|NCT02823574|585767781|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
162196019|NCT02823574|585767778|FG000|Treatment Period|Study Drug Toxicity|11|||
162196020|NCT02823574|585767779|FG001|Treatment Period|Study Drug Toxicity|2|||
162196021|NCT02823574|585767780|FG002|Treatment Period|Study Drug Toxicity|14|||
162196022|NCT02823574|585767781|FG003|Treatment Period|Study Drug Toxicity|4|||
162196023|NCT02823574|585767778|FG000|Treatment Period|Disease Progression|113|||
162196024|NCT02823574|585767779|FG001|Treatment Period|Disease Progression|64|||
162196025|NCT02823574|585767780|FG002|Treatment Period|Disease Progression|82|||
161820532|NCT00762411|584384531|FG000|Delayed Start|Caregiver Decision|1|||
161820533|NCT00762411|584384532|FG001|Delayed Start|Caregiver Decision|1|||
161820534|NCT00762411|584384531|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
161820535|NCT00762411|584384532|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
161820536|NCT00762411|584384531|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
161820537|NCT00762411|584384532|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
162196026|NCT02823574|585767781|FG003|Treatment Period|Disease Progression|43|||
162196027|NCT02823574|585767778|FG000|Treatment Period|Other reasons|5|||
162196028|NCT02823574|585767779|FG001|Treatment Period|Other reasons|9|||
162196029|NCT02823574|585767780|FG002|Treatment Period|Other reasons|3|||
162196030|NCT02823574|585767781|FG003|Treatment Period|Other reasons|6|||
162196031|NCT02823574|585767778|FG000|Treatment Period|Participant no longer meets study criteria|0|||
162196032|NCT02823574|585767779|FG001|Treatment Period|Participant no longer meets study criteria|0|||
162196033|NCT02823574|585767780|FG002|Treatment Period|Participant no longer meets study criteria|1|||
162196034|NCT02823574|585767781|FG003|Treatment Period|Participant no longer meets study criteria|0|||
162196035|NCT02823574|585767778|FG000|Treatment Period|Death|0|||
162196036|NCT02823574|585767779|FG001|Treatment Period|Death|0|||
162196037|NCT02823574|585767780|FG002|Treatment Period|Death|3|||
162196038|NCT02823574|585767781|FG003|Treatment Period|Death|1|||
162196039|NCT00590759|585767782|FG000|Overall Study|Death|52|||
162196040|NCT00590759|585767782|FG000|Overall Study|Lost to Follow-up|28|||
162196041|NCT02092909|585767787|FG000|Overall Study|Adverse Event|0|||
162196042|NCT02092909|585767788|FG001|Overall Study|Adverse Event|0|||
162196043|NCT02092909|585767789|FG002|Overall Study|Adverse Event|4|||
162196044|NCT02092909|585767790|FG003|Overall Study|Adverse Event|2|||
162196045|NCT02092909|585767787|FG000|Overall Study|Lack of Efficacy|0|||
162196046|NCT02092909|585767788|FG001|Overall Study|Lack of Efficacy|2|||
162196047|NCT02092909|585767789|FG002|Overall Study|Lack of Efficacy|1|||
162196048|NCT02092909|585767790|FG003|Overall Study|Lack of Efficacy|0|||
162196049|NCT02092909|585767787|FG000|Overall Study|Withdrawal by Subject|0|||
162196050|NCT02092909|585767788|FG001|Overall Study|Withdrawal by Subject|0|||
162196051|NCT02092909|585767789|FG002|Overall Study|Withdrawal by Subject|2|||
162196052|NCT02092909|585767790|FG003|Overall Study|Withdrawal by Subject|1|||
162196053|NCT02092909|585767787|FG000|Overall Study|Study terminated by Sponsor|0|||
162196054|NCT02092909|585767788|FG001|Overall Study|Study terminated by Sponsor|0|||
162196055|NCT02092909|585767789|FG002|Overall Study|Study terminated by Sponsor|0|||
162196056|NCT02092909|585767790|FG003|Overall Study|Study terminated by Sponsor|2|||
162196057|NCT02092909|585767787|FG000|Overall Study|Miscellaneous|1|||
162196058|NCT02092909|585767788|FG001|Overall Study|Miscellaneous|1|||
162196059|NCT02092909|585767789|FG002|Overall Study|Miscellaneous|2|||
162196060|NCT02092909|585767790|FG003|Overall Study|Miscellaneous|1|||
162196061|NCT00096278|585767791|FG000|Overall Study|No follow-up data|15|||
162196062|NCT00096278|585767792|FG001|Overall Study|No follow-up data|18|||
162196063|NCT00096278|585767791|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
162196064|NCT00096278|585767792|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
162196065|NCT02865083|585767793|FG000|Overall Study|Early Termination|3|||
162196066|NCT02865083|585767794|FG001|Overall Study|Early Termination|1|||
162196067|NCT02105688|585767795|FG000|Part A: Double-Blind|Adverse Event|1|||
162196068|NCT02105688|585767796|FG001|Part A: Double-Blind|Adverse Event|0|||
162196069|NCT02105688|585767795|FG000|Part A: Double-Blind|Death|0|||
162196070|NCT02105688|585767796|FG001|Part A: Double-Blind|Death|1|||
162196071|NCT02105688|585767795|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
162196072|NCT02105688|585767796|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
162196073|NCT02105688|585767795|FG000|Part A: Double-Blind|Physician Decision|0|||
162196074|NCT02105688|585767796|FG001|Part A: Double-Blind|Physician Decision|1|||
161820538|NCT00762411|584384531|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
161820539|NCT00762411|584384532|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
161926334|NCT01871727|584777160|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
162196075|NCT02105688|585767795|FG000|Part A: Double-Blind|Status Unknown|0|||
162196076|NCT02105688|585767796|FG001|Part A: Double-Blind|Status Unknown|2|||
162196077|NCT02105688|585767795|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
162196078|NCT02105688|585767796|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
162196079|NCT02105688|585767795|FG000|Part B: Observational Follow-up|Death|2|||
162196080|NCT02105688|585767796|FG001|Part B: Observational Follow-up|Death|1|||
162196081|NCT02105688|585767795|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
162196082|NCT02105688|585767796|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
162196083|NCT02105688|585767795|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
162196084|NCT02105688|585767796|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
162196085|NCT02105688|585767795|FG000|Part B: Observational Follow-up|Physician Decision|3|||
162196086|NCT02105688|585767796|FG001|Part B: Observational Follow-up|Physician Decision|1|||
162196087|NCT02959866|585767802|FG000|Overall Study|Withdrawal by Subject|1|||
162196088|NCT00636168|585767807|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
162196089|NCT00636168|585767808|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
162196090|NCT00636168|585767807|FG000|Randomized to Study Drug|Adverse Event|1|||
162196091|NCT00636168|585767808|FG001|Randomized to Study Drug|Adverse Event|0|||
162196092|NCT00636168|585767807|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
162196093|NCT00636168|585767808|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
162196094|NCT00636168|585767807|FG000|Treated With Study Drug|Recurrence of disease|135|||
162196095|NCT00636168|585767808|FG001|Treated With Study Drug|Recurrence of disease|282|||
162196096|NCT00636168|585767807|FG000|Treated With Study Drug|Adverse Event|250|||
162196097|NCT00636168|585767808|FG001|Treated With Study Drug|Adverse Event|22|||
162196098|NCT00636168|585767807|FG000|Treated With Study Drug|Participant withdrew consent|16|||
162196099|NCT00636168|585767808|FG001|Treated With Study Drug|Participant withdrew consent|21|||
162196100|NCT00636168|585767807|FG000|Treated With Study Drug|Poor/non-compliance|1|||
162196101|NCT00636168|585767808|FG001|Treated With Study Drug|Poor/non-compliance|3|||
162196102|NCT00636168|585767807|FG000|Treated With Study Drug|Death|3|||
162196103|NCT00636168|585767808|FG001|Treated With Study Drug|Death|0|||
162196104|NCT00636168|585767807|FG000|Treated With Study Drug|Pregnancy|1|||
162196105|NCT00636168|585767808|FG001|Treated With Study Drug|Pregnancy|0|||
162196106|NCT00636168|585767807|FG000|Treated With Study Drug|No longer meets study criteria|1|||
162196107|NCT00636168|585767808|FG001|Treated With Study Drug|No longer meets study criteria|0|||
162196108|NCT00636168|585767807|FG000|Treated With Study Drug|Other reason|1|||
161675545|NCT01621542|583865494|FG003|Overall Study|Withdrawal by Subject|3|||
161675546|NCT01621542|583865495|FG004|Overall Study|Withdrawal by Subject|3|||
161675547|NCT01621542|583865496|FG005|Overall Study|Withdrawal by Subject|3|||
161675548|NCT01621542|583865491|FG000|Overall Study|progression/treatment failure|2|||
162196109|NCT00636168|585767808|FG001|Treated With Study Drug|Other reason|3|||
161675549|NCT01621542|583865492|FG001|Overall Study|progression/treatment failure|4|||
162196110|NCT00636168|585767807|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
162196111|NCT00636168|585767808|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
162196112|NCT00636168|585767807|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
162196113|NCT00636168|585767808|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
162196114|NCT00636168|585767807|FG000|Long Term Follow-Up|Death|8|||
162196115|NCT00636168|585767808|FG001|Long Term Follow-Up|Death|9|||
162196116|NCT04529941|585767812|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
162196117|NCT04529941|585767813|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
162196118|NCT01005914|585767814|FG000|Overall Study|Adverse Event|4|||
162196119|NCT01005914|585767814|FG000|Overall Study|Death|4|||
162196120|NCT01005914|585767814|FG000|Overall Study|Lack of Efficacy|1|||
162196121|NCT01005914|585767814|FG000|Overall Study|Withdrawal by Subject|1|||
162196122|NCT02367794|585767815|FG000|Overall Study|Death|252|||
162196123|NCT02367794|585767816|FG001|Overall Study|Death|245|||
162196124|NCT02367794|585767817|FG002|Overall Study|Death|243|||
162196125|NCT02367794|585767815|FG000|Overall Study|Lost to Follow-up|1|||
162196126|NCT02367794|585767816|FG001|Overall Study|Lost to Follow-up|2|||
161926335|NCT01871727|584777161|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
162196127|NCT02367794|585767817|FG002|Overall Study|Lost to Follow-up|2|||
162196128|NCT02367794|585767815|FG000|Overall Study|Physician Decision|0|||
162196129|NCT02367794|585767816|FG001|Overall Study|Physician Decision|5|||
162196130|NCT02367794|585767817|FG002|Overall Study|Physician Decision|3|||
162196131|NCT02367794|585767815|FG000|Overall Study|Protocol Violation|1|||
162196132|NCT02367794|585767816|FG001|Overall Study|Protocol Violation|0|||
162196133|NCT02367794|585767817|FG002|Overall Study|Protocol Violation|1|||
162196134|NCT02367794|585767815|FG000|Overall Study|Withdrawal by Subject|25|||
162196135|NCT02367794|585767816|FG001|Overall Study|Withdrawal by Subject|12|||
162196136|NCT02367794|585767817|FG002|Overall Study|Withdrawal by Subject|20|||
162196137|NCT02367794|585767815|FG000|Overall Study|Brain metastasis|1|||
162196138|NCT02367794|585767816|FG001|Overall Study|Brain metastasis|0|||
162196139|NCT02367794|585767817|FG002|Overall Study|Brain metastasis|0|||
162196140|NCT02367794|585767815|FG000|Overall Study|Randomized in error|0|||
162196141|NCT02367794|585767816|FG001|Overall Study|Randomized in error|0|||
162196142|NCT02367794|585767817|FG002|Overall Study|Randomized in error|1|||
162196143|NCT02367794|585767815|FG000|Overall Study|Patient unable to receive carboplatin|0|||
162196144|NCT02367794|585767816|FG001|Overall Study|Patient unable to receive carboplatin|0|||
162196145|NCT02367794|585767817|FG002|Overall Study|Patient unable to receive carboplatin|1|||
162196146|NCT02367794|585767815|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
162196147|NCT02367794|585767816|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
162196148|NCT02367794|585767817|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
162196149|NCT02367794|585767815|FG000|Overall Study|Adverse Event|0|||
162196150|NCT02367794|585767816|FG001|Overall Study|Adverse Event|0|||
162196151|NCT02367794|585767817|FG002|Overall Study|Adverse Event|2|||
162196152|NCT02367794|585767815|FG000|Overall Study|Study Terminated By Sponsor|0|||
162196153|NCT02367794|585767816|FG001|Overall Study|Study Terminated By Sponsor|1|||
162196154|NCT02367794|585767817|FG002|Overall Study|Study Terminated By Sponsor|1|||
162196155|NCT02367794|585767815|FG000|Overall Study|Moved to Roll-Over Study|0|||
162196156|NCT02367794|585767816|FG001|Overall Study|Moved to Roll-Over Study|15|||
162196157|NCT02367794|585767817|FG002|Overall Study|Moved to Roll-Over Study|13|||
162196158|NCT02367794|585767815|FG000|Overall Study|Sponsor Request|60|||
162196159|NCT02367794|585767816|FG001|Overall Study|Sponsor Request|57|||
162196160|NCT02367794|585767817|FG002|Overall Study|Sponsor Request|45|||
162196161|NCT02367794|585767815|FG000|Overall Study|Moved into PTAP Study|0|||
162196162|NCT02367794|585767816|FG001|Overall Study|Moved into PTAP Study|2|||
162196163|NCT02367794|585767817|FG002|Overall Study|Moved into PTAP Study|3|||
162196164|NCT02367794|585767815|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
162196165|NCT02367794|585767816|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
162196166|NCT02367794|585767817|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
162196167|NCT02367794|585767815|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
162196168|NCT02367794|585767816|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
162196169|NCT02367794|585767817|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
162196170|NCT02367794|585767815|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
162196171|NCT02367794|585767816|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
162196172|NCT02367794|585767817|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
162196173|NCT02367794|585767815|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
162196174|NCT02367794|585767816|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
162196175|NCT02367794|585767817|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
162196176|NCT02010684|585767818|FG000|Overall Study|Lost to Follow-up|8|||
162196177|NCT02010684|585767819|FG001|Overall Study|Lost to Follow-up|18|||
162196178|NCT02010684|585767818|FG000|Overall Study|Withdrawal by Subject|4|||
162196179|NCT02010684|585767819|FG001|Overall Study|Withdrawal by Subject|5|||
162196180|NCT01986348|585767820|FG000|Overall Study|Death|8|||
162196181|NCT01986348|585767821|FG001|Overall Study|Death|22|||
162196182|NCT01986348|585767822|FG002|Overall Study|Death|10|||
162196183|NCT01986348|585767823|FG003|Overall Study|Death|21|||
162196184|NCT01986348|585767820|FG000|Overall Study|Lost to Follow-up|0|||
162196185|NCT01986348|585767821|FG001|Overall Study|Lost to Follow-up|0|||
162196186|NCT01986348|585767822|FG002|Overall Study|Lost to Follow-up|0|||
162196187|NCT01986348|585767823|FG003|Overall Study|Lost to Follow-up|2|||
162196188|NCT01986348|585767820|FG000|Overall Study|Physician Decision|0|||
162196189|NCT01986348|585767821|FG001|Overall Study|Physician Decision|0|||
162196190|NCT01986348|585767822|FG002|Overall Study|Physician Decision|0|||
161820540|NCT00762411|584384531|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
161820541|NCT00762411|584384532|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
161820542|NCT00762411|584384531|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
161820543|NCT00762411|584384532|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
161820544|NCT00762411|584384531|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
162196191|NCT01986348|585767823|FG003|Overall Study|Physician Decision|1|||
162196192|NCT01986348|585767820|FG000|Overall Study|Progressive Disease|0|||
162196193|NCT01986348|585767821|FG001|Overall Study|Progressive Disease|0|||
162196194|NCT01986348|585767822|FG002|Overall Study|Progressive Disease|2|||
162196195|NCT01986348|585767823|FG003|Overall Study|Progressive Disease|0|||
162196196|NCT01986348|585767820|FG000|Overall Study|Withdrawal by Participant|0|||
162196197|NCT01986348|585767821|FG001|Overall Study|Withdrawal by Participant|1|||
162196198|NCT01986348|585767822|FG002|Overall Study|Withdrawal by Participant|2|||
162196199|NCT01986348|585767823|FG003|Overall Study|Withdrawal by Participant|1|||
162196200|NCT01986348|585767820|FG000|Overall Study|Study Terminated by Sponsor|0|||
162196201|NCT01986348|585767821|FG001|Overall Study|Study Terminated by Sponsor|0|||
162196202|NCT01986348|585767822|FG002|Overall Study|Study Terminated by Sponsor|0|||
162196203|NCT01986348|585767823|FG003|Overall Study|Study Terminated by Sponsor|3|||
162196204|NCT01986348|585767820|FG000|Overall Study|Other-unspecified|0|||
162196205|NCT01986348|585767821|FG001|Overall Study|Other-unspecified|1|||
162196206|NCT01986348|585767822|FG002|Overall Study|Other-unspecified|0|||
162196207|NCT01986348|585767823|FG003|Overall Study|Other-unspecified|2|||
162196208|NCT00853957|585767828|FG000|Overall Study|Adverse Event|9|||
162196209|NCT00853957|585767829|FG001|Overall Study|Adverse Event|3|||
162196210|NCT00853957|585767828|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162196211|NCT00853957|585767829|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162196212|NCT00853957|585767828|FG000|Overall Study|Subject withdrew consent|4|||
161675550|NCT01621542|583865493|FG002|Overall Study|progression/treatment failure|3|||
161675551|NCT01621542|583865494|FG003|Overall Study|progression/treatment failure|7|||
161675552|NCT01621542|583865495|FG004|Overall Study|progression/treatment failure|3|||
161675553|NCT01621542|583865496|FG005|Overall Study|progression/treatment failure|5|||
162196213|NCT00853957|585767829|FG001|Overall Study|Subject withdrew consent|5|||
162196214|NCT00853957|585767828|FG000|Overall Study|Lost to Follow-up|1|||
162196215|NCT00853957|585767829|FG001|Overall Study|Lost to Follow-up|6|||
162196216|NCT00853957|585767828|FG000|Overall Study|Protocol deviation|0|||
162196217|NCT00853957|585767829|FG001|Overall Study|Protocol deviation|3|||
162196218|NCT01884571|585767830|FG000|Overall Study|Adverse Event|1|||
162196219|NCT01884571|585767830|FG000|Overall Study|Death|2|||
162196220|NCT01884571|585767830|FG000|Overall Study|Withdrawal by Subject|2|||
162196221|NCT01884571|585767830|FG000|Overall Study|Disease progression|3|||
162196222|NCT02942771|585767833|FG000|Overall Study|Adverse Event|1|||
162196223|NCT02942771|585767834|FG001|Overall Study|Adverse Event|0|||
162196224|NCT02942771|585767835|FG002|Overall Study|Adverse Event|0|||
162196225|NCT02942771|585767836|FG003|Overall Study|Adverse Event|0|||
162196226|NCT02942771|585767837|FG004|Overall Study|Adverse Event|2|||
162196227|NCT02942771|585767833|FG000|Overall Study|Lost to Follow-up|1|||
162196228|NCT02942771|585767834|FG001|Overall Study|Lost to Follow-up|0|||
162196229|NCT02942771|585767835|FG002|Overall Study|Lost to Follow-up|0|||
162196230|NCT02942771|585767836|FG003|Overall Study|Lost to Follow-up|0|||
162196231|NCT02942771|585767837|FG004|Overall Study|Lost to Follow-up|0|||
162196232|NCT02942771|585767833|FG000|Overall Study|Withdrawal by Subject|1|||
162196233|NCT02942771|585767834|FG001|Overall Study|Withdrawal by Subject|0|||
162196234|NCT02942771|585767835|FG002|Overall Study|Withdrawal by Subject|0|||
162196235|NCT02942771|585767836|FG003|Overall Study|Withdrawal by Subject|0|||
162196236|NCT02942771|585767837|FG004|Overall Study|Withdrawal by Subject|2|||
162196237|NCT02158806|585767838|FG000|Overall Study|Death|2|||
162196238|NCT02158806|585767839|FG001|Overall Study|Death|0|||
162196239|NCT02158806|585767838|FG000|Overall Study|Withdrawal by Subject|2|||
162196240|NCT02158806|585767839|FG001|Overall Study|Withdrawal by Subject|0|||
162196241|NCT02158806|585767838|FG000|Overall Study|Lost to Follow-up|0|||
162196242|NCT02158806|585767839|FG001|Overall Study|Lost to Follow-up|3|||
162196243|NCT02158806|585767838|FG000|Overall Study|Moved out of area|0|||
162196244|NCT02158806|585767839|FG001|Overall Study|Moved out of area|1|||
162196245|NCT02158806|585767838|FG000|Overall Study|Transferred to palliative care|0|||
162196246|NCT02158806|585767839|FG001|Overall Study|Transferred to palliative care|1|||
162196247|NCT01898299|585767840|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
162196248|NCT01898299|585767841|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
162196249|NCT02340806|585767845|FG000|Overall Study|Protocol Violation|2|||
162196250|NCT02340806|585767846|FG001|Overall Study|Protocol Violation|0|||
162196251|NCT02340806|585767845|FG000|Overall Study|epidural catheter replaced|2|||
162196252|NCT02340806|585767846|FG001|Overall Study|epidural catheter replaced|1|||
162196253|NCT02340806|585767845|FG000|Overall Study|history of chronic pain medication|1|||
162196254|NCT02340806|585767846|FG001|Overall Study|history of chronic pain medication|0|||
162196255|NCT02340806|585767845|FG000|Overall Study|re-dose < 90 min of CSE|1|||
162196256|NCT02340806|585767846|FG001|Overall Study|re-dose < 90 min of CSE|3|||
161675554|NCT01621542|583865491|FG000|Overall Study|Protocol Violation|0|||
162196257|NCT01186809|585767847|FG000|Overall Study|Death|30|||
162196258|NCT01159600|585767848|FG000|Overall Study|Not treated|0|||
162196259|NCT01159600|585767849|FG001|Overall Study|Not treated|0|||
162196260|NCT01159600|585767850|FG002|Overall Study|Not treated|1|||
162196261|NCT01159600|585767851|FG003|Overall Study|Not treated|0|||
162196262|NCT01159600|585767852|FG004|Overall Study|Not treated|0|||
162196263|NCT01159600|585767853|FG005|Overall Study|Not treated|1|||
162196264|NCT01159600|585767854|FG006|Overall Study|Not treated|2|||
162196265|NCT01159600|585767855|FG007|Overall Study|Not treated|2|||
162196266|NCT01159600|585767848|FG000|Overall Study|Adverse Event|7|||
162196267|NCT01159600|585767849|FG001|Overall Study|Adverse Event|2|||
162196268|NCT01159600|585767850|FG002|Overall Study|Adverse Event|5|||
162196269|NCT01159600|585767851|FG003|Overall Study|Adverse Event|1|||
162196270|NCT01159600|585767852|FG004|Overall Study|Adverse Event|8|||
162196271|NCT01159600|585767853|FG005|Overall Study|Adverse Event|6|||
162196272|NCT01159600|585767854|FG006|Overall Study|Adverse Event|7|||
162196273|NCT01159600|585767855|FG007|Overall Study|Adverse Event|5|||
162196274|NCT01159600|585767848|FG000|Overall Study|Lack of Efficacy|0|||
162196275|NCT01159600|585767849|FG001|Overall Study|Lack of Efficacy|0|||
162196276|NCT01159600|585767850|FG002|Overall Study|Lack of Efficacy|0|||
162196277|NCT01159600|585767851|FG003|Overall Study|Lack of Efficacy|0|||
162196278|NCT01159600|585767852|FG004|Overall Study|Lack of Efficacy|2|||
162196279|NCT01159600|585767853|FG005|Overall Study|Lack of Efficacy|0|||
162196280|NCT01159600|585767854|FG006|Overall Study|Lack of Efficacy|0|||
161675555|NCT01621542|583865492|FG001|Overall Study|Protocol Violation|0|||
161675556|NCT01621542|583865493|FG002|Overall Study|Protocol Violation|0|||
161675557|NCT01621542|583865494|FG003|Overall Study|Protocol Violation|1|||
161675558|NCT01621542|583865495|FG004|Overall Study|Protocol Violation|0|||
161675559|NCT01621542|583865496|FG005|Overall Study|Protocol Violation|0|||
161675560|NCT01621542|583865491|FG000|Overall Study|study stopped by sponsor|0|||
161675561|NCT01621542|583865492|FG001|Overall Study|study stopped by sponsor|0|||
161675562|NCT01621542|583865493|FG002|Overall Study|study stopped by sponsor|0|||
161675563|NCT01621542|583865494|FG003|Overall Study|study stopped by sponsor|1|||
161675564|NCT01621542|583865495|FG004|Overall Study|study stopped by sponsor|0|||
161675565|NCT01621542|583865496|FG005|Overall Study|study stopped by sponsor|0|||
161675566|NCT02632721|583865498|FG000|Overall Study|Adverse Event|0|||
162196281|NCT01159600|585767855|FG007|Overall Study|Lack of Efficacy|1|||
162196282|NCT01159600|585767848|FG000|Overall Study|Non compliant with protocol|2|||
162196283|NCT01159600|585767849|FG001|Overall Study|Non compliant with protocol|1|||
162196284|NCT01159600|585767850|FG002|Overall Study|Non compliant with protocol|0|||
162196285|NCT01159600|585767851|FG003|Overall Study|Non compliant with protocol|0|||
162196286|NCT01159600|585767852|FG004|Overall Study|Non compliant with protocol|2|||
162196287|NCT01159600|585767853|FG005|Overall Study|Non compliant with protocol|0|||
162196288|NCT01159600|585767854|FG006|Overall Study|Non compliant with protocol|2|||
162196289|NCT01159600|585767855|FG007|Overall Study|Non compliant with protocol|0|||
162196290|NCT01159600|585767848|FG000|Overall Study|Lost to Follow-up|2|||
162196291|NCT01159600|585767849|FG001|Overall Study|Lost to Follow-up|3|||
162196292|NCT01159600|585767850|FG002|Overall Study|Lost to Follow-up|4|||
162196293|NCT01159600|585767851|FG003|Overall Study|Lost to Follow-up|3|||
162196294|NCT01159600|585767852|FG004|Overall Study|Lost to Follow-up|3|||
162196295|NCT01159600|585767853|FG005|Overall Study|Lost to Follow-up|0|||
162196296|NCT01159600|585767854|FG006|Overall Study|Lost to Follow-up|3|||
162196297|NCT01159600|585767855|FG007|Overall Study|Lost to Follow-up|2|||
162196298|NCT01159600|585767848|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
162196299|NCT01159600|585767849|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
162196300|NCT01159600|585767850|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
162196301|NCT01159600|585767851|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
162196302|NCT01159600|585767852|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
162196303|NCT01159600|585767853|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
162196304|NCT01159600|585767854|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
162196305|NCT01159600|585767855|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
162196306|NCT01159600|585767848|FG000|Overall Study|Other reason not defined above|3|||
162196307|NCT01159600|585767849|FG001|Overall Study|Other reason not defined above|0|||
162196308|NCT01159600|585767850|FG002|Overall Study|Other reason not defined above|4|||
162196309|NCT01159600|585767851|FG003|Overall Study|Other reason not defined above|2|||
162196310|NCT01159600|585767852|FG004|Overall Study|Other reason not defined above|5|||
162196311|NCT01159600|585767853|FG005|Overall Study|Other reason not defined above|7|||
162196312|NCT01159600|585767854|FG006|Overall Study|Other reason not defined above|3|||
162196313|NCT01159600|585767855|FG007|Overall Study|Other reason not defined above|3|||
162196314|NCT05379400|585769185|FG000|Overall Study|Lost to Follow-up|1|||
162196315|NCT05379400|585769186|FG001|Overall Study|Lost to Follow-up|1|||
162196316|NCT04851587|585769188|FG000|Overall Study|Lost to Follow-up|18|||
162196317|NCT01020487|585769189|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
162196318|NCT01020487|585769190|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
161675567|NCT02632721|583865499|FG001|Overall Study|Adverse Event|0|||
161675568|NCT02632721|583865500|FG002|Overall Study|Adverse Event|2|||
161675569|NCT02632721|583865501|FG003|Overall Study|Adverse Event|5|||
161675570|NCT02632721|583865502|FG004|Overall Study|Adverse Event|3|||
162020502|NCT00545272|585130493|FG000|Overall Study|Adverse Event|0|||
162196319|NCT01020487|585769191|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
162196320|NCT01020487|585769189|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
162196321|NCT01020487|585769190|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
162196322|NCT01020487|585769191|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
162196323|NCT01020487|585769189|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
162196324|NCT01020487|585769190|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
162196325|NCT01020487|585769191|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
162196326|NCT01020487|585769189|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
162196327|NCT01020487|585769190|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
162196328|NCT01020487|585769191|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
162196329|NCT01020487|585769189|FG000|Part 2 Open-label Period|Adverse Event|0|||
162196330|NCT01020487|585769190|FG001|Part 2 Open-label Period|Adverse Event|4|||
162196331|NCT01020487|585769191|FG002|Part 2 Open-label Period|Adverse Event|1|||
162196332|NCT05878990|585769192|FG000|Overall Study|Lost to Follow-up|7|||
162196333|NCT05878990|585769192|FG000|Overall Study|Withdrawal by Subject|1|||
162196334|NCT03605745|585769193|FG000|Overall Study|Study was terminated for business reasons|47|||
162196335|NCT01279447|585769194|FG000|Overall Study|Lost to Follow-up|3|||
162196336|NCT01279447|585769195|FG001|Overall Study|Lost to Follow-up|1|||
162196337|NCT01074229|585769196|FG000|Overall Study|Lost to Follow-up|1|||
162196338|NCT01074229|585769197|FG001|Overall Study|Lost to Follow-up|0|||
162196339|NCT01074229|585769198|FG002|Overall Study|Lost to Follow-up|0|||
162196340|NCT01074229|585769196|FG000|Overall Study|Change to open surgical procedure|1|||
162196341|NCT01074229|585769197|FG001|Overall Study|Change to open surgical procedure|3|||
162196342|NCT01074229|585769198|FG002|Overall Study|Change to open surgical procedure|4|||
162196343|NCT01183013|585769199|FG000|Overall Study|Adverse Event|6|||
162196344|NCT01183013|585769200|FG001|Overall Study|Adverse Event|8|||
162196345|NCT01183013|585769201|FG002|Overall Study|Adverse Event|5|||
162196346|NCT01183013|585769202|FG003|Overall Study|Adverse Event|5|||
162196347|NCT01183013|585769203|FG004|Overall Study|Adverse Event|10|||
162196348|NCT01183013|585769204|FG005|Overall Study|Adverse Event|10|||
162196349|NCT01183013|585769205|FG006|Overall Study|Adverse Event|6|||
162196350|NCT01183013|585769199|FG000|Overall Study|Lack of Efficacy|3|||
162196351|NCT01183013|585769200|FG001|Overall Study|Lack of Efficacy|2|||
162196352|NCT01183013|585769201|FG002|Overall Study|Lack of Efficacy|1|||
162196353|NCT01183013|585769202|FG003|Overall Study|Lack of Efficacy|2|||
162196354|NCT01183013|585769203|FG004|Overall Study|Lack of Efficacy|1|||
162196355|NCT01183013|585769204|FG005|Overall Study|Lack of Efficacy|2|||
162196356|NCT01183013|585769205|FG006|Overall Study|Lack of Efficacy|0|||
162196357|NCT01183013|585769199|FG000|Overall Study|Protocol Violation|5|||
162196358|NCT01183013|585769200|FG001|Overall Study|Protocol Violation|2|||
162196359|NCT01183013|585769201|FG002|Overall Study|Protocol Violation|4|||
162196360|NCT01183013|585769202|FG003|Overall Study|Protocol Violation|0|||
162196361|NCT01183013|585769203|FG004|Overall Study|Protocol Violation|4|||
162196362|NCT01183013|585769204|FG005|Overall Study|Protocol Violation|3|||
162196363|NCT01183013|585769205|FG006|Overall Study|Protocol Violation|3|||
162196364|NCT01183013|585769199|FG000|Overall Study|Lost to Follow-up|7|||
162196365|NCT01183013|585769200|FG001|Overall Study|Lost to Follow-up|3|||
162196366|NCT01183013|585769201|FG002|Overall Study|Lost to Follow-up|4|||
162196367|NCT01183013|585769202|FG003|Overall Study|Lost to Follow-up|3|||
162196368|NCT01183013|585769203|FG004|Overall Study|Lost to Follow-up|2|||
162196369|NCT01183013|585769204|FG005|Overall Study|Lost to Follow-up|6|||
162196370|NCT01183013|585769205|FG006|Overall Study|Lost to Follow-up|5|||
162196371|NCT01183013|585769199|FG000|Overall Study|Withdrawal by Subject|9|||
162196372|NCT01183013|585769200|FG001|Overall Study|Withdrawal by Subject|13|||
162196373|NCT01183013|585769201|FG002|Overall Study|Withdrawal by Subject|10|||
162196374|NCT01183013|585769202|FG003|Overall Study|Withdrawal by Subject|8|||
162196375|NCT01183013|585769203|FG004|Overall Study|Withdrawal by Subject|7|||
162196376|NCT01183013|585769204|FG005|Overall Study|Withdrawal by Subject|9|||
162196377|NCT01183013|585769205|FG006|Overall Study|Withdrawal by Subject|10|||
162196378|NCT01183013|585769199|FG000|Overall Study|Reasons other than stated above|15|||
162196379|NCT01183013|585769200|FG001|Overall Study|Reasons other than stated above|11|||
162196380|NCT01183013|585769201|FG002|Overall Study|Reasons other than stated above|17|||
162196381|NCT01183013|585769202|FG003|Overall Study|Reasons other than stated above|12|||
162196382|NCT01183013|585769203|FG004|Overall Study|Reasons other than stated above|12|||
162196383|NCT01183013|585769204|FG005|Overall Study|Reasons other than stated above|15|||
162196384|NCT01183013|585769205|FG006|Overall Study|Reasons other than stated above|13|||
162196385|NCT01951105|585769208|FG000|Overall Study|Adverse Event|0|||
162196386|NCT01951105|585769209|FG001|Overall Study|Adverse Event|5|||
162196387|NCT01951105|585769210|FG002|Overall Study|Adverse Event|0|||
162196388|NCT01951105|585769208|FG000|Overall Study|Lost to Follow-up|0|||
162196389|NCT01951105|585769209|FG001|Overall Study|Lost to Follow-up|1|||
162196390|NCT01951105|585769210|FG002|Overall Study|Lost to Follow-up|0|||
162196391|NCT01951105|585769208|FG000|Overall Study|Protocol Violation|1|||
162196392|NCT01951105|585769209|FG001|Overall Study|Protocol Violation|1|||
162196393|NCT01951105|585769210|FG002|Overall Study|Protocol Violation|1|||
162196394|NCT01951105|585769208|FG000|Overall Study|Withdrawal by Subject|0|||
162196395|NCT01951105|585769209|FG001|Overall Study|Withdrawal by Subject|3|||
162196396|NCT01951105|585769210|FG002|Overall Study|Withdrawal by Subject|1|||
162196397|NCT02727998|585769211|FG000|Overall Study|Lost to Follow-up|3|||
162196398|NCT02727998|585769212|FG001|Overall Study|Lost to Follow-up|3|||
162196399|NCT02727998|585769211|FG000|Overall Study|Withdrawal by Subject|0|||
162196400|NCT02727998|585769212|FG001|Overall Study|Withdrawal by Subject|1|||
162196401|NCT00901459|585769217|FG000|Overall Study|Withdrawal by Subject|6|||
162196402|NCT00910871|585769225|FG000|Overall Study|Adverse Event|5|||
162196403|NCT00910871|585769225|FG000|Overall Study|Death|12|||
161820545|NCT00762411|584384532|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
162196404|NCT00910871|585769225|FG000|Overall Study|Lost to Follow-up|8|||
162196405|NCT00910871|585769225|FG000|Overall Study|Protocol Violation|11|||
162196406|NCT00910871|585769225|FG000|Overall Study|Withdrawal by Subject|12|||
162196407|NCT00910871|585769225|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
162196408|NCT00910871|585769225|FG000|Overall Study|Undefined|1|||
162196409|NCT00850993|585769226|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
162196410|NCT00850993|585769227|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
162196411|NCT00850993|585769228|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
162196412|NCT00850993|585769229|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
162196413|NCT04501614|585769235|FG000|Overall Study|Study Terminated by Sponsor|6|||
162196414|NCT04501614|585769236|FG001|Overall Study|Study Terminated by Sponsor|3|||
162196415|NCT04501614|585769235|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
162196416|NCT04501614|585769236|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
162196417|NCT02555397|585769240|FG000|Overall Study|Withdrawal by Subject|1|||
162196418|NCT02555397|585769241|FG001|Overall Study|Withdrawal by Subject|0|||
162196419|NCT02555397|585769242|FG002|Overall Study|Withdrawal by Subject|0|||
162196420|NCT02555397|585769243|FG003|Overall Study|Withdrawal by Subject|0|||
162196421|NCT02555397|585769244|FG004|Overall Study|Withdrawal by Subject|0|||
162196422|NCT01240785|585769250|FG000|Overall Study|Lost to Follow-up|1|||
162196423|NCT01240785|585769251|FG001|Overall Study|Lost to Follow-up|0|||
162196424|NCT01240785|585769250|FG000|Overall Study|Protocol Violation|0|||
162196425|NCT01240785|585769251|FG001|Overall Study|Protocol Violation|3|||
162196426|NCT00237809|585769252|FG000|Overall Study|Lost to Follow-up|11|||
162196427|NCT00237809|585769253|FG001|Overall Study|Lost to Follow-up|10|||
162196428|NCT00237809|585769254|FG002|Overall Study|Lost to Follow-up|9|||
162196429|NCT00237809|585769255|FG003|Overall Study|Lost to Follow-up|9|||
162196430|NCT02006641|585769256|FG000|Overall Study|Withdrawal before treatment|2|||
162196431|NCT02006641|585769257|FG001|Overall Study|Withdrawal before treatment|5|||
162196432|NCT02006641|585769258|FG002|Overall Study|Withdrawal before treatment|3|||
162196433|NCT02006641|585769256|FG000|Overall Study|Adverse Event|15|||
162196434|NCT02006641|585769257|FG001|Overall Study|Adverse Event|11|||
162196435|NCT02006641|585769258|FG002|Overall Study|Adverse Event|15|||
162196436|NCT02006641|585769256|FG000|Overall Study|Protocol Violation|0|||
162196437|NCT02006641|585769257|FG001|Overall Study|Protocol Violation|2|||
162196438|NCT02006641|585769258|FG002|Overall Study|Protocol Violation|2|||
162196439|NCT02006641|585769256|FG000|Overall Study|Lost to Follow-up|0|||
162196440|NCT02006641|585769257|FG001|Overall Study|Lost to Follow-up|1|||
162196441|NCT02006641|585769258|FG002|Overall Study|Lost to Follow-up|0|||
162196442|NCT02006641|585769256|FG000|Overall Study|Withdrawal by Subject|7|||
162196443|NCT02006641|585769257|FG001|Overall Study|Withdrawal by Subject|12|||
162196444|NCT02006641|585769258|FG002|Overall Study|Withdrawal by Subject|11|||
162196445|NCT02006641|585769256|FG000|Overall Study|Other reason: patient didn't show up|1|||
162196446|NCT02006641|585769257|FG001|Overall Study|Other reason: patient didn't show up|0|||
162196447|NCT02006641|585769258|FG002|Overall Study|Other reason: patient didn't show up|0|||
162196448|NCT02006641|585769256|FG000|Overall Study|Other reason:patient didn't want to come|0|||
162196449|NCT02006641|585769257|FG001|Overall Study|Other reason:patient didn't want to come|0|||
162196450|NCT02006641|585769258|FG002|Overall Study|Other reason:patient didn't want to come|1|||
162196451|NCT02006641|585769256|FG000|Overall Study|Other reason: patient has moved|1|||
162196452|NCT02006641|585769257|FG001|Overall Study|Other reason: patient has moved|0|||
162196453|NCT02006641|585769258|FG002|Overall Study|Other reason: patient has moved|1|||
161820546|NCT02710214|584384536|FG000|Overall Study|Lost to Follow-up|1|||
162196454|NCT02006641|585769256|FG000|Overall Study|Other reason: caregiver in hospital|0|||
162196455|NCT02006641|585769257|FG001|Overall Study|Other reason: caregiver in hospital|1|||
162196456|NCT02006641|585769258|FG002|Overall Study|Other reason: caregiver in hospital|0|||
162196457|NCT02006641|585769256|FG000|Overall Study|Other reason: patient's wife has died|0|||
162196458|NCT02006641|585769257|FG001|Overall Study|Other reason: patient's wife has died|0|||
162196459|NCT02006641|585769258|FG002|Overall Study|Other reason: patient's wife has died|1|||
161820547|NCT02710214|584384537|FG001|Overall Study|Lost to Follow-up|0|||
161820548|NCT02710214|584384536|FG000|Overall Study|Lack of Efficacy|0|||
162196460|NCT02006641|585769256|FG000|Overall Study|Other reason: hospitalisation|0|||
162196461|NCT02006641|585769257|FG001|Overall Study|Other reason: hospitalisation|1|||
162196462|NCT02006641|585769258|FG002|Overall Study|Other reason: hospitalisation|0|||
162196463|NCT02006641|585769256|FG000|Overall Study|Other reason: caregiver impossibility|0|||
162196464|NCT02006641|585769257|FG001|Overall Study|Other reason: caregiver impossibility|0|||
162196465|NCT02006641|585769258|FG002|Overall Study|Other reason: caregiver impossibility|1|||
162196466|NCT02006641|585769256|FG000|Overall Study|Other reason: protocol non-compliance|0|||
162196467|NCT02006641|585769257|FG001|Overall Study|Other reason: protocol non-compliance|0|||
162196468|NCT02006641|585769258|FG002|Overall Study|Other reason: protocol non-compliance|1|||
162196469|NCT02132195|585769262|FG000|Initial Assignment|Relapsed|14|||
162196470|NCT02132195|585769263|FG001|Initial Assignment|Relapsed|0|||
162196471|NCT02132195|585769264|FG002|Initial Assignment|Relapsed|0|||
161675571|NCT02632721|583865498|FG000|Overall Study|Dose limiting toxicity|0|||
161675572|NCT02632721|583865499|FG001|Overall Study|Dose limiting toxicity|0|||
161675573|NCT02632721|583865500|FG002|Overall Study|Dose limiting toxicity|0|||
161675574|NCT02632721|583865501|FG003|Overall Study|Dose limiting toxicity|1|||
161675575|NCT02632721|583865502|FG004|Overall Study|Dose limiting toxicity|0|||
161675576|NCT02632721|583865498|FG000|Overall Study|Progressive disease|3|||
161675577|NCT02632721|583865499|FG001|Overall Study|Progressive disease|0|||
161675578|NCT02632721|583865500|FG002|Overall Study|Progressive disease|4|||
161675579|NCT02632721|583865501|FG003|Overall Study|Progressive disease|6|||
161675580|NCT02632721|583865502|FG004|Overall Study|Progressive disease|5|||
161675581|NCT02632721|583865498|FG000|Overall Study|Refused to continue taking trial medication|0|||
161675582|NCT02632721|583865499|FG001|Overall Study|Refused to continue taking trial medication|1|||
161675583|NCT02632721|583865500|FG002|Overall Study|Refused to continue taking trial medication|1|||
161675584|NCT02632721|583865501|FG003|Overall Study|Refused to continue taking trial medication|1|||
161675585|NCT02632721|583865502|FG004|Overall Study|Refused to continue taking trial medication|2|||
161675586|NCT02632721|583865498|FG000|Overall Study|Inadequate clinical condition|0|||
161675587|NCT02632721|583865499|FG001|Overall Study|Inadequate clinical condition|0|||
161675588|NCT02632721|583865500|FG002|Overall Study|Inadequate clinical condition|0|||
161675589|NCT02632721|583865501|FG003|Overall Study|Inadequate clinical condition|0|||
161675590|NCT02632721|583865502|FG004|Overall Study|Inadequate clinical condition|1|||
161675591|NCT02632721|583865498|FG000|Overall Study|No meet eligibility|0|||
161675592|NCT02632721|583865499|FG001|Overall Study|No meet eligibility|0|||
161675593|NCT02632721|583865500|FG002|Overall Study|No meet eligibility|0|||
161675594|NCT02632721|583865501|FG003|Overall Study|No meet eligibility|0|||
162196472|NCT02132195|585769262|FG000|Rescue Therapy|Relapsed|0|||
161675595|NCT02632721|583865502|FG004|Overall Study|No meet eligibility|1|||
161675596|NCT02632721|583865498|FG000|Overall Study|Allergic reaction|0|||
161675597|NCT02632721|583865499|FG001|Overall Study|Allergic reaction|0|||
161675598|NCT02632721|583865500|FG002|Overall Study|Allergic reaction|0|||
161675599|NCT02632721|583865501|FG003|Overall Study|Allergic reaction|1|||
161675600|NCT02632721|583865502|FG004|Overall Study|Allergic reaction|0|||
161675601|NCT02632721|583865498|FG000|Overall Study|Receiving Decitabine locally|0|||
161675602|NCT02632721|583865499|FG001|Overall Study|Receiving Decitabine locally|0|||
161675603|NCT02632721|583865500|FG002|Overall Study|Receiving Decitabine locally|1|||
161675604|NCT02632721|583865501|FG003|Overall Study|Receiving Decitabine locally|0|||
161675605|NCT02632721|583865502|FG004|Overall Study|Receiving Decitabine locally|0|||
161675606|NCT02632721|583865498|FG000|Overall Study|No benefit from study treatment|1|||
161675607|NCT02632721|583865499|FG001|Overall Study|No benefit from study treatment|1|||
161675608|NCT02632721|583865500|FG002|Overall Study|No benefit from study treatment|0|||
161675609|NCT02632721|583865501|FG003|Overall Study|No benefit from study treatment|0|||
161675610|NCT02632721|583865502|FG004|Overall Study|No benefit from study treatment|1|||
161675611|NCT02632721|583865498|FG000|Overall Study|Patient wish for other treatment|0|||
161675612|NCT02632721|583865499|FG001|Overall Study|Patient wish for other treatment|1|||
161675613|NCT02632721|583865500|FG002|Overall Study|Patient wish for other treatment|0|||
161675614|NCT02632721|583865501|FG003|Overall Study|Patient wish for other treatment|0|||
162196473|NCT02132195|585769263|FG001|Rescue Therapy|Relapsed|0|||
162196474|NCT02132195|585769264|FG002|Rescue Therapy|Relapsed|7|||
162196475|NCT02132195|585769262|FG000|Rescue Therapy|Physician Decision|0|||
162196476|NCT02132195|585769263|FG001|Rescue Therapy|Physician Decision|0|||
162196477|NCT02132195|585769264|FG002|Rescue Therapy|Physician Decision|1|||
162196478|NCT02132195|585769262|FG000|Rescue Therapy|Withdrawal by Subject|0|||
162196479|NCT02132195|585769263|FG001|Rescue Therapy|Withdrawal by Subject|0|||
162196480|NCT02132195|585769264|FG002|Rescue Therapy|Withdrawal by Subject|1|||
161675615|NCT02632721|583865502|FG004|Overall Study|Patient wish for other treatment|0|||
161675616|NCT02632721|583865498|FG000|Overall Study|Relapsed Pneumonia|0|||
161675617|NCT02632721|583865499|FG001|Overall Study|Relapsed Pneumonia|0|||
161675618|NCT02632721|583865500|FG002|Overall Study|Relapsed Pneumonia|0|||
161675619|NCT02632721|583865501|FG003|Overall Study|Relapsed Pneumonia|0|||
161675620|NCT02632721|583865502|FG004|Overall Study|Relapsed Pneumonia|1|||
162196481|NCT02132195|585769262|FG000|Rescue Therapy|Adverse Event|0|||
161675621|NCT02632721|583865498|FG000|Overall Study|Therapy refractory AML|0|||
161675622|NCT02632721|583865499|FG001|Overall Study|Therapy refractory AML|0|||
161675623|NCT02632721|583865500|FG002|Overall Study|Therapy refractory AML|0|||
161675624|NCT02632721|583865501|FG003|Overall Study|Therapy refractory AML|0|||
161675625|NCT02632721|583865502|FG004|Overall Study|Therapy refractory AML|1|||
161675626|NCT02632721|583865498|FG000|Overall Study|Increase of white blood cell count|0|||
161675627|NCT02632721|583865499|FG001|Overall Study|Increase of white blood cell count|0|||
162196482|NCT02132195|585769263|FG001|Rescue Therapy|Adverse Event|0|||
162196483|NCT02132195|585769264|FG002|Rescue Therapy|Adverse Event|2|||
161675628|NCT02632721|583865500|FG002|Overall Study|Increase of white blood cell count|0|||
162196484|NCT00321555|585769267|FG000|Overall Study|Developed antibodies|1|||
162196485|NCT00321555|585769267|FG000|Overall Study|Switched to alternative treatment|3|||
161675629|NCT02632721|583865501|FG003|Overall Study|Increase of white blood cell count|0|||
162196486|NCT00321555|585769267|FG000|Overall Study|Physician Decision|1|||
162196487|NCT00321555|585769267|FG000|Overall Study|Disease progression on study|1|||
162196488|NCT02066389|585769268|FG000|Overall Study|Adverse Event|1|||
162196489|NCT02066389|585769269|FG001|Overall Study|Adverse Event|1|||
161675630|NCT02632721|583865502|FG004|Overall Study|Increase of white blood cell count|1|||
161675631|NCT02632721|583865498|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
161675632|NCT02632721|583865499|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
161675633|NCT02632721|583865500|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
161675634|NCT02632721|583865501|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
161675635|NCT02632721|583865502|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
161675636|NCT00544648|583865506|FG000|Overall Study|Withdrawal by Subject|1|||
161675637|NCT00544648|583865507|FG001|Overall Study|Withdrawal by Subject|0|||
161675638|NCT00544648|583865506|FG000|Overall Study|Adverse Event|1|||
161675639|NCT00544648|583865507|FG001|Overall Study|Adverse Event|1|||
161675640|NCT00544648|583865506|FG000|Overall Study|progression of disease|1|||
161675641|NCT00544648|583865507|FG001|Overall Study|progression of disease|0|||
161675642|NCT02663271|583865508|FG000|Overall Study|Withdrawal by Subject|5|||
161926336|NCT01871727|584777162|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
161926337|NCT01871727|584777163|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
161675643|NCT02663271|583865508|FG000|Overall Study|Lack of Efficacy|1|||
161675644|NCT01572675|583865509|FG000|Overall Study|End of prescribed treatment|140|||
161675645|NCT01572675|583865510|FG001|Overall Study|End of prescribed treatment|118|||
161675646|NCT01572675|583865509|FG000|Overall Study|Recovery|16|||
161675647|NCT01572675|583865510|FG001|Overall Study|Recovery|23|||
161675648|NCT01572675|583865509|FG000|Overall Study|Lack of Efficacy|31|||
161675649|NCT01572675|583865510|FG001|Overall Study|Lack of Efficacy|31|||
161675650|NCT01572675|583865509|FG000|Overall Study|Intolerance|6|||
162196490|NCT02066389|585769270|FG002|Overall Study|Adverse Event|1|||
162196491|NCT02066389|585769271|FG003|Overall Study|Adverse Event|1|||
162196492|NCT02066389|585769272|FG004|Overall Study|Adverse Event|5|||
162196493|NCT02066389|585769273|FG005|Overall Study|Adverse Event|1|||
162196494|NCT02066389|585769268|FG000|Overall Study|Withdrawal by Subject|4|||
162196495|NCT02066389|585769269|FG001|Overall Study|Withdrawal by Subject|0|||
162196496|NCT02066389|585769270|FG002|Overall Study|Withdrawal by Subject|5|||
162196497|NCT02066389|585769271|FG003|Overall Study|Withdrawal by Subject|1|||
162196498|NCT02066389|585769272|FG004|Overall Study|Withdrawal by Subject|1|||
162196499|NCT02066389|585769273|FG005|Overall Study|Withdrawal by Subject|2|||
162196500|NCT02066389|585769268|FG000|Overall Study|Lost to Follow-up|0|||
162196501|NCT02066389|585769269|FG001|Overall Study|Lost to Follow-up|0|||
162196502|NCT02066389|585769270|FG002|Overall Study|Lost to Follow-up|0|||
162196503|NCT02066389|585769271|FG003|Overall Study|Lost to Follow-up|1|||
162196504|NCT02066389|585769272|FG004|Overall Study|Lost to Follow-up|1|||
162196505|NCT02066389|585769273|FG005|Overall Study|Lost to Follow-up|1|||
162196506|NCT02066389|585769268|FG000|Overall Study|Randomized in Error|0|||
162196507|NCT02066389|585769269|FG001|Overall Study|Randomized in Error|0|||
162196508|NCT02066389|585769270|FG002|Overall Study|Randomized in Error|0|||
162196509|NCT02066389|585769271|FG003|Overall Study|Randomized in Error|0|||
162196510|NCT02066389|585769272|FG004|Overall Study|Randomized in Error|0|||
162196511|NCT02066389|585769273|FG005|Overall Study|Randomized in Error|1|||
162196512|NCT02561195|585769275|FG000|Vaccination 1 to 3|Adverse Event|4|||
161675651|NCT01572675|583865510|FG001|Overall Study|Intolerance|5|||
161926338|NCT01871727|584777164|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
161926339|NCT00002874|584777167|FG000|Overall Study|Withdrawal by Subject|1|||
162196513|NCT02561195|585769276|FG001|Vaccination 1 to 3|Adverse Event|5|||
162196514|NCT02561195|585769277|FG002|Vaccination 1 to 3|Adverse Event|0|||
162196515|NCT02561195|585769278|FG003|Vaccination 1 to 3|Adverse Event|3|||
162196516|NCT02561195|585769279|FG004|Vaccination 1 to 3|Adverse Event|4|||
162196517|NCT02561195|585769280|FG005|Vaccination 1 to 3|Adverse Event|0|||
162196518|NCT02561195|585769281|FG006|Vaccination 1 to 3|Adverse Event|0|||
161675652|NCT01572675|583865509|FG000|Overall Study|Improved symptoms|8|||
161926340|NCT00002874|584777168|FG001|Overall Study|Withdrawal by Subject|1|||
161926341|NCT00002874|584777167|FG000|Overall Study|Protocol Violation|44|||
161926342|NCT00002874|584777168|FG001|Overall Study|Protocol Violation|34|||
161926343|NCT01397747|584777185|FG000|Overall Study|Multitarget DNA test excluded|689|||
161926344|NCT01397747|584777185|FG000|Overall Study|Colonoscopy excluded|304|||
161926345|NCT01397747|584777185|FG000|Overall Study|FIT excluded|34|||
162196519|NCT02561195|585769282|FG007|Vaccination 1 to 3|Adverse Event|0|||
162196520|NCT02561195|585769283|FG008|Vaccination 1 to 3|Adverse Event|0|||
161675653|NCT01572675|583865510|FG001|Overall Study|Improved symptoms|2|||
161675654|NCT01572675|583865509|FG000|Overall Study|Surgical intervention|3|||
161675655|NCT01572675|583865510|FG001|Overall Study|Surgical intervention|6|||
161675656|NCT01572675|583865509|FG000|Overall Study|Withdrawal by Subject|5|||
161675657|NCT01572675|583865510|FG001|Overall Study|Withdrawal by Subject|1|||
161675658|NCT01572675|583865509|FG000|Overall Study|Physician Decision|2|||
161675659|NCT01572675|583865510|FG001|Overall Study|Physician Decision|2|||
161675660|NCT01572675|583865509|FG000|Overall Study|Death unrelated to coxibs|1|||
161675661|NCT01572675|583865510|FG001|Overall Study|Death unrelated to coxibs|1|||
161675662|NCT01572675|583865509|FG000|Overall Study|Other disease detected|1|||
161675663|NCT01572675|583865510|FG001|Overall Study|Other disease detected|1|||
161675664|NCT01572675|583865509|FG000|Overall Study|Unknown reason|1|||
161675665|NCT01572675|583865510|FG001|Overall Study|Unknown reason|1|||
161675666|NCT01572675|583865509|FG000|Overall Study|Rheumatologist new evaluation|0|||
161675667|NCT01572675|583865510|FG001|Overall Study|Rheumatologist new evaluation|1|||
161675668|NCT01572675|583865509|FG000|Overall Study|Missing data|1|||
161675669|NCT01572675|583865510|FG001|Overall Study|Missing data|4|||
161675670|NCT01572675|583865509|FG000|Overall Study|Lost to Follow-up|22|||
161675671|NCT01572675|583865510|FG001|Overall Study|Lost to Follow-up|27|||
161675672|NCT00999713|583865511|FG000|Overall Study|Physician Decision|2|||
161675673|NCT00999713|583865512|FG001|Overall Study|Physician Decision|0|||
161675674|NCT03346057|583865516|FG000|Overall Study|Death|1|||
161675675|NCT03346057|583865517|FG001|Overall Study|Death|2|||
161675676|NCT03346057|583865518|FG002|Overall Study|Death|0|||
161675677|NCT03346057|583865519|FG003|Overall Study|Death|0|||
161675678|NCT03346057|583865516|FG000|Overall Study|Lost to Follow-up|0|||
161675679|NCT03346057|583865517|FG001|Overall Study|Lost to Follow-up|2|||
161675680|NCT03346057|583865518|FG002|Overall Study|Lost to Follow-up|1|||
161675681|NCT03346057|583865519|FG003|Overall Study|Lost to Follow-up|0|||
161675682|NCT03346057|583865516|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
161675683|NCT03346057|583865517|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
161675684|NCT03346057|583865518|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
161675685|NCT03346057|583865519|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
161675686|NCT03346057|583865516|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
161675687|NCT03346057|583865517|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
161675688|NCT03346057|583865518|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
161675689|NCT03346057|583865519|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
161675690|NCT03346057|583865516|FG000|Overall Study|Physician Decision|3|||
161675691|NCT03346057|583865517|FG001|Overall Study|Physician Decision|2|||
161675692|NCT03346057|583865518|FG002|Overall Study|Physician Decision|0|||
161675693|NCT03346057|583865519|FG003|Overall Study|Physician Decision|2|||
161675694|NCT03346057|583865516|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
161675695|NCT03346057|583865517|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
161675696|NCT03346057|583865518|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
161675697|NCT03346057|583865519|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
161675698|NCT03346057|583865516|FG000|Overall Study|Withdrawal by Subject|1|||
162196521|NCT02561195|585769284|FG009|Vaccination 1 to 3|Adverse Event|0|||
162196522|NCT02561195|585769285|FG010|Vaccination 1 to 3|Adverse Event|0|||
162196523|NCT02561195|585769286|FG011|Vaccination 1 to 3|Adverse Event|0|||
162196524|NCT02561195|585769287|FG012|Vaccination 1 to 3|Adverse Event|0|||
161675699|NCT03346057|583865517|FG001|Overall Study|Withdrawal by Subject|0|||
161675700|NCT03346057|583865518|FG002|Overall Study|Withdrawal by Subject|0|||
161675701|NCT03346057|583865519|FG003|Overall Study|Withdrawal by Subject|0|||
161675702|NCT01351623|583865520|FG000|Overall Study|Protocol Violation|2|||
161675703|NCT01351623|583865520|FG000|Overall Study|Adverse Event|4|||
161675704|NCT01351623|583865520|FG000|Overall Study|Withdrawal by Subject|1|||
161926346|NCT00504309|584777186|FG000|Overall Study|Death|0|||
161926347|NCT00504309|584777187|FG001|Overall Study|Death|0|||
161926348|NCT00504309|584777188|FG002|Overall Study|Death|0|||
161926349|NCT00504309|584777189|FG003|Overall Study|Death|0|||
161926350|NCT00504309|584777190|FG004|Overall Study|Death|1|||
162196525|NCT02561195|585769288|FG013|Vaccination 1 to 3|Adverse Event|0|||
161675705|NCT01351623|583865520|FG000|Overall Study|Death|2|||
161675706|NCT02966223|583865523|FG000|Overall Study|Physician Decision|3|||
161675707|NCT02966223|583865523|FG000|Overall Study|Withdrawal by Subject|11|||
161675708|NCT02966223|583865523|FG000|Overall Study|Lost to Follow-up|1|||
161675709|NCT01326728|583865524|FG000|Overall Study|Death|13|||
161926351|NCT00504309|584777191|FG005|Overall Study|Death|0|||
162196526|NCT02561195|585769275|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
161675710|NCT01326728|583865525|FG001|Overall Study|Death|0|||
161675711|NCT01326728|583865524|FG000|Overall Study|Early closure of study|34|||
161675712|NCT01326728|583865525|FG001|Overall Study|Early closure of study|9|||
161675713|NCT04399122|583865528|FG000|Overall Study|Lost to Follow-up|2|||
161675714|NCT04399122|583865529|FG001|Overall Study|Lost to Follow-up|0|||
161675715|NCT04399122|583865528|FG000|Overall Study|Withdrawal by Subject|1|||
161675716|NCT04399122|583865529|FG001|Overall Study|Withdrawal by Subject|0|||
161675717|NCT02536755|583865531|FG000|Overall Study|Adverse Event|4|||
161675718|NCT04448756|583865535|FG000|Overall Study|Adverse Event|0|||
161675719|NCT04448756|583865536|FG001|Overall Study|Adverse Event|1|||
161675720|NCT04448756|583865537|FG002|Overall Study|Adverse Event|0|||
162196527|NCT02561195|585769276|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
162196528|NCT02561195|585769277|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
162196529|NCT02561195|585769278|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
162196530|NCT02561195|585769279|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
162196531|NCT02561195|585769280|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
162196532|NCT02561195|585769281|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
162196533|NCT02561195|585769282|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
162196534|NCT02561195|585769283|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
161675721|NCT04448756|583865535|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
161675722|NCT04448756|583865536|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
161675723|NCT04448756|583865537|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
161675724|NCT04448756|583865535|FG000|Overall Study|Withdrawal by Subject|0|||
162196535|NCT02561195|585769284|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
162196536|NCT02561195|585769285|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
162196537|NCT02561195|585769286|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
162196538|NCT02561195|585769287|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
162196539|NCT02561195|585769288|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
161675725|NCT04448756|583865536|FG001|Overall Study|Withdrawal by Subject|3|||
161675726|NCT04448756|583865537|FG002|Overall Study|Withdrawal by Subject|1|||
161675727|NCT04448756|583865535|FG000|Overall Study|Death|2|||
161675728|NCT04448756|583865536|FG001|Overall Study|Death|1|||
161675729|NCT04448756|583865537|FG002|Overall Study|Death|0|||
161820549|NCT02710214|584384537|FG001|Overall Study|Lack of Efficacy|1|||
161820550|NCT02710214|584384536|FG000|Overall Study|Death|0|||
161820551|NCT02710214|584384537|FG001|Overall Study|Death|1|||
162196540|NCT02561195|585769275|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162196541|NCT02561195|585769276|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
161820552|NCT02832167|584384538|FG000|Treatment Period 1|Disease progression|90|||
161820553|NCT02832167|584384538|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
162196542|NCT02561195|585769277|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162196543|NCT02561195|585769278|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
162196544|NCT02561195|585769279|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
162196545|NCT02561195|585769280|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
162196546|NCT02561195|585769281|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162196547|NCT02561195|585769282|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162196548|NCT02561195|585769283|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162196549|NCT02561195|585769284|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161675730|NCT02733185|583865538|FG000|Overall Study|Withdrawal by Subject|12|||
161675731|NCT02733185|583865539|FG001|Overall Study|Withdrawal by Subject|10|||
161675732|NCT02733185|583865540|FG002|Overall Study|Withdrawal by Subject|17|||
161675733|NCT02733185|583865541|FG003|Overall Study|Withdrawal by Subject|21|||
161820554|NCT02832167|584384538|FG000|Treatment Period 1|Death|2|||
161820555|NCT02832167|584384538|FG000|Treatment Period 1|Study Drug Toxicity|6|||
161820556|NCT02832167|584384538|FG000|Treatment Period 1|Participant request to discontinue|9|||
161820557|NCT02832167|584384538|FG000|Treatment Period 1|No longer meet study criteria|1|||
161820558|NCT02832167|584384538|FG000|Treatment Period 1|Participant withdrew consent|3|||
161820559|NCT02832167|584384538|FG000|Treatment Period 1|Other reasons|6|||
161820560|NCT02832167|584384538|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
161820561|NCT02832167|584384538|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
161820562|NCT02832167|584384538|FG000|Transition From Period 1 to Period 2|Death|2|||
161820563|NCT02832167|584384538|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
161820564|NCT02832167|584384538|FG000|Treatment Period 2|Disease progression|69|||
161820565|NCT02832167|584384538|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
161820566|NCT02832167|584384538|FG000|Treatment Period 2|Maximum clinical benefit|1|||
161820567|NCT02832167|584384538|FG000|Treatment Period 2|Study Drug Toxicity|5|||
161820568|NCT02832167|584384538|FG000|Treatment Period 2|Participant request to discontinue|2|||
161820569|NCT02832167|584384538|FG000|Treatment Period 2|Participant withdrew consent|3|||
161820570|NCT02832167|584384538|FG000|Treatment Period 2|Other reasons|3|||
161820571|NCT01754376|584384539|FG000|Overall Study|Adverse Event|1|||
162196550|NCT02561195|585769285|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162196551|NCT02561195|585769286|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162196552|NCT02561195|585769287|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161820572|NCT01754376|584384539|FG000|Overall Study|Lack of Efficacy|2|||
161820573|NCT04590781|584384540|FG000|Overall Study|Death|0|||
161820574|NCT04590781|584384541|FG001|Overall Study|Death|2|||
162196553|NCT02561195|585769288|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
162196554|NCT02561195|585769275|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
162196555|NCT02561195|585769276|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
162196556|NCT02561195|585769277|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
162196557|NCT02561195|585769278|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
162196558|NCT02561195|585769279|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
162196559|NCT02561195|585769280|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
162196560|NCT02561195|585769281|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
162196561|NCT02561195|585769282|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
162196562|NCT02561195|585769283|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
162196563|NCT02561195|585769284|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
162196564|NCT02561195|585769285|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
162196565|NCT02561195|585769286|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
161675734|NCT02733185|583865538|FG000|Overall Study|Death|46|||
161820575|NCT04590781|584384540|FG000|Overall Study|Withdrawal by Subject|2|||
161820576|NCT04590781|584384541|FG001|Overall Study|Withdrawal by Subject|0|||
161926352|NCT00504309|584777186|FG000|Overall Study|Withdrawal by Subject|0|||
162196566|NCT02561195|585769287|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
162196567|NCT02561195|585769288|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
162196568|NCT02561195|585769275|FG000|Vaccination 1 to 3|Other|7|||
162196569|NCT02561195|585769276|FG001|Vaccination 1 to 3|Other|3|||
162196570|NCT02561195|585769277|FG002|Vaccination 1 to 3|Other|1|||
162196571|NCT02561195|585769278|FG003|Vaccination 1 to 3|Other|7|||
162196572|NCT02561195|585769279|FG004|Vaccination 1 to 3|Other|5|||
162196573|NCT02561195|585769280|FG005|Vaccination 1 to 3|Other|1|||
162196574|NCT02561195|585769281|FG006|Vaccination 1 to 3|Other|0|||
162196575|NCT02561195|585769282|FG007|Vaccination 1 to 3|Other|0|||
162196576|NCT02561195|585769283|FG008|Vaccination 1 to 3|Other|0|||
162196577|NCT02561195|585769284|FG009|Vaccination 1 to 3|Other|0|||
162196578|NCT02561195|585769285|FG010|Vaccination 1 to 3|Other|0|||
162196579|NCT02561195|585769286|FG011|Vaccination 1 to 3|Other|0|||
162196580|NCT02561195|585769287|FG012|Vaccination 1 to 3|Other|0|||
162196581|NCT02561195|585769288|FG013|Vaccination 1 to 3|Other|0|||
162196582|NCT02561195|585769275|FG000|Vaccination 1 to 3|Protocol Violation|1|||
162196583|NCT02561195|585769276|FG001|Vaccination 1 to 3|Protocol Violation|0|||
162196584|NCT02561195|585769277|FG002|Vaccination 1 to 3|Protocol Violation|1|||
162196585|NCT02561195|585769278|FG003|Vaccination 1 to 3|Protocol Violation|2|||
162196586|NCT02561195|585769279|FG004|Vaccination 1 to 3|Protocol Violation|5|||
162196587|NCT02561195|585769280|FG005|Vaccination 1 to 3|Protocol Violation|2|||
162196588|NCT02561195|585769281|FG006|Vaccination 1 to 3|Protocol Violation|0|||
162196589|NCT02561195|585769282|FG007|Vaccination 1 to 3|Protocol Violation|0|||
162196590|NCT02561195|585769283|FG008|Vaccination 1 to 3|Protocol Violation|0|||
162196591|NCT02561195|585769284|FG009|Vaccination 1 to 3|Protocol Violation|0|||
162196592|NCT02561195|585769285|FG010|Vaccination 1 to 3|Protocol Violation|0|||
162196593|NCT02561195|585769286|FG011|Vaccination 1 to 3|Protocol Violation|0|||
162196594|NCT02561195|585769287|FG012|Vaccination 1 to 3|Protocol Violation|0|||
162196595|NCT02561195|585769288|FG013|Vaccination 1 to 3|Protocol Violation|0|||
162196596|NCT02561195|585769275|FG000|Vaccination 1 to 3|Death|2|||
162196597|NCT02561195|585769276|FG001|Vaccination 1 to 3|Death|1|||
162196598|NCT02561195|585769277|FG002|Vaccination 1 to 3|Death|0|||
162196599|NCT02561195|585769278|FG003|Vaccination 1 to 3|Death|2|||
162196600|NCT02561195|585769279|FG004|Vaccination 1 to 3|Death|0|||
162196601|NCT02561195|585769280|FG005|Vaccination 1 to 3|Death|0|||
162196602|NCT02561195|585769281|FG006|Vaccination 1 to 3|Death|0|||
162196603|NCT02561195|585769282|FG007|Vaccination 1 to 3|Death|0|||
162196604|NCT02561195|585769283|FG008|Vaccination 1 to 3|Death|0|||
162196605|NCT02561195|585769284|FG009|Vaccination 1 to 3|Death|0|||
162196606|NCT02561195|585769285|FG010|Vaccination 1 to 3|Death|0|||
162196607|NCT02561195|585769286|FG011|Vaccination 1 to 3|Death|0|||
162196608|NCT02561195|585769287|FG012|Vaccination 1 to 3|Death|0|||
162196609|NCT02561195|585769288|FG013|Vaccination 1 to 3|Death|0|||
162196610|NCT02561195|585769275|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
162196611|NCT02561195|585769276|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
162196612|NCT02561195|585769277|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
162196613|NCT02561195|585769278|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
162196614|NCT02561195|585769279|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
162196615|NCT02561195|585769280|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
162196616|NCT02561195|585769281|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
162196617|NCT02561195|585769282|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
162196618|NCT02561195|585769283|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
162196619|NCT02561195|585769284|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
162196620|NCT02561195|585769285|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
162196621|NCT02561195|585769286|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
162196622|NCT02561195|585769287|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
161926353|NCT00504309|584777187|FG001|Overall Study|Withdrawal by Subject|0|||
162196623|NCT02561195|585769288|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
162196624|NCT02561195|585769275|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
162196625|NCT02561195|585769276|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
162196626|NCT02561195|585769277|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
162196627|NCT02561195|585769278|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
162196628|NCT02561195|585769279|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
162196629|NCT02561195|585769280|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
162196630|NCT02561195|585769281|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
162196631|NCT02561195|585769282|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
162196632|NCT02561195|585769283|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
162196633|NCT02561195|585769284|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
162196634|NCT02561195|585769285|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
162196635|NCT02561195|585769286|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
162196636|NCT02561195|585769287|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
161675735|NCT02733185|583865539|FG001|Overall Study|Death|34|||
161675736|NCT02733185|583865540|FG002|Overall Study|Death|35|||
161675737|NCT02733185|583865541|FG003|Overall Study|Death|43|||
161675738|NCT02733185|583865538|FG000|Overall Study|Lost to Follow-up|17|||
161675739|NCT02733185|583865539|FG001|Overall Study|Lost to Follow-up|18|||
161675740|NCT02733185|583865540|FG002|Overall Study|Lost to Follow-up|16|||
161675741|NCT02733185|583865541|FG003|Overall Study|Lost to Follow-up|11|||
161675742|NCT02499770|583865545|FG000|Overall Study|Death|17|||
161675743|NCT02499770|583865546|FG001|Overall Study|Death|56|||
161675744|NCT02499770|583865545|FG000|Overall Study|Study completion|1|||
161675745|NCT02499770|583865546|FG001|Overall Study|Study completion|10|||
161675746|NCT02499770|583865545|FG000|Overall Study|Withdrawal by Subject|0|||
161675747|NCT02499770|583865546|FG001|Overall Study|Withdrawal by Subject|7|||
161675748|NCT02499770|583865545|FG000|Overall Study|Lost to Follow-up|0|||
161675749|NCT02499770|583865546|FG001|Overall Study|Lost to Follow-up|2|||
161675750|NCT02499770|583865545|FG000|Overall Study|Subject declined further treatment|1|||
161675751|NCT02499770|583865546|FG001|Overall Study|Subject declined further treatment|0|||
161675752|NCT02499770|583865545|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
161675753|NCT02499770|583865546|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
161675754|NCT02499770|583865545|FG000|Overall Study|Randomized but not enrolled|0|||
161675755|NCT02499770|583865546|FG001|Overall Study|Randomized but not enrolled|1|||
161675756|NCT04275297|583865547|FG000|Overall Study|Lost to Follow-up|1|||
161675757|NCT04275297|583865548|FG001|Overall Study|Lost to Follow-up|1|||
161675758|NCT01093326|583865549|FG000|Overall Study|Death|0|||
161675759|NCT01093326|583865550|FG001|Overall Study|Death|1|||
161675760|NCT01093326|583865551|FG002|Overall Study|Death|0|||
161675761|NCT01093326|583865549|FG000|Overall Study|Lack of Efficacy|7|||
161675762|NCT01093326|583865550|FG001|Overall Study|Lack of Efficacy|6|||
161675763|NCT01093326|583865551|FG002|Overall Study|Lack of Efficacy|3|||
161675764|NCT01093326|583865549|FG000|Overall Study|Lost to Follow-up|2|||
161675765|NCT01093326|583865550|FG001|Overall Study|Lost to Follow-up|5|||
161675766|NCT01093326|583865551|FG002|Overall Study|Lost to Follow-up|4|||
161675767|NCT01093326|583865549|FG000|Overall Study|Physician Decision|3|||
161675768|NCT01093326|583865550|FG001|Overall Study|Physician Decision|1|||
161675769|NCT01093326|583865551|FG002|Overall Study|Physician Decision|3|||
161675770|NCT01093326|583865549|FG000|Overall Study|Withdrawal by Subject|30|||
161675771|NCT01093326|583865550|FG001|Overall Study|Withdrawal by Subject|27|||
161675772|NCT01093326|583865551|FG002|Overall Study|Withdrawal by Subject|26|||
161675773|NCT01093326|583865549|FG000|Overall Study|Adverse Event|2|||
161675774|NCT01093326|583865550|FG001|Overall Study|Adverse Event|1|||
161675775|NCT01093326|583865551|FG002|Overall Study|Adverse Event|4|||
161675776|NCT01093326|583865549|FG000|Overall Study|Other|0|||
162196637|NCT02561195|585769288|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
162196638|NCT02561195|585769275|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162196639|NCT02561195|585769276|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162196640|NCT02561195|585769277|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161820577|NCT03686215|584384543|FG000|Overall Study|Adverse Event|0|||
161820578|NCT03686215|584384544|FG001|Overall Study|Adverse Event|0|||
161820579|NCT03686215|584384545|FG002|Overall Study|Adverse Event|7|||
161820580|NCT03686215|584384543|FG000|Overall Study|Physician Decision|0|||
161820581|NCT03686215|584384544|FG001|Overall Study|Physician Decision|0|||
162196641|NCT02561195|585769278|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162196642|NCT02561195|585769279|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162196643|NCT02561195|585769280|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162196644|NCT02561195|585769281|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161675777|NCT01093326|583865550|FG001|Overall Study|Other|0|||
161675778|NCT01093326|583865551|FG002|Overall Study|Other|1|||
161675779|NCT04225806|583865552|FG000|Overall Study|Trial termination|15|||
161675780|NCT07052682|583865555|FG000|Overall Study|Withdrawal by Subject|4|||
161820582|NCT03686215|584384545|FG002|Overall Study|Physician Decision|1|||
161820583|NCT03686215|584384543|FG000|Overall Study|Protocol Violation|0|||
161675781|NCT05460273|583865556|FG000|Overall Study|Death|43|||
161675782|NCT05460273|583865557|FG001|Overall Study|Death|9|||
161675783|NCT05460273|583865556|FG000|Overall Study|Lost to Follow-up|7|||
161675784|NCT05460273|583865557|FG001|Overall Study|Lost to Follow-up|0|||
161675785|NCT05460273|583865556|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
161675786|NCT05460273|583865557|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
161675787|NCT04124614|583865558|FG000|Placebo Run-in Period|Not Randomized|34|||
161675788|NCT04124614|583865559|FG001|Placebo Run-in Period|Not Randomized|0|||
161675789|NCT04124614|583865560|FG002|Placebo Run-in Period|Not Randomized|0|||
161675790|NCT04124614|583865558|FG000|Double Blind Treatment Period|Adverse Event|0|||
161675791|NCT04124614|583865559|FG001|Double Blind Treatment Period|Adverse Event|7|||
161820584|NCT03686215|584384544|FG001|Overall Study|Protocol Violation|0|||
161820585|NCT03686215|584384545|FG002|Overall Study|Protocol Violation|4|||
162196645|NCT02561195|585769282|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162196646|NCT02561195|585769283|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
162196647|NCT02561195|585769284|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
162196648|NCT02561195|585769285|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
161675792|NCT04124614|583865560|FG002|Double Blind Treatment Period|Adverse Event|22|||
161675793|NCT04124614|583865558|FG000|Double Blind Treatment Period|Death|0|||
161675794|NCT04124614|583865559|FG001|Double Blind Treatment Period|Death|0|||
162196649|NCT02561195|585769286|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
162196650|NCT02561195|585769287|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
162196651|NCT02561195|585769288|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
162196652|NCT02561195|585769275|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196653|NCT02561195|585769276|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196654|NCT02561195|585769277|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196655|NCT02561195|585769278|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196656|NCT02561195|585769279|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196657|NCT02561195|585769280|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196658|NCT02561195|585769281|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196659|NCT02561195|585769282|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196660|NCT02561195|585769283|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196661|NCT02561195|585769284|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196662|NCT02561195|585769285|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196663|NCT02561195|585769286|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196664|NCT02561195|585769287|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
162196665|NCT02561195|585769288|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
162196666|NCT02561195|585769275|FG000|Extension Stage (Vaccination 4)|Death|0|||
162196667|NCT02561195|585769276|FG001|Extension Stage (Vaccination 4)|Death|0|||
162196668|NCT02561195|585769277|FG002|Extension Stage (Vaccination 4)|Death|0|||
161675795|NCT04124614|583865560|FG002|Double Blind Treatment Period|Death|1|||
161820586|NCT03686215|584384543|FG000|Overall Study|Device issue|1|||
161820587|NCT03686215|584384544|FG001|Overall Study|Device issue|0|||
162020503|NCT00545272|585130494|FG001|Overall Study|Adverse Event|0|||
162196669|NCT02561195|585769278|FG003|Extension Stage (Vaccination 4)|Death|0|||
162196670|NCT02561195|585769279|FG004|Extension Stage (Vaccination 4)|Death|0|||
162196671|NCT02561195|585769280|FG005|Extension Stage (Vaccination 4)|Death|0|||
162196672|NCT02561195|585769281|FG006|Extension Stage (Vaccination 4)|Death|0|||
162196673|NCT02561195|585769282|FG007|Extension Stage (Vaccination 4)|Death|0|||
162196674|NCT02561195|585769283|FG008|Extension Stage (Vaccination 4)|Death|0|||
162196675|NCT02561195|585769284|FG009|Extension Stage (Vaccination 4)|Death|1|||
162196676|NCT02561195|585769285|FG010|Extension Stage (Vaccination 4)|Death|0|||
162196677|NCT02561195|585769286|FG011|Extension Stage (Vaccination 4)|Death|0|||
162196678|NCT02561195|585769287|FG012|Extension Stage (Vaccination 4)|Death|0|||
162196679|NCT02561195|585769288|FG013|Extension Stage (Vaccination 4)|Death|0|||
162196680|NCT02561195|585769275|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162196681|NCT02561195|585769276|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162196682|NCT02561195|585769277|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162196683|NCT02561195|585769278|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162196684|NCT02561195|585769279|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162196685|NCT02561195|585769280|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162196686|NCT02561195|585769281|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
162196687|NCT02561195|585769282|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
162196688|NCT02561195|585769283|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162196689|NCT02561195|585769284|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
162196690|NCT02561195|585769285|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
162196691|NCT02561195|585769286|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
162196692|NCT02561195|585769287|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
162196693|NCT02561195|585769288|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
162196694|NCT02561195|585769275|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162196695|NCT02561195|585769276|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162196696|NCT02561195|585769277|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162196697|NCT02561195|585769278|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162196698|NCT02561195|585769279|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162196699|NCT02561195|585769280|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162196700|NCT02561195|585769281|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162196701|NCT02561195|585769282|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162196702|NCT02561195|585769283|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162196703|NCT02561195|585769284|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162196704|NCT02561195|585769285|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
162196705|NCT02561195|585769286|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
162196706|NCT02561195|585769287|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
161675796|NCT04124614|583865558|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
162196707|NCT02561195|585769288|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
162196708|NCT02561195|585769275|FG000|Extension Stage (Vaccination 4)|Other|0|||
162196709|NCT02561195|585769276|FG001|Extension Stage (Vaccination 4)|Other|0|||
162196710|NCT02561195|585769277|FG002|Extension Stage (Vaccination 4)|Other|0|||
162196711|NCT02561195|585769278|FG003|Extension Stage (Vaccination 4)|Other|0|||
162196712|NCT02561195|585769279|FG004|Extension Stage (Vaccination 4)|Other|0|||
162196713|NCT02561195|585769280|FG005|Extension Stage (Vaccination 4)|Other|0|||
162196714|NCT02561195|585769281|FG006|Extension Stage (Vaccination 4)|Other|0|||
162196715|NCT02561195|585769282|FG007|Extension Stage (Vaccination 4)|Other|0|||
162196716|NCT02561195|585769283|FG008|Extension Stage (Vaccination 4)|Other|0|||
162196717|NCT02561195|585769284|FG009|Extension Stage (Vaccination 4)|Other|0|||
162196718|NCT02561195|585769285|FG010|Extension Stage (Vaccination 4)|Other|2|||
162196719|NCT02561195|585769286|FG011|Extension Stage (Vaccination 4)|Other|2|||
162196720|NCT02561195|585769287|FG012|Extension Stage (Vaccination 4)|Other|1|||
162196721|NCT02561195|585769288|FG013|Extension Stage (Vaccination 4)|Other|0|||
162196722|NCT02561195|585769275|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162196723|NCT02561195|585769276|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162196724|NCT02561195|585769277|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162196725|NCT02561195|585769278|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162196726|NCT02561195|585769279|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162196727|NCT02561195|585769280|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162196728|NCT02561195|585769281|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
162196729|NCT02561195|585769282|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162196730|NCT02561195|585769283|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162196731|NCT02561195|585769284|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162196732|NCT02561195|585769285|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
162196733|NCT02561195|585769286|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
162196734|NCT02561195|585769287|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
162196735|NCT02561195|585769288|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
162196736|NCT03905512|585769289|FG000|Overall Study|Withdrawal by Subject|9|||
162196737|NCT03905512|585769290|FG001|Overall Study|Withdrawal by Subject|8|||
162196738|NCT03905512|585769289|FG000|Overall Study|Adverse Event|1|||
162196739|NCT03905512|585769290|FG001|Overall Study|Adverse Event|2|||
162196740|NCT03905512|585769289|FG000|Overall Study|Lost to Follow-up|4|||
162196741|NCT03905512|585769290|FG001|Overall Study|Lost to Follow-up|3|||
162196742|NCT03905512|585769289|FG000|Overall Study|Other than Specified|7|||
162196743|NCT03905512|585769290|FG001|Overall Study|Other than Specified|4|||
162196744|NCT00070317|585769297|FG000|Overall Study|Inevaluable (Never Treated)|1|||
162196745|NCT00070317|585769297|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
162196746|NCT00070317|585769297|FG000|Overall Study|Ineligible required test not done|1|||
162196747|NCT00070317|585769297|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
162196748|NCT00070317|585769297|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
162196749|NCT00736502|585769298|FG000|Overall Study|Adverse Event|22|||
162196750|NCT00736502|585769298|FG000|Overall Study|Lack of Efficacy|16|||
162196751|NCT00736502|585769298|FG000|Overall Study|Lost to Follow-up|27|||
162196752|NCT03987074|585769300|FG000|Overall Study|Withdrew Consent|1|||
162196753|NCT03987074|585769301|FG001|Overall Study|Withdrew Consent|1|||
162196754|NCT03987074|585769302|FG002|Overall Study|Withdrew Consent|0|||
162196755|NCT03987074|585769303|FG003|Overall Study|Withdrew Consent|2|||
162196756|NCT03987074|585769304|FG004|Overall Study|Withdrew Consent|1|||
162196757|NCT03987074|585769300|FG000|Overall Study|Adverse Event|2|||
162196758|NCT03987074|585769301|FG001|Overall Study|Adverse Event|1|||
162196759|NCT03987074|585769302|FG002|Overall Study|Adverse Event|0|||
162196760|NCT03987074|585769303|FG003|Overall Study|Adverse Event|0|||
162196761|NCT03987074|585769304|FG004|Overall Study|Adverse Event|1|||
162196762|NCT03987074|585769300|FG000|Overall Study|Lost to Follow-up|0|||
162196763|NCT03987074|585769301|FG001|Overall Study|Lost to Follow-up|0|||
162196764|NCT03987074|585769302|FG002|Overall Study|Lost to Follow-up|1|||
162196765|NCT03987074|585769303|FG003|Overall Study|Lost to Follow-up|1|||
162196766|NCT03987074|585769304|FG004|Overall Study|Lost to Follow-up|0|||
162196767|NCT03987074|585769300|FG000|Overall Study|Investigator's Discretion|0|||
162196768|NCT03987074|585769301|FG001|Overall Study|Investigator's Discretion|0|||
162196769|NCT03987074|585769302|FG002|Overall Study|Investigator's Discretion|0|||
162196770|NCT03987074|585769303|FG003|Overall Study|Investigator's Discretion|1|||
162196771|NCT03987074|585769304|FG004|Overall Study|Investigator's Discretion|0|||
162196772|NCT00508144|585769305|FG000|Overall Study|Not eligible|6|||
162196773|NCT00508144|585769305|FG000|Overall Study|Death|5|||
161820588|NCT03686215|584384545|FG002|Overall Study|Device issue|2|||
161820589|NCT00063258|584384548|FG000|Overall Study|Physician Decision|2|||
161820590|NCT00063258|584384549|FG001|Overall Study|Physician Decision|0|||
161820591|NCT00063258|584384548|FG000|Overall Study|Lack of Efficacy|2|||
161820592|NCT00063258|584384549|FG001|Overall Study|Lack of Efficacy|0|||
161820593|NCT03988608|584384550|FG000|Overall Study|Adverse Event|1|||
161820594|NCT03988608|584384550|FG000|Overall Study|Lost to Follow-up|1|||
162196774|NCT01661972|585769306|FG000|Overall Study|Adverse Event|1|||
162196775|NCT01661972|585769307|FG001|Overall Study|Adverse Event|2|||
162196776|NCT01661972|585769306|FG000|Overall Study|Death during Treatment period|1|||
162196777|NCT01661972|585769307|FG001|Overall Study|Death during Treatment period|1|||
162196778|NCT01661972|585769306|FG000|Overall Study|Withdrawal by Subject|0|||
162196779|NCT01661972|585769307|FG001|Overall Study|Withdrawal by Subject|1|||
162196780|NCT02138838|585769310|FG000|Overall Study|Study Closure|7|||
162196781|NCT02138838|585769311|FG001|Overall Study|Study Closure|6|||
162196782|NCT02138838|585769310|FG000|Overall Study|Withdrawal by Subject|1|||
162196783|NCT02138838|585769311|FG001|Overall Study|Withdrawal by Subject|5|||
162196784|NCT01084772|585769314|FG000|Baseline|Withdrawal by Subject|7|||
162196785|NCT01084772|585769315|FG001|Baseline|Withdrawal by Subject|6|||
162196786|NCT01084772|585769314|FG000|3 Months|Death|1|||
162196787|NCT01084772|585769315|FG001|3 Months|Death|0|||
162196788|NCT01084772|585769314|FG000|3 Months|Study Termination|2|||
162196789|NCT01084772|585769315|FG001|3 Months|Study Termination|2|||
162196790|NCT01084772|585769314|FG000|1 Year|Withdrawal by Subject|0|||
162196791|NCT01084772|585769315|FG001|1 Year|Withdrawal by Subject|1|||
162196792|NCT01084772|585769314|FG000|1 Year|Lost to Follow-up|3|||
162196793|NCT01084772|585769315|FG001|1 Year|Lost to Follow-up|0|||
162196794|NCT01084772|585769314|FG000|1 Year|Study Termination|0|||
162196795|NCT01084772|585769315|FG001|1 Year|Study Termination|7|||
162196796|NCT01084772|585769314|FG000|2 Years|Withdrawal by Subject|1|||
162196797|NCT01084772|585769315|FG001|2 Years|Withdrawal by Subject|0|||
162196798|NCT01084772|585769314|FG000|2 Years|Lost to Follow-up|5|||
162196799|NCT01084772|585769315|FG001|2 Years|Lost to Follow-up|2|||
162196800|NCT01084772|585769314|FG000|2 Years|Study Termination|3|||
162196801|NCT01084772|585769315|FG001|2 Years|Study Termination|2|||
162196802|NCT01294644|585769316|FG000|Overall Study|Adverse Event|2|||
162196803|NCT01294644|585769317|FG001|Overall Study|Adverse Event|0|||
162196804|NCT01294644|585769318|FG002|Overall Study|Adverse Event|1|||
162196805|NCT01294644|585769316|FG000|Overall Study|Withdrawal by Subject|3|||
162196806|NCT01294644|585769317|FG001|Overall Study|Withdrawal by Subject|7|||
162196807|NCT01294644|585769318|FG002|Overall Study|Withdrawal by Subject|4|||
162196808|NCT01294644|585769316|FG000|Overall Study|Lost to Follow-up|3|||
162196809|NCT01294644|585769317|FG001|Overall Study|Lost to Follow-up|2|||
162196810|NCT01294644|585769318|FG002|Overall Study|Lost to Follow-up|5|||
162196811|NCT01294644|585769316|FG000|Overall Study|Miscellaneous Reason|2|||
162196812|NCT01294644|585769317|FG001|Overall Study|Miscellaneous Reason|1|||
162196813|NCT01294644|585769318|FG002|Overall Study|Miscellaneous Reason|4|||
162196814|NCT01517282|585769319|FG000|Overall Study|Consent withdrawn|0|||
162196815|NCT01517282|585769320|FG001|Overall Study|Consent withdrawn|1|||
162196816|NCT01517282|585769321|FG002|Overall Study|Consent withdrawn|1|||
162196817|NCT01517282|585769322|FG003|Overall Study|Consent withdrawn|1|||
162196818|NCT01517282|585769319|FG000|Overall Study|Physician Decision|1|||
162196819|NCT01517282|585769320|FG001|Overall Study|Physician Decision|0|||
162196820|NCT01517282|585769321|FG002|Overall Study|Physician Decision|0|||
162196821|NCT01517282|585769322|FG003|Overall Study|Physician Decision|0|||
162196822|NCT04520256|585769326|FG000|Overall Study|Lost to Follow-up|6|||
162196823|NCT04520256|585769327|FG001|Overall Study|Lost to Follow-up|4|||
162196824|NCT04520256|585769328|FG002|Overall Study|Lost to Follow-up|2|||
162196825|NCT04520256|585769329|FG003|Overall Study|Lost to Follow-up|3|||
162196826|NCT04520256|585769330|FG004|Overall Study|Lost to Follow-up|6|||
162196827|NCT04520256|585769331|FG005|Overall Study|Lost to Follow-up|6|||
162196828|NCT04520256|585769332|FG006|Overall Study|Lost to Follow-up|4|||
162196829|NCT04520256|585769333|FG007|Overall Study|Lost to Follow-up|6|||
162196830|NCT04520256|585769334|FG008|Overall Study|Lost to Follow-up|1|||
162196831|NCT04520256|585769335|FG009|Overall Study|Lost to Follow-up|3|||
162196832|NCT04520256|585769336|FG010|Overall Study|Lost to Follow-up|3|||
162196833|NCT04520256|585769337|FG011|Overall Study|Lost to Follow-up|2|||
162196834|NCT04520256|585769338|FG012|Overall Study|Lost to Follow-up|5|||
162196835|NCT04520256|585769339|FG013|Overall Study|Lost to Follow-up|3|||
162196836|NCT04520256|585769340|FG014|Overall Study|Lost to Follow-up|3|||
162196837|NCT04520256|585769341|FG015|Overall Study|Lost to Follow-up|6|||
162196838|NCT04520256|585769342|FG016|Overall Study|Lost to Follow-up|6|||
162196839|NCT04520256|585769343|FG017|Overall Study|Lost to Follow-up|4|||
162196840|NCT04520256|585769344|FG018|Overall Study|Lost to Follow-up|3|||
162196841|NCT04520256|585769345|FG019|Overall Study|Lost to Follow-up|3|||
162196842|NCT04520256|585769346|FG020|Overall Study|Lost to Follow-up|7|||
162020504|NCT00545272|585130495|FG002|Overall Study|Adverse Event|1|||
162196843|NCT04520256|585769347|FG021|Overall Study|Lost to Follow-up|3|||
162196844|NCT04520256|585769348|FG022|Overall Study|Lost to Follow-up|3|||
162196845|NCT04520256|585769349|FG023|Overall Study|Lost to Follow-up|8|||
162196846|NCT04520256|585769350|FG024|Overall Study|Lost to Follow-up|5|||
162196847|NCT04520256|585769351|FG025|Overall Study|Lost to Follow-up|4|||
162196848|NCT04520256|585769352|FG026|Overall Study|Lost to Follow-up|3|||
162196849|NCT04520256|585769353|FG027|Overall Study|Lost to Follow-up|4|||
162196850|NCT04520256|585769354|FG028|Overall Study|Lost to Follow-up|3|||
162196851|NCT04520256|585769355|FG029|Overall Study|Lost to Follow-up|4|||
162196852|NCT04520256|585769356|FG030|Overall Study|Lost to Follow-up|4|||
161675797|NCT04124614|583865559|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
161675798|NCT04124614|583865560|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
162196853|NCT04520256|585769357|FG031|Overall Study|Lost to Follow-up|4|||
162196854|NCT00760877|585770671|FG000|Overall Study|Protocol Violation|1|||
161675799|NCT04124614|583865558|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
161675800|NCT04124614|583865559|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
161675801|NCT04124614|583865560|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
161675802|NCT04124614|583865558|FG000|Double Blind Treatment Period|Physician Decision|0|||
161675803|NCT04124614|583865559|FG001|Double Blind Treatment Period|Physician Decision|0|||
161675804|NCT04124614|583865560|FG002|Double Blind Treatment Period|Physician Decision|3|||
161675805|NCT04124614|583865558|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
161675806|NCT04124614|583865559|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
161675807|NCT04124614|583865560|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
162196855|NCT00760877|585770672|FG001|Overall Study|Protocol Violation|0|||
162196856|NCT00760877|585770671|FG000|Overall Study|Non-compliance with protocol treatment|2|||
162196857|NCT00760877|585770672|FG001|Overall Study|Non-compliance with protocol treatment|1|||
162196858|NCT00760877|585770671|FG000|Overall Study|Pregnancy|1|||
162196859|NCT00760877|585770672|FG001|Overall Study|Pregnancy|4|||
162196860|NCT00760877|585770671|FG000|Overall Study|Death|2|||
162196861|NCT00760877|585770672|FG001|Overall Study|Death|1|||
162196862|NCT00760877|585770671|FG000|Overall Study|Withdrawal by Subject|7|||
162196863|NCT00760877|585770672|FG001|Overall Study|Withdrawal by Subject|3|||
162196864|NCT00760877|585770671|FG000|Overall Study|Adverse Event|19|||
162196865|NCT00760877|585770672|FG001|Overall Study|Adverse Event|12|||
162196866|NCT00760877|585770671|FG000|Overall Study|Participant diagnosed with AML|0|||
162196867|NCT00760877|585770672|FG001|Overall Study|Participant diagnosed with AML|1|||
162196868|NCT00760877|585770671|FG000|Overall Study|Participant not eligible to cross-over|0|||
162196869|NCT00760877|585770672|FG001|Overall Study|Participant not eligible to cross-over|1|||
162196870|NCT00760877|585770671|FG000|Overall Study|Physician Decision|1|||
162196871|NCT00760877|585770672|FG001|Overall Study|Physician Decision|2|||
162196872|NCT00760877|585770671|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
162196873|NCT00760877|585770672|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
162196874|NCT00760877|585770671|FG000|Overall Study|Treatment failure|1|||
162196875|NCT00760877|585770672|FG001|Overall Study|Treatment failure|0|||
162196876|NCT04413149|585770673|FG000|Overall Study|Death|10|||
162196877|NCT04413149|585770674|FG001|Overall Study|Death|5|||
162196878|NCT04413149|585770673|FG000|Overall Study|Lung transplantation|1|||
162196879|NCT04413149|585770674|FG001|Overall Study|Lung transplantation|0|||
162196880|NCT02878590|585770675|FG000|Overall Study|Withdrawal by Subject|2|||
162196881|NCT01730118|585770676|FG000|Dose Escalation|Death on study|5|||
162196882|NCT01730118|585770677|FG001|Dose Escalation|Death on study|7|||
162196883|NCT01730118|585770678|FG002|Dose Escalation|Death on study|2|||
162196884|NCT01730118|585770679|FG003|Dose Escalation|Death on study|6|||
161675808|NCT04124614|583865558|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
161675809|NCT04124614|583865559|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
161675810|NCT04124614|583865560|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
161675811|NCT04124614|583865558|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
161675812|NCT04124614|583865559|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
161675813|NCT04124614|583865560|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
161675814|NCT01650285|583867204|FG000|Overall Study|Adverse Event|1|||
161675815|NCT00907257|583867207|FG000|Overall Study|Adverse Event|0|||
161675816|NCT00907257|583867208|FG001|Overall Study|Adverse Event|4|||
161675817|NCT00907257|583867207|FG000|Overall Study|Protocol Violation|1|||
161675818|NCT00907257|583867208|FG001|Overall Study|Protocol Violation|2|||
161675819|NCT00907257|583867207|FG000|Overall Study|Lost to Follow-up|3|||
161675820|NCT00907257|583867208|FG001|Overall Study|Lost to Follow-up|3|||
161675821|NCT00907257|583867207|FG000|Overall Study|Withdrawal by Subject|1|||
161675822|NCT00907257|583867208|FG001|Overall Study|Withdrawal by Subject|2|||
161675823|NCT00907257|583867207|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
161675824|NCT00907257|583867208|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
161675825|NCT00907257|583867207|FG000|Overall Study|Moved|1|||
161675826|NCT00907257|583867208|FG001|Overall Study|Moved|0|||
161675827|NCT00907257|583867207|FG000|Overall Study|Personal Reasons|6|||
161675828|NCT00907257|583867208|FG001|Overall Study|Personal Reasons|1|||
161675829|NCT04163900|583867209|FG000|Overall Study|Radiological disease progression|112|||
161675830|NCT04163900|583867210|FG001|Overall Study|Radiological disease progression|127|||
161675831|NCT04163900|583867209|FG000|Overall Study|Study closure|98|||
161675832|NCT04163900|583867210|FG001|Overall Study|Study closure|133|||
161675833|NCT04163900|583867209|FG000|Overall Study|Adverse Event|78|||
161675834|NCT04163900|583867210|FG001|Overall Study|Adverse Event|32|||
161675835|NCT04163900|583867209|FG000|Overall Study|Withdrawal by Subject|37|||
162196885|NCT01730118|585770680|FG004|Dose Escalation|Death on study|0|||
162196886|NCT01730118|585770681|FG005|Dose Escalation|Death on study|0|||
162196887|NCT01730118|585770682|FG006|Dose Escalation|Death on study|0|||
162196888|NCT01730118|585770676|FG000|Dose Escalation|Died before treatment|0|||
161820595|NCT03988608|584384550|FG000|Overall Study|Withdrawal by Subject|3|||
161820596|NCT03988608|584384550|FG000|Overall Study|Death|1|||
161820597|NCT01456962|584384558|FG000|Overall Study|Lost to Follow-up|2|||
161820598|NCT01456962|584384559|FG001|Overall Study|Lost to Follow-up|1|||
161820599|NCT03387462|584384561|FG000|Overall Study|Lost to Follow-up|1|||
161820600|NCT01460628|584384562|FG000|Overall Study|Adverse Event|3|||
161820601|NCT01460628|584384562|FG000|Overall Study|Withdrawal by Subject|2|||
161820602|NCT05029687|584384581|FG000|Overall Study|Withdrawal by Subject|4|||
161820603|NCT05029687|584384582|FG001|Overall Study|Withdrawal by Subject|0|||
161820604|NCT05029687|584384583|FG002|Overall Study|Withdrawal by Subject|2|||
161820605|NCT05029687|584384581|FG000|Overall Study|Lost to Follow-up|4|||
161820606|NCT05029687|584384582|FG001|Overall Study|Lost to Follow-up|0|||
161820607|NCT05029687|584384583|FG002|Overall Study|Lost to Follow-up|2|||
161820608|NCT02854800|584384589|FG000|Overall Study|Protocol Violation|16|||
161820609|NCT02854800|584384590|FG001|Overall Study|Protocol Violation|11|||
161820610|NCT02854800|584384591|FG002|Overall Study|Protocol Violation|3|||
161820611|NCT02854800|584384589|FG000|Overall Study|Withdrawal by Subject|4|||
161820612|NCT02854800|584384590|FG001|Overall Study|Withdrawal by Subject|2|||
161820613|NCT02854800|584384591|FG002|Overall Study|Withdrawal by Subject|3|||
161820614|NCT02372006|584384603|FG000|Overall Study|Progressive disease|8|||
161820615|NCT02372006|584384604|FG001|Overall Study|Progressive disease|7|||
161820616|NCT02372006|584384605|FG002|Overall Study|Progressive disease|34|||
161820617|NCT02372006|584384603|FG000|Overall Study|Dose limiting toxicity|0|||
161675836|NCT04163900|583867210|FG001|Overall Study|Withdrawal by Subject|34|||
161675837|NCT04163900|583867209|FG000|Overall Study|Death|29|||
161675838|NCT04163900|583867210|FG001|Overall Study|Death|16|||
161675839|NCT04163900|583867209|FG000|Overall Study|Physician Decision|17|||
161675840|NCT04163900|583867210|FG001|Overall Study|Physician Decision|25|||
161675841|NCT04163900|583867209|FG000|Overall Study|Clinical disease progression|14|||
161675842|NCT04163900|583867210|FG001|Overall Study|Clinical disease progression|13|||
161675843|NCT04163900|583867209|FG000|Overall Study|Protocol Violation|3|||
161675844|NCT04163900|583867210|FG001|Overall Study|Protocol Violation|4|||
161675845|NCT04163900|583867209|FG000|Overall Study|Lost to Follow-up|0|||
161675846|NCT04163900|583867210|FG001|Overall Study|Lost to Follow-up|1|||
161675847|NCT01873417|583867212|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
161675848|NCT01873417|583867212|FG000|Overall Study|Adverse Event|24|||
161675849|NCT01873417|583867212|FG000|Overall Study|Lost to Follow-up|2|||
161675850|NCT01873417|583867212|FG000|Overall Study|Withdrawal by Subject|2|||
161675851|NCT01873417|583867212|FG000|Overall Study|Physician Decision|3|||
161675852|NCT00785044|583867213|FG000|Overall Study|Dosed at non-participating sites|152|||
161675853|NCT00785044|583867213|FG000|Overall Study|Death|77|||
161675854|NCT00785044|583867213|FG000|Overall Study|Lost to Follow-up|266|||
161675855|NCT00785044|583867213|FG000|Overall Study|Withdrawal by Subject|1|||
161675856|NCT01830855|583867214|FG000|Overall Study|Other|7|||
161675857|NCT01830855|583867215|FG001|Overall Study|Other|1|||
161675858|NCT01830855|583867216|FG002|Overall Study|Other|4|||
161675859|NCT01830855|583867217|FG003|Overall Study|Other|4|||
161675860|NCT01830855|583867214|FG000|Overall Study|Medication error without associated AE|1|||
161675861|NCT01830855|583867215|FG001|Overall Study|Medication error without associated AE|0|||
161675862|NCT01830855|583867216|FG002|Overall Study|Medication error without associated AE|0|||
161675863|NCT01830855|583867217|FG003|Overall Study|Medication error without associated AE|1|||
161675864|NCT01830855|583867214|FG000|Overall Study|Pregnancy|3|||
161820618|NCT02372006|584384604|FG001|Overall Study|Dose limiting toxicity|1|||
161820619|NCT02372006|584384605|FG002|Overall Study|Dose limiting toxicity|0|||
161820620|NCT02372006|584384603|FG000|Overall Study|Adverse Event|0|||
161820621|NCT02372006|584384604|FG001|Overall Study|Adverse Event|0|||
161820622|NCT02372006|584384605|FG002|Overall Study|Adverse Event|3|||
161820623|NCT02372006|584384603|FG000|Overall Study|Withdrawal by Subject|0|||
161820624|NCT02372006|584384604|FG001|Overall Study|Withdrawal by Subject|1|||
161675865|NCT01830855|583867215|FG001|Overall Study|Pregnancy|1|||
161675866|NCT01830855|583867216|FG002|Overall Study|Pregnancy|2|||
161675867|NCT01830855|583867217|FG003|Overall Study|Pregnancy|1|||
161675868|NCT01830855|583867214|FG000|Overall Study|No longer meets eligibility criteria|11|||
161675869|NCT01830855|583867215|FG001|Overall Study|No longer meets eligibility criteria|2|||
161675870|NCT01830855|583867216|FG002|Overall Study|No longer meets eligibility criteria|3|||
161675871|NCT01830855|583867217|FG003|Overall Study|No longer meets eligibility criteria|5|||
161675872|NCT01830855|583867214|FG000|Overall Study|Adverse Event|11|||
161675873|NCT01830855|583867215|FG001|Overall Study|Adverse Event|5|||
161675874|NCT01830855|583867216|FG002|Overall Study|Adverse Event|6|||
161820625|NCT02372006|584384605|FG002|Overall Study|Withdrawal by Subject|1|||
161820626|NCT02372006|584384603|FG000|Overall Study|Other reason for not completing|0|||
161820627|NCT02372006|584384604|FG001|Overall Study|Other reason for not completing|0|||
161820628|NCT02372006|584384605|FG002|Overall Study|Other reason for not completing|1|||
161820629|NCT03504085|584384606|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
161820630|NCT03504085|584384607|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
161820631|NCT03504085|584384606|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
161820632|NCT03504085|584384607|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
161820633|NCT04133311|584384609|FG000|Period 1 Double Masked Treatment Period|Death|1|||
161820634|NCT04133311|584384610|FG001|Period 1 Double Masked Treatment Period|Death|0|||
162196889|NCT01730118|585770677|FG001|Dose Escalation|Died before treatment|0|||
162196890|NCT01730118|585770678|FG002|Dose Escalation|Died before treatment|0|||
162196891|NCT01730118|585770679|FG003|Dose Escalation|Died before treatment|0|||
162196892|NCT01730118|585770680|FG004|Dose Escalation|Died before treatment|0|||
161820635|NCT04133311|584384611|FG002|Period 1 Double Masked Treatment Period|Death|0|||
162196893|NCT01730118|585770681|FG005|Dose Escalation|Died before treatment|0|||
162196894|NCT01730118|585770682|FG006|Dose Escalation|Died before treatment|1|||
162196895|NCT01730118|585770676|FG000|Dose Escalation|Chose to start a different treatment|1|||
162196896|NCT01730118|585770677|FG001|Dose Escalation|Chose to start a different treatment|0|||
162196897|NCT01730118|585770678|FG002|Dose Escalation|Chose to start a different treatment|0|||
162196898|NCT01730118|585770679|FG003|Dose Escalation|Chose to start a different treatment|0|||
162196899|NCT01730118|585770680|FG004|Dose Escalation|Chose to start a different treatment|0|||
162196900|NCT01730118|585770681|FG005|Dose Escalation|Chose to start a different treatment|0|||
162196901|NCT01730118|585770682|FG006|Dose Escalation|Chose to start a different treatment|0|||
162196902|NCT01730118|585770676|FG000|Dose Escalation|Withdrawal by Subject|0|||
162196903|NCT01730118|585770677|FG001|Dose Escalation|Withdrawal by Subject|0|||
162196904|NCT01730118|585770678|FG002|Dose Escalation|Withdrawal by Subject|1|||
162196905|NCT01730118|585770679|FG003|Dose Escalation|Withdrawal by Subject|0|||
162196906|NCT01730118|585770680|FG004|Dose Escalation|Withdrawal by Subject|0|||
162196907|NCT01730118|585770681|FG005|Dose Escalation|Withdrawal by Subject|0|||
162196908|NCT01730118|585770682|FG006|Dose Escalation|Withdrawal by Subject|0|||
162196909|NCT01730118|585770676|FG000|Dose Escalation|Disease progression prior to treatment|0|||
162196910|NCT01730118|585770677|FG001|Dose Escalation|Disease progression prior to treatment|0|||
162196911|NCT01730118|585770678|FG002|Dose Escalation|Disease progression prior to treatment|0|||
162196912|NCT01730118|585770679|FG003|Dose Escalation|Disease progression prior to treatment|0|||
162196913|NCT01730118|585770680|FG004|Dose Escalation|Disease progression prior to treatment|0|||
162196914|NCT01730118|585770681|FG005|Dose Escalation|Disease progression prior to treatment|0|||
162196915|NCT01730118|585770682|FG006|Dose Escalation|Disease progression prior to treatment|1|||
162196916|NCT01730118|585770676|FG000|Dose Expansion|Death|0|||
162196917|NCT01730118|585770677|FG001|Dose Expansion|Death|0|||
162196918|NCT01730118|585770678|FG002|Dose Expansion|Death|0|||
162196919|NCT01730118|585770679|FG003|Dose Expansion|Death|0|||
162196920|NCT01730118|585770680|FG004|Dose Expansion|Death|1|||
162196921|NCT01730118|585770681|FG005|Dose Expansion|Death|0|||
162196922|NCT01730118|585770682|FG006|Dose Expansion|Death|0|||
162196923|NCT01730118|585770676|FG000|Dose Expansion|Other medical condition|0|||
162196924|NCT01730118|585770677|FG001|Dose Expansion|Other medical condition|0|||
162196925|NCT01730118|585770678|FG002|Dose Expansion|Other medical condition|0|||
162196926|NCT01730118|585770679|FG003|Dose Expansion|Other medical condition|0|||
162196927|NCT01730118|585770680|FG004|Dose Expansion|Other medical condition|1|||
162196928|NCT01730118|585770681|FG005|Dose Expansion|Other medical condition|0|||
162196929|NCT01730118|585770682|FG006|Dose Expansion|Other medical condition|0|||
162196930|NCT01730118|585770676|FG000|Dose Expansion|Withdrawal by Subject|0|||
162196931|NCT01730118|585770677|FG001|Dose Expansion|Withdrawal by Subject|0|||
162196932|NCT01730118|585770678|FG002|Dose Expansion|Withdrawal by Subject|0|||
162196933|NCT01730118|585770679|FG003|Dose Expansion|Withdrawal by Subject|0|||
162196934|NCT01730118|585770680|FG004|Dose Expansion|Withdrawal by Subject|1|||
162196935|NCT01730118|585770681|FG005|Dose Expansion|Withdrawal by Subject|0|||
162196936|NCT01730118|585770682|FG006|Dose Expansion|Withdrawal by Subject|0|||
162196937|NCT01730118|585770676|FG000|Dose Expansion|Disease progression|0|||
161820636|NCT04133311|584384612|FG003|Period 1 Double Masked Treatment Period|Death|0|||
162196938|NCT01730118|585770677|FG001|Dose Expansion|Disease progression|0|||
162196939|NCT01730118|585770678|FG002|Dose Expansion|Disease progression|0|||
162196940|NCT01730118|585770679|FG003|Dose Expansion|Disease progression|0|||
161820637|NCT04133311|584384609|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
161820638|NCT04133311|584384610|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
161820639|NCT04133311|584384611|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
161820640|NCT04133311|584384612|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
161820641|NCT04133311|584384609|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
161820642|NCT04133311|584384610|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
161820643|NCT04133311|584384611|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
161820644|NCT04133311|584384612|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
162196941|NCT01730118|585770680|FG004|Dose Expansion|Disease progression|0|||
162196942|NCT01730118|585770681|FG005|Dose Expansion|Disease progression|1|||
162196943|NCT01730118|585770682|FG006|Dose Expansion|Disease progression|0|||
162196944|NCT01730118|585770676|FG000|Dose Expansion|Inability to return|0|||
162196945|NCT01730118|585770677|FG001|Dose Expansion|Inability to return|0|||
162196946|NCT01730118|585770678|FG002|Dose Expansion|Inability to return|0|||
162196947|NCT01730118|585770679|FG003|Dose Expansion|Inability to return|0|||
162196948|NCT01730118|585770680|FG004|Dose Expansion|Inability to return|0|||
162196949|NCT01730118|585770681|FG005|Dose Expansion|Inability to return|1|||
162196950|NCT01730118|585770682|FG006|Dose Expansion|Inability to return|0|||
162196951|NCT01730118|585770676|FG000|Dose Expansion|Physician Decision|0|||
162196952|NCT01730118|585770677|FG001|Dose Expansion|Physician Decision|0|||
162196953|NCT01730118|585770678|FG002|Dose Expansion|Physician Decision|0|||
162196954|NCT01730118|585770679|FG003|Dose Expansion|Physician Decision|0|||
162196955|NCT01730118|585770680|FG004|Dose Expansion|Physician Decision|0|||
162196956|NCT01730118|585770681|FG005|Dose Expansion|Physician Decision|1|||
162196957|NCT01730118|585770682|FG006|Dose Expansion|Physician Decision|0|||
162196958|NCT02880293|585770685|FG000|Overall Study|Inevaluable|5|||
162196959|NCT02101554|585770688|FG000|Overall Study|Protocol Violation|0|||
162196960|NCT02101554|585770689|FG001|Overall Study|Protocol Violation|1|||
162196961|NCT02101554|585770690|FG002|Overall Study|Protocol Violation|0|||
162196962|NCT02101554|585770688|FG000|Overall Study|Insufficient Clinical Response|0|||
162196963|NCT02101554|585770689|FG001|Overall Study|Insufficient Clinical Response|2|||
162196964|NCT02101554|585770690|FG002|Overall Study|Insufficient Clinical Response|0|||
162196965|NCT02101554|585770688|FG000|Overall Study|Adverse Event|2|||
162196966|NCT02101554|585770689|FG001|Overall Study|Adverse Event|1|||
162196967|NCT02101554|585770690|FG002|Overall Study|Adverse Event|1|||
162196968|NCT02101554|585770688|FG000|Overall Study|Lost to Follow-up|0|||
162196969|NCT02101554|585770689|FG001|Overall Study|Lost to Follow-up|1|||
162196970|NCT02101554|585770690|FG002|Overall Study|Lost to Follow-up|0|||
162196971|NCT02101554|585770688|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
162196972|NCT02101554|585770689|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
162196973|NCT02101554|585770690|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
162196974|NCT04049578|585770692|FG000|Overall Study|Physician Decision|1|||
162196975|NCT00668746|585770693|FG000|Overall Study|Lost to Follow-up|2|||
162196976|NCT00668746|585770694|FG001|Overall Study|Lost to Follow-up|1|||
162196977|NCT03409276|585770695|FG000|Overall Study|Withdrawal by Subject|0|||
162196978|NCT03409276|585770696|FG001|Overall Study|Withdrawal by Subject|0|||
162196979|NCT03409276|585770697|FG002|Overall Study|Withdrawal by Subject|0|||
162196980|NCT03409276|585770698|FG003|Overall Study|Withdrawal by Subject|0|||
162196981|NCT03409276|585770699|FG004|Overall Study|Withdrawal by Subject|1|||
162196982|NCT03409276|585770695|FG000|Overall Study|Lost to Follow-up|0|||
162196983|NCT03409276|585770696|FG001|Overall Study|Lost to Follow-up|0|||
162196984|NCT03409276|585770697|FG002|Overall Study|Lost to Follow-up|0|||
162196985|NCT03409276|585770698|FG003|Overall Study|Lost to Follow-up|2|||
162196986|NCT03409276|585770699|FG004|Overall Study|Lost to Follow-up|2|||
162196987|NCT05361304|585770709|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
162196988|NCT05361304|585770710|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
162196989|NCT05361304|585770709|FG000|Overall Study|COVID-19 Related|1|||
162196990|NCT05361304|585770710|FG001|Overall Study|COVID-19 Related|2|||
162196991|NCT05361304|585770709|FG000|Overall Study|Withdrawal by Subject|1|||
162196992|NCT05361304|585770710|FG001|Overall Study|Withdrawal by Subject|0|||
162196993|NCT03320941|585770711|FG000|Overall Study|subject/guardian decision|0|||
162196994|NCT03320941|585770712|FG001|Overall Study|subject/guardian decision|0|||
162196995|NCT03320941|585770713|FG002|Overall Study|subject/guardian decision|0|||
162196996|NCT03320941|585770714|FG003|Overall Study|subject/guardian decision|1|||
162196997|NCT03320941|585770715|FG004|Overall Study|subject/guardian decision|0|||
162196998|NCT02368691|585770717|FG000|Overall Study|Death|13|||
162196999|NCT02368691|585770717|FG000|Overall Study|Lack of Efficacy|15|||
162197000|NCT02368691|585770717|FG000|Overall Study|Physician Decision|4|||
162197001|NCT03314233|585770718|FG000|Overall Study|No longer eligible at time of delivery|1|||
162197002|NCT01797705|585770719|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
162197003|NCT01797705|585770719|FG000|Overall Study|Withdrawal by Subject|1|||
162197004|NCT01838447|585770720|FG000|Overall Study|Change in surgical plan|1|||
162197005|NCT01838447|585770721|FG001|Overall Study|Change in surgical plan|2|||
162197006|NCT01838447|585770720|FG000|Overall Study|Withdrawal by Subject|1|||
162197007|NCT01838447|585770721|FG001|Overall Study|Withdrawal by Subject|1|||
162197008|NCT01114217|585770723|FG000|Overall Study|Adverse Event|5|||
162197009|NCT01114217|585770724|FG001|Overall Study|Adverse Event|3|||
162197010|NCT01114217|585770723|FG000|Overall Study|Lost to Follow-up|17|||
162197011|NCT01114217|585770724|FG001|Overall Study|Lost to Follow-up|33|||
162197012|NCT01114217|585770723|FG000|Overall Study|Withdrawal by Subject|21|||
162197013|NCT01114217|585770724|FG001|Overall Study|Withdrawal by Subject|28|||
162197014|NCT01114217|585770723|FG000|Overall Study|Other-Clerical Error|3|||
162197015|NCT01114217|585770724|FG001|Overall Study|Other-Clerical Error|0|||
162197016|NCT01114217|585770723|FG000|Overall Study|Other-Early termination|6|||
162197017|NCT01114217|585770724|FG001|Overall Study|Other-Early termination|10|||
162197018|NCT01114217|585770723|FG000|Overall Study|Other-Procedure|1|||
162197019|NCT01114217|585770724|FG001|Overall Study|Other-Procedure|1|||
161675875|NCT01830855|583867217|FG003|Overall Study|Adverse Event|3|||
162197020|NCT01114217|585770723|FG000|Overall Study|Other-Pregnancy|2|||
162197021|NCT01114217|585770724|FG001|Overall Study|Other-Pregnancy|4|||
161675876|NCT01830855|583867214|FG000|Overall Study|Protocol deviation|10|||
161675877|NCT01830855|583867215|FG001|Overall Study|Protocol deviation|5|||
161675878|NCT01830855|583867216|FG002|Overall Study|Protocol deviation|6|||
161675879|NCT01830855|583867217|FG003|Overall Study|Protocol deviation|6|||
161675880|NCT01830855|583867214|FG000|Overall Study|Withdrawal by Subject|33|||
161675881|NCT01830855|583867215|FG001|Overall Study|Withdrawal by Subject|14|||
161675882|NCT01830855|583867216|FG002|Overall Study|Withdrawal by Subject|10|||
161675883|NCT01830855|583867217|FG003|Overall Study|Withdrawal by Subject|12|||
161675884|NCT01830855|583867214|FG000|Overall Study|No longer willing to participate|32|||
161675885|NCT01830855|583867215|FG001|Overall Study|No longer willing to participate|13|||
161675886|NCT01830855|583867216|FG002|Overall Study|No longer willing to participate|12|||
161675887|NCT01830855|583867217|FG003|Overall Study|No longer willing to participate|17|||
161675888|NCT01830855|583867214|FG000|Overall Study|Lost to Follow-up|47|||
161675889|NCT01830855|583867215|FG001|Overall Study|Lost to Follow-up|20|||
161675890|NCT01830855|583867216|FG002|Overall Study|Lost to Follow-up|23|||
161675891|NCT01830855|583867217|FG003|Overall Study|Lost to Follow-up|33|||
161675892|NCT00295633|583867219|FG000|Overall Study|Lack of Efficacy|19|||
161675893|NCT00295633|583867220|FG001|Overall Study|Lack of Efficacy|7|||
161675894|NCT00295633|583867221|FG002|Overall Study|Lack of Efficacy|16|||
162197022|NCT01114217|585770723|FG000|Overall Study|Other-Protocol Violation|1|||
162197023|NCT01114217|585770724|FG001|Overall Study|Other-Protocol Violation|3|||
162197024|NCT01114217|585770723|FG000|Overall Study|Other-Lack of Efficacy|1|||
162197025|NCT01114217|585770724|FG001|Overall Study|Other-Lack of Efficacy|0|||
162197026|NCT01114217|585770723|FG000|Overall Study|Other-Non Compliance|2|||
162197027|NCT01114217|585770724|FG001|Overall Study|Other-Non Compliance|0|||
162197028|NCT01114217|585770723|FG000|Overall Study|Other-Physician Decision|1|||
162197029|NCT01114217|585770724|FG001|Overall Study|Other-Physician Decision|1|||
162197030|NCT01114217|585770723|FG000|Overall Study|Other-Sponsor Decision|10|||
162197031|NCT01114217|585770724|FG001|Overall Study|Other-Sponsor Decision|12|||
162197032|NCT01114217|585770723|FG000|Overall Study|Other-Study Termination|0|||
162197033|NCT01114217|585770724|FG001|Overall Study|Other-Study Termination|1|||
162197034|NCT01114217|585770723|FG000|Overall Study|Other-Study Withdrawn|1|||
162197035|NCT01114217|585770724|FG001|Overall Study|Other-Study Withdrawn|1|||
162197036|NCT01114217|585770723|FG000|Overall Study|Other-Site Stopped Communicating|2|||
162197037|NCT01114217|585770724|FG001|Overall Study|Other-Site Stopped Communicating|0|||
162197038|NCT01114217|585770723|FG000|Overall Study|Other-Lost to Follow-up|1|||
162197039|NCT01114217|585770724|FG001|Overall Study|Other-Lost to Follow-up|0|||
162197040|NCT01114217|585770723|FG000|Overall Study|Other-Withdrawal by Subject|1|||
162197041|NCT01114217|585770724|FG001|Overall Study|Other-Withdrawal by Subject|1|||
162197042|NCT01837719|585770725|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
162197043|NCT01837719|585770725|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
162197044|NCT01703988|585770726|FG000|Overall Study|Investigator Judgment|0|||
162197045|NCT01703988|585770727|FG001|Overall Study|Investigator Judgment|0|||
162197046|NCT01703988|585770728|FG002|Overall Study|Investigator Judgment|0|||
162197047|NCT01703988|585770729|FG003|Overall Study|Investigator Judgment|1|||
162197048|NCT06247488|585770730|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
162197049|NCT06247488|585770731|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
162197050|NCT06247488|585770732|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
162197051|NCT06247488|585770733|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
162197052|NCT06247488|585770734|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
162197053|NCT06247488|585770735|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
162197054|NCT06247488|585770730|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
162197055|NCT06247488|585770731|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
162197056|NCT06247488|585770732|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
162197057|NCT06247488|585770733|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
162197058|NCT06247488|585770734|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
162197059|NCT06247488|585770735|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
161675895|NCT00295633|583867219|FG000|Overall Study|Withdrawal of consent by subject|16|||
161675896|NCT00295633|583867220|FG001|Overall Study|Withdrawal of consent by subject|16|||
161675897|NCT00295633|583867221|FG002|Overall Study|Withdrawal of consent by subject|26|||
161675898|NCT00295633|583867219|FG000|Overall Study|Adverse Event|9|||
161675899|NCT00295633|583867220|FG001|Overall Study|Adverse Event|17|||
161675900|NCT00295633|583867221|FG002|Overall Study|Adverse Event|9|||
162197060|NCT06247488|585770730|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
162197061|NCT06247488|585770731|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161675901|NCT00295633|583867219|FG000|Overall Study|Lost to Follow-up|6|||
162197062|NCT06247488|585770732|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161675902|NCT00295633|583867220|FG001|Overall Study|Lost to Follow-up|11|||
161675903|NCT00295633|583867221|FG002|Overall Study|Lost to Follow-up|7|||
162197063|NCT06247488|585770733|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
162197064|NCT06247488|585770734|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161675904|NCT00295633|583867219|FG000|Overall Study|Physician Decision|9|||
161675905|NCT00295633|583867220|FG001|Overall Study|Physician Decision|10|||
161675906|NCT00295633|583867221|FG002|Overall Study|Physician Decision|8|||
161675907|NCT00295633|583867219|FG000|Overall Study|Poor/Noncompliance|2|||
161675908|NCT00295633|583867220|FG001|Overall Study|Poor/Noncompliance|2|||
161675909|NCT00295633|583867221|FG002|Overall Study|Poor/Noncompliance|6|||
161675910|NCT00295633|583867219|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
161675911|NCT00295633|583867220|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
161675912|NCT00295633|583867221|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
161675913|NCT00295633|583867219|FG000|Overall Study|Death|1|||
161675914|NCT00295633|583867220|FG001|Overall Study|Death|1|||
161675915|NCT00295633|583867221|FG002|Overall Study|Death|0|||
161675916|NCT00295633|583867219|FG000|Overall Study|Administrative reason by sponsor|0|||
161675917|NCT00295633|583867220|FG001|Overall Study|Administrative reason by sponsor|0|||
161675918|NCT00295633|583867221|FG002|Overall Study|Administrative reason by sponsor|1|||
161675919|NCT01950247|583867222|FG000|Overall Study|Withdrawal by Subject|28|||
161675920|NCT01950247|583867223|FG001|Overall Study|Withdrawal by Subject|13|||
161675921|NCT01950247|583867222|FG000|Overall Study|Lost to Follow-up|18|||
161675922|NCT01950247|583867223|FG001|Overall Study|Lost to Follow-up|16|||
161675923|NCT01950247|583867222|FG000|Overall Study|Physician Decision|3|||
161675924|NCT01950247|583867223|FG001|Overall Study|Physician Decision|4|||
162197065|NCT06247488|585770735|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
162197066|NCT06247488|585770730|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
162197067|NCT06247488|585770731|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
162197068|NCT06247488|585770732|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
162197069|NCT06247488|585770733|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
162197070|NCT06247488|585770734|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
162197071|NCT06247488|585770735|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
162197072|NCT06247488|585770730|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
162197073|NCT06247488|585770731|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
161675925|NCT01950247|583867222|FG000|Overall Study|Adverse Event|3|||
161675926|NCT01950247|583867223|FG001|Overall Study|Adverse Event|2|||
161675927|NCT01950247|583867222|FG000|Overall Study|Death|1|||
161675928|NCT01950247|583867223|FG001|Overall Study|Death|1|||
161675929|NCT01950247|583867222|FG000|Overall Study|Not Defined|4|||
161675930|NCT01950247|583867223|FG001|Overall Study|Not Defined|10|||
161675931|NCT00763971|583867226|FG000|Overall Study|Adverse Event|5|||
161675932|NCT00763971|583867227|FG001|Overall Study|Adverse Event|2|||
161675933|NCT00763971|583867228|FG002|Overall Study|Adverse Event|4|||
161675934|NCT00763971|583867226|FG000|Overall Study|Protocol Violation|3|||
161675935|NCT00763971|583867227|FG001|Overall Study|Protocol Violation|3|||
161675936|NCT00763971|583867228|FG002|Overall Study|Protocol Violation|2|||
161675937|NCT00763971|583867226|FG000|Overall Study|Withdrawal by Subject|4|||
161675938|NCT00763971|583867227|FG001|Overall Study|Withdrawal by Subject|5|||
161675939|NCT00763971|583867228|FG002|Overall Study|Withdrawal by Subject|5|||
161675940|NCT00763971|583867226|FG000|Overall Study|Lost to Follow-up|0|||
161675941|NCT00763971|583867227|FG001|Overall Study|Lost to Follow-up|1|||
161675942|NCT00763971|583867228|FG002|Overall Study|Lost to Follow-up|0|||
161675943|NCT00763971|583867226|FG000|Overall Study|Lack of Efficacy|11|||
161675944|NCT00763971|583867227|FG001|Overall Study|Lack of Efficacy|22|||
161675945|NCT00763971|583867228|FG002|Overall Study|Lack of Efficacy|54|||
161675946|NCT00763971|583867226|FG000|Overall Study|Unable to swallow capsule|2|||
162197074|NCT06247488|585770732|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
162197075|NCT06247488|585770733|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
162197076|NCT06247488|585770734|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
161675947|NCT00763971|583867227|FG001|Overall Study|Unable to swallow capsule|1|||
162197077|NCT06247488|585770735|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
162197078|NCT06247488|585770730|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
162197079|NCT06247488|585770731|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
162197080|NCT06247488|585770732|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
162197081|NCT06247488|585770733|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
162197082|NCT06247488|585770734|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
162197083|NCT06247488|585770735|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
161675948|NCT00763971|583867228|FG002|Overall Study|Unable to swallow capsule|1|||
161675949|NCT00763971|583867226|FG000|Overall Study|Personal reason|3|||
161675950|NCT00763971|583867227|FG001|Overall Study|Personal reason|0|||
161675951|NCT00763971|583867228|FG002|Overall Study|Personal reason|0|||
161675952|NCT00763971|583867226|FG000|Overall Study|Exclusion criteria met|1|||
161675953|NCT00763971|583867227|FG001|Overall Study|Exclusion criteria met|0|||
161675954|NCT00763971|583867228|FG002|Overall Study|Exclusion criteria met|0|||
161675955|NCT00763971|583867226|FG000|Overall Study|Sponsor decision|1|||
161675956|NCT00763971|583867227|FG001|Overall Study|Sponsor decision|0|||
161820645|NCT04133311|584384609|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
162197084|NCT06247488|585770730|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
162197085|NCT06247488|585770731|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
161675957|NCT00763971|583867228|FG002|Overall Study|Sponsor decision|0|||
162020505|NCT00545272|585130496|FG003|Overall Study|Adverse Event|0|||
161675958|NCT00763971|583867226|FG000|Overall Study|Due to holiday season|2|||
161675959|NCT00763971|583867227|FG001|Overall Study|Due to holiday season|0|||
161675960|NCT00763971|583867228|FG002|Overall Study|Due to holiday season|1|||
161675961|NCT00763971|583867226|FG000|Overall Study|Randomization error|0|||
161675962|NCT00763971|583867227|FG001|Overall Study|Randomization error|0|||
161675963|NCT00763971|583867228|FG002|Overall Study|Randomization error|1|||
161675964|NCT00763971|583867226|FG000|Overall Study|Medical monitor decision|0|||
161675965|NCT00763971|583867227|FG001|Overall Study|Medical monitor decision|0|||
161820646|NCT04133311|584384610|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
161820647|NCT04133311|584384611|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
162197086|NCT06247488|585770732|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
162197087|NCT06247488|585770733|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
162197088|NCT06247488|585770734|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
162197089|NCT06247488|585770735|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
162197090|NCT00584909|585770741|FG000|Overall Study|Adverse Event|4|||
162197091|NCT03436797|585770742|FG000|Main Study|Withdrawal by Subject|2|||
162197092|NCT03436797|585770742|FG000|Main Study|Adverse Event|4|||
162197093|NCT03436797|585770742|FG000|Main Study|Lost to Follow-up|1|||
162197094|NCT03436797|585770742|FG000|Main Study|Death|1|||
162197095|NCT03436797|585770742|FG000|Main Study|Non-Specific|2|||
162197096|NCT03436797|585770742|FG000|Extended Dosing|Patient decision|1|||
162197097|NCT04739306|585770743|FG000|Main Study Period|Adverse Event|6|||
162197098|NCT04739306|585770744|FG001|Main Study Period|Adverse Event|7|||
161675966|NCT00763971|583867228|FG002|Overall Study|Medical monitor decision|1|||
162197099|NCT04739306|585770743|FG000|Main Study Period|Lost to Follow-up|4|||
162197100|NCT04739306|585770744|FG001|Main Study Period|Lost to Follow-up|6|||
162197101|NCT04739306|585770743|FG000|Main Study Period|Physician Decision|1|||
162197102|NCT04739306|585770744|FG001|Main Study Period|Physician Decision|1|||
162197103|NCT04739306|585770743|FG000|Main Study Period|Withdrawal by Subject|8|||
162197104|NCT04739306|585770744|FG001|Main Study Period|Withdrawal by Subject|6|||
162197105|NCT04739306|585770743|FG000|Main Study Period|Protocol Violation|0|||
162197106|NCT04739306|585770744|FG001|Main Study Period|Protocol Violation|1|||
162197107|NCT04739306|585770743|FG000|Main Study Period|War in Ukraine|1|||
162197108|NCT04739306|585770744|FG001|Main Study Period|War in Ukraine|1|||
162197109|NCT04175392|585770747|FG000|Overall Study|Withdrawal by Subject|3|||
162197110|NCT04175392|585770748|FG001|Overall Study|Withdrawal by Subject|2|||
162197111|NCT01103141|585770749|FG000|Overall Study|Death|0|||
162197112|NCT01103141|585770750|FG001|Overall Study|Death|1|||
162197113|NCT01103141|585770749|FG000|Overall Study|Lost to Follow-up|2|||
162197114|NCT01103141|585770750|FG001|Overall Study|Lost to Follow-up|1|||
162197115|NCT05072795|585770751|FG000|Overall Study|Lost to Follow-up|5|||
162197116|NCT00422162|585770755|FG000|Overall Study|Adverse Event|11|||
162197117|NCT00422162|585770756|FG001|Overall Study|Adverse Event|9|||
162197118|NCT00422162|585770755|FG000|Overall Study|Lack of Efficacy|4|||
162197119|NCT00422162|585770756|FG001|Overall Study|Lack of Efficacy|10|||
162197120|NCT00422162|585770755|FG000|Overall Study|Withdrawal by Subject|7|||
162197121|NCT00422162|585770756|FG001|Overall Study|Withdrawal by Subject|6|||
162197122|NCT00422162|585770755|FG000|Overall Study|Lost to Follow-up|1|||
162197123|NCT00422162|585770756|FG001|Overall Study|Lost to Follow-up|2|||
162197124|NCT00422162|585770755|FG000|Overall Study|Non-Compliant with Protocol|1|||
162197125|NCT00422162|585770756|FG001|Overall Study|Non-Compliant with Protocol|1|||
162197126|NCT00422162|585770755|FG000|Overall Study|Other|0|||
162197127|NCT00422162|585770756|FG001|Overall Study|Other|1|||
162197128|NCT00422162|585770755|FG000|Overall Study|Didn't Receive Treatment|0|||
162197129|NCT00422162|585770756|FG001|Overall Study|Didn't Receive Treatment|1|||
162197130|NCT05274906|585770757|FG000|Overall Study|Withdrawal by Subject|2|||
162197131|NCT05274906|585770758|FG001|Overall Study|Withdrawal by Subject|1|||
162197132|NCT00848198|585770759|FG000|Overall Study|Incomplete Case Report Forms|15|||
162197133|NCT02062827|585770763|FG000|Overall Study|Death|1|||
162197134|NCT02062827|585770764|FG001|Overall Study|Death|0|||
162197135|NCT02062827|585770765|FG002|Overall Study|Death|0|||
162197136|NCT02062827|585770766|FG003|Overall Study|Death|0|||
162197137|NCT02062827|585770767|FG004|Overall Study|Death|0|||
162197138|NCT02062827|585770768|FG005|Overall Study|Death|0|||
162197139|NCT02062827|585770769|FG006|Overall Study|Death|0|||
162197140|NCT02062827|585770770|FG007|Overall Study|Death|0|||
162197141|NCT02062827|585770763|FG000|Overall Study|Withdrawal by Subject|3|||
162197142|NCT02062827|585770764|FG001|Overall Study|Withdrawal by Subject|1|||
162197143|NCT02062827|585770765|FG002|Overall Study|Withdrawal by Subject|1|||
162197144|NCT02062827|585770766|FG003|Overall Study|Withdrawal by Subject|2|||
162197145|NCT02062827|585770767|FG004|Overall Study|Withdrawal by Subject|6|||
162197146|NCT02062827|585770768|FG005|Overall Study|Withdrawal by Subject|0|||
162197147|NCT02062827|585770769|FG006|Overall Study|Withdrawal by Subject|5|||
162197148|NCT02062827|585770770|FG007|Overall Study|Withdrawal by Subject|0|||
162197149|NCT02062827|585770763|FG000|Overall Study|Screen Fail|0|||
162197150|NCT02062827|585770764|FG001|Overall Study|Screen Fail|0|||
162197151|NCT02062827|585770765|FG002|Overall Study|Screen Fail|0|||
161675967|NCT00763971|583867226|FG000|Overall Study|Moved to another country|0|||
161675968|NCT00763971|583867227|FG001|Overall Study|Moved to another country|1|||
161675969|NCT00763971|583867228|FG002|Overall Study|Moved to another country|0|||
162197152|NCT02062827|585770766|FG003|Overall Study|Screen Fail|0|||
162197153|NCT02062827|585770767|FG004|Overall Study|Screen Fail|0|||
162197154|NCT02062827|585770768|FG005|Overall Study|Screen Fail|0|||
161675970|NCT00763971|583867226|FG000|Overall Study|Subject wanted dose reduction|0|||
162197155|NCT02062827|585770769|FG006|Overall Study|Screen Fail|0|||
162197156|NCT02062827|585770770|FG007|Overall Study|Screen Fail|8|||
162197157|NCT04930263|585770771|FG000|Overall Study|Withdrawal by Subject|3|||
162197158|NCT04930263|585770772|FG001|Overall Study|Withdrawal by Subject|5|||
161675971|NCT00763971|583867227|FG001|Overall Study|Subject wanted dose reduction|1|||
162197159|NCT02812706|585770774|FG000|Phase 1|Adverse Event|0|||
162197160|NCT02812706|585770775|FG001|Phase 1|Adverse Event|2|||
162197161|NCT02812706|585770776|FG002|Phase 1|Adverse Event|0|||
162197162|NCT02812706|585770774|FG000|Phase 1|Progressive disease|3|||
162197163|NCT02812706|585770775|FG001|Phase 1|Progressive disease|3|||
162197164|NCT02812706|585770776|FG002|Phase 1|Progressive disease|0|||
162197165|NCT02812706|585770774|FG000|Phase 2|Adverse Event|0|||
162197166|NCT02812706|585770775|FG001|Phase 2|Adverse Event|0|||
162197167|NCT02812706|585770776|FG002|Phase 2|Adverse Event|2|||
162197168|NCT02812706|585770774|FG000|Phase 2|Progressive disease|0|||
162197169|NCT02812706|585770775|FG001|Phase 2|Progressive disease|0|||
162197170|NCT02812706|585770776|FG002|Phase 2|Progressive disease|22|||
162197171|NCT02812706|585770774|FG000|Phase 2|Other-Unspecified|0|||
162197172|NCT02812706|585770775|FG001|Phase 2|Other-Unspecified|0|||
162197173|NCT02812706|585770776|FG002|Phase 2|Other-Unspecified|4|||
161820648|NCT04133311|584384612|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
161820649|NCT04133311|584384609|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
161820650|NCT04133311|584384610|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
161820651|NCT04133311|584384611|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
162197174|NCT02213458|585770777|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
162197175|NCT02213458|585770778|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
162197176|NCT02213458|585770777|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
162197177|NCT02213458|585770778|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
162197178|NCT02213458|585770777|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
162197179|NCT02213458|585770778|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
162197180|NCT02213458|585770777|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
162197181|NCT02213458|585770778|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
162197182|NCT02213458|585770777|FG000|Overall Study|Refused re-consent|6|||
162197183|NCT02213458|585770778|FG001|Overall Study|Refused re-consent|0|||
162197184|NCT02213458|585770777|FG000|Overall Study|Lost to Follow-up|2|||
162197185|NCT02213458|585770778|FG001|Overall Study|Lost to Follow-up|2|||
162197186|NCT02213458|585770777|FG000|Overall Study|Withdrawal by Subject|26|||
162197187|NCT02213458|585770778|FG001|Overall Study|Withdrawal by Subject|8|||
162197188|NCT01622088|585770779|FG000|Overall Study|Adverse Event|20|||
162197189|NCT01622088|585770779|FG000|Overall Study|Lost to Follow-up|1|||
162197190|NCT01622088|585770779|FG000|Overall Study|Withdrawal by Subject|20|||
162197191|NCT01622088|585770779|FG000|Overall Study|Investigator Decision|1|||
162197192|NCT01622088|585770779|FG000|Overall Study|Death|53|||
162197193|NCT01622088|585770779|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
162197194|NCT02971683|585770780|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
162197195|NCT02971683|585770781|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
162197196|NCT02971683|585770780|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
162197197|NCT02971683|585770781|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
162197198|NCT02971683|585770780|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
162197199|NCT02971683|585770781|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
162197200|NCT02971683|585770780|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
162197201|NCT02971683|585770781|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
162197202|NCT02971683|585770780|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
162197203|NCT02971683|585770781|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
162197204|NCT02971683|585770780|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
162197205|NCT02971683|585770781|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
162197206|NCT02971683|585770780|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
162197207|NCT02971683|585770781|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
162197208|NCT02971683|585770780|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
162197209|NCT02971683|585770781|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
162197210|NCT02971683|585770780|FG000|Open-Label|Lost to Follow-up|1|||
162197211|NCT02971683|585770781|FG001|Open-Label|Lost to Follow-up|0|||
162197212|NCT02971683|585770780|FG000|Open-Label|Participants withdrew consent|0|||
162197213|NCT02971683|585770781|FG001|Open-Label|Participants withdrew consent|2|||
162197214|NCT02971683|585770780|FG000|Open-Label|Participant request to discontinue study treatment|1|||
161820652|NCT04133311|584384612|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
161820653|NCT04133311|584384609|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
161820654|NCT04133311|584384610|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
162197215|NCT02971683|585770781|FG001|Open-Label|Participant request to discontinue study treatment|0|||
162197216|NCT02971683|585770780|FG000|Open-Label|Lack of Efficacy|2|||
162197217|NCT02971683|585770781|FG001|Open-Label|Lack of Efficacy|0|||
162197218|NCT02971683|585770780|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
162197219|NCT02971683|585770781|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
162197220|NCT02971683|585770780|FG000|Long-Term Open Label|Participant withdrew consent|1|||
162197221|NCT02971683|585770781|FG001|Long-Term Open Label|Participant withdrew consent|0|||
162197222|NCT02971683|585770780|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
161675972|NCT00763971|583867228|FG002|Overall Study|Subject wanted dose reduction|0|||
162197223|NCT02971683|585770781|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
162197224|NCT02971683|585770780|FG000|Long-Term Open Label|Adverse Event|1|||
162197225|NCT02971683|585770781|FG001|Long-Term Open Label|Adverse Event|2|||
162197226|NCT02971683|585770780|FG000|Long-Term Open Label|Lack of Efficacy|1|||
162197227|NCT02971683|585770781|FG001|Long-Term Open Label|Lack of Efficacy|1|||
162197228|NCT01468597|585770784|FG000|Overall Study|Found ineligible|17|||
162197229|NCT01468597|585770784|FG000|Overall Study|concomitant valves|12|||
162197230|NCT01468597|585770784|FG000|Overall Study|off-pump CABG|1|||
162197231|NCT01468597|585770784|FG000|Overall Study|no platelet function data|5|||
162197232|NCT00912964|585770785|FG000|Overall Study|Eligibility criterion not met|1|||
162197233|NCT00912964|585770786|FG001|Overall Study|Eligibility criterion not met|1|||
162197234|NCT00912964|585770787|FG002|Overall Study|Eligibility criterion not met|0|||
162197235|NCT00912964|585770785|FG000|Overall Study|Adverse Event|15|||
162197236|NCT00912964|585770786|FG001|Overall Study|Adverse Event|18|||
162197237|NCT00912964|585770787|FG002|Overall Study|Adverse Event|12|||
162197238|NCT00912964|585770785|FG000|Overall Study|Lack of Efficacy|11|||
162197239|NCT00912964|585770786|FG001|Overall Study|Lack of Efficacy|4|||
162197240|NCT00912964|585770787|FG002|Overall Study|Lack of Efficacy|3|||
162197241|NCT00912964|585770785|FG000|Overall Study|Withdrawal by Subject|20|||
162197242|NCT00912964|585770786|FG001|Overall Study|Withdrawal by Subject|12|||
162197243|NCT00912964|585770787|FG002|Overall Study|Withdrawal by Subject|18|||
162197244|NCT00912964|585770785|FG000|Overall Study|Lost to Follow-up|4|||
162197245|NCT00912964|585770786|FG001|Overall Study|Lost to Follow-up|3|||
162197246|NCT00912964|585770787|FG002|Overall Study|Lost to Follow-up|3|||
162197247|NCT00912964|585770785|FG000|Overall Study|Protocol Violation|5|||
162197248|NCT00912964|585770786|FG001|Overall Study|Protocol Violation|3|||
162197249|NCT00912964|585770787|FG002|Overall Study|Protocol Violation|8|||
162197250|NCT00912964|585770785|FG000|Overall Study|Taking exclusionary medications|7|||
162197251|NCT00912964|585770786|FG001|Overall Study|Taking exclusionary medications|4|||
162197252|NCT00912964|585770787|FG002|Overall Study|Taking exclusionary medications|8|||
162197253|NCT00912964|585770785|FG000|Overall Study|Medical History|1|||
162197254|NCT00912964|585770786|FG001|Overall Study|Medical History|0|||
162197255|NCT00912964|585770787|FG002|Overall Study|Medical History|0|||
162197256|NCT00912964|585770785|FG000|Overall Study|Non-compliance with study procedures|2|||
162197257|NCT00912964|585770786|FG001|Overall Study|Non-compliance with study procedures|0|||
162197258|NCT00912964|585770787|FG002|Overall Study|Non-compliance with study procedures|0|||
162197259|NCT00912964|585770785|FG000|Overall Study|Violation of exclusion criterion|0|||
162197260|NCT00912964|585770786|FG001|Overall Study|Violation of exclusion criterion|0|||
162197261|NCT00912964|585770787|FG002|Overall Study|Violation of exclusion criterion|2|||
162197262|NCT00912964|585770785|FG000|Overall Study|Randomized but never received study drug|0|||
162197263|NCT00912964|585770786|FG001|Overall Study|Randomized but never received study drug|1|||
162197264|NCT00912964|585770787|FG002|Overall Study|Randomized but never received study drug|0|||
162197265|NCT04433091|585770793|FG000|Overall Study|Lost to Follow-up|1|||
162197266|NCT04433091|585770794|FG001|Overall Study|Lost to Follow-up|0|||
162197267|NCT04433091|585770793|FG000|Overall Study|Withdrawn .|2|||
162197268|NCT04433091|585770794|FG001|Overall Study|Withdrawn .|4|||
162197269|NCT00676195|585772149|FG000|Overall Study|Lost to Follow-up|1|||
162197270|NCT00676195|585772149|FG000|Overall Study|Adverse Event|1|||
162197271|NCT00676195|585772149|FG000|Overall Study|Physician Decision|1|||
162197272|NCT03978130|585772153|FG000|Overall Study|Lost to Follow-up|13|||
162197273|NCT03978130|585772154|FG001|Overall Study|Lost to Follow-up|14|||
162197274|NCT03978130|585772153|FG000|Overall Study|Withdrawal by Subject|12|||
162197275|NCT03978130|585772154|FG001|Overall Study|Withdrawal by Subject|2|||
162197276|NCT03978130|585772153|FG000|Overall Study|Adverse Event|2|||
162197277|NCT03978130|585772154|FG001|Overall Study|Adverse Event|1|||
162197278|NCT02069366|585772160|FG000|Overall Study|Lost to Follow-up|0|||
162197279|NCT02069366|585772161|FG001|Overall Study|Lost to Follow-up|0|||
162197280|NCT02069366|585772162|FG002|Overall Study|Lost to Follow-up|1|||
161675973|NCT00763971|583867226|FG000|Overall Study|Lack of availability|0|||
161675974|NCT00763971|583867227|FG001|Overall Study|Lack of availability|1|||
161675975|NCT00763971|583867228|FG002|Overall Study|Lack of availability|0|||
161675976|NCT00763971|583867226|FG000|Overall Study|Performed final visit on phone|0|||
161675977|NCT00763971|583867227|FG001|Overall Study|Performed final visit on phone|1|||
161675978|NCT00763971|583867228|FG002|Overall Study|Performed final visit on phone|0|||
162197281|NCT02069366|585772163|FG003|Overall Study|Lost to Follow-up|0|||
162197282|NCT02069366|585772164|FG004|Overall Study|Lost to Follow-up|0|||
162197283|NCT02069366|585772165|FG005|Overall Study|Lost to Follow-up|2|||
162197284|NCT02069366|585772160|FG000|Overall Study|Protocol Violation|0|||
162197285|NCT02069366|585772161|FG001|Overall Study|Protocol Violation|0|||
162197286|NCT02069366|585772162|FG002|Overall Study|Protocol Violation|1|||
161675979|NCT00763971|583867226|FG000|Overall Study|Participation in 489-326 required|1|||
161675980|NCT00763971|583867227|FG001|Overall Study|Participation in 489-326 required|0|||
162197287|NCT02069366|585772163|FG003|Overall Study|Protocol Violation|0|||
162197288|NCT02069366|585772164|FG004|Overall Study|Protocol Violation|0|||
162197289|NCT02069366|585772165|FG005|Overall Study|Protocol Violation|0|||
161675981|NCT00763971|583867228|FG002|Overall Study|Participation in 489-326 required|0|||
161675982|NCT02713542|583867233|FG000|Overall Study|Use of prohibited medication|14|||
161675983|NCT02713542|583867234|FG001|Overall Study|Use of prohibited medication|5|||
161675984|NCT02713542|583867233|FG000|Overall Study|Withdrawal by Subject|4|||
161675985|NCT02713542|583867234|FG001|Overall Study|Withdrawal by Subject|1|||
161675986|NCT03631667|583867235|FG000|Overall Study|Withdrawal by Subject|3|||
161675987|NCT01641237|583867236|FG000|Period II|Withdrawal by Subject|1|||
161675988|NCT01641237|583867237|FG001|Period II|Withdrawal by Subject|0|||
161675989|NCT01641237|583867238|FG002|Period II|Withdrawal by Subject|0|||
161675990|NCT01641237|583867239|FG003|Period II|Withdrawal by Subject|0|||
161675991|NCT01641237|583867236|FG000|Period III|Lost to Follow-up|1|||
161675992|NCT01641237|583867237|FG001|Period III|Lost to Follow-up|0|||
161675993|NCT01641237|583867238|FG002|Period III|Lost to Follow-up|0|||
161675994|NCT01641237|583867239|FG003|Period III|Lost to Follow-up|0|||
161675995|NCT00884325|583867251|FG000|Overall Study|Lost to Follow-up|1|||
161675996|NCT00884325|583867252|FG001|Overall Study|Lost to Follow-up|2|||
161675997|NCT00884325|583867251|FG000|Overall Study|Lack of Efficacy|0|||
161675998|NCT00884325|583867252|FG001|Overall Study|Lack of Efficacy|1|||
161675999|NCT00884325|583867251|FG000|Overall Study|Withdrawal by Subject|1|||
161676000|NCT00884325|583867252|FG001|Overall Study|Withdrawal by Subject|1|||
161676001|NCT00884325|583867251|FG000|Overall Study|Not provided|1|||
161676002|NCT00884325|583867252|FG001|Overall Study|Not provided|0|||
161676003|NCT01446016|583867253|FG000|Overall Study|Lost to Follow-up|3|||
161676004|NCT01446016|583867253|FG000|Overall Study|Withdrawal by Subject|1|||
161676005|NCT01446016|583867253|FG000|Overall Study|Toxicity|3|||
161676006|NCT00404066|583867260|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
161676007|NCT00404066|583867260|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
161676008|NCT01949155|583867261|FG000|Overall Study|Lost to Follow-up|1|||
161676009|NCT01949155|583867262|FG001|Overall Study|Lost to Follow-up|0|||
161676010|NCT01949155|583867261|FG000|Overall Study|Protocol Violation|1|||
161676011|NCT01949155|583867262|FG001|Overall Study|Protocol Violation|0|||
162197290|NCT02069366|585772160|FG000|Overall Study|Withdrawal by Subject|1|||
162197291|NCT02069366|585772161|FG001|Overall Study|Withdrawal by Subject|0|||
162197292|NCT02069366|585772162|FG002|Overall Study|Withdrawal by Subject|1|||
162197293|NCT02069366|585772163|FG003|Overall Study|Withdrawal by Subject|2|||
162197294|NCT02069366|585772164|FG004|Overall Study|Withdrawal by Subject|0|||
162197295|NCT02069366|585772165|FG005|Overall Study|Withdrawal by Subject|0|||
162197296|NCT02030847|585772167|FG000|Overall Study|Death|10|||
162197297|NCT02030847|585772167|FG000|Overall Study|Disease Progression|15|||
162197298|NCT02030847|585772167|FG000|Overall Study|New Cancer Therapy|8|||
162197299|NCT02030847|585772167|FG000|Overall Study|Physician Decision|3|||
162197300|NCT02030847|585772167|FG000|Overall Study|Withdrawal by Subject|1|||
162197301|NCT00168805|585772168|FG000|Overall Study|Adverse Event|7|||
162197302|NCT00168805|585772169|FG001|Overall Study|Adverse Event|11|||
162197303|NCT00168805|585772170|FG002|Overall Study|Adverse Event|16|||
162197304|NCT00168805|585772168|FG000|Overall Study|Protocol Violation|12|||
162197305|NCT00168805|585772169|FG001|Overall Study|Protocol Violation|11|||
162197306|NCT00168805|585772170|FG002|Overall Study|Protocol Violation|8|||
162197307|NCT00168805|585772168|FG000|Overall Study|Lost to Follow-up|12|||
162197308|NCT00168805|585772169|FG001|Overall Study|Lost to Follow-up|17|||
162197309|NCT00168805|585772170|FG002|Overall Study|Lost to Follow-up|11|||
162197310|NCT00168805|585772168|FG000|Overall Study|Withdrawal by Subject|16|||
162197311|NCT00168805|585772169|FG001|Overall Study|Withdrawal by Subject|18|||
162197312|NCT00168805|585772170|FG002|Overall Study|Withdrawal by Subject|21|||
162197313|NCT00168805|585772168|FG000|Overall Study|Other|24|||
161676012|NCT05395104|583867263|FG000|Overall Study|Met Liver Stopping Criteria|1|||
161676013|NCT05395104|583867263|FG000|Overall Study|Withdrawal by Subject|1|||
161676014|NCT02448225|583867264|FG000|Overall Study|Withdrawal by Subject|1|||
161676015|NCT02448225|583867264|FG000|Overall Study|Did not get FSPG scan|18|||
161676016|NCT02448225|583867264|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
162020506|NCT00545272|585130497|FG004|Overall Study|Adverse Event|0|||
162020507|NCT00545272|585130498|FG005|Overall Study|Adverse Event|1|||
162197314|NCT00168805|585772169|FG001|Overall Study|Other|21|||
162197315|NCT00168805|585772170|FG002|Overall Study|Other|22|||
162197316|NCT00168805|585772168|FG000|Treatment|Adverse Event|25|||
162197317|NCT00168805|585772169|FG001|Treatment|Adverse Event|26|||
162197318|NCT00168805|585772170|FG002|Treatment|Adverse Event|32|||
162197319|NCT00168805|585772168|FG000|Treatment|Protocol Violation|3|||
161676017|NCT01287364|583867269|FG000|Overall Study|Adverse Event|0|||
161676018|NCT01287364|583867270|FG001|Overall Study|Adverse Event|3|||
161676019|NCT01287364|583867269|FG000|Overall Study|Protocol Violation|5|||
161676020|NCT01287364|583867270|FG001|Overall Study|Protocol Violation|5|||
161676021|NCT01287364|583867269|FG000|Overall Study|Other Reason|4|||
161676022|NCT01287364|583867270|FG001|Overall Study|Other Reason|2|||
161676023|NCT04422990|583867272|FG000|Overall Study|Withdrawal by Subject|0|||
162020508|NCT00545272|585130493|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162197320|NCT00168805|585772169|FG001|Treatment|Protocol Violation|5|||
162197321|NCT00168805|585772170|FG002|Treatment|Protocol Violation|5|||
162197322|NCT00168805|585772168|FG000|Treatment|Withdrawal by Subject|3|||
162197323|NCT00168805|585772169|FG001|Treatment|Withdrawal by Subject|7|||
162197324|NCT00168805|585772170|FG002|Treatment|Withdrawal by Subject|8|||
162197325|NCT00168805|585772168|FG000|Treatment|Other|18|||
162197326|NCT00168805|585772169|FG001|Treatment|Other|18|||
162197327|NCT00168805|585772170|FG002|Treatment|Other|17|||
162197328|NCT02995733|585772171|FG000|Overall Study|Study site closed|9|||
162197329|NCT02995733|585772172|FG001|Overall Study|Study site closed|10|||
162197330|NCT02995733|585772171|FG000|Overall Study|Death|3|||
162197331|NCT02995733|585772172|FG001|Overall Study|Death|4|||
162197332|NCT02995733|585772171|FG000|Overall Study|Withdrawal by Subject|6|||
162197333|NCT02995733|585772172|FG001|Overall Study|Withdrawal by Subject|2|||
162197334|NCT02995733|585772171|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
162197335|NCT02995733|585772172|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
162197336|NCT02995733|585772171|FG000|Overall Study|Lost to Follow-up|48|||
162197337|NCT02995733|585772172|FG001|Overall Study|Lost to Follow-up|37|||
162197338|NCT02995733|585772171|FG000|Overall Study|Other|0|||
162197339|NCT02995733|585772172|FG001|Overall Study|Other|1|||
162197340|NCT03785210|585772173|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
162197341|NCT03785210|585772174|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
162197342|NCT04468633|585772175|FG000|Overall Study|Withdrawal by Subject|4|||
162197343|NCT04468633|585772176|FG001|Overall Study|Withdrawal by Subject|0|||
162197344|NCT00460434|585772179|FG000|Overall Study|Lost to Follow-up|3|||
162197345|NCT00460434|585772180|FG001|Overall Study|Lost to Follow-up|7|||
162197346|NCT01498445|585772181|FG000|Overall Study|Lack of Efficacy|0|||
162197347|NCT01498445|585772182|FG001|Overall Study|Lack of Efficacy|0|||
162197348|NCT01498445|585772183|FG002|Overall Study|Lack of Efficacy|1|||
162197349|NCT01498445|585772184|FG003|Overall Study|Lack of Efficacy|2|||
162197350|NCT01498445|585772185|FG004|Overall Study|Lack of Efficacy|0|||
162197351|NCT01498445|585772186|FG005|Overall Study|Lack of Efficacy|0|||
162197352|NCT01498445|585772181|FG000|Overall Study|Screen Failure|0|||
162197353|NCT01498445|585772182|FG001|Overall Study|Screen Failure|0|||
162197354|NCT01498445|585772183|FG002|Overall Study|Screen Failure|0|||
162197355|NCT01498445|585772184|FG003|Overall Study|Screen Failure|0|||
162197356|NCT01498445|585772185|FG004|Overall Study|Screen Failure|1|||
162197357|NCT01498445|585772186|FG005|Overall Study|Screen Failure|1|||
162197358|NCT02722278|585772187|FG000|Overall Study|Withdrawal by Subject|5|||
162197359|NCT02722278|585772188|FG001|Overall Study|Withdrawal by Subject|3|||
162197360|NCT02722278|585772187|FG000|Overall Study|Adverse Event|4|||
162197361|NCT02722278|585772188|FG001|Overall Study|Adverse Event|1|||
162197362|NCT02722278|585772187|FG000|Overall Study|Lost to Follow-up|2|||
162197363|NCT02722278|585772188|FG001|Overall Study|Lost to Follow-up|0|||
162197364|NCT02722278|585772187|FG000|Overall Study|Protocol Violation|1|||
162197365|NCT02722278|585772188|FG001|Overall Study|Protocol Violation|0|||
162197366|NCT02722278|585772187|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
162197367|NCT02722278|585772188|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
162197368|NCT02722278|585772187|FG000|Overall Study|Subject declined after tx assignment|0|||
162197369|NCT02722278|585772188|FG001|Overall Study|Subject declined after tx assignment|1|||
162197370|NCT02722278|585772187|FG000|Overall Study|Site closure not study related|0|||
162197371|NCT02722278|585772188|FG001|Overall Study|Site closure not study related|1|||
162197372|NCT02465866|585772189|FG000|Period 3|Withdrawal by Subject|0|||
162197373|NCT02465866|585772190|FG001|Period 3|Withdrawal by Subject|1|||
162197374|NCT02465866|585772191|FG002|Period 3|Withdrawal by Subject|0|||
162197375|NCT02465866|585772192|FG003|Period 3|Withdrawal by Subject|0|||
162197376|NCT02023099|585772193|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
161676024|NCT04422990|583867273|FG001|Overall Study|Withdrawal by Subject|1|||
161676025|NCT04422990|583867272|FG000|Overall Study|Travel|3|||
162197377|NCT02023099|585772194|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
162197378|NCT02023099|585772195|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
162197379|NCT02023099|585772193|FG000|Overall Study|Withdrawn Consent|3|||
162197380|NCT02023099|585772194|FG001|Overall Study|Withdrawn Consent|0|||
162197381|NCT02023099|585772195|FG002|Overall Study|Withdrawn Consent|1|||
162197382|NCT02023099|585772193|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
162197383|NCT02023099|585772194|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
162197384|NCT02023099|585772195|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
162197385|NCT00203502|585772196|FG000|Overall Study|Death|1|||
162197386|NCT01469819|585772197|FG000|Overall Study|Withdrawal by Subject|1|||
161676026|NCT04422990|583867273|FG001|Overall Study|Travel|0|||
161676027|NCT01849497|583867278|FG000|Overall Study|Withdrawal by Subject|1|||
161676028|NCT01849497|583867279|FG001|Overall Study|Withdrawal by Subject|2|||
161676029|NCT01849497|583867278|FG000|Overall Study|Sponsor Decision|0|||
161676030|NCT01849497|583867279|FG001|Overall Study|Sponsor Decision|1|||
161676031|NCT01849497|583867278|FG000|Overall Study|Lost to Follow-up|0|||
161676032|NCT01849497|583867279|FG001|Overall Study|Lost to Follow-up|1|||
161676033|NCT02146599|583867280|FG000|Overall Study|Failed to meet inclusion criteria|5|||
161676034|NCT02101021|583867281|FG000|Overall Study|Death|4|||
161676035|NCT02101021|583867282|FG001|Overall Study|Death|3|||
162197387|NCT01469819|585772197|FG000|Overall Study|Did not meet inclusionary criteria|2|||
162197388|NCT01469819|585772197|FG000|Overall Study|Could not swallow SmartPill|2|||
162197389|NCT01469819|585772197|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
162197390|NCT00561678|585772198|FG000|Overall Study|Withdrawal by Subject|4|||
162197391|NCT00561678|585772199|FG001|Overall Study|Withdrawal by Subject|3|||
162197392|NCT00561678|585772198|FG000|Overall Study|surgery cancelled|1|||
162197393|NCT00561678|585772199|FG001|Overall Study|surgery cancelled|1|||
162197394|NCT00561678|585772198|FG000|Overall Study|surgery rescheduled to different site|2|||
162197395|NCT00561678|585772199|FG001|Overall Study|surgery rescheduled to different site|2|||
162197396|NCT00561678|585772198|FG000|Overall Study|anesthesia provider refusal|1|||
162197397|NCT00561678|585772199|FG001|Overall Study|anesthesia provider refusal|0|||
162197398|NCT01403805|585772200|FG000|Overall Study|Withdrawal by Subject|0|||
162197399|NCT01403805|585772201|FG001|Overall Study|Withdrawal by Subject|4|||
162197400|NCT01403805|585772200|FG000|Overall Study|Lost to Follow-up|0|||
162197401|NCT01403805|585772201|FG001|Overall Study|Lost to Follow-up|2|||
162197402|NCT01403805|585772200|FG000|Overall Study|Death|0|||
162197403|NCT01403805|585772201|FG001|Overall Study|Death|1|||
162197404|NCT01695993|585772204|FG000|Overall Study|Lost to Follow-up|2|||
162197405|NCT01695993|585772205|FG001|Overall Study|Lost to Follow-up|1|||
162197406|NCT01695993|585772206|FG002|Overall Study|Lost to Follow-up|3|||
162197407|NCT01695993|585772204|FG000|Overall Study|Withdrawal by Subject|2|||
162197408|NCT01695993|585772205|FG001|Overall Study|Withdrawal by Subject|2|||
162197409|NCT01695993|585772206|FG002|Overall Study|Withdrawal by Subject|2|||
161676036|NCT02101021|583867283|FG002|Overall Study|Death|6|||
161676037|NCT02101021|583867284|FG003|Overall Study|Death|0|||
161676038|NCT02101021|583867285|FG004|Overall Study|Death|3|||
161676039|NCT02101021|583867281|FG000|Overall Study|Withdrew Consent from study|1|||
161676040|NCT02101021|583867282|FG001|Overall Study|Withdrew Consent from study|1|||
161676041|NCT02101021|583867283|FG002|Overall Study|Withdrew Consent from study|0|||
161676042|NCT02101021|583867284|FG003|Overall Study|Withdrew Consent from study|2|||
161676043|NCT02101021|583867285|FG004|Overall Study|Withdrew Consent from study|0|||
161676044|NCT02101021|583867281|FG000|Overall Study|Lost to Follow-up|1|||
161676045|NCT02101021|583867282|FG001|Overall Study|Lost to Follow-up|0|||
161676046|NCT02101021|583867283|FG002|Overall Study|Lost to Follow-up|0|||
161676047|NCT02101021|583867284|FG003|Overall Study|Lost to Follow-up|0|||
161676048|NCT02101021|583867285|FG004|Overall Study|Lost to Follow-up|0|||
161676049|NCT02101021|583867281|FG000|Overall Study|Study Terminated by Sponsor|1|||
161676050|NCT02101021|583867282|FG001|Overall Study|Study Terminated by Sponsor|0|||
161676051|NCT02101021|583867283|FG002|Overall Study|Study Terminated by Sponsor|1|||
162197410|NCT01695993|585772204|FG000|Overall Study|To ill to continue|1|||
161676052|NCT02101021|583867284|FG003|Overall Study|Study Terminated by Sponsor|1|||
162197411|NCT01695993|585772205|FG001|Overall Study|To ill to continue|2|||
162197412|NCT01695993|585772206|FG002|Overall Study|To ill to continue|0|||
162197413|NCT01695993|585772204|FG000|Overall Study|Changed Medical Facility|0|||
161676053|NCT02101021|583867285|FG004|Overall Study|Study Terminated by Sponsor|1|||
162197414|NCT01695993|585772205|FG001|Overall Study|Changed Medical Facility|0|||
162197415|NCT01695993|585772206|FG002|Overall Study|Changed Medical Facility|1|||
162197416|NCT00472199|585772207|FG000|Overall Study|Adverse Event|19|||
162197417|NCT00472199|585772208|FG001|Overall Study|Adverse Event|23|||
162197418|NCT00472199|585772207|FG000|Overall Study|Lack of Efficacy|4|||
162197419|NCT00472199|585772208|FG001|Overall Study|Lack of Efficacy|25|||
162197420|NCT00472199|585772207|FG000|Overall Study|Lost to Follow-up|2|||
162197421|NCT00472199|585772208|FG001|Overall Study|Lost to Follow-up|4|||
161676054|NCT02322229|583867290|FG000|Overall Study|Physician Decision|2|||
161676055|NCT03065023|583867291|FG000|Overall Study|Progressive Disease|0|||
161676056|NCT03065023|583867292|FG001|Overall Study|Progressive Disease|1|||
162197422|NCT00472199|585772207|FG000|Overall Study|Protocol Violation|3|||
162197423|NCT00472199|585772208|FG001|Overall Study|Protocol Violation|2|||
162197424|NCT00472199|585772207|FG000|Overall Study|Withdrawal by Subject|6|||
162197425|NCT00472199|585772208|FG001|Overall Study|Withdrawal by Subject|5|||
162197426|NCT00472199|585772207|FG000|Overall Study|personal reason|0|||
162197427|NCT00472199|585772208|FG001|Overall Study|personal reason|1|||
162197428|NCT00472199|585772207|FG000|Overall Study|patient was asymptomatic|1|||
162197429|NCT00472199|585772208|FG001|Overall Study|patient was asymptomatic|0|||
162197430|NCT01601821|585772212|FG000|Overall Study|Death|2|||
162197431|NCT01601821|585772213|FG001|Overall Study|Death|5|||
162197432|NCT01601821|585772212|FG000|Overall Study|Protocol Violation|2|||
162197433|NCT01601821|585772213|FG001|Overall Study|Protocol Violation|2|||
162197434|NCT01601821|585772212|FG000|Overall Study|Lost to Follow-up|6|||
162197435|NCT01601821|585772213|FG001|Overall Study|Lost to Follow-up|14|||
162197436|NCT01601821|585772212|FG000|Overall Study|Withdrawal by Subject|1|||
162197437|NCT01601821|585772213|FG001|Overall Study|Withdrawal by Subject|0|||
162197438|NCT01601821|585772212|FG000|Overall Study|Graft Loss|6|||
162197439|NCT01601821|585772213|FG001|Overall Study|Graft Loss|6|||
162197440|NCT01601821|585772212|FG000|Overall Study|Study Events|7|||
162197441|NCT01601821|585772213|FG001|Overall Study|Study Events|1|||
162197442|NCT01601821|585772212|FG000|Overall Study|Other|5|||
162197443|NCT01601821|585772213|FG001|Overall Study|Other|1|||
162197444|NCT01901302|585772214|FG000|Overall Study|Adverse Event|2|||
162197445|NCT01901302|585772215|FG001|Overall Study|Adverse Event|1|||
162197446|NCT01901302|585772214|FG000|Overall Study|Lack of Efficacy|0|||
162197447|NCT01901302|585772215|FG001|Overall Study|Lack of Efficacy|2|||
162197448|NCT01901302|585772214|FG000|Overall Study|Study Terminated by Sponsor|23|||
162197449|NCT01901302|585772215|FG001|Overall Study|Study Terminated by Sponsor|20|||
162197450|NCT01901302|585772214|FG000|Overall Study|Withdrawal by Subject|2|||
162197451|NCT01901302|585772215|FG001|Overall Study|Withdrawal by Subject|0|||
162197452|NCT03708744|585772219|FG000|Overall Study|Withdrawal by Subject|0|||
162197453|NCT03708744|585772220|FG001|Overall Study|Withdrawal by Subject|0|||
162197454|NCT03708744|585772221|FG002|Overall Study|Withdrawal by Subject|1|||
162197455|NCT03708744|585772222|FG003|Overall Study|Withdrawal by Subject|0|||
162197456|NCT03166215|585772229|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
162197457|NCT03166215|585772230|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
162197458|NCT03166215|585772231|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
162197459|NCT03166215|585772229|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
162197460|NCT03166215|585772230|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
162197461|NCT03166215|585772231|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
162197462|NCT04985604|585772234|FG000|Overall Study|Death|4|||
162197463|NCT04985604|585772235|FG001|Overall Study|Death|6|||
162197464|NCT04985604|585772234|FG000|Overall Study|Withdrawal by Subject|0|||
162197465|NCT04985604|585772235|FG001|Overall Study|Withdrawal by Subject|1|||
162197466|NCT04598776|585772236|FG000|Overall Study|Protocol Violation|5|||
162197467|NCT04598776|585772236|FG000|Overall Study|Physician Decision|4|||
162197468|NCT02282761|585772237|FG000|Overall Study|Death|0|||
162197469|NCT02282761|585772238|FG001|Overall Study|Death|0|||
162197470|NCT02282761|585772239|FG002|Overall Study|Death|1|||
162197471|NCT02282761|585772237|FG000|Overall Study|Adverse Event|6|||
162197472|NCT02282761|585772238|FG001|Overall Study|Adverse Event|2|||
162197473|NCT02282761|585772239|FG002|Overall Study|Adverse Event|0|||
162197474|NCT02282761|585772237|FG000|Overall Study|Lack of Efficacy|11|||
162197475|NCT02282761|585772238|FG001|Overall Study|Lack of Efficacy|6|||
162197476|NCT02282761|585772239|FG002|Overall Study|Lack of Efficacy|17|||
162197477|NCT02282761|585772237|FG000|Overall Study|Lost to Follow-up|2|||
162197478|NCT02282761|585772238|FG001|Overall Study|Lost to Follow-up|2|||
162197479|NCT02282761|585772239|FG002|Overall Study|Lost to Follow-up|1|||
162197480|NCT02282761|585772237|FG000|Overall Study|Physician Decision|0|||
162197481|NCT02282761|585772238|FG001|Overall Study|Physician Decision|0|||
162197482|NCT02282761|585772239|FG002|Overall Study|Physician Decision|2|||
162197483|NCT02282761|585772237|FG000|Overall Study|Withdrawal by Subject|8|||
162197484|NCT02282761|585772238|FG001|Overall Study|Withdrawal by Subject|10|||
162197485|NCT02282761|585772239|FG002|Overall Study|Withdrawal by Subject|16|||
162197486|NCT02282761|585772237|FG000|Overall Study|Other|3|||
162197487|NCT02282761|585772238|FG001|Overall Study|Other|2|||
162197488|NCT02282761|585772239|FG002|Overall Study|Other|1|||
162197489|NCT00658632|585772242|FG000|Overall Study|Adverse Event|13|||
162197490|NCT00658632|585772243|FG001|Overall Study|Adverse Event|11|||
162197491|NCT00658632|585772242|FG000|Overall Study|Lost to Follow-up|25|||
161676057|NCT03065023|583867293|FG002|Overall Study|Progressive Disease|0|||
161676058|NCT03065023|583867294|FG003|Overall Study|Progressive Disease|0|||
162197492|NCT00658632|585772243|FG001|Overall Study|Lost to Follow-up|23|||
162197493|NCT00658632|585772242|FG000|Overall Study|Withdrawal by Subject|10|||
162197494|NCT00658632|585772243|FG001|Overall Study|Withdrawal by Subject|7|||
162197495|NCT00658632|585772242|FG000|Overall Study|Lack of Efficacy|0|||
162197496|NCT00658632|585772243|FG001|Overall Study|Lack of Efficacy|1|||
162197497|NCT00658632|585772242|FG000|Overall Study|Withdrawal of consent|8|||
162197498|NCT00658632|585772243|FG001|Overall Study|Withdrawal of consent|14|||
161676059|NCT03065023|583867295|FG004|Overall Study|Progressive Disease|0|||
161676060|NCT03065023|583867291|FG000|Overall Study|Death|2|||
161676061|NCT03065023|583867292|FG001|Overall Study|Death|0|||
161676062|NCT03065023|583867293|FG002|Overall Study|Death|1|||
161676063|NCT03065023|583867294|FG003|Overall Study|Death|1|||
161676064|NCT03065023|583867295|FG004|Overall Study|Death|0|||
161676065|NCT03065023|583867291|FG000|Overall Study|Lost to Follow-up|0|||
161676066|NCT03065023|583867292|FG001|Overall Study|Lost to Follow-up|1|||
161676067|NCT03065023|583867293|FG002|Overall Study|Lost to Follow-up|0|||
161676068|NCT03065023|583867294|FG003|Overall Study|Lost to Follow-up|0|||
161676069|NCT03065023|583867295|FG004|Overall Study|Lost to Follow-up|0|||
161676070|NCT03065023|583867291|FG000|Overall Study|Participant Decision|0|||
161676071|NCT03065023|583867292|FG001|Overall Study|Participant Decision|0|||
161676072|NCT03065023|583867293|FG002|Overall Study|Participant Decision|0|||
161676073|NCT03065023|583867294|FG003|Overall Study|Participant Decision|1|||
161676074|NCT03065023|583867295|FG004|Overall Study|Participant Decision|0|||
161676075|NCT03065023|583867291|FG000|Overall Study|Withdrawal by Subject|0|||
161676076|NCT03065023|583867292|FG001|Overall Study|Withdrawal by Subject|0|||
161676077|NCT03065023|583867293|FG002|Overall Study|Withdrawal by Subject|0|||
161676078|NCT03065023|583867294|FG003|Overall Study|Withdrawal by Subject|1|||
161676079|NCT03065023|583867295|FG004|Overall Study|Withdrawal by Subject|0|||
161676080|NCT00705432|583867296|FG000|Treatment Period|Adverse Event|45|||
161676081|NCT00705432|583867297|FG001|Treatment Period|Adverse Event|37|||
161676082|NCT00705432|583867298|FG002|Treatment Period|Adverse Event|51|||
161676083|NCT00705432|583867299|FG003|Treatment Period|Adverse Event|12|||
161676084|NCT00705432|583867300|FG004|Treatment Period|Adverse Event|8|||
161676085|NCT00705432|583867301|FG005|Treatment Period|Adverse Event|9|||
161676086|NCT00705432|583867296|FG000|Treatment Period|Treatment failure|92|||
161676087|NCT00705432|583867297|FG001|Treatment Period|Treatment failure|42|||
161676088|NCT00705432|583867298|FG002|Treatment Period|Treatment failure|33|||
161676089|NCT00705432|583867299|FG003|Treatment Period|Treatment failure|25|||
161676090|NCT00705432|583867300|FG004|Treatment Period|Treatment failure|13|||
161676091|NCT00705432|583867301|FG005|Treatment Period|Treatment failure|14|||
161676092|NCT00705432|583867296|FG000|Treatment Period|Non medical reason|26|||
161676093|NCT00705432|583867297|FG001|Treatment Period|Non medical reason|32|||
161676094|NCT00705432|583867298|FG002|Treatment Period|Non medical reason|37|||
161676095|NCT00705432|583867299|FG003|Treatment Period|Non medical reason|4|||
161676096|NCT00705432|583867300|FG004|Treatment Period|Non medical reason|7|||
161676097|NCT00705432|583867301|FG005|Treatment Period|Non medical reason|7|||
161676098|NCT00705432|583867296|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
161676099|NCT00705432|583867297|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
161676100|NCT00705432|583867298|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
161676101|NCT00705432|583867299|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
161676102|NCT00705432|583867300|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
161676103|NCT00705432|583867301|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
161676104|NCT00705432|583867296|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
161676105|NCT00705432|583867297|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
161676106|NCT00705432|583867298|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
161676107|NCT00705432|583867299|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
161676108|NCT00705432|583867300|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
162197499|NCT00658632|585772242|FG000|Overall Study|Pregnancy|1|||
162197500|NCT00658632|585772243|FG001|Overall Study|Pregnancy|1|||
162197501|NCT00658632|585772242|FG000|Overall Study|Other|7|||
162197502|NCT00658632|585772243|FG001|Overall Study|Other|8|||
162197503|NCT06312566|585772244|FG000|Overall Study|Protocol Violation|0|||
162197504|NCT06312566|585772245|FG001|Overall Study|Protocol Violation|1|||
162197505|NCT04551053|585772246|FG000|Overall Study|Death|10|||
162197506|NCT04551053|585772247|FG001|Overall Study|Death|9|||
162197507|NCT04551053|585772246|FG000|Overall Study|Lost to Follow-up|0|||
162197508|NCT04551053|585772247|FG001|Overall Study|Lost to Follow-up|2|||
162197509|NCT04551053|585772246|FG000|Overall Study|Study Terminated by Sponsor|57|||
162197510|NCT04551053|585772247|FG001|Overall Study|Study Terminated by Sponsor|65|||
162197511|NCT04551053|585772246|FG000|Overall Study|Withdrawal by Subject|12|||
162197512|NCT04551053|585772247|FG001|Overall Study|Withdrawal by Subject|5|||
162197513|NCT04551053|585772246|FG000|Overall Study|Adverse Event|2|||
162197514|NCT04551053|585772247|FG001|Overall Study|Adverse Event|0|||
162197515|NCT04551053|585772246|FG000|Overall Study|Lack of Efficacy|2|||
162197516|NCT04551053|585772247|FG001|Overall Study|Lack of Efficacy|1|||
162197517|NCT04551053|585772246|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
162197518|NCT04551053|585772247|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
162197519|NCT04551053|585772246|FG000|Overall Study|Splenapendectomi|1|||
162197520|NCT04551053|585772247|FG001|Overall Study|Splenapendectomi|0|||
162197521|NCT04551053|585772246|FG000|Overall Study|Medical Decision|1|||
162197522|NCT04551053|585772247|FG001|Overall Study|Medical Decision|1|||
162197523|NCT03861078|585772248|FG000|Overall Study|COVID-19 shut down|4|||
162197524|NCT03861078|585772248|FG000|Overall Study|Lost to Follow-up|1|||
162197525|NCT03861078|585772248|FG000|Overall Study|Protocol Violation|2|||
162197526|NCT03861078|585772248|FG000|Overall Study|lack of venous access|1|||
162197527|NCT01699178|585772250|FG000|Overall Study|Adverse Event|1|||
162197528|NCT01699178|585772251|FG001|Overall Study|Adverse Event|5|||
162197529|NCT01699178|585772250|FG000|Overall Study|Lost to Follow-up|1|||
162197530|NCT01699178|585772251|FG001|Overall Study|Lost to Follow-up|6|||
162197531|NCT01699178|585772250|FG000|Overall Study|Non-compliance with Study Drug|3|||
162197532|NCT01699178|585772251|FG001|Overall Study|Non-compliance with Study Drug|1|||
162197533|NCT01699178|585772250|FG000|Overall Study|Physician Decision|1|||
162197534|NCT01699178|585772251|FG001|Overall Study|Physician Decision|0|||
162197535|NCT01699178|585772250|FG000|Overall Study|Withdrawal by Subject|4|||
162197536|NCT01699178|585772251|FG001|Overall Study|Withdrawal by Subject|12|||
162197537|NCT01699178|585772250|FG000|Overall Study|Hematocrit >54%|1|||
162197538|NCT01699178|585772251|FG001|Overall Study|Hematocrit >54%|1|||
162197539|NCT01699178|585772250|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
162197540|NCT01699178|585772251|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
162197541|NCT01699178|585772250|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
162197542|NCT01699178|585772251|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
162197543|NCT04016415|585772253|FG000|Overall Study|Adverse Event|2|||
162197544|NCT04016415|585772254|FG001|Overall Study|Adverse Event|1|||
162197545|NCT04016415|585772253|FG000|Overall Study|Lost to Follow-up|6|||
162197546|NCT04016415|585772254|FG001|Overall Study|Lost to Follow-up|2|||
162197547|NCT04016415|585772253|FG000|Overall Study|Physician Decision|5|||
162197548|NCT04016415|585772254|FG001|Overall Study|Physician Decision|1|||
162197549|NCT04016415|585772253|FG000|Overall Study|Pregnancy|0|||
162197550|NCT04016415|585772254|FG001|Overall Study|Pregnancy|1|||
162197551|NCT04016415|585772253|FG000|Overall Study|Withdrawal by Subject|24|||
162197552|NCT04016415|585772254|FG001|Overall Study|Withdrawal by Subject|27|||
161926354|NCT00504309|584777188|FG002|Overall Study|Withdrawal by Subject|1|||
161926355|NCT00504309|584777189|FG003|Overall Study|Withdrawal by Subject|0|||
161926356|NCT00504309|584777190|FG004|Overall Study|Withdrawal by Subject|0|||
161926357|NCT00504309|584777191|FG005|Overall Study|Withdrawal by Subject|0|||
161926358|NCT00983957|584777194|FG000|Overall Study|Adverse Event|1|||
161926359|NCT00983957|584777194|FG000|Overall Study|Personal Reasons|1|||
161926360|NCT00397930|584778594|FG000|Overall Study|Personal reasons|14|||
161926361|NCT00397930|584778595|FG001|Overall Study|Personal reasons|8|||
161926362|NCT00397930|584778594|FG000|Overall Study|Other medical|9|||
161926363|NCT00397930|584778595|FG001|Overall Study|Other medical|4|||
161926364|NCT00397930|584778594|FG000|Overall Study|Unknown reasons|9|||
161926365|NCT00397930|584778595|FG001|Overall Study|Unknown reasons|14|||
161926366|NCT00397930|584778594|FG000|Overall Study|Noncompliant|3|||
161926367|NCT00397930|584778595|FG001|Overall Study|Noncompliant|2|||
161926368|NCT00397930|584778594|FG000|Overall Study|Too time-consuming|2|||
161926369|NCT00397930|584778595|FG001|Overall Study|Too time-consuming|9|||
161926370|NCT00397930|584778594|FG000|Overall Study|Started own yoga program|1|||
161926371|NCT00397930|584778595|FG001|Overall Study|Started own yoga program|1|||
161926372|NCT00397930|584778594|FG000|Overall Study|Did not want to be in control group|0|||
162197553|NCT04016415|585772253|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
161926373|NCT00397930|584778595|FG001|Overall Study|Did not want to be in control group|1|||
161926374|NCT00397930|584778594|FG000|Overall Study|Withdrawal by Subject|0|||
161926375|NCT00397930|584778595|FG001|Overall Study|Withdrawal by Subject|8|||
161926376|NCT00397930|584778594|FG000|Overall Study|Missing data|0|||
162197554|NCT04016415|585772254|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
162197555|NCT03547167|585772259|FG000|Overall Study|Withdrawal by Subject|34|||
162197556|NCT03547167|585772260|FG001|Overall Study|Withdrawal by Subject|12|||
162197557|NCT03547167|585772259|FG000|Overall Study|Screen Failure|0|||
162197558|NCT03547167|585772260|FG001|Overall Study|Screen Failure|1|||
162197559|NCT03547167|585772259|FG000|Overall Study|Lost to Follow-up|59|||
162197560|NCT03547167|585772260|FG001|Overall Study|Lost to Follow-up|15|||
162197561|NCT03547167|585772259|FG000|Overall Study|Death|4|||
162197562|NCT03547167|585772260|FG001|Overall Study|Death|2|||
162197563|NCT00645411|585772261|FG000|Overall Study|Adverse Event|0|||
162197564|NCT00645411|585772262|FG001|Overall Study|Adverse Event|0|||
162197565|NCT00645411|585772263|FG002|Overall Study|Adverse Event|0|||
162197566|NCT00645411|585772264|FG003|Overall Study|Adverse Event|2|||
162197567|NCT00645411|585772261|FG000|Overall Study|Withdrawal by Subject|2|||
162197568|NCT00645411|585772262|FG001|Overall Study|Withdrawal by Subject|1|||
162197569|NCT00645411|585772263|FG002|Overall Study|Withdrawal by Subject|19|||
162197570|NCT00645411|585772264|FG003|Overall Study|Withdrawal by Subject|21|||
162197571|NCT00645411|585772261|FG000|Overall Study|Lost to Follow-up|10|||
162197572|NCT00645411|585772262|FG001|Overall Study|Lost to Follow-up|5|||
162197573|NCT00645411|585772263|FG002|Overall Study|Lost to Follow-up|124|||
162197574|NCT00645411|585772264|FG003|Overall Study|Lost to Follow-up|75|||
162197575|NCT00645411|585772261|FG000|Overall Study|Protocol Violation|1|||
162197576|NCT00645411|585772262|FG001|Overall Study|Protocol Violation|0|||
162197577|NCT00645411|585772263|FG002|Overall Study|Protocol Violation|1|||
162197578|NCT00645411|585772264|FG003|Overall Study|Protocol Violation|0|||
162197579|NCT00645411|585772261|FG000|Overall Study|Inappropriate enrollment|0|||
162197580|NCT00645411|585772262|FG001|Overall Study|Inappropriate enrollment|0|||
162197581|NCT00645411|585772263|FG002|Overall Study|Inappropriate enrollment|4|||
162197582|NCT00645411|585772264|FG003|Overall Study|Inappropriate enrollment|1|||
162197583|NCT00645411|585772261|FG000|Overall Study|Unable to classify|0|||
162197584|NCT00645411|585772262|FG001|Overall Study|Unable to classify|0|||
162197585|NCT00645411|585772263|FG002|Overall Study|Unable to classify|3|||
162197586|NCT00645411|585772264|FG003|Overall Study|Unable to classify|4|||
161676109|NCT00705432|583867301|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
161820655|NCT04133311|584384611|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
161820656|NCT04133311|584384612|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
161820657|NCT04133311|584384609|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
161820658|NCT04133311|584384610|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
161820659|NCT04133311|584384611|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
161820660|NCT04133311|584384612|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
161820661|NCT04133311|584384609|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
161820662|NCT04133311|584384610|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
161820663|NCT04133311|584384611|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
161820664|NCT04133311|584384612|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
161820665|NCT01859598|584384615|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
161820666|NCT00672984|584384616|FG000|First Intervention|Adverse Event|5|||
161820667|NCT00672984|584384617|FG001|First Intervention|Adverse Event|0|||
161820668|NCT00672984|584384618|FG002|First Intervention|Adverse Event|0|||
161820669|NCT00672984|584384616|FG000|First Intervention|Withdrawal by Subject|1|||
161820670|NCT00672984|584384617|FG001|First Intervention|Withdrawal by Subject|2|||
161820671|NCT00672984|584384618|FG002|First Intervention|Withdrawal by Subject|2|||
161820672|NCT00672984|584384616|FG000|First Intervention|Sponsor decision|3|||
161820673|NCT00672984|584384617|FG001|First Intervention|Sponsor decision|0|||
161820674|NCT00672984|584384618|FG002|First Intervention|Sponsor decision|0|||
161820675|NCT00672984|584384616|FG000|Second Intervention|Non-compliance with facility policies|0|||
161820676|NCT00672984|584384617|FG001|Second Intervention|Non-compliance with facility policies|2|||
161820677|NCT00672984|584384618|FG002|Second Intervention|Non-compliance with facility policies|0|||
161820678|NCT00672984|584384616|FG000|Second Intervention|Withdrawal by Subject|0|||
161820679|NCT00672984|584384617|FG001|Second Intervention|Withdrawal by Subject|3|||
161820680|NCT00672984|584384618|FG002|Second Intervention|Withdrawal by Subject|0|||
161820681|NCT00672984|584384616|FG000|Second Intervention|Protocol Violation|0|||
161820682|NCT00672984|584384617|FG001|Second Intervention|Protocol Violation|1|||
161820683|NCT00672984|584384618|FG002|Second Intervention|Protocol Violation|1|||
161820684|NCT00672984|584384616|FG000|Third Intervention|Adverse Event|1|||
161820685|NCT00672984|584384617|FG001|Third Intervention|Adverse Event|0|||
161820686|NCT00672984|584384618|FG002|Third Intervention|Adverse Event|1|||
161820687|NCT00009945|584384619|FG000|Overall Study|no follow up data|7|||
161820688|NCT00009945|584384620|FG001|Overall Study|no follow up data|5|||
161820689|NCT01597791|584384621|FG000|Overall Study|Physician Decision|2|||
162197587|NCT03100370|585772268|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162197588|NCT03100370|585772269|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162197589|NCT03100370|585772270|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162197590|NCT03100370|585772271|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
162197591|NCT03100370|585772272|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161676110|NCT01102803|583867302|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
161676111|NCT01102803|583867303|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
161676112|NCT01102803|583867302|FG000|Post to Follow-Up|Lost to Follow-up|1|||
162197592|NCT03100370|585772273|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162197593|NCT02674399|585772274|FG000|Overall Study|Lost to Follow-up|2|||
162197594|NCT02674399|585772275|FG001|Overall Study|Lost to Follow-up|0|||
162197595|NCT01867307|585772276|FG000|Overall Study|Protocol Violation|2|||
162197596|NCT01867307|585772277|FG001|Overall Study|Protocol Violation|0|||
162197597|NCT01867307|585772276|FG000|Overall Study|Other Adverse Event|1|||
162197598|NCT01867307|585772277|FG001|Overall Study|Other Adverse Event|3|||
162197599|NCT00091572|585772278|FG000|Overall Study|Lost to Follow-up|1|||
162197600|NCT00091572|585772279|FG001|Overall Study|Lost to Follow-up|1|||
162197601|NCT00091572|585772278|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
162197602|NCT00091572|585772279|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
162197603|NCT00091572|585772278|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
162197604|NCT00091572|585772279|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
162197605|NCT00091572|585772278|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
162197606|NCT00091572|585772279|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
162197607|NCT00091572|585772278|FG000|Overall Study|Other Reason|6|||
162197608|NCT00091572|585772279|FG001|Overall Study|Other Reason|13|||
162197609|NCT00091572|585772278|FG000|Overall Study|Ongoing (still on treatment)|8|||
162197610|NCT00091572|585772279|FG001|Overall Study|Ongoing (still on treatment)|12|||
162197611|NCT00091572|585772278|FG000|Overall Study|Major Protocol Violation|2|||
162197612|NCT00091572|585772279|FG001|Overall Study|Major Protocol Violation|0|||
162197613|NCT00091572|585772278|FG000|Overall Study|Toxicity (Related AE)|53|||
162197614|NCT00091572|585772279|FG001|Overall Study|Toxicity (Related AE)|9|||
162197615|NCT01199302|585772285|FG000|Overall Study|Adverse Event|1|||
162197616|NCT01199302|585772286|FG001|Overall Study|Adverse Event|1|||
162197617|NCT01199302|585772287|FG002|Overall Study|Adverse Event|2|||
162197618|NCT01199302|585772288|FG003|Overall Study|Adverse Event|0|||
162197619|NCT01199302|585772285|FG000|Overall Study|Withdrawal by Subject|2|||
162197620|NCT01199302|585772286|FG001|Overall Study|Withdrawal by Subject|2|||
162197621|NCT01199302|585772287|FG002|Overall Study|Withdrawal by Subject|3|||
162197622|NCT01199302|585772288|FG003|Overall Study|Withdrawal by Subject|0|||
162197623|NCT01199302|585772285|FG000|Overall Study|Disease Progression|3|||
162197624|NCT01199302|585772286|FG001|Overall Study|Disease Progression|4|||
162197625|NCT01199302|585772287|FG002|Overall Study|Disease Progression|4|||
162197626|NCT01199302|585772288|FG003|Overall Study|Disease Progression|2|||
162197627|NCT01199302|585772285|FG000|Overall Study|Study Termination|13|||
162197628|NCT01199302|585772286|FG001|Overall Study|Study Termination|8|||
162197629|NCT01199302|585772287|FG002|Overall Study|Study Termination|11|||
162197630|NCT01199302|585772288|FG003|Overall Study|Study Termination|9|||
161676113|NCT01102803|583867303|FG001|Post to Follow-Up|Lost to Follow-up|3|||
161676114|NCT00521053|583867304|FG000|Observation Phase|Disease Progression|55|||
161676115|NCT00521053|583867304|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
161676116|NCT00521053|583867304|FG000|Observation Phase|Death|2|||
161676117|NCT00521053|583867304|FG000|Observation Phase|Adverse Event|1|||
161676118|NCT00521053|583867304|FG000|Observation Phase|Other non-study melanoma treatment|1|||
161676119|NCT00521053|583867304|FG000|Observation Phase|Physician Decision|1|||
161676120|NCT01557348|583867305|FG000|Overall Study|Adverse Event|6|||
161676121|NCT01557348|583867306|FG001|Overall Study|Adverse Event|16|||
161676122|NCT01557348|583867305|FG000|Overall Study|Infusion reaction event|5|||
161676123|NCT01557348|583867306|FG001|Overall Study|Infusion reaction event|5|||
161676124|NCT01557348|583867305|FG000|Overall Study|Death|7|||
161676125|NCT01557348|583867306|FG001|Overall Study|Death|4|||
161676126|NCT01557348|583867305|FG000|Overall Study|Insufficient Therapeutic Response|13|||
161676127|NCT01557348|583867306|FG001|Overall Study|Insufficient Therapeutic Response|28|||
161676128|NCT01557348|583867305|FG000|Overall Study|Withdrawal by Subject|5|||
161676129|NCT01557348|583867306|FG001|Overall Study|Withdrawal by Subject|4|||
161676130|NCT01557348|583867305|FG000|Overall Study|Lost to Follow-up|26|||
161676131|NCT01557348|583867306|FG001|Overall Study|Lost to Follow-up|22|||
161676132|NCT01557348|583867305|FG000|Overall Study|Administrative|18|||
161676133|NCT01557348|583867306|FG001|Overall Study|Administrative|11|||
161676134|NCT01667107|583867307|FG000|Overall Study|Adverse Event|4|||
161676135|NCT01667107|583867308|FG001|Overall Study|Adverse Event|3|||
161926377|NCT00397930|584778595|FG001|Overall Study|Missing data|4|||
161676136|NCT01667107|583867307|FG000|Overall Study|Tolerability issues|0|||
162197631|NCT01199302|585772285|FG000|Overall Study|Lost to Follow-up|0|||
162197632|NCT01199302|585772286|FG001|Overall Study|Lost to Follow-up|1|||
162197633|NCT01199302|585772287|FG002|Overall Study|Lost to Follow-up|0|||
162197634|NCT01199302|585772288|FG003|Overall Study|Lost to Follow-up|0|||
162197635|NCT01199302|585772285|FG000|Overall Study|Other|1|||
162197636|NCT01199302|585772286|FG001|Overall Study|Other|0|||
162197637|NCT01199302|585772287|FG002|Overall Study|Other|0|||
162197638|NCT01199302|585772288|FG003|Overall Study|Other|0|||
162197639|NCT04097535|585772291|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
162197640|NCT03070301|585772292|FG000|Overall Study|Progression of disease|16|||
161926378|NCT01158404|584778596|FG000|Overall Study|Withdrawal by Subject|0|||
161926379|NCT01158404|584778597|FG001|Overall Study|Withdrawal by Subject|1|||
161926380|NCT01158404|584778598|FG002|Overall Study|Withdrawal by Subject|0|||
161926381|NCT01158404|584778599|FG003|Overall Study|Withdrawal by Subject|0|||
161926382|NCT01158404|584778600|FG004|Overall Study|Withdrawal by Subject|3|||
161926383|NCT01158404|584778601|FG005|Overall Study|Withdrawal by Subject|1|||
161926384|NCT01158404|584778602|FG006|Overall Study|Withdrawal by Subject|0|||
161926385|NCT01158404|584778603|FG007|Overall Study|Withdrawal by Subject|1|||
162197641|NCT03070301|585772292|FG000|Overall Study|Physician Decision|3|||
162197642|NCT03070301|585772292|FG000|Overall Study|Withdrawal by Subject|1|||
162197643|NCT03820024|585772293|FG000|Overall Study|Physician Decision|1|||
162197644|NCT03820024|585772294|FG001|Overall Study|Physician Decision|2|||
162197645|NCT03322514|585773581|FG000|Overall Study|Withdrawal by Subject|1|||
162197646|NCT03322514|585773582|FG001|Overall Study|Withdrawal by Subject|1|||
162197647|NCT00088452|585773583|FG000|Overall Study|Did not receive intervention|1|||
162197648|NCT00088452|585773584|FG001|Overall Study|Did not receive intervention|0|||
162197649|NCT00088452|585773585|FG002|Overall Study|Did not receive intervention|1|||
162197650|NCT02081196|585773587|FG000|Overall Study|Lost to Follow-up|1|||
162197651|NCT00814632|585773591|FG000|Overall Study|Lack of Efficacy|2|||
162197652|NCT02514577|585773596|FG000|Overall Study|Lost to Follow-up|6|||
162197653|NCT02514577|585773597|FG001|Overall Study|Lost to Follow-up|6|||
162197654|NCT02514577|585773596|FG000|Overall Study|Protocol Violation|1|||
162197655|NCT02514577|585773597|FG001|Overall Study|Protocol Violation|0|||
162197656|NCT02514577|585773596|FG000|Overall Study|Withdrawal by Subject|6|||
162197657|NCT02514577|585773597|FG001|Overall Study|Withdrawal by Subject|6|||
162197658|NCT02514577|585773596|FG000|Overall Study|Adverse Event|1|||
162197659|NCT02514577|585773597|FG001|Overall Study|Adverse Event|1|||
162197660|NCT00489489|585773598|FG000|Overall Study|Not treated due to protocol violation|0|||
162197661|NCT00489489|585773599|FG001|Overall Study|Not treated due to protocol violation|1|||
162197662|NCT00489489|585773600|FG002|Overall Study|Not treated due to protocol violation|1|||
162197663|NCT00489489|585773598|FG000|Overall Study|Adverse Event|1|||
162197664|NCT00489489|585773599|FG001|Overall Study|Adverse Event|1|||
161926386|NCT01158404|584778596|FG000|Overall Study|Physician Decision|0|||
161926387|NCT01158404|584778597|FG001|Overall Study|Physician Decision|0|||
161926388|NCT01158404|584778598|FG002|Overall Study|Physician Decision|0|||
161926389|NCT01158404|584778599|FG003|Overall Study|Physician Decision|0|||
161926390|NCT01158404|584778600|FG004|Overall Study|Physician Decision|0|||
161926391|NCT01158404|584778601|FG005|Overall Study|Physician Decision|0|||
161926392|NCT01158404|584778602|FG006|Overall Study|Physician Decision|0|||
161926393|NCT01158404|584778603|FG007|Overall Study|Physician Decision|1|||
161926394|NCT01158404|584778596|FG000|Overall Study|Progressive Disease|0|||
161926395|NCT01158404|584778597|FG001|Overall Study|Progressive Disease|0|||
161926396|NCT01158404|584778598|FG002|Overall Study|Progressive Disease|0|||
161926397|NCT01158404|584778599|FG003|Overall Study|Progressive Disease|0|||
161926398|NCT01158404|584778600|FG004|Overall Study|Progressive Disease|0|||
161926399|NCT01158404|584778601|FG005|Overall Study|Progressive Disease|0|||
161926400|NCT01158404|584778602|FG006|Overall Study|Progressive Disease|1|||
161926401|NCT01158404|584778603|FG007|Overall Study|Progressive Disease|0|||
161926402|NCT02056288|584778604|FG000|In-Hospital Data|Surgery cancelled|1|||
161926403|NCT02056288|584778605|FG001|In-Hospital Data|Surgery cancelled|0|||
161926404|NCT02056288|584778604|FG000|In-Hospital Data|Protocol Violation|3|||
161926405|NCT02056288|584778605|FG001|In-Hospital Data|Protocol Violation|0|||
161926406|NCT02056288|584778604|FG000|In-Hospital Data|Physician Decision|1|||
161926407|NCT02056288|584778605|FG001|In-Hospital Data|Physician Decision|0|||
161926408|NCT02056288|584778604|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
161926409|NCT02056288|584778605|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
161926410|NCT02400580|584778608|FG000|Overall Study|Withdrawal by Subject|1|||
161926411|NCT02400580|584778609|FG001|Overall Study|Withdrawal by Subject|1|||
161926412|NCT02400580|584778608|FG000|Overall Study|Adverse Event|1|||
161926413|NCT02400580|584778609|FG001|Overall Study|Adverse Event|0|||
161926414|NCT00965094|584778610|FG000|Overall Study|Adverse Event|5|||
161926415|NCT00965094|584778611|FG001|Overall Study|Adverse Event|0|||
161926416|NCT00965094|584778610|FG000|Overall Study|Lost to Follow-up|0|||
161926417|NCT00965094|584778611|FG001|Overall Study|Lost to Follow-up|1|||
161926418|NCT01060111|584778612|FG000|Overall Study|Adverse Event|9|||
161926419|NCT01060111|584778613|FG001|Overall Study|Adverse Event|5|||
161926420|NCT01060111|584778614|FG002|Overall Study|Adverse Event|18|||
161926421|NCT01060111|584778612|FG000|Overall Study|Lack of Efficacy|2|||
161926422|NCT01060111|584778613|FG001|Overall Study|Lack of Efficacy|1|||
161926423|NCT01060111|584778614|FG002|Overall Study|Lack of Efficacy|0|||
161926424|NCT01060111|584778612|FG000|Overall Study|Inappropriate participant|5|||
162197665|NCT00489489|585773600|FG002|Overall Study|Adverse Event|1|||
162197666|NCT00489489|585773598|FG000|Overall Study|Protocol Violation|1|||
162197667|NCT00489489|585773599|FG001|Overall Study|Protocol Violation|0|||
162197668|NCT00489489|585773600|FG002|Overall Study|Protocol Violation|1|||
162197669|NCT00489489|585773598|FG000|Overall Study|Progressive disease|0|||
162197670|NCT00489489|585773599|FG001|Overall Study|Progressive disease|1|||
162197671|NCT00489489|585773600|FG002|Overall Study|Progressive disease|0|||
162020509|NCT00545272|585130494|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162020510|NCT00545272|585130495|FG002|Overall Study|Abnormal laboratory value(s)|0|||
162020511|NCT00545272|585130496|FG003|Overall Study|Abnormal laboratory value(s)|0|||
162020512|NCT00545272|585130497|FG004|Overall Study|Abnormal laboratory value(s)|0|||
162020513|NCT00545272|585130498|FG005|Overall Study|Abnormal laboratory value(s)|1|||
162020514|NCT00545272|585130493|FG000|Overall Study|Abnormal test procedure result(s)|0|||
162020515|NCT00545272|585130494|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162020516|NCT00545272|585130495|FG002|Overall Study|Abnormal test procedure result(s)|0|||
162020517|NCT00545272|585130496|FG003|Overall Study|Abnormal test procedure result(s)|0|||
162020518|NCT00545272|585130497|FG004|Overall Study|Abnormal test procedure result(s)|1|||
162020519|NCT00545272|585130498|FG005|Overall Study|Abnormal test procedure result(s)|0|||
162020520|NCT00545272|585130493|FG000|Overall Study|Lost to Follow-up|0|||
162197672|NCT00489489|585773598|FG000|Overall Study|Participant did not wish to continue|1|||
162197673|NCT00489489|585773599|FG001|Overall Study|Participant did not wish to continue|1|||
162197674|NCT00489489|585773600|FG002|Overall Study|Participant did not wish to continue|0|||
162197675|NCT00489489|585773598|FG000|Overall Study|Other than above|0|||
162197676|NCT00489489|585773599|FG001|Overall Study|Other than above|1|||
162020521|NCT00545272|585130494|FG001|Overall Study|Lost to Follow-up|0|||
162197677|NCT00489489|585773600|FG002|Overall Study|Other than above|0|||
162197678|NCT02136797|585773603|FG000|Overall Study|Not Treated|8|||
162197679|NCT04523571|585773604|FG000|Received 2 Doses|Withdrawal by Subject|0|||
162197680|NCT04523571|585773605|FG001|Received 2 Doses|Withdrawal by Subject|0|||
162197681|NCT04523571|585773606|FG002|Received 2 Doses|Withdrawal by Subject|0|||
162197682|NCT04523571|585773607|FG003|Received 2 Doses|Withdrawal by Subject|1|||
162197683|NCT04523571|585773608|FG004|Received 2 Doses|Withdrawal by Subject|1|||
162197684|NCT04523571|585773609|FG005|Received 2 Doses|Withdrawal by Subject|0|||
162197685|NCT04523571|585773604|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
162197686|NCT04523571|585773605|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
162197687|NCT04523571|585773606|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
162197688|NCT04523571|585773607|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
162197689|NCT04523571|585773608|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
162197690|NCT04523571|585773609|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
162197691|NCT04523571|585773604|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
162197692|NCT04523571|585773605|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
162197693|NCT04523571|585773606|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
162197694|NCT04523571|585773607|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
162197695|NCT04523571|585773608|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
162197696|NCT04523571|585773609|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
162197697|NCT04523571|585773604|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
162197698|NCT04523571|585773605|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
162197699|NCT04523571|585773606|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
162197700|NCT04523571|585773607|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
162197701|NCT04523571|585773608|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
162197702|NCT04523571|585773609|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
162197703|NCT04198428|585773610|FG000|Overall Study|Withdrawal by Subject|150|||
162197704|NCT04198428|585773611|FG001|Overall Study|Withdrawal by Subject|156|||
162197705|NCT00627523|585773612|FG000|Overall Study|Lack of Efficacy|1|||
161820690|NCT01597791|584384622|FG001|Overall Study|Physician Decision|1|||
161820691|NCT01597791|584384621|FG000|Overall Study|Cesarean Section|6|||
161820692|NCT01597791|584384622|FG001|Overall Study|Cesarean Section|7|||
161820693|NCT01597791|584384621|FG000|Overall Study|Subject withdrawal|0|||
161820694|NCT01597791|584384622|FG001|Overall Study|Subject withdrawal|1|||
161820695|NCT01597791|584384621|FG000|Overall Study|Protocol Violation|0|||
161820696|NCT01597791|584384622|FG001|Overall Study|Protocol Violation|1|||
161820697|NCT00354159|584384623|FG000|Randomized Study Period|Withdrawal by Subject|5|||
161820698|NCT00354159|584384624|FG001|Randomized Study Period|Withdrawal by Subject|3|||
161820699|NCT00354159|584384623|FG000|Randomized Study Period|Physician Decision|6|||
161820700|NCT00354159|584384624|FG001|Randomized Study Period|Physician Decision|10|||
161820701|NCT00354159|584384623|FG000|Randomized Study Period|Lost to Follow-up|4|||
161820702|NCT00354159|584384624|FG001|Randomized Study Period|Lost to Follow-up|0|||
161820703|NCT00354159|584384623|FG000|Randomized Study Period|Death|7|||
162020522|NCT00545272|585130495|FG002|Overall Study|Lost to Follow-up|0|||
162020523|NCT00545272|585130496|FG003|Overall Study|Lost to Follow-up|0|||
162020524|NCT00545272|585130497|FG004|Overall Study|Lost to Follow-up|1|||
162197706|NCT00627523|585773613|FG001|Overall Study|Lack of Efficacy|0|||
162197707|NCT00627523|585773612|FG000|Overall Study|Withdrawal by Subject|0|||
162197708|NCT00627523|585773613|FG001|Overall Study|Withdrawal by Subject|2|||
162020525|NCT00545272|585130498|FG005|Overall Study|Lost to Follow-up|0|||
162020526|NCT02934503|585130499|FG000|Overall Study|progression of disease|3|||
162020527|NCT02934503|585130499|FG000|Overall Study|Withdrawal by Subject|1|||
162020528|NCT00724867|585130500|FG000|Overall Study|Adverse Event|25|||
162197709|NCT00627523|585773612|FG000|Overall Study|Other|1|||
162197710|NCT00627523|585773613|FG001|Overall Study|Other|0|||
162197711|NCT04385849|585773616|FG000|Overall Study|Lost to Follow-up|1|||
162197712|NCT04385849|585773617|FG001|Overall Study|Lost to Follow-up|0|||
162197713|NCT02011568|585773620|FG000|Overall Study|Withdrawal by Subject|8|||
162197714|NCT02011568|585773621|FG001|Overall Study|Withdrawal by Subject|10|||
162197715|NCT02011568|585773620|FG000|Overall Study|Physician Decision|1|||
162197716|NCT02011568|585773621|FG001|Overall Study|Physician Decision|3|||
162197717|NCT01038128|585773623|FG000|Overall Study|Lack of Efficacy|1|||
162197718|NCT01038128|585773623|FG000|Overall Study|Lost to Follow-up|1|||
162197719|NCT01038128|585773623|FG000|Overall Study|Withdrawal by Subject|2|||
162197720|NCT03344458|585773628|FG000|Overall Study|Physician Decision|1|||
162197721|NCT03344458|585773628|FG000|Overall Study|Withdrawal by Subject|16|||
162197722|NCT03344458|585773628|FG000|Overall Study|Other reasons|10|||
162197723|NCT03344458|585773628|FG000|Overall Study|Lost to Follow-up|9|||
162197724|NCT03344458|585773628|FG000|Overall Study|Protocol Violation|3|||
162197725|NCT00396409|585773629|FG000|Period 1 - 2007|Adverse Event|0|||
162197726|NCT00396409|585773630|FG001|Period 1 - 2007|Adverse Event|1|||
162197727|NCT00396409|585773629|FG000|Period 1 - 2007|Lack of Efficacy|0|||
162197728|NCT00396409|585773630|FG001|Period 1 - 2007|Lack of Efficacy|1|||
162197729|NCT00396409|585773629|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
162197730|NCT00396409|585773630|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
162197731|NCT00396409|585773629|FG000|Period 1 - 2007|Lost to Follow-up|2|||
162197732|NCT00396409|585773630|FG001|Period 1 - 2007|Lost to Follow-up|3|||
162197733|NCT00396409|585773629|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
162197734|NCT00396409|585773630|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
162197735|NCT00396409|585773629|FG000|Period 2 - 2008|Protocol Violation|1|||
162197736|NCT00396409|585773630|FG001|Period 2 - 2008|Protocol Violation|0|||
162197737|NCT00396409|585773629|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
162197738|NCT00396409|585773630|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
162197739|NCT00396409|585773629|FG000|Period 2 - 2008|Lost to Follow-up|3|||
162197740|NCT00396409|585773630|FG001|Period 2 - 2008|Lost to Follow-up|1|||
162197741|NCT00331799|585773631|FG000|Overall Study|Withdrawal by Subject|2|||
162197742|NCT00331799|585773631|FG000|Overall Study|Sedation|1|||
162020529|NCT00724867|585130500|FG000|Overall Study|Lack of Efficacy|14|||
162020530|NCT00724867|585130500|FG000|Overall Study|Lost to Follow-up|12|||
162197743|NCT02889809|585773632|FG000|Overall Study|Withdrawal by Subject|30|||
162197744|NCT02889809|585773633|FG001|Overall Study|Withdrawal by Subject|21|||
162197745|NCT02889809|585773632|FG000|Overall Study|Lost to Follow-up|1|||
162197746|NCT02889809|585773633|FG001|Overall Study|Lost to Follow-up|1|||
162197747|NCT02889809|585773632|FG000|Overall Study|Site Closed|12|||
162197748|NCT02889809|585773633|FG001|Overall Study|Site Closed|11|||
162197749|NCT04203199|585773636|FG000|First Intervention Period|Lost to Follow-up|0|||
162197750|NCT04203199|585773637|FG001|First Intervention Period|Lost to Follow-up|1|||
162197751|NCT04203199|585773636|FG000|Second Intervention Period|Medication change|1|||
162197752|NCT04203199|585773637|FG001|Second Intervention Period|Medication change|0|||
162197753|NCT03960437|585773638|FG000|Overall Study|Removed by PI|4|||
162197754|NCT03960437|585773638|FG000|Overall Study|Lost to Follow-up|2|||
162197755|NCT03960437|585773638|FG000|Overall Study|Withdrawal by Subject|1|||
162197756|NCT03960437|585773638|FG000|Overall Study|Death|2|||
162197757|NCT01838499|585773644|FG000|Overall Study|Protocol Violation|0|||
162197758|NCT01838499|585773645|FG001|Overall Study|Protocol Violation|1|||
161820704|NCT00354159|584384624|FG001|Randomized Study Period|Death|9|||
162020531|NCT00724867|585130500|FG000|Overall Study|Non-compliance with study drug|6|||
162197759|NCT01838499|585773644|FG000|Overall Study|Lost to Follow-up|2|||
162197760|NCT01838499|585773645|FG001|Overall Study|Lost to Follow-up|4|||
162197761|NCT01838499|585773644|FG000|Overall Study|Lack of Efficacy|1|||
162197762|NCT01838499|585773645|FG001|Overall Study|Lack of Efficacy|2|||
162197763|NCT01838499|585773644|FG000|Overall Study|Adverse Event|2|||
162197764|NCT01838499|585773645|FG001|Overall Study|Adverse Event|1|||
162197765|NCT01838499|585773644|FG000|Overall Study|Withdrawal by Subject|19|||
162197766|NCT01838499|585773645|FG001|Overall Study|Withdrawal by Subject|9|||
162197767|NCT03614923|585773646|FG000|Overall Study|Withdrawal by Subject|2|||
162197768|NCT03614923|585773647|FG001|Overall Study|Withdrawal by Subject|1|||
162197769|NCT03614923|585773648|FG002|Overall Study|Withdrawal by Subject|1|||
162197770|NCT03614923|585773646|FG000|Overall Study|Adverse Event|0|||
162197771|NCT03614923|585773647|FG001|Overall Study|Adverse Event|2|||
162197772|NCT03614923|585773648|FG002|Overall Study|Adverse Event|1|||
162197773|NCT03614923|585773646|FG000|Overall Study|Lost to Follow-up|1|||
162197774|NCT03614923|585773647|FG001|Overall Study|Lost to Follow-up|0|||
162197775|NCT03614923|585773648|FG002|Overall Study|Lost to Follow-up|1|||
162197776|NCT03614923|585773646|FG000|Overall Study|Lack of Efficacy|2|||
162197777|NCT03614923|585773647|FG001|Overall Study|Lack of Efficacy|0|||
162197778|NCT03614923|585773648|FG002|Overall Study|Lack of Efficacy|1|||
162197779|NCT03614923|585773646|FG000|Overall Study|Non-compliance|0|||
162197780|NCT03614923|585773647|FG001|Overall Study|Non-compliance|1|||
162197781|NCT03614923|585773648|FG002|Overall Study|Non-compliance|0|||
162197782|NCT03614923|585773646|FG000|Overall Study|Other|0|||
162197783|NCT03614923|585773647|FG001|Overall Study|Other|1|||
162197784|NCT03614923|585773648|FG002|Overall Study|Other|1|||
162197785|NCT01136733|585773649|FG000|Phase 1b|Adverse Event|0|||
162197786|NCT01136733|585773650|FG001|Phase 1b|Adverse Event|3|||
162197787|NCT01136733|585773651|FG002|Phase 1b|Adverse Event|1|||
162197788|NCT01136733|585773652|FG003|Phase 1b|Adverse Event|0|||
162197789|NCT01136733|585773653|FG004|Phase 1b|Adverse Event|0|||
162197790|NCT01136733|585773654|FG005|Phase 1b|Adverse Event|0|||
162197791|NCT01136733|585773655|FG006|Phase 1b|Adverse Event|0|||
162197792|NCT01136733|585773649|FG000|Phase 1b|Participant Choice|0|||
162197793|NCT01136733|585773650|FG001|Phase 1b|Participant Choice|0|||
162197794|NCT01136733|585773651|FG002|Phase 1b|Participant Choice|1|||
162197795|NCT01136733|585773652|FG003|Phase 1b|Participant Choice|0|||
162197796|NCT01136733|585773653|FG004|Phase 1b|Participant Choice|0|||
162197797|NCT01136733|585773654|FG005|Phase 1b|Participant Choice|0|||
162197798|NCT01136733|585773655|FG006|Phase 1b|Participant Choice|0|||
162197799|NCT01136733|585773649|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
162197800|NCT01136733|585773650|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
162197801|NCT01136733|585773651|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
162197802|NCT01136733|585773652|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
162197803|NCT01136733|585773653|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
162197804|NCT01136733|585773654|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
162197805|NCT01136733|585773655|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
162197806|NCT01136733|585773649|FG000|Phase 1b|Clinical Progression|1|||
162197807|NCT01136733|585773650|FG001|Phase 1b|Clinical Progression|1|||
162197808|NCT01136733|585773651|FG002|Phase 1b|Clinical Progression|0|||
162197809|NCT01136733|585773652|FG003|Phase 1b|Clinical Progression|0|||
162197810|NCT01136733|585773653|FG004|Phase 1b|Clinical Progression|0|||
162197811|NCT01136733|585773654|FG005|Phase 1b|Clinical Progression|0|||
162197812|NCT01136733|585773655|FG006|Phase 1b|Clinical Progression|0|||
162197813|NCT01136733|585773649|FG000|Phase 2|Disease Progression|0|||
162197814|NCT01136733|585773650|FG001|Phase 2|Disease Progression|0|||
162197815|NCT01136733|585773651|FG002|Phase 2|Disease Progression|0|||
162197816|NCT01136733|585773652|FG003|Phase 2|Disease Progression|0|||
162020532|NCT00724867|585130500|FG000|Overall Study|Physician Decision|17|||
162020533|NCT00724867|585130500|FG000|Overall Study|Protocol Violation|1|||
162020534|NCT00724867|585130500|FG000|Overall Study|Withdrawal by Subject|31|||
162020535|NCT00724867|585130500|FG000|Overall Study|Sponsor decision to end study|14|||
162020536|NCT00724867|585130500|FG000|Overall Study|Subject incarcerated|1|||
162197817|NCT01136733|585773653|FG004|Phase 2|Disease Progression|30|||
162197818|NCT01136733|585773654|FG005|Phase 2|Disease Progression|32|||
162197819|NCT01136733|585773655|FG006|Phase 2|Disease Progression|38|||
162197820|NCT01136733|585773649|FG000|Phase 2|Adverse Event|0|||
162197821|NCT01136733|585773650|FG001|Phase 2|Adverse Event|0|||
162197822|NCT01136733|585773651|FG002|Phase 2|Adverse Event|0|||
162197823|NCT01136733|585773652|FG003|Phase 2|Adverse Event|0|||
162197824|NCT01136733|585773653|FG004|Phase 2|Adverse Event|11|||
162197825|NCT01136733|585773654|FG005|Phase 2|Adverse Event|13|||
162197826|NCT01136733|585773655|FG006|Phase 2|Adverse Event|5|||
162197827|NCT01136733|585773649|FG000|Phase 2|Participant Choice|0|||
162197828|NCT01136733|585773650|FG001|Phase 2|Participant Choice|0|||
162197829|NCT01136733|585773651|FG002|Phase 2|Participant Choice|0|||
162197830|NCT01136733|585773652|FG003|Phase 2|Participant Choice|0|||
162197831|NCT01136733|585773653|FG004|Phase 2|Participant Choice|3|||
162197832|NCT01136733|585773654|FG005|Phase 2|Participant Choice|0|||
162197833|NCT01136733|585773655|FG006|Phase 2|Participant Choice|1|||
162197834|NCT01136733|585773649|FG000|Phase 2|Administrative-Withdrew Consent|0|||
162197835|NCT01136733|585773650|FG001|Phase 2|Administrative-Withdrew Consent|0|||
162197836|NCT01136733|585773651|FG002|Phase 2|Administrative-Withdrew Consent|0|||
162197837|NCT01136733|585773652|FG003|Phase 2|Administrative-Withdrew Consent|0|||
162197838|NCT01136733|585773653|FG004|Phase 2|Administrative-Withdrew Consent|1|||
162197839|NCT01136733|585773654|FG005|Phase 2|Administrative-Withdrew Consent|0|||
162197840|NCT01136733|585773655|FG006|Phase 2|Administrative-Withdrew Consent|0|||
162197841|NCT01136733|585773649|FG000|Phase 2|Other|0|||
162197842|NCT01136733|585773650|FG001|Phase 2|Other|0|||
162197843|NCT01136733|585773651|FG002|Phase 2|Other|0|||
162197844|NCT01136733|585773652|FG003|Phase 2|Other|0|||
162197845|NCT01136733|585773653|FG004|Phase 2|Other|6|||
162197846|NCT01136733|585773654|FG005|Phase 2|Other|7|||
162197847|NCT01136733|585773655|FG006|Phase 2|Other|6|||
162197848|NCT01882088|585773657|FG000|Overall Study|Intolerance of esophageal manometry|1|||
162197849|NCT01882088|585773657|FG000|Overall Study|no possibility to place the catheter|1|||
162197850|NCT01882088|585773657|FG000|Overall Study|Protocol Violation|1|||
162197851|NCT01882088|585773657|FG000|Overall Study|inadequate pH-impedance tracings|2|||
162197852|NCT02186015|585773658|FG000|Overall Study|Physician Decision|1|||
162197853|NCT02186015|585773659|FG001|Overall Study|Physician Decision|0|||
162197854|NCT01533181|585773662|FG000|Overall Study|Disease progression pre-active treatment|0|||
162197855|NCT01533181|585773663|FG001|Overall Study|Disease progression pre-active treatment|1|||
162197856|NCT01533181|585773662|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
162197857|NCT01533181|585773663|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
162197858|NCT02720198|585773664|FG000|Overall Study|Withdrawal by Subject|0|||
162197859|NCT02720198|585773665|FG001|Overall Study|Withdrawal by Subject|1|||
162197860|NCT02592434|585773668|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
162197861|NCT02592434|585773669|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
162197862|NCT02592434|585773670|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
162197863|NCT02592434|585773668|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
162197864|NCT02592434|585773669|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
162197865|NCT02592434|585773670|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
162197866|NCT02592434|585773668|FG000|Open-Label Phase (18 Weeks)|Other|3|||
162197867|NCT02592434|585773669|FG001|Open-Label Phase (18 Weeks)|Other|0|||
162197868|NCT02592434|585773670|FG002|Open-Label Phase (18 Weeks)|Other|0|||
162197869|NCT02592434|585773668|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
162197870|NCT02592434|585773669|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
162197871|NCT02592434|585773670|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
162197872|NCT02592434|585773668|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
162197873|NCT02592434|585773669|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
162197874|NCT02592434|585773670|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
162197875|NCT02592434|585773668|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
162197876|NCT02592434|585773669|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
162197877|NCT02592434|585773670|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
162197878|NCT02592434|585773668|FG000|Double Blind Phase (26 Weeks)|Other|0|||
162197879|NCT02592434|585773669|FG001|Double Blind Phase (26 Weeks)|Other|1|||
162197880|NCT02592434|585773670|FG002|Double Blind Phase (26 Weeks)|Other|0|||
162197881|NCT02592434|585773668|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
162197882|NCT02592434|585773669|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
162197883|NCT02592434|585773670|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
162197884|NCT02592434|585773668|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
162197885|NCT02592434|585773669|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
162197886|NCT02592434|585773670|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
162197887|NCT02592434|585773668|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
162197888|NCT02592434|585773669|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
162197889|NCT02592434|585773670|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
162197890|NCT00147745|585773671|FG000|Overall Study|Withdrawal by Subject|1|||
162197891|NCT00147745|585773672|FG001|Overall Study|Withdrawal by Subject|0|||
162197892|NCT00147745|585773673|FG002|Overall Study|Withdrawal by Subject|0|||
162197893|NCT01757171|585773674|FG000|Overall Study|Adverse Event|5|||
162197894|NCT01757171|585773675|FG001|Overall Study|Adverse Event|1|||
162197895|NCT01757171|585773674|FG000|Overall Study|Disease Progression|1|||
162197896|NCT01757171|585773675|FG001|Overall Study|Disease Progression|0|||
161926425|NCT01060111|584778613|FG001|Overall Study|Inappropriate participant|4|||
161926426|NCT01060111|584778614|FG002|Overall Study|Inappropriate participant|5|||
161926427|NCT01060111|584778612|FG000|Overall Study|Participants' evasion for hospital visit|0|||
161926428|NCT01060111|584778613|FG001|Overall Study|Participants' evasion for hospital visit|3|||
161926429|NCT01060111|584778614|FG002|Overall Study|Participants' evasion for hospital visit|2|||
161926430|NCT01060111|584778612|FG000|Overall Study|Participants' non-cooperation|8|||
161926431|NCT01060111|584778613|FG001|Overall Study|Participants' non-cooperation|6|||
161926432|NCT01060111|584778614|FG002|Overall Study|Participants' non-cooperation|6|||
161926433|NCT01060111|584778612|FG000|Overall Study|Adverse event and insufficient effect|0|||
161926434|NCT01060111|584778613|FG001|Overall Study|Adverse event and insufficient effect|1|||
161926435|NCT01060111|584778614|FG002|Overall Study|Adverse event and insufficient effect|0|||
161926436|NCT01060111|584778612|FG000|Overall Study|Participants' non-cooperation|1|||
161926437|NCT01060111|584778613|FG001|Overall Study|Participants' non-cooperation|0|||
161926438|NCT01060111|584778614|FG002|Overall Study|Participants' non-cooperation|0|||
161926439|NCT01060111|584778612|FG000|Overall Study|Other|2|||
162197897|NCT01757171|585773674|FG000|Overall Study|Hospitalization|1|||
162197898|NCT01757171|585773675|FG001|Overall Study|Hospitalization|0|||
162197899|NCT01757171|585773674|FG000|Overall Study|ECOG decline|1|||
162197900|NCT01757171|585773675|FG001|Overall Study|ECOG decline|0|||
162197901|NCT00510783|585773678|FG000|Overall Study|Lost to Follow-up|29|||
162197902|NCT00510783|585773679|FG001|Overall Study|Lost to Follow-up|25|||
161926440|NCT01060111|584778613|FG001|Overall Study|Other|3|||
161926441|NCT01060111|584778614|FG002|Overall Study|Other|4|||
162197903|NCT00510783|585773678|FG000|Overall Study|Withdrawal by Subject|2|||
162197904|NCT00510783|585773679|FG001|Overall Study|Withdrawal by Subject|3|||
162197905|NCT00510783|585773678|FG000|Overall Study|Protocol Violation|0|||
162197906|NCT00510783|585773679|FG001|Overall Study|Protocol Violation|1|||
162197907|NCT00316121|585773680|FG000|Overall Study|Death|1|||
162197908|NCT00316121|585773681|FG001|Overall Study|Death|0|||
162197909|NCT00316121|585773680|FG000|Overall Study|Lost to Follow-up|14|||
162197910|NCT00316121|585773681|FG001|Overall Study|Lost to Follow-up|8|||
162197911|NCT00316121|585773680|FG000|Overall Study|Withdrawal by Subject|2|||
162197912|NCT00316121|585773681|FG001|Overall Study|Withdrawal by Subject|0|||
162197913|NCT00316121|585773680|FG000|Overall Study|Reason is missing|1|||
162197914|NCT00316121|585773681|FG001|Overall Study|Reason is missing|0|||
162197915|NCT00316121|585773680|FG000|Overall Study|Subject relocated|1|||
162197916|NCT00316121|585773681|FG001|Overall Study|Subject relocated|1|||
162197917|NCT00316121|585773680|FG000|Overall Study|Subject refused to return|1|||
162197918|NCT00316121|585773681|FG001|Overall Study|Subject refused to return|0|||
162197919|NCT00316121|585773680|FG000|Overall Study|Subject no show for visit x 3|1|||
162197920|NCT00316121|585773681|FG001|Overall Study|Subject no show for visit x 3|0|||
162197921|NCT00316121|585773680|FG000|Overall Study|Subject did not have 24 month visit|1|||
162197922|NCT00316121|585773681|FG001|Overall Study|Subject did not have 24 month visit|0|||
162197923|NCT00460577|585773687|FG000|Overall Study|Protocol Violation|2|||
162197924|NCT00460577|585773688|FG001|Overall Study|Protocol Violation|6|||
162197925|NCT04043806|585773689|FG000|Overall Study|Commercial drug is available for participants|13|||
162197926|NCT04043806|585773689|FG000|Overall Study|Physician Decision|2|||
162197927|NCT04043806|585773689|FG000|Overall Study|Other|12|||
162197928|NCT04043806|585773689|FG000|Overall Study|Adverse Event|2|||
162197929|NCT04043806|585773689|FG000|Overall Study|Lost to Follow-up|6|||
162197930|NCT04043806|585773689|FG000|Overall Study|Other non-compliance|2|||
162197931|NCT04043806|585773689|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
162197932|NCT04043806|585773689|FG000|Overall Study|Never Dosed|1|||
162197933|NCT04362176|585773690|FG000|Overall Study|Lost to Follow-up|5|||
162197934|NCT04362176|585773691|FG001|Overall Study|Lost to Follow-up|8|||
162197935|NCT04362176|585773690|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
162197936|NCT04362176|585773691|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
162197937|NCT02632045|585773693|FG000|Overall Study|Withdrawal by Subject|1|||
162197938|NCT02632045|585773694|FG001|Overall Study|Withdrawal by Subject|2|||
162197939|NCT00596960|585773696|FG000|Overall Study|Death|1|||
162197940|NCT00596960|585773697|FG001|Overall Study|Death|2|||
162197941|NCT00596960|585773696|FG000|Overall Study|Lost to Follow-up|6|||
162197942|NCT00596960|585773697|FG001|Overall Study|Lost to Follow-up|5|||
162197943|NCT00596960|585773696|FG000|Overall Study|Withdrawal by Subject|1|||
161926442|NCT01433978|584778615|FG000|Core Study|Adverse Event, Non-Fatal|0|||
161926443|NCT01433978|584778616|FG001|Core Study|Adverse Event, Non-Fatal|1|||
161926444|NCT01433978|584778617|FG002|Core Study|Adverse Event, Non-Fatal|0|||
162197944|NCT00596960|585773697|FG001|Overall Study|Withdrawal by Subject|0|||
162197945|NCT00596960|585773696|FG000|Overall Study|Incarcerated|2|||
161926445|NCT01433978|584778615|FG000|Core Study|Lack of Efficacy|5|||
162197946|NCT00596960|585773697|FG001|Overall Study|Incarcerated|0|||
162197947|NCT00596960|585773696|FG000|Overall Study|Physician Decision|1|||
162197948|NCT00596960|585773697|FG001|Overall Study|Physician Decision|0|||
162197949|NCT00596960|585773696|FG000|Overall Study|Protocol Violation|0|||
162197950|NCT00596960|585773697|FG001|Overall Study|Protocol Violation|1|||
162197951|NCT00596960|585773696|FG000|Overall Study|No alcohol use data|0|||
162197952|NCT00596960|585773697|FG001|Overall Study|No alcohol use data|1|||
162197953|NCT03503188|585773698|FG000|Overall Study|Non eligible in the sub study|0|||
162197954|NCT03503188|585773699|FG001|Overall Study|Non eligible in the sub study|1|||
162197955|NCT01885559|585773700|FG000|Overall Study|Lost to Follow-up|15|||
162197956|NCT01885559|585773701|FG001|Overall Study|Lost to Follow-up|16|||
162197957|NCT01885559|585773700|FG000|Overall Study|Less than full participation|9|||
162197958|NCT01885559|585773701|FG001|Overall Study|Less than full participation|19|||
162197959|NCT01885559|585773700|FG000|Overall Study|Protocol Violation|0|||
162197960|NCT01885559|585773701|FG001|Overall Study|Protocol Violation|1|||
162197961|NCT03122548|585773713|FG000|Overall Study|Death|2|||
162197962|NCT03122548|585773713|FG000|Overall Study|Progression - subject went into hospice|1|||
162197963|NCT03122548|585773713|FG000|Overall Study|Study Terminated by Sponsor|2|||
162197964|NCT01634165|585773717|FG000|Period 2|Adverse Event|0|||
162197965|NCT01634165|585773718|FG001|Period 2|Adverse Event|1|||
162197966|NCT01634165|585773719|FG002|Period 2|Adverse Event|0|||
162197967|NCT01634165|585773720|FG003|Period 2|Adverse Event|0|||
162197968|NCT00705614|585775357|FG000|Initial Intervention|Adverse Event|40|||
162197969|NCT00705614|585775358|FG001|Initial Intervention|Adverse Event|21|||
162197970|NCT00705614|585775357|FG000|Initial Intervention|Lost to Follow-up|310|||
162197971|NCT00705614|585775358|FG001|Initial Intervention|Lost to Follow-up|191|||
162197972|NCT00705614|585775357|FG000|Initial Intervention|Withdrawal by Subject|114|||
162197973|NCT00705614|585775358|FG001|Initial Intervention|Withdrawal by Subject|71|||
162197974|NCT00705614|585775357|FG000|Initial Intervention|Administrative Reason|51|||
162197975|NCT00705614|585775358|FG001|Initial Intervention|Administrative Reason|38|||
162197976|NCT00705614|585775357|FG000|Initial Intervention|Status completion unknown|3|||
162197977|NCT00705614|585775358|FG001|Initial Intervention|Status completion unknown|0|||
162197978|NCT00705614|585775357|FG000|Switch to Remicade|Adverse Event|0|||
162197979|NCT00705614|585775358|FG001|Switch to Remicade|Adverse Event|5|||
162197980|NCT00705614|585775357|FG000|Switch to Remicade|Lost to Follow-up|0|||
162197981|NCT00705614|585775358|FG001|Switch to Remicade|Lost to Follow-up|23|||
162197982|NCT00705614|585775357|FG000|Switch to Remicade|Withdrawal by Subject|0|||
162197983|NCT00705614|585775358|FG001|Switch to Remicade|Withdrawal by Subject|12|||
162197984|NCT00705614|585775357|FG000|Switch to Remicade|Administrative Reason|0|||
162197985|NCT00705614|585775358|FG001|Switch to Remicade|Administrative Reason|9|||
162197986|NCT02661490|585775359|FG000|Overall Study|Lost to Follow-up|0|||
162197987|NCT02661490|585775360|FG001|Overall Study|Lost to Follow-up|1|||
162197988|NCT02661490|585775361|FG002|Overall Study|Lost to Follow-up|0|||
161926446|NCT01433978|584778616|FG001|Core Study|Lack of Efficacy|1|||
161926447|NCT01433978|584778617|FG002|Core Study|Lack of Efficacy|0|||
161926448|NCT01433978|584778615|FG000|Core Study|Study Terminated by Sponsor|6|||
161926449|NCT01433978|584778616|FG001|Core Study|Study Terminated by Sponsor|9|||
161926450|NCT01433978|584778617|FG002|Core Study|Study Terminated by Sponsor|0|||
161926451|NCT01433978|584778615|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
161926452|NCT01433978|584778616|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
161926453|NCT01433978|584778617|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
161926454|NCT01433978|584778615|FG000|Extension Phase|Lack of Efficacy|0|||
161926455|NCT01433978|584778616|FG001|Extension Phase|Lack of Efficacy|0|||
161926456|NCT01433978|584778617|FG002|Extension Phase|Lack of Efficacy|1|||
161926457|NCT01433978|584778615|FG000|Extension Phase|Study Terminated by Sponsor|0|||
161926458|NCT01433978|584778616|FG001|Extension Phase|Study Terminated by Sponsor|0|||
161926459|NCT01433978|584778617|FG002|Extension Phase|Study Terminated by Sponsor|4|||
161926460|NCT01773889|584778619|FG000|Overall Study|lack of funding|2|||
161926461|NCT04233580|584778620|FG000|Overall Study|Adverse Event|3|||
162197989|NCT02661490|585775362|FG003|Overall Study|Lost to Follow-up|0|||
162197990|NCT02661490|585775363|FG004|Overall Study|Lost to Follow-up|2|||
162197991|NCT02661490|585775359|FG000|Overall Study|Withdrawal by Subject|2|||
162197992|NCT02661490|585775360|FG001|Overall Study|Withdrawal by Subject|0|||
162197993|NCT02661490|585775361|FG002|Overall Study|Withdrawal by Subject|2|||
162197994|NCT02661490|585775362|FG003|Overall Study|Withdrawal by Subject|0|||
162197995|NCT02661490|585775363|FG004|Overall Study|Withdrawal by Subject|0|||
162197996|NCT02661490|585775359|FG000|Overall Study|Death|1|||
162197997|NCT02661490|585775360|FG001|Overall Study|Death|1|||
162197998|NCT02661490|585775361|FG002|Overall Study|Death|0|||
162197999|NCT02661490|585775362|FG003|Overall Study|Death|1|||
162198000|NCT02661490|585775363|FG004|Overall Study|Death|0|||
162198001|NCT02661490|585775359|FG000|Overall Study|Reason not Specified|0|||
162198002|NCT02661490|585775360|FG001|Overall Study|Reason not Specified|0|||
162198003|NCT02661490|585775361|FG002|Overall Study|Reason not Specified|0|||
162198004|NCT02661490|585775362|FG003|Overall Study|Reason not Specified|0|||
162198005|NCT02661490|585775363|FG004|Overall Study|Reason not Specified|1|||
162198006|NCT00961298|585775364|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
162198007|NCT00961298|585775364|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
162198008|NCT00961298|585775364|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
162198009|NCT01232569|585775367|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
161926462|NCT04233580|584778621|FG001|Overall Study|Adverse Event|3|||
161926463|NCT04233580|584778620|FG000|Overall Study|Withdrawal by Subject|2|||
161926464|NCT04233580|584778621|FG001|Overall Study|Withdrawal by Subject|1|||
161926465|NCT03954938|584778622|FG000|Overall Study|Withdrawal by Subject|2|||
161926466|NCT03954938|584778622|FG000|Overall Study|Adverse Event|1|||
161926467|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
161926468|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
161926469|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
161926470|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
161926471|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
161926472|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
161926473|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
161926474|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
161926475|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
161926476|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
161926477|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
161926478|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
161926479|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
161926480|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
161926481|NCT00976391|584778623|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
161926482|NCT00976391|584778624|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
161926483|NCT00976391|584778623|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
161926484|NCT00976391|584778624|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
161926485|NCT00976391|584778623|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
161926486|NCT00976391|584778624|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
161926487|NCT00976391|584778623|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
161926488|NCT00976391|584778624|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
161926489|NCT00976391|584778623|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
161926490|NCT00976391|584778624|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
161926491|NCT00976391|584778623|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
161926492|NCT00976391|584778624|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
161926493|NCT00976391|584778623|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
161926494|NCT00976391|584778624|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
161926495|NCT00617903|584778625|FG000|Overall Study|Withdrawal by Subject|2|||
161926496|NCT00617903|584778626|FG001|Overall Study|Withdrawal by Subject|3|||
161926497|NCT00617903|584778625|FG000|Overall Study|Lost to Follow-up|1|||
161926498|NCT00617903|584778626|FG001|Overall Study|Lost to Follow-up|1|||
161926499|NCT00617903|584778625|FG000|Overall Study|Lack of Efficacy|0|||
161926500|NCT00617903|584778626|FG001|Overall Study|Lack of Efficacy|1|||
161926501|NCT00617903|584778625|FG000|Overall Study|Adverse Event|0|||
161926502|NCT00617903|584778626|FG001|Overall Study|Adverse Event|1|||
161926503|NCT00617903|584778625|FG000|Overall Study|noncompliance|0|||
161926504|NCT00617903|584778626|FG001|Overall Study|noncompliance|1|||
161926505|NCT01371565|584778627|FG000|Overall Study|Withdrawal by Subject|1|||
161926506|NCT01371565|584778627|FG000|Overall Study|Death|1|||
161926507|NCT01371565|584778627|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
161926508|NCT02565186|584778628|FG000|Overall Study|Adverse Event|113|||
161926509|NCT02565186|584778629|FG001|Overall Study|Adverse Event|148|||
161926510|NCT02565186|584778628|FG000|Overall Study|Lost to Follow-up|102|||
161926511|NCT02565186|584778629|FG001|Overall Study|Lost to Follow-up|93|||
161926512|NCT02565186|584778628|FG000|Overall Study|Non-Compliance|57|||
162198010|NCT01232569|585775368|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
162198011|NCT01232569|585775369|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
162198012|NCT01232569|585775370|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
162198013|NCT01232569|585775367|FG000|Double-blind Treatment Period|Escape|2|||
161926513|NCT02565186|584778629|FG001|Overall Study|Non-Compliance|55|||
162198014|NCT01232569|585775368|FG001|Double-blind Treatment Period|Escape|2|||
162198015|NCT01232569|585775369|FG002|Double-blind Treatment Period|Escape|0|||
162198016|NCT01232569|585775370|FG003|Double-blind Treatment Period|Escape|0|||
162198017|NCT01232569|585775367|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
162198018|NCT01232569|585775368|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161926514|NCT02565186|584778628|FG000|Overall Study|Withdrawal by Subject|229|||
161926515|NCT02565186|584778629|FG001|Overall Study|Withdrawal by Subject|214|||
161926516|NCT02565186|584778628|FG000|Overall Study|Physician Decision|18|||
161926517|NCT02565186|584778629|FG001|Overall Study|Physician Decision|16|||
161926518|NCT02565186|584778628|FG000|Overall Study|Sponsor Request|5|||
161926519|NCT02565186|584778629|FG001|Overall Study|Sponsor Request|9|||
161926520|NCT02565186|584778628|FG000|Overall Study|Missing|1|||
161926521|NCT02565186|584778629|FG001|Overall Study|Missing|0|||
161926522|NCT02565186|584778628|FG000|Overall Study|Did Not Receive Study Drug|55|||
162198019|NCT01232569|585775369|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
162198020|NCT01232569|585775370|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
162198021|NCT01232569|585775367|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
162198022|NCT01232569|585775368|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
162198023|NCT01232569|585775369|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
162198024|NCT01232569|585775370|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
162198025|NCT01232569|585775367|FG000|Double-blind Treatment Period|Physician Decision|1|||
162198026|NCT01232569|585775368|FG001|Double-blind Treatment Period|Physician Decision|0|||
162198027|NCT01232569|585775369|FG002|Double-blind Treatment Period|Physician Decision|0|||
162198028|NCT01232569|585775370|FG003|Double-blind Treatment Period|Physician Decision|0|||
162198029|NCT01232569|585775367|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
162198030|NCT01232569|585775368|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
162198031|NCT01232569|585775369|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
162198032|NCT01232569|585775370|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
162198033|NCT01232569|585775367|FG000|Double-blind Treatment Period|Death|2|||
162198034|NCT01232569|585775368|FG001|Double-blind Treatment Period|Death|0|||
162198035|NCT01232569|585775369|FG002|Double-blind Treatment Period|Death|0|||
162198036|NCT01232569|585775370|FG003|Double-blind Treatment Period|Death|0|||
162198037|NCT04044352|585775371|FG000|Overall Study|Lost to Follow-up|9|||
162198038|NCT04044352|585775371|FG000|Overall Study|Withdrawal by Subject|2|||
162198039|NCT02388932|585775376|FG000|Overall Study|Death|1|||
162198040|NCT05335005|585775379|FG000|Overall Study|Lost to Follow-up|1|||
162198041|NCT05927753|585775380|FG000|Overall Study|Withdrawal by Subject|0|||
162198042|NCT05927753|585775381|FG001|Overall Study|Withdrawal by Subject|2|||
162198043|NCT05927753|585775380|FG000|Overall Study|Physician Decision|0|||
162198044|NCT05927753|585775381|FG001|Overall Study|Physician Decision|1|||
162198045|NCT02123797|585775382|FG000|Baseline Intervention|Death|9|||
162198046|NCT02123797|585775383|FG001|Baseline Intervention|Death|16|||
162198047|NCT02123797|585775384|FG002|Baseline Intervention|Death|0|||
162198048|NCT02123797|585775385|FG003|Baseline Intervention|Death|0|||
162198049|NCT02123797|585775386|FG004|Baseline Intervention|Death|0|||
162198050|NCT02123797|585775382|FG000|Baseline Intervention|Withdrawal by Subject|2|||
162198051|NCT02123797|585775383|FG001|Baseline Intervention|Withdrawal by Subject|8|||
162198052|NCT02123797|585775384|FG002|Baseline Intervention|Withdrawal by Subject|0|||
162198053|NCT02123797|585775385|FG003|Baseline Intervention|Withdrawal by Subject|0|||
162198054|NCT02123797|585775386|FG004|Baseline Intervention|Withdrawal by Subject|0|||
162198055|NCT02123797|585775382|FG000|Baseline Intervention|Relocation|2|||
162198056|NCT02123797|585775383|FG001|Baseline Intervention|Relocation|0|||
162198057|NCT02123797|585775384|FG002|Baseline Intervention|Relocation|0|||
162198058|NCT02123797|585775385|FG003|Baseline Intervention|Relocation|0|||
162198059|NCT02123797|585775386|FG004|Baseline Intervention|Relocation|0|||
162198060|NCT02123797|585775382|FG000|Baseline Intervention|Out of window for initial survey|6|||
162198061|NCT02123797|585775383|FG001|Baseline Intervention|Out of window for initial survey|13|||
162198062|NCT02123797|585775384|FG002|Baseline Intervention|Out of window for initial survey|0|||
162198063|NCT02123797|585775385|FG003|Baseline Intervention|Out of window for initial survey|0|||
162198064|NCT02123797|585775386|FG004|Baseline Intervention|Out of window for initial survey|0|||
162198065|NCT02123797|585775382|FG000|Baseline Intervention|Lost to Follow-up|0|||
162198066|NCT02123797|585775383|FG001|Baseline Intervention|Lost to Follow-up|5|||
162198067|NCT02123797|585775384|FG002|Baseline Intervention|Lost to Follow-up|0|||
161926523|NCT02565186|584778629|FG001|Overall Study|Did Not Receive Study Drug|86|||
161926524|NCT04676646|584778630|FG000|Open-label Run-in Phase|Adverse Event|3|||
161926525|NCT04676646|584778631|FG001|Open-label Run-in Phase|Adverse Event|0|||
161926526|NCT04676646|584778632|FG002|Open-label Run-in Phase|Adverse Event|0|||
161926527|NCT04676646|584778630|FG000|Open-label Run-in Phase|Death|3|||
161676137|NCT01667107|583867308|FG001|Overall Study|Tolerability issues|2|||
161926528|NCT04676646|584778631|FG001|Open-label Run-in Phase|Death|0|||
161926529|NCT04676646|584778632|FG002|Open-label Run-in Phase|Death|0|||
162020537|NCT00724867|585130500|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
162020538|NCT00724867|585130500|FG000|Overall Study|Subject moved out of state|1|||
162198068|NCT02123797|585775385|FG003|Baseline Intervention|Lost to Follow-up|0|||
162198069|NCT02123797|585775386|FG004|Baseline Intervention|Lost to Follow-up|0|||
162198070|NCT02123797|585775382|FG000|Baseline Intervention|Other Disease|3|||
162198071|NCT02123797|585775383|FG001|Baseline Intervention|Other Disease|0|||
162198072|NCT02123797|585775384|FG002|Baseline Intervention|Other Disease|0|||
162198073|NCT02123797|585775385|FG003|Baseline Intervention|Other Disease|0|||
162198074|NCT02123797|585775386|FG004|Baseline Intervention|Other Disease|0|||
162198075|NCT02123797|585775382|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
162198076|NCT02123797|585775383|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
162198077|NCT02123797|585775384|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
162198078|NCT02123797|585775385|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
162198079|NCT02123797|585775386|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
162198080|NCT02123797|585775382|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
162198081|NCT02123797|585775383|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
162198082|NCT02123797|585775384|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
162198083|NCT02123797|585775385|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
162198084|NCT02123797|585775386|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
162198085|NCT02123797|585775382|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
162198086|NCT02123797|585775383|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
162198087|NCT02123797|585775384|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
162198088|NCT02123797|585775385|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
162198089|NCT02123797|585775386|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
162198090|NCT02123797|585775382|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
162198091|NCT02123797|585775383|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
162198092|NCT02123797|585775384|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
162198093|NCT02123797|585775385|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
162198094|NCT02123797|585775386|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
162198095|NCT02123797|585775382|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
162198096|NCT02123797|585775383|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
162198097|NCT02123797|585775384|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
162198098|NCT02123797|585775385|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
162198099|NCT02123797|585775386|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
162198100|NCT02123797|585775382|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
162198101|NCT02123797|585775383|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
162198102|NCT02123797|585775384|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
162198103|NCT02123797|585775385|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
162198104|NCT02123797|585775386|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
162198105|NCT02123797|585775382|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
162198106|NCT02123797|585775383|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
162198107|NCT02123797|585775384|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
162198108|NCT02123797|585775385|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
162198109|NCT02123797|585775386|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
162198110|NCT02123797|585775382|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
162198111|NCT02123797|585775383|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
162198112|NCT02123797|585775384|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
162198113|NCT02123797|585775385|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
162198114|NCT02123797|585775386|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
162198115|NCT02123797|585775382|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
162198116|NCT02123797|585775383|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
162198117|NCT02123797|585775384|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
162198118|NCT02123797|585775385|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
162198119|NCT02123797|585775386|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
162198120|NCT01375777|585775388|FG000|Overall Study|Withdrawal by Subject|0|||
162198121|NCT01375777|585775389|FG001|Overall Study|Withdrawal by Subject|2|||
162198122|NCT01375777|585775390|FG002|Overall Study|Withdrawal by Subject|1|||
162198123|NCT01375777|585775391|FG003|Overall Study|Withdrawal by Subject|0|||
162198124|NCT01375777|585775392|FG004|Overall Study|Withdrawal by Subject|1|||
162198125|NCT01375777|585775393|FG005|Overall Study|Withdrawal by Subject|1|||
162198126|NCT01375777|585775394|FG006|Overall Study|Withdrawal by Subject|1|||
162198127|NCT01375777|585775395|FG007|Overall Study|Withdrawal by Subject|2|||
161820705|NCT00354159|584384623|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
162198128|NCT01375777|585775396|FG008|Overall Study|Withdrawal by Subject|1|||
162198129|NCT01375777|585775388|FG000|Overall Study|Lost to Follow-up|1|||
162198130|NCT01375777|585775389|FG001|Overall Study|Lost to Follow-up|0|||
162198131|NCT01375777|585775390|FG002|Overall Study|Lost to Follow-up|0|||
162198132|NCT01375777|585775391|FG003|Overall Study|Lost to Follow-up|0|||
162198133|NCT01375777|585775392|FG004|Overall Study|Lost to Follow-up|0|||
162198134|NCT01375777|585775393|FG005|Overall Study|Lost to Follow-up|0|||
162198135|NCT01375777|585775394|FG006|Overall Study|Lost to Follow-up|1|||
162198136|NCT01375777|585775395|FG007|Overall Study|Lost to Follow-up|0|||
162198137|NCT01375777|585775396|FG008|Overall Study|Lost to Follow-up|0|||
161820706|NCT00354159|584384624|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
161820707|NCT00354159|584384623|FG000|Long-term Follow-up|Physician Decision|127|||
161820708|NCT00354159|584384624|FG001|Long-term Follow-up|Physician Decision|122|||
162198138|NCT01375777|585775388|FG000|Overall Study|Other|1|||
162198139|NCT01375777|585775389|FG001|Overall Study|Other|1|||
162198140|NCT01375777|585775390|FG002|Overall Study|Other|0|||
162198141|NCT01375777|585775391|FG003|Overall Study|Other|0|||
161820709|NCT00354159|584384623|FG000|Long-term Follow-up|Lost to Follow-up|1|||
162020539|NCT00724867|585130500|FG000|Overall Study|Elected to exit due to site closure|2|||
162198142|NCT01375777|585775392|FG004|Overall Study|Other|0|||
162198143|NCT01375777|585775393|FG005|Overall Study|Other|0|||
162198144|NCT01375777|585775394|FG006|Overall Study|Other|0|||
162198145|NCT01375777|585775395|FG007|Overall Study|Other|0|||
162198146|NCT01375777|585775396|FG008|Overall Study|Other|1|||
162198147|NCT00355784|585775397|FG000|Overall Study|Withdrawal by Subject|0|||
162198148|NCT00355784|585775398|FG001|Overall Study|Withdrawal by Subject|0|||
161820710|NCT00354159|584384624|FG001|Long-term Follow-up|Lost to Follow-up|0|||
162198149|NCT00355784|585775399|FG002|Overall Study|Withdrawal by Subject|2|||
162198150|NCT03602053|585775406|FG000|Overall Study|Withdrawal by Subject|7|||
162198151|NCT03602053|585775407|FG001|Overall Study|Withdrawal by Subject|9|||
162198152|NCT03602053|585775408|FG002|Overall Study|Withdrawal by Subject|7|||
162198153|NCT03602053|585775406|FG000|Overall Study|Lost to Follow-up|5|||
162198154|NCT03602053|585775407|FG001|Overall Study|Lost to Follow-up|6|||
162198155|NCT03602053|585775408|FG002|Overall Study|Lost to Follow-up|0|||
162198156|NCT03602053|585775406|FG000|Overall Study|Protocol Violation|3|||
162198157|NCT03602053|585775407|FG001|Overall Study|Protocol Violation|0|||
162198158|NCT03602053|585775408|FG002|Overall Study|Protocol Violation|4|||
162198159|NCT03602053|585775406|FG000|Overall Study|Physician Decision|1|||
162198160|NCT03602053|585775407|FG001|Overall Study|Physician Decision|0|||
162198161|NCT03602053|585775408|FG002|Overall Study|Physician Decision|0|||
162198162|NCT03602053|585775406|FG000|Overall Study|migration|2|||
162198163|NCT03602053|585775407|FG001|Overall Study|migration|3|||
162198164|NCT03602053|585775408|FG002|Overall Study|migration|0|||
162198165|NCT03602053|585775406|FG000|Overall Study|Other|1|||
162198166|NCT03602053|585775407|FG001|Overall Study|Other|0|||
162198167|NCT03602053|585775408|FG002|Overall Study|Other|0|||
162198168|NCT01234675|585775415|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
162198169|NCT01234675|585775416|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
162198170|NCT01234675|585775415|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
162198171|NCT01234675|585775416|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
162198172|NCT02409732|585775417|FG000|Overall Study|Withdrawal by Subject|4|||
162198173|NCT02409732|585775417|FG000|Overall Study|Lost to Follow-up|2|||
162198174|NCT00105521|585775419|FG000|Overall Study|Other|1|||
162198175|NCT00105521|585775420|FG001|Overall Study|Other|1|||
162198176|NCT00105521|585775421|FG002|Overall Study|Other|2|||
162198177|NCT00105521|585775422|FG003|Overall Study|Other|0|||
162198178|NCT00105521|585775419|FG000|Overall Study|Adverse Event|10|||
161926530|NCT04676646|584778630|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
161926531|NCT04676646|584778631|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
161926532|NCT04676646|584778632|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
161926533|NCT04676646|584778630|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
161926534|NCT04676646|584778631|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
161926535|NCT04676646|584778632|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
161926536|NCT04676646|584778630|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
161926537|NCT04676646|584778631|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
161926538|NCT04676646|584778632|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
161926539|NCT04676646|584778630|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
161926540|NCT04676646|584778631|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
161926541|NCT04676646|584778632|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
161926542|NCT04676646|584778630|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
161926543|NCT04676646|584778631|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
161926544|NCT04676646|584778632|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
161926545|NCT04676646|584778630|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
161926546|NCT04676646|584778631|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
161926547|NCT04676646|584778632|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
161926548|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
161926549|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
162198179|NCT00105521|585775420|FG001|Overall Study|Adverse Event|4|||
162198180|NCT00105521|585775421|FG002|Overall Study|Adverse Event|10|||
162198181|NCT00105521|585775422|FG003|Overall Study|Adverse Event|8|||
162198182|NCT00105521|585775419|FG000|Overall Study|Withdrawal by Subject|1|||
162198183|NCT00105521|585775420|FG001|Overall Study|Withdrawal by Subject|0|||
162198184|NCT00105521|585775421|FG002|Overall Study|Withdrawal by Subject|1|||
162198185|NCT00105521|585775422|FG003|Overall Study|Withdrawal by Subject|4|||
162198186|NCT00105521|585775419|FG000|Overall Study|Lack of Efficacy|0|||
162198187|NCT00105521|585775420|FG001|Overall Study|Lack of Efficacy|0|||
162198188|NCT00105521|585775421|FG002|Overall Study|Lack of Efficacy|0|||
161926550|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
161926551|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Death|0|||
161926552|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Death|1|||
161926553|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Death|2|||
161926554|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
161926555|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
161926556|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
161926557|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
161926558|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
161926559|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
161926560|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
161926561|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
161926562|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
161926563|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
161926564|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
161926565|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
161926566|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
161926567|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
161926568|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
161926569|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
161926570|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
161926571|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
161926572|NCT04676646|584778630|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
161926573|NCT04676646|584778631|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
161926574|NCT04676646|584778632|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
161926575|NCT04270760|584778633|FG000|Overall Study|Withdrawal by Subject|0|||
161926576|NCT04270760|584778634|FG001|Overall Study|Withdrawal by Subject|1|||
161926577|NCT04270760|584778635|FG002|Overall Study|Withdrawal by Subject|3|||
161926578|NCT04270760|584778636|FG003|Overall Study|Withdrawal by Subject|0|||
161926579|NCT04270760|584778637|FG004|Overall Study|Withdrawal by Subject|0|||
161926580|NCT04270760|584778633|FG000|Overall Study|Lost to Follow-up|1|||
161926581|NCT04270760|584778634|FG001|Overall Study|Lost to Follow-up|2|||
161926582|NCT04270760|584778635|FG002|Overall Study|Lost to Follow-up|1|||
161926583|NCT04270760|584778636|FG003|Overall Study|Lost to Follow-up|0|||
161926584|NCT04270760|584778637|FG004|Overall Study|Lost to Follow-up|0|||
161926585|NCT04270760|584778633|FG000|Overall Study|Death|0|||
161926586|NCT04270760|584778634|FG001|Overall Study|Death|0|||
161926587|NCT04270760|584778635|FG002|Overall Study|Death|0|||
161926588|NCT04270760|584778636|FG003|Overall Study|Death|0|||
161926589|NCT04270760|584778637|FG004|Overall Study|Death|1|||
161926590|NCT05156125|584778638|FG000|Overall Study|Lack of Efficacy|1|||
161926591|NCT05156125|584778639|FG001|Overall Study|Lack of Efficacy|1|||
162198189|NCT00105521|585775422|FG003|Overall Study|Lack of Efficacy|1|||
162198190|NCT00105521|585775419|FG000|Overall Study|Protocol Violation|3|||
161926592|NCT05156125|584778640|FG002|Overall Study|Lack of Efficacy|1|||
161926593|NCT05156125|584778638|FG000|Overall Study|Physician Decision|0|||
161926594|NCT05156125|584778639|FG001|Overall Study|Physician Decision|0|||
161926595|NCT05156125|584778640|FG002|Overall Study|Physician Decision|1|||
161926596|NCT05156125|584778638|FG000|Overall Study|Non-compliance|0|||
161926597|NCT05156125|584778639|FG001|Overall Study|Non-compliance|1|||
161926598|NCT05156125|584778640|FG002|Overall Study|Non-compliance|1|||
161926599|NCT05156125|584778638|FG000|Overall Study|Withdrawal by Subject|0|||
161926600|NCT05156125|584778639|FG001|Overall Study|Withdrawal by Subject|0|||
161926601|NCT05156125|584778640|FG002|Overall Study|Withdrawal by Subject|1|||
161926602|NCT05156125|584778638|FG000|Overall Study|Adverse Event|2|||
161926603|NCT05156125|584778639|FG001|Overall Study|Adverse Event|1|||
161926604|NCT05156125|584778640|FG002|Overall Study|Adverse Event|0|||
161926605|NCT03670628|584778641|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
161926606|NCT03670628|584778642|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
161926607|NCT03670628|584778641|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
161926608|NCT03670628|584778642|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
161926609|NCT00997126|584778646|FG000|Overall Study|Physician Decision|7|||
162198191|NCT00105521|585775420|FG001|Overall Study|Protocol Violation|5|||
162198192|NCT00105521|585775421|FG002|Overall Study|Protocol Violation|4|||
162198193|NCT00105521|585775422|FG003|Overall Study|Protocol Violation|4|||
161926610|NCT00997126|584778647|FG001|Overall Study|Physician Decision|11|||
161926611|NCT01755637|584778648|FG000|Period 1|Adverse Event|0|||
161926612|NCT01755637|584778649|FG001|Period 1|Adverse Event|1|||
161926613|NCT02287025|584778650|FG000|Overall Study|Not treated|2|||
161926614|NCT02287025|584778651|FG001|Overall Study|Not treated|0|||
161926615|NCT02287025|584778650|FG000|Overall Study|Progression of disease|3|||
161926616|NCT02287025|584778651|FG001|Overall Study|Progression of disease|2|||
161926617|NCT02287025|584778650|FG000|Overall Study|Adverse Event|2|||
161926618|NCT02287025|584778651|FG001|Overall Study|Adverse Event|4|||
161926619|NCT02287025|584778650|FG000|Overall Study|Withdrawal by Subject|2|||
161926620|NCT02287025|584778651|FG001|Overall Study|Withdrawal by Subject|2|||
161926621|NCT02287025|584778650|FG000|Overall Study|Screening failed|1|||
161926622|NCT02287025|584778651|FG001|Overall Study|Screening failed|1|||
161926623|NCT00899847|584778652|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
161926624|NCT03338023|584778653|FG000|Overall Study|Withdrawal by Subject|3|||
161926625|NCT03338023|584778654|FG001|Overall Study|Withdrawal by Subject|4|||
161926626|NCT03338023|584778653|FG000|Overall Study|Protocol Violation|3|||
161926627|NCT03338023|584778654|FG001|Overall Study|Protocol Violation|3|||
161926628|NCT03338023|584778653|FG000|Overall Study|Lost to Follow-up|2|||
161926629|NCT03338023|584778654|FG001|Overall Study|Lost to Follow-up|1|||
161926630|NCT03338023|584778653|FG000|Overall Study|Physician Decision|1|||
161926631|NCT03338023|584778654|FG001|Overall Study|Physician Decision|2|||
161926632|NCT04996264|584778655|FG000|Overall Study|Lost to Follow-up|0|||
161926633|NCT04996264|584778656|FG001|Overall Study|Lost to Follow-up|1|||
161926634|NCT04996264|584778655|FG000|Overall Study|Withdrawal by Subject|4|||
161926635|NCT04996264|584778656|FG001|Overall Study|Withdrawal by Subject|3|||
161926636|NCT04996264|584778655|FG000|Overall Study|1 left AMA|0|||
161926637|NCT04996264|584778656|FG001|Overall Study|1 left AMA|1|||
161926638|NCT04996264|584778655|FG000|Overall Study|Subject changed hospitals|0|||
161926639|NCT04996264|584778656|FG001|Overall Study|Subject changed hospitals|1|||
161926640|NCT04996264|584778655|FG000|Overall Study|unable to complete due to work|0|||
161926641|NCT04996264|584778656|FG001|Overall Study|unable to complete due to work|1|||
161926642|NCT00685698|584778657|FG000|Overall Study|Withdrawal by Subject|1|||
161926643|NCT00685698|584778657|FG000|Overall Study|Protocol Violation|6|||
161926644|NCT00685698|584778657|FG000|Overall Study|Adverse Event|3|||
161926645|NCT00685698|584778657|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
161926646|NCT00685698|584778657|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
161926647|NCT00685698|584778657|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
161926648|NCT02030418|584778658|FG000|Overall Study|Death|78|||
161926649|NCT02030418|584778658|FG000|Overall Study|Missed 12-Month Visit|9|||
161926650|NCT02030418|584778658|FG000|Overall Study|Withdrawn|57|||
161926651|NCT03412890|584778659|FG000|Overall Study|Adverse Event|5|||
161926652|NCT03412890|584778660|FG001|Overall Study|Adverse Event|5|||
161926653|NCT03412890|584778661|FG002|Overall Study|Adverse Event|9|||
161926654|NCT03412890|584778659|FG000|Overall Study|Protocol deviation|2|||
161926655|NCT03412890|584778660|FG001|Overall Study|Protocol deviation|1|||
161926656|NCT03412890|584778661|FG002|Overall Study|Protocol deviation|2|||
162198194|NCT00105521|585775419|FG000|Overall Study|Lost to Follow-up|0|||
162198195|NCT00105521|585775420|FG001|Overall Study|Lost to Follow-up|1|||
162198196|NCT00105521|585775421|FG002|Overall Study|Lost to Follow-up|0|||
162198197|NCT00105521|585775422|FG003|Overall Study|Lost to Follow-up|0|||
161926657|NCT03412890|584778659|FG000|Overall Study|Lost to Follow-up|7|||
161926658|NCT03412890|584778660|FG001|Overall Study|Lost to Follow-up|10|||
162198198|NCT00385697|585775423|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
161926659|NCT03412890|584778661|FG002|Overall Study|Lost to Follow-up|10|||
161926660|NCT03412890|584778659|FG000|Overall Study|Withdrawal by Subject|9|||
161926661|NCT03412890|584778660|FG001|Overall Study|Withdrawal by Subject|12|||
161926662|NCT03412890|584778661|FG002|Overall Study|Withdrawal by Subject|11|||
161926663|NCT03412890|584778659|FG000|Overall Study|Lack of Efficacy|2|||
161926664|NCT03412890|584778660|FG001|Overall Study|Lack of Efficacy|7|||
161926665|NCT03412890|584778661|FG002|Overall Study|Lack of Efficacy|5|||
161926666|NCT03412890|584778659|FG000|Overall Study|Other|5|||
161926667|NCT03412890|584778660|FG001|Overall Study|Other|6|||
161926668|NCT03412890|584778661|FG002|Overall Study|Other|5|||
161926669|NCT03412890|584778659|FG000|Overall Study|Participants who did not receive any study drug|0|||
161926670|NCT03412890|584778660|FG001|Overall Study|Participants who did not receive any study drug|1|||
161926671|NCT03412890|584778661|FG002|Overall Study|Participants who did not receive any study drug|0|||
161926672|NCT00887588|584778665|FG000|Core Period|Death|1|||
161926673|NCT00887588|584778666|FG001|Core Period|Death|1|||
161926674|NCT00887588|584778665|FG000|Core Period|Lost to Follow-up|3|||
161926675|NCT00887588|584778666|FG001|Core Period|Lost to Follow-up|1|||
161926676|NCT00887588|584778665|FG000|Core Period|Withdrawal by Subject|6|||
161926677|NCT00887588|584778666|FG001|Core Period|Withdrawal by Subject|8|||
161926678|NCT00887588|584778665|FG000|Core Period|Adverse Event|9|||
161926679|NCT00887588|584778666|FG001|Core Period|Adverse Event|11|||
161926680|NCT00887588|584778665|FG000|Extension Period|Adverse Event|4|||
162198199|NCT00385697|585775424|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
162198200|NCT00385697|585775425|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
162198201|NCT00385697|585775426|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
162198202|NCT00385697|585775427|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
162198203|NCT00385697|585775423|FG000|Open-label Segment 1|Lost to Follow-up|1|||
162198204|NCT00385697|585775424|FG001|Open-label Segment 1|Lost to Follow-up|0|||
162198205|NCT00385697|585775425|FG002|Open-label Segment 1|Lost to Follow-up|0|||
162198206|NCT00385697|585775426|FG003|Open-label Segment 1|Lost to Follow-up|0|||
162198207|NCT00385697|585775427|FG004|Open-label Segment 1|Lost to Follow-up|0|||
162198208|NCT00385697|585775423|FG000|Double-blind Segment 2|Adverse Event|0|||
162198209|NCT00385697|585775424|FG001|Double-blind Segment 2|Adverse Event|3|||
162198210|NCT00385697|585775425|FG002|Double-blind Segment 2|Adverse Event|1|||
162198211|NCT00385697|585775426|FG003|Double-blind Segment 2|Adverse Event|0|||
162198212|NCT00385697|585775427|FG004|Double-blind Segment 2|Adverse Event|0|||
162198213|NCT00385697|585775423|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
162198214|NCT00385697|585775424|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
162198215|NCT00385697|585775425|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
162198216|NCT00385697|585775426|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
162198217|NCT00385697|585775427|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
162198218|NCT00385697|585775423|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
162198219|NCT00385697|585775424|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
162198220|NCT00385697|585775425|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
162198221|NCT00385697|585775426|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
162198222|NCT00385697|585775427|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
162198223|NCT00385697|585775423|FG000|Double-blind Segment 2|Other|0|||
162198224|NCT00385697|585775424|FG001|Double-blind Segment 2|Other|2|||
162198225|NCT00385697|585775425|FG002|Double-blind Segment 2|Other|0|||
162198226|NCT00385697|585775426|FG003|Double-blind Segment 2|Other|0|||
162198227|NCT00385697|585775427|FG004|Double-blind Segment 2|Other|0|||
162198228|NCT01721109|585775439|FG000|Overall Study|Lack of Efficacy|1|||
162198229|NCT01721109|585775439|FG000|Overall Study|Non- Compliance with Study Drug|3|||
162198230|NCT01721109|585775439|FG000|Overall Study|Withdrew Consent|1|||
162198231|NCT01721109|585775439|FG000|Overall Study|Lost to Follow-up|2|||
162198232|NCT03045302|585775440|FG000|Overall Study|Pre-treatment adverse event|1|||
162198233|NCT00134056|585775441|FG000|Randomization|Not eligible for assigned treatment|22|||
162198234|NCT00134056|585775442|FG001|Randomization|Not eligible for assigned treatment|20|||
162198235|NCT00134056|585775441|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
162198236|NCT00134056|585775442|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
162198237|NCT00134056|585775441|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
162198238|NCT00134056|585775442|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
162198239|NCT00134056|585775441|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
162198240|NCT00134056|585775442|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
162198241|NCT00134056|585775441|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
162198242|NCT00134056|585775442|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
162198243|NCT00742560|585775444|FG000|Overall Study|Adverse Event|0|||
162198244|NCT00742560|585775445|FG001|Overall Study|Adverse Event|0|||
162198245|NCT00742560|585775446|FG002|Overall Study|Adverse Event|1|||
162198246|NCT00742560|585775447|FG003|Overall Study|Adverse Event|1|||
162198247|NCT00742560|585775448|FG004|Overall Study|Adverse Event|1|||
162198248|NCT00742560|585775444|FG000|Overall Study|Death|0|||
162198249|NCT00742560|585775445|FG001|Overall Study|Death|2|||
162198250|NCT00742560|585775446|FG002|Overall Study|Death|0|||
162198251|NCT00742560|585775447|FG003|Overall Study|Death|2|||
162198252|NCT00742560|585775448|FG004|Overall Study|Death|3|||
161820711|NCT00354159|584384623|FG000|Long-term Follow-up|Death|14|||
161820712|NCT00354159|584384624|FG001|Long-term Follow-up|Death|11|||
161820713|NCT00354159|584384623|FG000|Long-term Follow-up|Study Closed|29|||
161820714|NCT00354159|584384624|FG001|Long-term Follow-up|Study Closed|34|||
162020540|NCT03539549|585130501|FG000|Overall Study|Adverse Event|12|||
162198253|NCT00742560|585775444|FG000|Overall Study|Subject's Decision|1|||
162198254|NCT00742560|585775445|FG001|Overall Study|Subject's Decision|0|||
162198255|NCT00742560|585775446|FG002|Overall Study|Subject's Decision|2|||
162198256|NCT00742560|585775447|FG003|Overall Study|Subject's Decision|3|||
162198257|NCT00742560|585775448|FG004|Overall Study|Subject's Decision|3|||
162198258|NCT00742560|585775444|FG000|Overall Study|Investigator's Decision|0|||
162198259|NCT00742560|585775445|FG001|Overall Study|Investigator's Decision|0|||
162198260|NCT00742560|585775446|FG002|Overall Study|Investigator's Decision|4|||
162198261|NCT00742560|585775447|FG003|Overall Study|Investigator's Decision|1|||
162198262|NCT00742560|585775448|FG004|Overall Study|Investigator's Decision|0|||
162198263|NCT00742560|585775444|FG000|Overall Study|Disease Progression|1|||
162198264|NCT00742560|585775445|FG001|Overall Study|Disease Progression|0|||
162198265|NCT00742560|585775446|FG002|Overall Study|Disease Progression|5|||
162198266|NCT00742560|585775447|FG003|Overall Study|Disease Progression|17|||
162198267|NCT00742560|585775448|FG004|Overall Study|Disease Progression|16|||
162198268|NCT00742560|585775444|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
162198269|NCT00742560|585775445|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
162198270|NCT00742560|585775446|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
162198271|NCT00742560|585775447|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
162198272|NCT00742560|585775448|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
162198273|NCT00742560|585775444|FG000|Overall Study|Other|0|||
162198274|NCT00742560|585775445|FG001|Overall Study|Other|1|||
162198275|NCT00742560|585775446|FG002|Overall Study|Other|8|||
162198276|NCT00742560|585775447|FG003|Overall Study|Other|9|||
162198277|NCT00742560|585775448|FG004|Overall Study|Other|9|||
162198278|NCT00742560|585775444|FG000|Overall Study|MIssing|0|||
162198279|NCT00742560|585775445|FG001|Overall Study|MIssing|0|||
162198280|NCT00742560|585775446|FG002|Overall Study|MIssing|0|||
162198281|NCT00742560|585775447|FG003|Overall Study|MIssing|0|||
162198282|NCT00742560|585775448|FG004|Overall Study|MIssing|1|||
162198283|NCT01536795|585775449|FG000|Overall Study|Lost to Follow-up|0|||
162198284|NCT01536795|585775450|FG001|Overall Study|Lost to Follow-up|2|||
162198285|NCT01536795|585775449|FG000|Overall Study|Lack of Efficacy|1|||
162198286|NCT01536795|585775450|FG001|Overall Study|Lack of Efficacy|0|||
162198287|NCT02267746|585775451|FG000|Overall Study|Adverse Event|0|||
162198288|NCT02267746|585775452|FG001|Overall Study|Adverse Event|2|||
162198289|NCT02267746|585775453|FG002|Overall Study|Adverse Event|1|||
162198290|NCT02267746|585775451|FG000|Overall Study|Protocol Violation|8|||
162198291|NCT02267746|585775452|FG001|Overall Study|Protocol Violation|7|||
162198292|NCT02267746|585775453|FG002|Overall Study|Protocol Violation|3|||
162198293|NCT02267746|585775451|FG000|Overall Study|Lack of Efficacy|11|||
162198294|NCT02267746|585775452|FG001|Overall Study|Lack of Efficacy|11|||
162198295|NCT02267746|585775453|FG002|Overall Study|Lack of Efficacy|15|||
162198296|NCT02267746|585775451|FG000|Overall Study|Protocol Violation|1|||
162198297|NCT02267746|585775452|FG001|Overall Study|Protocol Violation|2|||
162198298|NCT02267746|585775453|FG002|Overall Study|Protocol Violation|1|||
162198299|NCT02267746|585775451|FG000|Overall Study|Miscellaneous|1|||
162198300|NCT02267746|585775452|FG001|Overall Study|Miscellaneous|0|||
162198301|NCT02267746|585775453|FG002|Overall Study|Miscellaneous|1|||
162198302|NCT05008224|585775454|FG000|Overall Study|Death|3|||
162198303|NCT05008224|585775454|FG000|Overall Study|Lost to Follow-up|2|||
162198304|NCT05008224|585775454|FG000|Overall Study|Did Not Continue on Extension Study|39|||
162198305|NCT05008224|585775454|FG000|Overall Study|Transferred to Extension Study|100|||
162198306|NCT05008224|585775454|FG000|Overall Study|Withdrawal by Subject|2|||
162198307|NCT00348283|585775455|FG000|Induction|Adverse Event|0|||
162198308|NCT00348283|585775456|FG001|Induction|Adverse Event|2|||
162198309|NCT00348283|585775455|FG000|Induction|Protocol Violation|0|||
162198310|NCT00348283|585775456|FG001|Induction|Protocol Violation|4|||
162198311|NCT00348283|585775455|FG000|Double Blind|Adverse Event|2|||
162198312|NCT00348283|585775456|FG001|Double Blind|Adverse Event|5|||
162198313|NCT00348283|585775455|FG000|Double Blind|Withdrawal by Subject|1|||
162198314|NCT00348283|585775456|FG001|Double Blind|Withdrawal by Subject|1|||
162198315|NCT00348283|585775455|FG000|Double Blind|Protocol Violation|0|||
162198316|NCT00348283|585775456|FG001|Double Blind|Protocol Violation|1|||
162198317|NCT00348283|585775455|FG000|Double Blind|Lack of Efficacy|2|||
162198318|NCT00348283|585775456|FG001|Double Blind|Lack of Efficacy|2|||
162198319|NCT00348283|585775455|FG000|Double Blind|Pregnancy|0|||
162198320|NCT00348283|585775456|FG001|Double Blind|Pregnancy|1|||
162198321|NCT00348283|585775455|FG000|Open Label|Adverse Event|0|||
162198322|NCT00348283|585775456|FG001|Open Label|Adverse Event|8|||
162198323|NCT00348283|585775455|FG000|Open Label|Withdrawal by Subject|0|||
162198324|NCT00348283|585775456|FG001|Open Label|Withdrawal by Subject|4|||
162198325|NCT00348283|585775455|FG000|Open Label|Lost to Follow-up|0|||
162198326|NCT00348283|585775456|FG001|Open Label|Lost to Follow-up|1|||
162198327|NCT00348283|585775455|FG000|Open Label|Lack of Efficacy|0|||
162198328|NCT00348283|585775456|FG001|Open Label|Lack of Efficacy|13|||
162198329|NCT00348283|585775455|FG000|Open Label|Administrative reasons|0|||
162198330|NCT00348283|585775456|FG001|Open Label|Administrative reasons|5|||
161926681|NCT00887588|584778666|FG001|Extension Period|Adverse Event|4|||
161926682|NCT00887588|584778665|FG000|Extension Period|Death|0|||
161926683|NCT00887588|584778666|FG001|Extension Period|Death|1|||
161926684|NCT00887588|584778665|FG000|Extension Period|Protocol deviation|1|||
161926685|NCT00887588|584778666|FG001|Extension Period|Protocol deviation|0|||
161926686|NCT00887588|584778665|FG000|Extension Period|Lost to Follow-up|1|||
162198331|NCT00348283|585775455|FG000|Open Label|Subject moved to the United States|0|||
162198332|NCT00348283|585775456|FG001|Open Label|Subject moved to the United States|1|||
162198333|NCT00348283|585775455|FG000|Open Label|Pregnancy|0|||
162198334|NCT00348283|585775456|FG001|Open Label|Pregnancy|1|||
162198335|NCT00348283|585775455|FG000|Open Label|Sponsor decision|0|||
162198336|NCT00348283|585775456|FG001|Open Label|Sponsor decision|1|||
162198337|NCT05878522|585775460|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162198338|NCT05878522|585775461|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162198339|NCT05878522|585775462|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162198340|NCT05878522|585775463|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162198341|NCT05878522|585775464|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162198342|NCT05878522|585775465|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162198343|NCT05878522|585775466|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162198344|NCT05878522|585775467|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162198345|NCT05878522|585775468|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
162198346|NCT05878522|585775469|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162198347|NCT05878522|585775470|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162198348|NCT05878522|585775471|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
162198349|NCT05878522|585775460|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
162198350|NCT05878522|585775461|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162198351|NCT05878522|585775462|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162198352|NCT05878522|585775463|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162198353|NCT05878522|585775464|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162198354|NCT05878522|585775465|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162198355|NCT05878522|585775466|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162198356|NCT05878522|585775467|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162198357|NCT05878522|585775468|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162198358|NCT05878522|585775469|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
162198359|NCT05878522|585775470|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162198360|NCT05878522|585775471|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
162198361|NCT05878522|585775460|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162198362|NCT05878522|585775461|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
162198363|NCT05878522|585775462|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162198364|NCT05878522|585775463|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
162198365|NCT05878522|585775464|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162198366|NCT05878522|585775465|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162198367|NCT05878522|585775466|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162198368|NCT05878522|585775467|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162198369|NCT05878522|585775468|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162198370|NCT05878522|585775469|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162198371|NCT05878522|585775470|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162198372|NCT05878522|585775471|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
162198373|NCT05878522|585775460|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162198374|NCT05878522|585775461|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162198375|NCT05878522|585775462|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162198376|NCT05878522|585775463|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162198377|NCT05878522|585775464|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
162198378|NCT05878522|585775465|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162198379|NCT05878522|585775466|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162198380|NCT05878522|585775467|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162198381|NCT05878522|585775468|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162198382|NCT05878522|585775469|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162198383|NCT05878522|585775470|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162198384|NCT05878522|585775471|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
162198385|NCT05263492|585775472|FG000|Overall Study|Adverse Event|1|||
162198386|NCT05263492|585775472|FG000|Overall Study|Disease progression during active treatment|3|||
162198387|NCT03747575|585775475|FG000|Overall Study|Withdrawal by Subject|6|||
162198388|NCT03747575|585775476|FG001|Overall Study|Withdrawal by Subject|3|||
162198389|NCT03747575|585775475|FG000|Overall Study|Lost to Follow-up|3|||
162198390|NCT03747575|585775476|FG001|Overall Study|Lost to Follow-up|3|||
162198391|NCT03747575|585775475|FG000|Overall Study|Adverse Event|0|||
162198392|NCT03747575|585775476|FG001|Overall Study|Adverse Event|1|||
162198393|NCT02260154|585775478|FG000|Overall Study|Screening failure|2|||
162198394|NCT03560206|585775479|FG000|Overall Study|Lost to Follow-up|19|||
162198395|NCT03560206|585775480|FG001|Overall Study|Lost to Follow-up|11|||
162198396|NCT03560206|585775479|FG000|Overall Study|Withdrawal by Subject|2|||
162198397|NCT03560206|585775480|FG001|Overall Study|Withdrawal by Subject|4|||
162198398|NCT03560206|585775479|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
162198399|NCT03560206|585775480|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
162198400|NCT03560206|585775479|FG000|Overall Study|Busy schedule|14|||
161926687|NCT00887588|584778666|FG001|Extension Period|Lost to Follow-up|0|||
161926688|NCT00567112|584778667|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
161926689|NCT00567112|584778668|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
161926690|NCT00567112|584778669|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
161926691|NCT00567112|584778667|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
161926692|NCT00567112|584778668|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
162198401|NCT03560206|585775480|FG001|Overall Study|Busy schedule|2|||
162198402|NCT03560206|585775479|FG000|Overall Study|patients' new health condition such as cancer|10|||
162198403|NCT03560206|585775480|FG001|Overall Study|patients' new health condition such as cancer|1|||
162198404|NCT00738400|585775481|FG000|Overall Study|Adverse Event|3|||
162198405|NCT00738400|585775482|FG001|Overall Study|Adverse Event|1|||
162020541|NCT03539549|585130501|FG000|Overall Study|Lost to Follow-up|1|||
162198406|NCT00738400|585775481|FG000|Overall Study|Withdrawal by Subject|0|||
162198407|NCT00738400|585775482|FG001|Overall Study|Withdrawal by Subject|1|||
162198408|NCT00738400|585775481|FG000|Overall Study|Lack of Efficacy|0|||
162198409|NCT00738400|585775482|FG001|Overall Study|Lack of Efficacy|1|||
162198410|NCT00738400|585775481|FG000|Overall Study|Lost to Follow-up|0|||
162198411|NCT00738400|585775482|FG001|Overall Study|Lost to Follow-up|3|||
162198412|NCT00738400|585775481|FG000|Overall Study|Protocol Violation|1|||
162198413|NCT00738400|585775482|FG001|Overall Study|Protocol Violation|0|||
162198414|NCT00738400|585775481|FG000|Overall Study|Non-compliant with study medication|0|||
162198415|NCT00738400|585775482|FG001|Overall Study|Non-compliant with study medication|1|||
162198416|NCT02255474|585775483|FG000|Overall Study|Lost to Follow-up|1|||
162198417|NCT02255474|585775484|FG001|Overall Study|Lost to Follow-up|1|||
162198418|NCT02255474|585775485|FG002|Overall Study|Lost to Follow-up|3|||
162198419|NCT02255474|585775483|FG000|Overall Study|Withdrawal by Subject|1|||
162198420|NCT02255474|585775484|FG001|Overall Study|Withdrawal by Subject|1|||
162198421|NCT02255474|585775485|FG002|Overall Study|Withdrawal by Subject|0|||
162198422|NCT02993926|585775487|FG000|Enantone Treatment Phase|Adverse Event|1|||
162198423|NCT02993926|585775488|FG001|Enantone Treatment Phase|Adverse Event|0|||
162198424|NCT02993926|585775489|FG002|Enantone Treatment Phase|Adverse Event|0|||
162198425|NCT02993926|585775487|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
162198426|NCT02993926|585775488|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
162198427|NCT02993926|585775489|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
162198428|NCT02993926|585775487|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
162198429|NCT02993926|585775488|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
162198430|NCT02993926|585775489|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
162198431|NCT02993926|585775487|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
162198432|NCT02993926|585775488|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
162198433|NCT02993926|585775489|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
162198434|NCT02009865|585775490|FG000|Overall Study|Adverse Event|0|||
162198435|NCT02009865|585775491|FG001|Overall Study|Adverse Event|2|||
162198436|NCT02009865|585775490|FG000|Overall Study|Protocol Violation|0|||
162198437|NCT02009865|585775491|FG001|Overall Study|Protocol Violation|2|||
162198438|NCT02009865|585775490|FG000|Overall Study|Withdrawal by Subject|1|||
162198439|NCT02009865|585775491|FG001|Overall Study|Withdrawal by Subject|1|||
162198440|NCT01760876|585775492|FG000|Overall Study|Non-cardiac death (head injury)|1|||
162198441|NCT01760876|585775492|FG000|Overall Study|Carcinoma of prostate|1|||
162198442|NCT01760876|585775492|FG000|Overall Study|Impaired renal function|1|||
162198443|NCT01760876|585775492|FG000|Overall Study|Major depression|1|||
162198444|NCT01760876|585775492|FG000|Overall Study|Very poor baseline OCT quality|2|||
162198445|NCT00732498|585775495|FG000|Overall Study|Ineligible|1|||
162198446|NCT00732498|585775495|FG000|Overall Study|Adverse Event|2|||
162198447|NCT00732498|585775495|FG000|Overall Study|Physician Decision|3|||
162198448|NCT03394508|585775498|FG000|Overall Study|Protocol Violation|0|||
162198449|NCT03394508|585775499|FG001|Overall Study|Protocol Violation|3|||
162198450|NCT03394508|585775498|FG000|Overall Study|Lost to Follow-up|1|||
162198451|NCT03394508|585775499|FG001|Overall Study|Lost to Follow-up|0|||
162198452|NCT04295499|585775501|FG000|Overall Study|moving out of state|1|||
162198453|NCT04295499|585775502|FG001|Overall Study|moving out of state|0|||
162198454|NCT04295499|585775501|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
162198455|NCT04295499|585775502|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
162198456|NCT01755598|585775503|FG000|Overall Study|Other|109|||
162198457|NCT01755598|585775504|FG001|Overall Study|Other|109|||
162198458|NCT01755598|585775503|FG000|Overall Study|Lost to Follow-up|32|||
162198459|NCT01755598|585775504|FG001|Overall Study|Lost to Follow-up|43|||
162198460|NCT01755598|585775503|FG000|Overall Study|Migrated/moved from study area|76|||
162198461|NCT01755598|585775504|FG001|Overall Study|Migrated/moved from study area|65|||
162198462|NCT01755598|585775503|FG000|Overall Study|Withdrawal by Subject|22|||
162198463|NCT01755598|585775504|FG001|Overall Study|Withdrawal by Subject|31|||
161820715|NCT02229084|584384626|FG000|Overall Study|Adverse Event|1|||
162198464|NCT01755598|585775503|FG000|Overall Study|Protocol Violation|7|||
162198465|NCT01755598|585775504|FG001|Overall Study|Protocol Violation|7|||
162198466|NCT01755598|585775503|FG000|Overall Study|Adverse Event|19|||
162198467|NCT01755598|585775504|FG001|Overall Study|Adverse Event|28|||
162198468|NCT00308113|585775505|FG000|Overall Study|Protocol closure|0|||
162198469|NCT00308113|585775506|FG001|Overall Study|Protocol closure|0|||
162198470|NCT00308113|585775507|FG002|Overall Study|Protocol closure|0|||
162198471|NCT00308113|585775508|FG003|Overall Study|Protocol closure|1|||
162198472|NCT02332889|585775509|FG000|Overall Study|Physician Decision|1|||
162198473|NCT02135445|585775512|FG000|Overall Study|Lost to Follow-up|1|||
161820716|NCT02229084|584384627|FG001|Overall Study|Adverse Event|0|||
162198474|NCT02135445|585775513|FG001|Overall Study|Lost to Follow-up|0|||
162198475|NCT02135445|585775512|FG000|Overall Study|Withdrawal by Subject|1|||
161926693|NCT00567112|584778669|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
161926694|NCT00567112|584778667|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
161926695|NCT00567112|584778668|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
161926696|NCT00567112|584778669|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
161926697|NCT03753542|584778673|FG000|Overall Study|Lost to Follow-up|9|||
161926698|NCT03753542|584778674|FG001|Overall Study|Lost to Follow-up|14|||
161926699|NCT04180696|584778677|FG000|Overall Study|Death|5|||
161926700|NCT04180696|584778678|FG001|Overall Study|Death|6|||
161926701|NCT04180696|584778677|FG000|Overall Study|Lost to Follow-up|1|||
161926702|NCT04180696|584778678|FG001|Overall Study|Lost to Follow-up|0|||
162020542|NCT03539549|585130501|FG000|Overall Study|Death|2|||
162198476|NCT02135445|585775513|FG001|Overall Study|Withdrawal by Subject|0|||
162198477|NCT03556891|585775514|FG000|Initial Pivotal Study|Adverse Event|4|||
162198478|NCT03556891|585775514|FG000|Initial Pivotal Study|MRI Need|3|||
161820717|NCT02229084|584384628|FG002|Overall Study|Adverse Event|0|||
161820718|NCT02229084|584384629|FG003|Overall Study|Adverse Event|0|||
161820719|NCT02229084|584384630|FG004|Overall Study|Adverse Event|0|||
161820720|NCT02229084|584384631|FG005|Overall Study|Adverse Event|0|||
161820721|NCT02229084|584384632|FG006|Overall Study|Adverse Event|0|||
161820722|NCT02229084|584384626|FG000|Overall Study|Lost to Follow-up|0|||
161820723|NCT02229084|584384627|FG001|Overall Study|Lost to Follow-up|0|||
161820724|NCT02229084|584384628|FG002|Overall Study|Lost to Follow-up|1|||
161820725|NCT02229084|584384629|FG003|Overall Study|Lost to Follow-up|1|||
161820726|NCT02229084|584384630|FG004|Overall Study|Lost to Follow-up|0|||
161820727|NCT02229084|584384631|FG005|Overall Study|Lost to Follow-up|0|||
161820728|NCT02229084|584384632|FG006|Overall Study|Lost to Follow-up|1|||
161820729|NCT02229084|584384626|FG000|Overall Study|Physician Decision|0|||
161820730|NCT02229084|584384627|FG001|Overall Study|Physician Decision|0|||
161820731|NCT02229084|584384628|FG002|Overall Study|Physician Decision|0|||
161820732|NCT02229084|584384629|FG003|Overall Study|Physician Decision|1|||
161820733|NCT02229084|584384630|FG004|Overall Study|Physician Decision|3|||
161820734|NCT02229084|584384631|FG005|Overall Study|Physician Decision|0|||
161820735|NCT02229084|584384632|FG006|Overall Study|Physician Decision|1|||
161820736|NCT02229084|584384626|FG000|Overall Study|Withdrawal by Subject|0|||
161820737|NCT02229084|584384627|FG001|Overall Study|Withdrawal by Subject|0|||
161820738|NCT02229084|584384628|FG002|Overall Study|Withdrawal by Subject|1|||
161820739|NCT02229084|584384629|FG003|Overall Study|Withdrawal by Subject|0|||
161820740|NCT02229084|584384630|FG004|Overall Study|Withdrawal by Subject|1|||
161820741|NCT02229084|584384631|FG005|Overall Study|Withdrawal by Subject|1|||
161820742|NCT02229084|584384632|FG006|Overall Study|Withdrawal by Subject|1|||
161820743|NCT02229084|584384626|FG000|Overall Study|Death|0|||
161820744|NCT02229084|584384627|FG001|Overall Study|Death|0|||
161820745|NCT02229084|584384628|FG002|Overall Study|Death|0|||
161820746|NCT02229084|584384629|FG003|Overall Study|Death|0|||
161820747|NCT02229084|584384630|FG004|Overall Study|Death|0|||
161820748|NCT02229084|584384631|FG005|Overall Study|Death|0|||
161820749|NCT02229084|584384632|FG006|Overall Study|Death|1|||
161820750|NCT01728116|584384635|FG000|Overall Study|Sponsor Terminated Study|106|||
161820751|NCT01728116|584384636|FG001|Overall Study|Sponsor Terminated Study|35|||
161820752|NCT01728116|584384635|FG000|Overall Study|Withdrawal by Subject|16|||
161820753|NCT01728116|584384636|FG001|Overall Study|Withdrawal by Subject|9|||
161820754|NCT01728116|584384635|FG000|Overall Study|Adverse Event|13|||
161820755|NCT01728116|584384636|FG001|Overall Study|Adverse Event|0|||
161820756|NCT01728116|584384635|FG000|Overall Study|Procedure/device failure|7|||
161820757|NCT01728116|584384636|FG001|Overall Study|Procedure/device failure|0|||
161820758|NCT01728116|584384635|FG000|Overall Study|Lost to Follow-up|9|||
161820759|NCT01728116|584384636|FG001|Overall Study|Lost to Follow-up|2|||
161820760|NCT01728116|584384635|FG000|Overall Study|Physician Decision|2|||
161820761|NCT01728116|584384636|FG001|Overall Study|Physician Decision|0|||
161820762|NCT01728116|584384635|FG000|Overall Study|Subject Non-Compliance|2|||
161820763|NCT01728116|584384636|FG001|Overall Study|Subject Non-Compliance|0|||
161820764|NCT01728116|584384635|FG000|Overall Study|Inter-current finding at procedure|1|||
161820765|NCT01728116|584384636|FG001|Overall Study|Inter-current finding at procedure|0|||
161820766|NCT01728116|584384635|FG000|Overall Study|Incorrectly enrolled in Study|0|||
161820767|NCT01728116|584384636|FG001|Overall Study|Incorrectly enrolled in Study|1|||
161820768|NCT01728116|584384635|FG000|Overall Study|various not noted previously|5|||
161820769|NCT01728116|584384636|FG001|Overall Study|various not noted previously|0|||
161820770|NCT01868243|584384640|FG000|Overall Study|Death|0|||
162198479|NCT03556891|585775514|FG000|Initial Pivotal Study|Device Failure|1|||
161820771|NCT01868243|584384641|FG001|Overall Study|Death|1|||
161820772|NCT01745094|584384643|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
161820773|NCT01745094|584384644|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
161820774|NCT01745094|584384645|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
161820775|NCT01745094|584384646|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
161820776|NCT01745094|584384643|FG000|Overall Study|Adverse Event|0|||
161820777|NCT01745094|584384644|FG001|Overall Study|Adverse Event|0|||
162020543|NCT03539549|585130501|FG000|Overall Study|Progressive Disease|1|||
162020544|NCT03539549|585130501|FG000|Overall Study|Reason not Specified|1|||
162020545|NCT00436345|585130502|FG000|Overall Study|ICU resident beyond follow-up period|3|||
162020546|NCT00436345|585130503|FG001|Overall Study|ICU resident beyond follow-up period|0|||
162020547|NCT04027608|585130504|FG000|Overall Study|Withdrawal by Subject|13|||
162020548|NCT04027608|585130505|FG001|Overall Study|Withdrawal by Subject|2|||
162020549|NCT04027608|585130504|FG000|Overall Study|Protocol Violation|2|||
162020550|NCT04027608|585130505|FG001|Overall Study|Protocol Violation|1|||
162020551|NCT04027608|585130504|FG000|Overall Study|Physician Decision|1|||
162020552|NCT04027608|585130505|FG001|Overall Study|Physician Decision|0|||
162020553|NCT04027608|585130504|FG000|Overall Study|Lost to Follow-up|20|||
162198480|NCT03556891|585775514|FG000|Initial Pivotal Study|Death|1|||
162198481|NCT03556891|585775514|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
162198482|NCT03556891|585775514|FG000|Initial Pivotal Study|Missing at random|1|||
162198483|NCT03556891|585775514|FG000|Initial Pivotal Study|Missing due to COVID|1|||
162198484|NCT03556891|585775514|FG000|Initial Pivotal Study|Protocol Violation|1|||
162198485|NCT01002547|585777438|FG000|Overall Study|Withdrawal by Subject|4|||
162198486|NCT01002547|585777439|FG001|Overall Study|Withdrawal by Subject|0|||
162198487|NCT01002547|585777440|FG002|Overall Study|Withdrawal by Subject|5|||
162198488|NCT01002547|585777438|FG000|Overall Study|Lost to Follow-up|2|||
162198489|NCT01002547|585777439|FG001|Overall Study|Lost to Follow-up|1|||
162198490|NCT01002547|585777440|FG002|Overall Study|Lost to Follow-up|1|||
162198491|NCT01002547|585777438|FG000|Overall Study|Physician Decision|1|||
162198492|NCT01002547|585777439|FG001|Overall Study|Physician Decision|0|||
162198493|NCT01002547|585777440|FG002|Overall Study|Physician Decision|0|||
162198494|NCT01002547|585777438|FG000|Overall Study|Death|0|||
162198495|NCT01002547|585777439|FG001|Overall Study|Death|2|||
162198496|NCT01002547|585777440|FG002|Overall Study|Death|2|||
162198497|NCT01002547|585777438|FG000|Overall Study|Adverse Event|1|||
162198498|NCT01002547|585777439|FG001|Overall Study|Adverse Event|0|||
162198499|NCT01002547|585777440|FG002|Overall Study|Adverse Event|0|||
161926703|NCT04180696|584778677|FG000|Overall Study|Withdrawal by Subject|0|||
161926704|NCT04180696|584778678|FG001|Overall Study|Withdrawal by Subject|1|||
161926705|NCT04210375|584778679|FG000|Overall Study|Death|0|||
161926706|NCT04210375|584778680|FG001|Overall Study|Death|1|||
161926707|NCT04210375|584778681|FG002|Overall Study|Death|0|||
161926708|NCT04210375|584778682|FG003|Overall Study|Death|0|||
161926709|NCT05752487|584778685|FG000|Overall Study|Enrolled, not treated|9|||
161926710|NCT05752487|584778685|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
161926711|NCT05752487|584778685|FG000|Overall Study|Withdrawal by Subject|2|||
161926712|NCT04124965|584778687|FG000|Overall Study|Adverse event, non-fatal|3|||
161926713|NCT04124965|584778688|FG001|Overall Study|Adverse event, non-fatal|1|||
161926714|NCT04124965|584778687|FG000|Overall Study|Withdrawal by Subject|1|||
161926715|NCT04124965|584778688|FG001|Overall Study|Withdrawal by Subject|1|||
161926716|NCT04124965|584778687|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
161926717|NCT04124965|584778688|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
162198500|NCT01184859|585777448|FG000|Period 1: Single Dose|Insufficient urine production|0|||
162198501|NCT01184859|585777449|FG001|Period 1: Single Dose|Insufficient urine production|1|||
162198502|NCT01184859|585777450|FG002|Period 1: Single Dose|Insufficient urine production|0|||
162198503|NCT01184859|585777451|FG003|Period 1: Single Dose|Insufficient urine production|0|||
162198504|NCT01184859|585777452|FG004|Period 1: Single Dose|Insufficient urine production|0|||
162198505|NCT01184859|585777448|FG000|Period 1: Single Dose|Protocol Violation|0|||
162198506|NCT01184859|585777449|FG001|Period 1: Single Dose|Protocol Violation|1|||
162198507|NCT01184859|585777450|FG002|Period 1: Single Dose|Protocol Violation|0|||
162198508|NCT01184859|585777451|FG003|Period 1: Single Dose|Protocol Violation|0|||
162198509|NCT01184859|585777452|FG004|Period 1: Single Dose|Protocol Violation|0|||
162198510|NCT01184859|585777448|FG000|Period 1: Single Dose|Adverse Event|0|||
162198511|NCT01184859|585777449|FG001|Period 1: Single Dose|Adverse Event|0|||
162198512|NCT01184859|585777450|FG002|Period 1: Single Dose|Adverse Event|0|||
162198513|NCT01184859|585777451|FG003|Period 1: Single Dose|Adverse Event|0|||
162198514|NCT01184859|585777452|FG004|Period 1: Single Dose|Adverse Event|1|||
162198515|NCT01184859|585777448|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
162198516|NCT01184859|585777449|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
162198517|NCT01184859|585777450|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
162198518|NCT01184859|585777451|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
162198519|NCT01184859|585777452|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
162198520|NCT01184859|585777448|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
162198521|NCT01184859|585777449|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
162198522|NCT01184859|585777450|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
161926718|NCT04124965|584778687|FG000|Overall Study|Pregnancy|1|||
161926719|NCT04124965|584778688|FG001|Overall Study|Pregnancy|0|||
161926720|NCT04124965|584778687|FG000|Overall Study|Sponsor and participant decision|0|||
162020554|NCT04027608|585130505|FG001|Overall Study|Lost to Follow-up|4|||
162020555|NCT04248491|585130506|FG000|Overall Study|Lost to Follow-up|1|||
162020556|NCT04248491|585130507|FG001|Overall Study|Lost to Follow-up|0|||
162198523|NCT01184859|585777451|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
162198524|NCT01184859|585777452|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
162198525|NCT00958711|585777462|FG000|Overall Study|Withdrawal by Subject|0|||
162198526|NCT00958711|585777463|FG001|Overall Study|Withdrawal by Subject|4|||
162198527|NCT00958711|585777462|FG000|Overall Study|Physician Decision|5|||
162198528|NCT00958711|585777463|FG001|Overall Study|Physician Decision|7|||
162198529|NCT00958711|585777462|FG000|Overall Study|Lost to Follow-up|4|||
162198530|NCT00958711|585777463|FG001|Overall Study|Lost to Follow-up|1|||
162198531|NCT00958711|585777462|FG000|Overall Study|Other|2|||
162198532|NCT00958711|585777463|FG001|Overall Study|Other|5|||
162198533|NCT00958711|585777462|FG000|Overall Study|Death|1|||
162198534|NCT00958711|585777463|FG001|Overall Study|Death|2|||
162198535|NCT00958711|585777462|FG000|Overall Study|Adverse Event|1|||
162198536|NCT00958711|585777463|FG001|Overall Study|Adverse Event|2|||
162198537|NCT03722485|585777464|FG000|Overall Study|Withdrawal by Subject|1|||
162198538|NCT03722485|585777465|FG001|Overall Study|Withdrawal by Subject|0|||
162198539|NCT03722485|585777464|FG000|Overall Study|Adverse Event|0|||
162198540|NCT03722485|585777465|FG001|Overall Study|Adverse Event|2|||
162198541|NCT03722485|585777464|FG000|Overall Study|subject discharged prior to study completion|1|||
162198542|NCT03722485|585777465|FG001|Overall Study|subject discharged prior to study completion|5|||
162198543|NCT03722485|585777464|FG000|Overall Study|eligibility criteria not met|2|||
162198544|NCT03722485|585777465|FG001|Overall Study|eligibility criteria not met|0|||
162198545|NCT03087851|585777470|FG000|Overall Study|Withdraw on medical grounds|0|||
162198546|NCT03087851|585777471|FG001|Overall Study|Withdraw on medical grounds|1|||
162198547|NCT03087851|585777472|FG002|Overall Study|Withdraw on medical grounds|2|||
162198548|NCT00409006|585777474|FG000|Overall Study|Death|15|||
162198549|NCT00409006|585777475|FG001|Overall Study|Death|6|||
162198550|NCT00409006|585777474|FG000|Overall Study|Lost to Follow-up|1|||
162198551|NCT00409006|585777475|FG001|Overall Study|Lost to Follow-up|2|||
162198552|NCT00409006|585777474|FG000|Overall Study|Withdrawal by Subject|3|||
162198553|NCT00409006|585777475|FG001|Overall Study|Withdrawal by Subject|2|||
162198554|NCT00409006|585777474|FG000|Overall Study|Physician Decision|1|||
162198555|NCT00409006|585777475|FG001|Overall Study|Physician Decision|2|||
162198556|NCT03672188|585777480|FG000|Overall Study|Withdrawal by Subject|0|||
161926721|NCT04124965|584778688|FG001|Overall Study|Sponsor and participant decision|1|||
161926722|NCT04124965|584778687|FG000|Overall Study|Personal surgery|0|||
161926723|NCT04124965|584778688|FG001|Overall Study|Personal surgery|1|||
161926724|NCT04124965|584778687|FG000|Overall Study|Physician Decision|0|||
161926725|NCT04124965|584778688|FG001|Overall Study|Physician Decision|1|||
161926726|NCT01214720|584778689|FG000|Overall Study|Alive and still on treatment|34|||
161926727|NCT01214720|584778690|FG001|Overall Study|Alive and still on treatment|18|||
161926728|NCT01214720|584778689|FG000|Overall Study|Alive and in follow-up|45|||
162198557|NCT03672188|585777481|FG001|Overall Study|Withdrawal by Subject|0|||
162198558|NCT03672188|585777482|FG002|Overall Study|Withdrawal by Subject|0|||
162198559|NCT03672188|585777483|FG003|Overall Study|Withdrawal by Subject|3|||
162198560|NCT03672188|585777484|FG004|Overall Study|Withdrawal by Subject|0|||
161820778|NCT01745094|584384645|FG002|Overall Study|Adverse Event|3|||
161820779|NCT01745094|584384646|FG003|Overall Study|Adverse Event|0|||
161820780|NCT01745094|584384643|FG000|Overall Study|Withdrawal by Subject|2|||
161820781|NCT01745094|584384644|FG001|Overall Study|Withdrawal by Subject|0|||
161820782|NCT01745094|584384645|FG002|Overall Study|Withdrawal by Subject|1|||
161820783|NCT01745094|584384646|FG003|Overall Study|Withdrawal by Subject|2|||
161820784|NCT01745094|584384643|FG000|Overall Study|Protocol Violation|1|||
161820785|NCT01745094|584384644|FG001|Overall Study|Protocol Violation|0|||
161820786|NCT01745094|584384645|FG002|Overall Study|Protocol Violation|3|||
161820787|NCT01745094|584384646|FG003|Overall Study|Protocol Violation|1|||
161820788|NCT01745094|584384643|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
161820789|NCT01745094|584384644|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
162020557|NCT01652469|585130516|FG000|Overall Study|Withdrawal by Subject|1|||
162020558|NCT01652469|585130517|FG001|Overall Study|Withdrawal by Subject|4|||
162198561|NCT03672188|585777485|FG005|Overall Study|Withdrawal by Subject|0|||
162198562|NCT03672188|585777486|FG006|Overall Study|Withdrawal by Subject|0|||
161820790|NCT01745094|584384645|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
161926729|NCT01214720|584778690|FG001|Overall Study|Alive and in follow-up|48|||
162020559|NCT01652469|585130516|FG000|Overall Study|Lost to Follow-up|0|||
162198563|NCT03672188|585777487|FG007|Overall Study|Withdrawal by Subject|0|||
162198564|NCT03672188|585777488|FG008|Overall Study|Withdrawal by Subject|0|||
162198565|NCT03672188|585777489|FG009|Overall Study|Withdrawal by Subject|0|||
162198566|NCT03672188|585777490|FG010|Overall Study|Withdrawal by Subject|0|||
162198567|NCT03672188|585777491|FG011|Overall Study|Withdrawal by Subject|0|||
162198568|NCT03672188|585777492|FG012|Overall Study|Withdrawal by Subject|0|||
162198569|NCT03672188|585777493|FG013|Overall Study|Withdrawal by Subject|0|||
162198570|NCT03672188|585777494|FG014|Overall Study|Withdrawal by Subject|0|||
162198571|NCT03672188|585777480|FG000|Overall Study|Death|0|||
162198572|NCT03672188|585777481|FG001|Overall Study|Death|0|||
162198573|NCT03672188|585777482|FG002|Overall Study|Death|0|||
162198574|NCT03672188|585777483|FG003|Overall Study|Death|0|||
162198575|NCT03672188|585777484|FG004|Overall Study|Death|0|||
162198576|NCT03672188|585777485|FG005|Overall Study|Death|0|||
162198577|NCT03672188|585777486|FG006|Overall Study|Death|0|||
162198578|NCT03672188|585777487|FG007|Overall Study|Death|0|||
162198579|NCT03672188|585777488|FG008|Overall Study|Death|0|||
162198580|NCT03672188|585777489|FG009|Overall Study|Death|0|||
162198581|NCT03672188|585777490|FG010|Overall Study|Death|0|||
162198582|NCT03672188|585777491|FG011|Overall Study|Death|0|||
162198583|NCT03672188|585777492|FG012|Overall Study|Death|1|||
162198584|NCT03672188|585777493|FG013|Overall Study|Death|0|||
162198585|NCT03672188|585777494|FG014|Overall Study|Death|0|||
162198586|NCT03672188|585777480|FG000|Overall Study|Lost to Follow-up|0|||
162198587|NCT03672188|585777481|FG001|Overall Study|Lost to Follow-up|0|||
162198588|NCT03672188|585777482|FG002|Overall Study|Lost to Follow-up|1|||
162198589|NCT03672188|585777483|FG003|Overall Study|Lost to Follow-up|0|||
162198590|NCT03672188|585777484|FG004|Overall Study|Lost to Follow-up|0|||
162198591|NCT03672188|585777485|FG005|Overall Study|Lost to Follow-up|0|||
162198592|NCT03672188|585777486|FG006|Overall Study|Lost to Follow-up|0|||
162198593|NCT03672188|585777487|FG007|Overall Study|Lost to Follow-up|0|||
162198594|NCT03672188|585777488|FG008|Overall Study|Lost to Follow-up|0|||
162198595|NCT03672188|585777489|FG009|Overall Study|Lost to Follow-up|0|||
162198596|NCT03672188|585777490|FG010|Overall Study|Lost to Follow-up|0|||
162198597|NCT03672188|585777491|FG011|Overall Study|Lost to Follow-up|0|||
162198598|NCT03672188|585777492|FG012|Overall Study|Lost to Follow-up|0|||
162198599|NCT03672188|585777493|FG013|Overall Study|Lost to Follow-up|0|||
162198600|NCT03672188|585777494|FG014|Overall Study|Lost to Follow-up|0|||
162198601|NCT03997409|585777495|FG000|Overall Study|Protocol Violation|1|||
162198602|NCT03997409|585777496|FG001|Overall Study|Protocol Violation|1|||
162198603|NCT03997409|585777497|FG002|Overall Study|Protocol Violation|0|||
162198604|NCT03997409|585777495|FG000|Overall Study|Withdrawal by Subject|3|||
162198605|NCT03997409|585777496|FG001|Overall Study|Withdrawal by Subject|0|||
162198606|NCT03997409|585777497|FG002|Overall Study|Withdrawal by Subject|0|||
162198607|NCT03997409|585777495|FG000|Overall Study|Lost to Follow-up|0|||
162198608|NCT03997409|585777496|FG001|Overall Study|Lost to Follow-up|0|||
162198609|NCT03997409|585777497|FG002|Overall Study|Lost to Follow-up|1|||
162198610|NCT03696342|585777498|FG000|Overall Study|Lost to Follow-up|1|||
162198611|NCT03696342|585777499|FG001|Overall Study|Lost to Follow-up|0|||
162198612|NCT01753323|585777501|FG000|Overall Study|Lack of Efficacy|0|||
162198613|NCT01753323|585777502|FG001|Overall Study|Lack of Efficacy|0|||
162198614|NCT01753323|585777503|FG002|Overall Study|Lack of Efficacy|8|||
162198615|NCT01753323|585777501|FG000|Overall Study|Protocol deviation|1|||
162198616|NCT01753323|585777502|FG001|Overall Study|Protocol deviation|0|||
162198617|NCT01753323|585777503|FG002|Overall Study|Protocol deviation|0|||
162198618|NCT01753323|585777501|FG000|Overall Study|Adverse Event|0|||
162198619|NCT01753323|585777502|FG001|Overall Study|Adverse Event|0|||
162198620|NCT01753323|585777503|FG002|Overall Study|Adverse Event|1|||
162198621|NCT01870999|585777504|FG000|Overall Study|Adverse Event|0|||
162198622|NCT01870999|585777505|FG001|Overall Study|Adverse Event|4|||
162198623|NCT01870999|585777506|FG002|Overall Study|Adverse Event|1|||
162198624|NCT01870999|585777504|FG000|Overall Study|Subject met withdrawal criteria|3|||
162198625|NCT01870999|585777505|FG001|Overall Study|Subject met withdrawal criteria|2|||
162198626|NCT01870999|585777506|FG002|Overall Study|Subject met withdrawal criteria|0|||
162198627|NCT01870999|585777504|FG000|Overall Study|Subject withdrawn by Investigator|1|||
162198628|NCT01870999|585777505|FG001|Overall Study|Subject withdrawn by Investigator|0|||
162198629|NCT01870999|585777506|FG002|Overall Study|Subject withdrawn by Investigator|0|||
162198630|NCT01870999|585777504|FG000|Overall Study|Withdrawal by Subject|0|||
162198631|NCT01870999|585777505|FG001|Overall Study|Withdrawal by Subject|2|||
162198632|NCT01870999|585777506|FG002|Overall Study|Withdrawal by Subject|5|||
162198633|NCT01870999|585777504|FG000|Overall Study|Protocol Violation|0|||
162198634|NCT01870999|585777505|FG001|Overall Study|Protocol Violation|0|||
162198635|NCT01870999|585777506|FG002|Overall Study|Protocol Violation|1|||
162198636|NCT01636258|585777507|FG000|Overall Study|Lost to Follow-up|1|||
162198637|NCT01636258|585777508|FG001|Overall Study|Lost to Follow-up|0|||
162198638|NCT03034772|585777519|FG000|Overall Study|Adverse Event|0|||
162198639|NCT03034772|585777520|FG001|Overall Study|Adverse Event|1|||
162198640|NCT03034772|585777519|FG000|Overall Study|Withdrawal by Subject|0|||
162198641|NCT03034772|585777520|FG001|Overall Study|Withdrawal by Subject|1|||
162198642|NCT00116584|585777521|FG000|Overall Study|Withdrawal by Subject|1|||
162198643|NCT00116584|585777522|FG001|Overall Study|Withdrawal by Subject|0|||
162198644|NCT00116584|585777521|FG000|Overall Study|Protocol Violation|1|||
162198645|NCT00116584|585777522|FG001|Overall Study|Protocol Violation|1|||
162198646|NCT01745380|585777523|FG000|Overall Study|Lost to Follow-up|1|||
162198647|NCT01745380|585777524|FG001|Overall Study|Lost to Follow-up|0|||
162198648|NCT01745380|585777523|FG000|Overall Study|Lack of Efficacy|0|||
162198649|NCT01745380|585777524|FG001|Overall Study|Lack of Efficacy|1|||
162198650|NCT02660034|585777525|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
162198651|NCT02660034|585777526|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
162198652|NCT02660034|585777527|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
162198653|NCT02660034|585777528|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
162198654|NCT02660034|585777529|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
162198655|NCT02660034|585777530|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
162198656|NCT02660034|585777531|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
162198657|NCT02660034|585777532|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
162198658|NCT02660034|585777533|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
162198659|NCT02660034|585777534|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
162198660|NCT02660034|585777535|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
162198661|NCT02660034|585777536|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
162198662|NCT02660034|585777537|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
162198663|NCT02660034|585777538|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
162198664|NCT02660034|585777525|FG000|Overall Study|Progressive Disease (Clinical)|7|||
162198665|NCT02660034|585777526|FG001|Overall Study|Progressive Disease (Clinical)|8|||
162198666|NCT02660034|585777527|FG002|Overall Study|Progressive Disease (Clinical)|3|||
162198667|NCT02660034|585777528|FG003|Overall Study|Progressive Disease (Clinical)|9|||
162198668|NCT02660034|585777529|FG004|Overall Study|Progressive Disease (Clinical)|3|||
162198669|NCT02660034|585777530|FG005|Overall Study|Progressive Disease (Clinical)|0|||
162198670|NCT02660034|585777531|FG006|Overall Study|Progressive Disease (Clinical)|0|||
162198671|NCT02660034|585777532|FG007|Overall Study|Progressive Disease (Clinical)|0|||
162198672|NCT02660034|585777533|FG008|Overall Study|Progressive Disease (Clinical)|0|||
162198673|NCT02660034|585777534|FG009|Overall Study|Progressive Disease (Clinical)|0|||
162198674|NCT02660034|585777535|FG010|Overall Study|Progressive Disease (Clinical)|0|||
162198675|NCT02660034|585777536|FG011|Overall Study|Progressive Disease (Clinical)|0|||
162198676|NCT02660034|585777537|FG012|Overall Study|Progressive Disease (Clinical)|0|||
162198677|NCT02660034|585777538|FG013|Overall Study|Progressive Disease (Clinical)|0|||
162198678|NCT02660034|585777525|FG000|Overall Study|Lost to Follow-up|0|||
162198679|NCT02660034|585777526|FG001|Overall Study|Lost to Follow-up|0|||
162198680|NCT02660034|585777527|FG002|Overall Study|Lost to Follow-up|1|||
162198681|NCT02660034|585777528|FG003|Overall Study|Lost to Follow-up|1|||
162198682|NCT02660034|585777529|FG004|Overall Study|Lost to Follow-up|0|||
162198683|NCT02660034|585777530|FG005|Overall Study|Lost to Follow-up|0|||
162198684|NCT02660034|585777531|FG006|Overall Study|Lost to Follow-up|0|||
162198685|NCT02660034|585777532|FG007|Overall Study|Lost to Follow-up|0|||
162198686|NCT02660034|585777533|FG008|Overall Study|Lost to Follow-up|0|||
162198687|NCT02660034|585777534|FG009|Overall Study|Lost to Follow-up|1|||
162198688|NCT02660034|585777535|FG010|Overall Study|Lost to Follow-up|1|||
162198689|NCT02660034|585777536|FG011|Overall Study|Lost to Follow-up|1|||
162198690|NCT02660034|585777537|FG012|Overall Study|Lost to Follow-up|0|||
162198691|NCT02660034|585777538|FG013|Overall Study|Lost to Follow-up|0|||
162198692|NCT02660034|585777525|FG000|Overall Study|Participant moved into special access scheme|1|||
162198693|NCT02660034|585777526|FG001|Overall Study|Participant moved into special access scheme|2|||
162198694|NCT02660034|585777527|FG002|Overall Study|Participant moved into special access scheme|0|||
162020560|NCT01652469|585130517|FG001|Overall Study|Lost to Follow-up|2|||
162020561|NCT01049009|585130518|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
162020562|NCT01049009|585130519|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
162020563|NCT01049009|585130518|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162020564|NCT01049009|585130519|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
162020565|NCT01049009|585130518|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
162020566|NCT01049009|585130519|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
162020567|NCT01049009|585130518|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
162020568|NCT01049009|585130519|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
162020569|NCT02644109|585130521|FG000|Overall Study|Adverse Event|0|||
162020570|NCT02644109|585130522|FG001|Overall Study|Adverse Event|4|||
162020571|NCT02474069|585130523|FG000|Selection Phase (SP)|Adverse Event|8|||
162020572|NCT02474069|585130524|FG001|Selection Phase (SP)|Adverse Event|0|||
162020573|NCT02474069|585130525|FG002|Selection Phase (SP)|Adverse Event|0|||
162020574|NCT02474069|585130523|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
162020575|NCT02474069|585130524|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
162020576|NCT02474069|585130525|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
162020577|NCT02474069|585130523|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
162020578|NCT02474069|585130524|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
162020579|NCT02474069|585130525|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
162020580|NCT02474069|585130523|FG000|Selection Phase (SP)|Physician Decision|1|||
162020581|NCT02474069|585130524|FG001|Selection Phase (SP)|Physician Decision|0|||
162020582|NCT02474069|585130525|FG002|Selection Phase (SP)|Physician Decision|0|||
162020583|NCT02474069|585130523|FG000|Selection Phase (SP)|Protocol Violation|1|||
162020584|NCT02474069|585130524|FG001|Selection Phase (SP)|Protocol Violation|0|||
162020585|NCT02474069|585130525|FG002|Selection Phase (SP)|Protocol Violation|0|||
162020586|NCT02474069|585130523|FG000|Selection Phase (SP)|No longer requires treatment|1|||
162020587|NCT02474069|585130524|FG001|Selection Phase (SP)|No longer requires treatment|0|||
162020588|NCT02474069|585130525|FG002|Selection Phase (SP)|No longer requires treatment|0|||
162020589|NCT02474069|585130523|FG000|Selection Phase (SP)|Technical Problem|1|||
162020590|NCT02474069|585130524|FG001|Selection Phase (SP)|Technical Problem|0|||
162020591|NCT02474069|585130525|FG002|Selection Phase (SP)|Technical Problem|0|||
162020592|NCT02474069|585130523|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
162020593|NCT02474069|585130524|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
162020594|NCT02474069|585130525|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
162020595|NCT02474069|585130523|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
162020596|NCT02474069|585130524|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
162198695|NCT02660034|585777528|FG003|Overall Study|Participant moved into special access scheme|0|||
162198696|NCT02660034|585777529|FG004|Overall Study|Participant moved into special access scheme|0|||
162198697|NCT02660034|585777530|FG005|Overall Study|Participant moved into special access scheme|0|||
162198698|NCT02660034|585777531|FG006|Overall Study|Participant moved into special access scheme|0|||
162198699|NCT02660034|585777532|FG007|Overall Study|Participant moved into special access scheme|0|||
162198700|NCT02660034|585777533|FG008|Overall Study|Participant moved into special access scheme|0|||
162198701|NCT02660034|585777534|FG009|Overall Study|Participant moved into special access scheme|0|||
162198702|NCT02660034|585777535|FG010|Overall Study|Participant moved into special access scheme|0|||
162198703|NCT02660034|585777536|FG011|Overall Study|Participant moved into special access scheme|0|||
162198704|NCT02660034|585777537|FG012|Overall Study|Participant moved into special access scheme|0|||
162198705|NCT02660034|585777538|FG013|Overall Study|Participant moved into special access scheme|0|||
162198706|NCT02660034|585777525|FG000|Overall Study|Adverse Event|1|||
162198707|NCT02660034|585777526|FG001|Overall Study|Adverse Event|0|||
162198708|NCT02660034|585777527|FG002|Overall Study|Adverse Event|0|||
162198709|NCT02660034|585777528|FG003|Overall Study|Adverse Event|0|||
162198710|NCT02660034|585777529|FG004|Overall Study|Adverse Event|0|||
162198711|NCT02660034|585777530|FG005|Overall Study|Adverse Event|0|||
162198712|NCT02660034|585777531|FG006|Overall Study|Adverse Event|0|||
162198713|NCT02660034|585777532|FG007|Overall Study|Adverse Event|0|||
162198714|NCT02660034|585777533|FG008|Overall Study|Adverse Event|0|||
162198715|NCT02660034|585777534|FG009|Overall Study|Adverse Event|0|||
162198716|NCT02660034|585777535|FG010|Overall Study|Adverse Event|0|||
162198717|NCT02660034|585777536|FG011|Overall Study|Adverse Event|0|||
162198718|NCT02660034|585777537|FG012|Overall Study|Adverse Event|0|||
162198719|NCT02660034|585777538|FG013|Overall Study|Adverse Event|0|||
162198720|NCT02660034|585777525|FG000|Overall Study|Sponsor Decision|0|||
162198721|NCT02660034|585777526|FG001|Overall Study|Sponsor Decision|1|||
162198722|NCT02660034|585777527|FG002|Overall Study|Sponsor Decision|2|||
162020597|NCT02474069|585130525|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
162020598|NCT02474069|585130523|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
162198723|NCT02660034|585777528|FG003|Overall Study|Sponsor Decision|2|||
162020599|NCT02474069|585130524|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
162020600|NCT02474069|585130525|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
162020601|NCT02474069|585130523|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
162198724|NCT02660034|585777529|FG004|Overall Study|Sponsor Decision|3|||
162198725|NCT02660034|585777530|FG005|Overall Study|Sponsor Decision|0|||
161676138|NCT01667107|583867307|FG000|Overall Study|Protocol Violation|0|||
162198726|NCT02660034|585777531|FG006|Overall Study|Sponsor Decision|0|||
162198727|NCT02660034|585777532|FG007|Overall Study|Sponsor Decision|0|||
162198728|NCT02660034|585777533|FG008|Overall Study|Sponsor Decision|0|||
162198729|NCT02660034|585777534|FG009|Overall Study|Sponsor Decision|0|||
162198730|NCT02660034|585777535|FG010|Overall Study|Sponsor Decision|0|||
162198731|NCT02660034|585777536|FG011|Overall Study|Sponsor Decision|0|||
162198732|NCT02660034|585777537|FG012|Overall Study|Sponsor Decision|0|||
162198733|NCT02660034|585777538|FG013|Overall Study|Sponsor Decision|1|||
162198734|NCT02660034|585777525|FG000|Overall Study|Withdrawal by Subject|0|||
162198735|NCT02660034|585777526|FG001|Overall Study|Withdrawal by Subject|0|||
162198736|NCT02660034|585777527|FG002|Overall Study|Withdrawal by Subject|0|||
162198737|NCT02660034|585777528|FG003|Overall Study|Withdrawal by Subject|0|||
162198738|NCT02660034|585777529|FG004|Overall Study|Withdrawal by Subject|0|||
162198739|NCT02660034|585777530|FG005|Overall Study|Withdrawal by Subject|0|||
162198740|NCT02660034|585777531|FG006|Overall Study|Withdrawal by Subject|1|||
162198741|NCT02660034|585777532|FG007|Overall Study|Withdrawal by Subject|1|||
162198742|NCT02660034|585777533|FG008|Overall Study|Withdrawal by Subject|1|||
162198743|NCT02660034|585777534|FG009|Overall Study|Withdrawal by Subject|0|||
162198744|NCT02660034|585777535|FG010|Overall Study|Withdrawal by Subject|0|||
162198745|NCT02660034|585777536|FG011|Overall Study|Withdrawal by Subject|1|||
162198746|NCT02660034|585777537|FG012|Overall Study|Withdrawal by Subject|2|||
162198747|NCT02660034|585777538|FG013|Overall Study|Withdrawal by Subject|0|||
162198748|NCT02660034|585777525|FG000|Overall Study|Death|0|||
162198749|NCT02660034|585777526|FG001|Overall Study|Death|0|||
162198750|NCT02660034|585777527|FG002|Overall Study|Death|0|||
162198751|NCT02660034|585777528|FG003|Overall Study|Death|0|||
162198752|NCT02660034|585777529|FG004|Overall Study|Death|0|||
162198753|NCT02660034|585777530|FG005|Overall Study|Death|13|||
162198754|NCT02660034|585777531|FG006|Overall Study|Death|14|||
162198755|NCT02660034|585777532|FG007|Overall Study|Death|10|||
162198756|NCT02660034|585777533|FG008|Overall Study|Death|9|||
162198757|NCT02660034|585777534|FG009|Overall Study|Death|21|||
162198758|NCT02660034|585777535|FG010|Overall Study|Death|17|||
162198759|NCT02660034|585777536|FG011|Overall Study|Death|15|||
162198760|NCT02660034|585777537|FG012|Overall Study|Death|18|||
162198761|NCT02660034|585777538|FG013|Overall Study|Death|7|||
162198762|NCT02660034|585777525|FG000|Overall Study|Physician Decision|0|||
162198763|NCT02660034|585777526|FG001|Overall Study|Physician Decision|0|||
162198764|NCT02660034|585777527|FG002|Overall Study|Physician Decision|0|||
162198765|NCT02660034|585777528|FG003|Overall Study|Physician Decision|0|||
162198766|NCT02660034|585777529|FG004|Overall Study|Physician Decision|0|||
162198767|NCT02660034|585777530|FG005|Overall Study|Physician Decision|0|||
162198768|NCT02660034|585777531|FG006|Overall Study|Physician Decision|0|||
162198769|NCT02660034|585777532|FG007|Overall Study|Physician Decision|0|||
162198770|NCT02660034|585777533|FG008|Overall Study|Physician Decision|0|||
162198771|NCT02660034|585777534|FG009|Overall Study|Physician Decision|0|||
162198772|NCT02660034|585777535|FG010|Overall Study|Physician Decision|0|||
162198773|NCT02660034|585777536|FG011|Overall Study|Physician Decision|0|||
162198774|NCT02660034|585777537|FG012|Overall Study|Physician Decision|0|||
162198775|NCT02660034|585777538|FG013|Overall Study|Physician Decision|1|||
162198776|NCT02660034|585777525|FG000|Overall Study|Participants transferred to LTE|0|||
162198777|NCT02660034|585777526|FG001|Overall Study|Participants transferred to LTE|0|||
161926730|NCT01214720|584778689|FG000|Overall Study|Lost to Follow-up|6|||
162198778|NCT02660034|585777527|FG002|Overall Study|Participants transferred to LTE|0|||
162198779|NCT02660034|585777528|FG003|Overall Study|Participants transferred to LTE|0|||
161926731|NCT01214720|584778690|FG001|Overall Study|Lost to Follow-up|2|||
161926732|NCT04625972|584778691|FG000|Overall Study|Death|3|||
161926733|NCT04625972|584778692|FG001|Overall Study|Death|2|||
162198780|NCT02660034|585777529|FG004|Overall Study|Participants transferred to LTE|0|||
162198781|NCT02660034|585777530|FG005|Overall Study|Participants transferred to LTE|10|||
162198782|NCT02660034|585777531|FG006|Overall Study|Participants transferred to LTE|8|||
162198783|NCT02660034|585777532|FG007|Overall Study|Participants transferred to LTE|8|||
162198784|NCT02660034|585777533|FG008|Overall Study|Participants transferred to LTE|10|||
162198785|NCT02660034|585777534|FG009|Overall Study|Participants transferred to LTE|1|||
161676139|NCT01667107|583867308|FG001|Overall Study|Protocol Violation|1|||
161676140|NCT01667107|583867307|FG000|Overall Study|Lack of Efficacy|0|||
161676141|NCT01667107|583867308|FG001|Overall Study|Lack of Efficacy|1|||
162198786|NCT02660034|585777535|FG010|Overall Study|Participants transferred to LTE|2|||
162198787|NCT02660034|585777536|FG011|Overall Study|Participants transferred to LTE|4|||
162198788|NCT02660034|585777537|FG012|Overall Study|Participants transferred to LTE|1|||
162198789|NCT02660034|585777538|FG013|Overall Study|Participants transferred to LTE|1|||
162198790|NCT04879823|585777550|FG000|Overall Study|Physician Decision|3|||
162198791|NCT04879823|585777551|FG001|Overall Study|Physician Decision|1|||
162198792|NCT04879823|585777550|FG000|Overall Study|Protocol Violation|2|||
162198793|NCT04879823|585777551|FG001|Overall Study|Protocol Violation|3|||
162198794|NCT04879823|585777550|FG000|Overall Study|Lost to Follow-up|43|||
162198795|NCT04879823|585777551|FG001|Overall Study|Lost to Follow-up|35|||
162198796|NCT00730925|585777552|FG000|Overall Study|Progressive Disease|21|||
161926734|NCT04625972|584778691|FG000|Overall Study|Lost to Follow-up|82|||
161926735|NCT04625972|584778692|FG001|Overall Study|Lost to Follow-up|38|||
161926736|NCT04625972|584778691|FG000|Overall Study|Physician Decision|2|||
161926737|NCT04625972|584778692|FG001|Overall Study|Physician Decision|0|||
161926738|NCT04625972|584778691|FG000|Overall Study|Protocol Violation|0|||
161926739|NCT04625972|584778692|FG001|Overall Study|Protocol Violation|1|||
161926740|NCT04625972|584778691|FG000|Overall Study|Withdrawal by Subject|37|||
161926741|NCT04625972|584778692|FG001|Overall Study|Withdrawal by Subject|24|||
161926742|NCT04625972|584778691|FG000|Overall Study|Not specified elsewhere|8|||
161926743|NCT04625972|584778692|FG001|Overall Study|Not specified elsewhere|6|||
161926744|NCT05591755|584778693|FG000|Overall Study|Screen Failure|1|||
161926745|NCT05591755|584778694|FG001|Overall Study|Screen Failure|0|||
161926746|NCT05591755|584778695|FG002|Overall Study|Screen Failure|0|||
161926747|NCT05591755|584778696|FG003|Overall Study|Screen Failure|0|||
161926748|NCT05591755|584778693|FG000|Overall Study|Protocol Violation|0|||
161926749|NCT05591755|584778694|FG001|Overall Study|Protocol Violation|0|||
161926750|NCT05591755|584778695|FG002|Overall Study|Protocol Violation|2|||
161926751|NCT05591755|584778696|FG003|Overall Study|Protocol Violation|0|||
161926752|NCT05591755|584778693|FG000|Overall Study|Withdrawal by Subject|0|||
161926753|NCT05591755|584778694|FG001|Overall Study|Withdrawal by Subject|1|||
161926754|NCT05591755|584778695|FG002|Overall Study|Withdrawal by Subject|0|||
161926755|NCT05591755|584778696|FG003|Overall Study|Withdrawal by Subject|0|||
161926756|NCT00433290|584778697|FG000|Overall Study|Adverse Event|24|||
161926757|NCT00433290|584778698|FG001|Overall Study|Adverse Event|7|||
161926758|NCT00433290|584778697|FG000|Overall Study|Lack of Efficacy|1|||
161926759|NCT00433290|584778698|FG001|Overall Study|Lack of Efficacy|5|||
161926760|NCT00433290|584778697|FG000|Overall Study|Withdrawal by Subject|4|||
161926761|NCT00433290|584778698|FG001|Overall Study|Withdrawal by Subject|2|||
161926762|NCT00433290|584778697|FG000|Overall Study|Protocol Violation|3|||
161926763|NCT00433290|584778698|FG001|Overall Study|Protocol Violation|2|||
161926764|NCT00433290|584778697|FG000|Overall Study|Physician Decision|2|||
161926765|NCT00433290|584778698|FG001|Overall Study|Physician Decision|0|||
161926766|NCT00433290|584778697|FG000|Overall Study|Entry Criteria Not Met|0|||
161926767|NCT00433290|584778698|FG001|Overall Study|Entry Criteria Not Met|1|||
161926768|NCT00433290|584778697|FG000|Overall Study|Lost to Follow-up|1|||
161926769|NCT00433290|584778698|FG001|Overall Study|Lost to Follow-up|0|||
161926770|NCT00086307|584778699|FG000|Overall Study|Lack of Efficacy|1|||
161926771|NCT00086307|584778700|FG001|Overall Study|Lack of Efficacy|1|||
161926772|NCT00086307|584778701|FG002|Overall Study|Lack of Efficacy|2|||
161926773|NCT00086307|584778699|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
161926774|NCT00086307|584778700|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
161926775|NCT00086307|584778701|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
161926776|NCT00086307|584778699|FG000|Overall Study|Nausea and headaches|0|||
161926777|NCT00086307|584778700|FG001|Overall Study|Nausea and headaches|0|||
161926778|NCT00086307|584778701|FG002|Overall Study|Nausea and headaches|1|||
161926779|NCT00086307|584778699|FG000|Overall Study|Constipation and sleepiness|0|||
161926780|NCT00086307|584778700|FG001|Overall Study|Constipation and sleepiness|0|||
161926781|NCT00086307|584778701|FG002|Overall Study|Constipation and sleepiness|1|||
161926782|NCT00086307|584778699|FG000|Overall Study|Suicidal ideation|0|||
161926783|NCT00086307|584778700|FG001|Overall Study|Suicidal ideation|0|||
161926784|NCT00086307|584778701|FG002|Overall Study|Suicidal ideation|1|||
161926785|NCT00086307|584778699|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
161926786|NCT00086307|584778700|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
161926787|NCT00086307|584778701|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
161926788|NCT00086307|584778699|FG000|Overall Study|Withdrawal by Subject|0|||
161926789|NCT00086307|584778700|FG001|Overall Study|Withdrawal by Subject|0|||
161926790|NCT00086307|584778701|FG002|Overall Study|Withdrawal by Subject|2|||
161926791|NCT03158311|584778704|FG000|Overall Study|Subject/Guardian Decision|10|||
161926792|NCT03158311|584778705|FG001|Overall Study|Subject/Guardian Decision|6|||
161926793|NCT03158311|584778706|FG002|Overall Study|Subject/Guardian Decision|11|||
161926794|NCT03158311|584778704|FG000|Overall Study|Adverse Event|5|||
161926795|NCT03158311|584778705|FG001|Overall Study|Adverse Event|3|||
161926796|NCT03158311|584778706|FG002|Overall Study|Adverse Event|3|||
161926797|NCT03158311|584778704|FG000|Overall Study|Techinical Problems|3|||
161926798|NCT03158311|584778705|FG001|Overall Study|Techinical Problems|1|||
161926799|NCT03158311|584778706|FG002|Overall Study|Techinical Problems|5|||
161926800|NCT03158311|584778704|FG000|Overall Study|Physician Decision|2|||
161926801|NCT03158311|584778705|FG001|Overall Study|Physician Decision|3|||
161926802|NCT03158311|584778706|FG002|Overall Study|Physician Decision|7|||
161926803|NCT03158311|584778704|FG000|Overall Study|Lost to Follow-up|1|||
162198797|NCT00730925|585777552|FG000|Overall Study|Dose reducing Event|2|||
162198798|NCT00730925|585777552|FG000|Overall Study|Other Averse Event|7|||
162198799|NCT00730925|585777552|FG000|Overall Study|Protocol Violation|1|||
162198800|NCT00730925|585777552|FG000|Overall Study|Withdrawal by Subject|1|||
162198801|NCT00730925|585777552|FG000|Overall Study|Switch to combination therapy|8|||
162198802|NCT00730925|585777552|FG000|Overall Study|Other|1|||
162198803|NCT02137239|585777553|FG000|Overall Study|Discontinued Study Treatment|0|||
162198804|NCT02137239|585777554|FG001|Overall Study|Discontinued Study Treatment|3|||
162198805|NCT02137239|585777553|FG000|Overall Study|Withdrew Consent|1|||
162198806|NCT02137239|585777554|FG001|Overall Study|Withdrew Consent|1|||
162198807|NCT02137239|585777553|FG000|Overall Study|Adverse Event|2|||
162198808|NCT02137239|585777554|FG001|Overall Study|Adverse Event|2|||
162198809|NCT04057937|585777555|FG000|Placebo-controlled Phase|Adverse Event|3|||
162198810|NCT04057937|585777556|FG001|Placebo-controlled Phase|Adverse Event|0|||
162198811|NCT04057937|585777555|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
162198812|NCT04057937|585777556|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
162198813|NCT04057937|585777555|FG000|Active-treatment Phase|Pregnancy|0|||
162198814|NCT04057937|585777556|FG001|Active-treatment Phase|Pregnancy|1|||
162198815|NCT04057937|585777555|FG000|Active-treatment Phase|Physician Decision|0|||
162198816|NCT04057937|585777556|FG001|Active-treatment Phase|Physician Decision|1|||
162198817|NCT02029521|585777557|FG000|Overall Study|Protocol Violation|1|||
162198818|NCT02029521|585777558|FG001|Overall Study|Protocol Violation|0|||
162198819|NCT02029521|585777557|FG000|Overall Study|Withdrawal by Subject|1|||
162198820|NCT02029521|585777558|FG001|Overall Study|Withdrawal by Subject|1|||
162198821|NCT01072396|585777559|FG000|Period One|Adverse Event|1|||
162198822|NCT01072396|585777560|FG001|Period One|Adverse Event|1|||
162198823|NCT01072396|585777559|FG000|Period One|Protocol Violation|2|||
162198824|NCT01072396|585777560|FG001|Period One|Protocol Violation|1|||
162198825|NCT01072396|585777559|FG000|Period One|Withdrawal by Subject|2|||
162198826|NCT01072396|585777560|FG001|Period One|Withdrawal by Subject|0|||
162198827|NCT01072396|585777559|FG000|Washout Period|Missing termination information|0|||
162198828|NCT01072396|585777560|FG001|Washout Period|Missing termination information|1|||
162198829|NCT01072396|585777559|FG000|Period Two|Adverse Event|0|||
162198830|NCT01072396|585777560|FG001|Period Two|Adverse Event|3|||
162198831|NCT01072396|585777559|FG000|Period Two|Lost to Follow-up|1|||
162198832|NCT01072396|585777560|FG001|Period Two|Lost to Follow-up|0|||
162198833|NCT02446912|585777561|FG000|Overall Study|Adverse Event|3|||
162198834|NCT02446912|585777562|FG001|Overall Study|Adverse Event|13|||
162198835|NCT02446912|585777563|FG002|Overall Study|Adverse Event|5|||
162198836|NCT02446912|585777561|FG000|Overall Study|Condition under investigation worsened|0|||
161926804|NCT03158311|584778705|FG001|Overall Study|Lost to Follow-up|1|||
161926805|NCT03158311|584778706|FG002|Overall Study|Lost to Follow-up|1|||
161926806|NCT03158311|584778704|FG000|Overall Study|Sponsor decision|1|||
161926807|NCT03158311|584778705|FG001|Overall Study|Sponsor decision|0|||
162020602|NCT02474069|585130524|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
162198837|NCT02446912|585777562|FG001|Overall Study|Condition under investigation worsened|1|||
162198838|NCT02446912|585777563|FG002|Overall Study|Condition under investigation worsened|1|||
162198839|NCT02446912|585777561|FG000|Overall Study|Study-specific withdrawal criteria|1|||
162198840|NCT02446912|585777562|FG001|Overall Study|Study-specific withdrawal criteria|0|||
162198841|NCT02446912|585777563|FG002|Overall Study|Study-specific withdrawal criteria|0|||
162198842|NCT02446912|585777561|FG000|Overall Study|Lack of Efficacy|1|||
162198843|NCT02446912|585777562|FG001|Overall Study|Lack of Efficacy|4|||
161683067|NCT01148537|583891234|FG001|Overall Study|Withdrawal by Subject|0|||
161926808|NCT03158311|584778706|FG002|Overall Study|Sponsor decision|0|||
162020603|NCT02474069|585130525|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
162020604|NCT02474069|585130523|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
162020605|NCT02474069|585130524|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
162198844|NCT02446912|585777563|FG002|Overall Study|Lack of Efficacy|7|||
162198845|NCT02446912|585777561|FG000|Overall Study|Lost to Follow-up|0|||
162198846|NCT02446912|585777562|FG001|Overall Study|Lost to Follow-up|0|||
162198847|NCT02446912|585777563|FG002|Overall Study|Lost to Follow-up|2|||
161926809|NCT03158311|584778704|FG000|Overall Study|Pregnancy|0|||
162198848|NCT02446912|585777561|FG000|Overall Study|Severe non-compliance to protocol|1|||
162198849|NCT02446912|585777562|FG001|Overall Study|Severe non-compliance to protocol|0|||
162198850|NCT02446912|585777563|FG002|Overall Study|Severe non-compliance to protocol|1|||
162198851|NCT02446912|585777561|FG000|Overall Study|Withdrawal by Subject|10|||
162198852|NCT02446912|585777562|FG001|Overall Study|Withdrawal by Subject|15|||
162198853|NCT02446912|585777563|FG002|Overall Study|Withdrawal by Subject|15|||
161676142|NCT03427125|583867309|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
161676143|NCT03427125|583867310|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
161676144|NCT03427125|583867311|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
161676145|NCT02281357|583867312|FG000|Overall Study|Adverse Event|2|||
161676146|NCT02281357|583867313|FG001|Overall Study|Adverse Event|1|||
161676147|NCT02281357|583867312|FG000|Overall Study|Lost to Follow-up|1|||
161676148|NCT02281357|583867313|FG001|Overall Study|Lost to Follow-up|0|||
161926810|NCT03158311|584778705|FG001|Overall Study|Pregnancy|2|||
161926811|NCT03158311|584778706|FG002|Overall Study|Pregnancy|0|||
162198854|NCT02446912|585777561|FG000|Overall Study|Miscellaneous|2|||
162198855|NCT02446912|585777562|FG001|Overall Study|Miscellaneous|2|||
162198856|NCT02446912|585777563|FG002|Overall Study|Miscellaneous|4|||
162198857|NCT01268488|585777564|FG000|Overall Study|Adverse Event|3|||
162198858|NCT01268488|585777564|FG000|Overall Study|Physician Decision|2|||
162198859|NCT01106586|585777567|FG000|Overall Study|Adverse Event|9|||
162198860|NCT01106586|585777568|FG001|Overall Study|Adverse Event|15|||
162198861|NCT01106586|585777567|FG000|Overall Study|Death|1|||
162198862|NCT01106586|585777568|FG001|Overall Study|Death|3|||
162198863|NCT01106586|585777567|FG000|Overall Study|Pregnancy|2|||
162198864|NCT01106586|585777568|FG001|Overall Study|Pregnancy|2|||
162198865|NCT01106586|585777567|FG000|Overall Study|Lack of Efficacy|1|||
162198866|NCT01106586|585777568|FG001|Overall Study|Lack of Efficacy|0|||
162198867|NCT01106586|585777567|FG000|Overall Study|Investigator's Discretion|5|||
162198868|NCT01106586|585777568|FG001|Overall Study|Investigator's Discretion|8|||
161926812|NCT03158311|584778704|FG000|Overall Study|Randomized in error|0|||
161926813|NCT03158311|584778705|FG001|Overall Study|Randomized in error|0|||
161676149|NCT02281357|583867312|FG000|Overall Study|Withdrawal by Subject|4|||
161676150|NCT02281357|583867313|FG001|Overall Study|Withdrawal by Subject|3|||
161926814|NCT03158311|584778706|FG002|Overall Study|Randomized in error|1|||
161926815|NCT00724503|584778707|FG000|Overall Study|Lost to Follow-up|4|||
161926816|NCT00724503|584778708|FG001|Overall Study|Lost to Follow-up|8|||
161926817|NCT00724503|584778707|FG000|Overall Study|Withdrawal by Subject|11|||
161926818|NCT00724503|584778708|FG001|Overall Study|Withdrawal by Subject|23|||
161926819|NCT00724503|584778707|FG000|Overall Study|Death|190|||
161926820|NCT00724503|584778708|FG001|Overall Study|Death|182|||
161926821|NCT00724503|584778707|FG000|Overall Study|Adverse Event|1|||
162020606|NCT02474069|585130525|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
162198869|NCT01106586|585777567|FG000|Overall Study|Withdrew Consent|18|||
162198870|NCT01106586|585777568|FG001|Overall Study|Withdrew Consent|30|||
161926822|NCT00724503|584778708|FG001|Overall Study|Adverse Event|0|||
162198871|NCT01106586|585777567|FG000|Overall Study|Lost to Follow-up|24|||
162198872|NCT01106586|585777568|FG001|Overall Study|Lost to Follow-up|20|||
162198873|NCT01106586|585777567|FG000|Overall Study|Participant Noncompliance|12|||
161926823|NCT00724503|584778707|FG000|Overall Study|Not otherwise specified|4|||
161926824|NCT00724503|584778708|FG001|Overall Study|Not otherwise specified|7|||
161926825|NCT01186419|584778709|FG000|Overall Study|Withdrawal by Subject|5|||
161926826|NCT01186419|584778710|FG001|Overall Study|Withdrawal by Subject|3|||
161926827|NCT01186419|584778709|FG000|Overall Study|Adverse Event|1|||
161926828|NCT01186419|584778710|FG001|Overall Study|Adverse Event|2|||
161926829|NCT01186419|584778709|FG000|Overall Study|Physician Decision|0|||
162198874|NCT01106586|585777568|FG001|Overall Study|Participant Noncompliance|10|||
162198875|NCT01106586|585777567|FG000|Overall Study|Protocol Violation|1|||
162198876|NCT01106586|585777568|FG001|Overall Study|Protocol Violation|0|||
162198877|NCT01106586|585777567|FG000|Overall Study|Participant Transferred to Another Study|212|||
162198878|NCT01106586|585777568|FG001|Overall Study|Participant Transferred to Another Study|197|||
162198879|NCT02991456|585777572|FG000|Overall Study|Adverse Event|2|||
162198880|NCT02991456|585777573|FG001|Overall Study|Adverse Event|0|||
162198881|NCT02991456|585777572|FG000|Overall Study|Lost to Follow-up|0|||
162198882|NCT02991456|585777573|FG001|Overall Study|Lost to Follow-up|2|||
162198883|NCT02991456|585777572|FG000|Overall Study|Withdrawal by Subject|1|||
162198884|NCT02991456|585777573|FG001|Overall Study|Withdrawal by Subject|0|||
162198885|NCT02058992|585777574|FG000|Overall Study|Lost to Follow-up|4|||
162198886|NCT02058992|585777574|FG000|Overall Study|Protocol Violation|92|||
162198887|NCT02058992|585777574|FG000|Overall Study|CRF Uncollected|20|||
162198888|NCT03953079|585777575|FG000|Core Study|Withdrawal by Subject|1|||
162198889|NCT03953079|585777576|FG001|Core Study|Withdrawal by Subject|2|||
162198890|NCT03953079|585777577|FG002|Core Study|Withdrawal by Subject|1|||
162198891|NCT03953079|585777575|FG000|Core Study|COVID-19|0|||
162198892|NCT03953079|585777576|FG001|Core Study|COVID-19|1|||
162198893|NCT03953079|585777577|FG002|Core Study|COVID-19|0|||
162198894|NCT03953079|585777575|FG000|Core Study|Difficulties leaving the house|0|||
162198895|NCT03953079|585777576|FG001|Core Study|Difficulties leaving the house|1|||
162198896|NCT03953079|585777577|FG002|Core Study|Difficulties leaving the house|0|||
162198897|NCT03953079|585777575|FG000|Extension Study|Withdrawal by Subject|1|||
162198898|NCT03953079|585777576|FG001|Extension Study|Withdrawal by Subject|0|||
162198899|NCT03953079|585777577|FG002|Extension Study|Withdrawal by Subject|0|||
162198900|NCT03953079|585777575|FG000|Extension Study|Received Rescue Treatment|5|||
162198901|NCT03953079|585777576|FG001|Extension Study|Received Rescue Treatment|6|||
162198902|NCT03953079|585777577|FG002|Extension Study|Received Rescue Treatment|5|||
162198903|NCT00936065|585777578|FG000|Overall Study|Adverse Event|1|||
162198904|NCT00936065|585777579|FG001|Overall Study|Adverse Event|0|||
162198905|NCT00936065|585777580|FG002|Overall Study|Adverse Event|1|||
162198906|NCT00936065|585777578|FG000|Overall Study|Lack of Efficacy|1|||
162198907|NCT00936065|585777579|FG001|Overall Study|Lack of Efficacy|0|||
161926830|NCT01186419|584778710|FG001|Overall Study|Physician Decision|3|||
161926831|NCT01186419|584778709|FG000|Overall Study|Other|1|||
161926832|NCT01186419|584778710|FG001|Overall Study|Other|1|||
161926833|NCT01560416|584778722|FG000|Randomized Phase|Crossover Participants|7|||
161926834|NCT01560416|584778723|FG001|Randomized Phase|Crossover Participants|0|||
161926835|NCT01033071|584778724|FG000|Overall Study|Adverse Event|28|||
161926836|NCT01033071|584778725|FG001|Overall Study|Adverse Event|51|||
161926837|NCT01033071|584778726|FG002|Overall Study|Adverse Event|26|||
161926838|NCT01033071|584778724|FG000|Overall Study|Protocol Violation|0|||
161926839|NCT01033071|584778725|FG001|Overall Study|Protocol Violation|2|||
161926840|NCT01033071|584778726|FG002|Overall Study|Protocol Violation|1|||
161926841|NCT01033071|584778724|FG000|Overall Study|Lost to Follow-up|4|||
161926842|NCT01033071|584778725|FG001|Overall Study|Lost to Follow-up|5|||
161926843|NCT01033071|584778726|FG002|Overall Study|Lost to Follow-up|5|||
161926844|NCT01033071|584778724|FG000|Overall Study|Withdrawal by Subject|17|||
161926845|NCT01033071|584778725|FG001|Overall Study|Withdrawal by Subject|14|||
161926846|NCT01033071|584778726|FG002|Overall Study|Withdrawal by Subject|11|||
161926847|NCT01033071|584778724|FG000|Overall Study|Lack of Efficacy|0|||
161926848|NCT01033071|584778725|FG001|Overall Study|Lack of Efficacy|1|||
161926849|NCT01033071|584778726|FG002|Overall Study|Lack of Efficacy|1|||
161926850|NCT01033071|584778724|FG000|Overall Study|Other|6|||
162198908|NCT00936065|585777580|FG002|Overall Study|Lack of Efficacy|1|||
162198909|NCT00936065|585777578|FG000|Overall Study|Lost to Follow-up|1|||
162198910|NCT00936065|585777579|FG001|Overall Study|Lost to Follow-up|0|||
162198911|NCT00936065|585777580|FG002|Overall Study|Lost to Follow-up|0|||
162198912|NCT00936065|585777578|FG000|Overall Study|Protocol Violation|1|||
162198913|NCT00936065|585777579|FG001|Overall Study|Protocol Violation|2|||
161926851|NCT01033071|584778725|FG001|Overall Study|Other|4|||
161926852|NCT01033071|584778726|FG002|Overall Study|Other|3|||
161926853|NCT00884949|584780158|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
162198914|NCT00936065|585777580|FG002|Overall Study|Protocol Violation|1|||
161926854|NCT00884949|584780158|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
161926855|NCT03684057|584780163|FG000|Overall Study|Withdrawal by Subject|4|||
161926856|NCT03684057|584780164|FG001|Overall Study|Withdrawal by Subject|5|||
161926857|NCT00758043|584780165|FG000|Overall Study|Adverse Event|1|||
161926858|NCT00758043|584780166|FG001|Overall Study|Adverse Event|20|||
162198915|NCT00936065|585777578|FG000|Overall Study|Withdrawal by Subject|0|||
161676151|NCT01162239|583867314|FG000|Treatment Phase|Withdrawal by Subject|1|||
161676152|NCT01162239|583867315|FG001|Treatment Phase|Withdrawal by Subject|3|||
161676153|NCT01162239|583867316|FG002|Treatment Phase|Withdrawal by Subject|2|||
161676154|NCT01162239|583867317|FG003|Treatment Phase|Withdrawal by Subject|3|||
161676155|NCT01162239|583867314|FG000|Treatment Phase|Death|0|||
161676156|NCT01162239|583867315|FG001|Treatment Phase|Death|0|||
161676157|NCT01162239|583867316|FG002|Treatment Phase|Death|0|||
161676158|NCT01162239|583867317|FG003|Treatment Phase|Death|1|||
161676159|NCT01162239|583867314|FG000|Treatment Phase|Lost to Follow-up|5|||
161676160|NCT01162239|583867315|FG001|Treatment Phase|Lost to Follow-up|4|||
161676161|NCT01162239|583867316|FG002|Treatment Phase|Lost to Follow-up|2|||
162198916|NCT00936065|585777579|FG001|Overall Study|Withdrawal by Subject|2|||
162198917|NCT00936065|585777580|FG002|Overall Study|Withdrawal by Subject|4|||
162198918|NCT01549951|585777584|FG000|Overall Study|Adverse Event|15|||
162198919|NCT01549951|585777584|FG000|Overall Study|Withdrawal by Subject|2|||
162198920|NCT01549951|585777584|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
162198921|NCT01549951|585777584|FG000|Overall Study|Progressive disease|29|||
162198922|NCT01549951|585777584|FG000|Overall Study|Symptomatic deterioration|1|||
162198923|NCT01549951|585777584|FG000|Overall Study|Other|2|||
162198924|NCT03689452|585777593|FG000|Overall Study|Lost to Follow-up|1|||
162198925|NCT03689452|585777594|FG001|Overall Study|Lost to Follow-up|1|||
162198926|NCT00525915|585777595|FG000|Overall Study|Non-Compliance|0|||
162198927|NCT00525915|585777596|FG001|Overall Study|Non-Compliance|1|||
162198928|NCT00525915|585777595|FG000|Overall Study|Disease Progression|5|||
162198929|NCT00525915|585777596|FG001|Overall Study|Disease Progression|6|||
162198930|NCT00525915|585777595|FG000|Overall Study|Withdrawal by Subject|1|||
162198931|NCT00525915|585777596|FG001|Overall Study|Withdrawal by Subject|0|||
162198932|NCT00525915|585777595|FG000|Overall Study|Refused Surgery|1|||
162198933|NCT00525915|585777596|FG001|Overall Study|Refused Surgery|2|||
162198934|NCT00525915|585777595|FG000|Overall Study|Unrelated illness|1|||
162198935|NCT00525915|585777596|FG001|Overall Study|Unrelated illness|0|||
162198936|NCT00267865|585777597|FG000|Induction Treatment|Died before completing.|2|||
162198937|NCT00267865|585777597|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
162198938|NCT02819141|585777600|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
162198939|NCT02819141|585777601|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
162198940|NCT00434577|585779364|FG000|Months 0-3|Serious Adverse Event|0|||
162198941|NCT00434577|585779365|FG001|Months 0-3|Serious Adverse Event|0|||
162198942|NCT00434577|585779366|FG002|Months 0-3|Serious Adverse Event|1|||
162198943|NCT00434577|585779367|FG003|Months 0-3|Serious Adverse Event|0|||
162198944|NCT00434577|585779368|FG004|Months 0-3|Serious Adverse Event|0|||
162198945|NCT00434577|585779364|FG000|Months 0-3|Adverse Event|0|||
162198946|NCT00434577|585779365|FG001|Months 0-3|Adverse Event|1|||
162198947|NCT00434577|585779366|FG002|Months 0-3|Adverse Event|1|||
162198948|NCT00434577|585779367|FG003|Months 0-3|Adverse Event|0|||
162198949|NCT00434577|585779368|FG004|Months 0-3|Adverse Event|0|||
162198950|NCT00434577|585779364|FG000|Months 0-3|Lost to Follow-up|0|||
162198951|NCT00434577|585779365|FG001|Months 0-3|Lost to Follow-up|0|||
162198952|NCT00434577|585779366|FG002|Months 0-3|Lost to Follow-up|0|||
162198953|NCT00434577|585779367|FG003|Months 0-3|Lost to Follow-up|0|||
162198954|NCT00434577|585779368|FG004|Months 0-3|Lost to Follow-up|2|||
162198955|NCT00434577|585779364|FG000|Months 0-3|Protocol Violation|1|||
162198956|NCT00434577|585779365|FG001|Months 0-3|Protocol Violation|0|||
162198957|NCT00434577|585779366|FG002|Months 0-3|Protocol Violation|1|||
161676162|NCT01162239|583867317|FG003|Treatment Phase|Lost to Follow-up|1|||
161676163|NCT01162239|583867314|FG000|Extended Follow-up|Lost to Follow-up|8|||
161676164|NCT01162239|583867315|FG001|Extended Follow-up|Lost to Follow-up|13|||
161676165|NCT01162239|583867316|FG002|Extended Follow-up|Lost to Follow-up|8|||
161676166|NCT01162239|583867317|FG003|Extended Follow-up|Lost to Follow-up|6|||
161676167|NCT05975840|583867318|FG000|Overall Study|Other|1|||
161676168|NCT05975840|583867319|FG001|Overall Study|Other|0|||
161676169|NCT05975840|583867320|FG002|Overall Study|Other|0|||
161820791|NCT01745094|584384646|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
161820792|NCT01745094|584384643|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
162198958|NCT00434577|585779367|FG003|Months 0-3|Protocol Violation|0|||
161676170|NCT05975840|583867321|FG003|Overall Study|Other|0|||
162198959|NCT00434577|585779368|FG004|Months 0-3|Protocol Violation|0|||
162198960|NCT00434577|585779364|FG000|Months 0-3|Withdrawal by Subject|2|||
162198961|NCT00434577|585779365|FG001|Months 0-3|Withdrawal by Subject|1|||
162198962|NCT00434577|585779366|FG002|Months 0-3|Withdrawal by Subject|1|||
161676171|NCT05975840|583867322|FG004|Overall Study|Other|1|||
161676172|NCT05975840|583867323|FG005|Overall Study|Other|0|||
161676173|NCT05975840|583867324|FG006|Overall Study|Other|0|||
162198963|NCT00434577|585779367|FG003|Months 0-3|Withdrawal by Subject|1|||
162198964|NCT00434577|585779368|FG004|Months 0-3|Withdrawal by Subject|1|||
162198965|NCT01537120|585779372|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
162198966|NCT01537120|585779372|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
162198967|NCT00644332|585779373|FG000|Overall Study|Adverse Event|11|||
162198968|NCT00644332|585779373|FG000|Overall Study|Withdrawal by Subject|6|||
161926859|NCT00758043|584780167|FG002|Overall Study|Adverse Event|12|||
161926860|NCT00758043|584780168|FG003|Overall Study|Adverse Event|62|||
161926861|NCT00758043|584780165|FG000|Overall Study|Lack of Efficacy|0|||
161926862|NCT00758043|584780166|FG001|Overall Study|Lack of Efficacy|6|||
161926863|NCT00758043|584780167|FG002|Overall Study|Lack of Efficacy|18|||
161926864|NCT00758043|584780168|FG003|Overall Study|Lack of Efficacy|12|||
161926865|NCT00758043|584780165|FG000|Overall Study|Refused Further Treatment|0|||
161926866|NCT00758043|584780166|FG001|Overall Study|Refused Further Treatment|11|||
161926867|NCT00758043|584780167|FG002|Overall Study|Refused Further Treatment|5|||
161926868|NCT00758043|584780168|FG003|Overall Study|Refused Further Treatment|8|||
161926869|NCT00758043|584780165|FG000|Overall Study|Lost to Follow-up|0|||
161926870|NCT00758043|584780166|FG001|Overall Study|Lost to Follow-up|2|||
161926871|NCT00758043|584780167|FG002|Overall Study|Lost to Follow-up|2|||
161926872|NCT00758043|584780168|FG003|Overall Study|Lost to Follow-up|5|||
161926873|NCT00758043|584780165|FG000|Overall Study|Withdrawal by Subject|0|||
161926874|NCT00758043|584780166|FG001|Overall Study|Withdrawal by Subject|1|||
161926875|NCT00758043|584780167|FG002|Overall Study|Withdrawal by Subject|1|||
161926876|NCT00758043|584780168|FG003|Overall Study|Withdrawal by Subject|4|||
161926877|NCT00758043|584780165|FG000|Overall Study|Required Prohibited Medication|0|||
161926878|NCT00758043|584780166|FG001|Overall Study|Required Prohibited Medication|0|||
161926879|NCT00758043|584780167|FG002|Overall Study|Required Prohibited Medication|1|||
161926880|NCT00758043|584780168|FG003|Overall Study|Required Prohibited Medication|3|||
161926881|NCT00758043|584780165|FG000|Overall Study|Non-Compliant With study Drug|0|||
161926882|NCT00758043|584780166|FG001|Overall Study|Non-Compliant With study Drug|0|||
161926883|NCT00758043|584780167|FG002|Overall Study|Non-Compliant With study Drug|0|||
161926884|NCT00758043|584780168|FG003|Overall Study|Non-Compliant With study Drug|1|||
161926885|NCT00758043|584780165|FG000|Overall Study|Other Reasons|0|||
161926886|NCT00758043|584780166|FG001|Overall Study|Other Reasons|1|||
161926887|NCT00758043|584780167|FG002|Overall Study|Other Reasons|0|||
161926888|NCT00758043|584780168|FG003|Overall Study|Other Reasons|5|||
161926889|NCT03422718|584780172|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
161926890|NCT03422718|584780173|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
161926891|NCT03422718|584780174|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
161926892|NCT03422718|584780175|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
161926893|NCT03422718|584780176|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
161926894|NCT03422718|584780177|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
161926895|NCT03422718|584780178|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
161926896|NCT03422718|584780179|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
161926897|NCT03422718|584780172|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
161926898|NCT03422718|584780173|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
161926899|NCT03422718|584780174|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
161926900|NCT03422718|584780175|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
161926901|NCT03422718|584780176|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
161926902|NCT03422718|584780177|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
161926903|NCT03422718|584780178|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
161926904|NCT03422718|584780179|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
161926905|NCT03422718|584780172|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
161926906|NCT03422718|584780173|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
161926907|NCT03422718|584780174|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
161926908|NCT03422718|584780175|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
161926909|NCT03422718|584780176|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
161926910|NCT03422718|584780177|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
161926911|NCT03422718|584780178|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
161926912|NCT03422718|584780179|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
161926913|NCT03422718|584780172|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
161926914|NCT03422718|584780173|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
162198969|NCT00644332|585779373|FG000|Overall Study|Completion Status Unknown|2|||
162198970|NCT00644332|585779373|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
162198971|NCT00644332|585779373|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
162198972|NCT03050372|585779374|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
162198973|NCT03050372|585779375|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
161926915|NCT03422718|584780174|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
161926916|NCT03422718|584780175|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
161926917|NCT03422718|584780176|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
161926918|NCT03422718|584780177|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
161926919|NCT03422718|584780178|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
161926920|NCT03422718|584780179|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
161926921|NCT03422718|584780172|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
162198974|NCT03050372|585779374|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
162198975|NCT03050372|585779375|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
162198976|NCT00443755|585779378|FG000|Overall Study|Withdrawal by Subject|2|||
162198977|NCT00443755|585779379|FG001|Overall Study|Withdrawal by Subject|1|||
162198978|NCT02775214|585779380|FG000|Overall Study|Withdrawal by Subject|2|||
162198979|NCT02775214|585779381|FG001|Overall Study|Withdrawal by Subject|0|||
162198980|NCT02706834|585779382|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162198981|NCT02706834|585779383|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
162198982|NCT02706834|585779384|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
162198983|NCT02706834|585779385|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
162198984|NCT02706834|585779386|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
162198985|NCT02706834|585779387|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
162198986|NCT02706834|585779388|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
162198987|NCT02706834|585779389|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
162198988|NCT02706834|585779390|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
162198989|NCT02706834|585779391|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
162198990|NCT02706834|585779392|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
162198991|NCT02706834|585779382|FG000|Overall Study|Lost to Follow-up|0|||
162198992|NCT02706834|585779383|FG001|Overall Study|Lost to Follow-up|0|||
162198993|NCT02706834|585779384|FG002|Overall Study|Lost to Follow-up|1|||
162198994|NCT02706834|585779385|FG003|Overall Study|Lost to Follow-up|0|||
162198995|NCT02706834|585779386|FG004|Overall Study|Lost to Follow-up|0|||
162198996|NCT02706834|585779387|FG005|Overall Study|Lost to Follow-up|0|||
162198997|NCT02706834|585779388|FG006|Overall Study|Lost to Follow-up|0|||
162198998|NCT02706834|585779389|FG007|Overall Study|Lost to Follow-up|0|||
162198999|NCT02706834|585779390|FG008|Overall Study|Lost to Follow-up|0|||
162199000|NCT02706834|585779391|FG009|Overall Study|Lost to Follow-up|0|||
162199001|NCT02706834|585779392|FG010|Overall Study|Lost to Follow-up|0|||
162199002|NCT02706834|585779382|FG000|Overall Study|Voluntary Withdrawal|1|||
162199003|NCT02706834|585779383|FG001|Overall Study|Voluntary Withdrawal|0|||
162199004|NCT02706834|585779384|FG002|Overall Study|Voluntary Withdrawal|0|||
162199005|NCT02706834|585779385|FG003|Overall Study|Voluntary Withdrawal|0|||
162199006|NCT02706834|585779386|FG004|Overall Study|Voluntary Withdrawal|0|||
162199007|NCT02706834|585779387|FG005|Overall Study|Voluntary Withdrawal|0|||
162199008|NCT02706834|585779388|FG006|Overall Study|Voluntary Withdrawal|0|||
162199009|NCT02706834|585779389|FG007|Overall Study|Voluntary Withdrawal|0|||
162199010|NCT02706834|585779390|FG008|Overall Study|Voluntary Withdrawal|0|||
162199011|NCT02706834|585779391|FG009|Overall Study|Voluntary Withdrawal|1|||
162199012|NCT02706834|585779392|FG010|Overall Study|Voluntary Withdrawal|0|||
162199013|NCT02706834|585779382|FG000|Overall Study|Other Reason Not Specified|1|||
162199014|NCT02706834|585779383|FG001|Overall Study|Other Reason Not Specified|0|||
162199015|NCT02706834|585779384|FG002|Overall Study|Other Reason Not Specified|0|||
162199016|NCT02706834|585779385|FG003|Overall Study|Other Reason Not Specified|0|||
162199017|NCT02706834|585779386|FG004|Overall Study|Other Reason Not Specified|1|||
161820793|NCT01745094|584384644|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
162199018|NCT02706834|585779387|FG005|Overall Study|Other Reason Not Specified|0|||
162199019|NCT02706834|585779388|FG006|Overall Study|Other Reason Not Specified|0|||
161820794|NCT01745094|584384645|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
162199020|NCT02706834|585779389|FG007|Overall Study|Other Reason Not Specified|0|||
162199021|NCT02706834|585779390|FG008|Overall Study|Other Reason Not Specified|0|||
162199022|NCT02706834|585779391|FG009|Overall Study|Other Reason Not Specified|0|||
162199023|NCT02706834|585779392|FG010|Overall Study|Other Reason Not Specified|0|||
162199024|NCT00678899|585779394|FG000|Overall Study|Adverse Event|1|||
162199025|NCT02543294|585779395|FG000|Overall Study|Lost to Follow-up|3|||
162199026|NCT02543294|585779395|FG000|Overall Study|Physician Decision|2|||
162199027|NCT02543294|585779395|FG000|Overall Study|Withdrawal by Subject|7|||
162199028|NCT01107353|585779401|FG000|Overall Study|Positive Drug Screen|1|||
162199029|NCT01107353|585779402|FG001|Overall Study|Positive Drug Screen|0|||
162199030|NCT02798861|585779405|FG000|Overall Study|Lost to Follow-up|22|||
162199031|NCT02798861|585779405|FG000|Overall Study|Withdrawal by Subject|1|||
162199032|NCT02475733|585779428|FG000|Overall Study|Withdrawal by Subject|1|||
162199033|NCT02475733|585779429|FG001|Overall Study|Withdrawal by Subject|0|||
162199034|NCT02475733|585779428|FG000|Overall Study|Physician Decision|1|||
162199035|NCT02475733|585779429|FG001|Overall Study|Physician Decision|0|||
162199036|NCT02131155|585779430|FG000|Overall Study|Adverse Event|1|||
162199037|NCT02131155|585779431|FG001|Overall Study|Adverse Event|0|||
162199038|NCT02131155|585779430|FG000|Overall Study|Treatment completed|1|||
162199039|NCT02131155|585779431|FG001|Overall Study|Treatment completed|0|||
162199040|NCT02131155|585779430|FG000|Overall Study|Primary tumour recurrence|2|||
162199041|NCT02131155|585779431|FG001|Overall Study|Primary tumour recurrence|1|||
162199042|NCT02131155|585779430|FG000|Overall Study|Refused to continue study medication|1|||
162199043|NCT02131155|585779431|FG001|Overall Study|Refused to continue study medication|0|||
162199044|NCT02131155|585779430|FG000|Overall Study|Study early termination|20|||
162199045|NCT02131155|585779431|FG001|Overall Study|Study early termination|10|||
162199046|NCT01887418|585779432|FG000|Overall Study|Travelling difficulties|0|||
162199047|NCT01887418|585779433|FG001|Overall Study|Travelling difficulties|0|||
162199048|NCT01887418|585779434|FG002|Overall Study|Travelling difficulties|1|||
162199049|NCT01014013|585779437|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
162199050|NCT01014013|585779438|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
162199051|NCT01014013|585779437|FG000|Overall Study|Clinical adverse experience|4|||
162199052|NCT01014013|585779438|FG001|Overall Study|Clinical adverse experience|2|||
162199053|NCT01014013|585779437|FG000|Overall Study|Laboratory adverse experience|1|||
162199054|NCT01014013|585779438|FG001|Overall Study|Laboratory adverse experience|1|||
162199055|NCT01014013|585779437|FG000|Overall Study|Protocol Violation|1|||
162199056|NCT01014013|585779438|FG001|Overall Study|Protocol Violation|3|||
162199057|NCT01014013|585779437|FG000|Overall Study|Withdrawal by Subject|7|||
162199058|NCT01014013|585779438|FG001|Overall Study|Withdrawal by Subject|4|||
162199059|NCT01014013|585779437|FG000|Overall Study|Clinical/microbiologic failure|1|||
162199060|NCT01014013|585779438|FG001|Overall Study|Clinical/microbiologic failure|2|||
162199061|NCT01014013|585779437|FG000|Overall Study|Pathogen culture = no growth|26|||
162199062|NCT01014013|585779438|FG001|Overall Study|Pathogen culture = no growth|34|||
162199063|NCT01014013|585779437|FG000|Overall Study|Negative urine culture|2|||
162199064|NCT01014013|585779438|FG001|Overall Study|Negative urine culture|0|||
162199065|NCT01014013|585779437|FG000|Overall Study|Pathogen resistant|7|||
162199066|NCT01014013|585779438|FG001|Overall Study|Pathogen resistant|4|||
162199067|NCT01014013|585779437|FG000|Overall Study|Physician Decision|0|||
162199068|NCT01014013|585779438|FG001|Overall Study|Physician Decision|1|||
162199069|NCT01014013|585779437|FG000|Overall Study|Another antibiotic therapy required|0|||
162199070|NCT01014013|585779438|FG001|Overall Study|Another antibiotic therapy required|1|||
162199071|NCT01014013|585779437|FG000|Overall Study|Appendectomy|1|||
162199072|NCT01014013|585779438|FG001|Overall Study|Appendectomy|0|||
162199073|NCT01014013|585779437|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
162199074|NCT01014013|585779438|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
162199075|NCT00442559|585779445|FG000|Overall Study|Lost to Follow-up|32|||
162199076|NCT00442559|585779446|FG001|Overall Study|Lost to Follow-up|34|||
162199077|NCT00442559|585779445|FG000|Overall Study|Protocol Violation|1|||
162199078|NCT00442559|585779446|FG001|Overall Study|Protocol Violation|1|||
162199079|NCT00442559|585779445|FG000|Overall Study|Withdrawal by Subject|1|||
162199080|NCT00442559|585779446|FG001|Overall Study|Withdrawal by Subject|0|||
162199081|NCT03906240|585779447|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
162199082|NCT03906240|585779448|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
162199083|NCT03906240|585779447|FG000|Overall Study|Lost to Follow-up|1|||
162199084|NCT03906240|585779448|FG001|Overall Study|Lost to Follow-up|0|||
162199085|NCT03906240|585779447|FG000|Overall Study|Withdrawal by Subject|0|||
162199086|NCT03906240|585779448|FG001|Overall Study|Withdrawal by Subject|1|||
162199087|NCT03575572|585779449|FG000|Overall Study|Withdrawal by Subject|2|||
162199088|NCT03575572|585779449|FG000|Overall Study|Physician Decision|2|||
162199089|NCT03647709|585779451|FG000|Overall Study|Lost to Follow-up|5|||
162199090|NCT03647709|585779451|FG000|Overall Study|Physician Decision|6|||
162199091|NCT03647709|585779451|FG000|Overall Study|Withdrawal by Subject|3|||
162199092|NCT05287178|585779452|FG000|Overall Study|Lost to Follow-up|2|||
162199093|NCT01426217|585779453|FG000|Overall Study|lost sample|8|||
162199094|NCT01426217|585779454|FG001|Overall Study|lost sample|14|||
162199095|NCT01920178|585779455|FG000|Overall Study|Lost to Follow-up|2|||
162199096|NCT01920178|585779456|FG001|Overall Study|Lost to Follow-up|1|||
162199097|NCT03023878|585779457|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
162199098|NCT03023878|585779457|FG000|Pre-Study Run-In Period|Death|1|||
162199099|NCT03023878|585779457|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
162199100|NCT03023878|585779457|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
162199101|NCT03023878|585779457|FG000|Treatment Period|Disease Progression|1|||
162199102|NCT03023878|585779457|FG000|Treatment Period|Withdrawal by Subject|1|||
162199103|NCT03023878|585779457|FG000|Treatment Period|Adverse Event|1|||
162199104|NCT03023878|585779457|FG000|Long Term Follow-Up Period|Death|2|||
162199105|NCT01812837|585779458|FG000|Overall Study|Lost to Follow-up|1|||
162199106|NCT01812837|585779459|FG001|Overall Study|Lost to Follow-up|1|||
162199107|NCT01812837|585779460|FG002|Overall Study|Lost to Follow-up|0|||
162199108|NCT01812837|585779458|FG000|Overall Study|Protocol Violation|1|||
162199109|NCT01812837|585779459|FG001|Overall Study|Protocol Violation|0|||
162199110|NCT01812837|585779460|FG002|Overall Study|Protocol Violation|0|||
162199111|NCT00288353|585779461|FG000|Overall Study|Lack of Efficacy|2|||
162199112|NCT00288353|585779462|FG001|Overall Study|Lack of Efficacy|2|||
162199113|NCT00288353|585779461|FG000|Overall Study|Withdrawal by Subject|5|||
162199114|NCT00288353|585779462|FG001|Overall Study|Withdrawal by Subject|5|||
162199115|NCT05234632|585779463|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
162199116|NCT05234632|585779464|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
162199117|NCT05234632|585779463|FG000|Overall Study|Withdrawal by Subject|2|||
162199118|NCT05234632|585779464|FG001|Overall Study|Withdrawal by Subject|0|||
162199119|NCT05234632|585779463|FG000|Overall Study|Adverse Event|0|||
162199120|NCT05234632|585779464|FG001|Overall Study|Adverse Event|4|||
162199121|NCT05234632|585779463|FG000|Overall Study|Physician Decision|1|||
162199122|NCT05234632|585779464|FG001|Overall Study|Physician Decision|1|||
162199123|NCT05234632|585779463|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
162199124|NCT05234632|585779464|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
162199125|NCT05234632|585779463|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
162199126|NCT05234632|585779464|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
162199127|NCT04799587|585779465|FG000|Overall Study|Withdrawal by Subject|0|||
162199128|NCT04799587|585779466|FG001|Overall Study|Withdrawal by Subject|1|||
162199129|NCT00728884|585779467|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
162199130|NCT00728884|585779467|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
162199131|NCT05216835|585779468|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
162199132|NCT05216835|585779469|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
162199133|NCT05216835|585779470|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
162199134|NCT05216835|585779471|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
162199135|NCT05216835|585779472|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
162199136|NCT05216835|585779473|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
162199137|NCT05216835|585779474|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
162199138|NCT05216835|585779475|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
162199139|NCT05216835|585779468|FG000|Overall Study|Death|0|||
162199140|NCT05216835|585779469|FG001|Overall Study|Death|0|||
162199141|NCT05216835|585779470|FG002|Overall Study|Death|0|||
162199142|NCT05216835|585779471|FG003|Overall Study|Death|1|||
162199143|NCT05216835|585779472|FG004|Overall Study|Death|1|||
162199144|NCT05216835|585779473|FG005|Overall Study|Death|1|||
162199145|NCT05216835|585779474|FG006|Overall Study|Death|1|||
162199146|NCT05216835|585779475|FG007|Overall Study|Death|1|||
162199147|NCT05216835|585779468|FG000|Overall Study|Physician Decision|0|||
162199148|NCT05216835|585779469|FG001|Overall Study|Physician Decision|0|||
162199149|NCT05216835|585779470|FG002|Overall Study|Physician Decision|0|||
162199150|NCT05216835|585779471|FG003|Overall Study|Physician Decision|0|||
162199151|NCT05216835|585779472|FG004|Overall Study|Physician Decision|0|||
162199152|NCT05216835|585779473|FG005|Overall Study|Physician Decision|1|||
162199153|NCT05216835|585779474|FG006|Overall Study|Physician Decision|1|||
162199154|NCT05216835|585779475|FG007|Overall Study|Physician Decision|0|||
162199155|NCT05216835|585779468|FG000|Overall Study|Study terminated by Sponsor|0|||
162199156|NCT05216835|585779469|FG001|Overall Study|Study terminated by Sponsor|0|||
162199157|NCT05216835|585779470|FG002|Overall Study|Study terminated by Sponsor|0|||
162199158|NCT05216835|585779471|FG003|Overall Study|Study terminated by Sponsor|0|||
162199159|NCT05216835|585779472|FG004|Overall Study|Study terminated by Sponsor|0|||
162199160|NCT05216835|585779473|FG005|Overall Study|Study terminated by Sponsor|0|||
162199161|NCT05216835|585779474|FG006|Overall Study|Study terminated by Sponsor|0|||
162199162|NCT05216835|585779475|FG007|Overall Study|Study terminated by Sponsor|1|||
162199163|NCT05216835|585779468|FG000|Overall Study|Withdrawal by Subject|1|||
162199164|NCT05216835|585779469|FG001|Overall Study|Withdrawal by Subject|0|||
162199165|NCT05216835|585779470|FG002|Overall Study|Withdrawal by Subject|1|||
162199166|NCT05216835|585779471|FG003|Overall Study|Withdrawal by Subject|0|||
162199167|NCT05216835|585779472|FG004|Overall Study|Withdrawal by Subject|1|||
162199168|NCT05216835|585779473|FG005|Overall Study|Withdrawal by Subject|0|||
162199169|NCT05216835|585779474|FG006|Overall Study|Withdrawal by Subject|0|||
162199170|NCT05216835|585779475|FG007|Overall Study|Withdrawal by Subject|1|||
162199171|NCT05216835|585779468|FG000|Overall Study|Other|0|||
162199172|NCT05216835|585779469|FG001|Overall Study|Other|1|||
162199173|NCT05216835|585779470|FG002|Overall Study|Other|0|||
162199174|NCT05216835|585779471|FG003|Overall Study|Other|0|||
162199175|NCT05216835|585779472|FG004|Overall Study|Other|0|||
162199176|NCT05216835|585779473|FG005|Overall Study|Other|0|||
162199177|NCT05216835|585779474|FG006|Overall Study|Other|0|||
162199178|NCT05216835|585779475|FG007|Overall Study|Other|0|||
162199179|NCT01075815|585779476|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
162199180|NCT01075815|585779477|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
162199181|NCT01075815|585779476|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
162199182|NCT01075815|585779477|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
162199183|NCT01075815|585779476|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
162199184|NCT01075815|585779477|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
162199185|NCT00617708|585779478|FG000|Overall Study|Adverse Event|0|||
162199186|NCT00617708|585779479|FG001|Overall Study|Adverse Event|6|||
162199187|NCT00617708|585779480|FG002|Overall Study|Adverse Event|9|||
162199188|NCT00617708|585779478|FG000|Overall Study|Withdrawal by Subject|1|||
162199189|NCT00617708|585779479|FG001|Overall Study|Withdrawal by Subject|1|||
162199190|NCT00617708|585779480|FG002|Overall Study|Withdrawal by Subject|7|||
162199191|NCT00617708|585779478|FG000|Overall Study|Death|0|||
162199192|NCT00617708|585779479|FG001|Overall Study|Death|6|||
162199193|NCT00617708|585779480|FG002|Overall Study|Death|5|||
162199194|NCT00617708|585779478|FG000|Overall Study|Progression/Relapse|7|||
162199195|NCT00617708|585779479|FG001|Overall Study|Progression/Relapse|40|||
162199196|NCT00617708|585779480|FG002|Overall Study|Progression/Relapse|36|||
162199197|NCT00617708|585779478|FG000|Overall Study|Not protocol specified|1|||
162199198|NCT00617708|585779479|FG001|Overall Study|Not protocol specified|4|||
162199199|NCT00617708|585779480|FG002|Overall Study|Not protocol specified|2|||
162199200|NCT00617708|585779478|FG000|Overall Study|Not eligible|1|||
162199201|NCT00617708|585779479|FG001|Overall Study|Not eligible|3|||
162199202|NCT00617708|585779480|FG002|Overall Study|Not eligible|5|||
162199203|NCT02374476|585779483|FG000|VT Induced Ablation|Screening Failures|36|||
162199204|NCT02374476|585779484|FG001|VT Induced Ablation|Screening Failures|0|||
162199205|NCT02374476|585779485|FG002|VT Induced Ablation|Screening Failures|0|||
162199206|NCT02374476|585779483|FG000|Arm Assignment|Withdrawal by Subject|0|||
162199207|NCT02374476|585779484|FG001|Arm Assignment|Withdrawal by Subject|0|||
162199208|NCT02374476|585779485|FG002|Arm Assignment|Withdrawal by Subject|1|||
162199209|NCT05431543|585779490|FG000|Overall Study|Medical History|1|||
162199210|NCT05431543|585779491|FG001|Overall Study|Medical History|0|||
162199211|NCT05431543|585779492|FG002|Overall Study|Medical History|0|||
162199212|NCT02924051|585779493|FG000|Overall Study|Withdrawal by Subject|1|||
162199213|NCT02924051|585779494|FG001|Overall Study|Withdrawal by Subject|9|||
162199214|NCT00914732|585779495|FG000|Overall Study|Lost to Follow-up|6|||
162199215|NCT00914732|585779496|FG001|Overall Study|Lost to Follow-up|7|||
162199216|NCT00914732|585779497|FG002|Overall Study|Lost to Follow-up|9|||
162199217|NCT00914732|585779495|FG000|Overall Study|Withdrawal by Subject|3|||
162199218|NCT00914732|585779496|FG001|Overall Study|Withdrawal by Subject|0|||
162199219|NCT00914732|585779497|FG002|Overall Study|Withdrawal by Subject|2|||
162199220|NCT00914732|585779495|FG000|Overall Study|Adverse Event|1|||
162199221|NCT00914732|585779496|FG001|Overall Study|Adverse Event|0|||
162020607|NCT02474069|585130523|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
162199222|NCT00914732|585779497|FG002|Overall Study|Adverse Event|0|||
162199223|NCT02130401|585779498|FG000|Overall Study|Poor enrollment|6|||
162199224|NCT02676778|585779503|FG000|Overall Study|Disease Progression|7|||
161676174|NCT05975840|583867325|FG007|Overall Study|Other|0|||
162199225|NCT02676778|585779504|FG001|Overall Study|Disease Progression|3|||
162199226|NCT02676778|585779505|FG002|Overall Study|Disease Progression|1|||
162199227|NCT02676778|585779503|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
162199228|NCT02676778|585779504|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
162199229|NCT02676778|585779505|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
162199230|NCT02676778|585779503|FG000|Overall Study|Withdrawal by Subject|3|||
162199231|NCT02676778|585779504|FG001|Overall Study|Withdrawal by Subject|2|||
162199232|NCT02676778|585779505|FG002|Overall Study|Withdrawal by Subject|0|||
162199233|NCT02676778|585779503|FG000|Overall Study|Other|4|||
162199234|NCT02676778|585779504|FG001|Overall Study|Other|3|||
162199235|NCT02676778|585779505|FG002|Overall Study|Other|0|||
162199236|NCT02676778|585779503|FG000|Overall Study|Adverse Event|2|||
162199237|NCT02676778|585779504|FG001|Overall Study|Adverse Event|3|||
162199238|NCT02676778|585779505|FG002|Overall Study|Adverse Event|0|||
161820795|NCT01745094|584384646|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
161820796|NCT01745094|584384643|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
162020608|NCT02474069|585130524|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
162020609|NCT02474069|585130525|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
162020610|NCT01474018|585130526|FG000|Overall Study|Lost to Follow-up|0|||
162020611|NCT01474018|585130527|FG001|Overall Study|Lost to Follow-up|1|||
162020612|NCT01474018|585130526|FG000|Overall Study|Withdrawal by Subject|0|||
162020613|NCT01474018|585130527|FG001|Overall Study|Withdrawal by Subject|2|||
162020614|NCT03801031|585130528|FG000|Overall Study|Lost to Follow-up|1|||
162020615|NCT03801031|585130529|FG001|Overall Study|Lost to Follow-up|0|||
162020616|NCT03801031|585130528|FG000|Overall Study|Unable to comply|1|||
162020617|NCT03801031|585130529|FG001|Overall Study|Unable to comply|0|||
162020618|NCT03801031|585130528|FG000|Overall Study|Withdrawal by Subject|0|||
162020619|NCT03801031|585130529|FG001|Overall Study|Withdrawal by Subject|1|||
162020620|NCT01942733|585130530|FG000|Overall Study|Lost to Follow-up|1|||
162020621|NCT01942733|585130530|FG000|Overall Study|Non-compliance with IMP|1|||
162020622|NCT01942733|585130530|FG000|Overall Study|Administrative|1|||
162020623|NCT00126490|585130531|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
162020624|NCT03462511|585130533|FG000|Overall Study|Withdrawal by Subject|2|||
162020625|NCT03462511|585130534|FG001|Overall Study|Withdrawal by Subject|3|||
162020626|NCT02925416|585130535|FG000|Overall Study|Adverse Event|2|||
162020627|NCT02925416|585130536|FG001|Overall Study|Adverse Event|0|||
162020628|NCT02625909|585130537|FG000|Overall Study|Death|2|||
162020629|NCT02625909|585130538|FG001|Overall Study|Death|0|||
162020630|NCT02625909|585130537|FG000|Overall Study|Lost to Follow-up|3|||
162020631|NCT02625909|585130538|FG001|Overall Study|Lost to Follow-up|5|||
162020632|NCT02625909|585130537|FG000|Overall Study|Lack of Efficacy|9|||
162020633|NCT02625909|585130538|FG001|Overall Study|Lack of Efficacy|2|||
161676175|NCT05975840|583867318|FG000|Overall Study|Lost to Follow-up|3|||
161676176|NCT05975840|583867319|FG001|Overall Study|Lost to Follow-up|6|||
162020634|NCT02625909|585130537|FG000|Overall Study|Reinfection|3|||
162020635|NCT02625909|585130538|FG001|Overall Study|Reinfection|2|||
162020636|NCT01598506|585130539|FG000|Overall Study|Withdrawal by Subject|2|||
161676177|NCT05975840|583867320|FG002|Overall Study|Lost to Follow-up|3|||
161676178|NCT05975840|583867321|FG003|Overall Study|Lost to Follow-up|1|||
161676179|NCT05975840|583867322|FG004|Overall Study|Lost to Follow-up|4|||
161676180|NCT05975840|583867323|FG005|Overall Study|Lost to Follow-up|1|||
161676181|NCT05975840|583867324|FG006|Overall Study|Lost to Follow-up|2|||
161676182|NCT05975840|583867325|FG007|Overall Study|Lost to Follow-up|4|||
161676183|NCT05975840|583867318|FG000|Overall Study|Migrated/moved from the study area|1|||
161676184|NCT05975840|583867319|FG001|Overall Study|Migrated/moved from the study area|0|||
161820797|NCT01745094|584384644|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
161820798|NCT01745094|584384645|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
161820799|NCT01745094|584384646|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
162020637|NCT02067676|585130544|FG000|Overall Study|Withdrawal by Subject|1|||
162020638|NCT02067676|585130545|FG001|Overall Study|Withdrawal by Subject|0|||
162020639|NCT02067676|585130546|FG002|Overall Study|Withdrawal by Subject|0|||
162199239|NCT03214198|585779510|FG000|Overall Study|Case Report Forms Uncollected|18|||
162199240|NCT03214198|585779510|FG000|Overall Study|Protocol Deviation|18|||
162199241|NCT03686176|585779511|FG000|Overall Study|Procedure cancelled|1|||
162199242|NCT03686176|585779512|FG001|Overall Study|Procedure cancelled|0|||
162199243|NCT03686176|585779513|FG002|Overall Study|Procedure cancelled|0|||
162199244|NCT03686176|585779511|FG000|Overall Study|VR Malfunction|1|||
162199245|NCT03686176|585779512|FG001|Overall Study|VR Malfunction|0|||
162199246|NCT03686176|585779513|FG002|Overall Study|VR Malfunction|0|||
162199247|NCT00925288|585781109|FG000|Overall Study|Lost to Follow-up|9|||
162199248|NCT00925288|585781110|FG001|Overall Study|Lost to Follow-up|7|||
162199249|NCT00635570|585781111|FG000|Overall Study|Lost to Follow-up|8|||
162199250|NCT00635570|585781112|FG001|Overall Study|Lost to Follow-up|8|||
162199251|NCT00635570|585781111|FG000|Overall Study|Withdrawal by Subject|1|||
162199252|NCT00635570|585781112|FG001|Overall Study|Withdrawal by Subject|1|||
162199253|NCT00635570|585781111|FG000|Overall Study|Adverse Event|2|||
162199254|NCT00635570|585781112|FG001|Overall Study|Adverse Event|0|||
162199255|NCT00635570|585781111|FG000|Overall Study|Physician Decision|1|||
162020640|NCT02067676|585130547|FG003|Overall Study|Withdrawal by Subject|0|||
162020641|NCT02067676|585130548|FG004|Overall Study|Withdrawal by Subject|0|||
162020642|NCT02067676|585130549|FG005|Overall Study|Withdrawal by Subject|0|||
162020643|NCT00476229|585130550|FG000|Overall Study|Progressive shortness of breath|1|||
162199256|NCT00635570|585781112|FG001|Overall Study|Physician Decision|0|||
161676185|NCT05975840|583867320|FG002|Overall Study|Migrated/moved from the study area|0|||
161676186|NCT05975840|583867321|FG003|Overall Study|Migrated/moved from the study area|0|||
162199257|NCT00635570|585781111|FG000|Overall Study|Did not complete survey|2|||
162199258|NCT00635570|585781112|FG001|Overall Study|Did not complete survey|1|||
162199259|NCT00635570|585781111|FG000|Overall Study|Early termination(No sexual activity)|1|||
162199260|NCT00635570|585781112|FG001|Overall Study|Early termination(No sexual activity)|1|||
162020644|NCT01010867|585130561|FG000|Overall Study|< 50% adherence to probiotic|1|||
162020645|NCT01668589|585130562|FG000|Overall Study|Lost to Follow-up|29|||
161926922|NCT03422718|584780173|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
161926923|NCT03422718|584780174|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
161926924|NCT03422718|584780175|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
161926925|NCT03422718|584780176|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
161926926|NCT03422718|584780177|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
161926927|NCT03422718|584780178|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
161926928|NCT03422718|584780179|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
161926929|NCT03422718|584780172|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
161926930|NCT03422718|584780173|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
161926931|NCT03422718|584780174|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
161926932|NCT03422718|584780175|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
161926933|NCT03422718|584780176|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
161926934|NCT03422718|584780177|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
161926935|NCT03422718|584780178|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
161926936|NCT03422718|584780179|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
161926937|NCT03197935|584780185|FG000|Overall Study|Death due to any cause|26|||
161926938|NCT03197935|584780186|FG001|Overall Study|Death due to any cause|15|||
161926939|NCT03197935|584780185|FG000|Overall Study|Lost to Follow-up|3|||
161926940|NCT03197935|584780186|FG001|Overall Study|Lost to Follow-up|5|||
161926941|NCT03197935|584780185|FG000|Overall Study|Physician Decision|2|||
161926942|NCT03197935|584780186|FG001|Overall Study|Physician Decision|1|||
161926943|NCT03197935|584780185|FG000|Overall Study|Withdrawal by Subject|16|||
161926944|NCT03197935|584780186|FG001|Overall Study|Withdrawal by Subject|8|||
161926945|NCT03315689|584780191|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
161926946|NCT03315689|584780192|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
161926947|NCT03315689|584780191|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
161926948|NCT03315689|584780192|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
161926949|NCT03315689|584780191|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
161926950|NCT03315689|584780192|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
161926951|NCT00864513|584780193|FG000|Overall Study|Withdrawal by Subject|3|||
161926952|NCT00762788|584780194|FG000|Overall Study|Lost to Follow-up|26|||
161926953|NCT00762788|584780195|FG001|Overall Study|Lost to Follow-up|37|||
161926954|NCT00762788|584780196|FG002|Overall Study|Lost to Follow-up|21|||
161926955|NCT00762788|584780197|FG003|Overall Study|Lost to Follow-up|26|||
161926956|NCT00762788|584780198|FG004|Overall Study|Lost to Follow-up|13|||
161926957|NCT00762788|584780199|FG005|Overall Study|Lost to Follow-up|21|||
161926958|NCT03073109|584780200|FG000|Overall Study|Adverse Event|0|||
161926959|NCT03073109|584780201|FG001|Overall Study|Adverse Event|1|||
161926960|NCT03073109|584780200|FG000|Overall Study|Other|2|||
161926961|NCT03073109|584780201|FG001|Overall Study|Other|0|||
161926962|NCT03073109|584780200|FG000|Overall Study|Lost to Follow-up|8|||
161926963|NCT03073109|584780201|FG001|Overall Study|Lost to Follow-up|1|||
161926964|NCT01297244|584780204|FG000|Overall Study|Progressive disease|22|||
161926965|NCT01297244|584780205|FG001|Overall Study|Progressive disease|3|||
161926966|NCT01297244|584780204|FG000|Overall Study|Adverse Event|9|||
161926967|NCT01297244|584780205|FG001|Overall Study|Adverse Event|1|||
161926968|NCT01297244|584780204|FG000|Overall Study|Death|1|||
161926969|NCT01297244|584780205|FG001|Overall Study|Death|1|||
161926970|NCT01297244|584780204|FG000|Overall Study|Clinical progression|1|||
161926971|NCT01297244|584780205|FG001|Overall Study|Clinical progression|1|||
161926972|NCT01297244|584780204|FG000|Overall Study|Withdrawal by Subject|2|||
161926973|NCT01297244|584780205|FG001|Overall Study|Withdrawal by Subject|0|||
161926974|NCT02595749|584780206|FG000|Overall Study|Withdrawal by Subject|12|||
161926975|NCT02595749|584780207|FG001|Overall Study|Withdrawal by Subject|7|||
161926976|NCT00669331|584780208|FG000|Randomisation to First Dose|Adverse Event|1|||
161926977|NCT00669331|584780209|FG001|Randomisation to First Dose|Adverse Event|0|||
161926978|NCT00669331|584780208|FG000|Randomisation to First Dose|Protocol Violation|1|||
161926979|NCT00669331|584780209|FG001|Randomisation to First Dose|Protocol Violation|0|||
161926980|NCT00669331|584780208|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
161926981|NCT00669331|584780209|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
161926982|NCT00669331|584780208|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
161926983|NCT00669331|584780209|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
161926984|NCT00669331|584780208|FG000|Randomisation to First Dose|Death|1|||
161926985|NCT00669331|584780209|FG001|Randomisation to First Dose|Death|0|||
161926986|NCT00669331|584780208|FG000|Randomisation to First Dose|Sponsor decision|0|||
161926987|NCT00669331|584780209|FG001|Randomisation to First Dose|Sponsor decision|1|||
161926988|NCT00669331|584780208|FG000|Randomisation to First Dose|Randomised in error|3|||
162020646|NCT01668589|585130563|FG001|Overall Study|Lost to Follow-up|37|||
161926989|NCT00669331|584780209|FG001|Randomisation to First Dose|Randomised in error|10|||
161926990|NCT00669331|584780208|FG000|Blinded Treatment Period|Adverse Event|16|||
161926991|NCT00669331|584780209|FG001|Blinded Treatment Period|Adverse Event|10|||
161926992|NCT00669331|584780208|FG000|Blinded Treatment Period|Protocol Violation|1|||
161926993|NCT00669331|584780209|FG001|Blinded Treatment Period|Protocol Violation|1|||
161926994|NCT00669331|584780208|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
162020647|NCT01668589|585130564|FG002|Overall Study|Lost to Follow-up|15|||
162020648|NCT01668589|585130565|FG003|Overall Study|Lost to Follow-up|5|||
162020649|NCT01668589|585130562|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
162020650|NCT01668589|585130563|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
162020651|NCT01668589|585130564|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
162020652|NCT01668589|585130565|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
162020653|NCT01668589|585130562|FG000|Overall Study|Death|12|||
162020654|NCT01668589|585130563|FG001|Overall Study|Death|3|||
162020655|NCT01668589|585130564|FG002|Overall Study|Death|2|||
162020656|NCT01668589|585130565|FG003|Overall Study|Death|11|||
162020657|NCT01668589|585130562|FG000|Overall Study|Other|44|||
162020658|NCT01668589|585130563|FG001|Overall Study|Other|10|||
162020659|NCT01668589|585130564|FG002|Overall Study|Other|7|||
162020660|NCT01668589|585130565|FG003|Overall Study|Other|15|||
162020661|NCT02302339|585130566|FG000|Overall Study|Lost to Follow-up|1|||
162020662|NCT02302339|585130567|FG001|Overall Study|Lost to Follow-up|0|||
162020663|NCT02302339|585130568|FG002|Overall Study|Lost to Follow-up|0|||
162020664|NCT02302339|585130569|FG003|Overall Study|Lost to Follow-up|0|||
162020665|NCT02302339|585130566|FG000|Overall Study|Withdrawal by Subject|0|||
162020666|NCT02302339|585130567|FG001|Overall Study|Withdrawal by Subject|2|||
162020667|NCT02302339|585130568|FG002|Overall Study|Withdrawal by Subject|1|||
162020668|NCT02302339|585130569|FG003|Overall Study|Withdrawal by Subject|0|||
162020669|NCT01827956|585130571|FG000|Overall Study|Protocol Violation|3|||
162020670|NCT04393454|585130572|FG000|Overall Study|Death|1|||
162020671|NCT04393454|585130572|FG000|Overall Study|Lost to Follow-up|1|||
161820800|NCT04610580|584384647|FG000|Two-way Crossover Period|Adverse Event|1|||
161820801|NCT04610580|584384648|FG001|Two-way Crossover Period|Adverse Event|0|||
161820802|NCT04610580|584384649|FG002|Two-way Crossover Period|Adverse Event|0|||
161820803|NCT04610580|584384650|FG003|Two-way Crossover Period|Adverse Event|0|||
161820804|NCT04610580|584384651|FG004|Two-way Crossover Period|Adverse Event|0|||
161820805|NCT04610580|584384652|FG005|Two-way Crossover Period|Adverse Event|0|||
161820806|NCT04610580|584384647|FG000|Two-way Crossover Period|Physician Decision|1|||
161820807|NCT04610580|584384648|FG001|Two-way Crossover Period|Physician Decision|0|||
161820808|NCT04610580|584384649|FG002|Two-way Crossover Period|Physician Decision|0|||
161820809|NCT04610580|584384650|FG003|Two-way Crossover Period|Physician Decision|0|||
161820810|NCT04610580|584384651|FG004|Two-way Crossover Period|Physician Decision|0|||
161820811|NCT04610580|584384652|FG005|Two-way Crossover Period|Physician Decision|0|||
161820812|NCT04610580|584384647|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
161820813|NCT04610580|584384648|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
161820814|NCT04610580|584384649|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
161820815|NCT04610580|584384650|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
161820816|NCT04610580|584384651|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
161820817|NCT04610580|584384652|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
161820818|NCT04610580|584384647|FG000|Two-way Crossover Period|Other than specified|0|||
161820819|NCT04610580|584384648|FG001|Two-way Crossover Period|Other than specified|1|||
161820820|NCT04610580|584384649|FG002|Two-way Crossover Period|Other than specified|0|||
161820821|NCT04610580|584384650|FG003|Two-way Crossover Period|Other than specified|0|||
161820822|NCT04610580|584384651|FG004|Two-way Crossover Period|Other than specified|0|||
161820823|NCT04610580|584384652|FG005|Two-way Crossover Period|Other than specified|0|||
161820824|NCT04610580|584384647|FG000|Washout Before Extension Period|Other than specified|0|||
161820825|NCT04610580|584384648|FG001|Washout Before Extension Period|Other than specified|1|||
161820826|NCT04610580|584384649|FG002|Washout Before Extension Period|Other than specified|0|||
161820827|NCT04610580|584384650|FG003|Washout Before Extension Period|Other than specified|0|||
161820828|NCT04610580|584384651|FG004|Washout Before Extension Period|Other than specified|0|||
161820829|NCT04610580|584384652|FG005|Washout Before Extension Period|Other than specified|0|||
161820830|NCT04610580|584384647|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
161820831|NCT04610580|584384648|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
161820832|NCT04610580|584384649|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
161820833|NCT04610580|584384650|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
161820834|NCT04610580|584384651|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
161820835|NCT04610580|584384652|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
161820836|NCT04610580|584384647|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161820837|NCT04610580|584384648|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161820838|NCT04610580|584384649|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161820839|NCT04610580|584384650|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161820840|NCT04610580|584384651|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
161820841|NCT04610580|584384652|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161820842|NCT01451541|584384654|FG000|Overall Study|Adverse Event|4|||
161820843|NCT01451541|584384655|FG001|Overall Study|Adverse Event|3|||
161820844|NCT01451541|584384656|FG002|Overall Study|Adverse Event|6|||
161820845|NCT01451541|584384654|FG000|Overall Study|Lack of Efficacy|2|||
162020672|NCT02752165|585130574|FG000|Overall Study|Withdrawal by Subject|6|||
162020673|NCT02752165|585130575|FG001|Overall Study|Withdrawal by Subject|6|||
162020674|NCT02752165|585130574|FG000|Overall Study|Protocol Violation|6|||
162020675|NCT02752165|585130575|FG001|Overall Study|Protocol Violation|5|||
162199261|NCT02176356|585781113|FG000|Overall Study|Screen Failure|14|||
162199262|NCT02176356|585781113|FG000|Overall Study|Lost to Follow-up|4|||
162199263|NCT02176356|585781113|FG000|Overall Study|Personal Reasons|3|||
162199264|NCT02176356|585781113|FG000|Overall Study|Other Miscellaneous Reasons|2|||
162199265|NCT00381888|585781114|FG000|Overall Study|Death|1|||
162199266|NCT00381888|585781114|FG000|Overall Study|Withdrawal by Subject|1|||
162199267|NCT00381888|585781114|FG000|Overall Study|Physician Decision|1|||
162199268|NCT00381888|585781114|FG000|Overall Study|Protocol Violation|9|||
162199269|NCT00381888|585781114|FG000|Overall Study|Had laparoscopic surgery|2|||
162199270|NCT00381888|585781114|FG000|Overall Study|Surgery was cancelled|2|||
162199271|NCT00381888|585781114|FG000|Overall Study|Adverse Event|1|||
162199272|NCT02255435|585781118|FG000|Overall Study|Patient's Limited Time Availability|0|||
162199273|NCT02255435|585781119|FG001|Overall Study|Patient's Limited Time Availability|0|||
162199274|NCT02255435|585781120|FG002|Overall Study|Patient's Limited Time Availability|0|||
162199275|NCT02255435|585781121|FG003|Overall Study|Patient's Limited Time Availability|0|||
162199276|NCT02255435|585781122|FG004|Overall Study|Patient's Limited Time Availability|0|||
162199277|NCT02255435|585781123|FG005|Overall Study|Patient's Limited Time Availability|0|||
162199278|NCT02255435|585781124|FG006|Overall Study|Patient's Limited Time Availability|0|||
162199279|NCT02255435|585781125|FG007|Overall Study|Patient's Limited Time Availability|1|||
162199280|NCT02255435|585781126|FG008|Overall Study|Patient's Limited Time Availability|0|||
162199281|NCT02255435|585781127|FG009|Overall Study|Patient's Limited Time Availability|0|||
162199282|NCT02255435|585781118|FG000|Overall Study|Withdrawal by Subject|0|||
162199283|NCT02255435|585781119|FG001|Overall Study|Withdrawal by Subject|0|||
162199284|NCT02255435|585781120|FG002|Overall Study|Withdrawal by Subject|0|||
162199285|NCT02255435|585781121|FG003|Overall Study|Withdrawal by Subject|0|||
162199286|NCT02255435|585781122|FG004|Overall Study|Withdrawal by Subject|0|||
162199287|NCT02255435|585781123|FG005|Overall Study|Withdrawal by Subject|0|||
162199288|NCT02255435|585781124|FG006|Overall Study|Withdrawal by Subject|0|||
162199289|NCT02255435|585781125|FG007|Overall Study|Withdrawal by Subject|0|||
162199290|NCT02255435|585781126|FG008|Overall Study|Withdrawal by Subject|1|||
162199291|NCT02255435|585781127|FG009|Overall Study|Withdrawal by Subject|4|||
162199292|NCT02255435|585781118|FG000|Overall Study|Administrative reasons|0|||
162199293|NCT02255435|585781119|FG001|Overall Study|Administrative reasons|0|||
162199294|NCT02255435|585781120|FG002|Overall Study|Administrative reasons|0|||
162199295|NCT02255435|585781121|FG003|Overall Study|Administrative reasons|0|||
162199296|NCT02255435|585781122|FG004|Overall Study|Administrative reasons|0|||
162199297|NCT02255435|585781123|FG005|Overall Study|Administrative reasons|0|||
162199298|NCT02255435|585781124|FG006|Overall Study|Administrative reasons|0|||
162199299|NCT02255435|585781125|FG007|Overall Study|Administrative reasons|0|||
162199300|NCT02255435|585781126|FG008|Overall Study|Administrative reasons|0|||
162199301|NCT02255435|585781127|FG009|Overall Study|Administrative reasons|2|||
162020676|NCT02752165|585130574|FG000|Overall Study|Lost to Follow-up|33|||
162020677|NCT02752165|585130575|FG001|Overall Study|Lost to Follow-up|38|||
162020678|NCT01704599|585130579|FG000|Overall Study|Adverse Event|1|||
162020679|NCT00494676|585130582|FG000|Allocation|Withdrawal by Subject|2|||
162199302|NCT02151643|585781128|FG000|Overall Study|Adverse Event|2|||
162199303|NCT02151643|585781129|FG001|Overall Study|Adverse Event|0|||
162199304|NCT02151643|585781130|FG002|Overall Study|Adverse Event|1|||
162199305|NCT02151643|585781131|FG003|Overall Study|Adverse Event|4|||
162199306|NCT02151643|585781132|FG004|Overall Study|Adverse Event|0|||
162199307|NCT02151643|585781128|FG000|Overall Study|Withdrawal by Subject|0|||
162199308|NCT02151643|585781129|FG001|Overall Study|Withdrawal by Subject|1|||
162199309|NCT02151643|585781130|FG002|Overall Study|Withdrawal by Subject|1|||
162199310|NCT02151643|585781131|FG003|Overall Study|Withdrawal by Subject|1|||
162199311|NCT02151643|585781132|FG004|Overall Study|Withdrawal by Subject|1|||
162199312|NCT02151643|585781128|FG000|Overall Study|Hyperphosphataemia|1|||
162199313|NCT02151643|585781129|FG001|Overall Study|Hyperphosphataemia|0|||
162199314|NCT02151643|585781130|FG002|Overall Study|Hyperphosphataemia|0|||
162020680|NCT00494676|585130583|FG001|Allocation|Withdrawal by Subject|4|||
162199315|NCT02151643|585781131|FG003|Overall Study|Hyperphosphataemia|0|||
162020681|NCT00494676|585130582|FG000|First Intervention|Withdrawal by Subject|1|||
162199316|NCT02151643|585781132|FG004|Overall Study|Hyperphosphataemia|1|||
162199317|NCT02151643|585781128|FG000|Overall Study|High Ferritin levels|3|||
162199318|NCT02151643|585781129|FG001|Overall Study|High Ferritin levels|3|||
162199319|NCT02151643|585781130|FG002|Overall Study|High Ferritin levels|2|||
162199320|NCT02151643|585781131|FG003|Overall Study|High Ferritin levels|2|||
162199321|NCT02151643|585781132|FG004|Overall Study|High Ferritin levels|1|||
162199322|NCT04307134|585781133|FG000|Overall Study|Lost to Follow-up|2|||
162199323|NCT04307134|585781133|FG000|Overall Study|Withdrawal by Subject|3|||
162199324|NCT04307134|585781133|FG000|Overall Study|Other|3|||
162199325|NCT04307134|585781133|FG000|Overall Study|Death|21|||
162199326|NCT04307134|585781133|FG000|Overall Study|Enrolled but not Treated|1|||
162020682|NCT00494676|585130583|FG001|First Intervention|Withdrawal by Subject|3|||
162199327|NCT01809691|585781134|FG000|Overall Study|Currently on Treatment|192|||
161820846|NCT01451541|584384655|FG001|Overall Study|Lack of Efficacy|0|||
161926995|NCT00669331|584780209|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
161926996|NCT00669331|584780208|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
161926997|NCT00669331|584780209|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
161926998|NCT00669331|584780208|FG000|Blinded Treatment Period|Death|0|||
161926999|NCT00669331|584780209|FG001|Blinded Treatment Period|Death|2|||
161927000|NCT00669331|584780208|FG000|Blinded Treatment Period|Physician Decision|3|||
161927001|NCT00669331|584780209|FG001|Blinded Treatment Period|Physician Decision|3|||
161927002|NCT00669331|584780208|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
161927003|NCT00669331|584780209|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
161927004|NCT03387046|584780215|FG000|Overall Study|Adverse Event|1|||
161927005|NCT03387046|584780216|FG001|Overall Study|Adverse Event|1|||
161927006|NCT00509600|584780217|FG000|Overall Study|Adverse Event|1|||
161927007|NCT00986232|584780220|FG000|Overall Study|Adverse Event|1|||
161927008|NCT00986232|584780221|FG001|Overall Study|Adverse Event|2|||
161927009|NCT00986232|584780222|FG002|Overall Study|Adverse Event|3|||
161927010|NCT00986232|584780223|FG003|Overall Study|Adverse Event|0|||
161927011|NCT00986232|584780220|FG000|Overall Study|Lost to Follow-up|19|||
161927012|NCT00986232|584780221|FG001|Overall Study|Lost to Follow-up|12|||
161927013|NCT00986232|584780222|FG002|Overall Study|Lost to Follow-up|12|||
161927014|NCT00986232|584780223|FG003|Overall Study|Lost to Follow-up|7|||
161927015|NCT00986232|584780220|FG000|Overall Study|Protocol Violation|2|||
161927016|NCT00986232|584780221|FG001|Overall Study|Protocol Violation|3|||
161927017|NCT00986232|584780222|FG002|Overall Study|Protocol Violation|0|||
161927018|NCT00986232|584780223|FG003|Overall Study|Protocol Violation|1|||
161927019|NCT00986232|584780220|FG000|Overall Study|Withdrawal by Subject|13|||
161927020|NCT00986232|584780221|FG001|Overall Study|Withdrawal by Subject|16|||
161927021|NCT00986232|584780222|FG002|Overall Study|Withdrawal by Subject|12|||
161676187|NCT05975840|583867322|FG004|Overall Study|Migrated/moved from the study area|0|||
161820847|NCT01451541|584384656|FG002|Overall Study|Lack of Efficacy|0|||
161820848|NCT01451541|584384654|FG000|Overall Study|Lost to Follow-up|4|||
161820849|NCT01451541|584384655|FG001|Overall Study|Lost to Follow-up|4|||
161820850|NCT01451541|584384656|FG002|Overall Study|Lost to Follow-up|7|||
161820851|NCT01451541|584384654|FG000|Overall Study|Withdrawal by Subject|15|||
161820852|NCT01451541|584384655|FG001|Overall Study|Withdrawal by Subject|8|||
161820853|NCT01451541|584384656|FG002|Overall Study|Withdrawal by Subject|6|||
161820854|NCT01451541|584384654|FG000|Overall Study|randomization error, noncompliance|11|||
161820855|NCT01451541|584384655|FG001|Overall Study|randomization error, noncompliance|10|||
161820856|NCT01451541|584384656|FG002|Overall Study|randomization error, noncompliance|8|||
161820857|NCT05665387|584384657|FG000|Overall Study|Withdrawal by Subject|1|||
161820858|NCT05665387|584384658|FG001|Overall Study|Withdrawal by Subject|0|||
161820859|NCT05665387|584384659|FG002|Overall Study|Withdrawal by Subject|1|||
161820860|NCT01824498|584384660|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
161820861|NCT01824498|584384661|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
161927022|NCT00986232|584780223|FG003|Overall Study|Withdrawal by Subject|3|||
161820862|NCT01824498|584384662|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
161820863|NCT01824498|584384663|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
161820864|NCT01824498|584384664|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
161820865|NCT01824498|584384665|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
161820866|NCT00006436|584384666|FG000|Overall Study|Refused further treatment|2|||
161820867|NCT00006436|584384666|FG000|Overall Study|Declined to participate (before treatment started)|1|||
161820868|NCT00939523|584384667|FG000|Overall Study|Lack of Efficacy|1|||
161820869|NCT00939523|584384667|FG000|Overall Study|Physician Decision|2|||
161820870|NCT01528735|584384674|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
161820871|NCT01528735|584384675|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
161820872|NCT01528735|584384674|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
161820873|NCT01528735|584384675|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
161820874|NCT03555695|584384676|FG000|Overall Study|Withdrawal by Subject|1|||
161820875|NCT03555695|584384676|FG000|Overall Study|Lost to Follow-up|1|||
161820876|NCT03555695|584384676|FG000|Overall Study|appendicitis (unrelated)|1|||
161820877|NCT03555695|584384676|FG000|Overall Study|pre-existing sciatica|1|||
161820878|NCT00757172|584384677|FG000|Overall Study|Withdrawal by Subject|4|||
161820879|NCT00757172|584384677|FG000|Overall Study|Physician Decision|3|||
161820880|NCT00757172|584384677|FG000|Overall Study|Progression|4|||
161820881|NCT01942135|584384680|FG000|Overall Study|Adverse Event|21|||
161820882|NCT01942135|584384681|FG001|Overall Study|Adverse Event|7|||
161820883|NCT01942135|584384680|FG000|Overall Study|Global Deterioration of Health Status|9|||
161820884|NCT01942135|584384681|FG001|Overall Study|Global Deterioration of Health Status|6|||
161820885|NCT01942135|584384680|FG000|Overall Study|Randomized Not Treated|2|||
161820886|NCT01942135|584384681|FG001|Overall Study|Randomized Not Treated|2|||
161820887|NCT01942135|584384680|FG000|Overall Study|Death|2|||
161820888|NCT01942135|584384681|FG001|Overall Study|Death|1|||
161820889|NCT01942135|584384680|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
161820890|NCT01942135|584384681|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
161820891|NCT01942135|584384680|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
161820892|NCT01942135|584384681|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
161820893|NCT01942135|584384680|FG000|Overall Study|Withdrawal by Subject|4|||
161820894|NCT01942135|584384681|FG001|Overall Study|Withdrawal by Subject|3|||
161820895|NCT01942135|584384680|FG000|Overall Study|Protocol Violation|1|||
161820896|NCT01942135|584384681|FG001|Overall Study|Protocol Violation|0|||
161927023|NCT00986232|584780220|FG000|Overall Study|Missed one or more bleeds|13|||
161927024|NCT00986232|584780221|FG001|Overall Study|Missed one or more bleeds|10|||
161820897|NCT01942135|584384680|FG000|Overall Study|Other|19|||
161820898|NCT01942135|584384681|FG001|Overall Study|Other|4|||
161820899|NCT01499043|584384682|FG000|Overall Study|Progressive disease (radiographic)|2|||
162199328|NCT01809691|585781135|FG001|Overall Study|Currently on Treatment|100|||
162199329|NCT01809691|585781134|FG000|Overall Study|No Protocol Treatment|10|||
162199330|NCT01809691|585781135|FG001|Overall Study|No Protocol Treatment|11|||
162199331|NCT01809691|585781134|FG000|Overall Study|Adverse Event|80|||
162199332|NCT01809691|585781135|FG001|Overall Study|Adverse Event|21|||
162199333|NCT01809691|585781134|FG000|Overall Study|Disease Progression|226|||
162199334|NCT01809691|585781135|FG001|Overall Study|Disease Progression|372|||
162199335|NCT01809691|585781134|FG000|Overall Study|Death|26|||
162199336|NCT01809691|585781135|FG001|Overall Study|Death|13|||
162199337|NCT01809691|585781134|FG000|Overall Study|Participant Refusal|70|||
162199338|NCT01809691|585781135|FG001|Overall Study|Participant Refusal|72|||
162199339|NCT01809691|585781134|FG000|Overall Study|Other, Not Specified|34|||
162199340|NCT01809691|585781135|FG001|Overall Study|Other, Not Specified|52|||
162199341|NCT03694210|585781136|FG000|Overall Study|Death|1|||
161820900|NCT01499043|584384682|FG000|Overall Study|Progressive disease (clinical)|1|||
161820901|NCT01499043|584384682|FG000|Overall Study|Withdrawal by Subject|2|||
161927025|NCT00986232|584780222|FG002|Overall Study|Missed one or more bleeds|6|||
161927026|NCT00986232|584780223|FG003|Overall Study|Missed one or more bleeds|7|||
161927027|NCT00986232|584780220|FG000|Overall Study|Incomplete safety follow-up|3|||
161927028|NCT00986232|584780221|FG001|Overall Study|Incomplete safety follow-up|7|||
161927029|NCT00986232|584780222|FG002|Overall Study|Incomplete safety follow-up|2|||
161927030|NCT00986232|584780223|FG003|Overall Study|Incomplete safety follow-up|2|||
161820902|NCT01499043|584384682|FG000|Overall Study|Adverse Event|1|||
161820903|NCT01596127|584384685|FG000|Overall Study|Patient Ineligible|1|||
161820904|NCT00685334|584384691|FG000|Overall Study|Withdrawal by Subject|5|||
162199342|NCT03694210|585781136|FG000|Overall Study|Screen Failure|7|||
162199343|NCT00907517|585781141|FG000|Overall Study|Progressive Disease|3|||
161820905|NCT00685334|584384692|FG001|Overall Study|Withdrawal by Subject|6|||
162199344|NCT00907517|585781142|FG001|Overall Study|Progressive Disease|3|||
161927031|NCT02568423|584780224|FG000|Overall Study|Lost to Follow-up|0|||
162199345|NCT00907517|585781143|FG002|Overall Study|Progressive Disease|4|||
161820906|NCT00685334|584384691|FG000|Overall Study|Lost to Follow-up|4|||
161820907|NCT00685334|584384692|FG001|Overall Study|Lost to Follow-up|0|||
162199346|NCT00907517|585781144|FG003|Overall Study|Progressive Disease|4|||
161927032|NCT02568423|584780225|FG001|Overall Study|Lost to Follow-up|2|||
162199347|NCT00907517|585781145|FG004|Overall Study|Progressive Disease|4|||
162199348|NCT00907517|585781141|FG000|Overall Study|Symptomatic Deterioration|0|||
162199349|NCT00907517|585781142|FG001|Overall Study|Symptomatic Deterioration|0|||
162199350|NCT00907517|585781143|FG002|Overall Study|Symptomatic Deterioration|0|||
162199351|NCT00907517|585781144|FG003|Overall Study|Symptomatic Deterioration|0|||
162199352|NCT00907517|585781145|FG004|Overall Study|Symptomatic Deterioration|1|||
162199353|NCT01732627|585781146|FG000|Overall Study|Withdrawal by Subject|1|||
162199354|NCT01732627|585781147|FG001|Overall Study|Withdrawal by Subject|0|||
162199355|NCT03541200|585781151|FG000|Overall Study|Adverse Event|19|||
162199356|NCT03541200|585781151|FG000|Overall Study|Death|1|||
162199357|NCT03541200|585781151|FG000|Overall Study|Lost to Follow-up|10|||
162199358|NCT03541200|585781151|FG000|Overall Study|Physician Decision|1|||
162199359|NCT03541200|585781151|FG000|Overall Study|Protocol Violation|51|||
162199360|NCT03541200|585781151|FG000|Overall Study|Withdrawal by Subject|23|||
162199361|NCT03541200|585781151|FG000|Overall Study|other|8|||
162199362|NCT02305797|585781152|FG000|Overall Study|Adverse Event|11|||
162199363|NCT02305797|585781153|FG001|Overall Study|Adverse Event|2|||
162199364|NCT02305797|585781152|FG000|Overall Study|Withdrawal by Subject|9|||
162199365|NCT02305797|585781153|FG001|Overall Study|Withdrawal by Subject|10|||
162199366|NCT02305797|585781152|FG000|Overall Study|Lack of Efficacy|6|||
162199367|NCT02305797|585781153|FG001|Overall Study|Lack of Efficacy|0|||
162199368|NCT02305797|585781152|FG000|Overall Study|Lost to Follow-up|5|||
162199369|NCT02305797|585781153|FG001|Overall Study|Lost to Follow-up|11|||
162199370|NCT02305797|585781152|FG000|Overall Study|Pregnancy|0|||
162199371|NCT02305797|585781153|FG001|Overall Study|Pregnancy|2|||
162199372|NCT02305797|585781152|FG000|Overall Study|Noncompliance|14|||
162199373|NCT02305797|585781153|FG001|Overall Study|Noncompliance|12|||
162199374|NCT02305797|585781152|FG000|Overall Study|Reason not collected|0|||
162199375|NCT02305797|585781153|FG001|Overall Study|Reason not collected|1|||
162199376|NCT03508830|585781154|FG000|Overall Study|Withdrawal by Subject|3|||
162199377|NCT03508830|585781155|FG001|Overall Study|Withdrawal by Subject|4|||
162199378|NCT03508830|585781154|FG000|Overall Study|Physician Decision|2|||
161927033|NCT02568423|584780226|FG002|Overall Study|Lost to Follow-up|0|||
161927034|NCT02568423|584780227|FG003|Overall Study|Lost to Follow-up|0|||
162199379|NCT03508830|585781155|FG001|Overall Study|Physician Decision|2|||
162199380|NCT02522299|585781156|FG000|Overall Study|Adverse Event|2|||
162199381|NCT02522299|585781157|FG001|Overall Study|Adverse Event|0|||
162199382|NCT02522299|585781156|FG000|Overall Study|Physician Decision|0|||
162199383|NCT02522299|585781157|FG001|Overall Study|Physician Decision|1|||
162199384|NCT02522299|585781156|FG000|Overall Study|Withdrawal by Subject|2|||
162199385|NCT02522299|585781157|FG001|Overall Study|Withdrawal by Subject|0|||
162199386|NCT02097056|585781158|FG000|Overall Study|Protocol Violation|2|||
162199387|NCT02097056|585781158|FG000|Overall Study|Withdrawal by Subject|15|||
162199388|NCT02097056|585781158|FG000|Overall Study|Lost to Follow-up|2|||
162199389|NCT02097056|585781158|FG000|Overall Study|Adverse Event|37|||
162199390|NCT02097056|585781158|FG000|Overall Study|Other|2|||
162199391|NCT04908800|585781161|FG000|Overall Study|Adverse Event|0|||
162199392|NCT04908800|585781162|FG001|Overall Study|Adverse Event|0|||
162199393|NCT04908800|585781163|FG002|Overall Study|Adverse Event|0|||
162199394|NCT04908800|585781164|FG003|Overall Study|Adverse Event|0|||
162199395|NCT04908800|585781165|FG004|Overall Study|Adverse Event|0|||
162199396|NCT04908800|585781166|FG005|Overall Study|Adverse Event|0|||
162199397|NCT04908800|585781167|FG006|Overall Study|Adverse Event|0|||
162199398|NCT04908800|585781168|FG007|Overall Study|Adverse Event|0|||
162199399|NCT04908800|585781169|FG008|Overall Study|Adverse Event|0|||
162199400|NCT04908800|585781170|FG009|Overall Study|Adverse Event|0|||
162199401|NCT04908800|585781171|FG010|Overall Study|Adverse Event|1|||
162199402|NCT04908800|585781172|FG011|Overall Study|Adverse Event|0|||
162199403|NCT04908800|585781173|FG012|Overall Study|Adverse Event|0|||
162199404|NCT03751280|585781174|FG000|Overall Study|Adverse Event|0|||
162199405|NCT03751280|585781175|FG001|Overall Study|Adverse Event|1|||
162199406|NCT03751280|585781174|FG000|Overall Study|Lost to Follow-up|3|||
162199407|NCT03751280|585781175|FG001|Overall Study|Lost to Follow-up|5|||
162199408|NCT03751280|585781174|FG000|Overall Study|Physician Decision|0|||
162199409|NCT03751280|585781175|FG001|Overall Study|Physician Decision|2|||
162199410|NCT03751280|585781174|FG000|Overall Study|Protocol Violation|0|||
162199411|NCT03751280|585781175|FG001|Overall Study|Protocol Violation|2|||
162199412|NCT03751280|585781174|FG000|Overall Study|Withdrawal by Subject|5|||
162199413|NCT03751280|585781175|FG001|Overall Study|Withdrawal by Subject|2|||
162199414|NCT00296504|585781177|FG000|Interim Analysis|Withdrawal by Subject|8|||
162199415|NCT00296504|585781178|FG001|Interim Analysis|Withdrawal by Subject|0|||
162199416|NCT00296504|585781179|FG002|Interim Analysis|Withdrawal by Subject|12|||
161927035|NCT02568423|584780228|FG004|Overall Study|Lost to Follow-up|0|||
162199417|NCT00296504|585781180|FG003|Interim Analysis|Withdrawal by Subject|0|||
162199418|NCT00296504|585781181|FG004|Interim Analysis|Withdrawal by Subject|5|||
162199419|NCT00296504|585781182|FG005|Interim Analysis|Withdrawal by Subject|5|||
162199420|NCT00296504|585781183|FG006|Interim Analysis|Withdrawal by Subject|9|||
162199421|NCT00296504|585781184|FG007|Interim Analysis|Withdrawal by Subject|3|||
162199422|NCT00296504|585781185|FG008|Interim Analysis|Withdrawal by Subject|0|||
162199423|NCT00296504|585781177|FG000|Interim Analysis|Lost to Follow-up|13|||
162199424|NCT00296504|585781178|FG001|Interim Analysis|Lost to Follow-up|3|||
162199425|NCT00296504|585781179|FG002|Interim Analysis|Lost to Follow-up|26|||
162199426|NCT00296504|585781180|FG003|Interim Analysis|Lost to Follow-up|8|||
162199427|NCT00296504|585781181|FG004|Interim Analysis|Lost to Follow-up|14|||
162199428|NCT00296504|585781182|FG005|Interim Analysis|Lost to Follow-up|4|||
161927036|NCT02568423|584780229|FG005|Overall Study|Lost to Follow-up|0|||
161927037|NCT02568423|584780230|FG006|Overall Study|Lost to Follow-up|0|||
161927038|NCT02568423|584780231|FG007|Overall Study|Lost to Follow-up|0|||
161927039|NCT02568423|584780224|FG000|Overall Study|Physician Decision|0|||
161927040|NCT02568423|584780225|FG001|Overall Study|Physician Decision|0|||
161927041|NCT02568423|584780226|FG002|Overall Study|Physician Decision|0|||
161927042|NCT02568423|584780227|FG003|Overall Study|Physician Decision|0|||
161927043|NCT02568423|584780228|FG004|Overall Study|Physician Decision|0|||
161927044|NCT02568423|584780229|FG005|Overall Study|Physician Decision|1|||
161927045|NCT02568423|584780230|FG006|Overall Study|Physician Decision|0|||
161927046|NCT02568423|584780231|FG007|Overall Study|Physician Decision|0|||
161927047|NCT03794544|584780232|FG000|Overall Study|Withdrawal by Subject|1|||
161927048|NCT03794544|584780233|FG001|Overall Study|Withdrawal by Subject|1|||
161927049|NCT03794544|584780234|FG002|Overall Study|Withdrawal by Subject|0|||
161927050|NCT03794544|584780235|FG003|Overall Study|Withdrawal by Subject|0|||
161927051|NCT03794544|584780232|FG000|Overall Study|Death|0|||
161927052|NCT03794544|584780233|FG001|Overall Study|Death|0|||
161927053|NCT03794544|584780234|FG002|Overall Study|Death|0|||
161927054|NCT03794544|584780235|FG003|Overall Study|Death|1|||
161927055|NCT03794544|584780232|FG000|Overall Study|Lost to Follow-up|0|||
161927056|NCT03794544|584780233|FG001|Overall Study|Lost to Follow-up|1|||
161927057|NCT03794544|584780234|FG002|Overall Study|Lost to Follow-up|1|||
161927058|NCT03794544|584780235|FG003|Overall Study|Lost to Follow-up|0|||
161927059|NCT03794544|584780232|FG000|Overall Study|Other|0|||
161927060|NCT03794544|584780233|FG001|Overall Study|Other|1|||
161927061|NCT03794544|584780234|FG002|Overall Study|Other|0|||
161927062|NCT03794544|584780235|FG003|Overall Study|Other|0|||
161927063|NCT02502383|584780237|FG000|Overall Study|Lost to Follow-up|130|||
161927064|NCT02502383|584780238|FG001|Overall Study|Lost to Follow-up|131|||
161927065|NCT02502383|584780237|FG000|Overall Study|Withdrawal by Subject|31|||
161927066|NCT02502383|584780238|FG001|Overall Study|Withdrawal by Subject|24|||
161927067|NCT01428713|584780239|FG000|Overall Study|Non-compliance|2|||
161927068|NCT01428713|584780240|FG001|Overall Study|Non-compliance|2|||
161927069|NCT01428713|584780239|FG000|Overall Study|Withdrawal by Subject|1|||
161927070|NCT01428713|584780240|FG001|Overall Study|Withdrawal by Subject|1|||
161927071|NCT01428713|584780239|FG000|Overall Study|Adverse Event|0|||
161927072|NCT01428713|584780240|FG001|Overall Study|Adverse Event|2|||
161927073|NCT00875667|584780243|FG000|Overall Study|Adverse Event|29|||
161927074|NCT00875667|584780244|FG001|Overall Study|Adverse Event|10|||
161927075|NCT00875667|584780243|FG000|Overall Study|Withdrawal by Subject|17|||
161927076|NCT00875667|584780244|FG001|Overall Study|Withdrawal by Subject|5|||
162199429|NCT00296504|585781183|FG006|Interim Analysis|Lost to Follow-up|11|||
162199430|NCT00296504|585781184|FG007|Interim Analysis|Lost to Follow-up|4|||
162199431|NCT00296504|585781185|FG008|Interim Analysis|Lost to Follow-up|0|||
161927077|NCT00875667|584780243|FG000|Overall Study|Death|7|||
161927078|NCT00875667|584780244|FG001|Overall Study|Death|2|||
161927079|NCT00875667|584780243|FG000|Overall Study|Protocol Violation|2|||
161927080|NCT00875667|584780244|FG001|Overall Study|Protocol Violation|0|||
161927081|NCT00875667|584780243|FG000|Overall Study|Disease Progression|100|||
161927082|NCT00875667|584780244|FG001|Overall Study|Disease Progression|49|||
161927083|NCT00875667|584780243|FG000|Overall Study|Miscellaneous|12|||
161927084|NCT00875667|584780244|FG001|Overall Study|Miscellaneous|6|||
161927085|NCT00875667|584780243|FG000|Overall Study|Randomized but no Study Drug Given|3|||
161927086|NCT00875667|584780244|FG001|Overall Study|Randomized but no Study Drug Given|1|||
161927087|NCT00120250|584780245|FG000|Overall Study|Lost to Follow-up|1|||
161927088|NCT00120250|584780246|FG001|Overall Study|Lost to Follow-up|1|||
161927089|NCT00120250|584780245|FG000|Overall Study|Protocol Violation|0|||
162199432|NCT00296504|585781177|FG000|Interim Analysis|Clinical Progression|1|||
162199433|NCT00296504|585781178|FG001|Interim Analysis|Clinical Progression|0|||
161927090|NCT00120250|584780246|FG001|Overall Study|Protocol Violation|1|||
161927091|NCT01967277|584780247|FG000|Overall Study|Lost to Follow-up|1|||
161927092|NCT01967277|584780248|FG001|Overall Study|Lost to Follow-up|2|||
161927093|NCT01967277|584780247|FG000|Overall Study|Unrelated illness|0|||
162199434|NCT00296504|585781179|FG002|Interim Analysis|Clinical Progression|1|||
162199435|NCT00296504|585781180|FG003|Interim Analysis|Clinical Progression|1|||
162199436|NCT00296504|585781181|FG004|Interim Analysis|Clinical Progression|0|||
162199437|NCT00296504|585781182|FG005|Interim Analysis|Clinical Progression|2|||
162199438|NCT00296504|585781183|FG006|Interim Analysis|Clinical Progression|1|||
162199439|NCT00296504|585781184|FG007|Interim Analysis|Clinical Progression|2|||
162199440|NCT00296504|585781185|FG008|Interim Analysis|Clinical Progression|0|||
162199441|NCT00296504|585781177|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
162199442|NCT00296504|585781178|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
162199443|NCT00296504|585781179|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
162199444|NCT00296504|585781180|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
162199445|NCT00296504|585781181|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
162199446|NCT00296504|585781182|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
162199447|NCT00296504|585781183|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
162199448|NCT00296504|585781184|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
162199449|NCT00296504|585781185|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
162199450|NCT00296504|585781177|FG000|Interim Analysis|Adverse Event|0|||
162199451|NCT00296504|585781178|FG001|Interim Analysis|Adverse Event|0|||
162199452|NCT00296504|585781179|FG002|Interim Analysis|Adverse Event|13|||
162199453|NCT00296504|585781180|FG003|Interim Analysis|Adverse Event|4|||
162199454|NCT00296504|585781181|FG004|Interim Analysis|Adverse Event|6|||
162199455|NCT00296504|585781182|FG005|Interim Analysis|Adverse Event|3|||
162199456|NCT00296504|585781183|FG006|Interim Analysis|Adverse Event|4|||
162199457|NCT00296504|585781184|FG007|Interim Analysis|Adverse Event|5|||
162199458|NCT00296504|585781185|FG008|Interim Analysis|Adverse Event|0|||
162199459|NCT00296504|585781177|FG000|Interim Analysis|Protocol Violation|0|||
162199460|NCT00296504|585781178|FG001|Interim Analysis|Protocol Violation|0|||
162199461|NCT00296504|585781179|FG002|Interim Analysis|Protocol Violation|2|||
162199462|NCT00296504|585781180|FG003|Interim Analysis|Protocol Violation|0|||
162199463|NCT00296504|585781181|FG004|Interim Analysis|Protocol Violation|1|||
162199464|NCT00296504|585781182|FG005|Interim Analysis|Protocol Violation|0|||
162199465|NCT00296504|585781183|FG006|Interim Analysis|Protocol Violation|0|||
162199466|NCT00296504|585781184|FG007|Interim Analysis|Protocol Violation|1|||
162199467|NCT00296504|585781185|FG008|Interim Analysis|Protocol Violation|0|||
162199468|NCT00296504|585781177|FG000|Interim Analysis|Insufficient CD4 Response|0|||
162199469|NCT00296504|585781178|FG001|Interim Analysis|Insufficient CD4 Response|0|||
162199470|NCT00296504|585781179|FG002|Interim Analysis|Insufficient CD4 Response|0|||
162199471|NCT00296504|585781180|FG003|Interim Analysis|Insufficient CD4 Response|0|||
162199472|NCT00296504|585781181|FG004|Interim Analysis|Insufficient CD4 Response|1|||
162199473|NCT00296504|585781182|FG005|Interim Analysis|Insufficient CD4 Response|1|||
162199474|NCT00296504|585781183|FG006|Interim Analysis|Insufficient CD4 Response|0|||
162199475|NCT00296504|585781184|FG007|Interim Analysis|Insufficient CD4 Response|0|||
162199476|NCT00296504|585781185|FG008|Interim Analysis|Insufficient CD4 Response|0|||
162199477|NCT00296504|585781177|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
162199478|NCT00296504|585781178|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
162199479|NCT00296504|585781179|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
162199480|NCT00296504|585781180|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
162199481|NCT00296504|585781181|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
162199482|NCT00296504|585781182|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
162199483|NCT00296504|585781183|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
162199484|NCT00296504|585781184|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
162199485|NCT00296504|585781185|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
161820908|NCT00685334|584384691|FG000|Overall Study|Chose to enter hospital|1|||
161820909|NCT00685334|584384692|FG001|Overall Study|Chose to enter hospital|1|||
161820910|NCT04577404|584384693|FG000|Overall Study|Adverse Event|31|||
161820911|NCT04577404|584384693|FG000|Overall Study|Death|1|||
161820912|NCT04577404|584384693|FG000|Overall Study|Lack of Efficacy|3|||
162199486|NCT00296504|585781177|FG000|Interim Analysis|Pregnancy|4|||
162199487|NCT00296504|585781178|FG001|Interim Analysis|Pregnancy|1|||
161820913|NCT04577404|584384693|FG000|Overall Study|Physician Decision|7|||
161820914|NCT04577404|584384693|FG000|Overall Study|Withdrawal by Subject|21|||
161820915|NCT04577404|584384693|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
161820916|NCT00820599|584385744|FG000|Overall Study|Death|129|||
161820917|NCT00820599|584385744|FG000|Overall Study|Withdrawal by Subject|2|||
161820918|NCT00202839|584385745|FG000|Overall Study|Adverse Event|1|||
162199488|NCT00296504|585781179|FG002|Interim Analysis|Pregnancy|4|||
162199489|NCT00296504|585781180|FG003|Interim Analysis|Pregnancy|2|||
162199490|NCT00296504|585781181|FG004|Interim Analysis|Pregnancy|0|||
162199491|NCT00296504|585781182|FG005|Interim Analysis|Pregnancy|1|||
162199492|NCT00296504|585781183|FG006|Interim Analysis|Pregnancy|1|||
161820919|NCT00202839|584385746|FG001|Overall Study|Adverse Event|5|||
161820920|NCT00202839|584385745|FG000|Overall Study|Physician Decision|12|||
161820921|NCT00202839|584385746|FG001|Overall Study|Physician Decision|0|||
161820922|NCT00202839|584385745|FG000|Overall Study|Withdrawal by Subject|6|||
162020683|NCT00494676|585130582|FG000|Second Intervention|Withdrawal by Subject|1|||
162199493|NCT00296504|585781184|FG007|Interim Analysis|Pregnancy|1|||
162199494|NCT00296504|585781185|FG008|Interim Analysis|Pregnancy|0|||
162199495|NCT00296504|585781177|FG000|Interim Analysis|Death|1|||
162199496|NCT00296504|585781178|FG001|Interim Analysis|Death|0|||
162199497|NCT00296504|585781179|FG002|Interim Analysis|Death|3|||
162199498|NCT00296504|585781180|FG003|Interim Analysis|Death|0|||
162199499|NCT00296504|585781181|FG004|Interim Analysis|Death|0|||
162199500|NCT00296504|585781182|FG005|Interim Analysis|Death|0|||
162199501|NCT00296504|585781183|FG006|Interim Analysis|Death|0|||
162199502|NCT00296504|585781184|FG007|Interim Analysis|Death|0|||
162199503|NCT00296504|585781185|FG008|Interim Analysis|Death|0|||
162199504|NCT00296504|585781177|FG000|Interim Analysis|Participant Non-compliant|0|||
162199505|NCT00296504|585781178|FG001|Interim Analysis|Participant Non-compliant|1|||
162199506|NCT00296504|585781179|FG002|Interim Analysis|Participant Non-compliant|2|||
162199507|NCT00296504|585781180|FG003|Interim Analysis|Participant Non-compliant|1|||
162199508|NCT00296504|585781181|FG004|Interim Analysis|Participant Non-compliant|1|||
162199509|NCT00296504|585781182|FG005|Interim Analysis|Participant Non-compliant|3|||
162199510|NCT00296504|585781183|FG006|Interim Analysis|Participant Non-compliant|6|||
162199511|NCT00296504|585781184|FG007|Interim Analysis|Participant Non-compliant|2|||
162199512|NCT00296504|585781185|FG008|Interim Analysis|Participant Non-compliant|0|||
162199513|NCT00296504|585781177|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162199514|NCT00296504|585781178|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162199515|NCT00296504|585781179|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
162199516|NCT00296504|585781180|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162199517|NCT00296504|585781181|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162199518|NCT00296504|585781182|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
162199519|NCT00296504|585781183|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162199520|NCT00296504|585781184|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162199521|NCT00296504|585781185|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
162199522|NCT00296504|585781177|FG000|Interim Analysis|To Simplify Treatment|0|||
162199523|NCT00296504|585781178|FG001|Interim Analysis|To Simplify Treatment|0|||
162199524|NCT00296504|585781179|FG002|Interim Analysis|To Simplify Treatment|1|||
162199525|NCT00296504|585781180|FG003|Interim Analysis|To Simplify Treatment|0|||
162199526|NCT00296504|585781181|FG004|Interim Analysis|To Simplify Treatment|0|||
162199527|NCT00296504|585781182|FG005|Interim Analysis|To Simplify Treatment|0|||
162199528|NCT00296504|585781183|FG006|Interim Analysis|To Simplify Treatment|2|||
162199529|NCT00296504|585781184|FG007|Interim Analysis|To Simplify Treatment|0|||
162199530|NCT00296504|585781185|FG008|Interim Analysis|To Simplify Treatment|0|||
162199531|NCT00296504|585781177|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
162199532|NCT00296504|585781178|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
162199533|NCT00296504|585781179|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
162199534|NCT00296504|585781180|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
162199535|NCT00296504|585781181|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
161676188|NCT05975840|583867323|FG005|Overall Study|Migrated/moved from the study area|0|||
161820923|NCT00202839|584385746|FG001|Overall Study|Withdrawal by Subject|2|||
161820924|NCT00202839|584385745|FG000|Overall Study|Protocol Violation|2|||
161820925|NCT00202839|584385746|FG001|Overall Study|Protocol Violation|1|||
161820926|NCT00202839|584385745|FG000|Overall Study|Lost to Follow-up|3|||
161820927|NCT00202839|584385746|FG001|Overall Study|Lost to Follow-up|2|||
161820928|NCT01662024|584385749|FG000|Overall Study|Pregnancy|2|||
161820929|NCT01662024|584385749|FG000|Overall Study|Withdrawal by Subject|3|||
161820930|NCT01490190|584385753|FG000|Overall Study|Withdrawal by Subject|9|||
161820931|NCT01490190|584385753|FG000|Overall Study|Adverse Event|17|||
161820932|NCT01490190|584385753|FG000|Overall Study|Protocol Violation|5|||
161820933|NCT01490190|584385753|FG000|Overall Study|Lost to Follow-up|13|||
161820934|NCT01490190|584385753|FG000|Overall Study|Relocation|1|||
161820935|NCT01490190|584385753|FG000|Overall Study|Inconvenience|1|||
161820936|NCT01490190|584385753|FG000|Overall Study|Ring expulsion|2|||
161820937|NCT02483416|584385756|FG000|Overall Study|Other reason|0|||
161820938|NCT02483416|584385757|FG001|Overall Study|Other reason|1|||
162199536|NCT00296504|585781182|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
162199537|NCT00296504|585781183|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
162199538|NCT00296504|585781184|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
162199539|NCT00296504|585781185|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
162199540|NCT00296504|585781177|FG000|Interim Analysis|Participant Moved|1|||
162199541|NCT00296504|585781178|FG001|Interim Analysis|Participant Moved|0|||
162199542|NCT00296504|585781179|FG002|Interim Analysis|Participant Moved|1|||
162199543|NCT00296504|585781180|FG003|Interim Analysis|Participant Moved|0|||
161820939|NCT02483416|584385756|FG000|Overall Study|Treatment stop|3|||
161820940|NCT02483416|584385757|FG001|Overall Study|Treatment stop|0|||
162199544|NCT00296504|585781181|FG004|Interim Analysis|Participant Moved|0|||
161820941|NCT00969124|584385760|FG000|Overall Study|Protocol Violation|2|||
161820942|NCT00969124|584385760|FG000|Overall Study|Inadequate bowel preparation|15|||
162199545|NCT00296504|585781182|FG005|Interim Analysis|Participant Moved|1|||
161676189|NCT05975840|583867324|FG006|Overall Study|Migrated/moved from the study area|0|||
161676190|NCT05975840|583867325|FG007|Overall Study|Migrated/moved from the study area|0|||
162199546|NCT00296504|585781183|FG006|Interim Analysis|Participant Moved|1|||
162199547|NCT00296504|585781184|FG007|Interim Analysis|Participant Moved|0|||
162199548|NCT00296504|585781185|FG008|Interim Analysis|Participant Moved|0|||
162199549|NCT00296504|585781177|FG000|Interim Analysis|Participant Was Incarcerated|2|||
162199550|NCT00296504|585781178|FG001|Interim Analysis|Participant Was Incarcerated|0|||
162199551|NCT00296504|585781179|FG002|Interim Analysis|Participant Was Incarcerated|1|||
162199552|NCT00296504|585781180|FG003|Interim Analysis|Participant Was Incarcerated|0|||
162199553|NCT00296504|585781181|FG004|Interim Analysis|Participant Was Incarcerated|0|||
162199554|NCT00296504|585781182|FG005|Interim Analysis|Participant Was Incarcerated|0|||
162199555|NCT00296504|585781183|FG006|Interim Analysis|Participant Was Incarcerated|0|||
162199556|NCT00296504|585781184|FG007|Interim Analysis|Participant Was Incarcerated|0|||
162199557|NCT00296504|585781185|FG008|Interim Analysis|Participant Was Incarcerated|0|||
162199558|NCT00296504|585781177|FG000|Interim Analysis|Resistance to FPV|0|||
162199559|NCT00296504|585781178|FG001|Interim Analysis|Resistance to FPV|0|||
162199560|NCT00296504|585781179|FG002|Interim Analysis|Resistance to FPV|1|||
162199561|NCT00296504|585781180|FG003|Interim Analysis|Resistance to FPV|0|||
162199562|NCT00296504|585781181|FG004|Interim Analysis|Resistance to FPV|0|||
162199563|NCT00296504|585781182|FG005|Interim Analysis|Resistance to FPV|0|||
162199564|NCT00296504|585781183|FG006|Interim Analysis|Resistance to FPV|0|||
162199565|NCT00296504|585781184|FG007|Interim Analysis|Resistance to FPV|0|||
162199566|NCT00296504|585781185|FG008|Interim Analysis|Resistance to FPV|0|||
162199567|NCT00296504|585781177|FG000|Interim Analysis|Physician Decision|0|||
162199568|NCT00296504|585781178|FG001|Interim Analysis|Physician Decision|0|||
162199569|NCT00296504|585781179|FG002|Interim Analysis|Physician Decision|1|||
162199570|NCT00296504|585781180|FG003|Interim Analysis|Physician Decision|0|||
162199571|NCT00296504|585781181|FG004|Interim Analysis|Physician Decision|0|||
162199572|NCT00296504|585781182|FG005|Interim Analysis|Physician Decision|0|||
162199573|NCT00296504|585781183|FG006|Interim Analysis|Physician Decision|0|||
162199574|NCT00296504|585781184|FG007|Interim Analysis|Physician Decision|0|||
162199575|NCT00296504|585781185|FG008|Interim Analysis|Physician Decision|0|||
162199576|NCT00296504|585781177|FG000|Interim Analysis|Principle Investigator Discretion|2|||
162199577|NCT00296504|585781178|FG001|Interim Analysis|Principle Investigator Discretion|0|||
162199578|NCT00296504|585781179|FG002|Interim Analysis|Principle Investigator Discretion|1|||
162199579|NCT00296504|585781180|FG003|Interim Analysis|Principle Investigator Discretion|1|||
162199580|NCT00296504|585781181|FG004|Interim Analysis|Principle Investigator Discretion|0|||
162199581|NCT00296504|585781182|FG005|Interim Analysis|Principle Investigator Discretion|0|||
162199582|NCT00296504|585781183|FG006|Interim Analysis|Principle Investigator Discretion|0|||
162199583|NCT00296504|585781184|FG007|Interim Analysis|Principle Investigator Discretion|0|||
162199584|NCT00296504|585781185|FG008|Interim Analysis|Principle Investigator Discretion|0|||
162199585|NCT00296504|585781177|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
162199586|NCT00296504|585781178|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
162199587|NCT00296504|585781179|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
162199588|NCT00296504|585781180|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
162199589|NCT00296504|585781181|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
162199590|NCT00296504|585781182|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
162199591|NCT00296504|585781183|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
162199592|NCT00296504|585781184|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
162199593|NCT00296504|585781185|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
162199594|NCT00296504|585781177|FG000|Interim Analysis|Non-adherence|2|||
162199595|NCT00296504|585781178|FG001|Interim Analysis|Non-adherence|0|||
162199596|NCT00296504|585781179|FG002|Interim Analysis|Non-adherence|0|||
162199597|NCT00296504|585781180|FG003|Interim Analysis|Non-adherence|0|||
162199598|NCT00296504|585781181|FG004|Interim Analysis|Non-adherence|1|||
162199599|NCT00296504|585781182|FG005|Interim Analysis|Non-adherence|0|||
162199600|NCT00296504|585781183|FG006|Interim Analysis|Non-adherence|0|||
161676191|NCT05975840|583867318|FG000|Overall Study|Withdrawal by Subject|0|||
161927094|NCT01967277|584780248|FG001|Overall Study|Unrelated illness|1|||
162199601|NCT00296504|585781184|FG007|Interim Analysis|Non-adherence|1|||
162199602|NCT00296504|585781185|FG008|Interim Analysis|Non-adherence|0|||
162199603|NCT00296504|585781177|FG000|Interim Analysis|Site Closing|1|||
162199604|NCT00296504|585781178|FG001|Interim Analysis|Site Closing|0|||
162199605|NCT00296504|585781179|FG002|Interim Analysis|Site Closing|0|||
162199606|NCT00296504|585781180|FG003|Interim Analysis|Site Closing|0|||
162199607|NCT00296504|585781181|FG004|Interim Analysis|Site Closing|0|||
162199608|NCT00296504|585781182|FG005|Interim Analysis|Site Closing|1|||
162199609|NCT00296504|585781183|FG006|Interim Analysis|Site Closing|2|||
162199610|NCT00296504|585781184|FG007|Interim Analysis|Site Closing|0|||
162199611|NCT00296504|585781185|FG008|Interim Analysis|Site Closing|0|||
162199612|NCT00296504|585781177|FG000|Interim Analysis|Lack of Personnel at Site|1|||
162199613|NCT00296504|585781178|FG001|Interim Analysis|Lack of Personnel at Site|0|||
162020684|NCT00494676|585130583|FG001|Second Intervention|Withdrawal by Subject|1|||
162020685|NCT02621151|585130584|FG000|Overall Study|Not eligible for trial|6|||
162020686|NCT04073225|585130585|FG000|Overall Study|Lost to Follow-up|4|||
162020687|NCT04073225|585130586|FG001|Overall Study|Lost to Follow-up|3|||
162020688|NCT04238819|585130592|FG000|Overall Study|Ongoing Treatment|0|||
162020689|NCT04238819|585130593|FG001|Overall Study|Ongoing Treatment|0|||
162020690|NCT04238819|585130594|FG002|Overall Study|Ongoing Treatment|0|||
162020691|NCT04238819|585130595|FG003|Overall Study|Ongoing Treatment|0|||
162020692|NCT04238819|585130596|FG004|Overall Study|Ongoing Treatment|1|||
162020693|NCT04238819|585130597|FG005|Overall Study|Ongoing Treatment|4|||
162020694|NCT04238819|585130598|FG006|Overall Study|Ongoing Treatment|0|||
162020695|NCT04238819|585130592|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
162020696|NCT04238819|585130593|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
162020697|NCT04238819|585130594|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
162020698|NCT04238819|585130595|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
162020699|NCT04238819|585130596|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
162020700|NCT04238819|585130597|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
162020701|NCT04238819|585130598|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
162020702|NCT04236141|585132003|FG000|Overall Study|Death|18|||
162020703|NCT04236141|585132004|FG001|Overall Study|Death|10|||
162020704|NCT04236141|585132003|FG000|Overall Study|Withdrawal by Participant|1|||
162020705|NCT04236141|585132004|FG001|Overall Study|Withdrawal by Participant|0|||
162020706|NCT04236141|585132003|FG000|Overall Study|Reason not Specified|1|||
162020707|NCT04236141|585132004|FG001|Overall Study|Reason not Specified|0|||
162020708|NCT04236141|585132003|FG000|Overall Study|Study terminated by Sponsor|8|||
162020709|NCT04236141|585132004|FG001|Overall Study|Study terminated by Sponsor|4|||
162020710|NCT01657461|585132005|FG000|Overall Study|Death|9|||
162020711|NCT01657461|585132006|FG001|Overall Study|Death|12|||
162020712|NCT01657461|585132005|FG000|Overall Study|Lost to Follow-up|0|||
162020713|NCT01657461|585132006|FG001|Overall Study|Lost to Follow-up|3|||
162020714|NCT01657461|585132005|FG000|Overall Study|Physician Decision|0|||
161820943|NCT00969124|584385760|FG000|Overall Study|Inability to reach cecum|9|||
161820944|NCT00969124|584385760|FG000|Overall Study|Previously unrecognized disease|3|||
161820945|NCT00969124|584385760|FG000|Overall Study|Technical error|1|||
161820946|NCT00210639|584385761|FG000|Overall Study|Lost to Follow-up|37|||
161820947|NCT00210639|584385762|FG001|Overall Study|Lost to Follow-up|29|||
161820948|NCT00210639|584385761|FG000|Overall Study|Withdrawal by Subject|8|||
161820949|NCT00210639|584385762|FG001|Overall Study|Withdrawal by Subject|1|||
161820950|NCT00210639|584385761|FG000|Overall Study|Other|18|||
161820951|NCT00210639|584385762|FG001|Overall Study|Other|12|||
161820952|NCT04697173|584385769|FG000|Overall Study|Withdrawal by Subject|34|||
161820953|NCT04697173|584385770|FG001|Overall Study|Withdrawal by Subject|38|||
161820954|NCT03277248|584385775|FG000|Overall Study|Adverse Event|3|||
161820955|NCT03277248|584385776|FG001|Overall Study|Adverse Event|1|||
161820956|NCT03277248|584385775|FG000|Overall Study|Subject Withdrawal of Consent|6|||
161820957|NCT03277248|584385776|FG001|Overall Study|Subject Withdrawal of Consent|23|||
161820958|NCT03277248|584385775|FG000|Overall Study|Investigator/Sponsor Decision|2|||
161820959|NCT03277248|584385776|FG001|Overall Study|Investigator/Sponsor Decision|2|||
161820960|NCT03277248|584385775|FG000|Overall Study|Pregnancy|4|||
161820961|NCT03277248|584385776|FG001|Overall Study|Pregnancy|1|||
161820962|NCT03277248|584385775|FG000|Overall Study|Lost to Follow-up|0|||
161820963|NCT03277248|584385776|FG001|Overall Study|Lost to Follow-up|2|||
161820964|NCT03277248|584385775|FG000|Overall Study|Lack of Efficacy|0|||
161820965|NCT03277248|584385776|FG001|Overall Study|Lack of Efficacy|2|||
161820966|NCT03277248|584385775|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
162020715|NCT01657461|585132006|FG001|Overall Study|Physician Decision|2|||
162020716|NCT01657461|585132005|FG000|Overall Study|Withdrawal by Subject|1|||
162020717|NCT01657461|585132006|FG001|Overall Study|Withdrawal by Subject|3|||
162020718|NCT00130247|585132007|FG000|Overall Study|Pregnancy|1|||
162020719|NCT00130247|585132008|FG001|Overall Study|Pregnancy|0|||
161820967|NCT03277248|584385776|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
162199614|NCT00296504|585781179|FG002|Interim Analysis|Lack of Personnel at Site|0|||
162199615|NCT00296504|585781180|FG003|Interim Analysis|Lack of Personnel at Site|0|||
162199616|NCT00296504|585781181|FG004|Interim Analysis|Lack of Personnel at Site|0|||
162199617|NCT00296504|585781182|FG005|Interim Analysis|Lack of Personnel at Site|0|||
162199618|NCT00296504|585781183|FG006|Interim Analysis|Lack of Personnel at Site|0|||
162199619|NCT00296504|585781184|FG007|Interim Analysis|Lack of Personnel at Site|0|||
162199620|NCT00296504|585781185|FG008|Interim Analysis|Lack of Personnel at Site|0|||
162199621|NCT00296504|585781177|FG000|Interim Analysis|Missed Schedule Date|1|||
162199622|NCT00296504|585781178|FG001|Interim Analysis|Missed Schedule Date|0|||
162199623|NCT00296504|585781179|FG002|Interim Analysis|Missed Schedule Date|0|||
162199624|NCT00296504|585781180|FG003|Interim Analysis|Missed Schedule Date|0|||
162199625|NCT00296504|585781181|FG004|Interim Analysis|Missed Schedule Date|0|||
162199626|NCT00296504|585781182|FG005|Interim Analysis|Missed Schedule Date|0|||
162199627|NCT00296504|585781183|FG006|Interim Analysis|Missed Schedule Date|0|||
162199628|NCT00296504|585781184|FG007|Interim Analysis|Missed Schedule Date|0|||
162199629|NCT00296504|585781185|FG008|Interim Analysis|Missed Schedule Date|0|||
162199630|NCT00296504|585781177|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
162199631|NCT00296504|585781178|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
162199632|NCT00296504|585781179|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
162199633|NCT00296504|585781180|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
162199634|NCT00296504|585781181|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
162199635|NCT00296504|585781182|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
162199636|NCT00296504|585781183|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
162199637|NCT00296504|585781184|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
162199638|NCT00296504|585781185|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
162199639|NCT00296504|585781177|FG000|Interim Analysis|Participant Stopped|0|||
162199640|NCT00296504|585781178|FG001|Interim Analysis|Participant Stopped|0|||
162199641|NCT00296504|585781179|FG002|Interim Analysis|Participant Stopped|0|||
162199642|NCT00296504|585781180|FG003|Interim Analysis|Participant Stopped|0|||
162199643|NCT00296504|585781181|FG004|Interim Analysis|Participant Stopped|1|||
162199644|NCT00296504|585781182|FG005|Interim Analysis|Participant Stopped|0|||
162199645|NCT00296504|585781183|FG006|Interim Analysis|Participant Stopped|0|||
162199646|NCT00296504|585781184|FG007|Interim Analysis|Participant Stopped|0|||
162199647|NCT00296504|585781185|FG008|Interim Analysis|Participant Stopped|0|||
162199648|NCT00296504|585781177|FG000|Interim Analysis|Physician and Participant Decision|0|||
162199649|NCT00296504|585781178|FG001|Interim Analysis|Physician and Participant Decision|0|||
162199650|NCT00296504|585781179|FG002|Interim Analysis|Physician and Participant Decision|0|||
162199651|NCT00296504|585781180|FG003|Interim Analysis|Physician and Participant Decision|0|||
162199652|NCT00296504|585781181|FG004|Interim Analysis|Physician and Participant Decision|0|||
162199653|NCT00296504|585781182|FG005|Interim Analysis|Physician and Participant Decision|1|||
162199654|NCT00296504|585781183|FG006|Interim Analysis|Physician and Participant Decision|0|||
162199655|NCT00296504|585781184|FG007|Interim Analysis|Physician and Participant Decision|0|||
162199656|NCT00296504|585781185|FG008|Interim Analysis|Physician and Participant Decision|0|||
162199657|NCT00296504|585781177|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
162199658|NCT00296504|585781178|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
162199659|NCT00296504|585781179|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
162199660|NCT00296504|585781180|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
162199661|NCT00296504|585781181|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
162199662|NCT00296504|585781182|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
162199663|NCT00296504|585781183|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
162199664|NCT00296504|585781184|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
162199665|NCT00296504|585781185|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
162199666|NCT00296504|585781177|FG000|Interim Analysis|Study Ended|0|||
162199667|NCT00296504|585781178|FG001|Interim Analysis|Study Ended|0|||
162199668|NCT00296504|585781179|FG002|Interim Analysis|Study Ended|0|||
162199669|NCT00296504|585781180|FG003|Interim Analysis|Study Ended|0|||
162199670|NCT00296504|585781181|FG004|Interim Analysis|Study Ended|0|||
162199671|NCT00296504|585781182|FG005|Interim Analysis|Study Ended|0|||
162199672|NCT00296504|585781183|FG006|Interim Analysis|Study Ended|1|||
162199673|NCT00296504|585781184|FG007|Interim Analysis|Study Ended|0|||
162199674|NCT00296504|585781185|FG008|Interim Analysis|Study Ended|0|||
162199675|NCT00296504|585781177|FG000|Interim Analysis|Participant Needed Interferon|0|||
162199676|NCT00296504|585781178|FG001|Interim Analysis|Participant Needed Interferon|0|||
162199677|NCT00296504|585781179|FG002|Interim Analysis|Participant Needed Interferon|0|||
162199678|NCT00296504|585781180|FG003|Interim Analysis|Participant Needed Interferon|0|||
161820968|NCT01993940|584385777|FG000|Overall Study|Adverse Event|16|||
162199679|NCT00296504|585781181|FG004|Interim Analysis|Participant Needed Interferon|0|||
162199680|NCT00296504|585781182|FG005|Interim Analysis|Participant Needed Interferon|0|||
162199681|NCT00296504|585781183|FG006|Interim Analysis|Participant Needed Interferon|0|||
161820969|NCT01993940|584385778|FG001|Overall Study|Adverse Event|11|||
161820970|NCT01993940|584385777|FG000|Overall Study|Withdrawal by Subject|15|||
162199682|NCT00296504|585781184|FG007|Interim Analysis|Participant Needed Interferon|1|||
162199683|NCT00296504|585781185|FG008|Interim Analysis|Participant Needed Interferon|0|||
162199684|NCT00296504|585781177|FG000|Interim Analysis|Ongoing|32|||
162199685|NCT00296504|585781178|FG001|Interim Analysis|Ongoing|12|||
162199686|NCT00296504|585781179|FG002|Interim Analysis|Ongoing|16|||
162199687|NCT00296504|585781180|FG003|Interim Analysis|Ongoing|22|||
162199688|NCT00296504|585781181|FG004|Interim Analysis|Ongoing|0|||
162199689|NCT00296504|585781182|FG005|Interim Analysis|Ongoing|0|||
162199690|NCT00296504|585781183|FG006|Interim Analysis|Ongoing|30|||
162199691|NCT00296504|585781184|FG007|Interim Analysis|Ongoing|1|||
162199692|NCT00296504|585781185|FG008|Interim Analysis|Ongoing|0|||
162199693|NCT00296504|585781177|FG000|Final Analysis|Withdrawal by Subject|0|||
161927095|NCT00585585|584780253|FG000|Overall Study|Adverse Event|1|||
161927096|NCT01964560|584780258|FG000|Overall Study|Adverse Event|23|||
161927097|NCT01964560|584780258|FG000|Overall Study|Lack of Efficacy|46|||
161927098|NCT01964560|584780258|FG000|Overall Study|Protocol deviation|2|||
161927099|NCT01964560|584780258|FG000|Overall Study|Lost to Follow-up|4|||
161927100|NCT01964560|584780258|FG000|Overall Study|Withdrawal by Subject|64|||
161927101|NCT01964560|584780258|FG000|Overall Study|Surgery-hemispherotomy|1|||
161927102|NCT01964560|584780258|FG000|Overall Study|Surgery|1|||
161927103|NCT01964560|584780258|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
161927104|NCT01964560|584780258|FG000|Overall Study|Patient and Investigator choice|1|||
161927105|NCT01964560|584780258|FG000|Overall Study|Patient was prescribed CBD|1|||
161927106|NCT01964560|584780258|FG000|Overall Study|Participant moved to another country|1|||
161927107|NCT02384460|584780274|FG000|Overall Study|Protocol Violation|0|||
161927108|NCT02384460|584780275|FG001|Overall Study|Protocol Violation|1|||
161927109|NCT02384460|584780274|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
161927110|NCT02384460|584780275|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
161927111|NCT02384460|584780274|FG000|Overall Study|Adverse Event|5|||
161927112|NCT02384460|584780275|FG001|Overall Study|Adverse Event|2|||
161927113|NCT02384460|584780274|FG000|Overall Study|Withdrawal by Subject|0|||
162199694|NCT00296504|585781178|FG001|Final Analysis|Withdrawal by Subject|0|||
162199695|NCT00296504|585781179|FG002|Final Analysis|Withdrawal by Subject|0|||
162199696|NCT00296504|585781180|FG003|Final Analysis|Withdrawal by Subject|0|||
162199697|NCT00296504|585781181|FG004|Final Analysis|Withdrawal by Subject|0|||
162199698|NCT00296504|585781182|FG005|Final Analysis|Withdrawal by Subject|0|||
162199699|NCT00296504|585781183|FG006|Final Analysis|Withdrawal by Subject|0|||
162199700|NCT00296504|585781184|FG007|Final Analysis|Withdrawal by Subject|0|||
162199701|NCT00296504|585781185|FG008|Final Analysis|Withdrawal by Subject|1|||
162199702|NCT00296504|585781177|FG000|Final Analysis|Lost to Follow-up|0|||
162199703|NCT00296504|585781178|FG001|Final Analysis|Lost to Follow-up|0|||
162199704|NCT00296504|585781179|FG002|Final Analysis|Lost to Follow-up|0|||
162199705|NCT00296504|585781180|FG003|Final Analysis|Lost to Follow-up|0|||
162199706|NCT00296504|585781181|FG004|Final Analysis|Lost to Follow-up|0|||
162199707|NCT00296504|585781182|FG005|Final Analysis|Lost to Follow-up|0|||
162199708|NCT00296504|585781183|FG006|Final Analysis|Lost to Follow-up|0|||
162199709|NCT00296504|585781184|FG007|Final Analysis|Lost to Follow-up|0|||
162199710|NCT00296504|585781185|FG008|Final Analysis|Lost to Follow-up|5|||
162199711|NCT00296504|585781177|FG000|Final Analysis|Insufficient Viral Load Response|0|||
162199712|NCT00296504|585781178|FG001|Final Analysis|Insufficient Viral Load Response|0|||
162199713|NCT00296504|585781179|FG002|Final Analysis|Insufficient Viral Load Response|0|||
162199714|NCT00296504|585781180|FG003|Final Analysis|Insufficient Viral Load Response|0|||
162199715|NCT00296504|585781181|FG004|Final Analysis|Insufficient Viral Load Response|0|||
162199716|NCT00296504|585781182|FG005|Final Analysis|Insufficient Viral Load Response|0|||
162199717|NCT00296504|585781183|FG006|Final Analysis|Insufficient Viral Load Response|0|||
161927114|NCT02384460|584780275|FG001|Overall Study|Withdrawal by Subject|3|||
161927115|NCT02384460|584780274|FG000|Overall Study|Elective medical treatment|1|||
161927116|NCT02384460|584780275|FG001|Overall Study|Elective medical treatment|0|||
161927117|NCT02384460|584780274|FG000|Overall Study|Non-compliance|1|||
161927118|NCT02384460|584780275|FG001|Overall Study|Non-compliance|0|||
161927119|NCT02301429|584780279|FG000|Overall Study|not acceptable vascular anatomy|3|||
161927120|NCT02217982|584780281|FG000|Overall Study|Trial discontinued|1|||
161927121|NCT02217982|584780282|FG001|Overall Study|Trial discontinued|0|||
162199718|NCT00296504|585781184|FG007|Final Analysis|Insufficient Viral Load Response|0|||
162199719|NCT00296504|585781185|FG008|Final Analysis|Insufficient Viral Load Response|6|||
162199720|NCT00296504|585781177|FG000|Final Analysis|Adverse Event|0|||
162199721|NCT00296504|585781178|FG001|Final Analysis|Adverse Event|0|||
162199722|NCT00296504|585781179|FG002|Final Analysis|Adverse Event|0|||
162199723|NCT00296504|585781180|FG003|Final Analysis|Adverse Event|0|||
162199724|NCT00296504|585781181|FG004|Final Analysis|Adverse Event|0|||
162199725|NCT00296504|585781182|FG005|Final Analysis|Adverse Event|0|||
161927122|NCT02217982|584780281|FG000|Overall Study|Adverse Event|0|||
161927123|NCT02217982|584780282|FG001|Overall Study|Adverse Event|1|||
161927124|NCT01279200|584780289|FG000|Overall Study|Withdrawal by Subject|1|||
161927125|NCT01279200|584780290|FG001|Overall Study|Withdrawal by Subject|3|||
162199726|NCT00296504|585781183|FG006|Final Analysis|Adverse Event|0|||
162199727|NCT00296504|585781184|FG007|Final Analysis|Adverse Event|0|||
162199728|NCT00296504|585781185|FG008|Final Analysis|Adverse Event|2|||
162199729|NCT00296504|585781177|FG000|Final Analysis|Pregnancy|0|||
162199730|NCT00296504|585781178|FG001|Final Analysis|Pregnancy|0|||
162199731|NCT00296504|585781179|FG002|Final Analysis|Pregnancy|0|||
162199732|NCT00296504|585781180|FG003|Final Analysis|Pregnancy|0|||
162199733|NCT00296504|585781181|FG004|Final Analysis|Pregnancy|0|||
162199734|NCT00296504|585781182|FG005|Final Analysis|Pregnancy|0|||
162199735|NCT00296504|585781183|FG006|Final Analysis|Pregnancy|0|||
162199736|NCT00296504|585781184|FG007|Final Analysis|Pregnancy|0|||
162199737|NCT00296504|585781185|FG008|Final Analysis|Pregnancy|4|||
162199738|NCT00296504|585781177|FG000|Final Analysis|Tuberculosis|0|||
162199739|NCT00296504|585781178|FG001|Final Analysis|Tuberculosis|0|||
162199740|NCT00296504|585781179|FG002|Final Analysis|Tuberculosis|0|||
162199741|NCT00296504|585781180|FG003|Final Analysis|Tuberculosis|0|||
162199742|NCT00296504|585781181|FG004|Final Analysis|Tuberculosis|0|||
162199743|NCT00296504|585781182|FG005|Final Analysis|Tuberculosis|0|||
162199744|NCT00296504|585781183|FG006|Final Analysis|Tuberculosis|0|||
162199745|NCT00296504|585781184|FG007|Final Analysis|Tuberculosis|0|||
161927126|NCT01279200|584780289|FG000|Overall Study|Patient withdrawal due to high cost|0|||
161927127|NCT01279200|584780290|FG001|Overall Study|Patient withdrawal due to high cost|1|||
161927128|NCT01279200|584780289|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
161927129|NCT01279200|584780290|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
161927130|NCT01279200|584780289|FG000|Overall Study|ultrasound screening failure|0|||
161927131|NCT01279200|584780290|FG001|Overall Study|ultrasound screening failure|1|||
161927132|NCT01279200|584780289|FG000|Overall Study|Lost to Follow-up|0|||
161927133|NCT01279200|584780290|FG001|Overall Study|Lost to Follow-up|1|||
161927134|NCT01279200|584780289|FG000|Overall Study|Adverse Event|1|||
161927135|NCT01279200|584780290|FG001|Overall Study|Adverse Event|0|||
161927136|NCT01399099|584780291|FG000|Overall Study|Lost to Follow-up|14|||
161927137|NCT01399099|584780291|FG000|Overall Study|Physician Decision|1|||
161927138|NCT01399099|584780291|FG000|Overall Study|Protocol Violation|1|||
161927139|NCT01399099|584780291|FG000|Overall Study|Skin Irritation|13|||
161927140|NCT01399099|584780291|FG000|Overall Study|Infection|1|||
162020720|NCT00130247|585132007|FG000|Overall Study|Post-randomization exclusion|1|||
162020721|NCT00130247|585132008|FG001|Overall Study|Post-randomization exclusion|2|||
161676192|NCT05975840|583867319|FG001|Overall Study|Withdrawal by Subject|5|||
161927141|NCT01399099|584780291|FG000|Overall Study|Miscellaneous|4|||
161927142|NCT01179516|584780292|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
161927143|NCT01179516|584780293|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
162199746|NCT00296504|585781185|FG008|Final Analysis|Tuberculosis|1|||
162199747|NCT00296504|585781177|FG000|Final Analysis|Participant Moved to Another Country|0|||
162199748|NCT00296504|585781178|FG001|Final Analysis|Participant Moved to Another Country|0|||
162199749|NCT00296504|585781179|FG002|Final Analysis|Participant Moved to Another Country|0|||
162199750|NCT00296504|585781180|FG003|Final Analysis|Participant Moved to Another Country|0|||
162199751|NCT00296504|585781181|FG004|Final Analysis|Participant Moved to Another Country|0|||
162199752|NCT00296504|585781182|FG005|Final Analysis|Participant Moved to Another Country|0|||
162199753|NCT00296504|585781183|FG006|Final Analysis|Participant Moved to Another Country|0|||
162199754|NCT00296504|585781184|FG007|Final Analysis|Participant Moved to Another Country|0|||
162199755|NCT00296504|585781185|FG008|Final Analysis|Participant Moved to Another Country|1|||
162199756|NCT00296504|585781177|FG000|Final Analysis|Poor Adherence|0|||
162199757|NCT00296504|585781178|FG001|Final Analysis|Poor Adherence|0|||
162199758|NCT00296504|585781179|FG002|Final Analysis|Poor Adherence|0|||
162199759|NCT00296504|585781180|FG003|Final Analysis|Poor Adherence|0|||
162199760|NCT00296504|585781181|FG004|Final Analysis|Poor Adherence|0|||
162199761|NCT00296504|585781182|FG005|Final Analysis|Poor Adherence|0|||
162199762|NCT00296504|585781183|FG006|Final Analysis|Poor Adherence|0|||
162199763|NCT00296504|585781184|FG007|Final Analysis|Poor Adherence|0|||
162199764|NCT00296504|585781185|FG008|Final Analysis|Poor Adherence|1|||
162199765|NCT02162771|585781186|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
162199766|NCT02162771|585781187|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
162199767|NCT02162771|585781186|FG000|Core Study Period (Part 2)|Adverse Event|4|||
162199768|NCT02162771|585781187|FG001|Core Study Period (Part 2)|Adverse Event|1|||
162199769|NCT02162771|585781186|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
162199770|NCT02162771|585781187|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
162199771|NCT02162771|585781186|FG000|Core Study Period (Part 2)|Physician Decision|0|||
162199772|NCT02162771|585781187|FG001|Core Study Period (Part 2)|Physician Decision|2|||
162199773|NCT02162771|585781186|FG000|Core Study Period (Part 2)|Death|1|||
162199774|NCT02162771|585781187|FG001|Core Study Period (Part 2)|Death|0|||
162199775|NCT02162771|585781186|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
162199776|NCT02162771|585781187|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
162199777|NCT02162771|585781186|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
162199778|NCT02162771|585781187|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
162199779|NCT02162771|585781186|FG000|Maintenance Study Period (Part 2)|Death|2|||
162199780|NCT02162771|585781187|FG001|Maintenance Study Period (Part 2)|Death|1|||
162199781|NCT02162771|585781186|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
162199782|NCT02162771|585781187|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
162199783|NCT02162771|585781186|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
162199784|NCT02162771|585781187|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
162199785|NCT02162771|585781186|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
162199786|NCT02162771|585781187|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
162199787|NCT01078571|585781191|FG000|Overall Study|Adverse Event|36|||
162199788|NCT01078571|585781191|FG000|Overall Study|Lack of effectiveness|36|||
162199789|NCT01078571|585781191|FG000|Overall Study|Reason not reported|21|||
162199790|NCT01078571|585781191|FG000|Overall Study|Withdrawal by Subject|12|||
162199791|NCT01078571|585781191|FG000|Overall Study|Lost to Follow-up|8|||
162199792|NCT01078571|585781191|FG000|Overall Study|Protocol Violation|2|||
162199793|NCT01047306|585781197|FG000|Overall Study|Withdrawal by Subject|2|||
162199794|NCT01047306|585781198|FG001|Overall Study|Withdrawal by Subject|0|||
162199795|NCT01047306|585781197|FG000|Overall Study|Lost to Follow-up|1|||
162199796|NCT01047306|585781198|FG001|Overall Study|Lost to Follow-up|0|||
162199797|NCT01878253|585781199|FG000|Overall Study|Death|1|||
162199798|NCT01878253|585781199|FG000|Overall Study|SIdus System Removal|3|||
162199799|NCT01878253|585781199|FG000|Overall Study|Withdrawal by Subject|1|||
162199800|NCT01878253|585781199|FG000|Overall Study|Lost to Follow-up|2|||
161820971|NCT01993940|584385778|FG001|Overall Study|Withdrawal by Subject|19|||
161820972|NCT01993940|584385777|FG000|Overall Study|Lost to Follow-up|2|||
161820973|NCT01993940|584385778|FG001|Overall Study|Lost to Follow-up|5|||
161820974|NCT01993940|584385777|FG000|Overall Study|Protocol Violation|5|||
162199801|NCT01878253|585781199|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
162199802|NCT00449033|585781204|FG000|Treatment Period|Adverse Event|117|||
162199803|NCT00449033|585781205|FG001|Treatment Period|Adverse Event|83|||
162199804|NCT00449033|585781204|FG000|Treatment Period|Death|21|||
162199805|NCT00449033|585781205|FG001|Treatment Period|Death|12|||
162199806|NCT00449033|585781204|FG000|Treatment Period|Lost to Follow-up|0|||
162199807|NCT00449033|585781205|FG001|Treatment Period|Lost to Follow-up|2|||
162199808|NCT00449033|585781204|FG000|Treatment Period|Physician Decision|4|||
162199809|NCT00449033|585781205|FG001|Treatment Period|Physician Decision|5|||
162020722|NCT00130247|585132007|FG000|Overall Study|Not compliant with DOT|0|||
162199810|NCT00449033|585781204|FG000|Treatment Period|Protocol Violation|8|||
162199811|NCT00449033|585781205|FG001|Treatment Period|Protocol Violation|7|||
162199812|NCT00449033|585781204|FG000|Treatment Period|Disease Progression|231|||
162199813|NCT00449033|585781205|FG001|Treatment Period|Disease Progression|288|||
162199814|NCT00449033|585781204|FG000|Treatment Period|Consent Withdrawn|36|||
162199815|NCT00449033|585781205|FG001|Treatment Period|Consent Withdrawn|20|||
162020723|NCT00130247|585132008|FG001|Overall Study|Not compliant with DOT|2|||
162199816|NCT00449033|585781204|FG000|Treatment Period|Amended Protocol Criteria|22|||
162199817|NCT00449033|585781205|FG001|Treatment Period|Amended Protocol Criteria|18|||
162199818|NCT00449033|585781204|FG000|Treatment Period|Non-compliance|7|||
162199819|NCT00449033|585781205|FG001|Treatment Period|Non-compliance|8|||
162199820|NCT00449033|585781204|FG000|Treatment Period|Second Malignancy|0|||
162199821|NCT00449033|585781205|FG001|Treatment Period|Second Malignancy|1|||
162199822|NCT00449033|585781204|FG000|Treatment Period|Reason Missing|0|||
162199823|NCT00449033|585781205|FG001|Treatment Period|Reason Missing|4|||
162199824|NCT00449033|585781204|FG000|Treatment Period|Treatment Ongoing|6|||
162199825|NCT00449033|585781205|FG001|Treatment Period|Treatment Ongoing|4|||
162199826|NCT00449033|585781204|FG000|Follow-up Period|Death|299|||
162199827|NCT00449033|585781205|FG001|Follow-up Period|Death|311|||
162199828|NCT00449033|585781204|FG000|Follow-up Period|Lost to Follow-up|6|||
162199829|NCT00449033|585781205|FG001|Follow-up Period|Lost to Follow-up|10|||
162199830|NCT00449033|585781204|FG000|Follow-up Period|Reason Missing|120|||
162199831|NCT00449033|585781205|FG001|Follow-up Period|Reason Missing|113|||
162199832|NCT04393779|585781208|FG000|Overall Study|Death|1|||
162199833|NCT04393779|585781208|FG000|Overall Study|Device reintervention or explant|4|||
162199834|NCT03802513|585781210|FG000|Overall Study|Lost to Follow-up|1|||
162199835|NCT02849509|585781218|FG000|Overall Study|Worsening of disease under study|1|||
162199836|NCT02849509|585781219|FG001|Overall Study|Worsening of disease under study|1|||
162199837|NCT02849509|585781220|FG002|Overall Study|Worsening of disease under study|1|||
162199838|NCT02849509|585781218|FG000|Overall Study|Worsening of other pre-existing disease|0|||
162199839|NCT02849509|585781219|FG001|Overall Study|Worsening of other pre-existing disease|1|||
162199840|NCT02849509|585781220|FG002|Overall Study|Worsening of other pre-existing disease|2|||
162199841|NCT02849509|585781218|FG000|Overall Study|Other adverse event|36|||
162199842|NCT02849509|585781219|FG001|Overall Study|Other adverse event|41|||
162199843|NCT02849509|585781220|FG002|Overall Study|Other adverse event|8|||
162199844|NCT02849509|585781218|FG000|Overall Study|Withdrawal by Subject|6|||
162199845|NCT02849509|585781219|FG001|Overall Study|Withdrawal by Subject|17|||
162199846|NCT02849509|585781220|FG002|Overall Study|Withdrawal by Subject|12|||
162199847|NCT02849509|585781218|FG000|Overall Study|Lost to Follow-up|27|||
162199848|NCT02849509|585781219|FG001|Overall Study|Lost to Follow-up|67|||
162199849|NCT02849509|585781220|FG002|Overall Study|Lost to Follow-up|36|||
162199850|NCT02849509|585781218|FG000|Overall Study|Other, reason not specified|14|||
162199851|NCT02849509|585781219|FG001|Overall Study|Other, reason not specified|29|||
162199852|NCT02849509|585781220|FG002|Overall Study|Other, reason not specified|25|||
162199853|NCT02849509|585781218|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
162199854|NCT02849509|585781219|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
161820975|NCT01993940|584385778|FG001|Overall Study|Protocol Violation|8|||
161820976|NCT01993940|584385777|FG000|Overall Study|Death|1|||
161820977|NCT01993940|584385778|FG001|Overall Study|Death|0|||
161820978|NCT01993940|584385777|FG000|Overall Study|Other - Miscellaneous|1|||
161820979|NCT01993940|584385778|FG001|Overall Study|Other - Miscellaneous|1|||
161820980|NCT01949532|584385779|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
161820981|NCT01949532|584385780|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
161820982|NCT00379353|584385781|FG000|Overall Study|Hospitalization|3|||
161820983|NCT00379353|584385782|FG001|Overall Study|Hospitalization|3|||
161820984|NCT00379353|584385781|FG000|Overall Study|Withdrawal by Subject|5|||
161820985|NCT00379353|584385782|FG001|Overall Study|Withdrawal by Subject|2|||
161820986|NCT00379353|584385781|FG000|Overall Study|Death|1|||
161820987|NCT00379353|584385782|FG001|Overall Study|Death|0|||
162199855|NCT02849509|585781220|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
162199856|NCT02784535|585781229|FG000|Overall Study|Adverse Event|1|||
162199857|NCT02784535|585781230|FG001|Overall Study|Adverse Event|0|||
162199858|NCT02784535|585781229|FG000|Overall Study|Withdrawal by Subject|0|||
162199859|NCT02784535|585781230|FG001|Overall Study|Withdrawal by Subject|1|||
162199860|NCT02784535|585781229|FG000|Overall Study|Physician Decision|0|||
162199861|NCT02784535|585781230|FG001|Overall Study|Physician Decision|1|||
162199862|NCT05615870|585781234|FG000|Overall Study|Lost to Follow-up|10|||
162199863|NCT05615870|585781235|FG001|Overall Study|Lost to Follow-up|13|||
162199864|NCT05615870|585781234|FG000|Overall Study|Physician Decision|2|||
162199865|NCT05615870|585781235|FG001|Overall Study|Physician Decision|0|||
162199866|NCT05615870|585781234|FG000|Overall Study|Withdrawal by Subject|0|||
162199867|NCT05615870|585781235|FG001|Overall Study|Withdrawal by Subject|2|||
162199868|NCT05615870|585781234|FG000|Overall Study|Protocol Violation|0|||
162199869|NCT05615870|585781235|FG001|Overall Study|Protocol Violation|3|||
162199870|NCT05615870|585781234|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
162199871|NCT05615870|585781235|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
162199872|NCT05615870|585781234|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
162199873|NCT05615870|585781235|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
162199874|NCT05615870|585781234|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
162199875|NCT05615870|585781235|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
162199876|NCT03520036|585781238|FG000|Overall Study|Adverse Event|1|||
162199877|NCT03520036|585781239|FG001|Overall Study|Adverse Event|2|||
162199878|NCT03520036|585781240|FG002|Overall Study|Adverse Event|0|||
162199879|NCT03520036|585781238|FG000|Overall Study|Protocol Violation|1|||
162199880|NCT03520036|585781239|FG001|Overall Study|Protocol Violation|0|||
162199881|NCT03520036|585781240|FG002|Overall Study|Protocol Violation|0|||
162199882|NCT03520036|585781238|FG000|Overall Study|Withdrawal by Subject|0|||
162199883|NCT03520036|585781239|FG001|Overall Study|Withdrawal by Subject|1|||
162199884|NCT03520036|585781240|FG002|Overall Study|Withdrawal by Subject|4|||
162199885|NCT03520036|585781238|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
162199886|NCT03520036|585781239|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
162199887|NCT03520036|585781240|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
162199888|NCT03005106|585781241|FG000|Overall Study|Lost to Follow-up|16|||
162199889|NCT03005106|585781241|FG000|Overall Study|Adverse Event|1|||
162199890|NCT03005106|585781241|FG000|Overall Study|Physician Decision|1|||
162199891|NCT03005106|585781241|FG000|Overall Study|Death|2|||
162199892|NCT01855399|585781242|FG000|6 Month|Lost to Follow-up|12|||
162199893|NCT01855399|585781243|FG001|6 Month|Lost to Follow-up|9|||
162199894|NCT01855399|585781242|FG000|6 Month|Withdrawal by Subject|8|||
162199895|NCT01855399|585781243|FG001|6 Month|Withdrawal by Subject|6|||
162199896|NCT01855399|585781242|FG000|12 Month|Lost to Follow-up|7|||
162199897|NCT01855399|585781243|FG001|12 Month|Lost to Follow-up|11|||
162199898|NCT00321672|585781244|FG000|Overall Study|Withdrawal by Subject|5|||
162199899|NCT00321672|585781245|FG001|Overall Study|Withdrawal by Subject|1|||
162199900|NCT00321672|585781246|FG002|Overall Study|Withdrawal by Subject|2|||
162199901|NCT00321672|585781247|FG003|Overall Study|Withdrawal by Subject|0|||
162199902|NCT00321672|585781244|FG000|Overall Study|Noncompliance|1|||
162199903|NCT00321672|585781245|FG001|Overall Study|Noncompliance|2|||
162199904|NCT00321672|585781246|FG002|Overall Study|Noncompliance|1|||
162199905|NCT00321672|585781247|FG003|Overall Study|Noncompliance|0|||
162199906|NCT00321672|585781244|FG000|Overall Study|Adverse Event|1|||
162199907|NCT00321672|585781245|FG001|Overall Study|Adverse Event|1|||
162199908|NCT00321672|585781246|FG002|Overall Study|Adverse Event|0|||
162199909|NCT00321672|585781247|FG003|Overall Study|Adverse Event|0|||
162199910|NCT00321672|585781244|FG000|Overall Study|Lack of Efficacy|1|||
162199911|NCT00321672|585781245|FG001|Overall Study|Lack of Efficacy|1|||
162199912|NCT00321672|585781246|FG002|Overall Study|Lack of Efficacy|0|||
162199913|NCT00321672|585781247|FG003|Overall Study|Lack of Efficacy|0|||
162199914|NCT00321672|585781244|FG000|Overall Study|Lost to Follow-up|2|||
162199915|NCT00321672|585781245|FG001|Overall Study|Lost to Follow-up|0|||
162199916|NCT00321672|585781246|FG002|Overall Study|Lost to Follow-up|4|||
162199917|NCT00321672|585781247|FG003|Overall Study|Lost to Follow-up|2|||
162199918|NCT00321672|585781244|FG000|Overall Study|Death|1|||
162199919|NCT00321672|585781245|FG001|Overall Study|Death|0|||
162199920|NCT00321672|585781246|FG002|Overall Study|Death|0|||
162199921|NCT00321672|585781247|FG003|Overall Study|Death|0|||
162199922|NCT00321672|585781244|FG000|Overall Study|Too far to travel for visits|1|||
162199923|NCT00321672|585781245|FG001|Overall Study|Too far to travel for visits|0|||
162199924|NCT00321672|585781246|FG002|Overall Study|Too far to travel for visits|0|||
162199925|NCT00321672|585781247|FG003|Overall Study|Too far to travel for visits|0|||
162199926|NCT00321672|585781244|FG000|Overall Study|Incarcerated|0|||
162199927|NCT00321672|585781245|FG001|Overall Study|Incarcerated|0|||
162199928|NCT00321672|585781246|FG002|Overall Study|Incarcerated|2|||
162199929|NCT00321672|585781247|FG003|Overall Study|Incarcerated|0|||
162199930|NCT00321672|585781244|FG000|Overall Study|Moved out of state|0|||
162199931|NCT00321672|585781245|FG001|Overall Study|Moved out of state|1|||
162199932|NCT00321672|585781246|FG002|Overall Study|Moved out of state|1|||
162199933|NCT00321672|585781247|FG003|Overall Study|Moved out of state|0|||
162199934|NCT00321672|585781244|FG000|Overall Study|Protocol Violation|0|||
162199935|NCT00321672|585781245|FG001|Overall Study|Protocol Violation|0|||
162199936|NCT00321672|585781246|FG002|Overall Study|Protocol Violation|1|||
162199937|NCT00321672|585781247|FG003|Overall Study|Protocol Violation|0|||
162199938|NCT00321672|585781244|FG000|Overall Study|Diagnosis of testicular cancer|0|||
162199939|NCT00321672|585781245|FG001|Overall Study|Diagnosis of testicular cancer|1|||
162199940|NCT00321672|585781246|FG002|Overall Study|Diagnosis of testicular cancer|0|||
162199941|NCT00321672|585781247|FG003|Overall Study|Diagnosis of testicular cancer|0|||
162199942|NCT00321672|585781244|FG000|Overall Study|Extensive travel required for new job|0|||
162199943|NCT00321672|585781245|FG001|Overall Study|Extensive travel required for new job|1|||
162199944|NCT00321672|585781246|FG002|Overall Study|Extensive travel required for new job|0|||
162199945|NCT00321672|585781247|FG003|Overall Study|Extensive travel required for new job|0|||
162199946|NCT00512902|585781248|FG000|Overall Study|Adverse Event|7|||
162199947|NCT00512902|585781248|FG000|Overall Study|Lost to Follow-up|1|||
162199948|NCT03019289|585781249|FG000|Overall Study|Adverse Event|1|||
162199949|NCT03019289|585781250|FG001|Overall Study|Adverse Event|0|||
162199950|NCT03019289|585781251|FG002|Overall Study|Adverse Event|0|||
162199951|NCT03019289|585781252|FG003|Overall Study|Adverse Event|0|||
162199952|NCT03019289|585781253|FG004|Overall Study|Adverse Event|0|||
162199953|NCT03019289|585781254|FG005|Overall Study|Adverse Event|0|||
162199954|NCT03019289|585781255|FG006|Overall Study|Adverse Event|0|||
162199955|NCT03019289|585781256|FG007|Overall Study|Adverse Event|0|||
162199956|NCT03019289|585781257|FG008|Overall Study|Adverse Event|1|||
162199957|NCT03019289|585781249|FG000|Overall Study|Other|1|||
162199958|NCT03019289|585781250|FG001|Overall Study|Other|0|||
162199959|NCT03019289|585781251|FG002|Overall Study|Other|0|||
162199960|NCT03019289|585781252|FG003|Overall Study|Other|0|||
162199961|NCT03019289|585781253|FG004|Overall Study|Other|0|||
162199962|NCT03019289|585781254|FG005|Overall Study|Other|0|||
162199963|NCT03019289|585781255|FG006|Overall Study|Other|0|||
162199964|NCT03019289|585781256|FG007|Overall Study|Other|0|||
162199965|NCT03019289|585781257|FG008|Overall Study|Other|0|||
162199966|NCT02389894|585781258|FG000|Overall Study|Death|4|||
162199967|NCT02389894|585781259|FG001|Overall Study|Death|5|||
162199968|NCT02389894|585781260|FG002|Overall Study|Death|3|||
162199969|NCT02389894|585781258|FG000|Overall Study|Withdrawal by Subject|2|||
162199970|NCT02389894|585781259|FG001|Overall Study|Withdrawal by Subject|4|||
162199971|NCT02389894|585781260|FG002|Overall Study|Withdrawal by Subject|5|||
162199972|NCT02389894|585781258|FG000|Overall Study|Lost to Follow-up|2|||
162199973|NCT02389894|585781259|FG001|Overall Study|Lost to Follow-up|1|||
162199974|NCT02389894|585781260|FG002|Overall Study|Lost to Follow-up|1|||
162199975|NCT00145496|585781261|FG000|Overall Study|Adverse Event|42|||
162199976|NCT00145496|585781262|FG001|Overall Study|Adverse Event|30|||
162199977|NCT00145496|585781261|FG000|Overall Study|Lack of Efficacy|12|||
162199978|NCT00145496|585781262|FG001|Overall Study|Lack of Efficacy|7|||
162199979|NCT00145496|585781261|FG000|Overall Study|Withdrawal by Subject|32|||
162199980|NCT00145496|585781262|FG001|Overall Study|Withdrawal by Subject|26|||
162199981|NCT00145496|585781261|FG000|Overall Study|Lost to Follow-up|12|||
162199982|NCT00145496|585781262|FG001|Overall Study|Lost to Follow-up|5|||
162199983|NCT00145496|585781261|FG000|Overall Study|Other|25|||
162199984|NCT00145496|585781262|FG001|Overall Study|Other|13|||
162199985|NCT01429285|585781265|FG000|Overall Study|Protocol Violation|9|||
162199986|NCT01429285|585781266|FG001|Overall Study|Protocol Violation|4|||
162199987|NCT01429285|585781265|FG000|Overall Study|Missing Data|5|||
162199988|NCT01429285|585781266|FG001|Overall Study|Missing Data|3|||
162199989|NCT01429285|585781265|FG000|Overall Study|Erroneously Enrolled Twice|8|||
162199990|NCT01429285|585781266|FG001|Overall Study|Erroneously Enrolled Twice|2|||
162199991|NCT01334606|585781267|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
161676193|NCT05975840|583867320|FG002|Overall Study|Withdrawal by Subject|2|||
161676194|NCT05975840|583867321|FG003|Overall Study|Withdrawal by Subject|2|||
161676195|NCT05975840|583867322|FG004|Overall Study|Withdrawal by Subject|0|||
161676196|NCT05975840|583867323|FG005|Overall Study|Withdrawal by Subject|2|||
161676197|NCT05975840|583867324|FG006|Overall Study|Withdrawal by Subject|2|||
161676198|NCT05975840|583867325|FG007|Overall Study|Withdrawal by Subject|1|||
162199992|NCT02312245|585781268|FG000|Overall Study|Death|0|||
161676199|NCT05975840|583867318|FG000|Overall Study|Protocol Violation|0|||
162020724|NCT01761162|585132013|FG000|Overall Study|Withdrawal by Subject|3|||
162199993|NCT02312245|585781269|FG001|Overall Study|Death|0|||
162199994|NCT02312245|585781270|FG002|Overall Study|Death|0|||
162199995|NCT02312245|585781271|FG003|Overall Study|Death|1|||
162199996|NCT02312245|585781268|FG000|Overall Study|Withdrawal by Subject|1|||
162199997|NCT02312245|585781269|FG001|Overall Study|Withdrawal by Subject|1|||
162199998|NCT02312245|585781270|FG002|Overall Study|Withdrawal by Subject|0|||
162199999|NCT02312245|585781271|FG003|Overall Study|Withdrawal by Subject|2|||
162200000|NCT02312245|585781268|FG000|Overall Study|Alternative Therapy|1|||
162200001|NCT02312245|585781269|FG001|Overall Study|Alternative Therapy|0|||
162200002|NCT02312245|585781270|FG002|Overall Study|Alternative Therapy|0|||
162200003|NCT02312245|585781271|FG003|Overall Study|Alternative Therapy|0|||
162200004|NCT02312245|585781268|FG000|Overall Study|Progression|0|||
162200005|NCT02312245|585781269|FG001|Overall Study|Progression|0|||
162200006|NCT02312245|585781270|FG002|Overall Study|Progression|0|||
162200007|NCT02312245|585781271|FG003|Overall Study|Progression|5|||
162200008|NCT02312245|585781268|FG000|Overall Study|Patient went to hospice|0|||
162200009|NCT02312245|585781269|FG001|Overall Study|Patient went to hospice|0|||
162200010|NCT02312245|585781270|FG002|Overall Study|Patient went to hospice|0|||
162200011|NCT02312245|585781271|FG003|Overall Study|Patient went to hospice|1|||
162200012|NCT02312245|585781268|FG000|Overall Study|Ineligible|1|||
162200013|NCT02312245|585781269|FG001|Overall Study|Ineligible|0|||
162200014|NCT02312245|585781270|FG002|Overall Study|Ineligible|0|||
162200015|NCT02312245|585781271|FG003|Overall Study|Ineligible|0|||
162200016|NCT00990314|585781274|FG000|Overall Study|Death|2|||
162200017|NCT00990314|585781274|FG000|Overall Study|Adverse Event|2|||
162200018|NCT00990314|585781274|FG000|Overall Study|Withdrawal by Subject|3|||
162200019|NCT00990314|585781274|FG000|Overall Study|Non-Compliance|1|||
162200020|NCT00990314|585781274|FG000|Overall Study|Physician Decision|3|||
162200021|NCT00990314|585781274|FG000|Overall Study|Lack of Efficacy|1|||
162200022|NCT01288729|585781281|FG000|Overall Study|Withdrawal by Subject|1|||
162200023|NCT01288729|585781282|FG001|Overall Study|Withdrawal by Subject|0|||
162200024|NCT02442622|585781283|FG000|Overall Study|Withdrawal by Subject|3|||
162200025|NCT02442622|585781284|FG001|Overall Study|Withdrawal by Subject|1|||
162200026|NCT04816708|585782747|FG000|Overall Study|Lost to Follow-up|10|||
162200027|NCT04816708|585782748|FG001|Overall Study|Lost to Follow-up|4|||
162200028|NCT03596905|585782749|FG000|Overall Study|Protocol Violation|0|||
162200029|NCT03596905|585782750|FG001|Overall Study|Protocol Violation|0|||
162200030|NCT03596905|585782751|FG002|Overall Study|Protocol Violation|0|||
162200031|NCT03596905|585782752|FG003|Overall Study|Protocol Violation|0|||
162200032|NCT03596905|585782753|FG004|Overall Study|Protocol Violation|1|||
162200033|NCT03596905|585782754|FG005|Overall Study|Protocol Violation|0|||
162200034|NCT03596905|585782755|FG006|Overall Study|Protocol Violation|0|||
162200035|NCT03596905|585782749|FG000|Overall Study|Withdrawal by Subject|0|||
162200036|NCT03596905|585782750|FG001|Overall Study|Withdrawal by Subject|2|||
162200037|NCT03596905|585782751|FG002|Overall Study|Withdrawal by Subject|1|||
162200038|NCT03596905|585782752|FG003|Overall Study|Withdrawal by Subject|0|||
162200039|NCT03596905|585782753|FG004|Overall Study|Withdrawal by Subject|2|||
162200040|NCT03596905|585782754|FG005|Overall Study|Withdrawal by Subject|0|||
162200041|NCT03596905|585782755|FG006|Overall Study|Withdrawal by Subject|0|||
162200042|NCT03596905|585782749|FG000|Overall Study|Participant moved and was unable to complete study|0|||
162200043|NCT03596905|585782750|FG001|Overall Study|Participant moved and was unable to complete study|1|||
162200044|NCT03596905|585782751|FG002|Overall Study|Participant moved and was unable to complete study|0|||
162200045|NCT03596905|585782752|FG003|Overall Study|Participant moved and was unable to complete study|0|||
162200046|NCT03596905|585782753|FG004|Overall Study|Participant moved and was unable to complete study|0|||
162200047|NCT03596905|585782754|FG005|Overall Study|Participant moved and was unable to complete study|0|||
162200048|NCT03596905|585782755|FG006|Overall Study|Participant moved and was unable to complete study|0|||
162200049|NCT03596905|585782749|FG000|Overall Study|Adverse Event|0|||
162200050|NCT03596905|585782750|FG001|Overall Study|Adverse Event|0|||
162200051|NCT03596905|585782751|FG002|Overall Study|Adverse Event|0|||
162200052|NCT03596905|585782752|FG003|Overall Study|Adverse Event|0|||
162200053|NCT03596905|585782753|FG004|Overall Study|Adverse Event|0|||
161676200|NCT05975840|583867319|FG001|Overall Study|Protocol Violation|1|||
161676201|NCT05975840|583867320|FG002|Overall Study|Protocol Violation|0|||
161676202|NCT05975840|583867321|FG003|Overall Study|Protocol Violation|0|||
161676203|NCT05975840|583867322|FG004|Overall Study|Protocol Violation|0|||
162200054|NCT03596905|585782754|FG005|Overall Study|Adverse Event|0|||
162200055|NCT03596905|585782755|FG006|Overall Study|Adverse Event|1|||
162200056|NCT03596905|585782749|FG000|Overall Study|Non-Compliance with eDiary|1|||
162200057|NCT03596905|585782750|FG001|Overall Study|Non-Compliance with eDiary|0|||
162200058|NCT03596905|585782751|FG002|Overall Study|Non-Compliance with eDiary|0|||
162200059|NCT03596905|585782752|FG003|Overall Study|Non-Compliance with eDiary|0|||
161676204|NCT05975840|583867323|FG005|Overall Study|Protocol Violation|0|||
161676205|NCT05975840|583867324|FG006|Overall Study|Protocol Violation|0|||
161676206|NCT05975840|583867325|FG007|Overall Study|Protocol Violation|0|||
161676207|NCT05975840|583867318|FG000|Overall Study|Adverse Event|0|||
162020725|NCT02160899|585132018|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
162200060|NCT03596905|585782753|FG004|Overall Study|Non-Compliance with eDiary|1|||
162200061|NCT03596905|585782754|FG005|Overall Study|Non-Compliance with eDiary|0|||
162200062|NCT03596905|585782755|FG006|Overall Study|Non-Compliance with eDiary|2|||
162200063|NCT03596905|585782749|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162200064|NCT03596905|585782750|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162200065|NCT03596905|585782751|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162200066|NCT03596905|585782752|FG003|Overall Study|Non-Compliance with Study Drug|0|||
162200067|NCT03596905|585782753|FG004|Overall Study|Non-Compliance with Study Drug|1|||
162200068|NCT03596905|585782754|FG005|Overall Study|Non-Compliance with Study Drug|0|||
162200069|NCT03596905|585782755|FG006|Overall Study|Non-Compliance with Study Drug|0|||
162200070|NCT03596905|585782749|FG000|Overall Study|Lost to Follow-up|0|||
162200071|NCT03596905|585782750|FG001|Overall Study|Lost to Follow-up|0|||
162200072|NCT03596905|585782751|FG002|Overall Study|Lost to Follow-up|0|||
162200073|NCT03596905|585782752|FG003|Overall Study|Lost to Follow-up|0|||
162200074|NCT03596905|585782753|FG004|Overall Study|Lost to Follow-up|0|||
162200075|NCT03596905|585782754|FG005|Overall Study|Lost to Follow-up|1|||
162200076|NCT03596905|585782755|FG006|Overall Study|Lost to Follow-up|0|||
162200077|NCT02236598|585782756|FG000|Overall Study|Adverse Event|0|||
162200078|NCT02236598|585782757|FG001|Overall Study|Adverse Event|1|||
162200079|NCT02236598|585782756|FG000|Overall Study|Withdrawal by Subject|0|||
162200080|NCT02236598|585782757|FG001|Overall Study|Withdrawal by Subject|1|||
162200081|NCT01323309|585782760|FG000|Overall Study|Death|9|||
162200082|NCT01323309|585782761|FG001|Overall Study|Death|15|||
162200083|NCT01323309|585782762|FG002|Overall Study|Death|5|||
162200084|NCT01323309|585782760|FG000|Overall Study|Lost to Follow-up|11|||
162200085|NCT01323309|585782761|FG001|Overall Study|Lost to Follow-up|14|||
162200086|NCT01323309|585782762|FG002|Overall Study|Lost to Follow-up|24|||
162200087|NCT01323309|585782760|FG000|Overall Study|Withdrawal by Subject|14|||
162200088|NCT01323309|585782761|FG001|Overall Study|Withdrawal by Subject|14|||
162200089|NCT01323309|585782762|FG002|Overall Study|Withdrawal by Subject|18|||
162200090|NCT01323309|585782760|FG000|Overall Study|Disease progression|5|||
162200091|NCT01323309|585782761|FG001|Overall Study|Disease progression|11|||
162200092|NCT01323309|585782762|FG002|Overall Study|Disease progression|4|||
162200093|NCT01190228|585782768|FG000|Overall Study|Protocol Violation|4|||
162200094|NCT01190228|585782769|FG001|Overall Study|Protocol Violation|0|||
162200095|NCT01190228|585782770|FG002|Overall Study|Protocol Violation|0|||
162200096|NCT01190228|585782768|FG000|Overall Study|Withdrawal by Subject|1|||
162200097|NCT01190228|585782769|FG001|Overall Study|Withdrawal by Subject|0|||
162200098|NCT01190228|585782770|FG002|Overall Study|Withdrawal by Subject|0|||
162200099|NCT01395914|585782776|FG000|Overall Study|Unrelated to study drug AE|6|||
162200100|NCT01395914|585782777|FG001|Overall Study|Unrelated to study drug AE|1|||
162200101|NCT01395914|585782776|FG000|Overall Study|Death|23|||
162200102|NCT01395914|585782777|FG001|Overall Study|Death|17|||
162200103|NCT01395914|585782776|FG000|Overall Study|Other|9|||
162200104|NCT01395914|585782777|FG001|Overall Study|Other|3|||
162200105|NCT01395914|585782776|FG000|Overall Study|Withdrawal by patient|27|||
162200106|NCT01395914|585782777|FG001|Overall Study|Withdrawal by patient|14|||
162200107|NCT01395914|585782776|FG000|Overall Study|Study drug-related AE|1|||
162200108|NCT01395914|585782777|FG001|Overall Study|Study drug-related AE|0|||
162200109|NCT01395914|585782776|FG000|Overall Study|Lost to Follow-up|6|||
162200110|NCT01395914|585782777|FG001|Overall Study|Lost to Follow-up|2|||
162200111|NCT01648699|585782778|FG000|Overall Study|Death|1|||
162200112|NCT01648699|585782778|FG000|Overall Study|Lost to Follow-up|2|||
162200113|NCT01648699|585782778|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
162200114|NCT04601857|585782779|FG000|Overall Study|Adverse Event/Serious Adverse Event|3|||
162200115|NCT04601857|585782780|FG001|Overall Study|Adverse Event/Serious Adverse Event|7|||
162200116|NCT04601857|585782779|FG000|Overall Study|Disease Progression|2|||
162200117|NCT04601857|585782780|FG001|Overall Study|Disease Progression|4|||
162200118|NCT04601857|585782779|FG000|Overall Study|Clinical Disease Progression|2|||
162200119|NCT04601857|585782780|FG001|Overall Study|Clinical Disease Progression|1|||
162200120|NCT04601857|585782779|FG000|Overall Study|Radiological Progression|4|||
162200121|NCT04601857|585782780|FG001|Overall Study|Radiological Progression|11|||
161820988|NCT00379353|584385781|FG000|Overall Study|Cardiac Tamponade|1|||
161820989|NCT00379353|584385782|FG001|Overall Study|Cardiac Tamponade|0|||
161820990|NCT00379353|584385781|FG000|Overall Study|Non-compliance|1|||
161820991|NCT00379353|584385782|FG001|Overall Study|Non-compliance|0|||
161820992|NCT00379353|584385781|FG000|Overall Study|Conflicting drug treatment|0|||
161820993|NCT00379353|584385782|FG001|Overall Study|Conflicting drug treatment|1|||
161820994|NCT01211262|584385787|FG000|Overall Study|Progressive Disease|18|||
161820995|NCT01211262|584385788|FG001|Overall Study|Progressive Disease|9|||
161820996|NCT01211262|584385787|FG000|Overall Study|Adverse Event|4|||
162200122|NCT04601857|585782779|FG000|Overall Study|Death|1|||
162200123|NCT04601857|585782780|FG001|Overall Study|Death|0|||
162200124|NCT04601857|585782779|FG000|Overall Study|Reason Not Specified|0|||
162200125|NCT04601857|585782780|FG001|Overall Study|Reason Not Specified|1|||
161820997|NCT01211262|584385788|FG001|Overall Study|Adverse Event|0|||
161820998|NCT01211262|584385787|FG000|Overall Study|Withdrawal of Consent|1|||
162200126|NCT04601857|585782779|FG000|Overall Study|At the Participant's Request|0|||
162200127|NCT04601857|585782780|FG001|Overall Study|At the Participant's Request|1|||
162200128|NCT00980954|585782781|FG000|Overall Study|Protocol Violation|9|||
162200129|NCT00980954|585782782|FG001|Overall Study|Protocol Violation|15|||
162200130|NCT04803214|585782783|FG000|Overall Study|Adverse Event|1|||
162200131|NCT04803214|585782784|FG001|Overall Study|Adverse Event|0|||
162200132|NCT04803214|585782783|FG000|Overall Study|Withdrawal by Subject|1|||
162200133|NCT04803214|585782784|FG001|Overall Study|Withdrawal by Subject|2|||
162200134|NCT04803214|585782783|FG000|Overall Study|Lost to Follow-up|2|||
162200135|NCT04803214|585782784|FG001|Overall Study|Lost to Follow-up|4|||
162200136|NCT04803214|585782783|FG000|Overall Study|Physician Decision|1|||
162200137|NCT04803214|585782784|FG001|Overall Study|Physician Decision|1|||
162200138|NCT04803214|585782783|FG000|Overall Study|Missed 12 month visit|0|||
162200139|NCT04803214|585782784|FG001|Overall Study|Missed 12 month visit|3|||
162200140|NCT02256488|585782788|FG000|Overall Study|Lost to Follow-up|6|||
162200141|NCT02256488|585782789|FG001|Overall Study|Lost to Follow-up|6|||
162200142|NCT02256488|585782790|FG002|Overall Study|Lost to Follow-up|9|||
162200143|NCT02256488|585782791|FG003|Overall Study|Lost to Follow-up|3|||
162200144|NCT02256488|585782788|FG000|Overall Study|OTHER|1|||
162200145|NCT02256488|585782789|FG001|Overall Study|OTHER|0|||
162200146|NCT02256488|585782790|FG002|Overall Study|OTHER|1|||
162200147|NCT02256488|585782791|FG003|Overall Study|OTHER|1|||
162200148|NCT02256488|585782788|FG000|Overall Study|Withdrawal by Subject|1|||
162200149|NCT02256488|585782789|FG001|Overall Study|Withdrawal by Subject|0|||
162200150|NCT02256488|585782790|FG002|Overall Study|Withdrawal by Subject|0|||
162200151|NCT02256488|585782791|FG003|Overall Study|Withdrawal by Subject|2|||
162200152|NCT04930445|585782792|FG000|Overall Study|Adverse Event|7|||
162200153|NCT04930445|585782792|FG000|Overall Study|Lost to Follow-up|1|||
162200154|NCT04930445|585782792|FG000|Overall Study|Physician Decision|1|||
162200155|NCT04930445|585782792|FG000|Overall Study|Lack of Efficacy|1|||
162200156|NCT04930445|585782792|FG000|Overall Study|Study Terminated by Sponsor|245|||
162200157|NCT04930445|585782792|FG000|Overall Study|Screen Failure|8|||
162200158|NCT04930445|585782792|FG000|Overall Study|Other|2|||
162200159|NCT00975130|585782793|FG000|Study Part 1|Adverse Event|150|||
162200160|NCT00975130|585782794|FG001|Study Part 1|Adverse Event|0|||
162200161|NCT00975130|585782795|FG002|Study Part 1|Adverse Event|0|||
162200162|NCT00975130|585782793|FG000|Study Part 1|Lost to Follow-up|19|||
162200163|NCT00975130|585782794|FG001|Study Part 1|Lost to Follow-up|0|||
162200164|NCT00975130|585782795|FG002|Study Part 1|Lost to Follow-up|0|||
162200165|NCT00975130|585782793|FG000|Study Part 1|Withdrawal by Subject|61|||
162200166|NCT00975130|585782794|FG001|Study Part 1|Withdrawal by Subject|0|||
162200167|NCT00975130|585782795|FG002|Study Part 1|Withdrawal by Subject|0|||
162200168|NCT00975130|585782793|FG000|Study Part 1|Protocol Violation|13|||
162200169|NCT00975130|585782794|FG001|Study Part 1|Protocol Violation|0|||
162200170|NCT00975130|585782795|FG002|Study Part 1|Protocol Violation|0|||
162200171|NCT00975130|585782793|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
162200172|NCT00975130|585782794|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
162200173|NCT00975130|585782795|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
162200174|NCT00975130|585782793|FG000|Study Part 1|Administrative|4|||
162200175|NCT00975130|585782794|FG001|Study Part 1|Administrative|0|||
162200176|NCT00975130|585782795|FG002|Study Part 1|Administrative|0|||
162200177|NCT00975130|585782793|FG000|Study Part 1|Withdrew Consent|24|||
162200178|NCT00975130|585782794|FG001|Study Part 1|Withdrew Consent|0|||
162200179|NCT00975130|585782795|FG002|Study Part 1|Withdrew Consent|0|||
162200180|NCT00975130|585782793|FG000|Study Part 2|Adverse Event|0|||
162200181|NCT00975130|585782794|FG001|Study Part 2|Adverse Event|14|||
162200182|NCT00975130|585782795|FG002|Study Part 2|Adverse Event|7|||
162200183|NCT00975130|585782793|FG000|Study Part 2|Lost to Follow-up|0|||
162200184|NCT00975130|585782794|FG001|Study Part 2|Lost to Follow-up|0|||
162200185|NCT00975130|585782795|FG002|Study Part 2|Lost to Follow-up|1|||
162200186|NCT00975130|585782793|FG000|Study Part 2|Withdrawal by Subject|0|||
162200187|NCT00975130|585782794|FG001|Study Part 2|Withdrawal by Subject|13|||
162200188|NCT00975130|585782795|FG002|Study Part 2|Withdrawal by Subject|5|||
162200189|NCT00975130|585782793|FG000|Study Part 2|Withdrew Consent|0|||
162200190|NCT00975130|585782794|FG001|Study Part 2|Withdrew Consent|6|||
162200191|NCT00975130|585782795|FG002|Study Part 2|Withdrew Consent|2|||
162200192|NCT00975130|585782793|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
162200193|NCT00975130|585782794|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
162200194|NCT00975130|585782795|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
162200195|NCT00975130|585782793|FG000|Study Part 2|Administrative|0|||
162200196|NCT00975130|585782794|FG001|Study Part 2|Administrative|1|||
162200197|NCT00975130|585782795|FG002|Study Part 2|Administrative|0|||
162200198|NCT00975130|585782793|FG000|Study Part 2|Protocol Violation|0|||
162200199|NCT00975130|585782794|FG001|Study Part 2|Protocol Violation|0|||
162200200|NCT00975130|585782795|FG002|Study Part 2|Protocol Violation|1|||
162200201|NCT01261793|585782796|FG000|Overall Study|Lack of Efficacy|44|||
162200202|NCT01261793|585782797|FG001|Overall Study|Lack of Efficacy|37|||
162200203|NCT01261793|585782798|FG002|Overall Study|Lack of Efficacy|32|||
162200204|NCT01261793|585782796|FG000|Overall Study|Protocol Violation|3|||
162200205|NCT01261793|585782797|FG001|Overall Study|Protocol Violation|5|||
162200206|NCT01261793|585782798|FG002|Overall Study|Protocol Violation|6|||
162200207|NCT01261793|585782796|FG000|Overall Study|Lost to Follow-up|10|||
162200208|NCT01261793|585782797|FG001|Overall Study|Lost to Follow-up|3|||
162200209|NCT01261793|585782798|FG002|Overall Study|Lost to Follow-up|7|||
162200210|NCT01261793|585782796|FG000|Overall Study|Withdrawal by Subject|12|||
162200211|NCT01261793|585782797|FG001|Overall Study|Withdrawal by Subject|14|||
162200212|NCT01261793|585782798|FG002|Overall Study|Withdrawal by Subject|14|||
162200213|NCT01261793|585782796|FG000|Overall Study|Death|3|||
162200214|NCT01261793|585782797|FG001|Overall Study|Death|1|||
162200215|NCT01261793|585782798|FG002|Overall Study|Death|0|||
162200216|NCT01261793|585782796|FG000|Overall Study|Adverse Event|9|||
162200217|NCT01261793|585782797|FG001|Overall Study|Adverse Event|24|||
162200218|NCT01261793|585782798|FG002|Overall Study|Adverse Event|19|||
162200219|NCT01261793|585782796|FG000|Overall Study|Patient non-availability|1|||
162200220|NCT01261793|585782797|FG001|Overall Study|Patient non-availability|1|||
162200221|NCT01261793|585782798|FG002|Overall Study|Patient non-availability|1|||
162200222|NCT01261793|585782796|FG000|Overall Study|Suspected pregnancy|1|||
162200223|NCT01261793|585782797|FG001|Overall Study|Suspected pregnancy|1|||
162200224|NCT01261793|585782798|FG002|Overall Study|Suspected pregnancy|0|||
162200225|NCT01261793|585782796|FG000|Overall Study|Patient non-compliance|1|||
162200226|NCT01261793|585782797|FG001|Overall Study|Patient non-compliance|0|||
162200227|NCT01261793|585782798|FG002|Overall Study|Patient non-compliance|1|||
162200228|NCT01261793|585782796|FG000|Overall Study|Patient pregnant|1|||
162200229|NCT01261793|585782797|FG001|Overall Study|Patient pregnant|0|||
162200230|NCT01261793|585782798|FG002|Overall Study|Patient pregnant|0|||
162200231|NCT01261793|585782796|FG000|Overall Study|Outside the study area|0|||
162200232|NCT01261793|585782797|FG001|Overall Study|Outside the study area|2|||
162200233|NCT01261793|585782798|FG002|Overall Study|Outside the study area|1|||
162200234|NCT01261793|585782796|FG000|Overall Study|Lack of efficacy & patient not available|0|||
162200235|NCT01261793|585782797|FG001|Overall Study|Lack of efficacy & patient not available|1|||
162200236|NCT01261793|585782798|FG002|Overall Study|Lack of efficacy & patient not available|0|||
162200237|NCT01261793|585782796|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
162200238|NCT01261793|585782797|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
162200239|NCT01261793|585782798|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
162200240|NCT01261793|585782796|FG000|Overall Study|Randomization error|0|||
162200241|NCT01261793|585782797|FG001|Overall Study|Randomization error|1|||
162200242|NCT01261793|585782798|FG002|Overall Study|Randomization error|0|||
162200243|NCT01261793|585782796|FG000|Overall Study|Patient unable to start IV line|0|||
162200244|NCT01261793|585782797|FG001|Overall Study|Patient unable to start IV line|0|||
162200245|NCT01261793|585782798|FG002|Overall Study|Patient unable to start IV line|1|||
162200246|NCT03219216|585782799|FG000|Overall Study|Lost to Follow-up|0|||
162200247|NCT03219216|585782800|FG001|Overall Study|Lost to Follow-up|1|||
162200248|NCT03305458|585782801|FG000|Overall Study|Withdrawal by Subject|50|||
162200249|NCT03305458|585782802|FG001|Overall Study|Withdrawal by Subject|46|||
162200250|NCT03305458|585782803|FG002|Overall Study|Withdrawal by Subject|93|||
162200251|NCT03305458|585782801|FG000|Overall Study|Lost to Follow-up|85|||
162200252|NCT03305458|585782802|FG001|Overall Study|Lost to Follow-up|85|||
162200253|NCT03305458|585782803|FG002|Overall Study|Lost to Follow-up|35|||
162200254|NCT04743999|585782805|FG000|3-month Questionnaire|Death|1|||
162200255|NCT04743999|585782805|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
162200256|NCT04743999|585782805|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
162200257|NCT04743999|585782805|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
162200258|NCT01721759|585782806|FG000|Treatment Period|Disease Progression|85|||
162200259|NCT01721759|585782806|FG000|Treatment Period|Study drug toxicity|14|||
162200260|NCT01721759|585782806|FG000|Treatment Period|Death|1|||
162200261|NCT01721759|585782806|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
162200262|NCT01721759|585782806|FG000|Treatment Period|Participant request to withdraw|3|||
162200263|NCT01721759|585782806|FG000|Treatment Period|Other Reasons|3|||
162200264|NCT01721759|585782806|FG000|End of Study Period|Participant Withdrew Consent|5|||
162200265|NCT01721759|585782806|FG000|End of Study Period|Death|101|||
162200266|NCT01721759|585782806|FG000|End of Study Period|Lost to Follow-up|1|||
162200267|NCT01721759|585782806|FG000|End of Study Period|Other Reasons|10|||
162200268|NCT03926117|585782807|FG000|Overall Study|Unclassified|1|||
162200269|NCT03926117|585782808|FG001|Overall Study|Unclassified|4|||
162200270|NCT03926117|585782809|FG002|Overall Study|Unclassified|1|||
162200271|NCT03926117|585782810|FG003|Overall Study|Unclassified|4|||
162200272|NCT03926117|585782807|FG000|Overall Study|Withdrawal by Subject|3|||
162200273|NCT03926117|585782808|FG001|Overall Study|Withdrawal by Subject|0|||
162200274|NCT03926117|585782809|FG002|Overall Study|Withdrawal by Subject|1|||
162200275|NCT03926117|585782810|FG003|Overall Study|Withdrawal by Subject|1|||
162200276|NCT03926117|585782807|FG000|Overall Study|Lost to Follow-up|0|||
162200277|NCT03926117|585782808|FG001|Overall Study|Lost to Follow-up|2|||
162200278|NCT03926117|585782809|FG002|Overall Study|Lost to Follow-up|1|||
162200279|NCT03926117|585782810|FG003|Overall Study|Lost to Follow-up|0|||
162200280|NCT03926117|585782807|FG000|Overall Study|Adverse Event|1|||
162200281|NCT03926117|585782808|FG001|Overall Study|Adverse Event|2|||
162200282|NCT03926117|585782809|FG002|Overall Study|Adverse Event|3|||
162200283|NCT03926117|585782810|FG003|Overall Study|Adverse Event|1|||
162200284|NCT03926117|585782807|FG000|Overall Study|Randomized but not treated|1|||
162200285|NCT03926117|585782808|FG001|Overall Study|Randomized but not treated|1|||
162200286|NCT03926117|585782809|FG002|Overall Study|Randomized but not treated|0|||
162200287|NCT03926117|585782810|FG003|Overall Study|Randomized but not treated|1|||
162200288|NCT03138499|585782811|FG000|Overall Study|Lost to Follow-up|1|||
162200289|NCT03138499|585782812|FG001|Overall Study|Lost to Follow-up|0|||
162200290|NCT03138499|585782811|FG000|Overall Study|Participants withdrew consent|1|||
162200291|NCT03138499|585782812|FG001|Overall Study|Participants withdrew consent|0|||
162200292|NCT03138499|585782811|FG000|Overall Study|Participant discontinued study before treatment|0|||
162200293|NCT03138499|585782812|FG001|Overall Study|Participant discontinued study before treatment|1|||
162200294|NCT03138499|585782811|FG000|Overall Study|Disease Progression|2|||
162200295|NCT03138499|585782812|FG001|Overall Study|Disease Progression|6|||
162200296|NCT03138499|585782811|FG000|Overall Study|Study drug toxicity|2|||
162200297|NCT03138499|585782812|FG001|Overall Study|Study drug toxicity|2|||
162200298|NCT03138499|585782811|FG000|Overall Study|Participant request to discontinue study treatment|1|||
162200299|NCT03138499|585782812|FG001|Overall Study|Participant request to discontinue study treatment|1|||
162200300|NCT03138499|585782811|FG000|Overall Study|Other reasons|2|||
162200301|NCT03138499|585782812|FG001|Overall Study|Other reasons|0|||
162200302|NCT01123200|585782813|FG000|Overall Study|Withdrawal by Subject|1|||
162200303|NCT02577315|585782816|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
162200304|NCT02577315|585782817|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
162200305|NCT01636778|585782820|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
162200306|NCT01636778|585782821|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
162200307|NCT01636778|585782822|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
162200308|NCT01636778|585782820|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
162200309|NCT01636778|585782821|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
162200310|NCT01636778|585782822|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
162200311|NCT01636778|585782820|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
162200312|NCT01636778|585782821|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
162200313|NCT01636778|585782822|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
162200314|NCT01636778|585782820|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
162200315|NCT01636778|585782821|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
162200316|NCT01636778|585782822|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
162200317|NCT01636778|585782820|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
162200318|NCT01636778|585782821|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
162200319|NCT01636778|585782822|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
162200320|NCT01636778|585782820|FG000|Follow-up Period After Part 2|Other|0|||
162200321|NCT01636778|585782821|FG001|Follow-up Period After Part 2|Other|0|||
162200322|NCT01636778|585782822|FG002|Follow-up Period After Part 2|Other|1|||
162200323|NCT01636778|585782820|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
162200324|NCT01636778|585782821|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
162200325|NCT01636778|585782822|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
162200326|NCT01636778|585782820|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
162200327|NCT01636778|585782821|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
162200328|NCT01636778|585782822|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
162200329|NCT00990821|585782826|FG000|Overall Study|Withdrawal by Subject|0|||
162200330|NCT00990821|585782827|FG001|Overall Study|Withdrawal by Subject|2|||
162200331|NCT00990821|585782828|FG002|Overall Study|Withdrawal by Subject|0|||
162200332|NCT00990821|585782829|FG003|Overall Study|Withdrawal by Subject|0|||
162200333|NCT00990821|585782830|FG004|Overall Study|Withdrawal by Subject|3|||
162200334|NCT00990821|585782831|FG005|Overall Study|Withdrawal by Subject|3|||
162200335|NCT00990821|585782832|FG006|Overall Study|Withdrawal by Subject|1|||
162200336|NCT00990821|585782833|FG007|Overall Study|Withdrawal by Subject|0|||
162200337|NCT00990821|585782834|FG008|Overall Study|Withdrawal by Subject|0|||
162200338|NCT00990821|585782835|FG009|Overall Study|Withdrawal by Subject|1|||
162200339|NCT00990821|585782836|FG010|Overall Study|Withdrawal by Subject|3|||
162200340|NCT00990821|585782837|FG011|Overall Study|Withdrawal by Subject|5|||
162200341|NCT00990821|585782838|FG012|Overall Study|Withdrawal by Subject|2|||
162200342|NCT00990821|585782839|FG013|Overall Study|Withdrawal by Subject|1|||
162200343|NCT03530345|585782840|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
162200344|NCT03530345|585782841|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
162200345|NCT03530345|585782840|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
162200346|NCT03530345|585782841|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
162200347|NCT03530345|585782840|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
162200348|NCT03530345|585782841|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
162200349|NCT03530345|585782840|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
162200350|NCT03530345|585782841|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
162200351|NCT00170950|585782844|FG000|Overall Study|Death|236|||
162200352|NCT00170950|585782845|FG001|Overall Study|Death|274|||
162200353|NCT00170950|585782844|FG000|Overall Study|Withdrawal by Subject|496|||
162200354|NCT00170950|585782845|FG001|Overall Study|Withdrawal by Subject|498|||
162200355|NCT00170950|585782844|FG000|Overall Study|Lost to Follow-up|134|||
162200356|NCT00170950|585782845|FG001|Overall Study|Lost to Follow-up|115|||
162200357|NCT00170950|585782844|FG000|Overall Study|Missing|2|||
162200358|NCT00170950|585782845|FG001|Overall Study|Missing|1|||
162200359|NCT00170950|585782844|FG000|Overall Study|Termination Data Not Recorded|17|||
162200360|NCT00170950|585782845|FG001|Overall Study|Termination Data Not Recorded|22|||
162200361|NCT00748098|585782846|FG000|First Treatment Intervention Period|Adverse Event|1|||
162200362|NCT00748098|585782847|FG001|First Treatment Intervention Period|Adverse Event|1|||
162200363|NCT00748098|585782846|FG000|First Treatment Intervention Period|Protocol Violation|1|||
162200364|NCT00748098|585782847|FG001|First Treatment Intervention Period|Protocol Violation|0|||
162200365|NCT00748098|585782846|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
162200366|NCT00748098|585782847|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
162200367|NCT00748098|585782846|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
162200368|NCT00748098|585782847|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
162200369|NCT00748098|585782846|FG000|First Taper Period|Protocol Violation|1|||
162200370|NCT00748098|585782847|FG001|First Taper Period|Protocol Violation|0|||
162200371|NCT00748098|585782846|FG000|First Taper Period|Withdrawal by Subject|2|||
162200372|NCT00748098|585782847|FG001|First Taper Period|Withdrawal by Subject|0|||
162200373|NCT00748098|585782846|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
162200374|NCT00748098|585782847|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
162200375|NCT00748098|585782846|FG000|1-Week Washout Period|Adverse Event|0|||
162200376|NCT00748098|585782847|FG001|1-Week Washout Period|Adverse Event|1|||
162200377|NCT00748098|585782846|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
162200378|NCT00748098|585782847|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
162200379|NCT00748098|585782846|FG000|Second Treatment Intervention Period|Adverse Event|4|||
162200380|NCT00748098|585782847|FG001|Second Treatment Intervention Period|Adverse Event|1|||
162200381|NCT00748098|585782846|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
162200382|NCT00748098|585782847|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
162200383|NCT00748098|585782846|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
162200384|NCT00748098|585782847|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
162200385|NCT02938520|585782850|FG000|Overall Study|On-going at the time of analysis|258|||
161927144|NCT01179516|584780294|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
161927145|NCT01179516|584780292|FG000|Overall Study|Lack of Efficacy|4|||
161927146|NCT01179516|584780293|FG001|Overall Study|Lack of Efficacy|2|||
161927147|NCT01179516|584780294|FG002|Overall Study|Lack of Efficacy|0|||
161927148|NCT01179516|584780292|FG000|Overall Study|Noncompliance with Study Drug|2|||
161927149|NCT01179516|584780293|FG001|Overall Study|Noncompliance with Study Drug|0|||
161927150|NCT01179516|584780294|FG002|Overall Study|Noncompliance with Study Drug|1|||
161927151|NCT01179516|584780292|FG000|Overall Study|Protocol Deviations|4|||
161927152|NCT01179516|584780293|FG001|Overall Study|Protocol Deviations|3|||
161927153|NCT01179516|584780294|FG002|Overall Study|Protocol Deviations|3|||
161927154|NCT01179516|584780292|FG000|Overall Study|Withdrawal of Consent|2|||
161927155|NCT01179516|584780293|FG001|Overall Study|Withdrawal of Consent|6|||
161927156|NCT01179516|584780294|FG002|Overall Study|Withdrawal of Consent|10|||
161927157|NCT01179516|584780292|FG000|Overall Study|Lost to Follow-up|7|||
161927158|NCT01179516|584780293|FG001|Overall Study|Lost to Follow-up|7|||
161927159|NCT01179516|584780294|FG002|Overall Study|Lost to Follow-up|3|||
161927160|NCT01179516|584780292|FG000|Overall Study|Other|2|||
161927161|NCT01179516|584780293|FG001|Overall Study|Other|0|||
161927162|NCT01179516|584780294|FG002|Overall Study|Other|2|||
161927163|NCT01668537|584780295|FG000|Overall Study|Request to Discontinue Prematurely|1|||
161927164|NCT01668537|584780296|FG001|Overall Study|Request to Discontinue Prematurely|1|||
161927165|NCT01668537|584780295|FG000|Overall Study|Subject unwilling/unable to comply|5|||
161927166|NCT01668537|584780296|FG001|Overall Study|Subject unwilling/unable to comply|0|||
161927167|NCT01668537|584780295|FG000|Overall Study|Reason Precludes Participation|1|||
161927168|NCT01668537|584780296|FG001|Overall Study|Reason Precludes Participation|0|||
161927169|NCT01668537|584780295|FG000|Overall Study|Lost to Follow-up|13|||
161927170|NCT01668537|584780296|FG001|Overall Study|Lost to Follow-up|6|||
162020726|NCT02160899|585132019|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
162200386|NCT02938520|585782851|FG001|Overall Study|On-going at the time of analysis|261|||
162200387|NCT02938520|585782850|FG000|Overall Study|Physician Decision|2|||
162200388|NCT02938520|585782851|FG001|Overall Study|Physician Decision|5|||
162200389|NCT02938520|585782850|FG000|Overall Study|Lost to Follow-up|2|||
162200390|NCT02938520|585782851|FG001|Overall Study|Lost to Follow-up|2|||
162200391|NCT02938520|585782850|FG000|Overall Study|Withdrawal by Subject|7|||
162200392|NCT02938520|585782851|FG001|Overall Study|Withdrawal by Subject|7|||
162200393|NCT02938520|585782850|FG000|Overall Study|Protocol Violation|0|||
161927171|NCT01668537|584780295|FG000|Overall Study|Other|2|||
161927172|NCT01668537|584780296|FG001|Overall Study|Other|3|||
161927173|NCT01149538|584780299|FG000|Overall Study|Lost to Follow-up|0|||
161927174|NCT01149538|584780300|FG001|Overall Study|Lost to Follow-up|1|||
161676208|NCT05975840|583867319|FG001|Overall Study|Adverse Event|0|||
161676209|NCT05975840|583867320|FG002|Overall Study|Adverse Event|0|||
161676210|NCT05975840|583867321|FG003|Overall Study|Adverse Event|1|||
161676211|NCT05975840|583867322|FG004|Overall Study|Adverse Event|0|||
161676212|NCT05975840|583867323|FG005|Overall Study|Adverse Event|0|||
161676213|NCT05975840|583867324|FG006|Overall Study|Adverse Event|0|||
161676214|NCT05975840|583867325|FG007|Overall Study|Adverse Event|0|||
161676215|NCT05975840|583867318|FG000|Overall Study|Death|0|||
161676216|NCT05975840|583867319|FG001|Overall Study|Death|1|||
161676217|NCT05975840|583867320|FG002|Overall Study|Death|0|||
161676218|NCT05975840|583867321|FG003|Overall Study|Death|0|||
161676219|NCT05975840|583867322|FG004|Overall Study|Death|0|||
161676220|NCT05975840|583867323|FG005|Overall Study|Death|0|||
161676221|NCT05975840|583867324|FG006|Overall Study|Death|0|||
161676222|NCT05975840|583867325|FG007|Overall Study|Death|1|||
161676223|NCT05390580|583867328|FG000|Overall Study|Physician Decision|3|||
161676224|NCT05390580|583867329|FG001|Overall Study|Physician Decision|2|||
161676225|NCT02129205|583867332|FG000|Overall Study|Withdrawal by Subject|0|||
161676226|NCT02129205|583867333|FG001|Overall Study|Withdrawal by Subject|0|||
161676227|NCT02129205|583867334|FG002|Overall Study|Withdrawal by Subject|0|||
161676228|NCT02129205|583867335|FG003|Overall Study|Withdrawal by Subject|0|||
161927175|NCT01149538|584780299|FG000|Overall Study|Withdrawal by Subject|5|||
161927176|NCT01149538|584780300|FG001|Overall Study|Withdrawal by Subject|3|||
161927177|NCT02336503|584780303|FG000|Overall Study|Lost to Follow-up|0|||
161676229|NCT02129205|583867336|FG004|Overall Study|Withdrawal by Subject|1|||
161676230|NCT02129205|583867337|FG005|Overall Study|Withdrawal by Subject|1|||
161676231|NCT02129205|583867338|FG006|Overall Study|Withdrawal by Subject|1|||
161676232|NCT02129205|583867339|FG007|Overall Study|Withdrawal by Subject|0|||
161676233|NCT02129205|583867340|FG008|Overall Study|Withdrawal by Subject|1|||
161676234|NCT02129205|583867341|FG009|Overall Study|Withdrawal by Subject|0|||
161676235|NCT02129205|583867332|FG000|Overall Study|Other|1|||
161676236|NCT02129205|583867333|FG001|Overall Study|Other|0|||
161676237|NCT02129205|583867334|FG002|Overall Study|Other|0|||
161676238|NCT02129205|583867335|FG003|Overall Study|Other|0|||
161676239|NCT02129205|583867336|FG004|Overall Study|Other|2|||
161676240|NCT02129205|583867337|FG005|Overall Study|Other|3|||
161676241|NCT02129205|583867338|FG006|Overall Study|Other|3|||
161676242|NCT02129205|583867339|FG007|Overall Study|Other|2|||
161676243|NCT02129205|583867340|FG008|Overall Study|Other|1|||
161676244|NCT02129205|583867341|FG009|Overall Study|Other|0|||
161676245|NCT02877927|583867342|FG000|Overall Study|Adverse Event|1|||
161676246|NCT02877927|583867343|FG001|Overall Study|Adverse Event|0|||
161676247|NCT02877927|583867342|FG000|Overall Study|Lost to Follow-up|37|||
161676248|NCT02877927|583867343|FG001|Overall Study|Lost to Follow-up|38|||
161676249|NCT02877927|583867342|FG000|Overall Study|Withdrawal by Subject|11|||
161676250|NCT02877927|583867343|FG001|Overall Study|Withdrawal by Subject|12|||
161676251|NCT02877927|583867342|FG000|Overall Study|Physician Decision|0|||
161676252|NCT02877927|583867343|FG001|Overall Study|Physician Decision|1|||
161676253|NCT02877927|583867342|FG000|Overall Study|Missed EOT/PTE Visit|5|||
161676254|NCT02877927|583867343|FG001|Overall Study|Missed EOT/PTE Visit|6|||
161927178|NCT02336503|584780304|FG001|Overall Study|Lost to Follow-up|3|||
161927179|NCT02336503|584780305|FG002|Overall Study|Lost to Follow-up|0|||
161927180|NCT02336503|584780306|FG003|Overall Study|Lost to Follow-up|2|||
161927181|NCT02336503|584780303|FG000|Overall Study|Withdrawal by Subject|2|||
161927182|NCT02336503|584780304|FG001|Overall Study|Withdrawal by Subject|0|||
161927183|NCT02336503|584780305|FG002|Overall Study|Withdrawal by Subject|0|||
161927184|NCT02336503|584780306|FG003|Overall Study|Withdrawal by Subject|4|||
161927185|NCT02336503|584780303|FG000|Overall Study|Adverse Event|0|||
161927186|NCT02336503|584780304|FG001|Overall Study|Adverse Event|0|||
161927187|NCT02336503|584780305|FG002|Overall Study|Adverse Event|1|||
161927188|NCT02336503|584780306|FG003|Overall Study|Adverse Event|0|||
161927189|NCT01436500|584780308|FG000|Overall Study|Death|1|||
161927190|NCT01436500|584780309|FG001|Overall Study|Death|0|||
162020727|NCT02160899|585132020|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
162020728|NCT02160899|585132021|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
161676255|NCT04376060|583867345|FG000|Overall Study|Physician Decision|1|||
161676256|NCT01791803|583867348|FG000|Overall Study|Withdrawal by Subject|0|||
161676257|NCT01791803|583867349|FG001|Overall Study|Withdrawal by Subject|0|||
162020729|NCT02160899|585132022|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
161676258|NCT01791803|583867350|FG002|Overall Study|Withdrawal by Subject|0|||
161676259|NCT01791803|583867351|FG003|Overall Study|Withdrawal by Subject|2|||
161676260|NCT01791803|583867348|FG000|Overall Study|Physician Decision|0|||
161676261|NCT01791803|583867349|FG001|Overall Study|Physician Decision|2|||
161676262|NCT01791803|583867350|FG002|Overall Study|Physician Decision|0|||
161927191|NCT01436500|584780310|FG002|Overall Study|Death|0|||
161927192|NCT01436500|584780311|FG003|Overall Study|Death|0|||
161927193|NCT01436500|584780312|FG004|Overall Study|Death|0|||
161676263|NCT01791803|583867351|FG003|Overall Study|Physician Decision|1|||
161676264|NCT01791803|583867348|FG000|Overall Study|Death|0|||
161676265|NCT01791803|583867349|FG001|Overall Study|Death|0|||
161676266|NCT01791803|583867350|FG002|Overall Study|Death|2|||
161676267|NCT01791803|583867351|FG003|Overall Study|Death|2|||
161676268|NCT04572854|583867352|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
161676269|NCT04572854|583867353|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
161676270|NCT04572854|583867354|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
161676271|NCT04572854|583867355|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
161676272|NCT04572854|583867352|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
161676273|NCT04572854|583867353|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
162020730|NCT02160899|585132023|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
162020731|NCT04129151|585132024|FG000|Overall Study|Adverse Event|1|||
162020732|NCT04129151|585132024|FG000|Overall Study|Disease Progression|7|||
162020733|NCT04129151|585132024|FG000|Overall Study|Study closure|1|||
162020734|NCT04473235|585132025|FG000|Overall Study|Lost to Follow-up|6|||
162020735|NCT04473235|585132026|FG001|Overall Study|Lost to Follow-up|5|||
162020736|NCT04473235|585132025|FG000|Overall Study|Declined continuation|2|||
162020737|NCT04473235|585132026|FG001|Overall Study|Declined continuation|0|||
162020738|NCT04473235|585132025|FG000|Overall Study|Physician Decision|1|||
162020739|NCT04473235|585132026|FG001|Overall Study|Physician Decision|1|||
162020740|NCT04473235|585132025|FG000|Overall Study|Protocol Violation|10|||
162020741|NCT04473235|585132026|FG001|Overall Study|Protocol Violation|6|||
162020742|NCT01945710|585132029|FG000|Overall Study|Progressive Disease|5|||
162020743|NCT01945710|585132030|FG001|Overall Study|Progressive Disease|4|||
162020744|NCT01945710|585132031|FG002|Overall Study|Progressive Disease|3|||
162020745|NCT01945710|585132032|FG003|Overall Study|Progressive Disease|2|||
162020746|NCT01945710|585132033|FG004|Overall Study|Progressive Disease|7|||
162020747|NCT01945710|585132034|FG005|Overall Study|Progressive Disease|3|||
162020748|NCT01945710|585132035|FG006|Overall Study|Progressive Disease|19|||
161676274|NCT04572854|583867354|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
161676275|NCT04572854|583867355|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
161676276|NCT00972777|583867358|FG000|Overall Study|Adverse Event|3|||
161676277|NCT00972777|583867359|FG001|Overall Study|Adverse Event|2|||
161676278|NCT00972777|583867358|FG000|Overall Study|Lost to Follow-up|0|||
161676279|NCT00972777|583867359|FG001|Overall Study|Lost to Follow-up|4|||
161676280|NCT00972777|583867358|FG000|Overall Study|Withdrawal by Subject|4|||
161676281|NCT00972777|583867359|FG001|Overall Study|Withdrawal by Subject|5|||
161676282|NCT00972777|583867358|FG000|Overall Study|Physician Decision|4|||
161676283|NCT00972777|583867359|FG001|Overall Study|Physician Decision|0|||
161676284|NCT00972777|583867358|FG000|Overall Study|Protocol Violation|0|||
161676285|NCT00972777|583867359|FG001|Overall Study|Protocol Violation|2|||
161676286|NCT00972777|583867358|FG000|Overall Study|Screening Failure|2|||
161676287|NCT00972777|583867359|FG001|Overall Study|Screening Failure|1|||
161676288|NCT00972777|583867358|FG000|Overall Study|Missed visit|1|||
161676289|NCT00972777|583867359|FG001|Overall Study|Missed visit|0|||
161927194|NCT01436500|584780308|FG000|Overall Study|Adverse Event|0|||
161927195|NCT01436500|584780309|FG001|Overall Study|Adverse Event|2|||
161927196|NCT01436500|584780310|FG002|Overall Study|Adverse Event|2|||
161927197|NCT01436500|584780311|FG003|Overall Study|Adverse Event|0|||
161927198|NCT01436500|584780312|FG004|Overall Study|Adverse Event|1|||
161927199|NCT01436500|584780308|FG000|Overall Study|Withdrawal by Subject|0|||
161927200|NCT01436500|584780309|FG001|Overall Study|Withdrawal by Subject|0|||
161927201|NCT01436500|584780310|FG002|Overall Study|Withdrawal by Subject|2|||
161927202|NCT01436500|584780311|FG003|Overall Study|Withdrawal by Subject|0|||
161927203|NCT01436500|584780312|FG004|Overall Study|Withdrawal by Subject|2|||
161927204|NCT01436500|584780308|FG000|Overall Study|Physician Decision|0|||
161927205|NCT01436500|584780309|FG001|Overall Study|Physician Decision|0|||
161927206|NCT01436500|584780310|FG002|Overall Study|Physician Decision|1|||
161927207|NCT01436500|584780311|FG003|Overall Study|Physician Decision|0|||
161927208|NCT01436500|584780312|FG004|Overall Study|Physician Decision|0|||
161927209|NCT01436500|584780308|FG000|Overall Study|liver transplant|1|||
161927210|NCT01436500|584780309|FG001|Overall Study|liver transplant|0|||
161927211|NCT01436500|584780310|FG002|Overall Study|liver transplant|0|||
161927212|NCT01436500|584780311|FG003|Overall Study|liver transplant|0|||
161927213|NCT01436500|584780312|FG004|Overall Study|liver transplant|0|||
161927214|NCT01436500|584780308|FG000|Overall Study|initiation of dialysis|0|||
161927215|NCT01436500|584780309|FG001|Overall Study|initiation of dialysis|0|||
161927216|NCT01436500|584780310|FG002|Overall Study|initiation of dialysis|0|||
161927217|NCT01436500|584780311|FG003|Overall Study|initiation of dialysis|0|||
161927218|NCT01436500|584780312|FG004|Overall Study|initiation of dialysis|1|||
161927219|NCT01436500|584780308|FG000|Overall Study|discontinued study drug|1|||
161927220|NCT01436500|584780309|FG001|Overall Study|discontinued study drug|0|||
162020749|NCT01945710|585132029|FG000|Overall Study|Adverse Event|0|||
161927221|NCT01436500|584780310|FG002|Overall Study|discontinued study drug|0|||
161927222|NCT01436500|584780311|FG003|Overall Study|discontinued study drug|0|||
161927223|NCT01436500|584780312|FG004|Overall Study|discontinued study drug|0|||
161676290|NCT05749952|583867362|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
161927224|NCT01436500|584780308|FG000|Overall Study|Other|0|||
161927225|NCT01436500|584780309|FG001|Overall Study|Other|1|||
162020750|NCT01945710|585132030|FG001|Overall Study|Adverse Event|1|||
162020751|NCT01945710|585132031|FG002|Overall Study|Adverse Event|0|||
162020752|NCT01945710|585132032|FG003|Overall Study|Adverse Event|0|||
162020753|NCT01945710|585132033|FG004|Overall Study|Adverse Event|0|||
162020754|NCT01945710|585132034|FG005|Overall Study|Adverse Event|0|||
162020755|NCT01945710|585132035|FG006|Overall Study|Adverse Event|0|||
162020756|NCT01945710|585132029|FG000|Overall Study|Other|2|||
162020757|NCT01945710|585132030|FG001|Overall Study|Other|0|||
162020758|NCT01945710|585132031|FG002|Overall Study|Other|3|||
162020759|NCT01945710|585132032|FG003|Overall Study|Other|1|||
162020760|NCT01945710|585132033|FG004|Overall Study|Other|1|||
162020761|NCT01945710|585132034|FG005|Overall Study|Other|0|||
162020762|NCT01945710|585132035|FG006|Overall Study|Other|4|||
162020763|NCT01945710|585132029|FG000|Overall Study|Withdrawal by Subject|0|||
162020764|NCT01945710|585132030|FG001|Overall Study|Withdrawal by Subject|1|||
162020765|NCT01945710|585132031|FG002|Overall Study|Withdrawal by Subject|1|||
162020766|NCT01945710|585132032|FG003|Overall Study|Withdrawal by Subject|0|||
162020767|NCT01945710|585132033|FG004|Overall Study|Withdrawal by Subject|1|||
162020768|NCT01945710|585132034|FG005|Overall Study|Withdrawal by Subject|0|||
162020769|NCT01945710|585132035|FG006|Overall Study|Withdrawal by Subject|0|||
162020770|NCT02730195|585132036|FG000|Overall Study|Withdrawal by Subject|1|||
162020771|NCT00745849|585132037|FG000|First Intervention|Withdrawal by Subject|0|||
162020772|NCT00745849|585132038|FG001|First Intervention|Withdrawal by Subject|1|||
162020773|NCT00745849|585132037|FG000|First Intervention|Lost to Follow-up|1|||
162020774|NCT00745849|585132038|FG001|First Intervention|Lost to Follow-up|1|||
162020775|NCT00745849|585132037|FG000|Second Intervention|Lost to Follow-up|2|||
162020776|NCT00745849|585132038|FG001|Second Intervention|Lost to Follow-up|1|||
162020777|NCT01139008|585132039|FG000|Overall Study|Withdrawal by Subject|5|||
162020778|NCT01139008|585132039|FG000|Overall Study|Non-compliant, lost product|1|||
162020779|NCT01754727|585132040|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
162020780|NCT02785770|585132043|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
162020781|NCT02785770|585132044|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
162200394|NCT02938520|585782851|FG001|Overall Study|Protocol Violation|1|||
162200395|NCT02938520|585782850|FG000|Overall Study|Lack of Efficacy|5|||
162200396|NCT02938520|585782851|FG001|Overall Study|Lack of Efficacy|3|||
162200397|NCT02938520|585782850|FG000|Overall Study|Adverse Event|9|||
162200398|NCT02938520|585782851|FG001|Overall Study|Adverse Event|4|||
162200399|NCT04448561|585782855|FG000|Overall Study|Noncompliance|1|||
162200400|NCT04448561|585782856|FG001|Overall Study|Noncompliance|0|||
162200401|NCT00506922|585783976|FG000|Overall Study|Physician Decision|0|||
162200402|NCT00506922|585783977|FG001|Overall Study|Physician Decision|0|||
162200403|NCT00506922|585783978|FG002|Overall Study|Physician Decision|0|||
162200404|NCT00506922|585783979|FG003|Overall Study|Physician Decision|2|||
162200405|NCT00506922|585783980|FG004|Overall Study|Physician Decision|0|||
162200406|NCT00506922|585783976|FG000|Overall Study|Withdrawal by Subject|0|||
162200407|NCT00506922|585783977|FG001|Overall Study|Withdrawal by Subject|0|||
162200408|NCT00506922|585783978|FG002|Overall Study|Withdrawal by Subject|0|||
162200409|NCT00506922|585783979|FG003|Overall Study|Withdrawal by Subject|0|||
162200410|NCT00506922|585783980|FG004|Overall Study|Withdrawal by Subject|1|||
162200411|NCT00508274|585783986|FG000|Overall Study|Adverse Event|5|||
162200412|NCT00508274|585783986|FG000|Overall Study|Death|7|||
162200413|NCT00508274|585783986|FG000|Overall Study|Disease progression|32|||
162200414|NCT00508274|585783986|FG000|Overall Study|Withdrawal by Subject|1|||
162200415|NCT00508274|585783986|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
162200416|NCT00508274|585783986|FG000|Overall Study|Missing|3|||
162200417|NCT00197106|585783987|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
162200418|NCT00197106|585783988|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
162200419|NCT00197106|585783989|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
162200420|NCT00197106|585783987|FG000|Overall Treatment Period|Lack of Efficacy|0|||
162200421|NCT00197106|585783988|FG001|Overall Treatment Period|Lack of Efficacy|1|||
162020782|NCT02785770|585132045|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
162020783|NCT02785770|585132046|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
162020784|NCT02785770|585132043|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
162020785|NCT02785770|585132044|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
162020786|NCT02785770|585132045|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
162020787|NCT02785770|585132046|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
162020788|NCT02785770|585132043|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
162200422|NCT00197106|585783989|FG002|Overall Treatment Period|Lack of Efficacy|0|||
162200423|NCT00197106|585783987|FG000|Overall Treatment Period|Lost to Follow-up|0|||
162200424|NCT00197106|585783988|FG001|Overall Treatment Period|Lost to Follow-up|0|||
162200425|NCT00197106|585783989|FG002|Overall Treatment Period|Lost to Follow-up|2|||
162200426|NCT00197106|585783987|FG000|Overall Treatment Period|Protocol Violation|0|||
162200427|NCT00197106|585783988|FG001|Overall Treatment Period|Protocol Violation|0|||
162020789|NCT02785770|585132044|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
162200428|NCT00197106|585783989|FG002|Overall Treatment Period|Protocol Violation|2|||
162200429|NCT00197106|585783987|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
162200430|NCT00197106|585783988|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
162200431|NCT00197106|585783989|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
162200432|NCT02531126|585783990|FG000|Overall Study|Non-compliance with protocol/protocol deviation|5|||
162200433|NCT02531126|585783991|FG001|Overall Study|Non-compliance with protocol/protocol deviation|0|||
162200434|NCT02531126|585783992|FG002|Overall Study|Non-compliance with protocol/protocol deviation|3|||
162200435|NCT02531126|585783993|FG003|Overall Study|Non-compliance with protocol/protocol deviation|0|||
162200436|NCT02531126|585783990|FG000|Overall Study|Adverse Event|16|||
162200437|NCT02531126|585783991|FG001|Overall Study|Adverse Event|13|||
162200438|NCT02531126|585783992|FG002|Overall Study|Adverse Event|27|||
162200439|NCT02531126|585783993|FG003|Overall Study|Adverse Event|4|||
162200440|NCT02531126|585783990|FG000|Overall Study|Lack of Efficacy|50|||
162200441|NCT02531126|585783991|FG001|Overall Study|Lack of Efficacy|32|||
162200442|NCT02531126|585783992|FG002|Overall Study|Lack of Efficacy|121|||
162200443|NCT02531126|585783993|FG003|Overall Study|Lack of Efficacy|0|||
162200444|NCT02531126|585783990|FG000|Overall Study|Withdrawal by Subject|38|||
162200445|NCT02531126|585783991|FG001|Overall Study|Withdrawal by Subject|31|||
162200446|NCT02531126|585783992|FG002|Overall Study|Withdrawal by Subject|96|||
162200447|NCT02531126|585783993|FG003|Overall Study|Withdrawal by Subject|6|||
162200448|NCT02531126|585783990|FG000|Overall Study|Pregnancy|2|||
162200449|NCT02531126|585783991|FG001|Overall Study|Pregnancy|3|||
162200450|NCT02531126|585783992|FG002|Overall Study|Pregnancy|2|||
162200451|NCT02531126|585783993|FG003|Overall Study|Pregnancy|0|||
162200452|NCT02531126|585783990|FG000|Overall Study|Switched to commercial drug|2|||
162200453|NCT02531126|585783991|FG001|Overall Study|Switched to commercial drug|4|||
162200454|NCT02531126|585783992|FG002|Overall Study|Switched to commercial drug|4|||
162200455|NCT02531126|585783993|FG003|Overall Study|Switched to commercial drug|0|||
162200456|NCT02531126|585783990|FG000|Overall Study|Other reasons|23|||
162200457|NCT02531126|585783991|FG001|Overall Study|Other reasons|29|||
162200458|NCT02531126|585783992|FG002|Overall Study|Other reasons|27|||
162200459|NCT02531126|585783993|FG003|Overall Study|Other reasons|15|||
162200460|NCT02531126|585783990|FG000|Overall Study|Physician Decision|6|||
162200461|NCT02531126|585783991|FG001|Overall Study|Physician Decision|6|||
162200462|NCT02531126|585783992|FG002|Overall Study|Physician Decision|28|||
162200463|NCT02531126|585783993|FG003|Overall Study|Physician Decision|0|||
162200464|NCT02531126|585783990|FG000|Overall Study|Non-compliance with investigational drug|1|||
162200465|NCT02531126|585783991|FG001|Overall Study|Non-compliance with investigational drug|0|||
162200466|NCT02531126|585783992|FG002|Overall Study|Non-compliance with investigational drug|0|||
162200467|NCT02531126|585783993|FG003|Overall Study|Non-compliance with investigational drug|0|||
162200468|NCT00762723|585783994|FG000|Overall Study|Study Terminated slow enrollement|5|||
162200469|NCT00762723|585783995|FG001|Overall Study|Study Terminated slow enrollement|5|||
162200470|NCT00762723|585783996|FG002|Overall Study|Study Terminated slow enrollement|3|||
162200471|NCT01572493|585783999|FG000|Overall Study|Physician Decision|1|||
162200472|NCT01572493|585784000|FG001|Overall Study|Physician Decision|0|||
162200473|NCT01572493|585784001|FG002|Overall Study|Physician Decision|0|||
162200474|NCT01572493|585784002|FG003|Overall Study|Physician Decision|0|||
162200475|NCT01572493|585784003|FG004|Overall Study|Physician Decision|0|||
162200476|NCT01572493|585784004|FG005|Overall Study|Physician Decision|0|||
162200477|NCT01572493|585784005|FG006|Overall Study|Physician Decision|0|||
162200478|NCT01572493|585784006|FG007|Overall Study|Physician Decision|0|||
162200479|NCT01572493|585784007|FG008|Overall Study|Physician Decision|0|||
162200480|NCT01572493|585783999|FG000|Overall Study|Switched to alternative treatment|0|||
162200481|NCT01572493|585784000|FG001|Overall Study|Switched to alternative treatment|1|||
162200482|NCT01572493|585784001|FG002|Overall Study|Switched to alternative treatment|2|||
162200483|NCT01572493|585784002|FG003|Overall Study|Switched to alternative treatment|1|||
162200484|NCT01572493|585784003|FG004|Overall Study|Switched to alternative treatment|2|||
162200485|NCT01572493|585784004|FG005|Overall Study|Switched to alternative treatment|0|||
162200486|NCT01572493|585784005|FG006|Overall Study|Switched to alternative treatment|2|||
162200487|NCT01572493|585784006|FG007|Overall Study|Switched to alternative treatment|0|||
162200488|NCT01572493|585784007|FG008|Overall Study|Switched to alternative treatment|2|||
162200489|NCT01572493|585783999|FG000|Overall Study|Death|0|||
162200490|NCT01572493|585784000|FG001|Overall Study|Death|0|||
162200491|NCT01572493|585784001|FG002|Overall Study|Death|0|||
162200492|NCT01572493|585784002|FG003|Overall Study|Death|1|||
162200493|NCT01572493|585784003|FG004|Overall Study|Death|0|||
162200494|NCT01572493|585784004|FG005|Overall Study|Death|1|||
162200495|NCT01572493|585784005|FG006|Overall Study|Death|0|||
162200496|NCT01572493|585784006|FG007|Overall Study|Death|0|||
162200497|NCT01572493|585784007|FG008|Overall Study|Death|0|||
162200498|NCT01572493|585783999|FG000|Overall Study|Adverse Event|0|||
162200499|NCT01572493|585784000|FG001|Overall Study|Adverse Event|0|||
162200500|NCT01572493|585784001|FG002|Overall Study|Adverse Event|0|||
162200501|NCT01572493|585784002|FG003|Overall Study|Adverse Event|0|||
162200502|NCT01572493|585784003|FG004|Overall Study|Adverse Event|0|||
162200503|NCT01572493|585784004|FG005|Overall Study|Adverse Event|0|||
162200504|NCT01572493|585784005|FG006|Overall Study|Adverse Event|1|||
162200505|NCT01572493|585784006|FG007|Overall Study|Adverse Event|0|||
162200506|NCT01572493|585784007|FG008|Overall Study|Adverse Event|0|||
162200507|NCT00609245|585784008|FG000|Overall Study|Adverse Event|1|||
162200508|NCT01090076|585784009|FG000|Overall Study|Death|1|||
162200509|NCT01090076|585784010|FG001|Overall Study|Death|1|||
162200510|NCT01090076|585784009|FG000|Overall Study|Withdrawal by Subject|0|||
162200511|NCT01090076|585784010|FG001|Overall Study|Withdrawal by Subject|1|||
162200512|NCT03022045|585784011|FG000|Overall Study|Adverse Event|0|||
162200513|NCT03022045|585784012|FG001|Overall Study|Adverse Event|1|||
162200514|NCT03022045|585784011|FG000|Overall Study|Withdrawal by Subject|1|||
162200515|NCT03022045|585784012|FG001|Overall Study|Withdrawal by Subject|1|||
162200516|NCT01284634|585784015|FG000|Overall Study|Adverse Event|1|||
162200517|NCT01284634|585784016|FG001|Overall Study|Adverse Event|0|||
162200518|NCT01284634|585784017|FG002|Overall Study|Adverse Event|2|||
162200519|NCT01284634|585784018|FG003|Overall Study|Adverse Event|1|||
162200520|NCT03807700|585784019|FG000|Overall Study|Withdrawal by Subject|2|||
162200521|NCT03807700|585784020|FG001|Overall Study|Withdrawal by Subject|1|||
162200522|NCT03132753|585784029|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
162200523|NCT03132753|585784030|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
162200524|NCT03132753|585784029|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
162200525|NCT03132753|585784030|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
162200526|NCT00084747|585784031|FG000|Overall Study|Relapsed|8|||
162200527|NCT00084747|585784031|FG000|Overall Study|Death|3|||
162200528|NCT00084747|585784031|FG000|Overall Study|Withdrawal by Subject|2|||
162200529|NCT01446042|585784035|FG000|Overall Study|Withdrawal by Subject|12|||
162200530|NCT01446042|585784036|FG001|Overall Study|Withdrawal by Subject|2|||
162200531|NCT01446042|585784037|FG002|Overall Study|Withdrawal by Subject|4|||
162200532|NCT01446042|585784035|FG000|Overall Study|Adverse Event|1|||
162200533|NCT01446042|585784036|FG001|Overall Study|Adverse Event|0|||
162200534|NCT01446042|585784037|FG002|Overall Study|Adverse Event|4|||
162200535|NCT01446042|585784035|FG000|Overall Study|Lost to Follow-up|5|||
162200536|NCT01446042|585784036|FG001|Overall Study|Lost to Follow-up|0|||
162200537|NCT01446042|585784037|FG002|Overall Study|Lost to Follow-up|0|||
162200538|NCT01446042|585784035|FG000|Overall Study|Other reasons|2|||
162200539|NCT01446042|585784036|FG001|Overall Study|Other reasons|1|||
161820999|NCT01211262|584385788|FG001|Overall Study|Withdrawal of Consent|0|||
161821000|NCT01211262|584385787|FG000|Overall Study|Other|0|||
161821001|NCT01211262|584385788|FG001|Overall Study|Other|1|||
162200540|NCT01446042|585784037|FG002|Overall Study|Other reasons|1|||
162200541|NCT05714345|585784045|FG000|Overall Study|Death|1|||
162200542|NCT05714345|585784046|FG001|Overall Study|Death|1|||
162200543|NCT01257698|585784056|FG000|Overall Study|Protocol Violation|4|||
162200544|NCT01257698|585784057|FG001|Overall Study|Protocol Violation|0|||
162200545|NCT00274846|585784060|FG000|Overall Study|Did not receive adequate NK cells|1|||
162200546|NCT04115319|585784064|FG000|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|2|||
162200547|NCT04115319|585784065|FG001|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|0|||
161821002|NCT01277510|584385791|FG000|Double-blind Phase|Non-compliance|0|||
161821003|NCT01277510|584385792|FG001|Double-blind Phase|Non-compliance|1|||
162200548|NCT04115319|585784064|FG000|Overall Study|Withdrawal by participant|17|||
162200549|NCT04115319|585784065|FG001|Overall Study|Withdrawal by participant|9|||
162200550|NCT04115319|585784064|FG000|Overall Study|Geopolitical Conflict Related|2|||
162200551|NCT04115319|585784065|FG001|Overall Study|Geopolitical Conflict Related|1|||
162200552|NCT04115319|585784064|FG000|Overall Study|COVID-19 Related|1|||
162200553|NCT04115319|585784065|FG001|Overall Study|COVID-19 Related|0|||
162200554|NCT04115319|585784064|FG000|Overall Study|Adverse Event|48|||
162200555|NCT04115319|585784065|FG001|Overall Study|Adverse Event|21|||
162200556|NCT04115319|585784064|FG000|Overall Study|Noncompliance with Study Drug|5|||
162200557|NCT04115319|585784065|FG001|Overall Study|Noncompliance with Study Drug|1|||
162200558|NCT04115319|585784064|FG000|Overall Study|Lack of Efficacy|6|||
162200559|NCT04115319|585784065|FG001|Overall Study|Lack of Efficacy|2|||
162200560|NCT04115319|585784064|FG000|Overall Study|Lost to Follow-up|6|||
162200561|NCT04115319|585784065|FG001|Overall Study|Lost to Follow-up|7|||
162200562|NCT04115319|585784064|FG000|Overall Study|Protocol Deviation|5|||
162200563|NCT04115319|585784065|FG001|Overall Study|Protocol Deviation|1|||
162200564|NCT04115319|585784064|FG000|Overall Study|Participant relocated|5|||
162200565|NCT04115319|585784065|FG001|Overall Study|Participant relocated|2|||
162200566|NCT04115319|585784064|FG000|Overall Study|Personal Reasons|0|||
162200567|NCT04115319|585784065|FG001|Overall Study|Personal Reasons|1|||
162200568|NCT04115319|585784064|FG000|Overall Study|Deemed Unsuitable for Participation|1|||
162200569|NCT04115319|585784065|FG001|Overall Study|Deemed Unsuitable for Participation|0|||
162200570|NCT02332824|585784068|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
162200571|NCT02332824|585784069|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
162200572|NCT02332824|585784070|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
162200573|NCT02332824|585784071|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
162200574|NCT02332824|585784072|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
162200575|NCT02332824|585784073|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
162200576|NCT02332824|585784068|FG000|Overall Study|Voluntary Withdrawal|1|||
162200577|NCT02332824|585784069|FG001|Overall Study|Voluntary Withdrawal|0|||
162200578|NCT02332824|585784070|FG002|Overall Study|Voluntary Withdrawal|0|||
162200579|NCT02332824|585784071|FG003|Overall Study|Voluntary Withdrawal|0|||
162200580|NCT02332824|585784072|FG004|Overall Study|Voluntary Withdrawal|0|||
162200581|NCT02332824|585784073|FG005|Overall Study|Voluntary Withdrawal|0|||
162200582|NCT02332824|585784068|FG000|Overall Study|Inconvenient schedule|1|||
162200583|NCT02332824|585784069|FG001|Overall Study|Inconvenient schedule|1|||
162200584|NCT02332824|585784070|FG002|Overall Study|Inconvenient schedule|0|||
162200585|NCT02332824|585784071|FG003|Overall Study|Inconvenient schedule|0|||
162200586|NCT02332824|585784072|FG004|Overall Study|Inconvenient schedule|0|||
162200587|NCT02332824|585784073|FG005|Overall Study|Inconvenient schedule|0|||
162200588|NCT02332824|585784068|FG000|Overall Study|Transfer|0|||
162200589|NCT02332824|585784069|FG001|Overall Study|Transfer|0|||
162200590|NCT02332824|585784070|FG002|Overall Study|Transfer|1|||
162200591|NCT02332824|585784071|FG003|Overall Study|Transfer|1|||
162200592|NCT02332824|585784072|FG004|Overall Study|Transfer|0|||
162200593|NCT02332824|585784073|FG005|Overall Study|Transfer|0|||
162200594|NCT03562117|585784074|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
162200595|NCT03562117|585784075|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
162200596|NCT03562117|585784076|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
162200597|NCT03928821|585784077|FG000|Overall Study|Death|0|||
162200598|NCT03928821|585784078|FG001|Overall Study|Death|1|||
162200599|NCT03928821|585784079|FG002|Overall Study|Death|0|||
162200600|NCT03928821|585784080|FG003|Overall Study|Death|0|||
162200601|NCT03928821|585784077|FG000|Overall Study|Lost to Follow-up|0|||
162200602|NCT03928821|585784078|FG001|Overall Study|Lost to Follow-up|2|||
162200603|NCT03928821|585784079|FG002|Overall Study|Lost to Follow-up|3|||
162200604|NCT03928821|585784080|FG003|Overall Study|Lost to Follow-up|0|||
162200605|NCT03928821|585784077|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
162200606|NCT03928821|585784078|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
162200607|NCT03928821|585784079|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
161927226|NCT01436500|584780310|FG002|Overall Study|Other|0|||
162200608|NCT03928821|585784080|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
162200609|NCT04150250|585784087|FG000|Overall Study|Lost to Follow-up|0|||
162200610|NCT04150250|585784088|FG001|Overall Study|Lost to Follow-up|2|||
162200611|NCT05379023|585784092|FG000|Overall Study|Lost to Follow-up|1|||
162200612|NCT05379023|585784093|FG001|Overall Study|Lost to Follow-up|0|||
162200613|NCT05379023|585784094|FG002|Overall Study|Lost to Follow-up|0|||
162200614|NCT05379023|585784092|FG000|Overall Study|Withdrawal by Subject|2|||
162200615|NCT05379023|585784093|FG001|Overall Study|Withdrawal by Subject|0|||
162200616|NCT05379023|585784094|FG002|Overall Study|Withdrawal by Subject|0|||
162200617|NCT05147662|585784095|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161927227|NCT01436500|584780311|FG003|Overall Study|Other|1|||
162200618|NCT05147662|585784095|FG000|Overall Study|Assigned to treatment but never treated|1|||
162200619|NCT03602859|585784097|FG000|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|10|||
162200620|NCT03602859|585784098|FG001|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
162200621|NCT03602859|585784099|FG002|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
162200622|NCT03602859|585784100|FG003|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
162200623|NCT03602859|585784097|FG000|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|2|||
162200624|NCT03602859|585784098|FG001|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
161927228|NCT01436500|584780312|FG004|Overall Study|Other|0|||
162200625|NCT03602859|585784099|FG002|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
162200626|NCT03602859|585784100|FG003|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
162200627|NCT03602859|585784097|FG000|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|3|||
162200628|NCT03602859|585784098|FG001|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
162200629|NCT03602859|585784099|FG002|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
162200630|NCT03602859|585784100|FG003|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
162200631|NCT03602859|585784097|FG000|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|6|||
162200632|NCT03602859|585784098|FG001|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
162200633|NCT03602859|585784099|FG002|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
162200634|NCT03602859|585784100|FG003|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
162200635|NCT03602859|585784097|FG000|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|10|||
162200636|NCT03602859|585784098|FG001|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
162200637|NCT03602859|585784099|FG002|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
162200638|NCT03602859|585784100|FG003|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
162200639|NCT03602859|585784097|FG000|Chemotherapy Run-In Period (Cycle 1)|Death|10|||
162200640|NCT03602859|585784098|FG001|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
162200641|NCT03602859|585784099|FG002|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
162200642|NCT03602859|585784100|FG003|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
162200643|NCT03602859|585784097|FG000|Chemotherapy Run-In Period (Cycle 1)|Other|27|||
162200644|NCT03602859|585784098|FG001|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
162200645|NCT03602859|585784099|FG002|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
162200646|NCT03602859|585784100|FG003|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
162200647|NCT03602859|585784097|FG000|Chemotherapy Run-In Period (Cycle 1)|Missing|1|||
162200648|NCT03602859|585784098|FG001|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
162200649|NCT03602859|585784099|FG002|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
162200650|NCT03602859|585784100|FG003|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
162200651|NCT03602859|585784097|FG000|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|10|||
162200652|NCT03602859|585784098|FG001|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
162200653|NCT03602859|585784099|FG002|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
162200654|NCT03602859|585784100|FG003|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
162200655|NCT03602859|585784097|FG000|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|0|||
162200656|NCT03602859|585784098|FG001|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|1|||
162200657|NCT03602859|585784099|FG002|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|5|||
162200658|NCT03602859|585784100|FG003|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|3|||
162200659|NCT03602859|585784097|FG000|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|0|||
162200660|NCT03602859|585784098|FG001|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|7|||
162200661|NCT03602859|585784099|FG002|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|11|||
162200662|NCT03602859|585784100|FG003|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|25|||
162200663|NCT03602859|585784097|FG000|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|0|||
162200664|NCT03602859|585784098|FG001|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|7|||
162200665|NCT03602859|585784099|FG002|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|14|||
162200666|NCT03602859|585784100|FG003|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|15|||
162200667|NCT03602859|585784097|FG000|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|0|||
162200668|NCT03602859|585784098|FG001|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|2|||
162200669|NCT03602859|585784099|FG002|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|1|||
162200670|NCT03602859|585784100|FG003|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|5|||
162200671|NCT03602859|585784097|FG000|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|0|||
162200672|NCT03602859|585784098|FG001|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
162200673|NCT03602859|585784099|FG002|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
162200674|NCT03602859|585784100|FG003|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|8|||
162200675|NCT03602859|585784097|FG000|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|0|||
162200676|NCT03602859|585784098|FG001|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|9|||
162200677|NCT03602859|585784099|FG002|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|11|||
162200678|NCT03602859|585784100|FG003|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|29|||
162200679|NCT03602859|585784097|FG000|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
162200680|NCT03602859|585784098|FG001|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
162200681|NCT03602859|585784099|FG002|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
162200682|NCT03602859|585784100|FG003|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|1|||
162200683|NCT03602859|585784097|FG000|Chemo Treatment Period (Cycle 2 to 6)|Death|0|||
162200684|NCT03602859|585784098|FG001|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
162200685|NCT03602859|585784099|FG002|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
162200686|NCT03602859|585784100|FG003|Chemo Treatment Period (Cycle 2 to 6)|Death|5|||
162200687|NCT03602859|585784097|FG000|Chemo Treatment Period (Cycle 2 to 6)|Other|0|||
162200688|NCT03602859|585784098|FG001|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
162200689|NCT03602859|585784099|FG002|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
162200690|NCT03602859|585784100|FG003|Chemo Treatment Period (Cycle 2 to 6)|Other|9|||
162200691|NCT03602859|585784097|FG000|Maintenance Period (Cycle 7 to 89)|Ongoing|0|||
162200692|NCT03602859|585784098|FG001|Maintenance Period (Cycle 7 to 89)|Ongoing|3|||
162200693|NCT03602859|585784099|FG002|Maintenance Period (Cycle 7 to 89)|Ongoing|23|||
162200694|NCT03602859|585784100|FG003|Maintenance Period (Cycle 7 to 89)|Ongoing|42|||
162200695|NCT03602859|585784097|FG000|Maintenance Period (Cycle 7 to 89)|Adverse Event|0|||
162200696|NCT03602859|585784098|FG001|Maintenance Period (Cycle 7 to 89)|Adverse Event|6|||
162200697|NCT03602859|585784099|FG002|Maintenance Period (Cycle 7 to 89)|Adverse Event|24|||
162200698|NCT03602859|585784100|FG003|Maintenance Period (Cycle 7 to 89)|Adverse Event|91|||
162200699|NCT03602859|585784097|FG000|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
162200700|NCT03602859|585784098|FG001|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
162200701|NCT03602859|585784099|FG002|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|1|||
162200702|NCT03602859|585784100|FG003|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|2|||
162200703|NCT03602859|585784097|FG000|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|0|||
162200704|NCT03602859|585784098|FG001|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|83|||
162200705|NCT03602859|585784099|FG002|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|251|||
162200706|NCT03602859|585784100|FG003|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|356|||
162200707|NCT03602859|585784097|FG000|Maintenance Period (Cycle 7 to 89)|Risk to Patient|0|||
162200708|NCT03602859|585784098|FG001|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
162200709|NCT03602859|585784099|FG002|Maintenance Period (Cycle 7 to 89)|Risk to Patient|1|||
162200710|NCT03602859|585784100|FG003|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
162200711|NCT03602859|585784097|FG000|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|0|||
162200712|NCT03602859|585784098|FG001|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
162200713|NCT03602859|585784099|FG002|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
162200714|NCT03602859|585784100|FG003|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|5|||
162200715|NCT03602859|585784097|FG000|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|0|||
162200716|NCT03602859|585784098|FG001|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|7|||
162200717|NCT03602859|585784099|FG002|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|22|||
162200718|NCT03602859|585784100|FG003|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|48|||
162200719|NCT03602859|585784097|FG000|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
162200720|NCT03602859|585784098|FG001|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
162200721|NCT03602859|585784099|FG002|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
162200722|NCT03602859|585784100|FG003|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
162200723|NCT03602859|585784097|FG000|Maintenance Period (Cycle 7 to 89)|Death|0|||
162200724|NCT03602859|585784098|FG001|Maintenance Period (Cycle 7 to 89)|Death|0|||
162200725|NCT03602859|585784099|FG002|Maintenance Period (Cycle 7 to 89)|Death|1|||
162200726|NCT03602859|585784100|FG003|Maintenance Period (Cycle 7 to 89)|Death|7|||
162200727|NCT03602859|585784097|FG000|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
162200728|NCT03602859|585784098|FG001|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|18|||
162200729|NCT03602859|585784099|FG002|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
162200730|NCT03602859|585784100|FG003|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
162200731|NCT03602859|585784097|FG000|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
162200732|NCT03602859|585784098|FG001|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
162200733|NCT03602859|585784099|FG002|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
161821004|NCT01277510|584385791|FG000|Double-blind Phase|Adverse Event|1|||
161821005|NCT01277510|584385792|FG001|Double-blind Phase|Adverse Event|0|||
161821006|NCT01277510|584385791|FG000|Double-blind Phase|Withdrawal by Subject|2|||
161821007|NCT01277510|584385792|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161821008|NCT01277510|584385791|FG000|Double-blind Phase|Administrative decision|7|||
162200734|NCT03602859|585784100|FG003|Maintenance Period (Cycle 7 to 89)|Investigator decision|1|||
162200735|NCT03602859|585784097|FG000|Maintenance Period (Cycle 7 to 89)|Other|0|||
162200736|NCT03602859|585784098|FG001|Maintenance Period (Cycle 7 to 89)|Other|2|||
162200737|NCT03602859|585784099|FG002|Maintenance Period (Cycle 7 to 89)|Other|2|||
162200738|NCT03602859|585784100|FG003|Maintenance Period (Cycle 7 to 89)|Other|12|||
162200739|NCT05244226|585785284|FG000|Overall Study|Adverse Event|1|||
162200740|NCT05244226|585785285|FG001|Overall Study|Adverse Event|0|||
162200741|NCT05244226|585785286|FG002|Overall Study|Adverse Event|0|||
162200742|NCT05244226|585785284|FG000|Overall Study|Lost to Follow-up|0|||
162200743|NCT05244226|585785285|FG001|Overall Study|Lost to Follow-up|0|||
162200744|NCT05244226|585785286|FG002|Overall Study|Lost to Follow-up|1|||
162200745|NCT05244226|585785284|FG000|Overall Study|Protocol Violation|0|||
162200746|NCT05244226|585785285|FG001|Overall Study|Protocol Violation|2|||
162200747|NCT05244226|585785286|FG002|Overall Study|Protocol Violation|2|||
162200748|NCT04050722|585785287|FG000|Overall Study|Withdrawal by Subject|1|||
162200749|NCT04050722|585785288|FG001|Overall Study|Withdrawal by Subject|0|||
162200750|NCT00111839|585785292|FG000|Overall Study|Disease Progression|30|||
162200751|NCT00111839|585785293|FG001|Overall Study|Disease Progression|33|||
162200752|NCT00111839|585785294|FG002|Overall Study|Disease Progression|33|||
162200753|NCT00111839|585785292|FG000|Overall Study|Adverse Event|5|||
162200754|NCT00111839|585785293|FG001|Overall Study|Adverse Event|3|||
162200755|NCT00111839|585785294|FG002|Overall Study|Adverse Event|1|||
162200756|NCT00111839|585785292|FG000|Overall Study|Protocol Violation|2|||
162200757|NCT00111839|585785293|FG001|Overall Study|Protocol Violation|4|||
162200758|NCT00111839|585785294|FG002|Overall Study|Protocol Violation|2|||
162200759|NCT00111839|585785292|FG000|Overall Study|Death|1|||
162200760|NCT00111839|585785293|FG001|Overall Study|Death|1|||
162200761|NCT00111839|585785294|FG002|Overall Study|Death|6|||
162200762|NCT00111839|585785292|FG000|Overall Study|Withdrawal by Subject|2|||
162200763|NCT00111839|585785293|FG001|Overall Study|Withdrawal by Subject|2|||
162200764|NCT00111839|585785294|FG002|Overall Study|Withdrawal by Subject|2|||
162200765|NCT00111839|585785292|FG000|Overall Study|Lost to Follow-up|1|||
162200766|NCT00111839|585785293|FG001|Overall Study|Lost to Follow-up|0|||
162200767|NCT00111839|585785294|FG002|Overall Study|Lost to Follow-up|0|||
162200768|NCT00111839|585785292|FG000|Overall Study|Logistical Constraint|1|||
162200769|NCT00111839|585785293|FG001|Overall Study|Logistical Constraint|0|||
162200770|NCT00111839|585785294|FG002|Overall Study|Logistical Constraint|0|||
162200771|NCT00111839|585785292|FG000|Overall Study|Other|6|||
162200772|NCT00111839|585785293|FG001|Overall Study|Other|3|||
162200773|NCT00111839|585785294|FG002|Overall Study|Other|3|||
162200774|NCT00111839|585785292|FG000|Overall Study|Randomized but Not Treated|0|||
162200775|NCT00111839|585785293|FG001|Overall Study|Randomized but Not Treated|0|||
162200776|NCT00111839|585785294|FG002|Overall Study|Randomized but Not Treated|2|||
162200777|NCT00377312|585785295|FG000|Overall Study|Adverse Event|1|||
162200778|NCT00377312|585785296|FG001|Overall Study|Adverse Event|1|||
162200779|NCT00382408|585785299|FG000|Overall Study|Did not meet protocol requirement|3|||
162200780|NCT00382408|585785300|FG001|Overall Study|Did not meet protocol requirement|3|||
162200781|NCT00382408|585785299|FG000|Overall Study|Protocol Violation|2|||
162200782|NCT00382408|585785300|FG001|Overall Study|Protocol Violation|2|||
162200783|NCT00382408|585785299|FG000|Overall Study|Physician Decision|1|||
162200784|NCT00382408|585785300|FG001|Overall Study|Physician Decision|0|||
162200785|NCT00382408|585785299|FG000|Overall Study|Withdrawal by Subject|17|||
162200786|NCT00382408|585785300|FG001|Overall Study|Withdrawal by Subject|6|||
162200787|NCT00382408|585785299|FG000|Overall Study|Pregnancy|2|||
161927229|NCT03983109|584780314|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
161927230|NCT03983109|584780315|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
161927231|NCT01068249|584780319|FG000|Overall Study|Death|1|||
161927232|NCT01068249|584780319|FG000|Overall Study|Withdrawal by Subject|3|||
161927233|NCT01740427|584780320|FG000|Overall Study|Objective Progression or Relapse|286|||
161927234|NCT01740427|584780321|FG001|Overall Study|Objective Progression or Relapse|172|||
162200788|NCT00382408|585785300|FG001|Overall Study|Pregnancy|0|||
162200789|NCT00382408|585785299|FG000|Overall Study|Lost to Follow-up|19|||
162200790|NCT00382408|585785300|FG001|Overall Study|Lost to Follow-up|8|||
162200791|NCT00382408|585785299|FG000|Overall Study|Other|100|||
162200792|NCT00382408|585785300|FG001|Overall Study|Other|35|||
162200793|NCT03924947|585785301|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
162200794|NCT03924947|585785302|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
162200795|NCT03924947|585785303|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
162200796|NCT03924947|585785304|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
162200797|NCT03924947|585785305|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
162200798|NCT03924947|585785306|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
162200799|NCT03085433|585785307|FG000|Overall Study|Withdrawal by Subject|2|||
162200800|NCT03085433|585785308|FG001|Overall Study|Withdrawal by Subject|4|||
162200801|NCT03085433|585785307|FG000|Overall Study|Physician Decision|33|||
162200802|NCT03085433|585785308|FG001|Overall Study|Physician Decision|50|||
162200803|NCT03809039|585785309|FG000|Part 1|Withdrawal by Subject|1|||
162200804|NCT03809039|585785310|FG001|Part 1|Withdrawal by Subject|0|||
162200805|NCT03809039|585785311|FG002|Part 1|Withdrawal by Subject|0|||
162200806|NCT03809039|585785312|FG003|Part 1|Withdrawal by Subject|1|||
162200807|NCT03809039|585785313|FG004|Part 1|Withdrawal by Subject|0|||
162200808|NCT03809039|585785314|FG005|Part 1|Withdrawal by Subject|0|||
162200809|NCT03809039|585785315|FG006|Part 1|Withdrawal by Subject|0|||
162200810|NCT03809039|585785316|FG007|Part 1|Withdrawal by Subject|0|||
162200811|NCT03809039|585785317|FG008|Part 1|Withdrawal by Subject|0|||
162200812|NCT03809039|585785309|FG000|Part 3|Withdrawn by study termination|0|||
162200813|NCT03809039|585785310|FG001|Part 3|Withdrawn by study termination|0|||
162200814|NCT03809039|585785311|FG002|Part 3|Withdrawn by study termination|0|||
162200815|NCT03809039|585785312|FG003|Part 3|Withdrawn by study termination|0|||
162200816|NCT03809039|585785313|FG004|Part 3|Withdrawn by study termination|0|||
162200817|NCT03809039|585785314|FG005|Part 3|Withdrawn by study termination|0|||
162200818|NCT03809039|585785315|FG006|Part 3|Withdrawn by study termination|0|||
162200819|NCT03809039|585785316|FG007|Part 3|Withdrawn by study termination|2|||
162200820|NCT03809039|585785317|FG008|Part 3|Withdrawn by study termination|6|||
162200821|NCT03451292|585785318|FG000|Overall Study|Death|44|||
162200822|NCT03451292|585785319|FG001|Overall Study|Death|59|||
162200823|NCT03451292|585785318|FG000|Overall Study|Withdrawal by Subject|18|||
162200824|NCT03451292|585785319|FG001|Overall Study|Withdrawal by Subject|13|||
162200825|NCT03451292|585785318|FG000|Overall Study|Transplantation|18|||
162200826|NCT03451292|585785319|FG001|Overall Study|Transplantation|12|||
162200827|NCT03451292|585785318|FG000|Overall Study|Lost to Follow-up|4|||
162200828|NCT03451292|585785319|FG001|Overall Study|Lost to Follow-up|12|||
162200829|NCT03451292|585785318|FG000|Overall Study|Physician Decision|4|||
162200830|NCT03451292|585785319|FG001|Overall Study|Physician Decision|3|||
162200831|NCT03451292|585785318|FG000|Overall Study|Adverse Event|3|||
162200832|NCT03451292|585785319|FG001|Overall Study|Adverse Event|3|||
162200833|NCT03451292|585785318|FG000|Overall Study|Non-compliance with Study Drug|2|||
162200834|NCT03451292|585785319|FG001|Overall Study|Non-compliance with Study Drug|0|||
162200835|NCT05271552|585785320|FG000|Overall Study|Adverse Event|4|||
162200836|NCT05271552|585785321|FG001|Overall Study|Adverse Event|6|||
162200837|NCT05271552|585785322|FG002|Overall Study|Adverse Event|3|||
162200838|NCT05271552|585785320|FG000|Overall Study|Death|1|||
162200839|NCT05271552|585785321|FG001|Overall Study|Death|1|||
162200840|NCT05271552|585785322|FG002|Overall Study|Death|1|||
162200841|NCT05271552|585785320|FG000|Overall Study|Lost to Follow-up|1|||
162200842|NCT05271552|585785321|FG001|Overall Study|Lost to Follow-up|5|||
162200843|NCT05271552|585785322|FG002|Overall Study|Lost to Follow-up|4|||
162200844|NCT05271552|585785320|FG000|Overall Study|Withdrawal by Subject|0|||
162200845|NCT05271552|585785321|FG001|Overall Study|Withdrawal by Subject|4|||
162200846|NCT05271552|585785322|FG002|Overall Study|Withdrawal by Subject|7|||
162200847|NCT05271552|585785320|FG000|Overall Study|Other medical reason.|1|||
162200848|NCT05271552|585785321|FG001|Overall Study|Other medical reason.|2|||
162200849|NCT05271552|585785322|FG002|Overall Study|Other medical reason.|0|||
162200850|NCT05271552|585785320|FG000|Overall Study|Other|3|||
162200851|NCT05271552|585785321|FG001|Overall Study|Other|3|||
162200852|NCT05271552|585785322|FG002|Overall Study|Other|6|||
162200853|NCT03840993|585785328|FG000|Overall Study|Adverse Event|1|||
162200854|NCT03840993|585785329|FG001|Overall Study|Adverse Event|0|||
162200855|NCT03840993|585785328|FG000|Overall Study|Lost to Follow-up|4|||
162200856|NCT03840993|585785329|FG001|Overall Study|Lost to Follow-up|0|||
162200857|NCT03840993|585785328|FG000|Overall Study|Physician Decision|0|||
162200858|NCT03840993|585785329|FG001|Overall Study|Physician Decision|1|||
162200859|NCT03840993|585785328|FG000|Overall Study|Pregnancy|0|||
162200860|NCT03840993|585785329|FG001|Overall Study|Pregnancy|1|||
162200861|NCT03840993|585785328|FG000|Overall Study|Withdrawal by Subject|1|||
162200862|NCT03840993|585785329|FG001|Overall Study|Withdrawal by Subject|3|||
162200863|NCT03840993|585785328|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
162200864|NCT03840993|585785329|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
162200865|NCT02176018|585785330|FG000|Overall Study|Adverse Event|0|||
162200866|NCT02176018|585785331|FG001|Overall Study|Adverse Event|2|||
162200867|NCT02176018|585785330|FG000|Overall Study|Lost to Follow-up|3|||
162200868|NCT02176018|585785331|FG001|Overall Study|Lost to Follow-up|1|||
162200869|NCT02176018|585785330|FG000|Overall Study|Protocol Violation|1|||
162200870|NCT02176018|585785331|FG001|Overall Study|Protocol Violation|1|||
162200871|NCT02176018|585785330|FG000|Overall Study|Withdrawal by Subject|1|||
162200872|NCT02176018|585785331|FG001|Overall Study|Withdrawal by Subject|2|||
162200873|NCT02253147|585785333|FG000|Overall Study|Protocol Violation|30|||
162200874|NCT02253147|585785333|FG000|Overall Study|Did not consent to study extension|9|||
162200875|NCT02253147|585785333|FG000|Overall Study|Conditional re-treatment at W52|5|||
162200876|NCT02253147|585785333|FG000|Overall Study|Lost to Follow-up|2|||
162200877|NCT02253147|585785333|FG000|Overall Study|Withdrawal by Subject|1|||
162200878|NCT02986659|585785334|FG000|First Intervention Period|Adverse Event|3|||
162200879|NCT02986659|585785335|FG001|First Intervention Period|Adverse Event|1|||
162200880|NCT02986659|585785334|FG000|First Intervention Period|Lost to Follow-up|1|||
162200881|NCT02986659|585785335|FG001|First Intervention Period|Lost to Follow-up|0|||
162200882|NCT02986659|585785334|FG000|First Intervention Period|Withdrawal by Subject|0|||
162200883|NCT02986659|585785335|FG001|First Intervention Period|Withdrawal by Subject|1|||
162200884|NCT02986659|585785334|FG000|Second Intervention Period|Adverse Event|0|||
162200885|NCT02986659|585785335|FG001|Second Intervention Period|Adverse Event|6|||
162200886|NCT02402465|585785336|FG000|Overall Study|Withdrawal by Subject|0|||
162200887|NCT02402465|585785337|FG001|Overall Study|Withdrawal by Subject|0|||
162200888|NCT02402465|585785338|FG002|Overall Study|Withdrawal by Subject|0|||
162200889|NCT02402465|585785339|FG003|Overall Study|Withdrawal by Subject|0|||
162200890|NCT02402465|585785340|FG004|Overall Study|Withdrawal by Subject|0|||
162200891|NCT02402465|585785341|FG005|Overall Study|Withdrawal by Subject|1|||
162200892|NCT02402465|585785336|FG000|Overall Study|Lost to Follow-up|0|||
162200893|NCT02402465|585785337|FG001|Overall Study|Lost to Follow-up|1|||
162200894|NCT02402465|585785338|FG002|Overall Study|Lost to Follow-up|0|||
162200895|NCT02402465|585785339|FG003|Overall Study|Lost to Follow-up|0|||
162200896|NCT02402465|585785340|FG004|Overall Study|Lost to Follow-up|1|||
162200897|NCT02402465|585785341|FG005|Overall Study|Lost to Follow-up|0|||
162200898|NCT01059526|585785342|FG000|Overall Study|Patient enrolled but not treated|20|||
162200899|NCT01059526|585785343|FG001|Overall Study|Patient enrolled but not treated|17|||
162200900|NCT01059526|585785342|FG000|Overall Study|Adverse Event|2|||
162200901|NCT01059526|585785343|FG001|Overall Study|Adverse Event|2|||
162200902|NCT01059526|585785342|FG000|Overall Study|Protocol Violation|0|||
162200903|NCT01059526|585785343|FG001|Overall Study|Protocol Violation|1|||
162200904|NCT01059526|585785342|FG000|Overall Study|Withdrawal by Subject|3|||
162200905|NCT01059526|585785343|FG001|Overall Study|Withdrawal by Subject|1|||
162200906|NCT01059526|585785342|FG000|Overall Study|Lost to Follow-up|4|||
162200907|NCT01059526|585785343|FG001|Overall Study|Lost to Follow-up|1|||
162200908|NCT01059526|585785342|FG000|Overall Study|Patient found to be dermatographic|1|||
162200909|NCT01059526|585785343|FG001|Overall Study|Patient found to be dermatographic|0|||
162200910|NCT01732588|585785344|FG000|First Intervention (7 Days)|Adverse Event|0|||
162200911|NCT01732588|585785345|FG001|First Intervention (7 Days)|Adverse Event|1|||
162200912|NCT01732588|585785346|FG002|First Intervention (7 Days)|Adverse Event|0|||
162200913|NCT02504502|585785349|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
162200914|NCT02504502|585785350|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
162200915|NCT02504502|585785349|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
162200916|NCT02504502|585785350|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
162200917|NCT01485991|585785354|FG000|Overall Study|Adverse Event|0|||
162200918|NCT01485991|585785355|FG001|Overall Study|Adverse Event|4|||
162200919|NCT01485991|585785354|FG000|Overall Study|Lost to Follow-up|13|||
162200920|NCT01485991|585785355|FG001|Overall Study|Lost to Follow-up|10|||
162200921|NCT01485991|585785354|FG000|Overall Study|Withdrawal by Subject|13|||
162200922|NCT01485991|585785355|FG001|Overall Study|Withdrawal by Subject|20|||
162200923|NCT01485991|585785354|FG000|Overall Study|randomized but not treated|6|||
162200924|NCT01485991|585785355|FG001|Overall Study|randomized but not treated|2|||
162200925|NCT01475370|585785356|FG000|Overall Study|Exacerbation of primary disease|2|||
162200926|NCT01475370|585785357|FG001|Overall Study|Exacerbation of primary disease|2|||
162200927|NCT01475370|585785358|FG002|Overall Study|Exacerbation of primary disease|2|||
162200928|NCT01475370|585785356|FG000|Overall Study|Study drug administration difficult|0|||
162200929|NCT01475370|585785357|FG001|Overall Study|Study drug administration difficult|1|||
162200930|NCT01475370|585785358|FG002|Overall Study|Study drug administration difficult|1|||
162200931|NCT01475370|585785356|FG000|Overall Study|Other than specified|1|||
162200932|NCT01475370|585785357|FG001|Overall Study|Other than specified|0|||
162200933|NCT01475370|585785358|FG002|Overall Study|Other than specified|0|||
162200934|NCT04203160|585785359|FG000|Overall Study|Alternative Therapy|3|||
162200935|NCT04203160|585785360|FG001|Overall Study|Alternative Therapy|0|||
162200936|NCT04203160|585785361|FG002|Overall Study|Alternative Therapy|1|||
162200937|NCT04203160|585785362|FG003|Overall Study|Alternative Therapy|0|||
162200938|NCT04203160|585785363|FG004|Overall Study|Alternative Therapy|0|||
162200939|NCT04203160|585785364|FG005|Overall Study|Alternative Therapy|2|||
162200940|NCT04203160|585785359|FG000|Overall Study|Withdrawal by Subject|4|||
162200941|NCT04203160|585785360|FG001|Overall Study|Withdrawal by Subject|5|||
162200942|NCT04203160|585785361|FG002|Overall Study|Withdrawal by Subject|0|||
162200943|NCT04203160|585785362|FG003|Overall Study|Withdrawal by Subject|0|||
162200944|NCT04203160|585785363|FG004|Overall Study|Withdrawal by Subject|0|||
162200945|NCT04203160|585785364|FG005|Overall Study|Withdrawal by Subject|4|||
162200946|NCT04203160|585785359|FG000|Overall Study|Adverse Event|7|||
162200947|NCT04203160|585785360|FG001|Overall Study|Adverse Event|5|||
162200948|NCT04203160|585785361|FG002|Overall Study|Adverse Event|0|||
162200949|NCT04203160|585785362|FG003|Overall Study|Adverse Event|0|||
162200950|NCT04203160|585785363|FG004|Overall Study|Adverse Event|0|||
162200951|NCT04203160|585785364|FG005|Overall Study|Adverse Event|0|||
162200952|NCT04203160|585785359|FG000|Overall Study|Sponsor Termination|1|||
162200953|NCT04203160|585785360|FG001|Overall Study|Sponsor Termination|0|||
162200954|NCT04203160|585785361|FG002|Overall Study|Sponsor Termination|0|||
162200955|NCT04203160|585785362|FG003|Overall Study|Sponsor Termination|0|||
162200956|NCT04203160|585785363|FG004|Overall Study|Sponsor Termination|0|||
162200957|NCT04203160|585785364|FG005|Overall Study|Sponsor Termination|0|||
162200958|NCT04203160|585785359|FG000|Overall Study|Physician Decision|3|||
162200959|NCT04203160|585785360|FG001|Overall Study|Physician Decision|2|||
162200960|NCT04203160|585785361|FG002|Overall Study|Physician Decision|0|||
162200961|NCT04203160|585785362|FG003|Overall Study|Physician Decision|0|||
162200962|NCT04203160|585785363|FG004|Overall Study|Physician Decision|0|||
162200963|NCT04203160|585785364|FG005|Overall Study|Physician Decision|0|||
162200964|NCT00679549|585785366|FG000|Overall Study|dropout|2|||
162200965|NCT00679549|585785367|FG001|Overall Study|dropout|4|||
162200966|NCT00679549|585785366|FG000|Overall Study|missing outcome echocardiograms|4|||
162200967|NCT00679549|585785367|FG001|Overall Study|missing outcome echocardiograms|5|||
162200968|NCT02744898|585785370|FG000|Overall Study|Progressive Disease|2|||
162200969|NCT02744898|585785370|FG000|Overall Study|Physician Decision|1|||
162200970|NCT02744898|585785370|FG000|Overall Study|Toxicity|1|||
162200971|NCT03048058|585785371|FG000|Overall Study|Lost to Follow-up|4|||
162200972|NCT03048058|585785372|FG001|Overall Study|Lost to Follow-up|0|||
162200973|NCT03048058|585785371|FG000|Overall Study|Withdrawal by Subject|0|||
162200974|NCT03048058|585785372|FG001|Overall Study|Withdrawal by Subject|4|||
162200975|NCT04736472|585785373|FG000|Overall Study|Lost to Follow-up|1|||
162200976|NCT04736472|585785374|FG001|Overall Study|Lost to Follow-up|0|||
162200977|NCT04736472|585785375|FG002|Overall Study|Lost to Follow-up|0|||
162200978|NCT04736472|585785373|FG000|Overall Study|Withdrawal by Subject|2|||
162200979|NCT04736472|585785374|FG001|Overall Study|Withdrawal by Subject|0|||
162200980|NCT04736472|585785375|FG002|Overall Study|Withdrawal by Subject|0|||
162200981|NCT04736472|585785373|FG000|Overall Study|Protocol Violation|48|||
162200982|NCT04736472|585785374|FG001|Overall Study|Protocol Violation|0|||
162200983|NCT04736472|585785375|FG002|Overall Study|Protocol Violation|6|||
162200984|NCT02268526|585785376|FG000|Overall Study|Adverse Event|0|||
162200985|NCT02268526|585785377|FG001|Overall Study|Adverse Event|2|||
162200986|NCT02268526|585785378|FG002|Overall Study|Adverse Event|1|||
162200987|NCT02268526|585785376|FG000|Overall Study|Death|1|||
162200988|NCT02268526|585785377|FG001|Overall Study|Death|11|||
162200989|NCT02268526|585785378|FG002|Overall Study|Death|0|||
162200990|NCT02268526|585785376|FG000|Overall Study|protocol deviation|0|||
162200991|NCT02268526|585785377|FG001|Overall Study|protocol deviation|1|||
162200992|NCT02268526|585785378|FG002|Overall Study|protocol deviation|0|||
162200993|NCT02268526|585785376|FG000|Overall Study|Physician Decision|0|||
162200994|NCT02268526|585785377|FG001|Overall Study|Physician Decision|0|||
162200995|NCT02268526|585785378|FG002|Overall Study|Physician Decision|1|||
162200996|NCT02268526|585785376|FG000|Overall Study|Subject/guardian decision|0|||
162200997|NCT02268526|585785377|FG001|Overall Study|Subject/guardian decision|7|||
162200998|NCT02268526|585785378|FG002|Overall Study|Subject/guardian decision|3|||
162200999|NCT00498797|585785381|FG000|Overall Study|Withdrawal by Subject|4|||
162201000|NCT00498797|585785382|FG001|Overall Study|Withdrawal by Subject|2|||
162201001|NCT00498797|585785381|FG000|Overall Study|Adverse Event|12|||
162201002|NCT00498797|585785382|FG001|Overall Study|Adverse Event|5|||
162201003|NCT00498797|585785381|FG000|Overall Study|Condition under investigation worsened|19|||
162201004|NCT00498797|585785382|FG001|Overall Study|Condition under investigation worsened|21|||
162201005|NCT00498797|585785381|FG000|Overall Study|Other|3|||
162201006|NCT00498797|585785382|FG001|Overall Study|Other|1|||
162201007|NCT00448344|585785386|FG000|Overall Study|Lost to Follow-up|20|||
162201008|NCT00448344|585785387|FG001|Overall Study|Lost to Follow-up|22|||
162201009|NCT00448344|585785386|FG000|Overall Study|Withdrawal by Subject|6|||
162201010|NCT00448344|585785387|FG001|Overall Study|Withdrawal by Subject|8|||
162201011|NCT00448344|585785386|FG000|Overall Study|Death|3|||
162201012|NCT00448344|585785387|FG001|Overall Study|Death|4|||
162201013|NCT00448344|585785386|FG000|Overall Study|Physician Decision|1|||
162201014|NCT00448344|585785387|FG001|Overall Study|Physician Decision|2|||
162201015|NCT01052714|585785393|FG000|Overall Study|Adverse Event|6|||
162201016|NCT01052714|585785394|FG001|Overall Study|Adverse Event|3|||
162201017|NCT01052714|585785395|FG002|Overall Study|Adverse Event|0|||
161821009|NCT01277510|584385792|FG001|Double-blind Phase|Administrative decision|9|||
161821010|NCT01277510|584385791|FG000|Double-blind Phase|Death|0|||
162201018|NCT01052714|585785393|FG000|Overall Study|Death|1|||
162201019|NCT01052714|585785394|FG001|Overall Study|Death|2|||
162201020|NCT01052714|585785395|FG002|Overall Study|Death|0|||
162201021|NCT01052714|585785393|FG000|Overall Study|Lost to Follow-up|2|||
162201022|NCT01052714|585785394|FG001|Overall Study|Lost to Follow-up|3|||
162201023|NCT01052714|585785395|FG002|Overall Study|Lost to Follow-up|0|||
162201024|NCT01052714|585785393|FG000|Overall Study|Physician Decision|9|||
162201025|NCT01052714|585785394|FG001|Overall Study|Physician Decision|9|||
162201026|NCT01052714|585785395|FG002|Overall Study|Physician Decision|1|||
162201027|NCT01052714|585785393|FG000|Overall Study|Withdrawal by Subject|7|||
162201028|NCT01052714|585785394|FG001|Overall Study|Withdrawal by Subject|12|||
162201029|NCT01052714|585785395|FG002|Overall Study|Withdrawal by Subject|1|||
162201030|NCT00417989|585785399|FG000|Overall Study|Withdrawal by Subject|13|||
162201031|NCT00417989|585785400|FG001|Overall Study|Withdrawal by Subject|13|||
162201032|NCT00417989|585785399|FG000|Overall Study|Lost to Follow-up|1|||
162201033|NCT00417989|585785400|FG001|Overall Study|Lost to Follow-up|6|||
162201034|NCT00417989|585785399|FG000|Overall Study|Protocol Violation|1|||
162201035|NCT00417989|585785400|FG001|Overall Study|Protocol Violation|0|||
162201036|NCT00417989|585785399|FG000|Overall Study|Death|0|||
162201037|NCT00417989|585785400|FG001|Overall Study|Death|1|||
162201038|NCT00417989|585785399|FG000|Overall Study|Physician Decision|5|||
162201039|NCT00417989|585785400|FG001|Overall Study|Physician Decision|2|||
162201040|NCT04212299|585785404|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
162201041|NCT02951052|585785405|FG000|Overall Study|Adverse Event|13|||
162201042|NCT02951052|585785406|FG001|Overall Study|Adverse Event|5|||
162201043|NCT02951052|585785405|FG000|Overall Study|Withdrawal by Subject|1|||
162201044|NCT02951052|585785406|FG001|Overall Study|Withdrawal by Subject|5|||
162201045|NCT02951052|585785405|FG000|Overall Study|Physician Decision|2|||
162201046|NCT02951052|585785406|FG001|Overall Study|Physician Decision|0|||
162201047|NCT02951052|585785405|FG000|Overall Study|Lost to Follow-up|1|||
162201048|NCT02951052|585785406|FG001|Overall Study|Lost to Follow-up|1|||
161821011|NCT01277510|584385792|FG001|Double-blind Phase|Death|1|||
161821012|NCT01277510|584385791|FG000|Double-blind Phase|Protocol-specified criteria|2|||
161821013|NCT01277510|584385792|FG001|Double-blind Phase|Protocol-specified criteria|6|||
161821014|NCT01277510|584385791|FG000|Double-blind Phase|Other|1|||
161821015|NCT01277510|584385792|FG001|Double-blind Phase|Other|1|||
161821016|NCT01277510|584385791|FG000|Open-label Phase|Administrative decision|4|||
161821017|NCT01277510|584385792|FG001|Open-label Phase|Administrative decision|3|||
161821018|NCT01277510|584385791|FG000|Open-label Phase|Protocol-specified criteria|1|||
161821019|NCT01277510|584385792|FG001|Open-label Phase|Protocol-specified criteria|0|||
161821020|NCT01277510|584385791|FG000|Open-label Phase|Never received investigational product|2|||
161821021|NCT01277510|584385792|FG001|Open-label Phase|Never received investigational product|0|||
161821022|NCT00533507|584385793|FG000|Overall Study|Withdrawal by Subject|1|||
161821023|NCT02119936|584385802|FG000|Overall Study|Lost to Follow-up|10|||
161821024|NCT00570128|584385803|FG000|Overall Study|Adverse Event|1|||
161821025|NCT00570128|584385804|FG001|Overall Study|Adverse Event|0|||
161821026|NCT00570128|584385803|FG000|Overall Study|Lost to Follow-up|1|||
161821027|NCT00570128|584385804|FG001|Overall Study|Lost to Follow-up|0|||
161821028|NCT00570128|584385803|FG000|Overall Study|Withdrawal by Subject|2|||
161821029|NCT00570128|584385804|FG001|Overall Study|Withdrawal by Subject|0|||
161821030|NCT01426854|584385807|FG000|Overall Study|Adverse Event|1|||
161821031|NCT01426854|584385808|FG001|Overall Study|Adverse Event|5|||
161821032|NCT01426854|584385807|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
161821033|NCT01426854|584385808|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
161821034|NCT01426854|584385807|FG000|Overall Study|Lost to Follow-up|3|||
161821035|NCT01426854|584385808|FG001|Overall Study|Lost to Follow-up|0|||
161821036|NCT01426854|584385807|FG000|Overall Study|Noncompliance|0|||
161821037|NCT01426854|584385808|FG001|Overall Study|Noncompliance|1|||
161821038|NCT01426854|584385807|FG000|Overall Study|Treatment Failure|0|||
161821039|NCT01426854|584385808|FG001|Overall Study|Treatment Failure|16|||
161821040|NCT01426854|584385807|FG000|Overall Study|Protocol Deviation|0|||
161821041|NCT01426854|584385808|FG001|Overall Study|Protocol Deviation|1|||
161821042|NCT01426854|584385807|FG000|Overall Study|Other|3|||
161927235|NCT01740427|584780320|FG000|Overall Study|Adverse Event|32|||
161927236|NCT01740427|584780321|FG001|Overall Study|Adverse Event|9|||
161927237|NCT01740427|584780320|FG000|Overall Study|Global Deterioration of Health Status|28|||
161927238|NCT01740427|584780321|FG001|Overall Study|Global Deterioration of Health Status|12|||
162201049|NCT02951052|585785405|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
161821043|NCT01426854|584385808|FG001|Overall Study|Other|2|||
161821044|NCT01566435|584385810|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
161821045|NCT00438633|584385811|FG000|Overall Study|Withdrawal by Subject|1|||
161821046|NCT00438633|584385812|FG001|Overall Study|Withdrawal by Subject|0|||
161821047|NCT00438633|584385811|FG000|Overall Study|Lost to Follow-up|15|||
161821048|NCT00438633|584385812|FG001|Overall Study|Lost to Follow-up|17|||
161927239|NCT01740427|584780320|FG000|Overall Study|Participant Refused Continued Treatment|27|||
161676291|NCT02246582|583868735|FG000|Overall Study|Withdrawal by Subject|3|||
161676292|NCT02246582|583868736|FG001|Overall Study|Withdrawal by Subject|4|||
161676293|NCT02060383|583868738|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
161821049|NCT04569084|584385813|FG000|Overall Study|Adverse Event|10|||
161821050|NCT04569084|584385814|FG001|Overall Study|Adverse Event|14|||
161821051|NCT04569084|584385813|FG000|Overall Study|Death|2|||
161821052|NCT04569084|584385814|FG001|Overall Study|Death|3|||
161821053|NCT04569084|584385813|FG000|Overall Study|Lost to Follow-up|1|||
161821054|NCT04569084|584385814|FG001|Overall Study|Lost to Follow-up|1|||
161821055|NCT04569084|584385813|FG000|Overall Study|Physician Decision|3|||
161821056|NCT04569084|584385814|FG001|Overall Study|Physician Decision|3|||
161821057|NCT04569084|584385813|FG000|Overall Study|Protocol Violation|2|||
161821058|NCT04569084|584385814|FG001|Overall Study|Protocol Violation|1|||
161821059|NCT04569084|584385813|FG000|Overall Study|Withdrawal by Subject|20|||
161821060|NCT04569084|584385814|FG001|Overall Study|Withdrawal by Subject|21|||
161821061|NCT04569084|584385813|FG000|Overall Study|Study terminated by sponsor|26|||
161821062|NCT04569084|584385814|FG001|Overall Study|Study terminated by sponsor|23|||
161821063|NCT04569084|584385813|FG000|Overall Study|Other|3|||
161821064|NCT04569084|584385814|FG001|Overall Study|Other|5|||
161821065|NCT03196284|584385815|FG000|Main Part|Withdrawal by Subject|0|||
161821066|NCT03196284|584385816|FG001|Main Part|Withdrawal by Subject|1|||
161821067|NCT03196284|584385817|FG002|Main Part|Withdrawal by Subject|0|||
161821068|NCT03196284|584385815|FG000|Extension Part|Lack of Efficacy|0|||
161821069|NCT03196284|584385816|FG001|Extension Part|Lack of Efficacy|0|||
161821070|NCT03196284|584385817|FG002|Extension Part|Lack of Efficacy|1|||
161821071|NCT03196284|584385815|FG000|Extension Part|Withdrawal by Subject|0|||
161821072|NCT03196284|584385816|FG001|Extension Part|Withdrawal by Subject|0|||
161821073|NCT03196284|584385817|FG002|Extension Part|Withdrawal by Subject|1|||
161821074|NCT03196284|584385815|FG000|Extension Part|Physician Decision|0|||
161821075|NCT03196284|584385816|FG001|Extension Part|Physician Decision|0|||
161821076|NCT03196284|584385817|FG002|Extension Part|Physician Decision|1|||
161821077|NCT03820947|584385818|FG000|Overall Study|Physician Decision|0|||
161821078|NCT03820947|584385819|FG001|Overall Study|Physician Decision|1|||
161821079|NCT03820947|584385820|FG002|Overall Study|Physician Decision|1|||
161821080|NCT03820947|584385821|FG003|Overall Study|Physician Decision|0|||
161821081|NCT03820947|584385822|FG004|Overall Study|Physician Decision|3|||
161821082|NCT03820947|584385818|FG000|Overall Study|Withdrawal by Subject|6|||
161821083|NCT03820947|584385819|FG001|Overall Study|Withdrawal by Subject|10|||
161821084|NCT03820947|584385820|FG002|Overall Study|Withdrawal by Subject|3|||
161821085|NCT03820947|584385821|FG003|Overall Study|Withdrawal by Subject|8|||
161821086|NCT03820947|584385822|FG004|Overall Study|Withdrawal by Subject|5|||
161821087|NCT03820947|584385818|FG000|Overall Study|Procedure Not Attempted|0|||
161821088|NCT03820947|584385819|FG001|Overall Study|Procedure Not Attempted|2|||
161821089|NCT03820947|584385820|FG002|Overall Study|Procedure Not Attempted|1|||
161821090|NCT03820947|584385821|FG003|Overall Study|Procedure Not Attempted|0|||
161821091|NCT03820947|584385822|FG004|Overall Study|Procedure Not Attempted|0|||
161821092|NCT03820947|584385818|FG000|Overall Study|Other Exit|1|||
161821093|NCT03820947|584385819|FG001|Overall Study|Other Exit|3|||
161821094|NCT03820947|584385820|FG002|Overall Study|Other Exit|3|||
161821095|NCT03820947|584385821|FG003|Overall Study|Other Exit|3|||
161821096|NCT03820947|584385822|FG004|Overall Study|Other Exit|0|||
161821097|NCT03820947|584385818|FG000|Overall Study|Follow-up Not Done|10|||
161821098|NCT03820947|584385819|FG001|Overall Study|Follow-up Not Done|13|||
161821099|NCT03820947|584385820|FG002|Overall Study|Follow-up Not Done|2|||
161821100|NCT03820947|584385821|FG003|Overall Study|Follow-up Not Done|3|||
161821101|NCT03820947|584385822|FG004|Overall Study|Follow-up Not Done|12|||
161821102|NCT03820947|584385818|FG000|Overall Study|Death|0|||
161821103|NCT03820947|584385819|FG001|Overall Study|Death|0|||
161821104|NCT03820947|584385820|FG002|Overall Study|Death|0|||
161821105|NCT03820947|584385821|FG003|Overall Study|Death|0|||
161821106|NCT03820947|584385822|FG004|Overall Study|Death|9|||
161821107|NCT03820947|584385818|FG000|Overall Study|Lost to Follow-up|4|||
161821108|NCT03820947|584385819|FG001|Overall Study|Lost to Follow-up|6|||
161821109|NCT03820947|584385820|FG002|Overall Study|Lost to Follow-up|0|||
161821110|NCT03820947|584385821|FG003|Overall Study|Lost to Follow-up|0|||
161821111|NCT03820947|584385822|FG004|Overall Study|Lost to Follow-up|9|||
161821112|NCT04729101|584387570|FG000|Overall Study|Adverse Event|1|||
161821113|NCT04729101|584387571|FG001|Overall Study|Adverse Event|0|||
161821114|NCT04729101|584387570|FG000|Overall Study|Physician Decision|1|||
161821115|NCT04729101|584387571|FG001|Overall Study|Physician Decision|0|||
161821116|NCT04729101|584387570|FG000|Overall Study|Withdrawal by Subject|1|||
161821117|NCT04729101|584387571|FG001|Overall Study|Withdrawal by Subject|0|||
161821118|NCT04556734|584387574|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
161821119|NCT04556734|584387575|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161821120|NCT04556734|584387576|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
161821121|NCT04556734|584387577|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161927240|NCT01740427|584780321|FG001|Overall Study|Participant Refused Continued Treatment|15|||
161927241|NCT01740427|584780320|FG000|Overall Study|Unspecified reasons|52|||
161927242|NCT01740427|584780321|FG001|Overall Study|Unspecified reasons|8|||
161927243|NCT01740427|584780320|FG000|Overall Study|Death|10|||
161927244|NCT01740427|584780321|FG001|Overall Study|Death|3|||
161927245|NCT01740427|584780320|FG000|Overall Study|Protocol Violation|5|||
161927246|NCT01740427|584780321|FG001|Overall Study|Protocol Violation|3|||
161927247|NCT01740427|584780320|FG000|Overall Study|Lost to Follow-up|3|||
161927248|NCT01740427|584780321|FG001|Overall Study|Lost to Follow-up|0|||
161927249|NCT01740427|584780320|FG000|Overall Study|Site Terminated by Sponsor|1|||
161927250|NCT01740427|584780321|FG001|Overall Study|Site Terminated by Sponsor|0|||
161927251|NCT02184156|584780323|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
161927252|NCT02184156|584780324|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
161927253|NCT02184156|584780323|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
161927254|NCT02184156|584780324|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
161927255|NCT02405962|584780326|FG000|Overall Study|Lost to Follow-up|1|||
161927256|NCT02405962|584780327|FG001|Overall Study|Lost to Follow-up|4|||
161927257|NCT02405962|584780326|FG000|Overall Study|A participant has moved to another place|0|||
161927258|NCT02405962|584780327|FG001|Overall Study|A participant has moved to another place|1|||
161927259|NCT01980888|584780328|FG000|Overall Study|Study Terminated by Sponsor|116|||
161927260|NCT01980888|584780329|FG001|Overall Study|Study Terminated by Sponsor|122|||
161927261|NCT01980888|584780328|FG000|Overall Study|Withdrew Consent|17|||
161927262|NCT01980888|584780329|FG001|Overall Study|Withdrew Consent|6|||
161927263|NCT01980888|584780328|FG000|Overall Study|Investigator's Discretion|8|||
161927264|NCT01980888|584780329|FG001|Overall Study|Investigator's Discretion|3|||
161927265|NCT01980888|584780328|FG000|Overall Study|Non-Compliance with Study Drug|3|||
161927266|NCT01980888|584780329|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161927267|NCT01018953|584780330|FG000|Overall Study|Adverse Event|2|||
161927268|NCT01018953|584780330|FG000|Overall Study|Withdrawal by Subject|1|||
161927269|NCT01018953|584780330|FG000|Overall Study|Study termination by sponsor|5|||
161927270|NCT01184118|584780331|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
161927271|NCT01184118|584780331|FG000|Overall Study|No physiologic confirmation of asthma|8|||
161927272|NCT01184118|584780331|FG000|Overall Study|FEV1 <60% predicted|2|||
161927273|NCT01184118|584780331|FG000|Overall Study|Exclusionary medical condition|2|||
161927274|NCT01184118|584780331|FG000|Overall Study|Withdrawal by Subject|5|||
161927275|NCT04073407|584780332|FG000|Part 1|Withdrawal by Subject|1|||
161927276|NCT04073407|584780333|FG001|Part 1|Withdrawal by Subject|0|||
161927277|NCT04073407|584780332|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
161927278|NCT04073407|584780333|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
161927279|NCT04073407|584780332|FG000|Part 2|Withdrawal by Subject|0|||
161927280|NCT04073407|584780333|FG001|Part 2|Withdrawal by Subject|1|||
161927281|NCT03791060|584781912|FG000|Overall Study|Withdrawal by Subject|1|||
161927282|NCT01011283|584781913|FG000|Overall Study|Adverse Event|4|||
161927283|NCT01011283|584781914|FG001|Overall Study|Adverse Event|2|||
161927284|NCT01011283|584781913|FG000|Overall Study|Progressive Disease|0|||
161927285|NCT01011283|584781914|FG001|Overall Study|Progressive Disease|2|||
161927286|NCT01011283|584781913|FG000|Overall Study|Terminated by Sponsor|5|||
161927287|NCT01011283|584781914|FG001|Overall Study|Terminated by Sponsor|5|||
161927288|NCT01011283|584781913|FG000|Overall Study|Other|2|||
161927289|NCT01011283|584781914|FG001|Overall Study|Other|2|||
161927290|NCT01717859|584781915|FG000|Overall Study|Adverse Event|5|||
161927291|NCT01717859|584781915|FG000|Overall Study|Moved out of state|1|||
161927292|NCT01717859|584781915|FG000|Overall Study|Patient concerned about mental health|1|||
161927293|NCT01717859|584781915|FG000|Overall Study|Lost to Follow-up|1|||
162201050|NCT02951052|585785406|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
162201051|NCT02951052|585785405|FG000|Overall Study|Protocol Violation|5|||
162201052|NCT02951052|585785406|FG001|Overall Study|Protocol Violation|3|||
162201053|NCT02951052|585785405|FG000|Overall Study|Lack of Efficacy|3|||
162201054|NCT02951052|585785406|FG001|Overall Study|Lack of Efficacy|4|||
162201055|NCT02951052|585785405|FG000|Overall Study|Ongoing|1|||
162201056|NCT02951052|585785406|FG001|Overall Study|Ongoing|0|||
161927294|NCT01717859|584781915|FG000|Overall Study|Withdrawal by Subject|2|||
161927295|NCT01623752|584781916|FG000|Phase 1 (78 Weeks)|No Data|249|||
161927296|NCT01623752|584781917|FG001|Phase 1 (78 Weeks)|No Data|66|||
161927297|NCT01623752|584781918|FG002|Phase 1 (78 Weeks)|No Data|2|||
161927298|NCT01623752|584781916|FG000|Phase 1 (78 Weeks)|Other|33|||
161927299|NCT01623752|584781917|FG001|Phase 1 (78 Weeks)|Other|20|||
161927300|NCT01623752|584781918|FG002|Phase 1 (78 Weeks)|Other|0|||
161927301|NCT01623752|584781916|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
162201057|NCT00651937|585787044|FG000|Overall Study|Withdrawal by Subject|4|||
162201058|NCT00651937|585787045|FG001|Overall Study|Withdrawal by Subject|1|||
161927302|NCT01623752|584781917|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
161927303|NCT01623752|584781918|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
161927304|NCT01623752|584781916|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
161927305|NCT01623752|584781917|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
161927306|NCT01623752|584781918|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
161927307|NCT01623752|584781916|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
161927308|NCT01623752|584781917|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
161927309|NCT01623752|584781918|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
161927310|NCT01623752|584781916|FG000|Phase 2 (78 Weeks)|Other|5|||
161927311|NCT01623752|584781917|FG001|Phase 2 (78 Weeks)|Other|1|||
161927312|NCT01623752|584781918|FG002|Phase 2 (78 Weeks)|Other|0|||
161927313|NCT01623752|584781916|FG000|Phase 2 (78 Weeks)|No Data|43|||
161927314|NCT01623752|584781917|FG001|Phase 2 (78 Weeks)|No Data|11|||
161927315|NCT01623752|584781918|FG002|Phase 2 (78 Weeks)|No Data|0|||
161927316|NCT01623752|584781916|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
161927317|NCT01623752|584781917|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
161927318|NCT01623752|584781918|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
161927319|NCT01814332|584781919|FG000|Overall Study|Adverse Event|8|||
161927320|NCT01814332|584781920|FG001|Overall Study|Adverse Event|3|||
161927321|NCT01814332|584781919|FG000|Overall Study|Withdrawal by Subject|3|||
161927322|NCT01814332|584781920|FG001|Overall Study|Withdrawal by Subject|8|||
161927323|NCT01814332|584781919|FG000|Overall Study|Protocol Violation|0|||
161927324|NCT01814332|584781920|FG001|Overall Study|Protocol Violation|4|||
161927325|NCT01814332|584781919|FG000|Overall Study|Lost to Follow-up|5|||
161927326|NCT01814332|584781920|FG001|Overall Study|Lost to Follow-up|1|||
161927327|NCT04389671|584781921|FG000|Overall Study|Death|7|||
161927328|NCT05987540|584781922|FG000|Overall Study|Withdrawal by Subject|2|||
161927329|NCT05987540|584781922|FG000|Overall Study|Death|1|||
161927330|NCT05987540|584781922|FG000|Overall Study|Study Termination|1|||
161927331|NCT05987540|584781922|FG000|Overall Study|Adverse Event|2|||
161927332|NCT04053452|584781923|FG000|Overall Study|Withdrawal by Subject|1|||
161927333|NCT04053452|584781924|FG001|Overall Study|Withdrawal by Subject|0|||
161927334|NCT04053452|584781923|FG000|Overall Study|Time restraint due to inpatient needs|1|||
161927335|NCT04053452|584781924|FG001|Overall Study|Time restraint due to inpatient needs|2|||
161927336|NCT01421134|584781925|FG000|Overall Study|Adverse Event|3|||
161927337|NCT01421134|584781926|FG001|Overall Study|Adverse Event|5|||
161927338|NCT01421134|584781925|FG000|Overall Study|Lack of Efficacy|2|||
161927339|NCT01421134|584781926|FG001|Overall Study|Lack of Efficacy|4|||
161927340|NCT01421134|584781925|FG000|Overall Study|Protocol Violation|0|||
161927341|NCT01421134|584781926|FG001|Overall Study|Protocol Violation|3|||
161927342|NCT01421134|584781925|FG000|Overall Study|Withdrawal by Subject|1|||
161927343|NCT01421134|584781926|FG001|Overall Study|Withdrawal by Subject|1|||
161927344|NCT01421134|584781925|FG000|Overall Study|Administrative|0|||
161821122|NCT04556734|584387578|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161821123|NCT04556734|584387579|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161821124|NCT04556734|584387580|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161821125|NCT04556734|584387581|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161821126|NCT04556734|584387574|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
161821127|NCT04556734|584387575|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161821128|NCT04556734|584387576|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161821129|NCT04556734|584387577|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161821130|NCT04556734|584387578|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161821131|NCT04556734|584387579|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161821132|NCT04556734|584387580|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161821133|NCT04556734|584387581|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161927345|NCT01421134|584781926|FG001|Overall Study|Administrative|1|||
161927346|NCT01421134|584781925|FG000|Overall Study|Lost to Follow-up|1|||
161927347|NCT01421134|584781926|FG001|Overall Study|Lost to Follow-up|1|||
161927348|NCT02959892|584781927|FG000|Overall Study|PET tracer synthesis failure|1|||
162201059|NCT01904019|585787048|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
162201060|NCT01904019|585787048|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
162201061|NCT01904019|585787048|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
162201062|NCT01904019|585787048|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
162201063|NCT01904019|585787048|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
162201064|NCT01904019|585787048|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
161927349|NCT02959892|584781928|FG001|Overall Study|PET tracer synthesis failure|0|||
161927350|NCT02959892|584781927|FG000|Overall Study|Study termination|0|||
161927351|NCT02959892|584781928|FG001|Overall Study|Study termination|1|||
162201065|NCT00509821|585787049|FG000|Study Period 1 (Induction)|Death|0|||
162201066|NCT00509821|585787050|FG001|Study Period 1 (Induction)|Death|1|||
162201067|NCT00509821|585787049|FG000|Study Period 1 (Induction)|Adverse Event|0|||
162201068|NCT00509821|585787050|FG001|Study Period 1 (Induction)|Adverse Event|2|||
161821134|NCT04556734|584387574|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161821135|NCT04556734|584387575|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161927352|NCT00122187|584781929|FG000|Overall Study|Withdrew because of resource limitations|2|||
161927353|NCT00122187|584781930|FG001|Overall Study|Withdrew because of resource limitations|2|||
161927354|NCT02061592|584781934|FG000|Period 1|Withdrawal by Subject|1|||
161927355|NCT02061592|584781935|FG001|Period 1|Withdrawal by Subject|0|||
161927356|NCT02061592|584781934|FG000|Period 1|Protocol Violation|1|||
161927357|NCT02061592|584781935|FG001|Period 1|Protocol Violation|0|||
161927358|NCT02061592|584781934|FG000|Period 2|Lost to Follow-up|0|||
161927359|NCT02061592|584781935|FG001|Period 2|Lost to Follow-up|1|||
161927360|NCT04433975|584781936|FG000|1-month Follow Up|Withdrawal by Subject|1|||
161927361|NCT04433975|584781937|FG001|1-month Follow Up|Withdrawal by Subject|1|||
161927362|NCT04433975|584781936|FG000|1-month Follow Up|Lost to Follow-up|21|||
161676294|NCT02060383|583868739|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
161927363|NCT04433975|584781937|FG001|1-month Follow Up|Lost to Follow-up|25|||
161927364|NCT04433975|584781936|FG000|3-month Follow Up|Lost to Follow-up|20|||
161927365|NCT04433975|584781937|FG001|3-month Follow Up|Lost to Follow-up|24|||
161927366|NCT04433975|584781936|FG000|3-month Follow Up|Death|1|||
161927367|NCT04433975|584781937|FG001|3-month Follow Up|Death|0|||
161927368|NCT04433975|584781936|FG000|3-month Follow Up|Withdrawal by Subject|2|||
161927369|NCT04433975|584781937|FG001|3-month Follow Up|Withdrawal by Subject|0|||
161927370|NCT04433975|584781936|FG000|6-month Follow Up|Lost to Follow-up|23|||
161927371|NCT04433975|584781937|FG001|6-month Follow Up|Lost to Follow-up|28|||
161927372|NCT04433975|584781936|FG000|6-month Follow Up|Withdrawal by Subject|1|||
162201069|NCT00509821|585787049|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
162201070|NCT00509821|585787050|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
162201071|NCT00552513|585787051|FG000|Overall Study|Lost to Follow-up|5|||
162201072|NCT00552513|585787052|FG001|Overall Study|Lost to Follow-up|1|||
162201073|NCT01816685|585787055|FG000|Overall Study|Lost to Follow-up|7|||
162201074|NCT01816685|585787056|FG001|Overall Study|Lost to Follow-up|9|||
162201075|NCT01816685|585787055|FG000|Overall Study|Surgery Cancelled|3|||
162201076|NCT01816685|585787056|FG001|Overall Study|Surgery Cancelled|2|||
162201077|NCT01157351|585787057|FG000|Overall Study|Adverse Event|5|||
162201078|NCT01157351|585787058|FG001|Overall Study|Adverse Event|4|||
162201079|NCT01157351|585787057|FG000|Overall Study|Death|1|||
162201080|NCT01157351|585787058|FG001|Overall Study|Death|0|||
162201081|NCT01157351|585787057|FG000|Overall Study|Lost to Follow-up|53|||
162201082|NCT01157351|585787058|FG001|Overall Study|Lost to Follow-up|55|||
162201083|NCT01157351|585787057|FG000|Overall Study|Withdrawal by Subject|37|||
162201084|NCT01157351|585787058|FG001|Overall Study|Withdrawal by Subject|27|||
162201085|NCT01157351|585787057|FG000|Overall Study|Physician Decision|5|||
162201086|NCT01157351|585787058|FG001|Overall Study|Physician Decision|4|||
162201087|NCT01157351|585787057|FG000|Overall Study|Protocol Violation|0|||
161927373|NCT04433975|584781937|FG001|6-month Follow Up|Withdrawal by Subject|1|||
162201088|NCT01157351|585787058|FG001|Overall Study|Protocol Violation|1|||
161927374|NCT04433975|584781936|FG000|9-month Follow Up|Lost to Follow-up|27|||
161927375|NCT04433975|584781937|FG001|9-month Follow Up|Lost to Follow-up|36|||
162201089|NCT01157351|585787057|FG000|Overall Study|Other|32|||
162201090|NCT01157351|585787058|FG001|Overall Study|Other|36|||
162201091|NCT01157351|585787057|FG000|Overall Study|Noncompliance with Study Drug|0|||
161927376|NCT04433975|584781936|FG000|9-month Follow Up|Death|0|||
161927377|NCT04433975|584781937|FG001|9-month Follow Up|Death|1|||
161927378|NCT04433975|584781936|FG000|12-month Follow Up|Lost to Follow-up|27|||
161927379|NCT04433975|584781937|FG001|12-month Follow Up|Lost to Follow-up|31|||
161927380|NCT04392635|584781938|FG000|Overall Study|Lost to Follow-up|0|||
161927381|NCT04392635|584781939|FG001|Overall Study|Lost to Follow-up|1|||
161927382|NCT00724893|584781948|FG000|Overall Study|Adverse Event|76|||
161927383|NCT00724893|584781949|FG001|Overall Study|Adverse Event|142|||
161927384|NCT00724893|584781948|FG000|Overall Study|Withdrawal by Subject|0|||
161927385|NCT00724893|584781949|FG001|Overall Study|Withdrawal by Subject|1|||
161927386|NCT00724893|584781948|FG000|Overall Study|Lack of virologic response|94|||
161927387|NCT00724893|584781949|FG001|Overall Study|Lack of virologic response|202|||
161927388|NCT00724893|584781948|FG000|Overall Study|Reason not specified|193|||
161927389|NCT00724893|584781949|FG001|Overall Study|Reason not specified|7|||
161927390|NCT00724893|584781948|FG000|Overall Study|Patient choice|0|||
161927391|NCT00724893|584781949|FG001|Overall Study|Patient choice|26|||
161927392|NCT00724893|584781948|FG000|Overall Study|Geographic reasons|0|||
161927393|NCT00724893|584781949|FG001|Overall Study|Geographic reasons|11|||
161927394|NCT00724893|584781948|FG000|Overall Study|Incarceration|0|||
161927395|NCT00724893|584781949|FG001|Overall Study|Incarceration|9|||
161927396|NCT00724893|584781948|FG000|Overall Study|Substance abuse|0|||
161927397|NCT00724893|584781949|FG001|Overall Study|Substance abuse|3|||
161927398|NCT00724893|584781948|FG000|Overall Study|Financial reasons|0|||
161927399|NCT00724893|584781949|FG001|Overall Study|Financial reasons|2|||
161927400|NCT00724893|584781948|FG000|Overall Study|Assigned shorter treatment|0|||
161927401|NCT00724893|584781949|FG001|Overall Study|Assigned shorter treatment|2|||
161927402|NCT00724893|584781948|FG000|Overall Study|Lost to Follow-up|0|||
161927403|NCT00724893|584781949|FG001|Overall Study|Lost to Follow-up|52|||
161927404|NCT00724893|584781948|FG000|Overall Study|Unknown, missing data|1|||
161927405|NCT00724893|584781949|FG001|Overall Study|Unknown, missing data|1|||
161927406|NCT01290731|584781950|FG000|Overall Study|Withdrawal by Subject|1|||
161927407|NCT02181738|584781958|FG000|Overall Study|Participant Withdrew Consent|2|||
161676295|NCT02060383|583868740|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
161676296|NCT02060383|583868741|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
161676297|NCT02060383|583868742|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
161676298|NCT02060383|583868738|FG000|Core Phase|Adverse Event|2|||
161927408|NCT02181738|584781959|FG001|Overall Study|Participant Withdrew Consent|1|||
161927409|NCT02181738|584781960|FG002|Overall Study|Participant Withdrew Consent|1|||
161927410|NCT02181738|584781961|FG003|Overall Study|Participant Withdrew Consent|1|||
161927411|NCT02181738|584781958|FG000|Overall Study|Lost to Follow-up|1|||
161927412|NCT02181738|584781959|FG001|Overall Study|Lost to Follow-up|2|||
161927413|NCT02181738|584781960|FG002|Overall Study|Lost to Follow-up|1|||
161927414|NCT02181738|584781961|FG003|Overall Study|Lost to Follow-up|1|||
161927415|NCT02181738|584781958|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
161927416|NCT02181738|584781959|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
161927417|NCT02181738|584781960|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
161927418|NCT02181738|584781961|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
161927419|NCT02181738|584781958|FG000|Overall Study|Poor/Non-Compliance|1|||
161927420|NCT02181738|584781959|FG001|Overall Study|Poor/Non-Compliance|0|||
161927421|NCT02181738|584781960|FG002|Overall Study|Poor/Non-Compliance|2|||
161927422|NCT02181738|584781961|FG003|Overall Study|Poor/Non-Compliance|1|||
161927423|NCT02181738|584781958|FG000|Overall Study|Disease Progression|28|||
161927424|NCT02181738|584781959|FG001|Overall Study|Disease Progression|35|||
161927425|NCT02181738|584781960|FG002|Overall Study|Disease Progression|40|||
161927426|NCT02181738|584781961|FG003|Overall Study|Disease Progression|0|||
161927427|NCT02181738|584781958|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
161927428|NCT02181738|584781959|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
161927429|NCT02181738|584781960|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
161927430|NCT02181738|584781961|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
161927431|NCT02181738|584781958|FG000|Overall Study|Study Drug Toxicity|6|||
161927432|NCT02181738|584781959|FG001|Overall Study|Study Drug Toxicity|11|||
161927433|NCT02181738|584781960|FG002|Overall Study|Study Drug Toxicity|8|||
161927434|NCT02181738|584781961|FG003|Overall Study|Study Drug Toxicity|1|||
161927435|NCT02181738|584781958|FG000|Overall Study|Other Reasons|14|||
162020790|NCT02785770|585132045|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
161927436|NCT02181738|584781959|FG001|Overall Study|Other Reasons|16|||
162020791|NCT02785770|585132046|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
161927437|NCT02181738|584781960|FG002|Overall Study|Other Reasons|28|||
161927438|NCT02181738|584781961|FG003|Overall Study|Other Reasons|0|||
161927439|NCT02181738|584781958|FG000|Overall Study|Maximum Clinical Benefit|3|||
161927440|NCT02181738|584781959|FG001|Overall Study|Maximum Clinical Benefit|0|||
161927441|NCT02181738|584781960|FG002|Overall Study|Maximum Clinical Benefit|1|||
161927442|NCT02181738|584781961|FG003|Overall Study|Maximum Clinical Benefit|0|||
161927443|NCT02181738|584781958|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
161927444|NCT02181738|584781959|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
161927445|NCT02181738|584781960|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
161927446|NCT02181738|584781961|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
161927447|NCT00888849|584781964|FG000|Overall Study|Death|4|||
161927448|NCT00888849|584781965|FG001|Overall Study|Death|7|||
161927449|NCT00888849|584781964|FG000|Overall Study|Lost to Follow-up|1|||
161927450|NCT00888849|584781965|FG001|Overall Study|Lost to Follow-up|2|||
161927451|NCT05064800|584781966|FG000|Period 3|Withdrawal by Subject|0|||
161927452|NCT05064800|584781967|FG001|Period 3|Withdrawal by Subject|0|||
161927453|NCT05064800|584781968|FG002|Period 3|Withdrawal by Subject|0|||
161927454|NCT05064800|584781969|FG003|Period 3|Withdrawal by Subject|0|||
161927455|NCT05064800|584781970|FG004|Period 3|Withdrawal by Subject|1|||
161927456|NCT05064800|584781971|FG005|Period 3|Withdrawal by Subject|0|||
161927457|NCT00629239|584781972|FG000|Overall Study|Adverse Event|7|||
161927458|NCT00629239|584781973|FG001|Overall Study|Adverse Event|4|||
161927459|NCT00629239|584781972|FG000|Overall Study|Physician Decision|1|||
161927460|NCT00629239|584781973|FG001|Overall Study|Physician Decision|0|||
161927461|NCT01851369|584781976|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927462|NCT01851369|584781977|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
162201092|NCT01157351|585787058|FG001|Overall Study|Noncompliance with Study Drug|3|||
162201093|NCT01157351|585787057|FG000|Overall Study|Randomized but not Treated|4|||
162201094|NCT01157351|585787058|FG001|Overall Study|Randomized but not Treated|2|||
162201095|NCT01589523|585787059|FG000|Overall Study|Withdrawal by Subject|1|||
162201096|NCT00792259|585787060|FG000|Overall Study|Poor Quality Scans|1|||
162201097|NCT00792259|585787061|FG001|Overall Study|Poor Quality Scans|0|||
162201098|NCT00792259|585787062|FG002|Overall Study|Poor Quality Scans|0|||
162201099|NCT00332488|585787063|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
162201100|NCT00332488|585787064|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
162201101|NCT00332488|585787065|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
162201102|NCT00332488|585787063|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
162201103|NCT00332488|585787064|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
162201104|NCT00332488|585787065|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
162201105|NCT00332488|585787063|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
162201106|NCT00332488|585787064|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
162201107|NCT00332488|585787065|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
162201108|NCT00332488|585787063|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
162201109|NCT00332488|585787064|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
162201110|NCT00332488|585787065|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
162201111|NCT00332488|585787063|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
162201112|NCT00332488|585787064|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
162201113|NCT00332488|585787065|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
162201114|NCT00332488|585787063|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
162201115|NCT00332488|585787064|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
162201116|NCT00332488|585787065|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
162201117|NCT00332488|585787063|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
162201118|NCT00332488|585787064|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
162201119|NCT00332488|585787065|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
162201120|NCT00332488|585787063|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
162201121|NCT00332488|585787064|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
162201122|NCT00332488|585787065|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
162201123|NCT00332488|585787063|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
162201124|NCT00332488|585787064|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
162201125|NCT00332488|585787065|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
161927463|NCT01851369|584781978|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927464|NCT01851369|584781979|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927465|NCT01851369|584781980|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927466|NCT01851369|584781981|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
161927467|NCT01851369|584781982|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927468|NCT01851369|584781983|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927469|NCT01851369|584781984|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927470|NCT01851369|584781985|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927471|NCT01851369|584781986|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927472|NCT01851369|584781987|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927473|NCT01851369|584781988|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161927474|NCT00183391|584781989|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
161927475|NCT00183391|584781990|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
161927476|NCT00183391|584781989|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
161927477|NCT00183391|584781990|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
161927478|NCT00395512|584781991|FG000|Overall Study|Adverse Event|3|||
161676299|NCT02060383|583868739|FG001|Core Phase|Adverse Event|0|||
161676300|NCT02060383|583868740|FG002|Core Phase|Adverse Event|0|||
161676301|NCT02060383|583868741|FG003|Core Phase|Adverse Event|2|||
161676302|NCT02060383|583868742|FG004|Core Phase|Adverse Event|6|||
161676303|NCT02060383|583868738|FG000|Core Phase|Administrative problems|0|||
161676304|NCT02060383|583868739|FG001|Core Phase|Administrative problems|1|||
161676305|NCT02060383|583868740|FG002|Core Phase|Administrative problems|0|||
161676306|NCT02060383|583868741|FG003|Core Phase|Administrative problems|0|||
161676307|NCT02060383|583868742|FG004|Core Phase|Administrative problems|0|||
161676308|NCT02060383|583868738|FG000|Core Phase|Protocol Violation|0|||
161676309|NCT02060383|583868739|FG001|Core Phase|Protocol Violation|0|||
162020792|NCT00813943|585132050|FG000|Overall Study|Ongoing at cut-off date|5|||
162020793|NCT00813943|585132051|FG001|Overall Study|Ongoing at cut-off date|5|||
162020794|NCT00813943|585132052|FG002|Overall Study|Ongoing at cut-off date|3|||
162020795|NCT01088048|585132053|FG000|Overall Study|Adverse Event|7|||
161676310|NCT02060383|583868740|FG002|Core Phase|Protocol Violation|0|||
161676311|NCT02060383|583868741|FG003|Core Phase|Protocol Violation|1|||
161676312|NCT02060383|583868742|FG004|Core Phase|Protocol Violation|0|||
161676313|NCT02060383|583868738|FG000|Core Phase|Withdrawal by Subject|0|||
161676314|NCT02060383|583868739|FG001|Core Phase|Withdrawal by Subject|0|||
161821136|NCT04556734|584387576|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161821137|NCT04556734|584387577|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161821138|NCT04556734|584387578|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161821139|NCT04556734|584387579|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161821140|NCT04556734|584387580|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161821141|NCT04556734|584387581|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161821142|NCT04556734|584387574|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
161821143|NCT04556734|584387575|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821144|NCT04556734|584387576|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821145|NCT04556734|584387577|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821146|NCT04556734|584387578|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821147|NCT04556734|584387579|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821148|NCT04556734|584387580|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821149|NCT04556734|584387581|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161821150|NCT04556734|584387574|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821151|NCT04556734|584387575|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821152|NCT04556734|584387576|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
161821153|NCT04556734|584387577|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821154|NCT04556734|584387578|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821155|NCT04556734|584387579|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821156|NCT04556734|584387580|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821157|NCT04556734|584387581|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161821158|NCT04556734|584387574|FG000|OLE Period (28 Weeks)|Not reported|0|||
161821159|NCT04556734|584387575|FG001|OLE Period (28 Weeks)|Not reported|0|||
161821160|NCT04556734|584387576|FG002|OLE Period (28 Weeks)|Not reported|0|||
161821161|NCT04556734|584387577|FG003|OLE Period (28 Weeks)|Not reported|0|||
161821162|NCT04556734|584387578|FG004|OLE Period (28 Weeks)|Not reported|0|||
161821163|NCT04556734|584387579|FG005|OLE Period (28 Weeks)|Not reported|1|||
161821164|NCT04556734|584387580|FG006|OLE Period (28 Weeks)|Not reported|0|||
161821165|NCT04556734|584387581|FG007|OLE Period (28 Weeks)|Not reported|0|||
161821166|NCT04556734|584387574|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821167|NCT04556734|584387575|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821168|NCT04556734|584387576|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821169|NCT04556734|584387577|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821170|NCT04556734|584387578|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821171|NCT04556734|584387579|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821172|NCT04556734|584387580|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161821173|NCT04556734|584387581|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
161821174|NCT04556734|584387574|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
161821175|NCT04556734|584387575|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
161821176|NCT04556734|584387576|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
161821177|NCT04556734|584387577|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
161821178|NCT04556734|584387578|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
161821179|NCT04556734|584387579|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
161821180|NCT04556734|584387580|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
161821181|NCT04556734|584387581|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
161821182|NCT04556734|584387574|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161821183|NCT04556734|584387575|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161821184|NCT04556734|584387576|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161821185|NCT04556734|584387577|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
162020796|NCT01088048|585132054|FG001|Overall Study|Adverse Event|9|||
162020797|NCT01088048|585132055|FG002|Overall Study|Adverse Event|7|||
161676315|NCT02060383|583868740|FG002|Core Phase|Withdrawal by Subject|0|||
161676316|NCT02060383|583868741|FG003|Core Phase|Withdrawal by Subject|4|||
161927479|NCT00395512|584781992|FG001|Overall Study|Adverse Event|8|||
161927480|NCT00395512|584781993|FG002|Overall Study|Adverse Event|6|||
161927481|NCT00395512|584781994|FG003|Overall Study|Adverse Event|6|||
161927482|NCT00395512|584781991|FG000|Overall Study|Protocol Violation|2|||
161927483|NCT00395512|584781992|FG001|Overall Study|Protocol Violation|3|||
161927484|NCT00395512|584781993|FG002|Overall Study|Protocol Violation|6|||
161927485|NCT00395512|584781994|FG003|Overall Study|Protocol Violation|7|||
161927486|NCT00395512|584781991|FG000|Overall Study|Lost to Follow-up|2|||
161927487|NCT00395512|584781992|FG001|Overall Study|Lost to Follow-up|6|||
161927488|NCT00395512|584781993|FG002|Overall Study|Lost to Follow-up|5|||
161927489|NCT00395512|584781994|FG003|Overall Study|Lost to Follow-up|5|||
161927490|NCT00395512|584781991|FG000|Overall Study|Withdrawal by Subject|6|||
161927491|NCT00395512|584781992|FG001|Overall Study|Withdrawal by Subject|5|||
161927492|NCT00395512|584781993|FG002|Overall Study|Withdrawal by Subject|5|||
161927493|NCT00395512|584781994|FG003|Overall Study|Withdrawal by Subject|12|||
161927494|NCT00395512|584781991|FG000|Overall Study|Physician Decision|6|||
161927495|NCT00395512|584781992|FG001|Overall Study|Physician Decision|4|||
161927496|NCT00395512|584781993|FG002|Overall Study|Physician Decision|2|||
161927497|NCT00395512|584781994|FG003|Overall Study|Physician Decision|2|||
161927498|NCT00395512|584781991|FG000|Overall Study|Other|1|||
161927499|NCT00395512|584781992|FG001|Overall Study|Other|1|||
161927500|NCT00395512|584781993|FG002|Overall Study|Other|0|||
161927501|NCT00395512|584781994|FG003|Overall Study|Other|0|||
161927502|NCT00395512|584781991|FG000|Overall Study|Hyperglycemic Rescue|18|||
161927503|NCT00395512|584781992|FG001|Overall Study|Hyperglycemic Rescue|10|||
161927504|NCT00395512|584781993|FG002|Overall Study|Hyperglycemic Rescue|4|||
161927505|NCT00395512|584781994|FG003|Overall Study|Hyperglycemic Rescue|6|||
161927506|NCT04584554|584781995|FG000|Overall Study|Withdrawal by Subject|2|||
161927507|NCT04584554|584781996|FG001|Overall Study|Withdrawal by Subject|2|||
161927508|NCT02021318|584782002|FG000|Overall Study|Adverse Event|2|||
161927509|NCT02021318|584782003|FG001|Overall Study|Adverse Event|1|||
161927510|NCT02021318|584782002|FG000|Overall Study|Death|33|||
161927511|NCT02021318|584782003|FG001|Overall Study|Death|34|||
161927512|NCT02021318|584782002|FG000|Overall Study|Lost to Follow-up|3|||
161927513|NCT02021318|584782003|FG001|Overall Study|Lost to Follow-up|3|||
161927514|NCT02021318|584782002|FG000|Overall Study|Progressive Disease|0|||
161927515|NCT02021318|584782003|FG001|Overall Study|Progressive Disease|1|||
161927516|NCT02021318|584782002|FG000|Overall Study|Withdrawal by Subject|30|||
161927517|NCT02021318|584782003|FG001|Overall Study|Withdrawal by Subject|18|||
161927518|NCT02021318|584782002|FG000|Overall Study|Physician Decision|3|||
161927519|NCT02021318|584782003|FG001|Overall Study|Physician Decision|3|||
161927520|NCT02021318|584782002|FG000|Overall Study|Miscellaneous|2|||
161927521|NCT02021318|584782003|FG001|Overall Study|Miscellaneous|3|||
161927522|NCT00165698|584782006|FG000|Overall Study|Adverse Event|2|||
161927523|NCT00165698|584782007|FG001|Overall Study|Adverse Event|10|||
161927524|NCT00165698|584782006|FG000|Overall Study|Lost to Follow-up|2|||
161927525|NCT00165698|584782007|FG001|Overall Study|Lost to Follow-up|2|||
161927526|NCT00165698|584782006|FG000|Overall Study|Withdrawal by Subject|2|||
161927527|NCT00165698|584782007|FG001|Overall Study|Withdrawal by Subject|1|||
161927528|NCT00165698|584782006|FG000|Overall Study|Protocol Violation|1|||
161927529|NCT00165698|584782007|FG001|Overall Study|Protocol Violation|0|||
161927530|NCT00165698|584782006|FG000|Overall Study|Not Taken/Lost the medicine|1|||
161927531|NCT00165698|584782007|FG001|Overall Study|Not Taken/Lost the medicine|2|||
161927532|NCT01483651|584782008|FG000|Overall Study|Withdrawal by Subject|0|||
161927533|NCT01483651|584782009|FG001|Overall Study|Withdrawal by Subject|1|||
161927534|NCT01483651|584782010|FG002|Overall Study|Withdrawal by Subject|1|||
162201126|NCT00332488|585787063|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
162201127|NCT00332488|585787064|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
162201128|NCT00332488|585787065|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
162201129|NCT00332488|585787063|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
162201130|NCT00332488|585787064|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
161927535|NCT01483651|584782011|FG003|Overall Study|Withdrawal by Subject|0|||
161927536|NCT01483651|584782012|FG004|Overall Study|Withdrawal by Subject|0|||
161927537|NCT01483651|584782013|FG005|Overall Study|Withdrawal by Subject|1|||
161927538|NCT02547935|584782020|FG000|Overall Study|Other|0|||
161927539|NCT02547935|584782021|FG001|Overall Study|Other|1|||
161927540|NCT02547935|584782022|FG002|Overall Study|Other|0|||
161676317|NCT02060383|583868742|FG004|Core Phase|Withdrawal by Subject|2|||
161927541|NCT02547935|584782020|FG000|Overall Study|Withdrawal by Subject|2|||
161927542|NCT02547935|584782021|FG001|Overall Study|Withdrawal by Subject|3|||
161927543|NCT02547935|584782022|FG002|Overall Study|Withdrawal by Subject|4|||
161927544|NCT02547935|584782020|FG000|Overall Study|Screen Failure|2|||
161927545|NCT02547935|584782021|FG001|Overall Study|Screen Failure|0|||
161927546|NCT02547935|584782022|FG002|Overall Study|Screen Failure|0|||
161927547|NCT02547935|584782020|FG000|Overall Study|Physician Decision|0|||
161927548|NCT02547935|584782021|FG001|Overall Study|Physician Decision|1|||
161927549|NCT02547935|584782022|FG002|Overall Study|Physician Decision|0|||
161927550|NCT02547935|584782020|FG000|Overall Study|Lost to Follow-up|0|||
161927551|NCT02547935|584782021|FG001|Overall Study|Lost to Follow-up|2|||
161927552|NCT02547935|584782022|FG002|Overall Study|Lost to Follow-up|1|||
161927553|NCT02547935|584782020|FG000|Overall Study|Death|1|||
161927554|NCT02547935|584782021|FG001|Overall Study|Death|1|||
161927555|NCT02547935|584782022|FG002|Overall Study|Death|0|||
161927556|NCT03020888|584782027|FG000|Overall Study|Physician Decision|4|||
161927557|NCT03020888|584782027|FG000|Overall Study|Withdrawal by Subject|6|||
161927558|NCT03020888|584782027|FG000|Overall Study|Insurance coverage|2|||
161927559|NCT03020888|584782027|FG000|Overall Study|Lost to Follow-up|1|||
161927560|NCT01928771|584782031|FG000|Overall Study|Adverse Event|6|||
161927561|NCT01928771|584782032|FG001|Overall Study|Adverse Event|5|||
161927562|NCT01928771|584782033|FG002|Overall Study|Adverse Event|1|||
161927563|NCT01928771|584782031|FG000|Overall Study|Death|2|||
161927564|NCT01928771|584782032|FG001|Overall Study|Death|2|||
161927565|NCT01928771|584782033|FG002|Overall Study|Death|2|||
161927566|NCT01928771|584782031|FG000|Overall Study|Lost to Follow-up|5|||
161927567|NCT01928771|584782032|FG001|Overall Study|Lost to Follow-up|6|||
161927568|NCT01928771|584782033|FG002|Overall Study|Lost to Follow-up|3|||
161927569|NCT01928771|584782031|FG000|Overall Study|Withdrawal by Subject|20|||
161927570|NCT01928771|584782032|FG001|Overall Study|Withdrawal by Subject|15|||
161927571|NCT01928771|584782033|FG002|Overall Study|Withdrawal by Subject|17|||
161927572|NCT01928771|584782031|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
161927573|NCT01928771|584782032|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
161927574|NCT01928771|584782033|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
161927575|NCT01928771|584782031|FG000|Overall Study|Other Reasons|9|||
161927576|NCT01928771|584782032|FG001|Overall Study|Other Reasons|9|||
161927577|NCT01928771|584782033|FG002|Overall Study|Other Reasons|14|||
161927578|NCT01928771|584782031|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
161927579|NCT01928771|584782032|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
161927580|NCT01928771|584782033|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
161927581|NCT01937117|584782034|FG000|Overall Study|Disease Progression|7|||
161927582|NCT01937117|584782034|FG000|Overall Study|Physician Decision|4|||
161927583|NCT01937117|584782034|FG000|Overall Study|Adverse Event|2|||
161927584|NCT01407367|584782039|FG000|Overall Study|Death|24|||
161927585|NCT01407367|584782040|FG001|Overall Study|Death|32|||
161927586|NCT01407367|584782039|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
161927587|NCT01407367|584782040|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
161927588|NCT01407367|584782039|FG000|Overall Study|Withdrawal by Subject|4|||
161927589|NCT01407367|584782040|FG001|Overall Study|Withdrawal by Subject|15|||
161927590|NCT01407367|584782039|FG000|Overall Study|Lost to Follow-up|0|||
161927591|NCT01407367|584782040|FG001|Overall Study|Lost to Follow-up|2|||
161927592|NCT01695772|584782044|FG000|Overall Study|Withdrawal by Subject|18|||
161927593|NCT01695772|584782044|FG000|Overall Study|Progressive Disease|8|||
161927594|NCT01695772|584782044|FG000|Overall Study|Investigator Decision|5|||
161927595|NCT01695772|584782044|FG000|Overall Study|Lost to Follow-up|4|||
161927596|NCT01695772|584782044|FG000|Overall Study|Protocol Violation|2|||
161927597|NCT01695772|584782044|FG000|Overall Study|Unspecified Reason|1|||
161927598|NCT00004859|584782045|FG000|Overall Study|Lack of Efficacy|43|||
161927599|NCT00004859|584782046|FG001|Overall Study|Lack of Efficacy|113|||
161927600|NCT00004859|584782045|FG000|Overall Study|Adverse Event|31|||
161927601|NCT00004859|584782046|FG001|Overall Study|Adverse Event|93|||
161927602|NCT00004859|584782045|FG000|Overall Study|Death|5|||
161927603|NCT00004859|584782046|FG001|Overall Study|Death|5|||
161927604|NCT00004859|584782045|FG000|Overall Study|Withdrawal by Subject|7|||
161927605|NCT00004859|584782046|FG001|Overall Study|Withdrawal by Subject|33|||
161927606|NCT00004859|584782045|FG000|Overall Study|Protocol Violation|2|||
161927607|NCT00004859|584782046|FG001|Overall Study|Protocol Violation|2|||
161927608|NCT00004859|584782045|FG000|Overall Study|other disease|0|||
161927609|NCT00004859|584782046|FG001|Overall Study|other disease|3|||
161927610|NCT00004859|584782045|FG000|Overall Study|error|3|||
161676318|NCT02060383|583868738|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
161676319|NCT02060383|583868739|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
161927611|NCT00004859|584782046|FG001|Overall Study|error|1|||
161927612|NCT00004859|584782045|FG000|Overall Study|missing data|14|||
161927613|NCT00004859|584782046|FG001|Overall Study|missing data|11|||
161927614|NCT00004859|584782045|FG000|Overall Study|Other|13|||
161927615|NCT00004859|584782046|FG001|Overall Study|Other|21|||
161927616|NCT03882801|584783658|FG000|Period 1|Adverse Event|0|||
161927617|NCT03882801|584783659|FG001|Period 1|Adverse Event|1|||
161927618|NCT03882801|584783658|FG000|Period 1|Non-compliance with study drug|1|||
161927619|NCT03882801|584783659|FG001|Period 1|Non-compliance with study drug|1|||
161927620|NCT03882801|584783658|FG000|Period 1|Never treated with study drug|1|||
161927621|NCT03882801|584783659|FG001|Period 1|Never treated with study drug|0|||
161927622|NCT03882801|584783658|FG000|Washout Period|Physician Decision|0|||
161927623|NCT03882801|584783659|FG001|Washout Period|Physician Decision|1|||
161927624|NCT03882801|584783658|FG000|Period 2|Non-compliance with study drug|0|||
161927625|NCT03882801|584783659|FG001|Period 2|Non-compliance with study drug|1|||
161927626|NCT01793129|584783660|FG000|Overall Study|Lost to Follow-up|3|||
161927627|NCT01793129|584783661|FG001|Overall Study|Lost to Follow-up|7|||
161927628|NCT01793129|584783660|FG000|Overall Study|Withdrawal by Subject|0|||
161927629|NCT01793129|584783661|FG001|Overall Study|Withdrawal by Subject|2|||
161927630|NCT01567085|584783664|FG000|Overall Study|Death|6|||
161927631|NCT01567085|584783664|FG000|Overall Study|Adverse Event|6|||
161927632|NCT01567085|584783664|FG000|Overall Study|Lost to Follow-up|3|||
161927633|NCT01567085|584783664|FG000|Overall Study|Graft loss|2|||
161927634|NCT01567085|584783664|FG000|Overall Study|Renal transplantectomy|1|||
161927635|NCT01567085|584783664|FG000|Overall Study|Returned to chronic dialysis|1|||
161927636|NCT01567085|584783664|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
161927637|NCT04193176|584783665|FG000|Overall Study|Withdrawal by Subject|6|||
161927638|NCT04193176|584783666|FG001|Overall Study|Withdrawal by Subject|10|||
161927639|NCT00944645|584783671|FG000|Period 2|Adverse Event|1|||
161927640|NCT00944645|584783672|FG001|Period 2|Adverse Event|0|||
161927641|NCT00944645|584783671|FG000|Period 2|Lost to Follow-up|0|||
161927642|NCT00944645|584783672|FG001|Period 2|Lost to Follow-up|3|||
161927643|NCT00944645|584783671|FG000|Period 2|Withdrawal by Subject|7|||
161927644|NCT00944645|584783672|FG001|Period 2|Withdrawal by Subject|6|||
161927645|NCT03537729|584783676|FG000|Overall Study|Death|2|||
161927646|NCT03537729|584783677|FG001|Overall Study|Death|2|||
161927647|NCT03537729|584783678|FG002|Overall Study|Death|7|||
161927648|NCT03537729|584783676|FG000|Overall Study|Withdrawal by Subject|3|||
161927649|NCT03537729|584783677|FG001|Overall Study|Withdrawal by Subject|3|||
161927650|NCT03537729|584783678|FG002|Overall Study|Withdrawal by Subject|0|||
161927651|NCT03537729|584783676|FG000|Overall Study|Subject Moved|8|||
161927652|NCT03537729|584783677|FG001|Overall Study|Subject Moved|5|||
161927653|NCT03537729|584783678|FG002|Overall Study|Subject Moved|4|||
161927654|NCT03537729|584783676|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
161927655|NCT03537729|584783677|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
161927656|NCT03537729|584783678|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
161927657|NCT03537729|584783676|FG000|Overall Study|COVID-19 Site Restrictions|11|||
161927658|NCT03537729|584783677|FG001|Overall Study|COVID-19 Site Restrictions|15|||
161927659|NCT03537729|584783678|FG002|Overall Study|COVID-19 Site Restrictions|18|||
161927660|NCT03537729|584783676|FG000|Overall Study|Decline in Health|5|||
161927661|NCT03537729|584783677|FG001|Overall Study|Decline in Health|9|||
161927662|NCT03537729|584783678|FG002|Overall Study|Decline in Health|4|||
161927663|NCT03537729|584783676|FG000|Overall Study|Determined Ineligible|0|||
161927664|NCT03537729|584783677|FG001|Overall Study|Determined Ineligible|0|||
161927665|NCT03537729|584783678|FG002|Overall Study|Determined Ineligible|1|||
161927666|NCT00284934|584783681|FG000|Overall Study|Adverse Event|1|||
161927667|NCT00284934|584783682|FG001|Overall Study|Adverse Event|2|||
161927668|NCT00284934|584783681|FG000|Overall Study|Other reasons|3|||
161927669|NCT00284934|584783682|FG001|Overall Study|Other reasons|1|||
161927670|NCT00454142|584783683|FG000|Overall Study|Withdrawal by Subject|1|||
161927671|NCT01783015|584783689|FG000|Blinded Treatment|Adverse Event|0|||
161927672|NCT01783015|584783690|FG001|Blinded Treatment|Adverse Event|1|||
161927673|NCT01783015|584783691|FG002|Blinded Treatment|Adverse Event|0|||
161927674|NCT01783015|584783689|FG000|Blinded Treatment|Protocol Violation|0|||
162020798|NCT01088048|585132056|FG003|Overall Study|Adverse Event|5|||
162020799|NCT01088048|585132057|FG004|Overall Study|Adverse Event|6|||
161676320|NCT02060383|583868740|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
161927675|NCT01783015|584783690|FG001|Blinded Treatment|Protocol Violation|1|||
161927676|NCT01783015|584783691|FG002|Blinded Treatment|Protocol Violation|0|||
161927677|NCT01783015|584783689|FG000|Blinded Treatment|Withdrawal by Subject|0|||
161927678|NCT01783015|584783690|FG001|Blinded Treatment|Withdrawal by Subject|1|||
161927679|NCT01783015|584783691|FG002|Blinded Treatment|Withdrawal by Subject|0|||
161927680|NCT01783015|584783689|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
161927681|NCT01783015|584783690|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
161927682|NCT01783015|584783691|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
161927683|NCT01783015|584783689|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
161927684|NCT01783015|584783690|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
161927685|NCT01783015|584783691|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
161927686|NCT01348698|584783692|FG000|Overall Study|Does not meet lesion size criteria|1|||
161927687|NCT01348698|584783692|FG000|Overall Study|Death|3|||
161927688|NCT01348698|584783692|FG000|Overall Study|PI decision to close study|68|||
161927689|NCT00504556|584783693|FG000|Overall Study|Adverse Event|11|||
161927690|NCT00504556|584783694|FG001|Overall Study|Adverse Event|11|||
161927691|NCT00504556|584783695|FG002|Overall Study|Adverse Event|14|||
161927692|NCT00504556|584783696|FG003|Overall Study|Adverse Event|13|||
161927693|NCT00504556|584783697|FG004|Overall Study|Adverse Event|5|||
161927694|NCT00504556|584783693|FG000|Overall Study|Death|3|||
161927695|NCT00504556|584783694|FG001|Overall Study|Death|3|||
161927696|NCT00504556|584783695|FG002|Overall Study|Death|1|||
161927697|NCT00504556|584783696|FG003|Overall Study|Death|0|||
161927698|NCT00504556|584783697|FG004|Overall Study|Death|2|||
161927699|NCT00504556|584783693|FG000|Overall Study|Protocol Violation|1|||
161927700|NCT00504556|584783694|FG001|Overall Study|Protocol Violation|3|||
161927701|NCT00504556|584783695|FG002|Overall Study|Protocol Violation|2|||
161927702|NCT00504556|584783696|FG003|Overall Study|Protocol Violation|1|||
161927703|NCT00504556|584783697|FG004|Overall Study|Protocol Violation|2|||
161927704|NCT00504556|584783693|FG000|Overall Study|Lost to Follow-up|0|||
161927705|NCT00504556|584783694|FG001|Overall Study|Lost to Follow-up|0|||
161927706|NCT00504556|584783695|FG002|Overall Study|Lost to Follow-up|1|||
161927707|NCT00504556|584783696|FG003|Overall Study|Lost to Follow-up|1|||
161927708|NCT00504556|584783697|FG004|Overall Study|Lost to Follow-up|1|||
161821186|NCT04556734|584387578|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
161821187|NCT04556734|584387579|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
161821188|NCT04556734|584387580|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
161821189|NCT04556734|584387581|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161927709|NCT00504556|584783693|FG000|Overall Study|Withdrawal by Subject|16|||
161927710|NCT00504556|584783694|FG001|Overall Study|Withdrawal by Subject|16|||
161927711|NCT00504556|584783695|FG002|Overall Study|Withdrawal by Subject|7|||
161927712|NCT00504556|584783696|FG003|Overall Study|Withdrawal by Subject|8|||
161927713|NCT00504556|584783697|FG004|Overall Study|Withdrawal by Subject|12|||
161927714|NCT00504556|584783693|FG000|Overall Study|administrative reasons|0|||
161821190|NCT01680016|584387583|FG000|Overall Study|Adverse Event|0|||
161821191|NCT01680016|584387584|FG001|Overall Study|Adverse Event|0|||
161821192|NCT01680016|584387585|FG002|Overall Study|Adverse Event|1|||
161821193|NCT01680016|584387586|FG003|Overall Study|Adverse Event|4|||
161821194|NCT01680016|584387583|FG000|Overall Study|The Subject went out of The Trial|1|||
161821195|NCT01680016|584387584|FG001|Overall Study|The Subject went out of The Trial|0|||
161821196|NCT01680016|584387585|FG002|Overall Study|The Subject went out of The Trial|3|||
161821197|NCT01680016|584387586|FG003|Overall Study|The Subject went out of The Trial|0|||
161821198|NCT01680016|584387583|FG000|Overall Study|Protocol Violation|0|||
161821199|NCT01680016|584387584|FG001|Overall Study|Protocol Violation|1|||
161821200|NCT01680016|584387585|FG002|Overall Study|Protocol Violation|0|||
161821201|NCT01680016|584387586|FG003|Overall Study|Protocol Violation|0|||
161821202|NCT01680016|584387583|FG000|Overall Study|Withdrawal by Subject|5|||
161821203|NCT01680016|584387584|FG001|Overall Study|Withdrawal by Subject|7|||
161821204|NCT01680016|584387585|FG002|Overall Study|Withdrawal by Subject|1|||
161821205|NCT01680016|584387586|FG003|Overall Study|Withdrawal by Subject|1|||
161821206|NCT01958060|584387588|FG000|Overall Study|Not treated|2|||
161821207|NCT01958060|584387589|FG001|Overall Study|Not treated|0|||
161927715|NCT00504556|584783694|FG001|Overall Study|administrative reasons|2|||
161821208|NCT01958060|584387590|FG002|Overall Study|Not treated|0|||
161821209|NCT01958060|584387591|FG003|Overall Study|Not treated|0|||
161927716|NCT00504556|584783695|FG002|Overall Study|administrative reasons|2|||
161927717|NCT00504556|584783696|FG003|Overall Study|administrative reasons|1|||
161927718|NCT00504556|584783697|FG004|Overall Study|administrative reasons|2|||
161927719|NCT00504556|584783693|FG000|Overall Study|did not meet entry criteria|2|||
161927720|NCT00504556|584783694|FG001|Overall Study|did not meet entry criteria|0|||
161927721|NCT00504556|584783695|FG002|Overall Study|did not meet entry criteria|1|||
161927722|NCT00504556|584783696|FG003|Overall Study|did not meet entry criteria|1|||
161927723|NCT00504556|584783697|FG004|Overall Study|did not meet entry criteria|0|||
161927724|NCT00504556|584783693|FG000|Overall Study|data monitor committee decision|0|||
161927725|NCT00504556|584783694|FG001|Overall Study|data monitor committee decision|0|||
161927726|NCT00504556|584783695|FG002|Overall Study|data monitor committee decision|0|||
161927727|NCT00504556|584783696|FG003|Overall Study|data monitor committee decision|100|||
161927728|NCT00504556|584783697|FG004|Overall Study|data monitor committee decision|0|||
161927729|NCT00504556|584783693|FG000|Overall Study|Other|2|||
161927730|NCT00504556|584783694|FG001|Overall Study|Other|2|||
161927731|NCT00504556|584783695|FG002|Overall Study|Other|2|||
161927732|NCT00504556|584783696|FG003|Overall Study|Other|3|||
161927733|NCT00504556|584783697|FG004|Overall Study|Other|0|||
161927734|NCT00504556|584783693|FG000|Overall Study|not in safety analysis set|0|||
161927735|NCT00504556|584783694|FG001|Overall Study|not in safety analysis set|1|||
161927736|NCT00504556|584783695|FG002|Overall Study|not in safety analysis set|1|||
161927737|NCT00504556|584783696|FG003|Overall Study|not in safety analysis set|0|||
161927738|NCT00504556|584783697|FG004|Overall Study|not in safety analysis set|1|||
161927739|NCT03558672|584783698|FG000|Overall Study|Study Early Termination|10|||
161927740|NCT03607695|584783699|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
161927741|NCT03607695|584783699|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
161927742|NCT02741193|584783700|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
161927743|NCT02741193|584783700|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
161927744|NCT01027416|584783701|FG000|Overall Study|Withdrawal by Subject|0|||
161927745|NCT01027416|584783702|FG001|Overall Study|Withdrawal by Subject|1|||
161927746|NCT01027416|584783701|FG000|Overall Study|Physician Decision|1|||
161927747|NCT01027416|584783702|FG001|Overall Study|Physician Decision|4|||
161927748|NCT01560988|584783728|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
161927749|NCT01560988|584783729|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
161927750|NCT01560988|584783728|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
161927751|NCT01560988|584783729|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
161927752|NCT01560988|584783728|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
161927753|NCT01560988|584783729|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
161927754|NCT01441414|584783732|FG000|Overall Study|Participant died|9|||
161927755|NCT01441414|584783732|FG000|Overall Study|Other reasons|3|||
161927756|NCT01441414|584783732|FG000|Overall Study|Study terminated by sponsor|2|||
161927757|NCT01441414|584783732|FG000|Overall Study|Subject refused further follow-up|1|||
161927758|NCT00500110|584783733|FG000|Overall Study|Withdrawal by Subject|3|||
161927759|NCT00605657|584783734|FG000|Overall Study|Adverse Event|1|||
161927760|NCT00605657|584783734|FG000|Overall Study|Protocol Violation|1|||
161927761|NCT04535362|584783738|FG000|Overall Study|Lost to Follow-up|3|||
161927762|NCT04535362|584783739|FG001|Overall Study|Lost to Follow-up|1|||
161927763|NCT02018887|584783747|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
161927764|NCT02018887|584783748|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927765|NCT02018887|584783749|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927766|NCT02018887|584783750|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927767|NCT02018887|584783751|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927768|NCT02018887|584783752|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927769|NCT02018887|584783753|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927770|NCT02018887|584783754|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927771|NCT02018887|584783755|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927772|NCT02018887|584783756|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927773|NCT02018887|584783757|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
161927774|NCT02018887|584783747|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927775|NCT02018887|584783748|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927776|NCT02018887|584783749|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927777|NCT02018887|584783750|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927778|NCT02018887|584783751|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
161927779|NCT02018887|584783752|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927780|NCT02018887|584783753|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
161927781|NCT02018887|584783754|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
161927782|NCT02018887|584783755|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927783|NCT02018887|584783756|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927784|NCT02018887|584783757|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
161927785|NCT02018887|584783747|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
161927786|NCT02018887|584783748|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
161927787|NCT02018887|584783749|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
161927788|NCT02018887|584783750|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
161927789|NCT02018887|584783751|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
161927790|NCT02018887|584783752|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
161927791|NCT02018887|584783753|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
161927792|NCT02018887|584783754|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
161927793|NCT02018887|584783755|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
161927794|NCT02018887|584783756|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
161927795|NCT02018887|584783757|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
161927796|NCT02018887|584783747|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
161927797|NCT02018887|584783748|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
161927798|NCT02018887|584783749|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
161927799|NCT02018887|584783750|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
161927800|NCT02018887|584783751|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
161927801|NCT02018887|584783752|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
161927802|NCT02018887|584783753|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
161927803|NCT02018887|584783754|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
161927804|NCT02018887|584783755|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
161927805|NCT02018887|584783756|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
161927806|NCT02018887|584783757|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
161927807|NCT01058005|584783758|FG000|Overall Study|Adverse Event|0|||
161927808|NCT01058005|584783759|FG001|Overall Study|Adverse Event|2|||
161927809|NCT01058005|584783760|FG002|Overall Study|Adverse Event|1|||
161927810|NCT01058005|584783758|FG000|Overall Study|Physician Decision|2|||
161927811|NCT01058005|584783759|FG001|Overall Study|Physician Decision|2|||
161927812|NCT01058005|584783760|FG002|Overall Study|Physician Decision|0|||
161927813|NCT01058005|584783758|FG000|Overall Study|Withdrawal by Subject|4|||
161927814|NCT01058005|584783759|FG001|Overall Study|Withdrawal by Subject|5|||
161927815|NCT01058005|584783760|FG002|Overall Study|Withdrawal by Subject|11|||
161927816|NCT01058005|584783758|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
161927817|NCT01058005|584783759|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
161927818|NCT01058005|584783760|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
161821210|NCT01958060|584387592|FG004|Overall Study|Not treated|1|||
161927819|NCT01058005|584783758|FG000|Overall Study|Reason Missing|5|||
161927820|NCT01058005|584783759|FG001|Overall Study|Reason Missing|3|||
161927821|NCT01058005|584783760|FG002|Overall Study|Reason Missing|1|||
161927822|NCT04882215|584783761|FG000|Overall Study|Withdrawal by Subject|5|||
161927823|NCT04882215|584783762|FG001|Overall Study|Withdrawal by Subject|0|||
161821211|NCT01958060|584387593|FG005|Overall Study|Not treated|0|||
161821212|NCT02846883|584387596|FG000|Overall Study|Death|0|||
161821213|NCT02846883|584387597|FG001|Overall Study|Death|1|||
161821214|NCT02846883|584387598|FG002|Overall Study|Death|1|||
161821215|NCT02846883|584387596|FG000|Overall Study|Lost to Follow-up|0|||
161821216|NCT02846883|584387597|FG001|Overall Study|Lost to Follow-up|0|||
161821217|NCT02846883|584387598|FG002|Overall Study|Lost to Follow-up|1|||
161821218|NCT02846883|584387596|FG000|Overall Study|Withdrawal by Subject|1|||
161821219|NCT02846883|584387597|FG001|Overall Study|Withdrawal by Subject|0|||
161821220|NCT02846883|584387598|FG002|Overall Study|Withdrawal by Subject|0|||
161821221|NCT02846883|584387596|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
161821222|NCT02846883|584387597|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
161821223|NCT02846883|584387598|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
161821224|NCT02846883|584387596|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
161821225|NCT02846883|584387597|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
161821226|NCT02846883|584387598|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
161821227|NCT00927251|584387599|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
161821228|NCT01011335|584387601|FG000|Overall Study|Lost to Follow-up|0|||
161821229|NCT01011335|584387602|FG001|Overall Study|Lost to Follow-up|0|||
161821230|NCT01011335|584387603|FG002|Overall Study|Lost to Follow-up|1|||
161821231|NCT01011335|584387604|FG003|Overall Study|Lost to Follow-up|1|||
161821232|NCT01011335|584387605|FG004|Overall Study|Lost to Follow-up|1|||
161821233|NCT01011335|584387606|FG005|Overall Study|Lost to Follow-up|1|||
161821234|NCT01011335|584387607|FG006|Overall Study|Lost to Follow-up|2|||
161821235|NCT01011335|584387608|FG007|Overall Study|Lost to Follow-up|2|||
161821236|NCT01011335|584387609|FG008|Overall Study|Lost to Follow-up|1|||
161821237|NCT01011335|584387610|FG009|Overall Study|Lost to Follow-up|0|||
161821238|NCT01011335|584387611|FG010|Overall Study|Lost to Follow-up|0|||
161821239|NCT01011335|584387612|FG011|Overall Study|Lost to Follow-up|1|||
161927824|NCT06083493|584783763|FG000|Overall Study|Technical issues with the interventional device|2|||
161927825|NCT06083493|584783764|FG001|Overall Study|Technical issues with the interventional device|2|||
161927826|NCT06083493|584783763|FG000|Overall Study|Performed incorrect visual task|1|||
161927827|NCT06083493|584783764|FG001|Overall Study|Performed incorrect visual task|0|||
161927828|NCT06083493|584783763|FG000|Overall Study|Insufficient baseline performance|0|||
161927829|NCT06083493|584783764|FG001|Overall Study|Insufficient baseline performance|1|||
161927830|NCT02460380|584783770|FG000|Overall Study|Withdrawal by Subject|10|||
161927831|NCT02460380|584783771|FG001|Overall Study|Withdrawal by Subject|5|||
161927832|NCT01936974|584783776|FG000|Overall Study|Physician Decision|2|||
161927833|NCT01936974|584783777|FG001|Overall Study|Physician Decision|5|||
161927834|NCT00063999|584783778|FG000|Overall Study|Withdrawal by Subject|1|||
161927835|NCT00063999|584783779|FG001|Overall Study|Withdrawal by Subject|0|||
161927836|NCT00063999|584783778|FG000|Overall Study|Ineligible|44|||
161927837|NCT00063999|584783779|FG001|Overall Study|Ineligible|24|||
161927838|NCT02497755|584783780|FG000|Overall Study|Protocol Violation|1|||
161927839|NCT02497755|584783781|FG001|Overall Study|Protocol Violation|0|||
161927840|NCT04560309|584783794|FG000|Overall Study|Meet drop out criteria|1|||
161927841|NCT04560309|584783795|FG001|Overall Study|Meet drop out criteria|1|||
161927842|NCT05085405|584783796|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
161927843|NCT05085405|584783797|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
161821240|NCT01011335|584387613|FG012|Overall Study|Lost to Follow-up|2|||
161821241|NCT01011335|584387601|FG000|Overall Study|Protocol Violation|0|||
161821242|NCT01011335|584387602|FG001|Overall Study|Protocol Violation|1|||
161821243|NCT01011335|584387603|FG002|Overall Study|Protocol Violation|0|||
161821244|NCT01011335|584387604|FG003|Overall Study|Protocol Violation|0|||
161927844|NCT05085405|584783798|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
161821245|NCT01011335|584387605|FG004|Overall Study|Protocol Violation|0|||
161927845|NCT05085405|584783799|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
161927846|NCT05085405|584783800|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
161927847|NCT05085405|584783801|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
161927848|NCT05085405|584783796|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
161927849|NCT05085405|584783797|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
161927850|NCT05085405|584783798|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
161927851|NCT05085405|584783799|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
161927852|NCT05085405|584783800|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
161927853|NCT05085405|584783801|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
161927854|NCT01860404|584783802|FG000|Overall Study|Lost to Follow-up|3|||
161927855|NCT01860404|584783803|FG001|Overall Study|Lost to Follow-up|4|||
161927856|NCT01860404|584783804|FG002|Overall Study|Lost to Follow-up|1|||
161927857|NCT01860404|584783805|FG003|Overall Study|Lost to Follow-up|6|||
161927858|NCT01860404|584783806|FG004|Overall Study|Lost to Follow-up|4|||
161927859|NCT01860404|584783802|FG000|Overall Study|Withdrawal by Subject|0|||
162020800|NCT01088048|585132058|FG005|Overall Study|Adverse Event|3|||
162020801|NCT01088048|585132059|FG006|Overall Study|Adverse Event|3|||
162020802|NCT01088048|585132060|FG007|Overall Study|Adverse Event|0|||
162020803|NCT01088048|585132061|FG008|Overall Study|Adverse Event|2|||
161821246|NCT01011335|584387606|FG005|Overall Study|Protocol Violation|0|||
161821247|NCT01011335|584387607|FG006|Overall Study|Protocol Violation|0|||
161821248|NCT01011335|584387608|FG007|Overall Study|Protocol Violation|0|||
161821249|NCT01011335|584387609|FG008|Overall Study|Protocol Violation|0|||
161821250|NCT01011335|584387610|FG009|Overall Study|Protocol Violation|0|||
161821251|NCT01011335|584387611|FG010|Overall Study|Protocol Violation|0|||
161821252|NCT01011335|584387612|FG011|Overall Study|Protocol Violation|0|||
161821253|NCT01011335|584387613|FG012|Overall Study|Protocol Violation|0|||
161821254|NCT01011335|584387601|FG000|Overall Study|Moved/deployed or no booster|1|||
161821255|NCT01011335|584387602|FG001|Overall Study|Moved/deployed or no booster|0|||
161821256|NCT01011335|584387603|FG002|Overall Study|Moved/deployed or no booster|0|||
161821257|NCT01011335|584387604|FG003|Overall Study|Moved/deployed or no booster|1|||
161821258|NCT01011335|584387605|FG004|Overall Study|Moved/deployed or no booster|0|||
161821259|NCT01011335|584387606|FG005|Overall Study|Moved/deployed or no booster|0|||
161821260|NCT01011335|584387607|FG006|Overall Study|Moved/deployed or no booster|1|||
161821261|NCT01011335|584387608|FG007|Overall Study|Moved/deployed or no booster|0|||
161821262|NCT01011335|584387609|FG008|Overall Study|Moved/deployed or no booster|1|||
161821263|NCT01011335|584387610|FG009|Overall Study|Moved/deployed or no booster|0|||
161821264|NCT01011335|584387611|FG010|Overall Study|Moved/deployed or no booster|2|||
161821265|NCT01011335|584387612|FG011|Overall Study|Moved/deployed or no booster|0|||
161821266|NCT01011335|584387613|FG012|Overall Study|Moved/deployed or no booster|0|||
161821267|NCT01011335|584387601|FG000|Overall Study|Adverse Event|0|||
161821268|NCT01011335|584387602|FG001|Overall Study|Adverse Event|0|||
161821269|NCT01011335|584387603|FG002|Overall Study|Adverse Event|0|||
161821270|NCT01011335|584387604|FG003|Overall Study|Adverse Event|0|||
161821271|NCT01011335|584387605|FG004|Overall Study|Adverse Event|0|||
161821272|NCT01011335|584387606|FG005|Overall Study|Adverse Event|0|||
161821273|NCT01011335|584387607|FG006|Overall Study|Adverse Event|0|||
161821274|NCT01011335|584387608|FG007|Overall Study|Adverse Event|0|||
161821275|NCT01011335|584387609|FG008|Overall Study|Adverse Event|0|||
161821276|NCT01011335|584387610|FG009|Overall Study|Adverse Event|0|||
161821277|NCT01011335|584387611|FG010|Overall Study|Adverse Event|4|||
161821278|NCT01011335|584387612|FG011|Overall Study|Adverse Event|0|||
161821279|NCT01011335|584387613|FG012|Overall Study|Adverse Event|1|||
161821280|NCT01813435|584387614|FG000|Overall Study|did not finish experimental regimen|1902|||
161821281|NCT01813435|584387615|FG001|Overall Study|did not finish experimental regimen|770|||
161821282|NCT01813435|584387614|FG000|Overall Study|Lost to Follow-up|268|||
161821283|NCT01813435|584387615|FG001|Overall Study|Lost to Follow-up|237|||
161821284|NCT01765751|584387622|FG000|Overall Study|Lost to Follow-up|0|||
161821285|NCT01765751|584387623|FG001|Overall Study|Lost to Follow-up|2|||
161821286|NCT01765751|584387624|FG002|Overall Study|Lost to Follow-up|1|||
161821287|NCT01120899|584387625|FG000|Overall Study|Withdrawal by Subject|3|||
161821288|NCT00452348|584387626|FG000|Overall Study|Adverse Event|6|||
161821289|NCT00452348|584387627|FG001|Overall Study|Adverse Event|9|||
161821290|NCT00452348|584387626|FG000|Overall Study|Lack of Efficacy|10|||
161821291|NCT00452348|584387627|FG001|Overall Study|Lack of Efficacy|9|||
161821292|NCT00452348|584387626|FG000|Overall Study|Lost to Follow-up|14|||
161821293|NCT00452348|584387627|FG001|Overall Study|Lost to Follow-up|8|||
161821294|NCT00452348|584387626|FG000|Overall Study|Protocol Violation|22|||
161821295|NCT00452348|584387627|FG001|Overall Study|Protocol Violation|28|||
161821296|NCT00452348|584387626|FG000|Overall Study|Withdrawal by Subject|18|||
161821297|NCT00452348|584387627|FG001|Overall Study|Withdrawal by Subject|21|||
161821298|NCT00452348|584387626|FG000|Overall Study|Other|9|||
161821299|NCT00452348|584387627|FG001|Overall Study|Other|9|||
161821300|NCT02435433|584387630|FG000|Overall Study|Withdrawal by Subject|2|||
161821301|NCT02435433|584387631|FG001|Overall Study|Withdrawal by Subject|3|||
161821302|NCT02435433|584387632|FG002|Overall Study|Withdrawal by Subject|1|||
161927860|NCT01860404|584783803|FG001|Overall Study|Withdrawal by Subject|0|||
161927861|NCT01860404|584783804|FG002|Overall Study|Withdrawal by Subject|4|||
161927862|NCT01860404|584783805|FG003|Overall Study|Withdrawal by Subject|0|||
161927863|NCT01860404|584783806|FG004|Overall Study|Withdrawal by Subject|0|||
161927864|NCT00356421|584783808|FG000|Overall Study|Lack of Efficacy|3|||
161927865|NCT00356421|584783809|FG001|Overall Study|Lack of Efficacy|0|||
161927866|NCT00356421|584783808|FG000|Overall Study|Withdrawal by Subject|9|||
161927867|NCT00356421|584783809|FG001|Overall Study|Withdrawal by Subject|2|||
161927868|NCT00356421|584783808|FG000|Overall Study|Related to study drug|15|||
161927869|NCT00356421|584783809|FG001|Overall Study|Related to study drug|12|||
161927870|NCT00356421|584783808|FG000|Overall Study|Not related to study drug|5|||
161927871|NCT00356421|584783809|FG001|Overall Study|Not related to study drug|3|||
161927872|NCT04689009|584783810|FG000|Overall Study|Adverse Event|1|||
161927873|NCT04689009|584783811|FG001|Overall Study|Adverse Event|0|||
161927874|NCT04689009|584783810|FG000|Overall Study|Lost to Follow-up|1|||
161927875|NCT04689009|584783811|FG001|Overall Study|Lost to Follow-up|2|||
161927876|NCT04689009|584783810|FG000|Overall Study|Withdrawal by Subject|4|||
161927877|NCT04689009|584783811|FG001|Overall Study|Withdrawal by Subject|3|||
161927878|NCT04689009|584783810|FG000|Overall Study|Protocol Violation|1|||
161927879|NCT04689009|584783811|FG001|Overall Study|Protocol Violation|0|||
161927880|NCT02187055|584783812|FG000|Overall Study|Lack of Efficacy|10|||
161927881|NCT02187055|584783813|FG001|Overall Study|Lack of Efficacy|3|||
161927882|NCT02187055|584783814|FG002|Overall Study|Lack of Efficacy|7|||
161927883|NCT02187055|584783812|FG000|Overall Study|Lost to Follow-up|2|||
161927884|NCT02187055|584783813|FG001|Overall Study|Lost to Follow-up|7|||
161927885|NCT02187055|584783814|FG002|Overall Study|Lost to Follow-up|3|||
161927886|NCT02187055|584783812|FG000|Overall Study|No longer meets eligibility criteria|0|||
161927887|NCT02187055|584783813|FG001|Overall Study|No longer meets eligibility criteria|2|||
161927888|NCT02187055|584783814|FG002|Overall Study|No longer meets eligibility criteria|0|||
161927889|NCT02187055|584783812|FG000|Overall Study|No longer willing to participate|6|||
161927890|NCT02187055|584783813|FG001|Overall Study|No longer willing to participate|8|||
161927891|NCT02187055|584783814|FG002|Overall Study|No longer willing to participate|10|||
161927892|NCT02187055|584783812|FG000|Overall Study|Other|5|||
161927893|NCT02187055|584783813|FG001|Overall Study|Other|6|||
161927894|NCT02187055|584783814|FG002|Overall Study|Other|3|||
161927895|NCT02187055|584783812|FG000|Overall Study|Protocol Violation|9|||
161927896|NCT02187055|584783813|FG001|Overall Study|Protocol Violation|9|||
161927897|NCT02187055|584783814|FG002|Overall Study|Protocol Violation|4|||
161927898|NCT02187055|584783812|FG000|Overall Study|Pregnancy|3|||
161927899|NCT02187055|584783813|FG001|Overall Study|Pregnancy|1|||
161927900|NCT02187055|584783814|FG002|Overall Study|Pregnancy|0|||
161927901|NCT02187055|584783812|FG000|Overall Study|Withdrawal by Subject|11|||
161927902|NCT02187055|584783813|FG001|Overall Study|Withdrawal by Subject|11|||
161927903|NCT02187055|584783814|FG002|Overall Study|Withdrawal by Subject|11|||
161927904|NCT02187055|584783812|FG000|Overall Study|Adverse Event|21|||
161927905|NCT02187055|584783813|FG001|Overall Study|Adverse Event|26|||
161927906|NCT02187055|584783814|FG002|Overall Study|Adverse Event|36|||
161927907|NCT02187055|584783812|FG000|Overall Study|Death|2|||
161927908|NCT02187055|584783813|FG001|Overall Study|Death|0|||
161927909|NCT02187055|584783814|FG002|Overall Study|Death|0|||
161927910|NCT00985790|584783817|FG000|Overall Study|Withdrawal by Subject|1|||
161927911|NCT00985790|584783818|FG001|Overall Study|Withdrawal by Subject|1|||
161927912|NCT00985790|584783817|FG000|Overall Study|Lost to Follow-up|6|||
161927913|NCT00985790|584783818|FG001|Overall Study|Lost to Follow-up|7|||
161927914|NCT04796207|584783819|FG000|Overall Study|Lost to Follow-up|7|||
161927915|NCT04796207|584783820|FG001|Overall Study|Lost to Follow-up|2|||
161927916|NCT01030900|584783821|FG000|Overall Study|Not treated due to congestive heart failure|1|||
161927917|NCT01030900|584783821|FG000|Overall Study|Not treated due to rapid disease|1|||
161927918|NCT00441896|584783822|FG000|Overall Study|Withdrawal by Subject|0|||
161927919|NCT00441896|584783823|FG001|Overall Study|Withdrawal by Subject|0|||
161927920|NCT00441896|584783824|FG002|Overall Study|Withdrawal by Subject|0|||
161927921|NCT00441896|584783825|FG003|Overall Study|Withdrawal by Subject|1|||
161927922|NCT00441896|584783826|FG004|Overall Study|Withdrawal by Subject|0|||
161927923|NCT00441896|584783827|FG005|Overall Study|Withdrawal by Subject|0|||
161927924|NCT00441896|584783828|FG006|Overall Study|Withdrawal by Subject|0|||
161927925|NCT00441896|584783829|FG007|Overall Study|Withdrawal by Subject|0|||
161927926|NCT00441896|584783830|FG008|Overall Study|Withdrawal by Subject|0|||
161927927|NCT00441896|584783831|FG009|Overall Study|Withdrawal by Subject|0|||
161927928|NCT00441896|584783822|FG000|Overall Study|Other|0|||
161927929|NCT00441896|584783823|FG001|Overall Study|Other|0|||
161927930|NCT00441896|584783824|FG002|Overall Study|Other|0|||
161927931|NCT00441896|584783825|FG003|Overall Study|Other|0|||
161927932|NCT00441896|584783826|FG004|Overall Study|Other|1|||
161927933|NCT00441896|584783827|FG005|Overall Study|Other|0|||
161927934|NCT00441896|584783828|FG006|Overall Study|Other|0|||
161927935|NCT00441896|584783829|FG007|Overall Study|Other|0|||
161927936|NCT00441896|584783830|FG008|Overall Study|Other|0|||
161927937|NCT00441896|584783831|FG009|Overall Study|Other|0|||
161927938|NCT01301092|584783832|FG000|Overall Study|Lost to Follow-up|0|||
161927939|NCT01301092|584783833|FG001|Overall Study|Lost to Follow-up|0|||
161927940|NCT01301092|584783834|FG002|Overall Study|Lost to Follow-up|1|||
161927941|NCT03334175|584783835|FG000|Overall Study|Lost to Follow-up|0|||
161927942|NCT03334175|584783836|FG001|Overall Study|Lost to Follow-up|1|||
161927943|NCT00520572|584785415|FG000|Overall Study|Adverse Event|9|||
161927944|NCT00520572|584785416|FG001|Overall Study|Adverse Event|3|||
161927945|NCT00520572|584785417|FG002|Overall Study|Adverse Event|6|||
161927946|NCT00520572|584785418|FG003|Overall Study|Adverse Event|9|||
161927947|NCT00520572|584785419|FG004|Overall Study|Adverse Event|7|||
161927948|NCT00520572|584785420|FG005|Overall Study|Adverse Event|2|||
161927949|NCT00520572|584785415|FG000|Overall Study|Withdrawal by Subject|0|||
161927950|NCT00520572|584785416|FG001|Overall Study|Withdrawal by Subject|9|||
161927951|NCT00520572|584785417|FG002|Overall Study|Withdrawal by Subject|5|||
161927952|NCT00520572|584785418|FG003|Overall Study|Withdrawal by Subject|2|||
161927953|NCT00520572|584785419|FG004|Overall Study|Withdrawal by Subject|2|||
161927954|NCT00520572|584785420|FG005|Overall Study|Withdrawal by Subject|0|||
161927955|NCT00520572|584785415|FG000|Overall Study|Protocol Violation|0|||
161927956|NCT00520572|584785416|FG001|Overall Study|Protocol Violation|0|||
161927957|NCT00520572|584785417|FG002|Overall Study|Protocol Violation|1|||
161927958|NCT00520572|584785418|FG003|Overall Study|Protocol Violation|0|||
161927959|NCT00520572|584785419|FG004|Overall Study|Protocol Violation|0|||
161927960|NCT00520572|584785420|FG005|Overall Study|Protocol Violation|0|||
161927961|NCT00520572|584785415|FG000|Overall Study|Lack of Efficacy|1|||
161927962|NCT00520572|584785416|FG001|Overall Study|Lack of Efficacy|1|||
161927963|NCT00520572|584785417|FG002|Overall Study|Lack of Efficacy|1|||
161927964|NCT00520572|584785418|FG003|Overall Study|Lack of Efficacy|2|||
161927965|NCT00520572|584785419|FG004|Overall Study|Lack of Efficacy|1|||
161927966|NCT00520572|584785420|FG005|Overall Study|Lack of Efficacy|0|||
161927967|NCT00520572|584785415|FG000|Overall Study|Lost to Follow-up|0|||
161927968|NCT00520572|584785416|FG001|Overall Study|Lost to Follow-up|0|||
161927969|NCT00520572|584785417|FG002|Overall Study|Lost to Follow-up|0|||
161927970|NCT00520572|584785418|FG003|Overall Study|Lost to Follow-up|0|||
161927971|NCT00520572|584785419|FG004|Overall Study|Lost to Follow-up|1|||
161927972|NCT00520572|584785420|FG005|Overall Study|Lost to Follow-up|0|||
161927973|NCT00520572|584785415|FG000|Overall Study|Incorrect enrollment|1|||
161821303|NCT02435433|584387633|FG003|Overall Study|Withdrawal by Subject|0|||
161821304|NCT02435433|584387634|FG004|Overall Study|Withdrawal by Subject|0|||
161821305|NCT02435433|584387630|FG000|Overall Study|Lost to Follow-up|2|||
161821306|NCT02435433|584387631|FG001|Overall Study|Lost to Follow-up|2|||
161821307|NCT02435433|584387632|FG002|Overall Study|Lost to Follow-up|4|||
161821308|NCT02435433|584387633|FG003|Overall Study|Lost to Follow-up|1|||
161821309|NCT02435433|584387634|FG004|Overall Study|Lost to Follow-up|0|||
161821310|NCT01243151|584387635|FG000|Overall Study|Adverse Event|0|||
161821311|NCT01243151|584387636|FG001|Overall Study|Adverse Event|1|||
161927974|NCT00520572|584785416|FG001|Overall Study|Incorrect enrollment|0|||
161927975|NCT00520572|584785417|FG002|Overall Study|Incorrect enrollment|1|||
161927976|NCT00520572|584785418|FG003|Overall Study|Incorrect enrollment|0|||
161927977|NCT00520572|584785419|FG004|Overall Study|Incorrect enrollment|1|||
161927978|NCT00520572|584785420|FG005|Overall Study|Incorrect enrollment|0|||
161927979|NCT00520572|584785415|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
161927980|NCT00520572|584785416|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
161927981|NCT00520572|584785417|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
161927982|NCT00520572|584785418|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
161927983|NCT00520572|584785419|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
161927984|NCT00520572|584785420|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
161927985|NCT00520572|584785415|FG000|Overall Study|Long break in taking Medication|0|||
161821312|NCT01243151|584387637|FG002|Overall Study|Adverse Event|0|||
161927986|NCT00520572|584785416|FG001|Overall Study|Long break in taking Medication|0|||
161927987|NCT00520572|584785417|FG002|Overall Study|Long break in taking Medication|0|||
161927988|NCT00520572|584785418|FG003|Overall Study|Long break in taking Medication|1|||
161927989|NCT00520572|584785419|FG004|Overall Study|Long break in taking Medication|0|||
161927990|NCT00520572|584785420|FG005|Overall Study|Long break in taking Medication|0|||
161927991|NCT00520572|584785415|FG000|Overall Study|Did not receive Treatment|1|||
161927992|NCT00520572|584785416|FG001|Overall Study|Did not receive Treatment|0|||
161927993|NCT00520572|584785417|FG002|Overall Study|Did not receive Treatment|1|||
161927994|NCT00520572|584785418|FG003|Overall Study|Did not receive Treatment|0|||
161927995|NCT00520572|584785419|FG004|Overall Study|Did not receive Treatment|0|||
161927996|NCT00520572|584785420|FG005|Overall Study|Did not receive Treatment|0|||
161927997|NCT03548415|584785423|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
161927998|NCT03548415|584785424|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
161927999|NCT03548415|584785425|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
161928000|NCT03548415|584785426|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
161928001|NCT03548415|584785427|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
161928002|NCT04605588|584785428|FG000|Overall Study|Withdrawal by Subject|1|||
161928003|NCT04605588|584785429|FG001|Overall Study|Withdrawal by Subject|0|||
161928004|NCT01230814|584785430|FG000|Overall Study|Lost to Follow-up|11|||
161928005|NCT01230814|584785431|FG001|Overall Study|Lost to Follow-up|3|||
161928006|NCT01230814|584785430|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
161928007|NCT01230814|584785431|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
161928008|NCT01803737|584785432|FG000|Overall Study|Lack of Time|1|||
161928009|NCT01803737|584785433|FG001|Overall Study|Lack of Time|0|||
161928010|NCT01803737|584785432|FG000|Overall Study|Medical Reason|0|||
161928011|NCT01803737|584785433|FG001|Overall Study|Medical Reason|1|||
161928012|NCT01803737|584785432|FG000|Overall Study|Lost to Follow-up|0|||
161928013|NCT01803737|584785433|FG001|Overall Study|Lost to Follow-up|2|||
161928014|NCT00676052|584785435|FG000|Overall Study|Adverse Event|0|||
161928015|NCT00676052|584785436|FG001|Overall Study|Adverse Event|1|||
161928016|NCT00676052|584785437|FG002|Overall Study|Adverse Event|1|||
161928017|NCT00676052|584785438|FG003|Overall Study|Adverse Event|2|||
161928018|NCT00676052|584785439|FG004|Overall Study|Adverse Event|2|||
161928019|NCT00676052|584785440|FG005|Overall Study|Adverse Event|2|||
161928020|NCT00676052|584785435|FG000|Overall Study|Lack of Efficacy|2|||
161928021|NCT00676052|584785436|FG001|Overall Study|Lack of Efficacy|2|||
161928022|NCT00676052|584785437|FG002|Overall Study|Lack of Efficacy|1|||
161928023|NCT00676052|584785438|FG003|Overall Study|Lack of Efficacy|1|||
162020804|NCT01088048|585132062|FG009|Overall Study|Adverse Event|2|||
162020805|NCT01088048|585132053|FG000|Overall Study|Withdrew Consent|1|||
162020806|NCT01088048|585132054|FG001|Overall Study|Withdrew Consent|1|||
162020807|NCT01088048|585132055|FG002|Overall Study|Withdrew Consent|1|||
162020808|NCT01088048|585132056|FG003|Overall Study|Withdrew Consent|1|||
162020809|NCT01088048|585132057|FG004|Overall Study|Withdrew Consent|2|||
162020810|NCT01088048|585132058|FG005|Overall Study|Withdrew Consent|1|||
162020811|NCT01088048|585132059|FG006|Overall Study|Withdrew Consent|0|||
162020812|NCT01088048|585132060|FG007|Overall Study|Withdrew Consent|2|||
162020813|NCT01088048|585132061|FG008|Overall Study|Withdrew Consent|2|||
162020814|NCT01088048|585132062|FG009|Overall Study|Withdrew Consent|1|||
162020815|NCT01088048|585132053|FG000|Overall Study|Concomitant Medication Prohibited|1|||
162020816|NCT01088048|585132054|FG001|Overall Study|Concomitant Medication Prohibited|0|||
162020817|NCT01088048|585132055|FG002|Overall Study|Concomitant Medication Prohibited|0|||
162020818|NCT01088048|585132056|FG003|Overall Study|Concomitant Medication Prohibited|0|||
162020819|NCT01088048|585132057|FG004|Overall Study|Concomitant Medication Prohibited|0|||
162020820|NCT01088048|585132058|FG005|Overall Study|Concomitant Medication Prohibited|0|||
162020821|NCT01088048|585132059|FG006|Overall Study|Concomitant Medication Prohibited|0|||
162020822|NCT01088048|585132060|FG007|Overall Study|Concomitant Medication Prohibited|0|||
162020823|NCT01088048|585132061|FG008|Overall Study|Concomitant Medication Prohibited|0|||
162020824|NCT01088048|585132062|FG009|Overall Study|Concomitant Medication Prohibited|0|||
162020825|NCT01088048|585132053|FG000|Overall Study|Investigator Request|2|||
162020826|NCT01088048|585132054|FG001|Overall Study|Investigator Request|2|||
162020827|NCT01088048|585132055|FG002|Overall Study|Investigator Request|0|||
162020828|NCT01088048|585132056|FG003|Overall Study|Investigator Request|0|||
162020829|NCT01088048|585132057|FG004|Overall Study|Investigator Request|3|||
162020830|NCT01088048|585132058|FG005|Overall Study|Investigator Request|1|||
162020831|NCT01088048|585132059|FG006|Overall Study|Investigator Request|1|||
162020832|NCT01088048|585132060|FG007|Overall Study|Investigator Request|0|||
162020833|NCT01088048|585132061|FG008|Overall Study|Investigator Request|0|||
162020834|NCT01088048|585132062|FG009|Overall Study|Investigator Request|0|||
162020835|NCT01088048|585132053|FG000|Overall Study|Patient Non-compliance|0|||
162020836|NCT01088048|585132054|FG001|Overall Study|Patient Non-compliance|1|||
162020837|NCT01088048|585132055|FG002|Overall Study|Patient Non-compliance|0|||
162020838|NCT01088048|585132056|FG003|Overall Study|Patient Non-compliance|0|||
162020839|NCT01088048|585132057|FG004|Overall Study|Patient Non-compliance|0|||
162020840|NCT01088048|585132058|FG005|Overall Study|Patient Non-compliance|0|||
162020841|NCT01088048|585132059|FG006|Overall Study|Patient Non-compliance|0|||
162020842|NCT01088048|585132060|FG007|Overall Study|Patient Non-compliance|0|||
162020843|NCT01088048|585132061|FG008|Overall Study|Patient Non-compliance|0|||
162020844|NCT01088048|585132062|FG009|Overall Study|Patient Non-compliance|0|||
162020845|NCT01088048|585132053|FG000|Overall Study|Disease Progression|7|||
162020846|NCT01088048|585132054|FG001|Overall Study|Disease Progression|4|||
162020847|NCT01088048|585132055|FG002|Overall Study|Disease Progression|3|||
162020848|NCT01088048|585132056|FG003|Overall Study|Disease Progression|5|||
162020849|NCT01088048|585132057|FG004|Overall Study|Disease Progression|3|||
162020850|NCT01088048|585132058|FG005|Overall Study|Disease Progression|3|||
162020851|NCT01088048|585132059|FG006|Overall Study|Disease Progression|2|||
162020852|NCT01088048|585132060|FG007|Overall Study|Disease Progression|1|||
161928024|NCT00676052|584785439|FG004|Overall Study|Lack of Efficacy|2|||
161928025|NCT00676052|584785440|FG005|Overall Study|Lack of Efficacy|1|||
161928026|NCT00676052|584785435|FG000|Overall Study|Protocol Violation|5|||
161928027|NCT00676052|584785436|FG001|Overall Study|Protocol Violation|3|||
161928028|NCT00676052|584785437|FG002|Overall Study|Protocol Violation|2|||
162020853|NCT01088048|585132061|FG008|Overall Study|Disease Progression|0|||
162020854|NCT01088048|585132062|FG009|Overall Study|Disease Progression|0|||
161928029|NCT00676052|584785438|FG003|Overall Study|Protocol Violation|2|||
162020855|NCT01088048|585132053|FG000|Overall Study|Death|1|||
161928030|NCT00676052|584785439|FG004|Overall Study|Protocol Violation|1|||
161928031|NCT00676052|584785440|FG005|Overall Study|Protocol Violation|2|||
161928032|NCT00676052|584785435|FG000|Overall Study|Lost to Follow-up|0|||
161928033|NCT00676052|584785436|FG001|Overall Study|Lost to Follow-up|0|||
161928034|NCT00676052|584785437|FG002|Overall Study|Lost to Follow-up|0|||
161928035|NCT00676052|584785438|FG003|Overall Study|Lost to Follow-up|0|||
161928036|NCT00676052|584785439|FG004|Overall Study|Lost to Follow-up|1|||
161928037|NCT00676052|584785440|FG005|Overall Study|Lost to Follow-up|0|||
161928038|NCT00676052|584785435|FG000|Overall Study|Physician Decision|1|||
161928039|NCT00676052|584785436|FG001|Overall Study|Physician Decision|1|||
161928040|NCT00676052|584785437|FG002|Overall Study|Physician Decision|1|||
161928041|NCT00676052|584785438|FG003|Overall Study|Physician Decision|0|||
161928042|NCT00676052|584785439|FG004|Overall Study|Physician Decision|0|||
161928043|NCT00676052|584785440|FG005|Overall Study|Physician Decision|1|||
161928044|NCT00676052|584785435|FG000|Overall Study|Withdrawal by Subject|1|||
161928045|NCT00676052|584785436|FG001|Overall Study|Withdrawal by Subject|0|||
161928046|NCT00676052|584785437|FG002|Overall Study|Withdrawal by Subject|1|||
161928047|NCT00676052|584785438|FG003|Overall Study|Withdrawal by Subject|0|||
161928048|NCT00676052|584785439|FG004|Overall Study|Withdrawal by Subject|0|||
161928049|NCT00676052|584785440|FG005|Overall Study|Withdrawal by Subject|0|||
161928050|NCT02930941|584785441|FG000|Overall Study|Lost to Follow-up|1|||
161928051|NCT02930941|584785442|FG001|Overall Study|Lost to Follow-up|2|||
161928052|NCT00289978|584785443|FG000|Overall Study|Withdrawal by Subject|31|||
161928053|NCT00289978|584785444|FG001|Overall Study|Withdrawal by Subject|17|||
161928054|NCT00289978|584785445|FG002|Overall Study|Withdrawal by Subject|28|||
161928055|NCT00289978|584785443|FG000|Overall Study|Adverse Event|22|||
161928056|NCT00289978|584785444|FG001|Overall Study|Adverse Event|13|||
161928057|NCT00289978|584785445|FG002|Overall Study|Adverse Event|18|||
161928058|NCT00289978|584785443|FG000|Overall Study|Lack of Efficacy|13|||
161928059|NCT00289978|584785444|FG001|Overall Study|Lack of Efficacy|6|||
161928060|NCT00289978|584785445|FG002|Overall Study|Lack of Efficacy|25|||
161928061|NCT00289978|584785443|FG000|Overall Study|Abnormal laboratory value(s)|20|||
161928062|NCT00289978|584785444|FG001|Overall Study|Abnormal laboratory value(s)|9|||
161928063|NCT00289978|584785445|FG002|Overall Study|Abnormal laboratory value(s)|1|||
161928064|NCT00289978|584785443|FG000|Overall Study|Lost to Follow-up|3|||
161928065|NCT00289978|584785444|FG001|Overall Study|Lost to Follow-up|5|||
161928066|NCT00289978|584785445|FG002|Overall Study|Lost to Follow-up|7|||
161928067|NCT00289978|584785443|FG000|Overall Study|Protocol Violation|5|||
161928068|NCT00289978|584785444|FG001|Overall Study|Protocol Violation|5|||
161928069|NCT00289978|584785445|FG002|Overall Study|Protocol Violation|4|||
161928070|NCT00289978|584785443|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161928071|NCT00289978|584785444|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161928072|NCT00289978|584785445|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161928073|NCT00289978|584785443|FG000|Overall Study|Death|1|||
161928074|NCT00289978|584785444|FG001|Overall Study|Death|0|||
161928075|NCT00289978|584785445|FG002|Overall Study|Death|2|||
161928076|NCT00903344|584785446|FG000|Overall Study|Pregnancy|2|||
161928077|NCT00903344|584785447|FG001|Overall Study|Pregnancy|3|||
161928078|NCT00903344|584785446|FG000|Overall Study|Lost to Follow-up|3|||
161928079|NCT00903344|584785447|FG001|Overall Study|Lost to Follow-up|0|||
161928080|NCT00585169|584785448|FG000|Overall Study|Withdrawal by Subject|1|||
161928081|NCT03055221|584785449|FG000|Overall Study|Adverse Event|2|||
161928082|NCT03055221|584785449|FG000|Overall Study|Withdrawal by Subject|4|||
161928083|NCT03055221|584785449|FG000|Overall Study|Death|6|||
161928084|NCT03055221|584785449|FG000|Overall Study|Physician Decision|1|||
161928085|NCT03055221|584785449|FG000|Overall Study|Study terminated by Sponsor|3|||
161928086|NCT03055221|584785449|FG000|Overall Study|Lost to Follow-up|4|||
161928087|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
161928088|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
161928089|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
161928090|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
161928091|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
161928092|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
161928093|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
162201131|NCT00332488|585787065|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
161928094|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
162201132|NCT00332488|585787063|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
161928095|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
161928096|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
162020856|NCT01088048|585132054|FG001|Overall Study|Death|5|||
162201133|NCT00332488|585787064|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
162201134|NCT00332488|585787065|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
162201135|NCT00371462|585787066|FG000|Overall Study|Withdrawal by Subject|1|||
162201136|NCT00371462|585787067|FG001|Overall Study|Withdrawal by Subject|0|||
162201137|NCT00371462|585787066|FG000|Overall Study|Other|7|||
161928097|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
161928098|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
161928099|NCT01243424|584785450|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
161928100|NCT01243424|584785451|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
161928101|NCT01243424|584785450|FG000|Discontinuation From Treatment|Not treated|5|||
161928102|NCT01243424|584785451|FG001|Discontinuation From Treatment|Not treated|4|||
161928103|NCT01243424|584785450|FG000|Discontinuation From Treatment|Adverse Event|457|||
161928104|NCT01243424|584785451|FG001|Discontinuation From Treatment|Adverse Event|523|||
161928105|NCT01243424|584785450|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
161928106|NCT01243424|584785451|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
161928107|NCT01243424|584785450|FG000|Discontinuation From Treatment|Protocol Violation|46|||
161928108|NCT01243424|584785451|FG001|Discontinuation From Treatment|Protocol Violation|47|||
161928109|NCT01243424|584785450|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
161928110|NCT01243424|584785451|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
161928111|NCT01243424|584785450|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
161928112|NCT01243424|584785451|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
161928113|NCT01243424|584785450|FG000|Discontinuation From Treatment|Other than listed above|230|||
161928114|NCT01243424|584785451|FG001|Discontinuation From Treatment|Other than listed above|211|||
161928115|NCT02391584|584785457|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
161928116|NCT02391584|584785458|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
161676321|NCT02060383|583868741|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
161676322|NCT02060383|583868742|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
161676323|NCT02060383|583868738|FG000|Extension Phase|Adverse Event|1|||
161676324|NCT02060383|583868739|FG001|Extension Phase|Adverse Event|1|||
161676325|NCT02060383|583868740|FG002|Extension Phase|Adverse Event|2|||
161676326|NCT02060383|583868741|FG003|Extension Phase|Adverse Event|0|||
161676327|NCT02060383|583868742|FG004|Extension Phase|Adverse Event|1|||
161676328|NCT02060383|583868738|FG000|Extension Phase|Withdrawal by Subject|0|||
161676329|NCT02060383|583868739|FG001|Extension Phase|Withdrawal by Subject|1|||
161676330|NCT02060383|583868740|FG002|Extension Phase|Withdrawal by Subject|0|||
161676331|NCT02060383|583868741|FG003|Extension Phase|Withdrawal by Subject|0|||
161676332|NCT02060383|583868742|FG004|Extension Phase|Withdrawal by Subject|2|||
161676333|NCT02060383|583868738|FG000|Extension Phase|Administrative problems|1|||
161676334|NCT02060383|583868739|FG001|Extension Phase|Administrative problems|0|||
161676335|NCT02060383|583868740|FG002|Extension Phase|Administrative problems|0|||
161676336|NCT02060383|583868741|FG003|Extension Phase|Administrative problems|0|||
161676337|NCT02060383|583868742|FG004|Extension Phase|Administrative problems|0|||
161676338|NCT02060383|583868738|FG000|Extension Phase|Death|0|||
161676339|NCT02060383|583868739|FG001|Extension Phase|Death|0|||
161676340|NCT02060383|583868740|FG002|Extension Phase|Death|1|||
161676341|NCT02060383|583868741|FG003|Extension Phase|Death|0|||
161676342|NCT02060383|583868742|FG004|Extension Phase|Death|1|||
161676343|NCT02060383|583868738|FG000|Extension Phase|Protocol Violation|0|||
161676344|NCT02060383|583868739|FG001|Extension Phase|Protocol Violation|0|||
161928117|NCT02391584|584785457|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
161928118|NCT02391584|584785458|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
161928119|NCT02391584|584785457|FG000|3 Month|Lost to Follow-up|1|||
161928120|NCT02391584|584785458|FG001|3 Month|Lost to Follow-up|0|||
161928121|NCT02391584|584785457|FG000|6 Month|Withdrawal by Subject|1|||
161928122|NCT02391584|584785458|FG001|6 Month|Withdrawal by Subject|0|||
161928123|NCT02391584|584785457|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
161928124|NCT02391584|584785458|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
161928125|NCT04621786|584785459|FG000|Overall Study|Lost to Follow-up|9|||
161928126|NCT04621786|584785459|FG000|Overall Study|Protocol Violation|3|||
161928127|NCT00710554|584785460|FG000|Overall Study|Adverse Event|24|||
161928128|NCT00710554|584785461|FG001|Overall Study|Adverse Event|7|||
161676345|NCT02060383|583868740|FG002|Extension Phase|Protocol Violation|0|||
161928129|NCT00710554|584785460|FG000|Overall Study|Withdrawal by Subject|7|||
161928130|NCT00710554|584785461|FG001|Overall Study|Withdrawal by Subject|3|||
161676346|NCT02060383|583868741|FG003|Extension Phase|Protocol Violation|0|||
161676347|NCT02060383|583868742|FG004|Extension Phase|Protocol Violation|1|||
161676348|NCT03426787|583868743|FG000|Overall Study|Withdrawal by Subject|6|||
161676349|NCT03426787|583868743|FG000|Overall Study|Lost to Follow-up|7|||
161821313|NCT01243151|584387638|FG003|Overall Study|Adverse Event|0|||
161821314|NCT01243151|584387639|FG004|Overall Study|Adverse Event|0|||
161821315|NCT01243151|584387635|FG000|Overall Study|Protocol Violation|0|||
161821316|NCT01243151|584387636|FG001|Overall Study|Protocol Violation|0|||
161821317|NCT01243151|584387637|FG002|Overall Study|Protocol Violation|1|||
161821318|NCT01243151|584387638|FG003|Overall Study|Protocol Violation|0|||
161821319|NCT01243151|584387639|FG004|Overall Study|Protocol Violation|0|||
161821320|NCT01243151|584387635|FG000|Overall Study|Other|0|||
161821321|NCT01243151|584387636|FG001|Overall Study|Other|0|||
161821322|NCT01243151|584387637|FG002|Overall Study|Other|0|||
161676350|NCT03426787|583868743|FG000|Overall Study|Unrelated to intervention death|1|||
161676351|NCT00257166|583868749|FG000|Overall Study|Adverse Event|18|||
161928131|NCT00710554|584785460|FG000|Overall Study|Lost to Follow-up|7|||
161928132|NCT00710554|584785461|FG001|Overall Study|Lost to Follow-up|1|||
161928133|NCT00710554|584785460|FG000|Overall Study|Lack of Efficacy|11|||
161928134|NCT00710554|584785461|FG001|Overall Study|Lack of Efficacy|12|||
161928135|NCT00710554|584785460|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
161928136|NCT00710554|584785461|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
161928137|NCT01093885|584785462|FG000|Overall Study|Adverse Event|4|||
161928138|NCT01093885|584785462|FG000|Overall Study|Lost to Follow-up|1|||
161928139|NCT00292370|584785463|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
161928140|NCT00292370|584785464|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
161928141|NCT00292370|584785465|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
161928142|NCT00292370|584785463|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
161928143|NCT00292370|584785464|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
161928144|NCT00292370|584785465|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
161928145|NCT00292370|584785463|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
161928146|NCT00292370|584785464|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
161928147|NCT00292370|584785465|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
161928148|NCT00292370|584785463|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
161928149|NCT00292370|584785464|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
161928150|NCT00292370|584785465|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
161928151|NCT00292370|584785463|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
161928152|NCT00292370|584785464|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
161928153|NCT00292370|584785465|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
161928154|NCT00292370|584785463|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
161928155|NCT00292370|584785464|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
161928156|NCT00292370|584785465|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
161928157|NCT01301001|584785466|FG000|First Intervention|Lost to Follow-up|4|||
161928158|NCT01301001|584785467|FG001|First Intervention|Lost to Follow-up|4|||
161928159|NCT01301001|584785466|FG000|First Intervention|Withdrawal by Subject|1|||
161928160|NCT01301001|584785467|FG001|First Intervention|Withdrawal by Subject|4|||
161928161|NCT01301001|584785466|FG000|First Intervention|Adverse Event|5|||
161928162|NCT01301001|584785467|FG001|First Intervention|Adverse Event|0|||
161928163|NCT01301001|584785466|FG000|First Intervention|Protocol Violation|0|||
161928164|NCT01301001|584785467|FG001|First Intervention|Protocol Violation|1|||
161928165|NCT01301001|584785466|FG000|Second Intervention|Adverse Event|2|||
161928166|NCT01301001|584785467|FG001|Second Intervention|Adverse Event|0|||
161928167|NCT01301001|584785466|FG000|Second Intervention|Withdrawal by Subject|2|||
161928168|NCT01301001|584785467|FG001|Second Intervention|Withdrawal by Subject|0|||
161928169|NCT01346709|584785468|FG000|Overall Study|Protocol Violation|35|||
161928170|NCT01346709|584785468|FG000|Overall Study|Lost to Follow-up|31|||
162201138|NCT00371462|585787067|FG001|Overall Study|Other|8|||
161928171|NCT01346709|584785468|FG000|Overall Study|Missing data in candidate risk factor|285|||
161928172|NCT02365064|584785473|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
161928173|NCT02365064|584785474|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
162201139|NCT03721978|585787068|FG000|Overall Study|Withdrawal by Subject|6|||
162201140|NCT03721978|585787069|FG001|Overall Study|Withdrawal by Subject|1|||
162201141|NCT03721978|585787068|FG000|Overall Study|Adverse Event|1|||
162201142|NCT03721978|585787069|FG001|Overall Study|Adverse Event|1|||
162201143|NCT03721978|585787068|FG000|Overall Study|Progressive Disease|1|||
162201144|NCT03721978|585787069|FG001|Overall Study|Progressive Disease|0|||
162201145|NCT03721978|585787068|FG000|Overall Study|Lost to Follow-up|5|||
162201146|NCT03721978|585787069|FG001|Overall Study|Lost to Follow-up|1|||
162201147|NCT03721978|585787068|FG000|Overall Study|Reason not Specified|0|||
162201148|NCT03721978|585787069|FG001|Overall Study|Reason not Specified|2|||
162201149|NCT02675998|585787070|FG000|8-Week Treatment Period|Adverse Event|6|||
162201150|NCT02675998|585787071|FG001|8-Week Treatment Period|Adverse Event|5|||
162201151|NCT02675998|585787072|FG002|8-Week Treatment Period|Adverse Event|6|||
162201152|NCT02675998|585787073|FG003|8-Week Treatment Period|Adverse Event|0|||
162201153|NCT02675998|585787070|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
162201154|NCT02675998|585787071|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
162201155|NCT02675998|585787072|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
162201156|NCT02675998|585787073|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
162201157|NCT02675998|585787070|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
162201158|NCT02675998|585787071|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
162201159|NCT02675998|585787072|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
162201160|NCT02675998|585787073|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
162201161|NCT02675998|585787070|FG000|8-Week Treatment Period|Physician Decision|1|||
162201162|NCT02675998|585787071|FG001|8-Week Treatment Period|Physician Decision|0|||
162201163|NCT02675998|585787072|FG002|8-Week Treatment Period|Physician Decision|2|||
162201164|NCT02675998|585787073|FG003|8-Week Treatment Period|Physician Decision|0|||
162201165|NCT02675998|585787070|FG000|8-Week Treatment Period|GI side Effects|1|||
162201166|NCT02675998|585787071|FG001|8-Week Treatment Period|GI side Effects|4|||
162201167|NCT02675998|585787072|FG002|8-Week Treatment Period|GI side Effects|2|||
162201168|NCT02675998|585787073|FG003|8-Week Treatment Period|GI side Effects|0|||
161821323|NCT01243151|584387638|FG003|Overall Study|Other|1|||
161821324|NCT01243151|584387639|FG004|Overall Study|Other|0|||
161821325|NCT01243151|584387635|FG000|Overall Study|Randomized but not treated|0|||
161821326|NCT01243151|584387636|FG001|Overall Study|Randomized but not treated|0|||
161821327|NCT01243151|584387637|FG002|Overall Study|Randomized but not treated|0|||
161821328|NCT01243151|584387638|FG003|Overall Study|Randomized but not treated|1|||
161821329|NCT01243151|584387639|FG004|Overall Study|Randomized but not treated|0|||
161821330|NCT03119662|584387640|FG000|Overall Study|Withdrawal by Subject|0|||
161821331|NCT03119662|584387641|FG001|Overall Study|Withdrawal by Subject|1|||
161821332|NCT02817828|584387642|FG000|Overall Study|Lost to Follow-up|41|||
161821333|NCT02817828|584387642|FG000|Overall Study|Adverse event not related to bleeding|104|||
161821334|NCT02817828|584387642|FG000|Overall Study|Adverse event related to bleeding|53|||
161821335|NCT02817828|584387642|FG000|Overall Study|Protocol Violation|11|||
161821336|NCT02817828|584387642|FG000|Overall Study|Pregnancy|7|||
161821337|NCT02817828|584387642|FG000|Overall Study|Pregnancy wish|15|||
161821338|NCT02817828|584387642|FG000|Overall Study|Withdrawal by Subject|78|||
161821339|NCT02817828|584387642|FG000|Overall Study|Other|26|||
161821340|NCT00522041|584387644|FG000|Overall Study|Adverse Event|9|||
161821341|NCT00522041|584387645|FG001|Overall Study|Adverse Event|3|||
161821342|NCT00522041|584387644|FG000|Overall Study|Protocol Violation|2|||
161821343|NCT00522041|584387645|FG001|Overall Study|Protocol Violation|0|||
161821344|NCT00522041|584387644|FG000|Overall Study|Lost to Follow-up|1|||
161821345|NCT00522041|584387645|FG001|Overall Study|Lost to Follow-up|4|||
161821346|NCT00522041|584387644|FG000|Overall Study|Voluntary withdrawal|5|||
161821347|NCT00522041|584387645|FG001|Overall Study|Voluntary withdrawal|4|||
161821348|NCT00522041|584387644|FG000|Overall Study|Did not receive treatment|0|||
161821349|NCT00522041|584387645|FG001|Overall Study|Did not receive treatment|1|||
161821350|NCT00544167|584387646|FG000|Overall Study|Adverse Event|21|||
161821351|NCT00544167|584387646|FG000|Overall Study|Physician Decision|8|||
161821352|NCT00874549|584387647|FG000|Overall Study|Adverse Event|0|||
161821353|NCT00874549|584387648|FG001|Overall Study|Adverse Event|0|||
161821354|NCT00874549|584387649|FG002|Overall Study|Adverse Event|1|||
161821355|NCT00874549|584387650|FG003|Overall Study|Adverse Event|0|||
161821356|NCT00874549|584387647|FG000|Overall Study|Protocol Violation|1|||
161821357|NCT00874549|584387648|FG001|Overall Study|Protocol Violation|0|||
161821358|NCT00874549|584387649|FG002|Overall Study|Protocol Violation|2|||
161821359|NCT00874549|584387650|FG003|Overall Study|Protocol Violation|1|||
161821360|NCT00874549|584387647|FG000|Overall Study|Lost to Follow-up|0|||
161821361|NCT00874549|584387648|FG001|Overall Study|Lost to Follow-up|0|||
161821362|NCT00874549|584387649|FG002|Overall Study|Lost to Follow-up|1|||
161821363|NCT00874549|584387650|FG003|Overall Study|Lost to Follow-up|0|||
161821364|NCT00874549|584387647|FG000|Overall Study|Withdrawal by Subject|0|||
161821365|NCT00874549|584387648|FG001|Overall Study|Withdrawal by Subject|1|||
161821366|NCT00874549|584387649|FG002|Overall Study|Withdrawal by Subject|0|||
161821367|NCT00874549|584387650|FG003|Overall Study|Withdrawal by Subject|1|||
161821368|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
161821369|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
161821370|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
161821371|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
161821372|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
161821373|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
161821374|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
161821375|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
161821376|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
161821377|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
161821378|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
161821379|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
161821380|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
161821381|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
161821382|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
161821383|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
161821384|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
161821385|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
161821386|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
161821387|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
161821388|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
161821389|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
161821390|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
161821391|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
162201169|NCT02675998|585787070|FG000|8-Week Treatment Period|Protocol Violation|1|||
161821392|NCT01710358|584387653|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
161676352|NCT00257166|583868750|FG001|Overall Study|Adverse Event|13|||
161676353|NCT00257166|583868749|FG000|Overall Study|Laboratory abnormality|1|||
161676354|NCT00257166|583868750|FG001|Overall Study|Laboratory abnormality|0|||
161676355|NCT00257166|583868749|FG000|Overall Study|Lost to Follow-up|8|||
161676356|NCT00257166|583868750|FG001|Overall Study|Lost to Follow-up|1|||
161676357|NCT00257166|583868749|FG000|Overall Study|Withdrawal by Subject|9|||
161676358|NCT00257166|583868750|FG001|Overall Study|Withdrawal by Subject|2|||
161676359|NCT00257166|583868749|FG000|Overall Study|Other|16|||
161676360|NCT00257166|583868750|FG001|Overall Study|Other|21|||
161676361|NCT00257166|583868749|FG000|Overall Study|Randomized, but not treated|1|||
161676362|NCT00257166|583868750|FG001|Overall Study|Randomized, but not treated|0|||
161676363|NCT02592551|583868751|FG000|Overall Study|Not evaluable|1|||
161676364|NCT02592551|583868752|FG001|Overall Study|Not evaluable|3|||
161676365|NCT02592551|583868753|FG002|Overall Study|Not evaluable|0|||
161676366|NCT00761306|583868754|FG000|Overall Study|Adverse Event|5|||
161676367|NCT00761306|583868754|FG000|Overall Study|Lack of Efficacy|4|||
161676368|NCT00761306|583868754|FG000|Overall Study|Protocol Violation|2|||
161676369|NCT00761306|583868754|FG000|Overall Study|Withdrawal of Consent|3|||
161676370|NCT00761306|583868754|FG000|Overall Study|Lost to Follow-up|1|||
161676371|NCT00761306|583868754|FG000|Overall Study|Administrative or Other Reasons|5|||
161676372|NCT05162027|583868755|FG000|Overall Study|Adverse Event|1|||
161676373|NCT05162027|583868756|FG001|Overall Study|Adverse Event|0|||
161676374|NCT00525044|583868757|FG000|Overall Study|Lost to Follow-up|0|||
161676375|NCT00525044|583868758|FG001|Overall Study|Lost to Follow-up|1|||
161676376|NCT02460497|583868764|FG000|Overall Study|Participant Requested Withdrawal|4|||
161676377|NCT02460497|583868764|FG000|Overall Study|Non-Compliance|1|||
161676378|NCT02460497|583868764|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
161676379|NCT02460497|583868764|FG000|Overall Study|Lost to Follow-up|2|||
161676380|NCT02460497|583868764|FG000|Overall Study|Investigator Decision|1|||
161676381|NCT00908583|583868765|FG000|Phase 1|Withdrawal by Subject|1|||
161676382|NCT00908583|583868765|FG000|Phase 1|Adverse Event|4|||
161676383|NCT00908583|583868765|FG000|Phase 2|Physician Decision|1|||
161676384|NCT00908583|583868765|FG000|Phase 2|Adverse Event|1|||
161676385|NCT00908583|583868765|FG000|Phase 3|Adverse Event|2|||
161676386|NCT00908583|583868765|FG000|Phase 4|Adverse Event|1|||
161676387|NCT00908583|583868765|FG000|Phase 4|Physician Decision|1|||
161676388|NCT00908583|583868765|FG000|Phase 5|Adverse Event|3|||
161676389|NCT00993954|583868766|FG000|Overall Study|Protocol Violation|21|||
161676390|NCT00993954|583868767|FG001|Overall Study|Protocol Violation|2|||
161676391|NCT00860951|583868770|FG000|Overall Study|Withdrawal by Subject|2|||
161676392|NCT00860951|583868770|FG000|Overall Study|Lost to Follow-up|5|||
161676393|NCT02982239|583868773|FG000|Overall Study|Lost to Follow-up|3|||
161676394|NCT02982239|583868774|FG001|Overall Study|Lost to Follow-up|2|||
161676395|NCT01628107|583868775|FG000|Overall Study|Withdrawal by Subject|17|||
161676396|NCT01628107|583868775|FG000|Overall Study|Lost to Follow-up|4|||
161676397|NCT01628107|583868775|FG000|Overall Study|Adverse Event|33|||
161676398|NCT01628107|583868775|FG000|Overall Study|Physician Decision|2|||
161676399|NCT01628107|583868775|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
161676400|NCT01628107|583868775|FG000|Overall Study|Non-compliant with Study Procedures|10|||
162201170|NCT02675998|585787071|FG001|8-Week Treatment Period|Protocol Violation|1|||
162201171|NCT02675998|585787072|FG002|8-Week Treatment Period|Protocol Violation|1|||
162201172|NCT02675998|585787073|FG003|8-Week Treatment Period|Protocol Violation|0|||
162201173|NCT02675998|585787070|FG000|8-Week Treatment Period|Other|3|||
162201174|NCT02675998|585787071|FG001|8-Week Treatment Period|Other|1|||
162201175|NCT02675998|585787072|FG002|8-Week Treatment Period|Other|2|||
162201176|NCT02675998|585787073|FG003|8-Week Treatment Period|Other|0|||
162201177|NCT02675998|585787070|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
162201178|NCT02675998|585787071|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
162201179|NCT02675998|585787072|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
162201180|NCT02675998|585787073|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
161676401|NCT01628107|583868775|FG000|Overall Study|Not Treated|8|||
161676402|NCT01628107|583868775|FG000|Overall Study|Sponsor Decision|11|||
161676403|NCT01628107|583868775|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
161676404|NCT01628107|583868775|FG000|Overall Study|Relocated|8|||
161676405|NCT01628107|583868775|FG000|Overall Study|Kidney Transplant|9|||
161676406|NCT01628107|583868775|FG000|Overall Study|Use of Standard of Care|9|||
161676407|NCT01086410|583868776|FG000|Overall Study|Adverse Event|1|||
161676408|NCT01086410|583868777|FG001|Overall Study|Adverse Event|0|||
161676409|NCT01086410|583868778|FG002|Overall Study|Adverse Event|0|||
161676410|NCT01086410|583868779|FG003|Overall Study|Adverse Event|2|||
161821393|NCT01710358|584387654|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
161676411|NCT01086410|583868776|FG000|Overall Study|Lack of Efficacy|1|||
161676412|NCT01086410|583868777|FG001|Overall Study|Lack of Efficacy|1|||
162020857|NCT01088048|585132055|FG002|Overall Study|Death|3|||
162201181|NCT02675998|585787070|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
161676413|NCT01086410|583868778|FG002|Overall Study|Lack of Efficacy|0|||
161676414|NCT01086410|583868779|FG003|Overall Study|Lack of Efficacy|0|||
161676415|NCT01086410|583868776|FG000|Overall Study|Protocol Violation|1|||
161676416|NCT01086410|583868777|FG001|Overall Study|Protocol Violation|1|||
161676417|NCT01086410|583868778|FG002|Overall Study|Protocol Violation|0|||
161676418|NCT01086410|583868779|FG003|Overall Study|Protocol Violation|0|||
161676419|NCT01086410|583868776|FG000|Overall Study|Lost to Follow-up|0|||
161676420|NCT01086410|583868777|FG001|Overall Study|Lost to Follow-up|0|||
161676421|NCT01086410|583868778|FG002|Overall Study|Lost to Follow-up|1|||
161676422|NCT01086410|583868779|FG003|Overall Study|Lost to Follow-up|0|||
161676423|NCT02230254|583868780|FG000|Overall Study|Lost to Follow-up|3|||
161676424|NCT00621751|583868781|FG000|Overall Study|Adverse Event|0|||
161676425|NCT00621751|583868782|FG001|Overall Study|Adverse Event|1|||
161676426|NCT03583450|583868783|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
161676427|NCT03583450|583868784|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
161676428|NCT01186939|583868785|FG000|Overall Study|Death|7|||
161676429|NCT01186939|583868785|FG000|Overall Study|Withdrawal by Subject|2|||
161676430|NCT01186939|583868785|FG000|Overall Study|No longer receiving clinical benefit|17|||
161676431|NCT01186939|583868785|FG000|Overall Study|Program closed|5|||
161676432|NCT01186939|583868785|FG000|Overall Study|Sponsor decision|4|||
161676433|NCT01186939|583868785|FG000|Overall Study|Started additional treatment|1|||
161676434|NCT01186939|583868785|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
161676435|NCT01186939|583868785|FG000|Overall Study|Myocardial infarction|1|||
161676436|NCT01186939|583868785|FG000|Overall Study|Bone marrow transplant|1|||
161676437|NCT01186939|583868785|FG000|Overall Study|Transformation to AML|1|||
161676438|NCT05097716|583868786|FG000|Period 1|Adverse Event|1|||
161821394|NCT01710358|584387655|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
161821395|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
161821396|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
161821397|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
161821398|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
161821399|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
161821400|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
161821401|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
161821402|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
161821403|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
161821404|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
161821405|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
161821406|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
161821407|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
161821408|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
161821409|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
161821410|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
161821411|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
161821412|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
161821413|NCT01710358|584387653|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
161821414|NCT01710358|584387654|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
161821415|NCT01710358|584387655|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
161821416|NCT01710358|584387653|FG000|Rescue Period|Adverse Event|0|||
161821417|NCT01710358|584387654|FG001|Rescue Period|Adverse Event|15|||
161821418|NCT01710358|584387655|FG002|Rescue Period|Adverse Event|0|||
161821419|NCT01710358|584387653|FG000|Rescue Period|Death|0|||
161821420|NCT01710358|584387654|FG001|Rescue Period|Death|1|||
161821421|NCT01710358|584387655|FG002|Rescue Period|Death|0|||
161821422|NCT01710358|584387653|FG000|Rescue Period|Lack of Efficacy|0|||
161821423|NCT01710358|584387654|FG001|Rescue Period|Lack of Efficacy|7|||
161821424|NCT01710358|584387655|FG002|Rescue Period|Lack of Efficacy|0|||
161821425|NCT01710358|584387653|FG000|Rescue Period|Withdrawal by Subject|0|||
161821426|NCT01710358|584387654|FG001|Rescue Period|Withdrawal by Subject|8|||
161821427|NCT01710358|584387655|FG002|Rescue Period|Withdrawal by Subject|0|||
161821428|NCT00799708|584387658|FG000|Overall Study|non-compliance|1|||
161821429|NCT00799708|584387659|FG001|Overall Study|non-compliance|0|||
161821430|NCT00799708|584387660|FG002|Overall Study|non-compliance|0|||
161821431|NCT00880334|584387661|FG000|Randomized Phase|Physician Decision|1|||
161821432|NCT00880334|584387662|FG001|Randomized Phase|Physician Decision|0|||
161821433|NCT00880334|584387661|FG000|Randomized Phase|Withdrawal by Subject|2|||
161821434|NCT00880334|584387662|FG001|Randomized Phase|Withdrawal by Subject|1|||
161821435|NCT00880334|584387661|FG000|Randomized Phase|Inadequate Labs|1|||
161821436|NCT00880334|584387662|FG001|Randomized Phase|Inadequate Labs|1|||
162201182|NCT02675998|585787071|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
161676439|NCT05097716|583868786|FG000|Period 1|Close contact with highly-transmissible infection|1|||
161676440|NCT00791258|583868789|FG000|Overall Study|Adverse Event|87|||
161676441|NCT00791258|583868789|FG000|Overall Study|Lost to Follow-up|18|||
161676442|NCT00791258|583868789|FG000|Overall Study|Protocol Violation|109|||
161821437|NCT00880334|584387661|FG000|Randomized Phase|Brain Metastasis|0|||
161821438|NCT00880334|584387662|FG001|Randomized Phase|Brain Metastasis|1|||
161821439|NCT00880334|584387661|FG000|Randomized Phase|Crossover Participants|0|||
161821440|NCT00880334|584387662|FG001|Randomized Phase|Crossover Participants|37|||
161821441|NCT03343639|584387663|FG000|Overall Study|Withdrawal by Subject|10|||
161821442|NCT03343639|584387664|FG001|Overall Study|Withdrawal by Subject|6|||
161821443|NCT03343639|584387663|FG000|Overall Study|Lost to Follow-up|4|||
161821444|NCT03343639|584387664|FG001|Overall Study|Lost to Follow-up|5|||
161821445|NCT03343639|584387663|FG000|Overall Study|Protocol Violation|0|||
161821446|NCT03343639|584387664|FG001|Overall Study|Protocol Violation|1|||
161821447|NCT00735696|584387669|FG000|Overall Study|Withdrawal by Subject|1|||
161821448|NCT00735696|584387669|FG000|Overall Study|Enrolled but never Treated|1|||
161821449|NCT00084864|584387670|FG000|Overall Study|Adverse Event|1|||
161821450|NCT00084864|584387671|FG001|Overall Study|Adverse Event|0|||
161821451|NCT00084864|584387672|FG002|Overall Study|Adverse Event|0|||
161821452|NCT00084864|584387673|FG003|Overall Study|Adverse Event|0|||
161821453|NCT02460835|584387678|FG000|Overall Study|Disease progression prior to treatment|3|||
161821454|NCT02460835|584387678|FG000|Overall Study|Unable to complete planning scans|2|||
161821455|NCT02460835|584387678|FG000|Overall Study|Decrease in performance status|1|||
161821456|NCT02460835|584387678|FG000|Overall Study|Withdrawal by Subject|3|||
161821457|NCT02460835|584387678|FG000|Overall Study|Underwent fractionated RT|10|||
161821458|NCT02460835|584387678|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
161821459|NCT02786953|584387693|FG000|Overall Study|Withdrawal by Subject|3|||
161821460|NCT02786953|584387694|FG001|Overall Study|Withdrawal by Subject|0|||
161821461|NCT02786953|584387693|FG000|Overall Study|Physician Decision|0|||
161821462|NCT02786953|584387694|FG001|Overall Study|Physician Decision|1|||
161821463|NCT01186458|584387700|FG000|Overall Study|Adverse Event|1|||
161821464|NCT04281472|584387701|FG000|Stage A|Lack of Efficacy|8|||
161821465|NCT04281472|584387702|FG001|Stage A|Lack of Efficacy|0|||
161821466|NCT04281472|584387703|FG002|Stage A|Lack of Efficacy|0|||
161821467|NCT04281472|584387701|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
161821468|NCT04281472|584387702|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
161821469|NCT04281472|584387703|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
161821470|NCT04281472|584387701|FG000|Stage A|Adverse Event|20|||
161821471|NCT04281472|584387702|FG001|Stage A|Adverse Event|0|||
161821472|NCT04281472|584387703|FG002|Stage A|Adverse Event|0|||
161821473|NCT04281472|584387701|FG000|Stage A|Death|1|||
161821474|NCT04281472|584387702|FG001|Stage A|Death|0|||
161821475|NCT04281472|584387703|FG002|Stage A|Death|0|||
161821476|NCT04281472|584387701|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
161821477|NCT04281472|584387702|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
161821478|NCT04281472|584387703|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
161821479|NCT04281472|584387701|FG000|Stage A|Lost to Follow-up|2|||
161821480|NCT04281472|584387702|FG001|Stage A|Lost to Follow-up|0|||
161821481|NCT04281472|584387703|FG002|Stage A|Lost to Follow-up|0|||
161821482|NCT04281472|584387701|FG000|Stage A|Non-compliance with study drug|1|||
161821483|NCT04281472|584387702|FG001|Stage A|Non-compliance with study drug|0|||
161821484|NCT04281472|584387703|FG002|Stage A|Non-compliance with study drug|0|||
161821485|NCT04281472|584387701|FG000|Stage A|Physician Decision|1|||
161821486|NCT04281472|584387702|FG001|Stage A|Physician Decision|0|||
161821487|NCT04281472|584387703|FG002|Stage A|Physician Decision|0|||
161821488|NCT04281472|584387701|FG000|Stage A|Prohibited medications|2|||
161821489|NCT04281472|584387702|FG001|Stage A|Prohibited medications|0|||
161821490|NCT04281472|584387703|FG002|Stage A|Prohibited medications|0|||
161821491|NCT04281472|584387701|FG000|Stage A|Withdrawal by Subject|11|||
161821492|NCT04281472|584387702|FG001|Stage A|Withdrawal by Subject|0|||
161821493|NCT04281472|584387703|FG002|Stage A|Withdrawal by Subject|0|||
161821494|NCT04281472|584387701|FG000|Stage A|Other|5|||
161821495|NCT04281472|584387702|FG001|Stage A|Other|0|||
161821496|NCT04281472|584387703|FG002|Stage A|Other|0|||
161821497|NCT04281472|584387701|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
161821498|NCT04281472|584387702|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
161821499|NCT04281472|584387703|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
161821500|NCT04281472|584387701|FG000|Stage B|Adverse Event|0|||
161821501|NCT04281472|584387702|FG001|Stage B|Adverse Event|3|||
161821502|NCT04281472|584387703|FG002|Stage B|Adverse Event|0|||
162201183|NCT02675998|585787072|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
161821503|NCT04281472|584387701|FG000|Stage B|Death|0|||
161821504|NCT04281472|584387702|FG001|Stage B|Death|0|||
161821505|NCT04281472|584387703|FG002|Stage B|Death|1|||
161821506|NCT04281472|584387701|FG000|Stage B|Lack of Efficacy|0|||
161821507|NCT04281472|584387702|FG001|Stage B|Lack of Efficacy|0|||
161928174|NCT02365064|584785473|FG000|Overall Study|Withdrawal by Subject|6|||
161821508|NCT04281472|584387703|FG002|Stage B|Lack of Efficacy|1|||
161821509|NCT04281472|584387701|FG000|Stage B|Lost to Follow-up|0|||
161821510|NCT04281472|584387702|FG001|Stage B|Lost to Follow-up|0|||
161821511|NCT04281472|584387703|FG002|Stage B|Lost to Follow-up|2|||
161821512|NCT04281472|584387701|FG000|Stage B|Prohibited medications|0|||
161821513|NCT04281472|584387702|FG001|Stage B|Prohibited medications|2|||
161821514|NCT04281472|584387703|FG002|Stage B|Prohibited medications|1|||
161928175|NCT02365064|584785474|FG001|Overall Study|Withdrawal by Subject|9|||
161928176|NCT02365064|584785473|FG000|Overall Study|Treatment intolerance|2|||
161928177|NCT02365064|584785474|FG001|Overall Study|Treatment intolerance|4|||
161928178|NCT00662038|584785483|FG000|Overall Study|Reason not specified|3|||
161928179|NCT00662038|584785483|FG000|Overall Study|Withdrawn consent|22|||
161928180|NCT00662038|584785483|FG000|Overall Study|Withdrawal by Subject|83|||
161928181|NCT00662038|584785483|FG000|Overall Study|Sponsor decision|1|||
161928182|NCT00662038|584785483|FG000|Overall Study|Physician Decision|19|||
161676443|NCT00791258|583868789|FG000|Overall Study|Withdrawal by Subject|40|||
161676444|NCT00791258|583868789|FG000|Overall Study|Did not take medication for >3 days|1|||
161676445|NCT00791258|583868789|FG000|Overall Study|subject left area|2|||
161676446|NCT00791258|583868789|FG000|Overall Study|non-compliance|3|||
161676447|NCT00791258|583868789|FG000|Overall Study|Subject incarcerated|1|||
161676448|NCT00791258|583868789|FG000|Overall Study|Subject required restricted medication|1|||
161676449|NCT00791258|583868789|FG000|Overall Study|Lack of Efficacy|1|||
161676450|NCT00436618|583868790|FG000|Overall Study|Withdrawal by Subject|5|||
161676451|NCT00436618|583868791|FG001|Overall Study|Withdrawal by Subject|8|||
161676452|NCT00436618|583868792|FG002|Overall Study|Withdrawal by Subject|11|||
161676453|NCT00436618|583868790|FG000|Overall Study|Adverse Event|8|||
161676454|NCT00436618|583868791|FG001|Overall Study|Adverse Event|8|||
161676455|NCT00436618|583868792|FG002|Overall Study|Adverse Event|9|||
161676456|NCT00436618|583868790|FG000|Overall Study|Alternate Treatment|3|||
161821515|NCT04281472|584387701|FG000|Stage B|Protocol Violation|0|||
161821516|NCT04281472|584387702|FG001|Stage B|Protocol Violation|1|||
161821517|NCT04281472|584387703|FG002|Stage B|Protocol Violation|1|||
161821518|NCT04281472|584387701|FG000|Stage B|Sponsor decision|0|||
161821519|NCT04281472|584387702|FG001|Stage B|Sponsor decision|0|||
161821520|NCT04281472|584387703|FG002|Stage B|Sponsor decision|1|||
161821521|NCT04281472|584387701|FG000|Stage B|Withdrawal by Subject|0|||
161821522|NCT04281472|584387702|FG001|Stage B|Withdrawal by Subject|3|||
161821523|NCT04281472|584387703|FG002|Stage B|Withdrawal by Subject|3|||
161821524|NCT04281472|584387701|FG000|Stage B|Other|0|||
161821525|NCT04281472|584387702|FG001|Stage B|Other|3|||
161821526|NCT04281472|584387703|FG002|Stage B|Other|0|||
161821527|NCT01055834|584387706|FG000|Treatment Period I|Adverse Event|1|||
161821528|NCT01055834|584387707|FG001|Treatment Period I|Adverse Event|0|||
161821529|NCT00467597|584387708|FG000|Overall Study|Withdrawal by Subject|2|||
161821530|NCT00467597|584387709|FG001|Overall Study|Withdrawal by Subject|0|||
161821531|NCT03141151|584387710|FG000|Overall Study|Lost to Follow-up|3|||
161821532|NCT03141151|584387711|FG001|Overall Study|Lost to Follow-up|2|||
161821533|NCT03141151|584387710|FG000|Overall Study|Withdrawal by Subject|3|||
161821534|NCT03141151|584387711|FG001|Overall Study|Withdrawal by Subject|2|||
161821535|NCT04561115|584387718|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
161821536|NCT04561115|584387719|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
161821537|NCT04561115|584387718|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
161821538|NCT04561115|584387719|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
161821539|NCT04561115|584387718|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
161821540|NCT04561115|584387719|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
161821541|NCT00743145|584387720|FG000|Overall Study|Withdrawal by Subject|1|||
161821542|NCT00743145|584387720|FG000|Overall Study|Adverse Event|2|||
161821543|NCT00743145|584387720|FG000|Overall Study|Pregnancy|1|||
161821544|NCT01670097|584387721|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
161821545|NCT01670097|584387722|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
161821546|NCT01670097|584387721|FG000|Overall Study|Study burden|1|||
161821547|NCT01670097|584387722|FG001|Overall Study|Study burden|0|||
161821548|NCT01670097|584387721|FG000|Overall Study|COPD exacerbation|0|||
161821549|NCT01670097|584387722|FG001|Overall Study|COPD exacerbation|1|||
161821550|NCT01670097|584387721|FG000|Overall Study|Neutropenia|0|||
161821551|NCT01670097|584387722|FG001|Overall Study|Neutropenia|1|||
161821552|NCT01670097|584387721|FG000|Overall Study|Clinical deterioration|0|||
161821553|NCT01670097|584387722|FG001|Overall Study|Clinical deterioration|1|||
161821554|NCT01670097|584387721|FG000|Overall Study|Disease progression|0|||
161821555|NCT01670097|584387722|FG001|Overall Study|Disease progression|1|||
161821556|NCT02311894|584387723|FG000|Overall Study|Discontinued in error|1|||
161821557|NCT02311894|584387723|FG000|Overall Study|Lost to Follow-up|1|||
161821558|NCT02311894|584387723|FG000|Overall Study|Adverse Event|1|||
161821559|NCT02311894|584387723|FG000|Overall Study|Withdrawal by Subject|1|||
161821560|NCT00884390|584387724|FG000|Overall Study|Adverse Event|0|||
161676457|NCT00436618|583868791|FG001|Overall Study|Alternate Treatment|4|||
161676458|NCT00436618|583868792|FG002|Overall Study|Alternate Treatment|12|||
161821561|NCT00884390|584387725|FG001|Overall Study|Adverse Event|1|||
161821562|NCT00884390|584387724|FG000|Overall Study|Lost to Follow-up|0|||
161821563|NCT00884390|584387725|FG001|Overall Study|Lost to Follow-up|1|||
161821564|NCT00884390|584387724|FG000|Overall Study|Physician Decision|2|||
161928183|NCT00662038|584785483|FG000|Overall Study|Lung transplantation|44|||
161821565|NCT00884390|584387725|FG001|Overall Study|Physician Decision|1|||
161821566|NCT00884390|584387724|FG000|Overall Study|Protocol Violation|4|||
161821567|NCT00884390|584387725|FG001|Overall Study|Protocol Violation|1|||
161821568|NCT00884390|584387724|FG000|Overall Study|Withdrawal by Subject|4|||
161821569|NCT00884390|584387725|FG001|Overall Study|Withdrawal by Subject|1|||
161821570|NCT00884390|584387724|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
161821571|NCT00884390|584387725|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
161821572|NCT00884390|584387724|FG000|Overall Study|Other|11|||
161821573|NCT00884390|584387725|FG001|Overall Study|Other|1|||
161821574|NCT01691612|584387726|FG000|Overall Study|deemed ineligible after 1st visit|6|||
161821575|NCT01691612|584387726|FG000|Overall Study|Adverse Event|1|||
161821576|NCT04049097|584387730|FG000|Overall Study|Adverse Event|18|||
161821577|NCT04049097|584387730|FG000|Overall Study|Death|2|||
161821578|NCT04049097|584387730|FG000|Overall Study|Lost to Follow-up|1|||
161821579|NCT04049097|584387730|FG000|Overall Study|Physician Decision|2|||
161821580|NCT04049097|584387730|FG000|Overall Study|Withdrawal by Subject|9|||
161821581|NCT04049097|584387730|FG000|Overall Study|Protocol Violation|2|||
161821582|NCT04049097|584387730|FG000|Overall Study|Other|1|||
161821583|NCT04049097|584387730|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
161821584|NCT01874535|584387734|FG000|Overall Study|Lost to Follow-up|10|||
161821585|NCT01874535|584387735|FG001|Overall Study|Lost to Follow-up|9|||
161821586|NCT01874535|584387734|FG000|Overall Study|incomplete symptom resolution|45|||
161821587|NCT01874535|584387735|FG001|Overall Study|incomplete symptom resolution|35|||
161821588|NCT05263505|584387737|FG000|Overall Study|Adverse Event|0|||
161821589|NCT05263505|584387738|FG001|Overall Study|Adverse Event|1|||
161821590|NCT02616380|584387739|FG000|Overall Study|Lost to Follow-up|1|||
161821591|NCT02616380|584387739|FG000|Overall Study|Other|2|||
161821592|NCT05065619|584387740|FG000|Up to Day 42|Lost to Follow-up|1|||
161821593|NCT05065619|584387741|FG001|Up to Day 42|Lost to Follow-up|0|||
161821594|NCT05065619|584387740|FG000|Up to Day 42|Withdrawal by Subject|1|||
161821595|NCT05065619|584387741|FG001|Up to Day 42|Withdrawal by Subject|0|||
161821596|NCT05065619|584387740|FG000|After Day 43|Lost to Follow-up|1|||
161821597|NCT05065619|584387741|FG001|After Day 43|Lost to Follow-up|0|||
161821598|NCT05065619|584387740|FG000|After Day 43|Physician Decision|3|||
161821599|NCT05065619|584387741|FG001|After Day 43|Physician Decision|0|||
161821600|NCT05065619|584387740|FG000|After Day 43|Withdrawal by Subject|1|||
161821601|NCT05065619|584387741|FG001|After Day 43|Withdrawal by Subject|2|||
161821602|NCT05065619|584387740|FG000|After Day 43|Public vaccination|6|||
161821603|NCT05065619|584387741|FG001|After Day 43|Public vaccination|8|||
161821604|NCT05065619|584387740|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
161821605|NCT05065619|584387741|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
161821606|NCT05065619|584387740|FG000|After Day 43|Study Terminated by Sponsor|88|||
161821607|NCT05065619|584387741|FG001|After Day 43|Study Terminated by Sponsor|16|||
161821608|NCT01050764|584387742|FG000|Overall Study|Death, before HSCT|1|||
161821609|NCT01050764|584387742|FG000|Overall Study|Donor mobilization failure, death|1|||
161821610|NCT01050764|584387742|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
161821611|NCT01929681|584387747|FG000|Overall Study|Withdrawal by Subject|1|||
161821612|NCT01929681|584387748|FG001|Overall Study|Withdrawal by Subject|0|||
161821613|NCT01929681|584387747|FG000|Overall Study|Physician Decision|1|||
161821614|NCT01929681|584387748|FG001|Overall Study|Physician Decision|1|||
161821615|NCT05315713|584387749|FG000|Overall Study|Death|5|||
161821616|NCT05315713|584387749|FG000|Overall Study|Progressive disease|1|||
161821617|NCT05315713|584387749|FG000|Overall Study|Withdrawal by Subject|1|||
161821618|NCT05315713|584387749|FG000|Overall Study|Study terminated by sponsor|1|||
161821619|NCT04194151|584387751|FG000|Overall Study|Physician Decision|1|||
161821620|NCT04194151|584387752|FG001|Overall Study|Physician Decision|1|||
161821621|NCT04194151|584387753|FG002|Overall Study|Physician Decision|1|||
161821622|NCT04194151|584387754|FG003|Overall Study|Physician Decision|1|||
161821623|NCT04194151|584387755|FG004|Overall Study|Physician Decision|0|||
161821624|NCT04194151|584387756|FG005|Overall Study|Physician Decision|1|||
161821625|NCT04194151|584387751|FG000|Overall Study|Monitorization problem|0|||
161821626|NCT04194151|584387752|FG001|Overall Study|Monitorization problem|1|||
161821627|NCT04194151|584387753|FG002|Overall Study|Monitorization problem|0|||
161821628|NCT04194151|584387754|FG003|Overall Study|Monitorization problem|0|||
161821629|NCT04194151|584387755|FG004|Overall Study|Monitorization problem|0|||
161821630|NCT04194151|584387756|FG005|Overall Study|Monitorization problem|0|||
161821631|NCT00421304|584387757|FG000|Overall Study|Lost to Follow-up|5|||
161821632|NCT00421304|584387758|FG001|Overall Study|Lost to Follow-up|2|||
161821633|NCT00421304|584387759|FG002|Overall Study|Lost to Follow-up|5|||
161821634|NCT00421304|584387757|FG000|Overall Study|Withdrawal by Subject|2|||
161821635|NCT00421304|584387758|FG001|Overall Study|Withdrawal by Subject|2|||
161821636|NCT00421304|584387759|FG002|Overall Study|Withdrawal by Subject|2|||
161821637|NCT00421304|584387757|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
161821638|NCT00421304|584387758|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
161821639|NCT00421304|584387759|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
161821640|NCT00421304|584387757|FG000|Overall Study|Did not attend Day 360 visit|0|||
161928184|NCT00662038|584785483|FG000|Overall Study|Lost to Follow-up|1|||
161928185|NCT00662038|584785483|FG000|Overall Study|Death|95|||
161928186|NCT00662038|584785483|FG000|Overall Study|Adverse Event|358|||
161928187|NCT00662038|584785483|FG000|Overall Study|Continued treatment|5|||
161928188|NCT00397046|584785484|FG000|Overall Study|Disease Progression|3|||
161928189|NCT00397046|584785485|FG001|Overall Study|Disease Progression|3|||
161928190|NCT00397046|584785486|FG002|Overall Study|Disease Progression|10|||
161928191|NCT00397046|584785487|FG003|Overall Study|Disease Progression|5|||
161676459|NCT00436618|583868790|FG000|Overall Study|Other Medical Problems|3|||
161676460|NCT00436618|583868791|FG001|Overall Study|Other Medical Problems|1|||
161676461|NCT00436618|583868792|FG002|Overall Study|Other Medical Problems|7|||
161676462|NCT00436618|583868790|FG000|Overall Study|Death|4|||
161676463|NCT00436618|583868791|FG001|Overall Study|Death|2|||
161676464|NCT00436618|583868792|FG002|Overall Study|Death|3|||
161676465|NCT00436618|583868790|FG000|Overall Study|New Primary or Other Reasons|6|||
161676466|NCT00436618|583868791|FG001|Overall Study|New Primary or Other Reasons|2|||
161928192|NCT01975285|584785488|FG000|Overall Study|Failed Block and follow up|2|||
161928193|NCT01975285|584785489|FG001|Overall Study|Failed Block and follow up|2|||
161928194|NCT02421510|584785490|FG000|Overall Study|Other|4|||
161928195|NCT02421510|584785491|FG001|Overall Study|Other|2|||
161928196|NCT02421510|584785492|FG002|Overall Study|Other|3|||
161928197|NCT02421510|584785490|FG000|Overall Study|Protocol Violation|1|||
161928198|NCT02421510|584785491|FG001|Overall Study|Protocol Violation|2|||
161928199|NCT02421510|584785492|FG002|Overall Study|Protocol Violation|0|||
161928200|NCT02421510|584785490|FG000|Overall Study|Death|1|||
161928201|NCT02421510|584785491|FG001|Overall Study|Death|0|||
161928202|NCT02421510|584785492|FG002|Overall Study|Death|0|||
161928203|NCT02421510|584785490|FG000|Overall Study|Noncompliance with study drug|1|||
161928204|NCT02421510|584785491|FG001|Overall Study|Noncompliance with study drug|0|||
161928205|NCT02421510|584785492|FG002|Overall Study|Noncompliance with study drug|0|||
161928206|NCT02421510|584785490|FG000|Overall Study|Physician Decision|1|||
161928207|NCT02421510|584785491|FG001|Overall Study|Physician Decision|1|||
161928208|NCT02421510|584785492|FG002|Overall Study|Physician Decision|3|||
161928209|NCT02421510|584785490|FG000|Overall Study|Adverse Event|9|||
161928210|NCT02421510|584785491|FG001|Overall Study|Adverse Event|10|||
161928211|NCT02421510|584785492|FG002|Overall Study|Adverse Event|18|||
161928212|NCT02421510|584785490|FG000|Overall Study|Pregnancy|1|||
161928213|NCT02421510|584785491|FG001|Overall Study|Pregnancy|1|||
161928214|NCT02421510|584785492|FG002|Overall Study|Pregnancy|0|||
161928215|NCT02421510|584785490|FG000|Overall Study|Withdrawal by Subject|14|||
161928216|NCT02421510|584785491|FG001|Overall Study|Withdrawal by Subject|18|||
161928217|NCT02421510|584785492|FG002|Overall Study|Withdrawal by Subject|12|||
161928218|NCT02421510|584785490|FG000|Overall Study|Lost to Follow-up|1|||
162201184|NCT02675998|585787073|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
162201185|NCT02675998|585787070|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
162201186|NCT02675998|585787071|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
161676467|NCT00436618|583868792|FG002|Overall Study|New Primary or Other Reasons|12|||
161676468|NCT00436618|583868790|FG000|Overall Study|Still on treatment|1|||
161676469|NCT00436618|583868791|FG001|Overall Study|Still on treatment|2|||
161676470|NCT00436618|583868792|FG002|Overall Study|Still on treatment|7|||
161676471|NCT00698204|583868793|FG000|Overall Study|Withdrawal by Subject|1|||
161676472|NCT00698204|583868794|FG001|Overall Study|Withdrawal by Subject|0|||
161676473|NCT00314249|583868795|FG000|Overall Study|Adverse Event|73|||
161676474|NCT00314249|583868796|FG001|Overall Study|Adverse Event|94|||
161676475|NCT00314249|583868795|FG000|Overall Study|Lack of Efficacy|33|||
161676476|NCT00314249|583868796|FG001|Overall Study|Lack of Efficacy|24|||
161676477|NCT00314249|583868795|FG000|Overall Study|Withdrawal by Subject|21|||
161676478|NCT00314249|583868796|FG001|Overall Study|Withdrawal by Subject|28|||
161676479|NCT00314249|583868795|FG000|Overall Study|Lost to Follow-up|15|||
161676480|NCT00314249|583868796|FG001|Overall Study|Lost to Follow-up|9|||
161676481|NCT00314249|583868795|FG000|Overall Study|Physician Decision|1|||
161676482|NCT00314249|583868796|FG001|Overall Study|Physician Decision|1|||
161676483|NCT00314249|583868795|FG000|Overall Study|Withdrawn for other reasons|4|||
161676484|NCT00314249|583868796|FG001|Overall Study|Withdrawn for other reasons|1|||
161676485|NCT00314249|583868795|FG000|Overall Study|Non-Compliant|5|||
161676486|NCT00314249|583868796|FG001|Overall Study|Non-Compliant|6|||
161676487|NCT00058552|583868797|FG000|Overall Study|Died prior to receiving treatment|4|||
161676488|NCT00058552|583868798|FG001|Overall Study|Died prior to receiving treatment|2|||
161928219|NCT02421510|584785491|FG001|Overall Study|Lost to Follow-up|1|||
161928220|NCT02421510|584785492|FG002|Overall Study|Lost to Follow-up|0|||
161676489|NCT00058552|583868797|FG000|Overall Study|Disease progression|52|||
161676490|NCT00058552|583868798|FG001|Overall Study|Disease progression|44|||
161676491|NCT00058552|583868797|FG000|Overall Study|Adverse Event|4|||
161928221|NCT04098302|584785500|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
161928222|NCT04098302|584785501|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
161928223|NCT04098302|584785502|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
161928224|NCT04098302|584785503|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
162020858|NCT01088048|585132056|FG003|Overall Study|Death|3|||
161676492|NCT00058552|583868798|FG001|Overall Study|Adverse Event|2|||
161676493|NCT00058552|583868797|FG000|Overall Study|Withdrawal by Subject|3|||
161676494|NCT00058552|583868798|FG001|Overall Study|Withdrawal by Subject|5|||
161676495|NCT00058552|583868797|FG000|Overall Study|Physician Decision|2|||
161676496|NCT00058552|583868798|FG001|Overall Study|Physician Decision|5|||
161676497|NCT00058552|583868797|FG000|Overall Study|Clinical disease progression|0|||
161676498|NCT00058552|583868798|FG001|Overall Study|Clinical disease progression|4|||
161676499|NCT02066311|583868799|FG000|Overall Study|Adverse Event|4|||
161676500|NCT02066311|583868799|FG000|Overall Study|Withdrawal by Subject|1|||
161676501|NCT01372150|583868802|FG000|Overall Study|Lack of Efficacy|3|||
161676502|NCT01372150|583868803|FG001|Overall Study|Lack of Efficacy|0|||
161676503|NCT01372150|583868804|FG002|Overall Study|Lack of Efficacy|1|||
161676504|NCT01372150|583868802|FG000|Overall Study|Lost to Follow-up|4|||
161676505|NCT01372150|583868803|FG001|Overall Study|Lost to Follow-up|5|||
161676506|NCT01372150|583868804|FG002|Overall Study|Lost to Follow-up|6|||
161676507|NCT01372150|583868802|FG000|Overall Study|Protocol Violation|1|||
161676508|NCT01372150|583868803|FG001|Overall Study|Protocol Violation|0|||
161676509|NCT01372150|583868804|FG002|Overall Study|Protocol Violation|3|||
161676510|NCT01372150|583868802|FG000|Overall Study|Withdrawal by Subject|2|||
161676511|NCT01372150|583868803|FG001|Overall Study|Withdrawal by Subject|7|||
161676512|NCT01372150|583868804|FG002|Overall Study|Withdrawal by Subject|2|||
161676513|NCT01372150|583868802|FG000|Overall Study|Other|1|||
161676514|NCT01372150|583868803|FG001|Overall Study|Other|0|||
161676515|NCT01372150|583868804|FG002|Overall Study|Other|2|||
161676516|NCT01372150|583868802|FG000|Overall Study|Adverse Event|2|||
161676517|NCT01372150|583868803|FG001|Overall Study|Adverse Event|1|||
161676518|NCT01372150|583868804|FG002|Overall Study|Adverse Event|2|||
161676519|NCT01372150|583868802|FG000|Overall Study|Randomized but not treated|0|||
161676520|NCT01372150|583868803|FG001|Overall Study|Randomized but not treated|1|||
161676521|NCT01372150|583868804|FG002|Overall Study|Randomized but not treated|0|||
161676522|NCT02316340|583868805|FG000|First Progression|Clinical progression|2|||
161676523|NCT02316340|583868806|FG001|First Progression|Clinical progression|1|||
161676524|NCT02316340|583868805|FG000|First Progression|Withdrawal by Subject|1|||
161676525|NCT02316340|583868806|FG001|First Progression|Withdrawal by Subject|0|||
161676526|NCT03781323|583868807|FG000|Overall Study|Withdrawal by Subject|1|||
161676527|NCT00770770|583868810|FG000|Overall Study|Lost to Follow-up|1|||
161676528|NCT00770770|583868811|FG001|Overall Study|Lost to Follow-up|0|||
161676529|NCT00770770|583868810|FG000|Overall Study|Withdrawal by Subject|1|||
161676530|NCT00770770|583868811|FG001|Overall Study|Withdrawal by Subject|0|||
161676531|NCT00770770|583868810|FG000|Overall Study|Death|0|||
161676532|NCT00770770|583868811|FG001|Overall Study|Death|1|||
161676533|NCT00770770|583868810|FG000|Overall Study|Study Terminated|8|||
161676534|NCT00770770|583868811|FG001|Overall Study|Study Terminated|0|||
161676535|NCT02486653|583868812|FG000|Overall Study|Withdrawal by Subject|1|||
161676536|NCT02486653|583868813|FG001|Overall Study|Withdrawal by Subject|3|||
161676537|NCT02486653|583868812|FG000|Overall Study|Protocol Violation|1|||
161676538|NCT02486653|583868813|FG001|Overall Study|Protocol Violation|0|||
161676539|NCT02486653|583868812|FG000|Overall Study|surgery cancelled|4|||
161676540|NCT02486653|583868813|FG001|Overall Study|surgery cancelled|1|||
161676541|NCT00800436|583868814|FG000|Overall Study|Withdrawal by Subject|0|||
161676542|NCT00800436|583868815|FG001|Overall Study|Withdrawal by Subject|0|||
161676543|NCT00800436|583868816|FG002|Overall Study|Withdrawal by Subject|1|||
161676544|NCT00800436|583868817|FG003|Overall Study|Withdrawal by Subject|1|||
161928225|NCT04098302|584785500|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
161928226|NCT04098302|584785501|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
161928227|NCT04098302|584785502|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
161928228|NCT04098302|584785503|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
161676545|NCT00800436|583868818|FG004|Overall Study|Withdrawal by Subject|0|||
161928229|NCT04098302|584785500|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
161928230|NCT04098302|584785501|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
161928231|NCT04098302|584785502|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
161928232|NCT04098302|584785503|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
161928233|NCT04098302|584785500|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
161928234|NCT04098302|584785501|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
161928235|NCT04098302|584785502|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
161928236|NCT04098302|584785503|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
161928237|NCT04098302|584785500|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
161928238|NCT04098302|584785501|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
161676546|NCT00800436|583868819|FG005|Overall Study|Withdrawal by Subject|0|||
161676547|NCT00800436|583868820|FG006|Overall Study|Withdrawal by Subject|0|||
161676548|NCT01230554|583868823|FG000|Overall Study|Lost to Follow-up|2|||
161676549|NCT01230554|583868823|FG000|Overall Study|Inability to maintain visit schedule|1|||
161676550|NCT01006265|583868824|FG000|Overall Study|Lost to Follow-up|1|||
161676551|NCT01006265|583868825|FG001|Overall Study|Lost to Follow-up|0|||
161676552|NCT01006265|583868826|FG002|Overall Study|Lost to Follow-up|1|||
161676553|NCT01006265|583868827|FG003|Overall Study|Lost to Follow-up|0|||
161928239|NCT04098302|584785502|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
161928240|NCT04098302|584785503|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
161928241|NCT04098302|584785500|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
161928242|NCT04098302|584785501|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
161928243|NCT04098302|584785502|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
161928244|NCT04098302|584785503|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
161928245|NCT04098302|584785500|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
161928246|NCT04098302|584785501|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
161928247|NCT04098302|584785502|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
161928248|NCT04098302|584785503|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
161928249|NCT04098302|584785500|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
161928250|NCT04098302|584785501|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
161928251|NCT04098302|584785502|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
161928252|NCT04098302|584785503|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
161928253|NCT05061706|584785504|FG000|Overall Study|Adverse Event|29|||
161928254|NCT05061706|584785505|FG001|Overall Study|Adverse Event|1|||
161928255|NCT05061706|584785504|FG000|Overall Study|Lack of Efficacy|0|||
161928256|NCT05061706|584785505|FG001|Overall Study|Lack of Efficacy|1|||
161928257|NCT05061706|584785504|FG000|Overall Study|Lost to Follow-up|2|||
161928258|NCT05061706|584785505|FG001|Overall Study|Lost to Follow-up|2|||
161928259|NCT05061706|584785504|FG000|Overall Study|Protocol Violation|3|||
161928260|NCT05061706|584785505|FG001|Overall Study|Protocol Violation|1|||
161928261|NCT05061706|584785504|FG000|Overall Study|Withdrawal by Subject|3|||
161928262|NCT05061706|584785505|FG001|Overall Study|Withdrawal by Subject|9|||
161928263|NCT00191152|584785506|FG000|Initial Treatment|Adverse Event|43|||
161928264|NCT00191152|584785507|FG001|Initial Treatment|Adverse Event|67|||
161928265|NCT00191152|584785506|FG000|Initial Treatment|Physician Decision|40|||
161928266|NCT00191152|584785507|FG001|Initial Treatment|Physician Decision|31|||
161928267|NCT00191152|584785506|FG000|Initial Treatment|Withdrawal by Subject|40|||
161928268|NCT00191152|584785507|FG001|Initial Treatment|Withdrawal by Subject|28|||
161928269|NCT00191152|584785506|FG000|Initial Treatment|Lost to Follow-up|0|||
161928270|NCT00191152|584785507|FG001|Initial Treatment|Lost to Follow-up|6|||
161928271|NCT00191152|584785506|FG000|Initial Treatment|Other|18|||
161928272|NCT00191152|584785507|FG001|Initial Treatment|Other|21|||
161928273|NCT00191152|584785506|FG000|Crossover Treatment|Adverse Event|8|||
161928274|NCT00191152|584785507|FG001|Crossover Treatment|Adverse Event|8|||
161928275|NCT00191152|584785506|FG000|Crossover Treatment|Physician Decision|7|||
161928276|NCT00191152|584785507|FG001|Crossover Treatment|Physician Decision|7|||
161928277|NCT00191152|584785506|FG000|Crossover Treatment|Withdrawal by Subject|6|||
161928278|NCT00191152|584785507|FG001|Crossover Treatment|Withdrawal by Subject|9|||
161928279|NCT00191152|584785506|FG000|Crossover Treatment|Lost to Follow-up|2|||
161928280|NCT00191152|584785507|FG001|Crossover Treatment|Lost to Follow-up|1|||
161928281|NCT00191152|584785506|FG000|Crossover Treatment|Other|4|||
161928282|NCT00191152|584785507|FG001|Crossover Treatment|Other|3|||
161928283|NCT00114777|584785511|FG000|Randomization to Month 36|Death|10|||
161676554|NCT01006265|583868824|FG000|Overall Study|Withdrawal by Subject|4|||
161676555|NCT01006265|583868825|FG001|Overall Study|Withdrawal by Subject|7|||
161676556|NCT01006265|583868826|FG002|Overall Study|Withdrawal by Subject|5|||
161676557|NCT01006265|583868827|FG003|Overall Study|Withdrawal by Subject|5|||
161676558|NCT01006265|583868824|FG000|Overall Study|Administrative reason|1|||
161676559|NCT01006265|583868825|FG001|Overall Study|Administrative reason|2|||
161676560|NCT01006265|583868826|FG002|Overall Study|Administrative reason|3|||
161676561|NCT01006265|583868827|FG003|Overall Study|Administrative reason|0|||
161676562|NCT01177384|583868828|FG000|Overall Study|Adverse Event|6|||
161676563|NCT01177384|583868829|FG001|Overall Study|Adverse Event|4|||
161676564|NCT01177384|583868828|FG000|Overall Study|Lack of Efficacy|0|||
161676565|NCT01177384|583868829|FG001|Overall Study|Lack of Efficacy|1|||
161676566|NCT01177384|583868828|FG000|Overall Study|Lost to Follow-up|3|||
161676567|NCT01177384|583868829|FG001|Overall Study|Lost to Follow-up|4|||
161676568|NCT01177384|583868828|FG000|Overall Study|Physician Decision|0|||
161676569|NCT01177384|583868829|FG001|Overall Study|Physician Decision|3|||
161676570|NCT01177384|583868828|FG000|Overall Study|Protocol Violation|0|||
161928284|NCT00114777|584785512|FG001|Randomization to Month 36|Death|4|||
161928285|NCT00114777|584785513|FG002|Randomization to Month 36|Death|3|||
161928286|NCT00114777|584785511|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
161928287|NCT00114777|584785512|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
161928288|NCT00114777|584785513|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
161928289|NCT00114777|584785511|FG000|Randomization to Month 36|Lack of Efficacy|19|||
161676571|NCT01177384|583868829|FG001|Overall Study|Protocol Violation|2|||
161676572|NCT01177384|583868828|FG000|Overall Study|Withdrawal by Subject|5|||
161928290|NCT00114777|584785512|FG001|Randomization to Month 36|Lack of Efficacy|15|||
161676573|NCT01177384|583868829|FG001|Overall Study|Withdrawal by Subject|12|||
161928291|NCT00114777|584785513|FG002|Randomization to Month 36|Lack of Efficacy|17|||
161928292|NCT00114777|584785511|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
161928293|NCT00114777|584785512|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
161821641|NCT00421304|584387758|FG001|Overall Study|Did not attend Day 360 visit|0|||
161821642|NCT00421304|584387759|FG002|Overall Study|Did not attend Day 360 visit|1|||
161821643|NCT00903877|584387760|FG000|Overall Study|Did not meet study criteria|33|||
161821644|NCT00903877|584387760|FG000|Overall Study|Withdrawal by Subject|3|||
161821645|NCT00903877|584387760|FG000|Overall Study|Adverse Event|2|||
161821646|NCT00903877|584387760|FG000|Overall Study|Lost to Follow-up|1|||
161928294|NCT00114777|584785513|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
161928295|NCT00114777|584785511|FG000|Randomization to Month 36|Adverse Event|34|||
161928296|NCT00114777|584785512|FG001|Randomization to Month 36|Adverse Event|35|||
161928297|NCT00114777|584785513|FG002|Randomization to Month 36|Adverse Event|44|||
161928298|NCT00114777|584785511|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
161928299|NCT00114777|584785512|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
161928300|NCT00114777|584785513|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
161928301|NCT00114777|584785511|FG000|Randomization to Month 36|Other|9|||
161928302|NCT00114777|584785512|FG001|Randomization to Month 36|Other|3|||
161928303|NCT00114777|584785513|FG002|Randomization to Month 36|Other|12|||
161928304|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Death|8|||
161928305|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Death|13|||
161928306|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Death|7|||
161928307|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
161928308|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
161928309|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
161928310|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
161928311|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
161928312|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
161928313|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
161928314|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
161928315|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
161928316|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
161928317|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
161928318|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
161928319|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
161928320|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
161928321|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
161928322|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
161928323|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
161928324|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
161928325|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
161928326|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
161928327|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
161928328|NCT00114777|584785511|FG000|Long-Term Extension to Month 84|Other|2|||
162020859|NCT01088048|585132057|FG004|Overall Study|Death|1|||
162020860|NCT01088048|585132058|FG005|Overall Study|Death|3|||
162020861|NCT01088048|585132059|FG006|Overall Study|Death|0|||
161821647|NCT00903877|584387760|FG000|Overall Study|Participation put on hold|4|||
161821648|NCT00919711|584387761|FG000|Overall Study|Withdrawal by Subject|15|||
161928329|NCT00114777|584785512|FG001|Long-Term Extension to Month 84|Other|0|||
161928330|NCT00114777|584785513|FG002|Long-Term Extension to Month 84|Other|2|||
161928331|NCT01181128|584785514|FG000|Overall Study|Withdrawal by Subject|2|||
161928332|NCT01181128|584785515|FG001|Overall Study|Withdrawal by Subject|2|||
161928333|NCT01181128|584785516|FG002|Overall Study|Withdrawal by Subject|0|||
161928334|NCT01181128|584785514|FG000|Overall Study|Death|1|||
161821649|NCT00919711|584387762|FG001|Overall Study|Withdrawal by Subject|7|||
161821650|NCT00919711|584387761|FG000|Overall Study|Adverse Event|13|||
161821651|NCT00919711|584387762|FG001|Overall Study|Adverse Event|3|||
161928335|NCT01181128|584785515|FG001|Overall Study|Death|0|||
161928336|NCT01181128|584785516|FG002|Overall Study|Death|0|||
161928337|NCT01181128|584785514|FG000|Overall Study|Physician Decision|2|||
161928338|NCT01181128|584785515|FG001|Overall Study|Physician Decision|0|||
161928339|NCT01181128|584785516|FG002|Overall Study|Physician Decision|0|||
161928340|NCT01181128|584785514|FG000|Overall Study|Adverse Event|0|||
161928341|NCT01181128|584785515|FG001|Overall Study|Adverse Event|2|||
161928342|NCT01181128|584785516|FG002|Overall Study|Adverse Event|0|||
161821652|NCT00919711|584387761|FG000|Overall Study|Other|1|||
161821653|NCT00919711|584387762|FG001|Overall Study|Other|2|||
161821654|NCT00919711|584387761|FG000|Overall Study|Administrative Decision|0|||
161821655|NCT00919711|584387762|FG001|Overall Study|Administrative Decision|1|||
161821656|NCT00919711|584387761|FG000|Overall Study|Lost to Follow-up|2|||
161821657|NCT00919711|584387762|FG001|Overall Study|Lost to Follow-up|0|||
161821658|NCT00919711|584387761|FG000|Overall Study|Death|1|||
161821659|NCT00919711|584387762|FG001|Overall Study|Death|0|||
161821660|NCT00919711|584387761|FG000|Overall Study|Noncompliance|1|||
161821661|NCT00919711|584387762|FG001|Overall Study|Noncompliance|0|||
161821662|NCT03694197|584387763|FG000|Overall Study|Adverse Event|9|||
161821663|NCT03694197|584387763|FG000|Overall Study|Protocol became inconvenient to participate|1|||
161821664|NCT03694197|584387763|FG000|Overall Study|Physician Decision|4|||
161821665|NCT03694197|584387763|FG000|Overall Study|Study terminated by sponsor|1350|||
161821666|NCT03694197|584387763|FG000|Overall Study|Participant moved|5|||
161821667|NCT03694197|584387763|FG000|Overall Study|Participant withdrew consent|10|||
161821668|NCT03694197|584387763|FG000|Overall Study|Related to IMP administration|1|||
161821669|NCT03694197|584387763|FG000|Overall Study|Not disclosed|5|||
161821670|NCT02940522|584389122|FG000|Overall Study|Lost to Follow-up|1|||
161821671|NCT02940522|584389123|FG001|Overall Study|Lost to Follow-up|2|||
161821672|NCT02940522|584389122|FG000|Overall Study|Withdrawal by Subject|1|||
161821673|NCT02940522|584389123|FG001|Overall Study|Withdrawal by Subject|0|||
161821674|NCT00274625|584389124|FG000|Overall Study|Lost to Follow-up|46|||
161821675|NCT00274625|584389125|FG001|Overall Study|Lost to Follow-up|54|||
161821676|NCT00274625|584389124|FG000|Overall Study|Excluded from analysis|14|||
161821677|NCT00274625|584389125|FG001|Overall Study|Excluded from analysis|8|||
161821678|NCT05135273|584389126|FG000|Overall Study|Recruited into the army|0|||
161821679|NCT05135273|584389127|FG001|Overall Study|Recruited into the army|0|||
161821680|NCT05135273|584389128|FG002|Overall Study|Recruited into the army|0|||
161821681|NCT05135273|584389129|FG003|Overall Study|Recruited into the army|0|||
161821682|NCT05135273|584389130|FG004|Overall Study|Recruited into the army|1|||
161821683|NCT05135273|584389131|FG005|Overall Study|Recruited into the army|0|||
161821684|NCT05135273|584389132|FG006|Overall Study|Recruited into the army|0|||
161821685|NCT05135273|584389133|FG007|Overall Study|Recruited into the army|0|||
161821686|NCT05135273|584389126|FG000|Overall Study|Moved away from study site|0|||
161821687|NCT05135273|584389127|FG001|Overall Study|Moved away from study site|0|||
161821688|NCT05135273|584389128|FG002|Overall Study|Moved away from study site|0|||
161821689|NCT05135273|584389129|FG003|Overall Study|Moved away from study site|0|||
161821690|NCT05135273|584389130|FG004|Overall Study|Moved away from study site|0|||
161821691|NCT05135273|584389131|FG005|Overall Study|Moved away from study site|1|||
161821692|NCT05135273|584389132|FG006|Overall Study|Moved away from study site|1|||
161821693|NCT05135273|584389133|FG007|Overall Study|Moved away from study site|0|||
161821694|NCT05135273|584389126|FG000|Overall Study|Travel|0|||
161821695|NCT05135273|584389127|FG001|Overall Study|Travel|0|||
161821696|NCT05135273|584389128|FG002|Overall Study|Travel|0|||
161821697|NCT05135273|584389129|FG003|Overall Study|Travel|0|||
161821698|NCT05135273|584389130|FG004|Overall Study|Travel|0|||
161821699|NCT05135273|584389131|FG005|Overall Study|Travel|0|||
161821700|NCT05135273|584389132|FG006|Overall Study|Travel|0|||
161821701|NCT05135273|584389133|FG007|Overall Study|Travel|1|||
161821702|NCT04264819|584389139|FG000|Overall Study|Physician Decision|19|||
161821703|NCT04264819|584389139|FG000|Overall Study|Adverse Event|12|||
161821704|NCT04264819|584389139|FG000|Overall Study|Withdrawal by Subject|11|||
161821705|NCT04264819|584389139|FG000|Overall Study|Lost to Follow-up|2|||
161821706|NCT04264819|584389139|FG000|Overall Study|Death|2|||
161821707|NCT01188226|584389147|FG000|Overall Study|Withdrawal by Subject|4|||
161821708|NCT04980456|584389148|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
161821709|NCT04980456|584389149|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
161821710|NCT04980456|584389148|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
161821711|NCT04980456|584389149|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
161821712|NCT04980456|584389148|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
161821713|NCT04980456|584389149|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
161821714|NCT04980456|584389148|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
161821715|NCT04980456|584389149|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
161821716|NCT00442351|584389152|FG000|Overall Study|Administrative|6|||
161821717|NCT00442351|584389153|FG001|Overall Study|Administrative|5|||
161821718|NCT00442351|584389152|FG000|Overall Study|Did not meet protocol eligibility|1|||
161821719|NCT00442351|584389153|FG001|Overall Study|Did not meet protocol eligibility|0|||
161821720|NCT00442351|584389152|FG000|Overall Study|Other|0|||
161821721|NCT00442351|584389153|FG001|Overall Study|Other|1|||
161821722|NCT00500318|584389154|FG000|Overall Study|Adverse Event|3|||
161821723|NCT00500318|584389155|FG001|Overall Study|Adverse Event|8|||
161821724|NCT00500318|584389154|FG000|Overall Study|Protocol Violation|1|||
161821725|NCT00500318|584389155|FG001|Overall Study|Protocol Violation|3|||
161821726|NCT00500318|584389154|FG000|Overall Study|Withdrawal by Subject|1|||
161821727|NCT00500318|584389155|FG001|Overall Study|Withdrawal by Subject|2|||
161821728|NCT00500318|584389154|FG000|Overall Study|Lack of Efficacy|0|||
161821729|NCT00500318|584389155|FG001|Overall Study|Lack of Efficacy|3|||
161821730|NCT00500318|584389154|FG000|Overall Study|Other Reason|0|||
161821731|NCT00500318|584389155|FG001|Overall Study|Other Reason|1|||
161821732|NCT01579006|584389159|FG000|Overall Study|Lack of Efficacy|10|||
161821733|NCT01579006|584389159|FG000|Overall Study|Adverse Event|13|||
161821734|NCT01579006|584389159|FG000|Overall Study|Withdrawal by Subject|5|||
161821735|NCT01579006|584389159|FG000|Overall Study|Non-compliance|3|||
161821736|NCT01579006|584389159|FG000|Overall Study|Due to participant's health fund|1|||
161821737|NCT01579006|584389159|FG000|Overall Study|Scheduled surgery|1|||
161821738|NCT01708954|584389163|FG000|Step 1|Disease progression|26|||
161821739|NCT01708954|584389164|FG001|Step 1|Disease progression|17|||
161821740|NCT01708954|584389165|FG002|Step 1|Disease progression|14|||
161821741|NCT01708954|584389163|FG000|Step 1|Adverse Event|3|||
161821742|NCT01708954|584389164|FG001|Step 1|Adverse Event|11|||
161821743|NCT01708954|584389165|FG002|Step 1|Adverse Event|13|||
161821744|NCT01708954|584389163|FG000|Step 1|Death|3|||
161821745|NCT01708954|584389164|FG001|Step 1|Death|2|||
161821746|NCT01708954|584389165|FG002|Step 1|Death|3|||
161821747|NCT01708954|584389163|FG000|Step 1|Withdrawal by Subject|2|||
161821748|NCT01708954|584389164|FG001|Step 1|Withdrawal by Subject|5|||
161821749|NCT01708954|584389165|FG002|Step 1|Withdrawal by Subject|3|||
161821750|NCT01708954|584389163|FG000|Step 1|Other complicating disease|0|||
161821751|NCT01708954|584389164|FG001|Step 1|Other complicating disease|2|||
161821752|NCT01708954|584389165|FG002|Step 1|Other complicating disease|0|||
161821753|NCT01708954|584389163|FG000|Step 1|Crossed over to Step 2|2|||
161821754|NCT01708954|584389164|FG001|Step 1|Crossed over to Step 2|0|||
161821755|NCT01708954|584389165|FG002|Step 1|Crossed over to Step 2|0|||
161821756|NCT01708954|584389163|FG000|Step 1|Symptomatic deterioration|1|||
161821757|NCT01708954|584389164|FG001|Step 1|Symptomatic deterioration|0|||
161821758|NCT01708954|584389165|FG002|Step 1|Symptomatic deterioration|1|||
161821759|NCT01708954|584389163|FG000|Step 1|Off-treatment reason not submitted|1|||
161928343|NCT01181128|584785514|FG000|Overall Study|Other|1|||
161676574|NCT00955279|583868830|FG000|Overall Study|Other|0|||
161676575|NCT00955279|583868831|FG001|Overall Study|Other|0|||
161676576|NCT00955279|583868832|FG002|Overall Study|Other|3|||
161676577|NCT00955279|583868830|FG000|Overall Study|Death|1|||
161676578|NCT00955279|583868831|FG001|Overall Study|Death|1|||
161676579|NCT00955279|583868832|FG002|Overall Study|Death|1|||
161676580|NCT00955279|583868830|FG000|Overall Study|Lost to Follow-up|0|||
161676581|NCT00955279|583868831|FG001|Overall Study|Lost to Follow-up|3|||
161676582|NCT00955279|583868832|FG002|Overall Study|Lost to Follow-up|1|||
161676583|NCT00955279|583868830|FG000|Overall Study|Withdrawal by Subject|2|||
161676584|NCT00955279|583868831|FG001|Overall Study|Withdrawal by Subject|0|||
161676585|NCT00955279|583868832|FG002|Overall Study|Withdrawal by Subject|3|||
161676586|NCT02921269|583868833|FG000|Overall Study|Did not complete DLT period|1|||
161676587|NCT00387764|583868844|FG000|Overall Study|Adverse Event|12|||
161676588|NCT00387764|583868844|FG000|Overall Study|Withdrawal by Subject|8|||
161676589|NCT00387764|583868844|FG000|Overall Study|Sponsor Terminated Study|1|||
161676590|NCT00387764|583868844|FG000|Overall Study|Physician Decision|1|||
161676591|NCT00387764|583868844|FG000|Overall Study|Other|2|||
161676592|NCT00387764|583868844|FG000|Overall Study|Death|7|||
161928344|NCT01181128|584785515|FG001|Overall Study|Other|1|||
161928345|NCT01181128|584785516|FG002|Overall Study|Other|1|||
161928346|NCT04477486|584785519|FG000|Overall Study|Death|2|||
161928347|NCT04477486|584785519|FG000|Overall Study|Ongoing at Time of Analysis|11|||
161928348|NCT01543503|584785521|FG000|Overall Study|Lost to Follow-up|32|||
161928349|NCT01543503|584785522|FG001|Overall Study|Lost to Follow-up|36|||
161676593|NCT01184053|583868845|FG000|Overall Study|progression while on treatment|3|||
161676594|NCT01174238|583868848|FG000|Overall Study|Lost to Follow-up|2|||
161821760|NCT01708954|584389164|FG001|Step 1|Off-treatment reason not submitted|1|||
161821761|NCT01708954|584389165|FG002|Step 1|Off-treatment reason not submitted|1|||
162020862|NCT01088048|585132060|FG007|Overall Study|Death|0|||
162020863|NCT01088048|585132061|FG008|Overall Study|Death|3|||
161676595|NCT02301936|583868849|FG000|Overall Study|Lost to Follow-up|1|||
161676596|NCT02301936|583868850|FG001|Overall Study|Lost to Follow-up|0|||
161676597|NCT00232141|583868854|FG000|Overall Study|Adverse Event|9|||
161821762|NCT01708954|584389163|FG000|Step 1|Ineligible or never received treatment|4|||
161821763|NCT01708954|584389164|FG001|Step 1|Ineligible or never received treatment|2|||
161821764|NCT01708954|584389165|FG002|Step 1|Ineligible or never received treatment|8|||
161821765|NCT01708954|584389163|FG000|Step 2|Disease progression|9|||
161821766|NCT01708954|584389164|FG001|Step 2|Disease progression|4|||
161821767|NCT01708954|584389165|FG002|Step 2|Disease progression|0|||
161821768|NCT01708954|584389163|FG000|Step 2|Adverse Event|3|||
161821769|NCT01708954|584389164|FG001|Step 2|Adverse Event|2|||
161821770|NCT01708954|584389165|FG002|Step 2|Adverse Event|0|||
161928350|NCT01543503|584785521|FG000|Overall Study|Adverse Event|9|||
161928351|NCT01543503|584785522|FG001|Overall Study|Adverse Event|13|||
162020864|NCT01088048|585132062|FG009|Overall Study|Death|1|||
161928352|NCT01543503|584785521|FG000|Overall Study|Lack of Efficacy|4|||
161928353|NCT01543503|584785522|FG001|Overall Study|Lack of Efficacy|16|||
161928354|NCT01543503|584785521|FG000|Overall Study|Participant withdrew informed consent|8|||
161928355|NCT01543503|584785522|FG001|Overall Study|Participant withdrew informed consent|10|||
161928356|NCT01543503|584785521|FG000|Overall Study|Change of jobs|0|||
161928357|NCT01543503|584785522|FG001|Overall Study|Change of jobs|1|||
161928358|NCT01543503|584785521|FG000|Overall Study|Intolerance to the biologic treatment|0|||
161928359|NCT01543503|584785522|FG001|Overall Study|Intolerance to the biologic treatment|1|||
161928360|NCT01543503|584785521|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
161928361|NCT01543503|584785522|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
161928362|NCT01543503|584785521|FG000|Overall Study|Participant did not complete last visit|0|||
161928363|NCT01543503|584785522|FG001|Overall Study|Participant did not complete last visit|2|||
161928364|NCT01543503|584785521|FG000|Overall Study|Refused to continue treatment|7|||
161928365|NCT01543503|584785522|FG001|Overall Study|Refused to continue treatment|0|||
161928366|NCT01543503|584785521|FG000|Overall Study|Incorrect medication received|1|||
161928367|NCT01543503|584785522|FG001|Overall Study|Incorrect medication received|0|||
161928368|NCT01543503|584785521|FG000|Overall Study|Participant moved to another city|2|||
161928369|NCT01543503|584785522|FG001|Overall Study|Participant moved to another city|0|||
161928370|NCT01543503|584785521|FG000|Overall Study|Participant will not return for visits|0|||
161928371|NCT01543503|584785522|FG001|Overall Study|Participant will not return for visits|2|||
161928372|NCT01543503|584785521|FG000|Overall Study|Participant transferred to another city|1|||
161928373|NCT01543503|584785522|FG001|Overall Study|Participant transferred to another city|0|||
161928374|NCT01543503|584785521|FG000|Overall Study|Participant moved to Scotland|1|||
161928375|NCT01543503|584785522|FG001|Overall Study|Participant moved to Scotland|0|||
161928376|NCT01543503|584785521|FG000|Overall Study|Participant decision to stop treatment|1|||
161928377|NCT01543503|584785522|FG001|Overall Study|Participant decision to stop treatment|0|||
161928378|NCT01543503|584785521|FG000|Overall Study|Investigator did not wish to participate|1|||
161928379|NCT01543503|584785522|FG001|Overall Study|Investigator did not wish to participate|1|||
161928380|NCT01543503|584785521|FG000|Overall Study|Participant recruited after closing date|0|||
161928381|NCT01543503|584785522|FG001|Overall Study|Participant recruited after closing date|1|||
161928382|NCT01543503|584785521|FG000|Overall Study|Site stopped participation|5|||
161928383|NCT01543503|584785522|FG001|Overall Study|Site stopped participation|1|||
161928384|NCT01543503|584785521|FG000|Overall Study|Participant did not attend a visit|1|||
161928385|NCT01543503|584785522|FG001|Overall Study|Participant did not attend a visit|0|||
161928386|NCT01543503|584785521|FG000|Overall Study|Moved to other rheumatologic site|0|||
161928387|NCT01543503|584785522|FG001|Overall Study|Moved to other rheumatologic site|1|||
161928388|NCT01543503|584785521|FG000|Overall Study|Participant consented to another study|0|||
161928389|NCT01543503|584785522|FG001|Overall Study|Participant consented to another study|2|||
161928390|NCT01543503|584785521|FG000|Overall Study|Participant went to United States|1|||
161928391|NCT01543503|584785522|FG001|Overall Study|Participant went to United States|0|||
161928392|NCT01543503|584785521|FG000|Overall Study|Screen failure|1|||
161928393|NCT01543503|584785522|FG001|Overall Study|Screen failure|0|||
161928394|NCT01986751|584785523|FG000|Overall Study|improperly consented|10|||
162201187|NCT02675998|585787072|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
162201188|NCT02675998|585787073|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
162201189|NCT02675998|585787070|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
162201190|NCT02675998|585787071|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
162201191|NCT02675998|585787072|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
162201192|NCT02675998|585787073|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
162201193|NCT02675998|585787070|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
162201194|NCT02675998|585787071|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
162201195|NCT02675998|585787072|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
162201196|NCT02675998|585787073|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
162201197|NCT02561078|585787082|FG000|Overall Study|Adverse Event|5|||
162201198|NCT02561078|585787083|FG001|Overall Study|Adverse Event|2|||
162201199|NCT02561078|585787082|FG000|Overall Study|Death|2|||
162201200|NCT02561078|585787083|FG001|Overall Study|Death|1|||
162201201|NCT02561078|585787082|FG000|Overall Study|Lost to Follow-up|2|||
162201202|NCT02561078|585787083|FG001|Overall Study|Lost to Follow-up|6|||
162201203|NCT02561078|585787082|FG000|Overall Study|Non-Compliance with Study Drug|6|||
162201204|NCT02561078|585787083|FG001|Overall Study|Non-Compliance with Study Drug|3|||
162201205|NCT02561078|585787082|FG000|Overall Study|Physician Decision|2|||
162201206|NCT02561078|585787083|FG001|Overall Study|Physician Decision|3|||
162201207|NCT02561078|585787082|FG000|Overall Study|Withdrawal by Subject|13|||
162201208|NCT02561078|585787083|FG001|Overall Study|Withdrawal by Subject|10|||
162201209|NCT00598871|585787084|FG000|Overall Study|Adverse Event|0|||
161928395|NCT01986751|584785524|FG001|Overall Study|improperly consented|2|||
161928396|NCT00052715|584785530|FG000|Overall Study|wrong histology|1|||
162020865|NCT01088048|585132053|FG000|Overall Study|Other|3|||
162201210|NCT00598871|585787085|FG001|Overall Study|Adverse Event|1|||
161676598|NCT00232141|583868855|FG001|Overall Study|Adverse Event|4|||
161676599|NCT00232141|583868854|FG000|Overall Study|Lack of Efficacy|0|||
161676600|NCT00232141|583868855|FG001|Overall Study|Lack of Efficacy|3|||
161676601|NCT00232141|583868854|FG000|Overall Study|Lost to Follow-up|9|||
161676602|NCT00232141|583868855|FG001|Overall Study|Lost to Follow-up|6|||
161676603|NCT00232141|583868854|FG000|Overall Study|Other|8|||
161676604|NCT00232141|583868855|FG001|Overall Study|Other|10|||
161676605|NCT00232141|583868854|FG000|Overall Study|Withdrawal by Subject|5|||
161676606|NCT00232141|583868855|FG001|Overall Study|Withdrawal by Subject|3|||
161676607|NCT00601250|583868859|FG000|Overall Study|Adverse Event|3|||
161676608|NCT00601250|583868860|FG001|Overall Study|Adverse Event|9|||
161676609|NCT00601250|583868859|FG000|Overall Study|Protocol Violation|3|||
161676610|NCT00601250|583868860|FG001|Overall Study|Protocol Violation|2|||
161676611|NCT00601250|583868859|FG000|Overall Study|Lost to Follow-up|2|||
161676612|NCT00601250|583868860|FG001|Overall Study|Lost to Follow-up|6|||
161676613|NCT00601250|583868859|FG000|Overall Study|Withdrawal by Subject|4|||
161676614|NCT00601250|583868860|FG001|Overall Study|Withdrawal by Subject|13|||
161676615|NCT00601250|583868859|FG000|Overall Study|Other incl. lack of efficacy|2|||
161676616|NCT00601250|583868860|FG001|Overall Study|Other incl. lack of efficacy|9|||
161676617|NCT01810016|583868861|FG000|Overall Study|Progressive disease|1|||
161676618|NCT01810016|583868862|FG001|Overall Study|Progressive disease|1|||
161676619|NCT01810016|583868863|FG002|Overall Study|Progressive disease|0|||
161676620|NCT01810016|583868861|FG000|Overall Study|Death|0|||
161676621|NCT01810016|583868862|FG001|Overall Study|Death|0|||
161676622|NCT01810016|583868863|FG002|Overall Study|Death|1|||
161676623|NCT06950879|583868865|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
161676624|NCT02229539|583870463|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
161676625|NCT02229539|583870464|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
161676626|NCT02229539|583870465|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
161676627|NCT02229539|583870463|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
161676628|NCT02229539|583870464|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
161676629|NCT02229539|583870465|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
161676630|NCT02229539|583870463|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
161676631|NCT02229539|583870464|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
161676632|NCT02229539|583870465|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
161676633|NCT02229539|583870463|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
161676634|NCT02229539|583870464|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
161676635|NCT02229539|583870465|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
161676636|NCT02229539|583870463|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
161676637|NCT02229539|583870464|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
161676638|NCT02229539|583870465|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
161676639|NCT02229539|583870463|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
161676640|NCT02229539|583870464|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
161676641|NCT02229539|583870465|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
161676642|NCT03441334|583870466|FG000|Overall Study|Withdrawal by Subject|1|||
161676643|NCT03441334|583870467|FG001|Overall Study|Withdrawal by Subject|0|||
161676644|NCT00088907|583870468|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
161676645|NCT00088907|583870469|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
161676646|NCT00088907|583870468|FG000|Randomized Study (Step 1)|Adverse Event|14|||
161676647|NCT00088907|583870469|FG001|Randomized Study (Step 1)|Adverse Event|19|||
161676648|NCT00088907|583870468|FG000|Randomized Study (Step 1)|Death|11|||
161676649|NCT00088907|583870469|FG001|Randomized Study (Step 1)|Death|12|||
161676650|NCT00088907|583870468|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
161676651|NCT00088907|583870469|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
161676652|NCT00088907|583870468|FG000|Randomized Study (Step 1)|complicating disease|3|||
161676653|NCT00088907|583870469|FG001|Randomized Study (Step 1)|complicating disease|1|||
161676654|NCT00088907|583870468|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
161676655|NCT00088907|583870469|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
161676656|NCT00088907|583870468|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
161676657|NCT00088907|583870469|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
161676658|NCT00088907|583870468|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
161676659|NCT00088907|583870469|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
161676660|NCT00088907|583870468|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
161676661|NCT00088907|583870469|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
161821771|NCT01708954|584389163|FG000|Step 2|Withdrawal by Subject|1|||
161821772|NCT01708954|584389164|FG001|Step 2|Withdrawal by Subject|1|||
161821773|NCT01708954|584389165|FG002|Step 2|Withdrawal by Subject|0|||
161821774|NCT01192776|584389166|FG000|Overall Study|Death|8|||
161821775|NCT01192776|584389167|FG001|Overall Study|Death|15|||
162020866|NCT01088048|585132054|FG001|Overall Study|Other|5|||
162020867|NCT01088048|585132055|FG002|Overall Study|Other|0|||
161676662|NCT00088907|583870468|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
161676663|NCT00088907|583870469|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
161821776|NCT01192776|584389168|FG002|Overall Study|Death|18|||
161676664|NCT00088907|583870468|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
161676665|NCT00088907|583870469|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
161676666|NCT00682448|583870476|FG000|Overall Study|Adverse Event|1|||
161676667|NCT00682448|583870477|FG001|Overall Study|Adverse Event|2|||
161676668|NCT00682448|583870476|FG000|Overall Study|Lack of Efficacy|1|||
161676669|NCT00682448|583870477|FG001|Overall Study|Lack of Efficacy|0|||
161676670|NCT00682448|583870476|FG000|Overall Study|Lost to Follow-up|1|||
161676671|NCT00682448|583870477|FG001|Overall Study|Lost to Follow-up|3|||
161676672|NCT00682448|583870476|FG000|Overall Study|Pregnancy|0|||
161676673|NCT00682448|583870477|FG001|Overall Study|Pregnancy|1|||
161676674|NCT00682448|583870476|FG000|Overall Study|Withdrawal by Subject|2|||
161676675|NCT00682448|583870477|FG001|Overall Study|Withdrawal by Subject|0|||
161676676|NCT04050670|583870480|FG000|Period 3|Physician Decision|0|||
161676677|NCT04050670|583870481|FG001|Period 3|Physician Decision|1|||
161676678|NCT04050670|583870482|FG002|Period 3|Physician Decision|0|||
161676679|NCT00268437|583870483|FG000|Overall Study|Ineligible|1|||
161676680|NCT02553265|583870484|FG000|Enrollment|Death|0|||
161676681|NCT02553265|583870485|FG001|Enrollment|Death|0|||
161676682|NCT02553265|583870486|FG002|Enrollment|Death|1|||
161676683|NCT02553265|583870484|FG000|First Intervention (28 Days)|Adverse Event|1|||
161676684|NCT02553265|583870485|FG001|First Intervention (28 Days)|Adverse Event|0|||
161676685|NCT02553265|583870486|FG002|First Intervention (28 Days)|Adverse Event|0|||
161676686|NCT02553265|583870484|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
161676687|NCT02553265|583870485|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
161676688|NCT02553265|583870486|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
161676689|NCT02553265|583870484|FG000|Second Intervention (28 Days)|Adverse Event|1|||
161676690|NCT02553265|583870485|FG001|Second Intervention (28 Days)|Adverse Event|0|||
161676691|NCT02553265|583870486|FG002|Second Intervention (28 Days)|Adverse Event|0|||
161676692|NCT02553265|583870484|FG000|Third Intervention (28 Days)|Adverse Event|1|||
161676693|NCT02553265|583870485|FG001|Third Intervention (28 Days)|Adverse Event|0|||
161676694|NCT02553265|583870486|FG002|Third Intervention (28 Days)|Adverse Event|0|||
161676695|NCT02553265|583870484|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
161676696|NCT02553265|583870485|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
161676697|NCT02553265|583870486|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
161676698|NCT00659529|583870487|FG000|Overall Study|Withdrawal by Subject|4|||
161676699|NCT00659529|583870487|FG000|Overall Study|Protocol Violation|3|||
161676700|NCT00659529|583870487|FG000|Overall Study|Screen failure|9|||
161676701|NCT01022996|583870491|FG000|Overall Study|Adverse Event|14|||
161676702|NCT01022996|583870491|FG000|Overall Study|Withdrawal by Subject|3|||
161676703|NCT01022996|583870491|FG000|Overall Study|Lost to Follow-up|1|||
161676704|NCT01022996|583870491|FG000|Overall Study|Administrative problems|6|||
161676705|NCT01022996|583870491|FG000|Overall Study|Disease Progression|32|||
161676706|NCT01022996|583870491|FG000|Overall Study|Protocol Violation|1|||
161676707|NCT02767323|583870492|FG000|Overall Study|Withdrawal by Subject|17|||
161676708|NCT02767323|583870493|FG001|Overall Study|Withdrawal by Subject|5|||
161676709|NCT02767323|583870494|FG002|Overall Study|Withdrawal by Subject|13|||
161676710|NCT02767323|583870495|FG003|Overall Study|Withdrawal by Subject|0|||
161676711|NCT02767323|583870492|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
161676712|NCT02767323|583870493|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
161676713|NCT02767323|583870494|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
161676714|NCT02767323|583870495|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
161676715|NCT00930722|583870496|FG000|Overall Study|Lost to Follow-up|16|||
161676716|NCT00930722|583870496|FG000|Overall Study|No longer willing to participate|9|||
161676717|NCT00930722|583870496|FG000|Overall Study|Study terminated by sponsor|2|||
161676718|NCT02023242|583870497|FG000|Overall Study|Lost to Follow-up|3|||
161676719|NCT02023242|583870498|FG001|Overall Study|Lost to Follow-up|1|||
161676720|NCT02023242|583870497|FG000|Overall Study|Death|0|||
161821777|NCT01192776|584389169|FG003|Overall Study|Death|15|||
161676721|NCT02023242|583870498|FG001|Overall Study|Death|1|||
161676722|NCT00710879|583870504|FG000|Overall Study|Lost to Follow-up|2|||
161676723|NCT00710879|583870505|FG001|Overall Study|Lost to Follow-up|1|||
161821778|NCT01192776|584389166|FG000|Overall Study|Lost to Follow-up|3|||
161821779|NCT01192776|584389167|FG001|Overall Study|Lost to Follow-up|6|||
161821780|NCT01192776|584389168|FG002|Overall Study|Lost to Follow-up|3|||
161821781|NCT01192776|584389169|FG003|Overall Study|Lost to Follow-up|5|||
161821782|NCT02587143|584389173|FG000|Overall Study|Adverse Event|1|||
161676724|NCT00710879|583870504|FG000|Overall Study|Protocol Violation|0|||
161676725|NCT00710879|583870505|FG001|Overall Study|Protocol Violation|3|||
161821783|NCT02587143|584389174|FG001|Overall Study|Adverse Event|0|||
161676726|NCT01809132|583870506|FG000|Overall Study|Withdrawal by Subject|0|||
161676727|NCT01809132|583870507|FG001|Overall Study|Withdrawal by Subject|0|||
161821784|NCT00611884|584389175|FG000|Overall Study|Adverse Event|1|||
161821785|NCT00611884|584389176|FG001|Overall Study|Adverse Event|0|||
161821786|NCT00611884|584389177|FG002|Overall Study|Adverse Event|0|||
161821787|NCT00611884|584389178|FG003|Overall Study|Adverse Event|1|||
161928397|NCT01774370|584785537|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
161928398|NCT01774370|584785537|FG000|Overall Study|Administered prior to the contract date|4|||
161928399|NCT01774370|584785537|FG000|Overall Study|Subjects of contraindications|34|||
161928400|NCT01774370|584785537|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
161928401|NCT01774370|584785537|FG000|Overall Study|Follow-up failure|34|||
161928402|NCT00514917|584785538|FG000|Overall Study|Death|4|||
161928403|NCT00514917|584785539|FG001|Overall Study|Death|10|||
161928404|NCT00514917|584785538|FG000|Overall Study|Protocol Violation|1|||
161928405|NCT00514917|584785539|FG001|Overall Study|Protocol Violation|0|||
161928406|NCT00514917|584785538|FG000|Overall Study|Lost to Follow-up|4|||
161928407|NCT00514917|584785539|FG001|Overall Study|Lost to Follow-up|3|||
161928408|NCT00514917|584785538|FG000|Overall Study|Withdrawal by Subject|18|||
161928409|NCT00514917|584785539|FG001|Overall Study|Withdrawal by Subject|16|||
161928410|NCT00514917|584785538|FG000|Overall Study|Discontinued due to study closure|88|||
161928411|NCT00514917|584785539|FG001|Overall Study|Discontinued due to study closure|81|||
161928412|NCT00514917|584785538|FG000|Overall Study|Undefined|11|||
161928413|NCT00514917|584785539|FG001|Overall Study|Undefined|5|||
161928414|NCT04243837|584785540|FG000|Overall Study|Adverse Event|2|||
161928415|NCT04243837|584785541|FG001|Overall Study|Adverse Event|1|||
161928416|NCT04243837|584785540|FG000|Overall Study|Withdrawal by Subject|4|||
161928417|NCT04243837|584785541|FG001|Overall Study|Withdrawal by Subject|2|||
161928418|NCT04243837|584785540|FG000|Overall Study|Covid-19 lock down|1|||
161928419|NCT04243837|584785541|FG001|Overall Study|Covid-19 lock down|0|||
161928420|NCT04243837|584785540|FG000|Overall Study|Study Terminated by Sponsor|11|||
161928421|NCT04243837|584785541|FG001|Overall Study|Study Terminated by Sponsor|12|||
161928422|NCT02280499|584785542|FG000|Overall Study|Death|14|||
161928423|NCT02280499|584785542|FG000|Overall Study|Lost to Follow-up|42|||
161928424|NCT02280499|584785542|FG000|Overall Study|Adverse Event|5|||
161928425|NCT01666314|584785548|FG000|Overall Study|Adverse Event|3|||
161928426|NCT01666314|584785549|FG001|Overall Study|Adverse Event|13|||
161928427|NCT01666314|584785550|FG002|Overall Study|Adverse Event|7|||
161928428|NCT01666314|584785551|FG003|Overall Study|Adverse Event|7|||
161928429|NCT01666314|584785548|FG000|Overall Study|Progressive Disease|11|||
161928430|NCT01666314|584785549|FG001|Overall Study|Progressive Disease|9|||
161928431|NCT01666314|584785550|FG002|Overall Study|Progressive Disease|19|||
161928432|NCT01666314|584785551|FG003|Overall Study|Progressive Disease|20|||
161928433|NCT01666314|584785548|FG000|Overall Study|Symptomatic Deterioration|1|||
161928434|NCT01666314|584785549|FG001|Overall Study|Symptomatic Deterioration|0|||
161928435|NCT01666314|584785550|FG002|Overall Study|Symptomatic Deterioration|2|||
161928436|NCT01666314|584785551|FG003|Overall Study|Symptomatic Deterioration|0|||
161928437|NCT01666314|584785548|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
161928438|NCT01666314|584785549|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
161928439|NCT01666314|584785550|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
161928440|NCT01666314|584785551|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
161928441|NCT01666314|584785548|FG000|Overall Study|Withdrawal by Subject|1|||
161928442|NCT01666314|584785549|FG001|Overall Study|Withdrawal by Subject|1|||
161928443|NCT01666314|584785550|FG002|Overall Study|Withdrawal by Subject|2|||
161928444|NCT01666314|584785551|FG003|Overall Study|Withdrawal by Subject|3|||
161928445|NCT01666314|584785548|FG000|Overall Study|Reason not Specified|10|||
161928446|NCT01666314|584785549|FG001|Overall Study|Reason not Specified|7|||
162020868|NCT01088048|585132056|FG003|Overall Study|Other|0|||
161821788|NCT00611884|584389175|FG000|Overall Study|Non-Compliance|1|||
161821789|NCT00611884|584389176|FG001|Overall Study|Non-Compliance|4|||
161821790|NCT00611884|584389177|FG002|Overall Study|Non-Compliance|2|||
161821791|NCT00611884|584389178|FG003|Overall Study|Non-Compliance|2|||
161821792|NCT00611884|584389175|FG000|Overall Study|Lack of Efficacy|0|||
161821793|NCT00611884|584389176|FG001|Overall Study|Lack of Efficacy|1|||
161821794|NCT00611884|584389177|FG002|Overall Study|Lack of Efficacy|0|||
161821795|NCT00611884|584389178|FG003|Overall Study|Lack of Efficacy|0|||
161821796|NCT00611884|584389175|FG000|Overall Study|Unclassified|7|||
161821797|NCT00611884|584389176|FG001|Overall Study|Unclassified|4|||
161821798|NCT00611884|584389177|FG002|Overall Study|Unclassified|2|||
161821799|NCT00611884|584389178|FG003|Overall Study|Unclassified|3|||
161821800|NCT00981799|584389179|FG000|Overall Study|Adverse Event|1|||
161821801|NCT00981799|584389180|FG001|Overall Study|Adverse Event|1|||
161928447|NCT01666314|584785550|FG002|Overall Study|Reason not Specified|5|||
161928448|NCT01666314|584785551|FG003|Overall Study|Reason not Specified|5|||
161928449|NCT03462563|584785555|FG000|Overall Study|Death|1|||
161928450|NCT03462563|584785556|FG001|Overall Study|Death|1|||
161928451|NCT03462563|584785555|FG000|Overall Study|Termination of study|2|||
161821802|NCT00981799|584389181|FG002|Overall Study|Adverse Event|0|||
161821803|NCT00981799|584389182|FG003|Overall Study|Adverse Event|0|||
161928452|NCT03462563|584785556|FG001|Overall Study|Termination of study|1|||
161928453|NCT03462563|584785555|FG000|Overall Study|Adverse Event|1|||
161928454|NCT03462563|584785556|FG001|Overall Study|Adverse Event|3|||
161928455|NCT03462563|584785555|FG000|Overall Study|Unspecified reason|10|||
161928456|NCT03462563|584785556|FG001|Overall Study|Unspecified reason|12|||
161928457|NCT03462563|584785555|FG000|Overall Study|Physician Decision|1|||
162201211|NCT01194271|585787086|FG000|Overall Study|Withdrawal by Subject|1|||
162201212|NCT01194271|585787086|FG000|Overall Study|Ineligible, Screen Failure|1|||
162201213|NCT01194271|585787086|FG000|Overall Study|Death|1|||
162201214|NCT00443898|585787087|FG000|Overall Study|Adverse Event|0|||
162201215|NCT00443898|585787088|FG001|Overall Study|Adverse Event|0|||
162201216|NCT00443898|585787089|FG002|Overall Study|Adverse Event|1|||
162201217|NCT00443898|585787090|FG003|Overall Study|Adverse Event|1|||
162201218|NCT00443898|585787087|FG000|Overall Study|Lack of Efficacy|2|||
162201219|NCT00443898|585787088|FG001|Overall Study|Lack of Efficacy|3|||
162201220|NCT00443898|585787089|FG002|Overall Study|Lack of Efficacy|3|||
162201221|NCT00443898|585787090|FG003|Overall Study|Lack of Efficacy|1|||
162201222|NCT00443898|585787087|FG000|Overall Study|Protocol Violation|1|||
161821804|NCT01717313|584389189|FG000|Phase A (Weeks 0 to 24)|Death|0|||
161821805|NCT01717313|584389190|FG001|Phase A (Weeks 0 to 24)|Death|1|||
161821806|NCT01717313|584389189|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
161821807|NCT01717313|584389190|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
161821808|NCT01717313|584389189|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
161821809|NCT01717313|584389190|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
161821810|NCT01717313|584389189|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
161821811|NCT01717313|584389190|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
161821812|NCT01717313|584389189|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
161821813|NCT01717313|584389190|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
161821814|NCT01717313|584389189|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
161821815|NCT01717313|584389190|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
161821816|NCT01717313|584389189|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
161821817|NCT01717313|584389190|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
161821818|NCT01717313|584389189|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
161821819|NCT01717313|584389190|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
161821820|NCT01717313|584389189|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
161821821|NCT01717313|584389190|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
161821822|NCT01943435|584389191|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
161821823|NCT01943435|584389192|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
161821824|NCT01943435|584389193|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
161821825|NCT01943435|584389191|FG000|Intervention Period|Withdrawal by Subject|3|||
161821826|NCT01943435|584389192|FG001|Intervention Period|Withdrawal by Subject|3|||
161821827|NCT01943435|584389193|FG002|Intervention Period|Withdrawal by Subject|4|||
161821828|NCT01943435|584389191|FG000|2 Month Follow up|Lost to Follow-up|2|||
161821829|NCT01943435|584389192|FG001|2 Month Follow up|Lost to Follow-up|3|||
161821830|NCT01943435|584389193|FG002|2 Month Follow up|Lost to Follow-up|0|||
161821831|NCT01943435|584389191|FG000|6 Month Follow up|Lost to Follow-up|12|||
161821832|NCT01943435|584389192|FG001|6 Month Follow up|Lost to Follow-up|7|||
161821833|NCT01943435|584389193|FG002|6 Month Follow up|Lost to Follow-up|15|||
161821834|NCT01617096|584389198|FG000|Overall Study|Withdrawal by Subject|96|||
161821835|NCT01617096|584389199|FG001|Overall Study|Withdrawal by Subject|81|||
161821836|NCT01617096|584389198|FG000|Overall Study|Lost to Follow-up|37|||
161821837|NCT01617096|584389199|FG001|Overall Study|Lost to Follow-up|32|||
161821838|NCT01617096|584389198|FG000|Overall Study|Physician Decision|10|||
161821839|NCT01617096|584389199|FG001|Overall Study|Physician Decision|18|||
161821840|NCT01617096|584389198|FG000|Overall Study|Death|4|||
161821841|NCT01617096|584389199|FG001|Overall Study|Death|3|||
161821842|NCT01617096|584389198|FG000|Overall Study|Other|1|||
161821843|NCT01617096|584389199|FG001|Overall Study|Other|3|||
161821844|NCT04535986|584389202|FG000|Overall Study|Death|4|||
161821845|NCT04535986|584389203|FG001|Overall Study|Death|5|||
161821846|NCT04535986|584389202|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
161821847|NCT04535986|584389203|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
161821848|NCT04535986|584389202|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
161821849|NCT04535986|584389203|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
161821850|NCT04535986|584389202|FG000|Overall Study|Adverse Event|10|||
161821851|NCT04535986|584389203|FG001|Overall Study|Adverse Event|1|||
161821852|NCT04535986|584389202|FG000|Overall Study|Lack of Efficacy|3|||
161821853|NCT04535986|584389203|FG001|Overall Study|Lack of Efficacy|2|||
161821854|NCT04535986|584389202|FG000|Overall Study|Investigator discretion|3|||
161821855|NCT04535986|584389203|FG001|Overall Study|Investigator discretion|0|||
161821856|NCT04535986|584389202|FG000|Overall Study|Withdrawal by Subject|32|||
162201223|NCT00443898|585787088|FG001|Overall Study|Protocol Violation|1|||
161821857|NCT04535986|584389203|FG001|Overall Study|Withdrawal by Subject|14|||
161821858|NCT04535986|584389202|FG000|Overall Study|Lost to Follow-up|5|||
161821859|NCT04535986|584389203|FG001|Overall Study|Lost to Follow-up|3|||
162020869|NCT01088048|585132057|FG004|Overall Study|Other|2|||
162201224|NCT00443898|585787089|FG002|Overall Study|Protocol Violation|1|||
161821860|NCT04535986|584389202|FG000|Overall Study|Other|7|||
161821861|NCT04535986|584389203|FG001|Overall Study|Other|3|||
161821862|NCT01532908|584389206|FG000|Overall Study|Not Transplanted|1|||
161821863|NCT01532908|584389207|FG001|Overall Study|Not Transplanted|0|||
162201225|NCT00443898|585787090|FG003|Overall Study|Protocol Violation|0|||
161821864|NCT01196390|584389208|FG000|Overall Study|Protocol Violation|4|||
161821865|NCT01196390|584389209|FG001|Overall Study|Protocol Violation|5|||
161821866|NCT00252564|584389210|FG000|Overall Study|Adverse Event|17|||
161821867|NCT00252564|584389211|FG001|Overall Study|Adverse Event|13|||
161821868|NCT00252564|584389210|FG000|Overall Study|Unrelated Complication|2|||
161821869|NCT00252564|584389211|FG001|Overall Study|Unrelated Complication|1|||
161928458|NCT03462563|584785556|FG001|Overall Study|Physician Decision|0|||
161928459|NCT05089357|584785557|FG000|Overall Study|Withdrawal by Subject|23|||
161928460|NCT05089357|584785557|FG000|Overall Study|Lost to Follow-up|6|||
161928461|NCT05089357|584785557|FG000|Overall Study|Medical reason|1|||
161928462|NCT05089357|584785557|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
161928463|NCT05089357|584785557|FG000|Overall Study|Pregnancy|2|||
161928464|NCT00689052|584785558|FG000|Overall Study|Adverse Event|4|||
161928465|NCT00689052|584785559|FG001|Overall Study|Adverse Event|6|||
161928466|NCT00689052|584785558|FG000|Overall Study|Protocol Violation|1|||
161928467|NCT00689052|584785559|FG001|Overall Study|Protocol Violation|0|||
161928468|NCT00689052|584785558|FG000|Overall Study|Lost to Follow-up|2|||
161928469|NCT00689052|584785559|FG001|Overall Study|Lost to Follow-up|0|||
161928470|NCT00689052|584785558|FG000|Overall Study|Withdrawal by Subject|2|||
161928471|NCT00689052|584785559|FG001|Overall Study|Withdrawal by Subject|0|||
161928472|NCT00689052|584785558|FG000|Overall Study|Early termination of the trial|22|||
161928473|NCT00689052|584785559|FG001|Overall Study|Early termination of the trial|24|||
161928474|NCT01860989|584785560|FG000|Overall Study|Unsatisfactory therapeutic|5|||
161928475|NCT04739709|584785563|FG000|Overall Study|Physician Decision|1|||
161928476|NCT04739709|584785564|FG001|Overall Study|Physician Decision|0|||
161928477|NCT03003468|584785565|FG000|Overall Study|Withdrawal by Subject|0|||
161928478|NCT03003468|584785566|FG001|Overall Study|Withdrawal by Subject|0|||
161928479|NCT03003468|584785567|FG002|Overall Study|Withdrawal by Subject|1|||
161928480|NCT03003468|584785565|FG000|Overall Study|No measurable lesions|0|||
161928481|NCT03003468|584785566|FG001|Overall Study|No measurable lesions|0|||
161928482|NCT03003468|584785567|FG002|Overall Study|No measurable lesions|1|||
161928483|NCT00421993|584785570|FG000|Overall Study|Withdrawal by Subject|22|||
161928484|NCT00421993|584785571|FG001|Overall Study|Withdrawal by Subject|23|||
161928485|NCT00421993|584785572|FG002|Overall Study|Withdrawal by Subject|23|||
161928486|NCT00421993|584785573|FG003|Overall Study|Withdrawal by Subject|24|||
161928487|NCT00421993|584785570|FG000|Overall Study|Lost to Follow-up|18|||
161928488|NCT00421993|584785571|FG001|Overall Study|Lost to Follow-up|19|||
161928489|NCT00421993|584785572|FG002|Overall Study|Lost to Follow-up|22|||
161928490|NCT00421993|584785573|FG003|Overall Study|Lost to Follow-up|20|||
161928491|NCT00421993|584785570|FG000|Overall Study|Adverse Event|11|||
161928492|NCT00421993|584785571|FG001|Overall Study|Adverse Event|1|||
161928493|NCT00421993|584785572|FG002|Overall Study|Adverse Event|6|||
161928494|NCT00421993|584785573|FG003|Overall Study|Adverse Event|4|||
161928495|NCT00421993|584785570|FG000|Overall Study|Protocol Violation|2|||
161928496|NCT00421993|584785571|FG001|Overall Study|Protocol Violation|2|||
161928497|NCT00421993|584785572|FG002|Overall Study|Protocol Violation|0|||
161928498|NCT00421993|584785573|FG003|Overall Study|Protocol Violation|1|||
161928499|NCT00421993|584785570|FG000|Overall Study|Lack of Efficacy|0|||
161928500|NCT00421993|584785571|FG001|Overall Study|Lack of Efficacy|3|||
161928501|NCT00421993|584785572|FG002|Overall Study|Lack of Efficacy|0|||
161928502|NCT00421993|584785573|FG003|Overall Study|Lack of Efficacy|5|||
162201226|NCT00443898|585787087|FG000|Overall Study|Withdrawal by Subject|11|||
162201227|NCT00443898|585787088|FG001|Overall Study|Withdrawal by Subject|10|||
161821870|NCT00252564|584389210|FG000|Overall Study|Disease Progression|14|||
161928503|NCT00421993|584785570|FG000|Overall Study|Pregnancy|0|||
161928504|NCT00421993|584785571|FG001|Overall Study|Pregnancy|1|||
161928505|NCT00421993|584785572|FG002|Overall Study|Pregnancy|1|||
161928506|NCT00421993|584785573|FG003|Overall Study|Pregnancy|2|||
161928507|NCT00421993|584785570|FG000|Overall Study|Subject transportation issues|0|||
161928508|NCT00421993|584785571|FG001|Overall Study|Subject transportation issues|0|||
161928509|NCT00421993|584785572|FG002|Overall Study|Subject transportation issues|0|||
161928510|NCT00421993|584785573|FG003|Overall Study|Subject transportation issues|1|||
161928511|NCT01751685|584785574|FG000|6-mo Followup|Missed study visit|1|||
162201228|NCT00443898|585787089|FG002|Overall Study|Withdrawal by Subject|10|||
161821871|NCT00252564|584389211|FG001|Overall Study|Disease Progression|20|||
161821872|NCT00252564|584389210|FG000|Overall Study|Death|0|||
161821873|NCT00252564|584389211|FG001|Overall Study|Death|3|||
161821874|NCT00252564|584389210|FG000|Overall Study|Physician Decision|1|||
161821875|NCT00252564|584389211|FG001|Overall Study|Physician Decision|0|||
161821876|NCT00252564|584389210|FG000|Overall Study|Lost to Follow-up|1|||
161928512|NCT01751685|584785575|FG001|6-mo Followup|Missed study visit|0|||
161928513|NCT01751685|584785574|FG000|6-mo Followup|Withdrawal by Subject|2|||
161928514|NCT01751685|584785575|FG001|6-mo Followup|Withdrawal by Subject|2|||
161928515|NCT01751685|584785574|FG000|6-mo Followup|Lost to Follow-up|0|||
161928516|NCT01751685|584785575|FG001|6-mo Followup|Lost to Follow-up|1|||
161928517|NCT01751685|584785574|FG000|12-mo Followup|Lost to Follow-up|5|||
161928518|NCT01751685|584785575|FG001|12-mo Followup|Lost to Follow-up|0|||
161928519|NCT01727154|584785580|FG000|Overall Study|Death|17|||
161821877|NCT00252564|584389211|FG001|Overall Study|Lost to Follow-up|0|||
161821878|NCT00252564|584389210|FG000|Overall Study|Patient Request|4|||
161821879|NCT00252564|584389211|FG001|Overall Study|Patient Request|5|||
161821880|NCT00252564|584389210|FG000|Overall Study|Withdrawal by Subject|0|||
161821881|NCT00252564|584389211|FG001|Overall Study|Withdrawal by Subject|2|||
161821882|NCT01632306|584389212|FG000|Overall Study|Protocol Violation|1|||
161821883|NCT01632306|584389213|FG001|Overall Study|Protocol Violation|0|||
161821884|NCT01632306|584389214|FG002|Overall Study|Protocol Violation|0|||
161821885|NCT02179190|584389219|FG000|Enrollment|Exit Prior to Device Attempt|11|||
161821886|NCT02179190|584389219|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
161821887|NCT02179190|584389219|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
161821888|NCT02179190|584389219|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
161821889|NCT02179190|584389219|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
161821890|NCT02179190|584389219|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
161821891|NCT03480022|584389220|FG000|Overall Study|Pregnancy|2|||
161821892|NCT03480022|584389221|FG001|Overall Study|Pregnancy|0|||
162201229|NCT00443898|585787090|FG003|Overall Study|Withdrawal by Subject|6|||
162201230|NCT00443898|585787087|FG000|Overall Study|Lost to Follow-up|10|||
162201231|NCT00443898|585787088|FG001|Overall Study|Lost to Follow-up|10|||
162201232|NCT00443898|585787089|FG002|Overall Study|Lost to Follow-up|14|||
161821893|NCT03480022|584389220|FG000|Overall Study|Adverse Event|6|||
161821894|NCT03480022|584389221|FG001|Overall Study|Adverse Event|0|||
161821895|NCT03480022|584389220|FG000|Overall Study|Lack of Efficacy|0|||
161821896|NCT03480022|584389221|FG001|Overall Study|Lack of Efficacy|2|||
161821897|NCT03480022|584389220|FG000|Overall Study|Physician Decision|0|||
161821898|NCT03480022|584389221|FG001|Overall Study|Physician Decision|1|||
161821899|NCT03480022|584389220|FG000|Overall Study|Withdrawal by Subject|2|||
161821900|NCT03480022|584389221|FG001|Overall Study|Withdrawal by Subject|0|||
161821901|NCT03480022|584389220|FG000|Overall Study|Medication concerns|1|||
161821902|NCT03480022|584389221|FG001|Overall Study|Medication concerns|0|||
161821903|NCT03480022|584389220|FG000|Overall Study|Family member COVID exposure|0|||
161821904|NCT03480022|584389221|FG001|Overall Study|Family member COVID exposure|1|||
161821905|NCT00881569|584389222|FG000|Overall Study|Disease progression|1|||
161821906|NCT00881569|584389223|FG001|Overall Study|Disease progression|1|||
161821907|NCT02623218|584389228|FG000|Overall Study|Lost to Follow-up|0|||
161821908|NCT02623218|584389229|FG001|Overall Study|Lost to Follow-up|1|||
161821909|NCT02623218|584389230|FG002|Overall Study|Lost to Follow-up|0|||
161821910|NCT02623218|584389231|FG003|Overall Study|Lost to Follow-up|0|||
161821911|NCT02623218|584389232|FG004|Overall Study|Lost to Follow-up|0|||
161821912|NCT00537095|584389236|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
161821913|NCT00537095|584389237|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
161821914|NCT00537095|584389236|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
161821915|NCT00537095|584389237|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
161821916|NCT00537095|584389236|FG000|Randomized Treatment Period (433 Days)|Death|3|||
161821917|NCT00537095|584389237|FG001|Randomized Treatment Period (433 Days)|Death|1|||
161821918|NCT00537095|584389236|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
161821919|NCT00537095|584389237|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
161821920|NCT00537095|584389236|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
161821921|NCT00537095|584389237|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
161821922|NCT00537095|584389236|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
161821923|NCT00537095|584389237|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
161821924|NCT00537095|584389236|FG000|Open-label Period (590 Days)|Adverse Event|2|||
161821925|NCT00537095|584389237|FG001|Open-label Period (590 Days)|Adverse Event|11|||
161821926|NCT00537095|584389236|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
161821927|NCT00537095|584389237|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
161821928|NCT00537095|584389236|FG000|Open-label Period (590 Days)|Death|2|||
161821929|NCT00537095|584389237|FG001|Open-label Period (590 Days)|Death|2|||
161821930|NCT00537095|584389236|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
161821931|NCT00537095|584389237|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
161821932|NCT00537095|584389236|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
161821933|NCT00537095|584389237|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
161821934|NCT01970592|584389238|FG000|Overall Study|Withdrawal by Subject|4|||
161821935|NCT01970592|584389238|FG000|Overall Study|Physician Decision|1|||
161821936|NCT01970592|584389238|FG000|Overall Study|Adverse Event|1|||
161821937|NCT03980522|584389241|FG000|Treatment Period|Adverse Event|1|||
161821938|NCT03980522|584389242|FG001|Treatment Period|Adverse Event|0|||
161821939|NCT03980522|584389243|FG002|Treatment Period|Adverse Event|0|||
161821940|NCT03980522|584389244|FG003|Treatment Period|Adverse Event|0|||
161821941|NCT03980522|584389245|FG004|Treatment Period|Adverse Event|0|||
161821942|NCT01320722|584389246|FG000|Overall Study|Did not Receive Intervention|3|||
161821943|NCT01320722|584389247|FG001|Overall Study|Did not Receive Intervention|2|||
162201233|NCT00443898|585787090|FG003|Overall Study|Lost to Follow-up|10|||
161928520|NCT01727154|584785580|FG000|Overall Study|Withdrawal by Subject|14|||
161928521|NCT01727154|584785580|FG000|Overall Study|Subject Withdrew Consent|18|||
161928522|NCT01727154|584785580|FG000|Overall Study|Study Terminated|6|||
161928523|NCT01727154|584785580|FG000|Overall Study|No Discontinuation Documentation|4|||
161928524|NCT00003474|584785581|FG000|Overall Study|Not Evaluable|14|||
161928525|NCT01198548|584785585|FG000|Overall Study|Disease Progression|9|||
161928526|NCT01198548|584785585|FG000|Overall Study|Administrative Decision|1|||
161928527|NCT02186171|584785587|FG000|Overall Study|Withdrawal by Subject|1|||
161928528|NCT02186171|584785588|FG001|Overall Study|Withdrawal by Subject|9|||
161928529|NCT02186171|584785587|FG000|Overall Study|Lost to Follow-up|2|||
161928530|NCT02186171|584785588|FG001|Overall Study|Lost to Follow-up|2|||
161928531|NCT02186171|584785587|FG000|Overall Study|Death|1|||
161928532|NCT02186171|584785588|FG001|Overall Study|Death|2|||
161928533|NCT02186171|584785587|FG000|Overall Study|Protocol-specified Criteria|0|||
161928534|NCT02186171|584785588|FG001|Overall Study|Protocol-specified Criteria|2|||
161928535|NCT01245062|584785589|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
161928536|NCT01245062|584785590|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
161928537|NCT01245062|584785591|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
161928538|NCT01245062|584785589|FG000|Randomization and Crossover Phase|Physician Decision|2|||
161928539|NCT01245062|584785590|FG001|Randomization and Crossover Phase|Physician Decision|4|||
161928540|NCT01245062|584785591|FG002|Randomization and Crossover Phase|Physician Decision|0|||
161928541|NCT01245062|584785589|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
161928542|NCT01245062|584785590|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
161928543|NCT01245062|584785591|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
161928544|NCT01245062|584785589|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
161928545|NCT01245062|584785590|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
161928546|NCT01245062|584785591|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
161928547|NCT01245062|584785589|FG000|Cross-over Phase|Lost to Follow-up|0|||
162201234|NCT00443898|585787087|FG000|Overall Study|Death|0|||
162201235|NCT00443898|585787088|FG001|Overall Study|Death|1|||
162201236|NCT00443898|585787089|FG002|Overall Study|Death|0|||
162201237|NCT00443898|585787090|FG003|Overall Study|Death|0|||
162201238|NCT00043186|585787091|FG000|Overall Study|Physician Decision|0|||
162201239|NCT00043186|585787092|FG001|Overall Study|Physician Decision|0|||
162201240|NCT00043186|585787093|FG002|Overall Study|Physician Decision|3|||
162201241|NCT00043186|585787094|FG003|Overall Study|Physician Decision|0|||
162201242|NCT00043186|585787095|FG004|Overall Study|Physician Decision|1|||
162201243|NCT00043186|585787096|FG005|Overall Study|Physician Decision|0|||
162201244|NCT00043186|585787097|FG006|Overall Study|Physician Decision|0|||
162201245|NCT00043186|585787098|FG007|Overall Study|Physician Decision|1|||
162201246|NCT00043186|585787099|FG008|Overall Study|Physician Decision|1|||
162201247|NCT00043186|585787091|FG000|Overall Study|Adverse Event|2|||
162201248|NCT00043186|585787092|FG001|Overall Study|Adverse Event|2|||
162201249|NCT00043186|585787093|FG002|Overall Study|Adverse Event|2|||
162201250|NCT00043186|585787094|FG003|Overall Study|Adverse Event|3|||
162201251|NCT00043186|585787095|FG004|Overall Study|Adverse Event|2|||
162201252|NCT00043186|585787096|FG005|Overall Study|Adverse Event|1|||
162201253|NCT00043186|585787097|FG006|Overall Study|Adverse Event|2|||
162201254|NCT00043186|585787098|FG007|Overall Study|Adverse Event|1|||
162201255|NCT00043186|585787099|FG008|Overall Study|Adverse Event|3|||
161928548|NCT01245062|584785590|FG001|Cross-over Phase|Lost to Follow-up|0|||
161928549|NCT01245062|584785591|FG002|Cross-over Phase|Lost to Follow-up|1|||
161928550|NCT01245062|584785589|FG000|Cross-over Phase|Physician Decision|0|||
161928551|NCT01245062|584785590|FG001|Cross-over Phase|Physician Decision|0|||
161928552|NCT01245062|584785591|FG002|Cross-over Phase|Physician Decision|1|||
161928553|NCT01245062|584785589|FG000|Cross-over Phase|Withdrew Consent|0|||
161928554|NCT01245062|584785590|FG001|Cross-over Phase|Withdrew Consent|0|||
161928555|NCT01245062|584785591|FG002|Cross-over Phase|Withdrew Consent|4|||
162201256|NCT00043186|585787091|FG000|Overall Study|Withdrawal by Subject|11|||
162201257|NCT00043186|585787092|FG001|Overall Study|Withdrawal by Subject|8|||
162201258|NCT00043186|585787093|FG002|Overall Study|Withdrawal by Subject|11|||
162201259|NCT00043186|585787094|FG003|Overall Study|Withdrawal by Subject|13|||
161928556|NCT01245062|584785589|FG000|Cross-over Phase|Study closed/ terminated|0|||
161928557|NCT01245062|584785590|FG001|Cross-over Phase|Study closed/ terminated|0|||
161928558|NCT01245062|584785591|FG002|Cross-over Phase|Study closed/ terminated|11|||
161928559|NCT06025695|584785592|FG000|Overall Study|Adverse Event|5|||
162201260|NCT00043186|585787095|FG004|Overall Study|Withdrawal by Subject|14|||
162201261|NCT00043186|585787096|FG005|Overall Study|Withdrawal by Subject|6|||
162201262|NCT00043186|585787097|FG006|Overall Study|Withdrawal by Subject|12|||
161676728|NCT01809132|583870508|FG002|Overall Study|Withdrawal by Subject|1|||
161676729|NCT04854434|583870509|FG000|Overall Study|Death|1|||
161676730|NCT04854434|583870510|FG001|Overall Study|Death|3|||
161676731|NCT04854434|583870511|FG002|Overall Study|Death|4|||
161928560|NCT06025695|584785593|FG001|Overall Study|Adverse Event|6|||
161928561|NCT06025695|584785592|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
161928562|NCT06025695|584785593|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
161928563|NCT06025695|584785592|FG000|Overall Study|Other|23|||
161928564|NCT06025695|584785593|FG001|Overall Study|Other|19|||
161928565|NCT06025695|584785592|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
161928566|NCT06025695|584785593|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
161928567|NCT01452347|584785594|FG000|Overall Study|Adverse Event|2|||
161928568|NCT01452347|584785595|FG001|Overall Study|Adverse Event|1|||
161928569|NCT01452347|584785594|FG000|Overall Study|Non compliance protocol|2|||
161928570|NCT01452347|584785595|FG001|Overall Study|Non compliance protocol|0|||
161928571|NCT01452347|584785594|FG000|Overall Study|Lost to Follow-up|2|||
161928572|NCT01452347|584785595|FG001|Overall Study|Lost to Follow-up|0|||
161928573|NCT01452347|584785594|FG000|Overall Study|Withdrawal by Subject|3|||
161928574|NCT01452347|584785595|FG001|Overall Study|Withdrawal by Subject|3|||
161928575|NCT01452347|584785594|FG000|Overall Study|Not treated|6|||
161928576|NCT01452347|584785595|FG001|Overall Study|Not treated|3|||
161928577|NCT01452347|584785594|FG000|Overall Study|Other reason not defined above|2|||
161928578|NCT01452347|584785595|FG001|Overall Study|Other reason not defined above|0|||
161928579|NCT05762744|584785596|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
161928580|NCT05762744|584785597|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
161928581|NCT05762744|584785596|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
161928582|NCT05762744|584785597|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
161928583|NCT02724644|584787724|FG000|Overall Study|Adverse Event|7|||
161928584|NCT02724644|584787725|FG001|Overall Study|Adverse Event|1|||
161928585|NCT02724644|584787724|FG000|Overall Study|Lost to Follow-up|6|||
161928586|NCT02724644|584787725|FG001|Overall Study|Lost to Follow-up|2|||
161928587|NCT02724644|584787724|FG000|Overall Study|Withdrawal by Subject|7|||
161928588|NCT02724644|584787725|FG001|Overall Study|Withdrawal by Subject|1|||
161928589|NCT02724644|584787724|FG000|Overall Study|Administrative|1|||
161928590|NCT02724644|584787725|FG001|Overall Study|Administrative|0|||
161928591|NCT01882829|584787726|FG000|Overall Study|Adverse Event|4|||
161928592|NCT01882829|584787726|FG000|Overall Study|Protocol Violation|1|||
161928593|NCT01882829|584787726|FG000|Overall Study|Withdrawal by Subject|1|||
161928594|NCT03312114|584787727|FG000|Overall Study|All the five enrolled dropped out of the|5|||
161928595|NCT02469961|584787734|FG000|Overall Study|Physician Decision|4|||
161928596|NCT02469961|584787735|FG001|Overall Study|Physician Decision|1|||
161928597|NCT01245751|584787743|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
161928598|NCT01245751|584787744|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
161928599|NCT01245751|584787745|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
161928600|NCT01245751|584787746|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
161928601|NCT01245751|584787743|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
161928602|NCT01245751|584787744|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
161928603|NCT01245751|584787745|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
161928604|NCT01245751|584787746|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
161928605|NCT01245751|584787743|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
161928606|NCT01245751|584787744|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
161928607|NCT01245751|584787745|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
161928608|NCT01245751|584787746|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
161928609|NCT01748552|584787751|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
162020870|NCT01088048|585132058|FG005|Overall Study|Other|0|||
162020871|NCT01088048|585132059|FG006|Overall Study|Other|0|||
162201263|NCT00043186|585787098|FG007|Overall Study|Withdrawal by Subject|9|||
162201264|NCT00043186|585787099|FG008|Overall Study|Withdrawal by Subject|10|||
162201265|NCT00043186|585787091|FG000|Overall Study|Death|0|||
162201266|NCT00043186|585787092|FG001|Overall Study|Death|0|||
161676732|NCT04854434|583870509|FG000|Overall Study|Study Terminated by Sponsor|2|||
161676733|NCT04854434|583870510|FG001|Overall Study|Study Terminated by Sponsor|0|||
161676734|NCT04854434|583870511|FG002|Overall Study|Study Terminated by Sponsor|0|||
161676735|NCT04854434|583870509|FG000|Overall Study|Other|1|||
161928610|NCT01748552|584787752|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
161928611|NCT01748552|584787753|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
161928612|NCT01748552|584787754|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
161928613|NCT01748552|584787755|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
161928614|NCT01748552|584787756|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
161928615|NCT01748552|584787757|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
161928616|NCT01748552|584787758|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
161928617|NCT01748552|584787759|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
162020872|NCT01088048|585132060|FG007|Overall Study|Other|2|||
162020873|NCT01088048|585132061|FG008|Overall Study|Other|0|||
162020874|NCT01088048|585132062|FG009|Overall Study|Other|0|||
162020875|NCT01343693|585132063|FG000|Overall Study|Lost to Follow-up|9|||
162020876|NCT00265148|585132064|FG000|Overall Study|Adverse Event|2|||
162020877|NCT00265148|585132065|FG001|Overall Study|Adverse Event|2|||
162020878|NCT00265148|585132064|FG000|Overall Study|Lack of Efficacy|0|||
162020879|NCT00265148|585132065|FG001|Overall Study|Lack of Efficacy|2|||
162020880|NCT00265148|585132064|FG000|Overall Study|Protocol Violation|3|||
162020881|NCT00265148|585132065|FG001|Overall Study|Protocol Violation|2|||
162020882|NCT00265148|585132064|FG000|Overall Study|Lost to Follow-up|0|||
162020883|NCT00265148|585132065|FG001|Overall Study|Lost to Follow-up|1|||
162020884|NCT00265148|585132064|FG000|Overall Study|Withdrawal by Subject|2|||
162020885|NCT00265148|585132065|FG001|Overall Study|Withdrawal by Subject|1|||
162201267|NCT00043186|585787093|FG002|Overall Study|Death|1|||
162201268|NCT00043186|585787094|FG003|Overall Study|Death|0|||
162201269|NCT00043186|585787095|FG004|Overall Study|Death|0|||
162201270|NCT00043186|585787096|FG005|Overall Study|Death|0|||
162201271|NCT00043186|585787097|FG006|Overall Study|Death|2|||
162201272|NCT00043186|585787098|FG007|Overall Study|Death|0|||
162201273|NCT00043186|585787099|FG008|Overall Study|Death|0|||
162201274|NCT00043186|585787091|FG000|Overall Study|Disease progression|1|||
162201275|NCT00043186|585787092|FG001|Overall Study|Disease progression|0|||
162201276|NCT00043186|585787093|FG002|Overall Study|Disease progression|0|||
162201277|NCT00043186|585787094|FG003|Overall Study|Disease progression|3|||
162201278|NCT00043186|585787095|FG004|Overall Study|Disease progression|0|||
162201279|NCT00043186|585787096|FG005|Overall Study|Disease progression|0|||
162201280|NCT00043186|585787097|FG006|Overall Study|Disease progression|0|||
162201281|NCT00043186|585787098|FG007|Overall Study|Disease progression|4|||
162201282|NCT00043186|585787099|FG008|Overall Study|Disease progression|0|||
162201283|NCT00043186|585787091|FG000|Overall Study|Ineligibility determined|0|||
162201284|NCT00043186|585787092|FG001|Overall Study|Ineligibility determined|0|||
162201285|NCT00043186|585787093|FG002|Overall Study|Ineligibility determined|0|||
162201286|NCT00043186|585787094|FG003|Overall Study|Ineligibility determined|0|||
162201287|NCT00043186|585787095|FG004|Overall Study|Ineligibility determined|0|||
162201288|NCT00043186|585787096|FG005|Overall Study|Ineligibility determined|0|||
162201289|NCT00043186|585787097|FG006|Overall Study|Ineligibility determined|0|||
162201290|NCT00043186|585787098|FG007|Overall Study|Ineligibility determined|0|||
162201291|NCT00043186|585787099|FG008|Overall Study|Ineligibility determined|1|||
162201292|NCT00043186|585787091|FG000|Overall Study|Lost to Follow-up|3|||
162201293|NCT00043186|585787092|FG001|Overall Study|Lost to Follow-up|5|||
162201294|NCT00043186|585787093|FG002|Overall Study|Lost to Follow-up|1|||
162201295|NCT00043186|585787094|FG003|Overall Study|Lost to Follow-up|1|||
162201296|NCT00043186|585787095|FG004|Overall Study|Lost to Follow-up|1|||
162201297|NCT00043186|585787096|FG005|Overall Study|Lost to Follow-up|1|||
162201298|NCT00043186|585787097|FG006|Overall Study|Lost to Follow-up|1|||
162201299|NCT00043186|585787098|FG007|Overall Study|Lost to Follow-up|1|||
162201300|NCT00043186|585787099|FG008|Overall Study|Lost to Follow-up|2|||
162201301|NCT00043186|585787091|FG000|Overall Study|Noncompliance|0|||
162201302|NCT00043186|585787092|FG001|Overall Study|Noncompliance|0|||
162201303|NCT00043186|585787093|FG002|Overall Study|Noncompliance|1|||
162201304|NCT00043186|585787094|FG003|Overall Study|Noncompliance|1|||
162201305|NCT00043186|585787095|FG004|Overall Study|Noncompliance|0|||
162201306|NCT00043186|585787096|FG005|Overall Study|Noncompliance|0|||
162201307|NCT00043186|585787097|FG006|Overall Study|Noncompliance|0|||
162201308|NCT00043186|585787098|FG007|Overall Study|Noncompliance|0|||
162201309|NCT00043186|585787099|FG008|Overall Study|Noncompliance|0|||
162201310|NCT00043186|585787091|FG000|Overall Study|Other|0|||
162201311|NCT00043186|585787092|FG001|Overall Study|Other|0|||
162201312|NCT00043186|585787093|FG002|Overall Study|Other|1|||
161676736|NCT04854434|583870510|FG001|Overall Study|Other|1|||
161676737|NCT04854434|583870511|FG002|Overall Study|Other|0|||
161821944|NCT01320722|584389248|FG002|Overall Study|Did not Receive Intervention|1|||
162020886|NCT00265148|585132064|FG000|Overall Study|Physician Decision|1|||
162201313|NCT00043186|585787094|FG003|Overall Study|Other|1|||
162201314|NCT00043186|585787095|FG004|Overall Study|Other|0|||
162201315|NCT00043186|585787096|FG005|Overall Study|Other|0|||
162020887|NCT00265148|585132065|FG001|Overall Study|Physician Decision|0|||
162201316|NCT00043186|585787097|FG006|Overall Study|Other|0|||
162201317|NCT00043186|585787098|FG007|Overall Study|Other|0|||
162201318|NCT00043186|585787099|FG008|Overall Study|Other|0|||
162201319|NCT01350102|585787107|FG000|Overall Study|Adverse Event|0|||
162201320|NCT01350102|585787108|FG001|Overall Study|Adverse Event|0|||
162020888|NCT00265148|585132064|FG000|Overall Study|Increasing frailty|0|||
162201321|NCT01350102|585787109|FG002|Overall Study|Adverse Event|1|||
162201322|NCT01350102|585787110|FG003|Overall Study|Adverse Event|0|||
162201323|NCT00550771|585787111|FG000|Overall Study|Adverse Event|11|||
162201324|NCT00550771|585787112|FG001|Overall Study|Adverse Event|3|||
162201325|NCT00550771|585787111|FG000|Overall Study|Discontinued for study-related reasons|0|||
162201326|NCT00550771|585787112|FG001|Overall Study|Discontinued for study-related reasons|1|||
162020889|NCT00265148|585132065|FG001|Overall Study|Increasing frailty|1|||
162020890|NCT00265148|585132064|FG000|Overall Study|Subject chose to change of the dose|1|||
162201327|NCT00550771|585787111|FG000|Overall Study|Physician Decision|2|||
162201328|NCT00550771|585787112|FG001|Overall Study|Physician Decision|0|||
162201329|NCT00550771|585787111|FG000|Overall Study|Withdrawal by Subject|0|||
162201330|NCT00550771|585787112|FG001|Overall Study|Withdrawal by Subject|1|||
162201331|NCT00550771|585787111|FG000|Overall Study|Protocol Violation|4|||
162201332|NCT00550771|585787112|FG001|Overall Study|Protocol Violation|5|||
162201333|NCT03681353|585787115|FG000|Overall Study|Lost to Follow-up|2|||
162201334|NCT03681353|585787115|FG000|Overall Study|Withdrawal by Subject|3|||
162201335|NCT03681353|585787115|FG000|Overall Study|withdrawn by PI|2|||
162201336|NCT00726388|585787118|FG000|Overall Study|Withdrawal by Subject|5|||
162201337|NCT00726388|585787118|FG000|Overall Study|Adverse Event|3|||
162201338|NCT00726388|585787118|FG000|Overall Study|Lost to Follow-up|10|||
162201339|NCT00726388|585787118|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
162201340|NCT00726388|585787118|FG000|Overall Study|Other|5|||
162201341|NCT00726388|585787118|FG000|Overall Study|Enrolled, Not Treated|79|||
162201342|NCT01145417|585787122|FG000|Overall Study|Death|1|||
162201343|NCT01145417|585787123|FG001|Overall Study|Death|0|||
162201344|NCT01145417|585787122|FG000|Overall Study|Lost to Follow-up|2|||
162201345|NCT01145417|585787123|FG001|Overall Study|Lost to Follow-up|1|||
162201346|NCT01145417|585787122|FG000|Overall Study|Withdrawal by Subject|1|||
162201347|NCT01145417|585787123|FG001|Overall Study|Withdrawal by Subject|2|||
162201348|NCT01145417|585787122|FG000|Overall Study|Pregnancy|1|||
162201349|NCT01145417|585787123|FG001|Overall Study|Pregnancy|0|||
162201350|NCT01145417|585787122|FG000|Overall Study|Adverse Event|0|||
162201351|NCT01145417|585787123|FG001|Overall Study|Adverse Event|1|||
162201352|NCT01145417|585787122|FG000|Overall Study|Study terminated by sponsor|35|||
162201353|NCT01145417|585787123|FG001|Overall Study|Study terminated by sponsor|43|||
162201354|NCT01145417|585787122|FG000|Overall Study|Other|1|||
162201355|NCT01145417|585787123|FG001|Overall Study|Other|0|||
162201356|NCT01441583|585787124|FG000|Overall Study|Withdrawal by Subject|1|||
162201357|NCT01441583|585787125|FG001|Overall Study|Withdrawal by Subject|1|||
162201358|NCT01441583|585787126|FG002|Overall Study|Withdrawal by Subject|1|||
162201359|NCT01441583|585787124|FG000|Overall Study|Death|1|||
162201360|NCT01441583|585787125|FG001|Overall Study|Death|0|||
162201361|NCT01441583|585787126|FG002|Overall Study|Death|4|||
162201362|NCT01441583|585787124|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
162201363|NCT01441583|585787125|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
162201364|NCT01441583|585787126|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
162201365|NCT03275402|585787127|FG000|Overall Study|Death|17|||
162201366|NCT03275402|585787127|FG000|Overall Study|Study terminated by sponsor|21|||
162201367|NCT03275402|585787127|FG000|Overall Study|Withdrawal by Subject|1|||
162201368|NCT02469077|585787129|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
162201369|NCT02469077|585787130|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
162201370|NCT02469077|585787129|FG000|Post Randomization/Intervention Period|Relocated|1|||
162201371|NCT02469077|585787130|FG001|Post Randomization/Intervention Period|Relocated|1|||
162201372|NCT02469077|585787129|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
162201373|NCT02469077|585787130|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
162201374|NCT02469077|585787129|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
162201375|NCT02469077|585787130|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
162201376|NCT02973477|585787131|FG000|First Intervention|Lost to Follow-up|0|||
162201377|NCT02973477|585787132|FG001|First Intervention|Lost to Follow-up|2|||
162201378|NCT02973477|585787131|FG000|Washout|Withdrawal by Subject|1|||
162201379|NCT02973477|585787132|FG001|Washout|Withdrawal by Subject|0|||
162201380|NCT02973477|585787131|FG000|Second Intervention|Lost to Follow-up|1|||
162201381|NCT02973477|585787132|FG001|Second Intervention|Lost to Follow-up|0|||
162201382|NCT02720081|585787133|FG000|Overall Study|Adverse Event|0|||
162201383|NCT02720081|585787134|FG001|Overall Study|Adverse Event|3|||
162201384|NCT02720081|585787133|FG000|Overall Study|Protocol Violation|4|||
162201385|NCT02720081|585787134|FG001|Overall Study|Protocol Violation|1|||
162201386|NCT05012397|585787135|FG000|Overall Study|Death|10|||
162201387|NCT05012397|585787135|FG000|Overall Study|Physician Decision|9|||
162201388|NCT05012397|585787135|FG000|Overall Study|Withdrawal by Subject|5|||
162201389|NCT05012397|585787135|FG000|Overall Study|Lost to Follow-up|2|||
162201390|NCT03334747|585787136|FG000|Treatment Phase|Technical problems|0|||
162201391|NCT03334747|585787137|FG001|Treatment Phase|Technical problems|0|||
162201392|NCT03334747|585787138|FG002|Treatment Phase|Technical problems|0|||
162201393|NCT03334747|585787139|FG003|Treatment Phase|Technical problems|0|||
162201394|NCT03334747|585787140|FG004|Treatment Phase|Technical problems|1|||
162201395|NCT03334747|585787141|FG005|Treatment Phase|Technical problems|0|||
162201396|NCT03334747|585787142|FG006|Treatment Phase|Technical problems|0|||
162201397|NCT03334747|585787143|FG007|Treatment Phase|Technical problems|0|||
162201398|NCT03334747|585787144|FG008|Treatment Phase|Technical problems|0|||
162201399|NCT03334747|585787136|FG000|Treatment Phase|Subject/guardian decision|1|||
162201400|NCT03334747|585787137|FG001|Treatment Phase|Subject/guardian decision|0|||
162201401|NCT03334747|585787138|FG002|Treatment Phase|Subject/guardian decision|0|||
162201402|NCT03334747|585787139|FG003|Treatment Phase|Subject/guardian decision|0|||
162201403|NCT03334747|585787140|FG004|Treatment Phase|Subject/guardian decision|0|||
162201404|NCT03334747|585787141|FG005|Treatment Phase|Subject/guardian decision|1|||
162201405|NCT03334747|585787142|FG006|Treatment Phase|Subject/guardian decision|0|||
162201406|NCT03334747|585787143|FG007|Treatment Phase|Subject/guardian decision|0|||
162201407|NCT03334747|585787144|FG008|Treatment Phase|Subject/guardian decision|0|||
162201408|NCT03334747|585787136|FG000|Follow-Up Phase|Subject/guardian decision|0|||
162201409|NCT03334747|585787137|FG001|Follow-Up Phase|Subject/guardian decision|0|||
162201410|NCT03334747|585787138|FG002|Follow-Up Phase|Subject/guardian decision|0|||
162201411|NCT03334747|585787139|FG003|Follow-Up Phase|Subject/guardian decision|0|||
162201412|NCT03334747|585787140|FG004|Follow-Up Phase|Subject/guardian decision|0|||
162201413|NCT03334747|585787141|FG005|Follow-Up Phase|Subject/guardian decision|0|||
162201414|NCT03334747|585787142|FG006|Follow-Up Phase|Subject/guardian decision|1|||
162201415|NCT03334747|585787143|FG007|Follow-Up Phase|Subject/guardian decision|0|||
162201416|NCT03334747|585787144|FG008|Follow-Up Phase|Subject/guardian decision|1|||
162201417|NCT00191984|585787145|FG000|Overall Study|Disease Progression|21|||
162201418|NCT00191984|585787145|FG000|Overall Study|Adverse Event|4|||
162201419|NCT00191984|585787145|FG000|Overall Study|Death|2|||
162201420|NCT00191984|585787145|FG000|Overall Study|Entry Criteria Exclusion|1|||
162201421|NCT00191984|585787145|FG000|Overall Study|Withdrawal by Subject|7|||
162201422|NCT00191984|585787145|FG000|Overall Study|Physician Decision|4|||
162201423|NCT03303521|585787146|FG000|Overall Study|Withdrawal by Subject|2|||
162201424|NCT03303521|585787147|FG001|Overall Study|Withdrawal by Subject|0|||
162201425|NCT03303521|585787146|FG000|Overall Study|Death|1|||
162201426|NCT03303521|585787147|FG001|Overall Study|Death|0|||
162201427|NCT03303521|585787146|FG000|Overall Study|Kidney transplantation|0|||
162201428|NCT03303521|585787147|FG001|Overall Study|Kidney transplantation|1|||
162201429|NCT03303521|585787146|FG000|Overall Study|Investigational product discontinuation|0|||
162201430|NCT03303521|585787147|FG001|Overall Study|Investigational product discontinuation|1|||
162201431|NCT03303521|585787146|FG000|Overall Study|Transferred to non-study dialysis center|1|||
162201432|NCT03303521|585787147|FG001|Overall Study|Transferred to non-study dialysis center|0|||
162201433|NCT03303521|585787146|FG000|Overall Study|Non-comliance to study protocol|0|||
162201434|NCT03303521|585787147|FG001|Overall Study|Non-comliance to study protocol|1|||
162201435|NCT03303521|585787146|FG000|Overall Study|Adverse Event|1|||
162201436|NCT03303521|585787147|FG001|Overall Study|Adverse Event|0|||
162201437|NCT01654289|585787148|FG000|Overall Study|Withdrawal by Subject|10|||
162201438|NCT01654289|585787149|FG001|Overall Study|Withdrawal by Subject|8|||
162201439|NCT01654289|585787150|FG002|Overall Study|Withdrawal by Subject|5|||
162201440|NCT01654289|585787148|FG000|Overall Study|Withdrew from intervention only|17|||
162201441|NCT01654289|585787149|FG001|Overall Study|Withdrew from intervention only|20|||
162201442|NCT01654289|585787150|FG002|Overall Study|Withdrew from intervention only|0|||
162201443|NCT00005908|585787154|FG000|Overall Study|Withdrawal by Subject|1|||
162201444|NCT00005908|585787155|FG001|Overall Study|Withdrawal by Subject|0|||
162201445|NCT04748445|585787156|FG000|Overall Study|No longer met eligibility criteria|12|||
162201446|NCT04748445|585787156|FG000|Overall Study|Other|36|||
162201447|NCT04748445|585787156|FG000|Overall Study|Withdrawal by Subject|553|||
162201448|NCT04748445|585787156|FG000|Overall Study|Lost to Follow-up|30|||
162201449|NCT04736602|585787157|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
162201450|NCT04736602|585787157|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
162201451|NCT00938041|585787164|FG000|Overall Study|Lost to Follow-up|6|||
162201452|NCT00938041|585787164|FG000|Overall Study|Received Alternative Therapy|1|||
162201453|NCT00938041|585787164|FG000|Overall Study|Progressive Disease|5|||
162201454|NCT00938041|585787164|FG000|Overall Study|Death|12|||
162201455|NCT00938041|585787164|FG000|Overall Study|Adrenal Insufficiency|3|||
162201456|NCT03042559|585787165|FG000|Overall Study|drop out|1|||
162201457|NCT03042559|585787166|FG001|Overall Study|drop out|1|||
162201458|NCT01536535|585787170|FG000|Overall Study|Withdrawal by Subject|10|||
162201459|NCT01536535|585787171|FG001|Overall Study|Withdrawal by Subject|5|||
162201460|NCT01536535|585787170|FG000|Overall Study|Lost to Follow-up|4|||
162201461|NCT01536535|585787171|FG001|Overall Study|Lost to Follow-up|6|||
162201462|NCT01536535|585787170|FG000|Overall Study|Physician Decision|1|||
162201463|NCT01536535|585787171|FG001|Overall Study|Physician Decision|1|||
162201464|NCT01536535|585787170|FG000|Overall Study|Participant moved|0|||
162201465|NCT01536535|585787171|FG001|Overall Study|Participant moved|1|||
162201466|NCT00428441|585787172|FG000|Overall Study|Lost to Follow-up|1|||
162201467|NCT00404547|585787173|FG000|Overall Study|Adverse Event|39|||
162201468|NCT00404547|585787174|FG001|Overall Study|Adverse Event|6|||
162201469|NCT00404547|585787173|FG000|Overall Study|Withdrawal by Subject|19|||
162201470|NCT00404547|585787174|FG001|Overall Study|Withdrawal by Subject|2|||
162201471|NCT00404547|585787173|FG000|Overall Study|Protocol Violation|0|||
162201472|NCT00404547|585787174|FG001|Overall Study|Protocol Violation|1|||
162201473|NCT00404547|585787173|FG000|Overall Study|Lost to Follow-up|20|||
162201474|NCT00404547|585787174|FG001|Overall Study|Lost to Follow-up|9|||
162201475|NCT00404547|585787173|FG000|Overall Study|Lack of compliance|5|||
162201476|NCT00404547|585787174|FG001|Overall Study|Lack of compliance|1|||
162201477|NCT00404547|585787173|FG000|Overall Study|Other|4|||
162201478|NCT00404547|585787174|FG001|Overall Study|Other|0|||
162201479|NCT00404547|585787173|FG000|Overall Study|Reason not stated|3|||
162201480|NCT00404547|585787174|FG001|Overall Study|Reason not stated|6|||
162201481|NCT00125853|585787175|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
162201482|NCT00125853|585787176|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
162201483|NCT00157209|585787177|FG000|Overall Study|Ongoing at data cut-off|10|||
162201484|NCT00157209|585787178|FG001|Overall Study|Ongoing at data cut-off|0|||
162201485|NCT04474691|585787179|FG000|Overall Study|Withdrawal by Subject|9|||
162020891|NCT00265148|585132065|FG001|Overall Study|Subject chose to change of the dose|0|||
162020892|NCT03760731|585132070|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
162020893|NCT03760731|585132071|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
162020894|NCT03760731|585132070|FG000|Treatment|Attended less than 70% of sessions|10|||
162020895|NCT03760731|585132071|FG001|Treatment|Attended less than 70% of sessions|15|||
162020896|NCT01092546|585132072|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
162020897|NCT01970358|585132073|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
162020898|NCT01970358|585132073|FG000|Overall Study|Ineligible at time of second consent|4|||
162020899|NCT01667419|585132074|FG000|Overall Study|Reason Not Specified|1|||
162020900|NCT01667419|585132075|FG001|Overall Study|Reason Not Specified|0|||
162020901|NCT01667419|585132076|FG002|Overall Study|Reason Not Specified|0|||
162020902|NCT01667419|585132077|FG003|Overall Study|Reason Not Specified|0|||
162020903|NCT01667419|585132074|FG000|Overall Study|Withdrawal by Subject|16|||
162020904|NCT01667419|585132075|FG001|Overall Study|Withdrawal by Subject|8|||
162020905|NCT01667419|585132076|FG002|Overall Study|Withdrawal by Subject|9|||
162020906|NCT01667419|585132077|FG003|Overall Study|Withdrawal by Subject|8|||
162020907|NCT01667419|585132074|FG000|Overall Study|Non-compliance|0|||
162020908|NCT01667419|585132075|FG001|Overall Study|Non-compliance|0|||
162020909|NCT01667419|585132076|FG002|Overall Study|Non-compliance|0|||
162020910|NCT01667419|585132077|FG003|Overall Study|Non-compliance|1|||
162020911|NCT01667419|585132074|FG000|Overall Study|Protocol Violation|1|||
162020912|NCT01667419|585132075|FG001|Overall Study|Protocol Violation|0|||
162020913|NCT01667419|585132076|FG002|Overall Study|Protocol Violation|0|||
162020914|NCT01667419|585132077|FG003|Overall Study|Protocol Violation|0|||
162020915|NCT01667419|585132074|FG000|Overall Study|Lost to Follow-up|7|||
162020916|NCT01667419|585132075|FG001|Overall Study|Lost to Follow-up|6|||
162020917|NCT01667419|585132076|FG002|Overall Study|Lost to Follow-up|2|||
162020918|NCT01667419|585132077|FG003|Overall Study|Lost to Follow-up|4|||
162020919|NCT01667419|585132074|FG000|Overall Study|Death|18|||
162020920|NCT01667419|585132075|FG001|Overall Study|Death|33|||
162020921|NCT01667419|585132076|FG002|Overall Study|Death|25|||
162020922|NCT01667419|585132077|FG003|Overall Study|Death|26|||
162201486|NCT01348763|585787180|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
162201487|NCT01348763|585787180|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
162201488|NCT04372186|585787181|FG000|Overall Study|Death|24|||
162201489|NCT04372186|585787182|FG001|Overall Study|Death|11|||
162201490|NCT04372186|585787181|FG000|Overall Study|Transferred to a different facility for care|0|||
162201491|NCT04372186|585787182|FG001|Overall Study|Transferred to a different facility for care|2|||
162201492|NCT00577096|585787183|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
162201493|NCT00577096|585787184|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
162201494|NCT00577096|585787183|FG000|Short Term Participation|Withdrawal by Subject|3|||
162020923|NCT03869216|585132079|FG000|Overall Study|prostate removed during the study|1|||
162020924|NCT03869216|585132080|FG001|Overall Study|prostate removed during the study|1|||
162201495|NCT00577096|585787184|FG001|Short Term Participation|Withdrawal by Subject|5|||
162201496|NCT00577096|585787183|FG000|Short Term Participation|Death|1|||
162201497|NCT00577096|585787184|FG001|Short Term Participation|Death|1|||
162201498|NCT00832650|585787185|FG000|Overall Study|Randomized but not treated|0|||
162201499|NCT00832650|585787186|FG001|Overall Study|Randomized but not treated|0|||
162201500|NCT00832650|585787187|FG002|Overall Study|Randomized but not treated|1|||
161821945|NCT01320722|584389249|FG003|Overall Study|Did not Receive Intervention|1|||
161821946|NCT01320722|584389250|FG004|Overall Study|Did not Receive Intervention|2|||
162020925|NCT03869216|585132079|FG000|Overall Study|Withdrawal by Subject|0|||
162020926|NCT03869216|585132080|FG001|Overall Study|Withdrawal by Subject|1|||
162201501|NCT00440037|585787189|FG000|Overall Study|Withdrawal by Subject|6|||
162201502|NCT00440037|585787189|FG000|Overall Study|Administrative decision|3|||
162201503|NCT03740919|585787192|FG000|Lead-in Period|Lost to Follow-up|1|||
162201504|NCT03740919|585787193|FG001|Lead-in Period|Lost to Follow-up|0|||
162201505|NCT03740919|585787194|FG002|Lead-in Period|Lost to Follow-up|0|||
162201506|NCT03740919|585787195|FG003|Lead-in Period|Lost to Follow-up|0|||
162201507|NCT03740919|585787192|FG000|Lead-in Period|Physician Decision|2|||
162201508|NCT03740919|585787193|FG001|Lead-in Period|Physician Decision|0|||
162201509|NCT03740919|585787194|FG002|Lead-in Period|Physician Decision|0|||
162201510|NCT03740919|585787195|FG003|Lead-in Period|Physician Decision|0|||
162201511|NCT03740919|585787192|FG000|Lead-in Period|Protocol Violation|1|||
162201512|NCT03740919|585787193|FG001|Lead-in Period|Protocol Violation|0|||
162201513|NCT03740919|585787194|FG002|Lead-in Period|Protocol Violation|0|||
162201514|NCT03740919|585787195|FG003|Lead-in Period|Protocol Violation|0|||
162201515|NCT03740919|585787192|FG000|Lead-in Period|Withdrawal by Subject|10|||
162201516|NCT03740919|585787193|FG001|Lead-in Period|Withdrawal by Subject|0|||
162201517|NCT03740919|585787194|FG002|Lead-in Period|Withdrawal by Subject|0|||
162201518|NCT03740919|585787195|FG003|Lead-in Period|Withdrawal by Subject|0|||
162201519|NCT03740919|585787192|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
162201520|NCT03740919|585787193|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
162201521|NCT03740919|585787194|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
162201522|NCT03740919|585787195|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
162201523|NCT03740919|585787192|FG000|Lead-in Period|Study Task Too Burdensome|1|||
162201524|NCT03740919|585787193|FG001|Lead-in Period|Study Task Too Burdensome|0|||
162201525|NCT03740919|585787194|FG002|Lead-in Period|Study Task Too Burdensome|0|||
162201526|NCT03740919|585787195|FG003|Lead-in Period|Study Task Too Burdensome|0|||
162201527|NCT03740919|585787192|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
162201528|NCT03740919|585787193|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
162201529|NCT03740919|585787194|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
162201530|NCT03740919|585787195|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
162201531|NCT03740919|585787192|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
162201532|NCT03740919|585787193|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
162201533|NCT03740919|585787194|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
162201534|NCT03740919|585787195|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
162201535|NCT03740919|585787192|FG000|Treatment Period|Adverse Event|0|||
162201536|NCT03740919|585787193|FG001|Treatment Period|Adverse Event|0|||
162201537|NCT03740919|585787194|FG002|Treatment Period|Adverse Event|2|||
162201538|NCT03740919|585787195|FG003|Treatment Period|Adverse Event|0|||
162201539|NCT03740919|585787192|FG000|Treatment Period|Protocol Violation|0|||
162201540|NCT03740919|585787193|FG001|Treatment Period|Protocol Violation|1|||
162201541|NCT03740919|585787194|FG002|Treatment Period|Protocol Violation|0|||
161676738|NCT03349775|583870512|FG000|Overall Study|Side Effects|1|||
161676739|NCT03349775|583870513|FG001|Overall Study|Side Effects|2|||
161821947|NCT01320722|584389246|FG000|Overall Study|Lost to Follow-up|0|||
161821948|NCT01320722|584389247|FG001|Overall Study|Lost to Follow-up|1|||
161821949|NCT01320722|584389248|FG002|Overall Study|Lost to Follow-up|0|||
162201542|NCT03740919|585787195|FG003|Treatment Period|Protocol Violation|0|||
162201543|NCT03740919|585787192|FG000|Treatment Period|Withdrawal by Subject|0|||
162201544|NCT03740919|585787193|FG001|Treatment Period|Withdrawal by Subject|7|||
162201545|NCT03740919|585787194|FG002|Treatment Period|Withdrawal by Subject|6|||
162201546|NCT03740919|585787195|FG003|Treatment Period|Withdrawal by Subject|2|||
162201547|NCT03740919|585787192|FG000|Treatment Period|Terminated by Sponsor|0|||
161676740|NCT03349775|583870512|FG000|Overall Study|Withdrawal by Subject|1|||
161821950|NCT01320722|584389249|FG003|Overall Study|Lost to Follow-up|1|||
161821951|NCT01320722|584389250|FG004|Overall Study|Lost to Follow-up|3|||
161821952|NCT01320722|584389246|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
161821953|NCT01320722|584389247|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
161821954|NCT01320722|584389248|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
161821955|NCT01320722|584389249|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
161821956|NCT01320722|584389250|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
161821957|NCT01320722|584389246|FG000|Overall Study|Participant Developed a Rash|0|||
161821958|NCT01320722|584389247|FG001|Overall Study|Participant Developed a Rash|0|||
161821959|NCT01320722|584389248|FG002|Overall Study|Participant Developed a Rash|2|||
161821960|NCT01320722|584389249|FG003|Overall Study|Participant Developed a Rash|1|||
161821961|NCT01320722|584389250|FG004|Overall Study|Participant Developed a Rash|1|||
161821962|NCT01320722|584389246|FG000|Overall Study|Non-compliant with Medication|0|||
161821963|NCT01320722|584389247|FG001|Overall Study|Non-compliant with Medication|0|||
161821964|NCT01320722|584389248|FG002|Overall Study|Non-compliant with Medication|1|||
161821965|NCT01320722|584389249|FG003|Overall Study|Non-compliant with Medication|0|||
161821966|NCT01320722|584389250|FG004|Overall Study|Non-compliant with Medication|0|||
161821967|NCT01320722|584389246|FG000|Overall Study|Adverse Event|0|||
161821968|NCT01320722|584389247|FG001|Overall Study|Adverse Event|0|||
161821969|NCT01320722|584389248|FG002|Overall Study|Adverse Event|3|||
161821970|NCT01320722|584389249|FG003|Overall Study|Adverse Event|6|||
161821971|NCT01320722|584389250|FG004|Overall Study|Adverse Event|0|||
161821972|NCT01320722|584389246|FG000|Overall Study|Not Compliant with Study Procedures|0|||
161821973|NCT01320722|584389247|FG001|Overall Study|Not Compliant with Study Procedures|0|||
161821974|NCT01320722|584389248|FG002|Overall Study|Not Compliant with Study Procedures|0|||
161821975|NCT01320722|584389249|FG003|Overall Study|Not Compliant with Study Procedures|4|||
161821976|NCT01320722|584389250|FG004|Overall Study|Not Compliant with Study Procedures|0|||
161821977|NCT01320722|584389246|FG000|Overall Study|Pregnancy|0|||
161821978|NCT01320722|584389247|FG001|Overall Study|Pregnancy|0|||
161821979|NCT01320722|584389248|FG002|Overall Study|Pregnancy|0|||
161821980|NCT01320722|584389249|FG003|Overall Study|Pregnancy|1|||
161821981|NCT01320722|584389250|FG004|Overall Study|Pregnancy|0|||
161821982|NCT01320722|584389246|FG000|Overall Study|Started an Exclusionary Medication|0|||
162201548|NCT03740919|585787193|FG001|Treatment Period|Terminated by Sponsor|1|||
162201549|NCT03740919|585787194|FG002|Treatment Period|Terminated by Sponsor|0|||
162201550|NCT03740919|585787195|FG003|Treatment Period|Terminated by Sponsor|0|||
162201551|NCT03740919|585787192|FG000|Treatment Period|Issue with Insulin Pump|0|||
162201552|NCT03740919|585787193|FG001|Treatment Period|Issue with Insulin Pump|1|||
162201553|NCT03740919|585787194|FG002|Treatment Period|Issue with Insulin Pump|0|||
162201554|NCT03740919|585787195|FG003|Treatment Period|Issue with Insulin Pump|0|||
162201555|NCT03740919|585787192|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
162201556|NCT03740919|585787193|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
162201557|NCT03740919|585787194|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
162201558|NCT03740919|585787195|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
162201559|NCT03740919|585787192|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
162201560|NCT03740919|585787193|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
162201561|NCT03740919|585787194|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
162201562|NCT03740919|585787195|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
162201563|NCT03740919|585787192|FG000|Treatment Period|Not Completing Diary|0|||
162201564|NCT03740919|585787193|FG001|Treatment Period|Not Completing Diary|0|||
162201565|NCT03740919|585787194|FG002|Treatment Period|Not Completing Diary|1|||
162201566|NCT03740919|585787195|FG003|Treatment Period|Not Completing Diary|0|||
162201567|NCT03740919|585787192|FG000|Treatment Period|Insulin Painful to Participant|0|||
162201568|NCT03740919|585787193|FG001|Treatment Period|Insulin Painful to Participant|0|||
162201569|NCT03740919|585787194|FG002|Treatment Period|Insulin Painful to Participant|1|||
162201570|NCT03740919|585787195|FG003|Treatment Period|Insulin Painful to Participant|0|||
162201571|NCT01911819|585787198|FG000|Overall Study|Adverse Event|0|||
162201572|NCT01911819|585787199|FG001|Overall Study|Adverse Event|1|||
162201573|NCT01911819|585787200|FG002|Overall Study|Adverse Event|0|||
162201574|NCT01911819|585787198|FG000|Overall Study|Withdrawal by Subject|1|||
162201575|NCT01911819|585787199|FG001|Overall Study|Withdrawal by Subject|1|||
162201576|NCT01911819|585787200|FG002|Overall Study|Withdrawal by Subject|0|||
162201577|NCT01207453|585787203|FG000|First Intervention|Adverse Event|2|||
162201578|NCT01207453|585787204|FG001|First Intervention|Adverse Event|1|||
162201579|NCT01207453|585787203|FG000|Washout|Adverse Event|1|||
162201580|NCT01207453|585787204|FG001|Washout|Adverse Event|0|||
162201581|NCT01207453|585787203|FG000|Washout|Lost to Follow-up|1|||
162201582|NCT01207453|585787204|FG001|Washout|Lost to Follow-up|0|||
162201583|NCT01207453|585787203|FG000|2nd Intervention|Adverse Event|1|||
162201584|NCT01207453|585787204|FG001|2nd Intervention|Adverse Event|2|||
162201585|NCT01207453|585787203|FG000|2nd Intervention|Lost to Follow-up|1|||
162201586|NCT01207453|585787204|FG001|2nd Intervention|Lost to Follow-up|0|||
162201587|NCT04374253|585787207|FG000|Overall Study|Adverse Event|0|||
162201588|NCT04374253|585787208|FG001|Overall Study|Adverse Event|26|||
162201589|NCT04374253|585787209|FG002|Overall Study|Adverse Event|2|||
162201590|NCT04374253|585787210|FG003|Overall Study|Adverse Event|12|||
162201591|NCT04374253|585787207|FG000|Overall Study|Study terminated by sponsor|13|||
162201592|NCT04374253|585787208|FG001|Overall Study|Study terminated by sponsor|593|||
162201593|NCT04374253|585787209|FG002|Overall Study|Study terminated by sponsor|21|||
162201594|NCT04374253|585787210|FG003|Overall Study|Study terminated by sponsor|567|||
162201595|NCT04374253|585787207|FG000|Overall Study|Withdrawal by Subject|0|||
162201596|NCT04374253|585787208|FG001|Overall Study|Withdrawal by Subject|55|||
162201597|NCT04374253|585787209|FG002|Overall Study|Withdrawal by Subject|3|||
162201598|NCT04374253|585787210|FG003|Overall Study|Withdrawal by Subject|40|||
162201599|NCT04374253|585787207|FG000|Overall Study|Physician Decision|1|||
162201600|NCT04374253|585787208|FG001|Overall Study|Physician Decision|10|||
162201601|NCT04374253|585787209|FG002|Overall Study|Physician Decision|1|||
162201602|NCT04374253|585787210|FG003|Overall Study|Physician Decision|10|||
162201603|NCT04374253|585787207|FG000|Overall Study|Protocol Violation|0|||
162201604|NCT04374253|585787208|FG001|Overall Study|Protocol Violation|0|||
162201605|NCT04374253|585787209|FG002|Overall Study|Protocol Violation|0|||
162201606|NCT04374253|585787210|FG003|Overall Study|Protocol Violation|2|||
162201607|NCT04374253|585787207|FG000|Overall Study|Death|0|||
162201608|NCT04374253|585787208|FG001|Overall Study|Death|3|||
162201609|NCT04374253|585787209|FG002|Overall Study|Death|1|||
162201610|NCT04374253|585787210|FG003|Overall Study|Death|1|||
162201611|NCT04374253|585787207|FG000|Overall Study|Lack of Efficacy|0|||
161821983|NCT01320722|584389247|FG001|Overall Study|Started an Exclusionary Medication|0|||
161821984|NCT01320722|584389248|FG002|Overall Study|Started an Exclusionary Medication|0|||
161821985|NCT01320722|584389249|FG003|Overall Study|Started an Exclusionary Medication|0|||
161821986|NCT01320722|584389250|FG004|Overall Study|Started an Exclusionary Medication|1|||
161821987|NCT01320722|584389246|FG000|Overall Study|Withdrew due to Health Condition|0|||
162020927|NCT03869216|585132079|FG000|Overall Study|Lost to Follow-up|3|||
162201612|NCT04374253|585787208|FG001|Overall Study|Lack of Efficacy|0|||
162201613|NCT04374253|585787209|FG002|Overall Study|Lack of Efficacy|0|||
162201614|NCT04374253|585787210|FG003|Overall Study|Lack of Efficacy|1|||
162201615|NCT04374253|585787207|FG000|Overall Study|Lost to Follow-up|1|||
162201616|NCT04374253|585787208|FG001|Overall Study|Lost to Follow-up|1|||
162201617|NCT04374253|585787209|FG002|Overall Study|Lost to Follow-up|0|||
162201618|NCT04374253|585787210|FG003|Overall Study|Lost to Follow-up|2|||
162201619|NCT04374253|585787207|FG000|Overall Study|Reason Not Specified|0|||
162201620|NCT04374253|585787208|FG001|Overall Study|Reason Not Specified|8|||
162201621|NCT04374253|585787209|FG002|Overall Study|Reason Not Specified|0|||
162201622|NCT04374253|585787210|FG003|Overall Study|Reason Not Specified|8|||
162201623|NCT02329223|585788744|FG000|Overall Study|Withdrawal by Subject|1|||
162201624|NCT02329223|585788745|FG001|Overall Study|Withdrawal by Subject|2|||
162201625|NCT02329223|585788746|FG002|Overall Study|Withdrawal by Subject|5|||
162201626|NCT02329223|585788744|FG000|Overall Study|Physician Decision|0|||
162201627|NCT02329223|585788745|FG001|Overall Study|Physician Decision|0|||
162201628|NCT02329223|585788746|FG002|Overall Study|Physician Decision|1|||
162201629|NCT02329223|585788744|FG000|Overall Study|Adverse Event|0|||
162201630|NCT02329223|585788745|FG001|Overall Study|Adverse Event|1|||
162201631|NCT02329223|585788746|FG002|Overall Study|Adverse Event|0|||
162201632|NCT02720185|585788749|FG000|Overall Study|Lost to Follow-up|1|||
162201633|NCT02507687|585788750|FG000|Overall Study|Adverse Event|3|||
162201634|NCT02507687|585788751|FG001|Overall Study|Adverse Event|2|||
162201635|NCT02507687|585788752|FG002|Overall Study|Adverse Event|2|||
162201636|NCT02507687|585788753|FG003|Overall Study|Adverse Event|2|||
162201637|NCT02507687|585788750|FG000|Overall Study|Withdrawal by Subject|1|||
162201638|NCT02507687|585788751|FG001|Overall Study|Withdrawal by Subject|4|||
162201639|NCT02507687|585788752|FG002|Overall Study|Withdrawal by Subject|6|||
162201640|NCT02507687|585788753|FG003|Overall Study|Withdrawal by Subject|6|||
162201641|NCT02507687|585788750|FG000|Overall Study|Protocol Violation|1|||
162201642|NCT02507687|585788751|FG001|Overall Study|Protocol Violation|0|||
162201643|NCT02507687|585788752|FG002|Overall Study|Protocol Violation|2|||
162201644|NCT02507687|585788753|FG003|Overall Study|Protocol Violation|0|||
162201645|NCT02507687|585788750|FG000|Overall Study|Lost to Follow-up|0|||
162201646|NCT02507687|585788751|FG001|Overall Study|Lost to Follow-up|0|||
162201647|NCT02507687|585788752|FG002|Overall Study|Lost to Follow-up|2|||
162201648|NCT02507687|585788753|FG003|Overall Study|Lost to Follow-up|1|||
162201649|NCT02507687|585788750|FG000|Overall Study|Screen Failure|0|||
162201650|NCT02507687|585788751|FG001|Overall Study|Screen Failure|0|||
162201651|NCT02507687|585788752|FG002|Overall Study|Screen Failure|1|||
162201652|NCT02507687|585788753|FG003|Overall Study|Screen Failure|0|||
162201653|NCT02507687|585788750|FG000|Overall Study|Other, Not Specified|0|||
162201654|NCT02507687|585788751|FG001|Overall Study|Other, Not Specified|0|||
162201655|NCT02507687|585788752|FG002|Overall Study|Other, Not Specified|2|||
162201656|NCT02507687|585788753|FG003|Overall Study|Other, Not Specified|4|||
162201657|NCT00275301|585788754|FG000|Overall Study|Adverse Event|5|||
162201658|NCT01503515|585788755|FG000|Overall Study|Adverse Event|4|||
162201659|NCT01503515|585788756|FG001|Overall Study|Adverse Event|5|||
162201660|NCT01503515|585788755|FG000|Overall Study|Death|0|||
161676741|NCT03349775|583870513|FG001|Overall Study|Withdrawal by Subject|1|||
161676742|NCT03349775|583870512|FG000|Overall Study|No primary outcome measurements|0|||
161676743|NCT03349775|583870513|FG001|Overall Study|No primary outcome measurements|1|||
161676744|NCT04479436|583870518|FG000|Overall Study|Progressive disease|26|||
161676745|NCT04479436|583870519|FG001|Overall Study|Progressive disease|1|||
161676746|NCT04479436|583870518|FG000|Overall Study|Adverse Event|6|||
161676747|NCT04479436|583870519|FG001|Overall Study|Adverse Event|0|||
161676748|NCT04479436|583870518|FG000|Overall Study|Withdrawal by Subject|5|||
161676749|NCT04479436|583870519|FG001|Overall Study|Withdrawal by Subject|0|||
161676750|NCT04479436|583870518|FG000|Overall Study|Clinical progression|1|||
161676751|NCT04479436|583870519|FG001|Overall Study|Clinical progression|0|||
161676752|NCT04479436|583870518|FG000|Overall Study|Physician Decision|1|||
161676753|NCT04479436|583870519|FG001|Overall Study|Physician Decision|0|||
161676754|NCT03383289|583870527|FG000|Overall Study|Death|83|||
161676755|NCT03383289|583870528|FG001|Overall Study|Death|78|||
162201661|NCT01503515|585788756|FG001|Overall Study|Death|1|||
162201662|NCT01503515|585788755|FG000|Overall Study|Physician Decision|14|||
162201663|NCT01503515|585788756|FG001|Overall Study|Physician Decision|23|||
162201664|NCT01503515|585788755|FG000|Overall Study|Withdrawal by Subject|0|||
161676756|NCT03383289|583870527|FG000|Overall Study|discharge from facility|84|||
161676757|NCT03383289|583870528|FG001|Overall Study|discharge from facility|84|||
161676758|NCT03383289|583870527|FG000|Overall Study|Withdrawal by Subject|4|||
161676759|NCT03383289|583870528|FG001|Overall Study|Withdrawal by Subject|1|||
162201665|NCT01503515|585788756|FG001|Overall Study|Withdrawal by Subject|1|||
162201666|NCT01503515|585788755|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
162201667|NCT01503515|585788756|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
162201668|NCT01503515|585788755|FG000|Overall Study|Ineligible|1|||
162201669|NCT01503515|585788756|FG001|Overall Study|Ineligible|1|||
161821988|NCT01320722|584389247|FG001|Overall Study|Withdrew due to Health Condition|0|||
161821989|NCT01320722|584389248|FG002|Overall Study|Withdrew due to Health Condition|0|||
161821990|NCT01320722|584389249|FG003|Overall Study|Withdrew due to Health Condition|0|||
161821991|NCT01320722|584389250|FG004|Overall Study|Withdrew due to Health Condition|1|||
161821992|NCT01091363|584389251|FG000|Overall Study|Withdrawal by Subject|11|||
161821993|NCT01091363|584389252|FG001|Overall Study|Withdrawal by Subject|15|||
162201670|NCT00520403|585788759|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
162201671|NCT00520403|585788759|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
162201672|NCT00520403|585788759|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
162201673|NCT00520403|585788759|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
162201674|NCT00520403|585788759|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
162201675|NCT00520403|585788759|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
162201676|NCT00520403|585788759|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
162201677|NCT00520403|585788759|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
162201678|NCT01797562|585788760|FG000|Overall Study|Protocol Violation|5|||
162201679|NCT00917462|585788763|FG000|Overall Study|Clinical Deterioration|1|||
162201680|NCT03341312|585788764|FG000|Period 1|Withdrawal by Subject|0|||
162201681|NCT03341312|585788765|FG001|Period 1|Withdrawal by Subject|1|||
162201682|NCT03341312|585788766|FG002|Period 1|Withdrawal by Subject|0|||
162201683|NCT03341312|585788767|FG003|Period 1|Withdrawal by Subject|0|||
162201684|NCT00744796|585788768|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
162201685|NCT05372913|585788772|FG000|Overall Study|Withdrawal by Subject|0|||
162201686|NCT05372913|585788773|FG001|Overall Study|Withdrawal by Subject|2|||
162201687|NCT05372913|585788772|FG000|Overall Study|Protocol Violation|2|||
162201688|NCT05372913|585788773|FG001|Overall Study|Protocol Violation|2|||
162201689|NCT05372913|585788772|FG000|Overall Study|Adverse Event|0|||
162201690|NCT05372913|585788773|FG001|Overall Study|Adverse Event|1|||
162201691|NCT05135156|585788777|FG000|Overall Study|Lost to Follow-up|0|||
162201692|NCT05135156|585788778|FG001|Overall Study|Lost to Follow-up|0|||
162201693|NCT05135156|585788779|FG002|Overall Study|Lost to Follow-up|2|||
162201694|NCT01379521|585788780|FG000|Overall Study -Treatment Period|Adverse Event|3|||
162201695|NCT01379521|585788781|FG001|Overall Study -Treatment Period|Adverse Event|0|||
162201696|NCT01379521|585788780|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
162201697|NCT01379521|585788781|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
162201698|NCT01379521|585788780|FG000|Overall Study -Treatment Period|Disease Progression|23|||
162201699|NCT01379521|585788781|FG001|Overall Study -Treatment Period|Disease Progression|22|||
162201700|NCT01379521|585788780|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
162201701|NCT01379521|585788781|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
162201702|NCT01379521|585788780|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
162201703|NCT01379521|585788781|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
162201704|NCT01379521|585788780|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
162201705|NCT01379521|585788781|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
162201706|NCT01379521|585788780|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
162201707|NCT01379521|585788781|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
162201708|NCT01379521|585788780|FG000|Overall Study -Treatment Period|Death|2|||
162201709|NCT01379521|585788781|FG001|Overall Study -Treatment Period|Death|1|||
162201710|NCT01379521|585788780|FG000|Post-Treatment Evaluations|Disease Progression|22|||
162201711|NCT01379521|585788781|FG001|Post-Treatment Evaluations|Disease Progression|20|||
162201712|NCT01379521|585788780|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
162201713|NCT01379521|585788781|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
162201714|NCT01379521|585788780|FG000|Post-Treatment Evaluations|Death|1|||
162201715|NCT01379521|585788781|FG001|Post-Treatment Evaluations|Death|0|||
162201716|NCT02538471|585788784|FG000|Overall Study|Progression of disease|2|||
162201717|NCT00475735|585788785|FG000|Treatment Period 1|Adverse Event|2|||
162201718|NCT00475735|585788786|FG001|Treatment Period 1|Adverse Event|0|||
162201719|NCT00475735|585788787|FG002|Treatment Period 1|Adverse Event|0|||
162201720|NCT00475735|585788788|FG003|Treatment Period 1|Adverse Event|0|||
162201721|NCT00475735|585788789|FG004|Treatment Period 1|Adverse Event|0|||
162201722|NCT00475735|585788790|FG005|Treatment Period 1|Adverse Event|0|||
162201723|NCT00475735|585788785|FG000|Treatment Period 1|Lack of Efficacy|1|||
162201724|NCT00475735|585788786|FG001|Treatment Period 1|Lack of Efficacy|0|||
162201725|NCT00475735|585788787|FG002|Treatment Period 1|Lack of Efficacy|0|||
162201726|NCT00475735|585788788|FG003|Treatment Period 1|Lack of Efficacy|0|||
162201727|NCT00475735|585788789|FG004|Treatment Period 1|Lack of Efficacy|0|||
162020928|NCT03869216|585132080|FG001|Overall Study|Lost to Follow-up|12|||
162201728|NCT00475735|585788790|FG005|Treatment Period 1|Lack of Efficacy|0|||
162201729|NCT00475735|585788785|FG000|Treatment Period 1|Lost to Follow-up|0|||
162201730|NCT00475735|585788786|FG001|Treatment Period 1|Lost to Follow-up|0|||
162201731|NCT00475735|585788787|FG002|Treatment Period 1|Lost to Follow-up|0|||
162201732|NCT00475735|585788788|FG003|Treatment Period 1|Lost to Follow-up|0|||
162201733|NCT00475735|585788789|FG004|Treatment Period 1|Lost to Follow-up|0|||
162201734|NCT00475735|585788790|FG005|Treatment Period 1|Lost to Follow-up|1|||
162201735|NCT00475735|585788785|FG000|Treatment Period 1|Protocol Violation|0|||
162201736|NCT00475735|585788786|FG001|Treatment Period 1|Protocol Violation|0|||
162201737|NCT00475735|585788787|FG002|Treatment Period 1|Protocol Violation|0|||
162201738|NCT00475735|585788788|FG003|Treatment Period 1|Protocol Violation|1|||
162201739|NCT00475735|585788789|FG004|Treatment Period 1|Protocol Violation|0|||
162201740|NCT00475735|585788790|FG005|Treatment Period 1|Protocol Violation|0|||
162201741|NCT00475735|585788785|FG000|Treatment Period 1|Withdrawal by Subject|1|||
162201742|NCT00475735|585788786|FG001|Treatment Period 1|Withdrawal by Subject|1|||
162201743|NCT00475735|585788787|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162201744|NCT00475735|585788788|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162201745|NCT00475735|585788789|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162201746|NCT00475735|585788790|FG005|Treatment Period 1|Withdrawal by Subject|0|||
162201747|NCT00475735|585788785|FG000|Treatment Period 1|DC due to AE but continuing|0|||
162201748|NCT00475735|585788786|FG001|Treatment Period 1|DC due to AE but continuing|0|||
162201749|NCT00475735|585788787|FG002|Treatment Period 1|DC due to AE but continuing|0|||
162201750|NCT00475735|585788788|FG003|Treatment Period 1|DC due to AE but continuing|1|||
162201751|NCT00475735|585788789|FG004|Treatment Period 1|DC due to AE but continuing|2|||
162201752|NCT00475735|585788790|FG005|Treatment Period 1|DC due to AE but continuing|2|||
162201753|NCT00475735|585788785|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
162201754|NCT00475735|585788786|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
162201755|NCT00475735|585788787|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
162201756|NCT00475735|585788788|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
162201757|NCT00475735|585788789|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
162201758|NCT00475735|585788790|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
162201759|NCT00475735|585788785|FG000|Treatment Washout|Lost to Follow-up|0|||
162201760|NCT00475735|585788786|FG001|Treatment Washout|Lost to Follow-up|1|||
162201761|NCT00475735|585788787|FG002|Treatment Washout|Lost to Follow-up|0|||
162201762|NCT00475735|585788788|FG003|Treatment Washout|Lost to Follow-up|0|||
162201763|NCT00475735|585788789|FG004|Treatment Washout|Lost to Follow-up|0|||
162201764|NCT00475735|585788790|FG005|Treatment Washout|Lost to Follow-up|0|||
162201765|NCT00475735|585788785|FG000|Treatment Washout|Protocol Violation|0|||
162201766|NCT00475735|585788786|FG001|Treatment Washout|Protocol Violation|1|||
162201767|NCT00475735|585788787|FG002|Treatment Washout|Protocol Violation|0|||
162201768|NCT00475735|585788788|FG003|Treatment Washout|Protocol Violation|0|||
162201769|NCT00475735|585788789|FG004|Treatment Washout|Protocol Violation|0|||
162201770|NCT00475735|585788790|FG005|Treatment Washout|Protocol Violation|0|||
162201771|NCT00475735|585788785|FG000|Treatment Period 2|Adverse Event|0|||
162201772|NCT00475735|585788786|FG001|Treatment Period 2|Adverse Event|1|||
162201773|NCT00475735|585788787|FG002|Treatment Period 2|Adverse Event|0|||
162201774|NCT00475735|585788788|FG003|Treatment Period 2|Adverse Event|2|||
162201775|NCT00475735|585788789|FG004|Treatment Period 2|Adverse Event|0|||
162201776|NCT00475735|585788790|FG005|Treatment Period 2|Adverse Event|0|||
162201777|NCT00475735|585788785|FG000|Treatment Period 2|Lack of Efficacy|0|||
162201778|NCT00475735|585788786|FG001|Treatment Period 2|Lack of Efficacy|0|||
162201779|NCT00475735|585788787|FG002|Treatment Period 2|Lack of Efficacy|0|||
162201780|NCT00475735|585788788|FG003|Treatment Period 2|Lack of Efficacy|0|||
162201781|NCT00475735|585788789|FG004|Treatment Period 2|Lack of Efficacy|0|||
162201782|NCT00475735|585788790|FG005|Treatment Period 2|Lack of Efficacy|1|||
162201783|NCT00475735|585788785|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162201784|NCT00475735|585788786|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162201785|NCT00475735|585788787|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162201786|NCT00475735|585788788|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161821994|NCT01091363|584389251|FG000|Overall Study|Lost to Follow-up|2|||
161821995|NCT01091363|584389252|FG001|Overall Study|Lost to Follow-up|2|||
161821996|NCT00160524|584389253|FG000|Overall Study|Adverse Event|119|||
161821997|NCT00160524|584389253|FG000|Overall Study|Adverse Event and Other|94|||
161821998|NCT00160524|584389253|FG000|Overall Study|Protocol Violation|16|||
161821999|NCT00160524|584389253|FG000|Overall Study|Protocol Violation and Other|2|||
161822000|NCT00160524|584389253|FG000|Overall Study|Withdrawal by Subject|141|||
161822001|NCT00160524|584389253|FG000|Overall Study|Withdrawal by Subject and Other|17|||
161822002|NCT00160524|584389253|FG000|Overall Study|Physician Decision|27|||
162201787|NCT00475735|585788789|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161822003|NCT00160524|584389253|FG000|Overall Study|Physician Decision and Other|6|||
161822004|NCT00160524|584389253|FG000|Overall Study|Lost to Follow-up|13|||
162201788|NCT00475735|585788790|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162201789|NCT01187407|585788791|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
162201790|NCT01187407|585788792|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162201791|NCT01187407|585788793|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162201792|NCT01187407|585788794|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161822005|NCT00160524|584389253|FG000|Overall Study|Lost to Follow-up and Other|1|||
161822006|NCT00160524|584389253|FG000|Overall Study|Lack of Efficacy|21|||
162201793|NCT01187407|585788795|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
162201794|NCT01187407|585788791|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
162201795|NCT01187407|585788792|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162201796|NCT01187407|585788793|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162201797|NCT01187407|585788794|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162201798|NCT01187407|585788795|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
162201799|NCT01187407|585788791|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
162201800|NCT01187407|585788792|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162201801|NCT01187407|585788793|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162201802|NCT01187407|585788794|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162201803|NCT01187407|585788795|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
162201804|NCT01187407|585788791|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
162201805|NCT01187407|585788792|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162201806|NCT01187407|585788793|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162201807|NCT01187407|585788794|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162201808|NCT01187407|585788795|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
162201809|NCT01187407|585788791|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
162201810|NCT01187407|585788792|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162201811|NCT01187407|585788793|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162201812|NCT01187407|585788794|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162201813|NCT01187407|585788795|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
162201814|NCT01187407|585788791|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
162201815|NCT01187407|585788792|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162201816|NCT01187407|585788793|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162201817|NCT01187407|585788794|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162201818|NCT01187407|585788795|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
162201819|NCT01187407|585788791|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
162201820|NCT01187407|585788792|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162201821|NCT01187407|585788793|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162201822|NCT01187407|585788794|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162201823|NCT01187407|585788795|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
162201824|NCT01187407|585788791|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
162201825|NCT01187407|585788792|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
162201826|NCT01187407|585788793|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
162201827|NCT01187407|585788794|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
162201828|NCT01187407|585788795|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
162201829|NCT01187407|585788791|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
162201830|NCT01187407|585788792|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
162201831|NCT01187407|585788793|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
162201832|NCT01187407|585788794|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
162201833|NCT01187407|585788795|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
162201834|NCT01187407|585788791|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
162201835|NCT01187407|585788792|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
162201836|NCT01187407|585788793|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
162201837|NCT01187407|585788794|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
162201838|NCT01187407|585788795|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
162201839|NCT01187407|585788791|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
162201840|NCT01187407|585788792|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
162201841|NCT01187407|585788793|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
162201842|NCT01187407|585788794|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
162201843|NCT01187407|585788795|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
161928618|NCT01748552|584787760|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
161928619|NCT01748552|584787761|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
161928620|NCT01748552|584787762|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
161928621|NCT01748552|584787751|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928622|NCT01748552|584787752|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928623|NCT01748552|584787753|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928624|NCT01748552|584787754|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928625|NCT01748552|584787755|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928626|NCT01748552|584787756|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928627|NCT01748552|584787757|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
161928628|NCT01748552|584787758|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
161928629|NCT01748552|584787759|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
161928630|NCT01748552|584787760|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
162201844|NCT01187407|585788791|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
162201845|NCT01187407|585788792|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
162201846|NCT01187407|585788793|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
162201847|NCT01187407|585788794|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
162201848|NCT01187407|585788795|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
162201849|NCT01187407|585788791|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
162201850|NCT01187407|585788792|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
162201851|NCT01187407|585788793|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
162201852|NCT01187407|585788794|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
162201853|NCT01187407|585788795|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
162201854|NCT01187407|585788791|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
162201855|NCT01187407|585788792|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
162201856|NCT01187407|585788793|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
162201857|NCT01187407|585788794|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
162201858|NCT01187407|585788795|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
162201859|NCT02382406|585788798|FG000|Study Treatment|Disease Progression|8|||
162201860|NCT02382406|585788799|FG001|Study Treatment|Disease Progression|0|||
162201861|NCT02382406|585788800|FG002|Study Treatment|Disease Progression|20|||
162201862|NCT02382406|585788798|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
162201863|NCT02382406|585788799|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
162201864|NCT02382406|585788800|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
162201865|NCT02382406|585788798|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
162201866|NCT02382406|585788799|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
162201867|NCT02382406|585788800|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
162201868|NCT02382406|585788798|FG000|Study Treatment|symptomatic deterioration|1|||
162201869|NCT02382406|585788799|FG001|Study Treatment|symptomatic deterioration|0|||
162201870|NCT02382406|585788800|FG002|Study Treatment|symptomatic deterioration|1|||
162201871|NCT02382406|585788798|FG000|Study Treatment|Death|0|||
162201872|NCT02382406|585788799|FG001|Study Treatment|Death|0|||
162201873|NCT02382406|585788800|FG002|Study Treatment|Death|2|||
162201874|NCT02382406|585788798|FG000|Follow up|Death|11|||
162201875|NCT02382406|585788799|FG001|Follow up|Death|0|||
162201876|NCT02382406|585788800|FG002|Follow up|Death|19|||
162201877|NCT02382406|585788798|FG000|Follow up|Symptomatic deterioration|1|||
162201878|NCT02382406|585788799|FG001|Follow up|Symptomatic deterioration|0|||
162201879|NCT02382406|585788800|FG002|Follow up|Symptomatic deterioration|1|||
162201880|NCT02382406|585788798|FG000|Follow up|Patient Refused Follow-up|1|||
162201881|NCT02382406|585788799|FG001|Follow up|Patient Refused Follow-up|0|||
162201882|NCT02382406|585788800|FG002|Follow up|Patient Refused Follow-up|0|||
162201883|NCT02382406|585788798|FG000|Follow up|Study Terminated|1|||
162201884|NCT02382406|585788799|FG001|Follow up|Study Terminated|0|||
162201885|NCT02382406|585788800|FG002|Follow up|Study Terminated|8|||
162201886|NCT02382406|585788798|FG000|Follow up|Withdrawal by Subject|0|||
162201887|NCT02382406|585788799|FG001|Follow up|Withdrawal by Subject|0|||
162201888|NCT02382406|585788800|FG002|Follow up|Withdrawal by Subject|2|||
162201889|NCT01713998|585788801|FG000|Overall Study|Lost to Follow-up|2|||
162201890|NCT01713998|585788802|FG001|Overall Study|Lost to Follow-up|0|||
162201891|NCT01713998|585788803|FG002|Overall Study|Lost to Follow-up|2|||
162201892|NCT01713998|585788801|FG000|Overall Study|Withdrawal by Subject|1|||
162201893|NCT01713998|585788802|FG001|Overall Study|Withdrawal by Subject|0|||
162201894|NCT01713998|585788803|FG002|Overall Study|Withdrawal by Subject|0|||
162201895|NCT02350127|585788804|FG000|4-Month Assessment|Withdrawal by Subject|10|||
162201896|NCT02350127|585788805|FG001|4-Month Assessment|Withdrawal by Subject|9|||
162201897|NCT02350127|585788804|FG000|4-Month Assessment|Death|1|||
162201898|NCT02350127|585788805|FG001|4-Month Assessment|Death|0|||
162201899|NCT02350127|585788804|FG000|8-Month Assessment|Death|1|||
162201900|NCT02350127|585788805|FG001|8-Month Assessment|Death|1|||
162201901|NCT02350127|585788804|FG000|8-Month Assessment|Withdrawal by Subject|5|||
161676760|NCT04439071|583870529|FG000|Overall Study|Lost to Follow-up|0|||
162201902|NCT02350127|585788805|FG001|8-Month Assessment|Withdrawal by Subject|8|||
162201903|NCT00050167|585788817|FG000|Overall Study|not eligible not invasive|1|||
162201904|NCT00050167|585788818|FG001|Overall Study|not eligible not invasive|1|||
162201905|NCT01363297|585788819|FG000|Overall Study|Other|0|||
162201906|NCT01363297|585788820|FG001|Overall Study|Other|0|||
162201907|NCT01363297|585788821|FG002|Overall Study|Other|0|||
162201908|NCT01363297|585788822|FG003|Overall Study|Other|0|||
162201909|NCT01363297|585788823|FG004|Overall Study|Other|1|||
162201910|NCT01363297|585788819|FG000|Overall Study|Death|3|||
162020929|NCT03869216|585132079|FG000|Overall Study|Changed clinical site or moved out of city|5|||
162020930|NCT03869216|585132080|FG001|Overall Study|Changed clinical site or moved out of city|9|||
162020931|NCT03869216|585132079|FG000|Overall Study|No primary care appointment scheduled|10|||
162020932|NCT03869216|585132080|FG001|Overall Study|No primary care appointment scheduled|4|||
162020933|NCT03869216|585132079|FG000|Overall Study|Death|1|||
162020934|NCT03869216|585132080|FG001|Overall Study|Death|1|||
162020935|NCT03646123|585132081|FG000|Overall Study|Withdrawal by Subject|2|||
162020936|NCT03646123|585132082|FG001|Overall Study|Withdrawal by Subject|2|||
162020937|NCT03646123|585132083|FG002|Overall Study|Withdrawal by Subject|3|||
162020938|NCT03646123|585132081|FG000|Overall Study|Study termination by sponsor|0|||
162020939|NCT03646123|585132082|FG001|Overall Study|Study termination by sponsor|45|||
162020940|NCT03646123|585132083|FG002|Overall Study|Study termination by sponsor|139|||
162020941|NCT03646123|585132081|FG000|Overall Study|Lost to Follow-up|4|||
162020942|NCT03646123|585132082|FG001|Overall Study|Lost to Follow-up|10|||
162020943|NCT03646123|585132083|FG002|Overall Study|Lost to Follow-up|10|||
162020944|NCT03646123|585132081|FG000|Overall Study|Death|2|||
162020945|NCT03646123|585132082|FG001|Overall Study|Death|1|||
162020946|NCT03646123|585132083|FG002|Overall Study|Death|1|||
162020947|NCT03646123|585132081|FG000|Overall Study|Other|2|||
162020948|NCT03646123|585132082|FG001|Overall Study|Other|0|||
162020949|NCT03646123|585132083|FG002|Overall Study|Other|2|||
162020950|NCT01068600|585132084|FG000|Overall Study|Withdrawal by Subject|5|||
162020951|NCT01068600|585132085|FG001|Overall Study|Withdrawal by Subject|6|||
162020952|NCT01068600|585132084|FG000|Overall Study|Adverse Event|3|||
162020953|NCT01068600|585132085|FG001|Overall Study|Adverse Event|3|||
162020954|NCT01068600|585132084|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162020955|NCT01068600|585132085|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162020956|NCT01068600|585132084|FG000|Overall Study|Lost to Follow-up|1|||
162020957|NCT01068600|585132085|FG001|Overall Study|Lost to Follow-up|2|||
162020958|NCT01068600|585132084|FG000|Overall Study|Protocol deviation|1|||
162020959|NCT01068600|585132085|FG001|Overall Study|Protocol deviation|1|||
162020960|NCT01068600|585132084|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162020961|NCT01068600|585132085|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
162020962|NCT01068600|585132084|FG000|Overall Study|Administrative problems|0|||
162020963|NCT01068600|585132085|FG001|Overall Study|Administrative problems|1|||
162020964|NCT01519869|585132086|FG000|Overall Study|Lost to Follow-up|1|||
162020965|NCT04075734|585132087|FG000|Overall Study|Lost to Follow-up|1|||
162020966|NCT04075734|585132088|FG001|Overall Study|Lost to Follow-up|1|||
162020967|NCT04075734|585132089|FG002|Overall Study|Lost to Follow-up|0|||
162020968|NCT04075734|585132087|FG000|Overall Study|Withdrawal by Subject|3|||
162020969|NCT04075734|585132088|FG001|Overall Study|Withdrawal by Subject|0|||
162020970|NCT04075734|585132089|FG002|Overall Study|Withdrawal by Subject|0|||
162020971|NCT02433080|585132091|FG000|Overall Study|Lost to Follow-up|1|||
162020972|NCT02433080|585132092|FG001|Overall Study|Lost to Follow-up|2|||
162020973|NCT02433080|585132091|FG000|Overall Study|Withdrawal by Subject|0|||
162201911|NCT01363297|585788820|FG001|Overall Study|Death|6|||
162201912|NCT01363297|585788821|FG002|Overall Study|Death|6|||
162201913|NCT01363297|585788822|FG003|Overall Study|Death|10|||
162201914|NCT01363297|585788823|FG004|Overall Study|Death|30|||
162201915|NCT02038803|585788827|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
162201916|NCT02038803|585788827|FG000|Overall Study|Lost to Follow-up|1|||
162201917|NCT04754594|585788828|FG000|Blinded Period|Withdrawal by Subject|4|||
162201918|NCT04754594|585788829|FG001|Blinded Period|Withdrawal by Subject|9|||
162201919|NCT04754594|585788830|FG002|Blinded Period|Withdrawal by Subject|0|||
162201920|NCT04754594|585788831|FG003|Blinded Period|Withdrawal by Subject|0|||
162201921|NCT04754594|585788828|FG000|Blinded Period|Protocol Violation|2|||
162201922|NCT04754594|585788829|FG001|Blinded Period|Protocol Violation|2|||
162201923|NCT04754594|585788830|FG002|Blinded Period|Protocol Violation|0|||
162201924|NCT04754594|585788831|FG003|Blinded Period|Protocol Violation|0|||
162020974|NCT02433080|585132092|FG001|Overall Study|Withdrawal by Subject|2|||
162020975|NCT02367833|585132094|FG000|Overall Study|Withdrawal by Subject|1|||
162020976|NCT02367833|585132095|FG001|Overall Study|Withdrawal by Subject|1|||
162020977|NCT02367833|585132096|FG002|Overall Study|Withdrawal by Subject|0|||
162020978|NCT02167139|585132097|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
162201925|NCT04754594|585788828|FG000|Blinded Period|Lost to Follow-up|1|||
162201926|NCT04754594|585788829|FG001|Blinded Period|Lost to Follow-up|1|||
162020979|NCT02167139|585132098|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
162201927|NCT04754594|585788830|FG002|Blinded Period|Lost to Follow-up|0|||
162020980|NCT02167139|585132099|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
162201928|NCT04754594|585788831|FG003|Blinded Period|Lost to Follow-up|0|||
162201929|NCT04754594|585788828|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
162201930|NCT04754594|585788829|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
162201931|NCT04754594|585788830|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
162201932|NCT04754594|585788831|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
162201933|NCT04754594|585788828|FG000|Unblinded Period|Withdrawal by Subject|6|||
162201934|NCT04754594|585788829|FG001|Unblinded Period|Withdrawal by Subject|8|||
162201935|NCT04754594|585788830|FG002|Unblinded Period|Withdrawal by Subject|0|||
162201936|NCT04754594|585788831|FG003|Unblinded Period|Withdrawal by Subject|0|||
162201937|NCT04754594|585788828|FG000|Unblinded Period|Lost to Follow-up|5|||
162201938|NCT04754594|585788829|FG001|Unblinded Period|Lost to Follow-up|3|||
162201939|NCT04754594|585788830|FG002|Unblinded Period|Lost to Follow-up|0|||
162201940|NCT04754594|585788831|FG003|Unblinded Period|Lost to Follow-up|0|||
162201941|NCT04754594|585788828|FG000|Unblinded Period|Protocol Violation|2|||
162201942|NCT04754594|585788829|FG001|Unblinded Period|Protocol Violation|4|||
162201943|NCT04754594|585788830|FG002|Unblinded Period|Protocol Violation|0|||
162201944|NCT04754594|585788831|FG003|Unblinded Period|Protocol Violation|0|||
162201945|NCT04754594|585788828|FG000|Unblinded Period|Other|3|||
162201946|NCT04754594|585788829|FG001|Unblinded Period|Other|0|||
162201947|NCT04754594|585788830|FG002|Unblinded Period|Other|0|||
162201948|NCT04754594|585788831|FG003|Unblinded Period|Other|0|||
162201949|NCT04754594|585788828|FG000|Infant Participants|Withdrawal by Subject|0|||
162201950|NCT04754594|585788829|FG001|Infant Participants|Withdrawal by Subject|0|||
162201951|NCT04754594|585788830|FG002|Infant Participants|Withdrawal by Subject|9|||
162201952|NCT04754594|585788831|FG003|Infant Participants|Withdrawal by Subject|17|||
162201953|NCT04754594|585788828|FG000|Infant Participants|Lost to Follow-up|0|||
162201954|NCT04754594|585788829|FG001|Infant Participants|Lost to Follow-up|0|||
162201955|NCT04754594|585788830|FG002|Infant Participants|Lost to Follow-up|4|||
162201956|NCT04754594|585788831|FG003|Infant Participants|Lost to Follow-up|10|||
162201957|NCT04754594|585788828|FG000|Infant Participants|Death|0|||
162201958|NCT04754594|585788829|FG001|Infant Participants|Death|0|||
162201959|NCT04754594|585788830|FG002|Infant Participants|Death|1|||
162201960|NCT04754594|585788831|FG003|Infant Participants|Death|1|||
162201961|NCT04754594|585788828|FG000|Infant Participants|Other|0|||
162201962|NCT04754594|585788829|FG001|Infant Participants|Other|0|||
162201963|NCT04754594|585788830|FG002|Infant Participants|Other|1|||
161928631|NCT01748552|584787761|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928632|NCT01748552|584787762|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161928633|NCT01386645|584787765|FG000|Overall Study|Physician Decision|0|||
161928634|NCT01386645|584787766|FG001|Overall Study|Physician Decision|0|||
161928635|NCT01386645|584787767|FG002|Overall Study|Physician Decision|1|||
161928636|NCT01386645|584787765|FG000|Overall Study|Withdrawal by Subject|0|||
161928637|NCT01386645|584787766|FG001|Overall Study|Withdrawal by Subject|1|||
161928638|NCT01386645|584787767|FG002|Overall Study|Withdrawal by Subject|1|||
161928639|NCT00527748|584787780|FG000|Overall Study|Other|3|||
161928640|NCT01160744|584787781|FG000|Overall Study|Withdrawal by Subject|11|||
161928641|NCT01160744|584787782|FG001|Overall Study|Withdrawal by Subject|5|||
161928642|NCT01160744|584787783|FG002|Overall Study|Withdrawal by Subject|6|||
161928643|NCT01160744|584787784|FG003|Overall Study|Withdrawal by Subject|4|||
161928644|NCT01160744|584787781|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
161928645|NCT01160744|584787782|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
161928646|NCT01160744|584787783|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
161928647|NCT01160744|584787784|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
161928648|NCT01502072|584787785|FG000|Overall Study|Withdrawal by Subject|1|||
161928649|NCT01502072|584787786|FG001|Overall Study|Withdrawal by Subject|0|||
161928650|NCT01502072|584787787|FG002|Overall Study|Withdrawal by Subject|0|||
161928651|NCT01502072|584787785|FG000|Overall Study|Death|0|||
161928652|NCT01502072|584787786|FG001|Overall Study|Death|1|||
161928653|NCT01502072|584787787|FG002|Overall Study|Death|0|||
162020981|NCT02167139|585132100|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
162201964|NCT04754594|585788831|FG003|Infant Participants|Other|1|||
162201965|NCT01247922|585788832|FG000|Overall Study|Disease progression|4|||
162201966|NCT02116582|585788833|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
162201967|NCT02116582|585788833|FG000|Overall Study|Adverse Event|22|||
162201968|NCT02116582|585788833|FG000|Overall Study|Death|9|||
162201969|NCT02116582|585788833|FG000|Overall Study|Progressive Disease|148|||
162201970|NCT02116582|585788833|FG000|Overall Study|Protocol Violation|3|||
161928654|NCT04821245|584787788|FG000|Overall Study|Withdrawal by Subject|3|||
161928655|NCT04821245|584787788|FG000|Overall Study|Physician Decision|1|||
161928656|NCT04821245|584787788|FG000|Overall Study|Protocol Violation|5|||
162201971|NCT02116582|585788833|FG000|Overall Study|Withdrawal by Subject|8|||
162201972|NCT02116582|585788833|FG000|Overall Study|Other: Miscellaneous|11|||
161928657|NCT02773537|584787796|FG000|Overall Study|Lost to Follow-up|0|||
161928658|NCT02773537|584787797|FG001|Overall Study|Lost to Follow-up|1|||
161676761|NCT04439071|583870530|FG001|Overall Study|Lost to Follow-up|3|||
161676762|NCT04439071|583870529|FG000|Overall Study|Withdrawal by Subject|3|||
162201973|NCT02116582|585788833|FG000|Overall Study|Lost to Follow-up|1|||
162201974|NCT02116582|585788833|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
162201975|NCT01876823|585788834|FG000|Overall Study|Withdrawal by Subject|5|||
162201976|NCT01876823|585788834|FG000|Overall Study|Physician Decision|2|||
162201977|NCT01876823|585788834|FG000|Overall Study|Patients moved|2|||
162201978|NCT00794573|585788839|FG000|Overall Study|Death|3|||
162201979|NCT00794573|585788840|FG001|Overall Study|Death|0|||
162201980|NCT00794573|585788839|FG000|Overall Study|Withdrawal by Subject|9|||
162201981|NCT00794573|585788840|FG001|Overall Study|Withdrawal by Subject|12|||
162201982|NCT00794573|585788839|FG000|Overall Study|Lost to Follow-up|26|||
162201983|NCT00794573|585788840|FG001|Overall Study|Lost to Follow-up|33|||
162201984|NCT03356145|585788841|FG000|Overall Study|Withdrawal by Subject|2|||
162201985|NCT03356145|585788842|FG001|Overall Study|Withdrawal by Subject|1|||
162201986|NCT03356145|585788841|FG000|Overall Study|Did not meet inclusion criteria|1|||
162201987|NCT03356145|585788842|FG001|Overall Study|Did not meet inclusion criteria|0|||
162201988|NCT00905255|585788845|FG000|Overall Study|Adverse Event|7|||
162201989|NCT00905255|585788846|FG001|Overall Study|Adverse Event|5|||
162201990|NCT00905255|585788845|FG000|Overall Study|Withdrawal by Subject|5|||
162201991|NCT00905255|585788846|FG001|Overall Study|Withdrawal by Subject|4|||
162201992|NCT00905255|585788845|FG000|Overall Study|Familial and Personal Reasons|1|||
162201993|NCT00905255|585788846|FG001|Overall Study|Familial and Personal Reasons|0|||
162201994|NCT01774929|585788847|FG000|Overall Study|Adverse Event|3|||
162201995|NCT02418819|585788851|FG000|Overall Study|Adverse Event|0|||
162201996|NCT02418819|585788852|FG001|Overall Study|Adverse Event|0|||
162201997|NCT02418819|585788853|FG002|Overall Study|Adverse Event|1|||
162201998|NCT02418819|585788854|FG003|Overall Study|Adverse Event|0|||
162201999|NCT02418819|585788851|FG000|Overall Study|Lost to Follow-up|1|||
162202000|NCT02418819|585788852|FG001|Overall Study|Lost to Follow-up|0|||
161676763|NCT04439071|583870530|FG001|Overall Study|Withdrawal by Subject|8|||
161676764|NCT04439071|583870529|FG000|Overall Study|Death|6|||
162202001|NCT02418819|585788853|FG002|Overall Study|Lost to Follow-up|0|||
162202002|NCT02418819|585788854|FG003|Overall Study|Lost to Follow-up|0|||
162202003|NCT02418819|585788851|FG000|Overall Study|No longer meets eligibility criteria|0|||
162202004|NCT02418819|585788852|FG001|Overall Study|No longer meets eligibility criteria|0|||
162202005|NCT02418819|585788853|FG002|Overall Study|No longer meets eligibility criteria|1|||
162202006|NCT02418819|585788854|FG003|Overall Study|No longer meets eligibility criteria|0|||
162202007|NCT02418819|585788851|FG000|Overall Study|No longer willing to participate|0|||
162202008|NCT02418819|585788852|FG001|Overall Study|No longer willing to participate|0|||
162202009|NCT02418819|585788853|FG002|Overall Study|No longer willing to participate|2|||
162202010|NCT02418819|585788854|FG003|Overall Study|No longer willing to participate|1|||
162202011|NCT01332318|585788858|FG000|Overall Study|Adverse Event|0|||
162202012|NCT01332318|585788859|FG001|Overall Study|Adverse Event|3|||
162202013|NCT01332318|585788860|FG002|Overall Study|Adverse Event|0|||
162202014|NCT01332318|585788861|FG003|Overall Study|Adverse Event|0|||
162202015|NCT01332318|585788858|FG000|Overall Study|Withdrawal by Subject|1|||
162202016|NCT01332318|585788859|FG001|Overall Study|Withdrawal by Subject|1|||
162202017|NCT01332318|585788860|FG002|Overall Study|Withdrawal by Subject|0|||
162202018|NCT01332318|585788861|FG003|Overall Study|Withdrawal by Subject|1|||
162202019|NCT01332318|585788858|FG000|Overall Study|Protocol Violation|1|||
162202020|NCT01332318|585788859|FG001|Overall Study|Protocol Violation|0|||
161676765|NCT04439071|583870530|FG001|Overall Study|Death|4|||
162202021|NCT01332318|585788860|FG002|Overall Study|Protocol Violation|1|||
161676766|NCT04439071|583870529|FG000|Overall Study|Other than specified|3|||
161676767|NCT04439071|583870530|FG001|Overall Study|Other than specified|3|||
161676768|NCT04439071|583870529|FG000|Overall Study|Randomized but not treated|2|||
161676769|NCT04439071|583870530|FG001|Overall Study|Randomized but not treated|0|||
162202022|NCT01332318|585788861|FG003|Overall Study|Protocol Violation|1|||
162202023|NCT02040532|585788862|FG000|Overall Study|Lost to Follow-up|1|||
162202024|NCT02040532|585788862|FG000|Overall Study|Physician Decision|4|||
162202025|NCT02040532|585788862|FG000|Overall Study|Adverse Event|4|||
162202026|NCT02040532|585788862|FG000|Overall Study|Withdrawal by Subject|3|||
162202027|NCT04382053|585788865|FG000|Overall Study|Death|6|||
162202028|NCT04382053|585788866|FG001|Overall Study|Death|8|||
162202029|NCT04382053|585788865|FG000|Overall Study|Lost to Follow-up|0|||
161676770|NCT00832117|583870531|FG000|Overall Study|Death|1|||
162020982|NCT02167139|585132097|FG000|Randomised, Double-blind|Adverse Event|2|||
162020983|NCT02167139|585132098|FG001|Randomised, Double-blind|Adverse Event|9|||
162202030|NCT04382053|585788866|FG001|Overall Study|Lost to Follow-up|2|||
162202031|NCT04382053|585788865|FG000|Overall Study|Protocol Deviation|1|||
162202032|NCT04382053|585788866|FG001|Overall Study|Protocol Deviation|2|||
162202033|NCT04382053|585788865|FG000|Overall Study|Withdrawal by Subject|2|||
162202034|NCT04382053|585788866|FG001|Overall Study|Withdrawal by Subject|1|||
162202035|NCT01399905|585788869|FG000|Overall Study|Withdrawal by Subject|1|||
162202036|NCT01399905|585788870|FG001|Overall Study|Withdrawal by Subject|1|||
162202037|NCT01786551|585788874|FG000|Overall Study|Participant withdrew consent|2|||
161676771|NCT00832117|583870531|FG000|Overall Study|Disease Progression|11|||
161676772|NCT00892177|583870532|FG000|Phase II|Ineligible|0|||
161676773|NCT00892177|583870533|FG001|Phase II|Ineligible|0|||
161676774|NCT00892177|583870534|FG002|Phase II|Ineligible|0|||
161676775|NCT00892177|583870535|FG003|Phase II|Ineligible|0|||
161676776|NCT00892177|583870536|FG004|Phase II|Ineligible|1|||
161676777|NCT00892177|583870537|FG005|Phase II|Ineligible|1|||
161676778|NCT00892177|583870532|FG000|Phase II|Withdrawal by Subject|0|||
161676779|NCT00892177|583870533|FG001|Phase II|Withdrawal by Subject|0|||
161676780|NCT00892177|583870534|FG002|Phase II|Withdrawal by Subject|0|||
161676781|NCT00892177|583870535|FG003|Phase II|Withdrawal by Subject|0|||
161676782|NCT00892177|583870536|FG004|Phase II|Withdrawal by Subject|4|||
161676783|NCT00892177|583870537|FG005|Phase II|Withdrawal by Subject|1|||
161676784|NCT01835015|583870542|FG000|Overall Study|Adverse Event|0|||
161676785|NCT01835015|583870543|FG001|Overall Study|Adverse Event|0|||
161676786|NCT01835015|583870544|FG002|Overall Study|Adverse Event|1|||
161676787|NCT01835015|583870545|FG003|Overall Study|Adverse Event|0|||
161676788|NCT01835015|583870546|FG004|Overall Study|Adverse Event|0|||
161676789|NCT00975715|583870550|FG000|Titration Period|Adverse Event|6|||
161676790|NCT00975715|583870551|FG001|Titration Period|Adverse Event|0|||
161676791|NCT00975715|583870550|FG000|Titration Period|Protocol Violation|1|||
161676792|NCT00975715|583870551|FG001|Titration Period|Protocol Violation|0|||
161676793|NCT00975715|583870550|FG000|Maintenance Period|Adverse Event|2|||
161676794|NCT00975715|583870551|FG001|Maintenance Period|Adverse Event|1|||
161676795|NCT01241552|583870555|FG000|Overall Study|Lack of Efficacy|1|||
161676796|NCT01241552|583870556|FG001|Overall Study|Lack of Efficacy|0|||
161676797|NCT01241552|583870557|FG002|Overall Study|Lack of Efficacy|0|||
161676798|NCT01241552|583870558|FG003|Overall Study|Lack of Efficacy|0|||
161676799|NCT01241552|583870555|FG000|Overall Study|Death|26|||
162202038|NCT01945086|585788875|FG000|Overall Study|Withdrawal by Subject|1|||
162202039|NCT01945086|585788876|FG001|Overall Study|Withdrawal by Subject|0|||
162202040|NCT01945086|585788877|FG002|Overall Study|Withdrawal by Subject|1|||
162202041|NCT01945086|585788875|FG000|Overall Study|Adverse Event|0|||
162202042|NCT01945086|585788876|FG001|Overall Study|Adverse Event|0|||
162202043|NCT01945086|585788877|FG002|Overall Study|Adverse Event|1|||
162202044|NCT01524887|585788880|FG000|Overall Study|Withdrawal by Subject|6|||
162202045|NCT01524887|585788881|FG001|Overall Study|Withdrawal by Subject|2|||
162202046|NCT01524887|585788882|FG002|Overall Study|Withdrawal by Subject|3|||
162202047|NCT01524887|585788880|FG000|Overall Study|Adverse Event|5|||
162202048|NCT01524887|585788881|FG001|Overall Study|Adverse Event|1|||
162202049|NCT01524887|585788882|FG002|Overall Study|Adverse Event|1|||
162202050|NCT01524887|585788880|FG000|Overall Study|Protocol Violation|0|||
162202051|NCT01524887|585788881|FG001|Overall Study|Protocol Violation|0|||
162202052|NCT01524887|585788882|FG002|Overall Study|Protocol Violation|1|||
162202053|NCT01524887|585788880|FG000|Overall Study|Study termination|73|||
162202054|NCT01524887|585788881|FG001|Overall Study|Study termination|87|||
162202055|NCT01524887|585788882|FG002|Overall Study|Study termination|79|||
162202056|NCT01524887|585788880|FG000|Overall Study|Withdrawal by Caregiver|0|||
162202057|NCT01524887|585788881|FG001|Overall Study|Withdrawal by Caregiver|0|||
162202058|NCT01524887|585788882|FG002|Overall Study|Withdrawal by Caregiver|2|||
162202059|NCT01524887|585788880|FG000|Overall Study|Use of prohibited medication|1|||
162202060|NCT01524887|585788881|FG001|Overall Study|Use of prohibited medication|0|||
162202061|NCT01524887|585788882|FG002|Overall Study|Use of prohibited medication|0|||
162202062|NCT01808144|585788883|FG000|Overall Study|Death|1|||
162202063|NCT01808144|585788884|FG001|Overall Study|Death|0|||
161676800|NCT01241552|583870556|FG001|Overall Study|Death|30|||
162020984|NCT02167139|585132099|FG002|Randomised, Double-blind|Adverse Event|0|||
162020985|NCT02167139|585132100|FG003|Randomised, Double-blind|Adverse Event|0|||
162020986|NCT02167139|585132097|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
162020987|NCT02167139|585132098|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
162020988|NCT02167139|585132099|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
162020989|NCT02167139|585132100|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
162202064|NCT01808144|585788883|FG000|Overall Study|Withdrawal by Subject|16|||
161676801|NCT01241552|583870557|FG002|Overall Study|Death|20|||
161676802|NCT01241552|583870558|FG003|Overall Study|Death|25|||
161676803|NCT01241552|583870555|FG000|Overall Study|Adverse Event|1|||
161822007|NCT00160524|584389253|FG000|Overall Study|Lack of Efficacy and Other|1|||
162020990|NCT02167139|585132097|FG000|Randomised, Double-blind|Other|3|||
162202065|NCT01808144|585788884|FG001|Overall Study|Withdrawal by Subject|23|||
162202066|NCT01808144|585788883|FG000|Overall Study|Lost to Follow-up|6|||
162202067|NCT01808144|585788884|FG001|Overall Study|Lost to Follow-up|3|||
162202068|NCT01808144|585788883|FG000|Overall Study|Protocol Violation|6|||
161676804|NCT01241552|583870556|FG001|Overall Study|Adverse Event|1|||
161676805|NCT01241552|583870557|FG002|Overall Study|Adverse Event|0|||
161676806|NCT01241552|583870558|FG003|Overall Study|Adverse Event|0|||
161676807|NCT01241552|583870555|FG000|Overall Study|Technical Problems|2|||
161676808|NCT01241552|583870556|FG001|Overall Study|Technical Problems|0|||
161676809|NCT01241552|583870557|FG002|Overall Study|Technical Problems|2|||
162202069|NCT01808144|585788884|FG001|Overall Study|Protocol Violation|6|||
162202070|NCT01808144|585788883|FG000|Overall Study|Gout flare|0|||
161676810|NCT01241552|583870558|FG003|Overall Study|Technical Problems|2|||
162202071|NCT01808144|585788884|FG001|Overall Study|Gout flare|1|||
162202072|NCT01808144|585788883|FG000|Overall Study|Adverse Event|11|||
162202073|NCT01808144|585788884|FG001|Overall Study|Adverse Event|15|||
162202074|NCT03993054|585788885|FG000|Overall Study|PI Decision|1|||
162202075|NCT00383500|585788886|FG000|Overall Study|Withdrawal by Subject|8|||
162202076|NCT00383500|585788887|FG001|Overall Study|Withdrawal by Subject|3|||
162202077|NCT00383500|585788888|FG002|Overall Study|Withdrawal by Subject|0|||
162202078|NCT00383500|585788886|FG000|Overall Study|Lost to Follow-up|0|||
162202079|NCT00383500|585788887|FG001|Overall Study|Lost to Follow-up|0|||
162202080|NCT00383500|585788888|FG002|Overall Study|Lost to Follow-up|2|||
162202081|NCT02093897|585790867|FG000|Overall Study|Physician Decision|1|||
162202082|NCT02093897|585790867|FG000|Overall Study|Planned age group closure - no's reached|17|||
162202083|NCT02093897|585790867|FG000|Overall Study|Adverse event, non-fatal|1|||
162202084|NCT02972242|585790868|FG000|Overall Study|Withdrawal by Subject|1|||
162202085|NCT02972242|585790869|FG001|Overall Study|Withdrawal by Subject|0|||
162202086|NCT04572997|585790873|FG000|Overall Study|Adverse Event|1|||
162202087|NCT03098797|585790874|FG000|Part 2 Open Label Extension|Adverse Event|2|||
162202088|NCT03098797|585790875|FG001|Part 2 Open Label Extension|Adverse Event|0|||
162202089|NCT02956278|585790876|FG000|Overall Study|Withdrawal by Subject|6|||
162202090|NCT02956278|585790877|FG001|Overall Study|Withdrawal by Subject|2|||
162202091|NCT02956278|585790878|FG002|Overall Study|Withdrawal by Subject|0|||
162202092|NCT01967719|585790879|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
162202093|NCT01967719|585790880|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
162202094|NCT01967719|585790881|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
162202095|NCT01967719|585790882|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
162202096|NCT01967719|585790879|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
162202097|NCT01967719|585790880|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
162202098|NCT01967719|585790881|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
162202099|NCT01967719|585790882|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
161676811|NCT01241552|583870555|FG000|Overall Study|Progressive Disease|0|||
161676812|NCT01241552|583870556|FG001|Overall Study|Progressive Disease|0|||
161676813|NCT01241552|583870557|FG002|Overall Study|Progressive Disease|1|||
161676814|NCT01241552|583870558|FG003|Overall Study|Progressive Disease|2|||
161676815|NCT01241552|583870555|FG000|Overall Study|Protocol Violation|0|||
161676816|NCT01241552|583870556|FG001|Overall Study|Protocol Violation|2|||
161676817|NCT01241552|583870557|FG002|Overall Study|Protocol Violation|6|||
161928659|NCT02773537|584787798|FG002|Overall Study|Lost to Follow-up|4|||
161928660|NCT01840163|584787799|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
161928661|NCT01840163|584787800|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
161928662|NCT01840163|584787799|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
162202100|NCT04357964|585790889|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
162202101|NCT04357964|585790890|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
162202102|NCT04357964|585790889|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
162202103|NCT04357964|585790890|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
162202104|NCT04357964|585790889|FG000|Overall Study|Adipose sample was insufficient quality|0|||
162202105|NCT04357964|585790890|FG001|Overall Study|Adipose sample was insufficient quality|1|||
162202106|NCT00733226|585790891|FG000|Overall Study|Withdrawal by Subject|1|||
162202107|NCT00733226|585790892|FG001|Overall Study|Withdrawal by Subject|0|||
162202108|NCT00733226|585790891|FG000|Overall Study|Lost to Follow-up|2|||
162202109|NCT00733226|585790892|FG001|Overall Study|Lost to Follow-up|0|||
162202110|NCT00733226|585790891|FG000|Overall Study|moved to another place|2|||
162202111|NCT00733226|585790892|FG001|Overall Study|moved to another place|0|||
162202112|NCT00848393|585790895|FG000|Overall Study|Protocol Violation|0|||
162202113|NCT00848393|585790896|FG001|Overall Study|Protocol Violation|0|||
162202114|NCT00848393|585790897|FG002|Overall Study|Protocol Violation|1|||
162202115|NCT00848393|585790895|FG000|Overall Study|surgical complications unrelated to stud|0|||
162202116|NCT00848393|585790896|FG001|Overall Study|surgical complications unrelated to stud|0|||
161676818|NCT01241552|583870558|FG003|Overall Study|Protocol Violation|1|||
161676819|NCT01241552|583870555|FG000|Overall Study|Withdrawal by Subject|7|||
161676820|NCT01241552|583870556|FG001|Overall Study|Withdrawal by Subject|15|||
161928663|NCT01840163|584787800|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
161928664|NCT01840163|584787799|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
161676821|NCT01241552|583870557|FG002|Overall Study|Withdrawal by Subject|14|||
161676822|NCT01241552|583870558|FG003|Overall Study|Withdrawal by Subject|15|||
161928665|NCT01840163|584787800|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
162202117|NCT00848393|585790897|FG002|Overall Study|surgical complications unrelated to stud|2|||
162202118|NCT00349622|585790904|FG000|Overall Study|Death|168|||
162202119|NCT00349622|585790905|FG001|Overall Study|Death|86|||
162202120|NCT00349622|585790904|FG000|Overall Study|Lost to Follow-up|5|||
162202121|NCT00349622|585790905|FG001|Overall Study|Lost to Follow-up|1|||
162202122|NCT00349622|585790904|FG000|Overall Study|Withdrawal by Subject|5|||
162202123|NCT00349622|585790905|FG001|Overall Study|Withdrawal by Subject|9|||
162020991|NCT02167139|585132098|FG001|Randomised, Double-blind|Other|0|||
162020992|NCT02167139|585132099|FG002|Randomised, Double-blind|Other|0|||
162020993|NCT02167139|585132100|FG003|Randomised, Double-blind|Other|0|||
162202124|NCT03296566|585790906|FG000|Overall Study|Lost to Follow-up|19|||
162202125|NCT03296566|585790907|FG001|Overall Study|Lost to Follow-up|46|||
162202126|NCT03296566|585790906|FG000|Overall Study|Withdrawal by Subject|0|||
162202127|NCT03296566|585790907|FG001|Overall Study|Withdrawal by Subject|3|||
162202128|NCT03511378|585790911|FG000|Overall Study|Withdrawal by Subject|2|||
162202129|NCT03511378|585790912|FG001|Overall Study|Withdrawal by Subject|2|||
162202130|NCT03511378|585790911|FG000|Overall Study|Patient not coming or schedule visit|1|||
162202131|NCT03511378|585790912|FG001|Overall Study|Patient not coming or schedule visit|0|||
162202132|NCT02229396|585790914|FG000|Overall Study|Adverse Event|6|||
161822008|NCT00160524|584389253|FG000|Overall Study|Other|20|||
161822009|NCT00021541|584389254|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
161822010|NCT00021541|584389255|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
161822011|NCT00021541|584389254|FG000|Period 1-First Treatment|Adverse Event|2|||
161822012|NCT00021541|584389255|FG001|Period 1-First Treatment|Adverse Event|1|||
161822013|NCT00021541|584389254|FG000|Period 1-First Treatment|non-adherence|3|||
161822014|NCT00021541|584389255|FG001|Period 1-First Treatment|non-adherence|0|||
161822015|NCT00021541|584389254|FG000|Period 1-First Treatment|Death|1|||
161822016|NCT00021541|584389255|FG001|Period 1-First Treatment|Death|0|||
161822017|NCT00021541|584389254|FG000|Period 1-First Treatment|Pts that did not progress|2|||
161822018|NCT00021541|584389255|FG001|Period 1-First Treatment|Pts that did not progress|2|||
161822019|NCT00021541|584389254|FG000|Period 1-First Treatment|Ineligible|0|||
161822020|NCT00021541|584389255|FG001|Period 1-First Treatment|Ineligible|2|||
161822021|NCT00021541|584389254|FG000|Period 2-crossover|refused phase B|2|||
161822022|NCT00021541|584389255|FG001|Period 2-crossover|refused phase B|2|||
161822023|NCT00021541|584389254|FG000|Period 2-crossover|Withdrawal by Subject|3|||
161822024|NCT00021541|584389255|FG001|Period 2-crossover|Withdrawal by Subject|4|||
161822025|NCT00021541|584389254|FG000|Period 2-crossover|Adverse Event|2|||
161822026|NCT00021541|584389255|FG001|Period 2-crossover|Adverse Event|2|||
161822027|NCT00021541|584389254|FG000|Period 2-crossover|non-adherence|1|||
161822028|NCT00021541|584389255|FG001|Period 2-crossover|non-adherence|0|||
161822029|NCT00021541|584389254|FG000|Period 2-crossover|Pts that did not progress|2|||
161822030|NCT00021541|584389255|FG001|Period 2-crossover|Pts that did not progress|3|||
161822031|NCT04892147|584389256|FG000|Overall Study|Withdrawal by Subject|2|||
161822032|NCT04892147|584389257|FG001|Overall Study|Withdrawal by Subject|0|||
161822033|NCT01215721|584389259|FG000|Overall Study|Adverse Event|2|||
161822034|NCT00045162|584389260|FG000|Overall Study|Ineligible|12|||
161822035|NCT00045162|584389261|FG001|Overall Study|Ineligible|8|||
161822036|NCT00045162|584389260|FG000|Overall Study|Not treated|7|||
161822037|NCT00045162|584389261|FG001|Overall Study|Not treated|2|||
161822038|NCT00045162|584389260|FG000|Overall Study|Adverse Event|55|||
161822039|NCT00045162|584389261|FG001|Overall Study|Adverse Event|50|||
161822040|NCT00045162|584389260|FG000|Overall Study|Lack of Efficacy|32|||
161822041|NCT00045162|584389261|FG001|Overall Study|Lack of Efficacy|29|||
161822042|NCT00045162|584389260|FG000|Overall Study|Death|10|||
161822043|NCT00045162|584389261|FG001|Overall Study|Death|10|||
161822044|NCT00045162|584389260|FG000|Overall Study|Withdrawal by Subject|5|||
162020994|NCT02167139|585132097|FG000|Transition-extension|Adverse Event|2|||
162202133|NCT02229396|585790915|FG001|Overall Study|Adverse Event|12|||
162202134|NCT02229396|585790916|FG002|Overall Study|Adverse Event|12|||
162202135|NCT02229396|585790914|FG000|Overall Study|Death|2|||
161822045|NCT00045162|584389261|FG001|Overall Study|Withdrawal by Subject|3|||
161822046|NCT00045162|584389260|FG000|Overall Study|Other|21|||
161822047|NCT00045162|584389261|FG001|Overall Study|Other|16|||
161822048|NCT01044433|584389262|FG000|Overall Study|Lost to Follow-up|3|||
161822049|NCT01044433|584389262|FG000|Overall Study|Withdrawal by Subject|3|||
161822050|NCT00826241|584389263|FG000|Overall Study|Withdrawal from Follow-up|1|||
161822051|NCT00826241|584389263|FG000|Overall Study|Withdrew consent|2|||
161822052|NCT00826241|584389263|FG000|Overall Study|Death|4|||
162202136|NCT02229396|585790915|FG001|Overall Study|Death|3|||
162202137|NCT02229396|585790916|FG002|Overall Study|Death|1|||
162202138|NCT02229396|585790914|FG000|Overall Study|Lost to Follow-up|14|||
162202139|NCT02229396|585790915|FG001|Overall Study|Lost to Follow-up|14|||
162202140|NCT02229396|585790916|FG002|Overall Study|Lost to Follow-up|21|||
162202141|NCT02229396|585790914|FG000|Overall Study|Protocol Violation|2|||
162202142|NCT02229396|585790915|FG001|Overall Study|Protocol Violation|1|||
162202143|NCT02229396|585790916|FG002|Overall Study|Protocol Violation|0|||
162202144|NCT02229396|585790914|FG000|Overall Study|Patient Incorrectly Randomized|0|||
162202145|NCT02229396|585790915|FG001|Overall Study|Patient Incorrectly Randomized|0|||
162202146|NCT02229396|585790916|FG002|Overall Study|Patient Incorrectly Randomized|1|||
162202147|NCT02229396|585790914|FG000|Overall Study|Other|10|||
162202148|NCT02229396|585790915|FG001|Overall Study|Other|18|||
162202149|NCT02229396|585790916|FG002|Overall Study|Other|15|||
162202150|NCT02229396|585790914|FG000|Overall Study|Withdrawal by Subject|42|||
162202151|NCT02229396|585790915|FG001|Overall Study|Withdrawal by Subject|28|||
162202152|NCT02229396|585790916|FG002|Overall Study|Withdrawal by Subject|41|||
162202153|NCT02229396|585790914|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
162202154|NCT02229396|585790915|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
161928666|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
161928667|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
161928668|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
161928669|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
161928670|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
161928671|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
161928672|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
161928673|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
161928674|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
162020995|NCT02167139|585132098|FG001|Transition-extension|Adverse Event|0|||
162020996|NCT02167139|585132099|FG002|Transition-extension|Adverse Event|2|||
162020997|NCT02167139|585132100|FG003|Transition-extension|Adverse Event|3|||
162020998|NCT02167139|585132097|FG000|Transition-extension|Withdrawal by Subject|2|||
162020999|NCT02167139|585132098|FG001|Transition-extension|Withdrawal by Subject|0|||
162021000|NCT02167139|585132099|FG002|Transition-extension|Withdrawal by Subject|4|||
162021001|NCT02167139|585132100|FG003|Transition-extension|Withdrawal by Subject|1|||
162021002|NCT02167139|585132097|FG000|Transition-extension|Lack of Efficacy|0|||
162021003|NCT02167139|585132098|FG001|Transition-extension|Lack of Efficacy|0|||
162021004|NCT02167139|585132099|FG002|Transition-extension|Lack of Efficacy|1|||
162202155|NCT02229396|585790916|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
162021005|NCT02167139|585132100|FG003|Transition-extension|Lack of Efficacy|1|||
162202156|NCT02229396|585790914|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
162202157|NCT02229396|585790915|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
162202158|NCT02229396|585790916|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
162202159|NCT03022578|585790920|FG000|Overall Study|Adverse Event|1|||
162202160|NCT03022578|585790920|FG000|Overall Study|Lack of Efficacy|2|||
162202161|NCT03022578|585790920|FG000|Overall Study|Withdrawal by Subject|1|||
162202162|NCT02679079|585790921|FG000|Overall Study|Adverse Event|2|||
162202163|NCT02679079|585790922|FG001|Overall Study|Adverse Event|0|||
162202164|NCT02679079|585790923|FG002|Overall Study|Adverse Event|2|||
162202165|NCT02679079|585790921|FG000|Overall Study|Protocol Violation|0|||
162202166|NCT02679079|585790922|FG001|Overall Study|Protocol Violation|1|||
162202167|NCT02679079|585790923|FG002|Overall Study|Protocol Violation|0|||
162202168|NCT02679079|585790921|FG000|Overall Study|Withdrawal by Subject|2|||
162202169|NCT02679079|585790922|FG001|Overall Study|Withdrawal by Subject|1|||
162202170|NCT02679079|585790923|FG002|Overall Study|Withdrawal by Subject|0|||
162202171|NCT00805285|585790926|FG000|Overall Study|Lack of Efficacy|1|||
162202172|NCT00839306|585790930|FG000|Overall Study|Adverse Event|3|||
162202173|NCT00839306|585790931|FG001|Overall Study|Adverse Event|5|||
162202174|NCT00839306|585790930|FG000|Overall Study|Lost to Follow-up|6|||
162202175|NCT00839306|585790931|FG001|Overall Study|Lost to Follow-up|9|||
162202176|NCT00839306|585790930|FG000|Overall Study|Withdrawal by Subject|5|||
162202177|NCT00839306|585790931|FG001|Overall Study|Withdrawal by Subject|7|||
162202178|NCT00839306|585790930|FG000|Overall Study|Lack of Efficacy|5|||
162202179|NCT00839306|585790931|FG001|Overall Study|Lack of Efficacy|4|||
162202180|NCT00839306|585790930|FG000|Overall Study|Other|6|||
162202181|NCT00839306|585790931|FG001|Overall Study|Other|18|||
162202182|NCT01812707|585790932|FG000|Overall Study|Adverse Event|0|||
162202183|NCT01812707|585790933|FG001|Overall Study|Adverse Event|0|||
162202184|NCT01812707|585790934|FG002|Overall Study|Adverse Event|0|||
162202185|NCT01812707|585790935|FG003|Overall Study|Adverse Event|2|||
162202186|NCT01812707|585790932|FG000|Overall Study|Poor compliance to protocol|1|||
162202187|NCT01812707|585790933|FG001|Overall Study|Poor compliance to protocol|0|||
161822053|NCT00826241|584389263|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
161822054|NCT00826241|584389263|FG000|Overall Study|Non-compliance|1|||
161822055|NCT00826241|584389263|FG000|Overall Study|Progression of disease|1|||
161822056|NCT00826241|584389263|FG000|Overall Study|Patient refused follow-up|3|||
161822057|NCT00826241|584389263|FG000|Overall Study|Lost to Follow-up|9|||
161822058|NCT00826241|584389263|FG000|Overall Study|Could not obtain records|1|||
161822059|NCT00826241|584389263|FG000|Overall Study|Screen failure|2|||
161822060|NCT00826241|584389263|FG000|Overall Study|Pt unable to proceed to registration|1|||
161822061|NCT00826241|584389263|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
161822062|NCT00556673|584389265|FG000|Overall Study|Protocol deviation|3|||
161822063|NCT00556673|584389266|FG001|Overall Study|Protocol deviation|2|||
161822064|NCT01971554|584389267|FG000|Overall Study|Lost to Follow-up|1|||
161822065|NCT01971554|584389268|FG001|Overall Study|Lost to Follow-up|0|||
161822066|NCT01971554|584389269|FG002|Overall Study|Lost to Follow-up|0|||
161822067|NCT01971554|584389270|FG003|Overall Study|Lost to Follow-up|0|||
161822068|NCT00087529|584389272|FG000|Overall Study|Death|1|||
161822069|NCT00087529|584389273|FG001|Overall Study|Death|0|||
161822070|NCT00087529|584389272|FG000|Overall Study|Adverse Event|0|||
161822071|NCT00087529|584389273|FG001|Overall Study|Adverse Event|8|||
161822072|NCT00087529|584389272|FG000|Overall Study|Pregnancy|0|||
161822073|NCT00087529|584389273|FG001|Overall Study|Pregnancy|1|||
161822074|NCT00087529|584389272|FG000|Overall Study|Lost to Follow-up|2|||
161822075|NCT00087529|584389273|FG001|Overall Study|Lost to Follow-up|3|||
161822076|NCT00087529|584389272|FG000|Overall Study|Participant Decision|14|||
161822077|NCT00087529|584389273|FG001|Overall Study|Participant Decision|37|||
161822078|NCT00087529|584389272|FG000|Overall Study|Physician Decision|4|||
161822079|NCT00087529|584389273|FG001|Overall Study|Physician Decision|8|||
161822080|NCT00087529|584389272|FG000|Overall Study|Initiation of Excluded Therapy|0|||
161822081|NCT00087529|584389273|FG001|Overall Study|Initiation of Excluded Therapy|1|||
161822082|NCT00087529|584389272|FG000|Overall Study|Participant Noncompliance|0|||
161822083|NCT00087529|584389273|FG001|Overall Study|Participant Noncompliance|1|||
161822084|NCT00087529|584389272|FG000|Overall Study|Disease Progression|5|||
161822085|NCT00087529|584389273|FG001|Overall Study|Disease Progression|4|||
161822086|NCT00087529|584389272|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
161822087|NCT00087529|584389273|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
161822088|NCT02535923|584389274|FG000|Overall Study|Lost to Follow-up|5|||
161822089|NCT02535923|584389275|FG001|Overall Study|Lost to Follow-up|5|||
161822090|NCT02535923|584389274|FG000|Overall Study|Withdrawal by Subject|4|||
161822091|NCT02535923|584389275|FG001|Overall Study|Withdrawal by Subject|3|||
161822092|NCT04388787|584389276|FG000|Blinded Period|Patient could not follow instructions|1|||
162202188|NCT01812707|585790934|FG002|Overall Study|Poor compliance to protocol|0|||
162202189|NCT01812707|585790935|FG003|Overall Study|Poor compliance to protocol|0|||
162202190|NCT01812707|585790932|FG000|Overall Study|Consent withdrawn by participant|1|||
162202191|NCT01812707|585790933|FG001|Overall Study|Consent withdrawn by participant|0|||
162202192|NCT01812707|585790934|FG002|Overall Study|Consent withdrawn by participant|0|||
161928675|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
161928676|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
161928677|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
161928678|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Other|6|||
161928679|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Other|3|||
161928680|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Other|0|||
161928681|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
161928682|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161928683|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161928684|NCT03636269|584787802|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
161928685|NCT03636269|584787803|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
161928686|NCT03636269|584787804|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
161928687|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Adverse Event|0|||
161928688|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Adverse Event|0|||
161928689|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Adverse Event|21|||
161928690|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
161928691|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
161928692|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
161928693|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
161928694|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
161928695|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
161928696|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
161928697|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
161928698|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
161928699|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Administrative|0|||
161928700|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Administrative|0|||
161928701|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Administrative|36|||
162202193|NCT01812707|585790935|FG003|Overall Study|Consent withdrawn by participant|0|||
162202194|NCT05060237|585790937|FG000|Overall Study|Withdrawal by Subject|4|||
162202195|NCT05060237|585790937|FG000|Overall Study|Screening failure|8|||
161822093|NCT04388787|584389276|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
161822094|NCT01350934|584391007|FG000|Base Study|Adverse Event|6|||
161822095|NCT01350934|584391008|FG001|Base Study|Adverse Event|0|||
161822096|NCT01350934|584391007|FG000|Base Study|Lost to Follow-up|1|||
161822097|NCT01350934|584391008|FG001|Base Study|Lost to Follow-up|0|||
161822098|NCT01350934|584391007|FG000|Base Study|Protocol Violation|1|||
161822099|NCT01350934|584391008|FG001|Base Study|Protocol Violation|1|||
161822100|NCT01350934|584391007|FG000|Base Study|Withdrawal by Subject|1|||
161822101|NCT01350934|584391008|FG001|Base Study|Withdrawal by Subject|2|||
161822102|NCT01350934|584391007|FG000|Base Study|Non-Compliance With Study Drug|2|||
161822103|NCT01350934|584391008|FG001|Base Study|Non-Compliance With Study Drug|0|||
161822104|NCT01350934|584391007|FG000|Extension Study|Adverse Event|2|||
161822105|NCT01350934|584391008|FG001|Extension Study|Adverse Event|1|||
161822106|NCT01350934|584391007|FG000|Extension Study|Lost to Follow-up|2|||
161822107|NCT01350934|584391008|FG001|Extension Study|Lost to Follow-up|0|||
161822108|NCT01350934|584391007|FG000|Extension Study|Protocol Violation|1|||
161822109|NCT01350934|584391008|FG001|Extension Study|Protocol Violation|1|||
161822110|NCT01350934|584391007|FG000|Extension Study|Lack of Efficacy|0|||
161822111|NCT01350934|584391008|FG001|Extension Study|Lack of Efficacy|1|||
161822112|NCT01350934|584391007|FG000|Extension Study|Withdrawal by Subject|0|||
161822113|NCT01350934|584391008|FG001|Extension Study|Withdrawal by Subject|1|||
161822114|NCT02415387|584391009|FG000|Overall Study|Withdrawal by Subject|6|||
161822115|NCT02415387|584391010|FG001|Overall Study|Withdrawal by Subject|1|||
161822116|NCT02415387|584391009|FG000|Overall Study|blood draw problem|0|||
161822117|NCT02415387|584391010|FG001|Overall Study|blood draw problem|1|||
161822118|NCT02415387|584391009|FG000|Overall Study|Protocol Violation|1|||
161822119|NCT02415387|584391010|FG001|Overall Study|Protocol Violation|0|||
161822120|NCT01151280|584391011|FG000|Overall Study|Adverse Event|1|||
161822121|NCT01151280|584391011|FG000|Overall Study|Lack of Efficacy|3|||
161822122|NCT02473393|584391013|FG000|Overall Study|Adverse Event|0|||
161822123|NCT02473393|584391014|FG001|Overall Study|Adverse Event|0|||
161822124|NCT02473393|584391015|FG002|Overall Study|Adverse Event|1|||
161822125|NCT02473393|584391016|FG003|Overall Study|Adverse Event|0|||
161822126|NCT02473393|584391013|FG000|Overall Study|Withdrawal by Subject|0|||
161822127|NCT02473393|584391014|FG001|Overall Study|Withdrawal by Subject|0|||
161822128|NCT02473393|584391015|FG002|Overall Study|Withdrawal by Subject|1|||
161822129|NCT02473393|584391016|FG003|Overall Study|Withdrawal by Subject|1|||
161822130|NCT02274558|584391019|FG000|Overall Study|Adverse Event|2|||
161822131|NCT02274558|584391020|FG001|Overall Study|Adverse Event|4|||
161822132|NCT02274558|584391021|FG002|Overall Study|Adverse Event|2|||
161822133|NCT02274558|584391019|FG000|Overall Study|Non-compliance|2|||
161928702|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Other|0|||
161928703|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Other|0|||
161928704|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Other|9|||
162021006|NCT02167139|585132097|FG000|Transition-extension|Other|1|||
161822134|NCT02274558|584391020|FG001|Overall Study|Non-compliance|1|||
161822135|NCT02274558|584391021|FG002|Overall Study|Non-compliance|0|||
161822136|NCT02274558|584391019|FG000|Overall Study|Withdrawal by Subject|1|||
161822137|NCT02274558|584391020|FG001|Overall Study|Withdrawal by Subject|5|||
161822138|NCT02274558|584391021|FG002|Overall Study|Withdrawal by Subject|4|||
161822139|NCT02274558|584391019|FG000|Overall Study|Death|0|||
161822140|NCT02274558|584391020|FG001|Overall Study|Death|0|||
161822141|NCT02274558|584391021|FG002|Overall Study|Death|1|||
161822142|NCT02274558|584391019|FG000|Overall Study|Lost to Follow-up|2|||
161822143|NCT02274558|584391020|FG001|Overall Study|Lost to Follow-up|1|||
161822144|NCT02274558|584391021|FG002|Overall Study|Lost to Follow-up|1|||
162202196|NCT01697592|585790938|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
162202197|NCT01697592|585790939|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162202198|NCT01697592|585790940|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162202199|NCT01697592|585790941|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162202200|NCT01697592|585790942|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162202201|NCT01697592|585790943|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162202202|NCT01697592|585790944|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162202203|NCT01697592|585790945|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162202204|NCT01697592|585790946|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
162202205|NCT01697592|585790947|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161822145|NCT02274558|584391019|FG000|Overall Study|Physician Decision|0|||
161822146|NCT02274558|584391020|FG001|Overall Study|Physician Decision|2|||
161822147|NCT02274558|584391021|FG002|Overall Study|Physician Decision|1|||
161822148|NCT02733627|584391022|FG000|Overall Study|Adverse Event|0|||
161822149|NCT02733627|584391023|FG001|Overall Study|Adverse Event|1|||
161822150|NCT02733627|584391024|FG002|Overall Study|Adverse Event|1|||
161822151|NCT02733627|584391025|FG003|Overall Study|Adverse Event|0|||
161822152|NCT02733627|584391022|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
161822153|NCT02733627|584391023|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
161822154|NCT02733627|584391024|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
161928705|NCT03636269|584787802|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
161928706|NCT03636269|584787803|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
161928707|NCT03636269|584787804|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
161928708|NCT02852434|584787822|FG000|Overall Study|Withdrawal by Subject|0|||
161928709|NCT02852434|584787823|FG001|Overall Study|Withdrawal by Subject|1|||
161928710|NCT02852434|584787822|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
161928711|NCT02852434|584787823|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
161928712|NCT03774810|584787826|FG000|Phase 1|Lack of Efficacy|21|||
161928713|NCT03774810|584787827|FG001|Phase 1|Lack of Efficacy|0|||
161928714|NCT03774810|584787828|FG002|Phase 1|Lack of Efficacy|0|||
161928715|NCT03774810|584787829|FG003|Phase 1|Lack of Efficacy|0|||
161928716|NCT03774810|584787830|FG004|Phase 1|Lack of Efficacy|0|||
161928717|NCT03774810|584787826|FG000|Phase 1|Withdrawal by Subject|9|||
161928718|NCT03774810|584787827|FG001|Phase 1|Withdrawal by Subject|0|||
161928719|NCT03774810|584787828|FG002|Phase 1|Withdrawal by Subject|0|||
161928720|NCT03774810|584787829|FG003|Phase 1|Withdrawal by Subject|0|||
161928721|NCT03774810|584787830|FG004|Phase 1|Withdrawal by Subject|0|||
161928722|NCT03774810|584787826|FG000|Phase 1|Lost to Follow-up|2|||
161928723|NCT03774810|584787827|FG001|Phase 1|Lost to Follow-up|0|||
161928724|NCT03774810|584787828|FG002|Phase 1|Lost to Follow-up|0|||
161928725|NCT03774810|584787829|FG003|Phase 1|Lost to Follow-up|0|||
161928726|NCT03774810|584787830|FG004|Phase 1|Lost to Follow-up|0|||
161928727|NCT03774810|584787826|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
161928728|NCT03774810|584787827|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
161822155|NCT02733627|584391025|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
161928729|NCT03774810|584787828|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
161928730|NCT03774810|584787829|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
161928731|NCT03774810|584787830|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
161928732|NCT03774810|584787826|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
161928733|NCT03774810|584787827|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
162021007|NCT02167139|585132098|FG001|Transition-extension|Other|0|||
161822156|NCT02246764|584391026|FG000|Overall Study|Adverse Event|15|||
161928734|NCT03774810|584787828|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
161928735|NCT03774810|584787829|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
162202206|NCT01697592|585790938|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162202207|NCT01697592|585790939|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161928736|NCT03774810|584787830|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
161928737|NCT03774810|584787826|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
162202208|NCT01697592|585790940|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162202209|NCT01697592|585790941|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162202210|NCT01697592|585790942|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162202211|NCT01697592|585790943|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
162202212|NCT01697592|585790944|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162202213|NCT01697592|585790945|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162202214|NCT01697592|585790946|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162202215|NCT01697592|585790947|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
162202216|NCT01697592|585790938|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
162202217|NCT01697592|585790939|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162202218|NCT01697592|585790940|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162202219|NCT01697592|585790941|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162202220|NCT01697592|585790942|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162202221|NCT01697592|585790943|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162202222|NCT01697592|585790944|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162202223|NCT01697592|585790945|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162202224|NCT01697592|585790946|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162202225|NCT01697592|585790947|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
162202226|NCT01697592|585790938|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
162202227|NCT01697592|585790939|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
162202228|NCT01697592|585790940|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
162202229|NCT01697592|585790941|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
162202230|NCT01697592|585790942|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
162202231|NCT01697592|585790943|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
162202232|NCT01697592|585790944|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
162202233|NCT01697592|585790945|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
162202234|NCT01697592|585790946|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
162202235|NCT01697592|585790947|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
162202236|NCT01697592|585790938|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
162202237|NCT01697592|585790939|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
162202238|NCT01697592|585790940|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
162202239|NCT01697592|585790941|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
161676823|NCT01241552|583870555|FG000|Overall Study|Physician Decision|2|||
161676824|NCT01241552|583870556|FG001|Overall Study|Physician Decision|4|||
161676825|NCT01241552|583870557|FG002|Overall Study|Physician Decision|2|||
161676826|NCT01241552|583870558|FG003|Overall Study|Physician Decision|3|||
161822157|NCT02246764|584391027|FG001|Overall Study|Adverse Event|29|||
161822158|NCT02246764|584391028|FG002|Overall Study|Adverse Event|1|||
162202240|NCT01697592|585790942|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161676827|NCT01241552|583870555|FG000|Overall Study|Lost to Follow-up|2|||
161822159|NCT02246764|584391026|FG000|Overall Study|Withdrawal by Subject|0|||
161822160|NCT02246764|584391027|FG001|Overall Study|Withdrawal by Subject|0|||
161822161|NCT02246764|584391028|FG002|Overall Study|Withdrawal by Subject|1|||
161822162|NCT02246764|584391026|FG000|Overall Study|Disallowed Concomitant Medication|1|||
161822163|NCT02246764|584391027|FG001|Overall Study|Disallowed Concomitant Medication|0|||
161822164|NCT02246764|584391028|FG002|Overall Study|Disallowed Concomitant Medication|0|||
161822165|NCT02246764|584391026|FG000|Overall Study|Physician Decision|0|||
161822166|NCT02246764|584391027|FG001|Overall Study|Physician Decision|2|||
161822167|NCT02246764|584391028|FG002|Overall Study|Physician Decision|1|||
161822168|NCT02246764|584391026|FG000|Overall Study|Protocol Violation|2|||
161822169|NCT02246764|584391027|FG001|Overall Study|Protocol Violation|1|||
161822170|NCT02246764|584391028|FG002|Overall Study|Protocol Violation|1|||
161822171|NCT05393271|584391029|FG000|Overall Study|Physician Decision|0|||
161822172|NCT05393271|584391030|FG001|Overall Study|Physician Decision|0|||
161822173|NCT05393271|584391031|FG002|Overall Study|Physician Decision|0|||
161822174|NCT05393271|584391032|FG003|Overall Study|Physician Decision|0|||
161822175|NCT05393271|584391033|FG004|Overall Study|Physician Decision|0|||
161822176|NCT05393271|584391034|FG005|Overall Study|Physician Decision|0|||
161822177|NCT05393271|584391035|FG006|Overall Study|Physician Decision|1|||
161822178|NCT05393271|584391036|FG007|Overall Study|Physician Decision|0|||
161822179|NCT05393271|584391037|FG008|Overall Study|Physician Decision|0|||
161822180|NCT05393271|584391038|FG009|Overall Study|Physician Decision|0|||
161822181|NCT05393271|584391039|FG010|Overall Study|Physician Decision|0|||
161822182|NCT02048813|584391040|FG000|Overall Study|Still on treatment|279|||
161822183|NCT02048813|584391041|FG001|Overall Study|Still on treatment|0|||
161822184|NCT02048813|584391040|FG000|Overall Study|Adverse Event|40|||
161822185|NCT02048813|584391041|FG001|Overall Study|Adverse Event|38|||
161822186|NCT02048813|584391040|FG000|Overall Study|Disease progression|13|||
161822187|NCT02048813|584391041|FG001|Overall Study|Disease progression|3|||
161822188|NCT02048813|584391040|FG000|Overall Study|Withdrawal by Subject|7|||
161822189|NCT02048813|584391041|FG001|Overall Study|Withdrawal by Subject|8|||
161822190|NCT02048813|584391040|FG000|Overall Study|Death|2|||
161822191|NCT02048813|584391041|FG001|Overall Study|Death|1|||
161822192|NCT02048813|584391040|FG000|Overall Study|Complication|2|||
161822193|NCT02048813|584391041|FG001|Overall Study|Complication|2|||
161928738|NCT03774810|584787827|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
161928739|NCT03774810|584787828|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
161928740|NCT03774810|584787829|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
161928741|NCT03774810|584787830|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
161928742|NCT03774810|584787826|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
161928743|NCT03774810|584787827|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
161928744|NCT03774810|584787828|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
161928745|NCT03774810|584787829|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
161928746|NCT03774810|584787830|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
161928747|NCT03774810|584787826|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
161928748|NCT03774810|584787827|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
161928749|NCT03774810|584787828|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
161928750|NCT03774810|584787829|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
161928751|NCT03774810|584787830|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
161928752|NCT03774810|584787826|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
161928753|NCT03774810|584787827|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
161928754|NCT03774810|584787828|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
161928755|NCT03774810|584787829|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
161928756|NCT03774810|584787830|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
161928757|NCT00927186|584787831|FG000|12 Months Primary Study|Adverse Event|5|||
161928758|NCT00927186|584787832|FG001|12 Months Primary Study|Adverse Event|2|||
161928759|NCT00927186|584787831|FG000|12 Months Primary Study|Lost to Follow-up|1|||
161928760|NCT00927186|584787832|FG001|12 Months Primary Study|Lost to Follow-up|0|||
161928761|NCT00927186|584787831|FG000|12 Months Primary Study|Protocol Violation|0|||
161928762|NCT00927186|584787832|FG001|12 Months Primary Study|Protocol Violation|1|||
161928763|NCT00927186|584787831|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
161928764|NCT00927186|584787832|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
161928765|NCT01145222|584787833|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
161928766|NCT01145222|584787834|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
161928767|NCT01145222|584787835|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
161928768|NCT01145222|584787836|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
161928769|NCT01145222|584787833|FG000|Overall Study|Poor bowel preparation|0|||
161928770|NCT01145222|584787834|FG001|Overall Study|Poor bowel preparation|0|||
161928771|NCT01145222|584787835|FG002|Overall Study|Poor bowel preparation|0|||
161928772|NCT01145222|584787836|FG003|Overall Study|Poor bowel preparation|1|||
161928773|NCT00604383|584787837|FG000|Overall Study|Withdrawal by Subject|33|||
161928774|NCT00604383|584787838|FG001|Overall Study|Withdrawal by Subject|31|||
161928775|NCT00604383|584787837|FG000|Overall Study|Lost to Follow-up|24|||
161928776|NCT00604383|584787838|FG001|Overall Study|Lost to Follow-up|19|||
161928777|NCT00604383|584787837|FG000|Overall Study|Death|14|||
161928778|NCT00604383|584787838|FG001|Overall Study|Death|22|||
161928779|NCT00604383|584787837|FG000|Overall Study|Adverse Event|16|||
161928780|NCT00604383|584787838|FG001|Overall Study|Adverse Event|9|||
161928781|NCT00604383|584787837|FG000|Overall Study|Physician Decision|0|||
161928782|NCT00604383|584787838|FG001|Overall Study|Physician Decision|3|||
161928783|NCT01698008|584787839|FG000|Overall Study|Withdrawal by Subject|1|||
161928784|NCT01698008|584787840|FG001|Overall Study|Withdrawal by Subject|2|||
161928785|NCT03994120|584787845|FG000|Overall Study|Lost to Follow-up|3|||
161928786|NCT03994120|584787846|FG001|Overall Study|Lost to Follow-up|1|||
161928787|NCT01429623|584787847|FG000|Overall Study|Death|1|||
162202241|NCT01697592|585790943|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
162202242|NCT01697592|585790944|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
162202243|NCT01697592|585790945|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
162202244|NCT01697592|585790946|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
162202245|NCT01697592|585790947|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
162202246|NCT01697592|585790938|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
162202247|NCT01697592|585790939|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162202248|NCT01697592|585790940|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162202249|NCT01697592|585790941|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
162202250|NCT01697592|585790942|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162202251|NCT01697592|585790943|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162202252|NCT01697592|585790944|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162202253|NCT01697592|585790945|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162202254|NCT01697592|585790946|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162202255|NCT01697592|585790947|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
162202256|NCT01697592|585790938|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
162202257|NCT01697592|585790939|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162202258|NCT01697592|585790940|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162202259|NCT01697592|585790941|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162202260|NCT01697592|585790942|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162202261|NCT01697592|585790943|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
162202262|NCT01697592|585790944|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162202263|NCT01697592|585790945|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
162202264|NCT01697592|585790946|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162202265|NCT01697592|585790947|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
162202266|NCT01697592|585790938|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
162202267|NCT01697592|585790939|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
162202268|NCT01697592|585790940|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
162202269|NCT01697592|585790941|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
162202270|NCT01697592|585790942|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
162202271|NCT01697592|585790943|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
162202272|NCT01697592|585790944|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
162202273|NCT01697592|585790945|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
162202274|NCT01697592|585790946|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
162202275|NCT01697592|585790947|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
162202276|NCT02396758|585790948|FG000|Overall Study|Withdrawal by Subject|2|||
162202277|NCT02396758|585790949|FG001|Overall Study|Withdrawal by Subject|0|||
162202278|NCT02396758|585790950|FG002|Overall Study|Withdrawal by Subject|0|||
162202279|NCT02396758|585790951|FG003|Overall Study|Withdrawal by Subject|1|||
162202280|NCT02396758|585790948|FG000|Overall Study|Lost to Follow-up|8|||
161676828|NCT01241552|583870556|FG001|Overall Study|Lost to Follow-up|11|||
161676829|NCT01241552|583870557|FG002|Overall Study|Lost to Follow-up|15|||
161928788|NCT01429623|584787848|FG001|Overall Study|Death|0|||
162202281|NCT02396758|585790949|FG001|Overall Study|Lost to Follow-up|5|||
162202282|NCT02396758|585790950|FG002|Overall Study|Lost to Follow-up|3|||
162202283|NCT02396758|585790951|FG003|Overall Study|Lost to Follow-up|3|||
162202284|NCT02396758|585790948|FG000|Overall Study|Death|1|||
162202285|NCT02396758|585790949|FG001|Overall Study|Death|1|||
162202286|NCT02396758|585790950|FG002|Overall Study|Death|0|||
162202287|NCT02396758|585790951|FG003|Overall Study|Death|1|||
162202288|NCT02396758|585790948|FG000|Overall Study|Randomized but not treated|1|||
162202289|NCT02396758|585790949|FG001|Overall Study|Randomized but not treated|0|||
162202290|NCT02396758|585790950|FG002|Overall Study|Randomized but not treated|1|||
162202291|NCT02396758|585790951|FG003|Overall Study|Randomized but not treated|0|||
162202292|NCT01631825|585790952|FG000|Overall Study|Adverse Event|42|||
162202293|NCT01631825|585790952|FG000|Overall Study|Lack of Efficacy|7|||
162202294|NCT01631825|585790952|FG000|Overall Study|Withdrawal by Subject|9|||
162202295|NCT01631825|585790952|FG000|Overall Study|Protocol Violation|4|||
162202296|NCT01631825|585790952|FG000|Overall Study|Discontinuation criteria|1|||
162202297|NCT01631825|585790952|FG000|Overall Study|Physician Decision|2|||
162202298|NCT02110225|585790953|FG000|Overall Study|Lost to Follow-up|0|||
162202299|NCT02110225|585790954|FG001|Overall Study|Lost to Follow-up|1|||
162202300|NCT02110225|585790955|FG002|Overall Study|Lost to Follow-up|0|||
162202301|NCT01116440|585790956|FG000|Treatment|Withdrawal by Subject|2|||
162202302|NCT01116440|585790957|FG001|Treatment|Withdrawal by Subject|2|||
162202303|NCT01116440|585790956|FG000|Treatment|Lost to Follow-up|1|||
162202304|NCT01116440|585790957|FG001|Treatment|Lost to Follow-up|1|||
162202305|NCT01116440|585790956|FG000|Treatment|Protocol Violation|0|||
161928789|NCT01429623|584787847|FG000|Overall Study|Adverse Event|7|||
161928790|NCT01429623|584787848|FG001|Overall Study|Adverse Event|14|||
161928791|NCT01429623|584787847|FG000|Overall Study|Withdrawal by Subject|19|||
161928792|NCT01429623|584787848|FG001|Overall Study|Withdrawal by Subject|13|||
161928793|NCT01429623|584787847|FG000|Overall Study|Physician Decision|2|||
161928794|NCT01429623|584787848|FG001|Overall Study|Physician Decision|3|||
161928795|NCT01429623|584787847|FG000|Overall Study|Protocol Violation|3|||
161928796|NCT01429623|584787848|FG001|Overall Study|Protocol Violation|2|||
161928797|NCT01429623|584787847|FG000|Overall Study|Assorted|1|||
161928798|NCT01429623|584787848|FG001|Overall Study|Assorted|2|||
161928799|NCT01429623|584787847|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
161928800|NCT01429623|584787848|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
161928801|NCT01429623|584787847|FG000|Overall Study|No post baseline data|4|||
161928802|NCT01429623|584787848|FG001|Overall Study|No post baseline data|4|||
161928803|NCT02619812|584787849|FG000|Overall Study|Withdrawal by Subject|0|||
161928804|NCT02619812|584787850|FG001|Overall Study|Withdrawal by Subject|0|||
161928805|NCT02619812|584787851|FG002|Overall Study|Withdrawal by Subject|1|||
161928806|NCT02619812|584787852|FG003|Overall Study|Withdrawal by Subject|2|||
161928807|NCT00981175|584787853|FG000|Primary Dose Vaccination|Adverse Event|1|||
161928808|NCT00981175|584787854|FG001|Primary Dose Vaccination|Adverse Event|0|||
161928809|NCT00981175|584787853|FG000|Primary Dose Vaccination|Protocol Violation|0|||
161928810|NCT00981175|584787854|FG001|Primary Dose Vaccination|Protocol Violation|1|||
161928811|NCT00981175|584787853|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
161928812|NCT00981175|584787854|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
161928813|NCT00981175|584787853|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
161928814|NCT00981175|584787854|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
161928815|NCT04985682|584787866|FG000|Overall Study|Withdrawal by Subject|1|||
161928816|NCT00621322|584787867|FG000|Overall Study|Lost to Follow-up|0|||
161928817|NCT00621322|584787868|FG001|Overall Study|Lost to Follow-up|0|||
161928818|NCT00621322|584787869|FG002|Overall Study|Lost to Follow-up|0|||
161928819|NCT00621322|584787870|FG003|Overall Study|Lost to Follow-up|0|||
161928820|NCT00621322|584787871|FG004|Overall Study|Lost to Follow-up|1|||
161928821|NCT00621322|584787872|FG005|Overall Study|Lost to Follow-up|0|||
161928822|NCT00621322|584787867|FG000|Overall Study|Physician Decision|0|||
161928823|NCT00621322|584787868|FG001|Overall Study|Physician Decision|0|||
161928824|NCT00621322|584787869|FG002|Overall Study|Physician Decision|1|||
161928825|NCT00621322|584787870|FG003|Overall Study|Physician Decision|1|||
162202306|NCT01116440|585790957|FG001|Treatment|Protocol Violation|2|||
162202307|NCT01116440|585790956|FG000|Treatment|Lack of Efficacy|0|||
162202308|NCT01116440|585790957|FG001|Treatment|Lack of Efficacy|1|||
162202309|NCT01116440|585790956|FG000|Treatment|Adverse Event|0|||
162202310|NCT01116440|585790957|FG001|Treatment|Adverse Event|1|||
162202311|NCT01116440|585790956|FG000|Withdrawal|Withdrawal by Subject|0|||
162202312|NCT01116440|585790957|FG001|Withdrawal|Withdrawal by Subject|1|||
162202313|NCT01116440|585790956|FG000|Withdrawal|Lost to Follow-up|0|||
162202314|NCT01116440|585790957|FG001|Withdrawal|Lost to Follow-up|1|||
161928826|NCT00621322|584787871|FG004|Overall Study|Physician Decision|0|||
162202315|NCT01116440|585790956|FG000|Follow-up|Lost to Follow-up|0|||
162202316|NCT01116440|585790957|FG001|Follow-up|Lost to Follow-up|1|||
162202317|NCT01116440|585790956|FG000|Follow-up|Withdrawal by Subject|0|||
162202318|NCT01116440|585790957|FG001|Follow-up|Withdrawal by Subject|1|||
162202319|NCT00774306|585790958|FG000|Overall Study|Adverse Event|3|||
162202320|NCT00774306|585790959|FG001|Overall Study|Adverse Event|0|||
161928827|NCT00621322|584787872|FG005|Overall Study|Physician Decision|0|||
161928828|NCT00621322|584787867|FG000|Overall Study|Withdrawal by Subject|0|||
161928829|NCT00621322|584787868|FG001|Overall Study|Withdrawal by Subject|0|||
161928830|NCT00621322|584787869|FG002|Overall Study|Withdrawal by Subject|0|||
162202321|NCT00774306|585790960|FG002|Overall Study|Adverse Event|0|||
161928831|NCT00621322|584787870|FG003|Overall Study|Withdrawal by Subject|1|||
161928832|NCT00621322|584787871|FG004|Overall Study|Withdrawal by Subject|0|||
161928833|NCT00621322|584787872|FG005|Overall Study|Withdrawal by Subject|2|||
161928834|NCT00621322|584787867|FG000|Overall Study|Migrated/moved from study area|1|||
161928835|NCT00621322|584787868|FG001|Overall Study|Migrated/moved from study area|0|||
161928836|NCT00621322|584787869|FG002|Overall Study|Migrated/moved from study area|1|||
161928837|NCT00621322|584787870|FG003|Overall Study|Migrated/moved from study area|1|||
161928838|NCT00621322|584787871|FG004|Overall Study|Migrated/moved from study area|0|||
161928839|NCT00621322|584787872|FG005|Overall Study|Migrated/moved from study area|2|||
161928840|NCT00756444|584787879|FG000|Overall Study|Adverse Event|1|||
161928841|NCT00756444|584787880|FG001|Overall Study|Adverse Event|1|||
161928842|NCT00756444|584787879|FG000|Overall Study|Withdrawal by Subject|6|||
161928843|NCT00756444|584787880|FG001|Overall Study|Withdrawal by Subject|8|||
161928844|NCT00756444|584787879|FG000|Overall Study|Lost to Follow-up|0|||
161928845|NCT00756444|584787880|FG001|Overall Study|Lost to Follow-up|1|||
161928846|NCT00756444|584787879|FG000|Overall Study|Death|5|||
161928847|NCT00756444|584787880|FG001|Overall Study|Death|4|||
161928848|NCT00756444|584787879|FG000|Overall Study|Disease Progression|2|||
161928849|NCT00756444|584787880|FG001|Overall Study|Disease Progression|7|||
161928850|NCT00756444|584787879|FG000|Overall Study|Ineligibility Determined|1|||
161928851|NCT00756444|584787880|FG001|Overall Study|Ineligibility Determined|0|||
161928852|NCT04865978|584787881|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
161928853|NCT04865978|584787882|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
161928854|NCT05587998|584787883|FG000|Overall Study|Withdrawal by Subject|1|||
161928855|NCT05587998|584787884|FG001|Overall Study|Withdrawal by Subject|1|||
161928856|NCT05587998|584787883|FG000|Overall Study|Not treated|3|||
161928857|NCT05587998|584787884|FG001|Overall Study|Not treated|1|||
161928858|NCT05587998|584787883|FG000|Overall Study|Non-compliance with study procedures|0|||
161928859|NCT05587998|584787884|FG001|Overall Study|Non-compliance with study procedures|1|||
161928860|NCT04263532|584787885|FG000|Overall Study|Withdrawal by Subject|2|||
161928861|NCT04263532|584787886|FG001|Overall Study|Withdrawal by Subject|0|||
161928862|NCT00601107|584787887|FG000|Overall Study|Adverse Event|0|||
161928863|NCT00601107|584787888|FG001|Overall Study|Adverse Event|1|||
161928864|NCT00601107|584787889|FG002|Overall Study|Adverse Event|3|||
161928865|NCT00601107|584787890|FG003|Overall Study|Adverse Event|0|||
161928866|NCT00601107|584787887|FG000|Overall Study|Withdrawal by Subject|5|||
161928867|NCT00601107|584787888|FG001|Overall Study|Withdrawal by Subject|4|||
161928868|NCT00601107|584787889|FG002|Overall Study|Withdrawal by Subject|7|||
161928869|NCT00601107|584787890|FG003|Overall Study|Withdrawal by Subject|4|||
161928870|NCT00601107|584787887|FG000|Overall Study|Lost to Follow-up|3|||
161928871|NCT00601107|584787888|FG001|Overall Study|Lost to Follow-up|3|||
161928872|NCT00601107|584787889|FG002|Overall Study|Lost to Follow-up|0|||
161928873|NCT00601107|584787890|FG003|Overall Study|Lost to Follow-up|3|||
161928874|NCT00601107|584787887|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
161928875|NCT00601107|584787888|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
161928876|NCT00601107|584787889|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
161928877|NCT00601107|584787890|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
161928878|NCT00601107|584787887|FG000|Overall Study|Worsening of Psoriasis|4|||
161928879|NCT00601107|584787888|FG001|Overall Study|Worsening of Psoriasis|1|||
161928880|NCT00601107|584787889|FG002|Overall Study|Worsening of Psoriasis|1|||
161928881|NCT00601107|584787890|FG003|Overall Study|Worsening of Psoriasis|4|||
161928882|NCT00601107|584787887|FG000|Overall Study|Undefined|1|||
161928883|NCT00601107|584787888|FG001|Overall Study|Undefined|0|||
161928884|NCT00601107|584787889|FG002|Overall Study|Undefined|1|||
162021008|NCT02167139|585132099|FG002|Transition-extension|Other|1|||
162202322|NCT00774306|585790961|FG003|Overall Study|Adverse Event|0|||
162202323|NCT00774306|585790958|FG000|Overall Study|Protocol Violation|2|||
162202324|NCT00774306|585790959|FG001|Overall Study|Protocol Violation|0|||
162202325|NCT00774306|585790960|FG002|Overall Study|Protocol Violation|3|||
162202326|NCT00774306|585790961|FG003|Overall Study|Protocol Violation|0|||
162202327|NCT00774306|585790958|FG000|Overall Study|Withdrawal by Subject|6|||
162202328|NCT00774306|585790959|FG001|Overall Study|Withdrawal by Subject|1|||
162202329|NCT00774306|585790960|FG002|Overall Study|Withdrawal by Subject|1|||
162202330|NCT00774306|585790961|FG003|Overall Study|Withdrawal by Subject|0|||
162202331|NCT00774306|585790958|FG000|Overall Study|Lost to Follow-up|6|||
162202332|NCT00774306|585790959|FG001|Overall Study|Lost to Follow-up|0|||
162202333|NCT00774306|585790960|FG002|Overall Study|Lost to Follow-up|4|||
162021009|NCT02167139|585132100|FG003|Transition-extension|Other|0|||
162202334|NCT00774306|585790961|FG003|Overall Study|Lost to Follow-up|5|||
162202335|NCT00774306|585790958|FG000|Overall Study|Death|1|||
162202336|NCT00774306|585790959|FG001|Overall Study|Death|1|||
161928885|NCT00601107|584787890|FG003|Overall Study|Undefined|0|||
161928886|NCT03892915|584787891|FG000|Overall Study|Lost to Follow-up|6|||
161928887|NCT03892915|584787892|FG001|Overall Study|Lost to Follow-up|12|||
161928888|NCT03892915|584787891|FG000|Overall Study|Death|0|||
161928889|NCT03892915|584787892|FG001|Overall Study|Death|2|||
161928890|NCT03892915|584787891|FG000|Overall Study|Withdrawal by Subject|1|||
161928891|NCT03892915|584787892|FG001|Overall Study|Withdrawal by Subject|1|||
161928892|NCT03892915|584787891|FG000|Overall Study|unsuccessful delivery|13|||
161928893|NCT03892915|584787892|FG001|Overall Study|unsuccessful delivery|18|||
161928894|NCT01078545|584787902|FG000|Overall Study|Lost to Follow-up|13|||
161928895|NCT01078545|584787902|FG000|Overall Study|Physician Decision|6|||
161928896|NCT01078545|584787902|FG000|Overall Study|Withdrawal by Subject|3|||
161928897|NCT01078545|584787902|FG000|Overall Study|Death|3|||
161928898|NCT01078545|584787902|FG000|Overall Study|Participant moved to another physician|1|||
161928899|NCT03501277|584787911|FG000|Intervention Period 1 (4 Days)|Other|0|||
161928900|NCT03501277|584787912|FG001|Intervention Period 1 (4 Days)|Other|0|||
161928901|NCT03501277|584787913|FG002|Intervention Period 1 (4 Days)|Other|1|||
161928902|NCT03501277|584787914|FG003|Intervention Period 1 (4 Days)|Other|0|||
161928903|NCT03501277|584787911|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
161928904|NCT03501277|584787912|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
161928905|NCT03501277|584787913|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
161928906|NCT03501277|584787914|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
161928907|NCT03501277|584787911|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
161928908|NCT03501277|584787912|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
161928909|NCT03501277|584787913|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
161928910|NCT03501277|584787914|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
161928911|NCT03501277|584787911|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
161928912|NCT03501277|584787912|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
161928913|NCT03501277|584787913|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
161928914|NCT03501277|584787914|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
161928915|NCT01489358|584787915|FG000|Overall Study|Lost to Follow-up|0|||
161928916|NCT01489358|584787916|FG001|Overall Study|Lost to Follow-up|0|||
161928917|NCT01489358|584787917|FG002|Overall Study|Lost to Follow-up|2|||
161928918|NCT01873833|584787918|FG000|Overall Study|Withdrawal by Subject|1|||
161928919|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Adverse Event|14|||
161928920|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Adverse Event|27|||
161928921|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Adverse Event|60|||
161928922|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Adverse Event|0|||
161928923|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Adverse Event|0|||
161928924|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Pregnancy|0|||
161928925|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Pregnancy|7|||
161928926|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Pregnancy|9|||
161928927|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Pregnancy|0|||
161928928|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Pregnancy|0|||
161928929|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
161928930|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
161928931|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
161928932|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
161928933|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
161928934|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
161928935|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
161928936|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
161928937|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
161928938|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
161928939|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Death|1|||
161928940|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Death|2|||
161928941|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Death|2|||
161928942|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Death|0|||
161928943|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Death|0|||
161928944|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
161928945|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
161928946|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
161928947|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
161928948|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
161928949|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
161928950|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
161928951|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
161928952|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
161928953|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
161928954|NCT00098293|584787919|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
161928955|NCT00098293|584787920|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
161928956|NCT00098293|584787921|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
161928957|NCT00098293|584787922|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
161928958|NCT00098293|584787923|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
162202337|NCT00774306|585790960|FG002|Overall Study|Death|0|||
162202338|NCT00774306|585790961|FG003|Overall Study|Death|0|||
162202339|NCT01126879|585790967|FG000|Overall Study|Progressive Disease|3|||
162202340|NCT01126879|585790968|FG001|Overall Study|Progressive Disease|1|||
161928959|NCT00098293|584787919|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
162202341|NCT01126879|585790967|FG000|Overall Study|Withdrawal by Subject|1|||
162202342|NCT01126879|585790968|FG001|Overall Study|Withdrawal by Subject|0|||
162202343|NCT01126879|585790967|FG000|Overall Study|Adverse Event|0|||
162202344|NCT01126879|585790968|FG001|Overall Study|Adverse Event|1|||
162202345|NCT01126879|585790967|FG000|Overall Study|Physician Decision|1|||
162202346|NCT01126879|585790968|FG001|Overall Study|Physician Decision|0|||
162202347|NCT00899379|585790971|FG000|Overall Study|Adverse Event|2|||
162202348|NCT00899379|585790972|FG001|Overall Study|Adverse Event|2|||
162202349|NCT00899379|585790973|FG002|Overall Study|Adverse Event|1|||
162202350|NCT00899379|585790974|FG003|Overall Study|Adverse Event|1|||
162202351|NCT00899379|585790975|FG004|Overall Study|Adverse Event|2|||
162202352|NCT00899379|585790971|FG000|Overall Study|Lack of Efficacy|0|||
162202353|NCT00899379|585790972|FG001|Overall Study|Lack of Efficacy|4|||
162202354|NCT00899379|585790973|FG002|Overall Study|Lack of Efficacy|3|||
162202355|NCT00899379|585790974|FG003|Overall Study|Lack of Efficacy|0|||
162202356|NCT00899379|585790975|FG004|Overall Study|Lack of Efficacy|1|||
162202357|NCT00899379|585790971|FG000|Overall Study|Lost to Follow-up|9|||
162202358|NCT00899379|585790972|FG001|Overall Study|Lost to Follow-up|3|||
162202359|NCT00899379|585790973|FG002|Overall Study|Lost to Follow-up|0|||
162202360|NCT00899379|585790974|FG003|Overall Study|Lost to Follow-up|6|||
162202361|NCT00899379|585790975|FG004|Overall Study|Lost to Follow-up|2|||
162202362|NCT00899379|585790971|FG000|Overall Study|Protocol Violation|0|||
162202363|NCT00899379|585790972|FG001|Overall Study|Protocol Violation|0|||
162202364|NCT00899379|585790973|FG002|Overall Study|Protocol Violation|1|||
162202365|NCT00899379|585790974|FG003|Overall Study|Protocol Violation|1|||
162202366|NCT00899379|585790975|FG004|Overall Study|Protocol Violation|0|||
162202367|NCT00899379|585790971|FG000|Overall Study|Withdrawal by Subject|2|||
162202368|NCT00899379|585790972|FG001|Overall Study|Withdrawal by Subject|4|||
162202369|NCT00899379|585790973|FG002|Overall Study|Withdrawal by Subject|2|||
162202370|NCT00899379|585790974|FG003|Overall Study|Withdrawal by Subject|3|||
162202371|NCT00899379|585790975|FG004|Overall Study|Withdrawal by Subject|6|||
162202372|NCT00899379|585790971|FG000|Overall Study|Pregnancy|0|||
162202373|NCT00899379|585790972|FG001|Overall Study|Pregnancy|0|||
162202374|NCT00899379|585790973|FG002|Overall Study|Pregnancy|1|||
162202375|NCT00899379|585790974|FG003|Overall Study|Pregnancy|0|||
162202376|NCT00899379|585790975|FG004|Overall Study|Pregnancy|1|||
162202377|NCT00899379|585790971|FG000|Overall Study|Patient Uncooperative|0|||
162202378|NCT00899379|585790972|FG001|Overall Study|Patient Uncooperative|1|||
162202379|NCT00899379|585790973|FG002|Overall Study|Patient Uncooperative|0|||
162202380|NCT00899379|585790974|FG003|Overall Study|Patient Uncooperative|1|||
162202381|NCT00899379|585790975|FG004|Overall Study|Patient Uncooperative|2|||
162202382|NCT00899379|585790971|FG000|Overall Study|Abnormal Baseline ECG|0|||
162202383|NCT00899379|585790972|FG001|Overall Study|Abnormal Baseline ECG|0|||
162202384|NCT00899379|585790973|FG002|Overall Study|Abnormal Baseline ECG|0|||
162202385|NCT00899379|585790974|FG003|Overall Study|Abnormal Baseline ECG|1|||
162202386|NCT00899379|585790975|FG004|Overall Study|Abnormal Baseline ECG|0|||
162202387|NCT00899379|585790971|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
162202388|NCT00899379|585790972|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
162202389|NCT00899379|585790973|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
162202390|NCT00899379|585790974|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162202391|NCT00899379|585790975|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162202392|NCT00899379|585790971|FG000|Overall Study|Not Completed/Entered Extn|5|||
162202393|NCT00899379|585790972|FG001|Overall Study|Not Completed/Entered Extn|1|||
162202394|NCT00899379|585790973|FG002|Overall Study|Not Completed/Entered Extn|6|||
162202395|NCT00899379|585790974|FG003|Overall Study|Not Completed/Entered Extn|4|||
161928960|NCT00098293|584787920|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
161928961|NCT00098293|584787921|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
161928962|NCT00098293|584787922|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
161928963|NCT00098293|584787923|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
161928964|NCT00098293|584787919|FG000|Open-label (OL) Phase|Adverse Event|0|||
162202396|NCT00899379|585790975|FG004|Overall Study|Not Completed/Entered Extn|3|||
162202397|NCT00899379|585790971|FG000|Overall Study|Study Terminated|3|||
162202398|NCT00899379|585790972|FG001|Overall Study|Study Terminated|0|||
162202399|NCT00899379|585790973|FG002|Overall Study|Study Terminated|3|||
162202400|NCT00899379|585790974|FG003|Overall Study|Study Terminated|3|||
162202401|NCT00899379|585790975|FG004|Overall Study|Study Terminated|1|||
162202402|NCT00899379|585790971|FG000|Overall Study|Lost to Follow-up|3|||
161676830|NCT01241552|583870558|FG003|Overall Study|Lost to Follow-up|16|||
161928965|NCT00098293|584787920|FG001|Open-label (OL) Phase|Adverse Event|3|||
162202403|NCT00899379|585790972|FG001|Overall Study|Lost to Follow-up|1|||
162202404|NCT00899379|585790973|FG002|Overall Study|Lost to Follow-up|0|||
162202405|NCT00899379|585790974|FG003|Overall Study|Lost to Follow-up|2|||
161928966|NCT00098293|584787921|FG002|Open-label (OL) Phase|Adverse Event|7|||
161928967|NCT00098293|584787922|FG003|Open-label (OL) Phase|Adverse Event|6|||
161928968|NCT00098293|584787923|FG004|Open-label (OL) Phase|Adverse Event|0|||
161928969|NCT00098293|584787919|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
161928970|NCT00098293|584787920|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
161928971|NCT00098293|584787921|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
161928972|NCT00098293|584787922|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
161928973|NCT00098293|584787923|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
161928974|NCT00098293|584787919|FG000|Open-label (OL) Phase|Pregnancy|0|||
161928975|NCT00098293|584787920|FG001|Open-label (OL) Phase|Pregnancy|1|||
161928976|NCT00098293|584787921|FG002|Open-label (OL) Phase|Pregnancy|0|||
161928977|NCT00098293|584787922|FG003|Open-label (OL) Phase|Pregnancy|3|||
161928978|NCT00098293|584787923|FG004|Open-label (OL) Phase|Pregnancy|0|||
161928979|NCT00098293|584787919|FG000|Open-label (OL) Phase|Protocol Violation|0|||
161928980|NCT00098293|584787920|FG001|Open-label (OL) Phase|Protocol Violation|6|||
161928981|NCT00098293|584787921|FG002|Open-label (OL) Phase|Protocol Violation|13|||
161928982|NCT00098293|584787922|FG003|Open-label (OL) Phase|Protocol Violation|16|||
161928983|NCT00098293|584787923|FG004|Open-label (OL) Phase|Protocol Violation|0|||
161928984|NCT00098293|584787919|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
161928985|NCT00098293|584787920|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
161928986|NCT00098293|584787921|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
161928987|NCT00098293|584787922|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
161928988|NCT00098293|584787923|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
161928989|NCT00098293|584787919|FG000|Open-label (OL) Phase|Death|0|||
161928990|NCT00098293|584787920|FG001|Open-label (OL) Phase|Death|2|||
161928991|NCT00098293|584787921|FG002|Open-label (OL) Phase|Death|3|||
161928992|NCT00098293|584787922|FG003|Open-label (OL) Phase|Death|0|||
161928993|NCT00098293|584787923|FG004|Open-label (OL) Phase|Death|0|||
162021010|NCT02167139|585132097|FG000|Transition-extension|Lost to Follow-up|1|||
162021011|NCT02167139|585132098|FG001|Transition-extension|Lost to Follow-up|0|||
162021012|NCT02167139|585132099|FG002|Transition-extension|Lost to Follow-up|0|||
162021013|NCT02167139|585132100|FG003|Transition-extension|Lost to Follow-up|0|||
162021014|NCT00996333|585132101|FG000|Overall Study|Screen failure|1|||
161676831|NCT04004429|583870559|FG000|Overall Study|Protocol Violation|1|||
161928994|NCT00098293|584787919|FG000|Supplemental Phase (SP)|Death|0|||
161928995|NCT00098293|584787920|FG001|Supplemental Phase (SP)|Death|0|||
161928996|NCT00098293|584787921|FG002|Supplemental Phase (SP)|Death|0|||
161928997|NCT00098293|584787922|FG003|Supplemental Phase (SP)|Death|0|||
161928998|NCT00098293|584787923|FG004|Supplemental Phase (SP)|Death|1|||
162021015|NCT00996333|585132101|FG000|Overall Study|Withdrawal by Subject|1|||
162021016|NCT00996333|585132101|FG000|Overall Study|Death|4|||
162021017|NCT00996333|585132101|FG000|Overall Study|Adverse Event|1|||
162021018|NCT00996333|585132101|FG000|Overall Study|Physician Decision|1|||
162021019|NCT00996333|585132101|FG000|Overall Study|Other|5|||
162021020|NCT01015638|585132102|FG000|Overall Study|Withdrawal by Subject|1|||
162021021|NCT01015638|585132103|FG001|Overall Study|Withdrawal by Subject|0|||
162021022|NCT02164461|585132104|FG000|Overall Study|Adverse Event|0|||
162021023|NCT02164461|585132105|FG001|Overall Study|Adverse Event|0|||
162021024|NCT02164461|585132106|FG002|Overall Study|Adverse Event|1|||
162021025|NCT02164461|585132104|FG000|Overall Study|Disease Progression|1|||
162021026|NCT02164461|585132105|FG001|Overall Study|Disease Progression|3|||
162021027|NCT02164461|585132106|FG002|Overall Study|Disease Progression|4|||
162021028|NCT02164461|585132104|FG000|Overall Study|Withdrawal by Subject|0|||
162021029|NCT02164461|585132105|FG001|Overall Study|Withdrawal by Subject|3|||
162021030|NCT02164461|585132106|FG002|Overall Study|Withdrawal by Subject|0|||
162021031|NCT00324961|585132110|FG000|Overall Study|Adverse Event|5|||
162021032|NCT00324961|585132110|FG000|Overall Study|Consent Withdrawn|11|||
162021033|NCT00324961|585132110|FG000|Overall Study|Lost to Follow-up|22|||
162021034|NCT00324961|585132110|FG000|Overall Study|Protocol Violation|3|||
162021035|NCT00324961|585132110|FG000|Overall Study|Other|2|||
162021036|NCT00344487|585132111|FG000|Overall Study|immunologic failure|1|||
162021037|NCT04927364|585132114|FG000|Overall Study|Withdrawal by Subject|3|||
162021038|NCT04927364|585132114|FG000|Overall Study|Unable to complete preassessment MRI|1|||
162021039|NCT01387542|585132124|FG000|Overall Study|Adverse Event|3|||
162021040|NCT01387542|585132124|FG000|Overall Study|Withdrawal by Subject|1|||
162021041|NCT01387542|585132124|FG000|Overall Study|Changed diagnosis|1|||
162021042|NCT01387542|585132124|FG000|Overall Study|Insufficient response|1|||
162021043|NCT01387542|585132124|FG000|Overall Study|Non-compliant|1|||
162021044|NCT01387542|585132124|FG000|Overall Study|Lost to Follow-up|1|||
162021045|NCT01761240|585132127|FG000|Overall Study|Progressive disease:radiology assessment|3|||
162021046|NCT01761240|585132128|FG001|Overall Study|Progressive disease:radiology assessment|3|||
162021047|NCT01761240|585132129|FG002|Overall Study|Progressive disease:radiology assessment|0|||
162021048|NCT01761240|585132130|FG003|Overall Study|Progressive disease:radiology assessment|0|||
162021049|NCT01761240|585132131|FG004|Overall Study|Progressive disease:radiology assessment|0|||
162021050|NCT01761240|585132127|FG000|Overall Study|Progressive disease:clinical assessment|0|||
162021051|NCT01761240|585132128|FG001|Overall Study|Progressive disease:clinical assessment|0|||
162021052|NCT01761240|585132129|FG002|Overall Study|Progressive disease:clinical assessment|3|||
162021053|NCT01761240|585132130|FG003|Overall Study|Progressive disease:clinical assessment|1|||
162021054|NCT01761240|585132131|FG004|Overall Study|Progressive disease:clinical assessment|0|||
162021055|NCT01761240|585132127|FG000|Overall Study|Withdrawal by Subject|0|||
162021056|NCT01761240|585132128|FG001|Overall Study|Withdrawal by Subject|0|||
162021057|NCT01761240|585132129|FG002|Overall Study|Withdrawal by Subject|0|||
162021058|NCT01761240|585132130|FG003|Overall Study|Withdrawal by Subject|3|||
162021059|NCT01761240|585132131|FG004|Overall Study|Withdrawal by Subject|1|||
162021060|NCT01761240|585132127|FG000|Overall Study|Adverse Event|0|||
162021061|NCT01761240|585132128|FG001|Overall Study|Adverse Event|0|||
162021062|NCT01761240|585132129|FG002|Overall Study|Adverse Event|0|||
162021063|NCT01761240|585132130|FG003|Overall Study|Adverse Event|1|||
162021064|NCT01761240|585132131|FG004|Overall Study|Adverse Event|6|||
162021065|NCT01761240|585132127|FG000|Overall Study|Death|0|||
162021066|NCT01761240|585132128|FG001|Overall Study|Death|1|||
162021067|NCT01761240|585132129|FG002|Overall Study|Death|1|||
162202406|NCT00899379|585790975|FG004|Overall Study|Lost to Follow-up|5|||
162202407|NCT00899379|585790971|FG000|Overall Study|Withdrawal by Subject|4|||
162202408|NCT00899379|585790972|FG001|Overall Study|Withdrawal by Subject|7|||
162202409|NCT00899379|585790973|FG002|Overall Study|Withdrawal by Subject|4|||
162202410|NCT00899379|585790974|FG003|Overall Study|Withdrawal by Subject|7|||
162202411|NCT00899379|585790975|FG004|Overall Study|Withdrawal by Subject|2|||
162202412|NCT00899379|585790971|FG000|Overall Study|Pregnancy|1|||
162021068|NCT01761240|585132130|FG003|Overall Study|Death|2|||
162021069|NCT01761240|585132131|FG004|Overall Study|Death|1|||
162021070|NCT01761240|585132127|FG000|Overall Study|Non-compliance|0|||
162202413|NCT00899379|585790972|FG001|Overall Study|Pregnancy|0|||
162202414|NCT00899379|585790973|FG002|Overall Study|Pregnancy|0|||
162021071|NCT01761240|585132128|FG001|Overall Study|Non-compliance|0|||
162021072|NCT01761240|585132129|FG002|Overall Study|Non-compliance|1|||
162021073|NCT01761240|585132130|FG003|Overall Study|Non-compliance|0|||
162021074|NCT01761240|585132131|FG004|Overall Study|Non-compliance|0|||
162202415|NCT00899379|585790974|FG003|Overall Study|Pregnancy|0|||
161928999|NCT00098293|584787919|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
161929000|NCT00098293|584787920|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
161929001|NCT00098293|584787921|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
161929002|NCT00098293|584787922|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
161929003|NCT00098293|584787923|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
161929004|NCT00098293|584787919|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
161929005|NCT00098293|584787920|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
161929006|NCT00098293|584787921|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
161929007|NCT00098293|584787922|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
161929008|NCT00098293|584787923|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
161929009|NCT00098293|584787919|FG000|Supplemental Phase (SP)|Other|0|||
161929010|NCT00098293|584787920|FG001|Supplemental Phase (SP)|Other|0|||
161929011|NCT00098293|584787921|FG002|Supplemental Phase (SP)|Other|0|||
161929012|NCT00098293|584787922|FG003|Supplemental Phase (SP)|Other|0|||
161929013|NCT00098293|584787923|FG004|Supplemental Phase (SP)|Other|22|||
161929014|NCT01968785|584787924|FG000|Overall Study|Withdrawal by Subject|1|||
161929015|NCT01968785|584787925|FG001|Overall Study|Withdrawal by Subject|0|||
161929016|NCT01350973|584787930|FG000|Overall Study|Adverse Event|4|||
161929017|NCT01350973|584787931|FG001|Overall Study|Adverse Event|7|||
161929018|NCT01350973|584787932|FG002|Overall Study|Adverse Event|7|||
161929019|NCT01350973|584787930|FG000|Overall Study|Voluntary Withdrawal|2|||
161929020|NCT01350973|584787931|FG001|Overall Study|Voluntary Withdrawal|1|||
161929021|NCT01350973|584787932|FG002|Overall Study|Voluntary Withdrawal|1|||
161929022|NCT03188705|584789740|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
161929023|NCT03188705|584789740|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
161676832|NCT04004429|583870560|FG001|Overall Study|Protocol Violation|0|||
161676833|NCT04004429|583870561|FG002|Overall Study|Protocol Violation|0|||
161676834|NCT04004429|583870559|FG000|Overall Study|Physician Decision|0|||
161676835|NCT04004429|583870560|FG001|Overall Study|Physician Decision|1|||
161822194|NCT02048813|584391040|FG000|Overall Study|Non-protocol therapy|0|||
161822195|NCT02048813|584391041|FG001|Overall Study|Non-protocol therapy|1|||
161822196|NCT02048813|584391040|FG000|Overall Study|Second primary cancer|2|||
161822197|NCT02048813|584391041|FG001|Overall Study|Second primary cancer|0|||
161822198|NCT02048813|584391040|FG000|Overall Study|Insurance|2|||
161822199|NCT02048813|584391041|FG001|Overall Study|Insurance|0|||
161822200|NCT02048813|584391040|FG000|Overall Study|Wound infection/healing|2|||
161822201|NCT02048813|584391041|FG001|Overall Study|Wound infection/healing|0|||
161822202|NCT02048813|584391040|FG000|Overall Study|Missed appointment|3|||
161822203|NCT02048813|584391041|FG001|Overall Study|Missed appointment|0|||
161822204|NCT02048813|584391040|FG000|Overall Study|Never started treatment|2|||
161822205|NCT02048813|584391041|FG001|Overall Study|Never started treatment|17|||
161822206|NCT03314857|584391042|FG000|Overall Study|Death|4|||
161822207|NCT03314857|584391042|FG000|Overall Study|Physician Decision|1|||
161822208|NCT01119625|584391043|FG000|Overall Study|Lost to Follow-up|1|||
161822209|NCT01119625|584391044|FG001|Overall Study|Lost to Follow-up|2|||
161822210|NCT01119625|584391043|FG000|Overall Study|Withdrawal by Subject|2|||
161822211|NCT01119625|584391044|FG001|Overall Study|Withdrawal by Subject|1|||
161822212|NCT01119625|584391043|FG000|Overall Study|Other|0|||
161822213|NCT01119625|584391044|FG001|Overall Study|Other|1|||
161822214|NCT01721772|584391049|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
161822215|NCT01721772|584391050|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
161822216|NCT01721772|584391049|FG000|Pre-Treatment|Poor/non-compliance|0|||
161822217|NCT01721772|584391050|FG001|Pre-Treatment|Poor/non-compliance|1|||
161822218|NCT01721772|584391049|FG000|Pre-Treatment|Participant withdrew consent|0|||
161822219|NCT01721772|584391050|FG001|Pre-Treatment|Participant withdrew consent|1|||
161822220|NCT01721772|584391049|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
161822221|NCT01721772|584391050|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
161822222|NCT01721772|584391049|FG000|Treatment|Disease progression|119|||
161822223|NCT01721772|584391050|FG001|Treatment|Disease progression|168|||
161822224|NCT01721772|584391049|FG000|Treatment|Study drug toxicity|19|||
161822225|NCT01721772|584391050|FG001|Treatment|Study drug toxicity|10|||
161822226|NCT01721772|584391049|FG000|Treatment|Adverse event unrelated to study drug|7|||
161822227|NCT01721772|584391050|FG001|Treatment|Adverse event unrelated to study drug|7|||
161822228|NCT01721772|584391049|FG000|Treatment|Maximum clinical benefit|16|||
161822229|NCT01721772|584391050|FG001|Treatment|Maximum clinical benefit|4|||
161822230|NCT01721772|584391049|FG000|Treatment|Other|19|||
161822231|NCT01721772|584391050|FG001|Treatment|Other|2|||
161822232|NCT01721772|584391049|FG000|Treatment|Participant withdrew consent|2|||
161822233|NCT01721772|584391050|FG001|Treatment|Participant withdrew consent|5|||
161822234|NCT01721772|584391049|FG000|Treatment|Participant request to discontinue study treatment|21|||
161822235|NCT01721772|584391050|FG001|Treatment|Participant request to discontinue study treatment|8|||
161822236|NCT01721772|584391049|FG000|Treatment|Death|1|||
161822237|NCT01721772|584391050|FG001|Treatment|Death|0|||
161822238|NCT01721772|584391049|FG000|Treatment|Not reported|1|||
161822239|NCT01721772|584391050|FG001|Treatment|Not reported|0|||
161929024|NCT03156621|584789742|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
161929025|NCT03156621|584789743|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
161676836|NCT04004429|583870561|FG002|Overall Study|Physician Decision|1|||
161676837|NCT04004429|583870559|FG000|Overall Study|Withdrawal by Subject|1|||
161822240|NCT01721772|584391049|FG000|Treatment|Poor/non-compliance|1|||
161822241|NCT01721772|584391050|FG001|Treatment|Poor/non-compliance|0|||
161822242|NCT01721772|584391049|FG000|Treatment|Lost to Follow-up|0|||
161822243|NCT01721772|584391050|FG001|Treatment|Lost to Follow-up|1|||
161822244|NCT02754492|584391051|FG000|Overall Study|Protocol Violation|2|||
161822245|NCT02754492|584391052|FG001|Overall Study|Protocol Violation|2|||
161822246|NCT02754492|584391053|FG002|Overall Study|Protocol Violation|0|||
161822247|NCT02754492|584391054|FG003|Overall Study|Protocol Violation|1|||
161822248|NCT02754492|584391051|FG000|Overall Study|Withdrawal by Subject|2|||
161822249|NCT02754492|584391052|FG001|Overall Study|Withdrawal by Subject|0|||
161822250|NCT02754492|584391053|FG002|Overall Study|Withdrawal by Subject|0|||
161822251|NCT02754492|584391054|FG003|Overall Study|Withdrawal by Subject|0|||
161822252|NCT02754492|584391051|FG000|Overall Study|Equipment malfuntion|0|||
161822253|NCT02754492|584391052|FG001|Overall Study|Equipment malfuntion|0|||
161822254|NCT02754492|584391053|FG002|Overall Study|Equipment malfuntion|2|||
161822255|NCT02754492|584391054|FG003|Overall Study|Equipment malfuntion|5|||
161822256|NCT02754492|584391051|FG000|Overall Study|Adverse Event|0|||
161822257|NCT02754492|584391052|FG001|Overall Study|Adverse Event|0|||
161822258|NCT02754492|584391053|FG002|Overall Study|Adverse Event|0|||
161822259|NCT02754492|584391054|FG003|Overall Study|Adverse Event|13|||
161822260|NCT02754492|584391051|FG000|Overall Study|Venous access issues not resulting in AE|0|||
161822261|NCT02754492|584391052|FG001|Overall Study|Venous access issues not resulting in AE|0|||
161822262|NCT02754492|584391053|FG002|Overall Study|Venous access issues not resulting in AE|0|||
161822263|NCT02754492|584391054|FG003|Overall Study|Venous access issues not resulting in AE|4|||
161822264|NCT01408888|584391055|FG000|First Intervention|Adverse Event|0|||
161822265|NCT01408888|584391056|FG001|First Intervention|Adverse Event|1|||
161822266|NCT01408888|584391055|FG000|First Intervention|Withdrawal by Subject|0|||
161822267|NCT01408888|584391056|FG001|First Intervention|Withdrawal by Subject|2|||
161822268|NCT01408888|584391055|FG000|Second Intervention|Withdrawal by Subject|1|||
161822269|NCT01408888|584391056|FG001|Second Intervention|Withdrawal by Subject|0|||
161822270|NCT01408888|584391055|FG000|Second Intervention|Adverse Event|1|||
161822271|NCT01408888|584391056|FG001|Second Intervention|Adverse Event|0|||
161822272|NCT04542694|584391057|FG000|Overall Study|The need for prohibited therapy|2|||
161822273|NCT04542694|584391058|FG001|Overall Study|The need for prohibited therapy|0|||
161822274|NCT04542694|584391057|FG000|Overall Study|Adverse Event|1|||
161822275|NCT04542694|584391058|FG001|Overall Study|Adverse Event|0|||
161822276|NCT04542694|584391057|FG000|Overall Study|Protocol Violation|1|||
161822277|NCT04542694|584391058|FG001|Overall Study|Protocol Violation|0|||
161822278|NCT04633642|584391061|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
161822279|NCT04633642|584391062|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
161822280|NCT05387408|584391063|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
161822281|NCT00397254|584391064|FG000|Overall Study|Lost to Follow-up|2|||
161822282|NCT00397254|584391065|FG001|Overall Study|Lost to Follow-up|2|||
161822283|NCT00152451|584391071|FG000|Overall Study|Adverse Event|4|||
161822284|NCT00323258|584391074|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
161822285|NCT00323258|584391075|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
161822286|NCT00323258|584391074|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
161822287|NCT00323258|584391075|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
162202416|NCT00899379|585790975|FG004|Overall Study|Pregnancy|0|||
162202417|NCT00899379|585790971|FG000|Overall Study|Patient Uncooperative|0|||
162202418|NCT00899379|585790972|FG001|Overall Study|Patient Uncooperative|0|||
162202419|NCT00899379|585790973|FG002|Overall Study|Patient Uncooperative|0|||
162202420|NCT00899379|585790974|FG003|Overall Study|Patient Uncooperative|1|||
162202421|NCT00899379|585790975|FG004|Overall Study|Patient Uncooperative|0|||
162202422|NCT00899379|585790971|FG000|Overall Study|Abnormal Prestudy Labs|0|||
162202423|NCT00899379|585790972|FG001|Overall Study|Abnormal Prestudy Labs|0|||
162202424|NCT00899379|585790973|FG002|Overall Study|Abnormal Prestudy Labs|0|||
162202425|NCT00899379|585790974|FG003|Overall Study|Abnormal Prestudy Labs|0|||
162202426|NCT00899379|585790975|FG004|Overall Study|Abnormal Prestudy Labs|2|||
162202427|NCT00899379|585790971|FG000|Overall Study|Abnormal Baseline ECG|0|||
162202428|NCT00899379|585790972|FG001|Overall Study|Abnormal Baseline ECG|0|||
162202429|NCT00899379|585790973|FG002|Overall Study|Abnormal Baseline ECG|1|||
162202430|NCT00899379|585790974|FG003|Overall Study|Abnormal Baseline ECG|1|||
162202431|NCT00899379|585790975|FG004|Overall Study|Abnormal Baseline ECG|0|||
162202432|NCT00899379|585790971|FG000|Overall Study|No Attack Pretreatment|3|||
161822288|NCT00323258|584391074|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
161822289|NCT00323258|584391075|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
161822290|NCT00323258|584391074|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
161822291|NCT00323258|584391075|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
161822292|NCT00323258|584391074|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
161822293|NCT00323258|584391075|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
161676838|NCT04004429|583870560|FG001|Overall Study|Withdrawal by Subject|1|||
161929026|NCT03156621|584789742|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
161929027|NCT03156621|584789743|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
161929028|NCT03016403|584789746|FG000|Baseline|Death|5|||
161929029|NCT03016403|584789747|FG001|Baseline|Death|8|||
161929030|NCT03016403|584789748|FG002|Baseline|Death|1|||
161929031|NCT03016403|584789749|FG003|Baseline|Death|0|||
161929032|NCT03016403|584789746|FG000|Baseline|Withdrawal by Subject|2|||
161676839|NCT04004429|583870561|FG002|Overall Study|Withdrawal by Subject|1|||
161676840|NCT00718549|583870562|FG000|Induction Phase|Disease Progression|1|||
161676841|NCT00718549|583870563|FG001|Induction Phase|Disease Progression|0|||
161676842|NCT00718549|583870564|FG002|Induction Phase|Disease Progression|0|||
161676843|NCT00718549|583870562|FG000|Induction Phase|Eligibility Criteria Violation|2|||
161676844|NCT00718549|583870563|FG001|Induction Phase|Eligibility Criteria Violation|0|||
161676845|NCT00718549|583870564|FG002|Induction Phase|Eligibility Criteria Violation|0|||
161676846|NCT00718549|583870562|FG000|Induction Phase|Early Termination - No Additional Info|59|||
161676847|NCT00718549|583870563|FG001|Induction Phase|Early Termination - No Additional Info|0|||
161676848|NCT00718549|583870564|FG002|Induction Phase|Early Termination - No Additional Info|0|||
161676849|NCT00718549|583870562|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
161676850|NCT00718549|583870563|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
161676851|NCT00718549|583870564|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
161676852|NCT00718549|583870562|FG000|Maintenance/ Observation Phase|Death|0|||
161676853|NCT00718549|583870563|FG001|Maintenance/ Observation Phase|Death|1|||
161676854|NCT00718549|583870564|FG002|Maintenance/ Observation Phase|Death|2|||
161929033|NCT03016403|584789747|FG001|Baseline|Withdrawal by Subject|8|||
161929034|NCT03016403|584789748|FG002|Baseline|Withdrawal by Subject|4|||
161929035|NCT03016403|584789749|FG003|Baseline|Withdrawal by Subject|10|||
161929036|NCT03016403|584789746|FG000|Baseline|Lost to Follow-up|9|||
161929037|NCT03016403|584789747|FG001|Baseline|Lost to Follow-up|11|||
161929038|NCT03016403|584789748|FG002|Baseline|Lost to Follow-up|6|||
161929039|NCT03016403|584789749|FG003|Baseline|Lost to Follow-up|24|||
161929040|NCT03016403|584789746|FG000|6-week Follow-up|Death|1|||
161929041|NCT03016403|584789747|FG001|6-week Follow-up|Death|4|||
161929042|NCT03016403|584789748|FG002|6-week Follow-up|Death|0|||
161929043|NCT03016403|584789749|FG003|6-week Follow-up|Death|0|||
161929044|NCT03016403|584789746|FG000|6-week Follow-up|Lost to Follow-up|2|||
161929045|NCT03016403|584789747|FG001|6-week Follow-up|Lost to Follow-up|7|||
161929046|NCT03016403|584789748|FG002|6-week Follow-up|Lost to Follow-up|4|||
161929047|NCT03016403|584789749|FG003|6-week Follow-up|Lost to Follow-up|8|||
161929048|NCT03016403|584789746|FG000|6-week Follow-up|Withdrawal by Subject|0|||
161929049|NCT03016403|584789747|FG001|6-week Follow-up|Withdrawal by Subject|2|||
161929050|NCT03016403|584789748|FG002|6-week Follow-up|Withdrawal by Subject|0|||
161929051|NCT03016403|584789749|FG003|6-week Follow-up|Withdrawal by Subject|1|||
161929052|NCT03016403|584789746|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
161929053|NCT03016403|584789747|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
161929054|NCT03016403|584789748|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
161929055|NCT03016403|584789749|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
161929056|NCT03016403|584789746|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
161929057|NCT03016403|584789747|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
161929058|NCT03016403|584789748|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
161929059|NCT03016403|584789749|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
161929060|NCT03016403|584789746|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
161929061|NCT03016403|584789747|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
161929062|NCT03016403|584789748|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
161929063|NCT03016403|584789749|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
161929064|NCT00799864|584789750|FG000|Overall Study|Participant reached a virologic endpoint|9|||
161929065|NCT00799864|584789751|FG001|Overall Study|Participant reached a virologic endpoint|2|||
161929066|NCT00799864|584789752|FG002|Overall Study|Participant reached a virologic endpoint|2|||
161929067|NCT00799864|584789753|FG003|Overall Study|Participant reached a virologic endpoint|0|||
161676855|NCT00718549|583870562|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
161929068|NCT00799864|584789754|FG004|Overall Study|Participant reached a virologic endpoint|0|||
161929069|NCT00799864|584789750|FG000|Overall Study|Other|2|||
161929070|NCT00799864|584789751|FG001|Overall Study|Other|1|||
161929071|NCT00799864|584789752|FG002|Overall Study|Other|0|||
161929072|NCT00799864|584789753|FG003|Overall Study|Other|0|||
161929073|NCT00799864|584789754|FG004|Overall Study|Other|0|||
161929074|NCT00225758|584789755|FG000|Overall Study|Adverse Event|4|||
161929075|NCT00576407|584789756|FG000|Overall Study|Death|7|||
161929076|NCT00576407|584789756|FG000|Overall Study|Physician Decision|1|||
161929077|NCT04641975|584789757|FG000|Overall Study|Protocol Violation|1|||
161929078|NCT04641975|584789758|FG001|Overall Study|Protocol Violation|2|||
161929079|NCT04641975|584789759|FG002|Overall Study|Protocol Violation|0|||
161929080|NCT04641975|584789760|FG003|Overall Study|Protocol Violation|0|||
161929081|NCT04641975|584789757|FG000|Overall Study|Adverse Event|0|||
161929082|NCT04641975|584789758|FG001|Overall Study|Adverse Event|0|||
161929083|NCT04641975|584789759|FG002|Overall Study|Adverse Event|1|||
161929084|NCT04641975|584789760|FG003|Overall Study|Adverse Event|1|||
161929085|NCT04641975|584789757|FG000|Overall Study|Withdrawal by Subject|1|||
161929086|NCT04641975|584789758|FG001|Overall Study|Withdrawal by Subject|0|||
161929087|NCT04641975|584789759|FG002|Overall Study|Withdrawal by Subject|0|||
161929088|NCT04641975|584789760|FG003|Overall Study|Withdrawal by Subject|0|||
161929089|NCT01259024|584789761|FG000|Overall Study|Physician Decision|1|||
161929090|NCT01657500|584789762|FG000|Overall Study|set impropperly matched|3|||
161929091|NCT01657500|584789763|FG001|Overall Study|set impropperly matched|3|||
161929092|NCT01657500|584789762|FG000|Overall Study|Lost to Follow-up|2|||
161929093|NCT01657500|584789763|FG001|Overall Study|Lost to Follow-up|2|||
161929094|NCT03142334|584789764|FG000|Overall Study|Death|18|||
161929095|NCT03142334|584789765|FG001|Overall Study|Death|33|||
161929096|NCT03142334|584789764|FG000|Overall Study|Withdrawal by Subject|15|||
161929097|NCT03142334|584789765|FG001|Overall Study|Withdrawal by Subject|11|||
161929098|NCT03142334|584789764|FG000|Overall Study|Ongoing on trial follow up|463|||
161929099|NCT03142334|584789765|FG001|Overall Study|Ongoing on trial follow up|454|||
161929100|NCT01217047|584789766|FG000|Overall Study|Lost to Follow-up|0|||
161929101|NCT01217047|584789767|FG001|Overall Study|Lost to Follow-up|1|||
161929102|NCT01217047|584789768|FG002|Overall Study|Lost to Follow-up|0|||
161929103|NCT03528577|584789771|FG000|Sequence 1|Failed Spirometry|1|||
161929104|NCT03528577|584789771|FG000|Sequence 1|Restricted medication|1|||
161929105|NCT03528577|584789771|FG000|Sequence 2|Adverse Event|1|||
161929106|NCT03528577|584789771|FG000|Sequence 2|Withdrawal by Subject|1|||
161929107|NCT03528577|584789771|FG000|Sequence 2|Failed Spirometry|1|||
161929108|NCT03528577|584789771|FG000|Sequence 3|Failed Spirometry|1|||
161929109|NCT03528577|584789771|FG000|Sequence 4|Failed Spirometry|2|||
161929110|NCT03528577|584789771|FG000|Sequence 4|Adverse Event|1|||
161929111|NCT03835117|584789772|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
161929112|NCT03835117|584789773|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
161929113|NCT03225989|584789777|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
161929114|NCT03225989|584789778|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
161929115|NCT03225989|584789779|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
161929116|NCT03225989|584789777|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
161929117|NCT03225989|584789778|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
161929118|NCT03225989|584789779|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
161929119|NCT03225989|584789777|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
161929120|NCT03225989|584789778|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
161929121|NCT03225989|584789779|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
161929122|NCT03225989|584789777|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
161929123|NCT03225989|584789778|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
161929124|NCT03225989|584789779|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
161929125|NCT03225989|584789777|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
161929126|NCT03225989|584789778|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
161929127|NCT03225989|584789779|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
161929128|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
161929129|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
161929130|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
161929131|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
161929132|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
161929133|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
161929134|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
161929135|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
161929136|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
161929137|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
161929138|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
161929139|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
161929140|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
161929141|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
161929142|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
161929143|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
161929144|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
161929145|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
161929146|NCT03225989|584789777|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
161929147|NCT03225989|584789778|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
161929148|NCT03225989|584789779|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
161929149|NCT03093870|584789783|FG000|Overall Study|Withdrawal by Subject|2|||
161929150|NCT03093870|584789784|FG001|Overall Study|Withdrawal by Subject|6|||
161929151|NCT03093870|584789785|FG002|Overall Study|Withdrawal by Subject|5|||
161929152|NCT03093870|584789783|FG000|Overall Study|Death|1|||
161929153|NCT03093870|584789784|FG001|Overall Study|Death|35|||
161929154|NCT03093870|584789785|FG002|Overall Study|Death|35|||
161929155|NCT03093870|584789783|FG000|Overall Study|Radiographic disease progression|10|||
161929156|NCT03093870|584789784|FG001|Overall Study|Radiographic disease progression|0|||
161929157|NCT03093870|584789785|FG002|Overall Study|Radiographic disease progression|0|||
161929158|NCT03093870|584789783|FG000|Overall Study|Clinical disease progression|1|||
161929159|NCT03093870|584789784|FG001|Overall Study|Clinical disease progression|0|||
161929160|NCT03093870|584789785|FG002|Overall Study|Clinical disease progression|0|||
162202433|NCT00899379|585790972|FG001|Overall Study|No Attack Pretreatment|5|||
162202434|NCT00899379|585790973|FG002|Overall Study|No Attack Pretreatment|5|||
162202435|NCT00899379|585790974|FG003|Overall Study|No Attack Pretreatment|6|||
162202436|NCT00899379|585790975|FG004|Overall Study|No Attack Pretreatment|4|||
162202437|NCT00899379|585790971|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
162202438|NCT00899379|585790972|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162202439|NCT00899379|585790973|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162202440|NCT00899379|585790974|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162202441|NCT00899379|585790975|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162202442|NCT00899379|585790971|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
162202443|NCT00899379|585790972|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
162202444|NCT00899379|585790973|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
162202445|NCT00899379|585790974|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
162202446|NCT00899379|585790975|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
162202447|NCT00809783|585790978|FG000|Overall Study|Death|1|||
162202448|NCT00809783|585790979|FG001|Overall Study|Death|0|||
162202449|NCT00809783|585790980|FG002|Overall Study|Death|0|||
162202450|NCT00809783|585790978|FG000|Overall Study|Adverse Event|34|||
162202451|NCT00809783|585790979|FG001|Overall Study|Adverse Event|52|||
162202452|NCT00809783|585790980|FG002|Overall Study|Adverse Event|71|||
162202453|NCT00809783|585790978|FG000|Overall Study|Lack of Efficacy|39|||
162202454|NCT00809783|585790979|FG001|Overall Study|Lack of Efficacy|52|||
162202455|NCT00809783|585790980|FG002|Overall Study|Lack of Efficacy|63|||
161929161|NCT03093870|584789783|FG000|Overall Study|Physician Decision|2|||
161929162|NCT03093870|584789784|FG001|Overall Study|Physician Decision|0|||
162021075|NCT05422638|585132132|FG000|Overall Study|Withdrawal by Subject|8|||
162021076|NCT05422638|585132133|FG001|Overall Study|Withdrawal by Subject|2|||
162202456|NCT00809783|585790978|FG000|Overall Study|Lost to Follow-up|0|||
162202457|NCT00809783|585790979|FG001|Overall Study|Lost to Follow-up|3|||
162202458|NCT00809783|585790980|FG002|Overall Study|Lost to Follow-up|4|||
162202459|NCT00809783|585790978|FG000|Overall Study|Withdrawal by Subject|47|||
162202460|NCT00809783|585790979|FG001|Overall Study|Withdrawal by Subject|72|||
162202461|NCT00809783|585790980|FG002|Overall Study|Withdrawal by Subject|64|||
162202462|NCT00809783|585790978|FG000|Overall Study|Protocol Violation|2|||
162202463|NCT00809783|585790979|FG001|Overall Study|Protocol Violation|6|||
162202464|NCT00809783|585790980|FG002|Overall Study|Protocol Violation|5|||
162202465|NCT00809783|585790978|FG000|Overall Study|Randomized, but not treated|3|||
161822294|NCT00323258|584391074|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
161822295|NCT00323258|584391075|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
161822296|NCT00323258|584391074|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
161822297|NCT00323258|584391075|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
162202466|NCT00809783|585790979|FG001|Overall Study|Randomized, but not treated|0|||
162202467|NCT00809783|585790980|FG002|Overall Study|Randomized, but not treated|2|||
162202468|NCT00809783|585790978|FG000|Overall Study|Study Terminated by Sponsor|378|||
162202469|NCT00809783|585790979|FG001|Overall Study|Study Terminated by Sponsor|626|||
162202470|NCT00809783|585790980|FG002|Overall Study|Study Terminated by Sponsor|565|||
162202471|NCT00809783|585790978|FG000|Overall Study|Other|21|||
162202472|NCT00809783|585790979|FG001|Overall Study|Other|21|||
162202473|NCT00809783|585790980|FG002|Overall Study|Other|16|||
162202474|NCT00126555|585790981|FG000|Overall Study|Withdrawal by Subject|1|||
161822298|NCT04473326|584391080|FG000|Overall Study|Death|0|||
161822299|NCT04473326|584391081|FG001|Overall Study|Death|1|||
161822300|NCT04473326|584391080|FG000|Overall Study|Withdrawal by Subject|1|||
161822301|NCT04473326|584391081|FG001|Overall Study|Withdrawal by Subject|2|||
161822302|NCT02046122|584391082|FG000|Overall Study|Physician Decision|8|||
161822303|NCT02046122|584391082|FG000|Overall Study|Withdrawal by Subject|1|||
161822304|NCT01097694|584391087|FG000|Overall Study|Adverse Event|5|||
161822305|NCT01097694|584391088|FG001|Overall Study|Adverse Event|0|||
161822306|NCT01097694|584391087|FG000|Overall Study|Lost to Follow-up|0|||
161822307|NCT01097694|584391088|FG001|Overall Study|Lost to Follow-up|3|||
161822308|NCT01097694|584391087|FG000|Overall Study|Withdrawal by Subject|3|||
161822309|NCT01097694|584391088|FG001|Overall Study|Withdrawal by Subject|1|||
161822310|NCT00668395|584391090|FG000|Overall Study|Withdrawal by Subject|4|||
161822311|NCT00668395|584391091|FG001|Overall Study|Withdrawal by Subject|4|||
161822312|NCT00668395|584391092|FG002|Overall Study|Withdrawal by Subject|1|||
161822313|NCT00668395|584391090|FG000|Overall Study|Adverse Event|1|||
161822314|NCT00668395|584391091|FG001|Overall Study|Adverse Event|1|||
161822315|NCT00668395|584391092|FG002|Overall Study|Adverse Event|0|||
161822316|NCT00668395|584391090|FG000|Overall Study|Physician Decision|1|||
161822317|NCT00668395|584391091|FG001|Overall Study|Physician Decision|1|||
161822318|NCT00668395|584391092|FG002|Overall Study|Physician Decision|0|||
161822319|NCT04164758|584391093|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
161822320|NCT04164758|584391094|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
161822321|NCT04164758|584391095|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
161822322|NCT04164758|584391093|FG000|Overall Study|Adverse Event|0|||
161822323|NCT04164758|584391094|FG001|Overall Study|Adverse Event|1|||
161822324|NCT04164758|584391095|FG002|Overall Study|Adverse Event|0|||
161822325|NCT03259165|584391096|FG000|Overall Study|COVID 19 pandemic|1|||
161822326|NCT03259165|584391097|FG001|Overall Study|COVID 19 pandemic|1|||
161822327|NCT01567527|584391100|FG000|Conversion Phase.|Protocol deviation|3|||
161822328|NCT01567527|584391101|FG001|Conversion Phase.|Protocol deviation|0|||
161822329|NCT01567527|584391102|FG002|Conversion Phase.|Protocol deviation|0|||
161822330|NCT01567527|584391103|FG003|Conversion Phase.|Protocol deviation|0|||
161822331|NCT01567527|584391104|FG004|Conversion Phase.|Protocol deviation|0|||
161822332|NCT01567527|584391100|FG000|Conversion Phase.|Met withdrawal criteria|10|||
161822333|NCT01567527|584391101|FG001|Conversion Phase.|Met withdrawal criteria|0|||
161822334|NCT01567527|584391102|FG002|Conversion Phase.|Met withdrawal criteria|0|||
161822335|NCT01567527|584391103|FG003|Conversion Phase.|Met withdrawal criteria|0|||
161822336|NCT01567527|584391104|FG004|Conversion Phase.|Met withdrawal criteria|0|||
161822337|NCT01567527|584391100|FG000|Conversion Phase.|Withdrawal by Subject|32|||
161822338|NCT01567527|584391101|FG001|Conversion Phase.|Withdrawal by Subject|0|||
161822339|NCT01567527|584391102|FG002|Conversion Phase.|Withdrawal by Subject|0|||
161822340|NCT01567527|584391103|FG003|Conversion Phase.|Withdrawal by Subject|0|||
161822341|NCT01567527|584391104|FG004|Conversion Phase.|Withdrawal by Subject|0|||
161822342|NCT01567527|584391100|FG000|Conversion Phase.|Lost to Follow-up|16|||
161929163|NCT03093870|584789785|FG002|Overall Study|Physician Decision|0|||
162202475|NCT00126555|585790981|FG000|Overall Study|Adverse Event|2|||
162202476|NCT00126555|585790981|FG000|Overall Study|Progressive Disease|3|||
161822343|NCT01567527|584391101|FG001|Conversion Phase.|Lost to Follow-up|0|||
161822344|NCT01567527|584391102|FG002|Conversion Phase.|Lost to Follow-up|0|||
161822345|NCT01567527|584391103|FG003|Conversion Phase.|Lost to Follow-up|0|||
161822346|NCT01567527|584391104|FG004|Conversion Phase.|Lost to Follow-up|0|||
161822347|NCT01567527|584391100|FG000|Conversion Phase.|Lack of Efficacy|2|||
161822348|NCT01567527|584391101|FG001|Conversion Phase.|Lack of Efficacy|0|||
161822349|NCT01567527|584391102|FG002|Conversion Phase.|Lack of Efficacy|0|||
161822350|NCT01567527|584391103|FG003|Conversion Phase.|Lack of Efficacy|0|||
161822351|NCT01567527|584391104|FG004|Conversion Phase.|Lack of Efficacy|0|||
161929164|NCT03093870|584789783|FG000|Overall Study|Adverse Event|7|||
161929165|NCT03093870|584789784|FG001|Overall Study|Adverse Event|0|||
161929166|NCT03093870|584789785|FG002|Overall Study|Adverse Event|0|||
161929167|NCT03093870|584789783|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
161929168|NCT03093870|584789784|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
161929169|NCT03093870|584789785|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
161929170|NCT03093870|584789783|FG000|Overall Study|Lost to Follow-up|0|||
161929171|NCT03093870|584789784|FG001|Overall Study|Lost to Follow-up|0|||
161929172|NCT03093870|584789785|FG002|Overall Study|Lost to Follow-up|1|||
161929173|NCT01530997|584789786|FG000|Overall Study|Physician Decision|1|||
161929174|NCT01530997|584789786|FG000|Overall Study|Withdrawal by Subject|1|||
161929175|NCT02318277|584789788|FG000|Overall Study|Physician Decision|0|||
161929176|NCT02318277|584789789|FG001|Overall Study|Physician Decision|0|||
161929177|NCT02318277|584789790|FG002|Overall Study|Physician Decision|0|||
161929178|NCT02318277|584789791|FG003|Overall Study|Physician Decision|0|||
161929179|NCT02318277|584789792|FG004|Overall Study|Physician Decision|0|||
161929180|NCT02318277|584789793|FG005|Overall Study|Physician Decision|0|||
161929181|NCT02318277|584789794|FG006|Overall Study|Physician Decision|0|||
161929182|NCT02318277|584789795|FG007|Overall Study|Physician Decision|1|||
161929183|NCT02318277|584789788|FG000|Overall Study|Other|0|||
161929184|NCT02318277|584789789|FG001|Overall Study|Other|0|||
161929185|NCT02318277|584789790|FG002|Overall Study|Other|0|||
161929186|NCT02318277|584789791|FG003|Overall Study|Other|0|||
162202477|NCT03441789|585790988|FG000|Overall Study|Withdrawal by Subject|1|||
162202478|NCT03441789|585790989|FG001|Overall Study|Withdrawal by Subject|1|||
161929187|NCT02318277|584789792|FG004|Overall Study|Other|0|||
161929188|NCT02318277|584789793|FG005|Overall Study|Other|0|||
161929189|NCT02318277|584789794|FG006|Overall Study|Other|1|||
161929190|NCT02318277|584789795|FG007|Overall Study|Other|0|||
161929191|NCT02318277|584789788|FG000|Overall Study|Withdrawal by Subject|0|||
161929192|NCT02318277|584789789|FG001|Overall Study|Withdrawal by Subject|0|||
161929193|NCT02318277|584789790|FG002|Overall Study|Withdrawal by Subject|1|||
161929194|NCT02318277|584789791|FG003|Overall Study|Withdrawal by Subject|0|||
161929195|NCT02318277|584789792|FG004|Overall Study|Withdrawal by Subject|1|||
161929196|NCT02318277|584789793|FG005|Overall Study|Withdrawal by Subject|1|||
161929197|NCT02318277|584789794|FG006|Overall Study|Withdrawal by Subject|6|||
161929198|NCT02318277|584789795|FG007|Overall Study|Withdrawal by Subject|14|||
161929199|NCT02318277|584789788|FG000|Overall Study|Participant trial terminated by sponsor|0|||
161929200|NCT02318277|584789789|FG001|Overall Study|Participant trial terminated by sponsor|0|||
161929201|NCT02318277|584789790|FG002|Overall Study|Participant trial terminated by sponsor|1|||
161929202|NCT02318277|584789791|FG003|Overall Study|Participant trial terminated by sponsor|0|||
161929203|NCT02318277|584789792|FG004|Overall Study|Participant trial terminated by sponsor|1|||
161929204|NCT02318277|584789793|FG005|Overall Study|Participant trial terminated by sponsor|2|||
161929205|NCT02318277|584789794|FG006|Overall Study|Participant trial terminated by sponsor|5|||
161929206|NCT02318277|584789795|FG007|Overall Study|Participant trial terminated by sponsor|16|||
161929207|NCT02318277|584789788|FG000|Overall Study|Lost to Follow-up|1|||
161929208|NCT02318277|584789789|FG001|Overall Study|Lost to Follow-up|0|||
161929209|NCT02318277|584789790|FG002|Overall Study|Lost to Follow-up|1|||
161929210|NCT02318277|584789791|FG003|Overall Study|Lost to Follow-up|0|||
161929211|NCT02318277|584789792|FG004|Overall Study|Lost to Follow-up|0|||
161929212|NCT02318277|584789793|FG005|Overall Study|Lost to Follow-up|0|||
161929213|NCT02318277|584789794|FG006|Overall Study|Lost to Follow-up|3|||
161929214|NCT02318277|584789795|FG007|Overall Study|Lost to Follow-up|4|||
161929215|NCT02318277|584789788|FG000|Overall Study|Death|5|||
161929216|NCT02318277|584789789|FG001|Overall Study|Death|3|||
161929217|NCT02318277|584789790|FG002|Overall Study|Death|1|||
161929218|NCT02318277|584789791|FG003|Overall Study|Death|4|||
162021077|NCT04695977|585132134|FG000|Overall Study|Sponsor Decision|9|||
162202479|NCT03441789|585790988|FG000|Overall Study|Adverse Event|0|||
162202480|NCT03441789|585790989|FG001|Overall Study|Adverse Event|1|||
162202481|NCT03441789|585790988|FG000|Overall Study|Protocol Violation|0|||
162202482|NCT03441789|585790989|FG001|Overall Study|Protocol Violation|1|||
162202483|NCT03441789|585790988|FG000|Overall Study|Lost to Follow-up|0|||
162202484|NCT03441789|585790989|FG001|Overall Study|Lost to Follow-up|1|||
162202485|NCT01780545|585790990|FG000|Overall Study|Withdrawal by Subject|3|||
162202486|NCT01780545|585790991|FG001|Overall Study|Withdrawal by Subject|1|||
162202487|NCT01780545|585790990|FG000|Overall Study|Lost to Follow-up|1|||
162202488|NCT01780545|585790991|FG001|Overall Study|Lost to Follow-up|1|||
161929219|NCT02318277|584789792|FG004|Overall Study|Death|6|||
161929220|NCT02318277|584789793|FG005|Overall Study|Death|5|||
162202489|NCT02581189|585790993|FG000|Overall Study|Failure to return|36|||
162202490|NCT02581189|585790993|FG000|Overall Study|Withdrew consent|5|||
162202491|NCT02581189|585790993|FG000|Overall Study|Death|3|||
161929221|NCT02318277|584789794|FG006|Overall Study|Death|34|||
161929222|NCT02318277|584789795|FG007|Overall Study|Death|58|||
161929223|NCT02318277|584789788|FG000|Overall Study|Transitioned to Hospice|0|||
162021078|NCT04695977|585132135|FG001|Overall Study|Sponsor Decision|4|||
162021079|NCT04695977|585132134|FG000|Overall Study|Death|2|||
162021080|NCT04695977|585132135|FG001|Overall Study|Death|5|||
162021081|NCT01868542|585133414|FG000|Overall Study|Protocol Violation|0|||
162202492|NCT02581189|585790993|FG000|Overall Study|Insufficient virological response|2|||
162202493|NCT02581189|585790993|FG000|Overall Study|Other, not specified|7|||
162202494|NCT01514864|585790994|FG000|Overall Study|Disease progression|7|||
162202495|NCT01514864|585790995|FG001|Overall Study|Disease progression|5|||
162202496|NCT01514864|585790994|FG000|Overall Study|Study drug toxicity|2|||
162202497|NCT01514864|585790995|FG001|Overall Study|Study drug toxicity|0|||
162202498|NCT02254681|585791003|FG000|Overall Study|Lack of Efficacy|6|||
162202499|NCT00396097|585791004|FG000|Overall Study|Withdrawal by Subject|17|||
162202500|NCT00396097|585791005|FG001|Overall Study|Withdrawal by Subject|17|||
162202501|NCT00396097|585791004|FG000|Overall Study|Lost to Follow-up|4|||
162202502|NCT00396097|585791005|FG001|Overall Study|Lost to Follow-up|9|||
161822352|NCT01567527|584391100|FG000|Conversion Phase.|Adverse Event|33|||
161822353|NCT01567527|584391101|FG001|Conversion Phase.|Adverse Event|0|||
161822354|NCT01567527|584391102|FG002|Conversion Phase.|Adverse Event|0|||
161822355|NCT01567527|584391103|FG003|Conversion Phase.|Adverse Event|0|||
161822356|NCT01567527|584391104|FG004|Conversion Phase.|Adverse Event|0|||
161822357|NCT01567527|584391100|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
161822358|NCT01567527|584391101|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
161822359|NCT01567527|584391102|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
161822360|NCT01567527|584391103|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
161822361|NCT01567527|584391104|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
161822362|NCT01567527|584391100|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
161822363|NCT01567527|584391101|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
161822364|NCT01567527|584391102|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
161822365|NCT01567527|584391103|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
161822366|NCT01567527|584391104|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
161822367|NCT01567527|584391100|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
161822368|NCT01567527|584391101|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
161822369|NCT01567527|584391102|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
161822370|NCT01567527|584391103|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
161822371|NCT01567527|584391104|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
161822372|NCT01567527|584391100|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
161822373|NCT01567527|584391101|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
161822374|NCT01567527|584391102|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
161822375|NCT01567527|584391103|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
161822376|NCT01567527|584391104|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
161822377|NCT01567527|584391100|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
161822378|NCT01567527|584391101|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
161822379|NCT01567527|584391102|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
161822380|NCT01567527|584391103|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
161822381|NCT01567527|584391104|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
161822382|NCT01567527|584391100|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
161822383|NCT01567527|584391101|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
161822384|NCT01567527|584391102|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
161822385|NCT01567527|584391103|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
161822386|NCT01567527|584391104|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
161822387|NCT01567527|584391100|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
161822388|NCT01567527|584391101|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
161822389|NCT01567527|584391102|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
161822390|NCT01567527|584391103|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
161822391|NCT01567527|584391104|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
161822392|NCT01567527|584391100|FG000|IM Depot Stabilization.|Protocol deviation|0|||
161822393|NCT01567527|584391101|FG001|IM Depot Stabilization.|Protocol deviation|0|||
161822394|NCT01567527|584391102|FG002|IM Depot Stabilization.|Protocol deviation|5|||
161822395|NCT01567527|584391103|FG003|IM Depot Stabilization.|Protocol deviation|0|||
161822396|NCT01567527|584391104|FG004|IM Depot Stabilization.|Protocol deviation|0|||
161822397|NCT01567527|584391100|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
161822398|NCT01567527|584391101|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
161822399|NCT01567527|584391102|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
161822400|NCT01567527|584391103|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
161929224|NCT02318277|584789789|FG001|Overall Study|Transitioned to Hospice|0|||
161929225|NCT02318277|584789790|FG002|Overall Study|Transitioned to Hospice|0|||
161929226|NCT02318277|584789791|FG003|Overall Study|Transitioned to Hospice|0|||
161929227|NCT02318277|584789792|FG004|Overall Study|Transitioned to Hospice|0|||
161929228|NCT02318277|584789793|FG005|Overall Study|Transitioned to Hospice|1|||
161929229|NCT02318277|584789794|FG006|Overall Study|Transitioned to Hospice|0|||
161929230|NCT02318277|584789795|FG007|Overall Study|Transitioned to Hospice|0|||
161929231|NCT03364686|584789796|FG000|Overall Study|Physician Decision|2|||
161929232|NCT01520714|584789797|FG000|Overall Study|Protocol Violation|0|||
161929233|NCT01520714|584789798|FG001|Overall Study|Protocol Violation|3|||
161929234|NCT01520714|584789797|FG000|Overall Study|Adverse Event|0|||
162202503|NCT00396097|585791004|FG000|Overall Study|Other|3|||
162202504|NCT00396097|585791005|FG001|Overall Study|Other|5|||
162202505|NCT00396097|585791004|FG000|Overall Study|Protocol Violation|0|||
162202506|NCT00396097|585791005|FG001|Overall Study|Protocol Violation|6|||
162202507|NCT00396097|585791004|FG000|Overall Study|Adverse Event|1|||
162202508|NCT00396097|585791005|FG001|Overall Study|Adverse Event|5|||
162202509|NCT00396097|585791004|FG000|Overall Study|Insufficient Clinical Response|1|||
162202510|NCT00396097|585791005|FG001|Overall Study|Insufficient Clinical Response|4|||
162202511|NCT03461211|585791006|FG000|Overall Study|Adverse Event|1|||
162202512|NCT03461211|585791007|FG001|Overall Study|Adverse Event|1|||
162202513|NCT03461211|585791006|FG000|Overall Study|Lack of Efficacy|0|||
162202514|NCT03461211|585791007|FG001|Overall Study|Lack of Efficacy|1|||
162202515|NCT02316847|585791009|FG000|Overall Study|Adverse Event|0|||
162202516|NCT02316847|585791010|FG001|Overall Study|Adverse Event|3|||
162202517|NCT02316847|585791009|FG000|Overall Study|Lost to Follow-up|0|||
162202518|NCT02316847|585791010|FG001|Overall Study|Lost to Follow-up|2|||
162202519|NCT02316847|585791009|FG000|Overall Study|Physician Decision|0|||
162202520|NCT02316847|585791010|FG001|Overall Study|Physician Decision|1|||
162202521|NCT02316847|585791009|FG000|Overall Study|Pregnancy|0|||
162202522|NCT02316847|585791010|FG001|Overall Study|Pregnancy|1|||
162202523|NCT02316847|585791009|FG000|Overall Study|Withdrawal by Subject|2|||
162202524|NCT02316847|585791010|FG001|Overall Study|Withdrawal by Subject|9|||
162202525|NCT02316847|585791009|FG000|Overall Study|Noncompliance with study drug|0|||
162202526|NCT02316847|585791010|FG001|Overall Study|Noncompliance with study drug|3|||
162202527|NCT02316847|585791009|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
161676856|NCT00718549|583870563|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
161929235|NCT01520714|584789798|FG001|Overall Study|Adverse Event|2|||
161929236|NCT01520714|584789797|FG000|Overall Study|Lack of Efficacy|0|||
161929237|NCT01520714|584789798|FG001|Overall Study|Lack of Efficacy|1|||
161929238|NCT01478087|584789802|FG000|Overall Study|due to sponsor closing study|1|||
161929239|NCT03566550|584789803|FG000|Overall Study|Withdrawal by Subject|0|||
161929240|NCT03566550|584789804|FG001|Overall Study|Withdrawal by Subject|1|||
161929241|NCT03518203|584789806|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
161929242|NCT03518203|584789806|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
161929243|NCT02829957|584789807|FG000|Overall Study|Lost to Follow-up|2|||
161929244|NCT02829957|584789808|FG001|Overall Study|Lost to Follow-up|1|||
162202528|NCT02316847|585791010|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
162202529|NCT01370018|585791011|FG000|Overall Study|Did not meet criteria for analysis|1|||
162202530|NCT02204319|585791012|FG000|Overall Study|Pregnancy|1|||
162202531|NCT02204319|585791012|FG000|Overall Study|Withdrawal by Subject|2|||
162202532|NCT02959177|585791013|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
162202533|NCT02959177|585791014|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
162202534|NCT02959177|585791015|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
162202535|NCT02959177|585791013|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
162202536|NCT02959177|585791014|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
162202537|NCT02959177|585791015|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
162202538|NCT02959177|585791013|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
162202539|NCT02959177|585791014|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
162202540|NCT02959177|585791015|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
162202541|NCT02959177|585791013|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
162202542|NCT02959177|585791014|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
162202543|NCT02959177|585791015|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
162202544|NCT02959177|585791013|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
162202545|NCT02959177|585791014|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
162202546|NCT02959177|585791015|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
162202547|NCT02959177|585791013|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
162202548|NCT02959177|585791014|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
162202549|NCT02959177|585791015|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
162202550|NCT02959177|585791013|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
162202551|NCT02959177|585791014|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
162202552|NCT02959177|585791015|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
162202553|NCT00588341|585791017|FG000|Overall Study|Withdrawal by Subject|3|||
161676857|NCT00718549|583870564|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
161676858|NCT00718549|583870562|FG000|Maintenance/ Observation Phase|Progression|0|||
161676859|NCT00718549|583870563|FG001|Maintenance/ Observation Phase|Progression|5|||
161676860|NCT00718549|583870564|FG002|Maintenance/ Observation Phase|Progression|14|||
161676861|NCT00718549|583870562|FG000|Maintenance/ Observation Phase|Relapse|0|||
161676862|NCT00718549|583870563|FG001|Maintenance/ Observation Phase|Relapse|3|||
161676863|NCT00718549|583870564|FG002|Maintenance/ Observation Phase|Relapse|2|||
161676864|NCT02606461|583870565|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161676865|NCT02606461|583870566|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161676866|NCT02606461|583870567|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
161676867|NCT02606461|583870568|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161676868|NCT02606461|583870569|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161676869|NCT02606461|583870570|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161676870|NCT00239226|583870571|FG000|Overall Study|permAF during stabilization period|0|||
161676871|NCT00239226|583870572|FG001|Overall Study|permAF during stabilization period|0|||
161676872|NCT00239226|583870573|FG002|Overall Study|permAF during stabilization period|0|||
161676873|NCT00239226|583870574|FG003|Overall Study|permAF during stabilization period|3|||
161676874|NCT00239226|583870571|FG000|Overall Study|Lost to Follow-up|1|||
161676875|NCT00239226|583870572|FG001|Overall Study|Lost to Follow-up|0|||
161676876|NCT00239226|583870573|FG002|Overall Study|Lost to Follow-up|1|||
161929245|NCT03511066|584789810|FG000|Overall Study|Withdrawal by Subject|1|||
161929246|NCT03511066|584789811|FG001|Overall Study|Withdrawal by Subject|2|||
161929247|NCT03511066|584789812|FG002|Overall Study|Withdrawal by Subject|3|||
161929248|NCT03511066|584789810|FG000|Overall Study|Lost to Follow-up|2|||
161929249|NCT03511066|584789811|FG001|Overall Study|Lost to Follow-up|3|||
161929250|NCT03511066|584789812|FG002|Overall Study|Lost to Follow-up|0|||
161929251|NCT04146909|584789813|FG000|Overall Study|Withdrawal by Subject|3|||
161929252|NCT04146909|584789813|FG000|Overall Study|Did not qualify after consented|1|||
161929253|NCT00345592|584789814|FG000|Overall Study|Death|14|||
161929254|NCT00345592|584789815|FG001|Overall Study|Death|16|||
161929255|NCT00345592|584789814|FG000|Overall Study|Withdrawal by Subject|11|||
161929256|NCT00345592|584789815|FG001|Overall Study|Withdrawal by Subject|8|||
161929257|NCT03467945|584789820|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161929258|NCT03467945|584789821|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161929259|NCT03467945|584789822|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161929260|NCT03467945|584789823|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161929261|NCT03467945|584789820|FG000|Treatment Period 3|Withdrawal by Subject|1|||
161929262|NCT03467945|584789821|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161929263|NCT03467945|584789822|FG002|Treatment Period 3|Withdrawal by Subject|2|||
161929264|NCT03467945|584789823|FG003|Treatment Period 3|Withdrawal by Subject|1|||
161929265|NCT03336866|584789838|FG000|Overall Study|Lost to Follow-up|2|||
161929266|NCT03336866|584789839|FG001|Overall Study|Lost to Follow-up|0|||
161929267|NCT03336866|584789840|FG002|Overall Study|Lost to Follow-up|3|||
161929268|NCT03336866|584789838|FG000|Overall Study|Withdrawal by Subject|1|||
161929269|NCT03336866|584789839|FG001|Overall Study|Withdrawal by Subject|1|||
161929270|NCT03336866|584789840|FG002|Overall Study|Withdrawal by Subject|0|||
161929271|NCT03336866|584789838|FG000|Overall Study|Noncompliance with clinic house rules|0|||
161929272|NCT03336866|584789839|FG001|Overall Study|Noncompliance with clinic house rules|0|||
161929273|NCT03336866|584789840|FG002|Overall Study|Noncompliance with clinic house rules|1|||
161929274|NCT00032487|584789841|FG000|Overall Study|Withdrawal by Subject|67|||
161929275|NCT00032487|584789842|FG001|Overall Study|Withdrawal by Subject|43|||
161929276|NCT00032487|584789841|FG000|Overall Study|Adverse Event|3|||
161929277|NCT00032487|584789842|FG001|Overall Study|Adverse Event|7|||
161929278|NCT00032487|584789841|FG000|Overall Study|Lost to Follow-up|57|||
161929279|NCT00032487|584789842|FG001|Overall Study|Lost to Follow-up|58|||
161929280|NCT00032487|584789841|FG000|Overall Study|Had other reason|12|||
161929281|NCT00032487|584789842|FG001|Overall Study|Had other reason|12|||
161929282|NCT02218268|584789843|FG000|24 Hour Washout|Physician Decision|11|||
161929283|NCT02218268|584789844|FG001|24 Hour Washout|Physician Decision|9|||
161929284|NCT03651336|584789845|FG000|Overall Study|Withdrawal by Subject|4|||
161929285|NCT01341990|584789846|FG000|Overall Study|Adverse Event|0|||
161929286|NCT01341990|584789847|FG001|Overall Study|Adverse Event|1|||
161929287|NCT01341990|584789846|FG000|Overall Study|Torn Study Lens|1|||
161929288|NCT01341990|584789847|FG001|Overall Study|Torn Study Lens|0|||
161929289|NCT01341990|584789846|FG000|Overall Study|Withdrawal by Subject|2|||
161929290|NCT01341990|584789847|FG001|Overall Study|Withdrawal by Subject|0|||
161929291|NCT01125748|584789849|FG000|Overall Study|Adverse Event|0|||
161929292|NCT01125748|584789850|FG001|Overall Study|Adverse Event|2|||
161929293|NCT01125748|584789849|FG000|Overall Study|Lost to Follow-up|0|||
161929294|NCT01125748|584789850|FG001|Overall Study|Lost to Follow-up|1|||
161929295|NCT01125748|584789849|FG000|Overall Study|Physician Decision|8|||
161929296|NCT01125748|584789850|FG001|Overall Study|Physician Decision|7|||
161929297|NCT01125748|584789849|FG000|Overall Study|Patient Decision to Withdraw|2|||
161929298|NCT01125748|584789850|FG001|Overall Study|Patient Decision to Withdraw|4|||
161929299|NCT01028391|584789851|FG000|Overall Study|Adverse Event|4|||
161929300|NCT01028391|584789852|FG001|Overall Study|Adverse Event|0|||
161929301|NCT01028391|584789851|FG000|Overall Study|Lack of Efficacy|0|||
161929302|NCT01028391|584789852|FG001|Overall Study|Lack of Efficacy|2|||
161929303|NCT01028391|584789851|FG000|Overall Study|Lost to Follow-up|3|||
161929304|NCT01028391|584789852|FG001|Overall Study|Lost to Follow-up|4|||
161929305|NCT01028391|584789851|FG000|Overall Study|Physician Decision|0|||
161929306|NCT01028391|584789852|FG001|Overall Study|Physician Decision|1|||
161929307|NCT01028391|584789851|FG000|Overall Study|Withdrawal by Subject|6|||
161929308|NCT01028391|584789852|FG001|Overall Study|Withdrawal by Subject|3|||
161929309|NCT01028391|584789851|FG000|Overall Study|Needed excluded medication|1|||
161929310|NCT01028391|584789852|FG001|Overall Study|Needed excluded medication|1|||
161929311|NCT01107457|584789853|FG000|Part A|Adverse Event|1|||
161929312|NCT01107457|584789854|FG001|Part A|Adverse Event|2|||
161929313|NCT01107457|584789855|FG002|Part A|Adverse Event|1|||
161929314|NCT01107457|584789856|FG003|Part A|Adverse Event|0|||
161929315|NCT01107457|584789857|FG004|Part A|Adverse Event|0|||
161929316|NCT01107457|584789858|FG005|Part A|Adverse Event|0|||
161929317|NCT01107457|584789853|FG000|Part A|Withdrawal by Subject|3|||
161929318|NCT01107457|584789854|FG001|Part A|Withdrawal by Subject|3|||
161929319|NCT01107457|584789855|FG002|Part A|Withdrawal by Subject|0|||
161929320|NCT01107457|584789856|FG003|Part A|Withdrawal by Subject|3|||
161929321|NCT01107457|584789857|FG004|Part A|Withdrawal by Subject|1|||
161929322|NCT01107457|584789858|FG005|Part A|Withdrawal by Subject|0|||
161929323|NCT01107457|584789853|FG000|Part A|Lost to Follow-up|0|||
161929324|NCT01107457|584789854|FG001|Part A|Lost to Follow-up|1|||
161929325|NCT01107457|584789855|FG002|Part A|Lost to Follow-up|0|||
161929326|NCT01107457|584789856|FG003|Part A|Lost to Follow-up|0|||
161929327|NCT01107457|584789857|FG004|Part A|Lost to Follow-up|0|||
161929328|NCT01107457|584789858|FG005|Part A|Lost to Follow-up|0|||
161929329|NCT01107457|584789853|FG000|Part A|Lack of Efficacy|1|||
161929330|NCT01107457|584789854|FG001|Part A|Lack of Efficacy|0|||
161929331|NCT01107457|584789855|FG002|Part A|Lack of Efficacy|0|||
161929332|NCT01107457|584789856|FG003|Part A|Lack of Efficacy|0|||
161929333|NCT01107457|584789857|FG004|Part A|Lack of Efficacy|0|||
161929334|NCT01107457|584789858|FG005|Part A|Lack of Efficacy|0|||
161929335|NCT01107457|584789853|FG000|Part A|Protocol Violation|0|||
161929336|NCT01107457|584789854|FG001|Part A|Protocol Violation|1|||
161929337|NCT01107457|584789855|FG002|Part A|Protocol Violation|0|||
161929338|NCT01107457|584789856|FG003|Part A|Protocol Violation|0|||
161929339|NCT01107457|584789857|FG004|Part A|Protocol Violation|0|||
161929340|NCT01107457|584789858|FG005|Part A|Protocol Violation|0|||
161929341|NCT01107457|584789853|FG000|Part B and C|Adverse Event|0|||
161929342|NCT01107457|584789854|FG001|Part B and C|Adverse Event|0|||
161929343|NCT01107457|584789855|FG002|Part B and C|Adverse Event|0|||
162202554|NCT00588341|585791017|FG000|Overall Study|Not treated due to metastatic disease|1|||
161676877|NCT00239226|583870574|FG003|Overall Study|Lost to Follow-up|0|||
161929344|NCT01107457|584789856|FG003|Part B and C|Adverse Event|0|||
161929345|NCT01107457|584789857|FG004|Part B and C|Adverse Event|0|||
161929346|NCT01107457|584789858|FG005|Part B and C|Adverse Event|12|||
161929347|NCT01107457|584789853|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
161929348|NCT01107457|584789854|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
161929349|NCT01107457|584789855|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
161929350|NCT01107457|584789856|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
161929351|NCT01107457|584789857|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
161929352|NCT01107457|584789858|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
161929353|NCT01107457|584789853|FG000|Part B and C|Physician Decision|0|||
161929354|NCT01107457|584789854|FG001|Part B and C|Physician Decision|0|||
161929355|NCT01107457|584789855|FG002|Part B and C|Physician Decision|0|||
161929356|NCT01107457|584789856|FG003|Part B and C|Physician Decision|0|||
161929357|NCT01107457|584789857|FG004|Part B and C|Physician Decision|0|||
162202555|NCT00588341|585791017|FG000|Overall Study|Patient ineligible|1|||
161676878|NCT01303965|583870576|FG000|Overall Study|Adverse Event|1|||
161929358|NCT01107457|584789858|FG005|Part B and C|Physician Decision|3|||
161929359|NCT01107457|584789853|FG000|Part B and C|Lack of Efficacy|0|||
161929360|NCT01107457|584789854|FG001|Part B and C|Lack of Efficacy|0|||
161929361|NCT01107457|584789855|FG002|Part B and C|Lack of Efficacy|0|||
161929362|NCT01107457|584789856|FG003|Part B and C|Lack of Efficacy|0|||
161929363|NCT01107457|584789857|FG004|Part B and C|Lack of Efficacy|0|||
161929364|NCT01107457|584789858|FG005|Part B and C|Lack of Efficacy|7|||
161929365|NCT01107457|584789853|FG000|Part B and C|Lost to Follow-up|0|||
161676879|NCT01303965|583870577|FG001|Overall Study|Adverse Event|1|||
161929366|NCT01107457|584789854|FG001|Part B and C|Lost to Follow-up|0|||
161929367|NCT01107457|584789855|FG002|Part B and C|Lost to Follow-up|0|||
161929368|NCT01107457|584789856|FG003|Part B and C|Lost to Follow-up|0|||
161929369|NCT01107457|584789857|FG004|Part B and C|Lost to Follow-up|0|||
161929370|NCT01107457|584789858|FG005|Part B and C|Lost to Follow-up|10|||
161929371|NCT01107457|584789853|FG000|Part B and C|Protocol Violation|0|||
161676880|NCT01303965|583870576|FG000|Overall Study|Death|0|||
161929372|NCT01107457|584789854|FG001|Part B and C|Protocol Violation|0|||
161929373|NCT01107457|584789855|FG002|Part B and C|Protocol Violation|0|||
161929374|NCT01107457|584789856|FG003|Part B and C|Protocol Violation|0|||
161929375|NCT01107457|584789857|FG004|Part B and C|Protocol Violation|0|||
162202556|NCT02642159|585791018|FG000|Overall Study|Randomized but not treated|1|||
162202557|NCT02642159|585791019|FG001|Overall Study|Randomized but not treated|0|||
161822401|NCT01567527|584391104|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
161822402|NCT01567527|584391100|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
161822403|NCT01567527|584391101|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
161822404|NCT01567527|584391102|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
162202558|NCT02642159|585791018|FG000|Overall Study|Adverse Event|10|||
162202559|NCT02642159|585791019|FG001|Overall Study|Adverse Event|4|||
162202560|NCT02642159|585791018|FG000|Overall Study|Withdrawal by Subject|9|||
162202561|NCT02642159|585791019|FG001|Overall Study|Withdrawal by Subject|1|||
162202562|NCT02642159|585791018|FG000|Overall Study|Poor compliance to study protocol|1|||
162202563|NCT02642159|585791019|FG001|Overall Study|Poor compliance to study protocol|0|||
162202564|NCT02642159|585791018|FG000|Overall Study|Other than specified above|10|||
162202565|NCT02642159|585791019|FG001|Overall Study|Other than specified above|3|||
162202566|NCT03746483|585791020|FG000|Overall Study|Adverse Event|0|||
162202567|NCT03746483|585791021|FG001|Overall Study|Adverse Event|1|||
162202568|NCT03746483|585791020|FG000|Overall Study|Lack of Efficacy|3|||
162202569|NCT03746483|585791021|FG001|Overall Study|Lack of Efficacy|2|||
162202570|NCT03746483|585791020|FG000|Overall Study|Lost to Follow-up|1|||
162202571|NCT03746483|585791021|FG001|Overall Study|Lost to Follow-up|0|||
162202572|NCT03746483|585791020|FG000|Overall Study|Protocol Violation|2|||
162202573|NCT03746483|585791021|FG001|Overall Study|Protocol Violation|0|||
162202574|NCT00853021|585791022|FG000|Overall Study|Adverse Event|2|||
162202575|NCT00853021|585791022|FG000|Overall Study|Withdrawal by Subject|2|||
162202576|NCT00853021|585791022|FG000|Overall Study|Death|1|||
161929376|NCT01107457|584789858|FG005|Part B and C|Protocol Violation|1|||
161929377|NCT01107457|584789853|FG000|Part B and C|Sponsor Decision|0|||
162202577|NCT02864147|585791023|FG000|Overall Study|Withdrawal by Subject|3|||
162202578|NCT02864147|585791024|FG001|Overall Study|Withdrawal by Subject|2|||
162202579|NCT02864147|585791025|FG002|Overall Study|Withdrawal by Subject|1|||
162202580|NCT02864147|585791023|FG000|Overall Study|Lost to Follow-up|0|||
162202581|NCT02864147|585791024|FG001|Overall Study|Lost to Follow-up|4|||
162202582|NCT02864147|585791025|FG002|Overall Study|Lost to Follow-up|0|||
162202583|NCT02864147|585791023|FG000|Overall Study|Adverse Event|0|||
162202584|NCT02864147|585791024|FG001|Overall Study|Adverse Event|1|||
162202585|NCT02864147|585791025|FG002|Overall Study|Adverse Event|0|||
162202586|NCT02864147|585791023|FG000|Overall Study|Pregnancy|4|||
162202587|NCT02864147|585791024|FG001|Overall Study|Pregnancy|0|||
162202588|NCT02864147|585791025|FG002|Overall Study|Pregnancy|0|||
162202589|NCT02864147|585791023|FG000|Overall Study|Physician Decision|0|||
162202590|NCT02864147|585791024|FG001|Overall Study|Physician Decision|0|||
162202591|NCT02864147|585791025|FG002|Overall Study|Physician Decision|1|||
162202592|NCT02864147|585791023|FG000|Overall Study|Opted for excisional procedures|0|||
162202593|NCT02864147|585791024|FG001|Overall Study|Opted for excisional procedures|0|||
162202594|NCT02864147|585791025|FG002|Overall Study|Opted for excisional procedures|3|||
162202595|NCT02269917|585791026|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
162202596|NCT02269917|585791027|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
161822405|NCT01567527|584391103|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
161822406|NCT01567527|584391104|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
161822407|NCT01567527|584391100|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
161822408|NCT01567527|584391101|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
161822409|NCT01567527|584391102|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
161822410|NCT01567527|584391103|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
161822411|NCT01567527|584391104|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
161822412|NCT01567527|584391100|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
161822413|NCT01567527|584391101|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
161822414|NCT01567527|584391102|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
161822415|NCT01567527|584391103|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
161822416|NCT01567527|584391104|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
161822417|NCT01567527|584391100|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
161822418|NCT01567527|584391101|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
161822419|NCT01567527|584391102|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
161822420|NCT01567527|584391103|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
161822421|NCT01567527|584391104|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
161929378|NCT01107457|584789854|FG001|Part B and C|Sponsor Decision|0|||
162202597|NCT02269917|585791028|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
162202598|NCT02269917|585791026|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
162202599|NCT02269917|585791027|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
161822422|NCT01567527|584391100|FG000|IM Depot Stabilization.|Adverse Event|0|||
161822423|NCT01567527|584391101|FG001|IM Depot Stabilization.|Adverse Event|0|||
162202600|NCT02269917|585791028|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
162202601|NCT02269917|585791026|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
162202602|NCT02269917|585791027|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
161822424|NCT01567527|584391102|FG002|IM Depot Stabilization.|Adverse Event|37|||
161822425|NCT01567527|584391103|FG003|IM Depot Stabilization.|Adverse Event|0|||
161929379|NCT01107457|584789855|FG002|Part B and C|Sponsor Decision|0|||
161929380|NCT01107457|584789856|FG003|Part B and C|Sponsor Decision|0|||
161929381|NCT01107457|584789857|FG004|Part B and C|Sponsor Decision|0|||
161929382|NCT01107457|584789858|FG005|Part B and C|Sponsor Decision|66|||
161929383|NCT01107457|584789853|FG000|Part B and C|Withdrawal by Subject|0|||
161929384|NCT01107457|584789854|FG001|Part B and C|Withdrawal by Subject|0|||
161929385|NCT01107457|584789855|FG002|Part B and C|Withdrawal by Subject|0|||
161929386|NCT01107457|584789856|FG003|Part B and C|Withdrawal by Subject|0|||
161929387|NCT01107457|584789857|FG004|Part B and C|Withdrawal by Subject|0|||
161929388|NCT01107457|584789858|FG005|Part B and C|Withdrawal by Subject|16|||
161929389|NCT01107457|584789853|FG000|Part B and C|Clinical Relapse|0|||
161929390|NCT01107457|584789854|FG001|Part B and C|Clinical Relapse|0|||
161929391|NCT01107457|584789855|FG002|Part B and C|Clinical Relapse|0|||
161929392|NCT01107457|584789856|FG003|Part B and C|Clinical Relapse|0|||
161929393|NCT01107457|584789857|FG004|Part B and C|Clinical Relapse|0|||
161929394|NCT01107457|584789858|FG005|Part B and C|Clinical Relapse|4|||
161929395|NCT00694161|584789859|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
161929396|NCT00694161|584789859|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
161929397|NCT00694161|584789859|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
161929398|NCT03601052|584789860|FG000|Overall Study|Lost to Follow-up|2|||
161929399|NCT01227395|584789861|FG000|Overall Study|Protocol Violation|0|||
162202603|NCT02269917|585791028|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
162202604|NCT02269917|585791026|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
162202605|NCT02269917|585791027|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
162202606|NCT02269917|585791028|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
162202607|NCT02269917|585791026|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
162202608|NCT02269917|585791027|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
162202609|NCT02269917|585791028|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
162202610|NCT02269917|585791026|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
162202611|NCT02269917|585791027|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
162202612|NCT02269917|585791028|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
162202613|NCT02269917|585791026|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
162202614|NCT02269917|585791027|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
162202615|NCT02269917|585791028|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
162202616|NCT02269917|585791026|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
162202617|NCT02269917|585791027|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
162202618|NCT02269917|585791028|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
162202619|NCT02269917|585791026|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
162202620|NCT02269917|585791027|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
161929400|NCT01227395|584789862|FG001|Overall Study|Protocol Violation|1|||
161929401|NCT00105508|584789863|FG000|Overall Study|Prephase Dropout|1|||
161929402|NCT00105508|584789864|FG001|Overall Study|Prephase Dropout|0|||
161929403|NCT00105508|584789863|FG000|Overall Study|Adverse Event|16|||
161929404|NCT00105508|584789864|FG001|Overall Study|Adverse Event|19|||
161929405|NCT00105508|584789863|FG000|Overall Study|Insufficient Efficacy|1|||
161929406|NCT00105508|584789864|FG001|Overall Study|Insufficient Efficacy|0|||
161929407|NCT00105508|584789863|FG000|Overall Study|Withdrawal by Subject|10|||
161929408|NCT00105508|584789864|FG001|Overall Study|Withdrawal by Subject|6|||
161929409|NCT00105508|584789863|FG000|Overall Study|Lost to Follow-up|3|||
161929410|NCT00105508|584789864|FG001|Overall Study|Lost to Follow-up|0|||
161929411|NCT00105508|584789863|FG000|Overall Study|Protocol Violation|1|||
161929412|NCT00105508|584789864|FG001|Overall Study|Protocol Violation|2|||
161929413|NCT00105508|584789863|FG000|Overall Study|Other|8|||
161929414|NCT00105508|584789864|FG001|Overall Study|Other|9|||
161929415|NCT00683384|584789865|FG000|Overall Study|Death|1|||
161929416|NCT00683384|584789865|FG000|Overall Study|Adverse Event|1|||
161929417|NCT00120874|584789866|FG000|Overall Study|Death|0|||
161929418|NCT00120874|584789867|FG001|Overall Study|Death|1|||
162021082|NCT01868542|585133415|FG001|Overall Study|Protocol Violation|1|||
161929419|NCT01108055|584789868|FG000|Overall Study|Ineligible|11|||
161929420|NCT01108055|584789868|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
162021083|NCT01868542|585133414|FG000|Overall Study|Unclassified|0|||
161929421|NCT01348490|584789871|FG000|Overall Study|Death|1|||
161929422|NCT01348490|584789871|FG000|Overall Study|Adverse Event|3|||
161929423|NCT01348490|584789871|FG000|Overall Study|Consent withdrawn|7|||
161929424|NCT01348490|584789871|FG000|Overall Study|Disease progression|3|||
161929425|NCT01348490|584789871|FG000|Overall Study|Lost to Follow-up|1|||
161929426|NCT01348490|584789871|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
162021084|NCT01868542|585133415|FG001|Overall Study|Unclassified|1|||
161929427|NCT01348490|584789871|FG000|Overall Study|Other Unspecified|8|||
161929428|NCT03632720|584789872|FG000|Overall Study|Adverse Event|2|||
161929429|NCT03632720|584789873|FG001|Overall Study|Adverse Event|0|||
161929430|NCT03632720|584789874|FG002|Overall Study|Adverse Event|0|||
161929431|NCT03632720|584789872|FG000|Overall Study|Lost to Follow-up|0|||
162202621|NCT02269917|585791028|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
162202622|NCT02269917|585791026|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
162202623|NCT02269917|585791027|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
162202624|NCT02269917|585791028|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
162202625|NCT02269917|585791026|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
162202626|NCT02269917|585791027|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
162202627|NCT02269917|585791028|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
162202628|NCT02269917|585791026|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
162202629|NCT02269917|585791027|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
162202630|NCT02269917|585791028|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
162202631|NCT02269917|585791026|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
162202632|NCT02269917|585791027|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
162202633|NCT02269917|585791028|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
162202634|NCT02269917|585791026|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
162202635|NCT02269917|585791027|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
162202636|NCT02269917|585791028|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
162202637|NCT02269917|585791026|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
162202638|NCT02269917|585791027|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
162202639|NCT02269917|585791028|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
161822426|NCT01567527|584391104|FG004|IM Depot Stabilization.|Adverse Event|0|||
161822427|NCT01567527|584391100|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
161822428|NCT01567527|584391101|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
161822429|NCT01567527|584391102|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
161822430|NCT01567527|584391103|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
161822431|NCT01567527|584391104|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
161822432|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
161822433|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
161822434|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
161822435|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
161822436|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
161822437|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
161822438|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
161822439|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
161822440|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
161822441|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
161822442|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
161822443|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
161822444|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
161822445|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
161822446|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
161822447|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
161822448|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
161822449|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
161822450|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
161822451|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
161822452|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161822453|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161822454|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161822455|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
161822456|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
161822457|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
161822458|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
161822459|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
161822460|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
161822461|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
161822462|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
161822463|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
161822464|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
161822465|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
161822466|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
161929432|NCT03632720|584789873|FG001|Overall Study|Lost to Follow-up|1|||
161929433|NCT03632720|584789874|FG002|Overall Study|Lost to Follow-up|0|||
162202640|NCT02269917|585791026|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
161929434|NCT03632720|584789872|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
161929435|NCT03632720|584789873|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
161929436|NCT03632720|584789874|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
161929437|NCT03632720|584789872|FG000|Overall Study|Screen failure|0|||
161929438|NCT03632720|584789873|FG001|Overall Study|Screen failure|1|||
161929439|NCT03632720|584789874|FG002|Overall Study|Screen failure|0|||
161929440|NCT01049828|584789875|FG000|Overall Study|Claustrophibia and Frustration|2|||
161929441|NCT02015104|584789876|FG000|Overall Study|Withdrew consent after first dose drug|1|||
161929442|NCT02015104|584789877|FG001|Overall Study|Withdrew consent after first dose drug|0|||
161929443|NCT02015104|584789876|FG000|Overall Study|Withdrew consent prior to treatment|0|||
161929444|NCT02015104|584789877|FG001|Overall Study|Withdrew consent prior to treatment|1|||
161929445|NCT03011372|584789878|FG000|Overall Study|Death|16|||
161929446|NCT03011372|584789878|FG000|Overall Study|Lost to Follow-up|2|||
161929447|NCT03011372|584789878|FG000|Overall Study|Sponsor Decision|17|||
161929448|NCT03011372|584789878|FG000|Overall Study|Withdrawal by Subject|7|||
161929449|NCT03011372|584789878|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
161929450|NCT03011372|584789878|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
161929451|NCT03011372|584789878|FG000|Overall Study|Sponsor's Decision|2|||
161929452|NCT03572218|584789879|FG000|Overall Study|Lost to Follow-up|3|||
161929453|NCT03572218|584789880|FG001|Overall Study|Lost to Follow-up|2|||
161929454|NCT03572218|584789879|FG000|Overall Study|No longer available for study visits|2|||
161929455|NCT03572218|584789880|FG001|Overall Study|No longer available for study visits|1|||
161929456|NCT03572218|584789879|FG000|Overall Study|No longer interested|1|||
161929457|NCT03572218|584789880|FG001|Overall Study|No longer interested|2|||
161929458|NCT03738215|584789881|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
161929459|NCT03738215|584789882|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
161929460|NCT03738215|584789883|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
161929461|NCT03738215|584789881|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
161929462|NCT03738215|584789882|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
161929463|NCT03738215|584789883|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161929464|NCT03738215|584789881|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
161929465|NCT03738215|584789882|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
161929466|NCT03738215|584789883|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
161929467|NCT03738215|584789881|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
161929468|NCT03738215|584789882|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
161929469|NCT03738215|584789883|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
161929470|NCT03738215|584789881|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
161929471|NCT03738215|584789882|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
161929472|NCT03738215|584789883|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
161929473|NCT03738215|584789881|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
161929474|NCT03738215|584789882|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
161929475|NCT03738215|584789883|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
161929476|NCT03738215|584789881|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
161929477|NCT03738215|584789882|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
161929478|NCT03738215|584789883|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
161929479|NCT03738215|584789881|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
161929480|NCT03738215|584789882|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
161929481|NCT03738215|584789883|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
161929482|NCT03738215|584789881|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
161929483|NCT03738215|584789882|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
161929484|NCT03738215|584789883|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
161929485|NCT03738215|584789881|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
161929486|NCT03738215|584789882|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
161929487|NCT03738215|584789883|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
161929488|NCT00853047|584789884|FG000|Core Phase|Participant Request|0|||
161929489|NCT00853047|584789885|FG001|Core Phase|Participant Request|0|||
161929490|NCT00853047|584789886|FG002|Core Phase|Participant Request|0|||
161929491|NCT00853047|584789887|FG003|Core Phase|Participant Request|1|||
161929492|NCT00853047|584789888|FG004|Core Phase|Participant Request|0|||
161929493|NCT00853047|584789889|FG005|Core Phase|Participant Request|0|||
161929494|NCT00853047|584789884|FG000|Open-Label Extension Phase|Participant Request|0|||
161929495|NCT00853047|584789885|FG001|Open-Label Extension Phase|Participant Request|0|||
161929496|NCT00853047|584789886|FG002|Open-Label Extension Phase|Participant Request|0|||
162021085|NCT03844945|585133416|FG000|Overall Study|Adverse Event|1|||
161929497|NCT00853047|584789887|FG003|Open-Label Extension Phase|Participant Request|0|||
161929498|NCT00853047|584789888|FG004|Open-Label Extension Phase|Participant Request|0|||
161929499|NCT00853047|584789889|FG005|Open-Label Extension Phase|Participant Request|7|||
162021086|NCT03844945|585133417|FG001|Overall Study|Adverse Event|1|||
162021087|NCT03844945|585133418|FG002|Overall Study|Adverse Event|4|||
162021088|NCT03844945|585133419|FG003|Overall Study|Adverse Event|0|||
162021089|NCT03844945|585133416|FG000|Overall Study|Withdrawal by Subject|0|||
162021090|NCT03844945|585133417|FG001|Overall Study|Withdrawal by Subject|0|||
162021091|NCT03844945|585133418|FG002|Overall Study|Withdrawal by Subject|1|||
162021092|NCT03844945|585133419|FG003|Overall Study|Withdrawal by Subject|0|||
162021093|NCT03844945|585133416|FG000|Overall Study|Lack of Efficacy|0|||
162021094|NCT03844945|585133417|FG001|Overall Study|Lack of Efficacy|0|||
162021095|NCT03844945|585133418|FG002|Overall Study|Lack of Efficacy|0|||
162021096|NCT03844945|585133419|FG003|Overall Study|Lack of Efficacy|1|||
162021097|NCT03254459|585133421|FG000|Overall Study|Adverse Event|7|||
162021098|NCT03254459|585133422|FG001|Overall Study|Adverse Event|20|||
162021099|NCT03254459|585133421|FG000|Overall Study|Withdrawal by Subject Consent|3|||
162021100|NCT03254459|585133422|FG001|Overall Study|Withdrawal by Subject Consent|1|||
162021101|NCT03254459|585133421|FG000|Overall Study|Lost to Follow-up|0|||
162021102|NCT03254459|585133422|FG001|Overall Study|Lost to Follow-up|1|||
162021103|NCT03254459|585133421|FG000|Overall Study|Miscellaneous|0|||
162021104|NCT03254459|585133422|FG001|Overall Study|Miscellaneous|1|||
162021105|NCT01904773|585133423|FG000|Screen|Screen failure|3|||
162021106|NCT01904773|585133424|FG001|Screen|Screen failure|0|||
162021107|NCT01904773|585133425|FG002|Screen|Screen failure|0|||
162021108|NCT01904773|585133426|FG003|Screen|Screen failure|0|||
162021109|NCT01904773|585133427|FG004|Screen|Screen failure|0|||
162021110|NCT01904773|585133428|FG005|Screen|Screen failure|0|||
162021111|NCT01904773|585133429|FG006|Screen|Screen failure|0|||
162021112|NCT01904773|585133430|FG007|Screen|Screen failure|0|||
162021113|NCT01904773|585133431|FG008|Screen|Screen failure|0|||
162021114|NCT01904773|585133423|FG000|Screen|Withdrawal by Subject|1|||
162021115|NCT01904773|585133424|FG001|Screen|Withdrawal by Subject|0|||
162021116|NCT01904773|585133425|FG002|Screen|Withdrawal by Subject|0|||
162021117|NCT01904773|585133426|FG003|Screen|Withdrawal by Subject|0|||
162021118|NCT01904773|585133427|FG004|Screen|Withdrawal by Subject|0|||
162021119|NCT01904773|585133428|FG005|Screen|Withdrawal by Subject|0|||
162021120|NCT01904773|585133429|FG006|Screen|Withdrawal by Subject|0|||
162021121|NCT01904773|585133430|FG007|Screen|Withdrawal by Subject|0|||
162021122|NCT01904773|585133431|FG008|Screen|Withdrawal by Subject|0|||
162021123|NCT01904773|585133423|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
162021124|NCT01904773|585133424|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
162021125|NCT01904773|585133425|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
162021126|NCT01904773|585133426|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
162021127|NCT01904773|585133427|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
162021128|NCT01904773|585133428|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
162021129|NCT01904773|585133429|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
162021130|NCT01904773|585133430|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
162021131|NCT01904773|585133431|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
162021132|NCT01904773|585133423|FG000|First Intervention|Adverse Event|0|||
161929500|NCT00853047|584789884|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
161929501|NCT00853047|584789885|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
161929502|NCT00853047|584789886|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
161929503|NCT00853047|584789887|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
161929504|NCT00853047|584789888|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
161929505|NCT00853047|584789889|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
161929506|NCT00853047|584789884|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
161929507|NCT00853047|584789885|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
161929508|NCT00853047|584789886|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
161929509|NCT00853047|584789887|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
161929510|NCT00853047|584789888|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
162021133|NCT01904773|585133424|FG001|First Intervention|Adverse Event|0|||
162021134|NCT01904773|585133425|FG002|First Intervention|Adverse Event|0|||
162021135|NCT01904773|585133426|FG003|First Intervention|Adverse Event|0|||
162021136|NCT01904773|585133427|FG004|First Intervention|Adverse Event|0|||
162021137|NCT01904773|585133428|FG005|First Intervention|Adverse Event|0|||
162021138|NCT01904773|585133429|FG006|First Intervention|Adverse Event|1|||
162021139|NCT01904773|585133430|FG007|First Intervention|Adverse Event|0|||
161929511|NCT00853047|584789889|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
162021140|NCT01904773|585133431|FG008|First Intervention|Adverse Event|0|||
162021141|NCT01904773|585133423|FG000|Placebo Washout First Intervention|Condition worsened|0|||
162021142|NCT01904773|585133424|FG001|Placebo Washout First Intervention|Condition worsened|1|||
162021143|NCT01904773|585133425|FG002|Placebo Washout First Intervention|Condition worsened|0|||
162021144|NCT01904773|585133426|FG003|Placebo Washout First Intervention|Condition worsened|0|||
162021145|NCT01904773|585133427|FG004|Placebo Washout First Intervention|Condition worsened|0|||
161929512|NCT00853047|584789884|FG000|Open-Label Extension Phase|Investigator Decision|0|||
161929513|NCT00853047|584789885|FG001|Open-Label Extension Phase|Investigator Decision|0|||
161929514|NCT00853047|584789886|FG002|Open-Label Extension Phase|Investigator Decision|0|||
161929515|NCT00853047|584789887|FG003|Open-Label Extension Phase|Investigator Decision|0|||
161929516|NCT00853047|584789888|FG004|Open-Label Extension Phase|Investigator Decision|0|||
161929517|NCT00853047|584789889|FG005|Open-Label Extension Phase|Investigator Decision|1|||
161929518|NCT00853047|584789884|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
161929519|NCT00853047|584789885|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
161929520|NCT00853047|584789886|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
161929521|NCT00853047|584789887|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
161929522|NCT00853047|584789888|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
161929523|NCT00853047|584789889|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
161929524|NCT02638493|584789890|FG000|Overall Study|Inability to provide semen samples|2|||
161929525|NCT02638493|584789891|FG001|Overall Study|Inability to provide semen samples|0|||
161929526|NCT02638493|584789892|FG002|Overall Study|Inability to provide semen samples|0|||
161929527|NCT01569763|584792308|FG000|Overall Study|Lack of Efficacy|2|||
161929528|NCT01569763|584792309|FG001|Overall Study|Lack of Efficacy|7|||
161929529|NCT01569763|584792308|FG000|Overall Study|Adverse Event|1|||
161929530|NCT01569763|584792309|FG001|Overall Study|Adverse Event|0|||
161929531|NCT01926509|584792310|FG000|Overall Study|vital sign met discontinuation criteria|1|||
161929532|NCT01926509|584792311|FG001|Overall Study|vital sign met discontinuation criteria|0|||
161929533|NCT01926509|584792312|FG002|Overall Study|vital sign met discontinuation criteria|0|||
161929534|NCT01926509|584792313|FG003|Overall Study|vital sign met discontinuation criteria|0|||
161929535|NCT02730169|584792314|FG000|Overall Study|Protocol Violation|1|||
161929536|NCT02730169|584792315|FG001|Overall Study|Protocol Violation|0|||
161929537|NCT02730169|584792316|FG002|Overall Study|Protocol Violation|0|||
161929538|NCT02730169|584792317|FG003|Overall Study|Protocol Violation|1|||
161929539|NCT02730169|584792314|FG000|Overall Study|Adverse Event|2|||
161929540|NCT02730169|584792315|FG001|Overall Study|Adverse Event|3|||
161929541|NCT02730169|584792316|FG002|Overall Study|Adverse Event|3|||
161929542|NCT02730169|584792317|FG003|Overall Study|Adverse Event|0|||
161929543|NCT02730169|584792314|FG000|Overall Study|Adverse Event of Special Interest|0|||
161929544|NCT02730169|584792315|FG001|Overall Study|Adverse Event of Special Interest|1|||
161929545|NCT02730169|584792316|FG002|Overall Study|Adverse Event of Special Interest|2|||
161929546|NCT02730169|584792317|FG003|Overall Study|Adverse Event of Special Interest|0|||
161929547|NCT02730169|584792314|FG000|Overall Study|Withdrawal by Subject|6|||
161929548|NCT02730169|584792315|FG001|Overall Study|Withdrawal by Subject|11|||
161929549|NCT02730169|584792316|FG002|Overall Study|Withdrawal by Subject|6|||
161929550|NCT02730169|584792317|FG003|Overall Study|Withdrawal by Subject|8|||
161929551|NCT02730169|584792314|FG000|Overall Study|Lost to Follow-up|5|||
161929552|NCT02730169|584792315|FG001|Overall Study|Lost to Follow-up|6|||
161929553|NCT02730169|584792316|FG002|Overall Study|Lost to Follow-up|5|||
161929554|NCT02730169|584792317|FG003|Overall Study|Lost to Follow-up|6|||
161929555|NCT02730169|584792314|FG000|Overall Study|Other|0|||
161929556|NCT02730169|584792315|FG001|Overall Study|Other|0|||
161929557|NCT02730169|584792316|FG002|Overall Study|Other|1|||
161929558|NCT02730169|584792317|FG003|Overall Study|Other|1|||
161929559|NCT03004183|584792318|FG000|Overall Study|Adverse Event|7|||
161929560|NCT03004183|584792318|FG000|Overall Study|Lost to Follow-up|1|||
161929561|NCT03004183|584792318|FG000|Overall Study|Physician Decision|40|||
161929562|NCT03004183|584792318|FG000|Overall Study|Withdrawal by Subject|1|||
161929563|NCT03004183|584792318|FG000|Overall Study|COVID-19|1|||
161929564|NCT02698787|584792322|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
161929565|NCT02698787|584792323|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
161929566|NCT02168439|584792327|FG000|Overall Study|Protocol Violation|0|||
161929567|NCT02168439|584792328|FG001|Overall Study|Protocol Violation|2|||
161929568|NCT02004275|584792329|FG000|Phase 1|Ineligible|0|||
161929569|NCT02004275|584792330|FG001|Phase 1|Ineligible|0|||
161929570|NCT02004275|584792331|FG002|Phase 1|Ineligible|0|||
161929571|NCT02004275|584792332|FG003|Phase 1|Ineligible|1|||
161929572|NCT02004275|584792333|FG004|Phase 1|Ineligible|1|||
161929573|NCT02004275|584792334|FG005|Phase 1|Ineligible|0|||
161929574|NCT02004275|584792329|FG000|Phase 1|Protocol Violation|0|||
161929575|NCT02004275|584792330|FG001|Phase 1|Protocol Violation|0|||
161929576|NCT02004275|584792331|FG002|Phase 1|Protocol Violation|0|||
161929577|NCT02004275|584792332|FG003|Phase 1|Protocol Violation|1|||
161929578|NCT02004275|584792333|FG004|Phase 1|Protocol Violation|0|||
161929579|NCT02004275|584792334|FG005|Phase 1|Protocol Violation|5|||
161929580|NCT02004275|584792329|FG000|Phase 2 Part 1|Ineligible|6|||
161929581|NCT02004275|584792330|FG001|Phase 2 Part 1|Ineligible|9|||
161929582|NCT02004275|584792331|FG002|Phase 2 Part 1|Ineligible|0|||
161929583|NCT02004275|584792332|FG003|Phase 2 Part 1|Ineligible|0|||
161929584|NCT02004275|584792333|FG004|Phase 2 Part 1|Ineligible|0|||
161929585|NCT02004275|584792334|FG005|Phase 2 Part 1|Ineligible|0|||
161929586|NCT02004275|584792329|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
161929587|NCT02004275|584792330|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
161929588|NCT02004275|584792331|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
161929589|NCT02004275|584792332|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
161929590|NCT02004275|584792333|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
161929591|NCT02004275|584792334|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
161929592|NCT02533674|584792335|FG000|Dose Level I|Progressive disease|1|||
161929593|NCT02533674|584792336|FG001|Dose Level I|Progressive disease|0|||
161929594|NCT02533674|584792337|FG002|Dose Level I|Progressive disease|0|||
161929595|NCT02533674|584792338|FG003|Dose Level I|Progressive disease|0|||
161929596|NCT02533674|584792339|FG004|Dose Level I|Progressive disease|0|||
161929597|NCT02533674|584792340|FG005|Dose Level I|Progressive disease|0|||
161929598|NCT02533674|584792341|FG006|Dose Level I|Progressive disease|0|||
161929599|NCT02533674|584792342|FG007|Dose Level I|Progressive disease|0|||
161929600|NCT02533674|584792335|FG000|Dose Level I|Withdrawal by Subject|1|||
161929601|NCT02533674|584792336|FG001|Dose Level I|Withdrawal by Subject|0|||
161929602|NCT02533674|584792337|FG002|Dose Level I|Withdrawal by Subject|0|||
161929603|NCT02533674|584792338|FG003|Dose Level I|Withdrawal by Subject|0|||
161929604|NCT02533674|584792339|FG004|Dose Level I|Withdrawal by Subject|0|||
161929605|NCT02533674|584792340|FG005|Dose Level I|Withdrawal by Subject|0|||
161929606|NCT02533674|584792341|FG006|Dose Level I|Withdrawal by Subject|0|||
161929607|NCT02533674|584792342|FG007|Dose Level I|Withdrawal by Subject|0|||
161929608|NCT02533674|584792335|FG000|Dose Level I|Physician Decision|1|||
161929609|NCT02533674|584792336|FG001|Dose Level I|Physician Decision|0|||
162021146|NCT01904773|585133428|FG005|Placebo Washout First Intervention|Condition worsened|0|||
161929610|NCT02533674|584792337|FG002|Dose Level I|Physician Decision|0|||
161929611|NCT02533674|584792338|FG003|Dose Level I|Physician Decision|0|||
161929612|NCT02533674|584792339|FG004|Dose Level I|Physician Decision|0|||
161676881|NCT01303965|583870577|FG001|Overall Study|Death|3|||
161676882|NCT01303965|583870576|FG000|Overall Study|Withdrawal by Subject|1|||
161676883|NCT01303965|583870577|FG001|Overall Study|Withdrawal by Subject|0|||
161676884|NCT01303965|583870576|FG000|Overall Study|Disease Progression|1|||
161676885|NCT01303965|583870577|FG001|Overall Study|Disease Progression|6|||
161676886|NCT04060563|583870582|FG000|Overall Study|Lost to Follow-up|1|||
161676887|NCT04060563|583870583|FG001|Overall Study|Lost to Follow-up|1|||
161676888|NCT04060563|583870582|FG000|Overall Study|Physician Decision|0|||
161676889|NCT04060563|583870583|FG001|Overall Study|Physician Decision|1|||
161676890|NCT00851682|583870584|FG000|Overall Study|screen failure|5|||
161676891|NCT00851682|583870585|FG001|Overall Study|screen failure|0|||
161929613|NCT02533674|584792340|FG005|Dose Level I|Physician Decision|0|||
161929614|NCT02533674|584792341|FG006|Dose Level I|Physician Decision|0|||
161929615|NCT02533674|584792342|FG007|Dose Level I|Physician Decision|0|||
161929616|NCT02533674|584792335|FG000|Dose Level I|Death|1|||
161929617|NCT02533674|584792336|FG001|Dose Level I|Death|0|||
161929618|NCT02533674|584792337|FG002|Dose Level I|Death|0|||
161929619|NCT02533674|584792338|FG003|Dose Level I|Death|0|||
161929620|NCT02533674|584792339|FG004|Dose Level I|Death|0|||
161929621|NCT02533674|584792340|FG005|Dose Level I|Death|0|||
161929622|NCT02533674|584792341|FG006|Dose Level I|Death|0|||
161929623|NCT02533674|584792342|FG007|Dose Level I|Death|0|||
161929624|NCT02533674|584792335|FG000|Dose Level I|Never Treated|1|||
161929625|NCT02533674|584792336|FG001|Dose Level I|Never Treated|0|||
161929626|NCT02533674|584792337|FG002|Dose Level I|Never Treated|0|||
161929627|NCT02533674|584792338|FG003|Dose Level I|Never Treated|0|||
161929628|NCT02533674|584792339|FG004|Dose Level I|Never Treated|0|||
161929629|NCT02533674|584792340|FG005|Dose Level I|Never Treated|0|||
161929630|NCT02533674|584792341|FG006|Dose Level I|Never Treated|0|||
161929631|NCT02533674|584792342|FG007|Dose Level I|Never Treated|0|||
161929632|NCT02533674|584792335|FG000|Dose Level II|Progressive disease|0|||
161929633|NCT02533674|584792336|FG001|Dose Level II|Progressive disease|3|||
161929634|NCT02533674|584792337|FG002|Dose Level II|Progressive disease|0|||
161929635|NCT02533674|584792338|FG003|Dose Level II|Progressive disease|0|||
161929636|NCT02533674|584792339|FG004|Dose Level II|Progressive disease|0|||
161929637|NCT02533674|584792340|FG005|Dose Level II|Progressive disease|0|||
161929638|NCT02533674|584792341|FG006|Dose Level II|Progressive disease|0|||
161929639|NCT02533674|584792342|FG007|Dose Level II|Progressive disease|0|||
161929640|NCT02533674|584792335|FG000|Dose Level II|Withdrawal by Subject|0|||
161929641|NCT02533674|584792336|FG001|Dose Level II|Withdrawal by Subject|1|||
161929642|NCT02533674|584792337|FG002|Dose Level II|Withdrawal by Subject|0|||
161929643|NCT02533674|584792338|FG003|Dose Level II|Withdrawal by Subject|0|||
161929644|NCT02533674|584792339|FG004|Dose Level II|Withdrawal by Subject|0|||
161929645|NCT02533674|584792340|FG005|Dose Level II|Withdrawal by Subject|0|||
161929646|NCT02533674|584792341|FG006|Dose Level II|Withdrawal by Subject|0|||
161929647|NCT02533674|584792342|FG007|Dose Level II|Withdrawal by Subject|0|||
161929648|NCT02533674|584792335|FG000|Dose Level II|Treatment-related AE|0|||
161929649|NCT02533674|584792336|FG001|Dose Level II|Treatment-related AE|1|||
161929650|NCT02533674|584792337|FG002|Dose Level II|Treatment-related AE|0|||
161929651|NCT02533674|584792338|FG003|Dose Level II|Treatment-related AE|0|||
161929652|NCT02533674|584792339|FG004|Dose Level II|Treatment-related AE|0|||
161929653|NCT02533674|584792340|FG005|Dose Level II|Treatment-related AE|0|||
161929654|NCT02533674|584792341|FG006|Dose Level II|Treatment-related AE|0|||
161929655|NCT02533674|584792342|FG007|Dose Level II|Treatment-related AE|0|||
161929656|NCT02533674|584792335|FG000|Dose Level II|Physician Decision|0|||
161929657|NCT02533674|584792336|FG001|Dose Level II|Physician Decision|1|||
161929658|NCT02533674|584792337|FG002|Dose Level II|Physician Decision|0|||
161929659|NCT02533674|584792338|FG003|Dose Level II|Physician Decision|0|||
161929660|NCT02533674|584792339|FG004|Dose Level II|Physician Decision|0|||
161929661|NCT02533674|584792340|FG005|Dose Level II|Physician Decision|0|||
161929662|NCT02533674|584792341|FG006|Dose Level II|Physician Decision|0|||
161929663|NCT02533674|584792342|FG007|Dose Level II|Physician Decision|0|||
161929664|NCT02533674|584792335|FG000|Dose Level II|Non-treatment-related AE|0|||
161929665|NCT02533674|584792336|FG001|Dose Level II|Non-treatment-related AE|1|||
161929666|NCT02533674|584792337|FG002|Dose Level II|Non-treatment-related AE|0|||
161929667|NCT02533674|584792338|FG003|Dose Level II|Non-treatment-related AE|0|||
161929668|NCT02533674|584792339|FG004|Dose Level II|Non-treatment-related AE|0|||
161929669|NCT02533674|584792340|FG005|Dose Level II|Non-treatment-related AE|0|||
161929670|NCT02533674|584792341|FG006|Dose Level II|Non-treatment-related AE|0|||
161929671|NCT02533674|584792342|FG007|Dose Level II|Non-treatment-related AE|0|||
161929672|NCT02533674|584792335|FG000|Dose Level III|Progressive disease|0|||
161676892|NCT01379573|583870589|FG000|Overall Study|Lost to Follow-up|1|||
161676893|NCT01379573|583870589|FG000|Overall Study|Screen Failure|10|||
161929673|NCT02533674|584792336|FG001|Dose Level III|Progressive disease|0|||
161929674|NCT02533674|584792337|FG002|Dose Level III|Progressive disease|2|||
161929675|NCT02533674|584792338|FG003|Dose Level III|Progressive disease|0|||
161676894|NCT01829425|583870600|FG000|Overall Study|Withdrawal by Subject|4|||
161929676|NCT02533674|584792339|FG004|Dose Level III|Progressive disease|0|||
161929677|NCT02533674|584792340|FG005|Dose Level III|Progressive disease|0|||
161929678|NCT02533674|584792341|FG006|Dose Level III|Progressive disease|0|||
161929679|NCT02533674|584792342|FG007|Dose Level III|Progressive disease|0|||
161929680|NCT02533674|584792335|FG000|Dose Level III|Withdrawal by Subject|0|||
161929681|NCT02533674|584792336|FG001|Dose Level III|Withdrawal by Subject|0|||
161929682|NCT02533674|584792337|FG002|Dose Level III|Withdrawal by Subject|1|||
161929683|NCT02533674|584792338|FG003|Dose Level III|Withdrawal by Subject|0|||
161929684|NCT02533674|584792339|FG004|Dose Level III|Withdrawal by Subject|0|||
161929685|NCT02533674|584792340|FG005|Dose Level III|Withdrawal by Subject|0|||
161929686|NCT02533674|584792341|FG006|Dose Level III|Withdrawal by Subject|0|||
161929687|NCT02533674|584792342|FG007|Dose Level III|Withdrawal by Subject|0|||
161929688|NCT02533674|584792335|FG000|Dose Level III|Treatment-related AE|0|||
161929689|NCT02533674|584792336|FG001|Dose Level III|Treatment-related AE|0|||
161929690|NCT02533674|584792337|FG002|Dose Level III|Treatment-related AE|1|||
161929691|NCT02533674|584792338|FG003|Dose Level III|Treatment-related AE|0|||
161929692|NCT02533674|584792339|FG004|Dose Level III|Treatment-related AE|0|||
161929693|NCT02533674|584792340|FG005|Dose Level III|Treatment-related AE|0|||
161929694|NCT02533674|584792341|FG006|Dose Level III|Treatment-related AE|0|||
161929695|NCT02533674|584792342|FG007|Dose Level III|Treatment-related AE|0|||
161929696|NCT02533674|584792335|FG000|Dose Level IV|Progressive disease|0|||
161929697|NCT02533674|584792336|FG001|Dose Level IV|Progressive disease|0|||
161929698|NCT02533674|584792337|FG002|Dose Level IV|Progressive disease|0|||
161929699|NCT02533674|584792338|FG003|Dose Level IV|Progressive disease|3|||
161929700|NCT02533674|584792339|FG004|Dose Level IV|Progressive disease|0|||
161929701|NCT02533674|584792340|FG005|Dose Level IV|Progressive disease|0|||
161929702|NCT02533674|584792341|FG006|Dose Level IV|Progressive disease|0|||
161929703|NCT02533674|584792342|FG007|Dose Level IV|Progressive disease|0|||
161929704|NCT02533674|584792335|FG000|Dose Level IV|Withdrawal by Subject|0|||
161929705|NCT02533674|584792336|FG001|Dose Level IV|Withdrawal by Subject|0|||
161929706|NCT02533674|584792337|FG002|Dose Level IV|Withdrawal by Subject|0|||
161929707|NCT02533674|584792338|FG003|Dose Level IV|Withdrawal by Subject|1|||
161929708|NCT02533674|584792339|FG004|Dose Level IV|Withdrawal by Subject|0|||
161929709|NCT02533674|584792340|FG005|Dose Level IV|Withdrawal by Subject|0|||
161929710|NCT02533674|584792341|FG006|Dose Level IV|Withdrawal by Subject|0|||
161929711|NCT02533674|584792342|FG007|Dose Level IV|Withdrawal by Subject|0|||
161929712|NCT02533674|584792335|FG000|Dose Level IV|Physician Decision|0|||
161929713|NCT02533674|584792336|FG001|Dose Level IV|Physician Decision|0|||
161929714|NCT02533674|584792337|FG002|Dose Level IV|Physician Decision|0|||
161929715|NCT02533674|584792338|FG003|Dose Level IV|Physician Decision|1|||
161929716|NCT02533674|584792339|FG004|Dose Level IV|Physician Decision|0|||
161929717|NCT02533674|584792340|FG005|Dose Level IV|Physician Decision|0|||
161929718|NCT02533674|584792341|FG006|Dose Level IV|Physician Decision|0|||
161929719|NCT02533674|584792342|FG007|Dose Level IV|Physician Decision|0|||
161929720|NCT02533674|584792335|FG000|Dose Level V|Progressive disease|0|||
161929721|NCT02533674|584792336|FG001|Dose Level V|Progressive disease|0|||
161929722|NCT02533674|584792337|FG002|Dose Level V|Progressive disease|0|||
161929723|NCT02533674|584792338|FG003|Dose Level V|Progressive disease|0|||
161929724|NCT02533674|584792339|FG004|Dose Level V|Progressive disease|3|||
161929725|NCT02533674|584792340|FG005|Dose Level V|Progressive disease|0|||
161929726|NCT02533674|584792341|FG006|Dose Level V|Progressive disease|0|||
161929727|NCT02533674|584792342|FG007|Dose Level V|Progressive disease|0|||
161929728|NCT02533674|584792335|FG000|Dose Level V|Withdrawal by Subject|0|||
161929729|NCT02533674|584792336|FG001|Dose Level V|Withdrawal by Subject|0|||
161929730|NCT02533674|584792337|FG002|Dose Level V|Withdrawal by Subject|0|||
161929731|NCT02533674|584792338|FG003|Dose Level V|Withdrawal by Subject|0|||
161929732|NCT02533674|584792339|FG004|Dose Level V|Withdrawal by Subject|1|||
161929733|NCT02533674|584792340|FG005|Dose Level V|Withdrawal by Subject|0|||
161929734|NCT02533674|584792341|FG006|Dose Level V|Withdrawal by Subject|0|||
161929735|NCT02533674|584792342|FG007|Dose Level V|Withdrawal by Subject|0|||
161929736|NCT02533674|584792335|FG000|Dose Level V|Physician Decision|0|||
161929737|NCT02533674|584792336|FG001|Dose Level V|Physician Decision|0|||
161929738|NCT02533674|584792337|FG002|Dose Level V|Physician Decision|0|||
161929739|NCT02533674|584792338|FG003|Dose Level V|Physician Decision|0|||
162202641|NCT02269917|585791027|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
161929740|NCT02533674|584792339|FG004|Dose Level V|Physician Decision|1|||
161929741|NCT02533674|584792340|FG005|Dose Level V|Physician Decision|0|||
161929742|NCT02533674|584792341|FG006|Dose Level V|Physician Decision|0|||
161929743|NCT02533674|584792342|FG007|Dose Level V|Physician Decision|0|||
161929744|NCT02533674|584792335|FG000|Dose Level VI|Progressive disease|0|||
161929745|NCT02533674|584792336|FG001|Dose Level VI|Progressive disease|0|||
161929746|NCT02533674|584792337|FG002|Dose Level VI|Progressive disease|0|||
161929747|NCT02533674|584792338|FG003|Dose Level VI|Progressive disease|0|||
161929748|NCT02533674|584792339|FG004|Dose Level VI|Progressive disease|0|||
161929749|NCT02533674|584792340|FG005|Dose Level VI|Progressive disease|7|||
161929750|NCT02533674|584792341|FG006|Dose Level VI|Progressive disease|0|||
161929751|NCT02533674|584792342|FG007|Dose Level VI|Progressive disease|0|||
161929752|NCT02533674|584792335|FG000|Dose Level VI|Withdrawal by Subject|0|||
161929753|NCT02533674|584792336|FG001|Dose Level VI|Withdrawal by Subject|0|||
162202642|NCT02269917|585791028|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
161929754|NCT02533674|584792337|FG002|Dose Level VI|Withdrawal by Subject|0|||
161929755|NCT02533674|584792338|FG003|Dose Level VI|Withdrawal by Subject|0|||
161929756|NCT02533674|584792339|FG004|Dose Level VI|Withdrawal by Subject|0|||
161929757|NCT02533674|584792340|FG005|Dose Level VI|Withdrawal by Subject|1|||
161929758|NCT02533674|584792341|FG006|Dose Level VI|Withdrawal by Subject|0|||
161929759|NCT02533674|584792342|FG007|Dose Level VI|Withdrawal by Subject|0|||
161929760|NCT02533674|584792335|FG000|Dose Level VI|Treatment-related AE|0|||
161929761|NCT02533674|584792336|FG001|Dose Level VI|Treatment-related AE|0|||
161929762|NCT02533674|584792337|FG002|Dose Level VI|Treatment-related AE|0|||
161929763|NCT02533674|584792338|FG003|Dose Level VI|Treatment-related AE|0|||
161929764|NCT02533674|584792339|FG004|Dose Level VI|Treatment-related AE|0|||
161929765|NCT02533674|584792340|FG005|Dose Level VI|Treatment-related AE|1|||
161929766|NCT02533674|584792341|FG006|Dose Level VI|Treatment-related AE|0|||
161929767|NCT02533674|584792342|FG007|Dose Level VI|Treatment-related AE|0|||
161929768|NCT02533674|584792335|FG000|Dose Level VII|Progressive disease|0|||
161929769|NCT02533674|584792336|FG001|Dose Level VII|Progressive disease|0|||
161929770|NCT02533674|584792337|FG002|Dose Level VII|Progressive disease|0|||
161929771|NCT02533674|584792338|FG003|Dose Level VII|Progressive disease|0|||
161929772|NCT02533674|584792339|FG004|Dose Level VII|Progressive disease|0|||
161929773|NCT02533674|584792340|FG005|Dose Level VII|Progressive disease|0|||
161929774|NCT02533674|584792341|FG006|Dose Level VII|Progressive disease|10|||
161929775|NCT02533674|584792342|FG007|Dose Level VII|Progressive disease|0|||
161929776|NCT02533674|584792335|FG000|Dose Level VII|Withdrawal by Subject|0|||
161929777|NCT02533674|584792336|FG001|Dose Level VII|Withdrawal by Subject|0|||
161929778|NCT02533674|584792337|FG002|Dose Level VII|Withdrawal by Subject|0|||
161929779|NCT02533674|584792338|FG003|Dose Level VII|Withdrawal by Subject|0|||
161929780|NCT02533674|584792339|FG004|Dose Level VII|Withdrawal by Subject|0|||
161929781|NCT02533674|584792340|FG005|Dose Level VII|Withdrawal by Subject|0|||
161929782|NCT02533674|584792341|FG006|Dose Level VII|Withdrawal by Subject|3|||
161929783|NCT02533674|584792342|FG007|Dose Level VII|Withdrawal by Subject|0|||
161929784|NCT02533674|584792335|FG000|Dose Level VII|Treatment-related AE|0|||
161929785|NCT02533674|584792336|FG001|Dose Level VII|Treatment-related AE|0|||
161929786|NCT02533674|584792337|FG002|Dose Level VII|Treatment-related AE|0|||
161929787|NCT02533674|584792338|FG003|Dose Level VII|Treatment-related AE|0|||
161929788|NCT02533674|584792339|FG004|Dose Level VII|Treatment-related AE|0|||
161929789|NCT02533674|584792340|FG005|Dose Level VII|Treatment-related AE|0|||
161929790|NCT02533674|584792341|FG006|Dose Level VII|Treatment-related AE|1|||
161929791|NCT02533674|584792342|FG007|Dose Level VII|Treatment-related AE|0|||
161929792|NCT02533674|584792335|FG000|Dose Level VII|Death|0|||
161929793|NCT02533674|584792336|FG001|Dose Level VII|Death|0|||
161929794|NCT02533674|584792337|FG002|Dose Level VII|Death|0|||
161929795|NCT02533674|584792338|FG003|Dose Level VII|Death|0|||
161929796|NCT02533674|584792339|FG004|Dose Level VII|Death|0|||
161929797|NCT02533674|584792340|FG005|Dose Level VII|Death|0|||
161929798|NCT02533674|584792341|FG006|Dose Level VII|Death|2|||
161929799|NCT02533674|584792342|FG007|Dose Level VII|Death|0|||
161929800|NCT02533674|584792335|FG000|Dose Level VIII|Progressive disease|0|||
161929801|NCT02533674|584792336|FG001|Dose Level VIII|Progressive disease|0|||
161929802|NCT02533674|584792337|FG002|Dose Level VIII|Progressive disease|0|||
161929803|NCT02533674|584792338|FG003|Dose Level VIII|Progressive disease|0|||
161929804|NCT02533674|584792339|FG004|Dose Level VIII|Progressive disease|0|||
161929805|NCT02533674|584792340|FG005|Dose Level VIII|Progressive disease|0|||
161929806|NCT02533674|584792341|FG006|Dose Level VIII|Progressive disease|0|||
161929807|NCT02533674|584792342|FG007|Dose Level VIII|Progressive disease|3|||
161929808|NCT02533674|584792335|FG000|Dose Level VIII|Withdrawal by Subject|0|||
161929809|NCT02533674|584792336|FG001|Dose Level VIII|Withdrawal by Subject|0|||
161929810|NCT02533674|584792337|FG002|Dose Level VIII|Withdrawal by Subject|0|||
161929811|NCT02533674|584792338|FG003|Dose Level VIII|Withdrawal by Subject|0|||
161929812|NCT02533674|584792339|FG004|Dose Level VIII|Withdrawal by Subject|0|||
161929813|NCT02533674|584792340|FG005|Dose Level VIII|Withdrawal by Subject|0|||
161929814|NCT02533674|584792341|FG006|Dose Level VIII|Withdrawal by Subject|0|||
161929815|NCT02533674|584792342|FG007|Dose Level VIII|Withdrawal by Subject|1|||
161929816|NCT02533674|584792335|FG000|Dose Level VIII|Treatment-related AE|0|||
161929817|NCT02533674|584792336|FG001|Dose Level VIII|Treatment-related AE|0|||
161929818|NCT02533674|584792337|FG002|Dose Level VIII|Treatment-related AE|0|||
161929819|NCT02533674|584792338|FG003|Dose Level VIII|Treatment-related AE|0|||
161929820|NCT02533674|584792339|FG004|Dose Level VIII|Treatment-related AE|0|||
161929821|NCT02533674|584792340|FG005|Dose Level VIII|Treatment-related AE|0|||
161929822|NCT02533674|584792341|FG006|Dose Level VIII|Treatment-related AE|0|||
161929823|NCT02533674|584792342|FG007|Dose Level VIII|Treatment-related AE|1|||
161929824|NCT02533674|584792335|FG000|Dose Level VIII|Never treated|0|||
161929825|NCT02533674|584792336|FG001|Dose Level VIII|Never treated|0|||
161929826|NCT02533674|584792337|FG002|Dose Level VIII|Never treated|0|||
161929827|NCT02533674|584792338|FG003|Dose Level VIII|Never treated|0|||
161929828|NCT02533674|584792339|FG004|Dose Level VIII|Never treated|0|||
161929829|NCT02533674|584792340|FG005|Dose Level VIII|Never treated|0|||
161929830|NCT02533674|584792341|FG006|Dose Level VIII|Never treated|0|||
161929831|NCT02533674|584792342|FG007|Dose Level VIII|Never treated|1|||
161929832|NCT01908699|584792350|FG000|Overall Study|Adverse Event|8|||
161929833|NCT01908699|584792351|FG001|Overall Study|Adverse Event|12|||
161929834|NCT01908699|584792350|FG000|Overall Study|Lack of Efficacy|2|||
161929835|NCT01908699|584792351|FG001|Overall Study|Lack of Efficacy|2|||
161929836|NCT01908699|584792350|FG000|Overall Study|Lost to Follow-up|2|||
161929837|NCT01908699|584792351|FG001|Overall Study|Lost to Follow-up|4|||
161929838|NCT01908699|584792350|FG000|Overall Study|Physician Decision|8|||
161929839|NCT01908699|584792351|FG001|Overall Study|Physician Decision|8|||
161929840|NCT01908699|584792350|FG000|Overall Study|Withdrawal by Subject|15|||
161929841|NCT01908699|584792351|FG001|Overall Study|Withdrawal by Subject|10|||
161929842|NCT01908699|584792350|FG000|Overall Study|Pregnancy|0|||
161929843|NCT01908699|584792351|FG001|Overall Study|Pregnancy|1|||
161929844|NCT01908699|584792350|FG000|Overall Study|Randomized in Error|1|||
161929845|NCT01908699|584792351|FG001|Overall Study|Randomized in Error|0|||
161929846|NCT01908699|584792350|FG000|Overall Study|Death|9|||
161929847|NCT01908699|584792351|FG001|Overall Study|Death|12|||
161929848|NCT01908699|584792350|FG000|Overall Study|Progressive Disease|30|||
161929849|NCT01908699|584792351|FG001|Overall Study|Progressive Disease|29|||
161929850|NCT01697501|584792352|FG000|Overall Study|Protocol Violation|2|||
161929851|NCT02242903|584792353|FG000|Overall Study|Withdrawal by Subject|1|||
161929852|NCT02242903|584792354|FG001|Overall Study|Withdrawal by Subject|0|||
161929853|NCT02242903|584792355|FG002|Overall Study|Withdrawal by Subject|0|||
161929854|NCT02242903|584792356|FG003|Overall Study|Withdrawal by Subject|0|||
161929855|NCT02242903|584792357|FG004|Overall Study|Withdrawal by Subject|0|||
161929856|NCT02242903|584792358|FG005|Overall Study|Withdrawal by Subject|0|||
161929857|NCT02242903|584792359|FG006|Overall Study|Withdrawal by Subject|0|||
161929858|NCT02105012|584792360|FG000|Overall Study|Withdrawal by Subject|11|||
162202643|NCT01770509|585791029|FG000|Overall Study|Injury|0|||
161929859|NCT02105012|584792360|FG000|Overall Study|Protocol Specified Criteria|9|||
161929860|NCT02105012|584792360|FG000|Overall Study|Lost to Follow-up|4|||
162202644|NCT01770509|585791030|FG001|Overall Study|Injury|1|||
162202645|NCT01770509|585791029|FG000|Overall Study|Lost to Follow-up|1|||
162202646|NCT01770509|585791030|FG001|Overall Study|Lost to Follow-up|2|||
162202647|NCT02865135|585791034|FG000|Overall Study|Death|0|||
162202648|NCT02865135|585791035|FG001|Overall Study|Death|1|||
162202649|NCT02865135|585791036|FG002|Overall Study|Death|0|||
162202650|NCT02865135|585791034|FG000|Overall Study|Progression|6|||
162202651|NCT02865135|585791035|FG001|Overall Study|Progression|2|||
162202652|NCT02865135|585791036|FG002|Overall Study|Progression|2|||
162202653|NCT00985621|585791037|FG000|Overall Study|Adverse Event|2|||
162202654|NCT00985621|585791038|FG001|Overall Study|Adverse Event|3|||
162202655|NCT00985621|585791039|FG002|Overall Study|Adverse Event|4|||
162202656|NCT00985621|585791040|FG003|Overall Study|Adverse Event|16|||
162202657|NCT00985621|585791037|FG000|Overall Study|Lack of Efficacy|10|||
162202658|NCT00985621|585791038|FG001|Overall Study|Lack of Efficacy|6|||
162202659|NCT00985621|585791039|FG002|Overall Study|Lack of Efficacy|5|||
162202660|NCT00985621|585791040|FG003|Overall Study|Lack of Efficacy|12|||
162202661|NCT00985621|585791037|FG000|Overall Study|Lost to Follow-up|2|||
162202662|NCT00985621|585791038|FG001|Overall Study|Lost to Follow-up|3|||
162202663|NCT00985621|585791039|FG002|Overall Study|Lost to Follow-up|4|||
162202664|NCT00985621|585791040|FG003|Overall Study|Lost to Follow-up|4|||
162202665|NCT00985621|585791037|FG000|Overall Study|Study Terminated by Sponsor|89|||
162202666|NCT00985621|585791038|FG001|Overall Study|Study Terminated by Sponsor|108|||
162202667|NCT00985621|585791039|FG002|Overall Study|Study Terminated by Sponsor|99|||
162202668|NCT00985621|585791040|FG003|Overall Study|Study Terminated by Sponsor|92|||
162202669|NCT00985621|585791037|FG000|Overall Study|Protocol Violation|1|||
162202670|NCT00985621|585791038|FG001|Overall Study|Protocol Violation|1|||
162202671|NCT00985621|585791039|FG002|Overall Study|Protocol Violation|1|||
162202672|NCT00985621|585791040|FG003|Overall Study|Protocol Violation|0|||
162202673|NCT00985621|585791037|FG000|Overall Study|Withdrawal by Subject|8|||
162202674|NCT00985621|585791038|FG001|Overall Study|Withdrawal by Subject|10|||
162202675|NCT00985621|585791039|FG002|Overall Study|Withdrawal by Subject|8|||
162202676|NCT00985621|585791040|FG003|Overall Study|Withdrawal by Subject|12|||
162202677|NCT00985621|585791037|FG000|Overall Study|Other|1|||
162202678|NCT00985621|585791038|FG001|Overall Study|Other|0|||
162202679|NCT00985621|585791039|FG002|Overall Study|Other|0|||
162202680|NCT00985621|585791040|FG003|Overall Study|Other|0|||
162202681|NCT00985621|585791037|FG000|Overall Study|Randomized but not Treated|1|||
162202682|NCT00985621|585791038|FG001|Overall Study|Randomized but not Treated|0|||
162202683|NCT00985621|585791039|FG002|Overall Study|Randomized but not Treated|2|||
162202684|NCT00985621|585791040|FG003|Overall Study|Randomized but not Treated|1|||
162202685|NCT04394624|585791044|FG000|Overall Study|Adverse Event|6|||
162202686|NCT04394624|585791045|FG001|Overall Study|Adverse Event|0|||
162202687|NCT04394624|585791044|FG000|Overall Study|Progressive disease|24|||
162202688|NCT04394624|585791045|FG001|Overall Study|Progressive disease|0|||
161929861|NCT02105012|584792360|FG000|Overall Study|Protocol Violation|4|||
161929862|NCT02105012|584792360|FG000|Overall Study|Physician Decision|3|||
161929863|NCT02105012|584792360|FG000|Overall Study|Adverse Event|1|||
161929864|NCT02105012|584792360|FG000|Overall Study|Lack of Efficacy|1|||
161929865|NCT00493285|584792361|FG000|Overall Study|Lost to Follow-up|0|||
161929866|NCT00493285|584792362|FG001|Overall Study|Lost to Follow-up|0|||
161929867|NCT00493285|584792363|FG002|Overall Study|Lost to Follow-up|0|||
161929868|NCT00493285|584792364|FG003|Overall Study|Lost to Follow-up|0|||
161929869|NCT00493285|584792365|FG004|Overall Study|Lost to Follow-up|1|||
161929870|NCT00493285|584792366|FG005|Overall Study|Lost to Follow-up|0|||
161929871|NCT03021005|584792367|FG000|Overall Study|Lost to Follow-up|39|||
161929872|NCT03021005|584792368|FG001|Overall Study|Lost to Follow-up|26|||
161929873|NCT00779909|584792371|FG000|Overall Study|Lost to Follow-up|1|||
161929874|NCT00779909|584792372|FG001|Overall Study|Lost to Follow-up|0|||
161929875|NCT00779909|584792373|FG002|Overall Study|Lost to Follow-up|0|||
161929876|NCT00779909|584792374|FG003|Overall Study|Lost to Follow-up|1|||
161929877|NCT00779909|584792371|FG000|Overall Study|Withdrawal by Subject|0|||
161929878|NCT00779909|584792372|FG001|Overall Study|Withdrawal by Subject|1|||
161929879|NCT00779909|584792373|FG002|Overall Study|Withdrawal by Subject|0|||
161929880|NCT00779909|584792374|FG003|Overall Study|Withdrawal by Subject|0|||
161929881|NCT01174459|584792378|FG000|Overall Study|case report form (CRF) not collected|5|||
161929882|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
161929883|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
161929884|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
161929885|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
161929886|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
161929887|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
161929888|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
161929889|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
161929890|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
161929891|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
161929892|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
161929893|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
161929894|NCT00290758|584792379|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
161929895|NCT00290758|584792380|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
161929896|NCT00290758|584792379|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
161929897|NCT00290758|584792380|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
161929898|NCT00215553|584792382|FG000|Overall Study|Adverse Event|0|||
161929899|NCT00215553|584792383|FG001|Overall Study|Adverse Event|1|||
161929900|NCT00215553|584792384|FG002|Overall Study|Adverse Event|2|||
161929901|NCT00215553|584792385|FG003|Overall Study|Adverse Event|1|||
161929902|NCT00215553|584792386|FG004|Overall Study|Adverse Event|2|||
161929903|NCT00215553|584792387|FG005|Overall Study|Adverse Event|6|||
161929904|NCT00215553|584792388|FG006|Overall Study|Adverse Event|0|||
161929905|NCT01111292|584792389|FG000|Treatment|Physician Decision|1|||
161929906|NCT01111292|584792390|FG001|Treatment|Physician Decision|1|||
161929907|NCT02006654|584792391|FG000|Overall Study|Withdrawal before treatment|4|||
161929908|NCT02006654|584792392|FG001|Overall Study|Withdrawal before treatment|2|||
161929909|NCT02006654|584792391|FG000|Overall Study|Adverse Event|16|||
161929910|NCT02006654|584792392|FG001|Overall Study|Adverse Event|17|||
161929911|NCT02006654|584792391|FG000|Overall Study|Death|1|||
161929912|NCT02006654|584792392|FG001|Overall Study|Death|0|||
161929913|NCT02006654|584792391|FG000|Overall Study|Withdrawal by Subject|14|||
161929914|NCT02006654|584792392|FG001|Overall Study|Withdrawal by Subject|12|||
161929915|NCT02006654|584792391|FG000|Overall Study|Protocol Violation|5|||
161929916|NCT02006654|584792392|FG001|Overall Study|Protocol Violation|8|||
161929917|NCT02006654|584792391|FG000|Overall Study|Lost to Follow-up|1|||
161929918|NCT02006654|584792392|FG001|Overall Study|Lost to Follow-up|0|||
161929919|NCT02006654|584792391|FG000|Overall Study|patient's will|2|||
161929920|NCT02006654|584792392|FG001|Overall Study|patient's will|1|||
161929921|NCT02006654|584792391|FG000|Overall Study|insufficient compliance|1|||
161929922|NCT02006654|584792392|FG001|Overall Study|insufficient compliance|0|||
161929923|NCT02006654|584792391|FG000|Overall Study|worsening cognitive condition|0|||
161929924|NCT02006654|584792392|FG001|Overall Study|worsening cognitive condition|1|||
161929925|NCT02006654|584792391|FG000|Overall Study|faecal incontinence|0|||
161929926|NCT02006654|584792392|FG001|Overall Study|faecal incontinence|1|||
161929927|NCT02006654|584792391|FG000|Overall Study|mood disorder|0|||
161929928|NCT02006654|584792392|FG001|Overall Study|mood disorder|1|||
161929929|NCT02006654|584792391|FG000|Overall Study|disallowed medication|1|||
161929930|NCT02006654|584792392|FG001|Overall Study|disallowed medication|0|||
161929931|NCT02006654|584792391|FG000|Overall Study|moving out of state|0|||
161929932|NCT02006654|584792392|FG001|Overall Study|moving out of state|1|||
161929933|NCT04193527|584792393|FG000|Overall Study|Other|1|||
161929934|NCT04193527|584792394|FG001|Overall Study|Other|1|||
161929935|NCT04193527|584792395|FG002|Overall Study|Other|0|||
161929936|NCT03808909|584792396|FG000|Overall Study|Lost to Follow-up|3|||
161929937|NCT03808909|584792397|FG001|Overall Study|Lost to Follow-up|0|||
161929938|NCT00676689|584792400|FG000|Overall Study|Screen Failure|2|||
161929939|NCT00676689|584792400|FG000|Overall Study|Death|2|||
161929940|NCT00676689|584792400|FG000|Overall Study|Lost to Follow-up|4|||
161929941|NCT00676689|584792400|FG000|Overall Study|Physician Decision|1|||
161822467|NCT01567527|584391100|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161822468|NCT01567527|584391101|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161929942|NCT00676689|584792400|FG000|Overall Study|Withdrawal by Subject|3|||
161929943|NCT00676689|584792400|FG000|Overall Study|Continuing FU|49|||
161929944|NCT01827943|584792401|FG000|Overall Study|Protocol Violation|8|||
161929945|NCT01827943|584792401|FG000|Overall Study|Never treated because of an rapid progression|1|||
161929946|NCT00501085|584792402|FG000|Overall Study|Lost to Follow-up|195|||
161929947|NCT00501085|584792402|FG000|Overall Study|Withdrawal by Subject|34|||
161929948|NCT00501085|584792402|FG000|Overall Study|Subject Decision|1|||
161929949|NCT00501085|584792402|FG000|Overall Study|Revision Surgery|7|||
161929950|NCT00501085|584792402|FG000|Overall Study|Explantation Surgery|26|||
161929951|NCT00501085|584792402|FG000|Overall Study|Adverse Event|4|||
161929952|NCT00501085|584792402|FG000|Overall Study|Non-Compliance|24|||
161929953|NCT00501085|584792402|FG000|Overall Study|Study closed by sponsor|109|||
161929954|NCT00501085|584792402|FG000|Overall Study|Other loss to follow-up|32|||
161929955|NCT01487161|584792403|FG000|Overall Study|Adverse Event|1|||
161929956|NCT01487161|584792404|FG001|Overall Study|Adverse Event|0|||
161822469|NCT01567527|584391102|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161822470|NCT01567527|584391103|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
161822471|NCT01567527|584391104|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
161822472|NCT02004691|584391105|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
161822473|NCT02004691|584391106|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
161822474|NCT02004691|584391105|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
161822475|NCT02004691|584391106|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
161822476|NCT02004691|584391105|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
161822477|NCT02004691|584391106|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
161822478|NCT02004691|584391105|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
161822479|NCT02004691|584391106|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
161822480|NCT02004691|584391105|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
161822481|NCT02004691|584391106|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
161822482|NCT02004691|584391105|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
161822483|NCT02004691|584391106|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
161822484|NCT01726803|584391107|FG000|Overall Study|Lost to Follow-up|6|||
161822485|NCT01726803|584391108|FG001|Overall Study|Lost to Follow-up|1|||
161822486|NCT01726803|584391107|FG000|Overall Study|Withdrawal by Subject|1|||
161822487|NCT01726803|584391108|FG001|Overall Study|Withdrawal by Subject|0|||
161822488|NCT03407729|584391110|FG000|Overall Study|Lost to Follow-up|2|||
161822489|NCT03407729|584391111|FG001|Overall Study|Lost to Follow-up|0|||
161822490|NCT03407729|584391110|FG000|Overall Study|Unable to schedule|0|||
161822491|NCT03407729|584391111|FG001|Overall Study|Unable to schedule|3|||
161822492|NCT00024258|584391114|FG000|Overall Study|Withdrawal by Subject|1|||
161822493|NCT00024258|584391114|FG000|Overall Study|Disease Progression|8|||
161822494|NCT00830167|584391117|FG000|Overall Study|Lack of Efficacy|26|||
161822495|NCT00830167|584391118|FG001|Overall Study|Lack of Efficacy|10|||
161822496|NCT00830167|584391117|FG000|Overall Study|Adverse Event|8|||
161822497|NCT00830167|584391118|FG001|Overall Study|Adverse Event|24|||
161822498|NCT00830167|584391117|FG000|Overall Study|Not meeting entrance criteria|2|||
161822499|NCT00830167|584391118|FG001|Overall Study|Not meeting entrance criteria|5|||
161822500|NCT00830167|584391117|FG000|Overall Study|Withdrawal by Subject|2|||
161822501|NCT00830167|584391118|FG001|Overall Study|Withdrawal by Subject|0|||
161822502|NCT00830167|584391117|FG000|Overall Study|Lost to Follow-up|0|||
161822503|NCT00830167|584391118|FG001|Overall Study|Lost to Follow-up|1|||
161929957|NCT01487161|584792405|FG002|Overall Study|Adverse Event|0|||
161929958|NCT01487161|584792406|FG003|Overall Study|Adverse Event|0|||
161929959|NCT01487161|584792403|FG000|Overall Study|Withdrawal by Subject|1|||
161929960|NCT01487161|584792404|FG001|Overall Study|Withdrawal by Subject|1|||
161929961|NCT01487161|584792405|FG002|Overall Study|Withdrawal by Subject|1|||
161929962|NCT01487161|584792406|FG003|Overall Study|Withdrawal by Subject|2|||
161929963|NCT01487161|584792403|FG000|Overall Study|missing data|0|||
161929964|NCT01487161|584792404|FG001|Overall Study|missing data|1|||
161929965|NCT01487161|584792405|FG002|Overall Study|missing data|0|||
161929966|NCT01487161|584792406|FG003|Overall Study|missing data|0|||
161929967|NCT01084135|584792407|FG000|20 Week|Physician Decision|0|||
161929968|NCT01084135|584792408|FG001|20 Week|Physician Decision|1|||
161929969|NCT00663351|584792409|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
161929970|NCT00663351|584792410|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
161822504|NCT00830167|584391117|FG000|Overall Study|Protocol Violation|0|||
161822505|NCT00830167|584391118|FG001|Overall Study|Protocol Violation|1|||
161822506|NCT00830167|584391117|FG000|Overall Study|Other|2|||
161822507|NCT00830167|584391118|FG001|Overall Study|Other|2|||
161676895|NCT01829425|583870601|FG001|Overall Study|Withdrawal by Subject|3|||
161676896|NCT01829425|583870600|FG000|Overall Study|Lost to Follow-up|2|||
161676897|NCT01829425|583870601|FG001|Overall Study|Lost to Follow-up|1|||
161676898|NCT03681951|583870602|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
161676899|NCT03681951|583870603|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676900|NCT03681951|583870604|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676901|NCT03681951|583870605|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676902|NCT03681951|583870606|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676903|NCT03681951|583870607|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676904|NCT03681951|583870608|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676905|NCT03681951|583870609|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161676906|NCT03681951|583870602|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
161929971|NCT00663351|584792409|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
161929972|NCT00663351|584792410|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
161929973|NCT00663351|584792409|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
161929974|NCT00663351|584792410|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
161929975|NCT00663351|584792409|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
161929976|NCT00663351|584792410|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
161929977|NCT00663351|584792409|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
161929978|NCT00663351|584792410|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
161929979|NCT00663351|584792409|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
161929980|NCT00663351|584792410|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
161929981|NCT02366130|584792411|FG000|Overall Study|Withdrawal by Subject|3|||
161929982|NCT02366130|584792411|FG000|Overall Study|Ineligible|6|||
161929983|NCT01065766|584792412|FG000|Overall Study|Assessed before the contracted date|1|||
161929984|NCT01065766|584792412|FG000|Overall Study|Contraindication to administration|6|||
161929985|NCT01065766|584792412|FG000|Overall Study|Violated dosage/administration|25|||
161929986|NCT01608308|584792416|FG000|Overall Study|pretreatment medical and billing reasons|0|||
161929987|NCT01608308|584792417|FG001|Overall Study|pretreatment medical and billing reasons|2|||
161929988|NCT03113136|584792418|FG000|Overall Study|Lost to Follow-up|22|||
161929989|NCT03113136|584792419|FG001|Overall Study|Lost to Follow-up|47|||
161929990|NCT03113136|584792420|FG002|Overall Study|Lost to Follow-up|54|||
161929991|NCT03113136|584792418|FG000|Overall Study|Withdrawal by Subject|4|||
161929992|NCT03113136|584792419|FG001|Overall Study|Withdrawal by Subject|13|||
161929993|NCT03113136|584792420|FG002|Overall Study|Withdrawal by Subject|14|||
161929994|NCT03113136|584792418|FG000|Overall Study|Ineligible|0|||
161929995|NCT03113136|584792419|FG001|Overall Study|Ineligible|2|||
161929996|NCT03113136|584792420|FG002|Overall Study|Ineligible|1|||
161929997|NCT03113136|584792418|FG000|Overall Study|Study Team Decision|1|||
161929998|NCT03113136|584792419|FG001|Overall Study|Study Team Decision|4|||
161929999|NCT03113136|584792420|FG002|Overall Study|Study Team Decision|0|||
161930000|NCT02362412|584792426|FG000|Treatment Period III|Lost to Follow-up|0|||
161930001|NCT02362412|584792427|FG001|Treatment Period III|Lost to Follow-up|1|||
161930002|NCT02675452|584792429|FG000|Overall Study|Sponsor decision|0|||
161930003|NCT02675452|584792430|FG001|Overall Study|Sponsor decision|0|||
161930004|NCT02675452|584792431|FG002|Overall Study|Sponsor decision|0|||
161930005|NCT02675452|584792432|FG003|Overall Study|Sponsor decision|0|||
161676907|NCT03681951|583870603|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676908|NCT03681951|583870604|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676909|NCT03681951|583870605|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676910|NCT03681951|583870606|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676911|NCT03681951|583870607|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676912|NCT03681951|583870608|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676913|NCT03681951|583870609|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161676914|NCT03681951|583870602|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
161676915|NCT03681951|583870603|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676916|NCT03681951|583870604|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676917|NCT03681951|583870605|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676918|NCT03681951|583870606|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676919|NCT03681951|583870607|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676920|NCT03681951|583870608|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676921|NCT03681951|583870609|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161676922|NCT01020448|583870610|FG000|Pre-assignment|Adverse Event|6|||
161676923|NCT01020448|583870610|FG000|Pre-assignment|Withdrawal by Subject|5|||
161930006|NCT02675452|584792433|FG004|Overall Study|Sponsor decision|0|||
161930007|NCT02675452|584792434|FG005|Overall Study|Sponsor decision|0|||
161930008|NCT02675452|584792435|FG006|Overall Study|Sponsor decision|0|||
161930009|NCT02675452|584792436|FG007|Overall Study|Sponsor decision|0|||
161930010|NCT02675452|584792437|FG008|Overall Study|Sponsor decision|0|||
161930011|NCT02675452|584792438|FG009|Overall Study|Sponsor decision|1|||
161930012|NCT02675452|584792439|FG010|Overall Study|Sponsor decision|0|||
161822508|NCT03428945|584391119|FG000|Overall Study|Lost to Follow-up|5|||
161822509|NCT03428945|584391120|FG001|Overall Study|Lost to Follow-up|3|||
161822510|NCT03428945|584391119|FG000|Overall Study|Withdrawal by Subject|10|||
161822511|NCT03428945|584391120|FG001|Overall Study|Withdrawal by Subject|10|||
161822512|NCT00982228|584391121|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
161822513|NCT00982228|584391122|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
161822514|NCT00982228|584391121|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
161822515|NCT00982228|584391122|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
161822516|NCT00982228|584391121|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
161822517|NCT00982228|584391122|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
161822518|NCT00982228|584391121|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
161822519|NCT00982228|584391122|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
161822520|NCT00982228|584391121|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
161822521|NCT00982228|584391122|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
161822522|NCT00982228|584391121|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
161822523|NCT00982228|584391122|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
161822524|NCT00982228|584391121|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
161822525|NCT00982228|584391122|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
161822526|NCT00982228|584391121|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
161822527|NCT00982228|584391122|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
161822528|NCT00982228|584391121|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
161822529|NCT00982228|584391122|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
161822530|NCT00982228|584391121|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
161822531|NCT00982228|584391122|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
161822532|NCT00360490|584391126|FG000|Overall Study|Adverse Event|4|||
161822533|NCT00360490|584391127|FG001|Overall Study|Adverse Event|2|||
161822534|NCT00360490|584391126|FG000|Overall Study|Lost to Follow-up|2|||
161822535|NCT00360490|584391127|FG001|Overall Study|Lost to Follow-up|1|||
161822536|NCT00360490|584391126|FG000|Overall Study|Physician Decision|2|||
161822537|NCT00360490|584391127|FG001|Overall Study|Physician Decision|1|||
161822538|NCT00360490|584391126|FG000|Overall Study|Protocol Violation|0|||
161822539|NCT00360490|584391127|FG001|Overall Study|Protocol Violation|4|||
161822540|NCT00360490|584391126|FG000|Overall Study|Withdrawal by Subject|1|||
161822541|NCT00360490|584391127|FG001|Overall Study|Withdrawal by Subject|3|||
161822542|NCT02289820|584391128|FG000|Overall Study|Withdrawal by Subject|2|||
161822543|NCT02289820|584391129|FG001|Overall Study|Withdrawal by Subject|1|||
161822544|NCT02289820|584391130|FG002|Overall Study|Withdrawal by Subject|2|||
161822545|NCT02289820|584391131|FG003|Overall Study|Withdrawal by Subject|1|||
161822546|NCT02289820|584391132|FG004|Overall Study|Withdrawal by Subject|0|||
161822547|NCT02289820|584391133|FG005|Overall Study|Withdrawal by Subject|0|||
161822548|NCT02289820|584391134|FG006|Overall Study|Withdrawal by Subject|1|||
161822549|NCT02289820|584391128|FG000|Overall Study|Death|0|||
161822550|NCT02289820|584391129|FG001|Overall Study|Death|0|||
161822551|NCT02289820|584391130|FG002|Overall Study|Death|1|||
161822552|NCT02289820|584391131|FG003|Overall Study|Death|0|||
161822553|NCT02289820|584391132|FG004|Overall Study|Death|0|||
161822554|NCT02289820|584391133|FG005|Overall Study|Death|0|||
161822555|NCT02289820|584391134|FG006|Overall Study|Death|0|||
161822556|NCT02289820|584391128|FG000|Overall Study|Lost to Follow-up|0|||
161822557|NCT02289820|584391129|FG001|Overall Study|Lost to Follow-up|0|||
161822558|NCT02289820|584391130|FG002|Overall Study|Lost to Follow-up|3|||
161822559|NCT02289820|584391131|FG003|Overall Study|Lost to Follow-up|1|||
161822560|NCT02289820|584391132|FG004|Overall Study|Lost to Follow-up|0|||
161822561|NCT02289820|584391133|FG005|Overall Study|Lost to Follow-up|1|||
161822562|NCT02289820|584391134|FG006|Overall Study|Lost to Follow-up|1|||
161822563|NCT02289820|584391128|FG000|Overall Study|withdrawal of consent|0|||
161822564|NCT02289820|584391129|FG001|Overall Study|withdrawal of consent|1|||
161822565|NCT02289820|584391130|FG002|Overall Study|withdrawal of consent|0|||
161822566|NCT02289820|584391131|FG003|Overall Study|withdrawal of consent|0|||
161822567|NCT02289820|584391132|FG004|Overall Study|withdrawal of consent|0|||
161822568|NCT02289820|584391133|FG005|Overall Study|withdrawal of consent|0|||
161822569|NCT02289820|584391134|FG006|Overall Study|withdrawal of consent|0|||
161822570|NCT02005276|584391135|FG000|Overall Study|No longer interested|5|||
161822571|NCT02005276|584391136|FG001|Overall Study|No longer interested|2|||
161822572|NCT02005276|584391137|FG002|Overall Study|No longer interested|3|||
161822573|NCT02005276|584391138|FG003|Overall Study|No longer interested|3|||
161822574|NCT00124618|584391139|FG000|Overall Study|Ineligible|1|||
161822575|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
161822576|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
161930013|NCT02675452|584792440|FG011|Overall Study|Sponsor decision|0|||
161822577|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
161822578|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
161822579|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
161930014|NCT02675452|584792441|FG012|Overall Study|Sponsor decision|0|||
161822580|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
161930015|NCT02675452|584792442|FG013|Overall Study|Sponsor decision|2|||
161822581|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
161930016|NCT02675452|584792443|FG014|Overall Study|Sponsor decision|1|||
161930017|NCT02675452|584792444|FG015|Overall Study|Sponsor decision|0|||
161930018|NCT02675452|584792445|FG016|Overall Study|Sponsor decision|1|||
161930019|NCT02675452|584792446|FG017|Overall Study|Sponsor decision|0|||
161930020|NCT02675452|584792447|FG018|Overall Study|Sponsor decision|0|||
161930021|NCT02675452|584792448|FG019|Overall Study|Sponsor decision|0|||
161930022|NCT02675452|584792449|FG020|Overall Study|Sponsor decision|0|||
161930023|NCT02675452|584792450|FG021|Overall Study|Sponsor decision|0|||
161930024|NCT02675452|584792451|FG022|Overall Study|Sponsor decision|0|||
161930025|NCT02675452|584792452|FG023|Overall Study|Sponsor decision|0|||
161930026|NCT02675452|584792453|FG024|Overall Study|Sponsor decision|0|||
161930027|NCT02675452|584792454|FG025|Overall Study|Sponsor decision|0|||
161930028|NCT02675452|584792455|FG026|Overall Study|Sponsor decision|2|||
161930029|NCT02675452|584792456|FG027|Overall Study|Sponsor decision|0|||
161930030|NCT02675452|584792457|FG028|Overall Study|Sponsor decision|0|||
161930031|NCT02675452|584792429|FG000|Overall Study|Withdrawal by Subject|0|||
161930032|NCT02675452|584792430|FG001|Overall Study|Withdrawal by Subject|0|||
161930033|NCT02675452|584792431|FG002|Overall Study|Withdrawal by Subject|0|||
161930034|NCT02675452|584792432|FG003|Overall Study|Withdrawal by Subject|0|||
161930035|NCT02675452|584792433|FG004|Overall Study|Withdrawal by Subject|0|||
161930036|NCT02675452|584792434|FG005|Overall Study|Withdrawal by Subject|0|||
161930037|NCT02675452|584792435|FG006|Overall Study|Withdrawal by Subject|0|||
161930038|NCT02675452|584792436|FG007|Overall Study|Withdrawal by Subject|0|||
161930039|NCT02675452|584792437|FG008|Overall Study|Withdrawal by Subject|0|||
161930040|NCT02675452|584792438|FG009|Overall Study|Withdrawal by Subject|1|||
161930041|NCT02675452|584792439|FG010|Overall Study|Withdrawal by Subject|0|||
161930042|NCT02675452|584792440|FG011|Overall Study|Withdrawal by Subject|1|||
161930043|NCT02675452|584792441|FG012|Overall Study|Withdrawal by Subject|0|||
161930044|NCT02675452|584792442|FG013|Overall Study|Withdrawal by Subject|1|||
161930045|NCT02675452|584792443|FG014|Overall Study|Withdrawal by Subject|1|||
161930046|NCT02675452|584792444|FG015|Overall Study|Withdrawal by Subject|0|||
161930047|NCT02675452|584792445|FG016|Overall Study|Withdrawal by Subject|2|||
161930048|NCT02675452|584792446|FG017|Overall Study|Withdrawal by Subject|0|||
161930049|NCT02675452|584792447|FG018|Overall Study|Withdrawal by Subject|0|||
161930050|NCT02675452|584792448|FG019|Overall Study|Withdrawal by Subject|0|||
161930051|NCT02675452|584792449|FG020|Overall Study|Withdrawal by Subject|0|||
161930052|NCT02675452|584792450|FG021|Overall Study|Withdrawal by Subject|0|||
161930053|NCT02675452|584792451|FG022|Overall Study|Withdrawal by Subject|3|||
161930054|NCT02675452|584792452|FG023|Overall Study|Withdrawal by Subject|0|||
161930055|NCT02675452|584792453|FG024|Overall Study|Withdrawal by Subject|1|||
161930056|NCT02675452|584792454|FG025|Overall Study|Withdrawal by Subject|0|||
161930057|NCT02675452|584792455|FG026|Overall Study|Withdrawal by Subject|1|||
161930058|NCT02675452|584792456|FG027|Overall Study|Withdrawal by Subject|3|||
161930059|NCT02675452|584792457|FG028|Overall Study|Withdrawal by Subject|4|||
161930060|NCT02675452|584792429|FG000|Overall Study|Death|0|||
161930061|NCT02675452|584792430|FG001|Overall Study|Death|0|||
161930062|NCT02675452|584792431|FG002|Overall Study|Death|1|||
161930063|NCT02675452|584792432|FG003|Overall Study|Death|0|||
161930064|NCT02675452|584792433|FG004|Overall Study|Death|0|||
161930065|NCT02675452|584792434|FG005|Overall Study|Death|1|||
161822582|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
161822583|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
161822584|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
161822585|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
161822586|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
161822587|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
161822588|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
161930066|NCT02675452|584792435|FG006|Overall Study|Death|0|||
161930067|NCT02675452|584792436|FG007|Overall Study|Death|0|||
161930068|NCT02675452|584792437|FG008|Overall Study|Death|1|||
161930069|NCT02675452|584792438|FG009|Overall Study|Death|0|||
161930070|NCT02675452|584792439|FG010|Overall Study|Death|0|||
161930071|NCT02675452|584792440|FG011|Overall Study|Death|0|||
161930072|NCT02675452|584792441|FG012|Overall Study|Death|1|||
161930073|NCT02675452|584792442|FG013|Overall Study|Death|0|||
161930074|NCT02675452|584792443|FG014|Overall Study|Death|0|||
161930075|NCT02675452|584792444|FG015|Overall Study|Death|2|||
161930076|NCT02675452|584792445|FG016|Overall Study|Death|0|||
161930077|NCT02675452|584792446|FG017|Overall Study|Death|0|||
161930078|NCT02675452|584792447|FG018|Overall Study|Death|4|||
161930079|NCT02675452|584792448|FG019|Overall Study|Death|3|||
161930080|NCT02675452|584792449|FG020|Overall Study|Death|3|||
161930081|NCT02675452|584792450|FG021|Overall Study|Death|3|||
161930082|NCT02675452|584792451|FG022|Overall Study|Death|7|||
161822589|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
161822590|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
161822591|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
161822592|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
161822593|NCT00950300|584391140|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
161822594|NCT00950300|584391141|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
161822595|NCT00950300|584391140|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
161822596|NCT00950300|584391141|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
161822597|NCT00950300|584391140|FG000|TFFU Period|Death|4|||
161822598|NCT00950300|584391141|FG001|TFFU Period|Death|1|||
161822599|NCT00950300|584391140|FG000|TFFU Period|Refused Treatment|10|||
161822600|NCT00950300|584391141|FG001|TFFU Period|Refused Treatment|11|||
161822601|NCT00950300|584391140|FG000|TFFU Period|Failure to Return|16|||
161822602|NCT00950300|584391141|FG001|TFFU Period|Failure to Return|16|||
161822603|NCT00950300|584391140|FG000|TFFU Period|Recurrence of Disease|63|||
161822604|NCT00950300|584391141|FG001|TFFU Period|Recurrence of Disease|72|||
161822605|NCT00950300|584391140|FG000|TFFU Period|Other|4|||
161822606|NCT00950300|584391141|FG001|TFFU Period|Other|3|||
161822607|NCT00950300|584391140|FG000|SFU Period|Death|44|||
161822608|NCT00950300|584391141|FG001|SFU Period|Death|42|||
161822609|NCT00950300|584391140|FG000|SFU Period|Lost to Follow-up|30|||
161822610|NCT00950300|584391141|FG001|SFU Period|Lost to Follow-up|28|||
161822611|NCT00950300|584391140|FG000|SFU Period|Withdrawal by Subject|4|||
161822612|NCT00950300|584391141|FG001|SFU Period|Withdrawal by Subject|8|||
161822613|NCT04750239|584391142|FG000|Overall Study|Withdrawal by Subject|2|||
161822614|NCT04750239|584391142|FG000|Overall Study|Trial terminated by sponsor|1|||
161822615|NCT01912807|584391143|FG000|Overall Study|Did not meet elegibility criteria|6|||
161822616|NCT01912807|584391144|FG001|Overall Study|Did not meet elegibility criteria|4|||
161822617|NCT01912807|584391143|FG000|Overall Study|Lost to Follow-up|36|||
161822618|NCT01912807|584391144|FG001|Overall Study|Lost to Follow-up|37|||
161822619|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Adverse Event|8|||
161822620|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Adverse Event|5|||
161822621|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Adverse Event|9|||
161822622|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Adverse Event|0|||
161822623|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Adverse Event|0|||
161822624|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Adverse Event|0|||
161822625|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
161822626|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
161822627|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
161822628|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
161822629|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
161822630|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
161822631|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
161822632|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
161822633|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
161822634|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
161822635|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
161822636|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
161822637|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Physician Decision|4|||
161822638|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Physician Decision|0|||
161822639|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Physician Decision|2|||
161822640|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Physician Decision|0|||
161822641|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Physician Decision|0|||
161822642|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Physician Decision|0|||
161822643|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Pregnancy|1|||
161822644|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Pregnancy|2|||
161822645|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Pregnancy|0|||
161822646|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Pregnancy|0|||
161822647|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Pregnancy|0|||
161822648|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Pregnancy|0|||
161822649|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
161822650|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
161822651|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
161822652|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
161822653|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
161822654|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
161822655|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
161822656|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
161822657|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
161822658|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
161822659|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
161822660|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
161822661|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
161930083|NCT02675452|584792452|FG023|Overall Study|Death|5|||
161822662|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
161930084|NCT02675452|584792453|FG024|Overall Study|Death|3|||
161930085|NCT02675452|584792454|FG025|Overall Study|Death|4|||
161930086|NCT02675452|584792455|FG026|Overall Study|Death|7|||
161930087|NCT02675452|584792456|FG027|Overall Study|Death|6|||
161930088|NCT02675452|584792457|FG028|Overall Study|Death|9|||
161930089|NCT02675452|584792429|FG000|Overall Study|Lost to Follow-up|0|||
161930090|NCT02675452|584792430|FG001|Overall Study|Lost to Follow-up|1|||
161930091|NCT02675452|584792431|FG002|Overall Study|Lost to Follow-up|0|||
161930092|NCT02675452|584792432|FG003|Overall Study|Lost to Follow-up|0|||
161930093|NCT02675452|584792433|FG004|Overall Study|Lost to Follow-up|0|||
161930094|NCT02675452|584792434|FG005|Overall Study|Lost to Follow-up|0|||
161930095|NCT02675452|584792435|FG006|Overall Study|Lost to Follow-up|0|||
161930096|NCT02675452|584792436|FG007|Overall Study|Lost to Follow-up|0|||
161930097|NCT02675452|584792437|FG008|Overall Study|Lost to Follow-up|0|||
161930098|NCT02675452|584792438|FG009|Overall Study|Lost to Follow-up|0|||
161822663|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
161822664|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
161822665|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
161822666|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
161822667|NCT02614196|584391145|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
161822668|NCT02614196|584391146|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
161822669|NCT02614196|584391147|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
161822670|NCT02614196|584391148|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
161822671|NCT02614196|584391149|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
161822672|NCT02614196|584391150|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
161822673|NCT02614196|584391145|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
161822674|NCT02614196|584391146|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
161822675|NCT02614196|584391147|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
161822676|NCT02614196|584391148|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
161822677|NCT02614196|584391149|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
161822678|NCT02614196|584391150|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
161822679|NCT02614196|584391145|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
161822680|NCT02614196|584391146|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
161822681|NCT02614196|584391147|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
161822682|NCT02614196|584391148|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
161822683|NCT02614196|584391149|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
161822684|NCT02614196|584391150|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
161822685|NCT02614196|584391145|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
161822686|NCT02614196|584391146|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
161822687|NCT02614196|584391147|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
161822688|NCT02614196|584391148|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
161822689|NCT02614196|584391149|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
161822690|NCT02614196|584391150|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
161822691|NCT02614196|584391145|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
161822692|NCT02614196|584391146|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
161822693|NCT02614196|584391147|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
161822694|NCT02614196|584391148|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
161822695|NCT02614196|584391149|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
161822696|NCT02614196|584391150|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
161822697|NCT01539239|584391151|FG000|Overall Study|Death|5|||
161822698|NCT01539239|584391152|FG001|Overall Study|Death|5|||
161822699|NCT01539239|584391151|FG000|Overall Study|Lost to Follow-up|7|||
161822700|NCT01539239|584391152|FG001|Overall Study|Lost to Follow-up|12|||
161822701|NCT01562613|584391153|FG000|Overall Study|Lost to Follow-up|2|||
161822702|NCT01562613|584391153|FG000|Overall Study|Withdrawal by Subject|2|||
161822703|NCT00633022|584391158|FG000|Overall Study|Adverse Event|1|||
161930099|NCT02675452|584792439|FG010|Overall Study|Lost to Follow-up|0|||
161930100|NCT02675452|584792440|FG011|Overall Study|Lost to Follow-up|0|||
161930101|NCT02675452|584792441|FG012|Overall Study|Lost to Follow-up|1|||
161930102|NCT02675452|584792442|FG013|Overall Study|Lost to Follow-up|0|||
161930103|NCT02675452|584792443|FG014|Overall Study|Lost to Follow-up|0|||
161822704|NCT00633022|584391159|FG001|Overall Study|Adverse Event|0|||
161822705|NCT00633022|584391160|FG002|Overall Study|Adverse Event|5|||
161822706|NCT00633022|584391158|FG000|Overall Study|Physician Decision|0|||
161822707|NCT00633022|584391159|FG001|Overall Study|Physician Decision|1|||
161930104|NCT02675452|584792444|FG015|Overall Study|Lost to Follow-up|0|||
161930105|NCT02675452|584792445|FG016|Overall Study|Lost to Follow-up|0|||
161930106|NCT02675452|584792446|FG017|Overall Study|Lost to Follow-up|0|||
161930107|NCT02675452|584792447|FG018|Overall Study|Lost to Follow-up|0|||
161930108|NCT02675452|584792448|FG019|Overall Study|Lost to Follow-up|0|||
161930109|NCT02675452|584792449|FG020|Overall Study|Lost to Follow-up|0|||
161930110|NCT02675452|584792450|FG021|Overall Study|Lost to Follow-up|0|||
161930111|NCT02675452|584792451|FG022|Overall Study|Lost to Follow-up|0|||
161930112|NCT02675452|584792452|FG023|Overall Study|Lost to Follow-up|0|||
161930113|NCT02675452|584792453|FG024|Overall Study|Lost to Follow-up|0|||
161930114|NCT02675452|584792454|FG025|Overall Study|Lost to Follow-up|0|||
161930115|NCT02675452|584792455|FG026|Overall Study|Lost to Follow-up|1|||
161930116|NCT02675452|584792456|FG027|Overall Study|Lost to Follow-up|0|||
161930117|NCT02675452|584792457|FG028|Overall Study|Lost to Follow-up|0|||
161930118|NCT02675452|584792429|FG000|Overall Study|Other|0|||
161930119|NCT02675452|584792430|FG001|Overall Study|Other|0|||
161930120|NCT02675452|584792431|FG002|Overall Study|Other|0|||
161930121|NCT02675452|584792432|FG003|Overall Study|Other|0|||
161930122|NCT02675452|584792433|FG004|Overall Study|Other|0|||
161930123|NCT02675452|584792434|FG005|Overall Study|Other|0|||
161930124|NCT02675452|584792435|FG006|Overall Study|Other|0|||
161930125|NCT02675452|584792436|FG007|Overall Study|Other|0|||
161930126|NCT02675452|584792437|FG008|Overall Study|Other|0|||
161930127|NCT02675452|584792438|FG009|Overall Study|Other|0|||
161930128|NCT02675452|584792439|FG010|Overall Study|Other|0|||
161930129|NCT02675452|584792440|FG011|Overall Study|Other|0|||
161930130|NCT02675452|584792441|FG012|Overall Study|Other|0|||
161930131|NCT02675452|584792442|FG013|Overall Study|Other|0|||
161930132|NCT02675452|584792443|FG014|Overall Study|Other|0|||
161930133|NCT02675452|584792444|FG015|Overall Study|Other|0|||
161930134|NCT02675452|584792445|FG016|Overall Study|Other|0|||
161930135|NCT02675452|584792446|FG017|Overall Study|Other|0|||
161930136|NCT02675452|584792447|FG018|Overall Study|Other|0|||
161930137|NCT02675452|584792448|FG019|Overall Study|Other|0|||
161930138|NCT02675452|584792449|FG020|Overall Study|Other|0|||
161930139|NCT02675452|584792450|FG021|Overall Study|Other|0|||
161930140|NCT02675452|584792451|FG022|Overall Study|Other|0|||
161930141|NCT02675452|584792452|FG023|Overall Study|Other|0|||
161930142|NCT02675452|584792453|FG024|Overall Study|Other|0|||
161930143|NCT02675452|584792454|FG025|Overall Study|Other|0|||
161930144|NCT02675452|584792455|FG026|Overall Study|Other|1|||
161930145|NCT02675452|584792456|FG027|Overall Study|Other|0|||
161930146|NCT02675452|584792457|FG028|Overall Study|Other|0|||
161930147|NCT00977561|584792458|FG000|Overall Study|Death|3|||
161930148|NCT00977561|584792459|FG001|Overall Study|Death|2|||
161930149|NCT00977561|584792458|FG000|Overall Study|Study terminated|0|||
161930150|NCT00977561|584792459|FG001|Overall Study|Study terminated|2|||
161930151|NCT00977561|584792458|FG000|Overall Study|Other|2|||
161930152|NCT00977561|584792459|FG001|Overall Study|Other|0|||
161930153|NCT04595370|584792460|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
161930154|NCT04595370|584792461|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
161930155|NCT04595370|584792462|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
161930156|NCT04595370|584792463|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
161930157|NCT04595370|584792464|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
161930158|NCT04595370|584792465|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
161930159|NCT04595370|584792460|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
161930160|NCT04595370|584792461|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
161930161|NCT04595370|584792462|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
161930162|NCT04595370|584792463|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
161930163|NCT04595370|584792464|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
161930164|NCT04595370|584792465|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
161930165|NCT04595370|584792460|FG000|Overall Study|Adverse Event|0|||
161930166|NCT04595370|584792461|FG001|Overall Study|Adverse Event|4|||
161930167|NCT04595370|584792462|FG002|Overall Study|Adverse Event|3|||
161930168|NCT04595370|584792463|FG003|Overall Study|Adverse Event|1|||
161930169|NCT04595370|584792464|FG004|Overall Study|Adverse Event|1|||
161930170|NCT04595370|584792465|FG005|Overall Study|Adverse Event|1|||
161930171|NCT04595370|584792460|FG000|Overall Study|Withdrawal of Consent|1|||
161930172|NCT04595370|584792461|FG001|Overall Study|Withdrawal of Consent|1|||
161930173|NCT04595370|584792462|FG002|Overall Study|Withdrawal of Consent|1|||
161930174|NCT04595370|584792463|FG003|Overall Study|Withdrawal of Consent|0|||
161930175|NCT04595370|584792464|FG004|Overall Study|Withdrawal of Consent|0|||
161930176|NCT04595370|584792465|FG005|Overall Study|Withdrawal of Consent|0|||
161930177|NCT04595370|584792460|FG000|Overall Study|Death|0|||
161930178|NCT04595370|584792461|FG001|Overall Study|Death|1|||
161930179|NCT04595370|584792462|FG002|Overall Study|Death|0|||
161930180|NCT04595370|584792463|FG003|Overall Study|Death|0|||
161930181|NCT04595370|584792464|FG004|Overall Study|Death|1|||
161930182|NCT04595370|584792465|FG005|Overall Study|Death|0|||
161930183|NCT04595370|584792460|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161930184|NCT04595370|584792461|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161930185|NCT04595370|584792462|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161930186|NCT04595370|584792463|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161930187|NCT04595370|584792464|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161930188|NCT04595370|584792465|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161930189|NCT04595370|584792460|FG000|Overall Study|Withdrawal by Subject|0|||
161930190|NCT04595370|584792461|FG001|Overall Study|Withdrawal by Subject|0|||
161930191|NCT04595370|584792462|FG002|Overall Study|Withdrawal by Subject|1|||
161930192|NCT04595370|584792463|FG003|Overall Study|Withdrawal by Subject|0|||
161930193|NCT04595370|584792464|FG004|Overall Study|Withdrawal by Subject|2|||
161930194|NCT04595370|584792465|FG005|Overall Study|Withdrawal by Subject|0|||
161930195|NCT04595370|584792460|FG000|Overall Study|Lost to Follow-up|0|||
161930196|NCT04595370|584792461|FG001|Overall Study|Lost to Follow-up|0|||
161930197|NCT04595370|584792462|FG002|Overall Study|Lost to Follow-up|0|||
161930198|NCT04595370|584792463|FG003|Overall Study|Lost to Follow-up|0|||
161930199|NCT04595370|584792464|FG004|Overall Study|Lost to Follow-up|1|||
161930200|NCT04595370|584792465|FG005|Overall Study|Lost to Follow-up|0|||
161930201|NCT04595370|584792460|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
161930202|NCT04595370|584792461|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
161930203|NCT04595370|584792462|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
161930204|NCT04595370|584792463|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
161930205|NCT04595370|584792464|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
161930206|NCT04595370|584792465|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
161930207|NCT03520387|584792466|FG000|Pre-Randomization|Withdrawal by Subject|1|||
161930208|NCT03520387|584792467|FG001|Pre-Randomization|Withdrawal by Subject|0|||
161930209|NCT03520387|584792468|FG002|Pre-Randomization|Withdrawal by Subject|0|||
161930210|NCT03520387|584792469|FG003|Pre-Randomization|Withdrawal by Subject|0|||
161930211|NCT03520387|584792470|FG004|Pre-Randomization|Withdrawal by Subject|0|||
161930212|NCT03520387|584792466|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
161930213|NCT03520387|584792467|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
161930214|NCT03520387|584792468|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
161930215|NCT03520387|584792469|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
161930216|NCT03520387|584792470|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
161930217|NCT00541775|584792471|FG000|Overall Study|Adverse Event|3|||
161930218|NCT00541775|584792472|FG001|Overall Study|Adverse Event|2|||
161930219|NCT00541775|584792473|FG002|Overall Study|Adverse Event|1|||
161930220|NCT00541775|584792471|FG000|Overall Study|Lack of Efficacy|0|||
161930221|NCT00541775|584792472|FG001|Overall Study|Lack of Efficacy|0|||
161930222|NCT00541775|584792473|FG002|Overall Study|Lack of Efficacy|3|||
161930223|NCT00541775|584792471|FG000|Overall Study|Lost to Follow-up|0|||
161930224|NCT00541775|584792472|FG001|Overall Study|Lost to Follow-up|0|||
161930225|NCT00541775|584792473|FG002|Overall Study|Lost to Follow-up|2|||
161930226|NCT00541775|584792471|FG000|Overall Study|Protocol Violation|1|||
161930227|NCT00541775|584792472|FG001|Overall Study|Protocol Violation|0|||
161930228|NCT00541775|584792473|FG002|Overall Study|Protocol Violation|0|||
161930229|NCT00541775|584792471|FG000|Overall Study|Withdrawal by Subject and Other|5|||
161930230|NCT00541775|584792472|FG001|Overall Study|Withdrawal by Subject and Other|0|||
161930231|NCT00541775|584792473|FG002|Overall Study|Withdrawal by Subject and Other|2|||
161930232|NCT01945242|584792474|FG000|Overall Study|Physician Decision|3|||
161930233|NCT01945242|584792475|FG001|Overall Study|Physician Decision|3|||
161930234|NCT04913675|584792477|FG000|Main Study (Up to Week 36)|Death|0|||
161930235|NCT04913675|584792478|FG001|Main Study (Up to Week 36)|Death|2|||
161676924|NCT01020448|583870610|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
161930236|NCT04913675|584792479|FG002|Main Study (Up to Week 36)|Death|2|||
161930237|NCT04913675|584792480|FG003|Main Study (Up to Week 36)|Death|0|||
161930238|NCT04913675|584792477|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
161930239|NCT04913675|584792478|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
161930240|NCT04913675|584792479|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
161930241|NCT04913675|584792480|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
161930242|NCT04913675|584792477|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
161930243|NCT04913675|584792478|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
161930244|NCT04913675|584792479|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
161930245|NCT04913675|584792480|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
161930246|NCT04913675|584792477|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
162202689|NCT04394624|585791044|FG000|Overall Study|Not related to COVID-19|1|||
162202690|NCT04394624|585791045|FG001|Overall Study|Not related to COVID-19|0|||
162202691|NCT00676663|585791046|FG000|Overall Study|Death|43|||
162202692|NCT00676663|585791047|FG001|Overall Study|Death|27|||
162202693|NCT00676663|585791046|FG000|Overall Study|Withdrew Consent|1|||
161676925|NCT01020448|583870610|FG000|Treatment|Adverse Event|11|||
161930247|NCT04913675|584792478|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
161930248|NCT04913675|584792479|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
161930249|NCT04913675|584792480|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
161930250|NCT04913675|584792477|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
161930251|NCT04913675|584792478|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
161930252|NCT04913675|584792479|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
162021147|NCT01904773|585133429|FG006|Placebo Washout First Intervention|Condition worsened|0|||
161676926|NCT01020448|583870610|FG000|Treatment|Consent Withdrawn|3|||
162021148|NCT01904773|585133430|FG007|Placebo Washout First Intervention|Condition worsened|0|||
162021149|NCT01904773|585133431|FG008|Placebo Washout First Intervention|Condition worsened|0|||
162021150|NCT01904773|585133423|FG000|Fifth Intervention|Adverse Event|0|||
162021151|NCT01904773|585133424|FG001|Fifth Intervention|Adverse Event|0|||
162021152|NCT01904773|585133425|FG002|Fifth Intervention|Adverse Event|0|||
162021153|NCT01904773|585133426|FG003|Fifth Intervention|Adverse Event|0|||
162021154|NCT01904773|585133427|FG004|Fifth Intervention|Adverse Event|0|||
162021155|NCT01904773|585133428|FG005|Fifth Intervention|Adverse Event|0|||
162021156|NCT01904773|585133429|FG006|Fifth Intervention|Adverse Event|0|||
162021157|NCT01904773|585133430|FG007|Fifth Intervention|Adverse Event|1|||
162021158|NCT01904773|585133431|FG008|Fifth Intervention|Adverse Event|0|||
162021159|NCT01904773|585133423|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
162021160|NCT01904773|585133424|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
162021161|NCT01904773|585133425|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
162021162|NCT01904773|585133426|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
162021163|NCT01904773|585133427|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
162021164|NCT01904773|585133428|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
162021165|NCT01904773|585133429|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
162021166|NCT01904773|585133430|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
162021167|NCT01904773|585133431|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
161822708|NCT00633022|584391160|FG002|Overall Study|Physician Decision|0|||
161822709|NCT00663234|584391162|FG000|Overall Study|Not willing to adhere to requirements|1|||
161822710|NCT01253564|584391165|FG000|Overall Study|Disease Progression|22|||
162021168|NCT00220779|585133432|FG000|Overall Study|Adverse Event|1|||
162021169|NCT00220779|585133433|FG001|Overall Study|Adverse Event|0|||
162021170|NCT00220779|585133434|FG002|Overall Study|Adverse Event|0|||
162021171|NCT00220779|585133432|FG000|Overall Study|Withdrawal by Subject|1|||
162021172|NCT00220779|585133433|FG001|Overall Study|Withdrawal by Subject|4|||
162021173|NCT00220779|585133434|FG002|Overall Study|Withdrawal by Subject|1|||
162021174|NCT00220779|585133432|FG000|Overall Study|Non-compliance|1|||
162021175|NCT00220779|585133433|FG001|Overall Study|Non-compliance|0|||
162021176|NCT00220779|585133434|FG002|Overall Study|Non-compliance|0|||
162021177|NCT00220779|585133432|FG000|Overall Study|Too time consuming|1|||
162021178|NCT00220779|585133433|FG001|Overall Study|Too time consuming|0|||
162021179|NCT00220779|585133434|FG002|Overall Study|Too time consuming|0|||
162021180|NCT00220779|585133432|FG000|Overall Study|Pregnancy|0|||
162021181|NCT00220779|585133433|FG001|Overall Study|Pregnancy|0|||
161822711|NCT01253564|584391165|FG000|Overall Study|Withdrawal by Subject|1|||
161822712|NCT01253564|584391165|FG000|Overall Study|Serious Adverse Event|1|||
161822713|NCT02129062|584392418|FG000|Overall Study|Death|1|||
161822714|NCT02129062|584392418|FG000|Overall Study|Disease Progression|2|||
161822715|NCT04662710|584392419|FG000|Overall Study|Death|14|||
161822716|NCT04662710|584392420|FG001|Overall Study|Death|331|||
161822717|NCT04662710|584392421|FG002|Overall Study|Death|367|||
161822718|NCT04662710|584392419|FG000|Overall Study|Ongoing|1|||
161822719|NCT04662710|584392420|FG001|Overall Study|Ongoing|109|||
161822720|NCT04662710|584392421|FG002|Overall Study|Ongoing|56|||
161822721|NCT04662710|584392419|FG000|Overall Study|Withdrawal by Subject|0|||
161822722|NCT04662710|584392420|FG001|Overall Study|Withdrawal by Subject|3|||
161822723|NCT04662710|584392421|FG002|Overall Study|Withdrawal by Subject|14|||
161822724|NCT02722616|584392423|FG000|Overall Study|Sponsor closed study after one month|2|||
161822725|NCT02722616|584392424|FG001|Overall Study|Sponsor closed study after one month|0|||
161822726|NCT02722616|584392425|FG002|Overall Study|Sponsor closed study after one month|0|||
161822727|NCT00224484|584392426|FG000|Overall Study|Serious Adverse Event|1|||
161822728|NCT00224484|584392427|FG001|Overall Study|Serious Adverse Event|1|||
161822729|NCT00224484|584392428|FG002|Overall Study|Serious Adverse Event|0|||
161822730|NCT00224484|584392426|FG000|Overall Study|Non-Serious Adverse Event|5|||
161822731|NCT00224484|584392427|FG001|Overall Study|Non-Serious Adverse Event|7|||
161822732|NCT00224484|584392428|FG002|Overall Study|Non-Serious Adverse Event|3|||
161822733|NCT00224484|584392426|FG000|Overall Study|Protocol Violation|2|||
161822734|NCT00224484|584392427|FG001|Overall Study|Protocol Violation|2|||
161822735|NCT00224484|584392428|FG002|Overall Study|Protocol Violation|0|||
161822736|NCT00224484|584392426|FG000|Overall Study|Withdrawal by Subject|49|||
161822737|NCT00224484|584392427|FG001|Overall Study|Withdrawal by Subject|18|||
161822738|NCT00224484|584392428|FG002|Overall Study|Withdrawal by Subject|16|||
161822739|NCT00224484|584392426|FG000|Overall Study|Migrated/moved from study area|18|||
161822740|NCT00224484|584392427|FG001|Overall Study|Migrated/moved from study area|5|||
162021182|NCT00220779|585133434|FG002|Overall Study|Pregnancy|2|||
162021183|NCT00220779|585133432|FG000|Overall Study|Lack of Efficacy|3|||
161822741|NCT00224484|584392428|FG002|Overall Study|Migrated/moved from study area|5|||
161822742|NCT00224484|584392426|FG000|Overall Study|Lost to Follow-up|66|||
161822743|NCT00224484|584392427|FG001|Overall Study|Lost to Follow-up|28|||
161822744|NCT00224484|584392428|FG002|Overall Study|Lost to Follow-up|36|||
161822745|NCT00224484|584392426|FG000|Overall Study|Reason not specified|5|||
161822746|NCT00224484|584392427|FG001|Overall Study|Reason not specified|4|||
162202694|NCT00676663|585791047|FG001|Overall Study|Withdrew Consent|8|||
162202695|NCT00676663|585791046|FG000|Overall Study|Lost to Follow-up|1|||
161822747|NCT00224484|584392428|FG002|Overall Study|Reason not specified|2|||
161822748|NCT00108628|584392431|FG000|Overall Study|Withdrawal by Subject|17|||
161822749|NCT00108628|584392432|FG001|Overall Study|Withdrawal by Subject|9|||
161822750|NCT00108628|584392431|FG000|Overall Study|Lack of Efficacy|2|||
161822751|NCT00108628|584392432|FG001|Overall Study|Lack of Efficacy|1|||
161822752|NCT00108628|584392431|FG000|Overall Study|Death|1|||
161822753|NCT00108628|584392432|FG001|Overall Study|Death|0|||
161822754|NCT01453153|584392433|FG000|Overall Study|Physician Decision|0|||
161822755|NCT01453153|584392434|FG001|Overall Study|Physician Decision|0|||
161822756|NCT01453153|584392435|FG002|Overall Study|Physician Decision|1|||
161822757|NCT01453153|584392433|FG000|Overall Study|Progressive Disease|3|||
161822758|NCT01453153|584392434|FG001|Overall Study|Progressive Disease|2|||
161822759|NCT01453153|584392435|FG002|Overall Study|Progressive Disease|16|||
161822760|NCT01453153|584392433|FG000|Overall Study|Withdrawal by Subject|0|||
161822761|NCT01453153|584392434|FG001|Overall Study|Withdrawal by Subject|1|||
161822762|NCT01453153|584392435|FG002|Overall Study|Withdrawal by Subject|2|||
161822763|NCT01453153|584392433|FG000|Overall Study|Adverse Event|1|||
161822764|NCT01453153|584392434|FG001|Overall Study|Adverse Event|1|||
161822765|NCT01453153|584392435|FG002|Overall Study|Adverse Event|1|||
161822766|NCT03547635|584392438|FG000|Overall Study|Adverse Event|5|||
161822767|NCT03547635|584392439|FG001|Overall Study|Adverse Event|2|||
161822768|NCT03547635|584392440|FG002|Overall Study|Adverse Event|3|||
161822769|NCT03547635|584392438|FG000|Overall Study|Lost to Follow-up|1|||
161822770|NCT03547635|584392439|FG001|Overall Study|Lost to Follow-up|3|||
161822771|NCT03547635|584392440|FG002|Overall Study|Lost to Follow-up|4|||
161822772|NCT03547635|584392438|FG000|Overall Study|Withdrawal by Subject|1|||
161822773|NCT03547635|584392439|FG001|Overall Study|Withdrawal by Subject|0|||
161822774|NCT03547635|584392440|FG002|Overall Study|Withdrawal by Subject|0|||
161822775|NCT03547635|584392438|FG000|Overall Study|Withdrawal By PI|0|||
161822776|NCT03547635|584392439|FG001|Overall Study|Withdrawal By PI|1|||
161822777|NCT03547635|584392440|FG002|Overall Study|Withdrawal By PI|0|||
161822778|NCT03547635|584392438|FG000|Overall Study|Withdrawal by Sponsor|0|||
161822779|NCT03547635|584392439|FG001|Overall Study|Withdrawal by Sponsor|0|||
161822780|NCT03547635|584392440|FG002|Overall Study|Withdrawal by Sponsor|1|||
161822781|NCT03547635|584392438|FG000|Overall Study|Errant Randomization before Treatment|0|||
161822782|NCT03547635|584392439|FG001|Overall Study|Errant Randomization before Treatment|1|||
161822783|NCT03547635|584392440|FG002|Overall Study|Errant Randomization before Treatment|0|||
161822784|NCT03547635|584392438|FG000|Overall Study|Withdrawal by Subject|1|||
161822785|NCT03547635|584392439|FG001|Overall Study|Withdrawal by Subject|0|||
161822786|NCT03547635|584392440|FG002|Overall Study|Withdrawal by Subject|0|||
161822787|NCT03243396|584392441|FG000|Overall Study|Lost to Follow-up|2|||
161822788|NCT03243396|584392442|FG001|Overall Study|Lost to Follow-up|3|||
161822789|NCT03243396|584392443|FG002|Overall Study|Lost to Follow-up|15|||
161822790|NCT03243396|584392444|FG003|Overall Study|Lost to Follow-up|8|||
161822791|NCT03243396|584392445|FG004|Overall Study|Lost to Follow-up|1|||
161822792|NCT03243396|584392446|FG005|Overall Study|Lost to Follow-up|4|||
161822793|NCT03243396|584392447|FG006|Overall Study|Lost to Follow-up|9|||
161822794|NCT03687242|584392448|FG000|Overall Study|Adverse Event|1|||
161822795|NCT00288704|584392449|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
161822796|NCT00288704|584392450|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
161822797|NCT00288704|584392451|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
161822798|NCT00288704|584392449|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
161822799|NCT00288704|584392450|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
161822800|NCT00288704|584392451|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
161822801|NCT00288704|584392449|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
161822802|NCT00288704|584392450|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
161822803|NCT00288704|584392451|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
161822804|NCT00288704|584392449|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
161822805|NCT00288704|584392450|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
161822806|NCT00288704|584392451|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
161930253|NCT04913675|584792480|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
161930254|NCT01541254|584792484|FG000|Overall Study|Withdrawal by Subject|1|||
161822807|NCT00288704|584392449|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
161822808|NCT00288704|584392450|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
161822809|NCT00288704|584392451|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
161822810|NCT00288704|584392449|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
161822811|NCT00288704|584392450|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
161822812|NCT00288704|584392451|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
161822813|NCT00288704|584392449|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
161822814|NCT00288704|584392450|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
161822815|NCT00288704|584392451|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
161676927|NCT01020448|583870610|FG000|Treatment|Disease Progression|2|||
161930255|NCT01541254|584792484|FG000|Overall Study|excluded - metal allergy|1|||
161930256|NCT01541254|584792484|FG000|Overall Study|enrolled after study closed|1|||
161930257|NCT01541254|584792484|FG000|Overall Study|GI bleed prior to procedure|1|||
161930258|NCT01541254|584792484|FG000|Overall Study|stent not required|1|||
161930259|NCT01541254|584792484|FG000|Overall Study|alternate stent used|1|||
161930260|NCT05660538|584792485|FG000|Overall Study|Adverse Event|0|||
161930261|NCT05660538|584792486|FG001|Overall Study|Adverse Event|0|||
161930262|NCT05660538|584792487|FG002|Overall Study|Adverse Event|1|||
161930263|NCT05660538|584792488|FG003|Overall Study|Adverse Event|0|||
161930264|NCT05660538|584792485|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
161930265|NCT05660538|584792486|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
161930266|NCT05660538|584792487|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
161930267|NCT05660538|584792488|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
161930268|NCT05660538|584792485|FG000|Overall Study|Lost to Follow-up|0|||
161930269|NCT05660538|584792486|FG001|Overall Study|Lost to Follow-up|0|||
161930270|NCT05660538|584792487|FG002|Overall Study|Lost to Follow-up|1|||
161930271|NCT05660538|584792488|FG003|Overall Study|Lost to Follow-up|1|||
161930272|NCT05660538|584792485|FG000|Overall Study|Death|0|||
161930273|NCT05660538|584792486|FG001|Overall Study|Death|0|||
161930274|NCT05660538|584792487|FG002|Overall Study|Death|1|||
161930275|NCT05660538|584792488|FG003|Overall Study|Death|0|||
161930276|NCT05660538|584792485|FG000|Overall Study|Physician Decision|0|||
161930277|NCT05660538|584792486|FG001|Overall Study|Physician Decision|0|||
161930278|NCT05660538|584792487|FG002|Overall Study|Physician Decision|0|||
161930279|NCT05660538|584792488|FG003|Overall Study|Physician Decision|1|||
161930280|NCT05660538|584792485|FG000|Overall Study|Sponsor Decision|1|||
161930281|NCT05660538|584792486|FG001|Overall Study|Sponsor Decision|0|||
161930282|NCT05660538|584792487|FG002|Overall Study|Sponsor Decision|0|||
161930283|NCT05660538|584792488|FG003|Overall Study|Sponsor Decision|0|||
161930284|NCT05660538|584792485|FG000|Overall Study|Other|1|||
162021184|NCT00220779|585133433|FG001|Overall Study|Lack of Efficacy|0|||
162021185|NCT00220779|585133434|FG002|Overall Study|Lack of Efficacy|1|||
162021186|NCT04518995|585133435|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
162021187|NCT04518995|585133436|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
162021188|NCT04518995|585133437|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
162021189|NCT04518995|585133435|FG000|Overall Study|Lack of Efficacy|2|||
162021190|NCT04518995|585133436|FG001|Overall Study|Lack of Efficacy|1|||
162021191|NCT04518995|585133437|FG002|Overall Study|Lack of Efficacy|0|||
162021192|NCT04518995|585133435|FG000|Overall Study|Non-compliance With Study Drug|0|||
162021193|NCT04518995|585133436|FG001|Overall Study|Non-compliance With Study Drug|3|||
162021194|NCT04518995|585133437|FG002|Overall Study|Non-compliance With Study Drug|2|||
162021195|NCT04518995|585133435|FG000|Overall Study|Pregnancy|0|||
162021196|NCT04518995|585133436|FG001|Overall Study|Pregnancy|0|||
162021197|NCT04518995|585133437|FG002|Overall Study|Pregnancy|1|||
162021198|NCT04518995|585133435|FG000|Overall Study|Protocol Violation|2|||
162021199|NCT04518995|585133436|FG001|Overall Study|Protocol Violation|0|||
162021200|NCT04518995|585133437|FG002|Overall Study|Protocol Violation|1|||
162021201|NCT04518995|585133435|FG000|Overall Study|Reason not Specified|4|||
162021202|NCT04518995|585133436|FG001|Overall Study|Reason not Specified|11|||
161676928|NCT01020448|583870610|FG000|Treatment|Lack of Efficacy|8|||
161676929|NCT01020448|583870610|FG000|Treatment|Lost to Follow-up|2|||
161676930|NCT01390272|583870621|FG000|Overall Study|Death|3|||
161822816|NCT00676650|584392452|FG000|Overall Study|Death|45|||
161822817|NCT00676650|584392453|FG001|Overall Study|Death|14|||
161822818|NCT00676650|584392452|FG000|Overall Study|Adverse Event|159|||
161676931|NCT01390272|583870622|FG001|Overall Study|Death|2|||
161822819|NCT00676650|584392453|FG001|Overall Study|Adverse Event|21|||
161822820|NCT00676650|584392452|FG000|Overall Study|Global deterioration of health status|66|||
161822821|NCT00676650|584392453|FG001|Overall Study|Global deterioration of health status|31|||
161822822|NCT00676650|584392452|FG000|Overall Study|Lost to Follow-up|0|||
161822823|NCT00676650|584392453|FG001|Overall Study|Lost to Follow-up|1|||
161822824|NCT00676650|584392452|FG000|Overall Study|Objective progression or relapse|189|||
161822825|NCT00676650|584392453|FG001|Overall Study|Objective progression or relapse|140|||
161930285|NCT05660538|584792486|FG001|Overall Study|Other|0|||
161930286|NCT05660538|584792487|FG002|Overall Study|Other|0|||
161930287|NCT05660538|584792488|FG003|Overall Study|Other|1|||
161930288|NCT05660538|584792485|FG000|Overall Study|Randomized but did not receive study drug|1|||
162021203|NCT04518995|585133437|FG002|Overall Study|Reason not Specified|2|||
162021204|NCT04518995|585133435|FG000|Overall Study|Lost to Follow-up|1|||
161930289|NCT05660538|584792486|FG001|Overall Study|Randomized but did not receive study drug|0|||
161930290|NCT05660538|584792487|FG002|Overall Study|Randomized but did not receive study drug|0|||
161930291|NCT05660538|584792488|FG003|Overall Study|Randomized but did not receive study drug|1|||
161930292|NCT05660538|584792485|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
161930293|NCT05660538|584792486|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
161930294|NCT05660538|584792487|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
161930295|NCT05660538|584792488|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
162021205|NCT04518995|585133436|FG001|Overall Study|Lost to Follow-up|10|||
161930296|NCT04518410|584792489|FG000|Overall Study|Lost to Follow-up|1|||
162021206|NCT04518995|585133437|FG002|Overall Study|Lost to Follow-up|6|||
162021207|NCT01511055|585133440|FG000|Overall Study|Withdrawal by Subject|6|||
162021208|NCT04590248|585133441|FG000|Overall Study|Lost to Follow-up|1|||
162021209|NCT04590248|585133441|FG000|Overall Study|Withdrawal by Subject|16|||
162021210|NCT04590248|585133441|FG000|Overall Study|Other|2|||
162021211|NCT02052414|585133444|FG000|Overall Study|Adverse Event|12|||
162021212|NCT02052414|585133444|FG000|Overall Study|Lack of Efficacy|2|||
162021213|NCT02052414|585133444|FG000|Overall Study|Withdrawal by Subject|3|||
162021214|NCT01235598|585133454|FG000|Overall Study|Adverse Event|0|||
162021215|NCT01235598|585133455|FG001|Overall Study|Adverse Event|3|||
162021216|NCT01235598|585133454|FG000|Overall Study|Lack of Efficacy|0|||
162021217|NCT01235598|585133455|FG001|Overall Study|Lack of Efficacy|1|||
162021218|NCT01235598|585133454|FG000|Overall Study|Withdrawal by Subject|1|||
162021219|NCT01235598|585133455|FG001|Overall Study|Withdrawal by Subject|0|||
162021220|NCT00395343|585133456|FG000|Overall Study|Adverse Event|13|||
162021221|NCT00395343|585133457|FG001|Overall Study|Adverse Event|5|||
162021222|NCT00395343|585133456|FG000|Overall Study|Lack of Efficacy|0|||
161930297|NCT04518410|584792490|FG001|Overall Study|Lost to Follow-up|1|||
161930298|NCT04518410|584792491|FG002|Overall Study|Lost to Follow-up|8|||
161930299|NCT04518410|584792492|FG003|Overall Study|Lost to Follow-up|5|||
161930300|NCT04518410|584792493|FG004|Overall Study|Lost to Follow-up|92|||
161930301|NCT04518410|584792494|FG005|Overall Study|Lost to Follow-up|25|||
161930302|NCT04518410|584792495|FG006|Overall Study|Lost to Follow-up|25|||
161930303|NCT04518410|584792496|FG007|Overall Study|Lost to Follow-up|3|||
161930304|NCT04518410|584792497|FG008|Overall Study|Lost to Follow-up|2|||
161930305|NCT04518410|584792498|FG009|Overall Study|Lost to Follow-up|13|||
161930306|NCT04518410|584792499|FG010|Overall Study|Lost to Follow-up|9|||
162021223|NCT00395343|585133457|FG001|Overall Study|Lack of Efficacy|1|||
162021224|NCT00395343|585133456|FG000|Overall Study|Lost to Follow-up|4|||
162021225|NCT00395343|585133457|FG001|Overall Study|Lost to Follow-up|4|||
162021226|NCT00395343|585133456|FG000|Overall Study|Physician Decision|2|||
162021227|NCT00395343|585133457|FG001|Overall Study|Physician Decision|4|||
162021228|NCT00395343|585133456|FG000|Overall Study|Protocol Violation|6|||
162021229|NCT00395343|585133457|FG001|Overall Study|Protocol Violation|8|||
162021230|NCT00395343|585133456|FG000|Overall Study|Withdrawal by Subject|11|||
162021231|NCT00395343|585133457|FG001|Overall Study|Withdrawal by Subject|12|||
162021232|NCT00395343|585133456|FG000|Overall Study|Other|5|||
162021233|NCT00395343|585133457|FG001|Overall Study|Other|2|||
162021234|NCT03860259|585133464|FG000|Overall Study|Lost to Follow-up|5|||
162021235|NCT03860259|585133465|FG001|Overall Study|Lost to Follow-up|5|||
162021236|NCT03860259|585133464|FG000|Overall Study|Protocol Violation|1|||
162021237|NCT03860259|585133465|FG001|Overall Study|Protocol Violation|0|||
162021238|NCT02280408|585133466|FG000|Overall Study|Lost to Follow-up|0|||
161822826|NCT00676650|584392452|FG000|Overall Study|Other|14|||
161822827|NCT00676650|584392453|FG001|Overall Study|Other|10|||
161822828|NCT00676650|584392452|FG000|Overall Study|Protocol Violation|3|||
161822829|NCT00676650|584392453|FG001|Overall Study|Protocol Violation|1|||
161822830|NCT00676650|584392452|FG000|Overall Study|Study terminated by sponsor|57|||
161822831|NCT00676650|584392453|FG001|Overall Study|Study terminated by sponsor|43|||
161822832|NCT00676650|584392452|FG000|Overall Study|Withdrawal by Subject|48|||
162202696|NCT00676663|585791047|FG001|Overall Study|Lost to Follow-up|3|||
162202697|NCT00714688|585791053|FG000|Overall Study|Lack of Efficacy|14|||
162202698|NCT00714688|585791054|FG001|Overall Study|Lack of Efficacy|1|||
162202699|NCT00714688|585791055|FG002|Overall Study|Lack of Efficacy|4|||
162202700|NCT00714688|585791053|FG000|Overall Study|Withdrawal by Subject|4|||
162202701|NCT00714688|585791054|FG001|Overall Study|Withdrawal by Subject|3|||
162202702|NCT00714688|585791055|FG002|Overall Study|Withdrawal by Subject|3|||
162202703|NCT00714688|585791053|FG000|Overall Study|Lost to Follow-up|5|||
161822833|NCT00676650|584392453|FG001|Overall Study|Withdrawal by Subject|24|||
161822834|NCT00676650|584392452|FG000|Overall Study|Randomized but not treated|3|||
161822835|NCT00676650|584392453|FG001|Overall Study|Randomized but not treated|4|||
161822836|NCT02297841|584392457|FG000|Overall Study|Withdrawal by Subject|1|||
162021239|NCT02280408|585133467|FG001|Overall Study|Lost to Follow-up|2|||
162021240|NCT02280408|585133468|FG002|Overall Study|Lost to Follow-up|0|||
162202704|NCT00714688|585791054|FG001|Overall Study|Lost to Follow-up|2|||
162202705|NCT00714688|585791055|FG002|Overall Study|Lost to Follow-up|0|||
161822837|NCT02297841|584392457|FG000|Overall Study|Protocol Violation|7|||
161822838|NCT05061992|584392458|FG000|Overall Study|Excess bowel movements|1|||
161822839|NCT05061992|584392459|FG001|Overall Study|Excess bowel movements|0|||
161822840|NCT05061992|584392458|FG000|Overall Study|Complications of Medical Care|1|||
161822841|NCT05061992|584392459|FG001|Overall Study|Complications of Medical Care|0|||
161822842|NCT05061992|584392458|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
161822843|NCT05061992|584392459|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
161930307|NCT04518410|584792500|FG011|Overall Study|Lost to Follow-up|13|||
161930308|NCT04518410|584792501|FG012|Overall Study|Lost to Follow-up|9|||
161930309|NCT04518410|584792502|FG013|Overall Study|Lost to Follow-up|13|||
161930310|NCT04518410|584792503|FG014|Overall Study|Lost to Follow-up|8|||
161930311|NCT04518410|584792504|FG015|Overall Study|Lost to Follow-up|10|||
161930312|NCT04518410|584792505|FG016|Overall Study|Lost to Follow-up|6|||
161930313|NCT04518410|584792506|FG017|Overall Study|Lost to Follow-up|13|||
161930314|NCT04518410|584792507|FG018|Overall Study|Lost to Follow-up|21|||
161930315|NCT04518410|584792508|FG019|Overall Study|Lost to Follow-up|6|||
161930316|NCT04518410|584792509|FG020|Overall Study|Lost to Follow-up|7|||
161930317|NCT04518410|584792510|FG021|Overall Study|Lost to Follow-up|21|||
161930318|NCT04518410|584792511|FG022|Overall Study|Lost to Follow-up|1|||
161930319|NCT04518410|584792512|FG023|Overall Study|Lost to Follow-up|7|||
161930320|NCT04518410|584792513|FG024|Overall Study|Lost to Follow-up|6|||
161930321|NCT04518410|584792489|FG000|Overall Study|Withdrawal by Subject|1|||
161930322|NCT04518410|584792490|FG001|Overall Study|Withdrawal by Subject|2|||
161930323|NCT04518410|584792491|FG002|Overall Study|Withdrawal by Subject|2|||
161930324|NCT04518410|584792492|FG003|Overall Study|Withdrawal by Subject|3|||
161930325|NCT04518410|584792493|FG004|Overall Study|Withdrawal by Subject|20|||
161822844|NCT05061992|584392458|FG000|Overall Study|Withdrawal by Subject|0|||
161822845|NCT05061992|584392459|FG001|Overall Study|Withdrawal by Subject|1|||
161822846|NCT01257581|584392464|FG000|Overall Study|Early Termination|3|||
161822847|NCT01257581|584392465|FG001|Overall Study|Early Termination|1|||
161822848|NCT01257581|584392466|FG002|Overall Study|Early Termination|2|||
161822849|NCT01257581|584392464|FG000|Overall Study|Death|2|||
161822850|NCT01257581|584392465|FG001|Overall Study|Death|2|||
161822851|NCT01257581|584392466|FG002|Overall Study|Death|4|||
161822852|NCT01157234|584392467|FG000|Overall Study|Withdrawal by Subject|1|||
161822853|NCT01157234|584392468|FG001|Overall Study|Withdrawal by Subject|0|||
161822854|NCT05996198|584392481|FG000|Overall Study|Withdrawal by Subject|1|||
161822855|NCT05996198|584392482|FG001|Overall Study|Withdrawal by Subject|0|||
161822856|NCT00059332|584392486|FG000|Overall Study|Withdrawal by Subject|2|||
161822857|NCT00059332|584392487|FG001|Overall Study|Withdrawal by Subject|1|||
161930326|NCT04518410|584792494|FG005|Overall Study|Withdrawal by Subject|20|||
161930327|NCT04518410|584792495|FG006|Overall Study|Withdrawal by Subject|25|||
161930328|NCT04518410|584792496|FG007|Overall Study|Withdrawal by Subject|6|||
161930329|NCT04518410|584792497|FG008|Overall Study|Withdrawal by Subject|1|||
161930330|NCT04518410|584792498|FG009|Overall Study|Withdrawal by Subject|12|||
161930331|NCT04518410|584792499|FG010|Overall Study|Withdrawal by Subject|5|||
161930332|NCT04518410|584792500|FG011|Overall Study|Withdrawal by Subject|7|||
161930333|NCT04518410|584792501|FG012|Overall Study|Withdrawal by Subject|2|||
161930334|NCT04518410|584792502|FG013|Overall Study|Withdrawal by Subject|13|||
161930335|NCT04518410|584792503|FG014|Overall Study|Withdrawal by Subject|4|||
161930336|NCT04518410|584792504|FG015|Overall Study|Withdrawal by Subject|9|||
161930337|NCT04518410|584792505|FG016|Overall Study|Withdrawal by Subject|0|||
161930338|NCT04518410|584792506|FG017|Overall Study|Withdrawal by Subject|15|||
161930339|NCT04518410|584792507|FG018|Overall Study|Withdrawal by Subject|12|||
161930340|NCT04518410|584792508|FG019|Overall Study|Withdrawal by Subject|9|||
161930341|NCT04518410|584792509|FG020|Overall Study|Withdrawal by Subject|14|||
161930342|NCT04518410|584792510|FG021|Overall Study|Withdrawal by Subject|3|||
161930343|NCT04518410|584792511|FG022|Overall Study|Withdrawal by Subject|2|||
161930344|NCT04518410|584792512|FG023|Overall Study|Withdrawal by Subject|9|||
161822858|NCT00059332|584392486|FG000|Overall Study|Lost to Follow-up|1|||
161822859|NCT00059332|584392487|FG001|Overall Study|Lost to Follow-up|1|||
161822860|NCT00487695|584392490|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
161822861|NCT00487695|584392491|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
161822862|NCT00487695|584392490|FG000|First Procedure|active wheezing (did not have procedure)|1|||
161822863|NCT00487695|584392491|FG001|First Procedure|active wheezing (did not have procedure)|0|||
161822864|NCT00487695|584392490|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
161822865|NCT00487695|584392491|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
161822866|NCT00487695|584392490|FG000|Second Procedure|active wheezing|0|||
161930345|NCT04518410|584792513|FG024|Overall Study|Withdrawal by Subject|8|||
161930346|NCT04518410|584792489|FG000|Overall Study|Other|1|||
161930347|NCT04518410|584792490|FG001|Overall Study|Other|0|||
161930348|NCT04518410|584792491|FG002|Overall Study|Other|0|||
161930349|NCT04518410|584792492|FG003|Overall Study|Other|1|||
161930350|NCT04518410|584792493|FG004|Overall Study|Other|6|||
161930351|NCT04518410|584792494|FG005|Overall Study|Other|6|||
161930352|NCT04518410|584792495|FG006|Overall Study|Other|5|||
161930353|NCT04518410|584792496|FG007|Overall Study|Other|2|||
161822867|NCT00487695|584392491|FG001|Second Procedure|active wheezing|1|||
161822868|NCT00487695|584392490|FG000|Second Procedure|Withdrawal by Subject|1|||
161822869|NCT00487695|584392491|FG001|Second Procedure|Withdrawal by Subject|2|||
161822870|NCT01698554|584392497|FG000|Overall Study|Adverse Event|2|||
161822871|NCT01698554|584392498|FG001|Overall Study|Adverse Event|5|||
161930354|NCT04518410|584792497|FG008|Overall Study|Other|0|||
161930355|NCT04518410|584792498|FG009|Overall Study|Other|1|||
161930356|NCT04518410|584792499|FG010|Overall Study|Other|0|||
161930357|NCT04518410|584792500|FG011|Overall Study|Other|2|||
161930358|NCT04518410|584792501|FG012|Overall Study|Other|0|||
161930359|NCT04518410|584792502|FG013|Overall Study|Other|0|||
161930360|NCT04518410|584792503|FG014|Overall Study|Other|0|||
161930361|NCT04518410|584792504|FG015|Overall Study|Other|3|||
161930362|NCT04518410|584792505|FG016|Overall Study|Other|1|||
161930363|NCT04518410|584792506|FG017|Overall Study|Other|1|||
161930364|NCT04518410|584792507|FG018|Overall Study|Other|1|||
161930365|NCT04518410|584792508|FG019|Overall Study|Other|0|||
161930366|NCT04518410|584792509|FG020|Overall Study|Other|1|||
161930367|NCT04518410|584792510|FG021|Overall Study|Other|0|||
161930368|NCT04518410|584792511|FG022|Overall Study|Other|1|||
161930369|NCT04518410|584792512|FG023|Overall Study|Other|2|||
161930370|NCT04518410|584792513|FG024|Overall Study|Other|2|||
161930371|NCT04518410|584792489|FG000|Overall Study|Protocol Violation|0|||
161930372|NCT04518410|584792490|FG001|Overall Study|Protocol Violation|0|||
161930373|NCT04518410|584792491|FG002|Overall Study|Protocol Violation|0|||
161930374|NCT04518410|584792492|FG003|Overall Study|Protocol Violation|2|||
161930375|NCT04518410|584792493|FG004|Overall Study|Protocol Violation|17|||
161930376|NCT04518410|584792494|FG005|Overall Study|Protocol Violation|1|||
161930377|NCT04518410|584792495|FG006|Overall Study|Protocol Violation|2|||
161930378|NCT04518410|584792496|FG007|Overall Study|Protocol Violation|1|||
161930379|NCT04518410|584792497|FG008|Overall Study|Protocol Violation|0|||
161930380|NCT04518410|584792498|FG009|Overall Study|Protocol Violation|0|||
161930381|NCT04518410|584792499|FG010|Overall Study|Protocol Violation|0|||
161930382|NCT04518410|584792500|FG011|Overall Study|Protocol Violation|0|||
161930383|NCT04518410|584792501|FG012|Overall Study|Protocol Violation|0|||
161930384|NCT04518410|584792502|FG013|Overall Study|Protocol Violation|0|||
161930385|NCT04518410|584792503|FG014|Overall Study|Protocol Violation|0|||
161930386|NCT04518410|584792504|FG015|Overall Study|Protocol Violation|0|||
161930387|NCT04518410|584792505|FG016|Overall Study|Protocol Violation|1|||
161930388|NCT04518410|584792506|FG017|Overall Study|Protocol Violation|1|||
161930389|NCT04518410|584792507|FG018|Overall Study|Protocol Violation|0|||
161930390|NCT04518410|584792508|FG019|Overall Study|Protocol Violation|0|||
161930391|NCT04518410|584792509|FG020|Overall Study|Protocol Violation|1|||
161930392|NCT04518410|584792510|FG021|Overall Study|Protocol Violation|2|||
161930393|NCT04518410|584792511|FG022|Overall Study|Protocol Violation|0|||
161930394|NCT04518410|584792512|FG023|Overall Study|Protocol Violation|3|||
161930395|NCT04518410|584792513|FG024|Overall Study|Protocol Violation|0|||
161930396|NCT04518410|584792489|FG000|Overall Study|Death|0|||
161930397|NCT04518410|584792490|FG001|Overall Study|Death|0|||
161930398|NCT04518410|584792491|FG002|Overall Study|Death|0|||
161930399|NCT04518410|584792492|FG003|Overall Study|Death|0|||
161930400|NCT04518410|584792493|FG004|Overall Study|Death|12|||
161930401|NCT04518410|584792494|FG005|Overall Study|Death|2|||
161930402|NCT04518410|584792495|FG006|Overall Study|Death|11|||
161930403|NCT04518410|584792496|FG007|Overall Study|Death|0|||
161930404|NCT04518410|584792497|FG008|Overall Study|Death|1|||
161930405|NCT04518410|584792498|FG009|Overall Study|Death|0|||
161930406|NCT04518410|584792499|FG010|Overall Study|Death|0|||
161930407|NCT04518410|584792500|FG011|Overall Study|Death|0|||
161930408|NCT04518410|584792501|FG012|Overall Study|Death|0|||
161822872|NCT01698554|584392499|FG002|Overall Study|Adverse Event|0|||
161822873|NCT01698554|584392500|FG003|Overall Study|Adverse Event|1|||
161822874|NCT01698554|584392497|FG000|Overall Study|Lost to Follow-up|1|||
161930409|NCT04518410|584792502|FG013|Overall Study|Death|1|||
161930410|NCT04518410|584792503|FG014|Overall Study|Death|1|||
161930411|NCT04518410|584792504|FG015|Overall Study|Death|0|||
161930412|NCT04518410|584792505|FG016|Overall Study|Death|0|||
161930413|NCT04518410|584792506|FG017|Overall Study|Death|1|||
161930414|NCT04518410|584792507|FG018|Overall Study|Death|4|||
161930415|NCT04518410|584792508|FG019|Overall Study|Death|4|||
161930416|NCT04518410|584792509|FG020|Overall Study|Death|1|||
161930417|NCT04518410|584792510|FG021|Overall Study|Death|0|||
161930418|NCT04518410|584792511|FG022|Overall Study|Death|0|||
161930419|NCT04518410|584792512|FG023|Overall Study|Death|0|||
161930420|NCT04518410|584792513|FG024|Overall Study|Death|0|||
161930421|NCT04518410|584792489|FG000|Overall Study|Requirement to start alternative therapy|0|||
161930422|NCT04518410|584792490|FG001|Overall Study|Requirement to start alternative therapy|0|||
161930423|NCT04518410|584792491|FG002|Overall Study|Requirement to start alternative therapy|1|||
161930424|NCT04518410|584792492|FG003|Overall Study|Requirement to start alternative therapy|0|||
162202706|NCT00714688|585791053|FG000|Overall Study|Adverse Event|2|||
162202707|NCT00714688|585791054|FG001|Overall Study|Adverse Event|15|||
162202708|NCT00714688|585791055|FG002|Overall Study|Adverse Event|19|||
161930425|NCT04518410|584792493|FG004|Overall Study|Requirement to start alternative therapy|0|||
161930426|NCT04518410|584792494|FG005|Overall Study|Requirement to start alternative therapy|0|||
161930427|NCT04518410|584792495|FG006|Overall Study|Requirement to start alternative therapy|0|||
161930428|NCT04518410|584792496|FG007|Overall Study|Requirement to start alternative therapy|0|||
161930429|NCT04518410|584792497|FG008|Overall Study|Requirement to start alternative therapy|0|||
161930430|NCT04518410|584792498|FG009|Overall Study|Requirement to start alternative therapy|0|||
161930431|NCT04518410|584792499|FG010|Overall Study|Requirement to start alternative therapy|0|||
161822875|NCT01698554|584392498|FG001|Overall Study|Lost to Follow-up|0|||
161822876|NCT01698554|584392499|FG002|Overall Study|Lost to Follow-up|0|||
161822877|NCT01698554|584392500|FG003|Overall Study|Lost to Follow-up|0|||
161822878|NCT01698554|584392497|FG000|Overall Study|Personal Reasons|0|||
161822879|NCT01698554|584392498|FG001|Overall Study|Personal Reasons|5|||
161822880|NCT01698554|584392499|FG002|Overall Study|Personal Reasons|1|||
161822881|NCT01698554|584392500|FG003|Overall Study|Personal Reasons|1|||
161822882|NCT01698554|584392497|FG000|Overall Study|Protocol Violation|2|||
161822883|NCT01698554|584392498|FG001|Overall Study|Protocol Violation|0|||
161822884|NCT01698554|584392499|FG002|Overall Study|Protocol Violation|1|||
161822885|NCT01698554|584392500|FG003|Overall Study|Protocol Violation|0|||
161822886|NCT01698554|584392497|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161822887|NCT01698554|584392498|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161822888|NCT01698554|584392499|FG002|Overall Study|Other Miscellaneous Reasons|0|||
161822889|NCT01698554|584392500|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161822890|NCT00697827|584392503|FG000|Overall Study|enrolled but not treated|2|||
161822891|NCT00697827|584392504|FG001|Overall Study|enrolled but not treated|1|||
161822892|NCT03732833|584392505|FG000|Overall Study|Adverse Event|0|||
161822893|NCT03732833|584392506|FG001|Overall Study|Adverse Event|3|||
161822894|NCT03732833|584392507|FG002|Overall Study|Adverse Event|1|||
161822895|NCT03732833|584392505|FG000|Overall Study|Withdrawal by Subject|11|||
161822896|NCT03732833|584392506|FG001|Overall Study|Withdrawal by Subject|13|||
161822897|NCT03732833|584392507|FG002|Overall Study|Withdrawal by Subject|8|||
161822898|NCT03732833|584392505|FG000|Overall Study|Lost to Follow-up|3|||
161822899|NCT03732833|584392506|FG001|Overall Study|Lost to Follow-up|5|||
161822900|NCT03732833|584392507|FG002|Overall Study|Lost to Follow-up|4|||
161822901|NCT03732833|584392505|FG000|Overall Study|Pregnancy|0|||
161822902|NCT03732833|584392506|FG001|Overall Study|Pregnancy|2|||
161822903|NCT03732833|584392507|FG002|Overall Study|Pregnancy|0|||
161822904|NCT03732833|584392505|FG000|Overall Study|Physician Decision|2|||
161822905|NCT03732833|584392506|FG001|Overall Study|Physician Decision|3|||
161822906|NCT03732833|584392507|FG002|Overall Study|Physician Decision|1|||
161822907|NCT03732833|584392505|FG000|Overall Study|Covid-19 related and other reasons|2|||
161822908|NCT03732833|584392506|FG001|Overall Study|Covid-19 related and other reasons|7|||
161822909|NCT03732833|584392507|FG002|Overall Study|Covid-19 related and other reasons|3|||
161822910|NCT00766493|584392508|FG000|30 Days Post-Procedure|Discontinued|7|||
161822911|NCT00766493|584392508|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
161822912|NCT00766493|584392508|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
161822913|NCT01849458|584392509|FG000|Overall Study|Lost to Follow-up|4|||
161822914|NCT01863433|584392510|FG000|Overall Study|Protocol Violation|1|||
161822915|NCT03950674|584392511|FG000|Overall Study|Death|16|||
162202709|NCT00714688|585791053|FG000|Overall Study|Subject Non-compliant|3|||
162202710|NCT00714688|585791054|FG001|Overall Study|Subject Non-compliant|5|||
162202711|NCT00714688|585791055|FG002|Overall Study|Subject Non-compliant|5|||
162202712|NCT00714688|585791053|FG000|Overall Study|Ineligible to Continue the Study|0|||
161822916|NCT03950674|584392512|FG001|Overall Study|Death|15|||
161822917|NCT03950674|584392511|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
161822918|NCT03950674|584392512|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
161822919|NCT01688882|584392519|FG000|Overall Study|Adverse Event|1|||
161822920|NCT01688882|584392520|FG001|Overall Study|Adverse Event|0|||
161822921|NCT01688882|584392519|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161822922|NCT01688882|584392520|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161822923|NCT01688882|584392519|FG000|Overall Study|Administrative problems|1|||
161822924|NCT01688882|584392520|FG001|Overall Study|Administrative problems|0|||
161822925|NCT00494013|584392525|FG000|Overall Study|Adverse Event|0|||
161822926|NCT00494013|584392526|FG001|Overall Study|Adverse Event|1|||
161822927|NCT00494013|584392525|FG000|Overall Study|Entry Criteria Not Met|1|||
161822928|NCT00494013|584392526|FG001|Overall Study|Entry Criteria Not Met|4|||
161822929|NCT00494013|584392525|FG000|Overall Study|Lost to Follow-up|5|||
161822930|NCT00494013|584392526|FG001|Overall Study|Lost to Follow-up|6|||
161822931|NCT00494013|584392525|FG000|Overall Study|Physician Decision|3|||
161822932|NCT00494013|584392526|FG001|Overall Study|Physician Decision|5|||
161822933|NCT00494013|584392525|FG000|Overall Study|Protocol Violation|8|||
161822934|NCT00494013|584392526|FG001|Overall Study|Protocol Violation|5|||
161822935|NCT00494013|584392525|FG000|Overall Study|Withdrawal by Subject|13|||
161822936|NCT00494013|584392526|FG001|Overall Study|Withdrawal by Subject|14|||
161822937|NCT00494013|584392525|FG000|Overall Study|Sponsor Decision|0|||
161822938|NCT00494013|584392526|FG001|Overall Study|Sponsor Decision|1|||
161822939|NCT00834613|584392528|FG000|First Intervention|Protocol Violation|1|||
161822940|NCT00834613|584392529|FG001|First Intervention|Protocol Violation|0|||
161822941|NCT04584983|584392530|FG000|Overall Study|Parental request for withdraw|2|||
161822942|NCT04584983|584392531|FG001|Overall Study|Parental request for withdraw|0|||
161822943|NCT02293460|584394007|FG000|Overall Study|Protocol Violation|1|||
161822944|NCT02293460|584394007|FG000|Overall Study|Lack of Efficacy|2|||
161822945|NCT02293460|584394007|FG000|Overall Study|Adverse Event|2|||
161822946|NCT02293460|584394007|FG000|Overall Study|Withdrawal by Subject|1|||
161822947|NCT01636934|584394009|FG000|Overall Study|Withdrawal by Subject|3|||
161822948|NCT01636934|584394010|FG001|Overall Study|Withdrawal by Subject|2|||
161822949|NCT01636934|584394009|FG000|Overall Study|Chemo cancel|1|||
161822950|NCT01636934|584394010|FG001|Overall Study|Chemo cancel|0|||
161822951|NCT01636934|584394009|FG000|Overall Study|Too ill to continue|1|||
161822952|NCT01636934|584394010|FG001|Overall Study|Too ill to continue|0|||
161822953|NCT01636934|584394009|FG000|Overall Study|Never started study medication|1|||
161822954|NCT01636934|584394010|FG001|Overall Study|Never started study medication|1|||
161822955|NCT03035890|584394018|FG000|Overall Study|Death|1|||
161822956|NCT02459418|584394024|FG000|Overall Study|Exclusion Criteria|4|||
161822957|NCT02459418|584394025|FG001|Overall Study|Exclusion Criteria|0|||
161822958|NCT02459418|584394024|FG000|Overall Study|Protocol Violation|0|||
161822959|NCT02459418|584394025|FG001|Overall Study|Protocol Violation|2|||
161822960|NCT02459418|584394024|FG000|Overall Study|Physician Decision|0|||
161822961|NCT02459418|584394025|FG001|Overall Study|Physician Decision|2|||
161822962|NCT02459418|584394024|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
161822963|NCT02459418|584394025|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
161822964|NCT02459418|584394024|FG000|Overall Study|Adverse Event|0|||
161822965|NCT02459418|584394025|FG001|Overall Study|Adverse Event|1|||
161822966|NCT02459418|584394024|FG000|Overall Study|Withdrawal by Subject|1|||
161822967|NCT02459418|584394025|FG001|Overall Study|Withdrawal by Subject|1|||
161822968|NCT02459418|584394024|FG000|Overall Study|Elevated Creatine Kinase|1|||
161822969|NCT02459418|584394025|FG001|Overall Study|Elevated Creatine Kinase|0|||
161822970|NCT02459418|584394024|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
161822971|NCT02459418|584394025|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
161822972|NCT03167606|584394026|FG000|Overall Study|Lost to Follow-up|73|||
161822973|NCT03167606|584394027|FG001|Overall Study|Lost to Follow-up|64|||
161822974|NCT03167606|584394026|FG000|Overall Study|Withdrawal by Subject|6|||
161822975|NCT03167606|584394027|FG001|Overall Study|Withdrawal by Subject|5|||
161822976|NCT03167606|584394026|FG000|Overall Study|Withdrawal by Investigator|0|||
161822977|NCT03167606|584394027|FG001|Overall Study|Withdrawal by Investigator|2|||
161822978|NCT00413049|584394028|FG000|Overall Study|Adverse Event|10|||
161822979|NCT00413049|584394029|FG001|Overall Study|Adverse Event|8|||
161822980|NCT00413049|584394028|FG000|Overall Study|Withdrawal by Subject|7|||
161822981|NCT00413049|584394029|FG001|Overall Study|Withdrawal by Subject|5|||
161822982|NCT00413049|584394028|FG000|Overall Study|Lost to Follow-up|2|||
161822983|NCT00413049|584394029|FG001|Overall Study|Lost to Follow-up|3|||
161822984|NCT00413049|584394028|FG000|Overall Study|Protocol Violation|3|||
161822985|NCT00413049|584394029|FG001|Overall Study|Protocol Violation|1|||
161822986|NCT00413049|584394028|FG000|Overall Study|Subject no longer requires study drug|0|||
161822987|NCT00413049|584394029|FG001|Overall Study|Subject no longer requires study drug|1|||
161822988|NCT00413049|584394028|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161822989|NCT00413049|584394029|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161822990|NCT00413049|584394028|FG000|Overall Study|Lack of Efficacy|1|||
161822991|NCT00413049|584394029|FG001|Overall Study|Lack of Efficacy|0|||
161822992|NCT03653026|584394036|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
161822993|NCT03653026|584394037|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
161822994|NCT03653026|584394038|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
161822995|NCT03653026|584394039|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
161822996|NCT03653026|584394036|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
161822997|NCT03653026|584394037|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
161822998|NCT03653026|584394038|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161822999|NCT03653026|584394039|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161823000|NCT03653026|584394036|FG000|Part 1: Placebo-controlled Period|Other|0|||
161823001|NCT03653026|584394037|FG001|Part 1: Placebo-controlled Period|Other|3|||
161823002|NCT03653026|584394038|FG002|Part 1: Placebo-controlled Period|Other|0|||
161823003|NCT03653026|584394039|FG003|Part 1: Placebo-controlled Period|Other|0|||
161930432|NCT04518410|584792500|FG011|Overall Study|Requirement to start alternative therapy|0|||
161930433|NCT04518410|584792501|FG012|Overall Study|Requirement to start alternative therapy|0|||
161930434|NCT04518410|584792502|FG013|Overall Study|Requirement to start alternative therapy|0|||
161823004|NCT03653026|584394036|FG000|Part 2: Open-label Extension|Adverse Event|0|||
161823005|NCT03653026|584394037|FG001|Part 2: Open-label Extension|Adverse Event|0|||
161823006|NCT03653026|584394038|FG002|Part 2: Open-label Extension|Adverse Event|1|||
161823007|NCT03653026|584394039|FG003|Part 2: Open-label Extension|Adverse Event|1|||
161930435|NCT04518410|584792503|FG014|Overall Study|Requirement to start alternative therapy|0|||
161930436|NCT04518410|584792504|FG015|Overall Study|Requirement to start alternative therapy|0|||
161930437|NCT04518410|584792505|FG016|Overall Study|Requirement to start alternative therapy|0|||
161930438|NCT04518410|584792506|FG017|Overall Study|Requirement to start alternative therapy|0|||
161930439|NCT04518410|584792507|FG018|Overall Study|Requirement to start alternative therapy|0|||
161930440|NCT04518410|584792508|FG019|Overall Study|Requirement to start alternative therapy|0|||
161930441|NCT04518410|584792509|FG020|Overall Study|Requirement to start alternative therapy|0|||
161930442|NCT04518410|584792510|FG021|Overall Study|Requirement to start alternative therapy|0|||
161930443|NCT04518410|584792511|FG022|Overall Study|Requirement to start alternative therapy|0|||
161930444|NCT04518410|584792512|FG023|Overall Study|Requirement to start alternative therapy|0|||
161930445|NCT04518410|584792513|FG024|Overall Study|Requirement to start alternative therapy|0|||
161930446|NCT04518410|584792489|FG000|Overall Study|Randomized but not treated|0|||
161930447|NCT04518410|584792490|FG001|Overall Study|Randomized but not treated|0|||
161930448|NCT04518410|584792491|FG002|Overall Study|Randomized but not treated|0|||
161930449|NCT04518410|584792492|FG003|Overall Study|Randomized but not treated|2|||
161930450|NCT04518410|584792493|FG004|Overall Study|Randomized but not treated|6|||
161930451|NCT04518410|584792494|FG005|Overall Study|Randomized but not treated|4|||
161930452|NCT04518410|584792495|FG006|Overall Study|Randomized but not treated|3|||
161930453|NCT04518410|584792496|FG007|Overall Study|Randomized but not treated|3|||
161930454|NCT04518410|584792497|FG008|Overall Study|Randomized but not treated|0|||
161930455|NCT04518410|584792498|FG009|Overall Study|Randomized but not treated|4|||
161930456|NCT04518410|584792499|FG010|Overall Study|Randomized but not treated|0|||
161930457|NCT04518410|584792500|FG011|Overall Study|Randomized but not treated|0|||
161930458|NCT04518410|584792501|FG012|Overall Study|Randomized but not treated|1|||
161930459|NCT04518410|584792502|FG013|Overall Study|Randomized but not treated|3|||
161930460|NCT04518410|584792503|FG014|Overall Study|Randomized but not treated|3|||
161930461|NCT04518410|584792504|FG015|Overall Study|Randomized but not treated|3|||
161930462|NCT04518410|584792505|FG016|Overall Study|Randomized but not treated|4|||
161930463|NCT04518410|584792506|FG017|Overall Study|Randomized but not treated|5|||
161930464|NCT04518410|584792507|FG018|Overall Study|Randomized but not treated|4|||
161930465|NCT04518410|584792508|FG019|Overall Study|Randomized but not treated|0|||
161930466|NCT04518410|584792509|FG020|Overall Study|Randomized but not treated|0|||
161930467|NCT04518410|584792510|FG021|Overall Study|Randomized but not treated|5|||
161930468|NCT04518410|584792511|FG022|Overall Study|Randomized but not treated|0|||
161930469|NCT04518410|584792512|FG023|Overall Study|Randomized but not treated|3|||
161930470|NCT04518410|584792513|FG024|Overall Study|Randomized but not treated|1|||
161930471|NCT04518410|584792489|FG000|Overall Study|Screen Fail but Randomized|0|||
161930472|NCT04518410|584792490|FG001|Overall Study|Screen Fail but Randomized|0|||
161930473|NCT04518410|584792491|FG002|Overall Study|Screen Fail but Randomized|0|||
161930474|NCT04518410|584792492|FG003|Overall Study|Screen Fail but Randomized|0|||
161930475|NCT04518410|584792493|FG004|Overall Study|Screen Fail but Randomized|2|||
161930476|NCT04518410|584792494|FG005|Overall Study|Screen Fail but Randomized|0|||
161823008|NCT03653026|584394036|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
161823009|NCT03653026|584394037|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
161823010|NCT03653026|584394038|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
161823011|NCT03653026|584394039|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
161823012|NCT03653026|584394036|FG000|Part 2: Open-label Extension|Other|0|||
161823013|NCT03653026|584394037|FG001|Part 2: Open-label Extension|Other|0|||
161823014|NCT03653026|584394038|FG002|Part 2: Open-label Extension|Other|1|||
161823015|NCT03653026|584394039|FG003|Part 2: Open-label Extension|Other|2|||
161823016|NCT02104817|584394042|FG000|Overall Study|Death|363|||
161823017|NCT02104817|584394043|FG001|Overall Study|Death|330|||
161823018|NCT02104817|584394042|FG000|Overall Study|Lost to Follow-up|3|||
161823019|NCT02104817|584394043|FG001|Overall Study|Lost to Follow-up|2|||
161823020|NCT02104817|584394042|FG000|Overall Study|Protocol Violation|0|||
161930477|NCT04518410|584792495|FG006|Overall Study|Screen Fail but Randomized|0|||
161930478|NCT04518410|584792496|FG007|Overall Study|Screen Fail but Randomized|0|||
161823021|NCT02104817|584394043|FG001|Overall Study|Protocol Violation|1|||
161823022|NCT02104817|584394042|FG000|Overall Study|Study terminated by sponsor|5854|||
161823023|NCT02104817|584394043|FG001|Overall Study|Study terminated by sponsor|5901|||
161823024|NCT02104817|584394042|FG000|Overall Study|Withdrawal by Subject|111|||
161823025|NCT02104817|584394043|FG001|Overall Study|Withdrawal by Subject|78|||
161823026|NCT02104817|584394042|FG000|Overall Study|Other reasons|128|||
161930479|NCT04518410|584792497|FG008|Overall Study|Screen Fail but Randomized|0|||
161823027|NCT02104817|584394043|FG001|Overall Study|Other reasons|135|||
161930480|NCT04518410|584792498|FG009|Overall Study|Screen Fail but Randomized|0|||
161823028|NCT00852917|584394044|FG000|Overall Study|Adverse Event|13|||
161823029|NCT00852917|584394045|FG001|Overall Study|Adverse Event|20|||
161823030|NCT00852917|584394046|FG002|Overall Study|Adverse Event|35|||
161823031|NCT00852917|584394047|FG003|Overall Study|Adverse Event|17|||
161823032|NCT00852917|584394044|FG000|Overall Study|Lack of Efficacy|21|||
161823033|NCT00852917|584394045|FG001|Overall Study|Lack of Efficacy|11|||
161823034|NCT00852917|584394046|FG002|Overall Study|Lack of Efficacy|11|||
161823035|NCT00852917|584394047|FG003|Overall Study|Lack of Efficacy|47|||
161823036|NCT00852917|584394044|FG000|Overall Study|Withdrawal by Subject|4|||
161823037|NCT00852917|584394045|FG001|Overall Study|Withdrawal by Subject|8|||
161823038|NCT00852917|584394046|FG002|Overall Study|Withdrawal by Subject|10|||
161823039|NCT00852917|584394047|FG003|Overall Study|Withdrawal by Subject|9|||
161823040|NCT00852917|584394044|FG000|Overall Study|Physician Decision|6|||
161823041|NCT00852917|584394045|FG001|Overall Study|Physician Decision|7|||
161823042|NCT00852917|584394046|FG002|Overall Study|Physician Decision|2|||
161823043|NCT00852917|584394047|FG003|Overall Study|Physician Decision|19|||
161823044|NCT00852917|584394044|FG000|Overall Study|Death|0|||
161823045|NCT00852917|584394045|FG001|Overall Study|Death|0|||
161823046|NCT00852917|584394046|FG002|Overall Study|Death|0|||
161823047|NCT00852917|584394047|FG003|Overall Study|Death|1|||
161823048|NCT01358877|584394048|FG000|Overall Study|Withdrawal by Subject|475|||
161823049|NCT01358877|584394049|FG001|Overall Study|Withdrawal by Subject|466|||
161823050|NCT01358877|584394048|FG000|Overall Study|Recurrence of disease|181|||
161823051|NCT01358877|584394049|FG001|Overall Study|Recurrence of disease|269|||
161823052|NCT01358877|584394048|FG000|Overall Study|Lost to Follow-up|181|||
161823053|NCT01358877|584394049|FG001|Overall Study|Lost to Follow-up|176|||
161823054|NCT01358877|584394048|FG000|Overall Study|Death|41|||
161823055|NCT01358877|584394049|FG001|Overall Study|Death|46|||
161823056|NCT01358877|584394048|FG000|Overall Study|Adverse Event|39|||
161823057|NCT01358877|584394049|FG001|Overall Study|Adverse Event|42|||
161823058|NCT01358877|584394048|FG000|Overall Study|Physician Decision|43|||
161823059|NCT01358877|584394049|FG001|Overall Study|Physician Decision|32|||
161823060|NCT01358877|584394048|FG000|Overall Study|Contralateral breast cancer|42|||
161823061|NCT01358877|584394049|FG001|Overall Study|Contralateral breast cancer|28|||
161823062|NCT01358877|584394048|FG000|Overall Study|Reason not specified|37|||
161823063|NCT01358877|584394049|FG001|Overall Study|Reason not specified|29|||
161823064|NCT02161549|584394053|FG000|Overall Study|Physician Decision|6|||
161823065|NCT02161549|584394054|FG001|Overall Study|Physician Decision|2|||
161823066|NCT03433703|584394055|FG000|Overall Study|Study terminated by Sponsor|2|||
161823067|NCT01583530|584394056|FG000|Overall Study|Adverse Event|0|||
161823068|NCT01583530|584394057|FG001|Overall Study|Adverse Event|0|||
161823069|NCT01583530|584394058|FG002|Overall Study|Adverse Event|0|||
161823070|NCT01583530|584394059|FG003|Overall Study|Adverse Event|0|||
161823071|NCT01583530|584394060|FG004|Overall Study|Adverse Event|0|||
161823072|NCT01583530|584394061|FG005|Overall Study|Adverse Event|1|||
161823073|NCT01583530|584394056|FG000|Overall Study|Withdrawal by Subject|0|||
161823074|NCT01583530|584394057|FG001|Overall Study|Withdrawal by Subject|3|||
161823075|NCT01583530|584394058|FG002|Overall Study|Withdrawal by Subject|0|||
161823076|NCT01583530|584394059|FG003|Overall Study|Withdrawal by Subject|1|||
161823077|NCT01583530|584394060|FG004|Overall Study|Withdrawal by Subject|1|||
161823078|NCT01583530|584394061|FG005|Overall Study|Withdrawal by Subject|2|||
161823079|NCT01583530|584394056|FG000|Overall Study|Lost to Follow-up|0|||
161823080|NCT01583530|584394057|FG001|Overall Study|Lost to Follow-up|0|||
161823081|NCT01583530|584394058|FG002|Overall Study|Lost to Follow-up|0|||
161823082|NCT01583530|584394059|FG003|Overall Study|Lost to Follow-up|0|||
161823083|NCT01583530|584394060|FG004|Overall Study|Lost to Follow-up|3|||
161823084|NCT01583530|584394061|FG005|Overall Study|Lost to Follow-up|0|||
161823085|NCT01583530|584394056|FG000|Overall Study|Lack of compliance|0|||
161823086|NCT01583530|584394057|FG001|Overall Study|Lack of compliance|0|||
161823087|NCT01583530|584394058|FG002|Overall Study|Lack of compliance|0|||
161823088|NCT01583530|584394059|FG003|Overall Study|Lack of compliance|0|||
161823089|NCT01583530|584394060|FG004|Overall Study|Lack of compliance|1|||
161823090|NCT01583530|584394061|FG005|Overall Study|Lack of compliance|0|||
161823091|NCT02416180|584394062|FG000|Overall Study|Withdrawal by Subject|1|||
161823092|NCT00640926|584394063|FG000|Overall Study|Adverse Event|2|||
161823093|NCT00640926|584394064|FG001|Overall Study|Adverse Event|3|||
161823094|NCT00640926|584394065|FG002|Overall Study|Adverse Event|2|||
161823095|NCT00640926|584394063|FG000|Overall Study|Lack of Efficacy|0|||
161823096|NCT00640926|584394064|FG001|Overall Study|Lack of Efficacy|2|||
161823097|NCT00640926|584394065|FG002|Overall Study|Lack of Efficacy|1|||
161823098|NCT00640926|584394063|FG000|Overall Study|Protocol Violation|2|||
161823099|NCT00640926|584394064|FG001|Overall Study|Protocol Violation|0|||
161823100|NCT00640926|584394065|FG002|Overall Study|Protocol Violation|2|||
161823101|NCT00640926|584394063|FG000|Overall Study|Lost to Follow-up|3|||
161823102|NCT00640926|584394064|FG001|Overall Study|Lost to Follow-up|1|||
161823103|NCT00640926|584394065|FG002|Overall Study|Lost to Follow-up|2|||
161930481|NCT04518410|584792499|FG010|Overall Study|Screen Fail but Randomized|0|||
161930482|NCT04518410|584792500|FG011|Overall Study|Screen Fail but Randomized|0|||
161930483|NCT04518410|584792501|FG012|Overall Study|Screen Fail but Randomized|0|||
161930484|NCT04518410|584792502|FG013|Overall Study|Screen Fail but Randomized|0|||
161930485|NCT04518410|584792503|FG014|Overall Study|Screen Fail but Randomized|0|||
161930486|NCT04518410|584792504|FG015|Overall Study|Screen Fail but Randomized|0|||
161823104|NCT00640926|584394063|FG000|Overall Study|Withdrawal by Subject|1|||
161823105|NCT00640926|584394064|FG001|Overall Study|Withdrawal by Subject|0|||
161823106|NCT00640926|584394065|FG002|Overall Study|Withdrawal by Subject|1|||
161823107|NCT02985398|584394066|FG000|Overall Study|Adverse Event|1|||
161823108|NCT02985398|584394066|FG000|Overall Study|Lost to Follow-up|4|||
161823109|NCT02985398|584394066|FG000|Overall Study|Withdrawal by Subject|8|||
161823110|NCT02985398|584394066|FG000|Overall Study|Study Burden|9|||
161823111|NCT01841073|584394067|FG000|Overall Study|Adverse Event|1|||
161823112|NCT01841073|584394068|FG001|Overall Study|Adverse Event|1|||
161823113|NCT01841073|584394067|FG000|Overall Study|Physician Decision|1|||
161823114|NCT01841073|584394068|FG001|Overall Study|Physician Decision|0|||
161823115|NCT01841073|584394067|FG000|Overall Study|Lost to Follow-up|0|||
161823116|NCT01841073|584394068|FG001|Overall Study|Lost to Follow-up|2|||
161823117|NCT00283842|584394073|FG000|Overall Study|Adverse Event|8|||
161823118|NCT00283842|584394074|FG001|Overall Study|Adverse Event|7|||
161930487|NCT04518410|584792505|FG016|Overall Study|Screen Fail but Randomized|0|||
161930488|NCT04518410|584792506|FG017|Overall Study|Screen Fail but Randomized|0|||
161930489|NCT04518410|584792507|FG018|Overall Study|Screen Fail but Randomized|0|||
161823119|NCT00283842|584394075|FG002|Overall Study|Adverse Event|21|||
161823120|NCT00283842|584394076|FG003|Overall Study|Adverse Event|21|||
161823121|NCT00283842|584394077|FG004|Overall Study|Adverse Event|5|||
161823122|NCT00283842|584394073|FG000|Overall Study|Protocol Violation|1|||
161823123|NCT00283842|584394074|FG001|Overall Study|Protocol Violation|5|||
161823124|NCT00283842|584394075|FG002|Overall Study|Protocol Violation|4|||
161823125|NCT00283842|584394076|FG003|Overall Study|Protocol Violation|0|||
161823126|NCT00283842|584394077|FG004|Overall Study|Protocol Violation|0|||
161823127|NCT00283842|584394073|FG000|Overall Study|Protocol deviation|0|||
161823128|NCT00283842|584394074|FG001|Overall Study|Protocol deviation|0|||
161823129|NCT00283842|584394075|FG002|Overall Study|Protocol deviation|0|||
161823130|NCT00283842|584394076|FG003|Overall Study|Protocol deviation|0|||
161823131|NCT00283842|584394077|FG004|Overall Study|Protocol deviation|2|||
161823132|NCT00283842|584394073|FG000|Overall Study|Withdrawal by Subject|2|||
161823133|NCT00283842|584394074|FG001|Overall Study|Withdrawal by Subject|1|||
161823134|NCT00283842|584394075|FG002|Overall Study|Withdrawal by Subject|1|||
161823135|NCT00283842|584394076|FG003|Overall Study|Withdrawal by Subject|5|||
161823136|NCT00283842|584394077|FG004|Overall Study|Withdrawal by Subject|4|||
161823137|NCT00283842|584394073|FG000|Overall Study|Lack of Efficacy|1|||
161823138|NCT00283842|584394074|FG001|Overall Study|Lack of Efficacy|3|||
161823139|NCT00283842|584394075|FG002|Overall Study|Lack of Efficacy|1|||
161823140|NCT00283842|584394076|FG003|Overall Study|Lack of Efficacy|0|||
161823141|NCT00283842|584394077|FG004|Overall Study|Lack of Efficacy|3|||
161823142|NCT00283842|584394073|FG000|Overall Study|Lost to Follow-up|0|||
161823143|NCT00283842|584394074|FG001|Overall Study|Lost to Follow-up|2|||
161823144|NCT00283842|584394075|FG002|Overall Study|Lost to Follow-up|4|||
161823145|NCT00283842|584394076|FG003|Overall Study|Lost to Follow-up|1|||
161823146|NCT00283842|584394077|FG004|Overall Study|Lost to Follow-up|1|||
161823147|NCT00550147|584394078|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
161823148|NCT00550147|584394078|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
161823149|NCT00550147|584394078|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
161823150|NCT00550147|584394078|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
161823151|NCT00550147|584394078|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
161823152|NCT02472639|584394079|FG000|Overall Study|Physician Decision|4|||
161823153|NCT02472639|584394080|FG001|Overall Study|Physician Decision|3|||
161823154|NCT00046839|584394081|FG000|Overall Study|Ineligible / No protocol treatment|0|||
161930490|NCT04518410|584792508|FG019|Overall Study|Screen Fail but Randomized|0|||
161930491|NCT04518410|584792509|FG020|Overall Study|Screen Fail but Randomized|0|||
161930492|NCT04518410|584792510|FG021|Overall Study|Screen Fail but Randomized|0|||
161930493|NCT04518410|584792511|FG022|Overall Study|Screen Fail but Randomized|0|||
161823155|NCT00046839|584394082|FG001|Overall Study|Ineligible / No protocol treatment|2|||
161823156|NCT00046839|584394081|FG000|Overall Study|Withdrawal of consent|1|||
161823157|NCT00046839|584394082|FG001|Overall Study|Withdrawal of consent|0|||
161823158|NCT00751023|584394084|FG000|Overall Study|Lost to Follow-up|11|||
161823159|NCT00751023|584394085|FG001|Overall Study|Lost to Follow-up|7|||
161823160|NCT02050321|584394086|FG000|Overall Study|Withdrawal by Subject|1|||
161823161|NCT02050321|584394086|FG000|Overall Study|Adverse Event|1|||
161823162|NCT04768114|584394087|FG000|Overall Study|Lost to Follow-up|5|||
161823163|NCT04768114|584394088|FG001|Overall Study|Lost to Follow-up|10|||
161823164|NCT04768114|584394087|FG000|Overall Study|Withdrawal by Subject|0|||
161930494|NCT04518410|584792512|FG023|Overall Study|Screen Fail but Randomized|0|||
161823165|NCT04768114|584394088|FG001|Overall Study|Withdrawal by Subject|1|||
161823166|NCT00715676|584394097|FG000|Overall Study|Adverse Event|3|||
162202713|NCT00714688|585791054|FG001|Overall Study|Ineligible to Continue the Study|1|||
162202714|NCT00714688|585791055|FG002|Overall Study|Ineligible to Continue the Study|1|||
162202715|NCT00714688|585791053|FG000|Overall Study|Sponsor's Decision|0|||
161930495|NCT04518410|584792513|FG024|Overall Study|Screen Fail but Randomized|0|||
161930496|NCT04518410|584792489|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930497|NCT04518410|584792490|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930498|NCT04518410|584792491|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930499|NCT04518410|584792492|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930500|NCT04518410|584792493|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
161930501|NCT04518410|584792494|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
161930502|NCT04518410|584792495|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
161930503|NCT04518410|584792496|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
161930504|NCT04518410|584792497|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
161930505|NCT04518410|584792498|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
161930506|NCT04518410|584792499|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
161930507|NCT04518410|584792500|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930508|NCT04518410|584792501|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930509|NCT04518410|584792502|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
161930510|NCT04518410|584792503|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
161930511|NCT04518410|584792504|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
161930512|NCT04518410|584792505|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
161930513|NCT04518410|584792506|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
161930514|NCT04518410|584792507|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
161930515|NCT04518410|584792508|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
161930516|NCT04518410|584792509|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
161930517|NCT04518410|584792510|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
161930518|NCT04518410|584792511|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
161930519|NCT04518410|584792512|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
161930520|NCT04518410|584792513|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
161930521|NCT04518410|584792489|FG000|Overall Study|Dual Enrolled Subject|0|||
161930522|NCT04518410|584792490|FG001|Overall Study|Dual Enrolled Subject|0|||
161930523|NCT04518410|584792491|FG002|Overall Study|Dual Enrolled Subject|0|||
161930524|NCT04518410|584792492|FG003|Overall Study|Dual Enrolled Subject|0|||
161930525|NCT04518410|584792493|FG004|Overall Study|Dual Enrolled Subject|0|||
161930526|NCT04518410|584792494|FG005|Overall Study|Dual Enrolled Subject|0|||
161930527|NCT04518410|584792495|FG006|Overall Study|Dual Enrolled Subject|0|||
161930528|NCT04518410|584792496|FG007|Overall Study|Dual Enrolled Subject|0|||
161930529|NCT04518410|584792497|FG008|Overall Study|Dual Enrolled Subject|0|||
161930530|NCT04518410|584792498|FG009|Overall Study|Dual Enrolled Subject|0|||
161930531|NCT04518410|584792499|FG010|Overall Study|Dual Enrolled Subject|0|||
161930532|NCT04518410|584792500|FG011|Overall Study|Dual Enrolled Subject|0|||
161930533|NCT04518410|584792501|FG012|Overall Study|Dual Enrolled Subject|0|||
161930534|NCT04518410|584792502|FG013|Overall Study|Dual Enrolled Subject|0|||
161930535|NCT04518410|584792503|FG014|Overall Study|Dual Enrolled Subject|0|||
161930536|NCT04518410|584792504|FG015|Overall Study|Dual Enrolled Subject|0|||
161930537|NCT04518410|584792505|FG016|Overall Study|Dual Enrolled Subject|0|||
161930538|NCT04518410|584792506|FG017|Overall Study|Dual Enrolled Subject|1|||
161930539|NCT04518410|584792507|FG018|Overall Study|Dual Enrolled Subject|0|||
161930540|NCT04518410|584792508|FG019|Overall Study|Dual Enrolled Subject|0|||
161930541|NCT04518410|584792509|FG020|Overall Study|Dual Enrolled Subject|0|||
161930542|NCT04518410|584792510|FG021|Overall Study|Dual Enrolled Subject|0|||
161930543|NCT04518410|584792511|FG022|Overall Study|Dual Enrolled Subject|0|||
161930544|NCT04518410|584792512|FG023|Overall Study|Dual Enrolled Subject|0|||
161930545|NCT04518410|584792513|FG024|Overall Study|Dual Enrolled Subject|0|||
161930546|NCT05737745|584792514|FG000|Overall Study|Withdrawal by Subject|0|||
161930547|NCT05737745|584792515|FG001|Overall Study|Withdrawal by Subject|6|||
161930548|NCT05737745|584792516|FG002|Overall Study|Withdrawal by Subject|1|||
161930549|NCT04648241|584792517|FG000|Overall Study|Lost to Follow-up|1|||
161930550|NCT04648241|584792518|FG001|Overall Study|Lost to Follow-up|0|||
161930551|NCT02057666|584792519|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
161930552|NCT02057666|584792520|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
161930553|NCT02057666|584792519|FG000|Double Blind Treatment Period|Poor tolerability|7|||
161930554|NCT02057666|584792520|FG001|Double Blind Treatment Period|Poor tolerability|2|||
161930555|NCT02057666|584792519|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
161930556|NCT02057666|584792520|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
161930557|NCT02057666|584792519|FG000|Double Blind Treatment Period|Physician Decision|1|||
161930558|NCT02057666|584792520|FG001|Double Blind Treatment Period|Physician Decision|0|||
161930559|NCT02057666|584792519|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
161930560|NCT02057666|584792520|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
161930561|NCT02057666|584792519|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
162202716|NCT00714688|585791054|FG001|Overall Study|Sponsor's Decision|2|||
162202717|NCT00714688|585791055|FG002|Overall Study|Sponsor's Decision|0|||
162202718|NCT00714688|585791053|FG000|Overall Study|Other|1|||
161930562|NCT02057666|584792520|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
161930563|NCT02057666|584792519|FG000|Double Blind Treatment Period|Sponsor's request|70|||
162202719|NCT00714688|585791054|FG001|Overall Study|Other|6|||
162202720|NCT00714688|585791055|FG002|Overall Study|Other|5|||
162202721|NCT00961896|585792639|FG000|Overall Study|Abnormal laboratory value|0|||
162202722|NCT00961896|585792640|FG001|Overall Study|Abnormal laboratory value|0|||
162202723|NCT00961896|585792641|FG002|Overall Study|Abnormal laboratory value|1|||
162202724|NCT00755716|585792642|FG000|Overall Study|Adverse Event|1|||
162202725|NCT00755716|585792643|FG001|Overall Study|Adverse Event|4|||
162202726|NCT00755716|585792644|FG002|Overall Study|Adverse Event|1|||
162202727|NCT00755716|585792642|FG000|Overall Study|Lack of Efficacy|2|||
162202728|NCT00755716|585792643|FG001|Overall Study|Lack of Efficacy|0|||
161930564|NCT02057666|584792520|FG001|Double Blind Treatment Period|Sponsor's request|34|||
162021241|NCT02280408|585133469|FG003|Overall Study|Lost to Follow-up|0|||
162202729|NCT00755716|585792644|FG002|Overall Study|Lack of Efficacy|0|||
162202730|NCT00755716|585792642|FG000|Overall Study|Lost to Follow-up|5|||
162202731|NCT00755716|585792643|FG001|Overall Study|Lost to Follow-up|3|||
161930565|NCT02057666|584792519|FG000|Open-Label Treatment Period|Poor tolerability|0|||
161930566|NCT02057666|584792520|FG001|Open-Label Treatment Period|Poor tolerability|1|||
161930567|NCT02057666|584792519|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
161930568|NCT02057666|584792520|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
161930569|NCT02057666|584792519|FG000|Open-Label Treatment Period|Sponsor's request|0|||
161930570|NCT02057666|584792520|FG001|Open-Label Treatment Period|Sponsor's request|4|||
161930571|NCT02569242|584792521|FG000|Overall Study|Death|1|||
161930572|NCT02569242|584792522|FG001|Overall Study|Death|0|||
161930573|NCT02569242|584792521|FG000|Overall Study|Withdrawal by Subject|0|||
161930574|NCT02569242|584792522|FG001|Overall Study|Withdrawal by Subject|1|||
161930575|NCT05661734|584792523|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
161930576|NCT05661734|584792523|FG000|Overall Study|Lost to Follow-up|13|||
161930577|NCT05661734|584792523|FG000|Overall Study|Enrolled but not dosed|2|||
161930578|NCT02489045|584792526|FG000|Overall Study|unable to collect usable data|53|||
161930579|NCT02489045|584792526|FG000|Follow-up|Lost to Follow-up|10|||
161930580|NCT00837330|584792527|FG000|Overall Study|Lost to Follow-up|1|||
161930581|NCT00837330|584792528|FG001|Overall Study|Lost to Follow-up|3|||
161930582|NCT02774278|584792529|FG000|Overall Study|Lack of Efficacy|199|||
161930583|NCT02774278|584792529|FG000|Overall Study|Death|29|||
161930584|NCT02774278|584792529|FG000|Overall Study|Adverse event/intercurrent illness|16|||
161930585|NCT02774278|584792529|FG000|Overall Study|Refused treatment/did not cooperate|9|||
161930586|NCT02774278|584792529|FG000|Overall Study|Administrative reasons|6|||
161930587|NCT02774278|584792529|FG000|Overall Study|Withdrawal by Subject|3|||
161930588|NCT02774278|584792529|FG000|Overall Study|Protocol Violation|2|||
161930589|NCT00694122|584792536|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
161930590|NCT00694122|584792537|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
161930591|NCT00694122|584792536|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
161930592|NCT00694122|584792537|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
161930593|NCT00694122|584792536|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
161930594|NCT00694122|584792537|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
161930595|NCT03339453|584792545|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
161930596|NCT03339453|584792546|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
161823167|NCT00715676|584394098|FG001|Overall Study|Adverse Event|5|||
161823168|NCT00715676|584394099|FG002|Overall Study|Adverse Event|21|||
161823169|NCT00715676|584394097|FG000|Overall Study|Withdrawal by Subject|1|||
161823170|NCT00715676|584394098|FG001|Overall Study|Withdrawal by Subject|3|||
161823171|NCT00715676|584394099|FG002|Overall Study|Withdrawal by Subject|8|||
161823172|NCT00715676|584394097|FG000|Overall Study|Lost to Follow-up|1|||
161823173|NCT00715676|584394098|FG001|Overall Study|Lost to Follow-up|2|||
161823174|NCT00715676|584394099|FG002|Overall Study|Lost to Follow-up|1|||
161823175|NCT00715676|584394097|FG000|Overall Study|Terminated by Sponsor|1|||
161823176|NCT00715676|584394098|FG001|Overall Study|Terminated by Sponsor|0|||
161823177|NCT00715676|584394099|FG002|Overall Study|Terminated by Sponsor|0|||
161930597|NCT00300495|584792548|FG000|Overall Study|Protocol Violation|4|||
161930598|NCT00300495|584792549|FG001|Overall Study|Protocol Violation|1|||
161930599|NCT00290238|584792559|FG000|Overall Study|Study terminated|27|||
161930600|NCT00290238|584792560|FG001|Overall Study|Study terminated|27|||
161930601|NCT00290238|584792559|FG000|Overall Study|Lost to Follow-up|0|||
161930602|NCT00290238|584792560|FG001|Overall Study|Lost to Follow-up|1|||
161930603|NCT00290238|584792559|FG000|Overall Study|Withdrawal by Subject|15|||
161823178|NCT00715676|584394097|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
161823179|NCT00715676|584394098|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
161823180|NCT00715676|584394099|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
161823181|NCT00715676|584394097|FG000|Overall Study|Use of Exclusionary Medication|0|||
161823182|NCT00715676|584394098|FG001|Overall Study|Use of Exclusionary Medication|0|||
161823183|NCT00715676|584394099|FG002|Overall Study|Use of Exclusionary Medication|1|||
161823184|NCT00715676|584394097|FG000|Overall Study|Elevated Blood Glucose|0|||
161930604|NCT00290238|584792560|FG001|Overall Study|Withdrawal by Subject|13|||
161823185|NCT00715676|584394098|FG001|Overall Study|Elevated Blood Glucose|1|||
161823186|NCT00715676|584394099|FG002|Overall Study|Elevated Blood Glucose|0|||
161823187|NCT01547728|584394100|FG000|Overall Study|Change in procedure and equipment|1|||
161823188|NCT01547728|584394100|FG000|Overall Study|Drug not ready for subject|1|||
161823189|NCT01547728|584394100|FG000|Overall Study|Screen failure|39|||
161823190|NCT03828539|584394101|FG000|Overall Study|Adverse Event|3|||
161823191|NCT03828539|584394102|FG001|Overall Study|Adverse Event|12|||
161930605|NCT03834883|584792561|FG000|Second Treatment|Withdrawal by Subject|1|||
161930606|NCT03834883|584792562|FG001|Second Treatment|Withdrawal by Subject|0|||
161930607|NCT03834883|584792563|FG002|Second Treatment|Withdrawal by Subject|0|||
161930608|NCT03834883|584792564|FG003|Second Treatment|Withdrawal by Subject|0|||
161930609|NCT03834883|584792561|FG000|Second Treatment|COVID-19 pandemic|1|||
161930610|NCT03834883|584792562|FG001|Second Treatment|COVID-19 pandemic|0|||
161930611|NCT03834883|584792563|FG002|Second Treatment|COVID-19 pandemic|1|||
161930612|NCT03834883|584792564|FG003|Second Treatment|COVID-19 pandemic|1|||
161930613|NCT01179399|584792565|FG000|Overall Study|Adverse Event|1|||
161930614|NCT01179399|584792565|FG000|Overall Study|Lack of Efficacy|30|||
161930615|NCT01179399|584792565|FG000|Overall Study|Withdrawal by Subject|1|||
161930616|NCT01213251|584794163|FG000|Overall Study|Death|2|||
161930617|NCT01213251|584794164|FG001|Overall Study|Death|1|||
161930618|NCT01213251|584794165|FG002|Overall Study|Death|2|||
161930619|NCT01213251|584794163|FG000|Overall Study|Exit|3|||
161930620|NCT01213251|584794164|FG001|Overall Study|Exit|2|||
161930621|NCT01213251|584794165|FG002|Overall Study|Exit|8|||
161930622|NCT01213251|584794163|FG000|Overall Study|Protocol Violation|1|||
161930623|NCT01213251|584794164|FG001|Overall Study|Protocol Violation|1|||
161930624|NCT01213251|584794165|FG002|Overall Study|Protocol Violation|0|||
161930625|NCT01213251|584794163|FG000|Overall Study|Missed 18-Month Follow-up|0|||
161930626|NCT01213251|584794164|FG001|Overall Study|Missed 18-Month Follow-up|0|||
161930627|NCT01213251|584794165|FG002|Overall Study|Missed 18-Month Follow-up|1|||
161930628|NCT02933151|584794166|FG000|Overall Study|Lost to Follow-up|19|||
161930629|NCT02933151|584794167|FG001|Overall Study|Lost to Follow-up|18|||
161930630|NCT02933151|584794166|FG000|Overall Study|Death|1732|||
161930631|NCT02933151|584794167|FG001|Overall Study|Death|1827|||
161930632|NCT02933151|584794166|FG000|Overall Study|Transplant|210|||
161930633|NCT02933151|584794167|FG001|Overall Study|Transplant|278|||
161930634|NCT02933151|584794166|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
161930635|NCT02933151|584794167|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
161930636|NCT02933151|584794166|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
161930637|NCT02933151|584794167|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
161930638|NCT02933151|584794166|FG000|Overall Study|Recovered Kidney Function|47|||
161930639|NCT02933151|584794167|FG001|Overall Study|Recovered Kidney Function|29|||
161930640|NCT00394472|584794168|FG000|Overall Study|Protocol Violation|1|||
161930641|NCT00394472|584794169|FG001|Overall Study|Protocol Violation|3|||
161930642|NCT00394472|584794168|FG000|Overall Study|incorrect enrolment|4|||
161930643|NCT00394472|584794169|FG001|Overall Study|incorrect enrolment|2|||
161930644|NCT00394472|584794168|FG000|Overall Study|Adverse Event|4|||
161930645|NCT00394472|584794169|FG001|Overall Study|Adverse Event|2|||
161930646|NCT00394472|584794168|FG000|Overall Study|Withdrawal by Subject|0|||
161930647|NCT00394472|584794169|FG001|Overall Study|Withdrawal by Subject|2|||
161930648|NCT00394472|584794168|FG000|Overall Study|Physician Decision|0|||
161930649|NCT00394472|584794169|FG001|Overall Study|Physician Decision|1|||
161930650|NCT00394472|584794168|FG000|Overall Study|Lost to Follow-up|0|||
161930651|NCT00394472|584794169|FG001|Overall Study|Lost to Follow-up|1|||
161930652|NCT03211858|584794170|FG000|Overall Study|Adverse Event|8|||
161930653|NCT03211858|584794171|FG001|Overall Study|Adverse Event|6|||
161930654|NCT03211858|584794170|FG000|Overall Study|Lack of Efficacy|0|||
161930655|NCT03211858|584794171|FG001|Overall Study|Lack of Efficacy|4|||
161930656|NCT03211858|584794170|FG000|Overall Study|Poor compliance to protocol|6|||
161930657|NCT03211858|584794171|FG001|Overall Study|Poor compliance to protocol|2|||
161930658|NCT03211858|584794170|FG000|Overall Study|Non-serious Hypoglycemia|1|||
161930659|NCT03211858|584794171|FG001|Overall Study|Non-serious Hypoglycemia|0|||
161930660|NCT03211858|584794170|FG000|Overall Study|Other than specified above|22|||
161930661|NCT03211858|584794171|FG001|Overall Study|Other than specified above|21|||
161930662|NCT01529112|584794174|FG000|Overall Study|Adverse Event|2|||
161930663|NCT01529112|584794175|FG001|Overall Study|Adverse Event|0|||
161930664|NCT01529112|584794174|FG000|Overall Study|Death|59|||
161930665|NCT01529112|584794175|FG001|Overall Study|Death|38|||
161930666|NCT01529112|584794174|FG000|Overall Study|Protocol Violation|1|||
161930667|NCT01529112|584794175|FG001|Overall Study|Protocol Violation|0|||
161930668|NCT01529112|584794174|FG000|Overall Study|Withdrawal by Subject|7|||
161930669|NCT01529112|584794175|FG001|Overall Study|Withdrawal by Subject|3|||
161930670|NCT00004228|584794176|FG000|Overall Study|Adverse Event|0|||
161930671|NCT00004228|584794177|FG001|Overall Study|Adverse Event|1|||
161930672|NCT00004228|584794178|FG002|Overall Study|Adverse Event|0|||
161930673|NCT00004228|584794179|FG003|Overall Study|Adverse Event|0|||
161930674|NCT00004228|584794180|FG004|Overall Study|Adverse Event|1|||
161930675|NCT00004228|584794181|FG005|Overall Study|Adverse Event|0|||
161930676|NCT00004228|584794182|FG006|Overall Study|Adverse Event|0|||
161930677|NCT00004228|584794176|FG000|Overall Study|Death|0|||
161930678|NCT00004228|584794177|FG001|Overall Study|Death|1|||
161930679|NCT00004228|584794178|FG002|Overall Study|Death|2|||
161930680|NCT00004228|584794179|FG003|Overall Study|Death|0|||
161930681|NCT00004228|584794180|FG004|Overall Study|Death|1|||
161930682|NCT00004228|584794181|FG005|Overall Study|Death|0|||
161930683|NCT00004228|584794182|FG006|Overall Study|Death|0|||
161930684|NCT00004228|584794176|FG000|Overall Study|Lack of Efficacy|1|||
161930685|NCT00004228|584794177|FG001|Overall Study|Lack of Efficacy|6|||
161930686|NCT00004228|584794178|FG002|Overall Study|Lack of Efficacy|5|||
161930687|NCT00004228|584794179|FG003|Overall Study|Lack of Efficacy|3|||
161930688|NCT00004228|584794180|FG004|Overall Study|Lack of Efficacy|9|||
161930689|NCT00004228|584794181|FG005|Overall Study|Lack of Efficacy|8|||
161930690|NCT00004228|584794182|FG006|Overall Study|Lack of Efficacy|4|||
161930691|NCT00004228|584794176|FG000|Overall Study|Lost to Follow-up|0|||
161930692|NCT00004228|584794177|FG001|Overall Study|Lost to Follow-up|0|||
161930693|NCT00004228|584794178|FG002|Overall Study|Lost to Follow-up|1|||
161930694|NCT00004228|584794179|FG003|Overall Study|Lost to Follow-up|0|||
161930695|NCT00004228|584794180|FG004|Overall Study|Lost to Follow-up|0|||
161930696|NCT00004228|584794181|FG005|Overall Study|Lost to Follow-up|0|||
161930697|NCT00004228|584794182|FG006|Overall Study|Lost to Follow-up|0|||
161930698|NCT00004228|584794176|FG000|Overall Study|Physician Decision|1|||
161930699|NCT00004228|584794177|FG001|Overall Study|Physician Decision|0|||
161930700|NCT00004228|584794178|FG002|Overall Study|Physician Decision|3|||
161930701|NCT00004228|584794179|FG003|Overall Study|Physician Decision|2|||
161930702|NCT00004228|584794180|FG004|Overall Study|Physician Decision|1|||
161930703|NCT00004228|584794181|FG005|Overall Study|Physician Decision|1|||
161930704|NCT00004228|584794182|FG006|Overall Study|Physician Decision|1|||
161930705|NCT00004228|584794176|FG000|Overall Study|Protocol Violation|0|||
161930706|NCT00004228|584794177|FG001|Overall Study|Protocol Violation|5|||
161930707|NCT00004228|584794178|FG002|Overall Study|Protocol Violation|2|||
161930708|NCT00004228|584794179|FG003|Overall Study|Protocol Violation|1|||
161930709|NCT00004228|584794180|FG004|Overall Study|Protocol Violation|1|||
161930710|NCT00004228|584794181|FG005|Overall Study|Protocol Violation|2|||
161930711|NCT00004228|584794182|FG006|Overall Study|Protocol Violation|0|||
161930712|NCT00004228|584794176|FG000|Overall Study|Withdrawal by Subject|3|||
161930713|NCT00004228|584794177|FG001|Overall Study|Withdrawal by Subject|0|||
161930714|NCT00004228|584794178|FG002|Overall Study|Withdrawal by Subject|1|||
161930715|NCT00004228|584794179|FG003|Overall Study|Withdrawal by Subject|0|||
161930716|NCT00004228|584794180|FG004|Overall Study|Withdrawal by Subject|2|||
161930717|NCT00004228|584794181|FG005|Overall Study|Withdrawal by Subject|1|||
161930718|NCT00004228|584794182|FG006|Overall Study|Withdrawal by Subject|2|||
161930719|NCT00004228|584794176|FG000|Overall Study|Other|0|||
161930720|NCT00004228|584794177|FG001|Overall Study|Other|0|||
161930721|NCT00004228|584794178|FG002|Overall Study|Other|1|||
161930722|NCT00004228|584794179|FG003|Overall Study|Other|0|||
161930723|NCT00004228|584794180|FG004|Overall Study|Other|0|||
161930724|NCT00004228|584794181|FG005|Overall Study|Other|0|||
161930725|NCT00004228|584794182|FG006|Overall Study|Other|0|||
161930726|NCT00004228|584794176|FG000|Overall Study|ineligible|4|||
161930727|NCT00004228|584794177|FG001|Overall Study|ineligible|2|||
161930728|NCT00004228|584794178|FG002|Overall Study|ineligible|4|||
161930729|NCT00004228|584794179|FG003|Overall Study|ineligible|1|||
162202732|NCT00755716|585792644|FG002|Overall Study|Lost to Follow-up|1|||
162202733|NCT00755716|585792642|FG000|Overall Study|work schedule issues|0|||
162202734|NCT00755716|585792643|FG001|Overall Study|work schedule issues|1|||
162202735|NCT00755716|585792644|FG002|Overall Study|work schedule issues|1|||
162202736|NCT01066897|585792645|FG000|Overall Study|Withdrawal by Subject|1|||
162202737|NCT01066897|585792646|FG001|Overall Study|Withdrawal by Subject|0|||
162202738|NCT01066897|585792645|FG000|Overall Study|stopped study after developing the flu.|1|||
162202739|NCT01066897|585792646|FG001|Overall Study|stopped study after developing the flu.|0|||
161930730|NCT00004228|584794180|FG004|Overall Study|ineligible|1|||
161930731|NCT00004228|584794181|FG005|Overall Study|ineligible|2|||
161930732|NCT00004228|584794182|FG006|Overall Study|ineligible|5|||
161930733|NCT00107614|584794183|FG000|Overall Study|Physician Decision|10|||
161930734|NCT00107614|584794183|FG000|Overall Study|Death|2|||
161930735|NCT01013870|584794184|FG000|Overall Study|Lost to Follow-up|1|||
161930736|NCT01013870|584794185|FG001|Overall Study|Lost to Follow-up|3|||
161930737|NCT02457546|584794187|FG000|Overall Study|Other reasons|4|||
161930738|NCT02457546|584794188|FG001|Overall Study|Other reasons|1|||
161930739|NCT02457546|584794187|FG000|Overall Study|Refused to complete study/procedures|1|||
161930740|NCT02457546|584794188|FG001|Overall Study|Refused to complete study/procedures|1|||
161930741|NCT02457546|584794187|FG000|Overall Study|Lost to Follow-up|4|||
161930742|NCT02457546|584794188|FG001|Overall Study|Lost to Follow-up|1|||
161930743|NCT02457546|584794187|FG000|Overall Study|Adverse Event|0|||
161930744|NCT02457546|584794188|FG001|Overall Study|Adverse Event|1|||
161930745|NCT00090402|584794189|FG000|Overall Study|Death|1|||
161930746|NCT00090402|584794190|FG001|Overall Study|Death|1|||
161930747|NCT00090402|584794191|FG002|Overall Study|Death|0|||
161930748|NCT00090402|584794189|FG000|Overall Study|subject moved|0|||
161930749|NCT00090402|584794190|FG001|Overall Study|subject moved|1|||
161930750|NCT00090402|584794191|FG002|Overall Study|subject moved|0|||
161930751|NCT00090402|584794189|FG000|Overall Study|stopped taking study medication|1|||
161930752|NCT00090402|584794190|FG001|Overall Study|stopped taking study medication|0|||
161930753|NCT00090402|584794191|FG002|Overall Study|stopped taking study medication|1|||
161930754|NCT01530256|584794194|FG000|Overall Study|Death|2|||
161930755|NCT00862277|584794195|FG000|Overall Study|Protocol Violation|1|||
161930756|NCT00862277|584794196|FG001|Overall Study|Protocol Violation|2|||
161930757|NCT00862277|584794197|FG002|Overall Study|Protocol Violation|5|||
161930758|NCT02462057|584794198|FG000|Overall Study|Left Vitality|32|||
161930759|NCT02462057|584794199|FG001|Overall Study|Left Vitality|27|||
162202740|NCT00265096|585792649|FG000|Overall Study|Adverse Event|14|||
162202741|NCT00265096|585792650|FG001|Overall Study|Adverse Event|18|||
162202742|NCT00265096|585792651|FG002|Overall Study|Adverse Event|18|||
162202743|NCT00265096|585792649|FG000|Overall Study|Lost to Follow-up|2|||
162202744|NCT00265096|585792650|FG001|Overall Study|Lost to Follow-up|5|||
162202745|NCT00265096|585792651|FG002|Overall Study|Lost to Follow-up|3|||
162202746|NCT00265096|585792649|FG000|Overall Study|Death|0|||
161823192|NCT03828539|584394101|FG000|Overall Study|Patient's/guardian's decision|3|||
161823193|NCT03828539|584394102|FG001|Overall Study|Patient's/guardian's decision|5|||
161823194|NCT03828539|584394101|FG000|Overall Study|Lost to Follow-up|4|||
161823195|NCT03828539|584394102|FG001|Overall Study|Lost to Follow-up|2|||
161823196|NCT03828539|584394101|FG000|Overall Study|Protocol Violation|3|||
161823197|NCT03828539|584394102|FG001|Overall Study|Protocol Violation|2|||
161823198|NCT03828539|584394101|FG000|Overall Study|Withdrawal of informed consent|2|||
161823199|NCT03828539|584394102|FG001|Overall Study|Withdrawal of informed consent|1|||
161823200|NCT03828539|584394101|FG000|Overall Study|New therapy for study indication|1|||
161823201|NCT03828539|584394102|FG001|Overall Study|New therapy for study indication|0|||
161823202|NCT01341405|584394103|FG000|Overall Study|Adverse Event|0|||
161823203|NCT01341405|584394104|FG001|Overall Study|Adverse Event|1|||
161823204|NCT01341405|584394105|FG002|Overall Study|Adverse Event|1|||
161823205|NCT01341405|584394103|FG000|Overall Study|Withdrawal by Subject|3|||
161823206|NCT01341405|584394104|FG001|Overall Study|Withdrawal by Subject|2|||
161823207|NCT01341405|584394105|FG002|Overall Study|Withdrawal by Subject|1|||
161823208|NCT02760433|584394106|FG000|Overall Study|Lost to Follow-up|1|||
161823209|NCT02760433|584394107|FG001|Overall Study|Lost to Follow-up|0|||
161823210|NCT02760433|584394108|FG002|Overall Study|Lost to Follow-up|1|||
161823211|NCT02760433|584394109|FG003|Overall Study|Lost to Follow-up|0|||
162202747|NCT00265096|585792650|FG001|Overall Study|Death|1|||
162202748|NCT00265096|585792651|FG002|Overall Study|Death|2|||
162202749|NCT00265096|585792649|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
162202750|NCT00265096|585792650|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
162202751|NCT00265096|585792651|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
162202752|NCT00265096|585792649|FG000|Overall Study|Other|11|||
162202753|NCT00265096|585792650|FG001|Overall Study|Other|19|||
162202754|NCT00265096|585792651|FG002|Overall Study|Other|10|||
162202755|NCT03568708|585792652|FG000|Overall Study|Withdrawal by Subject|1|||
162202756|NCT03568708|585792653|FG001|Overall Study|Withdrawal by Subject|1|||
162202757|NCT03568708|585792652|FG000|Overall Study|Lost to Follow-up|0|||
162202758|NCT03568708|585792653|FG001|Overall Study|Lost to Follow-up|1|||
162202759|NCT00666835|585792654|FG000|Overall Study|Withdrawal by Subject|5|||
162202760|NCT00666835|585792655|FG001|Overall Study|Withdrawal by Subject|2|||
162202761|NCT00666835|585792654|FG000|Overall Study|Lack of Efficacy|0|||
162202762|NCT00666835|585792655|FG001|Overall Study|Lack of Efficacy|1|||
162202763|NCT00666835|585792654|FG000|Overall Study|Incl./excl. not fulfilled|7|||
162202764|NCT00666835|585792655|FG001|Overall Study|Incl./excl. not fulfilled|2|||
162202765|NCT00666835|585792654|FG000|Overall Study|Adverse Event|7|||
162202766|NCT00666835|585792655|FG001|Overall Study|Adverse Event|6|||
162202767|NCT00666835|585792654|FG000|Overall Study|Protocol Violation|2|||
162202768|NCT00666835|585792655|FG001|Overall Study|Protocol Violation|0|||
162202769|NCT00666835|585792654|FG000|Overall Study|Death|15|||
162202770|NCT00666835|585792655|FG001|Overall Study|Death|4|||
162202771|NCT00666835|585792654|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
162202772|NCT00666835|585792655|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
162202773|NCT00666835|585792654|FG000|Overall Study|Hemoglobulin concentration|4|||
162202774|NCT00666835|585792655|FG001|Overall Study|Hemoglobulin concentration|3|||
162202775|NCT00666835|585792654|FG000|Overall Study|Planned operation|2|||
162202776|NCT00666835|585792655|FG001|Overall Study|Planned operation|0|||
162202777|NCT00666835|585792654|FG000|Overall Study|Physician Decision|1|||
162202778|NCT00666835|585792655|FG001|Overall Study|Physician Decision|2|||
162202779|NCT00511147|585792656|FG000|Overall Study|Withdrawal by Subject|1|||
162202780|NCT00511147|585792656|FG000|Overall Study|Disease progression|5|||
162202781|NCT00511147|585792656|FG000|Overall Study|Required platelet transfusion|1|||
162202782|NCT01525641|585792664|FG000|Overall Study|Case report form not collected|25|||
162202783|NCT01525641|585792664|FG000|Overall Study|No visit since the first visit|16|||
162202784|NCT01525641|585792664|FG000|Overall Study|Adverse Event|73|||
162202785|NCT01525641|585792664|FG000|Overall Study|Lack of Efficacy|24|||
162202786|NCT01525641|585792664|FG000|Overall Study|Improvement|5|||
162202787|NCT01525641|585792664|FG000|Overall Study|Lost to follow-up (relocation)|1|||
162202788|NCT01525641|585792664|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
162202789|NCT01525641|585792664|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
162202790|NCT01525641|585792664|FG000|Overall Study|Other than stated above|7|||
161823212|NCT02760433|584394110|FG004|Overall Study|Lost to Follow-up|0|||
161823213|NCT02760433|584394106|FG000|Overall Study|Withdrawal by Subject|23|||
162202791|NCT02853305|585792669|FG000|Overall Study|Death|287|||
162202792|NCT02853305|585792670|FG001|Overall Study|Death|249|||
162202793|NCT02853305|585792671|FG002|Overall Study|Death|300|||
162202794|NCT02853305|585792669|FG000|Overall Study|Withdrawal by Subject|2|||
162202795|NCT02853305|585792670|FG001|Overall Study|Withdrawal by Subject|8|||
161823214|NCT02760433|584394107|FG001|Overall Study|Withdrawal by Subject|9|||
161823215|NCT02760433|584394108|FG002|Overall Study|Withdrawal by Subject|0|||
161823216|NCT02760433|584394109|FG003|Overall Study|Withdrawal by Subject|2|||
161823217|NCT02760433|584394110|FG004|Overall Study|Withdrawal by Subject|9|||
161823218|NCT02760433|584394106|FG000|Overall Study|Lack of Response At Week 14|0|||
161823219|NCT02760433|584394107|FG001|Overall Study|Lack of Response At Week 14|0|||
161823220|NCT02760433|584394108|FG002|Overall Study|Lack of Response At Week 14|0|||
161823221|NCT02760433|584394109|FG003|Overall Study|Lack of Response At Week 14|0|||
161823222|NCT02760433|584394110|FG004|Overall Study|Lack of Response At Week 14|1|||
161823223|NCT02760433|584394106|FG000|Overall Study|Subject refused to continue the study|1|||
161823224|NCT02760433|584394107|FG001|Overall Study|Subject refused to continue the study|0|||
161823225|NCT02760433|584394108|FG002|Overall Study|Subject refused to continue the study|0|||
161823226|NCT02760433|584394109|FG003|Overall Study|Subject refused to continue the study|0|||
161823227|NCT02760433|584394110|FG004|Overall Study|Subject refused to continue the study|0|||
161823228|NCT02760433|584394106|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
161823229|NCT02760433|584394107|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
161823230|NCT02760433|584394108|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
161823231|NCT02760433|584394109|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
161823232|NCT02760433|584394110|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
161823233|NCT02760433|584394106|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
161823234|NCT02760433|584394107|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
161823235|NCT02760433|584394108|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
161823236|NCT02760433|584394109|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
161823237|NCT02760433|584394110|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
161823238|NCT03448692|584394115|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
161823239|NCT03448692|584394116|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
161823240|NCT03448692|584394115|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
161823241|NCT03448692|584394116|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
161823242|NCT03448692|584394115|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
161823243|NCT03448692|584394116|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
161823244|NCT03448692|584394115|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
161823245|NCT03448692|584394116|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
161823246|NCT03448692|584394115|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
161823247|NCT03448692|584394116|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
161823248|NCT02786927|584394119|FG000|Overall Study|Adverse Event|1|||
161823249|NCT02786927|584394119|FG000|Overall Study|Protocol Violation|4|||
161823250|NCT01801917|584394120|FG000|Period 1 - Randomized|Adverse Event|1|||
161823251|NCT01801917|584394121|FG001|Period 1 - Randomized|Adverse Event|0|||
161823252|NCT01801917|584394122|FG002|Period 1 - Randomized|Adverse Event|1|||
161823253|NCT01801917|584394123|FG003|Period 1 - Randomized|Adverse Event|0|||
161823254|NCT01924364|584394124|FG000|Overall Study|Physician Decision|3|||
161823255|NCT00265785|584394125|FG000|Overall Study|Adverse Event|4|||
161823256|NCT00265785|584394125|FG000|Overall Study|Withdrawal by Subject|3|||
161823257|NCT00265785|584394125|FG000|Overall Study|Progression/Relapse|15|||
161823258|NCT00265785|584394125|FG000|Overall Study|Not protocol specified|2|||
161823259|NCT00265785|584394125|FG000|Overall Study|Ineligible|1|||
161823260|NCT00265785|584394125|FG000|Overall Study|Did not receive protocol treatment|2|||
161823261|NCT03919695|584394126|FG000|3-month Follow-up|Death|1|||
161823262|NCT03919695|584394127|FG001|3-month Follow-up|Death|1|||
161823263|NCT03919695|584394126|FG000|3-month Follow-up|unable to contact|0|||
161823264|NCT03919695|584394127|FG001|3-month Follow-up|unable to contact|3|||
161823265|NCT03919695|584394126|FG000|3-month Follow-up|in prison|0|||
161823266|NCT03919695|584394127|FG001|3-month Follow-up|in prison|1|||
161823267|NCT03919695|584394126|FG000|6-month Follow-up|Death|0|||
161823268|NCT03919695|584394127|FG001|6-month Follow-up|Death|1|||
161823269|NCT03919695|584394126|FG000|6-month Follow-up|Lost to Follow-up|1|||
161823270|NCT03919695|584394127|FG001|6-month Follow-up|Lost to Follow-up|2|||
161823271|NCT03919695|584394126|FG000|6-month Follow-up|in prison|0|||
161823272|NCT03919695|584394127|FG001|6-month Follow-up|in prison|2|||
161823273|NCT03919695|584394126|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
161823274|NCT03919695|584394127|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
161823275|NCT03919695|584394126|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
161823276|NCT03919695|584394127|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
161823277|NCT02416934|584394128|FG000|Overall Study|given steroids|1|||
161823278|NCT02416934|584394129|FG001|Overall Study|given steroids|2|||
161823279|NCT02416934|584394128|FG000|Overall Study|Lost to Follow-up|0|||
161823280|NCT02416934|584394129|FG001|Overall Study|Lost to Follow-up|2|||
161823281|NCT02416934|584394128|FG000|Overall Study|Withdrawal by Subject|1|||
161930760|NCT02462057|584794200|FG002|Overall Study|Left Vitality|23|||
161930761|NCT02462057|584794201|FG003|Overall Study|Left Vitality|35|||
161930762|NCT02462057|584794202|FG004|Overall Study|Left Vitality|33|||
161930763|NCT02462057|584794198|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
161823282|NCT02416934|584394129|FG001|Overall Study|Withdrawal by Subject|0|||
161823283|NCT02416934|584394128|FG000|Overall Study|recruited during continuing renewal proc|0|||
161823284|NCT02416934|584394129|FG001|Overall Study|recruited during continuing renewal proc|1|||
161823285|NCT02416934|584394128|FG000|Overall Study|Protocol Violation|0|||
161823286|NCT02416934|584394129|FG001|Overall Study|Protocol Violation|1|||
161823287|NCT02416934|584394128|FG000|Overall Study|surgery started late|0|||
161823288|NCT02416934|584394129|FG001|Overall Study|surgery started late|1|||
161823289|NCT02416934|584394128|FG000|Overall Study|re-operation|1|||
161823290|NCT02416934|584394129|FG001|Overall Study|re-operation|0|||
161823291|NCT05467540|584394132|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
161823292|NCT05467540|584394132|FG000|3-Month Follow-up|Lost to Follow-up|4|||
161823293|NCT05467540|584394132|FG000|3-Month Follow-up|Death|5|||
161930764|NCT02462057|584794199|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
161930765|NCT02462057|584794200|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
161930766|NCT02462057|584794201|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
161930767|NCT02462057|584794202|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
161930768|NCT00474968|584794205|FG000|Overall Study|Withdrawal by Subject|8|||
161823294|NCT05467540|584394132|FG000|12-Month Follow-up|Lost to Follow-up|6|||
161823295|NCT05467540|584394132|FG000|12-Month Follow-up|Death|8|||
161823296|NCT05467540|584394132|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
161823297|NCT03382041|584394156|FG000|Overall Study|Consent Form Lost|2|||
161823298|NCT03382041|584394157|FG001|Overall Study|Consent Form Lost|1|||
161823299|NCT03382041|584394156|FG000|Overall Study|Withdrawal by Subject|1|||
161823300|NCT03382041|584394157|FG001|Overall Study|Withdrawal by Subject|4|||
161823301|NCT03382041|584394156|FG000|Overall Study|Lost to Follow-up|1|||
161823302|NCT03382041|584394157|FG001|Overall Study|Lost to Follow-up|4|||
161823303|NCT01374451|584394160|FG000|Overall Study|Administrative problems|1|||
161823304|NCT01374451|584394161|FG001|Overall Study|Administrative problems|0|||
161823305|NCT01337596|584394162|FG000|Overall Study|Withdrawal by Subject|0|||
161823306|NCT01337596|584394163|FG001|Overall Study|Withdrawal by Subject|0|||
161823307|NCT01337596|584394164|FG002|Overall Study|Withdrawal by Subject|0|||
161823308|NCT01337596|584394165|FG003|Overall Study|Withdrawal by Subject|0|||
161823309|NCT01337596|584394166|FG004|Overall Study|Withdrawal by Subject|2|||
161823310|NCT01337596|584394167|FG005|Overall Study|Withdrawal by Subject|0|||
161823311|NCT01337596|584394168|FG006|Overall Study|Withdrawal by Subject|0|||
161823312|NCT01337596|584394169|FG007|Overall Study|Withdrawal by Subject|0|||
161823313|NCT01337596|584394170|FG008|Overall Study|Withdrawal by Subject|0|||
161823314|NCT04640194|584394171|FG000|Overall Study|Adverse Event|3|||
161823315|NCT04640194|584394172|FG001|Overall Study|Adverse Event|7|||
161823316|NCT04640194|584394173|FG002|Overall Study|Adverse Event|0|||
161823317|NCT04640194|584394174|FG003|Overall Study|Adverse Event|5|||
161823318|NCT04640194|584394175|FG004|Overall Study|Adverse Event|0|||
161823319|NCT04640194|584394176|FG005|Overall Study|Adverse Event|4|||
161823320|NCT04640194|584394177|FG006|Overall Study|Adverse Event|0|||
161823321|NCT04640194|584394171|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
161930769|NCT00474968|584794206|FG001|Overall Study|Withdrawal by Subject|7|||
161930770|NCT00474968|584794205|FG000|Overall Study|Protocol Violation|9|||
161930771|NCT00474968|584794206|FG001|Overall Study|Protocol Violation|8|||
161930772|NCT00474968|584794205|FG000|Overall Study|Sample not collected|1|||
161930773|NCT00474968|584794206|FG001|Overall Study|Sample not collected|1|||
161930774|NCT04914000|584794207|FG000|Overall Study|Lost to Follow-up|8|||
161930775|NCT04914000|584794207|FG000|Overall Study|Withdrawal by Subject|1|||
161930776|NCT01096186|584794209|FG000|Overall Study|Adverse Event|16|||
161930777|NCT01096186|584794209|FG000|Overall Study|Death|4|||
161930778|NCT01096186|584794209|FG000|Overall Study|Lack of Efficacy|4|||
161930779|NCT01096186|584794209|FG000|Overall Study|Lost to Follow-up|2|||
161930780|NCT01096186|584794209|FG000|Overall Study|Withdrawal by Subject|22|||
161930781|NCT01096186|584794209|FG000|Overall Study|Physician Decision|1|||
161823322|NCT04640194|584394172|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
161676932|NCT01390272|583870621|FG000|Overall Study|Withdrawal by Subject|9|||
161930782|NCT01096186|584794209|FG000|Overall Study|Noncompliance with study drug|1|||
161930783|NCT01896986|584794210|FG000|Overall Study|samples lost|14|||
161930784|NCT01896986|584794211|FG001|Overall Study|samples lost|23|||
161823323|NCT04640194|584394173|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
161823324|NCT04640194|584394174|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
161823325|NCT04640194|584394175|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
161823326|NCT04640194|584394176|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
161823327|NCT04640194|584394177|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
161823328|NCT04640194|584394171|FG000|Overall Study|fibrinogen level too low|0|||
161930785|NCT01750281|584794212|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
161823329|NCT04640194|584394172|FG001|Overall Study|fibrinogen level too low|0|||
161823330|NCT04640194|584394173|FG002|Overall Study|fibrinogen level too low|0|||
161823331|NCT04640194|584394174|FG003|Overall Study|fibrinogen level too low|1|||
161930786|NCT01750281|584794213|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
161930787|NCT01750281|584794214|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
161930788|NCT01750281|584794212|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
161930789|NCT01750281|584794213|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
161930790|NCT01750281|584794214|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
161930791|NCT01750281|584794212|FG000|Overall Study|Did not receive treatment|0|||
161930792|NCT01750281|584794213|FG001|Overall Study|Did not receive treatment|1|||
161930793|NCT01750281|584794214|FG002|Overall Study|Did not receive treatment|0|||
161930794|NCT01658735|584794216|FG000|Overall Study|Lack of Efficacy|1|||
161930795|NCT01658735|584794217|FG001|Overall Study|Lack of Efficacy|0|||
161930796|NCT01658735|584794218|FG002|Overall Study|Lack of Efficacy|1|||
161930797|NCT01658735|584794216|FG000|Overall Study|Lost to Follow-up|1|||
161930798|NCT01658735|584794217|FG001|Overall Study|Lost to Follow-up|1|||
161930799|NCT01658735|584794218|FG002|Overall Study|Lost to Follow-up|0|||
161930800|NCT01658735|584794216|FG000|Overall Study|Protocol Violation|0|||
161930801|NCT01658735|584794217|FG001|Overall Study|Protocol Violation|1|||
161930802|NCT01658735|584794218|FG002|Overall Study|Protocol Violation|0|||
161930803|NCT01658735|584794216|FG000|Overall Study|Withdrawal by Subject|3|||
161930804|NCT01658735|584794217|FG001|Overall Study|Withdrawal by Subject|5|||
161930805|NCT01658735|584794218|FG002|Overall Study|Withdrawal by Subject|3|||
161930806|NCT03302936|584794222|FG000|Overall Study|Protocol Violation|3|||
161930807|NCT03302936|584794223|FG001|Overall Study|Protocol Violation|4|||
161930808|NCT01379937|584794224|FG000|Overall Study|Protocol Violation|0|||
161930809|NCT01379937|584794225|FG001|Overall Study|Protocol Violation|0|||
161930810|NCT01379937|584794226|FG002|Overall Study|Protocol Violation|0|||
161930811|NCT01379937|584794227|FG003|Overall Study|Protocol Violation|1|||
161930812|NCT01379937|584794224|FG000|Overall Study|Consent withdrawal|0|||
161930813|NCT01379937|584794225|FG001|Overall Study|Consent withdrawal|1|||
161930814|NCT01379937|584794226|FG002|Overall Study|Consent withdrawal|0|||
161930815|NCT01379937|584794227|FG003|Overall Study|Consent withdrawal|0|||
161930816|NCT01379937|584794224|FG000|Overall Study|Lost to Follow-up|1|||
161930817|NCT01379937|584794225|FG001|Overall Study|Lost to Follow-up|2|||
161930818|NCT01379937|584794226|FG002|Overall Study|Lost to Follow-up|2|||
161930819|NCT01379937|584794227|FG003|Overall Study|Lost to Follow-up|0|||
161930820|NCT01122680|584794228|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
161930821|NCT01122680|584794229|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
161930822|NCT01122680|584794230|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
161930823|NCT01122680|584794231|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
161930824|NCT01122680|584794228|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
161930825|NCT01122680|584794229|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
161930826|NCT01122680|584794230|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
161930827|NCT01122680|584794231|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
161930828|NCT01122680|584794228|FG000|Period 1 (4 Weeks)|Other|1|||
161930829|NCT01122680|584794229|FG001|Period 1 (4 Weeks)|Other|1|||
161930830|NCT01122680|584794230|FG002|Period 1 (4 Weeks)|Other|0|||
161930831|NCT01122680|584794231|FG003|Period 1 (4 Weeks)|Other|0|||
161930832|NCT01122680|584794228|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
161930833|NCT01122680|584794229|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
161930834|NCT01122680|584794230|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
161930835|NCT01122680|584794231|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
161930836|NCT01122680|584794228|FG000|Period 2 (4 Weeks)|Other|1|||
161930837|NCT01122680|584794229|FG001|Period 2 (4 Weeks)|Other|0|||
161930838|NCT01122680|584794230|FG002|Period 2 (4 Weeks)|Other|0|||
161930839|NCT01122680|584794231|FG003|Period 2 (4 Weeks)|Other|0|||
161930840|NCT01122680|584794228|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
161930841|NCT01122680|584794229|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
161930842|NCT01122680|584794230|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
161930843|NCT01122680|584794231|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
161930844|NCT01122680|584794228|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161930845|NCT01122680|584794229|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
161930846|NCT01122680|584794230|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161930847|NCT01122680|584794231|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161930848|NCT00079781|584794236|FG000|Pre-implant Period|Withdrawal by Subject|2|||
161930849|NCT00079781|584794237|FG001|Pre-implant Period|Withdrawal by Subject|0|||
161930850|NCT00079781|584794238|FG002|Pre-implant Period|Withdrawal by Subject|0|||
161930851|NCT00079781|584794236|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
161930852|NCT00079781|584794237|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
161930853|NCT00079781|584794238|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
161930854|NCT00079781|584794236|FG000|Follow-up Period|Withdrawal by Subject|3|||
161930855|NCT00079781|584794237|FG001|Follow-up Period|Withdrawal by Subject|0|||
161930856|NCT00079781|584794238|FG002|Follow-up Period|Withdrawal by Subject|1|||
161930857|NCT00079781|584794236|FG000|Follow-up Period|Lost to Follow-up|1|||
161930858|NCT00079781|584794237|FG001|Follow-up Period|Lost to Follow-up|0|||
161930859|NCT00079781|584794238|FG002|Follow-up Period|Lost to Follow-up|0|||
161930860|NCT00079781|584794236|FG000|Follow-up Period|Death|0|||
161930861|NCT00079781|584794237|FG001|Follow-up Period|Death|0|||
161930862|NCT00079781|584794238|FG002|Follow-up Period|Death|1|||
161930863|NCT00564070|584794239|FG000|Overall Study|Lost to Follow-up|9|||
161823332|NCT04640194|584394175|FG004|Overall Study|fibrinogen level too low|0|||
161823333|NCT04640194|584394176|FG005|Overall Study|fibrinogen level too low|0|||
161823334|NCT04640194|584394177|FG006|Overall Study|fibrinogen level too low|0|||
161823335|NCT04640194|584394171|FG000|Overall Study|mild bleeding|0|||
161823336|NCT04640194|584394172|FG001|Overall Study|mild bleeding|0|||
161823337|NCT04640194|584394173|FG002|Overall Study|mild bleeding|0|||
161823338|NCT04640194|584394174|FG003|Overall Study|mild bleeding|1|||
161823339|NCT04640194|584394175|FG004|Overall Study|mild bleeding|0|||
161823340|NCT04640194|584394176|FG005|Overall Study|mild bleeding|0|||
161823341|NCT04640194|584394177|FG006|Overall Study|mild bleeding|0|||
161823342|NCT04640194|584394171|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161823343|NCT04640194|584394172|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
161823344|NCT04640194|584394173|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161823345|NCT04640194|584394174|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161823346|NCT04640194|584394175|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161823347|NCT04640194|584394176|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161930864|NCT00564070|584794240|FG001|Overall Study|Lost to Follow-up|7|||
161930865|NCT00564070|584794239|FG000|Overall Study|Worsening depression, referred to care|3|||
161930866|NCT00564070|584794240|FG001|Overall Study|Worsening depression, referred to care|0|||
161930867|NCT02264821|584794243|FG000|Overall Study|Protocol Violation|1|||
161930868|NCT02264821|584794244|FG001|Overall Study|Protocol Violation|3|||
161930869|NCT02264821|584794245|FG002|Overall Study|Protocol Violation|6|||
161930870|NCT00552279|584794246|FG000|Overall Study|Adverse Event|0|||
161930871|NCT00552279|584794247|FG001|Overall Study|Adverse Event|1|||
161930872|NCT00552279|584794246|FG000|Overall Study|Withdrawal by Subject|12|||
161930873|NCT00552279|584794247|FG001|Overall Study|Withdrawal by Subject|1|||
161930874|NCT00552279|584794246|FG000|Overall Study|Lost to Follow-up|1|||
161930875|NCT00552279|584794247|FG001|Overall Study|Lost to Follow-up|0|||
161930876|NCT00552279|584794246|FG000|Overall Study|Other|1|||
161930877|NCT00552279|584794247|FG001|Overall Study|Other|1|||
161930878|NCT02067156|584794250|FG000|Overall Study|Lost to Follow-up|4|||
161930879|NCT01853280|584794251|FG000|Overall Study|Lack of Efficacy|2|||
161930880|NCT01853280|584794252|FG001|Overall Study|Lack of Efficacy|2|||
161930881|NCT01853280|584794251|FG000|Overall Study|Lost to Follow-up|0|||
161930882|NCT01853280|584794252|FG001|Overall Study|Lost to Follow-up|1|||
161930883|NCT01853280|584794251|FG000|Overall Study|Physician Decision|0|||
161823348|NCT04640194|584394177|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161823349|NCT03201003|584394181|FG000|Overall Study|Adverse Event|14|||
161823350|NCT03201003|584394182|FG001|Overall Study|Adverse Event|1|||
161823351|NCT03201003|584394181|FG000|Overall Study|Other reasons|5|||
161930884|NCT01853280|584794252|FG001|Overall Study|Physician Decision|1|||
161930885|NCT01853280|584794251|FG000|Overall Study|Withdrawal by Subject|0|||
161930886|NCT01853280|584794252|FG001|Overall Study|Withdrawal by Subject|1|||
161930887|NCT01853280|584794251|FG000|Overall Study|Ineligible|0|||
161930888|NCT01853280|584794252|FG001|Overall Study|Ineligible|1|||
161930889|NCT01655069|584794253|FG000|Overall Study|Physician Decision|0|||
161930890|NCT01655069|584794254|FG001|Overall Study|Physician Decision|0|||
161930891|NCT01655069|584794255|FG002|Overall Study|Physician Decision|0|||
161930892|NCT01655069|584794256|FG003|Overall Study|Physician Decision|1|||
161930893|NCT01655069|584794253|FG000|Overall Study|Adverse Event|6|||
161930894|NCT01655069|584794254|FG001|Overall Study|Adverse Event|7|||
161930895|NCT01655069|584794255|FG002|Overall Study|Adverse Event|2|||
161930896|NCT01655069|584794256|FG003|Overall Study|Adverse Event|3|||
161930897|NCT01655069|584794253|FG000|Overall Study|Lack of Efficacy|0|||
161930898|NCT01655069|584794254|FG001|Overall Study|Lack of Efficacy|1|||
161930899|NCT01655069|584794255|FG002|Overall Study|Lack of Efficacy|0|||
161930900|NCT01655069|584794256|FG003|Overall Study|Lack of Efficacy|0|||
161930901|NCT01655069|584794253|FG000|Overall Study|No Treatment Needed|0|||
161930902|NCT01655069|584794254|FG001|Overall Study|No Treatment Needed|1|||
161930903|NCT01655069|584794255|FG002|Overall Study|No Treatment Needed|0|||
161930904|NCT01655069|584794256|FG003|Overall Study|No Treatment Needed|0|||
161930905|NCT01655069|584794253|FG000|Overall Study|Withdrawal by Subject|2|||
161930906|NCT01655069|584794254|FG001|Overall Study|Withdrawal by Subject|3|||
161930907|NCT01655069|584794255|FG002|Overall Study|Withdrawal by Subject|0|||
161930908|NCT01655069|584794256|FG003|Overall Study|Withdrawal by Subject|0|||
161930909|NCT00104884|584794257|FG000|Overall Study|Disease progression|4|||
161930910|NCT02346370|584794258|FG000|Overall Study|Not treated|1|||
161930911|NCT02346370|584794259|FG001|Overall Study|Not treated|0|||
161930912|NCT02346370|584794260|FG002|Overall Study|Not treated|0|||
161930913|NCT02346370|584794258|FG000|Overall Study|Withdrawal of consent|1|||
161930914|NCT02346370|584794259|FG001|Overall Study|Withdrawal of consent|0|||
161930915|NCT02346370|584794260|FG002|Overall Study|Withdrawal of consent|0|||
161930916|NCT02346370|584794258|FG000|Overall Study|Death|1|||
161930917|NCT02346370|584794259|FG001|Overall Study|Death|3|||
161930918|NCT02346370|584794260|FG002|Overall Study|Death|1|||
161930919|NCT02346370|584794258|FG000|Overall Study|Sponsor discontinued study|5|||
161930920|NCT02346370|584794259|FG001|Overall Study|Sponsor discontinued study|0|||
161930921|NCT02346370|584794260|FG002|Overall Study|Sponsor discontinued study|2|||
161930922|NCT02346370|584794258|FG000|Overall Study|Radiologic progression|0|||
161930923|NCT02346370|584794259|FG001|Overall Study|Radiologic progression|0|||
161930924|NCT02346370|584794260|FG002|Overall Study|Radiologic progression|1|||
161930925|NCT02346370|584794258|FG000|Overall Study|Physician Decision|0|||
161823352|NCT03201003|584394182|FG001|Overall Study|Other reasons|1|||
161823353|NCT03201003|584394181|FG000|Overall Study|Withdrawal by Subject|4|||
161823354|NCT03201003|584394182|FG001|Overall Study|Withdrawal by Subject|1|||
161823355|NCT03201003|584394181|FG000|Overall Study|Lost to Follow-up|2|||
161823356|NCT03201003|584394182|FG001|Overall Study|Lost to Follow-up|0|||
161823357|NCT03201003|584394181|FG000|Overall Study|Protocol Violation|1|||
161930926|NCT02346370|584794259|FG001|Overall Study|Physician Decision|1|||
161930927|NCT02346370|584794260|FG002|Overall Study|Physician Decision|0|||
161930928|NCT03473301|584794261|FG000|Overall Study|Protocol Violation|4|||
161930929|NCT03473301|584794262|FG001|Overall Study|Protocol Violation|0|||
161930930|NCT03473301|584794263|FG002|Overall Study|Protocol Violation|0|||
161676933|NCT01390272|583870622|FG001|Overall Study|Withdrawal by Subject|5|||
161676934|NCT01390272|583870621|FG000|Overall Study|Patient moved, no longer eligible|5|||
161676935|NCT01390272|583870622|FG001|Overall Study|Patient moved, no longer eligible|8|||
161676936|NCT00590044|583870623|FG000|Overall Study|Withdrawal by Subject|2|||
161676937|NCT00590044|583870624|FG001|Overall Study|Withdrawal by Subject|2|||
161676938|NCT00590044|583870623|FG000|Overall Study|wrong insulin arm assigned|1|||
161676939|NCT00590044|583870624|FG001|Overall Study|wrong insulin arm assigned|0|||
161676940|NCT00590044|583870623|FG000|Overall Study|Protocol Violation|1|||
161676941|NCT00590044|583870624|FG001|Overall Study|Protocol Violation|0|||
161676942|NCT01514136|583870625|FG000|Test Period 1; Test A|Protocol Violation|1|||
161676943|NCT01514136|583870626|FG001|Test Period 1; Test A|Protocol Violation|0|||
161676944|NCT01514136|583870627|FG002|Test Period 1; Test A|Protocol Violation|0|||
161676945|NCT01514136|583870628|FG003|Test Period 1; Test A|Protocol Violation|0|||
161676946|NCT01514136|583870629|FG004|Test Period 1; Test A|Protocol Violation|0|||
161676947|NCT01514136|583870630|FG005|Test Period 1; Test A|Protocol Violation|0|||
161676948|NCT01514136|583870631|FG006|Test Period 1; Test A|Protocol Violation|0|||
161676949|NCT01514136|583870632|FG007|Test Period 1; Test A|Protocol Violation|0|||
161930931|NCT03473301|584794261|FG000|Overall Study|Withdrawal by Subject|0|||
161930932|NCT03473301|584794262|FG001|Overall Study|Withdrawal by Subject|1|||
161930933|NCT03473301|584794263|FG002|Overall Study|Withdrawal by Subject|0|||
161930934|NCT03473301|584794261|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
161930935|NCT03473301|584794262|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
161930936|NCT03473301|584794263|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
161676950|NCT01514136|583870625|FG000|Test Period 1; Test A|Break from study holiday|2|||
161676951|NCT01514136|583870626|FG001|Test Period 1; Test A|Break from study holiday|0|||
161676952|NCT01514136|583870627|FG002|Test Period 1; Test A|Break from study holiday|0|||
161676953|NCT01514136|583870628|FG003|Test Period 1; Test A|Break from study holiday|0|||
161676954|NCT01514136|583870629|FG004|Test Period 1; Test A|Break from study holiday|0|||
161676955|NCT01514136|583870630|FG005|Test Period 1; Test A|Break from study holiday|0|||
161676956|NCT01514136|583870631|FG006|Test Period 1; Test A|Break from study holiday|0|||
161676957|NCT01514136|583870632|FG007|Test Period 1; Test A|Break from study holiday|0|||
161676958|NCT01514136|583870625|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
161676959|NCT01514136|583870626|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
161930937|NCT00835042|584794264|FG000|First Intervention|Withdrawal by Subject|3|||
161930938|NCT00835042|584794265|FG001|First Intervention|Withdrawal by Subject|0|||
161930939|NCT00835042|584794264|FG000|First Intervention|Adverse Event|1|||
161930940|NCT00835042|584794265|FG001|First Intervention|Adverse Event|2|||
161930941|NCT00835042|584794264|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
161930942|NCT00835042|584794265|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
161930943|NCT02453191|584794267|FG000|Overall Study|Withdrawal by Subject|1|||
161930944|NCT02571244|584794268|FG000|Overall Study|Lost to Follow-up|0|||
161676960|NCT01514136|583870627|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
161676961|NCT01514136|583870628|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
161930945|NCT02571244|584794269|FG001|Overall Study|Lost to Follow-up|1|||
161930946|NCT02571244|584794268|FG000|Overall Study|Unable to reach out post discharge|3|||
161930947|NCT02571244|584794269|FG001|Overall Study|Unable to reach out post discharge|0|||
161930948|NCT01696214|584794272|FG000|Overall Study|Lost to Follow-up|1|||
161930949|NCT01696214|584794273|FG001|Overall Study|Lost to Follow-up|0|||
161930950|NCT01696214|584794274|FG002|Overall Study|Lost to Follow-up|0|||
161930951|NCT01696214|584794275|FG003|Overall Study|Lost to Follow-up|0|||
161930952|NCT02134028|584794276|FG000|Overall Study|Lack of Efficacy|1|||
161930953|NCT02134028|584794277|FG001|Overall Study|Lack of Efficacy|0|||
161930954|NCT02134028|584794278|FG002|Overall Study|Lack of Efficacy|3|||
161930955|NCT02134028|584794279|FG003|Overall Study|Lack of Efficacy|2|||
161930956|NCT02134028|584794280|FG004|Overall Study|Lack of Efficacy|1|||
161930957|NCT02134028|584794281|FG005|Overall Study|Lack of Efficacy|2|||
161930958|NCT02134028|584794282|FG006|Overall Study|Lack of Efficacy|1|||
161930959|NCT02134028|584794283|FG007|Overall Study|Lack of Efficacy|0|||
161930960|NCT02134028|584794276|FG000|Overall Study|Poor compliance to protocol|1|||
161930961|NCT02134028|584794277|FG001|Overall Study|Poor compliance to protocol|1|||
161930962|NCT02134028|584794278|FG002|Overall Study|Poor compliance to protocol|3|||
161930963|NCT02134028|584794279|FG003|Overall Study|Poor compliance to protocol|7|||
161930964|NCT02134028|584794280|FG004|Overall Study|Poor compliance to protocol|1|||
161930965|NCT02134028|584794281|FG005|Overall Study|Poor compliance to protocol|1|||
162202796|NCT02853305|585792671|FG002|Overall Study|Withdrawal by Subject|3|||
162202797|NCT02853305|585792669|FG000|Overall Study|Transferred to Extension Study|46|||
162202798|NCT02853305|585792670|FG001|Overall Study|Transferred to Extension Study|30|||
162202799|NCT02853305|585792671|FG002|Overall Study|Transferred to Extension Study|25|||
162202800|NCT02853305|585792669|FG000|Overall Study|Did Not Continue on Extension Study|16|||
162202801|NCT02853305|585792670|FG001|Overall Study|Did Not Continue on Extension Study|20|||
162202802|NCT02853305|585792671|FG002|Overall Study|Did Not Continue on Extension Study|24|||
162202803|NCT02381652|585792672|FG000|Overall Study|Withdrawal by Subject|0|||
162202804|NCT02381652|585792673|FG001|Overall Study|Withdrawal by Subject|0|||
162202805|NCT02381652|585792674|FG002|Overall Study|Withdrawal by Subject|1|||
161930966|NCT02134028|584794282|FG006|Overall Study|Poor compliance to protocol|0|||
161930967|NCT02134028|584794283|FG007|Overall Study|Poor compliance to protocol|0|||
161930968|NCT02134028|584794276|FG000|Overall Study|Other unspecified|4|||
161930969|NCT02134028|584794277|FG001|Overall Study|Other unspecified|22|||
161930970|NCT02134028|584794278|FG002|Overall Study|Other unspecified|33|||
161930971|NCT02134028|584794279|FG003|Overall Study|Other unspecified|64|||
161930972|NCT02134028|584794280|FG004|Overall Study|Other unspecified|8|||
161930973|NCT02134028|584794281|FG005|Overall Study|Other unspecified|6|||
161930974|NCT02134028|584794282|FG006|Overall Study|Other unspecified|2|||
161930975|NCT02134028|584794283|FG007|Overall Study|Other unspecified|1|||
161930976|NCT02134028|584794276|FG000|Overall Study|Adverse Event|3|||
161930977|NCT02134028|584794277|FG001|Overall Study|Adverse Event|19|||
161930978|NCT02134028|584794278|FG002|Overall Study|Adverse Event|13|||
161930979|NCT02134028|584794279|FG003|Overall Study|Adverse Event|32|||
161930980|NCT02134028|584794280|FG004|Overall Study|Adverse Event|4|||
161930981|NCT02134028|584794281|FG005|Overall Study|Adverse Event|5|||
161930982|NCT02134028|584794282|FG006|Overall Study|Adverse Event|1|||
161930983|NCT02134028|584794283|FG007|Overall Study|Adverse Event|2|||
161930984|NCT01309100|584794286|FG000|Overall Study|Protocol Violation|1|||
161930985|NCT01309100|584794286|FG000|Overall Study|Positive Slit lamp finding|1|||
161930986|NCT03722030|584794287|FG000|Overall Study|Withdrawal by Subject|1|||
161930987|NCT03722030|584794288|FG001|Overall Study|Withdrawal by Subject|0|||
161930988|NCT01663987|584794290|FG000|Overall Study|Adverse Event|7|||
161930989|NCT01663987|584794291|FG001|Overall Study|Adverse Event|2|||
161930990|NCT01663987|584794290|FG000|Overall Study|Lost to Follow-up|1|||
161930991|NCT01663987|584794291|FG001|Overall Study|Lost to Follow-up|1|||
161930992|NCT01663987|584794290|FG000|Overall Study|Withdrawal by Subject|2|||
161930993|NCT01663987|584794291|FG001|Overall Study|Withdrawal by Subject|3|||
161930994|NCT01663987|584794290|FG000|Overall Study|Other reason not defined above|3|||
161930995|NCT01663987|584794291|FG001|Overall Study|Other reason not defined above|0|||
161930996|NCT00545948|584794292|FG000|Overall Study|Not Treated|1|||
161930997|NCT00545948|584794293|FG001|Overall Study|Not Treated|1|||
161930998|NCT00545948|584794294|FG002|Overall Study|Not Treated|7|||
161930999|NCT02487199|584794297|FG000|Overall Study|Withdrew Consent|0|||
161931000|NCT02487199|584794298|FG001|Overall Study|Withdrew Consent|1|||
161931001|NCT00286455|584794299|FG000|Overall Study|Hyperglycemia rescue|19|||
161931002|NCT00286455|584794300|FG001|Overall Study|Hyperglycemia rescue|13|||
161931003|NCT00286455|584794301|FG002|Overall Study|Hyperglycemia rescue|10|||
161931004|NCT00286455|584794299|FG000|Overall Study|Adverse Event|1|||
161931005|NCT00286455|584794300|FG001|Overall Study|Adverse Event|3|||
161931006|NCT00286455|584794301|FG002|Overall Study|Adverse Event|2|||
161931007|NCT00286455|584794299|FG000|Overall Study|Lost to Follow-up|0|||
161931008|NCT00286455|584794300|FG001|Overall Study|Lost to Follow-up|3|||
161931009|NCT00286455|584794301|FG002|Overall Study|Lost to Follow-up|3|||
161931010|NCT00286455|584794299|FG000|Overall Study|Physician Decision|3|||
161931011|NCT00286455|584794300|FG001|Overall Study|Physician Decision|0|||
161931012|NCT00286455|584794301|FG002|Overall Study|Physician Decision|2|||
161931013|NCT00286455|584794299|FG000|Overall Study|Protocol Violation|1|||
161931014|NCT00286455|584794300|FG001|Overall Study|Protocol Violation|1|||
161931015|NCT00286455|584794301|FG002|Overall Study|Protocol Violation|0|||
161931016|NCT00286455|584794299|FG000|Overall Study|Participant Non-compliance|1|||
161931017|NCT00286455|584794300|FG001|Overall Study|Participant Non-compliance|0|||
161931018|NCT00286455|584794301|FG002|Overall Study|Participant Non-compliance|0|||
161931019|NCT00286455|584794299|FG000|Overall Study|Withdrawal by Subject|0|||
161931020|NCT00286455|584794300|FG001|Overall Study|Withdrawal by Subject|8|||
161931021|NCT00286455|584794301|FG002|Overall Study|Withdrawal by Subject|7|||
161931022|NCT01654250|584796362|FG000|Overall Study|Lost to Follow-up|1|||
161931023|NCT01654250|584796363|FG001|Overall Study|Lost to Follow-up|0|||
161931024|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
161931025|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
161931026|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
161931027|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
161931028|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
161931029|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
161931030|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
161931031|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
161931032|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
161931033|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
161931034|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
161931035|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
161931036|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
161931037|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
161931038|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
161931039|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
161931040|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
161823358|NCT03201003|584394182|FG001|Overall Study|Protocol Violation|0|||
161823359|NCT01709903|584394188|FG000|Overall Study|administrative problems|2|||
161823360|NCT01709903|584394189|FG001|Overall Study|administrative problems|6|||
161823361|NCT01709903|584394188|FG000|Overall Study|Abnormal test procedure results|1|||
161823362|NCT01709903|584394189|FG001|Overall Study|Abnormal test procedure results|0|||
161823363|NCT01709903|584394188|FG000|Overall Study|In ability to use device|1|||
161823364|NCT01709903|584394189|FG001|Overall Study|In ability to use device|1|||
161823365|NCT01709903|584394188|FG000|Overall Study|no longer needed study drug|0|||
161823366|NCT01709903|584394189|FG001|Overall Study|no longer needed study drug|1|||
161823367|NCT01709903|584394188|FG000|Overall Study|Lost to Follow-up|0|||
161823368|NCT01709903|584394189|FG001|Overall Study|Lost to Follow-up|2|||
161823369|NCT01709903|584394188|FG000|Overall Study|Death|2|||
161823370|NCT01709903|584394189|FG001|Overall Study|Death|0|||
161823371|NCT01709903|584394188|FG000|Overall Study|Protocol Violation|3|||
161823372|NCT01709903|584394189|FG001|Overall Study|Protocol Violation|2|||
161823373|NCT01709903|584394188|FG000|Overall Study|Lack of Efficacy|3|||
161823374|NCT01709903|584394189|FG001|Overall Study|Lack of Efficacy|3|||
161823375|NCT01709903|584394188|FG000|Overall Study|Withdrawal by Subject|6|||
161823376|NCT01709903|584394189|FG001|Overall Study|Withdrawal by Subject|6|||
161823377|NCT01709903|584394188|FG000|Overall Study|Adverse Event|11|||
161823378|NCT01709903|584394189|FG001|Overall Study|Adverse Event|18|||
161823379|NCT01751087|584394194|FG000|Overall Study|Withdrawal by Subject|1|||
161823380|NCT01751087|584394195|FG001|Overall Study|Withdrawal by Subject|0|||
161823381|NCT01751087|584394196|FG002|Overall Study|Withdrawal by Subject|0|||
161823382|NCT01751087|584394194|FG000|Overall Study|Physician Decision|0|||
161823383|NCT01751087|584394195|FG001|Overall Study|Physician Decision|0|||
161823384|NCT01751087|584394196|FG002|Overall Study|Physician Decision|1|||
161823385|NCT05377489|584394197|FG000|Overall Study|Withdrawal by Subject|122|||
161823386|NCT05377489|584394197|FG000|Overall Study|Lost to Follow-up|21|||
161823387|NCT05377489|584394197|FG000|Overall Study|Lack of Efficacy|10|||
161823388|NCT05377489|584394197|FG000|Overall Study|Adverse Event|5|||
161823389|NCT05377489|584394197|FG000|Overall Study|Death|4|||
161823390|NCT05377489|584394197|FG000|Overall Study|Physician Decision|3|||
161823391|NCT05377489|584394197|FG000|Overall Study|Protocol Violation|1|||
161823392|NCT05377489|584394197|FG000|Overall Study|Other|9|||
161823393|NCT00724958|584394198|FG000|Overall Study|Adverse Event|28|||
161823394|NCT00724958|584394198|FG000|Overall Study|Loss of Response|40|||
161823395|NCT00724958|584394198|FG000|Overall Study|No Response|18|||
161823396|NCT00724958|584394198|FG000|Overall Study|Remission|7|||
161823397|NCT00724958|584394198|FG000|Overall Study|Other Reason|76|||
161823398|NCT00724958|584394198|FG000|Overall Study|No documentation for end of therapy|13|||
161823399|NCT00697619|584394199|FG000|Overall Study|Lack of Efficacy|2|||
161823400|NCT00697619|584394200|FG001|Overall Study|Lack of Efficacy|2|||
161823401|NCT00697619|584394199|FG000|Overall Study|Adverse Event|4|||
161823402|NCT00697619|584394200|FG001|Overall Study|Adverse Event|6|||
161823403|NCT00559637|584396155|FG000|Overall Study|Adverse Event|22|||
161823404|NCT00559637|584396155|FG000|Overall Study|Withdrawal by Subject|4|||
161823405|NCT00559637|584396155|FG000|Overall Study|Protocol Violation|6|||
161823406|NCT00559637|584396155|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
161823407|NCT00559637|584396155|FG000|Overall Study|Failure to return|6|||
161823408|NCT00559637|584396155|FG000|Overall Study|Insufficient response|3|||
161823409|NCT00559637|584396155|FG000|Overall Study|Started requiring dialysis after month 7|2|||
161823410|NCT00559637|584396155|FG000|Overall Study|Suspected lung cancer|1|||
161823411|NCT00559637|584396155|FG000|Overall Study|Participation in another study|1|||
161823412|NCT00559637|584396155|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
161823413|NCT00559637|584396155|FG000|Overall Study|Change of center|1|||
161823414|NCT00559637|584396155|FG000|Overall Study|Change of home|1|||
161823415|NCT00559637|584396155|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
161823416|NCT01705717|584396156|FG000|Overall Study|Adverse Event|2|||
161823417|NCT01705717|584396157|FG001|Overall Study|Adverse Event|2|||
161823418|NCT01705717|584396156|FG000|Overall Study|Lack of Efficacy|0|||
161823419|NCT01705717|584396157|FG001|Overall Study|Lack of Efficacy|1|||
161823420|NCT01705717|584396156|FG000|Overall Study|Other|0|||
161823421|NCT01705717|584396157|FG001|Overall Study|Other|2|||
161823422|NCT02031237|584396158|FG000|Overall Study|Death|1|||
161823423|NCT02031237|584396159|FG001|Overall Study|Death|5|||
161823424|NCT02031237|584396160|FG002|Overall Study|Death|0|||
161823425|NCT02031237|584396158|FG000|Overall Study|Physician Decision|0|||
161823426|NCT02031237|584396159|FG001|Overall Study|Physician Decision|1|||
161823427|NCT02031237|584396160|FG002|Overall Study|Physician Decision|0|||
161823428|NCT02031237|584396158|FG000|Overall Study|Withdrawal by Subject|2|||
161823429|NCT02031237|584396159|FG001|Overall Study|Withdrawal by Subject|2|||
161823430|NCT02031237|584396160|FG002|Overall Study|Withdrawal by Subject|0|||
161823431|NCT02031237|584396158|FG000|Overall Study|Protocol Violation|2|||
161823432|NCT02031237|584396159|FG001|Overall Study|Protocol Violation|6|||
161823433|NCT02031237|584396160|FG002|Overall Study|Protocol Violation|0|||
161823434|NCT02031237|584396158|FG000|Overall Study|Alternate Treatment Given|0|||
161823435|NCT02031237|584396159|FG001|Overall Study|Alternate Treatment Given|0|||
161823436|NCT02031237|584396160|FG002|Overall Study|Alternate Treatment Given|3|||
161823437|NCT01074008|584396164|FG000|Overall Study|Adverse Event|0|||
161823438|NCT01074008|584396165|FG001|Overall Study|Adverse Event|1|||
161823439|NCT01074008|584396166|FG002|Overall Study|Adverse Event|0|||
161823440|NCT01074008|584396167|FG003|Overall Study|Adverse Event|0|||
161823441|NCT01074008|584396168|FG004|Overall Study|Adverse Event|0|||
161823442|NCT01074008|584396169|FG005|Overall Study|Adverse Event|0|||
161823443|NCT01074008|584396170|FG006|Overall Study|Adverse Event|0|||
161823444|NCT01074008|584396171|FG007|Overall Study|Adverse Event|0|||
161823445|NCT01074008|584396172|FG008|Overall Study|Adverse Event|0|||
161823446|NCT01074008|584396164|FG000|Overall Study|Withdrawal by Subject|1|||
161823447|NCT01074008|584396165|FG001|Overall Study|Withdrawal by Subject|1|||
161823448|NCT01074008|584396166|FG002|Overall Study|Withdrawal by Subject|1|||
161823449|NCT01074008|584396167|FG003|Overall Study|Withdrawal by Subject|0|||
161823450|NCT01074008|584396168|FG004|Overall Study|Withdrawal by Subject|1|||
161823451|NCT01074008|584396169|FG005|Overall Study|Withdrawal by Subject|0|||
161823452|NCT01074008|584396170|FG006|Overall Study|Withdrawal by Subject|0|||
161931041|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
161931042|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
161931043|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
161931044|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
161931045|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
161931046|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
161823453|NCT01074008|584396171|FG007|Overall Study|Withdrawal by Subject|0|||
161823454|NCT01074008|584396172|FG008|Overall Study|Withdrawal by Subject|0|||
161823455|NCT01074008|584396164|FG000|Overall Study|Lost to Follow-up|0|||
161823456|NCT01074008|584396165|FG001|Overall Study|Lost to Follow-up|1|||
161823457|NCT01074008|584396166|FG002|Overall Study|Lost to Follow-up|1|||
161823458|NCT01074008|584396167|FG003|Overall Study|Lost to Follow-up|1|||
161823459|NCT01074008|584396168|FG004|Overall Study|Lost to Follow-up|1|||
161823460|NCT01074008|584396169|FG005|Overall Study|Lost to Follow-up|0|||
161823461|NCT01074008|584396170|FG006|Overall Study|Lost to Follow-up|1|||
161823462|NCT01074008|584396171|FG007|Overall Study|Lost to Follow-up|0|||
161823463|NCT01074008|584396172|FG008|Overall Study|Lost to Follow-up|4|||
161823464|NCT02805309|584396175|FG000|Overall Study|Lost to Follow-up|2|||
161823465|NCT02805309|584396176|FG001|Overall Study|Lost to Follow-up|2|||
161823466|NCT02805309|584396177|FG002|Overall Study|Lost to Follow-up|2|||
161823467|NCT02805309|584396175|FG000|Overall Study|Post-Randomization Exclusion|0|||
161823468|NCT02805309|584396176|FG001|Overall Study|Post-Randomization Exclusion|2|||
161823469|NCT02805309|584396177|FG002|Overall Study|Post-Randomization Exclusion|1|||
161823470|NCT05480800|584396186|FG000|Overall Study|Withdrawal by Subject|0|||
161823471|NCT05480800|584396187|FG001|Overall Study|Withdrawal by Subject|0|||
161823472|NCT05480800|584396188|FG002|Overall Study|Withdrawal by Subject|2|||
161823473|NCT05480800|584396189|FG003|Overall Study|Withdrawal by Subject|1|||
161823474|NCT05480800|584396190|FG004|Overall Study|Withdrawal by Subject|0|||
161823475|NCT05480800|584396191|FG005|Overall Study|Withdrawal by Subject|0|||
161823476|NCT05480800|584396192|FG006|Overall Study|Withdrawal by Subject|1|||
161823477|NCT05480800|584396193|FG007|Overall Study|Withdrawal by Subject|0|||
161823478|NCT05480800|584396186|FG000|Overall Study|Other|0|||
161823479|NCT05480800|584396187|FG001|Overall Study|Other|0|||
161931047|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
161931048|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
161931049|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
161931050|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
161823480|NCT05480800|584396188|FG002|Overall Study|Other|0|||
161823481|NCT05480800|584396189|FG003|Overall Study|Other|0|||
161823482|NCT05480800|584396190|FG004|Overall Study|Other|0|||
161823483|NCT05480800|584396191|FG005|Overall Study|Other|0|||
161823484|NCT05480800|584396192|FG006|Overall Study|Other|1|||
161823485|NCT05480800|584396193|FG007|Overall Study|Other|0|||
161823486|NCT00377156|584396196|FG000|Overall Study|Death|23|||
161823487|NCT00377156|584396197|FG001|Overall Study|Death|19|||
161823488|NCT00377156|584396196|FG000|Overall Study|Withdrawal by Subject|16|||
161823489|NCT00377156|584396197|FG001|Overall Study|Withdrawal by Subject|24|||
161823490|NCT00377156|584396196|FG000|Overall Study|Had follow-up <90 d|3|||
161931051|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
161823491|NCT00377156|584396197|FG001|Overall Study|Had follow-up <90 d|6|||
161823492|NCT00377156|584396196|FG000|Overall Study|Cancellation|1|||
161823493|NCT00377156|584396197|FG001|Overall Study|Cancellation|0|||
161823494|NCT00377156|584396196|FG000|Overall Study|Refused testing|0|||
161823495|NCT00377156|584396197|FG001|Overall Study|Refused testing|1|||
161823496|NCT00377156|584396196|FG000|Overall Study|Ineligible|0|||
161823497|NCT00377156|584396197|FG001|Overall Study|Ineligible|1|||
161931052|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
161931053|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
161931054|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
161931055|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
161931056|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
161823498|NCT00377156|584396196|FG000|Overall Study|Disability or language problem|0|||
161823499|NCT00377156|584396197|FG001|Overall Study|Disability or language problem|1|||
161823500|NCT00377156|584396196|FG000|Overall Study|Other|5|||
161823501|NCT00377156|584396197|FG001|Overall Study|Other|2|||
161823502|NCT01802216|584396198|FG000|4 Month Visit|Participant did not show to visit|3|||
161823503|NCT01802216|584396199|FG001|4 Month Visit|Participant did not show to visit|4|||
161823504|NCT01802216|584396198|FG000|8 Month Visit|Participant did not show to visit|3|||
161823505|NCT01802216|584396199|FG001|8 Month Visit|Participant did not show to visit|5|||
161823506|NCT01802216|584396198|FG000|12 Month Visit|Participant did not show to visit|3|||
161823507|NCT01802216|584396199|FG001|12 Month Visit|Participant did not show to visit|4|||
161823508|NCT00683592|584396202|FG000|Overall Study|Adverse Event|12|||
161823509|NCT00683592|584396203|FG001|Overall Study|Adverse Event|4|||
161823510|NCT00683592|584396202|FG000|Overall Study|Withdrawal by Subject|11|||
161823511|NCT00683592|584396203|FG001|Overall Study|Withdrawal by Subject|11|||
161931057|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
161931058|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
161931059|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
161931060|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
161931061|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
161931062|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
161931063|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
161931064|NCT02596893|584796364|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
161931065|NCT02596893|584796365|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
161931066|NCT02596893|584796366|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
161931067|NCT02596893|584796367|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
161931068|NCT03280615|584796368|FG000|Overall Study|Lost to Follow-up|1|||
161931069|NCT03280615|584796369|FG001|Overall Study|Lost to Follow-up|2|||
161931070|NCT03280615|584796368|FG000|Overall Study|Adverse Event|1|||
161931071|NCT03280615|584796369|FG001|Overall Study|Adverse Event|1|||
161931072|NCT03280615|584796368|FG000|Overall Study|Withdrawal by Subject|2|||
161931073|NCT03280615|584796369|FG001|Overall Study|Withdrawal by Subject|2|||
161931074|NCT04432298|584796374|FG000|Overall Study|Other than specified|1|||
161931075|NCT04432298|584796375|FG001|Overall Study|Other than specified|0|||
161931076|NCT04432298|584796374|FG000|Overall Study|Lost to Follow-up|0|||
161931077|NCT04432298|584796375|FG001|Overall Study|Lost to Follow-up|1|||
161931078|NCT04432298|584796374|FG000|Overall Study|Death|3|||
161931079|NCT04432298|584796375|FG001|Overall Study|Death|2|||
161931080|NCT04432298|584796374|FG000|Overall Study|Withdrawal by Subject|2|||
161931081|NCT04432298|584796375|FG001|Overall Study|Withdrawal by Subject|0|||
161931082|NCT02451007|584796378|FG000|Overall Study|Withdrawal by Subject|4|||
161931083|NCT02451007|584796378|FG000|Overall Study|Adverse Event|1|||
161931084|NCT02451007|584796378|FG000|Overall Study|Disease Progression|2|||
161931085|NCT01716559|584796379|FG000|Overall Study|Adverse Event|11|||
161931086|NCT01716559|584796379|FG000|Overall Study|Death|21|||
161931087|NCT01716559|584796379|FG000|Overall Study|Withdrawal by Subject|4|||
161931088|NCT01716559|584796379|FG000|Overall Study|Other withdrawal reason|75|||
161931089|NCT00348374|584796380|FG000|Overall Study|Adverse Event|1|||
161931090|NCT00348374|584796381|FG001|Overall Study|Adverse Event|4|||
161931091|NCT00348374|584796380|FG000|Overall Study|Lost to Follow-up|1|||
161931092|NCT00348374|584796381|FG001|Overall Study|Lost to Follow-up|3|||
161931093|NCT00348374|584796380|FG000|Overall Study|Withdrawal by Subject|5|||
161931094|NCT00348374|584796381|FG001|Overall Study|Withdrawal by Subject|5|||
161931095|NCT00348374|584796380|FG000|Overall Study|Other|11|||
161931096|NCT00348374|584796381|FG001|Overall Study|Other|12|||
161931097|NCT00348374|584796380|FG000|Overall Study|ongoing at date of cutoff|1|||
161931098|NCT00348374|584796381|FG001|Overall Study|ongoing at date of cutoff|1|||
161931099|NCT00348374|584796380|FG000|Overall Study|randomized but did not receive treatment|0|||
161931100|NCT00348374|584796381|FG001|Overall Study|randomized but did not receive treatment|7|||
161931101|NCT02123511|584796390|FG000|Overall Study|Cancelled treatment|1|||
161931102|NCT02123511|584796391|FG001|Overall Study|Cancelled treatment|0|||
161931103|NCT02123511|584796390|FG000|Overall Study|Incomplete data|1|||
161931104|NCT02123511|584796391|FG001|Overall Study|Incomplete data|3|||
161931105|NCT02123511|584796390|FG000|Overall Study|Ineligible|0|||
161931106|NCT02123511|584796391|FG001|Overall Study|Ineligible|1|||
161931107|NCT01423084|584796392|FG000|Overall Study|Adverse Event|0|||
161931108|NCT01423084|584796393|FG001|Overall Study|Adverse Event|1|||
161931109|NCT01423084|584796392|FG000|Overall Study|Withdrawal by Subject|2|||
161931110|NCT01423084|584796393|FG001|Overall Study|Withdrawal by Subject|3|||
161931111|NCT01133977|584796397|FG000|Overall Study|Adverse Event|0|||
161931112|NCT01133977|584796398|FG001|Overall Study|Adverse Event|0|||
161931113|NCT01133977|584796399|FG002|Overall Study|Adverse Event|1|||
161931114|NCT01133977|584796400|FG003|Overall Study|Adverse Event|0|||
161931115|NCT01133977|584796401|FG004|Overall Study|Adverse Event|0|||
161931116|NCT01133977|584796397|FG000|Overall Study|Death|1|||
162202806|NCT03544229|585792675|FG000|Overall Study|Adverse Event|1|||
162202807|NCT03544229|585792676|FG001|Overall Study|Adverse Event|0|||
162202808|NCT03544229|585792677|FG002|Overall Study|Adverse Event|1|||
162202809|NCT03544229|585792678|FG003|Overall Study|Adverse Event|0|||
161931117|NCT01133977|584796398|FG001|Overall Study|Death|1|||
161931118|NCT01133977|584796399|FG002|Overall Study|Death|1|||
161931119|NCT01133977|584796400|FG003|Overall Study|Death|7|||
161931120|NCT01133977|584796401|FG004|Overall Study|Death|3|||
161931121|NCT01133977|584796397|FG000|Overall Study|Started a New Line of Therapy|2|||
161931122|NCT01133977|584796398|FG001|Overall Study|Started a New Line of Therapy|6|||
161931123|NCT01133977|584796399|FG002|Overall Study|Started a New Line of Therapy|4|||
161931124|NCT01133977|584796400|FG003|Overall Study|Started a New Line of Therapy|25|||
161931125|NCT01133977|584796401|FG004|Overall Study|Started a New Line of Therapy|33|||
161931126|NCT01133977|584796397|FG000|Overall Study|Lost to Follow-up|0|||
161931127|NCT01133977|584796398|FG001|Overall Study|Lost to Follow-up|0|||
161931128|NCT01133977|584796399|FG002|Overall Study|Lost to Follow-up|0|||
161931129|NCT01133977|584796400|FG003|Overall Study|Lost to Follow-up|2|||
161931130|NCT01133977|584796401|FG004|Overall Study|Lost to Follow-up|1|||
161931131|NCT01133977|584796397|FG000|Overall Study|Withdrawal by Subject|0|||
161931132|NCT01133977|584796398|FG001|Overall Study|Withdrawal by Subject|0|||
161931133|NCT01133977|584796399|FG002|Overall Study|Withdrawal by Subject|0|||
161931134|NCT01133977|584796400|FG003|Overall Study|Withdrawal by Subject|5|||
161931135|NCT01133977|584796401|FG004|Overall Study|Withdrawal by Subject|1|||
161931136|NCT01682603|584796402|FG000|Overall Study|Lost to Follow-up|3|||
161931137|NCT01791205|584796403|FG000|Phase II|Lack of Efficacy|6|||
161931138|NCT01791205|584796404|FG001|Phase II|Lack of Efficacy|0|||
161931139|NCT01791205|584796403|FG000|Phase II|Adverse Event|2|||
161931140|NCT01791205|584796404|FG001|Phase II|Adverse Event|0|||
161931141|NCT01791205|584796403|FG000|Phase II|Safety|1|||
161931142|NCT01791205|584796404|FG001|Phase II|Safety|0|||
161931143|NCT01791205|584796403|FG000|Phase II|Lost to Follow-up|1|||
161931144|NCT01791205|584796404|FG001|Phase II|Lost to Follow-up|0|||
161931145|NCT01791205|584796403|FG000|Phase II|Remission of disease|1|||
161931146|NCT01791205|584796404|FG001|Phase II|Remission of disease|0|||
161931147|NCT01791205|584796403|FG000|Phase II|Physician's decision|1|||
161931148|NCT01791205|584796404|FG001|Phase II|Physician's decision|0|||
161931149|NCT05345405|584796417|FG000|Overall Study|Withdrawal by Subject|2|||
161931150|NCT05345405|584796418|FG001|Overall Study|Withdrawal by Subject|0|||
161931151|NCT05345405|584796419|FG002|Overall Study|Withdrawal by Subject|0|||
161931152|NCT05345405|584796417|FG000|Overall Study|Did not meet eligibility criteria|0|||
161931153|NCT05345405|584796418|FG001|Overall Study|Did not meet eligibility criteria|2|||
161931154|NCT05345405|584796419|FG002|Overall Study|Did not meet eligibility criteria|0|||
161931155|NCT05345405|584796417|FG000|Overall Study|Lost to Follow-up|0|||
161931156|NCT05345405|584796418|FG001|Overall Study|Lost to Follow-up|0|||
161931157|NCT05345405|584796419|FG002|Overall Study|Lost to Follow-up|1|||
161931158|NCT04189588|584796420|FG000|Overall Study|Death|0|||
161931159|NCT04189588|584796421|FG001|Overall Study|Death|1|||
161931160|NCT04189588|584796420|FG000|Overall Study|Lost to Follow-up|0|||
161931161|NCT04189588|584796421|FG001|Overall Study|Lost to Follow-up|1|||
161931162|NCT03757715|584796424|FG000|Overall Study|Lost to Follow-up|4|||
161931163|NCT03757715|584796425|FG001|Overall Study|Lost to Follow-up|9|||
161931164|NCT03757715|584796424|FG000|Overall Study|Withdrawal by Subject|1|||
161931165|NCT03757715|584796425|FG001|Overall Study|Withdrawal by Subject|1|||
161931166|NCT00281580|584796426|FG000|Overall Study|Adverse Event|2|||
161931167|NCT00281580|584796427|FG001|Overall Study|Adverse Event|0|||
161931168|NCT00281580|584796428|FG002|Overall Study|Adverse Event|2|||
161931169|NCT00281580|584796429|FG003|Overall Study|Adverse Event|4|||
161931170|NCT00281580|584796430|FG004|Overall Study|Adverse Event|1|||
161931171|NCT00281580|584796431|FG005|Overall Study|Adverse Event|0|||
161931172|NCT00281580|584796432|FG006|Overall Study|Adverse Event|1|||
161931173|NCT00281580|584796433|FG007|Overall Study|Adverse Event|0|||
161931174|NCT00281580|584796434|FG008|Overall Study|Adverse Event|1|||
161931175|NCT00281580|584796435|FG009|Overall Study|Adverse Event|6|||
161931176|NCT00281580|584796436|FG010|Overall Study|Adverse Event|0|||
161931177|NCT00281580|584796437|FG011|Overall Study|Adverse Event|5|||
161931178|NCT00281580|584796438|FG012|Overall Study|Adverse Event|8|||
161931179|NCT00281580|584796439|FG013|Overall Study|Adverse Event|2|||
161676962|NCT01514136|583870629|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
161676963|NCT01514136|583870630|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
161676964|NCT01514136|583870631|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
161676965|NCT01514136|583870632|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
161676966|NCT01514136|583870625|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
161823512|NCT00683592|584396202|FG000|Overall Study|Lost to Follow-up|17|||
161823513|NCT00683592|584396203|FG001|Overall Study|Lost to Follow-up|17|||
161823514|NCT00683592|584396202|FG000|Overall Study|Lack of Efficacy|3|||
161823515|NCT00683592|584396203|FG001|Overall Study|Lack of Efficacy|7|||
161823516|NCT00683592|584396202|FG000|Overall Study|Physician Decision|0|||
161823517|NCT00683592|584396203|FG001|Overall Study|Physician Decision|1|||
161823518|NCT00683592|584396202|FG000|Overall Study|Non-compliance|3|||
161823519|NCT00683592|584396203|FG001|Overall Study|Non-compliance|5|||
161823520|NCT00683592|584396202|FG000|Overall Study|Other|1|||
161823521|NCT00683592|584396203|FG001|Overall Study|Other|1|||
161931180|NCT00281580|584796440|FG014|Overall Study|Adverse Event|3|||
161931181|NCT00281580|584796441|FG015|Overall Study|Adverse Event|3|||
161931182|NCT00281580|584796426|FG000|Overall Study|Protocol Violation|0|||
161931183|NCT00281580|584796427|FG001|Overall Study|Protocol Violation|0|||
161931184|NCT00281580|584796428|FG002|Overall Study|Protocol Violation|1|||
161931185|NCT00281580|584796429|FG003|Overall Study|Protocol Violation|1|||
161931186|NCT00281580|584796430|FG004|Overall Study|Protocol Violation|0|||
161931187|NCT00281580|584796431|FG005|Overall Study|Protocol Violation|0|||
161931188|NCT00281580|584796432|FG006|Overall Study|Protocol Violation|1|||
161931189|NCT00281580|584796433|FG007|Overall Study|Protocol Violation|0|||
161931190|NCT00281580|584796434|FG008|Overall Study|Protocol Violation|2|||
161931191|NCT00281580|584796435|FG009|Overall Study|Protocol Violation|0|||
161931192|NCT00281580|584796436|FG010|Overall Study|Protocol Violation|1|||
161931193|NCT00281580|584796437|FG011|Overall Study|Protocol Violation|2|||
161931194|NCT00281580|584796438|FG012|Overall Study|Protocol Violation|0|||
161823522|NCT03303417|584396212|FG000|Overall Study|Withdrawal by Subject|1|||
161823523|NCT03303417|584396213|FG001|Overall Study|Withdrawal by Subject|1|||
161823524|NCT02697617|584396214|FG000|Overall Study|Withdrawal by Subject|0|||
161823525|NCT02697617|584396215|FG001|Overall Study|Withdrawal by Subject|2|||
161823526|NCT02697617|584396214|FG000|Overall Study|Pregnancy|1|||
161823527|NCT02697617|584396215|FG001|Overall Study|Pregnancy|0|||
161823528|NCT00329160|584396218|FG000|Overall Study|Adverse Event|27|||
161823529|NCT00329160|584396218|FG000|Overall Study|Withdrawal by Subject|13|||
161823530|NCT00329160|584396218|FG000|Overall Study|Protocol Violation|2|||
161823531|NCT00329160|584396218|FG000|Overall Study|Did not Receive Study Drug|1|||
161823532|NCT00329160|584396218|FG000|Overall Study|Incomplete IVUS|45|||
161823533|NCT05212948|584396223|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
161823534|NCT05212948|584396224|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
161823535|NCT05212948|584396223|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
161823536|NCT05212948|584396224|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
161823537|NCT05212948|584396223|FG000|Initial Vaccination Period|Pregnancy|20|||
161823538|NCT05212948|584396224|FG001|Initial Vaccination Period|Pregnancy|14|||
161823539|NCT05212948|584396223|FG000|Initial Vaccination Period|Physician Decision|686|||
161823540|NCT05212948|584396224|FG001|Initial Vaccination Period|Physician Decision|401|||
161823541|NCT05212948|584396223|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
161823542|NCT05212948|584396224|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
161823543|NCT05212948|584396223|FG000|Initial Vaccination Period|Death|23|||
161823544|NCT05212948|584396224|FG001|Initial Vaccination Period|Death|18|||
161823545|NCT05212948|584396223|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
161823546|NCT05212948|584396224|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
161823547|NCT05212948|584396223|FG000|Initial Vaccination Period|Adverse Event|36|||
161823548|NCT05212948|584396224|FG001|Initial Vaccination Period|Adverse Event|23|||
161823549|NCT05212948|584396223|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
161823550|NCT05212948|584396224|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
161823551|NCT05212948|584396223|FG000|Crossover Vaccination Period|Pregnancy|6|||
161823552|NCT05212948|584396224|FG001|Crossover Vaccination Period|Pregnancy|1|||
161823553|NCT05212948|584396223|FG000|Crossover Vaccination Period|Physician Decision|49|||
161823554|NCT05212948|584396224|FG001|Crossover Vaccination Period|Physician Decision|24|||
161823555|NCT05212948|584396223|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
161823556|NCT05212948|584396224|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
161823557|NCT05212948|584396223|FG000|Crossover Vaccination Period|Death|10|||
161823558|NCT05212948|584396224|FG001|Crossover Vaccination Period|Death|5|||
161823559|NCT05212948|584396223|FG000|Crossover Vaccination Period|Adverse Event|9|||
161823560|NCT05212948|584396224|FG001|Crossover Vaccination Period|Adverse Event|4|||
161823561|NCT05347693|584396225|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
161823562|NCT05347693|584396226|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
161823563|NCT05347693|584396227|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
161823564|NCT05347693|584396225|FG000|Inpatient Period|Withdrawal of consent|10|||
161823565|NCT05347693|584396226|FG001|Inpatient Period|Withdrawal of consent|0|||
161823566|NCT05347693|584396227|FG002|Inpatient Period|Withdrawal of consent|0|||
161823567|NCT05347693|584396225|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
161823568|NCT05347693|584396226|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
161823569|NCT05347693|584396227|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
161823570|NCT05347693|584396225|FG000|Inpatient Period|Screening Failure|8|||
161823571|NCT05347693|584396226|FG001|Inpatient Period|Screening Failure|0|||
161823572|NCT05347693|584396227|FG002|Inpatient Period|Screening Failure|0|||
161823573|NCT05347693|584396225|FG000|Inpatient Period|Death|2|||
161823574|NCT05347693|584396226|FG001|Inpatient Period|Death|0|||
161823575|NCT05347693|584396227|FG002|Inpatient Period|Death|0|||
161823576|NCT05347693|584396225|FG000|Inpatient Period|Physician Decision|5|||
161823577|NCT05347693|584396226|FG001|Inpatient Period|Physician Decision|0|||
161823578|NCT05347693|584396227|FG002|Inpatient Period|Physician Decision|0|||
161823579|NCT05347693|584396225|FG000|Inpatient Period|Adverse Event|3|||
161823580|NCT05347693|584396226|FG001|Inpatient Period|Adverse Event|0|||
161823581|NCT05347693|584396227|FG002|Inpatient Period|Adverse Event|0|||
161823582|NCT05347693|584396225|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
161823583|NCT05347693|584396226|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
161823584|NCT05347693|584396227|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
161823585|NCT05347693|584396225|FG000|Outpatient Period|Adverse Event|0|||
161823586|NCT05347693|584396226|FG001|Outpatient Period|Adverse Event|9|||
161823587|NCT05347693|584396227|FG002|Outpatient Period|Adverse Event|0|||
161823588|NCT05347693|584396225|FG000|Outpatient Period|Death|0|||
161823589|NCT05347693|584396226|FG001|Outpatient Period|Death|6|||
161823590|NCT05347693|584396227|FG002|Outpatient Period|Death|2|||
161823591|NCT05347693|584396225|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
161823592|NCT05347693|584396226|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
161931195|NCT00281580|584796439|FG013|Overall Study|Protocol Violation|1|||
161931196|NCT00281580|584796440|FG014|Overall Study|Protocol Violation|1|||
161931197|NCT00281580|584796441|FG015|Overall Study|Protocol Violation|3|||
161931198|NCT00281580|584796426|FG000|Overall Study|Withdrawal by Subject|3|||
161931199|NCT00281580|584796427|FG001|Overall Study|Withdrawal by Subject|0|||
161931200|NCT00281580|584796428|FG002|Overall Study|Withdrawal by Subject|1|||
161931201|NCT00281580|584796429|FG003|Overall Study|Withdrawal by Subject|1|||
161931202|NCT00281580|584796430|FG004|Overall Study|Withdrawal by Subject|1|||
161931203|NCT00281580|584796431|FG005|Overall Study|Withdrawal by Subject|2|||
161931204|NCT00281580|584796432|FG006|Overall Study|Withdrawal by Subject|2|||
161931205|NCT00281580|584796433|FG007|Overall Study|Withdrawal by Subject|0|||
161931206|NCT00281580|584796434|FG008|Overall Study|Withdrawal by Subject|1|||
161931207|NCT00281580|584796435|FG009|Overall Study|Withdrawal by Subject|4|||
161931208|NCT00281580|584796436|FG010|Overall Study|Withdrawal by Subject|1|||
161931209|NCT00281580|584796437|FG011|Overall Study|Withdrawal by Subject|1|||
161931210|NCT00281580|584796438|FG012|Overall Study|Withdrawal by Subject|2|||
161931211|NCT00281580|584796439|FG013|Overall Study|Withdrawal by Subject|2|||
161931212|NCT00281580|584796440|FG014|Overall Study|Withdrawal by Subject|1|||
161931213|NCT00281580|584796441|FG015|Overall Study|Withdrawal by Subject|5|||
161931214|NCT00281580|584796426|FG000|Overall Study|Lack of Efficacy|2|||
161931215|NCT00281580|584796427|FG001|Overall Study|Lack of Efficacy|1|||
161931216|NCT00281580|584796428|FG002|Overall Study|Lack of Efficacy|1|||
161931217|NCT00281580|584796429|FG003|Overall Study|Lack of Efficacy|6|||
161931218|NCT00281580|584796430|FG004|Overall Study|Lack of Efficacy|2|||
161931219|NCT00281580|584796431|FG005|Overall Study|Lack of Efficacy|0|||
161931220|NCT00281580|584796432|FG006|Overall Study|Lack of Efficacy|0|||
161931221|NCT00281580|584796433|FG007|Overall Study|Lack of Efficacy|0|||
161931222|NCT00281580|584796434|FG008|Overall Study|Lack of Efficacy|0|||
161931223|NCT00281580|584796435|FG009|Overall Study|Lack of Efficacy|0|||
161931224|NCT00281580|584796436|FG010|Overall Study|Lack of Efficacy|0|||
161931225|NCT00281580|584796437|FG011|Overall Study|Lack of Efficacy|1|||
161931226|NCT00281580|584796438|FG012|Overall Study|Lack of Efficacy|0|||
161931227|NCT00281580|584796439|FG013|Overall Study|Lack of Efficacy|2|||
161931228|NCT00281580|584796440|FG014|Overall Study|Lack of Efficacy|1|||
161931229|NCT00281580|584796441|FG015|Overall Study|Lack of Efficacy|0|||
161931230|NCT00281580|584796426|FG000|Overall Study|Lost to Follow-up|0|||
161931231|NCT00281580|584796427|FG001|Overall Study|Lost to Follow-up|0|||
161931232|NCT00281580|584796428|FG002|Overall Study|Lost to Follow-up|0|||
161931233|NCT00281580|584796429|FG003|Overall Study|Lost to Follow-up|3|||
161931234|NCT00281580|584796430|FG004|Overall Study|Lost to Follow-up|0|||
161931235|NCT00281580|584796431|FG005|Overall Study|Lost to Follow-up|1|||
161931236|NCT00281580|584796432|FG006|Overall Study|Lost to Follow-up|0|||
161931237|NCT00281580|584796433|FG007|Overall Study|Lost to Follow-up|1|||
161931238|NCT00281580|584796434|FG008|Overall Study|Lost to Follow-up|2|||
161931239|NCT00281580|584796435|FG009|Overall Study|Lost to Follow-up|1|||
161931240|NCT00281580|584796436|FG010|Overall Study|Lost to Follow-up|1|||
161931241|NCT00281580|584796437|FG011|Overall Study|Lost to Follow-up|0|||
161931242|NCT00281580|584796438|FG012|Overall Study|Lost to Follow-up|1|||
161931243|NCT00281580|584796439|FG013|Overall Study|Lost to Follow-up|0|||
161931244|NCT00281580|584796440|FG014|Overall Study|Lost to Follow-up|0|||
161931245|NCT00281580|584796441|FG015|Overall Study|Lost to Follow-up|0|||
161931246|NCT00281580|584796426|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
161931247|NCT00281580|584796427|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
161931248|NCT00281580|584796428|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
161931249|NCT00281580|584796429|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
161931250|NCT00281580|584796430|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
161931251|NCT00281580|584796431|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
161931252|NCT00281580|584796432|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
161931253|NCT00281580|584796433|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
161931254|NCT00281580|584796434|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
161931255|NCT00281580|584796435|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
161931256|NCT00281580|584796436|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
161931257|NCT00281580|584796437|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
161931258|NCT00281580|584796438|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
161931259|NCT00281580|584796439|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
161931260|NCT00281580|584796440|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
161931261|NCT00281580|584796441|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
161931262|NCT05463705|584796442|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
161931263|NCT05463705|584796443|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
161931264|NCT05463705|584796444|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
161931265|NCT05463705|584796445|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
161931266|NCT05463705|584796446|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
161931267|NCT05463705|584796447|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
161931268|NCT03071965|584796448|FG000|Overall Study|Adverse Event|0|||
161931269|NCT03071965|584796449|FG001|Overall Study|Adverse Event|0|||
161931270|NCT03071965|584796450|FG002|Overall Study|Adverse Event|1|||
161931271|NCT03071965|584796451|FG003|Overall Study|Adverse Event|0|||
161931272|NCT03071965|584796448|FG000|Overall Study|Death|0|||
161931273|NCT03071965|584796449|FG001|Overall Study|Death|0|||
161931274|NCT03071965|584796450|FG002|Overall Study|Death|1|||
161823593|NCT05347693|584396227|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
161823594|NCT05347693|584396225|FG000|Outpatient Period|Lost to Follow-up|0|||
161823595|NCT05347693|584396226|FG001|Outpatient Period|Lost to Follow-up|0|||
161931275|NCT03071965|584796451|FG003|Overall Study|Death|1|||
161931276|NCT03071965|584796448|FG000|Overall Study|COVID-19|0|||
161931277|NCT03071965|584796449|FG001|Overall Study|COVID-19|1|||
161931278|NCT03071965|584796450|FG002|Overall Study|COVID-19|0|||
161931279|NCT03071965|584796451|FG003|Overall Study|COVID-19|1|||
161931280|NCT03071965|584796448|FG000|Overall Study|Other Health Reason|0|||
161931281|NCT03071965|584796449|FG001|Overall Study|Other Health Reason|0|||
161931282|NCT03071965|584796450|FG002|Overall Study|Other Health Reason|0|||
161931283|NCT03071965|584796451|FG003|Overall Study|Other Health Reason|1|||
161931284|NCT05529173|584796452|FG000|Overall Study|Physician Decision|3|||
161931285|NCT05529173|584796453|FG001|Overall Study|Physician Decision|6|||
161931286|NCT05529173|584796452|FG000|Overall Study|Sample shipment delay more than one day|4|||
161931287|NCT05529173|584796453|FG001|Overall Study|Sample shipment delay more than one day|0|||
161931288|NCT03760081|584796456|FG000|Overall Study|Miscellaneous|0|||
161931289|NCT03760081|584796457|FG001|Overall Study|Miscellaneous|1|||
161931290|NCT03760081|584796456|FG000|Overall Study|Progressive Disease|5|||
161931291|NCT03760081|584796457|FG001|Overall Study|Progressive Disease|10|||
161931292|NCT03760081|584796456|FG000|Overall Study|Death|1|||
161931293|NCT03760081|584796457|FG001|Overall Study|Death|1|||
161931294|NCT02662582|584796458|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
161931295|NCT02662582|584796459|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
161931296|NCT02662582|584796458|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
161931297|NCT02662582|584796459|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
161931298|NCT02662582|584796458|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
161931299|NCT02662582|584796459|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
161931300|NCT02662582|584796458|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161931301|NCT02662582|584796459|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161931302|NCT04034056|584796460|FG000|Overall Study|Withdrawal by Subject|2|||
161931303|NCT04034056|584796460|FG000|Overall Study|Reason Not Specified|13|||
161931304|NCT04034056|584796460|FG000|Overall Study|Adverse Event|56|||
161931305|NCT04135352|584796461|FG000|Overall Study|Not treated-randomization error|0|||
161931306|NCT04135352|584796462|FG001|Overall Study|Not treated-randomization error|0|||
161931307|NCT04135352|584796463|FG002|Overall Study|Not treated-randomization error|1|||
161931308|NCT04135352|584796464|FG003|Overall Study|Not treated-randomization error|0|||
161931309|NCT04135352|584796465|FG004|Overall Study|Not treated-randomization error|0|||
162202810|NCT03544229|585792675|FG000|Overall Study|Protocol Deviation|0|||
162202811|NCT03544229|585792676|FG001|Overall Study|Protocol Deviation|0|||
162202812|NCT03544229|585792677|FG002|Overall Study|Protocol Deviation|1|||
162202813|NCT03544229|585792678|FG003|Overall Study|Protocol Deviation|0|||
162202814|NCT03544229|585792675|FG000|Overall Study|Lost to Follow-up|3|||
162202815|NCT03544229|585792676|FG001|Overall Study|Lost to Follow-up|0|||
162202816|NCT03544229|585792677|FG002|Overall Study|Lost to Follow-up|0|||
162202817|NCT03544229|585792678|FG003|Overall Study|Lost to Follow-up|2|||
162202818|NCT03544229|585792675|FG000|Overall Study|Voluntary Withdrawal|2|||
162202819|NCT03544229|585792676|FG001|Overall Study|Voluntary Withdrawal|1|||
162202820|NCT03544229|585792677|FG002|Overall Study|Voluntary Withdrawal|3|||
161823596|NCT05347693|584396227|FG002|Outpatient Period|Lost to Follow-up|1|||
161823597|NCT05347693|584396225|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
161823598|NCT05347693|584396226|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
161823599|NCT05347693|584396227|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
161823600|NCT05347693|584396225|FG000|Outpatient Period|Scheduled hemodialysis|0|||
161823601|NCT05347693|584396226|FG001|Outpatient Period|Scheduled hemodialysis|1|||
161823602|NCT05347693|584396227|FG002|Outpatient Period|Scheduled hemodialysis|0|||
161931310|NCT04135352|584796466|FG005|Overall Study|Not treated-randomization error|0|||
161931311|NCT04135352|584796467|FG006|Overall Study|Not treated-randomization error|0|||
161931312|NCT04135352|584796468|FG007|Overall Study|Not treated-randomization error|0|||
161931313|NCT04135352|584796461|FG000|Overall Study|Withdrawal by Subject|0|||
161931314|NCT04135352|584796462|FG001|Overall Study|Withdrawal by Subject|0|||
161931315|NCT04135352|584796463|FG002|Overall Study|Withdrawal by Subject|2|||
161931316|NCT04135352|584796464|FG003|Overall Study|Withdrawal by Subject|0|||
162202821|NCT03544229|585792678|FG003|Overall Study|Voluntary Withdrawal|0|||
162202822|NCT03544229|585792675|FG000|Overall Study|Lack of Efficacy|0|||
162202823|NCT03544229|585792676|FG001|Overall Study|Lack of Efficacy|1|||
162202824|NCT03544229|585792677|FG002|Overall Study|Lack of Efficacy|0|||
161823603|NCT05347693|584396225|FG000|Outpatient Period|Severe HK|0|||
161823604|NCT05347693|584396226|FG001|Outpatient Period|Severe HK|0|||
161823605|NCT05347693|584396227|FG002|Outpatient Period|Severe HK|1|||
161823606|NCT05347693|584396225|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
161823607|NCT05347693|584396226|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
161823608|NCT05347693|584396227|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
161823609|NCT05347693|584396225|FG000|Outpatient Period|Start of dialysis|0|||
161823610|NCT05347693|584396226|FG001|Outpatient Period|Start of dialysis|0|||
161823611|NCT05347693|584396227|FG002|Outpatient Period|Start of dialysis|1|||
161823612|NCT05347693|584396225|FG000|Outpatient Period|The participant entered hemodialysis|0|||
161823613|NCT05347693|584396226|FG001|Outpatient Period|The participant entered hemodialysis|0|||
161823614|NCT05347693|584396227|FG002|Outpatient Period|The participant entered hemodialysis|1|||
161823615|NCT05347693|584396225|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
161823616|NCT05347693|584396226|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
161823617|NCT05347693|584396227|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
161823618|NCT05347693|584396225|FG000|Outpatient Period|Withdrawal by Subject|0|||
161823619|NCT05347693|584396226|FG001|Outpatient Period|Withdrawal by Subject|8|||
161823620|NCT05347693|584396227|FG002|Outpatient Period|Withdrawal by Subject|5|||
161823621|NCT01755975|584396228|FG000|Overall Study|Adverse Event|0|||
161823622|NCT01755975|584396229|FG001|Overall Study|Adverse Event|0|||
161823623|NCT01755975|584396230|FG002|Overall Study|Adverse Event|1|||
161823624|NCT01755975|584396231|FG003|Overall Study|Adverse Event|0|||
161823625|NCT01755975|584396232|FG004|Overall Study|Adverse Event|2|||
161823626|NCT01597479|584396233|FG000|Overall Study|Protocol Violation|1|||
161823627|NCT01597479|584396234|FG001|Overall Study|Protocol Violation|0|||
161823628|NCT01597479|584396233|FG000|Overall Study|Lost to Follow-up|1|||
161823629|NCT01597479|584396234|FG001|Overall Study|Lost to Follow-up|0|||
161823630|NCT02167594|584396235|FG000|Overall Study|Withdrawal by Subject|2|||
161823631|NCT02167594|584396236|FG001|Overall Study|Withdrawal by Subject|0|||
161823632|NCT02167594|584396237|FG002|Overall Study|Withdrawal by Subject|0|||
161823633|NCT02167594|584396235|FG000|Overall Study|Death|0|||
161823634|NCT02167594|584396236|FG001|Overall Study|Death|1|||
161823635|NCT02167594|584396237|FG002|Overall Study|Death|0|||
161823636|NCT02340780|584396238|FG000|Overall Study|Ineligible|1|||
161823637|NCT02858037|584396241|FG000|Overall Study|Death|1|||
161823638|NCT02858037|584396241|FG000|Overall Study|Withdrawal by Subject|18|||
161823639|NCT02858037|584396241|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
161823640|NCT02858037|584396241|FG000|Overall Study|Lost to Follow-up|3|||
161823641|NCT02858037|584396241|FG000|Overall Study|Other|4|||
161823642|NCT04320745|584396246|FG000|Overall Study|Adverse Event|26|||
161823643|NCT04320745|584396246|FG000|Overall Study|Withdrawal by Subject|4|||
161823644|NCT04320745|584396246|FG000|Overall Study|Lost to Follow-up|12|||
161823645|NCT04320745|584396246|FG000|Overall Study|Protocol Deviation|2|||
161823646|NCT04320745|584396246|FG000|Overall Study|Non-compliance With Study Drug|2|||
161823647|NCT04320745|584396246|FG000|Overall Study|Reason Not Specified|1|||
161823648|NCT01685008|584396249|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
161823649|NCT01685008|584396250|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
161823650|NCT01685008|584396251|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
161823651|NCT01685008|584396252|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
161823652|NCT01685008|584396249|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
161823653|NCT01685008|584396250|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
161823654|NCT01685008|584396251|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
161823655|NCT01685008|584396252|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
161823656|NCT01685008|584396249|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
161823657|NCT01685008|584396250|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
161823658|NCT01685008|584396251|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
161823659|NCT01685008|584396252|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
162202825|NCT03544229|585792678|FG003|Overall Study|Lack of Efficacy|0|||
162202826|NCT01836198|585792679|FG000|Part A, Period 2|Protocol Violation|0|||
161823660|NCT01685008|584396249|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
161823661|NCT01685008|584396250|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
161823662|NCT01685008|584396251|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
161823663|NCT01685008|584396252|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
161823664|NCT01685008|584396249|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
161823665|NCT01685008|584396250|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
161823666|NCT01685008|584396251|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
161823667|NCT01685008|584396252|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
161823668|NCT01963260|584396256|FG000|Overall Study|Withdrawal by Subject|2|||
161823669|NCT01963260|584396257|FG001|Overall Study|Withdrawal by Subject|0|||
161823670|NCT01963260|584396258|FG002|Overall Study|Withdrawal by Subject|0|||
161823671|NCT01963260|584396259|FG003|Overall Study|Withdrawal by Subject|1|||
161823672|NCT01963260|584396260|FG004|Overall Study|Withdrawal by Subject|2|||
161823673|NCT01963260|584396261|FG005|Overall Study|Withdrawal by Subject|0|||
161931317|NCT04135352|584796465|FG004|Overall Study|Withdrawal by Subject|0|||
161931318|NCT04135352|584796466|FG005|Overall Study|Withdrawal by Subject|0|||
161931319|NCT04135352|584796467|FG006|Overall Study|Withdrawal by Subject|0|||
161931320|NCT04135352|584796468|FG007|Overall Study|Withdrawal by Subject|0|||
161931321|NCT04135352|584796461|FG000|Overall Study|Sponsor Decision|0|||
161931322|NCT04135352|584796462|FG001|Overall Study|Sponsor Decision|0|||
161931323|NCT04135352|584796463|FG002|Overall Study|Sponsor Decision|2|||
161931324|NCT04135352|584796464|FG003|Overall Study|Sponsor Decision|5|||
161931325|NCT04135352|584796465|FG004|Overall Study|Sponsor Decision|1|||
161931326|NCT04135352|584796466|FG005|Overall Study|Sponsor Decision|4|||
161931327|NCT04135352|584796467|FG006|Overall Study|Sponsor Decision|0|||
161931328|NCT04135352|584796468|FG007|Overall Study|Sponsor Decision|0|||
161931329|NCT04135352|584796461|FG000|Overall Study|Physician Decision|0|||
161931330|NCT04135352|584796462|FG001|Overall Study|Physician Decision|0|||
161931331|NCT04135352|584796463|FG002|Overall Study|Physician Decision|1|||
161931332|NCT04135352|584796464|FG003|Overall Study|Physician Decision|0|||
161931333|NCT04135352|584796465|FG004|Overall Study|Physician Decision|1|||
162202827|NCT01836198|585792680|FG001|Part A, Period 2|Protocol Violation|1|||
162202828|NCT01836198|585792681|FG002|Part A, Period 2|Protocol Violation|0|||
162202829|NCT03187353|585792682|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
162202830|NCT03187353|585792683|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
162202831|NCT03187353|585792682|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
162202832|NCT03187353|585792683|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
162202833|NCT03187353|585792682|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
162202834|NCT03187353|585792683|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
162202835|NCT03187353|585792682|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
162202836|NCT03187353|585792683|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
162202837|NCT03187353|585792682|FG000|Washout (2 Weeks)|Adverse Event|2|||
162202838|NCT03187353|585792683|FG001|Washout (2 Weeks)|Adverse Event|0|||
161823674|NCT01963260|584396262|FG006|Overall Study|Withdrawal by Subject|0|||
161823675|NCT01963260|584396263|FG007|Overall Study|Withdrawal by Subject|0|||
161823676|NCT01963260|584396264|FG008|Overall Study|Withdrawal by Subject|0|||
161823677|NCT01963260|584396265|FG009|Overall Study|Withdrawal by Subject|0|||
161823678|NCT02340962|584396266|FG000|Overall Study|Lost to Follow-up|1|||
161823679|NCT02340962|584396267|FG001|Overall Study|Lost to Follow-up|0|||
161823680|NCT04994431|584396268|FG000|Overall Study|Adverse Event|1|||
161823681|NCT04994431|584396269|FG001|Overall Study|Adverse Event|0|||
161823682|NCT02151149|584396273|FG000|Treatment Period|Death|2|||
161823683|NCT02151149|584396274|FG001|Treatment Period|Death|3|||
161823684|NCT02151149|584396273|FG000|Treatment Period|Adverse Event|17|||
161823685|NCT02151149|584396274|FG001|Treatment Period|Adverse Event|14|||
161823686|NCT02151149|584396273|FG000|Treatment Period|Progressive Disease|25|||
161823687|NCT02151149|584396274|FG001|Treatment Period|Progressive Disease|24|||
161823688|NCT02151149|584396273|FG000|Treatment Period|Symptomatic Deterioration|2|||
161823689|NCT02151149|584396274|FG001|Treatment Period|Symptomatic Deterioration|10|||
161823690|NCT02151149|584396273|FG000|Treatment Period|Withdrawal by Subject|13|||
161823691|NCT02151149|584396274|FG001|Treatment Period|Withdrawal by Subject|11|||
161823692|NCT02151149|584396273|FG000|Treatment Period|Miscellaneous|8|||
161823693|NCT02151149|584396274|FG001|Treatment Period|Miscellaneous|7|||
161823694|NCT02151149|584396273|FG000|Treatment Period|Participants randomized but not treated|3|||
161823695|NCT02151149|584396274|FG001|Treatment Period|Participants randomized but not treated|2|||
161823696|NCT02151149|584396273|FG000|Follow-Up Period|Lost to Follow-up|2|||
161823697|NCT02151149|584396274|FG001|Follow-Up Period|Lost to Follow-up|3|||
161823698|NCT02151149|584396273|FG000|Follow-Up Period|Death|37|||
161823699|NCT02151149|584396274|FG001|Follow-Up Period|Death|34|||
161823700|NCT03419962|584396278|FG000|Overall Study|Change to other medication|1|||
161823701|NCT03419962|584396278|FG000|Overall Study|Refusal of continuing with trial drug|1|||
161823702|NCT03419962|584396278|FG000|Overall Study|Lost to Follow-up|3|||
161823703|NCT03419962|584396278|FG000|Overall Study|Difficulty in inhaling the doses|1|||
161823704|NCT03419962|584396278|FG000|Overall Study|Missing completion data|31|||
161823705|NCT03439085|584396279|FG000|Overall Study|Death|2|||
161823706|NCT03439085|584396279|FG000|Overall Study|Screen Failure|20|||
161823707|NCT02224053|584396280|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
161823708|NCT02224053|584396280|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
161823709|NCT02224053|584396280|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
161823710|NCT02224053|584396280|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
161823711|NCT02224053|584396280|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
161823712|NCT01898598|584396284|FG000|Overall Study|Adverse Event|1|||
161823713|NCT01898598|584396285|FG001|Overall Study|Adverse Event|0|||
161823714|NCT01898598|584396284|FG000|Overall Study|Withdrawal by Subject|3|||
161823715|NCT01898598|584396285|FG001|Overall Study|Withdrawal by Subject|0|||
161823716|NCT01898598|584396284|FG000|Overall Study|Lost to Follow-up|0|||
161931334|NCT04135352|584796466|FG005|Overall Study|Physician Decision|0|||
161931335|NCT04135352|584796467|FG006|Overall Study|Physician Decision|0|||
161931336|NCT04135352|584796468|FG007|Overall Study|Physician Decision|0|||
161931337|NCT04135352|584796461|FG000|Overall Study|Death|3|||
161931338|NCT04135352|584796462|FG001|Overall Study|Death|4|||
161931339|NCT04135352|584796463|FG002|Overall Study|Death|7|||
161931340|NCT04135352|584796464|FG003|Overall Study|Death|0|||
161931341|NCT04135352|584796465|FG004|Overall Study|Death|3|||
161931342|NCT04135352|584796466|FG005|Overall Study|Death|1|||
161931343|NCT04135352|584796467|FG006|Overall Study|Death|0|||
161931344|NCT04135352|584796468|FG007|Overall Study|Death|0|||
161931345|NCT01210443|584796469|FG000|Overall Study|Study terminated by sponsor|2|||
161931346|NCT02807181|584796470|FG000|Overall Study|Death|28|||
161931347|NCT02807181|584796471|FG001|Overall Study|Death|24|||
161931348|NCT02807181|584796470|FG000|Overall Study|Withdrawal by Subject|1|||
161931349|NCT02807181|584796471|FG001|Overall Study|Withdrawal by Subject|1|||
161931350|NCT02807181|584796470|FG000|Overall Study|Lost to Follow-up|0|||
161931351|NCT02807181|584796471|FG001|Overall Study|Lost to Follow-up|2|||
161931352|NCT02807181|584796470|FG000|Overall Study|Subject decision|1|||
161931353|NCT02807181|584796471|FG001|Overall Study|Subject decision|0|||
161931354|NCT02807181|584796470|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
161931355|NCT02807181|584796471|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
161931356|NCT02807181|584796470|FG000|Overall Study|In Study|3|||
161931357|NCT02807181|584796471|FG001|Overall Study|In Study|3|||
161931358|NCT02807181|584796470|FG000|Overall Study|Post Progression|3|||
161931359|NCT02807181|584796471|FG001|Overall Study|Post Progression|2|||
161931360|NCT01452789|584796476|FG000|Overall Study|Withdrawal by Subject|3|||
161931361|NCT01452789|584796477|FG001|Overall Study|Withdrawal by Subject|2|||
161931362|NCT00066170|584796478|FG000|Overall Study|Adverse Event|2|||
161931363|NCT00066170|584796479|FG001|Overall Study|Adverse Event|4|||
161931364|NCT00066170|584796480|FG002|Overall Study|Adverse Event|1|||
161931365|NCT00066170|584796481|FG003|Overall Study|Adverse Event|7|||
161931366|NCT00066170|584796478|FG000|Overall Study|Serious Adverse Event|0|||
161931367|NCT00066170|584796479|FG001|Overall Study|Serious Adverse Event|0|||
161931368|NCT00066170|584796480|FG002|Overall Study|Serious Adverse Event|1|||
161931369|NCT00066170|584796481|FG003|Overall Study|Serious Adverse Event|1|||
161931370|NCT00066170|584796478|FG000|Overall Study|Lost to Follow-up|0|||
161931371|NCT00066170|584796479|FG001|Overall Study|Lost to Follow-up|1|||
161931372|NCT00066170|584796480|FG002|Overall Study|Lost to Follow-up|0|||
161931373|NCT00066170|584796481|FG003|Overall Study|Lost to Follow-up|0|||
161931374|NCT00066170|584796478|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
161931375|NCT00066170|584796479|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
161931376|NCT00066170|584796480|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
161931377|NCT00066170|584796481|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
162202839|NCT03187353|585792682|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
162202840|NCT03187353|585792683|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
162202841|NCT02460562|585792686|FG000|Overall Study|Lost to Follow-up|15|||
162202842|NCT02460562|585792687|FG001|Overall Study|Lost to Follow-up|16|||
162202843|NCT01061775|585792688|FG000|Overall Study|Physician Decision|2|||
162202844|NCT01061775|585792688|FG000|Overall Study|Lost to Follow-up|1|||
162202845|NCT01924806|585792693|FG000|Overall Study|Physician Decision|2|||
162202846|NCT01924806|585792694|FG001|Overall Study|Physician Decision|1|||
162202847|NCT01954771|585792695|FG000|Overall Study|Missing HbA1c of end-point|1|||
161676967|NCT01514136|583870626|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
161676968|NCT01514136|583870627|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
161823717|NCT01898598|584396285|FG001|Overall Study|Lost to Follow-up|1|||
161823718|NCT01898598|584396284|FG000|Overall Study|Other|0|||
161823719|NCT01898598|584396285|FG001|Overall Study|Other|1|||
161823720|NCT03833427|584396286|FG000|Overall Study|Death|4|||
161823721|NCT03833427|584396287|FG001|Overall Study|Death|2|||
161823722|NCT03833427|584396288|FG002|Overall Study|Death|9|||
161823723|NCT03833427|584396289|FG003|Overall Study|Death|11|||
161823724|NCT03833427|584396290|FG004|Overall Study|Death|0|||
161823725|NCT03833427|584396291|FG005|Overall Study|Death|0|||
161823726|NCT03833427|584396292|FG006|Overall Study|Death|0|||
161823727|NCT03833427|584396286|FG000|Overall Study|Withdrawal by Subject|0|||
161823728|NCT03833427|584396287|FG001|Overall Study|Withdrawal by Subject|1|||
161823729|NCT03833427|584396288|FG002|Overall Study|Withdrawal by Subject|1|||
161823730|NCT03833427|584396289|FG003|Overall Study|Withdrawal by Subject|0|||
161823731|NCT03833427|584396290|FG004|Overall Study|Withdrawal by Subject|0|||
161823732|NCT03833427|584396291|FG005|Overall Study|Withdrawal by Subject|0|||
161823733|NCT03833427|584396292|FG006|Overall Study|Withdrawal by Subject|0|||
161823734|NCT03833427|584396286|FG000|Overall Study|Sponsor Decision|0|||
161931378|NCT00066170|584796478|FG000|Overall Study|Protocol Violation|3|||
161931379|NCT00066170|584796479|FG001|Overall Study|Protocol Violation|0|||
161931380|NCT00066170|584796480|FG002|Overall Study|Protocol Violation|0|||
161931381|NCT00066170|584796481|FG003|Overall Study|Protocol Violation|0|||
161931382|NCT00066170|584796478|FG000|Overall Study|Other|1|||
161931383|NCT00066170|584796479|FG001|Overall Study|Other|5|||
161931384|NCT00066170|584796480|FG002|Overall Study|Other|2|||
161931385|NCT00066170|584796481|FG003|Overall Study|Other|0|||
161931386|NCT01089543|584796484|FG000|Overall Study|Withdrawal by Subject|2|||
162202848|NCT01954771|585792696|FG001|Overall Study|Missing HbA1c of end-point|1|||
161931387|NCT01089543|584796485|FG001|Overall Study|Withdrawal by Subject|3|||
161931388|NCT01089543|584796486|FG002|Overall Study|Withdrawal by Subject|3|||
161931389|NCT01089543|584796487|FG003|Overall Study|Withdrawal by Subject|1|||
161931390|NCT01089543|584796484|FG000|Overall Study|Physician Decision|1|||
161931391|NCT01089543|584796485|FG001|Overall Study|Physician Decision|0|||
161931392|NCT01089543|584796486|FG002|Overall Study|Physician Decision|0|||
161931393|NCT01089543|584796487|FG003|Overall Study|Physician Decision|1|||
161931394|NCT01089543|584796484|FG000|Overall Study|Adverse Event|0|||
161931395|NCT01089543|584796485|FG001|Overall Study|Adverse Event|1|||
161931396|NCT01089543|584796486|FG002|Overall Study|Adverse Event|0|||
161931397|NCT01089543|584796487|FG003|Overall Study|Adverse Event|0|||
161931398|NCT00452530|584796488|FG000|Overall Study|Death|1|||
161931399|NCT00452530|584796489|FG001|Overall Study|Death|0|||
161931400|NCT00452530|584796488|FG000|Overall Study|Adverse Event|40|||
161931401|NCT00452530|584796489|FG001|Overall Study|Adverse Event|44|||
161931402|NCT00452530|584796488|FG000|Overall Study|Withdrawal by Subject|68|||
161931403|NCT00452530|584796489|FG001|Overall Study|Withdrawal by Subject|57|||
161931404|NCT00452530|584796488|FG000|Overall Study|Lost to Follow-up|1|||
161931405|NCT00452530|584796489|FG001|Overall Study|Lost to Follow-up|0|||
161931406|NCT00452530|584796488|FG000|Overall Study|Poor compliance/noncompliance|1|||
161931407|NCT00452530|584796489|FG001|Overall Study|Poor compliance/noncompliance|2|||
161931408|NCT00452530|584796488|FG000|Overall Study|No longer met study criteria|18|||
161931409|NCT00452530|584796489|FG001|Overall Study|No longer met study criteria|22|||
161931410|NCT00452530|584796488|FG000|Overall Study|Other|7|||
161931411|NCT00452530|584796489|FG001|Overall Study|Other|11|||
161931412|NCT00754559|584796491|FG000|Overall Study|Adverse Event|15|||
161931413|NCT00754559|584796491|FG000|Overall Study|Protocol Violation|11|||
161931414|NCT00754559|584796491|FG000|Overall Study|Lack of Efficacy|10|||
161931415|NCT00754559|584796491|FG000|Overall Study|Lost to Follow-up|2|||
161931416|NCT00754559|584796491|FG000|Overall Study|Administrative reason|1|||
161931417|NCT00754559|584796491|FG000|Overall Study|Other|5|||
161931418|NCT00754559|584796491|FG000|Overall Study|Withdrawal by Subject|3|||
161931419|NCT01248468|584796492|FG000|Overall Study|Administrative problem|1|||
161931420|NCT01248468|584796493|FG001|Overall Study|Administrative problem|0|||
161931421|NCT01248468|584796494|FG002|Overall Study|Administrative problem|0|||
161931422|NCT01248468|584796492|FG000|Overall Study|Lost to Follow-up|9|||
161931423|NCT01248468|584796493|FG001|Overall Study|Lost to Follow-up|12|||
161931424|NCT01248468|584796494|FG002|Overall Study|Lost to Follow-up|4|||
162202849|NCT01954771|585792697|FG002|Overall Study|Missing HbA1c of end-point|0|||
162202850|NCT01954771|585792695|FG000|Overall Study|Missing CGMS of end-point|1|||
162202851|NCT01954771|585792696|FG001|Overall Study|Missing CGMS of end-point|1|||
162202852|NCT01954771|585792697|FG002|Overall Study|Missing CGMS of end-point|0|||
162202853|NCT01954771|585792695|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
162202854|NCT01954771|585792696|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
162202855|NCT01954771|585792697|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
162202856|NCT03635775|585792701|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
162202857|NCT03635775|585792702|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
162202858|NCT03635775|585792703|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
162202859|NCT03635775|585792704|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
162202860|NCT01026103|585792705|FG000|Overall Study|Physician Decision|1|||
162202861|NCT01026103|585792705|FG000|Overall Study|did not receive study device bc of error|1|||
161931425|NCT01248468|584796492|FG000|Overall Study|Pregnancy|1|||
161931426|NCT01248468|584796493|FG001|Overall Study|Pregnancy|0|||
161931427|NCT01248468|584796494|FG002|Overall Study|Pregnancy|0|||
161931428|NCT01248468|584796492|FG000|Overall Study|Withdrawal by Subject|4|||
161931429|NCT01248468|584796493|FG001|Overall Study|Withdrawal by Subject|2|||
161931430|NCT01248468|584796494|FG002|Overall Study|Withdrawal by Subject|0|||
161931431|NCT02191397|584796495|FG000|Overall Study|Adverse Event|28|||
161931432|NCT02191397|584796496|FG001|Overall Study|Adverse Event|17|||
161931433|NCT02191397|584796495|FG000|Overall Study|Lack of Efficacy|10|||
161931434|NCT02191397|584796496|FG001|Overall Study|Lack of Efficacy|5|||
161931435|NCT02191397|584796495|FG000|Overall Study|Protocol Violation|0|||
161931436|NCT02191397|584796496|FG001|Overall Study|Protocol Violation|3|||
161931437|NCT02191397|584796495|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
161931438|NCT02191397|584796496|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
161931439|NCT02191397|584796495|FG000|Overall Study|Lost to Follow-up|10|||
161931440|NCT02191397|584796496|FG001|Overall Study|Lost to Follow-up|11|||
161931441|NCT02191397|584796495|FG000|Overall Study|Physician Decision|8|||
161931442|NCT02191397|584796496|FG001|Overall Study|Physician Decision|3|||
161931443|NCT02191397|584796495|FG000|Overall Study|Withdrawal by Subject|22|||
161931444|NCT02191397|584796496|FG001|Overall Study|Withdrawal by Subject|27|||
161931445|NCT00468546|584796499|FG000|Week 24 Analysis|Lack of Efficacy|83|||
162202862|NCT02498418|585792706|FG000|Overall Study|Lack of Efficacy|0|||
162202863|NCT02498418|585792707|FG001|Overall Study|Lack of Efficacy|0|||
162202864|NCT02498418|585792708|FG002|Overall Study|Lack of Efficacy|1|||
161931446|NCT00468546|584796500|FG001|Week 24 Analysis|Lack of Efficacy|37|||
161931447|NCT00468546|584796499|FG000|Week 24 Analysis|Refused treatment|5|||
161931448|NCT00468546|584796500|FG001|Week 24 Analysis|Refused treatment|5|||
161931449|NCT00468546|584796499|FG000|Week 24 Analysis|Adverse Event|1|||
161931450|NCT00468546|584796500|FG001|Week 24 Analysis|Adverse Event|8|||
161931451|NCT00468546|584796499|FG000|Week 24 Analysis|Failure to return|3|||
161931452|NCT00468546|584796500|FG001|Week 24 Analysis|Failure to return|4|||
161931453|NCT00468546|584796499|FG000|Week 24 Analysis|Rescue therapy|2|||
161931454|NCT00468546|584796500|FG001|Week 24 Analysis|Rescue therapy|0|||
161931455|NCT00468546|584796499|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
161931456|NCT00468546|584796500|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
161931457|NCT00468546|584796499|FG000|Week 24 Analysis|Due to clinical hold|1|||
161931458|NCT00468546|584796500|FG001|Week 24 Analysis|Due to clinical hold|0|||
161931459|NCT00468546|584796499|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
161931460|NCT00468546|584796500|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
161931461|NCT00468546|584796499|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
161931462|NCT00468546|584796500|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
161931463|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
161931464|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
161931465|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Death|1|||
161931466|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Death|0|||
161931467|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
161931468|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
161931469|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
161931470|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
161931471|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
161931472|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
161931473|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
161931474|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
161931475|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
161931476|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
161931477|NCT00468546|584796499|FG000|Week 24 to Week 104 Analysis|Other|17|||
161931478|NCT00468546|584796500|FG001|Week 24 to Week 104 Analysis|Other|14|||
161931479|NCT04000724|584796503|FG000|Overall Study|Withdrawal by Subject|5|||
161931480|NCT04000724|584796504|FG001|Overall Study|Withdrawal by Subject|3|||
161931481|NCT04000724|584796505|FG002|Overall Study|Withdrawal by Subject|4|||
161931482|NCT04000724|584796503|FG000|Overall Study|Lost to Follow-up|11|||
161931483|NCT04000724|584796504|FG001|Overall Study|Lost to Follow-up|7|||
161931484|NCT04000724|584796505|FG002|Overall Study|Lost to Follow-up|13|||
161931485|NCT00455455|584796506|FG000|Washout|Withdrawal by Subject|0|||
161931486|NCT00455455|584796507|FG001|Washout|Withdrawal by Subject|1|||
161931487|NCT00455455|584796506|FG000|Washout|Withdrawal by Subject|1|||
161931488|NCT00455455|584796507|FG001|Washout|Withdrawal by Subject|0|||
161931489|NCT00472641|584796508|FG000|Overall Study|Lack of Efficacy|3|||
161931490|NCT00472641|584796508|FG000|Overall Study|Adverse Event|3|||
161931491|NCT00472641|584796508|FG000|Overall Study|Lost to Follow-up|1|||
161931492|NCT01370538|584796509|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
161931493|NCT01370538|584796510|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
161931494|NCT01370538|584796509|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161931495|NCT01370538|584796510|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161931496|NCT01370538|584796509|FG000|Overall Study|Adverse Event|1|||
161931497|NCT01370538|584796510|FG001|Overall Study|Adverse Event|0|||
161931498|NCT01370538|584796509|FG000|Overall Study|Protocol Violation|8|||
161931499|NCT01370538|584796510|FG001|Overall Study|Protocol Violation|5|||
161931500|NCT01370538|584796509|FG000|Overall Study|Development of study specific withdrawal|1|||
161931501|NCT01370538|584796510|FG001|Overall Study|Development of study specific withdrawal|1|||
161931502|NCT01370538|584796509|FG000|Overall Study|Lost to follow up|6|||
161931503|NCT01370538|584796510|FG001|Overall Study|Lost to follow up|10|||
161931504|NCT00309244|584796511|FG000|Overall Study|Adverse Event|29|||
161931505|NCT00309244|584796512|FG001|Overall Study|Adverse Event|12|||
161931506|NCT00309244|584796511|FG000|Overall Study|Lost to Follow-up|6|||
161931507|NCT00309244|584796512|FG001|Overall Study|Lost to Follow-up|22|||
161931508|NCT00309244|584796511|FG000|Overall Study|Physician Decision|5|||
161931509|NCT00309244|584796512|FG001|Overall Study|Physician Decision|8|||
161931510|NCT00309244|584796511|FG000|Overall Study|Protocol Violation|6|||
161931511|NCT00309244|584796512|FG001|Overall Study|Protocol Violation|3|||
161931512|NCT00309244|584796511|FG000|Overall Study|Withdrawal by Subject|50|||
161931513|NCT00309244|584796512|FG001|Overall Study|Withdrawal by Subject|32|||
161931514|NCT00309244|584796511|FG000|Overall Study|Various|7|||
161931515|NCT00309244|584796512|FG001|Overall Study|Various|7|||
161931516|NCT00309244|584796511|FG000|Overall Study|Randomized but not dosed|11|||
161931517|NCT00309244|584796512|FG001|Overall Study|Randomized but not dosed|12|||
161931518|NCT00309244|584796511|FG000|Overall Study|Death|4|||
161931519|NCT00309244|584796512|FG001|Overall Study|Death|1|||
161931520|NCT01905267|584796513|FG000|Overall Study|Physician Decision|2|||
161931521|NCT01905267|584796514|FG001|Overall Study|Physician Decision|2|||
161931522|NCT03438656|584796515|FG000|Overall Study|Lost to Follow-up|2|||
161931523|NCT03335566|584796516|FG000|Overall Study|Adverse Event|0|||
161931524|NCT03335566|584796517|FG001|Overall Study|Adverse Event|1|||
161931525|NCT03335566|584796516|FG000|Overall Study|Lost to Follow-up|1|||
161931526|NCT03335566|584796517|FG001|Overall Study|Lost to Follow-up|0|||
161931527|NCT03335566|584796516|FG000|Overall Study|Technical Problems|1|||
161931528|NCT03335566|584796517|FG001|Overall Study|Technical Problems|0|||
161931529|NCT03335566|584796516|FG000|Overall Study|Protocol Violation|1|||
161931530|NCT03335566|584796517|FG001|Overall Study|Protocol Violation|0|||
161931531|NCT03335566|584796516|FG000|Overall Study|Other than specified above|1|||
161931532|NCT03335566|584796517|FG001|Overall Study|Other than specified above|2|||
161931533|NCT04223687|584796518|FG000|Overall Study|Missing primary outcome|1|||
161931534|NCT04223687|584796519|FG001|Overall Study|Missing primary outcome|0|||
161931535|NCT02945046|584796521|FG000|Overall Study|Adverse Event|1|||
161931536|NCT02945046|584796522|FG001|Overall Study|Adverse Event|0|||
161931537|NCT02945046|584796523|FG002|Overall Study|Adverse Event|2|||
161931538|NCT02945046|584796521|FG000|Overall Study|Withdrawal by Subject|3|||
161931539|NCT02945046|584796522|FG001|Overall Study|Withdrawal by Subject|3|||
161931540|NCT02945046|584796523|FG002|Overall Study|Withdrawal by Subject|3|||
161931541|NCT02945046|584796521|FG000|Overall Study|Protocol Violation|2|||
161931542|NCT02945046|584796522|FG001|Overall Study|Protocol Violation|3|||
161931543|NCT02945046|584796523|FG002|Overall Study|Protocol Violation|2|||
161931544|NCT02945046|584796521|FG000|Overall Study|Lost to Follow-up|1|||
161931545|NCT02945046|584796522|FG001|Overall Study|Lost to Follow-up|1|||
161931546|NCT02945046|584796523|FG002|Overall Study|Lost to Follow-up|0|||
161931547|NCT02945046|584796521|FG000|Overall Study|Lack of Efficacy|1|||
161931548|NCT02945046|584796522|FG001|Overall Study|Lack of Efficacy|2|||
161931549|NCT02945046|584796523|FG002|Overall Study|Lack of Efficacy|1|||
161931550|NCT02945046|584796521|FG000|Overall Study|Other than specified|5|||
161931551|NCT02945046|584796522|FG001|Overall Study|Other than specified|4|||
161931552|NCT02945046|584796523|FG002|Overall Study|Other than specified|7|||
161931553|NCT03259308|584796529|FG000|Overall Study|Adverse Event|5|||
161931554|NCT03259308|584796530|FG001|Overall Study|Adverse Event|4|||
161931555|NCT03259308|584796531|FG002|Overall Study|Adverse Event|1|||
161931556|NCT03259308|584796529|FG000|Overall Study|Withdrawal by Subject|2|||
161931557|NCT03259308|584796530|FG001|Overall Study|Withdrawal by Subject|1|||
161931558|NCT03259308|584796531|FG002|Overall Study|Withdrawal by Subject|3|||
161931559|NCT03259308|584796529|FG000|Overall Study|Lost to Follow-up|0|||
161931560|NCT03259308|584796530|FG001|Overall Study|Lost to Follow-up|0|||
161931561|NCT03259308|584796531|FG002|Overall Study|Lost to Follow-up|1|||
161931562|NCT03259308|584796529|FG000|Overall Study|Pregnancy|0|||
161931563|NCT03259308|584796530|FG001|Overall Study|Pregnancy|0|||
161931564|NCT03259308|584796531|FG002|Overall Study|Pregnancy|1|||
161931565|NCT03259308|584796529|FG000|Overall Study|Protocol Deviation|0|||
161931566|NCT03259308|584796530|FG001|Overall Study|Protocol Deviation|3|||
161931567|NCT03259308|584796531|FG002|Overall Study|Protocol Deviation|0|||
161931568|NCT03259308|584796529|FG000|Overall Study|Lack of Efficacy|0|||
161931569|NCT03259308|584796530|FG001|Overall Study|Lack of Efficacy|0|||
161931570|NCT03259308|584796531|FG002|Overall Study|Lack of Efficacy|1|||
161931571|NCT01117350|584796539|FG000|Comparative Period|Not Treated|5|||
161931572|NCT01117350|584796540|FG001|Comparative Period|Not Treated|8|||
161931573|NCT01117350|584796539|FG000|Comparative Period|Adverse Event|6|||
161931574|NCT01117350|584796540|FG001|Comparative Period|Adverse Event|33|||
161931575|NCT01117350|584796539|FG000|Comparative Period|Lost to Follow-up|11|||
161931576|NCT01117350|584796540|FG001|Comparative Period|Lost to Follow-up|7|||
161931577|NCT01117350|584796539|FG000|Comparative Period|Withdrawal by Subject|9|||
161931578|NCT01117350|584796540|FG001|Comparative Period|Withdrawal by Subject|13|||
161931579|NCT01117350|584796539|FG000|Comparative Period|Protocol Violation|8|||
161931580|NCT01117350|584796540|FG001|Comparative Period|Protocol Violation|12|||
161931581|NCT01117350|584796539|FG000|Comparative Period|Lack of Efficacy|1|||
161931582|NCT01117350|584796540|FG001|Comparative Period|Lack of Efficacy|0|||
161931583|NCT01117350|584796539|FG000|Comparative Period|Physician Decision|0|||
161931584|NCT01117350|584796540|FG001|Comparative Period|Physician Decision|1|||
161931585|NCT01117350|584796539|FG000|Comparative Period|Move to another city/country|2|||
161931586|NCT01117350|584796540|FG001|Comparative Period|Move to another city/country|1|||
161931587|NCT01117350|584796539|FG000|Extension Period|Not included in extension, not treated|0|||
161931588|NCT01117350|584796540|FG001|Extension Period|Not included in extension, not treated|50|||
161931589|NCT01117350|584796539|FG000|Extension Period|Adverse Event|0|||
161931590|NCT01117350|584796540|FG001|Extension Period|Adverse Event|2|||
161931591|NCT01117350|584796539|FG000|Extension Period|Protocol Violation|0|||
161931592|NCT01117350|584796540|FG001|Extension Period|Protocol Violation|2|||
161931593|NCT01117350|584796539|FG000|Extension Period|Lost to Follow-up|0|||
161931594|NCT01117350|584796540|FG001|Extension Period|Lost to Follow-up|2|||
161931595|NCT01117350|584796539|FG000|Extension Period|Withdrawal by Subject|0|||
161931596|NCT01117350|584796540|FG001|Extension Period|Withdrawal by Subject|3|||
161931597|NCT01117350|584796539|FG000|Extension Period|Lack of Efficacy|0|||
161931598|NCT01117350|584796540|FG001|Extension Period|Lack of Efficacy|2|||
161931599|NCT01117350|584796539|FG000|Extension Period|Inclusion criteria not respected|0|||
161931600|NCT01117350|584796540|FG001|Extension Period|Inclusion criteria not respected|1|||
161931601|NCT01117350|584796539|FG000|Extension Period|Prohibited medication|0|||
161931602|NCT01117350|584796540|FG001|Extension Period|Prohibited medication|1|||
161931603|NCT06868667|584796545|FG000|Overall Study|Death|0|||
161676969|NCT01514136|583870628|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
161676970|NCT01514136|583870629|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
161676971|NCT01514136|583870630|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
161676972|NCT01514136|583870631|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
161676973|NCT01514136|583870632|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
161676974|NCT01514136|583870625|FG000|Test Period 2; Test A*|Adverse Event|0|||
161676975|NCT01514136|583870626|FG001|Test Period 2; Test A*|Adverse Event|0|||
161676976|NCT01514136|583870627|FG002|Test Period 2; Test A*|Adverse Event|0|||
161676977|NCT01514136|583870628|FG003|Test Period 2; Test A*|Adverse Event|0|||
161676978|NCT01514136|583870629|FG004|Test Period 2; Test A*|Adverse Event|1|||
161676979|NCT01514136|583870630|FG005|Test Period 2; Test A*|Adverse Event|0|||
161676980|NCT01514136|583870631|FG006|Test Period 2; Test A*|Adverse Event|0|||
161676981|NCT01514136|583870632|FG007|Test Period 2; Test A*|Adverse Event|0|||
161676982|NCT01514136|583870625|FG000|Test Period 2; Test A*|Holiday|0|||
161676983|NCT01514136|583870626|FG001|Test Period 2; Test A*|Holiday|0|||
161676984|NCT01514136|583870627|FG002|Test Period 2; Test A*|Holiday|0|||
161676985|NCT01514136|583870628|FG003|Test Period 2; Test A*|Holiday|0|||
161676986|NCT01514136|583870629|FG004|Test Period 2; Test A*|Holiday|1|||
161676987|NCT01514136|583870630|FG005|Test Period 2; Test A*|Holiday|0|||
161676988|NCT01514136|583870631|FG006|Test Period 2; Test A*|Holiday|0|||
161676989|NCT01514136|583870632|FG007|Test Period 2; Test A*|Holiday|0|||
161676990|NCT01514136|583870625|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676991|NCT01514136|583870626|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676992|NCT01514136|583870627|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676993|NCT01514136|583870628|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676994|NCT01514136|583870629|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676995|NCT01514136|583870630|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
161676996|NCT01514136|583870631|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676997|NCT01514136|583870632|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
161676998|NCT01514136|583870625|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
161676999|NCT01514136|583870626|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
161677000|NCT01514136|583870627|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
161677001|NCT01514136|583870628|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
161677002|NCT01514136|583870629|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
161677003|NCT01514136|583870630|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
161677004|NCT01514136|583870631|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
161677005|NCT01514136|583870632|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
161677006|NCT01514136|583870625|FG000|Test Period 2; Test C*|holiday|0|||
161677007|NCT01514136|583870626|FG001|Test Period 2; Test C*|holiday|0|||
161677008|NCT01514136|583870627|FG002|Test Period 2; Test C*|holiday|0|||
161931604|NCT06868667|584796546|FG001|Overall Study|Death|4|||
161931605|NCT06868667|584796545|FG000|Overall Study|Lost to Follow-up|0|||
161931606|NCT06868667|584796546|FG001|Overall Study|Lost to Follow-up|1|||
161931607|NCT06868667|584796545|FG000|Overall Study|Withdrawal by Subject|1|||
162202865|NCT02498418|585792706|FG000|Overall Study|Withdrawal by Subject|2|||
162202866|NCT02498418|585792707|FG001|Overall Study|Withdrawal by Subject|0|||
162202867|NCT02498418|585792708|FG002|Overall Study|Withdrawal by Subject|3|||
162202868|NCT02498418|585792706|FG000|Overall Study|Lost to Follow-up|0|||
162202869|NCT02498418|585792707|FG001|Overall Study|Lost to Follow-up|1|||
162202870|NCT02498418|585792708|FG002|Overall Study|Lost to Follow-up|1|||
162202871|NCT02498418|585792706|FG000|Overall Study|Participant taken prohibited medication|0|||
162202872|NCT02498418|585792707|FG001|Overall Study|Participant taken prohibited medication|1|||
162202873|NCT02498418|585792708|FG002|Overall Study|Participant taken prohibited medication|1|||
162202874|NCT00762502|585792710|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
162202875|NCT00762502|585792711|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
162202876|NCT00762502|585792712|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
162202877|NCT00762502|585792710|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
162202878|NCT00762502|585792711|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
162202879|NCT00762502|585792712|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
162202880|NCT00762502|585792710|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
162202881|NCT00762502|585792711|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
162202882|NCT00762502|585792712|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
161677009|NCT01514136|583870628|FG003|Test Period 2; Test C*|holiday|0|||
162202883|NCT02996097|585792719|FG000|Overall Study|Lost to Follow-up|11|||
162202884|NCT02996097|585792720|FG001|Overall Study|Lost to Follow-up|11|||
161931608|NCT06868667|584796546|FG001|Overall Study|Withdrawal by Subject|0|||
161931609|NCT06868667|584796545|FG000|Overall Study|Ongoing|9|||
161931610|NCT06868667|584796546|FG001|Overall Study|Ongoing|9|||
161931611|NCT01251965|584798652|FG000|Overall Study|Participant/physician decision|1|||
161931612|NCT01251965|584798653|FG001|Overall Study|Participant/physician decision|2|||
161931613|NCT01251965|584798654|FG002|Overall Study|Participant/physician decision|0|||
161931614|NCT01251965|584798652|FG000|Overall Study|Death|0|||
161931615|NCT01251965|584798653|FG001|Overall Study|Death|0|||
161931616|NCT01251965|584798654|FG002|Overall Study|Death|11|||
161931617|NCT03681093|584798655|FG000|Overall Study|Subject decision|0|||
161931618|NCT03681093|584798656|FG001|Overall Study|Subject decision|2|||
161931619|NCT03681093|584798657|FG002|Overall Study|Subject decision|1|||
161931620|NCT01027754|584798658|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
161931621|NCT01027754|584798659|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
161931622|NCT01027754|584798658|FG000|Overall Study|Withdrawal by Subject|0|||
161931623|NCT01027754|584798659|FG001|Overall Study|Withdrawal by Subject|5|||
161931624|NCT02529488|584798660|FG000|Overall Study|Adverse Event|1|||
161677010|NCT01514136|583870629|FG004|Test Period 2; Test C*|holiday|0|||
161677011|NCT01514136|583870630|FG005|Test Period 2; Test C*|holiday|0|||
161677012|NCT01514136|583870631|FG006|Test Period 2; Test C*|holiday|1|||
161677013|NCT01514136|583870632|FG007|Test Period 2; Test C*|holiday|0|||
161677014|NCT01514136|583870625|FG000|Test Period 2; Test C*|Protocol Violation|0|||
161677015|NCT01514136|583870626|FG001|Test Period 2; Test C*|Protocol Violation|0|||
161677016|NCT01514136|583870627|FG002|Test Period 2; Test C*|Protocol Violation|0|||
161677017|NCT01514136|583870628|FG003|Test Period 2; Test C*|Protocol Violation|0|||
161677018|NCT01514136|583870629|FG004|Test Period 2; Test C*|Protocol Violation|0|||
161677019|NCT01514136|583870630|FG005|Test Period 2; Test C*|Protocol Violation|0|||
161677020|NCT01514136|583870631|FG006|Test Period 2; Test C*|Protocol Violation|1|||
161677021|NCT01514136|583870632|FG007|Test Period 2; Test C*|Protocol Violation|0|||
161677022|NCT00757003|583870636|FG000|Overall Study|Death|33|||
161677023|NCT00757003|583870636|FG000|Overall Study|Lost to Follow-up|9|||
161677024|NCT00757003|583870636|FG000|Overall Study|Withdrawal by Subject|4|||
161677025|NCT00757003|583870636|FG000|Overall Study|Surgically explanted|2|||
161677026|NCT00757003|583870636|FG000|Overall Study|Not implanted|1|||
161931625|NCT02529488|584798660|FG000|Overall Study|Death|3|||
161931626|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
161931627|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
161931628|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
161931629|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
161931630|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
161677027|NCT03044249|583870639|FG000|Overall Study|Adverse Event|4|||
161677028|NCT03044249|583870640|FG001|Overall Study|Adverse Event|9|||
161931631|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
161931632|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
161931633|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
161931634|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
161931635|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
161931636|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
161931637|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
161931638|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
161931639|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
161931640|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
161931641|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
161931642|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
161931643|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
162202885|NCT03638258|585792721|FG000|Overall Study|Adverse Event|1|||
162202886|NCT03638258|585792722|FG001|Overall Study|Adverse Event|0|||
162202887|NCT03638258|585792723|FG002|Overall Study|Adverse Event|2|||
162202888|NCT03638258|585792721|FG000|Overall Study|Lost to Follow-up|2|||
162202889|NCT03638258|585792722|FG001|Overall Study|Lost to Follow-up|4|||
162202890|NCT03638258|585792723|FG002|Overall Study|Lost to Follow-up|5|||
162202891|NCT03638258|585792721|FG000|Overall Study|Pregnancy|0|||
162202892|NCT03638258|585792722|FG001|Overall Study|Pregnancy|0|||
162202893|NCT03638258|585792723|FG002|Overall Study|Pregnancy|1|||
162202894|NCT03638258|585792721|FG000|Overall Study|Protocol Violation|0|||
161677029|NCT03044249|583870639|FG000|Overall Study|Lost to Follow-up|1|||
161677030|NCT03044249|583870640|FG001|Overall Study|Lost to Follow-up|0|||
161931644|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
161931645|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
161931646|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
162202895|NCT03638258|585792722|FG001|Overall Study|Protocol Violation|0|||
162202896|NCT03638258|585792723|FG002|Overall Study|Protocol Violation|1|||
161931647|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
162202897|NCT03638258|585792721|FG000|Overall Study|Withdrawal by Subject|4|||
162202898|NCT03638258|585792722|FG001|Overall Study|Withdrawal by Subject|5|||
162202899|NCT03638258|585792723|FG002|Overall Study|Withdrawal by Subject|12|||
162202900|NCT03638258|585792721|FG000|Overall Study|Lack of Efficacy|0|||
162202901|NCT03638258|585792722|FG001|Overall Study|Lack of Efficacy|0|||
162202902|NCT03638258|585792723|FG002|Overall Study|Lack of Efficacy|2|||
162202903|NCT02205476|585792724|FG000|Overall Study|Study termination by Sponsor|7|||
162202904|NCT02205476|585792725|FG001|Overall Study|Study termination by Sponsor|3|||
162202905|NCT02391545|585792738|FG000|Overall Study|Death|0|||
162202906|NCT02391545|585792739|FG001|Overall Study|Death|2|||
162202907|NCT02391545|585792738|FG000|Overall Study|Lost to Follow-up|0|||
162202908|NCT02391545|585792739|FG001|Overall Study|Lost to Follow-up|1|||
162202909|NCT02391545|585792738|FG000|Overall Study|Termination of study by sponsor|20|||
162202910|NCT02391545|585792739|FG001|Overall Study|Termination of study by sponsor|20|||
162202911|NCT02391545|585792738|FG000|Overall Study|Withdrawal by Subject|0|||
162202912|NCT02391545|585792739|FG001|Overall Study|Withdrawal by Subject|1|||
162202913|NCT02391545|585792738|FG000|Overall Study|Other Reasons|6|||
162202914|NCT02391545|585792739|FG001|Overall Study|Other Reasons|4|||
162202915|NCT02016690|585792740|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
162202916|NCT02016690|585792740|FG000|Overall Study|Excluded from SAS: Duplication|2|||
162202917|NCT02016690|585792740|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
162202918|NCT02016690|585792740|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
162202919|NCT02016690|585792740|FG000|Overall Study|Did not meet inclusion criteria|13|||
162202920|NCT02016690|585792740|FG000|Overall Study|Hospitalized for RSV at study start|3|||
162202921|NCT01222078|585792741|FG000|Overall Study|Early termination of the study|1|||
162202922|NCT04089332|585792742|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
161823735|NCT03833427|584396287|FG001|Overall Study|Sponsor Decision|0|||
161823736|NCT03833427|584396288|FG002|Overall Study|Sponsor Decision|1|||
161823737|NCT03833427|584396289|FG003|Overall Study|Sponsor Decision|3|||
161823738|NCT03833427|584396290|FG004|Overall Study|Sponsor Decision|0|||
161823739|NCT03833427|584396291|FG005|Overall Study|Sponsor Decision|0|||
161823740|NCT03833427|584396292|FG006|Overall Study|Sponsor Decision|0|||
161823741|NCT01499160|584396294|FG000|Overall Study|Adverse Event|1|||
161823742|NCT01499160|584396294|FG000|Overall Study|Withdrawal by Subject|1|||
161823743|NCT01438476|584396295|FG000|Overall Study|Protocol Violation|1|||
161823744|NCT01438476|584396296|FG001|Overall Study|Protocol Violation|0|||
161823745|NCT01438476|584396295|FG000|Overall Study|Withdrawal by Subject|1|||
161823746|NCT01438476|584396296|FG001|Overall Study|Withdrawal by Subject|0|||
161823747|NCT01438476|584396295|FG000|Overall Study|No Surgery- Disease|8|||
161823748|NCT01438476|584396296|FG001|Overall Study|No Surgery- Disease|10|||
161823749|NCT01438476|584396295|FG000|Overall Study|Communication barrier|0|||
161823750|NCT01438476|584396296|FG001|Overall Study|Communication barrier|1|||
161823751|NCT03294317|584396301|FG000|Overall Study|Physician Decision|1|||
161823752|NCT03294317|584396301|FG000|Overall Study|Withdrawal by Subject|6|||
161823753|NCT03294317|584396301|FG000|Overall Study|Lost to Follow-up|1|||
161823754|NCT03294317|584396301|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
161823755|NCT03294317|584396301|FG000|Overall Study|Failed HB lead implant|8|||
161823756|NCT03294317|584396301|FG000|Overall Study|Received CRT instead|1|||
161823757|NCT03294317|584396301|FG000|Overall Study|Exited after lead revision|2|||
161823758|NCT03847974|584396302|FG000|Overall Study|relocated out of region|3|||
161823759|NCT03847974|584396302|FG000|Overall Study|Withdrawal by Subject|2|||
161823760|NCT03847974|584396302|FG000|Overall Study|Adverse Event|1|||
161823761|NCT02911935|584396303|FG000|Overall Study|Lost to Follow-up|5|||
161823762|NCT02911935|584396304|FG001|Overall Study|Lost to Follow-up|7|||
161823763|NCT00603512|584396305|FG000|Overall Study|Adverse Event|0|||
161823764|NCT00603512|584396306|FG001|Overall Study|Adverse Event|2|||
161823765|NCT00603512|584396307|FG002|Overall Study|Adverse Event|4|||
161823766|NCT00603512|584396308|FG003|Overall Study|Adverse Event|4|||
161823767|NCT00603512|584396309|FG004|Overall Study|Adverse Event|2|||
161823768|NCT00603512|584396305|FG000|Overall Study|Lack of Efficacy|0|||
161823769|NCT00603512|584396306|FG001|Overall Study|Lack of Efficacy|1|||
161823770|NCT00603512|584396307|FG002|Overall Study|Lack of Efficacy|0|||
161823771|NCT00603512|584396308|FG003|Overall Study|Lack of Efficacy|0|||
161823772|NCT00603512|584396309|FG004|Overall Study|Lack of Efficacy|1|||
161823773|NCT00603512|584396305|FG000|Overall Study|Other|2|||
161823774|NCT00603512|584396306|FG001|Overall Study|Other|1|||
161823775|NCT00603512|584396307|FG002|Overall Study|Other|0|||
161823776|NCT00603512|584396308|FG003|Overall Study|Other|1|||
161823777|NCT00603512|584396309|FG004|Overall Study|Other|1|||
161823778|NCT00603512|584396305|FG000|Overall Study|Withdrawal by Subject|0|||
161823779|NCT00603512|584396306|FG001|Overall Study|Withdrawal by Subject|0|||
161823780|NCT00603512|584396307|FG002|Overall Study|Withdrawal by Subject|0|||
161823781|NCT00603512|584396308|FG003|Overall Study|Withdrawal by Subject|0|||
161823782|NCT00603512|584396309|FG004|Overall Study|Withdrawal by Subject|1|||
161823783|NCT00603512|584396305|FG000|Overall Study|Randomized but not treated|0|||
161931648|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
161931649|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
161931650|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
161931651|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
161931652|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
161931653|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
161931654|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
161931655|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
161931656|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
161931657|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
161931658|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
161931659|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
161931660|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
161931661|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
161931662|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
161931663|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
161931664|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
161931665|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
161931666|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
161931667|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
161931668|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
161931669|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
161931670|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
161931671|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
161931672|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
161931673|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
161931674|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
161931675|NCT01557244|584798667|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
161931676|NCT01557244|584798668|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
161931677|NCT01557244|584798669|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
161931678|NCT01557244|584798670|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
161931679|NCT01557244|584798671|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
161931680|NCT01557244|584798672|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
161931681|NCT01557244|584798673|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
161931682|NCT01557244|584798667|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
161931683|NCT01557244|584798668|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
161931684|NCT01557244|584798669|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
161931685|NCT01557244|584798670|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
161931686|NCT01557244|584798671|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
161931687|NCT01557244|584798672|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
161931688|NCT01557244|584798673|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
161931689|NCT01557244|584798667|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
161931690|NCT01557244|584798668|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
161931691|NCT01557244|584798669|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
161931692|NCT01557244|584798670|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
161931693|NCT01557244|584798671|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
161931694|NCT01557244|584798672|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
161931695|NCT01557244|584798673|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
161931696|NCT01557244|584798667|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161931697|NCT01557244|584798668|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161931698|NCT01557244|584798669|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161931699|NCT01557244|584798670|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
161931700|NCT01557244|584798671|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161931701|NCT01557244|584798672|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161931702|NCT01557244|584798673|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161931703|NCT01557244|584798667|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
161931704|NCT01557244|584798668|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
161931705|NCT01557244|584798669|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
162021242|NCT05188053|585133479|FG000|Overall Study|Lost to Follow-up|23|||
161823784|NCT00603512|584396306|FG001|Overall Study|Randomized but not treated|1|||
161823785|NCT00603512|584396307|FG002|Overall Study|Randomized but not treated|1|||
161823786|NCT00603512|584396308|FG003|Overall Study|Randomized but not treated|2|||
161823787|NCT00603512|584396309|FG004|Overall Study|Randomized but not treated|0|||
161823788|NCT04979858|584396310|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
161823789|NCT04979858|584396311|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
161823790|NCT04253236|584396312|FG000|Overall Study|Adverse Event|1|||
161823791|NCT04253236|584396313|FG001|Overall Study|Adverse Event|0|||
161823792|NCT04253236|584396312|FG000|Overall Study|Safety Concerns|1|||
161823793|NCT04253236|584396313|FG001|Overall Study|Safety Concerns|0|||
161823794|NCT04253236|584396312|FG000|Overall Study|Study Terminated by Sponsor|1|||
161823795|NCT04253236|584396313|FG001|Overall Study|Study Terminated by Sponsor|0|||
161823796|NCT01896505|584396314|FG000|Overall Study|Adverse Event|1|||
161823797|NCT01896505|584396315|FG001|Overall Study|Adverse Event|0|||
161823798|NCT01896505|584396316|FG002|Overall Study|Adverse Event|2|||
161823799|NCT01896505|584396317|FG003|Overall Study|Adverse Event|1|||
161823800|NCT01896505|584396318|FG004|Overall Study|Adverse Event|1|||
161823801|NCT01896505|584396319|FG005|Overall Study|Adverse Event|0|||
161823802|NCT01896505|584396314|FG000|Overall Study|Physician Decision|1|||
161823803|NCT01896505|584396315|FG001|Overall Study|Physician Decision|3|||
161823804|NCT01896505|584396316|FG002|Overall Study|Physician Decision|2|||
161823805|NCT01896505|584396317|FG003|Overall Study|Physician Decision|0|||
161823806|NCT01896505|584396318|FG004|Overall Study|Physician Decision|0|||
161823807|NCT01896505|584396319|FG005|Overall Study|Physician Decision|1|||
161823808|NCT01896505|584396314|FG000|Overall Study|Withdrawal by Subject|1|||
161823809|NCT01896505|584396315|FG001|Overall Study|Withdrawal by Subject|0|||
161823810|NCT01896505|584396316|FG002|Overall Study|Withdrawal by Subject|3|||
161823811|NCT01896505|584396317|FG003|Overall Study|Withdrawal by Subject|1|||
161823812|NCT01896505|584396318|FG004|Overall Study|Withdrawal by Subject|0|||
161823813|NCT01896505|584396319|FG005|Overall Study|Withdrawal by Subject|0|||
161823814|NCT01896505|584396314|FG000|Overall Study|Disease Progression|7|||
161823815|NCT01896505|584396315|FG001|Overall Study|Disease Progression|5|||
161823816|NCT01896505|584396316|FG002|Overall Study|Disease Progression|8|||
161823817|NCT01896505|584396317|FG003|Overall Study|Disease Progression|4|||
161823818|NCT01896505|584396318|FG004|Overall Study|Disease Progression|4|||
161823819|NCT01896505|584396319|FG005|Overall Study|Disease Progression|4|||
161823820|NCT01896505|584396314|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
161823821|NCT01896505|584396315|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
161823822|NCT01896505|584396316|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
161823823|NCT01896505|584396317|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
161823824|NCT01896505|584396318|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
161823825|NCT01896505|584396319|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
161823826|NCT01896505|584396314|FG000|Overall Study|Intercurrent illness|0|||
161823827|NCT01896505|584396315|FG001|Overall Study|Intercurrent illness|1|||
161823828|NCT01896505|584396316|FG002|Overall Study|Intercurrent illness|0|||
161823829|NCT01896505|584396317|FG003|Overall Study|Intercurrent illness|0|||
161823830|NCT01896505|584396318|FG004|Overall Study|Intercurrent illness|0|||
161823831|NCT01896505|584396319|FG005|Overall Study|Intercurrent illness|0|||
161823832|NCT01896505|584396314|FG000|Overall Study|Death|0|||
161823833|NCT01896505|584396315|FG001|Overall Study|Death|0|||
161823834|NCT01896505|584396316|FG002|Overall Study|Death|1|||
161823835|NCT01896505|584396317|FG003|Overall Study|Death|1|||
161823836|NCT01896505|584396318|FG004|Overall Study|Death|0|||
161823837|NCT01896505|584396319|FG005|Overall Study|Death|1|||
161823838|NCT02063217|584396320|FG000|Overall Study|Withdrawal by Subject|1|||
161823839|NCT02063217|584396321|FG001|Overall Study|Withdrawal by Subject|0|||
161823840|NCT02063217|584396322|FG002|Overall Study|Withdrawal by Subject|0|||
161823841|NCT04291508|584396323|FG000|Overall Study|Withdrawal by Subject|1|||
161823842|NCT04291508|584396324|FG001|Overall Study|Withdrawal by Subject|0|||
161823843|NCT04291508|584396325|FG002|Overall Study|Withdrawal by Subject|1|||
161823844|NCT04291508|584396326|FG003|Overall Study|Withdrawal by Subject|0|||
161823845|NCT04291508|584396323|FG000|Overall Study|lost to follow up|4|||
161823846|NCT04291508|584396324|FG001|Overall Study|lost to follow up|0|||
161823847|NCT04291508|584396325|FG002|Overall Study|lost to follow up|1|||
161823848|NCT04291508|584396326|FG003|Overall Study|lost to follow up|0|||
161823849|NCT03566238|584396327|FG000|Overall Study|Adverse Event|0|||
161823850|NCT03566238|584396328|FG001|Overall Study|Adverse Event|0|||
161823851|NCT03566238|584396329|FG002|Overall Study|Adverse Event|1|||
161823852|NCT03566238|584396327|FG000|Overall Study|Lack of Efficacy|5|||
161931706|NCT01557244|584798670|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
161931707|NCT01557244|584798671|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
161931708|NCT01557244|584798672|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
161931709|NCT01557244|584798673|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
161931710|NCT01313676|584798674|FG000|Overall Study|Adverse Event|395|||
161931711|NCT01313676|584798675|FG001|Overall Study|Adverse Event|365|||
161931712|NCT01313676|584798676|FG002|Overall Study|Adverse Event|372|||
161931713|NCT01313676|584798677|FG003|Overall Study|Adverse Event|333|||
161931714|NCT01313676|584798674|FG000|Overall Study|Lack of Efficacy|98|||
161931715|NCT01313676|584798675|FG001|Overall Study|Lack of Efficacy|90|||
161931716|NCT01313676|584798676|FG002|Overall Study|Lack of Efficacy|65|||
161931717|NCT01313676|584798677|FG003|Overall Study|Lack of Efficacy|46|||
161931718|NCT01313676|584798674|FG000|Overall Study|Protocol Violation|37|||
161931719|NCT01313676|584798675|FG001|Overall Study|Protocol Violation|44|||
161931720|NCT01313676|584798676|FG002|Overall Study|Protocol Violation|46|||
161931721|NCT01313676|584798677|FG003|Overall Study|Protocol Violation|44|||
161931722|NCT01313676|584798674|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
161931723|NCT01313676|584798675|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
161931724|NCT01313676|584798676|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
161931725|NCT01313676|584798677|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
161931726|NCT01313676|584798674|FG000|Overall Study|Study Closed/terminated|7|||
161931727|NCT01313676|584798675|FG001|Overall Study|Study Closed/terminated|6|||
161931728|NCT01313676|584798676|FG002|Overall Study|Study Closed/terminated|9|||
161931729|NCT01313676|584798677|FG003|Overall Study|Study Closed/terminated|9|||
161931730|NCT01313676|584798674|FG000|Overall Study|Lost to Follow-up|0|||
161931731|NCT01313676|584798675|FG001|Overall Study|Lost to Follow-up|0|||
161931732|NCT01313676|584798676|FG002|Overall Study|Lost to Follow-up|1|||
161931733|NCT01313676|584798677|FG003|Overall Study|Lost to Follow-up|0|||
161931734|NCT01313676|584798674|FG000|Overall Study|Physician Decision|53|||
161931735|NCT01313676|584798675|FG001|Overall Study|Physician Decision|64|||
161931736|NCT01313676|584798676|FG002|Overall Study|Physician Decision|62|||
161931737|NCT01313676|584798677|FG003|Overall Study|Physician Decision|48|||
161931738|NCT01313676|584798674|FG000|Overall Study|Decision by Participant or Proxy|643|||
161931739|NCT01313676|584798675|FG001|Overall Study|Decision by Participant or Proxy|527|||
161931740|NCT01313676|584798676|FG002|Overall Study|Decision by Participant or Proxy|515|||
161931741|NCT01313676|584798677|FG003|Overall Study|Decision by Participant or Proxy|492|||
161931742|NCT01313676|584798674|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
161931743|NCT01313676|584798675|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
161931744|NCT01313676|584798676|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
161931745|NCT01313676|584798677|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
161931746|NCT01313676|584798674|FG000|Overall Study|Investigator Site Closed|12|||
161931747|NCT01313676|584798675|FG001|Overall Study|Investigator Site Closed|11|||
161931748|NCT01313676|584798676|FG002|Overall Study|Investigator Site Closed|15|||
161931749|NCT01313676|584798677|FG003|Overall Study|Investigator Site Closed|10|||
161931750|NCT01313676|584798674|FG000|Overall Study|Missing|1|||
161931751|NCT01313676|584798675|FG001|Overall Study|Missing|1|||
161931752|NCT01313676|584798676|FG002|Overall Study|Missing|1|||
161931753|NCT01313676|584798677|FG003|Overall Study|Missing|0|||
161931754|NCT01902303|584798678|FG000|Overall Study|Adverse Event|0|||
161931755|NCT01902303|584798679|FG001|Overall Study|Adverse Event|1|||
161931756|NCT01902303|584798678|FG000|Overall Study|Lost to Follow-up|0|||
161931757|NCT01902303|584798679|FG001|Overall Study|Lost to Follow-up|1|||
161931758|NCT01902303|584798678|FG000|Overall Study|Protocol Violation|2|||
161931759|NCT01902303|584798679|FG001|Overall Study|Protocol Violation|2|||
161931760|NCT01902303|584798678|FG000|Overall Study|subject lost investigational product|0|||
161931761|NCT01902303|584798679|FG001|Overall Study|subject lost investigational product|1|||
161677031|NCT03044249|583870639|FG000|Overall Study|Non-compliance with Study Drug|1|||
161677032|NCT03044249|583870640|FG001|Overall Study|Non-compliance with Study Drug|0|||
161931762|NCT01902303|584798678|FG000|Overall Study|Did not develop a cold sore|21|||
161931763|NCT01902303|584798679|FG001|Overall Study|Did not develop a cold sore|19|||
161931764|NCT00326495|584798680|FG000|Overall Study|Switched to alternative treatment|1|||
162202923|NCT04089332|585792742|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
161677033|NCT03044249|583870639|FG000|Overall Study|Study Terminated by Sponsor|2|||
161931765|NCT00326495|584798680|FG000|Overall Study|Disease progression before treatment|1|||
161931766|NCT00326495|584798680|FG000|Overall Study|Refused further treatment|2|||
161931767|NCT00326495|584798680|FG000|Overall Study|Subject off study before assessment|1|||
161931768|NCT01897896|584798683|FG000|Overall Study|Death|1|||
161931769|NCT01897896|584798684|FG001|Overall Study|Death|0|||
161931770|NCT01897896|584798683|FG000|Overall Study|Adverse Event|11|||
161931771|NCT01897896|584798684|FG001|Overall Study|Adverse Event|1|||
161931772|NCT01897896|584798683|FG000|Overall Study|Lost to Follow-up|1|||
161931773|NCT01897896|584798684|FG001|Overall Study|Lost to Follow-up|0|||
161931774|NCT01897896|584798683|FG000|Overall Study|Non-compliance with study drug dosing|1|||
161931775|NCT01897896|584798684|FG001|Overall Study|Non-compliance with study drug dosing|1|||
161931776|NCT01897896|584798683|FG000|Overall Study|Withdrawal by Subject|7|||
161931777|NCT01897896|584798684|FG001|Overall Study|Withdrawal by Subject|1|||
161931778|NCT01897896|584798683|FG000|Overall Study|Require drug that interfere with study|1|||
161931779|NCT01897896|584798684|FG001|Overall Study|Require drug that interfere with study|4|||
161931780|NCT01897896|584798683|FG000|Overall Study|Protocol Violation|1|||
161931781|NCT01897896|584798684|FG001|Overall Study|Protocol Violation|1|||
161931782|NCT01897896|584798683|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
161931783|NCT01897896|584798684|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
161931784|NCT01897896|584798683|FG000|Overall Study|Caregiver can no longer participate|0|||
161931785|NCT01897896|584798684|FG001|Overall Study|Caregiver can no longer participate|2|||
161931786|NCT01897896|584798683|FG000|Overall Study|Other than specified|2|||
161931787|NCT01897896|584798684|FG001|Overall Study|Other than specified|1|||
161823853|NCT03566238|584396328|FG001|Overall Study|Lack of Efficacy|4|||
161823854|NCT03566238|584396329|FG002|Overall Study|Lack of Efficacy|2|||
161823855|NCT03566238|584396327|FG000|Overall Study|Other|0|||
161931788|NCT01292473|584798694|FG000|Overall Study|Adverse Event|1|||
161931789|NCT01292473|584798695|FG001|Overall Study|Adverse Event|0|||
161931790|NCT01292473|584798696|FG002|Overall Study|Adverse Event|1|||
161931791|NCT01292473|584798697|FG003|Overall Study|Adverse Event|1|||
161931792|NCT01292473|584798694|FG000|Overall Study|Lost to Follow-up|1|||
161931793|NCT01292473|584798695|FG001|Overall Study|Lost to Follow-up|1|||
161931794|NCT01292473|584798696|FG002|Overall Study|Lost to Follow-up|2|||
161931795|NCT01292473|584798697|FG003|Overall Study|Lost to Follow-up|2|||
161931796|NCT01292473|584798694|FG000|Overall Study|Withdrawal by Subject|3|||
161931797|NCT01292473|584798695|FG001|Overall Study|Withdrawal by Subject|4|||
161931798|NCT01292473|584798696|FG002|Overall Study|Withdrawal by Subject|3|||
161931799|NCT01292473|584798697|FG003|Overall Study|Withdrawal by Subject|3|||
161931800|NCT01292473|584798694|FG000|Overall Study|Physician Decision|0|||
161931801|NCT01292473|584798695|FG001|Overall Study|Physician Decision|1|||
161931802|NCT01292473|584798696|FG002|Overall Study|Physician Decision|0|||
161931803|NCT01292473|584798697|FG003|Overall Study|Physician Decision|0|||
161677034|NCT03044249|583870640|FG001|Overall Study|Study Terminated by Sponsor|0|||
161677035|NCT03044249|583870639|FG000|Overall Study|Withdrawal by Subject|2|||
161677036|NCT03044249|583870640|FG001|Overall Study|Withdrawal by Subject|5|||
161677037|NCT04263896|583870642|FG000|Overall Study|Withdrawal by Subject|2|||
161677038|NCT04263896|583870643|FG001|Overall Study|Withdrawal by Subject|4|||
161677039|NCT04263896|583870642|FG000|Overall Study|converted to open procedure|0|||
161677040|NCT04263896|583870643|FG001|Overall Study|converted to open procedure|1|||
161677041|NCT04263896|583870642|FG000|Overall Study|Lost to Follow-up|9|||
161677042|NCT04263896|583870643|FG001|Overall Study|Lost to Follow-up|11|||
161677043|NCT04263896|583870642|FG000|Overall Study|surveys lost in mail|5|||
161677044|NCT04263896|583870643|FG001|Overall Study|surveys lost in mail|3|||
161677045|NCT04263896|583870642|FG000|Overall Study|excluded from analysis|1|||
161677046|NCT04263896|583870643|FG001|Overall Study|excluded from analysis|0|||
161677047|NCT00880555|583871980|FG000|Overall Study|Physician Decision|0|||
161677048|NCT00880555|583871981|FG001|Overall Study|Physician Decision|8|||
161677049|NCT00880555|583871982|FG002|Overall Study|Physician Decision|0|||
161677050|NCT00880555|583871983|FG003|Overall Study|Physician Decision|2|||
161677051|NCT00880555|583871984|FG004|Overall Study|Physician Decision|1|||
161677052|NCT00880555|583871985|FG005|Overall Study|Physician Decision|0|||
161931804|NCT01292473|584798694|FG000|Overall Study|Disease Progression|0|||
161931805|NCT01292473|584798695|FG001|Overall Study|Disease Progression|1|||
161931806|NCT01292473|584798696|FG002|Overall Study|Disease Progression|3|||
161823856|NCT03566238|584396328|FG001|Overall Study|Other|1|||
161823857|NCT03566238|584396329|FG002|Overall Study|Other|0|||
161931807|NCT01292473|584798697|FG003|Overall Study|Disease Progression|6|||
161931808|NCT00458705|584798700|FG000|Overall Study|Adverse Event|4|||
161931809|NCT00458705|584798700|FG000|Overall Study|Not Treated|1|||
161931810|NCT02180672|584798701|FG000|Overall Study|Lost to Follow-up|5|||
161931811|NCT02180672|584798702|FG001|Overall Study|Lost to Follow-up|7|||
161931812|NCT00378560|584798706|FG000|Overall Study|Adverse Event|1|||
161931813|NCT00378560|584798707|FG001|Overall Study|Adverse Event|0|||
161823858|NCT00593827|584396336|FG000|Overall Study|On Active Treatment/Pending|0|||
161931814|NCT00378560|584798706|FG000|Overall Study|Lost to Follow-up|24|||
161931815|NCT00378560|584798707|FG001|Overall Study|Lost to Follow-up|29|||
161823859|NCT00593827|584396337|FG001|Overall Study|On Active Treatment/Pending|2|||
161823860|NCT00089973|584396338|FG000|Overall Study|Adverse Event|3|||
161931816|NCT00378560|584798706|FG000|Overall Study|Protocol Violation|2|||
161823861|NCT00089973|584396338|FG000|Overall Study|Withdrawal by Subject|1|||
161677053|NCT00880555|583871980|FG000|Overall Study|Withdrawal by Subject|1|||
161931817|NCT00378560|584798707|FG001|Overall Study|Protocol Violation|0|||
161931818|NCT00378560|584798706|FG000|Overall Study|Withdrawal by Subject|17|||
161677054|NCT00880555|583871981|FG001|Overall Study|Withdrawal by Subject|1|||
161931819|NCT00378560|584798707|FG001|Overall Study|Withdrawal by Subject|21|||
161931820|NCT00378560|584798706|FG000|Overall Study|Moved|4|||
161931821|NCT00378560|584798707|FG001|Overall Study|Moved|3|||
161823862|NCT00089973|584396338|FG000|Overall Study|Disease progression|45|||
161823863|NCT00089973|584396338|FG000|Overall Study|Death|1|||
161931822|NCT00378560|584798706|FG000|Overall Study|Pregnancy|7|||
161931823|NCT00378560|584798707|FG001|Overall Study|Pregnancy|5|||
162202924|NCT04089332|585792742|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
162202925|NCT02588027|585792751|FG000|Overall Study|Withdrawal by Subject|1|||
162202926|NCT02588027|585792752|FG001|Overall Study|Withdrawal by Subject|3|||
162202927|NCT02588027|585792751|FG000|Overall Study|Protocol Violation|4|||
162202928|NCT02588027|585792752|FG001|Overall Study|Protocol Violation|1|||
162202929|NCT00603278|585792756|FG000|Overall Study|Lack of Efficacy|35|||
162202930|NCT00603278|585792757|FG001|Overall Study|Lack of Efficacy|10|||
162202931|NCT00603278|585792758|FG002|Overall Study|Lack of Efficacy|11|||
161823864|NCT01049581|584396341|FG000|Overall Study|Lost to Follow-up|2|||
161823865|NCT01049581|584396342|FG001|Overall Study|Lost to Follow-up|1|||
161823866|NCT00653159|584397857|FG000|Overall Study|Adverse Event|4|||
161823867|NCT00653159|584397858|FG001|Overall Study|Adverse Event|1|||
161823868|NCT00653159|584397857|FG000|Overall Study|Lost to Follow-up|1|||
161823869|NCT00653159|584397858|FG001|Overall Study|Lost to Follow-up|2|||
161823870|NCT01872715|584397859|FG000|Overall Study|Adverse Event|1|||
161823871|NCT01872715|584397859|FG000|Overall Study|Protocol Violation|1|||
161823872|NCT01872715|584397859|FG000|Overall Study|Withdrawal by Subject|2|||
161823873|NCT01848210|584397860|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
161823874|NCT01848210|584397861|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
161823875|NCT01848210|584397860|FG000|Overall Study|Lost to Follow-up|24|||
161823876|NCT01848210|584397861|FG001|Overall Study|Lost to Follow-up|12|||
161823877|NCT01848210|584397860|FG000|Overall Study|Protocol Violation|3|||
161823878|NCT01848210|584397861|FG001|Overall Study|Protocol Violation|5|||
161823879|NCT01848210|584397860|FG000|Overall Study|Use of Forbidden Drugs|9|||
161823880|NCT01848210|584397861|FG001|Overall Study|Use of Forbidden Drugs|10|||
161823881|NCT01848210|584397860|FG000|Overall Study|Impedition Condition|5|||
161823882|NCT01848210|584397861|FG001|Overall Study|Impedition Condition|9|||
161823883|NCT01848210|584397860|FG000|Overall Study|Adverse Event|7|||
161823884|NCT01848210|584397861|FG001|Overall Study|Adverse Event|9|||
161823885|NCT01848210|584397860|FG000|Overall Study|Discontinuation Criterion|5|||
161823886|NCT01848210|584397861|FG001|Overall Study|Discontinuation Criterion|7|||
161823887|NCT01848210|584397860|FG000|Overall Study|Hypesensitivity|1|||
161823888|NCT01848210|584397861|FG001|Overall Study|Hypesensitivity|0|||
161823889|NCT01848210|584397860|FG000|Overall Study|Hepatic Function Alteration|4|||
161823890|NCT01848210|584397861|FG001|Overall Study|Hepatic Function Alteration|0|||
161823891|NCT01848210|584397860|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
161823892|NCT01848210|584397861|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
161823893|NCT01848210|584397860|FG000|Overall Study|Administrative|1|||
161823894|NCT01848210|584397861|FG001|Overall Study|Administrative|0|||
161823895|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
161823896|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
161823897|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
161823898|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
161823899|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
161823900|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
161823901|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
161823902|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
161823903|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
161823904|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
161823905|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
161823906|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
161823907|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
161823908|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
161823909|NCT04592419|584397862|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
161823910|NCT04592419|584397863|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
161823911|NCT04592419|584397862|FG000|Open-Label Extension Period|Adverse Event|1|||
161823912|NCT04592419|584397863|FG001|Open-Label Extension Period|Adverse Event|2|||
161823913|NCT04592419|584397862|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
161823914|NCT04592419|584397863|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
161823915|NCT04592419|584397862|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
161823916|NCT04592419|584397863|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
161823917|NCT04592419|584397862|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
161823918|NCT04592419|584397863|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
161823919|NCT04592419|584397862|FG000|Open-Label Extension Period|Sponsor Request|73|||
161823920|NCT04592419|584397863|FG001|Open-Label Extension Period|Sponsor Request|84|||
161823921|NCT00381849|584397864|FG000|Wash Out|Withdrawal by Subject|0|||
161823922|NCT00381849|584397865|FG001|Wash Out|Withdrawal by Subject|1|||
161823923|NCT01765270|584397869|FG000|Overall Study|Physician Decision|1|||
161823924|NCT01765270|584397870|FG001|Overall Study|Physician Decision|0|||
161823925|NCT01765270|584397869|FG000|Overall Study|Withdrawal by Subject|0|||
161823926|NCT01765270|584397870|FG001|Overall Study|Withdrawal by Subject|1|||
161823927|NCT00517192|584397871|FG000|Overall Study|Adverse Event|1|||
161823928|NCT00517192|584397872|FG001|Overall Study|Adverse Event|1|||
161931824|NCT00378560|584798706|FG000|Overall Study|Laboratory test values abnormal|1|||
161931825|NCT00378560|584798707|FG001|Overall Study|Laboratory test values abnormal|0|||
161931826|NCT02070380|584798708|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
161931827|NCT02070380|584798709|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
161931828|NCT02070380|584798710|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
161931829|NCT02070380|584798711|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
161931830|NCT02070380|584798708|FG000|Second Injection|Image sets missing or technically inadeq|0|||
161931831|NCT02070380|584798709|FG001|Second Injection|Image sets missing or technically inadeq|1|||
161931832|NCT02070380|584798710|FG002|Second Injection|Image sets missing or technically inadeq|0|||
161931833|NCT02070380|584798711|FG003|Second Injection|Image sets missing or technically inadeq|0|||
161931834|NCT02070380|584798708|FG000|Second Injection|Protocol Violation|0|||
161931835|NCT02070380|584798709|FG001|Second Injection|Protocol Violation|1|||
161931836|NCT02070380|584798710|FG002|Second Injection|Protocol Violation|1|||
161931837|NCT02070380|584798711|FG003|Second Injection|Protocol Violation|5|||
161931838|NCT03596983|584798726|FG000|Overall Study|Withdrawal by Subject|3|||
161931839|NCT03654326|584798727|FG000|Overall Study|Withdrawal by Subject|5|||
161931840|NCT03654326|584798728|FG001|Overall Study|Withdrawal by Subject|3|||
161931841|NCT03654326|584798727|FG000|Overall Study|Physician Decision|0|||
161931842|NCT03654326|584798728|FG001|Overall Study|Physician Decision|1|||
161931843|NCT03654326|584798727|FG000|Overall Study|Unable to adhere to study schedule|0|||
161931844|NCT03654326|584798728|FG001|Overall Study|Unable to adhere to study schedule|1|||
161931845|NCT03654326|584798727|FG000|Overall Study|Lost to Follow-up|1|||
161931846|NCT03654326|584798728|FG001|Overall Study|Lost to Follow-up|1|||
161931847|NCT05287685|584798729|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
161931848|NCT05287685|584798730|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
161931849|NCT05287685|584798729|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
161931850|NCT05287685|584798730|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
161931851|NCT04829214|584798731|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
161931852|NCT04829214|584798732|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
161931853|NCT04829214|584798731|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
161931854|NCT04829214|584798732|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
161931855|NCT06399471|584798733|FG000|Overall Study|Withdrawal by Subject|1|||
161931856|NCT00609973|584798735|FG000|Overall Study|Adverse Event|2|||
161931857|NCT00609973|584798736|FG001|Overall Study|Adverse Event|1|||
161931858|NCT00609973|584798735|FG000|Overall Study|Protocol Violation|4|||
161931859|NCT00609973|584798736|FG001|Overall Study|Protocol Violation|3|||
161931860|NCT00609973|584798735|FG000|Overall Study|Lost to Follow-up|2|||
161931861|NCT00609973|584798736|FG001|Overall Study|Lost to Follow-up|1|||
161931862|NCT00609973|584798735|FG000|Overall Study|Withdrawal by Subject|0|||
161931863|NCT00609973|584798736|FG001|Overall Study|Withdrawal by Subject|1|||
161931864|NCT01362270|584798739|FG000|Overall Study|Withdrawal by Subject|1|||
161931865|NCT01362270|584798740|FG001|Overall Study|Withdrawal by Subject|0|||
161931866|NCT01362270|584798739|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
161931867|NCT01362270|584798740|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
161931868|NCT01362270|584798739|FG000|Overall Study|Met excl. criteria before 1st session|1|||
161931869|NCT01362270|584798740|FG001|Overall Study|Met excl. criteria before 1st session|1|||
161931870|NCT01691482|584798743|FG000|Treatment Period 2|Adverse Event|0|||
161931871|NCT01691482|584798744|FG001|Treatment Period 2|Adverse Event|1|||
162202932|NCT00603278|585792759|FG003|Overall Study|Lack of Efficacy|8|||
162202933|NCT00603278|585792760|FG004|Overall Study|Lack of Efficacy|7|||
161823929|NCT00517192|584397871|FG000|Overall Study|Lost to Follow-up|1|||
161823930|NCT00517192|584397872|FG001|Overall Study|Lost to Follow-up|1|||
161823931|NCT00517192|584397871|FG000|Overall Study|Withdrawal by Subject|1|||
161823932|NCT00517192|584397872|FG001|Overall Study|Withdrawal by Subject|0|||
161823933|NCT00517192|584397871|FG000|Overall Study|Early termination of the trial|16|||
161823934|NCT00517192|584397872|FG001|Overall Study|Early termination of the trial|18|||
161823935|NCT04501094|584397876|FG000|Overall Study|Death (unrelated to research)|1|||
161823936|NCT04501094|584397877|FG001|Overall Study|Death (unrelated to research)|0|||
161823937|NCT05693805|584397880|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
161823938|NCT05693805|584397881|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
161823939|NCT02943993|584397884|FG000|Overall Study|Withdrawal by Subject|52|||
161823940|NCT02943993|584397884|FG000|Overall Study|Transfer to another institution|6|||
161823941|NCT02943993|584397884|FG000|Overall Study|Lost to Follow-up|135|||
161823942|NCT02943993|584397884|FG000|Overall Study|Death|98|||
161823943|NCT02943993|584397884|FG000|Overall Study|Other reason for premature termination|32|||
161823944|NCT02943993|584397884|FG000|Overall Study|Missing reason for termination|7|||
161823945|NCT02152982|584397886|FG000|Overall Study|Withdrawal by Subject|17|||
161823946|NCT02152982|584397887|FG001|Overall Study|Withdrawal by Subject|16|||
161823947|NCT02152982|584397886|FG000|Overall Study|Did not start treatment|11|||
161823948|NCT02152982|584397887|FG001|Overall Study|Did not start treatment|5|||
161823949|NCT02152982|584397886|FG000|Overall Study|Disease progression|41|||
161823950|NCT02152982|584397887|FG001|Overall Study|Disease progression|52|||
161823951|NCT02152982|584397886|FG000|Overall Study|Adverse Event|7|||
161823952|NCT02152982|584397887|FG001|Overall Study|Adverse Event|12|||
161823953|NCT02152982|584397886|FG000|Overall Study|Complicating disease|1|||
161823954|NCT02152982|584397887|FG001|Overall Study|Complicating disease|1|||
161823955|NCT02152982|584397886|FG000|Overall Study|Death|0|||
161823956|NCT02152982|584397887|FG001|Overall Study|Death|3|||
161823957|NCT02152982|584397886|FG000|Overall Study|Physician Decision|3|||
161823958|NCT02152982|584397887|FG001|Overall Study|Physician Decision|0|||
161823959|NCT02510261|584397888|FG000|Overall Study|Adverse Event|5|||
161823960|NCT02510261|584397889|FG001|Overall Study|Adverse Event|8|||
161823961|NCT02510261|584397890|FG002|Overall Study|Adverse Event|0|||
161823962|NCT02510261|584397888|FG000|Overall Study|Physician Decision|1|||
161823963|NCT02510261|584397889|FG001|Overall Study|Physician Decision|5|||
161823964|NCT02510261|584397890|FG002|Overall Study|Physician Decision|0|||
161823965|NCT02510261|584397888|FG000|Overall Study|Death|19|||
161823966|NCT02510261|584397889|FG001|Overall Study|Death|19|||
161823967|NCT02510261|584397890|FG002|Overall Study|Death|0|||
161823968|NCT02510261|584397888|FG000|Overall Study|Withdrawal by Subject|3|||
161823969|NCT02510261|584397889|FG001|Overall Study|Withdrawal by Subject|10|||
161823970|NCT02510261|584397890|FG002|Overall Study|Withdrawal by Subject|3|||
161823971|NCT02003222|584397892|FG000|Induction|Never started treatment|0|||
161823972|NCT02003222|584397893|FG001|Induction|Never started treatment|0|||
161823973|NCT02003222|584397894|FG002|Induction|Never started treatment|0|||
161823974|NCT02003222|584397895|FG003|Induction|Never started treatment|0|||
161823975|NCT02003222|584397896|FG004|Induction|Never started treatment|8|||
161823976|NCT02003222|584397892|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
161823977|NCT02003222|584397893|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
161823978|NCT02003222|584397894|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
161823979|NCT02003222|584397895|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
161823980|NCT02003222|584397896|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
161823981|NCT02003222|584397892|FG000|Induction|Adverse Event|0|||
161823982|NCT02003222|584397893|FG001|Induction|Adverse Event|0|||
161823983|NCT02003222|584397894|FG002|Induction|Adverse Event|0|||
161823984|NCT02003222|584397895|FG003|Induction|Adverse Event|0|||
161823985|NCT02003222|584397896|FG004|Induction|Adverse Event|13|||
161823986|NCT02003222|584397892|FG000|Induction|Alternative therapy|0|||
161823987|NCT02003222|584397893|FG001|Induction|Alternative therapy|0|||
161823988|NCT02003222|584397894|FG002|Induction|Alternative therapy|0|||
161823989|NCT02003222|584397895|FG003|Induction|Alternative therapy|0|||
161823990|NCT02003222|584397896|FG004|Induction|Alternative therapy|12|||
161823991|NCT02003222|584397892|FG000|Induction|Disease progression|0|||
161823992|NCT02003222|584397893|FG001|Induction|Disease progression|0|||
161823993|NCT02003222|584397894|FG002|Induction|Disease progression|0|||
161823994|NCT02003222|584397895|FG003|Induction|Disease progression|0|||
161823995|NCT02003222|584397896|FG004|Induction|Disease progression|22|||
161823996|NCT02003222|584397892|FG000|Induction|Death|0|||
161823997|NCT02003222|584397893|FG001|Induction|Death|0|||
161823998|NCT02003222|584397894|FG002|Induction|Death|0|||
161823999|NCT02003222|584397895|FG003|Induction|Death|0|||
161824000|NCT02003222|584397896|FG004|Induction|Death|3|||
161931872|NCT01691482|584798743|FG000|Treatment Period 2|Protocol Violation|1|||
161931873|NCT01691482|584798744|FG001|Treatment Period 2|Protocol Violation|1|||
161931874|NCT01953354|584798745|FG000|Overall Study|Withdrawal by Subject|0|||
161931875|NCT01953354|584798746|FG001|Overall Study|Withdrawal by Subject|1|||
161931876|NCT01953354|584798745|FG000|Overall Study|Decision of Sponsor|0|||
161931877|NCT01953354|584798746|FG001|Overall Study|Decision of Sponsor|1|||
161931878|NCT01953354|584798745|FG000|Overall Study|Disease Exacerbation|1|||
161931879|NCT01953354|584798746|FG001|Overall Study|Disease Exacerbation|0|||
161931880|NCT01392495|584798747|FG000|Overall Study|Death|3|||
161931881|NCT01392495|584798747|FG000|Overall Study|Administrative problems|8|||
161931882|NCT01392495|584798747|FG000|Overall Study|Withdrawal by Subject|2|||
161931883|NCT01392495|584798747|FG000|Overall Study|Adverse Event|3|||
161931884|NCT02965976|584798748|FG000|Overall Study|Withdrawal by Subject|2|||
161931885|NCT02965976|584798749|FG001|Overall Study|Withdrawal by Subject|0|||
161931886|NCT00806026|584798750|FG000|Overall Study|Death|0|||
161931887|NCT00806026|584798751|FG001|Overall Study|Death|0|||
161931888|NCT00806026|584798752|FG002|Overall Study|Death|0|||
161931889|NCT00806026|584798753|FG003|Overall Study|Death|1|||
161931890|NCT00806026|584798754|FG004|Overall Study|Death|0|||
161931891|NCT00806026|584798755|FG005|Overall Study|Death|0|||
161931892|NCT00806026|584798750|FG000|Overall Study|Did not meet entrance criteria|4|||
161931893|NCT00806026|584798751|FG001|Overall Study|Did not meet entrance criteria|1|||
161931894|NCT00806026|584798752|FG002|Overall Study|Did not meet entrance criteria|2|||
161931895|NCT00806026|584798753|FG003|Overall Study|Did not meet entrance criteria|1|||
161931896|NCT00806026|584798754|FG004|Overall Study|Did not meet entrance criteria|0|||
161931897|NCT00806026|584798755|FG005|Overall Study|Did not meet entrance criteria|0|||
161931898|NCT00806026|584798750|FG000|Overall Study|Lack of Efficacy|5|||
161931899|NCT00806026|584798751|FG001|Overall Study|Lack of Efficacy|18|||
161931900|NCT00806026|584798752|FG002|Overall Study|Lack of Efficacy|13|||
161931901|NCT00806026|584798753|FG003|Overall Study|Lack of Efficacy|4|||
161931902|NCT00806026|584798754|FG004|Overall Study|Lack of Efficacy|8|||
161931903|NCT00806026|584798755|FG005|Overall Study|Lack of Efficacy|7|||
161931904|NCT00806026|584798750|FG000|Overall Study|Lost to Follow-up|8|||
161931905|NCT00806026|584798751|FG001|Overall Study|Lost to Follow-up|15|||
161931906|NCT00806026|584798752|FG002|Overall Study|Lost to Follow-up|8|||
161931907|NCT00806026|584798753|FG003|Overall Study|Lost to Follow-up|2|||
161931908|NCT00806026|584798754|FG004|Overall Study|Lost to Follow-up|6|||
161931909|NCT00806026|584798755|FG005|Overall Study|Lost to Follow-up|6|||
161931910|NCT00806026|584798750|FG000|Overall Study|Withdrawal by Subject|14|||
161931911|NCT00806026|584798751|FG001|Overall Study|Withdrawal by Subject|17|||
161931912|NCT00806026|584798752|FG002|Overall Study|Withdrawal by Subject|9|||
161931913|NCT00806026|584798753|FG003|Overall Study|Withdrawal by Subject|2|||
161931914|NCT00806026|584798754|FG004|Overall Study|Withdrawal by Subject|5|||
161931915|NCT00806026|584798755|FG005|Overall Study|Withdrawal by Subject|3|||
161931916|NCT00806026|584798750|FG000|Overall Study|Other|3|||
161931917|NCT00806026|584798751|FG001|Overall Study|Other|6|||
161931918|NCT00806026|584798752|FG002|Overall Study|Other|8|||
161931919|NCT00806026|584798753|FG003|Overall Study|Other|2|||
161931920|NCT00806026|584798754|FG004|Overall Study|Other|0|||
161931921|NCT00806026|584798755|FG005|Overall Study|Other|4|||
161931922|NCT00806026|584798750|FG000|Overall Study|Protocol Violation|6|||
161931923|NCT00806026|584798751|FG001|Overall Study|Protocol Violation|9|||
161931924|NCT00806026|584798752|FG002|Overall Study|Protocol Violation|9|||
161931925|NCT00806026|584798753|FG003|Overall Study|Protocol Violation|0|||
161931926|NCT00806026|584798754|FG004|Overall Study|Protocol Violation|2|||
161931927|NCT00806026|584798755|FG005|Overall Study|Protocol Violation|3|||
161931928|NCT00806026|584798750|FG000|Overall Study|Adverse Event|52|||
161931929|NCT00806026|584798751|FG001|Overall Study|Adverse Event|35|||
161931930|NCT00806026|584798752|FG002|Overall Study|Adverse Event|44|||
161931931|NCT00806026|584798753|FG003|Overall Study|Adverse Event|17|||
161931932|NCT00806026|584798754|FG004|Overall Study|Adverse Event|9|||
161931933|NCT00806026|584798755|FG005|Overall Study|Adverse Event|9|||
161931934|NCT00819832|584798756|FG000|Overall Study|Sponsor Termination of Study|3|||
161931935|NCT00819832|584798757|FG001|Overall Study|Sponsor Termination of Study|0|||
161931936|NCT00819832|584798758|FG002|Overall Study|Sponsor Termination of Study|0|||
161931937|NCT00819832|584798759|FG003|Overall Study|Sponsor Termination of Study|0|||
161931938|NCT00819832|584798760|FG004|Overall Study|Sponsor Termination of Study|0|||
161931939|NCT00819832|584798761|FG005|Overall Study|Sponsor Termination of Study|0|||
161931940|NCT01370642|584798765|FG000|Overall Study|Adverse Event|2|||
161931941|NCT01370642|584798766|FG001|Overall Study|Adverse Event|1|||
161931942|NCT01370642|584798767|FG002|Overall Study|Adverse Event|1|||
161931943|NCT01370642|584798765|FG000|Overall Study|Detectable HCV RNA|0|||
161931944|NCT01370642|584798766|FG001|Overall Study|Detectable HCV RNA|0|||
161931945|NCT01370642|584798767|FG002|Overall Study|Detectable HCV RNA|22|||
161931946|NCT01370642|584798765|FG000|Overall Study|Lost to Follow-up|0|||
161931947|NCT01370642|584798766|FG001|Overall Study|Lost to Follow-up|0|||
161931948|NCT01370642|584798767|FG002|Overall Study|Lost to Follow-up|1|||
161931949|NCT01370642|584798765|FG000|Overall Study|Physician Decision|4|||
161931950|NCT01370642|584798766|FG001|Overall Study|Physician Decision|1|||
161824001|NCT02003222|584397892|FG000|Induction|Withdrawal by Subject|0|||
161824002|NCT02003222|584397893|FG001|Induction|Withdrawal by Subject|0|||
161824003|NCT02003222|584397894|FG002|Induction|Withdrawal by Subject|0|||
161824004|NCT02003222|584397895|FG003|Induction|Withdrawal by Subject|0|||
161824005|NCT02003222|584397896|FG004|Induction|Withdrawal by Subject|8|||
161824006|NCT02003222|584397892|FG000|Induction|Other reasons|0|||
162202934|NCT00603278|585792761|FG005|Overall Study|Lack of Efficacy|14|||
162202935|NCT00603278|585792756|FG000|Overall Study|Adverse Event|0|||
162202936|NCT00603278|585792757|FG001|Overall Study|Adverse Event|3|||
162202937|NCT00603278|585792758|FG002|Overall Study|Adverse Event|1|||
162202938|NCT00603278|585792759|FG003|Overall Study|Adverse Event|0|||
162202939|NCT00603278|585792760|FG004|Overall Study|Adverse Event|2|||
162202940|NCT00603278|585792761|FG005|Overall Study|Adverse Event|1|||
162202941|NCT00603278|585792756|FG000|Overall Study|Withdrawal by Subject|2|||
162202942|NCT00603278|585792757|FG001|Overall Study|Withdrawal by Subject|3|||
162202943|NCT00603278|585792758|FG002|Overall Study|Withdrawal by Subject|1|||
162202944|NCT00603278|585792759|FG003|Overall Study|Withdrawal by Subject|2|||
162202945|NCT00603278|585792760|FG004|Overall Study|Withdrawal by Subject|1|||
162202946|NCT00603278|585792761|FG005|Overall Study|Withdrawal by Subject|2|||
162202947|NCT00603278|585792756|FG000|Overall Study|Protocol Violation|3|||
162202948|NCT00603278|585792757|FG001|Overall Study|Protocol Violation|0|||
162202949|NCT00603278|585792758|FG002|Overall Study|Protocol Violation|1|||
162202950|NCT00603278|585792759|FG003|Overall Study|Protocol Violation|1|||
162202951|NCT00603278|585792760|FG004|Overall Study|Protocol Violation|0|||
162202952|NCT00603278|585792761|FG005|Overall Study|Protocol Violation|1|||
162202953|NCT00603278|585792756|FG000|Overall Study|Physician Decision|0|||
162202954|NCT00603278|585792757|FG001|Overall Study|Physician Decision|1|||
162202955|NCT00603278|585792758|FG002|Overall Study|Physician Decision|0|||
162202956|NCT00603278|585792759|FG003|Overall Study|Physician Decision|0|||
162202957|NCT00603278|585792760|FG004|Overall Study|Physician Decision|2|||
162202958|NCT00603278|585792761|FG005|Overall Study|Physician Decision|1|||
162202959|NCT00603278|585792756|FG000|Overall Study|Lost to Follow-up|1|||
162202960|NCT00603278|585792757|FG001|Overall Study|Lost to Follow-up|0|||
162202961|NCT00603278|585792758|FG002|Overall Study|Lost to Follow-up|0|||
162202962|NCT00603278|585792759|FG003|Overall Study|Lost to Follow-up|0|||
162202963|NCT00603278|585792760|FG004|Overall Study|Lost to Follow-up|1|||
162202964|NCT00603278|585792761|FG005|Overall Study|Lost to Follow-up|0|||
162202965|NCT00500539|585792762|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
162202966|NCT00500539|585792762|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
162202967|NCT00500539|585792762|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
162202968|NCT00500539|585792762|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
162202969|NCT00500539|585792762|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
162202970|NCT00500539|585792762|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
162202971|NCT00500539|585792762|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
162202972|NCT00500539|585792762|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
162202973|NCT00500539|585792762|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
162202974|NCT00500539|585792762|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
162202975|NCT00500539|585792762|FG000|Follow-up Period (16 Weeks)|Death|1|||
162202976|NCT00500539|585792762|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
162202977|NCT00500539|585792762|FG000|Follow-up Period (16 Weeks)|Missing|3|||
162202978|NCT04853394|585792763|FG000|Follow-up Interviews|Lost to Follow-up|22|||
162202979|NCT04853394|585792764|FG001|Follow-up Interviews|Lost to Follow-up|15|||
162202980|NCT01123642|585792767|FG000|Overall Study|Lost to Follow-up|23|||
162202981|NCT01123642|585792767|FG000|Overall Study|Withdrawal by Subject|9|||
162202982|NCT01123642|585792767|FG000|Overall Study|ineligible at baseline assessment|36|||
162202983|NCT04853238|585792768|FG000|Overall Study|Death|4|||
162202984|NCT04853238|585792769|FG001|Overall Study|Death|0|||
162202985|NCT04853238|585792770|FG002|Overall Study|Death|2|||
162202986|NCT04853238|585792768|FG000|Overall Study|Lost to Follow-up|16|||
162202987|NCT04853238|585792769|FG001|Overall Study|Lost to Follow-up|2|||
162202988|NCT04853238|585792770|FG002|Overall Study|Lost to Follow-up|37|||
162202989|NCT04853238|585792768|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
162202990|NCT04853238|585792769|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
162202991|NCT04853238|585792770|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
162202992|NCT04853238|585792768|FG000|Overall Study|Withdrawal by Subject|6|||
162202993|NCT04853238|585792769|FG001|Overall Study|Withdrawal by Subject|0|||
162202994|NCT04853238|585792770|FG002|Overall Study|Withdrawal by Subject|21|||
162202995|NCT04853238|585792768|FG000|Overall Study|Physician Decision|0|||
162202996|NCT04853238|585792769|FG001|Overall Study|Physician Decision|0|||
162202997|NCT04853238|585792770|FG002|Overall Study|Physician Decision|2|||
162202998|NCT04853238|585792768|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
162202999|NCT04853238|585792769|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
162203000|NCT04853238|585792770|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
162203001|NCT01772147|585794479|FG000|Overall Study|Adverse Event|13|||
162203002|NCT01772147|585794480|FG001|Overall Study|Adverse Event|10|||
162203003|NCT01772147|585794481|FG002|Overall Study|Adverse Event|6|||
162203004|NCT01772147|585794479|FG000|Overall Study|Withdrew Consent|7|||
162203005|NCT01772147|585794480|FG001|Overall Study|Withdrew Consent|8|||
162203006|NCT01772147|585794481|FG002|Overall Study|Withdrew Consent|4|||
162203007|NCT01772147|585794479|FG000|Overall Study|Lost to Follow-up|1|||
162203008|NCT01772147|585794480|FG001|Overall Study|Lost to Follow-up|0|||
162203009|NCT01772147|585794481|FG002|Overall Study|Lost to Follow-up|1|||
162203010|NCT01772147|585794479|FG000|Overall Study|Protocol Deviation|2|||
162203011|NCT01772147|585794480|FG001|Overall Study|Protocol Deviation|1|||
162203012|NCT01772147|585794481|FG002|Overall Study|Protocol Deviation|1|||
162203013|NCT01772147|585794479|FG000|Overall Study|Lack of Efficacy|8|||
162203014|NCT01772147|585794480|FG001|Overall Study|Lack of Efficacy|6|||
162203015|NCT01772147|585794481|FG002|Overall Study|Lack of Efficacy|6|||
162203016|NCT00796614|585794482|FG000|Overall Study|Adverse Event|1|||
162203017|NCT00796614|585794483|FG001|Overall Study|Adverse Event|2|||
162203018|NCT00796614|585794484|FG002|Overall Study|Adverse Event|0|||
162203019|NCT00796614|585794485|FG003|Overall Study|Adverse Event|0|||
162203020|NCT00796614|585794482|FG000|Overall Study|Protocol Violation|0|||
162203021|NCT00796614|585794483|FG001|Overall Study|Protocol Violation|0|||
162203022|NCT00796614|585794484|FG002|Overall Study|Protocol Violation|2|||
162203023|NCT00796614|585794485|FG003|Overall Study|Protocol Violation|0|||
162203024|NCT00796614|585794482|FG000|Overall Study|Lost to Follow-up|2|||
162203025|NCT00796614|585794483|FG001|Overall Study|Lost to Follow-up|2|||
162203026|NCT00796614|585794484|FG002|Overall Study|Lost to Follow-up|1|||
162203027|NCT00796614|585794485|FG003|Overall Study|Lost to Follow-up|0|||
162203028|NCT00796614|585794482|FG000|Overall Study|Withdrawal by Subject|1|||
162203029|NCT00796614|585794483|FG001|Overall Study|Withdrawal by Subject|0|||
162203030|NCT00796614|585794484|FG002|Overall Study|Withdrawal by Subject|0|||
162203031|NCT00796614|585794485|FG003|Overall Study|Withdrawal by Subject|1|||
162203032|NCT00796614|585794482|FG000|Overall Study|Other than stated|1|||
162203033|NCT00796614|585794483|FG001|Overall Study|Other than stated|0|||
162203034|NCT00796614|585794484|FG002|Overall Study|Other than stated|0|||
162203035|NCT00796614|585794485|FG003|Overall Study|Other than stated|0|||
162203036|NCT00740597|585794486|FG000|Overall Study|insurance would not cover treatment|1|||
162203037|NCT01983462|585794493|FG000|Overall Study|Adverse Event|1|||
162203038|NCT01983462|585794494|FG001|Overall Study|Adverse Event|0|||
162203039|NCT01983462|585794495|FG002|Overall Study|Adverse Event|0|||
162203040|NCT01902381|585794496|FG000|Overall Study|Withdrawal by Subject|1|||
162203041|NCT02762500|585794499|FG000|Overall Study|Lack of Efficacy|1|||
162203042|NCT02762500|585794500|FG001|Overall Study|Lack of Efficacy|0|||
162203043|NCT02762500|585794499|FG000|Overall Study|Withdrawal by Subject|1|||
162203044|NCT02762500|585794500|FG001|Overall Study|Withdrawal by Subject|1|||
162203045|NCT02762500|585794499|FG000|Overall Study|Adverse Event|0|||
162203046|NCT02762500|585794500|FG001|Overall Study|Adverse Event|2|||
162203047|NCT00488319|585794505|FG000|Overall Study|Adverse Event|1|||
162203048|NCT00488319|585794506|FG001|Overall Study|Adverse Event|2|||
162203049|NCT00488319|585794507|FG002|Overall Study|Adverse Event|23|||
162203050|NCT00488319|585794505|FG000|Overall Study|Lack of Efficacy|6|||
162203051|NCT00488319|585794506|FG001|Overall Study|Lack of Efficacy|12|||
162203052|NCT00488319|585794507|FG002|Overall Study|Lack of Efficacy|27|||
161931951|NCT01370642|584798767|FG002|Overall Study|Physician Decision|2|||
161931952|NCT01370642|584798765|FG000|Overall Study|Withdrawal by Subject|2|||
161931953|NCT01370642|584798766|FG001|Overall Study|Withdrawal by Subject|4|||
161931954|NCT01370642|584798767|FG002|Overall Study|Withdrawal by Subject|3|||
161931955|NCT00147537|584798774|FG000|Phase 1b|Death|0|||
161931956|NCT00147537|584798775|FG001|Phase 1b|Death|1|||
161931957|NCT00147537|584798776|FG002|Phase 1b|Death|2|||
161931958|NCT00147537|584798777|FG003|Phase 1b|Death|1|||
162203053|NCT00488319|585794505|FG000|Overall Study|Lost to Follow-up|3|||
162203054|NCT00488319|585794506|FG001|Overall Study|Lost to Follow-up|5|||
162203055|NCT00488319|585794507|FG002|Overall Study|Lost to Follow-up|16|||
162203056|NCT00488319|585794505|FG000|Overall Study|Withdrawal by Subject|5|||
162203057|NCT00488319|585794506|FG001|Overall Study|Withdrawal by Subject|20|||
162203058|NCT00488319|585794507|FG002|Overall Study|Withdrawal by Subject|44|||
162203059|NCT00488319|585794505|FG000|Overall Study|Other reasons for withdrawal|0|||
162203060|NCT00488319|585794506|FG001|Overall Study|Other reasons for withdrawal|4|||
162203061|NCT00488319|585794507|FG002|Overall Study|Other reasons for withdrawal|12|||
162203062|NCT00632931|585794518|FG000|Part 1, Period 1|Protocol Violation|1|||
161931959|NCT00147537|584798778|FG004|Phase 1b|Death|2|||
162203063|NCT00632931|585794519|FG001|Part 1, Period 1|Protocol Violation|0|||
162203064|NCT00632931|585794520|FG002|Part 1, Period 1|Protocol Violation|0|||
162203065|NCT00632931|585794518|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
162203066|NCT00632931|585794519|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
162203067|NCT00632931|585794520|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
162203068|NCT00632931|585794518|FG000|Part 2|Adverse Event|0|||
162203069|NCT00632931|585794519|FG001|Part 2|Adverse Event|0|||
162203070|NCT00632931|585794520|FG002|Part 2|Adverse Event|3|||
162203071|NCT00632931|585794518|FG000|Part 2|Death|0|||
162203072|NCT00632931|585794519|FG001|Part 2|Death|0|||
162203073|NCT00632931|585794520|FG002|Part 2|Death|1|||
162203074|NCT00632931|585794518|FG000|Part 2|Lack of Efficacy|0|||
162203075|NCT00632931|585794519|FG001|Part 2|Lack of Efficacy|0|||
162203076|NCT00632931|585794520|FG002|Part 2|Lack of Efficacy|17|||
162203077|NCT00632931|585794518|FG000|Part 2|Withdrawal by Subject|0|||
162203078|NCT00632931|585794519|FG001|Part 2|Withdrawal by Subject|0|||
162203079|NCT00632931|585794520|FG002|Part 2|Withdrawal by Subject|3|||
162203080|NCT02499835|585794526|FG000|Overall Study|Withdrawal by Subject|1|||
162203081|NCT02499835|585794527|FG001|Overall Study|Withdrawal by Subject|0|||
162203082|NCT02499835|585794528|FG002|Overall Study|Withdrawal by Subject|0|||
162203083|NCT02499835|585794529|FG003|Overall Study|Withdrawal by Subject|1|||
162203084|NCT02499835|585794526|FG000|Overall Study|Physician Decision|0|||
162203085|NCT02499835|585794527|FG001|Overall Study|Physician Decision|3|||
162203086|NCT02499835|585794528|FG002|Overall Study|Physician Decision|18|||
162203087|NCT02499835|585794529|FG003|Overall Study|Physician Decision|7|||
162203088|NCT02499835|585794526|FG000|Overall Study|Adverse Event|0|||
162203089|NCT02499835|585794527|FG001|Overall Study|Adverse Event|0|||
162203090|NCT02499835|585794528|FG002|Overall Study|Adverse Event|0|||
162203091|NCT02499835|585794529|FG003|Overall Study|Adverse Event|1|||
162203092|NCT02499835|585794526|FG000|Overall Study|Disease progression|2|||
162203093|NCT02499835|585794527|FG001|Overall Study|Disease progression|1|||
162203094|NCT02499835|585794528|FG002|Overall Study|Disease progression|0|||
162203095|NCT02499835|585794529|FG003|Overall Study|Disease progression|7|||
162203096|NCT03319719|585794537|FG000|Overall Study|Lost to Follow-up|1|||
162203097|NCT03193216|585794538|FG000|Overall Study|Lost to Follow-up|1|||
162203098|NCT03193216|585794539|FG001|Overall Study|Lost to Follow-up|0|||
162203099|NCT03193216|585794538|FG000|Overall Study|Withdrawal by Subject|5|||
162203100|NCT03193216|585794539|FG001|Overall Study|Withdrawal by Subject|0|||
162203101|NCT03193216|585794538|FG000|Overall Study|Physician Decision|4|||
162203102|NCT03193216|585794539|FG001|Overall Study|Physician Decision|0|||
162203103|NCT02490878|585794540|FG000|Overall Study|deemed ineligible|0|||
162203104|NCT02490878|585794541|FG001|Overall Study|deemed ineligible|1|||
162203105|NCT02490878|585794540|FG000|Overall Study|progression prior to treatment|0|||
162203106|NCT02490878|585794541|FG001|Overall Study|progression prior to treatment|1|||
162203107|NCT02490878|585794540|FG000|Overall Study|only submitted baseline QOL|0|||
162203108|NCT02490878|585794541|FG001|Overall Study|only submitted baseline QOL|1|||
162203109|NCT00317603|585794544|FG000|Overall Study|Progressive Disease|3|||
162203110|NCT00523549|585794545|FG000|Overall Study|Adverse Event|6|||
162203111|NCT00523549|585794546|FG001|Overall Study|Adverse Event|3|||
162203112|NCT00523549|585794545|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162203113|NCT00523549|585794546|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162203114|NCT00523549|585794545|FG000|Overall Study|Protocol Deviation|3|||
162203115|NCT00523549|585794546|FG001|Overall Study|Protocol Deviation|1|||
162203116|NCT00523549|585794545|FG000|Overall Study|Patient withdrew consent|7|||
162203117|NCT00523549|585794546|FG001|Overall Study|Patient withdrew consent|6|||
162203118|NCT00523549|585794545|FG000|Overall Study|Lost to Follow-up|3|||
162203119|NCT00523549|585794546|FG001|Overall Study|Lost to Follow-up|5|||
162203120|NCT00843115|585794547|FG000|Overall Study|Death|4|||
162203121|NCT00843115|585794547|FG000|Overall Study|Adverse Event|30|||
162203122|NCT00843115|585794547|FG000|Overall Study|Lost to Follow-up|4|||
162203123|NCT00843115|585794547|FG000|Overall Study|Withdrawal by Subject|17|||
162203124|NCT00843115|585794547|FG000|Overall Study|Family wanted meds stopped|1|||
162203125|NCT00843115|585794547|FG000|Overall Study|Family does not want continuation|1|||
162203126|NCT00843115|585794547|FG000|Overall Study|Patient forgot to take meds|1|||
162203127|NCT00843115|585794547|FG000|Overall Study|Does not meet entrance criteria|1|||
162203128|NCT00843115|585794547|FG000|Overall Study|Physician Decision|1|||
162203129|NCT00843115|585794547|FG000|Overall Study|Family discontinued meds|1|||
162203130|NCT00843115|585794547|FG000|Overall Study|patient took for 2 days then stopped|1|||
162203131|NCT00843115|585794547|FG000|Overall Study|patient never took the medication|1|||
162203132|NCT00843115|585794547|FG000|Overall Study|hospitalized due to deterioration|1|||
162203133|NCT00843115|585794547|FG000|Overall Study|week 12 not done|1|||
162203134|NCT00843115|585794547|FG000|Overall Study|Syndrome De Glissement|1|||
162203135|NCT02005029|585794548|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
162203136|NCT02005029|585794549|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
162203137|NCT02621047|585794550|FG000|Overall Study|Adverse Event|0|||
162203138|NCT02621047|585794551|FG001|Overall Study|Adverse Event|0|||
162203139|NCT02621047|585794552|FG002|Overall Study|Adverse Event|1|||
162203140|NCT03772041|585794555|FG000|Overall Study|Adverse Event|8|||
162203141|NCT03772041|585794556|FG001|Overall Study|Adverse Event|3|||
162203142|NCT03772041|585794555|FG000|Overall Study|Withdrawal by Subject|0|||
162203143|NCT03772041|585794556|FG001|Overall Study|Withdrawal by Subject|2|||
162203144|NCT03772041|585794555|FG000|Overall Study|Protocol Violation|4|||
162203145|NCT03772041|585794556|FG001|Overall Study|Protocol Violation|2|||
162203146|NCT03772041|585794555|FG000|Overall Study|Physician Decision|2|||
162203147|NCT03772041|585794556|FG001|Overall Study|Physician Decision|3|||
162203148|NCT03371485|585794559|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
162203149|NCT03371485|585794559|FG000|2-year Follow-up|Death|5|||
162203150|NCT01264887|585794560|FG000|Overall Study|Adverse Event|5|||
162203151|NCT01264887|585794560|FG000|Overall Study|Death|7|||
162203152|NCT01264887|585794560|FG000|Overall Study|Lack of Efficacy|5|||
162203153|NCT01264887|585794560|FG000|Overall Study|Physician Decision|4|||
162203154|NCT01264887|585794560|FG000|Overall Study|Withdrawal by Subject|6|||
162203155|NCT01264887|585794560|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
162203156|NCT01264887|585794560|FG000|Overall Study|Other|2|||
162203157|NCT00677092|585794566|FG000|Overall Study|Adverse Event|1|||
162203158|NCT00677092|585794566|FG000|Overall Study|Lost to Follow-up|1|||
162203159|NCT00677092|585794566|FG000|Overall Study|Withdrawal by Subject|3|||
162203160|NCT00677092|585794566|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
162203161|NCT04772313|585794571|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
162203162|NCT04772313|585794571|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
162203163|NCT02215954|585794572|FG000|Overall Study|Adverse Event|0|||
162203164|NCT02215954|585794573|FG001|Overall Study|Adverse Event|0|||
162203165|NCT02215954|585794574|FG002|Overall Study|Adverse Event|1|||
162203166|NCT02215954|585794572|FG000|Overall Study|Withdrawal by Subject|0|||
162203167|NCT02215954|585794573|FG001|Overall Study|Withdrawal by Subject|0|||
162203168|NCT02215954|585794574|FG002|Overall Study|Withdrawal by Subject|2|||
162203169|NCT02215954|585794572|FG000|Overall Study|Not exposed|1|||
162203170|NCT02215954|585794573|FG001|Overall Study|Not exposed|1|||
162203171|NCT02215954|585794574|FG002|Overall Study|Not exposed|3|||
162203172|NCT00784277|585794578|FG000|IR Treatment|Adverse Event|4|||
162203173|NCT00784277|585794579|FG001|IR Treatment|Adverse Event|8|||
162203174|NCT00784277|585794580|FG002|IR Treatment|Adverse Event|19|||
162203175|NCT00784277|585794581|FG003|IR Treatment|Adverse Event|35|||
162203176|NCT00784277|585794582|FG004|IR Treatment|Adverse Event|0|||
162203177|NCT00784277|585794583|FG005|IR Treatment|Adverse Event|0|||
162203178|NCT00784277|585794584|FG006|IR Treatment|Adverse Event|0|||
162203179|NCT00784277|585794578|FG000|IR Treatment|Lack of Efficacy|4|||
162203180|NCT00784277|585794579|FG001|IR Treatment|Lack of Efficacy|4|||
162203181|NCT00784277|585794580|FG002|IR Treatment|Lack of Efficacy|1|||
162203182|NCT00784277|585794581|FG003|IR Treatment|Lack of Efficacy|0|||
162203183|NCT00784277|585794582|FG004|IR Treatment|Lack of Efficacy|0|||
162203184|NCT00784277|585794583|FG005|IR Treatment|Lack of Efficacy|0|||
161677055|NCT00880555|583871982|FG002|Overall Study|Withdrawal by Subject|0|||
161824007|NCT02003222|584397893|FG001|Induction|Other reasons|0|||
162203185|NCT00784277|585794584|FG006|IR Treatment|Lack of Efficacy|0|||
162203186|NCT00784277|585794578|FG000|IR Treatment|Lost to Follow-up|1|||
162203187|NCT00784277|585794579|FG001|IR Treatment|Lost to Follow-up|0|||
162203188|NCT00784277|585794580|FG002|IR Treatment|Lost to Follow-up|1|||
162203189|NCT00784277|585794581|FG003|IR Treatment|Lost to Follow-up|0|||
162203190|NCT00784277|585794582|FG004|IR Treatment|Lost to Follow-up|0|||
162203191|NCT00784277|585794583|FG005|IR Treatment|Lost to Follow-up|0|||
162203192|NCT00784277|585794584|FG006|IR Treatment|Lost to Follow-up|0|||
162203193|NCT00784277|585794578|FG000|IR Treatment|Withdrawal by Subject|5|||
162203194|NCT00784277|585794579|FG001|IR Treatment|Withdrawal by Subject|1|||
161824008|NCT02003222|584397894|FG002|Induction|Other reasons|0|||
161824009|NCT02003222|584397895|FG003|Induction|Other reasons|0|||
161824010|NCT02003222|584397896|FG004|Induction|Other reasons|22|||
161824011|NCT02003222|584397892|FG000|Intensification|Never started treatment|0|||
161824012|NCT02003222|584397893|FG001|Intensification|Never started treatment|0|||
161824013|NCT02003222|584397894|FG002|Intensification|Never started treatment|0|||
161824014|NCT02003222|584397895|FG003|Intensification|Never started treatment|0|||
161824015|NCT02003222|584397896|FG004|Intensification|Never started treatment|2|||
161824016|NCT02003222|584397892|FG000|Intensification|Adverse Event|0|||
161824017|NCT02003222|584397893|FG001|Intensification|Adverse Event|0|||
161824018|NCT02003222|584397894|FG002|Intensification|Adverse Event|0|||
161824019|NCT02003222|584397895|FG003|Intensification|Adverse Event|0|||
161824020|NCT02003222|584397896|FG004|Intensification|Adverse Event|6|||
161824021|NCT02003222|584397892|FG000|Intensification|Alternative therapy|0|||
161824022|NCT02003222|584397893|FG001|Intensification|Alternative therapy|0|||
161824023|NCT02003222|584397894|FG002|Intensification|Alternative therapy|0|||
161824024|NCT02003222|584397895|FG003|Intensification|Alternative therapy|0|||
161824025|NCT02003222|584397896|FG004|Intensification|Alternative therapy|8|||
161824026|NCT02003222|584397892|FG000|Intensification|Disease progression|0|||
161824027|NCT02003222|584397893|FG001|Intensification|Disease progression|0|||
161824028|NCT02003222|584397894|FG002|Intensification|Disease progression|0|||
161824029|NCT02003222|584397895|FG003|Intensification|Disease progression|0|||
161824030|NCT02003222|584397896|FG004|Intensification|Disease progression|18|||
161824031|NCT02003222|584397892|FG000|Intensification|Withdrawal by Subject|0|||
161824032|NCT02003222|584397893|FG001|Intensification|Withdrawal by Subject|0|||
162203195|NCT00784277|585794580|FG002|IR Treatment|Withdrawal by Subject|4|||
162203196|NCT00784277|585794581|FG003|IR Treatment|Withdrawal by Subject|6|||
162203197|NCT00784277|585794582|FG004|IR Treatment|Withdrawal by Subject|0|||
162203198|NCT00784277|585794583|FG005|IR Treatment|Withdrawal by Subject|0|||
162203199|NCT00784277|585794584|FG006|IR Treatment|Withdrawal by Subject|0|||
162203200|NCT00784277|585794578|FG000|IR Treatment|Resolution Of Pain|0|||
162203201|NCT00784277|585794579|FG001|IR Treatment|Resolution Of Pain|1|||
162203202|NCT00784277|585794580|FG002|IR Treatment|Resolution Of Pain|0|||
162203203|NCT00784277|585794581|FG003|IR Treatment|Resolution Of Pain|0|||
162203204|NCT00784277|585794582|FG004|IR Treatment|Resolution Of Pain|0|||
162203205|NCT00784277|585794583|FG005|IR Treatment|Resolution Of Pain|0|||
162203206|NCT00784277|585794584|FG006|IR Treatment|Resolution Of Pain|0|||
162203207|NCT00784277|585794578|FG000|IR Treatment|Other|2|||
162203208|NCT00784277|585794579|FG001|IR Treatment|Other|3|||
162203209|NCT00784277|585794580|FG002|IR Treatment|Other|3|||
162203210|NCT00784277|585794581|FG003|IR Treatment|Other|2|||
162203211|NCT00784277|585794582|FG004|IR Treatment|Other|0|||
162203212|NCT00784277|585794583|FG005|IR Treatment|Other|0|||
162203213|NCT00784277|585794584|FG006|IR Treatment|Other|0|||
162203214|NCT00784277|585794578|FG000|ER Treatment|Adverse Event|0|||
162203215|NCT00784277|585794579|FG001|ER Treatment|Adverse Event|0|||
162203216|NCT00784277|585794580|FG002|ER Treatment|Adverse Event|0|||
162203217|NCT00784277|585794581|FG003|ER Treatment|Adverse Event|0|||
162203218|NCT00784277|585794582|FG004|ER Treatment|Adverse Event|1|||
162203219|NCT00784277|585794583|FG005|ER Treatment|Adverse Event|7|||
162203220|NCT00784277|585794584|FG006|ER Treatment|Adverse Event|7|||
162203221|NCT00784277|585794578|FG000|ER Treatment|Lack of Efficacy|0|||
162203222|NCT00784277|585794579|FG001|ER Treatment|Lack of Efficacy|0|||
162203223|NCT00784277|585794580|FG002|ER Treatment|Lack of Efficacy|0|||
162203224|NCT00784277|585794581|FG003|ER Treatment|Lack of Efficacy|0|||
162203225|NCT00784277|585794582|FG004|ER Treatment|Lack of Efficacy|3|||
162203226|NCT00784277|585794583|FG005|ER Treatment|Lack of Efficacy|4|||
162203227|NCT00784277|585794584|FG006|ER Treatment|Lack of Efficacy|0|||
162203228|NCT00784277|585794578|FG000|ER Treatment|Lost to Follow-up|0|||
162203229|NCT00784277|585794579|FG001|ER Treatment|Lost to Follow-up|0|||
162203230|NCT00784277|585794580|FG002|ER Treatment|Lost to Follow-up|0|||
162203231|NCT00784277|585794581|FG003|ER Treatment|Lost to Follow-up|0|||
162203232|NCT00784277|585794582|FG004|ER Treatment|Lost to Follow-up|0|||
162203233|NCT00784277|585794583|FG005|ER Treatment|Lost to Follow-up|2|||
162203234|NCT00784277|585794584|FG006|ER Treatment|Lost to Follow-up|0|||
162203235|NCT00784277|585794578|FG000|ER Treatment|Withdrawal by Subject|0|||
162203236|NCT00784277|585794579|FG001|ER Treatment|Withdrawal by Subject|0|||
162203237|NCT00784277|585794580|FG002|ER Treatment|Withdrawal by Subject|0|||
162203238|NCT00784277|585794581|FG003|ER Treatment|Withdrawal by Subject|0|||
162203239|NCT00784277|585794582|FG004|ER Treatment|Withdrawal by Subject|2|||
162203240|NCT00784277|585794583|FG005|ER Treatment|Withdrawal by Subject|5|||
162203241|NCT00784277|585794584|FG006|ER Treatment|Withdrawal by Subject|3|||
162203242|NCT00784277|585794578|FG000|ER Treatment|Study Medication Non-Compliant|0|||
162203243|NCT00784277|585794579|FG001|ER Treatment|Study Medication Non-Compliant|0|||
162203244|NCT00784277|585794580|FG002|ER Treatment|Study Medication Non-Compliant|0|||
162203245|NCT00784277|585794581|FG003|ER Treatment|Study Medication Non-Compliant|0|||
162203246|NCT00784277|585794582|FG004|ER Treatment|Study Medication Non-Compliant|2|||
162203247|NCT00784277|585794583|FG005|ER Treatment|Study Medication Non-Compliant|3|||
162203248|NCT00784277|585794584|FG006|ER Treatment|Study Medication Non-Compliant|3|||
162203249|NCT00784277|585794578|FG000|ER Treatment|Other|0|||
162203250|NCT00784277|585794579|FG001|ER Treatment|Other|0|||
162203251|NCT00784277|585794580|FG002|ER Treatment|Other|0|||
162203252|NCT00784277|585794581|FG003|ER Treatment|Other|0|||
162203253|NCT00784277|585794582|FG004|ER Treatment|Other|1|||
162203254|NCT00784277|585794583|FG005|ER Treatment|Other|3|||
162203255|NCT00784277|585794584|FG006|ER Treatment|Other|2|||
162203256|NCT01093222|585794585|FG000|Overall Study|Ineligible|6|||
162203257|NCT01093222|585794585|FG000|Overall Study|Adverse Event|7|||
162203258|NCT01093222|585794585|FG000|Overall Study|Progression/relapse|24|||
162203259|NCT01093222|585794585|FG000|Overall Study|Death|2|||
162203260|NCT01093222|585794585|FG000|Overall Study|Not protocol specified|1|||
162203261|NCT04194541|585794586|FG000|Day 1 Through 13|Lost to Follow-up|3|||
162203262|NCT04194541|585794586|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
162203263|NCT04194541|585794586|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
162203264|NCT02567227|585794587|FG000|9 Weeks|Adverse Event|5|||
162203265|NCT02567227|585794588|FG001|9 Weeks|Adverse Event|5|||
162203266|NCT02567227|585794587|FG000|9 Weeks|Withdrawal by Subject|18|||
162203267|NCT02567227|585794588|FG001|9 Weeks|Withdrawal by Subject|8|||
162203268|NCT02567227|585794587|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
162203269|NCT02567227|585794588|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
162203270|NCT02567227|585794587|FG000|6 Month|Death|2|||
162203271|NCT02567227|585794588|FG001|6 Month|Death|0|||
162203272|NCT02567227|585794587|FG000|6 Month|Lost to Follow-up|43|||
162203273|NCT02567227|585794588|FG001|6 Month|Lost to Follow-up|40|||
162203274|NCT02567227|585794587|FG000|12 Months|Lost to Follow-up|31|||
162203275|NCT02567227|585794588|FG001|12 Months|Lost to Follow-up|32|||
162203276|NCT02567227|585794587|FG000|12 Months|Death|0|||
162203277|NCT02567227|585794588|FG001|12 Months|Death|2|||
162203278|NCT00187135|585794589|FG000|Visit One|Withdrawal by Subject|1|||
162203279|NCT00187135|585794590|FG001|Visit One|Withdrawal by Subject|0|||
162203280|NCT00187135|585794591|FG002|Visit One|Withdrawal by Subject|0|||
162203281|NCT00187135|585794592|FG003|Visit One|Withdrawal by Subject|0|||
162203282|NCT00187135|585794593|FG004|Visit One|Withdrawal by Subject|0|||
162203283|NCT00187135|585794594|FG005|Visit One|Withdrawal by Subject|1|||
162203284|NCT00187135|585794589|FG000|Visit One|Physician Decision|3|||
162203285|NCT00187135|585794590|FG001|Visit One|Physician Decision|1|||
162203286|NCT00187135|585794591|FG002|Visit One|Physician Decision|0|||
162203287|NCT00187135|585794592|FG003|Visit One|Physician Decision|0|||
162203288|NCT00187135|585794593|FG004|Visit One|Physician Decision|0|||
162203289|NCT00187135|585794594|FG005|Visit One|Physician Decision|1|||
162203290|NCT00187135|585794589|FG000|Visit Two|Death|0|||
162203291|NCT00187135|585794590|FG001|Visit Two|Death|0|||
162203292|NCT00187135|585794591|FG002|Visit Two|Death|0|||
161931960|NCT00147537|584798779|FG005|Phase 1b|Death|2|||
161931961|NCT00147537|584798780|FG006|Phase 1b|Death|1|||
162203293|NCT00187135|585794592|FG003|Visit Two|Death|1|||
162203294|NCT00187135|585794593|FG004|Visit Two|Death|0|||
162203295|NCT00187135|585794594|FG005|Visit Two|Death|1|||
162203296|NCT00187135|585794589|FG000|Visit Two|Physician Decision|1|||
162203297|NCT00187135|585794590|FG001|Visit Two|Physician Decision|0|||
162203298|NCT00187135|585794591|FG002|Visit Two|Physician Decision|0|||
162203299|NCT00187135|585794592|FG003|Visit Two|Physician Decision|0|||
162203300|NCT00187135|585794593|FG004|Visit Two|Physician Decision|0|||
162203301|NCT00187135|585794594|FG005|Visit Two|Physician Decision|0|||
162203302|NCT00187135|585794589|FG000|Visit Two|Withdrawal by Subject|1|||
162203303|NCT00187135|585794590|FG001|Visit Two|Withdrawal by Subject|1|||
162203304|NCT00187135|585794591|FG002|Visit Two|Withdrawal by Subject|1|||
162203305|NCT00187135|585794592|FG003|Visit Two|Withdrawal by Subject|0|||
162203306|NCT00187135|585794593|FG004|Visit Two|Withdrawal by Subject|1|||
162203307|NCT00187135|585794594|FG005|Visit Two|Withdrawal by Subject|1|||
162203308|NCT00187135|585794589|FG000|Visit Two|Study Discontinued|3|||
162203309|NCT00187135|585794590|FG001|Visit Two|Study Discontinued|2|||
162203310|NCT00187135|585794591|FG002|Visit Two|Study Discontinued|1|||
162203311|NCT00187135|585794592|FG003|Visit Two|Study Discontinued|7|||
162203312|NCT00187135|585794593|FG004|Visit Two|Study Discontinued|5|||
162203313|NCT00187135|585794594|FG005|Visit Two|Study Discontinued|6|||
162203314|NCT00187135|585794589|FG000|Visit Three|Death|0|||
162203315|NCT00187135|585794590|FG001|Visit Three|Death|0|||
162203316|NCT00187135|585794591|FG002|Visit Three|Death|1|||
162203317|NCT00187135|585794592|FG003|Visit Three|Death|0|||
162203318|NCT00187135|585794593|FG004|Visit Three|Death|1|||
162203319|NCT00187135|585794594|FG005|Visit Three|Death|0|||
162203320|NCT00187135|585794589|FG000|Visit Three|Withdrawal by Subject|0|||
162203321|NCT00187135|585794590|FG001|Visit Three|Withdrawal by Subject|1|||
162203322|NCT00187135|585794591|FG002|Visit Three|Withdrawal by Subject|1|||
162203323|NCT00187135|585794592|FG003|Visit Three|Withdrawal by Subject|2|||
162203324|NCT00187135|585794593|FG004|Visit Three|Withdrawal by Subject|0|||
162203325|NCT00187135|585794594|FG005|Visit Three|Withdrawal by Subject|0|||
162203326|NCT00187135|585794589|FG000|Visit Three|Study Discontinued|7|||
162203327|NCT00187135|585794590|FG001|Visit Three|Study Discontinued|6|||
162203328|NCT00187135|585794591|FG002|Visit Three|Study Discontinued|7|||
162203329|NCT00187135|585794592|FG003|Visit Three|Study Discontinued|7|||
162203330|NCT00187135|585794593|FG004|Visit Three|Study Discontinued|7|||
162203331|NCT00187135|585794594|FG005|Visit Three|Study Discontinued|6|||
162203332|NCT01675050|585794597|FG000|Period One Treatment|Withdrawal by Subject|1|||
162203333|NCT01675050|585794598|FG001|Period One Treatment|Withdrawal by Subject|0|||
162203334|NCT00745121|585794599|FG000|Overall Study|Death|3|||
162203335|NCT00745121|585794600|FG001|Overall Study|Death|0|||
162203336|NCT00745121|585794599|FG000|Overall Study|Adverse Event|1|||
161677056|NCT00880555|583871983|FG003|Overall Study|Withdrawal by Subject|0|||
161677057|NCT00880555|583871984|FG004|Overall Study|Withdrawal by Subject|0|||
161677058|NCT00880555|583871985|FG005|Overall Study|Withdrawal by Subject|0|||
161677059|NCT00880555|583871980|FG000|Overall Study|Lack of resources (hired rater)|9|||
161677060|NCT00880555|583871981|FG001|Overall Study|Lack of resources (hired rater)|7|||
161677061|NCT00880555|583871982|FG002|Overall Study|Lack of resources (hired rater)|5|||
161677062|NCT00880555|583871983|FG003|Overall Study|Lack of resources (hired rater)|0|||
161677063|NCT00880555|583871984|FG004|Overall Study|Lack of resources (hired rater)|0|||
161931962|NCT00147537|584798781|FG007|Phase 1b|Death|3|||
161931963|NCT00147537|584798782|FG008|Phase 1b|Death|9|||
162203337|NCT00745121|585794600|FG001|Overall Study|Adverse Event|0|||
162203338|NCT00745121|585794599|FG000|Overall Study|Lost to Follow-up|1|||
162203339|NCT00745121|585794600|FG001|Overall Study|Lost to Follow-up|0|||
162203340|NCT00745121|585794599|FG000|Overall Study|Withdrawal by Subject|4|||
161677064|NCT00880555|583871985|FG005|Overall Study|Lack of resources (hired rater)|0|||
161677065|NCT00880555|583871980|FG000|Overall Study|Death|0|||
161677066|NCT00880555|583871981|FG001|Overall Study|Death|0|||
161677067|NCT00880555|583871982|FG002|Overall Study|Death|0|||
161677068|NCT00880555|583871983|FG003|Overall Study|Death|0|||
161677069|NCT00880555|583871984|FG004|Overall Study|Death|0|||
161677070|NCT00880555|583871985|FG005|Overall Study|Death|1|||
161677071|NCT00880555|583871980|FG000|Overall Study|Lost to Follow-up|0|||
161677072|NCT00880555|583871981|FG001|Overall Study|Lost to Follow-up|1|||
161677073|NCT00880555|583871982|FG002|Overall Study|Lost to Follow-up|0|||
161677074|NCT00880555|583871983|FG003|Overall Study|Lost to Follow-up|0|||
161677075|NCT00880555|583871984|FG004|Overall Study|Lost to Follow-up|0|||
161677076|NCT00880555|583871985|FG005|Overall Study|Lost to Follow-up|0|||
161677077|NCT04196803|583871986|FG000|Overall Study|Withdrawal by Subject|1|||
161677078|NCT04196803|583871987|FG001|Overall Study|Withdrawal by Subject|3|||
161677079|NCT04196803|583871986|FG000|Overall Study|Adverse Event|4|||
161677080|NCT04196803|583871987|FG001|Overall Study|Adverse Event|2|||
161677081|NCT04196803|583871986|FG000|Overall Study|Lost to Follow-up|0|||
161677082|NCT04196803|583871987|FG001|Overall Study|Lost to Follow-up|1|||
161677083|NCT01168973|583871988|FG000|Overall Study|Progressive Disease|341|||
162203341|NCT00745121|585794600|FG001|Overall Study|Withdrawal by Subject|2|||
162203342|NCT03280108|585794602|FG000|Overall Study|Lost to Follow-up|2|||
162203343|NCT03280108|585794603|FG001|Overall Study|Lost to Follow-up|0|||
162203344|NCT01820637|585794604|FG000|Overall Study|Death|2|||
162203345|NCT01820637|585794604|FG000|Overall Study|Withdrawal by Subject|1|||
162203346|NCT00264498|585794605|FG000|Randomized Treatment|Death|0|||
162203347|NCT00264498|585794606|FG001|Randomized Treatment|Death|3|||
162203348|NCT00264498|585794605|FG000|Randomized Treatment|Withdrawal by Subject|0|||
162203349|NCT00264498|585794606|FG001|Randomized Treatment|Withdrawal by Subject|1|||
162203350|NCT00264498|585794605|FG000|Randomized Treatment|Objective disease Progression|13|||
162203351|NCT00264498|585794606|FG001|Randomized Treatment|Objective disease Progression|14|||
162203352|NCT00264498|585794605|FG000|Randomized Treatment|Physician Decision|1|||
162203353|NCT00264498|585794606|FG001|Randomized Treatment|Physician Decision|0|||
162203354|NCT00264498|585794605|FG000|Randomized Treatment|Incorrectly randomized|1|||
162203355|NCT00264498|585794606|FG001|Randomized Treatment|Incorrectly randomized|0|||
162203356|NCT00264498|585794605|FG000|Randomized Treatment|Study Closure|1|||
162203357|NCT00264498|585794606|FG001|Randomized Treatment|Study Closure|0|||
162203358|NCT00264498|585794605|FG000|Randomized Treatment|Protocol Violation|1|||
162203359|NCT00264498|585794606|FG001|Randomized Treatment|Protocol Violation|0|||
162203360|NCT00264498|585794605|FG000|Crossover Treatment|Death|1|||
162203361|NCT00264498|585794606|FG001|Crossover Treatment|Death|3|||
162203362|NCT00264498|585794605|FG000|Crossover Treatment|Objective disease progression|4|||
162203363|NCT00264498|585794606|FG001|Crossover Treatment|Objective disease progression|5|||
162203364|NCT00264498|585794605|FG000|Crossover Treatment|Study closure|0|||
162203365|NCT00264498|585794606|FG001|Crossover Treatment|Study closure|1|||
162203366|NCT00264498|585794605|FG000|Crossover Treatment|Withdrawal by Subject|1|||
162203367|NCT00264498|585794606|FG001|Crossover Treatment|Withdrawal by Subject|0|||
162203368|NCT03794609|585794607|FG000|Overall Study|Other|10|||
162203369|NCT03794609|585794607|FG000|Overall Study|Withdrawal by Subject|66|||
162203370|NCT03794609|585794607|FG000|Overall Study|The child is enrolled in an interventional study|70|||
162203371|NCT03794609|585794607|FG000|Overall Study|Inclusion/exclusion criteria|8|||
162203372|NCT03794609|585794607|FG000|Overall Study|At sponsor's request|151|||
162203373|NCT03794609|585794607|FG000|Overall Study|Physician Decision|1|||
162203374|NCT03794609|585794607|FG000|Overall Study|Lost to Follow-up|5|||
162203375|NCT04543942|585794608|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
162203376|NCT04543942|585794609|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
162203377|NCT04543942|585794608|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
162203378|NCT04543942|585794609|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
161824033|NCT02003222|584397894|FG002|Intensification|Withdrawal by Subject|0|||
161824034|NCT02003222|584397895|FG003|Intensification|Withdrawal by Subject|0|||
161824035|NCT02003222|584397896|FG004|Intensification|Withdrawal by Subject|5|||
162203379|NCT00139659|585794612|FG000|Overall Study|Adverse Event|12|||
162203380|NCT00139659|585794613|FG001|Overall Study|Adverse Event|1|||
162203381|NCT00139659|585794612|FG000|Overall Study|Lack of Efficacy|1|||
162203382|NCT00139659|585794613|FG001|Overall Study|Lack of Efficacy|1|||
162203383|NCT00139659|585794612|FG000|Overall Study|Lost to Follow-up|7|||
162203384|NCT00139659|585794613|FG001|Overall Study|Lost to Follow-up|3|||
162203385|NCT00139659|585794612|FG000|Overall Study|Reason not Specified|6|||
161677084|NCT01168973|583871989|FG001|Overall Study|Progressive Disease|429|||
161824036|NCT02003222|584397892|FG000|Intensification|Other reasons|0|||
161677085|NCT01168973|583871988|FG000|Overall Study|Adverse Event|94|||
161677086|NCT01168973|583871989|FG001|Overall Study|Adverse Event|55|||
161677087|NCT01168973|583871988|FG000|Overall Study|Withdrawal by Subject|90|||
161677088|NCT01168973|583871989|FG001|Overall Study|Withdrawal by Subject|53|||
161677089|NCT01168973|583871988|FG000|Overall Study|Death|42|||
161824037|NCT02003222|584397893|FG001|Intensification|Other reasons|0|||
162203386|NCT00139659|585794613|FG001|Overall Study|Reason not Specified|3|||
162203387|NCT00139659|585794612|FG000|Overall Study|Withdrawal by Subject|14|||
162203388|NCT00139659|585794613|FG001|Overall Study|Withdrawal by Subject|10|||
162203389|NCT02625922|585794619|FG000|Overall Study|Non-availability of IMP|1|||
162203390|NCT02625922|585794620|FG001|Overall Study|Non-availability of IMP|1|||
162203391|NCT02625922|585794619|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
162203392|NCT02625922|585794620|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
162203393|NCT00640042|585794621|FG000|Enrollment|Did not receive study drug|83|||
162203394|NCT02359552|585794622|FG000|Overall Study|Lost to Follow-up|3|||
162203395|NCT02359552|585794623|FG001|Overall Study|Lost to Follow-up|4|||
162203396|NCT02391116|585794636|FG000|Treatment|Withdrawal by Subject|1|||
162203397|NCT02391116|585794636|FG000|Treatment|Protocol Violation|1|||
162203398|NCT02391116|585794636|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
162203399|NCT02391116|585794636|FG000|Treatment|AE with Clinical PD|3|||
162203400|NCT02391116|585794636|FG000|Safety Follow-up|Adverse Event|1|||
162203401|NCT02391116|585794636|FG000|Safety Follow-up|Withdrawal by Subject|4|||
162203402|NCT02391116|585794636|FG000|Safety Follow-up|Switching to Other Therapy|4|||
162203403|NCT02391116|585794636|FG000|Safety Follow-up|No Follow Up|1|||
161824038|NCT02003222|584397894|FG002|Intensification|Other reasons|0|||
161824039|NCT02003222|584397895|FG003|Intensification|Other reasons|0|||
162203404|NCT02391116|585794636|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
162203405|NCT02391116|585794636|FG000|Active Follow-up|Withdrawal by Subject|1|||
162203406|NCT02391116|585794636|FG000|Active Follow-up|Switching to Other Therapy|2|||
162203407|NCT02391116|585794636|FG000|Survival Follow-up|Withdrawal by Subject|3|||
162203408|NCT02391116|585794636|FG000|Survival Follow-up|Switching to Other Therapy|1|||
162203409|NCT01747629|585794638|FG000|Overall Study|Adverse Event|1|||
162203410|NCT01747629|585794639|FG001|Overall Study|Adverse Event|2|||
162203411|NCT01747629|585794638|FG000|Overall Study|Withdrawal by Subject|2|||
162203412|NCT01747629|585794639|FG001|Overall Study|Withdrawal by Subject|2|||
162203413|NCT01747629|585794638|FG000|Overall Study|Noncompliance|1|||
162203414|NCT01747629|585794639|FG001|Overall Study|Noncompliance|1|||
162203415|NCT01747629|585794638|FG000|Overall Study|Inclusion criteria not met|1|||
162203416|NCT01747629|585794639|FG001|Overall Study|Inclusion criteria not met|0|||
162203417|NCT01747629|585794638|FG000|Overall Study|Not treated|1|||
162203418|NCT01747629|585794639|FG001|Overall Study|Not treated|0|||
162203419|NCT01747629|585794638|FG000|Overall Study|Other|2|||
162203420|NCT01747629|585794639|FG001|Overall Study|Other|1|||
162203421|NCT00607789|585794640|FG000|Overall Study|Adverse Event|3|||
162203422|NCT00607789|585794641|FG001|Overall Study|Adverse Event|0|||
162203423|NCT00607789|585794640|FG000|Overall Study|Lack of Efficacy|0|||
162203424|NCT00607789|585794641|FG001|Overall Study|Lack of Efficacy|1|||
162203425|NCT00607789|585794640|FG000|Overall Study|Inadequate adherence|3|||
162203426|NCT00607789|585794641|FG001|Overall Study|Inadequate adherence|0|||
162203427|NCT00607789|585794640|FG000|Overall Study|Lost to Follow-up|0|||
162203428|NCT00607789|585794641|FG001|Overall Study|Lost to Follow-up|5|||
162203429|NCT00607789|585794640|FG000|Overall Study|Withdrawal by Subject|1|||
162203430|NCT00607789|585794641|FG001|Overall Study|Withdrawal by Subject|0|||
162203431|NCT01313299|585794642|FG000|Overall Study|Adverse Event|3|||
162203432|NCT01313299|585794643|FG001|Overall Study|Adverse Event|1|||
162203433|NCT01313299|585794644|FG002|Overall Study|Adverse Event|1|||
162203434|NCT01313299|585794642|FG000|Overall Study|Lost to Follow-up|1|||
162203435|NCT01313299|585794643|FG001|Overall Study|Lost to Follow-up|0|||
162203436|NCT01313299|585794644|FG002|Overall Study|Lost to Follow-up|0|||
162203437|NCT01313299|585794642|FG000|Overall Study|Protocol Violation|2|||
162203438|NCT01313299|585794643|FG001|Overall Study|Protocol Violation|0|||
161824040|NCT02003222|584397896|FG004|Intensification|Other reasons|8|||
161824041|NCT04941768|584397901|FG000|Overall Study|Lost to Follow-up|10|||
161824042|NCT04941768|584397901|FG000|Overall Study|Death|24|||
161824043|NCT04941768|584397901|FG000|Overall Study|Progressive Disease|4|||
161824044|NCT04941768|584397901|FG000|Overall Study|Withdrawal by Subject|4|||
161824045|NCT04941768|584397901|FG000|Overall Study|Other|3|||
161824046|NCT04941768|584397901|FG000|Overall Study|Treatment ongoing|21|||
161824047|NCT04941768|584397901|FG000|Overall Study|Off treatment and in follow-up|21|||
161824048|NCT03302078|584397903|FG000|Washout Period|Adverse Event|0|||
161824049|NCT03302078|584397904|FG001|Washout Period|Adverse Event|1|||
161824050|NCT01886872|584397905|FG000|Overall Study|Ineligible|7|||
161824051|NCT01886872|584397906|FG001|Overall Study|Ineligible|4|||
161824052|NCT01886872|584397907|FG002|Overall Study|Ineligible|12|||
161824053|NCT05148299|584397908|FG000|Treatment Period|Adverse Event|1|||
161824054|NCT05148299|584397908|FG000|Treatment Period|Physician Decision|1|||
161824055|NCT05148299|584397908|FG000|Treatment Period|Death|1|||
161824056|NCT05148299|584397908|FG000|Follow-up Period|Death|3|||
161824057|NCT01957150|584397909|FG000|Overall Study|Adverse Event|23|||
161824058|NCT01957150|584397910|FG001|Overall Study|Adverse Event|20|||
162203439|NCT01313299|585794644|FG002|Overall Study|Protocol Violation|0|||
162203440|NCT01313299|585794642|FG000|Overall Study|Withdrawal by Subject|1|||
162203441|NCT01313299|585794643|FG001|Overall Study|Withdrawal by Subject|0|||
162203442|NCT01313299|585794644|FG002|Overall Study|Withdrawal by Subject|2|||
161677090|NCT01168973|583871989|FG001|Overall Study|Death|45|||
161677091|NCT01168973|583871988|FG000|Overall Study|Physician Decision|37|||
161677092|NCT01168973|583871989|FG001|Overall Study|Physician Decision|19|||
161677093|NCT01168973|583871988|FG000|Overall Study|Sponsor Decision|2|||
161677094|NCT01168973|583871989|FG001|Overall Study|Sponsor Decision|1|||
161677095|NCT01168973|583871988|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
161677096|NCT01168973|583871989|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
161677097|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Adverse Event|2|||
161677098|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Adverse Event|2|||
162203443|NCT01313299|585794642|FG000|Overall Study|Family reason and moved out of state|0|||
162203444|NCT01313299|585794643|FG001|Overall Study|Family reason and moved out of state|2|||
162203445|NCT01313299|585794644|FG002|Overall Study|Family reason and moved out of state|0|||
162203446|NCT01313299|585794642|FG000|Overall Study|Lack of subject compliance|0|||
162203447|NCT01313299|585794643|FG001|Overall Study|Lack of subject compliance|0|||
162203448|NCT01313299|585794644|FG002|Overall Study|Lack of subject compliance|1|||
162203449|NCT02506881|585794645|FG000|First Intervention (Day 1)|Protocol Violation|0|||
162203450|NCT02506881|585794646|FG001|First Intervention (Day 1)|Protocol Violation|0|||
162203451|NCT02506881|585794647|FG002|First Intervention (Day 1)|Protocol Violation|1|||
162203452|NCT02506881|585794648|FG003|First Intervention (Day 1)|Protocol Violation|0|||
162203453|NCT02506881|585794645|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
162203454|NCT02506881|585794646|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
162203455|NCT02506881|585794647|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
162203456|NCT02506881|585794648|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
162203457|NCT02506881|585794645|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
162203458|NCT02506881|585794646|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
162203459|NCT02506881|585794647|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
162203460|NCT02506881|585794648|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
162203461|NCT01919398|585794649|FG000|Overall Study|Progressive Disease|0|||
162203462|NCT01919398|585794650|FG001|Overall Study|Progressive Disease|0|||
162203463|NCT01919398|585794651|FG002|Overall Study|Progressive Disease|4|||
162203464|NCT00746785|585796455|FG000|Overall Study|Lost to Follow-up|29|||
161677099|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Adverse Event|4|||
161677100|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Adverse Event|0|||
161677101|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Adverse Event|0|||
161677102|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Progressive disease|0|||
161677103|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Progressive disease|0|||
161677104|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Progressive disease|1|||
161677105|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Progressive disease|0|||
161677106|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Progressive disease|0|||
161677107|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
161677108|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
161677109|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
161931964|NCT00147537|584798783|FG009|Phase 1b|Death|0|||
161931965|NCT00147537|584798784|FG010|Phase 1b|Death|0|||
161931966|NCT00147537|584798774|FG000|Phase 1b|Lost to Follow-up|2|||
161931967|NCT00147537|584798775|FG001|Phase 1b|Lost to Follow-up|1|||
161931968|NCT00147537|584798776|FG002|Phase 1b|Lost to Follow-up|0|||
161931969|NCT00147537|584798777|FG003|Phase 1b|Lost to Follow-up|0|||
161931970|NCT00147537|584798778|FG004|Phase 1b|Lost to Follow-up|0|||
161931971|NCT00147537|584798779|FG005|Phase 1b|Lost to Follow-up|0|||
162203465|NCT00746785|585796456|FG001|Overall Study|Lost to Follow-up|25|||
162203466|NCT00746785|585796457|FG002|Overall Study|Lost to Follow-up|27|||
162203467|NCT01231464|585796458|FG000|Overall Study|Adverse Event|0|||
162203468|NCT01231464|585796459|FG001|Overall Study|Adverse Event|1|||
162203469|NCT01231464|585796458|FG000|Overall Study|Protocol Violation|1|||
161677110|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
161677111|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
161677112|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
161931972|NCT00147537|584798780|FG006|Phase 1b|Lost to Follow-up|2|||
162203470|NCT01231464|585796459|FG001|Overall Study|Protocol Violation|2|||
162203471|NCT01231464|585796458|FG000|Overall Study|Lost to Follow-up|1|||
162203472|NCT01231464|585796459|FG001|Overall Study|Lost to Follow-up|2|||
161677113|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
161677114|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
161677115|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
161677116|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
161677117|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
161677118|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
161677119|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
162203473|NCT01231464|585796458|FG000|Overall Study|Withdrawal by Subject|3|||
162203474|NCT01231464|585796459|FG001|Overall Study|Withdrawal by Subject|2|||
162203475|NCT00957996|585796460|FG000|Overall Study|Death|4|||
162203476|NCT00957996|585796461|FG001|Overall Study|Death|10|||
162203477|NCT00957996|585796460|FG000|Overall Study|Lost to Follow-up|4|||
162203478|NCT00957996|585796461|FG001|Overall Study|Lost to Follow-up|7|||
162203479|NCT00957996|585796460|FG000|Overall Study|Withdrawal by Subject|9|||
162203480|NCT00957996|585796461|FG001|Overall Study|Withdrawal by Subject|2|||
162203481|NCT00957996|585796460|FG000|Overall Study|Adverse Event|2|||
162203482|NCT00957996|585796461|FG001|Overall Study|Adverse Event|1|||
162203483|NCT00957996|585796460|FG000|Overall Study|Physician Decision|1|||
162203484|NCT00957996|585796461|FG001|Overall Study|Physician Decision|1|||
162203485|NCT00957996|585796460|FG000|Overall Study|Influenza-related complication|0|||
162203486|NCT00957996|585796461|FG001|Overall Study|Influenza-related complication|1|||
162203487|NCT00957996|585796460|FG000|Overall Study|Missing|1|||
162203488|NCT00957996|585796461|FG001|Overall Study|Missing|0|||
162203489|NCT00957996|585796460|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
162203490|NCT00957996|585796461|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
162203491|NCT00381797|585796468|FG000|Overall Study|Withdrawal by Subject|1|||
162203492|NCT00381797|585796469|FG001|Overall Study|Withdrawal by Subject|1|||
162203493|NCT00381797|585796470|FG002|Overall Study|Withdrawal by Subject|0|||
162203494|NCT00381797|585796471|FG003|Overall Study|Withdrawal by Subject|0|||
162203495|NCT00381797|585796472|FG004|Overall Study|Withdrawal by Subject|2|||
162203496|NCT00381797|585796468|FG000|Overall Study|Ineligible|0|||
162203497|NCT00381797|585796469|FG001|Overall Study|Ineligible|0|||
162203498|NCT00381797|585796470|FG002|Overall Study|Ineligible|0|||
162203499|NCT00381797|585796471|FG003|Overall Study|Ineligible|1|||
162203500|NCT00381797|585796472|FG004|Overall Study|Ineligible|0|||
162203501|NCT00684203|585796473|FG000|Overall Study|Adverse Event|6|||
162203502|NCT00684203|585796474|FG001|Overall Study|Adverse Event|4|||
162203503|NCT00684203|585796475|FG002|Overall Study|Adverse Event|8|||
162203504|NCT00684203|585796476|FG003|Overall Study|Adverse Event|0|||
162203505|NCT00684203|585796477|FG004|Overall Study|Adverse Event|0|||
162203506|NCT00684203|585796478|FG005|Overall Study|Adverse Event|0|||
162203507|NCT00684203|585796473|FG000|Overall Study|Protocol-defined clinical event|3|||
162203508|NCT00684203|585796474|FG001|Overall Study|Protocol-defined clinical event|1|||
162203509|NCT00684203|585796475|FG002|Overall Study|Protocol-defined clinical event|0|||
162203510|NCT00684203|585796476|FG003|Overall Study|Protocol-defined clinical event|0|||
162203511|NCT00684203|585796477|FG004|Overall Study|Protocol-defined clinical event|0|||
162203512|NCT00684203|585796478|FG005|Overall Study|Protocol-defined clinical event|0|||
162203513|NCT00684203|585796473|FG000|Overall Study|Withdrawal by Subject|0|||
162203514|NCT00684203|585796474|FG001|Overall Study|Withdrawal by Subject|2|||
162203515|NCT00684203|585796475|FG002|Overall Study|Withdrawal by Subject|1|||
162203516|NCT00684203|585796476|FG003|Overall Study|Withdrawal by Subject|0|||
162203517|NCT00684203|585796477|FG004|Overall Study|Withdrawal by Subject|0|||
162203518|NCT00684203|585796478|FG005|Overall Study|Withdrawal by Subject|0|||
162203519|NCT00684203|585796473|FG000|Overall Study|Did not meet protocol eligibility|0|||
162203520|NCT00684203|585796474|FG001|Overall Study|Did not meet protocol eligibility|1|||
162203521|NCT00684203|585796475|FG002|Overall Study|Did not meet protocol eligibility|0|||
162203522|NCT00684203|585796476|FG003|Overall Study|Did not meet protocol eligibility|0|||
162203523|NCT00684203|585796477|FG004|Overall Study|Did not meet protocol eligibility|0|||
162203524|NCT00684203|585796478|FG005|Overall Study|Did not meet protocol eligibility|0|||
162203525|NCT00730847|585796481|FG000|Overall Study|Adverse Event|1|||
162203526|NCT00730847|585796481|FG000|Overall Study|Protocol Violation|2|||
162203527|NCT00730847|585796481|FG000|Overall Study|Withdrawal by Subject|16|||
161677120|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
161677121|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
161824059|NCT01957150|584397909|FG000|Overall Study|Withdrawal by Subject|13|||
161824060|NCT01957150|584397910|FG001|Overall Study|Withdrawal by Subject|17|||
162203528|NCT00730847|585796481|FG000|Overall Study|Lost to Follow-up|67|||
162203529|NCT00730847|585796481|FG000|Overall Study|Unknown completion status|21|||
162203530|NCT00730847|585796481|FG000|Overall Study|Other|24|||
162203531|NCT00280683|585796482|FG000|Overall Study|Withdrawal by Subject|1|||
161677122|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
162203532|NCT00280683|585796483|FG001|Overall Study|Withdrawal by Subject|2|||
162203533|NCT00280683|585796482|FG000|Overall Study|Adverse Event|1|||
162203534|NCT00280683|585796483|FG001|Overall Study|Adverse Event|1|||
162203535|NCT01243411|585796484|FG000|Overall Study|Withdrawal by Subject|18|||
162203536|NCT01243411|585796484|FG000|Overall Study|Lost to Follow-up|10|||
161931973|NCT00147537|584798781|FG007|Phase 1b|Lost to Follow-up|0|||
162203537|NCT01243411|585796484|FG000|Overall Study|Adverse Event|5|||
162203538|NCT01243411|585796484|FG000|Overall Study|Other|8|||
162203539|NCT00922441|585796488|FG000|Overall Study|Protocol Violation|0|||
162203540|NCT00922441|585796489|FG001|Overall Study|Protocol Violation|0|||
162203541|NCT00922441|585796490|FG002|Overall Study|Protocol Violation|2|||
162203542|NCT00922441|585796488|FG000|Overall Study|Withdrawal by Subject|0|||
162203543|NCT00922441|585796489|FG001|Overall Study|Withdrawal by Subject|0|||
162203544|NCT00922441|585796490|FG002|Overall Study|Withdrawal by Subject|1|||
162203545|NCT00468858|585796496|FG000|Overall Study|Adverse Event|0|||
162203546|NCT00468858|585796497|FG001|Overall Study|Adverse Event|1|||
162203547|NCT00468858|585796498|FG002|Overall Study|Adverse Event|0|||
162203548|NCT00468858|585796496|FG000|Overall Study|Withdrawal by Subject|7|||
162203549|NCT00468858|585796497|FG001|Overall Study|Withdrawal by Subject|4|||
162203550|NCT00468858|585796498|FG002|Overall Study|Withdrawal by Subject|5|||
162203551|NCT00468858|585796496|FG000|Overall Study|Relocation|1|||
162203552|NCT00468858|585796497|FG001|Overall Study|Relocation|3|||
162203553|NCT00468858|585796498|FG002|Overall Study|Relocation|3|||
162203554|NCT00468858|585796496|FG000|Overall Study|Lost to Follow-up|1|||
162203555|NCT00468858|585796497|FG001|Overall Study|Lost to Follow-up|2|||
162203556|NCT00468858|585796498|FG002|Overall Study|Lost to Follow-up|5|||
162203557|NCT00468858|585796496|FG000|Overall Study|Other|0|||
162203558|NCT00468858|585796497|FG001|Overall Study|Other|0|||
162203559|NCT00468858|585796498|FG002|Overall Study|Other|1|||
162203560|NCT00797511|585796501|FG000|Overall Study|Withdrawal by Subject|1|||
162203561|NCT00439647|585796502|FG000|Overall Study|Withdrawal by Subject|25|||
162203562|NCT00439647|585796503|FG001|Overall Study|Withdrawal by Subject|22|||
162203563|NCT00439647|585796502|FG000|Overall Study|Death|15|||
162203564|NCT00439647|585796503|FG001|Overall Study|Death|18|||
162203565|NCT00439647|585796502|FG000|Overall Study|Adverse Event|11|||
162203566|NCT00439647|585796503|FG001|Overall Study|Adverse Event|11|||
162203567|NCT00439647|585796502|FG000|Overall Study|Lost to Follow-up|4|||
162203568|NCT00439647|585796503|FG001|Overall Study|Lost to Follow-up|12|||
162203569|NCT00439647|585796502|FG000|Overall Study|Protocol Violation|3|||
162203570|NCT00439647|585796503|FG001|Overall Study|Protocol Violation|4|||
162203571|NCT00439647|585796502|FG000|Overall Study|Lack of Efficacy|0|||
162203572|NCT00439647|585796503|FG001|Overall Study|Lack of Efficacy|4|||
162203573|NCT02109107|585796504|FG000|Overall Study|Lost to Follow-up|2|||
162203574|NCT00495612|585796505|FG000|Overall Study|Lost to Follow-up|1|||
162203575|NCT00495612|585796506|FG001|Overall Study|Lost to Follow-up|0|||
162203576|NCT00495612|585796505|FG000|Overall Study|Subject's Decision to Withdraw|3|||
162203577|NCT00495612|585796506|FG001|Overall Study|Subject's Decision to Withdraw|0|||
162203578|NCT06016127|585796509|FG000|Overall Study|Withdrawal by Subject|4|||
162203579|NCT06016127|585796510|FG001|Overall Study|Withdrawal by Subject|3|||
162203580|NCT03340766|585796515|FG000|Overall Study|Withdrawal by Subject|2|||
162203581|NCT03340766|585796516|FG001|Overall Study|Withdrawal by Subject|1|||
162203582|NCT03340766|585796517|FG002|Overall Study|Withdrawal by Subject|3|||
162203583|NCT03340766|585796515|FG000|Overall Study|Lost to Follow-up|0|||
162203584|NCT03340766|585796516|FG001|Overall Study|Lost to Follow-up|0|||
162203585|NCT03340766|585796517|FG002|Overall Study|Lost to Follow-up|1|||
162203586|NCT03340766|585796515|FG000|Overall Study|Death|6|||
162203587|NCT03340766|585796516|FG001|Overall Study|Death|7|||
162203588|NCT03340766|585796517|FG002|Overall Study|Death|4|||
162203589|NCT00240097|585796518|FG000|Part I|Adverse Event|1|||
162203590|NCT00240097|585796518|FG000|Part I|Death|1|||
162203591|NCT00240097|585796518|FG000|Part I|histology|1|||
162203592|NCT00240097|585796518|FG000|Part I|unevaluable|1|||
162203593|NCT00240097|585796518|FG000|Part II|did not continue from Part I|23|||
162203594|NCT02383927|585796519|FG000|Overall Study|Disease Progression|8|||
162203595|NCT02383927|585796520|FG001|Overall Study|Disease Progression|8|||
162203596|NCT02383927|585796521|FG002|Overall Study|Disease Progression|15|||
161824061|NCT01957150|584397909|FG000|Overall Study|Physician Decision|3|||
161824062|NCT01957150|584397910|FG001|Overall Study|Physician Decision|6|||
161824063|NCT01957150|584397909|FG000|Overall Study|Lost to Follow-up|4|||
161824064|NCT01957150|584397910|FG001|Overall Study|Lost to Follow-up|4|||
161824065|NCT01957150|584397909|FG000|Overall Study|Protocol Violation|1|||
162203597|NCT02383927|585796522|FG003|Overall Study|Disease Progression|4|||
162203598|NCT02383927|585796519|FG000|Overall Study|Physician Decision|0|||
161824066|NCT01957150|584397910|FG001|Overall Study|Protocol Violation|0|||
161824067|NCT01957150|584397909|FG000|Overall Study|Lack of Efficacy|11|||
162203599|NCT02383927|585796520|FG001|Overall Study|Physician Decision|0|||
162203600|NCT02383927|585796521|FG002|Overall Study|Physician Decision|2|||
162203601|NCT02383927|585796522|FG003|Overall Study|Physician Decision|0|||
162203602|NCT02383927|585796519|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
162203603|NCT02383927|585796520|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
161824068|NCT01957150|584397910|FG001|Overall Study|Lack of Efficacy|11|||
162203604|NCT02383927|585796521|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
162203605|NCT02383927|585796522|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
162203606|NCT02383927|585796519|FG000|Overall Study|Adverse Event|4|||
162203607|NCT02383927|585796520|FG001|Overall Study|Adverse Event|1|||
161931974|NCT00147537|584798782|FG008|Phase 1b|Lost to Follow-up|1|||
161931975|NCT00147537|584798783|FG009|Phase 1b|Lost to Follow-up|0|||
162203608|NCT02383927|585796521|FG002|Overall Study|Adverse Event|3|||
162203609|NCT02383927|585796522|FG003|Overall Study|Adverse Event|5|||
162203610|NCT02383927|585796519|FG000|Overall Study|Miscellaneous|1|||
162203611|NCT02383927|585796520|FG001|Overall Study|Miscellaneous|0|||
162203612|NCT02383927|585796521|FG002|Overall Study|Miscellaneous|0|||
162203613|NCT02383927|585796522|FG003|Overall Study|Miscellaneous|1|||
162203614|NCT02383927|585796519|FG000|Overall Study|Withdrawal by Subject|0|||
162203615|NCT02383927|585796520|FG001|Overall Study|Withdrawal by Subject|1|||
162203616|NCT02383927|585796521|FG002|Overall Study|Withdrawal by Subject|4|||
162203617|NCT02383927|585796522|FG003|Overall Study|Withdrawal by Subject|0|||
162203618|NCT00734851|585796523|FG000|Overall Study|Withdrawal by Subject|2|||
162203619|NCT00734851|585796523|FG000|Overall Study|Lost to Follow-up|1|||
162203620|NCT00734851|585796523|FG000|Overall Study|Physician Decision|18|||
162203621|NCT00818519|585796524|FG000|Overall Study|Adverse Event|2|||
162203622|NCT00818519|585796525|FG001|Overall Study|Adverse Event|2|||
162203623|NCT00818519|585796524|FG000|Overall Study|Lost to Follow-up|4|||
162203624|NCT00818519|585796525|FG001|Overall Study|Lost to Follow-up|6|||
162203625|NCT00818519|585796524|FG000|Overall Study|Protocol Violation|2|||
162203626|NCT00818519|585796525|FG001|Overall Study|Protocol Violation|1|||
162203627|NCT00818519|585796524|FG000|Overall Study|Pregnancy|0|||
162203628|NCT00818519|585796525|FG001|Overall Study|Pregnancy|1|||
162203629|NCT00818519|585796524|FG000|Overall Study|Withdrawal by Subject|4|||
162203630|NCT00818519|585796525|FG001|Overall Study|Withdrawal by Subject|9|||
162203631|NCT00818519|585796524|FG000|Overall Study|participant recovered completely|1|||
162203632|NCT00818519|585796525|FG001|Overall Study|participant recovered completely|0|||
162203633|NCT00818519|585796524|FG000|Overall Study|participant will leave for long tme|1|||
162203634|NCT00818519|585796525|FG001|Overall Study|participant will leave for long tme|0|||
162203635|NCT00981578|585796529|FG000|Overall Study|Death|1|||
161931976|NCT00147537|584798784|FG010|Phase 1b|Lost to Follow-up|0|||
161931977|NCT00147537|584798774|FG000|Phase 1b|Other|0|||
162203636|NCT00981578|585796529|FG000|Overall Study|Withdrawal by Subject|2|||
162203637|NCT01294358|585796534|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
162203638|NCT01294358|585796535|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
162203639|NCT01294358|585796536|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
162203640|NCT01294358|585796537|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
162203641|NCT01294358|585796538|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
162203642|NCT01294358|585796534|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
162203643|NCT01294358|585796535|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
162203644|NCT01294358|585796536|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
162203645|NCT01294358|585796537|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
162203646|NCT01294358|585796538|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
162203647|NCT01294358|585796534|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
162203648|NCT01294358|585796535|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
162203649|NCT01294358|585796536|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
162203650|NCT01294358|585796537|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
162203651|NCT01294358|585796538|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
162203652|NCT01294358|585796534|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
162203653|NCT01294358|585796535|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
161931978|NCT00147537|584798775|FG001|Phase 1b|Other|0|||
162203654|NCT01294358|585796536|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
162203655|NCT01294358|585796537|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
162203656|NCT01294358|585796538|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
162203657|NCT03613454|585796539|FG000|Overall Study|Protocol Violation|1|||
162203658|NCT03613454|585796540|FG001|Overall Study|Protocol Violation|0|||
162203659|NCT03613454|585796539|FG000|Overall Study|Protocol Violation|0|||
162203660|NCT03613454|585796540|FG001|Overall Study|Protocol Violation|1|||
162203661|NCT02963922|585796541|FG000|Overall Study|Adverse Event|15|||
162203662|NCT02963922|585796542|FG001|Overall Study|Adverse Event|6|||
161931979|NCT00147537|584798776|FG002|Phase 1b|Other|2|||
162203663|NCT02963922|585796541|FG000|Overall Study|Protocol deviation|6|||
162203664|NCT02963922|585796542|FG001|Overall Study|Protocol deviation|6|||
162203665|NCT02963922|585796541|FG000|Overall Study|Lack of Efficacy|1|||
161931980|NCT00147537|584798777|FG003|Phase 1b|Other|1|||
162203666|NCT02963922|585796542|FG001|Overall Study|Lack of Efficacy|1|||
162203667|NCT02963922|585796541|FG000|Overall Study|Lost to Follow-up|2|||
162203668|NCT02963922|585796542|FG001|Overall Study|Lost to Follow-up|3|||
161931981|NCT00147537|584798778|FG004|Phase 1b|Other|1|||
162203669|NCT02963922|585796541|FG000|Overall Study|Other|8|||
162203670|NCT02963922|585796542|FG001|Overall Study|Other|14|||
162203671|NCT01180790|585796552|FG000|Overall Study|Adverse Event|1|||
162203672|NCT01180790|585796553|FG001|Overall Study|Adverse Event|1|||
162203673|NCT01180790|585796554|FG002|Overall Study|Adverse Event|2|||
162203674|NCT01180790|585796555|FG003|Overall Study|Adverse Event|0|||
162203675|NCT01180790|585796556|FG004|Overall Study|Adverse Event|1|||
162203676|NCT01180790|585796557|FG005|Overall Study|Adverse Event|3|||
162203677|NCT01180790|585796558|FG006|Overall Study|Adverse Event|0|||
162203678|NCT01180790|585796552|FG000|Overall Study|Withdrawal by Subject|3|||
162203679|NCT01180790|585796553|FG001|Overall Study|Withdrawal by Subject|0|||
162203680|NCT01180790|585796554|FG002|Overall Study|Withdrawal by Subject|5|||
162203681|NCT01180790|585796555|FG003|Overall Study|Withdrawal by Subject|0|||
162203682|NCT01180790|585796556|FG004|Overall Study|Withdrawal by Subject|2|||
162203683|NCT01180790|585796557|FG005|Overall Study|Withdrawal by Subject|1|||
162203684|NCT01180790|585796558|FG006|Overall Study|Withdrawal by Subject|0|||
162203685|NCT01180790|585796552|FG000|Overall Study|Lost to Follow-up|3|||
162203686|NCT01180790|585796553|FG001|Overall Study|Lost to Follow-up|1|||
162203687|NCT01180790|585796554|FG002|Overall Study|Lost to Follow-up|0|||
162203688|NCT01180790|585796555|FG003|Overall Study|Lost to Follow-up|2|||
162203689|NCT01180790|585796556|FG004|Overall Study|Lost to Follow-up|1|||
162203690|NCT01180790|585796557|FG005|Overall Study|Lost to Follow-up|0|||
162203691|NCT01180790|585796558|FG006|Overall Study|Lost to Follow-up|1|||
162203692|NCT01180790|585796552|FG000|Overall Study|Physician Decision|1|||
162203693|NCT01180790|585796553|FG001|Overall Study|Physician Decision|0|||
162203694|NCT01180790|585796554|FG002|Overall Study|Physician Decision|0|||
162203695|NCT01180790|585796555|FG003|Overall Study|Physician Decision|1|||
162203696|NCT01180790|585796556|FG004|Overall Study|Physician Decision|0|||
162203697|NCT01180790|585796557|FG005|Overall Study|Physician Decision|0|||
162203698|NCT01180790|585796558|FG006|Overall Study|Physician Decision|0|||
162203699|NCT01180790|585796552|FG000|Overall Study|Lack of Efficacy|1|||
162203700|NCT01180790|585796553|FG001|Overall Study|Lack of Efficacy|2|||
162203701|NCT01180790|585796554|FG002|Overall Study|Lack of Efficacy|5|||
162203702|NCT01180790|585796555|FG003|Overall Study|Lack of Efficacy|6|||
162203703|NCT01180790|585796556|FG004|Overall Study|Lack of Efficacy|1|||
162203704|NCT01180790|585796557|FG005|Overall Study|Lack of Efficacy|3|||
162203705|NCT01180790|585796558|FG006|Overall Study|Lack of Efficacy|0|||
162203706|NCT01180790|585796552|FG000|Overall Study|compliance|0|||
162203707|NCT01180790|585796553|FG001|Overall Study|compliance|1|||
162203708|NCT01180790|585796554|FG002|Overall Study|compliance|0|||
162203709|NCT01180790|585796555|FG003|Overall Study|compliance|0|||
162203710|NCT01180790|585796556|FG004|Overall Study|compliance|0|||
162203711|NCT01180790|585796557|FG005|Overall Study|compliance|0|||
162203712|NCT01180790|585796558|FG006|Overall Study|compliance|0|||
162203713|NCT01180790|585796552|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
162203714|NCT01180790|585796553|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
162203715|NCT01180790|585796554|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
162203716|NCT01180790|585796555|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
162203717|NCT01180790|585796556|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
162203718|NCT01180790|585796557|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
162203719|NCT01180790|585796558|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
162203720|NCT00655668|585796559|FG000|Overall Study|Adverse Event|6|||
162203721|NCT00655668|585796559|FG000|Overall Study|Death|5|||
162203722|NCT00655668|585796559|FG000|Overall Study|Disease Progression|27|||
162203723|NCT00655668|585796559|FG000|Overall Study|Study Terminated|9|||
162203724|NCT00655668|585796559|FG000|Overall Study|Other|1|||
162203725|NCT00655668|585796559|FG000|Overall Study|New Lymphoma Treatment Started|4|||
162203726|NCT00655668|585796559|FG000|Overall Study|Withdrawal by Subject|2|||
162203727|NCT02335242|585796560|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
162203728|NCT02335242|585796561|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
162203729|NCT02335242|585796560|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
161931982|NCT00147537|584798779|FG005|Phase 1b|Other|1|||
161931983|NCT00147537|584798780|FG006|Phase 1b|Other|14|||
161931984|NCT00147537|584798781|FG007|Phase 1b|Other|4|||
161931985|NCT00147537|584798782|FG008|Phase 1b|Other|4|||
161931986|NCT00147537|584798783|FG009|Phase 1b|Other|0|||
161931987|NCT00147537|584798784|FG010|Phase 1b|Other|0|||
162203730|NCT02335242|585796561|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
162203731|NCT02335242|585796560|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
162203732|NCT02335242|585796561|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
161931988|NCT00147537|584798774|FG000|Phase 1b|Withdrawal by Subject|0|||
162203733|NCT04167085|585796562|FG000|Baseline|Withdrawal by Subject|2|||
162203734|NCT04167085|585796563|FG001|Baseline|Withdrawal by Subject|1|||
162203735|NCT04167085|585796562|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
162203736|NCT04167085|585796563|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
162203737|NCT03615404|585796564|FG000|Overall Study|Death|1|||
162203738|NCT03615404|585796564|FG000|Overall Study|vaccine did not pass quality assurance|1|||
161931989|NCT00147537|584798775|FG001|Phase 1b|Withdrawal by Subject|0|||
161931990|NCT00147537|584798776|FG002|Phase 1b|Withdrawal by Subject|0|||
162203739|NCT00257556|585796565|FG000|Overall Study|Adverse Event|1|||
162203740|NCT00257556|585796566|FG001|Overall Study|Adverse Event|4|||
162203741|NCT00257556|585796565|FG000|Overall Study|Physician Decision|6|||
162203742|NCT00257556|585796566|FG001|Overall Study|Physician Decision|0|||
162203743|NCT00257556|585796565|FG000|Overall Study|Did not meet hCG criterion|3|||
162203744|NCT00257556|585796566|FG001|Overall Study|Did not meet hCG criterion|0|||
162203745|NCT00257556|585796565|FG000|Overall Study|other reason|4|||
162203746|NCT00257556|585796566|FG001|Overall Study|other reason|6|||
162203747|NCT03873038|585796567|FG000|Part 2|Withdrawal by Subject|0|||
162203748|NCT03873038|585796568|FG001|Part 2|Withdrawal by Subject|0|||
162203749|NCT03873038|585796569|FG002|Part 2|Withdrawal by Subject|0|||
162203750|NCT03873038|585796570|FG003|Part 2|Withdrawal by Subject|0|||
162203751|NCT03873038|585796571|FG004|Part 2|Withdrawal by Subject|0|||
162203752|NCT03873038|585796572|FG005|Part 2|Withdrawal by Subject|1|||
162203753|NCT03873038|585796567|FG000|Part 2|Unknon|0|||
162203754|NCT03873038|585796568|FG001|Part 2|Unknon|0|||
162203755|NCT03873038|585796569|FG002|Part 2|Unknon|0|||
162203756|NCT03873038|585796570|FG003|Part 2|Unknon|0|||
162203757|NCT03873038|585796571|FG004|Part 2|Unknon|1|||
162203758|NCT03873038|585796572|FG005|Part 2|Unknon|0|||
162203759|NCT04222088|585796573|FG000|Overall Study|Lost to Follow-up|5|||
162203760|NCT04222088|585796574|FG001|Overall Study|Lost to Follow-up|1|||
162203761|NCT04222088|585796573|FG000|Overall Study|Withdrawal by Subject|4|||
162203762|NCT04222088|585796574|FG001|Overall Study|Withdrawal by Subject|0|||
162203763|NCT00595764|585796575|FG000|Overall Study|Protocol Violation|24|||
162203764|NCT00595764|585796576|FG001|Overall Study|Protocol Violation|19|||
162203765|NCT00595764|585796575|FG000|Overall Study|Missed Medication >1 week|10|||
162203766|NCT00595764|585796576|FG001|Overall Study|Missed Medication >1 week|17|||
162203767|NCT00595764|585796575|FG000|Overall Study|Missed 3 PM visits|1|||
162203768|NCT00595764|585796576|FG001|Overall Study|Missed 3 PM visits|7|||
162203769|NCT00595764|585796575|FG000|Overall Study|Withdrawal by Subject|4|||
162203770|NCT00595764|585796576|FG001|Overall Study|Withdrawal by Subject|0|||
162203771|NCT02820298|585796582|FG000|Overall Study|Withdrawal by Subject|0|||
162203772|NCT02820298|585796583|FG001|Overall Study|Withdrawal by Subject|1|||
162203773|NCT02820298|585796582|FG000|Overall Study|Physician Decision|1|||
162203774|NCT02820298|585796583|FG001|Overall Study|Physician Decision|0|||
162203775|NCT02820298|585796582|FG000|Overall Study|Protocol Violation|0|||
162203776|NCT02820298|585796583|FG001|Overall Study|Protocol Violation|1|||
162203777|NCT01780584|585796584|FG000|Overall Study|Death|1|||
162203778|NCT01780584|585796585|FG001|Overall Study|Death|0|||
162203779|NCT01780584|585796586|FG002|Overall Study|Death|1|||
162203780|NCT01780584|585796584|FG000|Overall Study|Adverse Event|0|||
162203781|NCT01780584|585796585|FG001|Overall Study|Adverse Event|1|||
162203782|NCT01780584|585796586|FG002|Overall Study|Adverse Event|0|||
162203783|NCT01780584|585796584|FG000|Overall Study|Protocol Violation|0|||
162203784|NCT01780584|585796585|FG001|Overall Study|Protocol Violation|0|||
162203785|NCT01780584|585796586|FG002|Overall Study|Protocol Violation|1|||
162203786|NCT00141271|585796591|FG000|Overall Study|Adverse Event|31|||
162203787|NCT00141271|585796592|FG001|Overall Study|Adverse Event|19|||
162203788|NCT00141271|585796593|FG002|Overall Study|Adverse Event|17|||
162203789|NCT00141271|585796591|FG000|Overall Study|Laboratory Abnormality|2|||
162203790|NCT00141271|585796592|FG001|Overall Study|Laboratory Abnormality|1|||
162203791|NCT00141271|585796593|FG002|Overall Study|Laboratory Abnormality|1|||
162203792|NCT00141271|585796591|FG000|Overall Study|Lack of Efficacy|7|||
162203793|NCT00141271|585796592|FG001|Overall Study|Lack of Efficacy|7|||
162203794|NCT00141271|585796593|FG002|Overall Study|Lack of Efficacy|3|||
161931991|NCT00147537|584798777|FG003|Phase 1b|Withdrawal by Subject|0|||
162203795|NCT00141271|585796591|FG000|Overall Study|Lost to Follow-up|15|||
162203796|NCT00141271|585796592|FG001|Overall Study|Lost to Follow-up|15|||
162203797|NCT00141271|585796593|FG002|Overall Study|Lost to Follow-up|21|||
162203798|NCT00141271|585796591|FG000|Overall Study|Withdrawal by Subject|14|||
162203799|NCT00141271|585796592|FG001|Overall Study|Withdrawal by Subject|9|||
162203800|NCT00141271|585796593|FG002|Overall Study|Withdrawal by Subject|10|||
162203801|NCT00141271|585796591|FG000|Overall Study|Other|11|||
162203802|NCT00141271|585796592|FG001|Overall Study|Other|12|||
162203803|NCT00141271|585796593|FG002|Overall Study|Other|5|||
162203804|NCT01544153|585796594|FG000|Overall Study|Under 18|0|||
162203805|NCT01544153|585796595|FG001|Overall Study|Under 18|1|||
162203806|NCT01544153|585796596|FG002|Overall Study|Under 18|0|||
162203807|NCT01544153|585796597|FG003|Overall Study|Under 18|0|||
162203808|NCT01544153|585796594|FG000|Overall Study|Non-smoker|0|||
162203809|NCT01544153|585796595|FG001|Overall Study|Non-smoker|0|||
162203810|NCT01544153|585796596|FG002|Overall Study|Non-smoker|1|||
162203811|NCT01544153|585796597|FG003|Overall Study|Non-smoker|0|||
162203812|NCT00390806|585796602|FG000|Overall Study|Lost to Follow-up|7|||
162203813|NCT00390806|585796603|FG001|Overall Study|Lost to Follow-up|6|||
162203814|NCT00390806|585796602|FG000|Overall Study|Protocol Violation|2|||
162203815|NCT00390806|585796603|FG001|Overall Study|Protocol Violation|2|||
162203816|NCT00390806|585796602|FG000|Overall Study|Withdrawal by Subject|12|||
162203817|NCT00390806|585796603|FG001|Overall Study|Withdrawal by Subject|15|||
162203818|NCT00390806|585796602|FG000|Overall Study|Investigator Decision|4|||
162203819|NCT00390806|585796603|FG001|Overall Study|Investigator Decision|6|||
162203820|NCT00390806|585796602|FG000|Overall Study|Death|1|||
162203821|NCT00390806|585796603|FG001|Overall Study|Death|0|||
162203822|NCT00390806|585796602|FG000|Overall Study|Physician Decision|0|||
162203823|NCT00390806|585796603|FG001|Overall Study|Physician Decision|1|||
162203824|NCT00390806|585796602|FG000|Overall Study|Ongoing|4|||
162203825|NCT00390806|585796603|FG001|Overall Study|Ongoing|2|||
162203826|NCT00884793|585796606|FG000|Overall Study|Withdrawal by Subject|1|||
162203827|NCT03169530|585796607|FG000|Overall Study|Study ended by NIH|15|||
162203828|NCT03169530|585796608|FG001|Overall Study|Study ended by NIH|17|||
162203829|NCT04783519|585796609|FG000|Overall Study|Withdrawal by Subject|2|||
162203830|NCT04783519|585796610|FG001|Overall Study|Withdrawal by Subject|7|||
162203831|NCT04783519|585796611|FG002|Overall Study|Withdrawal by Subject|3|||
162203832|NCT04783519|585796609|FG000|Overall Study|Lost to Follow-up|9|||
162203833|NCT04783519|585796610|FG001|Overall Study|Lost to Follow-up|7|||
162203834|NCT04783519|585796611|FG002|Overall Study|Lost to Follow-up|6|||
162203835|NCT01032200|585796612|FG000|Overall Study|Death|1|||
162203836|NCT01032200|585796613|FG001|Overall Study|Death|1|||
162203837|NCT01032200|585796612|FG000|Overall Study|Withdrawal by Subject|1|||
162203838|NCT01032200|585796613|FG001|Overall Study|Withdrawal by Subject|3|||
162203839|NCT01032200|585796612|FG000|Overall Study|Toxicity|0|||
162203840|NCT01032200|585796613|FG001|Overall Study|Toxicity|2|||
162203841|NCT01032200|585796612|FG000|Overall Study|Progression|1|||
162203842|NCT01032200|585796613|FG001|Overall Study|Progression|0|||
162203843|NCT01032200|585796612|FG000|Overall Study|Multiple|1|||
162203844|NCT01032200|585796613|FG001|Overall Study|Multiple|1|||
162203845|NCT00727259|585796617|FG000|Overall Study|Not all questionnaires completed|1055|||
162203846|NCT01021683|585796618|FG000|Overall Study|Lack of Efficacy|12|||
162203847|NCT01021683|585796618|FG000|Overall Study|Recovery of neutrophil count|51|||
162203848|NCT01021683|585796618|FG000|Overall Study|Other|8|||
162203849|NCT01374971|585796619|FG000|Overall Study|Withdrawal by Subject|1|||
162203850|NCT02273180|585796620|FG000|Overall Study|Adverse Event|2|||
162203851|NCT02273180|585796621|FG001|Overall Study|Adverse Event|2|||
162203852|NCT02273180|585796620|FG000|Overall Study|Lack of Efficacy|1|||
162203853|NCT02273180|585796621|FG001|Overall Study|Lack of Efficacy|0|||
162203854|NCT02273180|585796620|FG000|Overall Study|Protocol Violation|1|||
162203855|NCT02273180|585796621|FG001|Overall Study|Protocol Violation|7|||
162203856|NCT02273180|585796620|FG000|Overall Study|Randomized but not treated|1|||
162203857|NCT02273180|585796621|FG001|Overall Study|Randomized but not treated|0|||
162203858|NCT02273180|585796620|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
162203859|NCT02273180|585796621|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
162203860|NCT02273180|585796620|FG000|Overall Study|Other than specified above|21|||
162203861|NCT02273180|585796621|FG001|Overall Study|Other than specified above|10|||
162203862|NCT04531813|585796622|FG000|Overall Study|Protocol Violation|1|||
162203863|NCT04531813|585796622|FG000|Overall Study|Withdrawal by Subject|1|||
162203864|NCT04341584|585796625|FG000|Overall Study|Withdrew consent|0|||
162203865|NCT04341584|585796626|FG001|Overall Study|Withdrew consent|2|||
162203866|NCT04341584|585796627|FG002|Overall Study|Withdrew consent|2|||
162203867|NCT04341584|585796628|FG003|Overall Study|Withdrew consent|1|||
162203868|NCT01990313|585798096|FG000|Overall Study|Lost to Follow-up|1|||
162203869|NCT02412111|585798097|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
162203870|NCT02412111|585798098|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
162203871|NCT02412111|585798099|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
162203872|NCT02412111|585798097|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
162203873|NCT02412111|585798098|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
162203874|NCT02412111|585798099|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
162203875|NCT02412111|585798097|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
162203876|NCT02412111|585798098|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
162203877|NCT02412111|585798099|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
162203878|NCT02412111|585798097|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
162203879|NCT02412111|585798098|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
162203880|NCT02412111|585798099|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
162203881|NCT02412111|585798097|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
162203882|NCT02412111|585798098|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
161931992|NCT00147537|584798778|FG004|Phase 1b|Withdrawal by Subject|0|||
162203883|NCT02412111|585798099|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
162203884|NCT02412111|585798097|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
162203885|NCT02412111|585798098|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
162203886|NCT02412111|585798099|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
162203887|NCT02412111|585798097|FG000|Active Comparator Period (8 Weeks)|Other|0|||
162203888|NCT02412111|585798098|FG001|Active Comparator Period (8 Weeks)|Other|0|||
161824069|NCT01856192|584397911|FG000|Overall Study|Adverse Event|12|||
161824070|NCT01856192|584397912|FG001|Overall Study|Adverse Event|4|||
161824071|NCT01856192|584397911|FG000|Overall Study|Alternative therapy|0|||
161824072|NCT01856192|584397912|FG001|Overall Study|Alternative therapy|3|||
161824073|NCT01856192|584397911|FG000|Overall Study|Death|3|||
161824074|NCT01856192|584397912|FG001|Overall Study|Death|5|||
161824075|NCT01856192|584397911|FG000|Overall Study|Lack of Efficacy|0|||
161824076|NCT01856192|584397912|FG001|Overall Study|Lack of Efficacy|5|||
161824077|NCT01856192|584397911|FG000|Overall Study|Withdrawal by Subject|1|||
161824078|NCT01856192|584397912|FG001|Overall Study|Withdrawal by Subject|1|||
161824079|NCT01856192|584397911|FG000|Overall Study|Other diseases|1|||
161824080|NCT01856192|584397912|FG001|Overall Study|Other diseases|0|||
161824081|NCT01856192|584397911|FG000|Overall Study|Never started treatment|7|||
161824082|NCT01856192|584397912|FG001|Overall Study|Never started treatment|5|||
161824083|NCT01856192|584397911|FG000|Overall Study|Path ineligible|20|||
161824084|NCT01856192|584397912|FG001|Overall Study|Path ineligible|34|||
161824085|NCT01856192|584397911|FG000|Overall Study|Non-path ineligible|2|||
161824086|NCT01856192|584397912|FG001|Overall Study|Non-path ineligible|2|||
161824087|NCT01856192|584397911|FG000|Overall Study|Physician Decision|1|||
161824088|NCT01856192|584397912|FG001|Overall Study|Physician Decision|1|||
162203889|NCT02412111|585798099|FG002|Active Comparator Period (8 Weeks)|Other|2|||
162203890|NCT00837096|585798101|FG000|Overall Study|Physician Decision|1|||
162203891|NCT00837096|585798102|FG001|Overall Study|Physician Decision|1|||
162203892|NCT00837096|585798101|FG000|Overall Study|Not reported|9|||
162203893|NCT00837096|585798102|FG001|Overall Study|Not reported|8|||
162203894|NCT00721214|585798103|FG000|Overall Study|Chose another center for transplant|1|||
162203895|NCT00721214|585798103|FG000|Overall Study|Death|3|||
162203896|NCT00983905|585798104|FG000|Theophylline Alone|Adverse Event|1|||
162203897|NCT00983905|585798104|FG000|Colchicine Alone|Adverse Event|2|||
162203898|NCT01169636|585798105|FG000|Overall Study|Adverse Event|0|||
162203899|NCT01169636|585798106|FG001|Overall Study|Adverse Event|0|||
162203900|NCT01169636|585798107|FG002|Overall Study|Adverse Event|1|||
162203901|NCT01169636|585798108|FG003|Overall Study|Adverse Event|1|||
162203902|NCT01169636|585798109|FG004|Overall Study|Adverse Event|0|||
162203903|NCT01169636|585798105|FG000|Overall Study|Screen failure|0|||
162203904|NCT01169636|585798106|FG001|Overall Study|Screen failure|0|||
162203905|NCT01169636|585798107|FG002|Overall Study|Screen failure|2|||
162203906|NCT01169636|585798108|FG003|Overall Study|Screen failure|0|||
162203907|NCT01169636|585798109|FG004|Overall Study|Screen failure|0|||
162203908|NCT01169636|585798105|FG000|Overall Study|Withdrawal by Subject|0|||
162203909|NCT01169636|585798106|FG001|Overall Study|Withdrawal by Subject|0|||
162203910|NCT01169636|585798107|FG002|Overall Study|Withdrawal by Subject|0|||
162203911|NCT01169636|585798108|FG003|Overall Study|Withdrawal by Subject|0|||
162203912|NCT01169636|585798109|FG004|Overall Study|Withdrawal by Subject|3|||
162203913|NCT02396953|585798110|FG000|Overall Study|Withdrawal by Subject|0|||
162203914|NCT02396953|585798111|FG001|Overall Study|Withdrawal by Subject|0|||
162203915|NCT02396953|585798112|FG002|Overall Study|Withdrawal by Subject|1|||
162203916|NCT02396953|585798110|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
162203917|NCT02396953|585798111|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
162203918|NCT02396953|585798112|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
162203919|NCT02396953|585798110|FG000|Overall Study|Personal Reasons|1|||
162203920|NCT02396953|585798111|FG001|Overall Study|Personal Reasons|1|||
162203921|NCT02396953|585798112|FG002|Overall Study|Personal Reasons|0|||
162203922|NCT02624869|585798113|FG000|Overall Study|Lost to Follow-up|0|||
162203923|NCT02624869|585798114|FG001|Overall Study|Lost to Follow-up|0|||
162203924|NCT02624869|585798115|FG002|Overall Study|Lost to Follow-up|1|||
162203925|NCT02624869|585798113|FG000|Overall Study|Withdrawal by Subject|1|||
162203926|NCT02624869|585798114|FG001|Overall Study|Withdrawal by Subject|3|||
162203927|NCT02624869|585798115|FG002|Overall Study|Withdrawal by Subject|1|||
162203928|NCT00510198|585798116|FG000|Overall Study|Withdrawal by Subject|5|||
162203929|NCT00510198|585798117|FG001|Overall Study|Withdrawal by Subject|4|||
162203930|NCT02994784|585798119|FG000|6 Months Follow-up|Lost to Follow-up|3|||
162203931|NCT00494026|585798120|FG000|Overall Study|Sponsor Decision|4|||
162203932|NCT02466243|585798121|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
162203933|NCT02466243|585798122|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
162203934|NCT02466243|585798121|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
161824089|NCT01856192|584397911|FG000|Overall Study|Suspicion of progressive disease|1|||
161824090|NCT01856192|584397912|FG001|Overall Study|Suspicion of progressive disease|0|||
161824091|NCT01856192|584397911|FG000|Overall Study|Non-compliance|1|||
161824092|NCT01856192|584397912|FG001|Overall Study|Non-compliance|0|||
161824093|NCT00098475|584397913|FG000|Step 1|Progressive disease|33|||
161931993|NCT00147537|584798779|FG005|Phase 1b|Withdrawal by Subject|0|||
161931994|NCT00147537|584798780|FG006|Phase 1b|Withdrawal by Subject|0|||
161931995|NCT00147537|584798781|FG007|Phase 1b|Withdrawal by Subject|0|||
161931996|NCT00147537|584798782|FG008|Phase 1b|Withdrawal by Subject|2|||
161931997|NCT00147537|584798783|FG009|Phase 1b|Withdrawal by Subject|0|||
161931998|NCT00147537|584798784|FG010|Phase 1b|Withdrawal by Subject|0|||
161931999|NCT00147537|584798774|FG000|Phase 1b|Randomized but not treated|0|||
161932000|NCT00147537|584798775|FG001|Phase 1b|Randomized but not treated|0|||
161932001|NCT00147537|584798776|FG002|Phase 1b|Randomized but not treated|0|||
162203935|NCT02466243|585798122|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
162203936|NCT02466243|585798121|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
162203937|NCT02466243|585798122|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
162203938|NCT02466243|585798121|FG000|Part B Open-label Treatment Period|Missing|2|||
162203939|NCT02466243|585798122|FG001|Part B Open-label Treatment Period|Missing|2|||
162203940|NCT02895360|585798123|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
161932002|NCT00147537|584798777|FG003|Phase 1b|Randomized but not treated|0|||
162203941|NCT02895360|585798124|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
162203942|NCT02895360|585798125|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
162203943|NCT02895360|585798126|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
162203944|NCT02895360|585798127|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
162203945|NCT02895360|585798128|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
162203946|NCT02895360|585798123|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
162203947|NCT02895360|585798124|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
162203948|NCT02895360|585798125|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
162203949|NCT02895360|585798126|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
162203950|NCT02895360|585798127|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
162203951|NCT02895360|585798128|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
162203952|NCT02895360|585798123|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
162203953|NCT02895360|585798124|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
162203954|NCT02895360|585798125|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
161932003|NCT00147537|584798778|FG004|Phase 1b|Randomized but not treated|0|||
161932004|NCT00147537|584798779|FG005|Phase 1b|Randomized but not treated|0|||
161932005|NCT00147537|584798780|FG006|Phase 1b|Randomized but not treated|1|||
161932006|NCT00147537|584798781|FG007|Phase 1b|Randomized but not treated|0|||
161932007|NCT00147537|584798782|FG008|Phase 1b|Randomized but not treated|1|||
161932008|NCT00147537|584798783|FG009|Phase 1b|Randomized but not treated|0|||
161932009|NCT00147537|584798784|FG010|Phase 1b|Randomized but not treated|0|||
161932010|NCT00147537|584798774|FG000|Phase 2|Death|0|||
161932011|NCT00147537|584798775|FG001|Phase 2|Death|0|||
161932012|NCT00147537|584798776|FG002|Phase 2|Death|0|||
161932013|NCT00147537|584798777|FG003|Phase 2|Death|0|||
161932014|NCT00147537|584798778|FG004|Phase 2|Death|0|||
161932015|NCT00147537|584798779|FG005|Phase 2|Death|0|||
161932016|NCT00147537|584798780|FG006|Phase 2|Death|0|||
161932017|NCT00147537|584798781|FG007|Phase 2|Death|0|||
161932018|NCT00147537|584798782|FG008|Phase 2|Death|0|||
161932019|NCT00147537|584798783|FG009|Phase 2|Death|85|||
161932020|NCT00147537|584798784|FG010|Phase 2|Death|31|||
161932021|NCT00147537|584798774|FG000|Phase 2|Lost to Follow-up|0|||
161932022|NCT00147537|584798775|FG001|Phase 2|Lost to Follow-up|0|||
161932023|NCT00147537|584798776|FG002|Phase 2|Lost to Follow-up|0|||
161932024|NCT00147537|584798777|FG003|Phase 2|Lost to Follow-up|0|||
161932025|NCT00147537|584798778|FG004|Phase 2|Lost to Follow-up|0|||
161932026|NCT00147537|584798779|FG005|Phase 2|Lost to Follow-up|0|||
161932027|NCT00147537|584798780|FG006|Phase 2|Lost to Follow-up|0|||
161932028|NCT00147537|584798781|FG007|Phase 2|Lost to Follow-up|0|||
161932029|NCT00147537|584798782|FG008|Phase 2|Lost to Follow-up|0|||
161932030|NCT00147537|584798783|FG009|Phase 2|Lost to Follow-up|12|||
162203955|NCT02895360|585798126|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
162203956|NCT02895360|585798127|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
162203957|NCT02895360|585798128|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
161932031|NCT00147537|584798784|FG010|Phase 2|Lost to Follow-up|4|||
161932032|NCT00147537|584798774|FG000|Phase 2|Other|0|||
161932033|NCT00147537|584798775|FG001|Phase 2|Other|0|||
162203958|NCT02895360|585798123|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
161932034|NCT00147537|584798776|FG002|Phase 2|Other|0|||
161932035|NCT00147537|584798777|FG003|Phase 2|Other|0|||
161932036|NCT00147537|584798778|FG004|Phase 2|Other|0|||
161932037|NCT00147537|584798779|FG005|Phase 2|Other|0|||
161932038|NCT00147537|584798780|FG006|Phase 2|Other|0|||
161932039|NCT00147537|584798781|FG007|Phase 2|Other|0|||
161932040|NCT00147537|584798782|FG008|Phase 2|Other|0|||
161932041|NCT00147537|584798783|FG009|Phase 2|Other|47|||
161932042|NCT00147537|584798784|FG010|Phase 2|Other|12|||
161932043|NCT00147537|584798774|FG000|Phase 2|Withdrawal by Subject|0|||
161932044|NCT00147537|584798775|FG001|Phase 2|Withdrawal by Subject|0|||
162203959|NCT02895360|585798124|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
162203960|NCT02895360|585798125|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
162203961|NCT02895360|585798126|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
162203962|NCT02895360|585798127|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
162203963|NCT02895360|585798128|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
162203964|NCT02895360|585798123|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
162203965|NCT02895360|585798124|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
162203966|NCT02895360|585798125|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
162203967|NCT02895360|585798126|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
162203968|NCT02895360|585798127|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
162203969|NCT02895360|585798128|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
162203970|NCT02895360|585798123|FG000|Phase 2a|Adverse Event|0|||
162203971|NCT02895360|585798124|FG001|Phase 2a|Adverse Event|0|||
162203972|NCT02895360|585798125|FG002|Phase 2a|Adverse Event|0|||
162203973|NCT02895360|585798126|FG003|Phase 2a|Adverse Event|0|||
162203974|NCT02895360|585798127|FG004|Phase 2a|Adverse Event|0|||
162203975|NCT02895360|585798128|FG005|Phase 2a|Adverse Event|1|||
162203976|NCT02895360|585798123|FG000|Phase 2a|Progressive disease|0|||
162203977|NCT02895360|585798124|FG001|Phase 2a|Progressive disease|0|||
162203978|NCT02895360|585798125|FG002|Phase 2a|Progressive disease|0|||
162203979|NCT02895360|585798126|FG003|Phase 2a|Progressive disease|0|||
162203980|NCT02895360|585798127|FG004|Phase 2a|Progressive disease|11|||
162203981|NCT02895360|585798128|FG005|Phase 2a|Progressive disease|11|||
162203982|NCT00307164|585798131|FG000|Overall Study|Death|1|||
162203983|NCT00307164|585798132|FG001|Overall Study|Death|0|||
161932045|NCT00147537|584798776|FG002|Phase 2|Withdrawal by Subject|0|||
161932046|NCT00147537|584798777|FG003|Phase 2|Withdrawal by Subject|0|||
161932047|NCT00147537|584798778|FG004|Phase 2|Withdrawal by Subject|0|||
161932048|NCT00147537|584798779|FG005|Phase 2|Withdrawal by Subject|0|||
161932049|NCT00147537|584798780|FG006|Phase 2|Withdrawal by Subject|0|||
161932050|NCT00147537|584798781|FG007|Phase 2|Withdrawal by Subject|0|||
161932051|NCT00147537|584798782|FG008|Phase 2|Withdrawal by Subject|0|||
161932052|NCT00147537|584798783|FG009|Phase 2|Withdrawal by Subject|16|||
161932053|NCT00147537|584798784|FG010|Phase 2|Withdrawal by Subject|4|||
161932054|NCT00147537|584798774|FG000|Phase 2|Randomized but not treated|0|||
161932055|NCT00147537|584798775|FG001|Phase 2|Randomized but not treated|0|||
161932056|NCT00147537|584798776|FG002|Phase 2|Randomized but not treated|0|||
161932057|NCT00147537|584798777|FG003|Phase 2|Randomized but not treated|0|||
161932058|NCT00147537|584798778|FG004|Phase 2|Randomized but not treated|0|||
161932059|NCT00147537|584798779|FG005|Phase 2|Randomized but not treated|0|||
161932060|NCT00147537|584798780|FG006|Phase 2|Randomized but not treated|0|||
161932061|NCT00147537|584798781|FG007|Phase 2|Randomized but not treated|0|||
161932062|NCT00147537|584798782|FG008|Phase 2|Randomized but not treated|0|||
161932063|NCT00147537|584798783|FG009|Phase 2|Randomized but not treated|1|||
161932064|NCT00147537|584798784|FG010|Phase 2|Randomized but not treated|1|||
161932065|NCT01927861|584798785|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
161932066|NCT01927861|584798786|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
161932067|NCT01927861|584798785|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
161932068|NCT01927861|584798786|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
161932069|NCT00987935|584798787|FG000|Overall Study|Progressive disease|3|||
161932070|NCT00987935|584798788|FG001|Overall Study|Progressive disease|2|||
161932071|NCT00987935|584798789|FG002|Overall Study|Progressive disease|3|||
161932072|NCT00987935|584798790|FG003|Overall Study|Progressive disease|2|||
161932073|NCT00987935|584798791|FG004|Overall Study|Progressive disease|5|||
161932074|NCT00987935|584798792|FG005|Overall Study|Progressive disease|3|||
161932075|NCT00987935|584798793|FG006|Overall Study|Progressive disease|9|||
161932076|NCT00987935|584798794|FG007|Overall Study|Progressive disease|48|||
161932077|NCT00987935|584798795|FG008|Overall Study|Progressive disease|23|||
161932078|NCT00987935|584798787|FG000|Overall Study|Adverse Event|0|||
162203984|NCT00307164|585798131|FG000|Overall Study|Severe debilitation, unable to continue|1|||
162203985|NCT00307164|585798132|FG001|Overall Study|Severe debilitation, unable to continue|0|||
162203986|NCT00307164|585798131|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
162203987|NCT00307164|585798132|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
162203988|NCT00307164|585798131|FG000|Overall Study|Withdrawal by Subject|1|||
161932079|NCT00987935|584798788|FG001|Overall Study|Adverse Event|1|||
162203989|NCT00307164|585798132|FG001|Overall Study|Withdrawal by Subject|8|||
162203990|NCT00307164|585798131|FG000|Overall Study|Not compliant with requirements|4|||
161932080|NCT00987935|584798789|FG002|Overall Study|Adverse Event|0|||
161932081|NCT00987935|584798790|FG003|Overall Study|Adverse Event|1|||
161932082|NCT00987935|584798791|FG004|Overall Study|Adverse Event|1|||
161932083|NCT00987935|584798792|FG005|Overall Study|Adverse Event|0|||
161932084|NCT00987935|584798793|FG006|Overall Study|Adverse Event|2|||
161932085|NCT00987935|584798794|FG007|Overall Study|Adverse Event|10|||
161932086|NCT00987935|584798795|FG008|Overall Study|Adverse Event|6|||
161932087|NCT00987935|584798787|FG000|Overall Study|Refused to continue taking trial med.|1|||
162203991|NCT00307164|585798132|FG001|Overall Study|Not compliant with requirements|4|||
162203992|NCT00307164|585798131|FG000|Overall Study|Lost to Follow-up|6|||
162203993|NCT00307164|585798132|FG001|Overall Study|Lost to Follow-up|1|||
162203994|NCT03972137|585798137|FG000|Overall Study|Lost to Follow-up|2|||
162203995|NCT03972137|585798137|FG000|Overall Study|Withdrawal by Subject|4|||
162203996|NCT03226353|585798138|FG000|Overall Study|Withdrawal by Subject|1|||
162203997|NCT03226353|585798138|FG000|Overall Study|Screen Failure|5|||
161932088|NCT00987935|584798788|FG001|Overall Study|Refused to continue taking trial med.|0|||
161932089|NCT00987935|584798789|FG002|Overall Study|Refused to continue taking trial med.|0|||
161932090|NCT00987935|584798790|FG003|Overall Study|Refused to continue taking trial med.|0|||
161932091|NCT00987935|584798791|FG004|Overall Study|Refused to continue taking trial med.|1|||
161932092|NCT00987935|584798792|FG005|Overall Study|Refused to continue taking trial med.|0|||
161932093|NCT00987935|584798793|FG006|Overall Study|Refused to continue taking trial med.|4|||
161932094|NCT00987935|584798794|FG007|Overall Study|Refused to continue taking trial med.|4|||
161932095|NCT00987935|584798795|FG008|Overall Study|Refused to continue taking trial med.|2|||
161932096|NCT00987935|584798787|FG000|Overall Study|Reason other than those specified above|0|||
161932097|NCT00987935|584798788|FG001|Overall Study|Reason other than those specified above|0|||
161932098|NCT00987935|584798789|FG002|Overall Study|Reason other than those specified above|0|||
161932099|NCT00987935|584798790|FG003|Overall Study|Reason other than those specified above|0|||
161932100|NCT00987935|584798791|FG004|Overall Study|Reason other than those specified above|0|||
161932101|NCT00987935|584798792|FG005|Overall Study|Reason other than those specified above|0|||
161932102|NCT00987935|584798793|FG006|Overall Study|Reason other than those specified above|0|||
161932103|NCT00987935|584798794|FG007|Overall Study|Reason other than those specified above|0|||
161932104|NCT00987935|584798795|FG008|Overall Study|Reason other than those specified above|1|||
161932105|NCT00728182|584798796|FG000|Overall Study|Adverse Event|1|||
161932106|NCT00728182|584798797|FG001|Overall Study|Adverse Event|0|||
161932107|NCT00728182|584798796|FG000|Overall Study|Lost to Follow-up|2|||
161932108|NCT00728182|584798797|FG001|Overall Study|Lost to Follow-up|0|||
161932109|NCT00728182|584798796|FG000|Overall Study|Death|0|||
161932110|NCT00728182|584798797|FG001|Overall Study|Death|2|||
161932111|NCT00728182|584798796|FG000|Overall Study|Protocol Noncompliance|0|||
161932112|NCT00728182|584798797|FG001|Overall Study|Protocol Noncompliance|1|||
161932113|NCT01898091|584798800|FG000|Overall Study|Lost to Follow-up|1|||
161932114|NCT01898091|584798801|FG001|Overall Study|Lost to Follow-up|1|||
161932115|NCT01898091|584798800|FG000|Overall Study|Withdrawal by Subject|1|||
161932116|NCT01898091|584798801|FG001|Overall Study|Withdrawal by Subject|5|||
161932117|NCT03888482|584798804|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
161932118|NCT03888482|584798805|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
161932119|NCT03888482|584798804|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
161932120|NCT03888482|584798805|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
161932121|NCT02294019|584798806|FG000|Overall Study|Adverse Event|2|||
161932122|NCT02294019|584798806|FG000|Overall Study|Protocol Violation|68|||
161932123|NCT02294019|584798806|FG000|Overall Study|Lost to Follow-up|31|||
161932124|NCT02294019|584798806|FG000|Overall Study|Other|1|||
161932125|NCT02294019|584798806|FG000|Overall Study|Withdrawal by Subject|1|||
161932126|NCT01189227|584798808|FG000|Overall Study|Study terminated due to low accrual|6|||
161932127|NCT01189227|584798809|FG001|Overall Study|Study terminated due to low accrual|3|||
161932128|NCT01016015|584798810|FG000|Overall Study|Not Treated|3|||
161932129|NCT01016015|584798810|FG000|Overall Study|Withdrawal by Subject|1|||
161932130|NCT01016015|584798810|FG000|Overall Study|Adverse Event|15|||
161932131|NCT00362609|584798816|FG000|Overall Study|Withdrawal by Subject|0|||
161932132|NCT00362609|584798817|FG001|Overall Study|Withdrawal by Subject|1|||
161932133|NCT00362609|584798816|FG000|Overall Study|Protocol Violation|0|||
161932134|NCT00362609|584798817|FG001|Overall Study|Protocol Violation|1|||
161932135|NCT02205359|584798818|FG000|Overall Study|Death|293|||
161932136|NCT02205359|584798819|FG001|Overall Study|Death|327|||
161932137|NCT02205359|584798818|FG000|Overall Study|Lost to Follow-up|182|||
161932138|NCT02205359|584798819|FG001|Overall Study|Lost to Follow-up|162|||
161932139|NCT02205359|584798818|FG000|Overall Study|Physician Decision|51|||
161932140|NCT02205359|584798819|FG001|Overall Study|Physician Decision|53|||
161932141|NCT02205359|584798818|FG000|Overall Study|Withdrawal by Subject|167|||
161932142|NCT02205359|584798819|FG001|Overall Study|Withdrawal by Subject|169|||
161932143|NCT00236197|584798820|FG000|Overall Study|Withdrawal by Subject|3|||
161932144|NCT00236197|584798821|FG001|Overall Study|Withdrawal by Subject|2|||
162203998|NCT03168425|585798139|FG000|Overall Study|Lost to Follow-up|5|||
162203999|NCT03168425|585798140|FG001|Overall Study|Lost to Follow-up|8|||
162204000|NCT03168425|585798139|FG000|Overall Study|unable to confirm post op opioids|2|||
161932145|NCT00236197|584798820|FG000|Overall Study|Lost to Follow-up|1|||
161932146|NCT00236197|584798821|FG001|Overall Study|Lost to Follow-up|5|||
161932147|NCT00236197|584798820|FG000|Overall Study|Protocol Violation|0|||
161932148|NCT00236197|584798821|FG001|Overall Study|Protocol Violation|3|||
162204001|NCT03168425|585798140|FG001|Overall Study|unable to confirm post op opioids|3|||
161932149|NCT00236197|584798820|FG000|Overall Study|Medication non-compliance|1|||
161932150|NCT00236197|584798821|FG001|Overall Study|Medication non-compliance|2|||
161932151|NCT00236197|584798820|FG000|Overall Study|Other|0|||
161932152|NCT00236197|584798821|FG001|Overall Study|Other|2|||
161932153|NCT00480025|584798822|FG000|Overall Study|Protocol Violation|12|||
161932154|NCT00480025|584798823|FG001|Overall Study|Protocol Violation|7|||
162204002|NCT03029234|585798143|FG000|Overall Study|Sponsor Decision|1|||
162204003|NCT03029234|585798143|FG000|Overall Study|Withdrawal by Subject|5|||
162204004|NCT03029234|585798143|FG000|Overall Study|Death|91|||
162204005|NCT03029234|585798143|FG000|Overall Study|Lost to Follow-up|2|||
162204006|NCT00498433|585798144|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
162204007|NCT00498433|585798145|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
162204008|NCT00498433|585798146|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
162204009|NCT00498433|585798144|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
162204010|NCT00498433|585798145|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
162204011|NCT00498433|585798146|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
162204012|NCT00498433|585798144|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
162204013|NCT00498433|585798145|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
162204014|NCT00498433|585798146|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
162204015|NCT00498433|585798144|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
162204016|NCT00498433|585798145|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
162204017|NCT00498433|585798146|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
162204018|NCT01960114|585798147|FG000|Overall Study|Adverse Event|1|||
162204019|NCT01960114|585798148|FG001|Overall Study|Adverse Event|0|||
162204020|NCT01960114|585798147|FG000|Overall Study|Could not swallow study medication|0|||
162204021|NCT01960114|585798148|FG001|Overall Study|Could not swallow study medication|1|||
162204022|NCT01885936|585798155|FG000|Overall Study|Withdrawal by Subject|1|||
162204023|NCT01885936|585798156|FG001|Overall Study|Withdrawal by Subject|0|||
162204024|NCT03214250|585798157|FG000|Overall Study|Death|5|||
162204025|NCT03214250|585798158|FG001|Overall Study|Death|5|||
162204026|NCT03214250|585798159|FG002|Overall Study|Death|7|||
162204027|NCT03214250|585798160|FG003|Overall Study|Death|4|||
162204028|NCT03214250|585798161|FG004|Overall Study|Death|23|||
162204029|NCT03214250|585798162|FG005|Overall Study|Death|23|||
162204030|NCT03214250|585798163|FG006|Overall Study|Death|24|||
162204031|NCT03214250|585798157|FG000|Overall Study|Lost to Follow-up|0|||
162204032|NCT03214250|585798158|FG001|Overall Study|Lost to Follow-up|0|||
162204033|NCT03214250|585798159|FG002|Overall Study|Lost to Follow-up|0|||
162204034|NCT03214250|585798160|FG003|Overall Study|Lost to Follow-up|1|||
162204035|NCT03214250|585798161|FG004|Overall Study|Lost to Follow-up|1|||
162204036|NCT03214250|585798162|FG005|Overall Study|Lost to Follow-up|2|||
162204037|NCT03214250|585798163|FG006|Overall Study|Lost to Follow-up|0|||
161824094|NCT00098475|584397914|FG001|Step 1|Progressive disease|35|||
161824095|NCT00098475|584397915|FG002|Step 1|Progressive disease|2|||
161824096|NCT00098475|584397916|FG003|Step 1|Progressive disease|1|||
161824097|NCT00098475|584397913|FG000|Step 1|Adverse Event|56|||
161824098|NCT00098475|584397914|FG001|Step 1|Adverse Event|37|||
161824099|NCT00098475|584397915|FG002|Step 1|Adverse Event|0|||
161824100|NCT00098475|584397916|FG003|Step 1|Adverse Event|1|||
161824101|NCT00098475|584397913|FG000|Step 1|Death|8|||
161824102|NCT00098475|584397914|FG001|Step 1|Death|5|||
161824103|NCT00098475|584397915|FG002|Step 1|Death|0|||
161824104|NCT00098475|584397916|FG003|Step 1|Death|1|||
161824105|NCT00098475|584397913|FG000|Step 1|Withdrawal by Subject|14|||
161824106|NCT00098475|584397914|FG001|Step 1|Withdrawal by Subject|11|||
161824107|NCT00098475|584397915|FG002|Step 1|Withdrawal by Subject|0|||
161824108|NCT00098475|584397916|FG003|Step 1|Withdrawal by Subject|0|||
161824109|NCT00098475|584397913|FG000|Step 1|Physician Decision|5|||
161824110|NCT00098475|584397914|FG001|Step 1|Physician Decision|2|||
161824111|NCT00098475|584397915|FG002|Step 1|Physician Decision|0|||
161824112|NCT00098475|584397916|FG003|Step 1|Physician Decision|0|||
161824113|NCT00098475|584397913|FG000|Step 1|Alternative therapy|31|||
161824114|NCT00098475|584397914|FG001|Step 1|Alternative therapy|43|||
161824115|NCT00098475|584397915|FG002|Step 1|Alternative therapy|1|||
161824116|NCT00098475|584397916|FG003|Step 1|Alternative therapy|0|||
161824117|NCT00098475|584397913|FG000|Step 1|Other disease|2|||
161824118|NCT00098475|584397914|FG001|Step 1|Other disease|1|||
161824119|NCT00098475|584397915|FG002|Step 1|Other disease|1|||
161824120|NCT00098475|584397916|FG003|Step 1|Other disease|0|||
161824121|NCT00098475|584397913|FG000|Step 1|Never started treatment|0|||
161824122|NCT00098475|584397914|FG001|Step 1|Never started treatment|2|||
161824123|NCT00098475|584397915|FG002|Step 1|Never started treatment|0|||
161824124|NCT00098475|584397916|FG003|Step 1|Never started treatment|0|||
161824125|NCT00098475|584397913|FG000|Step 1|Still on treatment as of this analysis|14|||
161824126|NCT00098475|584397914|FG001|Step 1|Still on treatment as of this analysis|27|||
161824127|NCT00098475|584397915|FG002|Step 1|Still on treatment as of this analysis|0|||
161824128|NCT00098475|584397916|FG003|Step 1|Still on treatment as of this analysis|0|||
161824129|NCT00098475|584397913|FG000|Step 1|Knee surgery|1|||
161824130|NCT00098475|584397914|FG001|Step 1|Knee surgery|0|||
161824131|NCT00098475|584397915|FG002|Step 1|Knee surgery|0|||
161824132|NCT00098475|584397916|FG003|Step 1|Knee surgery|0|||
161824133|NCT00098475|584397913|FG000|Step 1|Complications|1|||
161824134|NCT00098475|584397914|FG001|Step 1|Complications|0|||
161824135|NCT00098475|584397915|FG002|Step 1|Complications|0|||
161824136|NCT00098475|584397916|FG003|Step 1|Complications|0|||
161824137|NCT00098475|584397913|FG000|Step 1|Cannot comply due to other tx|0|||
161824138|NCT00098475|584397914|FG001|Step 1|Cannot comply due to other tx|1|||
161824139|NCT00098475|584397915|FG002|Step 1|Cannot comply due to other tx|0|||
161824140|NCT00098475|584397916|FG003|Step 1|Cannot comply due to other tx|0|||
161824141|NCT00098475|584397913|FG000|Step 1|Both patient and physician's decision|2|||
162204038|NCT03214250|585798157|FG000|Overall Study|Other|0|||
162204039|NCT03214250|585798158|FG001|Overall Study|Other|0|||
162204040|NCT03214250|585798159|FG002|Overall Study|Other|0|||
162204041|NCT03214250|585798160|FG003|Overall Study|Other|0|||
162204042|NCT03214250|585798161|FG004|Overall Study|Other|1|||
162204043|NCT03214250|585798162|FG005|Overall Study|Other|1|||
162204044|NCT03214250|585798163|FG006|Overall Study|Other|2|||
162204045|NCT03214250|585798157|FG000|Overall Study|Remains on Study|2|||
162204046|NCT03214250|585798158|FG001|Overall Study|Remains on Study|2|||
162204047|NCT03214250|585798159|FG002|Overall Study|Remains on Study|0|||
162204048|NCT03214250|585798160|FG003|Overall Study|Remains on Study|1|||
162204049|NCT03214250|585798161|FG004|Overall Study|Remains on Study|7|||
162204050|NCT03214250|585798162|FG005|Overall Study|Remains on Study|5|||
162204051|NCT03214250|585798163|FG006|Overall Study|Remains on Study|3|||
162204052|NCT03214250|585798157|FG000|Overall Study|Withdrawal by Subject|0|||
162204053|NCT03214250|585798158|FG001|Overall Study|Withdrawal by Subject|0|||
162204054|NCT03214250|585798159|FG002|Overall Study|Withdrawal by Subject|1|||
162204055|NCT03214250|585798160|FG003|Overall Study|Withdrawal by Subject|2|||
162204056|NCT03214250|585798161|FG004|Overall Study|Withdrawal by Subject|5|||
162204057|NCT03214250|585798162|FG005|Overall Study|Withdrawal by Subject|0|||
162204058|NCT03214250|585798163|FG006|Overall Study|Withdrawal by Subject|2|||
162204059|NCT00427778|585798168|FG000|First Intervention (4 Weeks)|no longer interested|1|||
162204060|NCT00427778|585798169|FG001|First Intervention (4 Weeks)|no longer interested|0|||
162204061|NCT00427778|585798168|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
162204062|NCT00427778|585798169|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
162204063|NCT00427778|585798168|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
162204064|NCT00427778|585798169|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
162204065|NCT00427778|585798168|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
162204066|NCT00427778|585798169|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
162204067|NCT02845375|585798171|FG000|Overall Study|upper airway obstruction|1|||
162204068|NCT02845375|585798172|FG001|Overall Study|upper airway obstruction|2|||
162204069|NCT02845375|585798173|FG002|Overall Study|upper airway obstruction|1|||
162204070|NCT00225277|585798176|FG000|Overall Study|Adverse Event|30|||
162204071|NCT00225277|585798177|FG001|Overall Study|Adverse Event|34|||
162204072|NCT00225277|585798176|FG000|Overall Study|Lack of Efficacy|4|||
161824142|NCT00098475|584397914|FG001|Step 1|Both patient and physician's decision|1|||
162204073|NCT00225277|585798177|FG001|Overall Study|Lack of Efficacy|1|||
162204074|NCT00225277|585798176|FG000|Overall Study|Lost to Follow-up|4|||
161824143|NCT00098475|584397915|FG002|Step 1|Both patient and physician's decision|0|||
162021243|NCT05188053|585133480|FG001|Overall Study|Lost to Follow-up|30|||
162204075|NCT00225277|585798177|FG001|Overall Study|Lost to Follow-up|6|||
162204076|NCT00225277|585798176|FG000|Overall Study|Physician Decision|6|||
162204077|NCT00225277|585798177|FG001|Overall Study|Physician Decision|8|||
161932155|NCT00480025|584798822|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
161932156|NCT00480025|584798823|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
161932157|NCT00480025|584798822|FG000|Overall Study|Disease Progression / Recurrence|449|||
161932158|NCT00480025|584798823|FG001|Overall Study|Disease Progression / Recurrence|224|||
162204078|NCT00225277|585798176|FG000|Overall Study|Protocol Violation|6|||
162204079|NCT00225277|585798177|FG001|Overall Study|Protocol Violation|3|||
162204080|NCT00225277|585798176|FG000|Overall Study|Withdrawal by Subject|40|||
162204081|NCT00225277|585798177|FG001|Overall Study|Withdrawal by Subject|34|||
162204082|NCT00225277|585798176|FG000|Overall Study|Other|7|||
162204083|NCT00225277|585798177|FG001|Overall Study|Other|9|||
162204084|NCT02171130|585798183|FG000|Overall Study|Death|1|||
162204085|NCT02171130|585798183|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
162204086|NCT02171130|585798183|FG000|Overall Study|Discontinued; Site Termination|5|||
162204087|NCT02171130|585798183|FG000|Overall Study|Withdrawal by Subject|3|||
162204088|NCT02171130|585798183|FG000|Overall Study|Physician Decision|1|||
162204089|NCT02171130|585798183|FG000|Overall Study|Lost to Follow-up|1|||
162204090|NCT02171130|585798183|FG000|Overall Study|Met Exclusion Criteria|1|||
162204091|NCT00591409|585798184|FG000|Overall Study|Not Treated|0|||
162204092|NCT00591409|585798185|FG001|Overall Study|Not Treated|0|||
162204093|NCT00591409|585798186|FG002|Overall Study|Not Treated|0|||
162204094|NCT00591409|585798187|FG003|Overall Study|Not Treated|0|||
162204095|NCT00591409|585798188|FG004|Overall Study|Not Treated|1|||
162204096|NCT00591409|585798189|FG005|Overall Study|Not Treated|0|||
161932159|NCT00480025|584798822|FG000|Overall Study|Adverse Event|44|||
161932160|NCT00480025|584798823|FG001|Overall Study|Adverse Event|12|||
161932161|NCT00480025|584798822|FG000|Overall Study|Other|70|||
161932162|NCT00480025|584798823|FG001|Overall Study|Other|29|||
162021244|NCT05188053|585133479|FG000|Overall Study|Protocol Violation|16|||
162204097|NCT00591409|585798190|FG006|Overall Study|Not Treated|0|||
162204098|NCT00591409|585798191|FG007|Overall Study|Not Treated|0|||
162204099|NCT00591409|585798192|FG008|Overall Study|Not Treated|0|||
162204100|NCT00591409|585798193|FG009|Overall Study|Not Treated|1|||
162204101|NCT01340300|585798194|FG000|Overall Study|Lost to Follow-up|3|||
161932163|NCT00480025|584798822|FG000|Overall Study|SAE including intercurrent illness|76|||
161932164|NCT00480025|584798823|FG001|Overall Study|SAE including intercurrent illness|42|||
161932165|NCT01064622|584798824|FG000|Randomized Phase II|Withdrawal by Subject|2|||
161932166|NCT01064622|584798825|FG001|Randomized Phase II|Withdrawal by Subject|2|||
162204102|NCT01340300|585798195|FG001|Overall Study|Lost to Follow-up|0|||
162204103|NCT01340300|585798196|FG002|Overall Study|Lost to Follow-up|5|||
162204104|NCT01340300|585798197|FG003|Overall Study|Lost to Follow-up|10|||
162204105|NCT01340300|585798194|FG000|Overall Study|Withdrawal by Subject|5|||
162204106|NCT01340300|585798195|FG001|Overall Study|Withdrawal by Subject|6|||
162204107|NCT01340300|585798196|FG002|Overall Study|Withdrawal by Subject|6|||
162204108|NCT01340300|585798197|FG003|Overall Study|Withdrawal by Subject|3|||
162204109|NCT01340300|585798194|FG000|Overall Study|Adverse Event|1|||
162204110|NCT01340300|585798195|FG001|Overall Study|Adverse Event|0|||
162204111|NCT01340300|585798196|FG002|Overall Study|Adverse Event|4|||
162204112|NCT01340300|585798197|FG003|Overall Study|Adverse Event|0|||
162204113|NCT01340300|585798194|FG000|Overall Study|Physician Decision|0|||
162204114|NCT01340300|585798195|FG001|Overall Study|Physician Decision|1|||
162204115|NCT01340300|585798196|FG002|Overall Study|Physician Decision|0|||
162204116|NCT01340300|585798197|FG003|Overall Study|Physician Decision|0|||
162204117|NCT01340300|585798194|FG000|Overall Study|Unrelated sickness|0|||
162204118|NCT01340300|585798195|FG001|Overall Study|Unrelated sickness|2|||
162204119|NCT01340300|585798196|FG002|Overall Study|Unrelated sickness|0|||
162204120|NCT01340300|585798197|FG003|Overall Study|Unrelated sickness|1|||
162204121|NCT01951261|585798198|FG000|Overall Study|Death|1|||
162204122|NCT01951261|585798199|FG001|Overall Study|Death|0|||
162204123|NCT01951261|585798198|FG000|Overall Study|Lost to Follow-up|4|||
162204124|NCT01951261|585798199|FG001|Overall Study|Lost to Follow-up|3|||
162204125|NCT01951261|585798198|FG000|Overall Study|Protocol Violation|4|||
162204126|NCT01951261|585798199|FG001|Overall Study|Protocol Violation|3|||
162204127|NCT03927222|585798203|FG000|Overall Study|Progression|3|||
162204128|NCT03927222|585798203|FG000|Overall Study|CMV testing results inconclusive|1|||
162204129|NCT03927222|585798203|FG000|Overall Study|Unable to generate enough vaccines|1|||
162204130|NCT03927222|585798203|FG000|Overall Study|Early study termination|1|||
162204131|NCT03723915|585798209|FG000|Screening|Failed to meet screening requirements.|2|||
162204132|NCT03723915|585798209|FG000|On Treatment|Failed to meet treatment requirements|2|||
162204133|NCT02201771|585798210|FG000|Overall Study|Death|3|||
162204134|NCT02201771|585798211|FG001|Overall Study|Death|2|||
162204135|NCT02201771|585798212|FG002|Overall Study|Death|0|||
162204136|NCT02201771|585798210|FG000|Overall Study|Protocol Violation|10|||
162204137|NCT02201771|585798211|FG001|Overall Study|Protocol Violation|8|||
162204138|NCT02201771|585798212|FG002|Overall Study|Protocol Violation|10|||
162204139|NCT01287416|585798215|FG000|Pre-post Training|Withdrawal by Subject|17|||
162204140|NCT01287416|585798216|FG001|Pre-post Training|Withdrawal by Subject|24|||
162204141|NCT01287416|585798215|FG000|Pre-post Training|Lost to Follow-up|5|||
162204142|NCT01287416|585798216|FG001|Pre-post Training|Lost to Follow-up|1|||
161824144|NCT00098475|584397916|FG003|Step 1|Both patient and physician's decision|0|||
161824145|NCT00098475|584397913|FG000|Step 1|Incorrect disease assessment|2|||
161824146|NCT00098475|584397914|FG001|Step 1|Incorrect disease assessment|0|||
161824147|NCT00098475|584397915|FG002|Step 1|Incorrect disease assessment|0|||
161824148|NCT00098475|584397916|FG003|Step 1|Incorrect disease assessment|0|||
161824149|NCT00098475|584397913|FG000|Step 1|Off treatment for > specified timeframe|1|||
161824150|NCT00098475|584397914|FG001|Step 1|Off treatment for > specified timeframe|1|||
161824151|NCT00098475|584397915|FG002|Step 1|Off treatment for > specified timeframe|0|||
161932167|NCT01064622|584798824|FG000|Randomized Phase II|Protocol Violation|0|||
162204143|NCT01287416|585798215|FG000|6 Month Follow-up|Lost to Follow-up|3|||
162204144|NCT01287416|585798216|FG001|6 Month Follow-up|Lost to Follow-up|2|||
162204145|NCT03840148|585798225|FG000|Study Drug Disposition|Adverse Event|13|||
162204146|NCT03840148|585798226|FG001|Study Drug Disposition|Adverse Event|2|||
162204147|NCT03840148|585798225|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
162204148|NCT03840148|585798226|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
162204149|NCT03840148|585798225|FG000|Study Drug Disposition|Lack of Efficacy|3|||
161932168|NCT01064622|584798825|FG001|Randomized Phase II|Protocol Violation|1|||
162204150|NCT03840148|585798226|FG001|Study Drug Disposition|Lack of Efficacy|0|||
162204151|NCT03840148|585798225|FG000|Study Drug Disposition|Physician Decision|2|||
162204152|NCT03840148|585798226|FG001|Study Drug Disposition|Physician Decision|0|||
162204153|NCT03840148|585798225|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
162204154|NCT03840148|585798226|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
162204155|NCT03840148|585798225|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
162021245|NCT05188053|585133480|FG001|Overall Study|Protocol Violation|16|||
162204156|NCT03840148|585798226|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
162204157|NCT03840148|585798225|FG000|Study Completion Disposition|Physician Decision|2|||
162204158|NCT03840148|585798226|FG001|Study Completion Disposition|Physician Decision|0|||
162204159|NCT03840148|585798225|FG000|Study Completion Disposition|Covid-19 related|2|||
162204160|NCT03840148|585798226|FG001|Study Completion Disposition|Covid-19 related|0|||
162204161|NCT03840148|585798225|FG000|Study Completion Disposition|Lost to Follow-up|1|||
162204162|NCT03840148|585798226|FG001|Study Completion Disposition|Lost to Follow-up|1|||
162204163|NCT03840148|585798225|FG000|Study Completion Disposition|Death|1|||
162204164|NCT03840148|585798226|FG001|Study Completion Disposition|Death|0|||
162204165|NCT03840148|585798225|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
162204166|NCT03840148|585798226|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
162204167|NCT03849300|585798228|FG000|Overall Study|move out to different area|1|||
162204168|NCT03849300|585798229|FG001|Overall Study|move out to different area|3|||
162204169|NCT03849300|585798230|FG002|Overall Study|move out to different area|1|||
162204170|NCT03849300|585798231|FG003|Overall Study|move out to different area|4|||
162204171|NCT03849300|585798228|FG000|Overall Study|scheduling/transportation conflict|4|||
162204172|NCT03849300|585798229|FG001|Overall Study|scheduling/transportation conflict|4|||
162204173|NCT03849300|585798230|FG002|Overall Study|scheduling/transportation conflict|3|||
162204174|NCT03849300|585798231|FG003|Overall Study|scheduling/transportation conflict|2|||
162204175|NCT04839289|585798232|FG000|Overall Study|Withdrawal by Subject|1|||
162204176|NCT04839289|585798233|FG001|Overall Study|Withdrawal by Subject|0|||
162204177|NCT00464737|585798234|FG000|Overall Study|Adverse Event|12|||
162204178|NCT00464737|585798235|FG001|Overall Study|Adverse Event|17|||
162204179|NCT00464737|585798236|FG002|Overall Study|Adverse Event|33|||
162204180|NCT00464737|585798234|FG000|Overall Study|Lack of Efficacy|7|||
162204181|NCT00464737|585798235|FG001|Overall Study|Lack of Efficacy|7|||
162204182|NCT00464737|585798236|FG002|Overall Study|Lack of Efficacy|4|||
162204183|NCT00464737|585798234|FG000|Overall Study|Withdrawal by Subject|5|||
162204184|NCT00464737|585798235|FG001|Overall Study|Withdrawal by Subject|3|||
162204185|NCT00464737|585798236|FG002|Overall Study|Withdrawal by Subject|5|||
162204186|NCT00464737|585798234|FG000|Overall Study|Protocol Violation|1|||
161824152|NCT00098475|584397916|FG003|Step 1|Off treatment for > specified timeframe|0|||
161824153|NCT00098475|584397913|FG000|Step 1|Declining performance status|0|||
161824154|NCT00098475|584397914|FG001|Step 1|Declining performance status|1|||
161824155|NCT00098475|584397915|FG002|Step 1|Declining performance status|0|||
161824156|NCT00098475|584397916|FG003|Step 1|Declining performance status|0|||
161824157|NCT00098475|584397913|FG000|Step 1|Insurance issue|0|||
161824158|NCT00098475|584397914|FG001|Step 1|Insurance issue|1|||
161824159|NCT00098475|584397915|FG002|Step 1|Insurance issue|0|||
161824160|NCT00098475|584397916|FG003|Step 1|Insurance issue|0|||
161824161|NCT00098475|584397913|FG000|Step 1|Rising paraprotein|0|||
161824162|NCT00098475|584397914|FG001|Step 1|Rising paraprotein|1|||
161824163|NCT00098475|584397915|FG002|Step 1|Rising paraprotein|0|||
162204187|NCT00464737|585798235|FG001|Overall Study|Protocol Violation|1|||
162204188|NCT00464737|585798236|FG002|Overall Study|Protocol Violation|5|||
162204189|NCT00464737|585798234|FG000|Overall Study|Non-compliance|0|||
162204190|NCT00464737|585798235|FG001|Overall Study|Non-compliance|1|||
162204191|NCT00464737|585798236|FG002|Overall Study|Non-compliance|1|||
162204192|NCT00464737|585798234|FG000|Overall Study|Lost to Follow-up|5|||
162204193|NCT00464737|585798235|FG001|Overall Study|Lost to Follow-up|2|||
162204194|NCT00464737|585798236|FG002|Overall Study|Lost to Follow-up|5|||
162204195|NCT00464737|585798234|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
162204196|NCT00464737|585798235|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
162204197|NCT00464737|585798236|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
162204198|NCT00464737|585798234|FG000|Overall Study|Other: Subject left town; family illness|1|||
162204199|NCT00464737|585798235|FG001|Overall Study|Other: Subject left town; family illness|0|||
162204200|NCT00464737|585798236|FG002|Overall Study|Other: Subject left town; family illness|0|||
162204201|NCT00464737|585798234|FG000|Overall Study|Other: Study demands too great|0|||
162204202|NCT00464737|585798235|FG001|Overall Study|Other: Study demands too great|1|||
162204203|NCT00464737|585798236|FG002|Overall Study|Other: Study demands too great|0|||
161824164|NCT00098475|584397916|FG003|Step 1|Rising paraprotein|0|||
161824165|NCT00098475|584397913|FG000|Step 1|Referred to other physicians|0|||
162204204|NCT00464737|585798234|FG000|Overall Study|Other: Personal family reasons|0|||
162204205|NCT00464737|585798235|FG001|Overall Study|Other: Personal family reasons|0|||
162204206|NCT00464737|585798236|FG002|Overall Study|Other: Personal family reasons|1|||
162204207|NCT00464737|585798234|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
162204208|NCT00464737|585798235|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
162204209|NCT00464737|585798236|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
162204210|NCT00580047|585798239|FG000|Overall Study|Lost to Follow-up|1|||
162204211|NCT00580047|585798240|FG001|Overall Study|Lost to Follow-up|1|||
162204212|NCT00580047|585798241|FG002|Overall Study|Lost to Follow-up|0|||
162204213|NCT00580047|585798239|FG000|Overall Study|Withdrawal by Subject|1|||
162204214|NCT00580047|585798240|FG001|Overall Study|Withdrawal by Subject|1|||
162204215|NCT00580047|585798241|FG002|Overall Study|Withdrawal by Subject|2|||
162204216|NCT00580047|585798239|FG000|Overall Study|Withdrawal by Subject|1|||
162204217|NCT00580047|585798240|FG001|Overall Study|Withdrawal by Subject|0|||
162204218|NCT00580047|585798241|FG002|Overall Study|Withdrawal by Subject|0|||
161824166|NCT00098475|584397914|FG001|Step 1|Referred to other physicians|1|||
162204219|NCT03406507|585798244|FG000|Extension Period|Lack of Efficacy|0|||
162204220|NCT03406507|585798245|FG001|Extension Period|Lack of Efficacy|1|||
162204221|NCT01878383|585800415|FG000|Overall Study|Lost to Follow-up|0|||
162204222|NCT01878383|585800416|FG001|Overall Study|Lost to Follow-up|1499|||
162204223|NCT03464383|585800417|FG000|Overall Study|Lost to Follow-up|1|||
162204224|NCT03464383|585800418|FG001|Overall Study|Lost to Follow-up|0|||
162204225|NCT03464383|585800419|FG002|Overall Study|Lost to Follow-up|0|||
162204226|NCT03464383|585800417|FG000|Overall Study|Withdrawal by Subject|0|||
162204227|NCT03464383|585800418|FG001|Overall Study|Withdrawal by Subject|1|||
162204228|NCT03464383|585800419|FG002|Overall Study|Withdrawal by Subject|0|||
162204229|NCT03449134|585800420|FG000|52-Week Treatment Period|Death|2|||
162204230|NCT03449134|585800421|FG001|52-Week Treatment Period|Death|1|||
162204231|NCT03449134|585800422|FG002|52-Week Treatment Period|Death|0|||
162204232|NCT03449134|585800420|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
162204233|NCT03449134|585800421|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
162204234|NCT03449134|585800422|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
162204235|NCT03449134|585800420|FG000|52-Week Treatment Period|Physician Decision|2|||
162204236|NCT03449134|585800421|FG001|52-Week Treatment Period|Physician Decision|3|||
162204237|NCT03449134|585800422|FG002|52-Week Treatment Period|Physician Decision|3|||
162204238|NCT03449134|585800420|FG000|52-Week Treatment Period|Screen Failure|1|||
162204239|NCT03449134|585800421|FG001|52-Week Treatment Period|Screen Failure|0|||
162204240|NCT03449134|585800422|FG002|52-Week Treatment Period|Screen Failure|1|||
162204241|NCT03449134|585800420|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
161932169|NCT05330429|584798826|FG000|Overall Study|Study Terminated by Sponsor|4|||
161932170|NCT05330429|584798827|FG001|Overall Study|Study Terminated by Sponsor|33|||
161932171|NCT05330429|584798828|FG002|Overall Study|Study Terminated by Sponsor|12|||
161932172|NCT05330429|584798826|FG000|Overall Study|Death|5|||
161932173|NCT05330429|584798827|FG001|Overall Study|Death|2|||
161932174|NCT05330429|584798828|FG002|Overall Study|Death|4|||
161932175|NCT05330429|584798826|FG000|Overall Study|Withdrew Consent|0|||
161932176|NCT05330429|584798827|FG001|Overall Study|Withdrew Consent|5|||
162204242|NCT03449134|585800421|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
162204243|NCT03449134|585800422|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
162204244|NCT03449134|585800420|FG000|52-Week Treatment Period|Site Closure|1|||
162204245|NCT03449134|585800421|FG001|52-Week Treatment Period|Site Closure|0|||
162204246|NCT03449134|585800422|FG002|52-Week Treatment Period|Site Closure|0|||
162204247|NCT01960348|585800430|FG000|Overall Study|Adverse event, not serious|2|||
162204248|NCT01960348|585800431|FG001|Overall Study|Adverse event, not serious|2|||
162204249|NCT01960348|585800430|FG000|Overall Study|Adverse event, serious fatal|6|||
162204250|NCT01960348|585800431|FG001|Overall Study|Adverse event, serious fatal|5|||
162204251|NCT01960348|585800430|FG000|Overall Study|Adverse event, serious non-fatal|0|||
162204252|NCT01960348|585800431|FG001|Overall Study|Adverse event, serious non-fatal|3|||
162204253|NCT01960348|585800430|FG000|Overall Study|Withdrawal by Subject|1|||
162204254|NCT01960348|585800431|FG001|Overall Study|Withdrawal by Subject|11|||
162204255|NCT01960348|585800430|FG000|Overall Study|Physician Decision|0|||
162204256|NCT01960348|585800431|FG001|Overall Study|Physician Decision|1|||
162204257|NCT01960348|585800430|FG000|Overall Study|Protocol Violation|1|||
162204258|NCT01960348|585800431|FG001|Overall Study|Protocol Violation|0|||
162204259|NCT01821729|585800432|FG000|Overall Study|Withdrawal by Subject|1|||
162204260|NCT01093599|585800436|FG000|Overall Study|Lost to Follow-up|32|||
162204261|NCT01093599|585800437|FG001|Overall Study|Lost to Follow-up|46|||
162204262|NCT01644188|585800438|FG000|Overall Study|Adverse Event|44|||
162204263|NCT01644188|585800439|FG001|Overall Study|Adverse Event|20|||
162204264|NCT01644188|585800438|FG000|Overall Study|Poor compliance to protocol|26|||
162204265|NCT01644188|585800439|FG001|Overall Study|Poor compliance to protocol|14|||
162204266|NCT01644188|585800438|FG000|Overall Study|Physician Decision|1|||
162204267|NCT01644188|585800439|FG001|Overall Study|Physician Decision|3|||
162204268|NCT01644188|585800438|FG000|Overall Study|Participant moved|7|||
162204269|NCT01644188|585800439|FG001|Overall Study|Participant moved|2|||
162204270|NCT01644188|585800438|FG000|Overall Study|Related to auto-injector administration|2|||
162204271|NCT01644188|585800439|FG001|Overall Study|Related to auto-injector administration|2|||
161932177|NCT05330429|584798828|FG002|Overall Study|Withdrew Consent|4|||
161932178|NCT05330429|584798826|FG000|Overall Study|Investigator's Discretion|0|||
161932179|NCT05330429|584798827|FG001|Overall Study|Investigator's Discretion|1|||
161932180|NCT05330429|584798828|FG002|Overall Study|Investigator's Discretion|3|||
161932181|NCT05330429|584798826|FG000|Overall Study|Subject Decision|1|||
161932182|NCT05330429|584798827|FG001|Overall Study|Subject Decision|2|||
161932183|NCT05330429|584798828|FG002|Overall Study|Subject Decision|0|||
161932184|NCT05330429|584798826|FG000|Overall Study|Lost to Follow-up|0|||
162204272|NCT01644188|585800438|FG000|Overall Study|Consent withdrawn by participant|14|||
162204273|NCT01644188|585800439|FG001|Overall Study|Consent withdrawn by participant|7|||
162204274|NCT01644188|585800438|FG000|Overall Study|Selection criteria finally not met|2|||
162204275|NCT01644188|585800439|FG001|Overall Study|Selection criteria finally not met|0|||
162204276|NCT01644188|585800438|FG000|Overall Study|Lost to Follow-up|1|||
162204277|NCT01644188|585800439|FG001|Overall Study|Lost to Follow-up|0|||
162204278|NCT01644188|585800438|FG000|Overall Study|Death|4|||
162204279|NCT01644188|585800439|FG001|Overall Study|Death|3|||
162204280|NCT01644188|585800438|FG000|Overall Study|Last visit outside protocol visit window|14|||
162204281|NCT01644188|585800439|FG001|Overall Study|Last visit outside protocol visit window|16|||
162204282|NCT01644188|585800438|FG000|Overall Study|Site closure|1|||
162204283|NCT01644188|585800439|FG001|Overall Study|Site closure|1|||
162204284|NCT01644188|585800438|FG000|Overall Study|Other than specified above|6|||
162204285|NCT01644188|585800439|FG001|Overall Study|Other than specified above|7|||
162204286|NCT01845649|585800443|FG000|Overall Study|Adverse Event|7|||
162204287|NCT01845649|585800444|FG001|Overall Study|Adverse Event|10|||
162204288|NCT01845649|585800443|FG000|Overall Study|Lack of Efficacy|1|||
162204289|NCT01845649|585800444|FG001|Overall Study|Lack of Efficacy|1|||
162204290|NCT01845649|585800443|FG000|Overall Study|Lost to Follow-up|2|||
162204291|NCT01845649|585800444|FG001|Overall Study|Lost to Follow-up|2|||
162204292|NCT01845649|585800443|FG000|Overall Study|Withdrew Consent|12|||
162204293|NCT01845649|585800444|FG001|Overall Study|Withdrew Consent|4|||
162204294|NCT01845649|585800443|FG000|Overall Study|Protocol Deviation|7|||
162204295|NCT01845649|585800444|FG001|Overall Study|Protocol Deviation|4|||
162204296|NCT01845649|585800443|FG000|Overall Study|Reason not Specified|2|||
162204297|NCT01845649|585800444|FG001|Overall Study|Reason not Specified|1|||
162204298|NCT00526097|585800448|FG000|Overall Study|Adverse Event|6|||
162204299|NCT00526097|585800449|FG001|Overall Study|Adverse Event|44|||
162204300|NCT00526097|585800448|FG000|Overall Study|Protocol Violation|4|||
162204301|NCT00526097|585800449|FG001|Overall Study|Protocol Violation|10|||
162204302|NCT00526097|585800448|FG000|Overall Study|Withdrawal by Subject|3|||
162204303|NCT00526097|585800449|FG001|Overall Study|Withdrawal by Subject|1|||
162204304|NCT00526097|585800448|FG000|Overall Study|Other|2|||
162204305|NCT00526097|585800449|FG001|Overall Study|Other|1|||
162204306|NCT00966979|585800450|FG000|Overall Study|Death|1|||
162204307|NCT00966979|585800450|FG000|Overall Study|Lost to Follow-up|6|||
162204308|NCT00966979|585800450|FG000|Overall Study|Withdrawal by Subject|14|||
162204309|NCT00966979|585800450|FG000|Overall Study|Adverse Event|5|||
162204310|NCT00966979|585800450|FG000|Overall Study|Sponsor terminated early|49|||
162204311|NCT00966979|585800450|FG000|Overall Study|Censored because surgery not done|2|||
162204312|NCT00966979|585800450|FG000|Overall Study|Censored because study device was not implanted|14|||
162204313|NCT00966979|585800450|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
162204314|NCT03713281|585800451|FG000|Overall Study|Lens handling difficuluties|2|||
162204315|NCT03713281|585800451|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
162204316|NCT00329550|585800452|FG000|Overall Study|Adverse Event|3|||
162204317|NCT00329550|585800453|FG001|Overall Study|Adverse Event|4|||
162204318|NCT00329550|585800454|FG002|Overall Study|Adverse Event|2|||
162204319|NCT00329550|585800452|FG000|Overall Study|Withdrawal of Consent|1|||
162204320|NCT00329550|585800453|FG001|Overall Study|Withdrawal of Consent|0|||
162204321|NCT00329550|585800454|FG002|Overall Study|Withdrawal of Consent|1|||
162204322|NCT00329550|585800452|FG000|Overall Study|Due to Relocation|0|||
162204323|NCT00329550|585800453|FG001|Overall Study|Due to Relocation|0|||
162204324|NCT00329550|585800454|FG002|Overall Study|Due to Relocation|1|||
162204325|NCT01649557|585800458|FG000|Overall Study|Lost to Follow-up|5|||
162204326|NCT01649557|585800459|FG001|Overall Study|Lost to Follow-up|0|||
162204327|NCT01649557|585800460|FG002|Overall Study|Lost to Follow-up|3|||
162204328|NCT01649557|585800458|FG000|Overall Study|Adverse Event|7|||
162204329|NCT01649557|585800459|FG001|Overall Study|Adverse Event|5|||
162204330|NCT01649557|585800460|FG002|Overall Study|Adverse Event|1|||
162204331|NCT01649557|585800458|FG000|Overall Study|Met withdrawal criteria|4|||
162204332|NCT01649557|585800459|FG001|Overall Study|Met withdrawal criteria|0|||
162204333|NCT01649557|585800460|FG002|Overall Study|Met withdrawal criteria|0|||
162204334|NCT01649557|585800458|FG000|Overall Study|Physician Decision|8|||
162204335|NCT01649557|585800459|FG001|Overall Study|Physician Decision|2|||
162204336|NCT01649557|585800460|FG002|Overall Study|Physician Decision|1|||
162204337|NCT01649557|585800458|FG000|Overall Study|Withdrawal by Subject|15|||
162204338|NCT01649557|585800459|FG001|Overall Study|Withdrawal by Subject|5|||
162204339|NCT01649557|585800460|FG002|Overall Study|Withdrawal by Subject|4|||
162204340|NCT01649557|585800458|FG000|Overall Study|Protocol deviation|0|||
162204341|NCT01649557|585800459|FG001|Overall Study|Protocol deviation|2|||
162204342|NCT01649557|585800460|FG002|Overall Study|Protocol deviation|0|||
162204343|NCT01649557|585800458|FG000|Overall Study|Lack of Efficacy|5|||
162204344|NCT01649557|585800459|FG001|Overall Study|Lack of Efficacy|0|||
162204345|NCT01649557|585800460|FG002|Overall Study|Lack of Efficacy|0|||
162204346|NCT01011049|585800461|FG000|Overall Study|Protocol Violation|0|||
162204347|NCT01011049|585800462|FG001|Overall Study|Protocol Violation|0|||
162204348|NCT01011049|585800463|FG002|Overall Study|Protocol Violation|2|||
162204349|NCT01011049|585800464|FG003|Overall Study|Protocol Violation|0|||
162204350|NCT01011049|585800461|FG000|Overall Study|Lost to Follow-up|1|||
162204351|NCT01011049|585800462|FG001|Overall Study|Lost to Follow-up|2|||
162204352|NCT01011049|585800463|FG002|Overall Study|Lost to Follow-up|1|||
162204353|NCT01011049|585800464|FG003|Overall Study|Lost to Follow-up|0|||
162204354|NCT01011049|585800461|FG000|Overall Study|Withdrawal by Subject|0|||
162204355|NCT01011049|585800462|FG001|Overall Study|Withdrawal by Subject|0|||
162204356|NCT01011049|585800463|FG002|Overall Study|Withdrawal by Subject|1|||
162204357|NCT01011049|585800464|FG003|Overall Study|Withdrawal by Subject|0|||
162204358|NCT02815735|585800465|FG000|First Intervention (4 Weeks)|Discomfort|1|||
162204359|NCT02815735|585800466|FG001|First Intervention (4 Weeks)|Discomfort|0|||
162204360|NCT02815735|585800465|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
162204361|NCT02815735|585800466|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
162204362|NCT02815735|585800465|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
162204363|NCT02815735|585800466|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
162204364|NCT02815735|585800465|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
162204365|NCT02815735|585800466|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
162204366|NCT00352053|585800467|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
162204367|NCT00352053|585800468|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
162204368|NCT00352053|585800467|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
162204369|NCT00352053|585800468|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
162204370|NCT00352053|585800467|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
162204371|NCT00352053|585800468|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
162204372|NCT00352053|585800467|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
162204373|NCT00352053|585800468|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
162204374|NCT00352053|585800467|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
162204375|NCT00352053|585800468|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
162204376|NCT00352053|585800467|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
162204377|NCT00352053|585800468|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
162204378|NCT00352053|585800467|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
162204379|NCT00352053|585800468|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
162204380|NCT00352053|585800467|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
162204381|NCT00352053|585800468|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
162204382|NCT00352053|585800467|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
162204383|NCT00352053|585800468|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
162204384|NCT00352053|585800467|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
162204385|NCT00352053|585800468|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
162204386|NCT00352053|585800467|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
161932185|NCT05330429|584798827|FG001|Overall Study|Lost to Follow-up|1|||
161932186|NCT05330429|584798828|FG002|Overall Study|Lost to Follow-up|0|||
161932187|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
161932188|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
161932189|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
161932190|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Adverse Event|5|||
161932191|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Adverse Event|1|||
161932192|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Adverse Event|0|||
161932193|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
161932194|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
161932195|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
161932196|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Death|8|||
161932197|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Death|24|||
161932198|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Death|0|||
161932199|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
161932200|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
161932201|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
161932202|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
161932203|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
161932204|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
161932205|NCT02931539|584798832|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
161932206|NCT02931539|584798833|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
161932207|NCT02931539|584798834|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
161932208|NCT02931539|584798832|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
161932209|NCT02931539|584798833|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
161932210|NCT02931539|584798834|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
161932211|NCT06097273|584798837|FG000|Overall Study|Death|2|||
161932212|NCT06097273|584798838|FG001|Overall Study|Death|1|||
162204387|NCT00352053|585800468|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
162204388|NCT00352053|585800467|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
161932213|NCT06097273|584798839|FG002|Overall Study|Death|2|||
161932214|NCT06097273|584798840|FG003|Overall Study|Death|2|||
161932215|NCT06097273|584798837|FG000|Overall Study|Lost to Follow-up|27|||
161932216|NCT06097273|584798838|FG001|Overall Study|Lost to Follow-up|18|||
161932217|NCT06097273|584798839|FG002|Overall Study|Lost to Follow-up|36|||
161932218|NCT06097273|584798840|FG003|Overall Study|Lost to Follow-up|31|||
161932219|NCT06097273|584798837|FG000|Overall Study|Physician Decision|0|||
161932220|NCT06097273|584798838|FG001|Overall Study|Physician Decision|1|||
161932221|NCT06097273|584798839|FG002|Overall Study|Physician Decision|0|||
161932222|NCT06097273|584798840|FG003|Overall Study|Physician Decision|3|||
161932223|NCT06097273|584798837|FG000|Overall Study|Protocol Violation|1|||
161932224|NCT06097273|584798838|FG001|Overall Study|Protocol Violation|1|||
161932225|NCT06097273|584798839|FG002|Overall Study|Protocol Violation|2|||
161932226|NCT06097273|584798840|FG003|Overall Study|Protocol Violation|1|||
161932227|NCT06097273|584798837|FG000|Overall Study|Withdrawal by Subject|14|||
161932228|NCT06097273|584798838|FG001|Overall Study|Withdrawal by Subject|11|||
161932229|NCT06097273|584798839|FG002|Overall Study|Withdrawal by Subject|14|||
161932230|NCT06097273|584798840|FG003|Overall Study|Withdrawal by Subject|15|||
161932231|NCT06097273|584798837|FG000|Overall Study|Other Than Specified|7|||
161932232|NCT06097273|584798838|FG001|Overall Study|Other Than Specified|3|||
161932233|NCT06097273|584798839|FG002|Overall Study|Other Than Specified|11|||
161932234|NCT06097273|584798840|FG003|Overall Study|Other Than Specified|6|||
161932235|NCT00368849|584800420|FG000|Overall Study|Withdrawal by Subject|0|||
161932236|NCT00368849|584800421|FG001|Overall Study|Withdrawal by Subject|1|||
161932237|NCT00368849|584800420|FG000|Overall Study|Physician Decision|0|||
162204389|NCT00352053|585800468|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
162204390|NCT00352053|585800467|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
162204391|NCT00352053|585800468|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
162204392|NCT02435381|585800469|FG000|Overall Study|Lost to Follow-up|2|||
162204393|NCT02435381|585800470|FG001|Overall Study|Lost to Follow-up|1|||
162204394|NCT04150341|585800473|FG000|Overall Study|Physician Decision|0|||
162204395|NCT04150341|585800474|FG001|Overall Study|Physician Decision|0|||
162204396|NCT04150341|585800475|FG002|Overall Study|Physician Decision|1|||
162204397|NCT04150341|585800476|FG003|Overall Study|Physician Decision|0|||
162204398|NCT04150341|585800477|FG004|Overall Study|Physician Decision|0|||
162204399|NCT04150341|585800478|FG005|Overall Study|Physician Decision|0|||
162204400|NCT04150341|585800473|FG000|Overall Study|Adverse Event|0|||
162204401|NCT04150341|585800474|FG001|Overall Study|Adverse Event|0|||
162204402|NCT04150341|585800475|FG002|Overall Study|Adverse Event|0|||
162204403|NCT04150341|585800476|FG003|Overall Study|Adverse Event|0|||
162204404|NCT04150341|585800477|FG004|Overall Study|Adverse Event|1|||
162204405|NCT04150341|585800478|FG005|Overall Study|Adverse Event|0|||
162204406|NCT00875615|585800479|FG000|Overall Study|Withdrawal by Subject|1|||
162204407|NCT00405912|585800481|FG000|Overall Study|Withdrawal by Subject|12|||
162204408|NCT00405912|585800482|FG001|Overall Study|Withdrawal by Subject|11|||
162204409|NCT00405912|585800483|FG002|Overall Study|Withdrawal by Subject|12|||
162204410|NCT00405912|585800481|FG000|Overall Study|Lost to Follow-up|4|||
162204411|NCT00405912|585800482|FG001|Overall Study|Lost to Follow-up|8|||
162204412|NCT00405912|585800483|FG002|Overall Study|Lost to Follow-up|4|||
162204413|NCT03730662|585800484|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
162204414|NCT03730662|585800485|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
162204415|NCT03730662|585800486|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
162204416|NCT03730662|585800487|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
162204417|NCT03730662|585800484|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
162204418|NCT03730662|585800485|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
162204419|NCT03730662|585800486|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
162204420|NCT03730662|585800487|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
162204421|NCT03730662|585800484|FG000|Treatment Period (52 Weeks)|Death|6|||
162204422|NCT03730662|585800485|FG001|Treatment Period (52 Weeks)|Death|2|||
162204423|NCT03730662|585800486|FG002|Treatment Period (52 Weeks)|Death|2|||
162204424|NCT03730662|585800487|FG003|Treatment Period (52 Weeks)|Death|9|||
162204425|NCT03730662|585800484|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
162204426|NCT03730662|585800485|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
162204427|NCT03730662|585800486|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
162204428|NCT03730662|585800487|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
162204429|NCT03730662|585800484|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
162204430|NCT03730662|585800485|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
162204431|NCT03730662|585800486|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
162204432|NCT03730662|585800487|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
162204433|NCT03730662|585800484|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
162204434|NCT03730662|585800485|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
162204435|NCT03730662|585800486|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
162204436|NCT03730662|585800487|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
162204437|NCT03730662|585800484|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
162204438|NCT03730662|585800485|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
162204439|NCT03730662|585800486|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
162204440|NCT03730662|585800487|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
162204441|NCT03730662|585800484|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
162204442|NCT03730662|585800485|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
161932238|NCT00368849|584800421|FG001|Overall Study|Physician Decision|1|||
162204443|NCT03730662|585800486|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
162204444|NCT03730662|585800487|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
161932239|NCT01699685|584800422|FG000|Period 1|Adverse Event|1|||
162204445|NCT03730662|585800484|FG000|Variable Treatment Period|Adverse Event|1|||
162204446|NCT03730662|585800485|FG001|Variable Treatment Period|Adverse Event|2|||
161932240|NCT01699685|584800423|FG001|Period 1|Adverse Event|1|||
161824167|NCT00098475|584397915|FG002|Step 1|Referred to other physicians|0|||
161824168|NCT00098475|584397916|FG003|Step 1|Referred to other physicians|0|||
161824169|NCT00098475|584397913|FG000|Step 1|Criteria to continue treatment not met|0|||
161824170|NCT00098475|584397914|FG001|Step 1|Criteria to continue treatment not met|1|||
161824171|NCT00098475|584397915|FG002|Step 1|Criteria to continue treatment not met|0|||
161824172|NCT00098475|584397916|FG003|Step 1|Criteria to continue treatment not met|0|||
161824173|NCT00098475|584397913|FG000|Step 1|Misinterpretation of lab data|0|||
161824174|NCT00098475|584397914|FG001|Step 1|Misinterpretation of lab data|1|||
161824175|NCT00098475|584397915|FG002|Step 1|Misinterpretation of lab data|0|||
161824176|NCT00098475|584397916|FG003|Step 1|Misinterpretation of lab data|0|||
161824177|NCT00098475|584397913|FG000|Step 1|Patient fell with fracture|1|||
161824178|NCT00098475|584397914|FG001|Step 1|Patient fell with fracture|0|||
161824179|NCT00098475|584397915|FG002|Step 1|Patient fell with fracture|0|||
161824180|NCT00098475|584397916|FG003|Step 1|Patient fell with fracture|0|||
161824181|NCT00098475|584397913|FG000|Step 1|Not documented|0|||
161824182|NCT00098475|584397914|FG001|Step 1|Not documented|1|||
161824183|NCT00098475|584397915|FG002|Step 1|Not documented|0|||
161824184|NCT00098475|584397916|FG003|Step 1|Not documented|0|||
161824185|NCT00098475|584397913|FG000|Step 2|Disease progression|1|||
161824186|NCT00098475|584397914|FG001|Step 2|Disease progression|4|||
161824187|NCT00098475|584397915|FG002|Step 2|Disease progression|0|||
161824188|NCT00098475|584397916|FG003|Step 2|Disease progression|0|||
161824189|NCT00098475|584397913|FG000|Step 2|Adverse Event|2|||
161824190|NCT00098475|584397914|FG001|Step 2|Adverse Event|0|||
161824191|NCT00098475|584397915|FG002|Step 2|Adverse Event|0|||
161824192|NCT00098475|584397916|FG003|Step 2|Adverse Event|0|||
161824193|NCT00098475|584397913|FG000|Step 2|Withdrawal by Subject|0|||
161824194|NCT00098475|584397914|FG001|Step 2|Withdrawal by Subject|2|||
161824195|NCT00098475|584397915|FG002|Step 2|Withdrawal by Subject|0|||
161824196|NCT00098475|584397916|FG003|Step 2|Withdrawal by Subject|0|||
161824197|NCT00098475|584397913|FG000|Step 2|Physician Decision|0|||
161824198|NCT00098475|584397914|FG001|Step 2|Physician Decision|1|||
161824199|NCT00098475|584397915|FG002|Step 2|Physician Decision|0|||
161824200|NCT00098475|584397916|FG003|Step 2|Physician Decision|0|||
161824201|NCT00098475|584397913|FG000|Step 2|Alternative therapy|1|||
161824202|NCT00098475|584397914|FG001|Step 2|Alternative therapy|2|||
161824203|NCT00098475|584397915|FG002|Step 2|Alternative therapy|0|||
161824204|NCT00098475|584397916|FG003|Step 2|Alternative therapy|0|||
161824205|NCT00098475|584397913|FG000|Step 2|Never started treatment|1|||
161824206|NCT00098475|584397914|FG001|Step 2|Never started treatment|1|||
161824207|NCT00098475|584397915|FG002|Step 2|Never started treatment|0|||
161824208|NCT00098475|584397916|FG003|Step 2|Never started treatment|0|||
161824209|NCT03422068|584397917|FG000|Overall Study|Adverse Event|0|||
161824210|NCT03422068|584397918|FG001|Overall Study|Adverse Event|1|||
161824211|NCT03422068|584397917|FG000|Overall Study|Inconvenience to frequent study visits|0|||
161824212|NCT03422068|584397918|FG001|Overall Study|Inconvenience to frequent study visits|1|||
161824213|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
161824214|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
161824215|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
161824216|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
161824217|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
161824218|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
161824219|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
161824220|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
161824221|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
161824222|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
161824223|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
161824224|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
161824225|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
161824226|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
161824227|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
161824228|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
161824229|NCT01067521|584397921|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
161824230|NCT01067521|584397922|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
161824231|NCT01067521|584397921|FG000|Open-Label Period|Death|3|||
161824232|NCT01067521|584397922|FG001|Open-Label Period|Death|1|||
161824233|NCT01067521|584397921|FG000|Open-Label Period|Adverse Event|30|||
161824234|NCT01067521|584397922|FG001|Open-Label Period|Adverse Event|28|||
161824235|NCT01067521|584397921|FG000|Open-Label Period|Withdrawal by Subject|160|||
161824236|NCT01067521|584397922|FG001|Open-Label Period|Withdrawal by Subject|88|||
161824237|NCT01067521|584397921|FG000|Open-Label Period|Physician Decision|13|||
161824238|NCT01067521|584397922|FG001|Open-Label Period|Physician Decision|11|||
161824239|NCT01067521|584397921|FG000|Open-Label Period|Non-compliance with study drug|5|||
161824240|NCT01067521|584397922|FG001|Open-Label Period|Non-compliance with study drug|0|||
161824241|NCT01067521|584397921|FG000|Open-Label Period|Protocol Violation|3|||
161824242|NCT01067521|584397922|FG001|Open-Label Period|Protocol Violation|0|||
161824243|NCT01067521|584397921|FG000|Open-Label Period|Pregnancy|14|||
161824244|NCT01067521|584397922|FG001|Open-Label Period|Pregnancy|8|||
161824245|NCT01067521|584397921|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
161824246|NCT01067521|584397922|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
161824247|NCT01067521|584397921|FG000|Open-Label Period|Lost to Follow-up|21|||
162204447|NCT03730662|585800486|FG002|Variable Treatment Period|Adverse Event|0|||
162204448|NCT03730662|585800487|FG003|Variable Treatment Period|Adverse Event|7|||
162204449|NCT03730662|585800484|FG000|Variable Treatment Period|Death|9|||
162204450|NCT03730662|585800485|FG001|Variable Treatment Period|Death|0|||
162204451|NCT03730662|585800486|FG002|Variable Treatment Period|Death|6|||
162204452|NCT03730662|585800487|FG003|Variable Treatment Period|Death|26|||
162204453|NCT03730662|585800484|FG000|Variable Treatment Period|Lost to Follow-up|2|||
162204454|NCT03730662|585800485|FG001|Variable Treatment Period|Lost to Follow-up|1|||
162204455|NCT03730662|585800486|FG002|Variable Treatment Period|Lost to Follow-up|4|||
162204456|NCT03730662|585800487|FG003|Variable Treatment Period|Lost to Follow-up|11|||
162204457|NCT03730662|585800484|FG000|Variable Treatment Period|Personal Reason|0|||
162204458|NCT03730662|585800485|FG001|Variable Treatment Period|Personal Reason|2|||
162204459|NCT03730662|585800486|FG002|Variable Treatment Period|Personal Reason|1|||
162204460|NCT03730662|585800487|FG003|Variable Treatment Period|Personal Reason|6|||
162204461|NCT03730662|585800484|FG000|Variable Treatment Period|Physician Decision|0|||
162204462|NCT03730662|585800485|FG001|Variable Treatment Period|Physician Decision|0|||
162204463|NCT03730662|585800486|FG002|Variable Treatment Period|Physician Decision|0|||
162204464|NCT03730662|585800487|FG003|Variable Treatment Period|Physician Decision|3|||
162204465|NCT03730662|585800484|FG000|Variable Treatment Period|Protocol Violation|0|||
162204466|NCT03730662|585800485|FG001|Variable Treatment Period|Protocol Violation|1|||
162204467|NCT03730662|585800486|FG002|Variable Treatment Period|Protocol Violation|1|||
161824248|NCT01067521|584397922|FG001|Open-Label Period|Lost to Follow-up|20|||
161824249|NCT00057941|584397926|FG000|Overall Study|Death|1|||
161824250|NCT00057941|584397927|FG001|Overall Study|Death|2|||
161824251|NCT00057941|584397926|FG000|Overall Study|Adverse Event|7|||
161824252|NCT00057941|584397927|FG001|Overall Study|Adverse Event|9|||
161824253|NCT00057941|584397926|FG000|Overall Study|Lack of Efficacy|54|||
161824254|NCT00057941|584397927|FG001|Overall Study|Lack of Efficacy|53|||
161824255|NCT00057941|584397926|FG000|Overall Study|Withdrawal by Subject|6|||
161824256|NCT00057941|584397927|FG001|Overall Study|Withdrawal by Subject|1|||
161824257|NCT00057941|584397926|FG000|Overall Study|still on treatment|3|||
161824258|NCT00057941|584397927|FG001|Overall Study|still on treatment|1|||
161824259|NCT00057941|584397926|FG000|Overall Study|insurance, symptomatic deterioration|1|||
161824260|NCT00057941|584397927|FG001|Overall Study|insurance, symptomatic deterioration|3|||
161824261|NCT00057941|584397926|FG000|Overall Study|Ineligible|2|||
161824262|NCT00057941|584397927|FG001|Overall Study|Ineligible|5|||
161824263|NCT04142658|584397928|FG000|Overall Study|Death|2|||
161824264|NCT04142658|584397929|FG001|Overall Study|Death|1|||
161824265|NCT04142658|584397928|FG000|Overall Study|Lost to Follow-up|4|||
161824266|NCT04142658|584397929|FG001|Overall Study|Lost to Follow-up|13|||
161824267|NCT04142658|584397928|FG000|Overall Study|Withdrawal by Subject|9|||
161824268|NCT04142658|584397929|FG001|Overall Study|Withdrawal by Subject|16|||
161824269|NCT01781234|584397930|FG000|Overall Study|Adverse Event|2|||
161824270|NCT01781234|584397931|FG001|Overall Study|Adverse Event|0|||
161824271|NCT01781234|584397930|FG000|Overall Study|Protocol Violation|3|||
161824272|NCT01781234|584397931|FG001|Overall Study|Protocol Violation|0|||
161824273|NCT01781234|584397930|FG000|Overall Study|Withdrawal by Subject|4|||
161824274|NCT01781234|584397931|FG001|Overall Study|Withdrawal by Subject|3|||
162204468|NCT03730662|585800487|FG003|Variable Treatment Period|Protocol Violation|1|||
162204469|NCT03730662|585800484|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
162204470|NCT03730662|585800485|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
162204471|NCT03730662|585800486|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
162204472|NCT03730662|585800487|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
162204473|NCT00833898|585800488|FG000|Overall Study|Withdrawal by Subject|33|||
162204474|NCT00833898|585800489|FG001|Overall Study|Withdrawal by Subject|27|||
162204475|NCT00833898|585800488|FG000|Overall Study|Lost to Follow-up|7|||
161824275|NCT01685216|584397938|FG000|Overall Study|Did not receive study drug|1|||
161824276|NCT01294449|584397939|FG000|Overall Study|Death|11|||
161824277|NCT01294449|584397940|FG001|Overall Study|Death|12|||
161824278|NCT01294449|584397939|FG000|Overall Study|Withdrawal by Subject|1|||
161824279|NCT01294449|584397940|FG001|Overall Study|Withdrawal by Subject|3|||
161824280|NCT02466386|584397941|FG000|Overall Study|Adverse Event|5|||
162204476|NCT00833898|585800489|FG001|Overall Study|Lost to Follow-up|7|||
162204477|NCT00833898|585800488|FG000|Overall Study|Patient did not receive transplant|0|||
162204478|NCT00833898|585800489|FG001|Overall Study|Patient did not receive transplant|2|||
162204479|NCT03712449|585800498|FG000|Overall Study|Withdraw Consent|0|||
161824281|NCT02466386|584397941|FG000|Overall Study|Protocol Violation|2|||
161824282|NCT02466386|584397941|FG000|Overall Study|Withdrawal by Subject|14|||
161824283|NCT02466386|584397941|FG000|Overall Study|Lost to Follow-up|5|||
161824284|NCT02466386|584397941|FG000|Overall Study|Lack of Efficacy|8|||
161677123|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
161932241|NCT01699685|584800422|FG000|Period 1|Medical or ethical, noncompliance|2|||
162204480|NCT03712449|585800499|FG001|Overall Study|Withdraw Consent|1|||
162204481|NCT00666198|585800500|FG000|Overall Study|Protocol Violation|10|||
162204482|NCT00666198|585800500|FG000|Overall Study|No Visit After First Day of Treatment|13|||
162204483|NCT00666198|585800500|FG000|Overall Study|Safety Not Assessable|6|||
162204484|NCT00666198|585800500|FG000|Overall Study|No Drug Administration|4|||
162204485|NCT05153499|585800501|FG000|Overall Study|Withdrawal by Subject|1|||
162204486|NCT05153499|585800502|FG001|Overall Study|Withdrawal by Subject|0|||
162204487|NCT05153499|585800501|FG000|Overall Study|Clinical Hold|1|||
162204488|NCT05153499|585800502|FG001|Overall Study|Clinical Hold|0|||
162204489|NCT05153499|585800501|FG000|Overall Study|Study Termination|6|||
162204490|NCT05153499|585800502|FG001|Overall Study|Study Termination|5|||
162204491|NCT05109117|585800503|FG000|Overall Study|Lost to Follow-up|1|||
162204492|NCT05109117|585800503|FG000|Overall Study|Discontinued for non-compliance|1|||
162204493|NCT03220776|585800506|FG000|Overall Study|Claustrophobia|0|||
162204494|NCT03220776|585800507|FG001|Overall Study|Claustrophobia|1|||
162204495|NCT03220776|585800508|FG002|Overall Study|Claustrophobia|1|||
162204496|NCT03220776|585800509|FG003|Overall Study|Claustrophobia|0|||
162204497|NCT03220776|585800510|FG004|Overall Study|Claustrophobia|1|||
162204498|NCT03220776|585800511|FG005|Overall Study|Claustrophobia|0|||
162204499|NCT03220776|585800506|FG000|Overall Study|MRI Equipment Failure|1|||
162204500|NCT03220776|585800507|FG001|Overall Study|MRI Equipment Failure|0|||
162204501|NCT03220776|585800508|FG002|Overall Study|MRI Equipment Failure|0|||
162204502|NCT03220776|585800509|FG003|Overall Study|MRI Equipment Failure|0|||
162204503|NCT03220776|585800510|FG004|Overall Study|MRI Equipment Failure|0|||
162204504|NCT03220776|585800511|FG005|Overall Study|MRI Equipment Failure|0|||
162204505|NCT03220776|585800506|FG000|Overall Study|Inclimate Weather|0|||
162204506|NCT03220776|585800507|FG001|Overall Study|Inclimate Weather|0|||
162204507|NCT03220776|585800508|FG002|Overall Study|Inclimate Weather|0|||
162204508|NCT03220776|585800509|FG003|Overall Study|Inclimate Weather|0|||
162204509|NCT03220776|585800510|FG004|Overall Study|Inclimate Weather|0|||
162204510|NCT03220776|585800511|FG005|Overall Study|Inclimate Weather|1|||
162204511|NCT03220776|585800506|FG000|Overall Study|Physician Decision|0|||
162204512|NCT03220776|585800507|FG001|Overall Study|Physician Decision|0|||
162204513|NCT03220776|585800508|FG002|Overall Study|Physician Decision|0|||
162204514|NCT03220776|585800509|FG003|Overall Study|Physician Decision|1|||
162204515|NCT03220776|585800510|FG004|Overall Study|Physician Decision|0|||
162204516|NCT03220776|585800511|FG005|Overall Study|Physician Decision|0|||
162204517|NCT03220776|585800506|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
162204518|NCT03220776|585800507|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
162204519|NCT03220776|585800508|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
162204520|NCT03220776|585800509|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
162204521|NCT03220776|585800510|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
162204522|NCT03220776|585800511|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
162204523|NCT03220776|585800506|FG000|Overall Study|Protocol Violation|0|||
162204524|NCT03220776|585800507|FG001|Overall Study|Protocol Violation|0|||
162204525|NCT03220776|585800508|FG002|Overall Study|Protocol Violation|0|||
162204526|NCT03220776|585800509|FG003|Overall Study|Protocol Violation|2|||
162204527|NCT03220776|585800510|FG004|Overall Study|Protocol Violation|0|||
162204528|NCT03220776|585800511|FG005|Overall Study|Protocol Violation|1|||
162204529|NCT03220776|585800506|FG000|Overall Study|Withdrawal by Subject|1|||
162204530|NCT03220776|585800507|FG001|Overall Study|Withdrawal by Subject|0|||
162204531|NCT03220776|585800508|FG002|Overall Study|Withdrawal by Subject|0|||
162204532|NCT03220776|585800509|FG003|Overall Study|Withdrawal by Subject|0|||
162204533|NCT03220776|585800510|FG004|Overall Study|Withdrawal by Subject|0|||
162204534|NCT03220776|585800511|FG005|Overall Study|Withdrawal by Subject|0|||
162204535|NCT04491006|585800513|FG000|Overall Study|Adverse Event|0|||
162204536|NCT04491006|585800514|FG001|Overall Study|Adverse Event|3|||
162204537|NCT04491006|585800515|FG002|Overall Study|Adverse Event|5|||
162204538|NCT04491006|585800513|FG000|Overall Study|Withdrawal by Subject|1|||
162204539|NCT04491006|585800514|FG001|Overall Study|Withdrawal by Subject|0|||
162204540|NCT04491006|585800515|FG002|Overall Study|Withdrawal by Subject|2|||
162204541|NCT01177137|585800517|FG000|Overall Study|Withdrawal by Subject|10|||
162204542|NCT01177137|585800518|FG001|Overall Study|Withdrawal by Subject|10|||
162204543|NCT01177137|585800519|FG002|Overall Study|Withdrawal by Subject|2|||
162204544|NCT00583115|585800520|FG000|Overall Study|Death|1|||
162204545|NCT03569475|585800521|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
162204546|NCT03569475|585800522|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
162204547|NCT03569475|585800523|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
162204548|NCT03569475|585800521|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
162204549|NCT03569475|585800522|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
162204550|NCT03569475|585800523|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
162204551|NCT03569475|585800521|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
162204552|NCT03569475|585800522|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
161932242|NCT01699685|584800423|FG001|Period 1|Medical or ethical, noncompliance|0|||
162204553|NCT03569475|585800523|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
162204554|NCT03569475|585800521|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
162204555|NCT03569475|585800522|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
162204556|NCT03569475|585800523|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
161932243|NCT01699685|584800422|FG000|Period 1|Other|0|||
161932244|NCT01699685|584800423|FG001|Period 1|Other|1|||
161932245|NCT01699685|584800422|FG000|Period 1|Patient request|0|||
161932246|NCT01699685|584800423|FG001|Period 1|Patient request|1|||
161932247|NCT01699685|584800422|FG000|Period 2|Lost to Follow-up|1|||
161932248|NCT01699685|584800423|FG001|Period 2|Lost to Follow-up|0|||
161932249|NCT03635996|584800424|FG000|Overall Study|Study terminated by Sponsor|94|||
161932250|NCT03635996|584800424|FG000|Overall Study|Withdrawal by Subject|20|||
161932251|NCT03635996|584800424|FG000|Overall Study|Ablation|26|||
161932252|NCT03635996|584800424|FG000|Overall Study|Adverse Event|7|||
161932253|NCT03635996|584800424|FG000|Overall Study|Physician Decision|3|||
161932254|NCT03635996|584800424|FG000|Overall Study|Prohibited medication|5|||
161932255|NCT03635996|584800424|FG000|Overall Study|Did not meet eligibility criteria|5|||
161932256|NCT03635996|584800424|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
161932257|NCT03635996|584800424|FG000|Overall Study|Protocol Violation|1|||
161932258|NCT03635996|584800424|FG000|Overall Study|Lost to Follow-up|1|||
161932259|NCT02821000|584800425|FG000|Overall Study|Death|89|||
161932260|NCT02821000|584800425|FG000|Overall Study|Sponsor Decision|12|||
161932261|NCT02821000|584800425|FG000|Overall Study|Withdrawal by Subject|2|||
161932262|NCT05058456|584800426|FG000|Overall Study|Death|1|||
161932263|NCT05058456|584800426|FG000|Overall Study|End of Study data not yet due for release|34|||
161932264|NCT02802865|584800427|FG000|Overall Study|Pregnancy|1|||
162204557|NCT03569475|585800521|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
162204558|NCT03569475|585800522|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
161932265|NCT02802865|584800428|FG001|Overall Study|Pregnancy|1|||
161932266|NCT02802865|584800427|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
161932267|NCT02802865|584800428|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
161932268|NCT01862029|584800429|FG000|Overall Study|Physician Decision|1|||
161932269|NCT03931785|584800430|FG000|Overall Study|Lost to Follow-up|4|||
161932270|NCT03931785|584800431|FG001|Overall Study|Lost to Follow-up|1|||
161932271|NCT03931785|584800432|FG002|Overall Study|Lost to Follow-up|4|||
161932272|NCT03931785|584800433|FG003|Overall Study|Lost to Follow-up|3|||
161932273|NCT03931785|584800430|FG000|Overall Study|Adverse Event|1|||
161932274|NCT03931785|584800431|FG001|Overall Study|Adverse Event|0|||
161932275|NCT03931785|584800432|FG002|Overall Study|Adverse Event|3|||
161932276|NCT03931785|584800433|FG003|Overall Study|Adverse Event|4|||
161932277|NCT03931785|584800430|FG000|Overall Study|Protocol Violation|0|||
161932278|NCT03931785|584800431|FG001|Overall Study|Protocol Violation|1|||
161932279|NCT03931785|584800432|FG002|Overall Study|Protocol Violation|0|||
161932280|NCT03931785|584800433|FG003|Overall Study|Protocol Violation|0|||
161932281|NCT03931785|584800430|FG000|Overall Study|Noncompliance With Study drug|0|||
161932282|NCT03931785|584800431|FG001|Overall Study|Noncompliance With Study drug|1|||
161932283|NCT03931785|584800432|FG002|Overall Study|Noncompliance With Study drug|0|||
161932284|NCT03931785|584800433|FG003|Overall Study|Noncompliance With Study drug|0|||
161932285|NCT03931785|584800430|FG000|Overall Study|Other Not specified|0|||
161932286|NCT03931785|584800431|FG001|Overall Study|Other Not specified|2|||
161932287|NCT03931785|584800432|FG002|Overall Study|Other Not specified|2|||
161932288|NCT03931785|584800433|FG003|Overall Study|Other Not specified|2|||
161932289|NCT03931785|584800430|FG000|Overall Study|Withdrawal by Subject|0|||
161932290|NCT03931785|584800431|FG001|Overall Study|Withdrawal by Subject|2|||
161932291|NCT03931785|584800432|FG002|Overall Study|Withdrawal by Subject|4|||
161932292|NCT03931785|584800433|FG003|Overall Study|Withdrawal by Subject|1|||
161932293|NCT03931785|584800430|FG000|Overall Study|Pregnancy|0|||
161932294|NCT03931785|584800431|FG001|Overall Study|Pregnancy|0|||
161932295|NCT03931785|584800432|FG002|Overall Study|Pregnancy|0|||
161932296|NCT03931785|584800433|FG003|Overall Study|Pregnancy|1|||
161932297|NCT01832038|584800434|FG000|Overall Study|Death|5|||
161932298|NCT01832038|584800434|FG000|Overall Study|Adverse Event|50|||
161932299|NCT01832038|584800434|FG000|Overall Study|Lack of Efficacy|81|||
161932300|NCT01832038|584800434|FG000|Overall Study|Protocol Violation|7|||
161932301|NCT01832038|584800434|FG000|Overall Study|Lost to Follow-up|10|||
161932302|NCT01832038|584800434|FG000|Overall Study|Withdrawal by Subject|49|||
161932303|NCT01832038|584800434|FG000|Overall Study|Visit non-compliance|2|||
161932304|NCT01832038|584800434|FG000|Overall Study|Subject refused to return visit|2|||
161932305|NCT01832038|584800434|FG000|Overall Study|Not convenient to come back to site|2|||
161932306|NCT01832038|584800434|FG000|Overall Study|Participant was asked to quit|5|||
161932307|NCT01832038|584800434|FG000|Overall Study|Back home|1|||
161932308|NCT01832038|584800434|FG000|Overall Study|Pregnancy|1|||
161932309|NCT01832038|584800434|FG000|Overall Study|Low compliance|3|||
161932310|NCT01832038|584800434|FG000|Overall Study|Prohibit procedure|2|||
161932311|NCT01832038|584800434|FG000|Overall Study|Not possible to visit the hospital|1|||
161932312|NCT01832038|584800434|FG000|Overall Study|Changes of implementation system|3|||
161932313|NCT01832038|584800434|FG000|Overall Study|Plan to pregnancy|7|||
161932314|NCT01832038|584800434|FG000|Overall Study|Bad mood and has suicidal thought|1|||
161932315|NCT01832038|584800434|FG000|Overall Study|Prohibited concomitant medication|1|||
161932316|NCT01832038|584800434|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
161932317|NCT01832038|584800434|FG000|Overall Study|Subject considered the efficacy was poor|1|||
161932318|NCT03810365|584800435|FG000|Overall Study|Lost to Follow-up|2|||
161932319|NCT03810365|584800436|FG001|Overall Study|Lost to Follow-up|2|||
161932320|NCT03810365|584800435|FG000|Overall Study|Withdrawal by Subject|4|||
161932321|NCT03810365|584800436|FG001|Overall Study|Withdrawal by Subject|5|||
161932322|NCT00449787|584800437|FG000|Overall Study|Lost to Follow-up|10|||
161932323|NCT00449787|584800438|FG001|Overall Study|Lost to Follow-up|8|||
161932324|NCT00449787|584800437|FG000|Overall Study|Did not require medication|95|||
161932325|NCT00449787|584800438|FG001|Overall Study|Did not require medication|92|||
161824285|NCT02466386|584397941|FG000|Overall Study|Other|10|||
161824286|NCT05317195|584397942|FG000|Randomization|Withdrawal by Subject|1|||
161824287|NCT05317195|584397942|FG000|Randomization|Discontinued|6|||
161824288|NCT05317195|584397942|FG000|Admission|Withdrawal by Subject|2|||
161824289|NCT00889252|584397943|FG000|Overall Study|Adverse Event|2|||
161824290|NCT00889252|584397944|FG001|Overall Study|Adverse Event|4|||
161824291|NCT00889252|584397943|FG000|Overall Study|Withdrawal by Subject|3|||
161824292|NCT00889252|584397944|FG001|Overall Study|Withdrawal by Subject|0|||
161824293|NCT00889252|584397943|FG000|Overall Study|Protocol Violation|2|||
161824294|NCT00889252|584397944|FG001|Overall Study|Protocol Violation|0|||
161824295|NCT01833169|584397948|FG000|Overall Study|Disease Progression|99|||
161824296|NCT01833169|584397948|FG000|Overall Study|Adverse Event|33|||
161824297|NCT01833169|584397948|FG000|Overall Study|Withdrawal by Subject|9|||
161824298|NCT01833169|584397948|FG000|Overall Study|Death|3|||
162021246|NCT05188053|585133479|FG000|Overall Study|Physician Decision|3|||
162021247|NCT05188053|585133480|FG001|Overall Study|Physician Decision|0|||
162021248|NCT05188053|585133479|FG000|Overall Study|Withdrawal by Subject|0|||
162021249|NCT05188053|585133480|FG001|Overall Study|Withdrawal by Subject|1|||
162021250|NCT04198714|585133481|FG000|Overall Study|Physician Decision|0|||
162021251|NCT04198714|585133482|FG001|Overall Study|Physician Decision|1|||
162021252|NCT02355184|585133490|FG000|Overall Study|Lost to Follow-up|2|||
162021253|NCT02355184|585133490|FG000|Overall Study|Study Terminated|10|||
162021254|NCT06173063|585133491|FG000|Overall Study|Withdrawal by Subject|2|||
161824299|NCT01833169|584397948|FG000|Overall Study|Physician Decision|2|||
161824300|NCT04718129|584397953|FG000|Overall Study|Lost to Follow-up|6|||
161824301|NCT04718129|584397954|FG001|Overall Study|Lost to Follow-up|7|||
161824302|NCT02212457|584397955|FG000|Overall Study|Adverse Event|1|||
161824303|NCT02212457|584397956|FG001|Overall Study|Adverse Event|2|||
162021255|NCT01925131|585134726|FG000|Overall Study|Death|0|||
162021256|NCT01925131|585134727|FG001|Overall Study|Death|0|||
162021257|NCT01925131|585134728|FG002|Overall Study|Death|1|||
162021258|NCT01925131|585134729|FG003|Overall Study|Death|0|||
162021259|NCT01925131|585134730|FG004|Overall Study|Death|0|||
162021260|NCT01925131|585134731|FG005|Overall Study|Death|0|||
162021261|NCT01925131|585134726|FG000|Overall Study|Progression/Relapse|1|||
162021262|NCT01925131|585134727|FG001|Overall Study|Progression/Relapse|1|||
161824304|NCT02212457|584397957|FG002|Overall Study|Adverse Event|2|||
161824305|NCT02212457|584397958|FG003|Overall Study|Adverse Event|2|||
161824306|NCT02212457|584397959|FG004|Overall Study|Adverse Event|0|||
161824307|NCT02212457|584397960|FG005|Overall Study|Adverse Event|1|||
161824308|NCT02212457|584397955|FG000|Overall Study|Withdrawal by Subject|8|||
161824309|NCT02212457|584397956|FG001|Overall Study|Withdrawal by Subject|10|||
161824310|NCT02212457|584397957|FG002|Overall Study|Withdrawal by Subject|8|||
161824311|NCT02212457|584397958|FG003|Overall Study|Withdrawal by Subject|6|||
161824312|NCT02212457|584397959|FG004|Overall Study|Withdrawal by Subject|5|||
161824313|NCT02212457|584397960|FG005|Overall Study|Withdrawal by Subject|4|||
162021263|NCT01925131|585134728|FG002|Overall Study|Progression/Relapse|4|||
162021264|NCT01925131|585134729|FG003|Overall Study|Progression/Relapse|0|||
162021265|NCT01925131|585134730|FG004|Overall Study|Progression/Relapse|0|||
162021266|NCT01925131|585134731|FG005|Overall Study|Progression/Relapse|1|||
162021267|NCT01925131|585134726|FG000|Overall Study|Patient Refusal|1|||
162021268|NCT01925131|585134727|FG001|Overall Study|Patient Refusal|0|||
162204559|NCT03569475|585800523|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
162204560|NCT03569475|585800521|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
162204561|NCT03569475|585800522|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
162204562|NCT03569475|585800523|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
162204563|NCT03569475|585800521|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
162204564|NCT03569475|585800522|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
162204565|NCT03569475|585800523|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
162021269|NCT01925131|585134728|FG002|Overall Study|Patient Refusal|0|||
162021270|NCT01925131|585134729|FG003|Overall Study|Patient Refusal|0|||
162021271|NCT01925131|585134730|FG004|Overall Study|Patient Refusal|0|||
162021272|NCT01925131|585134731|FG005|Overall Study|Patient Refusal|0|||
162021273|NCT01925131|585134726|FG000|Overall Study|Adverse Event|0|||
161824314|NCT02212457|584397955|FG000|Overall Study|Lost to Follow-up|6|||
162021274|NCT01925131|585134727|FG001|Overall Study|Adverse Event|0|||
162021275|NCT01925131|585134728|FG002|Overall Study|Adverse Event|2|||
162021276|NCT01925131|585134729|FG003|Overall Study|Adverse Event|0|||
162021277|NCT01925131|585134730|FG004|Overall Study|Adverse Event|1|||
161824315|NCT02212457|584397956|FG001|Overall Study|Lost to Follow-up|7|||
162021278|NCT01925131|585134731|FG005|Overall Study|Adverse Event|3|||
162021279|NCT01925131|585134726|FG000|Overall Study|Other - Not Protocol Specified|3|||
162021280|NCT01925131|585134727|FG001|Overall Study|Other - Not Protocol Specified|1|||
161824316|NCT02212457|584397957|FG002|Overall Study|Lost to Follow-up|4|||
161824317|NCT02212457|584397958|FG003|Overall Study|Lost to Follow-up|1|||
162021281|NCT01925131|585134728|FG002|Overall Study|Other - Not Protocol Specified|2|||
162021282|NCT01925131|585134729|FG003|Overall Study|Other - Not Protocol Specified|5|||
162204566|NCT03569475|585800521|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
162204567|NCT03569475|585800522|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
162204568|NCT03569475|585800523|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
162204569|NCT03569475|585800521|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
162204570|NCT03569475|585800522|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
162204571|NCT03569475|585800523|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
162204572|NCT02630706|585800527|FG000|Overall Study|Adverse Event|2|||
162204573|NCT02630706|585800528|FG001|Overall Study|Adverse Event|1|||
162204574|NCT02630706|585800529|FG002|Overall Study|Adverse Event|1|||
162204575|NCT02630706|585800527|FG000|Overall Study|Lost to Follow-up|0|||
162204576|NCT02630706|585800528|FG001|Overall Study|Lost to Follow-up|1|||
162204577|NCT02630706|585800529|FG002|Overall Study|Lost to Follow-up|2|||
162204578|NCT02630706|585800527|FG000|Overall Study|Physician Decision|1|||
162204579|NCT02630706|585800528|FG001|Overall Study|Physician Decision|1|||
162204580|NCT02630706|585800529|FG002|Overall Study|Physician Decision|0|||
162204581|NCT02630706|585800527|FG000|Overall Study|Pregnancy|0|||
162204582|NCT02630706|585800528|FG001|Overall Study|Pregnancy|1|||
162204583|NCT02630706|585800529|FG002|Overall Study|Pregnancy|0|||
162204584|NCT02630706|585800527|FG000|Overall Study|Withdrawal by Subject|4|||
161824318|NCT02212457|584397959|FG004|Overall Study|Lost to Follow-up|8|||
161824319|NCT02212457|584397960|FG005|Overall Study|Lost to Follow-up|4|||
161824320|NCT02212457|584397955|FG000|Overall Study|Protocol Violation|2|||
161824321|NCT02212457|584397956|FG001|Overall Study|Protocol Violation|1|||
161824322|NCT02212457|584397957|FG002|Overall Study|Protocol Violation|0|||
161824323|NCT02212457|584397958|FG003|Overall Study|Protocol Violation|1|||
161824324|NCT02212457|584397959|FG004|Overall Study|Protocol Violation|2|||
161824325|NCT02212457|584397960|FG005|Overall Study|Protocol Violation|3|||
161824326|NCT02212457|584397955|FG000|Overall Study|Other|2|||
161824327|NCT02212457|584397956|FG001|Overall Study|Other|1|||
161824328|NCT02212457|584397957|FG002|Overall Study|Other|2|||
161824329|NCT02212457|584397958|FG003|Overall Study|Other|1|||
161824330|NCT02212457|584397959|FG004|Overall Study|Other|0|||
161824331|NCT02212457|584397960|FG005|Overall Study|Other|1|||
161824332|NCT01120691|584397963|FG000|Overall Study|Adverse Event|59|||
161824333|NCT01120691|584397964|FG001|Overall Study|Adverse Event|67|||
161824334|NCT01120691|584397965|FG002|Overall Study|Adverse Event|47|||
161824335|NCT01120691|584397963|FG000|Overall Study|Subject withdrew consent|33|||
161824336|NCT01120691|584397964|FG001|Overall Study|Subject withdrew consent|50|||
161824337|NCT01120691|584397965|FG002|Overall Study|Subject withdrew consent|44|||
161824338|NCT01120691|584397963|FG000|Overall Study|Death|21|||
161824339|NCT01120691|584397964|FG001|Overall Study|Death|22|||
161824340|NCT01120691|584397965|FG002|Overall Study|Death|24|||
161824341|NCT01120691|584397963|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
161824342|NCT01120691|584397964|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
161824343|NCT01120691|584397965|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
161824344|NCT01120691|584397963|FG000|Overall Study|Administrative problems|15|||
161824345|NCT01120691|584397964|FG001|Overall Study|Administrative problems|8|||
161824346|NCT01120691|584397965|FG002|Overall Study|Administrative problems|9|||
161824347|NCT01120691|584397963|FG000|Overall Study|Protocol deviation|13|||
161824348|NCT01120691|584397964|FG001|Overall Study|Protocol deviation|12|||
161824349|NCT01120691|584397965|FG002|Overall Study|Protocol deviation|12|||
161824350|NCT01120691|584397963|FG000|Overall Study|Lost to Follow-up|5|||
161824351|NCT01120691|584397964|FG001|Overall Study|Lost to Follow-up|6|||
161824352|NCT01120691|584397965|FG002|Overall Study|Lost to Follow-up|4|||
161824353|NCT01120691|584397963|FG000|Overall Study|Abnormal test procedure result(s)|3|||
161824354|NCT01120691|584397964|FG001|Overall Study|Abnormal test procedure result(s)|2|||
161824355|NCT01120691|584397965|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161824356|NCT01120691|584397963|FG000|Overall Study|Patient's inability to use the device|3|||
161824357|NCT01120691|584397964|FG001|Overall Study|Patient's inability to use the device|1|||
161824358|NCT01120691|584397965|FG002|Overall Study|Patient's inability to use the device|0|||
161824359|NCT01120691|584397963|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161824360|NCT01120691|584397964|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161824361|NCT01120691|584397965|FG002|Overall Study|Abnormal laboratory value(s)|4|||
161824362|NCT00772148|584397967|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
161824363|NCT00772148|584397968|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
161824364|NCT00772148|584397967|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
161824365|NCT00772148|584397968|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
161824366|NCT00772148|584397967|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
162204585|NCT02630706|585800528|FG001|Overall Study|Withdrawal by Subject|5|||
162204586|NCT02630706|585800529|FG002|Overall Study|Withdrawal by Subject|7|||
161824367|NCT00772148|584397968|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
161824368|NCT00772148|584397967|FG000|Maintenance Phase (Week 52)|Death|2|||
161824369|NCT00772148|584397968|FG001|Maintenance Phase (Week 52)|Death|2|||
161824370|NCT00772148|584397967|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
161824371|NCT00772148|584397968|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
162204587|NCT01678898|585800531|FG000|PB-102-F01|Adverse Event|0|||
162204588|NCT01678898|585800532|FG001|PB-102-F01|Adverse Event|1|||
162204589|NCT01678898|585800533|FG002|PB-102-F01|Adverse Event|0|||
162204590|NCT01678898|585800531|FG000|PB-102-F01|Physician Decision|0|||
162204591|NCT01678898|585800532|FG001|PB-102-F01|Physician Decision|1|||
162204592|NCT01678898|585800533|FG002|PB-102-F01|Physician Decision|0|||
162204593|NCT01894256|585800538|FG000|Part A|Adverse Event|0|||
162204594|NCT01894256|585800539|FG001|Part A|Adverse Event|1|||
162204595|NCT01894256|585800540|FG002|Part A|Adverse Event|0|||
162204596|NCT01894256|585800538|FG000|Part B|Death|0|||
162204597|NCT01894256|585800539|FG001|Part B|Death|1|||
162204598|NCT01894256|585800540|FG002|Part B|Death|1|||
162204599|NCT01894256|585800538|FG000|Part B|Withdrawal by Subject|0|||
162204600|NCT01894256|585800539|FG001|Part B|Withdrawal by Subject|1|||
161677124|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
161677125|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
161677126|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
161932326|NCT03574389|584800443|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
161932327|NCT03574389|584800444|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
161932328|NCT03574389|584800445|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
161932329|NCT03574389|584800446|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
161932330|NCT03574389|584800447|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
161932331|NCT03574389|584800448|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
161932332|NCT03574389|584800449|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
161932333|NCT03574389|584800443|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
161932334|NCT03574389|584800444|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
161932335|NCT03574389|584800445|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
161932336|NCT03574389|584800446|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
161932337|NCT03574389|584800447|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
161932338|NCT03574389|584800448|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
161932339|NCT03574389|584800449|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
161932340|NCT03574389|584800443|FG000|Vaccination Period|Other|6|||
161932341|NCT03574389|584800444|FG001|Vaccination Period|Other|0|||
161932342|NCT03574389|584800445|FG002|Vaccination Period|Other|0|||
161932343|NCT03574389|584800446|FG003|Vaccination Period|Other|0|||
161932344|NCT03574389|584800447|FG004|Vaccination Period|Other|0|||
161932345|NCT03574389|584800448|FG005|Vaccination Period|Other|0|||
161932346|NCT03574389|584800449|FG006|Vaccination Period|Other|0|||
161932347|NCT03574389|584800443|FG000|Vaccination Period|Adverse Event|0|||
161932348|NCT03574389|584800444|FG001|Vaccination Period|Adverse Event|1|||
161932349|NCT03574389|584800445|FG002|Vaccination Period|Adverse Event|0|||
161932350|NCT03574389|584800446|FG003|Vaccination Period|Adverse Event|0|||
161932351|NCT03574389|584800447|FG004|Vaccination Period|Adverse Event|0|||
161932352|NCT03574389|584800448|FG005|Vaccination Period|Adverse Event|0|||
161932353|NCT03574389|584800449|FG006|Vaccination Period|Adverse Event|0|||
161932354|NCT03574389|584800443|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
161932355|NCT03574389|584800444|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
161932356|NCT03574389|584800445|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
161932357|NCT03574389|584800446|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
161932358|NCT03574389|584800447|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
161932359|NCT03574389|584800448|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
161932360|NCT03574389|584800449|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
161932361|NCT02094885|584800454|FG000|Overall Study|Death|1|||
161932362|NCT02094885|584800455|FG001|Overall Study|Death|5|||
161677127|NCT03523728|583871990|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
161677128|NCT03523728|583871991|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
161677129|NCT03523728|583871992|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
161677130|NCT03523728|583871993|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
161677131|NCT03523728|583871994|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
161677132|NCT03523728|583871990|FG000|Stage 2 (24 Months)|Adverse Event|0|||
161677133|NCT03523728|583871991|FG001|Stage 2 (24 Months)|Adverse Event|0|||
161677134|NCT03523728|583871992|FG002|Stage 2 (24 Months)|Adverse Event|0|||
161677135|NCT03523728|583871993|FG003|Stage 2 (24 Months)|Adverse Event|1|||
161932363|NCT02094885|584800454|FG000|Overall Study|Withdrawn due to age|1|||
161932364|NCT02094885|584800455|FG001|Overall Study|Withdrawn due to age|0|||
162204601|NCT01894256|585800540|FG002|Part B|Withdrawal by Subject|0|||
161677136|NCT03523728|583871994|FG004|Stage 2 (24 Months)|Adverse Event|2|||
161677137|NCT03523728|583871990|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
161677138|NCT03523728|583871991|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
161932365|NCT00337194|584800456|FG000|Overall Study|Adverse Event|5|||
161932366|NCT00337194|584800457|FG001|Overall Study|Adverse Event|1|||
161932367|NCT00337194|584800456|FG000|Overall Study|Death|2|||
161932368|NCT00337194|584800457|FG001|Overall Study|Death|0|||
161932369|NCT00337194|584800456|FG000|Overall Study|Withdrawal by Subject|1|||
161932370|NCT00337194|584800457|FG001|Overall Study|Withdrawal by Subject|0|||
161932371|NCT00337194|584800456|FG000|Overall Study|Disease progression|1|||
161932372|NCT00337194|584800457|FG001|Overall Study|Disease progression|2|||
161677139|NCT03523728|583871992|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
161677140|NCT03523728|583871993|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
161677141|NCT03523728|583871994|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
161677142|NCT03523728|583871990|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
161677143|NCT03523728|583871991|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
161677144|NCT03523728|583871992|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
161677145|NCT03523728|583871993|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
161677146|NCT03523728|583871994|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
161677147|NCT03523728|583871990|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
161677148|NCT03523728|583871991|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
161677149|NCT03523728|583871992|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
161677150|NCT03523728|583871993|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
161677151|NCT03523728|583871994|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
161677152|NCT03523728|583871990|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
161677153|NCT03523728|583871991|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
161677154|NCT03523728|583871992|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
161677155|NCT03523728|583871993|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
161677156|NCT03523728|583871994|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
161677157|NCT01274715|583871995|FG000|Overall Study|Lost to Follow-up|1|||
161677158|NCT01274715|583871995|FG000|Overall Study|After consent, met exclusion criteria.|1|||
161677159|NCT01274715|583871995|FG000|Overall Study|After consent, met exclusion criteria.|1|||
161677160|NCT01274715|583871995|FG000|Overall Study|After consent, met exclusion criteria.|1|||
161677161|NCT00467779|583872000|FG000|Stage 1|Adverse Event|1|||
161677162|NCT00467779|583872001|FG001|Stage 1|Adverse Event|0|||
161677163|NCT00467779|583872002|FG002|Stage 1|Adverse Event|0|||
161677164|NCT00467779|583872003|FG003|Stage 1|Adverse Event|0|||
161677165|NCT00467779|583872004|FG004|Stage 1|Adverse Event|0|||
161677166|NCT00467779|583872005|FG005|Stage 1|Adverse Event|1|||
161677167|NCT00467779|583872006|FG006|Stage 1|Adverse Event|2|||
161677168|NCT00467779|583872007|FG007|Stage 1|Adverse Event|1|||
161677169|NCT00467779|583872008|FG008|Stage 1|Adverse Event|0|||
161677170|NCT00467779|583872009|FG009|Stage 1|Adverse Event|0|||
161677171|NCT00467779|583872010|FG010|Stage 1|Adverse Event|0|||
161677172|NCT00467779|583872011|FG011|Stage 1|Adverse Event|0|||
161677173|NCT00467779|583872012|FG012|Stage 1|Adverse Event|0|||
161677174|NCT00467779|583872013|FG013|Stage 1|Adverse Event|0|||
161677175|NCT00467779|583872014|FG014|Stage 1|Adverse Event|0|||
161677176|NCT00467779|583872000|FG000|Stage 1|Disease Progression|2|||
161677177|NCT00467779|583872001|FG001|Stage 1|Disease Progression|2|||
161677178|NCT00467779|583872002|FG002|Stage 1|Disease Progression|2|||
161677179|NCT00467779|583872003|FG003|Stage 1|Disease Progression|3|||
161677180|NCT00467779|583872004|FG004|Stage 1|Disease Progression|2|||
161677181|NCT00467779|583872005|FG005|Stage 1|Disease Progression|2|||
161677182|NCT00467779|583872006|FG006|Stage 1|Disease Progression|4|||
161677183|NCT00467779|583872007|FG007|Stage 1|Disease Progression|5|||
161677184|NCT00467779|583872008|FG008|Stage 1|Disease Progression|0|||
161677185|NCT00467779|583872009|FG009|Stage 1|Disease Progression|0|||
161677186|NCT00467779|583872010|FG010|Stage 1|Disease Progression|0|||
161677187|NCT00467779|583872011|FG011|Stage 1|Disease Progression|0|||
161677188|NCT00467779|583872012|FG012|Stage 1|Disease Progression|0|||
161677189|NCT00467779|583872013|FG013|Stage 1|Disease Progression|0|||
161677190|NCT00467779|583872014|FG014|Stage 1|Disease Progression|0|||
161677191|NCT00467779|583872000|FG000|Stage 1|Unspecified Reason|1|||
161677192|NCT00467779|583872001|FG001|Stage 1|Unspecified Reason|0|||
161932373|NCT00337194|584800456|FG000|Overall Study|Subsequent non-protocol therapy|3|||
161932374|NCT00337194|584800457|FG001|Overall Study|Subsequent non-protocol therapy|1|||
161932375|NCT01061710|584800460|FG000|Overall Study|Protocol Violation|14|||
161932376|NCT01903720|584800461|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
161932377|NCT01903720|584800461|FG000|Overall Study|Adverse Event|1|||
161677193|NCT00467779|583872002|FG002|Stage 1|Unspecified Reason|1|||
161677194|NCT00467779|583872003|FG003|Stage 1|Unspecified Reason|0|||
161932378|NCT01903720|584800461|FG000|Overall Study|Rescinding of informed consent|2|||
161932379|NCT01903720|584800461|FG000|Overall Study|Lost to Follow-up|2|||
162204602|NCT01894256|585800538|FG000|Part B|Lack of Efficacy|15|||
162204603|NCT01894256|585800539|FG001|Part B|Lack of Efficacy|12|||
161677195|NCT00467779|583872004|FG004|Stage 1|Unspecified Reason|1|||
161677196|NCT00467779|583872005|FG005|Stage 1|Unspecified Reason|2|||
161677197|NCT00467779|583872006|FG006|Stage 1|Unspecified Reason|0|||
161677198|NCT00467779|583872007|FG007|Stage 1|Unspecified Reason|0|||
161677199|NCT00467779|583872008|FG008|Stage 1|Unspecified Reason|0|||
161677200|NCT00467779|583872009|FG009|Stage 1|Unspecified Reason|0|||
161677201|NCT00467779|583872010|FG010|Stage 1|Unspecified Reason|0|||
161677202|NCT00467779|583872011|FG011|Stage 1|Unspecified Reason|0|||
161677203|NCT00467779|583872012|FG012|Stage 1|Unspecified Reason|0|||
161677204|NCT00467779|583872013|FG013|Stage 1|Unspecified Reason|0|||
161677205|NCT00467779|583872014|FG014|Stage 1|Unspecified Reason|0|||
161677206|NCT00467779|583872000|FG000|Stage 1|Physician Decision|0|||
161677207|NCT00467779|583872001|FG001|Stage 1|Physician Decision|1|||
161932380|NCT01903720|584800461|FG000|Overall Study|Treatment with alternative drug|1|||
161677208|NCT00467779|583872002|FG002|Stage 1|Physician Decision|0|||
161677209|NCT00467779|583872003|FG003|Stage 1|Physician Decision|0|||
161677210|NCT00467779|583872004|FG004|Stage 1|Physician Decision|0|||
161677211|NCT00467779|583872005|FG005|Stage 1|Physician Decision|0|||
161677212|NCT00467779|583872006|FG006|Stage 1|Physician Decision|0|||
161677213|NCT00467779|583872007|FG007|Stage 1|Physician Decision|0|||
161677214|NCT00467779|583872008|FG008|Stage 1|Physician Decision|0|||
161677215|NCT00467779|583872009|FG009|Stage 1|Physician Decision|0|||
161677216|NCT00467779|583872010|FG010|Stage 1|Physician Decision|0|||
161677217|NCT00467779|583872011|FG011|Stage 1|Physician Decision|0|||
161677218|NCT00467779|583872012|FG012|Stage 1|Physician Decision|0|||
161677219|NCT00467779|583872013|FG013|Stage 1|Physician Decision|0|||
161677220|NCT00467779|583872014|FG014|Stage 1|Physician Decision|0|||
161677221|NCT00467779|583872000|FG000|Stage 1|Withdrawal by Subject|0|||
161677222|NCT00467779|583872001|FG001|Stage 1|Withdrawal by Subject|0|||
161677223|NCT00467779|583872002|FG002|Stage 1|Withdrawal by Subject|0|||
161677224|NCT00467779|583872003|FG003|Stage 1|Withdrawal by Subject|0|||
161677225|NCT00467779|583872004|FG004|Stage 1|Withdrawal by Subject|0|||
161677226|NCT00467779|583872005|FG005|Stage 1|Withdrawal by Subject|0|||
161677227|NCT00467779|583872006|FG006|Stage 1|Withdrawal by Subject|1|||
161677228|NCT00467779|583872007|FG007|Stage 1|Withdrawal by Subject|1|||
161677229|NCT00467779|583872008|FG008|Stage 1|Withdrawal by Subject|0|||
161677230|NCT00467779|583872009|FG009|Stage 1|Withdrawal by Subject|0|||
161677231|NCT00467779|583872010|FG010|Stage 1|Withdrawal by Subject|0|||
161677232|NCT00467779|583872011|FG011|Stage 1|Withdrawal by Subject|0|||
161677233|NCT00467779|583872012|FG012|Stage 1|Withdrawal by Subject|0|||
161677234|NCT00467779|583872013|FG013|Stage 1|Withdrawal by Subject|0|||
161677235|NCT00467779|583872014|FG014|Stage 1|Withdrawal by Subject|0|||
161677236|NCT00467779|583872000|FG000|Stage 1A|Adverse Event|0|||
161677237|NCT00467779|583872001|FG001|Stage 1A|Adverse Event|0|||
161677238|NCT00467779|583872002|FG002|Stage 1A|Adverse Event|0|||
161677239|NCT00467779|583872003|FG003|Stage 1A|Adverse Event|0|||
161677240|NCT00467779|583872004|FG004|Stage 1A|Adverse Event|0|||
161677241|NCT00467779|583872005|FG005|Stage 1A|Adverse Event|0|||
161677242|NCT00467779|583872006|FG006|Stage 1A|Adverse Event|0|||
161677243|NCT00467779|583872007|FG007|Stage 1A|Adverse Event|0|||
161677244|NCT00467779|583872008|FG008|Stage 1A|Adverse Event|0|||
161677245|NCT00467779|583872009|FG009|Stage 1A|Adverse Event|0|||
161677246|NCT00467779|583872010|FG010|Stage 1A|Adverse Event|0|||
161677247|NCT00467779|583872011|FG011|Stage 1A|Adverse Event|0|||
161677248|NCT00467779|583872012|FG012|Stage 1A|Adverse Event|1|||
161677249|NCT00467779|583872013|FG013|Stage 1A|Adverse Event|0|||
161677250|NCT00467779|583872014|FG014|Stage 1A|Adverse Event|0|||
161677251|NCT00467779|583872000|FG000|Stage 1A|Death|0|||
161677252|NCT00467779|583872001|FG001|Stage 1A|Death|0|||
161677253|NCT00467779|583872002|FG002|Stage 1A|Death|0|||
161677254|NCT00467779|583872003|FG003|Stage 1A|Death|0|||
161677255|NCT00467779|583872004|FG004|Stage 1A|Death|0|||
161677256|NCT00467779|583872005|FG005|Stage 1A|Death|0|||
161677257|NCT00467779|583872006|FG006|Stage 1A|Death|0|||
161677258|NCT00467779|583872007|FG007|Stage 1A|Death|0|||
161677259|NCT00467779|583872008|FG008|Stage 1A|Death|0|||
161677260|NCT00467779|583872009|FG009|Stage 1A|Death|0|||
161677261|NCT00467779|583872010|FG010|Stage 1A|Death|0|||
161677262|NCT00467779|583872011|FG011|Stage 1A|Death|1|||
161677263|NCT00467779|583872012|FG012|Stage 1A|Death|1|||
161677264|NCT00467779|583872013|FG013|Stage 1A|Death|0|||
161677265|NCT00467779|583872014|FG014|Stage 1A|Death|0|||
161677266|NCT00467779|583872000|FG000|Stage 1A|Disease Progression|0|||
161677267|NCT00467779|583872001|FG001|Stage 1A|Disease Progression|0|||
161677268|NCT00467779|583872002|FG002|Stage 1A|Disease Progression|0|||
161677269|NCT00467779|583872003|FG003|Stage 1A|Disease Progression|0|||
161677270|NCT00467779|583872004|FG004|Stage 1A|Disease Progression|0|||
161677271|NCT00467779|583872005|FG005|Stage 1A|Disease Progression|0|||
161677272|NCT00467779|583872006|FG006|Stage 1A|Disease Progression|0|||
161677273|NCT00467779|583872007|FG007|Stage 1A|Disease Progression|0|||
161677274|NCT00467779|583872008|FG008|Stage 1A|Disease Progression|0|||
161824372|NCT00772148|584397967|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
161677275|NCT00467779|583872009|FG009|Stage 1A|Disease Progression|2|||
161677276|NCT00467779|583872010|FG010|Stage 1A|Disease Progression|2|||
161677277|NCT00467779|583872011|FG011|Stage 1A|Disease Progression|5|||
161677278|NCT00467779|583872012|FG012|Stage 1A|Disease Progression|2|||
161824373|NCT00772148|584397968|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
161677279|NCT00467779|583872013|FG013|Stage 1A|Disease Progression|0|||
161677280|NCT00467779|583872014|FG014|Stage 1A|Disease Progression|0|||
161677281|NCT00467779|583872000|FG000|Stage 1A|Physician Decision|0|||
161677282|NCT00467779|583872001|FG001|Stage 1A|Physician Decision|0|||
161677283|NCT00467779|583872002|FG002|Stage 1A|Physician Decision|0|||
161677284|NCT00467779|583872003|FG003|Stage 1A|Physician Decision|0|||
161677285|NCT00467779|583872004|FG004|Stage 1A|Physician Decision|0|||
161677286|NCT00467779|583872005|FG005|Stage 1A|Physician Decision|0|||
161677287|NCT00467779|583872006|FG006|Stage 1A|Physician Decision|0|||
161677288|NCT00467779|583872007|FG007|Stage 1A|Physician Decision|0|||
161677289|NCT00467779|583872008|FG008|Stage 1A|Physician Decision|0|||
161932381|NCT00159874|584800462|FG000|Overall Study|Adverse Event|2|||
161932382|NCT00159874|584800463|FG001|Overall Study|Adverse Event|2|||
161932383|NCT00159874|584800464|FG002|Overall Study|Adverse Event|5|||
161932384|NCT00159874|584800465|FG003|Overall Study|Adverse Event|1|||
161932385|NCT00159874|584800466|FG004|Overall Study|Adverse Event|1|||
161932386|NCT00159874|584800467|FG005|Overall Study|Adverse Event|2|||
161932387|NCT00159874|584800468|FG006|Overall Study|Adverse Event|0|||
161677290|NCT00467779|583872009|FG009|Stage 1A|Physician Decision|1|||
161677291|NCT00467779|583872010|FG010|Stage 1A|Physician Decision|0|||
161677292|NCT00467779|583872011|FG011|Stage 1A|Physician Decision|0|||
161677293|NCT00467779|583872012|FG012|Stage 1A|Physician Decision|0|||
161677294|NCT00467779|583872013|FG013|Stage 1A|Physician Decision|0|||
161677295|NCT00467779|583872014|FG014|Stage 1A|Physician Decision|0|||
161677296|NCT00467779|583872000|FG000|Stage 1A|Withdrawal by Subject|0|||
161677297|NCT00467779|583872001|FG001|Stage 1A|Withdrawal by Subject|0|||
161677298|NCT00467779|583872002|FG002|Stage 1A|Withdrawal by Subject|0|||
161677299|NCT00467779|583872003|FG003|Stage 1A|Withdrawal by Subject|0|||
161677300|NCT00467779|583872004|FG004|Stage 1A|Withdrawal by Subject|0|||
161677301|NCT00467779|583872005|FG005|Stage 1A|Withdrawal by Subject|0|||
161677302|NCT00467779|583872006|FG006|Stage 1A|Withdrawal by Subject|0|||
161677303|NCT00467779|583872007|FG007|Stage 1A|Withdrawal by Subject|0|||
161677304|NCT00467779|583872008|FG008|Stage 1A|Withdrawal by Subject|0|||
161677305|NCT00467779|583872009|FG009|Stage 1A|Withdrawal by Subject|0|||
161677306|NCT00467779|583872010|FG010|Stage 1A|Withdrawal by Subject|1|||
161677307|NCT00467779|583872011|FG011|Stage 1A|Withdrawal by Subject|1|||
161677308|NCT00467779|583872012|FG012|Stage 1A|Withdrawal by Subject|1|||
161677309|NCT00467779|583872013|FG013|Stage 1A|Withdrawal by Subject|0|||
161677310|NCT00467779|583872014|FG014|Stage 1A|Withdrawal by Subject|0|||
161677311|NCT00467779|583872000|FG000|Stage 1A|Unspecified Reason|0|||
161677312|NCT00467779|583872001|FG001|Stage 1A|Unspecified Reason|0|||
161677313|NCT00467779|583872002|FG002|Stage 1A|Unspecified Reason|0|||
161677314|NCT00467779|583872003|FG003|Stage 1A|Unspecified Reason|0|||
161677315|NCT00467779|583872004|FG004|Stage 1A|Unspecified Reason|0|||
161677316|NCT00467779|583872005|FG005|Stage 1A|Unspecified Reason|0|||
161677317|NCT00467779|583872006|FG006|Stage 1A|Unspecified Reason|0|||
161677318|NCT00467779|583872007|FG007|Stage 1A|Unspecified Reason|0|||
161677319|NCT00467779|583872008|FG008|Stage 1A|Unspecified Reason|0|||
161677320|NCT00467779|583872009|FG009|Stage 1A|Unspecified Reason|0|||
161677321|NCT00467779|583872010|FG010|Stage 1A|Unspecified Reason|0|||
161677322|NCT00467779|583872011|FG011|Stage 1A|Unspecified Reason|1|||
161677323|NCT00467779|583872012|FG012|Stage 1A|Unspecified Reason|1|||
161677324|NCT00467779|583872013|FG013|Stage 1A|Unspecified Reason|0|||
161677325|NCT00467779|583872014|FG014|Stage 1A|Unspecified Reason|0|||
161677326|NCT00467779|583872000|FG000|Stage 2|Adverse Event|0|||
161677327|NCT00467779|583872001|FG001|Stage 2|Adverse Event|0|||
162204604|NCT01894256|585800540|FG002|Part B|Lack of Efficacy|13|||
162204605|NCT00645099|585800544|FG000|Overall Study|Lack of Efficacy|15|||
162204606|NCT00645099|585800545|FG001|Overall Study|Lack of Efficacy|6|||
161677328|NCT00467779|583872002|FG002|Stage 2|Adverse Event|0|||
161677329|NCT00467779|583872003|FG003|Stage 2|Adverse Event|0|||
161677330|NCT00467779|583872004|FG004|Stage 2|Adverse Event|0|||
161677331|NCT00467779|583872005|FG005|Stage 2|Adverse Event|0|||
161677332|NCT00467779|583872006|FG006|Stage 2|Adverse Event|0|||
161677333|NCT00467779|583872007|FG007|Stage 2|Adverse Event|0|||
161677334|NCT00467779|583872008|FG008|Stage 2|Adverse Event|1|||
161677335|NCT00467779|583872009|FG009|Stage 2|Adverse Event|0|||
161677336|NCT00467779|583872010|FG010|Stage 2|Adverse Event|0|||
162204607|NCT00645099|585800544|FG000|Overall Study|Withdrawal by Subject|30|||
162204608|NCT00645099|585800545|FG001|Overall Study|Withdrawal by Subject|22|||
162204609|NCT00645099|585800544|FG000|Overall Study|Lost to Follow-up|6|||
162204610|NCT00645099|585800545|FG001|Overall Study|Lost to Follow-up|4|||
162204611|NCT00645099|585800544|FG000|Overall Study|Adverse Event|11|||
162204612|NCT00645099|585800545|FG001|Overall Study|Adverse Event|5|||
162204613|NCT00645099|585800544|FG000|Overall Study|Other|9|||
162204614|NCT00645099|585800545|FG001|Overall Study|Other|5|||
162204615|NCT01201915|585800546|FG000|Overall Study|Adverse Event|2|||
162204616|NCT01201915|585800547|FG001|Overall Study|Adverse Event|1|||
162204617|NCT01201915|585800548|FG002|Overall Study|Adverse Event|1|||
162204618|NCT01201915|585800546|FG000|Overall Study|Lost to Follow-up|0|||
161677337|NCT00467779|583872011|FG011|Stage 2|Adverse Event|0|||
161677338|NCT00467779|583872012|FG012|Stage 2|Adverse Event|0|||
161677339|NCT00467779|583872013|FG013|Stage 2|Adverse Event|0|||
161677340|NCT00467779|583872014|FG014|Stage 2|Adverse Event|0|||
161677341|NCT00467779|583872000|FG000|Stage 2|Death|0|||
161677342|NCT00467779|583872001|FG001|Stage 2|Death|0|||
161677343|NCT00467779|583872002|FG002|Stage 2|Death|0|||
161677344|NCT00467779|583872003|FG003|Stage 2|Death|0|||
161677345|NCT00467779|583872004|FG004|Stage 2|Death|0|||
161677346|NCT00467779|583872005|FG005|Stage 2|Death|0|||
161677347|NCT00467779|583872006|FG006|Stage 2|Death|0|||
161677348|NCT00467779|583872007|FG007|Stage 2|Death|0|||
161932388|NCT00159874|584800462|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
161932389|NCT00159874|584800463|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
161677349|NCT00467779|583872008|FG008|Stage 2|Death|1|||
161677350|NCT00467779|583872009|FG009|Stage 2|Death|0|||
161677351|NCT00467779|583872010|FG010|Stage 2|Death|0|||
161677352|NCT00467779|583872011|FG011|Stage 2|Death|0|||
161677353|NCT00467779|583872012|FG012|Stage 2|Death|0|||
161677354|NCT00467779|583872013|FG013|Stage 2|Death|0|||
161677355|NCT00467779|583872014|FG014|Stage 2|Death|0|||
161677356|NCT00467779|583872000|FG000|Stage 2|Disease Progression|0|||
161677357|NCT00467779|583872001|FG001|Stage 2|Disease Progression|0|||
161677358|NCT00467779|583872002|FG002|Stage 2|Disease Progression|0|||
161677359|NCT00467779|583872003|FG003|Stage 2|Disease Progression|0|||
161677360|NCT00467779|583872004|FG004|Stage 2|Disease Progression|0|||
161677361|NCT00467779|583872005|FG005|Stage 2|Disease Progression|0|||
161677362|NCT00467779|583872006|FG006|Stage 2|Disease Progression|0|||
161677363|NCT00467779|583872007|FG007|Stage 2|Disease Progression|0|||
161677364|NCT00467779|583872008|FG008|Stage 2|Disease Progression|16|||
161677365|NCT00467779|583872009|FG009|Stage 2|Disease Progression|0|||
161677366|NCT00467779|583872010|FG010|Stage 2|Disease Progression|0|||
161677367|NCT00467779|583872011|FG011|Stage 2|Disease Progression|0|||
161677368|NCT00467779|583872012|FG012|Stage 2|Disease Progression|0|||
161677369|NCT00467779|583872013|FG013|Stage 2|Disease Progression|0|||
161677370|NCT00467779|583872014|FG014|Stage 2|Disease Progression|0|||
161677371|NCT00467779|583872000|FG000|Stage 2|Unspecified Reason|0|||
161677372|NCT00467779|583872001|FG001|Stage 2|Unspecified Reason|0|||
161677373|NCT00467779|583872002|FG002|Stage 2|Unspecified Reason|0|||
161677374|NCT00467779|583872003|FG003|Stage 2|Unspecified Reason|0|||
161677375|NCT00467779|583872004|FG004|Stage 2|Unspecified Reason|0|||
161677376|NCT00467779|583872005|FG005|Stage 2|Unspecified Reason|0|||
161677377|NCT00467779|583872006|FG006|Stage 2|Unspecified Reason|0|||
161677378|NCT00467779|583872007|FG007|Stage 2|Unspecified Reason|0|||
161677379|NCT00467779|583872008|FG008|Stage 2|Unspecified Reason|3|||
161677380|NCT00467779|583872009|FG009|Stage 2|Unspecified Reason|0|||
161677381|NCT00467779|583872010|FG010|Stage 2|Unspecified Reason|0|||
161677382|NCT00467779|583872011|FG011|Stage 2|Unspecified Reason|0|||
161677383|NCT00467779|583872012|FG012|Stage 2|Unspecified Reason|0|||
161677384|NCT00467779|583872013|FG013|Stage 2|Unspecified Reason|0|||
161677385|NCT00467779|583872014|FG014|Stage 2|Unspecified Reason|0|||
161677386|NCT00467779|583872000|FG000|Stage 2A|Adverse Event|0|||
161677387|NCT00467779|583872001|FG001|Stage 2A|Adverse Event|0|||
161677388|NCT00467779|583872002|FG002|Stage 2A|Adverse Event|0|||
161677389|NCT00467779|583872003|FG003|Stage 2A|Adverse Event|0|||
161677390|NCT00467779|583872004|FG004|Stage 2A|Adverse Event|0|||
161677391|NCT00467779|583872005|FG005|Stage 2A|Adverse Event|0|||
161677392|NCT00467779|583872006|FG006|Stage 2A|Adverse Event|0|||
161677393|NCT00467779|583872007|FG007|Stage 2A|Adverse Event|0|||
161677394|NCT00467779|583872008|FG008|Stage 2A|Adverse Event|0|||
161677395|NCT00467779|583872009|FG009|Stage 2A|Adverse Event|0|||
161677396|NCT00467779|583872010|FG010|Stage 2A|Adverse Event|0|||
161677397|NCT00467779|583872011|FG011|Stage 2A|Adverse Event|0|||
161677398|NCT00467779|583872012|FG012|Stage 2A|Adverse Event|0|||
161677399|NCT00467779|583872013|FG013|Stage 2A|Adverse Event|2|||
161677400|NCT00467779|583872014|FG014|Stage 2A|Adverse Event|0|||
161677401|NCT00467779|583872000|FG000|Stage 2A|Death|0|||
161677402|NCT00467779|583872001|FG001|Stage 2A|Death|0|||
161677403|NCT00467779|583872002|FG002|Stage 2A|Death|0|||
161677404|NCT00467779|583872003|FG003|Stage 2A|Death|0|||
161677405|NCT00467779|583872004|FG004|Stage 2A|Death|0|||
161677406|NCT00467779|583872005|FG005|Stage 2A|Death|0|||
161677407|NCT00467779|583872006|FG006|Stage 2A|Death|0|||
161677408|NCT00467779|583872007|FG007|Stage 2A|Death|0|||
161677409|NCT00467779|583872008|FG008|Stage 2A|Death|0|||
161677410|NCT00467779|583872009|FG009|Stage 2A|Death|0|||
161677411|NCT00467779|583872010|FG010|Stage 2A|Death|0|||
161677412|NCT00467779|583872011|FG011|Stage 2A|Death|0|||
161677413|NCT00467779|583872012|FG012|Stage 2A|Death|0|||
161677414|NCT00467779|583872013|FG013|Stage 2A|Death|1|||
161677415|NCT00467779|583872014|FG014|Stage 2A|Death|0|||
161677416|NCT00467779|583872000|FG000|Stage 2A|Disease Progression|0|||
161677417|NCT00467779|583872001|FG001|Stage 2A|Disease Progression|0|||
161677418|NCT00467779|583872002|FG002|Stage 2A|Disease Progression|0|||
161932390|NCT00159874|584800464|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
161677419|NCT00467779|583872003|FG003|Stage 2A|Disease Progression|0|||
161677420|NCT00467779|583872004|FG004|Stage 2A|Disease Progression|0|||
161677421|NCT00467779|583872005|FG005|Stage 2A|Disease Progression|0|||
161677422|NCT00467779|583872006|FG006|Stage 2A|Disease Progression|0|||
161932391|NCT00159874|584800465|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
161677423|NCT00467779|583872007|FG007|Stage 2A|Disease Progression|0|||
161677424|NCT00467779|583872008|FG008|Stage 2A|Disease Progression|0|||
161677425|NCT00467779|583872009|FG009|Stage 2A|Disease Progression|0|||
161677426|NCT00467779|583872010|FG010|Stage 2A|Disease Progression|0|||
161677427|NCT00467779|583872011|FG011|Stage 2A|Disease Progression|0|||
161677428|NCT00467779|583872012|FG012|Stage 2A|Disease Progression|0|||
161677429|NCT00467779|583872013|FG013|Stage 2A|Disease Progression|10|||
161677430|NCT00467779|583872014|FG014|Stage 2A|Disease Progression|0|||
161677431|NCT00467779|583872000|FG000|Stage 2A|Unspecified Reason|0|||
162204619|NCT01201915|585800547|FG001|Overall Study|Lost to Follow-up|4|||
162204620|NCT01201915|585800548|FG002|Overall Study|Lost to Follow-up|0|||
162204621|NCT01201915|585800546|FG000|Overall Study|Physician Decision|3|||
162204622|NCT01201915|585800547|FG001|Overall Study|Physician Decision|0|||
162204623|NCT01201915|585800548|FG002|Overall Study|Physician Decision|0|||
161677432|NCT00467779|583872001|FG001|Stage 2A|Unspecified Reason|0|||
161677433|NCT00467779|583872002|FG002|Stage 2A|Unspecified Reason|0|||
161677434|NCT00467779|583872003|FG003|Stage 2A|Unspecified Reason|0|||
161677435|NCT00467779|583872004|FG004|Stage 2A|Unspecified Reason|0|||
161677436|NCT00467779|583872005|FG005|Stage 2A|Unspecified Reason|0|||
161677437|NCT00467779|583872006|FG006|Stage 2A|Unspecified Reason|0|||
161677438|NCT00467779|583872007|FG007|Stage 2A|Unspecified Reason|0|||
161677439|NCT00467779|583872008|FG008|Stage 2A|Unspecified Reason|0|||
162204624|NCT01201915|585800546|FG000|Overall Study|Subject Decision|3|||
162204625|NCT01201915|585800547|FG001|Overall Study|Subject Decision|3|||
162204626|NCT01201915|585800548|FG002|Overall Study|Subject Decision|5|||
162204627|NCT01201915|585800546|FG000|Overall Study|Target Lesion Progression|0|||
162204628|NCT01201915|585800547|FG001|Overall Study|Target Lesion Progression|3|||
162204629|NCT01201915|585800548|FG002|Overall Study|Target Lesion Progression|0|||
162204630|NCT02154516|585800549|FG000|Overall Study|Withdrawal by Subject|0|||
162204631|NCT02154516|585800550|FG001|Overall Study|Withdrawal by Subject|1|||
162204632|NCT02154516|585800549|FG000|Overall Study|Lost to Follow-up|1|||
162204633|NCT02154516|585800550|FG001|Overall Study|Lost to Follow-up|0|||
162204634|NCT02154516|585800549|FG000|Overall Study|Removal/revision of device|1|||
162204635|NCT02154516|585800550|FG001|Overall Study|Removal/revision of device|0|||
162204636|NCT02154516|585800549|FG000|Overall Study|Death|2|||
162204637|NCT02154516|585800550|FG001|Overall Study|Death|1|||
162204638|NCT00663923|585800551|FG000|Overall Study|Lost to Follow-up|2|||
162204639|NCT02316171|585800555|FG000|Overall Study|difficulties with urinary catheter|1|||
162204640|NCT02316171|585800556|FG001|Overall Study|difficulties with urinary catheter|0|||
162204641|NCT02316171|585800557|FG002|Overall Study|difficulties with urinary catheter|0|||
162204642|NCT02316171|585800558|FG003|Overall Study|difficulties with urinary catheter|0|||
162204643|NCT01804140|585800560|FG000|Overall Study|No sampling or biopsy procedures done|114|||
162204644|NCT00547300|585800561|FG000|Overall Study|Study was Administratively Terminated|25|||
162204645|NCT00547300|585800562|FG001|Overall Study|Study was Administratively Terminated|24|||
162204646|NCT00547300|585800561|FG000|Overall Study|Did not Meet Entry Criteria|0|||
162204647|NCT00547300|585800562|FG001|Overall Study|Did not Meet Entry Criteria|2|||
162204648|NCT02785900|585800563|FG000|Overall Study|Study Termination by Sponsor|64|||
162204649|NCT02785900|585800564|FG001|Overall Study|Study Termination by Sponsor|81|||
162204650|NCT02785900|585800563|FG000|Overall Study|Death|46|||
162204651|NCT02785900|585800564|FG001|Overall Study|Death|32|||
162204652|NCT02785900|585800563|FG000|Overall Study|Withdrawal by Subject|4|||
162204653|NCT02785900|585800564|FG001|Overall Study|Withdrawal by Subject|8|||
162204654|NCT02785900|585800563|FG000|Overall Study|Physician Decision|3|||
162204655|NCT02785900|585800564|FG001|Overall Study|Physician Decision|2|||
162204656|NCT04435522|585800567|FG000|Overall Study|Withdrawal by Subject|2|||
162204657|NCT04130061|585800568|FG000|Overall Study|OR team forgot to request membrane|1|||
162204658|NCT04130061|585800569|FG001|Overall Study|OR team forgot to request membrane|0|||
162204659|NCT00092521|585801752|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
162204660|NCT00092521|585801753|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
162204661|NCT00092521|585801754|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
162204662|NCT00092521|585801755|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
162204663|NCT00092521|585801752|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
162204664|NCT00092521|585801753|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
162204665|NCT00092521|585801754|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
162204666|NCT00092521|585801755|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
162204667|NCT00092521|585801752|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
162204668|NCT00092521|585801753|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
162204669|NCT00092521|585801754|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
161677440|NCT00467779|583872009|FG009|Stage 2A|Unspecified Reason|0|||
161677441|NCT00467779|583872010|FG010|Stage 2A|Unspecified Reason|0|||
161677442|NCT00467779|583872011|FG011|Stage 2A|Unspecified Reason|0|||
161824374|NCT00772148|584397967|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
161824375|NCT00772148|584397968|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
161824376|NCT00688844|584397969|FG000|Overall Study|Lost to Follow-up|10|||
161824377|NCT01321697|584397975|FG000|Overall Study|Study Terminated|7|||
161824378|NCT00857818|584397976|FG000|Overall Study|Lack of Efficacy|1|||
161824379|NCT00857818|584397977|FG001|Overall Study|Lack of Efficacy|0|||
162204670|NCT00092521|585801755|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
162204671|NCT00092521|585801752|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
162204672|NCT00092521|585801753|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
162204673|NCT00092521|585801754|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
161824380|NCT00857818|584397976|FG000|Overall Study|Adverse Event|3|||
162204674|NCT00092521|585801755|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
162204675|NCT00092521|585801752|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
161824381|NCT00857818|584397977|FG001|Overall Study|Adverse Event|0|||
162204676|NCT00092521|585801753|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
162204677|NCT00092521|585801754|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
162204678|NCT00092521|585801755|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
162204679|NCT00092521|585801752|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
162204680|NCT00092521|585801753|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
162204681|NCT00092521|585801754|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
162204682|NCT00092521|585801755|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
162204683|NCT00092521|585801752|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
162204684|NCT00092521|585801753|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
162204685|NCT00092521|585801754|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
162204686|NCT00092521|585801755|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
162204687|NCT00092521|585801752|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
162204688|NCT00092521|585801753|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
162204689|NCT00092521|585801754|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
162204690|NCT00092521|585801755|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
162204691|NCT00092521|585801752|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
162204692|NCT00092521|585801753|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
162204693|NCT00092521|585801754|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
162204694|NCT00092521|585801755|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
162204695|NCT00092521|585801752|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
162204696|NCT00092521|585801753|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
162204697|NCT00092521|585801754|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
162204698|NCT00092521|585801755|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
162204699|NCT00092521|585801752|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
162204700|NCT00092521|585801753|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
162204701|NCT00092521|585801754|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
162204702|NCT00092521|585801755|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
162204703|NCT00092521|585801752|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
162204704|NCT00092521|585801753|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
162204705|NCT00092521|585801754|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
162204706|NCT00092521|585801755|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
162204707|NCT00092521|585801752|FG000|Follow-Up (After Month 7)|Death|2|||
162204708|NCT00092521|585801753|FG001|Follow-Up (After Month 7)|Death|0|||
162204709|NCT00092521|585801754|FG002|Follow-Up (After Month 7)|Death|1|||
162204710|NCT00092521|585801755|FG003|Follow-Up (After Month 7)|Death|0|||
162204711|NCT00092521|585801752|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
162204712|NCT00092521|585801753|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
162204713|NCT00092521|585801754|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
162204714|NCT00092521|585801755|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
162204715|NCT00092521|585801752|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
162204716|NCT00092521|585801753|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
162204717|NCT00092521|585801754|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
162204718|NCT00092521|585801755|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
162204719|NCT00092521|585801752|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
162204720|NCT00092521|585801753|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
162204721|NCT00092521|585801754|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
162204722|NCT00092521|585801755|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
162204723|NCT00092521|585801752|FG000|Follow-Up (After Month 7)|Moved|32|||
162204724|NCT00092521|585801753|FG001|Follow-Up (After Month 7)|Moved|2|||
162204725|NCT00092521|585801754|FG002|Follow-Up (After Month 7)|Moved|28|||
162204726|NCT00092521|585801755|FG003|Follow-Up (After Month 7)|Moved|0|||
162204727|NCT00092521|585801752|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
162204728|NCT00092521|585801753|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
162204729|NCT00092521|585801754|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
162204730|NCT00092521|585801755|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
162204731|NCT00092521|585801752|FG000|Follow-Up (After Month 7)|Travel|2|||
161932392|NCT00159874|584800466|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
161932393|NCT00159874|584800467|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
161932394|NCT00159874|584800468|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
161932395|NCT00159874|584800462|FG000|Overall Study|Lack of Efficacy|2|||
161932396|NCT00159874|584800463|FG001|Overall Study|Lack of Efficacy|0|||
161932397|NCT00159874|584800464|FG002|Overall Study|Lack of Efficacy|1|||
161932398|NCT00159874|584800465|FG003|Overall Study|Lack of Efficacy|1|||
161932399|NCT00159874|584800466|FG004|Overall Study|Lack of Efficacy|0|||
161932400|NCT00159874|584800467|FG005|Overall Study|Lack of Efficacy|3|||
161932401|NCT00159874|584800468|FG006|Overall Study|Lack of Efficacy|0|||
161932402|NCT00159874|584800462|FG000|Overall Study|Lost to Follow-up|1|||
162204732|NCT00092521|585801753|FG001|Follow-Up (After Month 7)|Travel|0|||
162204733|NCT00092521|585801754|FG002|Follow-Up (After Month 7)|Travel|0|||
162204734|NCT00092521|585801755|FG003|Follow-Up (After Month 7)|Travel|0|||
161932403|NCT00159874|584800463|FG001|Overall Study|Lost to Follow-up|0|||
161932404|NCT00159874|584800464|FG002|Overall Study|Lost to Follow-up|3|||
161932405|NCT00159874|584800465|FG003|Overall Study|Lost to Follow-up|0|||
161932406|NCT00159874|584800466|FG004|Overall Study|Lost to Follow-up|1|||
162204735|NCT00092521|585801752|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
162204736|NCT00092521|585801753|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
162204737|NCT00092521|585801754|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
162204738|NCT00092521|585801755|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
162204739|NCT00092521|585801752|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
162204740|NCT00092521|585801753|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
162204741|NCT00092521|585801754|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
162204742|NCT00092521|585801755|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
162204743|NCT00092521|585801752|FG000|Extension Study (Group 4)|Adverse Event|0|||
162204744|NCT00092521|585801753|FG001|Extension Study (Group 4)|Adverse Event|0|||
162204745|NCT00092521|585801754|FG002|Extension Study (Group 4)|Adverse Event|0|||
162204746|NCT00092521|585801755|FG003|Extension Study (Group 4)|Adverse Event|2|||
162204747|NCT00092521|585801752|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
162204748|NCT00092521|585801753|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
162204749|NCT00092521|585801754|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
162204750|NCT00092521|585801755|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
162204751|NCT00092521|585801752|FG000|Extension Study (Group 4)|Pregnancy|0|||
162204752|NCT00092521|585801753|FG001|Extension Study (Group 4)|Pregnancy|0|||
162204753|NCT00092521|585801754|FG002|Extension Study (Group 4)|Pregnancy|0|||
162204754|NCT00092521|585801755|FG003|Extension Study (Group 4)|Pregnancy|4|||
162204755|NCT00092521|585801752|FG000|Extension Study (Group 4)|Protocol Violation|0|||
162204756|NCT00092521|585801753|FG001|Extension Study (Group 4)|Protocol Violation|0|||
162204757|NCT00092521|585801754|FG002|Extension Study (Group 4)|Protocol Violation|0|||
162204758|NCT00092521|585801755|FG003|Extension Study (Group 4)|Protocol Violation|2|||
162204759|NCT00092521|585801752|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
162204760|NCT00092521|585801753|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
162204761|NCT00092521|585801754|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
162204762|NCT00092521|585801755|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
162204763|NCT00092521|585801752|FG000|Extension Study (Group 4)|Moved|0|||
162204764|NCT00092521|585801753|FG001|Extension Study (Group 4)|Moved|0|||
162204765|NCT00092521|585801754|FG002|Extension Study (Group 4)|Moved|0|||
162204766|NCT00092521|585801755|FG003|Extension Study (Group 4)|Moved|16|||
162204767|NCT00092521|585801752|FG000|Extension Study (Group 4)|Site Terminated|0|||
162204768|NCT00092521|585801753|FG001|Extension Study (Group 4)|Site Terminated|0|||
162204769|NCT00092521|585801754|FG002|Extension Study (Group 4)|Site Terminated|0|||
162204770|NCT00092521|585801755|FG003|Extension Study (Group 4)|Site Terminated|4|||
162204771|NCT00092521|585801752|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
162204772|NCT00092521|585801753|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
162204773|NCT00092521|585801754|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
162204774|NCT00092521|585801755|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
162204775|NCT00560313|585801756|FG000|Overall Study|Adverse Events or Death|2|||
162204776|NCT00560313|585801756|FG000|Overall Study|Withdrawal by Subject|2|||
162204777|NCT00560313|585801756|FG000|Overall Study|Lost to Follow-up|1|||
162204778|NCT00560313|585801756|FG000|Overall Study|Protocol Violation|1|||
162204779|NCT00605566|585801757|FG000|Overall Study|Adverse Event|1|||
162204780|NCT00605566|585801757|FG000|Overall Study|Clinical deterioration|1|||
162204781|NCT00605566|585801757|FG000|Overall Study|Poor compliance in run-in period|1|||
162204782|NCT03475056|585801758|FG000|Overall Study|Lost to Follow-up|0|||
162204783|NCT03475056|585801759|FG001|Overall Study|Lost to Follow-up|1|||
162204784|NCT03475056|585801758|FG000|Overall Study|Moved from Area|0|||
162204785|NCT03475056|585801759|FG001|Overall Study|Moved from Area|2|||
162204786|NCT00113269|585801762|FG000|Overall Study|Not transplanted, donor issues|4|||
162204787|NCT00113269|585801763|FG001|Overall Study|Not transplanted, donor issues|0|||
162204788|NCT00113269|585801764|FG002|Overall Study|Not transplanted, donor issues|2|||
162204789|NCT00113269|585801765|FG003|Overall Study|Not transplanted, donor issues|2|||
162204790|NCT00113269|585801762|FG000|Overall Study|Not transplanted, recipient issues|2|||
162204791|NCT00113269|585801763|FG001|Overall Study|Not transplanted, recipient issues|1|||
162204792|NCT00113269|585801764|FG002|Overall Study|Not transplanted, recipient issues|7|||
162204793|NCT00113269|585801765|FG003|Overall Study|Not transplanted, recipient issues|4|||
162204794|NCT00113269|585801762|FG000|Overall Study|Early graft loss, technical|0|||
162204795|NCT00113269|585801763|FG001|Overall Study|Early graft loss, technical|0|||
162204796|NCT00113269|585801764|FG002|Overall Study|Early graft loss, technical|2|||
162204797|NCT00113269|585801765|FG003|Overall Study|Early graft loss, technical|0|||
162204798|NCT00113269|585801762|FG000|Overall Study|Death in operating room|0|||
162204799|NCT00113269|585801763|FG001|Overall Study|Death in operating room|0|||
162204800|NCT00113269|585801764|FG002|Overall Study|Death in operating room|0|||
161932407|NCT00159874|584800467|FG005|Overall Study|Lost to Follow-up|2|||
161932408|NCT00159874|584800468|FG006|Overall Study|Lost to Follow-up|1|||
161932409|NCT00159874|584800462|FG000|Overall Study|Other|8|||
161932410|NCT00159874|584800463|FG001|Overall Study|Other|8|||
161932411|NCT00159874|584800464|FG002|Overall Study|Other|8|||
161932412|NCT00159874|584800465|FG003|Overall Study|Other|0|||
162204801|NCT00113269|585801765|FG003|Overall Study|Death in operating room|1|||
162204802|NCT00113269|585801762|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
162204803|NCT00113269|585801763|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
162204804|NCT00113269|585801764|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
162204805|NCT00113269|585801765|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
162204806|NCT00113269|585801762|FG000|Overall Study|Adverse Event|2|||
162204807|NCT00113269|585801763|FG001|Overall Study|Adverse Event|7|||
162204808|NCT00113269|585801764|FG002|Overall Study|Adverse Event|11|||
162204809|NCT00113269|585801765|FG003|Overall Study|Adverse Event|7|||
162204810|NCT00113269|585801762|FG000|Overall Study|Withdrawal by Subject|4|||
162204811|NCT00113269|585801763|FG001|Overall Study|Withdrawal by Subject|3|||
162204812|NCT00113269|585801764|FG002|Overall Study|Withdrawal by Subject|4|||
162204813|NCT00113269|585801765|FG003|Overall Study|Withdrawal by Subject|2|||
162204814|NCT00113269|585801762|FG000|Overall Study|Graft loss|6|||
162204815|NCT00113269|585801763|FG001|Overall Study|Graft loss|6|||
162204816|NCT00113269|585801764|FG002|Overall Study|Graft loss|4|||
162204817|NCT00113269|585801765|FG003|Overall Study|Graft loss|9|||
162204818|NCT00113269|585801762|FG000|Overall Study|Protocol Violation|1|||
162204819|NCT00113269|585801763|FG001|Overall Study|Protocol Violation|0|||
162204820|NCT00113269|585801764|FG002|Overall Study|Protocol Violation|4|||
162204821|NCT00113269|585801765|FG003|Overall Study|Protocol Violation|2|||
162204822|NCT00113269|585801762|FG000|Overall Study|Lost to Follow-up|2|||
162204823|NCT00113269|585801763|FG001|Overall Study|Lost to Follow-up|3|||
162204824|NCT00113269|585801764|FG002|Overall Study|Lost to Follow-up|6|||
162204825|NCT00113269|585801765|FG003|Overall Study|Lost to Follow-up|3|||
162204826|NCT00113269|585801762|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
162204827|NCT00113269|585801763|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
162204828|NCT00113269|585801764|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
162204829|NCT00113269|585801765|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
162204830|NCT00113269|585801762|FG000|Overall Study|Discontinued due to rejection|0|||
162204831|NCT00113269|585801763|FG001|Overall Study|Discontinued due to rejection|0|||
162204832|NCT00113269|585801764|FG002|Overall Study|Discontinued due to rejection|1|||
162204833|NCT00113269|585801765|FG003|Overall Study|Discontinued due to rejection|0|||
162204834|NCT00113269|585801762|FG000|Overall Study|Moved|0|||
162204835|NCT00113269|585801763|FG001|Overall Study|Moved|1|||
162204836|NCT00113269|585801764|FG002|Overall Study|Moved|0|||
162204837|NCT00113269|585801765|FG003|Overall Study|Moved|3|||
162204838|NCT00113269|585801762|FG000|Overall Study|Received pancreas transplant|0|||
162204839|NCT00113269|585801763|FG001|Overall Study|Received pancreas transplant|0|||
162204840|NCT00113269|585801764|FG002|Overall Study|Received pancreas transplant|0|||
162204841|NCT00113269|585801765|FG003|Overall Study|Received pancreas transplant|2|||
162204842|NCT00113269|585801762|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
162204843|NCT00113269|585801763|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
162204844|NCT00113269|585801764|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
162204845|NCT00113269|585801765|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
162204846|NCT00113269|585801762|FG000|Overall Study|Did not meet eligibility criteria|1|||
162204847|NCT00113269|585801763|FG001|Overall Study|Did not meet eligibility criteria|0|||
162204848|NCT00113269|585801764|FG002|Overall Study|Did not meet eligibility criteria|0|||
162204849|NCT00113269|585801765|FG003|Overall Study|Did not meet eligibility criteria|1|||
162204850|NCT00113269|585801762|FG000|Overall Study|Unable to return for follow up|2|||
162204851|NCT00113269|585801763|FG001|Overall Study|Unable to return for follow up|1|||
162204852|NCT00113269|585801764|FG002|Overall Study|Unable to return for follow up|0|||
162204853|NCT00113269|585801765|FG003|Overall Study|Unable to return for follow up|0|||
162204854|NCT03864341|585801769|FG000|Overall Study|Withdrawal by Subject|1|||
162204855|NCT01066936|585801770|FG000|Overall Study|Death|2|||
162204856|NCT01066936|585801770|FG000|Overall Study|Device revised/removed|1|||
162204857|NCT01066936|585801770|FG000|Overall Study|Lost to Follow-up|3|||
162204858|NCT01066936|585801770|FG000|Overall Study|Withdrawal by Subject|4|||
162204859|NCT01904136|585801771|FG000|Overall Study|Physician Decision|0|||
162204860|NCT01904136|585801772|FG001|Overall Study|Physician Decision|0|||
162204861|NCT01904136|585801773|FG002|Overall Study|Physician Decision|0|||
162204862|NCT01904136|585801774|FG003|Overall Study|Physician Decision|0|||
162204863|NCT01904136|585801775|FG004|Overall Study|Physician Decision|0|||
162204864|NCT01904136|585801776|FG005|Overall Study|Physician Decision|1|||
162204865|NCT01904136|585801777|FG006|Overall Study|Physician Decision|0|||
162204866|NCT01904136|585801778|FG007|Overall Study|Physician Decision|0|||
162204867|NCT01904136|585801779|FG008|Overall Study|Physician Decision|0|||
162204868|NCT00853372|585801780|FG000|Overall Study|Death|30|||
162204869|NCT00853372|585801781|FG001|Overall Study|Death|26|||
162204870|NCT00853372|585801780|FG000|Overall Study|Lost to Follow-up|1|||
162204871|NCT00853372|585801781|FG001|Overall Study|Lost to Follow-up|2|||
162204872|NCT00853372|585801780|FG000|Overall Study|Full Consent Withdrawn|1|||
162204873|NCT00853372|585801781|FG001|Overall Study|Full Consent Withdrawn|1|||
162204874|NCT01580995|585801782|FG000|Overall Study|Lost to Follow-up|2|||
162204875|NCT01580995|585801783|FG001|Overall Study|Lost to Follow-up|2|||
162204876|NCT02517528|585801785|FG000|Overall Study|Withdrawal by Subject|1|||
161932413|NCT00159874|584800466|FG004|Overall Study|Other|2|||
161932414|NCT00159874|584800467|FG005|Overall Study|Other|1|||
161932415|NCT00159874|584800468|FG006|Overall Study|Other|3|||
161932416|NCT00159874|584800462|FG000|Overall Study|Protocol Violation|0|||
162204877|NCT02202109|585801789|FG000|Overall Study|Lost to Follow-up|88|||
162204878|NCT02202109|585801790|FG001|Overall Study|Lost to Follow-up|87|||
162204879|NCT02202109|585801789|FG000|Overall Study|Withdrawal by Subject|2|||
162204880|NCT02202109|585801790|FG001|Overall Study|Withdrawal by Subject|0|||
162204881|NCT01268098|585801793|FG000|Overall Study|Adverse Event|1|||
162204882|NCT01268098|585801794|FG001|Overall Study|Adverse Event|0|||
162204883|NCT04156399|585801801|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
162204884|NCT04156399|585801801|FG000|Overall Study|study suspension due to COVID pandemic|3|||
162204885|NCT01703845|585801802|FG000|Overall Study|Adverse Event|1|||
162204886|NCT01703845|585801803|FG001|Overall Study|Adverse Event|0|||
162204887|NCT01703845|585801802|FG000|Overall Study|Protocol Violation|1|||
162204888|NCT01703845|585801803|FG001|Overall Study|Protocol Violation|0|||
162204889|NCT01703845|585801802|FG000|Overall Study|other than stated above|1|||
162204890|NCT01703845|585801803|FG001|Overall Study|other than stated above|0|||
162204891|NCT03418493|585801808|FG000|Overall Study|Adverse Event|1|||
162204892|NCT03418493|585801809|FG001|Overall Study|Adverse Event|0|||
162204893|NCT03418493|585801810|FG002|Overall Study|Adverse Event|0|||
162204894|NCT03418493|585801811|FG003|Overall Study|Adverse Event|0|||
162204895|NCT03418493|585801812|FG004|Overall Study|Adverse Event|0|||
162204896|NCT03418493|585801813|FG005|Overall Study|Adverse Event|0|||
162204897|NCT03418493|585801814|FG006|Overall Study|Adverse Event|0|||
162204898|NCT03418493|585801815|FG007|Overall Study|Adverse Event|0|||
162204899|NCT03418493|585801816|FG008|Overall Study|Adverse Event|0|||
162204900|NCT03418493|585801817|FG009|Overall Study|Adverse Event|0|||
162204901|NCT03418493|585801818|FG010|Overall Study|Adverse Event|0|||
162204902|NCT03418493|585801808|FG000|Overall Study|Protocol Violation|0|||
162204903|NCT03418493|585801809|FG001|Overall Study|Protocol Violation|0|||
162204904|NCT03418493|585801810|FG002|Overall Study|Protocol Violation|0|||
162204905|NCT03418493|585801811|FG003|Overall Study|Protocol Violation|0|||
162204906|NCT03418493|585801812|FG004|Overall Study|Protocol Violation|0|||
162204907|NCT03418493|585801813|FG005|Overall Study|Protocol Violation|0|||
162204908|NCT03418493|585801814|FG006|Overall Study|Protocol Violation|0|||
162204909|NCT03418493|585801815|FG007|Overall Study|Protocol Violation|0|||
162204910|NCT03418493|585801816|FG008|Overall Study|Protocol Violation|0|||
162204911|NCT03418493|585801817|FG009|Overall Study|Protocol Violation|1|||
162204912|NCT03418493|585801818|FG010|Overall Study|Protocol Violation|0|||
162204913|NCT00719212|585801819|FG000|Overall Study|Death|41|||
162204914|NCT00719212|585801819|FG000|Overall Study|Lost to Follow-up|2|||
162204915|NCT00719212|585801819|FG000|Overall Study|Withdrawal by Subject|1|||
162204916|NCT04140266|585801821|FG000|Overall Study|Physician Decision|2|||
162204917|NCT04140266|585801822|FG001|Overall Study|Physician Decision|0|||
162204918|NCT04140266|585801821|FG000|Overall Study|Withdrawal by Subject|4|||
162204919|NCT04140266|585801822|FG001|Overall Study|Withdrawal by Subject|2|||
162204920|NCT00943618|585801823|FG000|Overall Study|Lost to Follow-up|38|||
162204921|NCT00943618|585801824|FG001|Overall Study|Lost to Follow-up|48|||
162204922|NCT00943618|585801825|FG002|Overall Study|Lost to Follow-up|20|||
162204923|NCT00943618|585801823|FG000|Overall Study|Discontinued Medication|17|||
162204924|NCT00943618|585801824|FG001|Overall Study|Discontinued Medication|29|||
162204925|NCT00943618|585801825|FG002|Overall Study|Discontinued Medication|11|||
162204926|NCT02637856|585801831|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
162204927|NCT02637856|585801832|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
162204928|NCT02637856|585801831|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
162204929|NCT02637856|585801832|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
162204930|NCT02637856|585801831|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
162204931|NCT02637856|585801832|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
162204932|NCT02637856|585801831|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
162204933|NCT02637856|585801832|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
162204934|NCT02637856|585801831|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
162204935|NCT02637856|585801832|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
162204936|NCT02637856|585801831|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
162204937|NCT02637856|585801832|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
161932417|NCT00159874|584800463|FG001|Overall Study|Protocol Violation|5|||
162204938|NCT02637856|585801831|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
162204939|NCT02637856|585801832|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
162204940|NCT02637856|585801831|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
162204941|NCT02637856|585801832|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
162204942|NCT02637856|585801831|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
162204943|NCT02637856|585801832|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
162204944|NCT02637856|585801831|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
162204945|NCT02637856|585801832|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
162204946|NCT02637856|585801831|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
162204947|NCT02637856|585801832|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
162204948|NCT02637856|585801831|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
162204949|NCT02637856|585801832|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
162204950|NCT02637856|585801831|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
162204951|NCT02637856|585801832|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
162204952|NCT01402063|585801833|FG000|Overall Study|Withdrawal by Subject|3|||
162204953|NCT01402063|585801834|FG001|Overall Study|Withdrawal by Subject|3|||
162204954|NCT02166047|585801835|FG000|Overall Study|Withdrawal by Participant|0|||
162204955|NCT02166047|585801836|FG001|Overall Study|Withdrawal by Participant|1|||
162204956|NCT02166047|585801837|FG002|Overall Study|Withdrawal by Participant|2|||
162204957|NCT02166047|585801838|FG003|Overall Study|Withdrawal by Participant|0|||
162204958|NCT02166047|585801839|FG004|Overall Study|Withdrawal by Participant|0|||
162204959|NCT02166047|585801840|FG005|Overall Study|Withdrawal by Participant|0|||
162204960|NCT02166047|585801841|FG006|Overall Study|Withdrawal by Participant|1|||
162204961|NCT02166047|585801842|FG007|Overall Study|Withdrawal by Participant|0|||
162204962|NCT02166047|585801843|FG008|Overall Study|Withdrawal by Participant|0|||
162204963|NCT02166047|585801844|FG009|Overall Study|Withdrawal by Participant|0|||
162204964|NCT02166047|585801845|FG010|Overall Study|Withdrawal by Participant|0|||
162204965|NCT02166047|585801846|FG011|Overall Study|Withdrawal by Participant|0|||
162204966|NCT02166047|585801835|FG000|Overall Study|Adverse Event|0|||
162204967|NCT02166047|585801836|FG001|Overall Study|Adverse Event|0|||
162204968|NCT02166047|585801837|FG002|Overall Study|Adverse Event|0|||
162204969|NCT02166047|585801838|FG003|Overall Study|Adverse Event|0|||
162204970|NCT02166047|585801839|FG004|Overall Study|Adverse Event|1|||
162204971|NCT02166047|585801840|FG005|Overall Study|Adverse Event|0|||
162204972|NCT02166047|585801841|FG006|Overall Study|Adverse Event|1|||
162204973|NCT02166047|585801842|FG007|Overall Study|Adverse Event|0|||
162204974|NCT02166047|585801843|FG008|Overall Study|Adverse Event|0|||
162204975|NCT02166047|585801844|FG009|Overall Study|Adverse Event|0|||
162204976|NCT02166047|585801845|FG010|Overall Study|Adverse Event|2|||
162204977|NCT02166047|585801846|FG011|Overall Study|Adverse Event|0|||
162204978|NCT00451555|585801851|FG000|Overall Study|Protocol Violation|2|||
162204979|NCT00451555|585801852|FG001|Overall Study|Protocol Violation|2|||
162204980|NCT00451555|585801851|FG000|Overall Study|Adverse Event|3|||
162204981|NCT00451555|585801852|FG001|Overall Study|Adverse Event|1|||
162204982|NCT00451555|585801851|FG000|Overall Study|Withdrawal by Subject|6|||
162204983|NCT00451555|585801852|FG001|Overall Study|Withdrawal by Subject|0|||
162204984|NCT00451555|585801851|FG000|Overall Study|Physician Decision|2|||
162204985|NCT00451555|585801852|FG001|Overall Study|Physician Decision|1|||
162204986|NCT01388478|585801859|FG000|Overall Study|Adverse Event|4|||
162204987|NCT01388478|585801859|FG000|Overall Study|Withdrawal by Subject|1|||
162204988|NCT01990664|585801860|FG000|Overall Study|Lost to Follow-up|2|||
161932418|NCT00159874|584800464|FG002|Overall Study|Protocol Violation|2|||
162204989|NCT01990664|585801861|FG001|Overall Study|Lost to Follow-up|6|||
162204990|NCT01990664|585801860|FG000|Overall Study|Withdrawal by Subject|2|||
162204991|NCT01990664|585801861|FG001|Overall Study|Withdrawal by Subject|3|||
162204992|NCT01990664|585801860|FG000|Overall Study|Protocol Violation|1|||
162204993|NCT01990664|585801861|FG001|Overall Study|Protocol Violation|0|||
162204994|NCT01990664|585801860|FG000|Overall Study|Lens Discomfort|1|||
162204995|NCT01990664|585801861|FG001|Overall Study|Lens Discomfort|1|||
162204996|NCT01990664|585801860|FG000|Overall Study|Lens Handling Difficulties|1|||
162204997|NCT01990664|585801861|FG001|Overall Study|Lens Handling Difficulties|0|||
162204998|NCT01990664|585801860|FG000|Overall Study|Unsatisfactory Visual Response|0|||
162204999|NCT01990664|585801861|FG001|Overall Study|Unsatisfactory Visual Response|1|||
162205000|NCT00619983|585801862|FG000|Test Drug Alone|Withdrawal by Subject|1|||
162205001|NCT00619983|585801863|FG001|Test Drug Alone|Withdrawal by Subject|0|||
162205002|NCT00619983|585801864|FG002|Test Drug Alone|Withdrawal by Subject|0|||
162205003|NCT00619983|585801865|FG003|Test Drug Alone|Withdrawal by Subject|1|||
162205004|NCT00619983|585801862|FG000|Test Drug Alone|Failure of daily diary device|1|||
162205005|NCT00619983|585801863|FG001|Test Drug Alone|Failure of daily diary device|1|||
162205006|NCT00619983|585801864|FG002|Test Drug Alone|Failure of daily diary device|2|||
162205007|NCT00619983|585801865|FG003|Test Drug Alone|Failure of daily diary device|2|||
162205008|NCT00297778|585801867|FG000|Overall Study|Adverse Event|16|||
162205009|NCT00297778|585801868|FG001|Overall Study|Adverse Event|10|||
161677443|NCT00467779|583872012|FG012|Stage 2A|Unspecified Reason|0|||
162205010|NCT00297778|585801867|FG000|Overall Study|Withdrawal by Subject|1|||
162205011|NCT00297778|585801868|FG001|Overall Study|Withdrawal by Subject|5|||
162205012|NCT00297778|585801867|FG000|Overall Study|Lack of Efficacy|2|||
162205013|NCT00297778|585801868|FG001|Overall Study|Lack of Efficacy|1|||
162205014|NCT00297778|585801867|FG000|Overall Study|Non-compliant with trial protocol|0|||
162205015|NCT00297778|585801868|FG001|Overall Study|Non-compliant with trial protocol|3|||
162205016|NCT00297778|585801867|FG000|Overall Study|Other|0|||
162205017|NCT00297778|585801868|FG001|Overall Study|Other|1|||
162205018|NCT02551692|585801876|FG000|Overall Study|Lost to Follow-up|0|||
162205019|NCT02551692|585801877|FG001|Overall Study|Lost to Follow-up|1|||
162205020|NCT02551692|585801878|FG002|Overall Study|Lost to Follow-up|4|||
162205021|NCT02551692|585801876|FG000|Overall Study|Withdrawal by Subject|1|||
162205022|NCT02551692|585801877|FG001|Overall Study|Withdrawal by Subject|0|||
162205023|NCT02551692|585801878|FG002|Overall Study|Withdrawal by Subject|1|||
162205024|NCT02965599|585801879|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
162205025|NCT02965599|585801880|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
162205026|NCT00230971|585801881|FG000|Randomization|No study drug administered|3|||
162205027|NCT00230971|585801882|FG001|Randomization|No study drug administered|3|||
162205028|NCT00230971|585801881|FG000|Baseline Participants|Lost to Follow-up|5|||
162205029|NCT00230971|585801882|FG001|Baseline Participants|Lost to Follow-up|12|||
162205030|NCT00230971|585801881|FG000|Baseline Participants|Death|6|||
162205031|NCT00230971|585801882|FG001|Baseline Participants|Death|5|||
162205032|NCT00230971|585801881|FG000|Baseline Participants|Withdrawal by Subject|7|||
162205033|NCT00230971|585801882|FG001|Baseline Participants|Withdrawal by Subject|1|||
162205034|NCT00230971|585801881|FG000|Baseline Participants|Adverse Event|1|||
162205035|NCT00230971|585801882|FG001|Baseline Participants|Adverse Event|0|||
162205036|NCT00230971|585801881|FG000|Baseline Participants|No bacteria observed|1|||
162205037|NCT00230971|585801882|FG001|Baseline Participants|No bacteria observed|0|||
162205038|NCT00230971|585801881|FG000|Baseline Participants|Failure to return|1|||
162205039|NCT00230971|585801882|FG001|Baseline Participants|Failure to return|1|||
162205040|NCT00230971|585801881|FG000|Baseline Participants|Reintervention|1|||
162205041|NCT00230971|585801882|FG001|Baseline Participants|Reintervention|0|||
162205042|NCT04267393|585801889|FG000|Randomization|Adverse Event|1|||
162205043|NCT04267393|585801890|FG001|Randomization|Adverse Event|0|||
162205044|NCT04267393|585801891|FG002|Randomization|Adverse Event|0|||
162205045|NCT04267393|585801889|FG000|Randomization|Administrative Reasons by Sponsor|0|||
162205046|NCT04267393|585801890|FG001|Randomization|Administrative Reasons by Sponsor|1|||
162205047|NCT04267393|585801891|FG002|Randomization|Administrative Reasons by Sponsor|0|||
162205048|NCT04267393|585801889|FG000|Treatment Period|Adverse Event|0|||
162205049|NCT04267393|585801890|FG001|Treatment Period|Adverse Event|2|||
162205050|NCT04267393|585801891|FG002|Treatment Period|Adverse Event|3|||
162205051|NCT04267393|585801889|FG000|Treatment Period|Participant Withdrew Consent|0|||
162205052|NCT04267393|585801890|FG001|Treatment Period|Participant Withdrew Consent|0|||
162205053|NCT04267393|585801891|FG002|Treatment Period|Participant Withdrew Consent|1|||
162205054|NCT04267393|585801889|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
162205055|NCT04267393|585801890|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
162205056|NCT04267393|585801891|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
162205057|NCT02799745|585801892|FG000|Overall Study|Participant moved out of state|1|||
162205058|NCT02799745|585801893|FG001|Overall Study|Participant moved out of state|0|||
162205059|NCT02799745|585801892|FG000|Overall Study|Discontinued due to planned surgery|1|||
162205060|NCT02799745|585801893|FG001|Overall Study|Discontinued due to planned surgery|0|||
162205061|NCT02799745|585801892|FG000|Overall Study|Withdrawal by Subject|16|||
162205062|NCT02799745|585801893|FG001|Overall Study|Withdrawal by Subject|25|||
162205063|NCT02799745|585801892|FG000|Overall Study|Protocol Deviation|4|||
162205064|NCT02799745|585801893|FG001|Overall Study|Protocol Deviation|5|||
162205065|NCT02799745|585801892|FG000|Overall Study|Progressive Disease|28|||
162205066|NCT02799745|585801893|FG001|Overall Study|Progressive Disease|38|||
162205067|NCT02799745|585801892|FG000|Overall Study|Lost to Follow-up|3|||
162205068|NCT02799745|585801893|FG001|Overall Study|Lost to Follow-up|2|||
162205069|NCT02799745|585801892|FG000|Overall Study|Death|3|||
162205070|NCT02799745|585801893|FG001|Overall Study|Death|0|||
162205071|NCT02799745|585801892|FG000|Overall Study|Adverse Event|0|||
162205072|NCT02799745|585801893|FG001|Overall Study|Adverse Event|1|||
162205073|NCT01726049|585803684|FG000|Overall Study|Death|1|||
162205074|NCT01726049|585803685|FG001|Overall Study|Death|1|||
162205075|NCT01726049|585803684|FG000|Overall Study|Adverse Event|4|||
162205076|NCT01726049|585803685|FG001|Overall Study|Adverse Event|1|||
162205077|NCT01726049|585803684|FG000|Overall Study|refused second HC|0|||
162205078|NCT01726049|585803685|FG001|Overall Study|refused second HC|2|||
162205079|NCT01222533|585803687|FG000|Overall Study|Adverse Event|5|||
162205080|NCT01222533|585803687|FG000|Overall Study|Withdrawal by Subject|5|||
162205081|NCT01222533|585803687|FG000|Overall Study|Other|4|||
162205082|NCT03834623|585803688|FG000|Overall Study|Progression|0|||
161824382|NCT00857818|584397976|FG000|Overall Study|Withdrawal by Subject|0|||
161824383|NCT00857818|584397977|FG001|Overall Study|Withdrawal by Subject|4|||
161824384|NCT00857818|584397976|FG000|Overall Study|Sponsor terminated study|6|||
161824385|NCT00857818|584397977|FG001|Overall Study|Sponsor terminated study|4|||
161932419|NCT00159874|584800465|FG003|Overall Study|Protocol Violation|0|||
162205083|NCT03834623|585803689|FG001|Overall Study|Progression|1|||
162205084|NCT01947517|585803690|FG000|Overall Study|Withdrawal by Subject|1|||
162205085|NCT01947517|585803691|FG001|Overall Study|Withdrawal by Subject|1|||
162205086|NCT00460564|585803692|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
162205087|NCT00460564|585803693|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
162205088|NCT00460564|585803694|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
162205089|NCT00460564|585803695|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
162205090|NCT00460564|585803696|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
162205091|NCT00460564|585803697|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
162205092|NCT00460564|585803698|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
162205093|NCT00460564|585803699|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
162205094|NCT00460564|585803692|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
162205095|NCT00460564|585803693|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162205096|NCT00460564|585803694|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162205097|NCT00460564|585803695|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162205098|NCT00460564|585803696|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162205099|NCT00460564|585803697|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162205100|NCT00460564|585803698|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162205101|NCT00460564|585803699|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
162205102|NCT00460564|585803692|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
162205103|NCT00460564|585803693|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
162205104|NCT00460564|585803694|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
162205105|NCT00460564|585803695|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
162205106|NCT00460564|585803696|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
162205107|NCT00460564|585803697|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
162205108|NCT00460564|585803698|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
162205109|NCT00460564|585803699|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
162205110|NCT00460564|585803692|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
162205111|NCT00460564|585803693|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
162205112|NCT00460564|585803694|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
162205113|NCT00460564|585803695|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
162205114|NCT00460564|585803696|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
162205115|NCT00460564|585803697|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
162205116|NCT00460564|585803698|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
162205117|NCT00460564|585803699|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
162205118|NCT00460564|585803692|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161677444|NCT00467779|583872013|FG013|Stage 2A|Unspecified Reason|7|||
161677445|NCT00467779|583872014|FG014|Stage 2A|Unspecified Reason|0|||
161677446|NCT00467779|583872000|FG000|Stage 2A|Withdrawal by Subject|0|||
161677447|NCT00467779|583872001|FG001|Stage 2A|Withdrawal by Subject|0|||
161677448|NCT00467779|583872002|FG002|Stage 2A|Withdrawal by Subject|0|||
161677449|NCT00467779|583872003|FG003|Stage 2A|Withdrawal by Subject|0|||
161677450|NCT00467779|583872004|FG004|Stage 2A|Withdrawal by Subject|0|||
161677451|NCT00467779|583872005|FG005|Stage 2A|Withdrawal by Subject|0|||
161677452|NCT00467779|583872006|FG006|Stage 2A|Withdrawal by Subject|0|||
161677453|NCT00467779|583872007|FG007|Stage 2A|Withdrawal by Subject|0|||
161677454|NCT00467779|583872008|FG008|Stage 2A|Withdrawal by Subject|0|||
161677455|NCT00467779|583872009|FG009|Stage 2A|Withdrawal by Subject|0|||
161677456|NCT00467779|583872010|FG010|Stage 2A|Withdrawal by Subject|0|||
161677457|NCT00467779|583872011|FG011|Stage 2A|Withdrawal by Subject|0|||
161677458|NCT00467779|583872012|FG012|Stage 2A|Withdrawal by Subject|0|||
161677459|NCT00467779|583872013|FG013|Stage 2A|Withdrawal by Subject|1|||
161677460|NCT00467779|583872014|FG014|Stage 2A|Withdrawal by Subject|0|||
161677461|NCT00467779|583872000|FG000|Stage 3|Adverse Event|0|||
161677462|NCT00467779|583872001|FG001|Stage 3|Adverse Event|0|||
161677463|NCT00467779|583872002|FG002|Stage 3|Adverse Event|0|||
161677464|NCT00467779|583872003|FG003|Stage 3|Adverse Event|0|||
161677465|NCT00467779|583872004|FG004|Stage 3|Adverse Event|0|||
161677466|NCT00467779|583872005|FG005|Stage 3|Adverse Event|0|||
161677467|NCT00467779|583872006|FG006|Stage 3|Adverse Event|0|||
161677468|NCT00467779|583872007|FG007|Stage 3|Adverse Event|0|||
161677469|NCT00467779|583872008|FG008|Stage 3|Adverse Event|0|||
161677470|NCT00467779|583872009|FG009|Stage 3|Adverse Event|0|||
162205119|NCT00460564|585803693|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162205120|NCT00460564|585803694|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162205121|NCT00460564|585803695|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162205122|NCT00460564|585803696|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
162205123|NCT00460564|585803697|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162205124|NCT00460564|585803698|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162205125|NCT00460564|585803699|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
162205126|NCT03226106|585803705|FG000|Overall Study|Withdrawal by Subject|2|||
162205127|NCT03226106|585803706|FG001|Overall Study|Withdrawal by Subject|0|||
162205128|NCT03226106|585803705|FG000|Overall Study|Adverse Event|1|||
162205129|NCT03226106|585803706|FG001|Overall Study|Adverse Event|0|||
162205130|NCT03226106|585803705|FG000|Overall Study|Lost to Follow-up|2|||
162205131|NCT03226106|585803706|FG001|Overall Study|Lost to Follow-up|0|||
162205132|NCT04349644|585803707|FG000|Allocation/Pretest|Lost to pretest|0|||
162205133|NCT04349644|585803708|FG001|Allocation/Pretest|Lost to pretest|3|||
161677471|NCT00467779|583872010|FG010|Stage 3|Adverse Event|0|||
161677472|NCT00467779|583872011|FG011|Stage 3|Adverse Event|0|||
161677473|NCT00467779|583872012|FG012|Stage 3|Adverse Event|0|||
161677474|NCT00467779|583872013|FG013|Stage 3|Adverse Event|0|||
161677475|NCT00467779|583872014|FG014|Stage 3|Adverse Event|2|||
162205134|NCT04349644|585803707|FG000|Posttest|Lost to posttest|0|||
162205135|NCT04349644|585803708|FG001|Posttest|Lost to posttest|8|||
162205136|NCT04349644|585803707|FG000|Posttest|Discontinued intervention|6|||
162205137|NCT04349644|585803708|FG001|Posttest|Discontinued intervention|0|||
162205138|NCT04349644|585803707|FG000|Follow-up|Lost to Follow-up|0|||
162205139|NCT04349644|585803708|FG001|Follow-up|Lost to Follow-up|2|||
162205140|NCT01084239|585803709|FG000|28-Day Follow-up|Lost to Follow-up|4|||
162205141|NCT01084239|585803710|FG001|28-Day Follow-up|Lost to Follow-up|9|||
162205142|NCT05006417|585803711|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
162205143|NCT04238520|585803712|FG000|Overall Study|Withdrawal by Subject|1|||
162205144|NCT04238520|585803713|FG001|Overall Study|Withdrawal by Subject|1|||
162205145|NCT04238520|585803712|FG000|Overall Study|Lost to Follow-up|1|||
162205146|NCT04238520|585803713|FG001|Overall Study|Lost to Follow-up|2|||
162205147|NCT04238520|585803712|FG000|Overall Study|Death|0|||
162205148|NCT04238520|585803713|FG001|Overall Study|Death|2|||
162205149|NCT04238520|585803712|FG000|Overall Study|Unsafe home environment for research staff|0|||
162205150|NCT04238520|585803713|FG001|Overall Study|Unsafe home environment for research staff|1|||
162205151|NCT01470599|585803714|FG000|Overall Study|Did not meet entrance criteria|1|||
162205152|NCT01470599|585803715|FG001|Overall Study|Did not meet entrance criteria|0|||
162205153|NCT01470599|585803714|FG000|Overall Study|Lost to Follow-up|2|||
162205154|NCT01470599|585803715|FG001|Overall Study|Lost to Follow-up|1|||
162205155|NCT01470599|585803714|FG000|Overall Study|Withdrawal by Subject|3|||
162205156|NCT01470599|585803715|FG001|Overall Study|Withdrawal by Subject|4|||
162205157|NCT01470599|585803714|FG000|Overall Study|Other|1|||
162205158|NCT01470599|585803715|FG001|Overall Study|Other|0|||
162205159|NCT01470599|585803714|FG000|Overall Study|Protocol Violation|3|||
162205160|NCT01470599|585803715|FG001|Overall Study|Protocol Violation|1|||
162205161|NCT01470599|585803714|FG000|Overall Study|Adverse event related to study drug|2|||
162205162|NCT01470599|585803715|FG001|Overall Study|Adverse event related to study drug|5|||
162205163|NCT01470599|585803714|FG000|Overall Study|Insufficient clinical response|6|||
162205164|NCT01470599|585803715|FG001|Overall Study|Insufficient clinical response|27|||
162205165|NCT01470599|585803714|FG000|Overall Study|Adverse event not related to study drug|1|||
162205166|NCT01470599|585803715|FG001|Overall Study|Adverse event not related to study drug|5|||
162205167|NCT00195442|585803716|FG000|Overall Study|Less than expected therapeutic effect|38|||
162205168|NCT00195442|585803716|FG000|Overall Study|Lost to Follow-up|27|||
162205169|NCT00195442|585803716|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
162205170|NCT00195442|585803716|FG000|Overall Study|Intermittent product shortage|21|||
162205171|NCT00195442|585803716|FG000|Overall Study|Death|7|||
162205172|NCT00195442|585803716|FG000|Overall Study|No reason specified|4|||
162205173|NCT00195442|585803716|FG000|Overall Study|Poor cooperation|2|||
162205174|NCT00195442|585803716|FG000|Overall Study|Other|14|||
162205175|NCT01917006|585803717|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
162205176|NCT01917006|585803718|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
162205177|NCT01917006|585803719|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
162205178|NCT01917006|585803720|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
162205179|NCT01917006|585803721|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
162205180|NCT01917006|585803722|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
162205181|NCT01917006|585803723|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
162205182|NCT01917006|585803724|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
162205183|NCT01917006|585803717|FG000|Randomized-treatment Period|Personal Reasons|0|||
162205184|NCT01917006|585803718|FG001|Randomized-treatment Period|Personal Reasons|0|||
162205185|NCT01917006|585803719|FG002|Randomized-treatment Period|Personal Reasons|0|||
162205186|NCT01917006|585803720|FG003|Randomized-treatment Period|Personal Reasons|0|||
162205187|NCT01917006|585803721|FG004|Randomized-treatment Period|Personal Reasons|0|||
162205188|NCT01917006|585803722|FG005|Randomized-treatment Period|Personal Reasons|1|||
162205189|NCT01917006|585803723|FG006|Randomized-treatment Period|Personal Reasons|0|||
162205190|NCT01917006|585803724|FG007|Randomized-treatment Period|Personal Reasons|0|||
162205191|NCT01917006|585803717|FG000|Randomized-treatment Period|Protocol Violation|1|||
162205192|NCT01917006|585803718|FG001|Randomized-treatment Period|Protocol Violation|0|||
162205193|NCT01917006|585803719|FG002|Randomized-treatment Period|Protocol Violation|0|||
162205194|NCT01917006|585803720|FG003|Randomized-treatment Period|Protocol Violation|0|||
162205195|NCT01917006|585803721|FG004|Randomized-treatment Period|Protocol Violation|0|||
162205196|NCT01917006|585803722|FG005|Randomized-treatment Period|Protocol Violation|0|||
162205197|NCT01917006|585803723|FG006|Randomized-treatment Period|Protocol Violation|0|||
162205198|NCT01917006|585803724|FG007|Randomized-treatment Period|Protocol Violation|0|||
162205199|NCT01917006|585803717|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162205200|NCT01917006|585803718|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162021283|NCT01925131|585134730|FG004|Overall Study|Other - Not Protocol Specified|10|||
162205201|NCT01917006|585803719|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162205202|NCT01917006|585803720|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162205203|NCT01917006|585803721|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162205204|NCT01917006|585803722|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162205205|NCT01917006|585803723|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
162205206|NCT01917006|585803724|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
162205207|NCT01917006|585803717|FG000|Open-label Period|Adverse Event|0|||
162205208|NCT01917006|585803718|FG001|Open-label Period|Adverse Event|0|||
162205209|NCT01917006|585803719|FG002|Open-label Period|Adverse Event|0|||
162205210|NCT01917006|585803720|FG003|Open-label Period|Adverse Event|0|||
162205211|NCT01917006|585803721|FG004|Open-label Period|Adverse Event|0|||
162205212|NCT01917006|585803722|FG005|Open-label Period|Adverse Event|0|||
162205213|NCT01917006|585803723|FG006|Open-label Period|Adverse Event|0|||
162205214|NCT01917006|585803724|FG007|Open-label Period|Adverse Event|1|||
162205215|NCT01917006|585803717|FG000|Open-label Period|Lost to Follow-up|0|||
162205216|NCT01917006|585803718|FG001|Open-label Period|Lost to Follow-up|0|||
162205217|NCT01917006|585803719|FG002|Open-label Period|Lost to Follow-up|0|||
162205218|NCT01917006|585803720|FG003|Open-label Period|Lost to Follow-up|0|||
162205219|NCT01917006|585803721|FG004|Open-label Period|Lost to Follow-up|0|||
162205220|NCT01917006|585803722|FG005|Open-label Period|Lost to Follow-up|0|||
162205221|NCT01917006|585803723|FG006|Open-label Period|Lost to Follow-up|0|||
162205222|NCT01917006|585803724|FG007|Open-label Period|Lost to Follow-up|1|||
162205223|NCT02509312|585803736|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
162205224|NCT02509312|585803737|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
162205225|NCT02509312|585803736|FG000|Overall Study|Obstetrician refusal|0|||
162205226|NCT02509312|585803737|FG001|Overall Study|Obstetrician refusal|1|||
162205227|NCT02509312|585803736|FG000|Overall Study|Patient elected for TOLAC|1|||
162205228|NCT02509312|585803737|FG001|Overall Study|Patient elected for TOLAC|0|||
162205229|NCT02509312|585803736|FG000|Overall Study|Cesarean deemed stat|1|||
162205230|NCT02509312|585803737|FG001|Overall Study|Cesarean deemed stat|0|||
162205231|NCT02509312|585803736|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
162205232|NCT02509312|585803737|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
162205233|NCT00702650|585803738|FG000|Overall Study|Withdrawal by Subject|9|||
162205234|NCT00702650|585803738|FG000|Overall Study|Non-Compliance of Study Drug|3|||
162205235|NCT00702650|585803738|FG000|Overall Study|Lost to Follow-up|2|||
162205236|NCT00702650|585803738|FG000|Overall Study|Non-Compliance with Site Directives|1|||
162205237|NCT00702650|585803738|FG000|Overall Study|Sponsor Request|1|||
162205238|NCT00702650|585803738|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
162205239|NCT00702650|585803738|FG000|Overall Study|Adverse Event|3|||
162205240|NCT01309243|585803739|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
162205241|NCT01309243|585803740|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
162205242|NCT01309243|585803739|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
162205243|NCT01309243|585803740|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
162205244|NCT01309243|585803739|FG000|Randomized Phase Through Week 96|Death|0|||
162205245|NCT01309243|585803740|FG001|Randomized Phase Through Week 96|Death|1|||
162205246|NCT01309243|585803739|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
162205247|NCT01309243|585803740|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
162205248|NCT01309243|585803739|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
162205249|NCT01309243|585803740|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
162205250|NCT01309243|585803739|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
162205251|NCT01309243|585803740|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
162205252|NCT01309243|585803739|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
162205253|NCT01309243|585803740|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
162205254|NCT01309243|585803739|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
162205255|NCT01309243|585803740|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
162205256|NCT01309243|585803739|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
162205257|NCT01309243|585803740|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
162205258|NCT01309243|585803739|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
162205259|NCT01309243|585803740|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
162205260|NCT01309243|585803739|FG000|Extension Phase|Lost to Follow-up|6|||
162205261|NCT01309243|585803740|FG001|Extension Phase|Lost to Follow-up|0|||
162205262|NCT00943722|585803742|FG000|Base Study|Adverse Event|0|||
162205263|NCT00943722|585803743|FG001|Base Study|Adverse Event|0|||
162205264|NCT00943722|585803744|FG002|Base Study|Adverse Event|0|||
162205265|NCT00943722|585803745|FG003|Base Study|Adverse Event|1|||
162205266|NCT00943722|585803746|FG004|Base Study|Adverse Event|0|||
162205267|NCT00943722|585803747|FG005|Base Study|Adverse Event|0|||
162205268|NCT00943722|585803748|FG006|Base Study|Adverse Event|0|||
162205269|NCT00943722|585803742|FG000|Base Study|Lost to Follow-up|12|||
162205270|NCT00943722|585803743|FG001|Base Study|Lost to Follow-up|8|||
162205271|NCT00943722|585803744|FG002|Base Study|Lost to Follow-up|10|||
162205272|NCT00943722|585803745|FG003|Base Study|Lost to Follow-up|8|||
162205273|NCT00943722|585803746|FG004|Base Study|Lost to Follow-up|11|||
162205274|NCT00943722|585803747|FG005|Base Study|Lost to Follow-up|0|||
162205275|NCT00943722|585803748|FG006|Base Study|Lost to Follow-up|0|||
162205276|NCT00943722|585803742|FG000|Base Study|Physician Decision|1|||
162205277|NCT00943722|585803743|FG001|Base Study|Physician Decision|0|||
162205278|NCT00943722|585803744|FG002|Base Study|Physician Decision|0|||
162205279|NCT00943722|585803745|FG003|Base Study|Physician Decision|0|||
162205280|NCT00943722|585803746|FG004|Base Study|Physician Decision|1|||
162205281|NCT00943722|585803747|FG005|Base Study|Physician Decision|0|||
162205282|NCT00943722|585803748|FG006|Base Study|Physician Decision|0|||
162205283|NCT00943722|585803742|FG000|Base Study|Pregnancy|0|||
162205284|NCT00943722|585803743|FG001|Base Study|Pregnancy|0|||
162205285|NCT00943722|585803744|FG002|Base Study|Pregnancy|1|||
162205286|NCT00943722|585803745|FG003|Base Study|Pregnancy|0|||
162205287|NCT00943722|585803746|FG004|Base Study|Pregnancy|2|||
162205288|NCT00943722|585803747|FG005|Base Study|Pregnancy|0|||
162205289|NCT00943722|585803748|FG006|Base Study|Pregnancy|0|||
162205290|NCT00943722|585803742|FG000|Base Study|Protocol Violation|0|||
162205291|NCT00943722|585803743|FG001|Base Study|Protocol Violation|1|||
162205292|NCT00943722|585803744|FG002|Base Study|Protocol Violation|0|||
162205293|NCT00943722|585803745|FG003|Base Study|Protocol Violation|0|||
162205294|NCT00943722|585803746|FG004|Base Study|Protocol Violation|2|||
162205295|NCT00943722|585803747|FG005|Base Study|Protocol Violation|0|||
162205296|NCT00943722|585803748|FG006|Base Study|Protocol Violation|0|||
162205297|NCT00943722|585803742|FG000|Base Study|Withdrawal by Subject|12|||
162205298|NCT00943722|585803743|FG001|Base Study|Withdrawal by Subject|13|||
162205299|NCT00943722|585803744|FG002|Base Study|Withdrawal by Subject|2|||
162205300|NCT00943722|585803745|FG003|Base Study|Withdrawal by Subject|13|||
162205301|NCT00943722|585803746|FG004|Base Study|Withdrawal by Subject|8|||
162205302|NCT00943722|585803747|FG005|Base Study|Withdrawal by Subject|0|||
162205303|NCT00943722|585803748|FG006|Base Study|Withdrawal by Subject|0|||
162205304|NCT00943722|585803742|FG000|Base Study|Month 12 visit not completed|0|||
162205305|NCT00943722|585803743|FG001|Base Study|Month 12 visit not completed|0|||
162205306|NCT00943722|585803744|FG002|Base Study|Month 12 visit not completed|0|||
162205307|NCT00943722|585803745|FG003|Base Study|Month 12 visit not completed|0|||
162205308|NCT00943722|585803746|FG004|Base Study|Month 12 visit not completed|2|||
162205309|NCT00943722|585803747|FG005|Base Study|Month 12 visit not completed|0|||
162205310|NCT00943722|585803748|FG006|Base Study|Month 12 visit not completed|0|||
162205311|NCT00943722|585803742|FG000|First Extension Study: EXT 1|Adverse Event|0|||
162205312|NCT00943722|585803743|FG001|First Extension Study: EXT 1|Adverse Event|0|||
162205313|NCT00943722|585803744|FG002|First Extension Study: EXT 1|Adverse Event|0|||
162205314|NCT00943722|585803745|FG003|First Extension Study: EXT 1|Adverse Event|0|||
162205315|NCT00943722|585803746|FG004|First Extension Study: EXT 1|Adverse Event|0|||
162205316|NCT00943722|585803747|FG005|First Extension Study: EXT 1|Adverse Event|1|||
162205317|NCT00943722|585803748|FG006|First Extension Study: EXT 1|Adverse Event|0|||
162205318|NCT00943722|585803742|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
162205319|NCT00943722|585803743|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
162205320|NCT00943722|585803744|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
162205321|NCT00943722|585803745|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
162205322|NCT00943722|585803746|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
162205323|NCT00943722|585803747|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
162205324|NCT00943722|585803748|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
162205325|NCT00943722|585803742|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
162205326|NCT00943722|585803743|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
162205327|NCT00943722|585803744|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
162205328|NCT00943722|585803745|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
162205329|NCT00943722|585803746|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
162205330|NCT00943722|585803747|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
162205331|NCT00943722|585803748|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
162205332|NCT00943722|585803742|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
162205333|NCT00943722|585803743|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
162205334|NCT00943722|585803744|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
162205335|NCT00943722|585803745|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
162205336|NCT00943722|585803746|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
162205337|NCT00943722|585803747|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
162205338|NCT00943722|585803748|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
162205339|NCT00943722|585803742|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
162205340|NCT00943722|585803743|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
162205341|NCT00943722|585803744|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
162205342|NCT00943722|585803745|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
162205343|NCT00943722|585803746|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
162205344|NCT00943722|585803747|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
162205345|NCT00943722|585803748|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
162205346|NCT00943722|585803742|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
162205347|NCT00943722|585803743|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
162205348|NCT00943722|585803744|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
161932420|NCT00159874|584800466|FG004|Overall Study|Protocol Violation|0|||
161932421|NCT00159874|584800467|FG005|Overall Study|Protocol Violation|0|||
161932422|NCT00159874|584800468|FG006|Overall Study|Protocol Violation|0|||
161932423|NCT00159874|584800462|FG000|Overall Study|Death|3|||
161932424|NCT00159874|584800463|FG001|Overall Study|Death|8|||
162205349|NCT00943722|585803745|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
162205350|NCT00943722|585803746|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
162205351|NCT00943722|585803747|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
162205352|NCT00943722|585803748|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
162205353|NCT00943722|585803742|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
162205354|NCT00943722|585803743|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
162205355|NCT00943722|585803744|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
162205356|NCT00943722|585803745|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
162205357|NCT00943722|585803746|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
162205358|NCT00943722|585803747|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
162205359|NCT00943722|585803748|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
162205360|NCT00943722|585803742|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
162205361|NCT00943722|585803743|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
162205362|NCT00943722|585803744|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
162205363|NCT00943722|585803745|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
162205364|NCT00943722|585803746|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
162205365|NCT00943722|585803747|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
162205366|NCT00943722|585803748|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
162205367|NCT00943722|585803742|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
162205368|NCT00943722|585803743|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
162205369|NCT00943722|585803744|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
162205370|NCT00943722|585803745|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
162205371|NCT00943722|585803746|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
162205372|NCT00943722|585803747|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
162205373|NCT00943722|585803748|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
162205374|NCT01772823|585803749|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
162205375|NCT01772823|585803750|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
162205376|NCT01772823|585803749|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
162205377|NCT01772823|585803750|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
162205378|NCT01772823|585803749|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
162205379|NCT01772823|585803750|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
162205380|NCT01772823|585803749|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
162205381|NCT01772823|585803750|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
162205382|NCT01772823|585803749|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
162205383|NCT01772823|585803750|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
162205384|NCT01772823|585803749|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
162205385|NCT01772823|585803750|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
162205386|NCT01772823|585803749|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
162205387|NCT01772823|585803750|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
162205388|NCT01772823|585803749|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
162205389|NCT01772823|585803750|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
162205390|NCT01772823|585803749|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
162205391|NCT01772823|585803750|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
162205392|NCT01772823|585803749|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
162205393|NCT01772823|585803750|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
162205394|NCT01772823|585803749|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
162205395|NCT01772823|585803750|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
162205396|NCT01772823|585803749|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
162205397|NCT01772823|585803750|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
162205398|NCT01772823|585803749|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
162205399|NCT01772823|585803750|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
162205400|NCT01772823|585803749|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
162205401|NCT01772823|585803750|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
162205402|NCT01772823|585803749|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
162205403|NCT01772823|585803750|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
162205404|NCT01772823|585803749|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
162205405|NCT01772823|585803750|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
162205406|NCT01004185|585803753|FG000|Overall Study|Adverse Event|1|||
161932425|NCT00159874|584800464|FG002|Overall Study|Death|15|||
161932426|NCT00159874|584800465|FG003|Overall Study|Death|0|||
161932427|NCT00159874|584800466|FG004|Overall Study|Death|1|||
161932428|NCT00159874|584800467|FG005|Overall Study|Death|2|||
161824386|NCT00857818|584397976|FG000|Overall Study|Investigator decision|1|||
162021284|NCT01925131|585134731|FG005|Overall Study|Other - Not Protocol Specified|6|||
162205407|NCT01004185|585803754|FG001|Overall Study|Adverse Event|1|||
162205408|NCT01004185|585803753|FG000|Overall Study|Lost to Follow-up|0|||
162205409|NCT01004185|585803754|FG001|Overall Study|Lost to Follow-up|1|||
162205410|NCT01004185|585803753|FG000|Overall Study|Lack of Efficacy|2|||
162205411|NCT01004185|585803754|FG001|Overall Study|Lack of Efficacy|1|||
162205412|NCT01004185|585803753|FG000|Overall Study|Sponsor Terminated Study|4|||
162205413|NCT01004185|585803754|FG001|Overall Study|Sponsor Terminated Study|5|||
162205414|NCT01004185|585803753|FG000|Overall Study|Withdrawal by Subject|2|||
162205415|NCT01004185|585803754|FG001|Overall Study|Withdrawal by Subject|1|||
162205416|NCT01037413|585803755|FG000|Part A: Skin Testing|Adverse Event|1|||
162205417|NCT01037413|585803756|FG001|Part A: Skin Testing|Adverse Event|0|||
162205418|NCT01037413|585803755|FG000|Part A: Skin Testing|Protocol Violation|1|||
162205419|NCT01037413|585803756|FG001|Part A: Skin Testing|Protocol Violation|0|||
162205420|NCT01037413|585803755|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
162205421|NCT01037413|585803756|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
162205422|NCT01037413|585803755|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
162205423|NCT01037413|585803756|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
162205424|NCT02560389|585803761|FG000|Overall Study|Lost to Follow-up|1|||
162205425|NCT02560389|585803762|FG001|Overall Study|Lost to Follow-up|2|||
162205426|NCT02560389|585803763|FG002|Overall Study|Lost to Follow-up|2|||
162205427|NCT02560389|585803761|FG000|Overall Study|Tested positive for illicit substance|0|||
162205428|NCT02560389|585803762|FG001|Overall Study|Tested positive for illicit substance|1|||
162205429|NCT02560389|585803763|FG002|Overall Study|Tested positive for illicit substance|0|||
162205430|NCT02716298|585803764|FG000|First Intervention (1 Month)|Lens discomfort|1|||
162205431|NCT02716298|585803765|FG001|First Intervention (1 Month)|Lens discomfort|1|||
162205432|NCT00713206|585803766|FG000|Overall Study|Lost to Follow-up|4|||
162205433|NCT00713206|585803767|FG001|Overall Study|Lost to Follow-up|4|||
162205434|NCT00713206|585803766|FG000|Overall Study|Death|1|||
162205435|NCT00713206|585803767|FG001|Overall Study|Death|0|||
162205436|NCT01114672|585803770|FG000|Overall Study|Death|0|||
162205437|NCT01114672|585803771|FG001|Overall Study|Death|1|||
162205438|NCT01114672|585803770|FG000|Overall Study|Withdrawal by Subject|2|||
162205439|NCT01114672|585803771|FG001|Overall Study|Withdrawal by Subject|1|||
162205440|NCT01114672|585803770|FG000|Overall Study|Lost to Follow-up|1|||
162205441|NCT01114672|585803771|FG001|Overall Study|Lost to Follow-up|0|||
162205442|NCT01114672|585803770|FG000|Overall Study|transplanted|1|||
162205443|NCT01114672|585803771|FG001|Overall Study|transplanted|0|||
162205444|NCT00827775|585803772|FG000|Overall Study|Withdrawal by Subject|0|||
162205445|NCT00827775|585803773|FG001|Overall Study|Withdrawal by Subject|5|||
162205446|NCT02212301|585803774|FG000|Period 1|Lost to Follow-up|0|||
162205447|NCT02212301|585803775|FG001|Period 1|Lost to Follow-up|1|||
162205448|NCT00866918|585803778|FG000|Overall Study|Death|1|||
162205449|NCT00866918|585803779|FG001|Overall Study|Death|5|||
162205450|NCT00866918|585803778|FG000|Overall Study|Lack of Efficacy|1|||
162205451|NCT00866918|585803779|FG001|Overall Study|Lack of Efficacy|1|||
162205452|NCT00866918|585803778|FG000|Overall Study|Physician Decision|10|||
162205453|NCT00866918|585803779|FG001|Overall Study|Physician Decision|2|||
162205454|NCT00866918|585803778|FG000|Overall Study|Ineligible|2|||
162205455|NCT00866918|585803779|FG001|Overall Study|Ineligible|4|||
162205456|NCT00866918|585803778|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
162205457|NCT00866918|585803779|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
162205458|NCT00866918|585803778|FG000|Overall Study|Secondary malignancy|1|||
162205459|NCT00866918|585803779|FG001|Overall Study|Secondary malignancy|0|||
162205460|NCT00527514|585803781|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
162021285|NCT05091567|585134732|FG000|Enrollment Phase|Death|37|||
162205461|NCT00527514|585803781|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
162205462|NCT00527514|585803781|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
162021286|NCT05091567|585134733|FG001|Enrollment Phase|Death|0|||
162021287|NCT05091567|585134734|FG002|Enrollment Phase|Death|0|||
162205463|NCT00527514|585803781|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
162205464|NCT00527514|585803781|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
162205465|NCT00527514|585803781|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
162021288|NCT05091567|585134732|FG000|Enrollment Phase|Adverse Event|21|||
162205466|NCT00527514|585803781|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
162205467|NCT03041701|585803782|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
162205468|NCT03041701|585803783|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
162021289|NCT05091567|585134733|FG001|Enrollment Phase|Adverse Event|0|||
162205469|NCT03041701|585803784|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
162205470|NCT03041701|585803782|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
162021290|NCT05091567|585134734|FG002|Enrollment Phase|Adverse Event|0|||
162021291|NCT05091567|585134732|FG000|Enrollment Phase|Progressive Disease|10|||
162205471|NCT03041701|585803783|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
162205472|NCT03041701|585803784|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
162205473|NCT00920699|585803791|FG000|Overall Study|Withdrawal by Subject|2|||
162205474|NCT00920699|585803792|FG001|Overall Study|Withdrawal by Subject|0|||
162205475|NCT00920699|585803793|FG002|Overall Study|Withdrawal by Subject|2|||
162205476|NCT00920699|585803791|FG000|Overall Study|no longer met eligibility|0|||
162205477|NCT00920699|585803792|FG001|Overall Study|no longer met eligibility|1|||
162205478|NCT00920699|585803793|FG002|Overall Study|no longer met eligibility|0|||
162205479|NCT00920699|585803791|FG000|Overall Study|Lost to Follow-up|0|||
162205480|NCT00920699|585803792|FG001|Overall Study|Lost to Follow-up|0|||
162205481|NCT00920699|585803793|FG002|Overall Study|Lost to Follow-up|2|||
162205482|NCT02287883|585803802|FG000|Overall Study|Death|8|||
162205483|NCT02287883|585803803|FG001|Overall Study|Death|7|||
162205484|NCT02287883|585803802|FG000|Overall Study|No longer eligible|222|||
162205485|NCT02287883|585803803|FG001|Overall Study|No longer eligible|182|||
162205486|NCT02287883|585803802|FG000|Overall Study|Non-response to survey|229|||
162205487|NCT02287883|585803803|FG001|Overall Study|Non-response to survey|237|||
162205488|NCT01281917|585803809|FG000|Overall Study|Withdrawal by Subject|1|||
162205489|NCT00802438|585803810|FG000|Overall Study|Screen Failure|20|||
162205490|NCT00802438|585803810|FG000|Overall Study|Withdrawal by Subject|7|||
162205491|NCT00802438|585803810|FG000|Overall Study|Physician Decision|1|||
162205492|NCT04016805|585803812|FG000|Overall Study|Sponsor's Discretion|30|||
162205493|NCT04016805|585803813|FG001|Overall Study|Sponsor's Discretion|6|||
162205494|NCT04016805|585803814|FG002|Overall Study|Sponsor's Discretion|5|||
162205495|NCT02101268|585803817|FG000|Randomized Treatment Phase|Subject Decision|8|||
162205496|NCT02101268|585803818|FG001|Randomized Treatment Phase|Subject Decision|4|||
162205497|NCT02101268|585803819|FG002|Randomized Treatment Phase|Subject Decision|0|||
162205498|NCT02101268|585803820|FG003|Randomized Treatment Phase|Subject Decision|0|||
162205499|NCT02101268|585803817|FG000|Randomized Treatment Phase|Physician Decision|4|||
162205500|NCT02101268|585803818|FG001|Randomized Treatment Phase|Physician Decision|1|||
162205501|NCT02101268|585803819|FG002|Randomized Treatment Phase|Physician Decision|0|||
162205502|NCT02101268|585803820|FG003|Randomized Treatment Phase|Physician Decision|0|||
162205503|NCT02101268|585803817|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
162205504|NCT02101268|585803818|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
162205505|NCT02101268|585803819|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
162205506|NCT02101268|585803820|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
162205507|NCT02101268|585803817|FG000|Randomized Treatment Phase|Adverse Event|6|||
162205508|NCT02101268|585803818|FG001|Randomized Treatment Phase|Adverse Event|0|||
162205509|NCT02101268|585803819|FG002|Randomized Treatment Phase|Adverse Event|0|||
162205510|NCT02101268|585803820|FG003|Randomized Treatment Phase|Adverse Event|0|||
162205511|NCT02101268|585803817|FG000|Randomized Treatment Phase|Death|5|||
162205512|NCT02101268|585803818|FG001|Randomized Treatment Phase|Death|4|||
162205513|NCT02101268|585803819|FG002|Randomized Treatment Phase|Death|0|||
162205514|NCT02101268|585803820|FG003|Randomized Treatment Phase|Death|0|||
162205515|NCT02101268|585803817|FG000|Randomized Treatment Phase|Disease Progression|4|||
162205516|NCT02101268|585803818|FG001|Randomized Treatment Phase|Disease Progression|1|||
162205517|NCT02101268|585803819|FG002|Randomized Treatment Phase|Disease Progression|0|||
162205518|NCT02101268|585803820|FG003|Randomized Treatment Phase|Disease Progression|0|||
162205519|NCT02101268|585803817|FG000|Extended Treatment Phase|Subject Decision|0|||
162205520|NCT02101268|585803818|FG001|Extended Treatment Phase|Subject Decision|0|||
162205521|NCT02101268|585803819|FG002|Extended Treatment Phase|Subject Decision|3|||
162205522|NCT02101268|585803820|FG003|Extended Treatment Phase|Subject Decision|2|||
162205523|NCT02101268|585803817|FG000|Extended Treatment Phase|Physician Decision|0|||
162205524|NCT02101268|585803818|FG001|Extended Treatment Phase|Physician Decision|0|||
162205525|NCT02101268|585803819|FG002|Extended Treatment Phase|Physician Decision|5|||
162205526|NCT02101268|585803820|FG003|Extended Treatment Phase|Physician Decision|2|||
162205527|NCT02101268|585803817|FG000|Extended Treatment Phase|Adverse Event|0|||
162205528|NCT02101268|585803818|FG001|Extended Treatment Phase|Adverse Event|0|||
162205529|NCT02101268|585803819|FG002|Extended Treatment Phase|Adverse Event|14|||
162205530|NCT02101268|585803820|FG003|Extended Treatment Phase|Adverse Event|18|||
162205531|NCT02101268|585803817|FG000|Extended Treatment Phase|Death|0|||
162205532|NCT02101268|585803818|FG001|Extended Treatment Phase|Death|0|||
162205533|NCT02101268|585803819|FG002|Extended Treatment Phase|Death|5|||
162205534|NCT02101268|585803820|FG003|Extended Treatment Phase|Death|1|||
162205535|NCT02101268|585803817|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
162205536|NCT02101268|585803818|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
162205537|NCT02101268|585803819|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
162205538|NCT02101268|585803820|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
162205539|NCT02101268|585803817|FG000|Extended Treatment Phase|Disease Progression|0|||
162205540|NCT02101268|585803818|FG001|Extended Treatment Phase|Disease Progression|0|||
162205541|NCT02101268|585803819|FG002|Extended Treatment Phase|Disease Progression|13|||
162205542|NCT02101268|585803820|FG003|Extended Treatment Phase|Disease Progression|6|||
162205543|NCT02101268|585803817|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
162205544|NCT02101268|585803818|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
162205545|NCT02101268|585803819|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
162205546|NCT02101268|585803820|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
162205547|NCT00740870|585803821|FG000|Overall Study|Not Catheterized|4|||
162205548|NCT00740870|585803821|FG000|Overall Study|Further testing contraindicated implant|17|||
162205549|NCT00819013|585803822|FG000|Overall Study|Not meeting continuing study eligibility|2|||
162205550|NCT00819013|585803823|FG001|Overall Study|Not meeting continuing study eligibility|1|||
162205551|NCT00819013|585803824|FG002|Overall Study|Not meeting continuing study eligibility|2|||
162205552|NCT00819013|585803825|FG003|Overall Study|Not meeting continuing study eligibility|1|||
162205553|NCT00819013|585803822|FG000|Overall Study|Adverse Event|0|||
162205554|NCT00819013|585803823|FG001|Overall Study|Adverse Event|0|||
162205555|NCT00819013|585803824|FG002|Overall Study|Adverse Event|1|||
162205556|NCT00819013|585803825|FG003|Overall Study|Adverse Event|0|||
162205557|NCT00819013|585803822|FG000|Overall Study|Withdrawal by Subject|1|||
162205558|NCT00819013|585803823|FG001|Overall Study|Withdrawal by Subject|0|||
162205559|NCT00819013|585803824|FG002|Overall Study|Withdrawal by Subject|1|||
162205560|NCT00819013|585803825|FG003|Overall Study|Withdrawal by Subject|0|||
162205561|NCT00819013|585803822|FG000|Overall Study|Lost to Follow-up|0|||
162205562|NCT00819013|585803823|FG001|Overall Study|Lost to Follow-up|0|||
162205563|NCT00819013|585803824|FG002|Overall Study|Lost to Follow-up|1|||
162205564|NCT00819013|585803825|FG003|Overall Study|Lost to Follow-up|2|||
162205565|NCT00819013|585803822|FG000|Overall Study|Death|0|||
162205566|NCT00819013|585803823|FG001|Overall Study|Death|0|||
162205567|NCT00819013|585803824|FG002|Overall Study|Death|0|||
162205568|NCT00819013|585803825|FG003|Overall Study|Death|1|||
162205569|NCT00576823|585803827|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
162205570|NCT00576823|585803828|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
162205571|NCT00576823|585803829|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
162205572|NCT00576823|585803827|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
162205573|NCT00576823|585803828|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
162205574|NCT00576823|585803829|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
162205575|NCT00839332|585803830|FG000|Phase 1|Disease Progression|38|||
162205576|NCT00839332|585803831|FG001|Phase 1|Disease Progression|0|||
162205577|NCT00839332|585803832|FG002|Phase 1|Disease Progression|0|||
162205578|NCT00839332|585803830|FG000|Phase 1|Adverse Event|6|||
162205579|NCT00839332|585803831|FG001|Phase 1|Adverse Event|0|||
162205580|NCT00839332|585803832|FG002|Phase 1|Adverse Event|0|||
162205581|NCT00839332|585803830|FG000|Phase 1|Withdrawal by Subject|4|||
162205582|NCT00839332|585803831|FG001|Phase 1|Withdrawal by Subject|0|||
162205583|NCT00839332|585803832|FG002|Phase 1|Withdrawal by Subject|0|||
162205584|NCT00839332|585803830|FG000|Phase 1|Physician Decision|2|||
162205585|NCT00839332|585803831|FG001|Phase 1|Physician Decision|0|||
162205586|NCT00839332|585803832|FG002|Phase 1|Physician Decision|0|||
162205587|NCT00839332|585803830|FG000|Phase 2|Protocol Violation|0|||
162205588|NCT00839332|585803831|FG001|Phase 2|Protocol Violation|1|||
162205589|NCT00839332|585803832|FG002|Phase 2|Protocol Violation|0|||
162205590|NCT00839332|585803830|FG000|Phase 2|Disease Progression|0|||
162205591|NCT00839332|585803831|FG001|Phase 2|Disease Progression|46|||
162205592|NCT00839332|585803832|FG002|Phase 2|Disease Progression|21|||
162205593|NCT00839332|585803830|FG000|Phase 2|Adverse Event|0|||
162205594|NCT00839332|585803831|FG001|Phase 2|Adverse Event|8|||
162205595|NCT00839332|585803832|FG002|Phase 2|Adverse Event|6|||
162205596|NCT00839332|585803830|FG000|Phase 2|Death|0|||
162205597|NCT00839332|585803831|FG001|Phase 2|Death|4|||
162205598|NCT00839332|585803832|FG002|Phase 2|Death|2|||
162205599|NCT00839332|585803830|FG000|Phase 2|Withdrawal by Subject|0|||
162205600|NCT00839332|585803831|FG001|Phase 2|Withdrawal by Subject|5|||
162205601|NCT00839332|585803832|FG002|Phase 2|Withdrawal by Subject|8|||
162205602|NCT00839332|585803830|FG000|Phase 2|Physician Decision|0|||
162205603|NCT00839332|585803831|FG001|Phase 2|Physician Decision|4|||
162205604|NCT00839332|585803832|FG002|Phase 2|Physician Decision|1|||
162205605|NCT00839332|585803830|FG000|Phase 2|Lost to Follow-up|0|||
162205606|NCT00839332|585803831|FG001|Phase 2|Lost to Follow-up|0|||
162205607|NCT00839332|585803832|FG002|Phase 2|Lost to Follow-up|1|||
162205608|NCT01200485|585803833|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
162205609|NCT01200485|585803834|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
162205610|NCT01200485|585803835|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
162205611|NCT01200485|585803833|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
162205612|NCT01200485|585803834|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
162205613|NCT01200485|585803835|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
162205614|NCT02132117|585803837|FG000|Overall Study|Adverse Event|6|||
162205615|NCT02132117|585803838|FG001|Overall Study|Adverse Event|1|||
162205616|NCT02132117|585803837|FG000|Overall Study|Lost to Follow-up|2|||
162205617|NCT02132117|585803838|FG001|Overall Study|Lost to Follow-up|2|||
162205618|NCT02132117|585803837|FG000|Overall Study|Personal Reasons|1|||
162205619|NCT02132117|585803838|FG001|Overall Study|Personal Reasons|2|||
162205620|NCT02132117|585803837|FG000|Overall Study|Other Miscellaneous Reasons|2|||
162205621|NCT02132117|585803838|FG001|Overall Study|Other Miscellaneous Reasons|0|||
162205622|NCT04947436|585803840|FG000|Overall Study|Lost to Follow-up|3|||
162205623|NCT04947436|585803841|FG001|Overall Study|Lost to Follow-up|7|||
162205624|NCT04947436|585803842|FG002|Overall Study|Lost to Follow-up|5|||
162205625|NCT04947436|585803840|FG000|Overall Study|Death|1|||
162205626|NCT04947436|585803841|FG001|Overall Study|Death|1|||
162205627|NCT04947436|585803842|FG002|Overall Study|Death|1|||
162205628|NCT01544309|585803845|FG000|Overall Study|Withdrawal by Subject|12|||
162205629|NCT01544309|585803846|FG001|Overall Study|Withdrawal by Subject|7|||
162205630|NCT01544309|585803845|FG000|Overall Study|Protocol Violation|2|||
162205631|NCT01544309|585803846|FG001|Overall Study|Protocol Violation|1|||
162205632|NCT01544309|585803845|FG000|Overall Study|Physician Decision|4|||
162205633|NCT01544309|585803846|FG001|Overall Study|Physician Decision|1|||
162205634|NCT01544309|585803845|FG000|Overall Study|Not performed pre-dose examination|1|||
162205635|NCT01544309|585803846|FG001|Overall Study|Not performed pre-dose examination|2|||
162205636|NCT01544309|585803845|FG000|Overall Study|Administered prohibit prior medication|1|||
162205637|NCT01544309|585803846|FG001|Overall Study|Administered prohibit prior medication|0|||
162205638|NCT03078751|585803847|FG000|Overall Study|Adverse Event|4|||
162205639|NCT03078751|585803848|FG001|Overall Study|Adverse Event|0|||
162205640|NCT03078751|585803847|FG000|Overall Study|Physician Decision|1|||
162205641|NCT03078751|585803848|FG001|Overall Study|Physician Decision|0|||
162205642|NCT03078751|585803847|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
162205643|NCT03078751|585803848|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
162205644|NCT03078751|585803847|FG000|Overall Study|Subject/guardian decision|8|||
162205645|NCT03078751|585803848|FG001|Overall Study|Subject/guardian decision|1|||
162205646|NCT03078751|585803847|FG000|Overall Study|Untreated|0|||
162205647|NCT03078751|585803848|FG001|Overall Study|Untreated|4|||
162205648|NCT04414397|585803849|FG000|Control Period|Withdrawal by Subject|2|||
162205649|NCT04414397|585803850|FG001|Control Period|Withdrawal by Subject|2|||
162205650|NCT04414397|585803849|FG000|Control Period|Lost to Follow-up|0|||
162205651|NCT04414397|585803850|FG001|Control Period|Lost to Follow-up|4|||
162205652|NCT04414397|585803849|FG000|Control Period|Protocol deviation|0|||
162205653|NCT04414397|585803850|FG001|Control Period|Protocol deviation|1|||
162205654|NCT04414397|585803849|FG000|Post-Control Period|Withdrawal by Subject|3|||
162205655|NCT04414397|585803850|FG001|Post-Control Period|Withdrawal by Subject|6|||
162205656|NCT04414397|585803849|FG000|Post-Control Period|Lost to Follow-up|4|||
162205657|NCT04414397|585803850|FG001|Post-Control Period|Lost to Follow-up|9|||
162205658|NCT04414397|585803849|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
162205659|NCT04414397|585803850|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
162205660|NCT04414397|585803849|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
162205661|NCT04414397|585803850|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
162205662|NCT02515097|585803852|FG000|Overall Study|Lost to Follow-up|4|||
162205663|NCT02515097|585803853|FG001|Overall Study|Lost to Follow-up|2|||
162205664|NCT02515097|585803852|FG000|Overall Study|Withdrawal by Subject|1|||
162205665|NCT02515097|585803853|FG001|Overall Study|Withdrawal by Subject|3|||
162205666|NCT02515097|585803852|FG000|Overall Study|Adverse Event|2|||
162205667|NCT02515097|585803853|FG001|Overall Study|Adverse Event|1|||
162205668|NCT01196741|585803854|FG000|Overall Study|Disease progression|34|||
162205669|NCT01196741|585803855|FG001|Overall Study|Disease progression|14|||
162205670|NCT01196741|585803854|FG000|Overall Study|Adverse Event|10|||
162205671|NCT01196741|585803855|FG001|Overall Study|Adverse Event|6|||
162205672|NCT01196741|585803854|FG000|Overall Study|Serious Adverse Event|3|||
162205673|NCT01196741|585803855|FG001|Overall Study|Serious Adverse Event|1|||
162205674|NCT01196741|585803854|FG000|Overall Study|Dose limiting Adverse Event|2|||
162205675|NCT01196741|585803855|FG001|Overall Study|Dose limiting Adverse Event|1|||
162205676|NCT01196741|585803854|FG000|Overall Study|Withdrawal by Subject|3|||
162205677|NCT01196741|585803855|FG001|Overall Study|Withdrawal by Subject|0|||
162205678|NCT01196741|585803854|FG000|Overall Study|Other reason|3|||
162205679|NCT01196741|585803855|FG001|Overall Study|Other reason|3|||
162205680|NCT01196741|585803854|FG000|Overall Study|Other|3|||
162205681|NCT01196741|585803855|FG001|Overall Study|Other|2|||
162205682|NCT01196741|585803854|FG000|Overall Study|Protocol Violation|2|||
162205683|NCT01196741|585803855|FG001|Overall Study|Protocol Violation|1|||
162205684|NCT03030599|585803856|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
162205685|NCT03030599|585803857|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
162205686|NCT03030599|585803858|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
162205687|NCT03030599|585803856|FG000|Open Label Treatment and Titration|Other|1|||
162205688|NCT03030599|585803857|FG001|Open Label Treatment and Titration|Other|0|||
162205689|NCT03030599|585803858|FG002|Open Label Treatment and Titration|Other|0|||
162205690|NCT03030599|585803856|FG000|Open Label Treatment and Titration|Physician Decision|3|||
162205691|NCT03030599|585803857|FG001|Open Label Treatment and Titration|Physician Decision|0|||
162205692|NCT03030599|585803858|FG002|Open Label Treatment and Titration|Physician Decision|0|||
162205693|NCT03030599|585803856|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
162205694|NCT03030599|585803857|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
162205695|NCT03030599|585803858|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
162205696|NCT03030599|585803856|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
162205697|NCT03030599|585803857|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
162205698|NCT03030599|585803858|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
162205699|NCT03030599|585803856|FG000|Open Label Treatment and Titration|Adverse Event|18|||
162205700|NCT03030599|585803857|FG001|Open Label Treatment and Titration|Adverse Event|0|||
162205701|NCT03030599|585803858|FG002|Open Label Treatment and Titration|Adverse Event|0|||
162205702|NCT03030599|585803856|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
162205703|NCT03030599|585803857|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
162205704|NCT03030599|585803858|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
162205705|NCT03030599|585803856|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
162205706|NCT03030599|585803857|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
162205707|NCT03030599|585803858|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
162205708|NCT03030599|585803856|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
162205709|NCT03030599|585803857|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
162205710|NCT03030599|585803858|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
162205711|NCT03030599|585803856|FG000|Stable Dose|Protocol deviation|3|||
162205712|NCT03030599|585803857|FG001|Stable Dose|Protocol deviation|0|||
162205713|NCT03030599|585803858|FG002|Stable Dose|Protocol deviation|0|||
162205714|NCT03030599|585803856|FG000|Stable Dose|Adverse Event|1|||
162205715|NCT03030599|585803857|FG001|Stable Dose|Adverse Event|0|||
162205716|NCT03030599|585803858|FG002|Stable Dose|Adverse Event|0|||
162205717|NCT03030599|585803856|FG000|Stable Dose|Lost to Follow-up|1|||
162205718|NCT03030599|585803857|FG001|Stable Dose|Lost to Follow-up|0|||
162205719|NCT03030599|585803858|FG002|Stable Dose|Lost to Follow-up|0|||
162205720|NCT03030599|585803856|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
162205721|NCT03030599|585803857|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
162205722|NCT03030599|585803858|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
162205723|NCT03030599|585803856|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
162205724|NCT03030599|585803857|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
162205725|NCT03030599|585803858|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
162205726|NCT03030599|585803856|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
162205727|NCT03030599|585803857|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
162205728|NCT03030599|585803858|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
162205729|NCT03030599|585803856|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
162205730|NCT03030599|585803857|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
162205731|NCT03030599|585803858|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
162205732|NCT03030599|585803856|FG000|Open-label Extension|Adverse Event|3|||
162205733|NCT03030599|585803857|FG001|Open-label Extension|Adverse Event|0|||
162205734|NCT03030599|585803858|FG002|Open-label Extension|Adverse Event|0|||
162205735|NCT03030599|585803856|FG000|Open-label Extension|Lost to Follow-up|2|||
162205736|NCT03030599|585803857|FG001|Open-label Extension|Lost to Follow-up|0|||
162205737|NCT03030599|585803858|FG002|Open-label Extension|Lost to Follow-up|0|||
162205738|NCT03030599|585803856|FG000|Open-label Extension|Lack of Efficacy|1|||
162205739|NCT03030599|585803857|FG001|Open-label Extension|Lack of Efficacy|0|||
162205740|NCT03030599|585803858|FG002|Open-label Extension|Lack of Efficacy|0|||
162205741|NCT03030599|585803856|FG000|Open-label Extension|Other Reason|1|||
162205742|NCT03030599|585803857|FG001|Open-label Extension|Other Reason|0|||
162205743|NCT03030599|585803858|FG002|Open-label Extension|Other Reason|0|||
162205744|NCT01592383|585803859|FG000|Overall Study|Adverse Event|1|||
162205745|NCT04582864|585803860|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
162205746|NCT04582864|585803860|FG000|Overall Study|Death|1|||
162205747|NCT01064856|585803861|FG000|Double-blind (DB) Period|Adverse Event|1|||
162205748|NCT01064856|585803862|FG001|Double-blind (DB) Period|Adverse Event|0|||
162205749|NCT01064856|585803863|FG002|Double-blind (DB) Period|Adverse Event|0|||
162205750|NCT01064856|585803864|FG003|Double-blind (DB) Period|Adverse Event|0|||
161677476|NCT00467779|583872000|FG000|Stage 3|Death|0|||
161677477|NCT00467779|583872001|FG001|Stage 3|Death|0|||
161932429|NCT00159874|584800468|FG006|Overall Study|Death|0|||
161932430|NCT00159874|584800462|FG000|Overall Study|Withdrawal by Subject|2|||
161932431|NCT00159874|584800463|FG001|Overall Study|Withdrawal by Subject|6|||
161932432|NCT00159874|584800464|FG002|Overall Study|Withdrawal by Subject|8|||
161932433|NCT00159874|584800465|FG003|Overall Study|Withdrawal by Subject|4|||
161932434|NCT00159874|584800466|FG004|Overall Study|Withdrawal by Subject|3|||
161932435|NCT00159874|584800467|FG005|Overall Study|Withdrawal by Subject|2|||
161932436|NCT00159874|584800468|FG006|Overall Study|Withdrawal by Subject|1|||
162205751|NCT01064856|585803861|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
162205752|NCT01064856|585803862|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
162205753|NCT01064856|585803863|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
162205754|NCT01064856|585803864|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
162205755|NCT01064856|585803861|FG000|Open-label (OL) Period|Adverse Event|0|||
162205756|NCT01064856|585803862|FG001|Open-label (OL) Period|Adverse Event|0|||
162205757|NCT01064856|585803863|FG002|Open-label (OL) Period|Adverse Event|12|||
162205758|NCT01064856|585803864|FG003|Open-label (OL) Period|Adverse Event|6|||
162205759|NCT01064856|585803861|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
162205760|NCT01064856|585803862|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
162205761|NCT01064856|585803863|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
162205762|NCT01064856|585803864|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
162205763|NCT01064856|585803861|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
162205764|NCT01064856|585803862|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
162205765|NCT01064856|585803863|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
162205766|NCT01064856|585803864|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
162205767|NCT01064856|585803861|FG000|Open-label (OL) Period|Other|0|||
162205768|NCT01064856|585803862|FG001|Open-label (OL) Period|Other|0|||
162205769|NCT01064856|585803863|FG002|Open-label (OL) Period|Other|7|||
162205770|NCT01064856|585803864|FG003|Open-label (OL) Period|Other|7|||
162205771|NCT02133131|585803865|FG000|Overall Study|Adverse Event|0|||
162205772|NCT02133131|585803866|FG001|Overall Study|Adverse Event|0|||
162205773|NCT02133131|585803867|FG002|Overall Study|Adverse Event|0|||
162205774|NCT02133131|585803868|FG003|Overall Study|Adverse Event|1|||
162205775|NCT02133131|585803869|FG004|Overall Study|Adverse Event|0|||
162205776|NCT02133131|585803870|FG005|Overall Study|Adverse Event|0|||
162205777|NCT02133131|585803871|FG006|Overall Study|Adverse Event|0|||
162205778|NCT02133131|585803865|FG000|Overall Study|Lost to Follow-up|1|||
162205779|NCT02133131|585803866|FG001|Overall Study|Lost to Follow-up|0|||
162205780|NCT02133131|585803867|FG002|Overall Study|Lost to Follow-up|0|||
162205781|NCT02133131|585803868|FG003|Overall Study|Lost to Follow-up|1|||
162205782|NCT02133131|585803869|FG004|Overall Study|Lost to Follow-up|0|||
162205783|NCT02133131|585803870|FG005|Overall Study|Lost to Follow-up|0|||
162205784|NCT02133131|585803871|FG006|Overall Study|Lost to Follow-up|0|||
162205785|NCT02133131|585803865|FG000|Overall Study|Status not recorded|4|||
162205786|NCT02133131|585803866|FG001|Overall Study|Status not recorded|5|||
162205787|NCT02133131|585803867|FG002|Overall Study|Status not recorded|1|||
162205788|NCT02133131|585803868|FG003|Overall Study|Status not recorded|4|||
162205789|NCT02133131|585803869|FG004|Overall Study|Status not recorded|0|||
162205790|NCT02133131|585803870|FG005|Overall Study|Status not recorded|0|||
162205791|NCT02133131|585803871|FG006|Overall Study|Status not recorded|0|||
162205792|NCT02133131|585803865|FG000|Overall Study|Ongoing in study|0|||
162205793|NCT02133131|585803866|FG001|Overall Study|Ongoing in study|0|||
162205794|NCT02133131|585803867|FG002|Overall Study|Ongoing in study|0|||
162205795|NCT02133131|585803868|FG003|Overall Study|Ongoing in study|0|||
162205796|NCT02133131|585803869|FG004|Overall Study|Ongoing in study|15|||
162205797|NCT02133131|585803870|FG005|Overall Study|Ongoing in study|14|||
162205798|NCT02133131|585803871|FG006|Overall Study|Ongoing in study|11|||
162205799|NCT02133131|585803865|FG000|Overall Study|Protocol Violation|0|||
162205800|NCT02133131|585803866|FG001|Overall Study|Protocol Violation|0|||
162205801|NCT02133131|585803867|FG002|Overall Study|Protocol Violation|0|||
162205802|NCT02133131|585803868|FG003|Overall Study|Protocol Violation|0|||
162205803|NCT02133131|585803869|FG004|Overall Study|Protocol Violation|0|||
162205804|NCT02133131|585803870|FG005|Overall Study|Protocol Violation|0|||
162205805|NCT02133131|585803871|FG006|Overall Study|Protocol Violation|1|||
162205806|NCT01679613|585803874|FG000|Overall Study|other than stated above|0|||
162205807|NCT01679613|585803875|FG001|Overall Study|other than stated above|1|||
162205808|NCT01679613|585803876|FG002|Overall Study|other than stated above|2|||
162205809|NCT01679613|585803877|FG003|Overall Study|other than stated above|2|||
162205810|NCT00509925|585803879|FG000|Overall Study|Personal reasons|0|||
162205811|NCT00509925|585803880|FG001|Overall Study|Personal reasons|1|||
162205812|NCT00951171|585803881|FG000|Overall Study|Adverse Event|2|||
162205813|NCT00951171|585803882|FG001|Overall Study|Adverse Event|0|||
162205814|NCT01932762|585805369|FG000|Overall Study|Withdrawal by Subject|1|||
162205815|NCT01932762|585805370|FG001|Overall Study|Withdrawal by Subject|2|||
162205816|NCT01932762|585805371|FG002|Overall Study|Withdrawal by Subject|0|||
162205817|NCT01932762|585805372|FG003|Overall Study|Withdrawal by Subject|0|||
162205818|NCT01932762|585805369|FG000|Overall Study|Lost to Follow-up|4|||
162205819|NCT01932762|585805370|FG001|Overall Study|Lost to Follow-up|0|||
162205820|NCT01932762|585805371|FG002|Overall Study|Lost to Follow-up|0|||
162205821|NCT01932762|585805372|FG003|Overall Study|Lost to Follow-up|1|||
161677478|NCT00467779|583872002|FG002|Stage 3|Death|0|||
161677479|NCT00467779|583872003|FG003|Stage 3|Death|0|||
161677480|NCT00467779|583872004|FG004|Stage 3|Death|0|||
162205822|NCT01932762|585805369|FG000|Overall Study|Physician Decision|1|||
162205823|NCT01932762|585805370|FG001|Overall Study|Physician Decision|0|||
162205824|NCT01932762|585805371|FG002|Overall Study|Physician Decision|0|||
162205825|NCT01932762|585805372|FG003|Overall Study|Physician Decision|0|||
162205826|NCT02210208|585805373|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
162205827|NCT02210208|585805373|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
162205828|NCT02210208|585805373|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
162205829|NCT00695136|585805374|FG000|Overall Study|Withdrawal by Subject|1|||
162205830|NCT00695136|585805374|FG000|Overall Study|unrelated adverse event|1|||
162205831|NCT01333111|585805376|FG000|Overall Study|patient undergoing major surgery|0|||
162205832|NCT01333111|585805377|FG001|Overall Study|patient undergoing major surgery|2|||
161932437|NCT00159874|584800462|FG000|Overall Study|Pregnancy|1|||
161932438|NCT00159874|584800463|FG001|Overall Study|Pregnancy|1|||
161932439|NCT00159874|584800464|FG002|Overall Study|Pregnancy|0|||
161932440|NCT00159874|584800465|FG003|Overall Study|Pregnancy|0|||
161932441|NCT00159874|584800466|FG004|Overall Study|Pregnancy|0|||
162205833|NCT01333111|585805378|FG002|Overall Study|patient undergoing major surgery|0|||
162205834|NCT01333111|585805376|FG000|Overall Study|personal reasons|0|||
162205835|NCT01333111|585805377|FG001|Overall Study|personal reasons|0|||
162205836|NCT01333111|585805378|FG002|Overall Study|personal reasons|1|||
162205837|NCT01333111|585805376|FG000|Overall Study|unclassified|1|||
162205838|NCT01333111|585805377|FG001|Overall Study|unclassified|0|||
162205839|NCT01333111|585805378|FG002|Overall Study|unclassified|0|||
162205840|NCT01333111|585805376|FG000|Overall Study|withdrawal criteria|0|||
162205841|NCT01333111|585805377|FG001|Overall Study|withdrawal criteria|1|||
162205842|NCT01333111|585805378|FG002|Overall Study|withdrawal criteria|0|||
162205843|NCT01333111|585805376|FG000|Overall Study|Non-compliance|1|||
162205844|NCT01333111|585805377|FG001|Overall Study|Non-compliance|0|||
162205845|NCT01333111|585805378|FG002|Overall Study|Non-compliance|0|||
162205846|NCT01333111|585805376|FG000|Overall Study|Ineffective therapy|0|||
162205847|NCT01333111|585805377|FG001|Overall Study|Ineffective therapy|0|||
162205848|NCT01333111|585805378|FG002|Overall Study|Ineffective therapy|1|||
162205849|NCT02161406|585805379|FG000|Overall Study|Death|2|||
162205850|NCT02161406|585805380|FG001|Overall Study|Death|1|||
162205851|NCT02161406|585805379|FG000|Overall Study|Lost to Follow-up|2|||
162205852|NCT02161406|585805380|FG001|Overall Study|Lost to Follow-up|1|||
162205853|NCT02161406|585805379|FG000|Overall Study|Withdrawal by Subject|2|||
162205854|NCT02161406|585805380|FG001|Overall Study|Withdrawal by Subject|4|||
162205855|NCT02161406|585805379|FG000|Overall Study|investigator withdrew subject|3|||
162205856|NCT02161406|585805380|FG001|Overall Study|investigator withdrew subject|1|||
162205857|NCT02161406|585805379|FG000|Overall Study|Lack of Efficacy|1|||
162205858|NCT02161406|585805380|FG001|Overall Study|Lack of Efficacy|1|||
162205859|NCT02161406|585805379|FG000|Overall Study|relocation|0|||
162205860|NCT02161406|585805380|FG001|Overall Study|relocation|1|||
162205861|NCT01929876|585805381|FG000|Period 2|Non-Compliance|1|||
162205862|NCT01468077|585805384|FG000|Overall Study|Adverse Event|2|||
162205863|NCT01468077|585805385|FG001|Overall Study|Adverse Event|2|||
162205864|NCT01468077|585805384|FG000|Overall Study|Lack of Efficacy|1|||
162205865|NCT01468077|585805385|FG001|Overall Study|Lack of Efficacy|1|||
162205866|NCT01468077|585805384|FG000|Overall Study|Physician Decision|1|||
162205867|NCT01468077|585805385|FG001|Overall Study|Physician Decision|0|||
162205868|NCT05446714|585805386|FG000|Overall Study|Lost to Follow-up|1|||
162205869|NCT05446714|585805387|FG001|Overall Study|Lost to Follow-up|3|||
162205870|NCT05446714|585805388|FG002|Overall Study|Lost to Follow-up|2|||
162205871|NCT05446714|585805386|FG000|Overall Study|Protocol Violation|2|||
162205872|NCT05446714|585805387|FG001|Overall Study|Protocol Violation|0|||
162205873|NCT05446714|585805388|FG002|Overall Study|Protocol Violation|0|||
162205874|NCT03024996|585805389|FG000|Overall Study|Death|57|||
162205875|NCT03024996|585805390|FG001|Overall Study|Death|55|||
162205876|NCT03024996|585805389|FG000|Overall Study|Disease relapse|1|||
162205877|NCT03024996|585805390|FG001|Overall Study|Disease relapse|0|||
162205878|NCT03024996|585805389|FG000|Overall Study|Lost to Follow-up|5|||
162205879|NCT03024996|585805390|FG001|Overall Study|Lost to Follow-up|10|||
162205880|NCT03024996|585805389|FG000|Overall Study|Other|3|||
162205881|NCT03024996|585805390|FG001|Overall Study|Other|3|||
162205882|NCT03024996|585805389|FG000|Overall Study|Physician Decision|0|||
162205883|NCT03024996|585805390|FG001|Overall Study|Physician Decision|1|||
162205884|NCT03024996|585805389|FG000|Overall Study|Study terminated by sponsor|303|||
162205885|NCT03024996|585805390|FG001|Overall Study|Study terminated by sponsor|283|||
162205886|NCT03024996|585805389|FG000|Overall Study|Withdrawal by Subject|21|||
162205887|NCT03024996|585805390|FG001|Overall Study|Withdrawal by Subject|36|||
161932442|NCT00159874|584800467|FG005|Overall Study|Pregnancy|0|||
161932443|NCT00159874|584800468|FG006|Overall Study|Pregnancy|0|||
161932444|NCT01104870|584800469|FG000|Overall Study|Adverse Event|1|||
162205888|NCT02418845|585805393|FG000|Overall Study|Lost to Follow-up|7|||
162205889|NCT02418845|585805394|FG001|Overall Study|Lost to Follow-up|2|||
162205890|NCT02418845|585805393|FG000|Overall Study|Lack of Efficacy|0|||
162205891|NCT02418845|585805394|FG001|Overall Study|Lack of Efficacy|3|||
162205892|NCT02418845|585805393|FG000|Overall Study|Physician Decision|5|||
162205893|NCT02418845|585805394|FG001|Overall Study|Physician Decision|5|||
162205894|NCT02418845|585805393|FG000|Overall Study|Protocol Violation|1|||
162205895|NCT02418845|585805394|FG001|Overall Study|Protocol Violation|0|||
162205896|NCT02418845|585805393|FG000|Overall Study|Withdrawal by Subject|3|||
162205897|NCT02418845|585805394|FG001|Overall Study|Withdrawal by Subject|2|||
162205898|NCT00478647|585805395|FG000|Overall Study|Adverse Event|1|||
162205899|NCT00478647|585805395|FG000|Overall Study|Withdrawal by Subject|1|||
162205900|NCT04333147|585805396|FG000|Overall Study|Adverse Event|43|||
162205901|NCT04333147|585805397|FG001|Overall Study|Adverse Event|40|||
162205902|NCT04333147|585805396|FG000|Overall Study|Lack of Efficacy|49|||
162205903|NCT04333147|585805397|FG001|Overall Study|Lack of Efficacy|48|||
162205904|NCT04333147|585805396|FG000|Overall Study|Lost to Follow-up|19|||
162205905|NCT04333147|585805397|FG001|Overall Study|Lost to Follow-up|16|||
162205906|NCT04333147|585805396|FG000|Overall Study|Physician Decision|17|||
162205907|NCT04333147|585805397|FG001|Overall Study|Physician Decision|20|||
162205908|NCT04333147|585805396|FG000|Overall Study|Withdrawal by Subject|65|||
162205909|NCT04333147|585805397|FG001|Overall Study|Withdrawal by Subject|68|||
162205910|NCT04333147|585805396|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
162205911|NCT04333147|585805397|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
162205912|NCT04333147|585805396|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
162205913|NCT04333147|585805397|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
162205914|NCT04333147|585805396|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
162205915|NCT04333147|585805397|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
162205916|NCT00487552|585805407|FG000|Overall Study|Unsuccessful magnet placements|3|||
162205917|NCT00487552|585805407|FG000|Overall Study|Death due to progressive malignancy|2|||
162205918|NCT00487552|585805407|FG000|Overall Study|Stent not placed|1|||
162205919|NCT03119688|585805408|FG000|Overall Study|Adverse Event|4|||
162205920|NCT00320398|585805409|FG000|Overall Study|Adverse Event|1|||
162205921|NCT00320398|585805410|FG001|Overall Study|Adverse Event|4|||
162205922|NCT00320398|585805409|FG000|Overall Study|Other|1|||
162205923|NCT00320398|585805410|FG001|Overall Study|Other|0|||
162205924|NCT00630552|585805411|FG000|Overall Study|Adverse Event|0|||
162205925|NCT00630552|585805412|FG001|Overall Study|Adverse Event|1|||
162205926|NCT00630552|585805413|FG002|Overall Study|Adverse Event|5|||
162205927|NCT00630552|585805414|FG003|Overall Study|Adverse Event|4|||
162205928|NCT00630552|585805415|FG004|Overall Study|Adverse Event|2|||
162205929|NCT00630552|585805411|FG000|Overall Study|Disease progression|5|||
162205930|NCT00630552|585805412|FG001|Overall Study|Disease progression|6|||
162205931|NCT00630552|585805413|FG002|Overall Study|Disease progression|27|||
162205932|NCT00630552|585805414|FG003|Overall Study|Disease progression|22|||
162205933|NCT00630552|585805415|FG004|Overall Study|Disease progression|31|||
162205934|NCT00630552|585805411|FG000|Overall Study|Never received IP|0|||
162205935|NCT00630552|585805412|FG001|Overall Study|Never received IP|0|||
162205936|NCT00630552|585805413|FG002|Overall Study|Never received IP|0|||
162205937|NCT00630552|585805414|FG003|Overall Study|Never received IP|2|||
162205938|NCT00630552|585805415|FG004|Overall Study|Never received IP|2|||
162205939|NCT00630552|585805411|FG000|Overall Study|Ineligibility determined|0|||
162205940|NCT00630552|585805412|FG001|Overall Study|Ineligibility determined|0|||
162205941|NCT00630552|585805413|FG002|Overall Study|Ineligibility determined|0|||
162205942|NCT00630552|585805414|FG003|Overall Study|Ineligibility determined|0|||
162205943|NCT00630552|585805415|FG004|Overall Study|Ineligibility determined|1|||
162205944|NCT00630552|585805411|FG000|Overall Study|Protocol Violation|0|||
162205945|NCT00630552|585805412|FG001|Overall Study|Protocol Violation|0|||
162205946|NCT00630552|585805413|FG002|Overall Study|Protocol Violation|0|||
162205947|NCT00630552|585805414|FG003|Overall Study|Protocol Violation|1|||
162205948|NCT00630552|585805415|FG004|Overall Study|Protocol Violation|0|||
162205949|NCT00630552|585805411|FG000|Overall Study|Physician Decision|0|||
162205950|NCT00630552|585805412|FG001|Overall Study|Physician Decision|0|||
162205951|NCT00630552|585805413|FG002|Overall Study|Physician Decision|0|||
162205952|NCT00630552|585805414|FG003|Overall Study|Physician Decision|0|||
162205953|NCT00630552|585805415|FG004|Overall Study|Physician Decision|1|||
162205954|NCT00630552|585805411|FG000|Overall Study|Death|0|||
162205955|NCT00630552|585805412|FG001|Overall Study|Death|0|||
162205956|NCT00630552|585805413|FG002|Overall Study|Death|1|||
162205957|NCT00630552|585805414|FG003|Overall Study|Death|2|||
162205958|NCT00630552|585805415|FG004|Overall Study|Death|2|||
162205959|NCT00630552|585805411|FG000|Overall Study|Withdrawal by Subject|0|||
162205960|NCT00630552|585805412|FG001|Overall Study|Withdrawal by Subject|0|||
161677481|NCT00467779|583872005|FG005|Stage 3|Death|0|||
161677482|NCT00467779|583872006|FG006|Stage 3|Death|0|||
162205961|NCT00630552|585805413|FG002|Overall Study|Withdrawal by Subject|0|||
162205962|NCT00630552|585805414|FG003|Overall Study|Withdrawal by Subject|1|||
162205963|NCT00630552|585805415|FG004|Overall Study|Withdrawal by Subject|0|||
162205964|NCT00630552|585805411|FG000|Overall Study|Other|0|||
162205965|NCT00630552|585805412|FG001|Overall Study|Other|0|||
162205966|NCT00630552|585805413|FG002|Overall Study|Other|4|||
162205967|NCT00630552|585805414|FG003|Overall Study|Other|2|||
162205968|NCT00630552|585805415|FG004|Overall Study|Other|0|||
162205969|NCT02705625|585805416|FG000|Overall Study|Protocol Violation|1|||
162205970|NCT02705625|585805417|FG001|Overall Study|Protocol Violation|0|||
162205971|NCT02705625|585805418|FG002|Overall Study|Protocol Violation|0|||
162205972|NCT02705625|585805416|FG000|Overall Study|Adverse Event|6|||
162205973|NCT02705625|585805417|FG001|Overall Study|Adverse Event|5|||
162205974|NCT02705625|585805418|FG002|Overall Study|Adverse Event|2|||
162205975|NCT02705625|585805416|FG000|Overall Study|Death|0|||
162205976|NCT02705625|585805417|FG001|Overall Study|Death|0|||
162205977|NCT02705625|585805418|FG002|Overall Study|Death|1|||
162205978|NCT02705625|585805416|FG000|Overall Study|Withdrawal by Subject|1|||
162205979|NCT02705625|585805417|FG001|Overall Study|Withdrawal by Subject|4|||
162205980|NCT02705625|585805418|FG002|Overall Study|Withdrawal by Subject|5|||
162205981|NCT02705625|585805416|FG000|Overall Study|Lost to Follow-up|0|||
162205982|NCT02705625|585805417|FG001|Overall Study|Lost to Follow-up|0|||
162205983|NCT02705625|585805418|FG002|Overall Study|Lost to Follow-up|1|||
162205984|NCT02705625|585805416|FG000|Overall Study|Non-compliance|0|||
162205985|NCT02705625|585805417|FG001|Overall Study|Non-compliance|1|||
162205986|NCT02705625|585805418|FG002|Overall Study|Non-compliance|1|||
162205987|NCT02705625|585805416|FG000|Overall Study|Overdosing|0|||
162205988|NCT02705625|585805417|FG001|Overall Study|Overdosing|0|||
162205989|NCT02705625|585805418|FG002|Overall Study|Overdosing|1|||
162205990|NCT00863798|585805419|FG000|Overall Study|Adverse Event|5|||
162205991|NCT00863798|585805420|FG001|Overall Study|Adverse Event|2|||
162205992|NCT00863798|585805421|FG002|Overall Study|Adverse Event|4|||
162205993|NCT00863798|585805419|FG000|Overall Study|Participant failed to return|2|||
162205994|NCT00863798|585805420|FG001|Overall Study|Participant failed to return|1|||
162205995|NCT00863798|585805421|FG002|Overall Study|Participant failed to return|0|||
162205996|NCT00863798|585805419|FG000|Overall Study|Investigator request|1|||
162205997|NCT00863798|585805420|FG001|Overall Study|Investigator request|2|||
162205998|NCT00863798|585805421|FG002|Overall Study|Investigator request|1|||
162205999|NCT00863798|585805419|FG000|Overall Study|Lack of Efficacy|4|||
162206000|NCT00863798|585805420|FG001|Overall Study|Lack of Efficacy|3|||
162206001|NCT00863798|585805421|FG002|Overall Study|Lack of Efficacy|6|||
162206002|NCT00863798|585805419|FG000|Overall Study|Lost to Follow-up|6|||
162206003|NCT00863798|585805420|FG001|Overall Study|Lost to Follow-up|9|||
162206004|NCT00863798|585805421|FG002|Overall Study|Lost to Follow-up|5|||
162206005|NCT00863798|585805419|FG000|Overall Study|Other|2|||
162206006|NCT00863798|585805420|FG001|Overall Study|Other|3|||
162206007|NCT00863798|585805421|FG002|Overall Study|Other|1|||
162206008|NCT00863798|585805419|FG000|Overall Study|Protocol Violation|0|||
162206009|NCT00863798|585805420|FG001|Overall Study|Protocol Violation|1|||
162206010|NCT00863798|585805421|FG002|Overall Study|Protocol Violation|1|||
162206011|NCT00863798|585805419|FG000|Overall Study|Withdrawal by Subject|8|||
162206012|NCT00863798|585805420|FG001|Overall Study|Withdrawal by Subject|7|||
162206013|NCT00863798|585805421|FG002|Overall Study|Withdrawal by Subject|4|||
162206014|NCT00863798|585805419|FG000|Overall Study|Randomized not treated|4|||
162206015|NCT00863798|585805420|FG001|Overall Study|Randomized not treated|2|||
162206016|NCT00863798|585805421|FG002|Overall Study|Randomized not treated|3|||
162206017|NCT02158247|585805422|FG000|Overall Study|Invisible vocal cords|5|||
162206018|NCT01057251|585805424|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
162206019|NCT01057251|585805425|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
162206020|NCT01057251|585805424|FG000|Overall Study|Adverse Event|4|||
162206021|NCT01057251|585805425|FG001|Overall Study|Adverse Event|2|||
162206022|NCT01057251|585805424|FG000|Overall Study|Lack of Efficacy|2|||
162206023|NCT01057251|585805425|FG001|Overall Study|Lack of Efficacy|11|||
162206024|NCT01057251|585805424|FG000|Overall Study|Protocol Violation|6|||
162206025|NCT01057251|585805425|FG001|Overall Study|Protocol Violation|2|||
162206026|NCT01057251|585805424|FG000|Overall Study|Withdrawal by Subject|4|||
162206027|NCT01057251|585805425|FG001|Overall Study|Withdrawal by Subject|5|||
162206028|NCT01057251|585805424|FG000|Overall Study|Lost to Follow-up|7|||
162206029|NCT01057251|585805425|FG001|Overall Study|Lost to Follow-up|6|||
162206030|NCT01057251|585805424|FG000|Overall Study|Other Reason|1|||
162206031|NCT01057251|585805425|FG001|Overall Study|Other Reason|1|||
162206032|NCT00784147|585805426|FG000|Overall Study|Lost to Follow-up|2|||
162206033|NCT00784147|585805427|FG001|Overall Study|Lost to Follow-up|4|||
162206034|NCT00784147|585805426|FG000|Overall Study|Withdrawal by Subject|1|||
162206035|NCT00784147|585805427|FG001|Overall Study|Withdrawal by Subject|3|||
162206036|NCT00784147|585805426|FG000|Overall Study|Physician Decision|2|||
162206037|NCT00784147|585805427|FG001|Overall Study|Physician Decision|1|||
162206038|NCT00784147|585805426|FG000|Overall Study|Protocol Violation|1|||
162206039|NCT00784147|585805427|FG001|Overall Study|Protocol Violation|1|||
162206040|NCT00784147|585805426|FG000|Overall Study|Death|2|||
162206041|NCT00784147|585805427|FG001|Overall Study|Death|0|||
162206042|NCT03596242|585805429|FG000|Overall Study|Lost to Follow-up|2|||
162206043|NCT03596242|585805430|FG001|Overall Study|Lost to Follow-up|2|||
162206044|NCT04544865|585805431|FG000|Overall Study|Death|0|||
162206045|NCT04544865|585805432|FG001|Overall Study|Death|2|||
162206046|NCT04544865|585805431|FG000|Overall Study|Lost to Follow-up|11|||
162206047|NCT04544865|585805432|FG001|Overall Study|Lost to Follow-up|7|||
162206048|NCT04544865|585805431|FG000|Overall Study|Withdrawal by Subject|0|||
162206049|NCT04544865|585805432|FG001|Overall Study|Withdrawal by Subject|1|||
162206050|NCT04544865|585805431|FG000|Overall Study|Other|0|||
162206051|NCT04544865|585805432|FG001|Overall Study|Other|1|||
162206052|NCT03357471|585805438|FG000|Overall Study|Adverse Event|1|||
162206053|NCT03357471|585805439|FG001|Overall Study|Adverse Event|0|||
162206054|NCT03357471|585805438|FG000|Overall Study|Lost to Follow-up|1|||
162206055|NCT03357471|585805439|FG001|Overall Study|Lost to Follow-up|0|||
162206056|NCT02973802|585805440|FG000|Overall Study|Lost to Follow-up|1|||
162206057|NCT02973802|585805440|FG000|Overall Study|Withdrawal by Subject|1|||
162206058|NCT00706914|585805441|FG000|Overall Study|Lack of Efficacy|0|||
162206059|NCT00706914|585805442|FG001|Overall Study|Lack of Efficacy|1|||
162206060|NCT00706914|585805443|FG002|Overall Study|Lack of Efficacy|0|||
162206061|NCT00706914|585805441|FG000|Overall Study|Lost to Follow-up|1|||
162206062|NCT00706914|585805442|FG001|Overall Study|Lost to Follow-up|0|||
162206063|NCT00706914|585805443|FG002|Overall Study|Lost to Follow-up|0|||
162206064|NCT00706914|585805441|FG000|Overall Study|Adverse Event|2|||
162206065|NCT00706914|585805442|FG001|Overall Study|Adverse Event|2|||
162206066|NCT00706914|585805443|FG002|Overall Study|Adverse Event|0|||
162206067|NCT00706914|585805441|FG000|Overall Study|Protocol Violation|3|||
162206068|NCT00706914|585805442|FG001|Overall Study|Protocol Violation|1|||
162206069|NCT00706914|585805443|FG002|Overall Study|Protocol Violation|1|||
162206070|NCT01850823|585805444|FG000|Overall Study|Early Visit Window|0|||
162206071|NCT01850823|585805445|FG001|Overall Study|Early Visit Window|1|||
162206072|NCT01850823|585805446|FG002|Overall Study|Early Visit Window|4|||
162206073|NCT01850823|585805444|FG000|Overall Study|Enrolled in Error|0|||
162206074|NCT01850823|585805445|FG001|Overall Study|Enrolled in Error|1|||
162206075|NCT01850823|585805446|FG002|Overall Study|Enrolled in Error|2|||
162206076|NCT01850823|585805444|FG000|Overall Study|Lack of Efficacy|1|||
162206077|NCT01850823|585805445|FG001|Overall Study|Lack of Efficacy|0|||
162206078|NCT01850823|585805446|FG002|Overall Study|Lack of Efficacy|0|||
162206079|NCT01850823|585805444|FG000|Overall Study|Lost to Follow-up|0|||
162206080|NCT01850823|585805445|FG001|Overall Study|Lost to Follow-up|0|||
162206081|NCT01850823|585805446|FG002|Overall Study|Lost to Follow-up|1|||
162206082|NCT01850823|585805444|FG000|Overall Study|Restricted Medication|0|||
162206083|NCT01850823|585805445|FG001|Overall Study|Restricted Medication|0|||
162206084|NCT01850823|585805446|FG002|Overall Study|Restricted Medication|2|||
162206085|NCT01850823|585805444|FG000|Overall Study|Significant worstening of SAR|0|||
162206086|NCT01850823|585805445|FG001|Overall Study|Significant worstening of SAR|1|||
162206087|NCT01850823|585805446|FG002|Overall Study|Significant worstening of SAR|0|||
162206088|NCT01850823|585805444|FG000|Overall Study|Withdrawal by Subject|2|||
162206089|NCT01850823|585805445|FG001|Overall Study|Withdrawal by Subject|0|||
162206090|NCT01850823|585805446|FG002|Overall Study|Withdrawal by Subject|1|||
162206091|NCT01202409|585805448|FG000|Overall Study|Adverse Event|1|||
162206092|NCT01202409|585805448|FG000|Overall Study|Ineligible - KRAS mutants|7|||
162206093|NCT01732926|585805451|FG000|Overall Study|Study Terminated by Sponsor|168|||
162206094|NCT01732926|585805452|FG001|Overall Study|Study Terminated by Sponsor|80|||
162206095|NCT01732926|585805451|FG000|Overall Study|Withdrawal by Subject|46|||
162206096|NCT01732926|585805452|FG001|Overall Study|Withdrawal by Subject|8|||
162206097|NCT01732926|585805451|FG000|Overall Study|Physician Decision|24|||
162206098|NCT01732926|585805452|FG001|Overall Study|Physician Decision|11|||
162206099|NCT01732926|585805451|FG000|Overall Study|Other Reason|21|||
162206100|NCT01732926|585805452|FG001|Overall Study|Other Reason|4|||
162206101|NCT01732926|585805451|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
162206102|NCT01732926|585805452|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
161824387|NCT00857818|584397977|FG001|Overall Study|Investigator decision|0|||
161824388|NCT02061280|584397981|FG000|Overall Study|Protocol Violation|12|||
161824389|NCT02061280|584397982|FG001|Overall Study|Protocol Violation|8|||
161824390|NCT02061280|584397981|FG000|Overall Study|moved out of state|0|||
161824391|NCT02061280|584397982|FG001|Overall Study|moved out of state|1|||
161824392|NCT02061280|584397981|FG000|Overall Study|Withdrawal by Subject|1|||
162021292|NCT05091567|585134733|FG001|Enrollment Phase|Progressive Disease|0|||
162021293|NCT05091567|585134734|FG002|Enrollment Phase|Progressive Disease|0|||
162206103|NCT01732926|585805451|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
162206104|NCT01732926|585805452|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
162206105|NCT00053352|585805457|FG000|Overall Study|Lost to Follow-up|0|||
162206106|NCT00053352|585805458|FG001|Overall Study|Lost to Follow-up|1|||
162206107|NCT00053352|585805457|FG000|Overall Study|Physician Decision|11|||
162206108|NCT00053352|585805458|FG001|Overall Study|Physician Decision|1|||
162206109|NCT00053352|585805457|FG000|Overall Study|Withdrawal by Subject|1|||
162206110|NCT00053352|585805458|FG001|Overall Study|Withdrawal by Subject|0|||
162206111|NCT00053352|585805457|FG000|Overall Study|Ineligible|8|||
162206112|NCT00053352|585805458|FG001|Overall Study|Ineligible|8|||
162206113|NCT00053352|585805457|FG000|Overall Study|Disease at new site|1|||
162206114|NCT00053352|585805458|FG001|Overall Study|Disease at new site|0|||
162206115|NCT00931918|585805461|FG000|Overall Study|Adverse Event|4|||
162206116|NCT00931918|585805462|FG001|Overall Study|Adverse Event|6|||
162206117|NCT00931918|585805461|FG000|Overall Study|Progressive Disease|2|||
162206118|NCT00931918|585805462|FG001|Overall Study|Progressive Disease|1|||
162206119|NCT00931918|585805461|FG000|Overall Study|Symptomatic Deterioration|1|||
162206120|NCT00931918|585805462|FG001|Overall Study|Symptomatic Deterioration|0|||
162206121|NCT00931918|585805461|FG000|Overall Study|Withdrawal by Patient|3|||
162206122|NCT00931918|585805462|FG001|Overall Study|Withdrawal by Patient|4|||
162206123|NCT00931918|585805461|FG000|Overall Study|Other Reason not Specified|4|||
162206124|NCT00931918|585805462|FG001|Overall Study|Other Reason not Specified|4|||
162206125|NCT00931918|585805461|FG000|Overall Study|Did not receive study drug|3|||
162206126|NCT00931918|585805462|FG001|Overall Study|Did not receive study drug|2|||
162206127|NCT00809341|585805463|FG000|Overall Study|Physician Decision|0|||
162206128|NCT00809341|585805464|FG001|Overall Study|Physician Decision|1|||
162206129|NCT00025506|585805469|FG000|Overall Study|Ineligible: clerical error|1|||
162206130|NCT00025506|585805469|FG000|Overall Study|Ineligible: wrong cell type|5|||
162206131|NCT00025506|585805469|FG000|Overall Study|Ineligible: inadequate pathology|2|||
162206132|NCT00025506|585805469|FG000|Overall Study|Never Treated|2|||
162206133|NCT04081389|585805474|FG000|Overall Study|Withdrawal by Subject|0|||
162206134|NCT04081389|585805475|FG001|Overall Study|Withdrawal by Subject|0|||
162206135|NCT04081389|585805476|FG002|Overall Study|Withdrawal by Subject|1|||
162206136|NCT04081389|585805477|FG003|Overall Study|Withdrawal by Subject|0|||
162206137|NCT00578318|585805478|FG000|Overall Study|Lost to Follow-up|2|||
162206138|NCT00578318|585805479|FG001|Overall Study|Lost to Follow-up|0|||
162206139|NCT00578318|585805478|FG000|Overall Study|Physician Decision|1|||
162206140|NCT00578318|585805479|FG001|Overall Study|Physician Decision|0|||
162206141|NCT00001941|585805481|FG000|Overall Study|not treated- rapidly progressing disease|0|||
162206142|NCT00001941|585805482|FG001|Overall Study|not treated- rapidly progressing disease|0|||
162206143|NCT00001941|585805483|FG002|Overall Study|not treated- rapidly progressing disease|0|||
162206144|NCT00001941|585805484|FG003|Overall Study|not treated- rapidly progressing disease|0|||
162206145|NCT00001941|585805485|FG004|Overall Study|not treated- rapidly progressing disease|1|||
162206146|NCT00510146|585805487|FG000|Double-Blind Treatment|Adverse Event|30|||
162206147|NCT00510146|585805488|FG001|Double-Blind Treatment|Adverse Event|13|||
162206148|NCT00510146|585805487|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
162206149|NCT00510146|585805488|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
162206150|NCT00510146|585805487|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
162206151|NCT00510146|585805488|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
162206152|NCT00510146|585805487|FG000|Double-Blind Treatment|Physician Decision|6|||
162206153|NCT00510146|585805488|FG001|Double-Blind Treatment|Physician Decision|0|||
162206154|NCT00510146|585805487|FG000|Double-Blind Treatment|Protocol Violation|1|||
162206155|NCT00510146|585805488|FG001|Double-Blind Treatment|Protocol Violation|2|||
162206156|NCT00510146|585805487|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
162206157|NCT00510146|585805488|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
162206158|NCT00510146|585805487|FG000|Double-Blind Treatment|Clinical Relapse|0|||
162206159|NCT00510146|585805488|FG001|Double-Blind Treatment|Clinical Relapse|1|||
162206160|NCT00510146|585805487|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
162206161|NCT00510146|585805488|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
162206162|NCT00510146|585805487|FG000|Open-Label Treatment|Adverse Event|22|||
162206163|NCT00510146|585805488|FG001|Open-Label Treatment|Adverse Event|8|||
162206164|NCT00510146|585805487|FG000|Open-Label Treatment|Death|1|||
162206165|NCT00510146|585805488|FG001|Open-Label Treatment|Death|1|||
162206166|NCT00510146|585805487|FG000|Open-Label Treatment|Lack of Efficacy|4|||
162206167|NCT00510146|585805488|FG001|Open-Label Treatment|Lack of Efficacy|0|||
162206168|NCT00510146|585805487|FG000|Open-Label Treatment|Lost to Follow-up|10|||
162206169|NCT00510146|585805488|FG001|Open-Label Treatment|Lost to Follow-up|1|||
162206170|NCT00510146|585805487|FG000|Open-Label Treatment|Physician Decision|3|||
162206171|NCT00510146|585805488|FG001|Open-Label Treatment|Physician Decision|1|||
162206172|NCT00510146|585805487|FG000|Open-Label Treatment|Protocol Violation|4|||
162206173|NCT00510146|585805488|FG001|Open-Label Treatment|Protocol Violation|2|||
162206174|NCT00510146|585805487|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
162206175|NCT00510146|585805488|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
162206176|NCT00510146|585805487|FG000|Open-Label Treatment|Clinical Relapse|1|||
162206177|NCT00510146|585805488|FG001|Open-Label Treatment|Clinical Relapse|1|||
162206178|NCT00510146|585805487|FG000|Open-Label Treatment|Sponsor Decision|2|||
162206179|NCT00510146|585805488|FG001|Open-Label Treatment|Sponsor Decision|0|||
162206180|NCT03640754|585805489|FG000|Overall Study|Withdrawal by Subject|1|||
162206181|NCT03640754|585805490|FG001|Overall Study|Withdrawal by Subject|0|||
162206182|NCT03640754|585805489|FG000|Overall Study|Lost to Follow-up|0|||
162206183|NCT03640754|585805490|FG001|Overall Study|Lost to Follow-up|1|||
162206184|NCT04380688|585805491|FG000|Overall Study|Death|2|||
162206185|NCT04380688|585805492|FG001|Overall Study|Death|2|||
162206186|NCT04380688|585805491|FG000|Overall Study|Lost to Follow-up|2|||
162206187|NCT04380688|585805492|FG001|Overall Study|Lost to Follow-up|4|||
162206188|NCT04380688|585805491|FG000|Overall Study|Withdrawal by Subject|3|||
162206189|NCT04380688|585805492|FG001|Overall Study|Withdrawal by Subject|3|||
162206190|NCT00919061|585805495|FG000|Overall Study|Adverse Event|1|||
162206191|NCT00919061|585805495|FG000|Overall Study|Withdrawal by Subject|1|||
162206192|NCT05294328|585805496|FG000|Overall Study|Adverse Event|1|||
162206193|NCT05294328|585805497|FG001|Overall Study|Adverse Event|0|||
162206194|NCT05294328|585805498|FG002|Overall Study|Adverse Event|0|||
162206195|NCT05294328|585805496|FG000|Overall Study|Physician Decision|1|||
162206196|NCT05294328|585805497|FG001|Overall Study|Physician Decision|1|||
162206197|NCT05294328|585805498|FG002|Overall Study|Physician Decision|0|||
162206198|NCT05294328|585805496|FG000|Overall Study|Withdrawal by Subject|0|||
162206199|NCT05294328|585805497|FG001|Overall Study|Withdrawal by Subject|2|||
162206200|NCT05294328|585805498|FG002|Overall Study|Withdrawal by Subject|1|||
162206201|NCT05294328|585805496|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
162206202|NCT05294328|585805497|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
162206203|NCT05294328|585805498|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
162206204|NCT02056873|585805499|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
162206205|NCT00664105|585807820|FG000|Overall Study|Death|3|||
162206206|NCT00664105|585807820|FG000|Overall Study|Withdrawal by Subject|5|||
162206207|NCT00664105|585807820|FG000|Overall Study|Adverse Event|9|||
162206208|NCT00664105|585807820|FG000|Overall Study|Disease progression|7|||
162206209|NCT00847132|585807824|FG000|Overall Study|Death|1|||
162206210|NCT00847132|585807825|FG001|Overall Study|Death|1|||
162206211|NCT00988533|585807827|FG000|Overall Study|Lost to Follow-up|3|||
162206212|NCT00913523|585807830|FG000|Overall Study|Withdrawal by Subject|3|||
162206213|NCT00913523|585807831|FG001|Overall Study|Withdrawal by Subject|2|||
162206214|NCT00913523|585807832|FG002|Overall Study|Withdrawal by Subject|2|||
162206215|NCT00913523|585807830|FG000|Overall Study|Lost to Follow-up|1|||
162206216|NCT00913523|585807831|FG001|Overall Study|Lost to Follow-up|1|||
162206217|NCT00913523|585807832|FG002|Overall Study|Lost to Follow-up|1|||
162206218|NCT00913523|585807830|FG000|Overall Study|Adverse Event|1|||
162206219|NCT00913523|585807831|FG001|Overall Study|Adverse Event|0|||
162206220|NCT00913523|585807832|FG002|Overall Study|Adverse Event|0|||
162206221|NCT00913523|585807830|FG000|Overall Study|Protocol Violation|5|||
162206222|NCT00913523|585807831|FG001|Overall Study|Protocol Violation|8|||
162206223|NCT00913523|585807832|FG002|Overall Study|Protocol Violation|8|||
162206224|NCT00913523|585807830|FG000|Overall Study|Pregnancy|1|||
162206225|NCT00913523|585807831|FG001|Overall Study|Pregnancy|3|||
162206226|NCT00913523|585807832|FG002|Overall Study|Pregnancy|0|||
162206227|NCT00913523|585807830|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
162206228|NCT00913523|585807831|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
162206229|NCT00913523|585807832|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
162206230|NCT01649297|585807834|FG000|Overall Study|Adverse Event|5|||
162206231|NCT01649297|585807835|FG001|Overall Study|Adverse Event|5|||
162206232|NCT01649297|585807836|FG002|Overall Study|Adverse Event|4|||
162206233|NCT01649297|585807837|FG003|Overall Study|Adverse Event|13|||
162206234|NCT01649297|585807838|FG004|Overall Study|Adverse Event|1|||
162206235|NCT01649297|585807834|FG000|Overall Study|Lack of Efficacy|0|||
162206236|NCT01649297|585807835|FG001|Overall Study|Lack of Efficacy|0|||
162206237|NCT01649297|585807836|FG002|Overall Study|Lack of Efficacy|0|||
162206238|NCT01649297|585807837|FG003|Overall Study|Lack of Efficacy|0|||
162206239|NCT01649297|585807838|FG004|Overall Study|Lack of Efficacy|1|||
162206240|NCT01649297|585807834|FG000|Overall Study|Non compliant with Protocol|1|||
162206241|NCT01649297|585807835|FG001|Overall Study|Non compliant with Protocol|0|||
162206242|NCT01649297|585807836|FG002|Overall Study|Non compliant with Protocol|3|||
162206243|NCT01649297|585807837|FG003|Overall Study|Non compliant with Protocol|2|||
162206244|NCT01649297|585807838|FG004|Overall Study|Non compliant with Protocol|1|||
162206245|NCT01649297|585807834|FG000|Overall Study|Lost to Follow-up|1|||
162206246|NCT01649297|585807835|FG001|Overall Study|Lost to Follow-up|1|||
162206247|NCT01649297|585807836|FG002|Overall Study|Lost to Follow-up|4|||
162206248|NCT01649297|585807837|FG003|Overall Study|Lost to Follow-up|3|||
162206249|NCT01649297|585807838|FG004|Overall Study|Lost to Follow-up|0|||
162206250|NCT01649297|585807834|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
162206251|NCT01649297|585807835|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
162206252|NCT01649297|585807836|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
162206253|NCT01649297|585807837|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
162206254|NCT01649297|585807838|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
162206255|NCT01649297|585807834|FG000|Overall Study|For other reason|4|||
162206256|NCT01649297|585807835|FG001|Overall Study|For other reason|1|||
162206257|NCT01649297|585807836|FG002|Overall Study|For other reason|2|||
162206258|NCT01649297|585807837|FG003|Overall Study|For other reason|0|||
162206259|NCT01649297|585807838|FG004|Overall Study|For other reason|0|||
162206260|NCT01685047|585807839|FG000|Overall Study|Withdrawal by Subject|20|||
162206261|NCT01685047|585807839|FG000|Overall Study|Death|26|||
162206262|NCT01685047|585807839|FG000|Overall Study|Lost to Follow-up|8|||
162206263|NCT01685047|585807839|FG000|Overall Study|Physician Decision|25|||
162206264|NCT01685047|585807839|FG000|Overall Study|Adverse Event|5|||
162206265|NCT01685047|585807839|FG000|Overall Study|patient withdrawn by sponsor|1|||
162206266|NCT02544113|585807840|FG000|Overall Study|Death|3|||
162206267|NCT02544113|585807841|FG001|Overall Study|Death|4|||
162206268|NCT02847637|585807845|FG000|Overall Study|Withdrawal by Subject|0|||
162206269|NCT02847637|585807846|FG001|Overall Study|Withdrawal by Subject|1|||
162206270|NCT02847637|585807847|FG002|Overall Study|Withdrawal by Subject|1|||
162206271|NCT02847637|585807848|FG003|Overall Study|Withdrawal by Subject|0|||
162206272|NCT02847637|585807845|FG000|Overall Study|Lost to Follow-up|1|||
162206273|NCT02847637|585807846|FG001|Overall Study|Lost to Follow-up|1|||
162206274|NCT02847637|585807847|FG002|Overall Study|Lost to Follow-up|0|||
162206275|NCT02847637|585807848|FG003|Overall Study|Lost to Follow-up|0|||
162206276|NCT01746108|585807849|FG000|Overall Study|Migrated /moved from study area|0|||
162206277|NCT01746108|585807850|FG001|Overall Study|Migrated /moved from study area|1|||
162206278|NCT01746108|585807851|FG002|Overall Study|Migrated /moved from study area|0|||
162206279|NCT01746108|585807849|FG000|Overall Study|Adverse event, non-fatal|0|||
162206280|NCT01746108|585807850|FG001|Overall Study|Adverse event, non-fatal|1|||
162206281|NCT01746108|585807851|FG002|Overall Study|Adverse event, non-fatal|0|||
162206282|NCT01746108|585807849|FG000|Overall Study|Withdrawal by Subject|0|||
162206283|NCT01746108|585807850|FG001|Overall Study|Withdrawal by Subject|1|||
162206284|NCT01746108|585807851|FG002|Overall Study|Withdrawal by Subject|0|||
162206285|NCT01746108|585807849|FG000|Overall Study|Lost to Follow-up|0|||
162206286|NCT01746108|585807850|FG001|Overall Study|Lost to Follow-up|1|||
162206287|NCT01746108|585807851|FG002|Overall Study|Lost to Follow-up|0|||
162206288|NCT03036150|585807852|FG000|Overall Study|Withdrawal by Subject|8|||
162206289|NCT03036150|585807853|FG001|Overall Study|Withdrawal by Subject|3|||
162206290|NCT03036150|585807852|FG000|Overall Study|Lost to Follow-up|2|||
162206291|NCT03036150|585807853|FG001|Overall Study|Lost to Follow-up|2|||
162206292|NCT02741713|585807860|FG000|Overall Study|Surgery type changed intra-operatively|2|||
162206293|NCT02741713|585807861|FG001|Overall Study|Surgery type changed intra-operatively|1|||
162206294|NCT00496626|585807862|FG000|Overall Study|Lost to Follow-up|0|||
162206295|NCT00496626|585807863|FG001|Overall Study|Lost to Follow-up|1|||
162206296|NCT00496626|585807862|FG000|Overall Study|Protocol Violation|1|||
162206297|NCT00496626|585807863|FG001|Overall Study|Protocol Violation|0|||
162206298|NCT00496626|585807862|FG000|Overall Study|Withdrawal by Subject|5|||
162206299|NCT00496626|585807863|FG001|Overall Study|Withdrawal by Subject|4|||
162206300|NCT00496626|585807862|FG000|Overall Study|Relocated|0|||
162206301|NCT00496626|585807863|FG001|Overall Study|Relocated|1|||
162206302|NCT00570921|585807864|FG000|Overall Study|Protocol Violation|1|||
162206303|NCT00570921|585807864|FG000|Overall Study|Physician Decision|1|||
162206304|NCT04191148|585807865|FG000|Overall Study|Withdrawal by Subject|1|||
162206305|NCT04191148|585807866|FG001|Overall Study|Withdrawal by Subject|0|||
162206306|NCT04191148|585807865|FG000|Overall Study|Adverse Event|1|||
162206307|NCT04191148|585807866|FG001|Overall Study|Adverse Event|0|||
162206308|NCT02647788|585807867|FG000|Overall Study|Lost to Follow-up|13|||
162206309|NCT02647788|585807868|FG001|Overall Study|Lost to Follow-up|11|||
162206310|NCT02647788|585807867|FG000|Overall Study|Did not want opiate|0|||
162206311|NCT02647788|585807868|FG001|Overall Study|Did not want opiate|1|||
162206312|NCT02647788|585807867|FG000|Overall Study|Withdrawal by Subject|1|||
162206313|NCT02647788|585807868|FG001|Overall Study|Withdrawal by Subject|0|||
162206314|NCT02647788|585807867|FG000|Overall Study|Felt itchy with assigned medication|1|||
162206315|NCT02647788|585807868|FG001|Overall Study|Felt itchy with assigned medication|0|||
162206316|NCT02647788|585807867|FG000|Overall Study|Felt nauseous with assigned medication|1|||
162206317|NCT02647788|585807868|FG001|Overall Study|Felt nauseous with assigned medication|1|||
162206318|NCT01274559|585807869|FG000|Overall Study|Adverse Event|57|||
162206319|NCT01274559|585807870|FG001|Overall Study|Adverse Event|13|||
162206320|NCT01274559|585807869|FG000|Overall Study|Death|1|||
162206321|NCT01274559|585807870|FG001|Overall Study|Death|1|||
162206322|NCT01274559|585807869|FG000|Overall Study|Lost to Follow-up|3|||
162206323|NCT01274559|585807870|FG001|Overall Study|Lost to Follow-up|3|||
162206324|NCT01274559|585807869|FG000|Overall Study|Non-compliance with Study Drug|2|||
162206325|NCT01274559|585807870|FG001|Overall Study|Non-compliance with Study Drug|4|||
162206326|NCT01274559|585807869|FG000|Overall Study|Physician Decision|2|||
162206327|NCT01274559|585807870|FG001|Overall Study|Physician Decision|1|||
162206328|NCT01274559|585807869|FG000|Overall Study|Protocol Violation|28|||
162206329|NCT01274559|585807870|FG001|Overall Study|Protocol Violation|23|||
162206330|NCT01274559|585807869|FG000|Overall Study|Study Terminated by Sponsor|79|||
162206331|NCT01274559|585807870|FG001|Overall Study|Study Terminated by Sponsor|87|||
162206332|NCT01274559|585807869|FG000|Overall Study|Withdrawal by Subject|25|||
162206333|NCT01274559|585807870|FG001|Overall Study|Withdrawal by Subject|13|||
162206334|NCT03201900|585807871|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
162206335|NCT03201900|585807871|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
162206336|NCT03201900|585807871|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
162206337|NCT03201900|585807871|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
162206338|NCT03201900|585807871|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
162206339|NCT03201900|585807871|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
162206340|NCT03201900|585807871|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
162206341|NCT03201900|585807871|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
162206342|NCT03201900|585807871|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
162206343|NCT03201900|585807871|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
162206344|NCT03201900|585807871|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
162206345|NCT03201900|585807871|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
162206346|NCT03201900|585807871|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
162206347|NCT01233999|585807872|FG000|Overall Study|Withdrawal by Subject|1|||
162206348|NCT01233999|585807872|FG000|Overall Study|Lost to Follow-up|1|||
162206349|NCT00550446|585807883|FG000|Up To Week 12|Adverse Event|2|||
162206350|NCT00550446|585807884|FG001|Up To Week 12|Adverse Event|2|||
162206351|NCT00550446|585807885|FG002|Up To Week 12|Adverse Event|0|||
162206352|NCT00550446|585807886|FG003|Up To Week 12|Adverse Event|0|||
162206353|NCT00550446|585807887|FG004|Up To Week 12|Adverse Event|2|||
162206354|NCT00550446|585807888|FG005|Up To Week 12|Adverse Event|2|||
162206355|NCT00550446|585807889|FG006|Up To Week 12|Adverse Event|1|||
162206356|NCT00550446|585807890|FG007|Up To Week 12|Adverse Event|0|||
162206357|NCT00550446|585807891|FG008|Up To Week 12|Adverse Event|0|||
162206358|NCT00550446|585807892|FG009|Up To Week 12|Adverse Event|0|||
162206359|NCT00550446|585807893|FG010|Up To Week 12|Adverse Event|0|||
162206360|NCT00550446|585807883|FG000|Up To Week 12|Lack of Efficacy|3|||
162206361|NCT00550446|585807884|FG001|Up To Week 12|Lack of Efficacy|1|||
162206362|NCT00550446|585807885|FG002|Up To Week 12|Lack of Efficacy|0|||
162206363|NCT00550446|585807886|FG003|Up To Week 12|Lack of Efficacy|1|||
162206364|NCT00550446|585807887|FG004|Up To Week 12|Lack of Efficacy|0|||
162206365|NCT00550446|585807888|FG005|Up To Week 12|Lack of Efficacy|3|||
162206366|NCT00550446|585807889|FG006|Up To Week 12|Lack of Efficacy|3|||
162206367|NCT00550446|585807890|FG007|Up To Week 12|Lack of Efficacy|0|||
162206368|NCT00550446|585807891|FG008|Up To Week 12|Lack of Efficacy|0|||
162206369|NCT00550446|585807892|FG009|Up To Week 12|Lack of Efficacy|0|||
162206370|NCT00550446|585807893|FG010|Up To Week 12|Lack of Efficacy|0|||
162206371|NCT00550446|585807883|FG000|Up To Week 12|Lost to Follow-up|0|||
162206372|NCT00550446|585807884|FG001|Up To Week 12|Lost to Follow-up|1|||
162206373|NCT00550446|585807885|FG002|Up To Week 12|Lost to Follow-up|0|||
162206374|NCT00550446|585807886|FG003|Up To Week 12|Lost to Follow-up|0|||
162206375|NCT00550446|585807887|FG004|Up To Week 12|Lost to Follow-up|1|||
162206376|NCT00550446|585807888|FG005|Up To Week 12|Lost to Follow-up|1|||
162206377|NCT00550446|585807889|FG006|Up To Week 12|Lost to Follow-up|2|||
162206378|NCT00550446|585807890|FG007|Up To Week 12|Lost to Follow-up|0|||
162206379|NCT00550446|585807891|FG008|Up To Week 12|Lost to Follow-up|0|||
162206380|NCT00550446|585807892|FG009|Up To Week 12|Lost to Follow-up|0|||
162206381|NCT00550446|585807893|FG010|Up To Week 12|Lost to Follow-up|0|||
162206382|NCT00550446|585807883|FG000|Up To Week 12|Withdrawal by Subject|2|||
162206383|NCT00550446|585807884|FG001|Up To Week 12|Withdrawal by Subject|0|||
162206384|NCT00550446|585807885|FG002|Up To Week 12|Withdrawal by Subject|3|||
162206385|NCT00550446|585807886|FG003|Up To Week 12|Withdrawal by Subject|2|||
162206386|NCT00550446|585807887|FG004|Up To Week 12|Withdrawal by Subject|0|||
162206387|NCT00550446|585807888|FG005|Up To Week 12|Withdrawal by Subject|1|||
162206388|NCT00550446|585807889|FG006|Up To Week 12|Withdrawal by Subject|3|||
162206389|NCT00550446|585807890|FG007|Up To Week 12|Withdrawal by Subject|0|||
162206390|NCT00550446|585807891|FG008|Up To Week 12|Withdrawal by Subject|0|||
162206391|NCT00550446|585807892|FG009|Up To Week 12|Withdrawal by Subject|0|||
162206392|NCT00550446|585807893|FG010|Up To Week 12|Withdrawal by Subject|0|||
162206393|NCT00550446|585807883|FG000|Up To Week 12|Other|3|||
162206394|NCT00550446|585807884|FG001|Up To Week 12|Other|0|||
162206395|NCT00550446|585807885|FG002|Up To Week 12|Other|0|||
162206396|NCT00550446|585807886|FG003|Up To Week 12|Other|0|||
162206397|NCT00550446|585807887|FG004|Up To Week 12|Other|0|||
162206398|NCT00550446|585807888|FG005|Up To Week 12|Other|1|||
162206399|NCT00550446|585807889|FG006|Up To Week 12|Other|4|||
162206400|NCT00550446|585807890|FG007|Up To Week 12|Other|0|||
162206401|NCT00550446|585807891|FG008|Up To Week 12|Other|0|||
162206402|NCT00550446|585807892|FG009|Up To Week 12|Other|0|||
162206403|NCT00550446|585807893|FG010|Up To Week 12|Other|0|||
162206404|NCT00550446|585807883|FG000|Up To Week 12|Randomized not treated|0|||
162206405|NCT00550446|585807884|FG001|Up To Week 12|Randomized not treated|1|||
162206406|NCT00550446|585807885|FG002|Up To Week 12|Randomized not treated|1|||
162206407|NCT00550446|585807886|FG003|Up To Week 12|Randomized not treated|0|||
162206408|NCT00550446|585807887|FG004|Up To Week 12|Randomized not treated|0|||
162206409|NCT00550446|585807888|FG005|Up To Week 12|Randomized not treated|0|||
162206410|NCT00550446|585807889|FG006|Up To Week 12|Randomized not treated|0|||
162206411|NCT00550446|585807890|FG007|Up To Week 12|Randomized not treated|0|||
162206412|NCT00550446|585807891|FG008|Up To Week 12|Randomized not treated|0|||
162206413|NCT00550446|585807892|FG009|Up To Week 12|Randomized not treated|0|||
162206414|NCT00550446|585807893|FG010|Up To Week 12|Randomized not treated|0|||
162206415|NCT00550446|585807883|FG000|Post Week 12|Adverse Event|2|||
162206416|NCT00550446|585807884|FG001|Post Week 12|Adverse Event|1|||
162206417|NCT00550446|585807885|FG002|Post Week 12|Adverse Event|1|||
162206418|NCT00550446|585807886|FG003|Post Week 12|Adverse Event|1|||
162206419|NCT00550446|585807887|FG004|Post Week 12|Adverse Event|1|||
162206420|NCT00550446|585807888|FG005|Post Week 12|Adverse Event|1|||
162206421|NCT00550446|585807889|FG006|Post Week 12|Adverse Event|0|||
162206422|NCT00550446|585807890|FG007|Post Week 12|Adverse Event|0|||
162206423|NCT00550446|585807891|FG008|Post Week 12|Adverse Event|0|||
162206424|NCT00550446|585807892|FG009|Post Week 12|Adverse Event|4|||
162206425|NCT00550446|585807893|FG010|Post Week 12|Adverse Event|0|||
162206426|NCT00550446|585807883|FG000|Post Week 12|Lack of Efficacy|0|||
162206427|NCT00550446|585807884|FG001|Post Week 12|Lack of Efficacy|0|||
162206428|NCT00550446|585807885|FG002|Post Week 12|Lack of Efficacy|1|||
162206429|NCT00550446|585807886|FG003|Post Week 12|Lack of Efficacy|0|||
162206430|NCT00550446|585807887|FG004|Post Week 12|Lack of Efficacy|0|||
162206431|NCT00550446|585807888|FG005|Post Week 12|Lack of Efficacy|0|||
162206432|NCT00550446|585807889|FG006|Post Week 12|Lack of Efficacy|0|||
162206433|NCT00550446|585807890|FG007|Post Week 12|Lack of Efficacy|1|||
162206434|NCT00550446|585807891|FG008|Post Week 12|Lack of Efficacy|1|||
162206435|NCT00550446|585807892|FG009|Post Week 12|Lack of Efficacy|2|||
162206436|NCT00550446|585807893|FG010|Post Week 12|Lack of Efficacy|1|||
162206437|NCT00550446|585807883|FG000|Post Week 12|Lost to Follow-up|0|||
162206438|NCT00550446|585807884|FG001|Post Week 12|Lost to Follow-up|0|||
162206439|NCT00550446|585807885|FG002|Post Week 12|Lost to Follow-up|1|||
162206440|NCT00550446|585807886|FG003|Post Week 12|Lost to Follow-up|1|||
162206441|NCT00550446|585807887|FG004|Post Week 12|Lost to Follow-up|0|||
162206442|NCT00550446|585807888|FG005|Post Week 12|Lost to Follow-up|0|||
162206443|NCT00550446|585807889|FG006|Post Week 12|Lost to Follow-up|1|||
162206444|NCT00550446|585807890|FG007|Post Week 12|Lost to Follow-up|0|||
162206445|NCT00550446|585807891|FG008|Post Week 12|Lost to Follow-up|0|||
162206446|NCT00550446|585807892|FG009|Post Week 12|Lost to Follow-up|0|||
162206447|NCT00550446|585807893|FG010|Post Week 12|Lost to Follow-up|0|||
162206448|NCT00550446|585807883|FG000|Post Week 12|Withdrawal by Subject|0|||
162206449|NCT00550446|585807884|FG001|Post Week 12|Withdrawal by Subject|0|||
162206450|NCT00550446|585807885|FG002|Post Week 12|Withdrawal by Subject|0|||
162206451|NCT00550446|585807886|FG003|Post Week 12|Withdrawal by Subject|0|||
162206452|NCT00550446|585807887|FG004|Post Week 12|Withdrawal by Subject|1|||
162206453|NCT00550446|585807888|FG005|Post Week 12|Withdrawal by Subject|0|||
162206454|NCT00550446|585807889|FG006|Post Week 12|Withdrawal by Subject|0|||
162206455|NCT00550446|585807890|FG007|Post Week 12|Withdrawal by Subject|0|||
162206456|NCT00550446|585807891|FG008|Post Week 12|Withdrawal by Subject|0|||
162206457|NCT00550446|585807892|FG009|Post Week 12|Withdrawal by Subject|0|||
162206458|NCT00550446|585807893|FG010|Post Week 12|Withdrawal by Subject|0|||
162206459|NCT00550446|585807883|FG000|Post Week 12|Other|1|||
162206460|NCT00550446|585807884|FG001|Post Week 12|Other|1|||
162206461|NCT00550446|585807885|FG002|Post Week 12|Other|0|||
162206462|NCT00550446|585807886|FG003|Post Week 12|Other|1|||
162206463|NCT00550446|585807887|FG004|Post Week 12|Other|0|||
162206464|NCT00550446|585807888|FG005|Post Week 12|Other|0|||
162206465|NCT00550446|585807889|FG006|Post Week 12|Other|1|||
162206466|NCT00550446|585807890|FG007|Post Week 12|Other|0|||
162206467|NCT00550446|585807891|FG008|Post Week 12|Other|1|||
162206468|NCT00550446|585807892|FG009|Post Week 12|Other|1|||
162206469|NCT00550446|585807893|FG010|Post Week 12|Other|0|||
162206470|NCT02482935|585807897|FG000|Period 1|Withdrawal by Subject|1|||
162206471|NCT02482935|585807898|FG001|Period 1|Withdrawal by Subject|0|||
162206472|NCT03503162|585807899|FG000|Overall Study|did not meet eligibility|1|||
162206473|NCT02835092|585807900|FG000|Overall Study|Withdrawal by Subject|3|||
162206474|NCT02835092|585807901|FG001|Overall Study|Withdrawal by Subject|6|||
162206475|NCT02835092|585807902|FG002|Overall Study|Withdrawal by Subject|3|||
162206476|NCT02835092|585807900|FG000|Overall Study|Lost to Follow-up|0|||
162206477|NCT02835092|585807901|FG001|Overall Study|Lost to Follow-up|2|||
162206478|NCT02835092|585807902|FG002|Overall Study|Lost to Follow-up|0|||
162206479|NCT02561806|585807903|FG000|Induction Period|Adverse Event|0|||
162206480|NCT02561806|585807904|FG001|Induction Period|Adverse Event|2|||
162206481|NCT02561806|585807903|FG000|Induction Period|Lack of Efficacy|1|||
162206482|NCT02561806|585807904|FG001|Induction Period|Lack of Efficacy|0|||
162206483|NCT02561806|585807903|FG000|Induction Period|Withdrawal by Subject|0|||
162206484|NCT02561806|585807904|FG001|Induction Period|Withdrawal by Subject|2|||
162206485|NCT02561806|585807903|FG000|Induction Period|Site staff became unblinded|1|||
162206486|NCT02561806|585807904|FG001|Induction Period|Site staff became unblinded|0|||
162206487|NCT02561806|585807903|FG000|Induction Period|Randomized but not treated|0|||
162206488|NCT02561806|585807904|FG001|Induction Period|Randomized but not treated|1|||
162206489|NCT02561806|585807903|FG000|Maintenance Period|Adverse Event|2|||
162206490|NCT02561806|585807904|FG001|Maintenance Period|Adverse Event|1|||
162206491|NCT02561806|585807903|FG000|Maintenance Period|Lack of Efficacy|3|||
162206492|NCT02561806|585807904|FG001|Maintenance Period|Lack of Efficacy|1|||
162206493|NCT02561806|585807903|FG000|Maintenance Period|Lost to Follow-up|2|||
162206494|NCT02561806|585807904|FG001|Maintenance Period|Lost to Follow-up|2|||
162206495|NCT02561806|585807903|FG000|Maintenance Period|Protocol Violation|1|||
162206496|NCT02561806|585807904|FG001|Maintenance Period|Protocol Violation|0|||
162206497|NCT02561806|585807903|FG000|Maintenance Period|Withdrawal by Subject|5|||
162206498|NCT02561806|585807904|FG001|Maintenance Period|Withdrawal by Subject|3|||
162206499|NCT02561806|585807903|FG000|Maintenance Period|Site staff became unblinded|0|||
162206500|NCT02561806|585807904|FG001|Maintenance Period|Site staff became unblinded|1|||
162206501|NCT02561806|585807903|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
162206502|NCT02561806|585807904|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
162206503|NCT02561806|585807903|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
162206504|NCT02561806|585807904|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
162206505|NCT00905034|585807906|FG000|Overall Study|Withdrawal by Subject|1|||
162206506|NCT00394589|585807907|FG000|Overall Study|Adverse Event|2|||
162206507|NCT00394589|585807908|FG001|Overall Study|Adverse Event|1|||
162206508|NCT00394589|585807909|FG002|Overall Study|Adverse Event|2|||
162206509|NCT00394589|585807907|FG000|Overall Study|Lack of Efficacy|2|||
162206510|NCT00394589|585807908|FG001|Overall Study|Lack of Efficacy|2|||
162206511|NCT00394589|585807909|FG002|Overall Study|Lack of Efficacy|3|||
162206512|NCT00394589|585807907|FG000|Overall Study|Protocol Violation|4|||
162206513|NCT00394589|585807908|FG001|Overall Study|Protocol Violation|0|||
162206514|NCT00394589|585807909|FG002|Overall Study|Protocol Violation|2|||
162206515|NCT03409731|585807911|FG000|Overall Study|Withdrawal by Subject|17|||
162206516|NCT03409731|585807911|FG000|Overall Study|Death|4|||
162206517|NCT01710800|585807919|FG000|Overall Study|Withdrawal by Subject|21|||
162206518|NCT01710800|585807919|FG000|Overall Study|Protocol Violation|1|||
162206519|NCT03891641|585807920|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
162206520|NCT03891641|585807921|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
162206521|NCT01585298|585807925|FG000|Overall Study|Study completion was not documented.|1|||
162206522|NCT01585298|585807925|FG000|Overall Study|Protocol deviation|1|||
162206523|NCT01585298|585807925|FG000|Overall Study|Administrative problems|4|||
162206524|NCT01585298|585807925|FG000|Overall Study|Lost to Follow-up|2|||
162206525|NCT01585298|585807925|FG000|Overall Study|Withdrawal by Subject|4|||
162206526|NCT01585298|585807925|FG000|Overall Study|Abnormal test procedure results|1|||
162206527|NCT01585298|585807925|FG000|Overall Study|Adverse Event|24|||
162206528|NCT01670188|585807926|FG000|Overall Study|Death|0|||
162206529|NCT01670188|585807927|FG001|Overall Study|Death|1|||
162206530|NCT02427958|585807930|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
162206531|NCT02427958|585807930|FG000|Overall Study|Lost to Follow-up|6|||
162206532|NCT02427958|585807930|FG000|Overall Study|Withdrawal by Subject|14|||
162206533|NCT02427958|585807930|FG000|Overall Study|Lack of Efficacy|1|||
162206534|NCT02025985|585807931|FG000|Overall Study|Consent withdrawn|0|||
162206535|NCT02025985|585807932|FG001|Overall Study|Consent withdrawn|0|||
162206536|NCT02025985|585807933|FG002|Overall Study|Consent withdrawn|1|||
162206537|NCT02025985|585807934|FG003|Overall Study|Consent withdrawn|0|||
162206538|NCT02025985|585807935|FG004|Overall Study|Consent withdrawn|0|||
162206539|NCT02025985|585807931|FG000|Overall Study|Termination of study by Sponsor|4|||
162206540|NCT02025985|585807932|FG001|Overall Study|Termination of study by Sponsor|3|||
162206541|NCT02025985|585807933|FG002|Overall Study|Termination of study by Sponsor|1|||
162206542|NCT02025985|585807934|FG003|Overall Study|Termination of study by Sponsor|1|||
162206543|NCT02025985|585807935|FG004|Overall Study|Termination of study by Sponsor|3|||
162206544|NCT02025985|585807931|FG000|Overall Study|Death|21|||
162206545|NCT02025985|585807932|FG001|Overall Study|Death|20|||
162206546|NCT02025985|585807933|FG002|Overall Study|Death|23|||
162206547|NCT02025985|585807934|FG003|Overall Study|Death|20|||
162206548|NCT02025985|585807935|FG004|Overall Study|Death|17|||
162206549|NCT03175198|585807936|FG000|Overall Study|Adverse Event|480|||
162206550|NCT03175198|585807936|FG000|Overall Study|No actual visit|120|||
162206551|NCT03175198|585807936|FG000|Overall Study|Registration rule not followed|4|||
162206552|NCT03175198|585807936|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
162206553|NCT03175198|585807936|FG000|Overall Study|Other personal reason|509|||
162206554|NCT03175198|585807936|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
162206555|NCT03175198|585807936|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
162206556|NCT03175198|585807936|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
162206557|NCT03175198|585807936|FG000|Overall Study|To conduct invasive treatment of operation|53|||
161932445|NCT01104870|584800470|FG001|Overall Study|Adverse Event|1|||
162206558|NCT03175198|585807936|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
162206559|NCT00545571|585807937|FG000|Overall Study|Administrative Reasons|1|||
162206560|NCT00545571|585807937|FG000|Overall Study|Adverse Event|2|||
162206561|NCT00545571|585807937|FG000|Overall Study|Death|5|||
162206562|NCT00545571|585807937|FG000|Overall Study|Lack of Efficacy|1|||
162206563|NCT00545571|585807937|FG000|Overall Study|Protocol Violation|2|||
162206564|NCT00545571|585807937|FG000|Overall Study|Refused Treatment|1|||
162206565|NCT00545571|585807937|FG000|Overall Study|Screen Failure|16|||
162206566|NCT00545571|585807937|FG000|Overall Study|Transfusion|12|||
162206567|NCT00545571|585807937|FG000|Overall Study|Early Termination of Study|24|||
162206568|NCT00545571|585807937|FG000|Overall Study|Kidney Transplantation|3|||
162206569|NCT00874497|585807938|FG000|Overall Study|Lost to Follow-up|2|||
162206570|NCT00874497|585807939|FG001|Overall Study|Lost to Follow-up|4|||
162206571|NCT00874497|585807938|FG000|Overall Study|Adverse Event|9|||
162206572|NCT00874497|585807939|FG001|Overall Study|Adverse Event|4|||
162206573|NCT00874497|585807938|FG000|Overall Study|Sponsor Discontinued Trial|7|||
162206574|NCT00874497|585807939|FG001|Overall Study|Sponsor Discontinued Trial|3|||
162206575|NCT00874497|585807938|FG000|Overall Study|Met Withdrawal Criteria|4|||
162206576|NCT00874497|585807939|FG001|Overall Study|Met Withdrawal Criteria|2|||
162206577|NCT00874497|585807938|FG000|Overall Study|Physician Decision|1|||
162206578|NCT00874497|585807939|FG001|Overall Study|Physician Decision|1|||
162206579|NCT00874497|585807938|FG000|Overall Study|Withdrawal by Subject|5|||
162206580|NCT00874497|585807939|FG001|Overall Study|Withdrawal by Subject|4|||
162206581|NCT00591591|585807940|FG000|Overall Study|Withdrawal by Subject|1|||
162206582|NCT00591591|585807941|FG001|Overall Study|Withdrawal by Subject|37|||
162206583|NCT00591591|585807940|FG000|Overall Study|Lack of Efficacy|10|||
162206584|NCT00591591|585807941|FG001|Overall Study|Lack of Efficacy|2|||
162206585|NCT01013740|585807942|FG000|Overall Study|Lost to Follow-up|3|||
162206586|NCT01013740|585807943|FG001|Overall Study|Lost to Follow-up|5|||
162206587|NCT01013740|585807942|FG000|Overall Study|Physician Decision|2|||
162206588|NCT01013740|585807943|FG001|Overall Study|Physician Decision|0|||
162206589|NCT01013740|585807942|FG000|Overall Study|Withdrawal by Subject|2|||
162206590|NCT01013740|585807943|FG001|Overall Study|Withdrawal by Subject|10|||
162206591|NCT01013740|585807942|FG000|Overall Study|study close / terminated : done in error|2|||
162206592|NCT01013740|585807943|FG001|Overall Study|study close / terminated : done in error|1|||
162206593|NCT01013740|585807942|FG000|Overall Study|Missing|2|||
162206594|NCT01013740|585807943|FG001|Overall Study|Missing|1|||
162206595|NCT01013740|585807942|FG000|Overall Study|Ongoing: Study records not completed|0|||
161677483|NCT00467779|583872007|FG007|Stage 3|Death|0|||
161932446|NCT01104870|584800471|FG002|Overall Study|Adverse Event|0|||
161932447|NCT01104870|584800469|FG000|Overall Study|Death|0|||
161932448|NCT01104870|584800470|FG001|Overall Study|Death|0|||
161932449|NCT01104870|584800471|FG002|Overall Study|Death|1|||
161932450|NCT01104870|584800469|FG000|Overall Study|Withdrawal by Subject|0|||
161932451|NCT01104870|584800470|FG001|Overall Study|Withdrawal by Subject|0|||
161932452|NCT01104870|584800471|FG002|Overall Study|Withdrawal by Subject|1|||
161932453|NCT02771145|584800477|FG000|Overall Study|Adverse Event|3|||
161932454|NCT02771145|584800477|FG000|Overall Study|Lost to Follow-up|1|||
161932455|NCT00276380|584800478|FG000|Overall Study|Adverse Event|5|||
161932456|NCT00276380|584800479|FG001|Overall Study|Adverse Event|3|||
161932457|NCT00276380|584800478|FG000|Overall Study|Lost to Follow-up|1|||
161932458|NCT00276380|584800479|FG001|Overall Study|Lost to Follow-up|1|||
162206596|NCT01013740|585807943|FG001|Overall Study|Ongoing: Study records not completed|2|||
161677484|NCT00467779|583872008|FG008|Stage 3|Death|0|||
161932459|NCT00276380|584800478|FG000|Overall Study|Withdrawal by Subject|3|||
162206597|NCT00607997|585807944|FG000|Overall Study|Lack of Efficacy|6|||
162206598|NCT00607997|585807945|FG001|Overall Study|Lack of Efficacy|20|||
162206599|NCT00607997|585807946|FG002|Overall Study|Lack of Efficacy|14|||
162206600|NCT00607997|585807947|FG003|Overall Study|Lack of Efficacy|10|||
162206601|NCT00607997|585807944|FG000|Overall Study|Death|8|||
162206602|NCT00607997|585807945|FG001|Overall Study|Death|5|||
162206603|NCT00607997|585807946|FG002|Overall Study|Death|2|||
162206604|NCT00607997|585807947|FG003|Overall Study|Death|5|||
162206605|NCT00607997|585807944|FG000|Overall Study|Adverse Event|3|||
162206606|NCT00607997|585807945|FG001|Overall Study|Adverse Event|1|||
162206607|NCT00607997|585807946|FG002|Overall Study|Adverse Event|2|||
162206608|NCT00607997|585807947|FG003|Overall Study|Adverse Event|0|||
162206609|NCT00607997|585807944|FG000|Overall Study|Physician Decision|4|||
162206610|NCT00607997|585807945|FG001|Overall Study|Physician Decision|1|||
162206611|NCT00607997|585807946|FG002|Overall Study|Physician Decision|0|||
162206612|NCT00607997|585807947|FG003|Overall Study|Physician Decision|0|||
162206613|NCT00607997|585807944|FG000|Overall Study|Relapse, recurrent illness|4|||
162206614|NCT00607997|585807945|FG001|Overall Study|Relapse, recurrent illness|0|||
162206615|NCT00607997|585807946|FG002|Overall Study|Relapse, recurrent illness|2|||
162206616|NCT00607997|585807947|FG003|Overall Study|Relapse, recurrent illness|0|||
162206617|NCT00607997|585807944|FG000|Overall Study|Other without explanation|2|||
162206618|NCT00607997|585807945|FG001|Overall Study|Other without explanation|0|||
162206619|NCT00607997|585807946|FG002|Overall Study|Other without explanation|4|||
162206620|NCT00607997|585807947|FG003|Overall Study|Other without explanation|1|||
162206621|NCT03811834|585807948|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
162206622|NCT01242371|585807949|FG000|Overall Study|Withdrawal by Subject|2|||
162206623|NCT01242371|585807950|FG001|Overall Study|Withdrawal by Subject|2|||
162206624|NCT01242371|585807949|FG000|Overall Study|Protocol Violation|0|||
162206625|NCT01242371|585807950|FG001|Overall Study|Protocol Violation|3|||
162206626|NCT06080438|585807953|FG000|Overall Study|Lost to Follow-up|2|||
162206627|NCT03589300|585807954|FG000|Overall Study|Adverse Event|2|||
162206628|NCT03589300|585807954|FG000|Overall Study|Death|4|||
162206629|NCT03589300|585807954|FG000|Overall Study|Lost to Follow-up|12|||
162206630|NCT03589300|585807954|FG000|Overall Study|Withdrawal by Subject|5|||
162206631|NCT01527500|585807955|FG000|Part A|Administrative|11|||
162206632|NCT01527500|585807956|FG001|Part A|Administrative|7|||
162206633|NCT01527500|585807955|FG000|Part A|Adverse Event|4|||
162206634|NCT01527500|585807956|FG001|Part A|Adverse Event|2|||
162206635|NCT01527500|585807955|FG000|Part A|Death|4|||
162206636|NCT01527500|585807956|FG001|Part A|Death|1|||
162206637|NCT01527500|585807955|FG000|Part A|Lost to Follow-up|0|||
162206638|NCT01527500|585807956|FG001|Part A|Lost to Follow-up|1|||
162206639|NCT01527500|585807955|FG000|Part A|Protocol Deviation|9|||
162206640|NCT01527500|585807956|FG001|Part A|Protocol Deviation|2|||
162206641|NCT01527500|585807955|FG000|Part A|Withdrawal by Subject|2|||
162206642|NCT01527500|585807956|FG001|Part A|Withdrawal by Subject|0|||
162206643|NCT01527500|585807955|FG000|Part B|Adverse Event|1|||
161932460|NCT00276380|584800479|FG001|Overall Study|Withdrawal by Subject|6|||
161932461|NCT00276380|584800478|FG000|Overall Study|Death|5|||
161932462|NCT00276380|584800479|FG001|Overall Study|Death|3|||
161932463|NCT00276380|584800478|FG000|Overall Study|Abnormal aPPT Levels|0|||
161932464|NCT00276380|584800479|FG001|Overall Study|Abnormal aPPT Levels|1|||
161932465|NCT02150863|584800480|FG000|Overall Study|Lost to Follow-up|0|||
161932466|NCT02150863|584800481|FG001|Overall Study|Lost to Follow-up|1|||
161932467|NCT02150863|584800482|FG002|Overall Study|Lost to Follow-up|0|||
161932468|NCT01651208|584800483|FG000|Overall Study|Lost to Follow-up|14|||
161932469|NCT01651208|584800484|FG001|Overall Study|Lost to Follow-up|16|||
161932470|NCT04008069|584800488|FG000|Open-Label Period|Adverse Event|1|||
161932471|NCT04008069|584800489|FG001|Open-Label Period|Adverse Event|0|||
161932472|NCT04008069|584800490|FG002|Open-Label Period|Adverse Event|0|||
161932473|NCT04008069|584800488|FG000|Open-Label Period|Lack of Efficacy|4|||
161932474|NCT04008069|584800489|FG001|Open-Label Period|Lack of Efficacy|0|||
161932475|NCT04008069|584800490|FG002|Open-Label Period|Lack of Efficacy|0|||
162206644|NCT01527500|585807956|FG001|Part B|Adverse Event|0|||
162206645|NCT00372255|585807957|FG000|Overall Study|Withdrawn for other reasons|2|||
162206646|NCT00372255|585807958|FG001|Overall Study|Withdrawn for other reasons|1|||
162206647|NCT00776984|585807959|FG000|Overall Study|Adverse Event|8|||
162206648|NCT00776984|585807960|FG001|Overall Study|Adverse Event|2|||
162206649|NCT00776984|585807959|FG000|Overall Study|Protocol Violation|4|||
162206650|NCT00776984|585807960|FG001|Overall Study|Protocol Violation|2|||
162206651|NCT00776984|585807959|FG000|Overall Study|Lost to Follow-up|2|||
162206652|NCT00776984|585807960|FG001|Overall Study|Lost to Follow-up|0|||
162206653|NCT00776984|585807959|FG000|Overall Study|Withdrawal by Subject|12|||
162206654|NCT00776984|585807960|FG001|Overall Study|Withdrawal by Subject|7|||
162206655|NCT00776984|585807959|FG000|Overall Study|Lack of Efficacy|0|||
161932476|NCT04008069|584800488|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
161932477|NCT04008069|584800489|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
161932478|NCT04008069|584800490|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
162206656|NCT00776984|585807960|FG001|Overall Study|Lack of Efficacy|1|||
162206657|NCT00776984|585807959|FG000|Overall Study|Other|5|||
162206658|NCT00776984|585807960|FG001|Overall Study|Other|9|||
161932479|NCT04008069|584800488|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
161932480|NCT04008069|584800489|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
161932481|NCT04008069|584800490|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
162206659|NCT02573883|585807966|FG000|Six Month Follow Up|Lost to Follow-up|1|||
162206660|NCT02573883|585807967|FG001|Six Month Follow Up|Lost to Follow-up|0|||
162206661|NCT02573883|585807968|FG002|Six Month Follow Up|Lost to Follow-up|0|||
162206662|NCT02573883|585807969|FG003|Six Month Follow Up|Lost to Follow-up|0|||
162206663|NCT02573883|585807966|FG000|One Year Follow Up|Lost to Follow-up|2|||
162206664|NCT02573883|585807967|FG001|One Year Follow Up|Lost to Follow-up|1|||
162206665|NCT02573883|585807968|FG002|One Year Follow Up|Lost to Follow-up|0|||
162206666|NCT02573883|585807969|FG003|One Year Follow Up|Lost to Follow-up|0|||
162206667|NCT01208870|585807975|FG000|Overall Study|Lost to Follow-up|2|||
162206668|NCT01208870|585807976|FG001|Overall Study|Lost to Follow-up|8|||
162206669|NCT00356759|585807977|FG000|Overall Study|Death|5|||
162206670|NCT00356759|585807978|FG001|Overall Study|Death|2|||
162206671|NCT00356759|585807977|FG000|Overall Study|Withdrawal by Subject|2|||
162206672|NCT00356759|585807978|FG001|Overall Study|Withdrawal by Subject|2|||
162206673|NCT00356759|585807977|FG000|Overall Study|Adverse Event|1|||
162206674|NCT00356759|585807978|FG001|Overall Study|Adverse Event|3|||
162206675|NCT00356759|585807977|FG000|Overall Study|Lost to Follow-up|1|||
162206676|NCT00356759|585807978|FG001|Overall Study|Lost to Follow-up|1|||
162206677|NCT00356759|585807977|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
162206678|NCT00356759|585807978|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
162206679|NCT01204775|585807979|FG000|Overall Study|Poor/non-compliance|0|||
162206680|NCT01204775|585807980|FG001|Overall Study|Poor/non-compliance|1|||
162206681|NCT01204775|585807979|FG000|Overall Study|Withdrawal by Subject|1|||
162206682|NCT01204775|585807980|FG001|Overall Study|Withdrawal by Subject|0|||
162206683|NCT00276016|585807981|FG000|Intervention 1|Withdrawal by Subject|0|||
162206684|NCT00276016|585807982|FG001|Intervention 1|Withdrawal by Subject|1|||
162206685|NCT00276016|585807983|FG002|Intervention 1|Withdrawal by Subject|0|||
162206686|NCT00276016|585807984|FG003|Intervention 1|Withdrawal by Subject|0|||
162206687|NCT00276016|585807985|FG004|Intervention 1|Withdrawal by Subject|0|||
162206688|NCT00276016|585807986|FG005|Intervention 1|Withdrawal by Subject|0|||
162206689|NCT01181609|585809869|FG000|Overall Study|Adverse Event|1|||
162206690|NCT01181609|585809869|FG000|Overall Study|Withdrawal by Subject|1|||
162206691|NCT01181609|585809869|FG000|Overall Study|Lost to Follow-up|1|||
162206692|NCT01181609|585809869|FG000|Overall Study|Death|50|||
162206693|NCT03991988|585809873|FG000|Overall Study|Withdrawal by Subject|2|||
162206694|NCT03991988|585809874|FG001|Overall Study|Withdrawal by Subject|2|||
162206695|NCT01751165|585809878|FG000|Overall Study|Adverse event, serious fatal|1|||
162206696|NCT01751165|585809879|FG001|Overall Study|Adverse event, serious fatal|0|||
162206697|NCT01751165|585809880|FG002|Overall Study|Adverse event, serious fatal|1|||
162206698|NCT01751165|585809878|FG000|Overall Study|Withdrawal by Subject|0|||
162206699|NCT01751165|585809879|FG001|Overall Study|Withdrawal by Subject|0|||
162206700|NCT01751165|585809880|FG002|Overall Study|Withdrawal by Subject|1|||
162206701|NCT01751165|585809878|FG000|Overall Study|Serious adverse event|0|||
162206702|NCT01751165|585809879|FG001|Overall Study|Serious adverse event|2|||
162206703|NCT01751165|585809880|FG002|Overall Study|Serious adverse event|0|||
162206704|NCT01751165|585809878|FG000|Overall Study|Lost to Follow-up|1|||
162206705|NCT01751165|585809879|FG001|Overall Study|Lost to Follow-up|1|||
162206706|NCT01751165|585809880|FG002|Overall Study|Lost to Follow-up|1|||
162206707|NCT01036165|585809881|FG000|Overall Study|Adverse Event|6|||
162206708|NCT01036165|585809881|FG000|Overall Study|Lost to Follow-up|2|||
162206709|NCT01036165|585809881|FG000|Overall Study|Withdrawal by Subject|3|||
161932482|NCT00511199|584800492|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
161932483|NCT00511199|584800493|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
161932484|NCT00511199|584800492|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
161932485|NCT00511199|584800493|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
162206710|NCT01036165|585809881|FG000|Overall Study|Device Related Issues|3|||
162206711|NCT01036165|585809881|FG000|Overall Study|Problems finding proper area to inject|1|||
162206712|NCT01475461|585809882|FG000|Run-in Period|Not meet eligibility criteria|16|||
162206713|NCT01475461|585809883|FG001|Run-in Period|Not meet eligibility criteria|0|||
162206714|NCT01475461|585809884|FG002|Run-in Period|Not meet eligibility criteria|0|||
162206715|NCT01475461|585809885|FG003|Run-in Period|Not meet eligibility criteria|0|||
162206716|NCT01475461|585809886|FG004|Run-in Period|Not meet eligibility criteria|0|||
162206717|NCT01475461|585809887|FG005|Run-in Period|Not meet eligibility criteria|0|||
162206718|NCT01475461|585809888|FG006|Run-in Period|Not meet eligibility criteria|0|||
162206719|NCT01475461|585809882|FG000|Run-in Period|Lost to Follow-up|7|||
162206720|NCT01475461|585809883|FG001|Run-in Period|Lost to Follow-up|0|||
162206721|NCT01475461|585809884|FG002|Run-in Period|Lost to Follow-up|0|||
162206722|NCT01475461|585809885|FG003|Run-in Period|Lost to Follow-up|0|||
162206723|NCT01475461|585809886|FG004|Run-in Period|Lost to Follow-up|0|||
162206724|NCT01475461|585809887|FG005|Run-in Period|Lost to Follow-up|0|||
162206725|NCT01475461|585809888|FG006|Run-in Period|Lost to Follow-up|0|||
162206726|NCT01475461|585809882|FG000|Run-in Period|Withdrawal by Subject|11|||
162206727|NCT01475461|585809883|FG001|Run-in Period|Withdrawal by Subject|0|||
162206728|NCT01475461|585809884|FG002|Run-in Period|Withdrawal by Subject|0|||
162206729|NCT01475461|585809885|FG003|Run-in Period|Withdrawal by Subject|0|||
162206730|NCT01475461|585809886|FG004|Run-in Period|Withdrawal by Subject|0|||
162206731|NCT01475461|585809887|FG005|Run-in Period|Withdrawal by Subject|0|||
162206732|NCT01475461|585809888|FG006|Run-in Period|Withdrawal by Subject|0|||
162206733|NCT01475461|585809882|FG000|Run-in Period|Other|3|||
162206734|NCT01475461|585809883|FG001|Run-in Period|Other|0|||
162206735|NCT01475461|585809884|FG002|Run-in Period|Other|0|||
162206736|NCT01475461|585809885|FG003|Run-in Period|Other|0|||
162206737|NCT01475461|585809886|FG004|Run-in Period|Other|0|||
162206738|NCT01475461|585809887|FG005|Run-in Period|Other|0|||
162206739|NCT01475461|585809888|FG006|Run-in Period|Other|0|||
162206740|NCT01475461|585809882|FG000|Run-in Period|Protocol Violation|4|||
162206741|NCT01475461|585809883|FG001|Run-in Period|Protocol Violation|0|||
162206742|NCT01475461|585809884|FG002|Run-in Period|Protocol Violation|0|||
162206743|NCT01475461|585809885|FG003|Run-in Period|Protocol Violation|0|||
162206744|NCT01475461|585809886|FG004|Run-in Period|Protocol Violation|0|||
162206745|NCT01475461|585809887|FG005|Run-in Period|Protocol Violation|0|||
162206746|NCT01475461|585809888|FG006|Run-in Period|Protocol Violation|0|||
162206747|NCT01475461|585809882|FG000|Treatment Period|Death|0|||
162206748|NCT01475461|585809883|FG001|Treatment Period|Death|0|||
162206749|NCT01475461|585809884|FG002|Treatment Period|Death|0|||
162206750|NCT01475461|585809885|FG003|Treatment Period|Death|1|||
162206751|NCT01475461|585809886|FG004|Treatment Period|Death|0|||
162206752|NCT01475461|585809887|FG005|Treatment Period|Death|0|||
162206753|NCT01475461|585809888|FG006|Treatment Period|Death|0|||
162206754|NCT01475461|585809882|FG000|Treatment Period|Lost to Follow-up|0|||
162206755|NCT01475461|585809883|FG001|Treatment Period|Lost to Follow-up|3|||
162206756|NCT01475461|585809884|FG002|Treatment Period|Lost to Follow-up|2|||
162206757|NCT01475461|585809885|FG003|Treatment Period|Lost to Follow-up|3|||
162206758|NCT01475461|585809886|FG004|Treatment Period|Lost to Follow-up|1|||
162206759|NCT01475461|585809887|FG005|Treatment Period|Lost to Follow-up|2|||
162206760|NCT01475461|585809888|FG006|Treatment Period|Lost to Follow-up|1|||
162206761|NCT01475461|585809882|FG000|Treatment Period|Withdrawal by Subject|0|||
162206762|NCT01475461|585809883|FG001|Treatment Period|Withdrawal by Subject|2|||
162206763|NCT01475461|585809884|FG002|Treatment Period|Withdrawal by Subject|2|||
162206764|NCT01475461|585809885|FG003|Treatment Period|Withdrawal by Subject|0|||
162206765|NCT01475461|585809886|FG004|Treatment Period|Withdrawal by Subject|2|||
162206766|NCT01475461|585809887|FG005|Treatment Period|Withdrawal by Subject|2|||
162206767|NCT01475461|585809888|FG006|Treatment Period|Withdrawal by Subject|0|||
162206768|NCT01475461|585809882|FG000|Treatment Period|Other|0|||
162206769|NCT01475461|585809883|FG001|Treatment Period|Other|1|||
162206770|NCT01475461|585809884|FG002|Treatment Period|Other|0|||
162206771|NCT01475461|585809885|FG003|Treatment Period|Other|0|||
162206772|NCT01475461|585809886|FG004|Treatment Period|Other|0|||
162206773|NCT01475461|585809887|FG005|Treatment Period|Other|0|||
162206774|NCT01475461|585809888|FG006|Treatment Period|Other|0|||
162206775|NCT01475461|585809882|FG000|Treatment Period|Protocol Violation|0|||
162206776|NCT01475461|585809883|FG001|Treatment Period|Protocol Violation|1|||
162206777|NCT01475461|585809884|FG002|Treatment Period|Protocol Violation|0|||
162206778|NCT01475461|585809885|FG003|Treatment Period|Protocol Violation|0|||
162206779|NCT01475461|585809886|FG004|Treatment Period|Protocol Violation|0|||
162206780|NCT01475461|585809887|FG005|Treatment Period|Protocol Violation|0|||
162206781|NCT01475461|585809888|FG006|Treatment Period|Protocol Violation|1|||
162206782|NCT01475461|585809882|FG000|Treatment Period|Lack of Efficacy|0|||
162206783|NCT01475461|585809883|FG001|Treatment Period|Lack of Efficacy|2|||
162206784|NCT01475461|585809884|FG002|Treatment Period|Lack of Efficacy|0|||
162206785|NCT01475461|585809885|FG003|Treatment Period|Lack of Efficacy|2|||
162206786|NCT01475461|585809886|FG004|Treatment Period|Lack of Efficacy|1|||
162206787|NCT01475461|585809887|FG005|Treatment Period|Lack of Efficacy|1|||
162206788|NCT01475461|585809888|FG006|Treatment Period|Lack of Efficacy|0|||
162206789|NCT01475461|585809882|FG000|Treatment Period|Medication Error|0|||
162206790|NCT01475461|585809883|FG001|Treatment Period|Medication Error|0|||
162206791|NCT01475461|585809884|FG002|Treatment Period|Medication Error|0|||
162206792|NCT01475461|585809885|FG003|Treatment Period|Medication Error|1|||
162206793|NCT01475461|585809886|FG004|Treatment Period|Medication Error|0|||
162206794|NCT01475461|585809887|FG005|Treatment Period|Medication Error|0|||
162206795|NCT01475461|585809888|FG006|Treatment Period|Medication Error|0|||
162206796|NCT01475461|585809882|FG000|Treatment Period|Adverse Event|0|||
162206797|NCT01475461|585809883|FG001|Treatment Period|Adverse Event|0|||
162206798|NCT01475461|585809884|FG002|Treatment Period|Adverse Event|0|||
162206799|NCT01475461|585809885|FG003|Treatment Period|Adverse Event|1|||
162206800|NCT01475461|585809886|FG004|Treatment Period|Adverse Event|0|||
162206801|NCT01475461|585809887|FG005|Treatment Period|Adverse Event|0|||
162206802|NCT01475461|585809888|FG006|Treatment Period|Adverse Event|0|||
162206803|NCT04051242|585809889|FG000|Overall Study|Withdrawal by Subject|1|||
162206804|NCT04051242|585809889|FG000|Overall Study|Physician Decision|1|||
162206805|NCT02262364|585809892|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
162206806|NCT01049984|585809893|FG000|Overall Study|Withdrawal by Subject|1|||
162206807|NCT01049984|585809894|FG001|Overall Study|Withdrawal by Subject|5|||
162206808|NCT01049984|585809893|FG000|Overall Study|Protocol Violation|3|||
162206809|NCT01049984|585809894|FG001|Overall Study|Protocol Violation|4|||
162206810|NCT01049984|585809893|FG000|Overall Study|Lost to Follow-up|2|||
162206811|NCT01049984|585809894|FG001|Overall Study|Lost to Follow-up|1|||
162206812|NCT01049984|585809893|FG000|Overall Study|Adverse Event|13|||
162206813|NCT01049984|585809894|FG001|Overall Study|Adverse Event|7|||
162206814|NCT01049984|585809893|FG000|Overall Study|Treatment failure|0|||
162206815|NCT01049984|585809894|FG001|Overall Study|Treatment failure|2|||
162206816|NCT00553605|585809895|FG000|Overall Study|Did not meet entrance criteria|1|||
162206817|NCT00553605|585809896|FG001|Overall Study|Did not meet entrance criteria|3|||
162206818|NCT00553605|585809895|FG000|Overall Study|Did not receive full dose|1|||
162206819|NCT00553605|585809896|FG001|Overall Study|Did not receive full dose|0|||
162206820|NCT00553605|585809895|FG000|Overall Study|Randomized but not treated|2|||
162206821|NCT00553605|585809896|FG001|Overall Study|Randomized but not treated|0|||
162206822|NCT01040403|585809900|FG000|Overall Study|Adverse Event|10|||
162206823|NCT01040403|585809900|FG000|Overall Study|Protocol Violation|2|||
162206824|NCT01040403|585809900|FG000|Overall Study|Lost to Follow-up|1|||
162206825|NCT01040403|585809900|FG000|Overall Study|Not treated|1|||
162206826|NCT01040403|585809900|FG000|Overall Study|Other reason not defined above|6|||
162206827|NCT01085812|585809902|FG000|Open-Label Period|Adverse Event|0|||
162206828|NCT01085812|585809903|FG001|Open-Label Period|Adverse Event|80|||
162206829|NCT01085812|585809902|FG000|Open-Label Period|Lack of Efficacy|0|||
162206830|NCT01085812|585809903|FG001|Open-Label Period|Lack of Efficacy|26|||
162206831|NCT01085812|585809902|FG000|Open-Label Period|Protocol Violation|0|||
162206832|NCT01085812|585809903|FG001|Open-Label Period|Protocol Violation|39|||
162206833|NCT01085812|585809902|FG000|Open-Label Period|Withdrawal by Subject|0|||
162206834|NCT01085812|585809903|FG001|Open-Label Period|Withdrawal by Subject|53|||
162206835|NCT01085812|585809902|FG000|Open-Label Period|Lost to Follow-up|0|||
162206836|NCT01085812|585809903|FG001|Open-Label Period|Lost to Follow-up|42|||
162206837|NCT01085812|585809902|FG000|Double-Blind Period|Adverse Event|3|||
162206838|NCT01085812|585809903|FG001|Double-Blind Period|Adverse Event|8|||
162206839|NCT01085812|585809902|FG000|Double-Blind Period|Protocol Violation|2|||
162206840|NCT01085812|585809903|FG001|Double-Blind Period|Protocol Violation|7|||
162206841|NCT01085812|585809902|FG000|Double-Blind Period|Withdrawal by Subject|11|||
162206842|NCT01085812|585809903|FG001|Double-Blind Period|Withdrawal by Subject|24|||
162206843|NCT01085812|585809902|FG000|Double-Blind Period|Lost to Follow-up|5|||
162206844|NCT01085812|585809903|FG001|Double-Blind Period|Lost to Follow-up|17|||
162206845|NCT01085812|585809902|FG000|Double-Blind Period|Other Reasons|0|||
162206846|NCT01085812|585809903|FG001|Double-Blind Period|Other Reasons|2|||
162206847|NCT01085812|585809902|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
162206848|NCT01085812|585809903|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
162206849|NCT01085812|585809902|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
162206850|NCT01085812|585809903|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
162206851|NCT01085812|585809902|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
162206852|NCT01085812|585809903|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
162206853|NCT01085812|585809902|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
162206854|NCT01085812|585809903|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
162206855|NCT01085812|585809902|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
162206856|NCT01085812|585809903|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
162206857|NCT04582669|585809907|FG000|Overall Study|Subject missed appointment(s).|1|||
162206858|NCT04582669|585809908|FG001|Overall Study|Subject missed appointment(s).|0|||
162206859|NCT04582669|585809909|FG002|Overall Study|Subject missed appointment(s).|1|||
162206860|NCT04582669|585809910|FG003|Overall Study|Subject missed appointment(s).|2|||
162206861|NCT04582669|585809907|FG000|Overall Study|Protocol Violation|0|||
161677485|NCT00467779|583872009|FG009|Stage 3|Death|0|||
161824393|NCT02061280|584397982|FG001|Overall Study|Withdrawal by Subject|2|||
161824394|NCT02061280|584397981|FG000|Overall Study|Lost to Follow-up|5|||
162206862|NCT04582669|585809908|FG001|Overall Study|Protocol Violation|1|||
162206863|NCT04582669|585809909|FG002|Overall Study|Protocol Violation|1|||
162206864|NCT04582669|585809910|FG003|Overall Study|Protocol Violation|0|||
162206865|NCT01874665|585809911|FG000|Overall Study|Adverse Event|6|||
162206866|NCT01874665|585809912|FG001|Overall Study|Adverse Event|2|||
162206867|NCT01874665|585809911|FG000|Overall Study|Withdrawal by Subject|4|||
162206868|NCT01874665|585809912|FG001|Overall Study|Withdrawal by Subject|1|||
162206869|NCT01874665|585809911|FG000|Overall Study|Physician Decision|3|||
162206870|NCT01874665|585809912|FG001|Overall Study|Physician Decision|0|||
162206871|NCT01874665|585809911|FG000|Overall Study|Clinical Progressive Disease|4|||
162206872|NCT01874665|585809912|FG001|Overall Study|Clinical Progressive Disease|3|||
162206873|NCT01874665|585809911|FG000|Overall Study|Study Terminated by Sponsor|0|||
162206874|NCT01874665|585809912|FG001|Overall Study|Study Terminated by Sponsor|2|||
162206875|NCT01874665|585809911|FG000|Overall Study|Documented Progressive Disease|11|||
162206876|NCT01874665|585809912|FG001|Overall Study|Documented Progressive Disease|7|||
162206877|NCT01874665|585809911|FG000|Overall Study|Other|2|||
161677486|NCT00467779|583872010|FG010|Stage 3|Death|0|||
162206878|NCT01874665|585809912|FG001|Overall Study|Other|0|||
162206879|NCT02447432|585809913|FG000|Epoch 001|Adverse Event|1|||
162206880|NCT02447432|585809914|FG001|Epoch 001|Adverse Event|1|||
162206881|NCT02447432|585809913|FG000|Epoch 001|Withdrawal by Subject|0|||
162206882|NCT02447432|585809914|FG001|Epoch 001|Withdrawal by Subject|4|||
162206883|NCT02447432|585809913|FG000|Epoch 001|Migrated/moved from study area|3|||
162206884|NCT02447432|585809914|FG001|Epoch 001|Migrated/moved from study area|5|||
162206885|NCT02447432|585809913|FG000|Epoch 001|Lost to Follow-up|1|||
162206886|NCT02447432|585809914|FG001|Epoch 001|Lost to Follow-up|3|||
162206887|NCT03245619|585809918|FG000|Part A (Up to Day 22)|Physician Decision|4|||
162206888|NCT03245619|585809919|FG001|Part A (Up to Day 22)|Physician Decision|6|||
162206889|NCT03245619|585809920|FG002|Part A (Up to Day 22)|Physician Decision|6|||
162206890|NCT03245619|585809921|FG003|Part A (Up to Day 22)|Physician Decision|0|||
162206891|NCT03245619|585809922|FG004|Part A (Up to Day 22)|Physician Decision|0|||
162206892|NCT03245619|585809923|FG005|Part A (Up to Day 22)|Physician Decision|0|||
162206893|NCT03245619|585809924|FG006|Part A (Up to Day 22)|Physician Decision|0|||
162206894|NCT03245619|585809925|FG007|Part A (Up to Day 22)|Physician Decision|0|||
162206895|NCT03245619|585809926|FG008|Part A (Up to Day 22)|Physician Decision|0|||
162206896|NCT03245619|585809927|FG009|Part A (Up to Day 22)|Physician Decision|0|||
162206897|NCT03245619|585809928|FG010|Part A (Up to Day 22)|Physician Decision|0|||
162206898|NCT03245619|585809929|FG011|Part A (Up to Day 22)|Physician Decision|0|||
162206899|NCT03245619|585809930|FG012|Part A (Up to Day 22)|Physician Decision|0|||
162206900|NCT03245619|585809931|FG013|Part A (Up to Day 22)|Physician Decision|0|||
162206901|NCT03245619|585809932|FG014|Part A (Up to Day 22)|Physician Decision|0|||
162206902|NCT03245619|585809933|FG015|Part A (Up to Day 22)|Physician Decision|0|||
162206903|NCT03245619|585809934|FG016|Part A (Up to Day 22)|Physician Decision|0|||
162206904|NCT00776659|585809935|FG000|Overall Study|Lost to Follow-up|15|||
162206905|NCT00776659|585809935|FG000|Overall Study|Withdrawal by Subject|10|||
162206906|NCT00776659|585809935|FG000|Overall Study|Study Terminated by Sponsor|1|||
162206907|NCT01336205|585809936|FG000|Overall Study|Other|22|||
162206908|NCT01336205|585809937|FG001|Overall Study|Other|9|||
162206909|NCT01336205|585809936|FG000|Overall Study|Lost to Follow-up|40|||
162206910|NCT01336205|585809937|FG001|Overall Study|Lost to Follow-up|20|||
162206911|NCT01336205|585809936|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
162206912|NCT01336205|585809937|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
162206913|NCT01336205|585809936|FG000|Overall Study|Lack of Efficacy|4|||
162206914|NCT01336205|585809937|FG001|Overall Study|Lack of Efficacy|0|||
162206915|NCT01336205|585809936|FG000|Overall Study|Severe noncompliance with protocol|9|||
162206916|NCT01336205|585809937|FG001|Overall Study|Severe noncompliance with protocol|2|||
162206917|NCT01336205|585809936|FG000|Overall Study|Adverse Event|56|||
162206918|NCT01336205|585809937|FG001|Overall Study|Adverse Event|6|||
162206919|NCT01336205|585809936|FG000|Overall Study|Death|1|||
162206920|NCT01336205|585809937|FG001|Overall Study|Death|1|||
162206921|NCT01336205|585809936|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
162206922|NCT01336205|585809937|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
162206923|NCT01336205|585809936|FG000|Overall Study|Withdrawal by Subject|72|||
162206924|NCT01336205|585809937|FG001|Overall Study|Withdrawal by Subject|38|||
162206925|NCT01336205|585809936|FG000|Overall Study|Did not receive treatment|4|||
162206926|NCT01336205|585809937|FG001|Overall Study|Did not receive treatment|0|||
162206927|NCT00129649|585809938|FG000|Overall Study|Withdrawal by Subject|76|||
162206928|NCT00129649|585809939|FG001|Overall Study|Withdrawal by Subject|65|||
162206929|NCT02246218|585809940|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162206930|NCT02246218|585809941|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162206931|NCT02246218|585809940|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
162206932|NCT02246218|585809941|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
162206933|NCT02246218|585809940|FG000|Overall Study|Adverse Event|1|||
161932486|NCT00511199|584800492|FG000|Overall Study|Withdrawal of Informed Consent|19|||
161932487|NCT00511199|584800493|FG001|Overall Study|Withdrawal of Informed Consent|4|||
162206934|NCT02246218|585809941|FG001|Overall Study|Adverse Event|1|||
162206935|NCT02246218|585809940|FG000|Overall Study|Lost to Follow-up|1|||
162206936|NCT02246218|585809941|FG001|Overall Study|Lost to Follow-up|0|||
162206937|NCT01321723|585809942|FG000|Overall Study|Adverse Event|3|||
162206938|NCT01321723|585809943|FG001|Overall Study|Adverse Event|5|||
162206939|NCT01321723|585809944|FG002|Overall Study|Adverse Event|2|||
162206940|NCT01321723|585809942|FG000|Overall Study|Withdrawal by Subject|2|||
162206941|NCT01321723|585809943|FG001|Overall Study|Withdrawal by Subject|0|||
162206942|NCT01321723|585809944|FG002|Overall Study|Withdrawal by Subject|2|||
162206943|NCT02547441|585809945|FG000|Double-Blind Study Period|Adverse Event|4|||
162206944|NCT02547441|585809946|FG001|Double-Blind Study Period|Adverse Event|9|||
162206945|NCT02547441|585809945|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
162206946|NCT02547441|585809946|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
162206947|NCT02547441|585809945|FG000|Double-Blind Study Period|Physician Decision|1|||
162206948|NCT02547441|585809946|FG001|Double-Blind Study Period|Physician Decision|0|||
162206949|NCT02547441|585809945|FG000|Double-Blind Study Period|Protocol Violation|1|||
162206950|NCT02547441|585809946|FG001|Double-Blind Study Period|Protocol Violation|2|||
162206951|NCT02547441|585809945|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
162206952|NCT02547441|585809946|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
162206953|NCT02547441|585809945|FG000|Double-Blind Study Period|Sponsor Decision|1|||
162206954|NCT02547441|585809946|FG001|Double-Blind Study Period|Sponsor Decision|0|||
162206955|NCT02547441|585809945|FG000|Open-Label Study Period|Adverse Event|10|||
162206956|NCT02547441|585809946|FG001|Open-Label Study Period|Adverse Event|11|||
162206957|NCT02547441|585809945|FG000|Open-Label Study Period|Lack of Efficacy|3|||
162206958|NCT02547441|585809946|FG001|Open-Label Study Period|Lack of Efficacy|2|||
162206959|NCT02547441|585809945|FG000|Open-Label Study Period|Lost to Follow-up|7|||
162206960|NCT02547441|585809946|FG001|Open-Label Study Period|Lost to Follow-up|8|||
162206961|NCT02547441|585809945|FG000|Open-Label Study Period|Physician Decision|1|||
162206962|NCT02547441|585809946|FG001|Open-Label Study Period|Physician Decision|0|||
162206963|NCT02547441|585809945|FG000|Open-Label Study Period|Protocol Violation|2|||
162206964|NCT02547441|585809946|FG001|Open-Label Study Period|Protocol Violation|0|||
162206965|NCT02547441|585809945|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
162206966|NCT02547441|585809946|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
162206967|NCT02547441|585809945|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
162206968|NCT02547441|585809946|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
162206969|NCT01322009|585809947|FG000|Overall Study|Death|0|||
162206970|NCT01322009|585809948|FG001|Overall Study|Death|1|||
162206971|NCT01322009|585809947|FG000|Overall Study|Adverse Event|0|||
162206972|NCT01322009|585809948|FG001|Overall Study|Adverse Event|1|||
162206973|NCT01322009|585809947|FG000|Overall Study|ng tube discontinued|0|||
162206974|NCT01322009|585809948|FG001|Overall Study|ng tube discontinued|1|||
162206975|NCT01657877|585809949|FG000|Overall Study|Withdrawal by Subject|4|||
162206976|NCT01657877|585809949|FG000|Overall Study|Protocol Violation|6|||
162206977|NCT01657877|585809949|FG000|Overall Study|Adverse Event|2|||
162206978|NCT01657877|585809949|FG000|Overall Study|Other Reason|2|||
162206979|NCT01978236|585809956|FG000|Overall Study|Discontinued due to study close|2|||
162206980|NCT00505414|585809958|FG000|Titration Phase|Adverse Event|0|||
162206981|NCT00505414|585809959|FG001|Titration Phase|Adverse Event|0|||
162206982|NCT00505414|585809960|FG002|Titration Phase|Adverse Event|0|||
162206983|NCT00505414|585809961|FG003|Titration Phase|Adverse Event|8|||
162206984|NCT00505414|585809962|FG004|Titration Phase|Adverse Event|3|||
162206985|NCT00505414|585809958|FG000|Titration Phase|Death|0|||
162206986|NCT00505414|585809959|FG001|Titration Phase|Death|0|||
162206987|NCT00505414|585809960|FG002|Titration Phase|Death|0|||
162206988|NCT00505414|585809961|FG003|Titration Phase|Death|2|||
162206989|NCT00505414|585809962|FG004|Titration Phase|Death|0|||
162206990|NCT00505414|585809958|FG000|Titration Phase|Lack of Efficacy|0|||
162206991|NCT00505414|585809959|FG001|Titration Phase|Lack of Efficacy|0|||
162206992|NCT00505414|585809960|FG002|Titration Phase|Lack of Efficacy|0|||
162206993|NCT00505414|585809961|FG003|Titration Phase|Lack of Efficacy|10|||
162206994|NCT00505414|585809962|FG004|Titration Phase|Lack of Efficacy|1|||
162206995|NCT00505414|585809958|FG000|Titration Phase|Protocol Violation|0|||
162206996|NCT00505414|585809959|FG001|Titration Phase|Protocol Violation|0|||
162206997|NCT00505414|585809960|FG002|Titration Phase|Protocol Violation|0|||
162206998|NCT00505414|585809961|FG003|Titration Phase|Protocol Violation|0|||
162206999|NCT00505414|585809962|FG004|Titration Phase|Protocol Violation|1|||
162207000|NCT00505414|585809958|FG000|Titration Phase|Withdrawal by Subject|0|||
161824395|NCT02061280|584397982|FG001|Overall Study|Lost to Follow-up|1|||
161824396|NCT01977456|584397983|FG000|Overall Study|Death|5|||
162207001|NCT00505414|585809959|FG001|Titration Phase|Withdrawal by Subject|0|||
162207002|NCT00505414|585809960|FG002|Titration Phase|Withdrawal by Subject|0|||
162207003|NCT00505414|585809961|FG003|Titration Phase|Withdrawal by Subject|3|||
162207004|NCT00505414|585809962|FG004|Titration Phase|Withdrawal by Subject|4|||
162207005|NCT00505414|585809958|FG000|Titration Phase|Underlying disease and therapy required|0|||
162207006|NCT00505414|585809959|FG001|Titration Phase|Underlying disease and therapy required|0|||
162207007|NCT00505414|585809960|FG002|Titration Phase|Underlying disease and therapy required|0|||
162207008|NCT00505414|585809961|FG003|Titration Phase|Underlying disease and therapy required|7|||
161824397|NCT01841060|584399749|FG000|Overall Study|Protocol Violation|10|||
162207009|NCT00505414|585809962|FG004|Titration Phase|Underlying disease and therapy required|3|||
162207010|NCT00505414|585809958|FG000|Maintenance Phase|Adverse Event|2|||
162207011|NCT00505414|585809959|FG001|Maintenance Phase|Adverse Event|2|||
162207012|NCT00505414|585809960|FG002|Maintenance Phase|Adverse Event|3|||
162207013|NCT00505414|585809961|FG003|Maintenance Phase|Adverse Event|0|||
162207014|NCT00505414|585809962|FG004|Maintenance Phase|Adverse Event|0|||
162207015|NCT00505414|585809958|FG000|Maintenance Phase|Death|2|||
162207016|NCT00505414|585809959|FG001|Maintenance Phase|Death|0|||
162207017|NCT00505414|585809960|FG002|Maintenance Phase|Death|1|||
161824398|NCT02419573|584399750|FG000|Overall Study|Lost to Follow-up|3|||
162207018|NCT00505414|585809961|FG003|Maintenance Phase|Death|0|||
162207019|NCT00505414|585809962|FG004|Maintenance Phase|Death|0|||
162207020|NCT00505414|585809958|FG000|Maintenance Phase|Lack of Efficacy|2|||
161932488|NCT00511199|584800492|FG000|Overall Study|Pregnancy|6|||
161932489|NCT00511199|584800493|FG001|Overall Study|Pregnancy|3|||
161932490|NCT00511199|584800492|FG000|Overall Study|Pregnancy Wish|16|||
161932491|NCT00511199|584800493|FG001|Overall Study|Pregnancy Wish|8|||
161932492|NCT00511199|584800492|FG000|Overall Study|Lost to Follow-up|40|||
161932493|NCT00511199|584800493|FG001|Overall Study|Lost to Follow-up|17|||
161932494|NCT00511199|584800492|FG000|Overall Study|Other Reason|78|||
161932495|NCT00511199|584800493|FG001|Overall Study|Other Reason|37|||
161932496|NCT01570192|584800498|FG000|Overall Study|no qualifying organism|6|||
161932497|NCT01570192|584800499|FG001|Overall Study|no qualifying organism|12|||
161932498|NCT01570192|584800498|FG000|Overall Study|changed to palliative care|1|||
161932499|NCT01570192|584800499|FG001|Overall Study|changed to palliative care|0|||
161932500|NCT01570192|584800498|FG000|Overall Study|Physician Decision|0|||
161932501|NCT01570192|584800499|FG001|Overall Study|Physician Decision|1|||
161932502|NCT01063881|584800500|FG000|Overall Study|Adverse Event|12|||
161932503|NCT01063881|584800501|FG001|Overall Study|Adverse Event|2|||
161932504|NCT01063881|584800502|FG002|Overall Study|Adverse Event|0|||
161932505|NCT01063881|584800500|FG000|Overall Study|Lost to Follow-up|13|||
161932506|NCT01063881|584800501|FG001|Overall Study|Lost to Follow-up|7|||
161932507|NCT01063881|584800502|FG002|Overall Study|Lost to Follow-up|1|||
161932508|NCT01063881|584800500|FG000|Overall Study|Withdrawal by Subject|25|||
161932509|NCT01063881|584800501|FG001|Overall Study|Withdrawal by Subject|1|||
161932510|NCT01063881|584800502|FG002|Overall Study|Withdrawal by Subject|0|||
161932511|NCT01063881|584800500|FG000|Overall Study|Reason for not completed not specified|5|||
162207021|NCT00505414|585809959|FG001|Maintenance Phase|Lack of Efficacy|1|||
162207022|NCT00505414|585809960|FG002|Maintenance Phase|Lack of Efficacy|1|||
162207023|NCT00505414|585809961|FG003|Maintenance Phase|Lack of Efficacy|0|||
162207024|NCT00505414|585809962|FG004|Maintenance Phase|Lack of Efficacy|0|||
162207025|NCT00505414|585809958|FG000|Maintenance Phase|Withdrawal by Subject|0|||
162207026|NCT00505414|585809959|FG001|Maintenance Phase|Withdrawal by Subject|0|||
162207027|NCT00505414|585809960|FG002|Maintenance Phase|Withdrawal by Subject|1|||
162207028|NCT00505414|585809961|FG003|Maintenance Phase|Withdrawal by Subject|0|||
162207029|NCT00505414|585809962|FG004|Maintenance Phase|Withdrawal by Subject|0|||
162207030|NCT00505414|585809958|FG000|Maintenance Phase|underlying disease and therapy required|0|||
162207031|NCT00505414|585809959|FG001|Maintenance Phase|underlying disease and therapy required|2|||
162207032|NCT00505414|585809960|FG002|Maintenance Phase|underlying disease and therapy required|2|||
162207033|NCT00505414|585809961|FG003|Maintenance Phase|underlying disease and therapy required|0|||
162207034|NCT00505414|585809962|FG004|Maintenance Phase|underlying disease and therapy required|0|||
162207035|NCT00634920|585809963|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
162207036|NCT00634920|585809964|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
162207037|NCT00634920|585809965|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
162207038|NCT00634920|585809963|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
162207039|NCT00634920|585809964|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
162207040|NCT00634920|585809965|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
162207041|NCT00634920|585809963|FG000|Period 1 - Pre-Randomization|Rejections|0|||
162207042|NCT00634920|585809964|FG001|Period 1 - Pre-Randomization|Rejections|0|||
162207043|NCT00634920|585809965|FG002|Period 1 - Pre-Randomization|Rejections|55|||
162207044|NCT00634920|585809963|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
162207045|NCT00634920|585809964|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
162207046|NCT00634920|585809965|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
162207047|NCT00634920|585809963|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
162207048|NCT00634920|585809964|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
162207049|NCT00634920|585809965|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
162207050|NCT00634920|585809963|FG000|Period 1 - Pre-Randomization|Other issues|0|||
161932512|NCT01063881|584800501|FG001|Overall Study|Reason for not completed not specified|1|||
161932513|NCT01063881|584800502|FG002|Overall Study|Reason for not completed not specified|0|||
161932514|NCT00407030|584800503|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
161932515|NCT00407030|584800504|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
161932516|NCT00407030|584800505|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
161932517|NCT00407030|584800503|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
161932518|NCT00407030|584800504|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
162207051|NCT00634920|585809964|FG001|Period 1 - Pre-Randomization|Other issues|0|||
162207052|NCT00634920|585809965|FG002|Period 1 - Pre-Randomization|Other issues|6|||
162207053|NCT00634920|585809963|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
162207054|NCT00634920|585809964|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
162207055|NCT00634920|585809965|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
162207056|NCT00634920|585809963|FG000|Period 2 - Post-Randomization|Rejection|11|||
162207057|NCT00634920|585809964|FG001|Period 2 - Post-Randomization|Rejection|5|||
162207058|NCT00634920|585809965|FG002|Period 2 - Post-Randomization|Rejection|0|||
161932519|NCT00407030|584800505|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
161932520|NCT00407030|584800503|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
161932521|NCT00407030|584800504|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
161932522|NCT00407030|584800505|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
162207059|NCT00634920|585809963|FG000|Period 2 - Post-Randomization|Death|2|||
162207060|NCT00634920|585809964|FG001|Period 2 - Post-Randomization|Death|5|||
162207061|NCT00634920|585809965|FG002|Period 2 - Post-Randomization|Death|0|||
162207062|NCT00634920|585809963|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
162207063|NCT00634920|585809964|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
162207064|NCT00634920|585809965|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
162207065|NCT00634920|585809963|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
162207066|NCT00634920|585809964|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
162207067|NCT00634920|585809965|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
162207068|NCT04353817|585809966|FG000|Overall Study|Adverse Event|0|||
162207069|NCT04353817|585809967|FG001|Overall Study|Adverse Event|1|||
162207070|NCT04358068|585809968|FG000|Overall Study|Did not initiate study treatment|2|||
162207071|NCT04358068|585809969|FG001|Overall Study|Did not initiate study treatment|2|||
162207072|NCT01193218|585809970|FG000|0-12 Weeks|Adverse Event|6|||
162207073|NCT01193218|585809971|FG001|0-12 Weeks|Adverse Event|0|||
162207074|NCT01193218|585809972|FG002|0-12 Weeks|Adverse Event|1|||
162207075|NCT01193218|585809973|FG003|0-12 Weeks|Adverse Event|0|||
162207076|NCT01193218|585809974|FG004|0-12 Weeks|Adverse Event|0|||
162207077|NCT01193218|585809975|FG005|0-12 Weeks|Adverse Event|2|||
162207078|NCT01193218|585809976|FG006|0-12 Weeks|Adverse Event|2|||
162207079|NCT01193218|585809977|FG007|0-12 Weeks|Adverse Event|0|||
162207080|NCT01193218|585809970|FG000|0-12 Weeks|Protocol Violation|0|||
162207081|NCT01193218|585809971|FG001|0-12 Weeks|Protocol Violation|0|||
162207082|NCT01193218|585809972|FG002|0-12 Weeks|Protocol Violation|0|||
162207083|NCT01193218|585809973|FG003|0-12 Weeks|Protocol Violation|0|||
162207084|NCT01193218|585809974|FG004|0-12 Weeks|Protocol Violation|1|||
162207085|NCT01193218|585809975|FG005|0-12 Weeks|Protocol Violation|1|||
162207086|NCT01193218|585809976|FG006|0-12 Weeks|Protocol Violation|0|||
162207087|NCT01193218|585809977|FG007|0-12 Weeks|Protocol Violation|0|||
162207088|NCT01193218|585809970|FG000|0-12 Weeks|Withdrawal by Subject|3|||
162207089|NCT01193218|585809971|FG001|0-12 Weeks|Withdrawal by Subject|0|||
162207090|NCT01193218|585809972|FG002|0-12 Weeks|Withdrawal by Subject|2|||
162207091|NCT01193218|585809973|FG003|0-12 Weeks|Withdrawal by Subject|0|||
162207092|NCT01193218|585809974|FG004|0-12 Weeks|Withdrawal by Subject|0|||
162207093|NCT01193218|585809975|FG005|0-12 Weeks|Withdrawal by Subject|0|||
162207094|NCT01193218|585809976|FG006|0-12 Weeks|Withdrawal by Subject|1|||
162207095|NCT01193218|585809977|FG007|0-12 Weeks|Withdrawal by Subject|0|||
162207096|NCT01193218|585809970|FG000|12-52 Weeks|Adverse Event|1|||
162207097|NCT01193218|585809971|FG001|12-52 Weeks|Adverse Event|0|||
162207098|NCT01193218|585809972|FG002|12-52 Weeks|Adverse Event|1|||
161824399|NCT02419573|584399751|FG001|Overall Study|Lost to Follow-up|0|||
161824400|NCT02419573|584399750|FG000|Overall Study|Withdrawal by Subject|1|||
161824401|NCT02419573|584399751|FG001|Overall Study|Withdrawal by Subject|0|||
161824402|NCT00493792|584399752|FG000|Overall Study|Death|55|||
161824403|NCT00493792|584399753|FG001|Overall Study|Death|50|||
161824404|NCT00493792|584399752|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
161824405|NCT00493792|584399753|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
161824406|NCT00685035|584399758|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
161824407|NCT00685035|584399759|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
161824408|NCT02426541|584399760|FG000|Overall Study|Protocol Violation|1|||
161824409|NCT02426541|584399761|FG001|Overall Study|Protocol Violation|0|||
161824410|NCT00784979|584399764|FG000|Overall Study|incomplete data|6|||
161824411|NCT04241133|584399765|FG000|Overall Study|COVID19 Precautions|14|||
161824412|NCT04241133|584399766|FG001|Overall Study|COVID19 Precautions|34|||
161824413|NCT04968925|584399773|FG000|Phase I- Period 1|COVID-19 related|0|||
161824414|NCT04968925|584399774|FG001|Phase I- Period 1|COVID-19 related|1|||
161824415|NCT04968925|584399775|FG002|Phase I- Period 1|COVID-19 related|0|||
161824416|NCT04968925|584399776|FG003|Phase I- Period 1|COVID-19 related|0|||
161824417|NCT04968925|584399773|FG000|Phase I- Period 1|Subject enrolled in error|1|||
161824418|NCT04968925|584399774|FG001|Phase I- Period 1|Subject enrolled in error|1|||
161824419|NCT04968925|584399775|FG002|Phase I- Period 1|Subject enrolled in error|0|||
161824420|NCT04968925|584399776|FG003|Phase I- Period 1|Subject enrolled in error|0|||
161824421|NCT04968925|584399773|FG000|Phase II- Period 1|COVID-19 Related|0|||
161824422|NCT04968925|584399774|FG001|Phase II- Period 1|COVID-19 Related|0|||
161824423|NCT04968925|584399775|FG002|Phase II- Period 1|COVID-19 Related|6|||
161824424|NCT04968925|584399776|FG003|Phase II- Period 1|COVID-19 Related|6|||
162207099|NCT01193218|585809973|FG003|12-52 Weeks|Adverse Event|2|||
162207100|NCT01193218|585809974|FG004|12-52 Weeks|Adverse Event|3|||
162207101|NCT01193218|585809975|FG005|12-52 Weeks|Adverse Event|3|||
162207102|NCT01193218|585809976|FG006|12-52 Weeks|Adverse Event|1|||
162207103|NCT01193218|585809977|FG007|12-52 Weeks|Adverse Event|2|||
162207104|NCT01193218|585809970|FG000|12-52 Weeks|Lack of Efficacy|0|||
162207105|NCT01193218|585809971|FG001|12-52 Weeks|Lack of Efficacy|0|||
162207106|NCT01193218|585809972|FG002|12-52 Weeks|Lack of Efficacy|0|||
162207107|NCT01193218|585809973|FG003|12-52 Weeks|Lack of Efficacy|0|||
162207108|NCT01193218|585809974|FG004|12-52 Weeks|Lack of Efficacy|0|||
162207109|NCT01193218|585809975|FG005|12-52 Weeks|Lack of Efficacy|0|||
161932523|NCT00407030|584800503|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
161932524|NCT00407030|584800504|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
161932525|NCT00407030|584800505|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
161932526|NCT00407030|584800503|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
161932527|NCT00407030|584800504|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
161932528|NCT00407030|584800505|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
161932529|NCT00407030|584800503|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
161932530|NCT00407030|584800504|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
161932531|NCT00407030|584800505|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
161932532|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
161932533|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
161932534|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
161932535|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
161932536|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
161932537|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
162021294|NCT05091567|585134732|FG000|Enrollment Phase|Withdrawal by Subject|8|||
162021295|NCT05091567|585134733|FG001|Enrollment Phase|Withdrawal by Subject|0|||
162207110|NCT01193218|585809976|FG006|12-52 Weeks|Lack of Efficacy|1|||
162207111|NCT01193218|585809977|FG007|12-52 Weeks|Lack of Efficacy|0|||
162207112|NCT01193218|585809970|FG000|12-52 Weeks|Withdrawal by Subject|3|||
162207113|NCT01193218|585809971|FG001|12-52 Weeks|Withdrawal by Subject|0|||
162207114|NCT01193218|585809972|FG002|12-52 Weeks|Withdrawal by Subject|3|||
162207115|NCT01193218|585809973|FG003|12-52 Weeks|Withdrawal by Subject|0|||
162207116|NCT01193218|585809974|FG004|12-52 Weeks|Withdrawal by Subject|0|||
162207117|NCT01193218|585809975|FG005|12-52 Weeks|Withdrawal by Subject|2|||
162207118|NCT01193218|585809976|FG006|12-52 Weeks|Withdrawal by Subject|1|||
162207119|NCT01193218|585809977|FG007|12-52 Weeks|Withdrawal by Subject|2|||
162207120|NCT01193218|585809970|FG000|12-52 Weeks|Other reason than above|1|||
162207121|NCT01193218|585809971|FG001|12-52 Weeks|Other reason than above|0|||
162207122|NCT01193218|585809972|FG002|12-52 Weeks|Other reason than above|0|||
162207123|NCT01193218|585809973|FG003|12-52 Weeks|Other reason than above|1|||
162207124|NCT01193218|585809974|FG004|12-52 Weeks|Other reason than above|1|||
162207125|NCT01193218|585809975|FG005|12-52 Weeks|Other reason than above|0|||
162207126|NCT01193218|585809976|FG006|12-52 Weeks|Other reason than above|0|||
162207127|NCT01193218|585809977|FG007|12-52 Weeks|Other reason than above|0|||
162207128|NCT00665223|585809980|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
162207129|NCT00665223|585809981|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
162207130|NCT00665223|585809982|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
162207131|NCT00665223|585809980|FG000|Randomized Phase (26 Weeks)|Death|0|||
162207132|NCT00665223|585809981|FG001|Randomized Phase (26 Weeks)|Death|0|||
162207133|NCT00665223|585809982|FG002|Randomized Phase (26 Weeks)|Death|1|||
162207134|NCT00665223|585809980|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
162207135|NCT00665223|585809981|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
162207136|NCT00665223|585809982|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
162207137|NCT00665223|585809980|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
162207138|NCT00665223|585809981|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
162207139|NCT00665223|585809982|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
162207140|NCT00665223|585809980|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
162207141|NCT00665223|585809981|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
162207142|NCT00665223|585809982|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
162207143|NCT00665223|585809980|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
162207144|NCT00665223|585809981|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
162207145|NCT00665223|585809982|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
162207146|NCT00665223|585809980|FG000|Open-Label Period (26 Weeks)|Death|0|||
162207147|NCT00665223|585809981|FG001|Open-Label Period (26 Weeks)|Death|1|||
162207148|NCT00665223|585809982|FG002|Open-Label Period (26 Weeks)|Death|0|||
162207149|NCT00665223|585809980|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
162021296|NCT05091567|585134734|FG002|Enrollment Phase|Withdrawal by Subject|0|||
162021297|NCT05091567|585134732|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
162207150|NCT00665223|585809981|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
162207151|NCT00665223|585809982|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
162207152|NCT00665223|585809980|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
162207153|NCT00665223|585809981|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
162207154|NCT00665223|585809982|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
162207155|NCT00665223|585809980|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
162207156|NCT00665223|585809981|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
162207157|NCT00665223|585809982|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
162207158|NCT00665223|585809980|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
162207159|NCT00665223|585809981|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
162207160|NCT00665223|585809982|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
162207161|NCT00363649|585809983|FG000|Overall Study|Withdrawal by Subject|1|||
162207162|NCT00363649|585809984|FG001|Overall Study|Withdrawal by Subject|1|||
161932538|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
161932539|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
161932540|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
161932541|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
161932542|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
161932543|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
161932544|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
161932545|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
161932546|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
161932547|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
161932548|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
161932549|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
161932550|NCT00407030|584800503|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
161932551|NCT00407030|584800504|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
161932552|NCT00407030|584800505|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
161932553|NCT00736476|584800506|FG000|Overall Study|Adverse Event|1|||
161932554|NCT00736476|584800507|FG001|Overall Study|Adverse Event|0|||
161932555|NCT01796470|584800508|FG000|Overall Study|Adverse Event|4|||
161932556|NCT01796470|584800509|FG001|Overall Study|Adverse Event|2|||
161932557|NCT01796470|584800510|FG002|Overall Study|Adverse Event|2|||
161932558|NCT01796470|584800511|FG003|Overall Study|Adverse Event|1|||
161932559|NCT01796470|584800512|FG004|Overall Study|Adverse Event|3|||
161932560|NCT01796470|584800508|FG000|Overall Study|Death|2|||
162207163|NCT00363649|585809983|FG000|Overall Study|Adverse Event|6|||
162207164|NCT00363649|585809984|FG001|Overall Study|Adverse Event|0|||
162207165|NCT00002597|585809985|FG000|Overall Study|Protocol Violation|19|||
162207166|NCT00002597|585809986|FG001|Overall Study|Protocol Violation|17|||
162207167|NCT00002597|585809985|FG000|Overall Study|Withdrawal by Subject|7|||
162207168|NCT00002597|585809986|FG001|Overall Study|Withdrawal by Subject|6|||
162207169|NCT00912223|585809987|FG000|Overall Study|Withdrawal by Subject|1|||
162207170|NCT00912223|585809987|FG000|Overall Study|Not transplanted|1|||
162207171|NCT00912223|585809987|FG000|Overall Study|Transformed disease|1|||
162207172|NCT00025662|585809991|FG000|Overall Study|Withdrawal by Subject|2|||
162207173|NCT00025662|585809991|FG000|Overall Study|Technical failure of manipulation|1|||
162207174|NCT02161185|585809992|FG000|Treatment Phase|Administrative/Other|7|||
162207175|NCT00582114|585809994|FG000|Overall Study|Death|4|||
162207176|NCT00582114|585809995|FG001|Overall Study|Death|4|||
161824425|NCT04968925|584399773|FG000|Phase II- Period 1|Subject enrolled in error|0|||
161824426|NCT04968925|584399774|FG001|Phase II- Period 1|Subject enrolled in error|0|||
161824427|NCT04968925|584399775|FG002|Phase II- Period 1|Subject enrolled in error|1|||
161824428|NCT04968925|584399776|FG003|Phase II- Period 1|Subject enrolled in error|0|||
161824429|NCT04968925|584399773|FG000|Phase II -Period 2|COVID-19 related|0|||
161824430|NCT04968925|584399774|FG001|Phase II -Period 2|COVID-19 related|0|||
161824431|NCT04968925|584399775|FG002|Phase II -Period 2|COVID-19 related|4|||
161824432|NCT04968925|584399776|FG003|Phase II -Period 2|COVID-19 related|3|||
161824433|NCT04968925|584399773|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
161824434|NCT04968925|584399774|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
161824435|NCT04968925|584399775|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
161824436|NCT04968925|584399776|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
161824437|NCT00835796|584399782|FG000|First Intervention|Withdrawal by Subject|0|||
161824438|NCT00835796|584399783|FG001|First Intervention|Withdrawal by Subject|1|||
161824439|NCT00396630|584399784|FG000|Overall Study|Lost to Follow-up|1|||
161824440|NCT00396630|584399785|FG001|Overall Study|Lost to Follow-up|1|||
161824441|NCT00396630|584399784|FG000|Overall Study|Withdrawal by Subject|1|||
161824442|NCT00396630|584399785|FG001|Overall Study|Withdrawal by Subject|1|||
161824443|NCT00396630|584399784|FG000|Overall Study|Not vaccinated at Visit 3|3|||
161824444|NCT00396630|584399785|FG001|Overall Study|Not vaccinated at Visit 3|3|||
161824445|NCT00876265|584399786|FG000|Overall Study|Miscellaneous reasons|4|||
161824446|NCT00876265|584399786|FG000|Overall Study|Lost to Follow-up|6|||
161824447|NCT00876265|584399786|FG000|Overall Study|Withdrawal by Subject|2|||
161824448|NCT02327325|584399787|FG000|Overall Study|Withdrawal by Subject|1|||
161824449|NCT02327325|584399788|FG001|Overall Study|Withdrawal by Subject|4|||
161824450|NCT02327325|584399789|FG002|Overall Study|Withdrawal by Subject|4|||
161824451|NCT02327325|584399787|FG000|Overall Study|Excluded by Study Team|0|||
161824452|NCT02327325|584399788|FG001|Overall Study|Excluded by Study Team|0|||
161824453|NCT02327325|584399789|FG002|Overall Study|Excluded by Study Team|1|||
161824454|NCT00651183|584399792|FG000|Overall Study|Lack of Efficacy|1|||
161824455|NCT00651183|584399793|FG001|Overall Study|Lack of Efficacy|0|||
161824456|NCT00651183|584399792|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
161932561|NCT01796470|584800509|FG001|Overall Study|Death|0|||
162207177|NCT00582114|585809994|FG000|Overall Study|Kidney Transplant|3|||
162207178|NCT00582114|585809995|FG001|Overall Study|Kidney Transplant|1|||
162207179|NCT00582114|585809994|FG000|Overall Study|Lost to Follow-up|7|||
162207180|NCT00582114|585809995|FG001|Overall Study|Lost to Follow-up|6|||
162207181|NCT00582114|585809994|FG000|Overall Study|Withdrawal by Subject|8|||
162207182|NCT00582114|585809995|FG001|Overall Study|Withdrawal by Subject|16|||
162207183|NCT00582114|585809994|FG000|Overall Study|Adverse Event|1|||
162207184|NCT00582114|585809995|FG001|Overall Study|Adverse Event|1|||
162207185|NCT00582114|585809994|FG000|Overall Study|Physician Decision|0|||
162207186|NCT00582114|585809995|FG001|Overall Study|Physician Decision|6|||
162207187|NCT00582114|585809994|FG000|Overall Study|Stopped by data safety monitoring board|19|||
162207188|NCT00582114|585809995|FG001|Overall Study|Stopped by data safety monitoring board|20|||
162207189|NCT00130728|585810000|FG000|Overall Study|Death|258|||
162207190|NCT00130728|585810001|FG001|Overall Study|Death|258|||
162207191|NCT00130728|585810000|FG000|Overall Study|Lost to Follow-up|4|||
162207192|NCT00130728|585810001|FG001|Overall Study|Lost to Follow-up|0|||
162207193|NCT00130728|585810000|FG000|Overall Study|Withdrawal by Subject|0|||
162207194|NCT00130728|585810001|FG001|Overall Study|Withdrawal by Subject|2|||
162207195|NCT00519285|585810008|FG000|Overall Study|Adverse Event|127|||
162207196|NCT00519285|585810009|FG001|Overall Study|Adverse Event|266|||
161824457|NCT00651183|584399793|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
161824458|NCT00651183|584399792|FG000|Overall Study|Tolerability insufficient|5|||
161824459|NCT00651183|584399793|FG001|Overall Study|Tolerability insufficient|2|||
161824460|NCT00651183|584399792|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
161824461|NCT00651183|584399793|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
161824462|NCT00651183|584399792|FG000|Overall Study|Withdrawal by Subject|6|||
161824463|NCT00651183|584399793|FG001|Overall Study|Withdrawal by Subject|3|||
161824464|NCT00651183|584399792|FG000|Overall Study|Lost to Follow-up|3|||
161824465|NCT00651183|584399793|FG001|Overall Study|Lost to Follow-up|1|||
161824466|NCT00651183|584399792|FG000|Overall Study|Other reasons|4|||
161824467|NCT00651183|584399793|FG001|Overall Study|Other reasons|2|||
161824468|NCT00651183|584399792|FG000|Overall Study|missing|1|||
161824469|NCT00651183|584399793|FG001|Overall Study|missing|0|||
161824470|NCT00695110|584399798|FG000|Treatment Period 1|Adverse Event|1|||
161824471|NCT00695110|584399798|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161824472|NCT00695110|584399798|FG000|Treatment Period 3|Withdrawal by Subject|1|||
161824473|NCT00695110|584399798|FG000|Treatment Period 4|Adverse Event|1|||
161824474|NCT01933919|584399808|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
161824475|NCT01933919|584399809|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
161824476|NCT01933919|584399808|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
161824477|NCT01933919|584399809|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
161824478|NCT01933919|584399808|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
161824479|NCT01933919|584399809|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
161824480|NCT01933919|584399808|FG000|Open-label Long-term Phase|Adverse Event|2|||
161824481|NCT01933919|584399809|FG001|Open-label Long-term Phase|Adverse Event|0|||
161824482|NCT01933919|584399808|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
161824483|NCT01933919|584399809|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
161824484|NCT01933919|584399808|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
161824485|NCT01933919|584399809|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
161824486|NCT01933919|584399808|FG000|Open-label Long-term Phase|Other|1|||
161824487|NCT01933919|584399809|FG001|Open-label Long-term Phase|Other|2|||
161824488|NCT02575339|584399810|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
161824489|NCT02575339|584399811|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
161824490|NCT02575339|584399812|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
161824491|NCT02575339|584399810|FG000|Study Treatment|Disease Progression|5|||
161824492|NCT02575339|584399811|FG001|Study Treatment|Disease Progression|2|||
161824493|NCT02575339|584399812|FG002|Study Treatment|Disease Progression|0|||
161824494|NCT02575339|584399810|FG000|Study Treatment|Adverse Event|1|||
161824495|NCT02575339|584399811|FG001|Study Treatment|Adverse Event|2|||
161824496|NCT02575339|584399812|FG002|Study Treatment|Adverse Event|0|||
161824497|NCT02575339|584399810|FG000|Follow up|Death|6|||
161824498|NCT02575339|584399811|FG001|Follow up|Death|2|||
161824499|NCT02575339|584399812|FG002|Follow up|Death|0|||
161824500|NCT02575339|584399810|FG000|Follow up|Study Terminated|0|||
161824501|NCT02575339|584399811|FG001|Follow up|Study Terminated|2|||
161824502|NCT02575339|584399812|FG002|Follow up|Study Terminated|0|||
161824503|NCT02575339|584399810|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
161824504|NCT02575339|584399811|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
161824505|NCT02575339|584399812|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
161824506|NCT04675775|584399813|FG000|Overall Study|Withdrawal by Subject|7|||
161824507|NCT00108082|584399816|FG000|Overall Study|Adverse Event|14|||
161824508|NCT00108082|584399817|FG001|Overall Study|Adverse Event|12|||
161824509|NCT00108082|584399818|FG002|Overall Study|Adverse Event|17|||
161824510|NCT00108082|584399816|FG000|Overall Study|Lost to Follow-up|6|||
161824511|NCT00108082|584399817|FG001|Overall Study|Lost to Follow-up|3|||
161824512|NCT00108082|584399818|FG002|Overall Study|Lost to Follow-up|7|||
161824513|NCT00108082|584399816|FG000|Overall Study|Consent Withdrawn|3|||
162207197|NCT00519285|585810008|FG000|Overall Study|Disease progression|334|||
162207198|NCT00519285|585810009|FG001|Overall Study|Disease progression|186|||
162207199|NCT00519285|585810008|FG000|Overall Study|Physician Decision|75|||
161932562|NCT01796470|584800510|FG002|Overall Study|Death|0|||
161932563|NCT01796470|584800511|FG003|Overall Study|Death|0|||
161932564|NCT01796470|584800512|FG004|Overall Study|Death|1|||
161932565|NCT01796470|584800508|FG000|Overall Study|Initiated New Therapy|9|||
161932566|NCT01796470|584800509|FG001|Overall Study|Initiated New Therapy|0|||
161932567|NCT01796470|584800510|FG002|Overall Study|Initiated New Therapy|0|||
161932568|NCT01796470|584800511|FG003|Overall Study|Initiated New Therapy|0|||
162207200|NCT00519285|585810009|FG001|Overall Study|Physician Decision|47|||
162207201|NCT00519285|585810008|FG000|Overall Study|Participant's request|53|||
162207202|NCT00519285|585810009|FG001|Overall Study|Participant's request|84|||
162207203|NCT00519285|585810008|FG000|Overall Study|Consent withdrawn|4|||
162207204|NCT00519285|585810009|FG001|Overall Study|Consent withdrawn|5|||
162207205|NCT00519285|585810008|FG000|Overall Study|Poor compliance to protocol|5|||
162207206|NCT00519285|585810009|FG001|Overall Study|Poor compliance to protocol|7|||
162207207|NCT00519285|585810008|FG000|Overall Study|Reason unspecified|5|||
162207208|NCT00519285|585810009|FG001|Overall Study|Reason unspecified|8|||
162207209|NCT00519285|585810008|FG000|Overall Study|Not treated|8|||
162207210|NCT00519285|585810009|FG001|Overall Study|Not treated|7|||
162207211|NCT00519285|585810008|FG000|Overall Study|Treatment ongoing|1|||
162207212|NCT00519285|585810009|FG001|Overall Study|Treatment ongoing|2|||
162207213|NCT02970305|585810010|FG000|Overall Study|Adverse Event|10|||
162207214|NCT02970305|585810011|FG001|Overall Study|Adverse Event|6|||
162207215|NCT02970305|585810010|FG000|Overall Study|Lack of Efficacy|1|||
162207216|NCT02970305|585810011|FG001|Overall Study|Lack of Efficacy|1|||
162207217|NCT02970305|585810010|FG000|Overall Study|Noncompliance with study drug|2|||
162207218|NCT02970305|585810011|FG001|Overall Study|Noncompliance with study drug|4|||
162207219|NCT02970305|585810010|FG000|Overall Study|Protocol Violation|2|||
162207220|NCT02970305|585810011|FG001|Overall Study|Protocol Violation|2|||
162207221|NCT02970305|585810010|FG000|Overall Study|Withdrawal by Subject|12|||
162207222|NCT02970305|585810011|FG001|Overall Study|Withdrawal by Subject|11|||
162207223|NCT02970305|585810010|FG000|Overall Study|Not further specified|1|||
162207224|NCT02970305|585810011|FG001|Overall Study|Not further specified|2|||
162207225|NCT02970305|585810010|FG000|Overall Study|Lost to Follow-up|1|||
162207226|NCT02970305|585810011|FG001|Overall Study|Lost to Follow-up|2|||
162207227|NCT02175745|585810012|FG000|Overall Study|Not Eligible|1|||
162207228|NCT00808899|585810014|FG000|Overall Study|Death|1|||
162207229|NCT00808899|585810014|FG000|Overall Study|Physician Decision|3|||
162207230|NCT04088500|585810015|FG000|Overall Study|Reason unknown|1|||
162207231|NCT04088500|585810015|FG000|Overall Study|Participant withdrew consent|1|||
162207232|NCT04088500|585810015|FG000|Overall Study|Disease progression|3|||
162207233|NCT02212197|585810017|FG000|Overall Study|Need for radiotherapy|1|||
162207234|NCT02212197|585810018|FG001|Overall Study|Need for radiotherapy|0|||
162207235|NCT02212197|585810019|FG002|Overall Study|Need for radiotherapy|0|||
162207236|NCT01078584|585810020|FG000|Overall Study|Final Status Unknown|1073|||
162207237|NCT01078584|585810020|FG000|Overall Study|Lost to Follow-up|670|||
162207238|NCT01078584|585810020|FG000|Overall Study|Non-serious Adverse Event|577|||
162207239|NCT01078584|585810020|FG000|Overall Study|Withdrawal of Consent|244|||
161932569|NCT01796470|584800512|FG004|Overall Study|Initiated New Therapy|2|||
161932570|NCT01796470|584800508|FG000|Overall Study|Lost to Follow-up|0|||
162207240|NCT01078584|585810020|FG000|Overall Study|Physician Withdrew from Study|90|||
162207241|NCT01078584|585810020|FG000|Overall Study|Non-compliance|67|||
161932571|NCT01796470|584800509|FG001|Overall Study|Lost to Follow-up|1|||
162207242|NCT01078584|585810020|FG000|Overall Study|Blood Pressure Controlled|49|||
162207243|NCT01078584|585810020|FG000|Overall Study|Physician Switched Medication|26|||
162207244|NCT01078584|585810020|FG000|Overall Study|Physician Discontinued Patient|12|||
162207245|NCT01078584|585810020|FG000|Overall Study|Lack of Efficacy|98|||
162207246|NCT01078584|585810020|FG000|Overall Study|Protocol Violation|75|||
162207247|NCT01078584|585810020|FG000|Overall Study|Serious Adverse Event|27|||
162207248|NCT01078584|585810020|FG000|Overall Study|Multiple Reasons|2|||
162207249|NCT05041439|585810021|FG000|Overall Study|Withdrawal by Subject|1|||
162207250|NCT05041439|585810022|FG001|Overall Study|Withdrawal by Subject|1|||
162207251|NCT05041439|585810021|FG000|Overall Study|Death|1|||
162207252|NCT05041439|585810022|FG001|Overall Study|Death|0|||
161932572|NCT01796470|584800510|FG002|Overall Study|Lost to Follow-up|0|||
161932573|NCT01796470|584800511|FG003|Overall Study|Lost to Follow-up|0|||
161932574|NCT01796470|584800512|FG004|Overall Study|Lost to Follow-up|0|||
161932575|NCT01796470|584800508|FG000|Overall Study|Physician Decision|5|||
161932576|NCT01796470|584800509|FG001|Overall Study|Physician Decision|4|||
161932577|NCT01796470|584800510|FG002|Overall Study|Physician Decision|1|||
161932578|NCT01796470|584800511|FG003|Overall Study|Physician Decision|0|||
162207253|NCT02979613|585810023|FG000|Double-Blind Phase|Withdrew Consent|2|||
162207254|NCT02979613|585810024|FG001|Double-Blind Phase|Withdrew Consent|4|||
162207255|NCT02979613|585810023|FG000|Double-Blind Phase|Pregnancy|2|||
162207256|NCT02979613|585810024|FG001|Double-Blind Phase|Pregnancy|2|||
161932579|NCT01796470|584800512|FG004|Overall Study|Physician Decision|1|||
161932580|NCT01796470|584800508|FG000|Overall Study|Progressive Disease|7|||
161932581|NCT01796470|584800509|FG001|Overall Study|Progressive Disease|7|||
161932582|NCT01796470|584800510|FG002|Overall Study|Progressive Disease|3|||
161932583|NCT01796470|584800511|FG003|Overall Study|Progressive Disease|2|||
161932584|NCT01796470|584800512|FG004|Overall Study|Progressive Disease|0|||
161932585|NCT01796470|584800508|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
161932586|NCT01796470|584800509|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
161932587|NCT01796470|584800510|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
161932588|NCT01796470|584800511|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
161932589|NCT01796470|584800512|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
161932590|NCT01796470|584800508|FG000|Overall Study|Withdrawal by Subject|7|||
161932591|NCT01796470|584800509|FG001|Overall Study|Withdrawal by Subject|0|||
161932592|NCT01796470|584800510|FG002|Overall Study|Withdrawal by Subject|0|||
161932593|NCT01796470|584800511|FG003|Overall Study|Withdrawal by Subject|0|||
161932594|NCT01796470|584800512|FG004|Overall Study|Withdrawal by Subject|1|||
161932595|NCT04818086|584800519|FG000|Overall Study|Physician Decision|1|||
161932596|NCT04818086|584800520|FG001|Overall Study|Physician Decision|0|||
161932597|NCT04818086|584800519|FG000|Overall Study|Withdrawal by Subject|0|||
161932598|NCT04818086|584800520|FG001|Overall Study|Withdrawal by Subject|1|||
161932599|NCT04128228|584800522|FG000|Overall Study|Withdrawal by Subject|3|||
161932600|NCT04128228|584800523|FG001|Overall Study|Withdrawal by Subject|3|||
161932601|NCT04128228|584800524|FG002|Overall Study|Withdrawal by Subject|0|||
161932602|NCT04128228|584800525|FG003|Overall Study|Withdrawal by Subject|0|||
161932603|NCT04128228|584800522|FG000|Overall Study|noncompliance|2|||
161932604|NCT04128228|584800523|FG001|Overall Study|noncompliance|2|||
161932605|NCT04128228|584800524|FG002|Overall Study|noncompliance|0|||
161932606|NCT04128228|584800525|FG003|Overall Study|noncompliance|0|||
161932607|NCT03760666|584800526|FG000|Overall Study|Adverse Event|2|||
161932608|NCT03760666|584800527|FG001|Overall Study|Adverse Event|4|||
161932609|NCT03760666|584800528|FG002|Overall Study|Adverse Event|1|||
161932610|NCT03760666|584800526|FG000|Overall Study|AML Disease Progression|3|||
161932611|NCT03760666|584800527|FG001|Overall Study|AML Disease Progression|3|||
161932612|NCT03760666|584800528|FG002|Overall Study|AML Disease Progression|0|||
161932613|NCT03760666|584800526|FG000|Overall Study|Physician Decision|0|||
161932614|NCT03760666|584800527|FG001|Overall Study|Physician Decision|3|||
161932615|NCT03760666|584800528|FG002|Overall Study|Physician Decision|0|||
161932616|NCT03760666|584800526|FG000|Overall Study|Withdrawal by Subject|0|||
161932617|NCT03760666|584800527|FG001|Overall Study|Withdrawal by Subject|1|||
161932618|NCT03760666|584800528|FG002|Overall Study|Withdrawal by Subject|0|||
161932619|NCT01800058|584800534|FG000|Overall Study|Lost to Follow-up|1|||
161932620|NCT00992394|584800539|FG000|Overall Study|Lack of Efficacy|6|||
161932621|NCT00992394|584800540|FG001|Overall Study|Lack of Efficacy|3|||
161932622|NCT00992394|584800539|FG000|Overall Study|Adverse Event|4|||
161932623|NCT00992394|584800540|FG001|Overall Study|Adverse Event|5|||
161932624|NCT00992394|584800539|FG000|Overall Study|Withdrawal by Subject|8|||
161932625|NCT00992394|584800540|FG001|Overall Study|Withdrawal by Subject|2|||
161932626|NCT00992394|584800539|FG000|Overall Study|Physician Decision|1|||
161932627|NCT00992394|584800540|FG001|Overall Study|Physician Decision|0|||
162207257|NCT02979613|585810023|FG000|Double-Blind Phase|Adverse Event|2|||
162207258|NCT02979613|585810024|FG001|Double-Blind Phase|Adverse Event|0|||
162207259|NCT02979613|585810023|FG000|Double-Blind Phase|Lost to Follow-up|1|||
162207260|NCT02979613|585810024|FG001|Double-Blind Phase|Lost to Follow-up|1|||
162207261|NCT02979613|585810023|FG000|Double-Blind Phase|Protocol Violation|1|||
161932628|NCT00992394|584800539|FG000|Overall Study|Protocol Violation|2|||
162207262|NCT02979613|585810024|FG001|Double-Blind Phase|Protocol Violation|1|||
162207263|NCT02979613|585810023|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
161932629|NCT00992394|584800540|FG001|Overall Study|Protocol Violation|4|||
161932630|NCT00992394|584800539|FG000|Overall Study|Lost to Follow-up|2|||
161932631|NCT00992394|584800540|FG001|Overall Study|Lost to Follow-up|0|||
161932632|NCT00992394|584800539|FG000|Overall Study|Other event|1|||
161932633|NCT00992394|584800540|FG001|Overall Study|Other event|0|||
161932634|NCT01245049|584800541|FG000|Overall Study|Migrated/moved from study area|0|||
161932635|NCT01245049|584800542|FG001|Overall Study|Migrated/moved from study area|1|||
162207264|NCT02979613|585810024|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
162207265|NCT02979613|585810023|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
161932636|NCT01245049|584800541|FG000|Overall Study|Withdrawal by Subject|0|||
161932637|NCT01245049|584800542|FG001|Overall Study|Withdrawal by Subject|1|||
162207266|NCT02979613|585810024|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
162207267|NCT02979613|585810023|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
162207268|NCT02979613|585810024|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
162207269|NCT02979613|585810023|FG000|Open-Label Extension (OLE) Phase|Death|0|||
162207270|NCT02979613|585810024|FG001|Open-Label Extension (OLE) Phase|Death|1|||
161932638|NCT01245049|584800541|FG000|Overall Study|Lost to Follow-up|1|||
161932639|NCT01245049|584800542|FG001|Overall Study|Lost to Follow-up|2|||
161932640|NCT00450749|584800543|FG000|Overall Study|Withdrawal by Subject|0|||
161932641|NCT00450749|584800544|FG001|Overall Study|Withdrawal by Subject|0|||
161932642|NCT00450749|584800545|FG002|Overall Study|Withdrawal by Subject|2|||
161932643|NCT00450749|584800543|FG000|Overall Study|Noncompliant|0|||
161932644|NCT00450749|584800544|FG001|Overall Study|Noncompliant|1|||
161932645|NCT00450749|584800545|FG002|Overall Study|Noncompliant|0|||
161932646|NCT02151604|584800546|FG000|Overall Study|Lost to Follow-up|3|||
161932647|NCT02151604|584800546|FG000|Overall Study|Withdrawal by Subject|2|||
161932648|NCT02151604|584800546|FG000|Overall Study|Physician Decision|3|||
161932649|NCT02151604|584800546|FG000|Overall Study|Death|1|||
161932650|NCT02568254|584800548|FG000|Period 2|Adverse Event|0|||
161932651|NCT02568254|584800549|FG001|Period 2|Adverse Event|0|||
161932652|NCT02568254|584800550|FG002|Period 2|Adverse Event|1|||
161932653|NCT02568254|584800551|FG003|Period 2|Adverse Event|0|||
161932654|NCT02568254|584800552|FG004|Period 2|Adverse Event|0|||
161932655|NCT02568254|584800553|FG005|Period 2|Adverse Event|0|||
161932656|NCT02568254|584800548|FG000|Period 3|Unstatisfactory Lens fitting|0|||
161932657|NCT02568254|584800549|FG001|Period 3|Unstatisfactory Lens fitting|0|||
161932658|NCT02568254|584800550|FG002|Period 3|Unstatisfactory Lens fitting|0|||
161932659|NCT02568254|584800551|FG003|Period 3|Unstatisfactory Lens fitting|0|||
161932660|NCT02568254|584800552|FG004|Period 3|Unstatisfactory Lens fitting|1|||
161932661|NCT02568254|584800553|FG005|Period 3|Unstatisfactory Lens fitting|0|||
161932662|NCT00655746|584800554|FG000|Overall Study|Withdrawal by Subject|1|||
161932663|NCT00561821|584800555|FG000|Overall Study|Not treated|0|||
161932664|NCT00561821|584800556|FG001|Overall Study|Not treated|0|||
161932665|NCT00561821|584800557|FG002|Overall Study|Not treated|1|||
161932666|NCT00561821|584800558|FG003|Overall Study|Not treated|0|||
161932667|NCT00561821|584800555|FG000|Overall Study|Withdrawal by Subject|0|||
161932668|NCT00561821|584800556|FG001|Overall Study|Withdrawal by Subject|1|||
161932669|NCT00561821|584800557|FG002|Overall Study|Withdrawal by Subject|0|||
161932670|NCT00561821|584800558|FG003|Overall Study|Withdrawal by Subject|2|||
161932671|NCT00561821|584800555|FG000|Overall Study|Reasons not related to trial|2|||
161932672|NCT00561821|584800556|FG001|Overall Study|Reasons not related to trial|1|||
161932673|NCT00561821|584800557|FG002|Overall Study|Reasons not related to trial|0|||
161932674|NCT00561821|584800558|FG003|Overall Study|Reasons not related to trial|0|||
161932675|NCT00561821|584800555|FG000|Overall Study|Other (reason not specified)|1|||
161932676|NCT00561821|584800556|FG001|Overall Study|Other (reason not specified)|1|||
161932677|NCT00561821|584800557|FG002|Overall Study|Other (reason not specified)|0|||
161932678|NCT00561821|584800558|FG003|Overall Study|Other (reason not specified)|0|||
161932679|NCT00561821|584800555|FG000|Overall Study|Adverse Event|2|||
161932680|NCT00561821|584800556|FG001|Overall Study|Adverse Event|3|||
161932681|NCT00561821|584800557|FG002|Overall Study|Adverse Event|1|||
161932682|NCT00561821|584800558|FG003|Overall Study|Adverse Event|1|||
161932683|NCT03178942|584800559|FG000|Overall Study|Withdrawal by Subject|2|||
161932684|NCT03178942|584800560|FG001|Overall Study|Withdrawal by Subject|0|||
161932685|NCT03178942|584800559|FG000|Overall Study|Lost to Follow-up|1|||
161932686|NCT03178942|584800560|FG001|Overall Study|Lost to Follow-up|2|||
161932687|NCT02562040|584802312|FG000|Overall Study|Lost to Follow-up|20|||
161932688|NCT02562040|584802313|FG001|Overall Study|Lost to Follow-up|28|||
161932689|NCT02562040|584802312|FG000|Overall Study|Withdrawal by Subject|8|||
161932690|NCT02562040|584802313|FG001|Overall Study|Withdrawal by Subject|7|||
161932691|NCT02562040|584802312|FG000|Overall Study|Adverse Event|1|||
161932692|NCT02562040|584802313|FG001|Overall Study|Adverse Event|0|||
161932693|NCT04359680|584802316|FG000|Overall Study|Withdrawal by Subject|29|||
161932694|NCT04359680|584802317|FG001|Overall Study|Withdrawal by Subject|24|||
161932695|NCT04359680|584802316|FG000|Overall Study|Adverse Event|6|||
161932696|NCT04359680|584802317|FG001|Overall Study|Adverse Event|2|||
161932697|NCT04359680|584802316|FG000|Overall Study|Lost to Follow-up|56|||
161932698|NCT04359680|584802317|FG001|Overall Study|Lost to Follow-up|59|||
161932699|NCT04359680|584802316|FG000|Overall Study|Protocol Violation|3|||
161932700|NCT04359680|584802317|FG001|Overall Study|Protocol Violation|5|||
161932701|NCT04359680|584802316|FG000|Overall Study|Physician Decision|1|||
161932702|NCT04359680|584802317|FG001|Overall Study|Physician Decision|1|||
161932703|NCT04359680|584802316|FG000|Overall Study|Sponsor Decision|0|||
161932704|NCT04359680|584802317|FG001|Overall Study|Sponsor Decision|1|||
161932705|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
161932706|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
161932707|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
161932708|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
162207271|NCT02979613|585810023|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
161932709|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
161932710|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
161932711|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
161932712|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
161932713|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
161932714|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
161932715|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
161932716|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
161932717|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
161932718|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
161932719|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
161932720|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
161932721|NCT01755156|584802319|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
161932722|NCT01755156|584802320|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
161932723|NCT01755156|584802319|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
161932724|NCT01755156|584802320|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
161932725|NCT01755156|584802319|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
161932726|NCT01755156|584802320|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
161932727|NCT03142451|584802321|FG000|Overall Study|Adverse Event|5|||
161932728|NCT03142451|584802322|FG001|Overall Study|Adverse Event|2|||
161932729|NCT03142451|584802321|FG000|Overall Study|Lost to Follow-up|25|||
161932730|NCT03142451|584802322|FG001|Overall Study|Lost to Follow-up|8|||
161932731|NCT03142451|584802321|FG000|Overall Study|Participant request|24|||
161932732|NCT03142451|584802322|FG001|Overall Study|Participant request|12|||
161932733|NCT03142451|584802321|FG000|Overall Study|Protocol Violation|3|||
161932734|NCT03142451|584802322|FG001|Overall Study|Protocol Violation|1|||
161932735|NCT03142451|584802321|FG000|Overall Study|Other|1|||
161932736|NCT03142451|584802322|FG001|Overall Study|Other|1|||
161932737|NCT05333965|584802323|FG000|First Intervention|Adverse Event|0|||
161932738|NCT05333965|584802324|FG001|First Intervention|Adverse Event|1|||
161932739|NCT05333965|584802323|FG000|First Intervention|Withdrawal by Subject|0|||
161932740|NCT05333965|584802324|FG001|First Intervention|Withdrawal by Subject|1|||
161932741|NCT03048019|584802325|FG000|Overall Study|Adverse Event|1|||
161932742|NCT03048019|584802326|FG001|Overall Study|Adverse Event|0|||
161932743|NCT01730729|584802329|FG000|Overall Study|Adverse Event|1|||
161932744|NCT01730729|584802329|FG000|Overall Study|Death|1|||
161932745|NCT01730729|584802329|FG000|Overall Study|Progressive Disease|12|||
161932746|NCT00871000|584802330|FG000|Overall Study|Withdrawal by Subject|1|||
161932747|NCT00871000|584802331|FG001|Overall Study|Withdrawal by Subject|0|||
161932748|NCT01052428|584802332|FG000|Overall Study|Death|1|||
161932749|NCT01052428|584802333|FG001|Overall Study|Death|0|||
161932750|NCT01052428|584802332|FG000|Overall Study|Withdrawal by Subject|0|||
161932751|NCT01052428|584802333|FG001|Overall Study|Withdrawal by Subject|1|||
161932752|NCT00382863|584802334|FG000|Overall Study|Death|9|||
161932753|NCT00382863|584802335|FG001|Overall Study|Death|9|||
161932754|NCT00382863|584802334|FG000|Overall Study|Lost to Follow-up|1|||
161932755|NCT00382863|584802335|FG001|Overall Study|Lost to Follow-up|2|||
161932756|NCT00382863|584802334|FG000|Overall Study|Withdrawal by Subject|5|||
161932757|NCT00382863|584802335|FG001|Overall Study|Withdrawal by Subject|25|||
161932758|NCT00203242|584802338|FG000|Overall Study|Lost to Follow-up|1|||
161932759|NCT02595437|584802339|FG000|Triferic Via IV|Withdrawal by Subject|1|||
161932760|NCT02837952|584802341|FG000|Overall Study|Adverse Event|0|||
161932761|NCT02837952|584802342|FG001|Overall Study|Adverse Event|1|||
161932762|NCT02837952|584802341|FG000|Overall Study|Withdrawal by Subject|4|||
161932763|NCT02837952|584802342|FG001|Overall Study|Withdrawal by Subject|5|||
161932764|NCT02837952|584802341|FG000|Overall Study|Medication Error|1|||
161932765|NCT02837952|584802342|FG001|Overall Study|Medication Error|0|||
161932766|NCT00835549|584802345|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
161932767|NCT00835549|584802346|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161932768|NCT00986102|584802360|FG000|Overall Study|Lost to Follow-up|0|||
161932769|NCT00986102|584802361|FG001|Overall Study|Lost to Follow-up|1|||
161932770|NCT00986102|584802362|FG002|Overall Study|Lost to Follow-up|0|||
161932771|NCT00986102|584802363|FG003|Overall Study|Lost to Follow-up|1|||
161932772|NCT00986102|584802360|FG000|Overall Study|Withdrawal by Subject|1|||
161932773|NCT00986102|584802361|FG001|Overall Study|Withdrawal by Subject|1|||
161932774|NCT00986102|584802362|FG002|Overall Study|Withdrawal by Subject|0|||
161932775|NCT00986102|584802363|FG003|Overall Study|Withdrawal by Subject|0|||
161932776|NCT02314247|584802364|FG000|Overall Study|Adverse Event|2|||
161932777|NCT02314247|584802365|FG001|Overall Study|Adverse Event|1|||
161932778|NCT02314247|584802366|FG002|Overall Study|Adverse Event|0|||
161932779|NCT02314247|584802364|FG000|Overall Study|Withdrawal by Subject|1|||
161932780|NCT02314247|584802365|FG001|Overall Study|Withdrawal by Subject|3|||
161932781|NCT02314247|584802366|FG002|Overall Study|Withdrawal by Subject|1|||
161932782|NCT02314247|584802364|FG000|Overall Study|Progression of Disease|6|||
161932783|NCT02314247|584802365|FG001|Overall Study|Progression of Disease|2|||
161932784|NCT02314247|584802366|FG002|Overall Study|Progression of Disease|0|||
161932785|NCT00489359|584802374|FG000|Overall Study|Death|0|||
161932786|NCT00489359|584802375|FG001|Overall Study|Death|2|||
161932787|NCT00489359|584802374|FG000|Overall Study|Progressive Disease|5|||
161932788|NCT00489359|584802375|FG001|Overall Study|Progressive Disease|6|||
161932789|NCT00489359|584802374|FG000|Overall Study|Lost to Follow-up|1|||
161932790|NCT00489359|584802375|FG001|Overall Study|Lost to Follow-up|0|||
161932791|NCT00489359|584802374|FG000|Overall Study|Withdrawal by Subject|1|||
161932792|NCT00489359|584802375|FG001|Overall Study|Withdrawal by Subject|5|||
161932793|NCT00489359|584802374|FG000|Overall Study|Adverse Event|0|||
161932794|NCT00489359|584802375|FG001|Overall Study|Adverse Event|16|||
161932795|NCT03180138|584802376|FG000|Overall Study|Mobile-phone could not be verified|2|||
161932796|NCT03180138|584802377|FG001|Overall Study|Mobile-phone could not be verified|13|||
161932797|NCT03180138|584802378|FG002|Overall Study|Mobile-phone could not be verified|15|||
161932798|NCT03180138|584802376|FG000|Overall Study|No prior immunization records|17|||
161932799|NCT03180138|584802377|FG001|Overall Study|No prior immunization records|0|||
161932800|NCT03180138|584802378|FG002|Overall Study|No prior immunization records|6|||
161932801|NCT03180138|584802376|FG000|Overall Study|Found to be >24 mon after randomization|3|||
161932802|NCT03180138|584802377|FG001|Overall Study|Found to be >24 mon after randomization|0|||
161932803|NCT03180138|584802378|FG002|Overall Study|Found to be >24 mon after randomization|3|||
161932804|NCT01260311|584802381|FG000|Overall Study|Adverse Event|11|||
161932805|NCT01260311|584802381|FG000|Overall Study|Lack of Efficacy|4|||
161932806|NCT01260311|584802381|FG000|Overall Study|Lost to Follow-up|25|||
161932807|NCT01260311|584802381|FG000|Overall Study|Withdrawal by Subject|6|||
161932808|NCT01260311|584802381|FG000|Overall Study|Financial Constraints|77|||
161932809|NCT01260311|584802381|FG000|Overall Study|Gone to Province|2|||
161932810|NCT01260311|584802381|FG000|Overall Study|Medication Stopped|1|||
161932811|NCT01260311|584802381|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
161932812|NCT01340170|584802382|FG000|Overall Study|Lost to Follow-up|2|||
161932813|NCT01340170|584802383|FG001|Overall Study|Lost to Follow-up|4|||
161932814|NCT01340170|584802384|FG002|Overall Study|Lost to Follow-up|0|||
161932815|NCT01340170|584802382|FG000|Overall Study|Implant failure|1|||
161932816|NCT01340170|584802383|FG001|Overall Study|Implant failure|3|||
161932817|NCT01340170|584802384|FG002|Overall Study|Implant failure|0|||
161932818|NCT03878602|584802385|FG000|Overall Study|cord blood donation|7|||
161932819|NCT03878602|584802386|FG001|Overall Study|cord blood donation|1|||
161932820|NCT03878602|584802385|FG000|Overall Study|incomplete data collection|2|||
161932821|NCT03878602|584802386|FG001|Overall Study|incomplete data collection|0|||
161932822|NCT02633527|584802387|FG000|Overall Study|Failed to meet eligibility|0|||
161932823|NCT02633527|584802388|FG001|Overall Study|Failed to meet eligibility|1|||
161932824|NCT02633527|584802389|FG002|Overall Study|Failed to meet eligibility|1|||
161932825|NCT02633527|584802390|FG003|Overall Study|Failed to meet eligibility|0|||
161932826|NCT02633527|584802391|FG004|Overall Study|Failed to meet eligibility|1|||
161932827|NCT02633527|584802387|FG000|Overall Study|Adverse Event|0|||
161932828|NCT02633527|584802388|FG001|Overall Study|Adverse Event|4|||
161932829|NCT02633527|584802389|FG002|Overall Study|Adverse Event|3|||
161932830|NCT02633527|584802390|FG003|Overall Study|Adverse Event|1|||
161932831|NCT02633527|584802391|FG004|Overall Study|Adverse Event|5|||
161932832|NCT02633527|584802387|FG000|Overall Study|Lost to Follow-up|1|||
161932833|NCT02633527|584802388|FG001|Overall Study|Lost to Follow-up|2|||
161932834|NCT02633527|584802389|FG002|Overall Study|Lost to Follow-up|5|||
161932835|NCT02633527|584802390|FG003|Overall Study|Lost to Follow-up|5|||
161932836|NCT02633527|584802391|FG004|Overall Study|Lost to Follow-up|4|||
161932837|NCT02633527|584802387|FG000|Overall Study|Withdrawal by Subject|0|||
161932838|NCT02633527|584802388|FG001|Overall Study|Withdrawal by Subject|3|||
161932839|NCT02633527|584802389|FG002|Overall Study|Withdrawal by Subject|5|||
161932840|NCT02633527|584802390|FG003|Overall Study|Withdrawal by Subject|4|||
161932841|NCT02633527|584802391|FG004|Overall Study|Withdrawal by Subject|4|||
161932842|NCT02633527|584802387|FG000|Overall Study|Protocol Violation|0|||
161932843|NCT02633527|584802388|FG001|Overall Study|Protocol Violation|1|||
161932844|NCT02633527|584802389|FG002|Overall Study|Protocol Violation|1|||
161932845|NCT02633527|584802390|FG003|Overall Study|Protocol Violation|1|||
161932846|NCT02633527|584802391|FG004|Overall Study|Protocol Violation|1|||
161932847|NCT02633527|584802387|FG000|Overall Study|Physician Decision|0|||
161932848|NCT02633527|584802388|FG001|Overall Study|Physician Decision|0|||
161932849|NCT02633527|584802389|FG002|Overall Study|Physician Decision|0|||
161932850|NCT02633527|584802390|FG003|Overall Study|Physician Decision|0|||
161932851|NCT02633527|584802391|FG004|Overall Study|Physician Decision|1|||
161932852|NCT02633527|584802387|FG000|Overall Study|Administrative reason|1|||
161932853|NCT02633527|584802388|FG001|Overall Study|Administrative reason|0|||
161932854|NCT02633527|584802389|FG002|Overall Study|Administrative reason|0|||
161932855|NCT02633527|584802390|FG003|Overall Study|Administrative reason|1|||
161932856|NCT02633527|584802391|FG004|Overall Study|Administrative reason|0|||
161932857|NCT02633527|584802387|FG000|Overall Study|Multiple reasons|1|||
161932858|NCT02633527|584802388|FG001|Overall Study|Multiple reasons|0|||
161932859|NCT02633527|584802389|FG002|Overall Study|Multiple reasons|2|||
161932860|NCT02633527|584802390|FG003|Overall Study|Multiple reasons|2|||
161932861|NCT02633527|584802391|FG004|Overall Study|Multiple reasons|1|||
161932862|NCT06091956|584802392|FG000|Overall Study|Withdrawal by Subject|1|||
161932863|NCT06091956|584802392|FG000|Overall Study|Complicating Disease|1|||
161932864|NCT02176525|584802395|FG000|Overall Study|Adverse Event|0|||
161932865|NCT02176525|584802396|FG001|Overall Study|Adverse Event|0|||
161932866|NCT02176525|584802397|FG002|Overall Study|Adverse Event|0|||
161932867|NCT02176525|584802398|FG003|Overall Study|Adverse Event|1|||
161932868|NCT02176525|584802399|FG004|Overall Study|Adverse Event|1|||
161932869|NCT02176525|584802400|FG005|Overall Study|Adverse Event|0|||
161932870|NCT02176525|584802401|FG006|Overall Study|Adverse Event|1|||
161932871|NCT02176525|584802402|FG007|Overall Study|Adverse Event|0|||
161932872|NCT02176525|584802395|FG000|Overall Study|not treated|1|||
161932873|NCT02176525|584802396|FG001|Overall Study|not treated|0|||
161932874|NCT02176525|584802397|FG002|Overall Study|not treated|0|||
161932875|NCT02176525|584802398|FG003|Overall Study|not treated|0|||
161932876|NCT02176525|584802399|FG004|Overall Study|not treated|0|||
161932877|NCT02176525|584802400|FG005|Overall Study|not treated|1|||
161932878|NCT02176525|584802401|FG006|Overall Study|not treated|0|||
161932879|NCT02176525|584802402|FG007|Overall Study|not treated|0|||
161932880|NCT02100644|584802405|FG000|LTG Escalation Phase|Adverse Event|9|||
161932881|NCT02100644|584802406|FG001|LTG Escalation Phase|Adverse Event|0|||
161932882|NCT02100644|584802407|FG002|LTG Escalation Phase|Adverse Event|0|||
161932883|NCT02100644|584802405|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
161932884|NCT02100644|584802406|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
161932885|NCT02100644|584802407|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
161932886|NCT02100644|584802405|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
161932887|NCT02100644|584802406|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
161932888|NCT02100644|584802407|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
161932889|NCT00478140|584802408|FG000|Overall Study|Clinical Disease Progression|1|||
161932890|NCT03163264|584802412|FG000|Overall Study|Withdrawal by Subject|13|||
161932891|NCT03163264|584802413|FG001|Overall Study|Withdrawal by Subject|3|||
161932892|NCT03163264|584802414|FG002|Overall Study|Withdrawal by Subject|4|||
161932893|NCT03163264|584802415|FG003|Overall Study|Withdrawal by Subject|2|||
161932894|NCT03163264|584802412|FG000|Overall Study|Lost to Follow-up|17|||
161932895|NCT03163264|584802413|FG001|Overall Study|Lost to Follow-up|20|||
161932896|NCT03163264|584802414|FG002|Overall Study|Lost to Follow-up|0|||
161932897|NCT03163264|584802415|FG003|Overall Study|Lost to Follow-up|0|||
161932898|NCT03163264|584802412|FG000|Overall Study|Death|0|||
161932899|NCT03163264|584802413|FG001|Overall Study|Death|2|||
161932900|NCT03163264|584802414|FG002|Overall Study|Death|0|||
161932901|NCT03163264|584802415|FG003|Overall Study|Death|0|||
161932902|NCT02614066|584802416|FG000|Overall Study|Death|6|||
161932903|NCT02614066|584802417|FG001|Overall Study|Death|14|||
161932904|NCT02614066|584802418|FG002|Overall Study|Death|11|||
161932905|NCT02614066|584802419|FG003|Overall Study|Death|29|||
161932906|NCT02614066|584802416|FG000|Overall Study|Full consent withdrawn|0|||
161932907|NCT02614066|584802417|FG001|Overall Study|Full consent withdrawn|1|||
161932908|NCT02614066|584802418|FG002|Overall Study|Full consent withdrawn|0|||
161932909|NCT02614066|584802419|FG003|Overall Study|Full consent withdrawn|8|||
161932910|NCT02614066|584802416|FG000|Overall Study|Lost to Follow-up|0|||
161932911|NCT02614066|584802417|FG001|Overall Study|Lost to Follow-up|2|||
161932912|NCT02614066|584802418|FG002|Overall Study|Lost to Follow-up|2|||
161932913|NCT02614066|584802419|FG003|Overall Study|Lost to Follow-up|2|||
161932914|NCT02614066|584802416|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
161932915|NCT02614066|584802417|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
161932916|NCT02614066|584802418|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
161932917|NCT02614066|584802419|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
161932918|NCT02614066|584802416|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
161932919|NCT02614066|584802417|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
161932920|NCT02614066|584802418|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
161932921|NCT02614066|584802419|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
161932922|NCT02614066|584802416|FG000|Overall Study|Reason not specified|0|||
161932923|NCT02614066|584802417|FG001|Overall Study|Reason not specified|2|||
161932924|NCT02614066|584802418|FG002|Overall Study|Reason not specified|1|||
161932925|NCT02614066|584802419|FG003|Overall Study|Reason not specified|1|||
161932926|NCT04565756|584802420|FG000|Overall Study|Withdrawal by Subject|0|||
161932927|NCT04565756|584802421|FG001|Overall Study|Withdrawal by Subject|0|||
161677487|NCT00467779|583872011|FG011|Stage 3|Death|0|||
161932928|NCT04565756|584802422|FG002|Overall Study|Withdrawal by Subject|0|||
161932929|NCT04565756|584802423|FG003|Overall Study|Withdrawal by Subject|0|||
161932930|NCT04565756|584802424|FG004|Overall Study|Withdrawal by Subject|1|||
161932931|NCT04565756|584802425|FG005|Overall Study|Withdrawal by Subject|0|||
161932932|NCT04565756|584802420|FG000|Overall Study|Protocol Violation|0|||
161932933|NCT04565756|584802421|FG001|Overall Study|Protocol Violation|0|||
161932934|NCT04565756|584802422|FG002|Overall Study|Protocol Violation|0|||
161932935|NCT04565756|584802423|FG003|Overall Study|Protocol Violation|0|||
161932936|NCT04565756|584802424|FG004|Overall Study|Protocol Violation|0|||
161932937|NCT04565756|584802425|FG005|Overall Study|Protocol Violation|1|||
161932938|NCT00968968|584802430|FG000|Overall Study|Study closed/terminated|10|||
161932939|NCT00968968|584802431|FG001|Overall Study|Study closed/terminated|10|||
161932940|NCT00968968|584802430|FG000|Overall Study|Protocol defined stopping criteria|3|||
161932941|NCT00968968|584802431|FG001|Overall Study|Protocol defined stopping criteria|1|||
161932942|NCT00968968|584802430|FG000|Overall Study|Withdrawal by Subject|2|||
161932943|NCT00968968|584802431|FG001|Overall Study|Withdrawal by Subject|0|||
161932944|NCT00968968|584802430|FG000|Overall Study|Physician Decision|1|||
161932945|NCT00968968|584802431|FG001|Overall Study|Physician Decision|2|||
161932946|NCT00968968|584802430|FG000|Overall Study|Lost to Follow-up|0|||
161932947|NCT00968968|584802431|FG001|Overall Study|Lost to Follow-up|1|||
161932948|NCT04401293|584802432|FG000|Overall Study|Withdrawal by Subject|1|||
161932949|NCT04401293|584802433|FG001|Overall Study|Withdrawal by Subject|3|||
161932950|NCT01026038|584802434|FG000|Overall Study|Lost to Follow-up|1|||
161932951|NCT01026038|584802435|FG001|Overall Study|Lost to Follow-up|1|||
161932952|NCT01026038|584802436|FG002|Overall Study|Lost to Follow-up|0|||
161932953|NCT03679884|584802437|FG000|Overall Study|Other|12|||
161932954|NCT03679884|584802438|FG001|Overall Study|Other|12|||
161932955|NCT03679884|584802439|FG002|Overall Study|Other|12|||
161932956|NCT03679884|584802440|FG003|Overall Study|Other|7|||
161932957|NCT03679884|584802441|FG004|Overall Study|Other|8|||
161932958|NCT03679884|584802437|FG000|Overall Study|Lack of Efficacy|15|||
161932959|NCT03679884|584802438|FG001|Overall Study|Lack of Efficacy|29|||
161932960|NCT03679884|584802439|FG002|Overall Study|Lack of Efficacy|13|||
161932961|NCT03679884|584802440|FG003|Overall Study|Lack of Efficacy|29|||
162021298|NCT05091567|585134733|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
162207272|NCT02979613|585810024|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
161824514|NCT00108082|584399817|FG001|Overall Study|Consent Withdrawn|3|||
161824515|NCT00108082|584399818|FG002|Overall Study|Consent Withdrawn|5|||
161824516|NCT00108082|584399816|FG000|Overall Study|Protocol Violation|1|||
161824517|NCT00108082|584399817|FG001|Overall Study|Protocol Violation|2|||
161824518|NCT00108082|584399818|FG002|Overall Study|Protocol Violation|0|||
161824519|NCT00108082|584399816|FG000|Overall Study|Lack of Efficacy|3|||
161824520|NCT00108082|584399817|FG001|Overall Study|Lack of Efficacy|1|||
161824521|NCT00108082|584399818|FG002|Overall Study|Lack of Efficacy|2|||
161824522|NCT00108082|584399816|FG000|Overall Study|Amendment 4: > Month 12|5|||
161824523|NCT00108082|584399817|FG001|Overall Study|Amendment 4: > Month 12|7|||
161824524|NCT00108082|584399818|FG002|Overall Study|Amendment 4: > Month 12|5|||
161824525|NCT00108082|584399816|FG000|Overall Study|Woman of Child-bearing Potential|2|||
161824526|NCT00108082|584399817|FG001|Overall Study|Woman of Child-bearing Potential|0|||
161824527|NCT00108082|584399818|FG002|Overall Study|Woman of Child-bearing Potential|2|||
161824528|NCT00108082|584399816|FG000|Overall Study|Incorrectly Randomized|0|||
161824529|NCT00108082|584399817|FG001|Overall Study|Incorrectly Randomized|0|||
161824530|NCT00108082|584399818|FG002|Overall Study|Incorrectly Randomized|2|||
161824531|NCT00108082|584399816|FG000|Overall Study|Non-compliance|1|||
161824532|NCT00108082|584399817|FG001|Overall Study|Non-compliance|0|||
161824533|NCT00108082|584399818|FG002|Overall Study|Non-compliance|2|||
161824534|NCT00108082|584399816|FG000|Overall Study|Stopped Study Medication|0|||
161932962|NCT03679884|584802441|FG004|Overall Study|Lack of Efficacy|10|||
162207273|NCT00612352|585811865|FG000|Overall Study|Adverse Event|1|||
162207274|NCT00612352|585811866|FG001|Overall Study|Adverse Event|0|||
162207275|NCT00612352|585811865|FG000|Overall Study|Withdrawal by Subject|3|||
162207276|NCT00612352|585811866|FG001|Overall Study|Withdrawal by Subject|5|||
162207277|NCT00612352|585811865|FG000|Overall Study|moved out of state|1|||
162207278|NCT00612352|585811866|FG001|Overall Study|moved out of state|0|||
162207279|NCT00612352|585811865|FG000|Overall Study|didn't return calls/show up on test date|4|||
162207280|NCT00612352|585811866|FG001|Overall Study|didn't return calls/show up on test date|1|||
162207281|NCT00263211|585811867|FG000|Overall Study|Death|1|||
162207282|NCT00263211|585811868|FG001|Overall Study|Death|0|||
162207283|NCT00263211|585811867|FG000|Overall Study|Withdrawal by Subject|3|||
162207284|NCT00263211|585811868|FG001|Overall Study|Withdrawal by Subject|0|||
161932963|NCT03679884|584802437|FG000|Overall Study|Death|1|||
161932964|NCT03679884|584802438|FG001|Overall Study|Death|0|||
161932965|NCT03679884|584802439|FG002|Overall Study|Death|0|||
161932966|NCT03679884|584802440|FG003|Overall Study|Death|0|||
161932967|NCT03679884|584802441|FG004|Overall Study|Death|0|||
161932968|NCT03679884|584802437|FG000|Overall Study|Adverse Event|2|||
162207285|NCT00263211|585811867|FG000|Overall Study|Protocol Violation|1|||
161677488|NCT00467779|583872012|FG012|Stage 3|Death|0|||
161677489|NCT00467779|583872013|FG013|Stage 3|Death|0|||
161677490|NCT00467779|583872014|FG014|Stage 3|Death|1|||
161677491|NCT00467779|583872000|FG000|Stage 3|Disease Progression|0|||
161677492|NCT00467779|583872001|FG001|Stage 3|Disease Progression|0|||
161677493|NCT00467779|583872002|FG002|Stage 3|Disease Progression|0|||
161677494|NCT00467779|583872003|FG003|Stage 3|Disease Progression|0|||
161677495|NCT00467779|583872004|FG004|Stage 3|Disease Progression|0|||
161677496|NCT00467779|583872005|FG005|Stage 3|Disease Progression|0|||
161677497|NCT00467779|583872006|FG006|Stage 3|Disease Progression|0|||
161677498|NCT00467779|583872007|FG007|Stage 3|Disease Progression|0|||
161677499|NCT00467779|583872008|FG008|Stage 3|Disease Progression|0|||
161677500|NCT00467779|583872009|FG009|Stage 3|Disease Progression|0|||
161677501|NCT00467779|583872010|FG010|Stage 3|Disease Progression|0|||
161677502|NCT00467779|583872011|FG011|Stage 3|Disease Progression|0|||
161677503|NCT00467779|583872012|FG012|Stage 3|Disease Progression|0|||
161932969|NCT03679884|584802438|FG001|Overall Study|Adverse Event|10|||
161932970|NCT03679884|584802439|FG002|Overall Study|Adverse Event|9|||
161932971|NCT03679884|584802440|FG003|Overall Study|Adverse Event|6|||
161932972|NCT03679884|584802441|FG004|Overall Study|Adverse Event|6|||
161932973|NCT03679884|584802437|FG000|Overall Study|Withdrawal by Subject|12|||
161932974|NCT03679884|584802438|FG001|Overall Study|Withdrawal by Subject|23|||
161932975|NCT03679884|584802439|FG002|Overall Study|Withdrawal by Subject|8|||
161932976|NCT03679884|584802440|FG003|Overall Study|Withdrawal by Subject|8|||
161677504|NCT00467779|583872013|FG013|Stage 3|Disease Progression|0|||
161677505|NCT00467779|583872014|FG014|Stage 3|Disease Progression|9|||
161677506|NCT00467779|583872000|FG000|Stage 3|Unspecified Reason|0|||
161932977|NCT03679884|584802441|FG004|Overall Study|Withdrawal by Subject|9|||
161677507|NCT00467779|583872001|FG001|Stage 3|Unspecified Reason|0|||
161932978|NCT03679884|584802437|FG000|Overall Study|Lost to Follow-up|1|||
161932979|NCT03679884|584802438|FG001|Overall Study|Lost to Follow-up|4|||
162207286|NCT00263211|585811868|FG001|Overall Study|Protocol Violation|0|||
161677508|NCT00467779|583872002|FG002|Stage 3|Unspecified Reason|0|||
162207287|NCT00263211|585811867|FG000|Overall Study|Disease Progression|0|||
162207288|NCT00263211|585811868|FG001|Overall Study|Disease Progression|1|||
162207289|NCT02820597|585811869|FG000|Overall Study|Lost to Follow-up|12|||
162207290|NCT04606199|585811870|FG000|Overall Study|Withdrawal by Subject|2|||
162207291|NCT00408928|585811871|FG000|Overall Study|Withdrawal by Subject|1|||
162207292|NCT00408928|585811871|FG000|Overall Study|Death|1|||
162207293|NCT00408928|585811871|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
162207294|NCT02512861|585811877|FG000|Overall Study|Protocol Violation|3|||
162207295|NCT02512861|585811878|FG001|Overall Study|Protocol Violation|7|||
162207296|NCT02512861|585811877|FG000|Overall Study|Physician Decision|3|||
162207297|NCT02512861|585811878|FG001|Overall Study|Physician Decision|1|||
162207298|NCT02512861|585811877|FG000|Overall Study|Withdrawal by Subject|0|||
162207299|NCT02512861|585811878|FG001|Overall Study|Withdrawal by Subject|1|||
162207300|NCT00337285|585811879|FG000|Overall Study|Withdrawal by Subject|42|||
162207301|NCT00337285|585811879|FG000|Overall Study|Lost to Follow-up|41|||
162207302|NCT00337285|585811879|FG000|Overall Study|Adverse Event|28|||
162207303|NCT00337285|585811879|FG000|Overall Study|Protocol Violation|27|||
162207304|NCT00337285|585811879|FG000|Overall Study|Lack of Efficacy|11|||
162207305|NCT00337285|585811879|FG000|Overall Study|Death|1|||
162207306|NCT00337285|585811879|FG000|Overall Study|Physician Decision|1|||
162207307|NCT00337285|585811879|FG000|Overall Study|Lack of protocol compliance|7|||
162207308|NCT00292981|585811880|FG000|Overall Study|Adverse Event|1|||
162207309|NCT00292981|585811880|FG000|Overall Study|Lost to Follow-up|13|||
162207310|NCT00292981|585811880|FG000|Overall Study|Withdrawal by Subject|22|||
162207311|NCT00292981|585811880|FG000|Overall Study|Other|3|||
162207312|NCT00594178|585811883|FG000|Overall Study|Physician Decision|5|||
162207313|NCT02971228|585811908|FG000|Overall Study|Withdrawal by Subject|1|||
162207314|NCT02971228|585811909|FG001|Overall Study|Withdrawal by Subject|1|||
162207315|NCT02971228|585811910|FG002|Overall Study|Withdrawal by Subject|0|||
162207316|NCT02971228|585811911|FG003|Overall Study|Withdrawal by Subject|0|||
162207317|NCT02971228|585811912|FG004|Overall Study|Withdrawal by Subject|0|||
162207318|NCT02971228|585811908|FG000|Overall Study|Logistical challenges|0|||
162207319|NCT02971228|585811909|FG001|Overall Study|Logistical challenges|1|||
162207320|NCT02971228|585811910|FG002|Overall Study|Logistical challenges|0|||
162207321|NCT02971228|585811911|FG003|Overall Study|Logistical challenges|0|||
162207322|NCT02971228|585811912|FG004|Overall Study|Logistical challenges|0|||
162207323|NCT01167192|585811915|FG000|Overall Study|Adverse Event|1|||
162207324|NCT01167192|585811915|FG000|Overall Study|Death|1|||
162207325|NCT01167192|585811915|FG000|Overall Study|Withdrawal by Subject|1|||
162207326|NCT01167192|585811915|FG000|Overall Study|Insurance denial|1|||
162207327|NCT04952701|585811916|FG000|Control Lens|Physician Decision|4|||
162207328|NCT04952701|585811916|FG000|Test Lens|Physician Decision|1|||
162207329|NCT04545476|585811917|FG000|Overall Study|Lost to Follow-up|1|||
162207330|NCT04545476|585811918|FG001|Overall Study|Lost to Follow-up|1|||
162207331|NCT04545476|585811919|FG002|Overall Study|Lost to Follow-up|0|||
161932980|NCT03679884|584802439|FG002|Overall Study|Lost to Follow-up|2|||
161932981|NCT03679884|584802440|FG003|Overall Study|Lost to Follow-up|0|||
161932982|NCT03679884|584802441|FG004|Overall Study|Lost to Follow-up|3|||
161932983|NCT01783938|584802450|FG000|Overall Study|Disease Progression|18|||
161932984|NCT01783938|584802451|FG001|Overall Study|Disease Progression|41|||
161932985|NCT01783938|584802450|FG000|Overall Study|Study Drug Toxicity|27|||
161932986|NCT01783938|584802451|FG001|Overall Study|Study Drug Toxicity|14|||
161932987|NCT01783938|584802450|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
161932988|NCT01783938|584802451|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
161932989|NCT01783938|584802450|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
161932990|NCT01783938|584802451|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
161932991|NCT01783938|584802450|FG000|Overall Study|Participant Withdrew Consent|2|||
161932992|NCT01783938|584802451|FG001|Overall Study|Participant Withdrew Consent|0|||
161932993|NCT01783938|584802450|FG000|Overall Study|Maximum Clinical Benefit|1|||
161932994|NCT01783938|584802451|FG001|Overall Study|Maximum Clinical Benefit|0|||
161932995|NCT01783938|584802450|FG000|Overall Study|Other Reasons|3|||
161932996|NCT01783938|584802451|FG001|Overall Study|Other Reasons|1|||
161932997|NCT00930176|584802453|FG000|Overall Study|Death|1|||
161932998|NCT01712074|584802458|FG000|Placebo Run-in Period|Adverse Event|2|||
161932999|NCT01712074|584802459|FG001|Placebo Run-in Period|Adverse Event|0|||
161933000|NCT01712074|584802460|FG002|Placebo Run-in Period|Adverse Event|0|||
161933001|NCT01712074|584802458|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
161933002|NCT01712074|584802459|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
161933003|NCT01712074|584802460|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
161933004|NCT01712074|584802458|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
161824535|NCT00108082|584399817|FG001|Overall Study|Stopped Study Medication|0|||
161824536|NCT00108082|584399818|FG002|Overall Study|Stopped Study Medication|1|||
161824537|NCT00108082|584399816|FG000|Overall Study|Site Closed Study|0|||
161824538|NCT00108082|584399817|FG001|Overall Study|Site Closed Study|2|||
161824539|NCT00108082|584399818|FG002|Overall Study|Site Closed Study|0|||
161824540|NCT00108082|584399816|FG000|Overall Study|Protocol Amendment|0|||
161824541|NCT00108082|584399817|FG001|Overall Study|Protocol Amendment|1|||
161824542|NCT00108082|584399818|FG002|Overall Study|Protocol Amendment|0|||
161824543|NCT00108082|584399816|FG000|Overall Study|Study Medication Not Tapered|0|||
161824544|NCT00108082|584399817|FG001|Overall Study|Study Medication Not Tapered|1|||
161824545|NCT00108082|584399818|FG002|Overall Study|Study Medication Not Tapered|0|||
161824546|NCT00108082|584399816|FG000|Overall Study|Subject Left Site Location|1|||
161824547|NCT00108082|584399817|FG001|Overall Study|Subject Left Site Location|0|||
161824548|NCT00108082|584399818|FG002|Overall Study|Subject Left Site Location|0|||
161824549|NCT00108082|584399816|FG000|Overall Study|Investigator Not at Site|1|||
161824550|NCT00108082|584399817|FG001|Overall Study|Investigator Not at Site|0|||
161824551|NCT00108082|584399818|FG002|Overall Study|Investigator Not at Site|0|||
161824552|NCT00108082|584399816|FG000|Overall Study|Blood Pressure Not Controlled|1|||
161824553|NCT00108082|584399817|FG001|Overall Study|Blood Pressure Not Controlled|0|||
161824554|NCT00108082|584399818|FG002|Overall Study|Blood Pressure Not Controlled|0|||
161824555|NCT01091103|584399822|FG000|Overall Study|Adverse Event|1|||
161824556|NCT01091103|584399822|FG000|Overall Study|Progressive Disease|3|||
161824557|NCT01270620|584399823|FG000|Overall Study|Withdrawal by Subject|1|||
161824558|NCT01270620|584399824|FG001|Overall Study|Withdrawal by Subject|3|||
161824559|NCT01045707|584399825|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
161824560|NCT01045707|584399826|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
161824561|NCT01045707|584399825|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
161824562|NCT01045707|584399826|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
161824563|NCT01045707|584399825|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
161824564|NCT01045707|584399826|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
161824565|NCT01045707|584399825|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
161824566|NCT01045707|584399826|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
161824567|NCT01045707|584399825|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
161824568|NCT01045707|584399826|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
161824569|NCT01045707|584399825|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
161824570|NCT01045707|584399826|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
161824571|NCT01045707|584399825|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
161824572|NCT01045707|584399826|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
161824573|NCT01045707|584399825|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
161824574|NCT01045707|584399826|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
161824575|NCT01045707|584399825|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
161933005|NCT01712074|584802459|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
161933006|NCT01712074|584802460|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
161824576|NCT01045707|584399826|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
161824577|NCT00348816|584399827|FG000|Overall Study|Noncompliance with radiation treatment|1|||
161824578|NCT00809965|584399828|FG000|Overall Study|Death|194|||
161824579|NCT00809965|584399829|FG001|Overall Study|Death|147|||
162207332|NCT04545476|585811920|FG003|Overall Study|Lost to Follow-up|0|||
162207333|NCT00846768|585811924|FG000|Overall Study|Adverse Event|0|||
162207334|NCT00846768|585811925|FG001|Overall Study|Adverse Event|1|||
162207335|NCT00846768|585811926|FG002|Overall Study|Adverse Event|0|||
162207336|NCT00846768|585811927|FG003|Overall Study|Adverse Event|0|||
162207337|NCT00644878|585811929|FG000|Overall Study|Adverse Event|2|||
162207338|NCT00644878|585811929|FG000|Overall Study|Abnormal laboratory value|3|||
162207339|NCT00644878|585811929|FG000|Overall Study|Protocol deviation|2|||
162207340|NCT00644878|585811929|FG000|Overall Study|Treatment duration completed as per protocol|11|||
162207341|NCT02143063|585811932|FG000|Overall Study|Lost to Follow-up|16|||
162207342|NCT02143063|585811933|FG001|Overall Study|Lost to Follow-up|28|||
162207343|NCT02143063|585811934|FG002|Overall Study|Lost to Follow-up|29|||
161824580|NCT00809965|584399830|FG002|Overall Study|Death|196|||
161824581|NCT00809965|584399828|FG000|Overall Study|Lost to Follow-up|17|||
161824582|NCT00809965|584399829|FG001|Overall Study|Lost to Follow-up|10|||
161824583|NCT00809965|584399830|FG002|Overall Study|Lost to Follow-up|18|||
161824584|NCT00809965|584399828|FG000|Overall Study|Withdrawal by Subject|405|||
161824585|NCT00809965|584399829|FG001|Overall Study|Withdrawal by Subject|448|||
161824586|NCT00809965|584399830|FG002|Overall Study|Withdrawal by Subject|441|||
161824587|NCT00809965|584399828|FG000|Overall Study|Other Reason|167|||
161824588|NCT00809965|584399829|FG001|Overall Study|Other Reason|170|||
161824589|NCT00809965|584399830|FG002|Overall Study|Other Reason|189|||
161824590|NCT02780167|584399831|FG000|Overall Study|Adverse Event|9|||
161824591|NCT02780167|584399832|FG001|Overall Study|Adverse Event|8|||
161824592|NCT02780167|584399833|FG002|Overall Study|Adverse Event|8|||
161824593|NCT02780167|584399834|FG003|Overall Study|Adverse Event|12|||
161824594|NCT02780167|584399835|FG004|Overall Study|Adverse Event|8|||
161824595|NCT02780167|584399831|FG000|Overall Study|Lack of Efficacy|6|||
161824596|NCT02780167|584399832|FG001|Overall Study|Lack of Efficacy|5|||
161824597|NCT02780167|584399833|FG002|Overall Study|Lack of Efficacy|6|||
161824598|NCT02780167|584399834|FG003|Overall Study|Lack of Efficacy|1|||
161824599|NCT02780167|584399835|FG004|Overall Study|Lack of Efficacy|0|||
161824600|NCT02780167|584399831|FG000|Overall Study|Lost to Follow-up|2|||
161824601|NCT02780167|584399832|FG001|Overall Study|Lost to Follow-up|0|||
161824602|NCT02780167|584399833|FG002|Overall Study|Lost to Follow-up|1|||
161824603|NCT02780167|584399834|FG003|Overall Study|Lost to Follow-up|0|||
161824604|NCT02780167|584399835|FG004|Overall Study|Lost to Follow-up|0|||
161824605|NCT02780167|584399831|FG000|Overall Study|Does not meet entrance criteria|0|||
161824606|NCT02780167|584399832|FG001|Overall Study|Does not meet entrance criteria|0|||
161824607|NCT02780167|584399833|FG002|Overall Study|Does not meet entrance criteria|1|||
161824608|NCT02780167|584399834|FG003|Overall Study|Does not meet entrance criteria|0|||
161824609|NCT02780167|584399835|FG004|Overall Study|Does not meet entrance criteria|0|||
161824610|NCT02780167|584399831|FG000|Overall Study|No longer meets eligibility criteria|0|||
161824611|NCT02780167|584399832|FG001|Overall Study|No longer meets eligibility criteria|0|||
161824612|NCT02780167|584399833|FG002|Overall Study|No longer meets eligibility criteria|0|||
161824613|NCT02780167|584399834|FG003|Overall Study|No longer meets eligibility criteria|1|||
161824614|NCT02780167|584399835|FG004|Overall Study|No longer meets eligibility criteria|1|||
161824615|NCT02780167|584399831|FG000|Overall Study|Protocol Violation|5|||
161824616|NCT02780167|584399832|FG001|Overall Study|Protocol Violation|5|||
161824617|NCT02780167|584399833|FG002|Overall Study|Protocol Violation|1|||
161824618|NCT02780167|584399834|FG003|Overall Study|Protocol Violation|1|||
161824619|NCT02780167|584399835|FG004|Overall Study|Protocol Violation|2|||
161824620|NCT02780167|584399831|FG000|Overall Study|Withdrawal by Subject|6|||
161824621|NCT02780167|584399832|FG001|Overall Study|Withdrawal by Subject|4|||
161824622|NCT02780167|584399833|FG002|Overall Study|Withdrawal by Subject|4|||
161824623|NCT02780167|584399834|FG003|Overall Study|Withdrawal by Subject|3|||
161824624|NCT02780167|584399835|FG004|Overall Study|Withdrawal by Subject|4|||
161824625|NCT02780167|584399831|FG000|Overall Study|Other|0|||
161824626|NCT02780167|584399832|FG001|Overall Study|Other|0|||
161824627|NCT02780167|584399833|FG002|Overall Study|Other|3|||
161824628|NCT02780167|584399834|FG003|Overall Study|Other|1|||
161824629|NCT02780167|584399835|FG004|Overall Study|Other|2|||
161824630|NCT05552261|584399837|FG000|Overall Study|Withdrawal by Subject|1|||
161824631|NCT05552261|584399837|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
161824632|NCT02315066|584399838|FG000|Overall Study|Lost to Follow-up|0|||
161824633|NCT02315066|584399839|FG001|Overall Study|Lost to Follow-up|1|||
161824634|NCT02315066|584399840|FG002|Overall Study|Lost to Follow-up|1|||
161824635|NCT02315066|584399841|FG003|Overall Study|Lost to Follow-up|0|||
161824636|NCT02315066|584399842|FG004|Overall Study|Lost to Follow-up|1|||
161824637|NCT02315066|584399843|FG005|Overall Study|Lost to Follow-up|0|||
161824638|NCT02315066|584399844|FG006|Overall Study|Lost to Follow-up|2|||
161824639|NCT02315066|584399845|FG007|Overall Study|Lost to Follow-up|1|||
161824640|NCT02315066|584399846|FG008|Overall Study|Lost to Follow-up|0|||
162207344|NCT02143063|585811932|FG000|Overall Study|Withdrawal by Subject|0|||
162207345|NCT02143063|585811933|FG001|Overall Study|Withdrawal by Subject|1|||
162207346|NCT02143063|585811934|FG002|Overall Study|Withdrawal by Subject|0|||
162207347|NCT02143063|585811932|FG000|Overall Study|Death|0|||
162207348|NCT02143063|585811933|FG001|Overall Study|Death|1|||
162021299|NCT05091567|585134734|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
162021300|NCT05091567|585134732|FG000|Enrollment Phase|Physician Decision|3|||
162021301|NCT05091567|585134733|FG001|Enrollment Phase|Physician Decision|0|||
162207349|NCT02143063|585811934|FG002|Overall Study|Death|1|||
162207350|NCT03517111|585811935|FG000|Enrolled|Withdrawal by Subject|0|||
162207351|NCT03517111|585811936|FG001|Enrolled|Withdrawal by Subject|1|||
162207352|NCT03517111|585811937|FG002|Enrolled|Withdrawal by Subject|0|||
162207353|NCT03517111|585811935|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
162207354|NCT03517111|585811936|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
162207355|NCT03517111|585811937|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
162207356|NCT03517111|585811935|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
162207357|NCT03517111|585811936|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
162207358|NCT03517111|585811937|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
162207359|NCT03517111|585811935|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
162207360|NCT03517111|585811936|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
162207361|NCT03517111|585811937|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
162207362|NCT03517111|585811935|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
162207363|NCT03517111|585811936|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
162207364|NCT03517111|585811937|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
162207365|NCT02062645|585811940|FG000|Overall Study|Adverse Event|2|||
162207366|NCT02062645|585811940|FG000|Overall Study|Protocol Violation|8|||
162207367|NCT02062645|585811940|FG000|Overall Study|Lost to Follow-up|5|||
162207368|NCT02864342|585811942|FG000|Overall Study|Eligibility Criteria Deviation|2|||
162207369|NCT02864342|585811943|FG001|Overall Study|Eligibility Criteria Deviation|3|||
162207370|NCT02864342|585811942|FG000|Overall Study|Withdrawal by Subject|4|||
162207371|NCT02864342|585811943|FG001|Overall Study|Withdrawal by Subject|2|||
162207372|NCT02864342|585811942|FG000|Overall Study|Device Technology Issue|6|||
162207373|NCT02864342|585811943|FG001|Overall Study|Device Technology Issue|7|||
161677509|NCT00467779|583872003|FG003|Stage 3|Unspecified Reason|0|||
161824641|NCT02315066|584399847|FG009|Overall Study|Lost to Follow-up|0|||
161824642|NCT02315066|584399848|FG010|Overall Study|Lost to Follow-up|1|||
161824643|NCT02315066|584399849|FG011|Overall Study|Lost to Follow-up|2|||
161824644|NCT02315066|584399850|FG012|Overall Study|Lost to Follow-up|0|||
161824645|NCT02315066|584399851|FG013|Overall Study|Lost to Follow-up|4|||
161824646|NCT02315066|584399838|FG000|Overall Study|Death|2|||
161824647|NCT02315066|584399839|FG001|Overall Study|Death|7|||
161824648|NCT02315066|584399840|FG002|Overall Study|Death|6|||
161824649|NCT02315066|584399841|FG003|Overall Study|Death|11|||
161824650|NCT02315066|584399842|FG004|Overall Study|Death|10|||
161824651|NCT02315066|584399843|FG005|Overall Study|Death|3|||
161824652|NCT02315066|584399844|FG006|Overall Study|Death|9|||
161824653|NCT02315066|584399845|FG007|Overall Study|Death|9|||
161824654|NCT02315066|584399846|FG008|Overall Study|Death|10|||
161824655|NCT02315066|584399847|FG009|Overall Study|Death|8|||
161824656|NCT02315066|584399848|FG010|Overall Study|Death|10|||
161824657|NCT02315066|584399849|FG011|Overall Study|Death|7|||
161824658|NCT02315066|584399850|FG012|Overall Study|Death|8|||
161824659|NCT02315066|584399851|FG013|Overall Study|Death|21|||
161824660|NCT02315066|584399838|FG000|Overall Study|Other|0|||
161824661|NCT02315066|584399839|FG001|Overall Study|Other|0|||
161824662|NCT02315066|584399840|FG002|Overall Study|Other|0|||
161824663|NCT02315066|584399841|FG003|Overall Study|Other|0|||
161824664|NCT02315066|584399842|FG004|Overall Study|Other|0|||
161824665|NCT02315066|584399843|FG005|Overall Study|Other|0|||
161824666|NCT02315066|584399844|FG006|Overall Study|Other|0|||
161824667|NCT02315066|584399845|FG007|Overall Study|Other|1|||
161824668|NCT02315066|584399846|FG008|Overall Study|Other|1|||
161824669|NCT02315066|584399847|FG009|Overall Study|Other|2|||
161824670|NCT02315066|584399848|FG010|Overall Study|Other|0|||
161824671|NCT02315066|584399849|FG011|Overall Study|Other|0|||
161824672|NCT02315066|584399850|FG012|Overall Study|Other|0|||
161824673|NCT02315066|584399851|FG013|Overall Study|Other|0|||
161824674|NCT02315066|584399838|FG000|Overall Study|Subject refused further follow-up|0|||
161824675|NCT02315066|584399839|FG001|Overall Study|Subject refused further follow-up|2|||
161824676|NCT02315066|584399840|FG002|Overall Study|Subject refused further follow-up|2|||
161824677|NCT02315066|584399841|FG003|Overall Study|Subject refused further follow-up|0|||
161824678|NCT02315066|584399842|FG004|Overall Study|Subject refused further follow-up|0|||
161824679|NCT02315066|584399843|FG005|Overall Study|Subject refused further follow-up|0|||
161824680|NCT02315066|584399844|FG006|Overall Study|Subject refused further follow-up|2|||
161824681|NCT02315066|584399845|FG007|Overall Study|Subject refused further follow-up|3|||
161824682|NCT02315066|584399846|FG008|Overall Study|Subject refused further follow-up|0|||
161824683|NCT02315066|584399847|FG009|Overall Study|Subject refused further follow-up|1|||
161824684|NCT02315066|584399848|FG010|Overall Study|Subject refused further follow-up|1|||
161824685|NCT02315066|584399849|FG011|Overall Study|Subject refused further follow-up|2|||
161824686|NCT02315066|584399850|FG012|Overall Study|Subject refused further follow-up|2|||
161824687|NCT02315066|584399851|FG013|Overall Study|Subject refused further follow-up|4|||
161824688|NCT02315066|584399838|FG000|Overall Study|Study ongoing at date of cut-off|0|||
162021302|NCT05091567|585134734|FG002|Enrollment Phase|Physician Decision|0|||
162207374|NCT02864342|585811942|FG000|Overall Study|Death|0|||
162207375|NCT02864342|585811943|FG001|Overall Study|Death|1|||
162207376|NCT02864342|585811942|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
162207377|NCT02864342|585811943|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
162207378|NCT02864342|585811942|FG000|Overall Study|Lost to Follow-up|1|||
162207379|NCT02864342|585811943|FG001|Overall Study|Lost to Follow-up|5|||
162207380|NCT02864342|585811942|FG000|Overall Study|Lost Device|1|||
162207381|NCT02864342|585811943|FG001|Overall Study|Lost Device|0|||
162207382|NCT02864342|585811942|FG000|Overall Study|Adverse Event|1|||
162207383|NCT02864342|585811943|FG001|Overall Study|Adverse Event|0|||
161824689|NCT02315066|584399839|FG001|Overall Study|Study ongoing at date of cut-off|0|||
161824690|NCT02315066|584399840|FG002|Overall Study|Study ongoing at date of cut-off|0|||
161824691|NCT02315066|584399841|FG003|Overall Study|Study ongoing at date of cut-off|0|||
161824692|NCT02315066|584399842|FG004|Overall Study|Study ongoing at date of cut-off|0|||
161824693|NCT02315066|584399843|FG005|Overall Study|Study ongoing at date of cut-off|0|||
161824694|NCT02315066|584399844|FG006|Overall Study|Study ongoing at date of cut-off|0|||
161824695|NCT02315066|584399845|FG007|Overall Study|Study ongoing at date of cut-off|0|||
161824696|NCT02315066|584399846|FG008|Overall Study|Study ongoing at date of cut-off|0|||
161824697|NCT02315066|584399847|FG009|Overall Study|Study ongoing at date of cut-off|0|||
161824698|NCT02315066|584399848|FG010|Overall Study|Study ongoing at date of cut-off|0|||
161824699|NCT02315066|584399849|FG011|Overall Study|Study ongoing at date of cut-off|0|||
161824700|NCT02315066|584399850|FG012|Overall Study|Study ongoing at date of cut-off|0|||
161824701|NCT02315066|584399851|FG013|Overall Study|Study ongoing at date of cut-off|1|||
161824702|NCT03259789|584399852|FG000|Overall Study|Adverse Event|3|||
161824703|NCT03259789|584399853|FG001|Overall Study|Adverse Event|2|||
161824704|NCT03259789|584399854|FG002|Overall Study|Adverse Event|1|||
161824705|NCT03259789|584399852|FG000|Overall Study|Withdrawal by Subject|9|||
161824706|NCT03259789|584399853|FG001|Overall Study|Withdrawal by Subject|5|||
161824707|NCT03259789|584399854|FG002|Overall Study|Withdrawal by Subject|1|||
161824708|NCT03259789|584399852|FG000|Overall Study|Lost to Follow-up|5|||
161824709|NCT03259789|584399853|FG001|Overall Study|Lost to Follow-up|9|||
161824710|NCT03259789|584399854|FG002|Overall Study|Lost to Follow-up|4|||
161824711|NCT03259789|584399852|FG000|Overall Study|Physician Decision|0|||
161824712|NCT03259789|584399853|FG001|Overall Study|Physician Decision|1|||
161824713|NCT03259789|584399854|FG002|Overall Study|Physician Decision|0|||
161824714|NCT00860262|584399858|FG000|Overall Study|Adverse Event|9|||
161824715|NCT00860262|584399859|FG001|Overall Study|Adverse Event|6|||
161824716|NCT00860262|584399860|FG002|Overall Study|Adverse Event|7|||
161824717|NCT00860262|584399858|FG000|Overall Study|Protocol Violation|0|||
161824718|NCT00860262|584399859|FG001|Overall Study|Protocol Violation|1|||
161824719|NCT00860262|584399860|FG002|Overall Study|Protocol Violation|0|||
161824720|NCT00860262|584399858|FG000|Overall Study|Lost to Follow-up|2|||
161824721|NCT00860262|584399859|FG001|Overall Study|Lost to Follow-up|0|||
161824722|NCT00860262|584399860|FG002|Overall Study|Lost to Follow-up|1|||
161824723|NCT00860262|584399858|FG000|Overall Study|Withdrawal by Subject|4|||
161824724|NCT00860262|584399859|FG001|Overall Study|Withdrawal by Subject|8|||
161824725|NCT00860262|584399860|FG002|Overall Study|Withdrawal by Subject|6|||
161824726|NCT00860262|584399858|FG000|Overall Study|Lack of Efficacy|0|||
161824727|NCT00860262|584399859|FG001|Overall Study|Lack of Efficacy|4|||
161824728|NCT00860262|584399860|FG002|Overall Study|Lack of Efficacy|3|||
161824729|NCT00860262|584399858|FG000|Overall Study|Other|5|||
161824730|NCT00860262|584399859|FG001|Overall Study|Other|3|||
161824731|NCT00860262|584399860|FG002|Overall Study|Other|1|||
161824732|NCT01183884|584399861|FG000|Overall Study|Progressive Disease|26|||
161824733|NCT01183884|584399861|FG000|Overall Study|Adverse Event|3|||
161824734|NCT01183884|584399861|FG000|Overall Study|Withdrawal by Subject|1|||
161824735|NCT01183884|584399861|FG000|Overall Study|Other Complicating Disease|3|||
161824736|NCT01183884|584399861|FG000|Overall Study|Not Treated|1|||
161824737|NCT01183884|584399861|FG000|Overall Study|Other|4|||
161824738|NCT02169336|584399862|FG000|Overall Study|Lack of Efficacy|1|||
161824739|NCT02169336|584399863|FG001|Overall Study|Lack of Efficacy|1|||
161824740|NCT02169336|584399864|FG002|Overall Study|Lack of Efficacy|0|||
161824741|NCT02169336|584399862|FG000|Overall Study|Adverse Event|2|||
161824742|NCT02169336|584399863|FG001|Overall Study|Adverse Event|3|||
161824743|NCT02169336|584399864|FG002|Overall Study|Adverse Event|1|||
161824744|NCT02169336|584399862|FG000|Overall Study|Withdrawal by Subject|1|||
161824745|NCT02169336|584399863|FG001|Overall Study|Withdrawal by Subject|0|||
161824746|NCT02169336|584399864|FG002|Overall Study|Withdrawal by Subject|0|||
161824747|NCT02169336|584399862|FG000|Overall Study|Physician Decision|0|||
161824748|NCT02169336|584399863|FG001|Overall Study|Physician Decision|0|||
161824749|NCT02169336|584399864|FG002|Overall Study|Physician Decision|1|||
161824750|NCT02169336|584399862|FG000|Overall Study|Subject declined to continue dosing|0|||
161824751|NCT02169336|584399863|FG001|Overall Study|Subject declined to continue dosing|0|||
161824752|NCT02169336|584399864|FG002|Overall Study|Subject declined to continue dosing|1|||
161824753|NCT01598896|584399865|FG000|Overall Study|Withdrawal by Subject|0|||
161824754|NCT01598896|584399866|FG001|Overall Study|Withdrawal by Subject|1|||
162207384|NCT00927901|585811944|FG000|Treatment Period 1|Subject withdrew consent|0|||
162207385|NCT00927901|585811945|FG001|Treatment Period 1|Subject withdrew consent|0|||
162207386|NCT00927901|585811946|FG002|Treatment Period 1|Subject withdrew consent|1|||
162207387|NCT00927901|585811947|FG003|Treatment Period 1|Subject withdrew consent|0|||
162207388|NCT00927901|585811944|FG000|Treatment Period 4|Adverse Event|0|||
162207389|NCT00927901|585811945|FG001|Treatment Period 4|Adverse Event|0|||
162207390|NCT00927901|585811946|FG002|Treatment Period 4|Adverse Event|0|||
162207391|NCT00927901|585811947|FG003|Treatment Period 4|Adverse Event|1|||
162207392|NCT00927901|585811944|FG000|Treatment Period 4|Subject withdrew consent|0|||
161677510|NCT00467779|583872004|FG004|Stage 3|Unspecified Reason|0|||
162207393|NCT00927901|585811945|FG001|Treatment Period 4|Subject withdrew consent|0|||
162207394|NCT00927901|585811946|FG002|Treatment Period 4|Subject withdrew consent|1|||
162207395|NCT00927901|585811947|FG003|Treatment Period 4|Subject withdrew consent|0|||
162207396|NCT01349036|585811948|FG000|Overall Study|Disease progression|13|||
162207397|NCT01349036|585811949|FG001|Overall Study|Disease progression|22|||
162207398|NCT01349036|585811948|FG000|Overall Study|Other|1|||
162207399|NCT01349036|585811949|FG001|Overall Study|Other|0|||
162207400|NCT01349036|585811948|FG000|Overall Study|Withdrawal by Subject|0|||
162207401|NCT01349036|585811949|FG001|Overall Study|Withdrawal by Subject|2|||
162207402|NCT03796208|585811950|FG000|Overall Study|Withdrawal by Subject|3|||
162207403|NCT03796208|585811951|FG001|Overall Study|Withdrawal by Subject|0|||
162207404|NCT03796208|585811950|FG000|Overall Study|Loss of pregnancy|1|||
162207405|NCT03796208|585811951|FG001|Overall Study|Loss of pregnancy|1|||
162207406|NCT03796208|585811950|FG000|Overall Study|Changed prenatal clinics|0|||
162207407|NCT03796208|585811951|FG001|Overall Study|Changed prenatal clinics|5|||
162207408|NCT03796208|585811950|FG000|Overall Study|Lost to Follow-up|20|||
161824755|NCT01598896|584399865|FG000|Overall Study|Lack of Efficacy|0|||
161824756|NCT01598896|584399866|FG001|Overall Study|Lack of Efficacy|1|||
161824757|NCT00420095|584399867|FG000|Overall Study|Adverse Event|1|||
161824758|NCT00420095|584399868|FG001|Overall Study|Adverse Event|0|||
161824759|NCT00420095|584399867|FG000|Overall Study|Protocol Violation|1|||
161824760|NCT00420095|584399868|FG001|Overall Study|Protocol Violation|1|||
161824761|NCT00420095|584399867|FG000|Overall Study|Lost to Follow-up|1|||
161824762|NCT00420095|584399868|FG001|Overall Study|Lost to Follow-up|0|||
161824763|NCT00393705|584399869|FG000|Overall Study|Adverse Event|0|||
161824764|NCT00393705|584399870|FG001|Overall Study|Adverse Event|2|||
161824765|NCT00393705|584399869|FG000|Overall Study|Death|0|||
161824766|NCT00393705|584399870|FG001|Overall Study|Death|1|||
161824767|NCT00393705|584399869|FG000|Overall Study|Lost to Follow-up|2|||
161824768|NCT00393705|584399870|FG001|Overall Study|Lost to Follow-up|2|||
161824769|NCT00393705|584399869|FG000|Overall Study|Entry Criteria Not Met|10|||
161824770|NCT00393705|584399870|FG001|Overall Study|Entry Criteria Not Met|10|||
161824771|NCT00393705|584399869|FG000|Overall Study|Protocol Violation|4|||
161824772|NCT00393705|584399870|FG001|Overall Study|Protocol Violation|3|||
161824773|NCT00393705|584399869|FG000|Overall Study|Withdrawal by Subject|5|||
161824774|NCT00393705|584399870|FG001|Overall Study|Withdrawal by Subject|3|||
161824775|NCT00393705|584399869|FG000|Overall Study|Physician Decision|2|||
162207409|NCT03796208|585811951|FG001|Overall Study|Lost to Follow-up|16|||
162207410|NCT01161628|585811952|FG000|Overall Study|Death|6|||
161824776|NCT00393705|584399870|FG001|Overall Study|Physician Decision|2|||
161824777|NCT04553406|584399873|FG000|Overall Study|Study Discontinuation|0|||
161824778|NCT04553406|584399874|FG001|Overall Study|Study Discontinuation|1|||
161824779|NCT03370510|584399875|FG000|Overall Study|COVID-19|2|||
161824780|NCT03370510|584399876|FG001|Overall Study|COVID-19|0|||
162207411|NCT01161628|585811952|FG000|Overall Study|Lack of Efficacy|2|||
162207412|NCT00746356|585811956|FG000|Overall Study|Withdrawal by Subject|2|||
161933007|NCT01712074|584802458|FG000|Placebo Run-in Period|Other|1|||
161933008|NCT01712074|584802459|FG001|Placebo Run-in Period|Other|0|||
162207413|NCT00746356|585811957|FG001|Overall Study|Withdrawal by Subject|3|||
162207414|NCT00746356|585811956|FG000|Overall Study|Death|7|||
162207415|NCT00746356|585811957|FG001|Overall Study|Death|3|||
162207416|NCT00746356|585811956|FG000|Overall Study|Lost to Follow-up|1|||
162207417|NCT00746356|585811957|FG001|Overall Study|Lost to Follow-up|0|||
162207418|NCT00746356|585811956|FG000|Overall Study|Removal of Device|0|||
162207419|NCT00746356|585811957|FG001|Overall Study|Removal of Device|1|||
162207420|NCT00746356|585811956|FG000|Overall Study|Patient relocated|1|||
162207421|NCT00746356|585811957|FG001|Overall Study|Patient relocated|0|||
162207422|NCT01263925|585811958|FG000|Overall Study|Protocol Violation|1|||
162207423|NCT01263925|585811959|FG001|Overall Study|Protocol Violation|0|||
162207424|NCT01263925|585811958|FG000|Overall Study|Lack of Efficacy|0|||
162207425|NCT01263925|585811959|FG001|Overall Study|Lack of Efficacy|1|||
162207426|NCT01263925|585811958|FG000|Overall Study|Adverse Event|23|||
162207427|NCT01263925|585811959|FG001|Overall Study|Adverse Event|22|||
162207428|NCT01263925|585811958|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
162207429|NCT01263925|585811959|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
162207430|NCT01263925|585811958|FG000|Overall Study|Withdrawal by Subject|6|||
162207431|NCT01263925|585811959|FG001|Overall Study|Withdrawal by Subject|8|||
162207432|NCT01263925|585811958|FG000|Overall Study|Other|4|||
162207433|NCT01263925|585811959|FG001|Overall Study|Other|4|||
162207434|NCT01263925|585811958|FG000|Overall Study|Lost to Follow-up|3|||
162207435|NCT01263925|585811959|FG001|Overall Study|Lost to Follow-up|1|||
162207436|NCT01263925|585811958|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
162207437|NCT01263925|585811959|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
162207438|NCT01263925|585811958|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
162207439|NCT01263925|585811959|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
162207440|NCT01263925|585811958|FG000|Overall Study|AE/ Withdrawal|1|||
162207441|NCT01263925|585811959|FG001|Overall Study|AE/ Withdrawal|4|||
162207442|NCT01263925|585811958|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
162207443|NCT01263925|585811959|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
162207444|NCT01263925|585811958|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
162207445|NCT01263925|585811959|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
162207446|NCT01263925|585811958|FG000|Overall Study|Withdrawal/ Not specified|0|||
162207447|NCT01263925|585811959|FG001|Overall Study|Withdrawal/ Not specified|1|||
162207448|NCT01125566|585811960|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
162207449|NCT01125566|585811961|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
162207450|NCT01125566|585811962|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
162207451|NCT01125566|585811960|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
162207452|NCT01125566|585811961|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
162207453|NCT01125566|585811962|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
162207454|NCT01125566|585811960|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
162207455|NCT01125566|585811961|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
162207456|NCT01125566|585811962|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
162207457|NCT01125566|585811960|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
162207458|NCT01125566|585811961|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
162207459|NCT01125566|585811962|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
161933009|NCT01712074|584802460|FG002|Placebo Run-in Period|Other|0|||
161933010|NCT01712074|584802458|FG000|Placebo Run-in Period|No longer willing to participate|1|||
161933011|NCT01712074|584802459|FG001|Placebo Run-in Period|No longer willing to participate|0|||
161933012|NCT01712074|584802460|FG002|Placebo Run-in Period|No longer willing to participate|0|||
161933013|NCT01712074|584802458|FG000|Double Blind Period|Adverse Event|0|||
161933014|NCT01712074|584802459|FG001|Double Blind Period|Adverse Event|2|||
161933015|NCT01712074|584802460|FG002|Double Blind Period|Adverse Event|1|||
161933016|NCT01712074|584802458|FG000|Double Blind Period|No longer willing to participate|0|||
161933017|NCT01712074|584802459|FG001|Double Blind Period|No longer willing to participate|2|||
161933018|NCT01712074|584802460|FG002|Double Blind Period|No longer willing to participate|4|||
161933019|NCT01712074|584802458|FG000|Double Blind Period|Death|0|||
162021303|NCT05091567|585134732|FG000|Enrollment Phase|Protocol Violation|2|||
162021304|NCT05091567|585134733|FG001|Enrollment Phase|Protocol Violation|0|||
162207460|NCT01125566|585811960|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
162207461|NCT01125566|585811961|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
162207462|NCT01125566|585811962|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
162207463|NCT01125566|585811960|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
162207464|NCT01125566|585811961|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
161933020|NCT01712074|584802459|FG001|Double Blind Period|Death|1|||
161933021|NCT01712074|584802460|FG002|Double Blind Period|Death|0|||
161933022|NCT01712074|584802458|FG000|Double Blind Period|Lost to Follow-up|0|||
161933023|NCT01712074|584802459|FG001|Double Blind Period|Lost to Follow-up|2|||
161824781|NCT05258630|584401718|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
161824782|NCT05258630|584401719|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
161824783|NCT05258630|584401718|FG000|Overall Study|Lost to Follow-up|0|||
161824784|NCT05258630|584401719|FG001|Overall Study|Lost to Follow-up|2|||
161824785|NCT03431337|584401720|FG000|Overall Study|Lost to Follow-up|21|||
161933024|NCT01712074|584802460|FG002|Double Blind Period|Lost to Follow-up|1|||
161933025|NCT01712074|584802458|FG000|Double Blind Period|Other|0|||
161933026|NCT01712074|584802459|FG001|Double Blind Period|Other|4|||
161933027|NCT01712074|584802460|FG002|Double Blind Period|Other|1|||
161933028|NCT01712074|584802458|FG000|Double Blind Period|Protocol Violation|0|||
161933029|NCT01712074|584802459|FG001|Double Blind Period|Protocol Violation|0|||
161933030|NCT01712074|584802460|FG002|Double Blind Period|Protocol Violation|1|||
161933031|NCT01712074|584802458|FG000|Double Blind Period|No longer met eligibility criteria|0|||
161933032|NCT01712074|584802459|FG001|Double Blind Period|No longer met eligibility criteria|3|||
161933033|NCT01712074|584802460|FG002|Double Blind Period|No longer met eligibility criteria|0|||
161933034|NCT03478787|584802461|FG000|Overall Study|Adverse Event|5|||
161933035|NCT03478787|584802462|FG001|Overall Study|Adverse Event|1|||
161933036|NCT03478787|584802461|FG000|Overall Study|Protocol Violation|3|||
161933037|NCT03478787|584802462|FG001|Overall Study|Protocol Violation|0|||
161933038|NCT03478787|584802461|FG000|Overall Study|Lack of Efficacy|7|||
161933039|NCT03478787|584802462|FG001|Overall Study|Lack of Efficacy|1|||
161933040|NCT03478787|584802461|FG000|Overall Study|Lost to Follow-up|9|||
161933041|NCT03478787|584802462|FG001|Overall Study|Lost to Follow-up|5|||
161933042|NCT03478787|584802461|FG000|Overall Study|Withdrawal by Subject|2|||
161933043|NCT03478787|584802462|FG001|Overall Study|Withdrawal by Subject|6|||
161933044|NCT03478787|584802461|FG000|Overall Study|Other, Not Specified|3|||
161933045|NCT03478787|584802462|FG001|Overall Study|Other, Not Specified|0|||
161933046|NCT02792257|584802467|FG000|Overall Study|Lost to Follow-up|3|||
161933047|NCT02792257|584802468|FG001|Overall Study|Lost to Follow-up|4|||
161933048|NCT02792257|584802467|FG000|Overall Study|Allergy|0|||
161933049|NCT02792257|584802468|FG001|Overall Study|Allergy|1|||
161933050|NCT02792257|584802467|FG000|Overall Study|Protocol Violation|2|||
161933051|NCT02792257|584802468|FG001|Overall Study|Protocol Violation|0|||
161933052|NCT02792257|584802467|FG000|Overall Study|Excessive Agitation|0|||
161933053|NCT02792257|584802468|FG001|Overall Study|Excessive Agitation|1|||
161933054|NCT02792257|584802467|FG000|Overall Study|Not Feeling Well|0|||
161933055|NCT02792257|584802468|FG001|Overall Study|Not Feeling Well|1|||
161933056|NCT02766478|584802470|FG000|Overall Study|Withdrawal by Subject|1|||
161933057|NCT02766478|584802471|FG001|Overall Study|Withdrawal by Subject|1|||
161933058|NCT01093573|584802472|FG000|Overall Study|Physician Decision|0|||
161933059|NCT01093573|584802473|FG001|Overall Study|Physician Decision|0|||
161933060|NCT01093573|584802474|FG002|Overall Study|Physician Decision|1|||
162207465|NCT01125566|585811962|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
162207466|NCT01125566|585811960|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
162207467|NCT01125566|585811961|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
162207468|NCT01125566|585811962|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
162207469|NCT01125566|585811960|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
162207470|NCT01125566|585811961|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
162207471|NCT01125566|585811962|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
162207472|NCT01125566|585811960|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
162207473|NCT01125566|585811961|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
162207474|NCT01125566|585811962|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
162207475|NCT01125566|585811960|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
162207476|NCT01125566|585811961|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
162207477|NCT01125566|585811962|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
162207478|NCT01125566|585811960|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
162207479|NCT01125566|585811961|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
162207480|NCT01125566|585811962|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
162207481|NCT01125566|585811960|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
162207482|NCT01125566|585811961|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
162207483|NCT01125566|585811962|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
162207484|NCT01560585|585811963|FG000|Overall Study|Physician Decision|3|||
162207485|NCT00983892|585811964|FG000|Overall Study|Withdrawal by Subject|10|||
162207486|NCT00983892|585811965|FG001|Overall Study|Withdrawal by Subject|12|||
161933061|NCT01093573|584802472|FG000|Overall Study|Insurance Denied|0|||
161933062|NCT01093573|584802473|FG001|Overall Study|Insurance Denied|0|||
161933063|NCT01093573|584802474|FG002|Overall Study|Insurance Denied|1|||
162021305|NCT05091567|585134734|FG002|Enrollment Phase|Protocol Violation|0|||
161933064|NCT05626686|584802475|FG000|Overall Study|Protocol Violation|3|||
161933065|NCT05626686|584802475|FG000|Overall Study|Withdrawal by Subject|3|||
161933066|NCT00682435|584802476|FG000|Overall Study|Insufficient data|5|||
161933067|NCT00682435|584802476|FG000|Overall Study|Erroneously enrolled twice|2|||
161933068|NCT00089583|584802477|FG000|Overall Study|Adverse Event|0|||
161933069|NCT00089583|584802478|FG001|Overall Study|Adverse Event|3|||
161933070|NCT00089583|584802477|FG000|Overall Study|Insufficient Viral Load Response|5|||
161933071|NCT00089583|584802478|FG001|Overall Study|Insufficient Viral Load Response|5|||
161933072|NCT00089583|584802477|FG000|Overall Study|Withdrawal by Subject|0|||
162207487|NCT01726517|585811966|FG000|Overall Study|Withdrawal by Subject|0|||
162207488|NCT01726517|585811967|FG001|Overall Study|Withdrawal by Subject|0|||
162207489|NCT01726517|585811968|FG002|Overall Study|Withdrawal by Subject|1|||
162207490|NCT01726517|585811969|FG003|Overall Study|Withdrawal by Subject|0|||
162207491|NCT01726517|585811970|FG004|Overall Study|Withdrawal by Subject|0|||
162207492|NCT02484547|585811979|FG000|Placebo-Controlled Period|Adverse Event|10|||
162207493|NCT02484547|585811980|FG001|Placebo-Controlled Period|Adverse Event|13|||
162207494|NCT02484547|585811981|FG002|Placebo-Controlled Period|Adverse Event|20|||
162207495|NCT02484547|585811982|FG003|Placebo-Controlled Period|Adverse Event|0|||
162207496|NCT02484547|585811983|FG004|Placebo-Controlled Period|Adverse Event|0|||
162207497|NCT02484547|585811984|FG005|Placebo-Controlled Period|Adverse Event|0|||
162207498|NCT02484547|585811985|FG006|Placebo-Controlled Period|Adverse Event|0|||
162207499|NCT02484547|585811979|FG000|Placebo-Controlled Period|Change of Treatment|0|||
162207500|NCT02484547|585811980|FG001|Placebo-Controlled Period|Change of Treatment|0|||
162207501|NCT02484547|585811981|FG002|Placebo-Controlled Period|Change of Treatment|1|||
162207502|NCT02484547|585811982|FG003|Placebo-Controlled Period|Change of Treatment|0|||
162207503|NCT02484547|585811983|FG004|Placebo-Controlled Period|Change of Treatment|0|||
162207504|NCT02484547|585811984|FG005|Placebo-Controlled Period|Change of Treatment|0|||
162207505|NCT02484547|585811985|FG006|Placebo-Controlled Period|Change of Treatment|0|||
162207506|NCT02484547|585811979|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
162207507|NCT02484547|585811980|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
162207508|NCT02484547|585811981|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
162207509|NCT02484547|585811982|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
162207510|NCT02484547|585811983|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
162207511|NCT02484547|585811984|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
162207512|NCT02484547|585811985|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
162207513|NCT02484547|585811979|FG000|Placebo-Controlled Period|Death|5|||
162207514|NCT02484547|585811980|FG001|Placebo-Controlled Period|Death|0|||
162207515|NCT02484547|585811981|FG002|Placebo-Controlled Period|Death|6|||
162207516|NCT02484547|585811982|FG003|Placebo-Controlled Period|Death|0|||
161824786|NCT03431337|584401721|FG001|Overall Study|Lost to Follow-up|19|||
161824787|NCT03431337|584401720|FG000|Overall Study|Withdrawal by Subject|8|||
161824788|NCT03431337|584401721|FG001|Overall Study|Withdrawal by Subject|3|||
161824789|NCT00894933|584401728|FG000|Overall Study|Lost to Follow-up|2|||
161824790|NCT00894933|584401728|FG000|Overall Study|Cancelled Procedure|1|||
161824791|NCT00894933|584401728|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
161824792|NCT00631007|584401730|FG000|Overall Study|Adverse Event|0|||
161824793|NCT00631007|584401731|FG001|Overall Study|Adverse Event|2|||
161824794|NCT00631007|584401732|FG002|Overall Study|Adverse Event|0|||
161824795|NCT00631007|584401733|FG003|Overall Study|Adverse Event|2|||
161824796|NCT00631007|584401734|FG004|Overall Study|Adverse Event|3|||
161824797|NCT00631007|584401735|FG005|Overall Study|Adverse Event|2|||
161824798|NCT00631007|584401730|FG000|Overall Study|Lost to Follow-up|2|||
161824799|NCT00631007|584401731|FG001|Overall Study|Lost to Follow-up|1|||
161824800|NCT00631007|584401732|FG002|Overall Study|Lost to Follow-up|2|||
161824801|NCT00631007|584401733|FG003|Overall Study|Lost to Follow-up|4|||
161824802|NCT00631007|584401734|FG004|Overall Study|Lost to Follow-up|5|||
161824803|NCT00631007|584401735|FG005|Overall Study|Lost to Follow-up|3|||
161824804|NCT00631007|584401730|FG000|Overall Study|Physician Decision|1|||
161824805|NCT00631007|584401731|FG001|Overall Study|Physician Decision|0|||
161824806|NCT00631007|584401732|FG002|Overall Study|Physician Decision|1|||
161824807|NCT00631007|584401733|FG003|Overall Study|Physician Decision|0|||
161824808|NCT00631007|584401734|FG004|Overall Study|Physician Decision|0|||
161824809|NCT00631007|584401735|FG005|Overall Study|Physician Decision|2|||
161824810|NCT00631007|584401730|FG000|Overall Study|Persistent Hyperglycemia|2|||
161824811|NCT00631007|584401731|FG001|Overall Study|Persistent Hyperglycemia|2|||
161824812|NCT00631007|584401732|FG002|Overall Study|Persistent Hyperglycemia|5|||
161824813|NCT00631007|584401733|FG003|Overall Study|Persistent Hyperglycemia|1|||
161824814|NCT00631007|584401734|FG004|Overall Study|Persistent Hyperglycemia|2|||
161824815|NCT00631007|584401735|FG005|Overall Study|Persistent Hyperglycemia|5|||
161824816|NCT00631007|584401730|FG000|Overall Study|Withdrawal by Subject|4|||
161824817|NCT00631007|584401731|FG001|Overall Study|Withdrawal by Subject|5|||
161824818|NCT00631007|584401732|FG002|Overall Study|Withdrawal by Subject|2|||
161824819|NCT00631007|584401733|FG003|Overall Study|Withdrawal by Subject|2|||
161824820|NCT00631007|584401734|FG004|Overall Study|Withdrawal by Subject|1|||
161824821|NCT00631007|584401735|FG005|Overall Study|Withdrawal by Subject|3|||
161824822|NCT00631007|584401730|FG000|Overall Study|Other|2|||
161824823|NCT00631007|584401731|FG001|Overall Study|Other|1|||
161824824|NCT00631007|584401732|FG002|Overall Study|Other|0|||
161824825|NCT00631007|584401733|FG003|Overall Study|Other|0|||
161824826|NCT00631007|584401734|FG004|Overall Study|Other|1|||
161824827|NCT00631007|584401735|FG005|Overall Study|Other|0|||
161933073|NCT00089583|584802478|FG001|Overall Study|Withdrawal by Subject|4|||
161933074|NCT00089583|584802477|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
162207517|NCT02484547|585811983|FG004|Placebo-Controlled Period|Death|0|||
162207518|NCT02484547|585811984|FG005|Placebo-Controlled Period|Death|0|||
162207519|NCT02484547|585811985|FG006|Placebo-Controlled Period|Death|0|||
162207520|NCT02484547|585811979|FG000|Placebo-Controlled Period|Disease Progression|2|||
162207521|NCT02484547|585811980|FG001|Placebo-Controlled Period|Disease Progression|0|||
162207522|NCT02484547|585811981|FG002|Placebo-Controlled Period|Disease Progression|1|||
162207523|NCT02484547|585811982|FG003|Placebo-Controlled Period|Disease Progression|0|||
162207524|NCT02484547|585811983|FG004|Placebo-Controlled Period|Disease Progression|0|||
162207525|NCT02484547|585811984|FG005|Placebo-Controlled Period|Disease Progression|0|||
162207526|NCT02484547|585811985|FG006|Placebo-Controlled Period|Disease Progression|0|||
162207527|NCT02484547|585811979|FG000|Placebo-Controlled Period|Investigator Decision|2|||
162207528|NCT02484547|585811980|FG001|Placebo-Controlled Period|Investigator Decision|2|||
162207529|NCT02484547|585811981|FG002|Placebo-Controlled Period|Investigator Decision|5|||
162207530|NCT02484547|585811982|FG003|Placebo-Controlled Period|Investigator Decision|0|||
162207531|NCT02484547|585811983|FG004|Placebo-Controlled Period|Investigator Decision|0|||
162207532|NCT02484547|585811984|FG005|Placebo-Controlled Period|Investigator Decision|0|||
162207533|NCT02484547|585811985|FG006|Placebo-Controlled Period|Investigator Decision|0|||
162207534|NCT02484547|585811979|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
162207535|NCT02484547|585811980|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
162207536|NCT02484547|585811981|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
162207537|NCT02484547|585811982|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
162207538|NCT02484547|585811983|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
162207539|NCT02484547|585811984|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
162207540|NCT02484547|585811985|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
162207541|NCT02484547|585811979|FG000|Placebo-Controlled Period|Relocation|1|||
162207542|NCT02484547|585811980|FG001|Placebo-Controlled Period|Relocation|1|||
162207543|NCT02484547|585811981|FG002|Placebo-Controlled Period|Relocation|1|||
162207544|NCT02484547|585811982|FG003|Placebo-Controlled Period|Relocation|0|||
162207545|NCT02484547|585811983|FG004|Placebo-Controlled Period|Relocation|0|||
162207546|NCT02484547|585811984|FG005|Placebo-Controlled Period|Relocation|0|||
162207547|NCT02484547|585811985|FG006|Placebo-Controlled Period|Relocation|0|||
162207548|NCT02484547|585811979|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
162207549|NCT02484547|585811980|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
162207550|NCT02484547|585811981|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
162207551|NCT02484547|585811982|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
162207552|NCT02484547|585811983|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
162207553|NCT02484547|585811984|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
162207554|NCT02484547|585811985|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
162207555|NCT02484547|585811979|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
162207556|NCT02484547|585811980|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
162207557|NCT02484547|585811981|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
162207558|NCT02484547|585811982|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162207559|NCT02484547|585811983|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162207560|NCT02484547|585811984|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162207561|NCT02484547|585811985|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
162207562|NCT02484547|585811979|FG000|Placebo-Controlled Period|Reason not Specified|216|||
162207563|NCT02484547|585811980|FG001|Placebo-Controlled Period|Reason not Specified|194|||
162207564|NCT02484547|585811981|FG002|Placebo-Controlled Period|Reason not Specified|183|||
162207565|NCT02484547|585811982|FG003|Placebo-Controlled Period|Reason not Specified|0|||
162207566|NCT02484547|585811983|FG004|Placebo-Controlled Period|Reason not Specified|0|||
162207567|NCT02484547|585811984|FG005|Placebo-Controlled Period|Reason not Specified|0|||
162207568|NCT02484547|585811985|FG006|Placebo-Controlled Period|Reason not Specified|0|||
162207569|NCT02484547|585811979|FG000|Long-Term Extension Period|Adverse Event|0|||
162207570|NCT02484547|585811980|FG001|Long-Term Extension Period|Adverse Event|0|||
162207571|NCT02484547|585811981|FG002|Long-Term Extension Period|Adverse Event|0|||
162207572|NCT02484547|585811982|FG003|Long-Term Extension Period|Adverse Event|0|||
162207573|NCT02484547|585811983|FG004|Long-Term Extension Period|Adverse Event|1|||
162207574|NCT02484547|585811984|FG005|Long-Term Extension Period|Adverse Event|3|||
162207575|NCT02484547|585811985|FG006|Long-Term Extension Period|Adverse Event|2|||
162207576|NCT02484547|585811979|FG000|Long-Term Extension Period|Death|0|||
162207577|NCT02484547|585811980|FG001|Long-Term Extension Period|Death|0|||
162207578|NCT02484547|585811981|FG002|Long-Term Extension Period|Death|0|||
162207579|NCT02484547|585811982|FG003|Long-Term Extension Period|Death|0|||
162207580|NCT02484547|585811983|FG004|Long-Term Extension Period|Death|0|||
162207581|NCT02484547|585811984|FG005|Long-Term Extension Period|Death|3|||
162207582|NCT02484547|585811985|FG006|Long-Term Extension Period|Death|0|||
162207583|NCT02484547|585811979|FG000|Long-Term Extension Period|Disease Progression|0|||
162207584|NCT02484547|585811980|FG001|Long-Term Extension Period|Disease Progression|0|||
162207585|NCT02484547|585811981|FG002|Long-Term Extension Period|Disease Progression|0|||
162207586|NCT02484547|585811982|FG003|Long-Term Extension Period|Disease Progression|0|||
162207587|NCT02484547|585811983|FG004|Long-Term Extension Period|Disease Progression|2|||
162207588|NCT02484547|585811984|FG005|Long-Term Extension Period|Disease Progression|4|||
162207589|NCT02484547|585811985|FG006|Long-Term Extension Period|Disease Progression|0|||
162207590|NCT02484547|585811979|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
162207591|NCT02484547|585811980|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
162207592|NCT02484547|585811981|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
162207593|NCT02484547|585811982|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
162207594|NCT02484547|585811983|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
162207595|NCT02484547|585811984|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
162207596|NCT02484547|585811985|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
162207597|NCT02484547|585811979|FG000|Long-Term Extension Period|Loss of Capacity|0|||
162207598|NCT02484547|585811980|FG001|Long-Term Extension Period|Loss of Capacity|0|||
161933075|NCT00089583|584802478|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
161933076|NCT00089583|584802477|FG000|Overall Study|Participant Refused Study Medication|0|||
161933077|NCT00089583|584802478|FG001|Overall Study|Participant Refused Study Medication|2|||
161933078|NCT00089583|584802477|FG000|Overall Study|Non-Compliance|0|||
161933079|NCT00089583|584802478|FG001|Overall Study|Non-Compliance|4|||
161933080|NCT00089583|584802477|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
161933081|NCT00089583|584802478|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
161933082|NCT00089583|584802477|FG000|Overall Study|Participant Management Criteria Met|0|||
161933083|NCT00089583|584802478|FG001|Overall Study|Participant Management Criteria Met|1|||
161933084|NCT00089583|584802477|FG000|Overall Study|Reason Not Provided|0|||
161933085|NCT00089583|584802478|FG001|Overall Study|Reason Not Provided|1|||
161933086|NCT00089583|584802477|FG000|Overall Study|Protocol Violation|0|||
161933087|NCT00089583|584802478|FG001|Overall Study|Protocol Violation|3|||
161933088|NCT00089583|584802477|FG000|Overall Study|Principal Investigator Decision|0|||
161933089|NCT00089583|584802478|FG001|Overall Study|Principal Investigator Decision|10|||
161933090|NCT00089583|584802477|FG000|Overall Study|Start of Disallowed Medication|0|||
161933091|NCT00089583|584802478|FG001|Overall Study|Start of Disallowed Medication|1|||
161933092|NCT00089583|584802477|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
161933093|NCT00089583|584802478|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
161933094|NCT00089583|584802477|FG000|Overall Study|Participant Incarcerated|0|||
161933095|NCT00089583|584802478|FG001|Overall Study|Participant Incarcerated|1|||
161933096|NCT01412983|584802479|FG000|1st Period|Ineligible|0|||
161933097|NCT01412983|584802480|FG001|1st Period|Ineligible|1|||
161933098|NCT01412983|584802479|FG000|1st Period|Positive slit lamp finding|0|||
161933099|NCT01412983|584802480|FG001|1st Period|Positive slit lamp finding|1|||
161933100|NCT01412983|584802479|FG000|1st Period|Unacceptable lens movement|0|||
161933101|NCT01412983|584802480|FG001|1st Period|Unacceptable lens movement|1|||
161933102|NCT01412983|584802479|FG000|1st Period|Inability to maintain wear|0|||
161933103|NCT01412983|584802480|FG001|1st Period|Inability to maintain wear|1|||
161933104|NCT02946996|584802481|FG000|Overall Study|non-evaluable|3|||
161933105|NCT02946996|584802482|FG001|Overall Study|non-evaluable|6|||
161933106|NCT02946996|584802483|FG002|Overall Study|non-evaluable|5|||
161933107|NCT00176254|584802484|FG000|Overall Study|Lost to Follow-up|1|||
161933108|NCT03289741|584802485|FG000|Overall Study|Adverse Event|1|||
161933109|NCT03289741|584802486|FG001|Overall Study|Adverse Event|1|||
161933110|NCT03289741|584802485|FG000|Overall Study|Physician Decision|2|||
161933111|NCT03289741|584802486|FG001|Overall Study|Physician Decision|2|||
161933112|NCT03289741|584802485|FG000|Overall Study|Withdrawal by Subject|1|||
161933113|NCT03289741|584802486|FG001|Overall Study|Withdrawal by Subject|0|||
161933114|NCT00537082|584802490|FG000|Overall Study|Adverse Event|6|||
161933115|NCT00537082|584802491|FG001|Overall Study|Adverse Event|6|||
161933116|NCT00537082|584802492|FG002|Overall Study|Adverse Event|3|||
161933117|NCT00537082|584802490|FG000|Overall Study|Protocol Violation|0|||
161933118|NCT00537082|584802491|FG001|Overall Study|Protocol Violation|2|||
161933119|NCT00537082|584802492|FG002|Overall Study|Protocol Violation|1|||
161933120|NCT00537082|584802490|FG000|Overall Study|Lack of Efficacy|0|||
161933121|NCT00537082|584802491|FG001|Overall Study|Lack of Efficacy|0|||
161933122|NCT00537082|584802492|FG002|Overall Study|Lack of Efficacy|2|||
161933123|NCT00537082|584802490|FG000|Overall Study|Withdrawal by Subject|0|||
161933124|NCT00537082|584802491|FG001|Overall Study|Withdrawal by Subject|1|||
161933125|NCT00537082|584802492|FG002|Overall Study|Withdrawal by Subject|0|||
162207599|NCT02484547|585811981|FG002|Long-Term Extension Period|Loss of Capacity|0|||
161933126|NCT00537082|584802490|FG000|Overall Study|Discontinued before initiating treatment|3|||
161933127|NCT00537082|584802491|FG001|Overall Study|Discontinued before initiating treatment|0|||
161933128|NCT00537082|584802492|FG002|Overall Study|Discontinued before initiating treatment|0|||
161933129|NCT04495478|584802493|FG000|Overall Study|Withdrawal by Subject|0|||
161933130|NCT04495478|584802494|FG001|Overall Study|Withdrawal by Subject|0|||
161933131|NCT04495478|584802495|FG002|Overall Study|Withdrawal by Subject|0|||
161933132|NCT04495478|584802496|FG003|Overall Study|Withdrawal by Subject|1|||
161933133|NCT04495478|584802497|FG004|Overall Study|Withdrawal by Subject|0|||
161933134|NCT04495478|584802498|FG005|Overall Study|Withdrawal by Subject|0|||
161933135|NCT04495478|584802499|FG006|Overall Study|Withdrawal by Subject|0|||
161933136|NCT04495478|584802493|FG000|Overall Study|Physician Decision|0|||
161933137|NCT04495478|584802494|FG001|Overall Study|Physician Decision|1|||
161933138|NCT04495478|584802495|FG002|Overall Study|Physician Decision|0|||
161933139|NCT04495478|584802496|FG003|Overall Study|Physician Decision|0|||
161933140|NCT04495478|584802497|FG004|Overall Study|Physician Decision|1|||
161933141|NCT04495478|584802498|FG005|Overall Study|Physician Decision|0|||
161933142|NCT04495478|584802499|FG006|Overall Study|Physician Decision|0|||
161933143|NCT01197300|584804121|FG000|Overall Study|Lost to Follow-up|0|||
161933144|NCT01197300|584804122|FG001|Overall Study|Lost to Follow-up|1|||
161933145|NCT01197300|584804121|FG000|Overall Study|Protocol Violation|0|||
162207600|NCT02484547|585811982|FG003|Long-Term Extension Period|Loss of Capacity|0|||
162207601|NCT02484547|585811983|FG004|Long-Term Extension Period|Loss of Capacity|1|||
161933146|NCT01197300|584804122|FG001|Overall Study|Protocol Violation|1|||
161933147|NCT02113878|584804125|FG000|Overall Study|Adverse Event|1|||
161933148|NCT02113878|584804126|FG001|Overall Study|Adverse Event|0|||
161933149|NCT02113878|584804125|FG000|Overall Study|Withdrawal by Subject|1|||
161933150|NCT02113878|584804126|FG001|Overall Study|Withdrawal by Subject|0|||
161933151|NCT02113878|584804125|FG000|Overall Study|patient non-compliance|1|||
161933152|NCT02113878|584804126|FG001|Overall Study|patient non-compliance|0|||
161933153|NCT02255279|584804127|FG000|Overall Study|Lost to Follow-up|2|||
161933154|NCT02255279|584804128|FG001|Overall Study|Lost to Follow-up|2|||
161933155|NCT02255279|584804127|FG000|Overall Study|Protocol Violation|0|||
161933156|NCT02255279|584804128|FG001|Overall Study|Protocol Violation|1|||
161933157|NCT02255279|584804127|FG000|Overall Study|Withdrawal by Subject|3|||
161933158|NCT02255279|584804128|FG001|Overall Study|Withdrawal by Subject|6|||
161933159|NCT02144337|584804150|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
161933160|NCT02144337|584804151|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
161933161|NCT02144337|584804150|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
162207602|NCT02484547|585811984|FG005|Long-Term Extension Period|Loss of Capacity|0|||
162207603|NCT02484547|585811985|FG006|Long-Term Extension Period|Loss of Capacity|0|||
162207604|NCT02484547|585811979|FG000|Long-Term Extension Period|Change of Treatment|0|||
162207605|NCT02484547|585811980|FG001|Long-Term Extension Period|Change of Treatment|0|||
162207606|NCT02484547|585811981|FG002|Long-Term Extension Period|Change of Treatment|0|||
162207607|NCT02484547|585811982|FG003|Long-Term Extension Period|Change of Treatment|0|||
162207608|NCT02484547|585811983|FG004|Long-Term Extension Period|Change of Treatment|0|||
162207609|NCT02484547|585811984|FG005|Long-Term Extension Period|Change of Treatment|0|||
162207610|NCT02484547|585811985|FG006|Long-Term Extension Period|Change of Treatment|1|||
162207611|NCT02484547|585811979|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
162207612|NCT02484547|585811980|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
162207613|NCT02484547|585811981|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
162207614|NCT02484547|585811982|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
162207615|NCT02484547|585811983|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
162207616|NCT02484547|585811984|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
162207617|NCT02484547|585811985|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
162207618|NCT02484547|585811979|FG000|Long-Term Extension Period|Investigator Decision|0|||
162207619|NCT02484547|585811980|FG001|Long-Term Extension Period|Investigator Decision|0|||
161933162|NCT02144337|584804151|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
161933163|NCT02144337|584804150|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
162207620|NCT02484547|585811981|FG002|Long-Term Extension Period|Investigator Decision|0|||
162207621|NCT02484547|585811982|FG003|Long-Term Extension Period|Investigator Decision|2|||
162207622|NCT02484547|585811983|FG004|Long-Term Extension Period|Investigator Decision|1|||
162207623|NCT02484547|585811984|FG005|Long-Term Extension Period|Investigator Decision|0|||
162207624|NCT02484547|585811985|FG006|Long-Term Extension Period|Investigator Decision|1|||
162207625|NCT02484547|585811979|FG000|Long-Term Extension Period|Relocation|0|||
162207626|NCT02484547|585811980|FG001|Long-Term Extension Period|Relocation|0|||
161933164|NCT02144337|584804151|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
161933165|NCT02144337|584804150|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
161933166|NCT02144337|584804151|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
161933167|NCT02144337|584804150|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
161933168|NCT02144337|584804151|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
161933169|NCT03400787|584804152|FG000|Overall Study|Lost to Follow-up|1|||
162207627|NCT02484547|585811981|FG002|Long-Term Extension Period|Relocation|0|||
162207628|NCT02484547|585811982|FG003|Long-Term Extension Period|Relocation|1|||
162207629|NCT02484547|585811983|FG004|Long-Term Extension Period|Relocation|1|||
162207630|NCT02484547|585811984|FG005|Long-Term Extension Period|Relocation|0|||
162207631|NCT02484547|585811985|FG006|Long-Term Extension Period|Relocation|0|||
162207632|NCT02484547|585811979|FG000|Long-Term Extension Period|Study Visit Burden|0|||
162207633|NCT02484547|585811980|FG001|Long-Term Extension Period|Study Visit Burden|0|||
162207634|NCT02484547|585811981|FG002|Long-Term Extension Period|Study Visit Burden|0|||
162207635|NCT02484547|585811982|FG003|Long-Term Extension Period|Study Visit Burden|2|||
162207636|NCT02484547|585811983|FG004|Long-Term Extension Period|Study Visit Burden|0|||
162207637|NCT02484547|585811984|FG005|Long-Term Extension Period|Study Visit Burden|0|||
162207638|NCT02484547|585811985|FG006|Long-Term Extension Period|Study Visit Burden|3|||
162207639|NCT02484547|585811979|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
162207640|NCT02484547|585811980|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
162207641|NCT02484547|585811981|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
162207642|NCT02484547|585811982|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
162207643|NCT02484547|585811983|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
162207644|NCT02484547|585811984|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
162207645|NCT02484547|585811985|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
162207646|NCT02484547|585811979|FG000|Long-Term Extension Period|Reason not Specified|0|||
162207647|NCT02484547|585811980|FG001|Long-Term Extension Period|Reason not Specified|0|||
162207648|NCT02484547|585811981|FG002|Long-Term Extension Period|Reason not Specified|0|||
162207649|NCT02484547|585811982|FG003|Long-Term Extension Period|Reason not Specified|119|||
162207650|NCT02484547|585811983|FG004|Long-Term Extension Period|Reason not Specified|117|||
162207651|NCT02484547|585811984|FG005|Long-Term Extension Period|Reason not Specified|223|||
162207652|NCT02484547|585811985|FG006|Long-Term Extension Period|Reason not Specified|231|||
162207653|NCT03765164|585811986|FG000|Pre-intervention|Withdrawal by Subject|5|||
162207654|NCT03765164|585811987|FG001|Pre-intervention|Withdrawal by Subject|6|||
162207655|NCT01813305|585811988|FG000|Overall Study|Withdrawal by Subject|12|||
162207656|NCT01813305|585811989|FG001|Overall Study|Withdrawal by Subject|5|||
162207657|NCT01813305|585811988|FG000|Overall Study|Safety Concern|4|||
162207658|NCT01813305|585811989|FG001|Overall Study|Safety Concern|0|||
162207659|NCT01813305|585811988|FG000|Overall Study|Ulcer became worse|4|||
161824828|NCT00683787|584401736|FG000|Overall Study|Progression|3|||
161824829|NCT00683787|584401737|FG001|Overall Study|Progression|3|||
161824830|NCT00683787|584401738|FG002|Overall Study|Progression|0|||
161824831|NCT00683787|584401736|FG000|Overall Study|Adverse Event|0|||
161824832|NCT00683787|584401737|FG001|Overall Study|Adverse Event|0|||
161824833|NCT00683787|584401738|FG002|Overall Study|Adverse Event|2|||
161824834|NCT02674633|584401739|FG000|Overall Study|Lost to Follow-up|3|||
161824835|NCT02674633|584401740|FG001|Overall Study|Lost to Follow-up|2|||
161824836|NCT02674633|584401739|FG000|Overall Study|Physician Decision|1|||
161824837|NCT02674633|584401740|FG001|Overall Study|Physician Decision|0|||
161824838|NCT02674633|584401739|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161824839|NCT02674633|584401740|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161824840|NCT00460109|584401741|FG000|Overall Study|Death|1|||
161824841|NCT04167618|584401742|FG000|Overall Study|Trial terminated by sponsor|1|||
161824842|NCT04167618|584401743|FG001|Overall Study|Trial terminated by sponsor|1|||
161824843|NCT01235715|584401744|FG000|Overall Study|Physician Decision|0|||
161824844|NCT01235715|584401745|FG001|Overall Study|Physician Decision|2|||
161824845|NCT03619876|584401746|FG000|Overall Study|Withdrawal by Subject|1|||
161824846|NCT03619876|584401747|FG001|Overall Study|Withdrawal by Subject|2|||
161824847|NCT03619876|584401746|FG000|Overall Study|Withdrawal due to incidental finding|0|||
161824848|NCT03619876|584401747|FG001|Overall Study|Withdrawal due to incidental finding|2|||
161824849|NCT02994394|584401748|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
161824850|NCT02994394|584401749|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
161824851|NCT02994394|584401750|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
161824852|NCT02994394|584401751|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
161824853|NCT02994394|584401752|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
162207660|NCT01813305|585811989|FG001|Overall Study|Ulcer became worse|0|||
162207661|NCT01813305|585811988|FG000|Overall Study|Physician Decision|4|||
162207662|NCT01813305|585811989|FG001|Overall Study|Physician Decision|0|||
162207663|NCT01813305|585811988|FG000|Overall Study|Lost to Follow-up|3|||
162207664|NCT01813305|585811989|FG001|Overall Study|Lost to Follow-up|1|||
162207665|NCT01813305|585811988|FG000|Overall Study|Protocol Violation|1|||
162207666|NCT01813305|585811989|FG001|Overall Study|Protocol Violation|0|||
162207667|NCT01813305|585811988|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
161824854|NCT02994394|584401753|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
161824855|NCT02994394|584401748|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
161824856|NCT02994394|584401749|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
162207668|NCT01813305|585811989|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
161824857|NCT02994394|584401750|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
161824858|NCT02994394|584401751|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
161824859|NCT02994394|584401752|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
161824860|NCT02994394|584401753|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
161824861|NCT02344745|584401754|FG000|Overall Study|Data collection sheets were lost|2|||
161824862|NCT02344745|584401755|FG001|Overall Study|Data collection sheets were lost|0|||
161824863|NCT02788513|584401756|FG000|Overall Study|Withdrawal by Subject|3|||
161824864|NCT02788513|584401757|FG001|Overall Study|Withdrawal by Subject|0|||
161824865|NCT02788513|584401758|FG002|Overall Study|Withdrawal by Subject|2|||
161824866|NCT02788513|584401759|FG003|Overall Study|Withdrawal by Subject|3|||
161824867|NCT02788513|584401760|FG004|Overall Study|Withdrawal by Subject|1|||
161824868|NCT02788513|584401756|FG000|Overall Study|Lost to Follow-up|1|||
161824869|NCT02788513|584401757|FG001|Overall Study|Lost to Follow-up|0|||
161824870|NCT02788513|584401758|FG002|Overall Study|Lost to Follow-up|0|||
161824871|NCT02788513|584401759|FG003|Overall Study|Lost to Follow-up|0|||
161824872|NCT02788513|584401760|FG004|Overall Study|Lost to Follow-up|1|||
161824873|NCT02788513|584401756|FG000|Overall Study|Adverse Event|5|||
161824874|NCT02788513|584401757|FG001|Overall Study|Adverse Event|8|||
161824875|NCT02788513|584401758|FG002|Overall Study|Adverse Event|4|||
161824876|NCT02788513|584401759|FG003|Overall Study|Adverse Event|2|||
161824877|NCT02788513|584401760|FG004|Overall Study|Adverse Event|2|||
161824878|NCT02788513|584401756|FG000|Overall Study|Protocol Violation|0|||
161824879|NCT02788513|584401757|FG001|Overall Study|Protocol Violation|0|||
161824880|NCT02788513|584401758|FG002|Overall Study|Protocol Violation|1|||
161824881|NCT02788513|584401759|FG003|Overall Study|Protocol Violation|1|||
161824882|NCT02788513|584401760|FG004|Overall Study|Protocol Violation|0|||
161824883|NCT02788513|584401756|FG000|Overall Study|Subject decided to stop taking treatment|0|||
161824884|NCT02788513|584401757|FG001|Overall Study|Subject decided to stop taking treatment|0|||
161824885|NCT02788513|584401758|FG002|Overall Study|Subject decided to stop taking treatment|1|||
161824886|NCT02788513|584401759|FG003|Overall Study|Subject decided to stop taking treatment|0|||
161824887|NCT02788513|584401760|FG004|Overall Study|Subject decided to stop taking treatment|0|||
161824888|NCT02788513|584401756|FG000|Overall Study|Decision by the study team|0|||
161824889|NCT02788513|584401757|FG001|Overall Study|Decision by the study team|0|||
161824890|NCT02788513|584401758|FG002|Overall Study|Decision by the study team|0|||
161824891|NCT02788513|584401759|FG003|Overall Study|Decision by the study team|0|||
161824892|NCT02788513|584401760|FG004|Overall Study|Decision by the study team|1|||
161824893|NCT04982445|584401762|FG000|Overall Study|Protocol Violation|1|||
161824894|NCT04982445|584401762|FG000|Overall Study|Withdrawal by Subject|4|||
161824895|NCT04982445|584401762|FG000|Overall Study|Lost to Follow-up|1|||
161824896|NCT03230487|584401766|FG000|Overall Study|Adverse Event|0|||
161824897|NCT03230487|584401767|FG001|Overall Study|Adverse Event|0|||
161824898|NCT03230487|584401768|FG002|Overall Study|Adverse Event|0|||
161824899|NCT03230487|584401769|FG003|Overall Study|Adverse Event|1|||
161824900|NCT03230487|584401770|FG004|Overall Study|Adverse Event|0|||
161824901|NCT03230487|584401771|FG005|Overall Study|Adverse Event|0|||
161824902|NCT01961882|584401774|FG000|Overall Study|Adverse Event|3|||
161824903|NCT01961882|584401775|FG001|Overall Study|Adverse Event|2|||
161824904|NCT01961882|584401774|FG000|Overall Study|Physician Decision|1|||
161824905|NCT01961882|584401775|FG001|Overall Study|Physician Decision|0|||
161824906|NCT01961882|584401774|FG000|Overall Study|Withdrawal by Subject|4|||
161824907|NCT01961882|584401775|FG001|Overall Study|Withdrawal by Subject|1|||
161824908|NCT01961882|584401774|FG000|Overall Study|Relapse of AML|39|||
161824909|NCT01961882|584401775|FG001|Overall Study|Relapse of AML|37|||
161824910|NCT01961882|584401774|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
161824911|NCT01961882|584401775|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
161824912|NCT01961882|584401774|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
161824913|NCT01961882|584401775|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
161824914|NCT01901848|584401776|FG000|Randomized and Treated|Lost to Follow-up|3|||
161824915|NCT01901848|584401777|FG001|Randomized and Treated|Lost to Follow-up|6|||
161824916|NCT01901848|584401776|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
161824917|NCT01901848|584401777|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
161824918|NCT02916693|584401778|FG000|Overall Study|Lost to Follow-up|7|||
161824919|NCT01190930|584401779|FG000|Induction|Adverse Event|17|||
161824920|NCT01190930|584401780|FG001|Induction|Adverse Event|0|||
161824921|NCT01190930|584401781|FG002|Induction|Adverse Event|0|||
161824922|NCT01190930|584401782|FG003|Induction|Adverse Event|0|||
161824923|NCT01190930|584401783|FG004|Induction|Adverse Event|0|||
161824924|NCT01190930|584401784|FG005|Induction|Adverse Event|0|||
161824925|NCT01190930|584401785|FG006|Induction|Adverse Event|0|||
161824926|NCT01190930|584401786|FG007|Induction|Adverse Event|0|||
161824927|NCT01190930|584401787|FG008|Induction|Adverse Event|0|||
161824928|NCT01190930|584401788|FG009|Induction|Adverse Event|0|||
161824929|NCT01190930|584401779|FG000|Induction|Death|34|||
161824930|NCT01190930|584401780|FG001|Induction|Death|0|||
161824931|NCT01190930|584401781|FG002|Induction|Death|0|||
161824932|NCT01190930|584401782|FG003|Induction|Death|0|||
161824933|NCT01190930|584401783|FG004|Induction|Death|0|||
161824934|NCT01190930|584401784|FG005|Induction|Death|0|||
161824935|NCT01190930|584401785|FG006|Induction|Death|0|||
161824936|NCT01190930|584401786|FG007|Induction|Death|0|||
161824937|NCT01190930|584401787|FG008|Induction|Death|0|||
161824938|NCT01190930|584401788|FG009|Induction|Death|0|||
161824939|NCT01190930|584401779|FG000|Induction|Lost to Follow-up|1|||
161824940|NCT01190930|584401780|FG001|Induction|Lost to Follow-up|0|||
161824941|NCT01190930|584401781|FG002|Induction|Lost to Follow-up|0|||
161824942|NCT01190930|584401782|FG003|Induction|Lost to Follow-up|0|||
161824943|NCT01190930|584401783|FG004|Induction|Lost to Follow-up|0|||
161824944|NCT01190930|584401784|FG005|Induction|Lost to Follow-up|0|||
161824945|NCT01190930|584401785|FG006|Induction|Lost to Follow-up|0|||
161824946|NCT01190930|584401786|FG007|Induction|Lost to Follow-up|0|||
161824947|NCT01190930|584401787|FG008|Induction|Lost to Follow-up|0|||
161824948|NCT01190930|584401788|FG009|Induction|Lost to Follow-up|0|||
161824949|NCT01190930|584401779|FG000|Induction|Physician Decision|125|||
161824950|NCT01190930|584401780|FG001|Induction|Physician Decision|3|||
161824951|NCT01190930|584401781|FG002|Induction|Physician Decision|0|||
161824952|NCT01190930|584401782|FG003|Induction|Physician Decision|0|||
161824953|NCT01190930|584401783|FG004|Induction|Physician Decision|0|||
161824954|NCT01190930|584401784|FG005|Induction|Physician Decision|0|||
161824955|NCT01190930|584401785|FG006|Induction|Physician Decision|0|||
161824956|NCT01190930|584401786|FG007|Induction|Physician Decision|0|||
161824957|NCT01190930|584401787|FG008|Induction|Physician Decision|0|||
161824958|NCT01190930|584401788|FG009|Induction|Physician Decision|0|||
161824959|NCT01190930|584401779|FG000|Induction|Withdrawal by Subject|9|||
161824960|NCT01190930|584401780|FG001|Induction|Withdrawal by Subject|0|||
161824961|NCT01190930|584401781|FG002|Induction|Withdrawal by Subject|0|||
161824962|NCT01190930|584401782|FG003|Induction|Withdrawal by Subject|0|||
161824963|NCT01190930|584401783|FG004|Induction|Withdrawal by Subject|0|||
161824964|NCT01190930|584401784|FG005|Induction|Withdrawal by Subject|0|||
161824965|NCT01190930|584401785|FG006|Induction|Withdrawal by Subject|0|||
161824966|NCT01190930|584401786|FG007|Induction|Withdrawal by Subject|0|||
161824967|NCT01190930|584401787|FG008|Induction|Withdrawal by Subject|0|||
161824968|NCT01190930|584401788|FG009|Induction|Withdrawal by Subject|0|||
161824969|NCT01190930|584401779|FG000|Induction|Refusal|235|||
161824970|NCT01190930|584401780|FG001|Induction|Refusal|0|||
161824971|NCT01190930|584401781|FG002|Induction|Refusal|0|||
161824972|NCT01190930|584401782|FG003|Induction|Refusal|0|||
161824973|NCT01190930|584401783|FG004|Induction|Refusal|0|||
161824974|NCT01190930|584401784|FG005|Induction|Refusal|0|||
161824975|NCT01190930|584401785|FG006|Induction|Refusal|0|||
162021306|NCT05091567|585134732|FG000|Enrollment Phase|Reason not Specified|1|||
162021307|NCT05091567|585134733|FG001|Enrollment Phase|Reason not Specified|0|||
162021308|NCT05091567|585134734|FG002|Enrollment Phase|Reason not Specified|0|||
161824976|NCT01190930|584401786|FG007|Induction|Refusal|0|||
161824977|NCT01190930|584401787|FG008|Induction|Refusal|0|||
161824978|NCT01190930|584401788|FG009|Induction|Refusal|0|||
161824979|NCT01190930|584401779|FG000|Induction|Inevaluable|23|||
161824980|NCT01190930|584401780|FG001|Induction|Inevaluable|1|||
161824981|NCT01190930|584401781|FG002|Induction|Inevaluable|0|||
161824982|NCT01190930|584401782|FG003|Induction|Inevaluable|0|||
161824983|NCT01190930|584401783|FG004|Induction|Inevaluable|0|||
162021309|NCT05091567|585134732|FG000|Randomized Phase|Death|0|||
161824984|NCT01190930|584401784|FG005|Induction|Inevaluable|0|||
161824985|NCT01190930|584401785|FG006|Induction|Inevaluable|0|||
161824986|NCT01190930|584401786|FG007|Induction|Inevaluable|0|||
161824987|NCT01190930|584401787|FG008|Induction|Inevaluable|0|||
161824988|NCT01190930|584401788|FG009|Induction|Inevaluable|0|||
161824989|NCT01190930|584401779|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
161824990|NCT01190930|584401780|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824991|NCT01190930|584401781|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824992|NCT01190930|584401782|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824993|NCT01190930|584401783|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
162207669|NCT03448536|585811990|FG000|Overall Study|Protocol Violation|2|||
162207670|NCT03448536|585811991|FG001|Overall Study|Protocol Violation|0|||
162207671|NCT03448536|585811990|FG000|Overall Study|Pregnancy|1|||
162207672|NCT03448536|585811991|FG001|Overall Study|Pregnancy|0|||
162207673|NCT03448536|585811990|FG000|Overall Study|Withdrawal by Subject|1|||
162207674|NCT03448536|585811991|FG001|Overall Study|Withdrawal by Subject|2|||
162207675|NCT03448536|585811990|FG000|Overall Study|Lost to Follow-up|3|||
162207676|NCT03448536|585811991|FG001|Overall Study|Lost to Follow-up|2|||
162207677|NCT03448536|585811990|FG000|Overall Study|Inadequate pain reporter|1|||
162207678|NCT03448536|585811991|FG001|Overall Study|Inadequate pain reporter|0|||
162207679|NCT03448536|585811990|FG000|Overall Study|Other|3|||
162207680|NCT03448536|585811991|FG001|Overall Study|Other|0|||
162207681|NCT03448536|585811990|FG000|Overall Study|Physician Decision|1|||
162207682|NCT03448536|585811991|FG001|Overall Study|Physician Decision|0|||
162207683|NCT01665599|585811992|FG000|Overall Study|Adverse Event|1|||
162207684|NCT01665599|585811992|FG000|Overall Study|Consent Withdrawn|1|||
162207685|NCT01665599|585811992|FG000|Overall Study|Investigator/Sponsor decision|1|||
162207686|NCT01665599|585811992|FG000|Overall Study|Death|1|||
162207687|NCT01665599|585811992|FG000|Overall Study|Lost to Follow-up|2|||
162207688|NCT01665599|585811992|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
162207689|NCT01665599|585811992|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
162207690|NCT00770588|585811993|FG000|Overall Study|Adverse Event|9|||
162207691|NCT00770588|585811994|FG001|Overall Study|Adverse Event|2|||
162207692|NCT00770588|585811993|FG000|Overall Study|Death caused by progression of disease|70|||
162207693|NCT00770588|585811994|FG001|Overall Study|Death caused by progression of disease|91|||
162207694|NCT00770588|585811993|FG000|Overall Study|Lost to Follow-up|1|||
162207695|NCT00770588|585811994|FG001|Overall Study|Lost to Follow-up|1|||
162207696|NCT00770588|585811993|FG000|Overall Study|Withdrawal by Subject|1|||
162207697|NCT00770588|585811994|FG001|Overall Study|Withdrawal by Subject|1|||
162207698|NCT01424189|585811995|FG000|Overall Study|Adverse Event|1|||
162207699|NCT01424189|585811996|FG001|Overall Study|Adverse Event|0|||
162207700|NCT01424189|585811995|FG000|Overall Study|Lost to Follow-up|4|||
162207701|NCT01424189|585811996|FG001|Overall Study|Lost to Follow-up|1|||
162207702|NCT01424189|585811995|FG000|Overall Study|Withdrawal by Subject|4|||
162207703|NCT01424189|585811996|FG001|Overall Study|Withdrawal by Subject|4|||
162207704|NCT01424189|585811995|FG000|Overall Study|Subject moved|1|||
162207705|NCT01424189|585811996|FG001|Overall Study|Subject moved|0|||
162207706|NCT01424189|585811995|FG000|Overall Study|Death|3|||
162207707|NCT01424189|585811996|FG001|Overall Study|Death|1|||
162207708|NCT03120949|585811997|FG000|Overall Study|randomized in error|1|||
162207709|NCT03120949|585811998|FG001|Overall Study|randomized in error|0|||
162207710|NCT03120949|585811997|FG000|Overall Study|Death|13|||
162207711|NCT03120949|585811998|FG001|Overall Study|Death|13|||
161677511|NCT00467779|583872005|FG005|Stage 3|Unspecified Reason|0|||
161677512|NCT00467779|583872006|FG006|Stage 3|Unspecified Reason|0|||
161677513|NCT00467779|583872007|FG007|Stage 3|Unspecified Reason|0|||
161677514|NCT00467779|583872008|FG008|Stage 3|Unspecified Reason|0|||
161677515|NCT00467779|583872009|FG009|Stage 3|Unspecified Reason|0|||
161677516|NCT00467779|583872010|FG010|Stage 3|Unspecified Reason|0|||
161677517|NCT00467779|583872011|FG011|Stage 3|Unspecified Reason|0|||
161677518|NCT00467779|583872012|FG012|Stage 3|Unspecified Reason|0|||
161677519|NCT00467779|583872013|FG013|Stage 3|Unspecified Reason|0|||
161677520|NCT00467779|583872014|FG014|Stage 3|Unspecified Reason|5|||
161677521|NCT01509079|583872015|FG000|Overall Study|Lack of Efficacy|0|||
161677522|NCT01509079|583872016|FG001|Overall Study|Lack of Efficacy|2|||
161677523|NCT01509079|583872015|FG000|Overall Study|started an excluded medication|0|||
161677524|NCT01509079|583872016|FG001|Overall Study|started an excluded medication|1|||
161677525|NCT01195090|583872017|FG000|Overall Study|Adverse Event|1|||
161677526|NCT01195090|583872018|FG001|Overall Study|Adverse Event|2|||
161677527|NCT01195090|583872017|FG000|Overall Study|Lost to Follow-up|2|||
161677528|NCT01195090|583872018|FG001|Overall Study|Lost to Follow-up|2|||
161677529|NCT01195090|583872017|FG000|Overall Study|Protocol Violation|3|||
162207712|NCT03120949|585811997|FG000|Overall Study|Lost to Follow-up|23|||
162207713|NCT03120949|585811998|FG001|Overall Study|Lost to Follow-up|13|||
162207714|NCT03120949|585811997|FG000|Overall Study|Withdrawal by Subject|139|||
162207715|NCT03120949|585811998|FG001|Overall Study|Withdrawal by Subject|124|||
161677530|NCT01195090|583872018|FG001|Overall Study|Protocol Violation|4|||
161677531|NCT05111041|583872019|FG000|Overall Study|Lost to Follow-up|6|||
161677532|NCT05111041|583872020|FG001|Overall Study|Lost to Follow-up|7|||
162207716|NCT03120949|585811997|FG000|Overall Study|Covid-19|43|||
161677533|NCT05111041|583872019|FG000|Overall Study|Withdrawal by Subject|1|||
162207717|NCT03120949|585811998|FG001|Overall Study|Covid-19|34|||
162207718|NCT03120949|585811997|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
162207719|NCT03120949|585811998|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
162207720|NCT03120949|585811997|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
162207721|NCT03120949|585811998|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
161677534|NCT05111041|583872020|FG001|Overall Study|Withdrawal by Subject|0|||
162207722|NCT03120949|585811997|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
162207723|NCT03120949|585811998|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
162207724|NCT03120949|585811997|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
162207725|NCT03120949|585811998|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
162207726|NCT03120949|585811997|FG000|Overall Study|Site was closed|2|||
162207727|NCT03120949|585811998|FG001|Overall Study|Site was closed|3|||
162207728|NCT03120949|585811997|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
162207729|NCT03120949|585811998|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
162207730|NCT03120949|585811997|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
162207731|NCT03120949|585811998|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
162207732|NCT03120949|585811997|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
162207733|NCT03120949|585811998|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
162207734|NCT03120949|585811997|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
162207735|NCT03120949|585811998|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
162207736|NCT03120949|585811997|FG000|Overall Study|Other: Adverse Event|0|||
162207737|NCT03120949|585811998|FG001|Overall Study|Other: Adverse Event|1|||
162207738|NCT03120949|585811997|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
162207739|NCT03120949|585811998|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
162207740|NCT03120949|585811997|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
162207741|NCT03120949|585811998|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
162207742|NCT03120949|585811997|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
162207743|NCT03120949|585811998|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
162207744|NCT03120949|585811997|FG000|Overall Study|Personal Reasons|0|||
162207745|NCT03120949|585811998|FG001|Overall Study|Personal Reasons|1|||
162207746|NCT03120949|585811997|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
162207747|NCT03120949|585811998|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
162207748|NCT03120949|585811997|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
162207749|NCT03120949|585811998|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
161824994|NCT01190930|584401784|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824995|NCT01190930|584401785|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824996|NCT01190930|584401786|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824997|NCT01190930|584401787|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824998|NCT01190930|584401788|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161824999|NCT01190930|584401779|FG000|Induction|High Risk Downs|80|||
161825000|NCT01190930|584401780|FG001|Induction|High Risk Downs|0|||
161825001|NCT01190930|584401781|FG002|Induction|High Risk Downs|0|||
161825002|NCT01190930|584401782|FG003|Induction|High Risk Downs|0|||
161825003|NCT01190930|584401783|FG004|Induction|High Risk Downs|0|||
161825004|NCT01190930|584401784|FG005|Induction|High Risk Downs|0|||
161825005|NCT01190930|584401785|FG006|Induction|High Risk Downs|0|||
161825006|NCT01190930|584401786|FG007|Induction|High Risk Downs|0|||
161825007|NCT01190930|584401787|FG008|Induction|High Risk Downs|0|||
161825008|NCT01190930|584401788|FG009|Induction|High Risk Downs|0|||
161825009|NCT01190930|584401779|FG000|Induction|Enrollment onto another COG Protocol|1|||
161825010|NCT01190930|584401780|FG001|Induction|Enrollment onto another COG Protocol|0|||
161825011|NCT01190930|584401781|FG002|Induction|Enrollment onto another COG Protocol|0|||
161825012|NCT01190930|584401782|FG003|Induction|Enrollment onto another COG Protocol|0|||
161825013|NCT01190930|584401783|FG004|Induction|Enrollment onto another COG Protocol|0|||
161825014|NCT01190930|584401784|FG005|Induction|Enrollment onto another COG Protocol|0|||
161825015|NCT01190930|584401785|FG006|Induction|Enrollment onto another COG Protocol|0|||
161825016|NCT01190930|584401786|FG007|Induction|Enrollment onto another COG Protocol|0|||
161825017|NCT01190930|584401787|FG008|Induction|Enrollment onto another COG Protocol|0|||
161825018|NCT01190930|584401788|FG009|Induction|Enrollment onto another COG Protocol|0|||
161825019|NCT01190930|584401779|FG000|Induction|Average Risk|1847|||
161825020|NCT01190930|584401780|FG001|Induction|Average Risk|0|||
161825021|NCT01190930|584401781|FG002|Induction|Average Risk|0|||
161825022|NCT01190930|584401782|FG003|Induction|Average Risk|0|||
161825023|NCT01190930|584401783|FG004|Induction|Average Risk|0|||
161825024|NCT01190930|584401784|FG005|Induction|Average Risk|0|||
161825025|NCT01190930|584401785|FG006|Induction|Average Risk|0|||
161825026|NCT01190930|584401786|FG007|Induction|Average Risk|0|||
161825027|NCT01190930|584401787|FG008|Induction|Average Risk|0|||
161825028|NCT01190930|584401788|FG009|Induction|Average Risk|0|||
161933170|NCT03400787|584804153|FG001|Overall Study|Lost to Follow-up|0|||
161933171|NCT03400787|584804152|FG000|Overall Study|Death|1|||
161933172|NCT03400787|584804153|FG001|Overall Study|Death|0|||
161933173|NCT03400787|584804152|FG000|Overall Study|Protocol Violation|0|||
161933174|NCT03400787|584804153|FG001|Overall Study|Protocol Violation|2|||
161933175|NCT03400787|584804152|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
161933176|NCT03400787|584804153|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
161933177|NCT02402907|584804156|FG000|Overall Study|Delivered vaginally|9|||
161933178|NCT02402907|584804157|FG001|Overall Study|Delivered vaginally|3|||
161933179|NCT02402907|584804156|FG000|Overall Study|Delivered outside of Sinai|1|||
161933180|NCT02402907|584804157|FG001|Overall Study|Delivered outside of Sinai|1|||
161933181|NCT02402907|584804156|FG000|Overall Study|Lost to follow up after C-Section|10|||
161933182|NCT02402907|584804157|FG001|Overall Study|Lost to follow up after C-Section|23|||
161933183|NCT01959919|584804159|FG000|Overall Study|Did not meet the eligibility criteria|2|||
161933184|NCT03439072|584804160|FG000|Overall Study|Withdrawal by Subject|2|||
161933185|NCT03439072|584804161|FG001|Overall Study|Withdrawal by Subject|3|||
161933186|NCT03439072|584804160|FG000|Overall Study|Physician Decision|0|||
161933187|NCT03439072|584804161|FG001|Overall Study|Physician Decision|1|||
161933188|NCT02003898|584804163|FG000|Overall Study|Death|3|||
161933189|NCT02003898|584804163|FG000|Overall Study|Lost to Follow-up|12|||
161933190|NCT02003898|584804163|FG000|Overall Study|Withdrawal by Subject|52|||
161933191|NCT01537432|584804164|FG000|Overall Study|Lost to Follow-up|3|||
161933192|NCT01537432|584804165|FG001|Overall Study|Lost to Follow-up|1|||
161933193|NCT01537432|584804164|FG000|Overall Study|Withdrawal by Subject|0|||
161933194|NCT01537432|584804165|FG001|Overall Study|Withdrawal by Subject|1|||
161933195|NCT01537432|584804164|FG000|Overall Study|Administrative problems|1|||
162207750|NCT03120949|585811997|FG000|Overall Study|Compliance With Medication|0|||
162207751|NCT03120949|585811998|FG001|Overall Study|Compliance With Medication|1|||
162207752|NCT03120949|585811997|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
162207753|NCT03120949|585811998|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
162207754|NCT03120949|585811997|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
162207755|NCT03120949|585811998|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
162207756|NCT03120949|585811997|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
162207757|NCT03120949|585811998|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
162207758|NCT00988117|585811999|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
162207759|NCT00988117|585811999|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
162207760|NCT01203956|585812000|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
162207761|NCT01203956|585812001|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
162207762|NCT02230306|585812004|FG000|Overall Study|Did not receive study treatment|1|||
162207763|NCT00312845|585812006|FG000|Overall Study|Adverse Event|19|||
162207764|NCT00312845|585812007|FG001|Overall Study|Adverse Event|5|||
162207765|NCT00312845|585812006|FG000|Overall Study|Death|2|||
162207766|NCT00312845|585812007|FG001|Overall Study|Death|2|||
162207767|NCT00312845|585812006|FG000|Overall Study|Withdrawal by Subject|14|||
162207768|NCT00312845|585812007|FG001|Overall Study|Withdrawal by Subject|6|||
162207769|NCT00312845|585812006|FG000|Overall Study|Disease Progression|56|||
162207770|NCT00312845|585812007|FG001|Overall Study|Disease Progression|77|||
162207771|NCT00312845|585812006|FG000|Overall Study|Lost to Follow-up|2|||
162207772|NCT00312845|585812007|FG001|Overall Study|Lost to Follow-up|0|||
162207773|NCT00312845|585812006|FG000|Overall Study|Other|6|||
162207774|NCT00312845|585812007|FG001|Overall Study|Other|5|||
162207775|NCT04206384|585812008|FG000|Overall Study|Withdrawal by Subject|8|||
162207776|NCT04206384|585812008|FG000|Overall Study|Adverse Event|2|||
162207777|NCT01121185|585812010|FG000|Overall Study|Not infused|0|||
162207778|NCT01121185|585812011|FG001|Overall Study|Not infused|1|||
162207779|NCT01121185|585812010|FG000|Overall Study|Not transplanted|1|||
161933196|NCT01537432|584804165|FG001|Overall Study|Administrative problems|0|||
161933197|NCT01537432|584804164|FG000|Overall Study|Adverse Event|1|||
161933198|NCT01537432|584804165|FG001|Overall Study|Adverse Event|0|||
161933199|NCT01537432|584804164|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161933200|NCT01537432|584804165|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161933201|NCT03682367|584804168|FG000|Overall Study|Protocol Violation|2|||
161933202|NCT03682367|584804169|FG001|Overall Study|Protocol Violation|1|||
161933203|NCT03682367|584804168|FG000|Overall Study|Closed Study Early|0|||
161933204|NCT03682367|584804169|FG001|Overall Study|Closed Study Early|3|||
161825029|NCT01190930|584401779|FG000|Induction|High Risk|1227|||
161825030|NCT01190930|584401780|FG001|Induction|High Risk|0|||
161825031|NCT01190930|584401781|FG002|Induction|High Risk|0|||
161825032|NCT01190930|584401782|FG003|Induction|High Risk|0|||
161825033|NCT01190930|584401783|FG004|Induction|High Risk|0|||
161825034|NCT01190930|584401784|FG005|Induction|High Risk|0|||
161825035|NCT01190930|584401785|FG006|Induction|High Risk|0|||
161825036|NCT01190930|584401786|FG007|Induction|High Risk|0|||
161825037|NCT01190930|584401787|FG008|Induction|High Risk|0|||
161825038|NCT01190930|584401788|FG009|Induction|High Risk|0|||
161825039|NCT01190930|584401779|FG000|Induction|Low Risk|443|||
161825040|NCT01190930|584401780|FG001|Induction|Low Risk|0|||
161825041|NCT01190930|584401781|FG002|Induction|Low Risk|0|||
161825042|NCT01190930|584401782|FG003|Induction|Low Risk|0|||
161825043|NCT01190930|584401783|FG004|Induction|Low Risk|0|||
161825044|NCT01190930|584401784|FG005|Induction|Low Risk|0|||
161825045|NCT01190930|584401785|FG006|Induction|Low Risk|0|||
161825046|NCT01190930|584401786|FG007|Induction|Low Risk|0|||
161825047|NCT01190930|584401787|FG008|Induction|Low Risk|0|||
161825048|NCT01190930|584401788|FG009|Induction|Low Risk|0|||
161825049|NCT01190930|584401779|FG000|Induction|Very High Risk|1012|||
161825050|NCT01190930|584401780|FG001|Induction|Very High Risk|0|||
161825051|NCT01190930|584401781|FG002|Induction|Very High Risk|0|||
161825052|NCT01190930|584401782|FG003|Induction|Very High Risk|0|||
161825053|NCT01190930|584401783|FG004|Induction|Very High Risk|0|||
161825054|NCT01190930|584401784|FG005|Induction|Very High Risk|0|||
161825055|NCT01190930|584401785|FG006|Induction|Very High Risk|0|||
161825056|NCT01190930|584401786|FG007|Induction|Very High Risk|0|||
161825057|NCT01190930|584401787|FG008|Induction|Very High Risk|0|||
161825058|NCT01190930|584401788|FG009|Induction|Very High Risk|0|||
161825059|NCT01190930|584401779|FG000|Induction|Philadelphia chromosome-positive|99|||
161825060|NCT01190930|584401780|FG001|Induction|Philadelphia chromosome-positive|0|||
161825061|NCT01190930|584401781|FG002|Induction|Philadelphia chromosome-positive|0|||
161825062|NCT01190930|584401782|FG003|Induction|Philadelphia chromosome-positive|0|||
161825063|NCT01190930|584401783|FG004|Induction|Philadelphia chromosome-positive|0|||
161825064|NCT01190930|584401784|FG005|Induction|Philadelphia chromosome-positive|0|||
161825065|NCT01190930|584401785|FG006|Induction|Philadelphia chromosome-positive|0|||
161825066|NCT01190930|584401786|FG007|Induction|Philadelphia chromosome-positive|0|||
161825067|NCT01190930|584401787|FG008|Induction|Philadelphia chromosome-positive|0|||
161825068|NCT01190930|584401788|FG009|Induction|Philadelphia chromosome-positive|0|||
161825069|NCT01190930|584401779|FG000|Induction|Incomplete Induction data|63|||
161825070|NCT01190930|584401780|FG001|Induction|Incomplete Induction data|0|||
161825071|NCT01190930|584401781|FG002|Induction|Incomplete Induction data|0|||
161825072|NCT01190930|584401782|FG003|Induction|Incomplete Induction data|0|||
161825073|NCT01190930|584401783|FG004|Induction|Incomplete Induction data|0|||
161825074|NCT01190930|584401784|FG005|Induction|Incomplete Induction data|0|||
161825075|NCT01190930|584401785|FG006|Induction|Incomplete Induction data|0|||
161825076|NCT01190930|584401786|FG007|Induction|Incomplete Induction data|0|||
161825077|NCT01190930|584401787|FG008|Induction|Incomplete Induction data|0|||
161825078|NCT01190930|584401788|FG009|Induction|Incomplete Induction data|0|||
161825079|NCT01190930|584401779|FG000|Induction|Progressive disease|0|||
161825080|NCT01190930|584401780|FG001|Induction|Progressive disease|1|||
161825081|NCT01190930|584401781|FG002|Induction|Progressive disease|0|||
161825082|NCT01190930|584401782|FG003|Induction|Progressive disease|0|||
161825083|NCT01190930|584401783|FG004|Induction|Progressive disease|0|||
161825084|NCT01190930|584401784|FG005|Induction|Progressive disease|0|||
161825085|NCT01190930|584401785|FG006|Induction|Progressive disease|0|||
161825086|NCT01190930|584401786|FG007|Induction|Progressive disease|0|||
161825087|NCT01190930|584401787|FG008|Induction|Progressive disease|0|||
161825088|NCT01190930|584401788|FG009|Induction|Progressive disease|0|||
161825089|NCT01190930|584401779|FG000|Induction|No treatment|3|||
161825090|NCT01190930|584401780|FG001|Induction|No treatment|0|||
161825091|NCT01190930|584401781|FG002|Induction|No treatment|0|||
161825092|NCT01190930|584401782|FG003|Induction|No treatment|0|||
161825093|NCT01190930|584401783|FG004|Induction|No treatment|0|||
161825094|NCT01190930|584401784|FG005|Induction|No treatment|0|||
161825095|NCT01190930|584401785|FG006|Induction|No treatment|0|||
161825096|NCT01190930|584401786|FG007|Induction|No treatment|0|||
161825097|NCT01190930|584401787|FG008|Induction|No treatment|0|||
161825098|NCT01190930|584401788|FG009|Induction|No treatment|0|||
161825099|NCT01190930|584401779|FG000|Induction|Ineligible|69|||
161825100|NCT01190930|584401780|FG001|Induction|Ineligible|4|||
161825101|NCT01190930|584401781|FG002|Induction|Ineligible|0|||
161933205|NCT05166902|584804170|FG000|First Intervention|Lost to Follow-up|0|||
161825102|NCT01190930|584401782|FG003|Induction|Ineligible|0|||
161825103|NCT01190930|584401783|FG004|Induction|Ineligible|0|||
161825104|NCT01190930|584401784|FG005|Induction|Ineligible|0|||
161825105|NCT01190930|584401785|FG006|Induction|Ineligible|0|||
161825106|NCT01190930|584401786|FG007|Induction|Ineligible|0|||
161825107|NCT01190930|584401787|FG008|Induction|Ineligible|0|||
161825108|NCT01190930|584401788|FG009|Induction|Ineligible|0|||
161825109|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
162021310|NCT05091567|585134733|FG001|Randomized Phase|Death|135|||
161933206|NCT05166902|584804171|FG001|First Intervention|Lost to Follow-up|1|||
161933207|NCT00128492|584804172|FG000|Overall Study|AE unrelated to study|2|||
161933208|NCT00128492|584804173|FG001|Overall Study|AE unrelated to study|9|||
161933209|NCT00128492|584804172|FG000|Overall Study|Study drug intolerance (AE)|2|||
161933210|NCT00128492|584804173|FG001|Overall Study|Study drug intolerance (AE)|8|||
161933211|NCT00128492|584804172|FG000|Overall Study|AE related to study|1|||
161933212|NCT00128492|584804173|FG001|Overall Study|AE related to study|4|||
161933213|NCT00128492|584804172|FG000|Overall Study|Death|1|||
161933214|NCT00128492|584804173|FG001|Overall Study|Death|0|||
162021311|NCT05091567|585134734|FG002|Randomized Phase|Death|112|||
162021312|NCT05091567|585134732|FG000|Randomized Phase|Progressive Disease|0|||
161825110|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
161825111|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
161825112|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
161825113|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
161825114|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
161825115|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
161825116|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
161825117|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
161825118|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
161825119|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Death|0|||
161825120|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Death|0|||
161825121|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Death|8|||
161825122|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Death|4|||
161825123|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Death|0|||
161825124|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Death|0|||
161825125|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Death|0|||
161825126|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Death|0|||
161825127|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Death|0|||
161825128|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Death|0|||
161825129|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
161825130|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
161825131|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
161825132|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
161825133|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
161825134|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
161825135|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
161825136|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
161825137|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
161825138|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
161825139|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825140|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
161825141|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
161825142|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
161825143|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825144|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825145|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825146|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825147|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825148|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161825149|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Refusal|0|||
161825150|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Refusal|2|||
161825151|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Refusal|694|||
161825152|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Refusal|4|||
161825153|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Refusal|0|||
161825154|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Refusal|3|||
161825155|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Refusal|0|||
161825156|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Refusal|0|||
161825157|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Refusal|0|||
161825158|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Refusal|0|||
161825159|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
161825160|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
161825161|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
161825162|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
161825163|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
161825164|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
161825165|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
161825166|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
161933215|NCT00128492|584804172|FG000|Overall Study|Lost to Follow-up|1|||
162021313|NCT05091567|585134733|FG001|Randomized Phase|Progressive Disease|2|||
161933216|NCT00128492|584804173|FG001|Overall Study|Lost to Follow-up|5|||
162207780|NCT01121185|585812011|FG001|Overall Study|Not transplanted|0|||
162207781|NCT01260142|585812012|FG000|Treatment Period 1|Study on hold|1|||
162207782|NCT01260142|585812013|FG001|Treatment Period 1|Study on hold|1|||
162207783|NCT01260142|585812014|FG002|Treatment Period 1|Study on hold|0|||
162207784|NCT01260142|585812015|FG003|Treatment Period 1|Study on hold|0|||
162207785|NCT01260142|585812016|FG004|Treatment Period 1|Study on hold|1|||
162207786|NCT01260142|585812017|FG005|Treatment Period 1|Study on hold|2|||
162207787|NCT01260142|585812012|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
162207788|NCT01260142|585812013|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
162207789|NCT01260142|585812014|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
162207790|NCT01260142|585812015|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
162207791|NCT01260142|585812016|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
162207792|NCT01260142|585812017|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
162207793|NCT01260142|585812012|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161825167|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
161825168|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
161825169|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825170|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
161825171|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825172|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825173|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825174|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825175|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825176|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825177|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825178|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161825179|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
161825180|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
161825181|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
161825182|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
161825183|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
161825184|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
161825185|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
161825186|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
161825187|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
161825188|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
161825189|NCT01190930|584401779|FG000|Post Induction Pre-Maintenance|Relapse|0|||
161825190|NCT01190930|584401780|FG001|Post Induction Pre-Maintenance|Relapse|0|||
161825191|NCT01190930|584401781|FG002|Post Induction Pre-Maintenance|Relapse|1|||
161825192|NCT01190930|584401782|FG003|Post Induction Pre-Maintenance|Relapse|0|||
161825193|NCT01190930|584401783|FG004|Post Induction Pre-Maintenance|Relapse|0|||
161825194|NCT01190930|584401784|FG005|Post Induction Pre-Maintenance|Relapse|0|||
161825195|NCT01190930|584401785|FG006|Post Induction Pre-Maintenance|Relapse|0|||
161825196|NCT01190930|584401786|FG007|Post Induction Pre-Maintenance|Relapse|0|||
161825197|NCT01190930|584401787|FG008|Post Induction Pre-Maintenance|Relapse|0|||
161825198|NCT01190930|584401788|FG009|Post Induction Pre-Maintenance|Relapse|0|||
161825199|NCT01190930|584401779|FG000|Maintenance|Adverse Event|0|||
161825200|NCT01190930|584401780|FG001|Maintenance|Adverse Event|0|||
161825201|NCT01190930|584401781|FG002|Maintenance|Adverse Event|0|||
161825202|NCT01190930|584401782|FG003|Maintenance|Adverse Event|0|||
161825203|NCT01190930|584401783|FG004|Maintenance|Adverse Event|0|||
161825204|NCT01190930|584401784|FG005|Maintenance|Adverse Event|1|||
161825205|NCT01190930|584401785|FG006|Maintenance|Adverse Event|1|||
161825206|NCT01190930|584401786|FG007|Maintenance|Adverse Event|3|||
161825207|NCT01190930|584401787|FG008|Maintenance|Adverse Event|3|||
161825208|NCT01190930|584401788|FG009|Maintenance|Adverse Event|0|||
161825209|NCT01190930|584401779|FG000|Maintenance|Death|0|||
161825210|NCT01190930|584401780|FG001|Maintenance|Death|0|||
161825211|NCT01190930|584401781|FG002|Maintenance|Death|0|||
161825212|NCT01190930|584401782|FG003|Maintenance|Death|1|||
161825213|NCT01190930|584401783|FG004|Maintenance|Death|0|||
161825214|NCT01190930|584401784|FG005|Maintenance|Death|0|||
161825215|NCT01190930|584401785|FG006|Maintenance|Death|2|||
161825216|NCT01190930|584401786|FG007|Maintenance|Death|2|||
161825217|NCT01190930|584401787|FG008|Maintenance|Death|2|||
161825218|NCT01190930|584401788|FG009|Maintenance|Death|2|||
161825219|NCT01190930|584401779|FG000|Maintenance|Lost to Follow-up|0|||
161825220|NCT01190930|584401780|FG001|Maintenance|Lost to Follow-up|0|||
161825221|NCT01190930|584401781|FG002|Maintenance|Lost to Follow-up|0|||
161825222|NCT01190930|584401782|FG003|Maintenance|Lost to Follow-up|0|||
161825223|NCT01190930|584401783|FG004|Maintenance|Lost to Follow-up|0|||
161825224|NCT01190930|584401784|FG005|Maintenance|Lost to Follow-up|0|||
161825225|NCT01190930|584401785|FG006|Maintenance|Lost to Follow-up|1|||
161825226|NCT01190930|584401786|FG007|Maintenance|Lost to Follow-up|1|||
161825227|NCT01190930|584401787|FG008|Maintenance|Lost to Follow-up|1|||
161933217|NCT00128492|584804172|FG000|Overall Study|Noncompliance|0|||
161933218|NCT00128492|584804173|FG001|Overall Study|Noncompliance|5|||
161933219|NCT00128492|584804172|FG000|Overall Study|Personal or administrative|10|||
161933220|NCT00128492|584804173|FG001|Overall Study|Personal or administrative|22|||
161933221|NCT00128492|584804172|FG000|Overall Study|Withdrawal by Subject|3|||
161933222|NCT00128492|584804173|FG001|Overall Study|Withdrawal by Subject|5|||
161933223|NCT00128492|584804172|FG000|Overall Study|Pregnancy|0|||
161933224|NCT00128492|584804173|FG001|Overall Study|Pregnancy|1|||
161933225|NCT03436420|584804175|FG000|Overall Study|Lack of Efficacy|3|||
161933226|NCT00756314|584804176|FG000|Overall Study|Lost to Follow-up|2|||
161933227|NCT00756314|584804177|FG001|Overall Study|Lost to Follow-up|59|||
161933228|NCT02605967|584804178|FG000|Overall Study|subject / guardian decision|1|||
161933229|NCT02605967|584804179|FG001|Overall Study|subject / guardian decision|2|||
161933230|NCT02605967|584804178|FG000|Overall Study|Physician Decision|10|||
161933231|NCT02605967|584804179|FG001|Overall Study|Physician Decision|1|||
161933232|NCT02605967|584804178|FG000|Overall Study|Death|4|||
161933233|NCT02605967|584804179|FG001|Overall Study|Death|2|||
161933234|NCT02605967|584804178|FG000|Overall Study|Adverse Event|1|||
161933235|NCT02605967|584804179|FG001|Overall Study|Adverse Event|0|||
161933236|NCT02605967|584804178|FG000|Overall Study|progressive disease|66|||
161933237|NCT02605967|584804179|FG001|Overall Study|progressive disease|35|||
161933238|NCT03627468|584804180|FG000|Overall Study|Adverse Event|5|||
161933239|NCT03627468|584804181|FG001|Overall Study|Adverse Event|33|||
161933240|NCT03627468|584804180|FG000|Overall Study|Withdrawal by Subject|13|||
161933241|NCT03627468|584804181|FG001|Overall Study|Withdrawal by Subject|23|||
161933242|NCT03627468|584804180|FG000|Overall Study|Physician Decision|1|||
161933243|NCT03627468|584804181|FG001|Overall Study|Physician Decision|0|||
161933244|NCT03627468|584804180|FG000|Overall Study|Protocol Violation|0|||
161933245|NCT03627468|584804181|FG001|Overall Study|Protocol Violation|2|||
161933246|NCT03627468|584804180|FG000|Overall Study|Lost to Follow-up|10|||
161933247|NCT03627468|584804181|FG001|Overall Study|Lost to Follow-up|16|||
161933248|NCT03627468|584804180|FG000|Overall Study|Death|1|||
161933249|NCT03627468|584804181|FG001|Overall Study|Death|0|||
161933250|NCT03627468|584804180|FG000|Overall Study|Pregnancy|1|||
161933251|NCT03627468|584804181|FG001|Overall Study|Pregnancy|1|||
161933252|NCT03627468|584804180|FG000|Overall Study|Lack of Efficacy|0|||
161933253|NCT03627468|584804181|FG001|Overall Study|Lack of Efficacy|2|||
161933254|NCT03627468|584804180|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
161933255|NCT03627468|584804181|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
161933256|NCT01475825|584804185|FG000|Overall Study|Adverse Event|41|||
161933257|NCT01475825|584804186|FG001|Overall Study|Adverse Event|15|||
161933258|NCT01475825|584804187|FG002|Overall Study|Adverse Event|27|||
161933259|NCT01475825|584804188|FG003|Overall Study|Adverse Event|11|||
161933260|NCT01475825|584804185|FG000|Overall Study|Death|1|||
161933261|NCT01475825|584804186|FG001|Overall Study|Death|0|||
161933262|NCT01475825|584804187|FG002|Overall Study|Death|1|||
161933263|NCT01475825|584804188|FG003|Overall Study|Death|0|||
161933264|NCT01475825|584804185|FG000|Overall Study|Lack of Efficacy|0|||
161933265|NCT01475825|584804186|FG001|Overall Study|Lack of Efficacy|0|||
161933266|NCT01475825|584804187|FG002|Overall Study|Lack of Efficacy|1|||
161933267|NCT01475825|584804188|FG003|Overall Study|Lack of Efficacy|0|||
161933268|NCT01475825|584804185|FG000|Overall Study|Lost to Follow-up|0|||
161933269|NCT01475825|584804186|FG001|Overall Study|Lost to Follow-up|0|||
161933270|NCT01475825|584804187|FG002|Overall Study|Lost to Follow-up|3|||
161933271|NCT01475825|584804188|FG003|Overall Study|Lost to Follow-up|1|||
161933272|NCT01475825|584804185|FG000|Overall Study|Non-compliance with Study Drug|1|||
161933273|NCT01475825|584804186|FG001|Overall Study|Non-compliance with Study Drug|2|||
161933274|NCT01475825|584804187|FG002|Overall Study|Non-compliance with Study Drug|4|||
161677535|NCT04912245|583872021|FG000|Overall Study|Withdrawal by Subject|21|||
161677536|NCT04912245|583872022|FG001|Overall Study|Withdrawal by Subject|4|||
161677537|NCT04912245|583872021|FG000|Overall Study|Lost to Follow-up|5|||
161677538|NCT04912245|583872022|FG001|Overall Study|Lost to Follow-up|11|||
161677539|NCT01205230|583872023|FG000|Overall Study|Adverse Event|4|||
161933275|NCT01475825|584804188|FG003|Overall Study|Non-compliance with Study Drug|0|||
161933276|NCT01475825|584804185|FG000|Overall Study|Other: Not available|0|||
161933277|NCT01475825|584804186|FG001|Overall Study|Other: Not available|0|||
161933278|NCT01475825|584804187|FG002|Overall Study|Other: Not available|2|||
161933279|NCT01475825|584804188|FG003|Overall Study|Other: Not available|0|||
161677540|NCT01205230|583872024|FG001|Overall Study|Adverse Event|0|||
161677541|NCT01205230|583872023|FG000|Overall Study|Physician Decision|1|||
161933280|NCT01475825|584804185|FG000|Overall Study|Protocol Violation|1|||
161933281|NCT01475825|584804186|FG001|Overall Study|Protocol Violation|0|||
161933282|NCT01475825|584804187|FG002|Overall Study|Protocol Violation|0|||
161933283|NCT01475825|584804188|FG003|Overall Study|Protocol Violation|0|||
161933284|NCT01475825|584804185|FG000|Overall Study|Physician Decision|0|||
161933285|NCT01475825|584804186|FG001|Overall Study|Physician Decision|1|||
161933286|NCT01475825|584804187|FG002|Overall Study|Physician Decision|0|||
161933287|NCT01475825|584804188|FG003|Overall Study|Physician Decision|0|||
161933288|NCT01475825|584804185|FG000|Overall Study|Withdrawal by Subject|8|||
161933289|NCT01475825|584804186|FG001|Overall Study|Withdrawal by Subject|3|||
161825228|NCT01190930|584401788|FG009|Maintenance|Lost to Follow-up|0|||
161825229|NCT01190930|584401779|FG000|Maintenance|Physician Decision|0|||
161825230|NCT01190930|584401780|FG001|Maintenance|Physician Decision|1|||
161933290|NCT01475825|584804187|FG002|Overall Study|Withdrawal by Subject|11|||
161933291|NCT01475825|584804188|FG003|Overall Study|Withdrawal by Subject|7|||
161933292|NCT01475825|584804185|FG000|Overall Study|Did not enter OLC|15|||
162207794|NCT01260142|585812013|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162207795|NCT01260142|585812014|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162207796|NCT01260142|585812015|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162207797|NCT01260142|585812016|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162207798|NCT01260142|585812017|FG005|Treatment Period 1|Withdrawal by Subject|1|||
162207799|NCT00496834|585812025|FG000|Overall Study|Withdrawal by Subject|4|||
162207800|NCT00496834|585812026|FG001|Overall Study|Withdrawal by Subject|6|||
162207801|NCT00496834|585812025|FG000|Overall Study|Contraindicated medication administered|0|||
162207802|NCT00496834|585812026|FG001|Overall Study|Contraindicated medication administered|1|||
162207803|NCT00496834|585812025|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
162207804|NCT00496834|585812026|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
162207805|NCT00496834|585812025|FG000|Overall Study|Adverse Event|5|||
162207806|NCT00496834|585812026|FG001|Overall Study|Adverse Event|3|||
162207807|NCT00496834|585812025|FG000|Overall Study|IP administration violation|2|||
162207808|NCT00496834|585812026|FG001|Overall Study|IP administration violation|0|||
162207809|NCT00496834|585812025|FG000|Overall Study|Lost to Follow-up|2|||
162207810|NCT00496834|585812026|FG001|Overall Study|Lost to Follow-up|0|||
162207811|NCT00496834|585812025|FG000|Overall Study|Blood Pressure control failure|2|||
162207812|NCT00496834|585812026|FG001|Overall Study|Blood Pressure control failure|1|||
162207813|NCT01503164|585812027|FG000|Overall Study|Withdrawal by Subject|2|||
162207814|NCT01503164|585812028|FG001|Overall Study|Withdrawal by Subject|1|||
162207815|NCT01227928|585812029|FG000|Overall Study|Lost to Follow-up|4|||
162207816|NCT01227928|585812030|FG001|Overall Study|Lost to Follow-up|2|||
162207817|NCT01227928|585812029|FG000|Overall Study|Withdrawal by Subject|4|||
162207818|NCT01227928|585812030|FG001|Overall Study|Withdrawal by Subject|3|||
162207819|NCT01227928|585812029|FG000|Overall Study|Death|14|||
162207820|NCT01227928|585812030|FG001|Overall Study|Death|12|||
162207821|NCT04088136|585812033|FG000|Overall Study|Withdrawal by Subject|5|||
162207822|NCT04088136|585812034|FG001|Overall Study|Withdrawal by Subject|0|||
162207823|NCT04088136|585812033|FG000|Overall Study|Lack of Efficacy|0|||
162207824|NCT04088136|585812034|FG001|Overall Study|Lack of Efficacy|1|||
161825231|NCT01190930|584401781|FG002|Maintenance|Physician Decision|0|||
161825232|NCT01190930|584401782|FG003|Maintenance|Physician Decision|5|||
161825233|NCT01190930|584401783|FG004|Maintenance|Physician Decision|9|||
161825234|NCT01190930|584401784|FG005|Maintenance|Physician Decision|4|||
161825235|NCT01190930|584401785|FG006|Maintenance|Physician Decision|8|||
161825236|NCT01190930|584401786|FG007|Maintenance|Physician Decision|8|||
161825237|NCT01190930|584401787|FG008|Maintenance|Physician Decision|10|||
161825238|NCT01190930|584401788|FG009|Maintenance|Physician Decision|17|||
161825239|NCT01190930|584401779|FG000|Maintenance|Withdrawal by Subject|0|||
161825240|NCT01190930|584401780|FG001|Maintenance|Withdrawal by Subject|0|||
161825241|NCT01190930|584401781|FG002|Maintenance|Withdrawal by Subject|0|||
161825242|NCT01190930|584401782|FG003|Maintenance|Withdrawal by Subject|0|||
161825243|NCT01190930|584401783|FG004|Maintenance|Withdrawal by Subject|0|||
161825244|NCT01190930|584401784|FG005|Maintenance|Withdrawal by Subject|0|||
161825245|NCT01190930|584401785|FG006|Maintenance|Withdrawal by Subject|2|||
161825246|NCT01190930|584401786|FG007|Maintenance|Withdrawal by Subject|1|||
161825247|NCT01190930|584401787|FG008|Maintenance|Withdrawal by Subject|4|||
161825248|NCT01190930|584401788|FG009|Maintenance|Withdrawal by Subject|1|||
161825249|NCT01190930|584401779|FG000|Maintenance|Refusal|0|||
161825250|NCT01190930|584401780|FG001|Maintenance|Refusal|1|||
161825251|NCT01190930|584401781|FG002|Maintenance|Refusal|0|||
161825252|NCT01190930|584401782|FG003|Maintenance|Refusal|2|||
161825253|NCT01190930|584401783|FG004|Maintenance|Refusal|0|||
161825254|NCT01190930|584401784|FG005|Maintenance|Refusal|4|||
161825255|NCT01190930|584401785|FG006|Maintenance|Refusal|5|||
161825256|NCT01190930|584401786|FG007|Maintenance|Refusal|17|||
161825257|NCT01190930|584401787|FG008|Maintenance|Refusal|13|||
161825258|NCT01190930|584401788|FG009|Maintenance|Refusal|6|||
162207825|NCT01494298|585812035|FG000|Overall Study|Protocol Violation|2|||
162207826|NCT01494298|585812036|FG001|Overall Study|Protocol Violation|8|||
162207827|NCT04159805|585812037|FG000|Overall Study|Withdrawal by Subject|0|||
161825259|NCT01190930|584401779|FG000|Maintenance|second malignant neoplasm|0|||
161825260|NCT01190930|584401780|FG001|Maintenance|second malignant neoplasm|0|||
161825261|NCT01190930|584401781|FG002|Maintenance|second malignant neoplasm|0|||
161825262|NCT01190930|584401782|FG003|Maintenance|second malignant neoplasm|1|||
161825263|NCT01190930|584401783|FG004|Maintenance|second malignant neoplasm|0|||
162207828|NCT04159805|585812038|FG001|Overall Study|Withdrawal by Subject|2|||
161825264|NCT01190930|584401784|FG005|Maintenance|second malignant neoplasm|1|||
162207829|NCT04159805|585812039|FG002|Overall Study|Withdrawal by Subject|2|||
161933293|NCT01475825|584804186|FG001|Overall Study|Did not enter OLC|11|||
161933294|NCT01475825|584804187|FG002|Overall Study|Did not enter OLC|15|||
161933295|NCT01475825|584804188|FG003|Overall Study|Did not enter OLC|11|||
161933296|NCT01903733|584804189|FG000|Overall Study|Death|23|||
161933297|NCT01903733|584804190|FG001|Overall Study|Death|54|||
161933298|NCT01903733|584804191|FG002|Overall Study|Death|30|||
161933299|NCT01903733|584804192|FG003|Overall Study|Death|98|||
161933300|NCT01903733|584804189|FG000|Overall Study|Participant refused further follow-up|35|||
161933301|NCT01903733|584804190|FG001|Overall Study|Participant refused further follow-up|38|||
161933302|NCT01903733|584804191|FG002|Overall Study|Participant refused further follow-up|13|||
161933303|NCT01903733|584804192|FG003|Overall Study|Participant refused further follow-up|9|||
161933304|NCT01903733|584804189|FG000|Overall Study|Lost to Follow-up|18|||
161933305|NCT01903733|584804190|FG001|Overall Study|Lost to Follow-up|19|||
161933306|NCT01903733|584804191|FG002|Overall Study|Lost to Follow-up|6|||
161933307|NCT01903733|584804192|FG003|Overall Study|Lost to Follow-up|9|||
161933308|NCT01903733|584804189|FG000|Overall Study|Other|10|||
161933309|NCT01903733|584804190|FG001|Overall Study|Other|15|||
161933310|NCT01903733|584804191|FG002|Overall Study|Other|12|||
161933311|NCT01903733|584804192|FG003|Overall Study|Other|3|||
161933312|NCT01903733|584804189|FG000|Overall Study|Missing|2|||
161933313|NCT01903733|584804190|FG001|Overall Study|Missing|0|||
161933314|NCT01903733|584804191|FG002|Overall Study|Missing|0|||
161933315|NCT01903733|584804192|FG003|Overall Study|Missing|0|||
161933316|NCT01903733|584804189|FG000|Overall Study|Investigator request|18|||
161933317|NCT01903733|584804190|FG001|Overall Study|Investigator request|0|||
162021314|NCT05091567|585134734|FG002|Randomized Phase|Progressive Disease|0|||
161825265|NCT01190930|584401785|FG006|Maintenance|second malignant neoplasm|0|||
161825266|NCT01190930|584401786|FG007|Maintenance|second malignant neoplasm|0|||
161825267|NCT01190930|584401787|FG008|Maintenance|second malignant neoplasm|1|||
162207830|NCT02930837|585812040|FG000|Overall Study|Adverse Event|6|||
161933318|NCT01903733|584804191|FG002|Overall Study|Investigator request|0|||
161933319|NCT01903733|584804192|FG003|Overall Study|Investigator request|0|||
161933320|NCT01714063|584804193|FG000|Overall Study|Equipment malfunction|2|||
161825268|NCT01190930|584401788|FG009|Maintenance|second malignant neoplasm|0|||
161825269|NCT01190930|584401779|FG000|Maintenance|Inevaluable|0|||
161825270|NCT01190930|584401780|FG001|Maintenance|Inevaluable|0|||
161825271|NCT01190930|584401781|FG002|Maintenance|Inevaluable|0|||
162207831|NCT02930837|585812040|FG000|Overall Study|Lost to Follow-up|5|||
162207832|NCT02930837|585812040|FG000|Overall Study|Withdrawal by Subject|1|||
161933321|NCT03721107|584804194|FG000|Overall Study|Adverse Event|1|||
161933322|NCT03721107|584804195|FG001|Overall Study|Adverse Event|1|||
161933323|NCT03721107|584804196|FG002|Overall Study|Adverse Event|6|||
161933324|NCT03721107|584804197|FG003|Overall Study|Adverse Event|5|||
161933325|NCT03721107|584804194|FG000|Overall Study|Lost to Follow-up|2|||
161933326|NCT03721107|584804195|FG001|Overall Study|Lost to Follow-up|0|||
161933327|NCT03721107|584804196|FG002|Overall Study|Lost to Follow-up|3|||
161933328|NCT03721107|584804197|FG003|Overall Study|Lost to Follow-up|0|||
161933329|NCT03721107|584804194|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
161933330|NCT03721107|584804195|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
161933331|NCT03721107|584804196|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
161933332|NCT03721107|584804197|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
161933333|NCT03721107|584804194|FG000|Overall Study|Physician Decision|0|||
161933334|NCT03721107|584804195|FG001|Overall Study|Physician Decision|1|||
161933335|NCT03721107|584804196|FG002|Overall Study|Physician Decision|0|||
161933336|NCT03721107|584804197|FG003|Overall Study|Physician Decision|0|||
161933337|NCT03721107|584804194|FG000|Overall Study|Pregnancy|0|||
162207833|NCT01393613|585812041|FG000|Overall Study|Adverse Event|11|||
162207834|NCT01393613|585812042|FG001|Overall Study|Adverse Event|11|||
162207835|NCT01393613|585812043|FG002|Overall Study|Adverse Event|13|||
162207836|NCT01393613|585812044|FG003|Overall Study|Adverse Event|22|||
162207837|NCT01393613|585812041|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
161677542|NCT01205230|583872024|FG001|Overall Study|Physician Decision|0|||
161933338|NCT03721107|584804195|FG001|Overall Study|Pregnancy|0|||
161933339|NCT03721107|584804196|FG002|Overall Study|Pregnancy|1|||
161933340|NCT03721107|584804197|FG003|Overall Study|Pregnancy|0|||
161933341|NCT03721107|584804194|FG000|Overall Study|Withdrawal by Subject|1|||
161933342|NCT03721107|584804195|FG001|Overall Study|Withdrawal by Subject|1|||
161825272|NCT01190930|584401782|FG003|Maintenance|Inevaluable|0|||
161933343|NCT03721107|584804196|FG002|Overall Study|Withdrawal by Subject|5|||
161677543|NCT03945591|583872025|FG000|Overall Study|Participant not transplanted|1|||
161677544|NCT03945591|583872025|FG000|Overall Study|Change in treatment plan|3|||
161933344|NCT03721107|584804197|FG003|Overall Study|Withdrawal by Subject|5|||
161933345|NCT03721107|584804194|FG000|Overall Study|Other|1|||
161933346|NCT03721107|584804195|FG001|Overall Study|Other|0|||
161933347|NCT03721107|584804196|FG002|Overall Study|Other|0|||
161933348|NCT03721107|584804197|FG003|Overall Study|Other|1|||
162207838|NCT01393613|585812042|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
161825273|NCT01190930|584401783|FG004|Maintenance|Inevaluable|0|||
161933349|NCT02369159|584804200|FG000|Overall Study|Adverse Event|0|||
161933350|NCT02369159|584804201|FG001|Overall Study|Adverse Event|1|||
161825274|NCT01190930|584401784|FG005|Maintenance|Inevaluable|1|||
162207839|NCT01393613|585812043|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
162207840|NCT01393613|585812044|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
162207841|NCT01393613|585812041|FG000|Overall Study|Physician Decision|2|||
162207842|NCT01393613|585812042|FG001|Overall Study|Physician Decision|0|||
162207843|NCT01393613|585812043|FG002|Overall Study|Physician Decision|0|||
162207844|NCT01393613|585812044|FG003|Overall Study|Physician Decision|1|||
162207845|NCT01393613|585812041|FG000|Overall Study|Withdrawal by Subject|15|||
162207846|NCT01393613|585812042|FG001|Overall Study|Withdrawal by Subject|25|||
162207847|NCT01393613|585812043|FG002|Overall Study|Withdrawal by Subject|23|||
162207848|NCT01393613|585812044|FG003|Overall Study|Withdrawal by Subject|21|||
162207849|NCT01393613|585812041|FG000|Overall Study|Protocol Deviation|2|||
162207850|NCT01393613|585812042|FG001|Overall Study|Protocol Deviation|1|||
162207851|NCT01393613|585812043|FG002|Overall Study|Protocol Deviation|0|||
162207852|NCT01393613|585812044|FG003|Overall Study|Protocol Deviation|0|||
162207853|NCT01393613|585812041|FG000|Overall Study|Lack of Efficacy|9|||
162207854|NCT01393613|585812042|FG001|Overall Study|Lack of Efficacy|20|||
162207855|NCT01393613|585812043|FG002|Overall Study|Lack of Efficacy|16|||
162207856|NCT01393613|585812044|FG003|Overall Study|Lack of Efficacy|21|||
162207857|NCT02998918|585812048|FG000|Overall Study|Withdrawal by Subject|1|||
162207858|NCT02998918|585812049|FG001|Overall Study|Withdrawal by Subject|0|||
162207859|NCT01071317|585812050|FG000|Overall Study|Lost to Follow-up|2|||
162207860|NCT01071317|585812051|FG001|Overall Study|Lost to Follow-up|2|||
162207861|NCT02388347|585813539|FG000|Overall Study|Withdrawal by Subject|0|||
162207862|NCT02388347|585813540|FG001|Overall Study|Withdrawal by Subject|0|||
162207863|NCT02388347|585813541|FG002|Overall Study|Withdrawal by Subject|1|||
162207864|NCT02388347|585813542|FG003|Overall Study|Withdrawal by Subject|0|||
162207865|NCT02388347|585813543|FG004|Overall Study|Withdrawal by Subject|0|||
162207866|NCT00497874|585813544|FG000|Overall Study|Withdrawal by Subject|48|||
162207867|NCT00497874|585813545|FG001|Overall Study|Withdrawal by Subject|17|||
162207868|NCT00497874|585813544|FG000|Overall Study|Illness|8|||
162207869|NCT00497874|585813545|FG001|Overall Study|Illness|4|||
162207870|NCT00497874|585813544|FG000|Overall Study|Death|2|||
162207871|NCT00497874|585813545|FG001|Overall Study|Death|4|||
162207872|NCT00497874|585813544|FG000|Overall Study|Unable to contact|52|||
162207873|NCT00497874|585813545|FG001|Overall Study|Unable to contact|67|||
162207874|NCT00497874|585813544|FG000|Overall Study|Unable to schedule|37|||
162207875|NCT00497874|585813545|FG001|Overall Study|Unable to schedule|24|||
162207876|NCT01101334|585813546|FG000|Overall Study|Adverse Event|9|||
162207877|NCT01101334|585813547|FG001|Overall Study|Adverse Event|4|||
162207878|NCT01101334|585813546|FG000|Overall Study|Death|7|||
162207879|NCT01101334|585813547|FG001|Overall Study|Death|1|||
162207880|NCT01101334|585813546|FG000|Overall Study|Withdrawal by Subject|4|||
162207881|NCT01101334|585813547|FG001|Overall Study|Withdrawal by Subject|3|||
162207882|NCT01101334|585813546|FG000|Overall Study|Withdrawal by Sponsor|1|||
162207883|NCT01101334|585813547|FG001|Overall Study|Withdrawal by Sponsor|1|||
162207884|NCT01101334|585813546|FG000|Overall Study|Progressive Disease|22|||
162207885|NCT01101334|585813547|FG001|Overall Study|Progressive Disease|35|||
162207886|NCT01101334|585813546|FG000|Overall Study|Other|2|||
162207887|NCT01101334|585813547|FG001|Overall Study|Other|1|||
162207888|NCT01774019|585813553|FG000|Overall Study|No longer meets protocol criteria|2|||
162207889|NCT01774019|585813554|FG001|Overall Study|No longer meets protocol criteria|0|||
162207890|NCT01774019|585813553|FG000|Overall Study|Withdrawal by Subject|1|||
162207891|NCT01774019|585813554|FG001|Overall Study|Withdrawal by Subject|0|||
162207892|NCT01774019|585813553|FG000|Overall Study|Surgery delayed > 120 days|1|||
162207893|NCT01774019|585813554|FG001|Overall Study|Surgery delayed > 120 days|0|||
162207894|NCT01774019|585813553|FG000|Overall Study|Patient refused surgery|1|||
162207895|NCT01774019|585813554|FG001|Overall Study|Patient refused surgery|1|||
162207896|NCT01774019|585813553|FG000|Overall Study|Unable to implant study device|1|||
162207897|NCT01774019|585813554|FG001|Overall Study|Unable to implant study device|0|||
162207898|NCT01774019|585813553|FG000|Overall Study|Lost to Follow-up|0|||
162207899|NCT01774019|585813554|FG001|Overall Study|Lost to Follow-up|3|||
162207900|NCT03470545|585813557|FG000|Overall Study|Death|0|||
162207901|NCT03470545|585813558|FG001|Overall Study|Death|1|||
161825275|NCT01190930|584401785|FG006|Maintenance|Inevaluable|1|||
161825276|NCT01190930|584401786|FG007|Maintenance|Inevaluable|1|||
161825277|NCT01190930|584401787|FG008|Maintenance|Inevaluable|0|||
161825278|NCT01190930|584401788|FG009|Maintenance|Inevaluable|0|||
161825279|NCT01190930|584401779|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
161825280|NCT01190930|584401780|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
161825281|NCT01190930|584401781|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
161825282|NCT01190930|584401782|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
162207902|NCT03470545|585813557|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
162207903|NCT03470545|585813558|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
162207904|NCT03470545|585813557|FG000|Overall Study|Adverse Event|2|||
162207905|NCT03470545|585813558|FG001|Overall Study|Adverse Event|0|||
162207906|NCT03470545|585813557|FG000|Overall Study|Withdrawal by Subject|1|||
162207907|NCT03470545|585813558|FG001|Overall Study|Withdrawal by Subject|1|||
161933351|NCT02369159|584804200|FG000|Overall Study|Lost to Follow-up|1|||
162207908|NCT03470545|585813557|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
162207909|NCT03470545|585813558|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
162207910|NCT01664923|585813559|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
162207911|NCT01664923|585813560|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
162207912|NCT01664923|585813559|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
162207913|NCT01664923|585813560|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
162207914|NCT01664923|585813559|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
162207915|NCT01664923|585813560|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
162207916|NCT01664923|585813559|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
162207917|NCT01664923|585813560|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
162207918|NCT01664923|585813559|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
162207919|NCT01664923|585813560|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
162207920|NCT01664923|585813559|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
162207921|NCT01664923|585813560|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
162207922|NCT01664923|585813559|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
162207923|NCT01664923|585813560|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
162207924|NCT01664923|585813559|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
162207925|NCT01664923|585813560|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
162207926|NCT01664923|585813559|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
162207927|NCT01664923|585813560|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
162207928|NCT01664923|585813559|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
162207929|NCT01664923|585813560|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
162207930|NCT01664923|585813559|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
162207931|NCT01664923|585813560|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
162207932|NCT01664923|585813559|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
162207933|NCT01664923|585813560|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
162207934|NCT01664923|585813559|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
162207935|NCT01664923|585813560|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
162207936|NCT01664923|585813559|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
162207937|NCT01664923|585813560|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
162207938|NCT00937521|585813563|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
162207939|NCT00937521|585813564|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
162207940|NCT00937521|585813565|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
162207941|NCT00937521|585813566|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
162207942|NCT00937521|585813567|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
162207943|NCT00937521|585813568|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
162207944|NCT00937521|585813569|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
162207945|NCT00937521|585813570|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
162207946|NCT00937521|585813563|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
162207947|NCT00937521|585813564|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
162207948|NCT00937521|585813565|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
162207949|NCT00937521|585813566|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
162207950|NCT00937521|585813567|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
162207951|NCT00937521|585813568|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
162207952|NCT00937521|585813569|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
162207953|NCT00937521|585813570|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
161825283|NCT01190930|584401783|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
161825284|NCT01190930|584401784|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
161825285|NCT01190930|584401785|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
161825286|NCT01190930|584401786|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
161825287|NCT01190930|584401787|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
161825288|NCT01190930|584401788|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
161825289|NCT01190930|584401779|FG000|Maintenance|Relapse|0|||
161825290|NCT01190930|584401780|FG001|Maintenance|Relapse|0|||
161825291|NCT01190930|584401781|FG002|Maintenance|Relapse|0|||
161825292|NCT01190930|584401782|FG003|Maintenance|Relapse|2|||
161825293|NCT01190930|584401783|FG004|Maintenance|Relapse|0|||
161825294|NCT01190930|584401784|FG005|Maintenance|Relapse|1|||
161825295|NCT01190930|584401785|FG006|Maintenance|Relapse|6|||
161825296|NCT01190930|584401786|FG007|Maintenance|Relapse|13|||
161825297|NCT01190930|584401787|FG008|Maintenance|Relapse|11|||
161825298|NCT01190930|584401788|FG009|Maintenance|Relapse|11|||
161825299|NCT01190930|584401779|FG000|Maintenance|Still on therapy|0|||
161825300|NCT01190930|584401780|FG001|Maintenance|Still on therapy|8|||
161825301|NCT01190930|584401781|FG002|Maintenance|Still on therapy|0|||
161825302|NCT01190930|584401782|FG003|Maintenance|Still on therapy|29|||
161825303|NCT01190930|584401783|FG004|Maintenance|Still on therapy|0|||
161933352|NCT02369159|584804201|FG001|Overall Study|Lost to Follow-up|1|||
161933353|NCT02369159|584804200|FG000|Overall Study|Withdrawal by Subject|7|||
161933354|NCT02369159|584804201|FG001|Overall Study|Withdrawal by Subject|0|||
161933355|NCT00563316|584804204|FG000|Overall Study|Adverse Event|2|||
161933356|NCT00563316|584804204|FG000|Overall Study|Physician Decision|1|||
161933357|NCT00563316|584804204|FG000|Overall Study|Lost to Follow-up|2|||
161933358|NCT00563316|584804204|FG000|Overall Study|Death|1|||
161933359|NCT00563316|584804204|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
161933360|NCT00563316|584804204|FG000|Overall Study|Other|1|||
161933361|NCT02991859|584804208|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933362|NCT02991859|584804209|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
161933363|NCT02991859|584804210|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933364|NCT02991859|584804211|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933365|NCT02991859|584804212|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
161933366|NCT02991859|584804213|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933367|NCT02991859|584804214|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933368|NCT02991859|584804215|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933369|NCT02991859|584804216|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933370|NCT02991859|584804217|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933371|NCT02991859|584804218|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933372|NCT02991859|584804219|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933373|NCT02991859|584804220|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933374|NCT02991859|584804221|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933375|NCT02991859|584804222|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933376|NCT02991859|584804223|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933377|NCT02991859|584804224|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
161933378|NCT02991859|584804208|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933379|NCT02991859|584804209|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933380|NCT02991859|584804210|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933381|NCT02991859|584804211|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933382|NCT02991859|584804212|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933383|NCT02991859|584804213|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933384|NCT02991859|584804214|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933385|NCT02991859|584804215|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933386|NCT02991859|584804216|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933387|NCT02991859|584804217|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933388|NCT02991859|584804218|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933389|NCT02991859|584804219|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933390|NCT02991859|584804220|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
161933391|NCT02991859|584804221|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
161933392|NCT02991859|584804222|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933393|NCT02991859|584804223|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933394|NCT02991859|584804224|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
161933395|NCT02991859|584804208|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933396|NCT02991859|584804209|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933397|NCT02991859|584804210|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933398|NCT02991859|584804211|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933399|NCT02991859|584804212|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933400|NCT02991859|584804213|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
161933401|NCT02991859|584804214|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933402|NCT02991859|584804215|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933403|NCT02991859|584804216|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933404|NCT02991859|584804217|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933405|NCT02991859|584804218|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933406|NCT02991859|584804219|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933407|NCT02991859|584804220|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933408|NCT02991859|584804221|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
162207954|NCT00937521|585813563|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
162207955|NCT00937521|585813564|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
162207956|NCT00937521|585813565|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
162207957|NCT00937521|585813566|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
162207958|NCT00937521|585813567|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
162207959|NCT00937521|585813568|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
162207960|NCT00937521|585813569|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
162207961|NCT00937521|585813570|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
162207962|NCT00937521|585813563|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
162207963|NCT00937521|585813564|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
162207964|NCT00937521|585813565|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
162207965|NCT00937521|585813566|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
162207966|NCT00937521|585813567|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
162207967|NCT00937521|585813568|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
162207968|NCT00937521|585813569|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
161825304|NCT01190930|584401784|FG005|Maintenance|Still on therapy|0|||
161825305|NCT01190930|584401785|FG006|Maintenance|Still on therapy|0|||
161825306|NCT01190930|584401786|FG007|Maintenance|Still on therapy|0|||
161825307|NCT01190930|584401787|FG008|Maintenance|Still on therapy|0|||
161825308|NCT01190930|584401788|FG009|Maintenance|Still on therapy|0|||
161825309|NCT00979212|584401792|FG000|Overall Study|Protocol Violation|1|||
161825310|NCT00979212|584401793|FG001|Overall Study|Protocol Violation|8|||
161825311|NCT00979212|584401792|FG000|Overall Study|No protocol therapy received|1|||
161825312|NCT00979212|584401793|FG001|Overall Study|No protocol therapy received|0|||
161825313|NCT00035555|584401794|FG000|Overall Study|Adverse Event|5|||
161825314|NCT00035555|584401795|FG001|Overall Study|Adverse Event|8|||
161825315|NCT00035555|584401796|FG002|Overall Study|Adverse Event|9|||
161825316|NCT00035555|584401794|FG000|Overall Study|Allograft loss|1|||
161825317|NCT00035555|584401795|FG001|Overall Study|Allograft loss|1|||
161825318|NCT00035555|584401796|FG002|Overall Study|Allograft loss|2|||
161825319|NCT00035555|584401794|FG000|Overall Study|Death|0|||
161825320|NCT00035555|584401795|FG001|Overall Study|Death|0|||
161825321|NCT00035555|584401796|FG002|Overall Study|Death|2|||
161825322|NCT00035555|584401794|FG000|Overall Study|Lost to Follow-up|0|||
161825323|NCT00035555|584401795|FG001|Overall Study|Lost to Follow-up|0|||
161825324|NCT00035555|584401796|FG002|Overall Study|Lost to Follow-up|1|||
161825325|NCT00035555|584401794|FG000|Overall Study|Noncompliance|0|||
161825326|NCT00035555|584401795|FG001|Overall Study|Noncompliance|1|||
161825327|NCT00035555|584401796|FG002|Overall Study|Noncompliance|1|||
161825328|NCT00035555|584401794|FG000|Overall Study|Prohibited medication|1|||
161825329|NCT00035555|584401795|FG001|Overall Study|Prohibited medication|1|||
161825330|NCT00035555|584401796|FG002|Overall Study|Prohibited medication|0|||
161825331|NCT00035555|584401794|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
161825332|NCT00035555|584401795|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
161825333|NCT00035555|584401796|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
161825334|NCT00035555|584401794|FG000|Overall Study|Withdrawal by Subject|2|||
161825335|NCT00035555|584401795|FG001|Overall Study|Withdrawal by Subject|0|||
161825336|NCT00035555|584401796|FG002|Overall Study|Withdrawal by Subject|2|||
161825337|NCT00035555|584401794|FG000|Overall Study|Investigator deemed not a good candidate|0|||
161825338|NCT00035555|584401795|FG001|Overall Study|Investigator deemed not a good candidate|0|||
161825339|NCT00035555|584401796|FG002|Overall Study|Investigator deemed not a good candidate|1|||
161825340|NCT00035555|584401794|FG000|Overall Study|Received cyclosporin in error|0|||
161825341|NCT00035555|584401795|FG001|Overall Study|Received cyclosporin in error|0|||
161825342|NCT00035555|584401796|FG002|Overall Study|Received cyclosporin in error|1|||
161825343|NCT00337428|584401797|FG000|Overall Study|Withdrawal by Subject|1|||
161825344|NCT00337428|584401798|FG001|Overall Study|Withdrawal by Subject|2|||
161825345|NCT00337428|584401797|FG000|Overall Study|Lack of Time|1|||
161825346|NCT00337428|584401798|FG001|Overall Study|Lack of Time|1|||
161825347|NCT00337428|584401797|FG000|Overall Study|Unwilling to Continue|1|||
161825348|NCT00337428|584401798|FG001|Overall Study|Unwilling to Continue|0|||
161825349|NCT00337428|584401797|FG000|Overall Study|Anorexia|1|||
161825350|NCT00337428|584401798|FG001|Overall Study|Anorexia|0|||
161825351|NCT02618382|584401799|FG000|Overall Study|Physician Decision|1|||
161825352|NCT02618382|584401799|FG000|Overall Study|Withdrawal by Subject|1|||
161825353|NCT02618382|584401799|FG000|Overall Study|Protocol Violation|1|||
161825354|NCT03223909|584401800|FG000|Overall Study|Protocol Violation|48|||
161825355|NCT03223909|584401801|FG001|Overall Study|Protocol Violation|45|||
161825356|NCT03223909|584401802|FG002|Overall Study|Protocol Violation|16|||
161825357|NCT04886063|584401809|FG000|Overall Study|Adverse Event|50|||
161825358|NCT04886063|584401809|FG000|Overall Study|Lack of Efficacy|31|||
161825359|NCT04886063|584401809|FG000|Overall Study|Withdrawal by Subject|45|||
161825360|NCT04886063|584401809|FG000|Overall Study|Physician Decision|3|||
161825361|NCT04886063|584401809|FG000|Overall Study|Protocol Violation|3|||
161825362|NCT04886063|584401809|FG000|Overall Study|Site closure|4|||
161825363|NCT04886063|584401809|FG000|Overall Study|Nursing home replacement|3|||
161825364|NCT04886063|584401809|FG000|Overall Study|Lost to Follow-up|5|||
161825365|NCT04886063|584401809|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
161825366|NCT04886063|584401809|FG000|Overall Study|>1 reason|20|||
161825367|NCT01628549|584401810|FG000|Overall Study|Adverse Event|1|||
161825368|NCT01628549|584401811|FG001|Overall Study|Adverse Event|1|||
161825369|NCT01628549|584401812|FG002|Overall Study|Adverse Event|0|||
162207969|NCT00937521|585813570|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
162207970|NCT00937521|585813563|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
162207971|NCT00937521|585813564|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
162207972|NCT00937521|585813565|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
162207973|NCT00937521|585813566|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
162207974|NCT00937521|585813567|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
162207975|NCT00937521|585813568|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
162207976|NCT00937521|585813569|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
162207977|NCT00937521|585813570|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
162207978|NCT00937521|585813563|FG000|Booster Phase|Adverse Event|0|||
162207979|NCT00937521|585813564|FG001|Booster Phase|Adverse Event|0|||
162207980|NCT00937521|585813565|FG002|Booster Phase|Adverse Event|0|||
162207981|NCT00937521|585813566|FG003|Booster Phase|Adverse Event|0|||
162207982|NCT00937521|585813567|FG004|Booster Phase|Adverse Event|0|||
162207983|NCT00937521|585813568|FG005|Booster Phase|Adverse Event|0|||
162207984|NCT00937521|585813569|FG006|Booster Phase|Adverse Event|1|||
162207985|NCT00937521|585813570|FG007|Booster Phase|Adverse Event|0|||
162207986|NCT00937521|585813563|FG000|Booster Phase|Withdrawal by Subject|1|||
162207987|NCT00937521|585813564|FG001|Booster Phase|Withdrawal by Subject|0|||
162207988|NCT00937521|585813565|FG002|Booster Phase|Withdrawal by Subject|0|||
162207989|NCT00937521|585813566|FG003|Booster Phase|Withdrawal by Subject|1|||
162207990|NCT00937521|585813567|FG004|Booster Phase|Withdrawal by Subject|0|||
162207991|NCT00937521|585813568|FG005|Booster Phase|Withdrawal by Subject|0|||
162207992|NCT00937521|585813569|FG006|Booster Phase|Withdrawal by Subject|0|||
162207993|NCT00937521|585813570|FG007|Booster Phase|Withdrawal by Subject|2|||
162207994|NCT00937521|585813563|FG000|Booster Phase|Lost to Follow-up|2|||
162207995|NCT00937521|585813564|FG001|Booster Phase|Lost to Follow-up|2|||
162207996|NCT00937521|585813565|FG002|Booster Phase|Lost to Follow-up|4|||
162207997|NCT00937521|585813566|FG003|Booster Phase|Lost to Follow-up|2|||
162207998|NCT00937521|585813567|FG004|Booster Phase|Lost to Follow-up|4|||
162207999|NCT00937521|585813568|FG005|Booster Phase|Lost to Follow-up|4|||
162208000|NCT00937521|585813569|FG006|Booster Phase|Lost to Follow-up|3|||
162208001|NCT00937521|585813570|FG007|Booster Phase|Lost to Follow-up|0|||
162208002|NCT00937521|585813563|FG000|Booster Phase|Administrative Reason|0|||
162208003|NCT00937521|585813564|FG001|Booster Phase|Administrative Reason|0|||
162208004|NCT00937521|585813565|FG002|Booster Phase|Administrative Reason|1|||
162208005|NCT00937521|585813566|FG003|Booster Phase|Administrative Reason|0|||
162208006|NCT00937521|585813567|FG004|Booster Phase|Administrative Reason|1|||
162208007|NCT00937521|585813568|FG005|Booster Phase|Administrative Reason|1|||
162208008|NCT00937521|585813569|FG006|Booster Phase|Administrative Reason|0|||
162208009|NCT00937521|585813570|FG007|Booster Phase|Administrative Reason|0|||
162208010|NCT00937521|585813563|FG000|Booster Phase|Protocol Deviation|0|||
162208011|NCT00937521|585813564|FG001|Booster Phase|Protocol Deviation|0|||
161933409|NCT02991859|584804222|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933410|NCT02991859|584804223|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933411|NCT02991859|584804224|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
161933412|NCT02991859|584804208|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933413|NCT02991859|584804209|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933414|NCT02991859|584804210|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
162208012|NCT00937521|585813565|FG002|Booster Phase|Protocol Deviation|0|||
162208013|NCT00937521|585813566|FG003|Booster Phase|Protocol Deviation|0|||
162208014|NCT00937521|585813567|FG004|Booster Phase|Protocol Deviation|0|||
162208015|NCT00937521|585813568|FG005|Booster Phase|Protocol Deviation|0|||
162208016|NCT00937521|585813569|FG006|Booster Phase|Protocol Deviation|1|||
162208017|NCT00937521|585813570|FG007|Booster Phase|Protocol Deviation|0|||
162208018|NCT04035577|585813571|FG000|Overall Study|Lost to Follow-up|1|||
162208019|NCT04035577|585813571|FG000|Overall Study|Withdrawal by Subject|1|||
162208020|NCT01426113|585813574|FG000|Overall Study|Study Discontinued|1|||
162208021|NCT01426113|585813575|FG001|Overall Study|Study Discontinued|1|||
162208022|NCT01426113|585813574|FG000|Overall Study|Adverse Event|0|||
162208023|NCT01426113|585813575|FG001|Overall Study|Adverse Event|1|||
161933415|NCT02991859|584804211|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
162208024|NCT00878553|585813576|FG000|Sleep Study|Withdrawal by Subject|2|||
162208025|NCT00878553|585813577|FG001|Sleep Study|Withdrawal by Subject|0|||
162208026|NCT00878553|585813578|FG002|Sleep Study|Withdrawal by Subject|0|||
162208027|NCT00878553|585813579|FG003|Sleep Study|Withdrawal by Subject|0|||
162208028|NCT00878553|585813580|FG004|Sleep Study|Withdrawal by Subject|0|||
162208029|NCT00878553|585813576|FG000|Sleep Study|Lost to Follow-up|1|||
162208030|NCT00878553|585813577|FG001|Sleep Study|Lost to Follow-up|0|||
161933416|NCT02991859|584804212|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933417|NCT02991859|584804213|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
162208031|NCT00878553|585813578|FG002|Sleep Study|Lost to Follow-up|0|||
162208032|NCT00878553|585813579|FG003|Sleep Study|Lost to Follow-up|0|||
162208033|NCT00878553|585813580|FG004|Sleep Study|Lost to Follow-up|0|||
162208034|NCT00878553|585813576|FG000|Sleep Study|car accident|1|||
162208035|NCT00878553|585813577|FG001|Sleep Study|car accident|0|||
162208036|NCT00878553|585813578|FG002|Sleep Study|car accident|0|||
162208037|NCT00878553|585813579|FG003|Sleep Study|car accident|0|||
162208038|NCT00878553|585813580|FG004|Sleep Study|car accident|0|||
162208039|NCT00878553|585813576|FG000|Sleep Study|family emergency|1|||
162208040|NCT00878553|585813577|FG001|Sleep Study|family emergency|0|||
162208041|NCT00878553|585813578|FG002|Sleep Study|family emergency|0|||
162208042|NCT00878553|585813579|FG003|Sleep Study|family emergency|0|||
162208043|NCT00878553|585813580|FG004|Sleep Study|family emergency|0|||
162208044|NCT00878553|585813576|FG000|PK Study|Withdrawal by Subject|0|||
162208045|NCT00878553|585813577|FG001|PK Study|Withdrawal by Subject|0|||
162208046|NCT00878553|585813578|FG002|PK Study|Withdrawal by Subject|0|||
162208047|NCT00878553|585813579|FG003|PK Study|Withdrawal by Subject|1|||
162208048|NCT00878553|585813580|FG004|PK Study|Withdrawal by Subject|0|||
162208049|NCT00909532|585813583|FG000|Overall Study|Adverse Event|4|||
162208050|NCT00909532|585813584|FG001|Overall Study|Adverse Event|1|||
162208051|NCT00909532|585813583|FG000|Overall Study|Pregnancy|0|||
162208052|NCT00909532|585813584|FG001|Overall Study|Pregnancy|1|||
162208053|NCT00909532|585813583|FG000|Overall Study|Prohibited Medication|2|||
162208054|NCT00909532|585813584|FG001|Overall Study|Prohibited Medication|1|||
162208055|NCT00909532|585813583|FG000|Overall Study|Withdrawal of Consent|1|||
162208056|NCT00909532|585813584|FG001|Overall Study|Withdrawal of Consent|1|||
162208057|NCT00909532|585813583|FG000|Overall Study|Noncompliance with Study Requirements|0|||
162208058|NCT00909532|585813584|FG001|Overall Study|Noncompliance with Study Requirements|2|||
162208059|NCT00909532|585813583|FG000|Overall Study|Physician Decision|1|||
162208060|NCT00909532|585813584|FG001|Overall Study|Physician Decision|0|||
162208061|NCT00909532|585813583|FG000|Overall Study|Wrong Genotype|1|||
162208062|NCT00909532|585813584|FG001|Overall Study|Wrong Genotype|0|||
162208063|NCT00909532|585813583|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
162208064|NCT00909532|585813584|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
162208065|NCT03188536|585813586|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
162208066|NCT03188536|585813586|FG000|Overall Study|Not participated/met inclusion criteria|1|||
162208067|NCT00118703|585813589|FG000|Overall Study|Protocol Violation|1|||
162208068|NCT00118703|585813590|FG001|Overall Study|Protocol Violation|0|||
162208069|NCT00118703|585813589|FG000|Overall Study|Adverse Event|1|||
162208070|NCT00118703|585813590|FG001|Overall Study|Adverse Event|1|||
162208071|NCT00118703|585813589|FG000|Overall Study|Participant took two different treatment|0|||
162208072|NCT00118703|585813590|FG001|Overall Study|Participant took two different treatment|1|||
162208073|NCT00118703|585813589|FG000|Overall Study|Withdrawal by Subject|2|||
162208074|NCT00118703|585813590|FG001|Overall Study|Withdrawal by Subject|5|||
162208075|NCT00118703|585813589|FG000|Overall Study|Lost to Follow-up|1|||
162208076|NCT00118703|585813590|FG001|Overall Study|Lost to Follow-up|2|||
162208077|NCT00461123|585813591|FG000|Overall Study|Adverse Event|1|||
162208078|NCT00461123|585813592|FG001|Overall Study|Adverse Event|0|||
162208079|NCT00461123|585813591|FG000|Overall Study|Lost to Follow-up|1|||
162208080|NCT00461123|585813592|FG001|Overall Study|Lost to Follow-up|1|||
162208081|NCT00461123|585813591|FG000|Overall Study|Protocol Violation|3|||
162208082|NCT00461123|585813592|FG001|Overall Study|Protocol Violation|2|||
162208083|NCT00461123|585813591|FG000|Overall Study|Withdrawal by Subject|1|||
162208084|NCT00461123|585813592|FG001|Overall Study|Withdrawal by Subject|3|||
162208085|NCT02024750|585813593|FG000|Overall Study|Withdrawal by Subject|2|||
162208086|NCT02024750|585813594|FG001|Overall Study|Withdrawal by Subject|1|||
161825370|NCT01628549|584401813|FG003|Overall Study|Adverse Event|4|||
162208087|NCT02261285|585813595|FG000|Overall Study|Disease progression|0|||
162208088|NCT02261285|585813596|FG001|Overall Study|Disease progression|0|||
162208089|NCT02261285|585813597|FG002|Overall Study|Disease progression|1|||
162208090|NCT02344173|585813598|FG000|Procedure|Ablation Procedure Not Performed|7|||
161825371|NCT01628549|584401810|FG000|Overall Study|Lost to Follow-up|3|||
161825372|NCT01628549|584401811|FG001|Overall Study|Lost to Follow-up|4|||
161825373|NCT01628549|584401812|FG002|Overall Study|Lost to Follow-up|3|||
161825374|NCT01628549|584401813|FG003|Overall Study|Lost to Follow-up|3|||
161825375|NCT01628549|584401810|FG000|Overall Study|Withdrawal by Subject|3|||
161825376|NCT01628549|584401811|FG001|Overall Study|Withdrawal by Subject|4|||
161825377|NCT01628549|584401812|FG002|Overall Study|Withdrawal by Subject|4|||
161825378|NCT01628549|584401813|FG003|Overall Study|Withdrawal by Subject|1|||
161825379|NCT01628549|584401810|FG000|Overall Study|Protocol Violation|2|||
162208091|NCT02344173|585813598|FG000|12-month Visit|Death|8|||
162208092|NCT02344173|585813598|FG000|12-month Visit|Withdrawal by Subject|30|||
162208093|NCT02344173|585813598|FG000|12-month Visit|Lost to Follow-up|58|||
162208094|NCT01209286|585813600|FG000|Overall Study|Adverse Event|4|||
162208095|NCT01209286|585813601|FG001|Overall Study|Adverse Event|3|||
162208096|NCT01209286|585813602|FG002|Overall Study|Adverse Event|1|||
162208097|NCT01209286|585813600|FG000|Overall Study|Hematological Relapse After Remission|0|||
162208098|NCT01209286|585813601|FG001|Overall Study|Hematological Relapse After Remission|1|||
161825380|NCT01628549|584401811|FG001|Overall Study|Protocol Violation|1|||
162208099|NCT01209286|585813602|FG002|Overall Study|Hematological Relapse After Remission|1|||
162208100|NCT01209286|585813600|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
161933418|NCT02991859|584804214|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933419|NCT02991859|584804215|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933420|NCT02991859|584804216|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933421|NCT02991859|584804217|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
161933422|NCT02991859|584804218|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933423|NCT02991859|584804219|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933424|NCT02991859|584804220|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933425|NCT02991859|584804221|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933426|NCT02991859|584804222|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933427|NCT02991859|584804223|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933428|NCT02991859|584804224|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161933429|NCT02991859|584804208|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933430|NCT02991859|584804209|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933431|NCT02991859|584804210|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933432|NCT02991859|584804211|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933433|NCT02991859|584804212|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933434|NCT02991859|584804213|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
162208101|NCT01209286|585813601|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
162208102|NCT01209286|585813602|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
162208103|NCT01209286|585813600|FG000|Overall Study|Physician Decision|0|||
162208104|NCT01209286|585813601|FG001|Overall Study|Physician Decision|2|||
162208105|NCT01209286|585813602|FG002|Overall Study|Physician Decision|0|||
162208106|NCT01209286|585813600|FG000|Overall Study|Other|0|||
162208107|NCT01209286|585813601|FG001|Overall Study|Other|1|||
162208108|NCT01209286|585813602|FG002|Overall Study|Other|0|||
162208109|NCT01891890|585813603|FG000|Overall Study|Lost to Follow-up|0|||
162208110|NCT01891890|585813604|FG001|Overall Study|Lost to Follow-up|0|||
162208111|NCT01891890|585813605|FG002|Overall Study|Lost to Follow-up|1|||
161933435|NCT02991859|584804214|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933436|NCT02991859|584804215|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933437|NCT02991859|584804216|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
161933438|NCT02991859|584804217|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933439|NCT02991859|584804218|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933440|NCT02991859|584804219|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933441|NCT02991859|584804220|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933442|NCT02991859|584804221|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933443|NCT02991859|584804222|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933444|NCT02991859|584804223|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933445|NCT02991859|584804224|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161933446|NCT00425854|584804232|FG000|Overall Study|Progressive Disease|19|||
161933447|NCT00425854|584804233|FG001|Overall Study|Progressive Disease|12|||
161933448|NCT00425854|584804232|FG000|Overall Study|Dose reduction toxicity AE|8|||
161933449|NCT00425854|584804233|FG001|Overall Study|Dose reduction toxicity AE|7|||
161933450|NCT00425854|584804232|FG000|Overall Study|Other Adverse Event|2|||
161933451|NCT00425854|584804233|FG001|Overall Study|Other Adverse Event|2|||
161933452|NCT01630811|584804234|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
161933453|NCT01630811|584804235|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
161933454|NCT01725308|584804238|FG000|Treatment Period I|Did Not Receive Drug|1|||
161933455|NCT01725308|584804239|FG001|Treatment Period I|Did Not Receive Drug|0|||
161933456|NCT01725308|584804240|FG002|Treatment Period I|Did Not Receive Drug|0|||
161933457|NCT01725308|584804238|FG000|Treatment Period I|Adverse Event|5|||
161933458|NCT01725308|584804239|FG001|Treatment Period I|Adverse Event|4|||
161933459|NCT01725308|584804240|FG002|Treatment Period I|Adverse Event|21|||
161933460|NCT01725308|584804238|FG000|Treatment Period I|Insufficient Response|7|||
161933461|NCT01725308|584804239|FG001|Treatment Period I|Insufficient Response|0|||
161933462|NCT01725308|584804240|FG002|Treatment Period I|Insufficient Response|5|||
161933463|NCT01725308|584804238|FG000|Treatment Period I|Worsening of the Target Disease|8|||
161933464|NCT01725308|584804239|FG001|Treatment Period I|Worsening of the Target Disease|0|||
161933465|NCT01725308|584804240|FG002|Treatment Period I|Worsening of the Target Disease|2|||
162208112|NCT01891890|585813603|FG000|Overall Study|Study ended before endpoint reached|7|||
162208113|NCT01891890|585813604|FG001|Overall Study|Study ended before endpoint reached|3|||
162208114|NCT01891890|585813605|FG002|Overall Study|Study ended before endpoint reached|6|||
162208115|NCT01215032|585813613|FG000|Overall Study|Adverse Event|3|||
161933466|NCT01725308|584804238|FG000|Treatment Period I|Changes in the Episodes|3|||
161933467|NCT01725308|584804239|FG001|Treatment Period I|Changes in the Episodes|0|||
161933468|NCT01725308|584804240|FG002|Treatment Period I|Changes in the Episodes|2|||
161933469|NCT01725308|584804238|FG000|Treatment Period I|Withdrawal of Consent|12|||
161933470|NCT01725308|584804239|FG001|Treatment Period I|Withdrawal of Consent|7|||
161933471|NCT01725308|584804240|FG002|Treatment Period I|Withdrawal of Consent|5|||
162208116|NCT01215032|585813613|FG000|Overall Study|Lack of Efficacy|17|||
162208117|NCT03605368|585813614|FG000|Overall Study|Lost to Follow-up|2|||
162208118|NCT03605368|585813615|FG001|Overall Study|Lost to Follow-up|1|||
161825381|NCT01628549|584401812|FG002|Overall Study|Protocol Violation|1|||
161825382|NCT01628549|584401813|FG003|Overall Study|Protocol Violation|0|||
161825383|NCT01628549|584401810|FG000|Overall Study|withdrawn for noncompliance|0|||
161825384|NCT01628549|584401811|FG001|Overall Study|withdrawn for noncompliance|2|||
161825385|NCT01628549|584401812|FG002|Overall Study|withdrawn for noncompliance|1|||
161825386|NCT01628549|584401813|FG003|Overall Study|withdrawn for noncompliance|0|||
161825387|NCT01628549|584401810|FG000|Overall Study|abnormal laboratory test results|0|||
161825388|NCT01628549|584401811|FG001|Overall Study|abnormal laboratory test results|0|||
161825389|NCT01628549|584401812|FG002|Overall Study|abnormal laboratory test results|1|||
161825390|NCT01628549|584401813|FG003|Overall Study|abnormal laboratory test results|0|||
161825391|NCT01628549|584401810|FG000|Overall Study|positive pregnancy test|0|||
161825392|NCT01628549|584401811|FG001|Overall Study|positive pregnancy test|0|||
161825393|NCT01628549|584401812|FG002|Overall Study|positive pregnancy test|0|||
161825394|NCT01628549|584401813|FG003|Overall Study|positive pregnancy test|1|||
161825395|NCT00177164|584401821|FG000|Overall Study|Protocol Violation|0|||
161825396|NCT00177164|584401822|FG001|Overall Study|Protocol Violation|7|||
161825397|NCT00177164|584401821|FG000|Overall Study|Lost to Follow-up|4|||
161825398|NCT00177164|584401822|FG001|Overall Study|Lost to Follow-up|5|||
161825399|NCT00177164|584401821|FG000|Overall Study|increase in alcohol and drug use|1|||
161825400|NCT00177164|584401822|FG001|Overall Study|increase in alcohol and drug use|2|||
161825401|NCT00177164|584401821|FG000|Overall Study|Adverse Event|1|||
161825402|NCT00177164|584401822|FG001|Overall Study|Adverse Event|0|||
161825403|NCT00177164|584401821|FG000|Overall Study|discharge from hospital|1|||
161825404|NCT00177164|584401822|FG001|Overall Study|discharge from hospital|0|||
161825405|NCT00177164|584401821|FG000|Overall Study|Lack of Efficacy|2|||
161825406|NCT00177164|584401822|FG001|Overall Study|Lack of Efficacy|1|||
161825407|NCT00177164|584401821|FG000|Overall Study|Pregnancy|0|||
161825408|NCT00177164|584401822|FG001|Overall Study|Pregnancy|1|||
161825409|NCT03807440|584401825|FG000|Overall Study|No documentation of index date 2|320|||
161825410|NCT03807440|584401825|FG000|Overall Study|No informed consent for index date 2|117|||
161825411|NCT02451358|584401826|FG000|Overall Study|Withdrawal by Subject|1|||
161825412|NCT02451358|584401827|FG001|Overall Study|Withdrawal by Subject|1|||
161825413|NCT02451358|584401828|FG002|Overall Study|Withdrawal by Subject|0|||
161825414|NCT02451358|584401829|FG003|Overall Study|Withdrawal by Subject|0|||
161825415|NCT02451358|584401826|FG000|Overall Study|Protocol Violation|0|||
161825416|NCT02451358|584401827|FG001|Overall Study|Protocol Violation|1|||
161825417|NCT02451358|584401828|FG002|Overall Study|Protocol Violation|1|||
161825418|NCT02451358|584401829|FG003|Overall Study|Protocol Violation|0|||
161825419|NCT06128525|584401830|FG000|Overall Study|Patient withdrew consent|1|||
161825420|NCT03414034|584401835|FG000|Overall Study|Adverse Event|6|||
161825421|NCT03414034|584401836|FG001|Overall Study|Adverse Event|1|||
161825422|NCT03414034|584401837|FG002|Overall Study|Adverse Event|1|||
161825423|NCT03414034|584401835|FG000|Overall Study|Death|0|||
161825424|NCT03414034|584401836|FG001|Overall Study|Death|0|||
161825425|NCT03414034|584401837|FG002|Overall Study|Death|1|||
161825426|NCT03414034|584401835|FG000|Overall Study|Non-compliance With Study Drug|0|||
161825427|NCT03414034|584401836|FG001|Overall Study|Non-compliance With Study Drug|0|||
161825428|NCT03414034|584401837|FG002|Overall Study|Non-compliance With Study Drug|1|||
161825429|NCT03414034|584401835|FG000|Overall Study|Physician Decision|1|||
161825430|NCT03414034|584401836|FG001|Overall Study|Physician Decision|3|||
161825431|NCT03414034|584401837|FG002|Overall Study|Physician Decision|2|||
161825432|NCT03414034|584401835|FG000|Overall Study|Withdrawal of Informed Consent|2|||
161825433|NCT03414034|584401836|FG001|Overall Study|Withdrawal of Informed Consent|1|||
161825434|NCT03414034|584401837|FG002|Overall Study|Withdrawal of Informed Consent|4|||
161825435|NCT03414034|584401835|FG000|Overall Study|Progressive Disease|15|||
161825436|NCT03414034|584401836|FG001|Overall Study|Progressive Disease|15|||
161825437|NCT03414034|584401837|FG002|Overall Study|Progressive Disease|17|||
161825438|NCT03414034|584401835|FG000|Overall Study|Miscellaneous|0|||
161825439|NCT03414034|584401836|FG001|Overall Study|Miscellaneous|0|||
161825440|NCT03414034|584401837|FG002|Overall Study|Miscellaneous|2|||
161825441|NCT01332968|584401839|FG000|Induction Period|Adverse Event|23|||
161825442|NCT01332968|584401840|FG001|Induction Period|Adverse Event|26|||
161825443|NCT01332968|584401841|FG002|Induction Period|Adverse Event|0|||
161825444|NCT01332968|584401842|FG003|Induction Period|Adverse Event|0|||
161825445|NCT01332968|584401843|FG004|Induction Period|Adverse Event|0|||
161825446|NCT01332968|584401844|FG005|Induction Period|Adverse Event|0|||
161825447|NCT01332968|584401845|FG006|Induction Period|Adverse Event|0|||
161825448|NCT01332968|584401846|FG007|Induction Period|Adverse Event|0|||
161825449|NCT01332968|584401839|FG000|Induction Period|Death|1|||
161825450|NCT01332968|584401840|FG001|Induction Period|Death|4|||
161825451|NCT01332968|584401841|FG002|Induction Period|Death|0|||
161825452|NCT01332968|584401842|FG003|Induction Period|Death|0|||
161825453|NCT01332968|584401843|FG004|Induction Period|Death|0|||
161825454|NCT01332968|584401844|FG005|Induction Period|Death|0|||
161825455|NCT01332968|584401845|FG006|Induction Period|Death|0|||
161825456|NCT01332968|584401846|FG007|Induction Period|Death|0|||
161825457|NCT01332968|584401839|FG000|Induction Period|Non-compliance|1|||
161825458|NCT01332968|584401840|FG001|Induction Period|Non-compliance|0|||
161825459|NCT01332968|584401841|FG002|Induction Period|Non-compliance|0|||
161933472|NCT01725308|584804238|FG000|Treatment Period I|Lost to Follow-up|3|||
161933473|NCT01725308|584804239|FG001|Treatment Period I|Lost to Follow-up|2|||
161933474|NCT01725308|584804240|FG002|Treatment Period I|Lost to Follow-up|2|||
161933475|NCT01725308|584804238|FG000|Treatment Period I|Protocol Deviations|3|||
161933476|NCT01725308|584804239|FG001|Treatment Period I|Protocol Deviations|1|||
161933477|NCT01725308|584804240|FG002|Treatment Period I|Protocol Deviations|1|||
161933478|NCT01725308|584804238|FG000|Treatment Period I|Miscellaneous|2|||
161933479|NCT01725308|584804239|FG001|Treatment Period I|Miscellaneous|0|||
161933480|NCT01725308|584804240|FG002|Treatment Period I|Miscellaneous|3|||
161933481|NCT01725308|584804238|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
161933482|NCT01725308|584804239|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
161933483|NCT01725308|584804240|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
161933484|NCT01725308|584804238|FG000|Treatment Period II|Did Not Receive Drug|4|||
162208119|NCT03605368|585813616|FG002|Overall Study|Lost to Follow-up|3|||
162208120|NCT03605368|585813617|FG003|Overall Study|Lost to Follow-up|2|||
162208121|NCT03605368|585813614|FG000|Overall Study|Withdrawal by Subject|0|||
162208122|NCT03605368|585813615|FG001|Overall Study|Withdrawal by Subject|0|||
162208123|NCT03605368|585813616|FG002|Overall Study|Withdrawal by Subject|4|||
162208124|NCT03605368|585813617|FG003|Overall Study|Withdrawal by Subject|3|||
162208125|NCT01020747|585813618|FG000|Overall Study|Withdrawal by Subject|1|||
162208126|NCT02881047|585813623|FG000|Overall Study|Adverse Event|1|||
161933485|NCT01725308|584804239|FG001|Treatment Period II|Did Not Receive Drug|0|||
161933486|NCT01725308|584804240|FG002|Treatment Period II|Did Not Receive Drug|0|||
161933487|NCT01725308|584804238|FG000|Treatment Period II|Adverse Event|13|||
161933488|NCT01725308|584804239|FG001|Treatment Period II|Adverse Event|8|||
161933489|NCT01725308|584804240|FG002|Treatment Period II|Adverse Event|20|||
161933490|NCT01725308|584804238|FG000|Treatment Period II|Insufficient Response|2|||
161933491|NCT01725308|584804239|FG001|Treatment Period II|Insufficient Response|4|||
161933492|NCT01725308|584804240|FG002|Treatment Period II|Insufficient Response|6|||
161933493|NCT01725308|584804238|FG000|Treatment Period II|Worsening of the Target Disease|1|||
161933494|NCT01725308|584804239|FG001|Treatment Period II|Worsening of the Target Disease|4|||
161933495|NCT01725308|584804240|FG002|Treatment Period II|Worsening of the Target Disease|2|||
161933496|NCT01725308|584804238|FG000|Treatment Period II|Changes in the Episodes|1|||
161933497|NCT01725308|584804239|FG001|Treatment Period II|Changes in the Episodes|0|||
161933498|NCT01725308|584804240|FG002|Treatment Period II|Changes in the Episodes|5|||
161933499|NCT01725308|584804238|FG000|Treatment Period II|Withdrawal of Consent|28|||
162208127|NCT02881047|585813623|FG000|Overall Study|Withdrawal by Subject|1|||
162208128|NCT03028012|585813624|FG000|Overall Study|Lost to Follow-up|2|||
161933500|NCT01725308|584804239|FG001|Treatment Period II|Withdrawal of Consent|2|||
161933501|NCT01725308|584804240|FG002|Treatment Period II|Withdrawal of Consent|16|||
161933502|NCT01725308|584804238|FG000|Treatment Period II|Lost to Follow-up|1|||
161933503|NCT01725308|584804239|FG001|Treatment Period II|Lost to Follow-up|5|||
161933504|NCT01725308|584804240|FG002|Treatment Period II|Lost to Follow-up|3|||
161933505|NCT01725308|584804238|FG000|Treatment Period II|Protocol Deviations|0|||
161933506|NCT01725308|584804239|FG001|Treatment Period II|Protocol Deviations|0|||
161933507|NCT01725308|584804240|FG002|Treatment Period II|Protocol Deviations|1|||
161933508|NCT01725308|584804238|FG000|Treatment Period II|Miscellaneous|5|||
161933509|NCT01725308|584804239|FG001|Treatment Period II|Miscellaneous|3|||
161933510|NCT01725308|584804240|FG002|Treatment Period II|Miscellaneous|7|||
161933511|NCT05652140|584804242|FG000|Overall Study|Lost to Follow-up|7|||
161933512|NCT05652140|584804243|FG001|Overall Study|Lost to Follow-up|16|||
161933513|NCT05652140|584804244|FG002|Overall Study|Lost to Follow-up|22|||
162208129|NCT03028012|585813625|FG001|Overall Study|Lost to Follow-up|3|||
162208130|NCT03028012|585813626|FG002|Overall Study|Lost to Follow-up|3|||
162208131|NCT01705145|585813630|FG000|Part B|Adverse Event|1|||
161933514|NCT05652140|584804245|FG003|Overall Study|Lost to Follow-up|31|||
161933515|NCT06048705|584804249|FG000|Overall Study|Physician Decision|1|||
161933516|NCT06048705|584804250|FG001|Overall Study|Physician Decision|0|||
161933517|NCT06048705|584804251|FG002|Overall Study|Physician Decision|0|||
162208132|NCT01077622|585813631|FG000|Overall Study|Physician Decision|2|||
162208133|NCT01077622|585813631|FG000|Overall Study|Withdrawal by Subject|1|||
161933518|NCT06048705|584804249|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
161933519|NCT06048705|584804250|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
162208134|NCT00424177|585813632|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
161933520|NCT06048705|584804251|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
161933521|NCT06048705|584804249|FG000|Overall Study|Death prior to lymphodepletion|0|||
161933522|NCT06048705|584804250|FG001|Overall Study|Death prior to lymphodepletion|0|||
161933523|NCT06048705|584804251|FG002|Overall Study|Death prior to lymphodepletion|1|||
162208135|NCT00424177|585813632|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
162208136|NCT00424177|585813632|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
161933524|NCT03378635|584804254|FG000|Overall Study|Adverse Event|1|||
161933525|NCT03378635|584804255|FG001|Overall Study|Adverse Event|0|||
161933526|NCT03378635|584804256|FG002|Overall Study|Adverse Event|0|||
161933527|NCT03378635|584804254|FG000|Overall Study|Withdrawal by Subject|1|||
161933528|NCT03378635|584804255|FG001|Overall Study|Withdrawal by Subject|0|||
162208137|NCT00424177|585813632|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
162208138|NCT00424177|585813632|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
162208139|NCT00424177|585813632|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
162208140|NCT00424177|585813632|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
162208141|NCT00424177|585813632|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
162208142|NCT00424177|585813632|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
162208143|NCT00424177|585813632|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
162208144|NCT01091519|585813635|FG000|Overall Study|Adverse Event|12|||
162208145|NCT01091519|585813636|FG001|Overall Study|Adverse Event|16|||
161825460|NCT01332968|584401842|FG003|Induction Period|Non-compliance|0|||
161825461|NCT01332968|584401843|FG004|Induction Period|Non-compliance|0|||
161825462|NCT01332968|584401844|FG005|Induction Period|Non-compliance|0|||
161825463|NCT01332968|584401845|FG006|Induction Period|Non-compliance|0|||
161825464|NCT01332968|584401846|FG007|Induction Period|Non-compliance|0|||
161825465|NCT01332968|584401839|FG000|Induction Period|Other|2|||
161825466|NCT01332968|584401840|FG001|Induction Period|Other|2|||
161825467|NCT01332968|584401841|FG002|Induction Period|Other|0|||
161825468|NCT01332968|584401842|FG003|Induction Period|Other|0|||
161825469|NCT01332968|584401843|FG004|Induction Period|Other|0|||
161825470|NCT01332968|584401844|FG005|Induction Period|Other|0|||
161825471|NCT01332968|584401845|FG006|Induction Period|Other|0|||
161825472|NCT01332968|584401846|FG007|Induction Period|Other|0|||
161825473|NCT01332968|584401839|FG000|Induction Period|Physician Decision|6|||
161825474|NCT01332968|584401840|FG001|Induction Period|Physician Decision|1|||
161825475|NCT01332968|584401841|FG002|Induction Period|Physician Decision|0|||
161825476|NCT01332968|584401842|FG003|Induction Period|Physician Decision|0|||
161825477|NCT01332968|584401843|FG004|Induction Period|Physician Decision|0|||
161825478|NCT01332968|584401844|FG005|Induction Period|Physician Decision|0|||
161825479|NCT01332968|584401845|FG006|Induction Period|Physician Decision|0|||
161825480|NCT01332968|584401846|FG007|Induction Period|Physician Decision|0|||
161825481|NCT01332968|584401839|FG000|Induction Period|Progressive Disease|15|||
161825482|NCT01332968|584401840|FG001|Induction Period|Progressive Disease|7|||
161825483|NCT01332968|584401841|FG002|Induction Period|Progressive Disease|0|||
161825484|NCT01332968|584401842|FG003|Induction Period|Progressive Disease|0|||
161825485|NCT01332968|584401843|FG004|Induction Period|Progressive Disease|0|||
161825486|NCT01332968|584401844|FG005|Induction Period|Progressive Disease|0|||
161825487|NCT01332968|584401845|FG006|Induction Period|Progressive Disease|0|||
161825488|NCT01332968|584401846|FG007|Induction Period|Progressive Disease|0|||
161825489|NCT01332968|584401839|FG000|Induction Period|Protocol Violation|3|||
161825490|NCT01332968|584401840|FG001|Induction Period|Protocol Violation|4|||
161825491|NCT01332968|584401841|FG002|Induction Period|Protocol Violation|0|||
161825492|NCT01332968|584401842|FG003|Induction Period|Protocol Violation|0|||
161825493|NCT01332968|584401843|FG004|Induction Period|Protocol Violation|0|||
161825494|NCT01332968|584401844|FG005|Induction Period|Protocol Violation|0|||
161825495|NCT01332968|584401845|FG006|Induction Period|Protocol Violation|0|||
161825496|NCT01332968|584401846|FG007|Induction Period|Protocol Violation|0|||
161825497|NCT01332968|584401839|FG000|Induction Period|Withdrawal by Subject|3|||
161825498|NCT01332968|584401840|FG001|Induction Period|Withdrawal by Subject|5|||
161825499|NCT01332968|584401841|FG002|Induction Period|Withdrawal by Subject|0|||
161825500|NCT01332968|584401842|FG003|Induction Period|Withdrawal by Subject|0|||
161825501|NCT01332968|584401843|FG004|Induction Period|Withdrawal by Subject|0|||
161825502|NCT01332968|584401844|FG005|Induction Period|Withdrawal by Subject|0|||
161825503|NCT01332968|584401845|FG006|Induction Period|Withdrawal by Subject|0|||
161825504|NCT01332968|584401846|FG007|Induction Period|Withdrawal by Subject|0|||
161825505|NCT01332968|584401839|FG000|Induction Period|Randomised but not treated|4|||
161825506|NCT01332968|584401840|FG001|Induction Period|Randomised but not treated|7|||
161825507|NCT01332968|584401841|FG002|Induction Period|Randomised but not treated|0|||
161825508|NCT01332968|584401842|FG003|Induction Period|Randomised but not treated|0|||
161825509|NCT01332968|584401843|FG004|Induction Period|Randomised but not treated|0|||
161825510|NCT01332968|584401844|FG005|Induction Period|Randomised but not treated|0|||
161825511|NCT01332968|584401845|FG006|Induction Period|Randomised but not treated|0|||
161825512|NCT01332968|584401846|FG007|Induction Period|Randomised but not treated|0|||
161825513|NCT01332968|584401839|FG000|Maintenance/Observation Period|Adverse Event|0|||
161825514|NCT01332968|584401840|FG001|Maintenance/Observation Period|Adverse Event|0|||
161825515|NCT01332968|584401841|FG002|Maintenance/Observation Period|Adverse Event|53|||
161825516|NCT01332968|584401842|FG003|Maintenance/Observation Period|Adverse Event|66|||
161825517|NCT01332968|584401843|FG004|Maintenance/Observation Period|Adverse Event|0|||
161825518|NCT01332968|584401844|FG005|Maintenance/Observation Period|Adverse Event|0|||
161825519|NCT01332968|584401845|FG006|Maintenance/Observation Period|Adverse Event|0|||
161825520|NCT01332968|584401846|FG007|Maintenance/Observation Period|Adverse Event|0|||
161825521|NCT01332968|584401839|FG000|Maintenance/Observation Period|Death|0|||
161825522|NCT01332968|584401840|FG001|Maintenance/Observation Period|Death|0|||
161825523|NCT01332968|584401841|FG002|Maintenance/Observation Period|Death|5|||
161825524|NCT01332968|584401842|FG003|Maintenance/Observation Period|Death|6|||
161825525|NCT01332968|584401843|FG004|Maintenance/Observation Period|Death|0|||
162208146|NCT01091519|585813635|FG000|Overall Study|Death|1|||
162208147|NCT01091519|585813636|FG001|Overall Study|Death|0|||
162208148|NCT01091519|585813635|FG000|Overall Study|Lack of Efficacy|16|||
162208149|NCT01091519|585813636|FG001|Overall Study|Lack of Efficacy|19|||
162208150|NCT01091519|585813635|FG000|Overall Study|Lost to Follow-up|14|||
162208151|NCT01091519|585813636|FG001|Overall Study|Lost to Follow-up|24|||
162208152|NCT01091519|585813635|FG000|Overall Study|Withdrawal by Subject|2|||
162208153|NCT01091519|585813636|FG001|Overall Study|Withdrawal by Subject|2|||
162208154|NCT01091519|585813635|FG000|Overall Study|Other|6|||
162208155|NCT01091519|585813636|FG001|Overall Study|Other|8|||
162208156|NCT01091519|585813635|FG000|Overall Study|Randomized not treated|4|||
162208157|NCT01091519|585813636|FG001|Overall Study|Randomized not treated|4|||
162208158|NCT00316589|585813639|FG000|Overall Study|Withdrawal by Subject|0|||
162208159|NCT00316589|585813640|FG001|Overall Study|Withdrawal by Subject|5|||
162208160|NCT00316589|585813641|FG002|Overall Study|Withdrawal by Subject|0|||
162208161|NCT00316589|585813642|FG003|Overall Study|Withdrawal by Subject|1|||
162208162|NCT00316589|585813639|FG000|Overall Study|Subject unwilling/unable to comply|0|||
162208163|NCT00316589|585813640|FG001|Overall Study|Subject unwilling/unable to comply|6|||
162208164|NCT00316589|585813641|FG002|Overall Study|Subject unwilling/unable to comply|0|||
162208165|NCT00316589|585813642|FG003|Overall Study|Subject unwilling/unable to comply|2|||
162208166|NCT00316589|585813639|FG000|Overall Study|Adverse Event|1|||
162208167|NCT00316589|585813640|FG001|Overall Study|Adverse Event|0|||
162208168|NCT00316589|585813641|FG002|Overall Study|Adverse Event|0|||
162208169|NCT00316589|585813642|FG003|Overall Study|Adverse Event|1|||
162208170|NCT00316589|585813639|FG000|Overall Study|Physician Decision|0|||
162208171|NCT00316589|585813640|FG001|Overall Study|Physician Decision|1|||
161677545|NCT03945591|583872025|FG000|Overall Study|Adverse Event|1|||
161825526|NCT01332968|584401844|FG005|Maintenance/Observation Period|Death|0|||
161825527|NCT01332968|584401845|FG006|Maintenance/Observation Period|Death|0|||
161825528|NCT01332968|584401846|FG007|Maintenance/Observation Period|Death|0|||
161825529|NCT01332968|584401839|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
161825530|NCT01332968|584401840|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
161825531|NCT01332968|584401841|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
161825532|NCT01332968|584401842|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
161825533|NCT01332968|584401843|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
161825534|NCT01332968|584401844|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
161825535|NCT01332968|584401845|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
161825536|NCT01332968|584401846|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
161825537|NCT01332968|584401839|FG000|Maintenance/Observation Period|Non-compliance|0|||
161825538|NCT01332968|584401840|FG001|Maintenance/Observation Period|Non-compliance|0|||
161825539|NCT01332968|584401841|FG002|Maintenance/Observation Period|Non-compliance|4|||
161825540|NCT01332968|584401842|FG003|Maintenance/Observation Period|Non-compliance|3|||
161825541|NCT01332968|584401843|FG004|Maintenance/Observation Period|Non-compliance|0|||
161825542|NCT01332968|584401844|FG005|Maintenance/Observation Period|Non-compliance|0|||
161825543|NCT01332968|584401845|FG006|Maintenance/Observation Period|Non-compliance|0|||
161825544|NCT01332968|584401846|FG007|Maintenance/Observation Period|Non-compliance|0|||
161825545|NCT01332968|584401839|FG000|Maintenance/Observation Period|Other|0|||
161825546|NCT01332968|584401840|FG001|Maintenance/Observation Period|Other|0|||
161825547|NCT01332968|584401841|FG002|Maintenance/Observation Period|Other|4|||
161825548|NCT01332968|584401842|FG003|Maintenance/Observation Period|Other|7|||
161825549|NCT01332968|584401843|FG004|Maintenance/Observation Period|Other|0|||
161825550|NCT01332968|584401844|FG005|Maintenance/Observation Period|Other|0|||
161825551|NCT01332968|584401845|FG006|Maintenance/Observation Period|Other|0|||
161825552|NCT01332968|584401846|FG007|Maintenance/Observation Period|Other|0|||
161825553|NCT01332968|584401839|FG000|Maintenance/Observation Period|Physician Decision|0|||
161825554|NCT01332968|584401840|FG001|Maintenance/Observation Period|Physician Decision|0|||
161825555|NCT01332968|584401841|FG002|Maintenance/Observation Period|Physician Decision|14|||
161825556|NCT01332968|584401842|FG003|Maintenance/Observation Period|Physician Decision|19|||
161825557|NCT01332968|584401843|FG004|Maintenance/Observation Period|Physician Decision|0|||
161825558|NCT01332968|584401844|FG005|Maintenance/Observation Period|Physician Decision|1|||
161933529|NCT03378635|584804256|FG002|Overall Study|Withdrawal by Subject|0|||
161933530|NCT02413346|584804257|FG000|Overall Study|Adverse Event|6|||
161933531|NCT02413346|584804258|FG001|Overall Study|Adverse Event|6|||
161933532|NCT02413346|584804257|FG000|Overall Study|Withdrawal by Subject|30|||
161933533|NCT02413346|584804258|FG001|Overall Study|Withdrawal by Subject|40|||
161933534|NCT02413346|584804257|FG000|Overall Study|Lost to Follow-up|17|||
161933535|NCT02413346|584804258|FG001|Overall Study|Lost to Follow-up|21|||
161933536|NCT02413346|584804257|FG000|Overall Study|Protocol Violation|2|||
161933537|NCT02413346|584804258|FG001|Overall Study|Protocol Violation|0|||
161933538|NCT02413346|584804257|FG000|Overall Study|Other Miscellaneous Reasons|4|||
161933539|NCT02413346|584804258|FG001|Overall Study|Other Miscellaneous Reasons|3|||
162021315|NCT05091567|585134732|FG000|Randomized Phase|Withdrawal by Subject|0|||
162208172|NCT00316589|585813641|FG002|Overall Study|Physician Decision|0|||
162208173|NCT00316589|585813642|FG003|Overall Study|Physician Decision|0|||
162208174|NCT00316589|585813639|FG000|Overall Study|Other reason|0|||
162208175|NCT00316589|585813640|FG001|Overall Study|Other reason|12|||
162208176|NCT00316589|585813641|FG002|Overall Study|Other reason|1|||
162208177|NCT00316589|585813642|FG003|Overall Study|Other reason|1|||
162208178|NCT01283971|585813645|FG000|Overall Study|Adverse Event|3|||
162208179|NCT01283971|585813646|FG001|Overall Study|Adverse Event|5|||
162208180|NCT01283971|585813645|FG000|Overall Study|Insufficient therapeutic responses|3|||
162208181|NCT01283971|585813646|FG001|Overall Study|Insufficient therapeutic responses|3|||
162208182|NCT01283971|585813645|FG000|Overall Study|Protocol Violation|5|||
162208183|NCT01283971|585813646|FG001|Overall Study|Protocol Violation|1|||
162208184|NCT01283971|585813645|FG000|Overall Study|Refused treatment|3|||
162208185|NCT01283971|585813646|FG001|Overall Study|Refused treatment|1|||
162208186|NCT01283971|585813645|FG000|Overall Study|Failure to return|0|||
162208187|NCT01283971|585813646|FG001|Overall Study|Failure to return|1|||
162208188|NCT01283971|585813645|FG000|Overall Study|Administrative reasons|1|||
162208189|NCT01283971|585813646|FG001|Overall Study|Administrative reasons|1|||
162208190|NCT00562484|585813652|FG000|Overall Study|Adverse Event|6|||
162208191|NCT00562484|585813653|FG001|Overall Study|Adverse Event|1|||
162208192|NCT00562484|585813652|FG000|Overall Study|Protocol Violation|11|||
162208193|NCT00562484|585813653|FG001|Overall Study|Protocol Violation|2|||
162208194|NCT00562484|585813652|FG000|Overall Study|Withdrawal by Subject|12|||
162208195|NCT00562484|585813653|FG001|Overall Study|Withdrawal by Subject|9|||
162208196|NCT00562484|585813652|FG000|Overall Study|Moved away from the study area|20|||
162208197|NCT00562484|585813653|FG001|Overall Study|Moved away from the study area|9|||
162208198|NCT00562484|585813652|FG000|Overall Study|Lost to Follow-up|132|||
162208199|NCT00562484|585813653|FG001|Overall Study|Lost to Follow-up|71|||
162208200|NCT00562484|585813652|FG000|Overall Study|Reason not provided or not specified|25|||
162208201|NCT00562484|585813653|FG001|Overall Study|Reason not provided or not specified|12|||
162208202|NCT02598934|585813657|FG000|Overall Study|Adverse Event|11|||
162208203|NCT02598934|585813658|FG001|Overall Study|Adverse Event|13|||
162208204|NCT02598934|585813657|FG000|Overall Study|Failure to Return|3|||
162208205|NCT02598934|585813658|FG001|Overall Study|Failure to Return|3|||
162208206|NCT02598934|585813657|FG000|Overall Study|Withdrawal by Subject|2|||
162208207|NCT02598934|585813658|FG001|Overall Study|Withdrawal by Subject|3|||
162208208|NCT02598934|585813657|FG000|Overall Study|Administrative|2|||
162208209|NCT02598934|585813658|FG001|Overall Study|Administrative|1|||
162208210|NCT02598934|585813657|FG000|Overall Study|Protocol Violation|1|||
162208211|NCT02598934|585813658|FG001|Overall Study|Protocol Violation|2|||
162208212|NCT00702520|585813660|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
162208213|NCT00702520|585813661|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
162208214|NCT00702520|585813662|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
162208215|NCT00702520|585813663|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
162208216|NCT00702520|585813660|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
162208217|NCT00702520|585813661|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
162208218|NCT00702520|585813662|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
162208219|NCT00702520|585813663|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
162208220|NCT00702520|585813660|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
162208221|NCT00702520|585813661|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
162208222|NCT00702520|585813662|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
162208223|NCT00702520|585813663|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
162208224|NCT02154347|585813664|FG000|Double-blind Period|Adverse Event|1|||
162208225|NCT02154347|585813665|FG001|Double-blind Period|Adverse Event|2|||
162208226|NCT02154347|585813664|FG000|Double-blind Period|Lack of Efficacy|1|||
162208227|NCT02154347|585813665|FG001|Double-blind Period|Lack of Efficacy|0|||
162208228|NCT02154347|585813664|FG000|Double-blind Period|Physician Decision|0|||
162208229|NCT02154347|585813665|FG001|Double-blind Period|Physician Decision|1|||
162208230|NCT02154347|585813664|FG000|Double-blind Period|Withdrawal by Subject|1|||
162208231|NCT02154347|585813665|FG001|Double-blind Period|Withdrawal by Subject|1|||
162208232|NCT02154347|585813664|FG000|Open-label Period|Adverse Event|3|||
162208233|NCT02154347|585813665|FG001|Open-label Period|Adverse Event|4|||
162208234|NCT02154347|585813664|FG000|Open-label Period|Lack of Efficacy|4|||
162021316|NCT05091567|585134733|FG001|Randomized Phase|Withdrawal by Subject|1|||
162021317|NCT05091567|585134734|FG002|Randomized Phase|Withdrawal by Subject|3|||
162208235|NCT02154347|585813665|FG001|Open-label Period|Lack of Efficacy|19|||
162208236|NCT02154347|585813664|FG000|Open-label Period|Protocol Violation|0|||
162208237|NCT02154347|585813665|FG001|Open-label Period|Protocol Violation|1|||
161933540|NCT01835431|584804261|FG000|Overall Study|Adverse Event|1|||
161933541|NCT01835431|584804262|FG001|Overall Study|Adverse Event|0|||
161933542|NCT01835431|584804261|FG000|Overall Study|other|0|||
161933543|NCT01835431|584804262|FG001|Overall Study|other|2|||
161933544|NCT01835431|584804261|FG000|Overall Study|Withdrawal by Subject|6|||
161933545|NCT01835431|584804262|FG001|Overall Study|Withdrawal by Subject|10|||
161933546|NCT01835431|584804261|FG000|Overall Study|Protocol Violation|1|||
161933547|NCT01835431|584804262|FG001|Overall Study|Protocol Violation|0|||
161933548|NCT00562861|584804265|FG000|Overall Study|Adverse Event|1|||
161933549|NCT00562861|584804266|FG001|Overall Study|Adverse Event|1|||
161933550|NCT00562861|584804265|FG000|Overall Study|Lack of Efficacy|5|||
161933551|NCT00562861|584804266|FG001|Overall Study|Lack of Efficacy|5|||
161933552|NCT00562861|584804265|FG000|Overall Study|noncompliance, moved|7|||
161933553|NCT00562861|584804266|FG001|Overall Study|noncompliance, moved|2|||
161933554|NCT00562861|584804265|FG000|Overall Study|Lost to Follow-up|7|||
161933555|NCT00562861|584804266|FG001|Overall Study|Lost to Follow-up|3|||
161933556|NCT00655356|584804269|FG000|Overall Study|Withdrawal by Subject|3|||
161933557|NCT00655356|584804270|FG001|Overall Study|Withdrawal by Subject|4|||
161933558|NCT00655356|584804269|FG000|Overall Study|Sponsor Request|10|||
162208238|NCT02154347|585813664|FG000|Open-label Period|Withdrawal by Subject|0|||
162208239|NCT02154347|585813665|FG001|Open-label Period|Withdrawal by Subject|1|||
162208240|NCT02481934|585813666|FG000|Overall Study|Death|2|||
162208241|NCT02473913|585813667|FG000|Overall Study|Lost to Follow-up|3|||
162208242|NCT02473913|585813668|FG001|Overall Study|Lost to Follow-up|3|||
162208243|NCT02250183|585813674|FG000|Overall Study|Withdrawal by Subject|2|||
162208244|NCT02250183|585813674|FG000|Overall Study|Adverse Event|5|||
162208245|NCT02250183|585813674|FG000|Overall Study|Lost to Follow-up|1|||
162208246|NCT03282799|585813675|FG000|Overall Study|Pregnancy|1|||
162208247|NCT03282799|585813676|FG001|Overall Study|Pregnancy|0|||
162208248|NCT03282799|585813675|FG000|Overall Study|Physician Decision|1|||
162208249|NCT03282799|585813676|FG001|Overall Study|Physician Decision|0|||
162208250|NCT03749616|585813677|FG000|Overall Study|Lost to Follow-up|4|||
162208251|NCT03749616|585813678|FG001|Overall Study|Lost to Follow-up|7|||
162208252|NCT03749616|585813677|FG000|Overall Study|Screen Failure|1|||
162208253|NCT03749616|585813678|FG001|Overall Study|Screen Failure|1|||
161933559|NCT00655356|584804270|FG001|Overall Study|Sponsor Request|4|||
161933560|NCT00655356|584804269|FG000|Overall Study|Adverse Event|1|||
161933561|NCT00655356|584804270|FG001|Overall Study|Adverse Event|1|||
161933562|NCT00655356|584804269|FG000|Overall Study|Protocol Violation|2|||
162208254|NCT03749616|585813677|FG000|Overall Study|Withdrawal by Subject|2|||
162208255|NCT03749616|585813678|FG001|Overall Study|Withdrawal by Subject|0|||
162208256|NCT03440047|585815616|FG000|Overall Study|Withdrawal by Subject|2|||
162208257|NCT01053247|585815622|FG000|Overall Study|Withdrawal by Subject|9|||
162208258|NCT01053247|585815623|FG001|Overall Study|Withdrawal by Subject|4|||
162208259|NCT01053247|585815624|FG002|Overall Study|Withdrawal by Subject|15|||
162208260|NCT01053247|585815622|FG000|Overall Study|Lack of Efficacy|1|||
162208261|NCT01053247|585815623|FG001|Overall Study|Lack of Efficacy|0|||
162208262|NCT01053247|585815624|FG002|Overall Study|Lack of Efficacy|1|||
162208263|NCT01053247|585815622|FG000|Overall Study|Protocol Violation|2|||
162208264|NCT01053247|585815623|FG001|Overall Study|Protocol Violation|1|||
162208265|NCT01053247|585815624|FG002|Overall Study|Protocol Violation|2|||
161825559|NCT01332968|584401845|FG006|Maintenance/Observation Period|Physician Decision|0|||
162208266|NCT01053247|585815622|FG000|Overall Study|Lost to Follow-up|8|||
162208267|NCT01053247|585815623|FG001|Overall Study|Lost to Follow-up|5|||
162208268|NCT01053247|585815624|FG002|Overall Study|Lost to Follow-up|7|||
162208269|NCT01053247|585815622|FG000|Overall Study|Adverse Event|0|||
162208270|NCT01053247|585815623|FG001|Overall Study|Adverse Event|9|||
162208271|NCT01053247|585815624|FG002|Overall Study|Adverse Event|3|||
162208272|NCT03458728|585815625|FG000|Overall Study|Adverse Event|1|||
162208273|NCT03458728|585815626|FG001|Overall Study|Adverse Event|0|||
162208274|NCT03458728|585815625|FG000|Overall Study|Physician Decision|1|||
162208275|NCT03458728|585815626|FG001|Overall Study|Physician Decision|0|||
162208276|NCT03458728|585815625|FG000|Overall Study|Progressive disease - clinical assessment|1|||
162208277|NCT03458728|585815626|FG001|Overall Study|Progressive disease - clinical assessment|0|||
162208278|NCT03458728|585815625|FG000|Overall Study|Progressive disease - radiological progression|21|||
161825560|NCT01332968|584401846|FG007|Maintenance/Observation Period|Physician Decision|0|||
162208279|NCT03458728|585815626|FG001|Overall Study|Progressive disease - radiological progression|6|||
162208280|NCT03458728|585815625|FG000|Overall Study|Withdrawal by Subject|0|||
162208281|NCT03458728|585815626|FG001|Overall Study|Withdrawal by Subject|1|||
162208282|NCT00908349|585815629|FG000|Overall Study|Adverse Event|10|||
162208283|NCT00908349|585815629|FG000|Overall Study|Withdrawal by Subject|9|||
162208284|NCT00908349|585815629|FG000|Overall Study|Physician Decision|5|||
161825561|NCT01332968|584401839|FG000|Maintenance/Observation Period|Progressive Disease|0|||
161825562|NCT01332968|584401840|FG001|Maintenance/Observation Period|Progressive Disease|0|||
161825563|NCT01332968|584401841|FG002|Maintenance/Observation Period|Progressive Disease|72|||
161825564|NCT01332968|584401842|FG003|Maintenance/Observation Period|Progressive Disease|40|||
161825565|NCT01332968|584401843|FG004|Maintenance/Observation Period|Progressive Disease|0|||
161825566|NCT01332968|584401844|FG005|Maintenance/Observation Period|Progressive Disease|0|||
161825567|NCT01332968|584401845|FG006|Maintenance/Observation Period|Progressive Disease|0|||
161825568|NCT01332968|584401846|FG007|Maintenance/Observation Period|Progressive Disease|0|||
161825569|NCT01332968|584401839|FG000|Maintenance/Observation Period|Protocol Violation|0|||
161825570|NCT01332968|584401840|FG001|Maintenance/Observation Period|Protocol Violation|0|||
161825571|NCT01332968|584401841|FG002|Maintenance/Observation Period|Protocol Violation|1|||
161825572|NCT01332968|584401842|FG003|Maintenance/Observation Period|Protocol Violation|1|||
161825573|NCT01332968|584401843|FG004|Maintenance/Observation Period|Protocol Violation|0|||
161825574|NCT01332968|584401844|FG005|Maintenance/Observation Period|Protocol Violation|0|||
161825575|NCT01332968|584401845|FG006|Maintenance/Observation Period|Protocol Violation|0|||
161825576|NCT01332968|584401846|FG007|Maintenance/Observation Period|Protocol Violation|0|||
161825577|NCT01332968|584401839|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
161825578|NCT01332968|584401840|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
161825579|NCT01332968|584401841|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
161825580|NCT01332968|584401842|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
161825581|NCT01332968|584401843|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
161825582|NCT01332968|584401844|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
161825583|NCT01332968|584401845|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
161825584|NCT01332968|584401846|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
161825585|NCT01332968|584401839|FG000|Follow-Up Period|Adverse Event|0|||
161825586|NCT01332968|584401840|FG001|Follow-Up Period|Adverse Event|0|||
161825587|NCT01332968|584401841|FG002|Follow-Up Period|Adverse Event|0|||
161825588|NCT01332968|584401842|FG003|Follow-Up Period|Adverse Event|0|||
161825589|NCT01332968|584401843|FG004|Follow-Up Period|Adverse Event|0|||
161825590|NCT01332968|584401844|FG005|Follow-Up Period|Adverse Event|0|||
161825591|NCT01332968|584401845|FG006|Follow-Up Period|Adverse Event|0|||
161825592|NCT01332968|584401846|FG007|Follow-Up Period|Adverse Event|4|||
161825593|NCT01332968|584401839|FG000|Follow-Up Period|Death|0|||
161825594|NCT01332968|584401840|FG001|Follow-Up Period|Death|0|||
161825595|NCT01332968|584401841|FG002|Follow-Up Period|Death|0|||
161825596|NCT01332968|584401842|FG003|Follow-Up Period|Death|0|||
161825597|NCT01332968|584401843|FG004|Follow-Up Period|Death|0|||
162208285|NCT00908349|585815629|FG000|Overall Study|Lost to Follow-up|5|||
162208286|NCT00908349|585815629|FG000|Overall Study|Various|6|||
162208287|NCT00971997|585815630|FG000|Overall Study|Adverse Event|2|||
162208288|NCT00971997|585815630|FG000|Overall Study|Death|1|||
162208289|NCT00971997|585815630|FG000|Overall Study|Protocol Violation|4|||
162208290|NCT00971997|585815630|FG000|Overall Study|Withdrawal by Subject|5|||
162208291|NCT00971997|585815630|FG000|Overall Study|Physician Decision|7|||
162208292|NCT04843579|585815634|FG000|Overall Study|Adverse Event|1|||
162208293|NCT04843579|585815634|FG000|Overall Study|Disease Progression|1|||
162208294|NCT04009629|585815635|FG000|Overall Study|Withdrawal by Subject|2|||
162208295|NCT04009629|585815636|FG001|Overall Study|Withdrawal by Subject|0|||
162208296|NCT00761956|585815637|FG000|Overall Study|Lost to Follow-up|6|||
162208297|NCT00761956|585815638|FG001|Overall Study|Lost to Follow-up|11|||
162208298|NCT00761956|585815637|FG000|Overall Study|Withdrawal by Subject|3|||
162208299|NCT00761956|585815638|FG001|Overall Study|Withdrawal by Subject|8|||
162208300|NCT00761956|585815637|FG000|Overall Study|Death|0|||
162208301|NCT00761956|585815638|FG001|Overall Study|Death|1|||
162208302|NCT00761956|585815637|FG000|Overall Study|Adverse Event|26|||
162208303|NCT00761956|585815638|FG001|Overall Study|Adverse Event|34|||
162208304|NCT04398368|585815644|FG000|Overall Study|Withdrawal by Subject|2|||
162208305|NCT03602586|585815645|FG000|Overall Study|Withdrawal by Subject|3|||
162208306|NCT00511836|585815648|FG000|Double-blind Period|Lost to Follow-up|1|||
162208307|NCT00511836|585815649|FG001|Double-blind Period|Lost to Follow-up|0|||
162208308|NCT00030823|585815652|FG000|Overall Study|Withdrawal by Subject|1|||
162208309|NCT01755546|585815654|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
162208310|NCT01755546|585815654|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
162208311|NCT01755546|585815654|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
162208312|NCT01755546|585815654|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
162208313|NCT01755546|585815654|FG000|Titration Phase|Adverse Event|11|||
162208314|NCT01755546|585815654|FG000|Titration Phase|Lack of Efficacy|18|||
162208315|NCT01755546|585815654|FG000|Titration Phase|Protocol Violation|9|||
162208316|NCT01755546|585815654|FG000|Titration Phase|Lost to Follow-up|2|||
162208317|NCT01755546|585815654|FG000|Titration Phase|Other and Continuing|22|||
162208318|NCT01755546|585815654|FG000|Titration Phase|Withdrawal by Subject|8|||
162208319|NCT01755546|585815654|FG000|Long Term Treatment|Adverse Event|12|||
162208320|NCT01755546|585815654|FG000|Long Term Treatment|Lack of Efficacy|6|||
162208321|NCT01755546|585815654|FG000|Long Term Treatment|Protocol Violation|10|||
162208322|NCT01755546|585815654|FG000|Long Term Treatment|Withdrawal by Subject|35|||
162208323|NCT01755546|585815654|FG000|Long Term Treatment|Lost to Follow-up|17|||
162208324|NCT01755546|585815654|FG000|Long Term Treatment|other and ongoing|41|||
162208325|NCT00891046|585815659|FG000|Overall Study|Protocol Violation|1|||
162208326|NCT00891046|585815660|FG001|Overall Study|Protocol Violation|1|||
162208327|NCT00891046|585815661|FG002|Overall Study|Protocol Violation|0|||
162208328|NCT00891046|585815662|FG003|Overall Study|Protocol Violation|0|||
161933563|NCT00655356|584804270|FG001|Overall Study|Protocol Violation|1|||
161933564|NCT00655356|584804269|FG000|Overall Study|Other Reason|1|||
161933565|NCT00655356|584804270|FG001|Overall Study|Other Reason|0|||
161933566|NCT01623154|584804273|FG000|Overall Study|Did not drink Pranactin Citric|4|||
161933567|NCT04349098|584804274|FG000|Overall Study|Death|16|||
161933568|NCT04349098|584804275|FG001|Overall Study|Death|8|||
161933569|NCT04349098|584804274|FG000|Overall Study|Lost to Follow-up|11|||
161933570|NCT04349098|584804275|FG001|Overall Study|Lost to Follow-up|8|||
161933571|NCT04349098|584804274|FG000|Overall Study|Withdrawal by Subject|8|||
161933572|NCT04349098|584804275|FG001|Overall Study|Withdrawal by Subject|5|||
161933573|NCT04349098|584804274|FG000|Overall Study|Other|3|||
161933574|NCT04349098|584804275|FG001|Overall Study|Other|5|||
161933575|NCT00800384|584804276|FG000|Overall Study|Withdrawal by Subject|24|||
161933576|NCT00800384|584804277|FG001|Overall Study|Withdrawal by Subject|17|||
161933577|NCT00800384|584804276|FG000|Overall Study|Lost to Follow-up|17|||
161933578|NCT00800384|584804277|FG001|Overall Study|Lost to Follow-up|26|||
161933579|NCT04280783|584806459|FG000|Overall Study|Family issues unrelated to the study.|1|||
161933580|NCT04280783|584806460|FG001|Overall Study|Family issues unrelated to the study.|0|||
161933581|NCT04280783|584806459|FG000|Overall Study|Withdrawal by Subject|0|||
161933582|NCT04280783|584806460|FG001|Overall Study|Withdrawal by Subject|1|||
162208329|NCT00891046|585815663|FG004|Overall Study|Protocol Violation|1|||
162208330|NCT00891046|585815659|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
162208331|NCT00891046|585815660|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162208332|NCT00891046|585815661|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
162208333|NCT00891046|585815662|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
162208334|NCT00891046|585815663|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
162208335|NCT00891046|585815659|FG000|Overall Study|Administrative problems|0|||
162208336|NCT00891046|585815660|FG001|Overall Study|Administrative problems|0|||
162208337|NCT00891046|585815661|FG002|Overall Study|Administrative problems|0|||
162208338|NCT00891046|585815662|FG003|Overall Study|Administrative problems|0|||
162208339|NCT00891046|585815663|FG004|Overall Study|Administrative problems|1|||
162208340|NCT00891046|585815659|FG000|Overall Study|Participant no longer required drug|0|||
161933583|NCT03443401|584806467|FG000|Overall Study|Lost to Follow-up|13|||
161933584|NCT03443401|584806467|FG000|Overall Study|Influential outlier|1|||
161933585|NCT02363283|584806468|FG000|Overall Study|Withdrawal by Subject|1|||
161933586|NCT02363283|584806468|FG000|Overall Study|Not eligible due to transaminitis|1|||
161933587|NCT00530257|584806474|FG000|Overall Study|Lost to Follow-up|1|||
161933588|NCT01394185|584806478|FG000|Overall Study|Withdrawal by Subject|2|||
161933589|NCT01394185|584806479|FG001|Overall Study|Withdrawal by Subject|0|||
161933590|NCT01394185|584806480|FG002|Overall Study|Withdrawal by Subject|0|||
161933591|NCT01394185|584806481|FG003|Overall Study|Withdrawal by Subject|0|||
161933592|NCT01394185|584806482|FG004|Overall Study|Withdrawal by Subject|1|||
161933593|NCT01394185|584806483|FG005|Overall Study|Withdrawal by Subject|0|||
161933594|NCT01394185|584806478|FG000|Overall Study|Change in protocol|3|||
161933595|NCT01394185|584806479|FG001|Overall Study|Change in protocol|0|||
161933596|NCT01394185|584806480|FG002|Overall Study|Change in protocol|0|||
161933597|NCT01394185|584806481|FG003|Overall Study|Change in protocol|0|||
161933598|NCT01394185|584806482|FG004|Overall Study|Change in protocol|3|||
161933599|NCT01394185|584806483|FG005|Overall Study|Change in protocol|0|||
161933600|NCT01394185|584806478|FG000|Overall Study|Protocol Violation|1|||
161933601|NCT01394185|584806479|FG001|Overall Study|Protocol Violation|0|||
161933602|NCT01394185|584806480|FG002|Overall Study|Protocol Violation|0|||
161933603|NCT01394185|584806481|FG003|Overall Study|Protocol Violation|1|||
161933604|NCT01394185|584806482|FG004|Overall Study|Protocol Violation|0|||
161933605|NCT01394185|584806483|FG005|Overall Study|Protocol Violation|1|||
161933606|NCT04110145|584806484|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
161933607|NCT04110145|584806485|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
161933608|NCT04110145|584806486|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
161933609|NCT04110145|584806487|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
161933610|NCT04110145|584806488|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
161933611|NCT05401409|584806489|FG000|Overall Study|Lost to Follow-up|1|||
161933612|NCT05401409|584806490|FG001|Overall Study|Lost to Follow-up|0|||
161933613|NCT02371889|584806491|FG000|Overall Study|Adverse medication effect|11|||
161933614|NCT02371889|584806492|FG001|Overall Study|Adverse medication effect|2|||
161933615|NCT02371889|584806491|FG000|Overall Study|Lost to Follow-up|6|||
161933616|NCT02371889|584806492|FG001|Overall Study|Lost to Follow-up|5|||
161933617|NCT02371889|584806491|FG000|Overall Study|Personal time constraints|2|||
161933618|NCT02371889|584806492|FG001|Overall Study|Personal time constraints|4|||
161933619|NCT02371889|584806491|FG000|Overall Study|Lack of Efficacy|0|||
161933620|NCT02371889|584806492|FG001|Overall Study|Lack of Efficacy|2|||
161933621|NCT02371889|584806491|FG000|Overall Study|Relapse|0|||
161933622|NCT02371889|584806492|FG001|Overall Study|Relapse|1|||
161933623|NCT02410200|584806496|FG000|Overall Study|Adverse Event|2|||
161825598|NCT01332968|584401844|FG005|Follow-Up Period|Death|0|||
161825599|NCT01332968|584401845|FG006|Follow-Up Period|Death|27|||
161825600|NCT01332968|584401846|FG007|Follow-Up Period|Death|30|||
161825601|NCT01332968|584401839|FG000|Follow-Up Period|Lost to Follow-up|0|||
161825602|NCT01332968|584401840|FG001|Follow-Up Period|Lost to Follow-up|0|||
161825603|NCT01332968|584401841|FG002|Follow-Up Period|Lost to Follow-up|0|||
161825604|NCT01332968|584401842|FG003|Follow-Up Period|Lost to Follow-up|0|||
161825605|NCT01332968|584401843|FG004|Follow-Up Period|Lost to Follow-up|0|||
161825606|NCT01332968|584401844|FG005|Follow-Up Period|Lost to Follow-up|0|||
161825607|NCT01332968|584401845|FG006|Follow-Up Period|Lost to Follow-up|11|||
161825608|NCT01332968|584401846|FG007|Follow-Up Period|Lost to Follow-up|15|||
161825609|NCT01332968|584401839|FG000|Follow-Up Period|Non-compliance|0|||
161825610|NCT01332968|584401840|FG001|Follow-Up Period|Non-compliance|0|||
161825611|NCT01332968|584401841|FG002|Follow-Up Period|Non-compliance|0|||
161825612|NCT01332968|584401842|FG003|Follow-Up Period|Non-compliance|0|||
161825613|NCT01332968|584401843|FG004|Follow-Up Period|Non-compliance|0|||
161825614|NCT01332968|584401844|FG005|Follow-Up Period|Non-compliance|0|||
161825615|NCT01332968|584401845|FG006|Follow-Up Period|Non-compliance|4|||
161825616|NCT01332968|584401846|FG007|Follow-Up Period|Non-compliance|9|||
161825617|NCT01332968|584401839|FG000|Follow-Up Period|Other|0|||
161825618|NCT01332968|584401840|FG001|Follow-Up Period|Other|0|||
161825619|NCT01332968|584401841|FG002|Follow-Up Period|Other|0|||
161825620|NCT01332968|584401842|FG003|Follow-Up Period|Other|0|||
161825621|NCT01332968|584401843|FG004|Follow-Up Period|Other|0|||
161825622|NCT01332968|584401844|FG005|Follow-Up Period|Other|0|||
161825623|NCT01332968|584401845|FG006|Follow-Up Period|Other|18|||
161825624|NCT01332968|584401846|FG007|Follow-Up Period|Other|21|||
161825625|NCT01332968|584401839|FG000|Follow-Up Period|Physician Decision|0|||
161825626|NCT01332968|584401840|FG001|Follow-Up Period|Physician Decision|0|||
161825627|NCT01332968|584401841|FG002|Follow-Up Period|Physician Decision|0|||
161825628|NCT01332968|584401842|FG003|Follow-Up Period|Physician Decision|0|||
161825629|NCT01332968|584401843|FG004|Follow-Up Period|Physician Decision|0|||
161825630|NCT01332968|584401844|FG005|Follow-Up Period|Physician Decision|0|||
161825631|NCT01332968|584401845|FG006|Follow-Up Period|Physician Decision|12|||
161825632|NCT01332968|584401846|FG007|Follow-Up Period|Physician Decision|15|||
161825633|NCT01332968|584401839|FG000|Follow-Up Period|Progressive Disease|0|||
161825634|NCT01332968|584401840|FG001|Follow-Up Period|Progressive Disease|0|||
161825635|NCT01332968|584401841|FG002|Follow-Up Period|Progressive Disease|0|||
161933624|NCT00432991|584806497|FG000|Overall Study|Protocol Violation|7|||
161933625|NCT00432991|584806498|FG001|Overall Study|Protocol Violation|12|||
161933626|NCT00363467|584806499|FG000|Overall Study|Physician Decision|1|||
161933627|NCT03160573|584806502|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
161933628|NCT03160573|584806503|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
161933629|NCT03160573|584806504|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
161933630|NCT03160573|584806505|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
161933631|NCT00101400|584806506|FG000|Survival Follow-Up|Alive|7|||
161933632|NCT02715856|584806511|FG000|Overall Study|Software Issues|12|||
161933633|NCT02715856|584806512|FG001|Overall Study|Software Issues|7|||
161933634|NCT02715856|584806511|FG000|Overall Study|Death|6|||
161933635|NCT02715856|584806512|FG001|Overall Study|Death|5|||
161933636|NCT02715856|584806511|FG000|Overall Study|Non- Compliant|0|||
161933637|NCT02715856|584806512|FG001|Overall Study|Non- Compliant|40|||
161933638|NCT02336555|584806513|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161933639|NCT02336555|584806514|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161933640|NCT02336555|584806513|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
161933641|NCT02336555|584806514|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
161933642|NCT02336555|584806513|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
161933643|NCT02336555|584806514|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
161933644|NCT04157738|584806522|FG000|Overall Study|Moved out of state|0|||
161933645|NCT04157738|584806523|FG001|Overall Study|Moved out of state|2|||
161933646|NCT04157738|584806522|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
161933647|NCT04157738|584806523|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
161933648|NCT00309946|584806524|FG000|Overall Study|Withdrawal by Subject|1|||
161933649|NCT02244957|584806525|FG000|Overall Study|Lack of Efficacy|1|||
161933650|NCT02244957|584806526|FG001|Overall Study|Lack of Efficacy|0|||
161933651|NCT01347086|584806527|FG000|Overall Study|failed screening visit|0|||
161933652|NCT01347086|584806528|FG001|Overall Study|failed screening visit|0|||
161933653|NCT01347086|584806529|FG002|Overall Study|failed screening visit|1|||
161933654|NCT01347086|584806530|FG003|Overall Study|failed screening visit|0|||
161933655|NCT01347086|584806531|FG004|Overall Study|failed screening visit|0|||
161933656|NCT01347086|584806532|FG005|Overall Study|failed screening visit|0|||
161933657|NCT01347086|584806533|FG006|Overall Study|failed screening visit|1|||
161933658|NCT01347086|584806534|FG007|Overall Study|failed screening visit|1|||
161933659|NCT01347086|584806535|FG008|Overall Study|failed screening visit|0|||
161933660|NCT01347086|584806536|FG009|Overall Study|failed screening visit|1|||
161933661|NCT02624687|584806539|FG000|Overall Study|Withdrawal by Subject|1|||
161933662|NCT02624687|584806540|FG001|Overall Study|Withdrawal by Subject|1|||
162208341|NCT00891046|585815660|FG001|Overall Study|Participant no longer required drug|2|||
162208342|NCT00891046|585815661|FG002|Overall Study|Participant no longer required drug|0|||
162208343|NCT00891046|585815662|FG003|Overall Study|Participant no longer required drug|0|||
162208344|NCT00891046|585815663|FG004|Overall Study|Participant no longer required drug|1|||
162208345|NCT00891046|585815659|FG000|Overall Study|Adverse Event|4|||
162208346|NCT00891046|585815660|FG001|Overall Study|Adverse Event|3|||
162208347|NCT00891046|585815661|FG002|Overall Study|Adverse Event|2|||
162208348|NCT00891046|585815662|FG003|Overall Study|Adverse Event|0|||
162208349|NCT00891046|585815663|FG004|Overall Study|Adverse Event|14|||
162208350|NCT00891046|585815659|FG000|Overall Study|Withdrawal by Subject|2|||
162208351|NCT00891046|585815660|FG001|Overall Study|Withdrawal by Subject|1|||
162208352|NCT00891046|585815661|FG002|Overall Study|Withdrawal by Subject|2|||
162208353|NCT00891046|585815662|FG003|Overall Study|Withdrawal by Subject|1|||
162208354|NCT00891046|585815663|FG004|Overall Study|Withdrawal by Subject|1|||
162208355|NCT00891046|585815659|FG000|Overall Study|Lost to Follow-up|0|||
162208356|NCT00891046|585815660|FG001|Overall Study|Lost to Follow-up|0|||
162208357|NCT00891046|585815661|FG002|Overall Study|Lost to Follow-up|0|||
162208358|NCT00891046|585815662|FG003|Overall Study|Lost to Follow-up|0|||
162208359|NCT00891046|585815663|FG004|Overall Study|Lost to Follow-up|1|||
162208360|NCT00362375|585815664|FG000|Overall Study|Lost to Follow-up|40|||
162208361|NCT00362375|585815665|FG001|Overall Study|Lost to Follow-up|35|||
162208362|NCT02106195|585815666|FG000|Overall Study|Adverse Event|2|||
162208363|NCT02106195|585815666|FG000|Overall Study|Protocol Violation|1|||
162208364|NCT04984239|585815667|FG000|Overall Study|Lost to Follow-up|1|||
162208365|NCT04702893|585815668|FG000|Overall Study|Other reasons than listed|11|||
162208366|NCT04702893|585815668|FG000|Overall Study|Withdrawal by Subject|3|||
162208367|NCT04702893|585815668|FG000|Overall Study|Lost to Follow-up|7|||
162208368|NCT04702893|585815668|FG000|Overall Study|Death|10|||
162208369|NCT04702893|585815668|FG000|Overall Study|Not treated|6|||
162208370|NCT01114139|585815670|FG000|Overall Study|Adverse Event|3|||
161933663|NCT02624687|584806539|FG000|Overall Study|medical leave from work|0|||
161933664|NCT02624687|584806540|FG001|Overall Study|medical leave from work|1|||
161933665|NCT03111108|584806541|FG000|Overall Study|Death|0|||
161933666|NCT03111108|584806542|FG001|Overall Study|Death|1|||
161933667|NCT03111108|584806541|FG000|Overall Study|Withdrawal by Subject|1|||
161933668|NCT03111108|584806542|FG001|Overall Study|Withdrawal by Subject|0|||
162208371|NCT01114139|585815671|FG001|Overall Study|Adverse Event|2|||
162208372|NCT01114139|585815670|FG000|Overall Study|Lost to Follow-up|15|||
161933669|NCT01514357|584806543|FG000|Overall Study|Screen failure|2|||
161933670|NCT01514357|584806544|FG001|Overall Study|Screen failure|0|||
161933671|NCT01514357|584806543|FG000|Overall Study|Withdrawal by Subject|2|||
161933672|NCT01514357|584806544|FG001|Overall Study|Withdrawal by Subject|0|||
161933673|NCT04691115|584806547|FG000|Overall Study|Withdrawal by Subject|0|||
161933674|NCT04691115|584806548|FG001|Overall Study|Withdrawal by Subject|0|||
161933675|NCT04691115|584806549|FG002|Overall Study|Withdrawal by Subject|0|||
161933676|NCT04691115|584806550|FG003|Overall Study|Withdrawal by Subject|0|||
161933677|NCT04691115|584806551|FG004|Overall Study|Withdrawal by Subject|0|||
161933678|NCT04691115|584806552|FG005|Overall Study|Withdrawal by Subject|1|||
161933679|NCT04691115|584806553|FG006|Overall Study|Withdrawal by Subject|0|||
161933680|NCT04691115|584806554|FG007|Overall Study|Withdrawal by Subject|0|||
161933681|NCT04691115|584806555|FG008|Overall Study|Withdrawal by Subject|0|||
161933682|NCT04691115|584806556|FG009|Overall Study|Withdrawal by Subject|0|||
161933683|NCT04691115|584806557|FG010|Overall Study|Withdrawal by Subject|0|||
161933684|NCT04691115|584806558|FG011|Overall Study|Withdrawal by Subject|0|||
161933685|NCT04691115|584806559|FG012|Overall Study|Withdrawal by Subject|0|||
161933686|NCT04691115|584806560|FG013|Overall Study|Withdrawal by Subject|0|||
161933687|NCT00830336|584806564|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
161933688|NCT00830336|584806565|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
161933689|NCT00867334|584806566|FG000|Overall Study|Withdrawal by Subject|0|||
161933690|NCT00867334|584806567|FG001|Overall Study|Withdrawal by Subject|1|||
161933691|NCT00867334|584806566|FG000|Overall Study|Withdrawal by Subject|1|||
161933692|NCT00867334|584806567|FG001|Overall Study|Withdrawal by Subject|0|||
161933693|NCT00867334|584806566|FG000|Overall Study|Withdrawal by Subject|1|||
161933694|NCT00867334|584806567|FG001|Overall Study|Withdrawal by Subject|0|||
161933695|NCT00347269|584806572|FG000|Overall Study|Lost to Follow-up|74|||
161933696|NCT00347269|584806573|FG001|Overall Study|Lost to Follow-up|65|||
161933697|NCT00347269|584806572|FG000|Overall Study|Withdrawal by Subject|18|||
161933698|NCT00347269|584806573|FG001|Overall Study|Withdrawal by Subject|38|||
161933699|NCT00347269|584806572|FG000|Overall Study|Death|2|||
161933700|NCT00347269|584806573|FG001|Overall Study|Death|3|||
161933701|NCT01689649|584806574|FG000|Overall Study|Lack of Efficacy|3|||
161933702|NCT01689649|584806574|FG000|Overall Study|Non-compliance|11|||
161933703|NCT01689649|584806574|FG000|Overall Study|Protocol Violation|3|||
161933704|NCT01689649|584806574|FG000|Overall Study|Lost to Follow-up|5|||
161933705|NCT04893811|584806575|FG000|Vaccination Phase|Death|1|||
161933706|NCT04893811|584806576|FG001|Vaccination Phase|Death|0|||
161933707|NCT04893811|584806575|FG000|Vaccination Phase|Lost to Follow-up|1|||
161933708|NCT04893811|584806576|FG001|Vaccination Phase|Lost to Follow-up|1|||
161933709|NCT04893811|584806575|FG000|Vaccination Phase|Protocol Violation|2|||
161933710|NCT04893811|584806576|FG001|Vaccination Phase|Protocol Violation|0|||
162208373|NCT01114139|585815671|FG001|Overall Study|Lost to Follow-up|3|||
162208374|NCT01114139|585815670|FG000|Overall Study|Withdrawal by Subject|17|||
162208375|NCT01114139|585815671|FG001|Overall Study|Withdrawal by Subject|6|||
162208376|NCT01114139|585815670|FG000|Overall Study|Other-Missed 1 visit|1|||
162208377|NCT01114139|585815671|FG001|Overall Study|Other-Missed 1 visit|0|||
162208378|NCT01114139|585815670|FG000|Overall Study|Other-Protocol Violation|1|||
162208379|NCT01114139|585815671|FG001|Overall Study|Other-Protocol Violation|0|||
162208380|NCT01114139|585815670|FG000|Overall Study|Other-Out of window for study drug dose|1|||
162208381|NCT01114139|585815671|FG001|Overall Study|Other-Out of window for study drug dose|0|||
162208382|NCT01114139|585815670|FG000|Overall Study|Other-Participant falsified records|0|||
162208383|NCT01114139|585815671|FG001|Overall Study|Other-Participant falsified records|1|||
162208384|NCT01114139|585815670|FG000|Overall Study|Other-Participant went on hospice|0|||
162208385|NCT01114139|585815671|FG001|Overall Study|Other-Participant went on hospice|1|||
162208386|NCT01114139|585815670|FG000|Overall Study|Other-Physician changed treatment|1|||
161933711|NCT04893811|584806575|FG000|Vaccination Phase|Withdrawal by Subject|2|||
161933712|NCT04893811|584806576|FG001|Vaccination Phase|Withdrawal by Subject|1|||
161933713|NCT04893811|584806575|FG000|Vaccination Phase|Other|0|||
161933714|NCT04893811|584806576|FG001|Vaccination Phase|Other|1|||
161933715|NCT04893811|584806575|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
161933716|NCT04893811|584806576|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
161933717|NCT04893811|584806575|FG000|Follow-up Phase|Lost to Follow-up|0|||
161933718|NCT04893811|584806576|FG001|Follow-up Phase|Lost to Follow-up|1|||
161933719|NCT03268499|584806577|FG000|Overall Study|Withdrawal by Subject|2|||
161933720|NCT03268499|584806578|FG001|Overall Study|Withdrawal by Subject|1|||
161933721|NCT01725282|584806583|FG000|Overall Study|Adverse Event|1|||
161933722|NCT01725282|584806584|FG001|Overall Study|Adverse Event|3|||
161933723|NCT01725282|584806585|FG002|Overall Study|Adverse Event|6|||
161933724|NCT01725282|584806586|FG003|Overall Study|Adverse Event|4|||
161933725|NCT01725282|584806583|FG000|Overall Study|Exacerbation of Target Disease|1|||
161933726|NCT01725282|584806584|FG001|Overall Study|Exacerbation of Target Disease|0|||
161933727|NCT01725282|584806585|FG002|Overall Study|Exacerbation of Target Disease|0|||
161933728|NCT01725282|584806586|FG003|Overall Study|Exacerbation of Target Disease|1|||
162208387|NCT01114139|585815671|FG001|Overall Study|Other-Physician changed treatment|0|||
162208388|NCT01114139|585815670|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
161933729|NCT01725282|584806583|FG000|Overall Study|Met Exclusion Criteria|0|||
161933730|NCT01725282|584806584|FG001|Overall Study|Met Exclusion Criteria|0|||
161933731|NCT01725282|584806585|FG002|Overall Study|Met Exclusion Criteria|1|||
161933732|NCT01725282|584806586|FG003|Overall Study|Met Exclusion Criteria|0|||
161933733|NCT01725282|584806583|FG000|Overall Study|Study Site Withdrawal|0|||
161933734|NCT01725282|584806584|FG001|Overall Study|Study Site Withdrawal|1|||
161933735|NCT01725282|584806585|FG002|Overall Study|Study Site Withdrawal|0|||
161933736|NCT01725282|584806586|FG003|Overall Study|Study Site Withdrawal|0|||
161933737|NCT01725282|584806583|FG000|Overall Study|Withdrawal by Subject|0|||
161933738|NCT01725282|584806584|FG001|Overall Study|Withdrawal by Subject|0|||
161933739|NCT01725282|584806585|FG002|Overall Study|Withdrawal by Subject|1|||
161933740|NCT01725282|584806586|FG003|Overall Study|Withdrawal by Subject|1|||
161933741|NCT01725282|584806583|FG000|Overall Study|Lack of Efficacy|0|||
161933742|NCT01725282|584806584|FG001|Overall Study|Lack of Efficacy|1|||
161933743|NCT01725282|584806585|FG002|Overall Study|Lack of Efficacy|0|||
161933744|NCT01725282|584806586|FG003|Overall Study|Lack of Efficacy|1|||
161933745|NCT04064567|584806587|FG000|Overall Study|Lost to Follow-up|23|||
161933746|NCT04064567|584806588|FG001|Overall Study|Lost to Follow-up|22|||
161933747|NCT04064567|584806587|FG000|Overall Study|Withdrawal by Subject|0|||
161933748|NCT04064567|584806588|FG001|Overall Study|Withdrawal by Subject|1|||
161933749|NCT04064567|584806587|FG000|Overall Study|Reincarcerated|7|||
161933750|NCT04064567|584806588|FG001|Overall Study|Reincarcerated|10|||
161933751|NCT04064567|584806587|FG000|Overall Study|Moved out of U.S.|0|||
161933752|NCT04064567|584806588|FG001|Overall Study|Moved out of U.S.|1|||
161933753|NCT05071027|584806589|FG000|Overall Study|Lost to Follow-up|1|||
161933754|NCT05071027|584806590|FG001|Overall Study|Lost to Follow-up|4|||
161933755|NCT04576481|584806591|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
161933756|NCT04576481|584806592|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
161933757|NCT04576481|584806593|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
161933758|NCT04576481|584806594|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
161933759|NCT03464461|584806600|FG000|Overall Study|exclusionary medication given ,|1|||
161933760|NCT03464461|584806601|FG001|Overall Study|exclusionary medication given ,|2|||
161933761|NCT03464461|584806602|FG002|Overall Study|exclusionary medication given ,|0|||
161933762|NCT03464461|584806600|FG000|Overall Study|Physician Decision|0|||
161933763|NCT03464461|584806601|FG001|Overall Study|Physician Decision|1|||
161933764|NCT03464461|584806602|FG002|Overall Study|Physician Decision|0|||
161933765|NCT05524948|584806603|FG000|Overall Study|Withdrawal by Subject|1|||
161933766|NCT05524948|584806604|FG001|Overall Study|Withdrawal by Subject|0|||
161933767|NCT05524948|584806603|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
161933768|NCT05524948|584806604|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
161933769|NCT05463952|584806605|FG000|Treatment|Progressive disease|4|||
161933770|NCT05463952|584806605|FG000|Treatment|Ongoing|2|||
161933771|NCT02739828|584806607|FG000|Overall Study|Adverse Event|1|||
161933772|NCT02739828|584806607|FG000|Overall Study|Lost to Follow-up|4|||
161933773|NCT04191733|584806609|FG000|Overall Study|Withdrawn due to study closure|13|||
161933774|NCT04191733|584806610|FG001|Overall Study|Withdrawn due to study closure|14|||
161933775|NCT04191733|584806609|FG000|Overall Study|Withdrawal by Subject|2|||
161933776|NCT04191733|584806610|FG001|Overall Study|Withdrawal by Subject|4|||
161933777|NCT04191733|584806609|FG000|Overall Study|Physician Decision|1|||
161933778|NCT04191733|584806610|FG001|Overall Study|Physician Decision|1|||
161933779|NCT04191733|584806609|FG000|Overall Study|Lost to Follow-up|5|||
161933780|NCT04191733|584806610|FG001|Overall Study|Lost to Follow-up|6|||
161933781|NCT04191733|584806609|FG000|Overall Study|Death|0|||
161933782|NCT04191733|584806610|FG001|Overall Study|Death|1|||
161677546|NCT00041080|583872026|FG000|Overall Study|Adverse Event|21|||
161677547|NCT00041080|583872027|FG001|Overall Study|Adverse Event|1|||
161677548|NCT00041080|583872026|FG000|Overall Study|Withdrawal by Subject|6|||
161677549|NCT00041080|583872027|FG001|Overall Study|Withdrawal by Subject|6|||
161677550|NCT00041080|583872026|FG000|Overall Study|Concommitant Illness/Other|1|||
161677551|NCT00041080|583872027|FG001|Overall Study|Concommitant Illness/Other|2|||
161933783|NCT02202577|584806613|FG000|Overall Study|Lost to Follow-up|6|||
161933784|NCT02202577|584806614|FG001|Overall Study|Lost to Follow-up|16|||
161933785|NCT02202577|584806613|FG000|Overall Study|Protocol Violation|7|||
161933786|NCT02202577|584806614|FG001|Overall Study|Protocol Violation|3|||
161933787|NCT01646216|584806615|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
161933788|NCT01646216|584806616|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
161933789|NCT01646216|584806615|FG000|Overall Study|Did not complete training|0|||
162021318|NCT05091567|585134732|FG000|Randomized Phase|Lost to Follow-up|0|||
161933790|NCT01646216|584806616|FG001|Overall Study|Did not complete training|2|||
161933791|NCT01646216|584806615|FG000|Overall Study|Investigator decision|1|||
161933792|NCT01646216|584806616|FG001|Overall Study|Investigator decision|1|||
161933793|NCT01514422|584806617|FG000|Overall Study|Lost to Follow-up|1|||
161933794|NCT03511209|584806618|FG000|Overall Study|Withdrawal by Subject|2|||
161933795|NCT03511209|584806619|FG001|Overall Study|Withdrawal by Subject|4|||
161677552|NCT00041080|583872026|FG000|Overall Study|Did not start therapy|1|||
161677553|NCT00041080|583872027|FG001|Overall Study|Did not start therapy|1|||
161933796|NCT03511209|584806618|FG000|Overall Study|Death|1|||
161933797|NCT03511209|584806619|FG001|Overall Study|Death|0|||
161933798|NCT03511209|584806618|FG000|Overall Study|Lost to Follow-up|0|||
161933799|NCT03511209|584806619|FG001|Overall Study|Lost to Follow-up|2|||
161933800|NCT02757963|584806622|FG000|Overall Study|Adverse Event|3|||
161933801|NCT02757963|584806622|FG000|Overall Study|Reached Stopping Criteria|1054|||
161933802|NCT02757963|584806622|FG000|Overall Study|Lost to Follow-up|5|||
161933803|NCT02757963|584806622|FG000|Overall Study|Physician Decision|1|||
161933804|NCT02757963|584806622|FG000|Overall Study|Withdrawal by Subject|34|||
161933805|NCT03769467|584806623|FG000|Overall Study|Adverse Event|1|||
161933806|NCT03769467|584806624|FG001|Overall Study|Adverse Event|1|||
161933807|NCT03769467|584806625|FG002|Overall Study|Adverse Event|0|||
161933808|NCT03769467|584806623|FG000|Overall Study|Death|3|||
161933809|NCT03769467|584806624|FG001|Overall Study|Death|3|||
161933810|NCT03769467|584806625|FG002|Overall Study|Death|0|||
161933811|NCT03769467|584806623|FG000|Overall Study|Study Terminated By Sponsor|2|||
161933812|NCT03769467|584806624|FG001|Overall Study|Study Terminated By Sponsor|1|||
161933813|NCT03769467|584806625|FG002|Overall Study|Study Terminated By Sponsor|0|||
161933814|NCT03769467|584806623|FG000|Overall Study|Withdrawal by Subject|0|||
161933815|NCT03769467|584806624|FG001|Overall Study|Withdrawal by Subject|1|||
161933816|NCT03769467|584806625|FG002|Overall Study|Withdrawal by Subject|0|||
161933817|NCT01887600|584806626|FG000|Overall Study|Death|39|||
161933818|NCT01887600|584806627|FG001|Overall Study|Death|16|||
161933819|NCT01887600|584806626|FG000|Overall Study|Lack of Efficacy|3|||
162208389|NCT01114139|585815671|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
162208390|NCT01951378|585815672|FG000|Overall Study|Study Terminated-Not completed|23|||
161933820|NCT01887600|584806627|FG001|Overall Study|Lack of Efficacy|26|||
161933821|NCT01887600|584806626|FG000|Overall Study|Lost to Follow-up|5|||
161933822|NCT01887600|584806627|FG001|Overall Study|Lost to Follow-up|1|||
161933823|NCT01887600|584806626|FG000|Overall Study|Physician Decision|7|||
161933824|NCT01887600|584806627|FG001|Overall Study|Physician Decision|8|||
161933825|NCT01887600|584806626|FG000|Overall Study|Protocol Deviation|3|||
161933826|NCT01887600|584806627|FG001|Overall Study|Protocol Deviation|0|||
161933827|NCT01887600|584806626|FG000|Overall Study|Withdrawal by Subject|58|||
161933828|NCT01887600|584806627|FG001|Overall Study|Withdrawal by Subject|52|||
161933829|NCT01887600|584806626|FG000|Overall Study|Adverse Event|21|||
162208391|NCT01951378|585815673|FG001|Overall Study|Study Terminated-Not completed|17|||
162208392|NCT00477464|585815675|FG000|Overall Study|Lost to Follow-up|1|||
162208393|NCT00477464|585815675|FG000|Overall Study|Death|36|||
161933830|NCT01887600|584806627|FG001|Overall Study|Adverse Event|9|||
161933831|NCT01887600|584806626|FG000|Overall Study|Non-compliance with study drug|3|||
161933832|NCT01887600|584806627|FG001|Overall Study|Non-compliance with study drug|0|||
161933833|NCT01887600|584806626|FG000|Overall Study|Miscellaneous|6|||
161933834|NCT01887600|584806627|FG001|Overall Study|Miscellaneous|2|||
161933835|NCT01887600|584806626|FG000|Overall Study|Progressive Disease|1|||
161933836|NCT01887600|584806627|FG001|Overall Study|Progressive Disease|0|||
161933837|NCT03688139|584806628|FG000|Overall Study|Lost to Follow-up|2|||
161933838|NCT03688139|584806629|FG001|Overall Study|Lost to Follow-up|0|||
161933839|NCT03688139|584806628|FG000|Overall Study|Physician Decision|0|||
161933840|NCT03688139|584806629|FG001|Overall Study|Physician Decision|1|||
161933841|NCT03688139|584806628|FG000|Overall Study|Withdrawal by Subject|2|||
161933842|NCT03688139|584806629|FG001|Overall Study|Withdrawal by Subject|3|||
161933843|NCT00127933|584806630|FG000|Overall Study|Randomized but not dosed|1|||
161933844|NCT00127933|584806631|FG001|Overall Study|Randomized but not dosed|0|||
161933845|NCT00498485|584806632|FG000|Overall Study|Adverse Event|1|||
161933846|NCT00498485|584806633|FG001|Overall Study|Adverse Event|5|||
161933847|NCT00452400|584806634|FG000|Overall Study|Adverse Event|1|||
161933848|NCT00452400|584806635|FG001|Overall Study|Adverse Event|1|||
161933849|NCT00452400|584806636|FG002|Overall Study|Adverse Event|5|||
161933850|NCT00452400|584806637|FG003|Overall Study|Adverse Event|0|||
161933851|NCT00452400|584806638|FG004|Overall Study|Adverse Event|2|||
161933852|NCT00452400|584806634|FG000|Overall Study|Protocol Violation|0|||
162208394|NCT00477464|585815675|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
162208395|NCT03568812|585815676|FG000|Overall Study|Physician Decision|0|||
161933853|NCT00452400|584806635|FG001|Overall Study|Protocol Violation|0|||
161933854|NCT00452400|584806636|FG002|Overall Study|Protocol Violation|1|||
161933855|NCT00452400|584806637|FG003|Overall Study|Protocol Violation|0|||
161933856|NCT00452400|584806638|FG004|Overall Study|Protocol Violation|0|||
161933857|NCT00452400|584806634|FG000|Overall Study|Lost to Follow-up|1|||
161933858|NCT00452400|584806635|FG001|Overall Study|Lost to Follow-up|0|||
161933859|NCT00452400|584806636|FG002|Overall Study|Lost to Follow-up|0|||
161933860|NCT00452400|584806637|FG003|Overall Study|Lost to Follow-up|0|||
161933861|NCT00452400|584806638|FG004|Overall Study|Lost to Follow-up|0|||
161933862|NCT00452400|584806634|FG000|Overall Study|Withdrawal by Subject|1|||
161933863|NCT00452400|584806635|FG001|Overall Study|Withdrawal by Subject|0|||
161933864|NCT00452400|584806636|FG002|Overall Study|Withdrawal by Subject|1|||
161933865|NCT00452400|584806637|FG003|Overall Study|Withdrawal by Subject|0|||
162208396|NCT03568812|585815677|FG001|Overall Study|Physician Decision|1|||
162021319|NCT05091567|585134733|FG001|Randomized Phase|Lost to Follow-up|1|||
162021320|NCT05091567|585134734|FG002|Randomized Phase|Lost to Follow-up|1|||
162021321|NCT05091567|585134732|FG000|Randomized Phase|Ongoing in Study|0|||
161933866|NCT00452400|584806638|FG004|Overall Study|Withdrawal by Subject|0|||
161933867|NCT00452400|584806634|FG000|Overall Study|Lack of Efficacy|2|||
161933868|NCT00452400|584806635|FG001|Overall Study|Lack of Efficacy|0|||
161933869|NCT00452400|584806636|FG002|Overall Study|Lack of Efficacy|0|||
161933870|NCT00452400|584806637|FG003|Overall Study|Lack of Efficacy|0|||
161933871|NCT00452400|584806638|FG004|Overall Study|Lack of Efficacy|0|||
161933872|NCT00452400|584806634|FG000|Overall Study|Other reasons not listed above|0|||
161933873|NCT00452400|584806635|FG001|Overall Study|Other reasons not listed above|0|||
161933874|NCT00452400|584806636|FG002|Overall Study|Other reasons not listed above|0|||
161933875|NCT00452400|584806637|FG003|Overall Study|Other reasons not listed above|1|||
161933876|NCT00452400|584806638|FG004|Overall Study|Other reasons not listed above|1|||
161933877|NCT01943825|584806639|FG000|Overall Study|Lost to Follow-up|9|||
161933878|NCT01943825|584806640|FG001|Overall Study|Lost to Follow-up|3|||
161933879|NCT01943825|584806641|FG002|Overall Study|Lost to Follow-up|12|||
161933880|NCT01943825|584806642|FG003|Overall Study|Lost to Follow-up|8|||
161933881|NCT01943825|584806639|FG000|Overall Study|Withdrawal by Subject|1|||
161933882|NCT01943825|584806640|FG001|Overall Study|Withdrawal by Subject|0|||
161933883|NCT01943825|584806641|FG002|Overall Study|Withdrawal by Subject|3|||
161933884|NCT01943825|584806642|FG003|Overall Study|Withdrawal by Subject|2|||
161933885|NCT01943825|584806639|FG000|Overall Study|Other than specified above|0|||
161933886|NCT01943825|584806640|FG001|Overall Study|Other than specified above|1|||
161933887|NCT01943825|584806641|FG002|Overall Study|Other than specified above|0|||
161933888|NCT01943825|584806642|FG003|Overall Study|Other than specified above|1|||
161933889|NCT01472835|584806645|FG000|Overall Study|Lost to Follow-up|2|||
161933890|NCT01472835|584806646|FG001|Overall Study|Lost to Follow-up|0|||
161933891|NCT01316900|584806663|FG000|Overall Study|Adverse Event|10|||
161933892|NCT01316900|584806664|FG001|Overall Study|Adverse Event|10|||
161933893|NCT01316900|584806665|FG002|Overall Study|Adverse Event|15|||
161933894|NCT01316900|584806666|FG003|Overall Study|Adverse Event|9|||
161933895|NCT01316900|584806663|FG000|Overall Study|Lack of Efficacy|17|||
161933896|NCT01316900|584806664|FG001|Overall Study|Lack of Efficacy|9|||
161933897|NCT01316900|584806665|FG002|Overall Study|Lack of Efficacy|5|||
161933898|NCT01316900|584806666|FG003|Overall Study|Lack of Efficacy|7|||
161933899|NCT01316900|584806663|FG000|Overall Study|Protocol Violation|7|||
161933900|NCT01316900|584806664|FG001|Overall Study|Protocol Violation|1|||
161933901|NCT01316900|584806665|FG002|Overall Study|Protocol Violation|4|||
161933902|NCT01316900|584806666|FG003|Overall Study|Protocol Violation|0|||
161933903|NCT01316900|584806663|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
161933904|NCT01316900|584806664|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
161933905|NCT01316900|584806665|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
161933906|NCT01316900|584806666|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
161933907|NCT01316900|584806663|FG000|Overall Study|Lost to Follow-up|1|||
161933908|NCT01316900|584806664|FG001|Overall Study|Lost to Follow-up|0|||
161933909|NCT01316900|584806665|FG002|Overall Study|Lost to Follow-up|1|||
161933910|NCT01316900|584806666|FG003|Overall Study|Lost to Follow-up|1|||
161933911|NCT01316900|584806663|FG000|Overall Study|Withdrawal by Subject|7|||
162021322|NCT05091567|585134733|FG001|Randomized Phase|Ongoing in Study|102|||
162021323|NCT05091567|585134734|FG002|Randomized Phase|Ongoing in Study|126|||
162021324|NCT01217307|585134735|FG000|Overall Study|Withdrawal by Subject|0|||
162021325|NCT01217307|585134736|FG001|Overall Study|Withdrawal by Subject|1|||
162021326|NCT01696929|585134739|FG000|Overall Study|Physician Decision|1|||
162021327|NCT01129583|585134741|FG000|Overall Study|Death|1|||
162021328|NCT01129583|585134742|FG001|Overall Study|Death|0|||
162021329|NCT01129583|585134741|FG000|Overall Study|Lost to Follow-up|1|||
162021330|NCT01129583|585134742|FG001|Overall Study|Lost to Follow-up|1|||
162021331|NCT01129583|585134741|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
162021332|NCT01129583|585134742|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
161933912|NCT01316900|584806664|FG001|Overall Study|Withdrawal by Subject|8|||
161933913|NCT01316900|584806665|FG002|Overall Study|Withdrawal by Subject|6|||
161933914|NCT01316900|584806666|FG003|Overall Study|Withdrawal by Subject|9|||
161933915|NCT05346640|584806667|FG000|Overall Study|Lack of Efficacy|2|||
161933916|NCT05346640|584806667|FG000|Overall Study|Lost to Follow-up|14|||
161933917|NCT05346640|584806667|FG000|Overall Study|Protocol Violation|4|||
161933918|NCT05346640|584806667|FG000|Overall Study|Withdrawal by Subject|2|||
161933919|NCT05346640|584806667|FG000|Overall Study|Physiological Complications|3|||
161933920|NCT05346640|584806667|FG000|Overall Study|Other Reason|3|||
161933921|NCT01703221|584806668|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
161933922|NCT01703221|584806669|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
161933923|NCT01703221|584806670|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161933924|NCT01703221|584806668|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
161933925|NCT01703221|584806669|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
161933926|NCT01703221|584806670|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
161933927|NCT01703221|584806668|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
161933928|NCT01703221|584806669|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161933929|NCT01703221|584806670|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161933930|NCT01703221|584806668|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
161933931|NCT01703221|584806669|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161933932|NCT01703221|584806670|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
161933933|NCT01703221|584806668|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161933934|NCT01703221|584806669|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161933935|NCT01703221|584806670|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
161933936|NCT01703221|584806668|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
161933937|NCT01703221|584806669|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
161933938|NCT01703221|584806670|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
161933939|NCT01703221|584806668|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
161933940|NCT01703221|584806669|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
161933941|NCT01703221|584806670|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
162208397|NCT00639769|585815679|FG000|Overall Study|Death|2|||
162208398|NCT00639769|585815679|FG000|Overall Study|Adverse Event|7|||
162208399|NCT00639769|585815679|FG000|Overall Study|Lack of Efficacy|1|||
162208400|NCT00639769|585815679|FG000|Overall Study|Disease progression|26|||
162208401|NCT00639769|585815679|FG000|Overall Study|Withdrawal by Subject|4|||
162208402|NCT00634842|585815680|FG000|Overall Study|Adverse Event|2|||
162208403|NCT00634842|585815681|FG001|Overall Study|Adverse Event|3|||
161933942|NCT01703221|584806668|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
161933943|NCT01703221|584806669|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
161933944|NCT01703221|584806670|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
161933945|NCT01152385|584806671|FG000|Overall Study|Withdrawal by Subject|3|||
161933946|NCT01152385|584806672|FG001|Overall Study|Withdrawal by Subject|1|||
161933947|NCT01152385|584806673|FG002|Overall Study|Withdrawal by Subject|1|||
161933948|NCT01152385|584806674|FG003|Overall Study|Withdrawal by Subject|1|||
161933949|NCT01152385|584806671|FG000|Overall Study|Protocol Violation|0|||
161933950|NCT01152385|584806672|FG001|Overall Study|Protocol Violation|0|||
161933951|NCT01152385|584806673|FG002|Overall Study|Protocol Violation|0|||
161933952|NCT01152385|584806674|FG003|Overall Study|Protocol Violation|1|||
161933953|NCT01152385|584806671|FG000|Overall Study|Adverse Event|1|||
161933954|NCT01152385|584806672|FG001|Overall Study|Adverse Event|1|||
161933955|NCT01152385|584806673|FG002|Overall Study|Adverse Event|0|||
161933956|NCT01152385|584806674|FG003|Overall Study|Adverse Event|0|||
161933957|NCT01152385|584806671|FG000|Overall Study|Study-specific withdrawal criteria|1|||
161933958|NCT01152385|584806672|FG001|Overall Study|Study-specific withdrawal criteria|1|||
161933959|NCT01152385|584806673|FG002|Overall Study|Study-specific withdrawal criteria|2|||
161933960|NCT01152385|584806674|FG003|Overall Study|Study-specific withdrawal criteria|0|||
161933961|NCT01152385|584806671|FG000|Overall Study|Other|4|||
161933962|NCT01152385|584806672|FG001|Overall Study|Other|3|||
161933963|NCT01152385|584806673|FG002|Overall Study|Other|2|||
161933964|NCT01152385|584806674|FG003|Overall Study|Other|3|||
161933965|NCT03927846|584806677|FG000|Overall Study|Lost to Follow-up|10|||
161933966|NCT03927846|584806678|FG001|Overall Study|Lost to Follow-up|11|||
161933967|NCT03061214|584806681|FG000|Overall Study|Withdrawal by Subject|21|||
161933968|NCT03061214|584806682|FG001|Overall Study|Withdrawal by Subject|26|||
161933969|NCT03061214|584806683|FG002|Overall Study|Withdrawal by Subject|9|||
161933970|NCT03061214|584806681|FG000|Overall Study|Lost to Follow-up|3|||
161933971|NCT03061214|584806682|FG001|Overall Study|Lost to Follow-up|1|||
161933972|NCT03061214|584806683|FG002|Overall Study|Lost to Follow-up|1|||
161933973|NCT03061214|584806681|FG000|Overall Study|Death|1|||
161933974|NCT03061214|584806682|FG001|Overall Study|Death|1|||
161933975|NCT03061214|584806683|FG002|Overall Study|Death|0|||
161933976|NCT05130281|584808353|FG000|Overall Study|Withdrawal by Subject|0|||
161933977|NCT05130281|584808354|FG001|Overall Study|Withdrawal by Subject|0|||
161933978|NCT05130281|584808355|FG002|Overall Study|Withdrawal by Subject|1|||
161933979|NCT06844812|584808356|FG000|Overall Study|Lost to Follow-up|5|||
161933980|NCT06844812|584808356|FG000|Overall Study|stigmatization concerns|2|||
161933981|NCT06844812|584808356|FG000|Overall Study|medication refusal|2|||
161933982|NCT06844812|584808356|FG000|Overall Study|concerns about possible side effects|2|||
161933983|NCT06844812|584808356|FG000|Overall Study|wanting to seek another specialist opinion|2|||
161933984|NCT06844812|584808356|FG000|Overall Study|side effects (dizziness)|1|||
161933985|NCT05520333|584808360|FG000|Overall Study|Lost to Follow-up|3|||
161933986|NCT05520333|584808361|FG001|Overall Study|Lost to Follow-up|6|||
161933987|NCT05069415|584808367|FG000|Overall Study|Withdrawal by Subject|2|||
161933988|NCT05069415|584808368|FG001|Overall Study|Withdrawal by Subject|0|||
161933989|NCT05069415|584808367|FG000|Overall Study|Adverse Event|2|||
161933990|NCT05069415|584808368|FG001|Overall Study|Adverse Event|0|||
161933991|NCT03701074|584808369|FG000|Overall Study|Physician Decision|1|||
161933992|NCT03701074|584808370|FG001|Overall Study|Physician Decision|0|||
161933993|NCT01661595|584808371|FG000|Phase 1: Week 0-4|Adverse Event|1|||
162208404|NCT00634842|585815680|FG000|Overall Study|Protocol Violation|8|||
162208405|NCT00634842|585815681|FG001|Overall Study|Protocol Violation|4|||
162208406|NCT00634842|585815680|FG000|Overall Study|Move to another state|1|||
161933994|NCT01661595|584808372|FG001|Phase 1: Week 0-4|Adverse Event|0|||
161933995|NCT01661595|584808373|FG002|Phase 1: Week 0-4|Adverse Event|0|||
161933996|NCT01661595|584808374|FG003|Phase 1: Week 0-4|Adverse Event|0|||
161933997|NCT01661595|584808371|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
161933998|NCT01661595|584808372|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
161933999|NCT01661595|584808373|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
161934000|NCT01661595|584808374|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
161934001|NCT01500135|584808375|FG000|Overall Study|Withdrawal of Consent|4|||
161934002|NCT01500135|584808376|FG001|Overall Study|Withdrawal of Consent|0|||
161934003|NCT01500135|584808375|FG000|Overall Study|Lost to Follow-up|6|||
161934004|NCT01500135|584808376|FG001|Overall Study|Lost to Follow-up|4|||
161934005|NCT01500135|584808375|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
161934006|NCT01500135|584808376|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
161934007|NCT01500135|584808375|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
161934008|NCT01500135|584808376|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
161934009|NCT01500135|584808375|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
161934010|NCT01500135|584808376|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
161934011|NCT01500135|584808375|FG000|Overall Study|Participant was a Safety Concern|1|||
161934012|NCT01500135|584808376|FG001|Overall Study|Participant was a Safety Concern|0|||
161934013|NCT01500135|584808375|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
161934014|NCT01500135|584808376|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
161934015|NCT00661687|584808377|FG000|Overall Study|Study related symptoms and complaints|5|||
161934016|NCT00661687|584808377|FG000|Overall Study|Positive slit lamp findings|4|||
161934017|NCT00661687|584808377|FG000|Overall Study|Inability to maintain wearing schedule|3|||
161934018|NCT00661687|584808377|FG000|Overall Study|Physician Decision|1|||
161934019|NCT00661687|584808377|FG000|Overall Study|Adverse Event|2|||
161934020|NCT00912509|584808378|FG000|Overall Study|Lost to Follow-up|1|||
161934021|NCT00912509|584808379|FG001|Overall Study|Lost to Follow-up|0|||
161934022|NCT00912509|584808378|FG000|Overall Study|Lack of Efficacy|4|||
161934023|NCT00912509|584808379|FG001|Overall Study|Lack of Efficacy|3|||
161934024|NCT05538728|584808380|FG000|Overall Study|Withdrawal by Subject|1|||
161934025|NCT05538728|584808381|FG001|Overall Study|Withdrawal by Subject|1|||
161934026|NCT01362530|584808383|FG000|Base Study (Cycle 1)|Adverse Event|2|||
161934027|NCT01362530|584808384|FG001|Base Study (Cycle 1)|Adverse Event|0|||
161934028|NCT01362530|584808383|FG000|Base Study (Cycle 1)|Physician Decision|0|||
161934029|NCT01362530|584808384|FG001|Base Study (Cycle 1)|Physician Decision|1|||
161934030|NCT01362530|584808383|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
161934031|NCT01362530|584808384|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
161934032|NCT01362530|584808383|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
161934033|NCT01362530|584808384|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
161934034|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
161934035|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
162208407|NCT00634842|585815681|FG001|Overall Study|Move to another state|0|||
162208408|NCT00634842|585815680|FG000|Overall Study|Inclusion criteria were not met|1|||
162208409|NCT00634842|585815681|FG001|Overall Study|Inclusion criteria were not met|0|||
162208410|NCT00634842|585815680|FG000|Overall Study|Lost to Follow-up|1|||
162208411|NCT00634842|585815681|FG001|Overall Study|Lost to Follow-up|2|||
162208412|NCT00634842|585815680|FG000|Overall Study|Physician Decision|1|||
162208413|NCT00634842|585815681|FG001|Overall Study|Physician Decision|0|||
162208414|NCT00634842|585815680|FG000|Overall Study|Withdrawal by Subject|1|||
162208415|NCT00634842|585815681|FG001|Overall Study|Withdrawal by Subject|3|||
162208416|NCT00634842|585815680|FG000|Overall Study|Lack of time and intolerance to drug|0|||
162208417|NCT00634842|585815681|FG001|Overall Study|Lack of time and intolerance to drug|1|||
162208418|NCT00634842|585815680|FG000|Overall Study|Discontinued due to injection|0|||
162208419|NCT00634842|585815681|FG001|Overall Study|Discontinued due to injection|2|||
162208420|NCT00634842|585815680|FG000|Overall Study|No need of study drug to treat diabetes|0|||
162208421|NCT00634842|585815681|FG001|Overall Study|No need of study drug to treat diabetes|1|||
162208422|NCT00634842|585815680|FG000|Overall Study|No wish to keep taking Avandia|0|||
162208423|NCT00634842|585815681|FG001|Overall Study|No wish to keep taking Avandia|1|||
162208424|NCT00634842|585815680|FG000|Overall Study|Subject off study drug for too long|0|||
162208425|NCT00634842|585815681|FG001|Overall Study|Subject off study drug for too long|1|||
162208426|NCT03294941|585815682|FG000|Overall Study|Withdrawal by Subject|0|||
162208427|NCT03294941|585815683|FG001|Overall Study|Withdrawal by Subject|2|||
161934036|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
161934037|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
161934038|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
161934039|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
161934040|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
162208428|NCT04629443|585815684|FG000|Overall Study|Adverse Event|2|||
162208429|NCT04629443|585815685|FG001|Overall Study|Adverse Event|1|||
162208430|NCT04629443|585815686|FG002|Overall Study|Adverse Event|2|||
161934041|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
161934042|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
161934043|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
161934044|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
161934045|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
161934046|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
161934047|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
161934048|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
161934049|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
161934050|NCT01362530|584808383|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
161934051|NCT01362530|584808384|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
161934052|NCT01517178|584808385|FG000|Period 1|Adverse Event|1|||
161934053|NCT01517178|584808386|FG001|Period 1|Adverse Event|2|||
161934054|NCT01517178|584808385|FG000|Period 1|Lack of Efficacy|0|||
161934055|NCT01517178|584808386|FG001|Period 1|Lack of Efficacy|1|||
161934056|NCT01517178|584808385|FG000|Period 1|E.g. study termination|3|||
161934057|NCT01517178|584808386|FG001|Period 1|E.g. study termination|1|||
161934058|NCT01517178|584808385|FG000|Period 1|Withdrawal by Subject|0|||
161934059|NCT01517178|584808386|FG001|Period 1|Withdrawal by Subject|1|||
161934060|NCT01517178|584808385|FG000|Period 2|Adverse Event|1|||
161934061|NCT01517178|584808386|FG001|Period 2|Adverse Event|0|||
161934062|NCT01517178|584808385|FG000|Period 2|Withdrawal by Subject|3|||
161934063|NCT01517178|584808386|FG001|Period 2|Withdrawal by Subject|0|||
161934064|NCT01517178|584808385|FG000|Period 2|E.g. study termination|2|||
161934065|NCT01517178|584808386|FG001|Period 2|E.g. study termination|2|||
161934066|NCT01557569|584808387|FG000|Overall Study|Adverse Event|2|||
161934067|NCT01557569|584808388|FG001|Overall Study|Adverse Event|0|||
161934068|NCT01557569|584808387|FG000|Overall Study|high blood pressure|0|||
161934069|NCT01557569|584808388|FG001|Overall Study|high blood pressure|1|||
161934070|NCT01557569|584808387|FG000|Overall Study|Withdrawal by Subject|3|||
161934071|NCT01557569|584808388|FG001|Overall Study|Withdrawal by Subject|5|||
161934072|NCT01557569|584808387|FG000|Overall Study|noncompliance with rules of residential|0|||
161934073|NCT01557569|584808388|FG001|Overall Study|noncompliance with rules of residential|1|||
161934074|NCT02254460|584808389|FG000|Overall Study|Adverse Event|1|||
161934075|NCT02254460|584808390|FG001|Overall Study|Adverse Event|0|||
161934076|NCT01050218|584808391|FG000|Overall Study|Adverse Event|37|||
161934077|NCT01050218|584808391|FG000|Overall Study|Lack of Efficacy|8|||
161934078|NCT01050218|584808391|FG000|Overall Study|Protocol Violation|3|||
161934079|NCT01050218|584808391|FG000|Overall Study|Withdrawal by Subject|18|||
161934080|NCT01050218|584808391|FG000|Overall Study|Discontinued by sponsor|18|||
161934081|NCT01050218|584808391|FG000|Overall Study|Compliance|2|||
161934082|NCT01050218|584808391|FG000|Overall Study|Failed to return|7|||
161934083|NCT01050218|584808391|FG000|Overall Study|Serious Adverse Event|1|||
161934084|NCT01050218|584808391|FG000|Overall Study|Family emergency|1|||
161934085|NCT01772693|584808392|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
161934086|NCT01772693|584808393|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
161934087|NCT01772693|584808392|FG000|Overall Study|Withdrawal by Subject|2|||
161934088|NCT01772693|584808393|FG001|Overall Study|Withdrawal by Subject|0|||
161934089|NCT01772693|584808392|FG000|Overall Study|Alternative Treatment|2|||
161934090|NCT01772693|584808393|FG001|Overall Study|Alternative Treatment|0|||
161934091|NCT01633112|584808394|FG000|Overall Study|Lack of Efficacy|1|||
161934092|NCT01633112|584808395|FG001|Overall Study|Lack of Efficacy|6|||
161934093|NCT01633112|584808396|FG002|Overall Study|Lack of Efficacy|13|||
161934094|NCT01633112|584808394|FG000|Overall Study|Abnormal laboratory value(s)|3|||
161934095|NCT01633112|584808395|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161934096|NCT01633112|584808396|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161934097|NCT01633112|584808394|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161934098|NCT01633112|584808395|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161934099|NCT01633112|584808396|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161934100|NCT01633112|584808394|FG000|Overall Study|Administrative problems|1|||
161934101|NCT01633112|584808395|FG001|Overall Study|Administrative problems|2|||
161934102|NCT01633112|584808396|FG002|Overall Study|Administrative problems|5|||
161934103|NCT01633112|584808394|FG000|Overall Study|Adverse Event|16|||
161934104|NCT01633112|584808395|FG001|Overall Study|Adverse Event|18|||
161934105|NCT01633112|584808396|FG002|Overall Study|Adverse Event|20|||
161934106|NCT01633112|584808394|FG000|Overall Study|Lost to Follow-up|7|||
162021333|NCT02891070|585134748|FG000|Overall Study|Adverse Event|1|||
162021334|NCT02891070|585134749|FG001|Overall Study|Adverse Event|0|||
161934107|NCT01633112|584808395|FG001|Overall Study|Lost to Follow-up|19|||
161934108|NCT01633112|584808396|FG002|Overall Study|Lost to Follow-up|6|||
161934109|NCT01633112|584808394|FG000|Overall Study|Protocol Violation|4|||
161934110|NCT01633112|584808395|FG001|Overall Study|Protocol Violation|0|||
161934111|NCT01633112|584808396|FG002|Overall Study|Protocol Violation|2|||
161934112|NCT01633112|584808394|FG000|Overall Study|Subject no longer requires study drug|0|||
161934113|NCT01633112|584808395|FG001|Overall Study|Subject no longer requires study drug|0|||
161934114|NCT01633112|584808396|FG002|Overall Study|Subject no longer requires study drug|1|||
161934115|NCT01633112|584808394|FG000|Overall Study|Withdrawal by Subject|20|||
161934116|NCT01633112|584808395|FG001|Overall Study|Withdrawal by Subject|12|||
161934117|NCT01633112|584808396|FG002|Overall Study|Withdrawal by Subject|41|||
161934118|NCT01633112|584808394|FG000|Overall Study|missing Study Completion CRF|1|||
161934119|NCT01633112|584808395|FG001|Overall Study|missing Study Completion CRF|1|||
161934120|NCT01633112|584808396|FG002|Overall Study|missing Study Completion CRF|4|||
161934121|NCT02872142|584808398|FG000|Overall Study|Adverse Event|2|||
161934122|NCT02872142|584808398|FG000|Overall Study|Death|1|||
161934123|NCT02872142|584808398|FG000|Overall Study|Participant Decision|3|||
161934124|NCT01550965|584808401|FG000|Overall Study|Adverse Event|26|||
161934125|NCT01550965|584808401|FG000|Overall Study|Withdrawal by Subject|10|||
161934126|NCT01550965|584808401|FG000|Overall Study|Lost to Follow-up|2|||
161934127|NCT01550965|584808401|FG000|Overall Study|Lack of Efficacy|59|||
161934128|NCT01550965|584808401|FG000|Overall Study|Other|13|||
161934129|NCT00160563|584808404|FG000|Overall Study|Adverse Event|1|||
161934130|NCT00160563|584808405|FG001|Overall Study|Adverse Event|1|||
161934131|NCT00160563|584808406|FG002|Overall Study|Adverse Event|1|||
161934132|NCT00160563|584808404|FG000|Overall Study|Lost to Follow-up|1|||
161934133|NCT00160563|584808405|FG001|Overall Study|Lost to Follow-up|1|||
161934134|NCT00160563|584808406|FG002|Overall Study|Lost to Follow-up|2|||
161934135|NCT00160563|584808404|FG000|Overall Study|Protocol Violation|0|||
161934136|NCT00160563|584808405|FG001|Overall Study|Protocol Violation|0|||
161934137|NCT00160563|584808406|FG002|Overall Study|Protocol Violation|3|||
161934138|NCT00160563|584808404|FG000|Overall Study|Withdrawal by Subject|1|||
161934139|NCT00160563|584808405|FG001|Overall Study|Withdrawal by Subject|2|||
161934140|NCT00160563|584808406|FG002|Overall Study|Withdrawal by Subject|3|||
161934141|NCT00160563|584808404|FG000|Overall Study|Other (listed in the study report)|48|||
161934142|NCT00160563|584808405|FG001|Overall Study|Other (listed in the study report)|40|||
161934143|NCT00160563|584808406|FG002|Overall Study|Other (listed in the study report)|81|||
161934144|NCT00160563|584808404|FG000|Overall Study|Missing reason|0|||
161934145|NCT00160563|584808405|FG001|Overall Study|Missing reason|1|||
161934146|NCT00160563|584808406|FG002|Overall Study|Missing reason|0|||
161934147|NCT01148771|584808412|FG000|Washout Period|Withdrawal by Subject|0|||
161934148|NCT01148771|584808413|FG001|Washout Period|Withdrawal by Subject|1|||
161934149|NCT01437189|584808414|FG000|Overall Study|Adverse Event|3|||
161934150|NCT01437189|584808414|FG000|Overall Study|Lack of Efficacy|4|||
161934151|NCT01437189|584808414|FG000|Overall Study|Withdrawal by Subject|8|||
161934152|NCT00595075|584808419|FG000|Overall Study|Withdrawal by Subject|1|||
161934153|NCT00595075|584808420|FG001|Overall Study|Withdrawal by Subject|0|||
161934154|NCT05261490|584808422|FG000|Overall Study|Other|1|||
161934155|NCT05261490|584808423|FG001|Overall Study|Other|0|||
161934156|NCT05261490|584808424|FG002|Overall Study|Other|0|||
161934157|NCT05261490|584808422|FG000|Overall Study|Study Terminated by Sponsor|1|||
161934158|NCT05261490|584808423|FG001|Overall Study|Study Terminated by Sponsor|1|||
161934159|NCT05261490|584808424|FG002|Overall Study|Study Terminated by Sponsor|4|||
161934160|NCT05261490|584808422|FG000|Overall Study|Death|1|||
161934161|NCT05261490|584808423|FG001|Overall Study|Death|2|||
161934162|NCT05261490|584808424|FG002|Overall Study|Death|0|||
161934163|NCT03777020|584808426|FG000|Overall Study|Withdrawal by Subject|4|||
161934164|NCT03777020|584808427|FG001|Overall Study|Withdrawal by Subject|4|||
161934165|NCT03777020|584808426|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
161934166|NCT03777020|584808427|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
161934167|NCT03460704|584808428|FG000|Overall Study|Withdrawal by Subject|11|||
161934168|NCT03460704|584808429|FG001|Overall Study|Withdrawal by Subject|14|||
161934169|NCT03460704|584808428|FG000|Overall Study|Study terminated by the Sponsor|29|||
161934170|NCT03460704|584808429|FG001|Overall Study|Study terminated by the Sponsor|19|||
161934171|NCT03460704|584808428|FG000|Overall Study|Adverse Event|10|||
161934172|NCT03460704|584808429|FG001|Overall Study|Adverse Event|5|||
161934173|NCT03460704|584808428|FG000|Overall Study|Death|3|||
161934174|NCT03460704|584808429|FG001|Overall Study|Death|2|||
161934175|NCT03460704|584808428|FG000|Overall Study|Non-Compliance with Study Drug|3|||
161934176|NCT03460704|584808429|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161934177|NCT03460704|584808428|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161934178|NCT03460704|584808429|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
161934179|NCT03460704|584808428|FG000|Overall Study|Other|2|||
161934180|NCT03460704|584808429|FG001|Overall Study|Other|1|||
161934181|NCT02913326|584808430|FG000|Overall Study|Reason not listed|0|||
161934182|NCT02913326|584808431|FG001|Overall Study|Reason not listed|1|||
161934183|NCT02913326|584808430|FG000|Overall Study|Lost to Follow-up|0|||
161934184|NCT02913326|584808431|FG001|Overall Study|Lost to Follow-up|1|||
161934185|NCT02913326|584808430|FG000|Overall Study|Adverse Event|1|||
161934186|NCT02913326|584808431|FG001|Overall Study|Adverse Event|0|||
161934187|NCT01767857|584808432|FG000|Overall Study|Adverse Event|27|||
161934188|NCT01767857|584808433|FG001|Overall Study|Adverse Event|7|||
161934189|NCT01767857|584808432|FG000|Overall Study|Death|28|||
161934190|NCT01767857|584808433|FG001|Overall Study|Death|13|||
161934191|NCT01767857|584808432|FG000|Overall Study|Lack of Efficacy|299|||
161934192|NCT01767857|584808433|FG001|Overall Study|Lack of Efficacy|151|||
162208431|NCT04629443|585815684|FG000|Overall Study|Progressive Disease|2|||
162208432|NCT04629443|585815685|FG001|Overall Study|Progressive Disease|3|||
162208433|NCT04629443|585815686|FG002|Overall Study|Progressive Disease|3|||
162208434|NCT04629443|585815684|FG000|Overall Study|Physician Decision|1|||
162208435|NCT04629443|585815685|FG001|Overall Study|Physician Decision|3|||
162208436|NCT04629443|585815686|FG002|Overall Study|Physician Decision|0|||
162208437|NCT01379703|585815692|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
162208438|NCT01379703|585815693|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
162208439|NCT01379703|585815694|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
162208440|NCT01379703|585815692|FG000|Study Start Through 9 Months|Adverse Event|0|||
162208441|NCT01379703|585815693|FG001|Study Start Through 9 Months|Adverse Event|14|||
162208442|NCT01379703|585815694|FG002|Study Start Through 9 Months|Adverse Event|10|||
162208443|NCT01379703|585815692|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
162208444|NCT01379703|585815693|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
162208445|NCT01379703|585815694|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
162208446|NCT01379703|585815692|FG000|Study Start Through 9 Months|Treatment Failure|0|||
162208447|NCT01379703|585815693|FG001|Study Start Through 9 Months|Treatment Failure|2|||
162208448|NCT01379703|585815694|FG002|Study Start Through 9 Months|Treatment Failure|2|||
162208449|NCT01379703|585815692|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
162208450|NCT01379703|585815693|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
162208451|NCT01379703|585815694|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
162208452|NCT01379703|585815692|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
162208453|NCT01379703|585815693|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
162208454|NCT01379703|585815694|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
162208455|NCT01379703|585815692|FG000|Study Start Through 9 Months|Medication not available|0|||
162208456|NCT01379703|585815693|FG001|Study Start Through 9 Months|Medication not available|2|||
162208457|NCT01379703|585815694|FG002|Study Start Through 9 Months|Medication not available|1|||
161677554|NCT00041080|583872026|FG000|Overall Study|Ineligible|1|||
161677555|NCT00041080|583872027|FG001|Overall Study|Ineligible|0|||
161677556|NCT01011439|583872028|FG000|Overall Study|Death|37|||
161677557|NCT01011439|583872028|FG000|Overall Study|Lost to Follow-up|4|||
161677558|NCT01011439|583872028|FG000|Overall Study|Withdrawal by Subject|1|||
161677559|NCT01011439|583872028|FG000|Overall Study|Sponsor's decision|15|||
161825636|NCT01332968|584401842|FG003|Follow-Up Period|Progressive Disease|0|||
161825637|NCT01332968|584401843|FG004|Follow-Up Period|Progressive Disease|0|||
161825638|NCT01332968|584401844|FG005|Follow-Up Period|Progressive Disease|0|||
161825639|NCT01332968|584401845|FG006|Follow-Up Period|Progressive Disease|126|||
161825640|NCT01332968|584401846|FG007|Follow-Up Period|Progressive Disease|106|||
161825641|NCT01332968|584401839|FG000|Follow-Up Period|Protocol Violation|0|||
161825642|NCT01332968|584401840|FG001|Follow-Up Period|Protocol Violation|0|||
161825643|NCT01332968|584401841|FG002|Follow-Up Period|Protocol Violation|0|||
161825644|NCT01332968|584401842|FG003|Follow-Up Period|Protocol Violation|0|||
161825645|NCT01332968|584401843|FG004|Follow-Up Period|Protocol Violation|0|||
161825646|NCT01332968|584401844|FG005|Follow-Up Period|Protocol Violation|0|||
161825647|NCT01332968|584401845|FG006|Follow-Up Period|Protocol Violation|1|||
161825648|NCT01332968|584401846|FG007|Follow-Up Period|Protocol Violation|0|||
161825649|NCT01332968|584401839|FG000|Follow-Up Period|Withdrawal by Subject|0|||
161825650|NCT01332968|584401840|FG001|Follow-Up Period|Withdrawal by Subject|0|||
161825651|NCT01332968|584401841|FG002|Follow-Up Period|Withdrawal by Subject|0|||
161825652|NCT01332968|584401842|FG003|Follow-Up Period|Withdrawal by Subject|0|||
161825653|NCT01332968|584401843|FG004|Follow-Up Period|Withdrawal by Subject|0|||
161825654|NCT01332968|584401844|FG005|Follow-Up Period|Withdrawal by Subject|0|||
161825655|NCT01332968|584401845|FG006|Follow-Up Period|Withdrawal by Subject|29|||
161825656|NCT01332968|584401846|FG007|Follow-Up Period|Withdrawal by Subject|32|||
161825657|NCT01332968|584401839|FG000|Follow-Up Period|No reason provided|0|||
161825658|NCT01332968|584401840|FG001|Follow-Up Period|No reason provided|0|||
161825659|NCT01332968|584401841|FG002|Follow-Up Period|No reason provided|0|||
161825660|NCT01332968|584401842|FG003|Follow-Up Period|No reason provided|0|||
161825661|NCT01332968|584401843|FG004|Follow-Up Period|No reason provided|0|||
161825662|NCT01332968|584401844|FG005|Follow-Up Period|No reason provided|0|||
161825663|NCT01332968|584401845|FG006|Follow-Up Period|No reason provided|2|||
161825664|NCT01332968|584401846|FG007|Follow-Up Period|No reason provided|3|||
161825665|NCT02351167|584401847|FG000|Overall Study|Withdrawal by Subject|19|||
161825666|NCT02351167|584401848|FG001|Overall Study|Withdrawal by Subject|18|||
161825667|NCT02351167|584401849|FG002|Overall Study|Withdrawal by Subject|21|||
161825668|NCT00194792|584401850|FG000|Overall Study|Withdrawal by Subject|1|||
161825669|NCT02448563|584401851|FG000|Overall Study|Lost to Follow-up|16|||
161825670|NCT02448563|584401852|FG001|Overall Study|Lost to Follow-up|10|||
161934193|NCT01767857|584808432|FG000|Overall Study|Lost to Follow-up|1|||
161934194|NCT01767857|584808433|FG001|Overall Study|Lost to Follow-up|1|||
162208458|NCT01379703|585815692|FG000|Study Start Through 9 Months|Poor general condition|0|||
162208459|NCT01379703|585815693|FG001|Study Start Through 9 Months|Poor general condition|1|||
162208460|NCT01379703|585815694|FG002|Study Start Through 9 Months|Poor general condition|0|||
162208461|NCT01379703|585815692|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
162208462|NCT01379703|585815693|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
162208463|NCT01379703|585815694|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
162208464|NCT01379703|585815692|FG000|Study Start Through 9 Months|Reason unknown|2|||
162208465|NCT01379703|585815693|FG001|Study Start Through 9 Months|Reason unknown|31|||
162208466|NCT01379703|585815694|FG002|Study Start Through 9 Months|Reason unknown|24|||
162208467|NCT01379703|585815692|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
162208468|NCT01379703|585815693|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
162208469|NCT01379703|585815694|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
162208470|NCT01379703|585815692|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
162208471|NCT01379703|585815693|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
162208472|NCT01379703|585815694|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
162208473|NCT01379703|585815692|FG000|9 Months Through 18 Months|Adverse Event|0|||
162208474|NCT01379703|585815693|FG001|9 Months Through 18 Months|Adverse Event|6|||
162208475|NCT01379703|585815694|FG002|9 Months Through 18 Months|Adverse Event|0|||
162208476|NCT01379703|585815692|FG000|9 Months Through 18 Months|Treatment failure|0|||
162208477|NCT01379703|585815693|FG001|9 Months Through 18 Months|Treatment failure|5|||
162208478|NCT01379703|585815694|FG002|9 Months Through 18 Months|Treatment failure|0|||
162208479|NCT01379703|585815692|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
162208480|NCT01379703|585815693|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
162208481|NCT01379703|585815694|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
161934195|NCT01767857|584808432|FG000|Overall Study|Withdrawal by Subject|38|||
161934196|NCT01767857|584808433|FG001|Overall Study|Withdrawal by Subject|18|||
161934197|NCT01767857|584808432|FG000|Overall Study|Physician Decision|17|||
161934198|NCT01767857|584808433|FG001|Overall Study|Physician Decision|10|||
162208482|NCT01379703|585815692|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
162208483|NCT01379703|585815693|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
162208484|NCT01379703|585815694|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
162208485|NCT01379703|585815692|FG000|9 Months Through 18 Months|Fatigue|0|||
162208486|NCT01379703|585815693|FG001|9 Months Through 18 Months|Fatigue|1|||
162208487|NCT01379703|585815694|FG002|9 Months Through 18 Months|Fatigue|0|||
162208488|NCT01379703|585815692|FG000|9 Months Through 18 Months|Reason Unknown|0|||
162208489|NCT01379703|585815693|FG001|9 Months Through 18 Months|Reason Unknown|23|||
162208490|NCT01379703|585815694|FG002|9 Months Through 18 Months|Reason Unknown|0|||
162208491|NCT01172639|585815695|FG000|Overall Study|Death|1|||
162208492|NCT01172639|585815696|FG001|Overall Study|Death|1|||
162208493|NCT01172639|585815697|FG002|Overall Study|Death|0|||
162208494|NCT01172639|585815698|FG003|Overall Study|Death|0|||
162208495|NCT01172639|585815699|FG004|Overall Study|Death|0|||
162208496|NCT01172639|585815695|FG000|Overall Study|Lost to Follow-up|9|||
162208497|NCT01172639|585815696|FG001|Overall Study|Lost to Follow-up|7|||
162208498|NCT01172639|585815697|FG002|Overall Study|Lost to Follow-up|11|||
162208499|NCT01172639|585815698|FG003|Overall Study|Lost to Follow-up|6|||
162208500|NCT01172639|585815699|FG004|Overall Study|Lost to Follow-up|6|||
162208501|NCT01172639|585815695|FG000|Overall Study|Withdrawal by Subject|3|||
162208502|NCT01172639|585815696|FG001|Overall Study|Withdrawal by Subject|3|||
162208503|NCT01172639|585815697|FG002|Overall Study|Withdrawal by Subject|5|||
161934199|NCT01767857|584808432|FG000|Overall Study|Protocol Terminated|1|||
162208504|NCT01172639|585815698|FG003|Overall Study|Withdrawal by Subject|5|||
162208505|NCT01172639|585815699|FG004|Overall Study|Withdrawal by Subject|0|||
161934200|NCT01767857|584808433|FG001|Overall Study|Protocol Terminated|0|||
161934201|NCT01767857|584808432|FG000|Overall Study|Randomized But Never Treated|19|||
161934202|NCT01767857|584808433|FG001|Overall Study|Randomized But Never Treated|13|||
161934203|NCT01421459|584808434|FG000|Overall Study|Adverse Event|6|||
161934204|NCT01421459|584808435|FG001|Overall Study|Adverse Event|10|||
161934205|NCT01421459|584808434|FG000|Overall Study|Death|1|||
161934206|NCT01421459|584808435|FG001|Overall Study|Death|1|||
161934207|NCT01421459|584808434|FG000|Overall Study|Lack of Efficacy|1|||
161934208|NCT01421459|584808435|FG001|Overall Study|Lack of Efficacy|2|||
161934209|NCT01421459|584808434|FG000|Overall Study|Lost to Follow-up|8|||
162208506|NCT01316887|585815700|FG000|Overall Study|Adverse Event|13|||
162208507|NCT01316887|585815701|FG001|Overall Study|Adverse Event|21|||
162208508|NCT01316887|585815702|FG002|Overall Study|Adverse Event|17|||
162208509|NCT01316887|585815700|FG000|Overall Study|Lack of Efficacy|9|||
161934210|NCT01421459|584808435|FG001|Overall Study|Lost to Follow-up|9|||
162208510|NCT01316887|585815701|FG001|Overall Study|Lack of Efficacy|3|||
162208511|NCT01316887|585815702|FG002|Overall Study|Lack of Efficacy|1|||
162208512|NCT01316887|585815700|FG000|Overall Study|Protocol Violation|2|||
162208513|NCT01316887|585815701|FG001|Overall Study|Protocol Violation|6|||
161934211|NCT01421459|584808434|FG000|Overall Study|Physician Decision|9|||
161934212|NCT01421459|584808435|FG001|Overall Study|Physician Decision|9|||
162208514|NCT01316887|585815702|FG002|Overall Study|Protocol Violation|6|||
162208515|NCT01316887|585815700|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
162208516|NCT01316887|585815701|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
162208517|NCT01316887|585815702|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
162208518|NCT01316887|585815700|FG000|Overall Study|Study Closed/Terminated|2|||
162208519|NCT01316887|585815701|FG001|Overall Study|Study Closed/Terminated|4|||
162208520|NCT01316887|585815702|FG002|Overall Study|Study Closed/Terminated|3|||
161677560|NCT02428855|583872029|FG000|Overall Study|Withdrawal by Subject|2|||
161677561|NCT00210184|583872030|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
161677562|NCT01338415|583872031|FG000|Core + Extension|Adverse Event|8|||
161677563|NCT01338415|583872032|FG001|Core + Extension|Adverse Event|6|||
161677564|NCT01338415|583872033|FG002|Core + Extension|Adverse Event|0|||
161677565|NCT01338415|583872031|FG000|Core + Extension|Withdrawal by Subject|1|||
161677566|NCT01338415|583872032|FG001|Core + Extension|Withdrawal by Subject|1|||
161677567|NCT01338415|583872033|FG002|Core + Extension|Withdrawal by Subject|0|||
161677568|NCT01338415|583872031|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
161677569|NCT01338415|583872032|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
161677570|NCT01338415|583872033|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
161677571|NCT01338415|583872031|FG000|Core + Extension|Other (administrative reason)|1|||
161677572|NCT01338415|583872032|FG001|Core + Extension|Other (administrative reason)|0|||
161825671|NCT02448563|584401851|FG000|Overall Study|Withdrawal by Subject|0|||
161825672|NCT02448563|584401852|FG001|Overall Study|Withdrawal by Subject|1|||
161825673|NCT00702507|584401854|FG000|Initial Treatment Phase|Adverse Event|2|||
162208521|NCT01316887|585815700|FG000|Overall Study|Lost to Follow-up|1|||
162208522|NCT01316887|585815701|FG001|Overall Study|Lost to Follow-up|7|||
162208523|NCT01316887|585815702|FG002|Overall Study|Lost to Follow-up|5|||
162208524|NCT01316887|585815700|FG000|Overall Study|Withdrawal by Subject|8|||
161825674|NCT00702507|584401854|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
161825675|NCT00702507|584401854|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
161825676|NCT00702507|584401854|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
161825677|NCT00702507|584401854|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
161825678|NCT00702507|584401854|FG000|Follow-up Phase|Protocol Violation|2|||
161825679|NCT00702507|584401854|FG000|Follow-up Phase|Lost to Follow-up|23|||
161825680|NCT00702507|584401854|FG000|Follow-up Phase|Late Enrollment|1|||
161825681|NCT00113919|584401855|FG000|Overall Study|Physician Decision|8|||
161825682|NCT00113919|584401855|FG000|Overall Study|Death|6|||
161825683|NCT00721955|584401863|FG000|Overall Study|Adverse Event|0|||
161825684|NCT00721955|584401864|FG001|Overall Study|Adverse Event|0|||
161825685|NCT00721955|584401865|FG002|Overall Study|Adverse Event|2|||
161825686|NCT04194008|584401870|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
161825687|NCT04194008|584401870|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
161825688|NCT04194008|584401870|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
161825689|NCT04194008|584401870|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
161825690|NCT04194008|584401870|FG000|Treatment Phase With Nerivio|Missing data|4|||
161825691|NCT04194008|584401870|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
161825692|NCT01785615|584401871|FG000|Dietary Phase|Lost to Follow-up|0|||
161825693|NCT01785615|584401872|FG001|Dietary Phase|Lost to Follow-up|0|||
161825694|NCT01785615|584401873|FG002|Dietary Phase|Lost to Follow-up|0|||
161825695|NCT01785615|584401874|FG003|Dietary Phase|Lost to Follow-up|24|||
161825696|NCT02522780|584401875|FG000|Overall Study|Consent withdrawn by subject|5|||
161825697|NCT02522780|584401876|FG001|Overall Study|Consent withdrawn by subject|7|||
161825698|NCT02522780|584401875|FG000|Overall Study|Protocol deviation|1|||
161825699|NCT02522780|584401876|FG001|Overall Study|Protocol deviation|3|||
161825700|NCT02522780|584401875|FG000|Overall Study|Subject refused endoscopic procedure|0|||
161825701|NCT02522780|584401876|FG001|Overall Study|Subject refused endoscopic procedure|1|||
161825702|NCT02522780|584401875|FG000|Overall Study|Adverse event, non-fatal|11|||
161825703|NCT02522780|584401876|FG001|Overall Study|Adverse event, non-fatal|16|||
161825704|NCT00926367|584401877|FG000|Overall Study|Withdrawal by Subject|0|||
161825705|NCT00926367|584401878|FG001|Overall Study|Withdrawal by Subject|1|||
161825706|NCT00926367|584401877|FG000|Overall Study|Lost to Follow-up|1|||
161825707|NCT00926367|584401878|FG001|Overall Study|Lost to Follow-up|0|||
161825708|NCT00926367|584401877|FG000|Overall Study|Skin Irritation|1|||
161825709|NCT00926367|584401878|FG001|Overall Study|Skin Irritation|2|||
161825710|NCT01517867|584401879|FG000|Overall Study|never started treatment|29|||
161825711|NCT01517867|584401880|FG001|Overall Study|never started treatment|32|||
161825712|NCT01517867|584401879|FG000|Overall Study|Withdrawal by Subject|34|||
161825713|NCT01517867|584401880|FG001|Overall Study|Withdrawal by Subject|30|||
161825714|NCT01517867|584401879|FG000|Overall Study|Still in treatment at study end|0|||
161825715|NCT01517867|584401880|FG001|Overall Study|Still in treatment at study end|3|||
161825716|NCT04203667|584401885|FG000|Overall Study|Withdrawal by Subject|1|||
161825717|NCT04203667|584401885|FG000|Overall Study|Lost to Follow-up|1|||
161825718|NCT04203667|584401885|FG000|Overall Study|Death|1|||
162208525|NCT01316887|585815701|FG001|Overall Study|Withdrawal by Subject|16|||
162208526|NCT01316887|585815702|FG002|Overall Study|Withdrawal by Subject|15|||
162208527|NCT02172950|585815703|FG000|Overall Study|Physician Decision|3|||
162208528|NCT02172950|585815704|FG001|Overall Study|Physician Decision|3|||
162208529|NCT02172950|585815703|FG000|Overall Study|Lack of Efficacy|1|||
162208530|NCT02172950|585815704|FG001|Overall Study|Lack of Efficacy|0|||
162208531|NCT02172950|585815703|FG000|Overall Study|Adverse Event|4|||
162208532|NCT02172950|585815704|FG001|Overall Study|Adverse Event|1|||
162208533|NCT02172950|585815703|FG000|Overall Study|Withdrawal by Subject|10|||
162208534|NCT02172950|585815704|FG001|Overall Study|Withdrawal by Subject|0|||
162208535|NCT02172950|585815703|FG000|Overall Study|Protocol Violation|1|||
162208536|NCT02172950|585815704|FG001|Overall Study|Protocol Violation|0|||
162208537|NCT02172950|585815703|FG000|Overall Study|Lost to Follow-up|1|||
162208538|NCT02172950|585815704|FG001|Overall Study|Lost to Follow-up|0|||
162208539|NCT02172950|585815703|FG000|Overall Study|Death|1|||
162208540|NCT02172950|585815704|FG001|Overall Study|Death|0|||
162208541|NCT02172950|585815703|FG000|Overall Study|Patient traveling|1|||
161934213|NCT01421459|584808434|FG000|Overall Study|Protocol Violation|8|||
161934214|NCT01421459|584808435|FG001|Overall Study|Protocol Violation|5|||
161934215|NCT01421459|584808434|FG000|Overall Study|Withdrawal by Subject|12|||
161934216|NCT01421459|584808435|FG001|Overall Study|Withdrawal by Subject|16|||
161934217|NCT01422382|584808436|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
161934218|NCT00967499|584808437|FG000|Overall Study|Adverse Event|0|||
161934219|NCT00967499|584808438|FG001|Overall Study|Adverse Event|1|||
161934220|NCT00967499|584808437|FG000|Overall Study|Protocol Violation|1|||
161934221|NCT00967499|584808438|FG001|Overall Study|Protocol Violation|0|||
162208542|NCT02172950|585815704|FG001|Overall Study|Patient traveling|0|||
162208543|NCT02172950|585815703|FG000|Overall Study|Patient went to other country|1|||
162208544|NCT02172950|585815704|FG001|Overall Study|Patient went to other country|0|||
162208545|NCT02172950|585815703|FG000|Overall Study|Patient relocated overseas|1|||
162208546|NCT02172950|585815704|FG001|Overall Study|Patient relocated overseas|1|||
162208547|NCT02172950|585815703|FG000|Overall Study|Patient moving|1|||
162208548|NCT02172950|585815704|FG001|Overall Study|Patient moving|0|||
162208549|NCT00469456|585815705|FG000|Overall Study|Adverse Event|4|||
162208550|NCT00469456|585815706|FG001|Overall Study|Adverse Event|3|||
162208551|NCT00469456|585815705|FG000|Overall Study|Protocol Violation|1|||
162208552|NCT00469456|585815706|FG001|Overall Study|Protocol Violation|0|||
162208553|NCT00469456|585815705|FG000|Overall Study|Withdrawal by Subject|4|||
162208554|NCT00469456|585815706|FG001|Overall Study|Withdrawal by Subject|1|||
162208555|NCT01086384|585815715|FG000|2-week Run-in Period|Adverse Event|1|||
162208556|NCT01086384|585815716|FG001|2-week Run-in Period|Adverse Event|0|||
162208557|NCT01086384|585815717|FG002|2-week Run-in Period|Adverse Event|0|||
162208558|NCT01086384|585815715|FG000|2-week Run-in Period|Protocol Violation|1|||
162208559|NCT01086384|585815716|FG001|2-week Run-in Period|Protocol Violation|0|||
162208560|NCT01086384|585815717|FG002|2-week Run-in Period|Protocol Violation|0|||
162208561|NCT01086384|585815715|FG000|2-week Run-in Period|Lost to Follow-up|1|||
162208562|NCT01086384|585815716|FG001|2-week Run-in Period|Lost to Follow-up|0|||
161934222|NCT00967499|584808437|FG000|Overall Study|Sponsor Decision|1|||
161934223|NCT00967499|584808438|FG001|Overall Study|Sponsor Decision|0|||
161934224|NCT00967499|584808437|FG000|Overall Study|Randomized but not treated|63|||
161934225|NCT00967499|584808438|FG001|Overall Study|Randomized but not treated|59|||
161934226|NCT02899754|584808439|FG000|Overall Study|Lost to Follow-up|7|||
161934227|NCT02899754|584808440|FG001|Overall Study|Lost to Follow-up|9|||
161934228|NCT04818229|584808441|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
161934229|NCT04818229|584808442|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
161934230|NCT04818229|584808443|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
161934231|NCT04818229|584808441|FG000|Overall Study|Adverse Event|3|||
161934232|NCT04818229|584808442|FG001|Overall Study|Adverse Event|1|||
161934233|NCT04818229|584808443|FG002|Overall Study|Adverse Event|1|||
161934234|NCT04818229|584808441|FG000|Overall Study|Withdrawal by Subject|0|||
161934235|NCT04818229|584808442|FG001|Overall Study|Withdrawal by Subject|0|||
161934236|NCT04818229|584808443|FG002|Overall Study|Withdrawal by Subject|2|||
161934237|NCT04818229|584808441|FG000|Overall Study|Lost to Follow-up|0|||
161934238|NCT04818229|584808442|FG001|Overall Study|Lost to Follow-up|0|||
161934239|NCT04818229|584808443|FG002|Overall Study|Lost to Follow-up|1|||
162208563|NCT01086384|585815717|FG002|2-week Run-in Period|Lost to Follow-up|0|||
162208564|NCT01086384|585815715|FG000|2-week Run-in Period|Physician Decision|6|||
162208565|NCT01086384|585815716|FG001|2-week Run-in Period|Physician Decision|0|||
162208566|NCT01086384|585815717|FG002|2-week Run-in Period|Physician Decision|0|||
162208567|NCT01086384|585815715|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
162208568|NCT01086384|585815716|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
162208569|NCT01086384|585815717|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161934240|NCT04082364|584808444|FG000|Overall Study|Death|23|||
161934241|NCT04082364|584808445|FG001|Overall Study|Death|1|||
161934242|NCT04082364|584808446|FG002|Overall Study|Death|1|||
161934243|NCT04082364|584808447|FG003|Overall Study|Death|2|||
161934244|NCT04082364|584808448|FG004|Overall Study|Death|1|||
162208570|NCT01086384|585815715|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
162208571|NCT01086384|585815716|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
162208572|NCT01086384|585815717|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
162208573|NCT01086384|585815715|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
162208574|NCT01086384|585815716|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
162208575|NCT01086384|585815717|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
162208576|NCT01086384|585815715|FG000|2-week Run-in Period|Randomized in Error|1|||
162208577|NCT01086384|585815716|FG001|2-week Run-in Period|Randomized in Error|0|||
162208578|NCT01086384|585815717|FG002|2-week Run-in Period|Randomized in Error|0|||
162208579|NCT01086384|585815715|FG000|Treatment Period|Withdrawal by Subject|0|||
162208580|NCT01086384|585815716|FG001|Treatment Period|Withdrawal by Subject|53|||
162208581|NCT01086384|585815717|FG002|Treatment Period|Withdrawal by Subject|55|||
162208582|NCT01086384|585815715|FG000|Treatment Period|Protocol Violation|0|||
162208583|NCT01086384|585815716|FG001|Treatment Period|Protocol Violation|26|||
162208584|NCT01086384|585815717|FG002|Treatment Period|Protocol Violation|17|||
162208585|NCT01086384|585815715|FG000|Treatment Period|Lack of Efficacy|0|||
162208586|NCT01086384|585815716|FG001|Treatment Period|Lack of Efficacy|22|||
161934245|NCT04082364|584808444|FG000|Overall Study|Lost to Follow-up|1|||
161934246|NCT04082364|584808445|FG001|Overall Study|Lost to Follow-up|0|||
161934247|NCT04082364|584808446|FG002|Overall Study|Lost to Follow-up|0|||
161934248|NCT04082364|584808447|FG003|Overall Study|Lost to Follow-up|0|||
161934249|NCT04082364|584808448|FG004|Overall Study|Lost to Follow-up|1|||
161934250|NCT04082364|584808444|FG000|Overall Study|Physician Decision|1|||
162208587|NCT01086384|585815717|FG002|Treatment Period|Lack of Efficacy|13|||
162208588|NCT01086384|585815715|FG000|Treatment Period|Adverse Event|0|||
162208589|NCT01086384|585815716|FG001|Treatment Period|Adverse Event|19|||
162208590|NCT01086384|585815717|FG002|Treatment Period|Adverse Event|15|||
162208591|NCT01086384|585815715|FG000|Treatment Period|Lost to Follow-up|0|||
161934251|NCT04082364|584808445|FG001|Overall Study|Physician Decision|1|||
161934252|NCT04082364|584808446|FG002|Overall Study|Physician Decision|0|||
161934253|NCT04082364|584808447|FG003|Overall Study|Physician Decision|2|||
161934254|NCT04082364|584808448|FG004|Overall Study|Physician Decision|1|||
161934255|NCT04082364|584808444|FG000|Overall Study|Withdrawal by Subject|1|||
161934256|NCT04082364|584808445|FG001|Overall Study|Withdrawal by Subject|1|||
161934257|NCT04082364|584808446|FG002|Overall Study|Withdrawal by Subject|0|||
161934258|NCT04082364|584808447|FG003|Overall Study|Withdrawal by Subject|0|||
161934259|NCT04082364|584808448|FG004|Overall Study|Withdrawal by Subject|1|||
161934260|NCT04082364|584808444|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
161934261|NCT04082364|584808445|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
161934262|NCT04082364|584808446|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
161934263|NCT04082364|584808447|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
161934264|NCT04082364|584808448|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
161934265|NCT04082364|584808444|FG000|Overall Study|Disease progression|0|||
161934266|NCT04082364|584808445|FG001|Overall Study|Disease progression|0|||
161934267|NCT04082364|584808446|FG002|Overall Study|Disease progression|0|||
161934268|NCT04082364|584808447|FG003|Overall Study|Disease progression|1|||
161934269|NCT04082364|584808448|FG004|Overall Study|Disease progression|0|||
161934270|NCT03186378|584808449|FG000|Overall Study|Lost to Follow-up|1|||
161934271|NCT03186378|584808450|FG001|Overall Study|Lost to Follow-up|0|||
161934272|NCT03247673|584808452|FG000|Overall Study|Withdrawal by Subject|1|||
161934273|NCT03247673|584808453|FG001|Overall Study|Withdrawal by Subject|0|||
161934274|NCT03247673|584808454|FG002|Overall Study|Withdrawal by Subject|3|||
161934275|NCT03247673|584808452|FG000|Overall Study|Lost to Follow-up|0|||
161934276|NCT03247673|584808453|FG001|Overall Study|Lost to Follow-up|0|||
161934277|NCT03247673|584808454|FG002|Overall Study|Lost to Follow-up|1|||
161934278|NCT02971137|584808459|FG000|Overall Study|Lost to Follow-up|44|||
161934279|NCT02971137|584808460|FG001|Overall Study|Lost to Follow-up|56|||
161934280|NCT04755231|584808461|FG000|Overall Study|Lost to Follow-up|5|||
161934281|NCT04755231|584808461|FG000|Overall Study|Withdrawal by Subject|5|||
161934282|NCT00215657|584808465|FG000|Overall Study|Adverse Event|5|||
161934283|NCT00215657|584808466|FG001|Overall Study|Adverse Event|1|||
161934284|NCT00215657|584808467|FG002|Overall Study|Adverse Event|3|||
161934285|NCT00215657|584808468|FG003|Overall Study|Adverse Event|0|||
161934286|NCT00215657|584808469|FG004|Overall Study|Adverse Event|3|||
161934287|NCT00215657|584808470|FG005|Overall Study|Adverse Event|1|||
161934288|NCT00215657|584808471|FG006|Overall Study|Adverse Event|0|||
161934289|NCT00215657|584808472|FG007|Overall Study|Adverse Event|3|||
162208592|NCT01086384|585815716|FG001|Treatment Period|Lost to Follow-up|11|||
162208593|NCT01086384|585815717|FG002|Treatment Period|Lost to Follow-up|9|||
162208594|NCT01086384|585815715|FG000|Treatment Period|Physician Decision|0|||
162208595|NCT01086384|585815716|FG001|Treatment Period|Physician Decision|9|||
161934290|NCT00215657|584808465|FG000|Overall Study|Withdrawal by Subject|6|||
161934291|NCT00215657|584808466|FG001|Overall Study|Withdrawal by Subject|3|||
161934292|NCT00215657|584808467|FG002|Overall Study|Withdrawal by Subject|3|||
161934293|NCT00215657|584808468|FG003|Overall Study|Withdrawal by Subject|1|||
162208596|NCT01086384|585815717|FG002|Treatment Period|Physician Decision|6|||
162208597|NCT01086384|585815715|FG000|Treatment Period|Study Closed/Terminated|0|||
161934294|NCT00215657|584808469|FG004|Overall Study|Withdrawal by Subject|6|||
161934295|NCT00215657|584808470|FG005|Overall Study|Withdrawal by Subject|1|||
161934296|NCT00215657|584808471|FG006|Overall Study|Withdrawal by Subject|10|||
162208598|NCT01086384|585815716|FG001|Treatment Period|Study Closed/Terminated|7|||
162208599|NCT01086384|585815717|FG002|Treatment Period|Study Closed/Terminated|8|||
162208600|NCT01086384|585815715|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
162208601|NCT01086384|585815716|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
162208602|NCT01086384|585815717|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
162208603|NCT01086384|585815715|FG000|Treatment Period|Received Treatment in Error|0|||
162208604|NCT01086384|585815716|FG001|Treatment Period|Received Treatment in Error|1|||
162208605|NCT01086384|585815717|FG002|Treatment Period|Received Treatment in Error|0|||
162208606|NCT02586415|585815718|FG000|Overall Study|Death|13|||
162208607|NCT02586415|585815719|FG001|Overall Study|Death|23|||
162208608|NCT02586415|585815718|FG000|Overall Study|Lost to Follow-up|1|||
162208609|NCT02586415|585815719|FG001|Overall Study|Lost to Follow-up|2|||
162208610|NCT00832000|585815720|FG000|Overall Study|Adverse Event|2|||
162208611|NCT00832000|585815721|FG001|Overall Study|Adverse Event|0|||
162208612|NCT00832000|585815720|FG000|Overall Study|Withdrawal by Subject|1|||
162208613|NCT00832000|585815721|FG001|Overall Study|Withdrawal by Subject|0|||
162208614|NCT00832000|585815720|FG000|Overall Study|No calls to IVR in either period|1|||
162208615|NCT00832000|585815721|FG001|Overall Study|No calls to IVR in either period|1|||
162208616|NCT00832000|585815720|FG000|Overall Study|No calls to IVR in period 2|2|||
162208617|NCT00832000|585815721|FG001|Overall Study|No calls to IVR in period 2|0|||
162208618|NCT03974100|585815722|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
162208619|NCT03974100|585815723|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
162208620|NCT03974100|585815724|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
162208621|NCT03974100|585815725|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
162208622|NCT03974100|585815726|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
162208623|NCT03974100|585815722|FG000|TP1 - Day 1 to Week 52|Death|1|||
162208624|NCT03974100|585815723|FG001|TP1 - Day 1 to Week 52|Death|0|||
162208625|NCT03974100|585815724|FG002|TP1 - Day 1 to Week 52|Death|0|||
162208626|NCT03974100|585815725|FG003|TP1 - Day 1 to Week 52|Death|0|||
162208627|NCT03974100|585815726|FG004|TP1 - Day 1 to Week 52|Death|0|||
162208628|NCT03974100|585815722|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
162208629|NCT03974100|585815723|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
162208630|NCT03974100|585815724|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
162208631|NCT03974100|585815725|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
162208632|NCT03974100|585815726|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
162208633|NCT03974100|585815722|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
162208634|NCT03974100|585815723|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
162208635|NCT03974100|585815724|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
162208636|NCT03974100|585815725|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
162208637|NCT03974100|585815726|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
162208638|NCT03974100|585815722|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
162208639|NCT03974100|585815723|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
162208640|NCT03974100|585815724|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
162208641|NCT03974100|585815725|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
162208642|NCT03974100|585815726|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
162208643|NCT03974100|585815722|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
162208644|NCT03974100|585815723|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
162208645|NCT03974100|585815724|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
162208646|NCT03974100|585815725|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
162208647|NCT03974100|585815726|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
162208648|NCT03974100|585815722|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
162208649|NCT03974100|585815723|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
162208650|NCT03974100|585815724|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
161677573|NCT01338415|583872033|FG002|Core + Extension|Other (administrative reason)|0|||
161934297|NCT00215657|584808472|FG007|Overall Study|Withdrawal by Subject|3|||
161934298|NCT00215657|584808465|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
161934299|NCT00215657|584808466|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
161934300|NCT00215657|584808467|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
161934301|NCT00215657|584808468|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
161934302|NCT00215657|584808469|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
161934303|NCT00215657|584808470|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
161934304|NCT00215657|584808471|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
161934305|NCT00215657|584808472|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
161934306|NCT00215657|584808465|FG000|Overall Study|Insufficient testosterone response|5|||
161934307|NCT00215657|584808466|FG001|Overall Study|Insufficient testosterone response|4|||
162208651|NCT03974100|585815725|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
162208652|NCT03974100|585815726|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
162208653|NCT03318783|585815727|FG000|Overall Study|Withdrawal by Subject|0|||
162208654|NCT03318783|585815728|FG001|Overall Study|Withdrawal by Subject|1|||
162208655|NCT03318783|585815727|FG000|Overall Study|Death|0|||
162208656|NCT03318783|585815728|FG001|Overall Study|Death|1|||
162208657|NCT03856047|585815729|FG000|Overall Study|Withdrawal by Subject|0|||
162208658|NCT03856047|585815730|FG001|Overall Study|Withdrawal by Subject|1|||
162208659|NCT03856047|585815731|FG002|Overall Study|Withdrawal by Subject|1|||
162208660|NCT03856047|585815732|FG003|Overall Study|Withdrawal by Subject|0|||
162208661|NCT03856047|585815733|FG004|Overall Study|Withdrawal by Subject|3|||
162208662|NCT03856047|585815734|FG005|Overall Study|Withdrawal by Subject|0|||
162208663|NCT03856047|585815735|FG006|Overall Study|Withdrawal by Subject|2|||
162208664|NCT03856047|585815729|FG000|Overall Study|Lost to Follow-up|4|||
162208665|NCT03856047|585815730|FG001|Overall Study|Lost to Follow-up|2|||
162208666|NCT03856047|585815731|FG002|Overall Study|Lost to Follow-up|3|||
162208667|NCT03856047|585815732|FG003|Overall Study|Lost to Follow-up|1|||
162208668|NCT03856047|585815733|FG004|Overall Study|Lost to Follow-up|4|||
162208669|NCT03856047|585815734|FG005|Overall Study|Lost to Follow-up|4|||
162208670|NCT03856047|585815735|FG006|Overall Study|Lost to Follow-up|4|||
162208671|NCT00338949|585815736|FG000|Subject Screening|Screen failures|11|||
162208672|NCT00338949|585815737|FG001|Subject Screening|Screen failures|11|||
162208673|NCT00338949|585815736|FG000|Randomization|Withdrawal by Subject|1|||
162208674|NCT00338949|585815737|FG001|Randomization|Withdrawal by Subject|0|||
162208675|NCT00338949|585815736|FG000|Randomization|Adverse Event|0|||
162208676|NCT00338949|585815737|FG001|Randomization|Adverse Event|5|||
162208677|NCT00436956|585815740|FG000|Overall Study|Not evaluable|1|||
162208678|NCT00436956|585815741|FG001|Overall Study|Not evaluable|0|||
162208679|NCT02719743|585815748|FG000|Overall Study|Consent withdrawal|0|||
162208680|NCT02719743|585815749|FG001|Overall Study|Consent withdrawal|2|||
162208681|NCT02719743|585815750|FG002|Overall Study|Consent withdrawal|0|||
162208682|NCT02719743|585815751|FG003|Overall Study|Consent withdrawal|1|||
162208683|NCT02719743|585815752|FG004|Overall Study|Consent withdrawal|0|||
162208684|NCT02719743|585815748|FG000|Overall Study|Migrated/moved from study area|0|||
162208685|NCT02719743|585815749|FG001|Overall Study|Migrated/moved from study area|0|||
162208686|NCT02719743|585815750|FG002|Overall Study|Migrated/moved from study area|0|||
162208687|NCT02719743|585815751|FG003|Overall Study|Migrated/moved from study area|0|||
162208688|NCT02719743|585815752|FG004|Overall Study|Migrated/moved from study area|2|||
162208689|NCT02719743|585815748|FG000|Overall Study|Lost to Follow-up|1|||
162208690|NCT02719743|585815749|FG001|Overall Study|Lost to Follow-up|1|||
162208691|NCT02719743|585815750|FG002|Overall Study|Lost to Follow-up|0|||
162208692|NCT02719743|585815751|FG003|Overall Study|Lost to Follow-up|0|||
162208693|NCT02719743|585815752|FG004|Overall Study|Lost to Follow-up|0|||
162208694|NCT01930214|585815753|FG000|Overall Study|Death|4|||
162208695|NCT01930214|585815754|FG001|Overall Study|Death|4|||
162208696|NCT01930214|585815755|FG002|Overall Study|Death|11|||
162208697|NCT01930214|585815753|FG000|Overall Study|Lost to Follow-up|12|||
162208698|NCT01930214|585815754|FG001|Overall Study|Lost to Follow-up|13|||
162208699|NCT01930214|585815755|FG002|Overall Study|Lost to Follow-up|12|||
162208700|NCT01930214|585815753|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
162208701|NCT01930214|585815754|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
162208702|NCT01930214|585815755|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
162208703|NCT01930214|585815753|FG000|Overall Study|Physician Decision|2|||
162208704|NCT01930214|585815754|FG001|Overall Study|Physician Decision|0|||
162208705|NCT01930214|585815755|FG002|Overall Study|Physician Decision|0|||
162208706|NCT02601209|585815756|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
162208707|NCT02601209|585815757|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
162208708|NCT02601209|585815758|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
162208709|NCT02601209|585815759|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
162208710|NCT02601209|585815760|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
162208711|NCT02601209|585815761|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
162208712|NCT02601209|585815762|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
162208713|NCT02601209|585815763|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
162208714|NCT02601209|585815764|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
162208715|NCT02601209|585815756|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
162208716|NCT02601209|585815757|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
162208717|NCT02601209|585815758|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
162208718|NCT02601209|585815759|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
162208719|NCT02601209|585815760|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
162208720|NCT02601209|585815761|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
162208721|NCT02601209|585815762|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
162208722|NCT02601209|585815763|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
162208723|NCT02601209|585815764|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
162208724|NCT02604342|585815766|FG000|Overall Study|Death|32|||
162208725|NCT02604342|585815767|FG001|Overall Study|Death|16|||
162208726|NCT02604342|585815766|FG000|Overall Study|Progression of disease|1|||
162208727|NCT02604342|585815767|FG001|Overall Study|Progression of disease|0|||
162208728|NCT02604342|585815766|FG000|Overall Study|Withdrawal by Subject|5|||
161934308|NCT00215657|584808467|FG002|Overall Study|Insufficient testosterone response|1|||
161934309|NCT00215657|584808468|FG003|Overall Study|Insufficient testosterone response|12|||
162208729|NCT02604342|585815767|FG001|Overall Study|Withdrawal by Subject|6|||
162208730|NCT02604342|585815766|FG000|Overall Study|Other|1|||
162208731|NCT02604342|585815767|FG001|Overall Study|Other|0|||
162208732|NCT02604342|585815766|FG000|Overall Study|Study Termination by Sponsor|1|||
162208733|NCT02604342|585815767|FG001|Overall Study|Study Termination by Sponsor|0|||
162208734|NCT02604342|585815766|FG000|Overall Study|Lost to Follow-up|1|||
162208735|NCT02604342|585815767|FG001|Overall Study|Lost to Follow-up|1|||
162208736|NCT02604342|585815766|FG000|Overall Study|Physician Decision|2|||
162208737|NCT02604342|585815767|FG001|Overall Study|Physician Decision|0|||
162208738|NCT01702519|585815768|FG000|Washout Period|Lost to Follow-up|1|||
162208739|NCT01702519|585815769|FG001|Washout Period|Lost to Follow-up|0|||
162208740|NCT01702519|585815768|FG000|Washout Period|Withdrawal by Subject|0|||
162208741|NCT01702519|585815769|FG001|Washout Period|Withdrawal by Subject|2|||
162208742|NCT03029819|585815770|FG000|Overall Study|Lost to Follow-up|3|||
162208743|NCT03029819|585815771|FG001|Overall Study|Lost to Follow-up|5|||
162208744|NCT03029819|585815770|FG000|Overall Study|Removed due to disruptive behavior|0|||
162208745|NCT03029819|585815771|FG001|Overall Study|Removed due to disruptive behavior|1|||
161934310|NCT00215657|584808469|FG004|Overall Study|Insufficient testosterone response|8|||
162208746|NCT03015181|585815772|FG000|Overall Study|Enrolled, but product never administered|1|||
161825719|NCT04203667|584401885|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
161825720|NCT01160640|584401886|FG000|Overall Study|Physician Decision|3|||
162208747|NCT03015181|585815773|FG001|Overall Study|Enrolled, but product never administered|0|||
162208748|NCT03015181|585815774|FG002|Overall Study|Enrolled, but product never administered|0|||
162208749|NCT03015181|585815775|FG003|Overall Study|Enrolled, but product never administered|0|||
162208750|NCT03015181|585815776|FG004|Overall Study|Enrolled, but product never administered|0|||
162208751|NCT03015181|585815777|FG005|Overall Study|Enrolled, but product never administered|0|||
162208752|NCT03015181|585815778|FG006|Overall Study|Enrolled, but product never administered|0|||
162208753|NCT03015181|585815772|FG000|Overall Study|Withdrawal by Subject|0|||
162208754|NCT03015181|585815773|FG001|Overall Study|Withdrawal by Subject|0|||
162208755|NCT03015181|585815774|FG002|Overall Study|Withdrawal by Subject|0|||
162208756|NCT03015181|585815775|FG003|Overall Study|Withdrawal by Subject|0|||
162208757|NCT03015181|585815776|FG004|Overall Study|Withdrawal by Subject|0|||
162208758|NCT03015181|585815777|FG005|Overall Study|Withdrawal by Subject|1|||
162208759|NCT03015181|585815778|FG006|Overall Study|Withdrawal by Subject|0|||
162208760|NCT03015181|585815772|FG000|Overall Study|Physician Decision|0|||
162208761|NCT03015181|585815773|FG001|Overall Study|Physician Decision|0|||
162208762|NCT03015181|585815774|FG002|Overall Study|Physician Decision|0|||
162208763|NCT03015181|585815775|FG003|Overall Study|Physician Decision|0|||
162208764|NCT03015181|585815776|FG004|Overall Study|Physician Decision|0|||
162208765|NCT03015181|585815777|FG005|Overall Study|Physician Decision|0|||
162208766|NCT03015181|585815778|FG006|Overall Study|Physician Decision|1|||
162208767|NCT01177228|585815788|FG000|Overall Study|Positive tuberculosis test|0|||
162208768|NCT01177228|585815789|FG001|Overall Study|Positive tuberculosis test|1|||
162208769|NCT01177228|585815790|FG002|Overall Study|Positive tuberculosis test|0|||
162208770|NCT01177228|585815791|FG003|Overall Study|Positive tuberculosis test|0|||
162208771|NCT01177228|585815788|FG000|Overall Study|Worsening disease activity|1|||
162208772|NCT01177228|585815789|FG001|Overall Study|Worsening disease activity|0|||
162208773|NCT01177228|585815790|FG002|Overall Study|Worsening disease activity|0|||
162208774|NCT01177228|585815791|FG003|Overall Study|Worsening disease activity|0|||
161825721|NCT01160640|584401887|FG001|Overall Study|Physician Decision|3|||
161825722|NCT01160640|584401886|FG000|Overall Study|Incarceration|1|||
161825723|NCT01160640|584401887|FG001|Overall Study|Incarceration|0|||
161825724|NCT01160640|584401886|FG000|Overall Study|Withdrawal by Subject|0|||
161825725|NCT01160640|584401887|FG001|Overall Study|Withdrawal by Subject|3|||
161825726|NCT01525628|584401888|FG000|Overall Study|Adverse Event|1|||
161825727|NCT01525628|584401889|FG001|Overall Study|Adverse Event|1|||
161825728|NCT01525628|584401890|FG002|Overall Study|Adverse Event|2|||
161825729|NCT01525628|584401891|FG003|Overall Study|Adverse Event|0|||
161825730|NCT01525628|584401892|FG004|Overall Study|Adverse Event|1|||
161825731|NCT01525628|584401888|FG000|Overall Study|Lack of Efficacy|0|||
161825732|NCT01525628|584401889|FG001|Overall Study|Lack of Efficacy|2|||
161825733|NCT01525628|584401890|FG002|Overall Study|Lack of Efficacy|2|||
161825734|NCT01525628|584401891|FG003|Overall Study|Lack of Efficacy|1|||
162208775|NCT01177228|585815788|FG000|Overall Study|Withdrawal by Subject|0|||
162208776|NCT01177228|585815789|FG001|Overall Study|Withdrawal by Subject|1|||
162208777|NCT01177228|585815790|FG002|Overall Study|Withdrawal by Subject|0|||
162208778|NCT01177228|585815791|FG003|Overall Study|Withdrawal by Subject|0|||
162208779|NCT01251887|585815792|FG000|Overall Study|Scheduling conflict|1|||
162208780|NCT01251887|585815793|FG001|Overall Study|Scheduling conflict|2|||
162208781|NCT01251887|585815794|FG002|Overall Study|Scheduling conflict|2|||
162208782|NCT01251887|585815792|FG000|Overall Study|Physician Decision|0|||
162208783|NCT01251887|585815793|FG001|Overall Study|Physician Decision|1|||
161825735|NCT01525628|584401892|FG004|Overall Study|Lack of Efficacy|2|||
161825736|NCT01525628|584401888|FG000|Overall Study|Protocol Violation|0|||
162208784|NCT01251887|585815794|FG002|Overall Study|Physician Decision|0|||
162208785|NCT03302559|585815800|FG000|Overall Study|Adverse Event|2|||
162208786|NCT03302559|585815800|FG000|Overall Study|Lost to Follow-up|1|||
162208787|NCT03302559|585815800|FG000|Overall Study|Withdrew Consent|3|||
162208788|NCT02080403|585816806|FG000|Overall Study|Adverse Event|5|||
161934311|NCT00215657|584808470|FG005|Overall Study|Insufficient testosterone response|12|||
161934312|NCT00215657|584808471|FG006|Overall Study|Insufficient testosterone response|4|||
161934313|NCT00215657|584808472|FG007|Overall Study|Insufficient testosterone response|7|||
161934314|NCT00215657|584808465|FG000|Overall Study|Other|3|||
162208789|NCT02080403|585816807|FG001|Overall Study|Adverse Event|1|||
162208790|NCT02080403|585816806|FG000|Overall Study|Death|0|||
162208791|NCT02080403|585816807|FG001|Overall Study|Death|2|||
162208792|NCT02080403|585816806|FG000|Overall Study|Lost to Follow-up|2|||
162208793|NCT02080403|585816807|FG001|Overall Study|Lost to Follow-up|0|||
162208794|NCT02080403|585816806|FG000|Overall Study|Pregnancy|0|||
162208795|NCT02080403|585816807|FG001|Overall Study|Pregnancy|1|||
162208796|NCT02080403|585816806|FG000|Overall Study|Protocol Violation|3|||
162208797|NCT02080403|585816807|FG001|Overall Study|Protocol Violation|7|||
162208798|NCT02080403|585816806|FG000|Overall Study|Withdrawal by Subject|5|||
162208799|NCT02080403|585816807|FG001|Overall Study|Withdrawal by Subject|1|||
162208800|NCT01999972|585816808|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
162208801|NCT01999972|585816809|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
162208802|NCT01999972|585816810|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
162208803|NCT01999972|585816811|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
162208804|NCT01999972|585816812|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
162208805|NCT01999972|585816813|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
162208806|NCT01999972|585816808|FG000|Dose Escalation Part|Death|0|||
162208807|NCT01999972|585816809|FG001|Dose Escalation Part|Death|1|||
161934315|NCT00215657|584808466|FG001|Overall Study|Other|1|||
161934316|NCT00215657|584808467|FG002|Overall Study|Other|2|||
161934317|NCT00215657|584808468|FG003|Overall Study|Other|3|||
161934318|NCT00215657|584808469|FG004|Overall Study|Other|5|||
161934319|NCT00215657|584808470|FG005|Overall Study|Other|4|||
161934320|NCT00215657|584808471|FG006|Overall Study|Other|6|||
161934321|NCT00215657|584808472|FG007|Overall Study|Other|1|||
161934322|NCT04754399|584808473|FG000|Overall Study|Adverse Event|5|||
161934323|NCT04754399|584808473|FG000|Overall Study|Withdrawal by Subject|6|||
161934324|NCT05259722|584808476|FG000|Overall Study|Adverse Event|2|||
161934325|NCT05259722|584808477|FG001|Overall Study|Adverse Event|24|||
161934326|NCT05259722|584808476|FG000|Overall Study|Lost to Follow-up|5|||
162208808|NCT01999972|585816810|FG002|Dose Escalation Part|Death|0|||
162208809|NCT01999972|585816811|FG003|Dose Escalation Part|Death|0|||
162208810|NCT01999972|585816812|FG004|Dose Escalation Part|Death|0|||
162208811|NCT01999972|585816813|FG005|Dose Escalation Part|Death|0|||
162208812|NCT01999972|585816808|FG000|Dose Escalation Part|Enrolled but not treated|0|||
162208813|NCT01999972|585816809|FG001|Dose Escalation Part|Enrolled but not treated|0|||
162208814|NCT01999972|585816810|FG002|Dose Escalation Part|Enrolled but not treated|1|||
162208815|NCT01999972|585816811|FG003|Dose Escalation Part|Enrolled but not treated|1|||
162208816|NCT01999972|585816812|FG004|Dose Escalation Part|Enrolled but not treated|0|||
162208817|NCT01999972|585816813|FG005|Dose Escalation Part|Enrolled but not treated|0|||
162208818|NCT01999972|585816808|FG000|Dose Escalation Part|Disease progression|3|||
162208819|NCT01999972|585816809|FG001|Dose Escalation Part|Disease progression|2|||
162208820|NCT01999972|585816810|FG002|Dose Escalation Part|Disease progression|3|||
162208821|NCT01999972|585816811|FG003|Dose Escalation Part|Disease progression|6|||
162208822|NCT01999972|585816812|FG004|Dose Escalation Part|Disease progression|0|||
162208823|NCT01999972|585816813|FG005|Dose Escalation Part|Disease progression|0|||
162208824|NCT01999972|585816808|FG000|Dose Escalation Part|Adverse Event|0|||
162208825|NCT01999972|585816809|FG001|Dose Escalation Part|Adverse Event|0|||
162208826|NCT01999972|585816810|FG002|Dose Escalation Part|Adverse Event|0|||
162208827|NCT01999972|585816811|FG003|Dose Escalation Part|Adverse Event|2|||
162208828|NCT01999972|585816812|FG004|Dose Escalation Part|Adverse Event|0|||
162208829|NCT01999972|585816813|FG005|Dose Escalation Part|Adverse Event|0|||
162208830|NCT01999972|585816808|FG000|Dose Escalation Part|Global deterioration of health status|1|||
162208831|NCT01999972|585816809|FG001|Dose Escalation Part|Global deterioration of health status|0|||
162208832|NCT01999972|585816810|FG002|Dose Escalation Part|Global deterioration of health status|0|||
162208833|NCT01999972|585816811|FG003|Dose Escalation Part|Global deterioration of health status|1|||
162208834|NCT01999972|585816812|FG004|Dose Escalation Part|Global deterioration of health status|0|||
162208835|NCT01999972|585816813|FG005|Dose Escalation Part|Global deterioration of health status|0|||
162208836|NCT01999972|585816808|FG000|Dose Expansion Part|Death|0|||
162208837|NCT01999972|585816809|FG001|Dose Expansion Part|Death|0|||
162208838|NCT01999972|585816810|FG002|Dose Expansion Part|Death|0|||
162208839|NCT01999972|585816811|FG003|Dose Expansion Part|Death|0|||
162208840|NCT01999972|585816812|FG004|Dose Expansion Part|Death|2|||
162208841|NCT01999972|585816813|FG005|Dose Expansion Part|Death|1|||
162208842|NCT01999972|585816808|FG000|Dose Expansion Part|Disease progression|0|||
162208843|NCT01999972|585816809|FG001|Dose Expansion Part|Disease progression|0|||
162208844|NCT01999972|585816810|FG002|Dose Expansion Part|Disease progression|0|||
162208845|NCT01999972|585816811|FG003|Dose Expansion Part|Disease progression|0|||
162208846|NCT01999972|585816812|FG004|Dose Expansion Part|Disease progression|9|||
162208847|NCT01999972|585816813|FG005|Dose Expansion Part|Disease progression|3|||
162208848|NCT01999972|585816808|FG000|Dose Expansion Part|Sponsor decision|0|||
162208849|NCT01999972|585816809|FG001|Dose Expansion Part|Sponsor decision|0|||
162208850|NCT01999972|585816810|FG002|Dose Expansion Part|Sponsor decision|0|||
162208851|NCT01999972|585816811|FG003|Dose Expansion Part|Sponsor decision|0|||
162208852|NCT01999972|585816812|FG004|Dose Expansion Part|Sponsor decision|1|||
162208853|NCT01999972|585816813|FG005|Dose Expansion Part|Sponsor decision|0|||
162208854|NCT01999972|585816808|FG000|Dose Expansion Part|Adverse Event|0|||
162208855|NCT01999972|585816809|FG001|Dose Expansion Part|Adverse Event|0|||
162208856|NCT01999972|585816810|FG002|Dose Expansion Part|Adverse Event|0|||
162208857|NCT01999972|585816811|FG003|Dose Expansion Part|Adverse Event|0|||
162208858|NCT01999972|585816812|FG004|Dose Expansion Part|Adverse Event|4|||
162208859|NCT01999972|585816813|FG005|Dose Expansion Part|Adverse Event|2|||
162208860|NCT01999972|585816808|FG000|Dose Expansion Part|Participant's non-compliance|0|||
162208861|NCT01999972|585816809|FG001|Dose Expansion Part|Participant's non-compliance|0|||
162208862|NCT01999972|585816810|FG002|Dose Expansion Part|Participant's non-compliance|0|||
162208863|NCT01999972|585816811|FG003|Dose Expansion Part|Participant's non-compliance|0|||
162208864|NCT01999972|585816812|FG004|Dose Expansion Part|Participant's non-compliance|0|||
162208865|NCT01999972|585816813|FG005|Dose Expansion Part|Participant's non-compliance|1|||
162208866|NCT01999972|585816808|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
162208867|NCT01999972|585816809|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
162208868|NCT01999972|585816810|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
162208869|NCT01999972|585816811|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
162208870|NCT01999972|585816812|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
161934327|NCT05259722|584808477|FG001|Overall Study|Lost to Follow-up|1|||
161934328|NCT05259722|584808476|FG000|Overall Study|Lack of Efficacy|8|||
161934329|NCT05259722|584808477|FG001|Overall Study|Lack of Efficacy|26|||
161934330|NCT05259722|584808476|FG000|Overall Study|Withdrawal by Subject|15|||
161934331|NCT05259722|584808477|FG001|Overall Study|Withdrawal by Subject|33|||
161934332|NCT05259722|584808476|FG000|Overall Study|Various reasons|3|||
162208871|NCT01999972|585816813|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
162208872|NCT01999972|585816808|FG000|Dose Expansion Part|Changed to standard of care|0|||
162208873|NCT01999972|585816809|FG001|Dose Expansion Part|Changed to standard of care|0|||
162208874|NCT01999972|585816810|FG002|Dose Expansion Part|Changed to standard of care|0|||
162208875|NCT01999972|585816811|FG003|Dose Expansion Part|Changed to standard of care|0|||
162208876|NCT01999972|585816812|FG004|Dose Expansion Part|Changed to standard of care|1|||
162208877|NCT01999972|585816813|FG005|Dose Expansion Part|Changed to standard of care|0|||
162208878|NCT01171183|585816814|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
161934333|NCT05259722|584808477|FG001|Overall Study|Various reasons|9|||
161825737|NCT01525628|584401889|FG001|Overall Study|Protocol Violation|0|||
161825738|NCT01525628|584401890|FG002|Overall Study|Protocol Violation|1|||
162208879|NCT01171183|585816815|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
162208880|NCT01171183|585816814|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
162208881|NCT01171183|585816815|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
162208882|NCT01171183|585816814|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
162208883|NCT01171183|585816815|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
162208884|NCT01171183|585816814|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
162208885|NCT01171183|585816815|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
162208886|NCT01171183|585816814|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
162208887|NCT01171183|585816815|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
162208888|NCT01171183|585816814|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
162208889|NCT01171183|585816815|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
162208890|NCT02826798|585816820|FG000|Overall Study|Withdrawal by Subject|0|||
162208891|NCT02826798|585816821|FG001|Overall Study|Withdrawal by Subject|1|||
162208892|NCT02826798|585816822|FG002|Overall Study|Withdrawal by Subject|0|||
162208893|NCT02826798|585816823|FG003|Overall Study|Withdrawal by Subject|1|||
162208894|NCT02826798|585816824|FG004|Overall Study|Withdrawal by Subject|0|||
162208895|NCT02806505|585816826|FG000|Overall Study|Adverse event/intercurrent illness|1|||
162208896|NCT02806505|585816827|FG001|Overall Study|Adverse event/intercurrent illness|3|||
162208897|NCT02806505|585816826|FG000|Overall Study|Death|4|||
162208898|NCT02806505|585816827|FG001|Overall Study|Death|0|||
162208899|NCT02806505|585816826|FG000|Overall Study|Did not cooperate/refused treatment|3|||
162208900|NCT02806505|585816827|FG001|Overall Study|Did not cooperate/refused treatment|3|||
162208901|NCT02806505|585816826|FG000|Overall Study|Failure to return|0|||
162208902|NCT02806505|585816827|FG001|Overall Study|Failure to return|1|||
162208903|NCT02806505|585816826|FG000|Overall Study|Insufficient therapeutic response|2|||
162208904|NCT02806505|585816827|FG001|Overall Study|Insufficient therapeutic response|4|||
162208905|NCT01722045|585816829|FG000|Overall Study|Adverse Event|8|||
162208906|NCT01722045|585816829|FG000|Overall Study|Death|3|||
162208907|NCT01722045|585816829|FG000|Overall Study|Withdrawal by Subject|8|||
162208908|NCT01722045|585816829|FG000|Overall Study|Lost to Follow-up|4|||
162208909|NCT01722045|585816829|FG000|Overall Study|Protocol Deviation|1|||
162208910|NCT01722045|585816829|FG000|Overall Study|Physician Decision|3|||
162208911|NCT01722045|585816829|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
162208912|NCT03898700|585816830|FG000|Overall Study|Withdrawal by Subject|2|||
162208913|NCT00701909|585816834|FG000|Overall Study|Withdrawal by Subject|0|||
162208914|NCT00701909|585816835|FG001|Overall Study|Withdrawal by Subject|1|||
162208915|NCT01844726|585816839|FG000|Overall Study|Withdrawal by Subject|0|||
162208916|NCT01844726|585816840|FG001|Overall Study|Withdrawal by Subject|1|||
162208917|NCT01844726|585816839|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
162208918|NCT01844726|585816840|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
162208919|NCT00916305|585816841|FG000|Overall Study|Lost to Follow-up|21|||
162208920|NCT00916305|585816842|FG001|Overall Study|Lost to Follow-up|27|||
162208921|NCT00916305|585816841|FG000|Overall Study|Withdrawal by Subject|0|||
162208922|NCT00916305|585816842|FG001|Overall Study|Withdrawal by Subject|1|||
162208923|NCT01288209|585816843|FG000|Overall Study|Withdrawal by Subject|1|||
162208924|NCT01288209|585816844|FG001|Overall Study|Withdrawal by Subject|3|||
162208925|NCT01288209|585816843|FG000|Overall Study|Other|1|||
162208926|NCT01288209|585816844|FG001|Overall Study|Other|0|||
162208927|NCT01646385|585816845|FG000|Overall Study|Death|202|||
162208928|NCT01646385|585816846|FG001|Overall Study|Death|222|||
162208929|NCT01646385|585816845|FG000|Overall Study|Switched to alternate biologic|636|||
161825739|NCT01525628|584401891|FG003|Overall Study|Protocol Violation|0|||
162208930|NCT01646385|585816846|FG001|Overall Study|Switched to alternate biologic|649|||
162208931|NCT00858247|585816849|FG000|Baseline Assessment|Withdrawal by Subject|1|||
162208932|NCT00858247|585816850|FG001|Baseline Assessment|Withdrawal by Subject|1|||
162208933|NCT00858247|585816849|FG000|Baseline Assessment|Poor IV access|1|||
162208934|NCT00858247|585816850|FG001|Baseline Assessment|Poor IV access|0|||
161825740|NCT01525628|584401892|FG004|Overall Study|Protocol Violation|0|||
161825741|NCT01525628|584401888|FG000|Overall Study|Lost to Follow-up|1|||
161825742|NCT01525628|584401889|FG001|Overall Study|Lost to Follow-up|1|||
161825743|NCT01525628|584401890|FG002|Overall Study|Lost to Follow-up|0|||
161825744|NCT01525628|584401891|FG003|Overall Study|Lost to Follow-up|0|||
161825745|NCT01525628|584401892|FG004|Overall Study|Lost to Follow-up|0|||
161825746|NCT01525628|584401888|FG000|Overall Study|Withdrawal by Subject|0|||
161825747|NCT01525628|584401889|FG001|Overall Study|Withdrawal by Subject|1|||
161825748|NCT01525628|584401890|FG002|Overall Study|Withdrawal by Subject|0|||
161825749|NCT01525628|584401891|FG003|Overall Study|Withdrawal by Subject|0|||
161825750|NCT01525628|584401892|FG004|Overall Study|Withdrawal by Subject|0|||
162208935|NCT00858247|585816849|FG000|Baseline Assessment|Protocol Violation|0|||
162208936|NCT00858247|585816850|FG001|Baseline Assessment|Protocol Violation|1|||
162208937|NCT00858247|585816849|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
162208938|NCT00858247|585816850|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
162208939|NCT03481556|585816851|FG000|Overall Study|Adverse Event|1|||
162208940|NCT03481556|585816852|FG001|Overall Study|Adverse Event|0|||
162208941|NCT03481556|585816853|FG002|Overall Study|Adverse Event|0|||
162208942|NCT03481556|585816854|FG003|Overall Study|Adverse Event|0|||
162208943|NCT03481556|585816851|FG000|Overall Study|Death|4|||
162208944|NCT03481556|585816852|FG001|Overall Study|Death|2|||
162208945|NCT03481556|585816853|FG002|Overall Study|Death|3|||
162208946|NCT03481556|585816854|FG003|Overall Study|Death|16|||
162208947|NCT03481556|585816851|FG000|Overall Study|Study Terminated by Sponsor|10|||
162208948|NCT03481556|585816852|FG001|Overall Study|Study Terminated by Sponsor|5|||
162208949|NCT03481556|585816853|FG002|Overall Study|Study Terminated by Sponsor|2|||
162208950|NCT03481556|585816854|FG003|Overall Study|Study Terminated by Sponsor|9|||
162208951|NCT01101997|585816855|FG000|Overall Study|Withdrawal by Subject|2|||
162208952|NCT00704171|585816856|FG000|Overall Study|Withdrawal by Subject|1|||
162208953|NCT00704171|585816857|FG001|Overall Study|Withdrawal by Subject|0|||
162208954|NCT00813098|585816860|FG000|Overall Study|Adverse Event|2|||
162208955|NCT00813098|585816861|FG001|Overall Study|Adverse Event|4|||
162208956|NCT00813098|585816862|FG002|Overall Study|Adverse Event|1|||
162208957|NCT00813098|585816860|FG000|Overall Study|Withdrawal by Subject|0|||
162208958|NCT00813098|585816861|FG001|Overall Study|Withdrawal by Subject|1|||
162208959|NCT00813098|585816862|FG002|Overall Study|Withdrawal by Subject|0|||
162208960|NCT00813098|585816860|FG000|Overall Study|Inability to complete study procedures|1|||
162208961|NCT00813098|585816861|FG001|Overall Study|Inability to complete study procedures|0|||
162208962|NCT00813098|585816862|FG002|Overall Study|Inability to complete study procedures|0|||
162208963|NCT00813098|585816860|FG000|Overall Study|Lost to Follow-up|0|||
162208964|NCT00813098|585816861|FG001|Overall Study|Lost to Follow-up|1|||
162208965|NCT00813098|585816862|FG002|Overall Study|Lost to Follow-up|0|||
162208966|NCT00813098|585816860|FG000|Overall Study|Protocol Violation|0|||
162208967|NCT00813098|585816861|FG001|Overall Study|Protocol Violation|0|||
162208968|NCT00813098|585816862|FG002|Overall Study|Protocol Violation|1|||
162208969|NCT00813098|585816860|FG000|Overall Study|Principal Investigator decision|0|||
162208970|NCT00813098|585816861|FG001|Overall Study|Principal Investigator decision|1|||
162208971|NCT00813098|585816862|FG002|Overall Study|Principal Investigator decision|0|||
162208972|NCT00813098|585816860|FG000|Overall Study|Withdrew Consent|0|||
162208973|NCT00813098|585816861|FG001|Overall Study|Withdrew Consent|1|||
162208974|NCT00813098|585816862|FG002|Overall Study|Withdrew Consent|0|||
162208975|NCT01772563|585816863|FG000|Cycle 1|Dose limiting toxicity|2|||
162208976|NCT01772563|585816863|FG000|Cycle 1|Progressive disease|2|||
162208977|NCT01772563|585816863|FG000|Cycle 2 and Beyond|Progressive disease|17|||
162208978|NCT01772563|585816863|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
162208979|NCT01772563|585816863|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
162208980|NCT02980705|585816874|FG000|Overall Study|Adverse Event|0|||
161677574|NCT01338415|583872031|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
161677575|NCT01338415|583872032|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
161677576|NCT01338415|583872033|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
161677577|NCT01338415|583872031|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
161677578|NCT01338415|583872032|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
161677579|NCT01338415|583872033|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
161677580|NCT01338415|583872031|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
161825751|NCT01525628|584401888|FG000|Overall Study|Other reason not defined above|0|||
161825752|NCT01525628|584401889|FG001|Overall Study|Other reason not defined above|0|||
162208981|NCT02980705|585816875|FG001|Overall Study|Adverse Event|1|||
162208982|NCT02980705|585816874|FG000|Overall Study|Withdrawal by Subject|6|||
162208983|NCT02980705|585816875|FG001|Overall Study|Withdrawal by Subject|9|||
162208984|NCT02980705|585816874|FG000|Overall Study|withdrew participation|0|||
162208985|NCT02980705|585816875|FG001|Overall Study|withdrew participation|1|||
162208986|NCT02980705|585816874|FG000|Overall Study|Lost to Follow-up|2|||
162208987|NCT02980705|585816875|FG001|Overall Study|Lost to Follow-up|0|||
161825753|NCT01525628|584401890|FG002|Overall Study|Other reason not defined above|0|||
161825754|NCT01525628|584401891|FG003|Overall Study|Other reason not defined above|3|||
161825755|NCT01525628|584401892|FG004|Overall Study|Other reason not defined above|0|||
161825756|NCT00787605|584401893|FG000|Overall Study|Administrative Problems|3|||
162208988|NCT00263575|585816876|FG000|Titration Period|Adverse Event|14|||
162208989|NCT00263575|585816876|FG000|Titration Period|Withdrawal by Subject|10|||
162208990|NCT00263575|585816876|FG000|Titration Period|Protocol Violation|9|||
162208991|NCT00263575|585816876|FG000|Titration Period|Sponsor Decision|2|||
162208992|NCT00263575|585816876|FG000|Titration Period|Other|2|||
162208993|NCT00263575|585816876|FG000|Titration Period|Lack of Efficacy|6|||
162208994|NCT00263575|585816876|FG000|Maintence Period|Adverse Event|23|||
162208995|NCT00263575|585816876|FG000|Maintence Period|Withdrawal by Subject|8|||
162208996|NCT00263575|585816876|FG000|Maintence Period|Protocol Violation|4|||
162208997|NCT00263575|585816876|FG000|Maintence Period|Lack of Efficacy|4|||
162208998|NCT00263575|585816876|FG000|Maintence Period|Physician Decision|6|||
162208999|NCT00263575|585816876|FG000|Maintence Period|Lost to Follow-up|1|||
162209000|NCT00263575|585816876|FG000|Maintence Period|Sponsor Decision|24|||
162209001|NCT00263575|585816876|FG000|Maintence Period|Other|7|||
162209002|NCT01880437|585816878|FG000|Overall Study|Death|12|||
162209003|NCT01880437|585816879|FG001|Overall Study|Death|4|||
162209004|NCT01880437|585816880|FG002|Overall Study|Death|17|||
162209005|NCT01880437|585816878|FG000|Overall Study|Study terminated by Sponsor|3|||
162209006|NCT01880437|585816879|FG001|Overall Study|Study terminated by Sponsor|0|||
162209007|NCT01880437|585816880|FG002|Overall Study|Study terminated by Sponsor|2|||
162209008|NCT01209598|585816881|FG000|Overall Study|Withdrawal by Subject|1|||
162209009|NCT01209598|585816882|FG001|Overall Study|Withdrawal by Subject|0|||
162209010|NCT01438840|585816883|FG000|Core Study|Adverse Event|0|||
162209011|NCT01438840|585816884|FG001|Core Study|Adverse Event|3|||
162209012|NCT01438840|585816885|FG002|Core Study|Adverse Event|0|||
162209013|NCT01438840|585816883|FG000|Core Study|Lack of Efficacy|15|||
162209014|NCT01438840|585816884|FG001|Core Study|Lack of Efficacy|7|||
162209015|NCT01438840|585816885|FG002|Core Study|Lack of Efficacy|0|||
162209016|NCT01438840|585816883|FG000|Core Study|Withdrawal of consent|1|||
162209017|NCT01438840|585816884|FG001|Core Study|Withdrawal of consent|0|||
162209018|NCT01438840|585816885|FG002|Core Study|Withdrawal of consent|0|||
162209019|NCT01438840|585816883|FG000|Extension Phase|Adverse Event|0|||
162209020|NCT01438840|585816884|FG001|Extension Phase|Adverse Event|0|||
162209021|NCT01438840|585816885|FG002|Extension Phase|Adverse Event|3|||
162209022|NCT01438840|585816883|FG000|Extension Phase|Lost to Follow-up|0|||
162209023|NCT01438840|585816884|FG001|Extension Phase|Lost to Follow-up|0|||
162209024|NCT01438840|585816885|FG002|Extension Phase|Lost to Follow-up|1|||
162209025|NCT01438840|585816883|FG000|Extension Phase|Withdrawal by Subject|0|||
162209026|NCT01438840|585816884|FG001|Extension Phase|Withdrawal by Subject|0|||
162209027|NCT01438840|585816885|FG002|Extension Phase|Withdrawal by Subject|3|||
162209028|NCT01438840|585816883|FG000|Extension Phase|Lack of Efficacy|0|||
162209029|NCT01438840|585816884|FG001|Extension Phase|Lack of Efficacy|0|||
162209030|NCT01438840|585816885|FG002|Extension Phase|Lack of Efficacy|2|||
162209031|NCT01438840|585816883|FG000|Extension Phase|Other|0|||
162209032|NCT01438840|585816884|FG001|Extension Phase|Other|0|||
162209033|NCT01438840|585816885|FG002|Extension Phase|Other|1|||
162209034|NCT00085566|585816886|FG000|Overall Study|Adverse Event|0|||
162209035|NCT00085566|585816887|FG001|Overall Study|Adverse Event|0|||
162209036|NCT00085566|585816888|FG002|Overall Study|Adverse Event|10|||
162209037|NCT00085566|585816886|FG000|Overall Study|Patient Not treated|0|||
162209038|NCT00085566|585816887|FG001|Overall Study|Patient Not treated|0|||
162209039|NCT00085566|585816888|FG002|Overall Study|Patient Not treated|3|||
162209040|NCT00085566|585816886|FG000|Overall Study|Clinical progression|0|||
162209041|NCT00085566|585816887|FG001|Overall Study|Clinical progression|0|||
162209042|NCT00085566|585816888|FG002|Overall Study|Clinical progression|1|||
162209043|NCT04688086|585816893|FG000|Overall Study|Lost to Follow-up|164|||
162209044|NCT04688086|585816893|FG000|Overall Study|Imaging error;|64|||
162209045|NCT01329419|585816896|FG000|Overall Study|Protocol Violation|235|||
162209046|NCT00934700|585816901|FG000|Overall Study|missing scan|5|||
162209047|NCT00934700|585816902|FG001|Overall Study|missing scan|9|||
162209048|NCT00934700|585816901|FG000|Overall Study|Death|8|||
162209049|NCT00934700|585816902|FG001|Overall Study|Death|3|||
162209050|NCT01831726|585816903|FG000|Overall Study|Adverse Event|16|||
162209051|NCT01831726|585816903|FG000|Overall Study|Death|7|||
162209052|NCT01831726|585816903|FG000|Overall Study|Disease Progression|49|||
162209053|NCT01831726|585816903|FG000|Overall Study|Physician Decision|1|||
162209054|NCT01831726|585816903|FG000|Overall Study|Subject/guardian decision|7|||
162209055|NCT00514813|585816904|FG000|Overall Study|Study terminated|14|||
162209056|NCT00514813|585816905|FG001|Overall Study|Study terminated|74|||
162209057|NCT00514813|585816906|FG002|Overall Study|Study terminated|40|||
162209058|NCT00514813|585816907|FG003|Overall Study|Study terminated|2|||
162209059|NCT00514813|585816904|FG000|Overall Study|Adverse Event|0|||
161825757|NCT00787605|584401894|FG001|Overall Study|Administrative Problems|0|||
161825758|NCT00787605|584401893|FG000|Overall Study|Adverse Event|14|||
161825759|NCT00787605|584401894|FG001|Overall Study|Adverse Event|25|||
161825760|NCT00787605|584401893|FG000|Overall Study|Lost to Follow-up|3|||
162209060|NCT00514813|585816905|FG001|Overall Study|Adverse Event|2|||
162209061|NCT00514813|585816906|FG002|Overall Study|Adverse Event|2|||
162209062|NCT00514813|585816907|FG003|Overall Study|Adverse Event|0|||
162209063|NCT00514813|585816904|FG000|Overall Study|Protocol Violation|1|||
162209064|NCT00514813|585816905|FG001|Overall Study|Protocol Violation|0|||
162209065|NCT00514813|585816906|FG002|Overall Study|Protocol Violation|0|||
162209066|NCT00514813|585816907|FG003|Overall Study|Protocol Violation|0|||
162209067|NCT00514813|585816904|FG000|Overall Study|Withdrawal by Subject|0|||
162209068|NCT00514813|585816905|FG001|Overall Study|Withdrawal by Subject|1|||
161825761|NCT00787605|584401894|FG001|Overall Study|Lost to Follow-up|6|||
162209069|NCT00514813|585816906|FG002|Overall Study|Withdrawal by Subject|0|||
162209070|NCT00514813|585816907|FG003|Overall Study|Withdrawal by Subject|0|||
162209071|NCT00514813|585816904|FG000|Overall Study|Lack of Efficacy|0|||
162209072|NCT00514813|585816905|FG001|Overall Study|Lack of Efficacy|1|||
161825762|NCT00787605|584401893|FG000|Overall Study|Protocol Violation|7|||
162209073|NCT00514813|585816906|FG002|Overall Study|Lack of Efficacy|0|||
162209074|NCT00514813|585816907|FG003|Overall Study|Lack of Efficacy|0|||
162209075|NCT00514813|585816904|FG000|Overall Study|Kidney transplant|0|||
162209076|NCT00514813|585816905|FG001|Overall Study|Kidney transplant|6|||
162209077|NCT00514813|585816906|FG002|Overall Study|Kidney transplant|2|||
162209078|NCT00514813|585816907|FG003|Overall Study|Kidney transplant|0|||
162209079|NCT00514813|585816904|FG000|Overall Study|Death|0|||
162209080|NCT00514813|585816905|FG001|Overall Study|Death|2|||
162209081|NCT00514813|585816906|FG002|Overall Study|Death|3|||
162209082|NCT00514813|585816907|FG003|Overall Study|Death|2|||
162209083|NCT01075100|585816910|FG000|Overall Study|Adverse Event|15|||
162209084|NCT01075100|585816911|FG001|Overall Study|Adverse Event|18|||
162209085|NCT01075100|585816910|FG000|Overall Study|Patient Request|4|||
162209086|NCT01075100|585816911|FG001|Overall Study|Patient Request|4|||
162209087|NCT01075100|585816910|FG000|Overall Study|Investigator Request|2|||
162209088|NCT01075100|585816911|FG001|Overall Study|Investigator Request|1|||
162209089|NCT01075100|585816910|FG000|Overall Study|Disease Progression|25|||
162209090|NCT01075100|585816911|FG001|Overall Study|Disease Progression|29|||
162209091|NCT01075100|585816910|FG000|Overall Study|Other|3|||
162209092|NCT01075100|585816911|FG001|Overall Study|Other|1|||
162209093|NCT00966264|585818129|FG000|Overall Study|Lost to Follow-up|4|||
162209094|NCT00966264|585818130|FG001|Overall Study|Lost to Follow-up|3|||
162209095|NCT03614676|585818131|FG000|Overall Study|Delivery before planned visit|2|||
162209096|NCT03614676|585818132|FG001|Overall Study|Delivery before planned visit|0|||
162209097|NCT03614676|585818131|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
162209098|NCT03614676|585818132|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
162209099|NCT03614676|585818131|FG000|Overall Study|Migrated / moved from the study area|30|||
162209100|NCT03614676|585818132|FG001|Overall Study|Migrated / moved from the study area|22|||
162209101|NCT03614676|585818131|FG000|Overall Study|Lost to Follow-up|17|||
162209102|NCT03614676|585818132|FG001|Overall Study|Lost to Follow-up|42|||
162209103|NCT03614676|585818131|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
162209104|NCT03614676|585818132|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
162209105|NCT03614676|585818131|FG000|Overall Study|Other|16|||
162209106|NCT03614676|585818132|FG001|Overall Study|Other|47|||
162209107|NCT03614676|585818131|FG000|Overall Study|Protocol Violation|0|||
161825763|NCT00787605|584401894|FG001|Overall Study|Protocol Violation|3|||
161825764|NCT00787605|584401893|FG000|Overall Study|Withdrawal by Subject|6|||
161825765|NCT00787605|584401894|FG001|Overall Study|Withdrawal by Subject|13|||
161825766|NCT00787605|584401893|FG000|Overall Study|Lack of Efficacy|13|||
161825767|NCT00787605|584401894|FG001|Overall Study|Lack of Efficacy|9|||
161825768|NCT01223027|584401895|FG000|Overall Study|Adverse Event|20|||
162209108|NCT03614676|585818132|FG001|Overall Study|Protocol Violation|2|||
162209109|NCT03614676|585818131|FG000|Overall Study|Neonatal event of interest|0|||
162209110|NCT03614676|585818132|FG001|Overall Study|Neonatal event of interest|6|||
162209111|NCT03614676|585818131|FG000|Overall Study|Death in infant greater than 28 days old|0|||
162209112|NCT03614676|585818132|FG001|Overall Study|Death in infant greater than 28 days old|12|||
162209113|NCT03614676|585818131|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
162209114|NCT03614676|585818132|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
162209115|NCT02034162|585818138|FG000|Double-blind|Lost to Follow-up|3|||
162209116|NCT02034162|585818139|FG001|Double-blind|Lost to Follow-up|0|||
162209117|NCT02034162|585818140|FG002|Double-blind|Lost to Follow-up|0|||
162209118|NCT02034162|585818138|FG000|Double-blind|Physician Decision|1|||
162209119|NCT02034162|585818139|FG001|Double-blind|Physician Decision|0|||
161677581|NCT01338415|583872032|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
161677582|NCT01338415|583872033|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
161677583|NCT01338415|583872031|FG000|Exceptional Use Treatment Period|Death|0|||
161677584|NCT01338415|583872032|FG001|Exceptional Use Treatment Period|Death|0|||
161677585|NCT01338415|583872033|FG002|Exceptional Use Treatment Period|Death|1|||
161677586|NCT01118325|583872034|FG000|Overall Study|Adverse Event|1|||
161677587|NCT01118325|583872035|FG001|Overall Study|Adverse Event|0|||
161677588|NCT01118325|583872036|FG002|Overall Study|Adverse Event|1|||
161677589|NCT00536809|583872037|FG000|Phase II|Adverse Event|1|||
161677590|NCT00536809|583872037|FG000|Phase II|Referred for surgical resection|1|||
161677591|NCT03334409|583872038|FG000|Overall Study|Did not meet inclusion criteria|1|||
161677592|NCT03334409|583872039|FG001|Overall Study|Did not meet inclusion criteria|0|||
161677593|NCT00233363|583872044|FG000|Overall Study|Adverse Event|1|||
161677594|NCT00233363|583872045|FG001|Overall Study|Adverse Event|2|||
161677595|NCT00233363|583872044|FG000|Overall Study|Lack of Efficacy|0|||
161677596|NCT00233363|583872045|FG001|Overall Study|Lack of Efficacy|2|||
161677597|NCT00233363|583872044|FG000|Overall Study|Withdrawal by Subject|1|||
161677598|NCT00233363|583872045|FG001|Overall Study|Withdrawal by Subject|1|||
161677599|NCT00233363|583872044|FG000|Overall Study|Aggravation of complication|1|||
161677600|NCT00233363|583872045|FG001|Overall Study|Aggravation of complication|0|||
161677601|NCT05215262|583872051|FG000|Overall Study|Lost to Follow-up|12|||
161677602|NCT05215262|583872052|FG001|Overall Study|Lost to Follow-up|0|||
161677603|NCT04880447|583872054|FG000|Overall Study|No vaccination information|1|||
161677604|NCT04880447|583872054|FG000|Overall Study|No adverse event information (missing information)|1|||
161677605|NCT04880447|583872054|FG000|Overall Study|Disease not covered in this study|35|||
161677606|NCT02871778|583872064|FG000|Part A: Treatment Period 1|Adverse Event|1|||
161677607|NCT02871778|583872065|FG001|Part A: Treatment Period 1|Adverse Event|1|||
161677608|NCT02871778|583872066|FG002|Part A: Treatment Period 1|Adverse Event|1|||
162021335|NCT02891070|585134748|FG000|Overall Study|Physician Decision|0|||
162209120|NCT02034162|585818140|FG002|Double-blind|Physician Decision|0|||
162209121|NCT02034162|585818138|FG000|Double-blind|Protocol Violation|0|||
162209122|NCT02034162|585818139|FG001|Double-blind|Protocol Violation|1|||
162209123|NCT02034162|585818140|FG002|Double-blind|Protocol Violation|0|||
162209124|NCT02034162|585818138|FG000|Double-blind|Withdrawal by Subject|5|||
162209125|NCT02034162|585818139|FG001|Double-blind|Withdrawal by Subject|7|||
162209126|NCT02034162|585818140|FG002|Double-blind|Withdrawal by Subject|0|||
162209127|NCT00760513|585818141|FG000|Overall Study|Withdrawal by Subject|5|||
161677609|NCT02871778|583872067|FG003|Part A: Treatment Period 1|Adverse Event|0|||
161677610|NCT02871778|583872068|FG004|Part A: Treatment Period 1|Adverse Event|0|||
161677611|NCT02871778|583872069|FG005|Part A: Treatment Period 1|Adverse Event|0|||
161677612|NCT02871778|583872070|FG006|Part A: Treatment Period 1|Adverse Event|0|||
161677613|NCT02871778|583872071|FG007|Part A: Treatment Period 1|Adverse Event|0|||
161677614|NCT02871778|583872064|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
161677615|NCT02871778|583872065|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
161825769|NCT01223027|584401896|FG001|Overall Study|Adverse Event|10|||
161825770|NCT01223027|584401895|FG000|Overall Study|Death|42|||
161825771|NCT01223027|584401896|FG001|Overall Study|Death|42|||
161825772|NCT01223027|584401895|FG000|Overall Study|Lost to Follow-up|2|||
161825773|NCT01223027|584401896|FG001|Overall Study|Lost to Follow-up|1|||
161825774|NCT01223027|584401895|FG000|Overall Study|Physician Decision|4|||
161825775|NCT01223027|584401896|FG001|Overall Study|Physician Decision|8|||
161825776|NCT01223027|584401895|FG000|Overall Study|Progressive Disease|167|||
161825777|NCT01223027|584401896|FG001|Overall Study|Progressive Disease|183|||
161825778|NCT01223027|584401895|FG000|Overall Study|Protocol Violation|2|||
161825779|NCT01223027|584401896|FG001|Overall Study|Protocol Violation|1|||
161825780|NCT01223027|584401895|FG000|Overall Study|Subject/guardian decicion|18|||
161825781|NCT01223027|584401896|FG001|Overall Study|Subject/guardian decicion|16|||
161825782|NCT01223027|584401895|FG000|Overall Study|New therapy for study indication|17|||
161825783|NCT01223027|584401896|FG001|Overall Study|New therapy for study indication|8|||
161825784|NCT01223027|584401895|FG000|Overall Study|Study terminated by sponsor|2|||
161825785|NCT01223027|584401896|FG001|Overall Study|Study terminated by sponsor|8|||
161825786|NCT03493919|584401897|FG000|Overall Study|Other|2|||
161825787|NCT03493919|584401898|FG001|Overall Study|Other|0|||
161825788|NCT03493919|584401899|FG002|Overall Study|Other|1|||
162209128|NCT00760513|585818142|FG001|Overall Study|Withdrawal by Subject|7|||
162209129|NCT02808975|585818147|FG000|Overall Study|Adverse Event|3|||
162209130|NCT02808975|585818148|FG001|Overall Study|Adverse Event|4|||
162209131|NCT02808975|585818147|FG000|Overall Study|Withdrew consent|9|||
162209132|NCT02808975|585818148|FG001|Overall Study|Withdrew consent|8|||
162209133|NCT02808975|585818147|FG000|Overall Study|Lost to Follow-up|4|||
162209134|NCT02808975|585818148|FG001|Overall Study|Lost to Follow-up|6|||
162209135|NCT02808975|585818147|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
162209136|NCT02808975|585818148|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
162209137|NCT02808975|585818147|FG000|Overall Study|Other, not specified|5|||
162209138|NCT02808975|585818148|FG001|Overall Study|Other, not specified|1|||
162209139|NCT00416598|585818149|FG000|Induction & Intensification|Adverse Event|38|||
162209140|NCT00416598|585818149|FG000|Induction & Intensification|Death|32|||
162209141|NCT00416598|585818149|FG000|Induction & Intensification|Withdrawal by Subject|46|||
162209142|NCT00416598|585818149|FG000|Induction & Intensification|Alternative Treatment|135|||
162209143|NCT00416598|585818149|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
162209144|NCT00416598|585818149|FG000|Induction & Intensification|Relapse/progression|29|||
162209145|NCT00416598|585818149|FG000|Induction & Intensification|Failed induction|87|||
162209146|NCT00416598|585818149|FG000|Decitabine Maintenance|Adverse Event|5|||
162209147|NCT00416598|585818149|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
162209148|NCT00416598|585818149|FG000|Decitabine Maintenance|Progression/relapse|38|||
162209149|NCT00416598|585818149|FG000|Decitabine Maintenance|Alternative treatment|2|||
162209150|NCT00416598|585818149|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
162209151|NCT02166476|585818156|FG000|Overall Study|Withdrawal by Subject|5|||
162209152|NCT02166476|585818157|FG001|Overall Study|Withdrawal by Subject|7|||
162209153|NCT02166476|585818156|FG000|Overall Study|Adverse Event|3|||
162209154|NCT02166476|585818157|FG001|Overall Study|Adverse Event|3|||
162209155|NCT02166476|585818156|FG000|Overall Study|Lost to Follow-up|5|||
162209156|NCT02166476|585818157|FG001|Overall Study|Lost to Follow-up|10|||
162209157|NCT02166476|585818156|FG000|Overall Study|Physician Decision|1|||
162209158|NCT02166476|585818157|FG001|Overall Study|Physician Decision|0|||
162209159|NCT02166476|585818156|FG000|Overall Study|Unable to Come for Visit|0|||
162209160|NCT02166476|585818157|FG001|Overall Study|Unable to Come for Visit|3|||
162209161|NCT04367480|585818164|FG000|Overall Study|Adverse Event|1|||
162209162|NCT04367480|585818165|FG001|Overall Study|Adverse Event|1|||
162209163|NCT04367480|585818164|FG000|Overall Study|Death|1|||
162209164|NCT04367480|585818165|FG001|Overall Study|Death|0|||
162209165|NCT04367480|585818164|FG000|Overall Study|Lost to Follow-up|1|||
162209166|NCT04367480|585818165|FG001|Overall Study|Lost to Follow-up|1|||
162209167|NCT04367480|585818164|FG000|Overall Study|Withdrawal by Subject|0|||
162209168|NCT04367480|585818165|FG001|Overall Study|Withdrawal by Subject|3|||
161677616|NCT02871778|583872066|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
162209169|NCT04367480|585818164|FG000|Overall Study|App glitch during the study|1|||
162209170|NCT04367480|585818165|FG001|Overall Study|App glitch during the study|0|||
162209171|NCT04367480|585818164|FG000|Overall Study|Device Distribution Error|0|||
162209172|NCT04367480|585818165|FG001|Overall Study|Device Distribution Error|2|||
162209173|NCT04367480|585818164|FG000|Overall Study|Ineligible after Randomization|0|||
162209174|NCT04367480|585818165|FG001|Overall Study|Ineligible after Randomization|1|||
162209175|NCT04367480|585818164|FG000|Overall Study|Other Medical Reasons|0|||
162209176|NCT04367480|585818165|FG001|Overall Study|Other Medical Reasons|2|||
162209177|NCT03382561|585818166|FG000|Overall Study|Disease progression|47|||
162209178|NCT03382561|585818167|FG001|Overall Study|Disease progression|6|||
161677617|NCT02871778|583872067|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
161677618|NCT02871778|583872068|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161677619|NCT02871778|583872069|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161677620|NCT02871778|583872070|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161677621|NCT02871778|583872071|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161677622|NCT02871778|583872064|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161677623|NCT02871778|583872065|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
162209179|NCT03382561|585818166|FG000|Overall Study|Adverse Event|10|||
162209180|NCT03382561|585818167|FG001|Overall Study|Adverse Event|2|||
162209181|NCT03382561|585818166|FG000|Overall Study|Death|8|||
162209182|NCT03382561|585818167|FG001|Overall Study|Death|3|||
162209183|NCT03382561|585818166|FG000|Overall Study|Withdrawal by Subject|6|||
162209184|NCT03382561|585818167|FG001|Overall Study|Withdrawal by Subject|5|||
162209185|NCT03382561|585818166|FG000|Overall Study|Alternative therapy|2|||
162209186|NCT03382561|585818167|FG001|Overall Study|Alternative therapy|8|||
162209187|NCT03382561|585818166|FG000|Overall Study|Never started treatment|3|||
161677624|NCT02871778|583872066|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
161677625|NCT02871778|583872067|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161677626|NCT02871778|583872068|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161677627|NCT02871778|583872069|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161677628|NCT02871778|583872070|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161677629|NCT02871778|583872071|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161677630|NCT02871778|583872064|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161677631|NCT02871778|583872065|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161677632|NCT02871778|583872066|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
161677633|NCT02871778|583872067|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161677634|NCT02871778|583872068|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161825789|NCT03493919|584401900|FG003|Overall Study|Other|0|||
161825790|NCT03493919|584401897|FG000|Overall Study|Withdrawal by Subject|9|||
161825791|NCT03493919|584401898|FG001|Overall Study|Withdrawal by Subject|3|||
161825792|NCT03493919|584401899|FG002|Overall Study|Withdrawal by Subject|1|||
161825793|NCT03493919|584401900|FG003|Overall Study|Withdrawal by Subject|1|||
161825794|NCT03493919|584401897|FG000|Overall Study|Lost to Follow-up|5|||
161825795|NCT03493919|584401898|FG001|Overall Study|Lost to Follow-up|0|||
161825796|NCT03493919|584401899|FG002|Overall Study|Lost to Follow-up|0|||
161825797|NCT03493919|584401900|FG003|Overall Study|Lost to Follow-up|3|||
161825798|NCT03493919|584401897|FG000|Overall Study|Adverse Event|0|||
161825799|NCT03493919|584401898|FG001|Overall Study|Adverse Event|1|||
161825800|NCT03493919|584401899|FG002|Overall Study|Adverse Event|0|||
161825801|NCT03493919|584401900|FG003|Overall Study|Adverse Event|0|||
161825802|NCT01475487|584401901|FG000|Overall Study|had to leave early for personal reasons|2|||
161825803|NCT01475487|584401902|FG001|Overall Study|had to leave early for personal reasons|1|||
161825804|NCT04428645|584401903|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
161825805|NCT00401245|584403733|FG000|Double Blind Titration Phase|Adverse Event|3|||
161825806|NCT00401245|584403734|FG001|Double Blind Titration Phase|Adverse Event|2|||
161825807|NCT00401245|584403735|FG002|Double Blind Titration Phase|Adverse Event|5|||
161825808|NCT00401245|584403736|FG003|Double Blind Titration Phase|Adverse Event|12|||
161825809|NCT00401245|584403737|FG004|Double Blind Titration Phase|Adverse Event|0|||
161825810|NCT00401245|584403738|FG005|Double Blind Titration Phase|Adverse Event|0|||
161825811|NCT00401245|584403739|FG006|Double Blind Titration Phase|Adverse Event|0|||
161825812|NCT00401245|584403740|FG007|Double Blind Titration Phase|Adverse Event|0|||
161825813|NCT00401245|584403733|FG000|Double Blind Titration Phase|Other|0|||
161825814|NCT00401245|584403734|FG001|Double Blind Titration Phase|Other|0|||
161825815|NCT00401245|584403735|FG002|Double Blind Titration Phase|Other|1|||
161825816|NCT00401245|584403736|FG003|Double Blind Titration Phase|Other|0|||
161825817|NCT00401245|584403737|FG004|Double Blind Titration Phase|Other|0|||
161825818|NCT00401245|584403738|FG005|Double Blind Titration Phase|Other|0|||
161825819|NCT00401245|584403739|FG006|Double Blind Titration Phase|Other|0|||
161825820|NCT00401245|584403740|FG007|Double Blind Titration Phase|Other|0|||
161825821|NCT00401245|584403733|FG000|Double Blind Titration Phase|Protocol Violation|0|||
161825822|NCT00401245|584403734|FG001|Double Blind Titration Phase|Protocol Violation|0|||
161825823|NCT00401245|584403735|FG002|Double Blind Titration Phase|Protocol Violation|0|||
161825824|NCT00401245|584403736|FG003|Double Blind Titration Phase|Protocol Violation|1|||
161825825|NCT00401245|584403737|FG004|Double Blind Titration Phase|Protocol Violation|0|||
161825826|NCT00401245|584403738|FG005|Double Blind Titration Phase|Protocol Violation|0|||
161825827|NCT00401245|584403739|FG006|Double Blind Titration Phase|Protocol Violation|0|||
161825828|NCT00401245|584403740|FG007|Double Blind Titration Phase|Protocol Violation|0|||
161825829|NCT00401245|584403733|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
161825830|NCT00401245|584403734|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
161825831|NCT00401245|584403735|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
162209188|NCT03382561|585818167|FG001|Overall Study|Never started treatment|6|||
162209189|NCT03382561|585818166|FG000|Overall Study|Lack of Efficacy|0|||
162209190|NCT03382561|585818167|FG001|Overall Study|Lack of Efficacy|1|||
162209191|NCT03382561|585818166|FG000|Overall Study|Physician Decision|0|||
162209192|NCT03382561|585818167|FG001|Overall Study|Physician Decision|1|||
162209193|NCT03382561|585818166|FG000|Overall Study|Other complicating disease|0|||
162209194|NCT03382561|585818167|FG001|Overall Study|Other complicating disease|1|||
162209195|NCT01131104|585818168|FG000|Overall Study|Withdrawal by Subject|3|||
162209196|NCT01131104|585818168|FG000|Overall Study|Physician Decision|4|||
162209197|NCT01131104|585818168|FG000|Overall Study|Information Not Available|5|||
162209198|NCT01131104|585818168|FG000|Overall Study|No Information on Index Date of Onset|1|||
162209199|NCT04523207|585818172|FG000|Overall Study|Adverse Event|5|||
162209200|NCT04523207|585818173|FG001|Overall Study|Adverse Event|1|||
162209201|NCT04523207|585818172|FG000|Overall Study|Lost to Follow-up|2|||
162209202|NCT04523207|585818173|FG001|Overall Study|Lost to Follow-up|0|||
162209203|NCT04523207|585818172|FG000|Overall Study|Withdrawal by Subject|2|||
162209204|NCT04523207|585818173|FG001|Overall Study|Withdrawal by Subject|0|||
162209205|NCT04523207|585818172|FG000|Overall Study|Progressive Disease|2|||
162209206|NCT04523207|585818173|FG001|Overall Study|Progressive Disease|1|||
162209207|NCT04523207|585818172|FG000|Overall Study|Other|7|||
162209208|NCT04523207|585818173|FG001|Overall Study|Other|1|||
162209209|NCT03113383|585818174|FG000|Overall Study|Death|4|||
162209210|NCT03113383|585818175|FG001|Overall Study|Death|0|||
162209211|NCT04469465|585818176|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
162209212|NCT04469465|585818177|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
162209213|NCT04469465|585818176|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
162209214|NCT04469465|585818177|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
162209215|NCT04469465|585818176|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
162209216|NCT04469465|585818177|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
162209217|NCT04469465|585818176|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
162209218|NCT04469465|585818177|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
162209219|NCT04469465|585818176|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
162209220|NCT04469465|585818177|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
162209221|NCT04469465|585818176|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
162209222|NCT04469465|585818177|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
162209223|NCT04469465|585818176|FG000|Long-Term Extension (LTE)|Death|0|||
162209224|NCT04469465|585818177|FG001|Long-Term Extension (LTE)|Death|1|||
162209225|NCT04469465|585818176|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
162209226|NCT04469465|585818177|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
162209227|NCT02438371|585818178|FG000|Overall Study|Lost to Follow-up|3|||
162209228|NCT02438371|585818179|FG001|Overall Study|Lost to Follow-up|2|||
162209229|NCT02438371|585818178|FG000|Overall Study|Withdrawal by Subject|1|||
162209230|NCT02438371|585818179|FG001|Overall Study|Withdrawal by Subject|1|||
162209231|NCT03065933|585818183|FG000|Overall Study|study terminated|5|||
162209232|NCT02536742|585818184|FG000|Overall Study|Did not start protocol therapy|1|||
162209233|NCT02536742|585818184|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
162209234|NCT01010204|585818185|FG000|Overall Study|Lost to Follow-up|2|||
162209235|NCT01010204|585818186|FG001|Overall Study|Lost to Follow-up|2|||
162209236|NCT01010204|585818185|FG000|Overall Study|Adverse Event|1|||
162209237|NCT01010204|585818186|FG001|Overall Study|Adverse Event|3|||
162209238|NCT01010204|585818185|FG000|Overall Study|Withdrawal by Subject|2|||
162209239|NCT01010204|585818186|FG001|Overall Study|Withdrawal by Subject|3|||
162209240|NCT01010204|585818185|FG000|Overall Study|psychiatric hospitalization|2|||
162209241|NCT01010204|585818186|FG001|Overall Study|psychiatric hospitalization|1|||
162209242|NCT01513330|585818187|FG000|SenSura Mio First,|Adverse Event|2|||
162209243|NCT01513330|585818188|FG001|SenSura Mio First,|Adverse Event|0|||
162209244|NCT01513330|585818187|FG000|SenSura Mio First,|Lack of Efficacy|0|||
162209245|NCT01513330|585818188|FG001|SenSura Mio First,|Lack of Efficacy|1|||
162209246|NCT01513330|585818187|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
162209247|NCT01513330|585818188|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
162209248|NCT01513330|585818187|FG000|SenSura Mio First,|Other|1|||
162209249|NCT01513330|585818188|FG001|SenSura Mio First,|Other|0|||
162209250|NCT01513330|585818187|FG000|Standard Care First,|Lack of Efficacy|2|||
162209251|NCT01513330|585818188|FG001|Standard Care First,|Lack of Efficacy|2|||
162209252|NCT01513330|585818187|FG000|Standard Care First,|Withdrawal by Subject|1|||
162209253|NCT01513330|585818188|FG001|Standard Care First,|Withdrawal by Subject|2|||
162209254|NCT01513330|585818187|FG000|Standard Care First,|Other|1|||
162209255|NCT01513330|585818188|FG001|Standard Care First,|Other|0|||
162209256|NCT01519778|585818189|FG000|Overall Study|Withdrawal by Subject|3|||
162209257|NCT01519778|585818189|FG000|Overall Study|Lost to Follow-up|10|||
162209258|NCT01519778|585818189|FG000|Overall Study|Physician Decision|1|||
162209259|NCT01547117|585818194|FG000|Overall Study|Physician Decision|0|||
162209260|NCT01547117|585818195|FG001|Overall Study|Physician Decision|1|||
162209261|NCT01547117|585818196|FG002|Overall Study|Physician Decision|1|||
162209262|NCT01547117|585818197|FG003|Overall Study|Physician Decision|3|||
162209263|NCT01547117|585818194|FG000|Overall Study|Withdrawal by Subject|1|||
162209264|NCT01547117|585818195|FG001|Overall Study|Withdrawal by Subject|2|||
162209265|NCT01547117|585818196|FG002|Overall Study|Withdrawal by Subject|1|||
162209266|NCT01547117|585818197|FG003|Overall Study|Withdrawal by Subject|2|||
162209267|NCT02229578|585818198|FG000|Overall Study|Withdrawal by Subject|1|||
162209268|NCT02229578|585818199|FG001|Overall Study|Withdrawal by Subject|3|||
162209269|NCT02229578|585818198|FG000|Overall Study|Protocol Violation|2|||
162209270|NCT02229578|585818199|FG001|Overall Study|Protocol Violation|0|||
162209271|NCT01496365|585818200|FG000|Overall Study|Adverse Event|2|||
162209272|NCT01496365|585818201|FG001|Overall Study|Adverse Event|3|||
162209273|NCT01496365|585818202|FG002|Overall Study|Adverse Event|3|||
162209274|NCT01496365|585818203|FG003|Overall Study|Adverse Event|2|||
162209275|NCT01496365|585818204|FG004|Overall Study|Adverse Event|5|||
162209276|NCT01496365|585818205|FG005|Overall Study|Adverse Event|6|||
162209277|NCT01496365|585818206|FG006|Overall Study|Adverse Event|4|||
162209278|NCT01496365|585818200|FG000|Overall Study|Withdrawal by Subject|6|||
162209279|NCT01496365|585818201|FG001|Overall Study|Withdrawal by Subject|6|||
162209280|NCT01496365|585818202|FG002|Overall Study|Withdrawal by Subject|0|||
162209281|NCT01496365|585818203|FG003|Overall Study|Withdrawal by Subject|1|||
162209282|NCT01496365|585818204|FG004|Overall Study|Withdrawal by Subject|3|||
162209283|NCT01496365|585818205|FG005|Overall Study|Withdrawal by Subject|2|||
162209284|NCT01496365|585818206|FG006|Overall Study|Withdrawal by Subject|1|||
162209285|NCT01496365|585818200|FG000|Overall Study|Protocol Violation|2|||
161825832|NCT00401245|584403736|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
161825833|NCT00401245|584403737|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
161825834|NCT00401245|584403738|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
161825835|NCT00401245|584403739|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
161825836|NCT00401245|584403740|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
161825837|NCT00401245|584403733|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161825838|NCT00401245|584403734|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
161825839|NCT00401245|584403735|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161825840|NCT00401245|584403736|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
161825841|NCT00401245|584403737|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161825842|NCT00401245|584403738|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161825843|NCT00401245|584403739|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161825844|NCT00401245|584403740|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161825845|NCT00401245|584403733|FG000|Open Label Phase|Adverse Event|5|||
161825846|NCT00401245|584403734|FG001|Open Label Phase|Adverse Event|14|||
161825847|NCT00401245|584403735|FG002|Open Label Phase|Adverse Event|6|||
161825848|NCT00401245|584403736|FG003|Open Label Phase|Adverse Event|7|||
161825849|NCT00401245|584403737|FG004|Open Label Phase|Adverse Event|0|||
161825850|NCT00401245|584403738|FG005|Open Label Phase|Adverse Event|0|||
161825851|NCT00401245|584403739|FG006|Open Label Phase|Adverse Event|0|||
161825852|NCT00401245|584403740|FG007|Open Label Phase|Adverse Event|0|||
161825853|NCT00401245|584403733|FG000|Open Label Phase|Lost to Follow-up|5|||
161825854|NCT00401245|584403734|FG001|Open Label Phase|Lost to Follow-up|7|||
161825855|NCT00401245|584403735|FG002|Open Label Phase|Lost to Follow-up|5|||
161825856|NCT00401245|584403736|FG003|Open Label Phase|Lost to Follow-up|4|||
161825857|NCT00401245|584403737|FG004|Open Label Phase|Lost to Follow-up|0|||
161825858|NCT00401245|584403738|FG005|Open Label Phase|Lost to Follow-up|0|||
161825859|NCT00401245|584403739|FG006|Open Label Phase|Lost to Follow-up|0|||
161825860|NCT00401245|584403740|FG007|Open Label Phase|Lost to Follow-up|0|||
161825861|NCT00401245|584403733|FG000|Open Label Phase|Other|4|||
161825862|NCT00401245|584403734|FG001|Open Label Phase|Other|8|||
161825863|NCT00401245|584403735|FG002|Open Label Phase|Other|7|||
161825864|NCT00401245|584403736|FG003|Open Label Phase|Other|8|||
161825865|NCT00401245|584403737|FG004|Open Label Phase|Other|0|||
161825866|NCT00401245|584403738|FG005|Open Label Phase|Other|0|||
161825867|NCT00401245|584403739|FG006|Open Label Phase|Other|0|||
161825868|NCT00401245|584403740|FG007|Open Label Phase|Other|0|||
161825869|NCT00401245|584403733|FG000|Open Label Phase|Protocol Violation|0|||
161825870|NCT00401245|584403734|FG001|Open Label Phase|Protocol Violation|1|||
161825871|NCT00401245|584403735|FG002|Open Label Phase|Protocol Violation|0|||
161825872|NCT00401245|584403736|FG003|Open Label Phase|Protocol Violation|1|||
161825873|NCT00401245|584403737|FG004|Open Label Phase|Protocol Violation|0|||
161825874|NCT00401245|584403738|FG005|Open Label Phase|Protocol Violation|0|||
161825875|NCT00401245|584403739|FG006|Open Label Phase|Protocol Violation|0|||
161825876|NCT00401245|584403740|FG007|Open Label Phase|Protocol Violation|0|||
161825877|NCT00401245|584403733|FG000|Open Label Phase|Withdrawal by Subject|3|||
161825878|NCT00401245|584403734|FG001|Open Label Phase|Withdrawal by Subject|3|||
161825879|NCT00401245|584403735|FG002|Open Label Phase|Withdrawal by Subject|2|||
161825880|NCT00401245|584403736|FG003|Open Label Phase|Withdrawal by Subject|1|||
161825881|NCT00401245|584403737|FG004|Open Label Phase|Withdrawal by Subject|0|||
161825882|NCT00401245|584403738|FG005|Open Label Phase|Withdrawal by Subject|0|||
161825883|NCT00401245|584403739|FG006|Open Label Phase|Withdrawal by Subject|0|||
161825884|NCT00401245|584403740|FG007|Open Label Phase|Withdrawal by Subject|0|||
162209286|NCT01496365|585818201|FG001|Overall Study|Protocol Violation|1|||
161825885|NCT00401245|584403733|FG000|Open Label Phase|Lack of Efficacy|4|||
161825886|NCT00401245|584403734|FG001|Open Label Phase|Lack of Efficacy|2|||
161825887|NCT00401245|584403735|FG002|Open Label Phase|Lack of Efficacy|3|||
162209287|NCT01496365|585818202|FG002|Overall Study|Protocol Violation|1|||
162209288|NCT01496365|585818203|FG003|Overall Study|Protocol Violation|0|||
162209289|NCT01496365|585818204|FG004|Overall Study|Protocol Violation|0|||
162209290|NCT01496365|585818205|FG005|Overall Study|Protocol Violation|1|||
162209291|NCT01496365|585818206|FG006|Overall Study|Protocol Violation|0|||
162209292|NCT01496365|585818200|FG000|Overall Study|Lack of Efficacy|1|||
162209293|NCT01496365|585818201|FG001|Overall Study|Lack of Efficacy|0|||
162209294|NCT01496365|585818202|FG002|Overall Study|Lack of Efficacy|0|||
162209295|NCT01496365|585818203|FG003|Overall Study|Lack of Efficacy|0|||
162209296|NCT01496365|585818204|FG004|Overall Study|Lack of Efficacy|0|||
162209297|NCT01496365|585818205|FG005|Overall Study|Lack of Efficacy|1|||
162209298|NCT01496365|585818206|FG006|Overall Study|Lack of Efficacy|0|||
162209299|NCT01496365|585818200|FG000|Overall Study|Lost to Follow-up|0|||
162209300|NCT01496365|585818201|FG001|Overall Study|Lost to Follow-up|1|||
162209301|NCT01496365|585818202|FG002|Overall Study|Lost to Follow-up|0|||
162209302|NCT01496365|585818203|FG003|Overall Study|Lost to Follow-up|0|||
162209303|NCT01496365|585818204|FG004|Overall Study|Lost to Follow-up|2|||
162209304|NCT01496365|585818205|FG005|Overall Study|Lost to Follow-up|0|||
162209305|NCT01496365|585818206|FG006|Overall Study|Lost to Follow-up|0|||
162209306|NCT01496365|585818200|FG000|Overall Study|Other|4|||
162209307|NCT01496365|585818201|FG001|Overall Study|Other|4|||
162209308|NCT01496365|585818202|FG002|Overall Study|Other|2|||
162209309|NCT01496365|585818203|FG003|Overall Study|Other|1|||
162209310|NCT01496365|585818204|FG004|Overall Study|Other|3|||
162209311|NCT01496365|585818205|FG005|Overall Study|Other|0|||
162209312|NCT01496365|585818206|FG006|Overall Study|Other|1|||
162209313|NCT01015677|585818207|FG000|Overall Study|Adverse Event|0|||
162209314|NCT01015677|585818208|FG001|Overall Study|Adverse Event|1|||
162209315|NCT01015677|585818209|FG002|Overall Study|Adverse Event|0|||
162209316|NCT01015677|585818207|FG000|Overall Study|Lack of Efficacy|0|||
162209317|NCT01015677|585818208|FG001|Overall Study|Lack of Efficacy|1|||
162209318|NCT01015677|585818209|FG002|Overall Study|Lack of Efficacy|0|||
162209319|NCT01015677|585818207|FG000|Overall Study|Protocol Violation|0|||
162209320|NCT01015677|585818208|FG001|Overall Study|Protocol Violation|1|||
162209321|NCT01015677|585818209|FG002|Overall Study|Protocol Violation|0|||
162209322|NCT01015677|585818207|FG000|Overall Study|Withdrawal by Subject|1|||
162209323|NCT01015677|585818208|FG001|Overall Study|Withdrawal by Subject|1|||
162209324|NCT01015677|585818209|FG002|Overall Study|Withdrawal by Subject|0|||
162209325|NCT01660256|585818210|FG000|Overall Study|Adverse Event|4|||
162209326|NCT01660256|585818211|FG001|Overall Study|Adverse Event|0|||
162209327|NCT01660256|585818212|FG002|Overall Study|Adverse Event|2|||
162209328|NCT01660256|585818210|FG000|Overall Study|Withdrawal by Subject|1|||
162209329|NCT01660256|585818211|FG001|Overall Study|Withdrawal by Subject|0|||
162209330|NCT01660256|585818212|FG002|Overall Study|Withdrawal by Subject|2|||
162209331|NCT03603639|585818215|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
162209332|NCT03603639|585818216|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
162209333|NCT03603639|585818217|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
162209334|NCT03603639|585818218|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
162209335|NCT03603639|585818219|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
162209336|NCT03603639|585818220|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
162209337|NCT03603639|585818215|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
162209338|NCT03603639|585818216|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
162209339|NCT03603639|585818217|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
162209340|NCT03603639|585818218|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
162209341|NCT03603639|585818219|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
162209342|NCT03603639|585818220|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
162209343|NCT02165397|585818226|FG000|Overall Study|Death|7|||
162209344|NCT02165397|585818227|FG001|Overall Study|Death|10|||
162209345|NCT02165397|585818228|FG002|Overall Study|Death|8|||
162209346|NCT02165397|585818226|FG000|Overall Study|Lost to Follow-up|1|||
162209347|NCT02165397|585818227|FG001|Overall Study|Lost to Follow-up|3|||
162209348|NCT02165397|585818228|FG002|Overall Study|Lost to Follow-up|0|||
162209349|NCT02165397|585818226|FG000|Overall Study|Withdrawal by Subject|6|||
162209350|NCT02165397|585818227|FG001|Overall Study|Withdrawal by Subject|6|||
162209351|NCT02165397|585818228|FG002|Overall Study|Withdrawal by Subject|1|||
161825888|NCT00401245|584403736|FG003|Open Label Phase|Lack of Efficacy|0|||
161825889|NCT00401245|584403737|FG004|Open Label Phase|Lack of Efficacy|0|||
162209352|NCT02165397|585818226|FG000|Overall Study|Other, Not Specified|0|||
162209353|NCT02165397|585818227|FG001|Overall Study|Other, Not Specified|0|||
162209354|NCT02165397|585818228|FG002|Overall Study|Other, Not Specified|1|||
161825890|NCT00401245|584403738|FG005|Open Label Phase|Lack of Efficacy|0|||
161825891|NCT00401245|584403739|FG006|Open Label Phase|Lack of Efficacy|0|||
161825892|NCT00401245|584403740|FG007|Open Label Phase|Lack of Efficacy|0|||
161825893|NCT00401245|584403733|FG000|Double Blind Tapering Phase|Adverse Event|0|||
161825894|NCT00401245|584403734|FG001|Double Blind Tapering Phase|Adverse Event|0|||
161825895|NCT00401245|584403735|FG002|Double Blind Tapering Phase|Adverse Event|0|||
161825896|NCT00401245|584403736|FG003|Double Blind Tapering Phase|Adverse Event|0|||
161825897|NCT00401245|584403737|FG004|Double Blind Tapering Phase|Adverse Event|1|||
161825898|NCT00401245|584403738|FG005|Double Blind Tapering Phase|Adverse Event|1|||
161825899|NCT00401245|584403739|FG006|Double Blind Tapering Phase|Adverse Event|2|||
161825900|NCT00401245|584403740|FG007|Double Blind Tapering Phase|Adverse Event|4|||
161825901|NCT00401245|584403733|FG000|Double Blind Tapering Phase|Investigator request|0|||
161825902|NCT00401245|584403734|FG001|Double Blind Tapering Phase|Investigator request|0|||
161825903|NCT00401245|584403735|FG002|Double Blind Tapering Phase|Investigator request|0|||
161825904|NCT00401245|584403736|FG003|Double Blind Tapering Phase|Investigator request|0|||
161825905|NCT00401245|584403737|FG004|Double Blind Tapering Phase|Investigator request|0|||
161825906|NCT00401245|584403738|FG005|Double Blind Tapering Phase|Investigator request|0|||
161825907|NCT00401245|584403739|FG006|Double Blind Tapering Phase|Investigator request|0|||
161825908|NCT00401245|584403740|FG007|Double Blind Tapering Phase|Investigator request|1|||
161825909|NCT00401245|584403733|FG000|Double Blind Tapering Phase|Other|0|||
161825910|NCT00401245|584403734|FG001|Double Blind Tapering Phase|Other|0|||
161825911|NCT00401245|584403735|FG002|Double Blind Tapering Phase|Other|0|||
161825912|NCT00401245|584403736|FG003|Double Blind Tapering Phase|Other|0|||
161825913|NCT00401245|584403737|FG004|Double Blind Tapering Phase|Other|1|||
161825914|NCT00401245|584403738|FG005|Double Blind Tapering Phase|Other|0|||
161825915|NCT00401245|584403739|FG006|Double Blind Tapering Phase|Other|2|||
161825916|NCT00401245|584403740|FG007|Double Blind Tapering Phase|Other|2|||
161825917|NCT00401245|584403733|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161825918|NCT00401245|584403734|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161825919|NCT00401245|584403735|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
162209355|NCT03898960|585818229|FG000|Overall Study|Death|10|||
162209356|NCT03463577|585818232|FG000|Overall Study|Lost to Follow-up|238|||
162209357|NCT03463577|585818233|FG001|Overall Study|Lost to Follow-up|435|||
162209358|NCT03463577|585818234|FG002|Overall Study|Lost to Follow-up|0|||
162209359|NCT03463577|585818235|FG003|Overall Study|Lost to Follow-up|0|||
162209360|NCT03463577|585818236|FG004|Overall Study|Lost to Follow-up|0|||
162209361|NCT03463577|585818237|FG005|Overall Study|Lost to Follow-up|0|||
162209362|NCT03463577|585818232|FG000|Overall Study|With unknown pregnancy outcome|0|||
162209363|NCT03463577|585818233|FG001|Overall Study|With unknown pregnancy outcome|5|||
162209364|NCT03463577|585818234|FG002|Overall Study|With unknown pregnancy outcome|0|||
162209365|NCT03463577|585818235|FG003|Overall Study|With unknown pregnancy outcome|0|||
162209366|NCT03463577|585818236|FG004|Overall Study|With unknown pregnancy outcome|0|||
162209367|NCT03463577|585818237|FG005|Overall Study|With unknown pregnancy outcome|0|||
162209368|NCT03463577|585818232|FG000|Overall Study|Maternal death|2|||
162209369|NCT03463577|585818233|FG001|Overall Study|Maternal death|0|||
162209370|NCT03463577|585818234|FG002|Overall Study|Maternal death|0|||
162209371|NCT03463577|585818235|FG003|Overall Study|Maternal death|0|||
162209372|NCT03463577|585818236|FG004|Overall Study|Maternal death|0|||
162209373|NCT03463577|585818237|FG005|Overall Study|Maternal death|0|||
162209374|NCT03463577|585818232|FG000|Overall Study|Neonatal death|0|||
162209375|NCT03463577|585818233|FG001|Overall Study|Neonatal death|0|||
162209376|NCT03463577|585818234|FG002|Overall Study|Neonatal death|0|||
162209377|NCT03463577|585818235|FG003|Overall Study|Neonatal death|15|||
162209378|NCT03463577|585818236|FG004|Overall Study|Neonatal death|17|||
162209379|NCT03463577|585818237|FG005|Overall Study|Neonatal death|0|||
162209380|NCT00236184|585818238|FG000|Overall Study|Adverse Event|5|||
162209381|NCT00236184|585818239|FG001|Overall Study|Adverse Event|2|||
162209382|NCT00236184|585818238|FG000|Overall Study|Lack of Efficacy|0|||
162209383|NCT00236184|585818239|FG001|Overall Study|Lack of Efficacy|1|||
162209384|NCT00236184|585818238|FG000|Overall Study|Lost to Follow-up|3|||
162209385|NCT00236184|585818239|FG001|Overall Study|Lost to Follow-up|4|||
162209386|NCT00236184|585818238|FG000|Overall Study|Physician Decision|1|||
162209387|NCT00236184|585818239|FG001|Overall Study|Physician Decision|1|||
162209388|NCT00236184|585818238|FG000|Overall Study|Withdrawal by Subject|3|||
162209389|NCT00236184|585818239|FG001|Overall Study|Withdrawal by Subject|0|||
162209390|NCT00236184|585818238|FG000|Overall Study|Protocol Violation|3|||
162209391|NCT00236184|585818239|FG001|Overall Study|Protocol Violation|0|||
162209392|NCT00236184|585818238|FG000|Overall Study|non-compliance with study drug|2|||
162209393|NCT00236184|585818239|FG001|Overall Study|non-compliance with study drug|1|||
161825920|NCT00401245|584403736|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161825921|NCT00401245|584403737|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
162209394|NCT00236184|585818238|FG000|Overall Study|other|1|||
162209395|NCT00236184|585818239|FG001|Overall Study|other|2|||
162209396|NCT01841697|585818240|FG000|Overall Study|Death|0|||
162209397|NCT01841697|585818241|FG001|Overall Study|Death|1|||
161825922|NCT00401245|584403738|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
161825923|NCT00401245|584403739|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
161825924|NCT00401245|584403740|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161825925|NCT00401245|584403733|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
161825926|NCT00401245|584403734|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
161825927|NCT00401245|584403735|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
161934334|NCT05259722|584808476|FG000|Overall Study|Not exposed to IMP|1|||
161934335|NCT05259722|584808477|FG001|Overall Study|Not exposed to IMP|12|||
161934336|NCT05259722|584808476|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
161934337|NCT05259722|584808477|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
161934338|NCT00962650|584808478|FG000|Overall Study|Transgastric DP was not completed|2|||
161934339|NCT00231465|584808479|FG000|Overall Study|Completed only one cycle|1|||
161934340|NCT00231465|584808479|FG000|Overall Study|Did not have follow up CT scans|1|||
162209398|NCT01841697|585818240|FG000|Overall Study|Lost to Follow-up|4|||
162209399|NCT01841697|585818241|FG001|Overall Study|Lost to Follow-up|1|||
162209400|NCT01841697|585818240|FG000|Overall Study|Withdrawal by Subject|16|||
162209401|NCT01841697|585818241|FG001|Overall Study|Withdrawal by Subject|16|||
162209402|NCT01777490|585818242|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
162209403|NCT01777490|585818243|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
162209404|NCT01777490|585818244|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
162209405|NCT01777490|585818245|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
162209406|NCT01898442|585818249|FG000|Overall Study|Hemolysis/technical problems|1|||
162209407|NCT01898442|585818250|FG001|Overall Study|Hemolysis/technical problems|2|||
162209408|NCT01898442|585818251|FG002|Overall Study|Hemolysis/technical problems|2|||
162209409|NCT01898442|585818249|FG000|Overall Study|Patient vomited pills|0|||
162209410|NCT01898442|585818250|FG001|Overall Study|Patient vomited pills|0|||
162209411|NCT01898442|585818251|FG002|Overall Study|Patient vomited pills|1|||
162209412|NCT00255944|585818252|FG000|Overall Study|Lost to Follow-up|797|||
162209413|NCT00255944|585818253|FG001|Overall Study|Lost to Follow-up|834|||
162209414|NCT00935259|585818261|FG000|Period 1|Administrative (scheduling conflict)|1|||
162209415|NCT00935259|585818262|FG001|Period 1|Administrative (scheduling conflict)|1|||
162209416|NCT01721746|585818265|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
162209417|NCT01721746|585818266|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
162209418|NCT01721746|585818265|FG000|Pre-Treatment|Withdrawal by Subject|1|||
162209419|NCT01721746|585818266|FG001|Pre-Treatment|Withdrawal by Subject|16|||
162209420|NCT01721746|585818265|FG000|Pre-Treatment|Poor/Non-compliance|1|||
162209421|NCT01721746|585818266|FG001|Pre-Treatment|Poor/Non-compliance|0|||
162209422|NCT01721746|585818265|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
162209423|NCT01721746|585818266|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
162209424|NCT01721746|585818265|FG000|Treatment|Disease Progression|192|||
162209425|NCT01721746|585818266|FG001|Treatment|Disease Progression|74|||
162209426|NCT01721746|585818265|FG000|Treatment|Study Drug Toxicity|19|||
161934341|NCT00420056|584808480|FG000|Overall Study|Objective progression or relapse|17|||
162209427|NCT01721746|585818266|FG001|Treatment|Study Drug Toxicity|11|||
162209428|NCT01721746|585818265|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
162209429|NCT01721746|585818266|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
162209430|NCT01721746|585818265|FG000|Treatment|Participant request to discontinue Study treatment|26|||
162209431|NCT01721746|585818266|FG001|Treatment|Participant request to discontinue Study treatment|7|||
162209432|NCT01721746|585818265|FG000|Treatment|Participant withdrew consent|4|||
162209433|NCT01721746|585818266|FG001|Treatment|Participant withdrew consent|2|||
162209434|NCT01721746|585818265|FG000|Treatment|Maximum Clinical Benefit|9|||
162209435|NCT01721746|585818266|FG001|Treatment|Maximum Clinical Benefit|3|||
162209436|NCT01721746|585818265|FG000|Treatment|Poor/Non-compliance|2|||
162209437|NCT01721746|585818266|FG001|Treatment|Poor/Non-compliance|0|||
162209438|NCT01721746|585818265|FG000|Treatment|Participant no longer met Study criteria|4|||
162209439|NCT01721746|585818266|FG001|Treatment|Participant no longer met Study criteria|0|||
162209440|NCT01721746|585818265|FG000|Treatment|Other reasons|6|||
162209441|NCT01721746|585818266|FG001|Treatment|Other reasons|2|||
162209442|NCT01841112|585818269|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
162209443|NCT01841112|585818270|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
162209444|NCT01841112|585818271|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
162209445|NCT01841112|585818272|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
162209446|NCT01841112|585818273|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
162209447|NCT02725008|585818279|FG000|Overall Study|Lost to Follow-up|7|||
162209448|NCT02725008|585818280|FG001|Overall Study|Lost to Follow-up|9|||
162209449|NCT02725008|585818279|FG000|Overall Study|Withdrawal by Subject|2|||
162209450|NCT02725008|585818280|FG001|Overall Study|Withdrawal by Subject|2|||
162209451|NCT02725008|585818279|FG000|Overall Study|Admitted to hospital|0|||
162209452|NCT02725008|585818280|FG001|Overall Study|Admitted to hospital|1|||
162209453|NCT00361842|585818281|FG000|Overall Study|Withdrawal by Subject|2|||
162209454|NCT00361842|585818282|FG001|Overall Study|Withdrawal by Subject|3|||
162209455|NCT00361842|585818281|FG000|Overall Study|Death|2|||
162209456|NCT00361842|585818282|FG001|Overall Study|Death|1|||
162209457|NCT00361842|585818281|FG000|Overall Study|Disease progression|19|||
162209458|NCT00361842|585818282|FG001|Overall Study|Disease progression|20|||
162209459|NCT00361842|585818281|FG000|Overall Study|Adverse Event|2|||
162209460|NCT00361842|585818282|FG001|Overall Study|Adverse Event|3|||
162209461|NCT00361842|585818281|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
162209462|NCT00361842|585818282|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
162209463|NCT00361842|585818281|FG000|Overall Study|Other|1|||
161934342|NCT03072875|584808483|FG000|Overall Study|Lost to Follow-up|1|||
162209464|NCT00361842|585818282|FG001|Overall Study|Other|0|||
162209465|NCT00361842|585818281|FG000|Overall Study|Other|0|||
162209466|NCT00361842|585818282|FG001|Overall Study|Other|2|||
162209467|NCT03821064|585818283|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
162209468|NCT00474383|585818285|FG000|Main Study|Adverse Event|11|||
162209469|NCT00474383|585818286|FG001|Main Study|Adverse Event|0|||
161934343|NCT03111732|584808484|FG000|Overall Study|Enrolled in different study|1|||
161934344|NCT03111732|584808484|FG000|Overall Study|Progressive disease|3|||
161934345|NCT03111732|584808484|FG000|Overall Study|Withdrawal by Subject|1|||
161934346|NCT02268851|584808490|FG000|Overall Study|Death|0|||
161934347|NCT02268851|584808491|FG001|Overall Study|Death|0|||
161934348|NCT02268851|584808492|FG002|Overall Study|Death|0|||
161934349|NCT02268851|584808493|FG003|Overall Study|Death|1|||
161934350|NCT02268851|584808494|FG004|Overall Study|Death|2|||
161934351|NCT02268851|584808495|FG005|Overall Study|Death|1|||
161934352|NCT02268851|584808490|FG000|Overall Study|Adverse Event|0|||
161934353|NCT02268851|584808491|FG001|Overall Study|Adverse Event|0|||
161934354|NCT02268851|584808492|FG002|Overall Study|Adverse Event|0|||
161934355|NCT02268851|584808493|FG003|Overall Study|Adverse Event|0|||
161934356|NCT02268851|584808494|FG004|Overall Study|Adverse Event|2|||
161934357|NCT02268851|584808495|FG005|Overall Study|Adverse Event|2|||
161934358|NCT02268851|584808490|FG000|Overall Study|Withdrawal by Subject|0|||
161934359|NCT02268851|584808491|FG001|Overall Study|Withdrawal by Subject|0|||
161934360|NCT02268851|584808492|FG002|Overall Study|Withdrawal by Subject|0|||
161934361|NCT02268851|584808493|FG003|Overall Study|Withdrawal by Subject|2|||
161934362|NCT02268851|584808494|FG004|Overall Study|Withdrawal by Subject|0|||
162021336|NCT02891070|585134749|FG001|Overall Study|Physician Decision|1|||
162021337|NCT02891070|585134748|FG000|Overall Study|Lost to Follow-up|4|||
162209470|NCT00474383|585818285|FG000|Main Study|Symptomatic Deterioration|1|||
162209471|NCT00474383|585818286|FG001|Main Study|Symptomatic Deterioration|0|||
162209472|NCT00474383|585818285|FG000|Main Study|Progressive Disease|23|||
162209473|NCT00474383|585818286|FG001|Main Study|Progressive Disease|0|||
162209474|NCT00474383|585818285|FG000|Main Study|Other|1|||
162209475|NCT00474383|585818286|FG001|Main Study|Other|0|||
162209476|NCT00474383|585818285|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
162209477|NCT00474383|585818286|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
162209478|NCT00474383|585818285|FG000|Extension|Progressive Disease|0|||
162209479|NCT00474383|585818286|FG001|Extension|Progressive Disease|5|||
162209480|NCT02641587|585820546|FG000|Confinement Period|Adverse Event|1|||
162209481|NCT02641587|585820547|FG001|Confinement Period|Adverse Event|0|||
162209482|NCT02641587|585820546|FG000|Confinement Period|Withdrawal by Subject|2|||
162209483|NCT02641587|585820547|FG001|Confinement Period|Withdrawal by Subject|1|||
162209484|NCT02641587|585820546|FG000|Ambulatory Period|Withdrawal by Subject|1|||
162209485|NCT02641587|585820547|FG001|Ambulatory Period|Withdrawal by Subject|0|||
162209486|NCT01150045|585820551|FG000|Overall Study|Protocol Violation|0|||
162209487|NCT01150045|585820552|FG001|Overall Study|Protocol Violation|1|||
162209488|NCT01150045|585820553|FG002|Overall Study|Protocol Violation|0|||
162209489|NCT01150045|585820554|FG003|Overall Study|Protocol Violation|1|||
162209490|NCT03194867|585820555|FG000|Overall Study|Incorrect completion of end of study form|0|||
162209491|NCT03194867|585820556|FG001|Overall Study|Incorrect completion of end of study form|0|||
162209492|NCT03194867|585820557|FG002|Overall Study|Incorrect completion of end of study form|1|||
162209493|NCT03194867|585820558|FG003|Overall Study|Incorrect completion of end of study form|0|||
162209494|NCT00464945|585820559|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
162209495|NCT00464945|585820560|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
162209496|NCT00464945|585820559|FG000|Infant Series|Protocol Violation|1|||
162209497|NCT00464945|585820560|FG001|Infant Series|Protocol Violation|0|||
162209498|NCT00464945|585820559|FG000|Infant Series|Lost to Follow-up|1|||
162209499|NCT00464945|585820560|FG001|Infant Series|Lost to Follow-up|0|||
162209500|NCT00464945|585820559|FG000|After Infant Series|Withdrawal by Subject|0|||
162209501|NCT00464945|585820560|FG001|After Infant Series|Withdrawal by Subject|2|||
162209502|NCT00464945|585820559|FG000|Toddler Dose|Lost to Follow-up|0|||
162209503|NCT00464945|585820560|FG001|Toddler Dose|Lost to Follow-up|1|||
162209504|NCT02094898|585820564|FG000|Overall Study|Clinical Worsening|2|||
162209505|NCT02094898|585820564|FG000|Overall Study|Adverse Event|2|||
162209506|NCT02094898|585820564|FG000|Overall Study|Lack of Efficacy|1|||
162209507|NCT03520075|585820565|FG000|Phase 1 (Dose Escalation)|Death|2|||
162209508|NCT03520075|585820566|FG001|Phase 1 (Dose Escalation)|Death|2|||
162209509|NCT03520075|585820567|FG002|Phase 1 (Dose Escalation)|Death|3|||
161934363|NCT02268851|584808495|FG005|Overall Study|Withdrawal by Subject|1|||
161934364|NCT02268851|584808490|FG000|Overall Study|Progressive Disease|1|||
161934365|NCT02268851|584808491|FG001|Overall Study|Progressive Disease|3|||
161934366|NCT02268851|584808492|FG002|Overall Study|Progressive Disease|0|||
161934367|NCT02268851|584808493|FG003|Overall Study|Progressive Disease|0|||
161934368|NCT02268851|584808494|FG004|Overall Study|Progressive Disease|1|||
161934369|NCT02268851|584808495|FG005|Overall Study|Progressive Disease|4|||
161934370|NCT02268851|584808490|FG000|Overall Study|Physician Decision|0|||
161934371|NCT02268851|584808491|FG001|Overall Study|Physician Decision|0|||
161825928|NCT00401245|584403736|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
161825929|NCT00401245|584403737|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
161825930|NCT00401245|584403738|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
161825931|NCT00401245|584403739|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
161825932|NCT00401245|584403740|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
161825933|NCT02014441|584403742|FG000|Overall Study|Withdrawal by Subject|12|||
161825934|NCT01363011|584403744|FG000|Main Study|Adverse Event|2|||
161825935|NCT01363011|584403745|FG001|Main Study|Adverse Event|3|||
161825936|NCT01363011|584403744|FG000|Main Study|Investigator's Discretion|1|||
161825937|NCT01363011|584403745|FG001|Main Study|Investigator's Discretion|1|||
161825938|NCT01363011|584403744|FG000|Main Study|Withdrew Consent|1|||
161825939|NCT01363011|584403745|FG001|Main Study|Withdrew Consent|4|||
161825940|NCT01363011|584403744|FG000|Main Study|Protocol Violation|0|||
161825941|NCT01363011|584403745|FG001|Main Study|Protocol Violation|1|||
161825942|NCT01363011|584403744|FG000|Extension Phase|Adverse Event|1|||
161825943|NCT01363011|584403745|FG001|Extension Phase|Adverse Event|1|||
161825944|NCT01363011|584403744|FG000|Extension Phase|Lack of Efficacy|0|||
161825945|NCT01363011|584403745|FG001|Extension Phase|Lack of Efficacy|1|||
161825946|NCT01363011|584403744|FG000|Extension Phase|Investigator's Discretion|2|||
161825947|NCT01363011|584403745|FG001|Extension Phase|Investigator's Discretion|2|||
161825948|NCT01363011|584403744|FG000|Extension Phase|Withdrew Consent|0|||
161825949|NCT01363011|584403745|FG001|Extension Phase|Withdrew Consent|1|||
161825950|NCT01363011|584403744|FG000|Extension Phase|Lost to Follow-up|0|||
161825951|NCT01363011|584403745|FG001|Extension Phase|Lost to Follow-up|2|||
161825952|NCT01363011|584403744|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
161825953|NCT01363011|584403745|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
161825954|NCT04412057|584403746|FG000|Overall Study|Death|3|||
162209510|NCT03520075|585820568|FG003|Phase 1 (Dose Escalation)|Death|2|||
162209511|NCT03520075|585820569|FG004|Phase 1 (Dose Escalation)|Death|6|||
162209512|NCT03520075|585820570|FG005|Phase 1 (Dose Escalation)|Death|5|||
162209513|NCT03520075|585820571|FG006|Phase 1 (Dose Escalation)|Death|3|||
162209514|NCT03520075|585820572|FG007|Phase 1 (Dose Escalation)|Death|2|||
162209515|NCT03520075|585820573|FG008|Phase 1 (Dose Escalation)|Death|3|||
162209516|NCT03520075|585820574|FG009|Phase 1 (Dose Escalation)|Death|1|||
162209517|NCT03520075|585820575|FG010|Phase 1 (Dose Escalation)|Death|5|||
162209518|NCT03520075|585820576|FG011|Phase 1 (Dose Escalation)|Death|7|||
162209519|NCT03520075|585820577|FG012|Phase 1 (Dose Escalation)|Death|11|||
162209520|NCT03520075|585820578|FG013|Phase 1 (Dose Escalation)|Death|0|||
162209521|NCT03520075|585820579|FG014|Phase 1 (Dose Escalation)|Death|0|||
162209522|NCT03520075|585820580|FG015|Phase 1 (Dose Escalation)|Death|0|||
162209523|NCT03520075|585820581|FG016|Phase 1 (Dose Escalation)|Death|0|||
162209524|NCT03520075|585820582|FG017|Phase 1 (Dose Escalation)|Death|0|||
162209525|NCT03520075|585820583|FG018|Phase 1 (Dose Escalation)|Death|0|||
162209526|NCT03520075|585820565|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
162209527|NCT03520075|585820566|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162209528|NCT03520075|585820567|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162209529|NCT03520075|585820568|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
162209530|NCT03520075|585820569|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
162209531|NCT03520075|585820570|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
162209532|NCT03520075|585820571|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162209533|NCT03520075|585820572|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
162209534|NCT03520075|585820573|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162209535|NCT03520075|585820574|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
161825955|NCT04412057|584403747|FG001|Overall Study|Death|7|||
161825956|NCT04412057|584403746|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
161825957|NCT04412057|584403747|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
161825958|NCT00114231|584403748|FG000|Overall Study|No consent|2|||
161825959|NCT00114231|584403749|FG001|Overall Study|No consent|0|||
161825960|NCT00114231|584403748|FG000|Overall Study|QARC requirement not met|1|||
161825961|NCT00114231|584403749|FG001|Overall Study|QARC requirement not met|0|||
161825962|NCT00114231|584403748|FG000|Overall Study|Suspected metastatic disease|1|||
161825963|NCT00114231|584403749|FG001|Overall Study|Suspected metastatic disease|0|||
161825964|NCT00114231|584403748|FG000|Overall Study|No adenocarcinoma|1|||
161934372|NCT02268851|584808492|FG002|Overall Study|Physician Decision|1|||
162209536|NCT03520075|585820575|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162209537|NCT03520075|585820576|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162209538|NCT03520075|585820577|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
162209539|NCT03520075|585820578|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161825965|NCT00114231|584403749|FG001|Overall Study|No adenocarcinoma|0|||
161825966|NCT00114231|584403748|FG000|Overall Study|Low creatinine clearance|0|||
161677635|NCT02871778|583872069|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161825967|NCT00114231|584403749|FG001|Overall Study|Low creatinine clearance|1|||
161825968|NCT00114231|584403748|FG000|Overall Study|Tumor size > 4cm|1|||
161825969|NCT00114231|584403749|FG001|Overall Study|Tumor size > 4cm|0|||
161934373|NCT02268851|584808493|FG003|Overall Study|Physician Decision|0|||
161934374|NCT02268851|584808494|FG004|Overall Study|Physician Decision|0|||
161934375|NCT02268851|584808495|FG005|Overall Study|Physician Decision|1|||
161934376|NCT02268851|584808490|FG000|Overall Study|Patient Compliance|0|||
161934377|NCT02268851|584808491|FG001|Overall Study|Patient Compliance|0|||
161934378|NCT02268851|584808492|FG002|Overall Study|Patient Compliance|0|||
161934379|NCT02268851|584808493|FG003|Overall Study|Patient Compliance|0|||
161934380|NCT02268851|584808494|FG004|Overall Study|Patient Compliance|1|||
161934381|NCT02268851|584808495|FG005|Overall Study|Patient Compliance|1|||
162209540|NCT03520075|585820579|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162209541|NCT03520075|585820580|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162209542|NCT03520075|585820581|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162209543|NCT03520075|585820582|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162209544|NCT03520075|585820583|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
162209545|NCT03520075|585820565|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209546|NCT03520075|585820566|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
162209547|NCT03520075|585820567|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209548|NCT03520075|585820568|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
162209549|NCT03520075|585820569|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
161934382|NCT02268851|584808490|FG000|Overall Study|Co-Morbid Condition|0|||
161934383|NCT02268851|584808491|FG001|Overall Study|Co-Morbid Condition|0|||
162209550|NCT03520075|585820570|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209551|NCT03520075|585820571|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209552|NCT03520075|585820572|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209553|NCT03520075|585820573|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209554|NCT03520075|585820574|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209555|NCT03520075|585820575|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
162209556|NCT03520075|585820576|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209557|NCT03520075|585820577|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
162209558|NCT03520075|585820578|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209559|NCT03520075|585820579|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209560|NCT03520075|585820580|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209561|NCT03520075|585820581|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209562|NCT03520075|585820582|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209563|NCT03520075|585820583|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
162209564|NCT03520075|585820565|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209565|NCT03520075|585820566|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209566|NCT03520075|585820567|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209567|NCT03520075|585820568|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209568|NCT03520075|585820569|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209569|NCT03520075|585820570|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209570|NCT03520075|585820571|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209571|NCT03520075|585820572|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209572|NCT03520075|585820573|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209573|NCT03520075|585820574|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
162209574|NCT03520075|585820575|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209575|NCT03520075|585820576|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161934384|NCT02268851|584808492|FG002|Overall Study|Co-Morbid Condition|0|||
161934385|NCT02268851|584808493|FG003|Overall Study|Co-Morbid Condition|0|||
161934386|NCT02268851|584808494|FG004|Overall Study|Co-Morbid Condition|1|||
162209576|NCT03520075|585820577|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
162209577|NCT03520075|585820578|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209578|NCT03520075|585820579|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209579|NCT03520075|585820580|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209580|NCT03520075|585820581|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209581|NCT03520075|585820582|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209582|NCT03520075|585820583|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
162209583|NCT03520075|585820565|FG000|Phase 2 (Dose Expansion)|Death|0|||
162209584|NCT03520075|585820566|FG001|Phase 2 (Dose Expansion)|Death|0|||
162209585|NCT03520075|585820567|FG002|Phase 2 (Dose Expansion)|Death|0|||
162209586|NCT03520075|585820568|FG003|Phase 2 (Dose Expansion)|Death|0|||
162209587|NCT03520075|585820569|FG004|Phase 2 (Dose Expansion)|Death|0|||
162209588|NCT03520075|585820570|FG005|Phase 2 (Dose Expansion)|Death|0|||
162209589|NCT03520075|585820571|FG006|Phase 2 (Dose Expansion)|Death|0|||
162209590|NCT03520075|585820572|FG007|Phase 2 (Dose Expansion)|Death|0|||
161934387|NCT02268851|584808495|FG005|Overall Study|Co-Morbid Condition|1|||
161934388|NCT01684033|584808498|FG000|Period 1, First 30 Days|Adverse Event|1|||
162021338|NCT02891070|585134749|FG001|Overall Study|Lost to Follow-up|4|||
161934389|NCT01684033|584808499|FG001|Period 1, First 30 Days|Adverse Event|1|||
161934390|NCT01684033|584808498|FG000|Period 1, First 30 Days|Noncompliance|1|||
161934391|NCT01684033|584808499|FG001|Period 1, First 30 Days|Noncompliance|0|||
162209591|NCT03520075|585820573|FG008|Phase 2 (Dose Expansion)|Death|0|||
162209592|NCT03520075|585820574|FG009|Phase 2 (Dose Expansion)|Death|0|||
162209593|NCT03520075|585820575|FG010|Phase 2 (Dose Expansion)|Death|0|||
162209594|NCT03520075|585820576|FG011|Phase 2 (Dose Expansion)|Death|0|||
162209595|NCT03520075|585820577|FG012|Phase 2 (Dose Expansion)|Death|0|||
162209596|NCT03520075|585820578|FG013|Phase 2 (Dose Expansion)|Death|20|||
162209597|NCT03520075|585820579|FG014|Phase 2 (Dose Expansion)|Death|13|||
162209598|NCT03520075|585820580|FG015|Phase 2 (Dose Expansion)|Death|9|||
162209599|NCT03520075|585820581|FG016|Phase 2 (Dose Expansion)|Death|5|||
162209600|NCT03520075|585820582|FG017|Phase 2 (Dose Expansion)|Death|14|||
162209601|NCT03520075|585820583|FG018|Phase 2 (Dose Expansion)|Death|12|||
162209602|NCT03520075|585820565|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209603|NCT03520075|585820566|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209604|NCT03520075|585820567|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209605|NCT03520075|585820568|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209606|NCT03520075|585820569|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209607|NCT03520075|585820570|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209608|NCT03520075|585820571|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209609|NCT03520075|585820572|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209610|NCT03520075|585820573|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209611|NCT03520075|585820574|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209612|NCT03520075|585820575|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209613|NCT03520075|585820576|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209614|NCT03520075|585820577|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209615|NCT03520075|585820578|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
162209616|NCT03520075|585820579|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
162209617|NCT03520075|585820580|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
162209618|NCT03520075|585820581|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
162209619|NCT03520075|585820582|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
162209620|NCT03520075|585820583|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
162209621|NCT03520075|585820565|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162021339|NCT02891070|585134748|FG000|Overall Study|Other|1|||
162209622|NCT03520075|585820566|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209623|NCT03520075|585820567|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209624|NCT03520075|585820568|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209625|NCT03520075|585820569|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209626|NCT03520075|585820570|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209627|NCT03520075|585820571|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209628|NCT03520075|585820572|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209629|NCT03520075|585820573|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209630|NCT03520075|585820574|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209631|NCT03520075|585820575|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209632|NCT03520075|585820576|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209633|NCT03520075|585820577|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209634|NCT03520075|585820578|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209635|NCT03520075|585820579|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
162209636|NCT03520075|585820580|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
162209637|NCT03520075|585820581|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209638|NCT03520075|585820582|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
162209639|NCT03520075|585820583|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
162209640|NCT03520075|585820565|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209641|NCT03520075|585820566|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209642|NCT03520075|585820567|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209643|NCT03520075|585820568|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209644|NCT03520075|585820569|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209645|NCT03520075|585820570|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209646|NCT03520075|585820571|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209647|NCT03520075|585820572|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209648|NCT03520075|585820573|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209649|NCT03520075|585820574|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209650|NCT03520075|585820575|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209651|NCT03520075|585820576|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209652|NCT03520075|585820577|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209653|NCT03520075|585820578|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
162209654|NCT03520075|585820579|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209655|NCT03520075|585820580|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209656|NCT03520075|585820581|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
162209657|NCT03520075|585820582|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
162209658|NCT03520075|585820583|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
162209659|NCT01432626|585820586|FG000|Overall Study|LV function recovered|2|||
162209660|NCT01432626|585820586|FG000|Overall Study|Withdrawal by Subject|2|||
162209661|NCT01432626|585820586|FG000|Overall Study|Only 1 image competed|2|||
162209662|NCT01432626|585820586|FG000|Overall Study|Imaging agent not available|1|||
162209663|NCT03305809|585820587|FG000|Overall Study|Adverse Event|2|||
162209664|NCT03305809|585820588|FG001|Overall Study|Adverse Event|2|||
162209665|NCT03305809|585820589|FG002|Overall Study|Adverse Event|6|||
162209666|NCT03305809|585820590|FG003|Overall Study|Adverse Event|6|||
162209667|NCT03305809|585820587|FG000|Overall Study|Death|0|||
162209668|NCT03305809|585820588|FG001|Overall Study|Death|0|||
162209669|NCT03305809|585820589|FG002|Overall Study|Death|1|||
162209670|NCT03305809|585820590|FG003|Overall Study|Death|1|||
162209671|NCT03305809|585820587|FG000|Overall Study|Lost to Follow-up|1|||
162209672|NCT03305809|585820588|FG001|Overall Study|Lost to Follow-up|2|||
162209673|NCT03305809|585820589|FG002|Overall Study|Lost to Follow-up|0|||
162209674|NCT03305809|585820590|FG003|Overall Study|Lost to Follow-up|0|||
162209675|NCT03305809|585820587|FG000|Overall Study|Sponsor Decision|1|||
162209676|NCT03305809|585820588|FG001|Overall Study|Sponsor Decision|0|||
162209677|NCT03305809|585820589|FG002|Overall Study|Sponsor Decision|1|||
162209678|NCT03305809|585820590|FG003|Overall Study|Sponsor Decision|8|||
162209679|NCT03305809|585820587|FG000|Overall Study|Physician Decision|0|||
162209680|NCT03305809|585820588|FG001|Overall Study|Physician Decision|0|||
162209681|NCT03305809|585820589|FG002|Overall Study|Physician Decision|2|||
162209682|NCT03305809|585820590|FG003|Overall Study|Physician Decision|4|||
162209683|NCT03305809|585820587|FG000|Overall Study|Progressive Disease|0|||
161677636|NCT02871778|583872070|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161677637|NCT02871778|583872071|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161677638|NCT02871778|583872064|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677639|NCT02871778|583872065|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
161677640|NCT02871778|583872066|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677641|NCT02871778|583872067|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677642|NCT02871778|583872068|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677643|NCT02871778|583872069|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677644|NCT02871778|583872070|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677645|NCT02871778|583872071|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
161677646|NCT02871778|583872064|FG000|Part A: Treatment Period 2|Adverse Event|2|||
161677647|NCT02871778|583872065|FG001|Part A: Treatment Period 2|Adverse Event|2|||
161677648|NCT02871778|583872066|FG002|Part A: Treatment Period 2|Adverse Event|0|||
161677649|NCT02871778|583872067|FG003|Part A: Treatment Period 2|Adverse Event|0|||
161677650|NCT02871778|583872068|FG004|Part A: Treatment Period 2|Adverse Event|0|||
161677651|NCT02871778|583872069|FG005|Part A: Treatment Period 2|Adverse Event|0|||
161677652|NCT02871778|583872070|FG006|Part A: Treatment Period 2|Adverse Event|0|||
161677653|NCT02871778|583872071|FG007|Part A: Treatment Period 2|Adverse Event|0|||
161677654|NCT02871778|583872064|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677655|NCT02871778|583872065|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677656|NCT02871778|583872066|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677657|NCT02871778|583872067|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
161677658|NCT02871778|583872068|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677659|NCT02871778|583872069|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677660|NCT02871778|583872070|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677661|NCT02871778|583872071|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
161677662|NCT02871778|583872064|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
161677663|NCT02871778|583872065|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161677664|NCT02871778|583872066|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
161677665|NCT02871778|583872067|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
162021340|NCT02891070|585134749|FG001|Overall Study|Other|0|||
161677666|NCT02871778|583872068|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161677667|NCT02871778|583872069|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161677668|NCT02871778|583872070|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161677669|NCT02871778|583872071|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161677670|NCT02871778|583872064|FG000|Part B: Treatment Period 3|Adverse Event|0|||
161677671|NCT02871778|583872065|FG001|Part B: Treatment Period 3|Adverse Event|0|||
161677672|NCT02871778|583872066|FG002|Part B: Treatment Period 3|Adverse Event|0|||
162209684|NCT03305809|585820588|FG001|Overall Study|Progressive Disease|0|||
162209685|NCT03305809|585820589|FG002|Overall Study|Progressive Disease|1|||
162209686|NCT03305809|585820590|FG003|Overall Study|Progressive Disease|0|||
162209687|NCT03305809|585820587|FG000|Overall Study|Protocol Violation|1|||
162209688|NCT03305809|585820588|FG001|Overall Study|Protocol Violation|0|||
162209689|NCT03305809|585820589|FG002|Overall Study|Protocol Violation|2|||
162209690|NCT03305809|585820590|FG003|Overall Study|Protocol Violation|3|||
162209691|NCT03305809|585820587|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
162209692|NCT03305809|585820588|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
162209693|NCT03305809|585820589|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
162209694|NCT03305809|585820590|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
161825970|NCT00114231|584403748|FG000|Overall Study|Tumor fixed on digital exam|0|||
161825971|NCT00114231|584403749|FG001|Overall Study|Tumor fixed on digital exam|1|||
161825972|NCT00114231|584403748|FG000|Overall Study|No Absolute Neutrophil Count|2|||
161825973|NCT00114231|584403749|FG001|Overall Study|No Absolute Neutrophil Count|0|||
161825974|NCT00114231|584403748|FG000|Overall Study|Biopsy done after registration|1|||
162209695|NCT03305809|585820587|FG000|Overall Study|Withdrawal by Subject|2|||
162209696|NCT03305809|585820588|FG001|Overall Study|Withdrawal by Subject|4|||
162209697|NCT03305809|585820589|FG002|Overall Study|Withdrawal by Subject|5|||
162209698|NCT03305809|585820590|FG003|Overall Study|Withdrawal by Subject|2|||
162209699|NCT03305809|585820587|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
162209700|NCT03305809|585820588|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
162209701|NCT03305809|585820589|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
162209702|NCT03305809|585820590|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
162209703|NCT00816556|585820593|FG000|Overall Study|Adverse Event|1|||
162209704|NCT00816556|585820594|FG001|Overall Study|Adverse Event|1|||
162209705|NCT00816556|585820595|FG002|Overall Study|Adverse Event|1|||
162209706|NCT00816556|585820593|FG000|Overall Study|Withdrawal by Subject|1|||
162209707|NCT00816556|585820594|FG001|Overall Study|Withdrawal by Subject|1|||
162209708|NCT00816556|585820595|FG002|Overall Study|Withdrawal by Subject|1|||
162209709|NCT00816556|585820593|FG000|Overall Study|Lost to Follow-up|0|||
162209710|NCT00816556|585820594|FG001|Overall Study|Lost to Follow-up|0|||
162209711|NCT00816556|585820595|FG002|Overall Study|Lost to Follow-up|1|||
162209712|NCT01657799|585820598|FG000|Overall Study|Adverse Event Related to progression|6|||
162209713|NCT01657799|585820599|FG001|Overall Study|Adverse Event Related to progression|8|||
162209714|NCT01657799|585820600|FG002|Overall Study|Adverse Event Related to progression|12|||
162209715|NCT01657799|585820598|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
162209716|NCT01657799|585820599|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
162209717|NCT01657799|585820600|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
162209718|NCT01657799|585820598|FG000|Overall Study|Withdrawal by Subject|13|||
162209719|NCT01657799|585820599|FG001|Overall Study|Withdrawal by Subject|10|||
162209720|NCT01657799|585820600|FG002|Overall Study|Withdrawal by Subject|10|||
162209721|NCT01657799|585820598|FG000|Overall Study|Lost to Follow-up|1|||
162209722|NCT01657799|585820599|FG001|Overall Study|Lost to Follow-up|0|||
162209723|NCT01657799|585820600|FG002|Overall Study|Lost to Follow-up|1|||
162209724|NCT01657799|585820598|FG000|Overall Study|Disease Progression|2|||
162209725|NCT01657799|585820599|FG001|Overall Study|Disease Progression|4|||
162209726|NCT01657799|585820600|FG002|Overall Study|Disease Progression|4|||
162209727|NCT01657799|585820598|FG000|Overall Study|Progressive Disease Clinical|7|||
162209728|NCT01657799|585820599|FG001|Overall Study|Progressive Disease Clinical|4|||
162209729|NCT01657799|585820600|FG002|Overall Study|Progressive Disease Clinical|7|||
162209730|NCT01657799|585820598|FG000|Overall Study|Radiographic & Clinical Progression|16|||
162209731|NCT01657799|585820599|FG001|Overall Study|Radiographic & Clinical Progression|11|||
162209732|NCT01657799|585820600|FG002|Overall Study|Radiographic & Clinical Progression|15|||
162209733|NCT01657799|585820598|FG000|Overall Study|Other|52|||
162209734|NCT01657799|585820599|FG001|Overall Study|Other|62|||
162209735|NCT01657799|585820600|FG002|Overall Study|Other|49|||
162209736|NCT03927690|585820601|FG000|Overall Study|Withdrawal by Subject|3|||
162209737|NCT03927690|585820602|FG001|Overall Study|Withdrawal by Subject|1|||
162209738|NCT03927690|585820603|FG002|Overall Study|Withdrawal by Subject|1|||
162209739|NCT03927690|585820601|FG000|Overall Study|Adverse Event|1|||
162209740|NCT03927690|585820602|FG001|Overall Study|Adverse Event|0|||
162209741|NCT03927690|585820603|FG002|Overall Study|Adverse Event|0|||
162209742|NCT03927690|585820601|FG000|Overall Study|Death|1|||
162209743|NCT03927690|585820602|FG001|Overall Study|Death|0|||
162209744|NCT03927690|585820603|FG002|Overall Study|Death|0|||
162209745|NCT03927690|585820601|FG000|Overall Study|Lost to Follow-up|2|||
162209746|NCT03927690|585820602|FG001|Overall Study|Lost to Follow-up|2|||
162209747|NCT03927690|585820603|FG002|Overall Study|Lost to Follow-up|1|||
162209748|NCT00174447|585820608|FG000|Overall Study|Adverse Event|19|||
161825975|NCT00114231|584403749|FG001|Overall Study|Biopsy done after registration|0|||
161825976|NCT02457819|584403750|FG000|Overall Study|reason not given|8|||
162209749|NCT00174447|585820608|FG000|Overall Study|Withdrawal by Subject|15|||
162209750|NCT00174447|585820608|FG000|Overall Study|Protocol Violation|1|||
161825977|NCT02457819|584403750|FG000|Overall Study|Withdrawal by Subject|24|||
161825978|NCT02457819|584403750|FG000|Overall Study|Protocol Violation|1|||
161825979|NCT02457819|584403750|FG000|Overall Study|non compliance with study drug|4|||
161825980|NCT02457819|584403750|FG000|Overall Study|Lost to Follow-up|10|||
161825981|NCT02457819|584403750|FG000|Overall Study|Lack of Efficacy|19|||
161825982|NCT02457819|584403750|FG000|Overall Study|Adverse Event|33|||
161825983|NCT03330236|584403753|FG000|Overall Study|Death|2|||
162209751|NCT00174447|585820608|FG000|Overall Study|Lack of Efficacy|1|||
162209752|NCT00174447|585820608|FG000|Overall Study|Administrative reason/Other|2|||
162209753|NCT00551135|585820617|FG000|Overall Study|Adverse Event|1|||
161677673|NCT02871778|583872067|FG003|Part B: Treatment Period 3|Adverse Event|0|||
161677674|NCT02871778|583872068|FG004|Part B: Treatment Period 3|Adverse Event|1|||
162209754|NCT00551135|585820618|FG001|Overall Study|Adverse Event|0|||
161677675|NCT02871778|583872069|FG005|Part B: Treatment Period 3|Adverse Event|1|||
161677676|NCT02871778|583872070|FG006|Part B: Treatment Period 3|Adverse Event|1|||
162021341|NCT02891070|585134748|FG000|Overall Study|Protocol Violation|0|||
162209755|NCT00551135|585820619|FG002|Overall Study|Adverse Event|1|||
162209756|NCT00551135|585820620|FG003|Overall Study|Adverse Event|1|||
162209757|NCT00551135|585820617|FG000|Overall Study|Lost to Follow-up|0|||
162209758|NCT00551135|585820618|FG001|Overall Study|Lost to Follow-up|0|||
162209759|NCT00551135|585820619|FG002|Overall Study|Lost to Follow-up|0|||
162209760|NCT00551135|585820620|FG003|Overall Study|Lost to Follow-up|1|||
162209761|NCT00551135|585820617|FG000|Overall Study|Other|3|||
162209762|NCT00551135|585820618|FG001|Overall Study|Other|2|||
162209763|NCT00551135|585820619|FG002|Overall Study|Other|1|||
162209764|NCT00551135|585820620|FG003|Overall Study|Other|2|||
162209765|NCT00551135|585820617|FG000|Overall Study|Withdrawal by Subject|1|||
162209766|NCT00551135|585820618|FG001|Overall Study|Withdrawal by Subject|0|||
162209767|NCT00551135|585820619|FG002|Overall Study|Withdrawal by Subject|3|||
162209768|NCT00551135|585820620|FG003|Overall Study|Withdrawal by Subject|1|||
162209769|NCT01588366|585820621|FG000|Overall Study|Adverse Event|0|||
162209770|NCT01588366|585820622|FG001|Overall Study|Adverse Event|1|||
162209771|NCT01588366|585820623|FG002|Overall Study|Adverse Event|0|||
162209772|NCT01588366|585820624|FG003|Overall Study|Adverse Event|1|||
162209773|NCT01588366|585820625|FG004|Overall Study|Adverse Event|0|||
162209774|NCT01588366|585820626|FG005|Overall Study|Adverse Event|2|||
162209775|NCT04962698|585820627|FG000|Motor Imagery|Technical difficulty|1|||
162209776|NCT04962698|585820628|FG001|Motor Imagery|Technical difficulty|0|||
162209777|NCT04962698|585820627|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
162209778|NCT04962698|585820628|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
162209779|NCT04962698|585820627|FG000|Kinesthetic MI|Technical difficulty|1|||
162209780|NCT04962698|585820628|FG001|Kinesthetic MI|Technical difficulty|0|||
162209781|NCT04962698|585820627|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
162209782|NCT04962698|585820628|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
162209783|NCT04962698|585820627|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
162209784|NCT04962698|585820628|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
162209785|NCT04962698|585820627|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
162209786|NCT04962698|585820628|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
162209787|NCT04962698|585820627|FG000|Virtual-hand Interaction|Technical difficulty|1|||
162209788|NCT04962698|585820628|FG001|Virtual-hand Interaction|Technical difficulty|0|||
162209789|NCT04962698|585820627|FG000|Robotic Action Observation|Technical difficulty|1|||
162209790|NCT04962698|585820628|FG001|Robotic Action Observation|Technical difficulty|0|||
162209791|NCT04962698|585820627|FG000|Rest|Technical difficulty|1|||
162209792|NCT04962698|585820628|FG001|Rest|Technical difficulty|0|||
162209793|NCT04962698|585820627|FG000|Rest|Exclusion criteria met after enrollment|0|||
162209794|NCT04962698|585820628|FG001|Rest|Exclusion criteria met after enrollment|2|||
162209795|NCT00585975|585820629|FG000|Overall Study|Withdrawal by Subject|3|||
162209796|NCT00585975|585820630|FG001|Overall Study|Withdrawal by Subject|3|||
162209797|NCT00585975|585820629|FG000|Overall Study|Lost to Follow-up|2|||
162209798|NCT00585975|585820630|FG001|Overall Study|Lost to Follow-up|1|||
162209799|NCT00585975|585820629|FG000|Overall Study|Enrollment met/over-enrolled|10|||
162209800|NCT00585975|585820630|FG001|Overall Study|Enrollment met/over-enrolled|9|||
162209801|NCT01129115|585820635|FG000|Overall Study|Adverse Event|1|||
162209802|NCT01129115|585820636|FG001|Overall Study|Adverse Event|2|||
162209803|NCT01129115|585820637|FG002|Overall Study|Adverse Event|3|||
162209804|NCT01129115|585820638|FG003|Overall Study|Adverse Event|3|||
162209805|NCT01129115|585820635|FG000|Overall Study|Withdrawal by Subject|1|||
162209806|NCT01129115|585820636|FG001|Overall Study|Withdrawal by Subject|3|||
162209807|NCT01129115|585820637|FG002|Overall Study|Withdrawal by Subject|1|||
162209808|NCT01129115|585820638|FG003|Overall Study|Withdrawal by Subject|4|||
162209809|NCT01129115|585820635|FG000|Overall Study|Protocol Violation|0|||
162209810|NCT01129115|585820636|FG001|Overall Study|Protocol Violation|2|||
161825984|NCT03330236|584403754|FG001|Overall Study|Death|1|||
161825985|NCT03330236|584403753|FG000|Overall Study|Withdrawal by Subject|2|||
161825986|NCT03330236|584403754|FG001|Overall Study|Withdrawal by Subject|4|||
161825987|NCT03330236|584403753|FG000|Overall Study|Lost to Follow-up|0|||
161825988|NCT03330236|584403754|FG001|Overall Study|Lost to Follow-up|2|||
161825989|NCT03330236|584403753|FG000|Overall Study|Physician Decision|2|||
161825990|NCT03330236|584403754|FG001|Overall Study|Physician Decision|0|||
161825991|NCT03330236|584403753|FG000|Overall Study|Protocol Violation|4|||
161825992|NCT03330236|584403754|FG001|Overall Study|Protocol Violation|3|||
161825993|NCT03330236|584403753|FG000|Overall Study|SedLine malfunction/blinding|19|||
162209811|NCT01129115|585820637|FG002|Overall Study|Protocol Violation|2|||
162209812|NCT01129115|585820638|FG003|Overall Study|Protocol Violation|2|||
162209813|NCT01121913|585820639|FG000|First Intervention Period|Adverse Event|0|||
162209814|NCT01121913|585820640|FG001|First Intervention Period|Adverse Event|0|||
162209815|NCT01121913|585820641|FG002|First Intervention Period|Adverse Event|1|||
162209816|NCT01121913|585820642|FG003|First Intervention Period|Adverse Event|0|||
162209817|NCT01121913|585820639|FG000|First Washout Period|Withdrawal by Subject|1|||
162209818|NCT01121913|585820640|FG001|First Washout Period|Withdrawal by Subject|0|||
162209819|NCT01121913|585820641|FG002|First Washout Period|Withdrawal by Subject|0|||
162209820|NCT01121913|585820642|FG003|First Washout Period|Withdrawal by Subject|0|||
162209821|NCT01121913|585820639|FG000|Second Intervention Period|Adverse Event|0|||
162209822|NCT01121913|585820640|FG001|Second Intervention Period|Adverse Event|0|||
162209823|NCT01121913|585820641|FG002|Second Intervention Period|Adverse Event|1|||
162209824|NCT01121913|585820642|FG003|Second Intervention Period|Adverse Event|0|||
162209825|NCT01121913|585820639|FG000|Second Washout Period|Withdrawal by Subject|0|||
162209826|NCT01121913|585820640|FG001|Second Washout Period|Withdrawal by Subject|0|||
162209827|NCT01121913|585820641|FG002|Second Washout Period|Withdrawal by Subject|1|||
162209828|NCT01121913|585820642|FG003|Second Washout Period|Withdrawal by Subject|0|||
162209829|NCT01121913|585820639|FG000|Third Washout Period|Adverse Event|1|||
162209830|NCT01121913|585820640|FG001|Third Washout Period|Adverse Event|0|||
162209831|NCT01121913|585820641|FG002|Third Washout Period|Adverse Event|0|||
162209832|NCT01121913|585820642|FG003|Third Washout Period|Adverse Event|0|||
162209833|NCT00690378|585820643|FG000|Overall Study|Adverse Event|1|||
162209834|NCT00690378|585820644|FG001|Overall Study|Adverse Event|0|||
162209835|NCT00690378|585820643|FG000|Overall Study|Withdrawal by Subject|2|||
162209836|NCT00690378|585820644|FG001|Overall Study|Withdrawal by Subject|0|||
162209837|NCT00690378|585820643|FG000|Overall Study|Protocol Violation|1|||
162209838|NCT00690378|585820644|FG001|Overall Study|Protocol Violation|0|||
162209839|NCT00690378|585820643|FG000|Overall Study|Lost to Follow-up|2|||
162209840|NCT00690378|585820644|FG001|Overall Study|Lost to Follow-up|3|||
162209841|NCT00690378|585820643|FG000|Overall Study|Did not meet inc/exc criteria|13|||
162209842|NCT00690378|585820644|FG001|Overall Study|Did not meet inc/exc criteria|11|||
162209843|NCT00690378|585820643|FG000|Overall Study|Social problem|1|||
162209844|NCT00690378|585820644|FG001|Overall Study|Social problem|0|||
162209845|NCT02019641|585820645|FG000|10-Week Follow up|Withdrawal by investigator|2|||
162209846|NCT02019641|585820646|FG001|10-Week Follow up|Withdrawal by investigator|0|||
162209847|NCT02019641|585820647|FG002|10-Week Follow up|Withdrawal by investigator|0|||
162209848|NCT02019641|585820645|FG000|10-Week Follow up|Withdrawal by Subject|1|||
162209849|NCT02019641|585820646|FG001|10-Week Follow up|Withdrawal by Subject|1|||
162209850|NCT02019641|585820647|FG002|10-Week Follow up|Withdrawal by Subject|0|||
162209851|NCT02019641|585820645|FG000|20-Week Follow up|Withdrawal by investigator|0|||
162209852|NCT02019641|585820646|FG001|20-Week Follow up|Withdrawal by investigator|0|||
162209853|NCT02019641|585820647|FG002|20-Week Follow up|Withdrawal by investigator|1|||
162209854|NCT03410108|585820650|FG000|Overall Study|Ongoing|41|||
162209855|NCT03410108|585820650|FG000|Overall Study|Adverse Event|4|||
162209856|NCT03410108|585820650|FG000|Overall Study|Progressive Disease|58|||
162209857|NCT03410108|585820650|FG000|Overall Study|Withdrawal by Subject|1|||
162209858|NCT01313624|585820651|FG000|Double-Blind Phase|Adverse Event|27|||
162209859|NCT01313624|585820652|FG001|Double-Blind Phase|Adverse Event|4|||
162209860|NCT01313624|585820651|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
162209861|NCT01313624|585820652|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
162209862|NCT01313624|585820651|FG000|Double-Blind Phase|Lost to Follow-up|0|||
162209863|NCT01313624|585820652|FG001|Double-Blind Phase|Lost to Follow-up|2|||
162209864|NCT01313624|585820651|FG000|Double-Blind Phase|Physician Decision|1|||
162209865|NCT01313624|585820652|FG001|Double-Blind Phase|Physician Decision|0|||
162209866|NCT01313624|585820651|FG000|Double-Blind Phase|Lack of Efficacy|1|||
162209867|NCT01313624|585820652|FG001|Double-Blind Phase|Lack of Efficacy|0|||
162209868|NCT01313624|585820651|FG000|Open-Label Phase|Adverse Event|1|||
162209869|NCT01313624|585820652|FG001|Open-Label Phase|Adverse Event|10|||
162209870|NCT01313624|585820651|FG000|Open-Label Phase|Withdrawal by Subject|2|||
162209871|NCT01313624|585820652|FG001|Open-Label Phase|Withdrawal by Subject|2|||
162209872|NCT01313624|585820651|FG000|Open-Label Phase|Lost to Follow-up|1|||
162209873|NCT01313624|585820652|FG001|Open-Label Phase|Lost to Follow-up|1|||
162209874|NCT05043883|585820653|FG000|Overall Study|Minimum required measurements could not be taken|4|||
162209875|NCT02447718|585820656|FG000|Overall Study|Lost to Follow-up|8|||
162209876|NCT02447718|585820657|FG001|Overall Study|Lost to Follow-up|0|||
162209877|NCT02447718|585820656|FG000|Overall Study|Withdrawal by Subject|3|||
162209878|NCT02447718|585820657|FG001|Overall Study|Withdrawal by Subject|0|||
162209879|NCT02447718|585820656|FG000|Overall Study|Screen Failure|1|||
161825994|NCT03330236|584403754|FG001|Overall Study|SedLine malfunction/blinding|14|||
161934392|NCT01684033|584808498|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
162209880|NCT02447718|585820657|FG001|Overall Study|Screen Failure|0|||
162209881|NCT00468130|585820660|FG000|Overall Study|Adverse Event|2|||
162209882|NCT00468130|585820661|FG001|Overall Study|Adverse Event|1|||
162209883|NCT00468130|585820660|FG000|Overall Study|Withdrawal by Subject|0|||
162209884|NCT00468130|585820661|FG001|Overall Study|Withdrawal by Subject|1|||
162209885|NCT03772613|585820662|FG000|Overall Study|Lost to Follow-up|0|||
162209886|NCT03772613|585820663|FG001|Overall Study|Lost to Follow-up|1|||
162209887|NCT03772613|585820664|FG002|Overall Study|Lost to Follow-up|1|||
162209888|NCT01837797|585820673|FG000|Period 1|Adverse Event|9|||
162209889|NCT01837797|585820674|FG001|Period 1|Adverse Event|0|||
162209890|NCT01837797|585820675|FG002|Period 1|Adverse Event|0|||
162209891|NCT01837797|585820676|FG003|Period 1|Adverse Event|0|||
162209892|NCT01837797|585820677|FG004|Period 1|Adverse Event|0|||
162209893|NCT01837797|585820673|FG000|Period 1|Withdrawal by Subject|6|||
162209894|NCT01837797|585820674|FG001|Period 1|Withdrawal by Subject|0|||
162209895|NCT01837797|585820675|FG002|Period 1|Withdrawal by Subject|0|||
162209896|NCT01837797|585820676|FG003|Period 1|Withdrawal by Subject|0|||
162209897|NCT01837797|585820677|FG004|Period 1|Withdrawal by Subject|0|||
161825995|NCT03330236|584403753|FG000|Overall Study|Volatile anesthetics used|11|||
161825996|NCT03330236|584403754|FG001|Overall Study|Volatile anesthetics used|8|||
161825997|NCT03330236|584403753|FG000|Overall Study|Surgery aborted/converted to open|60|||
161825998|NCT03330236|584403754|FG001|Overall Study|Surgery aborted/converted to open|52|||
161825999|NCT00763555|584403758|FG000|Overall Study|Adverse Event|2|||
161826000|NCT00763555|584403759|FG001|Overall Study|Adverse Event|1|||
161826001|NCT00763555|584403758|FG000|Overall Study|Withdrawal by Subject|2|||
162209898|NCT01837797|585820673|FG000|Period 1|Administrative reasons|76|||
162209899|NCT01837797|585820674|FG001|Period 1|Administrative reasons|0|||
162209900|NCT01837797|585820675|FG002|Period 1|Administrative reasons|0|||
161826002|NCT00763555|584403759|FG001|Overall Study|Withdrawal by Subject|6|||
162209901|NCT01837797|585820676|FG003|Period 1|Administrative reasons|0|||
162209902|NCT01837797|585820677|FG004|Period 1|Administrative reasons|0|||
162209903|NCT01837797|585820673|FG000|Period 1|Withdrawal of consent before treatment|1|||
161934393|NCT01684033|584808499|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
161934394|NCT01684033|584808498|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
161934395|NCT01684033|584808499|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
161934396|NCT01684033|584808498|FG000|Period 2, Second 30 Days|Adverse Event|1|||
161934397|NCT01684033|584808499|FG001|Period 2, Second 30 Days|Adverse Event|0|||
161934398|NCT03726879|584808500|FG000|Overall Study|Death|11|||
161934399|NCT03726879|584808501|FG001|Overall Study|Death|13|||
161934400|NCT03726879|584808500|FG000|Overall Study|Physician Decision|0|||
161934401|NCT03726879|584808501|FG001|Overall Study|Physician Decision|2|||
161934402|NCT03726879|584808500|FG000|Overall Study|Protocol Violation|0|||
161934403|NCT03726879|584808501|FG001|Overall Study|Protocol Violation|1|||
161934404|NCT03726879|584808500|FG000|Overall Study|Withdrawal by Subject|5|||
161934405|NCT03726879|584808501|FG001|Overall Study|Withdrawal by Subject|6|||
161934406|NCT03726879|584808500|FG000|Overall Study|TSH result is unstable|0|||
161934407|NCT03726879|584808501|FG001|Overall Study|TSH result is unstable|1|||
161934408|NCT03726879|584808500|FG000|Overall Study|Disease relapse|1|||
161934409|NCT03726879|584808501|FG001|Overall Study|Disease relapse|0|||
162209904|NCT01837797|585820674|FG001|Period 1|Withdrawal of consent before treatment|0|||
162209905|NCT01837797|585820675|FG002|Period 1|Withdrawal of consent before treatment|0|||
162209906|NCT01837797|585820676|FG003|Period 1|Withdrawal of consent before treatment|0|||
162209907|NCT01837797|585820677|FG004|Period 1|Withdrawal of consent before treatment|0|||
162209908|NCT01837797|585820673|FG000|Period 1|Other|10|||
162209909|NCT01837797|585820674|FG001|Period 1|Other|0|||
162209910|NCT01837797|585820675|FG002|Period 1|Other|0|||
162209911|NCT01837797|585820676|FG003|Period 1|Other|0|||
162209912|NCT01837797|585820677|FG004|Period 1|Other|0|||
162209913|NCT01837797|585820673|FG000|Period 2|Administrative or other reasons|0|||
162209914|NCT01837797|585820674|FG001|Period 2|Administrative or other reasons|5|||
162209915|NCT01837797|585820675|FG002|Period 2|Administrative or other reasons|2|||
162209916|NCT01837797|585820676|FG003|Period 2|Administrative or other reasons|4|||
162209917|NCT01837797|585820677|FG004|Period 2|Administrative or other reasons|0|||
162209918|NCT01837797|585820673|FG000|Period 2|Adverse Event|0|||
162209919|NCT01837797|585820674|FG001|Period 2|Adverse Event|0|||
162209920|NCT01837797|585820675|FG002|Period 2|Adverse Event|0|||
162209921|NCT01837797|585820676|FG003|Period 2|Adverse Event|1|||
162209922|NCT01837797|585820677|FG004|Period 2|Adverse Event|0|||
162209923|NCT01837797|585820673|FG000|Period 3|Adverse Event|0|||
162209924|NCT01837797|585820674|FG001|Period 3|Adverse Event|0|||
162209925|NCT01837797|585820675|FG002|Period 3|Adverse Event|0|||
162209926|NCT01837797|585820676|FG003|Period 3|Adverse Event|0|||
162209927|NCT01837797|585820677|FG004|Period 3|Adverse Event|1|||
162209928|NCT01837797|585820673|FG000|Period 3|Administrative reasons|0|||
162209929|NCT01837797|585820674|FG001|Period 3|Administrative reasons|0|||
162209930|NCT01837797|585820675|FG002|Period 3|Administrative reasons|0|||
162209931|NCT01837797|585820676|FG003|Period 3|Administrative reasons|0|||
162209932|NCT01837797|585820677|FG004|Period 3|Administrative reasons|20|||
162209933|NCT01837797|585820673|FG000|Period 3|Other|0|||
162209934|NCT01837797|585820674|FG001|Period 3|Other|0|||
162209935|NCT01837797|585820675|FG002|Period 3|Other|0|||
162209936|NCT01837797|585820676|FG003|Period 3|Other|0|||
162209937|NCT01837797|585820677|FG004|Period 3|Other|2|||
162209938|NCT03797989|585820698|FG000|VAC069A|Withdrawal by Subject|0|||
162209939|NCT03797989|585820699|FG001|VAC069A|Withdrawal by Subject|0|||
162209940|NCT03797989|585820700|FG002|VAC069A|Withdrawal by Subject|1|||
162209941|NCT03797989|585820701|FG003|VAC069A|Withdrawal by Subject|0|||
162209942|NCT03797989|585820702|FG004|VAC069A|Withdrawal by Subject|0|||
162209943|NCT03797989|585820703|FG005|VAC069A|Withdrawal by Subject|0|||
162209944|NCT03797989|585820704|FG006|VAC069A|Withdrawal by Subject|0|||
162209945|NCT03797989|585820705|FG007|VAC069A|Withdrawal by Subject|0|||
162209946|NCT03797989|585820706|FG008|VAC069A|Withdrawal by Subject|0|||
162209947|NCT03797989|585820707|FG009|VAC069A|Withdrawal by Subject|0|||
162209948|NCT03797989|585820708|FG010|VAC069A|Withdrawal by Subject|0|||
162209949|NCT03797989|585820709|FG011|VAC069A|Withdrawal by Subject|0|||
162209950|NCT04522778|585820711|FG000|Overall Study|Patient did not want to wear the device|1|||
162209951|NCT04522778|585820712|FG001|Overall Study|Patient did not want to wear the device|0|||
162209952|NCT04522778|585820711|FG000|Overall Study|Lost to Follow-up|0|||
162209953|NCT04522778|585820712|FG001|Overall Study|Lost to Follow-up|1|||
162209954|NCT04052997|585820713|FG000|Overall Study|Withdrawal by Subject|17|||
162209955|NCT04052997|585820713|FG000|Overall Study|Physician Decision|50|||
162209956|NCT04052997|585820713|FG000|Overall Study|Death|43|||
162209957|NCT04052997|585820713|FG000|Overall Study|Lost to Follow-up|5|||
162209958|NCT04052997|585820713|FG000|Overall Study|Progression of Disease|1|||
161934410|NCT03726879|584808500|FG000|Overall Study|Lost to Follow-up|3|||
161934411|NCT03726879|584808501|FG001|Overall Study|Lost to Follow-up|0|||
161934412|NCT02496156|584808503|FG000|Overall Study|Lost to Follow-up|5|||
161934413|NCT02496156|584808504|FG001|Overall Study|Lost to Follow-up|0|||
162021342|NCT02891070|585134749|FG001|Overall Study|Protocol Violation|1|||
162209959|NCT00069277|585820714|FG000|Overall Study|Adverse Event|3|||
162209960|NCT00069277|585820714|FG000|Overall Study|Withdrawal by Subject|1|||
162209961|NCT00069277|585820714|FG000|Overall Study|Progressive Disease|15|||
162209962|NCT00069277|585820714|FG000|Overall Study|Physician Decision|2|||
161934414|NCT02496156|584808503|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
161934415|NCT02496156|584808504|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
161934416|NCT00507507|584808505|FG000|Treatment Period|Lost to Follow-up|0|||
161934417|NCT00507507|584808506|FG001|Treatment Period|Lost to Follow-up|2|||
161934418|NCT00507507|584808505|FG000|Treatment Period|Physician Decision|4|||
161934419|NCT00507507|584808506|FG001|Treatment Period|Physician Decision|1|||
161934420|NCT00507507|584808505|FG000|Treatment Period|Protocol Violation|1|||
161934421|NCT00507507|584808506|FG001|Treatment Period|Protocol Violation|2|||
161934422|NCT00507507|584808505|FG000|Treatment Period|Adverse Event|1|||
161934423|NCT00507507|584808506|FG001|Treatment Period|Adverse Event|1|||
161934424|NCT00507507|584808505|FG000|Treatment Period|Withdrawal by Subject|46|||
161934425|NCT00507507|584808506|FG001|Treatment Period|Withdrawal by Subject|47|||
161934426|NCT00507507|584808505|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
161934427|NCT00507507|584808506|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
161934428|NCT00507507|584808505|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
161934429|NCT00507507|584808506|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
161934430|NCT00507507|584808505|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
161934431|NCT00507507|584808506|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
161934432|NCT00289900|584808509|FG000|Overall Study|Adverse Event|28|||
161934433|NCT00289900|584808510|FG001|Overall Study|Adverse Event|40|||
161934434|NCT00289900|584808511|FG002|Overall Study|Adverse Event|13|||
161934435|NCT00289900|584808512|FG003|Overall Study|Adverse Event|19|||
161934436|NCT00289900|584808513|FG004|Overall Study|Adverse Event|20|||
161934437|NCT00289900|584808514|FG005|Overall Study|Adverse Event|33|||
161934438|NCT00289900|584808509|FG000|Overall Study|Lost to Follow-up|7|||
161934439|NCT00289900|584808510|FG001|Overall Study|Lost to Follow-up|7|||
161934440|NCT00289900|584808511|FG002|Overall Study|Lost to Follow-up|8|||
161934441|NCT00289900|584808512|FG003|Overall Study|Lost to Follow-up|8|||
161934442|NCT00289900|584808513|FG004|Overall Study|Lost to Follow-up|4|||
161934443|NCT00289900|584808514|FG005|Overall Study|Lost to Follow-up|8|||
161934444|NCT00289900|584808509|FG000|Overall Study|Participant had flushing|18|||
161934445|NCT00289900|584808510|FG001|Overall Study|Participant had flushing|42|||
161934446|NCT00289900|584808511|FG002|Overall Study|Participant had flushing|1|||
161934447|NCT00289900|584808512|FG003|Overall Study|Participant had flushing|2|||
161934448|NCT00289900|584808513|FG004|Overall Study|Participant had flushing|0|||
161934449|NCT00289900|584808514|FG005|Overall Study|Participant had flushing|4|||
161934450|NCT00289900|584808509|FG000|Overall Study|Other|0|||
161934451|NCT00289900|584808510|FG001|Overall Study|Other|0|||
161934452|NCT00289900|584808511|FG002|Overall Study|Other|0|||
161934453|NCT00289900|584808512|FG003|Overall Study|Other|5|||
161934454|NCT00289900|584808513|FG004|Overall Study|Other|1|||
161934455|NCT00289900|584808514|FG005|Overall Study|Other|0|||
161934456|NCT00289900|584808509|FG000|Overall Study|Participant moved|1|||
161934457|NCT00289900|584808510|FG001|Overall Study|Participant moved|0|||
161934458|NCT00289900|584808511|FG002|Overall Study|Participant moved|0|||
161934459|NCT00289900|584808512|FG003|Overall Study|Participant moved|1|||
161934460|NCT00289900|584808513|FG004|Overall Study|Participant moved|1|||
161934461|NCT00289900|584808514|FG005|Overall Study|Participant moved|1|||
161934462|NCT00289900|584808509|FG000|Overall Study|Withdrawal by Subject|10|||
161934463|NCT00289900|584808510|FG001|Overall Study|Withdrawal by Subject|21|||
161934464|NCT00289900|584808511|FG002|Overall Study|Withdrawal by Subject|8|||
161934465|NCT00289900|584808512|FG003|Overall Study|Withdrawal by Subject|18|||
161934466|NCT00289900|584808513|FG004|Overall Study|Withdrawal by Subject|12|||
161934467|NCT00289900|584808514|FG005|Overall Study|Withdrawal by Subject|11|||
161934468|NCT00289900|584808509|FG000|Overall Study|Protocol Violation|3|||
161934469|NCT00289900|584808510|FG001|Overall Study|Protocol Violation|9|||
161934470|NCT00289900|584808511|FG002|Overall Study|Protocol Violation|2|||
161934471|NCT00289900|584808512|FG003|Overall Study|Protocol Violation|6|||
161934472|NCT00289900|584808513|FG004|Overall Study|Protocol Violation|7|||
161934473|NCT00289900|584808514|FG005|Overall Study|Protocol Violation|4|||
161934474|NCT00289900|584808509|FG000|Overall Study|site terminated|1|||
161934475|NCT00289900|584808510|FG001|Overall Study|site terminated|0|||
161934476|NCT00289900|584808511|FG002|Overall Study|site terminated|1|||
161934477|NCT00289900|584808512|FG003|Overall Study|site terminated|0|||
161934478|NCT00289900|584808513|FG004|Overall Study|site terminated|0|||
161934479|NCT00289900|584808514|FG005|Overall Study|site terminated|0|||
161934480|NCT00289900|584808509|FG000|Overall Study|Not treated|0|||
161934481|NCT00289900|584808510|FG001|Overall Study|Not treated|1|||
161934482|NCT00289900|584808511|FG002|Overall Study|Not treated|0|||
161934483|NCT00289900|584808512|FG003|Overall Study|Not treated|0|||
161934484|NCT00289900|584808513|FG004|Overall Study|Not treated|0|||
161934485|NCT00289900|584808514|FG005|Overall Study|Not treated|0|||
161934486|NCT03249558|584808515|FG000|Overall Study|Lost to Follow-up|2|||
161934487|NCT03249558|584808516|FG001|Overall Study|Lost to Follow-up|1|||
161934488|NCT03249558|584808517|FG002|Overall Study|Lost to Follow-up|4|||
161934489|NCT03249558|584808515|FG000|Overall Study|Physician Decision|1|||
161934490|NCT03249558|584808516|FG001|Overall Study|Physician Decision|0|||
161934491|NCT03249558|584808517|FG002|Overall Study|Physician Decision|0|||
161934492|NCT03249558|584808515|FG000|Overall Study|Withdrawal by Subject|6|||
161934493|NCT03249558|584808516|FG001|Overall Study|Withdrawal by Subject|5|||
161934494|NCT03249558|584808517|FG002|Overall Study|Withdrawal by Subject|7|||
161934495|NCT03249558|584808515|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
161934496|NCT03249558|584808516|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
161934497|NCT03249558|584808517|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
161934498|NCT03249558|584808515|FG000|Overall Study|Protocol Violation|1|||
161934499|NCT03249558|584808516|FG001|Overall Study|Protocol Violation|1|||
161934500|NCT03249558|584808517|FG002|Overall Study|Protocol Violation|2|||
161934501|NCT02656173|584808518|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
161934502|NCT02656173|584808519|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
161934503|NCT02656173|584808518|FG000|Overall Study|Adverse Event|7|||
161934504|NCT02656173|584808519|FG001|Overall Study|Adverse Event|5|||
161934505|NCT02656173|584808518|FG000|Overall Study|Withdrawal by Subject|1|||
161934506|NCT02656173|584808519|FG001|Overall Study|Withdrawal by Subject|3|||
161934507|NCT02656173|584808518|FG000|Overall Study|Protocol Violation|0|||
161934508|NCT02656173|584808519|FG001|Overall Study|Protocol Violation|1|||
161934509|NCT02656173|584808518|FG000|Overall Study|Miscellaneous|2|||
161934510|NCT02656173|584808519|FG001|Overall Study|Miscellaneous|0|||
161934511|NCT03449147|584808521|FG000|52-week Treatment Period|Death|0|||
161934512|NCT03449147|584808522|FG001|52-week Treatment Period|Death|1|||
161934513|NCT03449147|584808523|FG002|52-week Treatment Period|Death|0|||
161934514|NCT03449147|584808521|FG000|52-week Treatment Period|Lost to Follow-up|6|||
161934515|NCT03449147|584808522|FG001|52-week Treatment Period|Lost to Follow-up|2|||
161934516|NCT03449147|584808523|FG002|52-week Treatment Period|Lost to Follow-up|5|||
161934517|NCT03449147|584808521|FG000|52-week Treatment Period|Other|0|||
161934518|NCT03449147|584808522|FG001|52-week Treatment Period|Other|1|||
161934519|NCT03449147|584808523|FG002|52-week Treatment Period|Other|2|||
161934520|NCT03449147|584808521|FG000|52-week Treatment Period|Physician Decision|1|||
161934521|NCT03449147|584808522|FG001|52-week Treatment Period|Physician Decision|0|||
161934522|NCT03449147|584808523|FG002|52-week Treatment Period|Physician Decision|3|||
161934523|NCT03449147|584808521|FG000|52-week Treatment Period|Screen Failure|1|||
162209963|NCT04594733|585820715|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
162209964|NCT04594733|585820716|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
162209965|NCT04594733|585820715|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
162209966|NCT04594733|585820716|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
162209967|NCT04594733|585820715|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
162209968|NCT04594733|585820716|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
162209969|NCT01024036|585820721|FG000|Blinded Treatment|Adverse Event|1|||
162209970|NCT01024036|585820722|FG001|Blinded Treatment|Adverse Event|1|||
162209971|NCT01024036|585820721|FG000|Blinded Treatment|Lack of Efficacy|16|||
162209972|NCT01024036|585820722|FG001|Blinded Treatment|Lack of Efficacy|14|||
162209973|NCT01024036|585820721|FG000|Blinded Treatment|Physician Decision|1|||
162209974|NCT01024036|585820722|FG001|Blinded Treatment|Physician Decision|0|||
162209975|NCT01024036|585820721|FG000|Blinded Treatment|Death|0|||
162209976|NCT01024036|585820722|FG001|Blinded Treatment|Death|2|||
162209977|NCT01024036|585820721|FG000|Blinded Treatment|Withdrawal by Subject|4|||
162209978|NCT01024036|585820722|FG001|Blinded Treatment|Withdrawal by Subject|3|||
162209979|NCT01024036|585820721|FG000|Unblinded Treatment|Adverse Event|0|||
162209980|NCT01024036|585820722|FG001|Unblinded Treatment|Adverse Event|1|||
162209981|NCT01024036|585820721|FG000|Unblinded Treatment|Lack of Efficacy|0|||
162209982|NCT01024036|585820722|FG001|Unblinded Treatment|Lack of Efficacy|2|||
162209983|NCT01024036|585820721|FG000|Follow-Up Period|Lost to Follow-up|1|||
162209984|NCT01024036|585820722|FG001|Follow-Up Period|Lost to Follow-up|1|||
162209985|NCT01024036|585820721|FG000|Follow-Up Period|Withdrawal by Subject|0|||
162209986|NCT01024036|585820722|FG001|Follow-Up Period|Withdrawal by Subject|1|||
162209987|NCT01024036|585820721|FG000|Follow-Up Period|Adverse Event|4|||
162209988|NCT01024036|585820722|FG001|Follow-Up Period|Adverse Event|1|||
162209989|NCT03512288|585820727|FG000|Overall Study|Adverse Event|1|||
162209990|NCT03512288|585820728|FG001|Overall Study|Adverse Event|0|||
162209991|NCT03512288|585820727|FG000|Overall Study|Lost to Follow-up|12|||
162209992|NCT03512288|585820728|FG001|Overall Study|Lost to Follow-up|15|||
162209993|NCT03512288|585820727|FG000|Overall Study|Physician Decision|0|||
162209994|NCT03512288|585820728|FG001|Overall Study|Physician Decision|2|||
162209995|NCT03512288|585820727|FG000|Overall Study|Protocol Violation|6|||
161934524|NCT03449147|584808522|FG001|52-week Treatment Period|Screen Failure|2|||
161934525|NCT03449147|584808523|FG002|52-week Treatment Period|Screen Failure|0|||
161934526|NCT03449147|584808521|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
161934527|NCT03449147|584808522|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
161934528|NCT03449147|584808523|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
161934529|NCT03449147|584808521|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
161934530|NCT03449147|584808522|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
161934531|NCT03449147|584808523|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
161934532|NCT03449147|584808521|FG000|12-Week Off-Treatment Durability Period|Other|0|||
161934533|NCT03449147|584808522|FG001|12-Week Off-Treatment Durability Period|Other|1|||
161934534|NCT03449147|584808523|FG002|12-Week Off-Treatment Durability Period|Other|0|||
161934535|NCT00954538|584808525|FG000|Part III|Withdrawal by Subject|0|||
161934536|NCT00954538|584808526|FG001|Part III|Withdrawal by Subject|0|||
161934537|NCT00954538|584808527|FG002|Part III|Withdrawal by Subject|0|||
161934538|NCT00954538|584808528|FG003|Part III|Withdrawal by Subject|0|||
161934539|NCT00954538|584808529|FG004|Part III|Withdrawal by Subject|1|||
161934540|NCT00954538|584808530|FG005|Part III|Withdrawal by Subject|0|||
161934541|NCT00974233|584808534|FG000|Induction Chemoimmunotherapy|Death|2|||
161934542|NCT00974233|584808534|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
161934543|NCT00974233|584808534|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
161934544|NCT00974233|584808534|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
161934545|NCT00974233|584808534|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
161934546|NCT00974233|584808534|FG000|Maintenance Lenalidomide|Adverse Event|8|||
161934547|NCT01691092|584808535|FG000|Overall Study|Lost to Follow-up|10|||
161934548|NCT01691092|584808535|FG000|Overall Study|Physician Decision|4|||
161934549|NCT01691092|584808535|FG000|Overall Study|Withdrawal by Subject|3|||
161934550|NCT01691092|584808535|FG000|Overall Study|non-compliance|3|||
161934551|NCT01691092|584808535|FG000|Overall Study|used for different study|2|||
161934552|NCT01691092|584808535|FG000|Overall Study|screen fail|19|||
162209996|NCT03512288|585820728|FG001|Overall Study|Protocol Violation|4|||
162209997|NCT03512288|585820727|FG000|Overall Study|Medication error without associated adverse event|1|||
162209998|NCT03512288|585820728|FG001|Overall Study|Medication error without associated adverse event|0|||
162209999|NCT03512288|585820727|FG000|Overall Study|No longer met eligibility criteria|5|||
162210000|NCT03512288|585820728|FG001|Overall Study|No longer met eligibility criteria|2|||
162210001|NCT03512288|585820727|FG000|Overall Study|Withdrawal by parent/guardian|14|||
162210002|NCT03512288|585820728|FG001|Overall Study|Withdrawal by parent/guardian|18|||
162210003|NCT03512288|585820727|FG000|Overall Study|Other|1|||
162210004|NCT03512288|585820728|FG001|Overall Study|Other|1|||
162210005|NCT03512288|585820727|FG000|Overall Study|Randomized but not treated|1|||
162210006|NCT03512288|585820728|FG001|Overall Study|Randomized but not treated|1|||
162210007|NCT01482819|585820731|FG000|Overall Study|Lost to Follow-up|2|||
162210008|NCT01502371|585820734|FG000|Overall Study|Withdrawal by Subject|1|||
162210009|NCT01502371|585820735|FG001|Overall Study|Withdrawal by Subject|2|||
161677677|NCT02871778|583872071|FG007|Part B: Treatment Period 3|Adverse Event|0|||
161677678|NCT02653300|583872072|FG000|Overall Study|Withdrawal by Subject|2|||
161677679|NCT00911625|583872076|FG000|Overall Study|Lost to Follow-up|7|||
161677680|NCT00911625|583872077|FG001|Overall Study|Lost to Follow-up|0|||
161677681|NCT00888381|583872082|FG000|Overall Study|Lost to Follow-up|0|||
161677682|NCT00888381|583872083|FG001|Overall Study|Lost to Follow-up|1|||
161677683|NCT02729740|583872084|FG000|Overall Study|Early Termination|130|||
161677684|NCT02729740|583872084|FG000|Overall Study|Other|1|||
161677685|NCT00307333|583872085|FG000|Overall Study|Lost to Follow-up|11|||
161677686|NCT00307333|583872086|FG001|Overall Study|Lost to Follow-up|3|||
161677687|NCT04166383|583872087|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
161677688|NCT04166383|583872087|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
161677689|NCT04166383|583872087|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
161677690|NCT03044886|583872088|FG000|Overall Study|Lost to Follow-up|15|||
161677691|NCT03044886|583872089|FG001|Overall Study|Lost to Follow-up|10|||
161677692|NCT03044886|583872090|FG002|Overall Study|Lost to Follow-up|12|||
161677693|NCT03785678|583872093|FG000|Overall Study|Death|44|||
161677694|NCT03785678|583872094|FG001|Overall Study|Death|42|||
161677695|NCT03785678|583872093|FG000|Overall Study|Lost to Follow-up|4|||
161677696|NCT03785678|583872094|FG001|Overall Study|Lost to Follow-up|2|||
161677697|NCT03785678|583872093|FG000|Overall Study|Physician Decision|0|||
161677698|NCT03785678|583872094|FG001|Overall Study|Physician Decision|2|||
162210010|NCT01502371|585820736|FG002|Overall Study|Withdrawal by Subject|1|||
162210011|NCT01502371|585820737|FG003|Overall Study|Withdrawal by Subject|1|||
161677699|NCT03785678|583872093|FG000|Overall Study|Withdrawal by Subject|5|||
161677700|NCT03785678|583872094|FG001|Overall Study|Withdrawal by Subject|3|||
161677701|NCT01159912|583872095|FG000|Overall Study|Adverse Event|2|||
161677702|NCT01159912|583872096|FG001|Overall Study|Adverse Event|2|||
161677703|NCT01159912|583872097|FG002|Overall Study|Adverse Event|3|||
161677704|NCT01159912|583872095|FG000|Overall Study|Lack of Efficacy|23|||
161677705|NCT01159912|583872096|FG001|Overall Study|Lack of Efficacy|15|||
161934553|NCT01657942|584808536|FG000|Overall Study|Alternative Treatment|7|||
161934554|NCT01657942|584808536|FG000|Overall Study|Lost to Follow-up|1|||
161934555|NCT02904265|584809974|FG000|Overall Study|Physician Decision|1|||
161934556|NCT02904265|584809975|FG001|Overall Study|Physician Decision|2|||
161934557|NCT00185614|584809978|FG000|Inter-treatment Period|Physician Decision|1|||
161934558|NCT00185614|584809978|FG000|Inter-treatment Period|Relapse|2|||
161934559|NCT00185614|584809978|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
161934560|NCT01034657|584809987|FG000|Core Phase|Withdrawal by Subject|1|||
161934561|NCT01034657|584809988|FG001|Core Phase|Withdrawal by Subject|0|||
161934562|NCT01034657|584809989|FG002|Core Phase|Withdrawal by Subject|0|||
161934563|NCT01034657|584809987|FG000|Core Phase|Lack of Efficacy|2|||
161934564|NCT01034657|584809988|FG001|Core Phase|Lack of Efficacy|0|||
161934565|NCT01034657|584809989|FG002|Core Phase|Lack of Efficacy|0|||
161934566|NCT01034657|584809987|FG000|Core Phase|Abnormal laboratory value|1|||
161934567|NCT01034657|584809988|FG001|Core Phase|Abnormal laboratory value|0|||
161934568|NCT01034657|584809989|FG002|Core Phase|Abnormal laboratory value|0|||
161934569|NCT01034657|584809987|FG000|Core Phase|Adverse Event|8|||
161934570|NCT01034657|584809988|FG001|Core Phase|Adverse Event|0|||
161934571|NCT01034657|584809989|FG002|Core Phase|Adverse Event|0|||
161934572|NCT01034657|584809987|FG000|Core Phase|Protocol Violation|2|||
161934573|NCT01034657|584809988|FG001|Core Phase|Protocol Violation|0|||
161934574|NCT01034657|584809989|FG002|Core Phase|Protocol Violation|0|||
161934575|NCT01034657|584809987|FG000|Randomized Phase|Withdrawal by Subject|0|||
161934576|NCT01034657|584809988|FG001|Randomized Phase|Withdrawal by Subject|2|||
161934577|NCT01034657|584809989|FG002|Randomized Phase|Withdrawal by Subject|0|||
161934578|NCT01034657|584809987|FG000|Randomized Phase|Lack of Efficacy|5|||
161934579|NCT01034657|584809988|FG001|Randomized Phase|Lack of Efficacy|1|||
161934580|NCT01034657|584809989|FG002|Randomized Phase|Lack of Efficacy|0|||
161934581|NCT01034657|584809987|FG000|Randomized Phase|Abnormal laboratory value|0|||
161934582|NCT01034657|584809988|FG001|Randomized Phase|Abnormal laboratory value|1|||
161934583|NCT01034657|584809989|FG002|Randomized Phase|Abnormal laboratory value|0|||
161934584|NCT01034657|584809987|FG000|Randomized Phase|Adverse Event|0|||
161934585|NCT01034657|584809988|FG001|Randomized Phase|Adverse Event|2|||
161934586|NCT01034657|584809989|FG002|Randomized Phase|Adverse Event|1|||
161934587|NCT01225952|584810003|FG000|Overall Study|Lost to Follow-up|1|||
161934588|NCT01225952|584810004|FG001|Overall Study|Lost to Follow-up|0|||
162210012|NCT01502371|585820738|FG004|Overall Study|Withdrawal by Subject|1|||
162210013|NCT01502371|585820734|FG000|Overall Study|Adverse Event|2|||
162210014|NCT01502371|585820735|FG001|Overall Study|Adverse Event|1|||
162210015|NCT01502371|585820736|FG002|Overall Study|Adverse Event|0|||
162210016|NCT01502371|585820737|FG003|Overall Study|Adverse Event|4|||
162210017|NCT01502371|585820738|FG004|Overall Study|Adverse Event|3|||
162210018|NCT01502371|585820734|FG000|Overall Study|Treatment Failure|22|||
162210019|NCT01502371|585820735|FG001|Overall Study|Treatment Failure|20|||
162210020|NCT01502371|585820736|FG002|Overall Study|Treatment Failure|12|||
162210021|NCT01502371|585820737|FG003|Overall Study|Treatment Failure|19|||
162210022|NCT01502371|585820738|FG004|Overall Study|Treatment Failure|30|||
162210023|NCT01502371|585820734|FG000|Overall Study|Lack of Efficacy|3|||
162210024|NCT01502371|585820735|FG001|Overall Study|Lack of Efficacy|3|||
162210025|NCT01502371|585820736|FG002|Overall Study|Lack of Efficacy|2|||
162210026|NCT01502371|585820737|FG003|Overall Study|Lack of Efficacy|2|||
162210027|NCT01502371|585820738|FG004|Overall Study|Lack of Efficacy|4|||
162210028|NCT01502371|585820734|FG000|Overall Study|Physician Decision|3|||
162210029|NCT01502371|585820735|FG001|Overall Study|Physician Decision|0|||
162210030|NCT01502371|585820736|FG002|Overall Study|Physician Decision|0|||
162210031|NCT01502371|585820737|FG003|Overall Study|Physician Decision|0|||
162210032|NCT01502371|585820738|FG004|Overall Study|Physician Decision|1|||
162210033|NCT01502371|585820734|FG000|Overall Study|Noncompliance with Study Drug|0|||
162210034|NCT01502371|585820735|FG001|Overall Study|Noncompliance with Study Drug|0|||
161934589|NCT01225952|584810005|FG002|Overall Study|Lost to Follow-up|0|||
161934590|NCT01225952|584810003|FG000|Overall Study|Study Eye Explanted|0|||
161934591|NCT01225952|584810004|FG001|Overall Study|Study Eye Explanted|0|||
161934592|NCT01225952|584810005|FG002|Overall Study|Study Eye Explanted|1|||
161934593|NCT01225952|584810003|FG000|Overall Study|Withdrawal by Subject|4|||
161934594|NCT01225952|584810004|FG001|Overall Study|Withdrawal by Subject|4|||
161934595|NCT01225952|584810005|FG002|Overall Study|Withdrawal by Subject|5|||
162210035|NCT01502371|585820736|FG002|Overall Study|Noncompliance with Study Drug|1|||
162210036|NCT01502371|585820737|FG003|Overall Study|Noncompliance with Study Drug|2|||
162210037|NCT01502371|585820738|FG004|Overall Study|Noncompliance with Study Drug|1|||
162210038|NCT01502371|585820734|FG000|Overall Study|Technical Problems|1|||
161934596|NCT01225952|584810003|FG000|Overall Study|Surgical complications|1|||
161934597|NCT01225952|584810004|FG001|Overall Study|Surgical complications|0|||
161934598|NCT01225952|584810005|FG002|Overall Study|Surgical complications|0|||
161934599|NCT00889005|584810006|FG000|Overall Study|Lost to Follow-up|4|||
161934600|NCT00889005|584810007|FG001|Overall Study|Lost to Follow-up|2|||
161934601|NCT00889005|584810006|FG000|Overall Study|Withdrawal by Subject|4|||
161934602|NCT00889005|584810007|FG001|Overall Study|Withdrawal by Subject|0|||
161934603|NCT01998477|584810010|FG000|Overall Study|Lost to Follow-up|4|||
161934604|NCT01998477|584810011|FG001|Overall Study|Lost to Follow-up|5|||
161934605|NCT01998477|584810010|FG000|Overall Study|Withdrawal by Subject|6|||
161934606|NCT01998477|584810011|FG001|Overall Study|Withdrawal by Subject|0|||
162210039|NCT01502371|585820735|FG001|Overall Study|Technical Problems|0|||
162210040|NCT01502371|585820736|FG002|Overall Study|Technical Problems|2|||
162210041|NCT01502371|585820737|FG003|Overall Study|Technical Problems|4|||
162210042|NCT01502371|585820738|FG004|Overall Study|Technical Problems|1|||
162210043|NCT01502371|585820734|FG000|Overall Study|Protocol Violation|9|||
162210044|NCT01502371|585820735|FG001|Overall Study|Protocol Violation|5|||
162210045|NCT01502371|585820736|FG002|Overall Study|Protocol Violation|6|||
162210046|NCT01502371|585820737|FG003|Overall Study|Protocol Violation|5|||
162210047|NCT01502371|585820738|FG004|Overall Study|Protocol Violation|10|||
162210048|NCT01502371|585820734|FG000|Overall Study|Excluded Medication|0|||
162210049|NCT01502371|585820735|FG001|Overall Study|Excluded Medication|1|||
162210050|NCT01502371|585820736|FG002|Overall Study|Excluded Medication|1|||
162210051|NCT01502371|585820737|FG003|Overall Study|Excluded Medication|0|||
162210052|NCT01502371|585820738|FG004|Overall Study|Excluded Medication|1|||
162210053|NCT03325608|585820741|FG000|Overall Study|Lost to Follow-up|23|||
162210054|NCT03325608|585820742|FG001|Overall Study|Lost to Follow-up|23|||
162210055|NCT03325608|585820743|FG002|Overall Study|Lost to Follow-up|30|||
162210056|NCT03325608|585820744|FG003|Overall Study|Lost to Follow-up|30|||
162210057|NCT03325608|585820741|FG000|Overall Study|Death of Caregiver|0|||
162210058|NCT03325608|585820742|FG001|Overall Study|Death of Caregiver|0|||
162210059|NCT03325608|585820743|FG002|Overall Study|Death of Caregiver|2|||
162210060|NCT03325608|585820744|FG003|Overall Study|Death of Caregiver|2|||
162210061|NCT03325608|585820741|FG000|Overall Study|Death of Care Recipient|34|||
162210062|NCT03325608|585820742|FG001|Overall Study|Death of Care Recipient|34|||
162210063|NCT03325608|585820743|FG002|Overall Study|Death of Care Recipient|28|||
162210064|NCT03325608|585820744|FG003|Overall Study|Death of Care Recipient|28|||
162210065|NCT03325608|585820741|FG000|Overall Study|Withdrawal by Subject|49|||
162210066|NCT03325608|585820742|FG001|Overall Study|Withdrawal by Subject|49|||
162210067|NCT03325608|585820743|FG002|Overall Study|Withdrawal by Subject|35|||
162210068|NCT03325608|585820744|FG003|Overall Study|Withdrawal by Subject|35|||
161677706|NCT01159912|583872097|FG002|Overall Study|Lack of Efficacy|14|||
162210069|NCT03325608|585820741|FG000|Overall Study|Ineligible|7|||
162210070|NCT03325608|585820742|FG001|Overall Study|Ineligible|7|||
161677707|NCT01159912|583872095|FG000|Overall Study|Protocol Violation|1|||
162210071|NCT03325608|585820743|FG002|Overall Study|Ineligible|5|||
162210072|NCT03325608|585820744|FG003|Overall Study|Ineligible|5|||
162210073|NCT00942188|585820745|FG000|Overall Study|Adverse Event|0|||
162210074|NCT00942188|585820746|FG001|Overall Study|Adverse Event|3|||
161677708|NCT01159912|583872096|FG001|Overall Study|Protocol Violation|2|||
161677709|NCT01159912|583872097|FG002|Overall Study|Protocol Violation|3|||
161677710|NCT01159912|583872095|FG000|Overall Study|Lost to Follow-up|4|||
161677711|NCT01159912|583872096|FG001|Overall Study|Lost to Follow-up|0|||
161677712|NCT01159912|583872097|FG002|Overall Study|Lost to Follow-up|0|||
162210075|NCT00942188|585820747|FG002|Overall Study|Adverse Event|2|||
162210076|NCT00942188|585820748|FG003|Overall Study|Adverse Event|0|||
162210077|NCT00942188|585820745|FG000|Overall Study|Lack of Efficacy|0|||
162210078|NCT00942188|585820746|FG001|Overall Study|Lack of Efficacy|0|||
162210079|NCT00942188|585820747|FG002|Overall Study|Lack of Efficacy|0|||
162210080|NCT00942188|585820748|FG003|Overall Study|Lack of Efficacy|1|||
161677713|NCT01159912|583872095|FG000|Overall Study|Physician Decision|0|||
161677714|NCT01159912|583872096|FG001|Overall Study|Physician Decision|0|||
161677715|NCT01159912|583872097|FG002|Overall Study|Physician Decision|3|||
161677716|NCT01159912|583872095|FG000|Overall Study|Withdrawal by Subject|10|||
161677717|NCT01159912|583872096|FG001|Overall Study|Withdrawal by Subject|3|||
161677718|NCT01159912|583872097|FG002|Overall Study|Withdrawal by Subject|3|||
161677719|NCT00375219|583872098|FG000|Overall Study|Failure to achieve a response|16|||
161677720|NCT00375219|583872099|FG001|Overall Study|Failure to achieve a response|2|||
161677721|NCT00375219|583872100|FG002|Overall Study|Failure to achieve a response|0|||
161677722|NCT00375219|583872098|FG000|Overall Study|Adverse Event|8|||
162210081|NCT00942188|585820745|FG000|Overall Study|Protocol Violation|1|||
162210082|NCT00942188|585820746|FG001|Overall Study|Protocol Violation|1|||
162210083|NCT00942188|585820747|FG002|Overall Study|Protocol Violation|0|||
162210084|NCT00942188|585820748|FG003|Overall Study|Protocol Violation|0|||
162210085|NCT00942188|585820745|FG000|Overall Study|Lost to Follow-up|2|||
162210086|NCT00942188|585820746|FG001|Overall Study|Lost to Follow-up|1|||
162210087|NCT00942188|585820747|FG002|Overall Study|Lost to Follow-up|2|||
162210088|NCT00942188|585820748|FG003|Overall Study|Lost to Follow-up|0|||
162210089|NCT00942188|585820745|FG000|Overall Study|Withdrawal by Subject|1|||
162210090|NCT00942188|585820746|FG001|Overall Study|Withdrawal by Subject|3|||
162210091|NCT00942188|585820747|FG002|Overall Study|Withdrawal by Subject|4|||
162210092|NCT00942188|585820748|FG003|Overall Study|Withdrawal by Subject|2|||
162210093|NCT00942188|585820745|FG000|Overall Study|Physician Decision|0|||
162210094|NCT00942188|585820746|FG001|Overall Study|Physician Decision|0|||
162210095|NCT00942188|585820747|FG002|Overall Study|Physician Decision|1|||
162210096|NCT00942188|585820748|FG003|Overall Study|Physician Decision|0|||
162210097|NCT00942188|585820745|FG000|Overall Study|Sponsor Decision|0|||
162210098|NCT00942188|585820746|FG001|Overall Study|Sponsor Decision|2|||
162210099|NCT00942188|585820747|FG002|Overall Study|Sponsor Decision|0|||
162210100|NCT00942188|585820748|FG003|Overall Study|Sponsor Decision|1|||
162210101|NCT02188784|585820749|FG000|Overall Study|Death|3|||
162210102|NCT02188784|585820750|FG001|Overall Study|Death|1|||
162210103|NCT02188784|585820749|FG000|Overall Study|Lost to Follow-up|1|||
162210104|NCT02188784|585820750|FG001|Overall Study|Lost to Follow-up|0|||
162210105|NCT02188784|585820749|FG000|Overall Study|Withdrawal by Subject|3|||
162210106|NCT02188784|585820750|FG001|Overall Study|Withdrawal by Subject|9|||
162210107|NCT02188784|585820749|FG000|Overall Study|Physician Decision|2|||
162210108|NCT02188784|585820750|FG001|Overall Study|Physician Decision|3|||
162210109|NCT04811339|585820754|FG000|Overall Study|lack of transportation not wanting to return|4|||
162210110|NCT04811339|585820755|FG001|Overall Study|lack of transportation not wanting to return|8|||
162210111|NCT04811339|585820756|FG002|Overall Study|lack of transportation not wanting to return|0|||
162210112|NCT04811339|585820754|FG000|Overall Study|Adverse Event|3|||
162210113|NCT04811339|585820755|FG001|Overall Study|Adverse Event|0|||
162210114|NCT04811339|585820756|FG002|Overall Study|Adverse Event|0|||
162210115|NCT04811339|585820754|FG000|Overall Study|Lost to Follow-up|1|||
162210116|NCT04811339|585820755|FG001|Overall Study|Lost to Follow-up|0|||
162210117|NCT04811339|585820756|FG002|Overall Study|Lost to Follow-up|0|||
162210118|NCT04811339|585820754|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
162210119|NCT04811339|585820755|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
162210120|NCT04811339|585820756|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
162210121|NCT04811339|585820754|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
162210122|NCT04811339|585820755|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
162210123|NCT04811339|585820756|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
162210124|NCT04811339|585820754|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
162210125|NCT04811339|585820755|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
162210126|NCT04811339|585820756|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
162210127|NCT04811339|585820754|FG000|Overall Study|Withdrawal by Subject|0|||
161677723|NCT00375219|583872099|FG001|Overall Study|Adverse Event|2|||
161677724|NCT00375219|583872100|FG002|Overall Study|Adverse Event|1|||
161677725|NCT00375219|583872098|FG000|Overall Study|Protocol Violation|1|||
161677726|NCT00375219|583872099|FG001|Overall Study|Protocol Violation|0|||
161677727|NCT00375219|583872100|FG002|Overall Study|Protocol Violation|1|||
161677728|NCT00375219|583872098|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
161677729|NCT00375219|583872099|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
161677730|NCT00375219|583872100|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
161677731|NCT00375219|583872098|FG000|Overall Study|Lost to Follow-up|1|||
161677732|NCT00375219|583872099|FG001|Overall Study|Lost to Follow-up|1|||
161677733|NCT00375219|583872100|FG002|Overall Study|Lost to Follow-up|0|||
161677734|NCT00375219|583872098|FG000|Overall Study|Disease progression|18|||
161677735|NCT00375219|583872099|FG001|Overall Study|Disease progression|9|||
162210128|NCT04811339|585820755|FG001|Overall Study|Withdrawal by Subject|3|||
162210129|NCT04811339|585820756|FG002|Overall Study|Withdrawal by Subject|0|||
162210130|NCT04811339|585820754|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
162210131|NCT04811339|585820755|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
162210132|NCT04811339|585820756|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
162210133|NCT04811339|585820754|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
162210134|NCT04811339|585820755|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
162210135|NCT04811339|585820756|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
162210136|NCT00143598|585820757|FG000|Overall Study|Lost to Follow-up|23|||
162210137|NCT00143598|585820758|FG001|Overall Study|Lost to Follow-up|21|||
162210138|NCT00143598|585820757|FG000|Overall Study|Withdrawal by Subject|33|||
162210139|NCT00143598|585820758|FG001|Overall Study|Withdrawal by Subject|37|||
162210140|NCT00143598|585820757|FG000|Overall Study|Death|36|||
162210141|NCT00143598|585820758|FG001|Overall Study|Death|36|||
162210142|NCT04944784|585820761|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
162210143|NCT04944784|585820762|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
162210144|NCT04944784|585820763|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
162210145|NCT04944784|585820764|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
162210146|NCT04944784|585820761|FG000|Double-blind Period|Adverse Event|20|||
162210147|NCT04944784|585820762|FG001|Double-blind Period|Adverse Event|4|||
162210148|NCT04944784|585820763|FG002|Double-blind Period|Adverse Event|0|||
162210149|NCT04944784|585820764|FG003|Double-blind Period|Adverse Event|0|||
162210150|NCT04944784|585820761|FG000|Double-blind Period|Withdrawal by Subject|15|||
162210151|NCT04944784|585820762|FG001|Double-blind Period|Withdrawal by Subject|4|||
162210152|NCT04944784|585820763|FG002|Double-blind Period|Withdrawal by Subject|0|||
162210153|NCT04944784|585820764|FG003|Double-blind Period|Withdrawal by Subject|0|||
162210154|NCT04944784|585820761|FG000|Double-blind Period|Death|7|||
162210155|NCT04944784|585820762|FG001|Double-blind Period|Death|2|||
162210156|NCT04944784|585820763|FG002|Double-blind Period|Death|0|||
162210157|NCT04944784|585820764|FG003|Double-blind Period|Death|0|||
162210158|NCT04944784|585820761|FG000|Double-blind Period|Physician Decision|2|||
162210159|NCT04944784|585820762|FG001|Double-blind Period|Physician Decision|1|||
162210160|NCT04944784|585820763|FG002|Double-blind Period|Physician Decision|0|||
162210161|NCT04944784|585820764|FG003|Double-blind Period|Physician Decision|0|||
162210162|NCT04944784|585820761|FG000|Double-blind Period|Lack of Efficacy|0|||
162210163|NCT04944784|585820762|FG001|Double-blind Period|Lack of Efficacy|1|||
162210164|NCT04944784|585820763|FG002|Double-blind Period|Lack of Efficacy|0|||
162210165|NCT04944784|585820764|FG003|Double-blind Period|Lack of Efficacy|0|||
162210166|NCT04944784|585820761|FG000|Double-blind Period|Sponsor Request|2|||
162210167|NCT04944784|585820762|FG001|Double-blind Period|Sponsor Request|1|||
162210168|NCT04944784|585820763|FG002|Double-blind Period|Sponsor Request|0|||
161934607|NCT00129974|584810012|FG000|Overall Study|Other|1|||
161934608|NCT05122143|584810013|FG000|Overall Study|Adverse Event|1|||
162210169|NCT04944784|585820764|FG003|Double-blind Period|Sponsor Request|0|||
162210170|NCT04944784|585820761|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
162210171|NCT04944784|585820762|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
162210172|NCT04944784|585820763|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
162210173|NCT04944784|585820764|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
162210174|NCT04944784|585820761|FG000|Double-blind Period|Participant Choice|1|||
162210175|NCT04944784|585820762|FG001|Double-blind Period|Participant Choice|1|||
162210176|NCT04944784|585820763|FG002|Double-blind Period|Participant Choice|0|||
162210177|NCT04944784|585820764|FG003|Double-blind Period|Participant Choice|0|||
162210178|NCT04944784|585820761|FG000|Double-blind Period|Progressive Disease|2|||
162210179|NCT04944784|585820762|FG001|Double-blind Period|Progressive Disease|2|||
162210180|NCT04944784|585820763|FG002|Double-blind Period|Progressive Disease|0|||
162210181|NCT04944784|585820764|FG003|Double-blind Period|Progressive Disease|0|||
162210182|NCT04944784|585820761|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
162210183|NCT04944784|585820762|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
162210184|NCT04944784|585820763|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
162210185|NCT04944784|585820764|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
162210186|NCT04944784|585820761|FG000|Active Drug Period|Adverse Event|0|||
161934609|NCT05122143|584810014|FG001|Overall Study|Adverse Event|0|||
161934610|NCT05122143|584810015|FG002|Overall Study|Adverse Event|0|||
161934611|NCT05122143|584810016|FG003|Overall Study|Adverse Event|0|||
161934612|NCT05122143|584810017|FG004|Overall Study|Adverse Event|1|||
161934613|NCT05122143|584810018|FG005|Overall Study|Adverse Event|0|||
161934614|NCT05122143|584810013|FG000|Overall Study|Protocol non-compliance|0|||
161934615|NCT05122143|584810014|FG001|Overall Study|Protocol non-compliance|0|||
161934616|NCT05122143|584810015|FG002|Overall Study|Protocol non-compliance|1|||
162210187|NCT04944784|585820762|FG001|Active Drug Period|Adverse Event|0|||
162210188|NCT04944784|585820763|FG002|Active Drug Period|Adverse Event|3|||
162210189|NCT04944784|585820764|FG003|Active Drug Period|Adverse Event|6|||
162210190|NCT04944784|585820761|FG000|Active Drug Period|Withdrawal by Subject|0|||
162210191|NCT04944784|585820762|FG001|Active Drug Period|Withdrawal by Subject|0|||
162210192|NCT04944784|585820763|FG002|Active Drug Period|Withdrawal by Subject|4|||
162210193|NCT04944784|585820764|FG003|Active Drug Period|Withdrawal by Subject|7|||
162210194|NCT04944784|585820761|FG000|Active Drug Period|Death|0|||
162210195|NCT04944784|585820762|FG001|Active Drug Period|Death|0|||
162210196|NCT04944784|585820763|FG002|Active Drug Period|Death|3|||
162210197|NCT04944784|585820764|FG003|Active Drug Period|Death|4|||
162210198|NCT04944784|585820761|FG000|Active Drug Period|Lack of Efficacy|0|||
162210199|NCT04944784|585820762|FG001|Active Drug Period|Lack of Efficacy|0|||
162210200|NCT04944784|585820763|FG002|Active Drug Period|Lack of Efficacy|2|||
162210201|NCT04944784|585820764|FG003|Active Drug Period|Lack of Efficacy|2|||
162210202|NCT04944784|585820761|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
162210203|NCT04944784|585820762|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
162210204|NCT04944784|585820763|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
162210205|NCT04944784|585820764|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
162210206|NCT04944784|585820761|FG000|Active Drug Period|Participant Choice|0|||
162210207|NCT04944784|585820762|FG001|Active Drug Period|Participant Choice|0|||
162210208|NCT04944784|585820763|FG002|Active Drug Period|Participant Choice|0|||
162210209|NCT04944784|585820764|FG003|Active Drug Period|Participant Choice|1|||
162210210|NCT04944784|585820761|FG000|Active Drug Period|Progressive Disease|0|||
162210211|NCT04944784|585820762|FG001|Active Drug Period|Progressive Disease|0|||
162210212|NCT04944784|585820763|FG002|Active Drug Period|Progressive Disease|4|||
162210213|NCT04944784|585820764|FG003|Active Drug Period|Progressive Disease|4|||
162210214|NCT04944784|585820761|FG000|Active Drug Period|Lost to Follow-up|0|||
162210215|NCT04944784|585820762|FG001|Active Drug Period|Lost to Follow-up|0|||
162210216|NCT04944784|585820763|FG002|Active Drug Period|Lost to Follow-up|0|||
162210217|NCT04944784|585820764|FG003|Active Drug Period|Lost to Follow-up|1|||
162210218|NCT03900715|585820765|FG000|Overall Study|Protocol Deviation|1|||
162210219|NCT03900715|585820765|FG000|Overall Study|Lack of Efficacy|1|||
162210220|NCT03900715|585820765|FG000|Overall Study|Progressive Disease|6|||
162210221|NCT03900715|585820765|FG000|Overall Study|Adverse Event|2|||
162210222|NCT03900715|585820765|FG000|Overall Study|Other reasons|11|||
162210223|NCT01568112|585820766|FG000|Overall Study|Randomized But Not Treated|0|||
162210224|NCT01568112|585820767|FG001|Overall Study|Randomized But Not Treated|1|||
162210225|NCT01568112|585820768|FG002|Overall Study|Randomized But Not Treated|0|||
162210226|NCT01568112|585820769|FG003|Overall Study|Randomized But Not Treated|0|||
162210227|NCT01568112|585820766|FG000|Overall Study|Withdrew due to Adverse Event|2|||
162210228|NCT01568112|585820767|FG001|Overall Study|Withdrew due to Adverse Event|4|||
162210229|NCT01568112|585820768|FG002|Overall Study|Withdrew due to Adverse Event|6|||
162210230|NCT01568112|585820769|FG003|Overall Study|Withdrew due to Adverse Event|3|||
162210231|NCT01568112|585820766|FG000|Overall Study|Lost to Follow-up|0|||
162210232|NCT01568112|585820767|FG001|Overall Study|Lost to Follow-up|0|||
162210233|NCT01568112|585820768|FG002|Overall Study|Lost to Follow-up|0|||
162210234|NCT01568112|585820769|FG003|Overall Study|Lost to Follow-up|1|||
162210235|NCT01568112|585820766|FG000|Overall Study|Withdrawal by Subject|2|||
162210236|NCT01568112|585820767|FG001|Overall Study|Withdrawal by Subject|3|||
162210237|NCT01568112|585820768|FG002|Overall Study|Withdrawal by Subject|0|||
162210238|NCT01568112|585820769|FG003|Overall Study|Withdrawal by Subject|7|||
162210239|NCT01568112|585820766|FG000|Overall Study|Withdrawal by Physician|1|||
162210240|NCT01568112|585820767|FG001|Overall Study|Withdrawal by Physician|0|||
162210241|NCT01568112|585820768|FG002|Overall Study|Withdrawal by Physician|1|||
162210242|NCT01568112|585820769|FG003|Overall Study|Withdrawal by Physician|1|||
162236576|NCT01718353|585917002|FG001|Overall Study|Randomized but not treated|0|||
162236577|NCT01959516|585917003|FG000|Epoch 1|Adverse Event|4|||
162236578|NCT01959516|585917004|FG001|Epoch 1|Adverse Event|1|||
162236579|NCT01959516|585917003|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
162236580|NCT01959516|585917004|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
162236581|NCT01959516|585917003|FG000|Epoch 1|Subject withdrew consent|3|||
162236582|NCT01959516|585917004|FG001|Epoch 1|Subject withdrew consent|2|||
162236583|NCT01959516|585917003|FG000|Epoch 1|Administrative problems|1|||
161934617|NCT05122143|584810016|FG003|Overall Study|Protocol non-compliance|0|||
161934618|NCT05122143|584810017|FG004|Overall Study|Protocol non-compliance|0|||
161934619|NCT05122143|584810018|FG005|Overall Study|Protocol non-compliance|0|||
161934620|NCT05122143|584810013|FG000|Overall Study|Covid contact|0|||
161934621|NCT05122143|584810014|FG001|Overall Study|Covid contact|0|||
161934622|NCT05122143|584810015|FG002|Overall Study|Covid contact|0|||
161934623|NCT05122143|584810016|FG003|Overall Study|Covid contact|0|||
161934624|NCT05122143|584810017|FG004|Overall Study|Covid contact|1|||
161934625|NCT05122143|584810018|FG005|Overall Study|Covid contact|0|||
161934626|NCT00692237|584810019|FG000|Overall Study|Withdrawal by Subject|1|||
162236584|NCT01959516|585917004|FG001|Epoch 1|Administrative problems|0|||
161934627|NCT00692237|584810020|FG001|Overall Study|Withdrawal by Subject|3|||
161934628|NCT00692237|584810019|FG000|Overall Study|Adverse Event|0|||
161934629|NCT00692237|584810020|FG001|Overall Study|Adverse Event|1|||
162236585|NCT01959516|585917003|FG000|Epoch 1|Use of prohibited treatment|1|||
162236586|NCT01959516|585917004|FG001|Epoch 1|Use of prohibited treatment|0|||
162236587|NCT01959516|585917003|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
162236588|NCT01959516|585917004|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
162236589|NCT01959516|585917003|FG000|Epoch 1|Protocol deviation|0|||
162236590|NCT01959516|585917004|FG001|Epoch 1|Protocol deviation|1|||
162236591|NCT01959516|585917003|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
162236592|NCT01959516|585917004|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
162210243|NCT00730015|585822928|FG000|Overall Study|Adverse Event|11|||
162210244|NCT00730015|585822929|FG001|Overall Study|Adverse Event|10|||
162210245|NCT00730015|585822930|FG002|Overall Study|Adverse Event|8|||
162210246|NCT00730015|585822928|FG000|Overall Study|Protocol Violation|2|||
162210247|NCT00730015|585822929|FG001|Overall Study|Protocol Violation|6|||
162210248|NCT00730015|585822930|FG002|Overall Study|Protocol Violation|4|||
162210249|NCT00730015|585822928|FG000|Overall Study|Withdrawal by Subject|12|||
162210250|NCT00730015|585822929|FG001|Overall Study|Withdrawal by Subject|12|||
162210251|NCT00730015|585822930|FG002|Overall Study|Withdrawal by Subject|8|||
161934630|NCT00395447|584810021|FG000|Overall Study|Death|37|||
162210252|NCT00730015|585822928|FG000|Overall Study|Lost to Follow-up|4|||
162210253|NCT00730015|585822929|FG001|Overall Study|Lost to Follow-up|10|||
162210254|NCT00730015|585822930|FG002|Overall Study|Lost to Follow-up|3|||
162210255|NCT00730015|585822928|FG000|Overall Study|Lack of Efficacy|1|||
162210256|NCT00730015|585822929|FG001|Overall Study|Lack of Efficacy|2|||
162210257|NCT00730015|585822930|FG002|Overall Study|Lack of Efficacy|8|||
162210258|NCT00730015|585822928|FG000|Overall Study|Other Reason|1|||
162210259|NCT00730015|585822929|FG001|Overall Study|Other Reason|0|||
162210260|NCT00730015|585822930|FG002|Overall Study|Other Reason|1|||
162210261|NCT03062449|585822931|FG000|Overall Study|Withdrawal by Subject|7|||
162210262|NCT03062449|585822932|FG001|Overall Study|Withdrawal by Subject|1|||
161934631|NCT00395447|584810022|FG001|Overall Study|Death|32|||
161934632|NCT00395447|584810021|FG000|Overall Study|Lost to Follow-up|52|||
161934633|NCT00395447|584810022|FG001|Overall Study|Lost to Follow-up|43|||
161934634|NCT00395447|584810021|FG000|Overall Study|Withdrawal by Subject|24|||
162210263|NCT02370251|585822933|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
162210264|NCT02370251|585822933|FG000|Overall Study|Death|4|||
162210265|NCT04120376|585822934|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
162210266|NCT04120376|585822935|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
162210267|NCT02053610|585822936|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
162210268|NCT02053610|585822937|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
162210269|NCT02053610|585822936|FG000|Overall Study|Withdrew Consent|2|||
162210270|NCT02053610|585822937|FG001|Overall Study|Withdrew Consent|9|||
162210271|NCT02053610|585822936|FG000|Overall Study|Death|5|||
162210272|NCT02053610|585822937|FG001|Overall Study|Death|5|||
162210273|NCT02053610|585822936|FG000|Overall Study|Administrative/Other|1|||
162210274|NCT02053610|585822937|FG001|Overall Study|Administrative/Other|1|||
162210275|NCT02053610|585822936|FG000|Overall Study|Disease Progression|2|||
162210276|NCT02053610|585822937|FG001|Overall Study|Disease Progression|3|||
162210277|NCT02053610|585822936|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
162210278|NCT02053610|585822937|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
162210279|NCT02053610|585822936|FG000|Overall Study|Did not Receive Treatment|4|||
162210280|NCT02053610|585822937|FG001|Overall Study|Did not Receive Treatment|2|||
162210281|NCT02053610|585822936|FG000|Overall Study|Insufficient Therapeutic Response|1|||
162210282|NCT02053610|585822937|FG001|Overall Study|Insufficient Therapeutic Response|1|||
162210283|NCT02053610|585822936|FG000|Overall Study|Violation of Selection Criteria|1|||
162210284|NCT02053610|585822937|FG001|Overall Study|Violation of Selection Criteria|0|||
162210285|NCT01165177|585822938|FG000|Overall Study|Serious Adverse Event|227|||
162210286|NCT01165177|585822939|FG001|Overall Study|Serious Adverse Event|235|||
162210287|NCT01165177|585822938|FG000|Overall Study|Withdrawal by Subject|368|||
162210288|NCT01165177|585822939|FG001|Overall Study|Withdrawal by Subject|354|||
162210289|NCT01165177|585822938|FG000|Overall Study|Protocol Violation|19|||
162210290|NCT01165177|585822939|FG001|Overall Study|Protocol Violation|21|||
162210291|NCT01165177|585822938|FG000|Overall Study|Non-serious adverse event|30|||
162210292|NCT01165177|585822939|FG001|Overall Study|Non-serious adverse event|18|||
162210293|NCT01165177|585822938|FG000|Overall Study|Other unspecified reasons|47|||
162210294|NCT01165177|585822939|FG001|Overall Study|Other unspecified reasons|35|||
162210295|NCT01165177|585822938|FG000|Overall Study|Suspected HZ episode|0|||
162210296|NCT01165177|585822939|FG001|Overall Study|Suspected HZ episode|2|||
162210297|NCT01165177|585822938|FG000|Overall Study|Lost to Follow-up|183|||
162210298|NCT01165177|585822939|FG001|Overall Study|Lost to Follow-up|194|||
162210299|NCT01165177|585822938|FG000|Overall Study|Migrated/ moved from study area|48|||
162210300|NCT01165177|585822939|FG001|Overall Study|Migrated/ moved from study area|43|||
162210301|NCT05499130|585822940|FG000|Overall Study|Adverse Event|2|||
162210302|NCT05499130|585822941|FG001|Overall Study|Adverse Event|0|||
162210303|NCT05499130|585822942|FG002|Overall Study|Adverse Event|1|||
162210304|NCT05499130|585822943|FG003|Overall Study|Adverse Event|0|||
162210305|NCT05499130|585822944|FG004|Overall Study|Adverse Event|1|||
162210306|NCT05499130|585822945|FG005|Overall Study|Adverse Event|4|||
162210307|NCT05499130|585822946|FG006|Overall Study|Adverse Event|1|||
162210308|NCT05499130|585822947|FG007|Overall Study|Adverse Event|0|||
162210309|NCT05499130|585822940|FG000|Overall Study|Lack of Efficacy|1|||
162210310|NCT05499130|585822941|FG001|Overall Study|Lack of Efficacy|0|||
162210311|NCT05499130|585822942|FG002|Overall Study|Lack of Efficacy|0|||
162210312|NCT05499130|585822943|FG003|Overall Study|Lack of Efficacy|0|||
162210313|NCT05499130|585822944|FG004|Overall Study|Lack of Efficacy|5|||
161826003|NCT00763555|584403758|FG000|Overall Study|Lost to Follow-up|0|||
161826004|NCT00763555|584403759|FG001|Overall Study|Lost to Follow-up|3|||
161826005|NCT01729026|584403760|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
161826006|NCT01729026|584403761|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
161826007|NCT01729026|584403760|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
161826008|NCT01729026|584403761|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
161826009|NCT00298740|584403763|FG000|Overall Study|Lack of Efficacy|6|||
161826010|NCT00298740|584403763|FG000|Overall Study|Withdrawal by Subject|3|||
161826011|NCT00684567|584403765|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
161826012|NCT00684567|584403765|FG000|Monotherapy Period|Adverse Event|2|||
162210314|NCT05499130|585822945|FG005|Overall Study|Lack of Efficacy|0|||
162210315|NCT05499130|585822946|FG006|Overall Study|Lack of Efficacy|1|||
162210316|NCT05499130|585822947|FG007|Overall Study|Lack of Efficacy|0|||
162210317|NCT05499130|585822940|FG000|Overall Study|Withdrawal by Subject|2|||
162210318|NCT05499130|585822941|FG001|Overall Study|Withdrawal by Subject|0|||
162210319|NCT05499130|585822942|FG002|Overall Study|Withdrawal by Subject|0|||
162210320|NCT05499130|585822943|FG003|Overall Study|Withdrawal by Subject|0|||
162210321|NCT05499130|585822944|FG004|Overall Study|Withdrawal by Subject|1|||
162210322|NCT05499130|585822945|FG005|Overall Study|Withdrawal by Subject|2|||
162210323|NCT05499130|585822946|FG006|Overall Study|Withdrawal by Subject|0|||
162210324|NCT05499130|585822947|FG007|Overall Study|Withdrawal by Subject|0|||
162210325|NCT05499130|585822940|FG000|Overall Study|Lost to Follow-up|0|||
161934635|NCT00395447|584810022|FG001|Overall Study|Withdrawal by Subject|19|||
161934636|NCT00395447|584810021|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
161934637|NCT00395447|584810022|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
162210326|NCT05499130|585822941|FG001|Overall Study|Lost to Follow-up|0|||
162210327|NCT05499130|585822942|FG002|Overall Study|Lost to Follow-up|0|||
162210328|NCT05499130|585822943|FG003|Overall Study|Lost to Follow-up|0|||
162210329|NCT05499130|585822944|FG004|Overall Study|Lost to Follow-up|0|||
162210330|NCT05499130|585822945|FG005|Overall Study|Lost to Follow-up|2|||
162210331|NCT05499130|585822946|FG006|Overall Study|Lost to Follow-up|0|||
162210332|NCT05499130|585822947|FG007|Overall Study|Lost to Follow-up|0|||
162210333|NCT05499130|585822940|FG000|Overall Study|Other Than Specified|0|||
162210334|NCT05499130|585822941|FG001|Overall Study|Other Than Specified|0|||
162210335|NCT05499130|585822942|FG002|Overall Study|Other Than Specified|0|||
162210336|NCT05499130|585822943|FG003|Overall Study|Other Than Specified|0|||
162210337|NCT05499130|585822944|FG004|Overall Study|Other Than Specified|1|||
162210338|NCT05499130|585822945|FG005|Overall Study|Other Than Specified|1|||
161934638|NCT03766906|584810023|FG000|Overall Study|Withdrawal by Subject|6|||
162210339|NCT05499130|585822946|FG006|Overall Study|Other Than Specified|2|||
162210340|NCT05499130|585822947|FG007|Overall Study|Other Than Specified|0|||
162210341|NCT05499130|585822940|FG000|Overall Study|Protocol Violation|0|||
162210342|NCT05499130|585822941|FG001|Overall Study|Protocol Violation|0|||
162210343|NCT05499130|585822942|FG002|Overall Study|Protocol Violation|0|||
162210344|NCT05499130|585822943|FG003|Overall Study|Protocol Violation|0|||
161934639|NCT00836901|584810024|FG000|First Intervention|Withdrawal by Subject|1|||
161934640|NCT00836901|584810025|FG001|First Intervention|Withdrawal by Subject|0|||
161934641|NCT01047540|584810028|FG000|Overall Study|Protocol Violation|1|||
161934642|NCT01047540|584810029|FG001|Overall Study|Protocol Violation|0|||
161934643|NCT01047540|584810030|FG002|Overall Study|Protocol Violation|0|||
161934644|NCT01047540|584810031|FG003|Overall Study|Protocol Violation|0|||
161934645|NCT01047540|584810032|FG004|Overall Study|Protocol Violation|0|||
161934646|NCT01047540|584810028|FG000|Overall Study|Lost to Follow-up|1|||
161934647|NCT01047540|584810029|FG001|Overall Study|Lost to Follow-up|0|||
161934648|NCT01047540|584810030|FG002|Overall Study|Lost to Follow-up|0|||
161934649|NCT01047540|584810031|FG003|Overall Study|Lost to Follow-up|0|||
161934650|NCT01047540|584810032|FG004|Overall Study|Lost to Follow-up|0|||
161934651|NCT01047540|584810028|FG000|Overall Study|Withdrawal by Subject|1|||
161934652|NCT01047540|584810029|FG001|Overall Study|Withdrawal by Subject|0|||
161934653|NCT01047540|584810030|FG002|Overall Study|Withdrawal by Subject|3|||
161934654|NCT01047540|584810031|FG003|Overall Study|Withdrawal by Subject|0|||
161934655|NCT01047540|584810032|FG004|Overall Study|Withdrawal by Subject|1|||
161934656|NCT01047540|584810028|FG000|Overall Study|Pregnancy|1|||
161934657|NCT01047540|584810029|FG001|Overall Study|Pregnancy|0|||
161934658|NCT01047540|584810030|FG002|Overall Study|Pregnancy|0|||
161934659|NCT01047540|584810031|FG003|Overall Study|Pregnancy|0|||
161934660|NCT01047540|584810032|FG004|Overall Study|Pregnancy|0|||
161934661|NCT01047540|584810028|FG000|Overall Study|Adverse Event|1|||
162210345|NCT05499130|585822944|FG004|Overall Study|Protocol Violation|1|||
162210346|NCT05499130|585822945|FG005|Overall Study|Protocol Violation|0|||
162210347|NCT05499130|585822946|FG006|Overall Study|Protocol Violation|0|||
162210348|NCT05499130|585822947|FG007|Overall Study|Protocol Violation|0|||
162210349|NCT00781937|585822949|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
162210350|NCT00781937|585822950|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
162210351|NCT00781937|585822949|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
162210352|NCT00781937|585822950|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
162210353|NCT00781937|585822949|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
162210354|NCT00781937|585822950|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
162210355|NCT00781937|585822949|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
161677736|NCT00375219|583872100|FG002|Overall Study|Disease progression|12|||
161677737|NCT00375219|583872098|FG000|Overall Study|Death|4|||
161677738|NCT00375219|583872099|FG001|Overall Study|Death|3|||
161677739|NCT00375219|583872100|FG002|Overall Study|Death|7|||
161677740|NCT00375219|583872098|FG000|Overall Study|Hematologic resistance|1|||
161677741|NCT00375219|583872099|FG001|Overall Study|Hematologic resistance|0|||
161677742|NCT00375219|583872100|FG002|Overall Study|Hematologic resistance|0|||
161677743|NCT00375219|583872098|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
161677744|NCT00375219|583872099|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
161677745|NCT00375219|583872100|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
161677746|NCT00375219|583872098|FG000|Overall Study|Allograft|2|||
161677747|NCT00375219|583872099|FG001|Overall Study|Allograft|0|||
161677748|NCT00375219|583872100|FG002|Overall Study|Allograft|0|||
161677749|NCT00375219|583872098|FG000|Overall Study|Cord blood transplantation|1|||
161677750|NCT00375219|583872099|FG001|Overall Study|Cord blood transplantation|0|||
161677751|NCT00375219|583872100|FG002|Overall Study|Cord blood transplantation|0|||
161934662|NCT01047540|584810029|FG001|Overall Study|Adverse Event|0|||
161934663|NCT01047540|584810030|FG002|Overall Study|Adverse Event|0|||
161934664|NCT01047540|584810031|FG003|Overall Study|Adverse Event|0|||
161934665|NCT01047540|584810032|FG004|Overall Study|Adverse Event|0|||
161934666|NCT03032484|584810038|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
161934667|NCT03032484|584810039|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
161934668|NCT03032484|584810038|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
161934669|NCT03032484|584810039|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
161677752|NCT00375219|583872098|FG000|Overall Study|Withdrawal by Subject|1|||
161677753|NCT00375219|583872099|FG001|Overall Study|Withdrawal by Subject|0|||
161934670|NCT01335685|584810046|FG000|Overall Study|Study Terminated by Sponsor|2|||
161934671|NCT01335685|584810047|FG001|Overall Study|Study Terminated by Sponsor|1|||
161934672|NCT01335685|584810048|FG002|Overall Study|Study Terminated by Sponsor|1|||
161934673|NCT01335685|584810049|FG003|Overall Study|Study Terminated by Sponsor|10|||
161934674|NCT01335685|584810050|FG004|Overall Study|Study Terminated by Sponsor|0|||
161826013|NCT00684567|584403765|FG000|Monotherapy Period|Death|1|||
161826014|NCT00684567|584403765|FG000|Monotherapy Period|Progression of primary disease|11|||
161826015|NCT02744755|584403766|FG000|Study Period 1|Protocol Violation|2|||
161826016|NCT02744755|584403767|FG001|Study Period 1|Protocol Violation|1|||
161826017|NCT02744755|584403766|FG000|Study Period 1|not defined|0|||
161826018|NCT02744755|584403767|FG001|Study Period 1|not defined|1|||
161826019|NCT02744755|584403766|FG000|Study Period 1|Pregnancy|1|||
161826020|NCT02744755|584403767|FG001|Study Period 1|Pregnancy|0|||
161826021|NCT02744755|584403766|FG000|Study Period 1|Adverse Event|1|||
161826022|NCT02744755|584403767|FG001|Study Period 1|Adverse Event|1|||
161826023|NCT02744755|584403766|FG000|Study Period 1|Lost to Follow-up|1|||
161826024|NCT02744755|584403767|FG001|Study Period 1|Lost to Follow-up|1|||
161826025|NCT02744755|584403766|FG000|Study Period 1|Lack of Efficacy|1|||
161826026|NCT02744755|584403767|FG001|Study Period 1|Lack of Efficacy|0|||
161826027|NCT02744755|584403766|FG000|Study Period 1|Withdrawal by Subject|8|||
161826028|NCT02744755|584403767|FG001|Study Period 1|Withdrawal by Subject|4|||
161826029|NCT02744755|584403766|FG000|Study Period 2|Adverse Event|5|||
161826030|NCT02744755|584403767|FG001|Study Period 2|Adverse Event|0|||
161826031|NCT02744755|584403766|FG000|Study Period 2|Protocol Violation|1|||
161826032|NCT02744755|584403767|FG001|Study Period 2|Protocol Violation|0|||
161826033|NCT02744755|584403766|FG000|Study Period 2|not defined|3|||
161826034|NCT02744755|584403767|FG001|Study Period 2|not defined|2|||
161826035|NCT02744755|584403766|FG000|Study Period 2|Lost to Follow-up|0|||
161826036|NCT02744755|584403767|FG001|Study Period 2|Lost to Follow-up|2|||
161826037|NCT02744755|584403766|FG000|Study Period 2|Withdrawal by Subject|2|||
161826038|NCT02744755|584403767|FG001|Study Period 2|Withdrawal by Subject|2|||
161826039|NCT02744755|584403766|FG000|Study Period 2|Lack of Efficacy|3|||
161826040|NCT02744755|584403767|FG001|Study Period 2|Lack of Efficacy|2|||
161826041|NCT00965757|584403768|FG000|Double-blind Phase|Progression of concomitant disease|1|||
161826042|NCT00965757|584403769|FG001|Double-blind Phase|Progression of concomitant disease|2|||
161826043|NCT00965757|584403770|FG002|Double-blind Phase|Progression of concomitant disease|0|||
161826044|NCT00965757|584403771|FG003|Double-blind Phase|Progression of concomitant disease|0|||
161826045|NCT00965757|584403768|FG000|Double-blind Phase|Adverse drug reaction|2|||
161826046|NCT00965757|584403769|FG001|Double-blind Phase|Adverse drug reaction|1|||
161826047|NCT00965757|584403770|FG002|Double-blind Phase|Adverse drug reaction|0|||
161826048|NCT00965757|584403771|FG003|Double-blind Phase|Adverse drug reaction|0|||
161826049|NCT00965757|584403768|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
161826050|NCT00965757|584403769|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
161826051|NCT00965757|584403770|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
161826052|NCT00965757|584403771|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
161826053|NCT00965757|584403768|FG000|Double-blind Phase|Lack of Efficacy|7|||
161826054|NCT00965757|584403769|FG001|Double-blind Phase|Lack of Efficacy|11|||
161826055|NCT00965757|584403770|FG002|Double-blind Phase|Lack of Efficacy|0|||
161826056|NCT00965757|584403771|FG003|Double-blind Phase|Lack of Efficacy|0|||
161826057|NCT00965757|584403768|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
161826058|NCT00965757|584403769|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
161826059|NCT00965757|584403770|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
161826060|NCT00965757|584403771|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
161934675|NCT01335685|584810051|FG005|Overall Study|Study Terminated by Sponsor|4|||
161934676|NCT01335685|584810052|FG006|Overall Study|Study Terminated by Sponsor|2|||
161826061|NCT00965757|584403768|FG000|Double-blind Phase|Lost to Follow-up|0|||
161826062|NCT00965757|584403769|FG001|Double-blind Phase|Lost to Follow-up|1|||
161826063|NCT00965757|584403770|FG002|Double-blind Phase|Lost to Follow-up|0|||
161826064|NCT00965757|584403771|FG003|Double-blind Phase|Lost to Follow-up|0|||
161826065|NCT00965757|584403768|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
161826066|NCT00965757|584403769|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
161826067|NCT00965757|584403770|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
161826068|NCT00965757|584403771|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
161826069|NCT00965757|584403768|FG000|Double-blind Phase|Other|1|||
161826070|NCT00965757|584403769|FG001|Double-blind Phase|Other|0|||
161826071|NCT00965757|584403770|FG002|Double-blind Phase|Other|0|||
161677754|NCT00375219|583872100|FG002|Overall Study|Withdrawal by Subject|0|||
161677755|NCT02684279|583872103|FG000|Overall Study|Adverse Event|87|||
162210356|NCT00781937|585822950|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
162210357|NCT00781937|585822949|FG000|Main Trial Period Through Week 56|Unclassified|10|||
162210358|NCT00781937|585822950|FG001|Main Trial Period Through Week 56|Unclassified|15|||
162210359|NCT00781937|585822949|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
162210360|NCT00781937|585822950|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
162210361|NCT00781937|585822949|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
162210362|NCT00781937|585822950|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
162210363|NCT00013611|585822951|FG000|Overall Study|Lost to Follow-up|91|||
162210364|NCT00013611|585822952|FG001|Overall Study|Lost to Follow-up|100|||
162210365|NCT00543062|585822953|FG000|Overall Study|Withdrawal by Subject|1|||
162210366|NCT00543062|585822954|FG001|Overall Study|Withdrawal by Subject|0|||
162210367|NCT00543062|585822955|FG002|Overall Study|Withdrawal by Subject|2|||
162210368|NCT00543062|585822956|FG003|Overall Study|Withdrawal by Subject|0|||
162210369|NCT00543062|585822953|FG000|Overall Study|Adverse Event|0|||
162210370|NCT00543062|585822954|FG001|Overall Study|Adverse Event|1|||
162210371|NCT00543062|585822955|FG002|Overall Study|Adverse Event|1|||
162210372|NCT00543062|585822956|FG003|Overall Study|Adverse Event|1|||
162210373|NCT00543062|585822953|FG000|Overall Study|Protocol Violation|1|||
162210374|NCT00543062|585822954|FG001|Overall Study|Protocol Violation|0|||
162210375|NCT00543062|585822955|FG002|Overall Study|Protocol Violation|0|||
162210376|NCT00543062|585822956|FG003|Overall Study|Protocol Violation|0|||
162210377|NCT01663506|585822957|FG000|Overall Study|Lack of Efficacy|3|||
162210378|NCT01663506|585822957|FG000|Overall Study|Consent Withdrawal by Subject|1|||
162210379|NCT01663506|585822957|FG000|Overall Study|Lost to Follow-up|1|||
161677756|NCT02684279|583872103|FG000|Overall Study|Lack of Efficacy|4|||
161677757|NCT02684279|583872103|FG000|Overall Study|Lost to Follow-up|61|||
161677758|NCT02684279|583872103|FG000|Overall Study|Protocol Violation|6|||
161677759|NCT02684279|583872103|FG000|Overall Study|Pregnancy|8|||
161677760|NCT02684279|583872103|FG000|Overall Study|Withdrawal by Subject|92|||
161677761|NCT02684279|583872103|FG000|Overall Study|non-compliance with study drug|9|||
161677762|NCT02684279|583872103|FG000|Overall Study|non compliance with study visits|2|||
161677763|NCT02684279|583872103|FG000|Overall Study|subject to have surgery|1|||
161677764|NCT02684279|583872103|FG000|Overall Study|family emergency|1|||
161677765|NCT02684279|583872103|FG000|Overall Study|Site closures|7|||
161677766|NCT02684279|583872103|FG000|Overall Study|Physician Decision|1|||
161677767|NCT00228566|583872104|FG000|Overall Study|Adverse Event|31|||
161677768|NCT00228566|583872104|FG000|Overall Study|Lack of Efficacy|14|||
161677769|NCT00228566|583872104|FG000|Overall Study|Lost to Follow-up|16|||
161677770|NCT00228566|583872104|FG000|Overall Study|Physician Decision|5|||
161677771|NCT00228566|583872104|FG000|Overall Study|Withdrawal by Subject|4|||
161677772|NCT00228566|583872104|FG000|Overall Study|Miscellaneous|1|||
161677773|NCT01479829|583872105|FG000|Overall Study|Withdrawal by Subject|8|||
161677774|NCT01479829|583872106|FG001|Overall Study|Withdrawal by Subject|10|||
161677775|NCT01444456|583872111|FG000|Overall Study|Withdrawal by Subject|21|||
161677776|NCT01444456|583872111|FG000|Overall Study|Physician Decision|9|||
161677777|NCT01444456|583872111|FG000|Overall Study|Lost to Follow-up|37|||
161677778|NCT01444456|583872111|FG000|Overall Study|Death|73|||
161677779|NCT01444456|583872111|FG000|Overall Study|Ineligibility determined|23|||
161677780|NCT01444456|583872111|FG000|Overall Study|Other|18|||
161677781|NCT01444456|583872111|FG000|Overall Study|Not treated|104|||
161677782|NCT02142738|583873552|FG000|Overall Study|Adverse Event|13|||
161677783|NCT02142738|583873553|FG001|Overall Study|Adverse Event|9|||
161677784|NCT02142738|583873552|FG000|Overall Study|Death|92|||
161677785|NCT02142738|583873553|FG001|Overall Study|Death|112|||
161677786|NCT02142738|583873552|FG000|Overall Study|Lost to Follow-up|0|||
161934677|NCT01335685|584810053|FG007|Overall Study|Study Terminated by Sponsor|3|||
162210380|NCT01663506|585822957|FG000|Overall Study|Adverse Event|1|||
162210381|NCT01663506|585822957|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
162210382|NCT00328562|585822963|FG000|Overall Study|Disease progression|1|||
162210383|NCT04014790|585822964|FG000|Overall Study|Death|4|||
162210384|NCT04014790|585822964|FG000|Overall Study|Adverse Event|1|||
162210385|NCT04014790|585822964|FG000|Overall Study|Withdrawal by Subject|1|||
162210386|NCT03546816|585822965|FG000|Overall Study|Adverse Event|5|||
162210387|NCT03546816|585822966|FG001|Overall Study|Adverse Event|3|||
162210388|NCT03546816|585822965|FG000|Overall Study|Lack of Efficacy|2|||
162210389|NCT03546816|585822966|FG001|Overall Study|Lack of Efficacy|4|||
162210390|NCT03546816|585822965|FG000|Overall Study|Pregnancy|1|||
162210391|NCT03546816|585822966|FG001|Overall Study|Pregnancy|0|||
162210392|NCT03546816|585822965|FG000|Overall Study|Physician Decision|2|||
161677787|NCT02142738|583873553|FG001|Overall Study|Lost to Follow-up|3|||
161677788|NCT02142738|583873552|FG000|Overall Study|Withdrawal by Subject|6|||
161934678|NCT01335685|584810046|FG000|Overall Study|Withdrawal by Subject|1|||
162210393|NCT03546816|585822966|FG001|Overall Study|Physician Decision|0|||
162210394|NCT03546816|585822965|FG000|Overall Study|Withdrawal by Subject|8|||
162210395|NCT03546816|585822966|FG001|Overall Study|Withdrawal by Subject|10|||
162210396|NCT03546816|585822965|FG000|Overall Study|Lost to Follow-up|3|||
162210397|NCT03546816|585822966|FG001|Overall Study|Lost to Follow-up|2|||
162210398|NCT01161446|585822967|FG000|Overall Study|Lost to Follow-up|18|||
162210399|NCT01161446|585822968|FG001|Overall Study|Lost to Follow-up|14|||
161934679|NCT01335685|584810047|FG001|Overall Study|Withdrawal by Subject|0|||
161934680|NCT01335685|584810048|FG002|Overall Study|Withdrawal by Subject|0|||
161934681|NCT01335685|584810049|FG003|Overall Study|Withdrawal by Subject|1|||
161934682|NCT01335685|584810050|FG004|Overall Study|Withdrawal by Subject|0|||
162210400|NCT01161446|585822967|FG000|Overall Study|Withdrawal by Subject|0|||
162210401|NCT01161446|585822968|FG001|Overall Study|Withdrawal by Subject|1|||
162210402|NCT00810342|585822969|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
162210403|NCT00810342|585822970|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
162210404|NCT00810342|585822969|FG000|Month 1 Follow-up|Pregnancy|1|||
161934683|NCT01335685|584810051|FG005|Overall Study|Withdrawal by Subject|0|||
161934684|NCT01335685|584810052|FG006|Overall Study|Withdrawal by Subject|0|||
161934685|NCT01335685|584810053|FG007|Overall Study|Withdrawal by Subject|0|||
161934686|NCT01335685|584810046|FG000|Overall Study|Reason not Specified|0|||
161934687|NCT01335685|584810047|FG001|Overall Study|Reason not Specified|0|||
161934688|NCT01335685|584810048|FG002|Overall Study|Reason not Specified|1|||
161934689|NCT01335685|584810049|FG003|Overall Study|Reason not Specified|0|||
161934690|NCT01335685|584810050|FG004|Overall Study|Reason not Specified|0|||
161934691|NCT01335685|584810051|FG005|Overall Study|Reason not Specified|1|||
161934692|NCT01335685|584810052|FG006|Overall Study|Reason not Specified|0|||
161934693|NCT01335685|584810053|FG007|Overall Study|Reason not Specified|0|||
161934694|NCT02554474|584810056|FG000|Overall Study|Protocol Violation|1|||
162021343|NCT02891070|585134748|FG000|Overall Study|Withdrawal by Subject|1|||
162021344|NCT02891070|585134749|FG001|Overall Study|Withdrawal by Subject|2|||
162210405|NCT00810342|585822970|FG001|Month 1 Follow-up|Pregnancy|0|||
162210406|NCT00810342|585822969|FG000|6-month Follow-up|Lost to Follow-up|18|||
162210407|NCT00810342|585822970|FG001|6-month Follow-up|Lost to Follow-up|6|||
162210408|NCT00810342|585822969|FG000|6-month Follow-up|Pregnancy|6|||
162210409|NCT00810342|585822970|FG001|6-month Follow-up|Pregnancy|2|||
162210410|NCT00810342|585822969|FG000|12-month Followup|Pregnancy|9|||
162210411|NCT00810342|585822970|FG001|12-month Followup|Pregnancy|10|||
162210412|NCT00810342|585822969|FG000|12-month Followup|Lost to Follow-up|3|||
162210413|NCT00810342|585822970|FG001|12-month Followup|Lost to Follow-up|1|||
162210414|NCT02270671|585822971|FG000|Overall Study|Withdrawal by Subject|1|||
162210415|NCT02270671|585822972|FG001|Overall Study|Withdrawal by Subject|1|||
162210416|NCT02270671|585822971|FG000|Overall Study|Protocol Violation|0|||
162210417|NCT02270671|585822972|FG001|Overall Study|Protocol Violation|1|||
162210418|NCT02270671|585822971|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
162210419|NCT02270671|585822972|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
162210420|NCT02270671|585822971|FG000|Overall Study|Lost to Follow-up|2|||
162210421|NCT02270671|585822972|FG001|Overall Study|Lost to Follow-up|1|||
162210422|NCT02330562|585822975|FG000|Overall Study|Adverse Event|0|||
162210423|NCT02330562|585822976|FG001|Overall Study|Adverse Event|0|||
162210424|NCT02330562|585822977|FG002|Overall Study|Adverse Event|3|||
162210425|NCT02330562|585822978|FG003|Overall Study|Adverse Event|0|||
162210426|NCT02330562|585822979|FG004|Overall Study|Adverse Event|3|||
162210427|NCT02330562|585822980|FG005|Overall Study|Adverse Event|1|||
162210428|NCT02330562|585822981|FG006|Overall Study|Adverse Event|0|||
162210429|NCT02330562|585822982|FG007|Overall Study|Adverse Event|0|||
162210430|NCT02330562|585822983|FG008|Overall Study|Adverse Event|0|||
162210431|NCT02330562|585822984|FG009|Overall Study|Adverse Event|1|||
162210432|NCT02330562|585822985|FG010|Overall Study|Adverse Event|1|||
162210433|NCT02330562|585822975|FG000|Overall Study|Participant decision|1|||
162210434|NCT02330562|585822976|FG001|Overall Study|Participant decision|0|||
162210435|NCT02330562|585822977|FG002|Overall Study|Participant decision|4|||
162210436|NCT02330562|585822978|FG003|Overall Study|Participant decision|1|||
162210437|NCT02330562|585822979|FG004|Overall Study|Participant decision|5|||
162210438|NCT02330562|585822980|FG005|Overall Study|Participant decision|2|||
162210439|NCT02330562|585822981|FG006|Overall Study|Participant decision|0|||
162210440|NCT02330562|585822982|FG007|Overall Study|Participant decision|0|||
161934695|NCT02554474|584810057|FG001|Overall Study|Protocol Violation|1|||
161934696|NCT02554474|584810056|FG000|Overall Study|Health issue not related to the study|1|||
161934697|NCT02554474|584810057|FG001|Overall Study|Health issue not related to the study|0|||
162021345|NCT02891070|585134748|FG000|Overall Study|Death|3|||
162210441|NCT02330562|585822983|FG008|Overall Study|Participant decision|0|||
162210442|NCT02330562|585822984|FG009|Overall Study|Participant decision|3|||
162210443|NCT02330562|585822985|FG010|Overall Study|Participant decision|0|||
162210444|NCT02330562|585822975|FG000|Overall Study|Disease progression|5|||
162210445|NCT02330562|585822976|FG001|Overall Study|Disease progression|3|||
162210446|NCT02330562|585822977|FG002|Overall Study|Disease progression|20|||
162210447|NCT02330562|585822978|FG003|Overall Study|Disease progression|28|||
162210448|NCT02330562|585822979|FG004|Overall Study|Disease progression|23|||
162210449|NCT02330562|585822980|FG005|Overall Study|Disease progression|7|||
161934698|NCT02554474|584810056|FG000|Overall Study|Withdrawal by Subject|1|||
161934699|NCT02554474|584810057|FG001|Overall Study|Withdrawal by Subject|1|||
161934700|NCT03211832|584810058|FG000|Overall Study|No longer with agency|32|||
161934701|NCT03211832|584810059|FG001|Overall Study|No longer with agency|49|||
161934702|NCT03211832|584810060|FG002|Overall Study|No longer with agency|30|||
161934703|NCT03211832|584810058|FG000|Overall Study|Declined survey|3|||
161934704|NCT03211832|584810059|FG001|Overall Study|Declined survey|3|||
161934705|NCT03211832|584810060|FG002|Overall Study|Declined survey|2|||
161934706|NCT03211832|584810058|FG000|Overall Study|Not available during data collection|1|||
161934707|NCT03211832|584810059|FG001|Overall Study|Not available during data collection|0|||
161934708|NCT03211832|584810060|FG002|Overall Study|Not available during data collection|2|||
161934709|NCT00489476|584810064|FG000|Overall Study|Lost to Follow-up|0|||
161934710|NCT00489476|584810065|FG001|Overall Study|Lost to Follow-up|1|||
161934711|NCT00489476|584810066|FG002|Overall Study|Lost to Follow-up|0|||
161934712|NCT00489476|584810067|FG003|Overall Study|Lost to Follow-up|0|||
161934713|NCT04003389|584810070|FG000|Overall Study|Adverse Event|27|||
161934714|NCT04003389|584810071|FG001|Overall Study|Adverse Event|34|||
161934715|NCT04003389|584810072|FG002|Overall Study|Adverse Event|28|||
161934716|NCT04003389|584810070|FG000|Overall Study|Lost to Follow-up|39|||
161934717|NCT04003389|584810071|FG001|Overall Study|Lost to Follow-up|30|||
161934718|NCT04003389|584810072|FG002|Overall Study|Lost to Follow-up|33|||
161934719|NCT04003389|584810070|FG000|Overall Study|Protocol Violation|1|||
161934720|NCT04003389|584810071|FG001|Overall Study|Protocol Violation|6|||
161934721|NCT04003389|584810072|FG002|Overall Study|Protocol Violation|5|||
162210450|NCT02330562|585822981|FG006|Overall Study|Disease progression|1|||
162210451|NCT02330562|585822982|FG007|Overall Study|Disease progression|1|||
162210452|NCT02330562|585822983|FG008|Overall Study|Disease progression|1|||
161934722|NCT04003389|584810070|FG000|Overall Study|Withdrawal by Subject|119|||
161934723|NCT04003389|584810071|FG001|Overall Study|Withdrawal by Subject|79|||
161934724|NCT04003389|584810072|FG002|Overall Study|Withdrawal by Subject|85|||
161934725|NCT04003389|584810070|FG000|Overall Study|Miscellaneous|14|||
161934726|NCT04003389|584810071|FG001|Overall Study|Miscellaneous|11|||
161934727|NCT04003389|584810072|FG002|Overall Study|Miscellaneous|14|||
161934728|NCT04003389|584810070|FG000|Overall Study|Participant did not receive study drug|1|||
161934729|NCT04003389|584810071|FG001|Overall Study|Participant did not receive study drug|0|||
161934730|NCT04003389|584810072|FG002|Overall Study|Participant did not receive study drug|0|||
161934731|NCT03769116|584810077|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
161934732|NCT03769116|584810078|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
161934733|NCT03769116|584810077|FG000|Part 3 - Open Label|Physician Decision|1|||
161934734|NCT03769116|584810078|FG001|Part 3 - Open Label|Physician Decision|0|||
161934735|NCT03769116|584810077|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
161934736|NCT03769116|584810078|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
162210453|NCT02330562|585822984|FG009|Overall Study|Disease progression|0|||
162210454|NCT02330562|585822985|FG010|Overall Study|Disease progression|5|||
162210455|NCT02330562|585822975|FG000|Overall Study|Other reasons|0|||
162210456|NCT02330562|585822976|FG001|Overall Study|Other reasons|0|||
162210457|NCT02330562|585822977|FG002|Overall Study|Other reasons|0|||
162210458|NCT02330562|585822978|FG003|Overall Study|Other reasons|1|||
162210459|NCT02330562|585822979|FG004|Overall Study|Other reasons|0|||
162210460|NCT02330562|585822980|FG005|Overall Study|Other reasons|0|||
162210461|NCT02330562|585822981|FG006|Overall Study|Other reasons|0|||
162210462|NCT02330562|585822982|FG007|Overall Study|Other reasons|0|||
162210463|NCT02330562|585822983|FG008|Overall Study|Other reasons|0|||
161934737|NCT02514746|584810082|FG000|Overall Study|Chronically Ill|1|||
161934738|NCT02514746|584810083|FG001|Overall Study|Chronically Ill|2|||
161934739|NCT02514746|584810082|FG000|Overall Study|Physician Decision|4|||
161934740|NCT02514746|584810083|FG001|Overall Study|Physician Decision|2|||
162210464|NCT02330562|585822984|FG009|Overall Study|Other reasons|0|||
162210465|NCT02330562|585822985|FG010|Overall Study|Other reasons|0|||
162210466|NCT02330562|585822975|FG000|Overall Study|Withdrawal by Subject|0|||
162210467|NCT02330562|585822976|FG001|Overall Study|Withdrawal by Subject|0|||
162210468|NCT02330562|585822977|FG002|Overall Study|Withdrawal by Subject|0|||
162210469|NCT02330562|585822978|FG003|Overall Study|Withdrawal by Subject|0|||
162210470|NCT02330562|585822979|FG004|Overall Study|Withdrawal by Subject|0|||
161934741|NCT02514746|584810082|FG000|Overall Study|Withdrawal by Subject|12|||
161934742|NCT02514746|584810083|FG001|Overall Study|Withdrawal by Subject|10|||
161934743|NCT02514746|584810082|FG000|Overall Study|Other|5|||
161934744|NCT02514746|584810083|FG001|Overall Study|Other|1|||
162210471|NCT02330562|585822980|FG005|Overall Study|Withdrawal by Subject|0|||
162210472|NCT02330562|585822981|FG006|Overall Study|Withdrawal by Subject|0|||
162210473|NCT02330562|585822982|FG007|Overall Study|Withdrawal by Subject|0|||
161934745|NCT04003142|584810087|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
161934746|NCT04003142|584810088|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
161934747|NCT04003142|584810089|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
162210474|NCT02330562|585822983|FG008|Overall Study|Withdrawal by Subject|0|||
162021346|NCT02891070|585134749|FG001|Overall Study|Death|0|||
162021347|NCT02704143|585134750|FG000|Overall Study|disease progression|10|||
162210475|NCT02330562|585822984|FG009|Overall Study|Withdrawal by Subject|1|||
162210476|NCT02330562|585822985|FG010|Overall Study|Withdrawal by Subject|0|||
162210477|NCT00126659|585822988|FG000|Overall Study|Adverse Event|0|||
162210478|NCT00126659|585822989|FG001|Overall Study|Adverse Event|0|||
162210479|NCT00126659|585822990|FG002|Overall Study|Adverse Event|2|||
162210480|NCT04599855|585822994|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
162210481|NCT04599855|585822995|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
162210482|NCT04599855|585822996|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
162210483|NCT04599855|585822994|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
162210484|NCT04599855|585822995|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
162210485|NCT04599855|585822996|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
162210486|NCT04599855|585822994|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
162210487|NCT04599855|585822995|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
162210488|NCT04599855|585822996|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
162210489|NCT04599855|585822994|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
162210490|NCT04599855|585822995|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
162210491|NCT04599855|585822996|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
162210492|NCT04599855|585822994|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
162210493|NCT04599855|585822995|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
162210494|NCT04599855|585822996|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
162210495|NCT04599855|585822994|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
162210496|NCT04599855|585822995|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
162210497|NCT04599855|585822996|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
162210498|NCT04599855|585822994|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
162210499|NCT04599855|585822995|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
162210500|NCT04599855|585822996|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
162210501|NCT04599855|585822994|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
161826072|NCT00965757|584403771|FG003|Double-blind Phase|Other|0|||
161826073|NCT00965757|584403768|FG000|Extension Phase|Progression of concomitant disease|0|||
161826074|NCT00965757|584403769|FG001|Extension Phase|Progression of concomitant disease|0|||
161826075|NCT00965757|584403770|FG002|Extension Phase|Progression of concomitant disease|4|||
161826076|NCT00965757|584403771|FG003|Extension Phase|Progression of concomitant disease|2|||
161826077|NCT00965757|584403768|FG000|Extension Phase|Adverse drug reaction|0|||
161826078|NCT00965757|584403769|FG001|Extension Phase|Adverse drug reaction|0|||
161826079|NCT00965757|584403770|FG002|Extension Phase|Adverse drug reaction|6|||
161826080|NCT00965757|584403771|FG003|Extension Phase|Adverse drug reaction|3|||
161826081|NCT00965757|584403768|FG000|Extension Phase|Abnormal Laboratory Value|0|||
161826082|NCT00965757|584403769|FG001|Extension Phase|Abnormal Laboratory Value|0|||
161826083|NCT00965757|584403770|FG002|Extension Phase|Abnormal Laboratory Value|6|||
161826084|NCT00965757|584403771|FG003|Extension Phase|Abnormal Laboratory Value|1|||
162210502|NCT04599855|585822995|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
162210503|NCT04599855|585822996|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
162210504|NCT04599855|585822994|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
162210505|NCT04599855|585822995|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
162210506|NCT04599855|585822996|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
162210507|NCT04599855|585822994|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
162210508|NCT04599855|585822995|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
162210509|NCT04599855|585822996|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
162210510|NCT04599855|585822994|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
162210511|NCT04599855|585822995|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
162210512|NCT04599855|585822996|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
162210513|NCT04599855|585822994|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
162210514|NCT04599855|585822995|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
162210515|NCT04599855|585822996|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
162210516|NCT04599855|585822994|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
162210517|NCT04599855|585822995|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
162210518|NCT04599855|585822996|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
162210519|NCT04599855|585822994|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
162210520|NCT04599855|585822995|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
162210521|NCT04599855|585822996|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
162210522|NCT04294667|585822997|FG000|Overall Study|Lack of Efficacy|4|||
162210523|NCT04294667|585822998|FG001|Overall Study|Lack of Efficacy|4|||
162210524|NCT04294667|585822997|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
162210525|NCT04294667|585822998|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
162210526|NCT04294667|585822997|FG000|Overall Study|Patient has a Renal Flare|1|||
162210527|NCT04294667|585822998|FG001|Overall Study|Patient has a Renal Flare|0|||
162210528|NCT04294667|585822997|FG000|Overall Study|SLE Worsening|0|||
162210529|NCT04294667|585822998|FG001|Overall Study|SLE Worsening|1|||
162210530|NCT04294667|585822997|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
162210531|NCT04294667|585822998|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
162210532|NCT04294667|585822997|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
162210533|NCT04294667|585822998|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
162210534|NCT04294667|585822997|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
162210535|NCT04294667|585822998|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
162210536|NCT04294667|585822997|FG000|Overall Study|Subject Moved to Another State|0|||
161826085|NCT00965757|584403768|FG000|Extension Phase|Lack of Efficacy|0|||
161826086|NCT00965757|584403769|FG001|Extension Phase|Lack of Efficacy|0|||
162210537|NCT04294667|585822998|FG001|Overall Study|Subject Moved to Another State|1|||
162210538|NCT04294667|585822997|FG000|Overall Study|Adverse event, serious fatal|0|||
162210539|NCT04294667|585822998|FG001|Overall Study|Adverse event, serious fatal|1|||
162210540|NCT04294667|585822997|FG000|Overall Study|Adverse event, non-fatal|3|||
162210541|NCT04294667|585822998|FG001|Overall Study|Adverse event, non-fatal|4|||
162210542|NCT00548847|585822999|FG000|Overall Study|Disease progression|7|||
162210543|NCT00727415|585823000|FG000|Phase I|Dose Limiting Toxicity|2|||
162210544|NCT00302159|585823003|FG000|Overall Study|pt declined before treatment started|1|||
162210545|NCT00302159|585823003|FG000|Overall Study|pt started Avastin|1|||
162210546|NCT00853229|585823006|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
162210547|NCT00853229|585823007|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
162210548|NCT02312206|585823014|FG000|Overall Study|Adverse Event|3|||
162210549|NCT02312206|585823015|FG001|Overall Study|Adverse Event|6|||
162210550|NCT02312206|585823014|FG000|Overall Study|Withdrawal by Subject|6|||
162210551|NCT02312206|585823015|FG001|Overall Study|Withdrawal by Subject|6|||
162210552|NCT02312206|585823014|FG000|Overall Study|Physician Decision|7|||
162210553|NCT02312206|585823015|FG001|Overall Study|Physician Decision|6|||
162210554|NCT02312206|585823014|FG000|Overall Study|Death|31|||
162210555|NCT02312206|585823015|FG001|Overall Study|Death|36|||
162210556|NCT02312206|585823014|FG000|Overall Study|Study Terminated by Sponsor|81|||
162210557|NCT02312206|585823015|FG001|Overall Study|Study Terminated by Sponsor|74|||
162210558|NCT02312206|585823014|FG000|Overall Study|Patient transferred to hospice|0|||
162210559|NCT02312206|585823015|FG001|Overall Study|Patient transferred to hospice|1|||
162210560|NCT02312206|585823014|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
162236593|NCT01959516|585917003|FG000|Epoch 2|Subject withdrew consent|1|||
161826087|NCT00965757|584403770|FG002|Extension Phase|Lack of Efficacy|8|||
161826088|NCT00965757|584403771|FG003|Extension Phase|Lack of Efficacy|12|||
161826089|NCT00965757|584403768|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
161826090|NCT00965757|584403769|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
161826091|NCT00965757|584403770|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
162021348|NCT02551991|585134755|FG000|Overall Study|Death|5|||
162236594|NCT01959516|585917004|FG001|Epoch 2|Subject withdrew consent|0|||
162236595|NCT01959516|585917003|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
162236596|NCT01959516|585917004|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
162210561|NCT02312206|585823015|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
162210562|NCT02312206|585823014|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
162210563|NCT02312206|585823015|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
162210564|NCT02312206|585823014|FG000|Overall Study|Disease Progression|1|||
162210565|NCT02312206|585823015|FG001|Overall Study|Disease Progression|0|||
162210566|NCT03082612|585823016|FG000|Overall Study|Lost to Follow-up|2|||
162210567|NCT03082612|585823017|FG001|Overall Study|Lost to Follow-up|0|||
161934748|NCT04003142|584810090|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
161934749|NCT04003142|584810091|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
161934750|NCT04003142|584810087|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
161934751|NCT04003142|584810088|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
161934752|NCT04003142|584810089|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
161934753|NCT04003142|584810090|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
161934754|NCT04003142|584810091|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
161934755|NCT04003142|584810087|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
161934756|NCT04003142|584810088|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
161934757|NCT04003142|584810089|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
161934758|NCT04003142|584810090|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
161934759|NCT04003142|584810091|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
161934760|NCT04003142|584810087|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
161934761|NCT04003142|584810088|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
161934762|NCT04003142|584810089|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
161934763|NCT04003142|584810090|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
161934764|NCT04003142|584810091|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
161934765|NCT04003142|584810087|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
161934766|NCT04003142|584810088|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
161934767|NCT04003142|584810089|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
161934768|NCT04003142|584810090|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
161934769|NCT04003142|584810091|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
161934770|NCT04003142|584810087|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
161934771|NCT04003142|584810088|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
161934772|NCT04003142|584810089|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
161934773|NCT04003142|584810090|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
162210568|NCT01006616|585823018|FG000|Period 1 (6 Months)|Adverse Event|10|||
162210569|NCT01006616|585823019|FG001|Period 1 (6 Months)|Adverse Event|31|||
162210570|NCT01006616|585823020|FG002|Period 1 (6 Months)|Adverse Event|37|||
162210571|NCT01006616|585823021|FG003|Period 1 (6 Months)|Adverse Event|9|||
162210572|NCT01006616|585823018|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
162210573|NCT01006616|585823019|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
162210574|NCT01006616|585823020|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
162210575|NCT01006616|585823021|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
162210576|NCT01006616|585823018|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
162210577|NCT01006616|585823019|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
162210578|NCT01006616|585823020|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
162210579|NCT01006616|585823021|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
162210580|NCT01006616|585823018|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
162210581|NCT01006616|585823019|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
162210582|NCT01006616|585823020|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
162210583|NCT01006616|585823021|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
162210584|NCT01006616|585823018|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
162210585|NCT01006616|585823019|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
162210586|NCT01006616|585823020|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
162236597|NCT02581631|585917011|FG000|Overall Study|Disease progression|29|||
162236598|NCT02581631|585917012|FG001|Overall Study|Disease progression|19|||
161934774|NCT04003142|584810091|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
162236599|NCT02581631|585917013|FG002|Overall Study|Disease progression|13|||
162236600|NCT02581631|585917014|FG003|Overall Study|Disease progression|5|||
162236601|NCT02581631|585917015|FG004|Overall Study|Disease progression|8|||
162236602|NCT02581631|585917011|FG000|Overall Study|Study drug toxicity|4|||
162236603|NCT02581631|585917012|FG001|Overall Study|Study drug toxicity|6|||
162236604|NCT02581631|585917013|FG002|Overall Study|Study drug toxicity|7|||
162236605|NCT02581631|585917014|FG003|Overall Study|Study drug toxicity|0|||
162236606|NCT02581631|585917015|FG004|Overall Study|Study drug toxicity|3|||
162236607|NCT02581631|585917011|FG000|Overall Study|AE unrelated to study drug|3|||
162236608|NCT02581631|585917012|FG001|Overall Study|AE unrelated to study drug|1|||
162236609|NCT02581631|585917013|FG002|Overall Study|AE unrelated to study drug|1|||
162236610|NCT02581631|585917014|FG003|Overall Study|AE unrelated to study drug|0|||
162236611|NCT02581631|585917015|FG004|Overall Study|AE unrelated to study drug|2|||
162236612|NCT02581631|585917011|FG000|Overall Study|Request to discontinue|1|||
162236613|NCT02581631|585917012|FG001|Overall Study|Request to discontinue|0|||
162236614|NCT02581631|585917013|FG002|Overall Study|Request to discontinue|3|||
162236615|NCT02581631|585917014|FG003|Overall Study|Request to discontinue|0|||
161677789|NCT02142738|583873553|FG001|Overall Study|Withdrawal by Subject|7|||
161677790|NCT02142738|583873552|FG000|Overall Study|Follow up ended by sponsor|43|||
161826092|NCT00965757|584403771|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
161826093|NCT00965757|584403768|FG000|Extension Phase|Lost to Follow-up|0|||
161826094|NCT00965757|584403769|FG001|Extension Phase|Lost to Follow-up|0|||
162210587|NCT01006616|585823021|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
162210588|NCT01006616|585823018|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
162210589|NCT01006616|585823019|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
161677791|NCT02142738|583873553|FG001|Overall Study|Follow up ended by sponsor|20|||
161677792|NCT03713034|583873554|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
161677793|NCT03713034|583873555|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
161677794|NCT02615470|583873556|FG000|Overall Study|Lost to Follow-up|21|||
161677795|NCT02615470|583873557|FG001|Overall Study|Lost to Follow-up|32|||
161677796|NCT02982590|583873561|FG000|Overall Study|Lost to Follow-up|0|||
161677797|NCT02982590|583873562|FG001|Overall Study|Lost to Follow-up|1|||
161677798|NCT02982590|583873561|FG000|Overall Study|Death|4|||
161677799|NCT02982590|583873562|FG001|Overall Study|Death|0|||
161677800|NCT00419120|583873566|FG000|Long Term Follow up Period|study ongoing|10|||
161677801|NCT00388505|583873567|FG000|Overall Study|Adverse Event or Death|43|||
161677802|NCT00388505|583873568|FG001|Overall Study|Adverse Event or Death|17|||
161677803|NCT00388505|583873567|FG000|Overall Study|Withdrawal by Subject|24|||
161677804|NCT00388505|583873568|FG001|Overall Study|Withdrawal by Subject|9|||
161677805|NCT00388505|583873567|FG000|Overall Study|Lost to Follow-up|5|||
161677806|NCT00388505|583873568|FG001|Overall Study|Lost to Follow-up|3|||
161677807|NCT00388505|583873567|FG000|Overall Study|Inappropriate Enrollment|0|||
161677808|NCT00388505|583873568|FG001|Overall Study|Inappropriate Enrollment|1|||
161677809|NCT00388505|583873567|FG000|Overall Study|Administrative Reason|1|||
161677810|NCT00388505|583873568|FG001|Overall Study|Administrative Reason|0|||
161677811|NCT00388505|583873567|FG000|Overall Study|Protocol Violation|6|||
161677812|NCT00388505|583873568|FG001|Overall Study|Protocol Violation|5|||
161677813|NCT00388505|583873567|FG000|Overall Study|Unable to classify|4|||
161677814|NCT00388505|583873568|FG001|Overall Study|Unable to classify|3|||
161677815|NCT02667275|583873570|FG000|Overall Study|Protocol Violation|11|||
161677816|NCT02667275|583873571|FG001|Overall Study|Protocol Violation|7|||
161677817|NCT02667275|583873570|FG000|Overall Study|Lost to Follow-up|0|||
161677818|NCT02667275|583873571|FG001|Overall Study|Lost to Follow-up|2|||
161677819|NCT02667275|583873570|FG000|Overall Study|Withdrawal by Subject|0|||
161677820|NCT02667275|583873571|FG001|Overall Study|Withdrawal by Subject|5|||
161677821|NCT02667275|583873570|FG000|Overall Study|Discontinued early without completing|0|||
161677822|NCT02667275|583873571|FG001|Overall Study|Discontinued early without completing|1|||
161677823|NCT01756040|583873572|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
161677824|NCT01756040|583873572|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
161677825|NCT01756040|583873572|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
161826095|NCT00965757|584403770|FG002|Extension Phase|Lost to Follow-up|0|||
161826096|NCT00965757|584403771|FG003|Extension Phase|Lost to Follow-up|1|||
161826097|NCT00965757|584403768|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
161826098|NCT00965757|584403769|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
161826099|NCT00965757|584403770|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
161826100|NCT00965757|584403771|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
161826101|NCT00965757|584403768|FG000|Extension Phase|Protocol Violation|0|||
161826102|NCT00965757|584403769|FG001|Extension Phase|Protocol Violation|0|||
161826103|NCT00965757|584403770|FG002|Extension Phase|Protocol Violation|0|||
161826104|NCT00965757|584403771|FG003|Extension Phase|Protocol Violation|1|||
161826105|NCT00965757|584403768|FG000|Extension Phase|Other|0|||
161826106|NCT00965757|584403769|FG001|Extension Phase|Other|0|||
161826107|NCT00965757|584403770|FG002|Extension Phase|Other|2|||
161826108|NCT00965757|584403771|FG003|Extension Phase|Other|1|||
161826109|NCT01344018|584403775|FG000|Overall Study|Death|22|||
161826110|NCT01344018|584403776|FG001|Overall Study|Death|25|||
161826111|NCT01344018|584403775|FG000|Overall Study|Lost to Follow-up|4|||
161826112|NCT01344018|584403776|FG001|Overall Study|Lost to Follow-up|7|||
161826113|NCT04010227|584403777|FG000|Overall Study|Death|1|||
161826114|NCT04010227|584403778|FG001|Overall Study|Death|2|||
161826115|NCT04010227|584403777|FG000|Overall Study|Medical Reasons|4|||
161826116|NCT04010227|584403778|FG001|Overall Study|Medical Reasons|3|||
161826117|NCT04010227|584403777|FG000|Overall Study|Withdrawal by Subject|2|||
161826118|NCT04010227|584403778|FG001|Overall Study|Withdrawal by Subject|0|||
161826119|NCT04010227|584403777|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
161826120|NCT04010227|584403778|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
161826121|NCT02308696|584403779|FG000|Overall Study|Lost to Follow-up|28|||
161826122|NCT02308696|584403780|FG001|Overall Study|Lost to Follow-up|21|||
161826123|NCT02308696|584403779|FG000|Overall Study|Death|8|||
161826124|NCT02308696|584403780|FG001|Overall Study|Death|4|||
161826125|NCT02308696|584403779|FG000|Overall Study|Moved to a Higher Level of Care|17|||
161826126|NCT02308696|584403780|FG001|Overall Study|Moved to a Higher Level of Care|6|||
161826127|NCT02914457|584403781|FG000|Overall Study|Withdrawal by Subject|1|||
161934775|NCT04003142|584810087|FG000|Extension Period (40 Weeks)|Death|0|||
161934776|NCT04003142|584810088|FG001|Extension Period (40 Weeks)|Death|0|||
162210590|NCT01006616|585823020|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
162210591|NCT01006616|585823021|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
162210592|NCT01006616|585823018|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
162210593|NCT01006616|585823019|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
162210594|NCT01006616|585823020|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
162210595|NCT01006616|585823021|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
162210596|NCT01006616|585823018|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
162210597|NCT01006616|585823019|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
162210598|NCT01006616|585823020|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
162210599|NCT01006616|585823021|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
162210600|NCT01006616|585823018|FG000|Period 1 (6 Months)|Not Treated|0|||
162210601|NCT01006616|585823019|FG001|Period 1 (6 Months)|Not Treated|0|||
162210602|NCT01006616|585823020|FG002|Period 1 (6 Months)|Not Treated|1|||
162210603|NCT01006616|585823021|FG003|Period 1 (6 Months)|Not Treated|1|||
162210604|NCT01006616|585823018|FG000|Period 2 (18 Months)|Adverse Event|6|||
162210605|NCT01006616|585823019|FG001|Period 2 (18 Months)|Adverse Event|6|||
162210606|NCT01006616|585823020|FG002|Period 2 (18 Months)|Adverse Event|6|||
162210607|NCT01006616|585823021|FG003|Period 2 (18 Months)|Adverse Event|4|||
162210608|NCT01006616|585823018|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
162210609|NCT01006616|585823019|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
162210610|NCT01006616|585823020|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
162210611|NCT01006616|585823021|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
162210612|NCT01006616|585823018|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
162210613|NCT01006616|585823019|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
162210614|NCT01006616|585823020|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
162210615|NCT01006616|585823021|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
162210616|NCT01006616|585823018|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
162210617|NCT01006616|585823019|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
162210618|NCT01006616|585823020|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
162210619|NCT01006616|585823021|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
162210620|NCT01006616|585823018|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
162210621|NCT01006616|585823019|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
162210622|NCT01006616|585823020|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
162210623|NCT01006616|585823021|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
162210624|NCT01006616|585823018|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
162210625|NCT01006616|585823019|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
162210626|NCT01006616|585823020|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
162210627|NCT01006616|585823021|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
162210628|NCT01006616|585823018|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
161934777|NCT04003142|584810089|FG002|Extension Period (40 Weeks)|Death|0|||
161934778|NCT04003142|584810090|FG003|Extension Period (40 Weeks)|Death|0|||
161934779|NCT04003142|584810091|FG004|Extension Period (40 Weeks)|Death|1|||
161934780|NCT04003142|584810087|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
162210629|NCT01006616|585823019|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
162210630|NCT01006616|585823020|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
162210631|NCT01006616|585823021|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
162210632|NCT01006616|585823018|FG000|Period 2 (18 Months)|Study Terminated|63|||
162210633|NCT01006616|585823019|FG001|Period 2 (18 Months)|Study Terminated|46|||
162210634|NCT01006616|585823020|FG002|Period 2 (18 Months)|Study Terminated|44|||
162210635|NCT01006616|585823021|FG003|Period 2 (18 Months)|Study Terminated|70|||
162210636|NCT03672175|585823022|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
162210637|NCT03672175|585823023|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
162210638|NCT03672175|585823024|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
162210639|NCT03672175|585823022|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
162210640|NCT03672175|585823023|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
162210641|NCT03672175|585823024|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
162210642|NCT03672175|585823022|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
162210643|NCT03672175|585823023|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
161934781|NCT04003142|584810088|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
161934782|NCT04003142|584810089|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
162210644|NCT03672175|585823024|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
162210645|NCT03672175|585823022|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
162210646|NCT03672175|585823023|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
162210647|NCT03672175|585823024|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
162210648|NCT03672175|585823022|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
162210649|NCT03672175|585823023|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
162210650|NCT03672175|585823024|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
162210651|NCT03672175|585823022|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
162210652|NCT03672175|585823023|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
162210653|NCT03672175|585823024|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
162210654|NCT03672175|585823022|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
162210655|NCT03672175|585823023|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
162210656|NCT03672175|585823024|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
162210657|NCT03672175|585823022|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
162210658|NCT03672175|585823023|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
162210659|NCT03672175|585823024|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
162210660|NCT03672175|585823022|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
162210661|NCT03672175|585823023|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
162210662|NCT03672175|585823024|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
162210663|NCT03672175|585823022|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
162210664|NCT03672175|585823023|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
162210665|NCT03672175|585823024|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
162210666|NCT03672175|585823022|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
162210667|NCT03672175|585823023|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
162210668|NCT03672175|585823024|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
162210669|NCT03672175|585823022|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
162210670|NCT03672175|585823023|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
161826128|NCT02914457|584403781|FG000|Overall Study|Physician Decision|1|||
161826129|NCT02914457|584403781|FG000|Overall Study|No veins available for lead placement|1|||
161826130|NCT02914457|584403781|FG000|Overall Study|Electrical instability of patient|1|||
161826131|NCT02914457|584403781|FG000|Overall Study|ECG acquisition error due to sweating|1|||
161826132|NCT02914457|584403781|FG000|Overall Study|Protocol Violation|1|||
161826133|NCT01055886|584403782|FG000|Overall Study|Withdrawal by Subject|4|||
161826134|NCT01055886|584403783|FG001|Overall Study|Withdrawal by Subject|9|||
161826135|NCT01055886|584403782|FG000|Overall Study|Lost to Follow-up|1|||
161826136|NCT01055886|584403783|FG001|Overall Study|Lost to Follow-up|1|||
161826137|NCT01055886|584403782|FG000|Overall Study|Withdrawal by PI|0|||
161826138|NCT01055886|584403783|FG001|Overall Study|Withdrawal by PI|1|||
161826139|NCT04254809|584403786|FG000|Overall Study|Lost to Follow-up|5|||
161677826|NCT01179672|583873582|FG000|Overall Study|Adverse Event|17|||
161677827|NCT01179672|583873583|FG001|Overall Study|Adverse Event|8|||
161677828|NCT01179672|583873582|FG000|Overall Study|Withdrawal by Subject|10|||
161677829|NCT01179672|583873583|FG001|Overall Study|Withdrawal by Subject|12|||
161677830|NCT01179672|583873582|FG000|Overall Study|Entry Criteria Not Met|0|||
161677831|NCT01179672|583873583|FG001|Overall Study|Entry Criteria Not Met|2|||
161677832|NCT01179672|583873582|FG000|Overall Study|Lost to Follow-up|0|||
161677833|NCT01179672|583873583|FG001|Overall Study|Lost to Follow-up|1|||
161677834|NCT01179672|583873582|FG000|Overall Study|Protocol Violation|2|||
161677835|NCT01179672|583873583|FG001|Overall Study|Protocol Violation|2|||
161677836|NCT01179672|583873582|FG000|Overall Study|Physician Decision|1|||
161677837|NCT01179672|583873583|FG001|Overall Study|Physician Decision|1|||
161677838|NCT01994382|583873584|FG000|Overall Study|Informed consent withdrawn|0|||
161677839|NCT01994382|583873585|FG001|Overall Study|Informed consent withdrawn|0|||
161677840|NCT01994382|583873586|FG002|Overall Study|Informed consent withdrawn|0|||
161677841|NCT01994382|583873587|FG003|Overall Study|Informed consent withdrawn|0|||
161677842|NCT01994382|583873588|FG004|Overall Study|Informed consent withdrawn|0|||
161677843|NCT01994382|583873589|FG005|Overall Study|Informed consent withdrawn|0|||
161677844|NCT01994382|583873590|FG006|Overall Study|Informed consent withdrawn|1|||
161677845|NCT01994382|583873591|FG007|Overall Study|Informed consent withdrawn|0|||
161677846|NCT01994382|583873592|FG008|Overall Study|Informed consent withdrawn|0|||
162210671|NCT03672175|585823024|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
162210672|NCT03414047|585823025|FG000|Overall Study|Adverse Event|0|||
162210673|NCT03414047|585823026|FG001|Overall Study|Adverse Event|0|||
162210674|NCT03414047|585823027|FG002|Overall Study|Adverse Event|1|||
162210675|NCT03414047|585823028|FG003|Overall Study|Adverse Event|1|||
162210676|NCT03414047|585823025|FG000|Overall Study|Physician Decision|1|||
162210677|NCT03414047|585823026|FG001|Overall Study|Physician Decision|0|||
162210678|NCT03414047|585823027|FG002|Overall Study|Physician Decision|0|||
162210679|NCT03414047|585823028|FG003|Overall Study|Physician Decision|1|||
162210680|NCT03414047|585823025|FG000|Overall Study|Withdrawal by Subject|1|||
162210681|NCT03414047|585823026|FG001|Overall Study|Withdrawal by Subject|0|||
162210682|NCT03414047|585823027|FG002|Overall Study|Withdrawal by Subject|2|||
162210683|NCT03414047|585823028|FG003|Overall Study|Withdrawal by Subject|0|||
162210684|NCT01747837|585823033|FG000|Overall Study|Lost to Follow-up|5|||
162210685|NCT01747837|585823034|FG001|Overall Study|Lost to Follow-up|2|||
162210686|NCT01747837|585823033|FG000|Overall Study|Death|4|||
162210687|NCT01747837|585823034|FG001|Overall Study|Death|4|||
162210688|NCT03269695|585823039|FG000|Overall Study|Adverse Event|2|||
162210689|NCT03269695|585823040|FG001|Overall Study|Adverse Event|1|||
162210690|NCT03269695|585823039|FG000|Overall Study|Lack of Efficacy|0|||
162210691|NCT03269695|585823040|FG001|Overall Study|Lack of Efficacy|1|||
162210692|NCT03269695|585823039|FG000|Overall Study|Withdrawal by Subject|0|||
162210693|NCT03269695|585823040|FG001|Overall Study|Withdrawal by Subject|1|||
162210694|NCT01017263|585823041|FG000|Overall Study|not eligible|12|||
162210695|NCT00239681|585823042|FG000|Overall Study|Adverse Event|100|||
162210696|NCT00239681|585823043|FG001|Overall Study|Adverse Event|99|||
162210697|NCT00239681|585823042|FG000|Overall Study|Withdrawal by Subject|458|||
162210698|NCT00239681|585823043|FG001|Overall Study|Withdrawal by Subject|489|||
162210699|NCT00239681|585823042|FG000|Overall Study|Lost to Follow-up|28|||
162210700|NCT00239681|585823043|FG001|Overall Study|Lost to Follow-up|22|||
161677847|NCT01994382|583873593|FG009|Overall Study|Informed consent withdrawn|0|||
161677848|NCT01994382|583873594|FG010|Overall Study|Informed consent withdrawn|0|||
161677849|NCT01994382|583873595|FG011|Overall Study|Informed consent withdrawn|0|||
162021349|NCT02551991|585134756|FG001|Overall Study|Death|7|||
162210701|NCT00239681|585823042|FG000|Overall Study|Protocol Violation|4|||
162210702|NCT00239681|585823043|FG001|Overall Study|Protocol Violation|4|||
162210703|NCT00239681|585823042|FG000|Overall Study|Physician Decision|13|||
162210704|NCT00239681|585823043|FG001|Overall Study|Physician Decision|17|||
162210705|NCT00239681|585823042|FG000|Overall Study|No information chacked on CaseReportForm|90|||
162210706|NCT00239681|585823043|FG001|Overall Study|No information chacked on CaseReportForm|84|||
162210707|NCT00905359|585823046|FG000|Overall Study|Lost to Follow-up|17|||
162210708|NCT00905359|585823047|FG001|Overall Study|Lost to Follow-up|10|||
161677850|NCT01994382|583873596|FG012|Overall Study|Informed consent withdrawn|0|||
162210709|NCT00905359|585823046|FG000|Overall Study|Death|2|||
162210710|NCT00905359|585823047|FG001|Overall Study|Death|0|||
162210711|NCT00905359|585823046|FG000|Overall Study|Withdrawal consent|5|||
162210712|NCT00905359|585823047|FG001|Overall Study|Withdrawal consent|6|||
161677851|NCT01994382|583873597|FG013|Overall Study|Informed consent withdrawn|0|||
161677852|NCT01994382|583873598|FG014|Overall Study|Informed consent withdrawn|0|||
161677853|NCT01994382|583873599|FG015|Overall Study|Informed consent withdrawn|0|||
161677854|NCT01994382|583873600|FG016|Overall Study|Informed consent withdrawn|0|||
161677855|NCT01994382|583873584|FG000|Overall Study|Progressive disease|3|||
161677856|NCT01994382|583873585|FG001|Overall Study|Progressive disease|4|||
162210713|NCT02654132|585823048|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
162210714|NCT02654132|585823049|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
162210715|NCT02654132|585823048|FG000|Treatment Period|Disease progression|43|||
162210716|NCT02654132|585823049|FG001|Treatment Period|Disease progression|38|||
162210717|NCT02654132|585823048|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
162210718|NCT02654132|585823049|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
161934783|NCT04003142|584810090|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
161934784|NCT04003142|584810091|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
161934785|NCT04003142|584810087|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
161934786|NCT04003142|584810088|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
161934787|NCT04003142|584810089|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
161934788|NCT04003142|584810090|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
161934789|NCT04003142|584810091|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
161934790|NCT04003142|584810087|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
162210719|NCT02654132|585823048|FG000|Treatment Period|Other reasons|4|||
162210720|NCT02654132|585823049|FG001|Treatment Period|Other reasons|2|||
162210721|NCT02654132|585823048|FG000|Treatment Period|Study drug toxicity|2|||
162210722|NCT02654132|585823049|FG001|Treatment Period|Study drug toxicity|2|||
162210723|NCT02654132|585823048|FG000|Treatment Period|Withdrawal by Subject|2|||
162210724|NCT02654132|585823049|FG001|Treatment Period|Withdrawal by Subject|1|||
162210725|NCT02654132|585823048|FG000|Treatment Period|Maximum Clinical Benefit|0|||
162210726|NCT02654132|585823049|FG001|Treatment Period|Maximum Clinical Benefit|2|||
162210727|NCT02654132|585823048|FG000|Treatment Period|Participant request to discontinue|2|||
162210728|NCT02654132|585823049|FG001|Treatment Period|Participant request to discontinue|0|||
162210729|NCT02654132|585823048|FG000|Treatment Period|Administrative reasons by sponsor|0|||
162210730|NCT02654132|585823049|FG001|Treatment Period|Administrative reasons by sponsor|1|||
162210731|NCT02654132|585823048|FG000|Treatment Period|Death|1|||
162210732|NCT02654132|585823049|FG001|Treatment Period|Death|0|||
162210733|NCT00623363|585823050|FG000|Overall Study|Adverse Event|2|||
162210734|NCT00623363|585823051|FG001|Overall Study|Adverse Event|2|||
162210735|NCT04706793|585823052|FG000|Treatment|Disease worsening|10|||
162210736|NCT04706793|585823053|FG001|Treatment|Disease worsening|10|||
162210737|NCT04706793|585823052|FG000|Follow-up|Lack of Efficacy|1|||
162210738|NCT04706793|585823053|FG001|Follow-up|Lack of Efficacy|0|||
162210739|NCT04706793|585823052|FG000|Follow-up|Disease worsening|8|||
162210740|NCT04706793|585823053|FG001|Follow-up|Disease worsening|10|||
162210741|NCT04706793|585823052|FG000|Follow-up|Adverse Event|1|||
162210742|NCT04706793|585823053|FG001|Follow-up|Adverse Event|0|||
162210743|NCT03713320|585823054|FG000|Randomized Period|Adverse Event|1|||
162210744|NCT03713320|585823055|FG001|Randomized Period|Adverse Event|5|||
162210745|NCT03713320|585823056|FG002|Randomized Period|Adverse Event|0|||
161934791|NCT04003142|584810088|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
161934792|NCT04003142|584810089|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
162210746|NCT03713320|585823054|FG000|Randomized Period|Physician Decision|1|||
162210747|NCT03713320|585823055|FG001|Randomized Period|Physician Decision|1|||
162210748|NCT03713320|585823056|FG002|Randomized Period|Physician Decision|0|||
162210749|NCT03713320|585823054|FG000|Randomized Period|Withdrawal by Subject|4|||
162210750|NCT03713320|585823055|FG001|Randomized Period|Withdrawal by Subject|0|||
162210751|NCT03713320|585823056|FG002|Randomized Period|Withdrawal by Subject|0|||
162210752|NCT03713320|585823054|FG000|Randomized Period|Participant decision|3|||
162210753|NCT03713320|585823055|FG001|Randomized Period|Participant decision|1|||
162210754|NCT03713320|585823056|FG002|Randomized Period|Participant decision|0|||
162210755|NCT03713320|585823054|FG000|Randomized Period|Study terminated by sponsor|6|||
162210756|NCT03713320|585823055|FG001|Randomized Period|Study terminated by sponsor|3|||
162210757|NCT03713320|585823056|FG002|Randomized Period|Study terminated by sponsor|0|||
162210758|NCT03713320|585823054|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
162210759|NCT03713320|585823055|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
162210760|NCT03713320|585823056|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
162210761|NCT03713320|585823054|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
162210762|NCT03713320|585823055|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
161934793|NCT04003142|584810090|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
162210763|NCT03713320|585823056|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
162210764|NCT02725528|585823057|FG000|Overall Study|Lost to Follow-up|1|||
162210765|NCT02725528|585823058|FG001|Overall Study|Lost to Follow-up|4|||
162210766|NCT02725528|585823057|FG000|Overall Study|Withdrawal by Subject|0|||
162210767|NCT02725528|585823058|FG001|Overall Study|Withdrawal by Subject|1|||
162210768|NCT04354168|585823059|FG000|Overall Study|Lost to Follow-up|22|||
162210769|NCT02287233|585823060|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
162210770|NCT02287233|585823061|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
162210771|NCT02287233|585823062|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
162210772|NCT02287233|585823060|FG000|Overall Study|Adverse Event Related to Progression|0|||
162210773|NCT02287233|585823061|FG001|Overall Study|Adverse Event Related to Progression|2|||
162210774|NCT02287233|585823062|FG002|Overall Study|Adverse Event Related to Progression|8|||
162021350|NCT02551991|585134757|FG002|Overall Study|Death|8|||
161934794|NCT04003142|584810091|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
162210775|NCT02287233|585823060|FG000|Overall Study|Physician Decision|1|||
162210776|NCT02287233|585823061|FG001|Overall Study|Physician Decision|2|||
162210777|NCT02287233|585823062|FG002|Overall Study|Physician Decision|4|||
162210778|NCT02287233|585823060|FG000|Overall Study|Progressive Disease with Death|0|||
162210779|NCT02287233|585823061|FG001|Overall Study|Progressive Disease with Death|0|||
162210780|NCT02287233|585823062|FG002|Overall Study|Progressive Disease with Death|10|||
162210781|NCT02287233|585823060|FG000|Overall Study|Progressive Disease Without Death|2|||
162210782|NCT02287233|585823061|FG001|Overall Study|Progressive Disease Without Death|3|||
162210783|NCT02287233|585823062|FG002|Overall Study|Progressive Disease Without Death|20|||
162210784|NCT02287233|585823060|FG000|Overall Study|Withdrawal by Subject|1|||
162210785|NCT02287233|585823061|FG001|Overall Study|Withdrawal by Subject|1|||
162210786|NCT02287233|585823062|FG002|Overall Study|Withdrawal by Subject|7|||
162210787|NCT02287233|585823060|FG000|Overall Study|Other|3|||
162210788|NCT02287233|585823061|FG001|Overall Study|Other|0|||
162210789|NCT02287233|585823062|FG002|Overall Study|Other|15|||
162210790|NCT02287233|585823060|FG000|Overall Study|Did Not Receive Treatment|0|||
162210791|NCT02287233|585823061|FG001|Overall Study|Did Not Receive Treatment|0|||
162210792|NCT02287233|585823062|FG002|Overall Study|Did Not Receive Treatment|2|||
162210793|NCT02706847|585823063|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
162210794|NCT02706847|585823064|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
162210795|NCT02706847|585823065|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
162210796|NCT02706847|585823066|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
162210797|NCT02706847|585823063|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
162210798|NCT02706847|585823064|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
162210799|NCT02706847|585823065|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
162210800|NCT02706847|585823066|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
162210801|NCT02706847|585823063|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
162210802|NCT02706847|585823064|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
162210803|NCT02706847|585823065|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
162210804|NCT02706847|585823066|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
162210805|NCT02706847|585823063|FG000|Period 1: Day 1 to Week 12|Other|4|||
162210806|NCT02706847|585823064|FG001|Period 1: Day 1 to Week 12|Other|4|||
162210807|NCT02706847|585823065|FG002|Period 1: Day 1 to Week 12|Other|2|||
162210808|NCT02706847|585823066|FG003|Period 1: Day 1 to Week 12|Other|2|||
162210809|NCT02706847|585823063|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
162210810|NCT02706847|585823064|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
162210811|NCT02706847|585823065|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
162210812|NCT02706847|585823066|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
162210813|NCT02706847|585823063|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
162210814|NCT02706847|585823064|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
162210815|NCT02706847|585823065|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
161826140|NCT04254809|584403787|FG001|Overall Study|Lost to Follow-up|10|||
161826141|NCT02972515|584403788|FG000|Overall Study|Lost to Follow-up|78|||
161826142|NCT01928615|584403789|FG000|Overall Study|Study Terminated by Sponsor|2|||
161826143|NCT04531527|584403790|FG000|Overall Study|Found to be Ineligible|3|||
161826144|NCT01077258|584403798|FG000|Overall Study|Lost to Follow-up|1390|||
162210816|NCT02706847|585823066|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
162210817|NCT02706847|585823063|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
162210818|NCT02706847|585823064|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
162210819|NCT02706847|585823065|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
162210820|NCT02706847|585823066|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
162210821|NCT02706847|585823063|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
162210822|NCT02706847|585823064|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
162210823|NCT02706847|585823065|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
162210824|NCT02706847|585823066|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
162210825|NCT02706847|585823063|FG000|Period 1: Week 12 to Week 24|Other|1|||
162210826|NCT02706847|585823064|FG001|Period 1: Week 12 to Week 24|Other|0|||
162210827|NCT02706847|585823065|FG002|Period 1: Week 12 to Week 24|Other|1|||
162210828|NCT02706847|585823066|FG003|Period 1: Week 12 to Week 24|Other|4|||
162210829|NCT02706847|585823063|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
162210830|NCT02706847|585823064|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
162210831|NCT02706847|585823065|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
162210832|NCT02706847|585823066|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
162210833|NCT02706847|585823063|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
162210834|NCT02706847|585823064|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
161826145|NCT01077258|584403798|FG000|Overall Study|Adverse drug reaction|218|||
161826146|NCT01077258|584403798|FG000|Overall Study|Lack of Efficacy|663|||
161826147|NCT01077258|584403798|FG000|Overall Study|Clinical remission|37|||
161826148|NCT01077258|584403798|FG000|Overall Study|Other reasons|260|||
161826149|NCT00726895|584403799|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161826150|NCT00726895|584403800|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161826151|NCT01881737|584403802|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
161826152|NCT01881737|584403802|FG000|Overall Study|Withdrawal by Subject|1|||
161826153|NCT01881737|584403802|FG000|Overall Study|Worsening of baseline behavior|1|||
161826154|NCT03496298|584403805|FG000|Overall Study|Adverse Event|49|||
162210835|NCT02706847|585823065|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
162210836|NCT02706847|585823066|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
162210837|NCT02706847|585823063|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
162210838|NCT02706847|585823064|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
162210839|NCT02706847|585823065|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
162210840|NCT02706847|585823066|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
162210841|NCT02706847|585823063|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
162210842|NCT02706847|585823064|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
162210843|NCT02706847|585823065|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
162210844|NCT02706847|585823066|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
162210845|NCT02706847|585823063|FG000|Period 2: Week 24 to Week 260|Other|8|||
162210846|NCT02706847|585823064|FG001|Period 2: Week 24 to Week 260|Other|5|||
162210847|NCT02706847|585823065|FG002|Period 2: Week 24 to Week 260|Other|15|||
162210848|NCT02706847|585823066|FG003|Period 2: Week 24 to Week 260|Other|15|||
162210849|NCT01174264|585823067|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
162210850|NCT01174264|585823068|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
162210851|NCT01174264|585823069|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
162210852|NCT01174264|585823067|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
162210853|NCT01174264|585823068|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
162210854|NCT01174264|585823069|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
162210855|NCT01174264|585823067|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
162210856|NCT01174264|585823068|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
162210857|NCT01174264|585823069|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
162210858|NCT03432390|585823070|FG000|Apnea Period|Protocol Violation|2|||
162210859|NCT03432390|585823071|FG001|Apnea Period|Protocol Violation|2|||
162210860|NCT01774305|585823074|FG000|Overall Study|Physician Decision|1|||
162210861|NCT01774305|585823075|FG001|Overall Study|Physician Decision|0|||
162210862|NCT01185171|585823084|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
162210863|NCT01185171|585823084|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
162210864|NCT01185171|585823084|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
162210865|NCT01185171|585823084|FG000|Maintenance|Elevated liver transaminases|3|||
162210866|NCT01185171|585823084|FG000|Maintenance|Rush|2|||
162210867|NCT01185171|585823084|FG000|Maintenance|Diarrhea|1|||
162210868|NCT01185171|585823084|FG000|Maintenance|Xerostomia|1|||
162210869|NCT01185171|585823084|FG000|Maintenance|Nausea|1|||
162210870|NCT01185171|585823084|FG000|Maintenance|Comorbid Illness|2|||
162210871|NCT01185171|585823084|FG000|Maintenance|Withdrawal by Subject|1|||
162210872|NCT01185171|585823084|FG000|Maintenance|Disease Recurrence|1|||
162210873|NCT01482429|585823085|FG000|Care Usual|Protocol Violation|0|||
162210874|NCT01482429|585823086|FG001|Care Usual|Protocol Violation|172|||
162210875|NCT01482429|585823085|FG000|Care Usual|Lost to Follow-up|0|||
162210876|NCT01482429|585823086|FG001|Care Usual|Lost to Follow-up|1|||
162210877|NCT01482429|585823085|FG000|Protocol|Protocol Violation|275|||
162210878|NCT01482429|585823086|FG001|Protocol|Protocol Violation|0|||
162210879|NCT03561597|585823087|FG000|Overall Study|Lost to Follow-up|20|||
162210880|NCT00573651|585823088|FG000|Overall Study|Lost to Follow-up|3|||
162210881|NCT00573651|585823088|FG000|Overall Study|Withdrawal by Subject|1|||
162210882|NCT01225159|585823089|FG000|Overall Study|Change operation|1|||
162210883|NCT01225159|585823090|FG001|Overall Study|Change operation|0|||
162210884|NCT01220856|585823095|FG000|Overall Study|graft loss|3|||
162210885|NCT01220856|585823096|FG001|Overall Study|graft loss|3|||
162210886|NCT01220856|585823095|FG000|Overall Study|Lost to Follow-up|1|||
162210887|NCT01220856|585823096|FG001|Overall Study|Lost to Follow-up|0|||
162210888|NCT04814992|585823097|FG000|Overall Study|Withdrawal by Subject|6|||
162210889|NCT04814992|585823098|FG001|Overall Study|Withdrawal by Subject|3|||
162210890|NCT04814992|585823097|FG000|Overall Study|Lost to Follow-up|1|||
162210891|NCT04814992|585823098|FG001|Overall Study|Lost to Follow-up|4|||
162210892|NCT00691678|585823099|FG000|Overall Study|Adverse Event|5|||
162210893|NCT00691678|585823099|FG000|Overall Study|life events, pain|11|||
162210894|NCT05347485|585823103|FG000|Overall Study|Death|14|||
162210895|NCT05347485|585823103|FG000|Overall Study|Lost to Follow-up|2|||
162210896|NCT05347485|585823103|FG000|Overall Study|Withdrawal by Subject|13|||
162210897|NCT05347485|585823103|FG000|Overall Study|Progressive Disease|1|||
162210898|NCT05347485|585823103|FG000|Overall Study|Study Terminated by Sponsor|49|||
162210899|NCT05347485|585823103|FG000|Overall Study|Other|1|||
162210900|NCT05347485|585823103|FG000|Overall Study|Enrolled (consented) but not treated|4|||
162210901|NCT05347485|585823103|FG000|Overall Study|Disease Relapse|2|||
162210902|NCT05896696|585823104|FG000|Overall Study|Screening Failure|7|||
162210903|NCT05896696|585823104|FG000|Overall Study|Withdrawal by Subject|2|||
162210904|NCT00487825|585825153|FG000|Overall Study|Adverse Event|2|||
162210905|NCT00487825|585825154|FG001|Overall Study|Adverse Event|2|||
162210906|NCT00487825|585825153|FG000|Overall Study|Lack of Efficacy|1|||
162210907|NCT00487825|585825154|FG001|Overall Study|Lack of Efficacy|1|||
162210908|NCT00487825|585825153|FG000|Overall Study|Other|3|||
162210909|NCT00487825|585825154|FG001|Overall Study|Other|2|||
162210910|NCT01639742|585825155|FG000|Overall Study|Study Ongoing|17|||
162210911|NCT01639742|585825155|FG000|Overall Study|Lost to Follow-up|1|||
161934795|NCT04003142|584810087|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
161934796|NCT04003142|584810088|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
161934797|NCT04003142|584810089|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
161934798|NCT04003142|584810090|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
161934799|NCT04003142|584810091|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
161934800|NCT04806373|584810092|FG000|Overall Study|Withdrawal by Subject|1|||
161934801|NCT04806373|584810093|FG001|Overall Study|Withdrawal by Subject|1|||
161934802|NCT03382873|584810094|FG000|Overall Study|Lost to Follow-up|9|||
161934803|NCT03382873|584810095|FG001|Overall Study|Lost to Follow-up|10|||
161934804|NCT03382873|584810094|FG000|Overall Study|Withdrawal by Subject|6|||
162210912|NCT01256671|585825156|FG000|Overall Study|Adverse Event|29|||
162210913|NCT01256671|585825156|FG000|Overall Study|Lost to Follow-up|16|||
162210914|NCT01256671|585825156|FG000|Overall Study|Withdrawal by Subject|31|||
162210915|NCT01256671|585825156|FG000|Overall Study|Physician Decision|3|||
162210916|NCT01256671|585825156|FG000|Overall Study|Lack of Efficacy|4|||
162210917|NCT01256671|585825156|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
162210918|NCT01986114|585825157|FG000|Overall Study|Adverse Event|59|||
162210919|NCT01986114|585825157|FG000|Overall Study|Lack of Efficacy|23|||
162210920|NCT01986114|585825157|FG000|Overall Study|Withdrawal by Subject|58|||
162210921|NCT01986114|585825157|FG000|Overall Study|Noncompliance|3|||
162210922|NCT01986114|585825157|FG000|Overall Study|Protocol Violation|1|||
162210923|NCT01986114|585825157|FG000|Overall Study|Lost to Follow-up|5|||
162210924|NCT01986114|585825157|FG000|Overall Study|Other reason|7|||
162210925|NCT01190644|585825158|FG000|Overall Study|Death|2|||
162210926|NCT01190644|585825158|FG000|Overall Study|Disease progression|1|||
162210927|NCT02366143|585825159|FG000|Overall Study|Death|307|||
162210928|NCT02366143|585825160|FG001|Overall Study|Death|278|||
162210929|NCT02366143|585825161|FG002|Overall Study|Death|280|||
162210930|NCT02366143|585825159|FG000|Overall Study|Lost to Follow-up|2|||
162210931|NCT02366143|585825160|FG001|Overall Study|Lost to Follow-up|4|||
162210932|NCT02366143|585825161|FG002|Overall Study|Lost to Follow-up|2|||
162210933|NCT02366143|585825159|FG000|Overall Study|Physician Decision|1|||
162210934|NCT02366143|585825160|FG001|Overall Study|Physician Decision|2|||
162210935|NCT02366143|585825161|FG002|Overall Study|Physician Decision|1|||
162210936|NCT02366143|585825159|FG000|Overall Study|Protocol Violation|0|||
162210937|NCT02366143|585825160|FG001|Overall Study|Protocol Violation|0|||
162210938|NCT02366143|585825161|FG002|Overall Study|Protocol Violation|2|||
161934805|NCT03382873|584810095|FG001|Overall Study|Withdrawal by Subject|11|||
161934806|NCT03382873|584810094|FG000|Overall Study|Visit not completed due to pandemic|16|||
161934807|NCT03382873|584810095|FG001|Overall Study|Visit not completed due to pandemic|41|||
161934808|NCT03624036|584810096|FG000|Overall Study|Death|2|||
161934809|NCT03624036|584810097|FG001|Overall Study|Death|3|||
161934810|NCT03624036|584810098|FG002|Overall Study|Death|0|||
161934811|NCT03624036|584810099|FG003|Overall Study|Death|1|||
161934812|NCT03624036|584810096|FG000|Overall Study|Withdrawal by Subject|1|||
161934813|NCT03624036|584810097|FG001|Overall Study|Withdrawal by Subject|0|||
161934814|NCT03624036|584810098|FG002|Overall Study|Withdrawal by Subject|1|||
161934815|NCT03624036|584810099|FG003|Overall Study|Withdrawal by Subject|0|||
161934816|NCT03624036|584810096|FG000|Overall Study|Enrolled but Never Treated|1|||
161934817|NCT03624036|584810097|FG001|Overall Study|Enrolled but Never Treated|0|||
161934818|NCT03624036|584810098|FG002|Overall Study|Enrolled but Never Treated|0|||
162210939|NCT02366143|585825159|FG000|Overall Study|Withdrawal by Subject|16|||
162210940|NCT02366143|585825160|FG001|Overall Study|Withdrawal by Subject|17|||
162210941|NCT02366143|585825161|FG002|Overall Study|Withdrawal by Subject|22|||
162210942|NCT02366143|585825159|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
162210943|NCT02366143|585825160|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
162210944|NCT02366143|585825161|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
161934819|NCT03624036|584810099|FG003|Overall Study|Enrolled but Never Treated|0|||
161934820|NCT03624036|584810096|FG000|Overall Study|Reason not Specified|3|||
162210945|NCT02366143|585825159|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
162210946|NCT02366143|585825160|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
162210947|NCT02366143|585825161|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
162210948|NCT02366143|585825159|FG000|Overall Study|Randomization Error|1|||
162210949|NCT02366143|585825160|FG001|Overall Study|Randomization Error|0|||
162210950|NCT02366143|585825161|FG002|Overall Study|Randomization Error|0|||
161677857|NCT01994382|583873586|FG002|Overall Study|Progressive disease|4|||
162210951|NCT02366143|585825159|FG000|Overall Study|PI Move and Site Closure|1|||
162210952|NCT02366143|585825160|FG001|Overall Study|PI Move and Site Closure|0|||
161677858|NCT01994382|583873587|FG003|Overall Study|Progressive disease|3|||
161677859|NCT01994382|583873588|FG004|Overall Study|Progressive disease|2|||
162210953|NCT02366143|585825161|FG002|Overall Study|PI Move and Site Closure|1|||
162210954|NCT02366143|585825159|FG000|Overall Study|Study Terminated By Sponsor|0|||
161934821|NCT03624036|584810097|FG001|Overall Study|Reason not Specified|0|||
161934822|NCT03624036|584810098|FG002|Overall Study|Reason not Specified|2|||
161934823|NCT03624036|584810099|FG003|Overall Study|Reason not Specified|2|||
161934824|NCT01185366|584810108|FG000|First Line Therapy|Insurance Coverage Denied|1|||
161934825|NCT01185366|584810109|FG001|First Line Therapy|Insurance Coverage Denied|1|||
162210955|NCT02366143|585825160|FG001|Overall Study|Study Terminated By Sponsor|0|||
162210956|NCT02366143|585825161|FG002|Overall Study|Study Terminated By Sponsor|2|||
162210957|NCT02366143|585825159|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
162210958|NCT02366143|585825160|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
162210959|NCT02366143|585825161|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
162210960|NCT02366143|585825159|FG000|Overall Study|Patient moved to roll-over study|1|||
162210961|NCT02366143|585825160|FG001|Overall Study|Patient moved to roll-over study|19|||
162210962|NCT02366143|585825161|FG002|Overall Study|Patient moved to roll-over study|28|||
162210963|NCT02366143|585825159|FG000|Overall Study|Patient moved to commercial stock|0|||
162210964|NCT02366143|585825160|FG001|Overall Study|Patient moved to commercial stock|0|||
162210965|NCT02366143|585825161|FG002|Overall Study|Patient moved to commercial stock|1|||
162210966|NCT02366143|585825159|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
162210967|NCT02366143|585825160|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
162210968|NCT02366143|585825161|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
162210969|NCT02366143|585825159|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
162210970|NCT02366143|585825160|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
162210971|NCT02366143|585825161|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
162210972|NCT02366143|585825159|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
162210973|NCT02366143|585825160|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
162210974|NCT02366143|585825161|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
162210975|NCT02366143|585825159|FG000|Overall Study|Requester's instructions|1|||
162210976|NCT02366143|585825160|FG001|Overall Study|Requester's instructions|1|||
162210977|NCT02366143|585825161|FG002|Overall Study|Requester's instructions|1|||
162210978|NCT02366143|585825159|FG000|Overall Study|Uneligible|0|||
162210979|NCT02366143|585825160|FG001|Overall Study|Uneligible|1|||
162210980|NCT02366143|585825161|FG002|Overall Study|Uneligible|0|||
162210981|NCT02366143|585825159|FG000|Overall Study|Post Trial Migration|0|||
162210982|NCT02366143|585825160|FG001|Overall Study|Post Trial Migration|1|||
162210983|NCT02366143|585825161|FG002|Overall Study|Post Trial Migration|0|||
162210984|NCT02366143|585825159|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
162210985|NCT02366143|585825160|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
162210986|NCT02366143|585825161|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
162210987|NCT02366143|585825159|FG000|Overall Study|Patient switched to PTAP|0|||
162210988|NCT02366143|585825160|FG001|Overall Study|Patient switched to PTAP|1|||
162210989|NCT02366143|585825161|FG002|Overall Study|Patient switched to PTAP|0|||
162210990|NCT02366143|585825159|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
162210991|NCT02366143|585825160|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
162210992|NCT02366143|585825161|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
162210993|NCT04411186|585825162|FG000|Overall Study|Withdrawn due to protocol violation|0|||
162210994|NCT04411186|585825163|FG001|Overall Study|Withdrawn due to protocol violation|1|||
162210995|NCT02172911|585825164|FG000|Overall Study|Serious Adverse Event|0|||
162210996|NCT02172911|585825165|FG001|Overall Study|Serious Adverse Event|1|||
162210997|NCT02172911|585825164|FG000|Overall Study|Progression of Disease|0|||
162210998|NCT02172911|585825165|FG001|Overall Study|Progression of Disease|1|||
162210999|NCT02172911|585825164|FG000|Overall Study|Loss of insurance coverage|1|||
162211000|NCT02172911|585825165|FG001|Overall Study|Loss of insurance coverage|0|||
162211001|NCT00575042|585825168|FG000|Overall Study|Adverse Event|2|||
162211002|NCT00575042|585825168|FG000|Overall Study|Lost to Follow-up|1|||
162211003|NCT04795336|585825171|FG000|Overall Study|Withdrawal by Subject|3|||
162211004|NCT04795336|585825172|FG001|Overall Study|Withdrawal by Subject|4|||
162211005|NCT04795336|585825173|FG002|Overall Study|Withdrawal by Subject|3|||
162211006|NCT04795336|585825174|FG003|Overall Study|Withdrawal by Subject|12|||
162211007|NCT04795336|585825171|FG000|Overall Study|Lost study logs|0|||
162211008|NCT04795336|585825172|FG001|Overall Study|Lost study logs|1|||
162211009|NCT04795336|585825173|FG002|Overall Study|Lost study logs|0|||
162211010|NCT04795336|585825174|FG003|Overall Study|Lost study logs|2|||
162211011|NCT04795336|585825171|FG000|Overall Study|Did not take study medication|2|||
162211012|NCT04795336|585825172|FG001|Overall Study|Did not take study medication|0|||
162211013|NCT04795336|585825173|FG002|Overall Study|Did not take study medication|0|||
162211014|NCT04795336|585825174|FG003|Overall Study|Did not take study medication|0|||
162211015|NCT01266018|585825175|FG000|Overall Study|Physician Decision|1|||
162211016|NCT01266018|585825176|FG001|Overall Study|Physician Decision|0|||
162211017|NCT01266018|585825175|FG000|Overall Study|Progressive disease|0|||
162211018|NCT01266018|585825176|FG001|Overall Study|Progressive disease|1|||
162211019|NCT03167151|585825177|FG000|Overall Study|Withdrawal by Subject|1|||
162211020|NCT03167151|585825178|FG001|Overall Study|Withdrawal by Subject|0|||
162211021|NCT03167151|585825179|FG002|Overall Study|Withdrawal by Subject|0|||
162211022|NCT03167151|585825177|FG000|Overall Study|No evidence of tumour at surgery|0|||
162211023|NCT03167151|585825178|FG001|Overall Study|No evidence of tumour at surgery|1|||
162211024|NCT03167151|585825179|FG002|Overall Study|No evidence of tumour at surgery|1|||
162211025|NCT01458522|585825180|FG000|Overall Study|Withdrawal by Subject|2|||
162211026|NCT01458522|585825181|FG001|Overall Study|Withdrawal by Subject|2|||
162211027|NCT01458522|585825180|FG000|Overall Study|Physician Decision|1|||
162211028|NCT01458522|585825181|FG001|Overall Study|Physician Decision|9|||
161826155|NCT03496298|584403806|FG001|Overall Study|Adverse Event|68|||
161826156|NCT03496298|584403807|FG002|Overall Study|Adverse Event|79|||
161826157|NCT03496298|584403805|FG000|Overall Study|Study terminated by Sponsor|1050|||
161826158|NCT03496298|584403806|FG001|Overall Study|Study terminated by Sponsor|1063|||
161826159|NCT03496298|584403807|FG002|Overall Study|Study terminated by Sponsor|1071|||
161826160|NCT03496298|584403805|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
162211029|NCT00516139|585825182|FG000|Overall Study|Adverse Event|27|||
162211030|NCT00516139|585825182|FG000|Overall Study|Lost to Follow-up|1|||
162211031|NCT00516139|585825182|FG000|Overall Study|Protocol Violation|1|||
162211032|NCT00516139|585825182|FG000|Overall Study|Withdrawal by Subject|8|||
162211033|NCT00516139|585825182|FG000|Overall Study|Lack of Efficacy|1|||
162211034|NCT00589303|585825183|FG000|Overall Study|Withdrawal by Subject|2|||
162211035|NCT00589303|585825184|FG001|Overall Study|Withdrawal by Subject|1|||
162211036|NCT03021551|585825186|FG000|Overall Study|Equipment Issues|2|||
162211037|NCT03021551|585825186|FG000|Overall Study|Protocol Violation|1|||
162211038|NCT00490945|585825189|FG000|Overall Study|Adverse Event|0|||
162211039|NCT00490945|585825190|FG001|Overall Study|Adverse Event|1|||
162211040|NCT00490945|585825191|FG002|Overall Study|Adverse Event|0|||
162211041|NCT00490945|585825192|FG003|Overall Study|Adverse Event|0|||
161677860|NCT01994382|583873589|FG005|Overall Study|Progressive disease|3|||
161826161|NCT03496298|584403806|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
161826162|NCT03496298|584403807|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
161826163|NCT03496298|584403805|FG000|Overall Study|Withdrawal by Subject|176|||
161826164|NCT03496298|584403806|FG001|Overall Study|Withdrawal by Subject|154|||
161826165|NCT03496298|584403807|FG002|Overall Study|Withdrawal by Subject|151|||
162211042|NCT00490945|585825193|FG004|Overall Study|Adverse Event|0|||
162211043|NCT02706951|585825195|FG000|Period 1|Adverse Event|1|||
162211044|NCT02706951|585825196|FG001|Period 1|Adverse Event|5|||
162211045|NCT02706951|585825197|FG002|Period 1|Adverse Event|3|||
162211046|NCT02706951|585825198|FG003|Period 1|Adverse Event|0|||
161934826|NCT01185366|584810108|FG000|First Line Therapy|Withdrawal by Subject|1|||
161934827|NCT01185366|584810109|FG001|First Line Therapy|Withdrawal by Subject|0|||
161934828|NCT01185366|584810108|FG000|First Line Therapy|Lack of Metastatic Site|1|||
161934829|NCT01185366|584810109|FG001|First Line Therapy|Lack of Metastatic Site|0|||
161934830|NCT01185366|584810108|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
161934831|NCT01185366|584810109|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
161934832|NCT01185366|584810108|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
161934833|NCT01185366|584810109|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
162211047|NCT02706951|585825199|FG004|Period 1|Adverse Event|0|||
162211048|NCT02706951|585825195|FG000|Period 1|Withdrawal by Subject|10|||
162211049|NCT02706951|585825196|FG001|Period 1|Withdrawal by Subject|6|||
162211050|NCT02706951|585825197|FG002|Period 1|Withdrawal by Subject|6|||
162211051|NCT02706951|585825198|FG003|Period 1|Withdrawal by Subject|0|||
162211052|NCT02706951|585825199|FG004|Period 1|Withdrawal by Subject|0|||
162211053|NCT02706951|585825195|FG000|Period 1|Lost to Follow-up|0|||
162211054|NCT02706951|585825196|FG001|Period 1|Lost to Follow-up|4|||
162211055|NCT02706951|585825197|FG002|Period 1|Lost to Follow-up|1|||
162211056|NCT02706951|585825198|FG003|Period 1|Lost to Follow-up|0|||
162211057|NCT02706951|585825199|FG004|Period 1|Lost to Follow-up|0|||
162211058|NCT02706951|585825195|FG000|Period 1|Other|2|||
162211059|NCT02706951|585825196|FG001|Period 1|Other|1|||
162211060|NCT02706951|585825197|FG002|Period 1|Other|0|||
162211061|NCT02706951|585825198|FG003|Period 1|Other|0|||
162211062|NCT02706951|585825199|FG004|Period 1|Other|0|||
162211063|NCT02706951|585825195|FG000|Period 2|Adverse Event|0|||
162211064|NCT02706951|585825196|FG001|Period 2|Adverse Event|0|||
162211065|NCT02706951|585825197|FG002|Period 2|Adverse Event|0|||
162211066|NCT02706951|585825198|FG003|Period 2|Adverse Event|25|||
162211067|NCT02706951|585825199|FG004|Period 2|Adverse Event|34|||
162211068|NCT02706951|585825195|FG000|Period 2|Withdrawal by Subject|0|||
162211069|NCT02706951|585825196|FG001|Period 2|Withdrawal by Subject|0|||
162211070|NCT02706951|585825197|FG002|Period 2|Withdrawal by Subject|0|||
162211071|NCT02706951|585825198|FG003|Period 2|Withdrawal by Subject|38|||
162211072|NCT02706951|585825199|FG004|Period 2|Withdrawal by Subject|44|||
162211073|NCT02706951|585825195|FG000|Period 2|Lost to Follow-up|0|||
162211074|NCT02706951|585825196|FG001|Period 2|Lost to Follow-up|0|||
162211075|NCT02706951|585825197|FG002|Period 2|Lost to Follow-up|0|||
162211076|NCT02706951|585825198|FG003|Period 2|Lost to Follow-up|17|||
161934834|NCT01185366|584810108|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
161934835|NCT01185366|584810109|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
161934836|NCT01185366|584810108|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
161934837|NCT01185366|584810109|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
161934838|NCT02539394|584810114|FG000|Overall Study|Protocol Violation|1|||
162211077|NCT02706951|585825199|FG004|Period 2|Lost to Follow-up|9|||
162211078|NCT02706951|585825195|FG000|Period 2|COVID-19 Related|0|||
162211079|NCT02706951|585825196|FG001|Period 2|COVID-19 Related|0|||
162211080|NCT02706951|585825197|FG002|Period 2|COVID-19 Related|0|||
162211081|NCT02706951|585825198|FG003|Period 2|COVID-19 Related|1|||
162211082|NCT02706951|585825199|FG004|Period 2|COVID-19 Related|2|||
162211083|NCT02706951|585825195|FG000|Period 2|Other|0|||
162211084|NCT02706951|585825196|FG001|Period 2|Other|0|||
162211085|NCT02706951|585825197|FG002|Period 2|Other|0|||
162211086|NCT02706951|585825198|FG003|Period 2|Other|37|||
162211087|NCT02706951|585825199|FG004|Period 2|Other|31|||
162211088|NCT03491215|585825200|FG000|Overall Study|Death|6|||
162211089|NCT03491215|585825201|FG001|Overall Study|Death|2|||
162211090|NCT03491215|585825202|FG002|Overall Study|Death|1|||
162211091|NCT03491215|585825203|FG003|Overall Study|Death|0|||
162211092|NCT03491215|585825200|FG000|Overall Study|Physician Decision|1|||
162211093|NCT03491215|585825201|FG001|Overall Study|Physician Decision|0|||
162211094|NCT03491215|585825202|FG002|Overall Study|Physician Decision|0|||
162211095|NCT03491215|585825203|FG003|Overall Study|Physician Decision|0|||
162211096|NCT03297398|585825208|FG000|Overall Study|Sponsor's decision|6|||
162211097|NCT03297398|585825209|FG001|Overall Study|Sponsor's decision|9|||
162211098|NCT03297398|585825210|FG002|Overall Study|Sponsor's decision|7|||
162211099|NCT03297398|585825208|FG000|Overall Study|Adverse Event|1|||
162211100|NCT03297398|585825209|FG001|Overall Study|Adverse Event|4|||
162211101|NCT03297398|585825210|FG002|Overall Study|Adverse Event|4|||
162211102|NCT03297398|585825208|FG000|Overall Study|Withdrawal by Subject|1|||
162211103|NCT03297398|585825209|FG001|Overall Study|Withdrawal by Subject|2|||
162211104|NCT03297398|585825210|FG002|Overall Study|Withdrawal by Subject|2|||
162211105|NCT03297398|585825208|FG000|Overall Study|Protocol Violation|0|||
162211106|NCT03297398|585825209|FG001|Overall Study|Protocol Violation|2|||
162211107|NCT03297398|585825210|FG002|Overall Study|Protocol Violation|0|||
162211108|NCT03297398|585825208|FG000|Overall Study|Physician Decision|0|||
162211109|NCT03297398|585825209|FG001|Overall Study|Physician Decision|0|||
162211110|NCT03297398|585825210|FG002|Overall Study|Physician Decision|1|||
162211111|NCT03297398|585825208|FG000|Overall Study|Lost to Follow-up|0|||
162211112|NCT03297398|585825209|FG001|Overall Study|Lost to Follow-up|0|||
162211113|NCT03297398|585825210|FG002|Overall Study|Lost to Follow-up|1|||
162211114|NCT00611715|585825213|FG000|Overall Study|Disease Progression|24|||
162211115|NCT00611715|585825214|FG001|Overall Study|Disease Progression|4|||
161934839|NCT02539394|584810115|FG001|Overall Study|Protocol Violation|3|||
161934840|NCT02539394|584810114|FG000|Overall Study|Lost to Follow-up|1|||
161934841|NCT02539394|584810115|FG001|Overall Study|Lost to Follow-up|2|||
161934842|NCT02539394|584810114|FG000|Overall Study|Incomplete dataset|6|||
161934843|NCT02539394|584810115|FG001|Overall Study|Incomplete dataset|6|||
161934844|NCT03425188|584810117|FG000|Overall Study|Withdrawal by Subject|1|||
161934845|NCT00834587|584810118|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161934846|NCT00834587|584810119|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
161934847|NCT02536339|584810121|FG000|Overall Study|Death|20|||
161934848|NCT02536339|584810121|FG000|Overall Study|Withdrawal by Subject|3|||
161934849|NCT02536339|584810121|FG000|Overall Study|Lost to Follow-up|2|||
161934850|NCT02536339|584810121|FG000|Overall Study|Treatment discontinued|2|||
161934851|NCT02536339|584810121|FG000|Overall Study|Physician Decision|1|||
161934852|NCT01905683|584810124|FG000|Overall Study|Protocol Violation|1|||
161934853|NCT01905683|584810124|FG000|Overall Study|Re-injection criteria not met; others|13|||
161934854|NCT01905683|584810124|FG000|Overall Study|Physician Decision|1|||
161934855|NCT01905683|584810124|FG000|Overall Study|Lack of Efficacy|8|||
161934856|NCT01905683|584810124|FG000|Overall Study|Withdrawal by Subject|20|||
161934857|NCT01905683|584810124|FG000|Overall Study|Adverse Event|4|||
161934858|NCT01905683|584810124|FG000|Overall Study|Lost to Follow-up|4|||
161934859|NCT02037984|584810127|FG000|Overall Study|Lack of Efficacy|0|||
161934860|NCT02037984|584810128|FG001|Overall Study|Lack of Efficacy|0|||
161934861|NCT02037984|584810129|FG002|Overall Study|Lack of Efficacy|3|||
161934862|NCT02037984|584810130|FG003|Overall Study|Lack of Efficacy|10|||
161934863|NCT02037984|584810131|FG004|Overall Study|Lack of Efficacy|2|||
161934864|NCT02037984|584810132|FG005|Overall Study|Lack of Efficacy|2|||
161934865|NCT02037984|584810133|FG006|Overall Study|Lack of Efficacy|4|||
161934866|NCT02037984|584810134|FG007|Overall Study|Lack of Efficacy|3|||
161934867|NCT02037984|584810127|FG000|Overall Study|Lost to Follow-up|1|||
161934868|NCT02037984|584810128|FG001|Overall Study|Lost to Follow-up|0|||
161934869|NCT02037984|584810129|FG002|Overall Study|Lost to Follow-up|3|||
161934870|NCT02037984|584810130|FG003|Overall Study|Lost to Follow-up|5|||
161934871|NCT02037984|584810131|FG004|Overall Study|Lost to Follow-up|2|||
161934872|NCT02037984|584810132|FG005|Overall Study|Lost to Follow-up|2|||
161934873|NCT02037984|584810133|FG006|Overall Study|Lost to Follow-up|2|||
161934874|NCT02037984|584810134|FG007|Overall Study|Lost to Follow-up|4|||
161934875|NCT02037984|584810127|FG000|Overall Study|Physician Decision|0|||
161934876|NCT02037984|584810128|FG001|Overall Study|Physician Decision|0|||
161934877|NCT02037984|584810129|FG002|Overall Study|Physician Decision|0|||
161934878|NCT02037984|584810130|FG003|Overall Study|Physician Decision|0|||
161934879|NCT02037984|584810131|FG004|Overall Study|Physician Decision|0|||
161934880|NCT02037984|584810132|FG005|Overall Study|Physician Decision|0|||
161934881|NCT02037984|584810133|FG006|Overall Study|Physician Decision|1|||
161934882|NCT02037984|584810134|FG007|Overall Study|Physician Decision|0|||
161934883|NCT02037984|584810127|FG000|Overall Study|Protocol Violation|0|||
161934884|NCT02037984|584810128|FG001|Overall Study|Protocol Violation|0|||
162211116|NCT00611715|585825213|FG000|Overall Study|Withdrawal by Subject|5|||
162211117|NCT00611715|585825214|FG001|Overall Study|Withdrawal by Subject|1|||
162211118|NCT00611715|585825213|FG000|Overall Study|Adverse Event|9|||
162211119|NCT00611715|585825214|FG001|Overall Study|Adverse Event|1|||
162211120|NCT00611715|585825213|FG000|Overall Study|Death|1|||
162211121|NCT00611715|585825214|FG001|Overall Study|Death|0|||
162211122|NCT00611715|585825213|FG000|Overall Study|two patients are still on treatment|2|||
162211123|NCT00611715|585825214|FG001|Overall Study|two patients are still on treatment|0|||
162211124|NCT03634839|585825216|FG000|First Intervention (2 Hours)|Adverse Event|0|||
162211125|NCT03634839|585825217|FG001|First Intervention (2 Hours)|Adverse Event|2|||
162211126|NCT00350298|585825218|FG000|Overall Study|Death|7|||
162211127|NCT00350298|585825219|FG001|Overall Study|Death|8|||
161934885|NCT02037984|584810129|FG002|Overall Study|Protocol Violation|0|||
161934886|NCT02037984|584810130|FG003|Overall Study|Protocol Violation|0|||
161934887|NCT02037984|584810131|FG004|Overall Study|Protocol Violation|0|||
161934888|NCT02037984|584810132|FG005|Overall Study|Protocol Violation|1|||
161934889|NCT02037984|584810133|FG006|Overall Study|Protocol Violation|2|||
161934890|NCT02037984|584810134|FG007|Overall Study|Protocol Violation|0|||
161934891|NCT02037984|584810127|FG000|Overall Study|Technical Problems|0|||
161934892|NCT02037984|584810128|FG001|Overall Study|Technical Problems|0|||
161934893|NCT02037984|584810129|FG002|Overall Study|Technical Problems|3|||
161934894|NCT02037984|584810130|FG003|Overall Study|Technical Problems|3|||
161934895|NCT02037984|584810131|FG004|Overall Study|Technical Problems|2|||
161934896|NCT02037984|584810132|FG005|Overall Study|Technical Problems|3|||
161934897|NCT02037984|584810133|FG006|Overall Study|Technical Problems|4|||
161934898|NCT02037984|584810134|FG007|Overall Study|Technical Problems|2|||
161934899|NCT02037984|584810127|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161934900|NCT02037984|584810128|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161934901|NCT02037984|584810129|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
161934902|NCT02037984|584810130|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
162211128|NCT00350298|585825218|FG000|Overall Study|Lost to Follow-up|1|||
162211129|NCT00350298|585825219|FG001|Overall Study|Lost to Follow-up|2|||
162211130|NCT00350298|585825218|FG000|Overall Study|Withdrawal by Subject|1|||
161934903|NCT02037984|584810131|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
161934904|NCT02037984|584810132|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
162211131|NCT00350298|585825219|FG001|Overall Study|Withdrawal by Subject|3|||
161934905|NCT02037984|584810133|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
161934906|NCT02037984|584810134|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
161934907|NCT02037984|584810127|FG000|Overall Study|Withdrawal by Subject|0|||
161934908|NCT02037984|584810128|FG001|Overall Study|Withdrawal by Subject|0|||
161934909|NCT02037984|584810129|FG002|Overall Study|Withdrawal by Subject|0|||
161934910|NCT02037984|584810130|FG003|Overall Study|Withdrawal by Subject|1|||
161934911|NCT02037984|584810131|FG004|Overall Study|Withdrawal by Subject|1|||
161934912|NCT02037984|584810132|FG005|Overall Study|Withdrawal by Subject|3|||
161934913|NCT02037984|584810133|FG006|Overall Study|Withdrawal by Subject|0|||
161934914|NCT02037984|584810134|FG007|Overall Study|Withdrawal by Subject|1|||
161934915|NCT00581100|584811381|FG000|Overall Study|Death|1|||
161934916|NCT00581100|584811382|FG001|Overall Study|Death|0|||
161934917|NCT00581100|584811381|FG000|Overall Study|Adverse Event|2|||
161934918|NCT00581100|584811382|FG001|Overall Study|Adverse Event|1|||
161934919|NCT00581100|584811381|FG000|Overall Study|Withdrawal by Subject|1|||
161934920|NCT00581100|584811382|FG001|Overall Study|Withdrawal by Subject|4|||
161934921|NCT00581100|584811381|FG000|Overall Study|Other|3|||
161934922|NCT00581100|584811382|FG001|Overall Study|Other|0|||
161934923|NCT04129398|584811383|FG000|Overall Study|Physician Decision|2|||
161934924|NCT00590317|584811384|FG000|Overall Study|Lack of Efficacy|1|||
162211132|NCT00233389|585825222|FG000|Overall Study|Adverse Event|5|||
162211133|NCT00233389|585825223|FG001|Overall Study|Adverse Event|5|||
162211134|NCT00233389|585825222|FG000|Overall Study|Lack of Efficacy|11|||
162211135|NCT00233389|585825223|FG001|Overall Study|Lack of Efficacy|8|||
162211136|NCT00233389|585825222|FG000|Overall Study|Lost to Follow-up|1|||
162211137|NCT00233389|585825223|FG001|Overall Study|Lost to Follow-up|1|||
162211138|NCT00233389|585825222|FG000|Overall Study|Physician Decision|1|||
162211139|NCT00233389|585825223|FG001|Overall Study|Physician Decision|0|||
162211140|NCT00233389|585825222|FG000|Overall Study|Protocol Violation|0|||
162211141|NCT00233389|585825223|FG001|Overall Study|Protocol Violation|1|||
162211142|NCT00233389|585825222|FG000|Overall Study|Withdrawal by Subject|0|||
162211143|NCT00233389|585825223|FG001|Overall Study|Withdrawal by Subject|1|||
162211144|NCT00719043|585825229|FG000|Overall Study|Adverse Event|5|||
162211145|NCT00719043|585825230|FG001|Overall Study|Adverse Event|1|||
162211146|NCT00719043|585825231|FG002|Overall Study|Adverse Event|2|||
162211147|NCT00719043|585825232|FG003|Overall Study|Adverse Event|2|||
162211148|NCT00719043|585825233|FG004|Overall Study|Adverse Event|1|||
162211149|NCT00719043|585825234|FG005|Overall Study|Adverse Event|4|||
162211150|NCT00719043|585825235|FG006|Overall Study|Adverse Event|4|||
162211151|NCT00719043|585825229|FG000|Overall Study|Lost to Follow-up|14|||
162211152|NCT00719043|585825230|FG001|Overall Study|Lost to Follow-up|10|||
162211153|NCT00719043|585825231|FG002|Overall Study|Lost to Follow-up|8|||
162211154|NCT00719043|585825232|FG003|Overall Study|Lost to Follow-up|9|||
162211155|NCT00719043|585825233|FG004|Overall Study|Lost to Follow-up|10|||
162211156|NCT00719043|585825234|FG005|Overall Study|Lost to Follow-up|9|||
162211157|NCT00719043|585825235|FG006|Overall Study|Lost to Follow-up|9|||
162211158|NCT00719043|585825229|FG000|Overall Study|Protocol Violation|0|||
162211159|NCT00719043|585825230|FG001|Overall Study|Protocol Violation|0|||
162211160|NCT00719043|585825231|FG002|Overall Study|Protocol Violation|0|||
162211161|NCT00719043|585825232|FG003|Overall Study|Protocol Violation|0|||
162211162|NCT00719043|585825233|FG004|Overall Study|Protocol Violation|0|||
161934925|NCT00590317|584811385|FG001|Overall Study|Lack of Efficacy|5|||
161934926|NCT00993473|584811389|FG000|Overall Study|Adverse Event|0|||
161934927|NCT00993473|584811390|FG001|Overall Study|Adverse Event|2|||
161934928|NCT00993473|584811389|FG000|Overall Study|Protocol Violation|1|||
162211163|NCT00719043|585825234|FG005|Overall Study|Protocol Violation|1|||
162211164|NCT00719043|585825235|FG006|Overall Study|Protocol Violation|0|||
162211165|NCT00719043|585825229|FG000|Overall Study|Other|1|||
161934929|NCT00993473|584811390|FG001|Overall Study|Protocol Violation|2|||
161934930|NCT00993473|584811389|FG000|Overall Study|Lost to Follow-up|1|||
162021351|NCT02551991|585134758|FG003|Overall Study|Death|7|||
162211166|NCT00719043|585825230|FG001|Overall Study|Other|0|||
162211167|NCT00719043|585825231|FG002|Overall Study|Other|1|||
162211168|NCT00719043|585825232|FG003|Overall Study|Other|2|||
162211169|NCT00719043|585825233|FG004|Overall Study|Other|0|||
162211170|NCT00719043|585825234|FG005|Overall Study|Other|2|||
162211171|NCT00719043|585825235|FG006|Overall Study|Other|1|||
162211172|NCT00719043|585825229|FG000|Overall Study|Withdrawal by Subject|12|||
162211173|NCT00719043|585825230|FG001|Overall Study|Withdrawal by Subject|14|||
162211174|NCT00719043|585825231|FG002|Overall Study|Withdrawal by Subject|9|||
162211175|NCT00719043|585825232|FG003|Overall Study|Withdrawal by Subject|10|||
162211176|NCT00719043|585825233|FG004|Overall Study|Withdrawal by Subject|16|||
162211177|NCT00719043|585825234|FG005|Overall Study|Withdrawal by Subject|18|||
162211178|NCT00719043|585825235|FG006|Overall Study|Withdrawal by Subject|14|||
162211179|NCT04593823|585825236|FG000|Overall Study|Withdrawal by Subject|1|||
162211180|NCT04593823|585825237|FG001|Overall Study|Withdrawal by Subject|1|||
162211181|NCT04593823|585825236|FG000|Overall Study|Lost to Follow-up|0|||
162211182|NCT04593823|585825237|FG001|Overall Study|Lost to Follow-up|1|||
162211183|NCT00952848|585825244|FG000|Overall Study|Withdrawal by Subject|4|||
162211184|NCT00458393|585825245|FG000|Overall Study|Withdrawal by Subject|67|||
162211185|NCT00458393|585825246|FG001|Overall Study|Withdrawal by Subject|80|||
162211186|NCT00458393|585825245|FG000|Overall Study|Physician Decision|31|||
162211187|NCT00458393|585825246|FG001|Overall Study|Physician Decision|22|||
162211188|NCT00458393|585825245|FG000|Overall Study|Relocated|77|||
162211189|NCT00458393|585825246|FG001|Overall Study|Relocated|81|||
162211190|NCT00458393|585825245|FG000|Overall Study|Lost to Follow-up|115|||
162211191|NCT00458393|585825246|FG001|Overall Study|Lost to Follow-up|92|||
162211192|NCT00458393|585825245|FG000|Overall Study|Sites marked other on the form.|19|||
162211193|NCT00458393|585825246|FG001|Overall Study|Sites marked other on the form.|20|||
162211194|NCT02725567|585825247|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
162211195|NCT02725567|585825248|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
162211196|NCT02725567|585825247|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
162211197|NCT02725567|585825248|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
162211198|NCT02725567|585825247|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
162211199|NCT02725567|585825248|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
162211200|NCT02777242|585825249|FG000|Overall Study|Other|2|||
162211201|NCT02777242|585825249|FG000|Overall Study|Lost to Follow-up|1|||
162211202|NCT02777242|585825249|FG000|Overall Study|Multiple|1|||
162211203|NCT02777242|585825249|FG000|Overall Study|Sponsor's request|1|||
162211204|NCT02777242|585825249|FG000|Overall Study|Withdrawal by Subject|1|||
162211205|NCT01253447|585825251|FG000|Overall Study|Adverse Event|2|||
162211206|NCT02299427|585825252|FG000|Overall Study|Withdrawal by Subject|1|||
162211207|NCT02299427|585825253|FG001|Overall Study|Withdrawal by Subject|0|||
162211208|NCT02299427|585825252|FG000|Overall Study|Lost to Follow-up|1|||
162211209|NCT02299427|585825253|FG001|Overall Study|Lost to Follow-up|3|||
162211210|NCT02299427|585825252|FG000|Overall Study|not adherent to dog website use|21|||
162211211|NCT02299427|585825253|FG001|Overall Study|not adherent to dog website use|0|||
162211212|NCT01182181|585825261|FG000|First Intervention|Adverse Event|1|||
162211213|NCT01182181|585825262|FG001|First Intervention|Adverse Event|0|||
162211214|NCT01182181|585825261|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
162211215|NCT01182181|585825262|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
162211216|NCT00511797|585825263|FG000|Overall Study|Adverse Event|1|||
162211217|NCT00511797|585825264|FG001|Overall Study|Adverse Event|2|||
161934931|NCT00993473|584811390|FG001|Overall Study|Lost to Follow-up|0|||
161934932|NCT00993473|584811389|FG000|Overall Study|Withdrawal by Subject|1|||
161934933|NCT00993473|584811390|FG001|Overall Study|Withdrawal by Subject|5|||
161934934|NCT00993473|584811389|FG000|Overall Study|Technical problem with CGM device|0|||
161934935|NCT00993473|584811390|FG001|Overall Study|Technical problem with CGM device|1|||
161934936|NCT00993473|584811389|FG000|Overall Study|Family event|1|||
161934937|NCT00993473|584811390|FG001|Overall Study|Family event|0|||
161934938|NCT00770679|584811399|FG000|Overall Study|Lost to Follow-up|3|||
161934939|NCT00770679|584811399|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
161934940|NCT05451329|584811405|FG000|Overall Study|Adverse Event|1|||
161934941|NCT05451329|584811406|FG001|Overall Study|Adverse Event|1|||
161934942|NCT05451329|584811407|FG002|Overall Study|Adverse Event|0|||
161934943|NCT05451329|584811405|FG000|Overall Study|Withdrawal by Subject|1|||
161934944|NCT05451329|584811406|FG001|Overall Study|Withdrawal by Subject|0|||
162211218|NCT00511797|585825265|FG002|Overall Study|Adverse Event|2|||
162211219|NCT00511797|585825266|FG003|Overall Study|Adverse Event|2|||
162211220|NCT00511797|585825263|FG000|Overall Study|Lost to Follow-up|1|||
162211221|NCT00511797|585825264|FG001|Overall Study|Lost to Follow-up|0|||
162211222|NCT00511797|585825265|FG002|Overall Study|Lost to Follow-up|0|||
162211223|NCT00511797|585825266|FG003|Overall Study|Lost to Follow-up|1|||
162211224|NCT00511797|585825263|FG000|Overall Study|Pregnancy|0|||
162211225|NCT00511797|585825264|FG001|Overall Study|Pregnancy|0|||
162211226|NCT00511797|585825265|FG002|Overall Study|Pregnancy|0|||
162211227|NCT00511797|585825266|FG003|Overall Study|Pregnancy|1|||
162211228|NCT00511797|585825263|FG000|Overall Study|Protocol Violation|0|||
162211229|NCT00511797|585825264|FG001|Overall Study|Protocol Violation|2|||
162211230|NCT00511797|585825265|FG002|Overall Study|Protocol Violation|2|||
162211231|NCT00511797|585825266|FG003|Overall Study|Protocol Violation|3|||
162211232|NCT00511797|585825263|FG000|Overall Study|Withdrawal by Subject|3|||
162211233|NCT00511797|585825264|FG001|Overall Study|Withdrawal by Subject|3|||
161934945|NCT05451329|584811407|FG002|Overall Study|Withdrawal by Subject|0|||
162211234|NCT00511797|585825265|FG002|Overall Study|Withdrawal by Subject|4|||
161934946|NCT05451329|584811405|FG000|Overall Study|Investigational Product Lot exchange|1|||
161934947|NCT05451329|584811406|FG001|Overall Study|Investigational Product Lot exchange|1|||
162211235|NCT00511797|585825266|FG003|Overall Study|Withdrawal by Subject|2|||
162211236|NCT00511797|585825263|FG000|Overall Study|Never dispensed|1|||
161934948|NCT05451329|584811407|FG002|Overall Study|Investigational Product Lot exchange|0|||
162211237|NCT00511797|585825264|FG001|Overall Study|Never dispensed|0|||
162211238|NCT00511797|585825265|FG002|Overall Study|Never dispensed|1|||
162211239|NCT00511797|585825266|FG003|Overall Study|Never dispensed|3|||
162211240|NCT00511797|585825263|FG000|Overall Study|Study drug not taken|0|||
162211241|NCT00511797|585825264|FG001|Overall Study|Study drug not taken|1|||
162211242|NCT00511797|585825265|FG002|Overall Study|Study drug not taken|0|||
162211243|NCT00511797|585825266|FG003|Overall Study|Study drug not taken|1|||
162211244|NCT00511797|585825263|FG000|Overall Study|Partially missing diary|0|||
162211245|NCT00511797|585825264|FG001|Overall Study|Partially missing diary|0|||
162211246|NCT00511797|585825265|FG002|Overall Study|Partially missing diary|1|||
162211247|NCT00511797|585825266|FG003|Overall Study|Partially missing diary|0|||
162211248|NCT00511797|585825263|FG000|Overall Study|Other (moving etc)|1|||
162211249|NCT00511797|585825264|FG001|Overall Study|Other (moving etc)|0|||
162211250|NCT00511797|585825265|FG002|Overall Study|Other (moving etc)|1|||
162211251|NCT00511797|585825266|FG003|Overall Study|Other (moving etc)|2|||
162211252|NCT02413593|585825267|FG000|Overall Study|Lost to Follow-up|3|||
162211253|NCT02413593|585825267|FG000|Overall Study|Adverse Event|1|||
162211254|NCT03845075|585825268|FG000|Part 1 - DB|Withdrawal by Subject|1|||
162211255|NCT03845075|585825269|FG001|Part 1 - DB|Withdrawal by Subject|1|||
162211256|NCT03845075|585825270|FG002|Part 1 - DB|Withdrawal by Subject|0|||
162211257|NCT03845075|585825271|FG003|Part 1 - DB|Withdrawal by Subject|0|||
162211258|NCT03845075|585825268|FG000|Part 1 - DB|Adverse Event|0|||
162211259|NCT03845075|585825269|FG001|Part 1 - DB|Adverse Event|1|||
162211260|NCT03845075|585825270|FG002|Part 1 - DB|Adverse Event|0|||
162211261|NCT03845075|585825271|FG003|Part 1 - DB|Adverse Event|0|||
162211262|NCT03845075|585825268|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
162211263|NCT03845075|585825269|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
162211264|NCT03845075|585825270|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
162211265|NCT03845075|585825271|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
162211266|NCT02564718|585825272|FG000|Overall Study|Withdrew from treatment|0|||
162211267|NCT02564718|585825273|FG001|Overall Study|Withdrew from treatment|1|||
162211268|NCT00104637|585825274|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
162211269|NCT00104637|585825275|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
162211270|NCT00409409|585825276|FG000|Overall Study|Adverse Event|7|||
162211271|NCT00409409|585825277|FG001|Overall Study|Adverse Event|2|||
162211272|NCT00409409|585825276|FG000|Overall Study|Withdrawal by Subject|1|||
161934949|NCT00069953|584811408|FG000|Overall Study|Protocol Violation|2|||
161934950|NCT00113373|584811411|FG000|Overall Study|Ineligible: wrong primary|1|||
161934951|NCT00113373|584811411|FG000|Overall Study|Ineligible: second primary|1|||
161934952|NCT00113373|584811411|FG000|Overall Study|Never Treated|1|||
162211273|NCT00409409|585825277|FG001|Overall Study|Withdrawal by Subject|1|||
162211274|NCT00409409|585825276|FG000|Overall Study|Any other reason not above-mentioned|0|||
161934953|NCT02395627|584811412|FG000|Overall Study|Withdrawal by Subject|0|||
161934954|NCT02395627|584811413|FG001|Overall Study|Withdrawal by Subject|2|||
162211275|NCT00409409|585825277|FG001|Overall Study|Any other reason not above-mentioned|1|||
162211276|NCT03599622|585825278|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
162211277|NCT03599622|585825279|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
162211278|NCT03599622|585825280|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
162211279|NCT03599622|585825281|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
162211280|NCT03599622|585825278|FG000|Pre-Treatment Period|Other reasons|1|||
162211281|NCT03599622|585825279|FG001|Pre-Treatment Period|Other reasons|1|||
162211282|NCT03599622|585825280|FG002|Pre-Treatment Period|Other reasons|1|||
162211283|NCT03599622|585825281|FG003|Pre-Treatment Period|Other reasons|0|||
162211284|NCT03599622|585825278|FG000|Treatment Period|Adverse Event|11|||
162211285|NCT03599622|585825279|FG001|Treatment Period|Adverse Event|20|||
162211286|NCT03599622|585825280|FG002|Treatment Period|Adverse Event|18|||
162211287|NCT03599622|585825281|FG003|Treatment Period|Adverse Event|2|||
162211288|NCT03599622|585825278|FG000|Treatment Period|Lack of Efficacy|18|||
162211289|NCT03599622|585825279|FG001|Treatment Period|Lack of Efficacy|12|||
162211290|NCT03599622|585825280|FG002|Treatment Period|Lack of Efficacy|13|||
162211291|NCT03599622|585825281|FG003|Treatment Period|Lack of Efficacy|2|||
161934955|NCT02395627|584811414|FG002|Overall Study|Withdrawal by Subject|0|||
161934956|NCT02395627|584811412|FG000|Overall Study|Did not receive pembrolizumab|3|||
162211292|NCT03599622|585825278|FG000|Treatment Period|Withdrawal by Subject|5|||
162211293|NCT03599622|585825279|FG001|Treatment Period|Withdrawal by Subject|11|||
162211294|NCT03599622|585825280|FG002|Treatment Period|Withdrawal by Subject|16|||
162211295|NCT03599622|585825281|FG003|Treatment Period|Withdrawal by Subject|1|||
162211296|NCT03599622|585825278|FG000|Treatment Period|Other reasons|4|||
162211297|NCT03599622|585825279|FG001|Treatment Period|Other reasons|6|||
162211298|NCT03599622|585825280|FG002|Treatment Period|Other reasons|7|||
162211299|NCT03599622|585825281|FG003|Treatment Period|Other reasons|0|||
162211300|NCT03599622|585825278|FG000|Treatment Period|Lost to Follow-up|1|||
162211301|NCT03599622|585825279|FG001|Treatment Period|Lost to Follow-up|0|||
162211302|NCT03599622|585825280|FG002|Treatment Period|Lost to Follow-up|0|||
162211303|NCT03599622|585825281|FG003|Treatment Period|Lost to Follow-up|0|||
162211304|NCT03599622|585825278|FG000|Treatment Period|Study terminated by sponsor|7|||
162211305|NCT03599622|585825279|FG001|Treatment Period|Study terminated by sponsor|20|||
162211306|NCT03599622|585825280|FG002|Treatment Period|Study terminated by sponsor|15|||
162211307|NCT03599622|585825281|FG003|Treatment Period|Study terminated by sponsor|0|||
161934957|NCT02395627|584811413|FG001|Overall Study|Did not receive pembrolizumab|1|||
161934958|NCT02395627|584811414|FG002|Overall Study|Did not receive pembrolizumab|0|||
161934959|NCT03253627|584811415|FG000|Overall Study|Lost to Follow-up|1|||
161934960|NCT03253627|584811416|FG001|Overall Study|Lost to Follow-up|2|||
161934961|NCT03253627|584811415|FG000|Overall Study|Withdrawal by Subject|0|||
161934962|NCT03253627|584811416|FG001|Overall Study|Withdrawal by Subject|2|||
161677861|NCT01994382|583873590|FG006|Overall Study|Progressive disease|3|||
161677862|NCT01994382|583873591|FG007|Overall Study|Progressive disease|6|||
161677863|NCT01994382|583873592|FG008|Overall Study|Progressive disease|2|||
161677864|NCT01994382|583873593|FG009|Overall Study|Progressive disease|2|||
161677865|NCT01994382|583873594|FG010|Overall Study|Progressive disease|13|||
161677866|NCT01994382|583873595|FG011|Overall Study|Progressive disease|8|||
161677867|NCT01994382|583873596|FG012|Overall Study|Progressive disease|7|||
161677868|NCT01994382|583873597|FG013|Overall Study|Progressive disease|3|||
161677869|NCT01994382|583873598|FG014|Overall Study|Progressive disease|6|||
161934963|NCT03253627|584811415|FG000|Overall Study|Inability to complete MRI|1|||
161934964|NCT03253627|584811416|FG001|Overall Study|Inability to complete MRI|0|||
161934965|NCT04629521|584811423|FG000|Overall Study|Death|1|||
161934966|NCT04629521|584811423|FG000|Overall Study|Lost to Follow-up|3|||
161934967|NCT04629521|584811423|FG000|Overall Study|Subject withdrew consent|3|||
161934968|NCT04629521|584811423|FG000|Overall Study|Enrolled in error|1|||
161934969|NCT03163667|584811424|FG000|Overall Study|Death|15|||
161934970|NCT03163667|584811425|FG001|Overall Study|Death|27|||
162211308|NCT03599622|585825278|FG000|Treatment Period|Site terminated by sponsor|0|||
162211309|NCT03599622|585825279|FG001|Treatment Period|Site terminated by sponsor|1|||
162211310|NCT03599622|585825280|FG002|Treatment Period|Site terminated by sponsor|0|||
162211311|NCT03599622|585825281|FG003|Treatment Period|Site terminated by sponsor|0|||
162211312|NCT02485899|585825282|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
162211313|NCT02485899|585825283|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
162211314|NCT02485899|585825282|FG000|Overall Study|Withdrawal by Subject|1|||
162211315|NCT02485899|585825283|FG001|Overall Study|Withdrawal by Subject|0|||
162211316|NCT02485899|585825282|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
162211317|NCT02485899|585825283|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
162211318|NCT01006889|585825284|FG000|Overall Study|Withdrawal by Subject|3|||
161677870|NCT01994382|583873599|FG015|Overall Study|Progressive disease|44|||
161677871|NCT01994382|583873600|FG016|Overall Study|Progressive disease|28|||
161677872|NCT01994382|583873584|FG000|Overall Study|Physician Decision|0|||
161677873|NCT01994382|583873585|FG001|Overall Study|Physician Decision|1|||
161677874|NCT01994382|583873586|FG002|Overall Study|Physician Decision|0|||
161934971|NCT03163667|584811424|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
161934972|NCT03163667|584811425|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
161934973|NCT00979407|584811426|FG000|Overall Study|Withdrawal by Subject|3|||
161934974|NCT00979407|584811427|FG001|Overall Study|Withdrawal by Subject|4|||
161934975|NCT00979407|584811426|FG000|Overall Study|Lost to Follow-up|3|||
161934976|NCT00979407|584811427|FG001|Overall Study|Lost to Follow-up|3|||
161934977|NCT00855166|584811428|FG000|Overall Study|Adverse Event|0|||
161934978|NCT00855166|584811429|FG001|Overall Study|Adverse Event|2|||
161677875|NCT01994382|583873587|FG003|Overall Study|Physician Decision|0|||
161677876|NCT01994382|583873588|FG004|Overall Study|Physician Decision|0|||
161934979|NCT00855166|584811428|FG000|Overall Study|Death|0|||
161934980|NCT00855166|584811429|FG001|Overall Study|Death|1|||
161934981|NCT00855166|584811428|FG000|Overall Study|Withdrawal by Subject|1|||
161934982|NCT00855166|584811429|FG001|Overall Study|Withdrawal by Subject|4|||
161934983|NCT00855166|584811428|FG000|Overall Study|Poor/non-compliance|2|||
161934984|NCT00855166|584811429|FG001|Overall Study|Poor/non-compliance|0|||
161934985|NCT00855166|584811428|FG000|Overall Study|Administrative reasons by sponsor|1|||
161934986|NCT00855166|584811429|FG001|Overall Study|Administrative reasons by sponsor|0|||
161934987|NCT00855166|584811428|FG000|Overall Study|Subject no longer meets study criteria|1|||
161934988|NCT00855166|584811429|FG001|Overall Study|Subject no longer meets study criteria|1|||
162211319|NCT00823836|585825285|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
161934989|NCT02940223|584811430|FG000|Overall Study|Failed Requirement|2|||
161934990|NCT02940223|584811431|FG001|Overall Study|Failed Requirement|0|||
161934991|NCT05810597|584811433|FG000|Period 1|Adverse Event|2|||
161934992|NCT05810597|584811434|FG001|Period 1|Adverse Event|0|||
162211320|NCT00823836|585825286|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
162211321|NCT00823836|585825285|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
162211322|NCT00823836|585825286|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
162211323|NCT00823836|585825285|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
161677877|NCT01994382|583873589|FG005|Overall Study|Physician Decision|0|||
161677878|NCT01994382|583873590|FG006|Overall Study|Physician Decision|0|||
161677879|NCT01994382|583873591|FG007|Overall Study|Physician Decision|0|||
161677880|NCT01994382|583873592|FG008|Overall Study|Physician Decision|0|||
161677881|NCT01994382|583873593|FG009|Overall Study|Physician Decision|0|||
161934993|NCT05810597|584811433|FG000|Period 1|Physician Decision|1|||
161934994|NCT05810597|584811434|FG001|Period 1|Physician Decision|0|||
161934995|NCT01450631|584811435|FG000|Overall Study|Lost to Follow-up|2|||
162021352|NCT02551991|585134759|FG004|Overall Study|Death|17|||
162211324|NCT00823836|585825286|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
162211325|NCT00823836|585825285|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
162211326|NCT00823836|585825286|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
162211327|NCT00823836|585825285|FG000|Long-term Phase|Adverse Event|3|||
162211328|NCT00823836|585825286|FG001|Long-term Phase|Adverse Event|2|||
162211329|NCT00823836|585825285|FG000|Long-term Phase|Physician Decision|1|||
162211330|NCT00823836|585825286|FG001|Long-term Phase|Physician Decision|2|||
162211331|NCT00823836|585825285|FG000|Long-term Phase|Withdrawal by Subject|1|||
162211332|NCT00823836|585825286|FG001|Long-term Phase|Withdrawal by Subject|1|||
162211333|NCT01130168|585825287|FG000|Period 1|Withdrawal by Subject|0|||
162211334|NCT01130168|585825288|FG001|Period 1|Withdrawal by Subject|1|||
162211335|NCT01130168|585825289|FG002|Period 1|Withdrawal by Subject|0|||
162211336|NCT01130168|585825290|FG003|Period 1|Withdrawal by Subject|1|||
162211337|NCT01130168|585825291|FG004|Period 1|Withdrawal by Subject|0|||
162211338|NCT01130168|585825292|FG005|Period 1|Withdrawal by Subject|0|||
162211339|NCT01130168|585825287|FG000|Period 1|Discontinued For Other Reason|0|||
162211340|NCT01130168|585825288|FG001|Period 1|Discontinued For Other Reason|0|||
162211341|NCT01130168|585825289|FG002|Period 1|Discontinued For Other Reason|1|||
162211342|NCT01130168|585825290|FG003|Period 1|Discontinued For Other Reason|1|||
162211343|NCT01130168|585825291|FG004|Period 1|Discontinued For Other Reason|0|||
162211344|NCT01130168|585825292|FG005|Period 1|Discontinued For Other Reason|0|||
162211345|NCT01130168|585825287|FG000|Period 1|Adverse Event|0|||
162211346|NCT01130168|585825288|FG001|Period 1|Adverse Event|0|||
162211347|NCT01130168|585825289|FG002|Period 1|Adverse Event|0|||
162211348|NCT01130168|585825290|FG003|Period 1|Adverse Event|1|||
162211349|NCT01130168|585825291|FG004|Period 1|Adverse Event|0|||
162211350|NCT01130168|585825292|FG005|Period 1|Adverse Event|0|||
162211351|NCT02635386|585825293|FG000|Overall Study|Pregnancy|2|||
162211352|NCT02635386|585825294|FG001|Overall Study|Pregnancy|0|||
162211353|NCT02635386|585825295|FG002|Overall Study|Pregnancy|0|||
162211354|NCT02635386|585825296|FG003|Overall Study|Pregnancy|0|||
162211355|NCT02635386|585825297|FG004|Overall Study|Pregnancy|2|||
162211356|NCT02635386|585825293|FG000|Overall Study|Withdrawal by Subject|1|||
162211357|NCT02635386|585825294|FG001|Overall Study|Withdrawal by Subject|1|||
162211358|NCT02635386|585825295|FG002|Overall Study|Withdrawal by Subject|0|||
162211359|NCT02635386|585825296|FG003|Overall Study|Withdrawal by Subject|1|||
162211360|NCT02635386|585825297|FG004|Overall Study|Withdrawal by Subject|0|||
162211361|NCT02635386|585825293|FG000|Overall Study|Physician Decision|0|||
162211362|NCT02635386|585825294|FG001|Overall Study|Physician Decision|1|||
162211363|NCT02635386|585825295|FG002|Overall Study|Physician Decision|0|||
162211364|NCT02635386|585825296|FG003|Overall Study|Physician Decision|0|||
162211365|NCT02635386|585825297|FG004|Overall Study|Physician Decision|0|||
161826166|NCT03496298|584403805|FG000|Overall Study|Other|29|||
162211366|NCT02635386|585825293|FG000|Overall Study|Moved Out of State|0|||
162211367|NCT02635386|585825294|FG001|Overall Study|Moved Out of State|1|||
162211368|NCT02635386|585825295|FG002|Overall Study|Moved Out of State|0|||
162211369|NCT02635386|585825296|FG003|Overall Study|Moved Out of State|0|||
162211370|NCT02635386|585825297|FG004|Overall Study|Moved Out of State|0|||
162211371|NCT02635386|585825293|FG000|Overall Study|Noncompliant|0|||
162211372|NCT02635386|585825294|FG001|Overall Study|Noncompliant|2|||
162211373|NCT02635386|585825295|FG002|Overall Study|Noncompliant|1|||
162211374|NCT02635386|585825296|FG003|Overall Study|Noncompliant|1|||
162211375|NCT02635386|585825297|FG004|Overall Study|Noncompliant|1|||
162211376|NCT02635386|585825293|FG000|Overall Study|side effects|0|||
162211377|NCT02635386|585825294|FG001|Overall Study|side effects|0|||
162211378|NCT02635386|585825295|FG002|Overall Study|side effects|1|||
162211379|NCT02635386|585825296|FG003|Overall Study|side effects|4|||
162211380|NCT02635386|585825297|FG004|Overall Study|side effects|6|||
162211381|NCT02635386|585825293|FG000|Overall Study|needed other major surgery|0|||
162211382|NCT02635386|585825294|FG001|Overall Study|needed other major surgery|1|||
162211383|NCT02635386|585825295|FG002|Overall Study|needed other major surgery|0|||
161826167|NCT03496298|584403806|FG001|Overall Study|Other|20|||
162211384|NCT02635386|585825296|FG003|Overall Study|needed other major surgery|0|||
162211385|NCT02635386|585825297|FG004|Overall Study|needed other major surgery|0|||
162211386|NCT02635386|585825293|FG000|Overall Study|Other medical problems not drug related|0|||
162211387|NCT02635386|585825294|FG001|Overall Study|Other medical problems not drug related|0|||
162211388|NCT02635386|585825295|FG002|Overall Study|Other medical problems not drug related|0|||
161826168|NCT03496298|584403807|FG002|Overall Study|Other|23|||
161826169|NCT03496298|584403805|FG000|Overall Study|Randomized and not treated|1|||
161826170|NCT03496298|584403806|FG001|Overall Study|Randomized and not treated|1|||
161826171|NCT03496298|584403807|FG002|Overall Study|Randomized and not treated|1|||
162211389|NCT02635386|585825296|FG003|Overall Study|Other medical problems not drug related|1|||
162211390|NCT02635386|585825297|FG004|Overall Study|Other medical problems not drug related|0|||
162211391|NCT01781832|585825298|FG000|Overall Study|Withdrawal by Subject|1|||
162211392|NCT00745498|585825299|FG000|Overall Study|Lost to Follow-up|1|||
162211393|NCT00745498|585825300|FG001|Overall Study|Lost to Follow-up|1|||
162211394|NCT00745498|585825301|FG002|Overall Study|Lost to Follow-up|3|||
161934996|NCT01450631|584811436|FG001|Overall Study|Lost to Follow-up|4|||
161934997|NCT01450631|584811435|FG000|Overall Study|Withdrawal by Subject|1|||
161934998|NCT01450631|584811436|FG001|Overall Study|Withdrawal by Subject|0|||
161934999|NCT04903093|584811442|FG000|Overall Study|Withdrawal by Subject|0|||
161935000|NCT04903093|584811443|FG001|Overall Study|Withdrawal by Subject|0|||
162211395|NCT00745498|585825299|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
162211396|NCT00745498|585825300|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
162211397|NCT00745498|585825301|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
162211398|NCT00745498|585825299|FG000|Overall Study|Non-PDR related VH|0|||
162211399|NCT00745498|585825300|FG001|Overall Study|Non-PDR related VH|1|||
162211400|NCT00745498|585825301|FG002|Overall Study|Non-PDR related VH|1|||
162211401|NCT00745498|585825299|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
162211402|NCT00745498|585825300|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
162211403|NCT00745498|585825301|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
162211404|NCT02804399|585825304|FG000|Period 2|Adverse Event|0|||
162211405|NCT02804399|585825305|FG001|Period 2|Adverse Event|1|||
162211406|NCT02058836|585825307|FG000|Overall Study|Withdrawal by Subject|1|||
162211407|NCT02058836|585825308|FG001|Overall Study|Withdrawal by Subject|1|||
162211408|NCT00904722|585825310|FG000|Overall Study|Physician Decision|1|||
162211409|NCT01801982|585825311|FG000|Overall Study|Lost to Follow-up|1|||
162211410|NCT00727506|585825312|FG000|Overall Study|Adverse Event|0|||
162211411|NCT00727506|585825313|FG001|Overall Study|Adverse Event|0|||
162211412|NCT00727506|585825314|FG002|Overall Study|Adverse Event|4|||
162211413|NCT00727506|585825315|FG003|Overall Study|Adverse Event|4|||
162211414|NCT00727506|585825316|FG004|Overall Study|Adverse Event|1|||
162211415|NCT00727506|585825317|FG005|Overall Study|Adverse Event|8|||
162211416|NCT00727506|585825312|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
162211417|NCT00727506|585825313|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162211418|NCT00727506|585825314|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
162211419|NCT00727506|585825315|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162211420|NCT00727506|585825316|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162211421|NCT00727506|585825317|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162211422|NCT00727506|585825312|FG000|Overall Study|Progressive disease|4|||
162211423|NCT00727506|585825313|FG001|Overall Study|Progressive disease|7|||
162211424|NCT00727506|585825314|FG002|Overall Study|Progressive disease|9|||
162211425|NCT00727506|585825315|FG003|Overall Study|Progressive disease|28|||
162211426|NCT00727506|585825316|FG004|Overall Study|Progressive disease|38|||
162211427|NCT00727506|585825317|FG005|Overall Study|Progressive disease|28|||
162211428|NCT00727506|585825312|FG000|Overall Study|Refused to continue medication|0|||
162211429|NCT00727506|585825313|FG001|Overall Study|Refused to continue medication|1|||
162211430|NCT00727506|585825314|FG002|Overall Study|Refused to continue medication|2|||
162211431|NCT00727506|585825315|FG003|Overall Study|Refused to continue medication|3|||
162211432|NCT00727506|585825316|FG004|Overall Study|Refused to continue medication|1|||
162211433|NCT00727506|585825317|FG005|Overall Study|Refused to continue medication|2|||
162211434|NCT00727506|585825312|FG000|Overall Study|Other reason not described above|0|||
162211435|NCT00727506|585825313|FG001|Overall Study|Other reason not described above|0|||
162211436|NCT00727506|585825314|FG002|Overall Study|Other reason not described above|1|||
162211437|NCT00727506|585825315|FG003|Overall Study|Other reason not described above|4|||
162211438|NCT00727506|585825316|FG004|Overall Study|Other reason not described above|1|||
162211439|NCT00727506|585825317|FG005|Overall Study|Other reason not described above|1|||
162211440|NCT02650466|585825319|FG000|Overall Study|Physician Decision|1|||
161935001|NCT04903093|584811444|FG002|Overall Study|Withdrawal by Subject|0|||
161935002|NCT04903093|584811445|FG003|Overall Study|Withdrawal by Subject|1|||
161935003|NCT04903093|584811446|FG004|Overall Study|Withdrawal by Subject|0|||
161935004|NCT04903093|584811447|FG005|Overall Study|Withdrawal by Subject|0|||
161935005|NCT01390584|584811460|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
161935006|NCT01390584|584811461|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
161935007|NCT01390584|584811462|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
162211441|NCT02650466|585825319|FG000|Overall Study|Withdrawal by Subject|5|||
162211442|NCT02650466|585825319|FG000|Overall Study|Lost to Follow-up|1|||
162211443|NCT01214421|585825323|FG000|Overall Study|Lost to Follow-up|7|||
162211444|NCT01214421|585825324|FG001|Overall Study|Lost to Follow-up|3|||
162211445|NCT01214421|585825325|FG002|Overall Study|Lost to Follow-up|7|||
161935008|NCT00025233|584811463|FG000|Overall Study|Ineligible: wrong cell type|1|||
162211446|NCT01214421|585825326|FG003|Overall Study|Lost to Follow-up|3|||
162211447|NCT01214421|585825323|FG000|Overall Study|Adverse Event|16|||
162211448|NCT01214421|585825324|FG001|Overall Study|Adverse Event|35|||
162211449|NCT01214421|585825325|FG002|Overall Study|Adverse Event|14|||
162211450|NCT01214421|585825326|FG003|Overall Study|Adverse Event|3|||
162211451|NCT01214421|585825323|FG000|Overall Study|Sponsor Discontinued Site|1|||
162211452|NCT01214421|585825324|FG001|Overall Study|Sponsor Discontinued Site|2|||
162211453|NCT01214421|585825325|FG002|Overall Study|Sponsor Discontinued Site|0|||
162211454|NCT01214421|585825326|FG003|Overall Study|Sponsor Discontinued Site|0|||
162211455|NCT01214421|585825323|FG000|Overall Study|Withdrawal Criteria Met|3|||
162211456|NCT01214421|585825324|FG001|Overall Study|Withdrawal Criteria Met|0|||
162211457|NCT01214421|585825325|FG002|Overall Study|Withdrawal Criteria Met|2|||
162211458|NCT01214421|585825326|FG003|Overall Study|Withdrawal Criteria Met|1|||
162211459|NCT01214421|585825323|FG000|Overall Study|Physician Decision|2|||
162211460|NCT01214421|585825324|FG001|Overall Study|Physician Decision|0|||
162211461|NCT01214421|585825325|FG002|Overall Study|Physician Decision|4|||
162211462|NCT01214421|585825326|FG003|Overall Study|Physician Decision|0|||
162211463|NCT01214421|585825323|FG000|Overall Study|Withdrawal by Subject|21|||
162211464|NCT01214421|585825324|FG001|Overall Study|Withdrawal by Subject|18|||
162211465|NCT01214421|585825325|FG002|Overall Study|Withdrawal by Subject|11|||
162211466|NCT01214421|585825326|FG003|Overall Study|Withdrawal by Subject|2|||
162211467|NCT03049306|585825332|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
162211468|NCT03049306|585825333|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
162211469|NCT00903760|585827187|FG000|Overall Study|Disease Progression/Death|8|||
162211470|NCT00903760|585827188|FG001|Overall Study|Disease Progression/Death|6|||
162211471|NCT00903760|585827187|FG000|Overall Study|Stem Cell Transplant|8|||
162211472|NCT00903760|585827188|FG001|Overall Study|Stem Cell Transplant|4|||
162211473|NCT00903760|585827187|FG000|Overall Study|Physician Decision|1|||
162211474|NCT00903760|585827188|FG001|Overall Study|Physician Decision|2|||
162211475|NCT00903760|585827187|FG000|Overall Study|Death|0|||
162211476|NCT00903760|585827188|FG001|Overall Study|Death|1|||
162211477|NCT00903760|585827187|FG000|Overall Study|Lost to Follow-up|1|||
162211478|NCT00903760|585827188|FG001|Overall Study|Lost to Follow-up|0|||
162211479|NCT00903760|585827187|FG000|Overall Study|Withdrawal by Subject|1|||
162211480|NCT00903760|585827188|FG001|Overall Study|Withdrawal by Subject|2|||
162211481|NCT00903760|585827187|FG000|Overall Study|Off treatment for long period|0|||
162211482|NCT00903760|585827188|FG001|Overall Study|Off treatment for long period|1|||
162211483|NCT01638390|585827190|FG000|Overall Study|screening failures|21|||
162211484|NCT01536587|585827193|FG000|Overall Study|Adverse Event|2|||
162211485|NCT02666664|585827194|FG000|Overall Study|Physician Decision|0|||
162211486|NCT02666664|585827195|FG001|Overall Study|Physician Decision|1|||
162211487|NCT02666664|585827194|FG000|Overall Study|Protocol Violation|0|||
162211488|NCT02666664|585827195|FG001|Overall Study|Protocol Violation|2|||
162211489|NCT02666664|585827194|FG000|Overall Study|Other|0|||
162211490|NCT02666664|585827195|FG001|Overall Study|Other|1|||
162211491|NCT02666664|585827194|FG000|Overall Study|Adverse Event|12|||
162211492|NCT02666664|585827195|FG001|Overall Study|Adverse Event|37|||
162211493|NCT02666664|585827194|FG000|Overall Study|Withdrawal by participant|23|||
162211494|NCT02666664|585827195|FG001|Overall Study|Withdrawal by participant|40|||
162211495|NCT02666664|585827194|FG000|Overall Study|Sponsor decision|0|||
162211496|NCT02666664|585827195|FG001|Overall Study|Sponsor decision|1|||
162211497|NCT02666664|585827194|FG000|Overall Study|Lost to Follow-up|1|||
162211498|NCT02666664|585827195|FG001|Overall Study|Lost to Follow-up|2|||
162211499|NCT03210519|585827196|FG000|Overall Study|Adverse Event|2|||
162211500|NCT03210519|585827197|FG001|Overall Study|Adverse Event|0|||
162211501|NCT03865953|585827202|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
162211502|NCT03865953|585827203|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
162211503|NCT03865953|585827202|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
161826172|NCT00676494|584403810|FG000|Overall Study|Missed Visit|8|||
162211504|NCT03865953|585827203|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
162211505|NCT03865953|585827202|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
162211506|NCT03865953|585827203|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
162211507|NCT00412880|585827214|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
162211508|NCT00412880|585827214|FG000|Overall Study|Consent withdrawn|1|||
162211509|NCT00412880|585827214|FG000|Overall Study|Adverse Event|1|||
162211510|NCT00412880|585827214|FG000|Overall Study|Progressive disease|20|||
162211511|NCT02232399|585827215|FG000|Overall Study|Adverse Event|1|||
162211512|NCT02232399|585827216|FG001|Overall Study|Adverse Event|0|||
162211513|NCT02232399|585827215|FG000|Overall Study|Withdrawal by Subject|0|||
162211514|NCT02232399|585827216|FG001|Overall Study|Withdrawal by Subject|1|||
162211515|NCT01162135|585827224|FG000|Overall Study|Withdrawal by Subject|1|||
162211516|NCT01162135|585827224|FG000|Overall Study|Severe back pain|1|||
162211517|NCT01162135|585827224|FG000|Overall Study|Ineligible|1|||
162211518|NCT01777334|585827225|FG000|Overall Study|Adverse Event|18|||
162211519|NCT01777334|585827226|FG001|Overall Study|Adverse Event|14|||
162211520|NCT01777334|585827225|FG000|Overall Study|Lack of Efficacy|15|||
162211521|NCT01777334|585827226|FG001|Overall Study|Lack of Efficacy|29|||
162211522|NCT01777334|585827225|FG000|Overall Study|Protocol Violation|3|||
162211523|NCT01777334|585827226|FG001|Overall Study|Protocol Violation|7|||
162211524|NCT01777334|585827225|FG000|Overall Study|Lost to Follow-up|3|||
162211525|NCT01777334|585827226|FG001|Overall Study|Lost to Follow-up|2|||
161826173|NCT00676494|584403810|FG000|Overall Study|Withdrawal by Subject|6|||
161826174|NCT02608476|584403811|FG000|Overall Study|Withdrawal by Subject|30|||
161826175|NCT02608476|584403812|FG001|Overall Study|Withdrawal by Subject|37|||
161826176|NCT02608476|584403811|FG000|Overall Study|Lost to Follow-up|24|||
161826177|NCT02608476|584403812|FG001|Overall Study|Lost to Follow-up|24|||
162211526|NCT01777334|585827225|FG000|Overall Study|Withdrawal by Subject|14|||
162211527|NCT01777334|585827226|FG001|Overall Study|Withdrawal by Subject|11|||
162211528|NCT01216072|585827234|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
162211529|NCT01216072|585827235|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
162211530|NCT01216072|585827234|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
162211531|NCT01216072|585827235|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
162211532|NCT01216072|585827234|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
162211533|NCT01216072|585827235|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
162211534|NCT01216072|585827234|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
162211535|NCT01216072|585827235|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
162211536|NCT01216072|585827234|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
162211537|NCT01216072|585827235|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
162211538|NCT01216072|585827234|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
162211539|NCT01216072|585827235|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
162211540|NCT01216072|585827234|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
162211541|NCT01216072|585827235|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
162211542|NCT01216072|585827234|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
162211543|NCT01216072|585827235|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
162211544|NCT01216072|585827234|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
162211545|NCT01216072|585827235|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
162211546|NCT01216072|585827234|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
162211547|NCT01216072|585827235|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
162211548|NCT04799418|585827239|FG000|Overall Study|Death|1|||
162211549|NCT04799418|585827240|FG001|Overall Study|Death|1|||
162211550|NCT04799418|585827239|FG000|Overall Study|Lack of Efficacy|14|||
162211551|NCT04799418|585827240|FG001|Overall Study|Lack of Efficacy|14|||
162211552|NCT04799418|585827239|FG000|Overall Study|Withdrawal by Subject|10|||
162211553|NCT04799418|585827240|FG001|Overall Study|Withdrawal by Subject|7|||
162211554|NCT04799418|585827239|FG000|Overall Study|Adverse Event|3|||
162211555|NCT04799418|585827240|FG001|Overall Study|Adverse Event|2|||
162211556|NCT00107978|585827243|FG000|Overall Study|Adverse Event|1|||
161935009|NCT00025233|584811463|FG000|Overall Study|Ineligible: wrong primary|1|||
162211557|NCT00107978|585827244|FG001|Overall Study|Adverse Event|5|||
162211558|NCT00107978|585827243|FG000|Overall Study|Death|3|||
162211559|NCT00107978|585827244|FG001|Overall Study|Death|3|||
162211560|NCT00107978|585827243|FG000|Overall Study|Lost to Follow-up|20|||
162211561|NCT00107978|585827244|FG001|Overall Study|Lost to Follow-up|28|||
162211562|NCT00107978|585827243|FG000|Overall Study|Withdrawal by Subject|4|||
162211563|NCT00107978|585827244|FG001|Overall Study|Withdrawal by Subject|9|||
162211564|NCT00107978|585827243|FG000|Overall Study|Protocol Violation|0|||
162211565|NCT00107978|585827244|FG001|Overall Study|Protocol Violation|1|||
162211566|NCT00107978|585827243|FG000|Overall Study|Other|5|||
162211567|NCT00107978|585827244|FG001|Overall Study|Other|4|||
162211568|NCT02669407|585827245|FG000|Overall Study|Physician Decision|3|||
162211569|NCT00822770|585827247|FG000|Overall Study|Not treated|1|||
162211570|NCT00822770|585827248|FG001|Overall Study|Not treated|0|||
162211571|NCT00822770|585827247|FG000|Overall Study|Complication/Incomplete treatment|1|||
161935010|NCT00025233|584811463|FG000|Overall Study|Ineligible: improper prior treatment|1|||
162211572|NCT00822770|585827248|FG001|Overall Study|Complication/Incomplete treatment|0|||
162211573|NCT00822770|585827247|FG000|Overall Study|Death|1|||
162211574|NCT00822770|585827248|FG001|Overall Study|Death|1|||
162211575|NCT01296555|585827249|FG000|Overall Study|Adverse Event|0|||
162211576|NCT01296555|585827250|FG001|Overall Study|Adverse Event|0|||
162211577|NCT01296555|585827251|FG002|Overall Study|Adverse Event|1|||
162211578|NCT01296555|585827252|FG003|Overall Study|Adverse Event|1|||
162211579|NCT01296555|585827253|FG004|Overall Study|Adverse Event|2|||
162211580|NCT01296555|585827254|FG005|Overall Study|Adverse Event|4|||
162211581|NCT01296555|585827255|FG006|Overall Study|Adverse Event|1|||
162211582|NCT01296555|585827256|FG007|Overall Study|Adverse Event|4|||
162211583|NCT01296555|585827257|FG008|Overall Study|Adverse Event|3|||
162211584|NCT01296555|585827258|FG009|Overall Study|Adverse Event|1|||
162211585|NCT01296555|585827259|FG010|Overall Study|Adverse Event|0|||
162211586|NCT01296555|585827260|FG011|Overall Study|Adverse Event|4|||
162211587|NCT01296555|585827261|FG012|Overall Study|Adverse Event|1|||
162211588|NCT01296555|585827262|FG013|Overall Study|Adverse Event|4|||
162211589|NCT01296555|585827263|FG014|Overall Study|Adverse Event|0|||
162211590|NCT01296555|585827264|FG015|Overall Study|Adverse Event|0|||
162211591|NCT01296555|585827265|FG016|Overall Study|Adverse Event|0|||
162211592|NCT01296555|585827266|FG017|Overall Study|Adverse Event|0|||
162211593|NCT01296555|585827267|FG018|Overall Study|Adverse Event|0|||
162211594|NCT01296555|585827268|FG019|Overall Study|Adverse Event|1|||
162211595|NCT01296555|585827269|FG020|Overall Study|Adverse Event|0|||
162211596|NCT01296555|585827270|FG021|Overall Study|Adverse Event|0|||
162211597|NCT01296555|585827271|FG022|Overall Study|Adverse Event|0|||
162211598|NCT01296555|585827272|FG023|Overall Study|Adverse Event|0|||
162211599|NCT01296555|585827273|FG024|Overall Study|Adverse Event|0|||
162211600|NCT01296555|585827274|FG025|Overall Study|Adverse Event|0|||
162211601|NCT01296555|585827275|FG026|Overall Study|Adverse Event|0|||
162211602|NCT01296555|585827276|FG027|Overall Study|Adverse Event|0|||
162211603|NCT01296555|585827277|FG028|Overall Study|Adverse Event|0|||
162211604|NCT01296555|585827249|FG000|Overall Study|Reason Not Specified|0|||
162211605|NCT01296555|585827250|FG001|Overall Study|Reason Not Specified|0|||
162211606|NCT01296555|585827251|FG002|Overall Study|Reason Not Specified|0|||
162211607|NCT01296555|585827252|FG003|Overall Study|Reason Not Specified|0|||
162211608|NCT01296555|585827253|FG004|Overall Study|Reason Not Specified|0|||
162211609|NCT01296555|585827254|FG005|Overall Study|Reason Not Specified|0|||
162211610|NCT01296555|585827255|FG006|Overall Study|Reason Not Specified|0|||
162211611|NCT01296555|585827256|FG007|Overall Study|Reason Not Specified|0|||
162211612|NCT01296555|585827257|FG008|Overall Study|Reason Not Specified|0|||
162211613|NCT01296555|585827258|FG009|Overall Study|Reason Not Specified|0|||
162211614|NCT01296555|585827259|FG010|Overall Study|Reason Not Specified|0|||
162211615|NCT01296555|585827260|FG011|Overall Study|Reason Not Specified|0|||
162211616|NCT01296555|585827261|FG012|Overall Study|Reason Not Specified|0|||
162211617|NCT01296555|585827262|FG013|Overall Study|Reason Not Specified|1|||
162211618|NCT01296555|585827263|FG014|Overall Study|Reason Not Specified|2|||
162211619|NCT01296555|585827264|FG015|Overall Study|Reason Not Specified|3|||
162211620|NCT01296555|585827265|FG016|Overall Study|Reason Not Specified|7|||
162211621|NCT01296555|585827266|FG017|Overall Study|Reason Not Specified|4|||
162211622|NCT01296555|585827267|FG018|Overall Study|Reason Not Specified|3|||
162211623|NCT01296555|585827268|FG019|Overall Study|Reason Not Specified|7|||
162211624|NCT01296555|585827269|FG020|Overall Study|Reason Not Specified|11|||
162211625|NCT01296555|585827270|FG021|Overall Study|Reason Not Specified|5|||
162211626|NCT01296555|585827271|FG022|Overall Study|Reason Not Specified|5|||
162211627|NCT01296555|585827272|FG023|Overall Study|Reason Not Specified|7|||
162211628|NCT01296555|585827273|FG024|Overall Study|Reason Not Specified|2|||
162211629|NCT01296555|585827274|FG025|Overall Study|Reason Not Specified|2|||
162211630|NCT01296555|585827275|FG026|Overall Study|Reason Not Specified|19|||
162211631|NCT01296555|585827276|FG027|Overall Study|Reason Not Specified|11|||
162211632|NCT01296555|585827277|FG028|Overall Study|Reason Not Specified|9|||
162211633|NCT01296555|585827249|FG000|Overall Study|Physician Decision|0|||
161826178|NCT02608476|584403811|FG000|Overall Study|Adverse Event|2|||
162211634|NCT01296555|585827250|FG001|Overall Study|Physician Decision|0|||
162211635|NCT01296555|585827251|FG002|Overall Study|Physician Decision|0|||
162211636|NCT01296555|585827252|FG003|Overall Study|Physician Decision|0|||
162211637|NCT01296555|585827253|FG004|Overall Study|Physician Decision|1|||
162211638|NCT01296555|585827254|FG005|Overall Study|Physician Decision|0|||
162211639|NCT01296555|585827255|FG006|Overall Study|Physician Decision|0|||
162211640|NCT01296555|585827256|FG007|Overall Study|Physician Decision|0|||
162211641|NCT01296555|585827257|FG008|Overall Study|Physician Decision|0|||
162211642|NCT01296555|585827258|FG009|Overall Study|Physician Decision|0|||
162211643|NCT01296555|585827259|FG010|Overall Study|Physician Decision|0|||
162211644|NCT01296555|585827260|FG011|Overall Study|Physician Decision|0|||
162211645|NCT01296555|585827261|FG012|Overall Study|Physician Decision|0|||
162211646|NCT01296555|585827262|FG013|Overall Study|Physician Decision|1|||
162211647|NCT01296555|585827263|FG014|Overall Study|Physician Decision|0|||
162211648|NCT01296555|585827264|FG015|Overall Study|Physician Decision|0|||
162211649|NCT01296555|585827265|FG016|Overall Study|Physician Decision|0|||
162211650|NCT01296555|585827266|FG017|Overall Study|Physician Decision|0|||
162211651|NCT01296555|585827267|FG018|Overall Study|Physician Decision|0|||
162211652|NCT01296555|585827268|FG019|Overall Study|Physician Decision|1|||
162211653|NCT01296555|585827269|FG020|Overall Study|Physician Decision|0|||
162211654|NCT01296555|585827270|FG021|Overall Study|Physician Decision|0|||
162211655|NCT01296555|585827271|FG022|Overall Study|Physician Decision|0|||
162211656|NCT01296555|585827272|FG023|Overall Study|Physician Decision|0|||
162211657|NCT01296555|585827273|FG024|Overall Study|Physician Decision|0|||
162211658|NCT01296555|585827274|FG025|Overall Study|Physician Decision|0|||
162211659|NCT01296555|585827275|FG026|Overall Study|Physician Decision|0|||
162211660|NCT01296555|585827276|FG027|Overall Study|Physician Decision|0|||
162211661|NCT01296555|585827277|FG028|Overall Study|Physician Decision|0|||
162211662|NCT01296555|585827249|FG000|Overall Study|Progressive Disease|6|||
162211663|NCT01296555|585827250|FG001|Overall Study|Progressive Disease|3|||
162211664|NCT01296555|585827251|FG002|Overall Study|Progressive Disease|3|||
162211665|NCT01296555|585827252|FG003|Overall Study|Progressive Disease|7|||
162211666|NCT01296555|585827253|FG004|Overall Study|Progressive Disease|6|||
162211667|NCT01296555|585827254|FG005|Overall Study|Progressive Disease|16|||
162211668|NCT01296555|585827255|FG006|Overall Study|Progressive Disease|16|||
162211669|NCT01296555|585827256|FG007|Overall Study|Progressive Disease|8|||
162211670|NCT01296555|585827257|FG008|Overall Study|Progressive Disease|7|||
162211671|NCT01296555|585827258|FG009|Overall Study|Progressive Disease|18|||
162211672|NCT01296555|585827259|FG010|Overall Study|Progressive Disease|7|||
162211673|NCT01296555|585827260|FG011|Overall Study|Progressive Disease|14|||
162211674|NCT01296555|585827261|FG012|Overall Study|Progressive Disease|5|||
162211675|NCT01296555|585827262|FG013|Overall Study|Progressive Disease|12|||
162211676|NCT01296555|585827263|FG014|Overall Study|Progressive Disease|1|||
162211677|NCT01296555|585827264|FG015|Overall Study|Progressive Disease|1|||
162211678|NCT01296555|585827265|FG016|Overall Study|Progressive Disease|0|||
162211679|NCT01296555|585827266|FG017|Overall Study|Progressive Disease|0|||
162211680|NCT01296555|585827267|FG018|Overall Study|Progressive Disease|0|||
161677882|NCT01994382|583873594|FG010|Overall Study|Physician Decision|3|||
161677883|NCT01994382|583873595|FG011|Overall Study|Physician Decision|1|||
161677884|NCT01994382|583873596|FG012|Overall Study|Physician Decision|1|||
161677885|NCT01994382|583873597|FG013|Overall Study|Physician Decision|0|||
161677886|NCT01994382|583873598|FG014|Overall Study|Physician Decision|1|||
161677887|NCT01994382|583873599|FG015|Overall Study|Physician Decision|4|||
161677888|NCT01994382|583873600|FG016|Overall Study|Physician Decision|2|||
161677889|NCT01994382|583873584|FG000|Overall Study|Death|0|||
161677890|NCT01994382|583873585|FG001|Overall Study|Death|0|||
161677891|NCT01994382|583873586|FG002|Overall Study|Death|0|||
161677892|NCT01994382|583873587|FG003|Overall Study|Death|0|||
161677893|NCT01994382|583873588|FG004|Overall Study|Death|1|||
161677894|NCT01994382|583873589|FG005|Overall Study|Death|0|||
161677895|NCT01994382|583873590|FG006|Overall Study|Death|0|||
161677896|NCT01994382|583873591|FG007|Overall Study|Death|0|||
161677897|NCT01994382|583873592|FG008|Overall Study|Death|1|||
161677898|NCT01994382|583873593|FG009|Overall Study|Death|1|||
161677899|NCT01994382|583873594|FG010|Overall Study|Death|0|||
161677900|NCT01994382|583873595|FG011|Overall Study|Death|0|||
161677901|NCT01994382|583873596|FG012|Overall Study|Death|0|||
161677902|NCT01994382|583873597|FG013|Overall Study|Death|0|||
161677903|NCT01994382|583873598|FG014|Overall Study|Death|0|||
161677904|NCT01994382|583873599|FG015|Overall Study|Death|1|||
161677905|NCT01994382|583873600|FG016|Overall Study|Death|0|||
161677906|NCT01994382|583873584|FG000|Overall Study|Adverse Event|0|||
161677907|NCT01994382|583873585|FG001|Overall Study|Adverse Event|1|||
161677908|NCT01994382|583873586|FG002|Overall Study|Adverse Event|2|||
161677909|NCT01994382|583873587|FG003|Overall Study|Adverse Event|0|||
161677910|NCT01994382|583873588|FG004|Overall Study|Adverse Event|0|||
161677911|NCT01994382|583873589|FG005|Overall Study|Adverse Event|0|||
161677912|NCT01994382|583873590|FG006|Overall Study|Adverse Event|0|||
161677913|NCT01994382|583873591|FG007|Overall Study|Adverse Event|0|||
161677914|NCT01994382|583873592|FG008|Overall Study|Adverse Event|0|||
161677915|NCT01994382|583873593|FG009|Overall Study|Adverse Event|0|||
161677916|NCT01994382|583873594|FG010|Overall Study|Adverse Event|15|||
161677917|NCT01994382|583873595|FG011|Overall Study|Adverse Event|2|||
161677918|NCT01994382|583873596|FG012|Overall Study|Adverse Event|7|||
161677919|NCT01994382|583873597|FG013|Overall Study|Adverse Event|3|||
161677920|NCT01994382|583873598|FG014|Overall Study|Adverse Event|17|||
161677921|NCT01994382|583873599|FG015|Overall Study|Adverse Event|6|||
161677922|NCT01994382|583873600|FG016|Overall Study|Adverse Event|3|||
161677923|NCT01994382|583873584|FG000|Overall Study|Other than specified|0|||
161677924|NCT01994382|583873585|FG001|Overall Study|Other than specified|0|||
161677925|NCT01994382|583873586|FG002|Overall Study|Other than specified|0|||
161826179|NCT02608476|584403812|FG001|Overall Study|Adverse Event|8|||
161826180|NCT02608476|584403811|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
161677926|NCT01994382|583873587|FG003|Overall Study|Other than specified|0|||
161677927|NCT01994382|583873588|FG004|Overall Study|Other than specified|0|||
161677928|NCT01994382|583873589|FG005|Overall Study|Other than specified|0|||
161677929|NCT01994382|583873590|FG006|Overall Study|Other than specified|0|||
161677930|NCT01994382|583873591|FG007|Overall Study|Other than specified|0|||
161677931|NCT01994382|583873592|FG008|Overall Study|Other than specified|0|||
161677932|NCT01994382|583873593|FG009|Overall Study|Other than specified|0|||
161677933|NCT01994382|583873594|FG010|Overall Study|Other than specified|2|||
161677934|NCT01994382|583873595|FG011|Overall Study|Other than specified|0|||
161677935|NCT01994382|583873596|FG012|Overall Study|Other than specified|2|||
161677936|NCT01994382|583873597|FG013|Overall Study|Other than specified|0|||
161826181|NCT02608476|584403812|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
161677937|NCT01994382|583873598|FG014|Overall Study|Other than specified|0|||
161677938|NCT01994382|583873599|FG015|Overall Study|Other than specified|4|||
161677939|NCT01994382|583873600|FG016|Overall Study|Other than specified|4|||
162211681|NCT01296555|585827268|FG019|Overall Study|Progressive Disease|1|||
162211682|NCT01296555|585827269|FG020|Overall Study|Progressive Disease|0|||
162211683|NCT01296555|585827270|FG021|Overall Study|Progressive Disease|0|||
162211684|NCT01296555|585827271|FG022|Overall Study|Progressive Disease|0|||
162211685|NCT01296555|585827272|FG023|Overall Study|Progressive Disease|0|||
162211686|NCT01296555|585827273|FG024|Overall Study|Progressive Disease|1|||
162211687|NCT01296555|585827274|FG025|Overall Study|Progressive Disease|0|||
162211688|NCT01296555|585827275|FG026|Overall Study|Progressive Disease|5|||
162211689|NCT01296555|585827276|FG027|Overall Study|Progressive Disease|1|||
162211690|NCT01296555|585827277|FG028|Overall Study|Progressive Disease|0|||
162211691|NCT01296555|585827249|FG000|Overall Study|Protocol Violation|0|||
162211692|NCT01296555|585827250|FG001|Overall Study|Protocol Violation|0|||
162211693|NCT01296555|585827251|FG002|Overall Study|Protocol Violation|0|||
162211694|NCT01296555|585827252|FG003|Overall Study|Protocol Violation|0|||
162211695|NCT01296555|585827253|FG004|Overall Study|Protocol Violation|0|||
162211696|NCT01296555|585827254|FG005|Overall Study|Protocol Violation|0|||
162211697|NCT01296555|585827255|FG006|Overall Study|Protocol Violation|0|||
162211698|NCT01296555|585827256|FG007|Overall Study|Protocol Violation|0|||
162211699|NCT01296555|585827257|FG008|Overall Study|Protocol Violation|0|||
162211700|NCT01296555|585827258|FG009|Overall Study|Protocol Violation|0|||
162211701|NCT01296555|585827259|FG010|Overall Study|Protocol Violation|0|||
162211702|NCT01296555|585827260|FG011|Overall Study|Protocol Violation|0|||
162211703|NCT01296555|585827261|FG012|Overall Study|Protocol Violation|0|||
162211704|NCT01296555|585827262|FG013|Overall Study|Protocol Violation|1|||
162211705|NCT01296555|585827263|FG014|Overall Study|Protocol Violation|0|||
162211706|NCT01296555|585827264|FG015|Overall Study|Protocol Violation|0|||
162211707|NCT01296555|585827265|FG016|Overall Study|Protocol Violation|0|||
162211708|NCT01296555|585827266|FG017|Overall Study|Protocol Violation|0|||
162211709|NCT01296555|585827267|FG018|Overall Study|Protocol Violation|0|||
162211710|NCT01296555|585827268|FG019|Overall Study|Protocol Violation|0|||
162211711|NCT01296555|585827269|FG020|Overall Study|Protocol Violation|0|||
162211712|NCT01296555|585827270|FG021|Overall Study|Protocol Violation|0|||
162211713|NCT01296555|585827271|FG022|Overall Study|Protocol Violation|0|||
162211714|NCT01296555|585827272|FG023|Overall Study|Protocol Violation|0|||
162211715|NCT01296555|585827273|FG024|Overall Study|Protocol Violation|0|||
162211716|NCT01296555|585827274|FG025|Overall Study|Protocol Violation|0|||
162211717|NCT01296555|585827275|FG026|Overall Study|Protocol Violation|0|||
162211718|NCT01296555|585827276|FG027|Overall Study|Protocol Violation|0|||
162211719|NCT01296555|585827277|FG028|Overall Study|Protocol Violation|0|||
162211720|NCT01296555|585827249|FG000|Overall Study|Study Terminated By Sponsor|0|||
162211721|NCT01296555|585827250|FG001|Overall Study|Study Terminated By Sponsor|0|||
162211722|NCT01296555|585827251|FG002|Overall Study|Study Terminated By Sponsor|0|||
162211723|NCT01296555|585827252|FG003|Overall Study|Study Terminated By Sponsor|0|||
162211724|NCT01296555|585827253|FG004|Overall Study|Study Terminated By Sponsor|0|||
162211725|NCT01296555|585827254|FG005|Overall Study|Study Terminated By Sponsor|0|||
162211726|NCT01296555|585827255|FG006|Overall Study|Study Terminated By Sponsor|0|||
162211727|NCT01296555|585827256|FG007|Overall Study|Study Terminated By Sponsor|0|||
162211728|NCT01296555|585827257|FG008|Overall Study|Study Terminated By Sponsor|0|||
162211729|NCT01296555|585827258|FG009|Overall Study|Study Terminated By Sponsor|0|||
162211730|NCT01296555|585827259|FG010|Overall Study|Study Terminated By Sponsor|0|||
162211731|NCT01296555|585827260|FG011|Overall Study|Study Terminated By Sponsor|0|||
162211732|NCT01296555|585827261|FG012|Overall Study|Study Terminated By Sponsor|0|||
162211733|NCT01296555|585827262|FG013|Overall Study|Study Terminated By Sponsor|0|||
162211734|NCT01296555|585827263|FG014|Overall Study|Study Terminated By Sponsor|0|||
162211735|NCT01296555|585827264|FG015|Overall Study|Study Terminated By Sponsor|0|||
161935011|NCT00025233|584811463|FG000|Overall Study|Never treated|1|||
162211736|NCT01296555|585827265|FG016|Overall Study|Study Terminated By Sponsor|0|||
162211737|NCT01296555|585827266|FG017|Overall Study|Study Terminated By Sponsor|0|||
162211738|NCT01296555|585827267|FG018|Overall Study|Study Terminated By Sponsor|0|||
162211739|NCT01296555|585827268|FG019|Overall Study|Study Terminated By Sponsor|0|||
162211740|NCT01296555|585827269|FG020|Overall Study|Study Terminated By Sponsor|0|||
162211741|NCT01296555|585827270|FG021|Overall Study|Study Terminated By Sponsor|0|||
162211742|NCT01296555|585827271|FG022|Overall Study|Study Terminated By Sponsor|0|||
162211743|NCT01296555|585827272|FG023|Overall Study|Study Terminated By Sponsor|0|||
162211744|NCT01296555|585827273|FG024|Overall Study|Study Terminated By Sponsor|0|||
161935012|NCT00401830|584811464|FG000|Overall Study|Adverse Event|10|||
161935013|NCT00401830|584811465|FG001|Overall Study|Adverse Event|18|||
161935014|NCT00401830|584811464|FG000|Overall Study|Lack of Efficacy|11|||
161935015|NCT00401830|584811465|FG001|Overall Study|Lack of Efficacy|5|||
161935016|NCT00401830|584811464|FG000|Overall Study|Withdrawal by Subject|4|||
161935017|NCT00401830|584811465|FG001|Overall Study|Withdrawal by Subject|3|||
161935018|NCT00401830|584811464|FG000|Overall Study|Protocol Violation|3|||
161935019|NCT00401830|584811465|FG001|Overall Study|Protocol Violation|3|||
161935020|NCT00401830|584811464|FG000|Overall Study|Non-compliance with drug study|1|||
161935021|NCT00401830|584811465|FG001|Overall Study|Non-compliance with drug study|0|||
161935022|NCT00401830|584811464|FG000|Overall Study|Lost to Follow-up|1|||
161935023|NCT00401830|584811465|FG001|Overall Study|Lost to Follow-up|3|||
161935024|NCT00401830|584811464|FG000|Overall Study|Other: Personal / Family problems|1|||
161935025|NCT00401830|584811465|FG001|Overall Study|Other: Personal / Family problems|0|||
161935026|NCT01720602|584811466|FG000|Overall Study|Adverse Event|3|||
161935027|NCT01720602|584811466|FG000|Overall Study|Progressive disease on therapy|2|||
161935028|NCT01539525|584811467|FG000|Overall Study|Lost to Follow-up|19|||
161935029|NCT01539525|584811468|FG001|Overall Study|Lost to Follow-up|12|||
161935030|NCT01539525|584811469|FG002|Overall Study|Lost to Follow-up|11|||
161935031|NCT01539525|584811467|FG000|Overall Study|Withdrawal by Subject|0|||
161935032|NCT01539525|584811468|FG001|Overall Study|Withdrawal by Subject|3|||
161935033|NCT01539525|584811469|FG002|Overall Study|Withdrawal by Subject|2|||
161935034|NCT01539525|584811467|FG000|Overall Study|Protocol Violation|1|||
161935035|NCT01539525|584811468|FG001|Overall Study|Protocol Violation|1|||
161935036|NCT01539525|584811469|FG002|Overall Study|Protocol Violation|4|||
161935037|NCT02184442|584811470|FG000|Overall Study|Death|61|||
161935038|NCT02184442|584811471|FG001|Overall Study|Death|65|||
161935039|NCT02184442|584811470|FG000|Overall Study|Withdrawal by Subject|3|||
161935040|NCT02184442|584811471|FG001|Overall Study|Withdrawal by Subject|11|||
161935041|NCT01044459|584811472|FG000|Overall Study|Withdrawal by Subject|21|||
161935042|NCT01044459|584811473|FG001|Overall Study|Withdrawal by Subject|28|||
161935043|NCT01044459|584811472|FG000|Overall Study|Terminated by Sponsor|22|||
161935044|NCT01044459|584811473|FG001|Overall Study|Terminated by Sponsor|21|||
162211745|NCT01296555|585827274|FG025|Overall Study|Study Terminated By Sponsor|1|||
162211746|NCT01296555|585827275|FG026|Overall Study|Study Terminated By Sponsor|0|||
162211747|NCT01296555|585827276|FG027|Overall Study|Study Terminated By Sponsor|0|||
162211748|NCT01296555|585827277|FG028|Overall Study|Study Terminated By Sponsor|0|||
162211749|NCT01296555|585827249|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211750|NCT01296555|585827250|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211751|NCT01296555|585827251|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211752|NCT01296555|585827252|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211753|NCT01296555|585827253|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211754|NCT01296555|585827254|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211755|NCT01296555|585827255|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211756|NCT01296555|585827256|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211757|NCT01296555|585827257|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211758|NCT01296555|585827258|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211759|NCT01296555|585827259|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211760|NCT01296555|585827260|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211761|NCT01296555|585827261|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211762|NCT01296555|585827262|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211763|NCT01296555|585827263|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211764|NCT01296555|585827264|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211765|NCT01296555|585827265|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211766|NCT01296555|585827266|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211767|NCT01296555|585827267|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211768|NCT01296555|585827268|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
162211769|NCT01296555|585827269|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211770|NCT01296555|585827270|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211771|NCT01296555|585827271|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211772|NCT01296555|585827272|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211773|NCT01296555|585827273|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211774|NCT01296555|585827274|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211775|NCT01296555|585827275|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161935045|NCT01044459|584811472|FG000|Overall Study|Adverse Event|22|||
161935046|NCT01044459|584811473|FG001|Overall Study|Adverse Event|20|||
161935047|NCT01044459|584811472|FG000|Overall Study|Lack of Efficacy|23|||
161935048|NCT01044459|584811473|FG001|Overall Study|Lack of Efficacy|12|||
161935049|NCT01044459|584811472|FG000|Overall Study|Protocol Violation|11|||
161935050|NCT01044459|584811473|FG001|Overall Study|Protocol Violation|16|||
162211776|NCT01296555|585827276|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211777|NCT01296555|585827277|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
162211778|NCT01296555|585827249|FG000|Overall Study|Death|0|||
162211779|NCT01296555|585827250|FG001|Overall Study|Death|0|||
162211780|NCT01296555|585827251|FG002|Overall Study|Death|0|||
162211781|NCT01296555|585827252|FG003|Overall Study|Death|2|||
162211782|NCT01296555|585827253|FG004|Overall Study|Death|1|||
162211783|NCT01296555|585827254|FG005|Overall Study|Death|0|||
162211784|NCT01296555|585827255|FG006|Overall Study|Death|2|||
162211785|NCT01296555|585827256|FG007|Overall Study|Death|0|||
162211786|NCT01296555|585827257|FG008|Overall Study|Death|0|||
162211787|NCT01296555|585827258|FG009|Overall Study|Death|1|||
162211788|NCT01296555|585827259|FG010|Overall Study|Death|0|||
162211789|NCT01296555|585827260|FG011|Overall Study|Death|1|||
162211790|NCT01296555|585827261|FG012|Overall Study|Death|0|||
162211791|NCT01296555|585827262|FG013|Overall Study|Death|2|||
162211792|NCT01296555|585827263|FG014|Overall Study|Death|27|||
162211793|NCT01296555|585827264|FG015|Overall Study|Death|15|||
162211794|NCT01296555|585827265|FG016|Overall Study|Death|11|||
162211795|NCT01296555|585827266|FG017|Overall Study|Death|11|||
162211796|NCT01296555|585827267|FG018|Overall Study|Death|17|||
162211797|NCT01296555|585827268|FG019|Overall Study|Death|12|||
162211798|NCT01296555|585827269|FG020|Overall Study|Death|13|||
162211799|NCT01296555|585827270|FG021|Overall Study|Death|12|||
162211800|NCT01296555|585827271|FG022|Overall Study|Death|12|||
162211801|NCT01296555|585827272|FG023|Overall Study|Death|13|||
162211802|NCT01296555|585827273|FG024|Overall Study|Death|7|||
162211803|NCT01296555|585827274|FG025|Overall Study|Death|7|||
162211804|NCT01296555|585827275|FG026|Overall Study|Death|35|||
162211805|NCT01296555|585827276|FG027|Overall Study|Death|92|||
162211806|NCT01296555|585827277|FG028|Overall Study|Death|44|||
162211807|NCT01296555|585827249|FG000|Overall Study|Lost to Follow-up|0|||
162211808|NCT01296555|585827250|FG001|Overall Study|Lost to Follow-up|0|||
162211809|NCT01296555|585827251|FG002|Overall Study|Lost to Follow-up|0|||
162211810|NCT01296555|585827252|FG003|Overall Study|Lost to Follow-up|0|||
162211811|NCT01296555|585827253|FG004|Overall Study|Lost to Follow-up|0|||
162211812|NCT01296555|585827254|FG005|Overall Study|Lost to Follow-up|0|||
162211813|NCT01296555|585827255|FG006|Overall Study|Lost to Follow-up|0|||
162211814|NCT01296555|585827256|FG007|Overall Study|Lost to Follow-up|0|||
162211815|NCT01296555|585827257|FG008|Overall Study|Lost to Follow-up|0|||
162211816|NCT01296555|585827258|FG009|Overall Study|Lost to Follow-up|0|||
162211817|NCT01296555|585827259|FG010|Overall Study|Lost to Follow-up|0|||
162211818|NCT01296555|585827260|FG011|Overall Study|Lost to Follow-up|0|||
162211819|NCT01296555|585827261|FG012|Overall Study|Lost to Follow-up|0|||
162211820|NCT01296555|585827262|FG013|Overall Study|Lost to Follow-up|0|||
162211821|NCT01296555|585827263|FG014|Overall Study|Lost to Follow-up|2|||
162211822|NCT01296555|585827264|FG015|Overall Study|Lost to Follow-up|1|||
162211823|NCT01296555|585827265|FG016|Overall Study|Lost to Follow-up|0|||
162211824|NCT01296555|585827266|FG017|Overall Study|Lost to Follow-up|2|||
162211825|NCT01296555|585827267|FG018|Overall Study|Lost to Follow-up|0|||
162211826|NCT01296555|585827268|FG019|Overall Study|Lost to Follow-up|2|||
162211827|NCT01296555|585827269|FG020|Overall Study|Lost to Follow-up|3|||
162211828|NCT01296555|585827270|FG021|Overall Study|Lost to Follow-up|2|||
162211829|NCT01296555|585827271|FG022|Overall Study|Lost to Follow-up|0|||
162211830|NCT01296555|585827272|FG023|Overall Study|Lost to Follow-up|0|||
162211831|NCT01296555|585827273|FG024|Overall Study|Lost to Follow-up|0|||
162211832|NCT01296555|585827274|FG025|Overall Study|Lost to Follow-up|0|||
162211833|NCT01296555|585827275|FG026|Overall Study|Lost to Follow-up|3|||
162211834|NCT01296555|585827276|FG027|Overall Study|Lost to Follow-up|13|||
162211835|NCT01296555|585827277|FG028|Overall Study|Lost to Follow-up|5|||
162211836|NCT01296555|585827249|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162211837|NCT01296555|585827250|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162211838|NCT01296555|585827251|FG002|Overall Study|Non-Compliance With Study Drug|0|||
162211839|NCT01296555|585827252|FG003|Overall Study|Non-Compliance With Study Drug|0|||
162211840|NCT01296555|585827253|FG004|Overall Study|Non-Compliance With Study Drug|0|||
162211841|NCT01296555|585827254|FG005|Overall Study|Non-Compliance With Study Drug|0|||
162211842|NCT01296555|585827255|FG006|Overall Study|Non-Compliance With Study Drug|0|||
162211843|NCT01296555|585827256|FG007|Overall Study|Non-Compliance With Study Drug|1|||
162211844|NCT01296555|585827257|FG008|Overall Study|Non-Compliance With Study Drug|0|||
161935051|NCT01044459|584811472|FG000|Overall Study|Other Reason|7|||
162211845|NCT01296555|585827258|FG009|Overall Study|Non-Compliance With Study Drug|0|||
162211846|NCT01296555|585827259|FG010|Overall Study|Non-Compliance With Study Drug|0|||
162211847|NCT01296555|585827260|FG011|Overall Study|Non-Compliance With Study Drug|0|||
162211848|NCT01296555|585827261|FG012|Overall Study|Non-Compliance With Study Drug|0|||
162211849|NCT01296555|585827262|FG013|Overall Study|Non-Compliance With Study Drug|0|||
162211850|NCT01296555|585827263|FG014|Overall Study|Non-Compliance With Study Drug|0|||
162211851|NCT01296555|585827264|FG015|Overall Study|Non-Compliance With Study Drug|0|||
162211852|NCT01296555|585827265|FG016|Overall Study|Non-Compliance With Study Drug|0|||
162211853|NCT01296555|585827266|FG017|Overall Study|Non-Compliance With Study Drug|0|||
162211854|NCT01296555|585827267|FG018|Overall Study|Non-Compliance With Study Drug|0|||
162211855|NCT01296555|585827268|FG019|Overall Study|Non-Compliance With Study Drug|0|||
162211856|NCT01296555|585827269|FG020|Overall Study|Non-Compliance With Study Drug|0|||
162211857|NCT01296555|585827270|FG021|Overall Study|Non-Compliance With Study Drug|0|||
162211858|NCT01296555|585827271|FG022|Overall Study|Non-Compliance With Study Drug|0|||
162211859|NCT01296555|585827272|FG023|Overall Study|Non-Compliance With Study Drug|0|||
162211860|NCT01296555|585827273|FG024|Overall Study|Non-Compliance With Study Drug|0|||
162211861|NCT01296555|585827274|FG025|Overall Study|Non-Compliance With Study Drug|0|||
162211862|NCT01296555|585827275|FG026|Overall Study|Non-Compliance With Study Drug|0|||
162211863|NCT01296555|585827276|FG027|Overall Study|Non-Compliance With Study Drug|0|||
162211864|NCT01296555|585827277|FG028|Overall Study|Non-Compliance With Study Drug|0|||
162211865|NCT01296555|585827249|FG000|Overall Study|Withdrawal by Subject|0|||
162211866|NCT01296555|585827250|FG001|Overall Study|Withdrawal by Subject|0|||
162211867|NCT01296555|585827251|FG002|Overall Study|Withdrawal by Subject|0|||
162211868|NCT01296555|585827252|FG003|Overall Study|Withdrawal by Subject|0|||
162211869|NCT01296555|585827253|FG004|Overall Study|Withdrawal by Subject|1|||
162211870|NCT01296555|585827254|FG005|Overall Study|Withdrawal by Subject|0|||
162211871|NCT01296555|585827255|FG006|Overall Study|Withdrawal by Subject|1|||
162211872|NCT01296555|585827256|FG007|Overall Study|Withdrawal by Subject|0|||
162211873|NCT01296555|585827257|FG008|Overall Study|Withdrawal by Subject|0|||
162211874|NCT01296555|585827258|FG009|Overall Study|Withdrawal by Subject|0|||
162211875|NCT01296555|585827259|FG010|Overall Study|Withdrawal by Subject|1|||
162211876|NCT01296555|585827260|FG011|Overall Study|Withdrawal by Subject|1|||
162211877|NCT01296555|585827261|FG012|Overall Study|Withdrawal by Subject|0|||
162211878|NCT01296555|585827262|FG013|Overall Study|Withdrawal by Subject|0|||
162211879|NCT01296555|585827263|FG014|Overall Study|Withdrawal by Subject|3|||
162211880|NCT01296555|585827264|FG015|Overall Study|Withdrawal by Subject|0|||
162211881|NCT01296555|585827265|FG016|Overall Study|Withdrawal by Subject|2|||
162211882|NCT01296555|585827266|FG017|Overall Study|Withdrawal by Subject|1|||
162211883|NCT01296555|585827267|FG018|Overall Study|Withdrawal by Subject|0|||
162211884|NCT01296555|585827268|FG019|Overall Study|Withdrawal by Subject|1|||
162211885|NCT01296555|585827269|FG020|Overall Study|Withdrawal by Subject|1|||
162211886|NCT01296555|585827270|FG021|Overall Study|Withdrawal by Subject|1|||
162211887|NCT01296555|585827271|FG022|Overall Study|Withdrawal by Subject|3|||
162211888|NCT01296555|585827272|FG023|Overall Study|Withdrawal by Subject|0|||
162211889|NCT01296555|585827273|FG024|Overall Study|Withdrawal by Subject|0|||
162211890|NCT01296555|585827274|FG025|Overall Study|Withdrawal by Subject|0|||
162211891|NCT01296555|585827275|FG026|Overall Study|Withdrawal by Subject|8|||
161677940|NCT01994382|583873584|FG000|Overall Study|Withdrawal by Subject|0|||
161677941|NCT01994382|583873585|FG001|Overall Study|Withdrawal by Subject|0|||
161677942|NCT01994382|583873586|FG002|Overall Study|Withdrawal by Subject|0|||
161677943|NCT01994382|583873587|FG003|Overall Study|Withdrawal by Subject|0|||
161677944|NCT01994382|583873588|FG004|Overall Study|Withdrawal by Subject|0|||
161677945|NCT01994382|583873589|FG005|Overall Study|Withdrawal by Subject|0|||
161677946|NCT01994382|583873590|FG006|Overall Study|Withdrawal by Subject|0|||
161677947|NCT01994382|583873591|FG007|Overall Study|Withdrawal by Subject|0|||
161677948|NCT01994382|583873592|FG008|Overall Study|Withdrawal by Subject|0|||
161826182|NCT02608476|584403811|FG000|Overall Study|Noncompliance with treatment|1|||
161826183|NCT02608476|584403812|FG001|Overall Study|Noncompliance with treatment|5|||
161826184|NCT02608476|584403811|FG000|Overall Study|Lack of Efficacy|3|||
161826185|NCT02608476|584403812|FG001|Overall Study|Lack of Efficacy|1|||
161826186|NCT02608476|584403811|FG000|Overall Study|Other|0|||
161826187|NCT02608476|584403812|FG001|Overall Study|Other|1|||
161826188|NCT02608476|584403811|FG000|Overall Study|Physician Decision|1|||
161935052|NCT01044459|584811473|FG001|Overall Study|Other Reason|14|||
161935053|NCT01044459|584811472|FG000|Overall Study|COPD exacerbation|9|||
161935054|NCT01044459|584811473|FG001|Overall Study|COPD exacerbation|8|||
161935055|NCT01044459|584811472|FG000|Overall Study|Lost to Follow-up|18|||
162211892|NCT01296555|585827276|FG027|Overall Study|Withdrawal by Subject|4|||
162211893|NCT01296555|585827277|FG028|Overall Study|Withdrawal by Subject|2|||
162211894|NCT05178979|585827279|FG000|Overall Study|Death|0|||
162211895|NCT05178979|585827280|FG001|Overall Study|Death|5|||
162211896|NCT05178979|585827281|FG002|Overall Study|Death|0|||
162211897|NCT05178979|585827282|FG003|Overall Study|Death|3|||
162211898|NCT05178979|585827279|FG000|Overall Study|Adverse Event|0|||
162211899|NCT05178979|585827280|FG001|Overall Study|Adverse Event|1|||
161826189|NCT02608476|584403812|FG001|Overall Study|Physician Decision|0|||
162211900|NCT05178979|585827281|FG002|Overall Study|Adverse Event|0|||
161935056|NCT01044459|584811473|FG001|Overall Study|Lost to Follow-up|12|||
162211901|NCT05178979|585827282|FG003|Overall Study|Adverse Event|0|||
162211902|NCT05178979|585827279|FG000|Overall Study|Lost to Follow-up|1|||
162211903|NCT05178979|585827280|FG001|Overall Study|Lost to Follow-up|8|||
161677949|NCT01994382|583873593|FG009|Overall Study|Withdrawal by Subject|0|||
161677950|NCT01994382|583873594|FG010|Overall Study|Withdrawal by Subject|6|||
161826190|NCT02608476|584403811|FG000|Overall Study|Pregnancy|0|||
162211904|NCT05178979|585827281|FG002|Overall Study|Lost to Follow-up|3|||
162211905|NCT05178979|585827282|FG003|Overall Study|Lost to Follow-up|8|||
162211906|NCT00817336|585827283|FG000|Overall Study|Withdrawal by Subject|1|||
162211907|NCT00817336|585827284|FG001|Overall Study|Withdrawal by Subject|1|||
162211908|NCT02108652|585827285|FG000|Overall Study|Death|253|||
162211909|NCT02108652|585827285|FG000|Overall Study|Lost to Follow-up|2|||
162211910|NCT02108652|585827285|FG000|Overall Study|Withdrawal by Subject|16|||
162211911|NCT02108652|585827285|FG000|Overall Study|Study Terminated By Sponsor|31|||
162211912|NCT02108652|585827285|FG000|Overall Study|Non-Compliance|1|||
162211913|NCT02108652|585827285|FG000|Overall Study|Physician Decision|6|||
162211914|NCT02108652|585827285|FG000|Overall Study|Progression Of Disease|1|||
162211915|NCT01704547|585827286|FG000|Overall Study|Physician Decision|4|||
162211916|NCT01704547|585827286|FG000|Overall Study|Withdrawal by Subject|1|||
162211917|NCT02138253|585827290|FG000|Overall Study|Adverse Event|3|||
162211918|NCT02138253|585827291|FG001|Overall Study|Adverse Event|3|||
162211919|NCT02138253|585827290|FG000|Overall Study|Lost to Follow-up|2|||
162211920|NCT02138253|585827291|FG001|Overall Study|Lost to Follow-up|1|||
162211921|NCT02138253|585827290|FG000|Overall Study|Physician Decision|2|||
162211922|NCT02138253|585827291|FG001|Overall Study|Physician Decision|0|||
162211923|NCT02138253|585827290|FG000|Overall Study|Non compliance|1|||
162211924|NCT02138253|585827291|FG001|Overall Study|Non compliance|0|||
162211925|NCT02138253|585827290|FG000|Overall Study|Withdrawal by Subject|1|||
162211926|NCT02138253|585827291|FG001|Overall Study|Withdrawal by Subject|0|||
162211927|NCT01918371|585827292|FG000|Overall Study|Missing Data|1|||
162211928|NCT01918371|585827293|FG001|Overall Study|Missing Data|1|||
162211929|NCT01390441|585827298|FG000|Treatment Period|Protocol Violation|0|||
162211930|NCT01390441|585827299|FG001|Treatment Period|Protocol Violation|1|||
162211931|NCT01390441|585827300|FG002|Treatment Period|Protocol Violation|0|||
162211932|NCT01390441|585827301|FG003|Treatment Period|Protocol Violation|0|||
162211933|NCT01390441|585827302|FG004|Treatment Period|Protocol Violation|0|||
162211934|NCT01390441|585827298|FG000|Treatment Period|Physician Decision|0|||
162211935|NCT01390441|585827299|FG001|Treatment Period|Physician Decision|0|||
162211936|NCT01390441|585827300|FG002|Treatment Period|Physician Decision|0|||
162211937|NCT01390441|585827301|FG003|Treatment Period|Physician Decision|1|||
162211938|NCT01390441|585827302|FG004|Treatment Period|Physician Decision|0|||
162211939|NCT01390441|585827298|FG000|Treatment Period|Lack of Efficacy|0|||
162211940|NCT01390441|585827299|FG001|Treatment Period|Lack of Efficacy|0|||
162211941|NCT01390441|585827300|FG002|Treatment Period|Lack of Efficacy|0|||
162211942|NCT01390441|585827301|FG003|Treatment Period|Lack of Efficacy|0|||
162211943|NCT01390441|585827302|FG004|Treatment Period|Lack of Efficacy|1|||
162211944|NCT01390441|585827298|FG000|Treatment Period|Unknown due to early stopping of study|0|||
162211945|NCT01390441|585827299|FG001|Treatment Period|Unknown due to early stopping of study|0|||
162211946|NCT01390441|585827300|FG002|Treatment Period|Unknown due to early stopping of study|8|||
162211947|NCT01390441|585827301|FG003|Treatment Period|Unknown due to early stopping of study|11|||
162211948|NCT01390441|585827302|FG004|Treatment Period|Unknown due to early stopping of study|7|||
161935057|NCT02691494|584811478|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
161935058|NCT02691494|584811479|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
161935059|NCT02691494|584811480|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
161935060|NCT02691494|584811478|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
161935061|NCT02691494|584811479|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
161935062|NCT02691494|584811480|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
161935063|NCT02691494|584811478|FG000|Post-Treatment Follow-Up Period|Other|2|||
161935064|NCT02691494|584811479|FG001|Post-Treatment Follow-Up Period|Other|1|||
161935065|NCT02691494|584811480|FG002|Post-Treatment Follow-Up Period|Other|1|||
161935066|NCT02691494|584811478|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
161935067|NCT02691494|584811479|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
161935068|NCT02691494|584811480|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
161935069|NCT02691494|584811478|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
161935070|NCT02691494|584811479|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
161935071|NCT02691494|584811480|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
161935072|NCT00787800|584811481|FG000|Overall Study|Withdrawal by Subject|3|||
161935073|NCT00787800|584811482|FG001|Overall Study|Withdrawal by Subject|5|||
161935074|NCT00787800|584811481|FG000|Overall Study|Death|0|||
161935075|NCT00787800|584811482|FG001|Overall Study|Death|2|||
161935076|NCT04634331|584811486|FG000|Overall Study|Withdrawal by Subject|2|||
161935077|NCT04634331|584811487|FG001|Overall Study|Withdrawal by Subject|2|||
161935078|NCT00461812|584811491|FG000|Overall Study|study terminated|10|||
161935079|NCT02916433|584811492|FG000|Overall Study|Withdrawal by Subject|1|||
161935080|NCT02916433|584811493|FG001|Overall Study|Withdrawal by Subject|0|||
161935081|NCT02916433|584811492|FG000|Overall Study|Physician Decision|1|||
161935082|NCT02916433|584811493|FG001|Overall Study|Physician Decision|0|||
161935083|NCT01694771|584811494|FG000|Overall Study|Adverse Event|18|||
161935084|NCT01694771|584811495|FG001|Overall Study|Adverse Event|16|||
161935085|NCT01694771|584811494|FG000|Overall Study|Lack of Efficacy|1|||
161935086|NCT01694771|584811495|FG001|Overall Study|Lack of Efficacy|0|||
161935087|NCT01694771|584811494|FG000|Overall Study|Non compliance protocol|7|||
161935088|NCT01694771|584811495|FG001|Overall Study|Non compliance protocol|6|||
161935089|NCT01694771|584811494|FG000|Overall Study|Lost to Follow-up|2|||
161935090|NCT01694771|584811495|FG001|Overall Study|Lost to Follow-up|3|||
161935091|NCT01694771|584811494|FG000|Overall Study|Consent withdrawn|7|||
161935092|NCT01694771|584811495|FG001|Overall Study|Consent withdrawn|9|||
161935093|NCT01694771|584811494|FG000|Overall Study|Other reasons|5|||
161935094|NCT01694771|584811495|FG001|Overall Study|Other reasons|6|||
161935095|NCT00890097|584811496|FG000|Overall Study|Adverse Event|21|||
161935096|NCT00890097|584811497|FG001|Overall Study|Adverse Event|32|||
161935097|NCT00890097|584811498|FG002|Overall Study|Adverse Event|28|||
161935098|NCT00890097|584811496|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
161935099|NCT00890097|584811497|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
162211949|NCT01390441|585827298|FG000|Treatment Period|Adverse Event|0|||
162211950|NCT01390441|585827299|FG001|Treatment Period|Adverse Event|0|||
162211951|NCT01390441|585827300|FG002|Treatment Period|Adverse Event|1|||
162211952|NCT01390441|585827301|FG003|Treatment Period|Adverse Event|1|||
162211953|NCT01390441|585827302|FG004|Treatment Period|Adverse Event|2|||
162211954|NCT01390441|585827298|FG000|Treatment Period|Withdrawal by Subject|0|||
162211955|NCT01390441|585827299|FG001|Treatment Period|Withdrawal by Subject|0|||
162211956|NCT01390441|585827300|FG002|Treatment Period|Withdrawal by Subject|1|||
162211957|NCT01390441|585827301|FG003|Treatment Period|Withdrawal by Subject|0|||
162211958|NCT01390441|585827302|FG004|Treatment Period|Withdrawal by Subject|1|||
162211959|NCT01390441|585827298|FG000|Treatment Period|Lost to Follow-up|1|||
162211960|NCT01390441|585827299|FG001|Treatment Period|Lost to Follow-up|0|||
162211961|NCT01390441|585827300|FG002|Treatment Period|Lost to Follow-up|0|||
162211962|NCT01390441|585827301|FG003|Treatment Period|Lost to Follow-up|0|||
162211963|NCT01390441|585827302|FG004|Treatment Period|Lost to Follow-up|0|||
162211964|NCT01390441|585827298|FG000|Extension Period|Protocol Violation|3|||
162211965|NCT01390441|585827299|FG001|Extension Period|Protocol Violation|1|||
161826191|NCT02608476|584403812|FG001|Overall Study|Pregnancy|1|||
161826192|NCT02608476|584403811|FG000|Overall Study|Progressive disease|1|||
161826193|NCT02608476|584403812|FG001|Overall Study|Progressive disease|0|||
161826194|NCT02058160|584403813|FG000|Overall Study|Randomized but not treated|2|||
161826195|NCT02058160|584403814|FG001|Overall Study|Randomized but not treated|4|||
161826196|NCT02058160|584403813|FG000|Overall Study|Poor compliance to protocol|4|||
161826197|NCT02058160|584403814|FG001|Overall Study|Poor compliance to protocol|1|||
161826198|NCT02058160|584403813|FG000|Overall Study|Adverse Event|12|||
161826199|NCT02058160|584403814|FG001|Overall Study|Adverse Event|3|||
161826200|NCT02058160|584403813|FG000|Overall Study|Lost to Follow-up|1|||
161826201|NCT02058160|584403814|FG001|Overall Study|Lost to Follow-up|0|||
161826202|NCT02058160|584403813|FG000|Overall Study|Other than specified above|12|||
161826203|NCT02058160|584403814|FG001|Overall Study|Other than specified above|6|||
161826204|NCT01203917|584403816|FG000|Overall Study|Death|29|||
161826205|NCT01203917|584403816|FG000|Overall Study|Lost to Follow-up|2|||
162211966|NCT01390441|585827300|FG002|Extension Period|Protocol Violation|0|||
162211967|NCT01390441|585827301|FG003|Extension Period|Protocol Violation|1|||
162211968|NCT01390441|585827302|FG004|Extension Period|Protocol Violation|0|||
162211969|NCT03802617|585827303|FG000|Overall Study|Adverse Event|0|||
162211970|NCT03802617|585827304|FG001|Overall Study|Adverse Event|4|||
162211971|NCT03802617|585827305|FG002|Overall Study|Adverse Event|5|||
162211972|NCT03802617|585827306|FG003|Overall Study|Adverse Event|1|||
162211973|NCT03802617|585827303|FG000|Overall Study|Lack of Efficacy|0|||
162211974|NCT03802617|585827304|FG001|Overall Study|Lack of Efficacy|1|||
162211975|NCT03802617|585827305|FG002|Overall Study|Lack of Efficacy|0|||
162211976|NCT03802617|585827306|FG003|Overall Study|Lack of Efficacy|2|||
162211977|NCT03802617|585827303|FG000|Overall Study|Protocol Violation|1|||
162211978|NCT03802617|585827304|FG001|Overall Study|Protocol Violation|1|||
162211979|NCT03802617|585827305|FG002|Overall Study|Protocol Violation|1|||
162211980|NCT03802617|585827306|FG003|Overall Study|Protocol Violation|0|||
162211981|NCT03802617|585827303|FG000|Overall Study|Withdrawal by Subject|1|||
162211982|NCT03802617|585827304|FG001|Overall Study|Withdrawal by Subject|1|||
162211983|NCT03802617|585827305|FG002|Overall Study|Withdrawal by Subject|1|||
162211984|NCT03802617|585827306|FG003|Overall Study|Withdrawal by Subject|0|||
162211985|NCT03802617|585827303|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
162211986|NCT03802617|585827304|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
161826206|NCT01203917|584403816|FG000|Overall Study|Withdrawal by Subject|3|||
161826207|NCT01203917|584403816|FG000|Overall Study|Due to objective disease progression|1|||
162211987|NCT03802617|585827305|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
162211988|NCT03802617|585827306|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
162211989|NCT00621192|585827307|FG000|Overall Study|Withdrawal by Subject|0|||
162211990|NCT00621192|585827308|FG001|Overall Study|Withdrawal by Subject|0|||
162211991|NCT00621192|585827309|FG002|Overall Study|Withdrawal by Subject|2|||
162211992|NCT00621192|585827310|FG003|Overall Study|Withdrawal by Subject|0|||
162211993|NCT00621192|585827307|FG000|Overall Study|Physician Decision|1|||
162211994|NCT00621192|585827308|FG001|Overall Study|Physician Decision|3|||
162211995|NCT00621192|585827309|FG002|Overall Study|Physician Decision|0|||
162211996|NCT00621192|585827310|FG003|Overall Study|Physician Decision|0|||
162211997|NCT00621192|585827307|FG000|Overall Study|Protocol Violation|1|||
162211998|NCT00621192|585827308|FG001|Overall Study|Protocol Violation|0|||
162211999|NCT00621192|585827309|FG002|Overall Study|Protocol Violation|0|||
162212000|NCT00621192|585827310|FG003|Overall Study|Protocol Violation|1|||
162212001|NCT00621192|585827307|FG000|Overall Study|Adverse Event|0|||
162212002|NCT00621192|585827308|FG001|Overall Study|Adverse Event|1|||
162212003|NCT00621192|585827309|FG002|Overall Study|Adverse Event|0|||
162212004|NCT00621192|585827310|FG003|Overall Study|Adverse Event|1|||
162212005|NCT00621192|585827307|FG000|Overall Study|Death|2|||
162212006|NCT00621192|585827308|FG001|Overall Study|Death|5|||
162212007|NCT00621192|585827309|FG002|Overall Study|Death|0|||
162212008|NCT00621192|585827310|FG003|Overall Study|Death|0|||
162212009|NCT00621192|585827307|FG000|Overall Study|Final Assessments not Completed|0|||
162212010|NCT00621192|585827308|FG001|Overall Study|Final Assessments not Completed|0|||
162212011|NCT00621192|585827309|FG002|Overall Study|Final Assessments not Completed|3|||
162212012|NCT00621192|585827310|FG003|Overall Study|Final Assessments not Completed|1|||
162212013|NCT00267098|585827315|FG000|Overall Study|Death|0|||
162212014|NCT00267098|585827316|FG001|Overall Study|Death|0|||
162212015|NCT00267098|585827317|FG002|Overall Study|Death|57|||
162212016|NCT00267098|585827318|FG003|Overall Study|Death|66|||
162212017|NCT00267098|585827319|FG004|Overall Study|Death|14|||
162212018|NCT00267098|585827320|FG005|Overall Study|Death|23|||
162212019|NCT00267098|585827321|FG006|Overall Study|Death|28|||
162212020|NCT00267098|585827322|FG007|Overall Study|Death|9|||
162212021|NCT00267098|585827315|FG000|Overall Study|Lost to Follow-up|0|||
162212022|NCT00267098|585827316|FG001|Overall Study|Lost to Follow-up|0|||
162212023|NCT00267098|585827317|FG002|Overall Study|Lost to Follow-up|6|||
162212024|NCT00267098|585827318|FG003|Overall Study|Lost to Follow-up|5|||
161826208|NCT01203917|584403816|FG000|Overall Study|Due to EGFR M+I patient|1|||
161826209|NCT04106817|584403817|FG000|Overall Study|Lost to Follow-up|1|||
161826210|NCT04106817|584403818|FG001|Overall Study|Lost to Follow-up|0|||
161826211|NCT04106817|584403819|FG002|Overall Study|Lost to Follow-up|0|||
161826212|NCT02260635|584403820|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
161826213|NCT02260635|584403821|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
161826214|NCT02260635|584403820|FG000|Open-Label Extension|Study Termination|25|||
161826215|NCT02260635|584403821|FG001|Open-Label Extension|Study Termination|25|||
161826216|NCT02260635|584403820|FG000|Open-Label Extension|Withdrawal by Subject|1|||
162212025|NCT00267098|585827319|FG004|Overall Study|Lost to Follow-up|2|||
162212026|NCT00267098|585827320|FG005|Overall Study|Lost to Follow-up|3|||
162212027|NCT00267098|585827321|FG006|Overall Study|Lost to Follow-up|1|||
162212028|NCT00267098|585827322|FG007|Overall Study|Lost to Follow-up|1|||
162212029|NCT00267098|585827315|FG000|Overall Study|Withdrawal by Subject|8|||
162212030|NCT00267098|585827316|FG001|Overall Study|Withdrawal by Subject|0|||
162212031|NCT00267098|585827317|FG002|Overall Study|Withdrawal by Subject|24|||
162212032|NCT00267098|585827318|FG003|Overall Study|Withdrawal by Subject|21|||
162212033|NCT00267098|585827319|FG004|Overall Study|Withdrawal by Subject|12|||
162212034|NCT00267098|585827320|FG005|Overall Study|Withdrawal by Subject|9|||
162212035|NCT00267098|585827321|FG006|Overall Study|Withdrawal by Subject|12|||
162212036|NCT00267098|585827322|FG007|Overall Study|Withdrawal by Subject|5|||
162212037|NCT00267098|585827315|FG000|Overall Study|Physician Decision|5|||
162212038|NCT00267098|585827316|FG001|Overall Study|Physician Decision|0|||
161677951|NCT01994382|583873595|FG011|Overall Study|Withdrawal by Subject|0|||
161677952|NCT01994382|583873596|FG012|Overall Study|Withdrawal by Subject|2|||
161677953|NCT01994382|583873597|FG013|Overall Study|Withdrawal by Subject|0|||
161677954|NCT01994382|583873598|FG014|Overall Study|Withdrawal by Subject|4|||
161677955|NCT01994382|583873599|FG015|Overall Study|Withdrawal by Subject|3|||
161677956|NCT01994382|583873600|FG016|Overall Study|Withdrawal by Subject|0|||
161677957|NCT01994382|583873584|FG000|Overall Study|Lost to Follow-up|0|||
161677958|NCT01994382|583873585|FG001|Overall Study|Lost to Follow-up|0|||
161677959|NCT01994382|583873586|FG002|Overall Study|Lost to Follow-up|0|||
161677960|NCT01994382|583873587|FG003|Overall Study|Lost to Follow-up|0|||
161677961|NCT01994382|583873588|FG004|Overall Study|Lost to Follow-up|0|||
161677962|NCT01994382|583873589|FG005|Overall Study|Lost to Follow-up|0|||
161677963|NCT01994382|583873590|FG006|Overall Study|Lost to Follow-up|0|||
161677964|NCT01994382|583873591|FG007|Overall Study|Lost to Follow-up|0|||
161677965|NCT01994382|583873592|FG008|Overall Study|Lost to Follow-up|0|||
161677966|NCT01994382|583873593|FG009|Overall Study|Lost to Follow-up|0|||
161677967|NCT01994382|583873594|FG010|Overall Study|Lost to Follow-up|1|||
161677968|NCT01994382|583873595|FG011|Overall Study|Lost to Follow-up|0|||
161677969|NCT01994382|583873596|FG012|Overall Study|Lost to Follow-up|0|||
161677970|NCT01994382|583873597|FG013|Overall Study|Lost to Follow-up|0|||
161677971|NCT01994382|583873598|FG014|Overall Study|Lost to Follow-up|0|||
161677972|NCT01994382|583873599|FG015|Overall Study|Lost to Follow-up|0|||
161677973|NCT01994382|583873600|FG016|Overall Study|Lost to Follow-up|0|||
161677974|NCT01994382|583873584|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677975|NCT01994382|583873585|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677976|NCT01994382|583873586|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677977|NCT01994382|583873587|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677978|NCT01994382|583873588|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677979|NCT01994382|583873589|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677980|NCT01994382|583873590|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677981|NCT01994382|583873591|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677982|NCT01994382|583873592|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677983|NCT01994382|583873593|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677984|NCT01994382|583873594|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
161677985|NCT01994382|583873595|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677986|NCT01994382|583873596|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
162212039|NCT00267098|585827317|FG002|Overall Study|Physician Decision|7|||
162212040|NCT00267098|585827318|FG003|Overall Study|Physician Decision|11|||
162212041|NCT00267098|585827319|FG004|Overall Study|Physician Decision|5|||
161677987|NCT01994382|583873597|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677988|NCT01994382|583873598|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161677989|NCT01994382|583873599|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
161677990|NCT01994382|583873600|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
161677991|NCT01994382|583873584|FG000|Overall Study|Protocol violation/noncompliance|0|||
161677992|NCT01994382|583873585|FG001|Overall Study|Protocol violation/noncompliance|0|||
161677993|NCT01994382|583873586|FG002|Overall Study|Protocol violation/noncompliance|0|||
161677994|NCT01994382|583873587|FG003|Overall Study|Protocol violation/noncompliance|0|||
161677995|NCT01994382|583873588|FG004|Overall Study|Protocol violation/noncompliance|0|||
161677996|NCT01994382|583873589|FG005|Overall Study|Protocol violation/noncompliance|0|||
161677997|NCT01994382|583873590|FG006|Overall Study|Protocol violation/noncompliance|0|||
161677998|NCT01994382|583873591|FG007|Overall Study|Protocol violation/noncompliance|0|||
161677999|NCT01994382|583873592|FG008|Overall Study|Protocol violation/noncompliance|0|||
161935100|NCT00890097|584811498|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
161935101|NCT00890097|584811496|FG000|Overall Study|Withdrew Consent|9|||
161935102|NCT00890097|584811497|FG001|Overall Study|Withdrew Consent|6|||
161935103|NCT00890097|584811498|FG002|Overall Study|Withdrew Consent|9|||
161678000|NCT01994382|583873593|FG009|Overall Study|Protocol violation/noncompliance|0|||
161678001|NCT01994382|583873594|FG010|Overall Study|Protocol violation/noncompliance|0|||
161678002|NCT01994382|583873595|FG011|Overall Study|Protocol violation/noncompliance|1|||
161935104|NCT00890097|584811496|FG000|Overall Study|Lost to Follow-up|5|||
161935105|NCT00890097|584811497|FG001|Overall Study|Lost to Follow-up|5|||
162212042|NCT00267098|585827320|FG005|Overall Study|Physician Decision|4|||
162212043|NCT00267098|585827321|FG006|Overall Study|Physician Decision|3|||
162212044|NCT00267098|585827322|FG007|Overall Study|Physician Decision|0|||
161826217|NCT02260635|584403821|FG001|Open-Label Extension|Withdrawal by Subject|0|||
161826218|NCT03310619|584403822|FG000|Pre-Treatment Period|Death|1|||
161826219|NCT03310619|584403823|FG001|Pre-Treatment Period|Death|0|||
161826220|NCT03310619|584403824|FG002|Pre-Treatment Period|Death|0|||
161826221|NCT03310619|584403825|FG003|Pre-Treatment Period|Death|0|||
161826222|NCT03310619|584403826|FG004|Pre-Treatment Period|Death|1|||
161826223|NCT03310619|584403827|FG005|Pre-Treatment Period|Death|0|||
161826224|NCT03310619|584403828|FG006|Pre-Treatment Period|Death|0|||
161826225|NCT03310619|584403829|FG007|Pre-Treatment Period|Death|0|||
161826226|NCT03310619|584403822|FG000|Pre-Treatment Period|Other reasons|2|||
161826227|NCT03310619|584403823|FG001|Pre-Treatment Period|Other reasons|1|||
161826228|NCT03310619|584403824|FG002|Pre-Treatment Period|Other reasons|2|||
161826229|NCT03310619|584403825|FG003|Pre-Treatment Period|Other reasons|0|||
161826230|NCT03310619|584403826|FG004|Pre-Treatment Period|Other reasons|0|||
161826231|NCT03310619|584403827|FG005|Pre-Treatment Period|Other reasons|0|||
161826232|NCT03310619|584403828|FG006|Pre-Treatment Period|Other reasons|2|||
161826233|NCT03310619|584403829|FG007|Pre-Treatment Period|Other reasons|0|||
161826234|NCT03310619|584403822|FG000|Treatment Period|Death|1|||
161826235|NCT03310619|584403823|FG001|Treatment Period|Death|2|||
161826236|NCT03310619|584403824|FG002|Treatment Period|Death|0|||
161826237|NCT03310619|584403825|FG003|Treatment Period|Death|0|||
161826238|NCT03310619|584403826|FG004|Treatment Period|Death|1|||
161826239|NCT03310619|584403827|FG005|Treatment Period|Death|0|||
161826240|NCT03310619|584403828|FG006|Treatment Period|Death|2|||
161826241|NCT03310619|584403829|FG007|Treatment Period|Death|0|||
161826242|NCT03310619|584403822|FG000|Treatment Period|Adverse Event|0|||
161826243|NCT03310619|584403823|FG001|Treatment Period|Adverse Event|1|||
161826244|NCT03310619|584403824|FG002|Treatment Period|Adverse Event|4|||
161826245|NCT03310619|584403825|FG003|Treatment Period|Adverse Event|1|||
161826246|NCT03310619|584403826|FG004|Treatment Period|Adverse Event|0|||
161826247|NCT03310619|584403827|FG005|Treatment Period|Adverse Event|0|||
161826248|NCT03310619|584403828|FG006|Treatment Period|Adverse Event|0|||
161826249|NCT03310619|584403829|FG007|Treatment Period|Adverse Event|0|||
161826250|NCT03310619|584403822|FG000|Treatment Period|Withdrawal by participant|0|||
161826251|NCT03310619|584403823|FG001|Treatment Period|Withdrawal by participant|0|||
161826252|NCT03310619|584403824|FG002|Treatment Period|Withdrawal by participant|1|||
161826253|NCT03310619|584403825|FG003|Treatment Period|Withdrawal by participant|0|||
161826254|NCT03310619|584403826|FG004|Treatment Period|Withdrawal by participant|0|||
161826255|NCT03310619|584403827|FG005|Treatment Period|Withdrawal by participant|0|||
161826256|NCT03310619|584403828|FG006|Treatment Period|Withdrawal by participant|0|||
161826257|NCT03310619|584403829|FG007|Treatment Period|Withdrawal by participant|0|||
161826258|NCT03310619|584403822|FG000|Treatment Period|Lost to Follow-up|0|||
161826259|NCT03310619|584403823|FG001|Treatment Period|Lost to Follow-up|0|||
161826260|NCT03310619|584403824|FG002|Treatment Period|Lost to Follow-up|0|||
161826261|NCT03310619|584403825|FG003|Treatment Period|Lost to Follow-up|0|||
161826262|NCT03310619|584403826|FG004|Treatment Period|Lost to Follow-up|0|||
161826263|NCT03310619|584403827|FG005|Treatment Period|Lost to Follow-up|0|||
161826264|NCT03310619|584403828|FG006|Treatment Period|Lost to Follow-up|0|||
161826265|NCT03310619|584403829|FG007|Treatment Period|Lost to Follow-up|1|||
161826266|NCT03310619|584403822|FG000|Treatment Period|Study terminated by sponsor|0|||
161826267|NCT03310619|584403823|FG001|Treatment Period|Study terminated by sponsor|0|||
161826268|NCT03310619|584403824|FG002|Treatment Period|Study terminated by sponsor|0|||
161826269|NCT03310619|584403825|FG003|Treatment Period|Study terminated by sponsor|0|||
161826270|NCT03310619|584403826|FG004|Treatment Period|Study terminated by sponsor|0|||
161826271|NCT03310619|584403827|FG005|Treatment Period|Study terminated by sponsor|0|||
161826272|NCT03310619|584403828|FG006|Treatment Period|Study terminated by sponsor|0|||
161826273|NCT03310619|584403829|FG007|Treatment Period|Study terminated by sponsor|1|||
162212045|NCT00267098|585827315|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
162212046|NCT00267098|585827316|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162212047|NCT00267098|585827317|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162212048|NCT00267098|585827318|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161826274|NCT03310619|584403822|FG000|Treatment Period|Physician Decision|0|||
161826275|NCT03310619|584403823|FG001|Treatment Period|Physician Decision|0|||
161826276|NCT03310619|584403824|FG002|Treatment Period|Physician Decision|0|||
161826277|NCT03310619|584403825|FG003|Treatment Period|Physician Decision|0|||
162212049|NCT00267098|585827319|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
161826278|NCT03310619|584403826|FG004|Treatment Period|Physician Decision|3|||
161826279|NCT03310619|584403827|FG005|Treatment Period|Physician Decision|0|||
161826280|NCT03310619|584403828|FG006|Treatment Period|Physician Decision|0|||
161826281|NCT03310619|584403829|FG007|Treatment Period|Physician Decision|0|||
161826282|NCT03310619|584403822|FG000|Treatment Period|Other reasons|1|||
161826283|NCT03310619|584403823|FG001|Treatment Period|Other reasons|0|||
161826284|NCT03310619|584403824|FG002|Treatment Period|Other reasons|2|||
161826285|NCT03310619|584403825|FG003|Treatment Period|Other reasons|0|||
161826286|NCT03310619|584403826|FG004|Treatment Period|Other reasons|0|||
161826287|NCT03310619|584403827|FG005|Treatment Period|Other reasons|0|||
161935106|NCT00890097|584811498|FG002|Overall Study|Lost to Follow-up|5|||
161935107|NCT00890097|584811496|FG000|Overall Study|Noncompliance|0|||
161935108|NCT00890097|584811497|FG001|Overall Study|Noncompliance|4|||
161935109|NCT00890097|584811498|FG002|Overall Study|Noncompliance|4|||
161935110|NCT00890097|584811496|FG000|Overall Study|Sponsor Decision|7|||
161935111|NCT00890097|584811497|FG001|Overall Study|Sponsor Decision|11|||
161935112|NCT00890097|584811498|FG002|Overall Study|Sponsor Decision|7|||
161935113|NCT00890097|584811496|FG000|Overall Study|Did not attend final visit|2|||
161935114|NCT00890097|584811497|FG001|Overall Study|Did not attend final visit|3|||
161935115|NCT00890097|584811498|FG002|Overall Study|Did not attend final visit|0|||
161935116|NCT00890097|584811496|FG000|Overall Study|Subject Decision|3|||
161935117|NCT00890097|584811497|FG001|Overall Study|Subject Decision|2|||
161935118|NCT00890097|584811498|FG002|Overall Study|Subject Decision|6|||
161935119|NCT00890097|584811496|FG000|Overall Study|Randomization Error|2|||
161935120|NCT00890097|584811497|FG001|Overall Study|Randomization Error|0|||
161935121|NCT00890097|584811498|FG002|Overall Study|Randomization Error|0|||
161935122|NCT00890097|584811496|FG000|Overall Study|Failed inclusion criteria|3|||
161935123|NCT00890097|584811497|FG001|Overall Study|Failed inclusion criteria|4|||
161935124|NCT00890097|584811498|FG002|Overall Study|Failed inclusion criteria|0|||
161935125|NCT00890097|584811496|FG000|Overall Study|Transportation|0|||
161935126|NCT00890097|584811497|FG001|Overall Study|Transportation|2|||
161935127|NCT00890097|584811498|FG002|Overall Study|Transportation|0|||
161935128|NCT00890097|584811496|FG000|Overall Study|Subject Moved|0|||
161935129|NCT00890097|584811497|FG001|Overall Study|Subject Moved|4|||
161935130|NCT00890097|584811498|FG002|Overall Study|Subject Moved|0|||
161935131|NCT00890097|584811496|FG000|Overall Study|Protocol Deviation|1|||
161935132|NCT00890097|584811497|FG001|Overall Study|Protocol Deviation|1|||
161935133|NCT00890097|584811498|FG002|Overall Study|Protocol Deviation|1|||
161935134|NCT03878069|584811503|FG000|Overall Study|Death|0|||
161935135|NCT03878069|584811504|FG001|Overall Study|Death|1|||
161935136|NCT03878069|584811505|FG002|Overall Study|Death|0|||
161935137|NCT03810495|584811506|FG000|Overall Study|Lost to Follow-up|2|||
161935138|NCT03810495|584811506|FG000|Overall Study|Withdrawal by Subject|1|||
161935139|NCT03759379|584813857|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
161935140|NCT03759379|584813858|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
161935141|NCT03759379|584813857|FG000|Treatment Period|Death|2|||
161935142|NCT03759379|584813858|FG001|Treatment Period|Death|3|||
161935143|NCT03759379|584813857|FG000|Treatment Period|Lost to Follow-up|1|||
161935144|NCT03759379|584813858|FG001|Treatment Period|Lost to Follow-up|0|||
161935145|NCT03759379|584813857|FG000|Treatment Period|Physician Decision|0|||
161935146|NCT03759379|584813858|FG001|Treatment Period|Physician Decision|1|||
161935147|NCT04924608|584813859|FG000|Overall Study|Adverse Event|10|||
161935148|NCT04924608|584813860|FG001|Overall Study|Adverse Event|6|||
162212050|NCT00267098|585827320|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161935149|NCT04924608|584813859|FG000|Overall Study|Lost to Follow-up|1|||
161935150|NCT04924608|584813860|FG001|Overall Study|Lost to Follow-up|1|||
161935151|NCT04924608|584813859|FG000|Overall Study|Ongoing at the data cut-off date|54|||
161935152|NCT04924608|584813860|FG001|Overall Study|Ongoing at the data cut-off date|60|||
161935153|NCT04924608|584813859|FG000|Overall Study|Progressive Disease|2|||
162212051|NCT00267098|585827321|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162212052|NCT00267098|585827322|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162212053|NCT00267098|585827315|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162212054|NCT00267098|585827316|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
162212055|NCT00267098|585827317|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162212056|NCT00267098|585827318|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162212057|NCT00267098|585827319|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162212058|NCT00267098|585827320|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162212059|NCT00267098|585827321|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162212060|NCT00267098|585827322|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
162212061|NCT00267098|585827315|FG000|Overall Study|Site closure|0|||
162212062|NCT00267098|585827316|FG001|Overall Study|Site closure|0|||
162212063|NCT00267098|585827317|FG002|Overall Study|Site closure|0|||
162212064|NCT00267098|585827318|FG003|Overall Study|Site closure|1|||
162212065|NCT00267098|585827319|FG004|Overall Study|Site closure|0|||
162212066|NCT00267098|585827320|FG005|Overall Study|Site closure|1|||
162212067|NCT00267098|585827321|FG006|Overall Study|Site closure|1|||
162212068|NCT00267098|585827322|FG007|Overall Study|Site closure|0|||
162212069|NCT00267098|585827315|FG000|Overall Study|Explanted Medtronic device|0|||
161935154|NCT04924608|584813860|FG001|Overall Study|Progressive Disease|0|||
161935155|NCT04924608|584813859|FG000|Overall Study|Withdrawal by Subject|3|||
161935156|NCT04924608|584813860|FG001|Overall Study|Withdrawal by Subject|6|||
161935157|NCT04924608|584813859|FG000|Overall Study|Other reason|1|||
161935158|NCT04924608|584813860|FG001|Overall Study|Other reason|1|||
162212070|NCT00267098|585827316|FG001|Overall Study|Explanted Medtronic device|0|||
162212071|NCT00267098|585827317|FG002|Overall Study|Explanted Medtronic device|0|||
162212072|NCT00267098|585827318|FG003|Overall Study|Explanted Medtronic device|1|||
162212073|NCT00267098|585827319|FG004|Overall Study|Explanted Medtronic device|0|||
162212074|NCT00267098|585827320|FG005|Overall Study|Explanted Medtronic device|0|||
162212075|NCT00267098|585827321|FG006|Overall Study|Explanted Medtronic device|0|||
162212076|NCT00267098|585827322|FG007|Overall Study|Explanted Medtronic device|0|||
162212077|NCT00267098|585827315|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162212078|NCT00267098|585827316|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162212079|NCT00267098|585827317|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162212080|NCT00267098|585827318|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162212081|NCT00267098|585827319|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
162212082|NCT00267098|585827320|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162212083|NCT00267098|585827321|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162212084|NCT00267098|585827322|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
162212085|NCT00267098|585827315|FG000|Overall Study|Subject listed for heart transplant|0|||
162212086|NCT00267098|585827316|FG001|Overall Study|Subject listed for heart transplant|0|||
162212087|NCT00267098|585827317|FG002|Overall Study|Subject listed for heart transplant|0|||
162212088|NCT00267098|585827318|FG003|Overall Study|Subject listed for heart transplant|0|||
162212089|NCT00267098|585827319|FG004|Overall Study|Subject listed for heart transplant|0|||
162212090|NCT00267098|585827320|FG005|Overall Study|Subject listed for heart transplant|0|||
161826288|NCT03310619|584403828|FG006|Treatment Period|Other reasons|0|||
162212091|NCT00267098|585827321|FG006|Overall Study|Subject listed for heart transplant|1|||
162212092|NCT00267098|585827322|FG007|Overall Study|Subject listed for heart transplant|0|||
162212093|NCT00267098|585827315|FG000|Overall Study|Sponsor withdrew subject|0|||
162212094|NCT00267098|585827316|FG001|Overall Study|Sponsor withdrew subject|0|||
162212095|NCT00267098|585827317|FG002|Overall Study|Sponsor withdrew subject|0|||
162212096|NCT00267098|585827318|FG003|Overall Study|Sponsor withdrew subject|1|||
162212097|NCT00267098|585827319|FG004|Overall Study|Sponsor withdrew subject|0|||
162212098|NCT00267098|585827320|FG005|Overall Study|Sponsor withdrew subject|0|||
162212099|NCT00267098|585827321|FG006|Overall Study|Sponsor withdrew subject|0|||
162212100|NCT00267098|585827322|FG007|Overall Study|Sponsor withdrew subject|0|||
161826289|NCT03310619|584403829|FG007|Treatment Period|Other reasons|0|||
161826290|NCT00152516|584403834|FG000|Overall Study|Adverse Event|18|||
162212101|NCT04211389|585827324|FG000|Overall Study|Adverse Event|1|||
162212102|NCT04211389|585827325|FG001|Overall Study|Adverse Event|2|||
162212103|NCT04211389|585827324|FG000|Overall Study|Lost to Follow-up|15|||
162212104|NCT04211389|585827325|FG001|Overall Study|Lost to Follow-up|7|||
162212105|NCT04211389|585827324|FG000|Overall Study|Protocol Violation|0|||
162212106|NCT04211389|585827325|FG001|Overall Study|Protocol Violation|1|||
162212107|NCT04211389|585827324|FG000|Overall Study|Withdrawal by Subject|10|||
162212108|NCT04211389|585827325|FG001|Overall Study|Withdrawal by Subject|11|||
162212109|NCT00547534|585827329|FG000|Overall Study|Adverse Event|7|||
162212110|NCT00547534|585827329|FG000|Overall Study|Disease Progression|4|||
162212111|NCT00725543|585827333|FG000|Overall Study|Adverse Event|10|||
162212112|NCT00725543|585827333|FG000|Overall Study|Lack of Efficacy|3|||
162212113|NCT00725543|585827333|FG000|Overall Study|Withdrawal by Subject|10|||
162212114|NCT00725543|585827333|FG000|Overall Study|Physician Decision|5|||
162212115|NCT00725543|585827333|FG000|Overall Study|Lost to Follow-up|4|||
162212116|NCT00725543|585827333|FG000|Overall Study|Non-compliance|2|||
162212117|NCT00725543|585827333|FG000|Overall Study|Other|119|||
162212118|NCT02168478|585827334|FG000|Overall Study|Withdrawal by Subject|1|||
162212119|NCT02168478|585827334|FG000|Overall Study|Did Not Consent to Participation|2|||
162212120|NCT02168478|585827334|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
162212121|NCT01157377|585827335|FG000|Overall Study|Lost to Follow-up|0|||
162212122|NCT01157377|585827336|FG001|Overall Study|Lost to Follow-up|0|||
162212123|NCT01157377|585827337|FG002|Overall Study|Lost to Follow-up|1|||
162212124|NCT01157377|585827338|FG003|Overall Study|Lost to Follow-up|0|||
162212125|NCT01157377|585827339|FG004|Overall Study|Lost to Follow-up|1|||
162212126|NCT01157377|585827340|FG005|Overall Study|Lost to Follow-up|1|||
162212127|NCT01157377|585827341|FG006|Overall Study|Lost to Follow-up|0|||
162212128|NCT01157377|585827335|FG000|Overall Study|Personal Reasons|2|||
162212129|NCT01157377|585827336|FG001|Overall Study|Personal Reasons|1|||
162212130|NCT01157377|585827337|FG002|Overall Study|Personal Reasons|0|||
162212131|NCT01157377|585827338|FG003|Overall Study|Personal Reasons|1|||
162212132|NCT01157377|585827339|FG004|Overall Study|Personal Reasons|0|||
162212133|NCT01157377|585827340|FG005|Overall Study|Personal Reasons|0|||
162212134|NCT01157377|585827341|FG006|Overall Study|Personal Reasons|0|||
162212135|NCT01157377|585827335|FG000|Overall Study|Protocol Violation|0|||
162212136|NCT01157377|585827336|FG001|Overall Study|Protocol Violation|0|||
162212137|NCT01157377|585827337|FG002|Overall Study|Protocol Violation|0|||
162212138|NCT01157377|585827338|FG003|Overall Study|Protocol Violation|0|||
162212139|NCT01157377|585827339|FG004|Overall Study|Protocol Violation|0|||
162212140|NCT01157377|585827340|FG005|Overall Study|Protocol Violation|1|||
162212141|NCT01157377|585827341|FG006|Overall Study|Protocol Violation|0|||
162212142|NCT01157377|585827335|FG000|Overall Study|Lack of Efficacy|0|||
162212143|NCT01157377|585827336|FG001|Overall Study|Lack of Efficacy|0|||
162212144|NCT01157377|585827337|FG002|Overall Study|Lack of Efficacy|0|||
162212145|NCT01157377|585827338|FG003|Overall Study|Lack of Efficacy|0|||
162212146|NCT01157377|585827339|FG004|Overall Study|Lack of Efficacy|0|||
162212147|NCT01157377|585827340|FG005|Overall Study|Lack of Efficacy|0|||
162212148|NCT01157377|585827341|FG006|Overall Study|Lack of Efficacy|1|||
162212149|NCT01157377|585827335|FG000|Overall Study|Other Miscellaneous Reasons|0|||
162212150|NCT01157377|585827336|FG001|Overall Study|Other Miscellaneous Reasons|2|||
162212151|NCT01157377|585827337|FG002|Overall Study|Other Miscellaneous Reasons|0|||
162212152|NCT01157377|585827338|FG003|Overall Study|Other Miscellaneous Reasons|0|||
162212153|NCT01157377|585827339|FG004|Overall Study|Other Miscellaneous Reasons|1|||
162212154|NCT01157377|585827340|FG005|Overall Study|Other Miscellaneous Reasons|1|||
162212155|NCT01157377|585827341|FG006|Overall Study|Other Miscellaneous Reasons|1|||
162212156|NCT00087555|585827342|FG000|Overall Study|Adverse Event|3|||
162212157|NCT00087555|585827343|FG001|Overall Study|Adverse Event|6|||
162212158|NCT00087555|585827344|FG002|Overall Study|Adverse Event|14|||
162212159|NCT00087555|585827342|FG000|Overall Study|Lost to Follow-up|0|||
162212160|NCT00087555|585827343|FG001|Overall Study|Lost to Follow-up|1|||
162212161|NCT00087555|585827344|FG002|Overall Study|Lost to Follow-up|1|||
162212162|NCT00087555|585827342|FG000|Overall Study|Non - Compliance|1|||
162212163|NCT00087555|585827343|FG001|Overall Study|Non - Compliance|0|||
162212164|NCT00087555|585827344|FG002|Overall Study|Non - Compliance|0|||
162212165|NCT00087555|585827342|FG000|Overall Study|Protocol Violation|0|||
162212166|NCT00087555|585827343|FG001|Overall Study|Protocol Violation|0|||
162212167|NCT00087555|585827344|FG002|Overall Study|Protocol Violation|2|||
162212168|NCT00087555|585827342|FG000|Overall Study|Screen Failure|1|||
162212169|NCT00087555|585827343|FG001|Overall Study|Screen Failure|1|||
162212170|NCT00087555|585827344|FG002|Overall Study|Screen Failure|0|||
162212171|NCT00087555|585827342|FG000|Overall Study|Pregnancy|0|||
162212172|NCT00087555|585827343|FG001|Overall Study|Pregnancy|1|||
162212173|NCT00087555|585827344|FG002|Overall Study|Pregnancy|1|||
162212174|NCT00087555|585827342|FG000|Overall Study|Withdrawal by Subject|3|||
162212175|NCT00087555|585827343|FG001|Overall Study|Withdrawal by Subject|2|||
162212176|NCT00087555|585827344|FG002|Overall Study|Withdrawal by Subject|1|||
162212177|NCT00087555|585827342|FG000|Overall Study|Lack of Efficacy|2|||
162212178|NCT00087555|585827343|FG001|Overall Study|Lack of Efficacy|0|||
162212179|NCT00087555|585827344|FG002|Overall Study|Lack of Efficacy|1|||
162212180|NCT00087555|585827342|FG000|Overall Study|Non Compliance|0|||
162212181|NCT00087555|585827343|FG001|Overall Study|Non Compliance|0|||
162212182|NCT00087555|585827344|FG002|Overall Study|Non Compliance|1|||
161826291|NCT00152516|584403834|FG000|Overall Study|Lack and Loss of Efficacy|30|||
161826292|NCT00152516|584403834|FG000|Overall Study|Lost to Follow-up|5|||
161826293|NCT00152516|584403834|FG000|Overall Study|Withdrawal by Subject|8|||
161826294|NCT00152516|584403834|FG000|Overall Study|Protocol Violation|3|||
161826295|NCT00152516|584403834|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
161826296|NCT00152516|584403834|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
161826297|NCT00152516|584403834|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
161826298|NCT00152516|584403834|FG000|Overall Study|Other: Non-Compliance|2|||
161826299|NCT00152516|584403834|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
161826300|NCT00152516|584403834|FG000|Overall Study|Other: Moved Out Of State|1|||
161826301|NCT00152516|584403834|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
161826302|NCT00152516|584403834|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
161826303|NCT04660032|584403837|FG000|Overall Study|Protocol Violation|1|||
161826304|NCT04660032|584403838|FG001|Overall Study|Protocol Violation|1|||
161826305|NCT00090753|584403839|FG000|First Treatment Period|Adverse Event|20|||
161826306|NCT00090753|584403840|FG001|First Treatment Period|Adverse Event|8|||
161826307|NCT00090753|584403839|FG000|First Treatment Period|Death|88|||
161826308|NCT00090753|584403840|FG001|First Treatment Period|Death|62|||
161826309|NCT00090753|584403839|FG000|First Treatment Period|Lack of Efficacy|2|||
161826310|NCT00090753|584403840|FG001|First Treatment Period|Lack of Efficacy|1|||
161826311|NCT00090753|584403839|FG000|First Treatment Period|Refused Treatment|32|||
161826312|NCT00090753|584403840|FG001|First Treatment Period|Refused Treatment|25|||
161826313|NCT00090753|584403839|FG000|First Treatment Period|Lost to Follow-up|4|||
161826314|NCT00090753|584403840|FG001|First Treatment Period|Lost to Follow-up|4|||
161826315|NCT00090753|584403839|FG000|First Treatment Period|Renal Transplant|70|||
161826316|NCT00090753|584403840|FG001|First Treatment Period|Renal Transplant|50|||
161826317|NCT00090753|584403839|FG000|First Treatment Period|Mircera Commercialization|1|||
161826318|NCT00090753|584403840|FG001|First Treatment Period|Mircera Commercialization|0|||
161826319|NCT00090753|584403839|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
161826320|NCT00090753|584403840|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
161826321|NCT00090753|584403839|FG000|Extended Treatment Period|Adverse Event|11|||
161826322|NCT00090753|584403840|FG001|Extended Treatment Period|Adverse Event|0|||
161826323|NCT00090753|584403839|FG000|Extended Treatment Period|Death|58|||
161826324|NCT00090753|584403840|FG001|Extended Treatment Period|Death|30|||
161826325|NCT00090753|584403839|FG000|Extended Treatment Period|Lack of Efficacy|1|||
161826326|NCT00090753|584403840|FG001|Extended Treatment Period|Lack of Efficacy|0|||
161826327|NCT00090753|584403839|FG000|Extended Treatment Period|Refused Treatment|18|||
161826328|NCT00090753|584403840|FG001|Extended Treatment Period|Refused Treatment|12|||
162212183|NCT00087555|585827342|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
162212184|NCT00087555|585827343|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
162212185|NCT00087555|585827344|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
162212186|NCT00087555|585827342|FG000|Overall Study|Patient wanted to go back on Med|1|||
162212187|NCT00087555|585827343|FG001|Overall Study|Patient wanted to go back on Med|0|||
162212188|NCT00087555|585827344|FG002|Overall Study|Patient wanted to go back on Med|0|||
162212189|NCT01062971|585827345|FG000|Overall Study|Protocol Violation|1|||
162212190|NCT01062971|585827346|FG001|Overall Study|Protocol Violation|3|||
162212191|NCT01062971|585827345|FG000|Overall Study|Lost to Follow-up|3|||
162212192|NCT01062971|585827346|FG001|Overall Study|Lost to Follow-up|4|||
162212193|NCT05523219|585827347|FG000|Overall Study|Wrong inclusion|1|||
162212194|NCT05523219|585827347|FG000|Overall Study|Lost to Follow-up|7|||
162212195|NCT02760485|585827356|FG000|Phase 1|Death|3|||
162212196|NCT02760485|585827357|FG001|Phase 1|Death|6|||
162212197|NCT02760485|585827358|FG002|Phase 1|Death|0|||
162212198|NCT02760485|585827356|FG000|Phase 1|Withdrawal by Subject|2|||
162212199|NCT02760485|585827357|FG001|Phase 1|Withdrawal by Subject|0|||
161826329|NCT00090753|584403839|FG000|Extended Treatment Period|Lost to Follow-up|3|||
161826330|NCT00090753|584403840|FG001|Extended Treatment Period|Lost to Follow-up|1|||
161826331|NCT00090753|584403839|FG000|Extended Treatment Period|Renal Transplant|15|||
161826332|NCT00090753|584403840|FG001|Extended Treatment Period|Renal Transplant|12|||
161826333|NCT00090753|584403839|FG000|Extended Treatment Period|Mircera Commercialization|188|||
161826334|NCT00090753|584403840|FG001|Extended Treatment Period|Mircera Commercialization|93|||
162212200|NCT02760485|585827358|FG002|Phase 1|Withdrawal by Subject|0|||
162212201|NCT02760485|585827356|FG000|Phase 1|Progressive Disease|1|||
161935212|NCT05415215|584813874|FG000|Neoadjuvant Phase|Adverse Event|0|||
161935213|NCT05415215|584813875|FG001|Neoadjuvant Phase|Adverse Event|8|||
161935214|NCT05415215|584813876|FG002|Neoadjuvant Phase|Adverse Event|0|||
161935215|NCT05415215|584813877|FG003|Neoadjuvant Phase|Adverse Event|0|||
161935216|NCT05415215|584813878|FG004|Neoadjuvant Phase|Adverse Event|0|||
161935217|NCT05415215|584813879|FG005|Neoadjuvant Phase|Adverse Event|0|||
161935218|NCT05415215|584813880|FG006|Neoadjuvant Phase|Adverse Event|0|||
161935219|NCT05415215|584813881|FG007|Neoadjuvant Phase|Adverse Event|0|||
161935220|NCT05415215|584813874|FG000|Neoadjuvant Phase|Death|0|||
161935221|NCT05415215|584813875|FG001|Neoadjuvant Phase|Death|4|||
161935222|NCT05415215|584813876|FG002|Neoadjuvant Phase|Death|0|||
161935223|NCT05415215|584813877|FG003|Neoadjuvant Phase|Death|0|||
161935224|NCT05415215|584813878|FG004|Neoadjuvant Phase|Death|0|||
161935225|NCT05415215|584813879|FG005|Neoadjuvant Phase|Death|0|||
161935226|NCT05415215|584813880|FG006|Neoadjuvant Phase|Death|0|||
161935227|NCT05415215|584813881|FG007|Neoadjuvant Phase|Death|0|||
162212202|NCT02760485|585827357|FG001|Phase 1|Progressive Disease|0|||
162212203|NCT02760485|585827358|FG002|Phase 1|Progressive Disease|0|||
162212204|NCT02760485|585827356|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
162212205|NCT02760485|585827357|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
162212206|NCT02760485|585827358|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
162212207|NCT02760485|585827356|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
161935228|NCT05415215|584813874|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
162212208|NCT02760485|585827357|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
161935229|NCT05415215|584813875|FG001|Neoadjuvant Phase|Withdrawal by Subject|11|||
161935230|NCT05415215|584813876|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
161935231|NCT05415215|584813877|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
161935232|NCT05415215|584813878|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
161935233|NCT05415215|584813879|FG005|Neoadjuvant Phase|Withdrawal by Subject|0|||
161935234|NCT05415215|584813880|FG006|Neoadjuvant Phase|Withdrawal by Subject|0|||
162212209|NCT02760485|585827358|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
162212210|NCT02760485|585827356|FG000|Phase 2|Death|0|||
162212211|NCT02760485|585827357|FG001|Phase 2|Death|0|||
161935235|NCT05415215|584813881|FG007|Neoadjuvant Phase|Withdrawal by Subject|0|||
161935236|NCT05415215|584813874|FG000|Neoadjuvant Phase|Progressive Disease|0|||
161935237|NCT05415215|584813875|FG001|Neoadjuvant Phase|Progressive Disease|2|||
161935238|NCT05415215|584813876|FG002|Neoadjuvant Phase|Progressive Disease|0|||
161935239|NCT05415215|584813877|FG003|Neoadjuvant Phase|Progressive Disease|0|||
162212212|NCT02760485|585827358|FG002|Phase 2|Death|12|||
162212213|NCT02760485|585827356|FG000|Phase 2|Withdrawal by Subject|0|||
162212214|NCT02760485|585827357|FG001|Phase 2|Withdrawal by Subject|0|||
162212215|NCT02760485|585827358|FG002|Phase 2|Withdrawal by Subject|3|||
162212216|NCT02760485|585827356|FG000|Phase 2|Progressive Disease|0|||
162212217|NCT02760485|585827357|FG001|Phase 2|Progressive Disease|0|||
162212218|NCT02760485|585827358|FG002|Phase 2|Progressive Disease|1|||
162212219|NCT02760485|585827356|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
162212220|NCT02760485|585827357|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
162212221|NCT02760485|585827358|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
162212222|NCT03738397|585827359|FG000|Overall Study|Adverse Event|3|||
162212223|NCT03738397|585827360|FG001|Overall Study|Adverse Event|7|||
162212224|NCT03738397|585827359|FG000|Overall Study|Withdrawal by Subject|8|||
162212225|NCT03738397|585827360|FG001|Overall Study|Withdrawal by Subject|11|||
161826335|NCT00090753|584403839|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
162212226|NCT03738397|585827359|FG000|Overall Study|Lost to Follow-up|7|||
161826336|NCT00090753|584403840|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
162212227|NCT03738397|585827360|FG001|Overall Study|Lost to Follow-up|5|||
162212228|NCT03738397|585827359|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
162212229|NCT03738397|585827360|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
162212230|NCT03738397|585827359|FG000|Overall Study|Other|4|||
162212231|NCT03738397|585827360|FG001|Overall Study|Other|6|||
162212232|NCT01182207|585827363|FG000|First Intervention|Positive Hepatitis Results|0|||
162212233|NCT01182207|585827364|FG001|First Intervention|Positive Hepatitis Results|1|||
162212234|NCT01182207|585827363|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
162212235|NCT01182207|585827364|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
162212236|NCT01087814|585827365|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
162212237|NCT01087814|585827366|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
162212238|NCT01087814|585827365|FG000|Second Intervention (5 Days)|Physician Decision|1|||
162212239|NCT01087814|585827366|FG001|Second Intervention (5 Days)|Physician Decision|0|||
162212240|NCT01427738|585827367|FG000|Overall Study|Death|12|||
162212241|NCT01427738|585827368|FG001|Overall Study|Death|9|||
162212242|NCT01427738|585827367|FG000|Overall Study|Severe debilitation, unable to continue|0|||
162212243|NCT01427738|585827368|FG001|Overall Study|Severe debilitation, unable to continue|1|||
162212244|NCT01427738|585827367|FG000|Overall Study|Subject unable to get to clinic|5|||
162212245|NCT01427738|585827368|FG001|Overall Study|Subject unable to get to clinic|2|||
162212246|NCT01427738|585827367|FG000|Overall Study|Withdrawal by Subject|0|||
162212247|NCT01427738|585827368|FG001|Overall Study|Withdrawal by Subject|2|||
162212248|NCT01427738|585827367|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
162212249|NCT01427738|585827368|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
162212250|NCT01427738|585827367|FG000|Overall Study|Lost to Follow-up|1|||
162212251|NCT01427738|585827368|FG001|Overall Study|Lost to Follow-up|5|||
162212252|NCT00661713|585827369|FG000|Overall Study|Death|1|||
162212253|NCT00661713|585827370|FG001|Overall Study|Death|0|||
162212254|NCT00661713|585827371|FG002|Overall Study|Death|0|||
162212255|NCT00661713|585827372|FG003|Overall Study|Death|0|||
162212256|NCT00661713|585827373|FG004|Overall Study|Death|1|||
162212257|NCT00661713|585827374|FG005|Overall Study|Death|0|||
162212258|NCT00661713|585827375|FG006|Overall Study|Death|0|||
162212259|NCT00661713|585827376|FG007|Overall Study|Death|0|||
162212260|NCT00661713|585827369|FG000|Overall Study|Unable to Classify|1|||
162212261|NCT00661713|585827370|FG001|Overall Study|Unable to Classify|0|||
162212262|NCT00661713|585827371|FG002|Overall Study|Unable to Classify|0|||
162212263|NCT00661713|585827372|FG003|Overall Study|Unable to Classify|0|||
162212264|NCT00661713|585827373|FG004|Overall Study|Unable to Classify|0|||
162212265|NCT00661713|585827374|FG005|Overall Study|Unable to Classify|0|||
162212266|NCT00661713|585827375|FG006|Overall Study|Unable to Classify|0|||
162212267|NCT00661713|585827376|FG007|Overall Study|Unable to Classify|0|||
162212268|NCT00661713|585827369|FG000|Overall Study|Protocol Violation|1|||
162212269|NCT00661713|585827370|FG001|Overall Study|Protocol Violation|6|||
162212270|NCT00661713|585827371|FG002|Overall Study|Protocol Violation|3|||
162212271|NCT00661713|585827372|FG003|Overall Study|Protocol Violation|3|||
162212272|NCT00661713|585827373|FG004|Overall Study|Protocol Violation|0|||
162212273|NCT00661713|585827374|FG005|Overall Study|Protocol Violation|2|||
162212274|NCT00661713|585827375|FG006|Overall Study|Protocol Violation|2|||
162212275|NCT00661713|585827376|FG007|Overall Study|Protocol Violation|1|||
162212276|NCT00661713|585827369|FG000|Overall Study|Withdrawal by Subject|11|||
162212277|NCT00661713|585827370|FG001|Overall Study|Withdrawal by Subject|25|||
161826337|NCT01266603|584403849|FG000|Overall Study|Adverse Event|1|||
162212278|NCT00661713|585827371|FG002|Overall Study|Withdrawal by Subject|12|||
162212279|NCT00661713|585827372|FG003|Overall Study|Withdrawal by Subject|21|||
162212280|NCT00661713|585827373|FG004|Overall Study|Withdrawal by Subject|12|||
162212281|NCT00661713|585827374|FG005|Overall Study|Withdrawal by Subject|26|||
161826338|NCT01266603|584403849|FG000|Overall Study|Lack of Efficacy|14|||
161826339|NCT01266603|584403849|FG000|Overall Study|Withdrawal by Subject|1|||
162212282|NCT00661713|585827375|FG006|Overall Study|Withdrawal by Subject|45|||
162212283|NCT00661713|585827376|FG007|Overall Study|Withdrawal by Subject|9|||
162212284|NCT00661713|585827369|FG000|Overall Study|Lost to Follow-up|2|||
162212285|NCT00661713|585827370|FG001|Overall Study|Lost to Follow-up|7|||
162212286|NCT00661713|585827371|FG002|Overall Study|Lost to Follow-up|2|||
162212287|NCT00661713|585827372|FG003|Overall Study|Lost to Follow-up|2|||
162212288|NCT00661713|585827373|FG004|Overall Study|Lost to Follow-up|5|||
162212289|NCT00661713|585827374|FG005|Overall Study|Lost to Follow-up|7|||
162212290|NCT00661713|585827375|FG006|Overall Study|Lost to Follow-up|14|||
162212291|NCT00661713|585827376|FG007|Overall Study|Lost to Follow-up|1|||
162212292|NCT00661713|585827369|FG000|Overall Study|Administrative Reason|0|||
162212293|NCT00661713|585827370|FG001|Overall Study|Administrative Reason|1|||
162212294|NCT00661713|585827371|FG002|Overall Study|Administrative Reason|0|||
162212295|NCT00661713|585827372|FG003|Overall Study|Administrative Reason|2|||
162212296|NCT00661713|585827373|FG004|Overall Study|Administrative Reason|2|||
162212297|NCT00661713|585827374|FG005|Overall Study|Administrative Reason|2|||
162212298|NCT00661713|585827375|FG006|Overall Study|Administrative Reason|1|||
162212299|NCT00661713|585827376|FG007|Overall Study|Administrative Reason|0|||
162212300|NCT00661713|585827369|FG000|Overall Study|Adverse Event|0|||
162212301|NCT00661713|585827370|FG001|Overall Study|Adverse Event|0|||
162212302|NCT00661713|585827371|FG002|Overall Study|Adverse Event|0|||
162212303|NCT00661713|585827372|FG003|Overall Study|Adverse Event|0|||
162212304|NCT00661713|585827373|FG004|Overall Study|Adverse Event|0|||
162212305|NCT00661713|585827374|FG005|Overall Study|Adverse Event|0|||
162212306|NCT00661713|585827375|FG006|Overall Study|Adverse Event|1|||
162212307|NCT00661713|585827376|FG007|Overall Study|Adverse Event|0|||
162212308|NCT00661713|585827369|FG000|Overall Study|Inappropriate Enrollment|0|||
162212309|NCT00661713|585827370|FG001|Overall Study|Inappropriate Enrollment|0|||
162212310|NCT00661713|585827371|FG002|Overall Study|Inappropriate Enrollment|0|||
162212311|NCT00661713|585827372|FG003|Overall Study|Inappropriate Enrollment|0|||
162212312|NCT00661713|585827373|FG004|Overall Study|Inappropriate Enrollment|0|||
162212313|NCT00661713|585827374|FG005|Overall Study|Inappropriate Enrollment|0|||
162212314|NCT00661713|585827375|FG006|Overall Study|Inappropriate Enrollment|1|||
162212315|NCT00661713|585827376|FG007|Overall Study|Inappropriate Enrollment|0|||
162212316|NCT05314374|585827377|FG000|Overall Study|Adverse Event|2|||
162212317|NCT05314374|585827378|FG001|Overall Study|Adverse Event|2|||
162212318|NCT03783689|585827381|FG000|Overall Study|Adverse Event|2|||
162212319|NCT03783689|585827382|FG001|Overall Study|Adverse Event|0|||
162212320|NCT03783689|585827381|FG000|Overall Study|Lost to Follow-up|2|||
162212321|NCT03783689|585827382|FG001|Overall Study|Lost to Follow-up|1|||
162212322|NCT03783689|585827381|FG000|Overall Study|Physician Decision|2|||
162212323|NCT03783689|585827382|FG001|Overall Study|Physician Decision|1|||
162212324|NCT03783689|585827381|FG000|Overall Study|Withdrawal by Subject|3|||
162212325|NCT03783689|585827382|FG001|Overall Study|Withdrawal by Subject|3|||
162212326|NCT02392104|585827383|FG000|Overall Study|discontinuation of warfarin|3|||
162212327|NCT02392104|585827383|FG000|Overall Study|bleeding event|1|||
162212328|NCT02392104|585827383|FG000|Overall Study|transferred care to another doctor|2|||
162212329|NCT02392104|585827383|FG000|Overall Study|INR goal range changed|1|||
162212330|NCT02392104|585827383|FG000|Overall Study|admitted to skilled nursing facility|3|||
162212331|NCT02392104|585827383|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
162212332|NCT04887506|585827384|FG000|Overall Study|Death|1|||
162212333|NCT04887506|585827385|FG001|Overall Study|Death|1|||
162212334|NCT04887506|585827384|FG000|Overall Study|Withdrawal by Subject|0|||
162212335|NCT04887506|585827385|FG001|Overall Study|Withdrawal by Subject|3|||
162212336|NCT04887506|585827384|FG000|Overall Study|Adverse Event|4|||
162212337|NCT04887506|585827385|FG001|Overall Study|Adverse Event|3|||
162212338|NCT04887506|585827384|FG000|Overall Study|Other - Not Reported|1|||
162212339|NCT04887506|585827385|FG001|Overall Study|Other - Not Reported|1|||
162212340|NCT04590404|585827386|FG000|Overall Study|Death|16|||
162212341|NCT04590404|585827387|FG001|Overall Study|Death|17|||
162212342|NCT04590404|585827386|FG000|Overall Study|Withdrawal by Subject|7|||
162212343|NCT04590404|585827387|FG001|Overall Study|Withdrawal by Subject|2|||
162212344|NCT03912532|585827388|FG000|Overall Study|Adverse Event|3|||
162212345|NCT03912532|585827389|FG001|Overall Study|Adverse Event|3|||
162212346|NCT03912532|585827390|FG002|Overall Study|Adverse Event|2|||
162212347|NCT03912532|585827391|FG003|Overall Study|Adverse Event|2|||
162212348|NCT03912532|585827388|FG000|Overall Study|Lost to Follow-up|3|||
162212349|NCT03912532|585827389|FG001|Overall Study|Lost to Follow-up|2|||
162212350|NCT03912532|585827390|FG002|Overall Study|Lost to Follow-up|1|||
162212351|NCT03912532|585827391|FG003|Overall Study|Lost to Follow-up|2|||
162212352|NCT03912532|585827388|FG000|Overall Study|Withdrawal by Subject|1|||
162212353|NCT03912532|585827389|FG001|Overall Study|Withdrawal by Subject|1|||
162212354|NCT03912532|585827390|FG002|Overall Study|Withdrawal by Subject|2|||
162212355|NCT03912532|585827391|FG003|Overall Study|Withdrawal by Subject|0|||
162212356|NCT03912532|585827388|FG000|Overall Study|Physician Decision|1|||
162212357|NCT03912532|585827389|FG001|Overall Study|Physician Decision|0|||
162212358|NCT03912532|585827390|FG002|Overall Study|Physician Decision|0|||
162212359|NCT03912532|585827391|FG003|Overall Study|Physician Decision|3|||
162212360|NCT03912532|585827388|FG000|Overall Study|Other|0|||
162212361|NCT03912532|585827389|FG001|Overall Study|Other|1|||
162212362|NCT03912532|585827390|FG002|Overall Study|Other|1|||
161826340|NCT01266603|584403849|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
162212363|NCT03912532|585827391|FG003|Overall Study|Other|0|||
162212364|NCT03783871|585827394|FG000|Overall Study|Withdrawal by Subject|15|||
162212365|NCT03783871|585827394|FG000|Overall Study|Death|13|||
162212366|NCT03783871|585827394|FG000|Overall Study|Lost to Follow-up|2|||
162212367|NCT05990387|585827395|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
162212368|NCT05990387|585827396|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
162212369|NCT03522389|585827397|FG000|Overall Study|Lost to Follow-up|1|||
162212370|NCT03522389|585827398|FG001|Overall Study|Lost to Follow-up|1|||
162212371|NCT03522389|585827399|FG002|Overall Study|Lost to Follow-up|2|||
162212372|NCT03522389|585827397|FG000|Overall Study|had herniated nucleus pulposus|0|||
162212373|NCT03522389|585827398|FG001|Overall Study|had herniated nucleus pulposus|1|||
162212374|NCT03522389|585827399|FG002|Overall Study|had herniated nucleus pulposus|0|||
162212375|NCT03522389|585827397|FG000|Overall Study|go to work in other province|1|||
162212376|NCT03522389|585827398|FG001|Overall Study|go to work in other province|0|||
162212377|NCT03522389|585827399|FG002|Overall Study|go to work in other province|0|||
162212378|NCT00604188|585827400|FG000|Overall Study|Adverse Event|1|||
162212379|NCT00604188|585827401|FG001|Overall Study|Adverse Event|4|||
162212380|NCT00604188|585827400|FG000|Overall Study|Lost to Follow-up|17|||
162212381|NCT00604188|585827401|FG001|Overall Study|Lost to Follow-up|15|||
162212382|NCT00604188|585827400|FG000|Overall Study|Withdrawal by Subject|5|||
162212383|NCT00604188|585827401|FG001|Overall Study|Withdrawal by Subject|1|||
162212384|NCT00604188|585827400|FG000|Overall Study|Non-compliance with protocol|4|||
162212385|NCT00604188|585827401|FG001|Overall Study|Non-compliance with protocol|4|||
162212386|NCT00604188|585827400|FG000|Overall Study|Did not receive study drug|0|||
162212387|NCT00604188|585827401|FG001|Overall Study|Did not receive study drug|1|||
162212388|NCT02242643|585827404|FG000|Overall Study|Protocol Violation|1|||
162212389|NCT02242643|585827405|FG001|Overall Study|Protocol Violation|2|||
162212390|NCT02242643|585827404|FG000|Overall Study|Withdrawal by Subject|15|||
162212391|NCT02242643|585827405|FG001|Overall Study|Withdrawal by Subject|10|||
162212392|NCT02242643|585827404|FG000|Overall Study|Migrated/moved from study area|1|||
162212393|NCT02242643|585827405|FG001|Overall Study|Migrated/moved from study area|3|||
161826341|NCT02725411|584403852|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
161826342|NCT02725411|584403853|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
161826343|NCT02725411|584403854|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
161826344|NCT02725411|584403852|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
161826345|NCT02725411|584403853|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
161826346|NCT02725411|584403854|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
162212394|NCT02242643|585827404|FG000|Overall Study|Lost to Follow-up|54|||
162212395|NCT02242643|585827405|FG001|Overall Study|Lost to Follow-up|61|||
162212396|NCT02242643|585827404|FG000|Overall Study|Child placed in foster care by family|0|||
162212397|NCT02242643|585827405|FG001|Overall Study|Child placed in foster care by family|1|||
162212398|NCT02242643|585827404|FG000|Overall Study|Non-compliance|1|||
161826347|NCT02725411|584403852|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
161826348|NCT02725411|584403853|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
161826349|NCT02725411|584403854|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
161826350|NCT02725411|584403852|FG000|Treatment Period (56 Weeks)|Other|1|||
161826351|NCT02725411|584403853|FG001|Treatment Period (56 Weeks)|Other|4|||
161935240|NCT05415215|584813878|FG004|Neoadjuvant Phase|Progressive Disease|0|||
161935241|NCT05415215|584813879|FG005|Neoadjuvant Phase|Progressive Disease|0|||
161935242|NCT05415215|584813880|FG006|Neoadjuvant Phase|Progressive Disease|0|||
162212399|NCT02242643|585827405|FG001|Overall Study|Non-compliance|0|||
162212400|NCT02242643|585827404|FG000|Overall Study|Consent withdrawal by parent|1|||
162212401|NCT02242643|585827405|FG001|Overall Study|Consent withdrawal by parent|0|||
162212402|NCT02242643|585827404|FG000|Overall Study|Protocol requirements not followed|1|||
162212403|NCT02242643|585827405|FG001|Overall Study|Protocol requirements not followed|0|||
161935243|NCT05415215|584813881|FG007|Neoadjuvant Phase|Progressive Disease|0|||
161935244|NCT05415215|584813874|FG000|Neoadjuvant Phase|Reason not Specified|1|||
161935245|NCT05415215|584813875|FG001|Neoadjuvant Phase|Reason not Specified|4|||
162212404|NCT02242643|585827404|FG000|Overall Study|Language barrier|1|||
162212405|NCT02242643|585827405|FG001|Overall Study|Language barrier|0|||
162212406|NCT02242643|585827404|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
162212407|NCT02242643|585827405|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
162212408|NCT03526679|585828792|FG000|Overall Study|still under treatment|2|||
161826352|NCT02725411|584403854|FG002|Treatment Period (56 Weeks)|Other|5|||
161826353|NCT02725411|584403852|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
161826354|NCT02725411|584403853|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
161826355|NCT02725411|584403854|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
161935246|NCT05415215|584813876|FG002|Neoadjuvant Phase|Reason not Specified|0|||
161935247|NCT05415215|584813877|FG003|Neoadjuvant Phase|Reason not Specified|0|||
162212409|NCT03023722|585828793|FG000|Overall Study|No follow-up assessment|4|||
162212410|NCT03616964|585828794|FG000|Overall Study|Adverse Event|15|||
161826356|NCT02725411|584403852|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
161826357|NCT02725411|584403853|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
161826358|NCT02725411|584403854|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
161826359|NCT02725411|584403852|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
161826360|NCT02725411|584403853|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
161826361|NCT02725411|584403854|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
161826362|NCT02725411|584403852|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
161826363|NCT02725411|584403853|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
161826364|NCT02725411|584403854|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
161826365|NCT02725411|584403852|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
161826366|NCT02725411|584403853|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
161826367|NCT02725411|584403854|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
161826368|NCT02725411|584403852|FG000|Follow-up Period (24 Weeks)|Other|1|||
161826369|NCT02725411|584403853|FG001|Follow-up Period (24 Weeks)|Other|4|||
161826370|NCT02725411|584403854|FG002|Follow-up Period (24 Weeks)|Other|2|||
161826371|NCT02725411|584403852|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
161826372|NCT02725411|584403853|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
161826373|NCT02725411|584403854|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
161826374|NCT04307849|584403855|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
161826375|NCT04307849|584403856|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
161826376|NCT04307849|584403857|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
161826377|NCT04307849|584403858|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
161826378|NCT04307849|584403859|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
161826379|NCT04307849|584403860|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
161826380|NCT04307849|584403855|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161826381|NCT04307849|584403856|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161826382|NCT04307849|584403857|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
161826383|NCT04307849|584403858|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161826384|NCT04307849|584403859|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161826385|NCT04307849|584403860|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161826386|NCT04307849|584403855|FG000|Overall Study|Family member did not want them to continue|0|||
161826387|NCT04307849|584403856|FG001|Overall Study|Family member did not want them to continue|0|||
161826388|NCT04307849|584403857|FG002|Overall Study|Family member did not want them to continue|1|||
161826389|NCT04307849|584403858|FG003|Overall Study|Family member did not want them to continue|0|||
161826390|NCT04307849|584403859|FG004|Overall Study|Family member did not want them to continue|0|||
161826391|NCT04307849|584403860|FG005|Overall Study|Family member did not want them to continue|0|||
161826392|NCT04307849|584403855|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
161826393|NCT04307849|584403856|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
161826394|NCT04307849|584403857|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
161826395|NCT04307849|584403858|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
161826396|NCT04307849|584403859|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
161826397|NCT04307849|584403860|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
161826398|NCT00756717|584403861|FG000|Overall Study|Withdrawal by Subject|2|||
161826399|NCT02654015|584403862|FG000|Overall Study|Death|12|||
161826400|NCT02654015|584403862|FG000|Overall Study|Lost to Follow-up|3|||
161826401|NCT02418754|584403865|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
161826402|NCT02418754|584403866|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
161826403|NCT02418754|584403867|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
161826404|NCT02418754|584403868|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
161826405|NCT02418754|584403869|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
161826406|NCT02418754|584403865|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
161826407|NCT02418754|584403866|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
161826408|NCT02418754|584403867|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
161826409|NCT02418754|584403868|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
161826410|NCT02418754|584403869|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
161826411|NCT02418754|584403865|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
161826412|NCT02418754|584403866|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
161826413|NCT02418754|584403867|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
161826414|NCT02418754|584403868|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
161826415|NCT02418754|584403869|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
161826416|NCT02418754|584403865|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
161826417|NCT02418754|584403866|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
161826418|NCT02418754|584403867|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
161826419|NCT02418754|584403868|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
161826420|NCT02418754|584403869|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
161826421|NCT02418754|584403865|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
161826422|NCT02418754|584403866|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
161826423|NCT02418754|584403867|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
161826424|NCT02418754|584403868|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
161826425|NCT02418754|584403869|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
162212411|NCT03616964|585828795|FG001|Overall Study|Adverse Event|10|||
162212412|NCT03616964|585828796|FG002|Overall Study|Adverse Event|16|||
162212413|NCT03616964|585828794|FG000|Overall Study|Death|3|||
162212414|NCT03616964|585828795|FG001|Overall Study|Death|0|||
162212415|NCT03616964|585828796|FG002|Overall Study|Death|4|||
162212416|NCT03616964|585828794|FG000|Overall Study|Lack of Efficacy|4|||
162212417|NCT03616964|585828795|FG001|Overall Study|Lack of Efficacy|8|||
162212418|NCT03616964|585828796|FG002|Overall Study|Lack of Efficacy|8|||
162212419|NCT03616964|585828794|FG000|Overall Study|Lost to Follow-up|2|||
162212420|NCT03616964|585828795|FG001|Overall Study|Lost to Follow-up|1|||
161826426|NCT02418754|584403865|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
161826427|NCT02418754|584403866|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
161826428|NCT02418754|584403867|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
162212421|NCT03616964|585828796|FG002|Overall Study|Lost to Follow-up|3|||
162212422|NCT03616964|585828794|FG000|Overall Study|Withdrawal by Subject|18|||
162212423|NCT03616964|585828795|FG001|Overall Study|Withdrawal by Subject|14|||
162212424|NCT03616964|585828796|FG002|Overall Study|Withdrawal by Subject|21|||
162212425|NCT03616964|585828794|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
162212426|NCT03616964|585828795|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
162212427|NCT03616964|585828796|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
162212428|NCT03616964|585828794|FG000|Overall Study|Sponsor's Decision|1|||
162212429|NCT03616964|585828795|FG001|Overall Study|Sponsor's Decision|0|||
162212430|NCT03616964|585828796|FG002|Overall Study|Sponsor's Decision|0|||
162212431|NCT03616964|585828794|FG000|Overall Study|Physician Decision|0|||
162212432|NCT03616964|585828795|FG001|Overall Study|Physician Decision|2|||
162212433|NCT03616964|585828796|FG002|Overall Study|Physician Decision|0|||
162212434|NCT03616964|585828794|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
162212435|NCT03616964|585828795|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
162212436|NCT03616964|585828796|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
162212437|NCT03616964|585828794|FG000|Overall Study|Protocol Violation|0|||
162212438|NCT03616964|585828795|FG001|Overall Study|Protocol Violation|1|||
162212439|NCT03616964|585828796|FG002|Overall Study|Protocol Violation|0|||
162212440|NCT03616964|585828794|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
161826429|NCT02418754|584403868|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
162212441|NCT03616964|585828795|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
162212442|NCT03616964|585828796|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
162212443|NCT03616964|585828794|FG000|Overall Study|Randomized but Never Treated|1|||
162212444|NCT03616964|585828795|FG001|Overall Study|Randomized but Never Treated|1|||
162212445|NCT03616964|585828796|FG002|Overall Study|Randomized but Never Treated|1|||
162212446|NCT04596995|585828797|FG000|Overall Study|Lack of Efficacy|8|||
162212447|NCT04596995|585828797|FG000|Overall Study|Lost to Follow-up|3|||
162212448|NCT04596995|585828797|FG000|Overall Study|Withdrawal by Subject|12|||
161826430|NCT02418754|584403869|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
161826431|NCT02418754|584403865|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
161826432|NCT02418754|584403866|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
161826433|NCT02418754|584403867|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
161826434|NCT02418754|584403868|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
161826435|NCT02418754|584403869|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
161826436|NCT02418754|584403865|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
162212449|NCT04596995|585828797|FG000|Overall Study|Sponsor decision|3|||
162212450|NCT04596995|585828797|FG000|Overall Study|Enrolled in managed access program|3|||
162212451|NCT00129935|585828798|FG000|Overall Study|Adverse Event|18|||
162212452|NCT00129935|585828799|FG001|Overall Study|Adverse Event|56|||
162212453|NCT00129935|585828798|FG000|Overall Study|Death|1|||
162212454|NCT00129935|585828799|FG001|Overall Study|Death|1|||
162212455|NCT00129935|585828798|FG000|Overall Study|Withdrawal by Subject|7|||
162212456|NCT00129935|585828799|FG001|Overall Study|Withdrawal by Subject|20|||
162212457|NCT00129935|585828798|FG000|Overall Study|Protocol Violation|0|||
162212458|NCT00129935|585828799|FG001|Overall Study|Protocol Violation|4|||
162212459|NCT00129935|585828798|FG000|Overall Study|Physician Decision|3|||
162212460|NCT00129935|585828799|FG001|Overall Study|Physician Decision|4|||
162212461|NCT00129935|585828798|FG000|Overall Study|Recurrence|1|||
162212462|NCT00129935|585828799|FG001|Overall Study|Recurrence|3|||
162212463|NCT00129935|585828798|FG000|Overall Study|Second primary|0|||
162212464|NCT00129935|585828799|FG001|Overall Study|Second primary|1|||
162212465|NCT00129935|585828798|FG000|Overall Study|Other|3|||
162212466|NCT00129935|585828799|FG001|Overall Study|Other|2|||
162212467|NCT00129935|585828798|FG000|Overall Study|Crossed to the other arm|2|||
162212468|NCT00129935|585828799|FG001|Overall Study|Crossed to the other arm|1|||
162212469|NCT00129935|585828798|FG000|Overall Study|Incorrect study treatment|1|||
162212470|NCT00129935|585828799|FG001|Overall Study|Incorrect study treatment|0|||
162212471|NCT00590564|585828801|FG000|Overall Study|Withdrawal by Subject|4|||
162212472|NCT00590564|585828801|FG000|Overall Study|Lost to Follow-up|6|||
162212473|NCT00590564|585828801|FG000|Overall Study|Protocol Violation|1|||
162212474|NCT00590564|585828801|FG000|Overall Study|Patient Found to be Ineligible|1|||
162212475|NCT00590564|585828801|FG000|Overall Study|Patient Non-compliance|6|||
162212476|NCT02056626|585828802|FG000|Overall Study|patient did not follow directions|3|||
162212477|NCT02056626|585828803|FG001|Overall Study|patient did not follow directions|1|||
162212478|NCT02056626|585828804|FG002|Overall Study|patient did not follow directions|0|||
162212479|NCT02056626|585828805|FG003|Overall Study|patient did not follow directions|0|||
162212480|NCT04916002|585828807|FG000|Overall Study|Adverse Event|0|||
162212481|NCT04916002|585828808|FG001|Overall Study|Adverse Event|1|||
162212482|NCT04916002|585828809|FG002|Overall Study|Adverse Event|0|||
162212483|NCT04916002|585828810|FG003|Overall Study|Adverse Event|1|||
162212484|NCT04916002|585828811|FG004|Overall Study|Adverse Event|0|||
162212485|NCT04916002|585828807|FG000|Overall Study|Withdrawal by Subject|3|||
162212486|NCT04916002|585828808|FG001|Overall Study|Withdrawal by Subject|1|||
162212487|NCT04916002|585828809|FG002|Overall Study|Withdrawal by Subject|0|||
162212488|NCT04916002|585828810|FG003|Overall Study|Withdrawal by Subject|1|||
162212489|NCT04916002|585828811|FG004|Overall Study|Withdrawal by Subject|0|||
162212490|NCT04916002|585828807|FG000|Overall Study|Death|8|||
162212491|NCT04916002|585828808|FG001|Overall Study|Death|7|||
162212492|NCT04916002|585828809|FG002|Overall Study|Death|4|||
162212493|NCT04916002|585828810|FG003|Overall Study|Death|9|||
162212494|NCT04916002|585828811|FG004|Overall Study|Death|0|||
162212495|NCT04916002|585828807|FG000|Overall Study|Study Terminated by Sponsor|11|||
162212496|NCT04916002|585828808|FG001|Overall Study|Study Terminated by Sponsor|10|||
162212497|NCT04916002|585828809|FG002|Overall Study|Study Terminated by Sponsor|8|||
162212498|NCT04916002|585828810|FG003|Overall Study|Study Terminated by Sponsor|5|||
162212499|NCT04916002|585828811|FG004|Overall Study|Study Terminated by Sponsor|4|||
162212500|NCT04916002|585828807|FG000|Overall Study|End of trial|1|||
162212501|NCT04916002|585828808|FG001|Overall Study|End of trial|0|||
162212502|NCT04916002|585828809|FG002|Overall Study|End of trial|0|||
162212503|NCT04916002|585828810|FG003|Overall Study|End of trial|0|||
162212504|NCT04916002|585828811|FG004|Overall Study|End of trial|0|||
162212505|NCT04916002|585828807|FG000|Overall Study|Progressive disease|0|||
162212506|NCT04916002|585828808|FG001|Overall Study|Progressive disease|0|||
162212507|NCT04916002|585828809|FG002|Overall Study|Progressive disease|1|||
162212508|NCT04916002|585828810|FG003|Overall Study|Progressive disease|0|||
162212509|NCT04916002|585828811|FG004|Overall Study|Progressive disease|0|||
162212510|NCT04916002|585828807|FG000|Overall Study|Participant non-compliance|2|||
162212511|NCT04916002|585828808|FG001|Overall Study|Participant non-compliance|0|||
161935248|NCT05415215|584813878|FG004|Neoadjuvant Phase|Reason not Specified|0|||
161935249|NCT05415215|584813879|FG005|Neoadjuvant Phase|Reason not Specified|0|||
162212512|NCT04916002|585828809|FG002|Overall Study|Participant non-compliance|0|||
162212513|NCT04916002|585828810|FG003|Overall Study|Participant non-compliance|0|||
162212514|NCT04916002|585828811|FG004|Overall Study|Participant non-compliance|0|||
162212515|NCT04836559|585828812|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
162212516|NCT04836559|585828813|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
162212517|NCT04836559|585828814|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
162212518|NCT04836559|585828815|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
162212519|NCT04836559|585828816|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
162212520|NCT04836559|585828817|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
162212521|NCT04836559|585828818|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
162212522|NCT04836559|585828819|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
162212523|NCT04836559|585828812|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161935250|NCT05415215|584813880|FG006|Neoadjuvant Phase|Reason not Specified|0|||
161935251|NCT05415215|584813881|FG007|Neoadjuvant Phase|Reason not Specified|0|||
162212524|NCT04836559|585828813|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
162212525|NCT04836559|585828814|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
162212526|NCT04836559|585828815|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
162212527|NCT04836559|585828816|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
162212528|NCT04836559|585828817|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
162212529|NCT04836559|585828818|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
162212530|NCT04836559|585828819|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
162212531|NCT04836559|585828812|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
162212532|NCT04836559|585828813|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
162212533|NCT04836559|585828814|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
162212534|NCT04836559|585828815|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161935252|NCT05415215|584813874|FG000|Neoadjuvant Phase|Treatment Intolerance|1|||
161935253|NCT05415215|584813875|FG001|Neoadjuvant Phase|Treatment Intolerance|1|||
162212535|NCT04836559|585828816|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
162212536|NCT04836559|585828817|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
162212537|NCT04836559|585828818|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
162212538|NCT04836559|585828819|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161935254|NCT05415215|584813876|FG002|Neoadjuvant Phase|Treatment Intolerance|0|||
161935255|NCT05415215|584813877|FG003|Neoadjuvant Phase|Treatment Intolerance|0|||
161935256|NCT05415215|584813878|FG004|Neoadjuvant Phase|Treatment Intolerance|0|||
161935257|NCT05415215|584813879|FG005|Neoadjuvant Phase|Treatment Intolerance|0|||
161935258|NCT05415215|584813880|FG006|Neoadjuvant Phase|Treatment Intolerance|0|||
161935259|NCT05415215|584813881|FG007|Neoadjuvant Phase|Treatment Intolerance|0|||
161935260|NCT05415215|584813874|FG000|Neoadjuvant Phase|Lost to Follow-up|1|||
161935261|NCT05415215|584813875|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
161935262|NCT05415215|584813876|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
161935263|NCT05415215|584813877|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
161935264|NCT05415215|584813878|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
161935265|NCT05415215|584813879|FG005|Neoadjuvant Phase|Lost to Follow-up|0|||
161935266|NCT05415215|584813880|FG006|Neoadjuvant Phase|Lost to Follow-up|0|||
161935267|NCT05415215|584813881|FG007|Neoadjuvant Phase|Lost to Follow-up|0|||
161935268|NCT05415215|584813874|FG000|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161935269|NCT05415215|584813875|FG001|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161935270|NCT05415215|584813876|FG002|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161935271|NCT05415215|584813877|FG003|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
161935272|NCT05415215|584813878|FG004|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
162212539|NCT04836559|585828812|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
162212540|NCT04836559|585828813|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
162212541|NCT04836559|585828814|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
162212542|NCT04836559|585828815|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
162212543|NCT04836559|585828816|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
162212544|NCT04836559|585828817|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
162212545|NCT04836559|585828818|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
162212546|NCT04836559|585828819|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
162212547|NCT04836559|585828812|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162212548|NCT04836559|585828813|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162212549|NCT04836559|585828814|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162212550|NCT04836559|585828815|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
162212551|NCT04836559|585828816|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162212552|NCT04836559|585828817|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162212553|NCT04836559|585828818|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162212554|NCT04836559|585828819|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
162212555|NCT04836559|585828812|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
162212556|NCT04836559|585828813|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
162212557|NCT04836559|585828814|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
162212558|NCT04836559|585828815|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
162212559|NCT04836559|585828816|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
162212560|NCT04836559|585828817|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
162212561|NCT04836559|585828818|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
162212562|NCT04836559|585828819|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
162212563|NCT04836559|585828812|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
162212564|NCT04836559|585828813|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
161935273|NCT05415215|584813879|FG005|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161935274|NCT05415215|584813880|FG006|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161935275|NCT05415215|584813881|FG007|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
162212565|NCT04836559|585828814|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
162212566|NCT04836559|585828815|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
162212567|NCT04836559|585828816|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
162212568|NCT04836559|585828817|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
162212569|NCT04836559|585828818|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
162212570|NCT04836559|585828819|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
161826437|NCT02418754|584403866|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
161826438|NCT02418754|584403867|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
161826439|NCT02418754|584403868|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
162212571|NCT04836559|585828812|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
162212572|NCT04836559|585828813|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
162212573|NCT04836559|585828814|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
162212574|NCT04836559|585828815|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
162212575|NCT04836559|585828816|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
162212576|NCT04836559|585828817|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
162212577|NCT04836559|585828818|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
162212578|NCT04836559|585828819|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
162212579|NCT04836559|585828812|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162212580|NCT04836559|585828813|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162212581|NCT04836559|585828814|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162212582|NCT04836559|585828815|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162212583|NCT04836559|585828816|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162212584|NCT04836559|585828817|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162212585|NCT04836559|585828818|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
162212586|NCT04836559|585828819|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
162212587|NCT04978350|585828820|FG000|Overall Study|Lost to Follow-up|6|||
162212588|NCT05923112|585828821|FG000|Overall Study|Protocol Violation|4|||
162212589|NCT05923112|585828821|FG000|Overall Study|No informed consent on publication of study results|243|||
162212590|NCT04991766|585828822|FG000|Overall Study|Withdrawal by Subject|2|||
162212591|NCT04991766|585828823|FG001|Overall Study|Withdrawal by Subject|0|||
162212592|NCT05147350|585828829|FG000|Overall Study|Death|2|||
162212593|NCT05147350|585828830|FG001|Overall Study|Death|3|||
162212594|NCT05147350|585828831|FG002|Overall Study|Death|3|||
162212595|NCT05147350|585828832|FG003|Overall Study|Death|2|||
162212596|NCT05147350|585828833|FG004|Overall Study|Death|2|||
162212597|NCT05147350|585828834|FG005|Overall Study|Death|1|||
162212598|NCT05147350|585828835|FG006|Overall Study|Death|1|||
162212599|NCT05147350|585828836|FG007|Overall Study|Death|3|||
162212600|NCT05147350|585828829|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
162212601|NCT05147350|585828830|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
162212602|NCT05147350|585828831|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
162212603|NCT05147350|585828832|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
162212604|NCT05147350|585828833|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
161826440|NCT02418754|584403869|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
161826441|NCT02418754|584403865|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
161826442|NCT02418754|584403866|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
161826443|NCT02418754|584403867|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
161826444|NCT02418754|584403868|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
161826445|NCT02418754|584403869|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
161826446|NCT02418754|584403865|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
161826447|NCT02418754|584403866|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
161826448|NCT02418754|584403867|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
161826449|NCT02418754|584403868|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
161826450|NCT02418754|584403869|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
161826451|NCT02418754|584403865|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
161826452|NCT02418754|584403866|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
161826453|NCT02418754|584403867|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
161826454|NCT02418754|584403868|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
161935276|NCT05415215|584813874|FG000|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161935277|NCT05415215|584813875|FG001|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161935278|NCT05415215|584813876|FG002|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161935279|NCT05415215|584813877|FG003|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
161935280|NCT05415215|584813878|FG004|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
161935281|NCT05415215|584813879|FG005|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161935282|NCT05415215|584813880|FG006|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161935283|NCT05415215|584813881|FG007|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161935284|NCT05415215|584813874|FG000|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935285|NCT05415215|584813875|FG001|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935286|NCT05415215|584813876|FG002|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935287|NCT05415215|584813877|FG003|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935288|NCT05415215|584813878|FG004|Adjuvant Phase: Cross-over Period|Treatment Intolerance|1|||
161935289|NCT05415215|584813879|FG005|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935290|NCT05415215|584813880|FG006|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935291|NCT05415215|584813881|FG007|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161935292|NCT05415215|584813874|FG000|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935293|NCT05415215|584813875|FG001|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935294|NCT05415215|584813876|FG002|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935295|NCT05415215|584813877|FG003|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935296|NCT05415215|584813878|FG004|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935297|NCT05415215|584813879|FG005|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935298|NCT05415215|584813880|FG006|Adjuvant Phase: Continuation Period|Adverse Event|1|||
161935299|NCT05415215|584813881|FG007|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161935300|NCT05415215|584813874|FG000|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161935301|NCT05415215|584813875|FG001|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161935302|NCT05415215|584813876|FG002|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161935303|NCT05415215|584813877|FG003|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161826455|NCT02418754|584403869|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
161826456|NCT00761176|584403872|FG000|Overall Study|Death|1|||
161826457|NCT00761176|584403873|FG001|Overall Study|Death|0|||
161826458|NCT00761176|584403872|FG000|Overall Study|Withdrawal by Subject|1|||
161935304|NCT05415215|584813878|FG004|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161935305|NCT05415215|584813879|FG005|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|1|||
161826459|NCT00761176|584403873|FG001|Overall Study|Withdrawal by Subject|1|||
161826460|NCT02762994|584403874|FG000|Overall Study|Withdrawal by Subject|0|||
161826461|NCT02762994|584403875|FG001|Overall Study|Withdrawal by Subject|1|||
161826462|NCT02762994|584403876|FG002|Overall Study|Withdrawal by Subject|2|||
161826463|NCT02762994|584403877|FG003|Overall Study|Withdrawal by Subject|0|||
161826464|NCT02762994|584403874|FG000|Overall Study|Protocol Violation|1|||
161826465|NCT02762994|584403875|FG001|Overall Study|Protocol Violation|0|||
161826466|NCT02762994|584403876|FG002|Overall Study|Protocol Violation|0|||
161826467|NCT02762994|584403877|FG003|Overall Study|Protocol Violation|2|||
161826468|NCT05103657|584403880|FG000|Overall Study|Other reasons than listed|9|||
161826469|NCT05103657|584403881|FG001|Overall Study|Other reasons than listed|8|||
161826470|NCT05103657|584403880|FG000|Overall Study|Protocol deviation|2|||
161826471|NCT05103657|584403881|FG001|Overall Study|Protocol deviation|2|||
161826472|NCT05103657|584403880|FG000|Overall Study|No reason available|5|||
161826473|NCT05103657|584403881|FG001|Overall Study|No reason available|4|||
161826474|NCT05103657|584403880|FG000|Overall Study|Burden of study procedures|3|||
161826475|NCT05103657|584403881|FG001|Overall Study|Burden of study procedures|1|||
161826476|NCT05103657|584403880|FG000|Overall Study|Perceived lack of efficacy|1|||
161826477|NCT05103657|584403881|FG001|Overall Study|Perceived lack of efficacy|1|||
161826478|NCT05103657|584403880|FG000|Overall Study|Adverse Event|6|||
161826479|NCT05103657|584403881|FG001|Overall Study|Adverse Event|14|||
161826480|NCT05103657|584403880|FG000|Overall Study|Not Treated|1|||
161826481|NCT05103657|584403881|FG001|Overall Study|Not Treated|1|||
161826482|NCT02020967|584403882|FG000|Overall Study|Withdrawal by Subject|51|||
161826483|NCT02387762|584403885|FG000|Overall Study|Withdrawal by Subject|1|||
161826484|NCT02387762|584403886|FG001|Overall Study|Withdrawal by Subject|0|||
161935306|NCT05415215|584813880|FG006|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161935307|NCT05415215|584813881|FG007|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161935308|NCT05415215|584813874|FG000|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161935309|NCT05415215|584813875|FG001|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161935310|NCT05415215|584813876|FG002|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161826485|NCT00642811|584403889|FG000|Overall Study|Adverse Event|2|||
161826486|NCT00642811|584403890|FG001|Overall Study|Adverse Event|3|||
161826487|NCT00642811|584403891|FG002|Overall Study|Adverse Event|0|||
161826488|NCT00642811|584403892|FG003|Overall Study|Adverse Event|0|||
161826489|NCT00642811|584403893|FG004|Overall Study|Adverse Event|0|||
161826490|NCT00642811|584403894|FG005|Overall Study|Adverse Event|1|||
161678003|NCT01994382|583873596|FG012|Overall Study|Protocol violation/noncompliance|0|||
161678004|NCT01994382|583873597|FG013|Overall Study|Protocol violation/noncompliance|0|||
161678005|NCT01994382|583873598|FG014|Overall Study|Protocol violation/noncompliance|0|||
161678006|NCT01994382|583873599|FG015|Overall Study|Protocol violation/noncompliance|0|||
161678007|NCT01994382|583873600|FG016|Overall Study|Protocol violation/noncompliance|2|||
161678008|NCT01994382|583873584|FG000|Overall Study|Rolled over to Phase 2a|0|||
161678009|NCT01994382|583873585|FG001|Overall Study|Rolled over to Phase 2a|0|||
161678010|NCT01994382|583873586|FG002|Overall Study|Rolled over to Phase 2a|1|||
161678011|NCT01994382|583873587|FG003|Overall Study|Rolled over to Phase 2a|0|||
161678012|NCT01994382|583873588|FG004|Overall Study|Rolled over to Phase 2a|0|||
161678013|NCT01994382|583873589|FG005|Overall Study|Rolled over to Phase 2a|0|||
161678014|NCT01994382|583873590|FG006|Overall Study|Rolled over to Phase 2a|0|||
161678015|NCT01994382|583873591|FG007|Overall Study|Rolled over to Phase 2a|0|||
161678016|NCT01994382|583873592|FG008|Overall Study|Rolled over to Phase 2a|0|||
161678017|NCT01994382|583873593|FG009|Overall Study|Rolled over to Phase 2a|2|||
161678018|NCT01994382|583873594|FG010|Overall Study|Rolled over to Phase 2a|0|||
161678019|NCT01994382|583873595|FG011|Overall Study|Rolled over to Phase 2a|0|||
161678020|NCT01994382|583873596|FG012|Overall Study|Rolled over to Phase 2a|0|||
161678021|NCT01994382|583873597|FG013|Overall Study|Rolled over to Phase 2a|0|||
161678022|NCT01994382|583873598|FG014|Overall Study|Rolled over to Phase 2a|0|||
161678023|NCT01994382|583873599|FG015|Overall Study|Rolled over to Phase 2a|0|||
161678024|NCT01994382|583873600|FG016|Overall Study|Rolled over to Phase 2a|0|||
161678025|NCT04667377|583873601|FG000|Dose Escalation Period|Other not specified below|3|||
161678026|NCT04667377|583873602|FG001|Dose Escalation Period|Other not specified below|3|||
161678027|NCT04667377|583873603|FG002|Dose Escalation Period|Other not specified below|2|||
161678028|NCT04667377|583873604|FG003|Dose Escalation Period|Other not specified below|1|||
161678029|NCT04667377|583873605|FG004|Dose Escalation Period|Other not specified below|3|||
161678030|NCT04667377|583873601|FG000|Dose Escalation Period|Protocol Violation|2|||
161678031|NCT04667377|583873602|FG001|Dose Escalation Period|Protocol Violation|2|||
161678032|NCT04667377|583873603|FG002|Dose Escalation Period|Protocol Violation|0|||
161678033|NCT04667377|583873604|FG003|Dose Escalation Period|Protocol Violation|2|||
161678034|NCT04667377|583873605|FG004|Dose Escalation Period|Protocol Violation|1|||
161678035|NCT04667377|583873601|FG000|Dose Escalation Period|Burden of study procedures|2|||
161678036|NCT04667377|583873602|FG001|Dose Escalation Period|Burden of study procedures|1|||
161678037|NCT04667377|583873603|FG002|Dose Escalation Period|Burden of study procedures|1|||
161678038|NCT04667377|583873604|FG003|Dose Escalation Period|Burden of study procedures|1|||
161678039|NCT04667377|583873605|FG004|Dose Escalation Period|Burden of study procedures|5|||
161678040|NCT04667377|583873601|FG000|Dose Escalation Period|Change of residence|0|||
161678041|NCT04667377|583873602|FG001|Dose Escalation Period|Change of residence|0|||
161826491|NCT00642811|584403889|FG000|Overall Study|Developement of discontinuation criteria|0|||
161826492|NCT00642811|584403890|FG001|Overall Study|Developement of discontinuation criteria|0|||
161826493|NCT00642811|584403891|FG002|Overall Study|Developement of discontinuation criteria|0|||
161826494|NCT00642811|584403892|FG003|Overall Study|Developement of discontinuation criteria|0|||
161826495|NCT00642811|584403893|FG004|Overall Study|Developement of discontinuation criteria|1|||
161826496|NCT00642811|584403894|FG005|Overall Study|Developement of discontinuation criteria|0|||
161826497|NCT00642811|584403889|FG000|Overall Study|Severe Non-compliance to protocol|1|||
161826498|NCT00642811|584403890|FG001|Overall Study|Severe Non-compliance to protocol|0|||
161826499|NCT00642811|584403891|FG002|Overall Study|Severe Non-compliance to protocol|0|||
161826500|NCT00642811|584403892|FG003|Overall Study|Severe Non-compliance to protocol|0|||
161826501|NCT00642811|584403893|FG004|Overall Study|Severe Non-compliance to protocol|0|||
161826502|NCT00642811|584403894|FG005|Overall Study|Severe Non-compliance to protocol|0|||
161826503|NCT00642811|584403889|FG000|Overall Study|Other|0|||
161826504|NCT00642811|584403890|FG001|Overall Study|Other|1|||
161826505|NCT00642811|584403891|FG002|Overall Study|Other|0|||
161826506|NCT00642811|584403892|FG003|Overall Study|Other|1|||
161826507|NCT00642811|584403893|FG004|Overall Study|Other|0|||
161826508|NCT00642811|584403894|FG005|Overall Study|Other|0|||
161826509|NCT02614898|584403895|FG000|Overall Study|Participated until study termination|10|||
161826510|NCT02614898|584403896|FG001|Overall Study|Participated until study termination|26|||
161826511|NCT02614898|584403895|FG000|Overall Study|Lost to Follow-up|0|||
161826512|NCT02614898|584403896|FG001|Overall Study|Lost to Follow-up|2|||
161826513|NCT02614898|584403895|FG000|Overall Study|Physician Decision|1|||
161826514|NCT02614898|584403896|FG001|Overall Study|Physician Decision|8|||
161826515|NCT02614898|584403895|FG000|Overall Study|Study Terminated by Sponsor|3|||
161826516|NCT02614898|584403896|FG001|Overall Study|Study Terminated by Sponsor|0|||
161826517|NCT02614898|584403895|FG000|Overall Study|Withdrawal by Subject|0|||
161826518|NCT02614898|584403896|FG001|Overall Study|Withdrawal by Subject|2|||
161826519|NCT02614898|584403895|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161826520|NCT02614898|584403896|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161826521|NCT02614898|584403895|FG000|Overall Study|Other-Additional Information Unavailable|0|||
161826522|NCT02614898|584403896|FG001|Overall Study|Other-Additional Information Unavailable|11|||
161826523|NCT02614898|584403895|FG000|Overall Study|Missing|0|||
161826524|NCT02614898|584403896|FG001|Overall Study|Missing|1|||
162212605|NCT05147350|585828834|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
162212606|NCT05147350|585828835|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
162212607|NCT05147350|585828836|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
162212608|NCT05147350|585828829|FG000|Overall Study|Withdrawal by Subject|0|||
162212609|NCT05147350|585828830|FG001|Overall Study|Withdrawal by Subject|0|||
162212610|NCT05147350|585828831|FG002|Overall Study|Withdrawal by Subject|3|||
162212611|NCT05147350|585828832|FG003|Overall Study|Withdrawal by Subject|1|||
162212612|NCT05147350|585828833|FG004|Overall Study|Withdrawal by Subject|1|||
162212613|NCT05147350|585828834|FG005|Overall Study|Withdrawal by Subject|0|||
162212614|NCT05147350|585828835|FG006|Overall Study|Withdrawal by Subject|1|||
162212615|NCT05147350|585828836|FG007|Overall Study|Withdrawal by Subject|0|||
162212616|NCT05147350|585828829|FG000|Overall Study|Other Reasons|0|||
162212617|NCT05147350|585828830|FG001|Overall Study|Other Reasons|0|||
161678042|NCT04667377|583873603|FG002|Dose Escalation Period|Change of residence|1|||
161826525|NCT00810602|584403899|FG000|Overall Study|Withdrawal by Subject|8|||
161826526|NCT00810602|584403900|FG001|Overall Study|Withdrawal by Subject|3|||
161826527|NCT00434590|584403901|FG000|Overall Study|Administrative problems|5|||
162212618|NCT05147350|585828831|FG002|Overall Study|Other Reasons|2|||
162212619|NCT05147350|585828832|FG003|Overall Study|Other Reasons|0|||
162212620|NCT05147350|585828833|FG004|Overall Study|Other Reasons|0|||
162212621|NCT05147350|585828834|FG005|Overall Study|Other Reasons|2|||
162212622|NCT05147350|585828835|FG006|Overall Study|Other Reasons|1|||
162212623|NCT05147350|585828836|FG007|Overall Study|Other Reasons|1|||
162212624|NCT06136897|585828837|FG000|Overall Study|Ineligible|3|||
162212625|NCT06136897|585828837|FG000|Overall Study|Mutation status not confirmed|7|||
162212626|NCT06136897|585828837|FG000|Overall Study|Adverse Event|2|||
162212627|NCT06136897|585828837|FG000|Overall Study|Death|1|||
162212628|NCT06136897|585828837|FG000|Overall Study|Disease progression|18|||
162212629|NCT06136897|585828837|FG000|Overall Study|Other complicating disease|1|||
162212630|NCT06136897|585828837|FG000|Overall Study|Withdrawal by Subject|1|||
162212631|NCT06136897|585828837|FG000|Overall Study|Still on treatment|1|||
162212632|NCT06136897|585828837|FG000|Overall Study|Lost to Follow-up|1|||
162212633|NCT02947100|585828840|FG000|Overall Study|study terminated early|3|||
162212634|NCT02947100|585828840|FG000|Overall Study|did not meet inclusion criteria|1|||
162212635|NCT00992992|585828844|FG000|Overall Study|Lost to Follow-up|3|||
162212636|NCT00992992|585828844|FG000|Overall Study|Death|16|||
162212637|NCT00992992|585828844|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
162212638|NCT00992992|585828844|FG000|Overall Study|Sponsor Closed the Study|4|||
162212639|NCT00217022|585828846|FG000|Overall Study|Withdrawal by Subject|1|||
162212640|NCT00217022|585828847|FG001|Overall Study|Withdrawal by Subject|1|||
162212641|NCT00857233|585828848|FG000|Overall Study|Adverse Event|24|||
162212642|NCT00857233|585828848|FG000|Overall Study|Lack of Efficacy|1|||
162212643|NCT00857233|585828848|FG000|Overall Study|Non-compliance|1|||
162212644|NCT00857233|585828848|FG000|Overall Study|Withdrawal of Consent|9|||
161678043|NCT04667377|583873604|FG003|Dose Escalation Period|Change of residence|0|||
161826528|NCT00434590|584403902|FG001|Overall Study|Administrative problems|5|||
161826529|NCT00996437|584405987|FG000|Overall Study|Death|1|||
161826530|NCT00996437|584405988|FG001|Overall Study|Death|0|||
161826531|NCT00996437|584405987|FG000|Overall Study|Dropped|2|||
161826532|NCT00996437|584405988|FG001|Overall Study|Dropped|2|||
161826533|NCT00996437|584405987|FG000|Overall Study|Missed|2|||
161826534|NCT00996437|584405988|FG001|Overall Study|Missed|5|||
161826535|NCT02576717|584405989|FG000|Overall Study|Other Reasons|16|||
161826536|NCT02576717|584405990|FG001|Overall Study|Other Reasons|18|||
161826537|NCT02576717|584405991|FG002|Overall Study|Other Reasons|15|||
161826538|NCT02576717|584405989|FG000|Overall Study|Covid-19 Pandemic|0|||
161826539|NCT02576717|584405990|FG001|Overall Study|Covid-19 Pandemic|1|||
161826540|NCT02576717|584405991|FG002|Overall Study|Covid-19 Pandemic|1|||
161826541|NCT02576717|584405989|FG000|Overall Study|Sponsor Decision|0|||
161826542|NCT02576717|584405990|FG001|Overall Study|Sponsor Decision|0|||
161826543|NCT02576717|584405991|FG002|Overall Study|Sponsor Decision|1|||
161826544|NCT02576717|584405989|FG000|Overall Study|Physician Decision|3|||
161826545|NCT02576717|584405990|FG001|Overall Study|Physician Decision|8|||
161826546|NCT02576717|584405991|FG002|Overall Study|Physician Decision|9|||
161826547|NCT02576717|584405989|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
161826548|NCT02576717|584405990|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
161826549|NCT02576717|584405991|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
161826550|NCT02576717|584405989|FG000|Overall Study|Death|3|||
161826551|NCT02576717|584405990|FG001|Overall Study|Death|5|||
161826552|NCT02576717|584405991|FG002|Overall Study|Death|3|||
161826553|NCT02576717|584405989|FG000|Overall Study|Lost to Follow-up|9|||
161826554|NCT02576717|584405990|FG001|Overall Study|Lost to Follow-up|10|||
162212645|NCT00857233|585828848|FG000|Overall Study|Lost to Follow-up|4|||
162212646|NCT00857233|585828848|FG000|Overall Study|Nursing Home Placement|14|||
162212647|NCT00857233|585828848|FG000|Overall Study|Other Reasons|2|||
161826555|NCT02576717|584405991|FG002|Overall Study|Lost to Follow-up|19|||
161826556|NCT02576717|584405989|FG000|Overall Study|Protocol Violation|4|||
161826557|NCT02576717|584405990|FG001|Overall Study|Protocol Violation|0|||
161826558|NCT02576717|584405991|FG002|Overall Study|Protocol Violation|5|||
161935311|NCT05415215|584813877|FG003|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161935312|NCT05415215|584813878|FG004|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161935313|NCT05415215|584813879|FG005|Adjuvant Phase: Continuation Period|Withdrawal by Subject|1|||
161935314|NCT05415215|584813880|FG006|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161935315|NCT05415215|584813881|FG007|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161935316|NCT05415215|584813874|FG000|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161935317|NCT05415215|584813875|FG001|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161935318|NCT05415215|584813876|FG002|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161935319|NCT05415215|584813877|FG003|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161935320|NCT05415215|584813878|FG004|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161935321|NCT05415215|584813879|FG005|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
161935322|NCT05415215|584813880|FG006|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
161935323|NCT05415215|584813881|FG007|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161935324|NCT05415215|584813874|FG000|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935325|NCT05415215|584813875|FG001|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935326|NCT05415215|584813876|FG002|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935327|NCT05415215|584813877|FG003|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935328|NCT05415215|584813878|FG004|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935329|NCT05415215|584813879|FG005|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935330|NCT05415215|584813880|FG006|Adjuvant Phase: Continuation Period|Reason not Specified|1|||
161935331|NCT05415215|584813881|FG007|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161935332|NCT05415215|584813874|FG000|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161935333|NCT05415215|584813875|FG001|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161935334|NCT05415215|584813876|FG002|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161935335|NCT05415215|584813877|FG003|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161935336|NCT05415215|584813878|FG004|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161935337|NCT05415215|584813879|FG005|Adjuvant Phase: Continuation Period|Ongoing in Treatment|11|||
161935338|NCT05415215|584813880|FG006|Adjuvant Phase: Continuation Period|Ongoing in Treatment|9|||
161935339|NCT05415215|584813881|FG007|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
162212648|NCT01560871|585828849|FG000|Overall Study|transportation issues|2|||
162212649|NCT01560871|585828850|FG001|Overall Study|transportation issues|1|||
162212650|NCT01560871|585828849|FG000|Overall Study|relocation|1|||
162212651|NCT01560871|585828850|FG001|Overall Study|relocation|0|||
162212652|NCT01560871|585828849|FG000|Overall Study|readmission to a hospital|2|||
162212653|NCT01560871|585828850|FG001|Overall Study|readmission to a hospital|1|||
162212654|NCT01560871|585828849|FG000|Overall Study|Lost to Follow-up|1|||
162212655|NCT01560871|585828850|FG001|Overall Study|Lost to Follow-up|0|||
162212656|NCT01278615|585828851|FG000|Overall Study|Withdrawal by Subject|2|||
162212657|NCT04788511|585828852|FG000|Overall Study|Withdrawal by Subject|2|||
162212658|NCT04788511|585828853|FG001|Overall Study|Withdrawal by Subject|1|||
162212659|NCT04788511|585828852|FG000|Overall Study|Lost to Follow-up|2|||
162212660|NCT04788511|585828853|FG001|Overall Study|Lost to Follow-up|7|||
162212661|NCT04788511|585828852|FG000|Overall Study|Death|3|||
162212662|NCT04788511|585828853|FG001|Overall Study|Death|4|||
162212663|NCT03174782|585828854|FG000|Overall Study|Protocol Violation|1|||
162212664|NCT03174782|585828855|FG001|Overall Study|Protocol Violation|0|||
162212665|NCT03174782|585828854|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
162212666|NCT03174782|585828855|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
162212667|NCT00778921|585828856|FG000|Overall Study|Adverse Event|9|||
162212668|NCT00778921|585828857|FG001|Overall Study|Adverse Event|10|||
162212669|NCT00778921|585828858|FG002|Overall Study|Adverse Event|14|||
162212670|NCT00778921|585828856|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
162212671|NCT00778921|585828857|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
162212672|NCT00778921|585828858|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
161935340|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161935341|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
162212673|NCT00778921|585828856|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
162212674|NCT00778921|585828857|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
162212675|NCT00778921|585828858|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
162212676|NCT00778921|585828856|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
162212677|NCT00778921|585828857|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
162212678|NCT00778921|585828858|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
162212679|NCT00778921|585828856|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
162212680|NCT00778921|585828857|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
161935342|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161935343|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
162212681|NCT00778921|585828858|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
162212682|NCT00778921|585828856|FG000|Overall Study|Patient withdrew request|3|||
162212683|NCT00778921|585828857|FG001|Overall Study|Patient withdrew request|1|||
162212684|NCT00778921|585828858|FG002|Overall Study|Patient withdrew request|6|||
162212685|NCT00778921|585828856|FG000|Overall Study|Lost to Follow-up|0|||
162212686|NCT00778921|585828857|FG001|Overall Study|Lost to Follow-up|2|||
162212687|NCT00778921|585828858|FG002|Overall Study|Lost to Follow-up|1|||
162212688|NCT00778921|585828856|FG000|Overall Study|Administrative Problems|1|||
162212689|NCT00778921|585828857|FG001|Overall Study|Administrative Problems|2|||
162212690|NCT00778921|585828858|FG002|Overall Study|Administrative Problems|0|||
162212691|NCT00778921|585828856|FG000|Overall Study|Protocol Violation|3|||
162212692|NCT00778921|585828857|FG001|Overall Study|Protocol Violation|0|||
162212693|NCT00778921|585828858|FG002|Overall Study|Protocol Violation|2|||
162212694|NCT00778921|585828856|FG000|Overall Study|Not treated|0|||
162212695|NCT00778921|585828857|FG001|Overall Study|Not treated|2|||
162212696|NCT00778921|585828858|FG002|Overall Study|Not treated|2|||
162212697|NCT03178045|585828859|FG000|Overall Study|Withdrawal by Subject|5|||
162212698|NCT03178045|585828860|FG001|Overall Study|Withdrawal by Subject|7|||
162212699|NCT03178045|585828859|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
162212700|NCT03178045|585828860|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
162212701|NCT03178045|585828859|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
162212702|NCT03178045|585828860|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
162212703|NCT01078922|585828861|FG000|Overall Study|Adverse Event|1|||
162212704|NCT02353468|585828862|FG000|Overall Study|Study terminated|3|||
162212705|NCT00003477|585828865|FG000|Overall Study|Not evalauable|4|||
162212706|NCT00798304|585828866|FG000|Overall Study|Adverse Event|0|||
162212707|NCT00798304|585828867|FG001|Overall Study|Adverse Event|1|||
162212708|NCT00798304|585828868|FG002|Overall Study|Adverse Event|1|||
162212709|NCT00798304|585828866|FG000|Overall Study|Discontinuation by Sponsor|14|||
162212710|NCT00798304|585828867|FG001|Overall Study|Discontinuation by Sponsor|21|||
162212711|NCT00798304|585828868|FG002|Overall Study|Discontinuation by Sponsor|9|||
162212712|NCT02031536|585828870|FG000|Overall Study|ineligible|1|||
162212713|NCT02031536|585828871|FG001|Overall Study|ineligible|0|||
162212714|NCT04206085|585828874|FG000|Overall Study|Lost to Follow-up|0|||
162212715|NCT04206085|585828875|FG001|Overall Study|Lost to Follow-up|1|||
162212716|NCT04206085|585828876|FG002|Overall Study|Lost to Follow-up|0|||
162212717|NCT04206085|585828874|FG000|Overall Study|Lost to Follow-up|0|||
162212718|NCT04206085|585828875|FG001|Overall Study|Lost to Follow-up|0|||
162212719|NCT04206085|585828876|FG002|Overall Study|Lost to Follow-up|1|||
162212720|NCT03845023|585828877|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
162212721|NCT03845023|585828878|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
162212722|NCT03845023|585828879|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
162212723|NCT03845023|585828880|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
162212724|NCT03845023|585828877|FG000|Follow-Up (14 Days)|Adverse Event|0|||
162212725|NCT03845023|585828878|FG001|Follow-Up (14 Days)|Adverse Event|0|||
162212726|NCT03845023|585828879|FG002|Follow-Up (14 Days)|Adverse Event|1|||
162212727|NCT03845023|585828880|FG003|Follow-Up (14 Days)|Adverse Event|1|||
162212728|NCT02658175|585828881|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
162212729|NCT02658175|585828882|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
162212730|NCT02658175|585828883|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
162212731|NCT02658175|585828881|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
162212732|NCT02658175|585828882|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
162212733|NCT02658175|585828883|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
162212734|NCT02658175|585828881|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
162212735|NCT02658175|585828882|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
162212736|NCT02658175|585828883|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
162212737|NCT02658175|585828881|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
162212738|NCT02658175|585828882|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
162212739|NCT02658175|585828883|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
162212740|NCT02658175|585828881|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
162212741|NCT02658175|585828882|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
162212742|NCT02658175|585828883|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
162212743|NCT02658175|585828881|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
162212744|NCT02658175|585828882|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
162212745|NCT02658175|585828883|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
162212746|NCT02658175|585828881|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
162212747|NCT02658175|585828882|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
162212748|NCT02658175|585828883|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
162212749|NCT02658175|585828881|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
162212750|NCT02658175|585828882|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
162212751|NCT02658175|585828883|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
162212752|NCT02658175|585828881|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
161935344|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161935345|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161935346|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161935347|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|5|||
161935348|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935349|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935350|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935351|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935352|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935353|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935354|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161935355|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Death|1|||
161935356|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935357|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935358|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935359|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935360|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935361|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935362|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161935363|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|2|||
161935364|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935365|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935366|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935367|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935368|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935369|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935370|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161935371|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|1|||
161935372|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935373|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935374|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935375|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935376|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935377|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935378|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161935379|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|2|||
161935380|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161935381|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161935382|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161935383|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
162212753|NCT02658175|585828882|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
162212754|NCT02658175|585828883|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
162212755|NCT02658175|585828881|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
162212756|NCT02658175|585828882|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
162212757|NCT02658175|585828883|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
162212758|NCT02165826|585828888|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
162212759|NCT02165826|585828889|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
162212760|NCT02165826|585828890|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
162212761|NCT02165826|585828888|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
162212762|NCT02165826|585828889|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
162212763|NCT02165826|585828890|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
162212764|NCT02165826|585828888|FG000|Main Treatment Period|Lost to Follow-up|4|||
162212765|NCT02165826|585828889|FG001|Main Treatment Period|Lost to Follow-up|2|||
162212766|NCT02165826|585828890|FG002|Main Treatment Period|Lost to Follow-up|1|||
162212767|NCT02165826|585828888|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
162212768|NCT02165826|585828889|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
162212769|NCT02165826|585828890|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
162212770|NCT02165826|585828888|FG000|Main Treatment Period|Lack of Efficacy|2|||
162212771|NCT02165826|585828889|FG001|Main Treatment Period|Lack of Efficacy|0|||
162212772|NCT02165826|585828890|FG002|Main Treatment Period|Lack of Efficacy|0|||
162212773|NCT02165826|585828888|FG000|Main Treatment Period|Reason Not Specified|8|||
162212774|NCT02165826|585828889|FG001|Main Treatment Period|Reason Not Specified|5|||
161935384|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161935385|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161935386|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161935387|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|4|||
161935388|NCT05415215|584813874|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935389|NCT05415215|584813875|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935390|NCT05415215|584813876|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935391|NCT05415215|584813877|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935392|NCT05415215|584813878|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935393|NCT05415215|584813879|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935394|NCT05415215|584813880|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161935395|NCT05415215|584813881|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|25|||
161935396|NCT05415215|584813874|FG000|Follow-up Period|Ongoing in Follow-up|0|||
161935397|NCT05415215|584813875|FG001|Follow-up Period|Ongoing in Follow-up|0|||
161935398|NCT05415215|584813876|FG002|Follow-up Period|Ongoing in Follow-up|0|||
161935399|NCT05415215|584813877|FG003|Follow-up Period|Ongoing in Follow-up|0|||
161935400|NCT05415215|584813878|FG004|Follow-up Period|Ongoing in Follow-up|0|||
161935401|NCT05415215|584813879|FG005|Follow-up Period|Ongoing in Follow-up|44|||
161935402|NCT05415215|584813880|FG006|Follow-up Period|Ongoing in Follow-up|45|||
161935403|NCT05415215|584813881|FG007|Follow-up Period|Ongoing in Follow-up|51|||
161935404|NCT05415215|584813874|FG000|Follow-up Period|Adverse Event|0|||
161935405|NCT05415215|584813875|FG001|Follow-up Period|Adverse Event|0|||
161935406|NCT05415215|584813876|FG002|Follow-up Period|Adverse Event|0|||
161935407|NCT05415215|584813877|FG003|Follow-up Period|Adverse Event|0|||
161935408|NCT05415215|584813878|FG004|Follow-up Period|Adverse Event|0|||
161935409|NCT05415215|584813879|FG005|Follow-up Period|Adverse Event|0|||
161935410|NCT05415215|584813880|FG006|Follow-up Period|Adverse Event|1|||
161935411|NCT05415215|584813881|FG007|Follow-up Period|Adverse Event|0|||
161935412|NCT05415215|584813874|FG000|Follow-up Period|Lost to Follow-up|0|||
161935413|NCT05415215|584813875|FG001|Follow-up Period|Lost to Follow-up|0|||
161935414|NCT05415215|584813876|FG002|Follow-up Period|Lost to Follow-up|0|||
161935415|NCT05415215|584813877|FG003|Follow-up Period|Lost to Follow-up|0|||
161935416|NCT05415215|584813878|FG004|Follow-up Period|Lost to Follow-up|0|||
161935417|NCT05415215|584813879|FG005|Follow-up Period|Lost to Follow-up|1|||
161935418|NCT05415215|584813880|FG006|Follow-up Period|Lost to Follow-up|1|||
161935419|NCT05415215|584813881|FG007|Follow-up Period|Lost to Follow-up|0|||
161935420|NCT05415215|584813874|FG000|Follow-up Period|Withdrawal by Subject|0|||
161935421|NCT05415215|584813875|FG001|Follow-up Period|Withdrawal by Subject|0|||
161935422|NCT05415215|584813876|FG002|Follow-up Period|Withdrawal by Subject|0|||
161935423|NCT05415215|584813877|FG003|Follow-up Period|Withdrawal by Subject|0|||
161935424|NCT05415215|584813878|FG004|Follow-up Period|Withdrawal by Subject|0|||
161935425|NCT05415215|584813879|FG005|Follow-up Period|Withdrawal by Subject|0|||
161935426|NCT05415215|584813880|FG006|Follow-up Period|Withdrawal by Subject|0|||
161935427|NCT05415215|584813881|FG007|Follow-up Period|Withdrawal by Subject|2|||
161935428|NCT03727022|584813882|FG000|Phase A|Lost to Follow-up|2|||
161935429|NCT03727022|584813883|FG001|Phase A|Lost to Follow-up|3|||
161935430|NCT03727022|584813882|FG000|Phase A|Withdrawal by Subject|10|||
161935431|NCT03727022|584813883|FG001|Phase A|Withdrawal by Subject|9|||
161935432|NCT03727022|584813882|FG000|Phase B|Lost to Follow-up|0|||
161935433|NCT03727022|584813883|FG001|Phase B|Lost to Follow-up|1|||
161935434|NCT03727022|584813882|FG000|Phase B|Subject Non-Compliance|1|||
161935435|NCT03727022|584813883|FG001|Phase B|Subject Non-Compliance|0|||
161935436|NCT03727022|584813882|FG000|Phase B|Withdrawal by Subject|3|||
161935437|NCT03727022|584813883|FG001|Phase B|Withdrawal by Subject|3|||
161935438|NCT03727022|584813882|FG000|Phase B|Site Closure|4|||
161935439|NCT03727022|584813883|FG001|Phase B|Site Closure|0|||
162212775|NCT02165826|585828890|FG002|Main Treatment Period|Reason Not Specified|16|||
162212776|NCT02165826|585828888|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
162212777|NCT02165826|585828889|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
162212778|NCT02165826|585828890|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
162212779|NCT02165826|585828888|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
162212780|NCT02165826|585828889|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
162212781|NCT02165826|585828890|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
161935467|NCT05550818|584813887|FG000|Overall Study|Protocol Violation|1|||
161935468|NCT05550818|584813888|FG001|Overall Study|Protocol Violation|1|||
161935469|NCT05550818|584813887|FG000|Overall Study|Withdrawal by Subject|2|||
161935470|NCT05550818|584813888|FG001|Overall Study|Withdrawal by Subject|1|||
161935493|NCT02797522|584813895|FG000|Overall Study|Study Terminated by Sponsor|0|||
161935494|NCT02797522|584813896|FG001|Overall Study|Study Terminated by Sponsor|0|||
161935495|NCT02797522|584813897|FG002|Overall Study|Study Terminated by Sponsor|0|||
161935496|NCT02797522|584813898|FG003|Overall Study|Study Terminated by Sponsor|0|||
161935497|NCT02797522|584813899|FG004|Overall Study|Study Terminated by Sponsor|0|||
161935498|NCT02797522|584813900|FG005|Overall Study|Study Terminated by Sponsor|0|||
161935499|NCT02797522|584813901|FG006|Overall Study|Study Terminated by Sponsor|0|||
161935500|NCT02797522|584813902|FG007|Overall Study|Study Terminated by Sponsor|4|||
162212782|NCT02165826|585828888|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
162212783|NCT02165826|585828889|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
162212784|NCT02165826|585828890|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
162212785|NCT02165826|585828888|FG000|Down-Titration Period|Reason Not Specified|1|||
162212786|NCT02165826|585828889|FG001|Down-Titration Period|Reason Not Specified|0|||
161935501|NCT02797522|584813903|FG008|Overall Study|Study Terminated by Sponsor|2|||
161935502|NCT02797522|584813904|FG009|Overall Study|Study Terminated by Sponsor|4|||
161935503|NCT02797522|584813905|FG010|Overall Study|Study Terminated by Sponsor|1|||
162212787|NCT02165826|585828890|FG002|Down-Titration Period|Reason Not Specified|2|||
162212788|NCT02636608|585828894|FG000|Overall Study|Failure to Return|4|||
162212789|NCT02636608|585828894|FG000|Overall Study|Insufficient Virological Response|1|||
162212790|NCT02636608|585828894|FG000|Overall Study|Death|3|||
162212791|NCT02636608|585828894|FG000|Overall Study|Other|2|||
162212792|NCT02636608|585828894|FG000|Overall Study|Did Not Receive Treatment|1|||
161678044|NCT04667377|583873605|FG004|Dose Escalation Period|Change of residence|0|||
162212793|NCT04913948|585828896|FG000|Overall Study|Withdrawal by Subject|2|||
162212794|NCT04913948|585828896|FG000|Overall Study|Sample processing issues|1|||
162212795|NCT04913948|585828896|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
162212796|NCT05739994|585828900|FG000|Overall Study|Withdrawal by Subject|2|||
162212797|NCT05739994|585828901|FG001|Overall Study|Withdrawal by Subject|2|||
162212798|NCT05739994|585828902|FG002|Overall Study|Withdrawal by Subject|4|||
162212799|NCT00815919|585828903|FG000|Overall Study|Unrelated Fungal Infection|1|||
162212800|NCT00815919|585828903|FG000|Overall Study|AML Relapse|1|||
162212801|NCT00815919|585828903|FG000|Overall Study|Lack of Efficacy|2|||
162212802|NCT04750577|585828904|FG000|Overall Study|Adverse Event|2|||
162212803|NCT04750577|585828905|FG001|Overall Study|Adverse Event|10|||
162212804|NCT04750577|585828906|FG002|Overall Study|Adverse Event|8|||
162212805|NCT04750577|585828907|FG003|Overall Study|Adverse Event|1|||
162212806|NCT04750577|585828904|FG000|Overall Study|Change of residence|0|||
162212807|NCT04750577|585828905|FG001|Overall Study|Change of residence|0|||
161678045|NCT04667377|583873601|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
162212808|NCT04750577|585828906|FG002|Overall Study|Change of residence|1|||
161678046|NCT04667377|583873602|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
161678047|NCT04667377|583873603|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
162212809|NCT04750577|585828907|FG003|Overall Study|Change of residence|0|||
162212810|NCT04750577|585828904|FG000|Overall Study|Burden of study procedures|0|||
162212811|NCT04750577|585828905|FG001|Overall Study|Burden of study procedures|2|||
162212812|NCT04750577|585828906|FG002|Overall Study|Burden of study procedures|2|||
161678048|NCT04667377|583873604|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
162212813|NCT04750577|585828907|FG003|Overall Study|Burden of study procedures|0|||
162212814|NCT04750577|585828904|FG000|Overall Study|Prematurely discontinued|0|||
162212815|NCT04750577|585828905|FG001|Overall Study|Prematurely discontinued|0|||
162212816|NCT04750577|585828906|FG002|Overall Study|Prematurely discontinued|0|||
162212817|NCT04750577|585828907|FG003|Overall Study|Prematurely discontinued|2|||
162212818|NCT04750577|585828904|FG000|Overall Study|Protocol deviation|1|||
162212819|NCT04750577|585828905|FG001|Overall Study|Protocol deviation|1|||
162212820|NCT04750577|585828906|FG002|Overall Study|Protocol deviation|1|||
162212821|NCT04750577|585828907|FG003|Overall Study|Protocol deviation|1|||
162212822|NCT04750577|585828904|FG000|Overall Study|Other than listed|3|||
162212823|NCT04750577|585828905|FG001|Overall Study|Other than listed|2|||
162212824|NCT04750577|585828906|FG002|Overall Study|Other than listed|2|||
162212825|NCT04750577|585828907|FG003|Overall Study|Other than listed|1|||
162212826|NCT04750577|585828904|FG000|Overall Study|Not treated|0|||
162212827|NCT04750577|585828905|FG001|Overall Study|Not treated|0|||
162212828|NCT04750577|585828906|FG002|Overall Study|Not treated|0|||
161678049|NCT04667377|583873605|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
161678050|NCT04667377|583873601|FG000|Dose Escalation Period|Adverse Event|9|||
161826559|NCT02576717|584405989|FG000|Overall Study|Lack of Efficacy|24|||
161826560|NCT02576717|584405990|FG001|Overall Study|Lack of Efficacy|28|||
161826561|NCT02576717|584405991|FG002|Overall Study|Lack of Efficacy|20|||
161826562|NCT02576717|584405989|FG000|Overall Study|Adverse Event|26|||
161826563|NCT02576717|584405990|FG001|Overall Study|Adverse Event|32|||
161826564|NCT02576717|584405991|FG002|Overall Study|Adverse Event|26|||
161826565|NCT00399893|584405992|FG000|Overall Study|Withdrawal by Subject|1|||
161826566|NCT00399893|584405993|FG001|Overall Study|Withdrawal by Subject|0|||
161826567|NCT00407745|584406005|FG000|Overall Study|Lack of Efficacy|1|||
161826568|NCT00407745|584406006|FG001|Overall Study|Lack of Efficacy|2|||
161826569|NCT00407745|584406005|FG000|Overall Study|Withdrawal by Subject|3|||
162212829|NCT04750577|585828907|FG003|Overall Study|Not treated|2|||
161826570|NCT00407745|584406006|FG001|Overall Study|Withdrawal by Subject|3|||
161826571|NCT00407745|584406005|FG000|Overall Study|Protocol Violation|5|||
162021353|NCT02551991|585134755|FG000|Overall Study|Withdrawal by Subject|1|||
162021354|NCT02551991|585134756|FG001|Overall Study|Withdrawal by Subject|0|||
162021355|NCT02551991|585134757|FG002|Overall Study|Withdrawal by Subject|0|||
162212830|NCT02473042|585828909|FG000|Overall Study|Withdrawal by Subject|1|||
162212831|NCT02473042|585828910|FG001|Overall Study|Withdrawal by Subject|0|||
162212832|NCT02473042|585828909|FG000|Overall Study|Patient became ineligible after enrollment|2|||
162212833|NCT02473042|585828910|FG001|Overall Study|Patient became ineligible after enrollment|5|||
162212834|NCT02473042|585828909|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
162212835|NCT02473042|585828910|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
162212836|NCT02473042|585828909|FG000|Overall Study|PACU data unable to be collected|3|||
162212837|NCT02473042|585828910|FG001|Overall Study|PACU data unable to be collected|0|||
162212838|NCT04680637|585828913|FG000|Overall Study|Lost to Follow-up|0|||
162212839|NCT04680637|585828914|FG001|Overall Study|Lost to Follow-up|1|||
162212840|NCT04680637|585828915|FG002|Overall Study|Lost to Follow-up|0|||
162212841|NCT04680637|585828916|FG003|Overall Study|Lost to Follow-up|1|||
162212842|NCT04680637|585828913|FG000|Overall Study|Death|1|||
162212843|NCT04680637|585828914|FG001|Overall Study|Death|0|||
162212844|NCT04680637|585828915|FG002|Overall Study|Death|0|||
162212845|NCT04680637|585828916|FG003|Overall Study|Death|0|||
162212846|NCT04680637|585828913|FG000|Overall Study|Withdrawal by Subject|7|||
162212847|NCT04680637|585828914|FG001|Overall Study|Withdrawal by Subject|10|||
162212848|NCT04680637|585828915|FG002|Overall Study|Withdrawal by Subject|17|||
162212849|NCT04680637|585828916|FG003|Overall Study|Withdrawal by Subject|15|||
162212850|NCT04680637|585828913|FG000|Overall Study|Decision by Sponsor|21|||
162212851|NCT04680637|585828914|FG001|Overall Study|Decision by Sponsor|15|||
162212852|NCT04680637|585828915|FG002|Overall Study|Decision by Sponsor|7|||
162212853|NCT04680637|585828916|FG003|Overall Study|Decision by Sponsor|32|||
162212854|NCT01103232|585828919|FG000|Overall Study|Withdrawal by Subject|1|||
162212855|NCT01103232|585828920|FG001|Overall Study|Withdrawal by Subject|1|||
162212856|NCT01103232|585828919|FG000|Overall Study|Protocol Violation|0|||
162212857|NCT01103232|585828920|FG001|Overall Study|Protocol Violation|1|||
162212858|NCT00443599|585828921|FG000|Overall Study|Physician Decision|2|||
162212859|NCT00443599|585828922|FG001|Overall Study|Physician Decision|1|||
162212860|NCT00443599|585828921|FG000|Overall Study|Death|1|||
162212861|NCT00443599|585828922|FG001|Overall Study|Death|1|||
162212862|NCT00443599|585828921|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
162212863|NCT00443599|585828922|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
162212864|NCT05093504|585828923|FG000|Overall Study|Death|0|||
162212865|NCT05093504|585828924|FG001|Overall Study|Death|1|||
162212866|NCT03151551|585828925|FG000|Open-Label Treatment Period|Adverse Event|0|||
162212867|NCT03151551|585828926|FG001|Open-Label Treatment Period|Adverse Event|2|||
162212868|NCT03151551|585828925|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
162212869|NCT03151551|585828926|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
162212870|NCT03151551|585828925|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
162212871|NCT03151551|585828926|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
162212872|NCT03151551|585828925|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
162212873|NCT03151551|585828926|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
162212874|NCT03151551|585828925|FG000|Open-Label Treatment Period|Physician Decision|3|||
162212875|NCT03151551|585828926|FG001|Open-Label Treatment Period|Physician Decision|0|||
162212876|NCT03151551|585828925|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
162212877|NCT03151551|585828926|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
162212878|NCT03151551|585828925|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
162212879|NCT03151551|585828926|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
161678051|NCT04667377|583873602|FG001|Dose Escalation Period|Adverse Event|10|||
161678052|NCT04667377|583873603|FG002|Dose Escalation Period|Adverse Event|12|||
161678053|NCT04667377|583873604|FG003|Dose Escalation Period|Adverse Event|17|||
161678054|NCT04667377|583873605|FG004|Dose Escalation Period|Adverse Event|3|||
161826572|NCT00407745|584406006|FG001|Overall Study|Protocol Violation|3|||
161826573|NCT00407745|584406005|FG000|Overall Study|Adverse Event|8|||
161826574|NCT00407745|584406006|FG001|Overall Study|Adverse Event|8|||
161826575|NCT00407745|584406005|FG000|Overall Study|Other|2|||
161826576|NCT00407745|584406006|FG001|Overall Study|Other|0|||
161826577|NCT00407745|584406005|FG000|Overall Study|Randomized, unknown if treated|0|||
161826578|NCT00407745|584406006|FG001|Overall Study|Randomized, unknown if treated|1|||
161826579|NCT02940730|584406009|FG000|Intervention 2|Physician Decision|7|||
161826580|NCT02940730|584406010|FG001|Intervention 2|Physician Decision|0|||
161826581|NCT02960438|584406011|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
161826582|NCT02960438|584406012|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
161826583|NCT02960438|584406013|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
161826584|NCT02960438|584406014|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
161826585|NCT02960438|584406011|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
162021356|NCT02551991|585134758|FG003|Overall Study|Withdrawal by Subject|0|||
162212880|NCT03151551|585828925|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
162212881|NCT03151551|585828926|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
162212882|NCT03151551|585828925|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
162212883|NCT03151551|585828926|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
162212884|NCT03151551|585828925|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
162212885|NCT03151551|585828926|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
162212886|NCT01190449|585828927|FG000|Overall Study|Ineligible|0|||
162212887|NCT01190449|585828928|FG001|Overall Study|Ineligible|4|||
162212888|NCT02035696|585830887|FG000|Overall Study|Lost to Follow-up|0|||
162212889|NCT02035696|585830888|FG001|Overall Study|Lost to Follow-up|3|||
162212890|NCT02035696|585830889|FG002|Overall Study|Lost to Follow-up|1|||
162212891|NCT02035696|585830890|FG003|Overall Study|Lost to Follow-up|2|||
161826586|NCT02960438|584406012|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
161826587|NCT02960438|584406013|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
161826588|NCT02960438|584406014|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
161826589|NCT02960438|584406011|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
161826590|NCT02960438|584406012|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
161826591|NCT02960438|584406013|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
161826592|NCT02960438|584406014|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
161826593|NCT02960438|584406011|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
161826594|NCT02960438|584406012|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
161826595|NCT02960438|584406013|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
161826596|NCT02960438|584406014|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
161826597|NCT02960438|584406011|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
161826598|NCT02960438|584406012|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
161826599|NCT02960438|584406013|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
161826600|NCT02960438|584406014|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
161826601|NCT02960438|584406011|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
161826602|NCT02960438|584406012|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
161826603|NCT02960438|584406013|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
161826604|NCT02960438|584406014|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
161826605|NCT02960438|584406011|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
161826606|NCT02960438|584406012|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
161826607|NCT02960438|584406013|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
161826608|NCT02960438|584406014|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
161826609|NCT02960438|584406011|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
161826610|NCT02960438|584406012|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
161826611|NCT02960438|584406013|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
161826612|NCT02960438|584406014|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
161826613|NCT02960438|584406011|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
161826614|NCT02960438|584406012|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
161826615|NCT02960438|584406013|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
161826616|NCT02960438|584406014|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
161826617|NCT02960438|584406011|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
161826618|NCT02960438|584406012|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
161826619|NCT02960438|584406013|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
161826620|NCT02960438|584406014|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
161826621|NCT02960438|584406011|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
161826622|NCT02960438|584406012|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
161826623|NCT02960438|584406013|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
161826624|NCT02960438|584406014|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
161826625|NCT02960438|584406011|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
161826626|NCT02960438|584406012|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
161826627|NCT02960438|584406013|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
161826628|NCT02960438|584406014|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
161826629|NCT01522950|584406015|FG000|Overall Study|Withdrawal by Subject|3|||
161826630|NCT01522950|584406016|FG001|Overall Study|Withdrawal by Subject|2|||
161826631|NCT01522950|584406017|FG002|Overall Study|Withdrawal by Subject|1|||
161826632|NCT01522950|584406015|FG000|Overall Study|Adverse Event|3|||
161826633|NCT01522950|584406016|FG001|Overall Study|Adverse Event|1|||
161826634|NCT01522950|584406017|FG002|Overall Study|Adverse Event|1|||
161826635|NCT01522950|584406015|FG000|Overall Study|Protocol Violation|0|||
161826636|NCT01522950|584406016|FG001|Overall Study|Protocol Violation|0|||
161826637|NCT01522950|584406017|FG002|Overall Study|Protocol Violation|2|||
161826638|NCT01522950|584406015|FG000|Overall Study|Death|0|||
161826639|NCT01522950|584406016|FG001|Overall Study|Death|1|||
161826640|NCT01522950|584406017|FG002|Overall Study|Death|1|||
161826641|NCT01522950|584406015|FG000|Overall Study|Study Medication Sensitivity|0|||
161826642|NCT01522950|584406016|FG001|Overall Study|Study Medication Sensitivity|1|||
161826643|NCT01522950|584406017|FG002|Overall Study|Study Medication Sensitivity|0|||
161826644|NCT01064531|584406023|FG000|Overall Study|Lost to Follow-up|0|||
161826645|NCT01064531|584406024|FG001|Overall Study|Lost to Follow-up|2|||
161826646|NCT01064531|584406023|FG000|Overall Study|Physician Decision|0|||
161826647|NCT01064531|584406024|FG001|Overall Study|Physician Decision|1|||
161826648|NCT01064531|584406023|FG000|Overall Study|Withdrawal by Subject|2|||
161826649|NCT01064531|584406024|FG001|Overall Study|Withdrawal by Subject|2|||
161826650|NCT01064531|584406023|FG000|Overall Study|Revision due to femoral stem loosening|1|||
161826651|NCT01064531|584406024|FG001|Overall Study|Revision due to femoral stem loosening|0|||
161826652|NCT01064531|584406023|FG000|Overall Study|Revision due to dislocation|0|||
161826653|NCT01064531|584406024|FG001|Overall Study|Revision due to dislocation|1|||
161826654|NCT01064531|584406023|FG000|Overall Study|Death|0|||
161826655|NCT01064531|584406024|FG001|Overall Study|Death|1|||
161826656|NCT03449199|584406028|FG000|Overall Study|Lost to Follow-up|1|||
161826657|NCT03449199|584406029|FG001|Overall Study|Lost to Follow-up|1|||
161826658|NCT03449199|584406030|FG002|Overall Study|Lost to Follow-up|0|||
161826659|NCT03449199|584406028|FG000|Overall Study|Protocol Deviation|0|||
161826660|NCT03449199|584406029|FG001|Overall Study|Protocol Deviation|0|||
161826661|NCT03449199|584406030|FG002|Overall Study|Protocol Deviation|1|||
161826662|NCT03449199|584406028|FG000|Overall Study|Withdrawal by Subject|0|||
161826663|NCT03449199|584406029|FG001|Overall Study|Withdrawal by Subject|0|||
161826664|NCT03449199|584406030|FG002|Overall Study|Withdrawal by Subject|1|||
161826665|NCT03136406|584406031|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
161826666|NCT01201759|584406032|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
161826667|NCT01201759|584406033|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
161826668|NCT01201759|584406032|FG000|Visit 3 - Washout|Adverse Event|0|||
161826669|NCT01201759|584406033|FG001|Visit 3 - Washout|Adverse Event|3|||
161826670|NCT01201759|584406032|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
161826671|NCT01201759|584406033|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
161826672|NCT01201759|584406032|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
161826673|NCT01201759|584406033|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
161826674|NCT00906373|584406034|FG000|Overall Study|Withdrawal by Subject|0|||
161826675|NCT00906373|584406035|FG001|Overall Study|Withdrawal by Subject|5|||
161826676|NCT00906373|584406034|FG000|Overall Study|Other|0|||
161826677|NCT00906373|584406035|FG001|Overall Study|Other|1|||
161826678|NCT00906373|584406034|FG000|Overall Study|Still on treatment at cutoff date|0|||
161826679|NCT00906373|584406035|FG001|Overall Study|Still on treatment at cutoff date|2|||
161826680|NCT00848042|584406036|FG000|Overall Study|Death|1|||
161826681|NCT00848042|584406037|FG001|Overall Study|Death|2|||
161826682|NCT00848042|584406038|FG002|Overall Study|Death|0|||
161826683|NCT00848042|584406036|FG000|Overall Study|Other Therapy|3|||
161826684|NCT00848042|584406037|FG001|Overall Study|Other Therapy|0|||
161826685|NCT00848042|584406038|FG002|Overall Study|Other Therapy|0|||
161826686|NCT01652729|584406039|FG000|Overall Study|Withdrawal by Subject|14|||
161826687|NCT01652729|584406040|FG001|Overall Study|Withdrawal by Subject|7|||
161826688|NCT01652729|584406041|FG002|Overall Study|Withdrawal by Subject|7|||
161826689|NCT01652729|584406039|FG000|Overall Study|Adverse Event|4|||
161826690|NCT01652729|584406040|FG001|Overall Study|Adverse Event|0|||
161826691|NCT01652729|584406041|FG002|Overall Study|Adverse Event|3|||
161826692|NCT01652729|584406039|FG000|Overall Study|Physician Decision|1|||
161826693|NCT01652729|584406040|FG001|Overall Study|Physician Decision|0|||
161826694|NCT01652729|584406041|FG002|Overall Study|Physician Decision|1|||
161826695|NCT01652729|584406039|FG000|Overall Study|Protocol Violation|1|||
161826696|NCT01652729|584406040|FG001|Overall Study|Protocol Violation|0|||
161826697|NCT01652729|584406041|FG002|Overall Study|Protocol Violation|0|||
162212892|NCT02035696|585830887|FG000|Overall Study|Withdrawal by Subject|3|||
162212893|NCT02035696|585830888|FG001|Overall Study|Withdrawal by Subject|0|||
162212894|NCT02035696|585830889|FG002|Overall Study|Withdrawal by Subject|2|||
162212895|NCT02035696|585830890|FG003|Overall Study|Withdrawal by Subject|1|||
162212896|NCT01246999|585830891|FG000|Overall Study|Lost to Follow-up|0|||
162212897|NCT01246999|585830892|FG001|Overall Study|Lost to Follow-up|1|||
162212898|NCT01246999|585830893|FG002|Overall Study|Lost to Follow-up|0|||
162212899|NCT01246999|585830894|FG003|Overall Study|Lost to Follow-up|0|||
162212900|NCT01246999|585830891|FG000|Overall Study|Withdrawal by Subject|0|||
162212901|NCT01246999|585830892|FG001|Overall Study|Withdrawal by Subject|0|||
162212902|NCT01246999|585830893|FG002|Overall Study|Withdrawal by Subject|0|||
162212903|NCT01246999|585830894|FG003|Overall Study|Withdrawal by Subject|2|||
162212904|NCT01867047|585830895|FG000|Overall Study|Lost to Follow-up|3|||
162212905|NCT01867047|585830896|FG001|Overall Study|Lost to Follow-up|3|||
162212906|NCT01867047|585830895|FG000|Overall Study|Withdrawal by Subject|2|||
162212907|NCT01867047|585830896|FG001|Overall Study|Withdrawal by Subject|0|||
162212908|NCT01867047|585830895|FG000|Overall Study|Physician Decision|2|||
162212909|NCT01867047|585830896|FG001|Overall Study|Physician Decision|0|||
162212910|NCT01867047|585830895|FG000|Overall Study|surgery not indicated in protocol|1|||
162212911|NCT01867047|585830896|FG001|Overall Study|surgery not indicated in protocol|2|||
162212912|NCT00307047|585830897|FG000|Overall Study|Lost to Follow-up|35|||
162212913|NCT00307047|585830898|FG001|Overall Study|Lost to Follow-up|24|||
162212914|NCT00307047|585830897|FG000|Overall Study|Withdrawal by Subject|6|||
162212915|NCT00307047|585830898|FG001|Overall Study|Withdrawal by Subject|6|||
161826698|NCT01652729|584406039|FG000|Overall Study|Lost to Follow-up|6|||
161826699|NCT01652729|584406040|FG001|Overall Study|Lost to Follow-up|6|||
161678055|NCT04667377|583873601|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
161826700|NCT01652729|584406041|FG002|Overall Study|Lost to Follow-up|3|||
161826701|NCT01652729|584406039|FG000|Overall Study|Administrative|1|||
161826702|NCT01652729|584406040|FG001|Overall Study|Administrative|0|||
161826703|NCT01652729|584406041|FG002|Overall Study|Administrative|0|||
161826704|NCT00483548|584406042|FG000|Overall Study|Randomized; not treated with study drug|1|||
161826705|NCT00483548|584406043|FG001|Overall Study|Randomized; not treated with study drug|3|||
161826706|NCT00483548|584406042|FG000|Overall Study|Adverse Event|25|||
161826707|NCT00483548|584406043|FG001|Overall Study|Adverse Event|14|||
161826708|NCT00483548|584406042|FG000|Overall Study|Laboratory abnormality|1|||
161826709|NCT00483548|584406043|FG001|Overall Study|Laboratory abnormality|2|||
161826710|NCT00483548|584406042|FG000|Overall Study|Lack of Efficacy|4|||
161826711|NCT00483548|584406043|FG001|Overall Study|Lack of Efficacy|8|||
161826712|NCT00483548|584406042|FG000|Overall Study|Protocol Violation|11|||
161826713|NCT00483548|584406043|FG001|Overall Study|Protocol Violation|7|||
161826714|NCT00483548|584406042|FG000|Overall Study|Pregnancy|1|||
161826715|NCT00483548|584406043|FG001|Overall Study|Pregnancy|0|||
161826716|NCT00483548|584406042|FG000|Overall Study|Protocol required discontinuation|6|||
161826717|NCT00483548|584406043|FG001|Overall Study|Protocol required discontinuation|6|||
161826718|NCT00483548|584406042|FG000|Overall Study|Unable to comply with protocol schedule|1|||
161826719|NCT00483548|584406043|FG001|Overall Study|Unable to comply with protocol schedule|0|||
161826720|NCT00483548|584406042|FG000|Overall Study|Non-compliance with medication|2|||
161826721|NCT00483548|584406043|FG001|Overall Study|Non-compliance with medication|0|||
161826722|NCT00483548|584406042|FG000|Overall Study|Lost to Follow-up|3|||
161826723|NCT00483548|584406043|FG001|Overall Study|Lost to Follow-up|4|||
161826724|NCT00483548|584406042|FG000|Overall Study|Withdrawal by Subject|5|||
161826725|NCT00483548|584406043|FG001|Overall Study|Withdrawal by Subject|2|||
161826726|NCT04364737|584406047|FG000|Overall Study|Withdrawal by Subject|4|||
161826727|NCT04364737|584406048|FG001|Overall Study|Withdrawal by Subject|9|||
161826728|NCT04364737|584406047|FG000|Overall Study|Lost to Follow-up|1|||
161826729|NCT04364737|584406048|FG001|Overall Study|Lost to Follow-up|1|||
161826730|NCT01220609|584406049|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
161826731|NCT01220609|584406049|FG000|Overall Study|Ineligible- Wrong cell type|1|||
161826732|NCT01220609|584406049|FG000|Overall Study|Ineligible-Never treated|1|||
161826733|NCT00112294|584406050|FG000|Overall Study|Still on study|5|||
161826734|NCT00112294|584406051|FG001|Overall Study|Still on study|0|||
161826735|NCT05070754|584406061|FG000|Overall Study|Withdrawal by Subject|0|||
161826736|NCT05070754|584406062|FG001|Overall Study|Withdrawal by Subject|0|||
161826737|NCT05070754|584406063|FG002|Overall Study|Withdrawal by Subject|0|||
161826738|NCT05070754|584406064|FG003|Overall Study|Withdrawal by Subject|1|||
161826739|NCT05070754|584406061|FG000|Overall Study|Protocol Violation|0|||
161826740|NCT05070754|584406062|FG001|Overall Study|Protocol Violation|0|||
161826741|NCT05070754|584406063|FG002|Overall Study|Protocol Violation|0|||
161826742|NCT05070754|584406064|FG003|Overall Study|Protocol Violation|1|||
161826743|NCT01398787|584406065|FG000|Overall Study|Adverse Event|1|||
161826744|NCT00529217|584406068|FG000|Overall Study|Lack of Efficacy|2|||
161826745|NCT00529217|584406068|FG000|Overall Study|Unable to adhere to study schedule|2|||
161826746|NCT00372996|584406071|FG000|Overall Study|Death|11|||
161826747|NCT00372996|584406072|FG001|Overall Study|Death|4|||
161935538|NCT03031912|584813917|FG000|Overall Study|Lost to Follow-up|1|||
161935539|NCT03031912|584813918|FG001|Overall Study|Lost to Follow-up|1|||
161935540|NCT03031912|584813919|FG002|Overall Study|Lost to Follow-up|0|||
161935541|NCT03031912|584813920|FG003|Overall Study|Lost to Follow-up|1|||
161935542|NCT03031912|584813921|FG004|Overall Study|Lost to Follow-up|0|||
161935543|NCT03031912|584813922|FG005|Overall Study|Lost to Follow-up|0|||
161935544|NCT03031912|584813923|FG006|Overall Study|Lost to Follow-up|0|||
161935545|NCT03031912|584813924|FG007|Overall Study|Lost to Follow-up|0|||
161935546|NCT03031912|584813925|FG008|Overall Study|Lost to Follow-up|0|||
161935547|NCT03031912|584813926|FG009|Overall Study|Lost to Follow-up|0|||
162212916|NCT00307047|585830897|FG000|Overall Study|Physician Decision|1|||
162212917|NCT00307047|585830898|FG001|Overall Study|Physician Decision|2|||
162212918|NCT00307047|585830897|FG000|Overall Study|Lost to follow-up for other reasons|0|||
162212919|NCT00307047|585830898|FG001|Overall Study|Lost to follow-up for other reasons|1|||
162212920|NCT00307047|585830897|FG000|Overall Study|All death, all MI, all Revascularization|27|||
162212921|NCT00307047|585830898|FG001|Overall Study|All death, all MI, all Revascularization|16|||
162212922|NCT00379769|585830899|FG000|Main Study|Death|57|||
162212923|NCT00379769|585830900|FG001|Main Study|Death|67|||
162212924|NCT00379769|585830901|FG002|Main Study|Death|54|||
162212925|NCT00379769|585830902|FG003|Main Study|Death|72|||
162212926|NCT00379769|585830903|FG004|Main Study|Death|0|||
162212927|NCT00379769|585830904|FG005|Main Study|Death|0|||
162212928|NCT00379769|585830899|FG000|Main Study|Adverse Event|5|||
162212929|NCT00379769|585830900|FG001|Main Study|Adverse Event|8|||
162212930|NCT00379769|585830901|FG002|Main Study|Adverse Event|10|||
162212931|NCT00379769|585830902|FG003|Main Study|Adverse Event|11|||
162212932|NCT00379769|585830903|FG004|Main Study|Adverse Event|0|||
162212933|NCT00379769|585830904|FG005|Main Study|Adverse Event|0|||
162212934|NCT00379769|585830899|FG000|Main Study|Lost to Follow-up|29|||
162212935|NCT00379769|585830900|FG001|Main Study|Lost to Follow-up|29|||
162212936|NCT00379769|585830901|FG002|Main Study|Lost to Follow-up|25|||
162212937|NCT00379769|585830902|FG003|Main Study|Lost to Follow-up|26|||
162212938|NCT00379769|585830903|FG004|Main Study|Lost to Follow-up|0|||
162212939|NCT00379769|585830904|FG005|Main Study|Lost to Follow-up|0|||
162212940|NCT00379769|585830899|FG000|Main Study|Withdrawal by Subject|46|||
162212941|NCT00379769|585830900|FG001|Main Study|Withdrawal by Subject|56|||
162212942|NCT00379769|585830901|FG002|Main Study|Withdrawal by Subject|72|||
162212943|NCT00379769|585830902|FG003|Main Study|Withdrawal by Subject|70|||
162212944|NCT00379769|585830903|FG004|Main Study|Withdrawal by Subject|0|||
162212945|NCT00379769|585830904|FG005|Main Study|Withdrawal by Subject|0|||
162212946|NCT00379769|585830899|FG000|Main Study|Moved to survival status follow-up only|27|||
162212947|NCT00379769|585830900|FG001|Main Study|Moved to survival status follow-up only|25|||
162212948|NCT00379769|585830901|FG002|Main Study|Moved to survival status follow-up only|32|||
162212949|NCT00379769|585830902|FG003|Main Study|Moved to survival status follow-up only|36|||
162212950|NCT00379769|585830903|FG004|Main Study|Moved to survival status follow-up only|0|||
162212951|NCT00379769|585830904|FG005|Main Study|Moved to survival status follow-up only|0|||
162212952|NCT00379769|585830899|FG000|Main Study|Participant moved|3|||
162212953|NCT00379769|585830900|FG001|Main Study|Participant moved|2|||
162212954|NCT00379769|585830901|FG002|Main Study|Participant moved|3|||
162212955|NCT00379769|585830902|FG003|Main Study|Participant moved|3|||
161935565|NCT04097743|584813938|FG000|Overall Study|Non-compliance of the study instruction.|1|||
161935566|NCT04097743|584813939|FG001|Overall Study|Non-compliance of the study instruction.|0|||
162212956|NCT00379769|585830903|FG004|Main Study|Participant moved|0|||
162212957|NCT00379769|585830904|FG005|Main Study|Participant moved|0|||
162212958|NCT00379769|585830899|FG000|Main Study|Poor compliance|3|||
162212959|NCT00379769|585830900|FG001|Main Study|Poor compliance|2|||
162212960|NCT00379769|585830901|FG002|Main Study|Poor compliance|2|||
162212961|NCT00379769|585830902|FG003|Main Study|Poor compliance|1|||
162212962|NCT00379769|585830903|FG004|Main Study|Poor compliance|0|||
162212963|NCT00379769|585830904|FG005|Main Study|Poor compliance|0|||
162212964|NCT00379769|585830899|FG000|Main Study|Prohibited glucose lowering medication|0|||
162212965|NCT00379769|585830900|FG001|Main Study|Prohibited glucose lowering medication|3|||
162212966|NCT00379769|585830901|FG002|Main Study|Prohibited glucose lowering medication|0|||
162212967|NCT00379769|585830902|FG003|Main Study|Prohibited glucose lowering medication|1|||
162212968|NCT00379769|585830903|FG004|Main Study|Prohibited glucose lowering medication|0|||
162212969|NCT00379769|585830904|FG005|Main Study|Prohibited glucose lowering medication|0|||
162212970|NCT00379769|585830899|FG000|Main Study|Site closed|4|||
162212971|NCT00379769|585830900|FG001|Main Study|Site closed|4|||
162212972|NCT00379769|585830901|FG002|Main Study|Site closed|4|||
162212973|NCT00379769|585830902|FG003|Main Study|Site closed|8|||
162212974|NCT00379769|585830903|FG004|Main Study|Site closed|0|||
162212975|NCT00379769|585830904|FG005|Main Study|Site closed|0|||
162212976|NCT00379769|585830899|FG000|Main Study|Entry criteria violation|0|||
162212977|NCT00379769|585830900|FG001|Main Study|Entry criteria violation|0|||
162212978|NCT00379769|585830901|FG002|Main Study|Entry criteria violation|1|||
162212979|NCT00379769|585830902|FG003|Main Study|Entry criteria violation|1|||
162212980|NCT00379769|585830903|FG004|Main Study|Entry criteria violation|0|||
162212981|NCT00379769|585830904|FG005|Main Study|Entry criteria violation|0|||
162212982|NCT00379769|585830899|FG000|Main Study|Participant did not take study drug|0|||
162212983|NCT00379769|585830900|FG001|Main Study|Participant did not take study drug|0|||
162212984|NCT00379769|585830901|FG002|Main Study|Participant did not take study drug|1|||
162212985|NCT00379769|585830902|FG003|Main Study|Participant did not take study drug|0|||
162212986|NCT00379769|585830903|FG004|Main Study|Participant did not take study drug|0|||
162212987|NCT00379769|585830904|FG005|Main Study|Participant did not take study drug|0|||
162212988|NCT00379769|585830899|FG000|Main Study|Physician Decision|2|||
162212989|NCT00379769|585830900|FG001|Main Study|Physician Decision|2|||
162212990|NCT00379769|585830901|FG002|Main Study|Physician Decision|1|||
162212991|NCT00379769|585830902|FG003|Main Study|Physician Decision|1|||
162212992|NCT00379769|585830903|FG004|Main Study|Physician Decision|0|||
162212993|NCT00379769|585830904|FG005|Main Study|Physician Decision|0|||
162212994|NCT00379769|585830899|FG000|Main Study|Participant completed study at visit 27|1|||
162212995|NCT00379769|585830900|FG001|Main Study|Participant completed study at visit 27|0|||
162212996|NCT00379769|585830901|FG002|Main Study|Participant completed study at visit 27|0|||
162212997|NCT00379769|585830902|FG003|Main Study|Participant completed study at visit 27|0|||
162212998|NCT00379769|585830903|FG004|Main Study|Participant completed study at visit 27|0|||
162212999|NCT00379769|585830904|FG005|Main Study|Participant completed study at visit 27|0|||
162213000|NCT00379769|585830899|FG000|Main Study|Personal reasons|1|||
162213001|NCT00379769|585830900|FG001|Main Study|Personal reasons|0|||
162213002|NCT00379769|585830901|FG002|Main Study|Personal reasons|0|||
162213003|NCT00379769|585830902|FG003|Main Study|Personal reasons|0|||
162213004|NCT00379769|585830903|FG004|Main Study|Personal reasons|0|||
162213005|NCT00379769|585830904|FG005|Main Study|Personal reasons|0|||
162213006|NCT00379769|585830899|FG000|Main Study|Risk of heart failure|0|||
162021357|NCT02551991|585134759|FG004|Overall Study|Withdrawal by Subject|2|||
162213007|NCT00379769|585830900|FG001|Main Study|Risk of heart failure|1|||
162213008|NCT00379769|585830901|FG002|Main Study|Risk of heart failure|0|||
162213009|NCT00379769|585830902|FG003|Main Study|Risk of heart failure|0|||
162213010|NCT00379769|585830903|FG004|Main Study|Risk of heart failure|0|||
162213011|NCT00379769|585830904|FG005|Main Study|Risk of heart failure|0|||
162213012|NCT00379769|585830899|FG000|Main Study|Investigator refused to log temperature|0|||
162213013|NCT00379769|585830900|FG001|Main Study|Investigator refused to log temperature|0|||
162213014|NCT00379769|585830901|FG002|Main Study|Investigator refused to log temperature|1|||
162213015|NCT00379769|585830902|FG003|Main Study|Investigator refused to log temperature|0|||
162213016|NCT00379769|585830903|FG004|Main Study|Investigator refused to log temperature|0|||
162213017|NCT00379769|585830904|FG005|Main Study|Investigator refused to log temperature|0|||
162213018|NCT00379769|585830899|FG000|Main Study|Reason unspecified|0|||
162213019|NCT00379769|585830900|FG001|Main Study|Reason unspecified|0|||
162213020|NCT00379769|585830901|FG002|Main Study|Reason unspecified|1|||
162213021|NCT00379769|585830902|FG003|Main Study|Reason unspecified|0|||
162213022|NCT00379769|585830903|FG004|Main Study|Reason unspecified|0|||
162213023|NCT00379769|585830904|FG005|Main Study|Reason unspecified|0|||
162213024|NCT00379769|585830899|FG000|Observational Follow-up|Death|0|||
162213025|NCT00379769|585830900|FG001|Observational Follow-up|Death|0|||
162213026|NCT00379769|585830901|FG002|Observational Follow-up|Death|0|||
162213027|NCT00379769|585830902|FG003|Observational Follow-up|Death|0|||
162213028|NCT00379769|585830903|FG004|Observational Follow-up|Death|78|||
162213029|NCT00379769|585830904|FG005|Observational Follow-up|Death|70|||
162213030|NCT00379769|585830899|FG000|Observational Follow-up|Adverse Event|0|||
162213031|NCT00379769|585830900|FG001|Observational Follow-up|Adverse Event|0|||
162213032|NCT00379769|585830901|FG002|Observational Follow-up|Adverse Event|0|||
162213033|NCT00379769|585830902|FG003|Observational Follow-up|Adverse Event|0|||
162213034|NCT00379769|585830903|FG004|Observational Follow-up|Adverse Event|1|||
162213035|NCT00379769|585830904|FG005|Observational Follow-up|Adverse Event|0|||
162213036|NCT00379769|585830899|FG000|Observational Follow-up|Lost to Follow-up|0|||
162213037|NCT00379769|585830900|FG001|Observational Follow-up|Lost to Follow-up|0|||
162213038|NCT00379769|585830901|FG002|Observational Follow-up|Lost to Follow-up|0|||
162213039|NCT00379769|585830902|FG003|Observational Follow-up|Lost to Follow-up|0|||
162213040|NCT00379769|585830903|FG004|Observational Follow-up|Lost to Follow-up|25|||
162213041|NCT00379769|585830904|FG005|Observational Follow-up|Lost to Follow-up|27|||
162213042|NCT00379769|585830899|FG000|Observational Follow-up|Withdrawal by Subject|0|||
162213043|NCT00379769|585830900|FG001|Observational Follow-up|Withdrawal by Subject|0|||
162213044|NCT00379769|585830901|FG002|Observational Follow-up|Withdrawal by Subject|0|||
162213045|NCT00379769|585830902|FG003|Observational Follow-up|Withdrawal by Subject|0|||
162213046|NCT00379769|585830903|FG004|Observational Follow-up|Withdrawal by Subject|12|||
162213047|NCT00379769|585830904|FG005|Observational Follow-up|Withdrawal by Subject|12|||
162213048|NCT00379769|585830899|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
162213049|NCT00379769|585830900|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
162213050|NCT00379769|585830901|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
162213051|NCT00379769|585830902|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
162213052|NCT00379769|585830903|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
162213053|NCT00379769|585830904|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
162213054|NCT00379769|585830899|FG000|Observational Follow-up|Physician Decision|0|||
162213055|NCT00379769|585830900|FG001|Observational Follow-up|Physician Decision|0|||
162213056|NCT00379769|585830901|FG002|Observational Follow-up|Physician Decision|0|||
162213057|NCT00379769|585830902|FG003|Observational Follow-up|Physician Decision|0|||
162213058|NCT00379769|585830903|FG004|Observational Follow-up|Physician Decision|8|||
162213059|NCT00379769|585830904|FG005|Observational Follow-up|Physician Decision|8|||
162213060|NCT00379769|585830899|FG000|Observational Follow-up|Site Closed Early|0|||
162213061|NCT00379769|585830900|FG001|Observational Follow-up|Site Closed Early|0|||
162213062|NCT00379769|585830901|FG002|Observational Follow-up|Site Closed Early|0|||
162213063|NCT00379769|585830902|FG003|Observational Follow-up|Site Closed Early|0|||
162021358|NCT02551991|585134755|FG000|Overall Study|Lost to Follow-up|0|||
162021359|NCT02551991|585134756|FG001|Overall Study|Lost to Follow-up|0|||
162213064|NCT00379769|585830903|FG004|Observational Follow-up|Site Closed Early|6|||
162213065|NCT00379769|585830904|FG005|Observational Follow-up|Site Closed Early|7|||
162213066|NCT00379769|585830899|FG000|Observational Follow-up|Participant Moved|0|||
162213067|NCT00379769|585830900|FG001|Observational Follow-up|Participant Moved|0|||
162213068|NCT00379769|585830901|FG002|Observational Follow-up|Participant Moved|0|||
162213069|NCT00379769|585830902|FG003|Observational Follow-up|Participant Moved|0|||
162213070|NCT00379769|585830903|FG004|Observational Follow-up|Participant Moved|0|||
161826748|NCT00372996|584406073|FG002|Overall Study|Death|8|||
161826749|NCT00372996|584406074|FG003|Overall Study|Death|7|||
161826750|NCT00372996|584406071|FG000|Overall Study|Lost to Follow-up|0|||
161826751|NCT00372996|584406072|FG001|Overall Study|Lost to Follow-up|2|||
161826752|NCT00372996|584406073|FG002|Overall Study|Lost to Follow-up|0|||
161826753|NCT00372996|584406074|FG003|Overall Study|Lost to Follow-up|1|||
161826754|NCT00372996|584406071|FG000|Overall Study|Withdrawal by Subject|12|||
161826755|NCT00372996|584406072|FG001|Overall Study|Withdrawal by Subject|6|||
161826756|NCT00372996|584406073|FG002|Overall Study|Withdrawal by Subject|9|||
161826757|NCT00372996|584406074|FG003|Overall Study|Withdrawal by Subject|5|||
161826758|NCT00372996|584406071|FG000|Overall Study|Study Terminated by Sponsor|4|||
161826759|NCT00372996|584406072|FG001|Overall Study|Study Terminated by Sponsor|0|||
161826760|NCT00372996|584406073|FG002|Overall Study|Study Terminated by Sponsor|4|||
161826761|NCT00372996|584406074|FG003|Overall Study|Study Terminated by Sponsor|0|||
161826762|NCT00372996|584406071|FG000|Overall Study|Other|10|||
161826763|NCT00372996|584406072|FG001|Overall Study|Other|2|||
161826764|NCT00372996|584406073|FG002|Overall Study|Other|7|||
161826765|NCT00372996|584406074|FG003|Overall Study|Other|7|||
161826766|NCT01098539|584406075|FG000|Overall Study|Adverse Event|26|||
161826767|NCT01098539|584406076|FG001|Overall Study|Adverse Event|26|||
161826768|NCT01098539|584406075|FG000|Overall Study|Protocol Violation|1|||
161826769|NCT01098539|584406076|FG001|Overall Study|Protocol Violation|4|||
161826770|NCT01098539|584406075|FG000|Overall Study|Noncompliance|3|||
161826771|NCT01098539|584406076|FG001|Overall Study|Noncompliance|5|||
161826772|NCT01098539|584406075|FG000|Overall Study|Lost to Follow-up|4|||
161826773|NCT01098539|584406076|FG001|Overall Study|Lost to Follow-up|4|||
161826774|NCT01098539|584406075|FG000|Overall Study|Withdrawal by Subject|12|||
161826775|NCT01098539|584406076|FG001|Overall Study|Withdrawal by Subject|26|||
161826776|NCT01098539|584406075|FG000|Overall Study|Physician Decision|5|||
161826777|NCT01098539|584406076|FG001|Overall Study|Physician Decision|3|||
161826778|NCT03843125|584406077|FG000|Overall Study|Adverse Event|17|||
161826779|NCT03843125|584406078|FG001|Overall Study|Adverse Event|13|||
161826780|NCT03843125|584406079|FG002|Overall Study|Adverse Event|5|||
161826781|NCT03843125|584406080|FG003|Overall Study|Adverse Event|9|||
161826782|NCT03843125|584406077|FG000|Overall Study|Death|0|||
161826783|NCT03843125|584406078|FG001|Overall Study|Death|6|||
161826784|NCT03843125|584406079|FG002|Overall Study|Death|2|||
161826785|NCT03843125|584406080|FG003|Overall Study|Death|0|||
161935628|NCT02932410|584813974|FG000|Overall Study|Death|7|||
161935629|NCT02932410|584813975|FG001|Overall Study|Death|6|||
161935630|NCT02932410|584813976|FG002|Overall Study|Death|0|||
161935631|NCT02932410|584813977|FG003|Overall Study|Death|0|||
161826786|NCT03843125|584406077|FG000|Overall Study|Lack of Efficacy|14|||
161826787|NCT03843125|584406078|FG001|Overall Study|Lack of Efficacy|11|||
161826788|NCT03843125|584406079|FG002|Overall Study|Lack of Efficacy|9|||
161826789|NCT03843125|584406080|FG003|Overall Study|Lack of Efficacy|4|||
161826790|NCT03843125|584406077|FG000|Overall Study|Lost to Follow-up|3|||
161935632|NCT02932410|584813974|FG000|Overall Study|Lost to Follow-up|1|||
161935633|NCT02932410|584813975|FG001|Overall Study|Lost to Follow-up|2|||
162021360|NCT02551991|585134757|FG002|Overall Study|Lost to Follow-up|1|||
161826791|NCT03843125|584406078|FG001|Overall Study|Lost to Follow-up|4|||
161826792|NCT03843125|584406079|FG002|Overall Study|Lost to Follow-up|0|||
161826793|NCT03843125|584406080|FG003|Overall Study|Lost to Follow-up|2|||
161826794|NCT03843125|584406077|FG000|Overall Study|Other|12|||
161826795|NCT03843125|584406078|FG001|Overall Study|Other|14|||
161826796|NCT03843125|584406079|FG002|Overall Study|Other|3|||
161826797|NCT03843125|584406080|FG003|Overall Study|Other|4|||
161826798|NCT03843125|584406077|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
161826799|NCT03843125|584406078|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
161826800|NCT03843125|584406079|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
161826801|NCT03843125|584406080|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
161826802|NCT03843125|584406077|FG000|Overall Study|Study Terminated by Sponsor|318|||
161826803|NCT03843125|584406078|FG001|Overall Study|Study Terminated by Sponsor|318|||
161826804|NCT03843125|584406079|FG002|Overall Study|Study Terminated by Sponsor|163|||
161826805|NCT03843125|584406080|FG003|Overall Study|Study Terminated by Sponsor|163|||
161826806|NCT03843125|584406077|FG000|Overall Study|Withdrawal by Subject|23|||
161826807|NCT03843125|584406078|FG001|Overall Study|Withdrawal by Subject|12|||
161826808|NCT03843125|584406079|FG002|Overall Study|Withdrawal by Subject|6|||
161826809|NCT03843125|584406080|FG003|Overall Study|Withdrawal by Subject|9|||
161826810|NCT03843125|584406077|FG000|Overall Study|Missing data|0|||
161826811|NCT03843125|584406078|FG001|Overall Study|Missing data|1|||
161826812|NCT03843125|584406079|FG002|Overall Study|Missing data|1|||
161826813|NCT03843125|584406080|FG003|Overall Study|Missing data|0|||
161826814|NCT03173560|584406081|FG000|Overall Study|Death|70|||
161826815|NCT03173560|584406082|FG001|Overall Study|Death|60|||
161826816|NCT03173560|584406081|FG000|Overall Study|Lost to Follow-up|1|||
161826817|NCT03173560|584406082|FG001|Overall Study|Lost to Follow-up|4|||
161826818|NCT03173560|584406081|FG000|Overall Study|Withdrawal by Subject|10|||
161826819|NCT03173560|584406082|FG001|Overall Study|Withdrawal by Subject|5|||
161826820|NCT03173560|584406081|FG000|Overall Study|Other|0|||
161826821|NCT03173560|584406082|FG001|Overall Study|Other|1|||
161826822|NCT02174276|584406083|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
161826823|NCT02174276|584406084|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
161826824|NCT02174276|584406085|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
161826825|NCT02174276|584406086|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
161826826|NCT02174276|584406083|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
161826827|NCT02174276|584406084|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
161826828|NCT02174276|584406085|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
161826829|NCT02174276|584406086|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
161826830|NCT02174276|584406083|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
161826831|NCT02174276|584406084|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
161826832|NCT02174276|584406085|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
161826833|NCT02174276|584406086|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
161826834|NCT02174276|584406083|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
161826835|NCT02174276|584406084|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
161826836|NCT02174276|584406085|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
161826837|NCT02174276|584406086|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
161826838|NCT02174276|584406083|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
161826839|NCT02174276|584406084|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
161826840|NCT02174276|584406085|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
161826841|NCT02174276|584406086|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
161826842|NCT02174276|584406083|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
161826843|NCT02174276|584406084|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
161826844|NCT02174276|584406085|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
161826845|NCT02174276|584406086|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
161826846|NCT00725764|584406088|FG000|Overall Study|Withdrawal by Subject|2|||
161826847|NCT00725764|584406088|FG000|Overall Study|Physician Decision|1|||
161826848|NCT00725764|584406088|FG000|Overall Study|Progressive Disease|7|||
161826849|NCT00725764|584406088|FG000|Overall Study|Lost to Follow-up|1|||
161826850|NCT00725764|584406088|FG000|Overall Study|Death|1|||
161826851|NCT00725764|584406088|FG000|Overall Study|Participant non compliant with protocol|1|||
161826852|NCT00725764|584406088|FG000|Overall Study|Decline in performance status|1|||
161826853|NCT00434837|584406091|FG000|Overall Study|Lost to Follow-up|20|||
161826854|NCT00434837|584406092|FG001|Overall Study|Lost to Follow-up|23|||
161826855|NCT00434837|584406093|FG002|Overall Study|Lost to Follow-up|30|||
161826856|NCT00250705|584406094|FG000|Overall Study|Lack of Efficacy|2|||
161826857|NCT00587431|584406095|FG000|Overall Study|Adverse Event|1|||
161826858|NCT00587431|584406096|FG001|Overall Study|Adverse Event|0|||
161826859|NCT00587431|584406095|FG000|Overall Study|Withdrawal by Subject|0|||
161935634|NCT02932410|584813976|FG002|Overall Study|Lost to Follow-up|0|||
161826860|NCT00587431|584406096|FG001|Overall Study|Withdrawal by Subject|1|||
162021361|NCT02551991|585134758|FG003|Overall Study|Lost to Follow-up|0|||
161826861|NCT05467982|584406097|FG000|Overall Study|Death|0|||
161826862|NCT05467982|584406098|FG001|Overall Study|Death|1|||
161826863|NCT05467982|584406097|FG000|Overall Study|Lost to Follow-up|3|||
161678056|NCT04667377|583873602|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
161678057|NCT04667377|583873603|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
161678058|NCT04667377|583873604|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
161678059|NCT04667377|583873605|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
161678060|NCT04667377|583873601|FG000|Dose Escalation Period|Not treated|1|||
161678061|NCT04667377|583873602|FG001|Dose Escalation Period|Not treated|0|||
161678062|NCT04667377|583873603|FG002|Dose Escalation Period|Not treated|0|||
161678063|NCT04667377|583873604|FG003|Dose Escalation Period|Not treated|0|||
161678064|NCT04667377|583873605|FG004|Dose Escalation Period|Not treated|0|||
161678065|NCT04667377|583873601|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
161678066|NCT04667377|583873602|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
161678067|NCT04667377|583873603|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
161678068|NCT04667377|583873604|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
161678069|NCT04667377|583873605|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
161678070|NCT04667377|583873601|FG000|Dose Escalation Period|Lost to Follow-up|0|||
161678071|NCT04667377|583873602|FG001|Dose Escalation Period|Lost to Follow-up|1|||
161678072|NCT04667377|583873603|FG002|Dose Escalation Period|Lost to Follow-up|0|||
161678073|NCT04667377|583873604|FG003|Dose Escalation Period|Lost to Follow-up|0|||
161678074|NCT04667377|583873605|FG004|Dose Escalation Period|Lost to Follow-up|0|||
161678075|NCT04667377|583873601|FG000|Maintenance Period|Perceived lack of efficacy|0|||
161678076|NCT04667377|583873602|FG001|Maintenance Period|Perceived lack of efficacy|2|||
161678077|NCT04667377|583873603|FG002|Maintenance Period|Perceived lack of efficacy|1|||
161678078|NCT04667377|583873604|FG003|Maintenance Period|Perceived lack of efficacy|0|||
161678079|NCT04667377|583873605|FG004|Maintenance Period|Perceived lack of efficacy|1|||
161678080|NCT04667377|583873601|FG000|Maintenance Period|Adverse Event|2|||
161678081|NCT04667377|583873602|FG001|Maintenance Period|Adverse Event|8|||
161678082|NCT04667377|583873603|FG002|Maintenance Period|Adverse Event|5|||
161678083|NCT04667377|583873604|FG003|Maintenance Period|Adverse Event|4|||
161678084|NCT04667377|583873605|FG004|Maintenance Period|Adverse Event|1|||
161678085|NCT04667377|583873601|FG000|Maintenance Period|Adverse event: COVID infection|0|||
161678086|NCT04667377|583873602|FG001|Maintenance Period|Adverse event: COVID infection|1|||
161678087|NCT04667377|583873603|FG002|Maintenance Period|Adverse event: COVID infection|0|||
161678088|NCT04667377|583873604|FG003|Maintenance Period|Adverse event: COVID infection|0|||
161678089|NCT04667377|583873605|FG004|Maintenance Period|Adverse event: COVID infection|0|||
161935635|NCT02932410|584813977|FG003|Overall Study|Lost to Follow-up|0|||
161935636|NCT02932410|584813974|FG000|Overall Study|Parent/Subjects decision|6|||
161935637|NCT02932410|584813975|FG001|Overall Study|Parent/Subjects decision|6|||
161935638|NCT02932410|584813976|FG002|Overall Study|Parent/Subjects decision|1|||
162213071|NCT00379769|585830904|FG005|Observational Follow-up|Participant Moved|1|||
162213072|NCT00379769|585830899|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
162213073|NCT00379769|585830900|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
162213074|NCT00379769|585830901|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
162213075|NCT00379769|585830902|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
162213076|NCT00379769|585830903|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
162213077|NCT00379769|585830904|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
162213078|NCT02825251|585830905|FG000|Overall Study|Adverse Event|0|||
162213079|NCT02825251|585830906|FG001|Overall Study|Adverse Event|1|||
162213080|NCT02825251|585830905|FG000|Overall Study|Lost to Follow-up|0|||
162213081|NCT02825251|585830906|FG001|Overall Study|Lost to Follow-up|1|||
162213082|NCT02825251|585830905|FG000|Overall Study|Withdrawal by Subject|1|||
162213083|NCT02825251|585830906|FG001|Overall Study|Withdrawal by Subject|4|||
161678090|NCT04667377|583873601|FG000|Maintenance Period|COVID-related|0|||
161678091|NCT04667377|583873602|FG001|Maintenance Period|COVID-related|0|||
161678092|NCT04667377|583873603|FG002|Maintenance Period|COVID-related|1|||
161678093|NCT04667377|583873604|FG003|Maintenance Period|COVID-related|1|||
161678094|NCT04667377|583873605|FG004|Maintenance Period|COVID-related|0|||
161678095|NCT04667377|583873601|FG000|Maintenance Period|Protocol Violation|1|||
161678096|NCT04667377|583873602|FG001|Maintenance Period|Protocol Violation|0|||
161678097|NCT04667377|583873603|FG002|Maintenance Period|Protocol Violation|0|||
161678098|NCT04667377|583873604|FG003|Maintenance Period|Protocol Violation|0|||
161678099|NCT04667377|583873605|FG004|Maintenance Period|Protocol Violation|1|||
161678100|NCT04667377|583873601|FG000|Maintenance Period|Burden of study procedures|1|||
161935639|NCT02932410|584813977|FG003|Overall Study|Parent/Subjects decision|0|||
162213084|NCT02825251|585830905|FG000|Overall Study|Unclassified|2|||
161935640|NCT02932410|584813974|FG000|Overall Study|Physician Decision|0|||
161935641|NCT02932410|584813975|FG001|Overall Study|Physician Decision|1|||
161678101|NCT04667377|583873602|FG001|Maintenance Period|Burden of study procedures|2|||
162213085|NCT02825251|585830906|FG001|Overall Study|Unclassified|0|||
162213086|NCT01689363|585830915|FG000|Overall Study|Protocol Violation|0|||
162213087|NCT01689363|585830916|FG001|Overall Study|Protocol Violation|1|||
162213088|NCT01689363|585830917|FG002|Overall Study|Protocol Violation|0|||
162213089|NCT01689363|585830918|FG003|Overall Study|Protocol Violation|0|||
162213090|NCT01689363|585830919|FG004|Overall Study|Protocol Violation|0|||
162213091|NCT01689363|585830920|FG005|Overall Study|Protocol Violation|0|||
162213092|NCT01689363|585830921|FG006|Overall Study|Protocol Violation|0|||
162213093|NCT01689363|585830922|FG007|Overall Study|Protocol Violation|0|||
162213094|NCT00321685|585830923|FG000|Overall Study|Adverse Event|18|||
161678102|NCT04667377|583873603|FG002|Maintenance Period|Burden of study procedures|0|||
161678103|NCT04667377|583873604|FG003|Maintenance Period|Burden of study procedures|1|||
161678104|NCT04667377|583873605|FG004|Maintenance Period|Burden of study procedures|0|||
161678105|NCT04667377|583873601|FG000|Maintenance Period|Change of residence|0|||
161678106|NCT04667377|583873602|FG001|Maintenance Period|Change of residence|1|||
161678107|NCT04667377|583873603|FG002|Maintenance Period|Change of residence|0|||
161678108|NCT04667377|583873604|FG003|Maintenance Period|Change of residence|0|||
161678109|NCT04667377|583873605|FG004|Maintenance Period|Change of residence|1|||
161678110|NCT04667377|583873601|FG000|Maintenance Period|Missing|1|||
161678111|NCT04667377|583873602|FG001|Maintenance Period|Missing|0|||
161678112|NCT04667377|583873603|FG002|Maintenance Period|Missing|0|||
161678113|NCT04667377|583873604|FG003|Maintenance Period|Missing|0|||
161678114|NCT04667377|583873605|FG004|Maintenance Period|Missing|0|||
161678115|NCT04667377|583873601|FG000|Maintenance Period|Other than listed above|2|||
161678116|NCT04667377|583873602|FG001|Maintenance Period|Other than listed above|0|||
161678117|NCT04667377|583873603|FG002|Maintenance Period|Other than listed above|3|||
161678118|NCT04667377|583873604|FG003|Maintenance Period|Other than listed above|2|||
161678119|NCT04667377|583873605|FG004|Maintenance Period|Other than listed above|6|||
161678120|NCT04667377|583873601|FG000|Maintenance Period|Withdrawal by Subject|0|||
161678121|NCT04667377|583873602|FG001|Maintenance Period|Withdrawal by Subject|1|||
161678122|NCT04667377|583873603|FG002|Maintenance Period|Withdrawal by Subject|0|||
161678123|NCT04667377|583873604|FG003|Maintenance Period|Withdrawal by Subject|0|||
161678124|NCT04667377|583873605|FG004|Maintenance Period|Withdrawal by Subject|0|||
161678125|NCT04667377|583873601|FG000|Maintenance Period|Lost to Follow-up|1|||
161678126|NCT04667377|583873602|FG001|Maintenance Period|Lost to Follow-up|0|||
161678127|NCT04667377|583873603|FG002|Maintenance Period|Lost to Follow-up|1|||
161678128|NCT04667377|583873604|FG003|Maintenance Period|Lost to Follow-up|0|||
161678129|NCT04667377|583873605|FG004|Maintenance Period|Lost to Follow-up|1|||
161678130|NCT00359021|583873606|FG000|Overall Study|Adverse Event|26|||
161678131|NCT00359021|583873607|FG001|Overall Study|Adverse Event|8|||
161678132|NCT00359021|583873606|FG000|Overall Study|Subject Non-Compliant|1|||
161678133|NCT00359021|583873607|FG001|Overall Study|Subject Non-Compliant|2|||
161678134|NCT00359021|583873606|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
161678135|NCT00359021|583873607|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
161678136|NCT00359021|583873606|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
161678137|NCT00359021|583873607|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
161678138|NCT00359021|583873606|FG000|Overall Study|Withdrawal by Subject|2|||
161678139|NCT00359021|583873607|FG001|Overall Study|Withdrawal by Subject|9|||
161678140|NCT00359021|583873606|FG000|Overall Study|Lost to Follow-up|1|||
161678141|NCT00359021|583873607|FG001|Overall Study|Lost to Follow-up|0|||
161678142|NCT00359021|583873606|FG000|Overall Study|Other|4|||
161678143|NCT00359021|583873607|FG001|Overall Study|Other|1|||
161678144|NCT00359021|583873606|FG000|Overall Study|Pregnancy|1|||
161678145|NCT00359021|583873607|FG001|Overall Study|Pregnancy|0|||
161678146|NCT03861936|583873608|FG000|Overall Study|Withdrawal by Subject|4|||
161678147|NCT03861936|583873609|FG001|Overall Study|Withdrawal by Subject|1|||
161826864|NCT05467982|584406098|FG001|Overall Study|Lost to Follow-up|1|||
161826865|NCT03507686|584406107|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
161826866|NCT03507686|584406108|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
161826867|NCT03507686|584406107|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
161826868|NCT03507686|584406108|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
162213095|NCT00321685|585830923|FG000|Overall Study|Death|2|||
162213096|NCT00321685|585830923|FG000|Overall Study|Withdrawal by Subject|8|||
162213097|NCT00321685|585830923|FG000|Overall Study|Alternative therapy|1|||
162213098|NCT00321685|585830923|FG000|Overall Study|Complicating disese|1|||
162213099|NCT00321685|585830923|FG000|Overall Study|Other|5|||
162213100|NCT00321685|585830923|FG000|Overall Study|Not start protocol therapy|2|||
162213101|NCT00321685|585830923|FG000|Overall Study|Ineligible|2|||
162213102|NCT05064488|585830927|FG000|Overall Study|Withdrawal by Subject|2|||
161678148|NCT03861936|583873610|FG002|Overall Study|Withdrawal by Subject|3|||
161678149|NCT03861936|583873608|FG000|Overall Study|Lost to Follow-up|5|||
161826869|NCT03507686|584406107|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
161935642|NCT02932410|584813976|FG002|Overall Study|Physician Decision|0|||
162213103|NCT05064488|585830928|FG001|Overall Study|Withdrawal by Subject|0|||
161678150|NCT03861936|583873609|FG001|Overall Study|Lost to Follow-up|3|||
161678151|NCT03861936|583873610|FG002|Overall Study|Lost to Follow-up|3|||
162021362|NCT02551991|585134759|FG004|Overall Study|Lost to Follow-up|0|||
162021363|NCT02551991|585134755|FG000|Overall Study|Sponsor Decision|1|||
162021364|NCT02551991|585134756|FG001|Overall Study|Sponsor Decision|0|||
162213104|NCT02783573|585830929|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
162213105|NCT02783573|585830930|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
162213106|NCT02783573|585830931|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
162213107|NCT02783573|585830929|FG000|Placebo-Controlled Treatment Period|Death|4|||
162213108|NCT02783573|585830930|FG001|Placebo-Controlled Treatment Period|Death|2|||
162213109|NCT02783573|585830931|FG002|Placebo-Controlled Treatment Period|Death|3|||
162213110|NCT02783573|585830929|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
162213111|NCT02783573|585830930|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
162213112|NCT02783573|585830931|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
162213113|NCT02783573|585830929|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
162213114|NCT02783573|585830930|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
162213115|NCT02783573|585830931|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
162213116|NCT02783573|585830929|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
162213117|NCT02783573|585830930|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
162213118|NCT02783573|585830931|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
162213119|NCT02783573|585830929|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
162213120|NCT02783573|585830930|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
162213121|NCT02783573|585830931|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
162213122|NCT02783573|585830929|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
162213123|NCT02783573|585830930|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
162213124|NCT02783573|585830931|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
161678152|NCT03861936|583873608|FG000|Overall Study|Physician Decision|0|||
161826870|NCT03507686|584406108|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
161826871|NCT03507686|584406107|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
161826872|NCT03507686|584406108|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
161826873|NCT03507686|584406107|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
161826874|NCT03507686|584406108|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
161826875|NCT03507686|584406107|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
161826876|NCT03507686|584406108|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
161826877|NCT00585312|584406109|FG000|Overall Study|Adverse Event|3|||
161826878|NCT00585312|584406110|FG001|Overall Study|Adverse Event|0|||
161826879|NCT00585312|584406109|FG000|Overall Study|Lack of Efficacy|6|||
161826880|NCT00585312|584406110|FG001|Overall Study|Lack of Efficacy|11|||
161826881|NCT00585312|584406109|FG000|Overall Study|Lost to Follow-up|1|||
161826882|NCT00585312|584406110|FG001|Overall Study|Lost to Follow-up|1|||
161826883|NCT00585312|584406109|FG000|Overall Study|Reason not specified|2|||
161826884|NCT00585312|584406110|FG001|Overall Study|Reason not specified|0|||
161826885|NCT00585312|584406109|FG000|Overall Study|Withdrawal by Subject|5|||
161826886|NCT00585312|584406110|FG001|Overall Study|Withdrawal by Subject|1|||
161826887|NCT00585312|584406109|FG000|Overall Study|Study terminated by the sponsor|34|||
161826888|NCT00585312|584406110|FG001|Overall Study|Study terminated by the sponsor|31|||
161826889|NCT01263561|584406111|FG000|Overall Study|Death|1|||
161826890|NCT01263561|584406112|FG001|Overall Study|Death|2|||
161826891|NCT00879684|584406113|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
161826892|NCT00879684|584406114|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
161826893|NCT00879684|584406115|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
161826894|NCT00879684|584406116|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
161826895|NCT00879684|584406117|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
161826896|NCT00879684|584406118|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
161826897|NCT00879684|584406119|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
161826898|NCT00879684|584406113|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
161826899|NCT00879684|584406114|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
161826900|NCT00879684|584406115|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
161826901|NCT00879684|584406116|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
161826902|NCT00879684|584406117|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
161826903|NCT00879684|584406118|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
161826904|NCT00879684|584406119|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
161826905|NCT00879684|584406113|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
161826906|NCT00879684|584406114|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
161826907|NCT00879684|584406115|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
161826908|NCT00879684|584406116|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
161826909|NCT00879684|584406117|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
161826910|NCT00879684|584406118|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
161826911|NCT00879684|584406119|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
161826912|NCT00879684|584406113|FG000|Stage 1: Dose Escalation|Death|0|||
161826913|NCT00879684|584406114|FG001|Stage 1: Dose Escalation|Death|0|||
161826914|NCT00879684|584406115|FG002|Stage 1: Dose Escalation|Death|1|||
161935643|NCT02932410|584813977|FG003|Overall Study|Physician Decision|0|||
162213125|NCT02783573|585830929|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
162213126|NCT02783573|585830930|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
162213127|NCT02783573|585830931|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
162213128|NCT02783573|585830929|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
162213129|NCT02783573|585830930|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
162213130|NCT02783573|585830931|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
162213131|NCT02783573|585830929|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
162213132|NCT02783573|585830930|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
162213133|NCT02783573|585830931|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
162213134|NCT02783573|585830929|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
162213135|NCT02783573|585830930|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
162213136|NCT02783573|585830931|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
162213137|NCT02783573|585830929|FG000|Delayed-Start Period|Sponsor Decision|0|||
162213138|NCT02783573|585830930|FG001|Delayed-Start Period|Sponsor Decision|17|||
162213139|NCT02783573|585830931|FG002|Delayed-Start Period|Sponsor Decision|12|||
162213140|NCT01434680|585830934|FG000|Overall Study|Withdrawal by Subject|1|||
162213141|NCT01434680|585830935|FG001|Overall Study|Withdrawal by Subject|0|||
162213142|NCT01434680|585830936|FG002|Overall Study|Withdrawal by Subject|2|||
162213143|NCT01434680|585830937|FG003|Overall Study|Withdrawal by Subject|0|||
162213144|NCT01434680|585830934|FG000|Overall Study|Lost to Follow-up|1|||
162213145|NCT01434680|585830935|FG001|Overall Study|Lost to Follow-up|1|||
162213146|NCT01434680|585830936|FG002|Overall Study|Lost to Follow-up|0|||
162213147|NCT01434680|585830937|FG003|Overall Study|Lost to Follow-up|0|||
162213148|NCT01434680|585830934|FG000|Overall Study|Protocol Violation|1|||
162213149|NCT01434680|585830935|FG001|Overall Study|Protocol Violation|1|||
162213150|NCT01434680|585830936|FG002|Overall Study|Protocol Violation|0|||
162213151|NCT01434680|585830937|FG003|Overall Study|Protocol Violation|0|||
162213152|NCT01367847|585830939|FG000|Overall Study|Withdrawal by Subject|2|||
162213153|NCT01367847|585830940|FG001|Overall Study|Withdrawal by Subject|2|||
162213154|NCT01952847|585830945|FG000|Overall Study|Ineligible|1|||
162213155|NCT01952847|585830946|FG001|Overall Study|Ineligible|0|||
162213156|NCT01952847|585830947|FG002|Overall Study|Ineligible|0|||
162213157|NCT01952847|585830948|FG003|Overall Study|Ineligible|0|||
162213158|NCT01952847|585830945|FG000|Overall Study|Lack of Insurance Coverage|0|||
162213159|NCT01952847|585830946|FG001|Overall Study|Lack of Insurance Coverage|1|||
162213160|NCT01952847|585830947|FG002|Overall Study|Lack of Insurance Coverage|0|||
162213161|NCT01952847|585830948|FG003|Overall Study|Lack of Insurance Coverage|0|||
162213162|NCT01952847|585830945|FG000|Overall Study|Withdrawal by Subject|1|||
162213163|NCT01952847|585830946|FG001|Overall Study|Withdrawal by Subject|1|||
162213164|NCT01952847|585830947|FG002|Overall Study|Withdrawal by Subject|0|||
162213165|NCT01952847|585830948|FG003|Overall Study|Withdrawal by Subject|1|||
162213166|NCT05382039|585830949|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
162213167|NCT05382039|585830950|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
162213168|NCT05382039|585830951|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
162213169|NCT05382039|585830949|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
162213170|NCT05382039|585830950|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
162213171|NCT05382039|585830951|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
162213172|NCT05382039|585830949|FG000|Overall Study|waiting for confirmation|0|||
162213173|NCT05382039|585830950|FG001|Overall Study|waiting for confirmation|0|||
162213174|NCT05382039|585830951|FG002|Overall Study|waiting for confirmation|1|||
162213175|NCT04464421|585830952|FG000|Overall Study|Lost to Follow-up|2|||
162213176|NCT04464421|585830953|FG001|Overall Study|Lost to Follow-up|2|||
162213177|NCT02577003|585830954|FG000|Overall Study|Adverse Event|2|||
162021365|NCT02551991|585134757|FG002|Overall Study|Sponsor Decision|1|||
162213178|NCT02577003|585830955|FG001|Overall Study|Adverse Event|4|||
162213179|NCT02577003|585830954|FG000|Overall Study|Withdrawal by Subject|0|||
162213180|NCT02577003|585830955|FG001|Overall Study|Withdrawal by Subject|1|||
162213181|NCT02786004|585830956|FG000|Overall Study|Withdrawal by Subject|0|||
162213182|NCT02786004|585830957|FG001|Overall Study|Withdrawal by Subject|1|||
162213183|NCT01234883|585830958|FG000|Overall Study|Early treatment release|8|||
162213184|NCT01234883|585830959|FG001|Overall Study|Early treatment release|10|||
162213185|NCT01234883|585830958|FG000|Overall Study|Parent/guardian withdrew consent|1|||
162213186|NCT01234883|585830959|FG001|Overall Study|Parent/guardian withdrew consent|2|||
162213187|NCT01234883|585830958|FG000|Overall Study|Technical difficulties with IV infusion|0|||
162213188|NCT01234883|585830959|FG001|Overall Study|Technical difficulties with IV infusion|1|||
162213189|NCT01234883|585830958|FG000|Overall Study|Inclusion/exclusion failure|1|||
162213190|NCT01234883|585830959|FG001|Overall Study|Inclusion/exclusion failure|0|||
162213191|NCT01013961|585830960|FG000|Overall Study|Adverse Event|2|||
162213192|NCT01013961|585830961|FG001|Overall Study|Adverse Event|2|||
162213193|NCT01013961|585830960|FG000|Overall Study|Withdrawal by Subject|1|||
162213194|NCT01013961|585830961|FG001|Overall Study|Withdrawal by Subject|0|||
162213195|NCT01013961|585830960|FG000|Overall Study|Physician Decision|0|||
162213196|NCT01013961|585830961|FG001|Overall Study|Physician Decision|1|||
162213197|NCT01271504|585830962|FG000|Overall Study|Death|7|||
162213198|NCT01271504|585830963|FG001|Overall Study|Death|6|||
162213199|NCT01271504|585830964|FG002|Overall Study|Death|32|||
162213200|NCT01271504|585830965|FG003|Overall Study|Death|32|||
162213201|NCT01271504|585830962|FG000|Overall Study|Lost to Follow-up|0|||
162213202|NCT01271504|585830963|FG001|Overall Study|Lost to Follow-up|1|||
162213203|NCT01271504|585830964|FG002|Overall Study|Lost to Follow-up|3|||
162213204|NCT01271504|585830965|FG003|Overall Study|Lost to Follow-up|1|||
162213205|NCT01271504|585830962|FG000|Overall Study|Protocol Violation|0|||
162213206|NCT01271504|585830963|FG001|Overall Study|Protocol Violation|0|||
162213207|NCT01271504|585830964|FG002|Overall Study|Protocol Violation|0|||
162213208|NCT01271504|585830965|FG003|Overall Study|Protocol Violation|2|||
162213209|NCT01271504|585830962|FG000|Overall Study|Administrative Reasons|0|||
162213210|NCT01271504|585830963|FG001|Overall Study|Administrative Reasons|0|||
162213211|NCT01271504|585830964|FG002|Overall Study|Administrative Reasons|6|||
162213212|NCT01271504|585830965|FG003|Overall Study|Administrative Reasons|5|||
162213213|NCT01271504|585830962|FG000|Overall Study|Withdrawal by Subject|0|||
162213214|NCT01271504|585830963|FG001|Overall Study|Withdrawal by Subject|0|||
162213215|NCT01271504|585830964|FG002|Overall Study|Withdrawal by Subject|1|||
162213216|NCT01271504|585830965|FG003|Overall Study|Withdrawal by Subject|3|||
162213217|NCT01271504|585830962|FG000|Overall Study|Other|0|||
162213218|NCT01271504|585830963|FG001|Overall Study|Other|1|||
162213219|NCT01271504|585830964|FG002|Overall Study|Other|2|||
162213220|NCT01271504|585830965|FG003|Overall Study|Other|0|||
162213221|NCT00756457|585830974|FG000|Overall Study|Lost to Follow-up|1|||
162213222|NCT00756457|585830975|FG001|Overall Study|Lost to Follow-up|2|||
162213223|NCT02402322|585830976|FG000|Pretreatment|Withdrawal by Subject|3|||
162213224|NCT02402322|585830977|FG001|Pretreatment|Withdrawal by Subject|1|||
162213225|NCT02402322|585830978|FG002|Pretreatment|Withdrawal by Subject|1|||
162213226|NCT02402322|585830976|FG000|Follow-up|Withdrawal by Subject|6|||
162213227|NCT02402322|585830977|FG001|Follow-up|Withdrawal by Subject|3|||
162213228|NCT02402322|585830978|FG002|Follow-up|Withdrawal by Subject|24|||
162213229|NCT02818998|585830979|FG000|Overall Study|Adverse Event|3|||
162213230|NCT02818998|585830980|FG001|Overall Study|Adverse Event|2|||
162213231|NCT02818998|585830981|FG002|Overall Study|Adverse Event|1|||
162213232|NCT02818998|585830979|FG000|Overall Study|Lost to Follow-up|4|||
162213233|NCT02818998|585830980|FG001|Overall Study|Lost to Follow-up|1|||
162213234|NCT02818998|585830981|FG002|Overall Study|Lost to Follow-up|2|||
162213235|NCT02818998|585830979|FG000|Overall Study|Withdrawal by sponsor|0|||
162213236|NCT02818998|585830980|FG001|Overall Study|Withdrawal by sponsor|1|||
162213237|NCT02818998|585830981|FG002|Overall Study|Withdrawal by sponsor|1|||
162213238|NCT02818998|585830979|FG000|Overall Study|Death|3|||
162213239|NCT02818998|585830980|FG001|Overall Study|Death|6|||
162213240|NCT02818998|585830981|FG002|Overall Study|Death|8|||
162213241|NCT02818998|585830979|FG000|Overall Study|Withdrawal by Subject|7|||
162213242|NCT02818998|585830980|FG001|Overall Study|Withdrawal by Subject|6|||
162213243|NCT02818998|585830981|FG002|Overall Study|Withdrawal by Subject|6|||
162213244|NCT02818998|585830979|FG000|Overall Study|Physician Decision|1|||
162213245|NCT02818998|585830980|FG001|Overall Study|Physician Decision|0|||
162213246|NCT02818998|585830981|FG002|Overall Study|Physician Decision|0|||
162213247|NCT02472145|585830982|FG000|Overall Study|Death|10|||
162213248|NCT02472145|585830983|FG001|Overall Study|Death|101|||
162213249|NCT02472145|585830984|FG002|Overall Study|Death|99|||
162213250|NCT02472145|585830982|FG000|Overall Study|Lost to Follow-up|0|||
162213251|NCT02472145|585830983|FG001|Overall Study|Lost to Follow-up|1|||
162213252|NCT02472145|585830984|FG002|Overall Study|Lost to Follow-up|0|||
162213253|NCT02472145|585830982|FG000|Overall Study|Withdrawal by Subject|0|||
162213254|NCT02472145|585830983|FG001|Overall Study|Withdrawal by Subject|9|||
162021366|NCT02551991|585134758|FG003|Overall Study|Sponsor Decision|0|||
162213255|NCT02472145|585830984|FG002|Overall Study|Withdrawal by Subject|13|||
162213256|NCT02472145|585830982|FG000|Overall Study|Sponsor decision|0|||
162213257|NCT02472145|585830983|FG001|Overall Study|Sponsor decision|3|||
162213258|NCT02472145|585830984|FG002|Overall Study|Sponsor decision|2|||
162213259|NCT02472145|585830982|FG000|Overall Study|Other|0|||
162213260|NCT02472145|585830983|FG001|Overall Study|Other|45|||
162213261|NCT02472145|585830984|FG002|Overall Study|Other|43|||
162213262|NCT01080326|585830985|FG000|Overall Study|Patient deterioration prior to procedure|3|||
162213263|NCT01080326|585830985|FG000|Overall Study|Surgeon decision|1|||
162213264|NCT00632021|585830987|FG000|Overall Study|Withdrawal/death|4|||
162213265|NCT00632021|585830988|FG001|Overall Study|Withdrawal/death|7|||
162213266|NCT02250534|585830991|FG000|Overall Study|Lost to Follow-up|18|||
162213267|NCT02250534|585830992|FG001|Overall Study|Lost to Follow-up|28|||
162213268|NCT02250534|585830993|FG002|Overall Study|Lost to Follow-up|33|||
162213269|NCT02250534|585830991|FG000|Overall Study|Personal reasons|7|||
161826915|NCT00879684|584406116|FG003|Stage 1: Dose Escalation|Death|0|||
161826916|NCT00879684|584406117|FG004|Stage 1: Dose Escalation|Death|0|||
161826917|NCT00879684|584406118|FG005|Stage 1: Dose Escalation|Death|0|||
161826918|NCT00879684|584406119|FG006|Stage 1: Dose Escalation|Death|0|||
161826919|NCT00879684|584406113|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161826920|NCT00879684|584406114|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161826921|NCT00879684|584406115|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161826922|NCT00879684|584406116|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161826923|NCT00879684|584406117|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161826924|NCT00879684|584406118|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161826925|NCT00879684|584406119|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
162213270|NCT02250534|585830992|FG001|Overall Study|Personal reasons|8|||
162021367|NCT02551991|585134759|FG004|Overall Study|Sponsor Decision|5|||
162213271|NCT02250534|585830993|FG002|Overall Study|Personal reasons|14|||
162213272|NCT02250534|585830991|FG000|Overall Study|Adverse Event|6|||
162213273|NCT02250534|585830992|FG001|Overall Study|Adverse Event|3|||
162213274|NCT02250534|585830993|FG002|Overall Study|Adverse Event|8|||
162213275|NCT02250534|585830991|FG000|Overall Study|incarcerated|2|||
162213276|NCT02250534|585830992|FG001|Overall Study|incarcerated|1|||
162213277|NCT02250534|585830993|FG002|Overall Study|incarcerated|2|||
162213278|NCT02250534|585830991|FG000|Overall Study|Withdrawal by Subject|0|||
162213279|NCT02250534|585830992|FG001|Overall Study|Withdrawal by Subject|1|||
162213280|NCT02250534|585830993|FG002|Overall Study|Withdrawal by Subject|2|||
162213281|NCT02250534|585830991|FG000|Overall Study|Death|0|||
162213282|NCT02250534|585830992|FG001|Overall Study|Death|1|||
162213283|NCT02250534|585830993|FG002|Overall Study|Death|1|||
162213284|NCT02250534|585830991|FG000|Overall Study|Physician Decision|1|||
162213285|NCT02250534|585830992|FG001|Overall Study|Physician Decision|3|||
162213286|NCT02250534|585830993|FG002|Overall Study|Physician Decision|1|||
162213287|NCT02250534|585830991|FG000|Overall Study|Protocol Violation|1|||
162213288|NCT02250534|585830992|FG001|Overall Study|Protocol Violation|0|||
162213289|NCT02250534|585830993|FG002|Overall Study|Protocol Violation|1|||
162213290|NCT02250534|585830991|FG000|Overall Study|Reason unknown|1|||
162213291|NCT02250534|585830992|FG001|Overall Study|Reason unknown|0|||
162213292|NCT02250534|585830993|FG002|Overall Study|Reason unknown|0|||
162213293|NCT01628692|585830996|FG000|Overall Study|Lack of Efficacy|4|||
162213294|NCT01628692|585830997|FG001|Overall Study|Lack of Efficacy|4|||
162213295|NCT01628692|585830998|FG002|Overall Study|Lack of Efficacy|5|||
162213296|NCT01628692|585830999|FG003|Overall Study|Lack of Efficacy|1|||
162213297|NCT01628692|585831000|FG004|Overall Study|Lack of Efficacy|4|||
162213298|NCT01628692|585831001|FG005|Overall Study|Lack of Efficacy|7|||
162213299|NCT01628692|585830996|FG000|Overall Study|Adverse Event|2|||
162213300|NCT01628692|585830997|FG001|Overall Study|Adverse Event|0|||
162213301|NCT01628692|585830998|FG002|Overall Study|Adverse Event|2|||
162213302|NCT01628692|585830999|FG003|Overall Study|Adverse Event|0|||
162213303|NCT01628692|585831000|FG004|Overall Study|Adverse Event|0|||
162213304|NCT01628692|585831001|FG005|Overall Study|Adverse Event|0|||
162213305|NCT01628692|585830996|FG000|Overall Study|Withdrawal by Subject|0|||
162213306|NCT01628692|585830997|FG001|Overall Study|Withdrawal by Subject|1|||
162213307|NCT01628692|585830998|FG002|Overall Study|Withdrawal by Subject|1|||
162213308|NCT01628692|585830999|FG003|Overall Study|Withdrawal by Subject|0|||
161826926|NCT00879684|584406113|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
162213309|NCT01628692|585831000|FG004|Overall Study|Withdrawal by Subject|0|||
162213310|NCT01628692|585831001|FG005|Overall Study|Withdrawal by Subject|0|||
162213311|NCT01628692|585830996|FG000|Overall Study|Death|0|||
162213312|NCT01628692|585830997|FG001|Overall Study|Death|1|||
161826927|NCT00879684|584406114|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
161826928|NCT00879684|584406115|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
161826929|NCT00879684|584406116|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
161826930|NCT00879684|584406117|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
161826931|NCT00879684|584406118|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
161826932|NCT00879684|584406119|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
161826933|NCT00879684|584406113|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161826934|NCT00879684|584406114|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161826935|NCT00879684|584406115|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161826936|NCT00879684|584406116|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161826937|NCT00879684|584406117|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161826938|NCT00879684|584406118|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161826939|NCT00879684|584406119|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
161826940|NCT03185741|584406124|FG000|Baseline|Withdrawal by Subject|1|||
161826941|NCT03185741|584406125|FG001|Baseline|Withdrawal by Subject|3|||
161826942|NCT03185741|584406126|FG002|Baseline|Withdrawal by Subject|2|||
161826943|NCT03185741|584406124|FG000|Baseline|Lost to Follow-up|1|||
161826944|NCT03185741|584406125|FG001|Baseline|Lost to Follow-up|2|||
161826945|NCT03185741|584406126|FG002|Baseline|Lost to Follow-up|3|||
161826946|NCT03185741|584406124|FG000|3Month|Death|1|||
161826947|NCT03185741|584406125|FG001|3Month|Death|1|||
161826948|NCT03185741|584406126|FG002|3Month|Death|2|||
161826949|NCT03185741|584406124|FG000|3Month|Withdrawal by Subject|1|||
161826950|NCT03185741|584406125|FG001|3Month|Withdrawal by Subject|5|||
161826951|NCT03185741|584406126|FG002|3Month|Withdrawal by Subject|1|||
161826952|NCT03185741|584406124|FG000|3Month|Lost to Follow-up|7|||
162213313|NCT01628692|585830998|FG002|Overall Study|Death|0|||
162213314|NCT01628692|585830999|FG003|Overall Study|Death|0|||
162213315|NCT01628692|585831000|FG004|Overall Study|Death|0|||
162213316|NCT01628692|585831001|FG005|Overall Study|Death|0|||
162213317|NCT01628692|585830996|FG000|Overall Study|Poor compliance/noncompliance|1|||
162213318|NCT01628692|585830997|FG001|Overall Study|Poor compliance/noncompliance|0|||
162213319|NCT01628692|585830998|FG002|Overall Study|Poor compliance/noncompliance|0|||
162213320|NCT01628692|585830999|FG003|Overall Study|Poor compliance/noncompliance|0|||
162213321|NCT01628692|585831000|FG004|Overall Study|Poor compliance/noncompliance|0|||
162213322|NCT01628692|585831001|FG005|Overall Study|Poor compliance/noncompliance|0|||
162213323|NCT01628692|585830996|FG000|Overall Study|Administrative reason by sponsor|0|||
162213324|NCT01628692|585830997|FG001|Overall Study|Administrative reason by sponsor|0|||
162213325|NCT01628692|585830998|FG002|Overall Study|Administrative reason by sponsor|0|||
162213326|NCT01628692|585830999|FG003|Overall Study|Administrative reason by sponsor|0|||
162213327|NCT01628692|585831000|FG004|Overall Study|Administrative reason by sponsor|0|||
162213328|NCT01628692|585831001|FG005|Overall Study|Administrative reason by sponsor|1|||
162213329|NCT01628692|585830996|FG000|Overall Study|Completed 12 Week only|0|||
162021368|NCT02551991|585134755|FG000|Overall Study|Other|0|||
162213330|NCT01628692|585830997|FG001|Overall Study|Completed 12 Week only|0|||
162213331|NCT01628692|585830998|FG002|Overall Study|Completed 12 Week only|0|||
162213332|NCT01628692|585830999|FG003|Overall Study|Completed 12 Week only|0|||
162213333|NCT01628692|585831000|FG004|Overall Study|Completed 12 Week only|0|||
162213334|NCT01628692|585831001|FG005|Overall Study|Completed 12 Week only|1|||
162213335|NCT02437071|585831002|FG000|Overall Study|Withdrawal by Subject|1|||
162213336|NCT02437071|585831003|FG001|Overall Study|Withdrawal by Subject|0|||
162213337|NCT01587118|585831004|FG000|Overall Study|Adverse Event|3|||
162213338|NCT01587118|585831004|FG000|Overall Study|Lost to Follow-up|2|||
162213339|NCT01587118|585831004|FG000|Overall Study|Relocation|1|||
162213340|NCT01587118|585831004|FG000|Overall Study|nonresponse|1|||
162213341|NCT00537329|585831005|FG000|Overall Study|Death|10|||
162213342|NCT00537329|585831005|FG000|Overall Study|Adverse Event|3|||
162213343|NCT00537329|585831005|FG000|Overall Study|Lack of Efficacy|2|||
162213344|NCT00537329|585831005|FG000|Overall Study|Lost to Follow-up|6|||
162213345|NCT00537329|585831005|FG000|Overall Study|Withdrawal by Subject|4|||
161678153|NCT03861936|583873609|FG001|Overall Study|Physician Decision|1|||
161678154|NCT03861936|583873610|FG002|Overall Study|Physician Decision|0|||
161678155|NCT03861936|583873608|FG000|Overall Study|Protocol Deviation|0|||
161678156|NCT03861936|583873609|FG001|Overall Study|Protocol Deviation|0|||
161678157|NCT03861936|583873610|FG002|Overall Study|Protocol Deviation|1|||
161678158|NCT03861936|583873608|FG000|Overall Study|Reason not Specified|5|||
161678159|NCT03861936|583873609|FG001|Overall Study|Reason not Specified|5|||
161678160|NCT03861936|583873610|FG002|Overall Study|Reason not Specified|3|||
161678161|NCT03198520|583873615|FG000|Overall Study|Physician Decision|2|||
161678162|NCT03198520|583873615|FG000|Overall Study|Protocol Violation|2|||
162213346|NCT00537329|585831005|FG000|Overall Study|Other|1|||
162213347|NCT00224029|585831008|FG000|Overall Study|Lost to Follow-up|1|||
162213348|NCT00224029|585831008|FG000|Overall Study|Withdrawal by Subject|4|||
162213349|NCT00224029|585831008|FG000|Overall Study|Other|1|||
162213350|NCT00243022|585831009|FG000|Overall Study|Withdrawal by Subject|1|||
162213351|NCT00243022|585831010|FG001|Overall Study|Withdrawal by Subject|0|||
162213352|NCT00243022|585831009|FG000|Overall Study|Death|1|||
162213353|NCT00243022|585831010|FG001|Overall Study|Death|0|||
162213354|NCT00243022|585831009|FG000|Overall Study|Difficult Travel Distance|0|||
162213355|NCT00243022|585831010|FG001|Overall Study|Difficult Travel Distance|1|||
162213356|NCT01099579|585831011|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
162213357|NCT01099579|585831012|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
162213358|NCT01099579|585831013|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
162213359|NCT01099579|585831011|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
162213360|NCT01099579|585831012|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
162213361|NCT01099579|585831013|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
162213362|NCT01099579|585831011|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
162213363|NCT01099579|585831012|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
162213364|NCT01099579|585831013|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
162213365|NCT01099579|585831011|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
162213366|NCT01099579|585831012|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
162213367|NCT01099579|585831013|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
162213368|NCT01099579|585831011|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
162213369|NCT01099579|585831012|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
162213370|NCT01099579|585831013|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
162213371|NCT01099579|585831011|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
161678163|NCT03198520|583873615|FG000|Overall Study|Withdrawal by Subject|1|||
161678164|NCT03198520|583873615|FG000|Overall Study|Study Ended|1|||
161678165|NCT01670539|583873616|FG000|Overall Study|Death|3|||
161678166|NCT01670539|583873617|FG001|Overall Study|Death|5|||
162021369|NCT02551991|585134756|FG001|Overall Study|Other|0|||
162021370|NCT02551991|585134757|FG002|Overall Study|Other|0|||
162213372|NCT01099579|585831012|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
162213373|NCT01099579|585831013|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
162213374|NCT01099579|585831011|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
162213375|NCT01099579|585831012|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
162213376|NCT01099579|585831013|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
161678167|NCT01670539|583873616|FG000|Overall Study|Withdrawal by Subject|3|||
161678168|NCT01670539|583873617|FG001|Overall Study|Withdrawal by Subject|0|||
161678169|NCT04353596|583873618|FG000|Overall Study|Protocol Violation|4|||
161678170|NCT04353596|583873619|FG001|Overall Study|Protocol Violation|4|||
162021371|NCT02551991|585134758|FG003|Overall Study|Other|0|||
162213377|NCT01099579|585831011|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
162213378|NCT01099579|585831012|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
162213379|NCT01099579|585831013|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
162213380|NCT01099579|585831011|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
162213381|NCT01099579|585831012|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
162213382|NCT01099579|585831013|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
161935719|NCT04693715|584814010|FG000|Overall Study|Adverse Events Leading to Death|2|||
161935720|NCT04693715|584814011|FG001|Overall Study|Adverse Events Leading to Death|2|||
161935721|NCT04693715|584814012|FG002|Overall Study|Adverse Events Leading to Death|4|||
161935722|NCT04693715|584814010|FG000|Overall Study|Lost to Follow-up|0|||
161935723|NCT04693715|584814011|FG001|Overall Study|Lost to Follow-up|2|||
161935724|NCT04693715|584814012|FG002|Overall Study|Lost to Follow-up|2|||
161935725|NCT04693715|584814010|FG000|Overall Study|Physician Decision|0|||
161935726|NCT04693715|584814011|FG001|Overall Study|Physician Decision|1|||
161935727|NCT04693715|584814012|FG002|Overall Study|Physician Decision|0|||
161935728|NCT04693715|584814010|FG000|Overall Study|Withdrawal by Legal Authorized Representative|0|||
161935729|NCT04693715|584814011|FG001|Overall Study|Withdrawal by Legal Authorized Representative|1|||
161935730|NCT04693715|584814012|FG002|Overall Study|Withdrawal by Legal Authorized Representative|0|||
161935731|NCT04693715|584814010|FG000|Overall Study|Withdrawal by Subject|0|||
161935732|NCT04693715|584814011|FG001|Overall Study|Withdrawal by Subject|0|||
161935733|NCT04693715|584814012|FG002|Overall Study|Withdrawal by Subject|1|||
161935764|NCT04557735|584814027|FG000|Treatment Period (26 Weeks)|Withdrawal by Subject|1|||
161935765|NCT04557735|584814027|FG000|Treatment Period (26 Weeks)|Physician Decision|4|||
161935766|NCT04557735|584814027|FG000|Treatment Period (26 Weeks)|Death|5|||
161935767|NCT04557735|584814027|FG000|Treatment Period (26 Weeks)|Adverse Event|2|||
161935768|NCT04557735|584814027|FG000|Follow-Up Period (26 Weeks)|Physician Decision|1|||
161935769|NCT04557735|584814027|FG000|Follow-Up Period (26 Weeks)|Death|4|||
161935778|NCT05562934|584814033|FG000|Overall Study|Adverse Event|0|||
161935779|NCT05562934|584814034|FG001|Overall Study|Adverse Event|2|||
161935780|NCT05562934|584814035|FG002|Overall Study|Adverse Event|0|||
161935781|NCT05562934|584814036|FG003|Overall Study|Adverse Event|0|||
162213383|NCT01099579|585831011|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
161935782|NCT05562934|584814037|FG004|Overall Study|Adverse Event|2|||
161935783|NCT05562934|584814033|FG000|Overall Study|Lost to Follow-up|0|||
161935784|NCT05562934|584814034|FG001|Overall Study|Lost to Follow-up|0|||
161935785|NCT05562934|584814035|FG002|Overall Study|Lost to Follow-up|0|||
161935786|NCT05562934|584814036|FG003|Overall Study|Lost to Follow-up|0|||
162213384|NCT01099579|585831012|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
161935787|NCT05562934|584814037|FG004|Overall Study|Lost to Follow-up|1|||
161935788|NCT05562934|584814033|FG000|Overall Study|Protocol Violation|0|||
161935789|NCT05562934|584814034|FG001|Overall Study|Protocol Violation|0|||
161935790|NCT05562934|584814035|FG002|Overall Study|Protocol Violation|0|||
161935791|NCT05562934|584814036|FG003|Overall Study|Protocol Violation|1|||
161935792|NCT05562934|584814037|FG004|Overall Study|Protocol Violation|1|||
161935793|NCT05562934|584814033|FG000|Overall Study|Withdrawal by Subject|0|||
161935794|NCT05562934|584814034|FG001|Overall Study|Withdrawal by Subject|0|||
161935795|NCT05562934|584814035|FG002|Overall Study|Withdrawal by Subject|1|||
161935796|NCT05562934|584814036|FG003|Overall Study|Withdrawal by Subject|1|||
161935797|NCT05562934|584814037|FG004|Overall Study|Withdrawal by Subject|0|||
161935798|NCT05365217|584814038|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161935799|NCT05365217|584814039|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162213385|NCT01099579|585831013|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
162213386|NCT02569957|585831014|FG000|Overall Study|Withdrawal by Subject|0|||
162213387|NCT02569957|585831015|FG001|Overall Study|Withdrawal by Subject|1|||
162213388|NCT00572533|585831018|FG000|Overall Study|Death|4|||
162213389|NCT00572533|585831019|FG001|Overall Study|Death|1|||
162213390|NCT00572533|585831018|FG000|Overall Study|Received Kidney Transplant|2|||
162213391|NCT00572533|585831019|FG001|Overall Study|Received Kidney Transplant|1|||
161935840|NCT03997383|584814060|FG000|Double-blind Treatment Period|Adverse Event|4|||
161935841|NCT03997383|584814061|FG001|Double-blind Treatment Period|Adverse Event|3|||
161935842|NCT03997383|584814060|FG000|Double-blind Treatment Period|Death|4|||
161935843|NCT03997383|584814061|FG001|Double-blind Treatment Period|Death|4|||
161935844|NCT03997383|584814060|FG000|Double-blind Treatment Period|Physician Decision|2|||
161935845|NCT03997383|584814061|FG001|Double-blind Treatment Period|Physician Decision|0|||
161935846|NCT03997383|584814060|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
161935847|NCT03997383|584814061|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
161935848|NCT03997383|584814060|FG000|Open-label Extension Period|Ongoing|148|||
162021372|NCT02551991|585134759|FG004|Overall Study|Other|1|||
162213392|NCT00572533|585831018|FG000|Overall Study|Social Issues|1|||
162213393|NCT00572533|585831019|FG001|Overall Study|Social Issues|0|||
162213394|NCT00572533|585831018|FG000|Overall Study|Transfer out of Facility|0|||
162213395|NCT00572533|585831019|FG001|Overall Study|Transfer out of Facility|1|||
162213396|NCT02688530|585831023|FG000|Overall Study|Withdrawal by Subject|0|||
162213397|NCT02688530|585831024|FG001|Overall Study|Withdrawal by Subject|1|||
162213398|NCT02688530|585831025|FG002|Overall Study|Withdrawal by Subject|0|||
162213399|NCT02688530|585831026|FG003|Overall Study|Withdrawal by Subject|0|||
162213400|NCT02688530|585831023|FG000|Overall Study|Lost to Follow-up|0|||
162213401|NCT02688530|585831024|FG001|Overall Study|Lost to Follow-up|0|||
162213402|NCT02688530|585831025|FG002|Overall Study|Lost to Follow-up|2|||
162213403|NCT02688530|585831026|FG003|Overall Study|Lost to Follow-up|0|||
162213404|NCT01658020|585831027|FG000|Overall Study|Adverse Event|3|||
162213405|NCT01658020|585831028|FG001|Overall Study|Adverse Event|3|||
162213406|NCT01658020|585831027|FG000|Overall Study|Lost to Follow-up|1|||
162213407|NCT01658020|585831028|FG001|Overall Study|Lost to Follow-up|0|||
162213408|NCT01658020|585831027|FG000|Overall Study|Withdrawal by Subject|4|||
162213409|NCT01658020|585831028|FG001|Overall Study|Withdrawal by Subject|5|||
162213410|NCT01658020|585831027|FG000|Overall Study|Protocol Violation|0|||
162213411|NCT01658020|585831028|FG001|Overall Study|Protocol Violation|1|||
162213412|NCT01530087|585831035|FG000|Overall Study|Physician Decision|2|||
162213413|NCT02353871|585831036|FG000|Overall Study|Protocol deviation|0|||
162213414|NCT02353871|585831037|FG001|Overall Study|Protocol deviation|1|||
162213415|NCT02353871|585831036|FG000|Overall Study|Consent withdrawn|1|||
162213416|NCT02353871|585831037|FG001|Overall Study|Consent withdrawn|8|||
162213417|NCT02353871|585831036|FG000|Overall Study|Lost to Follow-up|2|||
162213418|NCT02353871|585831037|FG001|Overall Study|Lost to Follow-up|0|||
162213419|NCT02554383|585831040|FG000|Overall Study|Ineligible|3|||
162213420|NCT02554383|585831041|FG001|Overall Study|Ineligible|2|||
161678171|NCT04353596|583873618|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
161678172|NCT04353596|583873619|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
161678173|NCT01236573|583873620|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678174|NCT01236573|583873621|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678175|NCT01236573|583873622|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678176|NCT01236573|583873623|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161826953|NCT03185741|584406125|FG001|3Month|Lost to Follow-up|9|||
161826954|NCT03185741|584406126|FG002|3Month|Lost to Follow-up|8|||
162213421|NCT02554383|585831040|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
162213422|NCT02554383|585831041|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
162213423|NCT02554383|585831040|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
162213424|NCT02554383|585831041|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
162213425|NCT02554383|585831040|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
162213426|NCT02554383|585831041|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
162213427|NCT02918292|585831044|FG000|Study Enrollment Prior to Transplant|Death|1|||
162213428|NCT02918292|585831044|FG000|Study Follow up After Transplant|Death|6|||
162213429|NCT02581059|585831047|FG000|Study Treatment|Disease Progression|1|||
162213430|NCT02581059|585831048|FG001|Study Treatment|Disease Progression|1|||
162213431|NCT02581059|585831047|FG000|Study Treatment|Adverse Event|2|||
162213432|NCT02581059|585831048|FG001|Study Treatment|Adverse Event|1|||
162213433|NCT02581059|585831047|FG000|Study Treatment|Death|1|||
162213434|NCT02581059|585831048|FG001|Study Treatment|Death|1|||
162021373|NCT00942994|585134763|FG000|Overall Study|Adverse Event|7|||
161826955|NCT03185741|584406124|FG000|3Month|Unavailable for 3Month|11|||
161826956|NCT03185741|584406125|FG001|3Month|Unavailable for 3Month|10|||
161826957|NCT03185741|584406126|FG002|3Month|Unavailable for 3Month|11|||
161826958|NCT03185741|584406124|FG000|3Month|Protocol Violation|0|||
161826959|NCT03185741|584406125|FG001|3Month|Protocol Violation|0|||
161826960|NCT03185741|584406126|FG002|3Month|Protocol Violation|3|||
161826961|NCT03185741|584406124|FG000|6Month|Death|1|||
161826962|NCT03185741|584406125|FG001|6Month|Death|1|||
161826963|NCT03185741|584406126|FG002|6Month|Death|2|||
161826964|NCT03185741|584406124|FG000|6Month|Withdrawal by Subject|2|||
161826965|NCT03185741|584406125|FG001|6Month|Withdrawal by Subject|3|||
161826966|NCT03185741|584406126|FG002|6Month|Withdrawal by Subject|1|||
161826967|NCT03185741|584406124|FG000|6Month|Lost to Follow-up|16|||
161826968|NCT03185741|584406125|FG001|6Month|Lost to Follow-up|15|||
161826969|NCT03185741|584406126|FG002|6Month|Lost to Follow-up|16|||
161826970|NCT03573336|584406129|FG000|Overall Study|Study terminated|2|||
162021374|NCT00942994|585134764|FG001|Overall Study|Adverse Event|4|||
162021375|NCT00942994|585134763|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161826971|NCT03573336|584406130|FG001|Overall Study|Study terminated|4|||
161826972|NCT03573336|584406131|FG002|Overall Study|Study terminated|2|||
161826973|NCT03108820|584406132|FG000|Overall Study|Lost to Follow-up|30|||
162213435|NCT02581059|585831047|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
161826974|NCT03108820|584406133|FG001|Overall Study|Lost to Follow-up|28|||
162213436|NCT02581059|585831048|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
162213437|NCT02581059|585831047|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
162213438|NCT02581059|585831048|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
162213439|NCT02581059|585831047|FG000|Follow up|Death|1|||
162213440|NCT02581059|585831048|FG001|Follow up|Death|3|||
162213441|NCT02581059|585831047|FG000|Follow up|study terminated|1|||
162213442|NCT02581059|585831048|FG001|Follow up|study terminated|1|||
162213443|NCT02581059|585831047|FG000|Follow up|screen failure|0|||
162213444|NCT02581059|585831048|FG001|Follow up|screen failure|1|||
162213445|NCT02581059|585831047|FG000|Follow up|Patient started new clinical trial|1|||
162213446|NCT02581059|585831048|FG001|Follow up|Patient started new clinical trial|0|||
162213447|NCT03698019|585831049|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
162213448|NCT03698019|585831050|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
162213449|NCT03698019|585831049|FG000|Step 1: Registration|Withdrawal by Subject|7|||
162213450|NCT03698019|585831050|FG001|Step 1: Registration|Withdrawal by Subject|2|||
162213451|NCT03698019|585831049|FG000|Step 1: Registration|Toxicity|0|||
162213452|NCT03698019|585831050|FG001|Step 1: Registration|Toxicity|1|||
161826975|NCT03108820|584406132|FG000|Overall Study|Withdrawal by Subject|32|||
161826976|NCT03108820|584406133|FG001|Overall Study|Withdrawal by Subject|24|||
161826977|NCT03108820|584406132|FG000|Overall Study|Death|6|||
161826978|NCT03108820|584406133|FG001|Overall Study|Death|11|||
161826979|NCT01488448|584406139|FG000|Overall Study|Withdrawal by Subject|3|||
162213453|NCT03698019|585831049|FG000|Step 1: Registration|Disease Progression|0|||
162213454|NCT03698019|585831050|FG001|Step 1: Registration|Disease Progression|12|||
162213455|NCT03698019|585831049|FG000|Step 1: Registration|Co-morbidities|0|||
161826980|NCT01488448|584406140|FG001|Overall Study|Withdrawal by Subject|1|||
162213456|NCT03698019|585831050|FG001|Step 1: Registration|Co-morbidities|1|||
162213457|NCT03698019|585831049|FG000|Step 1: Registration|Scheduling Issues|1|||
162213458|NCT03698019|585831050|FG001|Step 1: Registration|Scheduling Issues|0|||
162213459|NCT03698019|585831049|FG000|Step 1: Registration|Participant Refusal|0|||
162213460|NCT03698019|585831050|FG001|Step 1: Registration|Participant Refusal|1|||
162213461|NCT03698019|585831049|FG000|Step 2: Surgery|Participant Refusal|2|||
162213462|NCT03698019|585831050|FG001|Step 2: Surgery|Participant Refusal|1|||
161826981|NCT01488448|584406139|FG000|Overall Study|Adverse Event|9|||
161826982|NCT01488448|584406140|FG001|Overall Study|Adverse Event|4|||
161826983|NCT01488448|584406139|FG000|Overall Study|Physician Decision|4|||
161826984|NCT01488448|584406140|FG001|Overall Study|Physician Decision|9|||
161826985|NCT01488448|584406139|FG000|Overall Study|Protocol Violation|4|||
161826986|NCT01488448|584406140|FG001|Overall Study|Protocol Violation|3|||
161826987|NCT00654641|584406141|FG000|Overall Study|Lost to Follow-up|2|||
161826988|NCT00654641|584406142|FG001|Overall Study|Lost to Follow-up|3|||
161826989|NCT01992094|584406143|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
161826990|NCT01992094|584406144|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
161826991|NCT01992094|584406145|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
161826992|NCT01992094|584406143|FG000|Overall Study|Adverse Event|1|||
162213463|NCT03698019|585831049|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
162213464|NCT03698019|585831050|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
162213465|NCT03698019|585831049|FG000|Step 2: Surgery|Metastatic Disease|16|||
162213466|NCT03698019|585831050|FG001|Step 2: Surgery|Metastatic Disease|9|||
162213467|NCT03698019|585831049|FG000|Step 2: Surgery|Residual Disease|2|||
162213468|NCT03698019|585831050|FG001|Step 2: Surgery|Residual Disease|1|||
162213469|NCT03698019|585831049|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
162213470|NCT03698019|585831050|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
162213471|NCT03698019|585831049|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
162213472|NCT03698019|585831050|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
162213473|NCT03698019|585831049|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
162213474|NCT03698019|585831050|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
162213475|NCT03698019|585831049|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
162213476|NCT03698019|585831050|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
162213477|NCT03698019|585831049|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
162213478|NCT03698019|585831050|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
162213479|NCT03698019|585831049|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
162213480|NCT03698019|585831050|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
162213481|NCT03698019|585831049|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
162213482|NCT03698019|585831050|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
162213483|NCT03698019|585831049|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
162213484|NCT03698019|585831050|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
162213485|NCT04340843|585831053|FG000|Overall Study|Adverse Event|0|||
162213486|NCT04340843|585831054|FG001|Overall Study|Adverse Event|2|||
162213487|NCT04340843|585831053|FG000|Overall Study|Withdrawal by Subject|0|||
162213488|NCT04340843|585831054|FG001|Overall Study|Withdrawal by Subject|2|||
162213489|NCT04021043|585832696|FG000|Overall Study|Adverse Event|3|||
162213490|NCT04021043|585832697|FG001|Overall Study|Adverse Event|1|||
162213491|NCT04021043|585832698|FG002|Overall Study|Adverse Event|1|||
161678177|NCT01236573|583873624|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678178|NCT01236573|583873625|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678179|NCT01236573|583873626|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
161678180|NCT01236573|583873627|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678181|NCT01236573|583873628|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
161678182|NCT01236573|583873629|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
161678183|NCT01236573|583873630|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161678184|NCT01236573|583873620|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678185|NCT01236573|583873621|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678186|NCT01236573|583873622|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678187|NCT01236573|583873623|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678188|NCT01236573|583873624|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678189|NCT01236573|583873625|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678190|NCT01236573|583873626|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678191|NCT01236573|583873627|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161678192|NCT01236573|583873628|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
161678193|NCT01236573|583873629|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161826993|NCT01992094|584406144|FG001|Overall Study|Adverse Event|0|||
162213492|NCT04021043|585832699|FG003|Overall Study|Adverse Event|0|||
162213493|NCT04021043|585832696|FG000|Overall Study|Death|2|||
162213494|NCT04021043|585832697|FG001|Overall Study|Death|3|||
162213495|NCT04021043|585832698|FG002|Overall Study|Death|1|||
162213496|NCT04021043|585832699|FG003|Overall Study|Death|3|||
161678194|NCT01236573|583873630|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
162213497|NCT04021043|585832696|FG000|Overall Study|Withdrawal by Subject|1|||
162213498|NCT04021043|585832697|FG001|Overall Study|Withdrawal by Subject|1|||
162213499|NCT04021043|585832698|FG002|Overall Study|Withdrawal by Subject|1|||
162213500|NCT04021043|585832699|FG003|Overall Study|Withdrawal by Subject|6|||
162213501|NCT04021043|585832696|FG000|Overall Study|Discontinued due to disease progression|4|||
162213502|NCT04021043|585832697|FG001|Overall Study|Discontinued due to disease progression|5|||
162213503|NCT04021043|585832698|FG002|Overall Study|Discontinued due to disease progression|7|||
162213504|NCT04021043|585832699|FG003|Overall Study|Discontinued due to disease progression|10|||
162213505|NCT00826228|585832700|FG000|Overall Study|Withdrawal by Subject|1|||
162213506|NCT04090528|585832703|FG000|Overall Study|participants still on study|9|||
162213507|NCT04090528|585832704|FG001|Overall Study|participants still on study|13|||
162213508|NCT04546217|585832705|FG000|Overall Study|Withdrawal by Subject|2|||
162213509|NCT04546217|585832706|FG001|Overall Study|Withdrawal by Subject|0|||
162213510|NCT04546217|585832705|FG000|Overall Study|Uncontrolled hypertension|1|||
162213511|NCT04546217|585832706|FG001|Overall Study|Uncontrolled hypertension|0|||
162213512|NCT02550938|585832707|FG000|Overall Study|Lost to Follow-up|8|||
162213513|NCT02550938|585832708|FG001|Overall Study|Lost to Follow-up|7|||
162213514|NCT02550938|585832709|FG002|Overall Study|Lost to Follow-up|12|||
161826994|NCT01992094|584406145|FG002|Overall Study|Adverse Event|0|||
162213515|NCT02550938|585832710|FG003|Overall Study|Lost to Follow-up|11|||
162213516|NCT02684123|585832711|FG000|Phase 1|Lack of Efficacy|5|||
162213517|NCT02684123|585832712|FG001|Phase 1|Lack of Efficacy|0|||
162213518|NCT02684123|585832711|FG000|Phase 1|Adverse Event|3|||
162213519|NCT02684123|585832712|FG001|Phase 1|Adverse Event|0|||
162213520|NCT02684123|585832711|FG000|Phase 1|Lost to Follow-up|0|||
162213521|NCT02684123|585832712|FG001|Phase 1|Lost to Follow-up|1|||
162213522|NCT02684123|585832711|FG000|Phase 2|Lack of Efficacy|1|||
162213523|NCT02684123|585832712|FG001|Phase 2|Lack of Efficacy|8|||
162213524|NCT01245140|585832717|FG000|Overall Study|Adverse Event|1|||
162213525|NCT01245140|585832718|FG001|Overall Study|Adverse Event|3|||
162213526|NCT01245140|585832717|FG000|Overall Study|Lack of Efficacy|2|||
162213527|NCT01245140|585832718|FG001|Overall Study|Lack of Efficacy|4|||
162213528|NCT01245140|585832717|FG000|Overall Study|Protocol Violation|0|||
162213529|NCT01245140|585832718|FG001|Overall Study|Protocol Violation|1|||
162213530|NCT01245140|585832717|FG000|Overall Study|Withdrawal by Subject|0|||
162213531|NCT01245140|585832718|FG001|Overall Study|Withdrawal by Subject|1|||
162213532|NCT01245140|585832717|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
162213533|NCT01245140|585832718|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
162213534|NCT02037477|585832719|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
162213535|NCT02037477|585832720|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
162213536|NCT02037477|585832721|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
162213537|NCT02037477|585832722|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
162213538|NCT02635360|585832723|FG000|Overall Study|Adverse Event|0|||
162213539|NCT02635360|585832724|FG001|Overall Study|Adverse Event|3|||
162213540|NCT02635360|585832723|FG000|Overall Study|Withdrawal by Subject|2|||
162213541|NCT02635360|585832724|FG001|Overall Study|Withdrawal by Subject|0|||
162213542|NCT02635360|585832723|FG000|Overall Study|Non-Compliance|3|||
162213543|NCT02635360|585832724|FG001|Overall Study|Non-Compliance|1|||
162213544|NCT02635360|585832723|FG000|Overall Study|Disease Progression|0|||
161678195|NCT01236573|583873620|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161678196|NCT01236573|583873621|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161826995|NCT01992094|584406143|FG000|Overall Study|Death|5|||
161826996|NCT01992094|584406144|FG001|Overall Study|Death|5|||
161826997|NCT01992094|584406145|FG002|Overall Study|Death|2|||
161826998|NCT01992094|584406143|FG000|Overall Study|Lost to Follow-up|26|||
161826999|NCT01992094|584406144|FG001|Overall Study|Lost to Follow-up|9|||
161827000|NCT01992094|584406145|FG002|Overall Study|Lost to Follow-up|13|||
161827001|NCT01992094|584406143|FG000|Overall Study|OTHER|4|||
161827002|NCT01992094|584406144|FG001|Overall Study|OTHER|0|||
161827003|NCT01992094|584406145|FG002|Overall Study|OTHER|0|||
161827004|NCT01992094|584406143|FG000|Overall Study|Protocol Violation|1|||
161827005|NCT01992094|584406144|FG001|Overall Study|Protocol Violation|0|||
161827006|NCT01992094|584406145|FG002|Overall Study|Protocol Violation|1|||
161827007|NCT01992094|584406143|FG000|Overall Study|Withdrawal by Subject|7|||
161827008|NCT01992094|584406144|FG001|Overall Study|Withdrawal by Subject|3|||
161827009|NCT01992094|584406145|FG002|Overall Study|Withdrawal by Subject|4|||
161827010|NCT03168906|584406146|FG000|Overall Study|Lack of Efficacy|6|||
161827011|NCT03168906|584406147|FG001|Overall Study|Lack of Efficacy|6|||
161827012|NCT01214239|584406148|FG000|Overall Study|Adverse Event|3|||
161827013|NCT01214239|584406149|FG001|Overall Study|Adverse Event|4|||
161827014|NCT01214239|584406148|FG000|Overall Study|Protocol Violation|2|||
161827015|NCT01214239|584406149|FG001|Overall Study|Protocol Violation|1|||
161827016|NCT01214239|584406148|FG000|Overall Study|Lost to Follow-up|1|||
161827017|NCT01214239|584406149|FG001|Overall Study|Lost to Follow-up|1|||
161827018|NCT01214239|584406148|FG000|Overall Study|Withdrawal by Subject|4|||
161827019|NCT01214239|584406149|FG001|Overall Study|Withdrawal by Subject|9|||
161827020|NCT01214239|584406148|FG000|Overall Study|Lack of Efficacy|1|||
161827021|NCT01214239|584406149|FG001|Overall Study|Lack of Efficacy|2|||
161827022|NCT01214239|584406148|FG000|Overall Study|patient's private reason|1|||
161827023|NCT01214239|584406149|FG001|Overall Study|patient's private reason|1|||
161827024|NCT03840382|584406150|FG000|Overall Study|Lost to Follow-up|11|||
161827025|NCT01142661|584406151|FG000|Overall Study|Adverse Event|2|||
161827026|NCT01142661|584406151|FG000|Overall Study|Withdrawal by Subject|1|||
161827027|NCT01142661|584406151|FG000|Overall Study|Physician Decision|1|||
161827028|NCT00965731|584406154|FG000|Overall Study|Death|0|||
161827029|NCT00965731|584406155|FG001|Overall Study|Death|4|||
161827030|NCT00965731|584406154|FG000|Overall Study|Withdrawal by Subject|0|||
161827031|NCT00965731|584406155|FG001|Overall Study|Withdrawal by Subject|1|||
161827032|NCT00965731|584406154|FG000|Overall Study|Other|7|||
161827033|NCT00965731|584406155|FG001|Overall Study|Other|15|||
161827034|NCT04773600|584406156|FG000|Overall Study|Withdrawal by Subject|15|||
161827035|NCT04773600|584406157|FG001|Overall Study|Withdrawal by Subject|9|||
161827036|NCT04773600|584406156|FG000|Overall Study|Lost to Follow-up|10|||
161827037|NCT04773600|584406157|FG001|Overall Study|Lost to Follow-up|6|||
161827038|NCT04773600|584406156|FG000|Overall Study|Adverse Event|8|||
161827039|NCT04773600|584406157|FG001|Overall Study|Adverse Event|2|||
161827040|NCT04773600|584406156|FG000|Overall Study|Lack of Efficacy|2|||
162213545|NCT02635360|585832724|FG001|Overall Study|Disease Progression|2|||
162213546|NCT02635360|585832723|FG000|Overall Study|Lost to Follow-up|1|||
162213547|NCT02635360|585832724|FG001|Overall Study|Lost to Follow-up|1|||
162213548|NCT04082429|585832725|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
162213549|NCT04082429|585832726|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
162213550|NCT04082429|585832727|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
162213551|NCT04082429|585832728|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
162213552|NCT04082429|585832729|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
162213553|NCT04082429|585832730|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
162213554|NCT04082429|585832731|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
162213555|NCT04082429|585832732|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
162213556|NCT04082429|585832733|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
162213557|NCT04082429|585832725|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162213558|NCT04082429|585832726|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162213559|NCT04082429|585832727|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162213560|NCT04082429|585832728|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162213561|NCT04082429|585832729|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
162213562|NCT04082429|585832730|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162213563|NCT04082429|585832731|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162213564|NCT04082429|585832732|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162213565|NCT04082429|585832733|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
162213566|NCT04082429|585832725|FG000|Main Part (After the Treatment Pause)|Death|0|||
162213567|NCT04082429|585832726|FG001|Main Part (After the Treatment Pause)|Death|0|||
162213568|NCT04082429|585832727|FG002|Main Part (After the Treatment Pause)|Death|0|||
162213569|NCT04082429|585832728|FG003|Main Part (After the Treatment Pause)|Death|0|||
162213570|NCT04082429|585832729|FG004|Main Part (After the Treatment Pause)|Death|1|||
162213571|NCT04082429|585832730|FG005|Main Part (After the Treatment Pause)|Death|0|||
162213572|NCT04082429|585832731|FG006|Main Part (After the Treatment Pause)|Death|0|||
162213573|NCT04082429|585832732|FG007|Main Part (After the Treatment Pause)|Death|0|||
162213574|NCT04082429|585832733|FG008|Main Part (After the Treatment Pause)|Death|0|||
162213575|NCT04082429|585832725|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
162213576|NCT04082429|585832726|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
162213577|NCT04082429|585832727|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
162213578|NCT04082429|585832728|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
162213579|NCT04082429|585832729|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
162213580|NCT04082429|585832730|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
162213581|NCT04082429|585832731|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
162213582|NCT04082429|585832732|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
162213583|NCT04082429|585832733|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
162213584|NCT04082429|585832725|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
162213585|NCT04082429|585832726|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
162213586|NCT04082429|585832727|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
162213587|NCT04082429|585832728|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
162213588|NCT04082429|585832729|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
162213589|NCT04082429|585832730|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
162213590|NCT04082429|585832731|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
162213591|NCT04082429|585832732|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
162213592|NCT04082429|585832733|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
162213593|NCT04082429|585832725|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
161827041|NCT04773600|584406157|FG001|Overall Study|Lack of Efficacy|3|||
161827042|NCT04773600|584406156|FG000|Overall Study|Noncompliance|2|||
161827043|NCT04773600|584406157|FG001|Overall Study|Noncompliance|0|||
161827044|NCT04773600|584406156|FG000|Overall Study|Protocol Violation|2|||
161827045|NCT04773600|584406157|FG001|Overall Study|Protocol Violation|0|||
161827046|NCT04773600|584406156|FG000|Overall Study|Physician Decision|0|||
161827047|NCT04773600|584406157|FG001|Overall Study|Physician Decision|1|||
161827048|NCT04773600|584406156|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
161827049|NCT04773600|584406157|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
161827050|NCT04773600|584406156|FG000|Overall Study|Emergency Travel Out of Country|1|||
161827051|NCT04773600|584406157|FG001|Overall Study|Emergency Travel Out of Country|0|||
161827052|NCT02839798|584407932|FG000|Overall Study|Withdrawal by Subject|2|||
161827053|NCT03180528|584407933|FG000|Overall Study|Adverse Event|1|||
161827054|NCT03180528|584407933|FG000|Overall Study|Withdrawal by Subject|1|||
161827055|NCT03180528|584407933|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
161827056|NCT02447887|584407934|FG000|Overall Study|Study was terminated|3|||
161827057|NCT03429049|584407935|FG000|Overall Study|Adverse Event|2|||
161827058|NCT03429049|584407936|FG001|Overall Study|Adverse Event|3|||
162213594|NCT04082429|585832726|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162213595|NCT04082429|585832727|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162213596|NCT04082429|585832728|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162213597|NCT04082429|585832729|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162213598|NCT04082429|585832730|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
162213599|NCT04082429|585832731|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162213600|NCT04082429|585832732|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162213601|NCT04082429|585832733|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
162213602|NCT04082429|585832725|FG000|Extension Part|Ongoing|0|||
162213603|NCT04082429|585832726|FG001|Extension Part|Ongoing|7|||
162213604|NCT04082429|585832727|FG002|Extension Part|Ongoing|17|||
162213605|NCT04082429|585832728|FG003|Extension Part|Ongoing|6|||
162213606|NCT04082429|585832729|FG004|Extension Part|Ongoing|45|||
162213607|NCT04082429|585832730|FG005|Extension Part|Ongoing|0|||
162213608|NCT04082429|585832731|FG006|Extension Part|Ongoing|10|||
162213609|NCT04082429|585832732|FG007|Extension Part|Ongoing|23|||
162213610|NCT04082429|585832733|FG008|Extension Part|Ongoing|25|||
162213611|NCT00334542|585832734|FG000|Overall Study|Adverse Event|3|||
162213612|NCT00334542|585832734|FG000|Overall Study|Withdrawal by Subject|1|||
162213613|NCT00334542|585832734|FG000|Overall Study|New cancer diagnosis|1|||
162213614|NCT03118050|585832735|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
162213615|NCT03118050|585832736|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
162213616|NCT03118050|585832737|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
162213617|NCT03118050|585832738|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
162213618|NCT03118050|585832739|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
162213619|NCT03118050|585832740|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
162213620|NCT03118050|585832741|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
162213621|NCT01454739|585832743|FG000|Overall Study|Protocol Violation|2|||
162213622|NCT01454739|585832744|FG001|Overall Study|Protocol Violation|3|||
162213623|NCT01454739|585832743|FG000|Overall Study|Withdrawal by Subject|2|||
162213624|NCT01454739|585832744|FG001|Overall Study|Withdrawal by Subject|6|||
162213625|NCT01454739|585832743|FG000|Overall Study|Other|3|||
162213626|NCT01454739|585832744|FG001|Overall Study|Other|5|||
162213627|NCT01454739|585832743|FG000|Overall Study|Physician Decision|0|||
162213628|NCT01454739|585832744|FG001|Overall Study|Physician Decision|5|||
162213629|NCT01454739|585832743|FG000|Overall Study|Lost to Follow-up|0|||
162213630|NCT01454739|585832744|FG001|Overall Study|Lost to Follow-up|1|||
162213631|NCT01454739|585832743|FG000|Overall Study|Adverse Event|0|||
162213632|NCT01454739|585832744|FG001|Overall Study|Adverse Event|1|||
162213633|NCT05765435|585832745|FG000|Overall Study|Lost to Follow-up|0|||
162213634|NCT05765435|585832746|FG001|Overall Study|Lost to Follow-up|1|||
162213635|NCT05765435|585832747|FG002|Overall Study|Lost to Follow-up|0|||
162213636|NCT05765435|585832745|FG000|Overall Study|Withdrawal by Subject|0|||
162213637|NCT05765435|585832746|FG001|Overall Study|Withdrawal by Subject|0|||
162213638|NCT05765435|585832747|FG002|Overall Study|Withdrawal by Subject|1|||
162213639|NCT04351269|585832748|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
162213640|NCT04351269|585832749|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
162213641|NCT04351269|585832750|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
162213642|NCT04351269|585832748|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
162213643|NCT04351269|585832749|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
162213644|NCT04351269|585832750|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
162213645|NCT04351269|585832748|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
162213646|NCT04351269|585832749|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
162213647|NCT04351269|585832750|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
162213648|NCT04351269|585832748|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
162213649|NCT04351269|585832749|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
162213650|NCT04351269|585832750|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
162213651|NCT04351269|585832748|FG000|Overall Study|Lost to Follow-up|1|||
162213652|NCT04351269|585832749|FG001|Overall Study|Lost to Follow-up|3|||
162213653|NCT04351269|585832750|FG002|Overall Study|Lost to Follow-up|0|||
162213654|NCT02980523|585832751|FG000|Overall Study|Lost to Follow-up|1|||
162213655|NCT02980523|585832752|FG001|Overall Study|Lost to Follow-up|4|||
162213656|NCT02980523|585832753|FG002|Overall Study|Lost to Follow-up|1|||
161827059|NCT03429049|584407935|FG000|Overall Study|Death|0|||
161827060|NCT03429049|584407936|FG001|Overall Study|Death|1|||
161827061|NCT03429049|584407935|FG000|Overall Study|Lack of Efficacy|4|||
161827062|NCT03429049|584407936|FG001|Overall Study|Lack of Efficacy|2|||
161827063|NCT03429049|584407935|FG000|Overall Study|Lost to Follow-up|9|||
161827064|NCT03429049|584407936|FG001|Overall Study|Lost to Follow-up|8|||
161827065|NCT03429049|584407935|FG000|Overall Study|Physician Decision|1|||
161827066|NCT03429049|584407936|FG001|Overall Study|Physician Decision|0|||
162213657|NCT02980523|585832754|FG003|Overall Study|Lost to Follow-up|2|||
162213658|NCT02980523|585832755|FG004|Overall Study|Lost to Follow-up|1|||
162213659|NCT02980523|585832751|FG000|Overall Study|Excluded from analysis|1|||
162213660|NCT02980523|585832752|FG001|Overall Study|Excluded from analysis|3|||
162213661|NCT02980523|585832753|FG002|Overall Study|Excluded from analysis|1|||
162213662|NCT02980523|585832754|FG003|Overall Study|Excluded from analysis|1|||
162213663|NCT02980523|585832755|FG004|Overall Study|Excluded from analysis|1|||
162213664|NCT02980523|585832751|FG000|Overall Study|Lack of Efficacy|1|||
162213665|NCT02980523|585832752|FG001|Overall Study|Lack of Efficacy|4|||
162213666|NCT02980523|585832753|FG002|Overall Study|Lack of Efficacy|4|||
162213667|NCT02980523|585832754|FG003|Overall Study|Lack of Efficacy|5|||
162213668|NCT02980523|585832755|FG004|Overall Study|Lack of Efficacy|8|||
162213669|NCT02980523|585832751|FG000|Overall Study|Did not receive intervention|0|||
162213670|NCT02980523|585832752|FG001|Overall Study|Did not receive intervention|0|||
162213671|NCT02980523|585832753|FG002|Overall Study|Did not receive intervention|0|||
162213672|NCT02980523|585832754|FG003|Overall Study|Did not receive intervention|1|||
162213673|NCT02980523|585832755|FG004|Overall Study|Did not receive intervention|0|||
162213674|NCT00633945|585832756|FG000|Overall Study|Physician Decision|2|||
162213675|NCT00882115|585832757|FG000|Overall Study|Withdrawal by Subject|3|||
162213676|NCT00882115|585832757|FG000|Overall Study|did not respond to DEP challe|6|||
161827067|NCT03429049|584407935|FG000|Overall Study|Protocol Violation|3|||
161827068|NCT03429049|584407936|FG001|Overall Study|Protocol Violation|0|||
161827069|NCT03429049|584407935|FG000|Overall Study|Sponsor Decision|2|||
161827070|NCT03429049|584407936|FG001|Overall Study|Sponsor Decision|0|||
162213677|NCT02552147|585832758|FG000|First Intervention (7 Days)|Protocol Violation|1|||
162213678|NCT02552147|585832759|FG001|First Intervention (7 Days)|Protocol Violation|0|||
162213679|NCT02552147|585832758|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
162213680|NCT02552147|585832759|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
162213681|NCT01850589|585832764|FG000|Overall Study|Withdrawal by Subject|8|||
162213682|NCT01850589|585832765|FG001|Overall Study|Withdrawal by Subject|0|||
162213683|NCT03912662|585832766|FG000|Overall Study|Adverse Event|3|||
162213684|NCT03912662|585832766|FG000|Overall Study|Adverse Event and Death|1|||
162213685|NCT03912662|585832766|FG000|Overall Study|Death|1|||
162213686|NCT03912662|585832766|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
162213687|NCT03912662|585832766|FG000|Overall Study|Mesh Removal|1|||
162213688|NCT03912662|585832766|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
162213689|NCT03912662|585832766|FG000|Overall Study|Early study termination|20|||
162213690|NCT03845140|585832767|FG000|Overall Study|Participant travelled outside study area|0|||
162213691|NCT03845140|585832768|FG001|Overall Study|Participant travelled outside study area|1|||
162213692|NCT03845140|585832769|FG002|Overall Study|Participant travelled outside study area|0|||
162213693|NCT03845140|585832770|FG003|Overall Study|Participant travelled outside study area|0|||
162213694|NCT03845140|585832771|FG004|Overall Study|Participant travelled outside study area|0|||
162213695|NCT03845140|585832772|FG005|Overall Study|Participant travelled outside study area|0|||
162213696|NCT01592045|585832773|FG000|Overall Study|Disease Progression|1|||
162213697|NCT01592045|585832774|FG001|Overall Study|Disease Progression|1|||
162213698|NCT01592045|585832773|FG000|Overall Study|Adverse Event|1|||
162213699|NCT01592045|585832774|FG001|Overall Study|Adverse Event|1|||
162213700|NCT01592045|585832773|FG000|Overall Study|Withdrawal by Subject|1|||
162213701|NCT01592045|585832774|FG001|Overall Study|Withdrawal by Subject|0|||
161827071|NCT03429049|584407935|FG000|Overall Study|Withdrawal by Subject|4|||
161827072|NCT03429049|584407936|FG001|Overall Study|Withdrawal by Subject|20|||
161827073|NCT03429049|584407935|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
161827074|NCT03429049|584407936|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
161827075|NCT04703855|584407937|FG000|Overall Study|Heart Transplant|1|||
161827076|NCT02418455|584407940|FG000|48-Week Treatment Period|Other- Not Specified|1|||
161827077|NCT02418455|584407940|FG000|Continuation Period|Sponsor Decision|7|||
161827078|NCT02001051|584407943|FG000|Overall Study|Deemed not eligible following enrollment|0|||
161827079|NCT02001051|584407944|FG001|Overall Study|Deemed not eligible following enrollment|1|||
161827080|NCT04205162|584407954|FG000|Overall Study|Lost to Follow-up|1|||
161827081|NCT04205162|584407955|FG001|Overall Study|Lost to Follow-up|0|||
161827082|NCT04205162|584407954|FG000|Overall Study|Withdrawal by Subject|2|||
161827083|NCT04205162|584407955|FG001|Overall Study|Withdrawal by Subject|0|||
161827084|NCT04205162|584407954|FG000|Overall Study|University closure due to COVID-19|1|||
161827085|NCT04205162|584407955|FG001|Overall Study|University closure due to COVID-19|0|||
161827086|NCT01999894|584407956|FG000|Overall Study|Adverse Event|9|||
161827087|NCT01999894|584407956|FG000|Overall Study|Lack of Efficacy|5|||
161827088|NCT01999894|584407956|FG000|Overall Study|Protocol Violation|1|||
161827089|NCT01999894|584407956|FG000|Overall Study|Withdrawal by Subject|7|||
161827090|NCT01999894|584407956|FG000|Overall Study|Lost to Follow-up|10|||
162213702|NCT01592045|585832773|FG000|Overall Study|Moved out of country|2|||
162213703|NCT01592045|585832774|FG001|Overall Study|Moved out of country|0|||
162213704|NCT03721705|585832777|FG000|Overall Study|Adverse Event|2|||
162213705|NCT03721705|585832778|FG001|Overall Study|Adverse Event|0|||
161827091|NCT01999894|584407956|FG000|Overall Study|Other Reason|3|||
161827092|NCT01999894|584407956|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
162213706|NCT03721705|585832777|FG000|Overall Study|Withdrawal by Subject|4|||
162213707|NCT03721705|585832778|FG001|Overall Study|Withdrawal by Subject|10|||
162213708|NCT03721705|585832777|FG000|Overall Study|No Suitable Study Partner|1|||
162213709|NCT03721705|585832778|FG001|Overall Study|No Suitable Study Partner|0|||
162213710|NCT03721705|585832777|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
162213711|NCT03721705|585832778|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
162213712|NCT03721705|585832777|FG000|Overall Study|Death|0|||
162213713|NCT03721705|585832778|FG001|Overall Study|Death|1|||
162213714|NCT01790295|585832779|FG000|Overall Study|Adverse Event|1|||
162213715|NCT01790295|585832779|FG000|Overall Study|Death|4|||
162213716|NCT01790295|585832779|FG000|Overall Study|Lack of Efficacy|2|||
162213717|NCT01790295|585832779|FG000|Overall Study|Study closure|4|||
162213718|NCT01843777|585832780|FG000|Overall Study|Withdrawal by Subject|1|||
162213719|NCT01843777|585832781|FG001|Overall Study|Withdrawal by Subject|0|||
162213720|NCT00420784|585832787|FG000|Overall Study|Adverse Event|11|||
162213721|NCT00420784|585832788|FG001|Overall Study|Adverse Event|29|||
162213722|NCT00420784|585832789|FG002|Overall Study|Adverse Event|10|||
162213723|NCT00420784|585832790|FG003|Overall Study|Adverse Event|5|||
162213724|NCT00420784|585832787|FG000|Overall Study|Withdrawal by Subject|0|||
162213725|NCT00420784|585832788|FG001|Overall Study|Withdrawal by Subject|1|||
162213726|NCT00420784|585832789|FG002|Overall Study|Withdrawal by Subject|0|||
161827093|NCT01546519|584407958|FG000|Overall Study|Adverse Event|0|||
161827094|NCT01546519|584407959|FG001|Overall Study|Adverse Event|0|||
161827095|NCT01546519|584407960|FG002|Overall Study|Adverse Event|1|||
161827096|NCT01546519|584407961|FG003|Overall Study|Adverse Event|1|||
161827097|NCT01546519|584407958|FG000|Overall Study|Death|0|||
161827098|NCT01546519|584407959|FG001|Overall Study|Death|1|||
161827099|NCT01546519|584407960|FG002|Overall Study|Death|3|||
161827100|NCT01546519|584407961|FG003|Overall Study|Death|1|||
161827101|NCT01546519|584407958|FG000|Overall Study|related to disease progression|2|||
161827102|NCT01546519|584407959|FG001|Overall Study|related to disease progression|2|||
161827103|NCT01546519|584407960|FG002|Overall Study|related to disease progression|2|||
161827104|NCT01546519|584407961|FG003|Overall Study|related to disease progression|1|||
161827105|NCT01546519|584407958|FG000|Overall Study|Physician Decision|6|||
161827106|NCT01546519|584407959|FG001|Overall Study|Physician Decision|5|||
161827107|NCT01546519|584407960|FG002|Overall Study|Physician Decision|2|||
161827108|NCT01546519|584407961|FG003|Overall Study|Physician Decision|3|||
161827109|NCT01546519|584407958|FG000|Overall Study|Withdrawal by Subject|1|||
161827110|NCT01546519|584407959|FG001|Overall Study|Withdrawal by Subject|0|||
161827111|NCT01546519|584407960|FG002|Overall Study|Withdrawal by Subject|0|||
161827112|NCT01546519|584407961|FG003|Overall Study|Withdrawal by Subject|0|||
161827113|NCT00779402|584407962|FG000|Treatment Phase 1|Disease Progression|1|||
161827114|NCT00779402|584407963|FG001|Treatment Phase 1|Disease Progression|0|||
161827115|NCT00779402|584407962|FG000|Treatment Phase 1|Adverse Event|2|||
161827116|NCT00779402|584407963|FG001|Treatment Phase 1|Adverse Event|0|||
161827117|NCT00779402|584407962|FG000|Treatment Phase 1|Protocol Violation|1|||
161827118|NCT00779402|584407963|FG001|Treatment Phase 1|Protocol Violation|0|||
161827119|NCT00779402|584407962|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
161827120|NCT00779402|584407963|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
161827121|NCT00779402|584407962|FG000|Treatment Phase 1|Lost to Follow-up|0|||
161827122|NCT00779402|584407963|FG001|Treatment Phase 1|Lost to Follow-up|1|||
161827123|NCT00779402|584407962|FG000|Treatment Phase 1|Death|0|||
161827124|NCT00779402|584407963|FG001|Treatment Phase 1|Death|1|||
161827125|NCT00779402|584407962|FG000|Treatment Phase 1|Intercurrent Illness|1|||
161827126|NCT00779402|584407963|FG001|Treatment Phase 1|Intercurrent Illness|1|||
161827127|NCT00779402|584407962|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
161827128|NCT00779402|584407963|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
161827129|NCT00779402|584407962|FG000|Treatment Phase 1|Other|4|||
161827130|NCT00779402|584407963|FG001|Treatment Phase 1|Other|2|||
161827131|NCT00779402|584407962|FG000|Treatment Phase 1|Closure of Study|3|||
161827132|NCT00779402|584407963|FG001|Treatment Phase 1|Closure of Study|2|||
161827133|NCT00779402|584407962|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
161827134|NCT00779402|584407963|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
161827135|NCT00779402|584407962|FG000|Surveillance Phase|Protocol Violation|0|||
161827136|NCT00779402|584407963|FG001|Surveillance Phase|Protocol Violation|1|||
161827137|NCT00779402|584407962|FG000|Surveillance Phase|Patient refused to continue|22|||
161827138|NCT00779402|584407963|FG001|Surveillance Phase|Patient refused to continue|14|||
161827139|NCT00779402|584407962|FG000|Surveillance Phase|Lost to Follow-up|2|||
161827140|NCT00779402|584407963|FG001|Surveillance Phase|Lost to Follow-up|1|||
161827141|NCT00779402|584407962|FG000|Surveillance Phase|Death|0|||
161827142|NCT00779402|584407963|FG001|Surveillance Phase|Death|1|||
162213727|NCT00420784|585832790|FG003|Overall Study|Withdrawal by Subject|0|||
162213728|NCT00420784|585832787|FG000|Overall Study|Lost to Follow-up|0|||
162213729|NCT00420784|585832788|FG001|Overall Study|Lost to Follow-up|0|||
162213730|NCT00420784|585832789|FG002|Overall Study|Lost to Follow-up|2|||
162213731|NCT00420784|585832790|FG003|Overall Study|Lost to Follow-up|1|||
162213732|NCT00420784|585832787|FG000|Overall Study|Virologic Stopping Rule|17|||
162213733|NCT00420784|585832788|FG001|Overall Study|Virologic Stopping Rule|26|||
162213734|NCT00420784|585832789|FG002|Overall Study|Virologic Stopping Rule|41|||
162213735|NCT00420784|585832790|FG003|Overall Study|Virologic Stopping Rule|67|||
162213736|NCT00420784|585832787|FG000|Overall Study|Other|1|||
162213737|NCT00420784|585832788|FG001|Overall Study|Other|2|||
162213738|NCT00420784|585832789|FG002|Overall Study|Other|0|||
162213739|NCT00420784|585832790|FG003|Overall Study|Other|5|||
162213740|NCT02599688|585832793|FG000|Overall Study|Lack of Efficacy|1|||
162213741|NCT02599688|585832793|FG000|Overall Study|Withdrawal by Subject|1|||
162213742|NCT02599688|585832793|FG000|Overall Study|Termination by Sponsor|2|||
162213743|NCT01318876|585832795|FG000|Day 8 Survey|email address invalid|96|||
162213744|NCT01318876|585832795|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
162213745|NCT01318876|585832795|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
162213746|NCT00443209|585832796|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
162213747|NCT00443209|585832797|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
162213748|NCT00443209|585832796|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
162213749|NCT00443209|585832797|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
162213750|NCT00443209|585832796|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
162213751|NCT00443209|585832797|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
162213752|NCT00443209|585832796|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
162213753|NCT00443209|585832797|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
162213754|NCT00443209|585832796|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
162213755|NCT00443209|585832797|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
162213756|NCT00443209|585832796|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
162213757|NCT00443209|585832797|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
162213758|NCT00443209|585832796|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
162213759|NCT00443209|585832797|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
162213760|NCT00443209|585832796|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
162213761|NCT00443209|585832797|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
162213762|NCT00443209|585832796|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
162213763|NCT00443209|585832797|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
162213764|NCT00443209|585832796|FG000|Months 1 to 12 Treatment Period|Missing|2|||
162213765|NCT00443209|585832797|FG001|Months 1 to 12 Treatment Period|Missing|1|||
162213766|NCT00443209|585832796|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
162213767|NCT00443209|585832797|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
162213768|NCT00443209|585832796|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
162213769|NCT00443209|585832797|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
162213770|NCT00443209|585832796|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
162213771|NCT00443209|585832797|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
162213772|NCT00443209|585832796|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
162213773|NCT00443209|585832797|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
162213774|NCT00443209|585832796|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
162213775|NCT00443209|585832797|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
162213776|NCT00443209|585832796|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
162213777|NCT00443209|585832797|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
162213778|NCT00443209|585832796|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
162213779|NCT00443209|585832797|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
162213780|NCT01101061|585832800|FG000|Overall Study|Adverse Event|0|||
162213781|NCT01101061|585832801|FG001|Overall Study|Adverse Event|0|||
162213782|NCT01101061|585832802|FG002|Overall Study|Adverse Event|1|||
162213783|NCT01101061|585832803|FG003|Overall Study|Adverse Event|0|||
162213784|NCT01101061|585832804|FG004|Overall Study|Adverse Event|0|||
162213785|NCT01101061|585832805|FG005|Overall Study|Adverse Event|0|||
162213786|NCT02049515|585832806|FG000|Overall Study|Adverse Event|46|||
162213787|NCT02049515|585832807|FG001|Overall Study|Adverse Event|2|||
162213788|NCT02049515|585832806|FG000|Overall Study|Protocol-specified Disease Progression|23|||
162213789|NCT02049515|585832807|FG001|Overall Study|Protocol-specified Disease Progression|2|||
162213790|NCT02049515|585832806|FG000|Overall Study|Death|6|||
162213791|NCT02049515|585832807|FG001|Overall Study|Death|0|||
161678197|NCT01236573|583873622|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
162213792|NCT02049515|585832806|FG000|Overall Study|Physician Decision|5|||
162213793|NCT02049515|585832807|FG001|Overall Study|Physician Decision|1|||
162213794|NCT02049515|585832806|FG000|Overall Study|Withdrawal by Subject|3|||
162213795|NCT02049515|585832807|FG001|Overall Study|Withdrawal by Subject|0|||
161827143|NCT00779402|584407962|FG000|Surveillance Phase|Intercurrent Illness|2|||
161827144|NCT00779402|584407963|FG001|Surveillance Phase|Intercurrent Illness|0|||
161827145|NCT00779402|584407962|FG000|Surveillance Phase|Other|5|||
161827146|NCT00779402|584407963|FG001|Surveillance Phase|Other|5|||
161827147|NCT00779402|584407962|FG000|Surveillance Phase|Withdrawal by Subject|4|||
161827148|NCT00779402|584407963|FG001|Surveillance Phase|Withdrawal by Subject|1|||
161827149|NCT00779402|584407962|FG000|Surveillance Phase|Closure of study|5|||
161827150|NCT00779402|584407963|FG001|Surveillance Phase|Closure of study|6|||
161827151|NCT00779402|584407962|FG000|Surveillance Phase|Completed Protocol Visits|3|||
161827152|NCT00779402|584407963|FG001|Surveillance Phase|Completed Protocol Visits|2|||
161827153|NCT00779402|584407962|FG000|Long-term Follow-up|Patient refused to continue|2|||
161827154|NCT00779402|584407963|FG001|Long-term Follow-up|Patient refused to continue|0|||
161827155|NCT00779402|584407962|FG000|Long-term Follow-up|Other|5|||
161827156|NCT00779402|584407963|FG001|Long-term Follow-up|Other|0|||
161827157|NCT00779402|584407962|FG000|Long-term Follow-up|Closure of Study|8|||
161935849|NCT03997383|584814061|FG001|Open-label Extension Period|Ongoing|151|||
162213796|NCT02049515|585832806|FG000|Overall Study|Termination of the Study by Sponsor|2|||
162213797|NCT02049515|585832807|FG001|Overall Study|Termination of the Study by Sponsor|0|||
162213798|NCT02049515|585832806|FG000|Overall Study|Protocol Violation|1|||
162213799|NCT02049515|585832807|FG001|Overall Study|Protocol Violation|1|||
162213800|NCT02049515|585832806|FG000|Overall Study|Clinical Deterioration|1|||
162213801|NCT02049515|585832807|FG001|Overall Study|Clinical Deterioration|0|||
162213802|NCT02049515|585832806|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
162213803|NCT02049515|585832807|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
162213804|NCT02049515|585832806|FG000|Overall Study|Treatment Interruption >42 Days|1|||
162213805|NCT02049515|585832807|FG001|Overall Study|Treatment Interruption >42 Days|0|||
162213806|NCT02049515|585832806|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
162213807|NCT02049515|585832807|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
162213808|NCT03513068|585832809|FG000|Overall Study|Death|1|||
161935850|NCT03997383|584814060|FG000|Open-label Extension Period|Adverse Event|4|||
161935851|NCT03997383|584814061|FG001|Open-label Extension Period|Adverse Event|1|||
161935852|NCT03997383|584814060|FG000|Open-label Extension Period|Death|8|||
161935853|NCT03997383|584814061|FG001|Open-label Extension Period|Death|9|||
161935854|NCT03997383|584814060|FG000|Open-label Extension Period|Physician Decision|1|||
161935855|NCT03997383|584814061|FG001|Open-label Extension Period|Physician Decision|1|||
161935856|NCT03997383|584814060|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
161935857|NCT03997383|584814061|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
161935858|NCT03997383|584814060|FG000|Open-label Extension Period|Reason Not Specified|2|||
161935859|NCT03997383|584814061|FG001|Open-label Extension Period|Reason Not Specified|0|||
161827158|NCT00779402|584407963|FG001|Long-term Follow-up|Closure of Study|4|||
162213809|NCT03513068|585832810|FG001|Overall Study|Death|0|||
162213810|NCT03513068|585832809|FG000|Overall Study|Withdrawal by Subject|4|||
162213811|NCT03513068|585832810|FG001|Overall Study|Withdrawal by Subject|6|||
162213812|NCT03636373|585832812|FG000|Overall Study|Study closure due to Covid-19|1|||
162213813|NCT03636373|585832813|FG001|Overall Study|Study closure due to Covid-19|0|||
161827159|NCT00779402|584407962|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
161827160|NCT00779402|584407963|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
162213814|NCT01236352|585832817|FG000|Overall Study|Death|0|||
162213815|NCT01236352|585832818|FG001|Overall Study|Death|0|||
162021376|NCT00942994|585134764|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161678198|NCT01236573|583873623|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161827161|NCT01519947|584407964|FG000|Overall Study|Death|0|||
161827162|NCT01519947|584407965|FG001|Overall Study|Death|0|||
161827163|NCT01519947|584407966|FG002|Overall Study|Death|0|||
161827164|NCT01519947|584407967|FG003|Overall Study|Death|1|||
161827165|NCT01519947|584407964|FG000|Overall Study|Protocol Violation|0|||
161827166|NCT01519947|584407965|FG001|Overall Study|Protocol Violation|0|||
161827167|NCT01519947|584407966|FG002|Overall Study|Protocol Violation|2|||
161827168|NCT01519947|584407967|FG003|Overall Study|Protocol Violation|1|||
161827169|NCT01519947|584407964|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
161827170|NCT01519947|584407965|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
161827171|NCT01519947|584407966|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
161827172|NCT01519947|584407967|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
161827173|NCT01519947|584407964|FG000|Overall Study|Development of Anemia|0|||
161827174|NCT01519947|584407965|FG001|Overall Study|Development of Anemia|1|||
161827175|NCT01519947|584407966|FG002|Overall Study|Development of Anemia|0|||
161827176|NCT01519947|584407967|FG003|Overall Study|Development of Anemia|1|||
161827177|NCT01519947|584407964|FG000|Overall Study|Blood Transfusion|0|||
161827178|NCT01519947|584407965|FG001|Overall Study|Blood Transfusion|1|||
161827179|NCT01519947|584407966|FG002|Overall Study|Blood Transfusion|1|||
161827180|NCT01519947|584407967|FG003|Overall Study|Blood Transfusion|0|||
161827181|NCT01519947|584407964|FG000|Overall Study|Withdrawal by Subject|0|||
161827182|NCT01519947|584407965|FG001|Overall Study|Withdrawal by Subject|1|||
161827183|NCT01519947|584407966|FG002|Overall Study|Withdrawal by Subject|0|||
161827184|NCT01519947|584407967|FG003|Overall Study|Withdrawal by Subject|1|||
161827185|NCT01519947|584407964|FG000|Overall Study|Lost to Follow-up|0|||
161827186|NCT01519947|584407965|FG001|Overall Study|Lost to Follow-up|0|||
162213816|NCT01236352|585832819|FG002|Overall Study|Death|0|||
162213817|NCT01236352|585832820|FG003|Overall Study|Death|0|||
162213818|NCT01236352|585832821|FG004|Overall Study|Death|0|||
162213819|NCT01236352|585832822|FG005|Overall Study|Death|0|||
162213820|NCT01236352|585832823|FG006|Overall Study|Death|0|||
162213821|NCT01236352|585832824|FG007|Overall Study|Death|1|||
162213822|NCT01236352|585832825|FG008|Overall Study|Death|0|||
162213823|NCT01236352|585832826|FG009|Overall Study|Death|0|||
162213824|NCT01236352|585832827|FG010|Overall Study|Death|0|||
162213825|NCT01236352|585832817|FG000|Overall Study|Withdrawal by Subject|0|||
162213826|NCT01236352|585832818|FG001|Overall Study|Withdrawal by Subject|0|||
162213827|NCT01236352|585832819|FG002|Overall Study|Withdrawal by Subject|0|||
162213828|NCT01236352|585832820|FG003|Overall Study|Withdrawal by Subject|0|||
162213829|NCT01236352|585832821|FG004|Overall Study|Withdrawal by Subject|0|||
162213830|NCT01236352|585832822|FG005|Overall Study|Withdrawal by Subject|0|||
162213831|NCT01236352|585832823|FG006|Overall Study|Withdrawal by Subject|0|||
162213832|NCT01236352|585832824|FG007|Overall Study|Withdrawal by Subject|0|||
162213833|NCT01236352|585832825|FG008|Overall Study|Withdrawal by Subject|0|||
162213834|NCT01236352|585832826|FG009|Overall Study|Withdrawal by Subject|2|||
162213835|NCT01236352|585832827|FG010|Overall Study|Withdrawal by Subject|1|||
162213836|NCT01236352|585832817|FG000|Overall Study|Adverse Event|0|||
162213837|NCT01236352|585832818|FG001|Overall Study|Adverse Event|0|||
162213838|NCT01236352|585832819|FG002|Overall Study|Adverse Event|0|||
162213839|NCT01236352|585832820|FG003|Overall Study|Adverse Event|0|||
162213840|NCT01236352|585832821|FG004|Overall Study|Adverse Event|0|||
162213841|NCT01236352|585832822|FG005|Overall Study|Adverse Event|0|||
162213842|NCT01236352|585832823|FG006|Overall Study|Adverse Event|2|||
162213843|NCT01236352|585832824|FG007|Overall Study|Adverse Event|0|||
162213844|NCT01236352|585832825|FG008|Overall Study|Adverse Event|0|||
162213845|NCT01236352|585832826|FG009|Overall Study|Adverse Event|4|||
162213846|NCT01236352|585832827|FG010|Overall Study|Adverse Event|1|||
162213847|NCT01236352|585832817|FG000|Overall Study|Study drug toxicity|0|||
162213848|NCT01236352|585832818|FG001|Overall Study|Study drug toxicity|0|||
162213849|NCT01236352|585832819|FG002|Overall Study|Study drug toxicity|0|||
161935935|NCT06433908|584817517|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|1|||
161935936|NCT06433908|584817518|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
162213850|NCT01236352|585832820|FG003|Overall Study|Study drug toxicity|0|||
162213851|NCT01236352|585832821|FG004|Overall Study|Study drug toxicity|0|||
162213852|NCT01236352|585832822|FG005|Overall Study|Study drug toxicity|1|||
162213853|NCT01236352|585832823|FG006|Overall Study|Study drug toxicity|1|||
162213854|NCT01236352|585832824|FG007|Overall Study|Study drug toxicity|0|||
162213855|NCT01236352|585832825|FG008|Overall Study|Study drug toxicity|0|||
162213856|NCT01236352|585832826|FG009|Overall Study|Study drug toxicity|2|||
162213857|NCT01236352|585832827|FG010|Overall Study|Study drug toxicity|2|||
162213858|NCT01236352|585832817|FG000|Overall Study|Disease progression|1|||
162213859|NCT01236352|585832818|FG001|Overall Study|Disease progression|2|||
162213860|NCT01236352|585832819|FG002|Overall Study|Disease progression|1|||
162213861|NCT01236352|585832820|FG003|Overall Study|Disease progression|2|||
162213862|NCT01236352|585832821|FG004|Overall Study|Disease progression|2|||
162213863|NCT01236352|585832822|FG005|Overall Study|Disease progression|2|||
162213864|NCT01236352|585832823|FG006|Overall Study|Disease progression|1|||
162213865|NCT01236352|585832824|FG007|Overall Study|Disease progression|3|||
162213866|NCT01236352|585832825|FG008|Overall Study|Disease progression|2|||
162213867|NCT01236352|585832826|FG009|Overall Study|Disease progression|2|||
162213868|NCT01236352|585832827|FG010|Overall Study|Disease progression|2|||
162213869|NCT01236352|585832817|FG000|Overall Study|Poor/Non-compliance|1|||
162213870|NCT01236352|585832818|FG001|Overall Study|Poor/Non-compliance|0|||
162213871|NCT01236352|585832819|FG002|Overall Study|Poor/Non-compliance|0|||
162213872|NCT01236352|585832820|FG003|Overall Study|Poor/Non-compliance|0|||
162213873|NCT01236352|585832821|FG004|Overall Study|Poor/Non-compliance|0|||
162213874|NCT01236352|585832822|FG005|Overall Study|Poor/Non-compliance|0|||
162213875|NCT01236352|585832823|FG006|Overall Study|Poor/Non-compliance|0|||
162213876|NCT01236352|585832824|FG007|Overall Study|Poor/Non-compliance|0|||
162213877|NCT01236352|585832825|FG008|Overall Study|Poor/Non-compliance|0|||
162213878|NCT01236352|585832826|FG009|Overall Study|Poor/Non-compliance|0|||
162213879|NCT01236352|585832827|FG010|Overall Study|Poor/Non-compliance|0|||
161678199|NCT01236573|583873624|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161935937|NCT06433908|584817519|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
162213880|NCT01236352|585832817|FG000|Overall Study|Maximum clinical benefit|1|||
162213881|NCT01236352|585832818|FG001|Overall Study|Maximum clinical benefit|1|||
162213882|NCT01236352|585832819|FG002|Overall Study|Maximum clinical benefit|1|||
162213883|NCT01236352|585832820|FG003|Overall Study|Maximum clinical benefit|0|||
162213884|NCT01236352|585832821|FG004|Overall Study|Maximum clinical benefit|2|||
162213885|NCT01236352|585832822|FG005|Overall Study|Maximum clinical benefit|0|||
162213886|NCT01236352|585832823|FG006|Overall Study|Maximum clinical benefit|3|||
162213887|NCT01236352|585832824|FG007|Overall Study|Maximum clinical benefit|1|||
162213888|NCT01236352|585832825|FG008|Overall Study|Maximum clinical benefit|1|||
162213889|NCT01236352|585832826|FG009|Overall Study|Maximum clinical benefit|4|||
162213890|NCT01236352|585832827|FG010|Overall Study|Maximum clinical benefit|2|||
162213891|NCT01236352|585832817|FG000|Overall Study|Subject request to discontinue treatment|0|||
162213892|NCT01236352|585832818|FG001|Overall Study|Subject request to discontinue treatment|0|||
162213893|NCT01236352|585832819|FG002|Overall Study|Subject request to discontinue treatment|1|||
162213894|NCT01236352|585832820|FG003|Overall Study|Subject request to discontinue treatment|1|||
162213895|NCT01236352|585832821|FG004|Overall Study|Subject request to discontinue treatment|0|||
162213896|NCT01236352|585832822|FG005|Overall Study|Subject request to discontinue treatment|1|||
162213897|NCT01236352|585832823|FG006|Overall Study|Subject request to discontinue treatment|0|||
162213898|NCT01236352|585832824|FG007|Overall Study|Subject request to discontinue treatment|0|||
162213899|NCT01236352|585832825|FG008|Overall Study|Subject request to discontinue treatment|0|||
162213900|NCT01236352|585832826|FG009|Overall Study|Subject request to discontinue treatment|1|||
162213901|NCT01236352|585832827|FG010|Overall Study|Subject request to discontinue treatment|4|||
162213902|NCT01236352|585832817|FG000|Overall Study|Subject to receive drug via EAP|1|||
161827187|NCT01519947|584407966|FG002|Overall Study|Lost to Follow-up|3|||
161827188|NCT01519947|584407967|FG003|Overall Study|Lost to Follow-up|2|||
161827189|NCT01519947|584407964|FG000|Overall Study|Poor Response|1|||
161827190|NCT01519947|584407965|FG001|Overall Study|Poor Response|0|||
161827191|NCT01519947|584407966|FG002|Overall Study|Poor Response|0|||
161827192|NCT01519947|584407967|FG003|Overall Study|Poor Response|1|||
161827193|NCT01519947|584407964|FG000|Overall Study|Adverse Event|1|||
161827194|NCT01519947|584407965|FG001|Overall Study|Adverse Event|0|||
161827195|NCT01519947|584407966|FG002|Overall Study|Adverse Event|1|||
161827196|NCT01519947|584407967|FG003|Overall Study|Adverse Event|1|||
161827197|NCT00693225|584407968|FG000|Overall Study|Lost to Follow-up|1|||
161827198|NCT00693225|584407969|FG001|Overall Study|Lost to Follow-up|2|||
161827199|NCT00693225|584407968|FG000|Overall Study|Adverse Event|1|||
161827200|NCT00693225|584407969|FG001|Overall Study|Adverse Event|3|||
161827201|NCT03585959|584407974|FG000|Overall Study|Physician Decision|1|||
161827202|NCT03585959|584407974|FG000|Overall Study|Unsuccessful Procedure|2|||
161827203|NCT01186016|584407976|FG000|Overall Study|Withdrawal by Subject|46|||
161827204|NCT01186016|584407977|FG001|Overall Study|Withdrawal by Subject|29|||
161827205|NCT03750695|584407979|FG000|Overall Study|Lost to Follow-up|0|||
161827206|NCT03750695|584407980|FG001|Overall Study|Lost to Follow-up|1|||
161827207|NCT01386125|584407981|FG000|Overall Study|Lost to Follow-up|3|||
161827208|NCT01386125|584407982|FG001|Overall Study|Lost to Follow-up|9|||
161827209|NCT01386125|584407981|FG000|Overall Study|Physician Decision|0|||
161827210|NCT01386125|584407982|FG001|Overall Study|Physician Decision|1|||
161827211|NCT01386125|584407981|FG000|Overall Study|Protocol Violation|5|||
161827212|NCT01386125|584407982|FG001|Overall Study|Protocol Violation|7|||
161827213|NCT01386125|584407981|FG000|Overall Study|Disease Progress|1|||
161827214|NCT01386125|584407982|FG001|Overall Study|Disease Progress|2|||
161827215|NCT01386125|584407981|FG000|Overall Study|Withdrawal by Subject|13|||
161827216|NCT01386125|584407982|FG001|Overall Study|Withdrawal by Subject|12|||
161827217|NCT01386125|584407981|FG000|Overall Study|Adverse Event|2|||
161827218|NCT01386125|584407982|FG001|Overall Study|Adverse Event|5|||
161827219|NCT01386125|584407981|FG000|Overall Study|Lack of Efficacy|0|||
161827220|NCT01386125|584407982|FG001|Overall Study|Lack of Efficacy|1|||
161827221|NCT01386125|584407981|FG000|Overall Study|Participant Leaving Country|1|||
161827222|NCT01386125|584407982|FG001|Overall Study|Participant Leaving Country|0|||
161827223|NCT01292837|584407983|FG000|Overall Study|Adverse Event|1|||
161827224|NCT01292837|584407983|FG000|Overall Study|Further treatment determined|1|||
161827225|NCT02661022|584407986|FG000|Overall Study|Withdrawal by Subject|3|||
161827226|NCT02661022|584407987|FG001|Overall Study|Withdrawal by Subject|0|||
161827227|NCT02661022|584407986|FG000|Overall Study|Adverse Event|1|||
161827228|NCT02661022|584407987|FG001|Overall Study|Adverse Event|1|||
161827229|NCT02661022|584407986|FG000|Overall Study|Physician Decision|1|||
161827230|NCT02661022|584407987|FG001|Overall Study|Physician Decision|0|||
161827231|NCT02661022|584407986|FG000|Overall Study|Progressive Disease|2|||
161827232|NCT02661022|584407987|FG001|Overall Study|Progressive Disease|1|||
162213903|NCT01236352|585832818|FG001|Overall Study|Subject to receive drug via EAP|1|||
162213904|NCT01236352|585832819|FG002|Overall Study|Subject to receive drug via EAP|1|||
162213905|NCT01236352|585832820|FG003|Overall Study|Subject to receive drug via EAP|0|||
161827233|NCT02359864|584407988|FG000|Overall Study|Withdrawal by Subject|1|||
161827234|NCT02359864|584407989|FG001|Overall Study|Withdrawal by Subject|0|||
161827235|NCT04480307|584407991|FG000|Overall Study|Withdrawal by Subject|0|||
161827236|NCT04480307|584407992|FG001|Overall Study|Withdrawal by Subject|1|||
161827237|NCT04480307|584407993|FG002|Overall Study|Withdrawal by Subject|0|||
161827238|NCT04480307|584407994|FG003|Overall Study|Withdrawal by Subject|0|||
162213906|NCT01236352|585832821|FG004|Overall Study|Subject to receive drug via EAP|0|||
161678200|NCT01236573|583873625|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161827239|NCT04480307|584407991|FG000|Overall Study|Adverse Event|0|||
161827240|NCT04480307|584407992|FG001|Overall Study|Adverse Event|0|||
161827241|NCT04480307|584407993|FG002|Overall Study|Adverse Event|0|||
161827242|NCT04480307|584407994|FG003|Overall Study|Adverse Event|1|||
162213907|NCT01236352|585832822|FG005|Overall Study|Subject to receive drug via EAP|0|||
162213908|NCT01236352|585832823|FG006|Overall Study|Subject to receive drug via EAP|0|||
162213909|NCT01236352|585832824|FG007|Overall Study|Subject to receive drug via EAP|2|||
162213910|NCT01236352|585832825|FG008|Overall Study|Subject to receive drug via EAP|0|||
162213911|NCT01236352|585832826|FG009|Overall Study|Subject to receive drug via EAP|4|||
162213912|NCT01236352|585832827|FG010|Overall Study|Subject to receive drug via EAP|0|||
162213913|NCT01236352|585832817|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
162213914|NCT01236352|585832818|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
162213915|NCT01236352|585832819|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
162213916|NCT01236352|585832820|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
162213917|NCT01236352|585832821|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
162213918|NCT01236352|585832822|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
162213919|NCT01236352|585832823|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
162213920|NCT01236352|585832824|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
162213921|NCT01236352|585832825|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
162213922|NCT01236352|585832826|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
162213923|NCT01236352|585832827|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
162213924|NCT01236352|585832817|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162213925|NCT01236352|585832818|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162213926|NCT01236352|585832819|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162213927|NCT01236352|585832820|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162213928|NCT01236352|585832821|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162213929|NCT01236352|585832822|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162213930|NCT01236352|585832823|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162213931|NCT01236352|585832824|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162213932|NCT01236352|585832825|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162213933|NCT01236352|585832826|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
162213934|NCT01236352|585832827|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
162213935|NCT01236352|585832817|FG000|Overall Study|Lack of response to drug|0|||
162213936|NCT01236352|585832818|FG001|Overall Study|Lack of response to drug|0|||
162213937|NCT01236352|585832819|FG002|Overall Study|Lack of response to drug|0|||
162213938|NCT01236352|585832820|FG003|Overall Study|Lack of response to drug|0|||
162213939|NCT01236352|585832821|FG004|Overall Study|Lack of response to drug|0|||
162213940|NCT01236352|585832822|FG005|Overall Study|Lack of response to drug|0|||
162213941|NCT01236352|585832823|FG006|Overall Study|Lack of response to drug|0|||
162213942|NCT01236352|585832824|FG007|Overall Study|Lack of response to drug|0|||
162213943|NCT01236352|585832825|FG008|Overall Study|Lack of response to drug|0|||
162213944|NCT01236352|585832826|FG009|Overall Study|Lack of response to drug|1|||
162213945|NCT01236352|585832827|FG010|Overall Study|Lack of response to drug|1|||
162213946|NCT01236352|585832817|FG000|Overall Study|Patient transferred to IST|0|||
162213947|NCT01236352|585832818|FG001|Overall Study|Patient transferred to IST|0|||
162213948|NCT01236352|585832819|FG002|Overall Study|Patient transferred to IST|0|||
162213949|NCT01236352|585832820|FG003|Overall Study|Patient transferred to IST|0|||
162213950|NCT01236352|585832821|FG004|Overall Study|Patient transferred to IST|0|||
162213951|NCT01236352|585832822|FG005|Overall Study|Patient transferred to IST|0|||
162213952|NCT01236352|585832823|FG006|Overall Study|Patient transferred to IST|0|||
161827243|NCT00609154|584407995|FG000|Overall Study|Protocol Violation|1|||
161827244|NCT00609154|584407996|FG001|Overall Study|Protocol Violation|2|||
161827245|NCT00609154|584407995|FG000|Overall Study|Unable to establish IV access|0|||
161827246|NCT00609154|584407996|FG001|Overall Study|Unable to establish IV access|4|||
161827247|NCT00609154|584407995|FG000|Overall Study|Adverse Event|0|||
161827248|NCT00609154|584407996|FG001|Overall Study|Adverse Event|2|||
161827249|NCT00515216|584407997|FG000|Overall Study|Withdrawal by Subject|1|||
161827250|NCT03023137|584408009|FG000|Overall Study|Multiple pregnancy|2|||
161827251|NCT03023137|584408010|FG001|Overall Study|Multiple pregnancy|4|||
161827252|NCT03023137|584408009|FG000|Overall Study|Lost to Follow-up|1|||
161827253|NCT03023137|584408010|FG001|Overall Study|Lost to Follow-up|1|||
161827254|NCT03023137|584408009|FG000|Overall Study|Protocol Violation|0|||
161827255|NCT03023137|584408010|FG001|Overall Study|Protocol Violation|4|||
161827256|NCT03023137|584408009|FG000|Overall Study|Lost the baby in a car accident|1|||
161827257|NCT03023137|584408010|FG001|Overall Study|Lost the baby in a car accident|0|||
161827258|NCT01450800|584408011|FG000|Overall Study|Protocol Violation|1|||
161827259|NCT01450800|584408012|FG001|Overall Study|Protocol Violation|3|||
161827260|NCT02795676|584408016|FG000|Overall Study|Adverse Event|2|||
161827261|NCT02795676|584408017|FG001|Overall Study|Adverse Event|0|||
161827262|NCT02795676|584408016|FG000|Overall Study|Withdrawal by Subject|3|||
161827263|NCT02795676|584408017|FG001|Overall Study|Withdrawal by Subject|1|||
161827264|NCT00732160|584408022|FG000|Overall Study|Adverse Event|1|||
161827265|NCT00732160|584408023|FG001|Overall Study|Adverse Event|0|||
162213953|NCT01236352|585832824|FG007|Overall Study|Patient transferred to IST|0|||
162213954|NCT01236352|585832825|FG008|Overall Study|Patient transferred to IST|0|||
162213955|NCT01236352|585832826|FG009|Overall Study|Patient transferred to IST|2|||
162213956|NCT01236352|585832827|FG010|Overall Study|Patient transferred to IST|6|||
162213957|NCT01575873|585832828|FG000|Overall Study|Withdrawal by Subject|15|||
162213958|NCT01575873|585832829|FG001|Overall Study|Withdrawal by Subject|20|||
162213959|NCT01575873|585832830|FG002|Overall Study|Withdrawal by Subject|34|||
162213960|NCT01575873|585832831|FG003|Overall Study|Withdrawal by Subject|34|||
162213961|NCT01575873|585832828|FG000|Overall Study|Adverse Event|7|||
162213962|NCT01575873|585832829|FG001|Overall Study|Adverse Event|7|||
162213963|NCT01575873|585832830|FG002|Overall Study|Adverse Event|9|||
162213964|NCT01575873|585832831|FG003|Overall Study|Adverse Event|12|||
162213965|NCT01575873|585832828|FG000|Overall Study|Lost to Follow-up|1|||
162213966|NCT01575873|585832829|FG001|Overall Study|Lost to Follow-up|3|||
162213967|NCT01575873|585832830|FG002|Overall Study|Lost to Follow-up|13|||
162213968|NCT01575873|585832831|FG003|Overall Study|Lost to Follow-up|5|||
162213969|NCT01575873|585832828|FG000|Overall Study|Death|3|||
162213970|NCT01575873|585832829|FG001|Overall Study|Death|2|||
162213971|NCT01575873|585832830|FG002|Overall Study|Death|8|||
162213972|NCT01575873|585832831|FG003|Overall Study|Death|9|||
162213973|NCT01575873|585832828|FG000|Overall Study|Noncompliance|1|||
162213974|NCT01575873|585832829|FG001|Overall Study|Noncompliance|2|||
162213975|NCT01575873|585832830|FG002|Overall Study|Noncompliance|4|||
162213976|NCT01575873|585832831|FG003|Overall Study|Noncompliance|3|||
162213977|NCT01575873|585832828|FG000|Overall Study|Administrative decision|1|||
162213978|NCT01575873|585832829|FG001|Overall Study|Administrative decision|1|||
162213979|NCT01575873|585832830|FG002|Overall Study|Administrative decision|1|||
162213980|NCT01575873|585832831|FG003|Overall Study|Administrative decision|0|||
162213981|NCT01575873|585832828|FG000|Overall Study|Protocol deviation|0|||
162213982|NCT01575873|585832829|FG001|Overall Study|Protocol deviation|1|||
162213983|NCT01575873|585832830|FG002|Overall Study|Protocol deviation|0|||
162213984|NCT01575873|585832831|FG003|Overall Study|Protocol deviation|1|||
162213985|NCT01575873|585832828|FG000|Overall Study|Requirement for Alternative Therapy|0|||
162213986|NCT01575873|585832829|FG001|Overall Study|Requirement for Alternative Therapy|0|||
162213987|NCT01575873|585832830|FG002|Overall Study|Requirement for Alternative Therapy|1|||
162213988|NCT01575873|585832831|FG003|Overall Study|Requirement for Alternative Therapy|1|||
162213989|NCT01575873|585832828|FG000|Overall Study|Other|0|||
162213990|NCT01575873|585832829|FG001|Overall Study|Other|0|||
162213991|NCT01575873|585832830|FG002|Overall Study|Other|4|||
162213992|NCT01575873|585832831|FG003|Overall Study|Other|2|||
162213993|NCT01850030|585832832|FG000|Overall Study|Adverse Event|64|||
162213994|NCT01850030|585832833|FG001|Overall Study|Adverse Event|82|||
162213995|NCT01850030|585832832|FG000|Overall Study|Lack of Efficacy|3|||
162213996|NCT01850030|585832833|FG001|Overall Study|Lack of Efficacy|1|||
162213997|NCT01850030|585832832|FG000|Overall Study|Lost to Follow-up|5|||
162213998|NCT01850030|585832833|FG001|Overall Study|Lost to Follow-up|5|||
162213999|NCT01850030|585832832|FG000|Overall Study|Withdrawal by Subject|3|||
162214000|NCT01850030|585832833|FG001|Overall Study|Withdrawal by Subject|4|||
162214001|NCT01850030|585832832|FG000|Overall Study|Protocol Violation|24|||
162214002|NCT01850030|585832833|FG001|Overall Study|Protocol Violation|28|||
162214003|NCT01850030|585832832|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
162214004|NCT01850030|585832833|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
162214005|NCT05903183|585832836|FG000|Main Trial Part (365 Days)|Death|1|||
162214006|NCT05903183|585832837|FG001|Main Trial Part (365 Days)|Death|0|||
162214007|NCT05903183|585832838|FG002|Main Trial Part (365 Days)|Death|0|||
162214008|NCT05903183|585832839|FG003|Main Trial Part (365 Days)|Death|0|||
162214009|NCT05903183|585832840|FG004|Main Trial Part (365 Days)|Death|0|||
162214010|NCT05903183|585832836|FG000|Main Trial Part (365 Days)|Other|1|||
162214011|NCT05903183|585832837|FG001|Main Trial Part (365 Days)|Other|2|||
162214012|NCT05903183|585832838|FG002|Main Trial Part (365 Days)|Other|1|||
162214013|NCT05903183|585832839|FG003|Main Trial Part (365 Days)|Other|0|||
162214014|NCT05903183|585832840|FG004|Main Trial Part (365 Days)|Other|0|||
161935938|NCT06433908|584817520|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
162214015|NCT05903183|585832836|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
162214016|NCT05903183|585832837|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
162214017|NCT05903183|585832838|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
162214018|NCT05903183|585832839|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
162214019|NCT05903183|585832840|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
162214020|NCT05903183|585832836|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
162214021|NCT05903183|585832837|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
162214022|NCT05903183|585832838|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
162214023|NCT05903183|585832839|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
162214024|NCT05903183|585832840|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
162214025|NCT05903183|585832836|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
162214026|NCT05903183|585832837|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
162214027|NCT05903183|585832838|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
162214028|NCT05903183|585832839|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
161827266|NCT00732160|584408024|FG002|Overall Study|Adverse Event|1|||
161827267|NCT00732160|584408025|FG003|Overall Study|Adverse Event|1|||
161827268|NCT00732160|584408022|FG000|Overall Study|scheduling|4|||
161827269|NCT00732160|584408023|FG001|Overall Study|scheduling|4|||
161827270|NCT00732160|584408024|FG002|Overall Study|scheduling|2|||
161827271|NCT00732160|584408025|FG003|Overall Study|scheduling|1|||
161827272|NCT02427399|584408028|FG000|Overall Study|Protocol Violation|14|||
161827273|NCT02427399|584408029|FG001|Overall Study|Protocol Violation|16|||
161827274|NCT02427399|584408030|FG002|Overall Study|Protocol Violation|12|||
161827275|NCT02427399|584408031|FG003|Overall Study|Protocol Violation|18|||
161827276|NCT02427399|584408032|FG004|Overall Study|Protocol Violation|15|||
161827277|NCT01115933|584408033|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
161827278|NCT00605176|584408036|FG000|Overall Study|Adverse Event|2|||
161827279|NCT00605176|584408037|FG001|Overall Study|Adverse Event|1|||
161827280|NCT00605176|584408038|FG002|Overall Study|Adverse Event|3|||
161827281|NCT00605176|584408036|FG000|Overall Study|Withdrawal by Subject|4|||
161827282|NCT00605176|584408037|FG001|Overall Study|Withdrawal by Subject|2|||
162214029|NCT05903183|585832840|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
162214030|NCT02647645|585832841|FG000|Overall Study|Lost to Follow-up|2|||
162214031|NCT02647645|585832842|FG001|Overall Study|Lost to Follow-up|1|||
162214032|NCT04599907|585832845|FG000|Overall Study|Withdrawal by Subject|1|||
162214033|NCT04599907|585832846|FG001|Overall Study|Withdrawal by Subject|7|||
162214034|NCT04599907|585832847|FG002|Overall Study|Withdrawal by Subject|6|||
162214035|NCT04599907|585832845|FG000|Overall Study|Lost to Follow-up|0|||
162214036|NCT04599907|585832846|FG001|Overall Study|Lost to Follow-up|1|||
162214037|NCT04599907|585832847|FG002|Overall Study|Lost to Follow-up|0|||
162214038|NCT03007732|585832848|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
162214039|NCT03007732|585832849|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
162214040|NCT03007732|585832850|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
162214041|NCT03007732|585832851|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
162214042|NCT03371823|585832852|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
162214043|NCT03371823|585832853|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
162214044|NCT01466790|585832855|FG000|Overall Study|Adverse Event|1|||
162214045|NCT01466790|585832856|FG001|Overall Study|Adverse Event|0|||
162214046|NCT01466790|585832857|FG002|Overall Study|Adverse Event|0|||
162214047|NCT01466790|585832858|FG003|Overall Study|Adverse Event|0|||
162214048|NCT01466790|585832859|FG004|Overall Study|Adverse Event|2|||
162214049|NCT01466790|585832860|FG005|Overall Study|Adverse Event|0|||
162214050|NCT01466790|585832861|FG006|Overall Study|Adverse Event|0|||
162214051|NCT01466790|585832862|FG007|Overall Study|Adverse Event|0|||
162214052|NCT01466790|585832855|FG000|Overall Study|Lost to Follow-up|2|||
162214053|NCT01466790|585832856|FG001|Overall Study|Lost to Follow-up|0|||
162214054|NCT01466790|585832857|FG002|Overall Study|Lost to Follow-up|0|||
162214055|NCT01466790|585832858|FG003|Overall Study|Lost to Follow-up|0|||
162214056|NCT01466790|585832859|FG004|Overall Study|Lost to Follow-up|0|||
162214057|NCT01466790|585832860|FG005|Overall Study|Lost to Follow-up|0|||
162214058|NCT01466790|585832861|FG006|Overall Study|Lost to Follow-up|0|||
162214059|NCT01466790|585832862|FG007|Overall Study|Lost to Follow-up|0|||
162214060|NCT01466790|585832855|FG000|Overall Study|Withdrawal by Subject|1|||
162214061|NCT01466790|585832856|FG001|Overall Study|Withdrawal by Subject|1|||
162214062|NCT01466790|585832857|FG002|Overall Study|Withdrawal by Subject|0|||
162214063|NCT01466790|585832858|FG003|Overall Study|Withdrawal by Subject|0|||
162214064|NCT01466790|585832859|FG004|Overall Study|Withdrawal by Subject|1|||
161827283|NCT00605176|584408038|FG002|Overall Study|Withdrawal by Subject|4|||
161935939|NCT06433908|584817517|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
161935940|NCT06433908|584817518|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|1|||
161935941|NCT06433908|584817519|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
161935942|NCT06433908|584817520|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
161935943|NCT06433908|584817517|FG000|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
161935944|NCT06433908|584817518|FG001|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
161935945|NCT06433908|584817519|FG002|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|1|||
161935946|NCT06433908|584817520|FG003|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
162214065|NCT01466790|585832860|FG005|Overall Study|Withdrawal by Subject|0|||
162214066|NCT01466790|585832861|FG006|Overall Study|Withdrawal by Subject|1|||
161827284|NCT00605176|584408036|FG000|Overall Study|Lost to Follow-up|2|||
162214067|NCT01466790|585832862|FG007|Overall Study|Withdrawal by Subject|1|||
162214068|NCT03668223|585832863|FG000|Overall Study|Death|10|||
162214069|NCT03668223|585832864|FG001|Overall Study|Death|5|||
162214070|NCT03668223|585832863|FG000|Overall Study|Lost to Follow-up|12|||
161827285|NCT00605176|584408037|FG001|Overall Study|Lost to Follow-up|2|||
161827286|NCT00605176|584408038|FG002|Overall Study|Lost to Follow-up|1|||
161827287|NCT00605176|584408036|FG000|Overall Study|Non-complicance with study procedures|1|||
161827288|NCT00605176|584408037|FG001|Overall Study|Non-complicance with study procedures|0|||
161935956|NCT04403880|584817524|FG000|Overall Study|Death|1|||
161935957|NCT04403880|584817525|FG001|Overall Study|Death|0|||
161935958|NCT04403880|584817526|FG002|Overall Study|Death|2|||
161935959|NCT04403880|584817527|FG003|Overall Study|Death|0|||
161935960|NCT04403880|584817528|FG004|Overall Study|Death|0|||
161935961|NCT04403880|584817529|FG005|Overall Study|Death|0|||
161935962|NCT04403880|584817530|FG006|Overall Study|Death|0|||
161935963|NCT04403880|584817524|FG000|Overall Study|Physician Decision|0|||
161935964|NCT04403880|584817525|FG001|Overall Study|Physician Decision|0|||
161935965|NCT04403880|584817526|FG002|Overall Study|Physician Decision|0|||
161935966|NCT04403880|584817527|FG003|Overall Study|Physician Decision|0|||
161935967|NCT04403880|584817528|FG004|Overall Study|Physician Decision|1|||
161935968|NCT04403880|584817529|FG005|Overall Study|Physician Decision|0|||
161935969|NCT04403880|584817530|FG006|Overall Study|Physician Decision|0|||
161935970|NCT04403880|584817524|FG000|Overall Study|Lost to Follow-up|4|||
161935971|NCT04403880|584817525|FG001|Overall Study|Lost to Follow-up|3|||
161935972|NCT04403880|584817526|FG002|Overall Study|Lost to Follow-up|8|||
161935973|NCT04403880|584817527|FG003|Overall Study|Lost to Follow-up|7|||
161935974|NCT04403880|584817528|FG004|Overall Study|Lost to Follow-up|8|||
161935975|NCT04403880|584817529|FG005|Overall Study|Lost to Follow-up|1|||
161935976|NCT04403880|584817530|FG006|Overall Study|Lost to Follow-up|8|||
161935977|NCT04403880|584817524|FG000|Overall Study|Withdrawal by Subject|8|||
161935978|NCT04403880|584817525|FG001|Overall Study|Withdrawal by Subject|9|||
161935979|NCT04403880|584817526|FG002|Overall Study|Withdrawal by Subject|22|||
161935980|NCT04403880|584817527|FG003|Overall Study|Withdrawal by Subject|16|||
161935981|NCT04403880|584817528|FG004|Overall Study|Withdrawal by Subject|16|||
161678201|NCT01236573|583873626|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161678202|NCT01236573|583873627|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161678203|NCT01236573|583873628|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161678204|NCT01236573|583873629|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161678205|NCT01236573|583873630|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
161678206|NCT05418673|583873633|FG000|Overall Study|Study Terminated by Sponsor|2|||
161678207|NCT05418673|583873634|FG001|Overall Study|Study Terminated by Sponsor|4|||
161678208|NCT05418673|583873633|FG000|Overall Study|Lost to Follow-up|1|||
161678209|NCT05418673|583873634|FG001|Overall Study|Lost to Follow-up|0|||
161678210|NCT02665052|583873635|FG000|Overall Study|Lost to Follow-up|1|||
161678211|NCT02665052|583873636|FG001|Overall Study|Lost to Follow-up|0|||
161678212|NCT02665052|583873637|FG002|Overall Study|Lost to Follow-up|0|||
161678213|NCT02665052|583873638|FG003|Overall Study|Lost to Follow-up|0|||
161678214|NCT02665052|583873635|FG000|Overall Study|Withdrawal by Subject|1|||
161678215|NCT02665052|583873636|FG001|Overall Study|Withdrawal by Subject|1|||
161678216|NCT02665052|583873637|FG002|Overall Study|Withdrawal by Subject|0|||
161935982|NCT04403880|584817529|FG005|Overall Study|Withdrawal by Subject|8|||
161935983|NCT04403880|584817530|FG006|Overall Study|Withdrawal by Subject|11|||
161935984|NCT04403880|584817524|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
161935985|NCT04403880|584817525|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|5|||
161935986|NCT04403880|584817526|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|12|||
161935987|NCT04403880|584817527|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
161935988|NCT04403880|584817528|FG004|Overall Study|Participant Unable to Adhere to Visit Schedule|8|||
161935989|NCT04403880|584817529|FG005|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
161935990|NCT04403880|584817530|FG006|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
161935991|NCT04403880|584817524|FG000|Overall Study|Participant Unable to Comply with Study Procedure|7|||
161678217|NCT02665052|583873638|FG003|Overall Study|Withdrawal by Subject|5|||
161935992|NCT04403880|584817525|FG001|Overall Study|Participant Unable to Comply with Study Procedure|1|||
161935993|NCT04403880|584817526|FG002|Overall Study|Participant Unable to Comply with Study Procedure|7|||
161935994|NCT04403880|584817527|FG003|Overall Study|Participant Unable to Comply with Study Procedure|9|||
161678218|NCT02665052|583873635|FG000|Overall Study|Adverse Event|1|||
161678219|NCT02665052|583873636|FG001|Overall Study|Adverse Event|1|||
161935995|NCT04403880|584817528|FG004|Overall Study|Participant Unable to Comply with Study Procedure|8|||
162214071|NCT03668223|585832864|FG001|Overall Study|Lost to Follow-up|12|||
161935996|NCT04403880|584817529|FG005|Overall Study|Participant Unable to Comply with Study Procedure|8|||
161935997|NCT04403880|584817530|FG006|Overall Study|Participant Unable to Comply with Study Procedure|19|||
161935998|NCT04403880|584817524|FG000|Overall Study|Pregnancy|2|||
162214072|NCT03668223|585832863|FG000|Overall Study|Withdrawal by Subject|8|||
161678220|NCT02665052|583873637|FG002|Overall Study|Adverse Event|0|||
161678221|NCT02665052|583873638|FG003|Overall Study|Adverse Event|0|||
161678222|NCT00823823|583873639|FG000|Overall Study|Lost to Follow-up|3|||
161935999|NCT04403880|584817525|FG001|Overall Study|Pregnancy|0|||
161936000|NCT04403880|584817526|FG002|Overall Study|Pregnancy|5|||
161936001|NCT04403880|584817527|FG003|Overall Study|Pregnancy|0|||
161936002|NCT04403880|584817528|FG004|Overall Study|Pregnancy|1|||
161936003|NCT04403880|584817529|FG005|Overall Study|Pregnancy|0|||
161936004|NCT04403880|584817530|FG006|Overall Study|Pregnancy|1|||
161936005|NCT04403880|584817524|FG000|Overall Study|Sponsor Decision|2|||
161936006|NCT04403880|584817525|FG001|Overall Study|Sponsor Decision|0|||
161936007|NCT04403880|584817526|FG002|Overall Study|Sponsor Decision|14|||
161936008|NCT04403880|584817527|FG003|Overall Study|Sponsor Decision|1|||
161936009|NCT04403880|584817528|FG004|Overall Study|Sponsor Decision|1|||
161936010|NCT04403880|584817529|FG005|Overall Study|Sponsor Decision|0|||
161936011|NCT04403880|584817530|FG006|Overall Study|Sponsor Decision|2|||
161936012|NCT04403880|584817524|FG000|Overall Study|Other|18|||
162214073|NCT03668223|585832864|FG001|Overall Study|Withdrawal by Subject|3|||
162214074|NCT05502783|585832865|FG000|Overall Study|Lack of Efficacy|1|||
162214075|NCT04870957|585832866|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
161936013|NCT04403880|584817525|FG001|Overall Study|Other|9|||
161936014|NCT04403880|584817526|FG002|Overall Study|Other|14|||
161936015|NCT04403880|584817527|FG003|Overall Study|Other|10|||
161936016|NCT04403880|584817528|FG004|Overall Study|Other|11|||
162214076|NCT04870957|585832867|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
162214077|NCT04870957|585832868|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
162214078|NCT04870957|585832869|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
161936017|NCT04403880|584817529|FG005|Overall Study|Other|12|||
161936018|NCT04403880|584817530|FG006|Overall Study|Other|15|||
162214079|NCT04870957|585832870|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
162214080|NCT04870957|585832871|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
162214081|NCT04870957|585832866|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
162214082|NCT04870957|585832867|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
162214083|NCT04870957|585832868|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
162214084|NCT04870957|585832869|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
162214085|NCT04870957|585832870|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
162214086|NCT04870957|585832871|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
162214087|NCT04870957|585832866|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
162214088|NCT04870957|585832867|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
162214089|NCT04870957|585832868|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
162214090|NCT04870957|585832869|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
162214091|NCT04870957|585832870|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
162214092|NCT04870957|585832871|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
162214093|NCT04870957|585832866|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
162214094|NCT04870957|585832867|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
162214095|NCT04870957|585832868|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
162214096|NCT04870957|585832869|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
162214097|NCT04870957|585832870|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
162214098|NCT04870957|585832871|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
162214099|NCT04870957|585832866|FG000|T2 (Randomization) - T3|Adverse Event|1|||
162214100|NCT04870957|585832867|FG001|T2 (Randomization) - T3|Adverse Event|1|||
162214101|NCT04870957|585832868|FG002|T2 (Randomization) - T3|Adverse Event|0|||
162214102|NCT04870957|585832869|FG003|T2 (Randomization) - T3|Adverse Event|0|||
162214103|NCT04870957|585832870|FG004|T2 (Randomization) - T3|Adverse Event|0|||
162214104|NCT04870957|585832871|FG005|T2 (Randomization) - T3|Adverse Event|0|||
162214105|NCT04870957|585832866|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
162214106|NCT04870957|585832867|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
162214107|NCT04870957|585832868|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
162214108|NCT04870957|585832869|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
162214109|NCT04870957|585832870|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
162214110|NCT04870957|585832871|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
162214111|NCT04870957|585832866|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
162214112|NCT04870957|585832867|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
162214113|NCT04870957|585832868|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
162214114|NCT04870957|585832869|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
161827289|NCT00605176|584408038|FG002|Overall Study|Non-complicance with study procedures|0|||
161827290|NCT00605176|584408036|FG000|Overall Study|Use of concomitant therapy|1|||
161827291|NCT00605176|584408037|FG001|Overall Study|Use of concomitant therapy|0|||
161827292|NCT00605176|584408038|FG002|Overall Study|Use of concomitant therapy|1|||
161827293|NCT00605176|584408036|FG000|Overall Study|Other (not due to AE)|1|||
161827294|NCT00605176|584408037|FG001|Overall Study|Other (not due to AE)|1|||
161827295|NCT00605176|584408038|FG002|Overall Study|Other (not due to AE)|0|||
161827296|NCT01086969|584408039|FG000|Overall Study|Withdrawal by Subject|1|||
162214115|NCT04870957|585832870|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
162214116|NCT04870957|585832871|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
162214117|NCT04870957|585832866|FG000|T2 (Randomization) - T3|Physician Decision|0|||
162214118|NCT04870957|585832867|FG001|T2 (Randomization) - T3|Physician Decision|0|||
162214119|NCT04870957|585832868|FG002|T2 (Randomization) - T3|Physician Decision|2|||
162214120|NCT04870957|585832869|FG003|T2 (Randomization) - T3|Physician Decision|1|||
162214121|NCT04870957|585832870|FG004|T2 (Randomization) - T3|Physician Decision|0|||
162214122|NCT04870957|585832871|FG005|T2 (Randomization) - T3|Physician Decision|0|||
162214123|NCT04870957|585832866|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
162214124|NCT04870957|585832867|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
162214125|NCT04870957|585832868|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
162214126|NCT04870957|585832869|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
162214127|NCT04870957|585832870|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
162214128|NCT04870957|585832871|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
162214129|NCT04870957|585832866|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
162214130|NCT04870957|585832867|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
162214131|NCT04870957|585832868|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
162214132|NCT04870957|585832869|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
162214133|NCT04870957|585832870|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
162214134|NCT04870957|585832871|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
162214135|NCT04870957|585832866|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
162214136|NCT04870957|585832867|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
162214137|NCT04870957|585832868|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
162214138|NCT04870957|585832869|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
162214139|NCT04870957|585832870|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
162214140|NCT04870957|585832871|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
162214141|NCT04870957|585832866|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
162214142|NCT04870957|585832867|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
162214143|NCT04870957|585832868|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
162214144|NCT04870957|585832869|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
162214145|NCT04870957|585832870|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
162214146|NCT04870957|585832871|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
162214147|NCT04870957|585832866|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
162214148|NCT04870957|585832867|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
162214149|NCT04870957|585832868|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
162214150|NCT04870957|585832869|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
162214151|NCT04870957|585832870|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
162214152|NCT04870957|585832871|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
162214153|NCT04870957|585832866|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
162214154|NCT04870957|585832867|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
162214155|NCT04870957|585832868|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
162214156|NCT04870957|585832869|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
162214157|NCT04870957|585832870|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
162214158|NCT04870957|585832871|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
162214159|NCT04870957|585832866|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
162214160|NCT04870957|585832867|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
162214161|NCT04870957|585832868|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
162214162|NCT04870957|585832869|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
162214163|NCT04870957|585832870|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
162214164|NCT04870957|585832871|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
162214165|NCT04870957|585832866|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
162214166|NCT04870957|585832867|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
162214167|NCT04870957|585832868|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
162214168|NCT04870957|585832869|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
162214169|NCT04870957|585832870|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
162214170|NCT04870957|585832871|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
162214171|NCT04870957|585832866|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
162214172|NCT04870957|585832867|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
162214173|NCT04870957|585832868|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
162214174|NCT04870957|585832869|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
162214175|NCT04870957|585832870|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
162214176|NCT04870957|585832871|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
162214177|NCT03733899|585832874|FG000|Period 1|Protocol Violation|0|||
162214178|NCT03733899|585832875|FG001|Period 1|Protocol Violation|0|||
161936055|NCT04138277|584817545|FG000|Pretreatment|Withdrawal by Subject|1|||
161936056|NCT04138277|584817546|FG001|Pretreatment|Withdrawal by Subject|0|||
161936057|NCT04138277|584817545|FG000|Treatment|Adverse Event|6|||
161936058|NCT04138277|584817546|FG001|Treatment|Adverse Event|2|||
161936059|NCT04138277|584817545|FG000|Treatment|Lost to Follow-up|1|||
161936060|NCT04138277|584817546|FG001|Treatment|Lost to Follow-up|0|||
161936061|NCT04138277|584817545|FG000|Treatment|Pregnancy|3|||
161936062|NCT04138277|584817546|FG001|Treatment|Pregnancy|0|||
161936063|NCT04138277|584817545|FG000|Treatment|COVID-19 pandemic|1|||
161936064|NCT04138277|584817546|FG001|Treatment|COVID-19 pandemic|0|||
161936065|NCT04138277|584817545|FG000|Treatment|Withdrawal by Subject|9|||
161936066|NCT04138277|584817546|FG001|Treatment|Withdrawal by Subject|3|||
161936067|NCT04138277|584817545|FG000|Treatment|Sponsor decision|1|||
161936068|NCT04138277|584817546|FG001|Treatment|Sponsor decision|0|||
161936069|NCT04138277|584817545|FG000|Treatment|Physician Decision|1|||
161936070|NCT04138277|584817546|FG001|Treatment|Physician Decision|0|||
161936071|NCT04138277|584817545|FG000|Treatment|Worsening of condition|1|||
161936072|NCT04138277|584817546|FG001|Treatment|Worsening of condition|2|||
161936073|NCT03768414|584817547|FG000|Overall Study|Adverse Event or side effects|72|||
161936074|NCT03768414|584817548|FG001|Overall Study|Adverse Event or side effects|28|||
161936075|NCT03768414|584817547|FG000|Overall Study|Refusal unrelated to adverse event|33|||
161936076|NCT03768414|584817548|FG001|Overall Study|Refusal unrelated to adverse event|33|||
161936077|NCT03768414|584817547|FG000|Overall Study|Progression/relapse|132|||
161936078|NCT03768414|584817548|FG001|Overall Study|Progression/relapse|60|||
161936079|NCT03768414|584817547|FG000|Overall Study|Death|9|||
161936080|NCT03768414|584817548|FG001|Overall Study|Death|6|||
161936081|NCT03768414|584817547|FG000|Overall Study|Other - not protocol specified|45|||
161936082|NCT03768414|584817548|FG001|Overall Study|Other - not protocol specified|18|||
161936083|NCT03768414|584817547|FG000|Overall Study|Reason under review|3|||
161936084|NCT03768414|584817548|FG001|Overall Study|Reason under review|2|||
162021377|NCT00942994|585134763|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162021378|NCT00942994|585134764|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162214179|NCT03733899|585832876|FG002|Period 1|Protocol Violation|0|||
162214180|NCT03733899|585832877|FG003|Period 1|Protocol Violation|0|||
162214181|NCT03733899|585832878|FG004|Period 1|Protocol Violation|0|||
162214182|NCT03733899|585832879|FG005|Period 1|Protocol Violation|1|||
162214183|NCT03733899|585832874|FG000|Period 2|Unscuccessful Treatment|0|||
162214184|NCT03733899|585832875|FG001|Period 2|Unscuccessful Treatment|1|||
162214185|NCT03733899|585832876|FG002|Period 2|Unscuccessful Treatment|0|||
162214186|NCT03733899|585832877|FG003|Period 2|Unscuccessful Treatment|0|||
162214187|NCT03733899|585832878|FG004|Period 2|Unscuccessful Treatment|0|||
162214188|NCT03733899|585832879|FG005|Period 2|Unscuccessful Treatment|0|||
162214189|NCT03733899|585832874|FG000|Period 3|Withdrawal by Subject|1|||
162214190|NCT03733899|585832875|FG001|Period 3|Withdrawal by Subject|0|||
162214191|NCT03733899|585832876|FG002|Period 3|Withdrawal by Subject|0|||
162214192|NCT03733899|585832877|FG003|Period 3|Withdrawal by Subject|0|||
162214193|NCT03733899|585832878|FG004|Period 3|Withdrawal by Subject|0|||
162214194|NCT03733899|585832879|FG005|Period 3|Withdrawal by Subject|0|||
162214195|NCT02859064|585834597|FG000|Overall Study|Progressive Disease|3|||
162214196|NCT02859064|585834597|FG000|Overall Study|Physician Decision|1|||
162214197|NCT02859064|585834597|FG000|Overall Study|Withdrawal by Subject|1|||
162214198|NCT02859064|585834597|FG000|Overall Study|Death|1|||
162214199|NCT00667459|585834601|FG000|Overall Study|Death|0|||
162214200|NCT00667459|585834602|FG001|Overall Study|Death|2|||
162214201|NCT00667459|585834601|FG000|Overall Study|Lost to Follow-up|8|||
162214202|NCT00667459|585834602|FG001|Overall Study|Lost to Follow-up|43|||
162214203|NCT02568397|585834603|FG000|Period 2|Withdrawal by Subject|0|||
162214204|NCT02568397|585834604|FG001|Period 2|Withdrawal by Subject|1|||
162214205|NCT02568397|585834603|FG000|Period 2|Physician Decision|0|||
162214206|NCT02568397|585834604|FG001|Period 2|Physician Decision|1|||
162214207|NCT00078377|585834605|FG000|Overall Study|Adverse Event|2|||
162214208|NCT00078377|585834606|FG001|Overall Study|Adverse Event|5|||
162214209|NCT00078377|585834607|FG002|Overall Study|Adverse Event|1|||
162214210|NCT00078377|585834605|FG000|Overall Study|Lack of Efficacy|2|||
162214211|NCT00078377|585834606|FG001|Overall Study|Lack of Efficacy|0|||
162214212|NCT00078377|585834607|FG002|Overall Study|Lack of Efficacy|2|||
162214213|NCT00078377|585834605|FG000|Overall Study|Lost to Follow-up|0|||
162214214|NCT00078377|585834606|FG001|Overall Study|Lost to Follow-up|1|||
162214215|NCT00078377|585834607|FG002|Overall Study|Lost to Follow-up|1|||
162214216|NCT00078377|585834605|FG000|Overall Study|Physician Decision|2|||
162214217|NCT00078377|585834606|FG001|Overall Study|Physician Decision|0|||
162214218|NCT00078377|585834607|FG002|Overall Study|Physician Decision|0|||
162214219|NCT00078377|585834605|FG000|Overall Study|Withdrawal by Subject|3|||
162214220|NCT00078377|585834606|FG001|Overall Study|Withdrawal by Subject|4|||
162214221|NCT00078377|585834607|FG002|Overall Study|Withdrawal by Subject|4|||
162214222|NCT00078377|585834605|FG000|Overall Study|Miscellaneous|2|||
162214223|NCT00078377|585834606|FG001|Overall Study|Miscellaneous|6|||
162214224|NCT00078377|585834607|FG002|Overall Study|Miscellaneous|1|||
162214225|NCT00581893|585834608|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
162214226|NCT00581893|585834609|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
162214227|NCT01381575|585834610|FG000|Overall Study|Serious Adverse Event|1|||
162214228|NCT01381575|585834611|FG001|Overall Study|Serious Adverse Event|0|||
162214229|NCT01381575|585834612|FG002|Overall Study|Serious Adverse Event|0|||
162214230|NCT01381575|585834610|FG000|Overall Study|Non-Serious Adverse Event|0|||
162214231|NCT01381575|585834611|FG001|Overall Study|Non-Serious Adverse Event|0|||
162214232|NCT01381575|585834612|FG002|Overall Study|Non-Serious Adverse Event|1|||
162214233|NCT01381575|585834610|FG000|Overall Study|Protocol Violation|0|||
162214234|NCT01381575|585834611|FG001|Overall Study|Protocol Violation|1|||
162214235|NCT01381575|585834612|FG002|Overall Study|Protocol Violation|1|||
162214236|NCT01381575|585834610|FG000|Overall Study|Withdrawal by Subject|15|||
162214237|NCT01381575|585834611|FG001|Overall Study|Withdrawal by Subject|9|||
162214238|NCT01381575|585834612|FG002|Overall Study|Withdrawal by Subject|7|||
162214239|NCT01381575|585834610|FG000|Overall Study|Migrated/moved from study area|2|||
162214240|NCT01381575|585834611|FG001|Overall Study|Migrated/moved from study area|12|||
162214241|NCT01381575|585834612|FG002|Overall Study|Migrated/moved from study area|2|||
162214242|NCT01381575|585834610|FG000|Overall Study|Lost to Follow-up|8|||
162214243|NCT01381575|585834611|FG001|Overall Study|Lost to Follow-up|17|||
162214244|NCT01381575|585834612|FG002|Overall Study|Lost to Follow-up|9|||
162214245|NCT03020069|585834613|FG000|Overall Study|Lost to Follow-up|0|||
162214246|NCT03020069|585834614|FG001|Overall Study|Lost to Follow-up|1|||
162214247|NCT01920932|585834615|FG000|Overall Study|Death|1|||
162214248|NCT01920932|585834615|FG000|Overall Study|Withdrawal of consent|1|||
162214249|NCT04486313|585834618|FG000|Overall Study|Lost to Follow-up|7|||
162214250|NCT04486313|585834619|FG001|Overall Study|Lost to Follow-up|9|||
162214251|NCT04486313|585834618|FG000|Overall Study|Withdrawal by Subject|8|||
162214252|NCT04486313|585834619|FG001|Overall Study|Withdrawal by Subject|6|||
162214253|NCT04486313|585834618|FG000|Overall Study|Physician Decision|1|||
162214254|NCT04486313|585834619|FG001|Overall Study|Physician Decision|1|||
162214255|NCT04486313|585834618|FG000|Overall Study|Death|2|||
162214256|NCT04486313|585834619|FG001|Overall Study|Death|0|||
162214257|NCT04486313|585834618|FG000|Overall Study|Protocol Violation|1|||
162214258|NCT04486313|585834619|FG001|Overall Study|Protocol Violation|1|||
162214259|NCT01375751|585834627|FG000|Overall Study|Other|0|||
162214260|NCT01375751|585834628|FG001|Overall Study|Other|1|||
162214261|NCT01375751|585834629|FG002|Overall Study|Other|0|||
162214262|NCT00940875|585834630|FG000|Treatment Phase|Adverse Event|9|||
162214263|NCT00940875|585834631|FG001|Treatment Phase|Adverse Event|3|||
162214264|NCT00940875|585834630|FG000|Treatment Phase|Death|3|||
162214265|NCT00940875|585834631|FG001|Treatment Phase|Death|5|||
162214266|NCT00940875|585834630|FG000|Treatment Phase|Lack of Efficacy|1|||
162214267|NCT00940875|585834631|FG001|Treatment Phase|Lack of Efficacy|0|||
162214268|NCT00940875|585834630|FG000|Treatment Phase|Withdrawal by Subject|3|||
162214269|NCT00940875|585834631|FG001|Treatment Phase|Withdrawal by Subject|0|||
162214270|NCT00940875|585834630|FG000|Treatment Phase|Disease progression|9|||
162214271|NCT00940875|585834631|FG001|Treatment Phase|Disease progression|11|||
162214272|NCT00940875|585834630|FG000|Treatment Phase|Physician Decision|1|||
162214273|NCT00940875|585834631|FG001|Treatment Phase|Physician Decision|0|||
162214274|NCT00940875|585834630|FG000|Post-Study Treatment|Death|0|||
162214275|NCT00940875|585834631|FG001|Post-Study Treatment|Death|1|||
162214276|NCT00940875|585834630|FG000|Post-Study Treatment|Disease Progression|0|||
162214277|NCT00940875|585834631|FG001|Post-Study Treatment|Disease Progression|2|||
162214278|NCT00943787|585834632|FG000|Overall Study|Physician Decision|4|||
162214279|NCT00943787|585834632|FG000|Overall Study|Withdrawal by Subject|3|||
162214280|NCT01547598|585834633|FG000|Overall Study|Withdrew consent|1|||
162214281|NCT01547598|585834634|FG001|Overall Study|Withdrew consent|1|||
162214282|NCT01547598|585834633|FG000|Overall Study|Lost to Follow-up|1|||
162214283|NCT01547598|585834634|FG001|Overall Study|Lost to Follow-up|1|||
162214284|NCT01547598|585834633|FG000|Overall Study|Adverse Event|1|||
162214285|NCT01547598|585834634|FG001|Overall Study|Adverse Event|1|||
162214286|NCT01547598|585834633|FG000|Overall Study|Protocol Violation|1|||
162214287|NCT01547598|585834634|FG001|Overall Study|Protocol Violation|1|||
162214288|NCT01547598|585834633|FG000|Overall Study|Other Miscellaneous Reasons|2|||
162214289|NCT01547598|585834634|FG001|Overall Study|Other Miscellaneous Reasons|1|||
162214290|NCT00872001|585834636|FG000|Overall Study|Adverse Event|34|||
162214291|NCT00872001|585834637|FG001|Overall Study|Adverse Event|23|||
162214292|NCT00872001|585834636|FG000|Overall Study|Protocol Defined Clinical Event|5|||
162214293|NCT00872001|585834637|FG001|Overall Study|Protocol Defined Clinical Event|7|||
162214294|NCT00872001|585834636|FG000|Overall Study|Lost to Follow-up|13|||
162214295|NCT00872001|585834637|FG001|Overall Study|Lost to Follow-up|12|||
162214296|NCT00872001|585834636|FG000|Overall Study|Withdrawal by Subject|18|||
162214297|NCT00872001|585834637|FG001|Overall Study|Withdrawal by Subject|30|||
162214298|NCT00872001|585834636|FG000|Overall Study|Protocol Violation|5|||
162214299|NCT00872001|585834637|FG001|Overall Study|Protocol Violation|8|||
162214300|NCT00872001|585834636|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
162214301|NCT00872001|585834637|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
162214302|NCT00872001|585834636|FG000|Overall Study|Administrative|23|||
162214303|NCT00872001|585834637|FG001|Overall Study|Administrative|15|||
162214304|NCT04071301|585834638|FG000|Overall Study|Withdrawal by Subject|6|||
162214305|NCT04071301|585834638|FG000|Overall Study|Death|1|||
162214306|NCT02879383|585834639|FG000|First 24 Weeks|Physician Decision|0|||
162214307|NCT02879383|585834640|FG001|First 24 Weeks|Physician Decision|1|||
162214308|NCT02879383|585834641|FG002|First 24 Weeks|Physician Decision|0|||
162214309|NCT02879383|585834642|FG003|First 24 Weeks|Physician Decision|0|||
162214310|NCT05186311|585834643|FG000|Part A: Serum|Withdrawal by Subject|1|||
162214311|NCT02125279|585834644|FG000|Overall Study|Lack of Efficacy|2|||
162214312|NCT02125279|585834644|FG000|Overall Study|Withdrawal by Subject|6|||
161936174|NCT03019406|584817580|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
161936175|NCT03019406|584817581|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
162214313|NCT02125279|585834644|FG000|Overall Study|Protocol Violation|1|||
162214314|NCT02125279|585834644|FG000|Overall Study|Lost to Follow-up|4|||
162214315|NCT01607879|585834649|FG000|Overall Study|Death|1|||
162214316|NCT01607879|585834650|FG001|Overall Study|Death|0|||
161936176|NCT03019406|584817582|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
162214317|NCT00825305|585834665|FG000|Overall Study|Adverse Event|1|||
162214318|NCT00825305|585834666|FG001|Overall Study|Adverse Event|1|||
162214319|NCT00825305|585834665|FG000|Overall Study|Withdrawal by Subject|6|||
162214320|NCT00825305|585834666|FG001|Overall Study|Withdrawal by Subject|12|||
162214321|NCT00825305|585834665|FG000|Overall Study|Inappropriate inclusion|1|||
162214322|NCT00825305|585834666|FG001|Overall Study|Inappropriate inclusion|0|||
162214323|NCT00825305|585834665|FG000|Overall Study|Protocol Violation|9|||
162214324|NCT00825305|585834666|FG001|Overall Study|Protocol Violation|9|||
162214325|NCT00825305|585834665|FG000|Overall Study|Can not be classified|0|||
161936177|NCT03019406|584817583|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
162214326|NCT00825305|585834666|FG001|Overall Study|Can not be classified|1|||
162214327|NCT04016272|585834667|FG000|Overall Study|Withdrawal by Subject|1|||
162214328|NCT04016272|585834668|FG001|Overall Study|Withdrawal by Subject|2|||
162214329|NCT00246090|585834673|FG000|Overall Study|Adverse Event|25|||
162214330|NCT00246090|585834673|FG000|Overall Study|Withdrawal by Subject|7|||
162214331|NCT00246090|585834673|FG000|Overall Study|Progressive Disease|212|||
162214332|NCT00246090|585834673|FG000|Overall Study|Clinical Progression|30|||
162214333|NCT00246090|585834673|FG000|Overall Study|Physician Decision|11|||
162214334|NCT00246090|585834673|FG000|Overall Study|Not Otherwise Specified|10|||
162214335|NCT03332784|585834676|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214336|NCT03332784|585834677|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
162214337|NCT03332784|585834678|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214338|NCT03332784|585834679|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214339|NCT03332784|585834680|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214340|NCT03332784|585834681|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214341|NCT03332784|585834682|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214342|NCT03332784|585834683|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214343|NCT03332784|585834684|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214344|NCT03332784|585834685|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214345|NCT03332784|585834686|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214346|NCT03332784|585834687|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214347|NCT03332784|585834688|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214348|NCT03332784|585834689|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214349|NCT03332784|585834690|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
162214350|NCT03332784|585834691|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214351|NCT03332784|585834692|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214352|NCT03332784|585834693|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214353|NCT03332784|585834694|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214354|NCT03332784|585834695|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
162214355|NCT00763451|585834701|FG000|Overall Study|Adverse Event|4|||
162214356|NCT00763451|585834702|FG001|Overall Study|Adverse Event|6|||
162214357|NCT00763451|585834703|FG002|Overall Study|Adverse Event|19|||
162214358|NCT00763451|585834704|FG003|Overall Study|Adverse Event|14|||
162214359|NCT00763451|585834701|FG000|Overall Study|Lack of Efficacy|1|||
162214360|NCT00763451|585834702|FG001|Overall Study|Lack of Efficacy|4|||
162214361|NCT00763451|585834703|FG002|Overall Study|Lack of Efficacy|3|||
162214362|NCT00763451|585834704|FG003|Overall Study|Lack of Efficacy|2|||
162214363|NCT00763451|585834701|FG000|Overall Study|Withdrawal by Subject|1|||
162214364|NCT00763451|585834702|FG001|Overall Study|Withdrawal by Subject|6|||
162214365|NCT00763451|585834703|FG002|Overall Study|Withdrawal by Subject|9|||
162214366|NCT00763451|585834704|FG003|Overall Study|Withdrawal by Subject|7|||
162214367|NCT00763451|585834701|FG000|Overall Study|Protocol Violation|0|||
162214368|NCT00763451|585834702|FG001|Overall Study|Protocol Violation|0|||
162214369|NCT00763451|585834703|FG002|Overall Study|Protocol Violation|1|||
162214370|NCT00763451|585834704|FG003|Overall Study|Protocol Violation|0|||
162214371|NCT00763451|585834701|FG000|Overall Study|Poor Compliance to Protocol|1|||
162214372|NCT00763451|585834702|FG001|Overall Study|Poor Compliance to Protocol|1|||
162214373|NCT00763451|585834703|FG002|Overall Study|Poor Compliance to Protocol|2|||
162214374|NCT00763451|585834704|FG003|Overall Study|Poor Compliance to Protocol|2|||
162214375|NCT00763451|585834701|FG000|Overall Study|Familial and Personal Reasons|5|||
162214376|NCT00763451|585834702|FG001|Overall Study|Familial and Personal Reasons|3|||
162214377|NCT00763451|585834703|FG002|Overall Study|Familial and Personal Reasons|5|||
162214378|NCT00763451|585834704|FG003|Overall Study|Familial and Personal Reasons|4|||
162214379|NCT00763451|585834701|FG000|Overall Study|Randomized but not Treated|1|||
162214380|NCT00763451|585834702|FG001|Overall Study|Randomized but not Treated|1|||
162214381|NCT00763451|585834703|FG002|Overall Study|Randomized but not Treated|0|||
162214382|NCT00763451|585834704|FG003|Overall Study|Randomized but not Treated|0|||
162214383|NCT00763451|585834701|FG000|Overall Study|Study Site Reason|0|||
162214384|NCT00763451|585834702|FG001|Overall Study|Study Site Reason|1|||
162214385|NCT00763451|585834703|FG002|Overall Study|Study Site Reason|1|||
162214386|NCT00763451|585834704|FG003|Overall Study|Study Site Reason|1|||
162214387|NCT02282917|585834708|FG000|Overall Study|Withdrawal by Subject|1|||
162214388|NCT02282917|585834708|FG000|Overall Study|Screen Failure/Not Eligible|1|||
162214389|NCT00115336|585834709|FG000|Overall Study|Hospital discharge before study drug|0|||
162214390|NCT00115336|585834710|FG001|Overall Study|Hospital discharge before study drug|1|||
162214391|NCT03149029|585834719|FG000|Overall Study|Adverse Event|2|||
162214392|NCT03149029|585834720|FG001|Overall Study|Adverse Event|0|||
162214393|NCT03735121|585834721|FG000|Overall Study|Death|3|||
162214394|NCT03735121|585834722|FG001|Overall Study|Death|6|||
162214395|NCT03735121|585834723|FG002|Overall Study|Death|19|||
162214396|NCT03735121|585834724|FG003|Overall Study|Death|97|||
162214397|NCT03735121|585834725|FG004|Overall Study|Death|205|||
162214398|NCT03735121|585834721|FG000|Overall Study|Lost to Follow-up|0|||
162214399|NCT03735121|585834722|FG001|Overall Study|Lost to Follow-up|0|||
162214400|NCT03735121|585834723|FG002|Overall Study|Lost to Follow-up|0|||
162214401|NCT03735121|585834724|FG003|Overall Study|Lost to Follow-up|2|||
162214402|NCT03735121|585834725|FG004|Overall Study|Lost to Follow-up|3|||
162214403|NCT03735121|585834721|FG000|Overall Study|New Therapy|0|||
162214404|NCT03735121|585834722|FG001|Overall Study|New Therapy|1|||
162214405|NCT03735121|585834723|FG002|Overall Study|New Therapy|0|||
162214406|NCT03735121|585834724|FG003|Overall Study|New Therapy|0|||
162214407|NCT03735121|585834725|FG004|Overall Study|New Therapy|0|||
162214408|NCT03735121|585834721|FG000|Overall Study|Study Ended by Sponsor|1|||
162214409|NCT03735121|585834722|FG001|Overall Study|Study Ended by Sponsor|0|||
162214410|NCT03735121|585834723|FG002|Overall Study|Study Ended by Sponsor|1|||
162214411|NCT03735121|585834724|FG003|Overall Study|Study Ended by Sponsor|17|||
162214412|NCT03735121|585834725|FG004|Overall Study|Study Ended by Sponsor|28|||
162214413|NCT03735121|585834721|FG000|Overall Study|Withdrawal by Subject|1|||
162214414|NCT03735121|585834722|FG001|Overall Study|Withdrawal by Subject|1|||
162214415|NCT03735121|585834723|FG002|Overall Study|Withdrawal by Subject|6|||
162214416|NCT03735121|585834724|FG003|Overall Study|Withdrawal by Subject|8|||
162214417|NCT03735121|585834725|FG004|Overall Study|Withdrawal by Subject|11|||
162214418|NCT02176863|585834726|FG000|Overall Study|Physician Decision|1|||
162214419|NCT02176863|585834727|FG001|Overall Study|Physician Decision|0|||
162214420|NCT02176863|585834728|FG002|Overall Study|Physician Decision|0|||
162214421|NCT02176863|585834729|FG003|Overall Study|Physician Decision|0|||
162214422|NCT02176863|585834730|FG004|Overall Study|Physician Decision|0|||
162214423|NCT02176863|585834726|FG000|Overall Study|Adverse Event|10|||
162214424|NCT02176863|585834727|FG001|Overall Study|Adverse Event|4|||
162214425|NCT02176863|585834728|FG002|Overall Study|Adverse Event|4|||
162214426|NCT02176863|585834729|FG003|Overall Study|Adverse Event|1|||
162214427|NCT02176863|585834730|FG004|Overall Study|Adverse Event|1|||
162214428|NCT02176863|585834726|FG000|Overall Study|Protocol Violation|2|||
162214429|NCT02176863|585834727|FG001|Overall Study|Protocol Violation|0|||
162214430|NCT02176863|585834728|FG002|Overall Study|Protocol Violation|1|||
162214431|NCT02176863|585834729|FG003|Overall Study|Protocol Violation|1|||
162214432|NCT02176863|585834730|FG004|Overall Study|Protocol Violation|0|||
162214433|NCT02176863|585834726|FG000|Overall Study|Withdrawal by Subject|4|||
162214434|NCT02176863|585834727|FG001|Overall Study|Withdrawal by Subject|2|||
162214435|NCT02176863|585834728|FG002|Overall Study|Withdrawal by Subject|2|||
162214436|NCT02176863|585834729|FG003|Overall Study|Withdrawal by Subject|3|||
162214437|NCT02176863|585834730|FG004|Overall Study|Withdrawal by Subject|4|||
162214438|NCT02176863|585834726|FG000|Overall Study|Reason not specified|0|||
162214439|NCT02176863|585834727|FG001|Overall Study|Reason not specified|1|||
162214440|NCT02176863|585834728|FG002|Overall Study|Reason not specified|1|||
162214441|NCT02176863|585834729|FG003|Overall Study|Reason not specified|2|||
162214442|NCT02176863|585834730|FG004|Overall Study|Reason not specified|1|||
162214443|NCT02176863|585834726|FG000|Overall Study|Lost to Follow-up|0|||
162214444|NCT02176863|585834727|FG001|Overall Study|Lost to Follow-up|1|||
162214445|NCT02176863|585834728|FG002|Overall Study|Lost to Follow-up|1|||
162214446|NCT02176863|585834729|FG003|Overall Study|Lost to Follow-up|0|||
162214447|NCT02176863|585834730|FG004|Overall Study|Lost to Follow-up|0|||
162214448|NCT02037256|585834731|FG000|Overall Study|Protocol Violation|0|||
162214449|NCT02037256|585834732|FG001|Overall Study|Protocol Violation|1|||
162214450|NCT02037256|585834731|FG000|Overall Study|Withdrawn prior to Velcade|0|||
162214451|NCT02037256|585834732|FG001|Overall Study|Withdrawn prior to Velcade|2|||
162214452|NCT00356811|585834735|FG000|Overall Study|Death|35|||
162214453|NCT00356811|585834735|FG000|Overall Study|Lost to Follow-up|2|||
162214454|NCT00356811|585834735|FG000|Overall Study|Withdrawal by Subject|6|||
162214455|NCT00356811|585834735|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
162214456|NCT00356811|585834735|FG000|Overall Study|Study Is Terminating|3|||
162214457|NCT00356811|585834735|FG000|Overall Study|Site Closed during Follow-up|2|||
162214458|NCT01310699|585834736|FG000|Overall Study|Patients did not complete tandem.|4|||
162214459|NCT01310699|585834737|FG001|Overall Study|Patients did not complete tandem.|6|||
162214460|NCT02386839|585834738|FG000|Overall Study|Death|1|||
162214461|NCT02386839|585834739|FG001|Overall Study|Death|0|||
162214462|NCT02386839|585834738|FG000|Overall Study|Withdrawal by Subject|9|||
162214463|NCT02386839|585834739|FG001|Overall Study|Withdrawal by Subject|10|||
162214464|NCT02386839|585834738|FG000|Overall Study|Lost to Follow-up|4|||
162214465|NCT02386839|585834739|FG001|Overall Study|Lost to Follow-up|4|||
162214466|NCT02386839|585834738|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
162214467|NCT02386839|585834739|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
162214468|NCT02386839|585834738|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
162214469|NCT02386839|585834739|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
162214470|NCT02386839|585834738|FG000|Overall Study|Other (unspecified)|1|||
162214471|NCT02386839|585834739|FG001|Overall Study|Other (unspecified)|0|||
162214472|NCT00926575|585834740|FG000|Overall Study|Adverse Event|1|||
162214473|NCT00926575|585834741|FG001|Overall Study|Adverse Event|1|||
162214474|NCT00926575|585834740|FG000|Overall Study|Death|4|||
162214475|NCT00926575|585834741|FG001|Overall Study|Death|4|||
162214476|NCT00926575|585834740|FG000|Overall Study|Lost to Follow-up|1|||
162214477|NCT00926575|585834741|FG001|Overall Study|Lost to Follow-up|1|||
162214478|NCT00926575|585834740|FG000|Overall Study|Physician Decision|1|||
162214479|NCT00926575|585834741|FG001|Overall Study|Physician Decision|2|||
162214480|NCT00926575|585834740|FG000|Overall Study|Protocol Violation|1|||
162214481|NCT00926575|585834741|FG001|Overall Study|Protocol Violation|0|||
162214482|NCT00926575|585834740|FG000|Overall Study|Withdrawal by Subject|8|||
162214483|NCT00926575|585834741|FG001|Overall Study|Withdrawal by Subject|9|||
162214484|NCT00490698|585834742|FG000|Overall Study|Withdrawal by Subject|1|||
162214485|NCT00490698|585834742|FG000|Overall Study|Disease Progression|7|||
162214486|NCT00490698|585834742|FG000|Overall Study|Physician Decision|2|||
162214487|NCT02101983|585834743|FG000|Overall Study|Physician Decision|1|||
162214488|NCT02101983|585834744|FG001|Overall Study|Physician Decision|0|||
162214489|NCT03725605|585834749|FG000|Overall Study|Unsuccessful TIL expansion|2|||
162214490|NCT04124471|585834750|FG000|Overall Study|screen failure|1|||
162214491|NCT01503086|585834751|FG000|Overall Study|Lost to Follow-up|0|||
162214492|NCT01503086|585834752|FG001|Overall Study|Lost to Follow-up|1|||
162214493|NCT01503086|585834753|FG002|Overall Study|Lost to Follow-up|0|||
162214494|NCT01503086|585834751|FG000|Overall Study|Did Not Start Treatment|4|||
162214495|NCT01503086|585834752|FG001|Overall Study|Did Not Start Treatment|3|||
162214496|NCT01503086|585834753|FG002|Overall Study|Did Not Start Treatment|3|||
162214497|NCT01503086|585834751|FG000|Overall Study|Progressive disease|3|||
162214498|NCT01503086|585834752|FG001|Overall Study|Progressive disease|1|||
162214499|NCT01503086|585834753|FG002|Overall Study|Progressive disease|0|||
162214500|NCT01503086|585834751|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
162214501|NCT01503086|585834752|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
162214502|NCT01503086|585834753|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
162214503|NCT01503086|585834751|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
162214504|NCT01503086|585834752|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
162214505|NCT01503086|585834753|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
162214506|NCT05970640|585834756|FG000|Overall Study|Adverse Event|1|||
162214507|NCT05970640|585834757|FG001|Overall Study|Adverse Event|3|||
162214508|NCT05970640|585834758|FG002|Overall Study|Adverse Event|1|||
162214509|NCT05970640|585834759|FG003|Overall Study|Adverse Event|0|||
162214510|NCT05970640|585834756|FG000|Overall Study|Withdrawal by Subject|0|||
162214511|NCT05970640|585834757|FG001|Overall Study|Withdrawal by Subject|0|||
162214512|NCT05970640|585834758|FG002|Overall Study|Withdrawal by Subject|1|||
162214513|NCT05970640|585834759|FG003|Overall Study|Withdrawal by Subject|1|||
162214514|NCT05970640|585834756|FG000|Overall Study|Sponsor decision|0|||
162214515|NCT05970640|585834757|FG001|Overall Study|Sponsor decision|0|||
162214516|NCT05970640|585834758|FG002|Overall Study|Sponsor decision|1|||
162214517|NCT05970640|585834759|FG003|Overall Study|Sponsor decision|1|||
162214518|NCT02394925|585834760|FG000|Overall Study|Adverse Event|1|||
162214519|NCT02394925|585834760|FG000|Overall Study|Lens Discomfort|3|||
162214520|NCT02394925|585834760|FG000|Overall Study|Lens handling difficulities|5|||
162214521|NCT02394925|585834760|FG000|Overall Study|Lost to Follow-up|9|||
162214522|NCT02394925|585834760|FG000|Overall Study|Protocol Violation|5|||
162214523|NCT02394925|585834760|FG000|Overall Study|No longer meet eligibility criteria|1|||
162214524|NCT02394925|585834760|FG000|Overall Study|Unsatisfactory Visual Response|5|||
162214525|NCT04650698|585836108|FG000|Overall Study|Protocol Violation|2|||
162214526|NCT04650698|585836109|FG001|Overall Study|Protocol Violation|1|||
162214527|NCT04650698|585836108|FG000|Overall Study|Withdrawal by Subject|0|||
162214528|NCT04650698|585836109|FG001|Overall Study|Withdrawal by Subject|1|||
162214529|NCT02358668|585836110|FG000|Overall Study|Adverse Event|2|||
162214530|NCT02358668|585836111|FG001|Overall Study|Adverse Event|0|||
162214531|NCT02358668|585836112|FG002|Overall Study|Adverse Event|0|||
162214532|NCT02358668|585836110|FG000|Overall Study|Withdrawal by Subject|0|||
162214533|NCT02358668|585836111|FG001|Overall Study|Withdrawal by Subject|1|||
162214534|NCT02358668|585836112|FG002|Overall Study|Withdrawal by Subject|0|||
162214535|NCT02104505|585836113|FG000|First Intervention (14 Days)|Adverse Event|2|||
162214536|NCT02104505|585836114|FG001|First Intervention (14 Days)|Adverse Event|0|||
162214537|NCT02104505|585836113|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
162214538|NCT02104505|585836114|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
161827297|NCT01086969|584408040|FG001|Overall Study|Withdrawal by Subject|2|||
161827298|NCT01086969|584408041|FG002|Overall Study|Withdrawal by Subject|0|||
161827299|NCT01609582|584408046|FG000|Overall Study|Adverse Event|20|||
161827300|NCT01609582|584408047|FG001|Overall Study|Adverse Event|18|||
162214539|NCT02104505|585836113|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
162214540|NCT02104505|585836114|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
162214541|NCT02104505|585836113|FG000|First Intervention (14 Days)|exclusionary condition|0|||
162214542|NCT02104505|585836114|FG001|First Intervention (14 Days)|exclusionary condition|1|||
162214543|NCT02104505|585836113|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
162214544|NCT02104505|585836114|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
162214545|NCT02104505|585836113|FG000|Second Intervention (14 Days)|Adverse Event|2|||
162214546|NCT02104505|585836114|FG001|Second Intervention (14 Days)|Adverse Event|0|||
162214547|NCT01730950|585836117|FG000|Overall Study|Protocol Violation|6|||
162214548|NCT01730950|585836118|FG001|Overall Study|Protocol Violation|6|||
161936187|NCT02556736|584817590|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
161936188|NCT02556736|584817591|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
161936189|NCT02556736|584817592|FG002|Open Label Treatment Period|Withdrawal by Subject|1|||
161936190|NCT02556736|584817593|FG003|Open Label Treatment Period|Withdrawal by Subject|1|||
161936191|NCT02556736|584817590|FG000|Open Label Treatment Period|Adverse Event|0|||
161936192|NCT02556736|584817591|FG001|Open Label Treatment Period|Adverse Event|0|||
161936193|NCT02556736|584817592|FG002|Open Label Treatment Period|Adverse Event|0|||
161936194|NCT02556736|584817593|FG003|Open Label Treatment Period|Adverse Event|1|||
161936195|NCT02556736|584817590|FG000|Long-Term Follow-up|Lost to Follow-up|1|||
161936196|NCT02556736|584817591|FG001|Long-Term Follow-up|Lost to Follow-up|0|||
161936197|NCT02556736|584817592|FG002|Long-Term Follow-up|Lost to Follow-up|0|||
161936198|NCT02556736|584817593|FG003|Long-Term Follow-up|Lost to Follow-up|1|||
162214549|NCT02737826|585836119|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
162214550|NCT02737826|585836120|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
162214551|NCT02737826|585836121|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
162214552|NCT02354651|585836122|FG000|Overall Study|Withdrawal by Subject|2|||
162214553|NCT02354651|585836122|FG000|Overall Study|Physician Decision|1|||
162214554|NCT01317875|585836123|FG000|Overall Study|Other|0|||
162214555|NCT01317875|585836124|FG001|Overall Study|Other|0|||
162214556|NCT01317875|585836125|FG002|Overall Study|Other|1|||
162214557|NCT01317875|585836126|FG003|Overall Study|Other|0|||
162214558|NCT01317875|585836127|FG004|Overall Study|Other|0|||
161936255|NCT01302834|584817618|FG000|Overall Study|Protocol Violation|17|||
161936256|NCT01302834|584817619|FG001|Overall Study|Protocol Violation|23|||
161936257|NCT01302834|584817618|FG000|Overall Study|HIV positive|1|||
161936258|NCT01302834|584817619|FG001|Overall Study|HIV positive|3|||
161936281|NCT05528510|584817625|FG000|Overall Study|Death|1|||
161936282|NCT05528510|584817626|FG001|Overall Study|Death|0|||
161936283|NCT05528510|584817627|FG002|Overall Study|Death|0|||
161936284|NCT05528510|584817625|FG000|Overall Study|Lost to Follow-up|1|||
161936285|NCT05528510|584817626|FG001|Overall Study|Lost to Follow-up|0|||
161936286|NCT05528510|584817627|FG002|Overall Study|Lost to Follow-up|0|||
161936287|NCT05528510|584817625|FG000|Overall Study|Withdrawal by Subject|4|||
161936288|NCT05528510|584817626|FG001|Overall Study|Withdrawal by Subject|1|||
161936289|NCT05528510|584817627|FG002|Overall Study|Withdrawal by Subject|3|||
161936290|NCT05528510|584817625|FG000|Overall Study|Other|2|||
161936291|NCT05528510|584817626|FG001|Overall Study|Other|2|||
161936292|NCT05528510|584817627|FG002|Overall Study|Other|1|||
162214559|NCT01317875|585836128|FG005|Overall Study|Other|0|||
162214560|NCT01317875|585836129|FG006|Overall Study|Other|0|||
162214561|NCT01317875|585836130|FG007|Overall Study|Other|0|||
162214562|NCT01317875|585836131|FG008|Overall Study|Other|0|||
162214563|NCT01317875|585836132|FG009|Overall Study|Other|0|||
162214564|NCT01317875|585836123|FG000|Overall Study|Noncompliance with study drug|0|||
162214565|NCT01317875|585836124|FG001|Overall Study|Noncompliance with study drug|0|||
162214566|NCT01317875|585836125|FG002|Overall Study|Noncompliance with study drug|1|||
162214567|NCT01317875|585836126|FG003|Overall Study|Noncompliance with study drug|0|||
162214568|NCT01317875|585836127|FG004|Overall Study|Noncompliance with study drug|0|||
162214569|NCT01317875|585836128|FG005|Overall Study|Noncompliance with study drug|0|||
162214570|NCT01317875|585836129|FG006|Overall Study|Noncompliance with study drug|0|||
162214571|NCT01317875|585836130|FG007|Overall Study|Noncompliance with study drug|0|||
162214572|NCT01317875|585836131|FG008|Overall Study|Noncompliance with study drug|0|||
162214573|NCT01317875|585836132|FG009|Overall Study|Noncompliance with study drug|0|||
162214574|NCT01317875|585836123|FG000|Overall Study|Progressive Disease|1|||
162214575|NCT01317875|585836124|FG001|Overall Study|Progressive Disease|0|||
162214576|NCT01317875|585836125|FG002|Overall Study|Progressive Disease|2|||
162214577|NCT01317875|585836126|FG003|Overall Study|Progressive Disease|0|||
162214578|NCT01317875|585836127|FG004|Overall Study|Progressive Disease|1|||
162214579|NCT01317875|585836128|FG005|Overall Study|Progressive Disease|0|||
162214580|NCT01317875|585836129|FG006|Overall Study|Progressive Disease|0|||
162214581|NCT01317875|585836130|FG007|Overall Study|Progressive Disease|1|||
162214582|NCT01317875|585836131|FG008|Overall Study|Progressive Disease|0|||
162214583|NCT01317875|585836132|FG009|Overall Study|Progressive Disease|0|||
162214584|NCT01317875|585836123|FG000|Overall Study|Withdrawal by Subject|0|||
162214585|NCT01317875|585836124|FG001|Overall Study|Withdrawal by Subject|0|||
162214586|NCT01317875|585836125|FG002|Overall Study|Withdrawal by Subject|0|||
162214587|NCT01317875|585836126|FG003|Overall Study|Withdrawal by Subject|0|||
162214588|NCT01317875|585836127|FG004|Overall Study|Withdrawal by Subject|1|||
162214589|NCT01317875|585836128|FG005|Overall Study|Withdrawal by Subject|0|||
162214590|NCT01317875|585836129|FG006|Overall Study|Withdrawal by Subject|0|||
162214591|NCT01317875|585836130|FG007|Overall Study|Withdrawal by Subject|3|||
162214592|NCT01317875|585836131|FG008|Overall Study|Withdrawal by Subject|0|||
162214593|NCT01317875|585836132|FG009|Overall Study|Withdrawal by Subject|0|||
162214594|NCT01317875|585836123|FG000|Overall Study|Physician Decision|0|||
162214595|NCT01317875|585836124|FG001|Overall Study|Physician Decision|1|||
162214596|NCT01317875|585836125|FG002|Overall Study|Physician Decision|1|||
162214597|NCT01317875|585836126|FG003|Overall Study|Physician Decision|0|||
162214598|NCT01317875|585836127|FG004|Overall Study|Physician Decision|2|||
162214599|NCT01317875|585836128|FG005|Overall Study|Physician Decision|0|||
162214600|NCT01317875|585836129|FG006|Overall Study|Physician Decision|0|||
162214601|NCT01317875|585836130|FG007|Overall Study|Physician Decision|2|||
162214602|NCT01317875|585836131|FG008|Overall Study|Physician Decision|0|||
162214603|NCT01317875|585836132|FG009|Overall Study|Physician Decision|0|||
162214604|NCT01317875|585836123|FG000|Overall Study|Death|0|||
162214605|NCT01317875|585836124|FG001|Overall Study|Death|0|||
162214606|NCT01317875|585836125|FG002|Overall Study|Death|2|||
162214607|NCT01317875|585836126|FG003|Overall Study|Death|1|||
162214608|NCT01317875|585836127|FG004|Overall Study|Death|0|||
162214609|NCT01317875|585836128|FG005|Overall Study|Death|1|||
162214610|NCT01317875|585836129|FG006|Overall Study|Death|0|||
162214611|NCT01317875|585836130|FG007|Overall Study|Death|4|||
162214612|NCT01317875|585836131|FG008|Overall Study|Death|0|||
162214613|NCT01317875|585836132|FG009|Overall Study|Death|0|||
162214614|NCT01317875|585836123|FG000|Overall Study|Adverse Event|2|||
162214615|NCT01317875|585836124|FG001|Overall Study|Adverse Event|1|||
162214616|NCT01317875|585836125|FG002|Overall Study|Adverse Event|2|||
162214617|NCT01317875|585836126|FG003|Overall Study|Adverse Event|1|||
162214618|NCT01317875|585836127|FG004|Overall Study|Adverse Event|5|||
162214619|NCT01317875|585836128|FG005|Overall Study|Adverse Event|1|||
162214620|NCT01317875|585836129|FG006|Overall Study|Adverse Event|2|||
162214621|NCT01317875|585836130|FG007|Overall Study|Adverse Event|5|||
162214622|NCT01317875|585836131|FG008|Overall Study|Adverse Event|0|||
162214623|NCT01317875|585836132|FG009|Overall Study|Adverse Event|0|||
162214624|NCT01377389|585836133|FG000|Overall Study|Withdrawal by Subject|1|||
162214625|NCT01377389|585836133|FG000|Overall Study|Screen failure|2|||
162214626|NCT00863512|585836143|FG000|Overall Study|Adverse Event|2|||
162214627|NCT00863512|585836144|FG001|Overall Study|Adverse Event|0|||
162214628|NCT00863512|585836143|FG000|Overall Study|Withdrawal by Subject|11|||
162214629|NCT00863512|585836144|FG001|Overall Study|Withdrawal by Subject|0|||
162214630|NCT00863512|585836143|FG000|Overall Study|Physician Decision|1|||
162214631|NCT00863512|585836144|FG001|Overall Study|Physician Decision|0|||
162214632|NCT05274750|585836148|FG000|Overall Study|Adverse Event|0|||
162214633|NCT05274750|585836149|FG001|Overall Study|Adverse Event|1|||
162214634|NCT05274750|585836148|FG000|Overall Study|Lost to Follow-up|2|||
162214635|NCT05274750|585836149|FG001|Overall Study|Lost to Follow-up|3|||
162214636|NCT05274750|585836148|FG000|Overall Study|Physician Decision|3|||
162214637|NCT05274750|585836149|FG001|Overall Study|Physician Decision|0|||
162214638|NCT05274750|585836148|FG000|Overall Study|Withdrawal by Subject|10|||
162214639|NCT05274750|585836149|FG001|Overall Study|Withdrawal by Subject|9|||
162214640|NCT05274750|585836148|FG000|Overall Study|GCP Violation|0|||
162214641|NCT05274750|585836149|FG001|Overall Study|GCP Violation|4|||
162214642|NCT05274750|585836148|FG000|Overall Study|Randomized, not treated|0|||
162214643|NCT05274750|585836149|FG001|Overall Study|Randomized, not treated|1|||
162214644|NCT04328623|585836154|FG000|Overall Study|Protocol Violation|0|||
162214645|NCT04328623|585836155|FG001|Overall Study|Protocol Violation|1|||
162214646|NCT04340947|585836156|FG000|7-day Washout Period|Lost to Follow-up|5|||
162214647|NCT04340947|585836157|FG001|7-day Washout Period|Lost to Follow-up|4|||
162214648|NCT02312557|585836158|FG000|Overall Study|Survival follow-up|4|||
162214649|NCT01437423|585836164|FG000|Overall Study|Lost to Follow-up|12|||
162214650|NCT01437423|585836164|FG000|Overall Study|Off label usage|3|||
162214651|NCT03721172|585836165|FG000|Placebo-controlled Phase|Adverse Event|7|||
162214652|NCT03721172|585836166|FG001|Placebo-controlled Phase|Adverse Event|7|||
162214653|NCT03721172|585836167|FG002|Placebo-controlled Phase|Adverse Event|0|||
162214654|NCT03721172|585836165|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
162214655|NCT03721172|585836166|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
162214656|NCT03721172|585836167|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
162214657|NCT03721172|585836165|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
162214658|NCT03721172|585836166|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
162214659|NCT03721172|585836167|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
162214660|NCT03721172|585836165|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
162214661|NCT03721172|585836166|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
162214662|NCT03721172|585836167|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
162214663|NCT03721172|585836165|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
162214664|NCT03721172|585836166|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
162214665|NCT03721172|585836167|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
162214666|NCT03721172|585836165|FG000|Placebo-controlled Phase|Other|3|||
162214667|NCT03721172|585836166|FG001|Placebo-controlled Phase|Other|0|||
162214668|NCT03721172|585836167|FG002|Placebo-controlled Phase|Other|0|||
162214669|NCT03721172|585836165|FG000|Apremilast Extension Phase|Adverse Event|0|||
162214670|NCT03721172|585836166|FG001|Apremilast Extension Phase|Adverse Event|0|||
162214671|NCT03721172|585836167|FG002|Apremilast Extension Phase|Adverse Event|10|||
162214672|NCT03721172|585836165|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
162214673|NCT03721172|585836166|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
162214674|NCT03721172|585836167|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
162214675|NCT03721172|585836165|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
162214676|NCT03721172|585836166|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
162214677|NCT03721172|585836167|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
162214678|NCT03721172|585836165|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
162214679|NCT03721172|585836166|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
162214680|NCT03721172|585836167|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
162214681|NCT03721172|585836165|FG000|Apremilast Extension Phase|Protocol Violation|0|||
162214682|NCT03721172|585836166|FG001|Apremilast Extension Phase|Protocol Violation|0|||
162214683|NCT03721172|585836167|FG002|Apremilast Extension Phase|Protocol Violation|1|||
162214684|NCT03721172|585836165|FG000|Apremilast Extension Phase|Physician Decision|0|||
162214685|NCT03721172|585836166|FG001|Apremilast Extension Phase|Physician Decision|0|||
162214686|NCT03721172|585836167|FG002|Apremilast Extension Phase|Physician Decision|1|||
162214687|NCT03721172|585836165|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
162214688|NCT03721172|585836166|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
162214689|NCT03721172|585836167|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
162214690|NCT03721172|585836165|FG000|Apremilast Extension Phase|Other|0|||
162214691|NCT03721172|585836166|FG001|Apremilast Extension Phase|Other|0|||
162214692|NCT03721172|585836167|FG002|Apremilast Extension Phase|Other|3|||
162214693|NCT03721172|585836165|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
161678223|NCT00823823|583873640|FG001|Overall Study|Lost to Follow-up|1|||
161678224|NCT00823823|583873639|FG000|Overall Study|Protocol Violation|5|||
162214694|NCT03721172|585836166|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
162214695|NCT03721172|585836167|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
162214696|NCT03934099|585836168|FG000|Overall Study|Adverse Event|0|||
162214697|NCT03934099|585836169|FG001|Overall Study|Adverse Event|3|||
162214698|NCT03934099|585836170|FG002|Overall Study|Adverse Event|1|||
162214699|NCT03934099|585836171|FG003|Overall Study|Adverse Event|0|||
162214700|NCT03934099|585836168|FG000|Overall Study|Lost to Follow-up|1|||
162214701|NCT03934099|585836169|FG001|Overall Study|Lost to Follow-up|2|||
162214702|NCT03934099|585836170|FG002|Overall Study|Lost to Follow-up|1|||
162214703|NCT03934099|585836171|FG003|Overall Study|Lost to Follow-up|1|||
162214704|NCT03934099|585836168|FG000|Overall Study|Protocol Violation|1|||
162214705|NCT03934099|585836169|FG001|Overall Study|Protocol Violation|0|||
162214706|NCT03934099|585836170|FG002|Overall Study|Protocol Violation|0|||
162214707|NCT03934099|585836171|FG003|Overall Study|Protocol Violation|0|||
162214708|NCT03934099|585836168|FG000|Overall Study|Withdrawal by Subject|2|||
162214709|NCT03934099|585836169|FG001|Overall Study|Withdrawal by Subject|0|||
162214710|NCT03934099|585836170|FG002|Overall Study|Withdrawal by Subject|1|||
162214711|NCT03934099|585836171|FG003|Overall Study|Withdrawal by Subject|1|||
162214712|NCT03934099|585836168|FG000|Overall Study|Other reasons|0|||
161678225|NCT00823823|583873640|FG001|Overall Study|Protocol Violation|5|||
162214713|NCT03934099|585836169|FG001|Overall Study|Other reasons|1|||
162214714|NCT03934099|585836170|FG002|Overall Study|Other reasons|0|||
162214715|NCT03934099|585836171|FG003|Overall Study|Other reasons|0|||
162214716|NCT02417441|585836172|FG000|Overall Study|Inconclusive due to missing data|52|||
162214717|NCT02417441|585836173|FG001|Overall Study|Inconclusive due to missing data|19|||
162214718|NCT05628285|585836174|FG000|Overall Study|Lost to Follow-up|1|||
162214719|NCT00983853|585836175|FG000|Overall Study|Lost to Follow-up|1|||
161678226|NCT02234284|583873641|FG000|Overall Study|Death|4|||
162214720|NCT00983853|585836176|FG001|Overall Study|Lost to Follow-up|1|||
162214721|NCT00983853|585836177|FG002|Overall Study|Lost to Follow-up|2|||
162214722|NCT00983853|585836178|FG003|Overall Study|Lost to Follow-up|2|||
162214723|NCT00983853|585836179|FG004|Overall Study|Lost to Follow-up|2|||
162214724|NCT00983853|585836180|FG005|Overall Study|Lost to Follow-up|1|||
162214725|NCT00983853|585836175|FG000|Overall Study|Withdrawal by Subject|0|||
162214726|NCT00983853|585836176|FG001|Overall Study|Withdrawal by Subject|0|||
162214727|NCT00983853|585836177|FG002|Overall Study|Withdrawal by Subject|1|||
162214728|NCT00983853|585836178|FG003|Overall Study|Withdrawal by Subject|0|||
162214729|NCT00983853|585836179|FG004|Overall Study|Withdrawal by Subject|1|||
162214730|NCT00983853|585836180|FG005|Overall Study|Withdrawal by Subject|0|||
162214731|NCT00983853|585836175|FG000|Overall Study|Unable to come to study follow-up visits|0|||
162214732|NCT00983853|585836176|FG001|Overall Study|Unable to come to study follow-up visits|1|||
162214733|NCT00983853|585836177|FG002|Overall Study|Unable to come to study follow-up visits|0|||
162214734|NCT00983853|585836178|FG003|Overall Study|Unable to come to study follow-up visits|0|||
162214735|NCT00983853|585836179|FG004|Overall Study|Unable to come to study follow-up visits|0|||
162214736|NCT00983853|585836180|FG005|Overall Study|Unable to come to study follow-up visits|0|||
162214737|NCT02339506|585836181|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
162214738|NCT02339506|585836182|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
162214739|NCT02339506|585836181|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
162214740|NCT02339506|585836182|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
162214741|NCT05555615|585836186|FG000|Overall Study|Adverse Event|7|||
162214742|NCT05555615|585836186|FG000|Overall Study|Lack of Efficacy|12|||
162214743|NCT05555615|585836186|FG000|Overall Study|Lost to Follow-up|10|||
162214744|NCT05555615|585836186|FG000|Overall Study|Noncompliance with study drug|5|||
162214745|NCT05555615|585836186|FG000|Overall Study|Physician Decision|2|||
162214746|NCT05555615|585836186|FG000|Overall Study|Study terminated by sponsor|80|||
162214747|NCT05555615|585836186|FG000|Overall Study|Prohibited medication use|2|||
162214748|NCT05555615|585836186|FG000|Overall Study|Withdrawal by Subject|20|||
162214749|NCT05555615|585836186|FG000|Overall Study|Not further specified|4|||
162214750|NCT03016598|585836187|FG000|Overall Study|Lost to Follow-up|0|||
162214751|NCT03016598|585836188|FG001|Overall Study|Lost to Follow-up|2|||
162214752|NCT00478205|585836192|FG000|Overall Study|Adverse Event|182|||
162214753|NCT00478205|585836193|FG001|Overall Study|Adverse Event|39|||
162214754|NCT00478205|585836192|FG000|Overall Study|Medication Non-compliance|9|||
162214755|NCT00478205|585836193|FG001|Overall Study|Medication Non-compliance|4|||
162214756|NCT00478205|585836192|FG000|Overall Study|Protocol Violation|15|||
162214757|NCT00478205|585836193|FG001|Overall Study|Protocol Violation|5|||
162214758|NCT00478205|585836192|FG000|Overall Study|Request of Investigator or Sponsor|4|||
162214759|NCT00478205|585836193|FG001|Overall Study|Request of Investigator or Sponsor|5|||
162214760|NCT00478205|585836192|FG000|Overall Study|Withdrawal by Subject|61|||
162214761|NCT00478205|585836193|FG001|Overall Study|Withdrawal by Subject|22|||
162214762|NCT00478205|585836192|FG000|Overall Study|Lack of Efficacy|1|||
162214763|NCT00478205|585836193|FG001|Overall Study|Lack of Efficacy|0|||
162214764|NCT00478205|585836192|FG000|Overall Study|Other|24|||
162214765|NCT00478205|585836193|FG001|Overall Study|Other|12|||
162214766|NCT01791413|585836194|FG000|Overall Study|Lost to Follow-up|5|||
162214767|NCT01791413|585836195|FG001|Overall Study|Lost to Follow-up|1|||
162214768|NCT01827046|585836205|FG000|Overall Study|Lost to Follow-up|1|||
162214769|NCT01827046|585836206|FG001|Overall Study|Lost to Follow-up|5|||
162214770|NCT01827046|585836205|FG000|Overall Study|Withdrawal by Subject|0|||
162214771|NCT01827046|585836206|FG001|Overall Study|Withdrawal by Subject|4|||
162214772|NCT05594589|585836207|FG000|Overall Study|Other|0|||
162214773|NCT05594589|585836208|FG001|Overall Study|Other|1|||
162214774|NCT05594589|585836209|FG002|Overall Study|Other|0|||
162214775|NCT00715117|585836213|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
162214776|NCT00715117|585836214|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
162214777|NCT01018732|585836218|FG000|Overall Study|Lost to Follow-up|0|||
162214778|NCT01018732|585836219|FG001|Overall Study|Lost to Follow-up|0|||
161827301|NCT01609582|584408046|FG000|Overall Study|Lost to Follow-up|10|||
161827302|NCT01609582|584408047|FG001|Overall Study|Lost to Follow-up|10|||
162214779|NCT01018732|585836220|FG002|Overall Study|Lost to Follow-up|3|||
162214780|NCT01018732|585836218|FG000|Overall Study|Protocol Violation|1|||
162214781|NCT01018732|585836219|FG001|Overall Study|Protocol Violation|1|||
161827303|NCT01609582|584408046|FG000|Overall Study|Withdrawal by Subject|21|||
161827304|NCT01609582|584408047|FG001|Overall Study|Withdrawal by Subject|15|||
161827305|NCT01609582|584408046|FG000|Overall Study|Study Terminated by Sponsor|1543|||
161827306|NCT01609582|584408047|FG001|Overall Study|Study Terminated by Sponsor|1548|||
161827307|NCT01609582|584408046|FG000|Overall Study|Other|9|||
161827308|NCT01609582|584408047|FG001|Overall Study|Other|10|||
161827309|NCT01609582|584408046|FG000|Overall Study|Randomized, but not treated|0|||
161827310|NCT01609582|584408047|FG001|Overall Study|Randomized, but not treated|3|||
161827311|NCT00819767|584408048|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161827312|NCT00819767|584408049|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162214782|NCT01018732|585836220|FG002|Overall Study|Protocol Violation|0|||
162214783|NCT01018732|585836218|FG000|Overall Study|Inappropriate Enrollment|0|||
162214784|NCT01018732|585836219|FG001|Overall Study|Inappropriate Enrollment|1|||
162214785|NCT01018732|585836220|FG002|Overall Study|Inappropriate Enrollment|0|||
162214786|NCT01018732|585836218|FG000|Overall Study|Unable to Classify|0|||
162214787|NCT01018732|585836219|FG001|Overall Study|Unable to Classify|0|||
162214788|NCT01018732|585836220|FG002|Overall Study|Unable to Classify|1|||
162214789|NCT01536171|585836221|FG000|Overall Study|Withdrawal by Subject|1|||
162214790|NCT01262092|585836222|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
162214791|NCT01262092|585836223|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
162214792|NCT01262092|585836222|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
162214793|NCT01262092|585836223|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
162214794|NCT01262092|585836222|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
162214795|NCT01262092|585836223|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
162214796|NCT01262092|585836222|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
162214797|NCT01262092|585836223|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
162214798|NCT03784820|585836224|FG000|Overall Study|Lost to Follow-up|5|||
162214799|NCT03784820|585836225|FG001|Overall Study|Lost to Follow-up|5|||
162214800|NCT03784820|585836226|FG002|Overall Study|Lost to Follow-up|3|||
162214801|NCT03784820|585836227|FG003|Overall Study|Lost to Follow-up|3|||
162214802|NCT00978562|585836228|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
162214803|NCT00569127|585836229|FG000|Overall Study|Adverse Event|57|||
162214804|NCT00569127|585836230|FG001|Overall Study|Adverse Event|47|||
162214805|NCT00569127|585836229|FG000|Overall Study|Withdrawal by Subject|13|||
162214806|NCT00569127|585836230|FG001|Overall Study|Withdrawal by Subject|27|||
162214807|NCT00569127|585836229|FG000|Overall Study|Progression|99|||
162214808|NCT00569127|585836230|FG001|Overall Study|Progression|100|||
162214809|NCT00569127|585836229|FG000|Overall Study|Death|4|||
162214810|NCT00569127|585836230|FG001|Overall Study|Death|3|||
162214811|NCT00569127|585836229|FG000|Overall Study|Other|20|||
162214812|NCT00569127|585836230|FG001|Overall Study|Other|19|||
162214813|NCT00569127|585836229|FG000|Overall Study|Lost to Follow-up|0|||
162214814|NCT00569127|585836230|FG001|Overall Study|Lost to Follow-up|3|||
162214815|NCT00569127|585836229|FG000|Overall Study|Not Eligible|14|||
162214816|NCT00569127|585836230|FG001|Overall Study|Not Eligible|11|||
162214817|NCT00569127|585836229|FG000|Overall Study|Still on Treatment|7|||
162214818|NCT00569127|585836230|FG001|Overall Study|Still on Treatment|3|||
162214819|NCT03569891|585836245|FG000|Lead-in|Ineligible during lead-in|8|||
162214820|NCT03569891|585836245|FG000|Lead-in|Withdrawal by Subject|3|||
162214821|NCT03569891|585836245|FG000|Lead-in|Risks related to COVID-19|2|||
162214822|NCT03569891|585836245|FG000|AMT-061|Adverse Event|1|||
162214823|NCT02201901|585836251|FG000|Overall Study|Randomized but never treated|0|||
161678227|NCT02234284|583873642|FG001|Overall Study|Death|2|||
162214824|NCT02201901|585836252|FG001|Overall Study|Randomized but never treated|1|||
162214825|NCT02201901|585836253|FG002|Overall Study|Randomized but never treated|0|||
162214826|NCT02201901|585836251|FG000|Overall Study|Lack of Efficacy|7|||
161678228|NCT02234284|583873641|FG000|Overall Study|Withdrawal by Subject|1|||
162214827|NCT02201901|585836252|FG001|Overall Study|Lack of Efficacy|1|||
162214828|NCT02201901|585836253|FG002|Overall Study|Lack of Efficacy|6|||
162214829|NCT02201901|585836251|FG000|Overall Study|Death|3|||
162214830|NCT02201901|585836252|FG001|Overall Study|Death|3|||
162214831|NCT02201901|585836253|FG002|Overall Study|Death|3|||
162214832|NCT02201901|585836251|FG000|Overall Study|Lost to Follow-up|2|||
162214833|NCT02201901|585836252|FG001|Overall Study|Lost to Follow-up|3|||
162214834|NCT02201901|585836253|FG002|Overall Study|Lost to Follow-up|2|||
162214835|NCT02201901|585836251|FG000|Overall Study|Withdrew Consent|2|||
162214836|NCT02201901|585836252|FG001|Overall Study|Withdrew Consent|0|||
162214837|NCT02201901|585836253|FG002|Overall Study|Withdrew Consent|2|||
162214838|NCT02201901|585836251|FG000|Overall Study|Adverse Event|1|||
162214839|NCT02201901|585836252|FG001|Overall Study|Adverse Event|1|||
162214840|NCT02201901|585836253|FG002|Overall Study|Adverse Event|0|||
162214841|NCT00469859|585836254|FG000|Overall Study|Inevaluable|0|||
162214842|NCT00469859|585836255|FG001|Overall Study|Inevaluable|2|||
162214843|NCT02419417|585838246|FG000|Overall Study|Disease progression|5|||
162214844|NCT02419417|585838247|FG001|Overall Study|Disease progression|4|||
162214845|NCT02419417|585838248|FG002|Overall Study|Disease progression|13|||
162214846|NCT02419417|585838249|FG003|Overall Study|Disease progression|10|||
162214847|NCT02419417|585838250|FG004|Overall Study|Disease progression|10|||
162214848|NCT02419417|585838251|FG005|Overall Study|Disease progression|3|||
162214849|NCT02419417|585838252|FG006|Overall Study|Disease progression|4|||
162214850|NCT02419417|585838253|FG007|Overall Study|Disease progression|5|||
162214851|NCT02419417|585838254|FG008|Overall Study|Disease progression|13|||
162214852|NCT02419417|585838255|FG009|Overall Study|Disease progression|9|||
162214853|NCT02419417|585838256|FG010|Overall Study|Disease progression|0|||
162214854|NCT02419417|585838246|FG000|Overall Study|Study drug toxicity|0|||
162214855|NCT02419417|585838247|FG001|Overall Study|Study drug toxicity|0|||
162214856|NCT02419417|585838248|FG002|Overall Study|Study drug toxicity|0|||
162214857|NCT02419417|585838249|FG003|Overall Study|Study drug toxicity|0|||
162214858|NCT02419417|585838250|FG004|Overall Study|Study drug toxicity|1|||
162214859|NCT02419417|585838251|FG005|Overall Study|Study drug toxicity|0|||
162214860|NCT02419417|585838252|FG006|Overall Study|Study drug toxicity|0|||
162214861|NCT02419417|585838253|FG007|Overall Study|Study drug toxicity|0|||
162214862|NCT02419417|585838254|FG008|Overall Study|Study drug toxicity|0|||
162214863|NCT02419417|585838255|FG009|Overall Study|Study drug toxicity|0|||
162214864|NCT02419417|585838256|FG010|Overall Study|Study drug toxicity|0|||
162214865|NCT02419417|585838246|FG000|Overall Study|Adverse event unrelated to study drug|0|||
162214866|NCT02419417|585838247|FG001|Overall Study|Adverse event unrelated to study drug|0|||
162214867|NCT02419417|585838248|FG002|Overall Study|Adverse event unrelated to study drug|0|||
162214868|NCT02419417|585838249|FG003|Overall Study|Adverse event unrelated to study drug|0|||
162214869|NCT02419417|585838250|FG004|Overall Study|Adverse event unrelated to study drug|2|||
162214870|NCT02419417|585838251|FG005|Overall Study|Adverse event unrelated to study drug|1|||
162214871|NCT02419417|585838252|FG006|Overall Study|Adverse event unrelated to study drug|0|||
162214872|NCT02419417|585838253|FG007|Overall Study|Adverse event unrelated to study drug|1|||
162214873|NCT02419417|585838254|FG008|Overall Study|Adverse event unrelated to study drug|0|||
162214874|NCT02419417|585838255|FG009|Overall Study|Adverse event unrelated to study drug|0|||
162214875|NCT02419417|585838256|FG010|Overall Study|Adverse event unrelated to study drug|0|||
162214876|NCT02419417|585838246|FG000|Overall Study|Participant request to discontinue|0|||
162214877|NCT02419417|585838247|FG001|Overall Study|Participant request to discontinue|0|||
162214878|NCT02419417|585838248|FG002|Overall Study|Participant request to discontinue|0|||
162214879|NCT02419417|585838249|FG003|Overall Study|Participant request to discontinue|0|||
162214880|NCT02419417|585838250|FG004|Overall Study|Participant request to discontinue|0|||
162214881|NCT02419417|585838251|FG005|Overall Study|Participant request to discontinue|0|||
162214882|NCT02419417|585838252|FG006|Overall Study|Participant request to discontinue|0|||
162214883|NCT02419417|585838253|FG007|Overall Study|Participant request to discontinue|0|||
162214884|NCT02419417|585838254|FG008|Overall Study|Participant request to discontinue|0|||
162214885|NCT02419417|585838255|FG009|Overall Study|Participant request to discontinue|1|||
162214886|NCT02419417|585838256|FG010|Overall Study|Participant request to discontinue|0|||
162214887|NCT02419417|585838246|FG000|Overall Study|Withdrawal by Subject|0|||
162214888|NCT02419417|585838247|FG001|Overall Study|Withdrawal by Subject|0|||
162214889|NCT02419417|585838248|FG002|Overall Study|Withdrawal by Subject|0|||
162214890|NCT02419417|585838249|FG003|Overall Study|Withdrawal by Subject|0|||
162214891|NCT02419417|585838250|FG004|Overall Study|Withdrawal by Subject|0|||
162214892|NCT02419417|585838251|FG005|Overall Study|Withdrawal by Subject|0|||
162214893|NCT02419417|585838252|FG006|Overall Study|Withdrawal by Subject|0|||
162214894|NCT02419417|585838253|FG007|Overall Study|Withdrawal by Subject|0|||
162214895|NCT02419417|585838254|FG008|Overall Study|Withdrawal by Subject|0|||
162214896|NCT02419417|585838255|FG009|Overall Study|Withdrawal by Subject|0|||
162214897|NCT02419417|585838256|FG010|Overall Study|Withdrawal by Subject|1|||
162214898|NCT01240551|585838257|FG000|Overall Study|Refused further treatment|3|||
162214899|NCT01240551|585838258|FG001|Overall Study|Refused further treatment|2|||
162214900|NCT01240551|585838257|FG000|Overall Study|Lost to Follow-up|1|||
162214901|NCT01240551|585838258|FG001|Overall Study|Lost to Follow-up|1|||
162214902|NCT01385748|585838259|FG000|Overall Study|Withdrawal by Subject|7|||
162214903|NCT01385748|585838260|FG001|Overall Study|Withdrawal by Subject|4|||
162214904|NCT01385748|585838261|FG002|Overall Study|Withdrawal by Subject|5|||
162214905|NCT01385748|585838259|FG000|Overall Study|Noncompliance|3|||
162214906|NCT01385748|585838260|FG001|Overall Study|Noncompliance|1|||
162214907|NCT01385748|585838261|FG002|Overall Study|Noncompliance|6|||
162214908|NCT01385748|585838259|FG000|Overall Study|Other|1|||
162214909|NCT01385748|585838260|FG001|Overall Study|Other|7|||
162214910|NCT01385748|585838261|FG002|Overall Study|Other|1|||
162214911|NCT01385748|585838259|FG000|Overall Study|Adverse Event|4|||
162214912|NCT01385748|585838260|FG001|Overall Study|Adverse Event|2|||
162214913|NCT01385748|585838261|FG002|Overall Study|Adverse Event|1|||
162214914|NCT01200342|585838262|FG000|Overall Study|Disease Progression|1|||
162214915|NCT00121667|585838272|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
162214916|NCT00121667|585838273|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
162214917|NCT00121667|585838274|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
162214918|NCT00121667|585838275|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
162214919|NCT00121667|585838272|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
162214920|NCT00121667|585838273|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
162214921|NCT00121667|585838274|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
162214922|NCT00121667|585838275|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
162214923|NCT00121667|585838272|FG000|Short Term (ST) Period|Adverse Event|5|||
162214924|NCT00121667|585838273|FG001|Short Term (ST) Period|Adverse Event|6|||
162214925|NCT00121667|585838274|FG002|Short Term (ST) Period|Adverse Event|5|||
162214926|NCT00121667|585838275|FG003|Short Term (ST) Period|Adverse Event|3|||
162214927|NCT00121667|585838272|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
162214928|NCT00121667|585838273|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
162214929|NCT00121667|585838274|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
162214930|NCT00121667|585838275|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
162214931|NCT00121667|585838272|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
162214932|NCT00121667|585838273|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
162214933|NCT00121667|585838274|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
162214934|NCT00121667|585838275|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
162214935|NCT00121667|585838272|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
162214936|NCT00121667|585838273|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
162214937|NCT00121667|585838274|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
162214938|NCT00121667|585838275|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
162214939|NCT00121667|585838272|FG000|Short Term (ST) Period|Other Reason|3|||
162214940|NCT00121667|585838273|FG001|Short Term (ST) Period|Other Reason|0|||
162214941|NCT00121667|585838274|FG002|Short Term (ST) Period|Other Reason|0|||
162214942|NCT00121667|585838275|FG003|Short Term (ST) Period|Other Reason|0|||
162214943|NCT00121667|585838272|FG000|Short Term (ST) Period|Death|0|||
162214944|NCT00121667|585838273|FG001|Short Term (ST) Period|Death|0|||
162214945|NCT00121667|585838274|FG002|Short Term (ST) Period|Death|0|||
162214946|NCT00121667|585838275|FG003|Short Term (ST) Period|Death|1|||
162214947|NCT00121667|585838272|FG000|Short Term (ST) Period|Pregnancy|0|||
162214948|NCT00121667|585838273|FG001|Short Term (ST) Period|Pregnancy|0|||
162214949|NCT00121667|585838274|FG002|Short Term (ST) Period|Pregnancy|0|||
162214950|NCT00121667|585838275|FG003|Short Term (ST) Period|Pregnancy|1|||
162214951|NCT00121667|585838272|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
162214952|NCT00121667|585838273|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
162214953|NCT00121667|585838274|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
162214954|NCT00121667|585838275|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
162214955|NCT00121667|585838272|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
162214956|NCT00121667|585838273|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
162214957|NCT00121667|585838274|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
162214958|NCT00121667|585838275|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
162214959|NCT00121667|585838272|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
162214960|NCT00121667|585838273|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
162214961|NCT00121667|585838274|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
162214962|NCT00121667|585838275|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
161678229|NCT02234284|583873642|FG001|Overall Study|Withdrawal by Subject|0|||
161678230|NCT02234284|583873641|FG000|Overall Study|Lost to Follow-up|20|||
161678231|NCT02234284|583873642|FG001|Overall Study|Lost to Follow-up|7|||
161678232|NCT01986920|583873645|FG000|A- 101 25%|Withdrawal by Subject|1|||
161678233|NCT01986920|583873646|FG001|A- 101 25%|Withdrawal by Subject|0|||
161678234|NCT01986920|583873647|FG002|A- 101 25%|Withdrawal by Subject|0|||
161678235|NCT01986920|583873648|FG003|A- 101 25%|Withdrawal by Subject|0|||
162214963|NCT00121667|585838272|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
162214964|NCT00121667|585838273|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
162214965|NCT00121667|585838274|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
162214966|NCT00121667|585838275|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
162214967|NCT00121667|585838272|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
162214968|NCT00121667|585838273|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
162214969|NCT00121667|585838274|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
162214970|NCT00121667|585838275|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
161678236|NCT01986920|583873645|FG000|A-101 32.5%|Withdrawal by Subject|0|||
161678237|NCT01986920|583873646|FG001|A-101 32.5%|Withdrawal by Subject|1|||
161678238|NCT01986920|583873647|FG002|A-101 32.5%|Withdrawal by Subject|0|||
161678239|NCT01986920|583873648|FG003|A-101 32.5%|Withdrawal by Subject|0|||
161678240|NCT01986920|583873645|FG000|A-101 40%|Withdrawal by Subject|0|||
161678241|NCT01986920|583873646|FG001|A-101 40%|Withdrawal by Subject|0|||
161678242|NCT01986920|583873647|FG002|A-101 40%|Withdrawal by Subject|1|||
161678243|NCT01986920|583873648|FG003|A-101 40%|Withdrawal by Subject|0|||
162214971|NCT00121667|585838272|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
162214972|NCT00121667|585838273|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
162214973|NCT00121667|585838274|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
162214974|NCT00121667|585838275|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
162214975|NCT00121667|585838272|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
162214976|NCT00121667|585838273|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
162214977|NCT00121667|585838274|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
162214978|NCT00121667|585838275|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
162214979|NCT00121667|585838272|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
162214980|NCT00121667|585838273|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
162214981|NCT00121667|585838274|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
162214982|NCT00121667|585838275|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
162214983|NCT00121667|585838272|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
162214984|NCT00121667|585838273|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
162214985|NCT00121667|585838274|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
162214986|NCT00121667|585838275|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
162214987|NCT04468230|585838276|FG000|Overall Study|Adverse Event|2|||
162214988|NCT02869867|585838278|FG000|Overall Study|Protocol Violation|1|||
162214989|NCT02869867|585838279|FG001|Overall Study|Protocol Violation|0|||
162214990|NCT02869867|585838278|FG000|Overall Study|Lost to Follow-up|5|||
162214991|NCT02869867|585838279|FG001|Overall Study|Lost to Follow-up|5|||
162214992|NCT02872012|585838295|FG000|Overall Study|Withdrawal by Subject|1|||
162214993|NCT02872012|585838296|FG001|Overall Study|Withdrawal by Subject|0|||
162214994|NCT02872012|585838297|FG002|Overall Study|Withdrawal by Subject|0|||
162214995|NCT02872012|585838298|FG003|Overall Study|Withdrawal by Subject|0|||
162214996|NCT02872012|585838299|FG004|Overall Study|Withdrawal by Subject|0|||
162214997|NCT01728623|585838300|FG000|Overall Study|Disease progression|26|||
162214998|NCT01728623|585838300|FG000|Overall Study|Adverse Event|1|||
162214999|NCT01728623|585838300|FG000|Overall Study|Withdrawal by Subject|1|||
162215000|NCT03000348|585838301|FG000|Overall Study|Adverse Event|1|||
162215001|NCT03000348|585838302|FG001|Overall Study|Adverse Event|1|||
162215002|NCT03000348|585838303|FG002|Overall Study|Adverse Event|1|||
162215003|NCT03000348|585838304|FG003|Overall Study|Adverse Event|1|||
162215004|NCT03000348|585838305|FG004|Overall Study|Adverse Event|1|||
162215005|NCT03000348|585838306|FG005|Overall Study|Adverse Event|1|||
162215006|NCT03000348|585838301|FG000|Overall Study|Lost to Follow-up|0|||
162215007|NCT03000348|585838302|FG001|Overall Study|Lost to Follow-up|0|||
162215008|NCT03000348|585838303|FG002|Overall Study|Lost to Follow-up|1|||
162215009|NCT03000348|585838304|FG003|Overall Study|Lost to Follow-up|0|||
162215010|NCT03000348|585838305|FG004|Overall Study|Lost to Follow-up|0|||
162215011|NCT03000348|585838306|FG005|Overall Study|Lost to Follow-up|0|||
162215012|NCT03000348|585838301|FG000|Overall Study|Withdrawal by Subject|0|||
162215013|NCT03000348|585838302|FG001|Overall Study|Withdrawal by Subject|1|||
162215014|NCT03000348|585838303|FG002|Overall Study|Withdrawal by Subject|0|||
162215015|NCT03000348|585838304|FG003|Overall Study|Withdrawal by Subject|0|||
162215016|NCT03000348|585838305|FG004|Overall Study|Withdrawal by Subject|0|||
162215017|NCT03000348|585838306|FG005|Overall Study|Withdrawal by Subject|0|||
162215018|NCT03000348|585838301|FG000|Overall Study|Consent|0|||
162215019|NCT03000348|585838302|FG001|Overall Study|Consent|0|||
162215020|NCT03000348|585838303|FG002|Overall Study|Consent|0|||
162215021|NCT03000348|585838304|FG003|Overall Study|Consent|0|||
162215022|NCT03000348|585838305|FG004|Overall Study|Consent|1|||
162215023|NCT03000348|585838306|FG005|Overall Study|Consent|0|||
162215024|NCT03000348|585838301|FG000|Overall Study|Failure to expectorate sputum|1|||
162215025|NCT03000348|585838302|FG001|Overall Study|Failure to expectorate sputum|0|||
162215026|NCT03000348|585838303|FG002|Overall Study|Failure to expectorate sputum|1|||
162215027|NCT03000348|585838304|FG003|Overall Study|Failure to expectorate sputum|0|||
162215028|NCT03000348|585838305|FG004|Overall Study|Failure to expectorate sputum|1|||
162215029|NCT03000348|585838306|FG005|Overall Study|Failure to expectorate sputum|0|||
162215030|NCT03000348|585838301|FG000|Overall Study|No gram negative|1|||
162215031|NCT03000348|585838302|FG001|Overall Study|No gram negative|2|||
162215032|NCT03000348|585838303|FG002|Overall Study|No gram negative|1|||
162215033|NCT03000348|585838304|FG003|Overall Study|No gram negative|1|||
162215034|NCT03000348|585838305|FG004|Overall Study|No gram negative|1|||
162215035|NCT03000348|585838306|FG005|Overall Study|No gram negative|1|||
162215036|NCT03000348|585838301|FG000|Overall Study|Patient had no transport|0|||
162215037|NCT03000348|585838302|FG001|Overall Study|Patient had no transport|0|||
162215038|NCT03000348|585838303|FG002|Overall Study|Patient had no transport|0|||
161678244|NCT01986920|583873645|FG000|Placebo|Withdrawal by Subject|0|||
162215039|NCT03000348|585838304|FG003|Overall Study|Patient had no transport|1|||
162215040|NCT03000348|585838305|FG004|Overall Study|Patient had no transport|0|||
162215041|NCT03000348|585838306|FG005|Overall Study|Patient had no transport|0|||
162215042|NCT03000348|585838301|FG000|Overall Study|Dosing|0|||
162215043|NCT03000348|585838302|FG001|Overall Study|Dosing|0|||
162215044|NCT03000348|585838303|FG002|Overall Study|Dosing|0|||
162215045|NCT03000348|585838304|FG003|Overall Study|Dosing|0|||
162215046|NCT03000348|585838305|FG004|Overall Study|Dosing|1|||
162215047|NCT03000348|585838306|FG005|Overall Study|Dosing|0|||
162215048|NCT00723125|585838307|FG000|Overall Study|Met Dx|1|||
162215049|NCT00723125|585838308|FG001|Overall Study|Met Dx|0|||
162215050|NCT00723125|585838307|FG000|Overall Study|Withdrawal by Subject|15|||
162215051|NCT00723125|585838308|FG001|Overall Study|Withdrawal by Subject|6|||
162215052|NCT00723125|585838307|FG000|Overall Study|Adverse Event|2|||
162215053|NCT00723125|585838308|FG001|Overall Study|Adverse Event|0|||
162215054|NCT01667549|585838309|FG000|Overall Study|Withdrawal by Subject|3|||
162215055|NCT01667549|585838310|FG001|Overall Study|Withdrawal by Subject|5|||
162215056|NCT01667549|585838311|FG002|Overall Study|Withdrawal by Subject|7|||
162215057|NCT01667549|585838312|FG003|Overall Study|Withdrawal by Subject|6|||
162215058|NCT01667549|585838313|FG004|Overall Study|Withdrawal by Subject|1|||
162215059|NCT01407276|585838314|FG000|Overall Study|Withdrawal by Subject|0|||
162215060|NCT01407276|585838315|FG001|Overall Study|Withdrawal by Subject|0|||
162215061|NCT01407276|585838316|FG002|Overall Study|Withdrawal by Subject|0|||
162215062|NCT01407276|585838317|FG003|Overall Study|Withdrawal by Subject|0|||
162215063|NCT01407276|585838318|FG004|Overall Study|Withdrawal by Subject|0|||
162215064|NCT01407276|585838319|FG005|Overall Study|Withdrawal by Subject|0|||
162215065|NCT01407276|585838320|FG006|Overall Study|Withdrawal by Subject|0|||
162215066|NCT01407276|585838321|FG007|Overall Study|Withdrawal by Subject|1|||
162215067|NCT01807182|585838323|FG000|Overall Study|Death|1|||
162215068|NCT01807182|585838323|FG000|Overall Study|New therapy|1|||
162215069|NCT01807182|585838323|FG000|Overall Study|Moved to hospice care|1|||
162215070|NCT04092452|585838325|FG000|Overall Study|Adverse Event|1|||
162215071|NCT04092452|585838326|FG001|Overall Study|Adverse Event|3|||
162215072|NCT04092452|585838327|FG002|Overall Study|Adverse Event|3|||
162215073|NCT04092452|585838328|FG003|Overall Study|Adverse Event|7|||
162215074|NCT04092452|585838325|FG000|Overall Study|Lack of Efficacy|1|||
162215075|NCT04092452|585838326|FG001|Overall Study|Lack of Efficacy|1|||
162215076|NCT04092452|585838327|FG002|Overall Study|Lack of Efficacy|1|||
162215077|NCT04092452|585838328|FG003|Overall Study|Lack of Efficacy|0|||
162215078|NCT04092452|585838325|FG000|Overall Study|Lost to Follow-up|4|||
162215079|NCT04092452|585838326|FG001|Overall Study|Lost to Follow-up|3|||
162215080|NCT04092452|585838327|FG002|Overall Study|Lost to Follow-up|5|||
162215081|NCT04092452|585838328|FG003|Overall Study|Lost to Follow-up|1|||
162215082|NCT04092452|585838325|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162215083|NCT04092452|585838326|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162215084|NCT04092452|585838327|FG002|Overall Study|Non-Compliance With Study Drug|1|||
162215085|NCT04092452|585838328|FG003|Overall Study|Non-Compliance With Study Drug|1|||
162215086|NCT04092452|585838325|FG000|Overall Study|Physician Decision|1|||
161678245|NCT01986920|583873646|FG001|Placebo|Withdrawal by Subject|0|||
161678246|NCT01986920|583873647|FG002|Placebo|Withdrawal by Subject|0|||
162215087|NCT04092452|585838326|FG001|Overall Study|Physician Decision|0|||
162215088|NCT04092452|585838327|FG002|Overall Study|Physician Decision|1|||
162215089|NCT04092452|585838328|FG003|Overall Study|Physician Decision|0|||
162215090|NCT04092452|585838325|FG000|Overall Study|Pregnancy|2|||
162215091|NCT04092452|585838326|FG001|Overall Study|Pregnancy|0|||
162215092|NCT04092452|585838327|FG002|Overall Study|Pregnancy|0|||
162215093|NCT04092452|585838328|FG003|Overall Study|Pregnancy|0|||
162215094|NCT04092452|585838325|FG000|Overall Study|Protocol Deviation|1|||
162215095|NCT04092452|585838326|FG001|Overall Study|Protocol Deviation|0|||
162215096|NCT04092452|585838327|FG002|Overall Study|Protocol Deviation|0|||
162215097|NCT04092452|585838328|FG003|Overall Study|Protocol Deviation|0|||
162215098|NCT04092452|585838325|FG000|Overall Study|Withdrawal by Subject|3|||
162215099|NCT04092452|585838326|FG001|Overall Study|Withdrawal by Subject|10|||
162215100|NCT04092452|585838327|FG002|Overall Study|Withdrawal by Subject|3|||
162215101|NCT04092452|585838328|FG003|Overall Study|Withdrawal by Subject|5|||
162215102|NCT04092452|585838325|FG000|Overall Study|Other|0|||
162215103|NCT04092452|585838326|FG001|Overall Study|Other|0|||
162215104|NCT04092452|585838327|FG002|Overall Study|Other|1|||
162215105|NCT04092452|585838328|FG003|Overall Study|Other|2|||
162215106|NCT01012947|585838337|FG000|Overall Study|Lost to Follow-up|131|||
162215107|NCT01012947|585838338|FG001|Overall Study|Lost to Follow-up|135|||
162215108|NCT01012947|585838339|FG002|Overall Study|Lost to Follow-up|130|||
162215109|NCT01012947|585838340|FG003|Overall Study|Lost to Follow-up|118|||
162215110|NCT01012947|585838341|FG004|Overall Study|Lost to Follow-up|142|||
162215111|NCT02127125|585838342|FG000|Overall Study|Lost to Follow-up|0|||
162215112|NCT02127125|585838343|FG001|Overall Study|Lost to Follow-up|0|||
162215113|NCT02127125|585838344|FG002|Overall Study|Lost to Follow-up|0|||
162215114|NCT02127125|585838345|FG003|Overall Study|Lost to Follow-up|0|||
162215115|NCT02127125|585838346|FG004|Overall Study|Lost to Follow-up|2|||
162215116|NCT02127125|585838347|FG005|Overall Study|Lost to Follow-up|1|||
162215117|NCT02127125|585838348|FG006|Overall Study|Lost to Follow-up|0|||
162215118|NCT02127125|585838349|FG007|Overall Study|Lost to Follow-up|0|||
162215119|NCT02127125|585838350|FG008|Overall Study|Lost to Follow-up|0|||
162215120|NCT02127125|585838342|FG000|Overall Study|Withdrawal by Subject|0|||
162215121|NCT02127125|585838343|FG001|Overall Study|Withdrawal by Subject|0|||
162215122|NCT02127125|585838344|FG002|Overall Study|Withdrawal by Subject|0|||
162215123|NCT02127125|585838345|FG003|Overall Study|Withdrawal by Subject|1|||
162215124|NCT02127125|585838346|FG004|Overall Study|Withdrawal by Subject|0|||
162215125|NCT02127125|585838347|FG005|Overall Study|Withdrawal by Subject|0|||
162215126|NCT02127125|585838348|FG006|Overall Study|Withdrawal by Subject|0|||
162215127|NCT02127125|585838349|FG007|Overall Study|Withdrawal by Subject|0|||
161678247|NCT01986920|583873648|FG003|Placebo|Withdrawal by Subject|1|||
162215128|NCT02127125|585838350|FG008|Overall Study|Withdrawal by Subject|0|||
162215129|NCT02127125|585838342|FG000|Overall Study|Physician Decision|0|||
162215130|NCT02127125|585838343|FG001|Overall Study|Physician Decision|0|||
162215131|NCT02127125|585838344|FG002|Overall Study|Physician Decision|1|||
162215132|NCT02127125|585838345|FG003|Overall Study|Physician Decision|0|||
161678248|NCT03023059|583873651|FG000|Overall Study|Withdrawal by Subject|5|||
161678249|NCT01526551|583873654|FG000|Overall Study|Lack of returned parental consent form|424|||
161678250|NCT00874770|583873655|FG000|Overall Study|Lack of Efficacy|2|||
161678251|NCT00874770|583873656|FG001|Overall Study|Lack of Efficacy|0|||
161678252|NCT00874770|583873657|FG002|Overall Study|Lack of Efficacy|0|||
161678253|NCT00874770|583873658|FG003|Overall Study|Lack of Efficacy|2|||
161678254|NCT00874770|583873655|FG000|Overall Study|Adverse Event|1|||
161678255|NCT00874770|583873656|FG001|Overall Study|Adverse Event|1|||
161678256|NCT00874770|583873657|FG002|Overall Study|Adverse Event|4|||
161678257|NCT00874770|583873658|FG003|Overall Study|Adverse Event|2|||
161678258|NCT00874770|583873655|FG000|Overall Study|Lost to Follow-up|1|||
161678259|NCT00874770|583873656|FG001|Overall Study|Lost to Follow-up|0|||
161678260|NCT00874770|583873657|FG002|Overall Study|Lost to Follow-up|0|||
161678261|NCT00874770|583873658|FG003|Overall Study|Lost to Follow-up|1|||
161678262|NCT00874770|583873655|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
161678263|NCT00874770|583873656|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
161678264|NCT00874770|583873657|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
161678265|NCT00874770|583873658|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
161678266|NCT01353508|583873659|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
161678267|NCT01353508|583873660|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
161678268|NCT01353508|583873661|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
161678269|NCT01353508|583873662|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
161678270|NCT01353508|583873659|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
161678271|NCT01353508|583873660|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
161678272|NCT01353508|583873661|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
161678273|NCT01353508|583873662|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
161678274|NCT00873366|583873663|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
161678275|NCT00873366|583873663|FG000|Overall Study|Off tamoxifen due to side effects|2|||
161678276|NCT00873366|583873663|FG000|Overall Study|Refused to continue DM-BT testing|3|||
161678277|NCT01576172|583873664|FG000|Overall Study|Ineligible|2|||
161678278|NCT01576172|583873665|FG001|Overall Study|Ineligible|1|||
162215133|NCT02127125|585838346|FG004|Overall Study|Physician Decision|1|||
162215134|NCT02127125|585838347|FG005|Overall Study|Physician Decision|2|||
162215135|NCT02127125|585838348|FG006|Overall Study|Physician Decision|0|||
162215136|NCT02127125|585838349|FG007|Overall Study|Physician Decision|0|||
161678279|NCT01576172|583873664|FG000|Overall Study|Withdrawal by Subject|2|||
161678280|NCT01576172|583873665|FG001|Overall Study|Withdrawal by Subject|0|||
162215137|NCT02127125|585838350|FG008|Overall Study|Physician Decision|0|||
161678281|NCT01576172|583873664|FG000|Overall Study|Insurance issue|1|||
162215138|NCT02498236|585838354|FG000|Overall Study|Did not show for testing|1|||
162215139|NCT02498236|585838355|FG001|Overall Study|Did not show for testing|0|||
161678282|NCT01576172|583873665|FG001|Overall Study|Insurance issue|0|||
161678283|NCT02092350|583873670|FG000|Overall Study|Adverse Event|0|||
161678284|NCT02092350|583873671|FG001|Overall Study|Adverse Event|3|||
161678285|NCT02092350|583873670|FG000|Overall Study|Death|2|||
161678286|NCT02092350|583873671|FG001|Overall Study|Death|5|||
161678287|NCT02092350|583873670|FG000|Overall Study|Lost to Follow-up|3|||
161678288|NCT02092350|583873671|FG001|Overall Study|Lost to Follow-up|1|||
161678289|NCT02092350|583873670|FG000|Overall Study|Protocol Violation|1|||
161678290|NCT02092350|583873671|FG001|Overall Study|Protocol Violation|0|||
161678291|NCT02092350|583873670|FG000|Overall Study|Physician Decision|1|||
161678292|NCT02092350|583873671|FG001|Overall Study|Physician Decision|1|||
161678293|NCT02092350|583873670|FG000|Overall Study|Screen Failure|1|||
161678294|NCT02092350|583873671|FG001|Overall Study|Screen Failure|0|||
161678295|NCT02092350|583873670|FG000|Overall Study|Withdrawal by Subject|2|||
161678296|NCT02092350|583873671|FG001|Overall Study|Withdrawal by Subject|2|||
161678297|NCT00646906|583873673|FG000|Crossover Period 1|Withdrawal by Subject|1|||
161678298|NCT00646906|583873674|FG001|Crossover Period 1|Withdrawal by Subject|0|||
161678299|NCT00646906|583873675|FG002|Crossover Period 1|Withdrawal by Subject|0|||
161678300|NCT00646906|583873676|FG003|Crossover Period 1|Withdrawal by Subject|0|||
161678301|NCT00646906|583873677|FG004|Crossover Period 1|Withdrawal by Subject|0|||
161678302|NCT00646906|583873678|FG005|Crossover Period 1|Withdrawal by Subject|1|||
161678303|NCT00646906|583873679|FG006|Crossover Period 1|Withdrawal by Subject|0|||
161678304|NCT00646906|583873673|FG000|Crossover Period 2|Withdrawal by Subject|0|||
161678305|NCT00646906|583873674|FG001|Crossover Period 2|Withdrawal by Subject|1|||
161678306|NCT00646906|583873675|FG002|Crossover Period 2|Withdrawal by Subject|2|||
161678307|NCT00646906|583873676|FG003|Crossover Period 2|Withdrawal by Subject|1|||
161678308|NCT00646906|583873677|FG004|Crossover Period 2|Withdrawal by Subject|0|||
161678309|NCT00646906|583873678|FG005|Crossover Period 2|Withdrawal by Subject|0|||
161678310|NCT00646906|583873679|FG006|Crossover Period 2|Withdrawal by Subject|0|||
161678311|NCT00646906|583873673|FG000|Crossover Period 2|Physician Decision|0|||
161678312|NCT00646906|583873674|FG001|Crossover Period 2|Physician Decision|0|||
161678313|NCT00646906|583873675|FG002|Crossover Period 2|Physician Decision|0|||
161678314|NCT00646906|583873676|FG003|Crossover Period 2|Physician Decision|0|||
161678315|NCT00646906|583873677|FG004|Crossover Period 2|Physician Decision|0|||
161678316|NCT00646906|583873678|FG005|Crossover Period 2|Physician Decision|0|||
161678317|NCT00646906|583873679|FG006|Crossover Period 2|Physician Decision|1|||
161678318|NCT02844920|583873683|FG000|Overall Study|Lost to Follow-up|2|||
161678319|NCT04534491|583873684|FG000|Overall Study|Not completed end-of-study interview|24|||
161678320|NCT04534491|583873684|FG000|Overall Study|Non-users|70|||
161678321|NCT04534491|583873684|FG000|Overall Study|Non-verifiable users|58|||
161678322|NCT00369785|583873690|FG000|Overall Study|Physician Decision|3|||
161678323|NCT00369785|583873691|FG001|Overall Study|Physician Decision|2|||
161678324|NCT00369785|583873690|FG000|Overall Study|Death|1|||
161678325|NCT00369785|583873691|FG001|Overall Study|Death|2|||
161678326|NCT00369785|583873690|FG000|Overall Study|Withdrawal by Subject|7|||
161678327|NCT00369785|583873691|FG001|Overall Study|Withdrawal by Subject|6|||
161678328|NCT00369785|583873690|FG000|Overall Study|Toxicity|6|||
161678329|NCT00369785|583873691|FG001|Overall Study|Toxicity|4|||
161678330|NCT00369785|583873690|FG000|Overall Study|Never started|0|||
161678331|NCT00369785|583873691|FG001|Overall Study|Never started|2|||
161678332|NCT00369785|583873690|FG000|Overall Study|Progression|4|||
161678333|NCT00369785|583873691|FG001|Overall Study|Progression|4|||
161678334|NCT00369785|583873690|FG000|Overall Study|Multiple reasons|6|||
161678335|NCT00369785|583873691|FG001|Overall Study|Multiple reasons|5|||
161678336|NCT00800683|583873692|FG000|Overall Study|Adverse Event|11|||
161678337|NCT00800683|583873693|FG001|Overall Study|Adverse Event|8|||
161678338|NCT00800683|583873692|FG000|Overall Study|Lost to Follow-up|3|||
161678339|NCT00800683|583873693|FG001|Overall Study|Lost to Follow-up|1|||
161678340|NCT00800683|583873692|FG000|Overall Study|Withdrawal by Subject|1|||
161678341|NCT00800683|583873693|FG001|Overall Study|Withdrawal by Subject|7|||
161678342|NCT00800683|583873692|FG000|Overall Study|Lack of Efficacy|1|||
161678343|NCT00800683|583873693|FG001|Overall Study|Lack of Efficacy|1|||
161678344|NCT00800683|583873692|FG000|Overall Study|Other|1|||
161678345|NCT00800683|583873693|FG001|Overall Study|Other|2|||
161678346|NCT02247960|583873695|FG000|Patient Consent and Randomization|Physician Decision|2|||
161678347|NCT02247960|583873696|FG001|Patient Consent and Randomization|Physician Decision|2|||
161678348|NCT02247960|583873695|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
161678349|NCT02247960|583873696|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
161678350|NCT02247960|583873695|FG000|Catheter Removed|Lost to Follow-up|7|||
161678351|NCT02247960|583873696|FG001|Catheter Removed|Lost to Follow-up|10|||
161678352|NCT02678416|583873697|FG000|Part 1|Withdrawal by Subject|1|||
161678353|NCT02678416|583873697|FG000|Part 2|Adverse Event|2|||
161678354|NCT02678416|583873697|FG000|Part 2|Withdrawal by Subject|1|||
161678355|NCT01848353|583873698|FG000|Phase 1|Withdrawal by Subject|3|||
162215140|NCT02498236|585838356|FG002|Overall Study|Did not show for testing|0|||
162215141|NCT02498236|585838357|FG003|Overall Study|Did not show for testing|0|||
162215142|NCT02498236|585838358|FG004|Overall Study|Did not show for testing|0|||
162215143|NCT02498236|585838359|FG005|Overall Study|Did not show for testing|0|||
162215144|NCT02498236|585838360|FG006|Overall Study|Did not show for testing|0|||
162215145|NCT02498236|585838361|FG007|Overall Study|Did not show for testing|1|||
162215146|NCT02498236|585838354|FG000|Overall Study|Equipment failure|0|||
162215147|NCT02498236|585838355|FG001|Overall Study|Equipment failure|0|||
162215148|NCT02498236|585838356|FG002|Overall Study|Equipment failure|0|||
162215149|NCT02498236|585838357|FG003|Overall Study|Equipment failure|0|||
162215150|NCT02498236|585838358|FG004|Overall Study|Equipment failure|0|||
162215151|NCT02498236|585838359|FG005|Overall Study|Equipment failure|0|||
162215152|NCT02498236|585838360|FG006|Overall Study|Equipment failure|1|||
162215153|NCT02498236|585838361|FG007|Overall Study|Equipment failure|0|||
162215154|NCT02498236|585838354|FG000|Overall Study|Withdrawal by Subject|0|||
162215155|NCT02498236|585838355|FG001|Overall Study|Withdrawal by Subject|0|||
162215156|NCT02498236|585838356|FG002|Overall Study|Withdrawal by Subject|0|||
161827313|NCT00685750|584408050|FG000|Overall Study|Tumor sampling failure|0|||
161827314|NCT00685750|584408051|FG001|Overall Study|Tumor sampling failure|0|||
161827315|NCT00685750|584408052|FG002|Overall Study|Tumor sampling failure|1|||
161827316|NCT00685750|584408053|FG003|Overall Study|Tumor sampling failure|0|||
161827317|NCT00685750|584408054|FG004|Overall Study|Tumor sampling failure|0|||
162215157|NCT02498236|585838357|FG003|Overall Study|Withdrawal by Subject|0|||
162215158|NCT02498236|585838358|FG004|Overall Study|Withdrawal by Subject|1|||
162215159|NCT02498236|585838359|FG005|Overall Study|Withdrawal by Subject|0|||
162215160|NCT02498236|585838360|FG006|Overall Study|Withdrawal by Subject|0|||
162215161|NCT02498236|585838361|FG007|Overall Study|Withdrawal by Subject|0|||
162215162|NCT03566979|585838363|FG000|Overall Study|Withdrawal by Subject|2|||
162215163|NCT03566979|585838364|FG001|Overall Study|Withdrawal by Subject|0|||
162215164|NCT03566979|585838365|FG002|Overall Study|Withdrawal by Subject|1|||
162215165|NCT03566979|585838366|FG003|Overall Study|Withdrawal by Subject|1|||
162215166|NCT03566979|585838363|FG000|Overall Study|Lost to Follow-up|2|||
162215167|NCT03566979|585838364|FG001|Overall Study|Lost to Follow-up|7|||
162215168|NCT03566979|585838365|FG002|Overall Study|Lost to Follow-up|9|||
162215169|NCT03566979|585838366|FG003|Overall Study|Lost to Follow-up|5|||
162215170|NCT03566979|585838363|FG000|Overall Study|Adverse Event|1|||
162215171|NCT03566979|585838364|FG001|Overall Study|Adverse Event|0|||
162215172|NCT03566979|585838365|FG002|Overall Study|Adverse Event|0|||
162215173|NCT03566979|585838366|FG003|Overall Study|Adverse Event|0|||
162215174|NCT01255761|585838367|FG000|Overall Study|Adverse Event|29|||
162215175|NCT01255761|585838368|FG001|Overall Study|Adverse Event|43|||
162215176|NCT01255761|585838367|FG000|Overall Study|Lack of Efficacy|86|||
162215177|NCT01255761|585838368|FG001|Overall Study|Lack of Efficacy|74|||
162215178|NCT01255761|585838367|FG000|Overall Study|Protocol Violation|9|||
162215179|NCT01255761|585838368|FG001|Overall Study|Protocol Violation|5|||
162215180|NCT01255761|585838367|FG000|Overall Study|Lost to Follow-up|10|||
162215181|NCT01255761|585838368|FG001|Overall Study|Lost to Follow-up|8|||
162215182|NCT01255761|585838367|FG000|Overall Study|Withdrawal by Subject|11|||
162215183|NCT01255761|585838368|FG001|Overall Study|Withdrawal by Subject|27|||
162215184|NCT01255761|585838367|FG000|Overall Study|Other Reasons|37|||
162215185|NCT01255761|585838368|FG001|Overall Study|Other Reasons|18|||
162215186|NCT02336425|585838369|FG000|Overall Study|Study terminated.|2|||
162215187|NCT02336425|585838370|FG001|Overall Study|Study terminated.|2|||
162215188|NCT02336425|585838371|FG002|Overall Study|Study terminated.|3|||
162215189|NCT02336425|585838372|FG003|Overall Study|Study terminated.|3|||
162215190|NCT00658606|585838373|FG000|Overall Study|Adverse Event|2|||
162215191|NCT00658606|585838374|FG001|Overall Study|Adverse Event|1|||
162215192|NCT00658606|585838373|FG000|Overall Study|Lack of Efficacy|6|||
162215193|NCT00658606|585838374|FG001|Overall Study|Lack of Efficacy|3|||
162215194|NCT00658606|585838373|FG000|Overall Study|Lost to Follow-up|1|||
162215195|NCT00658606|585838374|FG001|Overall Study|Lost to Follow-up|0|||
162215196|NCT00658606|585838373|FG000|Overall Study|Withdrawal by Subject|7|||
162215197|NCT00658606|585838374|FG001|Overall Study|Withdrawal by Subject|16|||
162215198|NCT00658606|585838373|FG000|Overall Study|Lack of Compliance|0|||
162215199|NCT00658606|585838374|FG001|Overall Study|Lack of Compliance|3|||
162215200|NCT01191008|585838375|FG000|Overall Study|Protocol Violation|7|||
162215201|NCT01191008|585838375|FG000|Overall Study|Lost to Follow-up|8|||
162215202|NCT02394665|585838378|FG000|Overall Study|Physician Decision|1|||
162215203|NCT02394665|585838379|FG001|Overall Study|Physician Decision|0|||
162215204|NCT02394665|585838380|FG002|Overall Study|Physician Decision|0|||
162215205|NCT03348631|585838381|FG000|Overall Study|Not Eligible, No treatment|0|||
161827318|NCT00685750|584408055|FG005|Overall Study|Tumor sampling failure|0|||
161827319|NCT00685750|584408056|FG006|Overall Study|Tumor sampling failure|0|||
161827320|NCT00685750|584408050|FG000|Overall Study|Patient didn't receive the treatment|0|||
161827321|NCT00685750|584408051|FG001|Overall Study|Patient didn't receive the treatment|0|||
162215206|NCT03348631|585838382|FG001|Overall Study|Not Eligible, No treatment|1|||
162215207|NCT03348631|585838381|FG000|Overall Study|Not Eligible, Treated|2|||
162215208|NCT03348631|585838382|FG001|Overall Study|Not Eligible, Treated|0|||
162215209|NCT03348631|585838381|FG000|Overall Study|Eligible, No Treatment|1|||
162215210|NCT03348631|585838382|FG001|Overall Study|Eligible, No Treatment|0|||
162215211|NCT01068210|585838383|FG000|Overall Study|Lost to Follow-up|1|||
162215212|NCT01068210|585838384|FG001|Overall Study|Lost to Follow-up|2|||
161936569|NCT01856478|584817663|FG000|Overall Study|Not treated|0|||
161936570|NCT01856478|584817664|FG001|Overall Study|Not treated|8|||
161936571|NCT01856478|584817663|FG000|Overall Study|Progressive disease per RECIST|146|||
161936572|NCT01856478|584817664|FG001|Overall Study|Progressive disease per RECIST|49|||
161936573|NCT01856478|584817663|FG000|Overall Study|Worsening of underlying cancer|6|||
161936574|NCT01856478|584817664|FG001|Overall Study|Worsening of underlying cancer|2|||
161936575|NCT01856478|584817663|FG000|Overall Study|Adverse events|57|||
161936576|NCT01856478|584817664|FG001|Overall Study|Adverse events|30|||
161936577|NCT01856478|584817663|FG000|Overall Study|Non-compliant with protocol|1|||
161936578|NCT01856478|584817664|FG001|Overall Study|Non-compliant with protocol|1|||
161936579|NCT01856478|584817663|FG000|Overall Study|Lost to Follow-up|1|||
161936580|NCT01856478|584817664|FG001|Overall Study|Lost to Follow-up|1|||
161936581|NCT01856478|584817663|FG000|Overall Study|Refused to continue trial medication|13|||
161936582|NCT01856478|584817664|FG001|Overall Study|Refused to continue trial medication|11|||
161936583|NCT01856478|584817663|FG000|Overall Study|Other reason than listed|4|||
161936584|NCT01856478|584817664|FG001|Overall Study|Other reason than listed|10|||
162215213|NCT01068210|585838385|FG002|Overall Study|Lost to Follow-up|2|||
162215214|NCT01068210|585838386|FG003|Overall Study|Lost to Follow-up|1|||
162215215|NCT01068210|585838383|FG000|Overall Study|Second cancer|0|||
162215216|NCT01068210|585838384|FG001|Overall Study|Second cancer|1|||
162215217|NCT01068210|585838385|FG002|Overall Study|Second cancer|0|||
162215218|NCT01068210|585838386|FG003|Overall Study|Second cancer|0|||
162215219|NCT01068210|585838383|FG000|Overall Study|Disease progression|0|||
162215220|NCT01068210|585838384|FG001|Overall Study|Disease progression|0|||
162215221|NCT01068210|585838385|FG002|Overall Study|Disease progression|0|||
162215222|NCT01068210|585838386|FG003|Overall Study|Disease progression|2|||
162215223|NCT03299959|585838395|FG000|Overall Study|Lost to Follow-up|7|||
162215224|NCT03299959|585838396|FG001|Overall Study|Lost to Follow-up|9|||
162215225|NCT03299959|585838395|FG000|Overall Study|Death|1|||
162215226|NCT03299959|585838396|FG001|Overall Study|Death|0|||
162215227|NCT03299959|585838395|FG000|Overall Study|Withdrawal by Subject|13|||
162215228|NCT03299959|585838396|FG001|Overall Study|Withdrawal by Subject|9|||
162215229|NCT03299959|585838395|FG000|Overall Study|Changes in study team and government regulations|1|||
162215230|NCT03299959|585838396|FG001|Overall Study|Changes in study team and government regulations|1|||
162215231|NCT03299959|585838395|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
162215232|NCT03299959|585838396|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
162215233|NCT01431950|585838397|FG000|Overall Study|Study Site Closed/Terminated|7|||
162215234|NCT01431950|585838398|FG001|Overall Study|Study Site Closed/Terminated|3|||
162215235|NCT01431950|585838397|FG000|Overall Study|Withdrawal by Subject|4|||
162215236|NCT01431950|585838398|FG001|Overall Study|Withdrawal by Subject|3|||
162215237|NCT01431950|585838397|FG000|Overall Study|Protocol Violation|2|||
162215238|NCT01431950|585838398|FG001|Overall Study|Protocol Violation|3|||
162215239|NCT01431950|585838397|FG000|Overall Study|Adverse Event|2|||
162215240|NCT01431950|585838398|FG001|Overall Study|Adverse Event|2|||
162215241|NCT01431950|585838397|FG000|Overall Study|Physician Decision|2|||
162215242|NCT01431950|585838398|FG001|Overall Study|Physician Decision|1|||
161936585|NCT05032820|584817665|FG000|Overall Study|Lost to Follow-up|1|||
161936586|NCT05032820|584817665|FG000|Overall Study|Withdrawal by Subject|1|||
162215243|NCT01431950|585838397|FG000|Overall Study|Lack of Efficacy|2|||
162215244|NCT01431950|585838398|FG001|Overall Study|Lack of Efficacy|1|||
162215245|NCT01431950|585838397|FG000|Overall Study|Lost to Follow-up|0|||
162215246|NCT01431950|585838398|FG001|Overall Study|Lost to Follow-up|1|||
162215247|NCT01431950|585838397|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
162215248|NCT01431950|585838398|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
162215249|NCT00738283|585838401|FG000|Overall Study|Death|1|||
162215250|NCT00738283|585838401|FG000|Overall Study|Transfer to another facility|2|||
162215251|NCT00738283|585838401|FG000|Overall Study|Discharge home prior to end of study|1|||
162215252|NCT01210651|585838402|FG000|Overall Study|Lost to Follow-up|1|||
162215253|NCT01210651|585838403|FG001|Overall Study|Lost to Follow-up|1|||
162215254|NCT01210651|585838402|FG000|Overall Study|schedule conflicts|1|||
162215255|NCT01210651|585838403|FG001|Overall Study|schedule conflicts|5|||
162215256|NCT01210651|585838402|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
162215257|NCT01210651|585838403|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
162215258|NCT01210651|585838402|FG000|Overall Study|Withdrawal by Subject|1|||
162215259|NCT01210651|585838403|FG001|Overall Study|Withdrawal by Subject|1|||
162215260|NCT01210651|585838402|FG000|Overall Study|Injury outside study|2|||
162215261|NCT01210651|585838403|FG001|Overall Study|Injury outside study|0|||
162215262|NCT03494985|585838404|FG000|Overall Study|Adverse Event|3|||
162215263|NCT03494985|585838405|FG001|Overall Study|Adverse Event|2|||
162215264|NCT03494985|585838406|FG002|Overall Study|Adverse Event|3|||
162215265|NCT03494985|585838407|FG003|Overall Study|Adverse Event|0|||
162215266|NCT03494985|585838404|FG000|Overall Study|Other (Withdrawal of consent)|2|||
162215267|NCT03494985|585838405|FG001|Overall Study|Other (Withdrawal of consent)|3|||
162215268|NCT03494985|585838406|FG002|Overall Study|Other (Withdrawal of consent)|2|||
162215269|NCT03494985|585838407|FG003|Overall Study|Other (Withdrawal of consent)|5|||
162215270|NCT03494985|585838404|FG000|Overall Study|Other (Not specified)|0|||
162215271|NCT03494985|585838405|FG001|Overall Study|Other (Not specified)|1|||
162215272|NCT03494985|585838406|FG002|Overall Study|Other (Not specified)|1|||
162215273|NCT03494985|585838407|FG003|Overall Study|Other (Not specified)|0|||
162215274|NCT02282059|585838410|FG000|Overall Study|Other|15|||
162215275|NCT02282059|585838411|FG001|Overall Study|Other|3|||
162215276|NCT02282059|585838410|FG000|Overall Study|Participant refused further follow-up|8|||
162215277|NCT02282059|585838411|FG001|Overall Study|Participant refused further follow-up|4|||
162215278|NCT02282059|585838410|FG000|Overall Study|Lost to Follow-up|19|||
162215279|NCT02282059|585838411|FG001|Overall Study|Lost to Follow-up|3|||
162215280|NCT02282059|585838410|FG000|Overall Study|Death|40|||
162215281|NCT02282059|585838411|FG001|Overall Study|Death|8|||
162215282|NCT03459846|585838412|FG000|Overall Study|Death|52|||
162215283|NCT03459846|585838413|FG001|Overall Study|Death|46|||
162215284|NCT03459846|585838412|FG000|Overall Study|Study terminated by sponsor|24|||
162215285|NCT03459846|585838413|FG001|Overall Study|Study terminated by sponsor|28|||
162215286|NCT03459846|585838412|FG000|Overall Study|Withdrawal by Subject|2|||
162215287|NCT03459846|585838413|FG001|Overall Study|Withdrawal by Subject|2|||
162215288|NCT04886518|585838420|FG000|Overall Study|Noncompliance with study drug|1|||
162215289|NCT04886518|585838421|FG001|Overall Study|Noncompliance with study drug|0|||
162215290|NCT04886518|585838422|FG002|Overall Study|Noncompliance with study drug|0|||
162215291|NCT04886518|585838420|FG000|Overall Study|Adverse Event|0|||
162215292|NCT04886518|585838421|FG001|Overall Study|Adverse Event|1|||
162215293|NCT04886518|585838422|FG002|Overall Study|Adverse Event|0|||
162215294|NCT04886518|585838420|FG000|Overall Study|Withdrawal by Subject|1|||
162215295|NCT04886518|585838421|FG001|Overall Study|Withdrawal by Subject|0|||
162215296|NCT04886518|585838422|FG002|Overall Study|Withdrawal by Subject|0|||
162215297|NCT01090011|585840738|FG000|Overall Study|Progressive disease|128|||
162215298|NCT01090011|585840738|FG000|Overall Study|Adverse Event|32|||
162215299|NCT01090011|585840738|FG000|Overall Study|Protocol Violation|1|||
162215300|NCT01090011|585840738|FG000|Overall Study|Refusal to start/continue medication|5|||
162215301|NCT01090011|585840738|FG000|Overall Study|Other reason not defined above|5|||
162215302|NCT03778294|585840739|FG000|Overall Study|Death|1|||
162215303|NCT03778294|585840739|FG000|Overall Study|Issues with insurance|1|||
162215304|NCT03778294|585840739|FG000|Overall Study|disease progression before treatment|2|||
162215305|NCT01845805|585840740|FG000|Overall Study|Withdrawal by Subject|1|||
162215306|NCT01845805|585840741|FG001|Overall Study|Withdrawal by Subject|2|||
162215307|NCT01845805|585840740|FG000|Overall Study|Disease Progression|13|||
162215308|NCT01845805|585840741|FG001|Overall Study|Disease Progression|14|||
162215309|NCT01845805|585840740|FG000|Overall Study|Drug-related Toxicity|4|||
162215310|NCT01845805|585840741|FG001|Overall Study|Drug-related Toxicity|0|||
162215311|NCT00127842|585840742|FG000|Overall Study|Adverse Event|15|||
162215312|NCT00127842|585840742|FG000|Overall Study|Withdrawal by Subject|3|||
162215313|NCT00127842|585840742|FG000|Overall Study|Lost to Follow-up|1|||
162215314|NCT00127842|585840742|FG000|Overall Study|Lack of Efficacy|12|||
162215315|NCT00127842|585840742|FG000|Overall Study|Noncompliance|2|||
162215316|NCT00127842|585840742|FG000|Overall Study|Protocol Violation|1|||
162215317|NCT00127842|585840742|FG000|Overall Study|Other|5|||
162215318|NCT01443403|585840743|FG000|Overall Study|Adverse Event|1|||
162215319|NCT01443403|585840744|FG001|Overall Study|Adverse Event|1|||
162215320|NCT01443403|585840745|FG002|Overall Study|Adverse Event|4|||
161936635|NCT04108208|584817671|FG000|Overall Study|Withdrawal by Subject|2|||
161936636|NCT04108208|584817672|FG001|Overall Study|Withdrawal by Subject|6|||
161936637|NCT04108208|584817671|FG000|Overall Study|other-ongoing|20|||
161936638|NCT04108208|584817672|FG001|Overall Study|other-ongoing|40|||
161936639|NCT04108208|584817671|FG000|Overall Study|Death|1|||
162215321|NCT01443403|585840746|FG003|Overall Study|Adverse Event|5|||
162215322|NCT01443403|585840743|FG000|Overall Study|Withdrawal by Subject|0|||
162215323|NCT01443403|585840744|FG001|Overall Study|Withdrawal by Subject|1|||
162215324|NCT01443403|585840745|FG002|Overall Study|Withdrawal by Subject|2|||
162215325|NCT01443403|585840746|FG003|Overall Study|Withdrawal by Subject|1|||
162215326|NCT01443403|585840743|FG000|Overall Study|Lost to Follow-up|0|||
162215327|NCT01443403|585840744|FG001|Overall Study|Lost to Follow-up|0|||
161936640|NCT04108208|584817672|FG001|Overall Study|Death|4|||
161936641|NCT04108208|584817671|FG000|Overall Study|Lost to Follow-up|2|||
162215328|NCT01443403|585840745|FG002|Overall Study|Lost to Follow-up|0|||
162215329|NCT01443403|585840746|FG003|Overall Study|Lost to Follow-up|1|||
162215330|NCT01443403|585840743|FG000|Overall Study|Protocol Violation|2|||
162215331|NCT01443403|585840744|FG001|Overall Study|Protocol Violation|1|||
162215332|NCT01443403|585840745|FG002|Overall Study|Protocol Violation|1|||
162215333|NCT01443403|585840746|FG003|Overall Study|Protocol Violation|1|||
162215334|NCT01443403|585840743|FG000|Overall Study|Use of Prohibited Treatment|2|||
162215335|NCT01443403|585840744|FG001|Overall Study|Use of Prohibited Treatment|3|||
162215336|NCT01443403|585840745|FG002|Overall Study|Use of Prohibited Treatment|0|||
162215337|NCT01443403|585840746|FG003|Overall Study|Use of Prohibited Treatment|0|||
162215338|NCT01443403|585840743|FG000|Overall Study|Other - Miscellaneous|1|||
162215339|NCT01443403|585840744|FG001|Overall Study|Other - Miscellaneous|0|||
162215340|NCT01443403|585840745|FG002|Overall Study|Other - Miscellaneous|0|||
162215341|NCT01443403|585840746|FG003|Overall Study|Other - Miscellaneous|1|||
161936642|NCT04108208|584817672|FG001|Overall Study|Lost to Follow-up|0|||
161936643|NCT04936308|584817673|FG000|Overall Study|Death|0|||
161936644|NCT04936308|584817674|FG001|Overall Study|Death|0|||
161936645|NCT04936308|584817675|FG002|Overall Study|Death|1|||
162215342|NCT03945773|585840747|FG000|Overall Study|Consent Withdrawn|1|||
162215343|NCT03945773|585840748|FG001|Overall Study|Consent Withdrawn|1|||
162215344|NCT03945773|585840747|FG000|Overall Study|Lost to Follow-up|1|||
162215345|NCT03945773|585840748|FG001|Overall Study|Lost to Follow-up|0|||
162215346|NCT03945773|585840747|FG000|Overall Study|Death|46|||
161936646|NCT04936308|584817673|FG000|Overall Study|Withdrawal by Subject|6|||
161936647|NCT04936308|584817674|FG001|Overall Study|Withdrawal by Subject|3|||
161936648|NCT04936308|584817675|FG002|Overall Study|Withdrawal by Subject|0|||
161936649|NCT04936308|584817673|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
161936650|NCT04936308|584817674|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
161936651|NCT04936308|584817675|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
161936652|NCT04936308|584817673|FG000|Overall Study|Completed protocol-required follow-up|1|||
162215347|NCT03945773|585840748|FG001|Overall Study|Death|22|||
162215348|NCT03945773|585840747|FG000|Overall Study|Physician Decision|1|||
162215349|NCT03945773|585840748|FG001|Overall Study|Physician Decision|0|||
162215350|NCT03945773|585840747|FG000|Overall Study|Other|1|||
162215351|NCT03945773|585840748|FG001|Overall Study|Other|0|||
162215352|NCT03945773|585840747|FG000|Overall Study|Ongoing at the time of DCO|4|||
162215353|NCT03945773|585840748|FG001|Overall Study|Ongoing at the time of DCO|3|||
162215354|NCT00725712|585840751|FG000|Overall Study|Withdrawal by Subject|2|||
162215355|NCT00725712|585840752|FG001|Overall Study|Withdrawal by Subject|1|||
162215356|NCT00725712|585840751|FG000|Overall Study|Protocol Violation|1|||
162215357|NCT00725712|585840752|FG001|Overall Study|Protocol Violation|0|||
162215358|NCT00725712|585840751|FG000|Overall Study|Progressive disease|37|||
162215359|NCT00725712|585840752|FG001|Overall Study|Progressive disease|16|||
162215360|NCT00725712|585840751|FG000|Overall Study|Clinical progression not based on RECIST|0|||
162215361|NCT00725712|585840752|FG001|Overall Study|Clinical progression not based on RECIST|3|||
162215362|NCT00725712|585840751|FG000|Overall Study|Adverse Event|5|||
162215363|NCT00725712|585840752|FG001|Overall Study|Adverse Event|5|||
162215364|NCT00725712|585840751|FG000|Overall Study|Death|2|||
161678356|NCT01848353|583873699|FG001|Phase 1|Withdrawal by Subject|1|||
161678357|NCT01848353|583873700|FG002|Phase 1|Withdrawal by Subject|0|||
161678358|NCT01848353|583873701|FG003|Phase 1|Withdrawal by Subject|0|||
161678359|NCT01848353|583873698|FG000|Phase 2|Withdrawal by Subject|3|||
161678360|NCT01848353|583873699|FG001|Phase 2|Withdrawal by Subject|2|||
161678361|NCT01848353|583873700|FG002|Phase 2|Withdrawal by Subject|0|||
161678362|NCT01848353|583873701|FG003|Phase 2|Withdrawal by Subject|0|||
161678363|NCT01848353|583873698|FG000|Phase 3|Withdrawal by Subject|1|||
161678364|NCT01848353|583873699|FG001|Phase 3|Withdrawal by Subject|1|||
161678365|NCT01848353|583873700|FG002|Phase 3|Withdrawal by Subject|0|||
161678366|NCT01848353|583873701|FG003|Phase 3|Withdrawal by Subject|0|||
161678367|NCT00736034|583873711|FG000|Overall Study|Adverse Event|2|||
161678368|NCT01910116|583873712|FG000|Overall Study|Adverse Event|0|||
161678369|NCT01910116|583873713|FG001|Overall Study|Adverse Event|3|||
161678370|NCT01910116|583873712|FG000|Overall Study|Lack of Efficacy|3|||
161678371|NCT01910116|583873713|FG001|Overall Study|Lack of Efficacy|4|||
161678372|NCT01910116|583873712|FG000|Overall Study|Lost to Follow-up|1|||
161678373|NCT01910116|583873713|FG001|Overall Study|Lost to Follow-up|0|||
161678374|NCT01910116|583873712|FG000|Overall Study|Protocol Violation|1|||
161678375|NCT01910116|583873713|FG001|Overall Study|Protocol Violation|2|||
161936653|NCT04936308|584817674|FG001|Overall Study|Completed protocol-required follow-up|2|||
161678376|NCT01910116|583873712|FG000|Overall Study|Withdrawal by Subject|8|||
161678377|NCT01910116|583873713|FG001|Overall Study|Withdrawal by Subject|3|||
161678378|NCT01910116|583873712|FG000|Overall Study|uncertain allocation|1|||
161678379|NCT01910116|583873713|FG001|Overall Study|uncertain allocation|3|||
161678380|NCT01910116|583873712|FG000|Overall Study|incomplete data|0|||
161678381|NCT01910116|583873713|FG001|Overall Study|incomplete data|1|||
162215365|NCT00725712|585840752|FG001|Overall Study|Death|0|||
162215366|NCT00725712|585840751|FG000|Overall Study|Other: Death|1|||
162215367|NCT00725712|585840752|FG001|Overall Study|Other: Death|0|||
162215368|NCT00725712|585840751|FG000|Overall Study|Hospitalized, unable to continue|0|||
162215369|NCT00725712|585840752|FG001|Overall Study|Hospitalized, unable to continue|1|||
162215370|NCT03595124|585840753|FG000|Overall Study|Physician Decision|1|||
162215371|NCT03595124|585840754|FG001|Overall Study|Physician Decision|1|||
162215372|NCT03595124|585840755|FG002|Overall Study|Physician Decision|1|||
162215373|NCT03595124|585840753|FG000|Overall Study|Ineligible|1|||
162215374|NCT03595124|585840754|FG001|Overall Study|Ineligible|1|||
162215375|NCT03595124|585840755|FG002|Overall Study|Ineligible|0|||
162215376|NCT03595124|585840753|FG000|Overall Study|Disease Progression|4|||
162215377|NCT03595124|585840754|FG001|Overall Study|Disease Progression|1|||
161678382|NCT02289352|583873716|FG000|Overall Study|Withdrawal by Subject|1|||
161678383|NCT02289352|583873717|FG001|Overall Study|Withdrawal by Subject|1|||
161678384|NCT02289352|583873718|FG002|Overall Study|Withdrawal by Subject|0|||
162215378|NCT03595124|585840755|FG002|Overall Study|Disease Progression|4|||
162215379|NCT03607422|585840756|FG000|Overall Study|Adverse Event|7|||
162215380|NCT03607422|585840757|FG001|Overall Study|Adverse Event|3|||
162215381|NCT03607422|585840758|FG002|Overall Study|Adverse Event|2|||
161936654|NCT04936308|584817675|FG002|Overall Study|Completed protocol-required follow-up|2|||
161936655|NCT04936308|584817673|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
161936656|NCT04936308|584817674|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
161936657|NCT04936308|584817675|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
162215382|NCT03607422|585840759|FG003|Overall Study|Adverse Event|0|||
162215383|NCT03607422|585840760|FG004|Overall Study|Adverse Event|2|||
162215384|NCT03607422|585840761|FG005|Overall Study|Adverse Event|0|||
162215385|NCT03607422|585840756|FG000|Overall Study|Withdrawal by Subject|11|||
161936658|NCT04936308|584817673|FG000|Overall Study|Other|3|||
161936659|NCT04936308|584817674|FG001|Overall Study|Other|0|||
161936660|NCT04936308|584817675|FG002|Overall Study|Other|2|||
161936661|NCT04770272|584817676|FG000|Overall Study|Death|1|||
161936662|NCT04770272|584817677|FG001|Overall Study|Death|0|||
161936663|NCT04770272|584817676|FG000|Overall Study|Withdrawal by Subject|11|||
161936664|NCT04770272|584817677|FG001|Overall Study|Withdrawal by Subject|12|||
161936665|NCT04770272|584817676|FG000|Overall Study|Protocol Violation|0|||
161936666|NCT04770272|584817677|FG001|Overall Study|Protocol Violation|2|||
161936667|NCT04770272|584817676|FG000|Overall Study|Adverse Event|23|||
161936668|NCT04770272|584817677|FG001|Overall Study|Adverse Event|21|||
161936669|NCT04770272|584817676|FG000|Overall Study|Physician Decision|7|||
161936670|NCT04770272|584817677|FG001|Overall Study|Physician Decision|3|||
161936671|NCT04770272|584817676|FG000|Overall Study|Disease progression|4|||
161936672|NCT04770272|584817677|FG001|Overall Study|Disease progression|8|||
161936673|NCT04770272|584817676|FG000|Overall Study|Switched to other therapy.|0|||
161936674|NCT04770272|584817677|FG001|Overall Study|Switched to other therapy.|2|||
161936699|NCT02363946|584817682|FG000|Overall Study|Lost to Follow-up|0|||
161936700|NCT02363946|584817683|FG001|Overall Study|Lost to Follow-up|0|||
161936701|NCT02363946|584817684|FG002|Overall Study|Lost to Follow-up|0|||
161936702|NCT02363946|584817685|FG003|Overall Study|Lost to Follow-up|0|||
161936703|NCT02363946|584817686|FG004|Overall Study|Lost to Follow-up|0|||
161936704|NCT02363946|584817687|FG005|Overall Study|Lost to Follow-up|0|||
161936705|NCT02363946|584817688|FG006|Overall Study|Lost to Follow-up|0|||
162215386|NCT03607422|585840757|FG001|Overall Study|Withdrawal by Subject|3|||
161936706|NCT02363946|584817689|FG007|Overall Study|Lost to Follow-up|1|||
161936707|NCT02363946|584817690|FG008|Overall Study|Lost to Follow-up|0|||
161936708|NCT02363946|584817691|FG009|Overall Study|Lost to Follow-up|0|||
161936709|NCT02363946|584817692|FG010|Overall Study|Lost to Follow-up|0|||
161936710|NCT02363946|584817693|FG011|Overall Study|Lost to Follow-up|0|||
161936711|NCT02363946|584817694|FG012|Overall Study|Lost to Follow-up|0|||
162215387|NCT03607422|585840758|FG002|Overall Study|Withdrawal by Subject|6|||
161936721|NCT03030261|584817702|FG000|Overall Study|Still receiving continuation therapy|5|||
161678385|NCT03606980|583873719|FG000|Overall Study|Lost to Follow-up|3|||
161678386|NCT03606980|583873720|FG001|Overall Study|Lost to Follow-up|2|||
161678387|NCT03606980|583873721|FG002|Overall Study|Lost to Follow-up|3|||
161678388|NCT03606980|583873719|FG000|Overall Study|Withdrawal by Subject|1|||
161678389|NCT03606980|583873720|FG001|Overall Study|Withdrawal by Subject|0|||
161936735|NCT01615029|584817709|FG000|Overall Study|Adverse Event|1|||
161936736|NCT01615029|584817710|FG001|Overall Study|Adverse Event|0|||
161936737|NCT01615029|584817711|FG002|Overall Study|Adverse Event|3|||
161936738|NCT01615029|584817712|FG003|Overall Study|Adverse Event|0|||
161936739|NCT01615029|584817713|FG004|Overall Study|Adverse Event|4|||
161936740|NCT01615029|584817709|FG000|Overall Study|Progressive disease|1|||
161936741|NCT01615029|584817710|FG001|Overall Study|Progressive disease|1|||
161936742|NCT01615029|584817711|FG002|Overall Study|Progressive disease|1|||
161936743|NCT01615029|584817712|FG003|Overall Study|Progressive disease|1|||
161936744|NCT01615029|584817713|FG004|Overall Study|Progressive disease|10|||
161936745|NCT01615029|584817709|FG000|Overall Study|Physician Decision|0|||
161936746|NCT01615029|584817710|FG001|Overall Study|Physician Decision|0|||
162215388|NCT03607422|585840759|FG003|Overall Study|Withdrawal by Subject|2|||
162215389|NCT03607422|585840760|FG004|Overall Study|Withdrawal by Subject|0|||
162215390|NCT03607422|585840761|FG005|Overall Study|Withdrawal by Subject|0|||
162215391|NCT03607422|585840756|FG000|Overall Study|Lost to Follow-up|0|||
162215392|NCT03607422|585840757|FG001|Overall Study|Lost to Follow-up|0|||
162215393|NCT03607422|585840758|FG002|Overall Study|Lost to Follow-up|1|||
162215394|NCT03607422|585840759|FG003|Overall Study|Lost to Follow-up|0|||
162215395|NCT03607422|585840760|FG004|Overall Study|Lost to Follow-up|0|||
162215396|NCT03607422|585840761|FG005|Overall Study|Lost to Follow-up|0|||
162215397|NCT03607422|585840756|FG000|Overall Study|Other|12|||
162215398|NCT03607422|585840757|FG001|Overall Study|Other|4|||
162215399|NCT03607422|585840758|FG002|Overall Study|Other|1|||
162215400|NCT03607422|585840759|FG003|Overall Study|Other|2|||
162215401|NCT03607422|585840760|FG004|Overall Study|Other|0|||
162215402|NCT03607422|585840761|FG005|Overall Study|Other|2|||
162215403|NCT03607422|585840756|FG000|Overall Study|Ongoing at Time of Analysis|8|||
162215404|NCT03607422|585840757|FG001|Overall Study|Ongoing at Time of Analysis|0|||
162215405|NCT03607422|585840758|FG002|Overall Study|Ongoing at Time of Analysis|2|||
162215406|NCT03607422|585840759|FG003|Overall Study|Ongoing at Time of Analysis|1|||
162215407|NCT03607422|585840760|FG004|Overall Study|Ongoing at Time of Analysis|1|||
162215408|NCT03607422|585840761|FG005|Overall Study|Ongoing at Time of Analysis|1|||
162215409|NCT03258723|585840764|FG000|Overall Study|COVID Interruption of study|54|||
162215410|NCT03258723|585840764|FG000|Overall Study|Lost to Follow-up|8|||
162215411|NCT04832971|585840765|FG000|Double-Blind (DB) Treatment Period|Death|1|||
162215412|NCT04832971|585840766|FG001|Double-Blind (DB) Treatment Period|Death|0|||
162215413|NCT04832971|585840767|FG002|Double-Blind (DB) Treatment Period|Death|0|||
162215414|NCT04832971|585840768|FG003|Double-Blind (DB) Treatment Period|Death|0|||
162215415|NCT04832971|585840769|FG004|Double-Blind (DB) Treatment Period|Death|0|||
162215416|NCT04832971|585840770|FG005|Double-Blind (DB) Treatment Period|Death|0|||
162215417|NCT04832971|585840771|FG006|Double-Blind (DB) Treatment Period|Death|0|||
162215418|NCT04832971|585840772|FG007|Double-Blind (DB) Treatment Period|Death|0|||
162215419|NCT04832971|585840773|FG008|Double-Blind (DB) Treatment Period|Death|0|||
162215420|NCT04832971|585840774|FG009|Double-Blind (DB) Treatment Period|Death|0|||
162215421|NCT04832971|585840765|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
162215422|NCT04832971|585840766|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
162215423|NCT04832971|585840767|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161678390|NCT03606980|583873721|FG002|Overall Study|Withdrawal by Subject|4|||
161678391|NCT02374021|583873723|FG000|Overall Study|Adverse Event|1|||
161678392|NCT02374021|583873724|FG001|Overall Study|Adverse Event|0|||
161678393|NCT02374021|583873723|FG000|Overall Study|Lost to Follow-up|3|||
161678394|NCT02374021|583873724|FG001|Overall Study|Lost to Follow-up|2|||
162215424|NCT04832971|585840768|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161936747|NCT01615029|584817711|FG002|Overall Study|Physician Decision|0|||
161936748|NCT01615029|584817712|FG003|Overall Study|Physician Decision|0|||
161936749|NCT01615029|584817713|FG004|Overall Study|Physician Decision|2|||
162215425|NCT04832971|585840769|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162215426|NCT04832971|585840770|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162215427|NCT04832971|585840771|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162215428|NCT04832971|585840772|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162215429|NCT04832971|585840773|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162215430|NCT04832971|585840774|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
162215431|NCT04832971|585840765|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
162215432|NCT04832971|585840766|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
162215433|NCT04832971|585840767|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
162215434|NCT04832971|585840768|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
162215435|NCT04832971|585840769|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162215436|NCT04832971|585840770|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162215437|NCT04832971|585840771|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162215438|NCT04832971|585840772|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162215439|NCT04832971|585840773|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162215440|NCT04832971|585840774|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
162215441|NCT04832971|585840765|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162215442|NCT04832971|585840766|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
162215443|NCT04832971|585840767|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162215444|NCT04832971|585840768|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162215445|NCT04832971|585840769|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162215446|NCT04832971|585840770|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162215447|NCT04832971|585840771|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162215448|NCT04832971|585840772|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162215449|NCT04832971|585840773|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162215450|NCT04832971|585840774|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
162215451|NCT04832971|585840765|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
162215452|NCT04832971|585840766|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
162215453|NCT04832971|585840767|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
162215454|NCT04832971|585840768|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
162215455|NCT04832971|585840769|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
162215456|NCT04832971|585840770|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
162215457|NCT04832971|585840771|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
162215458|NCT04832971|585840772|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
162215459|NCT04832971|585840773|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
162215460|NCT04832971|585840774|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
162215461|NCT04832971|585840765|FG000|Open-Label Extension (OLE) Period|Death|0|||
162215462|NCT04832971|585840766|FG001|Open-Label Extension (OLE) Period|Death|0|||
162215463|NCT04832971|585840767|FG002|Open-Label Extension (OLE) Period|Death|0|||
162215464|NCT04832971|585840768|FG003|Open-Label Extension (OLE) Period|Death|0|||
162215465|NCT04832971|585840769|FG004|Open-Label Extension (OLE) Period|Death|0|||
162215466|NCT04832971|585840770|FG005|Open-Label Extension (OLE) Period|Death|0|||
162215467|NCT04832971|585840771|FG006|Open-Label Extension (OLE) Period|Death|0|||
162215468|NCT04832971|585840772|FG007|Open-Label Extension (OLE) Period|Death|1|||
162215469|NCT04832971|585840773|FG008|Open-Label Extension (OLE) Period|Death|0|||
162215470|NCT04832971|585840774|FG009|Open-Label Extension (OLE) Period|Death|0|||
162215471|NCT04832971|585840765|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162215472|NCT04832971|585840766|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162215473|NCT04832971|585840767|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162215474|NCT04832971|585840768|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162215475|NCT04832971|585840769|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162215476|NCT04832971|585840770|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162215477|NCT04832971|585840771|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
162215478|NCT04832971|585840772|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
162215479|NCT04832971|585840773|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162215480|NCT04832971|585840774|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
162215481|NCT04832971|585840765|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
162215482|NCT04832971|585840766|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
162215483|NCT04832971|585840767|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
162215484|NCT04832971|585840768|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
162215485|NCT04832971|585840769|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
162215486|NCT04832971|585840770|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
162215487|NCT04832971|585840771|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
162215488|NCT04832971|585840772|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
162215489|NCT04832971|585840773|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
162215490|NCT04832971|585840774|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
162215491|NCT04832971|585840765|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162215492|NCT04832971|585840766|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162215493|NCT04832971|585840767|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162215494|NCT04832971|585840768|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162215495|NCT04832971|585840769|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
162215496|NCT04832971|585840770|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
162215497|NCT04832971|585840771|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162215498|NCT04832971|585840772|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
162215499|NCT04832971|585840773|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
162215500|NCT04832971|585840774|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
162215501|NCT04832971|585840765|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162215502|NCT04832971|585840766|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162215503|NCT04832971|585840767|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162215504|NCT04832971|585840768|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162215505|NCT04832971|585840769|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162215506|NCT04832971|585840770|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162215507|NCT04832971|585840771|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
162215508|NCT04832971|585840772|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
162215509|NCT04832971|585840773|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
162215510|NCT04832971|585840774|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
162215511|NCT01107899|585840775|FG000|Overall Study|Physician Decision|5|||
162215512|NCT01107899|585840776|FG001|Overall Study|Physician Decision|0|||
162215513|NCT01107899|585840777|FG002|Overall Study|Physician Decision|3|||
162215514|NCT01107899|585840775|FG000|Overall Study|Withdrawal by Subject|0|||
162215515|NCT01107899|585840776|FG001|Overall Study|Withdrawal by Subject|0|||
162215516|NCT01107899|585840777|FG002|Overall Study|Withdrawal by Subject|1|||
162215517|NCT03584152|585840778|FG000|Overall Study|Discontinued intervention|7|||
162215518|NCT03584152|585840779|FG001|Overall Study|Discontinued intervention|4|||
162215519|NCT04024462|585840780|FG000|Overall Study|Withdrawal by Subject|6|||
162215520|NCT04024462|585840781|FG001|Overall Study|Withdrawal by Subject|7|||
162215521|NCT04024462|585840780|FG000|Overall Study|Progressive Disease|0|||
162215522|NCT04024462|585840781|FG001|Overall Study|Progressive Disease|1|||
162215523|NCT04024462|585840780|FG000|Overall Study|Adverse Event|0|||
162215524|NCT04024462|585840781|FG001|Overall Study|Adverse Event|1|||
162215525|NCT04024462|585840780|FG000|Overall Study|Death|0|||
162215526|NCT04024462|585840781|FG001|Overall Study|Death|1|||
162215527|NCT04024462|585840780|FG000|Overall Study|Lost to Follow-up|1|||
162215528|NCT04024462|585840781|FG001|Overall Study|Lost to Follow-up|0|||
162215529|NCT04024462|585840780|FG000|Overall Study|Ongoing in the Study|94|||
162215530|NCT04024462|585840781|FG001|Overall Study|Ongoing in the Study|89|||
162215531|NCT00983749|585840786|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
162215532|NCT00983749|585840787|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
162215533|NCT04292470|585840788|FG000|Overall Study|Withdrawal by Subject|0|||
162215534|NCT04292470|585840789|FG001|Overall Study|Withdrawal by Subject|1|||
162215535|NCT02906020|585840803|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
162215536|NCT02906020|585840804|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
162215537|NCT02906020|585840805|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
162215538|NCT02906020|585840806|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
162215539|NCT02906020|585840807|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
162215540|NCT02906020|585840808|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
162215541|NCT02906020|585840809|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
162215542|NCT02906020|585840810|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
162215543|NCT02906020|585840811|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
162215544|NCT02906020|585840812|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
162215545|NCT02906020|585840813|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
162215546|NCT02906020|585840814|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
162215547|NCT02906020|585840815|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
162215548|NCT02906020|585840816|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
162215549|NCT02906020|585840817|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
162215550|NCT02906020|585840818|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
162215551|NCT02906020|585840803|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215552|NCT02906020|585840804|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215553|NCT02906020|585840805|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215554|NCT02906020|585840806|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215555|NCT02906020|585840807|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215556|NCT02906020|585840808|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215557|NCT02906020|585840809|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215558|NCT02906020|585840810|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215559|NCT02906020|585840811|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
162215560|NCT02906020|585840812|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
162215561|NCT02906020|585840813|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215562|NCT02906020|585840814|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215563|NCT02906020|585840815|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215564|NCT02906020|585840816|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215565|NCT02906020|585840817|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215566|NCT02906020|585840818|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
162215567|NCT02906020|585840803|FG000|Part 2: Double-blind Treatment Period|Other|0|||
162215568|NCT02906020|585840804|FG001|Part 2: Double-blind Treatment Period|Other|0|||
162215569|NCT02906020|585840805|FG002|Part 2: Double-blind Treatment Period|Other|0|||
162215570|NCT02906020|585840806|FG003|Part 2: Double-blind Treatment Period|Other|0|||
162215571|NCT02906020|585840807|FG004|Part 2: Double-blind Treatment Period|Other|0|||
162215572|NCT02906020|585840808|FG005|Part 2: Double-blind Treatment Period|Other|0|||
162215573|NCT02906020|585840809|FG006|Part 2: Double-blind Treatment Period|Other|0|||
162215574|NCT02906020|585840810|FG007|Part 2: Double-blind Treatment Period|Other|0|||
162215575|NCT02906020|585840811|FG008|Part 2: Double-blind Treatment Period|Other|6|||
161678395|NCT02374021|583873723|FG000|Overall Study|Physician Decision|0|||
161678396|NCT02374021|583873724|FG001|Overall Study|Physician Decision|3|||
161678397|NCT02374021|583873723|FG000|Overall Study|Withdrawal by Subject|6|||
161678398|NCT02374021|583873724|FG001|Overall Study|Withdrawal by Subject|5|||
161678399|NCT02374021|583873723|FG000|Overall Study|Poor Adherence|0|||
161678400|NCT02374021|583873724|FG001|Overall Study|Poor Adherence|1|||
161678401|NCT02374021|583873723|FG000|Overall Study|Scan protocol not followed|0|||
161678402|NCT02374021|583873724|FG001|Overall Study|Scan protocol not followed|1|||
161678403|NCT02374021|583873723|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
162215576|NCT02906020|585840812|FG009|Part 2: Double-blind Treatment Period|Other|10|||
162215577|NCT02906020|585840813|FG010|Part 2: Double-blind Treatment Period|Other|0|||
162215578|NCT02906020|585840814|FG011|Part 2: Double-blind Treatment Period|Other|0|||
162215579|NCT02906020|585840815|FG012|Part 2: Double-blind Treatment Period|Other|0|||
162215580|NCT02906020|585840816|FG013|Part 2: Double-blind Treatment Period|Other|0|||
162215581|NCT02906020|585840817|FG014|Part 2: Double-blind Treatment Period|Other|0|||
162215582|NCT02906020|585840818|FG015|Part 2: Double-blind Treatment Period|Other|0|||
162215583|NCT02906020|585840803|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215584|NCT02906020|585840804|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215585|NCT02906020|585840805|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215586|NCT02906020|585840806|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215587|NCT02906020|585840807|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215588|NCT02906020|585840808|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215589|NCT02906020|585840809|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215590|NCT02906020|585840810|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215591|NCT02906020|585840811|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215592|NCT02906020|585840812|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215593|NCT02906020|585840813|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215594|NCT02906020|585840814|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215595|NCT02906020|585840815|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
162215596|NCT02906020|585840816|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
162215597|NCT02906020|585840817|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215598|NCT02906020|585840818|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
162215599|NCT02906020|585840803|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215600|NCT02906020|585840804|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215601|NCT02906020|585840805|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215602|NCT02906020|585840806|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215603|NCT02906020|585840807|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215604|NCT02906020|585840808|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215605|NCT02906020|585840809|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215606|NCT02906020|585840810|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215607|NCT02906020|585840811|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215608|NCT02906020|585840812|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215609|NCT02906020|585840813|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215610|NCT02906020|585840814|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215611|NCT02906020|585840815|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
162215612|NCT02906020|585840816|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
162215613|NCT02906020|585840817|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
162215614|NCT02906020|585840818|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
162215615|NCT02906020|585840803|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215616|NCT02906020|585840804|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215617|NCT02906020|585840805|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215618|NCT02906020|585840806|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215619|NCT02906020|585840807|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215620|NCT02906020|585840808|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215621|NCT02906020|585840809|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215622|NCT02906020|585840810|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215623|NCT02906020|585840811|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215624|NCT02906020|585840812|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215625|NCT02906020|585840813|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215626|NCT02906020|585840814|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215627|NCT02906020|585840815|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
162215628|NCT02906020|585840816|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
162215629|NCT02906020|585840817|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215630|NCT02906020|585840818|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
162215631|NCT02906020|585840803|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215632|NCT02906020|585840804|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215633|NCT02906020|585840805|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215634|NCT02906020|585840806|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215635|NCT02906020|585840807|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215636|NCT02906020|585840808|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215637|NCT02906020|585840809|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215638|NCT02906020|585840810|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215639|NCT02906020|585840811|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215640|NCT02906020|585840812|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215641|NCT02906020|585840813|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215642|NCT02906020|585840814|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215643|NCT02906020|585840815|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
162215644|NCT02906020|585840816|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
162215645|NCT02906020|585840817|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215646|NCT02906020|585840818|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
162215647|NCT02906020|585840803|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162215648|NCT02906020|585840804|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162215649|NCT02906020|585840805|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162215650|NCT02906020|585840806|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162215651|NCT02906020|585840807|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162215652|NCT02906020|585840808|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162215653|NCT02906020|585840809|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162215654|NCT02906020|585840810|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162215655|NCT02906020|585840811|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162215656|NCT02906020|585840812|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162215657|NCT02906020|585840813|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162215658|NCT02906020|585840814|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
162215659|NCT02906020|585840815|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
162215660|NCT02906020|585840816|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
162215661|NCT02906020|585840817|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
162215662|NCT02906020|585840818|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
162215663|NCT02906020|585840803|FG000|Part 2: Long-term Follow-up Period|Other|0|||
162215664|NCT02906020|585840804|FG001|Part 2: Long-term Follow-up Period|Other|0|||
162215665|NCT02906020|585840805|FG002|Part 2: Long-term Follow-up Period|Other|0|||
162215666|NCT02906020|585840806|FG003|Part 2: Long-term Follow-up Period|Other|0|||
162215667|NCT02906020|585840807|FG004|Part 2: Long-term Follow-up Period|Other|0|||
162215668|NCT02906020|585840808|FG005|Part 2: Long-term Follow-up Period|Other|0|||
162215669|NCT02906020|585840809|FG006|Part 2: Long-term Follow-up Period|Other|0|||
162215670|NCT02906020|585840810|FG007|Part 2: Long-term Follow-up Period|Other|0|||
162215671|NCT02906020|585840811|FG008|Part 2: Long-term Follow-up Period|Other|0|||
162215672|NCT02906020|585840812|FG009|Part 2: Long-term Follow-up Period|Other|0|||
162215673|NCT02906020|585840813|FG010|Part 2: Long-term Follow-up Period|Other|0|||
162215674|NCT02906020|585840814|FG011|Part 2: Long-term Follow-up Period|Other|0|||
162215675|NCT02906020|585840815|FG012|Part 2: Long-term Follow-up Period|Other|13|||
162215676|NCT02906020|585840816|FG013|Part 2: Long-term Follow-up Period|Other|8|||
162215677|NCT02906020|585840817|FG014|Part 2: Long-term Follow-up Period|Other|3|||
162215678|NCT02906020|585840818|FG015|Part 2: Long-term Follow-up Period|Other|2|||
162215679|NCT01375673|585840824|FG000|Overall Study|Withdrawal by Subject|0|||
162215680|NCT01375673|585840825|FG001|Overall Study|Withdrawal by Subject|1|||
162215681|NCT04698915|585840830|FG000|Overall Study|Adverse Event|2|||
162215682|NCT04698915|585840831|FG001|Overall Study|Adverse Event|0|||
162215683|NCT04698915|585840830|FG000|Overall Study|Death|23|||
162215684|NCT04698915|585840831|FG001|Overall Study|Death|20|||
162215685|NCT04698915|585840830|FG000|Overall Study|Physician Decision|1|||
162215686|NCT04698915|585840831|FG001|Overall Study|Physician Decision|1|||
162215687|NCT04698915|585840830|FG000|Overall Study|Lost to Follow-up|1|||
162215688|NCT04698915|585840831|FG001|Overall Study|Lost to Follow-up|0|||
162215689|NCT04698915|585840830|FG000|Overall Study|Study Terminated by Sponsor|55|||
162215690|NCT04698915|585840831|FG001|Overall Study|Study Terminated by Sponsor|60|||
162215691|NCT04698915|585840830|FG000|Overall Study|Withdrawal by Subject|2|||
162215692|NCT04698915|585840831|FG001|Overall Study|Withdrawal by Subject|3|||
162215693|NCT01907906|585840832|FG000|Overall Study|Withdrawal by Subject|1|||
162215694|NCT01907906|585840833|FG001|Overall Study|Withdrawal by Subject|0|||
162215695|NCT01907906|585840832|FG000|Overall Study|Physician Decision|3|||
162215696|NCT01907906|585840833|FG001|Overall Study|Physician Decision|1|||
162215697|NCT00979953|585840834|FG000|Overall Study|Adverse Event|5|||
162215698|NCT00979953|585840835|FG001|Overall Study|Adverse Event|2|||
162215699|NCT00979953|585840836|FG002|Overall Study|Adverse Event|17|||
162215700|NCT00979953|585840837|FG003|Overall Study|Adverse Event|4|||
162215701|NCT00979953|585840834|FG000|Overall Study|Lack of Efficacy|1|||
162215702|NCT00979953|585840835|FG001|Overall Study|Lack of Efficacy|2|||
162215703|NCT00979953|585840836|FG002|Overall Study|Lack of Efficacy|0|||
161678404|NCT02374021|583873724|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
162215704|NCT00979953|585840837|FG003|Overall Study|Lack of Efficacy|0|||
162215705|NCT00979953|585840834|FG000|Overall Study|Lost to Follow-up|1|||
162215706|NCT00979953|585840835|FG001|Overall Study|Lost to Follow-up|1|||
162215707|NCT00979953|585840836|FG002|Overall Study|Lost to Follow-up|1|||
162215708|NCT00979953|585840837|FG003|Overall Study|Lost to Follow-up|0|||
162215709|NCT00979953|585840834|FG000|Overall Study|Withdrawal by Subject|0|||
162215710|NCT00979953|585840835|FG001|Overall Study|Withdrawal by Subject|0|||
162215711|NCT00979953|585840836|FG002|Overall Study|Withdrawal by Subject|2|||
162215712|NCT00979953|585840837|FG003|Overall Study|Withdrawal by Subject|1|||
162215713|NCT00979953|585840834|FG000|Overall Study|Protocol Violation|1|||
162215714|NCT00979953|585840835|FG001|Overall Study|Protocol Violation|0|||
162215715|NCT00979953|585840836|FG002|Overall Study|Protocol Violation|2|||
162215716|NCT00979953|585840837|FG003|Overall Study|Protocol Violation|2|||
162215717|NCT01124097|585840838|FG000|Overall Study|Withdrawal by Subject|4|||
162215718|NCT01124097|585840839|FG001|Overall Study|Withdrawal by Subject|3|||
162215719|NCT01124097|585840840|FG002|Overall Study|Withdrawal by Subject|2|||
162215720|NCT01124097|585840841|FG003|Overall Study|Withdrawal by Subject|3|||
162215721|NCT01124097|585840838|FG000|Overall Study|Lack of Efficacy|2|||
162215722|NCT01124097|585840839|FG001|Overall Study|Lack of Efficacy|3|||
162215723|NCT01124097|585840840|FG002|Overall Study|Lack of Efficacy|1|||
162215724|NCT01124097|585840841|FG003|Overall Study|Lack of Efficacy|3|||
162215725|NCT01124097|585840838|FG000|Overall Study|Adverse Event|24|||
162215726|NCT01124097|585840839|FG001|Overall Study|Adverse Event|15|||
162215727|NCT01124097|585840840|FG002|Overall Study|Adverse Event|15|||
162215728|NCT01124097|585840841|FG003|Overall Study|Adverse Event|7|||
162215729|NCT01124097|585840838|FG000|Overall Study|Protocol Violation|2|||
162215730|NCT01124097|585840839|FG001|Overall Study|Protocol Violation|0|||
162215731|NCT01124097|585840840|FG002|Overall Study|Protocol Violation|2|||
162215732|NCT01124097|585840841|FG003|Overall Study|Protocol Violation|1|||
162215733|NCT01124097|585840838|FG000|Overall Study|Physician Decision|2|||
162215734|NCT01124097|585840839|FG001|Overall Study|Physician Decision|1|||
162215735|NCT01124097|585840840|FG002|Overall Study|Physician Decision|0|||
162215736|NCT01124097|585840841|FG003|Overall Study|Physician Decision|0|||
162215737|NCT05687032|585840842|FG000|Treatment Phase|Adverse Event|13|||
162215738|NCT05687032|585840842|FG000|Treatment Phase|Death|1|||
162215739|NCT05687032|585840842|FG000|Treatment Phase|Physician Decision|3|||
162215740|NCT05687032|585840842|FG000|Treatment Phase|Progressive disease|9|||
162215741|NCT05687032|585840842|FG000|Treatment Phase|Withdrawal by Subject|5|||
162215742|NCT05687032|585840842|FG000|Follow-Up Phase|Death|16|||
162215743|NCT05687032|585840842|FG000|Follow-Up Phase|Ongoing|26|||
162215744|NCT04829747|585840846|FG000|Overall Study|Protocol Violation|1|||
162215745|NCT02367352|585840849|FG000|Overall Study|Progressive disease|7|||
162215746|NCT02367352|585840850|FG001|Overall Study|Progressive disease|0|||
162215747|NCT02367352|585840851|FG002|Overall Study|Progressive disease|0|||
162215748|NCT02367352|585840849|FG000|Overall Study|Participant Received Alternative Therapy|1|||
162215749|NCT02367352|585840850|FG001|Overall Study|Participant Received Alternative Therapy|0|||
162215750|NCT02367352|585840851|FG002|Overall Study|Participant Received Alternative Therapy|0|||
162215751|NCT02367352|585840849|FG000|Overall Study|Adverse Event|1|||
162215752|NCT02367352|585840850|FG001|Overall Study|Adverse Event|0|||
162215753|NCT02367352|585840851|FG002|Overall Study|Adverse Event|0|||
162215754|NCT05878873|585840852|FG000|Overall Study|Lost to Follow-up|2|||
162215755|NCT05878873|585840853|FG001|Overall Study|Lost to Follow-up|0|||
162215756|NCT02375347|585840855|FG000|Overall Study|Protocol Violation|1|||
162215757|NCT00425607|585840856|FG000|Overall Study|Death|1|||
162215758|NCT00425607|585840856|FG000|Overall Study|Withdrawal by Subject|1|||
162215759|NCT00193479|585840857|FG000|Induction Chemotherapy|Adverse Event|2|||
162215760|NCT00193479|585840857|FG000|Induction Chemotherapy|Disease Progression|1|||
162215761|NCT00193479|585840857|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
162215762|NCT00193479|585840857|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
162215763|NCT00079339|585840858|FG000|Overall Study|Adverse Event|1|||
162215764|NCT00079339|585840859|FG001|Overall Study|Adverse Event|7|||
162215765|NCT00079339|585840860|FG002|Overall Study|Adverse Event|2|||
162215766|NCT00079339|585840858|FG000|Overall Study|Death|1|||
162215767|NCT00079339|585840859|FG001|Overall Study|Death|0|||
162215768|NCT00079339|585840860|FG002|Overall Study|Death|0|||
162215769|NCT00079339|585840858|FG000|Overall Study|Non-compliance|0|||
162215770|NCT00079339|585840859|FG001|Overall Study|Non-compliance|0|||
162215771|NCT00079339|585840860|FG002|Overall Study|Non-compliance|1|||
162215772|NCT00079339|585840858|FG000|Overall Study|Withdrawal by Subject|0|||
162215773|NCT00079339|585840859|FG001|Overall Study|Withdrawal by Subject|4|||
162215774|NCT00079339|585840860|FG002|Overall Study|Withdrawal by Subject|1|||
162215775|NCT00079339|585840858|FG000|Overall Study|Disease progression|3|||
162215776|NCT00079339|585840859|FG001|Overall Study|Disease progression|28|||
162215777|NCT00079339|585840860|FG002|Overall Study|Disease progression|2|||
162215778|NCT02563548|585840861|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
162215779|NCT02563548|585840862|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
162215780|NCT02563548|585840863|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
162215781|NCT02563548|585840864|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
162215782|NCT02563548|585840865|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
162215783|NCT02563548|585840866|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
162215784|NCT02563548|585840861|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
162215785|NCT02563548|585840862|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
162215786|NCT02563548|585840863|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
162215787|NCT02563548|585840864|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
162215788|NCT02563548|585840865|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
162215789|NCT02563548|585840866|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
162215790|NCT02563548|585840861|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
162215791|NCT02563548|585840862|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
162215792|NCT02563548|585840863|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
162215793|NCT02563548|585840864|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
162215794|NCT02563548|585840865|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
162215795|NCT02563548|585840866|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
162215796|NCT02563548|585840861|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
162215797|NCT02563548|585840862|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
162215798|NCT02563548|585840863|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
162215799|NCT02563548|585840864|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
162215800|NCT02563548|585840865|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
162215801|NCT02563548|585840866|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
162215802|NCT02563548|585840861|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
162215803|NCT02563548|585840862|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
162215804|NCT02563548|585840863|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
162215805|NCT02563548|585840864|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
162215806|NCT02563548|585840865|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
162215807|NCT02563548|585840866|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
162215808|NCT02563548|585840861|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
162215809|NCT02563548|585840862|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
162215810|NCT02563548|585840863|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
162215811|NCT02563548|585840864|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
162215812|NCT02563548|585840865|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
162215813|NCT02563548|585840866|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
162215814|NCT02563548|585840861|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
162215815|NCT02563548|585840862|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
162215816|NCT02563548|585840863|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
162215817|NCT02563548|585840864|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
162215818|NCT02563548|585840865|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
162215819|NCT02563548|585840866|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
162215820|NCT02563548|585840861|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
162215821|NCT02563548|585840862|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
162215822|NCT02563548|585840863|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
162215823|NCT02563548|585840864|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
161827322|NCT00685750|584408052|FG002|Overall Study|Patient didn't receive the treatment|0|||
161827323|NCT00685750|584408053|FG003|Overall Study|Patient didn't receive the treatment|0|||
161827324|NCT00685750|584408054|FG004|Overall Study|Patient didn't receive the treatment|0|||
161827325|NCT00685750|584408055|FG005|Overall Study|Patient didn't receive the treatment|0|||
161827326|NCT00685750|584408056|FG006|Overall Study|Patient didn't receive the treatment|1|||
161827327|NCT00685750|584408050|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161827328|NCT00685750|584408051|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161827329|NCT00685750|584408052|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161827330|NCT00685750|584408053|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
161827331|NCT00685750|584408054|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
161827332|NCT00685750|584408055|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
161827333|NCT00685750|584408056|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
161827334|NCT00129116|584408059|FG000|Primary Phase|Lost to Follow-up|1|||
161827335|NCT00129116|584408060|FG001|Primary Phase|Lost to Follow-up|1|||
161827336|NCT00129116|584408061|FG002|Primary Phase|Lost to Follow-up|0|||
161827337|NCT00129116|584408062|FG003|Primary Phase|Lost to Follow-up|1|||
161827338|NCT00129116|584408063|FG004|Primary Phase|Lost to Follow-up|1|||
161827339|NCT00129116|584408059|FG000|Primary Phase|Protocol Violation|0|||
161827340|NCT00129116|584408060|FG001|Primary Phase|Protocol Violation|1|||
161827341|NCT00129116|584408061|FG002|Primary Phase|Protocol Violation|0|||
161827342|NCT00129116|584408062|FG003|Primary Phase|Protocol Violation|0|||
161827343|NCT00129116|584408063|FG004|Primary Phase|Protocol Violation|0|||
161827344|NCT00129116|584408059|FG000|Primary Phase|Adverse Event|1|||
161827345|NCT00129116|584408060|FG001|Primary Phase|Adverse Event|1|||
162215824|NCT02563548|585840865|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
162215825|NCT02563548|585840866|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
162215826|NCT02563548|585840861|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
162215827|NCT02563548|585840862|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
162215828|NCT02563548|585840863|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
162215829|NCT02563548|585840864|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
162215830|NCT02563548|585840865|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
162215831|NCT02563548|585840866|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
162215832|NCT02563548|585840861|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
162215833|NCT02563548|585840862|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
162215834|NCT02563548|585840863|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
162215835|NCT02563548|585840864|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
162215836|NCT02563548|585840865|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
162215837|NCT02563548|585840866|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
161827346|NCT00129116|584408061|FG002|Primary Phase|Adverse Event|0|||
161827347|NCT00129116|584408062|FG003|Primary Phase|Adverse Event|0|||
161827348|NCT00129116|584408063|FG004|Primary Phase|Adverse Event|0|||
161827349|NCT00129116|584408059|FG000|Primary Phase|Withdrawal by Subject|0|||
161827350|NCT00129116|584408060|FG001|Primary Phase|Withdrawal by Subject|1|||
161827351|NCT00129116|584408061|FG002|Primary Phase|Withdrawal by Subject|0|||
161827352|NCT00129116|584408062|FG003|Primary Phase|Withdrawal by Subject|0|||
161827353|NCT00129116|584408063|FG004|Primary Phase|Withdrawal by Subject|0|||
161827354|NCT00129116|584408059|FG000|Primary Phase|Other|0|||
161827355|NCT00129116|584408060|FG001|Primary Phase|Other|0|||
161827356|NCT00129116|584408061|FG002|Primary Phase|Other|1|||
161827357|NCT00129116|584408062|FG003|Primary Phase|Other|0|||
162215838|NCT02563548|585840861|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
162215839|NCT02563548|585840862|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
162215840|NCT02563548|585840863|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
162215841|NCT02563548|585840864|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
162215842|NCT02563548|585840865|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
162215843|NCT02563548|585840866|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
162215844|NCT02563548|585840861|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
162215845|NCT02563548|585840862|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
162215846|NCT02563548|585840863|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
162215847|NCT02563548|585840864|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
162215848|NCT02563548|585840865|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
162215849|NCT02563548|585840866|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
162215850|NCT00559377|585840867|FG000|Overall Study|Withdrawal by Subject|9|||
162215851|NCT00203047|585840874|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
162215852|NCT00203047|585840875|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
162215853|NCT00203047|585840874|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
162215854|NCT00203047|585840875|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
162215855|NCT00203047|585840874|FG000|Overall Study|Withdrawal by Subject|13|||
162215856|NCT00203047|585840875|FG001|Overall Study|Withdrawal by Subject|47|||
162215857|NCT00203047|585840874|FG000|Overall Study|Teva requested participant withdrawal|1|||
162215858|NCT00203047|585840875|FG001|Overall Study|Teva requested participant withdrawal|1|||
162215859|NCT00203047|585840874|FG000|Overall Study|Physician Decision|8|||
162215860|NCT00203047|585840875|FG001|Overall Study|Physician Decision|7|||
162215861|NCT00203047|585840874|FG000|Overall Study|Non-compliance|4|||
162215862|NCT00203047|585840875|FG001|Overall Study|Non-compliance|8|||
162215863|NCT00203047|585840874|FG000|Overall Study|Protocol Violation|1|||
162215864|NCT00203047|585840875|FG001|Overall Study|Protocol Violation|0|||
162215865|NCT00203047|585840874|FG000|Overall Study|Lost to Follow-up|11|||
162215866|NCT00203047|585840875|FG001|Overall Study|Lost to Follow-up|5|||
162215867|NCT00203047|585840874|FG000|Overall Study|Adverse Event|8|||
162215868|NCT00203047|585840875|FG001|Overall Study|Adverse Event|18|||
162215869|NCT00203047|585840874|FG000|Overall Study|Death|1|||
162215870|NCT00203047|585840875|FG001|Overall Study|Death|2|||
162215871|NCT00203047|585840874|FG000|Overall Study|Pregnancy|3|||
162215872|NCT00203047|585840875|FG001|Overall Study|Pregnancy|0|||
162215873|NCT00203047|585840874|FG000|Overall Study|Other|5|||
162215874|NCT00203047|585840875|FG001|Overall Study|Other|5|||
162215875|NCT02229227|585840876|FG000|Overall Study|Adverse Event|14|||
162215876|NCT02229227|585840877|FG001|Overall Study|Adverse Event|9|||
162215877|NCT02229227|585840876|FG000|Overall Study|Lack of Efficacy|3|||
162215878|NCT02229227|585840877|FG001|Overall Study|Lack of Efficacy|3|||
162215879|NCT02229227|585840876|FG000|Overall Study|Protocol Violation|6|||
161827358|NCT00129116|584408063|FG004|Primary Phase|Other|0|||
161827359|NCT00129116|584408059|FG000|Booster Phase|Lost to Follow-up|2|||
161827360|NCT00129116|584408060|FG001|Booster Phase|Lost to Follow-up|0|||
162215880|NCT02229227|585840877|FG001|Overall Study|Protocol Violation|8|||
162215881|NCT02229227|585840876|FG000|Overall Study|Protocol defined stopping criteria|1|||
161827361|NCT00129116|584408061|FG002|Booster Phase|Lost to Follow-up|0|||
162215882|NCT02229227|585840877|FG001|Overall Study|Protocol defined stopping criteria|3|||
162215883|NCT02229227|585840876|FG000|Overall Study|Lost to Follow-up|3|||
162215884|NCT02229227|585840877|FG001|Overall Study|Lost to Follow-up|3|||
162215885|NCT02229227|585840876|FG000|Overall Study|Study terminated by sponsor|11|||
162215886|NCT02229227|585840877|FG001|Overall Study|Study terminated by sponsor|11|||
162215887|NCT02229227|585840876|FG000|Overall Study|Withdrawal by Subject|8|||
162215888|NCT02229227|585840877|FG001|Overall Study|Withdrawal by Subject|12|||
162215889|NCT02229227|585840876|FG000|Overall Study|Other|0|||
162215890|NCT02229227|585840877|FG001|Overall Study|Other|1|||
162215891|NCT02229227|585840876|FG000|Overall Study|Physician Decision|5|||
162215892|NCT02229227|585840877|FG001|Overall Study|Physician Decision|12|||
162215893|NCT00340704|585840880|FG000|PK Study|Adverse Event|0|||
162215894|NCT00340704|585840881|FG001|PK Study|Adverse Event|1|||
162215895|NCT00340704|585840882|FG002|PK Study|Adverse Event|0|||
162215896|NCT00340704|585840883|FG003|PK Study|Adverse Event|0|||
162215897|NCT00340704|585840884|FG004|PK Study|Adverse Event|0|||
162215898|NCT00340704|585840885|FG005|PK Study|Adverse Event|0|||
162215899|NCT00340704|585840886|FG006|PK Study|Adverse Event|0|||
162215900|NCT00340704|585840887|FG007|PK Study|Adverse Event|0|||
162215901|NCT00340704|585840888|FG008|PK Study|Adverse Event|0|||
162215902|NCT00340704|585840880|FG000|PK Study|Not treated|0|||
162215903|NCT00340704|585840881|FG001|PK Study|Not treated|0|||
162215904|NCT00340704|585840882|FG002|PK Study|Not treated|1|||
162215905|NCT00340704|585840883|FG003|PK Study|Not treated|0|||
162215906|NCT00340704|585840884|FG004|PK Study|Not treated|0|||
162215907|NCT00340704|585840885|FG005|PK Study|Not treated|0|||
162215908|NCT00340704|585840886|FG006|PK Study|Not treated|0|||
162215909|NCT00340704|585840887|FG007|PK Study|Not treated|0|||
162215910|NCT00340704|585840888|FG008|PK Study|Not treated|0|||
162215911|NCT00340704|585840880|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
162215912|NCT00340704|585840881|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
162215913|NCT00340704|585840882|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
162215914|NCT00340704|585840883|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
162215915|NCT00340704|585840884|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
162215916|NCT00340704|585840885|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
162215917|NCT00340704|585840886|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
162215918|NCT00340704|585840887|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
162215919|NCT00340704|585840888|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
161827362|NCT00129116|584408062|FG003|Booster Phase|Lost to Follow-up|0|||
161827363|NCT00129116|584408063|FG004|Booster Phase|Lost to Follow-up|1|||
161827364|NCT02539368|584408064|FG000|Overall Study|Death|4|||
162215920|NCT00340704|585840880|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162215921|NCT00340704|585840881|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162215922|NCT00340704|585840882|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162215923|NCT00340704|585840883|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162215924|NCT00340704|585840884|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162215925|NCT00340704|585840885|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
162215926|NCT00340704|585840886|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162215927|NCT00340704|585840887|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162215928|NCT00340704|585840888|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
162215929|NCT00340704|585840880|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162215930|NCT00340704|585840881|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162215931|NCT00340704|585840882|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162215932|NCT00340704|585840883|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162215933|NCT00340704|585840884|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
162215934|NCT00340704|585840885|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
162215935|NCT00340704|585840886|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162215936|NCT00340704|585840887|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162215937|NCT00340704|585840888|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
162215938|NCT00340704|585840880|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
162215939|NCT00340704|585840881|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
162215940|NCT00340704|585840882|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
162215941|NCT00340704|585840883|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
162215942|NCT00340704|585840884|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
162215943|NCT00340704|585840885|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
162215944|NCT00340704|585840886|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
162215945|NCT00340704|585840887|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
162215946|NCT00340704|585840888|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
162215947|NCT01453023|585840889|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
162215948|NCT01453023|585840890|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
162215949|NCT01453023|585840889|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
162215950|NCT01453023|585840890|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
162215951|NCT01453023|585840889|FG000|Treatment Period 2|Protocol Violation|0|||
162215952|NCT01453023|585840890|FG001|Treatment Period 2|Protocol Violation|1|||
162215953|NCT01056263|585840905|FG000|Overall Study|Adverse Event|12|||
162215954|NCT01056263|585840905|FG000|Overall Study|Death|1|||
162215955|NCT01056263|585840905|FG000|Overall Study|Withdrawal by Subject|1|||
162215956|NCT01056263|585840905|FG000|Overall Study|Lack of Efficacy|29|||
162215957|NCT01056263|585840905|FG000|Overall Study|Progressive disease|2|||
162215958|NCT01056263|585840905|FG000|Overall Study|Neoplasm progression|1|||
162215959|NCT01056263|585840905|FG000|Overall Study|Objective progression or relapse|1|||
162215960|NCT01056263|585840905|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
162215961|NCT00365547|585840908|FG000|Overall Study|Insurance did not cover Avastin|1|||
162215962|NCT00365547|585840908|FG000|Overall Study|Screen failure|1|||
162215963|NCT00365547|585840908|FG000|Overall Study|Withdrawal by Subject|1|||
162215964|NCT03170518|585840909|FG000|Overall Study|Lost to Follow-up|4|||
162215965|NCT03170518|585840910|FG001|Overall Study|Lost to Follow-up|1|||
162215966|NCT03170518|585840911|FG002|Overall Study|Lost to Follow-up|0|||
162215967|NCT03170518|585840909|FG000|Overall Study|Physician Decision|1|||
162215968|NCT03170518|585840910|FG001|Overall Study|Physician Decision|0|||
162215969|NCT03170518|585840911|FG002|Overall Study|Physician Decision|0|||
162215970|NCT03170518|585840909|FG000|Overall Study|Withdrawal by Subject|4|||
162215971|NCT03170518|585840910|FG001|Overall Study|Withdrawal by Subject|5|||
162215972|NCT03170518|585840911|FG002|Overall Study|Withdrawal by Subject|2|||
162215973|NCT03170518|585840909|FG000|Overall Study|Site terminated by sponsor|0|||
162215974|NCT03170518|585840910|FG001|Overall Study|Site terminated by sponsor|1|||
162215975|NCT03170518|585840911|FG002|Overall Study|Site terminated by sponsor|0|||
162215976|NCT03170518|585840909|FG000|Overall Study|Non-compliance with study drug|1|||
162215977|NCT03170518|585840910|FG001|Overall Study|Non-compliance with study drug|0|||
162215978|NCT03170518|585840911|FG002|Overall Study|Non-compliance with study drug|1|||
162215979|NCT03170518|585840909|FG000|Overall Study|Withdrawal by parent/guardian|2|||
162215980|NCT03170518|585840910|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162215981|NCT03170518|585840911|FG002|Overall Study|Withdrawal by parent/guardian|0|||
162215982|NCT00546078|585840912|FG000|Overall Study|Lost to Follow-up|1|||
162215983|NCT00546078|585840913|FG001|Overall Study|Lost to Follow-up|3|||
162215984|NCT00546078|585840912|FG000|Overall Study|Withdrawal by Subject|2|||
162215985|NCT00546078|585840913|FG001|Overall Study|Withdrawal by Subject|3|||
162215986|NCT00546078|585840912|FG000|Overall Study|Other reason|1|||
162215987|NCT00546078|585840913|FG001|Overall Study|Other reason|1|||
162215988|NCT03512197|585840914|FG000|Overall Study|Guardian decision|1|||
162215989|NCT03512197|585840915|FG001|Overall Study|Guardian decision|1|||
162215990|NCT03512197|585840914|FG000|Overall Study|Lack of Efficacy|19|||
162215991|NCT03512197|585840915|FG001|Overall Study|Lack of Efficacy|11|||
162215992|NCT03512197|585840914|FG000|Overall Study|New Therapy for Study Indication|16|||
162215993|NCT03512197|585840915|FG001|Overall Study|New Therapy for Study Indication|16|||
162215994|NCT03512197|585840914|FG000|Overall Study|Physician Decision|60|||
162215995|NCT03512197|585840915|FG001|Overall Study|Physician Decision|60|||
162215996|NCT03512197|585840914|FG000|Overall Study|Protocol Violation|0|||
162215997|NCT03512197|585840915|FG001|Overall Study|Protocol Violation|2|||
162215998|NCT03512197|585840914|FG000|Overall Study|Terminated by Sponsored|46|||
162215999|NCT03512197|585840915|FG001|Overall Study|Terminated by Sponsored|50|||
162216000|NCT03512197|585840914|FG000|Overall Study|Subject Decision|15|||
162216001|NCT03512197|585840915|FG001|Overall Study|Subject Decision|12|||
162216002|NCT03512197|585840914|FG000|Overall Study|Withdrawal of informed consent|20|||
162216003|NCT03512197|585840915|FG001|Overall Study|Withdrawal of informed consent|14|||
162216004|NCT03512197|585840914|FG000|Overall Study|Adverse Event|30|||
162216005|NCT03512197|585840915|FG001|Overall Study|Adverse Event|34|||
162216006|NCT03512197|585840914|FG000|Overall Study|Death|14|||
162216007|NCT03512197|585840915|FG001|Overall Study|Death|9|||
162216008|NCT03512197|585840914|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
162216009|NCT03512197|585840915|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
162216010|NCT03512197|585840914|FG000|Overall Study|Missing|3|||
162216011|NCT03512197|585840915|FG001|Overall Study|Missing|13|||
162216012|NCT01806389|585840916|FG000|Overall Study|Withdrawal by Subject|4|||
162216013|NCT03842436|585840917|FG000|Overall Study|Lost to Follow-up|1|||
162216014|NCT01948076|585840918|FG000|Overall Study|Withdrawal by Subject|0|||
162216015|NCT01948076|585840919|FG001|Overall Study|Withdrawal by Subject|1|||
162216016|NCT00936598|585840925|FG000|Overall Study|Withdrawal by Subject|1|||
162216017|NCT00936598|585840926|FG001|Overall Study|Withdrawal by Subject|0|||
162216018|NCT00936598|585840925|FG000|Overall Study|Ineligible after consent|1|||
162216019|NCT00936598|585840926|FG001|Overall Study|Ineligible after consent|0|||
162216020|NCT00486252|585840927|FG000|Overall Study|Adverse Event|7|||
162216021|NCT00486252|585840927|FG000|Overall Study|Lack of Efficacy|9|||
162216022|NCT00486252|585840927|FG000|Overall Study|Lost to Follow-up|24|||
162216023|NCT00486252|585840927|FG000|Overall Study|Other|18|||
162216024|NCT02559310|585840928|FG000|Overall Study|Death|4|||
162216025|NCT02559310|585840929|FG001|Overall Study|Death|3|||
162216026|NCT02559310|585840928|FG000|Overall Study|Lost to Follow-up|5|||
162216027|NCT02559310|585840929|FG001|Overall Study|Lost to Follow-up|3|||
162216028|NCT02559310|585840928|FG000|Overall Study|Physician Decision|2|||
162216029|NCT02559310|585840929|FG001|Overall Study|Physician Decision|1|||
162216030|NCT02559310|585840928|FG000|Overall Study|Withdrawal by Subject|13|||
162216031|NCT02559310|585840929|FG001|Overall Study|Withdrawal by Subject|9|||
162216032|NCT02559310|585840928|FG000|Overall Study|Sponsor Decision|0|||
162216033|NCT02559310|585840929|FG001|Overall Study|Sponsor Decision|1|||
162216034|NCT02559310|585840928|FG000|Overall Study|Randomized but not treated|3|||
162216035|NCT02559310|585840929|FG001|Overall Study|Randomized but not treated|2|||
162216036|NCT04596540|585840930|FG000|Overall Study|Withdrawal by Subject|9|||
162216037|NCT04596540|585840931|FG001|Overall Study|Withdrawal by Subject|8|||
162216038|NCT04596540|585840932|FG002|Overall Study|Withdrawal by Subject|5|||
162216039|NCT04596540|585840930|FG000|Overall Study|Lost to Follow-up|1|||
162216040|NCT04596540|585840931|FG001|Overall Study|Lost to Follow-up|2|||
162216041|NCT04596540|585840932|FG002|Overall Study|Lost to Follow-up|1|||
162216042|NCT04596540|585840930|FG000|Overall Study|Sponsor Decision|2|||
162216043|NCT04596540|585840931|FG001|Overall Study|Sponsor Decision|0|||
162216044|NCT04596540|585840932|FG002|Overall Study|Sponsor Decision|0|||
162216045|NCT04596540|585840930|FG000|Overall Study|Physician Decision|0|||
162216046|NCT04596540|585840931|FG001|Overall Study|Physician Decision|1|||
162216047|NCT04596540|585840932|FG002|Overall Study|Physician Decision|1|||
162216048|NCT04596540|585840930|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
162216049|NCT04596540|585840931|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
162216050|NCT04596540|585840932|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
162216051|NCT04596540|585840930|FG000|Overall Study|Other Than Specified|5|||
162216052|NCT04596540|585840931|FG001|Overall Study|Other Than Specified|5|||
162216053|NCT04596540|585840932|FG002|Overall Study|Other Than Specified|2|||
162216054|NCT02633397|585840933|FG000|Overall Study|Adverse Event|8|||
162216055|NCT02633397|585840934|FG001|Overall Study|Adverse Event|8|||
162216056|NCT02633397|585840933|FG000|Overall Study|Study Burden|4|||
162216057|NCT02633397|585840934|FG001|Overall Study|Study Burden|1|||
162216058|NCT02633397|585840933|FG000|Overall Study|Treatment interruption|2|||
162216059|NCT02633397|585840934|FG001|Overall Study|Treatment interruption|5|||
162216060|NCT02633397|585840933|FG000|Overall Study|Death|2|||
162216061|NCT02633397|585840934|FG001|Overall Study|Death|2|||
162216062|NCT02633397|585840933|FG000|Overall Study|Physician Decision|0|||
162216063|NCT02633397|585840934|FG001|Overall Study|Physician Decision|1|||
162216064|NCT03595878|585840935|FG000|Overall Study|Death|2|||
162216065|NCT03595878|585840936|FG001|Overall Study|Death|1|||
162216066|NCT03595878|585840937|FG002|Overall Study|Death|0|||
162216067|NCT03595878|585840935|FG000|Overall Study|Disease progression|2|||
162216068|NCT03595878|585840936|FG001|Overall Study|Disease progression|1|||
162216069|NCT03595878|585840937|FG002|Overall Study|Disease progression|2|||
162216070|NCT03036124|585840938|FG000|Overall Study|Lost to Follow-up|0|||
162216071|NCT03036124|585840939|FG001|Overall Study|Lost to Follow-up|2|||
162216072|NCT03036124|585840938|FG000|Overall Study|Withdrawal by Subject|5|||
162216073|NCT03036124|585840939|FG001|Overall Study|Withdrawal by Subject|4|||
162216074|NCT04526665|585840940|FG000|Overall Study|Withdrawal by Subject|6|||
162216075|NCT04526665|585840941|FG001|Overall Study|Withdrawal by Subject|3|||
162216076|NCT04526665|585840940|FG000|Overall Study|Adverse Event|4|||
162216077|NCT04526665|585840941|FG001|Overall Study|Adverse Event|1|||
162216078|NCT04526665|585840940|FG000|Overall Study|Physician Decision|2|||
162216079|NCT04526665|585840941|FG001|Overall Study|Physician Decision|2|||
162216080|NCT04526665|585840940|FG000|Overall Study|Death|2|||
162216081|NCT04526665|585840941|FG001|Overall Study|Death|0|||
162216082|NCT04526665|585840940|FG000|Overall Study|Other|0|||
162216083|NCT04526665|585840941|FG001|Overall Study|Other|1|||
162216084|NCT04949802|585842427|FG000|Overall Study|Lost to Follow-up|3|||
162216085|NCT01439867|585842431|FG000|Overall Study|Non-compliance|0|||
162216086|NCT01439867|585842432|FG001|Overall Study|Non-compliance|1|||
162216087|NCT01439867|585842431|FG000|Overall Study|Withdrawal by Subject|1|||
162216088|NCT01439867|585842432|FG001|Overall Study|Withdrawal by Subject|2|||
162216089|NCT01439867|585842431|FG000|Overall Study|Administrative Decision|4|||
162216090|NCT01439867|585842432|FG001|Overall Study|Administrative Decision|5|||
162216091|NCT01439867|585842431|FG000|Overall Study|Protocol-specified Criteria|1|||
162216092|NCT01439867|585842432|FG001|Overall Study|Protocol-specified Criteria|0|||
162216093|NCT01020877|585842435|FG000|Second Intervention|Withdrawal by Subject|1|||
162216094|NCT01020877|585842436|FG001|Second Intervention|Withdrawal by Subject|0|||
162216095|NCT00433511|585842437|FG000|Step 1|Adverse Event|50|||
162216096|NCT00433511|585842438|FG001|Step 1|Adverse Event|157|||
162216097|NCT00433511|585842439|FG002|Step 1|Adverse Event|153|||
162216098|NCT00433511|585842437|FG000|Step 1|Withdrawal by Subject|45|||
162216099|NCT00433511|585842438|FG001|Step 1|Withdrawal by Subject|143|||
162216100|NCT00433511|585842439|FG002|Step 1|Withdrawal by Subject|154|||
162216101|NCT00433511|585842437|FG000|Step 1|Death|3|||
162216102|NCT00433511|585842438|FG001|Step 1|Death|1|||
162216103|NCT00433511|585842439|FG002|Step 1|Death|1|||
162216104|NCT00433511|585842437|FG000|Step 1|Physician Decision|1|||
162216105|NCT00433511|585842438|FG001|Step 1|Physician Decision|4|||
162216106|NCT00433511|585842439|FG002|Step 1|Physician Decision|3|||
162216107|NCT00433511|585842437|FG000|Step 1|Never started protocol therapy|28|||
162216108|NCT00433511|585842438|FG001|Step 1|Never started protocol therapy|64|||
162216109|NCT00433511|585842439|FG002|Step 1|Never started protocol therapy|66|||
162216110|NCT00433511|585842437|FG000|Step 1|Alternative therapy|2|||
162216111|NCT00433511|585842438|FG001|Step 1|Alternative therapy|1|||
162216112|NCT00433511|585842439|FG002|Step 1|Alternative therapy|3|||
162216113|NCT00433511|585842437|FG000|Step 1|Disease progression, relapse|5|||
162216114|NCT00433511|585842438|FG001|Step 1|Disease progression, relapse|3|||
162216115|NCT00433511|585842439|FG002|Step 1|Disease progression, relapse|3|||
162216116|NCT00433511|585842437|FG000|Step 1|Other complicating disease|2|||
162216117|NCT00433511|585842438|FG001|Step 1|Other complicating disease|6|||
162216118|NCT00433511|585842439|FG002|Step 1|Other complicating disease|3|||
162216119|NCT00433511|585842437|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
162216120|NCT00433511|585842438|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
162216121|NCT00433511|585842439|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
162216122|NCT00433511|585842437|FG000|Step 1|Suspected recurrence|0|||
162216123|NCT00433511|585842438|FG001|Step 1|Suspected recurrence|1|||
162216124|NCT00433511|585842439|FG002|Step 1|Suspected recurrence|0|||
162216125|NCT00433511|585842437|FG000|Step 1|Insurance/drug distribution issues|0|||
162216126|NCT00433511|585842438|FG001|Step 1|Insurance/drug distribution issues|1|||
162216127|NCT00433511|585842439|FG002|Step 1|Insurance/drug distribution issues|2|||
162216128|NCT00433511|585842437|FG000|Step 1|Patient moved|0|||
162216129|NCT00433511|585842438|FG001|Step 1|Patient moved|0|||
162216130|NCT00433511|585842439|FG002|Step 1|Patient moved|1|||
162216131|NCT00433511|585842437|FG000|Step 2 (Arm D)|Adverse Event|0|||
162216132|NCT00433511|585842438|FG001|Step 2 (Arm D)|Adverse Event|0|||
162216133|NCT00433511|585842439|FG002|Step 2 (Arm D)|Adverse Event|135|||
162216134|NCT00433511|585842437|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
162216135|NCT00433511|585842438|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
162216136|NCT00433511|585842439|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
162216137|NCT00433511|585842437|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
162216138|NCT00433511|585842438|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
162216139|NCT00433511|585842439|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
162216140|NCT00433511|585842437|FG000|Step 2 (Arm D)|Physician Decision|0|||
162216141|NCT00433511|585842438|FG001|Step 2 (Arm D)|Physician Decision|0|||
162216142|NCT00433511|585842439|FG002|Step 2 (Arm D)|Physician Decision|9|||
162216143|NCT00433511|585842437|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
162216144|NCT00433511|585842438|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
162216145|NCT00433511|585842439|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
162216146|NCT00433511|585842437|FG000|Step 2 (Arm D)|Other complicating disease|0|||
162216147|NCT00433511|585842438|FG001|Step 2 (Arm D)|Other complicating disease|0|||
162216148|NCT00433511|585842439|FG002|Step 2 (Arm D)|Other complicating disease|3|||
162216149|NCT00433511|585842437|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
162216150|NCT00433511|585842438|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
162216151|NCT00433511|585842439|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
162216152|NCT00433511|585842437|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
162216153|NCT00433511|585842438|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
162216154|NCT00433511|585842439|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
162216155|NCT00433511|585842437|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
162216156|NCT00433511|585842438|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
162216157|NCT00433511|585842439|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
162216158|NCT00433511|585842437|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
162216159|NCT00433511|585842438|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
162216160|NCT00433511|585842439|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
162216161|NCT01784523|585842440|FG000|Overall Study|Study closed early|7|||
162216162|NCT01784523|585842441|FG001|Overall Study|Study closed early|4|||
162216163|NCT04334278|585842446|FG000|Overall Study|Lost to Follow-up|0|||
162216164|NCT04334278|585842447|FG001|Overall Study|Lost to Follow-up|3|||
162216165|NCT04334278|585842446|FG000|Overall Study|Withdrawal by Subject|4|||
162216166|NCT04334278|585842447|FG001|Overall Study|Withdrawal by Subject|2|||
162216167|NCT01732549|585842452|FG000|Overall Study|Adverse Event|13|||
162216168|NCT01732549|585842453|FG001|Overall Study|Adverse Event|3|||
162216169|NCT01732549|585842452|FG000|Overall Study|Consent withdrawn|13|||
162216170|NCT01732549|585842453|FG001|Overall Study|Consent withdrawn|6|||
162216171|NCT01732549|585842452|FG000|Overall Study|Disease progression|37|||
162216172|NCT01732549|585842453|FG001|Overall Study|Disease progression|50|||
162216173|NCT01732549|585842452|FG000|Overall Study|Other|8|||
162216174|NCT01732549|585842453|FG001|Overall Study|Other|14|||
162216175|NCT01516749|585842454|FG000|Active Therapy|Lost to Follow-up|1|||
162216176|NCT01516749|585842454|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
162216177|NCT03994731|585842456|FG000|Pegloticase + IMM Period|Death|2|||
162216178|NCT03994731|585842457|FG001|Pegloticase + IMM Period|Death|0|||
162216179|NCT03994731|585842456|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
162216180|NCT03994731|585842457|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
162216181|NCT03994731|585842456|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
162216182|NCT03994731|585842457|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
162216183|NCT03377361|585842464|FG000|Pre-Treatment|Subject withdrew consent|0|||
162216184|NCT03377361|585842465|FG001|Pre-Treatment|Subject withdrew consent|0|||
162216185|NCT03377361|585842466|FG002|Pre-Treatment|Subject withdrew consent|0|||
162216186|NCT03377361|585842467|FG003|Pre-Treatment|Subject withdrew consent|0|||
162216187|NCT03377361|585842468|FG004|Pre-Treatment|Subject withdrew consent|0|||
162216188|NCT03377361|585842469|FG005|Pre-Treatment|Subject withdrew consent|0|||
162216189|NCT03377361|585842470|FG006|Pre-Treatment|Subject withdrew consent|0|||
162216190|NCT03377361|585842471|FG007|Pre-Treatment|Subject withdrew consent|3|||
162216191|NCT03377361|585842472|FG008|Pre-Treatment|Subject withdrew consent|1|||
162216192|NCT03377361|585842473|FG009|Pre-Treatment|Subject withdrew consent|0|||
162216193|NCT03377361|585842464|FG000|Pre-Treatment|Not Reported|0|||
162216194|NCT03377361|585842465|FG001|Pre-Treatment|Not Reported|0|||
162216195|NCT03377361|585842466|FG002|Pre-Treatment|Not Reported|0|||
162216196|NCT03377361|585842467|FG003|Pre-Treatment|Not Reported|0|||
162216197|NCT03377361|585842468|FG004|Pre-Treatment|Not Reported|0|||
162216198|NCT03377361|585842469|FG005|Pre-Treatment|Not Reported|0|||
162216199|NCT03377361|585842470|FG006|Pre-Treatment|Not Reported|0|||
162216200|NCT03377361|585842471|FG007|Pre-Treatment|Not Reported|0|||
162216201|NCT03377361|585842472|FG008|Pre-Treatment|Not Reported|3|||
162216202|NCT03377361|585842473|FG009|Pre-Treatment|Not Reported|0|||
162216203|NCT03377361|585842464|FG000|Treatment Period|Disease Progression|3|||
162216204|NCT03377361|585842465|FG001|Treatment Period|Disease Progression|2|||
162216205|NCT03377361|585842466|FG002|Treatment Period|Disease Progression|5|||
162216206|NCT03377361|585842467|FG003|Treatment Period|Disease Progression|3|||
162216207|NCT03377361|585842468|FG004|Treatment Period|Disease Progression|3|||
162216208|NCT03377361|585842469|FG005|Treatment Period|Disease Progression|3|||
162216209|NCT03377361|585842470|FG006|Treatment Period|Disease Progression|6|||
162216210|NCT03377361|585842471|FG007|Treatment Period|Disease Progression|106|||
162216211|NCT03377361|585842472|FG008|Treatment Period|Disease Progression|48|||
162216212|NCT03377361|585842473|FG009|Treatment Period|Disease Progression|59|||
162216213|NCT03377361|585842464|FG000|Treatment Period|Study Drug Toxicity|0|||
162216214|NCT03377361|585842465|FG001|Treatment Period|Study Drug Toxicity|0|||
162216215|NCT03377361|585842466|FG002|Treatment Period|Study Drug Toxicity|0|||
162216216|NCT03377361|585842467|FG003|Treatment Period|Study Drug Toxicity|1|||
162216217|NCT03377361|585842468|FG004|Treatment Period|Study Drug Toxicity|0|||
162216218|NCT03377361|585842469|FG005|Treatment Period|Study Drug Toxicity|0|||
162216219|NCT03377361|585842470|FG006|Treatment Period|Study Drug Toxicity|0|||
162216220|NCT03377361|585842471|FG007|Treatment Period|Study Drug Toxicity|7|||
162216221|NCT03377361|585842472|FG008|Treatment Period|Study Drug Toxicity|2|||
162216222|NCT03377361|585842473|FG009|Treatment Period|Study Drug Toxicity|16|||
162216223|NCT03377361|585842464|FG000|Treatment Period|Death|0|||
162216224|NCT03377361|585842465|FG001|Treatment Period|Death|0|||
162216225|NCT03377361|585842466|FG002|Treatment Period|Death|1|||
162216226|NCT03377361|585842467|FG003|Treatment Period|Death|0|||
162216227|NCT03377361|585842468|FG004|Treatment Period|Death|0|||
162216228|NCT03377361|585842469|FG005|Treatment Period|Death|0|||
162216229|NCT03377361|585842470|FG006|Treatment Period|Death|0|||
162216230|NCT03377361|585842471|FG007|Treatment Period|Death|2|||
162216231|NCT03377361|585842472|FG008|Treatment Period|Death|1|||
162216232|NCT03377361|585842473|FG009|Treatment Period|Death|3|||
162216233|NCT03377361|585842464|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162216234|NCT03377361|585842465|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162216235|NCT03377361|585842466|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162216236|NCT03377361|585842467|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162216237|NCT03377361|585842468|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162216238|NCT03377361|585842469|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162216239|NCT03377361|585842470|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
162216240|NCT03377361|585842471|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
162216241|NCT03377361|585842472|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
162216242|NCT03377361|585842473|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
162216243|NCT03377361|585842464|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
162216244|NCT03377361|585842465|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
162216245|NCT03377361|585842466|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
162216246|NCT03377361|585842467|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
162216247|NCT03377361|585842468|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
162216248|NCT03377361|585842469|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
162216249|NCT03377361|585842470|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
162216250|NCT03377361|585842471|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
162216251|NCT03377361|585842472|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
162216252|NCT03377361|585842473|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
162216253|NCT03377361|585842464|FG000|Treatment Period|Subject Withdrew Consent|0|||
162216254|NCT03377361|585842465|FG001|Treatment Period|Subject Withdrew Consent|0|||
162216255|NCT03377361|585842466|FG002|Treatment Period|Subject Withdrew Consent|0|||
162216256|NCT03377361|585842467|FG003|Treatment Period|Subject Withdrew Consent|0|||
162216257|NCT03377361|585842468|FG004|Treatment Period|Subject Withdrew Consent|0|||
162216258|NCT03377361|585842469|FG005|Treatment Period|Subject Withdrew Consent|0|||
162216259|NCT03377361|585842470|FG006|Treatment Period|Subject Withdrew Consent|0|||
162216260|NCT03377361|585842471|FG007|Treatment Period|Subject Withdrew Consent|0|||
162216261|NCT03377361|585842472|FG008|Treatment Period|Subject Withdrew Consent|2|||
162216262|NCT03377361|585842473|FG009|Treatment Period|Subject Withdrew Consent|1|||
162216263|NCT03377361|585842464|FG000|Treatment Period|No longer meets study criteria|0|||
162216264|NCT03377361|585842465|FG001|Treatment Period|No longer meets study criteria|1|||
162216265|NCT03377361|585842466|FG002|Treatment Period|No longer meets study criteria|0|||
162216266|NCT03377361|585842467|FG003|Treatment Period|No longer meets study criteria|0|||
162216267|NCT03377361|585842468|FG004|Treatment Period|No longer meets study criteria|0|||
162216268|NCT03377361|585842469|FG005|Treatment Period|No longer meets study criteria|0|||
162216269|NCT03377361|585842470|FG006|Treatment Period|No longer meets study criteria|0|||
162216270|NCT03377361|585842471|FG007|Treatment Period|No longer meets study criteria|1|||
162216271|NCT03377361|585842472|FG008|Treatment Period|No longer meets study criteria|0|||
162216272|NCT03377361|585842473|FG009|Treatment Period|No longer meets study criteria|0|||
162216273|NCT03377361|585842464|FG000|Treatment Period|Other Reasons|0|||
162216274|NCT03377361|585842465|FG001|Treatment Period|Other Reasons|0|||
162216275|NCT03377361|585842466|FG002|Treatment Period|Other Reasons|0|||
162216276|NCT03377361|585842467|FG003|Treatment Period|Other Reasons|3|||
162216277|NCT03377361|585842468|FG004|Treatment Period|Other Reasons|0|||
162216278|NCT03377361|585842469|FG005|Treatment Period|Other Reasons|0|||
162216279|NCT03377361|585842470|FG006|Treatment Period|Other Reasons|0|||
162216280|NCT03377361|585842471|FG007|Treatment Period|Other Reasons|2|||
162216281|NCT03377361|585842472|FG008|Treatment Period|Other Reasons|0|||
162216282|NCT03377361|585842473|FG009|Treatment Period|Other Reasons|1|||
162216283|NCT00742326|585842474|FG000|Overall Study|Physician Decision|0|||
162216284|NCT00742326|585842475|FG001|Overall Study|Physician Decision|1|||
162216285|NCT03698994|585842479|FG000|Overall Study|Adverse Event|2|||
162216286|NCT03698994|585842479|FG000|Overall Study|Death|1|||
162216287|NCT03698994|585842479|FG000|Overall Study|Physician Decision|1|||
162216288|NCT03698994|585842479|FG000|Overall Study|Withdrawal by Subject|3|||
162216289|NCT03698994|585842479|FG000|Overall Study|Progressive Disease|12|||
162216290|NCT03635086|585842482|FG000|Overall Study|Withdrawal of consent|0|||
162216291|NCT03635086|585842483|FG001|Overall Study|Withdrawal of consent|0|||
162216292|NCT03635086|585842484|FG002|Overall Study|Withdrawal of consent|1|||
162216293|NCT03635086|585842485|FG003|Overall Study|Withdrawal of consent|0|||
162216294|NCT03635086|585842486|FG004|Overall Study|Withdrawal of consent|0|||
162216295|NCT03635086|585842482|FG000|Overall Study|Adverse Event|0|||
162216296|NCT03635086|585842483|FG001|Overall Study|Adverse Event|1|||
162216297|NCT03635086|585842484|FG002|Overall Study|Adverse Event|0|||
162216298|NCT03635086|585842485|FG003|Overall Study|Adverse Event|0|||
162216299|NCT03635086|585842486|FG004|Overall Study|Adverse Event|0|||
162021379|NCT00942994|585134763|FG000|Overall Study|Patient withdrew consent|5|||
162021380|NCT00942994|585134764|FG001|Overall Study|Patient withdrew consent|8|||
162021381|NCT00942994|585134763|FG000|Overall Study|Lost to Follow-up|1|||
162021382|NCT00942994|585134764|FG001|Overall Study|Lost to Follow-up|4|||
162021383|NCT00942994|585134763|FG000|Overall Study|Protocol deviation|1|||
162216300|NCT03635086|585842482|FG000|Overall Study|Lost to Follow-up|1|||
162216301|NCT03635086|585842483|FG001|Overall Study|Lost to Follow-up|0|||
162216302|NCT03635086|585842484|FG002|Overall Study|Lost to Follow-up|0|||
162216303|NCT03635086|585842485|FG003|Overall Study|Lost to Follow-up|0|||
162216304|NCT03635086|585842486|FG004|Overall Study|Lost to Follow-up|0|||
162216305|NCT02196077|585842487|FG000|Overall Study|Adverse Event|4|||
162216306|NCT02196077|585842487|FG000|Overall Study|Lack of Efficacy|1|||
162216307|NCT02196077|585842487|FG000|Overall Study|Withdrawal by Subject|14|||
162216308|NCT02196077|585842487|FG000|Overall Study|Physician Decision|1|||
162021384|NCT00942994|585134764|FG001|Overall Study|Protocol deviation|2|||
162216309|NCT02196077|585842487|FG000|Overall Study|Lost to Follow-up|3|||
162216310|NCT02196077|585842487|FG000|Overall Study|Protocol Violation|24|||
162216311|NCT00732992|585842488|FG000|Overall Study|Adverse Event|1|||
162216312|NCT00732992|585842489|FG001|Overall Study|Adverse Event|1|||
162216313|NCT00732992|585842488|FG000|Overall Study|Objective Progression or Relapse|3|||
162216314|NCT00732992|585842489|FG001|Overall Study|Objective Progression or Relapse|5|||
162216315|NCT00732992|585842488|FG000|Overall Study|Global Deterioration of Health Status|1|||
162216316|NCT00732992|585842489|FG001|Overall Study|Global Deterioration of Health Status|0|||
162216317|NCT00732992|585842488|FG000|Overall Study|Withdrawal by Subject|1|||
162216318|NCT00732992|585842489|FG001|Overall Study|Withdrawal by Subject|0|||
162216319|NCT03482752|585842496|FG000|Overall Study|Withdrawal by Subject|2|||
162216320|NCT03482752|585842496|FG000|Overall Study|Lost to Follow-up|1|||
162216321|NCT03482752|585842496|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
162216322|NCT02844777|585842497|FG000|Overall Study|Withdrawal by Subject|2|||
162216323|NCT02844777|585842498|FG001|Overall Study|Withdrawal by Subject|0|||
162216324|NCT02844777|585842499|FG002|Overall Study|Withdrawal by Subject|0|||
162216325|NCT01776008|585842500|FG000|Overall Study|ineligible|2|||
162216326|NCT00150618|585842501|FG000|Overall Study|Adverse Event|2|||
162216327|NCT00150618|585842502|FG001|Overall Study|Adverse Event|2|||
162216328|NCT00150618|585842503|FG002|Overall Study|Adverse Event|6|||
162216329|NCT00150618|585842504|FG003|Overall Study|Adverse Event|9|||
162216330|NCT00150618|585842505|FG004|Overall Study|Adverse Event|5|||
162216331|NCT00150618|585842501|FG000|Overall Study|Withdrawal by Subject|6|||
162216332|NCT00150618|585842502|FG001|Overall Study|Withdrawal by Subject|8|||
162216333|NCT00150618|585842503|FG002|Overall Study|Withdrawal by Subject|8|||
162216334|NCT00150618|585842504|FG003|Overall Study|Withdrawal by Subject|4|||
162216335|NCT00150618|585842505|FG004|Overall Study|Withdrawal by Subject|5|||
162216336|NCT00150618|585842501|FG000|Overall Study|Lost to Follow-up|4|||
162216337|NCT00150618|585842502|FG001|Overall Study|Lost to Follow-up|1|||
162216338|NCT00150618|585842503|FG002|Overall Study|Lost to Follow-up|5|||
162216339|NCT00150618|585842504|FG003|Overall Study|Lost to Follow-up|8|||
162216340|NCT00150618|585842505|FG004|Overall Study|Lost to Follow-up|4|||
162216341|NCT00150618|585842501|FG000|Overall Study|Protocol Violation|1|||
162216342|NCT00150618|585842502|FG001|Overall Study|Protocol Violation|0|||
162216343|NCT00150618|585842503|FG002|Overall Study|Protocol Violation|0|||
162216344|NCT00150618|585842504|FG003|Overall Study|Protocol Violation|0|||
162216345|NCT00150618|585842505|FG004|Overall Study|Protocol Violation|1|||
162216346|NCT00150618|585842501|FG000|Overall Study|Lack of Efficacy|1|||
162216347|NCT00150618|585842502|FG001|Overall Study|Lack of Efficacy|4|||
162216348|NCT00150618|585842503|FG002|Overall Study|Lack of Efficacy|7|||
162216349|NCT00150618|585842504|FG003|Overall Study|Lack of Efficacy|4|||
162216350|NCT00150618|585842505|FG004|Overall Study|Lack of Efficacy|6|||
162216351|NCT00150618|585842501|FG000|Overall Study|No study meds|0|||
162216352|NCT00150618|585842502|FG001|Overall Study|No study meds|0|||
162216353|NCT00150618|585842503|FG002|Overall Study|No study meds|0|||
162216354|NCT00150618|585842504|FG003|Overall Study|No study meds|0|||
162216355|NCT00150618|585842505|FG004|Overall Study|No study meds|2|||
162216356|NCT00150618|585842501|FG000|Overall Study|Physician Decision|0|||
162021385|NCT00387790|585134765|FG000|Overall Study|Adverse Event|5|||
162216357|NCT00150618|585842502|FG001|Overall Study|Physician Decision|2|||
162216358|NCT00150618|585842503|FG002|Overall Study|Physician Decision|0|||
162216359|NCT00150618|585842504|FG003|Overall Study|Physician Decision|0|||
162216360|NCT00150618|585842505|FG004|Overall Study|Physician Decision|1|||
162216361|NCT00150618|585842501|FG000|Overall Study|Lack of compliance|2|||
162216362|NCT00150618|585842502|FG001|Overall Study|Lack of compliance|1|||
162216363|NCT00150618|585842503|FG002|Overall Study|Lack of compliance|1|||
162216364|NCT00150618|585842504|FG003|Overall Study|Lack of compliance|0|||
162216365|NCT00150618|585842505|FG004|Overall Study|Lack of compliance|1|||
162216366|NCT00150618|585842501|FG000|Overall Study|Abnormal ECG|1|||
162216367|NCT00150618|585842502|FG001|Overall Study|Abnormal ECG|0|||
162216368|NCT00150618|585842503|FG002|Overall Study|Abnormal ECG|0|||
162216369|NCT00150618|585842504|FG003|Overall Study|Abnormal ECG|0|||
162216370|NCT00150618|585842505|FG004|Overall Study|Abnormal ECG|0|||
162216371|NCT00150618|585842501|FG000|Overall Study|Sponsor's decision|0|||
162216372|NCT00150618|585842502|FG001|Overall Study|Sponsor's decision|0|||
162216373|NCT00150618|585842503|FG002|Overall Study|Sponsor's decision|0|||
162216374|NCT00150618|585842504|FG003|Overall Study|Sponsor's decision|1|||
162216375|NCT00150618|585842505|FG004|Overall Study|Sponsor's decision|0|||
162216376|NCT02493946|585842506|FG000|DB Period|Withdrawal by Subject|8|||
162216377|NCT02493946|585842507|FG001|DB Period|Withdrawal by Subject|5|||
162216378|NCT02493946|585842508|FG002|DB Period|Withdrawal by Subject|0|||
162216379|NCT02493946|585842506|FG000|Open Label Period|Withdrawal by Subject|0|||
162216380|NCT02493946|585842507|FG001|Open Label Period|Withdrawal by Subject|0|||
162216381|NCT02493946|585842508|FG002|Open Label Period|Withdrawal by Subject|74|||
162216382|NCT02493946|585842506|FG000|Open Label Period|Adverse Event|0|||
162216383|NCT02493946|585842507|FG001|Open Label Period|Adverse Event|0|||
162216384|NCT02493946|585842508|FG002|Open Label Period|Adverse Event|4|||
162216385|NCT02493946|585842506|FG000|Open Label Period|Lost to Follow-up|0|||
162216386|NCT02493946|585842507|FG001|Open Label Period|Lost to Follow-up|0|||
162216387|NCT02493946|585842508|FG002|Open Label Period|Lost to Follow-up|1|||
162216388|NCT02493946|585842506|FG000|Open Label Period|Investigator decision, non-compliance|0|||
161827365|NCT02539368|584408065|FG001|Overall Study|Death|2|||
161827366|NCT02539368|584408066|FG002|Overall Study|Death|1|||
161827367|NCT02539368|584408067|FG003|Overall Study|Death|0|||
161827368|NCT02539368|584408068|FG004|Overall Study|Death|0|||
162216389|NCT02493946|585842507|FG001|Open Label Period|Investigator decision, non-compliance|0|||
162216390|NCT02493946|585842508|FG002|Open Label Period|Investigator decision, non-compliance|2|||
162216391|NCT02493946|585842506|FG000|Open Label Period|Investigator decision, non-availability|0|||
162216392|NCT02493946|585842507|FG001|Open Label Period|Investigator decision, non-availability|0|||
162216393|NCT02493946|585842508|FG002|Open Label Period|Investigator decision, non-availability|1|||
162216394|NCT02493946|585842506|FG000|Open Label Period|Pregnancy|0|||
162216395|NCT02493946|585842507|FG001|Open Label Period|Pregnancy|0|||
162216396|NCT02493946|585842508|FG002|Open Label Period|Pregnancy|3|||
162216397|NCT02493946|585842506|FG000|Open Label Period|Site error|0|||
162216398|NCT02493946|585842507|FG001|Open Label Period|Site error|0|||
162216399|NCT02493946|585842508|FG002|Open Label Period|Site error|1|||
162216400|NCT00965497|585842509|FG000|Overall Study|Physician Decision|1|||
162216401|NCT02689453|585842510|FG000|Overall Study|Progressive disease|0|||
162216402|NCT02689453|585842511|FG001|Overall Study|Progressive disease|1|||
162216403|NCT02689453|585842512|FG002|Overall Study|Progressive disease|1|||
162216404|NCT01162486|585842513|FG000|Overall Study|low ANC|1|||
162216405|NCT01162486|585842514|FG001|Overall Study|low ANC|0|||
162216406|NCT01162486|585842515|FG002|Overall Study|low ANC|0|||
162216407|NCT01162486|585842516|FG003|Overall Study|low ANC|0|||
162216408|NCT01162486|585842517|FG004|Overall Study|low ANC|0|||
162216409|NCT01162486|585842513|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
162216410|NCT01162486|585842514|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
162216411|NCT01162486|585842515|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
162216412|NCT01162486|585842516|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
162216413|NCT01162486|585842517|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
162216414|NCT01162486|585842513|FG000|Overall Study|elevated LFTs|0|||
162216415|NCT01162486|585842514|FG001|Overall Study|elevated LFTs|0|||
161827369|NCT02539368|584408064|FG000|Overall Study|Withdrawal by Subject|44|||
161827370|NCT02539368|584408065|FG001|Overall Study|Withdrawal by Subject|35|||
162021386|NCT00387790|585134765|FG000|Overall Study|Lack of Efficacy|2|||
162021387|NCT00387790|585134765|FG000|Overall Study|Physician Decision|2|||
162216416|NCT01162486|585842515|FG002|Overall Study|elevated LFTs|1|||
162216417|NCT01162486|585842516|FG003|Overall Study|elevated LFTs|0|||
162216418|NCT01162486|585842517|FG004|Overall Study|elevated LFTs|0|||
162216419|NCT01162486|585842513|FG000|Overall Study|Pregnancy|0|||
162216420|NCT01162486|585842514|FG001|Overall Study|Pregnancy|0|||
162216421|NCT01162486|585842515|FG002|Overall Study|Pregnancy|0|||
161827371|NCT02539368|584408066|FG002|Overall Study|Withdrawal by Subject|9|||
161827372|NCT02539368|584408067|FG003|Overall Study|Withdrawal by Subject|1|||
162216422|NCT01162486|585842516|FG003|Overall Study|Pregnancy|1|||
162216423|NCT01162486|585842517|FG004|Overall Study|Pregnancy|0|||
162216424|NCT00794924|585842518|FG000|Overall Study|Lost to Follow-up|6|||
162216425|NCT00794924|585842519|FG001|Overall Study|Lost to Follow-up|8|||
162216426|NCT00794924|585842518|FG000|Overall Study|Withdrawal by Subject|48|||
162216427|NCT00794924|585842519|FG001|Overall Study|Withdrawal by Subject|60|||
162216428|NCT00794924|585842518|FG000|Overall Study|Adverse Event|6|||
162216429|NCT00794924|585842519|FG001|Overall Study|Adverse Event|2|||
162216430|NCT00953615|585842520|FG000|Overall Study|Adverse Event|1|||
162216431|NCT02296892|585842529|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
162216432|NCT02296892|585842530|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
162216433|NCT02296892|585842531|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
162216434|NCT02296892|585842529|FG000|Overall Study|Lost to Follow-up|5|||
162216435|NCT02296892|585842530|FG001|Overall Study|Lost to Follow-up|0|||
162216436|NCT02296892|585842531|FG002|Overall Study|Lost to Follow-up|1|||
161678405|NCT00732251|583873725|FG000|Overall Study|Lost to Follow-up|3|||
161678406|NCT00732251|583873725|FG000|Overall Study|Withdrawal by Subject|3|||
161678407|NCT00732251|583873725|FG000|Overall Study|Early Term due to Site Closure|1|||
161678408|NCT02737852|583875949|FG000|Overall Study|Withdrawal by Subject|2|||
161678409|NCT03688880|583875950|FG000|Overall Study|Withdrawal by Subject|0|||
161678410|NCT03688880|583875951|FG001|Overall Study|Withdrawal by Subject|2|||
161678411|NCT03688880|583875950|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
161678412|NCT03688880|583875951|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
161678413|NCT03688880|583875950|FG000|Overall Study|Lost to Follow-up|4|||
161678414|NCT03688880|583875951|FG001|Overall Study|Lost to Follow-up|7|||
161678415|NCT03688880|583875950|FG000|Overall Study|Adverse Event|0|||
161678416|NCT03688880|583875951|FG001|Overall Study|Adverse Event|2|||
161678417|NCT03688880|583875950|FG000|Overall Study|Device deficiencies|0|||
161678418|NCT03688880|583875951|FG001|Overall Study|Device deficiencies|2|||
161678419|NCT03688880|583875950|FG000|Overall Study|Other|10|||
161678420|NCT03688880|583875951|FG001|Overall Study|Other|16|||
161678421|NCT02807480|583875955|FG000|Overall Study|Withdrawal by Subject|14|||
161678422|NCT02807480|583875956|FG001|Overall Study|Withdrawal by Subject|10|||
161678423|NCT02163187|583875959|FG000|Overall Study|Device removed|1|||
161678424|NCT02163187|583875960|FG001|Overall Study|Device removed|0|||
161678425|NCT02163187|583875959|FG000|Overall Study|Progressive disease|1|||
161678426|NCT02163187|583875960|FG001|Overall Study|Progressive disease|0|||
161678427|NCT02369848|583875961|FG000|Overall Study|Death|1|||
161678428|NCT02369848|583875961|FG000|Overall Study|Withdrawal by Subject|2|||
162216437|NCT00383123|585842536|FG000|Overall Study|Adverse Event|1|||
162216438|NCT00383123|585842537|FG001|Overall Study|Adverse Event|0|||
162216439|NCT00383123|585842536|FG000|Overall Study|Lost to Follow-up|68|||
161678429|NCT02369848|583875961|FG000|Overall Study|Lost to Follow-up|1|||
161678430|NCT03281668|583875964|FG000|Overall Study|Physician Decision|1|||
161678431|NCT03281668|583875964|FG000|Overall Study|scheduling conflict, family circumstance|2|||
162216440|NCT00383123|585842537|FG001|Overall Study|Lost to Follow-up|61|||
162216441|NCT00383123|585842536|FG000|Overall Study|Protocol Violation|5|||
162216442|NCT00383123|585842537|FG001|Overall Study|Protocol Violation|1|||
162216443|NCT00383123|585842536|FG000|Overall Study|Withdrawal by Subject|27|||
162216444|NCT00383123|585842537|FG001|Overall Study|Withdrawal by Subject|18|||
162216445|NCT00383123|585842536|FG000|Overall Study|Other reason|10|||
162216446|NCT00383123|585842537|FG001|Overall Study|Other reason|6|||
162216447|NCT00250432|585842540|FG000|Overall Study|Adverse Event|25|||
162216448|NCT00250432|585842541|FG001|Overall Study|Adverse Event|29|||
162216449|NCT00250432|585842540|FG000|Overall Study|Lack of Efficacy|2|||
162216450|NCT00250432|585842541|FG001|Overall Study|Lack of Efficacy|1|||
162216451|NCT00250432|585842540|FG000|Overall Study|Lost to Follow-up|6|||
162216452|NCT00250432|585842541|FG001|Overall Study|Lost to Follow-up|5|||
162216453|NCT00250432|585842540|FG000|Overall Study|Patient Moved|0|||
162216454|NCT00250432|585842541|FG001|Overall Study|Patient Moved|1|||
162216455|NCT00250432|585842540|FG000|Overall Study|Protocol Violation|0|||
162216456|NCT00250432|585842541|FG001|Overall Study|Protocol Violation|3|||
162216457|NCT00250432|585842540|FG000|Overall Study|Withdrawal by Subject|6|||
162216458|NCT00250432|585842541|FG001|Overall Study|Withdrawal by Subject|2|||
162216459|NCT00250432|585842540|FG000|Overall Study|Pt died out of posttherapy report period|6|||
162216460|NCT00250432|585842541|FG001|Overall Study|Pt died out of posttherapy report period|5|||
162216461|NCT00250432|585842540|FG000|Overall Study|Pt was considered untreatable|0|||
162216462|NCT00250432|585842541|FG001|Overall Study|Pt was considered untreatable|1|||
162216463|NCT04147858|585842542|FG000|Overall Study|Adverse Event|6|||
162216464|NCT04147858|585842543|FG001|Overall Study|Adverse Event|6|||
162216465|NCT04147858|585842544|FG002|Overall Study|Adverse Event|6|||
162216466|NCT04147858|585842542|FG000|Overall Study|Lack of Efficacy|3|||
162216467|NCT04147858|585842543|FG001|Overall Study|Lack of Efficacy|3|||
162216468|NCT04147858|585842544|FG002|Overall Study|Lack of Efficacy|1|||
162216469|NCT04147858|585842542|FG000|Overall Study|Lost to Follow-up|1|||
162216470|NCT04147858|585842543|FG001|Overall Study|Lost to Follow-up|6|||
162216471|NCT04147858|585842544|FG002|Overall Study|Lost to Follow-up|2|||
162216472|NCT04147858|585842542|FG000|Overall Study|Withdrawal by Subject|3|||
162216473|NCT04147858|585842543|FG001|Overall Study|Withdrawal by Subject|4|||
162216474|NCT04147858|585842544|FG002|Overall Study|Withdrawal by Subject|10|||
162216475|NCT04147858|585842542|FG000|Overall Study|Subject Noncompliance, Other|4|||
162216476|NCT04147858|585842543|FG001|Overall Study|Subject Noncompliance, Other|3|||
162216477|NCT04147858|585842544|FG002|Overall Study|Subject Noncompliance, Other|1|||
162216478|NCT03375320|585842550|FG000|Overall Study|Adverse Event|34|||
162216479|NCT03375320|585842551|FG001|Overall Study|Adverse Event|9|||
162216480|NCT03375320|585842552|FG002|Overall Study|Adverse Event|10|||
162216481|NCT03375320|585842553|FG003|Overall Study|Adverse Event|0|||
162216482|NCT03375320|585842550|FG000|Overall Study|Death|6|||
162216483|NCT03375320|585842551|FG001|Overall Study|Death|3|||
162216484|NCT03375320|585842552|FG002|Overall Study|Death|0|||
162216485|NCT03375320|585842553|FG003|Overall Study|Death|0|||
162216486|NCT03375320|585842550|FG000|Overall Study|Withdrawal by Subject|7|||
162216487|NCT03375320|585842551|FG001|Overall Study|Withdrawal by Subject|4|||
162216488|NCT03375320|585842552|FG002|Overall Study|Withdrawal by Subject|5|||
162216489|NCT03375320|585842553|FG003|Overall Study|Withdrawal by Subject|4|||
162216490|NCT03375320|585842550|FG000|Overall Study|Progressive disease|55|||
162216491|NCT03375320|585842551|FG001|Overall Study|Progressive disease|41|||
162216492|NCT03375320|585842552|FG002|Overall Study|Progressive disease|29|||
162216493|NCT03375320|585842553|FG003|Overall Study|Progressive disease|24|||
162216494|NCT03375320|585842550|FG000|Overall Study|Alternative treatment|6|||
162216495|NCT03375320|585842551|FG001|Overall Study|Alternative treatment|1|||
162216496|NCT03375320|585842552|FG002|Overall Study|Alternative treatment|1|||
162216497|NCT03375320|585842553|FG003|Overall Study|Alternative treatment|0|||
162216498|NCT03375320|585842550|FG000|Overall Study|Other disease|1|||
162216499|NCT03375320|585842551|FG001|Overall Study|Other disease|1|||
162216500|NCT03375320|585842552|FG002|Overall Study|Other disease|3|||
162216501|NCT03375320|585842553|FG003|Overall Study|Other disease|0|||
161827373|NCT02539368|584408068|FG004|Overall Study|Withdrawal by Subject|3|||
162216502|NCT03375320|585842550|FG000|Overall Study|Withdrawal prior to initiation|2|||
162216503|NCT03375320|585842551|FG001|Overall Study|Withdrawal prior to initiation|2|||
162216504|NCT03375320|585842552|FG002|Overall Study|Withdrawal prior to initiation|1|||
162216505|NCT03375320|585842553|FG003|Overall Study|Withdrawal prior to initiation|0|||
162216506|NCT03375320|585842550|FG000|Overall Study|Physician Decision|1|||
161827374|NCT02539368|584408064|FG000|Overall Study|Physician Decision|49|||
161827375|NCT02539368|584408065|FG001|Overall Study|Physician Decision|15|||
161827376|NCT02539368|584408066|FG002|Overall Study|Physician Decision|7|||
161827377|NCT02539368|584408067|FG003|Overall Study|Physician Decision|0|||
161827378|NCT02539368|584408068|FG004|Overall Study|Physician Decision|2|||
161827379|NCT02539368|584408064|FG000|Overall Study|Lost to Follow-up|96|||
161827380|NCT02539368|584408065|FG001|Overall Study|Lost to Follow-up|21|||
161827381|NCT02539368|584408066|FG002|Overall Study|Lost to Follow-up|16|||
161827382|NCT02539368|584408067|FG003|Overall Study|Lost to Follow-up|4|||
161827383|NCT02539368|584408068|FG004|Overall Study|Lost to Follow-up|3|||
161827384|NCT02539368|584408064|FG000|Overall Study|Adverse Event|44|||
162216507|NCT03375320|585842551|FG001|Overall Study|Physician Decision|1|||
162216508|NCT03375320|585842552|FG002|Overall Study|Physician Decision|1|||
162216509|NCT03375320|585842553|FG003|Overall Study|Physician Decision|1|||
162021388|NCT00387790|585134765|FG000|Overall Study|Withdrawal by Subject|3|||
162021389|NCT00387790|585134765|FG000|Overall Study|Ineligible for study|2|||
162216510|NCT03375320|585842550|FG000|Overall Study|Non-compliance|1|||
162216511|NCT03375320|585842551|FG001|Overall Study|Non-compliance|0|||
162216512|NCT03375320|585842552|FG002|Overall Study|Non-compliance|0|||
162216513|NCT03375320|585842553|FG003|Overall Study|Non-compliance|0|||
162216514|NCT04907357|585842554|FG000|Overall Study|Death|0|||
162216515|NCT04907357|585842555|FG001|Overall Study|Death|1|||
162216516|NCT04907357|585842554|FG000|Overall Study|Lost to Follow-up|9|||
162216517|NCT04907357|585842555|FG001|Overall Study|Lost to Follow-up|18|||
162216518|NCT04907357|585842554|FG000|Overall Study|Physician Decision|1|||
162216519|NCT04907357|585842555|FG001|Overall Study|Physician Decision|0|||
162216520|NCT04907357|585842554|FG000|Overall Study|Withdrawal by Subject|0|||
162216521|NCT04907357|585842555|FG001|Overall Study|Withdrawal by Subject|1|||
162216522|NCT04907357|585842554|FG000|Overall Study|Unable to attend visits|1|||
162216523|NCT04907357|585842555|FG001|Overall Study|Unable to attend visits|0|||
162216524|NCT04907357|585842554|FG000|Overall Study|Incarcerated|1|||
162216525|NCT04907357|585842555|FG001|Overall Study|Incarcerated|1|||
162216526|NCT03358238|585842556|FG000|Overall Study|Withdrawal by Subject|0|||
162216527|NCT03358238|585842557|FG001|Overall Study|Withdrawal by Subject|1|||
162216528|NCT01340014|585842558|FG000|Period 1, First 7 Days|Adverse Event|1|||
162216529|NCT01340014|585842559|FG001|Period 1, First 7 Days|Adverse Event|0|||
162216530|NCT01340014|585842558|FG000|Period 1, First 7 Days|Personal Reasons|1|||
162216531|NCT01340014|585842559|FG001|Period 1, First 7 Days|Personal Reasons|0|||
162216532|NCT01340014|585842558|FG000|Period 2, Second 7 Days|Adverse Event|0|||
162216533|NCT01340014|585842559|FG001|Period 2, Second 7 Days|Adverse Event|1|||
162216534|NCT05101993|585842564|FG000|Overall Study|Withdrawal by Subject|1|||
162216535|NCT04577573|585842565|FG000|Overall Study|Technical - invalid protocol|0|||
162216536|NCT04577573|585842566|FG001|Overall Study|Technical - invalid protocol|2|||
162216537|NCT04577573|585842567|FG002|Overall Study|Technical - invalid protocol|0|||
162216538|NCT02113124|585844274|FG000|Overall Study|Unable to retrieve blood sample|1|||
162216539|NCT02113124|585844275|FG001|Overall Study|Unable to retrieve blood sample|1|||
162216540|NCT01888874|585844276|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
162216541|NCT01888874|585844277|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
162216542|NCT01888874|585844278|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
162216543|NCT01888874|585844279|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
162216544|NCT01888874|585844280|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
162216545|NCT01888874|585844281|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
162216546|NCT01888874|585844282|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
162216547|NCT01888874|585844276|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
162216548|NCT01888874|585844277|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
162216549|NCT01888874|585844278|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
162216550|NCT01888874|585844279|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
162216551|NCT01888874|585844280|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
162216552|NCT01888874|585844281|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
162216553|NCT01888874|585844282|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
162216554|NCT01888874|585844276|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
162216555|NCT01888874|585844277|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
162216556|NCT01888874|585844278|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
162216557|NCT01888874|585844279|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
162216558|NCT01888874|585844280|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
162216559|NCT01888874|585844281|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
162216560|NCT01888874|585844282|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
162216561|NCT01888874|585844276|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
162216562|NCT01888874|585844277|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
162216563|NCT01888874|585844278|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
162216564|NCT01888874|585844279|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
162216565|NCT01888874|585844280|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
162216566|NCT01888874|585844281|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
162216567|NCT01888874|585844282|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
162216568|NCT01888874|585844276|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162216569|NCT01888874|585844277|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162216570|NCT01888874|585844278|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162216571|NCT01888874|585844279|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162216572|NCT01888874|585844280|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
162216573|NCT01888874|585844281|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162216574|NCT01888874|585844282|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
162216575|NCT01888874|585844276|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
162216576|NCT01888874|585844277|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
162216577|NCT01888874|585844278|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
162216578|NCT01888874|585844279|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161936871|NCT05213624|584817740|FG000|Overall Study|Adverse Event|0|||
161936872|NCT05213624|584817741|FG001|Overall Study|Adverse Event|3|||
161936873|NCT05213624|584817742|FG002|Overall Study|Adverse Event|0|||
161936874|NCT05213624|584817743|FG003|Overall Study|Adverse Event|0|||
161936875|NCT05213624|584817740|FG000|Overall Study|Protocol deviation|0|||
161936876|NCT05213624|584817741|FG001|Overall Study|Protocol deviation|2|||
161936877|NCT05213624|584817742|FG002|Overall Study|Protocol deviation|0|||
161936878|NCT05213624|584817743|FG003|Overall Study|Protocol deviation|0|||
161936879|NCT05213624|584817740|FG000|Overall Study|Withdrawal by Subject|0|||
161936880|NCT05213624|584817741|FG001|Overall Study|Withdrawal by Subject|0|||
161936881|NCT05213624|584817742|FG002|Overall Study|Withdrawal by Subject|0|||
161936882|NCT05213624|584817743|FG003|Overall Study|Withdrawal by Subject|1|||
161936883|NCT05213624|584817740|FG000|Overall Study|Not treated|0|||
161936884|NCT05213624|584817741|FG001|Overall Study|Not treated|1|||
161936885|NCT05213624|584817742|FG002|Overall Study|Not treated|2|||
161936886|NCT05213624|584817743|FG003|Overall Study|Not treated|2|||
162216579|NCT01888874|585844280|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
162216580|NCT01888874|585844281|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
162216581|NCT01888874|585844282|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
162216582|NCT01888874|585844276|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
162216583|NCT01888874|585844277|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
162216584|NCT01888874|585844278|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
162216585|NCT01888874|585844279|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
162216586|NCT01888874|585844280|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
162216587|NCT01888874|585844281|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
162216588|NCT01888874|585844282|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
162216589|NCT01888874|585844276|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
162216590|NCT01888874|585844277|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
162216591|NCT01888874|585844278|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
162216592|NCT01888874|585844279|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
162216593|NCT01888874|585844280|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
162216594|NCT01888874|585844281|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
162216595|NCT01888874|585844282|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
162216596|NCT01888874|585844276|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
162216597|NCT01888874|585844277|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
162216598|NCT01888874|585844278|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
162216599|NCT01888874|585844279|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
162216600|NCT01888874|585844280|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
162216601|NCT01888874|585844281|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
162216602|NCT01888874|585844282|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
162216603|NCT01888874|585844276|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
162216604|NCT01888874|585844277|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
162216605|NCT01888874|585844278|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
162216606|NCT01888874|585844279|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
162216607|NCT01888874|585844280|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
162216608|NCT01888874|585844281|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
162216609|NCT01888874|585844282|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
162216610|NCT01888874|585844276|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
162216611|NCT01888874|585844277|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
162216612|NCT01888874|585844278|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
162216613|NCT01888874|585844279|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
162216614|NCT01888874|585844280|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
162216615|NCT01888874|585844281|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
162216616|NCT01888874|585844282|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
162216617|NCT01888874|585844276|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
162216618|NCT01888874|585844277|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
162216619|NCT01888874|585844278|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
162216620|NCT01888874|585844279|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
162216621|NCT01888874|585844280|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
162216622|NCT01888874|585844281|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
162216623|NCT01888874|585844282|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
162216624|NCT01888874|585844276|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
162216625|NCT01888874|585844277|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
162216626|NCT01888874|585844278|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
162216627|NCT01888874|585844279|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
162216628|NCT01888874|585844280|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
162216629|NCT01888874|585844281|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
162216630|NCT01888874|585844282|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
162216631|NCT02763215|585844283|FG000|Overall Study|Participants withdrew from study|3|||
162216632|NCT02763215|585844283|FG000|Overall Study|Missed visit|1|||
162216633|NCT02763215|585844283|FG000|Overall Study|Visit outside visit-window|1|||
162216634|NCT02763215|585844283|FG000|Overall Study|Death|1|||
162216635|NCT02763215|585844283|FG000|Overall Study|Lost to Follow-up|1|||
162216636|NCT02963090|585844285|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
162216637|NCT02963090|585844286|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
162216638|NCT00709228|585844287|FG000|Overall Study|Not treated|14|||
162216639|NCT00709228|585844287|FG000|Overall Study|Eligibility criteria not met|281|||
162216640|NCT00709228|585844287|FG000|Overall Study|Adverse events|2|||
162216641|NCT00709228|585844287|FG000|Overall Study|Discontinued treatment|14|||
162216642|NCT00709228|585844287|FG000|Overall Study|Did not enter follow-up|4|||
162216643|NCT00709228|585844287|FG000|Overall Study|Discontinued follow-up|5|||
162216644|NCT00709228|585844287|FG000|Overall Study|Disease progression|1|||
162216645|NCT00709228|585844287|FG000|Overall Study|Lost to Follow-up|6|||
162216646|NCT00709228|585844287|FG000|Overall Study|Non-compliance|5|||
162216647|NCT02179177|585844290|FG000|Overall Study|Lost to Follow-up|1|||
162216648|NCT02179177|585844291|FG001|Overall Study|Lost to Follow-up|1|||
162216649|NCT02179177|585844290|FG000|Overall Study|Withdrawal by Subject|1|||
162216650|NCT02179177|585844291|FG001|Overall Study|Withdrawal by Subject|1|||
162216651|NCT00022659|585844292|FG000|Overall Study|Ineligible: wrong primary|1|||
162216652|NCT00022659|585844292|FG000|Overall Study|Never treated|1|||
162216653|NCT00884650|585844293|FG000|Overall Study|Did not return complete pain diaries|7|||
162216654|NCT00884650|585844294|FG001|Overall Study|Did not return complete pain diaries|7|||
162216655|NCT00884650|585844293|FG000|Overall Study|Admitted Post-Op|1|||
162216656|NCT00884650|585844294|FG001|Overall Study|Admitted Post-Op|0|||
162216657|NCT00884650|585844293|FG000|Overall Study|Femoral Stress Fracture|1|||
162216658|NCT00884650|585844294|FG001|Overall Study|Femoral Stress Fracture|0|||
162216659|NCT00884650|585844293|FG000|Overall Study|Pain Pump Complication|0|||
162216660|NCT00884650|585844294|FG001|Overall Study|Pain Pump Complication|1|||
162216661|NCT04052425|585844295|FG000|24-Week Double-blind Period|Adverse Event|0|||
162216662|NCT04052425|585844296|FG001|24-Week Double-blind Period|Adverse Event|1|||
162216663|NCT04052425|585844297|FG002|24-Week Double-blind Period|Adverse Event|0|||
162216664|NCT04052425|585844298|FG003|24-Week Double-blind Period|Adverse Event|0|||
162216665|NCT04052425|585844295|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
162216666|NCT04052425|585844296|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
162216667|NCT04052425|585844297|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
162216668|NCT04052425|585844298|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
162216669|NCT04052425|585844295|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
162216670|NCT04052425|585844296|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
162216671|NCT04052425|585844297|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
162216672|NCT04052425|585844298|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
162216673|NCT04052425|585844295|FG000|24-Week Double-blind Period|Physician Decision|1|||
162216674|NCT04052425|585844296|FG001|24-Week Double-blind Period|Physician Decision|0|||
162216675|NCT04052425|585844297|FG002|24-Week Double-blind Period|Physician Decision|0|||
162216676|NCT04052425|585844298|FG003|24-Week Double-blind Period|Physician Decision|0|||
162216677|NCT04052425|585844295|FG000|24-Week Double-blind Period|Protocol Violation|1|||
162216678|NCT04052425|585844296|FG001|24-Week Double-blind Period|Protocol Violation|0|||
162216679|NCT04052425|585844297|FG002|24-Week Double-blind Period|Protocol Violation|0|||
162216680|NCT04052425|585844298|FG003|24-Week Double-blind Period|Protocol Violation|0|||
162216681|NCT04052425|585844295|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
162216682|NCT04052425|585844296|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
162216683|NCT04052425|585844297|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
162216684|NCT04052425|585844298|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
162216685|NCT04052425|585844295|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
162216686|NCT04052425|585844296|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
162216687|NCT04052425|585844297|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
162216688|NCT04052425|585844298|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
162216689|NCT04052425|585844295|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
162216690|NCT04052425|585844296|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
162216691|NCT04052425|585844297|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
162216692|NCT04052425|585844298|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
162216693|NCT04052425|585844295|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
162216694|NCT04052425|585844296|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
162216695|NCT04052425|585844297|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
162216696|NCT04052425|585844298|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
162216697|NCT04052425|585844295|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
162216698|NCT04052425|585844296|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
162216699|NCT04052425|585844297|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
162216700|NCT04052425|585844298|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
162216701|NCT04052425|585844295|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
162216702|NCT04052425|585844296|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
162216703|NCT04052425|585844297|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
162216704|NCT04052425|585844298|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
162216705|NCT04052425|585844295|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
162216706|NCT04052425|585844296|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
162216707|NCT04052425|585844297|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
162216708|NCT04052425|585844298|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
162216709|NCT04052425|585844295|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
162216710|NCT04052425|585844296|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
162216711|NCT04052425|585844297|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
162216712|NCT04052425|585844298|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
162216713|NCT04052425|585844295|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
162216714|NCT04052425|585844296|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
162216715|NCT04052425|585844297|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
162216716|NCT04052425|585844298|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
162216717|NCT00945672|585844301|FG000|Overall Study|Withdrawal by Subject|0|||
162216718|NCT00945672|585844302|FG001|Overall Study|Withdrawal by Subject|0|||
162216719|NCT00945672|585844303|FG002|Overall Study|Withdrawal by Subject|0|||
162216720|NCT00945672|585844304|FG003|Overall Study|Withdrawal by Subject|1|||
162216721|NCT01681992|585844307|FG000|Overall Study|Adverse Event|3|||
162216722|NCT01681992|585844308|FG001|Overall Study|Adverse Event|2|||
162216723|NCT01681992|585844309|FG002|Overall Study|Adverse Event|3|||
162216724|NCT01681992|585844307|FG000|Overall Study|Lost to Follow-up|36|||
162216725|NCT01681992|585844308|FG001|Overall Study|Lost to Follow-up|38|||
162216726|NCT01681992|585844309|FG002|Overall Study|Lost to Follow-up|53|||
162216727|NCT01681992|585844307|FG000|Overall Study|As Per Sponsor Decision|0|||
162216728|NCT01681992|585844308|FG001|Overall Study|As Per Sponsor Decision|0|||
162216729|NCT01681992|585844309|FG002|Overall Study|As Per Sponsor Decision|1|||
162216730|NCT01681992|585844307|FG000|Overall Study|Protocol Violation|0|||
162216731|NCT01681992|585844308|FG001|Overall Study|Protocol Violation|0|||
162216732|NCT01681992|585844309|FG002|Overall Study|Protocol Violation|1|||
162216733|NCT01681992|585844307|FG000|Overall Study|Withdrawal by Subject|27|||
162216734|NCT01681992|585844308|FG001|Overall Study|Withdrawal by Subject|30|||
162216735|NCT01681992|585844309|FG002|Overall Study|Withdrawal by Subject|25|||
162216736|NCT00447590|585844312|FG000|Overall Study|Withdrawal by Subject|26|||
162216737|NCT00447590|585844312|FG000|Overall Study|Lost to Follow-up|24|||
162216738|NCT00447590|585844312|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
162216739|NCT03880019|585844313|FG000|Overall Study|Competing disease|1|||
162216740|NCT01163474|585844319|FG000|Overall Study|Withdrawal by Subject|1|||
162216741|NCT01163474|585844319|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
162216742|NCT01163474|585844319|FG000|Overall Study|Lost to Follow-up|3|||
162216743|NCT02878603|585844320|FG000|Overall Study|Lost to Follow-up|4|||
162216744|NCT02878603|585844321|FG001|Overall Study|Lost to Follow-up|1|||
162216745|NCT02878603|585844320|FG000|Overall Study|Withdrawal by Subject|1|||
162216746|NCT02878603|585844321|FG001|Overall Study|Withdrawal by Subject|1|||
162216747|NCT02878603|585844320|FG000|Overall Study|Death|1|||
162216748|NCT02878603|585844321|FG001|Overall Study|Death|0|||
162216749|NCT02878603|585844320|FG000|Overall Study|Physician Decision|0|||
162216750|NCT02878603|585844321|FG001|Overall Study|Physician Decision|3|||
162216751|NCT03274895|585844322|FG000|Overall Study|Lack of Efficacy|1|||
162216752|NCT03274895|585844323|FG001|Overall Study|Lack of Efficacy|0|||
162216753|NCT03274895|585844322|FG000|Overall Study|Adverse Event|8|||
162216754|NCT03274895|585844323|FG001|Overall Study|Adverse Event|7|||
162216755|NCT03274895|585844322|FG000|Overall Study|Lost to Follow-up|1|||
162216756|NCT03274895|585844323|FG001|Overall Study|Lost to Follow-up|0|||
162216757|NCT03274895|585844322|FG000|Overall Study|Diagnosis not confirmed|3|||
162216758|NCT03274895|585844323|FG001|Overall Study|Diagnosis not confirmed|4|||
162216759|NCT01969851|585844324|FG000|Overall Study|Adverse Event|0|||
162216760|NCT01969851|585844325|FG001|Overall Study|Adverse Event|0|||
162216761|NCT01969851|585844326|FG002|Overall Study|Adverse Event|3|||
162216762|NCT01969851|585844324|FG000|Overall Study|Lack of Efficacy|0|||
162216763|NCT01969851|585844325|FG001|Overall Study|Lack of Efficacy|3|||
162216764|NCT01969851|585844326|FG002|Overall Study|Lack of Efficacy|1|||
162216765|NCT01969851|585844324|FG000|Overall Study|Withdrawal by Subject|1|||
162216766|NCT01969851|585844325|FG001|Overall Study|Withdrawal by Subject|0|||
162216767|NCT01969851|585844326|FG002|Overall Study|Withdrawal by Subject|1|||
162216768|NCT01969851|585844324|FG000|Overall Study|No effective dose in Titration period|0|||
162216769|NCT01969851|585844325|FG001|Overall Study|No effective dose in Titration period|0|||
162216770|NCT01969851|585844326|FG002|Overall Study|No effective dose in Titration period|1|||
162216771|NCT01969851|585844324|FG000|Overall Study|Sponsor decision|0|||
162216772|NCT01969851|585844325|FG001|Overall Study|Sponsor decision|0|||
162216773|NCT01969851|585844326|FG002|Overall Study|Sponsor decision|1|||
162216774|NCT01294436|585844327|FG000|Overall Study|Adverse Event|10|||
162216775|NCT01294436|585844328|FG001|Overall Study|Adverse Event|17|||
162216776|NCT01294436|585844327|FG000|Overall Study|Withdrawal by Subject|11|||
162216777|NCT01294436|585844328|FG001|Overall Study|Withdrawal by Subject|28|||
162216778|NCT01294436|585844327|FG000|Overall Study|subject no longer meets study criteria|5|||
162216779|NCT01294436|585844328|FG001|Overall Study|subject no longer meets study criteria|20|||
162216780|NCT01294436|585844327|FG000|Overall Study|poor/non-compliance|2|||
162216781|NCT01294436|585844328|FG001|Overall Study|poor/non-compliance|5|||
162216782|NCT02389764|585844329|FG000|Overall Study|Lack of Efficacy|9|||
162216783|NCT00585078|585844332|FG000|Overall Study|Withdrawal by Subject|4|||
162216784|NCT00585078|585844332|FG000|Overall Study|Poor performance status|1|||
162216785|NCT00585078|585844332|FG000|Overall Study|Disease Progression|24|||
162216786|NCT00585078|585844332|FG000|Overall Study|Adverse Event|10|||
162216787|NCT00585078|585844332|FG000|Overall Study|Death|1|||
162216788|NCT01814072|585844333|FG000|Overall Study|Lost to Follow-up|2|||
162216789|NCT01814072|585844334|FG001|Overall Study|Lost to Follow-up|2|||
162216790|NCT01814072|585844335|FG002|Overall Study|Lost to Follow-up|2|||
162216791|NCT01814072|585844336|FG003|Overall Study|Lost to Follow-up|0|||
162216792|NCT01814072|585844337|FG004|Overall Study|Lost to Follow-up|2|||
162216793|NCT01814072|585844338|FG005|Overall Study|Lost to Follow-up|3|||
162216794|NCT01814072|585844339|FG006|Overall Study|Lost to Follow-up|3|||
162216795|NCT01814072|585844340|FG007|Overall Study|Lost to Follow-up|1|||
162216796|NCT01814072|585844341|FG008|Overall Study|Lost to Follow-up|2|||
162216797|NCT01814072|585844342|FG009|Overall Study|Lost to Follow-up|3|||
162216798|NCT01814072|585844343|FG010|Overall Study|Lost to Follow-up|1|||
162216799|NCT01814072|585844344|FG011|Overall Study|Lost to Follow-up|2|||
162216800|NCT01814072|585844345|FG012|Overall Study|Lost to Follow-up|2|||
162216801|NCT01814072|585844346|FG013|Overall Study|Lost to Follow-up|1|||
162216802|NCT01814072|585844347|FG014|Overall Study|Lost to Follow-up|2|||
162216803|NCT01814072|585844348|FG015|Overall Study|Lost to Follow-up|1|||
162216804|NCT01814072|585844349|FG016|Overall Study|Lost to Follow-up|3|||
162216805|NCT01814072|585844350|FG017|Overall Study|Lost to Follow-up|1|||
162216806|NCT01814072|585844351|FG018|Overall Study|Lost to Follow-up|3|||
162216807|NCT01814072|585844352|FG019|Overall Study|Lost to Follow-up|3|||
162216808|NCT01814072|585844353|FG020|Overall Study|Lost to Follow-up|2|||
162216809|NCT01814072|585844354|FG021|Overall Study|Lost to Follow-up|1|||
162216810|NCT01814072|585844355|FG022|Overall Study|Lost to Follow-up|3|||
162216811|NCT01814072|585844356|FG023|Overall Study|Lost to Follow-up|1|||
162216812|NCT01814072|585844357|FG024|Overall Study|Lost to Follow-up|4|||
162216813|NCT01814072|585844358|FG025|Overall Study|Lost to Follow-up|1|||
162216814|NCT01814072|585844359|FG026|Overall Study|Lost to Follow-up|1|||
162216815|NCT01814072|585844360|FG027|Overall Study|Lost to Follow-up|2|||
162216816|NCT01814072|585844361|FG028|Overall Study|Lost to Follow-up|3|||
162216817|NCT01814072|585844362|FG029|Overall Study|Lost to Follow-up|3|||
162216818|NCT01814072|585844363|FG030|Overall Study|Lost to Follow-up|2|||
162216819|NCT01814072|585844364|FG031|Overall Study|Lost to Follow-up|0|||
162216820|NCT01814072|585844333|FG000|Overall Study|Withdrawal by Subject|2|||
162216821|NCT01814072|585844334|FG001|Overall Study|Withdrawal by Subject|0|||
162216822|NCT01814072|585844335|FG002|Overall Study|Withdrawal by Subject|1|||
162216823|NCT01814072|585844336|FG003|Overall Study|Withdrawal by Subject|0|||
162216824|NCT01814072|585844337|FG004|Overall Study|Withdrawal by Subject|2|||
162216825|NCT01814072|585844338|FG005|Overall Study|Withdrawal by Subject|3|||
162216826|NCT01814072|585844339|FG006|Overall Study|Withdrawal by Subject|1|||
162216827|NCT01814072|585844340|FG007|Overall Study|Withdrawal by Subject|0|||
162216828|NCT01814072|585844341|FG008|Overall Study|Withdrawal by Subject|1|||
162216829|NCT01814072|585844342|FG009|Overall Study|Withdrawal by Subject|2|||
162216830|NCT01814072|585844343|FG010|Overall Study|Withdrawal by Subject|0|||
162216831|NCT01814072|585844344|FG011|Overall Study|Withdrawal by Subject|0|||
162216832|NCT01814072|585844345|FG012|Overall Study|Withdrawal by Subject|1|||
162216833|NCT01814072|585844346|FG013|Overall Study|Withdrawal by Subject|1|||
162216834|NCT01814072|585844347|FG014|Overall Study|Withdrawal by Subject|1|||
162216835|NCT01814072|585844348|FG015|Overall Study|Withdrawal by Subject|1|||
162216836|NCT01814072|585844349|FG016|Overall Study|Withdrawal by Subject|0|||
162216837|NCT01814072|585844350|FG017|Overall Study|Withdrawal by Subject|0|||
162216838|NCT01814072|585844351|FG018|Overall Study|Withdrawal by Subject|0|||
162216839|NCT01814072|585844352|FG019|Overall Study|Withdrawal by Subject|2|||
162216840|NCT01814072|585844353|FG020|Overall Study|Withdrawal by Subject|0|||
162216841|NCT01814072|585844354|FG021|Overall Study|Withdrawal by Subject|0|||
162216842|NCT01814072|585844355|FG022|Overall Study|Withdrawal by Subject|1|||
162216843|NCT01814072|585844356|FG023|Overall Study|Withdrawal by Subject|0|||
162216844|NCT01814072|585844357|FG024|Overall Study|Withdrawal by Subject|2|||
162216845|NCT01814072|585844358|FG025|Overall Study|Withdrawal by Subject|1|||
162216846|NCT01814072|585844359|FG026|Overall Study|Withdrawal by Subject|1|||
162216847|NCT01814072|585844360|FG027|Overall Study|Withdrawal by Subject|2|||
162216848|NCT01814072|585844361|FG028|Overall Study|Withdrawal by Subject|1|||
162216849|NCT01814072|585844362|FG029|Overall Study|Withdrawal by Subject|0|||
162216850|NCT01814072|585844363|FG030|Overall Study|Withdrawal by Subject|0|||
162216851|NCT01814072|585844364|FG031|Overall Study|Withdrawal by Subject|0|||
162216852|NCT02781311|585844365|FG000|Overall Study|Adverse Event|2|||
162216853|NCT02781311|585844366|FG001|Overall Study|Adverse Event|6|||
162216854|NCT02781311|585844367|FG002|Overall Study|Adverse Event|1|||
162216855|NCT02781311|585844365|FG000|Overall Study|Withdrawal of Consent|11|||
162216856|NCT02781311|585844366|FG001|Overall Study|Withdrawal of Consent|12|||
162216857|NCT02781311|585844367|FG002|Overall Study|Withdrawal of Consent|2|||
162216858|NCT02781311|585844365|FG000|Overall Study|Lost to Follow-up|11|||
162216859|NCT02781311|585844366|FG001|Overall Study|Lost to Follow-up|8|||
162216860|NCT02781311|585844367|FG002|Overall Study|Lost to Follow-up|1|||
162216861|NCT02781311|585844365|FG000|Overall Study|Non-Compliance with Study Drug|2|||
162216862|NCT02781311|585844366|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162216863|NCT02781311|585844367|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162216864|NCT01011868|585844372|FG000|After Week 18 Follow-up|Adverse Event|8|||
162216865|NCT01011868|585844373|FG001|After Week 18 Follow-up|Adverse Event|6|||
162216866|NCT01011868|585844374|FG002|After Week 18 Follow-up|Adverse Event|13|||
162216867|NCT01011868|585844372|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
162216868|NCT01011868|585844373|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
162216869|NCT01011868|585844374|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
162216870|NCT01011868|585844372|FG000|After Week 18 Follow-up|Protocol Violation|1|||
162216871|NCT01011868|585844373|FG001|After Week 18 Follow-up|Protocol Violation|1|||
162216872|NCT01011868|585844374|FG002|After Week 18 Follow-up|Protocol Violation|1|||
162216873|NCT01011868|585844372|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
162216874|NCT01011868|585844373|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
162216875|NCT01011868|585844374|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
162216876|NCT01011868|585844372|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
162216877|NCT01011868|585844373|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
162216878|NCT01011868|585844374|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
162216879|NCT01011868|585844372|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
162216880|NCT01011868|585844373|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
162216881|NCT01011868|585844374|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
162216882|NCT01011868|585844372|FG000|After Week 78 Follow-up|Adverse Event|14|||
162216883|NCT01011868|585844373|FG001|After Week 78 Follow-up|Adverse Event|18|||
162216884|NCT01011868|585844374|FG002|After Week 78 Follow-up|Adverse Event|21|||
162216885|NCT01011868|585844372|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
162216886|NCT01011868|585844373|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
162216887|NCT01011868|585844374|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
162216888|NCT01011868|585844372|FG000|After Week 78 Follow-up|Protocol Violation|9|||
162216889|NCT01011868|585844373|FG001|After Week 78 Follow-up|Protocol Violation|1|||
162216890|NCT01011868|585844374|FG002|After Week 78 Follow-up|Protocol Violation|2|||
162216891|NCT01011868|585844372|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
162216892|NCT01011868|585844373|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
162216893|NCT01011868|585844374|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
162216894|NCT01011868|585844372|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
162216895|NCT01011868|585844373|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
162216896|NCT01011868|585844374|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
162216897|NCT01011868|585844372|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
162216898|NCT01011868|585844373|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
162216899|NCT01011868|585844374|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
162216900|NCT02615938|585844375|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
162216901|NCT02615938|585844376|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
162216902|NCT02615938|585844377|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
162216903|NCT02615938|585844378|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
162216904|NCT02615938|585844375|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
162216905|NCT02615938|585844376|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
162216906|NCT02615938|585844377|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
162216907|NCT02615938|585844378|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
162216908|NCT02615938|585844375|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
162216909|NCT02615938|585844376|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
161827385|NCT02539368|584408065|FG001|Overall Study|Adverse Event|5|||
161827386|NCT02539368|584408066|FG002|Overall Study|Adverse Event|9|||
161827387|NCT02539368|584408067|FG003|Overall Study|Adverse Event|0|||
161827388|NCT02539368|584408068|FG004|Overall Study|Adverse Event|3|||
161827389|NCT02539368|584408064|FG000|Overall Study|Participant Non-compliant|13|||
162216910|NCT02615938|585844377|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
162216911|NCT02615938|585844378|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
162216912|NCT04905849|585844380|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
162216913|NCT04905849|585844381|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
162216914|NCT00838929|585844386|FG000|Overall Study|Protocol Violation|0|||
162216915|NCT00838929|585844387|FG001|Overall Study|Protocol Violation|1|||
162216916|NCT00838929|585844388|FG002|Overall Study|Protocol Violation|0|||
162216917|NCT00838929|585844386|FG000|Overall Study|Disease progression|0|||
162216918|NCT00838929|585844387|FG001|Overall Study|Disease progression|2|||
162216919|NCT00838929|585844388|FG002|Overall Study|Disease progression|1|||
162216920|NCT04199052|585844396|FG000|Overall Study|Lost to Follow-up|11|||
162216921|NCT04199052|585844397|FG001|Overall Study|Lost to Follow-up|18|||
162216922|NCT00699842|585844398|FG000|Overall Study|Death|0|||
162216923|NCT00699842|585844399|FG001|Overall Study|Death|1|||
162216924|NCT00699842|585844400|FG002|Overall Study|Death|0|||
162216925|NCT01358331|585844401|FG000|Overall Study|Lost to Follow-up|0|||
162216926|NCT01358331|585844402|FG001|Overall Study|Lost to Follow-up|0|||
162216927|NCT01358331|585844403|FG002|Overall Study|Lost to Follow-up|0|||
162216928|NCT01358331|585844404|FG003|Overall Study|Lost to Follow-up|1|||
162216929|NCT01358331|585844405|FG004|Overall Study|Lost to Follow-up|0|||
162216930|NCT01358331|585844406|FG005|Overall Study|Lost to Follow-up|0|||
162216931|NCT01358331|585844401|FG000|Overall Study|Withdrawal by Subject|0|||
162216932|NCT01358331|585844402|FG001|Overall Study|Withdrawal by Subject|0|||
162216933|NCT01358331|585844403|FG002|Overall Study|Withdrawal by Subject|0|||
162216934|NCT01358331|585844404|FG003|Overall Study|Withdrawal by Subject|1|||
162216935|NCT01358331|585844405|FG004|Overall Study|Withdrawal by Subject|1|||
162216936|NCT01358331|585844406|FG005|Overall Study|Withdrawal by Subject|1|||
162216937|NCT01358331|585844401|FG000|Overall Study|Adverse Events|1|||
162216938|NCT01358331|585844402|FG001|Overall Study|Adverse Events|1|||
162216939|NCT01358331|585844403|FG002|Overall Study|Adverse Events|1|||
162216940|NCT01358331|585844404|FG003|Overall Study|Adverse Events|0|||
162216941|NCT01358331|585844405|FG004|Overall Study|Adverse Events|1|||
162216942|NCT01358331|585844406|FG005|Overall Study|Adverse Events|5|||
162216943|NCT01358331|585844401|FG000|Overall Study|Symptomatic Deterioration|0|||
162216944|NCT01358331|585844402|FG001|Overall Study|Symptomatic Deterioration|0|||
162216945|NCT01358331|585844403|FG002|Overall Study|Symptomatic Deterioration|0|||
162216946|NCT01358331|585844404|FG003|Overall Study|Symptomatic Deterioration|0|||
162216947|NCT01358331|585844405|FG004|Overall Study|Symptomatic Deterioration|1|||
162216948|NCT01358331|585844406|FG005|Overall Study|Symptomatic Deterioration|0|||
162216949|NCT01358331|585844401|FG000|Overall Study|Participants did not wish to continue|0|||
162216950|NCT01358331|585844402|FG001|Overall Study|Participants did not wish to continue|0|||
162216951|NCT01358331|585844403|FG002|Overall Study|Participants did not wish to continue|0|||
162216952|NCT01358331|585844404|FG003|Overall Study|Participants did not wish to continue|0|||
162216953|NCT01358331|585844405|FG004|Overall Study|Participants did not wish to continue|1|||
162216954|NCT01358331|585844406|FG005|Overall Study|Participants did not wish to continue|0|||
162216955|NCT01358331|585844401|FG000|Overall Study|Progress of disease under investigation|1|||
162216956|NCT01358331|585844402|FG001|Overall Study|Progress of disease under investigation|2|||
162216957|NCT01358331|585844403|FG002|Overall Study|Progress of disease under investigation|3|||
162216958|NCT01358331|585844404|FG003|Overall Study|Progress of disease under investigation|1|||
162216959|NCT01358331|585844405|FG004|Overall Study|Progress of disease under investigation|3|||
162216960|NCT01358331|585844406|FG005|Overall Study|Progress of disease under investigation|0|||
162216961|NCT04946942|585844407|FG000|Overall Study|Lost to Follow-up|6|||
161827390|NCT02539368|584408065|FG001|Overall Study|Participant Non-compliant|2|||
161827391|NCT02539368|584408066|FG002|Overall Study|Participant Non-compliant|1|||
161827392|NCT02539368|584408067|FG003|Overall Study|Participant Non-compliant|1|||
161827393|NCT02539368|584408068|FG004|Overall Study|Participant Non-compliant|0|||
161827394|NCT02539368|584408064|FG000|Overall Study|Other|145|||
161827395|NCT02539368|584408065|FG001|Overall Study|Other|18|||
161827396|NCT02539368|584408066|FG002|Overall Study|Other|24|||
161827397|NCT02539368|584408067|FG003|Overall Study|Other|1|||
161827398|NCT02539368|584408068|FG004|Overall Study|Other|3|||
161827399|NCT02539368|584408064|FG000|Overall Study|Missing|10|||
161827400|NCT02539368|584408065|FG001|Overall Study|Missing|3|||
161827401|NCT02539368|584408066|FG002|Overall Study|Missing|0|||
162216962|NCT04946942|585844408|FG001|Overall Study|Lost to Follow-up|2|||
162216963|NCT04946942|585844409|FG002|Overall Study|Lost to Follow-up|0|||
162216964|NCT03342196|585844410|FG000|Overall Study|Physician Decision|1|||
162216965|NCT02257918|585844411|FG000|Overall Study|Lost to Follow-up|4|||
162216966|NCT02257918|585844412|FG001|Overall Study|Lost to Follow-up|1|||
162216967|NCT02257918|585844413|FG002|Overall Study|Lost to Follow-up|0|||
162216968|NCT02257918|585844411|FG000|Overall Study|Withdrawal by Subject|0|||
162216969|NCT02257918|585844412|FG001|Overall Study|Withdrawal by Subject|0|||
162216970|NCT02257918|585844413|FG002|Overall Study|Withdrawal by Subject|1|||
162216971|NCT02257918|585844411|FG000|Overall Study|Pregnancy|0|||
161827402|NCT02539368|584408067|FG003|Overall Study|Missing|0|||
162216972|NCT02257918|585844412|FG001|Overall Study|Pregnancy|0|||
162216973|NCT02257918|585844413|FG002|Overall Study|Pregnancy|1|||
162216974|NCT03023423|585844416|FG000|Overall Study|Death|5|||
162216975|NCT03023423|585844417|FG001|Overall Study|Death|12|||
162216976|NCT03023423|585844418|FG002|Overall Study|Death|20|||
162216977|NCT03023423|585844416|FG000|Overall Study|Other|0|||
162216978|NCT03023423|585844417|FG001|Overall Study|Other|2|||
162216979|NCT03023423|585844418|FG002|Overall Study|Other|2|||
162216980|NCT03023423|585844416|FG000|Overall Study|Ongoing|2|||
162216981|NCT03023423|585844417|FG001|Overall Study|Ongoing|32|||
162216982|NCT03023423|585844418|FG002|Overall Study|Ongoing|24|||
162216983|NCT01151423|585844419|FG000|Overall Study|Study terminated by Sponsor|9|||
162216984|NCT01151423|585844420|FG001|Overall Study|Study terminated by Sponsor|10|||
162216985|NCT01151423|585844419|FG000|Overall Study|Protocol Violation|0|||
162216986|NCT01151423|585844420|FG001|Overall Study|Protocol Violation|1|||
162216987|NCT01151423|585844419|FG000|Overall Study|Physician Decision|1|||
162216988|NCT01151423|585844420|FG001|Overall Study|Physician Decision|1|||
162216989|NCT01151423|585844419|FG000|Overall Study|Pregnancy|0|||
162216990|NCT01151423|585844420|FG001|Overall Study|Pregnancy|1|||
162216991|NCT01151423|585844419|FG000|Overall Study|Death|0|||
162216992|NCT01151423|585844420|FG001|Overall Study|Death|1|||
162216993|NCT01151423|585844419|FG000|Overall Study|Adverse Event|3|||
162216994|NCT01151423|585844420|FG001|Overall Study|Adverse Event|0|||
162216995|NCT01151423|585844419|FG000|Overall Study|Withdrawal by Subject|1|||
162216996|NCT01151423|585844420|FG001|Overall Study|Withdrawal by Subject|3|||
162216997|NCT01151423|585844419|FG000|Overall Study|Lost to Follow-up|1|||
162216998|NCT01151423|585844420|FG001|Overall Study|Lost to Follow-up|0|||
162216999|NCT01151423|585844419|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
162217000|NCT01151423|585844420|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
162217001|NCT01151423|585844419|FG000|Overall Study|Participated in other clinical trial|1|||
162217002|NCT01151423|585844420|FG001|Overall Study|Participated in other clinical trial|0|||
162217003|NCT01263054|585844421|FG000|Overall Study|Death|1|||
162217004|NCT01263054|585844422|FG001|Overall Study|Death|0|||
162217005|NCT01263054|585844421|FG000|Overall Study|Lost to Follow-up|2|||
162217006|NCT01263054|585844422|FG001|Overall Study|Lost to Follow-up|2|||
162217007|NCT01263054|585844421|FG000|Overall Study|Withdrawal by Subject|1|||
162217008|NCT01263054|585844422|FG001|Overall Study|Withdrawal by Subject|3|||
162217009|NCT01263054|585844421|FG000|Overall Study|Qualification Violation|1|||
161827403|NCT02539368|584408068|FG004|Overall Study|Missing|0|||
161827404|NCT00251316|584408071|FG000|Overall Study|Physician Decision|2|||
162217010|NCT01263054|585844422|FG001|Overall Study|Qualification Violation|0|||
162217011|NCT01263054|585844421|FG000|Overall Study|Other|0|||
162217012|NCT01263054|585844422|FG001|Overall Study|Other|1|||
162217013|NCT00681668|585844423|FG000|Overall Study|Protocol Violation|1|||
162217014|NCT00681668|585844423|FG000|Overall Study|Withdrawal by Subject|1|||
162217015|NCT05226130|585844430|FG000|Overall Study|Lost to Follow-up|0|||
162217016|NCT05226130|585844431|FG001|Overall Study|Lost to Follow-up|1|||
162217017|NCT05226130|585844430|FG000|Overall Study|Not treatment adherent|0|||
162217018|NCT05226130|585844431|FG001|Overall Study|Not treatment adherent|2|||
162217019|NCT02520310|585844432|FG000|At 6 Months Clinical Follow-up|Death|1|||
162217020|NCT02520310|585844432|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
162217021|NCT02520310|585844432|FG000|AT 3 Year Clinical Follow-up|Death|2|||
162217022|NCT02520310|585844432|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
162217023|NCT02520310|585844432|FG000|AT 4 Year Clinical Follow-up|Death|1|||
162217024|NCT02520310|585844432|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
162217025|NCT02065882|585844435|FG000|Part I: PK/PD|Screening failure|5|||
162217026|NCT02065882|585844435|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
162217027|NCT02065882|585844435|FG000|Part I: PK/PD|Adverse Event|1|||
162217028|NCT02065882|585844435|FG000|Part II: Clinical Efficacy|Screening failure|7|||
162217029|NCT02065882|585844435|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
162217030|NCT02065882|585844435|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
162217031|NCT02065882|585844435|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
162217032|NCT02065882|585844435|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
162217033|NCT02065882|585844435|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
162217034|NCT01667926|585845806|FG000|Overall Study|Withdrawal by Subject|1|||
162217035|NCT01667926|585845807|FG001|Overall Study|Withdrawal by Subject|2|||
162217036|NCT01667926|585845808|FG002|Overall Study|Withdrawal by Subject|2|||
162217037|NCT01667926|585845806|FG000|Overall Study|Physician Decision|0|||
162217038|NCT01667926|585845807|FG001|Overall Study|Physician Decision|0|||
162217039|NCT01667926|585845808|FG002|Overall Study|Physician Decision|1|||
162217040|NCT01667926|585845806|FG000|Overall Study|Time committment|0|||
162217041|NCT01667926|585845807|FG001|Overall Study|Time committment|0|||
162217042|NCT01667926|585845808|FG002|Overall Study|Time committment|2|||
162217043|NCT01667926|585845806|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
162217044|NCT01667926|585845807|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
162217045|NCT01667926|585845808|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
162217046|NCT01667926|585845806|FG000|Overall Study|Lost to Follow-up|1|||
162217047|NCT01667926|585845807|FG001|Overall Study|Lost to Follow-up|2|||
162217048|NCT01667926|585845808|FG002|Overall Study|Lost to Follow-up|1|||
162217049|NCT01667926|585845806|FG000|Overall Study|Side effects|3|||
162217050|NCT01667926|585845807|FG001|Overall Study|Side effects|0|||
162217051|NCT01667926|585845808|FG002|Overall Study|Side effects|0|||
162217052|NCT01411241|585845812|FG000|Overall Study|Protocol Violation|0|||
162217053|NCT01411241|585845813|FG001|Overall Study|Protocol Violation|5|||
162217054|NCT01411241|585845812|FG000|Overall Study|Withdrawal by Subject|9|||
162217055|NCT01411241|585845813|FG001|Overall Study|Withdrawal by Subject|10|||
162217056|NCT01411241|585845812|FG000|Overall Study|Serious Adverse Event|0|||
162217057|NCT01411241|585845813|FG001|Overall Study|Serious Adverse Event|3|||
162217058|NCT01411241|585845812|FG000|Overall Study|Lost to Follow-up|2|||
162217059|NCT01411241|585845813|FG001|Overall Study|Lost to Follow-up|4|||
162217060|NCT02980042|585845816|FG000|Overall Study|Lost to Follow-up|5|||
162217061|NCT02980042|585845817|FG001|Overall Study|Lost to Follow-up|0|||
162217062|NCT02980042|585845816|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
162217063|NCT02980042|585845817|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
162217064|NCT03812029|585845822|FG000|Overall Study|Protocol Violation|1|||
162217065|NCT03812029|585845823|FG001|Overall Study|Protocol Violation|0|||
162217066|NCT03812029|585845824|FG002|Overall Study|Protocol Violation|0|||
162217067|NCT03812029|585845825|FG003|Overall Study|Protocol Violation|1|||
162217068|NCT03812029|585845826|FG004|Overall Study|Protocol Violation|0|||
162217069|NCT03812029|585845822|FG000|Overall Study|Withdrawal by Subject|1|||
162217070|NCT03812029|585845823|FG001|Overall Study|Withdrawal by Subject|0|||
162217071|NCT03812029|585845824|FG002|Overall Study|Withdrawal by Subject|0|||
162217072|NCT03812029|585845825|FG003|Overall Study|Withdrawal by Subject|2|||
162217073|NCT03812029|585845826|FG004|Overall Study|Withdrawal by Subject|2|||
162217074|NCT03812029|585845822|FG000|Overall Study|Stopping rules|0|||
162217075|NCT03812029|585845823|FG001|Overall Study|Stopping rules|1|||
162217076|NCT03812029|585845824|FG002|Overall Study|Stopping rules|0|||
162217077|NCT03812029|585845825|FG003|Overall Study|Stopping rules|0|||
162217078|NCT03812029|585845826|FG004|Overall Study|Stopping rules|0|||
162217079|NCT03812029|585845822|FG000|Overall Study|Adverse Event|0|||
162217080|NCT03812029|585845823|FG001|Overall Study|Adverse Event|9|||
162217081|NCT03812029|585845824|FG002|Overall Study|Adverse Event|0|||
162217082|NCT03812029|585845825|FG003|Overall Study|Adverse Event|3|||
162217083|NCT03812029|585845826|FG004|Overall Study|Adverse Event|5|||
162217084|NCT03812029|585845822|FG000|Overall Study|Lost to Follow-up|0|||
162217085|NCT03812029|585845823|FG001|Overall Study|Lost to Follow-up|0|||
162217086|NCT03812029|585845824|FG002|Overall Study|Lost to Follow-up|0|||
162217087|NCT03812029|585845825|FG003|Overall Study|Lost to Follow-up|0|||
162217088|NCT03812029|585845826|FG004|Overall Study|Lost to Follow-up|3|||
162217089|NCT04042077|585845830|FG000|Overall Study|Adverse Event|0|||
162217090|NCT04042077|585845831|FG001|Overall Study|Adverse Event|1|||
162217091|NCT04042077|585845830|FG000|Overall Study|Death|2|||
162217092|NCT04042077|585845831|FG001|Overall Study|Death|1|||
162217093|NCT04042077|585845830|FG000|Overall Study|Physician Decision|2|||
162217094|NCT04042077|585845831|FG001|Overall Study|Physician Decision|0|||
162217095|NCT04042077|585845830|FG000|Overall Study|Withdrawal by Subject|3|||
162021390|NCT04491604|585134766|FG000|Overall Study|Withdrawal by Subject|3|||
162021391|NCT01874340|585134769|FG000|Overall Study|Study terminated by Sponsor|6|||
162021392|NCT01874340|585134770|FG001|Overall Study|Study terminated by Sponsor|8|||
162217096|NCT04042077|585845831|FG001|Overall Study|Withdrawal by Subject|2|||
162217097|NCT04042077|585845830|FG000|Overall Study|Lack of Efficacy|0|||
162217098|NCT04042077|585845831|FG001|Overall Study|Lack of Efficacy|1|||
162217099|NCT01080300|585845832|FG000|Overall Study|Adverse Event|49|||
162217100|NCT01080300|585845833|FG001|Overall Study|Adverse Event|35|||
162217101|NCT01080300|585845832|FG000|Overall Study|Lack of Efficacy|12|||
162217102|NCT01080300|585845833|FG001|Overall Study|Lack of Efficacy|15|||
162217103|NCT01080300|585845832|FG000|Overall Study|Protocol Violation|7|||
162217104|NCT01080300|585845833|FG001|Overall Study|Protocol Violation|13|||
162217105|NCT01080300|585845832|FG000|Overall Study|Lost to Follow-up|10|||
162217106|NCT01080300|585845833|FG001|Overall Study|Lost to Follow-up|6|||
162021393|NCT01874340|585134771|FG002|Overall Study|Study terminated by Sponsor|8|||
162217107|NCT01080300|585845832|FG000|Overall Study|Death|0|||
162217108|NCT01080300|585845833|FG001|Overall Study|Death|1|||
162217109|NCT01080300|585845832|FG000|Overall Study|Withdrawal by Subject|12|||
162217110|NCT01080300|585845833|FG001|Overall Study|Withdrawal by Subject|28|||
162217111|NCT01080300|585845832|FG000|Overall Study|Reasons not specified|4|||
162217112|NCT01080300|585845833|FG001|Overall Study|Reasons not specified|6|||
162217113|NCT02269423|585845839|FG000|Overall Study|Discontinued due to change in residence|0|||
162217114|NCT02269423|585845840|FG001|Overall Study|Discontinued due to change in residence|1|||
162217115|NCT02269423|585845841|FG002|Overall Study|Discontinued due to change in residence|0|||
162217116|NCT02269423|585845842|FG003|Overall Study|Discontinued due to change in residence|1|||
162217117|NCT01305239|585845843|FG000|Overall Study|Adverse Event|22|||
162217118|NCT01305239|585845843|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
162021394|NCT01874340|585134772|FG003|Overall Study|Study terminated by Sponsor|4|||
162217119|NCT01754753|585845845|FG000|Overall Study|Study close|43|||
162217120|NCT01754753|585845846|FG001|Overall Study|Study close|44|||
162217121|NCT01754753|585845845|FG000|Overall Study|Lost to Follow-up|9|||
162217122|NCT01754753|585845846|FG001|Overall Study|Lost to Follow-up|5|||
162217123|NCT03229486|585845847|FG000|Overall Study|Protocol Violation|0|||
162217124|NCT03229486|585845848|FG001|Overall Study|Protocol Violation|1|||
162217125|NCT00856245|585845849|FG000|Overall Study|Was not transplanted|5|||
162217126|NCT04547023|585845854|FG000|Overall Study|Did Not Receive Intervention|3|||
162217127|NCT04547023|585845855|FG001|Overall Study|Did Not Receive Intervention|2|||
162217128|NCT04547023|585845854|FG000|Overall Study|Lost to Follow-up|1|||
162217129|NCT04547023|585845855|FG001|Overall Study|Lost to Follow-up|1|||
162217130|NCT01782690|585845858|FG000|Overall Study|Not reported|7|||
162021395|NCT01874340|585134769|FG000|Overall Study|Withdrawal by Subject|0|||
162217131|NCT01782690|585845858|FG000|Overall Study|Toxicity of gemcitabine|1|||
162217132|NCT01782690|585845858|FG000|Overall Study|Toxicity of erlotinib|1|||
162217133|NCT01782690|585845858|FG000|Overall Study|Lost to Follow-up|31|||
162217134|NCT01782690|585845858|FG000|Overall Study|Withdrawal of informed consent|2|||
162217135|NCT01782690|585845858|FG000|Overall Study|Absent rash|9|||
162217136|NCT01782690|585845858|FG000|Overall Study|Physician Decision|13|||
162217137|NCT01782690|585845858|FG000|Overall Study|Patient's wish|21|||
162217138|NCT01782690|585845858|FG000|Overall Study|Tumor progression|74|||
162217139|NCT01782690|585845858|FG000|Overall Study|Death|133|||
162217140|NCT01782690|585845858|FG000|Overall Study|Study completion unknown|7|||
162217141|NCT01637077|585845864|FG000|Overall Study|Cancel|1|||
162217142|NCT01637077|585845865|FG001|Overall Study|Cancel|1|||
162217143|NCT01637077|585845864|FG000|Overall Study|Withdrawal by Subject|1|||
162217144|NCT01637077|585845865|FG001|Overall Study|Withdrawal by Subject|0|||
162217145|NCT01637077|585845864|FG000|Overall Study|No cycle 1 questionnaire data|2|||
162217146|NCT01637077|585845865|FG001|Overall Study|No cycle 1 questionnaire data|0|||
162217147|NCT02638103|585845866|FG000|Overall Study|Adverse Event|13|||
162217148|NCT02638103|585845867|FG001|Overall Study|Adverse Event|12|||
162217149|NCT02638103|585845868|FG002|Overall Study|Adverse Event|19|||
162217150|NCT02638103|585845869|FG003|Overall Study|Adverse Event|12|||
162217151|NCT02638103|585845866|FG000|Overall Study|Withdrawal by Subject|43|||
162217152|NCT02638103|585845867|FG001|Overall Study|Withdrawal by Subject|53|||
162217153|NCT02638103|585845868|FG002|Overall Study|Withdrawal by Subject|30|||
162217154|NCT02638103|585845869|FG003|Overall Study|Withdrawal by Subject|61|||
162217155|NCT02638103|585845866|FG000|Overall Study|Protocol Violation|1|||
162217156|NCT02638103|585845867|FG001|Overall Study|Protocol Violation|2|||
162217157|NCT02638103|585845868|FG002|Overall Study|Protocol Violation|1|||
162217158|NCT02638103|585845869|FG003|Overall Study|Protocol Violation|4|||
162217159|NCT02638103|585845866|FG000|Overall Study|Pregnancy|2|||
162217160|NCT02638103|585845867|FG001|Overall Study|Pregnancy|3|||
162217161|NCT02638103|585845868|FG002|Overall Study|Pregnancy|0|||
162217162|NCT02638103|585845869|FG003|Overall Study|Pregnancy|1|||
162217163|NCT02638103|585845866|FG000|Overall Study|Non-compliance to Study Procedures|2|||
162217164|NCT02638103|585845867|FG001|Overall Study|Non-compliance to Study Procedures|1|||
162217165|NCT02638103|585845868|FG002|Overall Study|Non-compliance to Study Procedures|1|||
162217166|NCT02638103|585845869|FG003|Overall Study|Non-compliance to Study Procedures|1|||
162217167|NCT02638103|585845866|FG000|Overall Study|Lost to Follow-up|26|||
162217168|NCT02638103|585845867|FG001|Overall Study|Lost to Follow-up|33|||
162217169|NCT02638103|585845868|FG002|Overall Study|Lost to Follow-up|20|||
162217170|NCT02638103|585845869|FG003|Overall Study|Lost to Follow-up|37|||
162217171|NCT02638103|585845866|FG000|Overall Study|Lack of Efficacy|14|||
162217172|NCT02638103|585845867|FG001|Overall Study|Lack of Efficacy|10|||
162217173|NCT02638103|585845868|FG002|Overall Study|Lack of Efficacy|12|||
162217174|NCT02638103|585845869|FG003|Overall Study|Lack of Efficacy|22|||
162217175|NCT02638103|585845866|FG000|Overall Study|Other than specified|5|||
162217176|NCT02638103|585845867|FG001|Overall Study|Other than specified|4|||
162217177|NCT02638103|585845868|FG002|Overall Study|Other than specified|2|||
162217178|NCT02638103|585845869|FG003|Overall Study|Other than specified|4|||
162217179|NCT04277507|585845870|FG000|Overall Study|Lost to Follow-up|17|||
162217180|NCT04277507|585845870|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
162217181|NCT04277507|585845870|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
162217182|NCT04277507|585845870|FG000|Overall Study|Withdrawal by Subject|3|||
162217183|NCT04277507|585845870|FG000|Overall Study|Death due to COVID-19|1|||
162217184|NCT04277507|585845870|FG000|Overall Study|Data missing for full evaluation|5|||
162217185|NCT00583947|585845876|FG000|Cross-over Period|Adverse Event|2|||
162217186|NCT00583947|585845877|FG001|Cross-over Period|Adverse Event|0|||
162217187|NCT00583947|585845876|FG000|Cross-over Period|Withdrawal by Subject|2|||
162217188|NCT00583947|585845877|FG001|Cross-over Period|Withdrawal by Subject|0|||
162217189|NCT00583947|585845876|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
162217190|NCT00583947|585845877|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
162217191|NCT00583947|585845876|FG000|Cross-over Period|Other|1|||
162217192|NCT00583947|585845877|FG001|Cross-over Period|Other|1|||
162217193|NCT01261247|585845879|FG000|Overall Study|Ineligible|2|||
162217194|NCT01740154|585845880|FG000|Overall Study|Adverse Event|1|||
162217195|NCT03358472|585845881|FG000|Overall Study|Death|6|||
162217196|NCT03358472|585845882|FG001|Overall Study|Death|3|||
162217197|NCT03358472|585845883|FG002|Overall Study|Death|10|||
162217198|NCT03358472|585845881|FG000|Overall Study|Physician Decision|0|||
162217199|NCT03358472|585845882|FG001|Overall Study|Physician Decision|1|||
162217200|NCT03358472|585845883|FG002|Overall Study|Physician Decision|0|||
162217201|NCT03358472|585845881|FG000|Overall Study|Withdrawal by Subject|0|||
162217202|NCT03358472|585845882|FG001|Overall Study|Withdrawal by Subject|0|||
162217203|NCT03358472|585845883|FG002|Overall Study|Withdrawal by Subject|1|||
162217204|NCT03358472|585845881|FG000|Overall Study|On-going at clinical cut off date|9|||
162217205|NCT03358472|585845882|FG001|Overall Study|On-going at clinical cut off date|6|||
162217206|NCT03358472|585845883|FG002|Overall Study|On-going at clinical cut off date|5|||
161678432|NCT03281668|583875964|FG000|Overall Study|Withdrawal by Subject|4|||
161678433|NCT03281668|583875964|FG000|Overall Study|Lost to Follow-up|1|||
162217207|NCT03974022|585845884|FG000|Overall Study|Death|0|||
162217208|NCT03974022|585845885|FG001|Overall Study|Death|1|||
162217209|NCT03974022|585845886|FG002|Overall Study|Death|0|||
162217210|NCT03974022|585845887|FG003|Overall Study|Death|2|||
162217211|NCT03974022|585845888|FG004|Overall Study|Death|0|||
162217212|NCT03974022|585845889|FG005|Overall Study|Death|1|||
162217213|NCT03974022|585845890|FG006|Overall Study|Death|0|||
162217214|NCT03974022|585845891|FG007|Overall Study|Death|2|||
162217215|NCT03974022|585845892|FG008|Overall Study|Death|1|||
162217216|NCT03974022|585845893|FG009|Overall Study|Death|4|||
162217217|NCT03974022|585845894|FG010|Overall Study|Death|0|||
162217218|NCT03974022|585845895|FG011|Overall Study|Death|0|||
162217219|NCT03974022|585845896|FG012|Overall Study|Death|0|||
162217220|NCT03974022|585845897|FG013|Overall Study|Death|33|||
162217221|NCT03974022|585845898|FG014|Overall Study|Death|40|||
162217222|NCT03974022|585845884|FG000|Overall Study|Withdrawal by Subject|0|||
162217223|NCT03974022|585845885|FG001|Overall Study|Withdrawal by Subject|0|||
162217224|NCT03974022|585845886|FG002|Overall Study|Withdrawal by Subject|0|||
162217225|NCT03974022|585845887|FG003|Overall Study|Withdrawal by Subject|0|||
162217226|NCT03974022|585845888|FG004|Overall Study|Withdrawal by Subject|0|||
162217227|NCT03974022|585845889|FG005|Overall Study|Withdrawal by Subject|4|||
162217228|NCT03974022|585845890|FG006|Overall Study|Withdrawal by Subject|4|||
162217229|NCT03974022|585845891|FG007|Overall Study|Withdrawal by Subject|2|||
162217230|NCT03974022|585845892|FG008|Overall Study|Withdrawal by Subject|2|||
162217231|NCT03974022|585845893|FG009|Overall Study|Withdrawal by Subject|3|||
162217232|NCT03974022|585845894|FG010|Overall Study|Withdrawal by Subject|0|||
162217233|NCT03974022|585845895|FG011|Overall Study|Withdrawal by Subject|1|||
162217234|NCT03974022|585845896|FG012|Overall Study|Withdrawal by Subject|0|||
162217235|NCT03974022|585845897|FG013|Overall Study|Withdrawal by Subject|3|||
162217236|NCT03974022|585845898|FG014|Overall Study|Withdrawal by Subject|9|||
162217237|NCT03974022|585845884|FG000|Overall Study|Lost to Follow-up|0|||
162217238|NCT03974022|585845885|FG001|Overall Study|Lost to Follow-up|0|||
162217239|NCT03974022|585845886|FG002|Overall Study|Lost to Follow-up|0|||
162217240|NCT03974022|585845887|FG003|Overall Study|Lost to Follow-up|0|||
162217241|NCT03974022|585845888|FG004|Overall Study|Lost to Follow-up|0|||
162217242|NCT03974022|585845889|FG005|Overall Study|Lost to Follow-up|0|||
162217243|NCT03974022|585845890|FG006|Overall Study|Lost to Follow-up|1|||
162217244|NCT03974022|585845891|FG007|Overall Study|Lost to Follow-up|0|||
162217245|NCT03974022|585845892|FG008|Overall Study|Lost to Follow-up|0|||
162217246|NCT03974022|585845893|FG009|Overall Study|Lost to Follow-up|0|||
162217247|NCT03974022|585845894|FG010|Overall Study|Lost to Follow-up|0|||
162217248|NCT03974022|585845895|FG011|Overall Study|Lost to Follow-up|0|||
162217249|NCT03974022|585845896|FG012|Overall Study|Lost to Follow-up|0|||
162217250|NCT03974022|585845897|FG013|Overall Study|Lost to Follow-up|1|||
162217251|NCT03974022|585845898|FG014|Overall Study|Lost to Follow-up|1|||
162217252|NCT03974022|585845884|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
162217253|NCT03974022|585845885|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
162217254|NCT03974022|585845886|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
162217255|NCT03974022|585845887|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
162217256|NCT03974022|585845888|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
162217257|NCT03974022|585845889|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
162217258|NCT03974022|585845890|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
162217259|NCT03974022|585845891|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
162217260|NCT03974022|585845892|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
162217261|NCT03974022|585845893|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
162217262|NCT03974022|585845894|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
162217263|NCT03974022|585845895|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
162217264|NCT03974022|585845896|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
162217265|NCT03974022|585845897|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
162217266|NCT03974022|585845898|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
162217267|NCT04013971|585845901|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
162217268|NCT04013971|585845902|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
162217269|NCT04013971|585845901|FG000|Overall Study|Missing biomechanical data|0|||
162217270|NCT04013971|585845902|FG001|Overall Study|Missing biomechanical data|1|||
162217271|NCT05032066|585845905|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
162217272|NCT05032066|585845906|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
162217273|NCT05032066|585845907|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
162217274|NCT05032066|585845905|FG000|Part 1: Core Phase|Physician Decision|0|||
162217275|NCT05032066|585845906|FG001|Part 1: Core Phase|Physician Decision|1|||
162217276|NCT05032066|585845907|FG002|Part 1: Core Phase|Physician Decision|1|||
162217277|NCT05032066|585845905|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
162217278|NCT05032066|585845906|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
162217279|NCT05032066|585845907|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
162217280|NCT05032066|585845905|FG000|Part 1: Core Phase|Death|3|||
162217281|NCT05032066|585845906|FG001|Part 1: Core Phase|Death|4|||
162217282|NCT05032066|585845907|FG002|Part 1: Core Phase|Death|2|||
162217283|NCT05032066|585845905|FG000|Part 1: Core Phase|Adverse Event|2|||
162217284|NCT05032066|585845906|FG001|Part 1: Core Phase|Adverse Event|3|||
162217285|NCT05032066|585845907|FG002|Part 1: Core Phase|Adverse Event|0|||
162217286|NCT05032066|585845905|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
162217287|NCT05032066|585845906|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
162217288|NCT05032066|585845907|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
162217289|NCT05032066|585845905|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
162217290|NCT05032066|585845906|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
162217291|NCT05032066|585845907|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
162217292|NCT05032066|585845905|FG000|Part 2: Extension Phase|Physician Decision|1|||
162217293|NCT05032066|585845906|FG001|Part 2: Extension Phase|Physician Decision|2|||
162217294|NCT05032066|585845907|FG002|Part 2: Extension Phase|Physician Decision|0|||
162217295|NCT05032066|585845905|FG000|Part 2: Extension Phase|Death|2|||
162217296|NCT05032066|585845906|FG001|Part 2: Extension Phase|Death|4|||
162217297|NCT05032066|585845907|FG002|Part 2: Extension Phase|Death|5|||
162217298|NCT01124838|585845908|FG000|Overall Study|Miscellaneous|4|||
162217299|NCT01124838|585845909|FG001|Overall Study|Miscellaneous|2|||
162217300|NCT01124838|585845908|FG000|Overall Study|Adverse Event|7|||
162217301|NCT01124838|585845909|FG001|Overall Study|Adverse Event|11|||
162217302|NCT01124838|585845908|FG000|Overall Study|Lack of Efficacy|2|||
162217303|NCT01124838|585845909|FG001|Overall Study|Lack of Efficacy|0|||
162217304|NCT01124838|585845908|FG000|Overall Study|Withdrawal by Subject|3|||
162217305|NCT01124838|585845909|FG001|Overall Study|Withdrawal by Subject|2|||
162217306|NCT01124838|585845908|FG000|Overall Study|Lost to Follow-up|2|||
162217307|NCT01124838|585845909|FG001|Overall Study|Lost to Follow-up|0|||
162217308|NCT06719986|585845910|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
162217309|NCT06719986|585845911|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
162217310|NCT06719986|585845912|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
162217311|NCT06719986|585845910|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
162217312|NCT06719986|585845911|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
162217313|NCT06719986|585845912|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
162217314|NCT03213704|585845914|FG000|Overall Study|Physician Decision|3|||
162217315|NCT03213704|585845914|FG000|Overall Study|Protocol Violation|1|||
162217316|NCT03213704|585845914|FG000|Overall Study|Progressive disease|4|||
162217317|NCT01183390|585847836|FG000|First Intervention|Adverse Event|0|||
162217318|NCT01183390|585847837|FG001|First Intervention|Adverse Event|1|||
162217319|NCT04057573|585847840|FG000|24-Week Double-Blind Period|Adverse Event|2|||
162217320|NCT04057573|585847841|FG001|24-Week Double-Blind Period|Adverse Event|0|||
162217321|NCT04057573|585847842|FG002|24-Week Double-Blind Period|Adverse Event|0|||
162217322|NCT04057573|585847843|FG003|24-Week Double-Blind Period|Adverse Event|0|||
162217323|NCT04057573|585847840|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
162217324|NCT04057573|585847841|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
162217325|NCT04057573|585847842|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
162217326|NCT04057573|585847843|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
162217327|NCT04057573|585847840|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
162217328|NCT04057573|585847841|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
162217329|NCT04057573|585847842|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
162217330|NCT04057573|585847843|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
162217331|NCT04057573|585847840|FG000|24-Week Double-Blind Period|Physician Decision|1|||
162217332|NCT04057573|585847841|FG001|24-Week Double-Blind Period|Physician Decision|0|||
162217333|NCT04057573|585847842|FG002|24-Week Double-Blind Period|Physician Decision|0|||
162217334|NCT04057573|585847843|FG003|24-Week Double-Blind Period|Physician Decision|0|||
162217335|NCT04057573|585847840|FG000|24-Week Double-Blind Period|Pregnancy|1|||
162217336|NCT04057573|585847841|FG001|24-Week Double-Blind Period|Pregnancy|0|||
162217337|NCT04057573|585847842|FG002|24-Week Double-Blind Period|Pregnancy|0|||
162217338|NCT04057573|585847843|FG003|24-Week Double-Blind Period|Pregnancy|0|||
162217339|NCT04057573|585847840|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
162217340|NCT04057573|585847841|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
162217341|NCT04057573|585847842|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
162217342|NCT04057573|585847843|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
162217343|NCT04057573|585847840|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
162217344|NCT04057573|585847841|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
162217345|NCT04057573|585847842|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
162217346|NCT04057573|585847843|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
162217347|NCT04057573|585847840|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
162217348|NCT04057573|585847841|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
162217349|NCT04057573|585847842|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
162217350|NCT04057573|585847843|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
162217351|NCT04057573|585847840|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
162217352|NCT04057573|585847841|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
162217353|NCT04057573|585847842|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
162217354|NCT04057573|585847843|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
162217355|NCT04057573|585847840|FG000|24-Week Double-Blind Period|Not Treated|1|||
162217356|NCT04057573|585847841|FG001|24-Week Double-Blind Period|Not Treated|0|||
162217357|NCT04057573|585847842|FG002|24-Week Double-Blind Period|Not Treated|0|||
162217358|NCT04057573|585847843|FG003|24-Week Double-Blind Period|Not Treated|0|||
162217359|NCT04057573|585847840|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
162217360|NCT04057573|585847841|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
162217361|NCT04057573|585847842|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
162217362|NCT04057573|585847843|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
162217363|NCT04057573|585847840|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
162217364|NCT04057573|585847841|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
162217365|NCT04057573|585847842|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
162217366|NCT04057573|585847843|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
162217367|NCT04057573|585847840|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
162217368|NCT04057573|585847841|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
162217369|NCT04057573|585847842|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
162217370|NCT04057573|585847843|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
162217371|NCT04057573|585847840|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
162217372|NCT04057573|585847841|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
162217373|NCT04057573|585847842|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
162217374|NCT04057573|585847843|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
162217375|NCT04057573|585847840|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
162217376|NCT04057573|585847841|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
162217377|NCT04057573|585847842|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
162217378|NCT04057573|585847843|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
162217379|NCT04991753|585847844|FG000|Overall Study|Withdrawal by Subject|0|||
162217380|NCT04991753|585847845|FG001|Overall Study|Withdrawal by Subject|1|||
162217381|NCT00233480|585847848|FG000|Overall Study|Underwent status II heart transplant|0|||
162217382|NCT00233480|585847849|FG001|Overall Study|Underwent status II heart transplant|1|||
162217383|NCT00474526|585847850|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
162217384|NCT00474526|585847851|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
162217385|NCT00474526|585847852|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
162217386|NCT00474526|585847853|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
162217387|NCT00474526|585847854|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
162217388|NCT00474526|585847855|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
162217389|NCT00474526|585847856|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
162217390|NCT00474526|585847857|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
162217391|NCT00474526|585847858|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
162217392|NCT00474526|585847859|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
162217393|NCT00474526|585847860|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
162217394|NCT00474526|585847861|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
162217395|NCT00474526|585847862|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
162217396|NCT00474526|585847863|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
162217397|NCT00474526|585847864|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
162217398|NCT00474526|585847865|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
162217399|NCT00474526|585847866|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
162217400|NCT00474526|585847850|FG000|Overall Study|Adverse Event|2|||
162217401|NCT00474526|585847851|FG001|Overall Study|Adverse Event|0|||
162217402|NCT00474526|585847852|FG002|Overall Study|Adverse Event|2|||
162217403|NCT00474526|585847853|FG003|Overall Study|Adverse Event|4|||
162217404|NCT00474526|585847854|FG004|Overall Study|Adverse Event|2|||
162217405|NCT00474526|585847855|FG005|Overall Study|Adverse Event|1|||
162217406|NCT00474526|585847856|FG006|Overall Study|Adverse Event|1|||
162217407|NCT00474526|585847857|FG007|Overall Study|Adverse Event|0|||
162217408|NCT00474526|585847858|FG008|Overall Study|Adverse Event|0|||
162217409|NCT00474526|585847859|FG009|Overall Study|Adverse Event|0|||
162217410|NCT00474526|585847860|FG010|Overall Study|Adverse Event|0|||
162217411|NCT00474526|585847861|FG011|Overall Study|Adverse Event|0|||
162217412|NCT00474526|585847862|FG012|Overall Study|Adverse Event|0|||
162217413|NCT00474526|585847863|FG013|Overall Study|Adverse Event|0|||
162217414|NCT00474526|585847864|FG014|Overall Study|Adverse Event|1|||
162217415|NCT00474526|585847865|FG015|Overall Study|Adverse Event|1|||
162217416|NCT00474526|585847866|FG016|Overall Study|Adverse Event|0|||
162217417|NCT00474526|585847850|FG000|Overall Study|Death|0|||
162217418|NCT00474526|585847851|FG001|Overall Study|Death|0|||
162217419|NCT00474526|585847852|FG002|Overall Study|Death|0|||
162217420|NCT00474526|585847853|FG003|Overall Study|Death|0|||
162217421|NCT00474526|585847854|FG004|Overall Study|Death|0|||
162217422|NCT00474526|585847855|FG005|Overall Study|Death|0|||
162217423|NCT00474526|585847856|FG006|Overall Study|Death|0|||
162217424|NCT00474526|585847857|FG007|Overall Study|Death|0|||
162217425|NCT00474526|585847858|FG008|Overall Study|Death|0|||
162217426|NCT00474526|585847859|FG009|Overall Study|Death|0|||
162217427|NCT00474526|585847860|FG010|Overall Study|Death|0|||
162217428|NCT00474526|585847861|FG011|Overall Study|Death|0|||
162217429|NCT00474526|585847862|FG012|Overall Study|Death|0|||
162217430|NCT00474526|585847863|FG013|Overall Study|Death|3|||
162217431|NCT00474526|585847864|FG014|Overall Study|Death|0|||
161678434|NCT01858532|583875967|FG000|Overall Study|Adverse Event|58|||
162217432|NCT00474526|585847865|FG015|Overall Study|Death|0|||
162217433|NCT00474526|585847866|FG016|Overall Study|Death|0|||
162217434|NCT00474526|585847850|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162217435|NCT00474526|585847851|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
162217436|NCT00474526|585847852|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162217437|NCT00474526|585847853|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
162217438|NCT00474526|585847854|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
162217439|NCT00474526|585847855|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162217440|NCT00474526|585847856|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162217441|NCT00474526|585847857|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162217442|NCT00474526|585847858|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162217443|NCT00474526|585847859|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162217444|NCT00474526|585847860|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162217445|NCT00474526|585847861|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162217446|NCT00474526|585847862|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162217447|NCT00474526|585847863|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
162217448|NCT00474526|585847864|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
162217449|NCT00474526|585847865|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162217450|NCT00474526|585847866|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
162217451|NCT00474526|585847850|FG000|Overall Study|Lost to Follow-up|8|||
162217452|NCT00474526|585847851|FG001|Overall Study|Lost to Follow-up|6|||
162217453|NCT00474526|585847852|FG002|Overall Study|Lost to Follow-up|13|||
162217454|NCT00474526|585847853|FG003|Overall Study|Lost to Follow-up|29|||
162217455|NCT00474526|585847854|FG004|Overall Study|Lost to Follow-up|11|||
162217456|NCT00474526|585847855|FG005|Overall Study|Lost to Follow-up|5|||
162217457|NCT00474526|585847856|FG006|Overall Study|Lost to Follow-up|8|||
162217458|NCT00474526|585847857|FG007|Overall Study|Lost to Follow-up|1|||
162217459|NCT00474526|585847858|FG008|Overall Study|Lost to Follow-up|0|||
162217460|NCT00474526|585847859|FG009|Overall Study|Lost to Follow-up|6|||
162217461|NCT00474526|585847860|FG010|Overall Study|Lost to Follow-up|2|||
162217462|NCT00474526|585847861|FG011|Overall Study|Lost to Follow-up|4|||
162217463|NCT00474526|585847862|FG012|Overall Study|Lost to Follow-up|6|||
162217464|NCT00474526|585847863|FG013|Overall Study|Lost to Follow-up|74|||
162217465|NCT00474526|585847864|FG014|Overall Study|Lost to Follow-up|29|||
162217466|NCT00474526|585847865|FG015|Overall Study|Lost to Follow-up|4|||
162217467|NCT00474526|585847866|FG016|Overall Study|Lost to Follow-up|5|||
162217468|NCT00474526|585847850|FG000|Overall Study|Protocol Violation|2|||
162217469|NCT00474526|585847851|FG001|Overall Study|Protocol Violation|6|||
162217470|NCT00474526|585847852|FG002|Overall Study|Protocol Violation|4|||
162217471|NCT00474526|585847853|FG003|Overall Study|Protocol Violation|12|||
162217472|NCT00474526|585847854|FG004|Overall Study|Protocol Violation|3|||
162217473|NCT00474526|585847855|FG005|Overall Study|Protocol Violation|1|||
162217474|NCT00474526|585847856|FG006|Overall Study|Protocol Violation|3|||
162217475|NCT00474526|585847857|FG007|Overall Study|Protocol Violation|0|||
162217476|NCT00474526|585847858|FG008|Overall Study|Protocol Violation|0|||
162217477|NCT00474526|585847859|FG009|Overall Study|Protocol Violation|4|||
162217478|NCT00474526|585847860|FG010|Overall Study|Protocol Violation|2|||
162217479|NCT00474526|585847861|FG011|Overall Study|Protocol Violation|2|||
162217480|NCT00474526|585847862|FG012|Overall Study|Protocol Violation|4|||
162217481|NCT00474526|585847863|FG013|Overall Study|Protocol Violation|19|||
162217482|NCT00474526|585847864|FG014|Overall Study|Protocol Violation|9|||
162217483|NCT00474526|585847865|FG015|Overall Study|Protocol Violation|6|||
162217484|NCT00474526|585847866|FG016|Overall Study|Protocol Violation|2|||
162217485|NCT00474526|585847850|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
162217486|NCT00474526|585847851|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
162217487|NCT00474526|585847852|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
162217488|NCT00474526|585847853|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
162217489|NCT00474526|585847854|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
162217490|NCT00474526|585847855|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
162217491|NCT00474526|585847856|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
162217492|NCT00474526|585847857|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
162217493|NCT00474526|585847858|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
162217494|NCT00474526|585847859|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
162217495|NCT00474526|585847860|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
162217496|NCT00474526|585847861|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
162217497|NCT00474526|585847862|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
162217498|NCT00474526|585847863|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
162217499|NCT00474526|585847864|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
162217500|NCT00474526|585847865|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
162217501|NCT00474526|585847866|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
162217502|NCT00474526|585847850|FG000|Overall Study|Withdrawal by Subject|9|||
162217503|NCT00474526|585847851|FG001|Overall Study|Withdrawal by Subject|24|||
162217504|NCT00474526|585847852|FG002|Overall Study|Withdrawal by Subject|21|||
162217505|NCT00474526|585847853|FG003|Overall Study|Withdrawal by Subject|52|||
162217506|NCT00474526|585847854|FG004|Overall Study|Withdrawal by Subject|38|||
162217507|NCT00474526|585847855|FG005|Overall Study|Withdrawal by Subject|6|||
162217508|NCT00474526|585847856|FG006|Overall Study|Withdrawal by Subject|12|||
162217509|NCT00474526|585847857|FG007|Overall Study|Withdrawal by Subject|4|||
161936968|NCT01602380|584819106|FG000|Overall Study|Death|147|||
162217510|NCT00474526|585847858|FG008|Overall Study|Withdrawal by Subject|4|||
162217511|NCT00474526|585847859|FG009|Overall Study|Withdrawal by Subject|13|||
162217512|NCT00474526|585847860|FG010|Overall Study|Withdrawal by Subject|5|||
162217513|NCT00474526|585847861|FG011|Overall Study|Withdrawal by Subject|4|||
162217514|NCT00474526|585847862|FG012|Overall Study|Withdrawal by Subject|4|||
162217515|NCT00474526|585847863|FG013|Overall Study|Withdrawal by Subject|37|||
162217516|NCT00474526|585847864|FG014|Overall Study|Withdrawal by Subject|22|||
162217517|NCT00474526|585847865|FG015|Overall Study|Withdrawal by Subject|1|||
162217518|NCT00474526|585847866|FG016|Overall Study|Withdrawal by Subject|1|||
162217519|NCT00132678|585847871|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
162217520|NCT00132678|585847872|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
162217521|NCT00132678|585847873|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
162217522|NCT00132678|585847871|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
162217523|NCT00132678|585847872|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
162217524|NCT00132678|585847873|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
162217525|NCT00132678|585847871|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
162217526|NCT00132678|585847872|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
162217527|NCT00132678|585847873|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
162217528|NCT00132678|585847871|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
162217529|NCT00132678|585847872|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
162217530|NCT00132678|585847873|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
162217531|NCT00132678|585847871|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
162217532|NCT00132678|585847872|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
162217533|NCT00132678|585847873|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
162217534|NCT00132678|585847871|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
162217535|NCT00132678|585847872|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
162217536|NCT00132678|585847873|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
162217537|NCT00132678|585847871|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
162217538|NCT00132678|585847872|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
162217539|NCT00132678|585847873|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
162217540|NCT00132678|585847871|FG000|Period III (Open-Label Stabilization)|Death|2|||
162217541|NCT00132678|585847872|FG001|Period III (Open-Label Stabilization)|Death|0|||
162217542|NCT00132678|585847873|FG002|Period III (Open-Label Stabilization)|Death|0|||
162217543|NCT00132678|585847871|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
162217544|NCT00132678|585847872|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
162217545|NCT00132678|585847873|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
162217546|NCT00132678|585847871|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
162217547|NCT00132678|585847872|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
162217548|NCT00132678|585847873|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
162217549|NCT00132678|585847871|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
162217550|NCT00132678|585847872|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
162217551|NCT00132678|585847873|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
162217552|NCT00132678|585847871|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
162217553|NCT00132678|585847872|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
162217554|NCT00132678|585847873|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
162217555|NCT00132678|585847871|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
162217556|NCT00132678|585847872|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
162217557|NCT00132678|585847873|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
162217558|NCT00132678|585847871|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
162217559|NCT00132678|585847872|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
162217560|NCT00132678|585847873|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
162217561|NCT00132678|585847871|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
162217562|NCT00132678|585847872|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
162217563|NCT00132678|585847873|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
162217564|NCT00132678|585847871|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
162217565|NCT00132678|585847872|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
161936969|NCT01602380|584819107|FG001|Overall Study|Death|145|||
161936970|NCT01602380|584819106|FG000|Overall Study|Withdrawal by Subject|39|||
161936971|NCT01602380|584819107|FG001|Overall Study|Withdrawal by Subject|41|||
161678435|NCT01858532|583875968|FG001|Overall Study|Adverse Event|50|||
161936972|NCT01602380|584819106|FG000|Overall Study|Lost to Follow-up|15|||
162217566|NCT00132678|585847873|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
162217567|NCT00132678|585847871|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
162217568|NCT00132678|585847872|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
162217569|NCT00132678|585847873|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
162217570|NCT00132678|585847871|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
162217571|NCT00132678|585847872|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
162217572|NCT00132678|585847873|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
162217573|NCT00132678|585847871|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
161936973|NCT01602380|584819107|FG001|Overall Study|Lost to Follow-up|12|||
161936974|NCT01602380|584819106|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161936975|NCT01602380|584819107|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
161936976|NCT01602380|584819106|FG000|Overall Study|Other|2|||
162217574|NCT00132678|585847872|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
162217575|NCT00132678|585847873|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
162217576|NCT00132678|585847871|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
162217577|NCT00132678|585847872|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
162217578|NCT00132678|585847873|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
162217579|NCT00132678|585847871|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
162217580|NCT00132678|585847872|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
162217581|NCT00132678|585847873|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
162217582|NCT00132678|585847871|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
162217583|NCT00132678|585847872|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
162217584|NCT00132678|585847873|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
162217585|NCT00132678|585847871|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
162217586|NCT00132678|585847872|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
162217587|NCT00132678|585847873|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
162217588|NCT00953147|585847874|FG000|Overall Study|Adverse Event|8|||
162217589|NCT00953147|585847875|FG001|Overall Study|Adverse Event|16|||
162217590|NCT00953147|585847876|FG002|Overall Study|Adverse Event|6|||
162217591|NCT00953147|585847874|FG000|Overall Study|Protocol Violation|2|||
162217592|NCT00953147|585847875|FG001|Overall Study|Protocol Violation|8|||
162217593|NCT00953147|585847876|FG002|Overall Study|Protocol Violation|4|||
162217594|NCT00953147|585847874|FG000|Overall Study|Withdrawal by Subject|13|||
162217595|NCT00953147|585847875|FG001|Overall Study|Withdrawal by Subject|15|||
162217596|NCT00953147|585847876|FG002|Overall Study|Withdrawal by Subject|12|||
162217597|NCT00953147|585847874|FG000|Overall Study|Lost to Follow-up|8|||
162217598|NCT00953147|585847875|FG001|Overall Study|Lost to Follow-up|9|||
162217599|NCT00953147|585847876|FG002|Overall Study|Lost to Follow-up|4|||
162217600|NCT00953147|585847874|FG000|Overall Study|Physician Decision|2|||
162217601|NCT00953147|585847875|FG001|Overall Study|Physician Decision|7|||
162217602|NCT00953147|585847876|FG002|Overall Study|Physician Decision|3|||
162217603|NCT00953147|585847874|FG000|Overall Study|Other|4|||
162217604|NCT00953147|585847875|FG001|Overall Study|Other|11|||
162217605|NCT00953147|585847876|FG002|Overall Study|Other|13|||
162217606|NCT02514239|585847877|FG000|Overall Study|Refused to continue trial medication|0|||
162217607|NCT02514239|585847878|FG001|Overall Study|Refused to continue trial medication|0|||
162217608|NCT02514239|585847879|FG002|Overall Study|Refused to continue trial medication|0|||
162217609|NCT02514239|585847880|FG003|Overall Study|Refused to continue trial medication|0|||
162217610|NCT02514239|585847881|FG004|Overall Study|Refused to continue trial medication|0|||
162217611|NCT02514239|585847882|FG005|Overall Study|Refused to continue trial medication|0|||
162217612|NCT02514239|585847883|FG006|Overall Study|Refused to continue trial medication|0|||
162217613|NCT02514239|585847884|FG007|Overall Study|Refused to continue trial medication|0|||
161936977|NCT01602380|584819107|FG001|Overall Study|Other|0|||
162217614|NCT02514239|585847885|FG008|Overall Study|Refused to continue trial medication|0|||
162217615|NCT02514239|585847886|FG009|Overall Study|Refused to continue trial medication|1|||
162217616|NCT02514239|585847877|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
162217617|NCT02514239|585847878|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
162217618|NCT02514239|585847879|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
162217619|NCT02514239|585847880|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
162217620|NCT02514239|585847881|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
162217621|NCT02514239|585847882|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
162217622|NCT02514239|585847883|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
162217623|NCT02514239|585847884|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
162217624|NCT02514239|585847885|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
162217625|NCT02514239|585847886|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
162217626|NCT02514239|585847877|FG000|Overall Study|Not treated|0|||
162217627|NCT02514239|585847878|FG001|Overall Study|Not treated|1|||
162217628|NCT02514239|585847879|FG002|Overall Study|Not treated|0|||
162217629|NCT02514239|585847880|FG003|Overall Study|Not treated|0|||
162217630|NCT02514239|585847881|FG004|Overall Study|Not treated|0|||
162217631|NCT02514239|585847882|FG005|Overall Study|Not treated|0|||
162217632|NCT02514239|585847883|FG006|Overall Study|Not treated|0|||
162217633|NCT02514239|585847884|FG007|Overall Study|Not treated|0|||
162217634|NCT02514239|585847885|FG008|Overall Study|Not treated|0|||
162217635|NCT02514239|585847886|FG009|Overall Study|Not treated|0|||
162217636|NCT02514239|585847877|FG000|Overall Study|Other Adverse Events|2|||
162217637|NCT02514239|585847878|FG001|Overall Study|Other Adverse Events|0|||
162217638|NCT02514239|585847879|FG002|Overall Study|Other Adverse Events|0|||
162217639|NCT02514239|585847880|FG003|Overall Study|Other Adverse Events|1|||
162217640|NCT02514239|585847881|FG004|Overall Study|Other Adverse Events|0|||
162217641|NCT02514239|585847882|FG005|Overall Study|Other Adverse Events|1|||
162217642|NCT02514239|585847883|FG006|Overall Study|Other Adverse Events|0|||
162217643|NCT02514239|585847884|FG007|Overall Study|Other Adverse Events|1|||
162217644|NCT02514239|585847885|FG008|Overall Study|Other Adverse Events|2|||
162217645|NCT02514239|585847886|FG009|Overall Study|Other Adverse Events|0|||
162217646|NCT02514239|585847877|FG000|Overall Study|Progressive disease|3|||
162217647|NCT02514239|585847878|FG001|Overall Study|Progressive disease|3|||
162217648|NCT02514239|585847879|FG002|Overall Study|Progressive disease|2|||
162217649|NCT02514239|585847880|FG003|Overall Study|Progressive disease|2|||
162217650|NCT02514239|585847881|FG004|Overall Study|Progressive disease|3|||
162217651|NCT02514239|585847882|FG005|Overall Study|Progressive disease|3|||
162217652|NCT02514239|585847883|FG006|Overall Study|Progressive disease|4|||
162217653|NCT02514239|585847884|FG007|Overall Study|Progressive disease|2|||
162217654|NCT02514239|585847885|FG008|Overall Study|Progressive disease|5|||
162217655|NCT02514239|585847886|FG009|Overall Study|Progressive disease|0|||
162217656|NCT03299049|585847887|FG000|Overall Study|On-going|486|||
162217657|NCT03299049|585847888|FG001|Overall Study|On-going|481|||
162217658|NCT03299049|585847887|FG000|Overall Study|Withdrawal by Subject|6|||
162217659|NCT03299049|585847888|FG001|Overall Study|Withdrawal by Subject|21|||
162217660|NCT03299049|585847887|FG000|Overall Study|Physician Decision|5|||
162217661|NCT03299049|585847888|FG001|Overall Study|Physician Decision|1|||
162217662|NCT03299049|585847887|FG000|Overall Study|Lost to Follow-up|2|||
162217663|NCT03299049|585847888|FG001|Overall Study|Lost to Follow-up|0|||
162217664|NCT03299049|585847887|FG000|Overall Study|Pregnancy|1|||
162217665|NCT03299049|585847888|FG001|Overall Study|Pregnancy|3|||
162217666|NCT03299049|585847887|FG000|Overall Study|Protocol Violation|1|||
162217667|NCT03299049|585847888|FG001|Overall Study|Protocol Violation|1|||
161827405|NCT00251316|584408072|FG001|Overall Study|Physician Decision|3|||
162217668|NCT03299049|585847887|FG000|Overall Study|Lack of Efficacy|9|||
162217669|NCT03299049|585847888|FG001|Overall Study|Lack of Efficacy|3|||
162217670|NCT03299049|585847887|FG000|Overall Study|Adverse Event|12|||
162217671|NCT03299049|585847888|FG001|Overall Study|Adverse Event|13|||
162217672|NCT00699153|585847889|FG000|Overall Study|Lost to Follow-up|1|||
162217673|NCT00699153|585847890|FG001|Overall Study|Lost to Follow-up|0|||
162217674|NCT00699153|585847889|FG000|Overall Study|Adverse Event|0|||
162217675|NCT00699153|585847890|FG001|Overall Study|Adverse Event|2|||
162217676|NCT00699153|585847889|FG000|Overall Study|Protocol Violation|1|||
162217677|NCT00699153|585847890|FG001|Overall Study|Protocol Violation|0|||
162217678|NCT00699153|585847889|FG000|Overall Study|Travel Problem|1|||
162217679|NCT00699153|585847890|FG001|Overall Study|Travel Problem|0|||
162217680|NCT02521363|585847892|FG000|Overall Study|Withdrawal by Subject|1|||
162217681|NCT02521363|585847893|FG001|Overall Study|Withdrawal by Subject|2|||
162217682|NCT00953771|585847897|FG000|Overall Study|Death|1|||
162217683|NCT00953771|585847898|FG001|Overall Study|Death|0|||
162217684|NCT00974259|585847899|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
162217685|NCT00974259|585847900|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
162217686|NCT04201288|585847906|FG000|Overall Study|Death|1|||
162217687|NCT04201288|585847907|FG001|Overall Study|Death|1|||
162217688|NCT04201288|585847906|FG000|Overall Study|Lost to Follow-up|5|||
162217689|NCT04201288|585847907|FG001|Overall Study|Lost to Follow-up|3|||
162217690|NCT04201288|585847906|FG000|Overall Study|Withdrawal by Subject|1|||
162217691|NCT04201288|585847907|FG001|Overall Study|Withdrawal by Subject|0|||
162217692|NCT00592293|585847908|FG000|Overall Study|Withdrawal by Subject|1|||
162217693|NCT01606319|585847911|FG000|Overall Study|Lost to Follow-up|17|||
162217694|NCT01606319|585847912|FG001|Overall Study|Lost to Follow-up|14|||
162217695|NCT01606319|585847911|FG000|Overall Study|Withdrawal by Subject|9|||
162217696|NCT01606319|585847912|FG001|Overall Study|Withdrawal by Subject|12|||
162217697|NCT01606319|585847911|FG000|Overall Study|Physician Decision|1|||
162217698|NCT01606319|585847912|FG001|Overall Study|Physician Decision|2|||
162217699|NCT01606319|585847911|FG000|Overall Study|Lack of Efficacy|6|||
162217700|NCT01606319|585847912|FG001|Overall Study|Lack of Efficacy|8|||
162217701|NCT01606319|585847911|FG000|Overall Study|Adverse Event|1|||
161678436|NCT01858532|583875969|FG002|Overall Study|Adverse Event|23|||
162217702|NCT01606319|585847912|FG001|Overall Study|Adverse Event|4|||
162217703|NCT01270828|585847913|FG000|Pregabalin CR SB|Reason Unspecified|0|||
162217704|NCT01270828|585847914|FG001|Pregabalin CR SB|Reason Unspecified|0|||
162217705|NCT01270828|585847915|FG002|Pregabalin CR SB|Reason Unspecified|8|||
162217706|NCT01270828|585847913|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
162217707|NCT01270828|585847914|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
162217708|NCT01270828|585847915|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
162217709|NCT01270828|585847913|FG000|Pregabalin CR SB|Related adverse event|0|||
162217710|NCT01270828|585847914|FG001|Pregabalin CR SB|Related adverse event|0|||
162217711|NCT01270828|585847915|FG002|Pregabalin CR SB|Related adverse event|46|||
162217712|NCT01270828|585847913|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
162217713|NCT01270828|585847914|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
162217714|NCT01270828|585847915|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
162217715|NCT01270828|585847913|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
162217716|NCT01270828|585847914|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
162217717|NCT01270828|585847915|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
162217718|NCT01270828|585847913|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
162217719|NCT01270828|585847914|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
162217720|NCT01270828|585847915|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
162217721|NCT01270828|585847913|FG000|Pregabalin CR SB|Unrelated AE|0|||
162217722|NCT01270828|585847914|FG001|Pregabalin CR SB|Unrelated AE|0|||
161678437|NCT01858532|583875970|FG003|Overall Study|Adverse Event|28|||
162217723|NCT01270828|585847915|FG002|Pregabalin CR SB|Unrelated AE|8|||
162217724|NCT01270828|585847913|FG000|Pregabalin CR SB|Protocol Violation|0|||
162217725|NCT01270828|585847914|FG001|Pregabalin CR SB|Protocol Violation|0|||
162217726|NCT01270828|585847915|FG002|Pregabalin CR SB|Protocol Violation|8|||
162217727|NCT01270828|585847913|FG000|Double Blind Phase|Death|0|||
162217728|NCT01270828|585847914|FG001|Double Blind Phase|Death|1|||
162217729|NCT01270828|585847915|FG002|Double Blind Phase|Death|0|||
162217730|NCT01270828|585847913|FG000|Double Blind Phase|Protocol Violation|0|||
162217731|NCT01270828|585847914|FG001|Double Blind Phase|Protocol Violation|1|||
162217732|NCT01270828|585847915|FG002|Double Blind Phase|Protocol Violation|0|||
162217733|NCT01270828|585847913|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
162217734|NCT01270828|585847914|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
162217735|NCT01270828|585847915|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
162217736|NCT01270828|585847913|FG000|Double Blind Phase|Reason Unspecified|7|||
162217737|NCT01270828|585847914|FG001|Double Blind Phase|Reason Unspecified|4|||
162217738|NCT01270828|585847915|FG002|Double Blind Phase|Reason Unspecified|0|||
162217739|NCT01270828|585847913|FG000|Double Blind Phase|Withdrawal by Subject|6|||
162217740|NCT01270828|585847914|FG001|Double Blind Phase|Withdrawal by Subject|15|||
162217741|NCT01270828|585847915|FG002|Double Blind Phase|Withdrawal by Subject|0|||
162217742|NCT01270828|585847913|FG000|Double Blind Phase|Lost to Follow-up|1|||
162217743|NCT01270828|585847914|FG001|Double Blind Phase|Lost to Follow-up|2|||
162217744|NCT01270828|585847915|FG002|Double Blind Phase|Lost to Follow-up|0|||
162217745|NCT01270828|585847913|FG000|Double Blind Phase|Lack of Efficacy|2|||
162217746|NCT01270828|585847914|FG001|Double Blind Phase|Lack of Efficacy|11|||
162217747|NCT01270828|585847915|FG002|Double Blind Phase|Lack of Efficacy|0|||
162217748|NCT01270828|585847913|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
162217749|NCT01270828|585847914|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
161678438|NCT01858532|583875967|FG000|Overall Study|Withdrew consent|71|||
161678439|NCT01858532|583875968|FG001|Overall Study|Withdrew consent|93|||
161678440|NCT01858532|583875969|FG002|Overall Study|Withdrew consent|46|||
161678441|NCT01858532|583875970|FG003|Overall Study|Withdrew consent|27|||
161678442|NCT01858532|583875967|FG000|Overall Study|Lost to Follow-up|17|||
161678443|NCT01858532|583875968|FG001|Overall Study|Lost to Follow-up|26|||
161678444|NCT01858532|583875969|FG002|Overall Study|Lost to Follow-up|11|||
161678445|NCT01858532|583875970|FG003|Overall Study|Lost to Follow-up|14|||
161678446|NCT01858532|583875967|FG000|Overall Study|Deterioration of medical status|3|||
161678447|NCT01858532|583875968|FG001|Overall Study|Deterioration of medical status|4|||
161678448|NCT01858532|583875969|FG002|Overall Study|Deterioration of medical status|3|||
161678449|NCT01858532|583875970|FG003|Overall Study|Deterioration of medical status|7|||
161678450|NCT01858532|583875967|FG000|Overall Study|Investigator request|3|||
161678451|NCT01858532|583875968|FG001|Overall Study|Investigator request|4|||
161678452|NCT01858532|583875969|FG002|Overall Study|Investigator request|2|||
162217750|NCT01270828|585847915|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
162217751|NCT01270828|585847913|FG000|Double Blind Phase|Adverse event related to study drug|5|||
161678453|NCT01858532|583875970|FG003|Overall Study|Investigator request|6|||
161678454|NCT01858532|583875967|FG000|Overall Study|Other, not specified|29|||
161678455|NCT01858532|583875968|FG001|Overall Study|Other, not specified|15|||
161678456|NCT01858532|583875969|FG002|Overall Study|Other, not specified|13|||
161678457|NCT01858532|583875970|FG003|Overall Study|Other, not specified|11|||
162021396|NCT01874340|585134770|FG001|Overall Study|Withdrawal by Subject|0|||
162217752|NCT01270828|585847914|FG001|Double Blind Phase|Adverse event related to study drug|7|||
161678458|NCT02081534|583875976|FG000|Overall Study|Adverse Event|5|||
162217753|NCT01270828|585847915|FG002|Double Blind Phase|Adverse event related to study drug|0|||
162217754|NCT02870972|585847919|FG000|Overall Study|Adverse Event|1|||
162217755|NCT02870972|585847920|FG001|Overall Study|Adverse Event|0|||
162217756|NCT02870972|585847921|FG002|Overall Study|Adverse Event|0|||
162217757|NCT02870972|585847922|FG003|Overall Study|Adverse Event|0|||
162217758|NCT02870972|585847923|FG004|Overall Study|Adverse Event|0|||
161678459|NCT02081534|583875977|FG001|Overall Study|Adverse Event|4|||
162217759|NCT01821937|585847928|FG000|Overall Study|Adverse Event|0|||
162217760|NCT01821937|585847929|FG001|Overall Study|Adverse Event|3|||
162217761|NCT02615509|585847930|FG000|Overall Study|Lost to Follow-up|134|||
162217762|NCT02615509|585847930|FG000|Overall Study|Death|4|||
162217763|NCT02615509|585847930|FG000|Overall Study|Withdrawal by Subject|8|||
162217764|NCT03334253|585847931|FG000|Overall Study|Withdrawal by Subject|1|||
162217765|NCT03334253|585847932|FG001|Overall Study|Withdrawal by Subject|0|||
162217766|NCT03334253|585847931|FG000|Overall Study|Lost to Follow-up|4|||
162217767|NCT03334253|585847932|FG001|Overall Study|Lost to Follow-up|3|||
162217768|NCT03334253|585847931|FG000|Overall Study|Moved residence|2|||
162217769|NCT03334253|585847932|FG001|Overall Study|Moved residence|2|||
162217770|NCT00968526|585847933|FG000|Overall Study|Adverse Event|2|||
162217771|NCT00968526|585847934|FG001|Overall Study|Adverse Event|0|||
162217772|NCT00968526|585847933|FG000|Overall Study|Migrated/moved from study area|1|||
162217773|NCT00968526|585847934|FG001|Overall Study|Migrated/moved from study area|0|||
162217774|NCT02030002|585847938|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
162217775|NCT02030002|585847938|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
162217776|NCT02030002|585847938|FG000|Follow-up|Lost to Follow-up|2|||
162217777|NCT00609947|585847939|FG000|Overall Study|Death|1|||
162217778|NCT00504075|585847940|FG000|Overall Study|Adverse Event|1|||
162217779|NCT00504075|585847940|FG000|Overall Study|Lost to Follow-up|5|||
162217780|NCT00504075|585847940|FG000|Overall Study|Withdrawal by Subject|1|||
162217781|NCT00504075|585847940|FG000|Overall Study|Required other therapeutic intervention|1|||
162217782|NCT02406248|585847941|FG000|Overall Study|Death|7|||
162217783|NCT02406248|585847941|FG000|Overall Study|Withdrawal by Subject|2|||
162217784|NCT01689857|585847943|FG000|Overall Study|Lost to Follow-up|5|||
162217785|NCT01689857|585847944|FG001|Overall Study|Lost to Follow-up|2|||
162217786|NCT00479882|585847947|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
162217787|NCT00479882|585847948|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
162217788|NCT00479882|585847949|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
162217789|NCT00479882|585847950|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
162217790|NCT00479882|585847947|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
162217791|NCT00479882|585847948|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
162217792|NCT00479882|585847949|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
162217793|NCT00479882|585847950|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
162217794|NCT00479882|585847947|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
162217795|NCT00479882|585847948|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
162217796|NCT00479882|585847949|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
162217797|NCT00479882|585847950|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
162217798|NCT00479882|585847947|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
162217799|NCT00479882|585847948|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
162217800|NCT00479882|585847949|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
162217801|NCT00479882|585847950|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
162217802|NCT00479882|585847947|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
162217803|NCT00479882|585847948|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
162217804|NCT00479882|585847949|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
162217805|NCT00479882|585847950|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
162217806|NCT00479882|585847947|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
162217807|NCT00479882|585847948|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
162217808|NCT00479882|585847949|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
162217809|NCT00479882|585847950|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
162217810|NCT00479882|585847947|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
162217811|NCT00479882|585847948|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
162217812|NCT00479882|585847949|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
162217813|NCT00479882|585847950|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
162217814|NCT00479882|585847947|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
162217815|NCT00479882|585847948|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
162217816|NCT00479882|585847949|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
162217817|NCT00479882|585847950|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
162217818|NCT00479882|585847947|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
162217819|NCT00479882|585847948|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
162217820|NCT00479882|585847949|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
162217821|NCT00479882|585847950|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
161827406|NCT00398073|584408073|FG000|Overall Study|Withdrawal by Subject|1|||
161827407|NCT00398073|584408074|FG001|Overall Study|Withdrawal by Subject|0|||
161827408|NCT00708682|584408075|FG000|Infant Series|Adverse Event|1|||
161827409|NCT00708682|584408075|FG000|Infant Series|Lost to Follow-up|4|||
161827410|NCT00708682|584408075|FG000|Infant Series|Protocol Violation|1|||
161827411|NCT00708682|584408075|FG000|Infant Series|Parent/legal guardian request|6|||
161827412|NCT00708682|584408075|FG000|Infant Series|Failed to return|2|||
162217822|NCT00479882|585847947|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
162217823|NCT00479882|585847948|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
162217824|NCT00479882|585847949|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
162217825|NCT00479882|585847950|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
162217826|NCT00479882|585847947|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
162217827|NCT00479882|585847948|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
162217828|NCT00479882|585847949|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
162217829|NCT00479882|585847950|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
162217830|NCT00479882|585847947|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
162217831|NCT00479882|585847948|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
162217832|NCT00479882|585847949|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
162217833|NCT00479882|585847950|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
162217834|NCT00479882|585847947|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
162217835|NCT00479882|585847948|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
162217836|NCT00479882|585847949|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
162217837|NCT00479882|585847950|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
162217838|NCT00479882|585847947|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
162217839|NCT00479882|585847948|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
162217840|NCT00479882|585847949|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
162217841|NCT00479882|585847950|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
162217842|NCT03106753|585847951|FG000|Overall Study|Withdrawal by Subject|0|||
162217843|NCT03106753|585847952|FG001|Overall Study|Withdrawal by Subject|1|||
162217844|NCT01643044|585847953|FG000|Overall Study|Lost to Follow-up|1|||
162217845|NCT01643044|585847954|FG001|Overall Study|Lost to Follow-up|1|||
162217846|NCT01643044|585847953|FG000|Overall Study|Miscarried baby|2|||
162217847|NCT01643044|585847954|FG001|Overall Study|Miscarried baby|2|||
162217848|NCT01643044|585847953|FG000|Overall Study|Delivered outside of hospital|1|||
162217849|NCT01643044|585847954|FG001|Overall Study|Delivered outside of hospital|2|||
162217850|NCT03149042|585847955|FG000|Overall Study|Invasive FFR not performed|21|||
162217851|NCT03149042|585847955|FG000|Overall Study|Poor CT Image Quality|1|||
162217852|NCT03149042|585847955|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
162217853|NCT01023958|585847956|FG000|Overall Study|Progressive disease|48|||
162217854|NCT01023958|585847956|FG000|Overall Study|Other adverse event|1|||
162217855|NCT01023958|585847956|FG000|Overall Study|Refused to continue medication|1|||
162217856|NCT02362503|585847957|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
162217857|NCT02362503|585847958|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
162217858|NCT02362503|585847959|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
162217859|NCT02362503|585847957|FG000|Double-blind Period-Up to 8 Days|Death|1|||
162217860|NCT02362503|585847958|FG001|Double-blind Period-Up to 8 Days|Death|0|||
162217861|NCT02362503|585847959|FG002|Double-blind Period-Up to 8 Days|Death|0|||
162217862|NCT02362503|585847957|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
162217863|NCT02362503|585847958|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
162217864|NCT02362503|585847959|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
162217865|NCT02362503|585847957|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
162217866|NCT02362503|585847958|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
162217867|NCT02362503|585847959|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
162217868|NCT02362503|585847957|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
162217869|NCT02362503|585847958|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
162217870|NCT02362503|585847959|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
162217871|NCT02362503|585847957|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
162217872|NCT02362503|585847958|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
162217873|NCT02362503|585847959|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
162217874|NCT02362503|585847957|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
162217875|NCT02362503|585847958|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
162217876|NCT02362503|585847959|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
162217877|NCT02362503|585847957|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
162217878|NCT02362503|585847958|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
162217879|NCT02362503|585847959|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
162217880|NCT02362503|585847957|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
162217881|NCT02362503|585847958|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
162217882|NCT02362503|585847959|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
162217883|NCT02362503|585847957|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
162217884|NCT02362503|585847958|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
162217885|NCT02362503|585847959|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
162217886|NCT02362503|585847957|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
162217887|NCT02362503|585847958|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
162217888|NCT02362503|585847959|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
162217889|NCT02362503|585847957|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
162217890|NCT02362503|585847958|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
162217891|NCT02362503|585847959|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
162217892|NCT02362503|585847957|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
162217893|NCT02362503|585847958|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
162217894|NCT02362503|585847959|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
162217895|NCT02362503|585847957|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
162217896|NCT02362503|585847958|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
162217897|NCT02362503|585847959|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
162217898|NCT00762476|585847960|FG000|Overall Study|Adverse Event|7|||
162217899|NCT00762476|585847961|FG001|Overall Study|Adverse Event|1|||
162217900|NCT00762476|585847960|FG000|Overall Study|Lost to Follow-up|2|||
162217901|NCT00762476|585847961|FG001|Overall Study|Lost to Follow-up|0|||
162217902|NCT00762476|585847960|FG000|Overall Study|Protocol Violation|5|||
162217903|NCT00762476|585847961|FG001|Overall Study|Protocol Violation|6|||
162217904|NCT00762476|585847960|FG000|Overall Study|Physician Decision|2|||
162217905|NCT00762476|585847961|FG001|Overall Study|Physician Decision|14|||
162217906|NCT00762476|585847960|FG000|Overall Study|Withdrawal by Subject|6|||
162217907|NCT00762476|585847961|FG001|Overall Study|Withdrawal by Subject|12|||
162217908|NCT00762476|585847960|FG000|Overall Study|antibiotic use|0|||
162217909|NCT00762476|585847961|FG001|Overall Study|antibiotic use|1|||
162217910|NCT00762476|585847960|FG000|Overall Study|non-compliance with study visits|0|||
162217911|NCT00762476|585847961|FG001|Overall Study|non-compliance with study visits|2|||
162217912|NCT00762476|585847960|FG000|Overall Study|Seasonal allergies|1|||
162217913|NCT00762476|585847961|FG001|Overall Study|Seasonal allergies|0|||
162217914|NCT02838134|585847962|FG000|Overall Study|Lost to Follow-up|1|||
162217915|NCT02838134|585847963|FG001|Overall Study|Lost to Follow-up|2|||
162217916|NCT02838134|585847962|FG000|Overall Study|logistic problems|1|||
162217917|NCT02838134|585847963|FG001|Overall Study|logistic problems|1|||
162217918|NCT01912404|585847967|FG000|Overall Study|Due to personal reasons|1|||
162217919|NCT01912404|585847968|FG001|Overall Study|Due to personal reasons|0|||
162217920|NCT01430468|585847969|FG000|Overall Study|Physician Decision|2|||
162217921|NCT01430468|585847970|FG001|Overall Study|Physician Decision|1|||
162217922|NCT01430468|585847969|FG000|Overall Study|Withdrawal by Subject|5|||
162217923|NCT01430468|585847970|FG001|Overall Study|Withdrawal by Subject|5|||
162217924|NCT01281839|585847971|FG000|Overall Study|Lost to Follow-up|6|||
162217925|NCT01281839|585847972|FG001|Overall Study|Lost to Follow-up|3|||
162217926|NCT01281839|585847971|FG000|Overall Study|Withdrawal by Subject|4|||
162217927|NCT01281839|585847972|FG001|Overall Study|Withdrawal by Subject|10|||
162217928|NCT01281839|585847971|FG000|Overall Study|Reason not specified|0|||
162217929|NCT01281839|585847972|FG001|Overall Study|Reason not specified|1|||
162217930|NCT01443923|585847973|FG000|Overall Study|Adverse Event|1|||
162217931|NCT01443923|585847974|FG001|Overall Study|Adverse Event|0|||
162217932|NCT01245374|585847975|FG000|Overall Study|Protocol Violation|1|||
162217933|NCT01245374|585847975|FG000|Overall Study|Withdrawal by Subject|3|||
162217934|NCT04674189|585847976|FG000|Overall Study|Adverse Event|0|||
162217935|NCT04674189|585847977|FG001|Overall Study|Adverse Event|0|||
162217936|NCT04674189|585847978|FG002|Overall Study|Adverse Event|1|||
162217937|NCT04674189|585847976|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
162217938|NCT04674189|585847977|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
162217939|NCT04674189|585847978|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
162217940|NCT04674189|585847976|FG000|Overall Study|Physician Decision|1|||
162217941|NCT04674189|585847977|FG001|Overall Study|Physician Decision|0|||
162217942|NCT04674189|585847978|FG002|Overall Study|Physician Decision|0|||
162217943|NCT04674189|585847976|FG000|Overall Study|Withdrawal by Participant|83|||
162021397|NCT01874340|585134771|FG002|Overall Study|Withdrawal by Subject|0|||
162217944|NCT04674189|585847977|FG001|Overall Study|Withdrawal by Participant|71|||
162217945|NCT04674189|585847978|FG002|Overall Study|Withdrawal by Participant|142|||
162217946|NCT04674189|585847976|FG000|Overall Study|Lost to Follow-up|55|||
162217947|NCT04674189|585847977|FG001|Overall Study|Lost to Follow-up|53|||
162217948|NCT04674189|585847978|FG002|Overall Study|Lost to Follow-up|44|||
162217949|NCT04674189|585847976|FG000|Overall Study|Miscellaneous|27|||
162217950|NCT04674189|585847977|FG001|Overall Study|Miscellaneous|23|||
162217951|NCT04674189|585847978|FG002|Overall Study|Miscellaneous|207|||
162217952|NCT04674189|585847976|FG000|Overall Study|Did Not Receive Treatment|3|||
162217953|NCT04674189|585847977|FG001|Overall Study|Did Not Receive Treatment|1|||
162217954|NCT04674189|585847978|FG002|Overall Study|Did Not Receive Treatment|2|||
162217955|NCT02600897|585847983|FG000|Overall Study|Death|1|||
162217956|NCT02600897|585847984|FG001|Overall Study|Death|2|||
162217957|NCT02600897|585847985|FG002|Overall Study|Death|1|||
162217958|NCT02600897|585847986|FG003|Overall Study|Death|2|||
162217959|NCT02600897|585847987|FG004|Overall Study|Death|3|||
162217960|NCT02600897|585847988|FG005|Overall Study|Death|2|||
162217961|NCT02600897|585847989|FG006|Overall Study|Death|10|||
162217962|NCT02600897|585847990|FG007|Overall Study|Death|7|||
162217963|NCT02600897|585847991|FG008|Overall Study|Death|20|||
162217964|NCT02600897|585847983|FG000|Overall Study|Lost to Follow-up|1|||
162217965|NCT02600897|585847984|FG001|Overall Study|Lost to Follow-up|0|||
162217966|NCT02600897|585847985|FG002|Overall Study|Lost to Follow-up|0|||
162217967|NCT02600897|585847986|FG003|Overall Study|Lost to Follow-up|0|||
162217968|NCT02600897|585847987|FG004|Overall Study|Lost to Follow-up|0|||
162217969|NCT02600897|585847988|FG005|Overall Study|Lost to Follow-up|0|||
162217970|NCT02600897|585847989|FG006|Overall Study|Lost to Follow-up|0|||
162217971|NCT02600897|585847990|FG007|Overall Study|Lost to Follow-up|1|||
162217972|NCT02600897|585847991|FG008|Overall Study|Lost to Follow-up|0|||
162217973|NCT02600897|585847983|FG000|Overall Study|Withdrawal by Subject|0|||
162217974|NCT02600897|585847984|FG001|Overall Study|Withdrawal by Subject|0|||
162217975|NCT02600897|585847985|FG002|Overall Study|Withdrawal by Subject|0|||
162217976|NCT02600897|585847986|FG003|Overall Study|Withdrawal by Subject|0|||
162217977|NCT02600897|585847987|FG004|Overall Study|Withdrawal by Subject|0|||
162217978|NCT02600897|585847988|FG005|Overall Study|Withdrawal by Subject|0|||
162217979|NCT02600897|585847989|FG006|Overall Study|Withdrawal by Subject|0|||
162217980|NCT02600897|585847990|FG007|Overall Study|Withdrawal by Subject|4|||
162217981|NCT02600897|585847991|FG008|Overall Study|Withdrawal by Subject|2|||
162217982|NCT02600897|585847983|FG000|Overall Study|Reason Not Specified|0|||
162217983|NCT02600897|585847984|FG001|Overall Study|Reason Not Specified|0|||
162217984|NCT02600897|585847985|FG002|Overall Study|Reason Not Specified|0|||
162217985|NCT02600897|585847986|FG003|Overall Study|Reason Not Specified|0|||
162217986|NCT02600897|585847987|FG004|Overall Study|Reason Not Specified|0|||
162217987|NCT02600897|585847988|FG005|Overall Study|Reason Not Specified|0|||
162217988|NCT02600897|585847989|FG006|Overall Study|Reason Not Specified|0|||
162217989|NCT02600897|585847990|FG007|Overall Study|Reason Not Specified|0|||
162217990|NCT02600897|585847991|FG008|Overall Study|Reason Not Specified|1|||
162217991|NCT02614183|585847994|FG000|Double Blind Treatment Phase|Adverse Event|10|||
162217992|NCT02614183|585847995|FG001|Double Blind Treatment Phase|Adverse Event|9|||
162217993|NCT02614183|585847996|FG002|Double Blind Treatment Phase|Adverse Event|7|||
162217994|NCT02614183|585847994|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
162217995|NCT02614183|585847995|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
162217996|NCT02614183|585847996|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
162217997|NCT02614183|585847994|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
162217998|NCT02614183|585847995|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
162217999|NCT02614183|585847996|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
162218000|NCT02614183|585847994|FG000|Double Blind Treatment Phase|Physician Decision|7|||
162218001|NCT02614183|585847995|FG001|Double Blind Treatment Phase|Physician Decision|3|||
162218002|NCT02614183|585847996|FG002|Double Blind Treatment Phase|Physician Decision|2|||
162218003|NCT02614183|585847994|FG000|Double Blind Treatment Phase|Pregnancy|2|||
162218004|NCT02614183|585847995|FG001|Double Blind Treatment Phase|Pregnancy|1|||
162218005|NCT02614183|585847996|FG002|Double Blind Treatment Phase|Pregnancy|3|||
161827413|NCT00708682|584408075|FG000|Infant Series|Other|19|||
161827414|NCT00708682|584408075|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
161827415|NCT00708682|584408075|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
161827416|NCT00708682|584408075|FG000|Toddler Dose|Lost to Follow-up|3|||
161827417|NCT00708682|584408075|FG000|Toddler Dose|Failed to Return|4|||
161827418|NCT00569777|584408078|FG000|Overall Study|Withdrawal by Subject|4|||
161827419|NCT00569777|584408079|FG001|Overall Study|Withdrawal by Subject|0|||
161827420|NCT00569777|584408078|FG000|Overall Study|Adverse Event|3|||
161827421|NCT00569777|584408079|FG001|Overall Study|Adverse Event|0|||
161827422|NCT00569777|584408078|FG000|Overall Study|Lost to Follow-up|1|||
161827423|NCT00569777|584408079|FG001|Overall Study|Lost to Follow-up|0|||
162218006|NCT02614183|585847994|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
162218007|NCT02614183|585847995|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
162218008|NCT02614183|585847996|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
162218009|NCT02614183|585847994|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
162218010|NCT02614183|585847995|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
162218011|NCT02614183|585847996|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
162218012|NCT02614183|585847994|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
162218013|NCT02614183|585847995|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
162218014|NCT02614183|585847996|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
162218015|NCT02614183|585847994|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
162218016|NCT02614183|585847995|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
162218017|NCT02614183|585847996|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
162218018|NCT02614183|585847994|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
162218019|NCT02614183|585847995|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
162218020|NCT02614183|585847996|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
162218021|NCT02614183|585847994|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
162218022|NCT02614183|585847995|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
162218023|NCT02614183|585847996|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
162218024|NCT02614183|585847994|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
162218025|NCT02614183|585847995|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
162218026|NCT02614183|585847996|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
162218027|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
162218028|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
162218029|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
162218030|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
162218031|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
162218032|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
162218033|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
162218034|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
162218035|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
162218036|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
162218037|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
162218038|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
162218039|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
162218040|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
162218041|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
162218042|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
162218043|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
162218044|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
162218045|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
162218046|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
162218047|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
162218048|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
162218049|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
162218050|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
162218051|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
162218052|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
162218053|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
162218054|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
162218055|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
162218056|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
161678460|NCT02081534|583875978|FG002|Overall Study|Adverse Event|3|||
161678461|NCT02081534|583875979|FG003|Overall Study|Adverse Event|10|||
161678462|NCT02081534|583875980|FG004|Overall Study|Adverse Event|2|||
161678463|NCT02081534|583875981|FG005|Overall Study|Adverse Event|8|||
161678464|NCT02081534|583875982|FG006|Overall Study|Adverse Event|2|||
161678465|NCT02081534|583875976|FG000|Overall Study|Withdrawal by Subject|0|||
161678466|NCT02081534|583875977|FG001|Overall Study|Withdrawal by Subject|1|||
161678467|NCT02081534|583875978|FG002|Overall Study|Withdrawal by Subject|1|||
161827424|NCT00569777|584408078|FG000|Overall Study|scheduled eye surgery|0|||
162218057|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
162218058|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
161827425|NCT00569777|584408079|FG001|Overall Study|scheduled eye surgery|1|||
161827426|NCT00569777|584408078|FG000|Overall Study|did not meet exclusion criteria|1|||
161827427|NCT00569777|584408079|FG001|Overall Study|did not meet exclusion criteria|2|||
161678468|NCT02081534|583875979|FG003|Overall Study|Withdrawal by Subject|1|||
161678469|NCT02081534|583875980|FG004|Overall Study|Withdrawal by Subject|1|||
162218059|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
162218060|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
162218061|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
162218062|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
162218063|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
162218064|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
162218065|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
162218066|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
162218067|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
162218068|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
162218069|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
162218070|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
162218071|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
162218072|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
162218073|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
162218074|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
162218075|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
162218076|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
162218077|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
162218078|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
162218079|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
162218080|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
162218081|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
162218082|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
162218083|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
162218084|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
162218085|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
162218086|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
162218087|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
162218088|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
162218089|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
162218090|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
162218091|NCT00217737|585847997|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
162218092|NCT00217737|585847998|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
162218093|NCT00217737|585847999|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
162218094|NCT00217737|585848000|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
162218095|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
162218096|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
162218097|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
162218098|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
162218099|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
162218100|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
162218101|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
162218102|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
162218103|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Study suspension|0|||
162218104|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Study suspension|45|||
162218105|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Study suspension|0|||
162218106|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Study suspension|0|||
162021398|NCT01874340|585134772|FG003|Overall Study|Withdrawal by Subject|1|||
162021399|NCT00689117|585134776|FG000|Overall Study|Adverse Event|6|||
162021400|NCT00689117|585134777|FG001|Overall Study|Adverse Event|0|||
162218107|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
162218108|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
162218109|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
162218110|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
162218111|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Death|2|||
162218112|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Death|3|||
162218113|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Death|0|||
162218114|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Death|0|||
162218115|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
162218116|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
162218117|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
162218118|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
162218119|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
162218120|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
162218121|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
162218122|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
162218123|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
162218124|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
162218125|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
162218126|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
162218127|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
162218128|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
162218129|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
162218130|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
162218131|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
162218132|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
162218133|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
162218134|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
162218135|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
162218136|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
162218137|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
162218138|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
162218139|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
162218140|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
162218141|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
162218142|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
162218143|NCT00217737|585847997|FG000|Step 2 Randomization/Registration|Other|1|||
162218144|NCT00217737|585847998|FG001|Step 2 Randomization/Registration|Other|2|||
162218145|NCT00217737|585847999|FG002|Step 2 Randomization/Registration|Other|0|||
162218146|NCT00217737|585848000|FG003|Step 2 Randomization/Registration|Other|0|||
162218147|NCT04680533|585848001|FG000|Overall Study|Screen failure|1|||
162218148|NCT01484431|585849554|FG000|Period 1: High Dose|Physician Decision|0|||
162218149|NCT01484431|585849555|FG001|Period 1: High Dose|Physician Decision|1|||
162218150|NCT01484431|585849556|FG002|Period 1: High Dose|Physician Decision|0|||
162218151|NCT01484431|585849554|FG000|Period 2|Death|0|||
162218152|NCT01484431|585849555|FG001|Period 2|Death|1|||
162218153|NCT01484431|585849556|FG002|Period 2|Death|1|||
162218154|NCT01484431|585849554|FG000|Period 2|Physician Decision|0|||
162218155|NCT01484431|585849555|FG001|Period 2|Physician Decision|0|||
162218156|NCT01484431|585849556|FG002|Period 2|Physician Decision|1|||
162218157|NCT01484431|585849554|FG000|Period 2|Non-Compliance with Study Drug|1|||
162218158|NCT01484431|585849555|FG001|Period 2|Non-Compliance with Study Drug|0|||
162218159|NCT01484431|585849556|FG002|Period 2|Non-Compliance with Study Drug|0|||
162218160|NCT01251770|585849557|FG000|Overall Study|Protocol Violation|13|||
162218161|NCT01251770|585849558|FG001|Overall Study|Protocol Violation|7|||
162218162|NCT01901419|585849559|FG000|Overall Study|Protocol Violation|2|||
162218163|NCT01901419|585849560|FG001|Overall Study|Protocol Violation|6|||
162218164|NCT01901419|585849559|FG000|Overall Study|unavailable researchers|6|||
162218165|NCT01901419|585849560|FG001|Overall Study|unavailable researchers|3|||
162218166|NCT00475644|585849561|FG000|Overall Study|Protocol Violation|13|||
162218167|NCT00790400|585849568|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
162218168|NCT00790400|585849569|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
162218169|NCT00790400|585849568|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
162218170|NCT00790400|585849569|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
162218171|NCT00790400|585849568|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
162218172|NCT00790400|585849569|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
162218173|NCT00790400|585849568|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
162218174|NCT00790400|585849569|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
162218175|NCT00790400|585849568|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
162218176|NCT00790400|585849569|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
162218177|NCT00790400|585849568|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
162218178|NCT00790400|585849569|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
162218179|NCT00790400|585849568|FG000|Double-blind Period (Core Phase)|Death|1|||
161827428|NCT00569777|584408078|FG000|Overall Study|pregnant|1|||
161827429|NCT00569777|584408079|FG001|Overall Study|pregnant|0|||
162218180|NCT00790400|585849569|FG001|Double-blind Period (Core Phase)|Death|0|||
162218181|NCT00790400|585849568|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
162218182|NCT00790400|585849569|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
162218183|NCT00790400|585849568|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
162218184|NCT00790400|585849569|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
162218185|NCT00790400|585849568|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
162218186|NCT00790400|585849569|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
162218187|NCT00790400|585849568|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
162218188|NCT00790400|585849569|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
162218189|NCT00790400|585849568|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
162218190|NCT00790400|585849569|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
162218191|NCT00790400|585849568|FG000|Everolimus Period (Core or Extension)|Death|1|||
162218192|NCT00790400|585849569|FG001|Everolimus Period (Core or Extension)|Death|0|||
162218193|NCT00790400|585849568|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
162218194|NCT00790400|585849569|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
162218195|NCT00790400|585849568|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
162218196|NCT00790400|585849569|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
162218197|NCT00790400|585849568|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
162218198|NCT00790400|585849569|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
162218199|NCT02412735|585849572|FG000|Overall Study|Adverse Event|0|||
162218200|NCT02412735|585849573|FG001|Overall Study|Adverse Event|1|||
162218201|NCT02412735|585849574|FG002|Overall Study|Adverse Event|2|||
162218202|NCT02412735|585849572|FG000|Overall Study|Withdrawal by Subject|23|||
162218203|NCT02412735|585849573|FG001|Overall Study|Withdrawal by Subject|27|||
162218204|NCT02412735|585849574|FG002|Overall Study|Withdrawal by Subject|22|||
162218205|NCT02412735|585849572|FG000|Overall Study|Investigator Decision|3|||
162218206|NCT02412735|585849573|FG001|Overall Study|Investigator Decision|3|||
162218207|NCT02412735|585849574|FG002|Overall Study|Investigator Decision|2|||
162218208|NCT02412735|585849572|FG000|Overall Study|Lost to Follow-up|17|||
162218209|NCT02412735|585849573|FG001|Overall Study|Lost to Follow-up|11|||
162218210|NCT02412735|585849574|FG002|Overall Study|Lost to Follow-up|18|||
162218211|NCT02412735|585849572|FG000|Overall Study|Reason not Specified|3|||
162218212|NCT02412735|585849573|FG001|Overall Study|Reason not Specified|2|||
162218213|NCT02412735|585849574|FG002|Overall Study|Reason not Specified|2|||
162218214|NCT01006980|585849575|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
162218215|NCT01006980|585849576|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
162218216|NCT01006980|585849575|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
162218217|NCT01006980|585849576|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
162218218|NCT01006980|585849575|FG000|Vemurafenib and Dacarbazine|Death|13|||
162218219|NCT01006980|585849576|FG001|Vemurafenib and Dacarbazine|Death|12|||
162218220|NCT01006980|585849575|FG000|Vemurafenib and Dacarbazine|Progression|257|||
162218221|NCT01006980|585849576|FG001|Vemurafenib and Dacarbazine|Progression|218|||
162218222|NCT01006980|585849575|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
162218223|NCT01006980|585849576|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
162218224|NCT01006980|585849575|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
162218225|NCT01006980|585849576|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
162218226|NCT01006980|585849575|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
162218227|NCT01006980|585849576|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
162218228|NCT01006980|585849575|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
162218229|NCT01006980|585849576|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
162218230|NCT01006980|585849575|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
162218231|NCT01006980|585849576|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
162218232|NCT01006980|585849575|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
162218233|NCT01006980|585849576|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
162218234|NCT01006980|585849575|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
162218235|NCT01006980|585849576|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
162218236|NCT01006980|585849575|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
162218237|NCT01006980|585849576|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
162218238|NCT01006980|585849575|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
162218239|NCT01006980|585849576|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
162218240|NCT00078338|585849577|FG000|Overall Study|Adverse Event|31|||
162218241|NCT00078338|585849578|FG001|Overall Study|Adverse Event|24|||
162218242|NCT00078338|585849577|FG000|Overall Study|Lost to Follow-up|17|||
162218243|NCT00078338|585849578|FG001|Overall Study|Lost to Follow-up|2|||
162218244|NCT00078338|585849577|FG000|Overall Study|Protocol Violation|2|||
162218245|NCT00078338|585849578|FG001|Overall Study|Protocol Violation|2|||
162218246|NCT00078338|585849577|FG000|Overall Study|Disease Progression|4|||
162218247|NCT00078338|585849578|FG001|Overall Study|Disease Progression|7|||
162218248|NCT00078338|585849577|FG000|Overall Study|Other|28|||
162218249|NCT00078338|585849578|FG001|Overall Study|Other|16|||
162218250|NCT00078338|585849577|FG000|Overall Study|Subjects randomized, but not treated|3|||
162218251|NCT00078338|585849578|FG001|Overall Study|Subjects randomized, but not treated|3|||
161678470|NCT02081534|583875981|FG005|Overall Study|Withdrawal by Subject|0|||
161678471|NCT02081534|583875982|FG006|Overall Study|Withdrawal by Subject|1|||
162218252|NCT02124811|585849579|FG000|Overall Study|Early termination|2|||
162218253|NCT02124811|585849580|FG001|Overall Study|Early termination|2|||
162218254|NCT02124811|585849579|FG000|Overall Study|Withdrawal by Subject|1|||
162218255|NCT02124811|585849580|FG001|Overall Study|Withdrawal by Subject|0|||
162218256|NCT03445533|585849583|FG000|Overall Study|Progressive Disease|48|||
162218257|NCT03445533|585849584|FG001|Overall Study|Progressive Disease|81|||
162218258|NCT03445533|585849583|FG000|Overall Study|Adverse Event|60|||
162218259|NCT03445533|585849584|FG001|Overall Study|Adverse Event|64|||
162218260|NCT03445533|585849583|FG000|Overall Study|Death|9|||
162218261|NCT03445533|585849584|FG001|Overall Study|Death|19|||
162218262|NCT03445533|585849583|FG000|Overall Study|Miscellaneous|0|||
162218263|NCT03445533|585849584|FG001|Overall Study|Miscellaneous|16|||
162218264|NCT03445533|585849583|FG000|Overall Study|Withdrawal by Subject|3|||
162218265|NCT03445533|585849584|FG001|Overall Study|Withdrawal by Subject|4|||
162218266|NCT03445533|585849583|FG000|Overall Study|Physician Decision|1|||
162218267|NCT03445533|585849584|FG001|Overall Study|Physician Decision|3|||
162218268|NCT03445533|585849583|FG000|Overall Study|Sponsor Decision|0|||
162218269|NCT03445533|585849584|FG001|Overall Study|Sponsor Decision|1|||
162218270|NCT03445533|585849583|FG000|Overall Study|Lost to Follow-up|0|||
162218271|NCT03445533|585849584|FG001|Overall Study|Lost to Follow-up|1|||
162218272|NCT03445533|585849583|FG000|Overall Study|Never Received any Study Treatment|7|||
162218273|NCT03445533|585849584|FG001|Overall Study|Never Received any Study Treatment|4|||
162218274|NCT03274453|585849585|FG000|Overall Study|Lost to Follow-up|2|||
162218275|NCT03274453|585849586|FG001|Overall Study|Lost to Follow-up|5|||
162218276|NCT03274453|585849587|FG002|Overall Study|Lost to Follow-up|4|||
162218277|NCT03274453|585849588|FG003|Overall Study|Lost to Follow-up|1|||
162218278|NCT03274453|585849585|FG000|Overall Study|Physician Decision|2|||
162218279|NCT03274453|585849586|FG001|Overall Study|Physician Decision|0|||
162218280|NCT03274453|585849587|FG002|Overall Study|Physician Decision|0|||
162218281|NCT03274453|585849588|FG003|Overall Study|Physician Decision|3|||
162218282|NCT03274453|585849585|FG000|Overall Study|Surgery Cancelled|0|||
162218283|NCT03274453|585849586|FG001|Overall Study|Surgery Cancelled|1|||
162218284|NCT03274453|585849587|FG002|Overall Study|Surgery Cancelled|0|||
162218285|NCT03274453|585849588|FG003|Overall Study|Surgery Cancelled|0|||
162218286|NCT01294397|585849590|FG000|Overall Study|Withdrawal by Subject|1|||
162218287|NCT01294397|585849590|FG000|Overall Study|Administrative Decision|1|||
162218288|NCT01967069|585849591|FG000|Overall Study|Adverse Event|2|||
162218289|NCT01967069|585849592|FG001|Overall Study|Adverse Event|2|||
162218290|NCT01967069|585849591|FG000|Overall Study|Lost to Follow-up|5|||
162218291|NCT01967069|585849592|FG001|Overall Study|Lost to Follow-up|2|||
162218292|NCT01967069|585849591|FG000|Overall Study|Withdrawal by Subject|1|||
162218293|NCT01967069|585849592|FG001|Overall Study|Withdrawal by Subject|3|||
162218294|NCT01967069|585849591|FG000|Overall Study|Lack of Efficacy|0|||
162218295|NCT01967069|585849592|FG001|Overall Study|Lack of Efficacy|1|||
162218296|NCT05569421|585849593|FG000|Overall Study|Withdrawal by Subject|1|||
162218297|NCT05569421|585849594|FG001|Overall Study|Withdrawal by Subject|0|||
162218298|NCT05569421|585849595|FG002|Overall Study|Withdrawal by Subject|0|||
162218299|NCT01736540|585849597|FG000|Overall Study|Did not complete scan within 45 days|2|||
162218300|NCT01736540|585849597|FG000|Overall Study|Death|1|||
162218301|NCT01736540|585849597|FG000|Overall Study|Abnormal test procedure|1|||
162218302|NCT01736540|585849597|FG000|Overall Study|Withdrawal by Subject|5|||
162218303|NCT01736540|585849597|FG000|Overall Study|Protocol Violation|1|||
162218304|NCT01736540|585849597|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
162218305|NCT01736540|585849597|FG000|Overall Study|No show for MRI appointment|1|||
162218306|NCT01736540|585849597|FG000|Overall Study|Unable to make MRI appointment|3|||
162218307|NCT00790205|585849607|FG000|Overall Study|Lost to Follow-up|61|||
162218308|NCT00790205|585849608|FG001|Overall Study|Lost to Follow-up|71|||
162218309|NCT00790205|585849607|FG000|Overall Study|Withdrawal by Subject|299|||
162218310|NCT00790205|585849608|FG001|Overall Study|Withdrawal by Subject|363|||
162218311|NCT01031628|585849609|FG000|Overall Study|Study terminated early|0|||
162218312|NCT01031628|585849610|FG001|Overall Study|Study terminated early|1|||
162218313|NCT01031628|585849611|FG002|Overall Study|Study terminated early|3|||
162218314|NCT01031628|585849612|FG003|Overall Study|Study terminated early|0|||
162218315|NCT02643628|585849615|FG000|Overall Study|Lost to Follow-up|1|||
162218316|NCT02643628|585849616|FG001|Overall Study|Lost to Follow-up|4|||
161827430|NCT02056652|584408080|FG000|Overall Study|Withdrawal by Subject|1|||
161827431|NCT02056652|584408081|FG001|Overall Study|Withdrawal by Subject|0|||
161827432|NCT02056652|584408080|FG000|Overall Study|Lost to Follow-up|0|||
162218317|NCT02643628|585849615|FG000|Overall Study|Withdrawal by Subject|0|||
162218318|NCT02643628|585849616|FG001|Overall Study|Withdrawal by Subject|1|||
162218319|NCT02643628|585849615|FG000|Overall Study|Relocated out of state|0|||
162218320|NCT02643628|585849616|FG001|Overall Study|Relocated out of state|1|||
162218321|NCT05143138|585849617|FG000|Overall Study|Death|5|||
162218322|NCT05143138|585849618|FG001|Overall Study|Death|35|||
162218323|NCT05143138|585849619|FG002|Overall Study|Death|1|||
162218324|NCT05143138|585849617|FG000|Overall Study|Lost to Follow-up|2|||
162218325|NCT05143138|585849618|FG001|Overall Study|Lost to Follow-up|4|||
162218326|NCT05143138|585849619|FG002|Overall Study|Lost to Follow-up|0|||
162218327|NCT05143138|585849617|FG000|Overall Study|withdrawal|1|||
162218328|NCT05143138|585849618|FG001|Overall Study|withdrawal|1|||
162218329|NCT05143138|585849619|FG002|Overall Study|withdrawal|0|||
162218330|NCT04245345|585849622|FG000|Overall Study|Death|1|||
162218331|NCT04245345|585849622|FG000|Overall Study|Exited prior to implant|5|||
162218332|NCT04245345|585849622|FG000|Overall Study|Exited prior to 1-month|9|||
162218333|NCT04245345|585849622|FG000|Overall Study|Missed 1-month visit|3|||
161827433|NCT02056652|584408081|FG001|Overall Study|Lost to Follow-up|3|||
161827434|NCT00239005|584408086|FG000|Overall Study|Adverse Event|6|||
161827435|NCT00239005|584408087|FG001|Overall Study|Adverse Event|6|||
161827436|NCT00239005|584408086|FG000|Overall Study|Withdrawal by Subject|3|||
161827437|NCT00239005|584408087|FG001|Overall Study|Withdrawal by Subject|4|||
161827438|NCT00239005|584408086|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
161827439|NCT00239005|584408087|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
161827440|NCT00239005|584408086|FG000|Overall Study|Protocol Violation|1|||
161827441|NCT00239005|584408087|FG001|Overall Study|Protocol Violation|0|||
161827442|NCT00239005|584408086|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
161827443|NCT00239005|584408087|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
161827444|NCT00239005|584408086|FG000|Overall Study|Lost to Follow-up|0|||
161827445|NCT00239005|584408087|FG001|Overall Study|Lost to Follow-up|1|||
161827446|NCT00987831|584408089|FG000|Overall Study|Never flared in 12 months|1|||
161827447|NCT00987831|584408090|FG001|Overall Study|Never flared in 12 months|0|||
161827448|NCT00987831|584408091|FG002|Overall Study|Never flared in 12 months|0|||
161827449|NCT00987831|584408089|FG000|Overall Study|Lost to Follow-up|0|||
161827450|NCT00987831|584408090|FG001|Overall Study|Lost to Follow-up|3|||
161827451|NCT00987831|584408091|FG002|Overall Study|Lost to Follow-up|0|||
161827452|NCT03253094|584408092|FG000|Overall Study|Adverse Event|2|||
161827453|NCT03253094|584408093|FG001|Overall Study|Adverse Event|0|||
161827454|NCT03253094|584408094|FG002|Overall Study|Adverse Event|0|||
161827455|NCT03253094|584408095|FG003|Overall Study|Adverse Event|0|||
161827456|NCT03253094|584408096|FG004|Overall Study|Adverse Event|0|||
161827457|NCT03253094|584408097|FG005|Overall Study|Adverse Event|0|||
161827458|NCT03253094|584408092|FG000|Overall Study|Lack of Efficacy|0|||
161827459|NCT03253094|584408093|FG001|Overall Study|Lack of Efficacy|0|||
161827460|NCT03253094|584408094|FG002|Overall Study|Lack of Efficacy|2|||
161827461|NCT03253094|584408095|FG003|Overall Study|Lack of Efficacy|1|||
161827462|NCT03253094|584408096|FG004|Overall Study|Lack of Efficacy|2|||
161827463|NCT03253094|584408097|FG005|Overall Study|Lack of Efficacy|1|||
161827464|NCT03253094|584408092|FG000|Overall Study|Lost to Follow-up|0|||
161827465|NCT03253094|584408093|FG001|Overall Study|Lost to Follow-up|0|||
161827466|NCT03253094|584408094|FG002|Overall Study|Lost to Follow-up|1|||
161827467|NCT03253094|584408095|FG003|Overall Study|Lost to Follow-up|1|||
161827468|NCT03253094|584408096|FG004|Overall Study|Lost to Follow-up|0|||
161827469|NCT03253094|584408097|FG005|Overall Study|Lost to Follow-up|1|||
161827470|NCT03253094|584408092|FG000|Overall Study|Physician Decision|1|||
161827471|NCT03253094|584408093|FG001|Overall Study|Physician Decision|0|||
161827472|NCT03253094|584408094|FG002|Overall Study|Physician Decision|0|||
161827473|NCT03253094|584408095|FG003|Overall Study|Physician Decision|1|||
161827474|NCT03253094|584408096|FG004|Overall Study|Physician Decision|0|||
161827475|NCT03253094|584408097|FG005|Overall Study|Physician Decision|2|||
161827476|NCT03253094|584408092|FG000|Overall Study|Withdrawal by Subject|1|||
161827477|NCT03253094|584408093|FG001|Overall Study|Withdrawal by Subject|2|||
161827478|NCT03253094|584408094|FG002|Overall Study|Withdrawal by Subject|1|||
161827479|NCT03253094|584408095|FG003|Overall Study|Withdrawal by Subject|0|||
161827480|NCT03253094|584408096|FG004|Overall Study|Withdrawal by Subject|3|||
161827481|NCT03253094|584408097|FG005|Overall Study|Withdrawal by Subject|0|||
161827482|NCT03253094|584408092|FG000|Overall Study|Other|0|||
161827483|NCT03253094|584408093|FG001|Overall Study|Other|1|||
161827484|NCT03253094|584408094|FG002|Overall Study|Other|2|||
162218334|NCT04245345|585849622|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
162218335|NCT04245345|585849622|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
162218336|NCT04805073|585849626|FG000|Overall Study|study personnel not available|2|||
162218337|NCT04805073|585849627|FG001|Overall Study|study personnel not available|0|||
162218338|NCT04805073|585849626|FG000|Overall Study|spinal anesthesia failure|0|||
162218339|NCT04805073|585849627|FG001|Overall Study|spinal anesthesia failure|1|||
162218340|NCT04805073|585849626|FG000|Overall Study|Lost to Follow-up|0|||
162218341|NCT04805073|585849627|FG001|Overall Study|Lost to Follow-up|2|||
162218342|NCT00422734|585849631|FG000|Overall Study|Physician Decision|1|||
162218343|NCT00422734|585849632|FG001|Overall Study|Physician Decision|1|||
162218344|NCT00422734|585849631|FG000|Overall Study|Protocol Violation|1|||
162218345|NCT00422734|585849632|FG001|Overall Study|Protocol Violation|6|||
162218346|NCT00422734|585849631|FG000|Overall Study|Withdrawal by Subject|12|||
162218347|NCT00422734|585849632|FG001|Overall Study|Withdrawal by Subject|8|||
162218348|NCT00422734|585849631|FG000|Overall Study|Adverse Event|0|||
162218349|NCT00422734|585849632|FG001|Overall Study|Adverse Event|3|||
162218350|NCT00422734|585849631|FG000|Overall Study|Partner Decision|0|||
162218351|NCT00422734|585849632|FG001|Overall Study|Partner Decision|3|||
162218352|NCT01081886|585849633|FG000|Overall Study|Study termination|11|||
162218353|NCT01081886|585849634|FG001|Overall Study|Study termination|13|||
162218354|NCT02975102|585849638|FG000|Overall Study|Adverse Event|2|||
162218355|NCT02975102|585849639|FG001|Overall Study|Adverse Event|1|||
162218356|NCT03017742|585849640|FG000|Overall Study|Protocol Violation|36|||
162218357|NCT03017742|585849640|FG000|Overall Study|Withdrawal by Subject|37|||
162218358|NCT04148651|585849643|FG000|Overall Study|Lost to Follow-up|2|||
162218359|NCT05262751|585849644|FG000|Washout Period 2|Adverse Event|1|||
162218360|NCT05262751|585849645|FG001|Washout Period 2|Adverse Event|0|||
162218361|NCT05262751|585849646|FG002|Washout Period 2|Adverse Event|0|||
162218362|NCT05262751|585849647|FG003|Washout Period 2|Adverse Event|0|||
162218363|NCT05262751|585849648|FG004|Washout Period 2|Adverse Event|0|||
162218364|NCT05262751|585849649|FG005|Washout Period 2|Adverse Event|0|||
162218365|NCT05262751|585849644|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
162218366|NCT05262751|585849645|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
162218367|NCT05262751|585849646|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
162218368|NCT05262751|585849647|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
161827485|NCT03253094|584408095|FG003|Overall Study|Other|1|||
161827486|NCT03253094|584408096|FG004|Overall Study|Other|0|||
162218369|NCT05262751|585849648|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
162218370|NCT05262751|585849649|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
162218371|NCT03690427|585849652|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
162218372|NCT03690427|585849653|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
161827487|NCT03253094|584408097|FG005|Overall Study|Other|0|||
161827488|NCT00824369|584408098|FG000|Overall Study|Nolonger willing to participate in study|1|||
161827489|NCT00824369|584408099|FG001|Overall Study|Nolonger willing to participate in study|0|||
161827490|NCT00824369|584408100|FG002|Overall Study|Nolonger willing to participate in study|1|||
161827491|NCT00824369|584408101|FG003|Overall Study|Nolonger willing to participate in study|2|||
162021401|NCT00689117|585134778|FG002|Overall Study|Adverse Event|5|||
162021402|NCT00689117|585134779|FG003|Overall Study|Adverse Event|0|||
162218373|NCT03392168|585849654|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
162218374|NCT03392168|585849655|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
162218375|NCT03392168|585849656|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
162218376|NCT03392168|585849657|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
162218377|NCT03392168|585849654|FG000|Period 2: Cohort 2|Other|0|||
162218378|NCT03392168|585849655|FG001|Period 2: Cohort 2|Other|1|||
162218379|NCT03392168|585849656|FG002|Period 2: Cohort 2|Other|0|||
162218380|NCT03392168|585849657|FG003|Period 2: Cohort 2|Other|0|||
162218381|NCT02609672|585849658|FG000|Overall Study|Lost to Follow-up|3|||
162218382|NCT02609672|585849659|FG001|Overall Study|Lost to Follow-up|1|||
162218383|NCT03519204|585849660|FG000|Overall Study|Lost to Follow-up|3|||
162218384|NCT03519204|585849661|FG001|Overall Study|Lost to Follow-up|8|||
162218385|NCT03519204|585849660|FG000|Overall Study|Withdrawal by Subject|9|||
162218386|NCT03519204|585849661|FG001|Overall Study|Withdrawal by Subject|7|||
162218387|NCT03519204|585849660|FG000|Overall Study|Other Miscellaneous Reasons|1|||
162218388|NCT03519204|585849661|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161827492|NCT00824369|584408102|FG004|Overall Study|Nolonger willing to participate in study|0|||
161827493|NCT00824369|584408103|FG005|Overall Study|Nolonger willing to participate in study|1|||
161827494|NCT00824369|584408098|FG000|Overall Study|Lost to Follow-up|0|||
162218389|NCT01441635|585849665|FG000|Overall Study|Adverse Event|4|||
162218390|NCT01441635|585849666|FG001|Overall Study|Adverse Event|3|||
161678472|NCT02081534|583875976|FG000|Overall Study|Protocol Violation|0|||
161678473|NCT02081534|583875977|FG001|Overall Study|Protocol Violation|3|||
161678474|NCT02081534|583875978|FG002|Overall Study|Protocol Violation|0|||
161827495|NCT00824369|584408099|FG001|Overall Study|Lost to Follow-up|0|||
161827496|NCT00824369|584408100|FG002|Overall Study|Lost to Follow-up|0|||
161827497|NCT00824369|584408101|FG003|Overall Study|Lost to Follow-up|0|||
161827498|NCT00824369|584408102|FG004|Overall Study|Lost to Follow-up|1|||
161827499|NCT00824369|584408103|FG005|Overall Study|Lost to Follow-up|0|||
161827500|NCT02413294|584408104|FG000|Overall Study|Withdrawal by Subject|1|||
161827501|NCT02625974|584408105|FG000|Part 1|Lost to Follow-up|9|||
161827502|NCT02625974|584408106|FG001|Part 1|Lost to Follow-up|3|||
161827503|NCT02625974|584408105|FG000|Part 2|Lost to Follow-up|4|||
161827504|NCT02625974|584408106|FG001|Part 2|Lost to Follow-up|6|||
161827505|NCT02625974|584408105|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
161827506|NCT02625974|584408106|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
161827507|NCT01923311|584409324|FG000|Overall Study|Pregnancy|1|||
161827508|NCT01923311|584409325|FG001|Overall Study|Pregnancy|0|||
161827509|NCT01923311|584409324|FG000|Overall Study|Investigator's Discretion|1|||
161827510|NCT01923311|584409325|FG001|Overall Study|Investigator's Discretion|0|||
161827511|NCT01923311|584409324|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161827512|NCT01923311|584409325|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161827513|NCT01923311|584409324|FG000|Overall Study|Withdrew Consent|1|||
161827514|NCT01923311|584409325|FG001|Overall Study|Withdrew Consent|0|||
161827515|NCT01923311|584409324|FG000|Overall Study|Study Terminated by Sponsor|12|||
161827516|NCT01923311|584409325|FG001|Overall Study|Study Terminated by Sponsor|0|||
162218391|NCT01441635|585849667|FG002|Overall Study|Adverse Event|1|||
162218392|NCT01441635|585849668|FG003|Overall Study|Adverse Event|5|||
162218393|NCT01441635|585849669|FG004|Overall Study|Adverse Event|1|||
162218394|NCT01441635|585849670|FG005|Overall Study|Adverse Event|2|||
162218395|NCT01441635|585849671|FG006|Overall Study|Adverse Event|2|||
162218396|NCT01441635|585849672|FG007|Overall Study|Adverse Event|2|||
162218397|NCT01441635|585849673|FG008|Overall Study|Adverse Event|1|||
162218398|NCT01441635|585849674|FG009|Overall Study|Adverse Event|0|||
162218399|NCT01441635|585849665|FG000|Overall Study|Withdrawal by Subject|1|||
162218400|NCT01441635|585849666|FG001|Overall Study|Withdrawal by Subject|1|||
162218401|NCT01441635|585849667|FG002|Overall Study|Withdrawal by Subject|0|||
162218402|NCT01441635|585849668|FG003|Overall Study|Withdrawal by Subject|1|||
162218403|NCT01441635|585849669|FG004|Overall Study|Withdrawal by Subject|0|||
162218404|NCT01441635|585849670|FG005|Overall Study|Withdrawal by Subject|0|||
161678475|NCT02081534|583875979|FG003|Overall Study|Protocol Violation|0|||
161678476|NCT02081534|583875980|FG004|Overall Study|Protocol Violation|0|||
161678477|NCT02081534|583875981|FG005|Overall Study|Protocol Violation|0|||
161678478|NCT02081534|583875982|FG006|Overall Study|Protocol Violation|1|||
161678479|NCT02081534|583875976|FG000|Overall Study|Lost to Follow-up|0|||
161678480|NCT02081534|583875977|FG001|Overall Study|Lost to Follow-up|0|||
161678481|NCT02081534|583875978|FG002|Overall Study|Lost to Follow-up|0|||
161678482|NCT02081534|583875979|FG003|Overall Study|Lost to Follow-up|2|||
161678483|NCT02081534|583875980|FG004|Overall Study|Lost to Follow-up|1|||
161678484|NCT02081534|583875981|FG005|Overall Study|Lost to Follow-up|1|||
161678485|NCT02081534|583875982|FG006|Overall Study|Lost to Follow-up|0|||
161678486|NCT01848288|583875987|FG000|Overall Study|Death|1|||
161678487|NCT01848288|583875987|FG000|Overall Study|Protocol Violation|1|||
161678488|NCT01848288|583875987|FG000|Overall Study|Withdrawal by Subject|1|||
161678489|NCT01007032|583875989|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
162218405|NCT01441635|585849671|FG006|Overall Study|Withdrawal by Subject|2|||
162218406|NCT01441635|585849672|FG007|Overall Study|Withdrawal by Subject|0|||
162218407|NCT01441635|585849673|FG008|Overall Study|Withdrawal by Subject|1|||
162218408|NCT01441635|585849674|FG009|Overall Study|Withdrawal by Subject|1|||
162218409|NCT01441635|585849665|FG000|Overall Study|Lost to Follow-up|0|||
162218410|NCT01441635|585849666|FG001|Overall Study|Lost to Follow-up|1|||
162218411|NCT01441635|585849667|FG002|Overall Study|Lost to Follow-up|1|||
162218412|NCT01441635|585849668|FG003|Overall Study|Lost to Follow-up|1|||
162218413|NCT01441635|585849669|FG004|Overall Study|Lost to Follow-up|1|||
162218414|NCT01441635|585849670|FG005|Overall Study|Lost to Follow-up|3|||
162218415|NCT01441635|585849671|FG006|Overall Study|Lost to Follow-up|1|||
162218416|NCT01441635|585849672|FG007|Overall Study|Lost to Follow-up|1|||
162218417|NCT01441635|585849673|FG008|Overall Study|Lost to Follow-up|0|||
162218418|NCT01441635|585849674|FG009|Overall Study|Lost to Follow-up|1|||
162218419|NCT01441635|585849665|FG000|Overall Study|Noncompliance|0|||
162218420|NCT01441635|585849666|FG001|Overall Study|Noncompliance|1|||
162218421|NCT01441635|585849667|FG002|Overall Study|Noncompliance|0|||
162218422|NCT01441635|585849668|FG003|Overall Study|Noncompliance|0|||
162218423|NCT01441635|585849669|FG004|Overall Study|Noncompliance|0|||
161678490|NCT01007032|583875990|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
161678491|NCT01007032|583875991|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
161678492|NCT01007032|583875992|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
161678493|NCT01007032|583875989|FG000|Overall Study|Withdrawal by Subject|0|||
161678494|NCT01007032|583875990|FG001|Overall Study|Withdrawal by Subject|0|||
161678495|NCT01007032|583875991|FG002|Overall Study|Withdrawal by Subject|0|||
162218424|NCT01441635|585849670|FG005|Overall Study|Noncompliance|0|||
162218425|NCT01441635|585849671|FG006|Overall Study|Noncompliance|1|||
162218426|NCT01441635|585849672|FG007|Overall Study|Noncompliance|0|||
162218427|NCT01441635|585849673|FG008|Overall Study|Noncompliance|0|||
162218428|NCT01441635|585849674|FG009|Overall Study|Noncompliance|0|||
162218429|NCT01441635|585849665|FG000|Overall Study|Surgery or Invasive Intervention|0|||
162218430|NCT01441635|585849666|FG001|Overall Study|Surgery or Invasive Intervention|0|||
162218431|NCT01441635|585849667|FG002|Overall Study|Surgery or Invasive Intervention|1|||
161827517|NCT04129944|584409328|FG000|Overall Study|Death|0|||
161827518|NCT04129944|584409329|FG001|Overall Study|Death|0|||
161827519|NCT04129944|584409330|FG002|Overall Study|Death|0|||
162021403|NCT00689117|585134776|FG000|Overall Study|Lost to Follow-up|26|||
162218432|NCT01441635|585849668|FG003|Overall Study|Surgery or Invasive Intervention|0|||
162218433|NCT01441635|585849669|FG004|Overall Study|Surgery or Invasive Intervention|0|||
162218434|NCT01441635|585849670|FG005|Overall Study|Surgery or Invasive Intervention|0|||
162218435|NCT01441635|585849671|FG006|Overall Study|Surgery or Invasive Intervention|0|||
162218436|NCT01441635|585849672|FG007|Overall Study|Surgery or Invasive Intervention|0|||
161678496|NCT01007032|583875992|FG003|Overall Study|Withdrawal by Subject|1|||
161678497|NCT01841749|583875993|FG000|Overall Study|Protocol Violation|1|||
161678498|NCT02285920|583875994|FG000|Overall Study|Kidney transplantation|2|||
161678499|NCT02285920|583875995|FG001|Overall Study|Kidney transplantation|2|||
161827520|NCT04129944|584409331|FG003|Overall Study|Death|1|||
161827521|NCT04129944|584409328|FG000|Overall Study|Lost to Follow-up|1|||
162218437|NCT01441635|585849673|FG008|Overall Study|Surgery or Invasive Intervention|0|||
162218438|NCT01441635|585849674|FG009|Overall Study|Surgery or Invasive Intervention|0|||
162218439|NCT01441635|585849665|FG000|Overall Study|Received Exclusionary Medication|1|||
162218440|NCT01441635|585849666|FG001|Overall Study|Received Exclusionary Medication|0|||
162218441|NCT01441635|585849667|FG002|Overall Study|Received Exclusionary Medication|0|||
162218442|NCT01441635|585849668|FG003|Overall Study|Received Exclusionary Medication|0|||
162218443|NCT01441635|585849669|FG004|Overall Study|Received Exclusionary Medication|0|||
162218444|NCT01441635|585849670|FG005|Overall Study|Received Exclusionary Medication|0|||
162218445|NCT01441635|585849671|FG006|Overall Study|Received Exclusionary Medication|0|||
162218446|NCT01441635|585849672|FG007|Overall Study|Received Exclusionary Medication|0|||
162218447|NCT01441635|585849673|FG008|Overall Study|Received Exclusionary Medication|0|||
162218448|NCT01441635|585849674|FG009|Overall Study|Received Exclusionary Medication|0|||
162218449|NCT01441635|585849665|FG000|Overall Study|Other|0|||
162218450|NCT01441635|585849666|FG001|Overall Study|Other|0|||
162218451|NCT01441635|585849667|FG002|Overall Study|Other|0|||
162218452|NCT01441635|585849668|FG003|Overall Study|Other|0|||
162218453|NCT01441635|585849669|FG004|Overall Study|Other|0|||
162218454|NCT01441635|585849670|FG005|Overall Study|Other|0|||
162218455|NCT01441635|585849671|FG006|Overall Study|Other|0|||
162218456|NCT01441635|585849672|FG007|Overall Study|Other|1|||
162218457|NCT01441635|585849673|FG008|Overall Study|Other|0|||
162218458|NCT01441635|585849674|FG009|Overall Study|Other|0|||
162218459|NCT02637323|585849676|FG000|Overall Study|Lost to Follow-up|2|||
162218460|NCT02637323|585849677|FG001|Overall Study|Lost to Follow-up|0|||
162218461|NCT02637323|585849676|FG000|Overall Study|Protocol Violation|0|||
162218462|NCT02637323|585849677|FG001|Overall Study|Protocol Violation|1|||
162218463|NCT01154140|585849678|FG000|Overall Study|Death|71|||
161678500|NCT02285920|583875996|FG002|Overall Study|Kidney transplantation|2|||
161678501|NCT02285920|583875997|FG003|Overall Study|Kidney transplantation|0|||
161678502|NCT02285920|583875994|FG000|Overall Study|Change to peritoneal dialysis|0|||
161678503|NCT02285920|583875995|FG001|Overall Study|Change to peritoneal dialysis|0|||
161678504|NCT02285920|583875996|FG002|Overall Study|Change to peritoneal dialysis|1|||
161678505|NCT02285920|583875997|FG003|Overall Study|Change to peritoneal dialysis|0|||
161678506|NCT02285920|583875994|FG000|Overall Study|Transfer to non-participating unit|0|||
161827522|NCT04129944|584409329|FG001|Overall Study|Lost to Follow-up|0|||
162218464|NCT01154140|585849679|FG001|Overall Study|Death|81|||
162218465|NCT01154140|585849678|FG000|Overall Study|Lost to Follow-up|4|||
162218466|NCT01154140|585849679|FG001|Overall Study|Lost to Follow-up|5|||
162218467|NCT01154140|585849678|FG000|Overall Study|Withdrawal by Subject|12|||
162218468|NCT01154140|585849679|FG001|Overall Study|Withdrawal by Subject|13|||
162218469|NCT01154140|585849678|FG000|Overall Study|Other|3|||
162218470|NCT01154140|585849679|FG001|Overall Study|Other|1|||
161827523|NCT04129944|584409330|FG002|Overall Study|Lost to Follow-up|0|||
161827524|NCT04129944|584409331|FG003|Overall Study|Lost to Follow-up|0|||
161827525|NCT04129944|584409328|FG000|Overall Study|Withdrawal by Subject|1|||
161827526|NCT04129944|584409329|FG001|Overall Study|Withdrawal by Subject|0|||
161827527|NCT04129944|584409330|FG002|Overall Study|Withdrawal by Subject|1|||
161827528|NCT04129944|584409331|FG003|Overall Study|Withdrawal by Subject|2|||
161827529|NCT03941834|584409332|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
161827530|NCT03941834|584409333|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
161827531|NCT03941834|584409334|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
161827532|NCT03941834|584409332|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
161827533|NCT03941834|584409333|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
162218471|NCT01154140|585849678|FG000|Overall Study|Randomized but not treated|1|||
162218472|NCT01154140|585849679|FG001|Overall Study|Randomized but not treated|2|||
161678507|NCT02285920|583875995|FG001|Overall Study|Transfer to non-participating unit|1|||
161678508|NCT02285920|583875996|FG002|Overall Study|Transfer to non-participating unit|0|||
161678509|NCT02285920|583875997|FG003|Overall Study|Transfer to non-participating unit|0|||
162218473|NCT00358644|585849680|FG000|Overall Study|Progressive Disease|21|||
162218474|NCT00358644|585849680|FG000|Overall Study|Adverse Event|7|||
162218475|NCT00358644|585849680|FG000|Overall Study|Death|11|||
162218476|NCT00358644|585849680|FG000|Overall Study|Withdrawal by Subject|4|||
162218477|NCT00358644|585849680|FG000|Overall Study|Physician Decision|6|||
162218478|NCT00358644|585849680|FG000|Overall Study|Patient not eligible for study|1|||
161678510|NCT02285920|583875994|FG000|Overall Study|Dialysis discontinuation|0|||
161678511|NCT02285920|583875995|FG001|Overall Study|Dialysis discontinuation|1|||
161678512|NCT02285920|583875996|FG002|Overall Study|Dialysis discontinuation|0|||
162218479|NCT03327831|585849681|FG000|Overall Study|Lost to Follow-up|2|||
162218480|NCT00368875|585849682|FG000|Overall Study|Adverse Event|0|||
162218481|NCT00368875|585849683|FG001|Overall Study|Adverse Event|12|||
162218482|NCT00368875|585849682|FG000|Overall Study|Progressive disease|3|||
162218483|NCT00368875|585849683|FG001|Overall Study|Progressive disease|27|||
162218484|NCT00368875|585849682|FG000|Overall Study|Withdrawal by Subject|2|||
162218485|NCT00368875|585849683|FG001|Overall Study|Withdrawal by Subject|6|||
162218486|NCT00368875|585849682|FG000|Overall Study|Other Reason|0|||
162218487|NCT00368875|585849683|FG001|Overall Study|Other Reason|2|||
162218488|NCT00368875|585849682|FG000|Overall Study|Alternative Therapy|1|||
162218489|NCT00368875|585849683|FG001|Overall Study|Alternative Therapy|1|||
162218490|NCT02595372|585849684|FG000|Overall Study|Adverse Event|6|||
162218491|NCT02595372|585849684|FG000|Overall Study|Physician Decision|2|||
162218492|NCT02595372|585849684|FG000|Overall Study|Disease Progression|1|||
162218493|NCT00401258|585849687|FG000|Overall Study|Adverse Event|7|||
162218494|NCT04297618|585849697|FG000|Overall Study|Adverse Event|1|||
162218495|NCT04297618|585849697|FG000|Overall Study|Withdrawal by Subject|1|||
162218496|NCT04704219|585849698|FG000|Overall Study|Screen Failure|1|||
162218497|NCT04704219|585849698|FG000|Overall Study|Withdrawal by Subject|1|||
162218498|NCT04704219|585849698|FG000|Overall Study|Death|78|||
162218499|NCT04704219|585849698|FG000|Overall Study|Participants Ongoing|80|||
162218500|NCT03816761|585851786|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
162218501|NCT03816761|585851787|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
162218502|NCT03816761|585851788|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
162218503|NCT03816761|585851789|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
162218504|NCT03816761|585851790|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
162218505|NCT03816761|585851791|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
162218506|NCT03816761|585851786|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
162218507|NCT03816761|585851787|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
162218508|NCT03816761|585851788|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
162218509|NCT03816761|585851789|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
162218510|NCT03816761|585851790|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
162218511|NCT03816761|585851791|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
162218512|NCT00603525|585851801|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
162218513|NCT00603525|585851802|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
162218514|NCT00603525|585851803|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
162218515|NCT00603525|585851801|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
162218516|NCT00603525|585851802|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
162218517|NCT00603525|585851803|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
162218518|NCT00603525|585851801|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
162218519|NCT00603525|585851802|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
162218520|NCT00603525|585851803|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
162218521|NCT00603525|585851801|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
162218522|NCT00603525|585851802|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
162218523|NCT00603525|585851803|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
162218524|NCT00603525|585851801|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
162218525|NCT00603525|585851802|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
162218526|NCT00603525|585851803|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
162218527|NCT00603525|585851801|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
162218528|NCT00603525|585851802|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
161678513|NCT02285920|583875997|FG003|Overall Study|Dialysis discontinuation|0|||
161678514|NCT02285920|583875994|FG000|Overall Study|Death|2|||
161678515|NCT02285920|583875995|FG001|Overall Study|Death|0|||
161678516|NCT02285920|583875996|FG002|Overall Study|Death|2|||
162218529|NCT00603525|585851803|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
162218530|NCT00603525|585851801|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
162218531|NCT00603525|585851802|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
162218532|NCT00603525|585851803|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
162218533|NCT00603525|585851801|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
162218534|NCT00603525|585851802|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
162218535|NCT00603525|585851803|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
162218536|NCT00603525|585851801|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
162218537|NCT00603525|585851802|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
162218538|NCT00603525|585851803|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
162218539|NCT00603525|585851801|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
162218540|NCT00603525|585851802|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
162218541|NCT00603525|585851803|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
162218542|NCT00603525|585851801|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
162218543|NCT00603525|585851802|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
162218544|NCT00603525|585851803|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
162218545|NCT00603525|585851801|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
161827534|NCT03941834|584409334|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
161827535|NCT03941834|584409332|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
161827536|NCT03941834|584409333|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
161827537|NCT03941834|584409334|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
161827538|NCT03941834|584409332|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
161827539|NCT03941834|584409333|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
161827540|NCT03941834|584409334|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
161827541|NCT03941834|584409332|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
161827542|NCT03941834|584409333|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
161827543|NCT03941834|584409334|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
161827544|NCT03941834|584409332|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
161827545|NCT03941834|584409333|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
161827546|NCT03941834|584409334|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
161827547|NCT01560819|584409335|FG000|Overall Study|Physician Decision|1|||
161827548|NCT01560819|584409336|FG001|Overall Study|Physician Decision|0|||
161827549|NCT02012452|584409339|FG000|Overall Study|Lost to Follow-up|2|||
161827550|NCT02012452|584409340|FG001|Overall Study|Lost to Follow-up|1|||
161827551|NCT02012452|584409339|FG000|Overall Study|Withdrawal by Subject|4|||
161827552|NCT02012452|584409340|FG001|Overall Study|Withdrawal by Subject|0|||
161827553|NCT04403399|584409341|FG000|Period 2|Physician Decision|0|||
162218546|NCT00603525|585851802|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
162218547|NCT00603525|585851803|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
162218548|NCT00603525|585851801|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
162218549|NCT00603525|585851802|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
162218550|NCT00603525|585851803|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
162218551|NCT00603525|585851801|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
162218552|NCT00603525|585851802|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
162218553|NCT00603525|585851803|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
162218554|NCT00603525|585851801|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
162218555|NCT00603525|585851802|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
162218556|NCT00603525|585851803|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
162218557|NCT01483144|585851804|FG000|Overall Study|Adverse Event|9|||
162218558|NCT01483144|585851805|FG001|Overall Study|Adverse Event|4|||
162218559|NCT01483144|585851806|FG002|Overall Study|Adverse Event|6|||
162218560|NCT01483144|585851804|FG000|Overall Study|Withdrawal by Subject|0|||
161827554|NCT04403399|584409342|FG001|Period 2|Physician Decision|1|||
161827555|NCT00831233|584409345|FG000|Overall Study|Adverse Event|0|||
161827556|NCT00831233|584409346|FG001|Overall Study|Adverse Event|1|||
161827557|NCT00831233|584409345|FG000|Overall Study|Protocol Violation|1|||
161827558|NCT00831233|584409346|FG001|Overall Study|Protocol Violation|0|||
161827559|NCT00831233|584409345|FG000|Overall Study|Selection Criteria Not Met|2|||
161827560|NCT00831233|584409346|FG001|Overall Study|Selection Criteria Not Met|0|||
161827561|NCT00991510|584409347|FG000|Period I (Days 1-14)|Adverse Event|1|||
161827562|NCT00991510|584409348|FG001|Period I (Days 1-14)|Adverse Event|0|||
161827563|NCT00991510|584409347|FG000|Period III (Days 29-112)|Adverse Event|1|||
161827564|NCT00991510|584409348|FG001|Period III (Days 29-112)|Adverse Event|1|||
161827565|NCT03710590|584409349|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
161827566|NCT03710590|584409350|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
161827567|NCT02488824|584409351|FG000|Overall Study|Adverse Event|1|||
161827568|NCT02488824|584409352|FG001|Overall Study|Adverse Event|1|||
161827569|NCT01976728|584409353|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
161827570|NCT01976728|584409354|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
161827571|NCT01976728|584409355|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
162218561|NCT01483144|585851805|FG001|Overall Study|Withdrawal by Subject|2|||
162218562|NCT01483144|585851806|FG002|Overall Study|Withdrawal by Subject|5|||
161827572|NCT01976728|584409356|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
161827573|NCT02356211|584409357|FG000|Overall Study|Withdrawal by Subject|2|||
161827574|NCT02356211|584409358|FG001|Overall Study|Withdrawal by Subject|2|||
161827575|NCT02356211|584409357|FG000|Overall Study|ineligible|1|||
161827576|NCT02356211|584409358|FG001|Overall Study|ineligible|8|||
162218563|NCT01483144|585851804|FG000|Overall Study|Physician Decision|1|||
162218564|NCT01483144|585851805|FG001|Overall Study|Physician Decision|0|||
162218565|NCT01483144|585851806|FG002|Overall Study|Physician Decision|0|||
162218566|NCT01483144|585851804|FG000|Overall Study|Lost to Follow-up|2|||
162218567|NCT01483144|585851805|FG001|Overall Study|Lost to Follow-up|4|||
162218568|NCT01483144|585851806|FG002|Overall Study|Lost to Follow-up|1|||
162218569|NCT01483144|585851804|FG000|Overall Study|Protocol Violation|3|||
162218570|NCT01483144|585851805|FG001|Overall Study|Protocol Violation|3|||
162218571|NCT01483144|585851806|FG002|Overall Study|Protocol Violation|3|||
162218572|NCT02460575|585851807|FG000|Overall Study|Lost to Follow-up|1|||
162218573|NCT02460575|585851808|FG001|Overall Study|Lost to Follow-up|0|||
162218574|NCT04043143|585851809|FG000|Overall Study|Lost to Follow-up|5|||
162218575|NCT04043143|585851810|FG001|Overall Study|Lost to Follow-up|5|||
162218576|NCT04043143|585851809|FG000|Overall Study|screen failure|1|||
162218577|NCT04043143|585851810|FG001|Overall Study|screen failure|0|||
162218578|NCT04307940|585851811|FG000|Overall Study|Adverse Event|1|||
162218579|NCT04307940|585851812|FG001|Overall Study|Adverse Event|0|||
162218580|NCT04307940|585851813|FG002|Overall Study|Adverse Event|0|||
162218581|NCT04307940|585851811|FG000|Overall Study|Withdrawal by Subject|2|||
162218582|NCT04307940|585851812|FG001|Overall Study|Withdrawal by Subject|3|||
162218583|NCT04307940|585851813|FG002|Overall Study|Withdrawal by Subject|1|||
162218584|NCT04307940|585851811|FG000|Overall Study|Lost to Follow-up|2|||
162218585|NCT04307940|585851812|FG001|Overall Study|Lost to Follow-up|0|||
162218586|NCT04307940|585851813|FG002|Overall Study|Lost to Follow-up|1|||
162218587|NCT04624243|585851817|FG000|Overall Study|Death|0|||
162218588|NCT04624243|585851818|FG001|Overall Study|Death|1|||
162218589|NCT04624243|585851819|FG002|Overall Study|Death|0|||
162218590|NCT04624243|585851820|FG003|Overall Study|Death|0|||
162218591|NCT04624243|585851821|FG004|Overall Study|Death|0|||
162218592|NCT04624243|585851817|FG000|Overall Study|Lost to Follow-up|2|||
162218593|NCT04624243|585851818|FG001|Overall Study|Lost to Follow-up|3|||
162218594|NCT04624243|585851819|FG002|Overall Study|Lost to Follow-up|7|||
162218595|NCT04624243|585851820|FG003|Overall Study|Lost to Follow-up|1|||
162218596|NCT04624243|585851821|FG004|Overall Study|Lost to Follow-up|3|||
162218597|NCT04624243|585851817|FG000|Overall Study|Physician Decision|3|||
162218598|NCT04624243|585851818|FG001|Overall Study|Physician Decision|8|||
162218599|NCT04624243|585851819|FG002|Overall Study|Physician Decision|15|||
162218600|NCT04624243|585851820|FG003|Overall Study|Physician Decision|2|||
162218601|NCT04624243|585851821|FG004|Overall Study|Physician Decision|11|||
162218602|NCT04624243|585851817|FG000|Overall Study|Withdrawal by Subject|19|||
162218603|NCT04624243|585851818|FG001|Overall Study|Withdrawal by Subject|44|||
162218604|NCT04624243|585851819|FG002|Overall Study|Withdrawal by Subject|40|||
162218605|NCT04624243|585851820|FG003|Overall Study|Withdrawal by Subject|21|||
161678517|NCT02285920|583875997|FG003|Overall Study|Death|1|||
161827577|NCT01563237|584409360|FG000|Overall Study|Lost to Follow-up|6|||
161827578|NCT01563237|584409361|FG001|Overall Study|Lost to Follow-up|0|||
161827579|NCT01563237|584409360|FG000|Overall Study|Withdrawal by Subject|1|||
161827580|NCT01563237|584409361|FG001|Overall Study|Withdrawal by Subject|0|||
161827581|NCT01563237|584409360|FG000|Overall Study|Adverse Event|1|||
161827582|NCT01563237|584409361|FG001|Overall Study|Adverse Event|0|||
161827583|NCT01563237|584409360|FG000|Overall Study|Medical Reasons|1|||
161827584|NCT01563237|584409361|FG001|Overall Study|Medical Reasons|0|||
161827585|NCT01563237|584409360|FG000|Overall Study|Death|1|||
161827586|NCT01563237|584409361|FG001|Overall Study|Death|0|||
161827587|NCT02211014|584409362|FG000|Overall Study|Adverse Event|0|||
161827588|NCT02211014|584409363|FG001|Overall Study|Adverse Event|2|||
161827589|NCT02211014|584409362|FG000|Overall Study|Physician Decision|1|||
161827590|NCT02211014|584409363|FG001|Overall Study|Physician Decision|2|||
161827591|NCT02211014|584409362|FG000|Overall Study|Started another cancer therapy|1|||
161827592|NCT02211014|584409363|FG001|Overall Study|Started another cancer therapy|0|||
161827593|NCT02211014|584409362|FG000|Overall Study|Withdrawal by Subject|0|||
161827594|NCT02211014|584409363|FG001|Overall Study|Withdrawal by Subject|1|||
161827595|NCT02211014|584409362|FG000|Overall Study|In agreement with patient, no benefit|0|||
161827596|NCT02211014|584409363|FG001|Overall Study|In agreement with patient, no benefit|1|||
161827597|NCT01124695|584409364|FG000|Overall Study|Disease progression|77|||
161827598|NCT01124695|584409364|FG000|Overall Study|Adverse Event|11|||
162218606|NCT04624243|585851821|FG004|Overall Study|Withdrawal by Subject|39|||
162218607|NCT04624243|585851817|FG000|Overall Study|Miscellaneous|3|||
162218608|NCT04624243|585851818|FG001|Overall Study|Miscellaneous|12|||
162218609|NCT04624243|585851819|FG002|Overall Study|Miscellaneous|9|||
162218610|NCT04624243|585851820|FG003|Overall Study|Miscellaneous|4|||
162218611|NCT04624243|585851821|FG004|Overall Study|Miscellaneous|6|||
162218612|NCT04996004|585851822|FG000|Phase I|Death|1|||
162218613|NCT04996004|585851823|FG001|Phase I|Death|2|||
161827599|NCT01124695|584409364|FG000|Overall Study|Death|1|||
161827600|NCT01124695|584409364|FG000|Overall Study|Withdrawal by Subject|7|||
161827601|NCT01124695|584409364|FG000|Overall Study|Physician Decision|3|||
161827602|NCT01124695|584409364|FG000|Overall Study|Alternative therapy|9|||
161827603|NCT01124695|584409364|FG000|Overall Study|No documentation that patient went off treatment|4|||
161827604|NCT01124695|584409364|FG000|Overall Study|Ineligible|9|||
161937136|NCT00124306|584819167|FG000|Overall Study|Adverse Event|7|||
161937137|NCT00124306|584819168|FG001|Overall Study|Adverse Event|2|||
161937138|NCT00124306|584819167|FG000|Overall Study|Lost to Follow-up|10|||
161937139|NCT00124306|584819168|FG001|Overall Study|Lost to Follow-up|6|||
161937140|NCT00124306|584819167|FG000|Overall Study|Lack of Efficacy|3|||
161937141|NCT00124306|584819168|FG001|Overall Study|Lack of Efficacy|6|||
161937142|NCT00124306|584819167|FG000|Overall Study|Personal constraints|0|||
161937143|NCT00124306|584819168|FG001|Overall Study|Personal constraints|2|||
161827605|NCT01124695|584409364|FG000|Overall Study|Ineligible and never start treatment|2|||
161827606|NCT00097786|584409368|FG000|Overall Study|lost to follow-up for all-cause death|296|||
161827607|NCT00097786|584409369|FG001|Overall Study|lost to follow-up for all-cause death|292|||
161827608|NCT00097786|584409370|FG002|Overall Study|lost to follow-up for all-cause death|313|||
161827609|NCT00097786|584409371|FG003|Overall Study|lost to follow-up for all-cause death|310|||
161827610|NCT02668822|584409372|FG000|Overall Study|Protocol Violation|2|||
161827611|NCT02668822|584409373|FG001|Overall Study|Protocol Violation|0|||
161827612|NCT02668822|584409372|FG000|Overall Study|Study Terminated by Sponsor|7|||
161827613|NCT02668822|584409373|FG001|Overall Study|Study Terminated by Sponsor|9|||
161827614|NCT01647711|584409376|FG000|Overall Study|Progressive disease|6|||
161827615|NCT01647711|584409377|FG001|Overall Study|Progressive disease|2|||
161827616|NCT01647711|584409378|FG002|Overall Study|Progressive disease|6|||
161827617|NCT01647711|584409379|FG003|Overall Study|Progressive disease|8|||
161827618|NCT01647711|584409380|FG004|Overall Study|Progressive disease|2|||
161937144|NCT00124306|584819167|FG000|Overall Study|Use of unacceptable medication|1|||
161937145|NCT00124306|584819168|FG001|Overall Study|Use of unacceptable medication|0|||
161827619|NCT01647711|584409376|FG000|Overall Study|Other adverse event|0|||
162021404|NCT00689117|585134777|FG001|Overall Study|Lost to Follow-up|19|||
161937146|NCT00124306|584819167|FG000|Overall Study|Abnormal lab result|0|||
161937147|NCT00124306|584819168|FG001|Overall Study|Abnormal lab result|1|||
161827620|NCT01647711|584409377|FG001|Overall Study|Other adverse event|0|||
161827621|NCT01647711|584409378|FG002|Overall Study|Other adverse event|2|||
161678518|NCT00677820|583875998|FG000|Overall Study|Lost to Follow-up|1|||
161827622|NCT01647711|584409379|FG003|Overall Study|Other adverse event|0|||
161827623|NCT01647711|584409380|FG004|Overall Study|Other adverse event|2|||
161827624|NCT01647711|584409376|FG000|Overall Study|Protocol Violation|0|||
161827625|NCT01647711|584409377|FG001|Overall Study|Protocol Violation|0|||
161827626|NCT01647711|584409378|FG002|Overall Study|Protocol Violation|0|||
161827627|NCT01647711|584409379|FG003|Overall Study|Protocol Violation|0|||
161827628|NCT01647711|584409380|FG004|Overall Study|Protocol Violation|1|||
161827629|NCT01647711|584409376|FG000|Overall Study|Refused to continue taking medication|0|||
161827630|NCT01647711|584409377|FG001|Overall Study|Refused to continue taking medication|0|||
161827631|NCT01647711|584409378|FG002|Overall Study|Refused to continue taking medication|0|||
161827632|NCT01647711|584409379|FG003|Overall Study|Refused to continue taking medication|2|||
161827633|NCT01647711|584409380|FG004|Overall Study|Refused to continue taking medication|1|||
161827634|NCT01647711|584409376|FG000|Overall Study|Other reason not defined|0|||
161827635|NCT01647711|584409377|FG001|Overall Study|Other reason not defined|1|||
161827636|NCT01647711|584409378|FG002|Overall Study|Other reason not defined|1|||
161827637|NCT01647711|584409379|FG003|Overall Study|Other reason not defined|1|||
161827638|NCT01647711|584409380|FG004|Overall Study|Other reason not defined|0|||
161827639|NCT03036839|584409381|FG000|Overall Study|Adverse Event|0|||
161827640|NCT03036839|584409382|FG001|Overall Study|Adverse Event|0|||
161827641|NCT03036839|584409383|FG002|Overall Study|Adverse Event|1|||
162021405|NCT00689117|585134778|FG002|Overall Study|Lost to Follow-up|17|||
162021406|NCT00689117|585134779|FG003|Overall Study|Lost to Follow-up|11|||
162021407|NCT00689117|585134776|FG000|Overall Study|Lack of Efficacy|1|||
162021408|NCT00689117|585134777|FG001|Overall Study|Lack of Efficacy|2|||
162021409|NCT00689117|585134778|FG002|Overall Study|Lack of Efficacy|2|||
162021410|NCT00689117|585134779|FG003|Overall Study|Lack of Efficacy|2|||
162021411|NCT00689117|585134776|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
162021412|NCT00689117|585134777|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
162021413|NCT00689117|585134778|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
162021414|NCT00689117|585134779|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
162021415|NCT00689117|585134776|FG000|Overall Study|Withdrawal by Subject|19|||
162021416|NCT00689117|585134777|FG001|Overall Study|Withdrawal by Subject|18|||
162021417|NCT00689117|585134778|FG002|Overall Study|Withdrawal by Subject|26|||
162021418|NCT00689117|585134779|FG003|Overall Study|Withdrawal by Subject|13|||
162021419|NCT00689117|585134776|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
162021420|NCT00689117|585134777|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
162021421|NCT00689117|585134778|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
162021422|NCT00689117|585134779|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
162021423|NCT00689117|585134776|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
162021424|NCT00689117|585134777|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
162021425|NCT00689117|585134778|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161827642|NCT03036839|584409381|FG000|Overall Study|Death|3|||
161827643|NCT03036839|584409382|FG001|Overall Study|Death|0|||
162218614|NCT04996004|585851824|FG002|Phase I|Death|1|||
162218615|NCT04996004|585851825|FG003|Phase I|Death|0|||
162218616|NCT04996004|585851826|FG004|Phase I|Death|0|||
162218617|NCT04996004|585851827|FG005|Phase I|Death|0|||
161937148|NCT00124306|584819167|FG000|Overall Study|Other|2|||
162218618|NCT04996004|585851822|FG000|Phase I|Study terminated by sponsor|2|||
162218619|NCT04996004|585851823|FG001|Phase I|Study terminated by sponsor|1|||
162218620|NCT04996004|585851824|FG002|Phase I|Study terminated by sponsor|2|||
161937149|NCT00124306|584819168|FG001|Overall Study|Other|0|||
162218621|NCT04996004|585851825|FG003|Phase I|Study terminated by sponsor|0|||
162218622|NCT04996004|585851826|FG004|Phase I|Study terminated by sponsor|0|||
161678519|NCT00677820|583875999|FG001|Overall Study|Lost to Follow-up|0|||
161937164|NCT03369704|584819179|FG000|Treatment Epoch|technical problems|1|||
161937165|NCT03369704|584819180|FG001|Treatment Epoch|technical problems|0|||
161937166|NCT03369704|584819179|FG000|Treatment Epoch|Protocol Violation|1|||
161937167|NCT03369704|584819180|FG001|Treatment Epoch|Protocol Violation|0|||
161937168|NCT03369704|584819179|FG000|Treatment Epoch|Lost to Follow-up|0|||
161937169|NCT03369704|584819180|FG001|Treatment Epoch|Lost to Follow-up|1|||
161937170|NCT03369704|584819179|FG000|Treatment Epoch|Lack of Efficacy|0|||
161937171|NCT03369704|584819180|FG001|Treatment Epoch|Lack of Efficacy|2|||
161937172|NCT03369704|584819179|FG000|Treatment Epoch|Adverse Event|2|||
161937173|NCT03369704|584819180|FG001|Treatment Epoch|Adverse Event|0|||
161937174|NCT03369704|584819179|FG000|Follow-up Epoch|Lost to Follow-up|1|||
161937175|NCT03369704|584819180|FG001|Follow-up Epoch|Lost to Follow-up|0|||
162218623|NCT04996004|585851827|FG005|Phase I|Study terminated by sponsor|0|||
162218624|NCT04996004|585851822|FG000|Phase II|Study terminated by sponsor|0|||
162021426|NCT00689117|585134779|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162021427|NCT00689117|585134776|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
162021428|NCT00689117|585134777|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
162021429|NCT00689117|585134778|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
162021430|NCT00689117|585134779|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
162021431|NCT00689117|585134776|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
162021432|NCT00689117|585134777|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
161827644|NCT03036839|584409383|FG002|Overall Study|Death|3|||
161827645|NCT03036839|584409381|FG000|Overall Study|Withdrew Consent|0|||
162021433|NCT00689117|585134778|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
162021434|NCT00689117|585134779|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
162021435|NCT00689117|585134776|FG000|Overall Study|Use of Prohibitive Medication|2|||
162021436|NCT00689117|585134777|FG001|Overall Study|Use of Prohibitive Medication|1|||
162021437|NCT00689117|585134778|FG002|Overall Study|Use of Prohibitive Medication|3|||
162021438|NCT00689117|585134779|FG003|Overall Study|Use of Prohibitive Medication|0|||
162021439|NCT00689117|585134776|FG000|Overall Study|Pregnancy|0|||
162021440|NCT00689117|585134777|FG001|Overall Study|Pregnancy|2|||
162021441|NCT00689117|585134778|FG002|Overall Study|Pregnancy|0|||
162021442|NCT00689117|585134779|FG003|Overall Study|Pregnancy|2|||
162021443|NCT00689117|585134776|FG000|Overall Study|Incarceration|2|||
162021444|NCT00689117|585134777|FG001|Overall Study|Incarceration|0|||
162021445|NCT00689117|585134778|FG002|Overall Study|Incarceration|0|||
162021446|NCT00689117|585134779|FG003|Overall Study|Incarceration|0|||
162021447|NCT00689117|585134776|FG000|Overall Study|Fear of Birth Defects|0|||
162021448|NCT00689117|585134777|FG001|Overall Study|Fear of Birth Defects|0|||
162021449|NCT00689117|585134778|FG002|Overall Study|Fear of Birth Defects|1|||
162021450|NCT00689117|585134779|FG003|Overall Study|Fear of Birth Defects|0|||
162021451|NCT00689117|585134776|FG000|Overall Study|Transportation|1|||
162021452|NCT00689117|585134777|FG001|Overall Study|Transportation|0|||
162021453|NCT00689117|585134778|FG002|Overall Study|Transportation|0|||
162021454|NCT00689117|585134779|FG003|Overall Study|Transportation|0|||
162021455|NCT00689117|585134776|FG000|Overall Study|Patient Withdrew from Study|0|||
162021456|NCT00689117|585134777|FG001|Overall Study|Patient Withdrew from Study|0|||
162021457|NCT00689117|585134778|FG002|Overall Study|Patient Withdrew from Study|0|||
162021458|NCT00689117|585134779|FG003|Overall Study|Patient Withdrew from Study|1|||
162021459|NCT00689117|585134776|FG000|Overall Study|Personal Reason|0|||
162021460|NCT00689117|585134777|FG001|Overall Study|Personal Reason|1|||
162021461|NCT00689117|585134778|FG002|Overall Study|Personal Reason|0|||
162021462|NCT00689117|585134779|FG003|Overall Study|Personal Reason|0|||
162021463|NCT00689117|585134776|FG000|Overall Study|Dispensing Error|0|||
162021464|NCT00689117|585134777|FG001|Overall Study|Dispensing Error|1|||
162021465|NCT00689117|585134778|FG002|Overall Study|Dispensing Error|0|||
162021466|NCT00689117|585134779|FG003|Overall Study|Dispensing Error|0|||
162021467|NCT02597478|585134781|FG000|Overall Study|Withdrawal by Subject|2|||
162021468|NCT02597478|585134782|FG001|Overall Study|Withdrawal by Subject|0|||
162021469|NCT02597478|585134781|FG000|Overall Study|Change of opioid dose|1|||
162021470|NCT02597478|585134782|FG001|Overall Study|Change of opioid dose|0|||
162021471|NCT02597478|585134781|FG000|Overall Study|Insufficient exertional dyspnea|0|||
162021472|NCT02597478|585134782|FG001|Overall Study|Insufficient exertional dyspnea|1|||
162021473|NCT01536067|585134783|FG000|Overall Study|Disease Progression|1|||
162021474|NCT00606905|585134787|FG000|Overall Study|No Pregnancy|9|||
161827646|NCT03036839|584409382|FG001|Overall Study|Withdrew Consent|0|||
161827647|NCT03036839|584409383|FG002|Overall Study|Withdrew Consent|1|||
162218625|NCT04996004|585851823|FG001|Phase II|Study terminated by sponsor|0|||
162218626|NCT04996004|585851824|FG002|Phase II|Study terminated by sponsor|0|||
162218627|NCT04996004|585851825|FG003|Phase II|Study terminated by sponsor|20|||
162218628|NCT04996004|585851826|FG004|Phase II|Study terminated by sponsor|10|||
162218629|NCT04996004|585851827|FG005|Phase II|Study terminated by sponsor|10|||
162218630|NCT04996004|585851822|FG000|Phase II|Withdrawal by Subject|0|||
162218631|NCT04996004|585851823|FG001|Phase II|Withdrawal by Subject|0|||
162218632|NCT04996004|585851824|FG002|Phase II|Withdrawal by Subject|0|||
162218633|NCT04996004|585851825|FG003|Phase II|Withdrawal by Subject|0|||
162218634|NCT04996004|585851826|FG004|Phase II|Withdrawal by Subject|1|||
161827648|NCT01316419|584409384|FG000|Overall Study|Not treated|103|||
161827649|NCT01316419|584409384|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
161827650|NCT01316419|584409384|FG000|Overall Study|Lost to Follow-up|19|||
161827651|NCT00412737|584409386|FG000|Overall Study|Death|1|||
161827652|NCT00412737|584409387|FG001|Overall Study|Death|0|||
161827653|NCT00412737|584409386|FG000|Overall Study|Adverse Event|3|||
161827654|NCT00412737|584409387|FG001|Overall Study|Adverse Event|2|||
161827655|NCT00412737|584409386|FG000|Overall Study|Refused Treatment|6|||
161827656|NCT00412737|584409387|FG001|Overall Study|Refused Treatment|2|||
161827657|NCT00412737|584409386|FG000|Overall Study|Failure to Return|6|||
161827658|NCT00412737|584409387|FG001|Overall Study|Failure to Return|2|||
161827659|NCT03180801|584409389|FG000|Overall Study|Physician Decision|3|||
161827660|NCT03180801|584409390|FG001|Overall Study|Physician Decision|3|||
161827661|NCT03180801|584409391|FG002|Overall Study|Physician Decision|1|||
161827662|NCT03180801|584409389|FG000|Overall Study|Non-compliance|1|||
161827663|NCT03180801|584409390|FG001|Overall Study|Non-compliance|4|||
161827664|NCT03180801|584409391|FG002|Overall Study|Non-compliance|0|||
161827665|NCT03180801|584409389|FG000|Overall Study|Inoculation Target Reached|1|||
161827666|NCT03180801|584409390|FG001|Overall Study|Inoculation Target Reached|1|||
161827667|NCT03180801|584409391|FG002|Overall Study|Inoculation Target Reached|3|||
161827668|NCT03180801|584409389|FG000|Overall Study|Adverse Event|1|||
161827669|NCT03180801|584409390|FG001|Overall Study|Adverse Event|0|||
161827670|NCT03180801|584409391|FG002|Overall Study|Adverse Event|2|||
161827671|NCT03180801|584409389|FG000|Overall Study|Withdrawal by Subject|2|||
161827672|NCT03180801|584409390|FG001|Overall Study|Withdrawal by Subject|2|||
161827673|NCT03180801|584409391|FG002|Overall Study|Withdrawal by Subject|1|||
161827674|NCT03180801|584409389|FG000|Overall Study|Lost to Follow-up|0|||
161827675|NCT03180801|584409390|FG001|Overall Study|Lost to Follow-up|2|||
161827676|NCT03180801|584409391|FG002|Overall Study|Lost to Follow-up|3|||
161827677|NCT01049412|584409392|FG000|Period I|Withdrawal by Subject|4|||
161827678|NCT01049412|584409393|FG001|Period I|Withdrawal by Subject|6|||
161827679|NCT01049412|584409392|FG000|Period I|Lost to Follow-up|2|||
161827680|NCT01049412|584409393|FG001|Period I|Lost to Follow-up|2|||
161827681|NCT01049412|584409392|FG000|Period I|Physician Decision|0|||
161827682|NCT01049412|584409393|FG001|Period I|Physician Decision|3|||
161827683|NCT01049412|584409392|FG000|Period I|Protocol Violation|1|||
161827684|NCT01049412|584409393|FG001|Period I|Protocol Violation|2|||
161827685|NCT01049412|584409392|FG000|Period I|Adverse Event|1|||
161827686|NCT01049412|584409393|FG001|Period I|Adverse Event|0|||
161827687|NCT01049412|584409392|FG000|Period II|Withdrawal by Subject|2|||
161827688|NCT01049412|584409393|FG001|Period II|Withdrawal by Subject|3|||
161827689|NCT01049412|584409392|FG000|Period II|Adverse Event|1|||
161827690|NCT01049412|584409393|FG001|Period II|Adverse Event|0|||
161827691|NCT01049412|584409392|FG000|Period II|Lost to Follow-up|1|||
161827692|NCT01049412|584409393|FG001|Period II|Lost to Follow-up|0|||
161827693|NCT00868296|584409396|FG000|Overall Study|Adverse Event|0|||
161827694|NCT00868296|584409397|FG001|Overall Study|Adverse Event|2|||
161827695|NCT00868296|584409396|FG000|Overall Study|Withdrawal by Subject|0|||
161827696|NCT00868296|584409397|FG001|Overall Study|Withdrawal by Subject|1|||
161827697|NCT00573170|584409398|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
161827698|NCT00573170|584409399|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
161827699|NCT00573170|584409400|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
161827700|NCT00573170|584409401|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
161827701|NCT00573170|584409402|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
161827702|NCT00573170|584409403|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
161827703|NCT00573170|584409398|FG000|First Washout Period|Adverse Event|1|||
161827704|NCT00573170|584409399|FG001|First Washout Period|Adverse Event|1|||
161827705|NCT00573170|584409400|FG002|First Washout Period|Adverse Event|0|||
161827706|NCT00573170|584409401|FG003|First Washout Period|Adverse Event|0|||
161827707|NCT00573170|584409402|FG004|First Washout Period|Adverse Event|0|||
161827708|NCT00573170|584409403|FG005|First Washout Period|Adverse Event|1|||
161827709|NCT00573170|584409398|FG000|First Washout Period|Lack of Efficacy|0|||
161827710|NCT00573170|584409399|FG001|First Washout Period|Lack of Efficacy|0|||
161827711|NCT00573170|584409400|FG002|First Washout Period|Lack of Efficacy|0|||
161827712|NCT00573170|584409401|FG003|First Washout Period|Lack of Efficacy|0|||
161827713|NCT00573170|584409402|FG004|First Washout Period|Lack of Efficacy|0|||
161827714|NCT00573170|584409403|FG005|First Washout Period|Lack of Efficacy|1|||
161827715|NCT00573170|584409398|FG000|First Washout Period|Lost to Follow-up|1|||
161827716|NCT00573170|584409399|FG001|First Washout Period|Lost to Follow-up|1|||
161827717|NCT00573170|584409400|FG002|First Washout Period|Lost to Follow-up|0|||
161827718|NCT00573170|584409401|FG003|First Washout Period|Lost to Follow-up|2|||
161827719|NCT00573170|584409402|FG004|First Washout Period|Lost to Follow-up|0|||
161827720|NCT00573170|584409403|FG005|First Washout Period|Lost to Follow-up|2|||
161827721|NCT00573170|584409398|FG000|First Washout Period|Withdrawal by Subject|2|||
161827722|NCT00573170|584409399|FG001|First Washout Period|Withdrawal by Subject|0|||
161827723|NCT00573170|584409400|FG002|First Washout Period|Withdrawal by Subject|0|||
161827724|NCT00573170|584409401|FG003|First Washout Period|Withdrawal by Subject|2|||
161827725|NCT00573170|584409402|FG004|First Washout Period|Withdrawal by Subject|3|||
161827726|NCT00573170|584409403|FG005|First Washout Period|Withdrawal by Subject|3|||
161827727|NCT00573170|584409398|FG000|First Washout Period|Other|4|||
161827728|NCT00573170|584409399|FG001|First Washout Period|Other|0|||
161827729|NCT00573170|584409400|FG002|First Washout Period|Other|1|||
161827730|NCT00573170|584409401|FG003|First Washout Period|Other|1|||
161827731|NCT00573170|584409402|FG004|First Washout Period|Other|0|||
161827732|NCT00573170|584409403|FG005|First Washout Period|Other|0|||
161827733|NCT00573170|584409398|FG000|Second Washout Period|Adverse Event|1|||
161827734|NCT00573170|584409399|FG001|Second Washout Period|Adverse Event|0|||
161827735|NCT00573170|584409400|FG002|Second Washout Period|Adverse Event|0|||
161827736|NCT00573170|584409401|FG003|Second Washout Period|Adverse Event|0|||
161827737|NCT00573170|584409402|FG004|Second Washout Period|Adverse Event|1|||
161827738|NCT00573170|584409403|FG005|Second Washout Period|Adverse Event|0|||
161827739|NCT00573170|584409398|FG000|Second Washout Period|Protocol Violation|2|||
161827740|NCT00573170|584409399|FG001|Second Washout Period|Protocol Violation|1|||
161827741|NCT00573170|584409400|FG002|Second Washout Period|Protocol Violation|1|||
161827742|NCT00573170|584409401|FG003|Second Washout Period|Protocol Violation|0|||
161827743|NCT00573170|584409402|FG004|Second Washout Period|Protocol Violation|0|||
161827744|NCT00573170|584409403|FG005|Second Washout Period|Protocol Violation|0|||
161827745|NCT00573170|584409398|FG000|Second Washout Period|Withdrawal by Subject|1|||
161827746|NCT00573170|584409399|FG001|Second Washout Period|Withdrawal by Subject|1|||
161827747|NCT00573170|584409400|FG002|Second Washout Period|Withdrawal by Subject|2|||
161827748|NCT00573170|584409401|FG003|Second Washout Period|Withdrawal by Subject|0|||
161827749|NCT00573170|584409402|FG004|Second Washout Period|Withdrawal by Subject|1|||
161827750|NCT00573170|584409403|FG005|Second Washout Period|Withdrawal by Subject|0|||
161827751|NCT00573170|584409398|FG000|Second Washout Period|Lost to Follow-up|0|||
161827752|NCT00573170|584409399|FG001|Second Washout Period|Lost to Follow-up|0|||
161827753|NCT00573170|584409400|FG002|Second Washout Period|Lost to Follow-up|0|||
161827754|NCT00573170|584409401|FG003|Second Washout Period|Lost to Follow-up|1|||
161827755|NCT00573170|584409402|FG004|Second Washout Period|Lost to Follow-up|0|||
161827756|NCT00573170|584409403|FG005|Second Washout Period|Lost to Follow-up|0|||
161827757|NCT00573170|584409398|FG000|Second Washout Period|Other|1|||
161827758|NCT00573170|584409399|FG001|Second Washout Period|Other|2|||
161827759|NCT00573170|584409400|FG002|Second Washout Period|Other|1|||
161827760|NCT00573170|584409401|FG003|Second Washout Period|Other|4|||
161827761|NCT00573170|584409402|FG004|Second Washout Period|Other|6|||
161827762|NCT00573170|584409403|FG005|Second Washout Period|Other|2|||
161827763|NCT00573170|584409398|FG000|Third Treatment Period|Withdrawal by Subject|1|||
161827764|NCT00573170|584409399|FG001|Third Treatment Period|Withdrawal by Subject|0|||
161827765|NCT00573170|584409400|FG002|Third Treatment Period|Withdrawal by Subject|0|||
161827766|NCT00573170|584409401|FG003|Third Treatment Period|Withdrawal by Subject|0|||
161827767|NCT00573170|584409402|FG004|Third Treatment Period|Withdrawal by Subject|0|||
161827768|NCT00573170|584409403|FG005|Third Treatment Period|Withdrawal by Subject|0|||
161827769|NCT00573170|584409398|FG000|Third Treatment Period|Lost to Follow-up|0|||
161827770|NCT00573170|584409399|FG001|Third Treatment Period|Lost to Follow-up|0|||
161827771|NCT00573170|584409400|FG002|Third Treatment Period|Lost to Follow-up|0|||
161827772|NCT00573170|584409401|FG003|Third Treatment Period|Lost to Follow-up|0|||
161827773|NCT00573170|584409402|FG004|Third Treatment Period|Lost to Follow-up|0|||
161827774|NCT00573170|584409403|FG005|Third Treatment Period|Lost to Follow-up|2|||
161827775|NCT05966090|584409404|FG000|Overall Study|Lost to Follow-up|6|||
161827776|NCT05966090|584409405|FG001|Overall Study|Lost to Follow-up|6|||
161827777|NCT05966090|584409404|FG000|Overall Study|Adverse Event|1|||
161827778|NCT05966090|584409405|FG001|Overall Study|Adverse Event|1|||
161827779|NCT05966090|584409404|FG000|Overall Study|Withdrawal by Subject|1|||
161827780|NCT05966090|584409405|FG001|Overall Study|Withdrawal by Subject|1|||
161827781|NCT05966090|584409404|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161827782|NCT05966090|584409405|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161827783|NCT05966090|584409404|FG000|Overall Study|Other|1|||
161827784|NCT05966090|584409405|FG001|Overall Study|Other|1|||
161827785|NCT00804141|584409406|FG000|Overall Study|Adverse Event|157|||
161827786|NCT00804141|584409406|FG000|Overall Study|Death|4|||
161827787|NCT00804141|584409406|FG000|Overall Study|Failed to return|96|||
161827788|NCT00804141|584409406|FG000|Overall Study|Investigator request|8|||
161827789|NCT00804141|584409406|FG000|Overall Study|Protocol Violation|85|||
161827790|NCT00804141|584409406|FG000|Overall Study|Withdrawal by Subject|131|||
161827791|NCT00804141|584409406|FG000|Overall Study|Lack of Efficacy|46|||
161827792|NCT00804141|584409406|FG000|Overall Study|Other than specified|30|||
161827793|NCT00804141|584409406|FG000|Overall Study|Enrolled but not treated|6|||
161827794|NCT01142908|584409407|FG000|Overall Study|Lost to Follow-up|19|||
161827795|NCT01142908|584409408|FG001|Overall Study|Lost to Follow-up|13|||
161827796|NCT01142908|584409407|FG000|Overall Study|Death|1|||
161827797|NCT01142908|584409408|FG001|Overall Study|Death|4|||
161827798|NCT01142908|584409407|FG000|Overall Study|Excluded - did not meet criteria|9|||
161827799|NCT01142908|584409408|FG001|Overall Study|Excluded - did not meet criteria|5|||
161827800|NCT01142908|584409407|FG000|Overall Study|Withdrawal by Subject|3|||
161827801|NCT01142908|584409408|FG001|Overall Study|Withdrawal by Subject|0|||
161827802|NCT03235479|584409410|FG000|Overall Study|Lost to Follow-up|8|||
161827803|NCT03235479|584409411|FG001|Overall Study|Lost to Follow-up|11|||
161827804|NCT03235479|584409410|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
161827805|NCT03235479|584409411|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
161827806|NCT03235479|584409410|FG000|Overall Study|Pregnancy|1|||
161827807|NCT03235479|584409411|FG001|Overall Study|Pregnancy|0|||
161827808|NCT03235479|584409410|FG000|Overall Study|Protocol Deviation|1|||
161827809|NCT03235479|584409411|FG001|Overall Study|Protocol Deviation|3|||
161827810|NCT03235479|584409410|FG000|Overall Study|Technical Problems|3|||
161827811|NCT03235479|584409411|FG001|Overall Study|Technical Problems|2|||
161827812|NCT03235479|584409410|FG000|Overall Study|Withdrawal by Subject|2|||
161827813|NCT03235479|584409411|FG001|Overall Study|Withdrawal by Subject|2|||
161827814|NCT03235479|584409410|FG000|Overall Study|Other Reasons|3|||
161827815|NCT03235479|584409411|FG001|Overall Study|Other Reasons|5|||
161827816|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
161827817|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
161827818|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
161827819|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
161827820|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
161827821|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
161827822|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161827823|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161827824|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
161827825|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
161827826|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
161827827|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161827828|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
161827829|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
161827830|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
161827831|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
161827832|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Death|2|||
161827833|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Death|1|||
162021475|NCT00606905|585134788|FG001|Overall Study|No Pregnancy|6|||
162021476|NCT00606905|585134787|FG000|Overall Study|Non-Index Pregnancy|1|||
162021477|NCT00606905|585134788|FG001|Overall Study|Non-Index Pregnancy|4|||
162021478|NCT00606905|585134787|FG000|Overall Study|Withdrew|5|||
161827834|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Death|0|||
161827835|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Death|0|||
162021479|NCT00606905|585134788|FG001|Overall Study|Withdrew|5|||
162021480|NCT02386189|585134789|FG000|Overall Study|Lost to Follow-up|2|||
162021481|NCT02386189|585134790|FG001|Overall Study|Lost to Follow-up|3|||
162021482|NCT02386189|585134789|FG000|Overall Study|Withdrawal by Subject|1|||
162021483|NCT02386189|585134790|FG001|Overall Study|Withdrawal by Subject|0|||
162021484|NCT02386189|585134789|FG000|Overall Study|Death|1|||
162021485|NCT02386189|585134790|FG001|Overall Study|Death|0|||
162021486|NCT04657666|585134791|FG000|Period 1|Withdrawal of participant consent|2|||
162021487|NCT04657666|585134792|FG001|Period 1|Withdrawal of participant consent|1|||
162021488|NCT04657666|585134791|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
162021489|NCT04657666|585134792|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
162021490|NCT04657666|585134791|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
162021491|NCT04657666|585134792|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
162021492|NCT04657666|585134791|FG000|Period 2|Other|2|||
162021493|NCT04657666|585134792|FG001|Period 2|Other|0|||
162021494|NCT04657666|585134791|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
162021495|NCT04657666|585134792|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
162021496|NCT03120351|585134793|FG000|Overall Study|Physician Decision|1|||
162021497|NCT03120351|585134794|FG001|Overall Study|Physician Decision|1|||
162021498|NCT04931888|585134796|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
162021499|NCT04931888|585134797|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
162021500|NCT04931888|585134798|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
162021501|NCT04931888|585134799|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
162021502|NCT01022398|585134800|FG000|Overall Study|Study terminated|2|||
162021503|NCT01022398|585134801|FG001|Overall Study|Study terminated|2|||
162021504|NCT02969408|585134803|FG000|Overall Study|Adverse Event|2|||
162021505|NCT02969408|585134803|FG000|Overall Study|Withdrawal by Subject|8|||
162021506|NCT02969408|585134803|FG000|Overall Study|Lost to Follow-up|4|||
162021507|NCT02969408|585134803|FG000|Overall Study|Protocol Violation|1|||
162021508|NCT02969408|585134803|FG000|Overall Study|Other than specified|1|||
162021509|NCT04540198|585134804|FG000|Overall Study|Lost to Follow-up|25|||
162021510|NCT04540198|585134805|FG001|Overall Study|Lost to Follow-up|23|||
161827836|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
161827837|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
161827838|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
161827839|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
161827840|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
161827841|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
161827842|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
161827843|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
161827844|NCT03110380|584409421|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
161827845|NCT03110380|584409422|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
161827846|NCT03110380|584409423|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
161827847|NCT03110380|584409424|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
161827848|NCT03110380|584409421|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
161827849|NCT03110380|584409422|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
161827850|NCT03110380|584409423|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
161827851|NCT03110380|584409424|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
161827852|NCT03110380|584409421|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
161827853|NCT03110380|584409422|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
161827854|NCT03110380|584409423|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
161827855|NCT03110380|584409424|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
161827856|NCT03110380|584409421|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
161827857|NCT03110380|584409422|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
162021511|NCT04540198|585134804|FG000|Overall Study|Withdrawal by Subject|15|||
162021512|NCT04540198|585134805|FG001|Overall Study|Withdrawal by Subject|9|||
162021513|NCT04540198|585134804|FG000|Overall Study|Discontinued|1|||
162021514|NCT04540198|585134805|FG001|Overall Study|Discontinued|0|||
162021515|NCT02350478|585134806|FG000|Overall Study|Lost to Follow-up|5|||
162021516|NCT02350478|585134807|FG001|Overall Study|Lost to Follow-up|1|||
162021517|NCT03330002|585134815|FG000|Overall Study|Lost to Follow-up|15|||
162021518|NCT03330002|585134815|FG000|Overall Study|Death|7|||
162021519|NCT00486291|585134818|FG000|Overall Study|Adverse Event|3|||
162021520|NCT00486291|585134819|FG001|Overall Study|Adverse Event|4|||
162021521|NCT00486291|585134818|FG000|Overall Study|Lost to Follow-up|3|||
162021522|NCT00486291|585134819|FG001|Overall Study|Lost to Follow-up|7|||
162021523|NCT00486291|585134818|FG000|Overall Study|protocol non-compliance|10|||
162021524|NCT00486291|585134819|FG001|Overall Study|protocol non-compliance|15|||
162021525|NCT00486291|585134818|FG000|Overall Study|requirement for restricted medication|0|||
162021526|NCT00486291|585134819|FG001|Overall Study|requirement for restricted medication|3|||
161827858|NCT03110380|584409423|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
161827859|NCT03110380|584409424|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
161827860|NCT01206439|584409427|FG000|Overall Study|subject did not meet inclusion criteria|1|||
161827861|NCT05889039|584409429|FG000|Overall Study|error in completing survey|0|||
161827862|NCT05889039|584409430|FG001|Overall Study|error in completing survey|2|||
161827863|NCT05889039|584409431|FG002|Overall Study|error in completing survey|0|||
161827864|NCT05889039|584409432|FG003|Overall Study|error in completing survey|0|||
161827865|NCT05889039|584409429|FG000|Overall Study|Lost to Follow-up|4|||
161827866|NCT05889039|584409430|FG001|Overall Study|Lost to Follow-up|0|||
161827867|NCT05889039|584409431|FG002|Overall Study|Lost to Follow-up|0|||
162021527|NCT02745145|585134820|FG000|Overall Study|Adverse Event|1|||
162021528|NCT02745145|585134821|FG001|Overall Study|Adverse Event|0|||
162021529|NCT02745145|585134822|FG002|Overall Study|Adverse Event|0|||
162021530|NCT02745145|585134820|FG000|Overall Study|Death|0|||
162021531|NCT02745145|585134821|FG001|Overall Study|Death|1|||
162021532|NCT02745145|585134822|FG002|Overall Study|Death|0|||
162021533|NCT02745145|585134820|FG000|Overall Study|Progressive disease|0|||
162021534|NCT02745145|585134821|FG001|Overall Study|Progressive disease|0|||
162021535|NCT02745145|585134822|FG002|Overall Study|Progressive disease|1|||
162021536|NCT02745145|585134820|FG000|Overall Study|Withdrew consent|1|||
162021537|NCT02745145|585134821|FG001|Overall Study|Withdrew consent|1|||
162021538|NCT02745145|585134822|FG002|Overall Study|Withdrew consent|1|||
161678520|NCT00066742|583876000|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
162021539|NCT02745145|585134820|FG000|Overall Study|Study Termination|8|||
162021540|NCT02745145|585134821|FG001|Overall Study|Study Termination|3|||
162021541|NCT02745145|585134822|FG002|Overall Study|Study Termination|7|||
162021542|NCT04413617|585134828|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
162021543|NCT04413617|585134829|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
162021544|NCT04413617|585134830|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
162021545|NCT04413617|585134831|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
162021546|NCT04413617|585134832|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
162021547|NCT04413617|585134828|FG000|Overall Study|Protocol Violation|0|||
162021548|NCT04413617|585134829|FG001|Overall Study|Protocol Violation|1|||
162021549|NCT04413617|585134830|FG002|Overall Study|Protocol Violation|0|||
162021550|NCT04413617|585134831|FG003|Overall Study|Protocol Violation|0|||
162021551|NCT04413617|585134832|FG004|Overall Study|Protocol Violation|1|||
162021552|NCT04413617|585134828|FG000|Overall Study|Lack of Efficacy|2|||
162021553|NCT04413617|585134829|FG001|Overall Study|Lack of Efficacy|0|||
162021554|NCT04413617|585134830|FG002|Overall Study|Lack of Efficacy|2|||
162021555|NCT04413617|585134831|FG003|Overall Study|Lack of Efficacy|1|||
162021556|NCT04413617|585134832|FG004|Overall Study|Lack of Efficacy|0|||
162021557|NCT04413617|585134828|FG000|Overall Study|Withdrawal by Subject|3|||
162021558|NCT04413617|585134829|FG001|Overall Study|Withdrawal by Subject|4|||
162021559|NCT04413617|585134830|FG002|Overall Study|Withdrawal by Subject|2|||
162021560|NCT04413617|585134831|FG003|Overall Study|Withdrawal by Subject|5|||
162021561|NCT04413617|585134832|FG004|Overall Study|Withdrawal by Subject|3|||
162021562|NCT04413617|585134828|FG000|Overall Study|Death|1|||
162021563|NCT04413617|585134829|FG001|Overall Study|Death|0|||
161827868|NCT05889039|584409432|FG003|Overall Study|Lost to Follow-up|0|||
161827869|NCT01808248|584409435|FG000|Overall Study|Lack of Efficacy|3|||
161827870|NCT01808248|584409435|FG000|Overall Study|Withdrawal by Subject|1|||
161827871|NCT01808248|584409435|FG000|Overall Study|Lost to Follow-up|1|||
161827872|NCT04974580|584409438|FG000|Overall Study|Lost to Follow-up|33|||
161827873|NCT04974580|584409439|FG001|Overall Study|Lost to Follow-up|39|||
161827874|NCT04974580|584409440|FG002|Overall Study|Lost to Follow-up|30|||
161827875|NCT04974580|584409441|FG003|Overall Study|Lost to Follow-up|29|||
161827876|NCT02941523|584409445|FG000|Monotherapy|Withdrawal by Subject|0|||
161827877|NCT02941523|584409446|FG001|Monotherapy|Withdrawal by Subject|1|||
161827878|NCT02941523|584409445|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
161827879|NCT02941523|584409446|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
162021564|NCT04413617|585134830|FG002|Overall Study|Death|0|||
162021565|NCT04413617|585134831|FG003|Overall Study|Death|0|||
162021566|NCT04413617|585134832|FG004|Overall Study|Death|0|||
161827880|NCT02941523|584409445|FG000|Carboplatin Combination Therapy|Death|1|||
161827881|NCT02941523|584409446|FG001|Carboplatin Combination Therapy|Death|2|||
161827882|NCT02941523|584409445|FG000|Carboplatin Combination Therapy|Disease progression|2|||
161827883|NCT02941523|584409446|FG001|Carboplatin Combination Therapy|Disease progression|0|||
162021567|NCT04413617|585134828|FG000|Overall Study|Adverse Event|1|||
161937262|NCT03596645|584820015|FG000|Overall Study|Adverse Event|17|||
161937263|NCT03596645|584820016|FG001|Overall Study|Adverse Event|0|||
161937264|NCT03596645|584820015|FG000|Overall Study|Lack of Efficacy|8|||
161937265|NCT03596645|584820016|FG001|Overall Study|Lack of Efficacy|0|||
161937266|NCT03596645|584820015|FG000|Overall Study|Lost to Follow-up|1|||
161937267|NCT03596645|584820016|FG001|Overall Study|Lost to Follow-up|1|||
161937268|NCT03596645|584820015|FG000|Overall Study|Physician Decision|1|||
161937269|NCT03596645|584820016|FG001|Overall Study|Physician Decision|1|||
161937270|NCT03596645|584820015|FG000|Overall Study|Protocol Violation|1|||
161937271|NCT03596645|584820016|FG001|Overall Study|Protocol Violation|0|||
161937272|NCT03596645|584820015|FG000|Overall Study|Initiated Prohibited Medication|1|||
161937273|NCT03596645|584820016|FG001|Overall Study|Initiated Prohibited Medication|0|||
161937274|NCT03596645|584820015|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161937275|NCT03596645|584820016|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161937276|NCT03596645|584820015|FG000|Overall Study|No mucosal healing achieved|1|||
161937277|NCT03596645|584820016|FG001|Overall Study|No mucosal healing achieved|0|||
161937278|NCT03596645|584820015|FG000|Overall Study|Disease progression|1|||
161937279|NCT03596645|584820016|FG001|Overall Study|Disease progression|0|||
161937280|NCT03596645|584820015|FG000|Overall Study|Ongoing|37|||
161937281|NCT03596645|584820016|FG001|Overall Study|Ongoing|12|||
161937282|NCT03596645|584820015|FG000|Overall Study|Randomized but not treated|0|||
161937283|NCT03596645|584820016|FG001|Overall Study|Randomized but not treated|1|||
161937304|NCT04153149|584820021|FG000|Double Blind Period|Death|63|||
161937305|NCT04153149|584820022|FG001|Double Blind Period|Death|49|||
161937306|NCT04153149|584820023|FG002|Double Blind Period|Death|0|||
161937307|NCT04153149|584820024|FG003|Double Blind Period|Death|0|||
161937308|NCT04153149|584820021|FG000|Double Blind Period|Withdrawal by Subject|16|||
161937309|NCT04153149|584820022|FG001|Double Blind Period|Withdrawal by Subject|11|||
161937310|NCT04153149|584820023|FG002|Double Blind Period|Withdrawal by Subject|0|||
161937311|NCT04153149|584820024|FG003|Double Blind Period|Withdrawal by Subject|0|||
161937312|NCT04153149|584820021|FG000|Double Blind Period|Adverse Event|6|||
161937313|NCT04153149|584820022|FG001|Double Blind Period|Adverse Event|2|||
161937314|NCT04153149|584820023|FG002|Double Blind Period|Adverse Event|0|||
161937315|NCT04153149|584820024|FG003|Double Blind Period|Adverse Event|0|||
162021568|NCT04413617|585134829|FG001|Overall Study|Adverse Event|0|||
162021569|NCT04413617|585134830|FG002|Overall Study|Adverse Event|0|||
162021570|NCT04413617|585134831|FG003|Overall Study|Adverse Event|1|||
162021571|NCT04413617|585134832|FG004|Overall Study|Adverse Event|1|||
162021572|NCT04413617|585134828|FG000|Overall Study|COVID-19|0|||
162021573|NCT04413617|585134829|FG001|Overall Study|COVID-19|1|||
162021574|NCT04413617|585134830|FG002|Overall Study|COVID-19|0|||
162021575|NCT04413617|585134831|FG003|Overall Study|COVID-19|0|||
162021576|NCT04413617|585134832|FG004|Overall Study|COVID-19|0|||
162021577|NCT00775593|585134833|FG000|Overall Study|Unmet eligibility criteria|6|||
162021578|NCT00775593|585134833|FG000|Overall Study|Death|1|||
162021579|NCT00984620|585134836|FG000|Overall Study|Adverse Event|5|||
161827884|NCT02941523|584409445|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
161827885|NCT02941523|584409446|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
161827886|NCT04330157|584409447|FG000|Overall Study|Protocol Violation|4|||
161827887|NCT04330157|584409447|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
161827888|NCT03558139|584409448|FG000|Overall Study|Consent Withdrawn|1|||
161827889|NCT03558139|584409449|FG001|Overall Study|Consent Withdrawn|1|||
161827890|NCT03558139|584409450|FG002|Overall Study|Consent Withdrawn|4|||
161827891|NCT03558139|584409448|FG000|Overall Study|Death|5|||
161827892|NCT03558139|584409449|FG001|Overall Study|Death|3|||
161827893|NCT03558139|584409450|FG002|Overall Study|Death|8|||
161827894|NCT03558139|584409448|FG000|Overall Study|Lost to Follow-up|0|||
161827895|NCT03558139|584409449|FG001|Overall Study|Lost to Follow-up|0|||
161827896|NCT03558139|584409450|FG002|Overall Study|Lost to Follow-up|3|||
161827897|NCT03558139|584409448|FG000|Overall Study|Study Ended Per Protocol|0|||
161827898|NCT03558139|584409449|FG001|Overall Study|Study Ended Per Protocol|3|||
161827899|NCT03558139|584409450|FG002|Overall Study|Study Ended Per Protocol|6|||
161827900|NCT02752802|584409451|FG000|Overall Study|Contrast Volume Not Collected|1|||
161827901|NCT02752802|584409452|FG001|Overall Study|Contrast Volume Not Collected|0|||
161827902|NCT03689894|584409453|FG000|Overall Study|Adverse Event|1|||
161827903|NCT01378962|584409459|FG000|Overall Study|Death|14|||
161827904|NCT01378962|584409459|FG000|Overall Study|Lost to Follow-up|1|||
161827905|NCT01378962|584409459|FG000|Overall Study|Other|2|||
161827906|NCT00983918|584411426|FG000|Overall Study|conversion to open cholecystectomy|0|||
161827907|NCT00983918|584411427|FG001|Overall Study|conversion to open cholecystectomy|2|||
161827908|NCT00983918|584411428|FG002|Overall Study|conversion to open cholecystectomy|2|||
161827909|NCT00983918|584411429|FG003|Overall Study|conversion to open cholecystectomy|2|||
161937316|NCT04153149|584820021|FG000|Double Blind Period|Lost to Follow-up|2|||
161937317|NCT04153149|584820022|FG001|Double Blind Period|Lost to Follow-up|1|||
161937318|NCT04153149|584820023|FG002|Double Blind Period|Lost to Follow-up|0|||
161937319|NCT04153149|584820024|FG003|Double Blind Period|Lost to Follow-up|0|||
162021580|NCT00984620|585134837|FG001|Overall Study|Adverse Event|5|||
162021581|NCT00984620|585134836|FG000|Overall Study|Lost to Follow-up|1|||
162021582|NCT00984620|585134837|FG001|Overall Study|Lost to Follow-up|1|||
162021583|NCT00984620|585134836|FG000|Overall Study|Withdrawal by Subject|0|||
162021584|NCT00984620|585134837|FG001|Overall Study|Withdrawal by Subject|2|||
162021585|NCT00984620|585134836|FG000|Overall Study|reason other than listed above|0|||
162021586|NCT00984620|585134837|FG001|Overall Study|reason other than listed above|4|||
162021587|NCT01703754|585134838|FG000|Overall Study|Clinically significant disease progression|2|||
162021588|NCT01703754|585134839|FG001|Overall Study|Clinically significant disease progression|2|||
162021589|NCT01703754|585134840|FG002|Overall Study|Clinically significant disease progression|1|||
162021590|NCT01703754|585134838|FG000|Overall Study|Adverse Event|1|||
162021591|NCT01703754|585134839|FG001|Overall Study|Adverse Event|1|||
161827910|NCT01796964|584411435|FG000|Overall Study|Adverse Event|1|||
161827911|NCT01796964|584411436|FG001|Overall Study|Adverse Event|1|||
161827912|NCT01796964|584411435|FG000|Overall Study|Death|1|||
161827913|NCT01796964|584411436|FG001|Overall Study|Death|0|||
161827914|NCT01796964|584411435|FG000|Overall Study|Protocol Violation|0|||
161827915|NCT01796964|584411436|FG001|Overall Study|Protocol Violation|1|||
161827916|NCT01796964|584411435|FG000|Overall Study|Withdrawal by Subject|1|||
161827917|NCT01796964|584411436|FG001|Overall Study|Withdrawal by Subject|1|||
161827918|NCT01345318|584411457|FG000|Overall Study|Adverse Event|16|||
161827919|NCT01345318|584411457|FG000|Overall Study|Lack of Efficacy|17|||
161937320|NCT04153149|584820021|FG000|Double Blind Period|Withdrawal by guardian|0|||
161937321|NCT04153149|584820022|FG001|Double Blind Period|Withdrawal by guardian|2|||
161937322|NCT04153149|584820023|FG002|Double Blind Period|Withdrawal by guardian|0|||
161937323|NCT04153149|584820024|FG003|Double Blind Period|Withdrawal by guardian|0|||
162021592|NCT01703754|585134840|FG002|Overall Study|Adverse Event|0|||
162021593|NCT01703754|585134838|FG000|Overall Study|Withdrawal by Subject|2|||
162021594|NCT01703754|585134839|FG001|Overall Study|Withdrawal by Subject|0|||
161827920|NCT01345318|584411457|FG000|Overall Study|Lost to Follow-up|2|||
161827921|NCT01345318|584411457|FG000|Overall Study|Protocol Violation|1|||
161827922|NCT01345318|584411457|FG000|Overall Study|Withdrawal by Subject|41|||
161827923|NCT01345318|584411457|FG000|Overall Study|Other|3|||
161827924|NCT01685073|584411458|FG000|Overall Study|Lost to Follow-up|6|||
161827925|NCT01685073|584411459|FG001|Overall Study|Lost to Follow-up|8|||
161827926|NCT01685073|584411458|FG000|Overall Study|Withdrawal by Subject|24|||
161827927|NCT01685073|584411459|FG001|Overall Study|Withdrawal by Subject|24|||
161827928|NCT01239472|584411462|FG000|Overall Study|Withdrawal by Subject|5|||
161827929|NCT01239472|584411463|FG001|Overall Study|Withdrawal by Subject|1|||
161827930|NCT01239472|584411462|FG000|Overall Study|Adverse Event|0|||
161827931|NCT01239472|584411463|FG001|Overall Study|Adverse Event|1|||
161827932|NCT01239472|584411462|FG000|Overall Study|Lack of Efficacy|0|||
161827933|NCT01239472|584411463|FG001|Overall Study|Lack of Efficacy|1|||
161827934|NCT02695719|584411467|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
162021595|NCT01703754|585134840|FG002|Overall Study|Withdrawal by Subject|0|||
162021596|NCT00947882|585134841|FG000|Overall Study|Adverse Event|0|||
162021597|NCT00947882|585134842|FG001|Overall Study|Adverse Event|1|||
161827935|NCT02695719|584411468|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
161827936|NCT02695719|584411467|FG000|Overall Study|Significant Protocol Deviation|0|||
161827937|NCT02695719|584411468|FG001|Overall Study|Significant Protocol Deviation|1|||
161827938|NCT02695719|584411467|FG000|Overall Study|Voluntary Withdrawal|1|||
162021598|NCT00947882|585134843|FG002|Overall Study|Adverse Event|4|||
162021599|NCT00947882|585134844|FG003|Overall Study|Adverse Event|4|||
162021600|NCT00947882|585134841|FG000|Overall Study|Withdrawal by Subject|2|||
162021601|NCT00947882|585134842|FG001|Overall Study|Withdrawal by Subject|0|||
162021602|NCT00947882|585134843|FG002|Overall Study|Withdrawal by Subject|8|||
162021603|NCT00947882|585134844|FG003|Overall Study|Withdrawal by Subject|2|||
162021604|NCT00947882|585134841|FG000|Overall Study|Protocol Violation|0|||
162021605|NCT00947882|585134842|FG001|Overall Study|Protocol Violation|0|||
162021606|NCT00947882|585134843|FG002|Overall Study|Protocol Violation|1|||
162021607|NCT00947882|585134844|FG003|Overall Study|Protocol Violation|0|||
162021608|NCT00947882|585134841|FG000|Overall Study|Lost to Follow-up|0|||
162021609|NCT00947882|585134842|FG001|Overall Study|Lost to Follow-up|2|||
162021610|NCT00947882|585134843|FG002|Overall Study|Lost to Follow-up|1|||
162021611|NCT00947882|585134844|FG003|Overall Study|Lost to Follow-up|0|||
162021612|NCT00947882|585134841|FG000|Overall Study|Other/Unknown|10|||
162021613|NCT00947882|585134842|FG001|Overall Study|Other/Unknown|13|||
162021614|NCT00947882|585134843|FG002|Overall Study|Other/Unknown|3|||
162021615|NCT00947882|585134844|FG003|Overall Study|Other/Unknown|6|||
162021616|NCT00947882|585134841|FG000|Overall Study|Trial Terminated by Sponsor|62|||
162021617|NCT00947882|585134842|FG001|Overall Study|Trial Terminated by Sponsor|61|||
162021618|NCT00947882|585134843|FG002|Overall Study|Trial Terminated by Sponsor|62|||
162021619|NCT00947882|585134844|FG003|Overall Study|Trial Terminated by Sponsor|70|||
162021620|NCT02379637|585134845|FG000|Overall Study|Protocol Violation|0|||
162021621|NCT02379637|585134846|FG001|Overall Study|Protocol Violation|1|||
162021622|NCT02379637|585134845|FG000|Overall Study|Adverse Event|1|||
162021623|NCT02379637|585134846|FG001|Overall Study|Adverse Event|0|||
162021624|NCT02379637|585134845|FG000|Overall Study|Withdrawal by Subject|1|||
162021625|NCT02379637|585134846|FG001|Overall Study|Withdrawal by Subject|0|||
162021626|NCT02447302|585134847|FG000|Overall Study|Physician Decision|1|||
162021627|NCT02447302|585134848|FG001|Overall Study|Physician Decision|0|||
162021628|NCT02447302|585134849|FG002|Overall Study|Physician Decision|0|||
162021629|NCT02447302|585134847|FG000|Overall Study|Adverse Event|4|||
162021630|NCT02447302|585134848|FG001|Overall Study|Adverse Event|3|||
162021631|NCT02447302|585134849|FG002|Overall Study|Adverse Event|0|||
162021632|NCT02447302|585134847|FG000|Overall Study|Withdrawal by Subject|0|||
162021633|NCT02447302|585134848|FG001|Overall Study|Withdrawal by Subject|1|||
162021634|NCT02447302|585134849|FG002|Overall Study|Withdrawal by Subject|5|||
162021635|NCT02447302|585134847|FG000|Overall Study|Sponsor Decision|0|||
162021636|NCT02447302|585134848|FG001|Overall Study|Sponsor Decision|0|||
162021637|NCT02447302|585134849|FG002|Overall Study|Sponsor Decision|1|||
162021638|NCT01561313|585134857|FG000|Overall Study|Withdrawal by Subject|1|||
162021639|NCT01561313|585134858|FG001|Overall Study|Withdrawal by Subject|0|||
162021640|NCT01561313|585134857|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
162021641|NCT01561313|585134858|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
162021642|NCT01742286|585134861|FG000|Escalation Phase|Administrative problems|1|||
162021643|NCT01742286|585134862|FG001|Escalation Phase|Administrative problems|1|||
161827939|NCT02695719|584411468|FG001|Overall Study|Voluntary Withdrawal|0|||
161827940|NCT01714739|584411471|FG000|Overall Study|Disease progression|3|||
161827941|NCT01714739|584411472|FG001|Overall Study|Disease progression|5|||
161827942|NCT01714739|584411473|FG002|Overall Study|Disease progression|5|||
161827943|NCT01714739|584411474|FG003|Overall Study|Disease progression|204|||
161827944|NCT01714739|584411475|FG004|Overall Study|Disease progression|1|||
162021644|NCT01742286|585134863|FG002|Escalation Phase|Administrative problems|0|||
162021645|NCT01742286|585134864|FG003|Escalation Phase|Administrative problems|0|||
162021646|NCT01742286|585134865|FG004|Escalation Phase|Administrative problems|0|||
162021647|NCT01742286|585134866|FG005|Escalation Phase|Administrative problems|0|||
162021648|NCT01742286|585134867|FG006|Escalation Phase|Administrative problems|2|||
161827945|NCT01714739|584411476|FG005|Overall Study|Disease progression|3|||
161827946|NCT01714739|584411477|FG006|Overall Study|Disease progression|5|||
161827947|NCT01714739|584411471|FG000|Overall Study|Study drug toxicity|1|||
161827948|NCT01714739|584411472|FG001|Overall Study|Study drug toxicity|1|||
161827949|NCT01714739|584411473|FG002|Overall Study|Study drug toxicity|1|||
161827950|NCT01714739|584411474|FG003|Overall Study|Study drug toxicity|15|||
162218635|NCT04996004|585851827|FG005|Phase II|Withdrawal by Subject|2|||
162218636|NCT04996004|585851822|FG000|Phase II|Death|0|||
162218637|NCT04996004|585851823|FG001|Phase II|Death|0|||
162218638|NCT04996004|585851824|FG002|Phase II|Death|0|||
162218639|NCT04996004|585851825|FG003|Phase II|Death|12|||
162218640|NCT04996004|585851826|FG004|Phase II|Death|2|||
162218641|NCT04996004|585851827|FG005|Phase II|Death|9|||
162218642|NCT04996004|585851822|FG000|Phase II|Other|0|||
162218643|NCT04996004|585851823|FG001|Phase II|Other|0|||
161937324|NCT04153149|584820021|FG000|Double Blind Period|Reason Not Specified|5|||
162218644|NCT04996004|585851824|FG002|Phase II|Other|0|||
161937325|NCT04153149|584820022|FG001|Double Blind Period|Reason Not Specified|4|||
161937326|NCT04153149|584820023|FG002|Double Blind Period|Reason Not Specified|0|||
161937327|NCT04153149|584820024|FG003|Double Blind Period|Reason Not Specified|0|||
161937328|NCT04153149|584820021|FG000|Double Blind Period|Physician Decision|2|||
161937329|NCT04153149|584820022|FG001|Double Blind Period|Physician Decision|0|||
161937330|NCT04153149|584820023|FG002|Double Blind Period|Physician Decision|0|||
161937331|NCT04153149|584820024|FG003|Double Blind Period|Physician Decision|0|||
161937332|NCT04153149|584820021|FG000|Open Label Extension Period|Death|0|||
161937333|NCT04153149|584820022|FG001|Open Label Extension Period|Death|0|||
161937334|NCT04153149|584820023|FG002|Open Label Extension Period|Death|7|||
161937335|NCT04153149|584820024|FG003|Open Label Extension Period|Death|3|||
161937336|NCT04153149|584820021|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
161937337|NCT04153149|584820022|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
161937338|NCT04153149|584820023|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
161937339|NCT04153149|584820024|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
161937340|NCT04153149|584820021|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
161937341|NCT04153149|584820022|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
161937342|NCT04153149|584820023|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
161937343|NCT04153149|584820024|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
161937344|NCT04153149|584820021|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
161937345|NCT04153149|584820022|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
161937346|NCT04153149|584820023|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
161937347|NCT04153149|584820024|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
162218645|NCT04996004|585851825|FG003|Phase II|Other|0|||
162218646|NCT04996004|585851826|FG004|Phase II|Other|0|||
162218647|NCT04996004|585851827|FG005|Phase II|Other|1|||
161827951|NCT01714739|584411475|FG004|Overall Study|Study drug toxicity|0|||
162021649|NCT01742286|585134861|FG000|Escalation Phase|Adverse Event|0|||
162021650|NCT01742286|585134862|FG001|Escalation Phase|Adverse Event|1|||
162021651|NCT01742286|585134863|FG002|Escalation Phase|Adverse Event|2|||
162021652|NCT01742286|585134864|FG003|Escalation Phase|Adverse Event|0|||
161827952|NCT01714739|584411476|FG005|Overall Study|Study drug toxicity|0|||
161827953|NCT01714739|584411477|FG006|Overall Study|Study drug toxicity|5|||
161827954|NCT01714739|584411471|FG000|Overall Study|Death|0|||
161827955|NCT01714739|584411472|FG001|Overall Study|Death|0|||
161827956|NCT01714739|584411473|FG002|Overall Study|Death|0|||
161827957|NCT01714739|584411474|FG003|Overall Study|Death|1|||
161827958|NCT01714739|584411475|FG004|Overall Study|Death|0|||
161827959|NCT01714739|584411476|FG005|Overall Study|Death|0|||
161827960|NCT01714739|584411477|FG006|Overall Study|Death|0|||
161827961|NCT01714739|584411471|FG000|Overall Study|Adverse Event unrelated to drug|0|||
161827962|NCT01714739|584411472|FG001|Overall Study|Adverse Event unrelated to drug|0|||
161827963|NCT01714739|584411473|FG002|Overall Study|Adverse Event unrelated to drug|3|||
161827964|NCT01714739|584411474|FG003|Overall Study|Adverse Event unrelated to drug|21|||
161827965|NCT01714739|584411475|FG004|Overall Study|Adverse Event unrelated to drug|0|||
161827966|NCT01714739|584411476|FG005|Overall Study|Adverse Event unrelated to drug|0|||
161827967|NCT01714739|584411477|FG006|Overall Study|Adverse Event unrelated to drug|0|||
161827968|NCT01714739|584411471|FG000|Overall Study|Participant request to stop therapy|0|||
161827969|NCT01714739|584411472|FG001|Overall Study|Participant request to stop therapy|1|||
161827970|NCT01714739|584411473|FG002|Overall Study|Participant request to stop therapy|0|||
162021653|NCT01742286|585134865|FG004|Escalation Phase|Adverse Event|0|||
162021654|NCT01742286|585134866|FG005|Escalation Phase|Adverse Event|1|||
161827971|NCT01714739|584411474|FG003|Overall Study|Participant request to stop therapy|6|||
161827972|NCT01714739|584411475|FG004|Overall Study|Participant request to stop therapy|0|||
161827973|NCT01714739|584411476|FG005|Overall Study|Participant request to stop therapy|0|||
161827974|NCT01714739|584411477|FG006|Overall Study|Participant request to stop therapy|0|||
161827975|NCT01714739|584411471|FG000|Overall Study|Participant withdrew consent|0|||
161827976|NCT01714739|584411472|FG001|Overall Study|Participant withdrew consent|1|||
161827977|NCT01714739|584411473|FG002|Overall Study|Participant withdrew consent|0|||
161827978|NCT01714739|584411474|FG003|Overall Study|Participant withdrew consent|8|||
161827979|NCT01714739|584411475|FG004|Overall Study|Participant withdrew consent|0|||
161827980|NCT01714739|584411476|FG005|Overall Study|Participant withdrew consent|0|||
161827981|NCT01714739|584411477|FG006|Overall Study|Participant withdrew consent|0|||
161827982|NCT01714739|584411471|FG000|Overall Study|Lost to Follow-up|0|||
161827983|NCT01714739|584411472|FG001|Overall Study|Lost to Follow-up|0|||
161827984|NCT01714739|584411473|FG002|Overall Study|Lost to Follow-up|0|||
161827985|NCT01714739|584411474|FG003|Overall Study|Lost to Follow-up|1|||
161827986|NCT01714739|584411475|FG004|Overall Study|Lost to Follow-up|0|||
161827987|NCT01714739|584411476|FG005|Overall Study|Lost to Follow-up|0|||
161827988|NCT01714739|584411477|FG006|Overall Study|Lost to Follow-up|0|||
161827989|NCT01714739|584411471|FG000|Overall Study|Maximum clinical benefit|0|||
162021655|NCT01742286|585134867|FG006|Escalation Phase|Adverse Event|0|||
162021656|NCT01742286|585134861|FG000|Escalation Phase|Disease progression|3|||
162021657|NCT01742286|585134862|FG001|Escalation Phase|Disease progression|7|||
162021658|NCT01742286|585134863|FG002|Escalation Phase|Disease progression|4|||
162021659|NCT01742286|585134864|FG003|Escalation Phase|Disease progression|1|||
162021660|NCT01742286|585134865|FG004|Escalation Phase|Disease progression|4|||
162021661|NCT01742286|585134866|FG005|Escalation Phase|Disease progression|3|||
161827990|NCT01714739|584411472|FG001|Overall Study|Maximum clinical benefit|1|||
161827991|NCT01714739|584411473|FG002|Overall Study|Maximum clinical benefit|1|||
161827992|NCT01714739|584411474|FG003|Overall Study|Maximum clinical benefit|3|||
161827993|NCT01714739|584411475|FG004|Overall Study|Maximum clinical benefit|0|||
161827994|NCT01714739|584411476|FG005|Overall Study|Maximum clinical benefit|0|||
161827995|NCT01714739|584411477|FG006|Overall Study|Maximum clinical benefit|0|||
161827996|NCT01714739|584411471|FG000|Overall Study|Poor/non-comliance|0|||
161827997|NCT01714739|584411472|FG001|Overall Study|Poor/non-comliance|1|||
161827998|NCT01714739|584411473|FG002|Overall Study|Poor/non-comliance|0|||
161827999|NCT01714739|584411474|FG003|Overall Study|Poor/non-comliance|1|||
161828000|NCT01714739|584411475|FG004|Overall Study|Poor/non-comliance|0|||
161828001|NCT01714739|584411476|FG005|Overall Study|Poor/non-comliance|0|||
162021662|NCT01742286|585134867|FG006|Escalation Phase|Disease progression|2|||
162021663|NCT01742286|585134861|FG000|Escalation Phase|Death|0|||
162021664|NCT01742286|585134862|FG001|Escalation Phase|Death|0|||
162021665|NCT01742286|585134863|FG002|Escalation Phase|Death|0|||
161678521|NCT00066742|583876000|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
162021666|NCT01742286|585134864|FG003|Escalation Phase|Death|0|||
162021667|NCT01742286|585134865|FG004|Escalation Phase|Death|0|||
161828002|NCT01714739|584411477|FG006|Overall Study|Poor/non-comliance|0|||
161828003|NCT01714739|584411471|FG000|Overall Study|No longer meets study criteria|0|||
161828004|NCT01714739|584411472|FG001|Overall Study|No longer meets study criteria|0|||
161828005|NCT01714739|584411473|FG002|Overall Study|No longer meets study criteria|0|||
161828006|NCT01714739|584411474|FG003|Overall Study|No longer meets study criteria|1|||
162021668|NCT01742286|585134866|FG005|Escalation Phase|Death|1|||
162021669|NCT01742286|585134867|FG006|Escalation Phase|Death|0|||
162021670|NCT01742286|585134861|FG000|Escalation Phase|Physician Decision|0|||
162021671|NCT01742286|585134862|FG001|Escalation Phase|Physician Decision|3|||
162021672|NCT01742286|585134863|FG002|Escalation Phase|Physician Decision|0|||
162021673|NCT01742286|585134864|FG003|Escalation Phase|Physician Decision|1|||
162021674|NCT01742286|585134865|FG004|Escalation Phase|Physician Decision|0|||
162021675|NCT01742286|585134866|FG005|Escalation Phase|Physician Decision|0|||
162021676|NCT01742286|585134867|FG006|Escalation Phase|Physician Decision|2|||
162021677|NCT01742286|585134861|FG000|Escalation Phase|Subject/guardian decision|1|||
162021678|NCT01742286|585134862|FG001|Escalation Phase|Subject/guardian decision|0|||
162021679|NCT01742286|585134863|FG002|Escalation Phase|Subject/guardian decision|0|||
162021680|NCT01742286|585134864|FG003|Escalation Phase|Subject/guardian decision|0|||
162021681|NCT01742286|585134865|FG004|Escalation Phase|Subject/guardian decision|0|||
162021682|NCT01742286|585134866|FG005|Escalation Phase|Subject/guardian decision|0|||
162021683|NCT01742286|585134867|FG006|Escalation Phase|Subject/guardian decision|0|||
162021684|NCT01742286|585134861|FG000|Expansion Phase|Administrative problems|0|||
162021685|NCT01742286|585134862|FG001|Expansion Phase|Administrative problems|0|||
162021686|NCT01742286|585134863|FG002|Expansion Phase|Administrative problems|0|||
162021687|NCT01742286|585134864|FG003|Expansion Phase|Administrative problems|0|||
162218648|NCT05543174|585851828|FG000|Overall Study|Ongoing|7|||
162218649|NCT03374488|585851829|FG000|Overall Study|Death|13|||
162218650|NCT03374488|585851830|FG001|Overall Study|Death|13|||
162218651|NCT03374488|585851829|FG000|Overall Study|Withdrawal by Subject|3|||
162218652|NCT03374488|585851830|FG001|Overall Study|Withdrawal by Subject|1|||
162218653|NCT03374488|585851829|FG000|Overall Study|Physician Decision|3|||
162218654|NCT03374488|585851830|FG001|Overall Study|Physician Decision|0|||
162236616|NCT02581631|585917015|FG004|Overall Study|Request to discontinue|1|||
162021688|NCT01742286|585134865|FG004|Expansion Phase|Administrative problems|0|||
162021689|NCT01742286|585134866|FG005|Expansion Phase|Administrative problems|0|||
162021690|NCT01742286|585134867|FG006|Expansion Phase|Administrative problems|5|||
162021691|NCT01742286|585134861|FG000|Expansion Phase|Physician Decision|0|||
162021692|NCT01742286|585134862|FG001|Expansion Phase|Physician Decision|0|||
162021693|NCT01742286|585134863|FG002|Expansion Phase|Physician Decision|4|||
162021694|NCT01742286|585134864|FG003|Expansion Phase|Physician Decision|0|||
162021695|NCT01742286|585134865|FG004|Expansion Phase|Physician Decision|0|||
162021696|NCT01742286|585134866|FG005|Expansion Phase|Physician Decision|0|||
162021697|NCT01742286|585134867|FG006|Expansion Phase|Physician Decision|9|||
162021698|NCT01742286|585134861|FG000|Expansion Phase|Adverse Event|0|||
162021699|NCT01742286|585134862|FG001|Expansion Phase|Adverse Event|0|||
162021700|NCT01742286|585134863|FG002|Expansion Phase|Adverse Event|0|||
162021701|NCT01742286|585134864|FG003|Expansion Phase|Adverse Event|0|||
162021702|NCT01742286|585134865|FG004|Expansion Phase|Adverse Event|0|||
162021703|NCT01742286|585134866|FG005|Expansion Phase|Adverse Event|0|||
161828007|NCT01714739|584411475|FG004|Overall Study|No longer meets study criteria|0|||
162021704|NCT01742286|585134867|FG006|Expansion Phase|Adverse Event|6|||
162021705|NCT01742286|585134861|FG000|Expansion Phase|Disease progression|0|||
161828008|NCT01714739|584411476|FG005|Overall Study|No longer meets study criteria|0|||
161828009|NCT01714739|584411477|FG006|Overall Study|No longer meets study criteria|0|||
161828010|NCT01714739|584411471|FG000|Overall Study|Other reason|0|||
161828011|NCT01714739|584411472|FG001|Overall Study|Other reason|0|||
161828012|NCT01714739|584411473|FG002|Overall Study|Other reason|0|||
161828013|NCT01714739|584411474|FG003|Overall Study|Other reason|3|||
161828014|NCT01714739|584411475|FG004|Overall Study|Other reason|1|||
161828015|NCT01714739|584411476|FG005|Overall Study|Other reason|0|||
161828016|NCT01714739|584411477|FG006|Overall Study|Other reason|0|||
161828017|NCT02250651|584411478|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
161828018|NCT02250651|584411479|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
161828019|NCT02250651|584411480|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
161828020|NCT02250651|584411478|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
161828021|NCT02250651|584411479|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
161828022|NCT02250651|584411480|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
161828023|NCT02250651|584411478|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
161828024|NCT02250651|584411479|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
161828025|NCT02250651|584411480|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
161828026|NCT02250651|584411478|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
161828027|NCT02250651|584411479|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
161828028|NCT02250651|584411480|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
161828029|NCT02250651|584411478|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
161828030|NCT02250651|584411479|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
162021706|NCT01742286|585134862|FG001|Expansion Phase|Disease progression|0|||
162021707|NCT01742286|585134863|FG002|Expansion Phase|Disease progression|3|||
162021708|NCT01742286|585134864|FG003|Expansion Phase|Disease progression|0|||
162021709|NCT01742286|585134865|FG004|Expansion Phase|Disease progression|0|||
162021710|NCT01742286|585134866|FG005|Expansion Phase|Disease progression|0|||
161937418|NCT04573881|584820333|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
161942235|NCT00663260|584838356|FG000|Overall Study|Withdrawal by Subject|3|||
161942236|NCT00663260|584838357|FG001|Overall Study|Withdrawal by Subject|1|||
161942237|NCT00663260|584838358|FG002|Overall Study|Withdrawal by Subject|6|||
161942238|NCT00663260|584838356|FG000|Overall Study|Death|1|||
161942239|NCT00663260|584838357|FG001|Overall Study|Death|0|||
161942240|NCT00663260|584838358|FG002|Overall Study|Death|1|||
161942241|NCT00663260|584838356|FG000|Overall Study|Lost to Follow-up|0|||
161942242|NCT00663260|584838357|FG001|Overall Study|Lost to Follow-up|1|||
162021711|NCT01742286|585134867|FG006|Expansion Phase|Disease progression|15|||
162021712|NCT01742286|585134861|FG000|Expansion Phase|Withdrawal by Subject|0|||
162021713|NCT01742286|585134862|FG001|Expansion Phase|Withdrawal by Subject|0|||
162021714|NCT01742286|585134863|FG002|Expansion Phase|Withdrawal by Subject|0|||
162021715|NCT01742286|585134864|FG003|Expansion Phase|Withdrawal by Subject|0|||
162021716|NCT01742286|585134865|FG004|Expansion Phase|Withdrawal by Subject|0|||
162021717|NCT01742286|585134866|FG005|Expansion Phase|Withdrawal by Subject|0|||
162021718|NCT01742286|585134867|FG006|Expansion Phase|Withdrawal by Subject|1|||
162021719|NCT01233232|585134868|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
161937419|NCT00866775|584821705|FG000|Overall Study|Adverse Event|5|||
161937420|NCT00866775|584821706|FG001|Overall Study|Adverse Event|19|||
161937421|NCT00866775|584821705|FG000|Overall Study|Death|1|||
161937422|NCT00866775|584821706|FG001|Overall Study|Death|0|||
161937423|NCT00866775|584821705|FG000|Overall Study|Lost to Follow-up|0|||
162021720|NCT01233232|585134869|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
162021721|NCT01233232|585134870|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
162021722|NCT00843284|585137818|FG000|Overall Study|Adverse Event|39|||
162021723|NCT00843284|585137818|FG000|Overall Study|Lack of Efficacy|5|||
162021724|NCT00843284|585137818|FG000|Overall Study|Lost to Follow-up|11|||
162021725|NCT00843284|585137818|FG000|Overall Study|Other|10|||
162021726|NCT00843284|585137818|FG000|Overall Study|Withdrawal by Subject|4|||
162218655|NCT03104075|585851831|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
162218656|NCT03104075|585851832|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
162218657|NCT04896008|585851833|FG000|Overall Study|Ongoing|70|||
162218658|NCT04896008|585851834|FG001|Overall Study|Ongoing|38|||
162218659|NCT04896008|585851833|FG000|Overall Study|Adverse Event|0|||
162218660|NCT04896008|585851834|FG001|Overall Study|Adverse Event|2|||
162218661|NCT04896008|585851833|FG000|Overall Study|Death|5|||
162218662|NCT04896008|585851834|FG001|Overall Study|Death|10|||
162218663|NCT04896008|585851833|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
162236617|NCT02581631|585917011|FG000|Overall Study|participant withdrew consent|3|||
161937424|NCT00866775|584821706|FG001|Overall Study|Lost to Follow-up|4|||
161937425|NCT00866775|584821705|FG000|Overall Study|Physician Decision|0|||
161937426|NCT00866775|584821706|FG001|Overall Study|Physician Decision|3|||
161937427|NCT00866775|584821705|FG000|Overall Study|Protocol Violation|3|||
161937428|NCT00866775|584821706|FG001|Overall Study|Protocol Violation|4|||
161937429|NCT00866775|584821705|FG000|Overall Study|Withdrawal by Subject|4|||
161937430|NCT00866775|584821706|FG001|Overall Study|Withdrawal by Subject|4|||
162021727|NCT00843284|585137818|FG000|Overall Study|Death|3|||
162021728|NCT01794338|585137821|FG000|Overall Study|Death|2|||
162021729|NCT01794338|585137822|FG001|Overall Study|Death|0|||
162021730|NCT01794338|585137821|FG000|Overall Study|Lost to Follow-up|6|||
162021731|NCT01794338|585137822|FG001|Overall Study|Lost to Follow-up|9|||
162021732|NCT01282463|585137823|FG000|Overall Study|Lost to Follow-up|1|||
162236618|NCT02581631|585917012|FG001|Overall Study|participant withdrew consent|0|||
162236619|NCT02581631|585917013|FG002|Overall Study|participant withdrew consent|1|||
161828031|NCT02250651|584411480|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
161828032|NCT02250651|584411478|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
161828033|NCT02250651|584411479|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
161828034|NCT02250651|584411480|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
161828035|NCT02250651|584411478|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
161828036|NCT02250651|584411479|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
161828037|NCT02250651|584411480|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
161828038|NCT02250651|584411478|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
161828039|NCT02250651|584411479|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
161828040|NCT02250651|584411480|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
161828041|NCT02250651|584411478|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
161828042|NCT02250651|584411479|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
161828043|NCT02250651|584411480|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
161828044|NCT02250651|584411478|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
161828045|NCT02250651|584411479|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
161828046|NCT02250651|584411480|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
161828047|NCT02250651|584411478|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
161937431|NCT00866775|584821705|FG000|Overall Study|met exit criteria|23|||
161937432|NCT00866775|584821706|FG001|Overall Study|met exit criteria|17|||
162236620|NCT02581631|585917014|FG003|Overall Study|participant withdrew consent|0|||
162236621|NCT02581631|585917015|FG004|Overall Study|participant withdrew consent|0|||
162236622|NCT02581631|585917011|FG000|Overall Study|Maximum clinical benefit|1|||
162236623|NCT02581631|585917012|FG001|Overall Study|Maximum clinical benefit|7|||
162236624|NCT02581631|585917013|FG002|Overall Study|Maximum clinical benefit|1|||
162236625|NCT02581631|585917014|FG003|Overall Study|Maximum clinical benefit|3|||
162236626|NCT02581631|585917015|FG004|Overall Study|Maximum clinical benefit|13|||
161937433|NCT00866775|584821705|FG000|Overall Study|discontinued due to communication error|0|||
161937434|NCT00866775|584821706|FG001|Overall Study|discontinued due to communication error|1|||
161937435|NCT00833703|584821707|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
161937436|NCT00833703|584821708|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
161937437|NCT00003907|584821709|FG000|Overall Study|Adverse Event|2|||
161937438|NCT00003907|584821710|FG001|Overall Study|Adverse Event|11|||
161937439|NCT00003907|584821709|FG000|Overall Study|Death|2|||
162218664|NCT04896008|585851834|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
162218665|NCT04896008|585851833|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
162021733|NCT01282463|585137824|FG001|Overall Study|Lost to Follow-up|0|||
162021734|NCT01282463|585137825|FG002|Overall Study|Lost to Follow-up|0|||
162021735|NCT01282463|585137823|FG000|Overall Study|Withdrawal by Subject|6|||
162021736|NCT01282463|585137824|FG001|Overall Study|Withdrawal by Subject|2|||
161937440|NCT00003907|584821710|FG001|Overall Study|Death|0|||
161937441|NCT00003907|584821709|FG000|Overall Study|Withdrawal by Subject|1|||
161937442|NCT00003907|584821710|FG001|Overall Study|Withdrawal by Subject|3|||
161937443|NCT00003907|584821709|FG000|Overall Study|Progressive disease|4|||
161937444|NCT00003907|584821710|FG001|Overall Study|Progressive disease|4|||
161937445|NCT00003907|584821709|FG000|Overall Study|Complicating disease|1|||
161937446|NCT00003907|584821710|FG001|Overall Study|Complicating disease|0|||
161937447|NCT00003907|584821709|FG000|Overall Study|Other|1|||
161937448|NCT00003907|584821710|FG001|Overall Study|Other|3|||
161937449|NCT00003907|584821709|FG000|Overall Study|ineligible or not treated|2|||
161937450|NCT00003907|584821710|FG001|Overall Study|ineligible or not treated|2|||
161937451|NCT00414609|584821713|FG000|Core Study|Adverse Event|9|||
162021737|NCT01282463|585137825|FG002|Overall Study|Withdrawal by Subject|3|||
162021738|NCT01282463|585137823|FG000|Overall Study|"Never Treated Death"|0|||
162021739|NCT01282463|585137824|FG001|Overall Study|"Never Treated Death"|1|||
162021740|NCT01282463|585137825|FG002|Overall Study|"Never Treated Death"|0|||
162021741|NCT01282463|585137823|FG000|Overall Study|"Never Treated PD"|0|||
162021742|NCT01282463|585137824|FG001|Overall Study|"Never Treated PD"|1|||
162021743|NCT01282463|585137825|FG002|Overall Study|"Never Treated PD"|0|||
162021744|NCT01282463|585137823|FG000|Overall Study|Protocol Violation|0|||
162021745|NCT01282463|585137824|FG001|Overall Study|Protocol Violation|0|||
161937452|NCT00414609|584821714|FG001|Core Study|Adverse Event|11|||
161937453|NCT00414609|584821715|FG002|Core Study|Adverse Event|0|||
161937454|NCT00414609|584821713|FG000|Core Study|Abnormal laboratory values|0|||
161937455|NCT00414609|584821714|FG001|Core Study|Abnormal laboratory values|1|||
162021746|NCT01282463|585137825|FG002|Overall Study|Protocol Violation|1|||
162021747|NCT01282463|585137823|FG000|Overall Study|Physician Decision|1|||
162021748|NCT01282463|585137824|FG001|Overall Study|Physician Decision|0|||
162021749|NCT01282463|585137825|FG002|Overall Study|Physician Decision|0|||
162021750|NCT03320824|585137826|FG000|Overall Study|Withdrawal by Subject|8|||
162021751|NCT03320824|585137827|FG001|Overall Study|Withdrawal by Subject|1|||
162021752|NCT03320824|585137826|FG000|Overall Study|Lost to Follow-up|10|||
162021753|NCT03320824|585137827|FG001|Overall Study|Lost to Follow-up|1|||
162021754|NCT03320824|585137826|FG000|Overall Study|moved out of state|0|||
162021755|NCT03320824|585137827|FG001|Overall Study|moved out of state|1|||
162021756|NCT03320824|585137826|FG000|Overall Study|could not complete final visit|0|||
162021757|NCT03320824|585137827|FG001|Overall Study|could not complete final visit|1|||
162021758|NCT00955305|585137828|FG000|Overall Study|Disease progression|39|||
162021759|NCT00955305|585137829|FG001|Overall Study|Disease progression|41|||
162218666|NCT04896008|585851834|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
161937456|NCT00414609|584821715|FG002|Core Study|Abnormal laboratory values|0|||
161937457|NCT00414609|584821713|FG000|Core Study|Abnormal test procedure results|1|||
161937458|NCT00414609|584821714|FG001|Core Study|Abnormal test procedure results|1|||
161937459|NCT00414609|584821715|FG002|Core Study|Abnormal test procedure results|0|||
162021760|NCT00955305|585137828|FG000|Overall Study|Adverse Event|22|||
162021761|NCT00955305|585137829|FG001|Overall Study|Adverse Event|22|||
162021762|NCT00955305|585137828|FG000|Overall Study|Death|2|||
162021763|NCT00955305|585137829|FG001|Overall Study|Death|1|||
162218667|NCT04896008|585851833|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
162218668|NCT04896008|585851834|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
162218669|NCT04896008|585851833|FG000|Overall Study|Withdrawal by Subject|1|||
162218670|NCT04896008|585851834|FG001|Overall Study|Withdrawal by Subject|4|||
162218671|NCT04896008|585851833|FG000|Overall Study|Investigator Decision|2|||
162218672|NCT04896008|585851834|FG001|Overall Study|Investigator Decision|0|||
162218673|NCT04896008|585851833|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
162218674|NCT04896008|585851834|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
162218675|NCT00944229|585851837|FG000|Overall Study|Withdrawal by Subject|11|||
162218676|NCT00944229|585851837|FG000|Overall Study|Physician Decision|14|||
162218677|NCT01810939|585851840|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
162218678|NCT01810939|585851841|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
161937460|NCT00414609|584821713|FG000|Core Study|Protocol deviation|0|||
161937461|NCT00414609|584821714|FG001|Core Study|Protocol deviation|1|||
162021764|NCT00955305|585137828|FG000|Overall Study|Withdrawal by Subject|5|||
162021765|NCT00955305|585137829|FG001|Overall Study|Withdrawal by Subject|4|||
162021766|NCT00955305|585137828|FG000|Overall Study|Alternative therapy|4|||
162021767|NCT00955305|585137829|FG001|Overall Study|Alternative therapy|0|||
162021768|NCT00955305|585137828|FG000|Overall Study|Other complicating disease|2|||
162021769|NCT00955305|585137829|FG001|Overall Study|Other complicating disease|4|||
162021770|NCT00955305|585137828|FG000|Overall Study|Physician Decision|1|||
162021771|NCT00955305|585137829|FG001|Overall Study|Physician Decision|0|||
162021772|NCT00955305|585137828|FG000|Overall Study|Continued presence of residual disease|0|||
162021773|NCT00955305|585137829|FG001|Overall Study|Continued presence of residual disease|1|||
162021774|NCT00955305|585137828|FG000|Overall Study|Functional decline|2|||
162021775|NCT00955305|585137829|FG001|Overall Study|Functional decline|0|||
162021776|NCT00955305|585137828|FG000|Overall Study|Maximum response achieved|0|||
162021777|NCT00955305|585137829|FG001|Overall Study|Maximum response achieved|1|||
162021778|NCT00955305|585137828|FG000|Overall Study|Lost to Follow-up|0|||
162021779|NCT00955305|585137829|FG001|Overall Study|Lost to Follow-up|1|||
162021780|NCT00955305|585137828|FG000|Overall Study|No off-treatment reason submitted|1|||
162021781|NCT00955305|585137829|FG001|Overall Study|No off-treatment reason submitted|0|||
162021782|NCT00955305|585137828|FG000|Overall Study|Never started protocol treatment|5|||
162021783|NCT00955305|585137829|FG001|Overall Study|Never started protocol treatment|5|||
162021784|NCT00955305|585137828|FG000|Overall Study|Ineligible|5|||
162021785|NCT00955305|585137829|FG001|Overall Study|Ineligible|7|||
162021786|NCT00109590|585137830|FG000|Overall Study|Lost to Follow-up|1|||
162021787|NCT00109590|585137831|FG001|Overall Study|Lost to Follow-up|0|||
162021788|NCT00109590|585137832|FG002|Overall Study|Lost to Follow-up|1|||
162021789|NCT00109590|585137830|FG000|Overall Study|Never Started Treatment|1|||
162021790|NCT00109590|585137831|FG001|Overall Study|Never Started Treatment|2|||
162021791|NCT00109590|585137832|FG002|Overall Study|Never Started Treatment|3|||
162021792|NCT01221285|585137833|FG000|Overall Study|Withdrawal by Subject|1|||
162021793|NCT00588861|585137834|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
162021794|NCT00588861|585137835|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
161828048|NCT02250651|584411479|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
161828049|NCT02250651|584411480|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
161828050|NCT02250651|584411478|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
161828051|NCT02250651|584411479|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
161828052|NCT02250651|584411480|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
161828053|NCT02250651|584411478|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
161828054|NCT02250651|584411479|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
161828055|NCT02250651|584411480|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
161828056|NCT02250651|584411478|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
161828057|NCT02250651|584411479|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
161828058|NCT02250651|584411480|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
161828059|NCT02250651|584411478|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
161828060|NCT02250651|584411479|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
161828061|NCT02250651|584411480|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
161828062|NCT01264835|584411481|FG000|Overall Study|Lost to Follow-up|1|||
161828063|NCT01557920|584411486|FG000|Overall Study|Withdrawal by Subject|2|||
161828064|NCT01557920|584411487|FG001|Overall Study|Withdrawal by Subject|3|||
161828065|NCT01557920|584411486|FG000|Overall Study|Lack of Efficacy|1|||
161828066|NCT01557920|584411487|FG001|Overall Study|Lack of Efficacy|0|||
161828067|NCT01466036|584411488|FG000|Overall Study|Death|1|||
161828068|NCT01466036|584411489|FG001|Overall Study|Death|1|||
161828069|NCT01466036|584411488|FG000|Overall Study|Physician Decision|0|||
161828070|NCT01466036|584411489|FG001|Overall Study|Physician Decision|4|||
161828071|NCT01466036|584411488|FG000|Overall Study|Adverse Event|2|||
161828072|NCT01466036|584411489|FG001|Overall Study|Adverse Event|6|||
161828073|NCT01466036|584411488|FG000|Overall Study|Withdrawal by Subject|2|||
162021795|NCT00588861|585137834|FG000|6 Months|Patients did not return for follow-up|98|||
162021796|NCT00588861|585137835|FG001|6 Months|Patients did not return for follow-up|73|||
161828074|NCT01466036|584411489|FG001|Overall Study|Withdrawal by Subject|8|||
161828075|NCT01466036|584411488|FG000|Overall Study|progression/relapse|14|||
161828076|NCT01466036|584411489|FG001|Overall Study|progression/relapse|21|||
161828077|NCT01466036|584411488|FG000|Overall Study|prolonged treatment delay|1|||
161828078|NCT01466036|584411489|FG001|Overall Study|prolonged treatment delay|1|||
161828079|NCT00220727|584411518|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
161828080|NCT00220727|584411519|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
161828081|NCT02508116|584411522|FG000|Overall Study|Lost to Follow-up|2|||
161828082|NCT02508116|584411523|FG001|Overall Study|Lost to Follow-up|3|||
161828083|NCT02508116|584411522|FG000|Overall Study|Withdrawal by Subject|3|||
161828084|NCT02508116|584411523|FG001|Overall Study|Withdrawal by Subject|2|||
161828085|NCT02508116|584411522|FG000|Overall Study|Protocol Violation|1|||
161828086|NCT02508116|584411523|FG001|Overall Study|Protocol Violation|2|||
161828087|NCT02508116|584411522|FG000|Overall Study|Physician Decision|2|||
161828088|NCT02508116|584411523|FG001|Overall Study|Physician Decision|0|||
161828089|NCT00109850|584411527|FG000|Overall Study|Adverse Event|1|||
161828090|NCT00109850|584411527|FG000|Overall Study|Death|2|||
161828091|NCT00109850|584411527|FG000|Overall Study|Ineligible|1|||
161828092|NCT00476593|584411528|FG000|Overall Study|Lost to Follow-up|10|||
161828093|NCT00476593|584411529|FG001|Overall Study|Lost to Follow-up|2|||
161828094|NCT00476593|584411530|FG002|Overall Study|Lost to Follow-up|8|||
161828095|NCT00476593|584411531|FG003|Overall Study|Lost to Follow-up|22|||
161828096|NCT03430011|584411532|FG000|Pre-Treatment|Death|1|||
161828097|NCT03430011|584411533|FG001|Pre-Treatment|Death|0|||
161828098|NCT03430011|584411534|FG002|Pre-Treatment|Death|0|||
161828099|NCT03430011|584411535|FG003|Pre-Treatment|Death|0|||
161828100|NCT03430011|584411536|FG004|Pre-Treatment|Death|1|||
161828101|NCT03430011|584411537|FG005|Pre-Treatment|Death|0|||
161828102|NCT03430011|584411538|FG006|Pre-Treatment|Death|1|||
161828103|NCT03430011|584411539|FG007|Pre-Treatment|Death|0|||
161828104|NCT03430011|584411532|FG000|Pre-Treatment|Screen Fail|0|||
161828105|NCT03430011|584411533|FG001|Pre-Treatment|Screen Fail|0|||
161828106|NCT03430011|584411534|FG002|Pre-Treatment|Screen Fail|0|||
161828107|NCT03430011|584411535|FG003|Pre-Treatment|Screen Fail|0|||
161828108|NCT03430011|584411536|FG004|Pre-Treatment|Screen Fail|1|||
161828109|NCT03430011|584411537|FG005|Pre-Treatment|Screen Fail|0|||
161828110|NCT03430011|584411538|FG006|Pre-Treatment|Screen Fail|0|||
161828111|NCT03430011|584411539|FG007|Pre-Treatment|Screen Fail|0|||
162021797|NCT00588861|585137834|FG000|1 Year|Patients did not return for follow-up|89|||
162021798|NCT00588861|585137835|FG001|1 Year|Patients did not return for follow-up|82|||
162021799|NCT00588861|585137834|FG000|2 Years|Patients did not return for follow-up|92|||
162021800|NCT00588861|585137835|FG001|2 Years|Patients did not return for follow-up|87|||
162021801|NCT00588861|585137834|FG000|4 Years|Patients did not return for follow-up|91|||
162021802|NCT00588861|585137835|FG001|4 Years|Patients did not return for follow-up|103|||
162021803|NCT00588861|585137834|FG000|6 Years|Patients did not return for follow-up|104|||
162218679|NCT01810939|585851842|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
161828112|NCT03430011|584411532|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828113|NCT03430011|584411533|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828114|NCT03430011|584411534|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
161828115|NCT03430011|584411535|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828116|NCT03430011|584411536|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828117|NCT03430011|584411537|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828118|NCT03430011|584411538|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828119|NCT03430011|584411539|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
161828120|NCT03430011|584411532|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
161828121|NCT03430011|584411533|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
161828122|NCT03430011|584411534|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
161828123|NCT03430011|584411535|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
161937462|NCT00414609|584821715|FG002|Core Study|Protocol deviation|0|||
161937463|NCT00414609|584821713|FG000|Core Study|Patient withdrew consent|10|||
161937464|NCT00414609|584821714|FG001|Core Study|Patient withdrew consent|11|||
161937465|NCT00414609|584821715|FG002|Core Study|Patient withdrew consent|0|||
161937466|NCT00414609|584821713|FG000|Core Study|Lost to Follow-up|7|||
161937467|NCT00414609|584821714|FG001|Core Study|Lost to Follow-up|4|||
161937468|NCT00414609|584821715|FG002|Core Study|Lost to Follow-up|0|||
161937469|NCT00414609|584821713|FG000|Core Study|Administrative problems|0|||
161937470|NCT00414609|584821714|FG001|Core Study|Administrative problems|2|||
161937471|NCT00414609|584821715|FG002|Core Study|Administrative problems|0|||
161937472|NCT00414609|584821713|FG000|Core Study|Death|7|||
161937473|NCT00414609|584821714|FG001|Core Study|Death|14|||
161937474|NCT00414609|584821715|FG002|Core Study|Death|0|||
161937475|NCT00414609|584821713|FG000|Extension Study|Adverse Event|0|||
161937476|NCT00414609|584821714|FG001|Extension Study|Adverse Event|0|||
161937477|NCT00414609|584821715|FG002|Extension Study|Adverse Event|14|||
161937478|NCT00414609|584821713|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
161937479|NCT00414609|584821714|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
161937480|NCT00414609|584821715|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
161828124|NCT03430011|584411536|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
161828125|NCT03430011|584411537|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
161937481|NCT00414609|584821713|FG000|Extension Study|Withdrawal by Subject|0|||
162218680|NCT01810939|585851840|FG000|Part A Treatment Period|Protocol Violation|2|||
162218681|NCT01810939|585851841|FG001|Part A Treatment Period|Protocol Violation|0|||
162218682|NCT01810939|585851842|FG002|Part A Treatment Period|Protocol Violation|0|||
162218683|NCT01810939|585851840|FG000|Part A Treatment Period|Adverse Event|10|||
162218684|NCT01810939|585851841|FG001|Part A Treatment Period|Adverse Event|0|||
162218685|NCT01810939|585851842|FG002|Part A Treatment Period|Adverse Event|0|||
162218686|NCT01810939|585851840|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
162218687|NCT01810939|585851841|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
162218688|NCT01810939|585851842|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
161937482|NCT00414609|584821714|FG001|Extension Study|Withdrawal by Subject|0|||
161937483|NCT00414609|584821715|FG002|Extension Study|Withdrawal by Subject|13|||
161937484|NCT00414609|584821713|FG000|Extension Study|Lost to Follow-up|0|||
161937485|NCT00414609|584821714|FG001|Extension Study|Lost to Follow-up|0|||
162218689|NCT01810939|585851840|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
162218690|NCT01810939|585851841|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
162218691|NCT01810939|585851842|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
162218692|NCT01810939|585851840|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
162218693|NCT01810939|585851841|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
162218694|NCT01810939|585851842|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
162218695|NCT01810939|585851840|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
161937486|NCT00414609|584821715|FG002|Extension Study|Lost to Follow-up|10|||
161937487|NCT00414609|584821713|FG000|Extension Study|Administrative problems|0|||
161937488|NCT00414609|584821714|FG001|Extension Study|Administrative problems|0|||
161937489|NCT00414609|584821715|FG002|Extension Study|Administrative problems|1|||
161937490|NCT00414609|584821713|FG000|Extension Study|Death|0|||
161937491|NCT00414609|584821714|FG001|Extension Study|Death|0|||
161937492|NCT00414609|584821715|FG002|Extension Study|Death|17|||
161937493|NCT00266032|584821716|FG000|Treatment|Adverse Event|42|||
161937494|NCT00266032|584821717|FG001|Treatment|Adverse Event|26|||
161937495|NCT00266032|584821718|FG002|Treatment|Adverse Event|10|||
161937496|NCT00266032|584821716|FG000|Treatment|Lost to Follow-up|19|||
161937497|NCT00266032|584821717|FG001|Treatment|Lost to Follow-up|4|||
161937498|NCT00266032|584821718|FG002|Treatment|Lost to Follow-up|2|||
161937499|NCT00266032|584821716|FG000|Treatment|Pregnancy|3|||
161937500|NCT00266032|584821717|FG001|Treatment|Pregnancy|2|||
161937501|NCT00266032|584821718|FG002|Treatment|Pregnancy|2|||
161937502|NCT00266032|584821716|FG000|Treatment|Protocol Violation|6|||
161937503|NCT00266032|584821717|FG001|Treatment|Protocol Violation|14|||
161937504|NCT00266032|584821718|FG002|Treatment|Protocol Violation|13|||
161937505|NCT00266032|584821716|FG000|Treatment|Withdrawal by Subject|28|||
161937506|NCT00266032|584821717|FG001|Treatment|Withdrawal by Subject|13|||
161937507|NCT00266032|584821718|FG002|Treatment|Withdrawal by Subject|12|||
161937508|NCT00266032|584821716|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
161937509|NCT00266032|584821717|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
161937510|NCT00266032|584821718|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
161937511|NCT00266032|584821716|FG000|Open-label Safety Extension|Adverse Event|5|||
161937512|NCT00266032|584821717|FG001|Open-label Safety Extension|Adverse Event|0|||
161937513|NCT00266032|584821718|FG002|Open-label Safety Extension|Adverse Event|4|||
161937514|NCT00266032|584821716|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
161937515|NCT00266032|584821717|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
161937516|NCT00266032|584821718|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
161937517|NCT00266032|584821716|FG000|Open-label Safety Extension|Pregnancy|4|||
161937518|NCT00266032|584821717|FG001|Open-label Safety Extension|Pregnancy|1|||
161937519|NCT00266032|584821718|FG002|Open-label Safety Extension|Pregnancy|2|||
161937520|NCT00266032|584821716|FG000|Open-label Safety Extension|Protocol Violation|1|||
161937521|NCT00266032|584821717|FG001|Open-label Safety Extension|Protocol Violation|3|||
161937522|NCT00266032|584821718|FG002|Open-label Safety Extension|Protocol Violation|2|||
161937523|NCT00266032|584821716|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
161937524|NCT00266032|584821717|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
161937525|NCT00266032|584821718|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
161937526|NCT00266032|584821716|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
161937527|NCT00266032|584821717|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
161937528|NCT00266032|584821718|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
161937529|NCT00124657|584821720|FG000|Overall Study|Toxicity|0|||
161937530|NCT00124657|584821721|FG001|Overall Study|Toxicity|0|||
161937531|NCT00124657|584821722|FG002|Overall Study|Toxicity|1|||
161937532|NCT00124657|584821720|FG000|Overall Study|Non-compliance|1|||
161937533|NCT00124657|584821721|FG001|Overall Study|Non-compliance|0|||
161937534|NCT00124657|584821722|FG002|Overall Study|Non-compliance|4|||
161937535|NCT00124657|584821720|FG000|Overall Study|Progressive disease|14|||
161937536|NCT00124657|584821721|FG001|Overall Study|Progressive disease|5|||
161937537|NCT00124657|584821722|FG002|Overall Study|Progressive disease|27|||
161937538|NCT00124657|584821720|FG000|Overall Study|Intercurrent illness|1|||
161937539|NCT00124657|584821721|FG001|Overall Study|Intercurrent illness|0|||
161937540|NCT00124657|584821722|FG002|Overall Study|Intercurrent illness|0|||
161937541|NCT02367885|584821725|FG000|Overall Study|Lost to Follow-up|1|||
161937542|NCT02367885|584821726|FG001|Overall Study|Lost to Follow-up|0|||
161937543|NCT02367885|584821727|FG002|Overall Study|Lost to Follow-up|0|||
161937544|NCT02367885|584821725|FG000|Overall Study|Withdrawal by Subject|1|||
161937545|NCT02367885|584821726|FG001|Overall Study|Withdrawal by Subject|0|||
161937546|NCT02367885|584821727|FG002|Overall Study|Withdrawal by Subject|0|||
161937547|NCT01378195|584821728|FG000|Overall Study|Lost to Follow-up|29|||
161937548|NCT01378195|584821729|FG001|Overall Study|Lost to Follow-up|18|||
161937549|NCT00752219|584821730|FG000|Overall Study|Clinical failure|0|||
161937550|NCT00752219|584821731|FG001|Overall Study|Clinical failure|1|||
161937551|NCT00752219|584821730|FG000|Overall Study|Adverse Event|5|||
161937552|NCT00752219|584821731|FG001|Overall Study|Adverse Event|3|||
161937553|NCT00752219|584821730|FG000|Overall Study|Protocol deviation|1|||
161828126|NCT03430011|584411538|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
161828127|NCT03430011|584411539|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
161828128|NCT03430011|584411532|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
161828129|NCT03430011|584411533|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
161828130|NCT03430011|584411534|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
161828131|NCT03430011|584411535|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
161828132|NCT03430011|584411536|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
161828133|NCT03430011|584411537|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
161937554|NCT00752219|584821731|FG001|Overall Study|Protocol deviation|0|||
161937555|NCT00752219|584821730|FG000|Overall Study|Lost to Follow-up|1|||
161828134|NCT03430011|584411538|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
161828135|NCT03430011|584411539|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
161937556|NCT00752219|584821731|FG001|Overall Study|Lost to Follow-up|2|||
161937557|NCT00752219|584821730|FG000|Overall Study|Randomized but not treated|1|||
161937558|NCT00752219|584821731|FG001|Overall Study|Randomized but not treated|0|||
161937559|NCT00752219|584821730|FG000|Overall Study|Other|3|||
161937560|NCT00752219|584821731|FG001|Overall Study|Other|0|||
161937561|NCT03533491|584821733|FG000|Overall Study|Lost to Follow-up|2|||
161937562|NCT05418426|584821737|FG000|Overall Study|Adverse Event|0|||
161937563|NCT05418426|584821738|FG001|Overall Study|Adverse Event|1|||
161937564|NCT05418426|584821739|FG002|Overall Study|Adverse Event|0|||
161937565|NCT05418426|584821737|FG000|Overall Study|Withdrawal by Subject|0|||
161937566|NCT05418426|584821738|FG001|Overall Study|Withdrawal by Subject|1|||
161937567|NCT05418426|584821739|FG002|Overall Study|Withdrawal by Subject|0|||
161937568|NCT05418426|584821737|FG000|Overall Study|Protocol Violation|0|||
161937569|NCT05418426|584821738|FG001|Overall Study|Protocol Violation|0|||
161937570|NCT05418426|584821739|FG002|Overall Study|Protocol Violation|1|||
161828136|NCT03430011|584411532|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
161828137|NCT03430011|584411533|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
161828138|NCT03430011|584411534|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
161828139|NCT03430011|584411535|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
161828140|NCT03430011|584411536|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
161828141|NCT03430011|584411537|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
161828142|NCT03430011|584411538|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
161828143|NCT03430011|584411539|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
161828144|NCT03430011|584411532|FG000|JCARH125 Treatment|Death|4|||
161828145|NCT03430011|584411533|FG001|JCARH125 Treatment|Death|19|||
161828146|NCT03430011|584411534|FG002|JCARH125 Treatment|Death|10|||
161828147|NCT03430011|584411535|FG003|JCARH125 Treatment|Death|8|||
161828148|NCT03430011|584411536|FG004|JCARH125 Treatment|Death|5|||
161828149|NCT03430011|584411537|FG005|JCARH125 Treatment|Death|3|||
161828150|NCT03430011|584411538|FG006|JCARH125 Treatment|Death|4|||
162021804|NCT00588861|585137835|FG001|6 Years|Patients did not return for follow-up|109|||
162021805|NCT00588861|585137834|FG000|8 Years|Patients did not return for follow-up|105|||
162021806|NCT00588861|585137835|FG001|8 Years|Patients did not return for follow-up|114|||
162021807|NCT00588861|585137834|FG000|10 Years|Incomplete due to study termination|107|||
161828151|NCT03430011|584411539|FG007|JCARH125 Treatment|Death|2|||
161828152|NCT03430011|584411532|FG000|JCARH125 Treatment|Other reasons|1|||
161828153|NCT03430011|584411533|FG001|JCARH125 Treatment|Other reasons|0|||
161828154|NCT03430011|584411534|FG002|JCARH125 Treatment|Other reasons|4|||
161828155|NCT03430011|584411535|FG003|JCARH125 Treatment|Other reasons|2|||
161828156|NCT03430011|584411536|FG004|JCARH125 Treatment|Other reasons|2|||
161828157|NCT03430011|584411537|FG005|JCARH125 Treatment|Other reasons|1|||
161828158|NCT03430011|584411538|FG006|JCARH125 Treatment|Other reasons|3|||
161828159|NCT03430011|584411539|FG007|JCARH125 Treatment|Other reasons|2|||
161828160|NCT00559364|584411541|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
161828161|NCT00559364|584411542|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
161828162|NCT04126343|584411543|FG000|Overall Study|Adverse Event|0|||
161937571|NCT01682720|584821748|FG000|Overall Study|Randomized but Not Treated|0|||
161937572|NCT01682720|584821749|FG001|Overall Study|Randomized but Not Treated|1|||
161937573|NCT01682720|584821750|FG002|Overall Study|Randomized but Not Treated|1|||
161937574|NCT01682720|584821751|FG003|Overall Study|Randomized but Not Treated|0|||
161937575|NCT01682720|584821748|FG000|Overall Study|Terminated by Sponsor|83|||
161937576|NCT01682720|584821749|FG001|Overall Study|Terminated by Sponsor|0|||
161937577|NCT01682720|584821750|FG002|Overall Study|Terminated by Sponsor|0|||
161937578|NCT01682720|584821751|FG003|Overall Study|Terminated by Sponsor|0|||
161937579|NCT01682720|584821748|FG000|Overall Study|Efficacy Failure|0|||
161937580|NCT01682720|584821749|FG001|Overall Study|Efficacy Failure|3|||
161828163|NCT04126343|584411544|FG001|Overall Study|Adverse Event|0|||
161828164|NCT04126343|584411545|FG002|Overall Study|Adverse Event|0|||
161828165|NCT04126343|584411546|FG003|Overall Study|Adverse Event|0|||
161828166|NCT04126343|584411547|FG004|Overall Study|Adverse Event|0|||
161828167|NCT04126343|584411548|FG005|Overall Study|Adverse Event|1|||
161828168|NCT04126343|584411543|FG000|Overall Study|Withdrawal by Subject|0|||
161828169|NCT04126343|584411544|FG001|Overall Study|Withdrawal by Subject|0|||
161828170|NCT04126343|584411545|FG002|Overall Study|Withdrawal by Subject|0|||
161828171|NCT04126343|584411546|FG003|Overall Study|Withdrawal by Subject|1|||
161937581|NCT01682720|584821750|FG002|Overall Study|Efficacy Failure|3|||
161937582|NCT01682720|584821751|FG003|Overall Study|Efficacy Failure|30|||
161937583|NCT01682720|584821748|FG000|Overall Study|Lost to Follow-up|1|||
161937584|NCT01682720|584821749|FG001|Overall Study|Lost to Follow-up|1|||
161937585|NCT01682720|584821750|FG002|Overall Study|Lost to Follow-up|0|||
161937586|NCT01682720|584821751|FG003|Overall Study|Lost to Follow-up|6|||
161828172|NCT04126343|584411547|FG004|Overall Study|Withdrawal by Subject|0|||
161828173|NCT04126343|584411548|FG005|Overall Study|Withdrawal by Subject|0|||
161828174|NCT04126343|584411543|FG000|Overall Study|Related to COVID-19 pandemic|3|||
161828175|NCT04126343|584411544|FG001|Overall Study|Related to COVID-19 pandemic|4|||
161828176|NCT04126343|584411545|FG002|Overall Study|Related to COVID-19 pandemic|3|||
161828177|NCT04126343|584411546|FG003|Overall Study|Related to COVID-19 pandemic|3|||
161828178|NCT04126343|584411547|FG004|Overall Study|Related to COVID-19 pandemic|3|||
161828179|NCT04126343|584411548|FG005|Overall Study|Related to COVID-19 pandemic|3|||
161828180|NCT01235442|584411549|FG000|Overall Study|Lost to Follow-up|12|||
161828181|NCT01235442|584411550|FG001|Overall Study|Lost to Follow-up|10|||
161828182|NCT01235442|584411549|FG000|Overall Study|Death|0|||
161828183|NCT01235442|584411550|FG001|Overall Study|Death|2|||
161828184|NCT01235442|584411549|FG000|Overall Study|Pregnancy|1|||
161828185|NCT01235442|584411550|FG001|Overall Study|Pregnancy|1|||
161828186|NCT01235442|584411549|FG000|Overall Study|Ineligibility determined|5|||
161828187|NCT01235442|584411550|FG001|Overall Study|Ineligibility determined|4|||
161828188|NCT01235442|584411549|FG000|Overall Study|Protocol Violation|3|||
161828189|NCT01235442|584411550|FG001|Overall Study|Protocol Violation|3|||
161828190|NCT01235442|584411549|FG000|Overall Study|Adverse Event|4|||
161828191|NCT01235442|584411550|FG001|Overall Study|Adverse Event|6|||
161828192|NCT01235442|584411549|FG000|Overall Study|Withdrawal by Subject|15|||
161828193|NCT01235442|584411550|FG001|Overall Study|Withdrawal by Subject|9|||
161828194|NCT01235442|584411549|FG000|Overall Study|Lack of Efficacy|1|||
161828195|NCT01235442|584411550|FG001|Overall Study|Lack of Efficacy|3|||
161828196|NCT01235442|584411549|FG000|Overall Study|Noncompliance|1|||
161828197|NCT01235442|584411550|FG001|Overall Study|Noncompliance|2|||
161828198|NCT01235442|584411549|FG000|Overall Study|Administrative decision|1|||
161828199|NCT01235442|584411550|FG001|Overall Study|Administrative decision|2|||
161828200|NCT01235442|584411549|FG000|Overall Study|Other unspecified|1|||
161828201|NCT01235442|584411550|FG001|Overall Study|Other unspecified|2|||
161828202|NCT00330460|584411555|FG000|Overall Study|Physician Decision|1|||
161828203|NCT00330460|584411556|FG001|Overall Study|Physician Decision|0|||
161828204|NCT00330460|584411555|FG000|Overall Study|Adverse Event|10|||
161828205|NCT00330460|584411556|FG001|Overall Study|Adverse Event|8|||
161828206|NCT00330460|584411555|FG000|Overall Study|Withdrawal by Subject|18|||
161828207|NCT00330460|584411556|FG001|Overall Study|Withdrawal by Subject|17|||
161828208|NCT00330460|584411555|FG000|Overall Study|Death|1|||
161828209|NCT00330460|584411556|FG001|Overall Study|Death|1|||
161828210|NCT00330460|584411555|FG000|Overall Study|Ineligibility determined|1|||
161828211|NCT00330460|584411556|FG001|Overall Study|Ineligibility determined|3|||
161828212|NCT00330460|584411555|FG000|Overall Study|Lost to Follow-up|8|||
161828213|NCT00330460|584411556|FG001|Overall Study|Lost to Follow-up|3|||
161828214|NCT00330460|584411555|FG000|Overall Study|Noncompliance|2|||
161828215|NCT00330460|584411556|FG001|Overall Study|Noncompliance|1|||
161828216|NCT00330460|584411555|FG000|Overall Study|Other|1|||
161828217|NCT00330460|584411556|FG001|Overall Study|Other|0|||
161828218|NCT01857973|584411561|FG000|Overall Study|Subject did not meet required BG range|3|||
161828219|NCT01857973|584411561|FG000|Overall Study|drop out after 3 failed attempts|1|||
161828220|NCT01857973|584411561|FG000|Overall Study|Physician Decision|1|||
161828221|NCT01701973|584411564|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828222|NCT01701973|584411565|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
161828223|NCT01701973|584411566|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828224|NCT01701973|584411567|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828225|NCT01701973|584411568|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828226|NCT01701973|584411569|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828227|NCT01701973|584411570|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161828228|NCT01701973|584411571|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161937587|NCT01682720|584821748|FG000|Overall Study|Subject Withdrew Consent|0|||
161937588|NCT01682720|584821749|FG001|Overall Study|Subject Withdrew Consent|0|||
161937589|NCT01682720|584821750|FG002|Overall Study|Subject Withdrew Consent|2|||
161937590|NCT01682720|584821751|FG003|Overall Study|Subject Withdrew Consent|2|||
161937591|NCT01682720|584821748|FG000|Overall Study|Adverse Event|1|||
161937592|NCT01682720|584821749|FG001|Overall Study|Adverse Event|0|||
161828229|NCT02663882|584411572|FG000|Overall Study|Lost to Follow-up|4|||
161828230|NCT02663882|584411573|FG001|Overall Study|Lost to Follow-up|2|||
161828231|NCT03712124|584411576|FG000|Overall Study|Protocol Violation|1|||
161828232|NCT03712124|584411577|FG001|Overall Study|Protocol Violation|0|||
161828233|NCT00602537|584411581|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
161828234|NCT00602537|584411582|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
161828235|NCT00602537|584411581|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
161828236|NCT00602537|584411582|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
161828237|NCT00602537|584411581|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
161828238|NCT00602537|584411582|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
161828239|NCT00602537|584411581|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
161828240|NCT00602537|584411582|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
161828241|NCT00602537|584411581|FG000|Follow Up Study Comparison|Adverse Event|1|||
161828242|NCT00602537|584411582|FG001|Follow Up Study Comparison|Adverse Event|0|||
161937593|NCT01682720|584821750|FG002|Overall Study|Adverse Event|1|||
161937594|NCT01682720|584821751|FG003|Overall Study|Adverse Event|1|||
161828243|NCT00602537|584411581|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
161828244|NCT00602537|584411582|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
161828245|NCT00602537|584411581|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
161828246|NCT00602537|584411582|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
161828247|NCT00388037|584411583|FG000|Overall Study|Protocol Violation|1|||
161828248|NCT04314843|584411584|FG000|Overall Study|Death|2|||
161828249|NCT04314843|584411585|FG001|Overall Study|Death|2|||
161828250|NCT04314843|584411584|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
161828251|NCT04314843|584411585|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
161828252|NCT00869440|584411586|FG000|Overall Study|Withdrawal by Subject|1|||
161828253|NCT00869440|584411587|FG001|Overall Study|Withdrawal by Subject|0|||
161828254|NCT00869440|584411588|FG002|Overall Study|Withdrawal by Subject|0|||
161828255|NCT00869440|584411589|FG003|Overall Study|Withdrawal by Subject|0|||
161828256|NCT00869440|584411586|FG000|Overall Study|Physician Decision|1|||
161828257|NCT00869440|584411587|FG001|Overall Study|Physician Decision|1|||
161828258|NCT00869440|584411588|FG002|Overall Study|Physician Decision|0|||
161828259|NCT00869440|584411589|FG003|Overall Study|Physician Decision|0|||
161828260|NCT01899326|584411591|FG000|Overall Study|Withdrawal by Subject|1|||
161828261|NCT01899326|584411591|FG000|Overall Study|Adverse Event|2|||
161828262|NCT01899326|584411591|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
161828263|NCT01435031|584411592|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
161828264|NCT01435031|584411592|FG000|ITT at 1 Month|Death|1|||
161828265|NCT01435031|584411592|FG000|ITT at 1 Month|Lost to Follow-up|4|||
161828266|NCT01435031|584411592|FG000|ITT at 6 Months|Death|2|||
161828267|NCT01435031|584411592|FG000|ITT at 6 Months|Lost to Follow-up|3|||
161828268|NCT01435031|584411592|FG000|ITT at 1 Year|Death|1|||
161828269|NCT01435031|584411592|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
161828270|NCT01435031|584411592|FG000|ITT at 1 Year|Lost to Follow-up|6|||
161828271|NCT01435031|584411592|FG000|ITT at 2 Years|Death|7|||
161828272|NCT01435031|584411592|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
161828273|NCT01435031|584411592|FG000|ITT at 2 Years|Lost to Follow-up|4|||
161828274|NCT01435031|584411592|FG000|ITT at 3 Years|Death|5|||
161828275|NCT01435031|584411592|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
161828276|NCT01435031|584411592|FG000|ITT at 3 Years|Lost to Follow-up|4|||
161678522|NCT00066742|583876000|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
161678523|NCT00066742|583876000|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
161678524|NCT00066742|583876000|FG000|Induction Chemoradiotherapy|Ineligible|3|||
161678525|NCT00066742|583876000|FG000|Consolidation Chemotherapy|not protocol specified|1|||
161678526|NCT00066742|583876000|FG000|Consolidation Chemotherapy|Ineligible|2|||
161678527|NCT02357134|583876001|FG000|Overall Study|Lost to Follow-up|1|||
161678528|NCT02357134|583876002|FG001|Overall Study|Lost to Follow-up|0|||
161678529|NCT02357134|583876003|FG002|Overall Study|Lost to Follow-up|0|||
161678530|NCT02357134|583876004|FG003|Overall Study|Lost to Follow-up|0|||
161678531|NCT02716675|583876005|FG000|Overall Study|Death|2|||
161678532|NCT02716675|583876006|FG001|Overall Study|Death|3|||
161678533|NCT02716675|583876007|FG002|Overall Study|Death|0|||
161678534|NCT02716675|583876005|FG000|Overall Study|Physician Decision|2|||
161678535|NCT02716675|583876006|FG001|Overall Study|Physician Decision|1|||
161678536|NCT02716675|583876007|FG002|Overall Study|Physician Decision|1|||
161937595|NCT01687595|584821752|FG000|Overall Study|Withdrawal by Subject|8|||
161937596|NCT01687595|584821753|FG001|Overall Study|Withdrawal by Subject|0|||
161937597|NCT01687595|584821752|FG000|Overall Study|Lost to Follow-up|3|||
161937598|NCT01687595|584821753|FG001|Overall Study|Lost to Follow-up|1|||
161828277|NCT01435031|584411592|FG000|ITT at 4 Years|Death|4|||
161828278|NCT01435031|584411592|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
161828279|NCT01435031|584411592|FG000|ITT at 4 Years|Lost to Follow-up|1|||
161678537|NCT02716675|583876005|FG000|Overall Study|Lost to Follow-up|100|||
161678538|NCT02716675|583876006|FG001|Overall Study|Lost to Follow-up|87|||
161678539|NCT02716675|583876007|FG002|Overall Study|Lost to Follow-up|99|||
161937599|NCT01687595|584821752|FG000|Overall Study|Investigator's decision|1|||
161937600|NCT01687595|584821753|FG001|Overall Study|Investigator's decision|0|||
161678540|NCT02716675|583876005|FG000|Overall Study|Withdrawal by Subject|22|||
161678541|NCT02716675|583876006|FG001|Overall Study|Withdrawal by Subject|25|||
161828280|NCT00104247|584411593|FG000|Overall Study|Withdrawal by Subject|1|||
161828281|NCT00104247|584411594|FG001|Overall Study|Withdrawal by Subject|0|||
161828282|NCT00104247|584411593|FG000|Overall Study|Noncompliant with dosing|0|||
161828283|NCT00104247|584411594|FG001|Overall Study|Noncompliant with dosing|1|||
161828284|NCT03718117|584411596|FG000|Overall Study|Death|12|||
161828285|NCT03718117|584411597|FG001|Overall Study|Death|11|||
161937601|NCT01687595|584821752|FG000|Overall Study|Sponsor's decision|1|||
161828286|NCT03718117|584411598|FG002|Overall Study|Death|0|||
161828287|NCT03718117|584411596|FG000|Overall Study|Other|0|||
161828288|NCT03718117|584411597|FG001|Overall Study|Other|1|||
161828289|NCT03718117|584411598|FG002|Overall Study|Other|0|||
161828290|NCT03718117|584411596|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
161828291|NCT03718117|584411597|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
161828292|NCT03718117|584411598|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
161828293|NCT03718117|584411596|FG000|Overall Study|Participant not met eligibility criteria|0|||
161828294|NCT03718117|584411597|FG001|Overall Study|Participant not met eligibility criteria|0|||
161828295|NCT03718117|584411598|FG002|Overall Study|Participant not met eligibility criteria|2|||
161828296|NCT02030535|584411599|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
161828297|NCT01588548|584411600|FG000|Overall Study|Withdrawal by Subject|0|||
161828298|NCT01588548|584411601|FG001|Overall Study|Withdrawal by Subject|1|||
161828299|NCT01588548|584411602|FG002|Overall Study|Withdrawal by Subject|1|||
161828300|NCT01588548|584411603|FG003|Overall Study|Withdrawal by Subject|1|||
161828301|NCT01588548|584411604|FG004|Overall Study|Withdrawal by Subject|2|||
161828302|NCT01588548|584411605|FG005|Overall Study|Withdrawal by Subject|3|||
161828303|NCT01588548|584411600|FG000|Overall Study|Adverse Event|0|||
161828304|NCT01588548|584411601|FG001|Overall Study|Adverse Event|0|||
161828305|NCT01588548|584411602|FG002|Overall Study|Adverse Event|1|||
161828306|NCT01588548|584411603|FG003|Overall Study|Adverse Event|2|||
161828307|NCT01588548|584411604|FG004|Overall Study|Adverse Event|1|||
161828308|NCT01588548|584411605|FG005|Overall Study|Adverse Event|0|||
161828309|NCT01588548|584411600|FG000|Overall Study|Condition Under Investigation Worsened|3|||
161828310|NCT01588548|584411601|FG001|Overall Study|Condition Under Investigation Worsened|6|||
161828311|NCT01588548|584411602|FG002|Overall Study|Condition Under Investigation Worsened|4|||
161828312|NCT01588548|584411603|FG003|Overall Study|Condition Under Investigation Worsened|4|||
161828313|NCT01588548|584411604|FG004|Overall Study|Condition Under Investigation Worsened|3|||
161828314|NCT01588548|584411605|FG005|Overall Study|Condition Under Investigation Worsened|3|||
161828315|NCT01835548|584411608|FG000|Dose Optimization Period|Adverse Event|0|||
161828316|NCT01835548|584411609|FG001|Dose Optimization Period|Adverse Event|0|||
161828317|NCT01835548|584411610|FG002|Dose Optimization Period|Adverse Event|1|||
161828318|NCT01835548|584411608|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
161828319|NCT01835548|584411609|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
161828320|NCT01835548|584411610|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
161828321|NCT01835548|584411608|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161828322|NCT01835548|584411609|FG001|Double-Blind Treatment Period|Adverse Event|1|||
162021808|NCT00588861|585137835|FG001|10 Years|Incomplete due to study termination|114|||
161828323|NCT01835548|584411610|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161828324|NCT01835548|584411608|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161828325|NCT01835548|584411609|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161828326|NCT01835548|584411610|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161828327|NCT01169038|584411611|FG000|Overall Study|Death|1|||
161828328|NCT01169038|584411611|FG000|Overall Study|Adverse Event|5|||
161828329|NCT01169038|584411611|FG000|Overall Study|Required antibiotic administration|1|||
161828330|NCT01634854|584411612|FG000|Overall Study|Cesarean delivery|2|||
161828331|NCT01634854|584411613|FG001|Overall Study|Cesarean delivery|7|||
161828332|NCT02490800|584411614|FG000|Overall Study|Adverse Event|0|||
161828333|NCT02490800|584411615|FG001|Overall Study|Adverse Event|0|||
161828334|NCT02490800|584411616|FG002|Overall Study|Adverse Event|0|||
161828335|NCT02490800|584411617|FG003|Overall Study|Adverse Event|2|||
161828336|NCT02490800|584411618|FG004|Overall Study|Adverse Event|3|||
161828337|NCT02490800|584411619|FG005|Overall Study|Adverse Event|2|||
161828338|NCT02490800|584411620|FG006|Overall Study|Adverse Event|0|||
162021809|NCT00490529|585137840|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
162021810|NCT00490529|585137840|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
162021811|NCT00490529|585137840|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
162021812|NCT00490529|585137840|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
162021813|NCT00490529|585137840|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
162021814|NCT00490529|585137840|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
162021815|NCT02617485|585137850|FG000|Treatment and Observation Period|Adverse Event|9|||
162021816|NCT02617485|585137851|FG001|Treatment and Observation Period|Adverse Event|1|||
162021817|NCT02617485|585137850|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
162021818|NCT02617485|585137851|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
162021819|NCT02617485|585137850|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
162021820|NCT02617485|585137851|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
162021821|NCT02617485|585137850|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
162021822|NCT02617485|585137851|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
162021823|NCT02617485|585137850|FG000|Treatment and Observation Period|Physician Decision|0|||
162021824|NCT02617485|585137851|FG001|Treatment and Observation Period|Physician Decision|1|||
161828339|NCT02490800|584411621|FG007|Overall Study|Adverse Event|0|||
162021825|NCT02617485|585137850|FG000|Follow-up Period|Adverse Event|1|||
162021826|NCT02617485|585137851|FG001|Follow-up Period|Adverse Event|0|||
162021827|NCT02617485|585137850|FG000|Follow-up Period|Withdrawal by Subject|1|||
162021828|NCT02617485|585137851|FG001|Follow-up Period|Withdrawal by Subject|0|||
162021829|NCT02617485|585137850|FG000|Follow-up Period|Disease progression|2|||
161828340|NCT02490800|584411622|FG008|Overall Study|Adverse Event|0|||
161828341|NCT02490800|584411623|FG009|Overall Study|Adverse Event|0|||
161828342|NCT02490800|584411624|FG010|Overall Study|Adverse Event|0|||
161828343|NCT02490800|584411625|FG011|Overall Study|Adverse Event|2|||
161828344|NCT02490800|584411626|FG012|Overall Study|Adverse Event|2|||
161828345|NCT02490800|584411614|FG000|Overall Study|Withdrawal by Subject|0|||
161828346|NCT02490800|584411615|FG001|Overall Study|Withdrawal by Subject|0|||
161828347|NCT02490800|584411616|FG002|Overall Study|Withdrawal by Subject|0|||
161828348|NCT02490800|584411617|FG003|Overall Study|Withdrawal by Subject|1|||
161828349|NCT02490800|584411618|FG004|Overall Study|Withdrawal by Subject|0|||
161828350|NCT02490800|584411619|FG005|Overall Study|Withdrawal by Subject|0|||
161828351|NCT02490800|584411620|FG006|Overall Study|Withdrawal by Subject|0|||
161828352|NCT02490800|584411621|FG007|Overall Study|Withdrawal by Subject|0|||
161828353|NCT02490800|584411622|FG008|Overall Study|Withdrawal by Subject|1|||
161828354|NCT02490800|584411623|FG009|Overall Study|Withdrawal by Subject|0|||
161828355|NCT02490800|584411624|FG010|Overall Study|Withdrawal by Subject|0|||
161828356|NCT02490800|584411625|FG011|Overall Study|Withdrawal by Subject|0|||
162021830|NCT02617485|585137851|FG001|Follow-up Period|Disease progression|1|||
162021831|NCT02617485|585137850|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
162021832|NCT02617485|585137851|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
162021833|NCT02617485|585137850|FG000|Follow-up Period|Patient needed radiotherapy|9|||
162021834|NCT02617485|585137851|FG001|Follow-up Period|Patient needed radiotherapy|5|||
162021835|NCT02617485|585137850|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
162021836|NCT02617485|585137851|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
162021837|NCT00791076|585137855|FG000|Overall Study|Study was terminated,PI left institution|8|||
162218696|NCT01810939|585851841|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
162218697|NCT01810939|585851842|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
162218698|NCT01810939|585851840|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
162218699|NCT01810939|585851841|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
162218700|NCT01810939|585851842|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
162218701|NCT01810939|585851840|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
162218702|NCT01810939|585851841|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
162218703|NCT01810939|585851842|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
162218704|NCT01810939|585851840|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
162218705|NCT01810939|585851841|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
162218706|NCT01810939|585851842|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
162218707|NCT01810939|585851840|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
162218708|NCT01810939|585851841|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
162218709|NCT01810939|585851842|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
162218710|NCT01810939|585851840|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
162218711|NCT01810939|585851841|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
162218712|NCT01810939|585851842|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
162218713|NCT01810939|585851840|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
162218714|NCT01810939|585851841|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
162021838|NCT00669409|585137856|FG000|Part 2|Withdrawal by Subject|0|||
162021839|NCT00669409|585137857|FG001|Part 2|Withdrawal by Subject|0|||
162021840|NCT00669409|585137858|FG002|Part 2|Withdrawal by Subject|0|||
162021841|NCT00669409|585137859|FG003|Part 2|Withdrawal by Subject|0|||
162021842|NCT00669409|585137860|FG004|Part 2|Withdrawal by Subject|0|||
162021843|NCT00669409|585137861|FG005|Part 2|Withdrawal by Subject|0|||
162021844|NCT00669409|585137862|FG006|Part 2|Withdrawal by Subject|0|||
162021845|NCT00669409|585137863|FG007|Part 2|Withdrawal by Subject|0|||
162021846|NCT00669409|585137864|FG008|Part 2|Withdrawal by Subject|0|||
162021847|NCT00669409|585137865|FG009|Part 2|Withdrawal by Subject|1|||
161828357|NCT02490800|584411626|FG012|Overall Study|Withdrawal by Subject|0|||
161828358|NCT02490800|584411614|FG000|Overall Study|Progressive disease|3|||
161828359|NCT02490800|584411615|FG001|Overall Study|Progressive disease|3|||
161828360|NCT02490800|584411616|FG002|Overall Study|Progressive disease|3|||
161828361|NCT02490800|584411617|FG003|Overall Study|Progressive disease|4|||
161828362|NCT02490800|584411618|FG004|Overall Study|Progressive disease|4|||
161828363|NCT02490800|584411619|FG005|Overall Study|Progressive disease|1|||
161828364|NCT02490800|584411620|FG006|Overall Study|Progressive disease|4|||
161828365|NCT02490800|584411621|FG007|Overall Study|Progressive disease|3|||
161828366|NCT02490800|584411622|FG008|Overall Study|Progressive disease|6|||
161828367|NCT02490800|584411623|FG009|Overall Study|Progressive disease|2|||
162021848|NCT00669409|585137866|FG010|Part 2|Withdrawal by Subject|0|||
162021849|NCT00095940|585137869|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
162021850|NCT00095940|585137870|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
162218715|NCT01810939|585851842|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
162218716|NCT01810939|585851840|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
162218717|NCT01810939|585851841|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
162218718|NCT01810939|585851842|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
162218719|NCT01810939|585851840|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
162218720|NCT01810939|585851841|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
162218721|NCT01810939|585851842|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
162218722|NCT01810939|585851840|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
162218723|NCT01810939|585851841|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
162218724|NCT01810939|585851842|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
162218725|NCT01810939|585851840|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
162218726|NCT01810939|585851841|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
162218727|NCT01810939|585851842|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
162218728|NCT04497389|585851845|FG000|Overall Study|Withdrawal by Subject|1|||
162218729|NCT04497389|585851846|FG001|Overall Study|Withdrawal by Subject|0|||
162218730|NCT04400487|585851847|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
162021851|NCT00095940|585137871|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
162021852|NCT00095940|585137872|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
162021853|NCT00095940|585137873|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
162021854|NCT00095940|585137874|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
162021855|NCT00095940|585137875|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
161828368|NCT02490800|584411624|FG010|Overall Study|Progressive disease|7|||
161828369|NCT02490800|584411625|FG011|Overall Study|Progressive disease|1|||
161828370|NCT02490800|584411626|FG012|Overall Study|Progressive disease|10|||
162218731|NCT04400487|585851847|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
162218732|NCT04400487|585851847|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
162218733|NCT03322540|585851853|FG000|Overall Study|Death|21|||
162218734|NCT03322540|585851854|FG001|Overall Study|Death|28|||
162218735|NCT03322540|585851853|FG000|Overall Study|Lost to Follow-up|0|||
162218736|NCT03322540|585851854|FG001|Overall Study|Lost to Follow-up|1|||
162218737|NCT03322540|585851853|FG000|Overall Study|Physician Decision|7|||
162218738|NCT03322540|585851854|FG001|Overall Study|Physician Decision|6|||
162218739|NCT03322540|585851853|FG000|Overall Study|Withdrawal by Subject|3|||
162218740|NCT03322540|585851854|FG001|Overall Study|Withdrawal by Subject|1|||
162218741|NCT03322540|585851853|FG000|Overall Study|Study terminated by sponsor|0|||
162218742|NCT03322540|585851854|FG001|Overall Study|Study terminated by sponsor|1|||
162218743|NCT01594827|585851857|FG000|Overall Study|Adverse Event|1|||
162218744|NCT01594827|585851858|FG001|Overall Study|Adverse Event|0|||
162218745|NCT01594827|585851857|FG000|Overall Study|Physician Decision|3|||
162218746|NCT01594827|585851858|FG001|Overall Study|Physician Decision|0|||
162218747|NCT01677299|585851859|FG000|Overall Study|Adverse Event|0|||
162218748|NCT01677299|585851860|FG001|Overall Study|Adverse Event|2|||
162218749|NCT01677299|585851861|FG002|Overall Study|Adverse Event|1|||
162218750|NCT01677299|585851862|FG003|Overall Study|Adverse Event|0|||
162218751|NCT01677299|585851859|FG000|Overall Study|Withdrawal by Subject|0|||
162218752|NCT01677299|585851860|FG001|Overall Study|Withdrawal by Subject|1|||
162218753|NCT01677299|585851861|FG002|Overall Study|Withdrawal by Subject|0|||
162218754|NCT01677299|585851862|FG003|Overall Study|Withdrawal by Subject|1|||
162218755|NCT02153905|585851863|FG000|Overall Study|Death|1|||
162218756|NCT02153905|585851864|FG001|Overall Study|Death|0|||
162218757|NCT00520845|585851865|FG000|Overall Study|Death|3|||
162218758|NCT00520845|585851865|FG000|Overall Study|Adverse Event|4|||
162218759|NCT00520845|585851865|FG000|Overall Study|Disease Progression, relapse|13|||
162218760|NCT00520845|585851865|FG000|Overall Study|Withdrawal by Subject|1|||
162218761|NCT00520845|585851865|FG000|Overall Study|Alternative Therapy|1|||
161828371|NCT02490800|584411614|FG000|Overall Study|Patient enrolled in post-trial access|0|||
162218762|NCT00351377|585851867|FG000|Overall Study|Adverse Event|5|||
162218763|NCT00351377|585851867|FG000|Overall Study|Death|1|||
162218764|NCT00351377|585851867|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162218765|NCT02493062|585851869|FG000|Overall Study|Physician Decision|12|||
162218766|NCT03926195|585851870|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
162218767|NCT03926195|585851871|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
162218768|NCT03926195|585851870|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
161828372|NCT02490800|584411615|FG001|Overall Study|Patient enrolled in post-trial access|0|||
161828373|NCT02490800|584411616|FG002|Overall Study|Patient enrolled in post-trial access|0|||
161828374|NCT02490800|584411617|FG003|Overall Study|Patient enrolled in post-trial access|0|||
161828375|NCT02490800|584411618|FG004|Overall Study|Patient enrolled in post-trial access|0|||
161828376|NCT02490800|584411619|FG005|Overall Study|Patient enrolled in post-trial access|0|||
161828377|NCT02490800|584411620|FG006|Overall Study|Patient enrolled in post-trial access|0|||
161828378|NCT02490800|584411621|FG007|Overall Study|Patient enrolled in post-trial access|0|||
162218769|NCT03926195|585851871|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
162236627|NCT02581631|585917011|FG000|Overall Study|Other Reasons|1|||
162021856|NCT00095940|585137876|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
162021857|NCT00095940|585137877|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
162021858|NCT00095940|585137869|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
162021859|NCT00095940|585137870|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
162021860|NCT00095940|585137871|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
162021861|NCT00095940|585137872|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
161828379|NCT02490800|584411622|FG008|Overall Study|Patient enrolled in post-trial access|0|||
161828380|NCT02490800|584411623|FG009|Overall Study|Patient enrolled in post-trial access|1|||
161828381|NCT02490800|584411624|FG010|Overall Study|Patient enrolled in post-trial access|1|||
161828382|NCT02490800|584411625|FG011|Overall Study|Patient enrolled in post-trial access|0|||
161828383|NCT02490800|584411626|FG012|Overall Study|Patient enrolled in post-trial access|6|||
161828384|NCT03257254|584411627|FG000|Overall Study|Withdrawal by Subject|7|||
161828385|NCT03257254|584411627|FG000|Overall Study|Lost to Follow-up|9|||
161828386|NCT03257254|584411627|FG000|Overall Study|Study discontinued by sponsor|5|||
161828387|NCT02219308|584411628|FG000|Overall Study|Withdrawal by Subject|1|||
161828388|NCT02219308|584411629|FG001|Overall Study|Withdrawal by Subject|2|||
162218770|NCT03926195|585851870|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
162218771|NCT03926195|585851871|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
162218772|NCT03926195|585851870|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
162218773|NCT03926195|585851871|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
162218774|NCT03926195|585851870|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
162218775|NCT03926195|585851871|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
162218776|NCT03926195|585851870|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
161828389|NCT03581188|584413531|FG000|Overall Study|Inclusion criteria not met|3|||
161828390|NCT03581188|584413532|FG001|Overall Study|Inclusion criteria not met|2|||
161828391|NCT03581188|584413531|FG000|Overall Study|Lost to Follow-up|5|||
161828392|NCT03581188|584413532|FG001|Overall Study|Lost to Follow-up|5|||
161828393|NCT03581188|584413531|FG000|Overall Study|Discontinued intervention|11|||
162021862|NCT00095940|585137873|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
162021863|NCT00095940|585137874|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
162021864|NCT00095940|585137875|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
162021865|NCT00095940|585137876|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
162021866|NCT00095940|585137877|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
162021867|NCT00095940|585137869|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
162021868|NCT00095940|585137870|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
162021869|NCT00095940|585137871|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
162021870|NCT00095940|585137872|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
162021871|NCT00095940|585137873|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
162021872|NCT00095940|585137874|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
162021873|NCT00095940|585137875|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
162021874|NCT00095940|585137876|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
162021875|NCT00095940|585137877|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
162021876|NCT01716052|585137878|FG000|Overall Study|Withdrawal of funding|1|||
162021877|NCT01716052|585137879|FG001|Overall Study|Withdrawal of funding|1|||
162021878|NCT02864862|585137885|FG000|Overall Study|Lost to Follow-up|1|||
162021879|NCT02864862|585137886|FG001|Overall Study|Lost to Follow-up|0|||
162021880|NCT02864862|585137887|FG002|Overall Study|Lost to Follow-up|1|||
162021881|NCT02864862|585137885|FG000|Overall Study|Protocol Violation|0|||
162021882|NCT02864862|585137886|FG001|Overall Study|Protocol Violation|0|||
162021883|NCT02864862|585137887|FG002|Overall Study|Protocol Violation|1|||
162021884|NCT01523275|585137891|FG000|Overall Study|Lost to Follow-up|1|||
162021885|NCT01523275|585137892|FG001|Overall Study|Lost to Follow-up|2|||
162021886|NCT01523275|585137891|FG000|Overall Study|Withdrawal by Subject|1|||
162021887|NCT01523275|585137892|FG001|Overall Study|Withdrawal by Subject|0|||
162021888|NCT03263702|585137893|FG000|Overall Study|Lost to Follow-up|2|||
161828394|NCT03581188|584413532|FG001|Overall Study|Discontinued intervention|8|||
161828395|NCT00109837|584413535|FG000|Overall Study|Adverse Event|2|||
161828396|NCT00109837|584413535|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
161828397|NCT00109837|584413535|FG000|Overall Study|Death|1|||
161828398|NCT00109837|584413535|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
161828399|NCT00109837|584413535|FG000|Overall Study|Not treated|1|||
161828400|NCT00109837|584413535|FG000|Overall Study|Ineligible|1|||
161828401|NCT01989676|584413536|FG000|Overall Study|Death|52|||
161828402|NCT01989676|584413537|FG001|Overall Study|Death|60|||
161828403|NCT01989676|584413536|FG000|Overall Study|Protocol Violation|2|||
161828404|NCT01989676|584413537|FG001|Overall Study|Protocol Violation|1|||
161828405|NCT01989676|584413536|FG000|Overall Study|Lost to Follow-up|8|||
161828406|NCT01989676|584413537|FG001|Overall Study|Lost to Follow-up|18|||
161828407|NCT01989676|584413536|FG000|Overall Study|No longer willing to participate in study|26|||
161828408|NCT01989676|584413537|FG001|Overall Study|No longer willing to participate in study|26|||
161828409|NCT01989676|584413536|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
161828410|NCT01989676|584413537|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
161828411|NCT01989676|584413536|FG000|Overall Study|Other|4|||
161828412|NCT01989676|584413537|FG001|Overall Study|Other|3|||
161828413|NCT01619579|584413538|FG000|Overall Study|Withdrawal by Subject|0|||
161828414|NCT01619579|584413539|FG001|Overall Study|Withdrawal by Subject|3|||
161828415|NCT02190279|584413541|FG000|Overall Study|Withdrawal consent|1|||
161828416|NCT02190279|584413542|FG001|Overall Study|Withdrawal consent|0|||
161828417|NCT02190279|584413543|FG002|Overall Study|Withdrawal consent|1|||
161828418|NCT02190279|584413541|FG000|Overall Study|Lost to Follow-up|2|||
161828419|NCT02190279|584413542|FG001|Overall Study|Lost to Follow-up|0|||
161828420|NCT02190279|584413543|FG002|Overall Study|Lost to Follow-up|0|||
161828421|NCT02190279|584413541|FG000|Overall Study|Refused further treatment|0|||
161828422|NCT02190279|584413542|FG001|Overall Study|Refused further treatment|0|||
161828423|NCT02190279|584413543|FG002|Overall Study|Refused further treatment|1|||
161828424|NCT02190279|584413541|FG000|Overall Study|Screening failure|0|||
161828425|NCT02190279|584413542|FG001|Overall Study|Screening failure|0|||
161828426|NCT02190279|584413543|FG002|Overall Study|Screening failure|1|||
161828427|NCT02688387|584413544|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828428|NCT02688387|584413545|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828429|NCT02688387|584413546|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
161828430|NCT02688387|584413547|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828431|NCT02688387|584413548|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828432|NCT02688387|584413549|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828433|NCT02688387|584413550|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828434|NCT02688387|584413551|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828435|NCT02688387|584413552|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828436|NCT02688387|584413553|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828437|NCT02688387|584413554|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828438|NCT02688387|584413555|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828439|NCT02688387|584413556|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828440|NCT02688387|584413557|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828441|NCT02688387|584413558|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828442|NCT02688387|584413559|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828443|NCT02688387|584413560|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828444|NCT02688387|584413561|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828445|NCT02688387|584413562|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828446|NCT02688387|584413563|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828447|NCT02688387|584413564|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828448|NCT02688387|584413565|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161828449|NCT02688387|584413544|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828450|NCT02688387|584413545|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828451|NCT02688387|584413546|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828452|NCT02688387|584413547|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
161828453|NCT02688387|584413548|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828454|NCT02688387|584413549|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828455|NCT02688387|584413550|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828456|NCT02688387|584413551|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828457|NCT02688387|584413552|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828458|NCT02688387|584413553|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
162021889|NCT03263702|585137894|FG001|Overall Study|Lost to Follow-up|2|||
162021890|NCT03263702|585137893|FG000|Overall Study|Withdrawal by Subject|1|||
162021891|NCT03263702|585137894|FG001|Overall Study|Withdrawal by Subject|2|||
162021892|NCT03598114|585137895|FG000|Overall Study|Staff turnover/left the program|3|||
162021893|NCT03598114|585137896|FG001|Overall Study|Staff turnover/left the program|39|||
162021894|NCT02527200|585137897|FG000|Overall Study|Withdrawal by Subject|3|||
161678542|NCT02716675|583876007|FG002|Overall Study|Withdrawal by Subject|20|||
161678543|NCT02716675|583876005|FG000|Overall Study|Protocol Violation|0|||
162021895|NCT02527200|585137898|FG001|Overall Study|Withdrawal by Subject|2|||
162021896|NCT02527200|585137899|FG002|Overall Study|Withdrawal by Subject|1|||
162021897|NCT02527200|585137900|FG003|Overall Study|Withdrawal by Subject|0|||
162021898|NCT02527200|585137897|FG000|Overall Study|Unclassified|0|||
162021899|NCT02527200|585137898|FG001|Overall Study|Unclassified|1|||
161678544|NCT02716675|583876006|FG001|Overall Study|Protocol Violation|3|||
161678545|NCT02716675|583876007|FG002|Overall Study|Protocol Violation|1|||
162021900|NCT02527200|585137899|FG002|Overall Study|Unclassified|0|||
162021901|NCT02527200|585137900|FG003|Overall Study|Unclassified|0|||
162021902|NCT02527200|585137897|FG000|Overall Study|Lost to Follow-up|0|||
162021903|NCT02527200|585137898|FG001|Overall Study|Lost to Follow-up|0|||
162021904|NCT02527200|585137899|FG002|Overall Study|Lost to Follow-up|1|||
161678546|NCT02716675|583876005|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
161678547|NCT02716675|583876006|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
162021905|NCT02527200|585137900|FG003|Overall Study|Lost to Follow-up|0|||
161678548|NCT02716675|583876007|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
162021906|NCT00966875|585137901|FG000|Part A|Adverse Event|2|||
162021907|NCT00966875|585137902|FG001|Part A|Adverse Event|1|||
162021908|NCT00966875|585137903|FG002|Part A|Adverse Event|0|||
162021909|NCT00966875|585137904|FG003|Part A|Adverse Event|1|||
162021910|NCT00966875|585137905|FG004|Part A|Adverse Event|0|||
162021911|NCT00966875|585137906|FG005|Part A|Adverse Event|1|||
162021912|NCT00966875|585137907|FG006|Part A|Adverse Event|0|||
162021913|NCT00966875|585137908|FG007|Part A|Adverse Event|3|||
162021914|NCT00966875|585137909|FG008|Part A|Adverse Event|3|||
162021915|NCT00966875|585137901|FG000|Part A|Entry Criteria|0|||
162021916|NCT00966875|585137902|FG001|Part A|Entry Criteria|0|||
162021917|NCT00966875|585137903|FG002|Part A|Entry Criteria|0|||
162021918|NCT00966875|585137904|FG003|Part A|Entry Criteria|0|||
162021919|NCT00966875|585137905|FG004|Part A|Entry Criteria|0|||
162021920|NCT00966875|585137906|FG005|Part A|Entry Criteria|2|||
162021921|NCT00966875|585137907|FG006|Part A|Entry Criteria|0|||
162021922|NCT00966875|585137908|FG007|Part A|Entry Criteria|0|||
161828459|NCT02688387|584413554|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828460|NCT02688387|584413555|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828461|NCT02688387|584413556|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828462|NCT02688387|584413557|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828463|NCT02688387|584413558|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828464|NCT02688387|584413559|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828465|NCT02688387|584413560|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828466|NCT02688387|584413561|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828467|NCT02688387|584413562|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828468|NCT02688387|584413563|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828469|NCT02688387|584413564|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828470|NCT02688387|584413565|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828471|NCT02688387|584413544|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828472|NCT02688387|584413545|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
161828473|NCT02688387|584413546|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828474|NCT02688387|584413547|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828475|NCT02688387|584413548|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828476|NCT02688387|584413549|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828477|NCT02688387|584413550|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828478|NCT02688387|584413551|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828479|NCT02688387|584413552|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162021923|NCT00966875|585137909|FG008|Part A|Entry Criteria|0|||
162021924|NCT00966875|585137901|FG000|Part A|Lack of Efficacy|0|||
162021925|NCT00966875|585137902|FG001|Part A|Lack of Efficacy|1|||
162021926|NCT00966875|585137903|FG002|Part A|Lack of Efficacy|0|||
162021927|NCT00966875|585137904|FG003|Part A|Lack of Efficacy|0|||
162021928|NCT00966875|585137905|FG004|Part A|Lack of Efficacy|0|||
162021929|NCT00966875|585137906|FG005|Part A|Lack of Efficacy|0|||
162021930|NCT00966875|585137907|FG006|Part A|Lack of Efficacy|4|||
162021931|NCT00966875|585137908|FG007|Part A|Lack of Efficacy|0|||
162021932|NCT00966875|585137909|FG008|Part A|Lack of Efficacy|0|||
162021933|NCT00966875|585137901|FG000|Part A|Lost to Follow-up|2|||
162021934|NCT00966875|585137902|FG001|Part A|Lost to Follow-up|0|||
162021935|NCT00966875|585137903|FG002|Part A|Lost to Follow-up|0|||
162021936|NCT00966875|585137904|FG003|Part A|Lost to Follow-up|0|||
162021937|NCT00966875|585137905|FG004|Part A|Lost to Follow-up|0|||
162021938|NCT00966875|585137906|FG005|Part A|Lost to Follow-up|1|||
162021939|NCT00966875|585137907|FG006|Part A|Lost to Follow-up|0|||
162021940|NCT00966875|585137908|FG007|Part A|Lost to Follow-up|0|||
162021941|NCT00966875|585137909|FG008|Part A|Lost to Follow-up|0|||
162021942|NCT00966875|585137901|FG000|Part A|Parent/Caregiver Decision|0|||
162021943|NCT00966875|585137902|FG001|Part A|Parent/Caregiver Decision|0|||
162021944|NCT00966875|585137903|FG002|Part A|Parent/Caregiver Decision|0|||
162021945|NCT00966875|585137904|FG003|Part A|Parent/Caregiver Decision|1|||
162021946|NCT00966875|585137905|FG004|Part A|Parent/Caregiver Decision|0|||
162021947|NCT00966875|585137906|FG005|Part A|Parent/Caregiver Decision|0|||
161828480|NCT02688387|584413553|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828481|NCT02688387|584413554|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162021948|NCT00966875|585137907|FG006|Part A|Parent/Caregiver Decision|0|||
162021949|NCT00966875|585137908|FG007|Part A|Parent/Caregiver Decision|0|||
162021950|NCT00966875|585137909|FG008|Part A|Parent/Caregiver Decision|0|||
162021951|NCT00966875|585137901|FG000|Part A|Physician Decision|0|||
162021952|NCT00966875|585137902|FG001|Part A|Physician Decision|0|||
162021953|NCT00966875|585137903|FG002|Part A|Physician Decision|0|||
162021954|NCT00966875|585137904|FG003|Part A|Physician Decision|0|||
162021955|NCT00966875|585137905|FG004|Part A|Physician Decision|1|||
162021956|NCT00966875|585137906|FG005|Part A|Physician Decision|0|||
162021957|NCT00966875|585137907|FG006|Part A|Physician Decision|1|||
162021958|NCT00966875|585137908|FG007|Part A|Physician Decision|0|||
162021959|NCT00966875|585137909|FG008|Part A|Physician Decision|2|||
162021960|NCT00966875|585137901|FG000|Part A|Sponsor Decision|0|||
162021961|NCT00966875|585137902|FG001|Part A|Sponsor Decision|0|||
161937602|NCT01687595|584821753|FG001|Overall Study|Sponsor's decision|0|||
161937603|NCT01687595|584821752|FG000|Overall Study|Noncompliance|1|||
161937604|NCT01687595|584821753|FG001|Overall Study|Noncompliance|2|||
161937605|NCT01687595|584821752|FG000|Overall Study|Other than specified|56|||
161937606|NCT01687595|584821753|FG001|Overall Study|Other than specified|7|||
161937607|NCT04204902|584821754|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
161937608|NCT04204902|584821755|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
161937609|NCT03829683|584821756|FG000|Overall Study|Lost to Follow-up|1|||
161937610|NCT03829683|584821757|FG001|Overall Study|Lost to Follow-up|0|||
161937611|NCT03829683|584821756|FG000|Overall Study|Physician Decision|3|||
161937612|NCT03829683|584821757|FG001|Overall Study|Physician Decision|1|||
161937613|NCT03829683|584821756|FG000|Overall Study|Withdrawal by Subject|0|||
161937614|NCT03829683|584821757|FG001|Overall Study|Withdrawal by Subject|1|||
161937615|NCT03829683|584821756|FG000|Overall Study|Discharge from hospital|1|||
161937616|NCT03829683|584821757|FG001|Overall Study|Discharge from hospital|0|||
161937617|NCT00803049|584821762|FG000|Overall Study|Adverse Event|21|||
161937618|NCT00803049|584821763|FG001|Overall Study|Adverse Event|33|||
161937619|NCT00803049|584821764|FG002|Overall Study|Adverse Event|13|||
161937620|NCT00803049|584821765|FG003|Overall Study|Adverse Event|27|||
161937621|NCT00803049|584821762|FG000|Overall Study|Lack of Efficacy|10|||
161937622|NCT00803049|584821763|FG001|Overall Study|Lack of Efficacy|19|||
161937623|NCT00803049|584821764|FG002|Overall Study|Lack of Efficacy|6|||
161937624|NCT00803049|584821765|FG003|Overall Study|Lack of Efficacy|13|||
161937625|NCT00803049|584821762|FG000|Overall Study|Lost to Follow-up|0|||
161937626|NCT00803049|584821763|FG001|Overall Study|Lost to Follow-up|2|||
161937627|NCT00803049|584821764|FG002|Overall Study|Lost to Follow-up|0|||
161937628|NCT00803049|584821765|FG003|Overall Study|Lost to Follow-up|3|||
161937629|NCT00803049|584821762|FG000|Overall Study|Death|2|||
161937630|NCT00803049|584821763|FG001|Overall Study|Death|1|||
161937631|NCT00803049|584821764|FG002|Overall Study|Death|0|||
161937632|NCT00803049|584821765|FG003|Overall Study|Death|2|||
161937633|NCT00803049|584821762|FG000|Overall Study|Progressive Disease|6|||
161937634|NCT00803049|584821763|FG001|Overall Study|Progressive Disease|10|||
161937635|NCT00803049|584821764|FG002|Overall Study|Progressive Disease|6|||
161937636|NCT00803049|584821765|FG003|Overall Study|Progressive Disease|6|||
161937637|NCT00803049|584821762|FG000|Overall Study|Withdrawal by Subject|19|||
161937638|NCT00803049|584821763|FG001|Overall Study|Withdrawal by Subject|43|||
161937639|NCT00803049|584821764|FG002|Overall Study|Withdrawal by Subject|16|||
161937640|NCT00803049|584821765|FG003|Overall Study|Withdrawal by Subject|44|||
161937641|NCT00803049|584821762|FG000|Overall Study|Protocol Violation|0|||
161937642|NCT00803049|584821763|FG001|Overall Study|Protocol Violation|1|||
161937643|NCT00803049|584821764|FG002|Overall Study|Protocol Violation|1|||
161937644|NCT00803049|584821765|FG003|Overall Study|Protocol Violation|0|||
161937645|NCT00803049|584821762|FG000|Overall Study|Randomized and Not Treated|0|||
161937646|NCT00803049|584821763|FG001|Overall Study|Randomized and Not Treated|0|||
161937647|NCT00803049|584821764|FG002|Overall Study|Randomized and Not Treated|0|||
161937648|NCT00803049|584821765|FG003|Overall Study|Randomized and Not Treated|2|||
161937649|NCT00803049|584821762|FG000|Overall Study|Other than Specified Above|3|||
161937650|NCT00803049|584821763|FG001|Overall Study|Other than Specified Above|9|||
161937651|NCT00803049|584821764|FG002|Overall Study|Other than Specified Above|2|||
161937652|NCT00803049|584821765|FG003|Overall Study|Other than Specified Above|5|||
161937653|NCT01272219|584821766|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
161937654|NCT01272219|584821767|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
161937655|NCT01272219|584821768|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
161937656|NCT01272219|584821769|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
161937657|NCT01272219|584821770|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
161937658|NCT01272219|584821771|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
161937659|NCT01272219|584821766|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
161937660|NCT01272219|584821767|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
161937661|NCT01272219|584821768|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
161937662|NCT01272219|584821769|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
161937663|NCT01272219|584821770|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
161937664|NCT01272219|584821771|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
161937665|NCT01272219|584821766|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
161937666|NCT01272219|584821767|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
161937667|NCT01272219|584821768|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
161937668|NCT01272219|584821769|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
161937669|NCT01272219|584821770|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
161937670|NCT01272219|584821771|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
161937671|NCT01272219|584821766|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
161937672|NCT01272219|584821767|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
161937673|NCT01272219|584821768|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
161937674|NCT01272219|584821769|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
161937675|NCT01272219|584821770|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
161937676|NCT01272219|584821771|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
162021962|NCT00966875|585137903|FG002|Part A|Sponsor Decision|1|||
162021963|NCT00966875|585137904|FG003|Part A|Sponsor Decision|0|||
162021964|NCT00966875|585137905|FG004|Part A|Sponsor Decision|1|||
162021965|NCT00966875|585137906|FG005|Part A|Sponsor Decision|0|||
162021966|NCT00966875|585137907|FG006|Part A|Sponsor Decision|0|||
162021967|NCT00966875|585137908|FG007|Part A|Sponsor Decision|2|||
162021968|NCT00966875|585137909|FG008|Part A|Sponsor Decision|1|||
162021969|NCT00966875|585137901|FG000|Part A|Withdrawal by Subject|2|||
162021970|NCT00966875|585137902|FG001|Part A|Withdrawal by Subject|2|||
162021971|NCT00966875|585137903|FG002|Part A|Withdrawal by Subject|1|||
162021972|NCT00966875|585137904|FG003|Part A|Withdrawal by Subject|1|||
162021973|NCT00966875|585137905|FG004|Part A|Withdrawal by Subject|3|||
162021974|NCT00966875|585137906|FG005|Part A|Withdrawal by Subject|0|||
162021975|NCT00966875|585137907|FG006|Part A|Withdrawal by Subject|5|||
162021976|NCT00966875|585137908|FG007|Part A|Withdrawal by Subject|1|||
162021977|NCT00966875|585137909|FG008|Part A|Withdrawal by Subject|1|||
162021978|NCT00966875|585137901|FG000|Part A|Protocol Violation|0|||
162021979|NCT00966875|585137902|FG001|Part A|Protocol Violation|0|||
162021980|NCT00966875|585137903|FG002|Part A|Protocol Violation|0|||
162021981|NCT00966875|585137904|FG003|Part A|Protocol Violation|0|||
162021982|NCT00966875|585137905|FG004|Part A|Protocol Violation|0|||
162021983|NCT00966875|585137906|FG005|Part A|Protocol Violation|0|||
162021984|NCT00966875|585137907|FG006|Part A|Protocol Violation|2|||
162021985|NCT00966875|585137908|FG007|Part A|Protocol Violation|1|||
162021986|NCT00966875|585137909|FG008|Part A|Protocol Violation|1|||
162021987|NCT00966875|585137901|FG000|Part B|Adverse Event|0|||
162021988|NCT00966875|585137902|FG001|Part B|Adverse Event|1|||
162021989|NCT00966875|585137903|FG002|Part B|Adverse Event|1|||
162021990|NCT00966875|585137904|FG003|Part B|Adverse Event|0|||
162021991|NCT00966875|585137905|FG004|Part B|Adverse Event|1|||
162021992|NCT00966875|585137906|FG005|Part B|Adverse Event|0|||
162021993|NCT00966875|585137907|FG006|Part B|Adverse Event|5|||
162021994|NCT00966875|585137908|FG007|Part B|Adverse Event|2|||
162021995|NCT00966875|585137909|FG008|Part B|Adverse Event|2|||
162021996|NCT00966875|585137901|FG000|Part B|Death|0|||
162021997|NCT00966875|585137902|FG001|Part B|Death|0|||
162021998|NCT00966875|585137903|FG002|Part B|Death|1|||
162021999|NCT00966875|585137904|FG003|Part B|Death|0|||
162022000|NCT00966875|585137905|FG004|Part B|Death|0|||
162022001|NCT00966875|585137906|FG005|Part B|Death|0|||
162022002|NCT00966875|585137907|FG006|Part B|Death|0|||
162022003|NCT00966875|585137908|FG007|Part B|Death|1|||
162022004|NCT00966875|585137909|FG008|Part B|Death|0|||
162022005|NCT00966875|585137901|FG000|Part B|Lack of Efficacy|2|||
162022006|NCT00966875|585137902|FG001|Part B|Lack of Efficacy|1|||
162022007|NCT00966875|585137903|FG002|Part B|Lack of Efficacy|1|||
162022008|NCT00966875|585137904|FG003|Part B|Lack of Efficacy|1|||
162022009|NCT00966875|585137905|FG004|Part B|Lack of Efficacy|2|||
162022010|NCT00966875|585137906|FG005|Part B|Lack of Efficacy|3|||
162022011|NCT00966875|585137907|FG006|Part B|Lack of Efficacy|12|||
162022012|NCT00966875|585137908|FG007|Part B|Lack of Efficacy|9|||
162022013|NCT00966875|585137909|FG008|Part B|Lack of Efficacy|6|||
162022014|NCT00966875|585137901|FG000|Part B|Lost to Follow-up|0|||
162022015|NCT00966875|585137902|FG001|Part B|Lost to Follow-up|0|||
162022016|NCT00966875|585137903|FG002|Part B|Lost to Follow-up|0|||
162022017|NCT00966875|585137904|FG003|Part B|Lost to Follow-up|1|||
162022018|NCT00966875|585137905|FG004|Part B|Lost to Follow-up|0|||
162022019|NCT00966875|585137906|FG005|Part B|Lost to Follow-up|0|||
162022020|NCT00966875|585137907|FG006|Part B|Lost to Follow-up|0|||
162022021|NCT00966875|585137908|FG007|Part B|Lost to Follow-up|0|||
162022022|NCT00966875|585137909|FG008|Part B|Lost to Follow-up|1|||
162022023|NCT00966875|585137901|FG000|Part B|Physician Decision|0|||
162022024|NCT00966875|585137902|FG001|Part B|Physician Decision|0|||
162022025|NCT00966875|585137903|FG002|Part B|Physician Decision|1|||
162022026|NCT00966875|585137904|FG003|Part B|Physician Decision|0|||
162022027|NCT00966875|585137905|FG004|Part B|Physician Decision|2|||
162022028|NCT00966875|585137906|FG005|Part B|Physician Decision|1|||
162022029|NCT00966875|585137907|FG006|Part B|Physician Decision|0|||
162022030|NCT00966875|585137908|FG007|Part B|Physician Decision|0|||
162022031|NCT00966875|585137909|FG008|Part B|Physician Decision|2|||
162022032|NCT00966875|585137901|FG000|Part B|Sponsor Decision|1|||
162022033|NCT00966875|585137902|FG001|Part B|Sponsor Decision|0|||
162022034|NCT00966875|585137903|FG002|Part B|Sponsor Decision|0|||
162022035|NCT00966875|585137904|FG003|Part B|Sponsor Decision|0|||
162022036|NCT00966875|585137905|FG004|Part B|Sponsor Decision|0|||
162022037|NCT00966875|585137906|FG005|Part B|Sponsor Decision|1|||
162022038|NCT00966875|585137907|FG006|Part B|Sponsor Decision|0|||
162022039|NCT00966875|585137908|FG007|Part B|Sponsor Decision|2|||
162022040|NCT00966875|585137909|FG008|Part B|Sponsor Decision|1|||
162022041|NCT00966875|585137901|FG000|Part B|Withdrawal by Subject|2|||
162022042|NCT00966875|585137902|FG001|Part B|Withdrawal by Subject|1|||
162022043|NCT00966875|585137903|FG002|Part B|Withdrawal by Subject|2|||
162022044|NCT00966875|585137904|FG003|Part B|Withdrawal by Subject|1|||
162022045|NCT00966875|585137905|FG004|Part B|Withdrawal by Subject|2|||
161678549|NCT02716675|583876005|FG000|Overall Study|Other|38|||
161678550|NCT02716675|583876006|FG001|Overall Study|Other|47|||
161678551|NCT02716675|583876007|FG002|Overall Study|Other|48|||
161678552|NCT00290290|583876012|FG000|Overall Study|Death|3|||
161678553|NCT00290290|583876013|FG001|Overall Study|Death|4|||
161678554|NCT00290290|583876012|FG000|Overall Study|Withdrawal by Subject|2|||
161678555|NCT00290290|583876013|FG001|Overall Study|Withdrawal by Subject|2|||
161678556|NCT00290290|583876012|FG000|Overall Study|Underwent clean surgical procedure|13|||
161678557|NCT00290290|583876013|FG001|Overall Study|Underwent clean surgical procedure|12|||
161678558|NCT00003895|583876018|FG000|Overall Study|Adverse Event|4|||
161678559|NCT00003895|583876019|FG001|Overall Study|Adverse Event|0|||
161678560|NCT00003895|583876018|FG000|Overall Study|Lack of Efficacy|1|||
161678561|NCT00003895|583876019|FG001|Overall Study|Lack of Efficacy|1|||
161678562|NCT00003895|583876018|FG000|Overall Study|Patient Vacation|2|||
161937677|NCT01272219|584821766|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
161937678|NCT01272219|584821767|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
161937679|NCT01272219|584821768|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
161937680|NCT01272219|584821769|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
161937681|NCT01272219|584821770|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
161937682|NCT01272219|584821771|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
161937683|NCT01272219|584821766|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
161937684|NCT01272219|584821767|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
161937685|NCT01272219|584821768|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
161937686|NCT01272219|584821769|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
161937687|NCT01272219|584821770|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
161937688|NCT01272219|584821771|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
161937689|NCT01272219|584821766|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
161937690|NCT01272219|584821767|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
161937691|NCT01272219|584821768|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
161937692|NCT01272219|584821769|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
161937693|NCT01272219|584821770|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
161937694|NCT01272219|584821771|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
161937695|NCT01272219|584821766|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
161937696|NCT01272219|584821767|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
161937697|NCT01272219|584821768|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
161937698|NCT01272219|584821769|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
161937699|NCT01272219|584821770|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
161937700|NCT01272219|584821771|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
161937701|NCT01272219|584821766|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
161937702|NCT01272219|584821767|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
161937703|NCT01272219|584821768|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
161937704|NCT01272219|584821769|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
161937705|NCT01272219|584821770|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
161937706|NCT01272219|584821771|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
161937707|NCT01272219|584821766|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
161937708|NCT01272219|584821767|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
161937709|NCT01272219|584821768|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
161937710|NCT01272219|584821769|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
161937711|NCT01272219|584821770|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
161937712|NCT01272219|584821771|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
161937713|NCT01272219|584821766|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
161937714|NCT01272219|584821767|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
161937715|NCT01272219|584821768|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
161937716|NCT01272219|584821769|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
161937717|NCT01272219|584821770|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
161937718|NCT01272219|584821771|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
161937719|NCT01272219|584821766|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
161937720|NCT01272219|584821767|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
161937721|NCT01272219|584821768|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
161937722|NCT01272219|584821769|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
161937723|NCT01272219|584821770|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
161937724|NCT01272219|584821771|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
161937725|NCT01272219|584821766|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
161937726|NCT01272219|584821767|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
161937727|NCT01272219|584821768|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
161937728|NCT01272219|584821769|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
161937729|NCT01272219|584821770|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
161678563|NCT00003895|583876019|FG001|Overall Study|Patient Vacation|0|||
162022046|NCT00966875|585137906|FG005|Part B|Withdrawal by Subject|1|||
162022047|NCT00966875|585137907|FG006|Part B|Withdrawal by Subject|4|||
162022048|NCT00966875|585137908|FG007|Part B|Withdrawal by Subject|5|||
162022049|NCT00966875|585137909|FG008|Part B|Withdrawal by Subject|5|||
162022050|NCT00966875|585137901|FG000|Part B|Entry Criteria|0|||
162022051|NCT00966875|585137902|FG001|Part B|Entry Criteria|0|||
162022052|NCT00966875|585137903|FG002|Part B|Entry Criteria|0|||
162022053|NCT00966875|585137904|FG003|Part B|Entry Criteria|0|||
162022054|NCT00966875|585137905|FG004|Part B|Entry Criteria|0|||
162022055|NCT00966875|585137906|FG005|Part B|Entry Criteria|0|||
162022056|NCT00966875|585137907|FG006|Part B|Entry Criteria|1|||
162022057|NCT00966875|585137908|FG007|Part B|Entry Criteria|0|||
162022058|NCT00966875|585137909|FG008|Part B|Entry Criteria|1|||
162022059|NCT00444678|585137910|FG000|Overall Study|Toxicity|11|||
162022060|NCT00444678|585137910|FG000|Overall Study|Disease Progression|12|||
162022061|NCT00444678|585137910|FG000|Overall Study|Death|3|||
162022062|NCT00444678|585137910|FG000|Overall Study|Physician Decision|3|||
162022063|NCT00444678|585137910|FG000|Overall Study|Withdrawal by Subject|2|||
162022064|NCT01305577|585137913|FG000|Overall Study|Adverse Event|2|||
162022065|NCT01305577|585137914|FG001|Overall Study|Adverse Event|2|||
162022066|NCT01305577|585137915|FG002|Overall Study|Adverse Event|1|||
162022067|NCT01305577|585137913|FG000|Overall Study|Withdrawal by Subject|7|||
162022068|NCT01305577|585137914|FG001|Overall Study|Withdrawal by Subject|5|||
162022069|NCT01305577|585137915|FG002|Overall Study|Withdrawal by Subject|6|||
162022070|NCT01305577|585137913|FG000|Overall Study|Lost to Follow-up|4|||
162022071|NCT01305577|585137914|FG001|Overall Study|Lost to Follow-up|3|||
162022072|NCT01305577|585137915|FG002|Overall Study|Lost to Follow-up|2|||
162022073|NCT01305577|585137913|FG000|Overall Study|Protocol Deviation|0|||
162022074|NCT01305577|585137914|FG001|Overall Study|Protocol Deviation|1|||
162022075|NCT01305577|585137915|FG002|Overall Study|Protocol Deviation|1|||
162022076|NCT00796978|585137916|FG000|Overall Study|Cardiac adverse event|5|||
162022077|NCT00796978|585137916|FG000|Overall Study|Adverse Event|4|||
162022078|NCT00796978|585137916|FG000|Overall Study|Withdrawal by Subject|3|||
162022079|NCT01256190|585137917|FG000|Overall Study|Lost to Follow-up|2|||
162022080|NCT01256190|585137918|FG001|Overall Study|Lost to Follow-up|0|||
162022081|NCT02834793|585137919|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
162022082|NCT02834793|585137920|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
162022083|NCT02834793|585137921|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
162022084|NCT02834793|585137922|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
162022085|NCT02834793|585137919|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
162022086|NCT02834793|585137920|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
162022087|NCT02834793|585137921|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
162022088|NCT02834793|585137922|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
162022089|NCT02834793|585137919|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
162022090|NCT02834793|585137920|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
162022091|NCT02834793|585137921|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
162022092|NCT02834793|585137922|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
162022093|NCT02834793|585137919|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
162022094|NCT02834793|585137920|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
162022095|NCT02834793|585137921|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
162022096|NCT02834793|585137922|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
162022097|NCT02834793|585137919|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
162022098|NCT02834793|585137920|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
162022099|NCT02834793|585137921|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
162022100|NCT02834793|585137922|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
162022101|NCT02834793|585137919|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
162022102|NCT02834793|585137920|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
162022103|NCT02834793|585137921|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
162022104|NCT02834793|585137922|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
162022105|NCT02834793|585137919|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
162022106|NCT02834793|585137920|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
162022107|NCT02834793|585137921|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
162022108|NCT02834793|585137922|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
162022109|NCT02834793|585137919|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
162022110|NCT02834793|585137920|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
162022111|NCT02834793|585137921|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
162022112|NCT02834793|585137922|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
162022113|NCT02834793|585137919|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
162022114|NCT02834793|585137920|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
162022115|NCT02834793|585137921|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
162022116|NCT02834793|585137922|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
162022117|NCT02834793|585137919|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
162022118|NCT02834793|585137920|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
162022119|NCT02834793|585137921|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
161828482|NCT02688387|584413555|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828483|NCT02688387|584413556|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828484|NCT02688387|584413557|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828485|NCT02688387|584413558|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
162022120|NCT02834793|585137922|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
162022121|NCT02834793|585137919|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
162022122|NCT02834793|585137920|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
162022123|NCT02834793|585137921|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
162022124|NCT02834793|585137922|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
162218777|NCT03926195|585851871|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
162218778|NCT03054337|585851872|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
162218779|NCT03054337|585851873|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
162218780|NCT03054337|585851874|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
162218781|NCT03054337|585851875|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
162218782|NCT03054337|585851876|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
162218783|NCT03054337|585851877|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
162218784|NCT01327612|585851878|FG000|Overall Study|Withdrawal by Subject|0|||
162218785|NCT01327612|585851879|FG001|Overall Study|Withdrawal by Subject|0|||
162218786|NCT01327612|585851880|FG002|Overall Study|Withdrawal by Subject|0|||
162218787|NCT01327612|585851881|FG003|Overall Study|Withdrawal by Subject|0|||
162218788|NCT01327612|585851882|FG004|Overall Study|Withdrawal by Subject|0|||
162218789|NCT01327612|585851883|FG005|Overall Study|Withdrawal by Subject|1|||
161678564|NCT00003895|583876018|FG000|Overall Study|Withdrawal by Subject|0|||
161942243|NCT00663260|584838358|FG002|Overall Study|Lost to Follow-up|0|||
162022125|NCT02834793|585137919|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
162022126|NCT02834793|585137920|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
162022127|NCT02834793|585137921|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
162022128|NCT02834793|585137922|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
162022129|NCT02834793|585137919|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
162022130|NCT02834793|585137920|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
162022131|NCT02834793|585137921|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
162022132|NCT02834793|585137922|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
162022133|NCT02834793|585137919|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
162022134|NCT02834793|585137920|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
162022135|NCT02834793|585137921|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
162022136|NCT02834793|585137922|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
162022137|NCT02834793|585137919|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
162022138|NCT02834793|585137920|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
162022139|NCT02834793|585137921|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
162022140|NCT02834793|585137922|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
162022141|NCT02364336|585137923|FG000|Overall Study|Adverse Event|0|||
162218790|NCT01327612|585851884|FG006|Overall Study|Withdrawal by Subject|0|||
162218791|NCT01327612|585851878|FG000|Overall Study|Disease Progression|1|||
162218792|NCT01327612|585851879|FG001|Overall Study|Disease Progression|1|||
162218793|NCT01327612|585851880|FG002|Overall Study|Disease Progression|1|||
162218794|NCT01327612|585851881|FG003|Overall Study|Disease Progression|0|||
162218795|NCT01327612|585851882|FG004|Overall Study|Disease Progression|1|||
162218796|NCT01327612|585851883|FG005|Overall Study|Disease Progression|2|||
162218797|NCT01327612|585851884|FG006|Overall Study|Disease Progression|2|||
162218798|NCT01327612|585851878|FG000|Overall Study|Administrative Decision|0|||
162236628|NCT02581631|585917012|FG001|Overall Study|Other Reasons|0|||
161942244|NCT00663260|584838356|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
161942245|NCT00663260|584838357|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
161942246|NCT00663260|584838358|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
161942247|NCT01506726|584838359|FG000|Overall Study|Adverse Event|1|||
161942248|NCT01506726|584838360|FG001|Overall Study|Adverse Event|2|||
161942249|NCT00522379|584838361|FG000|Overall Study|Adverse Event|12|||
161942250|NCT00522379|584838362|FG001|Overall Study|Adverse Event|15|||
161942251|NCT00522379|584838363|FG002|Overall Study|Adverse Event|12|||
161942252|NCT00522379|584838364|FG003|Overall Study|Adverse Event|5|||
161942253|NCT00522379|584838365|FG004|Overall Study|Adverse Event|17|||
161942254|NCT00522379|584838361|FG000|Overall Study|Lack of Efficacy|3|||
161942255|NCT00522379|584838362|FG001|Overall Study|Lack of Efficacy|0|||
161942256|NCT00522379|584838363|FG002|Overall Study|Lack of Efficacy|2|||
161942257|NCT00522379|584838364|FG003|Overall Study|Lack of Efficacy|2|||
161942258|NCT00522379|584838365|FG004|Overall Study|Lack of Efficacy|7|||
161942259|NCT00522379|584838361|FG000|Overall Study|Withdrawal by Subject|2|||
161942260|NCT00522379|584838362|FG001|Overall Study|Withdrawal by Subject|3|||
161942261|NCT00522379|584838363|FG002|Overall Study|Withdrawal by Subject|1|||
161942262|NCT00522379|584838364|FG003|Overall Study|Withdrawal by Subject|2|||
161942263|NCT00522379|584838365|FG004|Overall Study|Withdrawal by Subject|0|||
162218799|NCT01327612|585851879|FG001|Overall Study|Administrative Decision|0|||
162218800|NCT01327612|585851880|FG002|Overall Study|Administrative Decision|0|||
162218801|NCT01327612|585851881|FG003|Overall Study|Administrative Decision|1|||
162218802|NCT01327612|585851882|FG004|Overall Study|Administrative Decision|0|||
162218803|NCT01327612|585851883|FG005|Overall Study|Administrative Decision|0|||
162218804|NCT01327612|585851884|FG006|Overall Study|Administrative Decision|0|||
162218805|NCT01327612|585851878|FG000|Overall Study|Death|0|||
162218806|NCT01327612|585851879|FG001|Overall Study|Death|0|||
162218807|NCT01327612|585851880|FG002|Overall Study|Death|0|||
162218808|NCT01327612|585851881|FG003|Overall Study|Death|0|||
162218809|NCT01327612|585851882|FG004|Overall Study|Death|1|||
162218810|NCT01327612|585851883|FG005|Overall Study|Death|0|||
162218811|NCT01327612|585851884|FG006|Overall Study|Death|0|||
162218812|NCT01661205|585851887|FG000|Overall Study|Physician Decision|2|||
162218813|NCT00874731|585851889|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
162218814|NCT00874731|585851890|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
162236629|NCT02581631|585917013|FG002|Overall Study|Other Reasons|2|||
161828486|NCT02688387|584413559|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828487|NCT02688387|584413560|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828488|NCT02688387|584413561|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828489|NCT02688387|584413562|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828490|NCT02688387|584413563|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828491|NCT02688387|584413564|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828492|NCT02688387|584413565|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161828493|NCT02688387|584413544|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828494|NCT02688387|584413545|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828495|NCT02688387|584413546|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
161828496|NCT02688387|584413547|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828497|NCT02688387|584413548|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
161828498|NCT02688387|584413549|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828499|NCT02688387|584413550|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828500|NCT02688387|584413551|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828501|NCT02688387|584413552|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828502|NCT02688387|584413553|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828503|NCT02688387|584413554|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828504|NCT02688387|584413555|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828505|NCT02688387|584413556|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828506|NCT02688387|584413557|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828507|NCT02688387|584413558|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828508|NCT02688387|584413559|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828509|NCT02688387|584413560|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828510|NCT02688387|584413561|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828511|NCT02688387|584413562|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828512|NCT02688387|584413563|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828513|NCT02688387|584413564|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828514|NCT02688387|584413565|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161828515|NCT02688387|584413544|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
161828516|NCT02688387|584413545|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828517|NCT02688387|584413546|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828518|NCT02688387|584413547|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828519|NCT02688387|584413548|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828520|NCT02688387|584413549|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161942264|NCT00522379|584838361|FG000|Overall Study|Protocol Violation|1|||
161942265|NCT00522379|584838362|FG001|Overall Study|Protocol Violation|1|||
161942266|NCT00522379|584838363|FG002|Overall Study|Protocol Violation|2|||
161942267|NCT00522379|584838364|FG003|Overall Study|Protocol Violation|0|||
161942268|NCT00522379|584838365|FG004|Overall Study|Protocol Violation|0|||
161942269|NCT00522379|584838361|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
161942270|NCT00522379|584838362|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
161942271|NCT00522379|584838363|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
161942272|NCT00522379|584838364|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
161942273|NCT00522379|584838365|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
161942274|NCT00522379|584838361|FG000|Overall Study|Lost to Follow-up|1|||
161942275|NCT00522379|584838362|FG001|Overall Study|Lost to Follow-up|0|||
161942276|NCT00522379|584838363|FG002|Overall Study|Lost to Follow-up|4|||
161942277|NCT00522379|584838364|FG003|Overall Study|Lost to Follow-up|2|||
161942278|NCT00522379|584838365|FG004|Overall Study|Lost to Follow-up|2|||
162022142|NCT02364336|585137924|FG001|Overall Study|Adverse Event|1|||
162022143|NCT01731938|585137925|FG000|Preliminary Part I|Withdrawal by Subject|2|||
162022144|NCT01731938|585137926|FG001|Preliminary Part I|Withdrawal by Subject|2|||
162022145|NCT01731938|585137925|FG000|Preliminary Part I|Physician Decision|1|||
162022146|NCT01731938|585137926|FG001|Preliminary Part I|Physician Decision|0|||
162022147|NCT01731938|585137925|FG000|Preliminary Part I|Lost to Follow-up|0|||
162022148|NCT01731938|585137926|FG001|Preliminary Part I|Lost to Follow-up|3|||
162022149|NCT01731938|585137925|FG000|Preliminary Part I|Missed Week 6 visit|0|||
162022150|NCT01731938|585137926|FG001|Preliminary Part I|Missed Week 6 visit|3|||
162022151|NCT01731938|585137925|FG000|Primary Part II|Withdrawal by Subject|5|||
162022152|NCT01731938|585137926|FG001|Primary Part II|Withdrawal by Subject|4|||
162022153|NCT01731938|585137925|FG000|Primary Part II|Lost to Follow-up|4|||
162022154|NCT01731938|585137926|FG001|Primary Part II|Lost to Follow-up|5|||
162022155|NCT01731938|585137925|FG000|Primary Part II|Death|2|||
162022156|NCT01731938|585137926|FG001|Primary Part II|Death|1|||
162022157|NCT01731938|585137925|FG000|Primary Part II|Missed Week 6 visit|2|||
162022158|NCT01731938|585137926|FG001|Primary Part II|Missed Week 6 visit|3|||
162022159|NCT03319745|585137927|FG000|Overall Study|Death|1|||
162022160|NCT03319745|585137927|FG000|Overall Study|Toxicity Precluding Surgery|1|||
162022161|NCT00870103|585137928|FG000|Overall Study|Physician Decision|2|||
162022162|NCT00870103|585137928|FG000|Overall Study|Lost to Follow-up|2|||
162022163|NCT01317550|585137929|FG000|Overall Study|Withdrawal by Subject|1|||
162022164|NCT01317550|585137930|FG001|Overall Study|Withdrawal by Subject|0|||
162022165|NCT01317550|585137931|FG002|Overall Study|Withdrawal by Subject|0|||
162022166|NCT01317550|585137932|FG003|Overall Study|Withdrawal by Subject|0|||
162022167|NCT01317550|585137929|FG000|Overall Study|Lack of compliance study med|1|||
162022168|NCT01317550|585137930|FG001|Overall Study|Lack of compliance study med|0|||
162022169|NCT01317550|585137931|FG002|Overall Study|Lack of compliance study med|0|||
162022170|NCT01317550|585137932|FG003|Overall Study|Lack of compliance study med|0|||
162022171|NCT03179202|585137933|FG000|Overall Study|Screen Failure|67|||
162022172|NCT03179202|585137933|FG000|Overall Study|Subject Lost to Follow Up|12|||
162022173|NCT03179202|585137933|FG000|Overall Study|Withdrawal by Subject|7|||
162022174|NCT03179202|585137933|FG000|Overall Study|Adverse Event|3|||
162022175|NCT03179202|585137933|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
162022176|NCT03179202|585137933|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
162022177|NCT03255629|585137934|FG000|Overall Study|Adverse Event|1|||
162022178|NCT03255629|585137935|FG001|Overall Study|Adverse Event|0|||
162022179|NCT03255629|585137934|FG000|Overall Study|did not experience hypoglycemia|2|||
162022180|NCT03255629|585137935|FG001|Overall Study|did not experience hypoglycemia|1|||
162022181|NCT02779556|585137936|FG000|Baseline|Partial baseline interview completed|1|||
162022182|NCT02779556|585137937|FG001|Baseline|Partial baseline interview completed|0|||
162022183|NCT02779556|585137936|FG000|3 Months|Lost to Follow-up|40|||
162022184|NCT02779556|585137937|FG001|3 Months|Lost to Follow-up|29|||
162022185|NCT02779556|585137936|FG000|3 Months|Missed 3 month clinic visit|27|||
162022186|NCT02779556|585137937|FG001|3 Months|Missed 3 month clinic visit|19|||
162022187|NCT02779556|585137936|FG000|6 Month|Lost to Follow-up|33|||
162022188|NCT02779556|585137937|FG001|6 Month|Lost to Follow-up|39|||
162022189|NCT02779556|585137936|FG000|6 Month HbA1c|No value collected during window|69|||
162218815|NCT00874731|585851891|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
162218816|NCT00874731|585851889|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
161828521|NCT02688387|584413550|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828522|NCT02688387|584413551|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
162022190|NCT02779556|585137937|FG001|6 Month HbA1c|No value collected during window|50|||
162022191|NCT02779556|585137936|FG000|12 Month HbA1c|No value collected during window|138|||
162022192|NCT02779556|585137937|FG001|12 Month HbA1c|No value collected during window|102|||
162022193|NCT03110770|585137939|FG000|Overall Study|Death|1|||
162022194|NCT03110770|585137940|FG001|Overall Study|Death|0|||
162022195|NCT03110770|585137941|FG002|Overall Study|Death|0|||
162022196|NCT03110770|585137942|FG003|Overall Study|Death|1|||
162218817|NCT00874731|585851890|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
162022197|NCT03110770|585137943|FG004|Overall Study|Death|0|||
162022198|NCT03110770|585137939|FG000|Overall Study|Enrolled but did not receive product|0|||
162022199|NCT03110770|585137940|FG001|Overall Study|Enrolled but did not receive product|0|||
162022200|NCT03110770|585137941|FG002|Overall Study|Enrolled but did not receive product|0|||
162022201|NCT03110770|585137942|FG003|Overall Study|Enrolled but did not receive product|8|||
162022202|NCT03110770|585137943|FG004|Overall Study|Enrolled but did not receive product|7|||
162218818|NCT00874731|585851891|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
162218819|NCT00874731|585851889|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
162218820|NCT00874731|585851890|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
162218821|NCT00874731|585851891|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
162218822|NCT00955708|585851892|FG000|Overall Study|Death|269|||
162218823|NCT00955708|585851892|FG000|Overall Study|Lost to Follow-up|72|||
162218824|NCT00955708|585851892|FG000|Overall Study|Physician Decision|36|||
162218825|NCT00955708|585851892|FG000|Overall Study|Protocol Violation|134|||
162218826|NCT00955708|585851892|FG000|Overall Study|Registry Conclusion|186|||
161828523|NCT02688387|584413552|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828524|NCT02688387|584413553|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828525|NCT02688387|584413554|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828526|NCT02688387|584413555|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828527|NCT02688387|584413556|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828528|NCT02688387|584413557|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828529|NCT02688387|584413558|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828530|NCT02688387|584413559|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828531|NCT02688387|584413560|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828532|NCT02688387|584413561|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828533|NCT02688387|584413562|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828534|NCT02688387|584413563|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828535|NCT02688387|584413564|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828536|NCT02688387|584413565|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161828537|NCT02688387|584413544|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828538|NCT02688387|584413545|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828539|NCT02688387|584413546|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828540|NCT02688387|584413547|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828541|NCT02688387|584413548|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828542|NCT02688387|584413549|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828543|NCT02688387|584413550|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828544|NCT02688387|584413551|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828545|NCT02688387|584413552|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828546|NCT02688387|584413553|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162022203|NCT03110770|585137939|FG000|Overall Study|Lost to Follow-up|0|||
162022204|NCT03110770|585137940|FG001|Overall Study|Lost to Follow-up|0|||
162022205|NCT03110770|585137941|FG002|Overall Study|Lost to Follow-up|0|||
161828547|NCT02688387|584413554|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
161828548|NCT02688387|584413555|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828549|NCT02688387|584413556|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828550|NCT02688387|584413557|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162022206|NCT03110770|585137942|FG003|Overall Study|Lost to Follow-up|53|||
162022207|NCT03110770|585137943|FG004|Overall Study|Lost to Follow-up|45|||
162022208|NCT03110770|585137939|FG000|Overall Study|Investigator Decision|0|||
162022209|NCT03110770|585137940|FG001|Overall Study|Investigator Decision|0|||
162022210|NCT03110770|585137941|FG002|Overall Study|Investigator Decision|0|||
162022211|NCT03110770|585137942|FG003|Overall Study|Investigator Decision|5|||
162022212|NCT03110770|585137943|FG004|Overall Study|Investigator Decision|3|||
162022213|NCT03110770|585137939|FG000|Overall Study|Withdrawal by Subject|0|||
162022214|NCT03110770|585137940|FG001|Overall Study|Withdrawal by Subject|0|||
162022215|NCT03110770|585137941|FG002|Overall Study|Withdrawal by Subject|0|||
162022216|NCT03110770|585137942|FG003|Overall Study|Withdrawal by Subject|24|||
162022217|NCT03110770|585137943|FG004|Overall Study|Withdrawal by Subject|24|||
162022218|NCT03110770|585137939|FG000|Overall Study|Moved from area|5|||
162022219|NCT03110770|585137940|FG001|Overall Study|Moved from area|0|||
162022220|NCT03110770|585137941|FG002|Overall Study|Moved from area|2|||
162022221|NCT03110770|585137942|FG003|Overall Study|Moved from area|42|||
162022222|NCT03110770|585137943|FG004|Overall Study|Moved from area|43|||
162022223|NCT03110770|585137939|FG000|Overall Study|Illness/Injury unrelated to product|0|||
162022224|NCT03110770|585137940|FG001|Overall Study|Illness/Injury unrelated to product|0|||
162022225|NCT03110770|585137941|FG002|Overall Study|Illness/Injury unrelated to product|0|||
162022226|NCT03110770|585137942|FG003|Overall Study|Illness/Injury unrelated to product|0|||
162022227|NCT03110770|585137943|FG004|Overall Study|Illness/Injury unrelated to product|1|||
162022228|NCT01086358|585137944|FG000|First Intervention|Lost to Follow-up|9|||
162022229|NCT01086358|585137945|FG001|First Intervention|Lost to Follow-up|4|||
162022230|NCT01086358|585137944|FG000|First Intervention|Withdrawal by Subject|0|||
161678565|NCT00003895|583876019|FG001|Overall Study|Withdrawal by Subject|3|||
161828551|NCT02688387|584413558|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828552|NCT02688387|584413559|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828553|NCT02688387|584413560|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828554|NCT02688387|584413561|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
162022231|NCT01086358|585137945|FG001|First Intervention|Withdrawal by Subject|1|||
162022232|NCT01086358|585137944|FG000|Second Intervention|Lost to Follow-up|4|||
162022233|NCT01086358|585137945|FG001|Second Intervention|Lost to Follow-up|4|||
162022234|NCT02888119|585137946|FG000|Overall Study|Lost to Follow-up|5|||
162022235|NCT02888119|585137947|FG001|Overall Study|Lost to Follow-up|4|||
161678566|NCT01380730|583876020|FG000|Overall Study|Death|0|||
162022236|NCT02888119|585137948|FG002|Overall Study|Lost to Follow-up|0|||
162022237|NCT02082340|585137949|FG000|Overall Study|Lost to Follow-up|1|||
162022238|NCT02082340|585137950|FG001|Overall Study|Lost to Follow-up|1|||
162022239|NCT00833417|585137951|FG000|Overall Study|Adverse Event|5|||
162022240|NCT00833417|585137952|FG001|Overall Study|Adverse Event|16|||
162022241|NCT00833417|585137951|FG000|Overall Study|Death|1|||
161828555|NCT02688387|584413562|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828556|NCT02688387|584413563|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828557|NCT02688387|584413564|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828558|NCT02688387|584413565|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161828559|NCT02688387|584413544|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828560|NCT02688387|584413545|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828561|NCT02688387|584413546|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828562|NCT02688387|584413547|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828563|NCT02688387|584413548|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828564|NCT02688387|584413549|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828565|NCT02688387|584413550|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828566|NCT02688387|584413551|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161942279|NCT00522379|584838361|FG000|Overall Study|Randomization error|0|||
161942280|NCT00522379|584838362|FG001|Overall Study|Randomization error|0|||
161942281|NCT00522379|584838363|FG002|Overall Study|Randomization error|0|||
161942282|NCT00522379|584838364|FG003|Overall Study|Randomization error|0|||
161942283|NCT00522379|584838365|FG004|Overall Study|Randomization error|1|||
161942284|NCT00522379|584838361|FG000|Overall Study|Dispensing error|1|||
161942285|NCT00522379|584838362|FG001|Overall Study|Dispensing error|0|||
161942286|NCT00522379|584838363|FG002|Overall Study|Dispensing error|0|||
161942287|NCT00522379|584838364|FG003|Overall Study|Dispensing error|1|||
161942288|NCT00522379|584838365|FG004|Overall Study|Dispensing error|0|||
161942289|NCT00522379|584838361|FG000|Overall Study|Subject Moved|1|||
161942290|NCT00522379|584838362|FG001|Overall Study|Subject Moved|1|||
161942291|NCT00522379|584838363|FG002|Overall Study|Subject Moved|0|||
161942292|NCT00522379|584838364|FG003|Overall Study|Subject Moved|0|||
161942293|NCT00522379|584838365|FG004|Overall Study|Subject Moved|0|||
161942294|NCT00522379|584838361|FG000|Overall Study|Sponsor Request|0|||
161942295|NCT00522379|584838362|FG001|Overall Study|Sponsor Request|1|||
161942296|NCT00522379|584838363|FG002|Overall Study|Sponsor Request|0|||
161942297|NCT00522379|584838364|FG003|Overall Study|Sponsor Request|0|||
161942298|NCT00522379|584838365|FG004|Overall Study|Sponsor Request|0|||
161942299|NCT00522379|584838361|FG000|Overall Study|Family Problem|0|||
161942300|NCT00522379|584838362|FG001|Overall Study|Family Problem|0|||
161942301|NCT00522379|584838363|FG002|Overall Study|Family Problem|1|||
161942302|NCT00522379|584838364|FG003|Overall Study|Family Problem|0|||
161942303|NCT00522379|584838365|FG004|Overall Study|Family Problem|0|||
161942304|NCT00522379|584838361|FG000|Overall Study|Site Closed|0|||
161942305|NCT00522379|584838362|FG001|Overall Study|Site Closed|0|||
161942306|NCT00522379|584838363|FG002|Overall Study|Site Closed|0|||
161942307|NCT00522379|584838364|FG003|Overall Study|Site Closed|1|||
161942308|NCT00522379|584838365|FG004|Overall Study|Site Closed|0|||
161942309|NCT00522379|584838361|FG000|Overall Study|Subject Withdrawal|0|||
161942310|NCT00522379|584838362|FG001|Overall Study|Subject Withdrawal|0|||
161942311|NCT00522379|584838363|FG002|Overall Study|Subject Withdrawal|0|||
161942312|NCT00522379|584838364|FG003|Overall Study|Subject Withdrawal|1|||
161942313|NCT00522379|584838365|FG004|Overall Study|Subject Withdrawal|0|||
161942314|NCT03213509|584838366|FG000|Overall Study|Did not consent for verbal autopsy|4|||
161942315|NCT03213509|584838367|FG001|Overall Study|Did not consent for verbal autopsy|5|||
161942316|NCT02303821|584838368|FG000|Overall Study|Withdrawal by Subject|0|||
161942317|NCT02303821|584838369|FG001|Overall Study|Withdrawal by Subject|0|||
161942318|NCT02303821|584838370|FG002|Overall Study|Withdrawal by Subject|0|||
161942319|NCT02303821|584838371|FG003|Overall Study|Withdrawal by Subject|0|||
161942320|NCT02303821|584838372|FG004|Overall Study|Withdrawal by Subject|0|||
161942321|NCT02303821|584838373|FG005|Overall Study|Withdrawal by Subject|0|||
161942322|NCT02303821|584838374|FG006|Overall Study|Withdrawal by Subject|0|||
161942323|NCT02303821|584838375|FG007|Overall Study|Withdrawal by Subject|2|||
161942324|NCT02303821|584838368|FG000|Overall Study|Death|0|||
161942325|NCT02303821|584838369|FG001|Overall Study|Death|2|||
161942326|NCT02303821|584838370|FG002|Overall Study|Death|0|||
161942327|NCT02303821|584838371|FG003|Overall Study|Death|0|||
161942328|NCT02303821|584838372|FG004|Overall Study|Death|0|||
161942329|NCT02303821|584838373|FG005|Overall Study|Death|3|||
161942330|NCT02303821|584838374|FG006|Overall Study|Death|41|||
161942331|NCT02303821|584838375|FG007|Overall Study|Death|29|||
161942332|NCT02303821|584838368|FG000|Overall Study|Lost to Follow-up|0|||
161942333|NCT02303821|584838369|FG001|Overall Study|Lost to Follow-up|0|||
161942334|NCT02303821|584838370|FG002|Overall Study|Lost to Follow-up|0|||
161942335|NCT02303821|584838371|FG003|Overall Study|Lost to Follow-up|0|||
161942336|NCT02303821|584838372|FG004|Overall Study|Lost to Follow-up|0|||
161942337|NCT02303821|584838373|FG005|Overall Study|Lost to Follow-up|0|||
161942338|NCT02303821|584838374|FG006|Overall Study|Lost to Follow-up|1|||
161942339|NCT02303821|584838375|FG007|Overall Study|Lost to Follow-up|0|||
161942340|NCT02303821|584838368|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
161942341|NCT02303821|584838369|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
162022242|NCT00833417|585137952|FG001|Overall Study|Death|3|||
162022243|NCT00833417|585137951|FG000|Overall Study|Lost to Follow-up|1|||
162022244|NCT00833417|585137952|FG001|Overall Study|Lost to Follow-up|2|||
162022245|NCT00833417|585137951|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
162022246|NCT00833417|585137952|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
162022247|NCT00833417|585137951|FG000|Overall Study|Patient Decision to Withdraw|4|||
162022248|NCT00833417|585137952|FG001|Overall Study|Patient Decision to Withdraw|23|||
162022249|NCT00833417|585137951|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
162022250|NCT00833417|585137952|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
162022251|NCT00833417|585137951|FG000|Overall Study|Disease Progression|18|||
162022252|NCT00833417|585137952|FG001|Overall Study|Disease Progression|17|||
162022253|NCT00833417|585137951|FG000|Overall Study|Reason Not Specified|0|||
162022254|NCT00833417|585137952|FG001|Overall Study|Reason Not Specified|1|||
162022255|NCT01625260|585137953|FG000|Overall Study|Adverse Event|3|||
162022256|NCT01625260|585137954|FG001|Overall Study|Adverse Event|0|||
162022257|NCT01625260|585137953|FG000|Overall Study|Study Terminated by Investigator|2|||
162022258|NCT01625260|585137954|FG001|Overall Study|Study Terminated by Investigator|0|||
162022259|NCT01625260|585137953|FG000|Overall Study|Disease Progression|2|||
162022260|NCT01625260|585137954|FG001|Overall Study|Disease Progression|0|||
162022261|NCT01625260|585137953|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
162022262|NCT01625260|585137954|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
162022263|NCT05573386|585137955|FG000|Overall Study|Withdrawal by Subject|3|||
162022264|NCT05573386|585137956|FG001|Overall Study|Withdrawal by Subject|2|||
162022265|NCT03899805|585137957|FG000|Overall Study|Physician Decision|3|||
162022266|NCT03899805|585137958|FG001|Overall Study|Physician Decision|0|||
162218827|NCT00955708|585851892|FG000|Overall Study|Product removed from service|94|||
162218828|NCT00955708|585851892|FG000|Overall Study|Patient Refused to participate further|116|||
162218829|NCT00955708|585851892|FG000|Overall Study|Closure of study location|60|||
162218830|NCT00955708|585851892|FG000|Overall Study|Patient changed care provider/moved|91|||
162218831|NCT05105087|585851893|FG000|Overall Study|Withdrawal by Subject|2|||
162218832|NCT05105087|585851893|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
162218833|NCT00581477|585851898|FG000|Overall Study|Physician Decision|2|||
162218834|NCT01735175|585851899|FG000|Overall Study|Withdrawal by Subject|9|||
162218835|NCT01735175|585851900|FG001|Overall Study|Withdrawal by Subject|2|||
162218836|NCT01735175|585851899|FG000|Overall Study|Lost to Follow-up|4|||
162218837|NCT01735175|585851900|FG001|Overall Study|Lost to Follow-up|2|||
162218838|NCT01735175|585851899|FG000|Overall Study|Death|3|||
162218839|NCT01735175|585851900|FG001|Overall Study|Death|2|||
162218840|NCT01735175|585851899|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
162218841|NCT01735175|585851900|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
162218842|NCT00755417|585851901|FG000|Overall Study|Adverse Event|28|||
162218843|NCT00755417|585851902|FG001|Overall Study|Adverse Event|20|||
162218844|NCT00755417|585851903|FG002|Overall Study|Adverse Event|7|||
162218845|NCT00755417|585851901|FG000|Overall Study|Lack of Efficacy|8|||
162218846|NCT00755417|585851902|FG001|Overall Study|Lack of Efficacy|4|||
162218847|NCT00755417|585851903|FG002|Overall Study|Lack of Efficacy|9|||
162218848|NCT00755417|585851901|FG000|Overall Study|Protocol Violation|2|||
162218849|NCT00755417|585851902|FG001|Overall Study|Protocol Violation|1|||
162218850|NCT00755417|585851903|FG002|Overall Study|Protocol Violation|1|||
162218851|NCT00755417|585851901|FG000|Overall Study|Lost to Follow-up|3|||
162218852|NCT00755417|585851902|FG001|Overall Study|Lost to Follow-up|0|||
162218853|NCT00755417|585851903|FG002|Overall Study|Lost to Follow-up|1|||
162022267|NCT03899805|585137959|FG002|Overall Study|Physician Decision|2|||
162022268|NCT03899805|585137957|FG000|Overall Study|Withdrawal by Subject|1|||
162022269|NCT03899805|585137958|FG001|Overall Study|Withdrawal by Subject|0|||
162022270|NCT03899805|585137959|FG002|Overall Study|Withdrawal by Subject|2|||
162022271|NCT03899805|585137957|FG000|Overall Study|Progressive Disease|10|||
162022272|NCT03899805|585137958|FG001|Overall Study|Progressive Disease|18|||
162022273|NCT03899805|585137959|FG002|Overall Study|Progressive Disease|12|||
162022274|NCT03899805|585137957|FG000|Overall Study|Adverse Event|3|||
162022275|NCT03899805|585137958|FG001|Overall Study|Adverse Event|1|||
162022276|NCT03899805|585137959|FG002|Overall Study|Adverse Event|0|||
162022277|NCT03899805|585137957|FG000|Overall Study|Death|2|||
162022278|NCT03899805|585137958|FG001|Overall Study|Death|0|||
162022279|NCT03899805|585137959|FG002|Overall Study|Death|0|||
162022280|NCT03899805|585137957|FG000|Overall Study|Came off for surgery|0|||
162022281|NCT03899805|585137958|FG001|Overall Study|Came off for surgery|0|||
162022282|NCT03899805|585137959|FG002|Overall Study|Came off for surgery|1|||
162022283|NCT05246514|585137960|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
162022284|NCT05246514|585137960|FG000|Overall Study|Withdrawal by Subject|1|||
162022285|NCT05246514|585137960|FG000|Overall Study|Death|13|||
162022286|NCT04195893|585137961|FG000|Second Intervention|Withdrawal by Subject|1|||
162022287|NCT04195893|585137962|FG001|Second Intervention|Withdrawal by Subject|0|||
162022288|NCT01802073|585137963|FG000|Overall Study|Lost to Follow-up|0|||
162022289|NCT01802073|585137964|FG001|Overall Study|Lost to Follow-up|1|||
162022290|NCT01802073|585137963|FG000|Overall Study|Non-compliant|4|||
162218854|NCT00755417|585851901|FG000|Overall Study|Withdrawal by Subject|12|||
162022291|NCT01802073|585137964|FG001|Overall Study|Non-compliant|2|||
162022292|NCT01802073|585137963|FG000|Overall Study|Withdrawal by Subject|1|||
162022293|NCT01802073|585137964|FG001|Overall Study|Withdrawal by Subject|1|||
162022294|NCT01802073|585137963|FG000|Overall Study|Physician Decision|0|||
162022295|NCT01802073|585137964|FG001|Overall Study|Physician Decision|7|||
162022296|NCT01137604|585137968|FG000|Overall Study|Adverse Event|3|||
162022297|NCT01137604|585137969|FG001|Overall Study|Adverse Event|6|||
162022298|NCT01137604|585137970|FG002|Overall Study|Adverse Event|9|||
162022299|NCT01137604|585137971|FG003|Overall Study|Adverse Event|9|||
162022300|NCT01137604|585137968|FG000|Overall Study|Participant Choice|0|||
162022301|NCT01137604|585137969|FG001|Overall Study|Participant Choice|2|||
162022302|NCT01137604|585137970|FG002|Overall Study|Participant Choice|2|||
162022303|NCT01137604|585137971|FG003|Overall Study|Participant Choice|0|||
162022304|NCT01137604|585137968|FG000|Overall Study|Withdrawal of consent|0|||
162022305|NCT01137604|585137969|FG001|Overall Study|Withdrawal of consent|0|||
162022306|NCT01137604|585137970|FG002|Overall Study|Withdrawal of consent|0|||
162022307|NCT01137604|585137971|FG003|Overall Study|Withdrawal of consent|2|||
162022308|NCT01137604|585137968|FG000|Overall Study|Clinical progression/deterioration|1|||
162022309|NCT01137604|585137969|FG001|Overall Study|Clinical progression/deterioration|2|||
162022310|NCT01137604|585137970|FG002|Overall Study|Clinical progression/deterioration|2|||
162022311|NCT01137604|585137971|FG003|Overall Study|Clinical progression/deterioration|0|||
162022312|NCT01776307|585137972|FG000|Overall Study|Not dosed|0|||
162022313|NCT01776307|585137973|FG001|Overall Study|Not dosed|0|||
162022314|NCT01776307|585137974|FG002|Overall Study|Not dosed|1|||
162022315|NCT01297491|585137983|FG000|Overall Study|Adverse Event|11|||
162022316|NCT01297491|585137984|FG001|Overall Study|Adverse Event|6|||
162022317|NCT01297491|585137983|FG000|Overall Study|Physician Decision|3|||
162022318|NCT01297491|585137984|FG001|Overall Study|Physician Decision|2|||
162022319|NCT01297491|585137983|FG000|Overall Study|Progressive disease|11|||
162022320|NCT01297491|585137984|FG001|Overall Study|Progressive disease|20|||
162022321|NCT01297491|585137983|FG000|Overall Study|Patient/Guardian decision|3|||
162022322|NCT01297491|585137984|FG001|Overall Study|Patient/Guardian decision|4|||
162022323|NCT01297491|585137983|FG000|Overall Study|Death|2|||
162022324|NCT01297491|585137984|FG001|Overall Study|Death|1|||
162022325|NCT01327482|585137990|FG000|Overall Study|Adverse Event|1|||
162022326|NCT00312195|585137991|FG000|Overall Study|Adverse Event|4|||
162022327|NCT00312195|585137992|FG001|Overall Study|Adverse Event|6|||
162022328|NCT00312195|585137991|FG000|Overall Study|Lost to Follow-up|1|||
162022329|NCT00312195|585137992|FG001|Overall Study|Lost to Follow-up|0|||
162022330|NCT00312195|585137991|FG000|Overall Study|Protocol Violation|1|||
162022331|NCT00312195|585137992|FG001|Overall Study|Protocol Violation|0|||
162022332|NCT01018810|585137993|FG000|Overall Study|Withdrawal by Subject|0|||
162022333|NCT01018810|585137994|FG001|Overall Study|Withdrawal by Subject|1|||
162022334|NCT01018810|585137995|FG002|Overall Study|Withdrawal by Subject|0|||
162022335|NCT01018810|585137996|FG003|Overall Study|Withdrawal by Subject|0|||
162022336|NCT01018810|585137997|FG004|Overall Study|Withdrawal by Subject|0|||
162022337|NCT01018810|585137993|FG000|Overall Study|Sponsor Decision|2|||
162022338|NCT01018810|585137994|FG001|Overall Study|Sponsor Decision|0|||
162022339|NCT01018810|585137995|FG002|Overall Study|Sponsor Decision|1|||
162022340|NCT01018810|585137996|FG003|Overall Study|Sponsor Decision|1|||
162022341|NCT01018810|585137997|FG004|Overall Study|Sponsor Decision|1|||
162022342|NCT04145219|585137998|FG000|Overall Study|Adverse Event|18|||
162022343|NCT04145219|585137999|FG001|Overall Study|Adverse Event|6|||
162022344|NCT04145219|585137998|FG000|Overall Study|Lost to Follow-up|2|||
162022345|NCT04145219|585137999|FG001|Overall Study|Lost to Follow-up|3|||
162022346|NCT04145219|585137998|FG000|Overall Study|Physician Decision|0|||
162022347|NCT04145219|585137999|FG001|Overall Study|Physician Decision|2|||
162022348|NCT04145219|585137998|FG000|Overall Study|Withdrawal by Subject|12|||
162022349|NCT04145219|585137999|FG001|Overall Study|Withdrawal by Subject|8|||
162022350|NCT04145219|585137998|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
162022351|NCT04145219|585137999|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
162022352|NCT01459497|585138007|FG000|Overall Study|Inability to meet trial constraints.|1|||
162022353|NCT01459497|585138008|FG001|Overall Study|Inability to meet trial constraints.|0|||
162022354|NCT01459497|585138007|FG000|Overall Study|Physician Decision|1|||
162022355|NCT01459497|585138008|FG001|Overall Study|Physician Decision|1|||
162022356|NCT01459497|585138007|FG000|Overall Study|Hospitalization.|0|||
162022357|NCT01459497|585138008|FG001|Overall Study|Hospitalization.|3|||
162022358|NCT01459497|585138007|FG000|Overall Study|Disease progression.|0|||
162022359|NCT01459497|585138008|FG001|Overall Study|Disease progression.|1|||
162022360|NCT03530124|585138009|FG000|Overall Study|Withdrawal by Subject|0|||
162022361|NCT03530124|585138010|FG001|Overall Study|Withdrawal by Subject|1|||
162022362|NCT03530124|585138009|FG000|Overall Study|Protocol Violation|1|||
162022363|NCT03530124|585138010|FG001|Overall Study|Protocol Violation|0|||
162022364|NCT03530124|585138009|FG000|Overall Study|Discharged prior to study completion|1|||
162022365|NCT03530124|585138010|FG001|Overall Study|Discharged prior to study completion|0|||
162022366|NCT00862082|585138011|FG000|Overall Study|Sponsor decision to terminate the study|5|||
162022367|NCT00862082|585138012|FG001|Overall Study|Sponsor decision to terminate the study|0|||
161828567|NCT02688387|584413552|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828568|NCT02688387|584413553|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828569|NCT02688387|584413554|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828570|NCT02688387|584413555|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828571|NCT02688387|584413556|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828572|NCT02688387|584413557|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828573|NCT02688387|584413558|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
161828574|NCT02688387|584413559|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828575|NCT02688387|584413560|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828576|NCT02688387|584413561|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828577|NCT02688387|584413562|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828578|NCT02688387|584413563|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828579|NCT02688387|584413564|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161937730|NCT01272219|584821771|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
161937731|NCT01272219|584821766|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
161937732|NCT01272219|584821767|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
161937733|NCT01272219|584821768|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
161937734|NCT01272219|584821769|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
161937735|NCT01272219|584821770|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
161937736|NCT01272219|584821771|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
161937737|NCT01272219|584821766|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
161937738|NCT01272219|584821767|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
161937739|NCT01272219|584821768|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
161937740|NCT01272219|584821769|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
161937741|NCT01272219|584821770|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
161937742|NCT01272219|584821771|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
161937743|NCT01272219|584821766|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
161937744|NCT01272219|584821767|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
161937745|NCT01272219|584821768|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
161937746|NCT01272219|584821769|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
161937747|NCT01272219|584821770|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
161937748|NCT01272219|584821771|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
161937749|NCT05021224|584821777|FG000|Overall Study|Did not complete all survey items|4|||
161937750|NCT05021224|584821778|FG001|Overall Study|Did not complete all survey items|1|||
161937751|NCT05021224|584821779|FG002|Overall Study|Did not complete all survey items|0|||
161937752|NCT05021224|584821780|FG003|Overall Study|Did not complete all survey items|2|||
161937753|NCT03996395|584821781|FG000|Overall Study|Lost to Follow-up|4|||
161937754|NCT03996395|584821781|FG000|Overall Study|Withdrawal by Subject|1|||
161937755|NCT03996395|584821781|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
161937756|NCT03973489|584821789|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
161937757|NCT03973489|584821790|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
161937758|NCT03973489|584821791|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
161937759|NCT03973489|584821792|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
161937760|NCT03973489|584821793|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
161937761|NCT03973489|584821794|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
161937762|NCT03973489|584821795|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
161937763|NCT03973489|584821796|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
161937764|NCT03973489|584821789|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161937765|NCT03973489|584821790|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161937766|NCT03973489|584821791|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161937767|NCT03973489|584821792|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
161937768|NCT03973489|584821793|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
161937769|NCT03973489|584821794|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161937770|NCT03973489|584821795|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161937771|NCT03973489|584821796|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161937772|NCT03973489|584821789|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
161937773|NCT03973489|584821790|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
161937774|NCT03973489|584821791|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
161937775|NCT03973489|584821792|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
161937776|NCT03973489|584821793|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
161937777|NCT03973489|584821794|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
161937778|NCT03973489|584821795|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
161937779|NCT03973489|584821796|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
161937780|NCT03973489|584821789|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
161937781|NCT03973489|584821790|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
161937782|NCT03973489|584821791|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
162022368|NCT00862082|585138011|FG000|Overall Study|Withdrawal by Subject|0|||
162022369|NCT00862082|585138012|FG001|Overall Study|Withdrawal by Subject|1|||
162022370|NCT02791763|585138015|FG000|Overall Study|Protocol Violation|0|||
162022371|NCT02791763|585138016|FG001|Overall Study|Protocol Violation|0|||
162022372|NCT02791763|585138017|FG002|Overall Study|Protocol Violation|1|||
162022373|NCT02791763|585138015|FG000|Overall Study|Withdrawal by Subject|5|||
162022374|NCT02791763|585138016|FG001|Overall Study|Withdrawal by Subject|1|||
162022375|NCT02791763|585138017|FG002|Overall Study|Withdrawal by Subject|0|||
162022376|NCT02791763|585138015|FG000|Overall Study|Physician Decision|0|||
162022377|NCT02791763|585138016|FG001|Overall Study|Physician Decision|1|||
162022378|NCT02791763|585138017|FG002|Overall Study|Physician Decision|0|||
162022379|NCT02791763|585138015|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
162022380|NCT02791763|585138016|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
162022381|NCT02791763|585138017|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
162022382|NCT02791763|585138015|FG000|Overall Study|Cancer event|1|||
162022383|NCT02791763|585138016|FG001|Overall Study|Cancer event|3|||
162022384|NCT02791763|585138017|FG002|Overall Study|Cancer event|0|||
162022385|NCT02791763|585138015|FG000|Overall Study|Participant had renal transplant|3|||
162022386|NCT02791763|585138016|FG001|Overall Study|Participant had renal transplant|0|||
162022387|NCT02791763|585138017|FG002|Overall Study|Participant had renal transplant|0|||
162022388|NCT02791763|585138015|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
162022389|NCT02791763|585138016|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
161937783|NCT03973489|584821792|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
161937784|NCT03973489|584821793|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
161937785|NCT03973489|584821794|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
161937786|NCT03973489|584821795|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
161937787|NCT03973489|584821796|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
161937788|NCT03973489|584821789|FG000|Second Intervention (1 Day)|Adverse Event|0|||
161937789|NCT03973489|584821790|FG001|Second Intervention (1 Day)|Adverse Event|0|||
161937790|NCT03973489|584821791|FG002|Second Intervention (1 Day)|Adverse Event|0|||
161937791|NCT03973489|584821792|FG003|Second Intervention (1 Day)|Adverse Event|1|||
161937792|NCT03973489|584821793|FG004|Second Intervention (1 Day)|Adverse Event|0|||
161937793|NCT03973489|584821794|FG005|Second Intervention (1 Day)|Adverse Event|0|||
161937794|NCT03973489|584821795|FG006|Second Intervention (1 Day)|Adverse Event|0|||
161937795|NCT03973489|584821796|FG007|Second Intervention (1 Day)|Adverse Event|0|||
161937796|NCT03301415|584821797|FG000|Overall Study|Lost to Follow-up|2|||
161937797|NCT03301415|584821797|FG000|Overall Study|Unable to comply with visit schedule|2|||
161937798|NCT00392288|584821798|FG000|Overall Study|Adverse Event|17|||
161937799|NCT00392288|584821799|FG001|Overall Study|Adverse Event|7|||
161937800|NCT00392288|584821800|FG002|Overall Study|Adverse Event|8|||
161937801|NCT00392288|584821798|FG000|Overall Study|Lack of Efficacy|8|||
162022390|NCT02791763|585138017|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
162022391|NCT02791763|585138015|FG000|Overall Study|Adverse Event|12|||
161678567|NCT01380730|583876021|FG001|Overall Study|Death|0|||
161678568|NCT01380730|583876022|FG002|Overall Study|Death|0|||
162022392|NCT02791763|585138016|FG001|Overall Study|Adverse Event|13|||
161937802|NCT00392288|584821799|FG001|Overall Study|Lack of Efficacy|5|||
161937803|NCT00392288|584821800|FG002|Overall Study|Lack of Efficacy|3|||
161937804|NCT00392288|584821798|FG000|Overall Study|Protocol Violation|1|||
161937805|NCT00392288|584821799|FG001|Overall Study|Protocol Violation|3|||
161937806|NCT00392288|584821800|FG002|Overall Study|Protocol Violation|1|||
161937807|NCT00392288|584821798|FG000|Overall Study|Lost to Follow-up|1|||
161937808|NCT00392288|584821799|FG001|Overall Study|Lost to Follow-up|1|||
161937809|NCT00392288|584821800|FG002|Overall Study|Lost to Follow-up|1|||
161937810|NCT00392288|584821798|FG000|Overall Study|Withdrawal by Subject|1|||
162022393|NCT02791763|585138017|FG002|Overall Study|Adverse Event|7|||
161828580|NCT02688387|584413565|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161828581|NCT02688387|584413544|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828582|NCT02688387|584413545|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828583|NCT02688387|584413546|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828584|NCT02688387|584413547|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828585|NCT02688387|584413548|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828586|NCT02688387|584413549|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828587|NCT02688387|584413550|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828588|NCT02688387|584413551|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828589|NCT02688387|584413552|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828590|NCT02688387|584413553|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828591|NCT02688387|584413554|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828592|NCT02688387|584413555|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828593|NCT02688387|584413556|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828594|NCT02688387|584413557|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828595|NCT02688387|584413558|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828596|NCT02688387|584413559|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828597|NCT02688387|584413560|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828598|NCT02688387|584413561|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828599|NCT02688387|584413562|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828600|NCT02688387|584413563|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828601|NCT02688387|584413564|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
161828602|NCT02688387|584413565|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161828603|NCT02688387|584413544|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828604|NCT02688387|584413545|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828605|NCT02688387|584413546|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828606|NCT02688387|584413547|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828607|NCT02688387|584413548|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828608|NCT02688387|584413549|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828609|NCT02688387|584413550|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828610|NCT02688387|584413551|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828611|NCT02688387|584413552|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828612|NCT02688387|584413553|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828613|NCT02688387|584413554|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828614|NCT02688387|584413555|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828615|NCT02688387|584413556|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828616|NCT02688387|584413557|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828617|NCT02688387|584413558|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828618|NCT02688387|584413559|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828619|NCT02688387|584413560|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828620|NCT02688387|584413561|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828621|NCT02688387|584413562|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
161828622|NCT02688387|584413563|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828623|NCT02688387|584413564|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
161828624|NCT02688387|584413565|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161828625|NCT02688387|584413544|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828626|NCT02688387|584413545|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828627|NCT02688387|584413546|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828628|NCT02688387|584413547|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161937811|NCT00392288|584821799|FG001|Overall Study|Withdrawal by Subject|0|||
162022394|NCT05334212|585138018|FG000|Overall Study|Study terminated prematurely|7|||
162022395|NCT01031836|585139547|FG000|Stage I|Adverse Event|1|||
162022396|NCT01031836|585139548|FG001|Stage I|Adverse Event|1|||
162022397|NCT01031836|585139549|FG002|Stage I|Adverse Event|0|||
162022398|NCT01031836|585139550|FG003|Stage I|Adverse Event|0|||
162022399|NCT01031836|585139551|FG004|Stage I|Adverse Event|0|||
162022400|NCT01031836|585139552|FG005|Stage I|Adverse Event|0|||
162022401|NCT01031836|585139547|FG000|Stage I|Other|0|||
162022402|NCT01031836|585139548|FG001|Stage I|Other|1|||
162022403|NCT01031836|585139549|FG002|Stage I|Other|0|||
162022404|NCT01031836|585139550|FG003|Stage I|Other|0|||
162022405|NCT01031836|585139551|FG004|Stage I|Other|0|||
162022406|NCT01031836|585139552|FG005|Stage I|Other|1|||
162022407|NCT01031836|585139547|FG000|Stage II|Adverse Event|0|||
162022408|NCT01031836|585139548|FG001|Stage II|Adverse Event|0|||
162022409|NCT01031836|585139549|FG002|Stage II|Adverse Event|2|||
162022410|NCT01031836|585139550|FG003|Stage II|Adverse Event|2|||
162022411|NCT01031836|585139551|FG004|Stage II|Adverse Event|1|||
162022412|NCT01031836|585139552|FG005|Stage II|Adverse Event|1|||
162022413|NCT01031836|585139547|FG000|Stage II|Other|2|||
162022414|NCT01031836|585139548|FG001|Stage II|Other|0|||
162022415|NCT01031836|585139549|FG002|Stage II|Other|0|||
162022416|NCT01031836|585139550|FG003|Stage II|Other|1|||
162022417|NCT01031836|585139551|FG004|Stage II|Other|1|||
162022418|NCT01031836|585139552|FG005|Stage II|Other|0|||
162022419|NCT01888432|585139557|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
162022420|NCT01888432|585139558|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
162022421|NCT01888432|585139557|FG000|12-month Analysis (FAS)|Physician Decision|1|||
162022422|NCT01888432|585139558|FG001|12-month Analysis (FAS)|Physician Decision|1|||
162022423|NCT01888432|585139557|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
162022424|NCT01888432|585139558|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
162022425|NCT01888432|585139557|FG000|12-month Analysis (FAS)|Death|4|||
162022426|NCT01888432|585139558|FG001|12-month Analysis (FAS)|Death|3|||
162022427|NCT01888432|585139557|FG000|24-month Analysis (FAS)|Graft loss|0|||
162022428|NCT01888432|585139558|FG001|24-month Analysis (FAS)|Graft loss|1|||
162022429|NCT01888432|585139557|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
162022430|NCT01888432|585139558|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
162022431|NCT01888432|585139557|FG000|24-month Analysis (FAS)|Physician Decision|2|||
162022432|NCT01888432|585139558|FG001|24-month Analysis (FAS)|Physician Decision|4|||
162022433|NCT01888432|585139557|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
162022434|NCT01888432|585139558|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
162022435|NCT01888432|585139557|FG000|24-month Analysis (FAS)|Death|8|||
162022436|NCT01888432|585139558|FG001|24-month Analysis (FAS)|Death|4|||
162022437|NCT01888432|585139557|FG000|36-month Analysis (Extension)|Death|1|||
162022438|NCT01888432|585139558|FG001|36-month Analysis (Extension)|Death|0|||
162022439|NCT01754402|585139562|FG000|Overall Study|Death|0|||
162022440|NCT01754402|585139563|FG001|Overall Study|Death|0|||
162022441|NCT01754402|585139564|FG002|Overall Study|Death|1|||
162022442|NCT01754402|585139562|FG000|Overall Study|Adverse Event|2|||
162022443|NCT01754402|585139563|FG001|Overall Study|Adverse Event|2|||
162022444|NCT01754402|585139564|FG002|Overall Study|Adverse Event|1|||
162022445|NCT01754402|585139562|FG000|Overall Study|Withdrawal by Subject|0|||
162022446|NCT01754402|585139563|FG001|Overall Study|Withdrawal by Subject|0|||
162022447|NCT01754402|585139564|FG002|Overall Study|Withdrawal by Subject|1|||
162022448|NCT01754402|585139562|FG000|Overall Study|Lack of Efficacy|0|||
162022449|NCT01754402|585139563|FG001|Overall Study|Lack of Efficacy|0|||
162022450|NCT01754402|585139564|FG002|Overall Study|Lack of Efficacy|1|||
162022451|NCT02051933|585139565|FG000|Overall Study|Physician Decision|0|||
162022452|NCT02051933|585139566|FG001|Overall Study|Physician Decision|1|||
162022453|NCT01954927|585139567|FG000|Overall Study|Withdrawal by Subject|3|||
162022454|NCT01954927|585139568|FG001|Overall Study|Withdrawal by Subject|1|||
162022455|NCT02156271|585139569|FG000|Overall Study|Physician Decision|4|||
162022456|NCT02156271|585139570|FG001|Overall Study|Physician Decision|3|||
162022457|NCT02123251|585139571|FG000|Overall Study|Death|1|||
162022458|NCT02123251|585139572|FG001|Overall Study|Death|1|||
162022459|NCT02123251|585139571|FG000|Overall Study|Withdrawal by Subject|0|||
162022460|NCT02123251|585139572|FG001|Overall Study|Withdrawal by Subject|3|||
161678569|NCT01380730|583876023|FG003|Overall Study|Death|0|||
162022461|NCT02123251|585139571|FG000|Overall Study|Lost Medicaid eligibility|29|||
162022462|NCT02123251|585139572|FG001|Overall Study|Lost Medicaid eligibility|22|||
162022463|NCT02123251|585139571|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
162022464|NCT02123251|585139572|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
162022465|NCT00375609|585139579|FG000|Overall Study|Did not receive treatment|1|||
162022466|NCT00375609|585139580|FG001|Overall Study|Did not receive treatment|0|||
162022467|NCT00375609|585139581|FG002|Overall Study|Did not receive treatment|0|||
162022468|NCT00375609|585139579|FG000|Overall Study|Adverse Event|0|||
162022469|NCT00375609|585139580|FG001|Overall Study|Adverse Event|3|||
162022470|NCT00375609|585139581|FG002|Overall Study|Adverse Event|0|||
162022471|NCT00375609|585139579|FG000|Overall Study|Lost to Follow-up|1|||
162022472|NCT00375609|585139580|FG001|Overall Study|Lost to Follow-up|0|||
162022473|NCT00375609|585139581|FG002|Overall Study|Lost to Follow-up|0|||
162022474|NCT00375609|585139579|FG000|Overall Study|Physician Decision|0|||
162022475|NCT00375609|585139580|FG001|Overall Study|Physician Decision|0|||
162022476|NCT00375609|585139581|FG002|Overall Study|Physician Decision|1|||
162022477|NCT00375609|585139579|FG000|Overall Study|Withdrawal by Subject|1|||
162022478|NCT00375609|585139580|FG001|Overall Study|Withdrawal by Subject|4|||
162022479|NCT00375609|585139581|FG002|Overall Study|Withdrawal by Subject|0|||
162022480|NCT00375609|585139579|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
162022481|NCT00375609|585139580|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
162022482|NCT00375609|585139581|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
162022483|NCT02338882|585139582|FG000|Overall Study|Death|1|||
162022484|NCT02338882|585139583|FG001|Overall Study|Death|0|||
162022485|NCT02338882|585139582|FG000|Overall Study|Lost to Follow-up|6|||
162022486|NCT02338882|585139583|FG001|Overall Study|Lost to Follow-up|3|||
162022487|NCT02184455|585139586|FG000|Overall Study|Lost to Follow-up|1|||
162022488|NCT02248675|585139593|FG000|Overall Study|Lost to Follow-up|3|||
162022489|NCT02248675|585139594|FG001|Overall Study|Lost to Follow-up|1|||
162022490|NCT00617669|585139595|FG000|Overall Study|Withdrawal by Subject|71|||
162022491|NCT00617669|585139596|FG001|Overall Study|Withdrawal by Subject|77|||
162022492|NCT00617669|585139595|FG000|Overall Study|Lost to Follow-up|3|||
162022493|NCT00617669|585139596|FG001|Overall Study|Lost to Follow-up|2|||
162022494|NCT00617669|585139595|FG000|Overall Study|Adverse Event|87|||
162022495|NCT00617669|585139596|FG001|Overall Study|Adverse Event|76|||
162022496|NCT00617669|585139595|FG000|Overall Study|Protocol Violation|2|||
162022497|NCT00617669|585139596|FG001|Overall Study|Protocol Violation|3|||
162022498|NCT00617669|585139595|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
162022499|NCT00617669|585139596|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
162022500|NCT00617669|585139595|FG000|Overall Study|Patients randomized but not treated|2|||
162022501|NCT00617669|585139596|FG001|Overall Study|Patients randomized but not treated|3|||
162022502|NCT03745820|585139599|FG000|Overall Study|Adverse Event|0|||
162022503|NCT03745820|585139600|FG001|Overall Study|Adverse Event|3|||
162022504|NCT03745820|585139601|FG002|Overall Study|Adverse Event|2|||
162022505|NCT03745820|585139599|FG000|Overall Study|Non-Compliance with Study Drug|4|||
162022506|NCT03745820|585139600|FG001|Overall Study|Non-Compliance with Study Drug|3|||
162022507|NCT03745820|585139601|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162022508|NCT03745820|585139599|FG000|Overall Study|Withdrawal by Subject|4|||
162022509|NCT03745820|585139600|FG001|Overall Study|Withdrawal by Subject|4|||
162022510|NCT03745820|585139601|FG002|Overall Study|Withdrawal by Subject|4|||
162022511|NCT03745820|585139599|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
162022512|NCT03745820|585139600|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
162022513|NCT03745820|585139601|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
162022514|NCT03745820|585139599|FG000|Overall Study|Lost to Follow-up|2|||
162022515|NCT03745820|585139600|FG001|Overall Study|Lost to Follow-up|0|||
162022516|NCT03745820|585139601|FG002|Overall Study|Lost to Follow-up|3|||
162022517|NCT03745820|585139599|FG000|Overall Study|Reason not Specified|2|||
162022518|NCT03745820|585139600|FG001|Overall Study|Reason not Specified|4|||
162022519|NCT03745820|585139601|FG002|Overall Study|Reason not Specified|1|||
162022520|NCT04250077|585139610|FG000|Overall Study|Withdrawal by Subject|0|||
162022521|NCT04250077|585139611|FG001|Overall Study|Withdrawal by Subject|1|||
162022522|NCT04250077|585139612|FG002|Overall Study|Withdrawal by Subject|0|||
162022523|NCT04250077|585139610|FG000|Overall Study|Lost to Follow-up|2|||
162022524|NCT04250077|585139611|FG001|Overall Study|Lost to Follow-up|3|||
162022525|NCT04250077|585139612|FG002|Overall Study|Lost to Follow-up|0|||
162022526|NCT00926029|585139613|FG000|Overall Study|Lost to Follow-up|2|||
162022527|NCT00926029|585139614|FG001|Overall Study|Lost to Follow-up|1|||
162022528|NCT00926029|585139615|FG002|Overall Study|Lost to Follow-up|1|||
162022529|NCT02471612|585139616|FG000|Overall Study|Lost to Follow-up|2|||
162022530|NCT03206788|585139617|FG000|Overall Study|Withdrawal by Subject|0|||
162022531|NCT03206788|585139618|FG001|Overall Study|Withdrawal by Subject|1|||
162022532|NCT03206788|585139617|FG000|Overall Study|Adverse Event|0|||
162022533|NCT03206788|585139618|FG001|Overall Study|Adverse Event|1|||
162022534|NCT03206788|585139617|FG000|Overall Study|Physician Decision|0|||
162022535|NCT03206788|585139618|FG001|Overall Study|Physician Decision|1|||
162022536|NCT01024309|585139621|FG000|Overall Study|Physician Decision|4|||
162022537|NCT01024309|585139622|FG001|Overall Study|Physician Decision|0|||
162022538|NCT01024309|585139621|FG000|Overall Study|Withdrawal by Subject|4|||
162022539|NCT01024309|585139622|FG001|Overall Study|Withdrawal by Subject|4|||
162022540|NCT00567255|585139623|FG000|Overall Study|Adverse Event|241|||
162022541|NCT00567255|585139624|FG001|Overall Study|Adverse Event|68|||
162022542|NCT00567255|585139623|FG000|Overall Study|Lost to Follow-up|77|||
162022543|NCT00567255|585139624|FG001|Overall Study|Lost to Follow-up|48|||
162022544|NCT00567255|585139623|FG000|Overall Study|Withdrawal by Subject|75|||
162022545|NCT00567255|585139624|FG001|Overall Study|Withdrawal by Subject|56|||
162022546|NCT00567255|585139623|FG000|Overall Study|Lack of Efficacy|19|||
162022547|NCT00567255|585139624|FG001|Overall Study|Lack of Efficacy|33|||
162022548|NCT00567255|585139623|FG000|Overall Study|Protocol Violation|20|||
162022549|NCT00567255|585139624|FG001|Overall Study|Protocol Violation|8|||
162022550|NCT00567255|585139623|FG000|Overall Study|Pregnancy|6|||
162022551|NCT00567255|585139624|FG001|Overall Study|Pregnancy|0|||
162022552|NCT00567255|585139623|FG000|Overall Study|Drug noncompliance,moved,other|25|||
162022553|NCT00567255|585139624|FG001|Overall Study|Drug noncompliance,moved,other|15|||
162022554|NCT03672097|585139627|FG000|Period 1|Withdrawal by Subject|2|||
162022555|NCT03672097|585139627|FG000|Period 1|Adverse Event|1|||
162022556|NCT03672097|585139627|FG000|Period 1|Did not receive treatment|1|||
162022557|NCT03672097|585139627|FG000|Period 2|Withdrawal by Subject|3|||
162022558|NCT03672097|585139627|FG000|Period 2|Other|1|||
162022559|NCT02424578|585139628|FG000|Overall Study|Withdrawal by Subject|0|||
162022560|NCT02424578|585139629|FG001|Overall Study|Withdrawal by Subject|1|||
162022561|NCT00080899|585139630|FG000|Overall Study|Adverse Event|1|||
162022562|NCT02872935|585139631|FG000|Overall Study|Other|0|||
162022563|NCT02872935|585139632|FG001|Overall Study|Other|1|||
162022564|NCT05343624|585139633|FG000|Overall Study|Chart review not completed|1|||
162022565|NCT00910299|585139635|FG000|Overall Study|Withdrawal by Subject|16|||
162022566|NCT00910299|585139636|FG001|Overall Study|Withdrawal by Subject|13|||
162022567|NCT00910299|585139635|FG000|Overall Study|Sponsor Decision|58|||
162022568|NCT00910299|585139636|FG001|Overall Study|Sponsor Decision|60|||
162022569|NCT00910299|585139635|FG000|Overall Study|Didn't receive any study drug|2|||
162022570|NCT00910299|585139636|FG001|Overall Study|Didn't receive any study drug|1|||
162022571|NCT01456897|585139637|FG000|Overall Study|Adverse Event|19|||
162022572|NCT01456897|585139638|FG001|Overall Study|Adverse Event|22|||
162022573|NCT01456897|585139637|FG000|Overall Study|Protocol Violation|3|||
162022574|NCT01456897|585139638|FG001|Overall Study|Protocol Violation|4|||
162022575|NCT01456897|585139637|FG000|Overall Study|Physician Decision|5|||
162022576|NCT01456897|585139638|FG001|Overall Study|Physician Decision|3|||
162022577|NCT01456897|585139637|FG000|Overall Study|Withdrawal by Subject|44|||
162022578|NCT01456897|585139638|FG001|Overall Study|Withdrawal by Subject|17|||
162022579|NCT01456897|585139637|FG000|Overall Study|Lack of Efficacy|4|||
162022580|NCT01456897|585139638|FG001|Overall Study|Lack of Efficacy|11|||
162022581|NCT04535453|585139639|FG000|Overall Study|Death|0|||
162022582|NCT04535453|585139640|FG001|Overall Study|Death|1|||
162022583|NCT04535453|585139641|FG002|Overall Study|Death|0|||
162022584|NCT04535453|585139642|FG003|Overall Study|Death|0|||
162022585|NCT04535453|585139643|FG004|Overall Study|Death|0|||
162022586|NCT04535453|585139644|FG005|Overall Study|Death|0|||
162022587|NCT04535453|585139645|FG006|Overall Study|Death|0|||
162022588|NCT04535453|585139646|FG007|Overall Study|Death|0|||
162022589|NCT04535453|585139647|FG008|Overall Study|Death|0|||
162022590|NCT04535453|585139648|FG009|Overall Study|Death|0|||
162022591|NCT04535453|585139649|FG010|Overall Study|Death|0|||
162022592|NCT04535453|585139650|FG011|Overall Study|Death|0|||
162022593|NCT04535453|585139639|FG000|Overall Study|Lost to Follow-up|1|||
162022594|NCT04535453|585139640|FG001|Overall Study|Lost to Follow-up|1|||
162022595|NCT04535453|585139641|FG002|Overall Study|Lost to Follow-up|1|||
162022596|NCT04535453|585139642|FG003|Overall Study|Lost to Follow-up|0|||
162022597|NCT04535453|585139643|FG004|Overall Study|Lost to Follow-up|3|||
162022598|NCT04535453|585139644|FG005|Overall Study|Lost to Follow-up|1|||
162022599|NCT04535453|585139645|FG006|Overall Study|Lost to Follow-up|0|||
162022600|NCT04535453|585139646|FG007|Overall Study|Lost to Follow-up|0|||
162022601|NCT04535453|585139647|FG008|Overall Study|Lost to Follow-up|1|||
162022602|NCT04535453|585139648|FG009|Overall Study|Lost to Follow-up|1|||
162022603|NCT04535453|585139649|FG010|Overall Study|Lost to Follow-up|0|||
162022604|NCT04535453|585139650|FG011|Overall Study|Lost to Follow-up|0|||
162022605|NCT04535453|585139639|FG000|Overall Study|Physician Decision|0|||
162022606|NCT04535453|585139640|FG001|Overall Study|Physician Decision|0|||
162022607|NCT04535453|585139641|FG002|Overall Study|Physician Decision|0|||
162022608|NCT04535453|585139642|FG003|Overall Study|Physician Decision|1|||
162022609|NCT04535453|585139643|FG004|Overall Study|Physician Decision|0|||
162022610|NCT04535453|585139644|FG005|Overall Study|Physician Decision|0|||
162022611|NCT04535453|585139645|FG006|Overall Study|Physician Decision|0|||
162022612|NCT04535453|585139646|FG007|Overall Study|Physician Decision|0|||
162022613|NCT04535453|585139647|FG008|Overall Study|Physician Decision|0|||
162022614|NCT04535453|585139648|FG009|Overall Study|Physician Decision|0|||
162022615|NCT04535453|585139649|FG010|Overall Study|Physician Decision|0|||
162022616|NCT04535453|585139650|FG011|Overall Study|Physician Decision|0|||
162022617|NCT04535453|585139639|FG000|Overall Study|Withdrawal by Subject|3|||
162022618|NCT04535453|585139640|FG001|Overall Study|Withdrawal by Subject|6|||
162022619|NCT04535453|585139641|FG002|Overall Study|Withdrawal by Subject|3|||
162022620|NCT04535453|585139642|FG003|Overall Study|Withdrawal by Subject|3|||
162022621|NCT04535453|585139643|FG004|Overall Study|Withdrawal by Subject|2|||
162022622|NCT04535453|585139644|FG005|Overall Study|Withdrawal by Subject|1|||
162022623|NCT04535453|585139645|FG006|Overall Study|Withdrawal by Subject|1|||
162022624|NCT04535453|585139646|FG007|Overall Study|Withdrawal by Subject|1|||
162022625|NCT04535453|585139647|FG008|Overall Study|Withdrawal by Subject|1|||
162022626|NCT04535453|585139648|FG009|Overall Study|Withdrawal by Subject|1|||
162022627|NCT04535453|585139649|FG010|Overall Study|Withdrawal by Subject|0|||
162022628|NCT04535453|585139650|FG011|Overall Study|Withdrawal by Subject|1|||
162022629|NCT04535453|585139639|FG000|Overall Study|Other|0|||
162022630|NCT04535453|585139640|FG001|Overall Study|Other|0|||
162022631|NCT04535453|585139641|FG002|Overall Study|Other|1|||
162022632|NCT04535453|585139642|FG003|Overall Study|Other|0|||
162022633|NCT04535453|585139643|FG004|Overall Study|Other|1|||
162022634|NCT04535453|585139644|FG005|Overall Study|Other|0|||
162022635|NCT04535453|585139645|FG006|Overall Study|Other|1|||
162022636|NCT04535453|585139646|FG007|Overall Study|Other|1|||
162022637|NCT04535453|585139647|FG008|Overall Study|Other|1|||
162022638|NCT04535453|585139648|FG009|Overall Study|Other|0|||
162022639|NCT04535453|585139649|FG010|Overall Study|Other|0|||
162022640|NCT04535453|585139650|FG011|Overall Study|Other|0|||
162022641|NCT02929407|585139651|FG000|Overall Study|Adverse Event|1|||
162022642|NCT00916929|585139652|FG000|Overall Study|Lost to Follow-up|1|||
162022643|NCT00916929|585139653|FG001|Overall Study|Lost to Follow-up|3|||
162022644|NCT00916929|585139652|FG000|Overall Study|Death|5|||
162022645|NCT00916929|585139653|FG001|Overall Study|Death|10|||
162022646|NCT00916929|585139652|FG000|Overall Study|Withdrawal by Subject|1|||
162022647|NCT00916929|585139653|FG001|Overall Study|Withdrawal by Subject|5|||
162022648|NCT00916929|585139652|FG000|Overall Study|Left ventricular epicardial lead|1|||
162022649|NCT00916929|585139653|FG001|Overall Study|Left ventricular epicardial lead|2|||
162022650|NCT00916929|585139652|FG000|Overall Study|Transferred to hospice care|1|||
162022651|NCT00916929|585139653|FG001|Overall Study|Transferred to hospice care|1|||
162022652|NCT00916929|585139652|FG000|Overall Study|System explant|1|||
162022653|NCT00916929|585139653|FG001|Overall Study|System explant|0|||
162022654|NCT00916929|585139652|FG000|Overall Study|Moved to another state|0|||
162022655|NCT00916929|585139653|FG001|Overall Study|Moved to another state|1|||
162022656|NCT00916929|585139652|FG000|Overall Study|Device unable to process impedance data|0|||
162022657|NCT00916929|585139653|FG001|Overall Study|Device unable to process impedance data|7|||
162022658|NCT02878798|585139654|FG000|Overall Study|Withdrawal by Subject|5|||
162022659|NCT02878798|585139655|FG001|Overall Study|Withdrawal by Subject|4|||
162022660|NCT02878798|585139654|FG000|Overall Study|Lost to Follow-up|2|||
162022661|NCT02878798|585139655|FG001|Overall Study|Lost to Follow-up|2|||
162022662|NCT02878798|585139654|FG000|Overall Study|Protocol Violation|0|||
162022663|NCT02878798|585139655|FG001|Overall Study|Protocol Violation|1|||
162022664|NCT01309282|585139656|FG000|Overall Study|Lost to Follow-up|1|||
162022665|NCT02762370|585139657|FG000|Overall Study|Protocol Violation|1|||
162022666|NCT02762370|585139658|FG001|Overall Study|Protocol Violation|0|||
162022667|NCT01708902|585139662|FG000|Overall Study|Adverse Event|3|||
162022668|NCT01708902|585139663|FG001|Overall Study|Adverse Event|4|||
162022669|NCT01708902|585139664|FG002|Overall Study|Adverse Event|9|||
162022670|NCT01708902|585139665|FG003|Overall Study|Adverse Event|2|||
162022671|NCT01708902|585139666|FG004|Overall Study|Adverse Event|7|||
162022672|NCT01708902|585139667|FG005|Overall Study|Adverse Event|3|||
162022673|NCT01708902|585139668|FG006|Overall Study|Adverse Event|5|||
162022674|NCT01708902|585139662|FG000|Overall Study|Lack of Efficacy|3|||
162022675|NCT01708902|585139663|FG001|Overall Study|Lack of Efficacy|1|||
162022676|NCT01708902|585139664|FG002|Overall Study|Lack of Efficacy|0|||
162022677|NCT01708902|585139665|FG003|Overall Study|Lack of Efficacy|0|||
162022678|NCT01708902|585139666|FG004|Overall Study|Lack of Efficacy|0|||
162022679|NCT01708902|585139667|FG005|Overall Study|Lack of Efficacy|1|||
162022680|NCT01708902|585139668|FG006|Overall Study|Lack of Efficacy|0|||
162022681|NCT01708902|585139662|FG000|Overall Study|Non compliance with protocol|0|||
162022682|NCT01708902|585139663|FG001|Overall Study|Non compliance with protocol|2|||
162022683|NCT01708902|585139664|FG002|Overall Study|Non compliance with protocol|1|||
162022684|NCT01708902|585139665|FG003|Overall Study|Non compliance with protocol|3|||
162022685|NCT01708902|585139666|FG004|Overall Study|Non compliance with protocol|0|||
162022686|NCT01708902|585139667|FG005|Overall Study|Non compliance with protocol|0|||
162022687|NCT01708902|585139668|FG006|Overall Study|Non compliance with protocol|0|||
162022688|NCT01708902|585139662|FG000|Overall Study|Lost to Follow-up|2|||
162022689|NCT01708902|585139663|FG001|Overall Study|Lost to Follow-up|1|||
162022690|NCT01708902|585139664|FG002|Overall Study|Lost to Follow-up|2|||
162022691|NCT01708902|585139665|FG003|Overall Study|Lost to Follow-up|2|||
162022692|NCT01708902|585139666|FG004|Overall Study|Lost to Follow-up|0|||
162022693|NCT01708902|585139667|FG005|Overall Study|Lost to Follow-up|0|||
162022694|NCT01708902|585139668|FG006|Overall Study|Lost to Follow-up|1|||
162236630|NCT02581631|585917014|FG003|Overall Study|Other Reasons|2|||
162236631|NCT02581631|585917015|FG004|Overall Study|Other Reasons|3|||
162236632|NCT02581631|585917011|FG000|Overall Study|Poor/Non-Compliance|0|||
162236633|NCT02581631|585917012|FG001|Overall Study|Poor/Non-Compliance|0|||
162236634|NCT02581631|585917013|FG002|Overall Study|Poor/Non-Compliance|1|||
162236635|NCT02581631|585917014|FG003|Overall Study|Poor/Non-Compliance|0|||
162236636|NCT02581631|585917015|FG004|Overall Study|Poor/Non-Compliance|0|||
162236637|NCT01759368|585917016|FG000|Overall Study|Lost to Follow-up|1|||
162236638|NCT01759368|585917017|FG001|Overall Study|Lost to Follow-up|0|||
162236639|NCT01191268|585917018|FG000|Overall Study|Withdrawal by Subject|19|||
162236640|NCT01191268|585917019|FG001|Overall Study|Withdrawal by Subject|25|||
162236641|NCT01191268|585917020|FG002|Overall Study|Withdrawal by Subject|21|||
162022695|NCT01708902|585139662|FG000|Overall Study|Refused to continue trial medication|8|||
162022696|NCT01708902|585139663|FG001|Overall Study|Refused to continue trial medication|0|||
162022697|NCT01708902|585139664|FG002|Overall Study|Refused to continue trial medication|4|||
162022698|NCT01708902|585139665|FG003|Overall Study|Refused to continue trial medication|2|||
162022699|NCT01708902|585139666|FG004|Overall Study|Refused to continue trial medication|8|||
162022700|NCT01708902|585139667|FG005|Overall Study|Refused to continue trial medication|1|||
162022701|NCT01708902|585139668|FG006|Overall Study|Refused to continue trial medication|1|||
162022702|NCT01708902|585139662|FG000|Overall Study|Other Reason|1|||
162022703|NCT01708902|585139663|FG001|Overall Study|Other Reason|0|||
162022704|NCT01708902|585139664|FG002|Overall Study|Other Reason|1|||
162022705|NCT01708902|585139665|FG003|Overall Study|Other Reason|1|||
162022706|NCT01708902|585139666|FG004|Overall Study|Other Reason|1|||
162022707|NCT01708902|585139667|FG005|Overall Study|Other Reason|2|||
162022708|NCT01708902|585139668|FG006|Overall Study|Other Reason|0|||
162022709|NCT00530816|585139672|FG000|Overall Study|Progressive Disease|16|||
162022710|NCT00530816|585139673|FG001|Overall Study|Progressive Disease|24|||
162022711|NCT00530816|585139674|FG002|Overall Study|Progressive Disease|24|||
162022712|NCT00530816|585139672|FG000|Overall Study|Adverse Event|6|||
162022713|NCT00530816|585139673|FG001|Overall Study|Adverse Event|13|||
162218855|NCT00755417|585851902|FG001|Overall Study|Withdrawal by Subject|12|||
162218856|NCT00755417|585851903|FG002|Overall Study|Withdrawal by Subject|12|||
162218857|NCT00755417|585851901|FG000|Overall Study|Not specified or missing data|9|||
162022714|NCT00530816|585139674|FG002|Overall Study|Adverse Event|7|||
162022715|NCT00530816|585139672|FG000|Overall Study|Other|3|||
162022716|NCT00530816|585139673|FG001|Overall Study|Other|3|||
162022717|NCT00530816|585139674|FG002|Overall Study|Other|4|||
162022718|NCT00530816|585139672|FG000|Overall Study|Withdrawal by Subject|1|||
162022719|NCT00530816|585139673|FG001|Overall Study|Withdrawal by Subject|2|||
162022720|NCT00530816|585139674|FG002|Overall Study|Withdrawal by Subject|6|||
162022721|NCT02445794|585139675|FG000|Overall Study|Adverse Event|0|||
162022722|NCT02445794|585139676|FG001|Overall Study|Adverse Event|0|||
162022723|NCT02445794|585139677|FG002|Overall Study|Adverse Event|2|||
162022724|NCT02445794|585139678|FG003|Overall Study|Adverse Event|0|||
162022725|NCT01388985|585139679|FG000|Overall Study|Death|0|||
162022726|NCT01388985|585139680|FG001|Overall Study|Death|1|||
162022727|NCT01388985|585139679|FG000|Overall Study|Lost to Follow-up|30|||
162022728|NCT01388985|585139680|FG001|Overall Study|Lost to Follow-up|30|||
162022729|NCT01388985|585139679|FG000|Overall Study|Withdrawal by Subject|13|||
162022730|NCT01388985|585139680|FG001|Overall Study|Withdrawal by Subject|4|||
162022731|NCT01388985|585139679|FG000|Overall Study|Subject unavailable|1|||
162022732|NCT01388985|585139680|FG001|Overall Study|Subject unavailable|1|||
162022733|NCT01388985|585139679|FG000|Overall Study|Other (no reason)|0|||
162022734|NCT01388985|585139680|FG001|Overall Study|Other (no reason)|1|||
162022735|NCT01388985|585139679|FG000|Overall Study|Error of nurse|5|||
162022736|NCT01388985|585139680|FG001|Overall Study|Error of nurse|1|||
162022737|NCT01057589|585139681|FG000|Overall Study|Disease Progression|35|||
162022738|NCT01057589|585139681|FG000|Overall Study|Adverse Event|10|||
162218858|NCT00755417|585851902|FG001|Overall Study|Not specified or missing data|18|||
162218859|NCT00755417|585851903|FG002|Overall Study|Not specified or missing data|12|||
162218860|NCT02803593|585851904|FG000|Overall Study|Lost to Follow-up|17|||
162218861|NCT02803593|585851905|FG001|Overall Study|Lost to Follow-up|35|||
162218862|NCT03933462|585851906|FG000|Overall Study|Adverse Event|2|||
162218863|NCT03933462|585851907|FG001|Overall Study|Adverse Event|0|||
162218864|NCT04210843|585851908|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
162218865|NCT04210843|585851909|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
162218866|NCT04210843|585851908|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
162218867|NCT04210843|585851909|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
162218868|NCT04210843|585851908|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
162218869|NCT04210843|585851909|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
162218870|NCT04210843|585851908|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
162218871|NCT04210843|585851909|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
162218872|NCT04210843|585851908|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
162218873|NCT04210843|585851909|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
162218874|NCT04210843|585851908|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
162218875|NCT04210843|585851909|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
162022739|NCT01057589|585139681|FG000|Overall Study|Physician Decision|8|||
162022740|NCT01057589|585139681|FG000|Overall Study|Withdrawal by Subject|3|||
162022741|NCT01057589|585139681|FG000|Overall Study|Sponsor Decision|1|||
162022742|NCT01057589|585139681|FG000|Overall Study|Death|8|||
162022743|NCT01057589|585139681|FG000|Overall Study|Lost to Follow-up|1|||
162022744|NCT01519167|585139684|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
162022745|NCT01519167|585139685|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
162022746|NCT01519167|585139684|FG000|Overall Study|Adverse Event|0|||
162022747|NCT01519167|585139685|FG001|Overall Study|Adverse Event|1|||
162022748|NCT01519167|585139684|FG000|Overall Study|Lack of Efficacy|0|||
161937812|NCT00392288|584821800|FG002|Overall Study|Withdrawal by Subject|2|||
162218876|NCT04210843|585851908|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
162218877|NCT04210843|585851909|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
162218878|NCT04210843|585851908|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
162218879|NCT04210843|585851909|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
162218880|NCT04210843|585851908|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
162218881|NCT04210843|585851909|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
162218882|NCT04210843|585851908|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
162218883|NCT04210843|585851909|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
162218884|NCT04210843|585851908|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
162218885|NCT04210843|585851909|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
162218886|NCT04210843|585851908|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
162218887|NCT04210843|585851909|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
162218888|NCT04210843|585851908|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
162218889|NCT04210843|585851909|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
162218890|NCT04210843|585851908|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
162218891|NCT04210843|585851909|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
162218892|NCT04210843|585851908|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
162218893|NCT04210843|585851909|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
162218894|NCT04210843|585851908|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
162218895|NCT04210843|585851909|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
162218896|NCT04210843|585851908|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
162218897|NCT04210843|585851909|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
162218898|NCT04210843|585851908|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
162218899|NCT04210843|585851909|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
162218900|NCT04210843|585851908|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
162218901|NCT04210843|585851909|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
162218902|NCT04210843|585851908|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
162218903|NCT04210843|585851909|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
162236642|NCT01191268|585917018|FG000|Overall Study|Adverse Event|21|||
161937813|NCT00392288|584821798|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
161937814|NCT00392288|584821799|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
161937815|NCT00392288|584821800|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
161937816|NCT00392288|584821798|FG000|Overall Study|Other|3|||
161937817|NCT00392288|584821799|FG001|Overall Study|Other|4|||
161937818|NCT00392288|584821800|FG002|Overall Study|Other|1|||
161937819|NCT02544763|584821801|FG000|Overall Study|Adverse Event|8|||
161937820|NCT02544763|584821802|FG001|Overall Study|Adverse Event|8|||
161937821|NCT02544763|584821803|FG002|Overall Study|Adverse Event|0|||
161937822|NCT02544763|584821801|FG000|Overall Study|Withdrawn by parent/guardian|1|||
161937823|NCT02544763|584821802|FG001|Overall Study|Withdrawn by parent/guardian|1|||
161937824|NCT02544763|584821803|FG002|Overall Study|Withdrawn by parent/guardian|1|||
161937825|NCT02544763|584821801|FG000|Overall Study|Met withdrawal criteria|0|||
161937826|NCT02544763|584821802|FG001|Overall Study|Met withdrawal criteria|2|||
161937827|NCT02544763|584821803|FG002|Overall Study|Met withdrawal criteria|0|||
161937828|NCT02544763|584821801|FG000|Overall Study|Physician Decision|0|||
161937829|NCT02544763|584821802|FG001|Overall Study|Physician Decision|1|||
161937830|NCT02544763|584821803|FG002|Overall Study|Physician Decision|0|||
161937831|NCT02544763|584821801|FG000|Overall Study|Difficulties taking IMP|1|||
161937832|NCT02544763|584821802|FG001|Overall Study|Difficulties taking IMP|0|||
161937833|NCT02544763|584821803|FG002|Overall Study|Difficulties taking IMP|0|||
161937834|NCT02097225|584821804|FG000|Dose Level 4|Adverse Event|0|||
161937835|NCT02097225|584821805|FG001|Dose Level 4|Adverse Event|0|||
161937836|NCT02097225|584821806|FG002|Dose Level 4|Adverse Event|0|||
161937837|NCT02097225|584821807|FG003|Dose Level 4|Adverse Event|0|||
161937838|NCT02097225|584821808|FG004|Dose Level 4|Adverse Event|1|||
161937839|NCT00911157|584821811|FG000|Overall Study|Adverse Event|4|||
161937840|NCT00911157|584821812|FG001|Overall Study|Adverse Event|1|||
161937841|NCT00911157|584821811|FG000|Overall Study|Withdrawal by Subject|1|||
161937842|NCT00911157|584821812|FG001|Overall Study|Withdrawal by Subject|1|||
161937843|NCT00911157|584821811|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
161937844|NCT00911157|584821812|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
161937845|NCT00911157|584821811|FG000|Overall Study|Need to treat for lung cancer|1|||
161937846|NCT00911157|584821812|FG001|Overall Study|Need to treat for lung cancer|0|||
161937847|NCT02528305|584821815|FG000|Overall Study|Withdrawal by Subject|1|||
161937848|NCT02528305|584821815|FG000|Overall Study|Adverse Event|1|||
161937849|NCT02528305|584821815|FG000|Overall Study|Physician Decision|1|||
161937850|NCT01852214|584821816|FG000|Period 1|Adverse Event|1|||
161937851|NCT01852214|584821817|FG001|Period 1|Adverse Event|2|||
161937852|NCT01852214|584821816|FG000|Period 1|Withdrawal by Subject|0|||
161937853|NCT01852214|584821817|FG001|Period 1|Withdrawal by Subject|1|||
161937854|NCT01852214|584821816|FG000|Washout Period|Withdrawal by Subject|0|||
162218904|NCT04210843|585851908|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
161937855|NCT01852214|584821817|FG001|Washout Period|Withdrawal by Subject|1|||
161937856|NCT04091438|584821818|FG000|Treatment Period 1 (1 Day)|Other|1|||
161937857|NCT04091438|584821819|FG001|Treatment Period 1 (1 Day)|Other|0|||
161937858|NCT04091438|584821818|FG000|Washout Period (1 Day)|Protocol deviation|0|||
161937859|NCT04091438|584821819|FG001|Washout Period (1 Day)|Protocol deviation|1|||
161937860|NCT04091438|584821818|FG000|Washout Period (1 Day)|Other|0|||
161937861|NCT04091438|584821819|FG001|Washout Period (1 Day)|Other|1|||
161937862|NCT00421408|584821820|FG000|Overall Study|Lost to Follow-up|30|||
161937863|NCT00421408|584821821|FG001|Overall Study|Lost to Follow-up|20|||
161937864|NCT00421408|584821820|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
161937865|NCT00421408|584821821|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
161937866|NCT00553475|584821824|FG000|Overall Study|Adverse Event|7|||
161937867|NCT00553475|584821825|FG001|Overall Study|Adverse Event|17|||
161937868|NCT00553475|584821826|FG002|Overall Study|Adverse Event|13|||
162218905|NCT04210843|585851909|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
162218906|NCT04210843|585851908|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
162218907|NCT04210843|585851909|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
162218908|NCT04210843|585851908|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
162218909|NCT04210843|585851909|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
162218910|NCT04210843|585851908|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
162218911|NCT04210843|585851909|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
162218912|NCT01266161|585851916|FG000|Overall Study|Ineligible|1|||
162218913|NCT01266161|585851917|FG001|Overall Study|Ineligible|0|||
162218914|NCT01266161|585851916|FG000|Overall Study|Lack of Efficacy|0|||
161937869|NCT00553475|584821824|FG000|Overall Study|Lack of Efficacy|7|||
161937870|NCT00553475|584821825|FG001|Overall Study|Lack of Efficacy|1|||
161937871|NCT00553475|584821826|FG002|Overall Study|Lack of Efficacy|0|||
161937872|NCT00553475|584821824|FG000|Overall Study|Withdrawal by Subject|1|||
161937873|NCT00553475|584821825|FG001|Overall Study|Withdrawal by Subject|1|||
161937874|NCT00553475|584821826|FG002|Overall Study|Withdrawal by Subject|0|||
161937875|NCT00553475|584821824|FG000|Overall Study|Physician Decision|1|||
161937876|NCT00553475|584821825|FG001|Overall Study|Physician Decision|0|||
161937877|NCT00553475|584821826|FG002|Overall Study|Physician Decision|0|||
161937878|NCT00553475|584821824|FG000|Overall Study|Due to moving|0|||
161937879|NCT00553475|584821825|FG001|Overall Study|Due to moving|1|||
161937880|NCT00553475|584821826|FG002|Overall Study|Due to moving|0|||
161937881|NCT01308788|584821827|FG000|2-year Treatment|medication change by treating physician|4|||
161937882|NCT01308788|584821828|FG001|2-year Treatment|medication change by treating physician|11|||
161937883|NCT00322218|584821829|FG000|Overall Study|Death|3|||
162218915|NCT01266161|585851917|FG001|Overall Study|Lack of Efficacy|1|||
162218916|NCT01266161|585851916|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
162218917|NCT01266161|585851917|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
162218918|NCT01436305|585851918|FG000|Overall Study|Death|1|||
162218919|NCT01436305|585851919|FG001|Overall Study|Death|0|||
162218920|NCT01436305|585851920|FG002|Overall Study|Death|0|||
162218921|NCT01436305|585851918|FG000|Overall Study|Lost to Follow-up|0|||
162218922|NCT01436305|585851919|FG001|Overall Study|Lost to Follow-up|1|||
162218923|NCT01436305|585851920|FG002|Overall Study|Lost to Follow-up|0|||
162218924|NCT01436305|585851918|FG000|Overall Study|Withdrawal by Subject|1|||
162218925|NCT01436305|585851919|FG001|Overall Study|Withdrawal by Subject|3|||
162218926|NCT01436305|585851920|FG002|Overall Study|Withdrawal by Subject|0|||
162218927|NCT01485120|585851923|FG000|Overall Study|Withdrawal by Subject|2|||
162218928|NCT02344342|585851924|FG000|Overall Study|Industry partner dropped out|11|||
162218929|NCT02344342|585851925|FG001|Overall Study|Industry partner dropped out|9|||
162218930|NCT02344342|585851926|FG002|Overall Study|Industry partner dropped out|14|||
162218931|NCT02344342|585851927|FG003|Overall Study|Industry partner dropped out|10|||
162218932|NCT00848484|585851928|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
162218933|NCT00848484|585851929|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
162218934|NCT00848484|585851928|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
162218935|NCT00848484|585851929|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
162218936|NCT00848484|585851928|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
162218937|NCT00848484|585851929|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
162218938|NCT00848484|585851928|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
162218939|NCT00848484|585851929|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
162218940|NCT00848484|585851928|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
162218941|NCT00848484|585851929|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
162218942|NCT02567708|585851931|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
162218943|NCT02567708|585851932|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
162236643|NCT01191268|585917019|FG001|Overall Study|Adverse Event|13|||
161937884|NCT00322218|584821830|FG001|Overall Study|Death|6|||
161937885|NCT04101331|584823782|FG000|Overall Study|Adverse Event|9|||
161937886|NCT04101331|584823782|FG000|Overall Study|Disease progression|82|||
161937887|NCT04101331|584823782|FG000|Overall Study|Withdrawal by Subject|1|||
161828629|NCT02688387|584413548|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828630|NCT02688387|584413549|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828631|NCT02688387|584413550|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828632|NCT02688387|584413551|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828633|NCT02688387|584413552|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828634|NCT02688387|584413553|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162218944|NCT02567708|585851931|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
162218945|NCT02567708|585851932|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
162218946|NCT02567708|585851931|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
162218947|NCT02567708|585851932|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
162218948|NCT02567708|585851931|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
162218949|NCT02567708|585851932|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
162218950|NCT00706654|585851933|FG000|Conversion Phase|Lost to Follow-up|4|||
162218951|NCT00706654|585851934|FG001|Conversion Phase|Lost to Follow-up|0|||
162218952|NCT00706654|585851935|FG002|Conversion Phase|Lost to Follow-up|0|||
162218953|NCT00706654|585851936|FG003|Conversion Phase|Lost to Follow-up|0|||
162218954|NCT00706654|585851933|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
162218955|NCT00706654|585851934|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
162218956|NCT00706654|585851935|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
162218957|NCT00706654|585851936|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
162218958|NCT00706654|585851933|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
162218959|NCT00706654|585851934|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
162218960|NCT00706654|585851935|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
162218961|NCT00706654|585851936|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
162218962|NCT00706654|585851933|FG000|Conversion Phase|Withdrawn by Investigator|14|||
162218963|NCT00706654|585851934|FG001|Conversion Phase|Withdrawn by Investigator|0|||
162218964|NCT00706654|585851935|FG002|Conversion Phase|Withdrawn by Investigator|0|||
162218965|NCT00706654|585851936|FG003|Conversion Phase|Withdrawn by Investigator|0|||
162218966|NCT00706654|585851933|FG000|Conversion Phase|Withdrew Consent|38|||
162218967|NCT00706654|585851934|FG001|Conversion Phase|Withdrew Consent|0|||
162218968|NCT00706654|585851935|FG002|Conversion Phase|Withdrew Consent|0|||
162218969|NCT00706654|585851936|FG003|Conversion Phase|Withdrew Consent|0|||
162218970|NCT00706654|585851933|FG000|Conversion Phase|Adverse Event|18|||
162218971|NCT00706654|585851934|FG001|Conversion Phase|Adverse Event|0|||
162218972|NCT00706654|585851935|FG002|Conversion Phase|Adverse Event|0|||
162218973|NCT00706654|585851936|FG003|Conversion Phase|Adverse Event|0|||
162218974|NCT00706654|585851933|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
162218975|NCT00706654|585851934|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
162218976|NCT00706654|585851935|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161828635|NCT02688387|584413554|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
162218977|NCT00706654|585851936|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
162218978|NCT00706654|585851933|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
162218979|NCT00706654|585851934|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
162218980|NCT00706654|585851935|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
162218981|NCT00706654|585851936|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
162218982|NCT00706654|585851933|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
162218983|NCT00706654|585851934|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
162218984|NCT00706654|585851935|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
162218985|NCT00706654|585851936|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
162218986|NCT00706654|585851933|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
162218987|NCT00706654|585851934|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
162218988|NCT00706654|585851935|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
162218989|NCT00706654|585851936|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
162218990|NCT00706654|585851933|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
161828636|NCT02688387|584413555|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828637|NCT02688387|584413556|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828638|NCT02688387|584413557|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828639|NCT02688387|584413558|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828640|NCT02688387|584413559|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828641|NCT02688387|584413560|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828642|NCT02688387|584413561|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828643|NCT02688387|584413562|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828644|NCT02688387|584413563|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
161828645|NCT02688387|584413564|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828646|NCT02688387|584413565|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161828647|NCT02938442|584413566|FG000|Overall Study|Death|0|||
161828648|NCT02938442|584413567|FG001|Overall Study|Death|1|||
161828649|NCT02938442|584413566|FG000|Overall Study|Lost to Follow-up|0|||
161937888|NCT04101331|584823782|FG000|Overall Study|Investigator decision|6|||
162218991|NCT00706654|585851934|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
162218992|NCT00706654|585851935|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
162218993|NCT00706654|585851936|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
162218994|NCT00706654|585851933|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
161937889|NCT04101331|584823782|FG000|Overall Study|Death|6|||
161937890|NCT04101331|584823782|FG000|Overall Study|Allogenic transplant|1|||
161937891|NCT04616196|584823783|FG000|Overall Study|Progressive Disease|3|||
161937892|NCT04616196|584823784|FG001|Overall Study|Progressive Disease|0|||
161937893|NCT04616196|584823785|FG002|Overall Study|Progressive Disease|4|||
161937894|NCT04616196|584823786|FG003|Overall Study|Progressive Disease|1|||
161937895|NCT04616196|584823783|FG000|Overall Study|Death|2|||
161937896|NCT04616196|584823784|FG001|Overall Study|Death|4|||
161937897|NCT04616196|584823785|FG002|Overall Study|Death|1|||
161937898|NCT04616196|584823786|FG003|Overall Study|Death|0|||
161937899|NCT04616196|584823783|FG000|Overall Study|Withdrawal by Subject|0|||
161937900|NCT04616196|584823784|FG001|Overall Study|Withdrawal by Subject|2|||
161937901|NCT04616196|584823785|FG002|Overall Study|Withdrawal by Subject|0|||
161937902|NCT04616196|584823786|FG003|Overall Study|Withdrawal by Subject|0|||
161937903|NCT04616196|584823783|FG000|Overall Study|Lost to Follow-up|1|||
161937904|NCT04616196|584823784|FG001|Overall Study|Lost to Follow-up|0|||
161937905|NCT04616196|584823785|FG002|Overall Study|Lost to Follow-up|0|||
161937906|NCT04616196|584823786|FG003|Overall Study|Lost to Follow-up|0|||
161937907|NCT04616196|584823783|FG000|Overall Study|Sponsor request|2|||
161937908|NCT04616196|584823784|FG001|Overall Study|Sponsor request|1|||
161937909|NCT04616196|584823785|FG002|Overall Study|Sponsor request|1|||
161937910|NCT04616196|584823786|FG003|Overall Study|Sponsor request|2|||
161937911|NCT06790303|584823789|FG000|Overall Study|Study Terminated by sponsor|4|||
161937912|NCT06790303|584823789|FG000|Overall Study|Death|4|||
161937913|NCT02579759|584823792|FG000|Overall Study|Protocol Violation|2|||
161937914|NCT02579759|584823793|FG001|Overall Study|Protocol Violation|0|||
161937915|NCT02579759|584823794|FG002|Overall Study|Protocol Violation|0|||
161937916|NCT02579759|584823792|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
161937917|NCT02579759|584823793|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
161937918|NCT02579759|584823794|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
161937919|NCT02579759|584823792|FG000|Overall Study|BfArM hold|13|||
161937920|NCT02579759|584823793|FG001|Overall Study|BfArM hold|12|||
161937921|NCT02579759|584823794|FG002|Overall Study|BfArM hold|12|||
161937922|NCT02579759|584823792|FG000|Overall Study|Sponsor stopped Dose 2|0|||
161937923|NCT02579759|584823793|FG001|Overall Study|Sponsor stopped Dose 2|41|||
161937924|NCT02579759|584823794|FG002|Overall Study|Sponsor stopped Dose 2|0|||
161937925|NCT02579759|584823792|FG000|Overall Study|Non compliance|0|||
161937926|NCT02579759|584823793|FG001|Overall Study|Non compliance|1|||
161937927|NCT02579759|584823794|FG002|Overall Study|Non compliance|0|||
161937928|NCT02579759|584823792|FG000|Overall Study|Pregnancy|0|||
161937929|NCT02579759|584823793|FG001|Overall Study|Pregnancy|1|||
161937930|NCT02579759|584823794|FG002|Overall Study|Pregnancy|0|||
161937931|NCT02579759|584823792|FG000|Overall Study|Inclusion/exclusion criteria|0|||
161937932|NCT02579759|584823793|FG001|Overall Study|Inclusion/exclusion criteria|0|||
161937933|NCT02579759|584823794|FG002|Overall Study|Inclusion/exclusion criteria|1|||
161937934|NCT02579759|584823792|FG000|Overall Study|Adverse Event|4|||
161937935|NCT02579759|584823793|FG001|Overall Study|Adverse Event|3|||
161937936|NCT02579759|584823794|FG002|Overall Study|Adverse Event|1|||
161937937|NCT02579759|584823792|FG000|Overall Study|Withdrawal by Subject|3|||
161937938|NCT02579759|584823793|FG001|Overall Study|Withdrawal by Subject|3|||
161937939|NCT02579759|584823794|FG002|Overall Study|Withdrawal by Subject|5|||
161937940|NCT02579759|584823792|FG000|Overall Study|Lost to Follow-up|2|||
162218995|NCT00706654|585851934|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
162218996|NCT00706654|585851935|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
162218997|NCT00706654|585851936|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
162218998|NCT00706654|585851933|FG000|Oral Stabilization Phase|Withdrew consent|55|||
162218999|NCT00706654|585851934|FG001|Oral Stabilization Phase|Withdrew consent|0|||
162219000|NCT00706654|585851935|FG002|Oral Stabilization Phase|Withdrew consent|0|||
161937941|NCT02579759|584823793|FG001|Overall Study|Lost to Follow-up|2|||
161937942|NCT02579759|584823794|FG002|Overall Study|Lost to Follow-up|2|||
161937943|NCT01904279|584823799|FG000|Overall Study|Lack of Efficacy|2|||
161937944|NCT01904279|584823800|FG001|Overall Study|Lack of Efficacy|3|||
161937945|NCT01904279|584823799|FG000|Overall Study|Withdrawal by Subject|1|||
161937946|NCT01904279|584823800|FG001|Overall Study|Withdrawal by Subject|0|||
161937947|NCT03283241|584823803|FG000|Overall Study|Adverse Event|4|||
161937948|NCT03283241|584823804|FG001|Overall Study|Adverse Event|1|||
161937949|NCT03283241|584823803|FG000|Overall Study|Withdrawal by Subject|0|||
161937950|NCT03283241|584823804|FG001|Overall Study|Withdrawal by Subject|1|||
162022749|NCT01519167|585139685|FG001|Overall Study|Lack of Efficacy|1|||
162236644|NCT01191268|585917020|FG002|Overall Study|Adverse Event|8|||
161937951|NCT03283241|584823803|FG000|Overall Study|Subject relocated to Finland|0|||
161937952|NCT03283241|584823804|FG001|Overall Study|Subject relocated to Finland|1|||
161937953|NCT00666263|584823805|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
162219001|NCT00706654|585851936|FG003|Oral Stabilization Phase|Withdrew consent|0|||
162219002|NCT00706654|585851933|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
162219003|NCT00706654|585851934|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
162219004|NCT00706654|585851935|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
162219005|NCT00706654|585851936|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
162219006|NCT00706654|585851933|FG000|Oral Stabilization Phase|Adverse Event|21|||
162219007|NCT00706654|585851934|FG001|Oral Stabilization Phase|Adverse Event|0|||
162219008|NCT00706654|585851935|FG002|Oral Stabilization Phase|Adverse Event|0|||
162219009|NCT00706654|585851936|FG003|Oral Stabilization Phase|Adverse Event|0|||
161828650|NCT02938442|584413567|FG001|Overall Study|Lost to Follow-up|1|||
161828651|NCT02938442|584413566|FG000|Overall Study|Physician Decision|0|||
161828652|NCT02938442|584413567|FG001|Overall Study|Physician Decision|1|||
161828653|NCT02938442|584413566|FG000|Overall Study|Withdrawal by Subject|2|||
161828654|NCT02938442|584413567|FG001|Overall Study|Withdrawal by Subject|0|||
161828655|NCT00802178|584413568|FG000|Overall Study|Lack of Efficacy|36|||
161828656|NCT00802178|584413568|FG000|Overall Study|Insufficient tolerability (IT)|17|||
161828657|NCT00802178|584413568|FG000|Overall Study|Withdrawal by Subject|18|||
161828658|NCT00802178|584413568|FG000|Overall Study|Other|32|||
161828659|NCT00802178|584413568|FG000|Overall Study|Lack of efficacy and patient wish|1|||
161828660|NCT00802178|584413568|FG000|Overall Study|IT and patient wish|8|||
161828661|NCT00802178|584413568|FG000|Overall Study|Patients wish and other reason|1|||
161828662|NCT01606228|584413569|FG000|Overall Study|Lost to Follow-up|20|||
161828663|NCT01606228|584413569|FG000|Overall Study|Withdrawal by Subject|3|||
161828664|NCT01606228|584413569|FG000|Overall Study|Non-compliant|3|||
161828665|NCT01606228|584413569|FG000|Overall Study|Lack of Efficacy|2|||
161828666|NCT01606228|584413569|FG000|Overall Study|Adverse Event|1|||
161828667|NCT01115855|584413570|FG000|Overall Study|Adverse Event|16|||
161828668|NCT01115855|584413571|FG001|Overall Study|Adverse Event|18|||
161828669|NCT01115855|584413570|FG000|Overall Study|Death|6|||
161828670|NCT01115855|584413571|FG001|Overall Study|Death|5|||
161828671|NCT01115855|584413570|FG000|Overall Study|Lab Abnormality|1|||
161828672|NCT01115855|584413571|FG001|Overall Study|Lab Abnormality|1|||
161828673|NCT01115855|584413570|FG000|Overall Study|Protocol Violation|0|||
161828674|NCT01115855|584413571|FG001|Overall Study|Protocol Violation|1|||
161828675|NCT01115855|584413570|FG000|Overall Study|Withdrawal by Subject|5|||
161828676|NCT01115855|584413571|FG001|Overall Study|Withdrawal by Subject|5|||
161937954|NCT00666263|584823806|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
161937955|NCT00666263|584823805|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
161937956|NCT00666263|584823806|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
161937957|NCT00666263|584823805|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
161937958|NCT00666263|584823806|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
161937959|NCT02439957|584823807|FG000|Overall Study|Study Terminated|3|||
161937960|NCT02439957|584823808|FG001|Overall Study|Study Terminated|3|||
161937961|NCT00586157|584823809|FG000|First Intervention|Worsening behavior|1|||
161937962|NCT00586157|584823810|FG001|First Intervention|Worsening behavior|0|||
161937963|NCT00586157|584823809|FG000|Second Intervention|Withdrawal by Subject|1|||
161937964|NCT00586157|584823810|FG001|Second Intervention|Withdrawal by Subject|0|||
161937965|NCT00586157|584823809|FG000|Second Intervention|Worsening behavior|1|||
161937966|NCT00586157|584823810|FG001|Second Intervention|Worsening behavior|0|||
161937967|NCT00586157|584823809|FG000|Second Intervention|Adverse Event|0|||
161937968|NCT00586157|584823810|FG001|Second Intervention|Adverse Event|1|||
161937969|NCT00831389|584823811|FG000|Overall Study|Withdrawal by Subject|0|||
161937970|NCT00831389|584823812|FG001|Overall Study|Withdrawal by Subject|1|||
161937971|NCT00278161|584823814|FG000|Overall Study|Death|11|||
161937972|NCT01817777|584823815|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
161937973|NCT01817777|584823816|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
161937974|NCT01817777|584823817|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
162219010|NCT00706654|585851933|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
162219011|NCT00706654|585851934|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
162219012|NCT00706654|585851935|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
162219013|NCT00706654|585851936|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
162219014|NCT00706654|585851933|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
162219015|NCT00706654|585851934|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
162236645|NCT01191268|585917018|FG000|Overall Study|Physician Decision|6|||
161828677|NCT01115855|584413570|FG000|Overall Study|Other|8|||
161828678|NCT01115855|584413571|FG001|Overall Study|Other|6|||
161828679|NCT04100096|584413572|FG000|Overall Study|Adverse Event|19|||
161828680|NCT04100096|584413573|FG001|Overall Study|Adverse Event|7|||
161828681|NCT04100096|584413572|FG000|Overall Study|Lack of Efficacy|0|||
161828682|NCT04100096|584413573|FG001|Overall Study|Lack of Efficacy|1|||
161828683|NCT04100096|584413572|FG000|Overall Study|Lost to Follow-up|13|||
161937975|NCT01817777|584823815|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
161937976|NCT01817777|584823816|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
161937977|NCT01817777|584823817|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
161828684|NCT04100096|584413573|FG001|Overall Study|Lost to Follow-up|11|||
162219016|NCT00706654|585851935|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
162219017|NCT00706654|585851936|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
162219018|NCT00706654|585851933|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
162219019|NCT00706654|585851934|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
162219020|NCT00706654|585851935|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
162219021|NCT00706654|585851936|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
162219022|NCT00706654|585851933|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
162219023|NCT00706654|585851934|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
162219024|NCT00706654|585851935|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
162219025|NCT00706654|585851936|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
162219026|NCT00706654|585851933|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
162219027|NCT00706654|585851934|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
162219028|NCT00706654|585851935|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
162219029|NCT00706654|585851936|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
162219030|NCT00706654|585851933|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
162219031|NCT00706654|585851934|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
162219032|NCT00706654|585851935|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
162219033|NCT00706654|585851936|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
162219034|NCT00706654|585851933|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
162219035|NCT00706654|585851934|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
162219036|NCT00706654|585851935|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
162219037|NCT00706654|585851936|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
162219038|NCT00706654|585851933|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
162219039|NCT00706654|585851934|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
162219040|NCT00706654|585851935|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
162219041|NCT00706654|585851936|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
162219042|NCT00706654|585851933|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
162219043|NCT00706654|585851934|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
162219044|NCT00706654|585851935|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
162219045|NCT00706654|585851936|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
162219046|NCT00706654|585851933|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
162219047|NCT00706654|585851934|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
162219048|NCT00706654|585851935|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
162219049|NCT00706654|585851936|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
162219050|NCT01001390|585851937|FG000|Overall Study|Failure to wear AFO device|2|||
162219051|NCT01001390|585851938|FG001|Overall Study|Failure to wear AFO device|0|||
162219052|NCT01151215|585851942|FG000|Overall Study|Worsening of condition under study|1|||
162219053|NCT01151215|585851943|FG001|Overall Study|Worsening of condition under study|1|||
162219054|NCT01151215|585851944|FG002|Overall Study|Worsening of condition under study|1|||
162219055|NCT01151215|585851942|FG000|Overall Study|Death|16|||
162219056|NCT01151215|585851943|FG001|Overall Study|Death|20|||
162219057|NCT01151215|585851944|FG002|Overall Study|Death|11|||
162219058|NCT01151215|585851942|FG000|Overall Study|Lost to Follow-up|0|||
162219059|NCT01151215|585851943|FG001|Overall Study|Lost to Follow-up|0|||
162219060|NCT01151215|585851944|FG002|Overall Study|Lost to Follow-up|3|||
162219061|NCT01151215|585851942|FG000|Overall Study|Withdrawal by Subject|3|||
162219062|NCT01151215|585851943|FG001|Overall Study|Withdrawal by Subject|1|||
162219063|NCT01151215|585851944|FG002|Overall Study|Withdrawal by Subject|2|||
162219064|NCT01151215|585851942|FG000|Overall Study|Disease progression|0|||
162219065|NCT01151215|585851943|FG001|Overall Study|Disease progression|1|||
162219066|NCT01151215|585851944|FG002|Overall Study|Disease progression|1|||
162219067|NCT01151215|585851942|FG000|Overall Study|Safety as judged by the investigator|0|||
161678570|NCT01380730|583876024|FG004|Overall Study|Death|1|||
161678571|NCT01380730|583876025|FG005|Overall Study|Death|0|||
161678572|NCT01380730|583876026|FG006|Overall Study|Death|0|||
161678573|NCT01380730|583876027|FG007|Overall Study|Death|0|||
161678574|NCT00962390|583876037|FG000|Overall Study|Adverse Event|0|||
161678575|NCT00962390|583876038|FG001|Overall Study|Adverse Event|0|||
161678576|NCT00962390|583876039|FG002|Overall Study|Adverse Event|3|||
161678577|NCT00962390|583876040|FG003|Overall Study|Adverse Event|1|||
161678578|NCT00962390|583876037|FG000|Overall Study|Lost to Follow-up|2|||
162219068|NCT01151215|585851943|FG001|Overall Study|Safety as judged by the investigator|0|||
162219069|NCT01151215|585851944|FG002|Overall Study|Safety as judged by the investigator|1|||
161937978|NCT01817777|584823815|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
162219070|NCT02956837|585851945|FG000|Overall Study|Serious Adverse Events|0|||
162219071|NCT02956837|585851946|FG001|Overall Study|Serious Adverse Events|1|||
162219072|NCT02956837|585851947|FG002|Overall Study|Serious Adverse Events|0|||
161678579|NCT00962390|583876038|FG001|Overall Study|Lost to Follow-up|2|||
161937979|NCT01817777|584823816|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
161937980|NCT01817777|584823817|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
161678580|NCT00962390|583876039|FG002|Overall Study|Lost to Follow-up|0|||
161678581|NCT00962390|583876040|FG003|Overall Study|Lost to Follow-up|0|||
162219073|NCT02956837|585851948|FG003|Overall Study|Serious Adverse Events|0|||
162219074|NCT02956837|585851945|FG000|Overall Study|Withdrawal by Subject|0|||
162219075|NCT02956837|585851946|FG001|Overall Study|Withdrawal by Subject|1|||
162219076|NCT02956837|585851947|FG002|Overall Study|Withdrawal by Subject|0|||
162219077|NCT02956837|585851948|FG003|Overall Study|Withdrawal by Subject|3|||
162219078|NCT02956837|585851945|FG000|Overall Study|Lost to Follow-up|0|||
162219079|NCT02956837|585851946|FG001|Overall Study|Lost to Follow-up|1|||
162219080|NCT02956837|585851947|FG002|Overall Study|Lost to Follow-up|2|||
162219081|NCT02956837|585851948|FG003|Overall Study|Lost to Follow-up|0|||
162219082|NCT02597712|585851953|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
162219083|NCT02597712|585851954|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
162219084|NCT02597712|585851953|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
162219085|NCT02597712|585851954|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
162219086|NCT02597712|585851953|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
162219087|NCT02597712|585851954|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
162219088|NCT01727505|585851955|FG000|First 24 Hours|Adverse Event|0|||
162219089|NCT01727505|585851956|FG001|First 24 Hours|Adverse Event|1|||
162219090|NCT01727505|585851955|FG000|Second 24 Hours|Missing data|0|||
162219091|NCT01727505|585851956|FG001|Second 24 Hours|Missing data|1|||
162219092|NCT00513708|585851960|FG000|Overall Study|Lost to Follow-up|4|||
162219093|NCT00513708|585851961|FG001|Overall Study|Lost to Follow-up|4|||
162219094|NCT00513708|585851962|FG002|Overall Study|Lost to Follow-up|4|||
162219095|NCT01564277|585851963|FG000|Overall Study|Protocol Violation|0|||
162219096|NCT01564277|585851964|FG001|Overall Study|Protocol Violation|1|||
162219097|NCT01564277|585851963|FG000|Overall Study|Physician Decision|1|||
162219098|NCT01564277|585851964|FG001|Overall Study|Physician Decision|0|||
162219099|NCT01594970|585851965|FG000|Overall Study|Non-Adverse Event Related|4|||
161937981|NCT01817777|584823815|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
162219100|NCT01594970|585851966|FG001|Overall Study|Non-Adverse Event Related|5|||
162219101|NCT01594970|585851967|FG002|Overall Study|Non-Adverse Event Related|6|||
162219102|NCT01594970|585851965|FG000|Overall Study|Adverse Event|17|||
162219103|NCT01594970|585851966|FG001|Overall Study|Adverse Event|23|||
162219104|NCT01594970|585851967|FG002|Overall Study|Adverse Event|23|||
162219105|NCT01594970|585851965|FG000|Overall Study|Lost to Follow-up|54|||
162219106|NCT01594970|585851966|FG001|Overall Study|Lost to Follow-up|54|||
162219107|NCT01594970|585851967|FG002|Overall Study|Lost to Follow-up|37|||
162219108|NCT01299480|585851970|FG000|Overall Study|No longer willing to participate|19|||
162219109|NCT01299480|585851971|FG001|Overall Study|No longer willing to participate|17|||
162219110|NCT01299480|585851972|FG002|Overall Study|No longer willing to participate|14|||
162219111|NCT01299480|585851973|FG003|Overall Study|No longer willing to participate|13|||
162219112|NCT01299480|585851974|FG004|Overall Study|No longer willing to participate|10|||
162219113|NCT01299480|585851970|FG000|Overall Study|Protocol Violation|7|||
162219114|NCT01299480|585851971|FG001|Overall Study|Protocol Violation|5|||
162219115|NCT01299480|585851972|FG002|Overall Study|Protocol Violation|8|||
162219116|NCT01299480|585851973|FG003|Overall Study|Protocol Violation|1|||
162219117|NCT01299480|585851974|FG004|Overall Study|Protocol Violation|1|||
162219118|NCT01299480|585851970|FG000|Overall Study|Withdrawal by Subject|3|||
162219119|NCT01299480|585851971|FG001|Overall Study|Withdrawal by Subject|4|||
162219120|NCT01299480|585851972|FG002|Overall Study|Withdrawal by Subject|7|||
162219121|NCT01299480|585851973|FG003|Overall Study|Withdrawal by Subject|3|||
162219122|NCT01299480|585851974|FG004|Overall Study|Withdrawal by Subject|4|||
162219123|NCT01299480|585851970|FG000|Overall Study|Adverse Event|6|||
162219124|NCT01299480|585851971|FG001|Overall Study|Adverse Event|4|||
162219125|NCT01299480|585851972|FG002|Overall Study|Adverse Event|5|||
162219126|NCT01299480|585851973|FG003|Overall Study|Adverse Event|4|||
162219127|NCT01299480|585851974|FG004|Overall Study|Adverse Event|0|||
162219128|NCT01299480|585851970|FG000|Overall Study|Withdrawal due to pregnancy|0|||
162219129|NCT01299480|585851971|FG001|Overall Study|Withdrawal due to pregnancy|1|||
162219130|NCT01299480|585851972|FG002|Overall Study|Withdrawal due to pregnancy|1|||
162219131|NCT01299480|585851973|FG003|Overall Study|Withdrawal due to pregnancy|0|||
161937982|NCT01817777|584823816|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
162219132|NCT01299480|585851974|FG004|Overall Study|Withdrawal due to pregnancy|0|||
162219133|NCT01299480|585851970|FG000|Overall Study|Physician Decision|1|||
162219134|NCT01299480|585851971|FG001|Overall Study|Physician Decision|1|||
162219135|NCT01299480|585851972|FG002|Overall Study|Physician Decision|0|||
162219136|NCT01299480|585851973|FG003|Overall Study|Physician Decision|2|||
162219137|NCT01299480|585851974|FG004|Overall Study|Physician Decision|0|||
162219138|NCT01299480|585851970|FG000|Overall Study|Lost to Follow-up|3|||
162219139|NCT01299480|585851971|FG001|Overall Study|Lost to Follow-up|1|||
162219140|NCT01299480|585851972|FG002|Overall Study|Lost to Follow-up|2|||
162219141|NCT01299480|585851973|FG003|Overall Study|Lost to Follow-up|1|||
162219142|NCT01299480|585851974|FG004|Overall Study|Lost to Follow-up|2|||
162219143|NCT01299480|585851970|FG000|Overall Study|Other|3|||
162219144|NCT01299480|585851971|FG001|Overall Study|Other|2|||
162219145|NCT01299480|585851972|FG002|Overall Study|Other|3|||
162219146|NCT01299480|585851973|FG003|Overall Study|Other|0|||
162219147|NCT01299480|585851974|FG004|Overall Study|Other|3|||
162219148|NCT01299480|585851970|FG000|Overall Study|Started, but not vaccinated|0|||
162219149|NCT01299480|585851971|FG001|Overall Study|Started, but not vaccinated|0|||
162219150|NCT01299480|585851972|FG002|Overall Study|Started, but not vaccinated|1|||
162219151|NCT01299480|585851973|FG003|Overall Study|Started, but not vaccinated|1|||
162219152|NCT01299480|585851974|FG004|Overall Study|Started, but not vaccinated|0|||
162219153|NCT04276051|585851975|FG000|Overall Study|Lost to Follow-up|0|||
161937983|NCT01817777|584823817|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
161937984|NCT01817777|584823815|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
161937985|NCT01817777|584823816|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
161937986|NCT01817777|584823817|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
161937987|NCT00443456|584823818|FG000|Overall Study|Adverse Event|16|||
162219154|NCT04276051|585851976|FG001|Overall Study|Lost to Follow-up|1|||
162219155|NCT04276051|585851975|FG000|Overall Study|Physician Decision|0|||
162219156|NCT04276051|585851976|FG001|Overall Study|Physician Decision|1|||
162219157|NCT04276051|585851975|FG000|Overall Study|Withdrawal by Subject|1|||
162219158|NCT04276051|585851976|FG001|Overall Study|Withdrawal by Subject|1|||
162219159|NCT03838731|585853838|FG000|Overall Study|Pregnancy|0|||
162219160|NCT03838731|585853839|FG001|Overall Study|Pregnancy|1|||
162219161|NCT03838731|585853838|FG000|Overall Study|Withdrawal of consent|1|||
162219162|NCT03838731|585853839|FG001|Overall Study|Withdrawal of consent|0|||
162219163|NCT02706405|585853848|FG000|Overall Study|Death|3|||
162219164|NCT02706405|585853849|FG001|Overall Study|Death|2|||
162219165|NCT02706405|585853850|FG002|Overall Study|Death|0|||
162219166|NCT02706405|585853851|FG003|Overall Study|Death|1|||
162219167|NCT02706405|585853852|FG004|Overall Study|Death|0|||
162219168|NCT02706405|585853853|FG005|Overall Study|Death|0|||
162219169|NCT02706405|585853854|FG006|Overall Study|Death|3|||
162219170|NCT02706405|585853855|FG007|Overall Study|Death|4|||
162219171|NCT02706405|585853848|FG000|Overall Study|Disease progression|0|||
162219172|NCT02706405|585853849|FG001|Overall Study|Disease progression|0|||
162219173|NCT02706405|585853850|FG002|Overall Study|Disease progression|0|||
162219174|NCT02706405|585853851|FG003|Overall Study|Disease progression|0|||
162219175|NCT02706405|585853852|FG004|Overall Study|Disease progression|0|||
162219176|NCT02706405|585853853|FG005|Overall Study|Disease progression|0|||
162219177|NCT02706405|585853854|FG006|Overall Study|Disease progression|0|||
162219178|NCT02706405|585853855|FG007|Overall Study|Disease progression|1|||
162219179|NCT02706405|585853848|FG000|Overall Study|Pt moved to new therapy|0|||
162219180|NCT02706405|585853849|FG001|Overall Study|Pt moved to new therapy|0|||
162219181|NCT02706405|585853850|FG002|Overall Study|Pt moved to new therapy|0|||
162219182|NCT02706405|585853851|FG003|Overall Study|Pt moved to new therapy|0|||
162219183|NCT02706405|585853852|FG004|Overall Study|Pt moved to new therapy|0|||
162219184|NCT02706405|585853853|FG005|Overall Study|Pt moved to new therapy|1|||
162219185|NCT02706405|585853854|FG006|Overall Study|Pt moved to new therapy|0|||
162219186|NCT02706405|585853855|FG007|Overall Study|Pt moved to new therapy|1|||
162219187|NCT02706405|585853848|FG000|Overall Study|Physician Decision|1|||
162219188|NCT02706405|585853849|FG001|Overall Study|Physician Decision|0|||
162219189|NCT02706405|585853850|FG002|Overall Study|Physician Decision|0|||
162219190|NCT02706405|585853851|FG003|Overall Study|Physician Decision|0|||
162219191|NCT02706405|585853852|FG004|Overall Study|Physician Decision|0|||
162219192|NCT02706405|585853853|FG005|Overall Study|Physician Decision|0|||
162219193|NCT02706405|585853854|FG006|Overall Study|Physician Decision|0|||
162219194|NCT02706405|585853855|FG007|Overall Study|Physician Decision|0|||
162219195|NCT00789360|585853862|FG000|Overall Study|Protocol Violation|3|||
162219196|NCT00789360|585853863|FG001|Overall Study|Protocol Violation|1|||
162219197|NCT03559062|585853864|FG000|Overall Study|Other|0|||
162219198|NCT03559062|585853865|FG001|Overall Study|Other|1|||
162219199|NCT03559062|585853866|FG002|Overall Study|Other|0|||
162219200|NCT01757197|585853867|FG000|Overall Study|Death|2|||
161937988|NCT00443456|584823818|FG000|Overall Study|Move|1|||
161937989|NCT00443456|584823818|FG000|Overall Study|Withdrawal by Subject|1|||
161937990|NCT03242434|584823819|FG000|Overall Study|Death|0|||
161937991|NCT03242434|584823820|FG001|Overall Study|Death|2|||
161937992|NCT01592747|584823826|FG000|Overall Study|Loss of Therapeutic Response|107|||
161937993|NCT01592747|584823827|FG001|Overall Study|Loss of Therapeutic Response|108|||
162219201|NCT03443414|585853868|FG000|Overall Study|Adverse Event|6|||
162219202|NCT03443414|585853869|FG001|Overall Study|Adverse Event|0|||
162219203|NCT03443414|585853870|FG002|Overall Study|Adverse Event|4|||
162219204|NCT03443414|585853871|FG003|Overall Study|Adverse Event|2|||
162219205|NCT03443414|585853872|FG004|Overall Study|Adverse Event|3|||
162219206|NCT03443414|585853868|FG000|Overall Study|Withdrawal by Subject|3|||
162219207|NCT03443414|585853869|FG001|Overall Study|Withdrawal by Subject|2|||
162219208|NCT03443414|585853870|FG002|Overall Study|Withdrawal by Subject|2|||
161937994|NCT01592747|584823828|FG002|Overall Study|Loss of Therapeutic Response|100|||
162219209|NCT03443414|585853871|FG003|Overall Study|Withdrawal by Subject|2|||
162219210|NCT03443414|585853872|FG004|Overall Study|Withdrawal by Subject|1|||
162219211|NCT03443414|585853868|FG000|Overall Study|Death|0|||
162219212|NCT03443414|585853869|FG001|Overall Study|Death|1|||
162219213|NCT03443414|585853870|FG002|Overall Study|Death|0|||
162219214|NCT03443414|585853871|FG003|Overall Study|Death|1|||
161678582|NCT00962390|583876037|FG000|Overall Study|Protocol Violation|1|||
161678583|NCT00962390|583876038|FG001|Overall Study|Protocol Violation|0|||
161678584|NCT00962390|583876039|FG002|Overall Study|Protocol Violation|0|||
161678585|NCT00962390|583876040|FG003|Overall Study|Protocol Violation|0|||
161678586|NCT00962390|583876037|FG000|Overall Study|Withdrawal by Subject|1|||
161678587|NCT00962390|583876038|FG001|Overall Study|Withdrawal by Subject|1|||
161678588|NCT00962390|583876039|FG002|Overall Study|Withdrawal by Subject|1|||
161678589|NCT00962390|583876040|FG003|Overall Study|Withdrawal by Subject|0|||
161678590|NCT02613884|583876041|FG000|Overall Study|Death|1|||
161678591|NCT02613884|583876041|FG000|Overall Study|Lost to Follow-up|1|||
161678592|NCT00433914|583876044|FG000|Overall Study|Withdrawal by Subject|0|||
161678593|NCT00433914|583876045|FG001|Overall Study|Withdrawal by Subject|2|||
161678594|NCT00433914|583876044|FG000|Overall Study|Lost to Follow-up|0|||
161678595|NCT00433914|583876045|FG001|Overall Study|Lost to Follow-up|1|||
161678596|NCT00766090|583876046|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678597|NCT00766090|583876047|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678598|NCT00766090|583876048|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678599|NCT00766090|583876049|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678600|NCT00766090|583876050|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678601|NCT00766090|583876051|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678602|NCT00766090|583876052|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161937995|NCT01592747|584823826|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
161937996|NCT01592747|584823827|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
161937997|NCT01592747|584823828|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
161937998|NCT01592747|584823826|FG000|Overall Study|Adverse Event|1|||
161937999|NCT01592747|584823827|FG001|Overall Study|Adverse Event|0|||
162219215|NCT03443414|585853872|FG004|Overall Study|Death|0|||
162219216|NCT03443414|585853868|FG000|Overall Study|Reason not specified|2|||
162219217|NCT03443414|585853869|FG001|Overall Study|Reason not specified|0|||
162219218|NCT03443414|585853870|FG002|Overall Study|Reason not specified|0|||
162219219|NCT03443414|585853871|FG003|Overall Study|Reason not specified|0|||
162219220|NCT03443414|585853872|FG004|Overall Study|Reason not specified|1|||
161678603|NCT00766090|583876053|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
162219221|NCT02522728|585853875|FG000|Overall Study|Withdrawal by Subject|6|||
162219222|NCT02522728|585853876|FG001|Overall Study|Withdrawal by Subject|6|||
162219223|NCT02522728|585853875|FG000|Overall Study|Death|4|||
162219224|NCT02522728|585853876|FG001|Overall Study|Death|3|||
162219225|NCT02522728|585853875|FG000|Overall Study|Adverse Event|2|||
162219226|NCT02522728|585853876|FG001|Overall Study|Adverse Event|1|||
162219227|NCT02522728|585853875|FG000|Overall Study|Did not receive randomized study device|0|||
162219228|NCT02522728|585853876|FG001|Overall Study|Did not receive randomized study device|1|||
162219229|NCT01099917|585853878|FG000|Overall Study|Adverse Event|3|||
162219230|NCT01099917|585853878|FG000|Overall Study|Not Treated|24|||
162219231|NCT03355209|585853879|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
162219232|NCT03355209|585853880|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
161678604|NCT00766090|583876054|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
161678605|NCT00766090|583876055|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678606|NCT00766090|583876056|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161678607|NCT00766090|583876057|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161938000|NCT01592747|584823828|FG002|Overall Study|Adverse Event|0|||
161678608|NCT00766090|583876046|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
161938001|NCT01592747|584823826|FG000|Overall Study|Protocol Violation|4|||
161938002|NCT01592747|584823827|FG001|Overall Study|Protocol Violation|0|||
161938003|NCT01592747|584823828|FG002|Overall Study|Protocol Violation|4|||
161938004|NCT01592747|584823826|FG000|Overall Study|Lack of Efficacy|0|||
162219233|NCT03355209|585853881|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
161938005|NCT01592747|584823827|FG001|Overall Study|Lack of Efficacy|1|||
161938006|NCT01592747|584823828|FG002|Overall Study|Lack of Efficacy|0|||
161938007|NCT01592747|584823826|FG000|Overall Study|Withdrawal by Subject|2|||
161938008|NCT01592747|584823827|FG001|Overall Study|Withdrawal by Subject|0|||
161938009|NCT01592747|584823828|FG002|Overall Study|Withdrawal by Subject|2|||
161938010|NCT01592747|584823826|FG000|Overall Study|Lost to Follow-up|1|||
161938011|NCT01592747|584823827|FG001|Overall Study|Lost to Follow-up|0|||
162219234|NCT03355209|585853882|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
162219235|NCT03355209|585853883|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
162219236|NCT03355209|585853884|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
162219237|NCT03355209|585853879|FG000|Part 1: Double-Blind Period|Death|0|||
162219238|NCT03355209|585853880|FG001|Part 1: Double-Blind Period|Death|0|||
162219239|NCT03355209|585853881|FG002|Part 1: Double-Blind Period|Death|1|||
162219240|NCT03355209|585853882|FG003|Part 1: Double-Blind Period|Death|0|||
162219241|NCT03355209|585853883|FG004|Part 1: Double-Blind Period|Death|0|||
162219242|NCT03355209|585853884|FG005|Part 1: Double-Blind Period|Death|0|||
162219243|NCT03355209|585853879|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
162219244|NCT03355209|585853880|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
162219245|NCT03355209|585853881|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
162219246|NCT03355209|585853882|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
162219247|NCT03355209|585853883|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
162219248|NCT03355209|585853884|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
162219249|NCT03355209|585853879|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
162219250|NCT03355209|585853880|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
162219251|NCT03355209|585853881|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
162219252|NCT03355209|585853882|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
162219253|NCT03355209|585853883|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
162219254|NCT03355209|585853884|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
162219255|NCT03355209|585853879|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
162219256|NCT03355209|585853880|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
161938012|NCT01592747|584823828|FG002|Overall Study|Lost to Follow-up|1|||
161938013|NCT01592747|584823826|FG000|Overall Study|Other Reasons|1|||
161938014|NCT01592747|584823827|FG001|Overall Study|Other Reasons|1|||
161938015|NCT01592747|584823828|FG002|Overall Study|Other Reasons|0|||
161938016|NCT01935947|584823831|FG000|Overall Study|Adverse Event|0|||
161938017|NCT01935947|584823832|FG001|Overall Study|Adverse Event|2|||
161938018|NCT01935947|584823833|FG002|Overall Study|Adverse Event|0|||
161938019|NCT01935947|584823831|FG000|Overall Study|Diease Progression|2|||
161938020|NCT01935947|584823832|FG001|Overall Study|Diease Progression|2|||
161938021|NCT01935947|584823833|FG002|Overall Study|Diease Progression|2|||
161938022|NCT01935947|584823831|FG000|Overall Study|Death|1|||
161938023|NCT01935947|584823832|FG001|Overall Study|Death|0|||
161938024|NCT01935947|584823833|FG002|Overall Study|Death|0|||
161938025|NCT02853136|584823836|FG000|Wash-out|Adverse Event|0|||
161938026|NCT02853136|584823837|FG001|Wash-out|Adverse Event|0|||
161938027|NCT02853136|584823838|FG002|Wash-out|Adverse Event|0|||
161938028|NCT02853136|584823839|FG003|Wash-out|Adverse Event|1|||
161938029|NCT00841815|584823840|FG000|Washout|Withdrawal by Subject|0|||
161938030|NCT00841815|584823841|FG001|Washout|Withdrawal by Subject|1|||
161938031|NCT02758626|584823851|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
161938032|NCT02758626|584823852|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
161938033|NCT02758626|584823851|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
162219257|NCT03355209|585853881|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
162219258|NCT03355209|585853882|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
162219259|NCT03355209|585853883|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
162219260|NCT03355209|585853884|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
162219261|NCT03355209|585853879|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
162219262|NCT03355209|585853880|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
162219263|NCT03355209|585853881|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
162219264|NCT03355209|585853882|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
162219265|NCT03355209|585853883|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
162219266|NCT03355209|585853884|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
161938034|NCT02758626|584823852|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
162219267|NCT03355209|585853879|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
162219268|NCT03355209|585853880|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
162236646|NCT01191268|585917019|FG001|Overall Study|Physician Decision|8|||
161938035|NCT02758626|584823851|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
161938036|NCT02758626|584823852|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
161938037|NCT02758626|584823851|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
161938038|NCT02758626|584823852|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
161938039|NCT00456365|584823855|FG000|Overall Study|Lost to Follow-up|1|||
161938040|NCT00456365|584823856|FG001|Overall Study|Lost to Follow-up|3|||
161938041|NCT00456365|584823855|FG000|Overall Study|Withdrawal by Subject|4|||
161938042|NCT00456365|584823856|FG001|Overall Study|Withdrawal by Subject|7|||
162219269|NCT03355209|585853881|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
162219270|NCT03355209|585853882|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
161938043|NCT00456365|584823855|FG000|Overall Study|Pregnancy|1|||
161938044|NCT00456365|584823856|FG001|Overall Study|Pregnancy|1|||
161938045|NCT00456365|584823855|FG000|Overall Study|oncologic diagnosis|1|||
161938046|NCT00456365|584823856|FG001|Overall Study|oncologic diagnosis|1|||
161938047|NCT02096354|584823860|FG000|Overall Study|Physician Decision|4|||
161938048|NCT02096354|584823861|FG001|Overall Study|Physician Decision|5|||
161938049|NCT02096354|584823862|FG002|Overall Study|Physician Decision|0|||
161938050|NCT02096354|584823860|FG000|Overall Study|Withdrawal by Subject|3|||
161938051|NCT02096354|584823861|FG001|Overall Study|Withdrawal by Subject|1|||
161938052|NCT02096354|584823862|FG002|Overall Study|Withdrawal by Subject|0|||
161938053|NCT02096354|584823860|FG000|Overall Study|Adverse Event|7|||
161938054|NCT02096354|584823861|FG001|Overall Study|Adverse Event|4|||
161938055|NCT02096354|584823862|FG002|Overall Study|Adverse Event|0|||
161938056|NCT02096354|584823860|FG000|Overall Study|Ineligible|0|||
161938057|NCT02096354|584823861|FG001|Overall Study|Ineligible|0|||
161938058|NCT02096354|584823862|FG002|Overall Study|Ineligible|11|||
161938059|NCT03715829|584823863|FG000|Dose Ranging Period|Adverse Event|2|||
161938060|NCT03715829|584823864|FG001|Dose Ranging Period|Adverse Event|4|||
161938061|NCT03715829|584823865|FG002|Dose Ranging Period|Adverse Event|5|||
161938062|NCT03715829|584823866|FG003|Dose Ranging Period|Adverse Event|2|||
161938063|NCT03715829|584823867|FG004|Dose Ranging Period|Adverse Event|3|||
161938064|NCT03715829|584823868|FG005|Dose Ranging Period|Adverse Event|3|||
161938065|NCT03715829|584823869|FG006|Dose Ranging Period|Adverse Event|0|||
161938066|NCT03715829|584823870|FG007|Dose Ranging Period|Adverse Event|0|||
161938067|NCT03715829|584823871|FG008|Dose Ranging Period|Adverse Event|0|||
161938068|NCT03715829|584823872|FG009|Dose Ranging Period|Adverse Event|0|||
161938069|NCT03715829|584823873|FG010|Dose Ranging Period|Adverse Event|0|||
161938070|NCT03715829|584823863|FG000|Dose Ranging Period|Lack of Efficacy|0|||
161938071|NCT03715829|584823864|FG001|Dose Ranging Period|Lack of Efficacy|1|||
161938072|NCT03715829|584823865|FG002|Dose Ranging Period|Lack of Efficacy|0|||
161938073|NCT03715829|584823866|FG003|Dose Ranging Period|Lack of Efficacy|1|||
161938074|NCT03715829|584823867|FG004|Dose Ranging Period|Lack of Efficacy|0|||
161938075|NCT03715829|584823868|FG005|Dose Ranging Period|Lack of Efficacy|0|||
161938076|NCT03715829|584823869|FG006|Dose Ranging Period|Lack of Efficacy|0|||
161938077|NCT03715829|584823870|FG007|Dose Ranging Period|Lack of Efficacy|0|||
161938078|NCT03715829|584823871|FG008|Dose Ranging Period|Lack of Efficacy|0|||
161938079|NCT03715829|584823872|FG009|Dose Ranging Period|Lack of Efficacy|0|||
161938080|NCT03715829|584823873|FG010|Dose Ranging Period|Lack of Efficacy|0|||
161938081|NCT03715829|584823863|FG000|Dose Ranging Period|Lost to Follow-up|2|||
161938082|NCT03715829|584823864|FG001|Dose Ranging Period|Lost to Follow-up|0|||
161938083|NCT03715829|584823865|FG002|Dose Ranging Period|Lost to Follow-up|1|||
161938084|NCT03715829|584823866|FG003|Dose Ranging Period|Lost to Follow-up|1|||
161938085|NCT03715829|584823867|FG004|Dose Ranging Period|Lost to Follow-up|1|||
161938086|NCT03715829|584823868|FG005|Dose Ranging Period|Lost to Follow-up|2|||
161938087|NCT03715829|584823869|FG006|Dose Ranging Period|Lost to Follow-up|0|||
161938088|NCT03715829|584823870|FG007|Dose Ranging Period|Lost to Follow-up|0|||
161938089|NCT03715829|584823871|FG008|Dose Ranging Period|Lost to Follow-up|0|||
161938090|NCT03715829|584823872|FG009|Dose Ranging Period|Lost to Follow-up|0|||
161938091|NCT03715829|584823873|FG010|Dose Ranging Period|Lost to Follow-up|0|||
161938092|NCT03715829|584823863|FG000|Dose Ranging Period|Protocol Violation|0|||
161938093|NCT03715829|584823864|FG001|Dose Ranging Period|Protocol Violation|0|||
161938094|NCT03715829|584823865|FG002|Dose Ranging Period|Protocol Violation|0|||
161938095|NCT03715829|584823866|FG003|Dose Ranging Period|Protocol Violation|1|||
161938096|NCT03715829|584823867|FG004|Dose Ranging Period|Protocol Violation|0|||
162022750|NCT01519167|585139684|FG000|Overall Study|Medical condition changes&deep sedation|0|||
162219271|NCT03355209|585853883|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
162219272|NCT03355209|585853884|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
162219273|NCT03355209|585853879|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
162219274|NCT03355209|585853880|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
162219275|NCT03355209|585853881|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
162219276|NCT03355209|585853882|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
162236647|NCT01191268|585917020|FG002|Overall Study|Physician Decision|9|||
161938097|NCT03715829|584823868|FG005|Dose Ranging Period|Protocol Violation|0|||
161938098|NCT03715829|584823869|FG006|Dose Ranging Period|Protocol Violation|0|||
161938099|NCT03715829|584823870|FG007|Dose Ranging Period|Protocol Violation|0|||
161938100|NCT03715829|584823871|FG008|Dose Ranging Period|Protocol Violation|0|||
161938101|NCT03715829|584823872|FG009|Dose Ranging Period|Protocol Violation|0|||
161938102|NCT03715829|584823873|FG010|Dose Ranging Period|Protocol Violation|0|||
161938103|NCT03715829|584823863|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
161938104|NCT03715829|584823864|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
161938105|NCT03715829|584823865|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
161938106|NCT03715829|584823866|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
161938107|NCT03715829|584823867|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
161938108|NCT03715829|584823868|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
162219277|NCT03355209|585853883|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
162219278|NCT03355209|585853884|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
162219279|NCT03355209|585853879|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
162219280|NCT03355209|585853880|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
162219281|NCT03355209|585853881|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
162219282|NCT03355209|585853882|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162219283|NCT03355209|585853883|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
161938109|NCT03715829|584823869|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
161938110|NCT03715829|584823870|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
161938111|NCT03715829|584823871|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
161938112|NCT03715829|584823872|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
161938113|NCT03715829|584823873|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
161938114|NCT03715829|584823863|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161938115|NCT03715829|584823864|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161938116|NCT03715829|584823865|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
161938117|NCT03715829|584823866|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161938118|NCT03715829|584823867|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161938119|NCT03715829|584823868|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161938120|NCT03715829|584823869|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161938121|NCT03715829|584823870|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161938122|NCT03715829|584823871|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161938123|NCT03715829|584823872|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161938124|NCT03715829|584823873|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
161938125|NCT03715829|584823863|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161938126|NCT03715829|584823864|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161938127|NCT03715829|584823865|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
161938128|NCT03715829|584823866|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161938129|NCT03715829|584823867|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
161938130|NCT03715829|584823868|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161938131|NCT03715829|584823869|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161938132|NCT03715829|584823870|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161938133|NCT03715829|584823871|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161938134|NCT03715829|584823872|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
161938135|NCT03715829|584823873|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
162219284|NCT03355209|585853884|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162219285|NCT03355209|585853879|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
162219286|NCT03355209|585853880|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
162219287|NCT03355209|585853881|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
162219288|NCT03355209|585853882|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
162219289|NCT03355209|585853883|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
162219290|NCT03355209|585853884|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
162219291|NCT03355209|585853879|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
162219292|NCT03355209|585853880|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
161828685|NCT04100096|584413572|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161828686|NCT04100096|584413573|FG001|Overall Study|Non-Compliance With Study Drug|3|||
161828687|NCT04100096|584413572|FG000|Overall Study|Protocol Deviation|1|||
161828688|NCT04100096|584413573|FG001|Overall Study|Protocol Deviation|1|||
161828689|NCT04100096|584413572|FG000|Overall Study|Withdrawal by Participant|13|||
161828690|NCT04100096|584413573|FG001|Overall Study|Withdrawal by Participant|15|||
161828691|NCT01684215|584413574|FG000|Phase 1, Part 1|Adverse Event|1|||
161828692|NCT01684215|584413575|FG001|Phase 1, Part 1|Adverse Event|0|||
161828693|NCT01684215|584413576|FG002|Phase 1, Part 1|Adverse Event|0|||
161828694|NCT01684215|584413577|FG003|Phase 1, Part 1|Adverse Event|0|||
161828695|NCT01684215|584413574|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
161828696|NCT01684215|584413575|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
161828697|NCT01684215|584413576|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
161828698|NCT01684215|584413577|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
161828699|NCT01684215|584413574|FG000|Phase 1, Part 2|Adverse Event|0|||
161828700|NCT01684215|584413575|FG001|Phase 1, Part 2|Adverse Event|0|||
161828701|NCT01684215|584413576|FG002|Phase 1, Part 2|Adverse Event|1|||
161828702|NCT01684215|584413577|FG003|Phase 1, Part 2|Adverse Event|0|||
161828703|NCT01684215|584413574|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
161828704|NCT01684215|584413575|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
161828705|NCT01684215|584413576|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
161828706|NCT01684215|584413577|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
162022751|NCT01519167|585139685|FG001|Overall Study|Medical condition changes&deep sedation|2|||
162022752|NCT01519167|585139684|FG000|Overall Study|Physician Decision|0|||
162022753|NCT01519167|585139685|FG001|Overall Study|Physician Decision|1|||
162022754|NCT00870584|585139691|FG000|Overall Study|Adverse Event|3|||
162022755|NCT00870584|585139692|FG001|Overall Study|Adverse Event|3|||
162022756|NCT00870584|585139691|FG000|Overall Study|Withdrawal by Subject|6|||
162022757|NCT00870584|585139692|FG001|Overall Study|Withdrawal by Subject|7|||
162022758|NCT00870584|585139691|FG000|Overall Study|Lost to Follow-up|5|||
162022759|NCT00870584|585139692|FG001|Overall Study|Lost to Follow-up|1|||
162022760|NCT00870584|585139691|FG000|Overall Study|Protocol Deviation|2|||
162022761|NCT00870584|585139692|FG001|Overall Study|Protocol Deviation|2|||
162022762|NCT02560025|585139693|FG000|Overall Study|Ineligible after consent/ registration|3|||
162022763|NCT01497366|585139694|FG000|Overall Study|Virologic failure|2|||
162022764|NCT01497366|585139695|FG001|Overall Study|Virologic failure|50|||
162022765|NCT01497366|585139694|FG000|Overall Study|Lost to Follow-up|11|||
162022766|NCT01497366|585139695|FG001|Overall Study|Lost to Follow-up|10|||
162022767|NCT01497366|585139694|FG000|Overall Study|Withdrawal by Subject|6|||
161828707|NCT01684215|584413574|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
161828708|NCT01684215|584413575|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
161828709|NCT01684215|584413576|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
161828710|NCT01684215|584413577|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
161938136|NCT03715829|584823863|FG000|Dose Ranging Period|Other|0|||
161938137|NCT03715829|584823864|FG001|Dose Ranging Period|Other|0|||
161938138|NCT03715829|584823865|FG002|Dose Ranging Period|Other|2|||
161938139|NCT03715829|584823866|FG003|Dose Ranging Period|Other|0|||
161938140|NCT03715829|584823867|FG004|Dose Ranging Period|Other|0|||
161938141|NCT03715829|584823868|FG005|Dose Ranging Period|Other|3|||
161938142|NCT03715829|584823869|FG006|Dose Ranging Period|Other|0|||
161938143|NCT03715829|584823870|FG007|Dose Ranging Period|Other|0|||
161938144|NCT03715829|584823871|FG008|Dose Ranging Period|Other|0|||
161938145|NCT03715829|584823872|FG009|Dose Ranging Period|Other|0|||
161938146|NCT03715829|584823873|FG010|Dose Ranging Period|Other|0|||
161938147|NCT03715829|584823863|FG000|Extension Period|Adverse Event|0|||
161938148|NCT03715829|584823864|FG001|Extension Period|Adverse Event|0|||
161938149|NCT03715829|584823865|FG002|Extension Period|Adverse Event|0|||
161938150|NCT03715829|584823866|FG003|Extension Period|Adverse Event|0|||
161938151|NCT03715829|584823867|FG004|Extension Period|Adverse Event|0|||
161938152|NCT03715829|584823868|FG005|Extension Period|Adverse Event|0|||
161938153|NCT03715829|584823869|FG006|Extension Period|Adverse Event|3|||
161938154|NCT03715829|584823870|FG007|Extension Period|Adverse Event|1|||
161938155|NCT03715829|584823871|FG008|Extension Period|Adverse Event|6|||
161938156|NCT03715829|584823872|FG009|Extension Period|Adverse Event|0|||
162022768|NCT01497366|585139695|FG001|Overall Study|Withdrawal by Subject|6|||
162022769|NCT01497366|585139694|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
161828711|NCT01684215|584413574|FG000|Phase 2|Death|0|||
161828712|NCT01684215|584413575|FG001|Phase 2|Death|0|||
161828713|NCT01684215|584413576|FG002|Phase 2|Death|0|||
161828714|NCT01684215|584413577|FG003|Phase 2|Death|8|||
161828715|NCT01684215|584413574|FG000|Phase 2|Study terminated by sponsor|0|||
161828716|NCT01684215|584413575|FG001|Phase 2|Study terminated by sponsor|0|||
161828717|NCT01684215|584413576|FG002|Phase 2|Study terminated by sponsor|0|||
161828718|NCT01684215|584413577|FG003|Phase 2|Study terminated by sponsor|30|||
161828719|NCT01684215|584413574|FG000|Phase 2|Enrolled but not treated|0|||
161828720|NCT01684215|584413575|FG001|Phase 2|Enrolled but not treated|0|||
161828721|NCT01684215|584413576|FG002|Phase 2|Enrolled but not treated|0|||
161828722|NCT01684215|584413577|FG003|Phase 2|Enrolled but not treated|1|||
161828723|NCT01684215|584413574|FG000|Phase 2|Lost to Follow-up|0|||
161828724|NCT01684215|584413575|FG001|Phase 2|Lost to Follow-up|0|||
161828725|NCT01684215|584413576|FG002|Phase 2|Lost to Follow-up|0|||
161828726|NCT01684215|584413577|FG003|Phase 2|Lost to Follow-up|4|||
161828727|NCT00480324|584413578|FG000|Overall Study|Adverse Event|1|||
161828728|NCT00480324|584413579|FG001|Overall Study|Adverse Event|1|||
161828729|NCT00480324|584413578|FG000|Overall Study|Protocol Violation|0|||
161828730|NCT00480324|584413579|FG001|Overall Study|Protocol Violation|1|||
161828731|NCT00480324|584413578|FG000|Overall Study|Withdrawal by Subject|14|||
161828732|NCT00480324|584413579|FG001|Overall Study|Withdrawal by Subject|5|||
161828733|NCT00480324|584413578|FG000|Overall Study|Lost to Follow-up|17|||
161828734|NCT00480324|584413579|FG001|Overall Study|Lost to Follow-up|8|||
161828735|NCT00480324|584413578|FG000|Overall Study|Subject's mother pregnant|0|||
161828736|NCT00480324|584413579|FG001|Overall Study|Subject's mother pregnant|1|||
161828737|NCT00784134|584413580|FG000|Overall Study|Lost to Follow-up|3|||
161828738|NCT00784134|584413581|FG001|Overall Study|Lost to Follow-up|6|||
161828739|NCT03785145|584413582|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
161828740|NCT03785145|584413583|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
161828741|NCT03785145|584413582|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
161828742|NCT03785145|584413583|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
161828743|NCT03785145|584413582|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
161828744|NCT03785145|584413583|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
161938157|NCT03715829|584823873|FG010|Extension Period|Adverse Event|0|||
162022770|NCT01497366|585139695|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
162022771|NCT01497366|585139694|FG000|Overall Study|Other|5|||
162022772|NCT01497366|585139695|FG001|Overall Study|Other|0|||
162022773|NCT01497366|585139694|FG000|Overall Study|Death|1|||
162022774|NCT01497366|585139695|FG001|Overall Study|Death|1|||
162022775|NCT01497366|585139694|FG000|Overall Study|Randomized but not treated|7|||
162022776|NCT01497366|585139695|FG001|Overall Study|Randomized but not treated|21|||
162022777|NCT02745080|585139705|FG000|Overall Study|Adverse Event|13|||
162022778|NCT02745080|585139706|FG001|Overall Study|Adverse Event|21|||
162022779|NCT02745080|585139705|FG000|Overall Study|Lack of Efficacy|11|||
162022780|NCT02745080|585139706|FG001|Overall Study|Lack of Efficacy|23|||
162022781|NCT02745080|585139705|FG000|Overall Study|Lost to Follow-up|3|||
162022782|NCT02745080|585139706|FG001|Overall Study|Lost to Follow-up|3|||
162022783|NCT02745080|585139705|FG000|Overall Study|Physician Decision|3|||
162022784|NCT02745080|585139706|FG001|Overall Study|Physician Decision|0|||
161938158|NCT03715829|584823863|FG000|Extension Period|Lack of Efficacy|0|||
161938159|NCT03715829|584823864|FG001|Extension Period|Lack of Efficacy|0|||
161938160|NCT03715829|584823865|FG002|Extension Period|Lack of Efficacy|0|||
161938161|NCT03715829|584823866|FG003|Extension Period|Lack of Efficacy|0|||
161938162|NCT03715829|584823867|FG004|Extension Period|Lack of Efficacy|0|||
161938163|NCT03715829|584823868|FG005|Extension Period|Lack of Efficacy|0|||
161938164|NCT03715829|584823869|FG006|Extension Period|Lack of Efficacy|1|||
161938165|NCT03715829|584823870|FG007|Extension Period|Lack of Efficacy|9|||
161938166|NCT03715829|584823871|FG008|Extension Period|Lack of Efficacy|2|||
161938167|NCT03715829|584823872|FG009|Extension Period|Lack of Efficacy|0|||
161938168|NCT03715829|584823873|FG010|Extension Period|Lack of Efficacy|0|||
161938169|NCT03715829|584823863|FG000|Extension Period|Lost to Follow-up|0|||
162022785|NCT02745080|585139705|FG000|Overall Study|Protocol Violation|3|||
162022786|NCT02745080|585139706|FG001|Overall Study|Protocol Violation|1|||
162022787|NCT02745080|585139705|FG000|Overall Study|Withdrawal by Subject|22|||
162022788|NCT02745080|585139706|FG001|Overall Study|Withdrawal by Subject|41|||
162022789|NCT00472030|585139710|FG000|Overall Study|Physician Decision|1|||
162022790|NCT00472030|585139711|FG001|Overall Study|Physician Decision|0|||
162022791|NCT00829504|585139712|FG000|First Intervention|Adverse Event|1|||
162022792|NCT00829504|585139713|FG001|First Intervention|Adverse Event|0|||
162022793|NCT00829504|585139712|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
162022794|NCT00829504|585139713|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
162022795|NCT00829504|585139712|FG000|Second Intervention|Physician Decision|1|||
162022796|NCT00829504|585139713|FG001|Second Intervention|Physician Decision|0|||
162022797|NCT01598129|585140879|FG000|Overall Study|Disease progression|6|||
162022798|NCT01598129|585140879|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
162022799|NCT01598129|585140879|FG000|Overall Study|Withdrawal by Subject|1|||
162022800|NCT00591318|585140880|FG000|Overall Study|Lack of Efficacy|2|||
162022801|NCT00591318|585140881|FG001|Overall Study|Lack of Efficacy|0|||
162022802|NCT00591318|585140880|FG000|Overall Study|Adverse Event|2|||
162022803|NCT00591318|585140881|FG001|Overall Study|Adverse Event|0|||
162022804|NCT00647270|585140882|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
162022805|NCT00647270|585140883|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
162022806|NCT00647270|585140884|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
162022807|NCT00647270|585140882|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
162022808|NCT00647270|585140883|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
162022809|NCT00647270|585140884|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
162022810|NCT00647270|585140882|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
162022811|NCT00647270|585140883|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
162022812|NCT00647270|585140884|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
162022813|NCT00647270|585140882|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
162022814|NCT00647270|585140883|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
162022815|NCT00647270|585140884|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
162022816|NCT00647270|585140882|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
162022817|NCT00647270|585140883|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
162022818|NCT00647270|585140884|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
162022819|NCT00647270|585140882|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
162022820|NCT00647270|585140883|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
162022821|NCT00647270|585140884|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
162022822|NCT00647270|585140882|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
162022823|NCT00647270|585140883|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
162022824|NCT00647270|585140884|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
161938170|NCT03715829|584823864|FG001|Extension Period|Lost to Follow-up|0|||
161938171|NCT03715829|584823865|FG002|Extension Period|Lost to Follow-up|0|||
162022825|NCT03615040|585140885|FG000|Overall Study|Withdrawal by Subject|2|||
162022826|NCT03615040|585140886|FG001|Overall Study|Withdrawal by Subject|1|||
162022827|NCT03615040|585140885|FG000|Overall Study|Physician Decision|2|||
162022828|NCT03615040|585140886|FG001|Overall Study|Physician Decision|2|||
161938172|NCT03715829|584823866|FG003|Extension Period|Lost to Follow-up|0|||
161938173|NCT03715829|584823867|FG004|Extension Period|Lost to Follow-up|0|||
161938174|NCT03715829|584823868|FG005|Extension Period|Lost to Follow-up|0|||
162219293|NCT03355209|585853881|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
162219294|NCT03355209|585853882|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
162219295|NCT03355209|585853883|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
162219296|NCT03355209|585853884|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
162219297|NCT00604708|585853890|FG000|Overall Study|Withdrawal by Subject|9|||
162219298|NCT00604708|585853891|FG001|Overall Study|Withdrawal by Subject|10|||
162219299|NCT00604708|585853890|FG000|Overall Study|Protocol Violation|2|||
162219300|NCT00604708|585853891|FG001|Overall Study|Protocol Violation|8|||
162219301|NCT00604708|585853890|FG000|Overall Study|Lost to Follow-up|5|||
162219302|NCT00604708|585853891|FG001|Overall Study|Lost to Follow-up|5|||
161828745|NCT03785145|584413582|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
161828746|NCT03785145|584413583|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
161938175|NCT03715829|584823869|FG006|Extension Period|Lost to Follow-up|0|||
161938176|NCT03715829|584823870|FG007|Extension Period|Lost to Follow-up|0|||
161938177|NCT03715829|584823871|FG008|Extension Period|Lost to Follow-up|2|||
162219303|NCT00604708|585853890|FG000|Overall Study|administrative reasons|9|||
162219304|NCT00604708|585853891|FG001|Overall Study|administrative reasons|11|||
161828747|NCT03785145|584413582|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
161828748|NCT03785145|584413583|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
161828749|NCT03785145|584413582|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
161828750|NCT03785145|584413583|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
161828751|NCT03785145|584413582|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
161828752|NCT03785145|584413583|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
161828753|NCT03785145|584413582|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
161828754|NCT03785145|584413583|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
161828755|NCT03785145|584413582|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
161828756|NCT03785145|584413583|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
161828757|NCT03785145|584413582|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
161828758|NCT03785145|584413583|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
161828759|NCT03785145|584413582|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
161828760|NCT03785145|584413583|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
161828761|NCT00966381|584413584|FG000|Overall Study|Withdrawal by Subject|2|||
161828762|NCT00966381|584413585|FG001|Overall Study|Withdrawal by Subject|2|||
161828763|NCT01915940|584413586|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
161828764|NCT01915940|584413587|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
161828765|NCT01915940|584413588|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
161828766|NCT01915940|584413586|FG000|Treatment Period|Decision of Participant|0|||
161828767|NCT01915940|584413587|FG001|Treatment Period|Decision of Participant|1|||
161828768|NCT01915940|584413588|FG002|Treatment Period|Decision of Participant|3|||
161828769|NCT01915940|584413586|FG000|Treatment Period|Adverse Event|0|||
161828770|NCT01915940|584413587|FG001|Treatment Period|Adverse Event|9|||
161828771|NCT01915940|584413588|FG002|Treatment Period|Adverse Event|1|||
161828772|NCT01915940|584413586|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
161828773|NCT01915940|584413587|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
161828774|NCT01915940|584413588|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
161828775|NCT03686150|584413589|FG000|Overall Study|Withdrawal by Subject|1|||
161828776|NCT03686150|584413590|FG001|Overall Study|Withdrawal by Subject|1|||
161828777|NCT03686150|584413591|FG002|Overall Study|Withdrawal by Subject|1|||
161828778|NCT03686150|584413592|FG003|Overall Study|Withdrawal by Subject|0|||
161828779|NCT03686150|584413593|FG004|Overall Study|Withdrawal by Subject|1|||
161828780|NCT03686150|584413594|FG005|Overall Study|Withdrawal by Subject|2|||
161828781|NCT03686150|584413589|FG000|Overall Study|Physician Decision|1|||
161828782|NCT03686150|584413590|FG001|Overall Study|Physician Decision|0|||
161828783|NCT03686150|584413591|FG002|Overall Study|Physician Decision|0|||
161828784|NCT03686150|584413592|FG003|Overall Study|Physician Decision|0|||
161828785|NCT03686150|584413593|FG004|Overall Study|Physician Decision|0|||
161828786|NCT03686150|584413594|FG005|Overall Study|Physician Decision|1|||
161828787|NCT03686150|584413589|FG000|Overall Study|Lost to Follow-up|0|||
161828788|NCT03686150|584413590|FG001|Overall Study|Lost to Follow-up|1|||
161828789|NCT03686150|584413591|FG002|Overall Study|Lost to Follow-up|0|||
161828790|NCT03686150|584413592|FG003|Overall Study|Lost to Follow-up|0|||
161828791|NCT03686150|584413593|FG004|Overall Study|Lost to Follow-up|0|||
161828792|NCT03686150|584413594|FG005|Overall Study|Lost to Follow-up|0|||
161828793|NCT02443324|584413595|FG000|Overall Study|Death|4|||
161828794|NCT02443324|584413596|FG001|Overall Study|Death|1|||
161828795|NCT02443324|584413597|FG002|Overall Study|Death|0|||
161828796|NCT02443324|584413598|FG003|Overall Study|Death|3|||
161828797|NCT02443324|584413599|FG004|Overall Study|Death|1|||
161828798|NCT02443324|584413600|FG005|Overall Study|Death|3|||
161828799|NCT02443324|584413601|FG006|Overall Study|Death|2|||
161938178|NCT03715829|584823872|FG009|Extension Period|Lost to Follow-up|0|||
161938179|NCT03715829|584823873|FG010|Extension Period|Lost to Follow-up|0|||
162022829|NCT03615040|585140885|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
162022830|NCT03615040|585140886|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
162022831|NCT03615040|585140885|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
162219305|NCT00604708|585853890|FG000|Overall Study|Adverse Event|6|||
162219306|NCT00604708|585853891|FG001|Overall Study|Adverse Event|6|||
162219307|NCT01277887|585853893|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
162219308|NCT01277887|585853894|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
162219309|NCT01277887|585853893|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
162219310|NCT01277887|585853894|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
162219311|NCT01277887|585853893|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
162219312|NCT01277887|585853894|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
162219313|NCT00415051|585853895|FG000|Overall Study|Protocol Violation|1|||
162219314|NCT04916730|585853897|FG000|Overall Study|Withdrawal by Subject|4|||
162219315|NCT04916730|585853898|FG001|Overall Study|Withdrawal by Subject|2|||
162219316|NCT04916730|585853897|FG000|Overall Study|Lost to Follow-up|0|||
162219317|NCT04916730|585853898|FG001|Overall Study|Lost to Follow-up|2|||
162219318|NCT04916730|585853897|FG000|Overall Study|Physician Decision|1|||
162219319|NCT04916730|585853898|FG001|Overall Study|Physician Decision|0|||
162219320|NCT00617929|585853901|FG000|Overall Study|Physician Decision|1|||
162219321|NCT00760747|585853911|FG000|Study Period II|Adverse Event|3|||
162219322|NCT00760747|585853912|FG001|Study Period II|Adverse Event|4|||
162219323|NCT00760747|585853911|FG000|Study Period II|Lack of Efficacy|0|||
162219324|NCT00760747|585853912|FG001|Study Period II|Lack of Efficacy|6|||
162219325|NCT00760747|585853911|FG000|Study Period II|Parent/Caregiver Decision|3|||
162219326|NCT00760747|585853912|FG001|Study Period II|Parent/Caregiver Decision|0|||
162219327|NCT00760747|585853911|FG000|Study Period II|Protocol Violation|6|||
162219328|NCT00760747|585853912|FG001|Study Period II|Protocol Violation|3|||
162219329|NCT00760747|585853911|FG000|Study Period II|Withdrawal by Subject|1|||
162219330|NCT00760747|585853912|FG001|Study Period II|Withdrawal by Subject|0|||
162219331|NCT00760747|585853911|FG000|Study Period II|No drug administered|0|||
162219332|NCT00760747|585853912|FG001|Study Period II|No drug administered|1|||
162219333|NCT00760747|585853911|FG000|Study Period III|Adverse Event|1|||
162219334|NCT00760747|585853912|FG001|Study Period III|Adverse Event|0|||
162219335|NCT00760747|585853911|FG000|Study Period III|Lack of Efficacy|1|||
162219336|NCT00760747|585853912|FG001|Study Period III|Lack of Efficacy|0|||
162219337|NCT00760747|585853911|FG000|Study Period III|Parent/Caregiver Decision|0|||
162219338|NCT00760747|585853912|FG001|Study Period III|Parent/Caregiver Decision|1|||
162219339|NCT00760747|585853911|FG000|Study Period III|Protocol Violation|1|||
162219340|NCT00760747|585853912|FG001|Study Period III|Protocol Violation|1|||
162219341|NCT00760747|585853911|FG000|Study Period III|Physician Decision|0|||
162219342|NCT00760747|585853912|FG001|Study Period III|Physician Decision|1|||
162219343|NCT04160988|585853913|FG000|Overall Study|poor image quality|28|||
162219344|NCT00844597|585853914|FG000|Overall Study|Adverse Event|0|||
162219345|NCT00844597|585853915|FG001|Overall Study|Adverse Event|0|||
162219346|NCT00844597|585853916|FG002|Overall Study|Adverse Event|0|||
162219347|NCT00844597|585853917|FG003|Overall Study|Adverse Event|1|||
162219348|NCT00844597|585853918|FG004|Overall Study|Adverse Event|0|||
162219349|NCT00844597|585853919|FG005|Overall Study|Adverse Event|0|||
162219350|NCT01250509|585853920|FG000|Overall Study|Lost to Follow-up|5|||
162219351|NCT01250509|585853921|FG001|Overall Study|Lost to Follow-up|2|||
162219352|NCT00108745|585853926|FG000|Overall Study|Withdrawal by Subject|19|||
162219353|NCT00108745|585853927|FG001|Overall Study|Withdrawal by Subject|12|||
162219354|NCT00108745|585853928|FG002|Overall Study|Withdrawal by Subject|12|||
162219355|NCT00108745|585853926|FG000|Overall Study|Never Treated|8|||
162219356|NCT00108745|585853927|FG001|Overall Study|Never Treated|10|||
162219357|NCT00108745|585853928|FG002|Overall Study|Never Treated|12|||
162219358|NCT00108745|585853926|FG000|Overall Study|Ineligible|7|||
161828800|NCT02443324|584413595|FG000|Overall Study|Lost to Follow-up|0|||
161828801|NCT02443324|584413596|FG001|Overall Study|Lost to Follow-up|0|||
161828802|NCT02443324|584413597|FG002|Overall Study|Lost to Follow-up|0|||
161828803|NCT02443324|584413598|FG003|Overall Study|Lost to Follow-up|1|||
161828804|NCT02443324|584413599|FG004|Overall Study|Lost to Follow-up|0|||
161828805|NCT02443324|584413600|FG005|Overall Study|Lost to Follow-up|1|||
161828806|NCT02443324|584413601|FG006|Overall Study|Lost to Follow-up|0|||
161828807|NCT02443324|584413595|FG000|Overall Study|Physician Decision|0|||
161828808|NCT02443324|584413596|FG001|Overall Study|Physician Decision|3|||
161828809|NCT02443324|584413597|FG002|Overall Study|Physician Decision|5|||
161828810|NCT02443324|584413598|FG003|Overall Study|Physician Decision|1|||
161828811|NCT02443324|584413599|FG004|Overall Study|Physician Decision|1|||
161828812|NCT02443324|584413600|FG005|Overall Study|Physician Decision|0|||
161828813|NCT02443324|584413601|FG006|Overall Study|Physician Decision|2|||
161828814|NCT02443324|584413595|FG000|Overall Study|Progressive Disease|20|||
161828815|NCT02443324|584413596|FG001|Overall Study|Progressive Disease|20|||
161828816|NCT02443324|584413597|FG002|Overall Study|Progressive Disease|13|||
161828817|NCT02443324|584413598|FG003|Overall Study|Progressive Disease|10|||
161828818|NCT02443324|584413599|FG004|Overall Study|Progressive Disease|13|||
161828819|NCT02443324|584413600|FG005|Overall Study|Progressive Disease|17|||
162219359|NCT00108745|585853927|FG001|Overall Study|Ineligible|13|||
161938180|NCT03715829|584823863|FG000|Extension Period|Protocol Violation|0|||
161938181|NCT03715829|584823864|FG001|Extension Period|Protocol Violation|0|||
161938182|NCT03715829|584823865|FG002|Extension Period|Protocol Violation|0|||
161938183|NCT03715829|584823866|FG003|Extension Period|Protocol Violation|0|||
161938184|NCT03715829|584823867|FG004|Extension Period|Protocol Violation|0|||
161938185|NCT03715829|584823868|FG005|Extension Period|Protocol Violation|0|||
161938186|NCT03715829|584823869|FG006|Extension Period|Protocol Violation|0|||
161938187|NCT03715829|584823870|FG007|Extension Period|Protocol Violation|0|||
161938188|NCT03715829|584823871|FG008|Extension Period|Protocol Violation|1|||
161938189|NCT03715829|584823872|FG009|Extension Period|Protocol Violation|0|||
161938190|NCT03715829|584823873|FG010|Extension Period|Protocol Violation|0|||
161938191|NCT03715829|584823863|FG000|Extension Period|Withdrawal by Subject|0|||
161938192|NCT03715829|584823864|FG001|Extension Period|Withdrawal by Subject|0|||
161938193|NCT03715829|584823865|FG002|Extension Period|Withdrawal by Subject|0|||
161938194|NCT03715829|584823866|FG003|Extension Period|Withdrawal by Subject|0|||
161938195|NCT03715829|584823867|FG004|Extension Period|Withdrawal by Subject|0|||
161938196|NCT03715829|584823868|FG005|Extension Period|Withdrawal by Subject|0|||
161938197|NCT03715829|584823869|FG006|Extension Period|Withdrawal by Subject|3|||
161938198|NCT03715829|584823870|FG007|Extension Period|Withdrawal by Subject|3|||
161938199|NCT03715829|584823871|FG008|Extension Period|Withdrawal by Subject|12|||
161938200|NCT03715829|584823872|FG009|Extension Period|Withdrawal by Subject|3|||
161938201|NCT03715829|584823873|FG010|Extension Period|Withdrawal by Subject|0|||
161938202|NCT03715829|584823863|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
161938203|NCT03715829|584823864|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
161938204|NCT03715829|584823865|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
161938205|NCT03715829|584823866|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
161938206|NCT03715829|584823867|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
161938207|NCT03715829|584823868|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
161938208|NCT03715829|584823869|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
161938209|NCT03715829|584823870|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
161938210|NCT03715829|584823871|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
161938211|NCT03715829|584823872|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
161938212|NCT03715829|584823873|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
161938213|NCT03715829|584823863|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
161938214|NCT03715829|584823864|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
161938215|NCT03715829|584823865|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
161938216|NCT03715829|584823866|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
161938217|NCT03715829|584823867|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
161938218|NCT03715829|584823868|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
161938219|NCT03715829|584823869|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
161938220|NCT03715829|584823870|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
161938221|NCT03715829|584823871|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
161938222|NCT03715829|584823872|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
161938223|NCT03715829|584823873|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
161938224|NCT03715829|584823863|FG000|Extension Period|Other|0|||
161938225|NCT03715829|584823864|FG001|Extension Period|Other|0|||
161938226|NCT03715829|584823865|FG002|Extension Period|Other|0|||
161938227|NCT03715829|584823866|FG003|Extension Period|Other|0|||
161938228|NCT03715829|584823867|FG004|Extension Period|Other|0|||
161938229|NCT03715829|584823868|FG005|Extension Period|Other|0|||
161938230|NCT03715829|584823869|FG006|Extension Period|Other|1|||
161938231|NCT03715829|584823870|FG007|Extension Period|Other|2|||
161938232|NCT03715829|584823871|FG008|Extension Period|Other|4|||
161938233|NCT03715829|584823872|FG009|Extension Period|Other|0|||
161938234|NCT03715829|584823873|FG010|Extension Period|Other|0|||
161938235|NCT03647137|584823875|FG000|Overall Study|Scan Limitation|2|||
161938236|NCT03647137|584823876|FG001|Overall Study|Scan Limitation|1|||
161938237|NCT03647137|584823877|FG002|Overall Study|Scan Limitation|1|||
161938238|NCT03647137|584823878|FG003|Overall Study|Scan Limitation|2|||
161938239|NCT03579719|584823879|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
161938240|NCT01443026|584823880|FG000|Overall Study|Physician Decision|1|||
161938241|NCT01443026|584823881|FG001|Overall Study|Physician Decision|0|||
161938242|NCT01443026|584823880|FG000|Overall Study|Death|0|||
161938243|NCT01443026|584823881|FG001|Overall Study|Death|1|||
161938244|NCT01443026|584823880|FG000|Overall Study|Withdrawal by Subject|0|||
161938245|NCT01443026|584823881|FG001|Overall Study|Withdrawal by Subject|3|||
161938246|NCT01443026|584823880|FG000|Overall Study|Lost to Follow-up|2|||
161938247|NCT01443026|584823881|FG001|Overall Study|Lost to Follow-up|1|||
161938248|NCT03900650|584823882|FG000|Overall Study|Withdrawal by Subject|1|||
161938249|NCT03900650|584823883|FG001|Overall Study|Withdrawal by Subject|1|||
161938250|NCT03900650|584823884|FG002|Overall Study|Withdrawal by Subject|0|||
161938251|NCT03900650|584823885|FG003|Overall Study|Withdrawal by Subject|0|||
161938252|NCT03900650|584823882|FG000|Overall Study|Withdrawn by staff|1|||
161938253|NCT03900650|584823883|FG001|Overall Study|Withdrawn by staff|0|||
161938254|NCT03900650|584823884|FG002|Overall Study|Withdrawn by staff|0|||
161938255|NCT03900650|584823885|FG003|Overall Study|Withdrawn by staff|0|||
161938256|NCT00829868|584823886|FG000|Washout|Physician Decision|1|||
161938257|NCT00829868|584823887|FG001|Washout|Physician Decision|0|||
161938258|NCT01554904|584823891|FG000|Overall Study|Withdrawal by Subject|3|||
161938259|NCT01554904|584823891|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
161938260|NCT01051661|584823896|FG000|Overall Study|Adverse Event|1|||
161938261|NCT01051661|584823897|FG001|Overall Study|Adverse Event|1|||
161938262|NCT01051661|584823898|FG002|Overall Study|Adverse Event|1|||
161938263|NCT01051661|584823899|FG003|Overall Study|Adverse Event|1|||
161938264|NCT01051661|584823900|FG004|Overall Study|Adverse Event|0|||
161938265|NCT01051661|584823901|FG005|Overall Study|Adverse Event|0|||
161938266|NCT01051661|584823896|FG000|Overall Study|Lost to Follow-up|13|||
161938267|NCT01051661|584823897|FG001|Overall Study|Lost to Follow-up|22|||
161938268|NCT01051661|584823898|FG002|Overall Study|Lost to Follow-up|15|||
161938269|NCT01051661|584823899|FG003|Overall Study|Lost to Follow-up|17|||
161938270|NCT01051661|584823900|FG004|Overall Study|Lost to Follow-up|10|||
161938271|NCT01051661|584823901|FG005|Overall Study|Lost to Follow-up|24|||
161938272|NCT01051661|584823896|FG000|Overall Study|Migrated/moved from study area|1|||
161938273|NCT01051661|584823897|FG001|Overall Study|Migrated/moved from study area|6|||
161938274|NCT01051661|584823898|FG002|Overall Study|Migrated/moved from study area|6|||
161938275|NCT01051661|584823899|FG003|Overall Study|Migrated/moved from study area|8|||
161938276|NCT01051661|584823900|FG004|Overall Study|Migrated/moved from study area|7|||
161938277|NCT01051661|584823901|FG005|Overall Study|Migrated/moved from study area|3|||
161938278|NCT01051661|584823896|FG000|Overall Study|Refused blood sampling|0|||
161938279|NCT01051661|584823897|FG001|Overall Study|Refused blood sampling|0|||
161938280|NCT01051661|584823898|FG002|Overall Study|Refused blood sampling|0|||
161938281|NCT01051661|584823899|FG003|Overall Study|Refused blood sampling|0|||
161938282|NCT01051661|584823900|FG004|Overall Study|Refused blood sampling|0|||
162219360|NCT00108745|585853928|FG002|Overall Study|Ineligible|13|||
162219361|NCT01228175|585853929|FG000|Overall Study|Lost to Follow-up|64|||
162219362|NCT01228175|585853930|FG001|Overall Study|Lost to Follow-up|50|||
162219363|NCT01228175|585853929|FG000|Overall Study|Withdrawal by Subject|1|||
162219364|NCT01228175|585853930|FG001|Overall Study|Withdrawal by Subject|2|||
162219365|NCT01228175|585853929|FG000|Overall Study|Physician Decision|1|||
162219366|NCT01228175|585853930|FG001|Overall Study|Physician Decision|1|||
162219367|NCT00243074|585853932|FG000|Overall Study|Ineligible|6|||
162219368|NCT00243074|585853932|FG000|Overall Study|Adverse Event|6|||
162219369|NCT00243074|585853932|FG000|Overall Study|Withdrawal by Subject|2|||
162219370|NCT00243074|585853932|FG000|Overall Study|Lack of Efficacy|36|||
162219371|NCT00243074|585853932|FG000|Overall Study|Death|2|||
162219372|NCT00243074|585853932|FG000|Overall Study|not protocol specified|1|||
162219373|NCT00243074|585853932|FG000|Overall Study|Did not receive any treatment|1|||
162219374|NCT00402051|585853937|FG000|Overall Study|Progressive Disease|13|||
162219375|NCT00402051|585853938|FG001|Overall Study|Progressive Disease|20|||
162219376|NCT00402051|585853937|FG000|Overall Study|Adverse Event|11|||
162219377|NCT00402051|585853938|FG001|Overall Study|Adverse Event|4|||
162219378|NCT00402051|585853937|FG000|Overall Study|Physician Decision|7|||
162219379|NCT00402051|585853938|FG001|Overall Study|Physician Decision|3|||
162219380|NCT00402051|585853937|FG000|Overall Study|Withdrawal by Subject|3|||
162219381|NCT00402051|585853938|FG001|Overall Study|Withdrawal by Subject|3|||
162219382|NCT00402051|585853937|FG000|Overall Study|Death - Related to Study Drug|1|||
162219383|NCT00402051|585853938|FG001|Overall Study|Death - Related to Study Drug|2|||
162219384|NCT00402051|585853937|FG000|Overall Study|Death Due to Study Disease|2|||
162219385|NCT00402051|585853938|FG001|Overall Study|Death Due to Study Disease|1|||
162219386|NCT00402051|585853937|FG000|Overall Study|Death Due to Adverse Event|0|||
162219387|NCT00402051|585853938|FG001|Overall Study|Death Due to Adverse Event|2|||
161938283|NCT01051661|584823901|FG005|Overall Study|Refused blood sampling|1|||
162219388|NCT00402051|585853937|FG000|Overall Study|Lost to Follow-up|1|||
161938284|NCT01051661|584823896|FG000|Overall Study|Data not reliable|1|||
161938285|NCT01051661|584823897|FG001|Overall Study|Data not reliable|0|||
162219389|NCT00402051|585853938|FG001|Overall Study|Lost to Follow-up|0|||
162219390|NCT04463680|585853943|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
162219391|NCT04463680|585853943|FG000|Overall Study|Not eligible due to implant duration of use|1|||
162236648|NCT01191268|585917018|FG000|Overall Study|Lost to Follow-up|8|||
161938286|NCT01051661|584823898|FG002|Overall Study|Data not reliable|0|||
161938287|NCT01051661|584823899|FG003|Overall Study|Data not reliable|0|||
161938288|NCT01051661|584823900|FG004|Overall Study|Data not reliable|0|||
161938289|NCT01051661|584823901|FG005|Overall Study|Data not reliable|1|||
161938290|NCT01051661|584823896|FG000|Overall Study|Unable to attend visit(s)|2|||
162022832|NCT03615040|585140886|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
162022833|NCT03615040|585140885|FG000|Overall Study|Death|0|||
162022834|NCT03615040|585140886|FG001|Overall Study|Death|2|||
162022835|NCT01743001|585140889|FG000|Overall Study|Physician Decision|1|||
162022836|NCT01743001|585140890|FG001|Overall Study|Physician Decision|0|||
162022837|NCT01743001|585140889|FG000|Overall Study|Pregnancy|1|||
162022838|NCT01743001|585140890|FG001|Overall Study|Pregnancy|0|||
162022839|NCT01743001|585140889|FG000|Overall Study|Death|1|||
162022840|NCT01743001|585140890|FG001|Overall Study|Death|0|||
162022841|NCT02657408|585140893|FG000|Overall Study|Adverse Event|3|||
162022842|NCT02657408|585140894|FG001|Overall Study|Adverse Event|7|||
162022843|NCT01403948|585140895|FG000|Overall Study|Progressive disease|0|||
162219392|NCT04463680|585853943|FG000|Overall Study|Withdrawal by Subject|3|||
162219393|NCT05239598|585853946|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
162219394|NCT05239598|585853947|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
162219395|NCT05239598|585853946|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
162219396|NCT05239598|585853947|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
162219397|NCT02592707|585853948|FG000|Overall Study|Consent Withdrawn|0|||
162219398|NCT02592707|585853949|FG001|Overall Study|Consent Withdrawn|1|||
162219399|NCT02592707|585853950|FG002|Overall Study|Consent Withdrawn|2|||
162219400|NCT02592707|585853951|FG003|Overall Study|Consent Withdrawn|0|||
162219401|NCT02592707|585853948|FG000|Overall Study|Death|1|||
162219402|NCT02592707|585853949|FG001|Overall Study|Death|0|||
162219403|NCT02592707|585853950|FG002|Overall Study|Death|0|||
162219404|NCT02592707|585853951|FG003|Overall Study|Death|0|||
162219405|NCT02592707|585853948|FG000|Overall Study|Progressive Disease|4|||
162219406|NCT02592707|585853949|FG001|Overall Study|Progressive Disease|4|||
162219407|NCT02592707|585853950|FG002|Overall Study|Progressive Disease|3|||
162219408|NCT02592707|585853951|FG003|Overall Study|Progressive Disease|3|||
162219409|NCT02592707|585853948|FG000|Overall Study|Other|0|||
162219410|NCT02592707|585853949|FG001|Overall Study|Other|0|||
162219411|NCT02592707|585853950|FG002|Overall Study|Other|1|||
162219412|NCT02592707|585853951|FG003|Overall Study|Other|2|||
162219413|NCT02592707|585853948|FG000|Overall Study|Never entered LTFU period|1|||
162219414|NCT02592707|585853949|FG001|Overall Study|Never entered LTFU period|0|||
162219415|NCT02592707|585853950|FG002|Overall Study|Never entered LTFU period|0|||
162219416|NCT02592707|585853951|FG003|Overall Study|Never entered LTFU period|2|||
162219417|NCT02998476|585853954|FG000|Overall Study|Lost to Follow-up|1|||
162219418|NCT02998476|585853955|FG001|Overall Study|Lost to Follow-up|0|||
162219419|NCT02998476|585853954|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
162219420|NCT02998476|585853955|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
162219421|NCT02998476|585853954|FG000|Overall Study|Withdrawal by Subject|1|||
162219422|NCT02998476|585853955|FG001|Overall Study|Withdrawal by Subject|2|||
162219423|NCT02998476|585853954|FG000|Overall Study|Death|45|||
162219424|NCT02998476|585853955|FG001|Overall Study|Death|2|||
162219425|NCT02998476|585853954|FG000|Overall Study|Other|6|||
162219426|NCT02998476|585853955|FG001|Overall Study|Other|1|||
162219427|NCT04855734|585853956|FG000|Overall Study|Lost to Follow-up|2|||
162219428|NCT04855734|585853957|FG001|Overall Study|Lost to Follow-up|2|||
162219429|NCT03832595|585853958|FG000|Overall Study|Death|142|||
162219430|NCT03832595|585853959|FG001|Overall Study|Death|130|||
162219431|NCT03832595|585853958|FG000|Overall Study|Medical management without dialysis|37|||
162219432|NCT03832595|585853959|FG001|Overall Study|Medical management without dialysis|1|||
162219433|NCT00344032|585853962|FG000|Overall Study|Adverse Event|0|||
162219434|NCT00344032|585853963|FG001|Overall Study|Adverse Event|1|||
162219435|NCT00344032|585853962|FG000|Overall Study|Withdrawal by Subject|6|||
162219436|NCT00344032|585853963|FG001|Overall Study|Withdrawal by Subject|2|||
162219437|NCT00344032|585853962|FG000|Overall Study|Lost to Follow-up|4|||
162219438|NCT00344032|585853963|FG001|Overall Study|Lost to Follow-up|6|||
162219439|NCT00344032|585853962|FG000|Overall Study|Physician Decision|4|||
162219440|NCT00344032|585853963|FG001|Overall Study|Physician Decision|1|||
162219441|NCT05131477|585853966|FG000|PART 1|Withdrawal by Subject|2|||
161678609|NCT00766090|583876047|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678610|NCT00766090|583876048|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162022844|NCT01403948|585140896|FG001|Overall Study|Progressive disease|2|||
162022845|NCT01403948|585140897|FG002|Overall Study|Progressive disease|2|||
162219442|NCT05131477|585853967|FG001|PART 1|Withdrawal by Subject|9|||
162219443|NCT05131477|585853968|FG002|PART 1|Withdrawal by Subject|6|||
162219444|NCT05131477|585853969|FG003|PART 1|Withdrawal by Subject|2|||
161678611|NCT00766090|583876049|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
162022846|NCT01403948|585140898|FG003|Overall Study|Progressive disease|4|||
162022847|NCT01403948|585140899|FG004|Overall Study|Progressive disease|2|||
162219445|NCT05131477|585853970|FG004|PART 1|Withdrawal by Subject|8|||
162219446|NCT05131477|585853971|FG005|PART 1|Withdrawal by Subject|0|||
162219447|NCT05131477|585853972|FG006|PART 1|Withdrawal by Subject|0|||
162219448|NCT05131477|585853973|FG007|PART 1|Withdrawal by Subject|0|||
162219449|NCT05131477|585853974|FG008|PART 1|Withdrawal by Subject|0|||
162219450|NCT05131477|585853975|FG009|PART 1|Withdrawal by Subject|0|||
162022848|NCT01403948|585140900|FG005|Overall Study|Progressive disease|6|||
162219451|NCT05131477|585853976|FG010|PART 1|Withdrawal by Subject|0|||
161938291|NCT01051661|584823897|FG001|Overall Study|Unable to attend visit(s)|4|||
161938292|NCT01051661|584823898|FG002|Overall Study|Unable to attend visit(s)|2|||
161938293|NCT01051661|584823899|FG003|Overall Study|Unable to attend visit(s)|1|||
161938294|NCT01051661|584823900|FG004|Overall Study|Unable to attend visit(s)|3|||
161938295|NCT01051661|584823901|FG005|Overall Study|Unable to attend visit(s)|2|||
161938296|NCT01051661|584823896|FG000|Overall Study|Consent not received from both parents|0|||
161938297|NCT01051661|584823897|FG001|Overall Study|Consent not received from both parents|0|||
161938298|NCT01051661|584823898|FG002|Overall Study|Consent not received from both parents|0|||
161938299|NCT01051661|584823899|FG003|Overall Study|Consent not received from both parents|0|||
161938300|NCT01051661|584823900|FG004|Overall Study|Consent not received from both parents|0|||
161938301|NCT01051661|584823901|FG005|Overall Study|Consent not received from both parents|1|||
161938302|NCT01051661|584823896|FG000|Overall Study|Failure to comply with protocol|0|||
161938303|NCT01051661|584823897|FG001|Overall Study|Failure to comply with protocol|0|||
161938304|NCT01051661|584823898|FG002|Overall Study|Failure to comply with protocol|2|||
161938305|NCT01051661|584823899|FG003|Overall Study|Failure to comply with protocol|0|||
161938306|NCT01051661|584823900|FG004|Overall Study|Failure to comply with protocol|0|||
161938307|NCT01051661|584823901|FG005|Overall Study|Failure to comply with protocol|0|||
161938308|NCT01051661|584823896|FG000|Overall Study|Subject lost legal representation|0|||
161938309|NCT01051661|584823897|FG001|Overall Study|Subject lost legal representation|0|||
161938310|NCT01051661|584823898|FG002|Overall Study|Subject lost legal representation|0|||
161938311|NCT01051661|584823899|FG003|Overall Study|Subject lost legal representation|0|||
161938312|NCT01051661|584823900|FG004|Overall Study|Subject lost legal representation|1|||
161938313|NCT01051661|584823901|FG005|Overall Study|Subject lost legal representation|0|||
161938314|NCT01051661|584823896|FG000|Overall Study|Protocol Violation|0|||
161938315|NCT01051661|584823897|FG001|Overall Study|Protocol Violation|0|||
161938316|NCT01051661|584823898|FG002|Overall Study|Protocol Violation|0|||
161938317|NCT01051661|584823899|FG003|Overall Study|Protocol Violation|1|||
161938318|NCT01051661|584823900|FG004|Overall Study|Protocol Violation|2|||
161938319|NCT01051661|584823901|FG005|Overall Study|Protocol Violation|1|||
161938320|NCT01051661|584823896|FG000|Overall Study|Withdrawal by Subject|16|||
161938321|NCT01051661|584823897|FG001|Overall Study|Withdrawal by Subject|30|||
161938322|NCT01051661|584823898|FG002|Overall Study|Withdrawal by Subject|13|||
161938323|NCT01051661|584823899|FG003|Overall Study|Withdrawal by Subject|28|||
161938324|NCT01051661|584823900|FG004|Overall Study|Withdrawal by Subject|12|||
161938325|NCT01051661|584823901|FG005|Overall Study|Withdrawal by Subject|34|||
161938326|NCT01681849|584823902|FG000|Overall Study|Protocol Violation|2|||
161938327|NCT01681849|584823903|FG001|Overall Study|Protocol Violation|0|||
161938328|NCT01681849|584823904|FG002|Overall Study|Protocol Violation|0|||
161938329|NCT01681849|584823902|FG000|Overall Study|Withdrawal by Subject|3|||
161938330|NCT01681849|584823903|FG001|Overall Study|Withdrawal by Subject|5|||
161938331|NCT01681849|584823904|FG002|Overall Study|Withdrawal by Subject|33|||
161938332|NCT01681849|584823902|FG000|Overall Study|Lost to Follow-up|3|||
161938333|NCT01681849|584823903|FG001|Overall Study|Lost to Follow-up|2|||
161938334|NCT01681849|584823904|FG002|Overall Study|Lost to Follow-up|6|||
161938335|NCT04525183|584823905|FG000|Overall Study|Withdrawal by Subject|0|||
161938336|NCT04525183|584823906|FG001|Overall Study|Withdrawal by Subject|0|||
161938337|NCT04525183|584823907|FG002|Overall Study|Withdrawal by Subject|3|||
161938338|NCT04525183|584823905|FG000|Overall Study|Study non-compliance|0|||
161938339|NCT04525183|584823906|FG001|Overall Study|Study non-compliance|0|||
161938340|NCT04525183|584823907|FG002|Overall Study|Study non-compliance|1|||
161938341|NCT04525183|584823905|FG000|Overall Study|Recurrent disease before starting on study|0|||
161938342|NCT04525183|584823906|FG001|Overall Study|Recurrent disease before starting on study|0|||
161938343|NCT04525183|584823907|FG002|Overall Study|Recurrent disease before starting on study|1|||
161938344|NCT01166646|584823909|FG000|Overall Study|Protocol Violation|0|||
161938345|NCT01166646|584823910|FG001|Overall Study|Protocol Violation|1|||
161938346|NCT01166646|584823909|FG000|Overall Study|Adverse Event|1|||
161938347|NCT01166646|584823910|FG001|Overall Study|Adverse Event|0|||
161938348|NCT05142306|584823911|FG000|Overall Study|Withdrawal by Subject|0|||
161938349|NCT05142306|584823912|FG001|Overall Study|Withdrawal by Subject|0|||
161938350|NCT05142306|584823913|FG002|Overall Study|Withdrawal by Subject|1|||
161938351|NCT04079920|584823914|FG000|Overall Study|Adverse event, not related to study drug|2|||
161938352|NCT04079920|584823914|FG000|Overall Study|Adverse event related to study drug|10|||
161938353|NCT04079920|584823914|FG000|Overall Study|Death|2|||
161938354|NCT04079920|584823914|FG000|Overall Study|Lost to Follow-up|22|||
162219452|NCT05131477|585853977|FG011|PART 1|Withdrawal by Subject|0|||
162219453|NCT05131477|585853978|FG012|PART 1|Withdrawal by Subject|0|||
162219454|NCT05131477|585853979|FG013|PART 1|Withdrawal by Subject|0|||
161938355|NCT04079920|584823914|FG000|Overall Study|Physician Decision|1|||
161938356|NCT04079920|584823914|FG000|Overall Study|Withdrawal by Subject|11|||
161938357|NCT05430919|584823915|FG000|Overall Study|Protocol Violation|0|||
161938358|NCT05430919|584823916|FG001|Overall Study|Protocol Violation|0|||
161938359|NCT05430919|584823917|FG002|Overall Study|Protocol Violation|1|||
161938360|NCT05430919|584823918|FG003|Overall Study|Protocol Violation|0|||
161938361|NCT05430919|584823915|FG000|Overall Study|Lost to Follow-up|0|||
161938362|NCT05430919|584823916|FG001|Overall Study|Lost to Follow-up|1|||
162022849|NCT01403948|585140901|FG006|Overall Study|Progressive disease|2|||
162022850|NCT01403948|585140902|FG007|Overall Study|Progressive disease|4|||
162022851|NCT01403948|585140903|FG008|Overall Study|Progressive disease|5|||
162022852|NCT01403948|585140904|FG009|Overall Study|Progressive disease|5|||
162022853|NCT01403948|585140895|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
162022854|NCT01403948|585140896|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
162022855|NCT01403948|585140897|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
162022856|NCT01403948|585140898|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
162022857|NCT01403948|585140899|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
162022858|NCT01403948|585140900|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
162022859|NCT01403948|585140901|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
162022860|NCT01403948|585140902|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
162022861|NCT01403948|585140903|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
162022862|NCT01403948|585140904|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
162022863|NCT01403948|585140895|FG000|Overall Study|Lost to Follow-up|0|||
162022864|NCT01403948|585140896|FG001|Overall Study|Lost to Follow-up|0|||
162022865|NCT01403948|585140897|FG002|Overall Study|Lost to Follow-up|0|||
162022866|NCT01403948|585140898|FG003|Overall Study|Lost to Follow-up|0|||
162022867|NCT01403948|585140899|FG004|Overall Study|Lost to Follow-up|0|||
162022868|NCT01403948|585140900|FG005|Overall Study|Lost to Follow-up|0|||
162022869|NCT01403948|585140901|FG006|Overall Study|Lost to Follow-up|0|||
161938363|NCT05430919|584823917|FG002|Overall Study|Lost to Follow-up|0|||
161938364|NCT05430919|584823918|FG003|Overall Study|Lost to Follow-up|0|||
161938365|NCT05430919|584823915|FG000|Overall Study|Withdrawal by Subject|3|||
161938366|NCT05430919|584823916|FG001|Overall Study|Withdrawal by Subject|0|||
161938367|NCT05430919|584823917|FG002|Overall Study|Withdrawal by Subject|0|||
161938368|NCT05430919|584823918|FG003|Overall Study|Withdrawal by Subject|1|||
161938369|NCT05014919|584823919|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
161938370|NCT05014919|584823920|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
161938371|NCT05014919|584823921|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
161938372|NCT05014919|584823919|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
161938373|NCT05014919|584823920|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
161938374|NCT05014919|584823921|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
161938375|NCT05014919|584823919|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
161938376|NCT05014919|584823920|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
161938377|NCT05014919|584823921|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
161938378|NCT05014919|584823919|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
161938379|NCT05014919|584823920|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
161938380|NCT05014919|584823921|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
161938381|NCT05014919|584823919|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
161938382|NCT05014919|584823920|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
161938383|NCT05014919|584823921|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
161938384|NCT05014919|584823919|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
161938385|NCT05014919|584823920|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
161938386|NCT05014919|584823921|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
161938387|NCT05014919|584823919|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
161938388|NCT05014919|584823920|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
161938389|NCT05014919|584823921|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
161938390|NCT05014919|584823919|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
161938391|NCT05014919|584823920|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
161938392|NCT05014919|584823921|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
161938393|NCT04126174|584823927|FG000|Overall Study|Lost to Follow-up|3|||
161938394|NCT04126174|584823928|FG001|Overall Study|Lost to Follow-up|3|||
161938395|NCT03773562|584823929|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
161938396|NCT03773562|584823929|FG000|Overall Study|Lost to Follow-up|10|||
161938397|NCT03773562|584823929|FG000|Overall Study|Withdrawal by Subject|1|||
161938398|NCT05305651|584823930|FG000|Overall Study|Death|1|||
161938399|NCT05305651|584823930|FG000|Overall Study|Withdrawal by Subject|4|||
161938400|NCT05305651|584823930|FG000|Overall Study|Lost to Follow-up|4|||
161938401|NCT01491919|584823933|FG000|Overall Study|Insufficient PK sampling|1|||
161938402|NCT01491919|584823934|FG001|Overall Study|Insufficient PK sampling|2|||
161938403|NCT01491919|584823935|FG002|Overall Study|Insufficient PK sampling|1|||
161938404|NCT05375929|584823938|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
162022870|NCT01403948|585140902|FG007|Overall Study|Lost to Follow-up|0|||
162022871|NCT01403948|585140903|FG008|Overall Study|Lost to Follow-up|0|||
162022872|NCT01403948|585140904|FG009|Overall Study|Lost to Follow-up|1|||
162022873|NCT01403948|585140895|FG000|Overall Study|Refused cont. medication|0|||
161938405|NCT05375929|584823939|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
162022874|NCT01403948|585140896|FG001|Overall Study|Refused cont. medication|0|||
162022875|NCT01403948|585140897|FG002|Overall Study|Refused cont. medication|0|||
162022876|NCT01403948|585140898|FG003|Overall Study|Refused cont. medication|0|||
161938406|NCT05375929|584823940|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
161938407|NCT05375929|584823941|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
161938408|NCT05375929|584823938|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
161938409|NCT05375929|584823939|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
161938410|NCT05375929|584823940|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
161938411|NCT05375929|584823941|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
161938412|NCT05375929|584823938|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
161938413|NCT05375929|584823939|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
161938414|NCT05375929|584823940|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
161938415|NCT05375929|584823941|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
161938416|NCT05375929|584823938|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
161938417|NCT05375929|584823939|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
161938418|NCT05375929|584823940|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
161938419|NCT05375929|584823941|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
161938420|NCT05375929|584823938|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
161938421|NCT05375929|584823939|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
161938422|NCT05375929|584823940|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
161938423|NCT05375929|584823941|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
161938424|NCT05375929|584823938|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
161938425|NCT05375929|584823939|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
161938426|NCT05375929|584823940|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
161938427|NCT05375929|584823941|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
161938428|NCT05375929|584823938|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
161938429|NCT05375929|584823939|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
161938430|NCT05375929|584823940|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
161938431|NCT05375929|584823941|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
161938432|NCT05375929|584823938|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
161938433|NCT05375929|584823939|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
161938434|NCT05375929|584823940|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
161938435|NCT05375929|584823941|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
161938436|NCT05375929|584823938|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
161938437|NCT05375929|584823939|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
161938438|NCT05375929|584823940|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
161938439|NCT05375929|584823941|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
161938440|NCT05375929|584823938|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
161938441|NCT05375929|584823939|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
161938442|NCT05375929|584823940|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
161938443|NCT05375929|584823941|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
161938444|NCT04105725|584823942|FG000|Primary Intervention|Lost to Follow-up|0|||
161938445|NCT04105725|584823943|FG001|Primary Intervention|Lost to Follow-up|2|||
161938446|NCT04105725|584823942|FG000|Primary Intervention|Withdrawal by Subject|0|||
161938447|NCT04105725|584823943|FG001|Primary Intervention|Withdrawal by Subject|1|||
161938448|NCT00773461|584823944|FG000|Overall Study|Adverse Event|1|||
161938449|NCT00773461|584823945|FG001|Overall Study|Adverse Event|3|||
161938450|NCT00773461|584823944|FG000|Overall Study|Withdrawal by Subject|4|||
161938451|NCT00773461|584823945|FG001|Overall Study|Withdrawal by Subject|1|||
161938452|NCT03379870|584825566|FG000|Overall Study|Lost to Follow-up|1|||
161938453|NCT03379870|584825567|FG001|Overall Study|Lost to Follow-up|0|||
161938454|NCT03379870|584825566|FG000|Overall Study|Protocol Violation|1|||
162219455|NCT05131477|585853966|FG000|PART 1|Physician Decision|1|||
162219456|NCT05131477|585853967|FG001|PART 1|Physician Decision|0|||
162219457|NCT05131477|585853968|FG002|PART 1|Physician Decision|0|||
161938455|NCT03379870|584825567|FG001|Overall Study|Protocol Violation|1|||
162219458|NCT05131477|585853969|FG003|PART 1|Physician Decision|0|||
162219459|NCT05131477|585853970|FG004|PART 1|Physician Decision|0|||
162219460|NCT05131477|585853971|FG005|PART 1|Physician Decision|0|||
162219461|NCT05131477|585853972|FG006|PART 1|Physician Decision|0|||
162219462|NCT05131477|585853973|FG007|PART 1|Physician Decision|0|||
162219463|NCT05131477|585853974|FG008|PART 1|Physician Decision|0|||
162219464|NCT05131477|585853975|FG009|PART 1|Physician Decision|0|||
162219465|NCT05131477|585853976|FG010|PART 1|Physician Decision|0|||
162219466|NCT05131477|585853977|FG011|PART 1|Physician Decision|0|||
162219467|NCT05131477|585853978|FG012|PART 1|Physician Decision|0|||
162219468|NCT05131477|585853979|FG013|PART 1|Physician Decision|0|||
162219469|NCT05131477|585853966|FG000|PART 1|Adverse Event|3|||
162219470|NCT05131477|585853967|FG001|PART 1|Adverse Event|5|||
162219471|NCT05131477|585853968|FG002|PART 1|Adverse Event|1|||
161938456|NCT00003645|584825568|FG000|Overall Study|Death|4|||
162219472|NCT05131477|585853969|FG003|PART 1|Adverse Event|6|||
162219473|NCT05131477|585853970|FG004|PART 1|Adverse Event|4|||
162219474|NCT05131477|585853971|FG005|PART 1|Adverse Event|0|||
162219475|NCT05131477|585853972|FG006|PART 1|Adverse Event|0|||
161938457|NCT00003645|584825569|FG001|Overall Study|Death|1|||
161938458|NCT00003645|584825568|FG000|Overall Study|Lost to Follow-up|7|||
161938459|NCT00003645|584825569|FG001|Overall Study|Lost to Follow-up|8|||
161938460|NCT00003645|584825568|FG000|Overall Study|Withdrawal by Subject|1|||
161938461|NCT00003645|584825569|FG001|Overall Study|Withdrawal by Subject|3|||
161938462|NCT01373281|584825574|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
161938463|NCT01373281|584825575|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
161938464|NCT01373281|584825574|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
161938465|NCT01373281|584825575|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
161938466|NCT01373281|584825574|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
161938467|NCT01373281|584825575|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
161938468|NCT01373281|584825574|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
161938469|NCT01373281|584825575|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
161938470|NCT01373281|584825574|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
161938471|NCT01373281|584825575|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
161938472|NCT01373281|584825574|FG000|Surveillance Expansion Period|Protocol Violation|9|||
161938473|NCT01373281|584825575|FG001|Surveillance Expansion Period|Protocol Violation|1|||
161938474|NCT01373281|584825574|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
161938475|NCT01373281|584825575|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
161938476|NCT01373281|584825574|FG000|Surveillance Expansion Period|Serious adverse event|3|||
161938477|NCT01373281|584825575|FG001|Surveillance Expansion Period|Serious adverse event|4|||
161938478|NCT02296476|584825576|FG000|Overall Study|Disease Progression|6|||
161938479|NCT02296476|584825577|FG001|Overall Study|Disease Progression|4|||
161938480|NCT02296476|584825578|FG002|Overall Study|Disease Progression|2|||
161938481|NCT00980044|584825579|FG000|Overall Study|Withdrawal by Subject|5|||
161938482|NCT00980044|584825580|FG001|Overall Study|Withdrawal by Subject|7|||
161938483|NCT00980044|584825581|FG002|Overall Study|Withdrawal by Subject|3|||
161938484|NCT00980044|584825579|FG000|Overall Study|Protocol Violation|0|||
161938485|NCT00980044|584825580|FG001|Overall Study|Protocol Violation|0|||
161938486|NCT00980044|584825581|FG002|Overall Study|Protocol Violation|2|||
161938487|NCT03502681|584825582|FG000|Overall Study|Adverse Event|1|||
161938488|NCT03502681|584825583|FG001|Overall Study|Adverse Event|1|||
161938489|NCT03502681|584825582|FG000|Overall Study|Disease Progression|2|||
161938490|NCT03502681|584825583|FG001|Overall Study|Disease Progression|1|||
161938491|NCT02254291|584825584|FG000|Overall Study|Withdrawal by Subject|0|||
161938492|NCT02254291|584825585|FG001|Overall Study|Withdrawal by Subject|3|||
161938493|NCT02254291|584825586|FG002|Overall Study|Withdrawal by Subject|1|||
161938494|NCT02254291|584825584|FG000|Overall Study|Missing follow-up information|0|||
161938495|NCT02254291|584825585|FG001|Overall Study|Missing follow-up information|0|||
161938496|NCT02254291|584825586|FG002|Overall Study|Missing follow-up information|1|||
161938497|NCT03436732|584825589|FG000|Overall Study|Not treated-enrolled in different study|1|||
161938498|NCT03436732|584825590|FG001|Overall Study|Not treated-enrolled in different study|0|||
161938499|NCT03436732|584825589|FG000|Overall Study|Off study after cycle 1|1|||
161938500|NCT03436732|584825590|FG001|Overall Study|Off study after cycle 1|0|||
161938501|NCT03436732|584825589|FG000|Overall Study|Adverse Event|2|||
161938502|NCT03436732|584825590|FG001|Overall Study|Adverse Event|0|||
161938503|NCT03436732|584825589|FG000|Overall Study|Death|0|||
161938504|NCT03436732|584825590|FG001|Overall Study|Death|1|||
161938505|NCT03257657|584825597|FG000|Overall Study|Lost to Follow-up|0|||
161938506|NCT03257657|584825598|FG001|Overall Study|Lost to Follow-up|3|||
161938507|NCT03257657|584825597|FG000|Overall Study|Withdrawn|0|||
161938508|NCT03257657|584825598|FG001|Overall Study|Withdrawn|1|||
161938509|NCT03257657|584825597|FG000|Overall Study|Noted not eligible right after enrolled|0|||
161938510|NCT03257657|584825598|FG001|Overall Study|Noted not eligible right after enrolled|1|||
161938511|NCT02801578|584825599|FG000|Overall Study|Adverse Event|2|||
161938512|NCT00668642|584825607|FG000|First Off-cycle|Cancer progression|1|||
161938513|NCT00668642|584825608|FG001|First Off-cycle|Cancer progression|0|||
161938514|NCT00668642|584825607|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
161938515|NCT00668642|584825608|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
161938516|NCT02014467|584825609|FG000|Overall Study|Adverse Event|4|||
161938517|NCT02014467|584825610|FG001|Overall Study|Adverse Event|0|||
162219476|NCT05131477|585853973|FG007|PART 1|Adverse Event|0|||
161938518|NCT02014467|584825609|FG000|Overall Study|Protocol Violation|3|||
161938519|NCT02014467|584825610|FG001|Overall Study|Protocol Violation|0|||
161938520|NCT02014467|584825609|FG000|Overall Study|Physician Decision|2|||
161938521|NCT02014467|584825610|FG001|Overall Study|Physician Decision|3|||
161938522|NCT02014467|584825609|FG000|Overall Study|Withdrawal by Subject|16|||
161938523|NCT02014467|584825610|FG001|Overall Study|Withdrawal by Subject|4|||
161938524|NCT01230060|584825611|FG000|Overall Study|Withdrawal by Subject|1|||
161938525|NCT01217892|584825613|FG000|Overall Study|Adverse Event|1|||
162219477|NCT05131477|585853974|FG008|PART 1|Adverse Event|0|||
161938526|NCT01217892|584825614|FG001|Overall Study|Adverse Event|1|||
161938527|NCT01217892|584825615|FG002|Overall Study|Adverse Event|1|||
161938528|NCT01217892|584825616|FG003|Overall Study|Adverse Event|0|||
161938529|NCT01217892|584825613|FG000|Overall Study|Withdrawal by Subject|0|||
161938530|NCT01217892|584825614|FG001|Overall Study|Withdrawal by Subject|2|||
161938531|NCT01217892|584825615|FG002|Overall Study|Withdrawal by Subject|1|||
161938532|NCT01217892|584825616|FG003|Overall Study|Withdrawal by Subject|0|||
161938533|NCT01217892|584825613|FG000|Overall Study|Lab value|1|||
161938534|NCT01217892|584825614|FG001|Overall Study|Lab value|0|||
161938535|NCT01217892|584825615|FG002|Overall Study|Lab value|1|||
161938536|NCT01217892|584825616|FG003|Overall Study|Lab value|0|||
161938537|NCT01217892|584825613|FG000|Overall Study|Subject no longer meets study criteria|5|||
161938538|NCT01217892|584825614|FG001|Overall Study|Subject no longer meets study criteria|2|||
161938539|NCT01217892|584825615|FG002|Overall Study|Subject no longer meets study criteria|4|||
161938540|NCT01217892|584825616|FG003|Overall Study|Subject no longer meets study criteria|8|||
161938541|NCT01217892|584825613|FG000|Overall Study|Incorrect enrollment|0|||
161938542|NCT01217892|584825614|FG001|Overall Study|Incorrect enrollment|1|||
161938543|NCT01217892|584825615|FG002|Overall Study|Incorrect enrollment|1|||
161938544|NCT01217892|584825616|FG003|Overall Study|Incorrect enrollment|0|||
161938545|NCT01217892|584825613|FG000|Overall Study|Poor/Non-Compliance|0|||
161938546|NCT01217892|584825614|FG001|Overall Study|Poor/Non-Compliance|0|||
161938547|NCT01217892|584825615|FG002|Overall Study|Poor/Non-Compliance|1|||
161938548|NCT01217892|584825616|FG003|Overall Study|Poor/Non-Compliance|0|||
161938549|NCT02157610|584825618|FG000|Overall Study|Death|4|||
161938550|NCT02157610|584825619|FG001|Overall Study|Death|4|||
161938551|NCT00814983|584825620|FG000|Overall Study|Screen failure|1|||
161938552|NCT00814983|584825621|FG001|Overall Study|Screen failure|0|||
161938553|NCT00814983|584825620|FG000|Overall Study|Withdrawal by Subject|1|||
162219478|NCT05131477|585853975|FG009|PART 1|Adverse Event|0|||
162219479|NCT05131477|585853976|FG010|PART 1|Adverse Event|0|||
162219480|NCT05131477|585853977|FG011|PART 1|Adverse Event|0|||
162219481|NCT05131477|585853978|FG012|PART 1|Adverse Event|0|||
161938554|NCT00814983|584825621|FG001|Overall Study|Withdrawal by Subject|0|||
161938555|NCT00814983|584825620|FG000|Overall Study|Graft failure|1|||
161938556|NCT00814983|584825621|FG001|Overall Study|Graft failure|0|||
161938557|NCT02327169|584825622|FG000|Overall Study|Progressive Disease|1|||
161938558|NCT02327169|584825623|FG001|Overall Study|Progressive Disease|3|||
161938559|NCT02327169|584825624|FG002|Overall Study|Progressive Disease|4|||
162219482|NCT05131477|585853979|FG013|PART 1|Adverse Event|0|||
162219483|NCT05131477|585853966|FG000|PART 1|unclassified|1|||
162219484|NCT05131477|585853967|FG001|PART 1|unclassified|1|||
162219485|NCT05131477|585853968|FG002|PART 1|unclassified|0|||
162219486|NCT05131477|585853969|FG003|PART 1|unclassified|0|||
162219487|NCT05131477|585853970|FG004|PART 1|unclassified|4|||
162219488|NCT05131477|585853971|FG005|PART 1|unclassified|0|||
162219489|NCT05131477|585853972|FG006|PART 1|unclassified|0|||
162219490|NCT05131477|585853973|FG007|PART 1|unclassified|0|||
162219491|NCT05131477|585853974|FG008|PART 1|unclassified|0|||
162219492|NCT05131477|585853975|FG009|PART 1|unclassified|0|||
162219493|NCT05131477|585853976|FG010|PART 1|unclassified|0|||
162219494|NCT05131477|585853977|FG011|PART 1|unclassified|0|||
162219495|NCT05131477|585853978|FG012|PART 1|unclassified|0|||
162219496|NCT05131477|585853979|FG013|PART 1|unclassified|0|||
162219497|NCT05131477|585853966|FG000|PART 1|Randomized and not treated|0|||
162219498|NCT05131477|585853967|FG001|PART 1|Randomized and not treated|0|||
162219499|NCT05131477|585853968|FG002|PART 1|Randomized and not treated|0|||
162219500|NCT05131477|585853969|FG003|PART 1|Randomized and not treated|1|||
162219501|NCT05131477|585853970|FG004|PART 1|Randomized and not treated|1|||
162219502|NCT05131477|585853971|FG005|PART 1|Randomized and not treated|0|||
162219503|NCT05131477|585853972|FG006|PART 1|Randomized and not treated|0|||
162219504|NCT05131477|585853973|FG007|PART 1|Randomized and not treated|0|||
162219505|NCT05131477|585853974|FG008|PART 1|Randomized and not treated|0|||
162219506|NCT05131477|585853975|FG009|PART 1|Randomized and not treated|0|||
162219507|NCT05131477|585853976|FG010|PART 1|Randomized and not treated|0|||
162219508|NCT05131477|585853977|FG011|PART 1|Randomized and not treated|0|||
162219509|NCT05131477|585853978|FG012|PART 1|Randomized and not treated|0|||
162219510|NCT05131477|585853979|FG013|PART 1|Randomized and not treated|0|||
162219511|NCT05131477|585853966|FG000|PART 1|Protocol Violation|2|||
162219512|NCT05131477|585853967|FG001|PART 1|Protocol Violation|0|||
161938560|NCT02327169|584825625|FG003|Overall Study|Progressive Disease|3|||
161938561|NCT02327169|584825626|FG004|Overall Study|Progressive Disease|4|||
162219513|NCT05131477|585853968|FG002|PART 1|Protocol Violation|0|||
162219514|NCT05131477|585853969|FG003|PART 1|Protocol Violation|1|||
161938562|NCT02327169|584825627|FG005|Overall Study|Progressive Disease|3|||
161938563|NCT02327169|584825628|FG006|Overall Study|Progressive Disease|3|||
161938564|NCT02327169|584825629|FG007|Overall Study|Progressive Disease|3|||
162219515|NCT05131477|585853970|FG004|PART 1|Protocol Violation|0|||
162219516|NCT05131477|585853971|FG005|PART 1|Protocol Violation|0|||
162219517|NCT05131477|585853972|FG006|PART 1|Protocol Violation|0|||
162219518|NCT05131477|585853973|FG007|PART 1|Protocol Violation|0|||
162219519|NCT05131477|585853974|FG008|PART 1|Protocol Violation|0|||
162219520|NCT05131477|585853975|FG009|PART 1|Protocol Violation|0|||
162219521|NCT05131477|585853976|FG010|PART 1|Protocol Violation|0|||
162219522|NCT05131477|585853977|FG011|PART 1|Protocol Violation|0|||
162219523|NCT05131477|585853978|FG012|PART 1|Protocol Violation|0|||
162219524|NCT05131477|585853979|FG013|PART 1|Protocol Violation|0|||
162219525|NCT05131477|585853966|FG000|PART 1|Lack of Efficacy|0|||
162022877|NCT01403948|585140899|FG004|Overall Study|Refused cont. medication|1|||
162022878|NCT01403948|585140900|FG005|Overall Study|Refused cont. medication|0|||
162022879|NCT01403948|585140901|FG006|Overall Study|Refused cont. medication|0|||
162022880|NCT01403948|585140902|FG007|Overall Study|Refused cont. medication|0|||
162022881|NCT01403948|585140903|FG008|Overall Study|Refused cont. medication|0|||
162022882|NCT01403948|585140904|FG009|Overall Study|Refused cont. medication|1|||
162022883|NCT01403948|585140895|FG000|Overall Study|other than above|1|||
162022884|NCT01403948|585140896|FG001|Overall Study|other than above|2|||
162219526|NCT05131477|585853967|FG001|PART 1|Lack of Efficacy|1|||
162219527|NCT05131477|585853968|FG002|PART 1|Lack of Efficacy|1|||
162219528|NCT05131477|585853969|FG003|PART 1|Lack of Efficacy|2|||
162219529|NCT05131477|585853970|FG004|PART 1|Lack of Efficacy|5|||
162219530|NCT05131477|585853971|FG005|PART 1|Lack of Efficacy|0|||
162219531|NCT05131477|585853972|FG006|PART 1|Lack of Efficacy|0|||
162219532|NCT05131477|585853973|FG007|PART 1|Lack of Efficacy|0|||
162219533|NCT05131477|585853974|FG008|PART 1|Lack of Efficacy|0|||
162219534|NCT05131477|585853975|FG009|PART 1|Lack of Efficacy|0|||
162219535|NCT05131477|585853976|FG010|PART 1|Lack of Efficacy|0|||
162219536|NCT05131477|585853977|FG011|PART 1|Lack of Efficacy|0|||
162219537|NCT05131477|585853978|FG012|PART 1|Lack of Efficacy|0|||
162219538|NCT05131477|585853979|FG013|PART 1|Lack of Efficacy|0|||
162219539|NCT05131477|585853966|FG000|PART 2|Withdrawal by Subject|0|||
162219540|NCT05131477|585853967|FG001|PART 2|Withdrawal by Subject|0|||
162219541|NCT05131477|585853968|FG002|PART 2|Withdrawal by Subject|0|||
162219542|NCT05131477|585853969|FG003|PART 2|Withdrawal by Subject|0|||
162219543|NCT05131477|585853970|FG004|PART 2|Withdrawal by Subject|0|||
162219544|NCT05131477|585853971|FG005|PART 2|Withdrawal by Subject|0|||
162219545|NCT05131477|585853972|FG006|PART 2|Withdrawal by Subject|2|||
162219546|NCT05131477|585853973|FG007|PART 2|Withdrawal by Subject|0|||
162022885|NCT01403948|585140897|FG002|Overall Study|other than above|1|||
162022886|NCT01403948|585140898|FG003|Overall Study|other than above|0|||
162219547|NCT05131477|585853974|FG008|PART 2|Withdrawal by Subject|0|||
162219548|NCT05131477|585853975|FG009|PART 2|Withdrawal by Subject|0|||
162219549|NCT05131477|585853976|FG010|PART 2|Withdrawal by Subject|2|||
162219550|NCT05131477|585853977|FG011|PART 2|Withdrawal by Subject|0|||
162219551|NCT05131477|585853978|FG012|PART 2|Withdrawal by Subject|2|||
162219552|NCT05131477|585853979|FG013|PART 2|Withdrawal by Subject|2|||
162219553|NCT05131477|585853966|FG000|PART 2|Other|0|||
162219554|NCT05131477|585853967|FG001|PART 2|Other|0|||
161828820|NCT02443324|584413601|FG006|Overall Study|Progressive Disease|10|||
161828821|NCT02443324|584413595|FG000|Overall Study|Withdrawal by Subject|0|||
161828822|NCT02443324|584413596|FG001|Overall Study|Withdrawal by Subject|0|||
161828823|NCT02443324|584413597|FG002|Overall Study|Withdrawal by Subject|3|||
161828824|NCT02443324|584413598|FG003|Overall Study|Withdrawal by Subject|1|||
161828825|NCT02443324|584413599|FG004|Overall Study|Withdrawal by Subject|1|||
161828826|NCT02443324|584413600|FG005|Overall Study|Withdrawal by Subject|0|||
161828827|NCT02443324|584413601|FG006|Overall Study|Withdrawal by Subject|1|||
161828828|NCT02443324|584413595|FG000|Overall Study|Adverse Event|0|||
161828829|NCT02443324|584413596|FG001|Overall Study|Adverse Event|1|||
161828830|NCT02443324|584413597|FG002|Overall Study|Adverse Event|3|||
161828831|NCT02443324|584413598|FG003|Overall Study|Adverse Event|0|||
161828832|NCT02443324|584413599|FG004|Overall Study|Adverse Event|4|||
161828833|NCT02443324|584413600|FG005|Overall Study|Adverse Event|3|||
161828834|NCT02443324|584413601|FG006|Overall Study|Adverse Event|3|||
161828835|NCT02443324|584413595|FG000|Overall Study|Enrolled but Never Treated|0|||
161828836|NCT02443324|584413596|FG001|Overall Study|Enrolled but Never Treated|0|||
161828837|NCT02443324|584413597|FG002|Overall Study|Enrolled but Never Treated|1|||
161828838|NCT02443324|584413598|FG003|Overall Study|Enrolled but Never Treated|0|||
161828839|NCT02443324|584413599|FG004|Overall Study|Enrolled but Never Treated|1|||
161828840|NCT02443324|584413600|FG005|Overall Study|Enrolled but Never Treated|0|||
161828841|NCT02443324|584413601|FG006|Overall Study|Enrolled but Never Treated|1|||
161828842|NCT04025684|584413612|FG000|Overall Study|Withdrawal by Subject|1|||
161828843|NCT04025684|584413613|FG001|Overall Study|Withdrawal by Subject|1|||
161828844|NCT04025684|584413614|FG002|Overall Study|Withdrawal by Subject|0|||
161828845|NCT04025684|584413615|FG003|Overall Study|Withdrawal by Subject|0|||
161828846|NCT04025684|584413612|FG000|Overall Study|Multiple reasons|1|||
161828847|NCT04025684|584413613|FG001|Overall Study|Multiple reasons|3|||
161828848|NCT04025684|584413614|FG002|Overall Study|Multiple reasons|0|||
161828849|NCT04025684|584413615|FG003|Overall Study|Multiple reasons|1|||
161828850|NCT01844531|584413616|FG000|Overall Study|Withdrawal by Subject|0|||
161828851|NCT01844531|584413617|FG001|Overall Study|Withdrawal by Subject|1|||
161828852|NCT01844531|584413618|FG002|Overall Study|Withdrawal by Subject|0|||
161828853|NCT01844531|584413619|FG003|Overall Study|Withdrawal by Subject|0|||
161828854|NCT01546922|584413620|FG000|First Period of 10 Weeks|Protocol Violation|3|||
161828855|NCT01546922|584413621|FG001|First Period of 10 Weeks|Protocol Violation|1|||
161828856|NCT01546922|584413620|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
161828857|NCT01546922|584413621|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
161828858|NCT01546922|584413620|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
162022887|NCT01403948|585140899|FG004|Overall Study|other than above|1|||
162022888|NCT01403948|585140900|FG005|Overall Study|other than above|1|||
162022889|NCT01403948|585140901|FG006|Overall Study|other than above|2|||
162022890|NCT01403948|585140902|FG007|Overall Study|other than above|0|||
162022891|NCT01403948|585140903|FG008|Overall Study|other than above|0|||
162022892|NCT01403948|585140904|FG009|Overall Study|other than above|0|||
162022893|NCT01090323|585140905|FG000|Overall Study|Adverse Event|12|||
162022894|NCT01090323|585140906|FG001|Overall Study|Adverse Event|2|||
162022895|NCT01090323|585140905|FG000|Overall Study|Abnormal Lab Values|3|||
162022896|NCT01090323|585140906|FG001|Overall Study|Abnormal Lab Values|1|||
162022897|NCT01090323|585140905|FG000|Overall Study|Abnormal Test Procedure Results|2|||
162219555|NCT05131477|585853968|FG002|PART 2|Other|0|||
162219556|NCT05131477|585853969|FG003|PART 2|Other|0|||
162219557|NCT05131477|585853970|FG004|PART 2|Other|0|||
162219558|NCT05131477|585853971|FG005|PART 2|Other|0|||
162219559|NCT05131477|585853972|FG006|PART 2|Other|0|||
162219560|NCT05131477|585853973|FG007|PART 2|Other|0|||
162219561|NCT05131477|585853974|FG008|PART 2|Other|1|||
162219562|NCT05131477|585853975|FG009|PART 2|Other|1|||
162219563|NCT05131477|585853976|FG010|PART 2|Other|0|||
162219564|NCT05131477|585853977|FG011|PART 2|Other|0|||
162219565|NCT05131477|585853978|FG012|PART 2|Other|1|||
162219566|NCT05131477|585853979|FG013|PART 2|Other|0|||
162219567|NCT05131477|585853966|FG000|PART 2|Lack of Efficacy|0|||
162219568|NCT05131477|585853967|FG001|PART 2|Lack of Efficacy|0|||
162219569|NCT05131477|585853968|FG002|PART 2|Lack of Efficacy|0|||
162219570|NCT05131477|585853969|FG003|PART 2|Lack of Efficacy|0|||
162219571|NCT05131477|585853970|FG004|PART 2|Lack of Efficacy|0|||
162219572|NCT05131477|585853971|FG005|PART 2|Lack of Efficacy|1|||
162219573|NCT05131477|585853972|FG006|PART 2|Lack of Efficacy|1|||
162219574|NCT05131477|585853973|FG007|PART 2|Lack of Efficacy|0|||
162219575|NCT05131477|585853974|FG008|PART 2|Lack of Efficacy|3|||
162219576|NCT05131477|585853975|FG009|PART 2|Lack of Efficacy|0|||
162219577|NCT05131477|585853976|FG010|PART 2|Lack of Efficacy|1|||
162219578|NCT05131477|585853977|FG011|PART 2|Lack of Efficacy|0|||
162219579|NCT05131477|585853978|FG012|PART 2|Lack of Efficacy|2|||
162219580|NCT05131477|585853979|FG013|PART 2|Lack of Efficacy|0|||
162219581|NCT05131477|585853966|FG000|PART 2|Unclassified|0|||
162219582|NCT05131477|585853967|FG001|PART 2|Unclassified|0|||
162219583|NCT05131477|585853968|FG002|PART 2|Unclassified|0|||
162219584|NCT05131477|585853969|FG003|PART 2|Unclassified|0|||
162219585|NCT05131477|585853970|FG004|PART 2|Unclassified|0|||
162219586|NCT05131477|585853971|FG005|PART 2|Unclassified|0|||
162219587|NCT05131477|585853972|FG006|PART 2|Unclassified|0|||
162022898|NCT01090323|585140906|FG001|Overall Study|Abnormal Test Procedure Results|0|||
162022899|NCT01090323|585140905|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
162022900|NCT01090323|585140906|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162022901|NCT01090323|585140905|FG000|Overall Study|Condition no longer requires drug|5|||
162022902|NCT01090323|585140906|FG001|Overall Study|Condition no longer requires drug|4|||
162022903|NCT01090323|585140905|FG000|Overall Study|Protocol Violation|2|||
162022904|NCT01090323|585140906|FG001|Overall Study|Protocol Violation|1|||
162022905|NCT01090323|585140905|FG000|Overall Study|Withdrew consent|33|||
162022906|NCT01090323|585140906|FG001|Overall Study|Withdrew consent|11|||
162022907|NCT01090323|585140905|FG000|Overall Study|Lost to Follow-up|11|||
162022908|NCT01090323|585140906|FG001|Overall Study|Lost to Follow-up|6|||
162022909|NCT01090323|585140905|FG000|Overall Study|Administrative problems|6|||
162022910|NCT01090323|585140906|FG001|Overall Study|Administrative problems|4|||
162219588|NCT05131477|585853973|FG007|PART 2|Unclassified|0|||
162219589|NCT05131477|585853974|FG008|PART 2|Unclassified|0|||
162219590|NCT05131477|585853975|FG009|PART 2|Unclassified|0|||
162219591|NCT05131477|585853976|FG010|PART 2|Unclassified|1|||
161828859|NCT01546922|584413621|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
162022911|NCT01090323|585140905|FG000|Overall Study|Death|1|||
162219592|NCT05131477|585853977|FG011|PART 2|Unclassified|0|||
162219593|NCT05131477|585853978|FG012|PART 2|Unclassified|0|||
162022912|NCT01090323|585140906|FG001|Overall Study|Death|2|||
162022913|NCT01090323|585140905|FG000|Overall Study|Stopped end of core|7|||
162022914|NCT01090323|585140906|FG001|Overall Study|Stopped end of core|0|||
162022915|NCT01090323|585140905|FG000|Overall Study|Stopped end of extension 1#|3|||
162219594|NCT05131477|585853979|FG013|PART 2|Unclassified|0|||
162219595|NCT05131477|585853966|FG000|PART 2|Re-randomized and not treated|0|||
162219596|NCT05131477|585853967|FG001|PART 2|Re-randomized and not treated|0|||
162219597|NCT05131477|585853968|FG002|PART 2|Re-randomized and not treated|0|||
162022916|NCT01090323|585140906|FG001|Overall Study|Stopped end of extension 1#|1|||
162022917|NCT05498701|585140907|FG000|Period 3|Adverse Event|1|||
162219598|NCT05131477|585853969|FG003|PART 2|Re-randomized and not treated|0|||
162219599|NCT05131477|585853970|FG004|PART 2|Re-randomized and not treated|0|||
162219600|NCT05131477|585853971|FG005|PART 2|Re-randomized and not treated|0|||
162219601|NCT05131477|585853972|FG006|PART 2|Re-randomized and not treated|0|||
162219602|NCT05131477|585853973|FG007|PART 2|Re-randomized and not treated|1|||
162219603|NCT05131477|585853974|FG008|PART 2|Re-randomized and not treated|0|||
162219604|NCT05131477|585853975|FG009|PART 2|Re-randomized and not treated|0|||
162219605|NCT05131477|585853976|FG010|PART 2|Re-randomized and not treated|1|||
162219606|NCT05131477|585853977|FG011|PART 2|Re-randomized and not treated|0|||
162219607|NCT05131477|585853978|FG012|PART 2|Re-randomized and not treated|1|||
162219608|NCT05131477|585853979|FG013|PART 2|Re-randomized and not treated|1|||
161678612|NCT00766090|583876050|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678613|NCT00766090|583876051|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678614|NCT00766090|583876052|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678615|NCT00766090|583876053|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678616|NCT00766090|583876054|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678617|NCT00766090|583876055|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678618|NCT00766090|583876056|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678619|NCT00766090|583876057|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161678620|NCT00766090|583876046|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161678621|NCT00766090|583876047|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678622|NCT00766090|583876048|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678623|NCT00766090|583876049|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161938565|NCT02327169|584825630|FG008|Overall Study|Progressive Disease|4|||
161938566|NCT02327169|584825631|FG009|Overall Study|Progressive Disease|4|||
161938567|NCT02327169|584825632|FG010|Overall Study|Progressive Disease|4|||
161938568|NCT02327169|584825633|FG011|Overall Study|Progressive Disease|3|||
161938569|NCT02327169|584825634|FG012|Overall Study|Progressive Disease|1|||
161938570|NCT02327169|584825635|FG013|Overall Study|Progressive Disease|3|||
161938571|NCT02327169|584825636|FG014|Overall Study|Progressive Disease|3|||
161938572|NCT02327169|584825622|FG000|Overall Study|Adverse Event|2|||
161938573|NCT02327169|584825623|FG001|Overall Study|Adverse Event|0|||
161938574|NCT02327169|584825624|FG002|Overall Study|Adverse Event|1|||
161938575|NCT02327169|584825625|FG003|Overall Study|Adverse Event|0|||
161938576|NCT02327169|584825626|FG004|Overall Study|Adverse Event|1|||
161938577|NCT02327169|584825627|FG005|Overall Study|Adverse Event|0|||
161938578|NCT02327169|584825628|FG006|Overall Study|Adverse Event|0|||
161938579|NCT02327169|584825629|FG007|Overall Study|Adverse Event|0|||
161938580|NCT02327169|584825630|FG008|Overall Study|Adverse Event|0|||
161938581|NCT02327169|584825631|FG009|Overall Study|Adverse Event|2|||
161938582|NCT02327169|584825632|FG010|Overall Study|Adverse Event|0|||
161938583|NCT02327169|584825633|FG011|Overall Study|Adverse Event|3|||
161938584|NCT02327169|584825634|FG012|Overall Study|Adverse Event|0|||
161938585|NCT02327169|584825635|FG013|Overall Study|Adverse Event|2|||
161938586|NCT02327169|584825636|FG014|Overall Study|Adverse Event|1|||
161938587|NCT02327169|584825622|FG000|Overall Study|Symptomatic Deterioration|0|||
161938588|NCT02327169|584825623|FG001|Overall Study|Symptomatic Deterioration|0|||
161938589|NCT02327169|584825624|FG002|Overall Study|Symptomatic Deterioration|1|||
161938590|NCT02327169|584825625|FG003|Overall Study|Symptomatic Deterioration|0|||
161938591|NCT02327169|584825626|FG004|Overall Study|Symptomatic Deterioration|1|||
161938592|NCT02327169|584825627|FG005|Overall Study|Symptomatic Deterioration|1|||
161938593|NCT02327169|584825628|FG006|Overall Study|Symptomatic Deterioration|0|||
161938594|NCT02327169|584825629|FG007|Overall Study|Symptomatic Deterioration|0|||
161938595|NCT02327169|584825630|FG008|Overall Study|Symptomatic Deterioration|2|||
161938596|NCT02327169|584825631|FG009|Overall Study|Symptomatic Deterioration|1|||
161938597|NCT02327169|584825632|FG010|Overall Study|Symptomatic Deterioration|0|||
161938598|NCT02327169|584825633|FG011|Overall Study|Symptomatic Deterioration|0|||
161938599|NCT02327169|584825634|FG012|Overall Study|Symptomatic Deterioration|0|||
161938600|NCT02327169|584825635|FG013|Overall Study|Symptomatic Deterioration|2|||
161938601|NCT02327169|584825636|FG014|Overall Study|Symptomatic Deterioration|1|||
162219609|NCT02194829|585853980|FG000|Overall Study|Adverse Event|2|||
161678624|NCT00766090|583876050|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161828860|NCT01546922|584413620|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
161828861|NCT01546922|584413621|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
161828862|NCT01546922|584413620|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
161828863|NCT01546922|584413621|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
161828864|NCT01613378|584413629|FG000|Overall Study|Lack of Efficacy|13|||
161828865|NCT01613378|584413629|FG000|Overall Study|Adverse Event|11|||
161828866|NCT01613378|584413629|FG000|Overall Study|Withdrawal by Subject|8|||
161828867|NCT01613378|584413629|FG000|Overall Study|Death|2|||
161828868|NCT01613378|584413629|FG000|Overall Study|Lost to Follow-up|1|||
161828869|NCT01613378|584413629|FG000|Overall Study|Other Reason|4|||
161828870|NCT00418522|584413630|FG000|Overall Study|Adverse Event|7|||
161828871|NCT00418522|584413631|FG001|Overall Study|Adverse Event|1|||
161828872|NCT00418522|584413630|FG000|Overall Study|Lack of Efficacy|1|||
161828873|NCT00418522|584413631|FG001|Overall Study|Lack of Efficacy|3|||
161828874|NCT00418522|584413630|FG000|Overall Study|Lost to Follow-up|10|||
161828875|NCT00418522|584413631|FG001|Overall Study|Lost to Follow-up|4|||
161828876|NCT00418522|584413630|FG000|Overall Study|Withdrawal by Subject|31|||
161828877|NCT00418522|584413631|FG001|Overall Study|Withdrawal by Subject|7|||
161938602|NCT02327169|584825622|FG000|Overall Study|Reason Not Specified|0|||
161938603|NCT02327169|584825623|FG001|Overall Study|Reason Not Specified|0|||
161938604|NCT02327169|584825624|FG002|Overall Study|Reason Not Specified|1|||
162219610|NCT02194829|585853981|FG001|Overall Study|Adverse Event|2|||
162219611|NCT02194829|585853980|FG000|Overall Study|Death|0|||
162219612|NCT02194829|585853981|FG001|Overall Study|Death|1|||
162219613|NCT02194829|585853980|FG000|Overall Study|Disease progression|0|||
162219614|NCT02194829|585853981|FG001|Overall Study|Disease progression|1|||
162219615|NCT02194829|585853980|FG000|Overall Study|Withdrawal by Subject|0|||
162219616|NCT02194829|585853981|FG001|Overall Study|Withdrawal by Subject|1|||
162219617|NCT02194829|585853980|FG000|Overall Study|Never started protocol therapy|0|||
162219618|NCT02194829|585853981|FG001|Overall Study|Never started protocol therapy|1|||
162219619|NCT06840769|585853983|FG000|Overall Study|Withdrawal by Subject|1|||
162219620|NCT06840769|585853984|FG001|Overall Study|Withdrawal by Subject|0|||
161938605|NCT02327169|584825625|FG003|Overall Study|Reason Not Specified|0|||
161938606|NCT02327169|584825626|FG004|Overall Study|Reason Not Specified|0|||
161938607|NCT02327169|584825627|FG005|Overall Study|Reason Not Specified|0|||
161938608|NCT02327169|584825628|FG006|Overall Study|Reason Not Specified|0|||
161938609|NCT02327169|584825629|FG007|Overall Study|Reason Not Specified|0|||
161938610|NCT02327169|584825630|FG008|Overall Study|Reason Not Specified|0|||
161938611|NCT02327169|584825631|FG009|Overall Study|Reason Not Specified|1|||
161938612|NCT02327169|584825632|FG010|Overall Study|Reason Not Specified|2|||
161938613|NCT02327169|584825633|FG011|Overall Study|Reason Not Specified|1|||
161938614|NCT02327169|584825634|FG012|Overall Study|Reason Not Specified|0|||
161938615|NCT02327169|584825635|FG013|Overall Study|Reason Not Specified|0|||
161938616|NCT02327169|584825636|FG014|Overall Study|Reason Not Specified|2|||
161938617|NCT02327169|584825622|FG000|Overall Study|Withdrawal by Subject|1|||
161938618|NCT02327169|584825623|FG001|Overall Study|Withdrawal by Subject|0|||
161938619|NCT02327169|584825624|FG002|Overall Study|Withdrawal by Subject|0|||
161938620|NCT02327169|584825625|FG003|Overall Study|Withdrawal by Subject|0|||
161938621|NCT02327169|584825626|FG004|Overall Study|Withdrawal by Subject|1|||
161938622|NCT02327169|584825627|FG005|Overall Study|Withdrawal by Subject|0|||
161938623|NCT02327169|584825628|FG006|Overall Study|Withdrawal by Subject|0|||
161938624|NCT02327169|584825629|FG007|Overall Study|Withdrawal by Subject|1|||
161938625|NCT02327169|584825630|FG008|Overall Study|Withdrawal by Subject|0|||
161938626|NCT02327169|584825631|FG009|Overall Study|Withdrawal by Subject|0|||
161938627|NCT02327169|584825632|FG010|Overall Study|Withdrawal by Subject|0|||
162219621|NCT06840769|585853985|FG002|Overall Study|Withdrawal by Subject|0|||
162219622|NCT06840769|585853986|FG003|Overall Study|Withdrawal by Subject|0|||
162219623|NCT06840769|585853987|FG004|Overall Study|Withdrawal by Subject|0|||
162219624|NCT02726945|585853988|FG000|Overall Study|Withdrawal by Subject|0|||
162219625|NCT02726945|585853989|FG001|Overall Study|Withdrawal by Subject|0|||
162219626|NCT02726945|585853990|FG002|Overall Study|Withdrawal by Subject|1|||
162219627|NCT02726945|585853988|FG000|Overall Study|Elected to have total knee replacement|0|||
162219628|NCT02726945|585853989|FG001|Overall Study|Elected to have total knee replacement|1|||
162219629|NCT02726945|585853990|FG002|Overall Study|Elected to have total knee replacement|0|||
162219630|NCT05992922|585853991|FG000|Overall Study|Adverse Event|6|||
162219631|NCT05992922|585853992|FG001|Overall Study|Adverse Event|0|||
162219632|NCT05992922|585853991|FG000|Overall Study|Sponsor Termination of Study|14|||
162219633|NCT05992922|585853992|FG001|Overall Study|Sponsor Termination of Study|20|||
162219634|NCT03939689|585855602|FG000|Overall Study|Radiographic progression|14|||
162219635|NCT03939689|585855603|FG001|Overall Study|Radiographic progression|17|||
162219636|NCT03939689|585855602|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
162219637|NCT03939689|585855603|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
162219638|NCT03939689|585855602|FG000|Overall Study|Adverse Event|1|||
162219639|NCT03939689|585855603|FG001|Overall Study|Adverse Event|8|||
162219640|NCT03939689|585855602|FG000|Overall Study|Unequivocal clinical progression|2|||
162219641|NCT03939689|585855603|FG001|Overall Study|Unequivocal clinical progression|5|||
162219642|NCT03939689|585855602|FG000|Overall Study|Other|1|||
162219643|NCT03939689|585855603|FG001|Overall Study|Other|4|||
162219644|NCT03939689|585855602|FG000|Overall Study|Death|0|||
162219645|NCT03939689|585855603|FG001|Overall Study|Death|3|||
162219646|NCT03939689|585855602|FG000|Overall Study|Participant decision|0|||
161938628|NCT02327169|584825633|FG011|Overall Study|Withdrawal by Subject|0|||
161938629|NCT02327169|584825634|FG012|Overall Study|Withdrawal by Subject|0|||
161938630|NCT02327169|584825635|FG013|Overall Study|Withdrawal by Subject|0|||
162219647|NCT03939689|585855603|FG001|Overall Study|Participant decision|3|||
162219648|NCT03939689|585855602|FG000|Overall Study|Withdrawal of consent|2|||
162219649|NCT03939689|585855603|FG001|Overall Study|Withdrawal of consent|1|||
162219650|NCT03939689|585855602|FG000|Overall Study|Investigator decision|1|||
162219651|NCT03939689|585855603|FG001|Overall Study|Investigator decision|0|||
162219652|NCT04427280|585855604|FG000|Overall Study|Withdrawal by Subject|0|||
162219653|NCT04427280|585855605|FG001|Overall Study|Withdrawal by Subject|2|||
162219654|NCT02473965|585855607|FG000|Overall Study|Adverse Event|6|||
161938631|NCT02327169|584825636|FG014|Overall Study|Withdrawal by Subject|3|||
162219655|NCT02473965|585855608|FG001|Overall Study|Adverse Event|4|||
162219656|NCT02473965|585855607|FG000|Overall Study|MG worsening|4|||
162219657|NCT02473965|585855608|FG001|Overall Study|MG worsening|1|||
162219658|NCT02473965|585855607|FG000|Overall Study|Withdrawal by Subject|2|||
162219659|NCT02473965|585855608|FG001|Overall Study|Withdrawal by Subject|3|||
162219660|NCT02473965|585855607|FG000|Overall Study|Physician Decision|0|||
162219661|NCT02473965|585855608|FG001|Overall Study|Physician Decision|2|||
162219662|NCT01920477|585855611|FG000|Overall Study|Adverse Event|0|||
162219663|NCT01920477|585855612|FG001|Overall Study|Adverse Event|1|||
162219664|NCT01920477|585855611|FG000|Overall Study|Lack of Efficacy|1|||
162219665|NCT01920477|585855612|FG001|Overall Study|Lack of Efficacy|0|||
162219666|NCT01920477|585855611|FG000|Overall Study|Study closed/terminated|14|||
162219667|NCT01920477|585855612|FG001|Overall Study|Study closed/terminated|15|||
162219668|NCT01920477|585855611|FG000|Overall Study|Withdrawal by Subject|0|||
162219669|NCT01920477|585855612|FG001|Overall Study|Withdrawal by Subject|1|||
162219670|NCT01681277|585855613|FG000|Overall Study|Adverse Event|1|||
162219671|NCT01681277|585855614|FG001|Overall Study|Adverse Event|0|||
162219672|NCT01681277|585855615|FG002|Overall Study|Adverse Event|0|||
162219673|NCT01681277|585855616|FG003|Overall Study|Adverse Event|0|||
162219674|NCT01681277|585855617|FG004|Overall Study|Adverse Event|0|||
161938632|NCT02327169|584825622|FG000|Overall Study|Lost to Follow-up|0|||
161938633|NCT02327169|584825623|FG001|Overall Study|Lost to Follow-up|0|||
161938634|NCT02327169|584825624|FG002|Overall Study|Lost to Follow-up|0|||
161938635|NCT02327169|584825625|FG003|Overall Study|Lost to Follow-up|0|||
161938636|NCT02327169|584825626|FG004|Overall Study|Lost to Follow-up|1|||
161938637|NCT02327169|584825627|FG005|Overall Study|Lost to Follow-up|0|||
161938638|NCT02327169|584825628|FG006|Overall Study|Lost to Follow-up|0|||
162219675|NCT02304705|585855618|FG000|Overall Study|Withdrawal by Subject|2|||
162219676|NCT02304705|585855619|FG001|Overall Study|Withdrawal by Subject|0|||
162219677|NCT02304705|585855618|FG000|Overall Study|Physician Decision|2|||
162219678|NCT02304705|585855619|FG001|Overall Study|Physician Decision|4|||
162219679|NCT02304705|585855618|FG000|Overall Study|Death|0|||
162219680|NCT02304705|585855619|FG001|Overall Study|Death|1|||
162219681|NCT02304705|585855618|FG000|Overall Study|Lost to Follow-up|0|||
162219682|NCT02304705|585855619|FG001|Overall Study|Lost to Follow-up|2|||
162219683|NCT02038842|585855620|FG000|Overall Study|Withdrawal by Subject|2|||
162219684|NCT02038842|585855621|FG001|Overall Study|Withdrawal by Subject|2|||
162219685|NCT02038842|585855622|FG002|Overall Study|Withdrawal by Subject|0|||
162219686|NCT02038842|585855623|FG003|Overall Study|Withdrawal by Subject|0|||
162219687|NCT02038842|585855620|FG000|Overall Study|Participant decision|0|||
162219688|NCT02038842|585855621|FG001|Overall Study|Participant decision|0|||
162219689|NCT02038842|585855622|FG002|Overall Study|Participant decision|2|||
162219690|NCT02038842|585855623|FG003|Overall Study|Participant decision|1|||
162219691|NCT02038842|585855620|FG000|Overall Study|Adverse Event|0|||
162219692|NCT02038842|585855621|FG001|Overall Study|Adverse Event|0|||
162219693|NCT02038842|585855622|FG002|Overall Study|Adverse Event|3|||
162219694|NCT02038842|585855623|FG003|Overall Study|Adverse Event|1|||
162219695|NCT02038842|585855620|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
162219696|NCT02038842|585855621|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
162219697|NCT02038842|585855622|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
162219698|NCT02038842|585855623|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
162219699|NCT00847626|585855629|FG000|Overall Study|Adverse Event|10|||
162219700|NCT00847626|585855630|FG001|Overall Study|Adverse Event|10|||
162219701|NCT00847626|585855631|FG002|Overall Study|Adverse Event|6|||
162219702|NCT00847626|585855632|FG003|Overall Study|Adverse Event|19|||
162219703|NCT00847626|585855633|FG004|Overall Study|Adverse Event|11|||
161938639|NCT02327169|584825629|FG007|Overall Study|Lost to Follow-up|0|||
161938640|NCT02327169|584825630|FG008|Overall Study|Lost to Follow-up|0|||
161938641|NCT02327169|584825631|FG009|Overall Study|Lost to Follow-up|0|||
161938642|NCT02327169|584825632|FG010|Overall Study|Lost to Follow-up|0|||
161938643|NCT02327169|584825633|FG011|Overall Study|Lost to Follow-up|0|||
161938644|NCT02327169|584825634|FG012|Overall Study|Lost to Follow-up|0|||
162219704|NCT00847626|585855634|FG005|Overall Study|Adverse Event|22|||
162219705|NCT00847626|585855635|FG006|Overall Study|Adverse Event|4|||
162219706|NCT00847626|585855636|FG007|Overall Study|Adverse Event|6|||
162219707|NCT00847626|585855637|FG008|Overall Study|Adverse Event|3|||
162219708|NCT00847626|585855638|FG009|Overall Study|Adverse Event|6|||
162219709|NCT00847626|585855639|FG010|Overall Study|Adverse Event|6|||
162219710|NCT00847626|585855629|FG000|Overall Study|Protocol Violation|2|||
162219711|NCT00847626|585855630|FG001|Overall Study|Protocol Violation|1|||
162219712|NCT00847626|585855631|FG002|Overall Study|Protocol Violation|2|||
162219713|NCT00847626|585855632|FG003|Overall Study|Protocol Violation|1|||
162219714|NCT00847626|585855633|FG004|Overall Study|Protocol Violation|1|||
161938645|NCT02327169|584825635|FG013|Overall Study|Lost to Follow-up|0|||
161938646|NCT02327169|584825636|FG014|Overall Study|Lost to Follow-up|0|||
161938647|NCT03787615|584825637|FG000|Overall Study|Withdrawal by Subject|2|||
162219715|NCT00847626|585855634|FG005|Overall Study|Protocol Violation|1|||
162219716|NCT00847626|585855635|FG006|Overall Study|Protocol Violation|1|||
162219717|NCT00847626|585855636|FG007|Overall Study|Protocol Violation|1|||
162022918|NCT05498701|585140908|FG001|Period 3|Adverse Event|0|||
162022919|NCT01864005|585140909|FG000|Overall Study|Protocol Violation|0|||
162022920|NCT01864005|585140910|FG001|Overall Study|Protocol Violation|1|||
162022921|NCT01864005|585140909|FG000|Overall Study|Withdrawal by Subject|0|||
162022922|NCT01864005|585140910|FG001|Overall Study|Withdrawal by Subject|1|||
162022923|NCT01864005|585140909|FG000|Overall Study|Incorrect enrolment|1|||
162022924|NCT01864005|585140910|FG001|Overall Study|Incorrect enrolment|0|||
162022925|NCT01864005|585140909|FG000|Overall Study|Disease need|1|||
162022926|NCT01864005|585140910|FG001|Overall Study|Disease need|1|||
162022927|NCT01864005|585140909|FG000|Overall Study|Need GP IIb/IIIa|1|||
162022928|NCT01864005|585140910|FG001|Overall Study|Need GP IIb/IIIa|3|||
162022929|NCT02184572|585140911|FG000|Overall Study|Lost to Follow-up|29|||
162219718|NCT00847626|585855637|FG008|Overall Study|Protocol Violation|0|||
162219719|NCT00847626|585855638|FG009|Overall Study|Protocol Violation|1|||
162219720|NCT00847626|585855639|FG010|Overall Study|Protocol Violation|1|||
162219721|NCT00847626|585855629|FG000|Overall Study|Lost to Follow-up|0|||
162219722|NCT00847626|585855630|FG001|Overall Study|Lost to Follow-up|1|||
162219723|NCT00847626|585855631|FG002|Overall Study|Lost to Follow-up|1|||
162219724|NCT00847626|585855632|FG003|Overall Study|Lost to Follow-up|1|||
162219725|NCT00847626|585855633|FG004|Overall Study|Lost to Follow-up|0|||
162219726|NCT00847626|585855634|FG005|Overall Study|Lost to Follow-up|3|||
162219727|NCT00847626|585855635|FG006|Overall Study|Lost to Follow-up|1|||
162219728|NCT00847626|585855636|FG007|Overall Study|Lost to Follow-up|3|||
162219729|NCT00847626|585855637|FG008|Overall Study|Lost to Follow-up|1|||
162219730|NCT00847626|585855638|FG009|Overall Study|Lost to Follow-up|0|||
162219731|NCT00847626|585855639|FG010|Overall Study|Lost to Follow-up|1|||
162219732|NCT00847626|585855629|FG000|Overall Study|Withdrawal by Subject|5|||
162219733|NCT00847626|585855630|FG001|Overall Study|Withdrawal by Subject|5|||
162219734|NCT00847626|585855631|FG002|Overall Study|Withdrawal by Subject|3|||
162219735|NCT00847626|585855632|FG003|Overall Study|Withdrawal by Subject|8|||
162219736|NCT00847626|585855633|FG004|Overall Study|Withdrawal by Subject|12|||
162219737|NCT00847626|585855634|FG005|Overall Study|Withdrawal by Subject|9|||
162219738|NCT00847626|585855635|FG006|Overall Study|Withdrawal by Subject|8|||
162219739|NCT00847626|585855636|FG007|Overall Study|Withdrawal by Subject|4|||
162219740|NCT00847626|585855637|FG008|Overall Study|Withdrawal by Subject|4|||
162219741|NCT00847626|585855638|FG009|Overall Study|Withdrawal by Subject|5|||
161828878|NCT00418522|584413630|FG000|Overall Study|Other|27|||
161828879|NCT00418522|584413631|FG001|Overall Study|Other|23|||
161828880|NCT00418522|584413630|FG000|Overall Study|Randomized but did not receive treatment|7|||
162022930|NCT02184572|585140912|FG001|Overall Study|Lost to Follow-up|21|||
162022931|NCT02184572|585140911|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
162022932|NCT02184572|585140912|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
162022933|NCT02184572|585140911|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
162219742|NCT00847626|585855639|FG010|Overall Study|Withdrawal by Subject|2|||
162219743|NCT00847626|585855629|FG000|Overall Study|Lack of Efficacy|3|||
162219744|NCT00847626|585855630|FG001|Overall Study|Lack of Efficacy|1|||
162219745|NCT00847626|585855631|FG002|Overall Study|Lack of Efficacy|0|||
162219746|NCT00847626|585855632|FG003|Overall Study|Lack of Efficacy|1|||
161828881|NCT00418522|584413631|FG001|Overall Study|Randomized but did not receive treatment|4|||
161828882|NCT01005329|584413632|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
161828883|NCT02147587|584413633|FG000|Overall Study|Adverse Event|9|||
161828884|NCT02147587|584413634|FG001|Overall Study|Adverse Event|4|||
161828885|NCT02147587|584413633|FG000|Overall Study|Lack of Efficacy|2|||
161828886|NCT02147587|584413634|FG001|Overall Study|Lack of Efficacy|1|||
161828887|NCT01315028|584413639|FG000|Overall Study|Lost to Follow-up|1|||
161828888|NCT01315028|584413640|FG001|Overall Study|Lost to Follow-up|0|||
161828889|NCT01315028|584413639|FG000|Overall Study|Death|0|||
161828890|NCT01315028|584413640|FG001|Overall Study|Death|1|||
161828891|NCT02531594|584413641|FG000|Overall Study|Withdrawal by Subject|7|||
161828892|NCT02531594|584413642|FG001|Overall Study|Withdrawal by Subject|8|||
161828893|NCT01175473|584413656|FG000|Overall Study|Adverse Event|2|||
161828894|NCT01175473|584413657|FG001|Overall Study|Adverse Event|2|||
161828895|NCT04234464|584413660|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
161831521|NCT03135899|584424796|FG004|Overall Study|Withdrawal by Subject|0|||
161831522|NCT03135899|584424797|FG005|Overall Study|Withdrawal by Subject|2|||
161831523|NCT03135899|584424798|FG006|Overall Study|Withdrawal by Subject|0|||
161831524|NCT03135899|584424799|FG007|Overall Study|Withdrawal by Subject|0|||
161831525|NCT04373551|584424800|FG000|Overall Study|Lost to Follow-up|15|||
161831526|NCT04373551|584424800|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
161831527|NCT02914236|584424801|FG000|Overall Study|Lost to Follow-up|1|||
161831528|NCT01042535|584424802|FG000|Overall Study|disease progression prior to treatment|3|||
161831529|NCT01042535|584424802|FG000|Overall Study|disease progression during treatment|3|||
161831530|NCT01042535|584424802|FG000|Overall Study|complications from other disease|2|||
161831531|NCT03438539|584424809|FG000|Overall Study|Lost to Follow-up|8|||
161831532|NCT03438539|584424810|FG001|Overall Study|Lost to Follow-up|4|||
161831533|NCT03438539|584424811|FG002|Overall Study|Lost to Follow-up|10|||
161828896|NCT04234464|584413661|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
161828897|NCT00983528|584413662|FG000|Overall Study|Death|4|||
161828898|NCT00983528|584413662|FG000|Overall Study|Lost to Follow-up|1|||
161828899|NCT00983528|584413662|FG000|Overall Study|Study Terminated|1|||
161828900|NCT03635983|584413663|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
161828901|NCT03635983|584413664|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
161828902|NCT03635983|584413663|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161828903|NCT03635983|584413664|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161828904|NCT03635983|584413663|FG000|Pre-Treatment Period|Other reasons|0|||
161828905|NCT03635983|584413664|FG001|Pre-Treatment Period|Other reasons|1|||
161828906|NCT03635983|584413663|FG000|Pre-Treatment Period|Disease Progression|0|||
161828907|NCT03635983|584413664|FG001|Pre-Treatment Period|Disease Progression|1|||
161828908|NCT03635983|584413663|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
161828909|NCT03635983|584413664|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
161828910|NCT03635983|584413663|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
161828911|NCT03635983|584413664|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
161828912|NCT03635983|584413663|FG000|Treatment Period|Withdrawal by Subject|3|||
161828913|NCT03635983|584413664|FG001|Treatment Period|Withdrawal by Subject|5|||
161828914|NCT03635983|584413663|FG000|Treatment Period|Death|3|||
161828915|NCT03635983|584413664|FG001|Treatment Period|Death|5|||
161828916|NCT03635983|584413663|FG000|Treatment Period|Poor/Non-compliance|2|||
161828917|NCT03635983|584413664|FG001|Treatment Period|Poor/Non-compliance|1|||
161828918|NCT03635983|584413663|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
161828919|NCT03635983|584413664|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
161828920|NCT03635983|584413663|FG000|Treatment Period|Other reasons|7|||
161828921|NCT03635983|584413664|FG001|Treatment Period|Other reasons|4|||
161828922|NCT03635983|584413663|FG000|Treatment Period|Disease progression|230|||
161828923|NCT03635983|584413664|FG001|Treatment Period|Disease progression|201|||
161828924|NCT03635983|584413663|FG000|Treatment Period|Study drug toxicity|35|||
161828925|NCT03635983|584413664|FG001|Treatment Period|Study drug toxicity|36|||
161828926|NCT03635983|584413663|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
161828927|NCT03635983|584413664|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
161828928|NCT03635983|584413663|FG000|Treatment Period|Maximum clinical benefit|3|||
161828929|NCT03635983|584413664|FG001|Treatment Period|Maximum clinical benefit|5|||
161828930|NCT03635983|584413663|FG000|Treatment Period|Administrative reason by the sponsor|1|||
161828931|NCT03635983|584413664|FG001|Treatment Period|Administrative reason by the sponsor|2|||
161828932|NCT03635983|584413663|FG000|Treatment Period|Lost to Follow-up|0|||
161938648|NCT03787615|584825637|FG000|Overall Study|Lost to Follow-up|2|||
161938649|NCT01229111|584825639|FG000|Overall Study|Death|1|||
161938650|NCT04102514|584825640|FG000|Overall Study|Death|3|||
161938651|NCT04102514|584825641|FG001|Overall Study|Death|0|||
161938652|NCT04102514|584825642|FG002|Overall Study|Death|0|||
161938653|NCT04102514|584825643|FG003|Overall Study|Death|0|||
161938654|NCT04102514|584825640|FG000|Overall Study|Lost to Follow-up|0|||
161938655|NCT04102514|584825641|FG001|Overall Study|Lost to Follow-up|0|||
161938656|NCT04102514|584825642|FG002|Overall Study|Lost to Follow-up|3|||
161938657|NCT04102514|584825643|FG003|Overall Study|Lost to Follow-up|0|||
161938658|NCT04102514|584825640|FG000|Overall Study|Physician Decision|0|||
161938659|NCT04102514|584825641|FG001|Overall Study|Physician Decision|0|||
161938660|NCT04102514|584825642|FG002|Overall Study|Physician Decision|1|||
161938661|NCT04102514|584825643|FG003|Overall Study|Physician Decision|0|||
161938662|NCT04102514|584825640|FG000|Overall Study|Withdrawal by Subject|7|||
161938663|NCT04102514|584825641|FG001|Overall Study|Withdrawal by Subject|13|||
161938664|NCT04102514|584825642|FG002|Overall Study|Withdrawal by Subject|7|||
161938665|NCT04102514|584825643|FG003|Overall Study|Withdrawal by Subject|14|||
161938666|NCT04102514|584825640|FG000|Overall Study|Moved to longterm care facility|6|||
161938667|NCT04102514|584825641|FG001|Overall Study|Moved to longterm care facility|0|||
161938668|NCT04102514|584825642|FG002|Overall Study|Moved to longterm care facility|4|||
161938669|NCT04102514|584825643|FG003|Overall Study|Moved to longterm care facility|0|||
161938670|NCT00619918|584825644|FG000|Overall Study|Withdrawal by Subject|4|||
161938671|NCT00619918|584825645|FG001|Overall Study|Withdrawal by Subject|3|||
161938672|NCT00619918|584825644|FG000|Overall Study|Physician Decision|2|||
161938673|NCT00619918|584825645|FG001|Overall Study|Physician Decision|4|||
161828933|NCT03635983|584413664|FG001|Treatment Period|Lost to Follow-up|1|||
161828934|NCT03365791|584413666|FG000|Overall Study|Adverse Event|5|||
161828935|NCT03365791|584413666|FG000|Overall Study|Death|1|||
161828936|NCT03365791|584413666|FG000|Overall Study|Lost to Follow-up|1|||
161828937|NCT03365791|584413666|FG000|Overall Study|Physician Decision|9|||
161938674|NCT00619918|584825644|FG000|Overall Study|Transfer to outside facility|3|||
161938675|NCT00619918|584825645|FG001|Overall Study|Transfer to outside facility|3|||
161938676|NCT00619918|584825644|FG000|Overall Study|Left before receiving first dose|7|||
161938677|NCT00619918|584825645|FG001|Overall Study|Left before receiving first dose|6|||
161938678|NCT00619918|584825644|FG000|Overall Study|ICU admission|4|||
161938679|NCT00619918|584825645|FG001|Overall Study|ICU admission|6|||
161938680|NCT01969409|584825651|FG000|Overall Study|Death|2|||
162022934|NCT02184572|585140912|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
162022935|NCT02184572|585140911|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
162022936|NCT02184572|585140912|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
162022937|NCT02184572|585140911|FG000|Overall Study|Traveling Outside The Country|1|||
162022938|NCT02184572|585140912|FG001|Overall Study|Traveling Outside The Country|0|||
162022939|NCT02184572|585140911|FG000|Overall Study|Withdrawal by Subject|14|||
162022940|NCT02184572|585140912|FG001|Overall Study|Withdrawal by Subject|9|||
162022941|NCT00763698|585140913|FG000|Overall Study|Unsuccessful Implant|5|||
162022942|NCT00763698|585140913|FG000|Overall Study|Death|4|||
162022943|NCT00763698|585140913|FG000|Overall Study|Withdrawal by Subject|1|||
162022944|NCT03679754|585140920|FG000|Overall Study|Investigator request|1|||
162022945|NCT00964171|585140921|FG000|Overall Study|Death|5|||
162219747|NCT00847626|585855633|FG004|Overall Study|Lack of Efficacy|2|||
162219748|NCT00847626|585855634|FG005|Overall Study|Lack of Efficacy|0|||
162219749|NCT00847626|585855635|FG006|Overall Study|Lack of Efficacy|6|||
162219750|NCT00847626|585855636|FG007|Overall Study|Lack of Efficacy|2|||
162219751|NCT00847626|585855637|FG008|Overall Study|Lack of Efficacy|5|||
162219752|NCT00847626|585855638|FG009|Overall Study|Lack of Efficacy|1|||
161828938|NCT03365791|584413666|FG000|Overall Study|Progressive disease|51|||
161938681|NCT01969409|584825652|FG001|Overall Study|Death|2|||
161938682|NCT01969409|584825651|FG000|Overall Study|Transplant|1|||
161938683|NCT01969409|584825652|FG001|Overall Study|Transplant|1|||
161938684|NCT01969409|584825651|FG000|Overall Study|Withdrawal by Subject|0|||
161938685|NCT01969409|584825652|FG001|Overall Study|Withdrawal by Subject|1|||
161938686|NCT00721110|584825653|FG000|Overall Study|Ultram use|1|||
161938687|NCT00721110|584825654|FG001|Overall Study|Ultram use|0|||
161938688|NCT00721110|584825655|FG002|Overall Study|Ultram use|0|||
161938689|NCT00721110|584825656|FG003|Overall Study|Ultram use|0|||
161938690|NCT00721110|584825653|FG000|Overall Study|vertical incision|0|||
161938691|NCT00721110|584825654|FG001|Overall Study|vertical incision|0|||
161938692|NCT00721110|584825655|FG002|Overall Study|vertical incision|1|||
161938693|NCT00721110|584825656|FG003|Overall Study|vertical incision|0|||
161938694|NCT02852005|584825658|FG000|Overall Study|Lost to Follow-up|0|||
161938695|NCT02852005|584825659|FG001|Overall Study|Lost to Follow-up|0|||
161938696|NCT02852005|584825660|FG002|Overall Study|Lost to Follow-up|0|||
161938697|NCT02852005|584825661|FG003|Overall Study|Lost to Follow-up|0|||
161938698|NCT02852005|584825662|FG004|Overall Study|Lost to Follow-up|1|||
161938699|NCT02852005|584825658|FG000|Overall Study|Withdrawal by Subject|1|||
161938700|NCT02852005|584825659|FG001|Overall Study|Withdrawal by Subject|0|||
161938701|NCT02852005|584825660|FG002|Overall Study|Withdrawal by Subject|0|||
161938702|NCT02852005|584825661|FG003|Overall Study|Withdrawal by Subject|0|||
161938703|NCT02852005|584825662|FG004|Overall Study|Withdrawal by Subject|0|||
161938704|NCT01922895|584825663|FG000|Overall Study|Death|0|||
161938705|NCT01922895|584825664|FG001|Overall Study|Death|1|||
161938706|NCT01922895|584825663|FG000|Overall Study|Withdrawal by Subject|1|||
161938707|NCT01922895|584825664|FG001|Overall Study|Withdrawal by Subject|2|||
161938708|NCT01922895|584825663|FG000|Overall Study|Lost to Follow-up|5|||
161938709|NCT01922895|584825664|FG001|Overall Study|Lost to Follow-up|11|||
161938710|NCT01916226|584825665|FG000|Overall Study|Adverse Event|1|||
161938711|NCT01916226|584825666|FG001|Overall Study|Adverse Event|0|||
161938712|NCT01916226|584825667|FG002|Overall Study|Adverse Event|1|||
161938713|NCT01916226|584825668|FG003|Overall Study|Adverse Event|1|||
161938714|NCT01916226|584825665|FG000|Overall Study|Lack of Efficacy|0|||
161938715|NCT01916226|584825666|FG001|Overall Study|Lack of Efficacy|0|||
161938716|NCT01916226|584825667|FG002|Overall Study|Lack of Efficacy|2|||
161938717|NCT01916226|584825668|FG003|Overall Study|Lack of Efficacy|1|||
162022946|NCT03179319|585140925|FG000|Overall Study|Lost to Follow-up|6|||
162022947|NCT03179319|585140926|FG001|Overall Study|Lost to Follow-up|0|||
162022948|NCT01120717|585140927|FG000|Overall Study|Withdrawal by Subject|11|||
162022949|NCT01120717|585140928|FG001|Overall Study|Withdrawal by Subject|6|||
162022950|NCT01120717|585140927|FG000|Overall Study|Adverse Event|10|||
162219753|NCT00847626|585855639|FG010|Overall Study|Lack of Efficacy|7|||
162219754|NCT00847626|585855629|FG000|Overall Study|Other|1|||
161828939|NCT03365791|584413666|FG000|Overall Study|Subject/guardian decision|5|||
161828940|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
161828941|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161828942|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161828943|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161828944|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161828945|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161828946|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161828947|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161938718|NCT01916226|584825665|FG000|Overall Study|Protocol Violation|0|||
161938719|NCT01916226|584825666|FG001|Overall Study|Protocol Violation|1|||
161938720|NCT01916226|584825667|FG002|Overall Study|Protocol Violation|0|||
161938721|NCT01916226|584825668|FG003|Overall Study|Protocol Violation|1|||
161938722|NCT01916226|584825665|FG000|Overall Study|Physician Decision|0|||
162219755|NCT00847626|585855630|FG001|Overall Study|Other|5|||
162022951|NCT01120717|585140928|FG001|Overall Study|Adverse Event|6|||
162022952|NCT01120717|585140927|FG000|Overall Study|Protocol Deviation|2|||
162022953|NCT01120717|585140928|FG001|Overall Study|Protocol Deviation|5|||
162219756|NCT00847626|585855631|FG002|Overall Study|Other|4|||
162219757|NCT00847626|585855632|FG003|Overall Study|Other|1|||
162022954|NCT01120717|585140927|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
162022955|NCT01120717|585140928|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
162219758|NCT00847626|585855633|FG004|Overall Study|Other|2|||
162219759|NCT00847626|585855634|FG005|Overall Study|Other|2|||
162219760|NCT00847626|585855635|FG006|Overall Study|Other|2|||
162219761|NCT00847626|585855636|FG007|Overall Study|Other|3|||
162219762|NCT00847626|585855637|FG008|Overall Study|Other|1|||
162219763|NCT00847626|585855638|FG009|Overall Study|Other|1|||
162022956|NCT01120717|585140927|FG000|Overall Study|Lost to Follow-up|2|||
162022957|NCT01120717|585140928|FG001|Overall Study|Lost to Follow-up|3|||
162022958|NCT01120717|585140927|FG000|Overall Study|Death|3|||
162022959|NCT01120717|585140928|FG001|Overall Study|Death|1|||
162022960|NCT01120717|585140927|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
162022961|NCT01120717|585140928|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
162022962|NCT02640508|585140933|FG000|Overall Study|Death|19|||
162022963|NCT02640508|585140933|FG000|Overall Study|Withdrawal by Subject|8|||
162022964|NCT02640508|585140933|FG000|Overall Study|Physician Decision|1|||
162022965|NCT02640508|585140933|FG000|Overall Study|Lost to Follow-up|1|||
162022966|NCT04534686|585140935|FG000|Baseline Measurement|Lost to Follow-up|4|||
162219764|NCT00847626|585855639|FG010|Overall Study|Other|3|||
162219765|NCT03057847|585855640|FG000|Overall Study|Lost to Follow-up|16|||
162022967|NCT04534686|585140936|FG001|Baseline Measurement|Lost to Follow-up|6|||
162022968|NCT04534686|585140935|FG000|Baseline Measurement|Withdrawal by Subject|3|||
162022969|NCT04534686|585140936|FG001|Baseline Measurement|Withdrawal by Subject|1|||
162022970|NCT04534686|585140935|FG000|Intervention|Withdrawal by Subject|2|||
162022971|NCT04534686|585140936|FG001|Intervention|Withdrawal by Subject|2|||
162022972|NCT03179605|585140937|FG000|Overall Study|Withdrawal by Subject|1|||
162022973|NCT00635999|585140938|FG000|Overall Study|Withdrawal by Subject|4|||
162022974|NCT00635999|585140939|FG001|Overall Study|Withdrawal by Subject|2|||
162022975|NCT00635999|585140940|FG002|Overall Study|Withdrawal by Subject|1|||
162022976|NCT00711477|585140941|FG000|Overall Study|Adverse Event|3|||
162022977|NCT00711477|585140942|FG001|Overall Study|Adverse Event|1|||
162022978|NCT00711477|585140941|FG000|Overall Study|Lost to Follow-up|0|||
162219766|NCT02138786|585855646|FG000|Overall Study|Adverse Event|0|||
162219767|NCT02138786|585855647|FG001|Overall Study|Adverse Event|2|||
162219768|NCT02138786|585855648|FG002|Overall Study|Adverse Event|1|||
162219769|NCT02138786|585855646|FG000|Overall Study|Death|1|||
162219770|NCT02138786|585855647|FG001|Overall Study|Death|7|||
162219771|NCT02138786|585855648|FG002|Overall Study|Death|2|||
162219772|NCT02138786|585855646|FG000|Overall Study|Disease Progression|1|||
162219773|NCT02138786|585855647|FG001|Overall Study|Disease Progression|1|||
162219774|NCT02138786|585855648|FG002|Overall Study|Disease Progression|3|||
162219775|NCT02138786|585855646|FG000|Overall Study|Withdrawal by Subject|1|||
162219776|NCT02138786|585855647|FG001|Overall Study|Withdrawal by Subject|2|||
162219777|NCT02138786|585855648|FG002|Overall Study|Withdrawal by Subject|0|||
162219778|NCT02138786|585855646|FG000|Overall Study|Patient's Wish|0|||
162219779|NCT02138786|585855647|FG001|Overall Study|Patient's Wish|2|||
162219780|NCT02138786|585855648|FG002|Overall Study|Patient's Wish|0|||
162219781|NCT02138786|585855646|FG000|Overall Study|Sponsor Terminated Study|0|||
162219782|NCT02138786|585855647|FG001|Overall Study|Sponsor Terminated Study|1|||
162219783|NCT02138786|585855648|FG002|Overall Study|Sponsor Terminated Study|1|||
162219784|NCT02138786|585855646|FG000|Overall Study|Non-Compliance|0|||
162219785|NCT02138786|585855647|FG001|Overall Study|Non-Compliance|0|||
162219786|NCT02138786|585855648|FG002|Overall Study|Non-Compliance|1|||
162219787|NCT02088957|585855649|FG000|Overall Study|Lack of Efficacy|1|||
162022979|NCT00711477|585140942|FG001|Overall Study|Lost to Follow-up|1|||
162219788|NCT02088957|585855650|FG001|Overall Study|Lack of Efficacy|0|||
162219789|NCT00426127|585855651|FG000|Overall Study|Adverse Event|1|||
162219790|NCT00426127|585855651|FG000|Overall Study|Removed due to disease progression|1|||
162219791|NCT03111095|585855652|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
162219792|NCT03111095|585855653|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
162219793|NCT03111095|585855652|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
162022980|NCT00711477|585140941|FG000|Overall Study|Noncompliance|0|||
162022981|NCT00711477|585140942|FG001|Overall Study|Noncompliance|1|||
162022982|NCT01396070|585140944|FG000|Overall Study|Withdrawal by Subject|2|||
162022983|NCT01396070|585140944|FG000|Overall Study|Death|2|||
162022984|NCT01396070|585140944|FG000|Overall Study|Adverse Event|8|||
162022985|NCT01396070|585140944|FG000|Overall Study|Physician Decision|3|||
162022986|NCT01396070|585140944|FG000|Overall Study|Lack of Efficacy|4|||
162219794|NCT03111095|585855653|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
162219795|NCT04638660|585855659|FG000|Overall Study|Withdrawal by Subject|2|||
162219796|NCT04638660|585855660|FG001|Overall Study|Withdrawal by Subject|0|||
162219797|NCT04638660|585855659|FG000|Overall Study|Lost to Follow-up|1|||
161938723|NCT01916226|584825666|FG001|Overall Study|Physician Decision|0|||
161938724|NCT01916226|584825667|FG002|Overall Study|Physician Decision|0|||
161938725|NCT01916226|584825668|FG003|Overall Study|Physician Decision|1|||
162219798|NCT04638660|585855660|FG001|Overall Study|Lost to Follow-up|0|||
162219799|NCT04076943|585855665|FG000|Overall Study|Withdrawal by Subject|12|||
162219800|NCT04076943|585855665|FG000|Overall Study|Adverse Event|1|||
162219801|NCT04076943|585855665|FG000|Overall Study|Progressive Disease|2|||
162219802|NCT04076943|585855665|FG000|Overall Study|Death|13|||
162219803|NCT04076943|585855665|FG000|Overall Study|Other than specified|6|||
162219804|NCT03080493|585855666|FG000|Overall Study|Did not provide NRS pain results|1|||
162219805|NCT03080493|585855667|FG001|Overall Study|Did not provide NRS pain results|0|||
162219806|NCT03080493|585855666|FG000|Overall Study|Adverse Event|0|||
162219807|NCT03080493|585855667|FG001|Overall Study|Adverse Event|1|||
162219808|NCT03080493|585855666|FG000|Overall Study|Randomization error (parity group)|0|||
162219809|NCT03080493|585855667|FG001|Overall Study|Randomization error (parity group)|1|||
162219810|NCT01602510|585855668|FG000|Open Label Phase|Adverse Event|46|||
162219811|NCT01602510|585855669|FG001|Open Label Phase|Adverse Event|0|||
162219812|NCT01602510|585855670|FG002|Open Label Phase|Adverse Event|0|||
162219813|NCT01602510|585855668|FG000|Open Label Phase|Lack of Efficacy|22|||
162219814|NCT01602510|585855669|FG001|Open Label Phase|Lack of Efficacy|0|||
162219815|NCT01602510|585855670|FG002|Open Label Phase|Lack of Efficacy|0|||
162219816|NCT01602510|585855668|FG000|Open Label Phase|Protocol Violation|15|||
162219817|NCT01602510|585855669|FG001|Open Label Phase|Protocol Violation|0|||
162219818|NCT01602510|585855670|FG002|Open Label Phase|Protocol Violation|0|||
162219819|NCT01602510|585855668|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
162219820|NCT01602510|585855669|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
162219821|NCT01602510|585855670|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
162219822|NCT01602510|585855668|FG000|Open Label Phase|Lost to Follow-up|22|||
162219823|NCT01602510|585855669|FG001|Open Label Phase|Lost to Follow-up|0|||
162219824|NCT01602510|585855670|FG002|Open Label Phase|Lost to Follow-up|0|||
162219825|NCT01602510|585855668|FG000|Open Label Phase|Physician Decision|19|||
162219826|NCT01602510|585855669|FG001|Open Label Phase|Physician Decision|0|||
162219827|NCT01602510|585855670|FG002|Open Label Phase|Physician Decision|0|||
162219828|NCT01602510|585855668|FG000|Open Label Phase|Withdrawal by Subject|57|||
162219829|NCT01602510|585855669|FG001|Open Label Phase|Withdrawal by Subject|0|||
162219830|NCT01602510|585855670|FG002|Open Label Phase|Withdrawal by Subject|0|||
162219831|NCT01602510|585855668|FG000|Randomized Phase|Adverse Event|0|||
161938726|NCT03760068|584825671|FG000|Overall Study|Withdrawal by Subject|7|||
161938727|NCT03760068|584825672|FG001|Overall Study|Withdrawal by Subject|8|||
162219832|NCT01602510|585855669|FG001|Randomized Phase|Adverse Event|2|||
162219833|NCT01602510|585855670|FG002|Randomized Phase|Adverse Event|6|||
162219834|NCT01602510|585855668|FG000|Randomized Phase|Lack of Efficacy|0|||
162219835|NCT01602510|585855669|FG001|Randomized Phase|Lack of Efficacy|4|||
162219836|NCT01602510|585855670|FG002|Randomized Phase|Lack of Efficacy|4|||
162219837|NCT01602510|585855668|FG000|Randomized Phase|Protocol Violation|0|||
162219838|NCT01602510|585855669|FG001|Randomized Phase|Protocol Violation|3|||
162219839|NCT01602510|585855670|FG002|Randomized Phase|Protocol Violation|3|||
162219840|NCT01602510|585855668|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
162219841|NCT01602510|585855669|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
162219842|NCT01602510|585855670|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
162219843|NCT01602510|585855668|FG000|Randomized Phase|Lost to Follow-up|0|||
162219844|NCT01602510|585855669|FG001|Randomized Phase|Lost to Follow-up|1|||
162219845|NCT01602510|585855670|FG002|Randomized Phase|Lost to Follow-up|3|||
162219846|NCT01602510|585855668|FG000|Randomized Phase|Physician Decision|0|||
162219847|NCT01602510|585855669|FG001|Randomized Phase|Physician Decision|0|||
162219848|NCT01602510|585855670|FG002|Randomized Phase|Physician Decision|2|||
162219849|NCT01602510|585855668|FG000|Randomized Phase|Withdrawal by Subject|0|||
162219850|NCT01602510|585855669|FG001|Randomized Phase|Withdrawal by Subject|6|||
162219851|NCT01602510|585855670|FG002|Randomized Phase|Withdrawal by Subject|7|||
162219852|NCT01261000|585855671|FG000|Overall Study|Screen failure|1|||
162219853|NCT01825577|585855672|FG000|Overall Study|Physician Decision|2|||
162219854|NCT01825577|585855672|FG000|Overall Study|Withdrawal by Subject|1|||
162219855|NCT01825577|585855672|FG000|Overall Study|Withdrawn by family members|2|||
162219856|NCT01825577|585855672|FG000|Overall Study|Lack of Efficacy|3|||
162219857|NCT01427725|585855677|FG000|Overall Study|Lost to Follow-up|17|||
162219858|NCT01427725|585855677|FG000|Overall Study|Protocol Violation|1|||
162219859|NCT01427725|585855677|FG000|Overall Study|Drug not administered|1|||
162219860|NCT01427725|585855677|FG000|Overall Study|Failure to visit|7|||
162219861|NCT01427725|585855677|FG000|Overall Study|Adverse Event|46|||
162219862|NCT01427725|585855677|FG000|Overall Study|Failure to visit after administration|40|||
162219863|NCT01427725|585855677|FG000|Overall Study|Patient's rejection|27|||
162236649|NCT01191268|585917019|FG001|Overall Study|Lost to Follow-up|5|||
162236650|NCT01191268|585917020|FG002|Overall Study|Lost to Follow-up|9|||
162236651|NCT01191268|585917018|FG000|Overall Study|Entry Criteria Not Met|3|||
162236652|NCT01191268|585917019|FG001|Overall Study|Entry Criteria Not Met|1|||
162236653|NCT01191268|585917020|FG002|Overall Study|Entry Criteria Not Met|1|||
162219864|NCT01427725|585855677|FG000|Overall Study|Transfer to a different hospital|17|||
162219865|NCT01427725|585855677|FG000|Overall Study|Lack of Efficacy|8|||
162219866|NCT01427725|585855677|FG000|Overall Study|Death|7|||
162219867|NCT01427725|585855677|FG000|Overall Study|Symptom improvement|6|||
162219868|NCT01427725|585855677|FG000|Overall Study|AE and Patient's rejection|5|||
162219869|NCT01427725|585855677|FG000|Overall Study|Physician Decision|5|||
162219870|NCT01427725|585855677|FG000|Overall Study|Exacerbation of underlying disease|5|||
162219871|NCT01427725|585855677|FG000|Overall Study|Oral feeding difficulty|5|||
162219872|NCT01427725|585855677|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
162219873|NCT01427725|585855677|FG000|Overall Study|Forgetting prescription|1|||
162219874|NCT01427725|585855677|FG000|Overall Study|Other|2|||
162219875|NCT01374568|585855678|FG000|Overall Study|Lab unable to analyze BTM|0|||
162219876|NCT01374568|585855679|FG001|Overall Study|Lab unable to analyze BTM|2|||
162219877|NCT04230122|585855680|FG000|Overall Study|Lost to Follow-up|1|||
162219878|NCT04230122|585855681|FG001|Overall Study|Lost to Follow-up|0|||
162219879|NCT01361594|585855683|FG000|Overall Study|Withdrawal by Subject|1|||
162219880|NCT01361594|585855684|FG001|Overall Study|Withdrawal by Subject|2|||
162219881|NCT02762903|585855686|FG000|Overall Study|Lost to Follow-up|0|||
162219882|NCT02762903|585855687|FG001|Overall Study|Lost to Follow-up|1|||
162219883|NCT00570908|585855691|FG000|Overall Study|Adverse Event|5|||
162219884|NCT00570908|585855691|FG000|Overall Study|Withdrawal by Subject|2|||
162219885|NCT00277095|585855692|FG000|Overall Study|Death|2|||
162219886|NCT00277095|585855692|FG000|Overall Study|Explanted|7|||
162219887|NCT00277095|585855692|FG000|Overall Study|Lost to Follow-up|2|||
162219888|NCT00277095|585855692|FG000|Overall Study|Missed Follow-up|9|||
162219889|NCT00277095|585855692|FG000|Overall Study|Physician Decision|1|||
162219890|NCT01213524|585855693|FG000|Baseline|Withdrawal by Subject|5|||
162219891|NCT01213524|585855693|FG000|Baseline|high breath alcohol levels|1|||
162219892|NCT01213524|585855693|FG000|Baseline|Physician Decision|1|||
162219893|NCT01213524|585855693|FG000|Session 2|Withdrawal by Subject|5|||
162219894|NCT01213524|585855693|FG000|Session 3|Withdrawal by Subject|4|||
162219895|NCT01213524|585855693|FG000|Session 4|Physician Decision|1|||
162219896|NCT01213524|585855693|FG000|Session 4|Withdrawal by Subject|2|||
162219897|NCT05415748|585855700|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
162219898|NCT05415748|585855701|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
162219899|NCT05415748|585855702|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
162219900|NCT05415748|585855703|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
162219901|NCT05415748|585855700|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
162219902|NCT05415748|585855701|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
162219903|NCT05415748|585855702|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
162219904|NCT05415748|585855703|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
162219905|NCT01447576|585855704|FG000|Overall Study|Lost to Follow-up|52|||
162219906|NCT01447576|585855704|FG000|Overall Study|Adverse Event|127|||
162219907|NCT01447576|585855704|FG000|Overall Study|Participant met withdrawal criteria|40|||
162219908|NCT01447576|585855704|FG000|Overall Study|Withdrawal by Subject|100|||
162219909|NCT01447576|585855704|FG000|Overall Study|Protocol deviation|83|||
162219910|NCT01447576|585855704|FG000|Overall Study|Lack of Efficacy|68|||
162219911|NCT01447576|585855704|FG000|Overall Study|Physician Decision|6|||
162219912|NCT00975676|585855705|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
162219913|NCT00975676|585855706|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
162219914|NCT02209181|585855707|FG000|Overall Study|Adverse Event|1|||
162219915|NCT02209181|585855708|FG001|Overall Study|Adverse Event|0|||
162219916|NCT02209181|585855709|FG002|Overall Study|Adverse Event|1|||
162219917|NCT02209181|585855710|FG003|Overall Study|Adverse Event|0|||
162219918|NCT02209181|585855707|FG000|Overall Study|Withdrawal by Subject|0|||
162219919|NCT02209181|585855708|FG001|Overall Study|Withdrawal by Subject|1|||
162219920|NCT02209181|585855709|FG002|Overall Study|Withdrawal by Subject|0|||
162219921|NCT02209181|585855710|FG003|Overall Study|Withdrawal by Subject|0|||
162219922|NCT02548078|585855711|FG000|Overall Study|Serious adverse event/Adverse event|1|||
162219923|NCT02548078|585855712|FG001|Overall Study|Serious adverse event/Adverse event|0|||
162219924|NCT02548078|585855711|FG000|Overall Study|Moved from study area|3|||
162219925|NCT02548078|585855712|FG001|Overall Study|Moved from study area|3|||
162219926|NCT02548078|585855711|FG000|Overall Study|Lost to Follow-up|1|||
162219927|NCT02548078|585855712|FG001|Overall Study|Lost to Follow-up|3|||
162219928|NCT02579772|585855713|FG000|Overall Study|Withdrawal by Subject|0|||
162219929|NCT02579772|585855714|FG001|Overall Study|Withdrawal by Subject|1|||
162219930|NCT02579772|585855713|FG000|Overall Study|Usage of additional antioxidants|1|||
162219931|NCT02579772|585855714|FG001|Overall Study|Usage of additional antioxidants|0|||
162219932|NCT02579772|585855713|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
162219933|NCT02579772|585855714|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
162219934|NCT01040169|585855715|FG000|Overall Study|Lost to Follow-up|3|||
162219935|NCT01040169|585855716|FG001|Overall Study|Lost to Follow-up|8|||
162219936|NCT00350727|585855717|FG000|Phase I: Dose Escalation|Adverse Event|4|||
162219937|NCT00350727|585855718|FG001|Phase I: Dose Escalation|Adverse Event|0|||
162219938|NCT00350727|585855719|FG002|Phase I: Dose Escalation|Adverse Event|0|||
162219939|NCT00350727|585855717|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
162219940|NCT00350727|585855718|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
162219941|NCT00350727|585855719|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
162219942|NCT00350727|585855717|FG000|Phase I: Dose Escalation|Death|1|||
162219943|NCT00350727|585855718|FG001|Phase I: Dose Escalation|Death|0|||
162022987|NCT02636361|585140945|FG000|Period 4|Physician Decision|0|||
162022988|NCT02636361|585140946|FG001|Period 4|Physician Decision|0|||
162022989|NCT02636361|585140947|FG002|Period 4|Physician Decision|0|||
162022990|NCT02636361|585140948|FG003|Period 4|Physician Decision|1|||
162022991|NCT02636361|585140949|FG004|Period 4|Physician Decision|0|||
162022992|NCT02695420|585140950|FG000|Overall Study|Death|0|||
162022993|NCT02695420|585140951|FG001|Overall Study|Death|1|||
162022994|NCT02695420|585140952|FG002|Overall Study|Death|0|||
162022995|NCT02695420|585140953|FG003|Overall Study|Death|0|||
162022996|NCT03037580|585140958|FG000|Overall Study|Withdrawal by Subject|3|||
162022997|NCT03037580|585140959|FG001|Overall Study|Withdrawal by Subject|0|||
162022998|NCT03037580|585140958|FG000|Overall Study|Adverse Event|1|||
162022999|NCT03037580|585140959|FG001|Overall Study|Adverse Event|0|||
162023000|NCT03037580|585140958|FG000|Overall Study|Study Terminated by Sponsor|12|||
162023001|NCT03037580|585140959|FG001|Overall Study|Study Terminated by Sponsor|15|||
162023002|NCT03037580|585140958|FG000|Overall Study|Death|0|||
162023003|NCT03037580|585140959|FG001|Overall Study|Death|1|||
162023004|NCT02036853|585140960|FG000|Overall Study|Adverse Event|0|||
162023005|NCT02036853|585140961|FG001|Overall Study|Adverse Event|2|||
162023006|NCT02036853|585140960|FG000|Overall Study|Lack of Efficacy|0|||
162023007|NCT02036853|585140961|FG001|Overall Study|Lack of Efficacy|2|||
162023008|NCT02036853|585140960|FG000|Overall Study|Physician Decision|0|||
162023009|NCT02036853|585140961|FG001|Overall Study|Physician Decision|1|||
162023010|NCT02036853|585140960|FG000|Overall Study|Withdrawal by Subject|0|||
162023011|NCT02036853|585140961|FG001|Overall Study|Withdrawal by Subject|1|||
162023012|NCT00228553|585140962|FG000|Overall Study|Adverse Event|112|||
162023013|NCT00228553|585140962|FG000|Overall Study|Lack of Efficacy|34|||
162023014|NCT00228553|585140962|FG000|Overall Study|Lost to Follow-up|67|||
162023015|NCT00228553|585140962|FG000|Overall Study|Physician Decision|48|||
162023016|NCT00228553|585140962|FG000|Overall Study|Protocol Violation|6|||
162023017|NCT00228553|585140962|FG000|Overall Study|Withdrawal by Subject|115|||
162023018|NCT00228553|585140962|FG000|Overall Study|Pregnancy|2|||
162023019|NCT00228553|585140962|FG000|Overall Study|Miscellaneous|46|||
162023020|NCT04530136|585140963|FG000|Overall Study|Lost to Follow-up|2|||
162023021|NCT04530136|585140964|FG001|Overall Study|Lost to Follow-up|3|||
162023022|NCT04530136|585140963|FG000|Overall Study|Withdrawal by Subject|1|||
162023023|NCT04530136|585140964|FG001|Overall Study|Withdrawal by Subject|0|||
162023024|NCT04530136|585140963|FG000|Overall Study|Death|0|||
162023025|NCT04530136|585140964|FG001|Overall Study|Death|1|||
162023026|NCT02087423|585140966|FG000|Overall Study|Withdrawal by Subject|20|||
162023027|NCT02087423|585140967|FG001|Overall Study|Withdrawal by Subject|20|||
162023028|NCT02087423|585140968|FG002|Overall Study|Withdrawal by Subject|3|||
162023029|NCT02087423|585140966|FG000|Overall Study|Death|68|||
162023030|NCT02087423|585140967|FG001|Overall Study|Death|207|||
162219944|NCT00350727|585855719|FG002|Phase I: Dose Escalation|Death|0|||
162219945|NCT00350727|585855717|FG000|Phase I: Dose Escalation|Physician Decision|1|||
162219946|NCT00350727|585855718|FG001|Phase I: Dose Escalation|Physician Decision|0|||
162219947|NCT00350727|585855719|FG002|Phase I: Dose Escalation|Physician Decision|0|||
162219948|NCT00350727|585855717|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
162219949|NCT00350727|585855718|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
162219950|NCT00350727|585855719|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
162219951|NCT00350727|585855717|FG000|Phase II|Disease Progression|0|||
162219952|NCT00350727|585855718|FG001|Phase II|Disease Progression|15|||
162219953|NCT00350727|585855719|FG002|Phase II|Disease Progression|16|||
162219954|NCT00350727|585855717|FG000|Phase II|Clinical Deterioration|0|||
162219955|NCT00350727|585855718|FG001|Phase II|Clinical Deterioration|1|||
162219956|NCT00350727|585855719|FG002|Phase II|Clinical Deterioration|0|||
162219957|NCT00350727|585855717|FG000|Phase II|Withdrawal by Subject|0|||
162219958|NCT00350727|585855718|FG001|Phase II|Withdrawal by Subject|2|||
162219959|NCT00350727|585855719|FG002|Phase II|Withdrawal by Subject|1|||
161828948|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
162023031|NCT02087423|585140968|FG002|Overall Study|Death|40|||
162023032|NCT02087423|585140966|FG000|Overall Study|Lost to Follow-up|0|||
162023033|NCT02087423|585140967|FG001|Overall Study|Lost to Follow-up|2|||
162023034|NCT02087423|585140968|FG002|Overall Study|Lost to Follow-up|0|||
162023035|NCT02087423|585140966|FG000|Overall Study|Terminated from study at final DCO|23|||
162023036|NCT02087423|585140967|FG001|Overall Study|Terminated from study at final DCO|36|||
162023037|NCT02087423|585140968|FG002|Overall Study|Terminated from study at final DCO|25|||
162023038|NCT01136785|585140976|FG000|Overall Study|Protocol Violation|2|||
162023039|NCT01136785|585140977|FG001|Overall Study|Protocol Violation|1|||
162023040|NCT02873429|585140978|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
162023041|NCT02873429|585140979|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
162023042|NCT02873429|585140978|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
162023043|NCT02873429|585140979|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
162219960|NCT00350727|585855717|FG000|Phase II|Adverse Event|0|||
161938728|NCT03760068|584825671|FG000|Overall Study|Adverse Event|1|||
161938729|NCT03760068|584825672|FG001|Overall Study|Adverse Event|2|||
161938730|NCT03760068|584825671|FG000|Overall Study|Administrative Decision by Sponsor|0|||
161938731|NCT03760068|584825672|FG001|Overall Study|Administrative Decision by Sponsor|2|||
161938732|NCT03760068|584825671|FG000|Overall Study|Physician Decision|1|||
161938733|NCT03760068|584825672|FG001|Overall Study|Physician Decision|2|||
161938734|NCT03760068|584825671|FG000|Overall Study|Lost to Follow-up|4|||
161938735|NCT03760068|584825672|FG001|Overall Study|Lost to Follow-up|9|||
161938736|NCT03760068|584825671|FG000|Overall Study|Subject Moved Out of State|1|||
161938737|NCT03760068|584825672|FG001|Overall Study|Subject Moved Out of State|0|||
161938738|NCT00680914|584825673|FG000|Overall Study|Consent withdrawal|6|||
161938739|NCT00680914|584825674|FG001|Overall Study|Consent withdrawal|3|||
161938740|NCT00680914|584825673|FG000|Overall Study|Lost to Follow-up|4|||
161938741|NCT00680914|584825674|FG001|Overall Study|Lost to Follow-up|0|||
161938742|NCT00680914|584825673|FG000|Overall Study|serious adverse event (SAE)|0|||
161938743|NCT00680914|584825674|FG001|Overall Study|serious adverse event (SAE)|1|||
161938744|NCT04439903|584825687|FG000|Overall Study|Withdrawal by Subject|2|||
161938745|NCT04439903|584825687|FG000|Overall Study|Screen Failure|1|||
161938746|NCT03204812|584825696|FG000|Overall Study|Adverse Event|3|||
161938747|NCT01027351|584825697|FG000|Overall Study|Withdrawal by Subject|1|||
161828949|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
161828950|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828951|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828952|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828953|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828954|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828955|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828956|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828957|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161828958|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
161828959|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828960|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828961|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828962|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828963|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828964|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828965|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828966|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161828967|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
161828968|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161828969|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161938748|NCT01027351|584825698|FG001|Overall Study|Withdrawal by Subject|0|||
161938749|NCT01027351|584825699|FG002|Overall Study|Withdrawal by Subject|1|||
161938750|NCT01027351|584825700|FG003|Overall Study|Withdrawal by Subject|0|||
161938751|NCT01027351|584825701|FG004|Overall Study|Withdrawal by Subject|3|||
161938752|NCT01027351|584825702|FG005|Overall Study|Withdrawal by Subject|5|||
161938753|NCT01027351|584825697|FG000|Overall Study|Lost to Follow-up|1|||
161938754|NCT01027351|584825698|FG001|Overall Study|Lost to Follow-up|1|||
161938755|NCT01027351|584825699|FG002|Overall Study|Lost to Follow-up|0|||
161938756|NCT01027351|584825700|FG003|Overall Study|Lost to Follow-up|1|||
161938757|NCT01027351|584825701|FG004|Overall Study|Lost to Follow-up|6|||
162219961|NCT00350727|585855718|FG001|Phase II|Adverse Event|1|||
162219962|NCT00350727|585855719|FG002|Phase II|Adverse Event|1|||
162219963|NCT00350727|585855717|FG000|Phase II|Death|0|||
162219964|NCT00350727|585855718|FG001|Phase II|Death|0|||
162219965|NCT00350727|585855719|FG002|Phase II|Death|2|||
162219966|NCT00350727|585855717|FG000|Phase II|Sponsor Terminated Study|0|||
161938758|NCT01027351|584825702|FG005|Overall Study|Lost to Follow-up|0|||
161938759|NCT01027351|584825697|FG000|Overall Study|Inappropriate enrollment|0|||
161938760|NCT01027351|584825698|FG001|Overall Study|Inappropriate enrollment|0|||
161938761|NCT01027351|584825699|FG002|Overall Study|Inappropriate enrollment|0|||
161938762|NCT01027351|584825700|FG003|Overall Study|Inappropriate enrollment|0|||
161938763|NCT01027351|584825701|FG004|Overall Study|Inappropriate enrollment|1|||
161938764|NCT01027351|584825702|FG005|Overall Study|Inappropriate enrollment|0|||
161938765|NCT01027351|584825697|FG000|Overall Study|Protocol Violation|1|||
161938766|NCT01027351|584825698|FG001|Overall Study|Protocol Violation|0|||
161938767|NCT01027351|584825699|FG002|Overall Study|Protocol Violation|0|||
161938768|NCT01027351|584825700|FG003|Overall Study|Protocol Violation|1|||
161938769|NCT01027351|584825701|FG004|Overall Study|Protocol Violation|1|||
161938770|NCT01027351|584825702|FG005|Overall Study|Protocol Violation|0|||
161938771|NCT04650893|584825703|FG000|Overall Study|Lost to Follow-up|11|||
161938772|NCT04650893|584825704|FG001|Overall Study|Lost to Follow-up|10|||
161938773|NCT04650893|584825705|FG002|Overall Study|Lost to Follow-up|11|||
161938774|NCT04309500|584825709|FG000|Overall Study|Lost to Follow-up|1|||
161938775|NCT04309500|584825710|FG001|Overall Study|Lost to Follow-up|0|||
161938776|NCT04309500|584825711|FG002|Overall Study|Lost to Follow-up|0|||
161938777|NCT04309500|584825712|FG003|Overall Study|Lost to Follow-up|0|||
161938778|NCT00913835|584825713|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
161938779|NCT00913835|584825714|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
161938780|NCT00913835|584825713|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
161938781|NCT00913835|584825714|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
161938782|NCT00913835|584825713|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
161938783|NCT00913835|584825714|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
161938784|NCT00913835|584825713|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
161938785|NCT00913835|584825714|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
161938786|NCT00913835|584825713|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
161938787|NCT00913835|584825714|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
161938788|NCT00637156|584825715|FG000|Overall Study|Withdrawal by Subject|0|||
161938789|NCT00637156|584825716|FG001|Overall Study|Withdrawal by Subject|7|||
161938790|NCT00637156|584825715|FG000|Overall Study|Death|0|||
161938791|NCT00637156|584825716|FG001|Overall Study|Death|1|||
161938792|NCT00637156|584825715|FG000|Overall Study|Lost to Follow-up|10|||
161938793|NCT00637156|584825716|FG001|Overall Study|Lost to Follow-up|16|||
161938794|NCT02679274|584825717|FG000|Overall Study|Withdrawal by Subject|1|||
161938795|NCT02679274|584825718|FG001|Overall Study|Withdrawal by Subject|0|||
161938796|NCT03193437|584825725|FG000|Overall Study|Adverse Event|4|||
161938797|NCT03193437|584825725|FG000|Overall Study|Withdrawal by Subject|2|||
161938798|NCT03193437|584825725|FG000|Overall Study|Disease Progression|2|||
161938799|NCT03058952|584827181|FG000|Overall Study|Adverse Event|1|||
161938800|NCT03058952|584827182|FG001|Overall Study|Adverse Event|0|||
161938801|NCT03058952|584827181|FG000|Overall Study|Lost to Follow-up|15|||
161938802|NCT03058952|584827182|FG001|Overall Study|Lost to Follow-up|15|||
161938803|NCT03058952|584827181|FG000|Overall Study|Withdrawal by Subject|7|||
161938804|NCT03058952|584827182|FG001|Overall Study|Withdrawal by Subject|11|||
161938805|NCT03768336|584827183|FG000|Overall Study|Lost to Follow-up|3|||
161938806|NCT03768336|584827184|FG001|Overall Study|Lost to Follow-up|2|||
161938807|NCT03768336|584827183|FG000|Overall Study|Became Ineligible|2|||
162219967|NCT00350727|585855718|FG001|Phase II|Sponsor Terminated Study|0|||
162219968|NCT00350727|585855719|FG002|Phase II|Sponsor Terminated Study|1|||
162219969|NCT00350727|585855717|FG000|Phase II|Enrolled in Rollover Study|0|||
162219970|NCT00350727|585855718|FG001|Phase II|Enrolled in Rollover Study|0|||
161938808|NCT03768336|584827184|FG001|Overall Study|Became Ineligible|0|||
161938809|NCT03768336|584827183|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
162219971|NCT00350727|585855719|FG002|Phase II|Enrolled in Rollover Study|1|||
162219972|NCT03128671|585855720|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
161938810|NCT03768336|584827184|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
161938811|NCT03768336|584827183|FG000|Overall Study|Missed final survey (post-treatment|0|||
161938812|NCT03768336|584827184|FG001|Overall Study|Missed final survey (post-treatment|1|||
161938813|NCT02278003|584827185|FG000|Overall Study|Withdrawal by Subject|11|||
162023044|NCT02873429|585140978|FG000|16 Weeks|Lost to Follow-up|3|||
162219973|NCT03128671|585855721|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
161938814|NCT02278003|584827186|FG001|Overall Study|Withdrawal by Subject|0|||
162219974|NCT03128671|585855720|FG000|Allocation|Death|1|||
162219975|NCT03128671|585855721|FG001|Allocation|Death|0|||
162219976|NCT03128671|585855720|FG000|Allocation|Withdrawal by Subject|4|||
162219977|NCT03128671|585855721|FG001|Allocation|Withdrawal by Subject|0|||
162219978|NCT03128671|585855720|FG000|Intervention|Withdrawal by Subject|11|||
162219979|NCT03128671|585855721|FG001|Intervention|Withdrawal by Subject|10|||
162219980|NCT03128671|585855720|FG000|Intervention|Palliative/hospice care initiated|9|||
162219981|NCT03128671|585855721|FG001|Intervention|Palliative/hospice care initiated|10|||
162219982|NCT03128671|585855720|FG000|Intervention|Death|13|||
162219983|NCT03128671|585855721|FG001|Intervention|Death|11|||
162219984|NCT03128671|585855720|FG000|Intervention|Interrupted by hurricane|1|||
162219985|NCT03128671|585855721|FG001|Intervention|Interrupted by hurricane|0|||
162219986|NCT03128671|585855720|FG000|Intervention|Physician Decision|2|||
162219987|NCT03128671|585855721|FG001|Intervention|Physician Decision|3|||
162219988|NCT04641962|585855722|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
162219989|NCT04641962|585855723|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
162219990|NCT04641962|585855724|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
162219991|NCT04641962|585855725|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
162219992|NCT04641962|585855726|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
162219993|NCT04641962|585855722|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
162219994|NCT04641962|585855723|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
162219995|NCT04641962|585855724|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
162219996|NCT04641962|585855725|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
162219997|NCT04641962|585855726|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
162219998|NCT04641962|585855722|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
162219999|NCT04641962|585855723|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
162220000|NCT04641962|585855724|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
162220001|NCT04641962|585855725|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
161938815|NCT02278003|584827185|FG000|Overall Study|Not Treated|1|||
161938816|NCT02278003|584827186|FG001|Overall Study|Not Treated|0|||
161938817|NCT02278003|584827185|FG000|Overall Study|Recognition task improperly completed|7|||
161938818|NCT02278003|584827186|FG001|Overall Study|Recognition task improperly completed|0|||
161938819|NCT01397253|584827187|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
161938820|NCT01397253|584827188|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
161938821|NCT00442702|584827193|FG000|Titration Period|Adverse Event|2|||
161938822|NCT00442702|584827194|FG001|Titration Period|Adverse Event|0|||
161938823|NCT00442702|584827193|FG000|Titration Period|Death|3|||
161938824|NCT00442702|584827194|FG001|Titration Period|Death|2|||
161938825|NCT00442702|584827193|FG000|Titration Period|Insufficient Therapeutic Response|1|||
161938826|NCT00442702|584827194|FG001|Titration Period|Insufficient Therapeutic Response|0|||
161938827|NCT00442702|584827193|FG000|Titration Period|Refused Treatment|4|||
161938828|NCT00442702|584827194|FG001|Titration Period|Refused Treatment|1|||
161938829|NCT00442702|584827193|FG000|Titration Period|Failure to return|1|||
161938830|NCT00442702|584827194|FG001|Titration Period|Failure to return|0|||
161938831|NCT00442702|584827193|FG000|Titration Period|Hospitalized in another hospital|1|||
161938832|NCT00442702|584827194|FG001|Titration Period|Hospitalized in another hospital|0|||
161938833|NCT00442702|584827193|FG000|Evaluation Period|Adverse Event|1|||
161938834|NCT00442702|584827194|FG001|Evaluation Period|Adverse Event|0|||
161938835|NCT00442702|584827193|FG000|Evaluation Period|Death|1|||
161938836|NCT00442702|584827194|FG001|Evaluation Period|Death|1|||
161938837|NCT00442702|584827193|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
161938838|NCT00442702|584827194|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
162220002|NCT04641962|585855726|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
162220003|NCT04641962|585855722|FG000|DBT Period: Up to 52 Weeks|Death|1|||
162220004|NCT04641962|585855723|FG001|DBT Period: Up to 52 Weeks|Death|0|||
162220005|NCT04641962|585855724|FG002|DBT Period: Up to 52 Weeks|Death|0|||
162220006|NCT04641962|585855725|FG003|DBT Period: Up to 52 Weeks|Death|0|||
162220007|NCT04641962|585855726|FG004|DBT Period: Up to 52 Weeks|Death|0|||
162220008|NCT04641962|585855722|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
162220009|NCT04641962|585855723|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
162220010|NCT04641962|585855724|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
162220011|NCT04641962|585855725|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
162220012|NCT04641962|585855726|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
162220013|NCT04641962|585855722|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
162220014|NCT04641962|585855723|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
162220015|NCT04641962|585855724|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
162220016|NCT04641962|585855725|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
162220017|NCT04641962|585855726|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
161938839|NCT00442702|584827193|FG000|Evaluation Period|Refused treatment|1|||
161938840|NCT00442702|584827194|FG001|Evaluation Period|Refused treatment|1|||
161938841|NCT00442702|584827193|FG000|Evaluation Period|Renal transplant|0|||
161938842|NCT00442702|584827194|FG001|Evaluation Period|Renal transplant|1|||
161938843|NCT00442702|584827193|FG000|Evaluation Period|Failure to return|1|||
161938844|NCT00442702|584827194|FG001|Evaluation Period|Failure to return|0|||
162023045|NCT02873429|585140979|FG001|16 Weeks|Lost to Follow-up|0|||
162023046|NCT00612807|585140980|FG000|Overall Study|Withdrawal by Subject|2|||
162023047|NCT00612807|585140981|FG001|Overall Study|Withdrawal by Subject|0|||
162023048|NCT00744042|585140982|FG000|Overall Study|Withdrawal by Subject|1|||
162023049|NCT01516034|585140983|FG000|Overall Study|Physician Decision|1|||
162023050|NCT01516034|585140983|FG000|Overall Study|Lack of Efficacy|7|||
162023051|NCT01033448|585140984|FG000|Overall Study|Withdrawal by Subject|4|||
162023052|NCT01033448|585140984|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
162023053|NCT01033448|585140984|FG000|Overall Study|Lost to Follow-up|3|||
162023054|NCT01033448|585140984|FG000|Overall Study|Withdrew due to other reasons|3|||
162023055|NCT01033448|585140984|FG000|Overall Study|Unknown disposition|1|||
162023056|NCT00599339|585140987|FG000|Overall Study|Adverse Event|79|||
162023057|NCT00599339|585140987|FG000|Overall Study|Withdrawal by Subject|137|||
162023058|NCT00599339|585140987|FG000|Overall Study|Other Reason|179|||
162023059|NCT00599339|585140987|FG000|Overall Study|Lost to Follow-up|221|||
162023060|NCT00599339|585140987|FG000|Overall Study|No valid data consent|36|||
162023061|NCT00599339|585140987|FG000|Overall Study|Study Termination Status Unknown|12|||
162023062|NCT05564052|585140988|FG000|Overall Study|Withdrawal by Subject|0|||
162023063|NCT05564052|585140989|FG001|Overall Study|Withdrawal by Subject|0|||
162023064|NCT05564052|585140990|FG002|Overall Study|Withdrawal by Subject|0|||
162023065|NCT05564052|585140991|FG003|Overall Study|Withdrawal by Subject|1|||
162023066|NCT04189224|585140993|FG000|Period 2|Adverse Event|0|||
162023067|NCT04189224|585140994|FG001|Period 2|Adverse Event|1|||
162023068|NCT03818035|585140996|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
162220018|NCT04641962|585855722|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
162220019|NCT04641962|585855723|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
162220020|NCT04641962|585855724|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
162220021|NCT04641962|585855725|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
162220022|NCT04641962|585855726|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
162220023|NCT00862836|585855727|FG000|Overall Study|Withdrawal by Subject|1|||
162220024|NCT03277352|585855730|FG000|Overall Study|Study Terminated By Sponsor|2|||
162220025|NCT03277352|585855730|FG000|Overall Study|Withdrawal by Subject|4|||
162220026|NCT03277352|585855730|FG000|Overall Study|Death|4|||
162220027|NCT02271984|585857646|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162220028|NCT02271984|585857647|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162220029|NCT02271984|585857648|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162220030|NCT02271984|585857649|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162220031|NCT02271984|585857650|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162023069|NCT03818035|585140997|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
162023070|NCT03818035|585140998|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
162023071|NCT03818035|585140999|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
162023072|NCT03818035|585140996|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
162023073|NCT03818035|585140997|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
162023074|NCT03818035|585140998|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
162023075|NCT03818035|585140999|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
162023076|NCT03818035|585140996|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
162023077|NCT03818035|585140997|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
162023078|NCT03818035|585140998|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
162023079|NCT03818035|585140999|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
162023080|NCT03818035|585140996|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
162023081|NCT03818035|585140997|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
162023082|NCT03818035|585140998|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
162220032|NCT02271984|585857651|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
162220033|NCT02271984|585857652|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162220034|NCT02271984|585857653|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
162220035|NCT02271984|585857654|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162023083|NCT03818035|585140999|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
162023084|NCT03818035|585140996|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
162023085|NCT03818035|585140997|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
162023086|NCT03818035|585140998|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
162023087|NCT03818035|585140999|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
162220036|NCT02271984|585857655|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162220037|NCT02271984|585857656|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162220038|NCT02271984|585857657|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
162220039|NCT01088984|585857658|FG000|Phase 1|Death|2|||
162220040|NCT01088984|585857659|FG001|Phase 1|Death|1|||
161938845|NCT00442702|584827193|FG000|Evaluation Period|Site closure|0|||
161938846|NCT00442702|584827194|FG001|Evaluation Period|Site closure|1|||
161938847|NCT01444781|584827195|FG000|Overall Study|Lost to Follow-up|0|||
161938848|NCT01444781|584827196|FG001|Overall Study|Lost to Follow-up|3|||
161938849|NCT01444781|584827197|FG002|Overall Study|Lost to Follow-up|1|||
161938850|NCT01444781|584827195|FG000|Overall Study|Withdrawal by Subject|3|||
161938851|NCT01444781|584827196|FG001|Overall Study|Withdrawal by Subject|1|||
162220041|NCT01088984|585857658|FG000|Phase 1|Disease Progression|2|||
162220042|NCT01088984|585857659|FG001|Phase 1|Disease Progression|4|||
162220043|NCT01088984|585857658|FG000|Phase 1|Other|1|||
162220044|NCT01088984|585857659|FG001|Phase 1|Other|1|||
162220045|NCT01088984|585857658|FG000|Phase 2|Death|0|||
162220046|NCT01088984|585857659|FG001|Phase 2|Death|5|||
162220047|NCT01088984|585857658|FG000|Phase 2|Withdrawal by Subject|0|||
162220048|NCT01088984|585857659|FG001|Phase 2|Withdrawal by Subject|1|||
162220049|NCT01088984|585857658|FG000|Phase 2|DIsease Progression|0|||
162220050|NCT01088984|585857659|FG001|Phase 2|DIsease Progression|25|||
162220051|NCT01088984|585857658|FG000|Phase 2|Other|0|||
162220052|NCT01088984|585857659|FG001|Phase 2|Other|1|||
162220053|NCT01228318|585857660|FG000|Overall Study|Clinic no show to receive intervention|1|||
162220054|NCT01228318|585857661|FG001|Overall Study|Clinic no show to receive intervention|0|||
162220055|NCT01228318|585857660|FG000|Overall Study|Unable to contact|2|||
162220056|NCT01228318|585857661|FG001|Overall Study|Unable to contact|5|||
162220057|NCT01228318|585857660|FG000|Overall Study|Moved|0|||
162220058|NCT01228318|585857661|FG001|Overall Study|Moved|2|||
162220059|NCT01228318|585857660|FG000|Overall Study|Incarcerated|1|||
162220060|NCT01228318|585857661|FG001|Overall Study|Incarcerated|0|||
162220061|NCT00770029|585857662|FG000|Overall Study|Lost to Follow-up|2|||
162220062|NCT00770029|585857663|FG001|Overall Study|Lost to Follow-up|0|||
162220063|NCT00770029|585857662|FG000|Overall Study|Withdrawal by Subject|3|||
162220064|NCT00770029|585857663|FG001|Overall Study|Withdrawal by Subject|3|||
162220065|NCT00770029|585857662|FG000|Overall Study|Adverse Event|1|||
162220066|NCT00770029|585857663|FG001|Overall Study|Adverse Event|0|||
162220067|NCT03140280|585857664|FG000|Overall Study|Physician Decision|5|||
161938852|NCT01444781|584827197|FG002|Overall Study|Withdrawal by Subject|2|||
161938853|NCT00500331|584827200|FG000|Overall Study|Adverse Event|0|||
161938854|NCT00500331|584827201|FG001|Overall Study|Adverse Event|2|||
161938855|NCT00500331|584827202|FG002|Overall Study|Adverse Event|0|||
161938856|NCT00500331|584827203|FG003|Overall Study|Adverse Event|1|||
161938857|NCT00500331|584827204|FG004|Overall Study|Adverse Event|2|||
161938858|NCT00500331|584827205|FG005|Overall Study|Adverse Event|2|||
161938859|NCT00500331|584827206|FG006|Overall Study|Adverse Event|0|||
161938860|NCT00500331|584827200|FG000|Overall Study|Lost to Follow-up|1|||
161938861|NCT00500331|584827201|FG001|Overall Study|Lost to Follow-up|1|||
161938862|NCT00500331|584827202|FG002|Overall Study|Lost to Follow-up|1|||
161938863|NCT00500331|584827203|FG003|Overall Study|Lost to Follow-up|2|||
161938864|NCT00500331|584827204|FG004|Overall Study|Lost to Follow-up|1|||
161938865|NCT00500331|584827205|FG005|Overall Study|Lost to Follow-up|0|||
161938866|NCT00500331|584827206|FG006|Overall Study|Lost to Follow-up|0|||
161938867|NCT00500331|584827200|FG000|Overall Study|Protocol Violation|3|||
161938868|NCT00500331|584827201|FG001|Overall Study|Protocol Violation|1|||
161938869|NCT00500331|584827202|FG002|Overall Study|Protocol Violation|1|||
162220068|NCT05620108|585857675|FG000|Overall Study|Physician Decision|1|||
162220069|NCT05620108|585857676|FG001|Overall Study|Physician Decision|2|||
162220070|NCT05602727|585857677|FG000|Overall Study|Physician Decision|0|||
162220071|NCT05602727|585857678|FG001|Overall Study|Physician Decision|1|||
162220072|NCT05602727|585857679|FG002|Overall Study|Physician Decision|0|||
162220073|NCT05602727|585857677|FG000|Overall Study|Randomized by mistake without study medication|1|||
162220074|NCT05602727|585857678|FG001|Overall Study|Randomized by mistake without study medication|0|||
162220075|NCT05602727|585857679|FG002|Overall Study|Randomized by mistake without study medication|0|||
162220076|NCT05602727|585857677|FG000|Overall Study|Study termination by Sponsor|18|||
161938870|NCT00500331|584827203|FG003|Overall Study|Protocol Violation|0|||
161938871|NCT00500331|584827204|FG004|Overall Study|Protocol Violation|1|||
161938872|NCT00500331|584827205|FG005|Overall Study|Protocol Violation|1|||
161938873|NCT00500331|584827206|FG006|Overall Study|Protocol Violation|1|||
161938874|NCT00500331|584827200|FG000|Overall Study|Withdrawal by Subject|4|||
161938875|NCT00500331|584827201|FG001|Overall Study|Withdrawal by Subject|0|||
162023088|NCT03818035|585140996|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
162220077|NCT05602727|585857678|FG001|Overall Study|Study termination by Sponsor|15|||
162220078|NCT05602727|585857679|FG002|Overall Study|Study termination by Sponsor|19|||
162220079|NCT05602727|585857677|FG000|Overall Study|Withdrawal by Subject|2|||
162220080|NCT05602727|585857678|FG001|Overall Study|Withdrawal by Subject|1|||
161938876|NCT00500331|584827202|FG002|Overall Study|Withdrawal by Subject|1|||
161678625|NCT00766090|583876051|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678626|NCT00766090|583876052|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678627|NCT00766090|583876053|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161828970|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161828971|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161828972|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
162220081|NCT05602727|585857679|FG002|Overall Study|Withdrawal by Subject|1|||
162220082|NCT05602727|585857677|FG000|Overall Study|Various reasons|1|||
161828973|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161828974|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161938877|NCT00500331|584827203|FG003|Overall Study|Withdrawal by Subject|5|||
161938878|NCT00500331|584827204|FG004|Overall Study|Withdrawal by Subject|0|||
161938879|NCT00500331|584827205|FG005|Overall Study|Withdrawal by Subject|1|||
161938880|NCT00500331|584827206|FG006|Overall Study|Withdrawal by Subject|1|||
162220083|NCT05602727|585857678|FG001|Overall Study|Various reasons|6|||
162220084|NCT05602727|585857679|FG002|Overall Study|Various reasons|1|||
162220085|NCT03412773|585857683|FG000|Overall Study|Lost to Follow-up|0|||
162220086|NCT03412773|585857684|FG001|Overall Study|Lost to Follow-up|7|||
162220087|NCT03412773|585857685|FG002|Overall Study|Lost to Follow-up|6|||
162220088|NCT03412773|585857683|FG000|Overall Study|Withdrawal by Subject|0|||
162220089|NCT03412773|585857684|FG001|Overall Study|Withdrawal by Subject|15|||
162220090|NCT03412773|585857685|FG002|Overall Study|Withdrawal by Subject|19|||
162220091|NCT03412773|585857683|FG000|Overall Study|Study Closed By Sponsor|3|||
162220092|NCT03412773|585857684|FG001|Overall Study|Study Closed By Sponsor|46|||
161938881|NCT00500331|584827200|FG000|Overall Study|Lack of Efficacy|3|||
161938882|NCT00500331|584827201|FG001|Overall Study|Lack of Efficacy|1|||
161938883|NCT00500331|584827202|FG002|Overall Study|Lack of Efficacy|0|||
162220093|NCT03412773|585857685|FG002|Overall Study|Study Closed By Sponsor|33|||
162220094|NCT03412773|585857683|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
162220095|NCT03412773|585857684|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
162220096|NCT03412773|585857685|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
162220097|NCT03412773|585857683|FG000|Overall Study|Death|7|||
162220098|NCT03412773|585857684|FG001|Overall Study|Death|259|||
162220099|NCT03412773|585857685|FG002|Overall Study|Death|273|||
162220100|NCT03412773|585857683|FG000|Overall Study|Physician Decision|0|||
162220101|NCT03412773|585857684|FG001|Overall Study|Physician Decision|0|||
162220102|NCT03412773|585857685|FG002|Overall Study|Physician Decision|1|||
162220103|NCT02643303|585857692|FG000|Overall Study|Progressive Disease|4|||
162220104|NCT02643303|585857693|FG001|Overall Study|Progressive Disease|4|||
162220105|NCT02643303|585857694|FG002|Overall Study|Progressive Disease|1|||
162220106|NCT02643303|585857695|FG003|Overall Study|Progressive Disease|12|||
162220107|NCT02643303|585857696|FG004|Overall Study|Progressive Disease|6|||
162220108|NCT02643303|585857697|FG005|Overall Study|Progressive Disease|4|||
162220109|NCT02643303|585857698|FG006|Overall Study|Progressive Disease|8|||
162220110|NCT02643303|585857699|FG007|Overall Study|Progressive Disease|2|||
162220111|NCT02643303|585857700|FG008|Overall Study|Progressive Disease|6|||
162220112|NCT02643303|585857692|FG000|Overall Study|Adverse Event|0|||
162220113|NCT02643303|585857693|FG001|Overall Study|Adverse Event|1|||
161828975|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161938884|NCT00500331|584827203|FG003|Overall Study|Lack of Efficacy|0|||
161938885|NCT00500331|584827204|FG004|Overall Study|Lack of Efficacy|0|||
161938886|NCT00500331|584827205|FG005|Overall Study|Lack of Efficacy|0|||
161938887|NCT00500331|584827206|FG006|Overall Study|Lack of Efficacy|0|||
161938888|NCT00500331|584827200|FG000|Overall Study|Liver function test abnormality|0|||
161938889|NCT00500331|584827201|FG001|Overall Study|Liver function test abnormality|0|||
161938890|NCT00500331|584827202|FG002|Overall Study|Liver function test abnormality|1|||
162220114|NCT02643303|585857694|FG002|Overall Study|Adverse Event|0|||
162220115|NCT02643303|585857695|FG003|Overall Study|Adverse Event|0|||
162220116|NCT02643303|585857696|FG004|Overall Study|Adverse Event|1|||
162220117|NCT02643303|585857697|FG005|Overall Study|Adverse Event|0|||
162220118|NCT02643303|585857698|FG006|Overall Study|Adverse Event|0|||
162220119|NCT02643303|585857699|FG007|Overall Study|Adverse Event|0|||
162220120|NCT02643303|585857700|FG008|Overall Study|Adverse Event|0|||
162220121|NCT02643303|585857692|FG000|Overall Study|Withdrawal by Subject|0|||
162220122|NCT02643303|585857693|FG001|Overall Study|Withdrawal by Subject|0|||
161938891|NCT00500331|584827203|FG003|Overall Study|Liver function test abnormality|0|||
161938892|NCT00500331|584827204|FG004|Overall Study|Liver function test abnormality|0|||
162220123|NCT02643303|585857694|FG002|Overall Study|Withdrawal by Subject|0|||
162220124|NCT02643303|585857695|FG003|Overall Study|Withdrawal by Subject|1|||
162220125|NCT02643303|585857696|FG004|Overall Study|Withdrawal by Subject|0|||
162220126|NCT02643303|585857697|FG005|Overall Study|Withdrawal by Subject|0|||
162220127|NCT02643303|585857698|FG006|Overall Study|Withdrawal by Subject|1|||
162220128|NCT02643303|585857699|FG007|Overall Study|Withdrawal by Subject|1|||
162220129|NCT02643303|585857700|FG008|Overall Study|Withdrawal by Subject|1|||
161938893|NCT00500331|584827205|FG005|Overall Study|Liver function test abnormality|0|||
161938894|NCT00500331|584827206|FG006|Overall Study|Liver function test abnormality|0|||
161938895|NCT00500331|584827200|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
161938896|NCT00500331|584827201|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
161938897|NCT00500331|584827202|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
161938898|NCT00500331|584827203|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
161938899|NCT00500331|584827204|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
162023089|NCT03818035|585140997|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
162023090|NCT03818035|585140998|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
162023091|NCT03818035|585140999|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
162023092|NCT03818035|585140996|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
162023093|NCT03818035|585140997|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
162023094|NCT03818035|585140998|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
162023095|NCT03818035|585140999|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
162023096|NCT03818035|585140996|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
162023097|NCT03818035|585140997|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
162220130|NCT00626197|585857703|FG000|Overall Study|Did not cooperate|2|||
162220131|NCT00626197|585857704|FG001|Overall Study|Did not cooperate|6|||
162220132|NCT00626197|585857705|FG002|Overall Study|Did not cooperate|1|||
162220133|NCT00626197|585857703|FG000|Overall Study|Failure to return|6|||
162220134|NCT00626197|585857704|FG001|Overall Study|Failure to return|5|||
162220135|NCT00626197|585857705|FG002|Overall Study|Failure to return|6|||
162220136|NCT00626197|585857703|FG000|Overall Study|Adverse event, serious fatal|3|||
162220137|NCT00626197|585857704|FG001|Overall Study|Adverse event, serious fatal|6|||
162220138|NCT00626197|585857705|FG002|Overall Study|Adverse event, serious fatal|6|||
162220139|NCT00626197|585857703|FG000|Overall Study|Adverse Event|1|||
162220140|NCT00626197|585857704|FG001|Overall Study|Adverse Event|1|||
162220141|NCT00626197|585857705|FG002|Overall Study|Adverse Event|2|||
161938900|NCT00500331|584827205|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
161938901|NCT00500331|584827206|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
161938902|NCT00500331|584827200|FG000|Overall Study|Didn't return for continuation of study|1|||
161938903|NCT00500331|584827201|FG001|Overall Study|Didn't return for continuation of study|0|||
161938904|NCT00500331|584827202|FG002|Overall Study|Didn't return for continuation of study|0|||
161938905|NCT00500331|584827203|FG003|Overall Study|Didn't return for continuation of study|0|||
161938906|NCT00500331|584827204|FG004|Overall Study|Didn't return for continuation of study|0|||
162023098|NCT03818035|585140998|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
162220142|NCT00626197|585857703|FG000|Overall Study|Withdrawal by Subject|17|||
162220143|NCT00626197|585857704|FG001|Overall Study|Withdrawal by Subject|17|||
162220144|NCT00626197|585857705|FG002|Overall Study|Withdrawal by Subject|7|||
162220145|NCT00626197|585857703|FG000|Overall Study|Administrative reasons|15|||
162220146|NCT00626197|585857704|FG001|Overall Study|Administrative reasons|19|||
162220147|NCT00626197|585857705|FG002|Overall Study|Administrative reasons|55|||
162220148|NCT05332912|585857710|FG000|Overall Study|Withdrawal by Subject|0|||
162220149|NCT05332912|585857711|FG001|Overall Study|Withdrawal by Subject|1|||
162220150|NCT05332912|585857712|FG002|Overall Study|Withdrawal by Subject|2|||
162220151|NCT05332912|585857713|FG003|Overall Study|Withdrawal by Subject|0|||
162220152|NCT05332912|585857710|FG000|Overall Study|Lost to Follow-up|0|||
162220153|NCT05332912|585857711|FG001|Overall Study|Lost to Follow-up|0|||
162220154|NCT05332912|585857712|FG002|Overall Study|Lost to Follow-up|1|||
162220155|NCT05332912|585857713|FG003|Overall Study|Lost to Follow-up|0|||
162220156|NCT05282121|585857714|FG000|Overall Study|Adverse Event|1|||
162220157|NCT05282121|585857715|FG001|Overall Study|Adverse Event|1|||
162220158|NCT05282121|585857716|FG002|Overall Study|Adverse Event|4|||
162220159|NCT05282121|585857717|FG003|Overall Study|Adverse Event|1|||
162220160|NCT05282121|585857714|FG000|Overall Study|Study Terminated by Sponsor|1|||
162220161|NCT05282121|585857715|FG001|Overall Study|Study Terminated by Sponsor|2|||
161938907|NCT00500331|584827205|FG005|Overall Study|Didn't return for continuation of study|0|||
161938908|NCT00500331|584827206|FG006|Overall Study|Didn't return for continuation of study|0|||
161938909|NCT00500331|584827200|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
161938910|NCT00500331|584827201|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
161938911|NCT00500331|584827202|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
161938912|NCT00500331|584827203|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
161938913|NCT00500331|584827204|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
161938914|NCT00500331|584827205|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
161938915|NCT00500331|584827206|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
161938916|NCT00500331|584827200|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
161938917|NCT00500331|584827201|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
161938918|NCT00500331|584827202|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
161938919|NCT00500331|584827203|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
161938920|NCT00500331|584827204|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
161938921|NCT00500331|584827205|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
161938922|NCT00500331|584827206|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
161938923|NCT00500331|584827200|FG000|Overall Study|Participant was randomized by mistake|1|||
161938924|NCT00500331|584827201|FG001|Overall Study|Participant was randomized by mistake|0|||
161938925|NCT00500331|584827202|FG002|Overall Study|Participant was randomized by mistake|0|||
161938926|NCT00500331|584827203|FG003|Overall Study|Participant was randomized by mistake|0|||
161938927|NCT00500331|584827204|FG004|Overall Study|Participant was randomized by mistake|0|||
161938928|NCT00500331|584827205|FG005|Overall Study|Participant was randomized by mistake|0|||
161938929|NCT00500331|584827206|FG006|Overall Study|Participant was randomized by mistake|0|||
161938930|NCT00500331|584827200|FG000|Overall Study|Diabetologist nurse in the study|0|||
161938931|NCT00500331|584827201|FG001|Overall Study|Diabetologist nurse in the study|0|||
161938932|NCT00500331|584827202|FG002|Overall Study|Diabetologist nurse in the study|1|||
161938933|NCT00500331|584827203|FG003|Overall Study|Diabetologist nurse in the study|0|||
161938934|NCT00500331|584827204|FG004|Overall Study|Diabetologist nurse in the study|0|||
161938935|NCT00500331|584827205|FG005|Overall Study|Diabetologist nurse in the study|0|||
161938936|NCT00500331|584827206|FG006|Overall Study|Diabetologist nurse in the study|0|||
161938937|NCT00500331|584827200|FG000|Overall Study|State ban of biological samples export|0|||
161938938|NCT00500331|584827201|FG001|Overall Study|State ban of biological samples export|0|||
161938939|NCT00500331|584827202|FG002|Overall Study|State ban of biological samples export|0|||
161938940|NCT00500331|584827203|FG003|Overall Study|State ban of biological samples export|1|||
161938941|NCT00500331|584827204|FG004|Overall Study|State ban of biological samples export|0|||
161938942|NCT00500331|584827205|FG005|Overall Study|State ban of biological samples export|0|||
161938943|NCT00500331|584827206|FG006|Overall Study|State ban of biological samples export|0|||
162023099|NCT03818035|585140999|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
161938944|NCT00500331|584827200|FG000|Overall Study|Protocol violated|0|||
161938945|NCT00500331|584827201|FG001|Overall Study|Protocol violated|0|||
161938946|NCT00500331|584827202|FG002|Overall Study|Protocol violated|0|||
161938947|NCT00500331|584827203|FG003|Overall Study|Protocol violated|1|||
161938948|NCT00500331|584827204|FG004|Overall Study|Protocol violated|0|||
161938949|NCT00500331|584827205|FG005|Overall Study|Protocol violated|0|||
161938950|NCT00500331|584827206|FG006|Overall Study|Protocol violated|0|||
162023100|NCT03818035|585140996|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
161938951|NCT03345550|584827207|FG000|Overall Study|Withdrawal by Subject|1|||
161938952|NCT03345550|584827208|FG001|Overall Study|Withdrawal by Subject|0|||
161938953|NCT03345550|584827207|FG000|Overall Study|Lost to Follow-up|4|||
161938954|NCT03345550|584827208|FG001|Overall Study|Lost to Follow-up|5|||
161938955|NCT01149460|584827210|FG000|Overall Study|Withdrawal by Subject|0|||
161938956|NCT01149460|584827211|FG001|Overall Study|Withdrawal by Subject|2|||
161938957|NCT03014089|584827212|FG000|Overall Study|Withdrawal by Subject|0|||
161938958|NCT03014089|584827213|FG001|Overall Study|Withdrawal by Subject|1|||
161938959|NCT03014089|584827214|FG002|Overall Study|Withdrawal by Subject|1|||
161938960|NCT03014089|584827215|FG003|Overall Study|Withdrawal by Subject|1|||
161938961|NCT03014089|584827212|FG000|Overall Study|Lost to Follow-up|1|||
161938962|NCT03014089|584827213|FG001|Overall Study|Lost to Follow-up|0|||
161938963|NCT03014089|584827214|FG002|Overall Study|Lost to Follow-up|0|||
161938964|NCT03014089|584827215|FG003|Overall Study|Lost to Follow-up|0|||
161938965|NCT03014089|584827212|FG000|Overall Study|Adverse Event|1|||
161678628|NCT00766090|583876054|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678629|NCT00766090|583876055|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678630|NCT00766090|583876056|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678631|NCT00766090|583876057|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161678632|NCT00766090|583876046|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678633|NCT00766090|583876047|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678634|NCT00766090|583876048|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
161678635|NCT00766090|583876049|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678636|NCT00766090|583876050|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678637|NCT00766090|583876051|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678638|NCT00766090|583876052|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678639|NCT00766090|583876053|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678640|NCT00766090|583876054|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678641|NCT00766090|583876055|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678642|NCT00766090|583876056|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678643|NCT00766090|583876057|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
161678644|NCT00766090|583876046|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678645|NCT00766090|583876047|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678646|NCT00766090|583876048|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678647|NCT00766090|583876049|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678648|NCT00766090|583876050|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
161938966|NCT03014089|584827213|FG001|Overall Study|Adverse Event|0|||
161938967|NCT03014089|584827214|FG002|Overall Study|Adverse Event|1|||
161938968|NCT03014089|584827215|FG003|Overall Study|Adverse Event|0|||
161938969|NCT00321932|584827216|FG000|Overall Study|Death|3|||
161938970|NCT00321932|584827217|FG001|Overall Study|Death|6|||
161938971|NCT00321932|584827216|FG000|Overall Study|Withdrawal by Subject|3|||
161938972|NCT00321932|584827217|FG001|Overall Study|Withdrawal by Subject|6|||
161938973|NCT00321932|584827216|FG000|Overall Study|Early relapse|2|||
161938974|NCT00321932|584827217|FG001|Overall Study|Early relapse|8|||
161938975|NCT00321932|584827216|FG000|Overall Study|Missing data|2|||
161938976|NCT00321932|584827217|FG001|Overall Study|Missing data|1|||
161938977|NCT00734032|584827218|FG000|Overall Study|Adverse Event|0|||
161938978|NCT00734032|584827219|FG001|Overall Study|Adverse Event|1|||
161938979|NCT00734032|584827220|FG002|Overall Study|Adverse Event|0|||
161938980|NCT00734032|584827221|FG003|Overall Study|Adverse Event|0|||
161938981|NCT03468998|584827224|FG000|Overall Study|Withdrawal by Subject|1|||
161938982|NCT03468998|584827225|FG001|Overall Study|Withdrawal by Subject|1|||
161938983|NCT03468998|584827226|FG002|Overall Study|Withdrawal by Subject|0|||
161938984|NCT03468998|584827227|FG003|Overall Study|Withdrawal by Subject|4|||
161938985|NCT03468998|584827228|FG004|Overall Study|Withdrawal by Subject|1|||
161938986|NCT03468998|584827229|FG005|Overall Study|Withdrawal by Subject|0|||
161938987|NCT00137449|584827230|FG000|Overall Study|Disease Progression|8|||
162220162|NCT05282121|585857716|FG002|Overall Study|Study Terminated by Sponsor|2|||
162220163|NCT05282121|585857717|FG003|Overall Study|Study Terminated by Sponsor|2|||
162220164|NCT05282121|585857714|FG000|Overall Study|Other than listed|0|||
162220165|NCT05282121|585857715|FG001|Overall Study|Other than listed|0|||
162220166|NCT05282121|585857716|FG002|Overall Study|Other than listed|1|||
161678649|NCT00766090|583876051|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161938988|NCT00137449|584827231|FG001|Overall Study|Disease Progression|13|||
161938989|NCT00137449|584827230|FG000|Overall Study|Death|4|||
161938990|NCT00137449|584827231|FG001|Overall Study|Death|3|||
161938991|NCT00137449|584827230|FG000|Overall Study|Adverse Event|3|||
161938992|NCT00137449|584827231|FG001|Overall Study|Adverse Event|1|||
161938993|NCT00137449|584827230|FG000|Overall Study|Withdrawal by Subject|1|||
161938994|NCT00137449|584827231|FG001|Overall Study|Withdrawal by Subject|1|||
161938995|NCT01356940|584827232|FG000|First Intervention (28 Days)|Adverse Event|1|||
161938996|NCT01356940|584827233|FG001|First Intervention (28 Days)|Adverse Event|0|||
161938997|NCT01356940|584827232|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
162220167|NCT05282121|585857717|FG003|Overall Study|Other than listed|0|||
162220168|NCT05282121|585857714|FG000|Overall Study|No reason available|0|||
161938998|NCT01356940|584827233|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
161938999|NCT03412591|584827234|FG000|Overall Study|Withdrawal by Subject|1|||
161939000|NCT03412591|584827235|FG001|Overall Study|Withdrawal by Subject|8|||
161939001|NCT03412591|584827234|FG000|Overall Study|Adverse Event|0|||
161939002|NCT03412591|584827235|FG001|Overall Study|Adverse Event|1|||
161939003|NCT02272985|584827236|FG000|Overall Study|Withdrawal by Subject|1|||
161939004|NCT02272985|584827236|FG000|Overall Study|hip fracture|1|||
161939005|NCT02272985|584827236|FG000|Overall Study|kidney transplantation|1|||
161939006|NCT02489279|584827243|FG000|Overall Study|Lost to Follow-up|12|||
161939007|NCT02489279|584827244|FG001|Overall Study|Lost to Follow-up|10|||
161939008|NCT02263547|584827245|FG000|Overall Study|Adverse Event|1|||
161939009|NCT02263547|584827245|FG000|Overall Study|Lost to Follow-up|2|||
161939010|NCT03440411|584827248|FG000|Overall Study|Adverse Event|0|||
161939011|NCT03440411|584827249|FG001|Overall Study|Adverse Event|0|||
162220169|NCT05282121|585857715|FG001|Overall Study|No reason available|0|||
162220170|NCT05282121|585857716|FG002|Overall Study|No reason available|1|||
162220171|NCT05282121|585857717|FG003|Overall Study|No reason available|0|||
162220172|NCT01174446|585857720|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
162220173|NCT01174446|585857721|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
162220174|NCT01174446|585857722|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
162220175|NCT01174446|585857723|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
162220176|NCT01174446|585857720|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
162220177|NCT01174446|585857721|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
162220178|NCT01174446|585857722|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
162220179|NCT01174446|585857723|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
162220180|NCT01174446|585857720|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
162220181|NCT01174446|585857721|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
161678650|NCT00766090|583876052|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161828976|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
161939012|NCT03440411|584827250|FG002|Overall Study|Adverse Event|1|||
161939013|NCT03440411|584827251|FG003|Overall Study|Adverse Event|0|||
161939014|NCT03440411|584827248|FG000|Overall Study|PD|2|||
161939015|NCT03440411|584827249|FG001|Overall Study|PD|1|||
161939016|NCT03440411|584827250|FG002|Overall Study|PD|1|||
161939017|NCT03440411|584827251|FG003|Overall Study|PD|1|||
161939018|NCT03440411|584827248|FG000|Overall Study|Withdrawal by Subject|1|||
161939019|NCT03440411|584827249|FG001|Overall Study|Withdrawal by Subject|0|||
161939020|NCT03440411|584827250|FG002|Overall Study|Withdrawal by Subject|0|||
161939021|NCT03440411|584827251|FG003|Overall Study|Withdrawal by Subject|0|||
161939022|NCT03440411|584827248|FG000|Overall Study|Closed study by sponsor|0|||
161939023|NCT03440411|584827249|FG001|Overall Study|Closed study by sponsor|0|||
161939024|NCT03440411|584827250|FG002|Overall Study|Closed study by sponsor|0|||
161939025|NCT03440411|584827251|FG003|Overall Study|Closed study by sponsor|1|||
161939026|NCT00505687|584827252|FG000|Overall Study|Important protocol violation|2|||
161939027|NCT00505687|584827252|FG000|Overall Study|Lack of Efficacy|15|||
161939028|NCT00505687|584827252|FG000|Overall Study|Adverse Event|48|||
161939029|NCT00505687|584827252|FG000|Overall Study|Subject withdrew consent|15|||
161939030|NCT00505687|584827252|FG000|Overall Study|Lost to Follow-up|1|||
161939031|NCT00505687|584827252|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
161939032|NCT00505687|584827252|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
161939033|NCT00505687|584827252|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
161939034|NCT00505687|584827252|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
161939035|NCT00505687|584827252|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
161939036|NCT00505687|584827252|FG000|Overall Study|Other: Disease Progression|1|||
161939037|NCT00505687|584827252|FG000|Overall Study|Other: As Per Sponsor|8|||
161939038|NCT03707821|584827253|FG000|Overall Study|Protocol Violation|0|||
161939039|NCT03707821|584827254|FG001|Overall Study|Protocol Violation|1|||
161828977|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828978|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828979|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828980|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828981|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828982|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828983|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828984|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161828985|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
161828986|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828987|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828988|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828989|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828990|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828991|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828992|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161828993|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
162023101|NCT03818035|585140997|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
162220182|NCT01174446|585857722|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
162220183|NCT01174446|585857723|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
162220184|NCT01174446|585857720|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
162220185|NCT01174446|585857721|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
162220186|NCT01174446|585857722|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
162220187|NCT01174446|585857723|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
162220188|NCT03301155|585857724|FG000|Overall Study|Сompliance with exclusion criteria|8|||
162220189|NCT03301155|585857725|FG001|Overall Study|Сompliance with exclusion criteria|7|||
162220190|NCT03510455|585857726|FG000|Overall Study|Physician Decision|1|||
162220191|NCT00384189|585857727|FG000|Overall Study|Reason Not Specified|50|||
162220192|NCT00384189|585857728|FG001|Overall Study|Reason Not Specified|57|||
162220193|NCT00384189|585857729|FG002|Overall Study|Reason Not Specified|58|||
162220194|NCT00384189|585857730|FG003|Overall Study|Reason Not Specified|40|||
162220195|NCT04958642|585857731|FG000|Overall Study|Transferred to OLEX program|3|||
162220196|NCT04958642|585857732|FG001|Overall Study|Transferred to OLEX program|0|||
162220197|NCT04958642|585857733|FG002|Overall Study|Transferred to OLEX program|5|||
161828994|NCT00739973|584413667|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
161828995|NCT00739973|584413668|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161828996|NCT00739973|584413669|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161828997|NCT00739973|584413670|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161828998|NCT00739973|584413671|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161828999|NCT00739973|584413672|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161829000|NCT00739973|584413673|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161829001|NCT00739973|584413674|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161829002|NCT00739973|584413675|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161829003|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
161829004|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
161829005|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
161829006|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
161829007|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
161829008|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
161829009|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
161829010|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
161829011|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
161829012|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829013|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829014|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829015|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829016|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
161829017|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829018|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829019|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
161829020|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161829021|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
161829022|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
162220198|NCT04958642|585857731|FG000|Overall Study|Death|0|||
162220199|NCT04958642|585857732|FG001|Overall Study|Death|0|||
162220200|NCT04958642|585857733|FG002|Overall Study|Death|1|||
162220201|NCT04958642|585857731|FG000|Overall Study|Withdrawal by Subject|4|||
162220202|NCT04958642|585857732|FG001|Overall Study|Withdrawal by Subject|9|||
162220203|NCT04958642|585857733|FG002|Overall Study|Withdrawal by Subject|13|||
162220204|NCT04958642|585857731|FG000|Overall Study|Investigator's Decision|0|||
162220205|NCT04958642|585857732|FG001|Overall Study|Investigator's Decision|0|||
162220206|NCT04958642|585857733|FG002|Overall Study|Investigator's Decision|1|||
161829023|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829024|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829025|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829026|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829027|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829028|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829029|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161829030|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
161829031|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
161829032|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
161829033|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
161829034|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
161829035|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
161829036|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
161829037|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
161829038|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
161829039|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829040|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829041|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
161829042|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829043|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829044|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829045|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829046|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829047|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161829048|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161829049|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
161829050|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161829051|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
161829052|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161829053|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161829054|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
161829055|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
161829056|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161829057|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
161829058|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
161829059|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
161829060|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
161829061|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
161829062|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
161829063|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
161829064|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
161829065|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
161829066|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829067|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829068|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829069|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829070|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829071|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829072|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
162220207|NCT04958642|585857731|FG000|Overall Study|Adverse Event|1|||
162220208|NCT04958642|585857732|FG001|Overall Study|Adverse Event|0|||
162220209|NCT04958642|585857733|FG002|Overall Study|Adverse Event|1|||
162220210|NCT04958642|585857731|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
162220211|NCT04958642|585857732|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
162220212|NCT04958642|585857733|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
162220213|NCT04958642|585857731|FG000|Overall Study|Lost to Follow-up|1|||
162220214|NCT04958642|585857732|FG001|Overall Study|Lost to Follow-up|0|||
162220215|NCT04958642|585857733|FG002|Overall Study|Lost to Follow-up|0|||
162220216|NCT04958642|585857731|FG000|Overall Study|Transferred to EAP following study termination|0|||
162220217|NCT04958642|585857732|FG001|Overall Study|Transferred to EAP following study termination|0|||
162220218|NCT04958642|585857733|FG002|Overall Study|Transferred to EAP following study termination|1|||
162220219|NCT04958642|585857731|FG000|Overall Study|Transferred to Expanded Access Program|1|||
162220220|NCT04958642|585857732|FG001|Overall Study|Transferred to Expanded Access Program|0|||
162220221|NCT04958642|585857733|FG002|Overall Study|Transferred to Expanded Access Program|0|||
162220222|NCT02942004|585857734|FG000|Overall Study|Withdrawal by Subject|0|||
162220223|NCT02942004|585857735|FG001|Overall Study|Withdrawal by Subject|2|||
162220224|NCT02942004|585857736|FG002|Overall Study|Withdrawal by Subject|3|||
162220225|NCT02942004|585857734|FG000|Overall Study|Lost to Follow-up|1|||
162220226|NCT02942004|585857735|FG001|Overall Study|Lost to Follow-up|1|||
162220227|NCT02942004|585857736|FG002|Overall Study|Lost to Follow-up|2|||
162220228|NCT02942004|585857734|FG000|Overall Study|Randomized but not dosed|3|||
162220229|NCT02942004|585857735|FG001|Overall Study|Randomized but not dosed|9|||
162220230|NCT02942004|585857736|FG002|Overall Study|Randomized but not dosed|4|||
162220231|NCT05627258|585857737|FG000|Overall Study|Lost to Follow-up|1|||
162220232|NCT05627258|585857738|FG001|Overall Study|Lost to Follow-up|0|||
162220233|NCT05627258|585857739|FG002|Overall Study|Lost to Follow-up|0|||
162220234|NCT05627258|585857740|FG003|Overall Study|Lost to Follow-up|0|||
162220235|NCT05627258|585857741|FG004|Overall Study|Lost to Follow-up|0|||
161939040|NCT03707821|584827253|FG000|Overall Study|Unsatisfactory Visual Response|1|||
161939041|NCT03707821|584827254|FG001|Overall Study|Unsatisfactory Visual Response|0|||
161939042|NCT03707821|584827253|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
161939043|NCT03707821|584827254|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
161939044|NCT01432444|584827255|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
161939045|NCT01432444|584827256|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
161939046|NCT01432444|584827257|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
161939047|NCT01432444|584827255|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
161939048|NCT01432444|584827256|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
161939049|NCT01432444|584827257|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
161939050|NCT01432444|584827255|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
161939051|NCT01432444|584827256|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
161939052|NCT01432444|584827257|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
161939053|NCT01432444|584827255|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
161939054|NCT01432444|584827256|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
161939055|NCT01432444|584827257|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
161939056|NCT01432444|584827255|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
161939057|NCT01432444|584827256|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
161939058|NCT01432444|584827257|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
161939059|NCT01432444|584827255|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
161939060|NCT01432444|584827256|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
161939061|NCT01432444|584827257|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
161939062|NCT01432444|584827255|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
161939063|NCT01432444|584827256|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
161939064|NCT01432444|584827257|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
161939065|NCT01432444|584827255|FG000|Treatment Phase|Lost to Follow-up|0|||
161939066|NCT01432444|584827256|FG001|Treatment Phase|Lost to Follow-up|33|||
161939067|NCT01432444|584827257|FG002|Treatment Phase|Lost to Follow-up|0|||
161939068|NCT01432444|584827255|FG000|Treatment Phase|Adverse Event|0|||
161939069|NCT01432444|584827256|FG001|Treatment Phase|Adverse Event|37|||
161939070|NCT01432444|584827257|FG002|Treatment Phase|Adverse Event|0|||
161939071|NCT01432444|584827255|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
161939072|NCT01432444|584827256|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
161939073|NCT01432444|584827257|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
161939074|NCT01432444|584827255|FG000|Treatment Phase|Physician Decision|0|||
161939075|NCT01432444|584827256|FG001|Treatment Phase|Physician Decision|5|||
161939076|NCT01432444|584827257|FG002|Treatment Phase|Physician Decision|0|||
161939077|NCT01432444|584827255|FG000|Treatment Phase|Withdrawal by Subject|0|||
161939078|NCT01432444|584827256|FG001|Treatment Phase|Withdrawal by Subject|41|||
162220236|NCT05627258|585857742|FG005|Overall Study|Lost to Follow-up|0|||
162220237|NCT05627258|585857737|FG000|Overall Study|Withdrawal by Subject|0|||
162220238|NCT05627258|585857738|FG001|Overall Study|Withdrawal by Subject|0|||
162220239|NCT05627258|585857739|FG002|Overall Study|Withdrawal by Subject|0|||
162220240|NCT05627258|585857740|FG003|Overall Study|Withdrawal by Subject|0|||
162220241|NCT05627258|585857741|FG004|Overall Study|Withdrawal by Subject|2|||
162220242|NCT05627258|585857742|FG005|Overall Study|Withdrawal by Subject|0|||
162220243|NCT05627258|585857737|FG000|Overall Study|Enrolled, but product not administered|1|||
162220244|NCT05627258|585857738|FG001|Overall Study|Enrolled, but product not administered|0|||
162220245|NCT05627258|585857739|FG002|Overall Study|Enrolled, but product not administered|0|||
162220246|NCT05627258|585857740|FG003|Overall Study|Enrolled, but product not administered|0|||
162220247|NCT05627258|585857741|FG004|Overall Study|Enrolled, but product not administered|0|||
162220248|NCT05627258|585857742|FG005|Overall Study|Enrolled, but product not administered|0|||
162220249|NCT05627258|585857737|FG000|Overall Study|Other subject illness/injury|1|||
162220250|NCT05627258|585857738|FG001|Overall Study|Other subject illness/injury|0|||
162220251|NCT05627258|585857739|FG002|Overall Study|Other subject illness/injury|0|||
162220252|NCT05627258|585857740|FG003|Overall Study|Other subject illness/injury|0|||
162220253|NCT05627258|585857741|FG004|Overall Study|Other subject illness/injury|0|||
162220254|NCT05627258|585857742|FG005|Overall Study|Other subject illness/injury|0|||
162220255|NCT05627258|585857737|FG000|Overall Study|Subject moved from area|0|||
162220256|NCT05627258|585857738|FG001|Overall Study|Subject moved from area|0|||
162220257|NCT05627258|585857739|FG002|Overall Study|Subject moved from area|1|||
162220258|NCT05627258|585857740|FG003|Overall Study|Subject moved from area|0|||
162220259|NCT05627258|585857741|FG004|Overall Study|Subject moved from area|0|||
162220260|NCT05627258|585857742|FG005|Overall Study|Subject moved from area|0|||
162220261|NCT04517669|585857743|FG000|Overall Study|Lost to Follow-up|2|||
162220262|NCT04517669|585857743|FG000|Overall Study|Withdrawal by Subject|3|||
162220263|NCT04517669|585857743|FG000|Overall Study|Drug withdrawn|44|||
162220264|NCT04517669|585857743|FG000|Overall Study|Other|1|||
162220265|NCT04517669|585857743|FG000|Overall Study|Eligibility criteria not met|4|||
162220266|NCT04517669|585857743|FG000|Overall Study|Did not receive treatment|3|||
161939079|NCT01432444|584827257|FG002|Treatment Phase|Withdrawal by Subject|0|||
161939080|NCT01432444|584827255|FG000|Treatment Phase|Protocol Deviation|0|||
161939081|NCT01432444|584827256|FG001|Treatment Phase|Protocol Deviation|3|||
161939082|NCT01432444|584827257|FG002|Treatment Phase|Protocol Deviation|0|||
161939083|NCT01432444|584827255|FG000|Treatment Phase|Lack of Efficacy|0|||
161939084|NCT01432444|584827256|FG001|Treatment Phase|Lack of Efficacy|10|||
161939085|NCT01432444|584827257|FG002|Treatment Phase|Lack of Efficacy|0|||
161939086|NCT01432444|584827255|FG000|Extension Phase|Lost to Follow-up|0|||
161939087|NCT01432444|584827256|FG001|Extension Phase|Lost to Follow-up|0|||
161939088|NCT01432444|584827257|FG002|Extension Phase|Lost to Follow-up|17|||
161939089|NCT01432444|584827255|FG000|Extension Phase|Adverse Event|0|||
161939090|NCT01432444|584827256|FG001|Extension Phase|Adverse Event|0|||
161939091|NCT01432444|584827257|FG002|Extension Phase|Adverse Event|10|||
161939092|NCT01432444|584827255|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
161939093|NCT01432444|584827256|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
161939094|NCT01432444|584827257|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
161939095|NCT01432444|584827255|FG000|Extension Phase|Met Withdrawal Criteria|0|||
161939096|NCT01432444|584827256|FG001|Extension Phase|Met Withdrawal Criteria|0|||
161939097|NCT01432444|584827257|FG002|Extension Phase|Met Withdrawal Criteria|144|||
161939098|NCT01432444|584827255|FG000|Extension Phase|Physician Decision|0|||
161939099|NCT01432444|584827256|FG001|Extension Phase|Physician Decision|0|||
162023102|NCT03818035|585140998|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
162220267|NCT01923662|585857744|FG000|Overall Study|Withdrawal by Subject|1|||
161939100|NCT01432444|584827257|FG002|Extension Phase|Physician Decision|1|||
161939101|NCT01432444|584827255|FG000|Extension Phase|Withdrawal by Subject|0|||
161939102|NCT01432444|584827256|FG001|Extension Phase|Withdrawal by Subject|0|||
161939103|NCT01432444|584827257|FG002|Extension Phase|Withdrawal by Subject|13|||
161939104|NCT02301897|584827258|FG000|Treatment Course 1|Non-Compliance|0|||
162220268|NCT01199068|585857745|FG000|Overall Study|Unacceptable toxicity|0|||
162220269|NCT01199068|585857746|FG001|Overall Study|Unacceptable toxicity|0|||
161939105|NCT02301897|584827259|FG001|Treatment Course 1|Non-Compliance|0|||
162220270|NCT01199068|585857747|FG002|Overall Study|Unacceptable toxicity|2|||
162220271|NCT01199068|585857745|FG000|Overall Study|Progressive disease|3|||
162220272|NCT01199068|585857746|FG001|Overall Study|Progressive disease|3|||
162220273|NCT01199068|585857747|FG002|Overall Study|Progressive disease|6|||
162220274|NCT01199068|585857745|FG000|Overall Study|Withdrawal by Subject|0|||
162220275|NCT01199068|585857746|FG001|Overall Study|Withdrawal by Subject|0|||
161939106|NCT02301897|584827260|FG002|Treatment Course 1|Non-Compliance|1|||
162220276|NCT01199068|585857747|FG002|Overall Study|Withdrawal by Subject|1|||
161939107|NCT02301897|584827258|FG000|Treatment Course 1|Adverse Event|1|||
161939108|NCT02301897|584827259|FG001|Treatment Course 1|Adverse Event|1|||
161939109|NCT02301897|584827260|FG002|Treatment Course 1|Adverse Event|0|||
161939110|NCT02301897|584827258|FG000|Treatment Course 1|Lost to Follow-up|1|||
161939111|NCT02301897|584827259|FG001|Treatment Course 1|Lost to Follow-up|2|||
162220277|NCT01250925|585857748|FG000|Overall Study|Lost to Follow-up|1|||
162220278|NCT01250925|585857749|FG001|Overall Study|Lost to Follow-up|1|||
162220279|NCT01250925|585857750|FG002|Overall Study|Lost to Follow-up|0|||
162220280|NCT01250925|585857748|FG000|Overall Study|Withdrawal by Subject|2|||
162220281|NCT01250925|585857749|FG001|Overall Study|Withdrawal by Subject|0|||
162220282|NCT01250925|585857750|FG002|Overall Study|Withdrawal by Subject|0|||
162220283|NCT01250925|585857748|FG000|Overall Study|Protocol Violation|2|||
162220284|NCT01250925|585857749|FG001|Overall Study|Protocol Violation|0|||
162220285|NCT01250925|585857750|FG002|Overall Study|Protocol Violation|0|||
162220286|NCT01250925|585857748|FG000|Overall Study|Physician Decision|0|||
162220287|NCT01250925|585857749|FG001|Overall Study|Physician Decision|2|||
162220288|NCT01250925|585857750|FG002|Overall Study|Physician Decision|1|||
162220289|NCT01250925|585857748|FG000|Overall Study|Adverse Event|0|||
162220290|NCT01250925|585857749|FG001|Overall Study|Adverse Event|0|||
162220291|NCT01250925|585857750|FG002|Overall Study|Adverse Event|1|||
162220292|NCT00678301|585857754|FG000|Overall Study|Non-compliance with study procedures|0|||
162220293|NCT00678301|585857755|FG001|Overall Study|Non-compliance with study procedures|1|||
162220294|NCT00678301|585857754|FG000|Overall Study|Adverse Event|1|||
162220295|NCT00678301|585857755|FG001|Overall Study|Adverse Event|0|||
162220296|NCT00678301|585857754|FG000|Overall Study|Withdrawal by Subject|4|||
161939112|NCT02301897|584827260|FG002|Treatment Course 1|Lost to Follow-up|1|||
161939113|NCT02301897|584827258|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
161939114|NCT02301897|584827259|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
161939115|NCT02301897|584827260|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
161939116|NCT02301897|584827258|FG000|Treatment Course 1|Withdrawal by Subject|0|||
161939117|NCT02301897|584827259|FG001|Treatment Course 1|Withdrawal by Subject|0|||
161939118|NCT02301897|584827260|FG002|Treatment Course 1|Withdrawal by Subject|2|||
161939119|NCT02301897|584827258|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
161939120|NCT02301897|584827259|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
162220297|NCT00678301|585857755|FG001|Overall Study|Withdrawal by Subject|0|||
161939121|NCT02301897|584827260|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
161939122|NCT02301897|584827258|FG000|Treatment Course 2|Lost to Follow-up|0|||
161939123|NCT02301897|584827259|FG001|Treatment Course 2|Lost to Follow-up|2|||
161939124|NCT02301897|584827260|FG002|Treatment Course 2|Lost to Follow-up|0|||
161939125|NCT02301897|584827258|FG000|Treatment Course 2|Pregnancy|0|||
161939126|NCT02301897|584827259|FG001|Treatment Course 2|Pregnancy|1|||
161939127|NCT02301897|584827260|FG002|Treatment Course 2|Pregnancy|1|||
161939128|NCT02301897|584827258|FG000|Treatment Course 2|Withdrawal by Subject|0|||
161939129|NCT02301897|584827259|FG001|Treatment Course 2|Withdrawal by Subject|2|||
161939130|NCT02301897|584827260|FG002|Treatment Course 2|Withdrawal by Subject|0|||
161939131|NCT02301897|584827258|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
161939132|NCT02301897|584827259|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
161939133|NCT02301897|584827260|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
161939134|NCT03673176|584827261|FG000|Overall Study|Death prior to intervention|1|||
161939135|NCT03673176|584827261|FG000|Overall Study|Death following intervention|3|||
161939136|NCT03673176|584827261|FG000|Overall Study|Withdrawal by Subject|1|||
161939137|NCT00337168|584827262|FG000|Overall Study|Death|5|||
161939138|NCT00337168|584827262|FG000|Overall Study|Not protocol specified|2|||
161939139|NCT00337168|584827262|FG000|Overall Study|Did not start therapy|1|||
161939140|NCT02332928|584827265|FG000|Overall Study|Withdrawal by Subject|0|||
161939141|NCT02332928|584827266|FG001|Overall Study|Withdrawal by Subject|2|||
162023103|NCT03818035|585140999|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
162023104|NCT03818035|585140996|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
162023105|NCT03818035|585140997|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
162023106|NCT03818035|585140998|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
162023107|NCT03818035|585140999|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
161939142|NCT02332928|584827265|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
162220298|NCT00678301|585857754|FG000|Overall Study|Lost to Follow-up|3|||
162220299|NCT00678301|585857755|FG001|Overall Study|Lost to Follow-up|1|||
162220300|NCT02476175|585857758|FG000|Overall Study|Adverse Event|2|||
162220301|NCT01016262|585857764|FG000|Double-blind Phase|Adverse Event|0|||
162220302|NCT01016262|585857765|FG001|Double-blind Phase|Adverse Event|0|||
161939143|NCT02332928|584827266|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
161939144|NCT02378480|584827267|FG000|Overall Study|Physician Decision|1|||
161939145|NCT02378480|584827268|FG001|Overall Study|Physician Decision|1|||
161939146|NCT02378480|584827267|FG000|Overall Study|Death|1|||
162220303|NCT01016262|585857766|FG002|Double-blind Phase|Adverse Event|1|||
162220304|NCT01016262|585857767|FG003|Double-blind Phase|Adverse Event|0|||
162220305|NCT01016262|585857768|FG004|Double-blind Phase|Adverse Event|0|||
162220306|NCT01016262|585857769|FG005|Double-blind Phase|Adverse Event|0|||
162220307|NCT01016262|585857764|FG000|Double-blind Phase|Lack of Efficacy|1|||
162220308|NCT01016262|585857765|FG001|Double-blind Phase|Lack of Efficacy|0|||
162220309|NCT01016262|585857766|FG002|Double-blind Phase|Lack of Efficacy|5|||
162220310|NCT01016262|585857767|FG003|Double-blind Phase|Lack of Efficacy|0|||
162220311|NCT01016262|585857768|FG004|Double-blind Phase|Lack of Efficacy|0|||
162220312|NCT01016262|585857769|FG005|Double-blind Phase|Lack of Efficacy|0|||
162220313|NCT01016262|585857764|FG000|Double-blind Phase|Disease Progression|0|||
162220314|NCT01016262|585857765|FG001|Double-blind Phase|Disease Progression|1|||
162220315|NCT01016262|585857766|FG002|Double-blind Phase|Disease Progression|2|||
162220316|NCT01016262|585857767|FG003|Double-blind Phase|Disease Progression|0|||
162220317|NCT01016262|585857768|FG004|Double-blind Phase|Disease Progression|0|||
162220318|NCT01016262|585857769|FG005|Double-blind Phase|Disease Progression|0|||
162220319|NCT01016262|585857764|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
162220320|NCT01016262|585857765|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
162220321|NCT01016262|585857766|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
162220322|NCT01016262|585857767|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
162220323|NCT01016262|585857768|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
162220324|NCT01016262|585857769|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
162220325|NCT01016262|585857764|FG000|Open-Label Phase|Adverse Event|0|||
162220326|NCT01016262|585857765|FG001|Open-Label Phase|Adverse Event|0|||
162220327|NCT01016262|585857766|FG002|Open-Label Phase|Adverse Event|0|||
162220328|NCT01016262|585857767|FG003|Open-Label Phase|Adverse Event|1|||
162220329|NCT01016262|585857768|FG004|Open-Label Phase|Adverse Event|0|||
161831534|NCT03438539|584424812|FG003|Overall Study|Lost to Follow-up|9|||
161831535|NCT03438539|584424813|FG004|Overall Study|Lost to Follow-up|3|||
161831536|NCT03438539|584424814|FG005|Overall Study|Lost to Follow-up|8|||
161831537|NCT00655850|584424815|FG000|Overall Study|Death|2|||
161831538|NCT00655850|584424815|FG000|Overall Study|Withdrawal by Subject|1|||
161831539|NCT00918463|584424816|FG000|Overall Study|Death|1|||
161831540|NCT00918463|584424816|FG000|Overall Study|Lack of Efficacy|1|||
161831541|NCT01715896|584424817|FG000|Overall Study|Lost to Follow-up|0|||
161831542|NCT01715896|584424818|FG001|Overall Study|Lost to Follow-up|2|||
161831543|NCT01715896|584424817|FG000|Overall Study|Withdrawal by Subject|1|||
161831544|NCT01715896|584424818|FG001|Overall Study|Withdrawal by Subject|4|||
161831545|NCT01715896|584424817|FG000|Overall Study|Other|2|||
161831546|NCT01715896|584424818|FG001|Overall Study|Other|5|||
161831547|NCT01045993|584424820|FG000|Overall Study|Treated-later found eligibility not met|0|||
161831548|NCT01045993|584424821|FG001|Overall Study|Treated-later found eligibility not met|1|||
161831549|NCT01045993|584424822|FG002|Overall Study|Treated-later found eligibility not met|0|||
161831550|NCT01045993|584424823|FG003|Overall Study|Treated-later found eligibility not met|0|||
161831551|NCT01659736|584424824|FG000|Treatment Period|Adverse Event|1|||
161831552|NCT01659736|584424825|FG001|Treatment Period|Adverse Event|1|||
161831553|NCT01659736|584424824|FG000|Treatment Period|Protocol Violation|3|||
161831554|NCT01659736|584424825|FG001|Treatment Period|Protocol Violation|1|||
161831555|NCT01659736|584424824|FG000|Treatment Period|Withdrawal by Subject|1|||
161831556|NCT01659736|584424825|FG001|Treatment Period|Withdrawal by Subject|0|||
161831557|NCT01659736|584424824|FG000|3-month Follow-up|Lost to Follow-up|0|||
161831558|NCT01659736|584424825|FG001|3-month Follow-up|Lost to Follow-up|1|||
161831559|NCT00685802|584424832|FG000|Washout Period of 7 Days|Protocol Violation|2|||
161831560|NCT00685802|584424833|FG001|Washout Period of 7 Days|Protocol Violation|0|||
161831561|NCT00685802|584424832|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161831562|NCT00685802|584424833|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161831563|NCT03336242|584424834|FG000|Overall Study|Adverse Event|0|||
161831564|NCT03336242|584424835|FG001|Overall Study|Adverse Event|1|||
161831565|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
161831566|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
161831567|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
161831568|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
161831569|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
161831570|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
161831571|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
161831572|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
161831573|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
161831574|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
161831575|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
161831576|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
161831577|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
161831578|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
162220330|NCT01016262|585857769|FG005|Open-Label Phase|Adverse Event|0|||
162220331|NCT01016262|585857764|FG000|Open-Label Phase|Lost to Follow-up|0|||
162220332|NCT01016262|585857765|FG001|Open-Label Phase|Lost to Follow-up|0|||
162220333|NCT01016262|585857766|FG002|Open-Label Phase|Lost to Follow-up|0|||
162220334|NCT01016262|585857767|FG003|Open-Label Phase|Lost to Follow-up|0|||
162220335|NCT01016262|585857768|FG004|Open-Label Phase|Lost to Follow-up|1|||
162220336|NCT01016262|585857769|FG005|Open-Label Phase|Lost to Follow-up|0|||
162220337|NCT01016262|585857764|FG000|Open-Label Phase|Lack of Efficacy|0|||
161939147|NCT02378480|584827268|FG001|Overall Study|Death|2|||
161939148|NCT02378480|584827267|FG000|Overall Study|Randomized, but Not Treated|6|||
161939149|NCT02378480|584827268|FG001|Overall Study|Randomized, but Not Treated|4|||
161939150|NCT02378480|584827267|FG000|Overall Study|Adverse Event|0|||
161939151|NCT02378480|584827268|FG001|Overall Study|Adverse Event|1|||
161939152|NCT02378480|584827267|FG000|Overall Study|Missed EOT/PTE Visit|1|||
161939153|NCT02378480|584827268|FG001|Overall Study|Missed EOT/PTE Visit|2|||
161939154|NCT02378480|584827267|FG000|Overall Study|Withdrawal by Subject|9|||
161939155|NCT02378480|584827268|FG001|Overall Study|Withdrawal by Subject|4|||
161939156|NCT02378480|584827267|FG000|Overall Study|Lost to Follow-up|10|||
161939157|NCT02378480|584827268|FG001|Overall Study|Lost to Follow-up|18|||
161939158|NCT03802916|584827272|FG000|Overall Study|Adverse Event|0|||
161939159|NCT03802916|584827273|FG001|Overall Study|Adverse Event|1|||
161939160|NCT03802916|584827272|FG000|Overall Study|Withdrawal by Subject|0|||
161939161|NCT03802916|584827273|FG001|Overall Study|Withdrawal by Subject|1|||
161939162|NCT03663582|584827274|FG000|Overall Study|Physician Decision|1|||
161939163|NCT00480532|584827277|FG000|Overall Study|Withdrawal by Subject|2|||
161939164|NCT00480532|584827278|FG001|Overall Study|Withdrawal by Subject|4|||
161939165|NCT00480532|584827279|FG002|Overall Study|Withdrawal by Subject|3|||
161939166|NCT00480532|584827280|FG003|Overall Study|Withdrawal by Subject|1|||
161939167|NCT00480532|584827277|FG000|Overall Study|Protocol Violation|0|||
161939168|NCT00480532|584827278|FG001|Overall Study|Protocol Violation|0|||
161939169|NCT00480532|584827279|FG002|Overall Study|Protocol Violation|1|||
161939170|NCT00480532|584827280|FG003|Overall Study|Protocol Violation|0|||
161939171|NCT01285102|584827281|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
161939172|NCT00557440|584827282|FG000|Treatment Period 1|Adverse Event|0|||
161939173|NCT00557440|584827283|FG001|Treatment Period 1|Adverse Event|0|||
161939174|NCT00557440|584827284|FG002|Treatment Period 1|Adverse Event|1|||
161939175|NCT05763381|584827285|FG000|Overall Study|Lost to Follow-up|2|||
161939176|NCT05763381|584827286|FG001|Overall Study|Lost to Follow-up|3|||
161939177|NCT05763381|584827285|FG000|Overall Study|Withdrawal by Subject|1|||
161939178|NCT05763381|584827286|FG001|Overall Study|Withdrawal by Subject|2|||
161939179|NCT02697448|584827287|FG000|Overall Study|Protocol Violation|2|||
161939180|NCT02697448|584827288|FG001|Overall Study|Protocol Violation|4|||
161939181|NCT02697448|584827287|FG000|Overall Study|Clinical concerns during ablation|1|||
162023108|NCT03818035|585140996|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
162023109|NCT03818035|585140997|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
162023110|NCT03818035|585140998|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
162220338|NCT01016262|585857765|FG001|Open-Label Phase|Lack of Efficacy|0|||
162220339|NCT01016262|585857766|FG002|Open-Label Phase|Lack of Efficacy|0|||
162220340|NCT01016262|585857767|FG003|Open-Label Phase|Lack of Efficacy|1|||
162220341|NCT01016262|585857768|FG004|Open-Label Phase|Lack of Efficacy|0|||
162220342|NCT01016262|585857769|FG005|Open-Label Phase|Lack of Efficacy|0|||
162220343|NCT01016262|585857764|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
162220344|NCT01016262|585857765|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
162220345|NCT01016262|585857766|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
162220346|NCT01016262|585857767|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
162220347|NCT01016262|585857768|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
162220348|NCT01016262|585857769|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
162220349|NCT03738475|585857770|FG000|Overall Study|Participant Non-Compliance|1|||
162220350|NCT03738475|585857771|FG001|Overall Study|Participant Non-Compliance|0|||
162220351|NCT00677534|585857772|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
162220352|NCT00677534|585857772|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
162220353|NCT00677534|585857772|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
162220354|NCT00667394|585857773|FG000|Overall Study|Adverse Event|3|||
162220355|NCT00667394|585857774|FG001|Overall Study|Adverse Event|0|||
162220356|NCT00667394|585857773|FG000|Overall Study|Progressive disease|1|||
162220357|NCT00667394|585857774|FG001|Overall Study|Progressive disease|0|||
161939182|NCT02697448|584827288|FG001|Overall Study|Clinical concerns during ablation|1|||
161939183|NCT02697448|584827287|FG000|Overall Study|No data collected|2|||
161939184|NCT02697448|584827288|FG001|Overall Study|No data collected|0|||
161939185|NCT05473715|584827289|FG000|Overall Study|Trial terminate|2|||
161939186|NCT05473715|584827290|FG001|Overall Study|Trial terminate|1|||
161939187|NCT02592863|584827294|FG000|Overall Study|Withdrawal by Subject|2|||
161939188|NCT02592863|584827295|FG001|Overall Study|Withdrawal by Subject|2|||
161939189|NCT02592863|584827294|FG000|Overall Study|Lost to Follow-up|1|||
162220358|NCT02224703|585857780|FG000|Overall Study|Adverse Event|0|||
162220359|NCT02224703|585857781|FG001|Overall Study|Adverse Event|5|||
162220360|NCT02224703|585857782|FG002|Overall Study|Adverse Event|0|||
162220361|NCT02224703|585857780|FG000|Overall Study|Withdrawn by investigator|1|||
162220362|NCT02224703|585857781|FG001|Overall Study|Withdrawn by investigator|0|||
162220363|NCT02224703|585857782|FG002|Overall Study|Withdrawn by investigator|0|||
162220364|NCT02224703|585857780|FG000|Overall Study|Advised by medical monitor|1|||
162220365|NCT02224703|585857781|FG001|Overall Study|Advised by medical monitor|0|||
162220366|NCT02224703|585857782|FG002|Overall Study|Advised by medical monitor|0|||
162220367|NCT02224703|585857780|FG000|Overall Study|Withdrawn by parent/guardian|0|||
162220368|NCT02224703|585857781|FG001|Overall Study|Withdrawn by parent/guardian|1|||
162220369|NCT02224703|585857782|FG002|Overall Study|Withdrawn by parent/guardian|0|||
162220370|NCT02224703|585857780|FG000|Overall Study|Lack of Efficacy|1|||
162220371|NCT02224703|585857781|FG001|Overall Study|Lack of Efficacy|0|||
162220372|NCT02224703|585857782|FG002|Overall Study|Lack of Efficacy|0|||
162220373|NCT00863681|585857785|FG000|Overall Study|Other|2|||
162220374|NCT00863681|585857786|FG001|Overall Study|Other|0|||
162220375|NCT00863681|585857787|FG002|Overall Study|Other|0|||
162220376|NCT00863681|585857785|FG000|Overall Study|Missing|1|||
162220377|NCT00863681|585857786|FG001|Overall Study|Missing|0|||
162220378|NCT00863681|585857787|FG002|Overall Study|Missing|0|||
162220379|NCT00863681|585857785|FG000|Overall Study|Death|40|||
162220380|NCT00863681|585857786|FG001|Overall Study|Death|23|||
162220381|NCT00863681|585857787|FG002|Overall Study|Death|6|||
162220382|NCT00863681|585857785|FG000|Overall Study|Withdrawal by Subject|12|||
162220383|NCT00863681|585857786|FG001|Overall Study|Withdrawal by Subject|5|||
162220384|NCT00863681|585857787|FG002|Overall Study|Withdrawal by Subject|2|||
162220385|NCT00863681|585857785|FG000|Overall Study|Protocol Violation|2|||
162220386|NCT00863681|585857786|FG001|Overall Study|Protocol Violation|0|||
162220387|NCT00863681|585857787|FG002|Overall Study|Protocol Violation|0|||
162220388|NCT00863681|585857785|FG000|Overall Study|Lost to Follow-up|3|||
162220389|NCT00863681|585857786|FG001|Overall Study|Lost to Follow-up|0|||
162220390|NCT00863681|585857787|FG002|Overall Study|Lost to Follow-up|3|||
162220391|NCT00863681|585857785|FG000|Overall Study|Adverse Event|28|||
162220392|NCT00863681|585857786|FG001|Overall Study|Adverse Event|10|||
162220393|NCT00863681|585857787|FG002|Overall Study|Adverse Event|6|||
162220394|NCT00863681|585857785|FG000|Overall Study|Lack of Efficacy|2|||
162220395|NCT00863681|585857786|FG001|Overall Study|Lack of Efficacy|2|||
162220396|NCT00863681|585857787|FG002|Overall Study|Lack of Efficacy|1|||
162220397|NCT00863681|585857785|FG000|Overall Study|Non-compliance with study drug|1|||
162220398|NCT00863681|585857786|FG001|Overall Study|Non-compliance with study drug|3|||
162220399|NCT00863681|585857787|FG002|Overall Study|Non-compliance with study drug|0|||
162220400|NCT02922023|585857788|FG000|Overall Study|Lost to Follow-up|2|||
162220401|NCT02922023|585857789|FG001|Overall Study|Lost to Follow-up|0|||
162220402|NCT01304498|585857791|FG000|Overall Study|Adverse Event|1|||
162220403|NCT01304498|585857792|FG001|Overall Study|Adverse Event|1|||
162220404|NCT01304498|585857791|FG000|Overall Study|Withdrawal by Subject|2|||
162220405|NCT01304498|585857792|FG001|Overall Study|Withdrawal by Subject|3|||
162220406|NCT01304498|585857791|FG000|Overall Study|Protocol Violation|1|||
162220407|NCT01304498|585857792|FG001|Overall Study|Protocol Violation|0|||
162220408|NCT01304498|585857791|FG000|Overall Study|Lost to Follow-up|2|||
162220409|NCT01304498|585857792|FG001|Overall Study|Lost to Follow-up|1|||
162220410|NCT03325777|585857793|FG000|Overall Study|Lost to Follow-up|9|||
162220411|NCT03325777|585857794|FG001|Overall Study|Lost to Follow-up|12|||
162220412|NCT03004404|585857796|FG000|Period 2|Adverse Event|0|||
162220413|NCT03004404|585857797|FG001|Period 2|Adverse Event|0|||
162220414|NCT03004404|585857798|FG002|Period 2|Adverse Event|0|||
162220415|NCT03004404|585857799|FG003|Period 2|Adverse Event|0|||
162220416|NCT03004404|585857800|FG004|Period 2|Adverse Event|0|||
162220417|NCT03004404|585857801|FG005|Period 2|Adverse Event|0|||
161829073|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161829074|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
162220418|NCT03004404|585857802|FG006|Period 2|Adverse Event|0|||
162220419|NCT03004404|585857803|FG007|Period 2|Adverse Event|0|||
162220420|NCT03004404|585857804|FG008|Period 2|Adverse Event|1|||
162220421|NCT03004404|585857805|FG009|Period 2|Adverse Event|0|||
162220422|NCT03004404|585857806|FG010|Period 2|Adverse Event|0|||
162220423|NCT03004404|585857807|FG011|Period 2|Adverse Event|0|||
162220424|NCT03004404|585857808|FG012|Period 2|Adverse Event|0|||
162220425|NCT03004404|585857809|FG013|Period 2|Adverse Event|0|||
161939190|NCT02592863|584827295|FG001|Overall Study|Lost to Follow-up|1|||
162220426|NCT03004404|585857810|FG014|Period 2|Adverse Event|0|||
162220427|NCT03004404|585857811|FG015|Period 2|Adverse Event|1|||
162220428|NCT02990468|585857815|FG000|Phase 2: MTD|Change in treatment|0|||
162220429|NCT02990468|585857816|FG001|Phase 2: MTD|Change in treatment|0|||
162220430|NCT02990468|585857817|FG002|Phase 2: MTD|Change in treatment|1|||
162220431|NCT01721954|585857822|FG000|Overall Study|Death|58|||
162220432|NCT01721954|585857823|FG001|Overall Study|Death|64|||
162220433|NCT01721954|585857822|FG000|Overall Study|Withdrawal by Subject|8|||
161939191|NCT02743221|584827296|FG000|Overall Study|Progressive disease|29|||
162220434|NCT01721954|585857823|FG001|Overall Study|Withdrawal by Subject|4|||
162220435|NCT01721954|585857822|FG000|Overall Study|Adverse Event|2|||
162220436|NCT01721954|585857823|FG001|Overall Study|Adverse Event|0|||
162220437|NCT01721954|585857822|FG000|Overall Study|Lost to Follow-up|2|||
162220438|NCT01721954|585857823|FG001|Overall Study|Lost to Follow-up|1|||
162220439|NCT01195623|585857824|FG000|Overall Study|Lost to Follow-up|35|||
162220440|NCT01195623|585857825|FG001|Overall Study|Lost to Follow-up|37|||
162220441|NCT00534495|585857827|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
162220442|NCT00534495|585857828|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
162220443|NCT00534495|585857829|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
162220444|NCT00534495|585857827|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
162220445|NCT00534495|585857828|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
162220446|NCT00534495|585857829|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
162220447|NCT00534495|585857827|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
162220448|NCT00534495|585857828|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
162220449|NCT00534495|585857829|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
162220450|NCT00534495|585857827|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
162220451|NCT00534495|585857828|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
162220452|NCT00534495|585857829|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
162220453|NCT00534495|585857827|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
162220454|NCT00534495|585857828|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
162220455|NCT00534495|585857829|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
162220456|NCT00534495|585857827|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
162220457|NCT00534495|585857828|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
162220458|NCT00534495|585857829|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
162220459|NCT00534495|585857827|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
162220460|NCT00534495|585857828|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
162220461|NCT00534495|585857829|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
162220462|NCT00534495|585857827|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
162220463|NCT00534495|585857828|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
162220464|NCT00534495|585857829|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
162220465|NCT00534495|585857827|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
162220466|NCT00534495|585857828|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
162220467|NCT00534495|585857829|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
162220468|NCT02920970|585857832|FG000|First Intervention|Protocol Violation|0|||
162220469|NCT02920970|585857833|FG001|First Intervention|Protocol Violation|1|||
162220470|NCT02920970|585857832|FG000|First Intervention|Adverse Event|0|||
162220471|NCT02920970|585857833|FG001|First Intervention|Adverse Event|1|||
162220472|NCT02920970|585857832|FG000|Second Intervention|Poor Lens Fit|1|||
162220473|NCT02920970|585857833|FG001|Second Intervention|Poor Lens Fit|0|||
162220474|NCT01711853|585857834|FG000|Overall Study|Not treated|3|||
162220475|NCT04191616|585857835|FG000|Pre-assignment Period|Did not receive study treatment|2|||
162220476|NCT04191616|585857835|FG000|Treatment Period|Death|37|||
162220477|NCT04191616|585857835|FG000|Treatment Period|Sponsor decision|11|||
162220478|NCT04191616|585857835|FG000|Treatment Period|Withdrawal by Subject|4|||
162220479|NCT02670122|585857839|FG000|Overall Study|Lost to Follow-up|4|||
162220480|NCT00632502|585857840|FG000|Overall Study|Adverse Event|0|||
162220481|NCT00632502|585857841|FG001|Overall Study|Adverse Event|1|||
162220482|NCT00632502|585857840|FG000|Overall Study|Randomized not treated|3|||
162220483|NCT00632502|585857841|FG001|Overall Study|Randomized not treated|0|||
162220484|NCT04535544|585857842|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
162220485|NCT04535544|585857843|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
162220486|NCT04535544|585857844|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
162220487|NCT04535544|585857845|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
162220488|NCT04535544|585857842|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
162220489|NCT04535544|585857843|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
162220490|NCT04535544|585857844|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
162220491|NCT04535544|585857845|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
162220492|NCT04535544|585857842|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
162220493|NCT04535544|585857843|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
162220494|NCT04535544|585857844|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
162220495|NCT04535544|585857845|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
162220496|NCT04535544|585857842|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
162220497|NCT04535544|585857843|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
162220498|NCT04535544|585857844|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
162220499|NCT04535544|585857845|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
162220500|NCT04535544|585857842|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
162220501|NCT04535544|585857843|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
162220502|NCT04535544|585857844|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
162220503|NCT04535544|585857845|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
162220504|NCT04535544|585857842|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
161829075|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
162220505|NCT04535544|585857843|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
162220506|NCT04535544|585857844|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
162220507|NCT04535544|585857845|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
162220508|NCT04535544|585857842|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
162220509|NCT04535544|585857843|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
162220510|NCT04535544|585857844|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
162220511|NCT04535544|585857845|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
162220512|NCT04535544|585857842|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
162220513|NCT04535544|585857843|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
162220514|NCT04535544|585857844|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
162220515|NCT04535544|585857845|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
162220516|NCT03554629|585860161|FG000|Overall Study|Inadequate data|6|||
162220517|NCT01182441|585860164|FG000|Overall Study|Patient Still in Follow-up|152|||
162220518|NCT01182441|585860165|FG001|Overall Study|Patient Still in Follow-up|72|||
162220519|NCT01182441|585860164|FG000|Overall Study|Death|37|||
162220520|NCT01182441|585860165|FG001|Overall Study|Death|25|||
162220521|NCT01182441|585860164|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
162220522|NCT01182441|585860165|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
162220523|NCT01182441|585860164|FG000|Overall Study|Lost to Follow-up|5|||
162220524|NCT01182441|585860165|FG001|Overall Study|Lost to Follow-up|8|||
162220525|NCT01182441|585860164|FG000|Overall Study|Withdrawal by Subject|6|||
162220526|NCT01182441|585860165|FG001|Overall Study|Withdrawal by Subject|13|||
162220527|NCT01182441|585860164|FG000|Overall Study|Implant Not Attempted|4|||
162220528|NCT01182441|585860165|FG001|Overall Study|Implant Not Attempted|0|||
162220529|NCT01182441|585860164|FG000|Overall Study|Adverse Event|2|||
162220530|NCT01182441|585860165|FG001|Overall Study|Adverse Event|0|||
162220531|NCT01182441|585860164|FG000|Overall Study|Physician Decision|1|||
162220532|NCT01182441|585860165|FG001|Overall Study|Physician Decision|1|||
162220533|NCT03480932|585860166|FG000|Overall Study|Death|1|||
162220534|NCT03480932|585860167|FG001|Overall Study|Death|1|||
162220535|NCT03480932|585860168|FG002|Overall Study|Death|0|||
162220536|NCT03480932|585860166|FG000|Overall Study|Lost to Follow-up|0|||
162220537|NCT03480932|585860167|FG001|Overall Study|Lost to Follow-up|2|||
162220538|NCT03480932|585860168|FG002|Overall Study|Lost to Follow-up|3|||
162220539|NCT03480932|585860166|FG000|Overall Study|Incarcerated|2|||
162220540|NCT03480932|585860167|FG001|Overall Study|Incarcerated|2|||
162220541|NCT03480932|585860168|FG002|Overall Study|Incarcerated|2|||
162220542|NCT00663702|585860169|FG000|Overall Study|Adverse Event|8|||
162220543|NCT00663702|585860170|FG001|Overall Study|Adverse Event|4|||
162220544|NCT00663702|585860169|FG000|Overall Study|Withdrawal by Subject|3|||
162220545|NCT00663702|585860170|FG001|Overall Study|Withdrawal by Subject|1|||
162220546|NCT00663702|585860169|FG000|Overall Study|Pregnancy|0|||
162220547|NCT00663702|585860170|FG001|Overall Study|Pregnancy|1|||
162220548|NCT00663702|585860169|FG000|Overall Study|Lost to Follow-up|3|||
162220549|NCT00663702|585860170|FG001|Overall Study|Lost to Follow-up|0|||
162220550|NCT00663702|585860169|FG000|Overall Study|Death|1|||
162220551|NCT00663702|585860170|FG001|Overall Study|Death|1|||
162220552|NCT00663702|585860169|FG000|Overall Study|Lack of Efficacy|3|||
162220553|NCT00663702|585860170|FG001|Overall Study|Lack of Efficacy|3|||
162220554|NCT03056300|585860171|FG000|Overall Study|Surgical reason per study protocol|3|||
162220555|NCT05262517|585860178|FG000|Overall Study|Randomized but not treated|5|||
162220556|NCT05262517|585860179|FG001|Overall Study|Randomized but not treated|11|||
162220557|NCT05577715|585860180|FG000|Overall Study|Withdrawal by Subject|1|||
162220558|NCT05577715|585860180|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
162220559|NCT05577715|585860180|FG000|Overall Study|Lost to Follow-up|1|||
162220560|NCT05577715|585860180|FG000|Overall Study|Death|6|||
162220561|NCT05048238|585860181|FG000|Overall Study|Withdrawal by Subject|1|||
162220562|NCT00335140|585860187|FG000|Overall Study|Ineligible|1|||
162220563|NCT00737477|585860191|FG000|Overall Study|Adverse Event|9|||
162220564|NCT00737477|585860191|FG000|Overall Study|Death|9|||
162220565|NCT00737477|585860191|FG000|Overall Study|Treatment Refusal|1|||
162220566|NCT00737477|585860191|FG000|Overall Study|Withdrawal by Subject|1|||
162220567|NCT00737477|585860191|FG000|Overall Study|Renal Transplantation|10|||
162220568|NCT00737477|585860191|FG000|Overall Study|Other|4|||
161939192|NCT02743221|584827297|FG001|Overall Study|Progressive disease|38|||
161939193|NCT02743221|584827296|FG000|Overall Study|Adverse Event|17|||
161939194|NCT02743221|584827297|FG001|Overall Study|Adverse Event|14|||
161939195|NCT02743221|584827296|FG000|Overall Study|non medical reason|8|||
162220569|NCT01132820|585860192|FG000|Overall Study|Ineligible: wrong cell type|1|||
162220570|NCT01132820|585860192|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
161939196|NCT02743221|584827297|FG001|Overall Study|non medical reason|2|||
161939197|NCT02743221|584827296|FG000|Overall Study|Physician Decision|2|||
161939198|NCT02743221|584827297|FG001|Overall Study|Physician Decision|5|||
162220571|NCT01132820|585860192|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
162220572|NCT01132820|585860192|FG000|Overall Study|Never treated|1|||
162220573|NCT01132820|585860192|FG000|Overall Study|Inadequate data|1|||
162220574|NCT01370655|585860193|FG000|Period 1|Adverse Event|2|||
161939199|NCT02743221|584827296|FG000|Overall Study|Patient not eligible, not treated|0|||
162220575|NCT01370655|585860194|FG001|Period 1|Adverse Event|0|||
162220576|NCT01370655|585860195|FG002|Period 1|Adverse Event|0|||
162220577|NCT01370655|585860196|FG003|Period 1|Adverse Event|0|||
162220578|NCT01370655|585860197|FG004|Period 1|Adverse Event|0|||
161829076|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
161829077|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
161829078|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
162220579|NCT01370655|585860198|FG005|Period 1|Adverse Event|0|||
162220580|NCT01370655|585860199|FG006|Period 1|Adverse Event|1|||
162220581|NCT01370655|585860200|FG007|Period 1|Adverse Event|0|||
162220582|NCT01370655|585860201|FG008|Period 1|Adverse Event|0|||
162220583|NCT01370655|585860202|FG009|Period 1|Adverse Event|0|||
162220584|NCT01370655|585860203|FG010|Period 1|Adverse Event|0|||
162220585|NCT01370655|585860204|FG011|Period 1|Adverse Event|0|||
162220586|NCT01370655|585860193|FG000|Period 2|Adverse Event|0|||
162220587|NCT01370655|585860194|FG001|Period 2|Adverse Event|0|||
162220588|NCT01370655|585860195|FG002|Period 2|Adverse Event|1|||
162220589|NCT01370655|585860196|FG003|Period 2|Adverse Event|0|||
162220590|NCT01370655|585860197|FG004|Period 2|Adverse Event|1|||
162220591|NCT01370655|585860198|FG005|Period 2|Adverse Event|0|||
162220592|NCT01370655|585860199|FG006|Period 2|Adverse Event|0|||
162220593|NCT01370655|585860200|FG007|Period 2|Adverse Event|1|||
162220594|NCT01370655|585860201|FG008|Period 2|Adverse Event|0|||
162220595|NCT01370655|585860202|FG009|Period 2|Adverse Event|0|||
162220596|NCT01370655|585860203|FG010|Period 2|Adverse Event|0|||
162220597|NCT01370655|585860204|FG011|Period 2|Adverse Event|0|||
162220598|NCT01370655|585860193|FG000|Period 2|met protocol specified stopping criteria|0|||
162220599|NCT01370655|585860194|FG001|Period 2|met protocol specified stopping criteria|0|||
162220600|NCT01370655|585860195|FG002|Period 2|met protocol specified stopping criteria|1|||
162220601|NCT01370655|585860196|FG003|Period 2|met protocol specified stopping criteria|0|||
162220602|NCT01370655|585860197|FG004|Period 2|met protocol specified stopping criteria|0|||
162220603|NCT01370655|585860198|FG005|Period 2|met protocol specified stopping criteria|0|||
162220604|NCT01370655|585860199|FG006|Period 2|met protocol specified stopping criteria|1|||
162220605|NCT01370655|585860200|FG007|Period 2|met protocol specified stopping criteria|0|||
162220606|NCT01370655|585860201|FG008|Period 2|met protocol specified stopping criteria|1|||
162220607|NCT01370655|585860202|FG009|Period 2|met protocol specified stopping criteria|0|||
162220608|NCT01370655|585860203|FG010|Period 2|met protocol specified stopping criteria|1|||
162220609|NCT01370655|585860204|FG011|Period 2|met protocol specified stopping criteria|0|||
162220610|NCT01370655|585860193|FG000|Period 2|Withdrawal by Subject|0|||
162220611|NCT01370655|585860194|FG001|Period 2|Withdrawal by Subject|0|||
162220612|NCT01370655|585860195|FG002|Period 2|Withdrawal by Subject|0|||
162220613|NCT01370655|585860196|FG003|Period 2|Withdrawal by Subject|0|||
162220614|NCT01370655|585860197|FG004|Period 2|Withdrawal by Subject|0|||
162220615|NCT01370655|585860198|FG005|Period 2|Withdrawal by Subject|0|||
162220616|NCT01370655|585860199|FG006|Period 2|Withdrawal by Subject|0|||
162220617|NCT01370655|585860200|FG007|Period 2|Withdrawal by Subject|0|||
162220618|NCT01370655|585860201|FG008|Period 2|Withdrawal by Subject|1|||
162220619|NCT01370655|585860202|FG009|Period 2|Withdrawal by Subject|0|||
162220620|NCT01370655|585860203|FG010|Period 2|Withdrawal by Subject|0|||
161829079|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
161829080|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
161829081|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
161829082|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
161829083|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
161829084|NCT00739973|584413667|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161829085|NCT00739973|584413668|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
161829086|NCT00739973|584413669|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162220621|NCT01370655|585860204|FG011|Period 2|Withdrawal by Subject|0|||
162220622|NCT01730378|585860205|FG000|Overall Study|Lost to Follow-up|1|||
162220623|NCT01730378|585860206|FG001|Overall Study|Lost to Follow-up|0|||
162220624|NCT02687035|585860207|FG000|Overall Study|Withdrawal by Subject|1|||
162220625|NCT02687035|585860207|FG000|Overall Study|Death|87|||
162220626|NCT02687035|585860207|FG000|Overall Study|Lost to Follow-up|1|||
162220627|NCT02687035|585860207|FG000|Overall Study|Missed Visit|87|||
162220628|NCT02687035|585860207|FG000|Overall Study|Did not receive Study Device|8|||
162220629|NCT05000216|585860211|FG000|Stage 1|Lost to Follow-up|0|||
162220630|NCT05000216|585860212|FG001|Stage 1|Lost to Follow-up|0|||
162220631|NCT05000216|585860213|FG002|Stage 1|Lost to Follow-up|0|||
162220632|NCT05000216|585860214|FG003|Stage 1|Lost to Follow-up|0|||
162220633|NCT05000216|585860215|FG004|Stage 1|Lost to Follow-up|0|||
162220634|NCT05000216|585860216|FG005|Stage 1|Lost to Follow-up|0|||
162220635|NCT05000216|585860217|FG006|Stage 1|Lost to Follow-up|1|||
162220636|NCT05000216|585860218|FG007|Stage 1|Lost to Follow-up|1|||
162220637|NCT05000216|585860219|FG008|Stage 1|Lost to Follow-up|0|||
162220638|NCT05000216|585860220|FG009|Stage 1|Lost to Follow-up|2|||
162220639|NCT05000216|585860221|FG010|Stage 1|Lost to Follow-up|3|||
162220640|NCT05000216|585860222|FG011|Stage 1|Lost to Follow-up|0|||
162220641|NCT05000216|585860223|FG012|Stage 1|Lost to Follow-up|0|||
162220642|NCT05000216|585860224|FG013|Stage 1|Lost to Follow-up|0|||
162220643|NCT05000216|585860225|FG014|Stage 1|Lost to Follow-up|0|||
162220644|NCT05000216|585860226|FG015|Stage 1|Lost to Follow-up|0|||
162220645|NCT05000216|585860227|FG016|Stage 1|Lost to Follow-up|0|||
162220646|NCT05000216|585860228|FG017|Stage 1|Lost to Follow-up|0|||
162220647|NCT05000216|585860229|FG018|Stage 1|Lost to Follow-up|0|||
162220648|NCT05000216|585860230|FG019|Stage 1|Lost to Follow-up|0|||
162220649|NCT05000216|585860231|FG020|Stage 1|Lost to Follow-up|0|||
162220650|NCT05000216|585860232|FG021|Stage 1|Lost to Follow-up|0|||
162220651|NCT05000216|585860211|FG000|Stage 1|Physician Decision|0|||
162220652|NCT05000216|585860212|FG001|Stage 1|Physician Decision|0|||
162220653|NCT05000216|585860213|FG002|Stage 1|Physician Decision|0|||
162220654|NCT05000216|585860214|FG003|Stage 1|Physician Decision|0|||
162220655|NCT05000216|585860215|FG004|Stage 1|Physician Decision|0|||
162220656|NCT05000216|585860216|FG005|Stage 1|Physician Decision|0|||
162220657|NCT05000216|585860217|FG006|Stage 1|Physician Decision|0|||
162220658|NCT05000216|585860218|FG007|Stage 1|Physician Decision|1|||
162220659|NCT05000216|585860219|FG008|Stage 1|Physician Decision|1|||
162220660|NCT05000216|585860220|FG009|Stage 1|Physician Decision|0|||
162220661|NCT05000216|585860221|FG010|Stage 1|Physician Decision|0|||
162220662|NCT05000216|585860222|FG011|Stage 1|Physician Decision|0|||
162220663|NCT05000216|585860223|FG012|Stage 1|Physician Decision|0|||
162220664|NCT05000216|585860224|FG013|Stage 1|Physician Decision|0|||
162220665|NCT05000216|585860225|FG014|Stage 1|Physician Decision|0|||
162220666|NCT05000216|585860226|FG015|Stage 1|Physician Decision|0|||
162220667|NCT05000216|585860227|FG016|Stage 1|Physician Decision|0|||
162220668|NCT05000216|585860228|FG017|Stage 1|Physician Decision|0|||
162220669|NCT05000216|585860229|FG018|Stage 1|Physician Decision|0|||
162220670|NCT05000216|585860230|FG019|Stage 1|Physician Decision|0|||
162220671|NCT05000216|585860231|FG020|Stage 1|Physician Decision|0|||
162220672|NCT05000216|585860232|FG021|Stage 1|Physician Decision|0|||
162220673|NCT05000216|585860211|FG000|Stage 1|Withdrawal by Subject|0|||
162220674|NCT05000216|585860212|FG001|Stage 1|Withdrawal by Subject|1|||
162220675|NCT05000216|585860213|FG002|Stage 1|Withdrawal by Subject|0|||
162220676|NCT05000216|585860214|FG003|Stage 1|Withdrawal by Subject|0|||
162220677|NCT05000216|585860215|FG004|Stage 1|Withdrawal by Subject|0|||
162220678|NCT05000216|585860216|FG005|Stage 1|Withdrawal by Subject|0|||
162220679|NCT05000216|585860217|FG006|Stage 1|Withdrawal by Subject|0|||
162220680|NCT05000216|585860218|FG007|Stage 1|Withdrawal by Subject|0|||
162220681|NCT05000216|585860219|FG008|Stage 1|Withdrawal by Subject|0|||
162220682|NCT05000216|585860220|FG009|Stage 1|Withdrawal by Subject|3|||
162220683|NCT05000216|585860221|FG010|Stage 1|Withdrawal by Subject|10|||
162220684|NCT05000216|585860222|FG011|Stage 1|Withdrawal by Subject|0|||
162220685|NCT05000216|585860223|FG012|Stage 1|Withdrawal by Subject|0|||
162220686|NCT05000216|585860224|FG013|Stage 1|Withdrawal by Subject|0|||
162220687|NCT05000216|585860225|FG014|Stage 1|Withdrawal by Subject|0|||
162220688|NCT05000216|585860226|FG015|Stage 1|Withdrawal by Subject|0|||
162220689|NCT05000216|585860227|FG016|Stage 1|Withdrawal by Subject|0|||
162220690|NCT05000216|585860228|FG017|Stage 1|Withdrawal by Subject|0|||
162220691|NCT05000216|585860229|FG018|Stage 1|Withdrawal by Subject|0|||
162220692|NCT05000216|585860230|FG019|Stage 1|Withdrawal by Subject|0|||
162220693|NCT05000216|585860231|FG020|Stage 1|Withdrawal by Subject|0|||
162220694|NCT05000216|585860232|FG021|Stage 1|Withdrawal by Subject|0|||
162220695|NCT05000216|585860211|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
162220696|NCT05000216|585860212|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
162220697|NCT05000216|585860213|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
162220698|NCT05000216|585860214|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
162220699|NCT05000216|585860215|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
162220700|NCT05000216|585860216|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
162220701|NCT05000216|585860217|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
162220702|NCT05000216|585860218|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
162220703|NCT05000216|585860219|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
162220704|NCT05000216|585860220|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
162220705|NCT05000216|585860221|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
162220706|NCT05000216|585860222|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
162220707|NCT05000216|585860223|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
162220708|NCT05000216|585860224|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
162220709|NCT05000216|585860225|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
162220710|NCT05000216|585860226|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
162220711|NCT05000216|585860227|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
162220712|NCT05000216|585860228|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
162220713|NCT05000216|585860229|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
162220714|NCT05000216|585860230|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
162220715|NCT05000216|585860231|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
162220716|NCT05000216|585860232|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
162220717|NCT05000216|585860211|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220718|NCT05000216|585860212|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220719|NCT05000216|585860213|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220720|NCT05000216|585860214|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162236654|NCT01191268|585917018|FG000|Overall Study|Death|0|||
162220721|NCT05000216|585860215|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220722|NCT05000216|585860216|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220723|NCT05000216|585860217|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220724|NCT05000216|585860218|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220725|NCT05000216|585860219|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
162220726|NCT05000216|585860220|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220727|NCT05000216|585860221|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220728|NCT05000216|585860222|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220729|NCT05000216|585860223|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220730|NCT05000216|585860224|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220731|NCT05000216|585860225|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220732|NCT05000216|585860226|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220733|NCT05000216|585860227|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220734|NCT05000216|585860228|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220735|NCT05000216|585860229|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220736|NCT05000216|585860230|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220737|NCT05000216|585860231|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220738|NCT05000216|585860232|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
162220739|NCT05000216|585860211|FG000|Stage 1|Other|0|||
162220740|NCT05000216|585860212|FG001|Stage 1|Other|0|||
162023111|NCT03818035|585140999|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
162023112|NCT03818035|585140996|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
162023113|NCT03818035|585140997|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
162023114|NCT03818035|585140998|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
162023115|NCT03818035|585140999|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
162023116|NCT03818035|585140996|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
162220741|NCT05000216|585860213|FG002|Stage 1|Other|0|||
162220742|NCT05000216|585860214|FG003|Stage 1|Other|0|||
162220743|NCT05000216|585860215|FG004|Stage 1|Other|1|||
162220744|NCT05000216|585860216|FG005|Stage 1|Other|0|||
162220745|NCT05000216|585860217|FG006|Stage 1|Other|0|||
162220746|NCT05000216|585860218|FG007|Stage 1|Other|2|||
162220747|NCT05000216|585860219|FG008|Stage 1|Other|0|||
162220748|NCT05000216|585860220|FG009|Stage 1|Other|0|||
162220749|NCT05000216|585860221|FG010|Stage 1|Other|1|||
162220750|NCT05000216|585860222|FG011|Stage 1|Other|1|||
162220751|NCT05000216|585860223|FG012|Stage 1|Other|0|||
162220752|NCT05000216|585860224|FG013|Stage 1|Other|0|||
162220753|NCT05000216|585860225|FG014|Stage 1|Other|0|||
162220754|NCT05000216|585860226|FG015|Stage 1|Other|0|||
162220755|NCT05000216|585860227|FG016|Stage 1|Other|0|||
162220756|NCT05000216|585860228|FG017|Stage 1|Other|0|||
162220757|NCT05000216|585860229|FG018|Stage 1|Other|0|||
162220758|NCT05000216|585860230|FG019|Stage 1|Other|0|||
162220759|NCT05000216|585860231|FG020|Stage 1|Other|0|||
162220760|NCT05000216|585860232|FG021|Stage 1|Other|0|||
162220761|NCT05000216|585860211|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
162220762|NCT05000216|585860212|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
162220763|NCT05000216|585860213|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
162220764|NCT05000216|585860214|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
162220765|NCT05000216|585860215|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
162220766|NCT05000216|585860216|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
162220767|NCT05000216|585860217|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
162220768|NCT05000216|585860218|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
162220769|NCT05000216|585860219|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
162220770|NCT05000216|585860220|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
162220771|NCT05000216|585860221|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
162220772|NCT05000216|585860222|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
162220773|NCT05000216|585860223|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
162220774|NCT05000216|585860224|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
161829087|NCT00739973|584413670|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161829088|NCT00739973|584413671|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
162023117|NCT03818035|585140997|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
162023118|NCT03818035|585140998|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
162023119|NCT03818035|585140999|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
162220775|NCT05000216|585860225|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
162220776|NCT05000216|585860226|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
162220777|NCT05000216|585860227|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
162220778|NCT05000216|585860228|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
162220779|NCT05000216|585860229|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
162220780|NCT05000216|585860230|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
162220781|NCT05000216|585860231|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
162220782|NCT05000216|585860232|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
162220783|NCT05000216|585860211|FG000|Stage 2|Lost to Follow-up|0|||
162220784|NCT05000216|585860212|FG001|Stage 2|Lost to Follow-up|0|||
162220785|NCT05000216|585860213|FG002|Stage 2|Lost to Follow-up|0|||
162220786|NCT05000216|585860214|FG003|Stage 2|Lost to Follow-up|0|||
162220787|NCT05000216|585860215|FG004|Stage 2|Lost to Follow-up|0|||
162220788|NCT05000216|585860216|FG005|Stage 2|Lost to Follow-up|0|||
162220789|NCT05000216|585860217|FG006|Stage 2|Lost to Follow-up|0|||
162220790|NCT05000216|585860218|FG007|Stage 2|Lost to Follow-up|0|||
162220791|NCT05000216|585860219|FG008|Stage 2|Lost to Follow-up|0|||
162220792|NCT05000216|585860220|FG009|Stage 2|Lost to Follow-up|0|||
162220793|NCT05000216|585860221|FG010|Stage 2|Lost to Follow-up|0|||
162220794|NCT05000216|585860222|FG011|Stage 2|Lost to Follow-up|0|||
162220795|NCT05000216|585860223|FG012|Stage 2|Lost to Follow-up|0|||
162220796|NCT05000216|585860224|FG013|Stage 2|Lost to Follow-up|0|||
162220797|NCT05000216|585860225|FG014|Stage 2|Lost to Follow-up|0|||
162220798|NCT05000216|585860226|FG015|Stage 2|Lost to Follow-up|0|||
162220799|NCT05000216|585860227|FG016|Stage 2|Lost to Follow-up|4|||
162220800|NCT05000216|585860228|FG017|Stage 2|Lost to Follow-up|0|||
162220801|NCT05000216|585860229|FG018|Stage 2|Lost to Follow-up|0|||
162220802|NCT05000216|585860230|FG019|Stage 2|Lost to Follow-up|0|||
162220803|NCT05000216|585860231|FG020|Stage 2|Lost to Follow-up|0|||
162220804|NCT05000216|585860232|FG021|Stage 2|Lost to Follow-up|0|||
162220805|NCT05000216|585860211|FG000|Stage 2|Physician Decision|0|||
162220806|NCT05000216|585860212|FG001|Stage 2|Physician Decision|0|||
162220807|NCT05000216|585860213|FG002|Stage 2|Physician Decision|0|||
162220808|NCT05000216|585860214|FG003|Stage 2|Physician Decision|0|||
162220809|NCT05000216|585860215|FG004|Stage 2|Physician Decision|0|||
162220810|NCT05000216|585860216|FG005|Stage 2|Physician Decision|0|||
162220811|NCT05000216|585860217|FG006|Stage 2|Physician Decision|0|||
162220812|NCT05000216|585860218|FG007|Stage 2|Physician Decision|0|||
162220813|NCT05000216|585860219|FG008|Stage 2|Physician Decision|0|||
162220814|NCT05000216|585860220|FG009|Stage 2|Physician Decision|0|||
162220815|NCT05000216|585860221|FG010|Stage 2|Physician Decision|0|||
162220816|NCT05000216|585860222|FG011|Stage 2|Physician Decision|0|||
162220817|NCT05000216|585860223|FG012|Stage 2|Physician Decision|1|||
162220818|NCT05000216|585860224|FG013|Stage 2|Physician Decision|0|||
162220819|NCT05000216|585860225|FG014|Stage 2|Physician Decision|0|||
162220820|NCT05000216|585860226|FG015|Stage 2|Physician Decision|0|||
162220821|NCT05000216|585860227|FG016|Stage 2|Physician Decision|0|||
162220822|NCT05000216|585860228|FG017|Stage 2|Physician Decision|0|||
162220823|NCT05000216|585860229|FG018|Stage 2|Physician Decision|0|||
162220824|NCT05000216|585860230|FG019|Stage 2|Physician Decision|0|||
162220825|NCT05000216|585860231|FG020|Stage 2|Physician Decision|0|||
162220826|NCT05000216|585860232|FG021|Stage 2|Physician Decision|0|||
162220827|NCT05000216|585860211|FG000|Stage 2|Withdrawal by Subject|0|||
162220828|NCT05000216|585860212|FG001|Stage 2|Withdrawal by Subject|0|||
162220829|NCT05000216|585860213|FG002|Stage 2|Withdrawal by Subject|0|||
162220830|NCT05000216|585860214|FG003|Stage 2|Withdrawal by Subject|0|||
162220831|NCT05000216|585860215|FG004|Stage 2|Withdrawal by Subject|0|||
162220832|NCT05000216|585860216|FG005|Stage 2|Withdrawal by Subject|0|||
162220833|NCT05000216|585860217|FG006|Stage 2|Withdrawal by Subject|0|||
162220834|NCT05000216|585860218|FG007|Stage 2|Withdrawal by Subject|0|||
162220835|NCT05000216|585860219|FG008|Stage 2|Withdrawal by Subject|0|||
162220836|NCT05000216|585860220|FG009|Stage 2|Withdrawal by Subject|0|||
162220837|NCT05000216|585860221|FG010|Stage 2|Withdrawal by Subject|0|||
162220838|NCT05000216|585860222|FG011|Stage 2|Withdrawal by Subject|0|||
162220839|NCT05000216|585860223|FG012|Stage 2|Withdrawal by Subject|0|||
162220840|NCT05000216|585860224|FG013|Stage 2|Withdrawal by Subject|0|||
162220841|NCT05000216|585860225|FG014|Stage 2|Withdrawal by Subject|2|||
162220842|NCT05000216|585860226|FG015|Stage 2|Withdrawal by Subject|0|||
162220843|NCT05000216|585860227|FG016|Stage 2|Withdrawal by Subject|9|||
162220844|NCT05000216|585860228|FG017|Stage 2|Withdrawal by Subject|0|||
162220845|NCT05000216|585860229|FG018|Stage 2|Withdrawal by Subject|0|||
162220846|NCT05000216|585860230|FG019|Stage 2|Withdrawal by Subject|0|||
162220847|NCT05000216|585860231|FG020|Stage 2|Withdrawal by Subject|0|||
162220848|NCT05000216|585860232|FG021|Stage 2|Withdrawal by Subject|0|||
162220849|NCT05000216|585860211|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
162220850|NCT05000216|585860212|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
162220851|NCT05000216|585860213|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
162220852|NCT05000216|585860214|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
162220853|NCT05000216|585860215|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
162220854|NCT05000216|585860216|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
162220855|NCT05000216|585860217|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
162220856|NCT05000216|585860218|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
162220857|NCT05000216|585860219|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
162220858|NCT05000216|585860220|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
162220859|NCT05000216|585860221|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
161678651|NCT00766090|583876053|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162220860|NCT05000216|585860222|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
162220861|NCT05000216|585860223|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
162220862|NCT05000216|585860224|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
162220863|NCT05000216|585860225|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
162220864|NCT05000216|585860226|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
162220865|NCT05000216|585860227|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
162220866|NCT05000216|585860228|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
162220867|NCT05000216|585860229|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
162220868|NCT05000216|585860230|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
162220869|NCT05000216|585860231|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
162220870|NCT05000216|585860232|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
162220871|NCT05000216|585860211|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220872|NCT05000216|585860212|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220873|NCT05000216|585860213|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220874|NCT05000216|585860214|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220875|NCT05000216|585860215|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220876|NCT05000216|585860216|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220877|NCT05000216|585860217|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220878|NCT05000216|585860218|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220879|NCT05000216|585860219|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220880|NCT05000216|585860220|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220881|NCT05000216|585860221|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220882|NCT05000216|585860222|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220883|NCT05000216|585860223|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220884|NCT05000216|585860224|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220885|NCT05000216|585860225|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
162220886|NCT05000216|585860226|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220887|NCT05000216|585860227|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
162220888|NCT05000216|585860228|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220889|NCT05000216|585860229|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220890|NCT05000216|585860230|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220891|NCT05000216|585860231|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220892|NCT05000216|585860232|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
162220893|NCT05000216|585860211|FG000|Stage 2|Other reason|0|||
162220894|NCT05000216|585860212|FG001|Stage 2|Other reason|0|||
162220895|NCT05000216|585860213|FG002|Stage 2|Other reason|0|||
162220896|NCT05000216|585860214|FG003|Stage 2|Other reason|0|||
162220897|NCT05000216|585860215|FG004|Stage 2|Other reason|0|||
162220898|NCT05000216|585860216|FG005|Stage 2|Other reason|0|||
162220899|NCT05000216|585860217|FG006|Stage 2|Other reason|0|||
162220900|NCT05000216|585860218|FG007|Stage 2|Other reason|0|||
162220901|NCT05000216|585860219|FG008|Stage 2|Other reason|0|||
162220902|NCT05000216|585860220|FG009|Stage 2|Other reason|0|||
162220903|NCT05000216|585860221|FG010|Stage 2|Other reason|0|||
162220904|NCT05000216|585860222|FG011|Stage 2|Other reason|0|||
162220905|NCT05000216|585860223|FG012|Stage 2|Other reason|0|||
162220906|NCT05000216|585860224|FG013|Stage 2|Other reason|0|||
162220907|NCT05000216|585860225|FG014|Stage 2|Other reason|0|||
162220908|NCT05000216|585860226|FG015|Stage 2|Other reason|0|||
161678652|NCT00766090|583876054|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678653|NCT00766090|583876055|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678654|NCT00766090|583876056|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161678655|NCT00766090|583876057|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
162220909|NCT05000216|585860227|FG016|Stage 2|Other reason|1|||
162220910|NCT05000216|585860228|FG017|Stage 2|Other reason|0|||
162220911|NCT05000216|585860229|FG018|Stage 2|Other reason|0|||
162220912|NCT05000216|585860230|FG019|Stage 2|Other reason|0|||
162220913|NCT05000216|585860231|FG020|Stage 2|Other reason|0|||
162220914|NCT05000216|585860232|FG021|Stage 2|Other reason|0|||
162220915|NCT05000216|585860211|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
162220916|NCT05000216|585860212|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
162220917|NCT05000216|585860213|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
162220918|NCT05000216|585860214|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
162220919|NCT05000216|585860215|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
162220920|NCT05000216|585860216|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
161939200|NCT02743221|584827297|FG001|Overall Study|Patient not eligible, not treated|1|||
161939201|NCT01946880|584827300|FG000|Overall Study|Lost to Follow-up|1|||
161939202|NCT01946880|584827301|FG001|Overall Study|Lost to Follow-up|0|||
162220921|NCT05000216|585860217|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
162220922|NCT05000216|585860218|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
162220923|NCT05000216|585860219|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
162220924|NCT05000216|585860220|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
162220925|NCT05000216|585860221|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
162220926|NCT05000216|585860222|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
162220927|NCT05000216|585860223|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
162220928|NCT05000216|585860224|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
162220929|NCT05000216|585860225|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
162220930|NCT05000216|585860226|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
162220931|NCT05000216|585860227|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
162220932|NCT05000216|585860228|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
162220933|NCT05000216|585860229|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
162220934|NCT05000216|585860230|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
162220935|NCT05000216|585860231|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
162220936|NCT05000216|585860232|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
162220937|NCT05000216|585860211|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220938|NCT05000216|585860212|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220939|NCT05000216|585860213|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220940|NCT05000216|585860214|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220941|NCT05000216|585860215|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220942|NCT05000216|585860216|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220943|NCT05000216|585860217|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220944|NCT05000216|585860218|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220945|NCT05000216|585860219|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220946|NCT05000216|585860220|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220947|NCT05000216|585860221|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220948|NCT05000216|585860222|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220949|NCT05000216|585860223|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220950|NCT05000216|585860224|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220951|NCT05000216|585860225|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220952|NCT05000216|585860226|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
162220953|NCT05000216|585860227|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220954|NCT05000216|585860228|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220955|NCT05000216|585860229|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220956|NCT05000216|585860230|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220957|NCT05000216|585860231|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220958|NCT05000216|585860232|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
162220959|NCT05000216|585860211|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220960|NCT05000216|585860212|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220961|NCT05000216|585860213|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220962|NCT05000216|585860214|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220963|NCT05000216|585860215|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220964|NCT05000216|585860216|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220965|NCT05000216|585860217|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220966|NCT05000216|585860218|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220967|NCT05000216|585860219|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220968|NCT05000216|585860220|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220969|NCT05000216|585860221|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220970|NCT05000216|585860222|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220971|NCT05000216|585860223|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220972|NCT05000216|585860224|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
162220973|NCT05000216|585860225|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220974|NCT05000216|585860226|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
161939203|NCT01946880|584827300|FG000|Overall Study|Physician Decision|1|||
161939204|NCT01946880|584827301|FG001|Overall Study|Physician Decision|1|||
162220975|NCT05000216|585860227|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220976|NCT05000216|585860228|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220977|NCT05000216|585860229|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
162220978|NCT05000216|585860230|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220979|NCT05000216|585860231|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162236655|NCT01191268|585917019|FG001|Overall Study|Death|1|||
162236656|NCT01191268|585917020|FG002|Overall Study|Death|3|||
162236657|NCT01191268|585917018|FG000|Overall Study|Protocol Violation|1|||
162236658|NCT01191268|585917019|FG001|Overall Study|Protocol Violation|0|||
162236659|NCT01191268|585917020|FG002|Overall Study|Protocol Violation|1|||
162236660|NCT01191268|585917018|FG000|Overall Study|Sponsor Decision|0|||
162236661|NCT01191268|585917019|FG001|Overall Study|Sponsor Decision|2|||
162236662|NCT01191268|585917020|FG002|Overall Study|Sponsor Decision|0|||
162236663|NCT02027623|585917021|FG000|Overall Study|Lost to Follow-up|3|||
162236664|NCT02027623|585917022|FG001|Overall Study|Lost to Follow-up|3|||
162236665|NCT02027623|585917021|FG000|Overall Study|Withdrawal by Subject|6|||
162236666|NCT02027623|585917022|FG001|Overall Study|Withdrawal by Subject|9|||
162236667|NCT01211288|585917023|FG000|Overall Study|Lost to Follow-up|1|||
162236668|NCT01211288|585917024|FG001|Overall Study|Lost to Follow-up|1|||
162236669|NCT01270971|585917025|FG000|Overall Study|Withdrawal by Subject|24|||
162236670|NCT01270971|585917026|FG001|Overall Study|Withdrawal by Subject|11|||
162236671|NCT01270971|585917025|FG000|Overall Study|Lost to Follow-up|18|||
162236672|NCT01270971|585917026|FG001|Overall Study|Lost to Follow-up|5|||
162236673|NCT01270971|585917025|FG000|Overall Study|Adverse Event|1|||
162236674|NCT01270971|585917026|FG001|Overall Study|Adverse Event|2|||
162236675|NCT01270971|585917025|FG000|Overall Study|Non compliance|2|||
162236676|NCT01270971|585917026|FG001|Overall Study|Non compliance|2|||
162236677|NCT01270971|585917025|FG000|Overall Study|Non-specific|7|||
162236678|NCT01270971|585917026|FG001|Overall Study|Non-specific|3|||
162236679|NCT01551212|585917027|FG000|Overall Study|Graft loss/Retransplantation|0|||
162236680|NCT01551212|585917028|FG001|Overall Study|Graft loss/Retransplantation|1|||
162236681|NCT01551212|585917027|FG000|Overall Study|Administrative problems|1|||
162236682|NCT01551212|585917028|FG001|Overall Study|Administrative problems|2|||
162220980|NCT05000216|585860232|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
162220981|NCT04481373|585860233|FG000|Overall Study|Protocol Violation|1|||
162220982|NCT04481373|585860234|FG001|Overall Study|Protocol Violation|0|||
162220983|NCT04481373|585860233|FG000|Overall Study|Viral load in hospital not over 1000|2|||
162220984|NCT04481373|585860234|FG001|Overall Study|Viral load in hospital not over 1000|1|||
162220985|NCT04481373|585860233|FG000|Overall Study|Death before hospital discharge|1|||
162220986|NCT04481373|585860234|FG001|Overall Study|Death before hospital discharge|0|||
162220987|NCT02057575|585860236|FG000|Overall Study|Adverse Event|0|||
162220988|NCT02057575|585860237|FG001|Overall Study|Adverse Event|2|||
162220989|NCT02057575|585860238|FG002|Overall Study|Adverse Event|0|||
162220990|NCT02057575|585860239|FG003|Overall Study|Adverse Event|1|||
162220991|NCT02057575|585860236|FG000|Overall Study|Withdrawal by Subject|1|||
162220992|NCT02057575|585860237|FG001|Overall Study|Withdrawal by Subject|0|||
162220993|NCT02057575|585860238|FG002|Overall Study|Withdrawal by Subject|0|||
162220994|NCT02057575|585860239|FG003|Overall Study|Withdrawal by Subject|0|||
162220995|NCT02057575|585860236|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
162220996|NCT02057575|585860237|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
162220997|NCT02057575|585860238|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
162220998|NCT02057575|585860239|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
162220999|NCT02057575|585860236|FG000|Overall Study|Protocol Violation|0|||
162221000|NCT02057575|585860237|FG001|Overall Study|Protocol Violation|1|||
162221001|NCT02057575|585860238|FG002|Overall Study|Protocol Violation|0|||
162221002|NCT02057575|585860239|FG003|Overall Study|Protocol Violation|0|||
162221003|NCT00332462|585860240|FG000|Overall Study|Adverse Event|5|||
162221004|NCT00332462|585860240|FG000|Overall Study|Abnormal Lab Value|1|||
162221005|NCT00332462|585860240|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
162221006|NCT00332462|585860240|FG000|Overall Study|no longer requires study drug|1|||
162221007|NCT00332462|585860240|FG000|Overall Study|Death|3|||
162221008|NCT00332462|585860240|FG000|Overall Study|Graft Loss|2|||
162221009|NCT02979249|585860244|FG000|Overall Study|Lost to Follow-up|2|||
162221010|NCT02979249|585860244|FG000|Overall Study|Withdrawal by Subject|4|||
162221011|NCT01125046|585860245|FG000|First 6 Months of Treatment|Death|1|||
162221012|NCT01125046|585860245|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
162221013|NCT01125046|585860245|FG000|First 6 Months of Treatment|Non-compliance|1|||
162221014|NCT01125046|585860245|FG000|First 6 Months of Treatment|Surgery|1|||
162221015|NCT01125046|585860245|FG000|First 6 Months of Treatment|Progressive Disease|7|||
162221016|NCT01125046|585860245|FG000|First 6 Months of Treatment|Adverse Event|2|||
162221017|NCT01125046|585860245|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
162221018|NCT01125046|585860245|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
162221019|NCT01125046|585860245|FG000|Follow-up/Data Cut Off Point|Death|29|||
162221020|NCT01125046|585860245|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
162221021|NCT01685229|585860246|FG000|Overall Study|Subjects missing Study Exit form|3|||
162221022|NCT01685229|585860247|FG001|Overall Study|Subjects missing Study Exit form|1|||
162221023|NCT01685229|585860246|FG000|Overall Study|Lost to Follow-up|16|||
162221024|NCT01685229|585860247|FG001|Overall Study|Lost to Follow-up|10|||
162221025|NCT01685229|585860246|FG000|Overall Study|Withdrawal by Subject|6|||
162221026|NCT01685229|585860247|FG001|Overall Study|Withdrawal by Subject|5|||
162221027|NCT01685229|585860246|FG000|Overall Study|Death|1|||
162221028|NCT01685229|585860247|FG001|Overall Study|Death|0|||
162221029|NCT00659880|585860262|FG000|Overall Study|Lost to Follow-up|5|||
162221030|NCT01853475|585860263|FG000|Overall Study|Withdrawal by Subject|0|||
162221031|NCT01853475|585860264|FG001|Overall Study|Withdrawal by Subject|1|||
162221032|NCT01853475|585860265|FG002|Overall Study|Withdrawal by Subject|0|||
162221033|NCT02159040|585860266|FG000|Overall Study|Death|1|||
162221034|NCT02766777|585860270|FG000|Overall Study|Adverse Event|12|||
162221035|NCT02766777|585860270|FG000|Overall Study|Lost to Follow-up|16|||
162221036|NCT02766777|585860270|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162221037|NCT02766777|585860270|FG000|Overall Study|Protocol Violation|1|||
162221038|NCT02766777|585860270|FG000|Overall Study|Withdrawal by Subject|4|||
162221039|NCT01886287|585860271|FG000|Overall Study|Radiographic disease progression|1|||
162221040|NCT01886287|585860271|FG000|Overall Study|Clinical progression due to disease|1|||
162221041|NCT02964325|585860272|FG000|Overall Study|Lost to Follow-up|3|||
162221042|NCT02964325|585860273|FG001|Overall Study|Lost to Follow-up|3|||
162221043|NCT02964325|585860272|FG000|Overall Study|Physician Decision|5|||
162221044|NCT02964325|585860273|FG001|Overall Study|Physician Decision|4|||
162221045|NCT02964325|585860272|FG000|Overall Study|Death|1|||
162221046|NCT02964325|585860273|FG001|Overall Study|Death|3|||
162221047|NCT02964325|585860272|FG000|Overall Study|Withdrawal by Subject|2|||
162221048|NCT02964325|585860273|FG001|Overall Study|Withdrawal by Subject|1|||
162221049|NCT02964325|585860272|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
162221050|NCT02964325|585860273|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
162221051|NCT03596762|585860274|FG000|Overall Study|Protocol Violation|0|||
162221052|NCT03596762|585860275|FG001|Overall Study|Protocol Violation|0|||
162221053|NCT03596762|585860276|FG002|Overall Study|Protocol Violation|0|||
161939205|NCT01946880|584827300|FG000|Overall Study|Withdrawal by Subject|3|||
161939206|NCT01946880|584827301|FG001|Overall Study|Withdrawal by Subject|2|||
161939207|NCT01946880|584827300|FG000|Overall Study|Met Primary Endpoint|1|||
161939208|NCT01946880|584827301|FG001|Overall Study|Met Primary Endpoint|0|||
161939209|NCT01946880|584827300|FG000|Overall Study|Personal and Family Issues|1|||
162221054|NCT03596762|585860277|FG003|Overall Study|Protocol Violation|0|||
162221055|NCT03596762|585860278|FG004|Overall Study|Protocol Violation|1|||
162221056|NCT03596762|585860274|FG000|Overall Study|Adverse Event|2|||
162221057|NCT03596762|585860275|FG001|Overall Study|Adverse Event|0|||
162221058|NCT03596762|585860276|FG002|Overall Study|Adverse Event|1|||
162221059|NCT03596762|585860277|FG003|Overall Study|Adverse Event|0|||
162221060|NCT03596762|585860278|FG004|Overall Study|Adverse Event|5|||
162221061|NCT03596762|585860274|FG000|Overall Study|Withdrawal by Subject|2|||
162221062|NCT03596762|585860275|FG001|Overall Study|Withdrawal by Subject|1|||
162221063|NCT03596762|585860276|FG002|Overall Study|Withdrawal by Subject|0|||
162221064|NCT03596762|585860277|FG003|Overall Study|Withdrawal by Subject|1|||
162221065|NCT03596762|585860278|FG004|Overall Study|Withdrawal by Subject|1|||
162221066|NCT02510040|585860279|FG000|Overall Study|Deemed no longer eligible|18|||
162221067|NCT02510040|585860280|FG001|Overall Study|Deemed no longer eligible|3|||
162221068|NCT02510040|585860281|FG002|Overall Study|Deemed no longer eligible|1|||
162221069|NCT03842228|585860282|FG000|Overall Study|Adverse Event|1|||
162221070|NCT03842228|585860283|FG001|Overall Study|Adverse Event|1|||
162221071|NCT03842228|585860284|FG002|Overall Study|Adverse Event|1|||
162221072|NCT03842228|585860285|FG003|Overall Study|Adverse Event|0|||
162221073|NCT03842228|585860286|FG004|Overall Study|Adverse Event|0|||
162221074|NCT03842228|585860287|FG005|Overall Study|Adverse Event|0|||
161939210|NCT01946880|584827301|FG001|Overall Study|Personal and Family Issues|0|||
161939211|NCT02609503|584827302|FG000|Overall Study|Adverse Event|1|||
161939212|NCT02609503|584827302|FG000|Overall Study|Death|1|||
162221075|NCT03842228|585860288|FG006|Overall Study|Adverse Event|0|||
162221076|NCT03842228|585860282|FG000|Overall Study|Death|0|||
162221077|NCT03842228|585860283|FG001|Overall Study|Death|1|||
162221078|NCT03842228|585860284|FG002|Overall Study|Death|0|||
162221079|NCT03842228|585860285|FG003|Overall Study|Death|0|||
162221080|NCT03842228|585860286|FG004|Overall Study|Death|0|||
162221081|NCT03842228|585860287|FG005|Overall Study|Death|0|||
162221082|NCT03842228|585860288|FG006|Overall Study|Death|0|||
162221083|NCT03842228|585860282|FG000|Overall Study|Withdrawal by Subject|0|||
162221084|NCT03842228|585860283|FG001|Overall Study|Withdrawal by Subject|0|||
162221085|NCT03842228|585860284|FG002|Overall Study|Withdrawal by Subject|2|||
162221086|NCT03842228|585860285|FG003|Overall Study|Withdrawal by Subject|1|||
162221087|NCT03842228|585860286|FG004|Overall Study|Withdrawal by Subject|0|||
162221088|NCT03842228|585860287|FG005|Overall Study|Withdrawal by Subject|0|||
162221089|NCT03842228|585860288|FG006|Overall Study|Withdrawal by Subject|2|||
162221090|NCT03842228|585860282|FG000|Overall Study|Progression|8|||
162221091|NCT03842228|585860283|FG001|Overall Study|Progression|1|||
162221092|NCT03842228|585860284|FG002|Overall Study|Progression|7|||
162221093|NCT03842228|585860285|FG003|Overall Study|Progression|5|||
162221094|NCT03842228|585860286|FG004|Overall Study|Progression|4|||
162221095|NCT03842228|585860287|FG005|Overall Study|Progression|2|||
162221096|NCT03842228|585860288|FG006|Overall Study|Progression|3|||
162221097|NCT02195479|585860301|FG000|Overall Study|Lost to Follow-up|18|||
162221098|NCT02195479|585860302|FG001|Overall Study|Lost to Follow-up|15|||
162221099|NCT02195479|585860301|FG000|Overall Study|Death|217|||
162221100|NCT02195479|585860302|FG001|Overall Study|Death|171|||
162221101|NCT02195479|585860301|FG000|Overall Study|Physician Decision|1|||
162221102|NCT02195479|585860302|FG001|Overall Study|Physician Decision|0|||
162221103|NCT02195479|585860301|FG000|Overall Study|Withdrawal by Subject|30|||
162221104|NCT02195479|585860302|FG001|Overall Study|Withdrawal by Subject|30|||
162221105|NCT02195479|585860301|FG000|Overall Study|Other|3|||
162221106|NCT02195479|585860302|FG001|Overall Study|Other|4|||
162221107|NCT02195479|585860301|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
162221108|NCT02195479|585860302|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
162221109|NCT01834586|585860303|FG000|Overall Study|Adverse Event|1|||
162221110|NCT01263509|585860306|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
162221111|NCT01263509|585860307|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
162221112|NCT01263509|585860308|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
162221113|NCT01263509|585860309|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
162221114|NCT01263509|585860306|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
162221115|NCT01263509|585860307|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
162221116|NCT01263509|585860308|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
162221117|NCT01263509|585860309|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
162221118|NCT01263509|585860306|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
162221119|NCT01263509|585860307|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
162221120|NCT01263509|585860308|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
162221121|NCT01263509|585860309|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
162221122|NCT01263509|585860306|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
162221123|NCT01263509|585860307|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
162221124|NCT01263509|585860308|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162221125|NCT01263509|585860309|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
162221126|NCT01263509|585860306|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
162221127|NCT01263509|585860307|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
162221128|NCT01263509|585860308|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
162221129|NCT01263509|585860309|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
162221130|NCT01371825|585860317|FG000|Overall Study|Death|4|||
162221131|NCT00895895|585860318|FG000|Period 1|Adverse Event|7|||
162221132|NCT00895895|585860319|FG001|Period 1|Adverse Event|6|||
162221133|NCT00895895|585860320|FG002|Period 1|Adverse Event|4|||
162221134|NCT00895895|585860321|FG003|Period 1|Adverse Event|6|||
162221135|NCT00895895|585860322|FG004|Period 1|Adverse Event|7|||
162221136|NCT00895895|585860318|FG000|Period 1|Death|0|||
162221137|NCT00895895|585860319|FG001|Period 1|Death|0|||
162221138|NCT00895895|585860320|FG002|Period 1|Death|0|||
162221139|NCT00895895|585860321|FG003|Period 1|Death|0|||
162221140|NCT00895895|585860322|FG004|Period 1|Death|1|||
162221141|NCT00895895|585860318|FG000|Period 1|discontinued by sponsor|2|||
162221142|NCT00895895|585860319|FG001|Period 1|discontinued by sponsor|1|||
161939213|NCT02609503|584827302|FG000|Overall Study|Withdrawal by Subject|1|||
162221143|NCT00895895|585860320|FG002|Period 1|discontinued by sponsor|2|||
162221144|NCT00895895|585860321|FG003|Period 1|discontinued by sponsor|1|||
162221145|NCT00895895|585860322|FG004|Period 1|discontinued by sponsor|1|||
162221146|NCT00895895|585860318|FG000|Period 1|failed to return|0|||
162221147|NCT00895895|585860319|FG001|Period 1|failed to return|0|||
162221148|NCT00895895|585860320|FG002|Period 1|failed to return|1|||
162221149|NCT00895895|585860321|FG003|Period 1|failed to return|0|||
162221150|NCT00895895|585860322|FG004|Period 1|failed to return|1|||
162221151|NCT00895895|585860318|FG000|Period 1|investigator request|0|||
162221152|NCT00895895|585860319|FG001|Period 1|investigator request|1|||
162221153|NCT00895895|585860320|FG002|Period 1|investigator request|0|||
162221154|NCT00895895|585860321|FG003|Period 1|investigator request|0|||
162221155|NCT00895895|585860322|FG004|Period 1|investigator request|0|||
162221156|NCT00895895|585860318|FG000|Period 1|Lost to Follow-up|2|||
161678656|NCT00766090|583876046|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678657|NCT00766090|583876047|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678658|NCT00766090|583876048|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
161678659|NCT00766090|583876049|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161939214|NCT02609503|584827302|FG000|Overall Study|Disease progression|1|||
162221157|NCT00895895|585860319|FG001|Period 1|Lost to Follow-up|1|||
161939215|NCT02951819|584827303|FG000|Overall Study|Death|9|||
161939216|NCT02951819|584827304|FG001|Overall Study|Death|7|||
161939217|NCT02951819|584827303|FG000|Overall Study|Withdrawal by Subject|3|||
161939218|NCT02951819|584827304|FG001|Overall Study|Withdrawal by Subject|0|||
161939219|NCT02951819|584827303|FG000|Overall Study|Adverse Event|1|||
161939220|NCT02951819|584827304|FG001|Overall Study|Adverse Event|0|||
161939221|NCT02951819|584827303|FG000|Overall Study|Lack of Efficacy|4|||
162221158|NCT00895895|585860320|FG002|Period 1|Lost to Follow-up|3|||
162221159|NCT00895895|585860321|FG003|Period 1|Lost to Follow-up|2|||
162221160|NCT00895895|585860322|FG004|Period 1|Lost to Follow-up|3|||
162221161|NCT00895895|585860318|FG000|Period 1|Other|1|||
162221162|NCT00895895|585860319|FG001|Period 1|Other|2|||
162221163|NCT00895895|585860320|FG002|Period 1|Other|1|||
162221164|NCT00895895|585860321|FG003|Period 1|Other|1|||
162221165|NCT00895895|585860322|FG004|Period 1|Other|1|||
162221166|NCT00895895|585860318|FG000|Period 1|Protocol Violation|0|||
162221167|NCT00895895|585860319|FG001|Period 1|Protocol Violation|1|||
162221168|NCT00895895|585860320|FG002|Period 1|Protocol Violation|0|||
161939222|NCT02951819|584827304|FG001|Overall Study|Lack of Efficacy|0|||
161939223|NCT02951819|584827303|FG000|Overall Study|Lost to Follow-up|1|||
161939224|NCT02951819|584827304|FG001|Overall Study|Lost to Follow-up|0|||
161939225|NCT02951819|584827303|FG000|Overall Study|Progressive Disease|1|||
161939226|NCT02951819|584827304|FG001|Overall Study|Progressive Disease|0|||
161939227|NCT02951819|584827303|FG000|Overall Study|Other|9|||
161939228|NCT02951819|584827304|FG001|Overall Study|Other|0|||
161939229|NCT02799043|584827305|FG000|Overall Study|Adverse Event|0|||
161939230|NCT02799043|584827306|FG001|Overall Study|Adverse Event|1|||
161939231|NCT02799043|584827305|FG000|Overall Study|Death|1|||
161939232|NCT02799043|584827306|FG001|Overall Study|Death|1|||
161939233|NCT02799043|584827305|FG000|Overall Study|Lost to Follow-up|3|||
161939234|NCT02799043|584827306|FG001|Overall Study|Lost to Follow-up|6|||
161939235|NCT02799043|584827305|FG000|Overall Study|Withdrawal by Subject|4|||
161939236|NCT02799043|584827306|FG001|Overall Study|Withdrawal by Subject|4|||
161939237|NCT02799043|584827305|FG000|Overall Study|Moved to different country|0|||
161939238|NCT02799043|584827306|FG001|Overall Study|Moved to different country|1|||
161939239|NCT02799043|584827305|FG000|Overall Study|Trial Screen Failure|1|||
161939240|NCT02799043|584827306|FG001|Overall Study|Trial Screen Failure|0|||
161939241|NCT02799043|584827305|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
161939242|NCT02799043|584827306|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
161939243|NCT04642079|584827307|FG000|Overall Study|Lost to Follow-up|2|||
161939244|NCT04642079|584827308|FG001|Overall Study|Lost to Follow-up|5|||
161939245|NCT04642079|584827309|FG002|Overall Study|Lost to Follow-up|2|||
161939246|NCT04642079|584827310|FG003|Overall Study|Lost to Follow-up|0|||
161939247|NCT04642079|584827307|FG000|Overall Study|Withdrawal by Subject|0|||
161939248|NCT04642079|584827308|FG001|Overall Study|Withdrawal by Subject|4|||
161939249|NCT04642079|584827309|FG002|Overall Study|Withdrawal by Subject|1|||
161939250|NCT04642079|584827310|FG003|Overall Study|Withdrawal by Subject|2|||
161939251|NCT04642079|584827307|FG000|Overall Study|Other|0|||
161939252|NCT04642079|584827308|FG001|Overall Study|Other|0|||
161939253|NCT04642079|584827309|FG002|Overall Study|Other|0|||
161939254|NCT04642079|584827310|FG003|Overall Study|Other|1|||
162023120|NCT03818035|585140996|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
162221169|NCT00895895|585860321|FG003|Period 1|Protocol Violation|0|||
162221170|NCT00895895|585860322|FG004|Period 1|Protocol Violation|0|||
162221171|NCT00895895|585860318|FG000|Period 1|Withdrawal by Subject|6|||
162221172|NCT00895895|585860319|FG001|Period 1|Withdrawal by Subject|6|||
162221173|NCT00895895|585860320|FG002|Period 1|Withdrawal by Subject|8|||
162221174|NCT00895895|585860321|FG003|Period 1|Withdrawal by Subject|2|||
162221175|NCT00895895|585860322|FG004|Period 1|Withdrawal by Subject|4|||
162221176|NCT00895895|585860318|FG000|Period 1|unsatisfactory response-efficacy|2|||
161678660|NCT00766090|583876050|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
162221177|NCT00895895|585860319|FG001|Period 1|unsatisfactory response-efficacy|0|||
161678661|NCT00766090|583876051|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161939255|NCT04642079|584827307|FG000|Overall Study|No longer met eligibility criteria|1|||
161939256|NCT04642079|584827308|FG001|Overall Study|No longer met eligibility criteria|0|||
161939257|NCT04642079|584827309|FG002|Overall Study|No longer met eligibility criteria|1|||
161939258|NCT04642079|584827310|FG003|Overall Study|No longer met eligibility criteria|1|||
161939259|NCT02226653|584827313|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
162221178|NCT00895895|585860320|FG002|Period 1|unsatisfactory response-efficacy|0|||
162221179|NCT00895895|585860321|FG003|Period 1|unsatisfactory response-efficacy|0|||
162221180|NCT00895895|585860322|FG004|Period 1|unsatisfactory response-efficacy|0|||
162221181|NCT00895895|585860318|FG000|Period 1|randomized and not treated|1|||
162221182|NCT00895895|585860319|FG001|Period 1|randomized and not treated|3|||
161829089|NCT00739973|584413672|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161829090|NCT00739973|584413673|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
161829091|NCT00739973|584413674|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161829092|NCT00739973|584413675|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161829093|NCT04149535|584413676|FG000|Overall Study|Death|11|||
161829094|NCT04149535|584413677|FG001|Overall Study|Death|7|||
161829095|NCT04149535|584413676|FG000|Overall Study|Physician Decision|10|||
161829096|NCT04149535|584413677|FG001|Overall Study|Physician Decision|4|||
161829097|NCT04149535|584413676|FG000|Overall Study|Withdrawal by Subject|6|||
161829098|NCT04149535|584413677|FG001|Overall Study|Withdrawal by Subject|7|||
161829099|NCT04149535|584413676|FG000|Overall Study|Not described|2|||
161829100|NCT04149535|584413677|FG001|Overall Study|Not described|0|||
161829101|NCT02175368|584413678|FG000|Overall Study|Lost to Follow-up|1|||
161829102|NCT02875028|584413679|FG000|Washout Period|Withdrawal by Subject|0|||
161829103|NCT02875028|584413680|FG001|Washout Period|Withdrawal by Subject|1|||
161829104|NCT05068284|584413681|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
161829105|NCT05068284|584413682|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
161829106|NCT05068284|584413683|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161829107|NCT05068284|584413684|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161829108|NCT05068284|584413685|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161829109|NCT05068284|584413686|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161829110|NCT05068284|584413687|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161829111|NCT05068284|584413688|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161829112|NCT05068284|584413681|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161829113|NCT05068284|584413682|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161939260|NCT02226653|584827314|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
161939261|NCT02226653|584827313|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
161939262|NCT02226653|584827314|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
161939263|NCT02420314|584827318|FG000|Overall Study|Withdrawal by Subject|1|||
162221183|NCT00895895|585860320|FG002|Period 1|randomized and not treated|1|||
162221184|NCT00895895|585860321|FG003|Period 1|randomized and not treated|1|||
162221185|NCT00895895|585860322|FG004|Period 1|randomized and not treated|2|||
162221186|NCT00895895|585860318|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
162221187|NCT00895895|585860319|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
162221188|NCT00895895|585860320|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
162221189|NCT00895895|585860321|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
162221190|NCT00895895|585860322|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
162221191|NCT00895895|585860318|FG000|After Period 1, Prior to Period 2|Other|0|||
162221192|NCT00895895|585860319|FG001|After Period 1, Prior to Period 2|Other|0|||
162221193|NCT00895895|585860320|FG002|After Period 1, Prior to Period 2|Other|1|||
162221194|NCT00895895|585860321|FG003|After Period 1, Prior to Period 2|Other|0|||
162221195|NCT00895895|585860322|FG004|After Period 1, Prior to Period 2|Other|0|||
162221196|NCT00895895|585860318|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
162221197|NCT00895895|585860319|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
162221198|NCT00895895|585860320|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
162221199|NCT00895895|585860321|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
162221200|NCT00895895|585860322|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
162221201|NCT00895895|585860318|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
162221202|NCT00895895|585860319|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
162221203|NCT00895895|585860320|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
162221204|NCT00895895|585860321|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
162221205|NCT00895895|585860322|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
162221206|NCT00895895|585860318|FG000|Period 2|Adverse Event|3|||
162221207|NCT00895895|585860319|FG001|Period 2|Adverse Event|3|||
162221208|NCT00895895|585860320|FG002|Period 2|Adverse Event|5|||
162221209|NCT00895895|585860321|FG003|Period 2|Adverse Event|2|||
161939264|NCT02420314|584827318|FG000|Overall Study|Protocol Violation|1|||
162221210|NCT00895895|585860322|FG004|Period 2|Adverse Event|5|||
161939265|NCT01618708|584827319|FG000|Overall Study|Adverse Event|10|||
161939266|NCT01618708|584827320|FG001|Overall Study|Adverse Event|10|||
161939267|NCT01618708|584827319|FG000|Overall Study|Lost to Follow-up|3|||
161939268|NCT01618708|584827320|FG001|Overall Study|Lost to Follow-up|3|||
161939269|NCT01618708|584827319|FG000|Overall Study|Withdrawal by Subject|17|||
161829114|NCT05068284|584413683|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
161829115|NCT05068284|584413684|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161939270|NCT01618708|584827320|FG001|Overall Study|Withdrawal by Subject|22|||
162023121|NCT03818035|585140997|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
162221211|NCT00895895|585860318|FG000|Period 2|Death|0|||
162221212|NCT00895895|585860319|FG001|Period 2|Death|0|||
162221213|NCT00895895|585860320|FG002|Period 2|Death|1|||
162221214|NCT00895895|585860321|FG003|Period 2|Death|0|||
162221215|NCT00895895|585860322|FG004|Period 2|Death|0|||
162221216|NCT00895895|585860318|FG000|Period 2|discontinued by sponsor|44|||
162221217|NCT00895895|585860319|FG001|Period 2|discontinued by sponsor|44|||
162221218|NCT00895895|585860320|FG002|Period 2|discontinued by sponsor|38|||
162221219|NCT00895895|585860321|FG003|Period 2|discontinued by sponsor|46|||
162221220|NCT00895895|585860322|FG004|Period 2|discontinued by sponsor|37|||
162221221|NCT00895895|585860318|FG000|Period 2|failed to return|2|||
162221222|NCT00895895|585860319|FG001|Period 2|failed to return|0|||
162221223|NCT00895895|585860320|FG002|Period 2|failed to return|0|||
162221224|NCT00895895|585860321|FG003|Period 2|failed to return|0|||
162221225|NCT00895895|585860322|FG004|Period 2|failed to return|0|||
162221226|NCT00895895|585860318|FG000|Period 2|investigator request|2|||
162221227|NCT00895895|585860319|FG001|Period 2|investigator request|0|||
162221228|NCT00895895|585860320|FG002|Period 2|investigator request|0|||
162221229|NCT00895895|585860321|FG003|Period 2|investigator request|0|||
162221230|NCT00895895|585860322|FG004|Period 2|investigator request|0|||
162221231|NCT00895895|585860318|FG000|Period 2|Lost to Follow-up|1|||
162221232|NCT00895895|585860319|FG001|Period 2|Lost to Follow-up|2|||
162221233|NCT00895895|585860320|FG002|Period 2|Lost to Follow-up|1|||
162221234|NCT00895895|585860321|FG003|Period 2|Lost to Follow-up|1|||
162221235|NCT00895895|585860322|FG004|Period 2|Lost to Follow-up|0|||
162221236|NCT00895895|585860318|FG000|Period 2|Other|1|||
162221237|NCT00895895|585860319|FG001|Period 2|Other|1|||
162221238|NCT00895895|585860320|FG002|Period 2|Other|3|||
162221239|NCT00895895|585860321|FG003|Period 2|Other|1|||
162221240|NCT00895895|585860322|FG004|Period 2|Other|1|||
162221241|NCT00895895|585860318|FG000|Period 2|Protocol Violation|1|||
162221242|NCT00895895|585860319|FG001|Period 2|Protocol Violation|0|||
162221243|NCT00895895|585860320|FG002|Period 2|Protocol Violation|1|||
162221244|NCT00895895|585860321|FG003|Period 2|Protocol Violation|1|||
162221245|NCT00895895|585860322|FG004|Period 2|Protocol Violation|1|||
162221246|NCT00895895|585860318|FG000|Period 2|Withdrawal by Subject|0|||
162221247|NCT00895895|585860319|FG001|Period 2|Withdrawal by Subject|2|||
162221248|NCT00895895|585860320|FG002|Period 2|Withdrawal by Subject|0|||
162221249|NCT00895895|585860321|FG003|Period 2|Withdrawal by Subject|3|||
162221250|NCT00895895|585860322|FG004|Period 2|Withdrawal by Subject|5|||
162221251|NCT00895895|585860318|FG000|Period 2|unsatisfactory response-efficacy|2|||
162221252|NCT00895895|585860319|FG001|Period 2|unsatisfactory response-efficacy|1|||
162221253|NCT00895895|585860320|FG002|Period 2|unsatisfactory response-efficacy|0|||
162221254|NCT00895895|585860321|FG003|Period 2|unsatisfactory response-efficacy|0|||
162221255|NCT00895895|585860322|FG004|Period 2|unsatisfactory response-efficacy|0|||
162221256|NCT03019640|585860323|FG000|Overall Study|Screen Failures|4|||
162221257|NCT03019640|585860323|FG000|Overall Study|Adverse Event|3|||
162221258|NCT03019640|585860323|FG000|Overall Study|Participant Relapsed|1|||
162221259|NCT01889069|585860326|FG000|Overall Study|Death|18|||
162221260|NCT01889069|585860326|FG000|Overall Study|Progression of Disease|14|||
162221261|NCT01889069|585860326|FG000|Overall Study|Lost to Follow-up|6|||
162221262|NCT01889069|585860326|FG000|Overall Study|Other|4|||
162221263|NCT01889069|585860326|FG000|Overall Study|Consent Withdrawal|3|||
162221264|NCT01426347|585860330|FG000|Overall Study|Lost to Follow-up|0|||
162221265|NCT01426347|585860331|FG001|Overall Study|Lost to Follow-up|3|||
162221266|NCT01426347|585860330|FG000|Overall Study|Protocol Violation|2|||
162221267|NCT01426347|585860331|FG001|Overall Study|Protocol Violation|0|||
161678662|NCT00766090|583876052|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678663|NCT00766090|583876053|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678664|NCT00766090|583876054|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678665|NCT00766090|583876055|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678666|NCT00766090|583876056|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678667|NCT00766090|583876057|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161678668|NCT00766090|583876046|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
161678669|NCT00766090|583876047|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
161829116|NCT05068284|584413685|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161829117|NCT05068284|584413686|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161829118|NCT05068284|584413687|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161829119|NCT05068284|584413688|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161829120|NCT05068284|584413681|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
161829121|NCT05068284|584413682|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
161829122|NCT05068284|584413683|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
161829123|NCT05068284|584413684|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
161829124|NCT05068284|584413685|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
161829125|NCT05068284|584413686|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
161829126|NCT05068284|584413687|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
161829127|NCT05068284|584413688|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
161829128|NCT05068284|584413681|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161829129|NCT05068284|584413682|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161829130|NCT05068284|584413683|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
161829131|NCT05068284|584413684|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161829132|NCT05068284|584413685|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
162221268|NCT01426347|585860330|FG000|Overall Study|Withdrawal by Subject|5|||
162221269|NCT01426347|585860331|FG001|Overall Study|Withdrawal by Subject|0|||
162221270|NCT00455741|585860332|FG000|Overall Study|Physician Decision|0|||
162221271|NCT00455741|585860333|FG001|Overall Study|Physician Decision|1|||
162221272|NCT03041792|585860334|FG000|Overall Study|Adverse Event|4|||
162221273|NCT03041792|585860335|FG001|Overall Study|Adverse Event|0|||
162221274|NCT03041792|585860334|FG000|Overall Study|Death in the family|0|||
162221275|NCT03041792|585860335|FG001|Overall Study|Death in the family|2|||
162221276|NCT03041792|585860334|FG000|Overall Study|Randomized but not treated|0|||
162221277|NCT03041792|585860335|FG001|Overall Study|Randomized but not treated|1|||
162221278|NCT04978090|585860336|FG000|Overall Study|unable to adequately fit device|2|||
162221279|NCT01509547|585860341|FG000|Overall Study|Lost to Follow-up|24|||
162221280|NCT01509547|585860342|FG001|Overall Study|Lost to Follow-up|14|||
162221281|NCT01509547|585860341|FG000|Overall Study|Withdrawal by Subject|11|||
162221282|NCT01509547|585860342|FG001|Overall Study|Withdrawal by Subject|24|||
162221283|NCT01509547|585860341|FG000|Overall Study|Physician Decision|0|||
162221284|NCT01509547|585860342|FG001|Overall Study|Physician Decision|1|||
162221285|NCT02227992|585860343|FG000|Overall Study|Lost to Follow-up|1|||
162221286|NCT02227992|585860344|FG001|Overall Study|Lost to Follow-up|1|||
162221287|NCT01371708|585860347|FG000|Overall Study|Insufficient clinical response|3|||
162221288|NCT01371708|585860348|FG001|Overall Study|Insufficient clinical response|2|||
162221289|NCT01371708|585860349|FG002|Overall Study|Insufficient clinical response|0|||
162221290|NCT01371708|585860347|FG000|Overall Study|Lost to Follow-up|5|||
162221291|NCT01371708|585860348|FG001|Overall Study|Lost to Follow-up|9|||
162221292|NCT01371708|585860349|FG002|Overall Study|Lost to Follow-up|7|||
162221293|NCT01371708|585860347|FG000|Overall Study|Protocol Violation|2|||
162221294|NCT01371708|585860348|FG001|Overall Study|Protocol Violation|1|||
162221295|NCT01371708|585860349|FG002|Overall Study|Protocol Violation|2|||
162221296|NCT01371708|585860347|FG000|Overall Study|No longer willing to participate|7|||
162221297|NCT01371708|585860348|FG001|Overall Study|No longer willing to participate|7|||
162221298|NCT01371708|585860349|FG002|Overall Study|No longer willing to participate|13|||
162221299|NCT01371708|585860347|FG000|Overall Study|Medication error/not related to AE|0|||
162221300|NCT01371708|585860348|FG001|Overall Study|Medication error/not related to AE|1|||
162221301|NCT01371708|585860349|FG002|Overall Study|Medication error/not related to AE|0|||
162221302|NCT01371708|585860347|FG000|Overall Study|Other|3|||
162221303|NCT01371708|585860348|FG001|Overall Study|Other|2|||
162221304|NCT01371708|585860349|FG002|Overall Study|Other|4|||
162221305|NCT01371708|585860347|FG000|Overall Study|Adverse Event|5|||
162221306|NCT01371708|585860348|FG001|Overall Study|Adverse Event|8|||
162221307|NCT01371708|585860349|FG002|Overall Study|Adverse Event|12|||
162221308|NCT01371708|585860347|FG000|Overall Study|Started but did not receive treatment|1|||
162221309|NCT01371708|585860348|FG001|Overall Study|Started but did not receive treatment|0|||
162221310|NCT01371708|585860349|FG002|Overall Study|Started but did not receive treatment|1|||
162221311|NCT02514551|585860350|FG000|Overall Study|Lost to Follow-up|0|||
162221312|NCT02514551|585860351|FG001|Overall Study|Lost to Follow-up|1|||
162221313|NCT02514551|585860350|FG000|Overall Study|Participant Never Treated|0|||
162221314|NCT02514551|585860351|FG001|Overall Study|Participant Never Treated|2|||
162221315|NCT00996606|585860362|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
162221316|NCT00996606|585860362|FG000|Overall Study|Insufficient Therapeutic Response|2|||
162221317|NCT00996606|585860362|FG000|Overall Study|Protocol Violation|1|||
162221318|NCT00996606|585860362|FG000|Overall Study|Withdrawal by Subject|3|||
162221319|NCT03197766|585860363|FG000|Overall Study|Withdrawal by Subject|2|||
162221320|NCT03197766|585860364|FG001|Overall Study|Withdrawal by Subject|0|||
162221321|NCT02964013|585862438|FG000|Overall Study|Death|58|||
162221322|NCT02964013|585862439|FG001|Overall Study|Death|239|||
162221323|NCT02964013|585862440|FG002|Overall Study|Death|38|||
161939271|NCT01618708|584827319|FG000|Overall Study|Lack of Efficacy|8|||
161939272|NCT01618708|584827320|FG001|Overall Study|Lack of Efficacy|8|||
161939273|NCT01618708|584827319|FG000|Overall Study|Technical problems|2|||
161939274|NCT01618708|584827320|FG001|Overall Study|Technical problems|0|||
161939275|NCT01618708|584827319|FG000|Overall Study|Other than specified above|1|||
161939276|NCT01618708|584827320|FG001|Overall Study|Other than specified above|1|||
161939277|NCT01618708|584827319|FG000|Overall Study|Randomized but not treated|3|||
161939278|NCT01618708|584827320|FG001|Overall Study|Randomized but not treated|2|||
161939279|NCT03131479|584827323|FG000|Overall Study|Adverse Event|0|||
161939280|NCT03131479|584827324|FG001|Overall Study|Adverse Event|0|||
161939281|NCT03131479|584827325|FG002|Overall Study|Adverse Event|1|||
161939282|NCT03131479|584827326|FG003|Overall Study|Adverse Event|1|||
161939283|NCT03131479|584827327|FG004|Overall Study|Adverse Event|0|||
161939284|NCT03131479|584827323|FG000|Overall Study|Subject/Guardian Decision|0|||
161939285|NCT03131479|584827324|FG001|Overall Study|Subject/Guardian Decision|0|||
161939286|NCT03131479|584827325|FG002|Overall Study|Subject/Guardian Decision|0|||
161939287|NCT03131479|584827326|FG003|Overall Study|Subject/Guardian Decision|1|||
161939288|NCT03131479|584827327|FG004|Overall Study|Subject/Guardian Decision|0|||
161939289|NCT02412436|584827328|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
161939290|NCT02412436|584827328|FG000|Overall Study|Lost to Follow-up|6|||
161939291|NCT02412436|584827328|FG000|Overall Study|Unable to get to clinic|3|||
162221324|NCT02964013|585862441|FG003|Overall Study|Death|10|||
162221325|NCT02964013|585862442|FG004|Overall Study|Death|33|||
162221326|NCT02964013|585862438|FG000|Overall Study|Lost to Follow-up|1|||
162221327|NCT02964013|585862439|FG001|Overall Study|Lost to Follow-up|4|||
162221328|NCT02964013|585862440|FG002|Overall Study|Lost to Follow-up|2|||
162221329|NCT02964013|585862441|FG003|Overall Study|Lost to Follow-up|0|||
162221330|NCT02964013|585862442|FG004|Overall Study|Lost to Follow-up|0|||
162221331|NCT02964013|585862438|FG000|Overall Study|Physician Decision|0|||
162221332|NCT02964013|585862439|FG001|Overall Study|Physician Decision|1|||
162221333|NCT02964013|585862440|FG002|Overall Study|Physician Decision|0|||
162221334|NCT02964013|585862441|FG003|Overall Study|Physician Decision|0|||
162221335|NCT02964013|585862442|FG004|Overall Study|Physician Decision|0|||
162221336|NCT02964013|585862438|FG000|Overall Study|Sponsor Decision|3|||
162221337|NCT02964013|585862439|FG001|Overall Study|Sponsor Decision|22|||
162221338|NCT02964013|585862440|FG002|Overall Study|Sponsor Decision|11|||
162221339|NCT02964013|585862441|FG003|Overall Study|Sponsor Decision|0|||
162221340|NCT02964013|585862442|FG004|Overall Study|Sponsor Decision|7|||
162221341|NCT02964013|585862438|FG000|Overall Study|Withdrawal by Subject|6|||
162221342|NCT02964013|585862439|FG001|Overall Study|Withdrawal by Subject|27|||
162221343|NCT02964013|585862440|FG002|Overall Study|Withdrawal by Subject|9|||
162221344|NCT02964013|585862441|FG003|Overall Study|Withdrawal by Subject|0|||
162221345|NCT02964013|585862442|FG004|Overall Study|Withdrawal by Subject|0|||
162221346|NCT02964013|585862438|FG000|Overall Study|Not Treated|0|||
162221347|NCT02964013|585862439|FG001|Overall Study|Not Treated|2|||
162221348|NCT02964013|585862440|FG002|Overall Study|Not Treated|0|||
162221349|NCT02964013|585862441|FG003|Overall Study|Not Treated|1|||
162221350|NCT02964013|585862442|FG004|Overall Study|Not Treated|0|||
162221351|NCT01123070|585862443|FG000|Part B Double Blind Period|Protocol Violation|0|||
162221352|NCT01123070|585862444|FG001|Part B Double Blind Period|Protocol Violation|0|||
162221353|NCT01123070|585862445|FG002|Part B Double Blind Period|Protocol Violation|0|||
162221354|NCT01123070|585862446|FG003|Part B Double Blind Period|Protocol Violation|1|||
162221355|NCT01123070|585862443|FG000|Part B Double Blind Period|Adverse Event|0|||
162221356|NCT01123070|585862444|FG001|Part B Double Blind Period|Adverse Event|0|||
162221357|NCT01123070|585862445|FG002|Part B Double Blind Period|Adverse Event|2|||
162221358|NCT01123070|585862446|FG003|Part B Double Blind Period|Adverse Event|0|||
162221359|NCT01123070|585862443|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
162221360|NCT01123070|585862444|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
162221361|NCT01123070|585862445|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
162221362|NCT01123070|585862446|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
162221363|NCT04942366|585862447|FG000|Overall Study|Withdrawal by Subject|5|||
161939292|NCT02412436|584827328|FG000|Overall Study|Death|1|||
161939293|NCT02412436|584827328|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
161939294|NCT01111552|584827329|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
161939295|NCT01111552|584827330|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161939296|NCT01111552|584827331|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161939297|NCT01111552|584827332|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
162221364|NCT04942366|585862448|FG001|Overall Study|Withdrawal by Subject|5|||
162221365|NCT00747227|585862451|FG000|Overall Study|Death|3|||
162221366|NCT00747227|585862452|FG001|Overall Study|Death|1|||
162221367|NCT00747227|585862451|FG000|Overall Study|Withdrawal by Subject|1|||
162221368|NCT00747227|585862452|FG001|Overall Study|Withdrawal by Subject|0|||
162221369|NCT00747227|585862451|FG000|Overall Study|Lost to Follow-up|1|||
162221370|NCT00747227|585862452|FG001|Overall Study|Lost to Follow-up|2|||
162221371|NCT00747227|585862451|FG000|Overall Study|Illness|1|||
162221372|NCT00747227|585862452|FG001|Overall Study|Illness|1|||
162221373|NCT03284229|585862453|FG000|Overall Study|Lost to Follow-up|3|||
162221374|NCT00918879|585862454|FG000|Overall Study|Withdrawal by Subject|4|||
162221375|NCT00918879|585862455|FG001|Overall Study|Withdrawal by Subject|4|||
162221376|NCT00918879|585862454|FG000|Overall Study|Lost to Follow-up|1|||
162221377|NCT00918879|585862455|FG001|Overall Study|Lost to Follow-up|1|||
162221378|NCT00918879|585862454|FG000|Overall Study|Severe non-compliance to protocol|1|||
162221379|NCT00918879|585862455|FG001|Overall Study|Severe non-compliance to protocol|1|||
162221380|NCT03339245|585862463|FG000|Overall Study|Adverse Event|1|||
162221381|NCT03339245|585862464|FG001|Overall Study|Adverse Event|1|||
162221382|NCT03339245|585862463|FG000|Overall Study|Withdrawal by Subject|1|||
162221383|NCT03339245|585862464|FG001|Overall Study|Withdrawal by Subject|0|||
162221384|NCT03435692|585862472|FG000|Overall Study|Lack of Efficacy|2|||
162221385|NCT03435692|585862473|FG001|Overall Study|Lack of Efficacy|2|||
162221386|NCT03435692|585862474|FG002|Overall Study|Lack of Efficacy|0|||
162221387|NCT01818531|585862480|FG000|Overall Study|Withdrawn for case delay after block|1|||
162221388|NCT01818531|585862481|FG001|Overall Study|Withdrawn for case delay after block|0|||
162221389|NCT01818531|585862480|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
162221390|NCT01818531|585862481|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
162221391|NCT01818531|585862480|FG000|Overall Study|Withdrawn for failure to place block|0|||
162221392|NCT01818531|585862481|FG001|Overall Study|Withdrawn for failure to place block|1|||
162221393|NCT00214019|585862482|FG000|Overall Study|Lost to Follow-up|11|||
162221394|NCT00214019|585862482|FG000|Overall Study|Withdrawal by Subject|2|||
162221395|NCT00214019|585862482|FG000|Overall Study|Screen Failed prior to randomization|17|||
161939298|NCT01111552|584827333|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161939299|NCT01111552|584827329|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
162221396|NCT00477490|585862483|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
162221397|NCT00477490|585862484|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
162221398|NCT00477490|585862485|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
162221399|NCT00477490|585862486|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
162221400|NCT00477490|585862487|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
162221401|NCT00477490|585862488|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
162221402|NCT00477490|585862489|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
162221403|NCT00477490|585862490|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
162221404|NCT00477490|585862491|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
162221405|NCT00477490|585862483|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
162221406|NCT00477490|585862484|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
162221407|NCT00477490|585862485|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
162221408|NCT00477490|585862486|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
162221409|NCT00477490|585862487|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
162221410|NCT00477490|585862488|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
162221411|NCT00477490|585862489|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
162221412|NCT00477490|585862490|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
162221413|NCT00477490|585862491|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
162221414|NCT00477490|585862483|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
162221415|NCT00477490|585862484|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
162221416|NCT00477490|585862485|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
162221417|NCT00477490|585862486|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
162221418|NCT00477490|585862487|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
162221419|NCT00477490|585862488|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
162221420|NCT00477490|585862489|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
162221421|NCT00477490|585862490|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
162221422|NCT00477490|585862491|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
162221423|NCT00477490|585862483|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
162221424|NCT00477490|585862484|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
162221425|NCT00477490|585862485|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
162221426|NCT00477490|585862486|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
161939300|NCT01111552|584827330|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161939301|NCT01111552|584827331|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161939302|NCT01111552|584827332|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161939303|NCT01111552|584827333|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161939304|NCT01111552|584827329|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
161939305|NCT01111552|584827330|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161939306|NCT01111552|584827331|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161939307|NCT01111552|584827332|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
162221427|NCT00477490|585862487|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
162221428|NCT00477490|585862488|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
162221429|NCT00477490|585862489|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
162221430|NCT00477490|585862490|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
162221431|NCT00477490|585862491|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
162221432|NCT00477490|585862483|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
162221433|NCT00477490|585862484|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
162221434|NCT00477490|585862485|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
162221435|NCT00477490|585862486|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
162221436|NCT00477490|585862487|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
162221437|NCT00477490|585862488|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
162221438|NCT00477490|585862489|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
162221439|NCT00477490|585862490|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
162221440|NCT00477490|585862491|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
162221441|NCT00477490|585862483|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
162221442|NCT00477490|585862484|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
162221443|NCT00477490|585862485|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
161939308|NCT01111552|584827333|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161939309|NCT01111552|584827329|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
162221444|NCT00477490|585862486|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
162221445|NCT00477490|585862487|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
162221446|NCT00477490|585862488|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
162221447|NCT00477490|585862489|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
162221448|NCT00477490|585862490|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
162221449|NCT00477490|585862491|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
162221450|NCT00477490|585862483|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
162221451|NCT00477490|585862484|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
162221452|NCT00477490|585862485|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
162221453|NCT00477490|585862486|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
162221454|NCT00477490|585862487|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
162221455|NCT00477490|585862488|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
162221456|NCT00477490|585862489|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
162221457|NCT00477490|585862490|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
162221458|NCT00477490|585862491|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
162221459|NCT00477490|585862483|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
162221460|NCT00477490|585862484|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
162221461|NCT00477490|585862485|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
162221462|NCT00477490|585862486|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
162221463|NCT00477490|585862487|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
162221464|NCT00477490|585862488|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
162221465|NCT00477490|585862489|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
162221466|NCT00477490|585862490|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
162221467|NCT00477490|585862491|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
162221468|NCT00477490|585862483|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
162221469|NCT00477490|585862484|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
162221470|NCT00477490|585862485|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
162221471|NCT00477490|585862486|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
162221472|NCT00477490|585862487|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
162221473|NCT00477490|585862488|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
162221474|NCT00477490|585862489|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
162221475|NCT00477490|585862490|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
161829133|NCT05068284|584413686|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161829134|NCT05068284|584413687|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
162221476|NCT00477490|585862491|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
162221477|NCT00477490|585862483|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
162221478|NCT00477490|585862484|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
162221479|NCT00477490|585862485|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
162221480|NCT00477490|585862486|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
162221481|NCT00477490|585862487|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
162221482|NCT00477490|585862488|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
162221483|NCT00477490|585862489|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
162221484|NCT00477490|585862490|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
162221485|NCT00477490|585862491|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
162221486|NCT00477490|585862483|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
162221487|NCT00477490|585862484|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
162221488|NCT00477490|585862485|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
162221489|NCT00477490|585862486|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
162221490|NCT00477490|585862487|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
162221491|NCT00477490|585862488|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
162221492|NCT00477490|585862489|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
162221493|NCT00477490|585862490|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
162221494|NCT00477490|585862491|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
162221495|NCT00477490|585862483|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162221496|NCT00477490|585862484|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
162221497|NCT00477490|585862485|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162221498|NCT00477490|585862486|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162221499|NCT00477490|585862487|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162221500|NCT00477490|585862488|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162221501|NCT00477490|585862489|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162221502|NCT00477490|585862490|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162221503|NCT00477490|585862491|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
162221504|NCT00477490|585862483|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
162221505|NCT00477490|585862484|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
162221506|NCT00477490|585862485|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
162221507|NCT00477490|585862486|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
161939310|NCT01111552|584827330|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
161939311|NCT01111552|584827331|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
161939312|NCT01111552|584827332|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
161939313|NCT01111552|584827333|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
162221508|NCT00477490|585862487|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
162221509|NCT00477490|585862488|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
162221510|NCT00477490|585862489|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
162221511|NCT00477490|585862490|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
162221512|NCT00477490|585862491|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
162221513|NCT00477490|585862483|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
162221514|NCT00477490|585862484|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
162221515|NCT00477490|585862485|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
162221516|NCT00477490|585862486|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
162221517|NCT00477490|585862487|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
162023122|NCT03818035|585140998|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
161939314|NCT01111552|584827329|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
161939315|NCT01111552|584827330|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
162023123|NCT03818035|585140999|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
162221518|NCT00477490|585862488|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161939316|NCT01111552|584827331|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
162023124|NCT03818035|585140996|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
162023125|NCT03818035|585140997|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
162023126|NCT03818035|585140998|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
162023127|NCT03818035|585140999|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
162023128|NCT03338959|585142593|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
162023129|NCT03338959|585142593|FG000|Overall Study|Physician Decision|1|||
162023130|NCT00409331|585142595|FG000|Overall Study|Physician Decision|1|||
162023131|NCT00281658|585142596|FG000|Randomized Phase|Adverse Event|0|||
162023132|NCT00281658|585142597|FG001|Randomized Phase|Adverse Event|2|||
162023133|NCT00281658|585142598|FG002|Randomized Phase|Adverse Event|0|||
162023134|NCT00281658|585142599|FG003|Randomized Phase|Adverse Event|0|||
162023135|NCT00281658|585142596|FG000|Randomized Phase|Lost to Follow-up|34|||
162023136|NCT00281658|585142597|FG001|Randomized Phase|Lost to Follow-up|27|||
162023137|NCT00281658|585142598|FG002|Randomized Phase|Lost to Follow-up|0|||
162023138|NCT00281658|585142599|FG003|Randomized Phase|Lost to Follow-up|0|||
162023139|NCT00281658|585142596|FG000|Randomized Phase|Withdrawal by Subject|8|||
162023140|NCT00281658|585142597|FG001|Randomized Phase|Withdrawal by Subject|7|||
162023141|NCT00281658|585142598|FG002|Randomized Phase|Withdrawal by Subject|0|||
162023142|NCT00281658|585142599|FG003|Randomized Phase|Withdrawal by Subject|0|||
162023143|NCT00281658|585142596|FG000|Randomized Phase|Study closed/terminated|1|||
162023144|NCT00281658|585142597|FG001|Randomized Phase|Study closed/terminated|1|||
162023145|NCT00281658|585142598|FG002|Randomized Phase|Study closed/terminated|0|||
162023146|NCT00281658|585142599|FG003|Randomized Phase|Study closed/terminated|0|||
162023147|NCT00281658|585142596|FG000|Randomized Phase|Disease progression|36|||
162023148|NCT00281658|585142597|FG001|Randomized Phase|Disease progression|27|||
162023149|NCT00281658|585142598|FG002|Randomized Phase|Disease progression|0|||
162023150|NCT00281658|585142599|FG003|Randomized Phase|Disease progression|0|||
162023151|NCT00281658|585142596|FG000|Randomized Phase|Physician Decision|1|||
162023152|NCT00281658|585142597|FG001|Randomized Phase|Physician Decision|1|||
162023153|NCT00281658|585142598|FG002|Randomized Phase|Physician Decision|0|||
162023154|NCT00281658|585142599|FG003|Randomized Phase|Physician Decision|0|||
162023155|NCT00281658|585142596|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
162023156|NCT00281658|585142597|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
162023157|NCT00281658|585142598|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
162023158|NCT00281658|585142599|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
162023159|NCT00281658|585142596|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
162023160|NCT00281658|585142597|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
162023161|NCT00281658|585142598|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
161939317|NCT01111552|584827332|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
161939318|NCT01111552|584827333|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
161939319|NCT01111552|584827329|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
161939320|NCT01111552|584827330|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
161939321|NCT01111552|584827331|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
162023162|NCT00281658|585142599|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
162023163|NCT00281658|585142596|FG000|Randomized Phase|Treatment ongoing|1|||
162023164|NCT00281658|585142597|FG001|Randomized Phase|Treatment ongoing|0|||
162023165|NCT00281658|585142598|FG002|Randomized Phase|Treatment ongoing|0|||
162023166|NCT00281658|585142599|FG003|Randomized Phase|Treatment ongoing|0|||
162023167|NCT00281658|585142596|FG000|Open Label Phase|Adverse Event|0|||
162236683|NCT01551212|585917027|FG000|Overall Study|Lost to Follow-up|0|||
162221519|NCT00477490|585862489|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
162221520|NCT00477490|585862490|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
162221521|NCT00477490|585862491|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
162221522|NCT01465763|585862494|FG000|Overall Study|Withdrawal by Subject|4|||
162221523|NCT01465763|585862495|FG001|Overall Study|Withdrawal by Subject|0|||
162221524|NCT01465763|585862496|FG002|Overall Study|Withdrawal by Subject|1|||
162221525|NCT01465763|585862494|FG000|Overall Study|Insufficient Clinical Response|11|||
162221526|NCT01465763|585862495|FG001|Overall Study|Insufficient Clinical Response|0|||
162221527|NCT01465763|585862496|FG002|Overall Study|Insufficient Clinical Response|1|||
162221528|NCT01465763|585862494|FG000|Overall Study|Adverse Event|9|||
162221529|NCT01465763|585862495|FG001|Overall Study|Adverse Event|0|||
162221530|NCT01465763|585862496|FG002|Overall Study|Adverse Event|1|||
162221531|NCT01465763|585862494|FG000|Overall Study|Other|2|||
162221532|NCT01465763|585862495|FG001|Overall Study|Other|0|||
162221533|NCT01465763|585862496|FG002|Overall Study|Other|0|||
162221534|NCT01465763|585862494|FG000|Overall Study|Protocol Violation|4|||
162221535|NCT01465763|585862495|FG001|Overall Study|Protocol Violation|1|||
162221536|NCT01465763|585862496|FG002|Overall Study|Protocol Violation|1|||
162221537|NCT01465763|585862494|FG000|Overall Study|Death|1|||
162221538|NCT01465763|585862495|FG001|Overall Study|Death|0|||
162221539|NCT01465763|585862496|FG002|Overall Study|Death|0|||
162221540|NCT01646177|585862497|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
162221541|NCT01646177|585862498|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
162221542|NCT01646177|585862499|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
162221543|NCT01646177|585862500|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
162023168|NCT00281658|585142597|FG001|Open Label Phase|Adverse Event|0|||
162023169|NCT00281658|585142598|FG002|Open Label Phase|Adverse Event|1|||
162023170|NCT00281658|585142599|FG003|Open Label Phase|Adverse Event|0|||
162023171|NCT00281658|585142596|FG000|Open Label Phase|Lost to Follow-up|0|||
162023172|NCT00281658|585142597|FG001|Open Label Phase|Lost to Follow-up|0|||
162023173|NCT00281658|585142598|FG002|Open Label Phase|Lost to Follow-up|16|||
162023174|NCT00281658|585142599|FG003|Open Label Phase|Lost to Follow-up|2|||
162023175|NCT00281658|585142596|FG000|Open Label Phase|Withdrawal by Subject|0|||
162023176|NCT00281658|585142597|FG001|Open Label Phase|Withdrawal by Subject|0|||
162023177|NCT00281658|585142598|FG002|Open Label Phase|Withdrawal by Subject|3|||
162023178|NCT00281658|585142599|FG003|Open Label Phase|Withdrawal by Subject|2|||
162023179|NCT00281658|585142596|FG000|Open Label Phase|Disease progression|0|||
162023180|NCT00281658|585142597|FG001|Open Label Phase|Disease progression|0|||
162023181|NCT00281658|585142598|FG002|Open Label Phase|Disease progression|18|||
162023182|NCT00281658|585142599|FG003|Open Label Phase|Disease progression|0|||
162023183|NCT00281658|585142596|FG000|Open Label Phase|Physician Decision|0|||
162023184|NCT00281658|585142597|FG001|Open Label Phase|Physician Decision|0|||
162221544|NCT01646177|585862501|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162221545|NCT01646177|585862502|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162221546|NCT01646177|585862503|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162023185|NCT00281658|585142598|FG002|Open Label Phase|Physician Decision|1|||
162023186|NCT00281658|585142599|FG003|Open Label Phase|Physician Decision|0|||
162023187|NCT00281658|585142596|FG000|Open Label Phase|Relocation of patient|0|||
162023188|NCT00281658|585142597|FG001|Open Label Phase|Relocation of patient|0|||
162023189|NCT00281658|585142598|FG002|Open Label Phase|Relocation of patient|1|||
162236684|NCT01551212|585917028|FG001|Overall Study|Lost to Follow-up|1|||
162236685|NCT01551212|585917027|FG000|Overall Study|Protocol Violation|0|||
162236686|NCT01551212|585917028|FG001|Overall Study|Protocol Violation|1|||
162236687|NCT01551212|585917027|FG000|Overall Study|Withdrawal by Subject|0|||
162236688|NCT01551212|585917028|FG001|Overall Study|Withdrawal by Subject|7|||
162236689|NCT01551212|585917027|FG000|Overall Study|Death|2|||
162236690|NCT01551212|585917028|FG001|Overall Study|Death|4|||
162236691|NCT01551212|585917027|FG000|Overall Study|Never Received Study Treatment|2|||
162236692|NCT01551212|585917028|FG001|Overall Study|Never Received Study Treatment|4|||
162236693|NCT04217590|585917029|FG000|Overall Study|Other|1|||
162236694|NCT04217590|585917030|FG001|Overall Study|Other|1|||
162236695|NCT04217590|585917029|FG000|Overall Study|Withdrawal by Subject|3|||
162236696|NCT04217590|585917030|FG001|Overall Study|Withdrawal by Subject|1|||
162236697|NCT04217590|585917029|FG000|Overall Study|Death|0|||
162236698|NCT04217590|585917030|FG001|Overall Study|Death|1|||
162236699|NCT01013285|585917031|FG000|Overall Study|Death|48|||
162236700|NCT01013285|585917032|FG001|Overall Study|Death|89|||
162236701|NCT01395888|585917033|FG000|2-week Run-in Period|Adverse Event|2|||
162236702|NCT01395888|585917034|FG001|2-week Run-in Period|Adverse Event|0|||
162236703|NCT01395888|585917035|FG002|2-week Run-in Period|Adverse Event|0|||
162236704|NCT01395888|585917033|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
162236705|NCT01395888|585917034|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
162236706|NCT01395888|585917035|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
162236707|NCT01395888|585917033|FG000|2-week Run-in Period|Lost to Follow-up|1|||
162236708|NCT01395888|585917034|FG001|2-week Run-in Period|Lost to Follow-up|0|||
162221547|NCT01646177|585862504|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162221548|NCT01646177|585862505|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162221549|NCT01646177|585862506|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162221550|NCT01646177|585862507|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162221551|NCT01646177|585862508|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
162221552|NCT01646177|585862497|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
162221553|NCT01646177|585862498|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
162221554|NCT01646177|585862499|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
162221555|NCT01646177|585862500|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
162221556|NCT01646177|585862501|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162221557|NCT01646177|585862502|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162221558|NCT01646177|585862503|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162023190|NCT00281658|585142599|FG003|Open Label Phase|Relocation of patient|0|||
162023191|NCT00281658|585142596|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
162023192|NCT00281658|585142597|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
162023193|NCT00281658|585142598|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
162023194|NCT00281658|585142599|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
162023195|NCT02151773|585142600|FG000|Overall Study|Protocol Deviation|64|||
162023196|NCT03680742|585142601|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
162023197|NCT02894502|585142604|FG000|Baseline|Withdrawal by Subject|24|||
162023198|NCT02894502|585142605|FG001|Baseline|Withdrawal by Subject|31|||
162023199|NCT02894502|585142606|FG002|Baseline|Withdrawal by Subject|36|||
162023200|NCT02894502|585142604|FG000|Baseline|Death|3|||
162023201|NCT02894502|585142605|FG001|Baseline|Death|1|||
162023202|NCT02894502|585142606|FG002|Baseline|Death|9|||
162023203|NCT02894502|585142604|FG000|First Follow up|Withdrawal by Subject|32|||
162023204|NCT02894502|585142605|FG001|First Follow up|Withdrawal by Subject|29|||
162023205|NCT02894502|585142606|FG002|First Follow up|Withdrawal by Subject|37|||
162023206|NCT02894502|585142604|FG000|First Follow up|Death|2|||
162023207|NCT02894502|585142605|FG001|First Follow up|Death|2|||
162023208|NCT02894502|585142606|FG002|First Follow up|Death|3|||
162023209|NCT02894502|585142604|FG000|Second Follow up|Withdrawal by Subject|13|||
162023210|NCT02894502|585142605|FG001|Second Follow up|Withdrawal by Subject|15|||
162023211|NCT02894502|585142606|FG002|Second Follow up|Withdrawal by Subject|13|||
162023212|NCT02894502|585142604|FG000|Second Follow up|Death|2|||
162023213|NCT02894502|585142605|FG001|Second Follow up|Death|3|||
162023214|NCT02894502|585142606|FG002|Second Follow up|Death|1|||
162023215|NCT02894502|585142604|FG000|Third Follow up|Withdrawal by Subject|5|||
162023216|NCT02894502|585142605|FG001|Third Follow up|Withdrawal by Subject|6|||
162023217|NCT02894502|585142606|FG002|Third Follow up|Withdrawal by Subject|3|||
162023218|NCT02894502|585142604|FG000|Third Follow up|Death|1|||
162023219|NCT02894502|585142605|FG001|Third Follow up|Death|1|||
162023220|NCT02894502|585142606|FG002|Third Follow up|Death|0|||
162023221|NCT01410357|585142607|FG000|Overall Study|Death|2|||
162023222|NCT01410357|585142608|FG001|Overall Study|Death|1|||
162023223|NCT01410357|585142607|FG000|Overall Study|Withdrawal by Subject|1|||
162023224|NCT01410357|585142608|FG001|Overall Study|Withdrawal by Subject|2|||
162023225|NCT01410357|585142607|FG000|Overall Study|Lost to Follow-up|23|||
162023226|NCT01410357|585142608|FG001|Overall Study|Lost to Follow-up|21|||
162023227|NCT01206322|585142612|FG000|Overall Study|Adverse Event|0|||
162023228|NCT01206322|585142613|FG001|Overall Study|Adverse Event|0|||
162023229|NCT01206322|585142614|FG002|Overall Study|Adverse Event|0|||
162023230|NCT01206322|585142615|FG003|Overall Study|Adverse Event|1|||
162023231|NCT00003590|585142619|FG000|Overall Study|Ineligible Patient|1|||
162023232|NCT00003590|585142619|FG000|Overall Study|Adverse Event|7|||
162023233|NCT00003590|585142619|FG000|Overall Study|Withdrawal by Subject|1|||
162023234|NCT00003590|585142619|FG000|Overall Study|Lack of Efficacy|11|||
162023235|NCT00003590|585142619|FG000|Overall Study|Death|1|||
162023236|NCT00003590|585142619|FG000|Overall Study|Physician Decision|1|||
162023237|NCT01589653|585142622|FG000|Overall Study|Protocol Violation|3|||
162023238|NCT01589653|585142623|FG001|Overall Study|Protocol Violation|1|||
162023239|NCT01589653|585142622|FG000|Overall Study|Withdrawal criteria|4|||
162023240|NCT01589653|585142623|FG001|Overall Study|Withdrawal criteria|7|||
162023241|NCT01589653|585142622|FG000|Overall Study|Unclassified|0|||
162023242|NCT01589653|585142623|FG001|Overall Study|Unclassified|3|||
162221559|NCT01646177|585862504|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162023243|NCT03700684|585142626|FG000|Overall Study|COVID-19|0|||
162023244|NCT03700684|585142627|FG001|Overall Study|COVID-19|0|||
162023245|NCT03700684|585142628|FG002|Overall Study|COVID-19|2|||
162023246|NCT04140227|585142629|FG000|Overall Study|Withdrawal by Subject|26|||
162023247|NCT04140227|585142629|FG000|Overall Study|Lost to Follow-up|8|||
162023248|NCT04140227|585142629|FG000|Overall Study|Adverse Event|8|||
162023249|NCT04140227|585142629|FG000|Overall Study|Death|1|||
162023250|NCT04140227|585142629|FG000|Overall Study|Other|3|||
162023251|NCT04140227|585142629|FG000|Overall Study|Protocol Violation|2|||
162023252|NCT00538785|585142630|FG000|Overall Study|Death|9|||
162023253|NCT00538785|585142631|FG001|Overall Study|Death|10|||
162221560|NCT01646177|585862505|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162221561|NCT01646177|585862506|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162221562|NCT01646177|585862507|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162221563|NCT01646177|585862508|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
162221564|NCT01646177|585862497|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
162221565|NCT01646177|585862498|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
162221566|NCT01646177|585862499|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
162221567|NCT01646177|585862500|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
162221568|NCT01646177|585862501|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162221569|NCT01646177|585862502|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162221570|NCT01646177|585862503|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162221571|NCT01646177|585862504|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162221572|NCT01646177|585862505|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162221573|NCT01646177|585862506|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162221574|NCT01646177|585862507|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162221575|NCT01646177|585862508|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
162221576|NCT01646177|585862497|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
162221577|NCT01646177|585862498|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
162221578|NCT01646177|585862499|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
162221579|NCT01646177|585862500|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
162221580|NCT01646177|585862501|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162221581|NCT01646177|585862502|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162221582|NCT01646177|585862503|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162221583|NCT01646177|585862504|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162221584|NCT01646177|585862505|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162221585|NCT01646177|585862506|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162221586|NCT01646177|585862507|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162221587|NCT01646177|585862508|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
162221588|NCT01646177|585862497|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161939322|NCT01111552|584827332|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
161939323|NCT01111552|584827333|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
161939324|NCT01111552|584827329|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
161939325|NCT01111552|584827330|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161939326|NCT01111552|584827331|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161939327|NCT01111552|584827332|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161939328|NCT01111552|584827333|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161939329|NCT01111552|584827329|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
161939330|NCT01111552|584827330|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
161939331|NCT01111552|584827331|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
161939332|NCT01111552|584827332|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
161939333|NCT01111552|584827333|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
161939334|NCT01111552|584827329|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161939335|NCT01111552|584827330|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161939336|NCT01111552|584827331|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161939337|NCT01111552|584827332|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
161939338|NCT01111552|584827333|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161939339|NCT01111552|584827329|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
161939340|NCT01111552|584827330|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
161939341|NCT01111552|584827331|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
161939342|NCT01111552|584827332|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
161939343|NCT01111552|584827333|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
161939344|NCT01111552|584827329|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
161939345|NCT01111552|584827330|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
162221589|NCT01646177|585862498|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162221590|NCT01646177|585862499|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
162221591|NCT01646177|585862500|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
162221592|NCT01646177|585862501|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162221593|NCT01646177|585862502|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162221594|NCT01646177|585862503|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162221595|NCT01646177|585862504|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162221596|NCT01646177|585862505|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162221597|NCT01646177|585862506|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161939346|NCT01111552|584827331|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
161939347|NCT01111552|584827332|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
161939348|NCT01111552|584827333|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
161939349|NCT01111552|584827329|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
161939350|NCT01111552|584827330|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
161939351|NCT01111552|584827331|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
161939352|NCT01111552|584827332|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
161939353|NCT01111552|584827333|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
161939354|NCT01111552|584827329|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
161939355|NCT01111552|584827330|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
161939356|NCT01111552|584827331|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
161939357|NCT01111552|584827332|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
161939358|NCT01111552|584827333|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
161939359|NCT01111552|584827329|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161939360|NCT01111552|584827330|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161939361|NCT01111552|584827331|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
161939362|NCT01111552|584827332|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161939363|NCT01111552|584827333|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161939364|NCT04976855|584827335|FG000|Part I|Withdrawal by Subject|0|||
161939365|NCT04976855|584827336|FG001|Part I|Withdrawal by Subject|1|||
161939366|NCT04976855|584827337|FG002|Part I|Withdrawal by Subject|0|||
161939367|NCT04976855|584827338|FG003|Part I|Withdrawal by Subject|0|||
161939368|NCT04976855|584827339|FG004|Part I|Withdrawal by Subject|0|||
161939369|NCT04976855|584827340|FG005|Part I|Withdrawal by Subject|0|||
161939370|NCT04976855|584827341|FG006|Part I|Withdrawal by Subject|0|||
161939371|NCT04976855|584827335|FG000|Part II|Adverse Event|0|||
161939372|NCT04976855|584827336|FG001|Part II|Adverse Event|0|||
161939373|NCT04976855|584827337|FG002|Part II|Adverse Event|0|||
161939374|NCT04976855|584827338|FG003|Part II|Adverse Event|1|||
161939375|NCT04976855|584827339|FG004|Part II|Adverse Event|0|||
161939376|NCT04976855|584827340|FG005|Part II|Adverse Event|0|||
161939377|NCT04976855|584827341|FG006|Part II|Adverse Event|0|||
161939378|NCT04976855|584827335|FG000|Part II|Withdrawal by Subject|0|||
161939379|NCT04976855|584827336|FG001|Part II|Withdrawal by Subject|0|||
161939380|NCT04976855|584827337|FG002|Part II|Withdrawal by Subject|0|||
161939381|NCT04976855|584827338|FG003|Part II|Withdrawal by Subject|0|||
161939382|NCT04976855|584827339|FG004|Part II|Withdrawal by Subject|1|||
161939383|NCT04976855|584827340|FG005|Part II|Withdrawal by Subject|0|||
161939384|NCT04976855|584827341|FG006|Part II|Withdrawal by Subject|0|||
161939385|NCT04976855|584827335|FG000|Part II|Lost to Follow-up|0|||
161939386|NCT04976855|584827336|FG001|Part II|Lost to Follow-up|0|||
161939387|NCT04976855|584827337|FG002|Part II|Lost to Follow-up|0|||
161939388|NCT04976855|584827338|FG003|Part II|Lost to Follow-up|0|||
161939389|NCT04976855|584827339|FG004|Part II|Lost to Follow-up|0|||
161939390|NCT04976855|584827340|FG005|Part II|Lost to Follow-up|1|||
161939391|NCT04976855|584827341|FG006|Part II|Lost to Follow-up|0|||
161939392|NCT02038036|584827342|FG000|Core Study|Adverse Event|7|||
161939393|NCT02038036|584827343|FG001|Core Study|Adverse Event|7|||
161939394|NCT02038036|584827342|FG000|Core Study|Death|1|||
161939395|NCT02038036|584827343|FG001|Core Study|Death|1|||
161939396|NCT02038036|584827342|FG000|Core Study|Disease progression|2|||
161939397|NCT02038036|584827343|FG001|Core Study|Disease progression|2|||
161939398|NCT02038036|584827342|FG000|Core Study|Lost to Follow-up|0|||
161939399|NCT02038036|584827343|FG001|Core Study|Lost to Follow-up|1|||
161939400|NCT02038036|584827342|FG000|Core Study|Physician Decision|2|||
161939401|NCT02038036|584827343|FG001|Core Study|Physician Decision|1|||
161939402|NCT02038036|584827342|FG000|Core Study|Subject/guardian decision|0|||
161939403|NCT02038036|584827343|FG001|Core Study|Subject/guardian decision|1|||
161939404|NCT02038036|584827342|FG000|Core Study|Withdrawal by Subject|3|||
161939405|NCT02038036|584827343|FG001|Core Study|Withdrawal by Subject|1|||
161939406|NCT02038036|584827342|FG000|Crossover Period|Withdrawal by Subject|0|||
161939407|NCT02038036|584827343|FG001|Crossover Period|Withdrawal by Subject|3|||
161939408|NCT02038036|584827342|FG000|Crossover Period|Adverse Event|0|||
161939409|NCT02038036|584827343|FG001|Crossover Period|Adverse Event|9|||
162221598|NCT01646177|585862507|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162221599|NCT01646177|585862508|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
162221600|NCT01646177|585862497|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
162221601|NCT01646177|585862498|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
162221602|NCT01646177|585862499|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
162221603|NCT01646177|585862500|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162221604|NCT01646177|585862501|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162221605|NCT01646177|585862502|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162221606|NCT01646177|585862503|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162221607|NCT01646177|585862504|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162221608|NCT01646177|585862505|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162221609|NCT01646177|585862506|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162221610|NCT01646177|585862507|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162221611|NCT01646177|585862508|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
162221612|NCT01646177|585862497|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162221613|NCT01646177|585862498|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162221614|NCT01646177|585862499|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162221615|NCT01646177|585862500|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162221616|NCT01646177|585862501|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
162221617|NCT01646177|585862502|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
162221618|NCT01646177|585862503|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
162221619|NCT01646177|585862504|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
162221620|NCT01646177|585862505|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162221621|NCT01646177|585862506|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162221622|NCT01646177|585862507|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162221623|NCT01646177|585862508|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
162221624|NCT01646177|585862497|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162221625|NCT01646177|585862498|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162221626|NCT01646177|585862499|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162221627|NCT01646177|585862500|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162221628|NCT01646177|585862501|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
162221629|NCT01646177|585862502|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
162221630|NCT01646177|585862503|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
162221631|NCT01646177|585862504|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
162221632|NCT01646177|585862505|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162221633|NCT01646177|585862506|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162221634|NCT01646177|585862507|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162221635|NCT01646177|585862508|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
162221636|NCT01646177|585862497|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162221637|NCT01646177|585862498|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162221638|NCT01646177|585862499|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162221639|NCT01646177|585862500|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162221640|NCT01646177|585862501|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
162221641|NCT01646177|585862502|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
162221642|NCT01646177|585862503|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
162221643|NCT01646177|585862504|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
162221644|NCT01646177|585862505|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162221645|NCT01646177|585862506|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162221646|NCT01646177|585862507|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162221647|NCT01646177|585862508|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
162221648|NCT01646177|585862497|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162221649|NCT01646177|585862498|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162221650|NCT01646177|585862499|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162221651|NCT01646177|585862500|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162221652|NCT01646177|585862501|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
162221653|NCT01646177|585862502|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
162221654|NCT01646177|585862503|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
162221655|NCT01646177|585862504|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
162221656|NCT01646177|585862505|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161829135|NCT05068284|584413688|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161829136|NCT05068284|584413681|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161829137|NCT05068284|584413682|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161829138|NCT05068284|584413683|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161829139|NCT05068284|584413684|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
161939410|NCT02038036|584827342|FG000|Crossover Period|Death|0|||
162221657|NCT01646177|585862506|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162221658|NCT01646177|585862507|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162221659|NCT01646177|585862508|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
162221660|NCT01646177|585862497|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162221661|NCT01646177|585862498|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162221662|NCT01646177|585862499|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162221663|NCT01646177|585862500|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162221664|NCT01646177|585862501|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
161939411|NCT02038036|584827343|FG001|Crossover Period|Death|2|||
161939412|NCT02038036|584827342|FG000|Crossover Period|Disease progression|0|||
161939413|NCT02038036|584827343|FG001|Crossover Period|Disease progression|3|||
161939414|NCT02038036|584827342|FG000|Crossover Period|Lost to Follow-up|0|||
161939415|NCT02038036|584827343|FG001|Crossover Period|Lost to Follow-up|1|||
161939416|NCT02038036|584827342|FG000|Crossover Period|Physician Decision|0|||
161939417|NCT02038036|584827343|FG001|Crossover Period|Physician Decision|2|||
161939418|NCT00908141|584827352|FG000|Overall Study|Withdrawal by Subject|0|||
161939419|NCT00908141|584827353|FG001|Overall Study|Withdrawal by Subject|1|||
161939420|NCT02657356|584828627|FG000|Overall Study|Death|1|||
161939421|NCT02657356|584828628|FG001|Overall Study|Death|0|||
161939422|NCT02657356|584828627|FG000|Overall Study|Withdrawal by Subject|5|||
161939423|NCT02657356|584828628|FG001|Overall Study|Withdrawal by Subject|6|||
161939424|NCT02657356|584828627|FG000|Overall Study|Terminated by Sponsor|8|||
161939425|NCT02657356|584828628|FG001|Overall Study|Terminated by Sponsor|5|||
161939426|NCT02657356|584828627|FG000|Overall Study|Rolled over to EAP study|6|||
161939427|NCT02657356|584828628|FG001|Overall Study|Rolled over to EAP study|4|||
161939428|NCT03514134|584828629|FG000|Overall Study|Lost to Follow-up|0|||
161939429|NCT03514134|584828630|FG001|Overall Study|Lost to Follow-up|1|||
161939430|NCT00856557|584828633|FG000|Overall Study|No patients with contextual flags|12|||
161939431|NCT00856557|584828634|FG001|Overall Study|No patients with contextual flags|16|||
161939432|NCT02684461|584828635|FG000|Overall Study|Adverse Event|1|||
161939433|NCT02684461|584828636|FG001|Overall Study|Adverse Event|0|||
161939434|NCT02684461|584828637|FG002|Overall Study|Adverse Event|0|||
161939435|NCT02684461|584828635|FG000|Overall Study|Lack of Efficacy|1|||
162221665|NCT01646177|585862502|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
162221666|NCT01646177|585862503|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
162221667|NCT01646177|585862504|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
162221668|NCT01646177|585862505|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162221669|NCT01646177|585862506|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162221670|NCT01646177|585862507|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162221671|NCT01646177|585862508|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
162221672|NCT01646177|585862497|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162221673|NCT01646177|585862498|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162221674|NCT01646177|585862499|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162221675|NCT01646177|585862500|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162221676|NCT01646177|585862501|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
162221677|NCT01646177|585862502|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
162221678|NCT01646177|585862503|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162221679|NCT01646177|585862504|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
162221680|NCT01646177|585862505|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162221681|NCT01646177|585862506|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162221682|NCT01646177|585862507|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162221683|NCT01646177|585862508|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
162221684|NCT01646177|585862497|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162221685|NCT01646177|585862498|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162221686|NCT01646177|585862499|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162221687|NCT01646177|585862500|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162221688|NCT01646177|585862501|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
162221689|NCT01646177|585862502|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
162221690|NCT01646177|585862503|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
162221691|NCT01646177|585862504|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
161939436|NCT02684461|584828636|FG001|Overall Study|Lack of Efficacy|2|||
161939437|NCT02684461|584828637|FG002|Overall Study|Lack of Efficacy|0|||
161939438|NCT04507763|584828647|FG000|Overall Study|Participants did not meet entrance criteria|201|||
161939439|NCT03322566|584828648|FG000|Overall Study|Death|34|||
161939440|NCT03322566|584828649|FG001|Overall Study|Death|35|||
161939441|NCT03322566|584828650|FG002|Overall Study|Death|23|||
161939442|NCT03322566|584828648|FG000|Overall Study|Physician Decision|6|||
162221692|NCT01646177|585862505|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161939443|NCT03322566|584828649|FG001|Overall Study|Physician Decision|7|||
162221693|NCT01646177|585862506|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162221694|NCT01646177|585862507|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162221695|NCT01646177|585862508|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
162221696|NCT01646177|585862497|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
162221697|NCT01646177|585862498|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
162221698|NCT01646177|585862499|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
162221699|NCT01646177|585862500|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
162221700|NCT01646177|585862501|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
162221701|NCT01646177|585862502|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
162221702|NCT01646177|585862503|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
162221703|NCT01646177|585862504|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
162221704|NCT01646177|585862505|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
162221705|NCT01646177|585862506|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
162221706|NCT01646177|585862507|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
162221707|NCT01646177|585862508|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
162221708|NCT01646177|585862497|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162221709|NCT01646177|585862498|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162221710|NCT01646177|585862499|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162221711|NCT01646177|585862500|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162221712|NCT01646177|585862501|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
162221713|NCT01646177|585862502|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
162221714|NCT01646177|585862503|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
162221715|NCT01646177|585862504|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
162221716|NCT01646177|585862505|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162221717|NCT01646177|585862506|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162221718|NCT01646177|585862507|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162221719|NCT01646177|585862508|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
162221720|NCT01646177|585862497|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162221721|NCT01646177|585862498|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162221722|NCT01646177|585862499|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162221723|NCT01646177|585862500|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162221724|NCT01646177|585862501|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162221725|NCT01646177|585862502|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162221726|NCT01646177|585862503|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162221727|NCT01646177|585862504|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
162221728|NCT01646177|585862505|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162221729|NCT01646177|585862506|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162221730|NCT01646177|585862507|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162221731|NCT01646177|585862508|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
162221732|NCT01646177|585862497|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162221733|NCT01646177|585862498|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162221734|NCT01646177|585862499|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162221735|NCT01646177|585862500|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162221736|NCT01646177|585862501|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162221737|NCT01646177|585862502|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
162221738|NCT01646177|585862503|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
162221739|NCT01646177|585862504|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
162221740|NCT01646177|585862505|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162221741|NCT01646177|585862506|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162221742|NCT01646177|585862507|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162221743|NCT01646177|585862508|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
162221744|NCT01646177|585862497|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162221745|NCT01646177|585862498|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162221746|NCT01646177|585862499|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162221747|NCT01646177|585862500|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162221748|NCT01646177|585862501|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161939444|NCT03322566|584828650|FG002|Overall Study|Physician Decision|2|||
161939445|NCT03322566|584828648|FG000|Overall Study|Withdrawal by Subject|4|||
161939446|NCT03322566|584828649|FG001|Overall Study|Withdrawal by Subject|3|||
161939447|NCT03322566|584828650|FG002|Overall Study|Withdrawal by Subject|6|||
161939448|NCT03322566|584828648|FG000|Overall Study|Lost to Follow-up|0|||
161939449|NCT03322566|584828649|FG001|Overall Study|Lost to Follow-up|0|||
161939450|NCT03322566|584828650|FG002|Overall Study|Lost to Follow-up|1|||
162221749|NCT01646177|585862502|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161939451|NCT03322566|584828648|FG000|Overall Study|Study terminated by sponsor|1|||
162221750|NCT01646177|585862503|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162221751|NCT01646177|585862504|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
162221752|NCT01646177|585862505|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
162221753|NCT01646177|585862506|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
162221754|NCT01646177|585862507|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
162221755|NCT01646177|585862508|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
162221756|NCT01646177|585862497|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162221757|NCT01646177|585862498|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162221758|NCT01646177|585862499|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162221759|NCT01646177|585862500|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162221760|NCT01646177|585862501|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162221761|NCT01646177|585862502|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162221762|NCT01646177|585862503|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162221763|NCT01646177|585862504|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
162221764|NCT01646177|585862505|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
162221765|NCT01646177|585862506|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
162221766|NCT01646177|585862507|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
162221767|NCT01646177|585862508|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
162221768|NCT01646177|585862497|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162221769|NCT01646177|585862498|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162221770|NCT01646177|585862499|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162221771|NCT01646177|585862500|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162221772|NCT01646177|585862501|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162221773|NCT01646177|585862502|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162221774|NCT01646177|585862503|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162221775|NCT01646177|585862504|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
162221776|NCT01646177|585862505|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
162221777|NCT01646177|585862506|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
162221778|NCT01646177|585862507|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
162221779|NCT01646177|585862508|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
162221780|NCT01646177|585862497|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162221781|NCT01646177|585862498|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162221782|NCT01646177|585862499|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162221783|NCT01646177|585862500|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162221784|NCT01646177|585862501|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162221785|NCT01646177|585862502|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162221786|NCT01646177|585862503|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162221787|NCT01646177|585862504|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
162221788|NCT01646177|585862505|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
162221789|NCT01646177|585862506|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
162221790|NCT01646177|585862507|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
162221791|NCT01646177|585862508|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
162221792|NCT01646177|585862497|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162221793|NCT01646177|585862498|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162221794|NCT01646177|585862499|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162221795|NCT01646177|585862500|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162221796|NCT01646177|585862501|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162221797|NCT01646177|585862502|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162221798|NCT01646177|585862503|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162221799|NCT01646177|585862504|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
162221800|NCT01646177|585862505|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
162221801|NCT01646177|585862506|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
162221802|NCT01646177|585862507|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
162221803|NCT01646177|585862508|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
162221804|NCT01646177|585862497|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162221805|NCT01646177|585862498|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162221806|NCT01646177|585862499|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162221807|NCT01646177|585862500|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162023254|NCT00538785|585142630|FG000|Overall Study|Withdrawal of consent|9|||
162221808|NCT01646177|585862501|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162221809|NCT01646177|585862502|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162221810|NCT01646177|585862503|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162221811|NCT01646177|585862504|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
162221812|NCT01646177|585862505|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
162221813|NCT01646177|585862506|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
162221814|NCT01646177|585862507|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
162221815|NCT01646177|585862508|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
162221816|NCT01646177|585862497|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162221817|NCT01646177|585862498|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162221818|NCT01646177|585862499|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162221819|NCT01646177|585862500|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162221820|NCT01646177|585862501|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162221821|NCT01646177|585862502|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162221822|NCT01646177|585862503|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162221823|NCT01646177|585862504|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162221824|NCT01646177|585862505|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
162221825|NCT01646177|585862506|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
162221826|NCT01646177|585862507|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
162221827|NCT01646177|585862508|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
162221828|NCT01646177|585862497|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162221829|NCT01646177|585862498|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162221830|NCT01646177|585862499|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162221831|NCT01646177|585862500|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162221832|NCT01646177|585862501|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162221833|NCT01646177|585862502|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162221834|NCT01646177|585862503|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162221835|NCT01646177|585862504|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162221836|NCT01646177|585862505|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
162221837|NCT01646177|585862506|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
162221838|NCT01646177|585862507|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
162221839|NCT01646177|585862508|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
162221840|NCT01646177|585862497|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162221841|NCT01646177|585862498|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162221842|NCT01646177|585862499|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162221843|NCT01646177|585862500|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162221844|NCT01646177|585862501|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162221845|NCT01646177|585862502|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162221846|NCT01646177|585862503|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162221847|NCT01646177|585862504|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162221848|NCT01646177|585862505|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
162221849|NCT01646177|585862506|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
162221850|NCT01646177|585862507|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
162221851|NCT01646177|585862508|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
162221852|NCT01646177|585862497|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162221853|NCT01646177|585862498|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162221854|NCT01646177|585862499|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162221855|NCT01646177|585862500|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162221856|NCT01646177|585862501|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162221857|NCT01646177|585862502|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162221858|NCT01646177|585862503|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162221859|NCT01646177|585862504|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162221860|NCT01646177|585862505|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162221861|NCT01646177|585862506|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
162221862|NCT01646177|585862507|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
162221863|NCT01646177|585862508|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
162221864|NCT01038427|585862511|FG000|Overall Study|Lost to follow up|1|||
162221865|NCT01038427|585862512|FG001|Overall Study|Lost to follow up|1|||
162221866|NCT01038427|585862513|FG002|Overall Study|Lost to follow up|0|||
162221867|NCT01038427|585862511|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
162221868|NCT01038427|585862512|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
162221869|NCT01038427|585862513|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
162221870|NCT01038427|585862511|FG000|Overall Study|Withdrew consent|0|||
162221871|NCT01038427|585862512|FG001|Overall Study|Withdrew consent|0|||
162221872|NCT01038427|585862513|FG002|Overall Study|Withdrew consent|1|||
162023255|NCT00538785|585142631|FG001|Overall Study|Withdrawal of consent|7|||
162023256|NCT00538785|585142630|FG000|Overall Study|Lost to Follow-up|1|||
162023257|NCT00538785|585142631|FG001|Overall Study|Lost to Follow-up|0|||
162023258|NCT01767142|585142633|FG000|Overall Study|Lost to Follow-up|3|||
161829140|NCT05068284|584413685|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162023259|NCT03317405|585142634|FG000|Overall Study|Withdrawal by Subject|1|||
162023260|NCT03317405|585142635|FG001|Overall Study|Withdrawal by Subject|0|||
162023261|NCT03317405|585142636|FG002|Overall Study|Withdrawal by Subject|0|||
162023262|NCT03317405|585142634|FG000|Overall Study|Physician Decision|0|||
162023263|NCT03317405|585142635|FG001|Overall Study|Physician Decision|0|||
162023264|NCT03317405|585142636|FG002|Overall Study|Physician Decision|1|||
162023265|NCT03317405|585142634|FG000|Overall Study|Surgery Rescheduled|0|||
162023266|NCT03317405|585142635|FG001|Overall Study|Surgery Rescheduled|1|||
162023267|NCT03317405|585142636|FG002|Overall Study|Surgery Rescheduled|0|||
162023268|NCT00635219|585142637|FG000|Overall Study|Adverse Event|12|||
162023269|NCT00635219|585142638|FG001|Overall Study|Adverse Event|10|||
162023270|NCT00635219|585142639|FG002|Overall Study|Adverse Event|18|||
162023271|NCT00635219|585142640|FG003|Overall Study|Adverse Event|15|||
162023272|NCT00635219|585142641|FG004|Overall Study|Adverse Event|19|||
162023273|NCT00635219|585142637|FG000|Overall Study|Lack of Efficacy|5|||
162023274|NCT00635219|585142638|FG001|Overall Study|Lack of Efficacy|6|||
162023275|NCT00635219|585142639|FG002|Overall Study|Lack of Efficacy|3|||
162023276|NCT00635219|585142640|FG003|Overall Study|Lack of Efficacy|4|||
162023277|NCT00635219|585142641|FG004|Overall Study|Lack of Efficacy|6|||
162023278|NCT00635219|585142637|FG000|Overall Study|Non-compliance With Study Product|0|||
162023279|NCT00635219|585142638|FG001|Overall Study|Non-compliance With Study Product|0|||
162221873|NCT01038427|585862511|FG000|Overall Study|Adverse Event|2|||
162221874|NCT01038427|585862512|FG001|Overall Study|Adverse Event|2|||
162221875|NCT01038427|585862513|FG002|Overall Study|Adverse Event|1|||
162221876|NCT01038427|585862511|FG000|Overall Study|Enrolled in error|0|||
162221877|NCT01038427|585862512|FG001|Overall Study|Enrolled in error|1|||
162221878|NCT01038427|585862513|FG002|Overall Study|Enrolled in error|1|||
162221879|NCT01038427|585862511|FG000|Overall Study|Other|0|||
162221880|NCT01038427|585862512|FG001|Overall Study|Other|2|||
162221881|NCT01038427|585862513|FG002|Overall Study|Other|0|||
162221882|NCT02992691|585862514|FG000|Overall Study|Adverse Event|2|||
162221883|NCT02992691|585862514|FG000|Overall Study|Withdrawal by Subject|1|||
162221884|NCT00588692|585862515|FG000|Overall Study|Withdrawal by Subject|4|||
162221885|NCT00588692|585862516|FG001|Overall Study|Withdrawal by Subject|2|||
162221886|NCT00588692|585862515|FG000|Overall Study|Hip Surgery|0|||
162221887|NCT00588692|585862516|FG001|Overall Study|Hip Surgery|1|||
162221888|NCT00588692|585862515|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
162221889|NCT00588692|585862516|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
162221890|NCT00588692|585862515|FG000|Overall Study|Cancer|1|||
162221891|NCT00588692|585862516|FG001|Overall Study|Cancer|0|||
162221892|NCT00588692|585862515|FG000|Overall Study|Death|1|||
162221893|NCT00588692|585862516|FG001|Overall Study|Death|0|||
162221894|NCT00820170|585862518|FG000|Overall Study|Adverse Event|0|||
162221895|NCT00820170|585862519|FG001|Overall Study|Adverse Event|0|||
162221896|NCT00820170|585862520|FG002|Overall Study|Adverse Event|0|||
162221897|NCT00820170|585862521|FG003|Overall Study|Adverse Event|0|||
162221898|NCT00820170|585862522|FG004|Overall Study|Adverse Event|2|||
162221899|NCT00820170|585862518|FG000|Overall Study|Progressive Disease|0|||
162221900|NCT00820170|585862519|FG001|Overall Study|Progressive Disease|0|||
162221901|NCT00820170|585862520|FG002|Overall Study|Progressive Disease|0|||
162221902|NCT00820170|585862521|FG003|Overall Study|Progressive Disease|0|||
162221903|NCT00820170|585862522|FG004|Overall Study|Progressive Disease|2|||
162221904|NCT03538938|585862523|FG000|Overall Study|Death|0|||
162221905|NCT03538938|585862524|FG001|Overall Study|Death|0|||
162221906|NCT03538938|585862525|FG002|Overall Study|Death|2|||
162221907|NCT03538938|585862526|FG003|Overall Study|Death|0|||
162221908|NCT03538938|585862527|FG004|Overall Study|Death|0|||
162221909|NCT03538938|585862528|FG005|Overall Study|Death|1|||
162221910|NCT03538938|585862529|FG006|Overall Study|Death|0|||
162221911|NCT03538938|585862530|FG007|Overall Study|Death|1|||
162023280|NCT00635219|585142639|FG002|Overall Study|Non-compliance With Study Product|0|||
162221912|NCT03538938|585862531|FG008|Overall Study|Death|1|||
162221913|NCT03538938|585862532|FG009|Overall Study|Death|1|||
162221914|NCT03538938|585862533|FG010|Overall Study|Death|0|||
162023281|NCT00635219|585142640|FG003|Overall Study|Non-compliance With Study Product|2|||
162023282|NCT00635219|585142641|FG004|Overall Study|Non-compliance With Study Product|1|||
162023283|NCT00635219|585142637|FG000|Overall Study|Protocol Violation|0|||
162023284|NCT00635219|585142638|FG001|Overall Study|Protocol Violation|2|||
162023285|NCT00635219|585142639|FG002|Overall Study|Protocol Violation|3|||
162023286|NCT00635219|585142640|FG003|Overall Study|Protocol Violation|2|||
162221915|NCT03538938|585862534|FG011|Overall Study|Death|0|||
162221916|NCT03538938|585862535|FG012|Overall Study|Death|1|||
162221917|NCT03538938|585862536|FG013|Overall Study|Death|1|||
162221918|NCT03538938|585862537|FG014|Overall Study|Death|0|||
162221919|NCT03538938|585862538|FG015|Overall Study|Death|1|||
162221920|NCT03538938|585862523|FG000|Overall Study|Withdrawal by Subject|4|||
162221921|NCT03538938|585862524|FG001|Overall Study|Withdrawal by Subject|6|||
162221922|NCT03538938|585862525|FG002|Overall Study|Withdrawal by Subject|5|||
162221923|NCT03538938|585862526|FG003|Overall Study|Withdrawal by Subject|3|||
162221924|NCT03538938|585862527|FG004|Overall Study|Withdrawal by Subject|0|||
162221925|NCT03538938|585862528|FG005|Overall Study|Withdrawal by Subject|0|||
162221926|NCT03538938|585862529|FG006|Overall Study|Withdrawal by Subject|3|||
162221927|NCT03538938|585862530|FG007|Overall Study|Withdrawal by Subject|1|||
162221928|NCT03538938|585862531|FG008|Overall Study|Withdrawal by Subject|5|||
162221929|NCT03538938|585862532|FG009|Overall Study|Withdrawal by Subject|1|||
162221930|NCT03538938|585862533|FG010|Overall Study|Withdrawal by Subject|2|||
162221931|NCT03538938|585862534|FG011|Overall Study|Withdrawal by Subject|1|||
162221932|NCT03538938|585862535|FG012|Overall Study|Withdrawal by Subject|3|||
162221933|NCT03538938|585862536|FG013|Overall Study|Withdrawal by Subject|0|||
162221934|NCT03538938|585862537|FG014|Overall Study|Withdrawal by Subject|2|||
162221935|NCT03538938|585862538|FG015|Overall Study|Withdrawal by Subject|4|||
162221936|NCT03538938|585862523|FG000|Overall Study|Incarcerated|0|||
162221937|NCT03538938|585862524|FG001|Overall Study|Incarcerated|0|||
162221938|NCT03538938|585862525|FG002|Overall Study|Incarcerated|0|||
162221939|NCT03538938|585862526|FG003|Overall Study|Incarcerated|0|||
162221940|NCT03538938|585862527|FG004|Overall Study|Incarcerated|0|||
162221941|NCT03538938|585862528|FG005|Overall Study|Incarcerated|0|||
162221942|NCT03538938|585862529|FG006|Overall Study|Incarcerated|0|||
162221943|NCT03538938|585862530|FG007|Overall Study|Incarcerated|0|||
162221944|NCT03538938|585862531|FG008|Overall Study|Incarcerated|0|||
162221945|NCT03538938|585862532|FG009|Overall Study|Incarcerated|0|||
162221946|NCT03538938|585862533|FG010|Overall Study|Incarcerated|0|||
162221947|NCT03538938|585862534|FG011|Overall Study|Incarcerated|1|||
162221948|NCT03538938|585862535|FG012|Overall Study|Incarcerated|0|||
162221949|NCT03538938|585862536|FG013|Overall Study|Incarcerated|0|||
162221950|NCT03538938|585862537|FG014|Overall Study|Incarcerated|0|||
162221951|NCT03538938|585862538|FG015|Overall Study|Incarcerated|0|||
162221952|NCT00755105|585862539|FG000|Overall Study|Withdrawal by Subject|9|||
162221953|NCT00755105|585862540|FG001|Overall Study|Withdrawal by Subject|11|||
162221954|NCT00755105|585862541|FG002|Overall Study|Withdrawal by Subject|4|||
162221955|NCT03995316|585862542|FG000|Overall Study|Lost to Follow-up|10|||
162221956|NCT03995316|585862543|FG001|Overall Study|Lost to Follow-up|3|||
162221957|NCT02202785|585862544|FG000|Overall Study|Study Terminated by Sponsor|1|||
162221958|NCT02202785|585862545|FG001|Overall Study|Study Terminated by Sponsor|6|||
162221959|NCT02202785|585862546|FG002|Overall Study|Study Terminated by Sponsor|4|||
162221960|NCT02202785|585862544|FG000|Overall Study|Withdrawal by Subject|0|||
162221961|NCT02202785|585862545|FG001|Overall Study|Withdrawal by Subject|1|||
162221962|NCT02202785|585862546|FG002|Overall Study|Withdrawal by Subject|0|||
162221963|NCT02202785|585862544|FG000|Overall Study|Lost to Follow-up|0|||
162221964|NCT02202785|585862545|FG001|Overall Study|Lost to Follow-up|1|||
162221965|NCT02202785|585862546|FG002|Overall Study|Lost to Follow-up|0|||
162221966|NCT02202785|585862544|FG000|Overall Study|Reason not Specified|10|||
162221967|NCT02202785|585862545|FG001|Overall Study|Reason not Specified|7|||
162221968|NCT02202785|585862546|FG002|Overall Study|Reason not Specified|13|||
162221969|NCT02180243|585862547|FG000|Overall Study|Withdrawal by Subject|12|||
162221970|NCT02180243|585862548|FG001|Overall Study|Withdrawal by Subject|12|||
162221971|NCT02180243|585862547|FG000|Overall Study|Lost to Follow-up|12|||
162221972|NCT02180243|585862548|FG001|Overall Study|Lost to Follow-up|2|||
162221973|NCT01137578|585862549|FG000|Overall Study|Participant requested to Discontinue|3|||
162221974|NCT01137578|585862550|FG001|Overall Study|Participant requested to Discontinue|0|||
162221975|NCT01137578|585862551|FG002|Overall Study|Participant requested to Discontinue|0|||
162221976|NCT01137578|585862549|FG000|Overall Study|Withdrawal by Subject|1|||
162221977|NCT01137578|585862550|FG001|Overall Study|Withdrawal by Subject|0|||
162221978|NCT01137578|585862551|FG002|Overall Study|Withdrawal by Subject|0|||
162221979|NCT01137578|585862549|FG000|Overall Study|Other|12|||
162221980|NCT01137578|585862550|FG001|Overall Study|Other|2|||
162221981|NCT01137578|585862551|FG002|Overall Study|Other|6|||
162221982|NCT03651700|585862552|FG000|Overall Study|Withdrawal by Subject|1|||
162221983|NCT03651700|585862553|FG001|Overall Study|Withdrawal by Subject|0|||
162221984|NCT05479734|585862555|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
162221985|NCT05479734|585862556|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
162221986|NCT05479734|585862555|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
162221987|NCT05479734|585862556|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
162221988|NCT05479734|585862555|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
162221989|NCT05479734|585862556|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
161829141|NCT05068284|584413686|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161829142|NCT05068284|584413687|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161829143|NCT05068284|584413688|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
162221990|NCT05479734|585862555|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
162221991|NCT05479734|585862556|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
162221992|NCT01461005|585862557|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
162221993|NCT00203268|585862558|FG000|Early Treatment|only treated one headache|2|||
162221994|NCT00203268|585862558|FG000|Early Treatment|Lost to Follow-up|1|||
162221995|NCT00203268|585862558|FG000|Early Treatment|Withdrawal by Subject|1|||
162221996|NCT00600613|585862559|FG000|Overall Study|Protocol Deviation|1|||
162221997|NCT00664534|585862560|FG000|Overall Study|Adverse Event|2|||
161829144|NCT05068284|584413681|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161829145|NCT05068284|584413682|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161829146|NCT05068284|584413683|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
161829147|NCT05068284|584413684|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
161829148|NCT05068284|584413685|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161829149|NCT05068284|584413686|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161829150|NCT05068284|584413687|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161939452|NCT03322566|584828649|FG001|Overall Study|Study terminated by sponsor|0|||
161939453|NCT03322566|584828650|FG002|Overall Study|Study terminated by sponsor|1|||
161939454|NCT01602484|584828651|FG000|Overall Study|Airway issues unrelated to study|0|||
161939455|NCT01602484|584828652|FG001|Overall Study|Airway issues unrelated to study|1|||
162221998|NCT00664534|585862561|FG001|Overall Study|Adverse Event|3|||
162221999|NCT00664534|585862560|FG000|Overall Study|Lost to Follow-up|6|||
162222000|NCT00664534|585862561|FG001|Overall Study|Lost to Follow-up|10|||
162222001|NCT00664534|585862560|FG000|Overall Study|Protocol Violation|10|||
162222002|NCT00664534|585862561|FG001|Overall Study|Protocol Violation|8|||
162222003|NCT00664534|585862560|FG000|Overall Study|Withdrawal by Subject|7|||
162222004|NCT00664534|585862561|FG001|Overall Study|Withdrawal by Subject|6|||
162222005|NCT00664534|585862560|FG000|Overall Study|Physician Decision|8|||
162222006|NCT00664534|585862561|FG001|Overall Study|Physician Decision|0|||
162222007|NCT00664534|585862560|FG000|Overall Study|Sponsor decision|8|||
162222008|NCT00664534|585862561|FG001|Overall Study|Sponsor decision|6|||
162222009|NCT00935532|585862566|FG000|Overall Study|Adverse Event|11|||
162222010|NCT00935532|585862567|FG001|Overall Study|Adverse Event|6|||
162222011|NCT00935532|585862566|FG000|Overall Study|Death|1|||
162222012|NCT00935532|585862567|FG001|Overall Study|Death|0|||
162222013|NCT00935532|585862566|FG000|Overall Study|Lost to Follow-up|1|||
162222014|NCT00935532|585862567|FG001|Overall Study|Lost to Follow-up|0|||
162222015|NCT00935532|585862566|FG000|Overall Study|Physician Decision|1|||
162222016|NCT00935532|585862567|FG001|Overall Study|Physician Decision|2|||
162222017|NCT00935532|585862566|FG000|Overall Study|Protocol Violation|2|||
162222018|NCT00935532|585862567|FG001|Overall Study|Protocol Violation|1|||
162222019|NCT00935532|585862566|FG000|Overall Study|Subject Decision|2|||
162222020|NCT00935532|585862567|FG001|Overall Study|Subject Decision|1|||
162222021|NCT00935532|585862566|FG000|Overall Study|Sponsor Decision|0|||
162222022|NCT00935532|585862567|FG001|Overall Study|Sponsor Decision|1|||
162222023|NCT00935532|585862566|FG000|Overall Study|Loss Glucose Control|4|||
161678670|NCT00766090|583876048|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
161939456|NCT00425555|584828655|FG000|Overall Study|Withdrawal by Subject|11|||
161939457|NCT00425555|584828656|FG001|Overall Study|Withdrawal by Subject|8|||
161939458|NCT00425555|584828655|FG000|Overall Study|Lost to Follow-up|0|||
161939459|NCT00425555|584828656|FG001|Overall Study|Lost to Follow-up|1|||
162222024|NCT00935532|585862567|FG001|Overall Study|Loss Glucose Control|0|||
162222025|NCT01399918|585862569|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
162222026|NCT00245960|585862570|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
162222027|NCT00245960|585862571|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
162222028|NCT00245960|585862570|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
161678671|NCT00766090|583876049|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
161678672|NCT00766090|583876050|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
161678673|NCT00766090|583876051|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
161678674|NCT00766090|583876052|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
161678675|NCT00766090|583876053|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
161678676|NCT00766090|583876054|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
161678677|NCT00766090|583876055|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
161939460|NCT00425555|584828655|FG000|Overall Study|Administrative problems|3|||
161939461|NCT00425555|584828656|FG001|Overall Study|Administrative problems|0|||
161939462|NCT00425555|584828655|FG000|Overall Study|Death|1|||
161939463|NCT00425555|584828656|FG001|Overall Study|Death|2|||
161939464|NCT00425555|584828655|FG000|Overall Study|New cancer therapy|2|||
161939465|NCT00425555|584828656|FG001|Overall Study|New cancer therapy|1|||
161939466|NCT00425555|584828655|FG000|Overall Study|Disease progression|36|||
162222029|NCT00245960|585862571|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
161939467|NCT00425555|584828656|FG001|Overall Study|Disease progression|33|||
162222030|NCT00245960|585862570|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
161939468|NCT00425555|584828655|FG000|Overall Study|Adverse Event|25|||
162222031|NCT00245960|585862571|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
162222032|NCT00245960|585862570|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
162222033|NCT00245960|585862571|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
162222034|NCT00245960|585862570|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
162222035|NCT00245960|585862571|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
162222036|NCT00245960|585862570|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
162222037|NCT00245960|585862571|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
162222038|NCT00245960|585862570|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
162222039|NCT00245960|585862571|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
162222040|NCT00245960|585862570|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
162222041|NCT00245960|585862571|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
162222042|NCT00245960|585862570|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
162222043|NCT00245960|585862571|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
162222044|NCT00245960|585862570|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
162222045|NCT00245960|585862571|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
162222046|NCT00245960|585862570|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
162222047|NCT00245960|585862571|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
162222048|NCT00245960|585862570|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
162222049|NCT00245960|585862571|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
162222050|NCT01436253|585862573|FG000|Overall Study|Lost to Follow-up|182|||
162222051|NCT01436253|585862573|FG000|Overall Study|Not meeting all eligibility criteria|117|||
162222052|NCT03083665|585862575|FG000|Double-Blind Period|Adverse Event|5|||
162222053|NCT03083665|585862576|FG001|Double-Blind Period|Adverse Event|4|||
162222054|NCT03083665|585862577|FG002|Double-Blind Period|Adverse Event|5|||
162023287|NCT00635219|585142641|FG004|Overall Study|Protocol Violation|4|||
162222055|NCT03083665|585862578|FG003|Double-Blind Period|Adverse Event|0|||
162222056|NCT03083665|585862579|FG004|Double-Blind Period|Adverse Event|0|||
162222057|NCT03083665|585862580|FG005|Double-Blind Period|Adverse Event|0|||
162222058|NCT03083665|585862575|FG000|Double-Blind Period|Lack of Efficacy|0|||
162222059|NCT03083665|585862576|FG001|Double-Blind Period|Lack of Efficacy|0|||
162222060|NCT03083665|585862577|FG002|Double-Blind Period|Lack of Efficacy|1|||
162222061|NCT03083665|585862578|FG003|Double-Blind Period|Lack of Efficacy|0|||
162222062|NCT03083665|585862579|FG004|Double-Blind Period|Lack of Efficacy|0|||
162023288|NCT00635219|585142637|FG000|Overall Study|Withdrawal of Consent|8|||
161829151|NCT05068284|584413688|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161829152|NCT05068284|584413681|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829153|NCT05068284|584413682|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829154|NCT05068284|584413683|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
161829155|NCT05068284|584413684|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829156|NCT05068284|584413685|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829157|NCT05068284|584413686|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829158|NCT05068284|584413687|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829159|NCT05068284|584413688|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161829160|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
162222063|NCT03083665|585862580|FG005|Double-Blind Period|Lack of Efficacy|0|||
162222064|NCT03083665|585862575|FG000|Double-Blind Period|Protocol Violation|1|||
161829161|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161829162|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161829163|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161829164|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161829165|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
162222065|NCT03083665|585862576|FG001|Double-Blind Period|Protocol Violation|0|||
162222066|NCT03083665|585862577|FG002|Double-Blind Period|Protocol Violation|1|||
162222067|NCT03083665|585862578|FG003|Double-Blind Period|Protocol Violation|0|||
162222068|NCT03083665|585862579|FG004|Double-Blind Period|Protocol Violation|0|||
162222069|NCT03083665|585862580|FG005|Double-Blind Period|Protocol Violation|0|||
162222070|NCT03083665|585862575|FG000|Double-Blind Period|Lost to Follow-up|1|||
162222071|NCT03083665|585862576|FG001|Double-Blind Period|Lost to Follow-up|0|||
162222072|NCT03083665|585862577|FG002|Double-Blind Period|Lost to Follow-up|1|||
162222073|NCT03083665|585862578|FG003|Double-Blind Period|Lost to Follow-up|0|||
162222074|NCT03083665|585862579|FG004|Double-Blind Period|Lost to Follow-up|0|||
162222075|NCT03083665|585862580|FG005|Double-Blind Period|Lost to Follow-up|0|||
162222076|NCT03083665|585862575|FG000|Double-Blind Period|Withdrawal by Subject|3|||
162222077|NCT03083665|585862576|FG001|Double-Blind Period|Withdrawal by Subject|0|||
162222078|NCT03083665|585862577|FG002|Double-Blind Period|Withdrawal by Subject|0|||
162222079|NCT03083665|585862578|FG003|Double-Blind Period|Withdrawal by Subject|0|||
162222080|NCT03083665|585862579|FG004|Double-Blind Period|Withdrawal by Subject|0|||
162222081|NCT03083665|585862580|FG005|Double-Blind Period|Withdrawal by Subject|0|||
162222082|NCT03083665|585862575|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
162222083|NCT03083665|585862576|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
162222084|NCT03083665|585862577|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
162222085|NCT03083665|585862578|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
162222086|NCT03083665|585862579|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
162222087|NCT03083665|585862580|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
162222088|NCT03083665|585862575|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
162222089|NCT03083665|585862576|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
162222090|NCT03083665|585862577|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
162222091|NCT03083665|585862578|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
162222092|NCT03083665|585862579|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
162222093|NCT03083665|585862580|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
162222094|NCT03083665|585862575|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
162222095|NCT03083665|585862576|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
162222096|NCT03083665|585862577|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
162222097|NCT03083665|585862578|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
162222098|NCT03083665|585862579|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
162222099|NCT03083665|585862580|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
162222100|NCT03083665|585862575|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
162222101|NCT03083665|585862576|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
162222102|NCT03083665|585862577|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
161939469|NCT00425555|584828656|FG001|Overall Study|Adverse Event|15|||
161939470|NCT00425555|584828655|FG000|Overall Study|Protocol Violation|1|||
161939471|NCT00425555|584828656|FG001|Overall Study|Protocol Violation|0|||
161939472|NCT01674062|584828665|FG000|Overall Study|Insufficient Therapeutic Response|56|||
161939473|NCT01674062|584828666|FG001|Overall Study|Insufficient Therapeutic Response|26|||
161939474|NCT01674062|584828665|FG000|Overall Study|Other|8|||
161939475|NCT01674062|584828666|FG001|Overall Study|Other|1|||
161939476|NCT01674062|584828665|FG000|Overall Study|Adverse Event|1|||
161939477|NCT01674062|584828666|FG001|Overall Study|Adverse Event|1|||
161939478|NCT01674062|584828665|FG000|Overall Study|Death|0|||
162222103|NCT03083665|585862578|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
162222104|NCT03083665|585862579|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
161829166|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161829167|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161829168|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
161829169|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161829170|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161829171|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161829172|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161829173|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
161829174|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
161829175|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161829176|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
161829177|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161829178|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161829179|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161829180|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161829181|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161829182|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
161829183|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161829184|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
161829185|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161829186|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161829187|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161829188|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161829189|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161829190|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
162222105|NCT03083665|585862580|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
162222106|NCT03083665|585862575|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
162222107|NCT03083665|585862576|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
162222108|NCT03083665|585862577|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
162222109|NCT03083665|585862578|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
162222110|NCT03083665|585862579|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
162222111|NCT03083665|585862580|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
162222112|NCT03083665|585862575|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
162222113|NCT03083665|585862576|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
162222114|NCT03083665|585862577|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
162222115|NCT03083665|585862578|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
162222116|NCT03083665|585862579|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
162222117|NCT03083665|585862580|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
162222118|NCT03083665|585862575|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
162222119|NCT03083665|585862576|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
162222120|NCT03083665|585862577|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
162222121|NCT03083665|585862578|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
162222122|NCT03083665|585862579|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
162222123|NCT03083665|585862580|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
162222124|NCT03083665|585862575|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
162222125|NCT03083665|585862576|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
162222126|NCT03083665|585862577|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
162222127|NCT03083665|585862578|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
162222128|NCT03083665|585862579|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
162222129|NCT03083665|585862580|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
162222130|NCT03083665|585862575|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
162222131|NCT03083665|585862576|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
162222132|NCT03083665|585862577|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
162222133|NCT03083665|585862578|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
162222134|NCT03083665|585862579|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
162222135|NCT03083665|585862580|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
162222136|NCT02519348|585862581|FG000|Overall Study|Death|31|||
162222137|NCT02519348|585862582|FG001|Overall Study|Death|74|||
162222138|NCT02519348|585862583|FG002|Overall Study|Death|47|||
162222139|NCT02519348|585862584|FG003|Overall Study|Death|54|||
162222140|NCT02519348|585862585|FG004|Overall Study|Death|63|||
162222141|NCT02519348|585862586|FG005|Overall Study|Death|18|||
162222142|NCT02519348|585862587|FG006|Overall Study|Death|2|||
162222143|NCT02519348|585862588|FG007|Overall Study|Death|5|||
162222144|NCT02519348|585862589|FG008|Overall Study|Death|5|||
162222145|NCT02519348|585862581|FG000|Overall Study|Withdrawal by Subject|4|||
162222146|NCT02519348|585862582|FG001|Overall Study|Withdrawal by Subject|7|||
162222147|NCT02519348|585862583|FG002|Overall Study|Withdrawal by Subject|4|||
162222148|NCT02519348|585862584|FG003|Overall Study|Withdrawal by Subject|3|||
162222149|NCT02519348|585862585|FG004|Overall Study|Withdrawal by Subject|3|||
162222150|NCT02519348|585862586|FG005|Overall Study|Withdrawal by Subject|2|||
162222151|NCT02519348|585862587|FG006|Overall Study|Withdrawal by Subject|0|||
162222152|NCT02519348|585862588|FG007|Overall Study|Withdrawal by Subject|0|||
162222153|NCT02519348|585862589|FG008|Overall Study|Withdrawal by Subject|1|||
162222154|NCT02519348|585862581|FG000|Overall Study|Lost to Follow-up|0|||
162023289|NCT00635219|585142638|FG001|Overall Study|Withdrawal of Consent|6|||
162023290|NCT00635219|585142639|FG002|Overall Study|Withdrawal of Consent|8|||
162023291|NCT00635219|585142640|FG003|Overall Study|Withdrawal of Consent|11|||
162023292|NCT00635219|585142641|FG004|Overall Study|Withdrawal of Consent|8|||
162023293|NCT00635219|585142637|FG000|Overall Study|Lost to Follow-up|0|||
162023294|NCT00635219|585142638|FG001|Overall Study|Lost to Follow-up|0|||
162023295|NCT00635219|585142639|FG002|Overall Study|Lost to Follow-up|2|||
162023296|NCT00635219|585142640|FG003|Overall Study|Lost to Follow-up|0|||
162023297|NCT00635219|585142641|FG004|Overall Study|Lost to Follow-up|3|||
162023298|NCT00635219|585142637|FG000|Overall Study|Administrative or Other Reasons|0|||
162023299|NCT00635219|585142638|FG001|Overall Study|Administrative or Other Reasons|1|||
162023300|NCT00635219|585142639|FG002|Overall Study|Administrative or Other Reasons|1|||
161678678|NCT00766090|583876056|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
161678679|NCT00766090|583876057|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
162023301|NCT00635219|585142640|FG003|Overall Study|Administrative or Other Reasons|0|||
162222155|NCT02519348|585862582|FG001|Overall Study|Lost to Follow-up|0|||
162222156|NCT02519348|585862583|FG002|Overall Study|Lost to Follow-up|1|||
162222157|NCT02519348|585862584|FG003|Overall Study|Lost to Follow-up|0|||
162222158|NCT02519348|585862585|FG004|Overall Study|Lost to Follow-up|2|||
162222159|NCT02519348|585862586|FG005|Overall Study|Lost to Follow-up|1|||
162222160|NCT02519348|585862587|FG006|Overall Study|Lost to Follow-up|1|||
162222161|NCT02519348|585862588|FG007|Overall Study|Lost to Follow-up|0|||
162222162|NCT02519348|585862589|FG008|Overall Study|Lost to Follow-up|0|||
162222163|NCT02519348|585862581|FG000|Overall Study|Other|0|||
162222164|NCT02519348|585862582|FG001|Overall Study|Other|3|||
162222165|NCT02519348|585862583|FG002|Overall Study|Other|0|||
162222166|NCT02519348|585862584|FG003|Overall Study|Other|0|||
162222167|NCT02519348|585862585|FG004|Overall Study|Other|1|||
162222168|NCT02519348|585862586|FG005|Overall Study|Other|0|||
162222169|NCT02519348|585862587|FG006|Overall Study|Other|0|||
162222170|NCT02519348|585862588|FG007|Overall Study|Other|0|||
162222171|NCT02519348|585862589|FG008|Overall Study|Other|0|||
162222172|NCT02519348|585862581|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
162222173|NCT02519348|585862582|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
162222174|NCT02519348|585862583|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
162222175|NCT02519348|585862584|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
162222176|NCT02519348|585862585|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
162222177|NCT02519348|585862586|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
162222178|NCT02519348|585862587|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
162222179|NCT02519348|585862588|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
162222180|NCT02519348|585862589|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
162222181|NCT04844879|585862590|FG000|Overall Study|Death|1|||
162222182|NCT04844879|585862590|FG000|Overall Study|Withdrawal by Subject|1|||
161678680|NCT00766090|583876046|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162023302|NCT00635219|585142641|FG004|Overall Study|Administrative or Other Reasons|1|||
162023303|NCT04093024|585142644|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
162222183|NCT04844879|585862590|FG000|Overall Study|Adverse Event|1|||
162222184|NCT04103892|585862596|FG000|Overall Study|Adverse Event|0|||
162222185|NCT04103892|585862597|FG001|Overall Study|Adverse Event|0|||
162222186|NCT04103892|585862598|FG002|Overall Study|Adverse Event|0|||
162222187|NCT04103892|585862599|FG003|Overall Study|Adverse Event|3|||
161678681|NCT00766090|583876047|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
162023304|NCT04093024|585142645|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
162023305|NCT04093024|585142644|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
162222188|NCT04103892|585862596|FG000|Overall Study|Lost to Follow-up|0|||
162222189|NCT04103892|585862597|FG001|Overall Study|Lost to Follow-up|0|||
162222190|NCT04103892|585862598|FG002|Overall Study|Lost to Follow-up|2|||
162222191|NCT04103892|585862599|FG003|Overall Study|Lost to Follow-up|0|||
162222192|NCT04103892|585862596|FG000|Overall Study|Protocol Violation|0|||
162222193|NCT04103892|585862597|FG001|Overall Study|Protocol Violation|0|||
162222194|NCT04103892|585862598|FG002|Overall Study|Protocol Violation|1|||
162222195|NCT04103892|585862599|FG003|Overall Study|Protocol Violation|1|||
162222196|NCT04103892|585862596|FG000|Overall Study|Withdrawal by Subject|1|||
162222197|NCT04103892|585862597|FG001|Overall Study|Withdrawal by Subject|0|||
162222198|NCT04103892|585862598|FG002|Overall Study|Withdrawal by Subject|2|||
162222199|NCT04103892|585862599|FG003|Overall Study|Withdrawal by Subject|5|||
162222200|NCT04103892|585862596|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
162222201|NCT04103892|585862597|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
162222202|NCT04103892|585862598|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
162222203|NCT04103892|585862599|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
162222204|NCT05576662|585862600|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
162222205|NCT05576662|585862601|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
162222206|NCT05576662|585862600|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
162222207|NCT05576662|585862601|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
162222208|NCT05576662|585862600|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
162222209|NCT05576662|585862601|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
162222210|NCT05576662|585862600|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
162222211|NCT05576662|585862601|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
162222212|NCT00281320|585862602|FG000|Overall Study|Adverse Event|12|||
162222213|NCT00281320|585862603|FG001|Overall Study|Adverse Event|9|||
162222214|NCT00281320|585862602|FG000|Overall Study|Lack of Efficacy|4|||
162222215|NCT00281320|585862603|FG001|Overall Study|Lack of Efficacy|3|||
162222216|NCT00281320|585862602|FG000|Overall Study|Withdrawal by Subject|5|||
162222217|NCT00281320|585862603|FG001|Overall Study|Withdrawal by Subject|6|||
162222218|NCT00281320|585862602|FG000|Overall Study|Lost to Follow-up|1|||
162222219|NCT00281320|585862603|FG001|Overall Study|Lost to Follow-up|2|||
162222220|NCT00281320|585862602|FG000|Overall Study|Other|3|||
162222221|NCT00281320|585862603|FG001|Overall Study|Other|1|||
162222222|NCT03008005|585862606|FG000|Overall Study|Physician Decision|1|||
162222223|NCT03008005|585862607|FG001|Overall Study|Physician Decision|0|||
162222224|NCT03008005|585862608|FG002|Overall Study|Physician Decision|0|||
161678682|NCT00766090|583876048|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678683|NCT00766090|583876049|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678684|NCT00766090|583876050|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678685|NCT00766090|583876051|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
161678686|NCT00766090|583876052|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678687|NCT00766090|583876053|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678688|NCT00766090|583876054|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678689|NCT00766090|583876055|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678690|NCT00766090|583876056|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678691|NCT00766090|583876057|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161678692|NCT00766090|583876046|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678693|NCT00766090|583876047|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
161678694|NCT00766090|583876048|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678695|NCT00766090|583876049|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
161678696|NCT00766090|583876050|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678697|NCT00766090|583876051|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678698|NCT00766090|583876052|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678699|NCT00766090|583876053|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678700|NCT00766090|583876054|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678701|NCT00766090|583876055|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678702|NCT00766090|583876056|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161678703|NCT00766090|583876057|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
161678704|NCT00766090|583876046|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678705|NCT00766090|583876047|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678706|NCT00766090|583876048|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678707|NCT00766090|583876049|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678708|NCT00766090|583876050|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
161678709|NCT00766090|583876051|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678710|NCT00766090|583876052|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678711|NCT00766090|583876053|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678712|NCT00766090|583876054|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678713|NCT00766090|583876055|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678714|NCT00766090|583876056|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
162222225|NCT03008005|585862606|FG000|Overall Study|Withdrawal by Subject|1|||
162222226|NCT03008005|585862607|FG001|Overall Study|Withdrawal by Subject|0|||
161678715|NCT00766090|583876057|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161678716|NCT03024970|583876061|FG000|First Intervention|Adverse Event|1|||
161678717|NCT03024970|583876062|FG001|First Intervention|Adverse Event|0|||
162222227|NCT03008005|585862608|FG002|Overall Study|Withdrawal by Subject|0|||
162023306|NCT04093024|585142645|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
162023307|NCT04093024|585142644|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
162023308|NCT04093024|585142645|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
162023309|NCT04093024|585142644|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
162023310|NCT04093024|585142645|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
162023311|NCT00435045|585142652|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
162023312|NCT00435045|585142653|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
162023313|NCT00435045|585142652|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
162023314|NCT00435045|585142653|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
162023315|NCT00435045|585142652|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
162023316|NCT00435045|585142653|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
162023317|NCT00435045|585142652|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
162023318|NCT00435045|585142653|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
162023319|NCT00435045|585142652|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
162023320|NCT00435045|585142653|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
162023321|NCT00435045|585142652|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
161829191|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161829192|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
161829193|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829194|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829195|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829196|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161939479|NCT01674062|584828666|FG001|Overall Study|Death|1|||
161939480|NCT01674062|584828665|FG000|Overall Study|Programming Error|1|||
161939481|NCT01674062|584828666|FG001|Overall Study|Programming Error|0|||
161939482|NCT04661839|584828667|FG000|Overall Study|Not Treated|0|||
161939483|NCT04661839|584828668|FG001|Overall Study|Not Treated|0|||
161939484|NCT04661839|584828669|FG002|Overall Study|Not Treated|1|||
161939485|NCT04661839|584828670|FG003|Overall Study|Not Treated|0|||
161939486|NCT04661839|584828667|FG000|Overall Study|Lost to Follow-up|1|||
161939487|NCT04661839|584828668|FG001|Overall Study|Lost to Follow-up|0|||
161939488|NCT04661839|584828669|FG002|Overall Study|Lost to Follow-up|0|||
161939489|NCT04661839|584828670|FG003|Overall Study|Lost to Follow-up|1|||
161939490|NCT03895372|584828671|FG000|Investigational Treatment Period|Adverse Event|1|||
161939491|NCT03895372|584828672|FG001|Investigational Treatment Period|Adverse Event|0|||
161939492|NCT03895372|584828673|FG002|Investigational Treatment Period|Adverse Event|0|||
161939493|NCT03895372|584828674|FG003|Investigational Treatment Period|Adverse Event|0|||
161939494|NCT03895372|584828675|FG004|Investigational Treatment Period|Adverse Event|0|||
161939495|NCT03895372|584828676|FG005|Investigational Treatment Period|Adverse Event|0|||
161939496|NCT03895372|584828677|FG006|Investigational Treatment Period|Adverse Event|4|||
161939497|NCT03895372|584828678|FG007|Investigational Treatment Period|Adverse Event|3|||
161939498|NCT03895372|584828671|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
161939499|NCT03895372|584828672|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
161939500|NCT03895372|584828673|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
161939501|NCT03895372|584828674|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
161939502|NCT03895372|584828675|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
161939503|NCT03895372|584828676|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
161939504|NCT03895372|584828677|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
161939505|NCT03895372|584828678|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
161939506|NCT03895372|584828671|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
161939507|NCT03895372|584828672|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
161939508|NCT03895372|584828673|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
161939509|NCT03895372|584828674|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
161939510|NCT03895372|584828675|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
161939511|NCT03895372|584828676|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
161939512|NCT03895372|584828677|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
161939513|NCT03895372|584828678|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
161939514|NCT03895372|584828671|FG000|Investigational Treatment Period|Other|0|||
161939515|NCT03895372|584828672|FG001|Investigational Treatment Period|Other|0|||
161939516|NCT03895372|584828673|FG002|Investigational Treatment Period|Other|0|||
161939517|NCT03895372|584828674|FG003|Investigational Treatment Period|Other|0|||
161939518|NCT03895372|584828675|FG004|Investigational Treatment Period|Other|0|||
161939519|NCT03895372|584828676|FG005|Investigational Treatment Period|Other|1|||
161939520|NCT03895372|584828677|FG006|Investigational Treatment Period|Other|0|||
161939521|NCT03895372|584828678|FG007|Investigational Treatment Period|Other|2|||
161939522|NCT03895372|584828671|FG000|Investigational Treatment Period|Protocol Violation|0|||
161829197|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829198|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829199|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161829200|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
161829201|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
161829202|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
162222228|NCT03008005|585862606|FG000|Overall Study|Ineligible|0|||
161939523|NCT03895372|584828672|FG001|Investigational Treatment Period|Protocol Violation|0|||
161939524|NCT03895372|584828673|FG002|Investigational Treatment Period|Protocol Violation|0|||
162222229|NCT03008005|585862607|FG001|Overall Study|Ineligible|1|||
162222230|NCT03008005|585862608|FG002|Overall Study|Ineligible|0|||
162222231|NCT00475228|585862610|FG000|Overall Study|Lost to Follow-up|17|||
162222232|NCT00475228|585862611|FG001|Overall Study|Lost to Follow-up|17|||
162222233|NCT03633799|585862620|FG000|Overall Study|Adverse Event|349|||
162222234|NCT03633799|585862620|FG000|Overall Study|Withdrawal by Subject|288|||
162222235|NCT03633799|585862620|FG000|Overall Study|Lost to Follow-up|97|||
162222236|NCT03633799|585862620|FG000|Overall Study|Physician Decision|9|||
162222237|NCT03633799|585862620|FG000|Overall Study|Protocol Violation|4|||
162222238|NCT03633799|585862620|FG000|Overall Study|Pregnancy|20|||
162222239|NCT03633799|585862620|FG000|Overall Study|other|39|||
162222240|NCT03633799|585862620|FG000|Overall Study|ongoing within third year of study|106|||
162222241|NCT03633799|585862620|FG000|Overall Study|unsuccessful study drug placement|19|||
162222242|NCT03551691|585862623|FG000|Overall Study|Withdrawal by Subject|3|||
162222243|NCT03551691|585862624|FG001|Overall Study|Withdrawal by Subject|3|||
162222244|NCT02367040|585862625|FG000|Overall Study|Lost to Follow-up|1|||
162222245|NCT02367040|585862626|FG001|Overall Study|Lost to Follow-up|1|||
162222246|NCT02367040|585862625|FG000|Overall Study|Lack of Efficacy|1|||
162222247|NCT02367040|585862626|FG001|Overall Study|Lack of Efficacy|0|||
162222248|NCT02367040|585862625|FG000|Overall Study|Additional primary malignancy|1|||
162222249|NCT02367040|585862626|FG001|Overall Study|Additional primary malignancy|1|||
161939525|NCT03895372|584828674|FG003|Investigational Treatment Period|Protocol Violation|1|||
161939526|NCT03895372|584828675|FG004|Investigational Treatment Period|Protocol Violation|0|||
161939527|NCT03895372|584828676|FG005|Investigational Treatment Period|Protocol Violation|0|||
161939528|NCT03895372|584828677|FG006|Investigational Treatment Period|Protocol Violation|0|||
161939529|NCT03895372|584828678|FG007|Investigational Treatment Period|Protocol Violation|0|||
161939530|NCT03895372|584828671|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
161939531|NCT03895372|584828672|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
161939532|NCT03895372|584828673|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
161939533|NCT03895372|584828674|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
161939534|NCT03895372|584828675|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
161939535|NCT03895372|584828676|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
161939536|NCT03895372|584828677|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
161939537|NCT03895372|584828678|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
161939538|NCT03895372|584828671|FG000|Extension Treatment Period|Adverse Event|0|||
161939539|NCT03895372|584828672|FG001|Extension Treatment Period|Adverse Event|1|||
161939540|NCT03895372|584828673|FG002|Extension Treatment Period|Adverse Event|0|||
161939541|NCT03895372|584828674|FG003|Extension Treatment Period|Adverse Event|1|||
161939542|NCT03895372|584828675|FG004|Extension Treatment Period|Adverse Event|0|||
161939543|NCT03895372|584828676|FG005|Extension Treatment Period|Adverse Event|0|||
161939544|NCT03895372|584828677|FG006|Extension Treatment Period|Adverse Event|3|||
161939545|NCT03895372|584828678|FG007|Extension Treatment Period|Adverse Event|3|||
162222250|NCT02367040|585862625|FG000|Overall Study|AE not associated with clinical disease progression|117|||
162222251|NCT02367040|585862626|FG001|Overall Study|AE not associated with clinical disease progression|12|||
162222252|NCT02367040|585862625|FG000|Overall Study|AE associated with clinical disease progression|1|||
162222253|NCT02367040|585862626|FG001|Overall Study|AE associated with clinical disease progression|4|||
162222254|NCT02367040|585862625|FG000|Overall Study|Physician Decision|2|||
162222255|NCT02367040|585862626|FG001|Overall Study|Physician Decision|8|||
162222256|NCT02367040|585862625|FG000|Overall Study|Non-compliance to study drug|1|||
161829203|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
161829204|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
161829205|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
161829206|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
161829207|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
162222257|NCT02367040|585862626|FG001|Overall Study|Non-compliance to study drug|0|||
162222258|NCT02367040|585862625|FG000|Overall Study|Failure to meet continuation criteria|1|||
162222259|NCT02367040|585862626|FG001|Overall Study|Failure to meet continuation criteria|0|||
162222260|NCT02367040|585862625|FG000|Overall Study|Switching to other therapy|2|||
162222261|NCT02367040|585862626|FG001|Overall Study|Switching to other therapy|0|||
162222262|NCT02367040|585862625|FG000|Overall Study|Withdrawal by Subject|51|||
162222263|NCT02367040|585862626|FG001|Overall Study|Withdrawal by Subject|16|||
162222264|NCT02367040|585862625|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
162222265|NCT02367040|585862626|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162222266|NCT02367040|585862625|FG000|Overall Study|Patient decision|40|||
162222267|NCT02367040|585862626|FG001|Overall Study|Patient decision|14|||
162222268|NCT02367040|585862625|FG000|Overall Study|Required procedure failed|1|||
162222269|NCT02367040|585862626|FG001|Overall Study|Required procedure failed|0|||
162222270|NCT02367040|585862625|FG000|Overall Study|Randomized by mistake with study treatment|1|||
162222271|NCT02367040|585862626|FG001|Overall Study|Randomized by mistake with study treatment|0|||
162222272|NCT02367040|585862625|FG000|Overall Study|Protocol Violation|1|||
162222273|NCT02367040|585862626|FG001|Overall Study|Protocol Violation|0|||
162222274|NCT02367040|585862625|FG000|Overall Study|Progressive disease - radiological progression|54|||
162222275|NCT02367040|585862626|FG001|Overall Study|Progressive disease - radiological progression|80|||
162222276|NCT02367040|585862625|FG000|Overall Study|Progressive disease - clinical progression|6|||
162222277|NCT02367040|585862626|FG001|Overall Study|Progressive disease - clinical progression|6|||
162222278|NCT02367040|585862625|FG000|Overall Study|Drug not administered|3|||
162222279|NCT02367040|585862626|FG001|Overall Study|Drug not administered|2|||
162222280|NCT02367040|585862625|FG000|Overall Study|Progressive disease|0|||
162222281|NCT02367040|585862626|FG001|Overall Study|Progressive disease|1|||
162222282|NCT02367040|585862625|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
162222283|NCT02367040|585862626|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
162222284|NCT02367040|585862625|FG000|Overall Study|Death|2|||
162222285|NCT02367040|585862626|FG001|Overall Study|Death|0|||
162222286|NCT02367040|585862625|FG000|Overall Study|Study terminated by sponsor|19|||
162222287|NCT02367040|585862626|FG001|Overall Study|Study terminated by sponsor|2|||
162222288|NCT02477618|585862627|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
162222289|NCT02477618|585862628|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
162222290|NCT02477618|585862627|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
162222291|NCT02477618|585862628|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
162222292|NCT02477618|585862627|FG000|Overall Study|Adverse Event|1|||
162222293|NCT02477618|585862628|FG001|Overall Study|Adverse Event|1|||
162222294|NCT02477618|585862627|FG000|Overall Study|Transferred Away from Study Site|1|||
162222295|NCT02477618|585862628|FG001|Overall Study|Transferred Away from Study Site|0|||
162222296|NCT02477618|585862627|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
162222297|NCT02477618|585862628|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
162222298|NCT05855967|585862629|FG000|Overall Study|Withdrawal by Subject|7|||
162222299|NCT05855967|585862630|FG001|Overall Study|Withdrawal by Subject|5|||
162222300|NCT05855967|585862629|FG000|Overall Study|Lost to Follow-up|2|||
162222301|NCT05855967|585862630|FG001|Overall Study|Lost to Follow-up|1|||
162222302|NCT02446821|585862631|FG000|Overall Study|Adverse Event|28|||
162222303|NCT02446821|585862631|FG000|Overall Study|Withdrawal by Subject|6|||
162222304|NCT02446821|585862631|FG000|Overall Study|Lost to Follow-up|22|||
162222305|NCT02446821|585862631|FG000|Overall Study|other|9|||
162222306|NCT02446821|585862631|FG000|Overall Study|insertion failure|3|||
162222307|NCT02284009|585862635|FG000|Overall Study|Adverse Event|3|||
162222308|NCT02284009|585862636|FG001|Overall Study|Adverse Event|0|||
162222309|NCT02284009|585862635|FG000|Overall Study|Lost to Follow-up|1|||
162222310|NCT02284009|585862636|FG001|Overall Study|Lost to Follow-up|3|||
162222311|NCT02284009|585862635|FG000|Overall Study|Physician Decision|0|||
162222312|NCT02284009|585862636|FG001|Overall Study|Physician Decision|2|||
162222313|NCT02284009|585862635|FG000|Overall Study|Withdrawal by Subject|2|||
162222314|NCT02284009|585862636|FG001|Overall Study|Withdrawal by Subject|5|||
162222315|NCT04147195|585862637|FG000|Overall Study|Adverse Event|0|||
162222316|NCT04147195|585862638|FG001|Overall Study|Adverse Event|3|||
162222317|NCT04147195|585862637|FG000|Overall Study|Study Terminated by Sponsor|4|||
162222318|NCT04147195|585862638|FG001|Overall Study|Study Terminated by Sponsor|2|||
162222319|NCT04147195|585862637|FG000|Overall Study|Withdrawal by Subject|0|||
162222320|NCT04147195|585862638|FG001|Overall Study|Withdrawal by Subject|1|||
162222321|NCT03841526|585862639|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
162222322|NCT03841526|585862640|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
162222323|NCT03841526|585862641|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
162222324|NCT03841526|585862642|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
162222325|NCT03841526|585862643|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
162222326|NCT03841526|585862644|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
162222327|NCT03841526|585862639|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
162222328|NCT03841526|585862640|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
162222329|NCT03841526|585862641|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
162222330|NCT03841526|585862642|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
162222331|NCT03841526|585862643|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
162222332|NCT03841526|585862644|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
162222333|NCT03841526|585862639|FG000|Outpatient Phase Treatment|Physician Decision|0|||
162222334|NCT03841526|585862640|FG001|Outpatient Phase Treatment|Physician Decision|1|||
162222335|NCT03841526|585862641|FG002|Outpatient Phase Treatment|Physician Decision|0|||
162222336|NCT03841526|585862642|FG003|Outpatient Phase Treatment|Physician Decision|0|||
162222337|NCT03841526|585862643|FG004|Outpatient Phase Treatment|Physician Decision|0|||
162222338|NCT03841526|585862644|FG005|Outpatient Phase Treatment|Physician Decision|0|||
162222339|NCT03841526|585862639|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
162222340|NCT03841526|585862640|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
162222341|NCT03841526|585862641|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
162222342|NCT03841526|585862642|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
161829208|NCT05068284|584413681|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829209|NCT05068284|584413682|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829210|NCT05068284|584413683|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829211|NCT05068284|584413684|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829212|NCT05068284|584413685|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829213|NCT05068284|584413686|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829214|NCT05068284|584413687|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
161829215|NCT05068284|584413688|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
161829216|NCT04039919|584415715|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161829217|NCT04039919|584415716|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161829218|NCT04039919|584415717|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162222343|NCT03841526|585862643|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
162222344|NCT03841526|585862644|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
162222345|NCT01876082|585865070|FG000|Overall Study|Withdrawal by Subject|0|||
162222346|NCT01876082|585865071|FG001|Overall Study|Withdrawal by Subject|2|||
162222347|NCT01876082|585865070|FG000|Overall Study|Protocol Violation|1|||
162222348|NCT01876082|585865071|FG001|Overall Study|Protocol Violation|0|||
162222349|NCT01876082|585865070|FG000|Overall Study|Adverse Event|1|||
162222350|NCT01876082|585865071|FG001|Overall Study|Adverse Event|1|||
162222351|NCT01876082|585865070|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
162222352|NCT01876082|585865071|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
162222353|NCT03829501|585865080|FG000|Overall Study|Withdrawal of Consent|2|||
162222354|NCT03829501|585865081|FG001|Overall Study|Withdrawal of Consent|0|||
162222355|NCT03829501|585865082|FG002|Overall Study|Withdrawal of Consent|3|||
161829219|NCT04039919|584415718|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161829220|NCT04039919|584415719|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161829221|NCT04039919|584415715|FG000|Treatment Period 1|Sponsor's decision|0|||
161829222|NCT04039919|584415716|FG001|Treatment Period 1|Sponsor's decision|0|||
161829223|NCT04039919|584415717|FG002|Treatment Period 1|Sponsor's decision|0|||
161829224|NCT04039919|584415718|FG003|Treatment Period 1|Sponsor's decision|0|||
161829225|NCT04039919|584415719|FG004|Treatment Period 1|Sponsor's decision|16|||
161829226|NCT04039919|584415715|FG000|Treatment Period 5|Withdrawal by Subject|1|||
161829227|NCT04039919|584415716|FG001|Treatment Period 5|Withdrawal by Subject|0|||
161829228|NCT04039919|584415717|FG002|Treatment Period 5|Withdrawal by Subject|0|||
161829229|NCT04039919|584415718|FG003|Treatment Period 5|Withdrawal by Subject|0|||
161829230|NCT04039919|584415719|FG004|Treatment Period 5|Withdrawal by Subject|0|||
161939546|NCT03895372|584828671|FG000|Extension Treatment Period|Other|1|||
161939547|NCT03895372|584828672|FG001|Extension Treatment Period|Other|3|||
161939548|NCT03895372|584828673|FG002|Extension Treatment Period|Other|0|||
161939549|NCT03895372|584828674|FG003|Extension Treatment Period|Other|0|||
161939550|NCT03895372|584828675|FG004|Extension Treatment Period|Other|1|||
161939551|NCT03895372|584828676|FG005|Extension Treatment Period|Other|0|||
161939552|NCT03895372|584828677|FG006|Extension Treatment Period|Other|0|||
162222356|NCT03829501|585865083|FG003|Overall Study|Withdrawal of Consent|0|||
161829231|NCT03250299|584415727|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
162222357|NCT03829501|585865084|FG004|Overall Study|Withdrawal of Consent|1|||
162222358|NCT03829501|585865085|FG005|Overall Study|Withdrawal of Consent|1|||
162222359|NCT03829501|585865086|FG006|Overall Study|Withdrawal of Consent|0|||
161829232|NCT03250299|584415728|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
161829233|NCT03250299|584415729|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
161829234|NCT03250299|584415730|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
161829235|NCT03250299|584415731|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
161939553|NCT03895372|584828678|FG007|Extension Treatment Period|Other|2|||
161939554|NCT03895372|584828671|FG000|Extension Treatment Period|Pregnancy|0|||
162222360|NCT03829501|585865087|FG007|Overall Study|Withdrawal of Consent|10|||
162222361|NCT03829501|585865088|FG008|Overall Study|Withdrawal of Consent|10|||
161829236|NCT03250299|584415727|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
161939555|NCT03895372|584828672|FG001|Extension Treatment Period|Pregnancy|0|||
161939556|NCT03895372|584828673|FG002|Extension Treatment Period|Pregnancy|0|||
161939557|NCT03895372|584828674|FG003|Extension Treatment Period|Pregnancy|0|||
161939558|NCT03895372|584828675|FG004|Extension Treatment Period|Pregnancy|1|||
161939559|NCT03895372|584828676|FG005|Extension Treatment Period|Pregnancy|0|||
162222362|NCT03829501|585865089|FG009|Overall Study|Withdrawal of Consent|3|||
162222363|NCT03829501|585865090|FG010|Overall Study|Withdrawal of Consent|4|||
162222364|NCT03829501|585865091|FG011|Overall Study|Withdrawal of Consent|4|||
162222365|NCT03829501|585865092|FG012|Overall Study|Withdrawal of Consent|4|||
162222366|NCT03829501|585865093|FG013|Overall Study|Withdrawal of Consent|0|||
162222367|NCT03829501|585865094|FG014|Overall Study|Withdrawal of Consent|3|||
162222368|NCT03829501|585865095|FG015|Overall Study|Withdrawal of Consent|0|||
162222369|NCT03829501|585865096|FG016|Overall Study|Withdrawal of Consent|1|||
162222370|NCT03829501|585865097|FG017|Overall Study|Withdrawal of Consent|1|||
162222371|NCT03829501|585865098|FG018|Overall Study|Withdrawal of Consent|0|||
162222372|NCT03829501|585865099|FG019|Overall Study|Withdrawal of Consent|0|||
162222373|NCT03829501|585865100|FG020|Overall Study|Withdrawal of Consent|3|||
162222374|NCT03829501|585865101|FG021|Overall Study|Withdrawal of Consent|0|||
162222375|NCT03829501|585865102|FG022|Overall Study|Withdrawal of Consent|1|||
162222376|NCT03829501|585865080|FG000|Overall Study|PD|0|||
162222377|NCT03829501|585865081|FG001|Overall Study|PD|0|||
162222378|NCT03829501|585865082|FG002|Overall Study|PD|0|||
162222379|NCT03829501|585865083|FG003|Overall Study|PD|2|||
162222380|NCT03829501|585865084|FG004|Overall Study|PD|0|||
162222381|NCT03829501|585865085|FG005|Overall Study|PD|0|||
162222382|NCT03829501|585865086|FG006|Overall Study|PD|0|||
162222383|NCT03829501|585865087|FG007|Overall Study|PD|0|||
162222384|NCT03829501|585865088|FG008|Overall Study|PD|0|||
162222385|NCT03829501|585865089|FG009|Overall Study|PD|0|||
162222386|NCT03829501|585865090|FG010|Overall Study|PD|0|||
162222387|NCT03829501|585865091|FG011|Overall Study|PD|0|||
162222388|NCT03829501|585865092|FG012|Overall Study|PD|0|||
162222389|NCT03829501|585865093|FG013|Overall Study|PD|0|||
162222390|NCT03829501|585865094|FG014|Overall Study|PD|0|||
162222391|NCT03829501|585865095|FG015|Overall Study|PD|1|||
162222392|NCT03829501|585865096|FG016|Overall Study|PD|0|||
162222393|NCT03829501|585865097|FG017|Overall Study|PD|0|||
162222394|NCT03829501|585865098|FG018|Overall Study|PD|0|||
162222395|NCT03829501|585865099|FG019|Overall Study|PD|0|||
162222396|NCT03829501|585865100|FG020|Overall Study|PD|1|||
162222397|NCT03829501|585865101|FG021|Overall Study|PD|0|||
162222398|NCT03829501|585865102|FG022|Overall Study|PD|0|||
162222399|NCT03829501|585865080|FG000|Overall Study|Study Terminated by Sponsor|0|||
162222400|NCT03829501|585865081|FG001|Overall Study|Study Terminated by Sponsor|0|||
162222401|NCT03829501|585865082|FG002|Overall Study|Study Terminated by Sponsor|0|||
162222402|NCT03829501|585865083|FG003|Overall Study|Study Terminated by Sponsor|0|||
162222403|NCT03829501|585865084|FG004|Overall Study|Study Terminated by Sponsor|0|||
162222404|NCT03829501|585865085|FG005|Overall Study|Study Terminated by Sponsor|0|||
162222405|NCT03829501|585865086|FG006|Overall Study|Study Terminated by Sponsor|0|||
162222406|NCT03829501|585865087|FG007|Overall Study|Study Terminated by Sponsor|3|||
162222407|NCT03829501|585865088|FG008|Overall Study|Study Terminated by Sponsor|1|||
162222408|NCT03829501|585865089|FG009|Overall Study|Study Terminated by Sponsor|0|||
162222409|NCT03829501|585865090|FG010|Overall Study|Study Terminated by Sponsor|0|||
162222410|NCT03829501|585865091|FG011|Overall Study|Study Terminated by Sponsor|0|||
162222411|NCT03829501|585865092|FG012|Overall Study|Study Terminated by Sponsor|0|||
162222412|NCT03829501|585865093|FG013|Overall Study|Study Terminated by Sponsor|0|||
162222413|NCT03829501|585865094|FG014|Overall Study|Study Terminated by Sponsor|3|||
162222414|NCT03829501|585865095|FG015|Overall Study|Study Terminated by Sponsor|2|||
162222415|NCT03829501|585865096|FG016|Overall Study|Study Terminated by Sponsor|2|||
162222416|NCT03829501|585865097|FG017|Overall Study|Study Terminated by Sponsor|0|||
162222417|NCT03829501|585865098|FG018|Overall Study|Study Terminated by Sponsor|0|||
162222418|NCT03829501|585865099|FG019|Overall Study|Study Terminated by Sponsor|0|||
162222419|NCT03829501|585865100|FG020|Overall Study|Study Terminated by Sponsor|1|||
161829237|NCT03250299|584415728|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
161829238|NCT03250299|584415729|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
162222420|NCT03829501|585865101|FG021|Overall Study|Study Terminated by Sponsor|0|||
162222421|NCT03829501|585865102|FG022|Overall Study|Study Terminated by Sponsor|3|||
162222422|NCT03829501|585865080|FG000|Overall Study|Lost to Follow Up|0|||
162222423|NCT03829501|585865081|FG001|Overall Study|Lost to Follow Up|0|||
162222424|NCT03829501|585865082|FG002|Overall Study|Lost to Follow Up|0|||
162222425|NCT03829501|585865083|FG003|Overall Study|Lost to Follow Up|0|||
162222426|NCT03829501|585865084|FG004|Overall Study|Lost to Follow Up|1|||
162222427|NCT03829501|585865085|FG005|Overall Study|Lost to Follow Up|0|||
162222428|NCT03829501|585865086|FG006|Overall Study|Lost to Follow Up|0|||
162222429|NCT03829501|585865087|FG007|Overall Study|Lost to Follow Up|2|||
162222430|NCT03829501|585865088|FG008|Overall Study|Lost to Follow Up|2|||
162222431|NCT03829501|585865089|FG009|Overall Study|Lost to Follow Up|0|||
162222432|NCT03829501|585865090|FG010|Overall Study|Lost to Follow Up|2|||
162222433|NCT03829501|585865091|FG011|Overall Study|Lost to Follow Up|1|||
161829239|NCT03250299|584415730|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
161829240|NCT03250299|584415731|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
161829241|NCT03250299|584415727|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
161829242|NCT03250299|584415728|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
161829243|NCT03250299|584415729|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
161829244|NCT03250299|584415730|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
161829245|NCT03250299|584415731|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
161829246|NCT03250299|584415727|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
161829247|NCT03250299|584415728|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
161829248|NCT03250299|584415729|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
161829249|NCT03250299|584415730|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
161829250|NCT03250299|584415731|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
161829251|NCT03346070|584415732|FG000|Overall Study|Death|0|||
161939560|NCT03895372|584828677|FG006|Extension Treatment Period|Pregnancy|0|||
161939561|NCT03895372|584828678|FG007|Extension Treatment Period|Pregnancy|0|||
161939562|NCT03895372|584828671|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
161939563|NCT03895372|584828672|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
161939564|NCT03895372|584828673|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
161939565|NCT03895372|584828674|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
161939566|NCT03895372|584828675|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
161939567|NCT03895372|584828676|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
162222434|NCT03829501|585865092|FG012|Overall Study|Lost to Follow Up|0|||
162222435|NCT03829501|585865093|FG013|Overall Study|Lost to Follow Up|1|||
162222436|NCT03829501|585865094|FG014|Overall Study|Lost to Follow Up|1|||
162222437|NCT03829501|585865095|FG015|Overall Study|Lost to Follow Up|0|||
162222438|NCT03829501|585865096|FG016|Overall Study|Lost to Follow Up|0|||
162222439|NCT03829501|585865097|FG017|Overall Study|Lost to Follow Up|0|||
162222440|NCT03829501|585865098|FG018|Overall Study|Lost to Follow Up|0|||
162222441|NCT03829501|585865099|FG019|Overall Study|Lost to Follow Up|0|||
162222442|NCT03829501|585865100|FG020|Overall Study|Lost to Follow Up|0|||
162222443|NCT03829501|585865101|FG021|Overall Study|Lost to Follow Up|0|||
162222444|NCT03829501|585865102|FG022|Overall Study|Lost to Follow Up|1|||
162222445|NCT03829501|585865080|FG000|Overall Study|Death|2|||
162222446|NCT03829501|585865081|FG001|Overall Study|Death|4|||
162222447|NCT03829501|585865082|FG002|Overall Study|Death|5|||
162222448|NCT03829501|585865083|FG003|Overall Study|Death|6|||
162222449|NCT03829501|585865084|FG004|Overall Study|Death|5|||
162222450|NCT03829501|585865085|FG005|Overall Study|Death|4|||
162222451|NCT03829501|585865086|FG006|Overall Study|Death|5|||
162222452|NCT03829501|585865087|FG007|Overall Study|Death|24|||
162222453|NCT03829501|585865088|FG008|Overall Study|Death|22|||
162222454|NCT03829501|585865089|FG009|Overall Study|Death|6|||
162222455|NCT03829501|585865090|FG010|Overall Study|Death|3|||
162222456|NCT03829501|585865091|FG011|Overall Study|Death|10|||
162222457|NCT03829501|585865092|FG012|Overall Study|Death|10|||
162222458|NCT03829501|585865093|FG013|Overall Study|Death|5|||
162222459|NCT03829501|585865094|FG014|Overall Study|Death|7|||
162222460|NCT03829501|585865095|FG015|Overall Study|Death|2|||
162222461|NCT03829501|585865096|FG016|Overall Study|Death|2|||
162222462|NCT03829501|585865097|FG017|Overall Study|Death|1|||
162222463|NCT03829501|585865098|FG018|Overall Study|Death|1|||
162222464|NCT03829501|585865099|FG019|Overall Study|Death|1|||
162222465|NCT03829501|585865100|FG020|Overall Study|Death|1|||
162222466|NCT03829501|585865101|FG021|Overall Study|Death|2|||
162222467|NCT03829501|585865102|FG022|Overall Study|Death|3|||
162222468|NCT03829501|585865080|FG000|Overall Study|Miscellaneous|0|||
162222469|NCT03829501|585865081|FG001|Overall Study|Miscellaneous|0|||
162222470|NCT03829501|585865082|FG002|Overall Study|Miscellaneous|1|||
162222471|NCT03829501|585865083|FG003|Overall Study|Miscellaneous|0|||
162222472|NCT03829501|585865084|FG004|Overall Study|Miscellaneous|0|||
162222473|NCT03829501|585865085|FG005|Overall Study|Miscellaneous|0|||
162222474|NCT03829501|585865086|FG006|Overall Study|Miscellaneous|0|||
162222475|NCT03829501|585865087|FG007|Overall Study|Miscellaneous|1|||
162222476|NCT03829501|585865088|FG008|Overall Study|Miscellaneous|0|||
162222477|NCT03829501|585865089|FG009|Overall Study|Miscellaneous|0|||
162222478|NCT03829501|585865090|FG010|Overall Study|Miscellaneous|0|||
162222479|NCT03829501|585865091|FG011|Overall Study|Miscellaneous|0|||
162222480|NCT03829501|585865092|FG012|Overall Study|Miscellaneous|0|||
162222481|NCT03829501|585865093|FG013|Overall Study|Miscellaneous|0|||
162222482|NCT03829501|585865094|FG014|Overall Study|Miscellaneous|0|||
161939568|NCT03895372|584828677|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
162222483|NCT03829501|585865095|FG015|Overall Study|Miscellaneous|0|||
162222484|NCT03829501|585865096|FG016|Overall Study|Miscellaneous|0|||
162222485|NCT03829501|585865097|FG017|Overall Study|Miscellaneous|0|||
162222486|NCT03829501|585865098|FG018|Overall Study|Miscellaneous|0|||
162222487|NCT03829501|585865099|FG019|Overall Study|Miscellaneous|0|||
162222488|NCT03829501|585865100|FG020|Overall Study|Miscellaneous|0|||
162222489|NCT03829501|585865101|FG021|Overall Study|Miscellaneous|0|||
162222490|NCT03829501|585865102|FG022|Overall Study|Miscellaneous|1|||
162222491|NCT04707664|585865108|FG000|Overall Study|Adverse Event|2|||
162222492|NCT04707664|585865109|FG001|Overall Study|Adverse Event|0|||
162222493|NCT04707664|585865108|FG000|Overall Study|Death|1|||
161829252|NCT03346070|584415733|FG001|Overall Study|Death|0|||
161829253|NCT03346070|584415734|FG002|Overall Study|Death|0|||
161829254|NCT03346070|584415735|FG003|Overall Study|Death|0|||
162222494|NCT04707664|585865109|FG001|Overall Study|Death|2|||
162222495|NCT04707664|585865108|FG000|Overall Study|Withdrawal by Subject|13|||
162222496|NCT04707664|585865109|FG001|Overall Study|Withdrawal by Subject|21|||
162222497|NCT04707664|585865108|FG000|Overall Study|Lost to Follow-up|11|||
162222498|NCT04707664|585865109|FG001|Overall Study|Lost to Follow-up|13|||
162222499|NCT04707664|585865108|FG000|Overall Study|Not treated|2|||
162222500|NCT04707664|585865109|FG001|Overall Study|Not treated|0|||
162222501|NCT00357110|585865110|FG000|Overall Study|Early study termination|5|||
162222502|NCT00357110|585865111|FG001|Overall Study|Early study termination|5|||
162222503|NCT00288639|585865112|FG000|Overall Study|Adverse Event|5|||
162222504|NCT00288639|585865112|FG000|Overall Study|Lack of Efficacy|4|||
162222505|NCT00288639|585865112|FG000|Overall Study|Withdrawal by Subject|2|||
162222506|NCT00288639|585865112|FG000|Overall Study|Other|1|||
162222507|NCT01195948|585865113|FG000|Overall Study|Lost to Follow-up|0|||
162222508|NCT01195948|585865114|FG001|Overall Study|Lost to Follow-up|1|||
162222509|NCT01195948|585865115|FG002|Overall Study|Lost to Follow-up|2|||
162222510|NCT01498887|585865118|FG000|Overall Study|Administrative problems|1|||
162222511|NCT01498887|585865119|FG001|Overall Study|Administrative problems|0|||
162222512|NCT01498887|585865118|FG000|Overall Study|Lost to Follow-up|1|||
162222513|NCT01498887|585865119|FG001|Overall Study|Lost to Follow-up|1|||
162222514|NCT01498887|585865118|FG000|Overall Study|Withdrawal by Subject|1|||
162222515|NCT01498887|585865119|FG001|Overall Study|Withdrawal by Subject|0|||
162222516|NCT01498887|585865118|FG000|Overall Study|Protocol Violation|1|||
162222517|NCT01498887|585865119|FG001|Overall Study|Protocol Violation|3|||
162222518|NCT01498887|585865118|FG000|Overall Study|Lack of Efficacy|5|||
162222519|NCT01498887|585865119|FG001|Overall Study|Lack of Efficacy|3|||
162222520|NCT01498887|585865118|FG000|Overall Study|Abnormal result from test procedure|1|||
162222521|NCT01498887|585865119|FG001|Overall Study|Abnormal result from test procedure|1|||
162222522|NCT01498887|585865118|FG000|Overall Study|Abnormal laboratory value|2|||
162222523|NCT01498887|585865119|FG001|Overall Study|Abnormal laboratory value|2|||
162222524|NCT01498887|585865118|FG000|Overall Study|Adverse Event|4|||
162222525|NCT01498887|585865119|FG001|Overall Study|Adverse Event|1|||
162222526|NCT04079868|585865120|FG000|Overall Study|Lost to Follow-up|100|||
162222527|NCT04079868|585865121|FG001|Overall Study|Lost to Follow-up|200|||
162222528|NCT04079868|585865120|FG000|Overall Study|Physician Decision|100|||
162222529|NCT04079868|585865121|FG001|Overall Study|Physician Decision|0|||
162222530|NCT04335591|585865122|FG000|Overall Study|Adverse Event|5|||
162222531|NCT04335591|585865123|FG001|Overall Study|Adverse Event|2|||
162023322|NCT00435045|585142653|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
161829255|NCT03346070|584415736|FG004|Overall Study|Death|1|||
162222532|NCT04335591|585865124|FG002|Overall Study|Adverse Event|3|||
162222533|NCT04335591|585865125|FG003|Overall Study|Adverse Event|2|||
162222534|NCT04335591|585865122|FG000|Overall Study|Protocol Violation|1|||
162222535|NCT04335591|585865123|FG001|Overall Study|Protocol Violation|0|||
162222536|NCT04335591|585865124|FG002|Overall Study|Protocol Violation|0|||
162222537|NCT04335591|585865125|FG003|Overall Study|Protocol Violation|0|||
162222538|NCT04335591|585865122|FG000|Overall Study|Withdrawal by Subject|8|||
162222539|NCT04335591|585865123|FG001|Overall Study|Withdrawal by Subject|4|||
162222540|NCT04335591|585865124|FG002|Overall Study|Withdrawal by Subject|4|||
162222541|NCT04335591|585865125|FG003|Overall Study|Withdrawal by Subject|5|||
162222542|NCT04335591|585865122|FG000|Overall Study|Subject planning pregnancy|0|||
162222543|NCT04335591|585865123|FG001|Overall Study|Subject planning pregnancy|1|||
162222544|NCT04335591|585865124|FG002|Overall Study|Subject planning pregnancy|0|||
162222545|NCT04335591|585865125|FG003|Overall Study|Subject planning pregnancy|0|||
162222546|NCT04335591|585865122|FG000|Overall Study|Ukrainian Russian war conflict|4|||
162222547|NCT04335591|585865123|FG001|Overall Study|Ukrainian Russian war conflict|5|||
162222548|NCT04335591|585865124|FG002|Overall Study|Ukrainian Russian war conflict|2|||
162222549|NCT04335591|585865125|FG003|Overall Study|Ukrainian Russian war conflict|0|||
162222550|NCT01077128|585865135|FG000|Overall Study|Adverse Event|8|||
162222551|NCT01077128|585865135|FG000|Overall Study|Lack of Efficacy|1|||
162222552|NCT01077128|585865135|FG000|Overall Study|Disease exacerbation|1|||
162222553|NCT01077128|585865135|FG000|Overall Study|Adverse event and consent withdrawal|1|||
162222554|NCT01077128|585865135|FG000|Overall Study|Adverse event and disease exacerbation|1|||
162222555|NCT01077128|585865135|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
162222556|NCT01077128|585865135|FG000|Overall Study|Other|54|||
162222557|NCT03338296|585865143|FG000|Overall Study|Adverse Event|0|||
162222558|NCT03338296|585865144|FG001|Overall Study|Adverse Event|1|||
162222559|NCT03338296|585865143|FG000|Overall Study|Withdrawal by Subject|14|||
162222560|NCT03338296|585865144|FG001|Overall Study|Withdrawal by Subject|13|||
162222561|NCT03338296|585865143|FG000|Overall Study|Lost to Follow-up|10|||
162222562|NCT03338296|585865144|FG001|Overall Study|Lost to Follow-up|10|||
162222563|NCT03338296|585865143|FG000|Overall Study|Study Terminated by Sponsor|77|||
162222564|NCT03338296|585865144|FG001|Overall Study|Study Terminated by Sponsor|76|||
162222565|NCT03338296|585865143|FG000|Overall Study|Other|2|||
162222566|NCT03338296|585865144|FG001|Overall Study|Other|7|||
162222567|NCT03338296|585865143|FG000|Overall Study|Missing|0|||
162222568|NCT03338296|585865144|FG001|Overall Study|Missing|1|||
162222569|NCT01939353|585865145|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
162222570|NCT01939353|585865145|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
162222571|NCT01939353|585865145|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
162222572|NCT01939353|585865145|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
162222573|NCT01939353|585865145|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
162222574|NCT04421950|585865149|FG000|Overall Study|Dropped or lost to follow up|4|||
162222575|NCT04421950|585865150|FG001|Overall Study|Dropped or lost to follow up|2|||
162222576|NCT04546425|585865151|FG000|Overall Study|Protocol Violation|1|||
162222577|NCT04546425|585865152|FG001|Overall Study|Protocol Violation|1|||
162222578|NCT04546425|585865153|FG002|Overall Study|Protocol Violation|0|||
162222579|NCT04546425|585865154|FG003|Overall Study|Protocol Violation|0|||
162222580|NCT04546425|585865151|FG000|Overall Study|Adverse Event|3|||
162222581|NCT04546425|585865152|FG001|Overall Study|Adverse Event|0|||
162222582|NCT04546425|585865153|FG002|Overall Study|Adverse Event|0|||
162222583|NCT04546425|585865154|FG003|Overall Study|Adverse Event|0|||
162222584|NCT04546425|585865151|FG000|Overall Study|Lost to Follow-up|5|||
162222585|NCT04546425|585865152|FG001|Overall Study|Lost to Follow-up|4|||
162222586|NCT04546425|585865153|FG002|Overall Study|Lost to Follow-up|0|||
162222587|NCT04546425|585865154|FG003|Overall Study|Lost to Follow-up|0|||
162222588|NCT04546425|585865151|FG000|Overall Study|No Longer met eligibility criteria|3|||
162222589|NCT04546425|585865152|FG001|Overall Study|No Longer met eligibility criteria|3|||
162222590|NCT04546425|585865153|FG002|Overall Study|No Longer met eligibility criteria|1|||
162222591|NCT04546425|585865154|FG003|Overall Study|No Longer met eligibility criteria|1|||
162222592|NCT04546425|585865151|FG000|Overall Study|Withdrawal by parent/guardian|6|||
162222593|NCT04546425|585865152|FG001|Overall Study|Withdrawal by parent/guardian|5|||
162222594|NCT04546425|585865153|FG002|Overall Study|Withdrawal by parent/guardian|1|||
162222595|NCT04546425|585865154|FG003|Overall Study|Withdrawal by parent/guardian|1|||
162222596|NCT00967005|585865155|FG000|Overall Study|Lost to Follow-up|7|||
162222597|NCT00967005|585865156|FG001|Overall Study|Lost to Follow-up|10|||
162222598|NCT05071053|585865157|FG000|Overall Study|Progressive disease|30|||
162222599|NCT05071053|585865157|FG000|Overall Study|Adverse Event|5|||
162222600|NCT02593123|585865158|FG000|Overall Study|Physician Decision|2|||
162222601|NCT02593123|585865159|FG001|Overall Study|Physician Decision|1|||
162222602|NCT02593123|585865158|FG000|Overall Study|Relapse|1|||
162222603|NCT02593123|585865159|FG001|Overall Study|Relapse|1|||
162222604|NCT03945825|585865166|FG000|Overall Study|Enrolled but treatment not administered|0|||
162222605|NCT03945825|585865167|FG001|Overall Study|Enrolled but treatment not administered|0|||
162222606|NCT03945825|585865168|FG002|Overall Study|Enrolled but treatment not administered|0|||
162222607|NCT03945825|585865169|FG003|Overall Study|Enrolled but treatment not administered|0|||
162222608|NCT03945825|585865170|FG004|Overall Study|Enrolled but treatment not administered|1|||
162222609|NCT03945825|585865171|FG005|Overall Study|Enrolled but treatment not administered|0|||
162222610|NCT03945825|585865166|FG000|Overall Study|Lost to Follow-up|1|||
162222611|NCT03945825|585865167|FG001|Overall Study|Lost to Follow-up|5|||
162222612|NCT03945825|585865168|FG002|Overall Study|Lost to Follow-up|0|||
162222613|NCT03945825|585865169|FG003|Overall Study|Lost to Follow-up|1|||
162222614|NCT03945825|585865170|FG004|Overall Study|Lost to Follow-up|2|||
162222615|NCT03945825|585865171|FG005|Overall Study|Lost to Follow-up|2|||
162222616|NCT03945825|585865166|FG000|Overall Study|Withdrawal by Subject|1|||
162222617|NCT03945825|585865167|FG001|Overall Study|Withdrawal by Subject|0|||
162222618|NCT03945825|585865168|FG002|Overall Study|Withdrawal by Subject|1|||
162222619|NCT03945825|585865169|FG003|Overall Study|Withdrawal by Subject|1|||
162222620|NCT03945825|585865170|FG004|Overall Study|Withdrawal by Subject|0|||
162222621|NCT03945825|585865171|FG005|Overall Study|Withdrawal by Subject|1|||
162222622|NCT00846807|585865174|FG000|Overall Study|Adverse Event|270|||
162222623|NCT00846807|585865174|FG000|Overall Study|Lost to Follow-up|94|||
162222624|NCT00846807|585865174|FG000|Overall Study|Withdrawal by Subject|56|||
162222625|NCT00846807|585865174|FG000|Overall Study|Non compliant with European label|7|||
162222626|NCT00846807|585865174|FG000|Overall Study|Switch to other anticoagulants|89|||
162222627|NCT00846807|585865174|FG000|Overall Study|No prescription after hospital discharge|56|||
162222628|NCT00846807|585865174|FG000|Overall Study|Other|60|||
162222629|NCT00737698|585865175|FG000|Overall Study|Withdrawal by Subject|6|||
162222630|NCT00737698|585865176|FG001|Overall Study|Withdrawal by Subject|5|||
162222631|NCT00737698|585865177|FG002|Overall Study|Withdrawal by Subject|3|||
162222632|NCT00737698|585865175|FG000|Overall Study|Death|0|||
162222633|NCT00737698|585865176|FG001|Overall Study|Death|0|||
162222634|NCT00737698|585865177|FG002|Overall Study|Death|1|||
162222635|NCT01067846|585865178|FG000|Overall Study|Lost to Follow-up|17|||
162222636|NCT01067846|585865179|FG001|Overall Study|Lost to Follow-up|19|||
162222637|NCT01067846|585865178|FG000|Overall Study|Withdrawal by Subject|1|||
162222638|NCT01067846|585865179|FG001|Overall Study|Withdrawal by Subject|0|||
162222639|NCT01067846|585865178|FG000|Overall Study|participation in other tx study|1|||
162222640|NCT01067846|585865179|FG001|Overall Study|participation in other tx study|0|||
162222641|NCT02817906|585865180|FG000|Overall Study|Adverse Event|3|||
162222642|NCT02817906|585865181|FG001|Overall Study|Adverse Event|0|||
162222643|NCT02817906|585865180|FG000|Overall Study|Lack of Efficacy|1|||
162222644|NCT02817906|585865181|FG001|Overall Study|Lack of Efficacy|0|||
162222645|NCT02817906|585865180|FG000|Overall Study|Protocol Violation|1|||
162222646|NCT02817906|585865181|FG001|Overall Study|Protocol Violation|1|||
161829256|NCT03346070|584415732|FG000|Overall Study|Lost to Follow-up|0|||
161829257|NCT03346070|584415733|FG001|Overall Study|Lost to Follow-up|1|||
162222647|NCT02817906|585865180|FG000|Overall Study|Study Terminated by Sponsor|2|||
161829258|NCT03346070|584415734|FG002|Overall Study|Lost to Follow-up|2|||
162222648|NCT02817906|585865181|FG001|Overall Study|Study Terminated by Sponsor|2|||
162222649|NCT02817906|585865180|FG000|Overall Study|Withdrawal by Subject|7|||
162222650|NCT02817906|585865181|FG001|Overall Study|Withdrawal by Subject|0|||
162222651|NCT02817906|585865180|FG000|Overall Study|Other|2|||
162222652|NCT02817906|585865181|FG001|Overall Study|Other|2|||
162222653|NCT03686423|585865190|FG000|Overall Study|Withdrawal by Subject|9|||
162222654|NCT03686423|585865190|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
162222655|NCT04954326|585865191|FG000|Overall Study|Protocol Violation|0|||
162222656|NCT04954326|585865192|FG001|Overall Study|Protocol Violation|1|||
162222657|NCT04954326|585865191|FG000|Overall Study|Death|0|||
162222658|NCT04954326|585865192|FG001|Overall Study|Death|2|||
162222659|NCT04954326|585865191|FG000|Overall Study|Physician Decision|0|||
162222660|NCT04954326|585865192|FG001|Overall Study|Physician Decision|1|||
162222661|NCT01495598|585865195|FG000|Overall Study|Death during follow up period|2|||
162222662|NCT01495598|585865195|FG000|Overall Study|Death on study|1|||
162222663|NCT01495598|585865195|FG000|Overall Study|Lost to Follow-up|3|||
162222664|NCT01495598|585865195|FG000|Overall Study|Physician Decision|8|||
162222665|NCT00669877|585865198|FG000|Overall Study|Disease Progression/Death|4|||
162222666|NCT01110408|585865199|FG000|Overall Study|Protocol Violation|1|||
162222667|NCT01110408|585865200|FG001|Overall Study|Protocol Violation|0|||
162222668|NCT03635099|585865201|FG000|Period 1|Adverse Event|1|||
162222669|NCT03635099|585865202|FG001|Period 1|Adverse Event|0|||
162222670|NCT03635099|585865203|FG002|Period 1|Adverse Event|0|||
162222671|NCT03635099|585865204|FG003|Period 1|Adverse Event|1|||
162222672|NCT03635099|585865205|FG004|Period 1|Adverse Event|0|||
162222673|NCT03635099|585865206|FG005|Period 1|Adverse Event|0|||
162222674|NCT03635099|585865207|FG006|Period 1|Adverse Event|0|||
162222675|NCT03635099|585865208|FG007|Period 1|Adverse Event|0|||
162023323|NCT00435045|585142652|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
162023324|NCT00435045|585142653|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
162023325|NCT00435045|585142652|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
162023326|NCT00435045|585142653|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
162023327|NCT00435045|585142652|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
162023328|NCT00435045|585142653|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
162023329|NCT00435045|585142652|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
162023330|NCT00435045|585142653|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
162023331|NCT00435045|585142652|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
162023332|NCT00435045|585142653|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
162023333|NCT03052426|585142654|FG000|Overall Study|Withdrawal by Subject|0|||
162023334|NCT03052426|585142655|FG001|Overall Study|Withdrawal by Subject|1|||
162023335|NCT03052426|585142656|FG002|Overall Study|Withdrawal by Subject|0|||
162023336|NCT03052426|585142654|FG000|Overall Study|Lost to Follow-up|2|||
162023337|NCT03052426|585142655|FG001|Overall Study|Lost to Follow-up|0|||
162023338|NCT03052426|585142656|FG002|Overall Study|Lost to Follow-up|1|||
162023339|NCT01290796|585142663|FG000|Overall Study|Lost to Follow-up|21|||
162023340|NCT01290796|585142663|FG000|Overall Study|Withdrawal by Subject|4|||
162023341|NCT01290796|585142663|FG000|Overall Study|Physician Decision|2|||
162023342|NCT01290796|585142663|FG000|Overall Study|Secondary Surgical Intervention|2|||
162023343|NCT01290796|585142663|FG000|Overall Study|Withdrawal by Sponsor|1|||
161829259|NCT03346070|584415735|FG003|Overall Study|Lost to Follow-up|0|||
162023344|NCT00865280|585142664|FG000|Overall Study|Withdrawal by Subject|4|||
162023345|NCT00865280|585142665|FG001|Overall Study|Withdrawal by Subject|1|||
162023346|NCT00865280|585142664|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
162023347|NCT00865280|585142665|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
162023348|NCT00865280|585142664|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
162023349|NCT00865280|585142665|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
162023350|NCT00865280|585142664|FG000|Overall Study|Exclusion Condition|1|||
162222676|NCT03635099|585865201|FG000|Period 1|Protocol Violation|0|||
162222677|NCT03635099|585865202|FG001|Period 1|Protocol Violation|0|||
162222678|NCT03635099|585865203|FG002|Period 1|Protocol Violation|1|||
162222679|NCT03635099|585865204|FG003|Period 1|Protocol Violation|0|||
162222680|NCT03635099|585865205|FG004|Period 1|Protocol Violation|0|||
162222681|NCT03635099|585865206|FG005|Period 1|Protocol Violation|0|||
162222682|NCT03635099|585865207|FG006|Period 1|Protocol Violation|0|||
162222683|NCT03635099|585865208|FG007|Period 1|Protocol Violation|0|||
162222684|NCT03635099|585865201|FG000|Period 1|Lost to Follow-up|0|||
162222685|NCT03635099|585865202|FG001|Period 1|Lost to Follow-up|0|||
162222686|NCT03635099|585865203|FG002|Period 1|Lost to Follow-up|1|||
162222687|NCT03635099|585865204|FG003|Period 1|Lost to Follow-up|2|||
162222688|NCT03635099|585865205|FG004|Period 1|Lost to Follow-up|1|||
162222689|NCT03635099|585865206|FG005|Period 1|Lost to Follow-up|0|||
162222690|NCT03635099|585865207|FG006|Period 1|Lost to Follow-up|1|||
162222691|NCT03635099|585865208|FG007|Period 1|Lost to Follow-up|2|||
162222692|NCT03635099|585865201|FG000|Period 1|Withdrawal by Subject|3|||
162222693|NCT03635099|585865202|FG001|Period 1|Withdrawal by Subject|3|||
162222694|NCT03635099|585865203|FG002|Period 1|Withdrawal by Subject|5|||
162222695|NCT03635099|585865204|FG003|Period 1|Withdrawal by Subject|2|||
162222696|NCT03635099|585865205|FG004|Period 1|Withdrawal by Subject|2|||
162222697|NCT03635099|585865206|FG005|Period 1|Withdrawal by Subject|0|||
162222698|NCT03635099|585865207|FG006|Period 1|Withdrawal by Subject|3|||
162222699|NCT03635099|585865208|FG007|Period 1|Withdrawal by Subject|0|||
162222700|NCT03635099|585865201|FG000|Period 1|History of suicidal ideation|0|||
162222701|NCT03635099|585865202|FG001|Period 1|History of suicidal ideation|0|||
162222702|NCT03635099|585865203|FG002|Period 1|History of suicidal ideation|1|||
162222703|NCT03635099|585865204|FG003|Period 1|History of suicidal ideation|0|||
162222704|NCT03635099|585865205|FG004|Period 1|History of suicidal ideation|0|||
162222705|NCT03635099|585865206|FG005|Period 1|History of suicidal ideation|0|||
162222706|NCT03635099|585865207|FG006|Period 1|History of suicidal ideation|0|||
162222707|NCT03635099|585865208|FG007|Period 1|History of suicidal ideation|0|||
162222708|NCT03635099|585865201|FG000|Period 1|pursue other treatment options|0|||
162222709|NCT03635099|585865202|FG001|Period 1|pursue other treatment options|0|||
162222710|NCT03635099|585865203|FG002|Period 1|pursue other treatment options|0|||
162222711|NCT03635099|585865204|FG003|Period 1|pursue other treatment options|0|||
162222712|NCT03635099|585865205|FG004|Period 1|pursue other treatment options|0|||
162222713|NCT03635099|585865206|FG005|Period 1|pursue other treatment options|1|||
162222714|NCT03635099|585865207|FG006|Period 1|pursue other treatment options|0|||
162222715|NCT03635099|585865208|FG007|Period 1|pursue other treatment options|0|||
162222716|NCT03635099|585865201|FG000|Not Eligible for Period 2|Pregnancy|0|||
162222717|NCT03635099|585865202|FG001|Not Eligible for Period 2|Pregnancy|0|||
162222718|NCT03635099|585865203|FG002|Not Eligible for Period 2|Pregnancy|0|||
162023351|NCT00865280|585142665|FG001|Overall Study|Exclusion Condition|0|||
162222719|NCT03635099|585865204|FG003|Not Eligible for Period 2|Pregnancy|1|||
162222720|NCT03635099|585865205|FG004|Not Eligible for Period 2|Pregnancy|0|||
162222721|NCT03635099|585865206|FG005|Not Eligible for Period 2|Pregnancy|0|||
162222722|NCT03635099|585865207|FG006|Not Eligible for Period 2|Pregnancy|0|||
162222723|NCT03635099|585865208|FG007|Not Eligible for Period 2|Pregnancy|0|||
162222724|NCT03635099|585865201|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
162222725|NCT03635099|585865202|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
162222726|NCT03635099|585865203|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
162222727|NCT03635099|585865204|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
162222728|NCT03635099|585865205|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
162222729|NCT03635099|585865206|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
162222730|NCT03635099|585865207|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
162222731|NCT03635099|585865208|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
161829260|NCT03346070|584415736|FG004|Overall Study|Lost to Follow-up|0|||
162222732|NCT03635099|585865201|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
162222733|NCT03635099|585865202|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
162222734|NCT03635099|585865203|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
162222735|NCT03635099|585865204|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
162222736|NCT03635099|585865205|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
162222737|NCT03635099|585865206|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
162222738|NCT03635099|585865207|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
162222739|NCT03635099|585865208|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
162222740|NCT03635099|585865201|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
162222741|NCT03635099|585865202|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
162222742|NCT03635099|585865203|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
162222743|NCT03635099|585865204|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
162222744|NCT03635099|585865205|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
162222745|NCT03635099|585865206|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
162222746|NCT03635099|585865207|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
162222747|NCT03635099|585865208|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
162222748|NCT03635099|585865201|FG000|Period 2|Adverse Event|0|||
162222749|NCT03635099|585865202|FG001|Period 2|Adverse Event|0|||
162222750|NCT03635099|585865203|FG002|Period 2|Adverse Event|1|||
162222751|NCT03635099|585865204|FG003|Period 2|Adverse Event|0|||
162222752|NCT03635099|585865205|FG004|Period 2|Adverse Event|1|||
162222753|NCT03635099|585865206|FG005|Period 2|Adverse Event|0|||
162222754|NCT03635099|585865207|FG006|Period 2|Adverse Event|0|||
162222755|NCT03635099|585865208|FG007|Period 2|Adverse Event|0|||
162222756|NCT03635099|585865201|FG000|Period 2|Lost to Follow-up|0|||
162222757|NCT03635099|585865202|FG001|Period 2|Lost to Follow-up|0|||
162222758|NCT03635099|585865203|FG002|Period 2|Lost to Follow-up|1|||
162222759|NCT03635099|585865204|FG003|Period 2|Lost to Follow-up|0|||
162222760|NCT03635099|585865205|FG004|Period 2|Lost to Follow-up|4|||
162222761|NCT03635099|585865206|FG005|Period 2|Lost to Follow-up|0|||
162222762|NCT03635099|585865207|FG006|Period 2|Lost to Follow-up|0|||
162222763|NCT03635099|585865208|FG007|Period 2|Lost to Follow-up|0|||
162222764|NCT03635099|585865201|FG000|Period 2|Withdrawal by Subject|0|||
162222765|NCT03635099|585865202|FG001|Period 2|Withdrawal by Subject|0|||
162222766|NCT03635099|585865203|FG002|Period 2|Withdrawal by Subject|7|||
162222767|NCT03635099|585865204|FG003|Period 2|Withdrawal by Subject|4|||
162222768|NCT03635099|585865205|FG004|Period 2|Withdrawal by Subject|7|||
162222769|NCT03635099|585865206|FG005|Period 2|Withdrawal by Subject|0|||
162222770|NCT03635099|585865207|FG006|Period 2|Withdrawal by Subject|0|||
162222771|NCT03635099|585865208|FG007|Period 2|Withdrawal by Subject|0|||
162222772|NCT01289210|585865209|FG000|Overall Study|Adverse Event|1|||
162222773|NCT06285240|585865210|FG000|Overall Study|Withdrawal by Subject|2|||
162222774|NCT06285240|585865211|FG001|Overall Study|Withdrawal by Subject|0|||
162222775|NCT06285240|585865212|FG002|Overall Study|Withdrawal by Subject|0|||
162222776|NCT06285240|585865213|FG003|Overall Study|Withdrawal by Subject|0|||
162222777|NCT06285240|585865210|FG000|Overall Study|Serious Adverse Event|0|||
162222778|NCT06285240|585865211|FG001|Overall Study|Serious Adverse Event|0|||
162222779|NCT06285240|585865212|FG002|Overall Study|Serious Adverse Event|1|||
162222780|NCT06285240|585865213|FG003|Overall Study|Serious Adverse Event|0|||
162222781|NCT05140915|585865216|FG000|Overall Study|Lost to Follow-up|2|||
162222782|NCT05140915|585865217|FG001|Overall Study|Lost to Follow-up|1|||
162222783|NCT04879849|585865222|FG000|Overall Study|Lost to Follow-up|0|||
162222784|NCT04879849|585865223|FG001|Overall Study|Lost to Follow-up|0|||
162222785|NCT04879849|585865224|FG002|Overall Study|Lost to Follow-up|0|||
162222786|NCT04879849|585865225|FG003|Overall Study|Lost to Follow-up|1|||
162222787|NCT04879849|585865226|FG004|Overall Study|Lost to Follow-up|0|||
162222788|NCT04879849|585865227|FG005|Overall Study|Lost to Follow-up|0|||
162222789|NCT04879849|585865228|FG006|Overall Study|Lost to Follow-up|0|||
162222790|NCT04879849|585865229|FG007|Overall Study|Lost to Follow-up|0|||
162222791|NCT04879849|585865222|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
162222792|NCT04879849|585865223|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
162222793|NCT04879849|585865224|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
162222794|NCT04879849|585865225|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
162222795|NCT04879849|585865226|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
162222796|NCT04879849|585865227|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
162222797|NCT04879849|585865228|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
162222798|NCT04879849|585865229|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
162222799|NCT04879849|585865222|FG000|Overall Study|Withdrawal by Subject|0|||
162222800|NCT04879849|585865223|FG001|Overall Study|Withdrawal by Subject|0|||
162222801|NCT04879849|585865224|FG002|Overall Study|Withdrawal by Subject|0|||
162222802|NCT04879849|585865225|FG003|Overall Study|Withdrawal by Subject|0|||
162222803|NCT04879849|585865226|FG004|Overall Study|Withdrawal by Subject|2|||
162222804|NCT04879849|585865227|FG005|Overall Study|Withdrawal by Subject|0|||
162222805|NCT04879849|585865228|FG006|Overall Study|Withdrawal by Subject|1|||
162222806|NCT04879849|585865229|FG007|Overall Study|Withdrawal by Subject|0|||
162222807|NCT04879849|585865222|FG000|Overall Study|Progressive Disease|0|||
162222808|NCT04879849|585865223|FG001|Overall Study|Progressive Disease|0|||
162222809|NCT04879849|585865224|FG002|Overall Study|Progressive Disease|1|||
162222810|NCT04879849|585865225|FG003|Overall Study|Progressive Disease|0|||
162222811|NCT04879849|585865226|FG004|Overall Study|Progressive Disease|0|||
162222812|NCT04879849|585865227|FG005|Overall Study|Progressive Disease|0|||
162222813|NCT04879849|585865228|FG006|Overall Study|Progressive Disease|0|||
162222814|NCT04879849|585865229|FG007|Overall Study|Progressive Disease|0|||
162222815|NCT04879849|585865222|FG000|Overall Study|Death|0|||
162222816|NCT04879849|585865223|FG001|Overall Study|Death|0|||
162222817|NCT04879849|585865224|FG002|Overall Study|Death|1|||
162222818|NCT04879849|585865225|FG003|Overall Study|Death|1|||
162222819|NCT04879849|585865226|FG004|Overall Study|Death|1|||
162222820|NCT04879849|585865227|FG005|Overall Study|Death|2|||
162222821|NCT04879849|585865228|FG006|Overall Study|Death|1|||
162222822|NCT04879849|585865229|FG007|Overall Study|Death|2|||
162222823|NCT04879849|585865222|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
162222824|NCT04879849|585865223|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
162222825|NCT04879849|585865224|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
162222826|NCT04879849|585865225|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
162222827|NCT04879849|585865226|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
162222828|NCT04879849|585865227|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
162222829|NCT04879849|585865228|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
162222830|NCT04879849|585865229|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
162222831|NCT04879849|585865222|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162222832|NCT04879849|585865223|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162222833|NCT04879849|585865224|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162222834|NCT04879849|585865225|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162222835|NCT04879849|585865226|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162222836|NCT04879849|585865227|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162222837|NCT04879849|585865228|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
162222838|NCT04879849|585865229|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
162222839|NCT04879849|585865222|FG000|Overall Study|Reason Not Specified|1|||
162222840|NCT04879849|585865223|FG001|Overall Study|Reason Not Specified|0|||
162222841|NCT04879849|585865224|FG002|Overall Study|Reason Not Specified|0|||
162222842|NCT04879849|585865225|FG003|Overall Study|Reason Not Specified|0|||
162222843|NCT04879849|585865226|FG004|Overall Study|Reason Not Specified|0|||
162222844|NCT04879849|585865227|FG005|Overall Study|Reason Not Specified|0|||
162222845|NCT04879849|585865228|FG006|Overall Study|Reason Not Specified|0|||
162222846|NCT04879849|585865229|FG007|Overall Study|Reason Not Specified|0|||
162222847|NCT05292586|585865234|FG000|Overall Study|Withdrawal by Subject|3|||
162222848|NCT05292586|585865235|FG001|Overall Study|Withdrawal by Subject|10|||
162222849|NCT05292586|585865234|FG000|Overall Study|Randomization error|3|||
162222850|NCT05292586|585865235|FG001|Overall Study|Randomization error|7|||
162222851|NCT05292586|585865234|FG000|Overall Study|Adverse Event|3|||
162222852|NCT05292586|585865235|FG001|Overall Study|Adverse Event|0|||
162222853|NCT05292586|585865234|FG000|Overall Study|Lost to Follow-up|0|||
162222854|NCT05292586|585865235|FG001|Overall Study|Lost to Follow-up|1|||
162222855|NCT05292586|585865234|FG000|Overall Study|Patient refused treatment|1|||
162222856|NCT05292586|585865235|FG001|Overall Study|Patient refused treatment|0|||
162222857|NCT05292586|585865234|FG000|Overall Study|Patient could not travel to the study site|1|||
162222858|NCT05292586|585865235|FG001|Overall Study|Patient could not travel to the study site|0|||
162222859|NCT05292586|585865234|FG000|Overall Study|Technical issues with the masterscope|0|||
162222860|NCT05292586|585865235|FG001|Overall Study|Technical issues with the masterscope|3|||
162222861|NCT05292586|585865234|FG000|Overall Study|Patient moved to a different state|0|||
162222862|NCT05292586|585865235|FG001|Overall Study|Patient moved to a different state|1|||
162222863|NCT03007420|585865248|FG000|Overall Study|Withdrawal by Subject|0|||
162222864|NCT03007420|585865249|FG001|Overall Study|Withdrawal by Subject|2|||
162222865|NCT03007420|585865248|FG000|Overall Study|Physician Decision|0|||
162222866|NCT03007420|585865249|FG001|Overall Study|Physician Decision|1|||
162222867|NCT01435772|585865252|FG000|Overall Study|Adverse Event|1|||
161829261|NCT03346070|584415732|FG000|Overall Study|Physician Decision|0|||
161829262|NCT03346070|584415733|FG001|Overall Study|Physician Decision|0|||
161829263|NCT03346070|584415734|FG002|Overall Study|Physician Decision|0|||
161829264|NCT03346070|584415735|FG003|Overall Study|Physician Decision|1|||
162222868|NCT01435772|585865253|FG001|Overall Study|Adverse Event|0|||
162222869|NCT01435772|585865254|FG002|Overall Study|Adverse Event|2|||
162222870|NCT01435772|585865252|FG000|Overall Study|Withdrawal by Subject|0|||
162222871|NCT01435772|585865253|FG001|Overall Study|Withdrawal by Subject|1|||
162222872|NCT01435772|585865254|FG002|Overall Study|Withdrawal by Subject|3|||
162222873|NCT01435772|585865252|FG000|Overall Study|Other - study termination|2|||
162222874|NCT01435772|585865253|FG001|Overall Study|Other - study termination|2|||
162222875|NCT01435772|585865254|FG002|Overall Study|Other - study termination|10|||
162222876|NCT03238963|585865255|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
162222877|NCT03238963|585865256|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
162222878|NCT03238963|585865255|FG000|Overall Study|Withdrawal by Subject|1|||
162222879|NCT03238963|585865256|FG001|Overall Study|Withdrawal by Subject|1|||
162222880|NCT03238963|585865255|FG000|Overall Study|Lost to Follow-up|1|||
162222881|NCT03238963|585865256|FG001|Overall Study|Lost to Follow-up|0|||
162222882|NCT03238963|585865255|FG000|Overall Study|Protocol Violation|1|||
162222883|NCT03238963|585865256|FG001|Overall Study|Protocol Violation|1|||
162222884|NCT03238963|585865255|FG000|Overall Study|Adverse Event|1|||
162222885|NCT03238963|585865256|FG001|Overall Study|Adverse Event|0|||
162222886|NCT05823012|585865257|FG000|Titration Period|Adverse Event|1|||
162222887|NCT05823012|585865257|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
162222888|NCT05823012|585865257|FG000|Maintenance Period|Adverse Event|1|||
162222889|NCT05823012|585865257|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
162222890|NCT05823012|585865257|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
162222891|NCT01424813|585865258|FG000|Overall Study|Withdrawal by Subject|3|||
162222892|NCT01424813|585865259|FG001|Overall Study|Withdrawal by Subject|0|||
162222893|NCT01424813|585865258|FG000|Overall Study|Protocol Violation|1|||
162222894|NCT01424813|585865259|FG001|Overall Study|Protocol Violation|0|||
162222895|NCT01424813|585865258|FG000|Overall Study|Other|1|||
162222896|NCT01424813|585865259|FG001|Overall Study|Other|2|||
162222897|NCT07149155|585865260|FG000|Overall Study|Lost to Follow-up|10|||
162222898|NCT00515671|585866513|FG000|Overall Study|Lost to Follow-up|13|||
162222899|NCT00515671|585866514|FG001|Overall Study|Lost to Follow-up|10|||
162222900|NCT00515671|585866513|FG000|Overall Study|Withdrawal by Subject|3|||
162222901|NCT00515671|585866514|FG001|Overall Study|Withdrawal by Subject|5|||
162222902|NCT00515671|585866513|FG000|Overall Study|incarcerated|1|||
162222903|NCT00515671|585866514|FG001|Overall Study|incarcerated|2|||
162222904|NCT02993406|585866525|FG000|Overall Study|Withdrawal by Subject|170|||
162222905|NCT02993406|585866526|FG001|Overall Study|Withdrawal by Subject|196|||
162222906|NCT02993406|585866525|FG000|Overall Study|Physician Decision|3|||
161829265|NCT03346070|584415736|FG004|Overall Study|Physician Decision|1|||
161829266|NCT03346070|584415732|FG000|Overall Study|Withdrawal by Subject|1|||
161829267|NCT03346070|584415733|FG001|Overall Study|Withdrawal by Subject|0|||
161829268|NCT03346070|584415734|FG002|Overall Study|Withdrawal by Subject|0|||
161829269|NCT03346070|584415735|FG003|Overall Study|Withdrawal by Subject|1|||
161829270|NCT03346070|584415736|FG004|Overall Study|Withdrawal by Subject|0|||
161829271|NCT03346070|584415732|FG000|Overall Study|Study medication not received as planned|2|||
162222907|NCT02993406|585866526|FG001|Overall Study|Physician Decision|5|||
162222908|NCT02993406|585866525|FG000|Overall Study|Lost to Follow-up|12|||
162222909|NCT02993406|585866526|FG001|Overall Study|Lost to Follow-up|13|||
162222910|NCT02993406|585866525|FG000|Overall Study|Unclassifiable Response|105|||
162222911|NCT02993406|585866526|FG001|Overall Study|Unclassifiable Response|139|||
162222912|NCT02993406|585866525|FG000|Overall Study|Administrative decision|1|||
162222913|NCT02993406|585866526|FG001|Overall Study|Administrative decision|0|||
162222914|NCT02993406|585866525|FG000|Overall Study|Sponsor decision|4|||
162222915|NCT02993406|585866526|FG001|Overall Study|Sponsor decision|5|||
161829272|NCT03346070|584415733|FG001|Overall Study|Study medication not received as planned|3|||
161829273|NCT03346070|584415734|FG002|Overall Study|Study medication not received as planned|2|||
161829274|NCT03346070|584415735|FG003|Overall Study|Study medication not received as planned|3|||
161829275|NCT03346070|584415736|FG004|Overall Study|Study medication not received as planned|2|||
161829276|NCT03346070|584415732|FG000|Overall Study|Screen Failure|0|||
161829277|NCT03346070|584415733|FG001|Overall Study|Screen Failure|0|||
161829278|NCT03346070|584415734|FG002|Overall Study|Screen Failure|0|||
161829279|NCT03346070|584415735|FG003|Overall Study|Screen Failure|1|||
161829280|NCT03346070|584415736|FG004|Overall Study|Screen Failure|1|||
161829281|NCT00977548|584415738|FG000|Overall Study|Ineligible|4|||
161829282|NCT00977548|584415738|FG000|Overall Study|Adverse Event|8|||
161829283|NCT00977548|584415738|FG000|Overall Study|Withdrawal by Subject|1|||
161829284|NCT00988208|584415739|FG000|Overall Study|Adverse Event|71|||
161829285|NCT00988208|584415740|FG001|Overall Study|Adverse Event|122|||
161829286|NCT00988208|584415739|FG000|Overall Study|Disease Progression|103|||
161829287|NCT00988208|584415740|FG001|Overall Study|Disease Progression|89|||
161829288|NCT00988208|584415739|FG000|Overall Study|Withdrawal by Subject|50|||
161829289|NCT00988208|584415740|FG001|Overall Study|Withdrawal by Subject|57|||
161829290|NCT00988208|584415739|FG000|Overall Study|Death|9|||
161829291|NCT00988208|584415740|FG001|Overall Study|Death|15|||
161829292|NCT00988208|584415739|FG000|Overall Study|Lost to Follow-up|2|||
161829293|NCT00988208|584415740|FG001|Overall Study|Lost to Follow-up|3|||
161829294|NCT00988208|584415739|FG000|Overall Study|Protocol Violation|9|||
161829295|NCT00988208|584415740|FG001|Overall Study|Protocol Violation|2|||
161829296|NCT00988208|584415739|FG000|Overall Study|Sponsor Decision|102|||
161829297|NCT00988208|584415740|FG001|Overall Study|Sponsor Decision|78|||
161829298|NCT00988208|584415739|FG000|Overall Study|Clinical Progression|17|||
161829299|NCT00988208|584415740|FG001|Overall Study|Clinical Progression|16|||
161829300|NCT00988208|584415739|FG000|Overall Study|Biochemical Progression|21|||
161829301|NCT00988208|584415740|FG001|Overall Study|Biochemical Progression|7|||
161829302|NCT00988208|584415739|FG000|Overall Study|Clinical Deterioration|7|||
161829303|NCT00988208|584415740|FG001|Overall Study|Clinical Deterioration|14|||
161829304|NCT00988208|584415739|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
161829305|NCT00988208|584415740|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
161829306|NCT00988208|584415739|FG000|Overall Study|Other|8|||
161829307|NCT00988208|584415740|FG001|Overall Study|Other|3|||
161939569|NCT03895372|584828678|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
162222916|NCT02942277|585866527|FG000|Year 1|Withdrawal by Subject|0|||
162222917|NCT02942277|585866528|FG001|Year 1|Withdrawal by Subject|0|||
162222918|NCT02942277|585866529|FG002|Year 1|Withdrawal by Subject|0|||
162222919|NCT02942277|585866530|FG003|Year 1|Withdrawal by Subject|0|||
162222920|NCT02942277|585866531|FG004|Year 1|Withdrawal by Subject|1|||
162222921|NCT02942277|585866532|FG005|Year 1|Withdrawal by Subject|3|||
162222922|NCT02942277|585866533|FG006|Year 1|Withdrawal by Subject|0|||
162222923|NCT02942277|585866534|FG007|Year 1|Withdrawal by Subject|1|||
162222924|NCT02942277|585866535|FG008|Year 1|Withdrawal by Subject|0|||
162222925|NCT02942277|585866536|FG009|Year 1|Withdrawal by Subject|0|||
162222926|NCT02942277|585866537|FG010|Year 1|Withdrawal by Subject|3|||
162222927|NCT02942277|585866527|FG000|Year 1|Travel|0|||
162222928|NCT02942277|585866528|FG001|Year 1|Travel|1|||
162222929|NCT02942277|585866529|FG002|Year 1|Travel|0|||
162222930|NCT02942277|585866530|FG003|Year 1|Travel|0|||
162222931|NCT02942277|585866531|FG004|Year 1|Travel|4|||
162222932|NCT02942277|585866532|FG005|Year 1|Travel|5|||
162222933|NCT02942277|585866533|FG006|Year 1|Travel|0|||
162222934|NCT02942277|585866534|FG007|Year 1|Travel|0|||
162222935|NCT02942277|585866535|FG008|Year 1|Travel|0|||
162222936|NCT02942277|585866536|FG009|Year 1|Travel|0|||
162222937|NCT02942277|585866537|FG010|Year 1|Travel|8|||
162222938|NCT02942277|585866527|FG000|Year 1|Joined Army|0|||
161939570|NCT03685149|584828679|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
162222939|NCT02942277|585866528|FG001|Year 1|Joined Army|1|||
162222940|NCT02942277|585866529|FG002|Year 1|Joined Army|0|||
162222941|NCT02942277|585866530|FG003|Year 1|Joined Army|0|||
162222942|NCT02942277|585866531|FG004|Year 1|Joined Army|0|||
162222943|NCT02942277|585866532|FG005|Year 1|Joined Army|0|||
162222944|NCT02942277|585866533|FG006|Year 1|Joined Army|0|||
162222945|NCT02942277|585866534|FG007|Year 1|Joined Army|0|||
162222946|NCT02942277|585866535|FG008|Year 1|Joined Army|0|||
162222947|NCT02942277|585866536|FG009|Year 1|Joined Army|0|||
162222948|NCT02942277|585866537|FG010|Year 1|Joined Army|0|||
162222949|NCT02942277|585866527|FG000|Year 1|Subject met withdrawal criteria|0|||
162222950|NCT02942277|585866528|FG001|Year 1|Subject met withdrawal criteria|0|||
162222951|NCT02942277|585866529|FG002|Year 1|Subject met withdrawal criteria|0|||
162222952|NCT02942277|585866530|FG003|Year 1|Subject met withdrawal criteria|1|||
162222953|NCT02942277|585866531|FG004|Year 1|Subject met withdrawal criteria|0|||
162222954|NCT02942277|585866532|FG005|Year 1|Subject met withdrawal criteria|0|||
162222955|NCT02942277|585866533|FG006|Year 1|Subject met withdrawal criteria|0|||
162222956|NCT02942277|585866534|FG007|Year 1|Subject met withdrawal criteria|0|||
162222957|NCT02942277|585866535|FG008|Year 1|Subject met withdrawal criteria|0|||
162222958|NCT02942277|585866536|FG009|Year 1|Subject met withdrawal criteria|0|||
162222959|NCT02942277|585866537|FG010|Year 1|Subject met withdrawal criteria|0|||
162222960|NCT02942277|585866527|FG000|Year 1|Lost to Follow-up|0|||
162222961|NCT02942277|585866528|FG001|Year 1|Lost to Follow-up|0|||
162222962|NCT02942277|585866529|FG002|Year 1|Lost to Follow-up|0|||
162222963|NCT02942277|585866530|FG003|Year 1|Lost to Follow-up|0|||
162222964|NCT02942277|585866531|FG004|Year 1|Lost to Follow-up|1|||
162222965|NCT02942277|585866532|FG005|Year 1|Lost to Follow-up|0|||
162222966|NCT02942277|585866533|FG006|Year 1|Lost to Follow-up|0|||
162222967|NCT02942277|585866534|FG007|Year 1|Lost to Follow-up|0|||
162222968|NCT02942277|585866535|FG008|Year 1|Lost to Follow-up|0|||
162222969|NCT02942277|585866536|FG009|Year 1|Lost to Follow-up|0|||
162222970|NCT02942277|585866537|FG010|Year 1|Lost to Follow-up|2|||
162222971|NCT02942277|585866527|FG000|Year 1|Protocol Violation|0|||
162222972|NCT02942277|585866528|FG001|Year 1|Protocol Violation|0|||
162222973|NCT02942277|585866529|FG002|Year 1|Protocol Violation|0|||
162222974|NCT02942277|585866530|FG003|Year 1|Protocol Violation|0|||
162222975|NCT02942277|585866531|FG004|Year 1|Protocol Violation|1|||
162222976|NCT02942277|585866532|FG005|Year 1|Protocol Violation|1|||
162222977|NCT02942277|585866533|FG006|Year 1|Protocol Violation|0|||
162222978|NCT02942277|585866534|FG007|Year 1|Protocol Violation|0|||
162222979|NCT02942277|585866535|FG008|Year 1|Protocol Violation|0|||
162222980|NCT02942277|585866536|FG009|Year 1|Protocol Violation|0|||
162222981|NCT02942277|585866537|FG010|Year 1|Protocol Violation|2|||
162222982|NCT02942277|585866527|FG000|Year 1|Pregnancy|0|||
162222983|NCT02942277|585866528|FG001|Year 1|Pregnancy|0|||
162222984|NCT02942277|585866529|FG002|Year 1|Pregnancy|0|||
162222985|NCT02942277|585866530|FG003|Year 1|Pregnancy|0|||
162222986|NCT02942277|585866531|FG004|Year 1|Pregnancy|0|||
162222987|NCT02942277|585866532|FG005|Year 1|Pregnancy|1|||
162222988|NCT02942277|585866533|FG006|Year 1|Pregnancy|0|||
162222989|NCT02942277|585866534|FG007|Year 1|Pregnancy|0|||
162222990|NCT02942277|585866535|FG008|Year 1|Pregnancy|0|||
162222991|NCT02942277|585866536|FG009|Year 1|Pregnancy|0|||
162222992|NCT02942277|585866537|FG010|Year 1|Pregnancy|0|||
162222993|NCT02942277|585866527|FG000|Year 2|Lost to Follow-up|0|||
162222994|NCT02942277|585866528|FG001|Year 2|Lost to Follow-up|0|||
162222995|NCT02942277|585866529|FG002|Year 2|Lost to Follow-up|0|||
162222996|NCT02942277|585866530|FG003|Year 2|Lost to Follow-up|0|||
162222997|NCT02942277|585866531|FG004|Year 2|Lost to Follow-up|2|||
162222998|NCT02942277|585866532|FG005|Year 2|Lost to Follow-up|1|||
162222999|NCT02942277|585866533|FG006|Year 2|Lost to Follow-up|0|||
162223000|NCT02942277|585866534|FG007|Year 2|Lost to Follow-up|0|||
162223001|NCT02942277|585866535|FG008|Year 2|Lost to Follow-up|0|||
162223002|NCT02942277|585866536|FG009|Year 2|Lost to Follow-up|0|||
162223003|NCT02942277|585866537|FG010|Year 2|Lost to Follow-up|0|||
162223004|NCT02942277|585866527|FG000|Year 2|Did not rescreen|0|||
162223005|NCT02942277|585866528|FG001|Year 2|Did not rescreen|0|||
162223006|NCT02942277|585866529|FG002|Year 2|Did not rescreen|1|||
162223007|NCT02942277|585866530|FG003|Year 2|Did not rescreen|1|||
162223008|NCT02942277|585866531|FG004|Year 2|Did not rescreen|9|||
162223009|NCT02942277|585866532|FG005|Year 2|Did not rescreen|6|||
162223010|NCT02942277|585866533|FG006|Year 2|Did not rescreen|0|||
162223011|NCT02942277|585866534|FG007|Year 2|Did not rescreen|1|||
162223012|NCT02942277|585866535|FG008|Year 2|Did not rescreen|0|||
162223013|NCT02942277|585866536|FG009|Year 2|Did not rescreen|0|||
162223014|NCT02942277|585866537|FG010|Year 2|Did not rescreen|21|||
162223015|NCT02942277|585866527|FG000|Year 2|Met withdrawal criteria|0|||
162223016|NCT02942277|585866528|FG001|Year 2|Met withdrawal criteria|0|||
162223017|NCT02942277|585866529|FG002|Year 2|Met withdrawal criteria|0|||
162223018|NCT02942277|585866530|FG003|Year 2|Met withdrawal criteria|0|||
162223019|NCT02942277|585866531|FG004|Year 2|Met withdrawal criteria|1|||
162223020|NCT02942277|585866532|FG005|Year 2|Met withdrawal criteria|2|||
162223021|NCT02942277|585866533|FG006|Year 2|Met withdrawal criteria|0|||
162223022|NCT02942277|585866534|FG007|Year 2|Met withdrawal criteria|0|||
162223023|NCT02942277|585866535|FG008|Year 2|Met withdrawal criteria|0|||
162223024|NCT02942277|585866536|FG009|Year 2|Met withdrawal criteria|0|||
162223025|NCT02942277|585866537|FG010|Year 2|Met withdrawal criteria|1|||
162223026|NCT02942277|585866527|FG000|Year 2|Travel|0|||
162223027|NCT02942277|585866528|FG001|Year 2|Travel|1|||
162223028|NCT02942277|585866529|FG002|Year 2|Travel|0|||
162223029|NCT02942277|585866530|FG003|Year 2|Travel|0|||
162223030|NCT02942277|585866531|FG004|Year 2|Travel|0|||
162223031|NCT02942277|585866532|FG005|Year 2|Travel|1|||
162223032|NCT02942277|585866533|FG006|Year 2|Travel|0|||
162223033|NCT02942277|585866534|FG007|Year 2|Travel|0|||
162223034|NCT02942277|585866535|FG008|Year 2|Travel|0|||
162223035|NCT02942277|585866536|FG009|Year 2|Travel|1|||
162223036|NCT02942277|585866537|FG010|Year 2|Travel|3|||
162223037|NCT02942277|585866527|FG000|Year 2|Non-compliant|0|||
162223038|NCT02942277|585866528|FG001|Year 2|Non-compliant|0|||
162223039|NCT02942277|585866529|FG002|Year 2|Non-compliant|0|||
162223040|NCT02942277|585866530|FG003|Year 2|Non-compliant|0|||
162223041|NCT02942277|585866531|FG004|Year 2|Non-compliant|1|||
162223042|NCT02942277|585866532|FG005|Year 2|Non-compliant|1|||
162223043|NCT02942277|585866533|FG006|Year 2|Non-compliant|0|||
162223044|NCT02942277|585866534|FG007|Year 2|Non-compliant|0|||
162223045|NCT02942277|585866535|FG008|Year 2|Non-compliant|0|||
162223046|NCT02942277|585866536|FG009|Year 2|Non-compliant|0|||
162023352|NCT00865280|585142664|FG000|Overall Study|Adverse Event|0|||
162023353|NCT00865280|585142665|FG001|Overall Study|Adverse Event|1|||
162023354|NCT00329797|585142666|FG000|Overall Study|Protocol Violation|1|||
162023355|NCT00329797|585142667|FG001|Overall Study|Protocol Violation|0|||
162023356|NCT00329797|585142666|FG000|Overall Study|Withdrawal by Subject|6|||
162023357|NCT00329797|585142667|FG001|Overall Study|Withdrawal by Subject|6|||
162023358|NCT03091348|585142675|FG000|Overall Study|Lost to Follow-up|2|||
162023359|NCT03091348|585142676|FG001|Overall Study|Lost to Follow-up|1|||
162023360|NCT00499590|585142677|FG000|Overall Study|Study Terminated|112|||
162023361|NCT00499590|585142678|FG001|Overall Study|Study Terminated|112|||
162023362|NCT00499590|585142679|FG002|Overall Study|Study Terminated|112|||
162023363|NCT00499590|585142677|FG000|Overall Study|Not treated|1|||
162023364|NCT00499590|585142678|FG001|Overall Study|Not treated|0|||
162023365|NCT00499590|585142679|FG002|Overall Study|Not treated|1|||
162023366|NCT02633020|585142682|FG000|Overall Study|Adverse Event|1|||
162023367|NCT02633020|585142683|FG001|Overall Study|Adverse Event|0|||
162023368|NCT00934440|585142684|FG000|Overall Study|Lost to Follow-up|1|||
162023369|NCT02152956|585142685|FG000|Overall Study|Adverse Event|0|||
162023370|NCT02152956|585142686|FG001|Overall Study|Adverse Event|0|||
162023371|NCT02152956|585142687|FG002|Overall Study|Adverse Event|0|||
162023372|NCT02152956|585142688|FG003|Overall Study|Adverse Event|0|||
162023373|NCT02152956|585142689|FG004|Overall Study|Adverse Event|0|||
162023374|NCT02152956|585142690|FG005|Overall Study|Adverse Event|0|||
162023375|NCT02152956|585142691|FG006|Overall Study|Adverse Event|0|||
162023376|NCT02152956|585142692|FG007|Overall Study|Adverse Event|0|||
162023377|NCT02152956|585142693|FG008|Overall Study|Adverse Event|0|||
162023378|NCT02152956|585142694|FG009|Overall Study|Adverse Event|0|||
162023379|NCT02152956|585142695|FG010|Overall Study|Adverse Event|0|||
162023380|NCT02152956|585142696|FG011|Overall Study|Adverse Event|4|||
162023381|NCT02152956|585142697|FG012|Overall Study|Adverse Event|0|||
162023382|NCT02152956|585142685|FG000|Overall Study|Death|0|||
162023383|NCT02152956|585142686|FG001|Overall Study|Death|3|||
162023384|NCT02152956|585142687|FG002|Overall Study|Death|3|||
162023385|NCT02152956|585142688|FG003|Overall Study|Death|4|||
162023386|NCT02152956|585142689|FG004|Overall Study|Death|1|||
162023387|NCT02152956|585142690|FG005|Overall Study|Death|2|||
162023388|NCT02152956|585142691|FG006|Overall Study|Death|6|||
162023389|NCT02152956|585142692|FG007|Overall Study|Death|6|||
162023390|NCT02152956|585142693|FG008|Overall Study|Death|4|||
162023391|NCT02152956|585142694|FG009|Overall Study|Death|5|||
162023392|NCT02152956|585142695|FG010|Overall Study|Death|3|||
162023393|NCT02152956|585142696|FG011|Overall Study|Death|143|||
162023394|NCT02152956|585142697|FG012|Overall Study|Death|12|||
162023395|NCT02152956|585142685|FG000|Overall Study|Lost to Follow-up|0|||
162023396|NCT02152956|585142686|FG001|Overall Study|Lost to Follow-up|1|||
162023397|NCT02152956|585142687|FG002|Overall Study|Lost to Follow-up|0|||
162023398|NCT02152956|585142688|FG003|Overall Study|Lost to Follow-up|0|||
162223047|NCT02942277|585866537|FG010|Year 2|Non-compliant|0|||
162223048|NCT02942277|585866527|FG000|Year 2|Withdrawal by Subject|0|||
162223049|NCT02942277|585866528|FG001|Year 2|Withdrawal by Subject|0|||
162023399|NCT02152956|585142689|FG004|Overall Study|Lost to Follow-up|0|||
162023400|NCT02152956|585142690|FG005|Overall Study|Lost to Follow-up|0|||
162023401|NCT02152956|585142691|FG006|Overall Study|Lost to Follow-up|0|||
162023402|NCT02152956|585142692|FG007|Overall Study|Lost to Follow-up|0|||
162223050|NCT02942277|585866529|FG002|Year 2|Withdrawal by Subject|0|||
162223051|NCT02942277|585866530|FG003|Year 2|Withdrawal by Subject|0|||
162023403|NCT02152956|585142693|FG008|Overall Study|Lost to Follow-up|0|||
162023404|NCT02152956|585142694|FG009|Overall Study|Lost to Follow-up|0|||
162023405|NCT02152956|585142695|FG010|Overall Study|Lost to Follow-up|0|||
162023406|NCT02152956|585142696|FG011|Overall Study|Lost to Follow-up|3|||
162223052|NCT02942277|585866531|FG004|Year 2|Withdrawal by Subject|0|||
162223053|NCT02942277|585866532|FG005|Year 2|Withdrawal by Subject|0|||
162223054|NCT02942277|585866533|FG006|Year 2|Withdrawal by Subject|1|||
162223055|NCT02942277|585866534|FG007|Year 2|Withdrawal by Subject|0|||
162023407|NCT02152956|585142697|FG012|Overall Study|Lost to Follow-up|0|||
162023408|NCT02152956|585142685|FG000|Overall Study|Withdrawal by Subject|1|||
162023409|NCT02152956|585142686|FG001|Overall Study|Withdrawal by Subject|0|||
162023410|NCT02152956|585142687|FG002|Overall Study|Withdrawal by Subject|1|||
162023411|NCT02152956|585142688|FG003|Overall Study|Withdrawal by Subject|0|||
162223056|NCT02942277|585866535|FG008|Year 2|Withdrawal by Subject|0|||
162223057|NCT02942277|585866536|FG009|Year 2|Withdrawal by Subject|0|||
162223058|NCT02942277|585866537|FG010|Year 2|Withdrawal by Subject|0|||
162223059|NCT04325282|585866538|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
162223060|NCT04325282|585866539|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
162223061|NCT04325282|585866538|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
162223062|NCT04325282|585866539|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
162223063|NCT04020185|585866544|FG000|Overall Study|Death|0|||
162223064|NCT04020185|585866545|FG001|Overall Study|Death|0|||
162223065|NCT04020185|585866546|FG002|Overall Study|Death|1|||
162223066|NCT04020185|585866547|FG003|Overall Study|Death|2|||
162223067|NCT04020185|585866548|FG004|Overall Study|Death|1|||
162223068|NCT04020185|585866549|FG005|Overall Study|Death|0|||
162223069|NCT04020185|585866550|FG006|Overall Study|Death|1|||
162223070|NCT04020185|585866551|FG007|Overall Study|Death|0|||
162223071|NCT04020185|585866544|FG000|Overall Study|Consent withdrawn|1|||
162223072|NCT04020185|585866545|FG001|Overall Study|Consent withdrawn|0|||
162223073|NCT04020185|585866546|FG002|Overall Study|Consent withdrawn|0|||
162223074|NCT04020185|585866547|FG003|Overall Study|Consent withdrawn|0|||
162223075|NCT04020185|585866548|FG004|Overall Study|Consent withdrawn|2|||
162223076|NCT04020185|585866549|FG005|Overall Study|Consent withdrawn|0|||
162223077|NCT04020185|585866550|FG006|Overall Study|Consent withdrawn|1|||
162223078|NCT04020185|585866551|FG007|Overall Study|Consent withdrawn|1|||
162223079|NCT04020185|585866544|FG000|Overall Study|Patient in hospice|0|||
162223080|NCT04020185|585866545|FG001|Overall Study|Patient in hospice|1|||
162223081|NCT04020185|585866546|FG002|Overall Study|Patient in hospice|0|||
161829308|NCT02000531|584415745|FG000|Overall Study|Lost to Follow-up|1|||
162223082|NCT04020185|585866547|FG003|Overall Study|Patient in hospice|0|||
161829309|NCT02000531|584415746|FG001|Overall Study|Lost to Follow-up|0|||
162223083|NCT04020185|585866548|FG004|Overall Study|Patient in hospice|0|||
162223084|NCT04020185|585866549|FG005|Overall Study|Patient in hospice|0|||
161829310|NCT02000531|584415745|FG000|Overall Study|Discontinued due to data cut-off|3|||
161829311|NCT02000531|584415746|FG001|Overall Study|Discontinued due to data cut-off|8|||
162223085|NCT04020185|585866550|FG006|Overall Study|Patient in hospice|0|||
162223086|NCT04020185|585866551|FG007|Overall Study|Patient in hospice|0|||
162223087|NCT04020185|585866544|FG000|Overall Study|Continuing on expanded access|0|||
162223088|NCT04020185|585866545|FG001|Overall Study|Continuing on expanded access|0|||
162223089|NCT04020185|585866546|FG002|Overall Study|Continuing on expanded access|0|||
162223090|NCT04020185|585866547|FG003|Overall Study|Continuing on expanded access|0|||
162223091|NCT04020185|585866548|FG004|Overall Study|Continuing on expanded access|0|||
162223092|NCT04020185|585866549|FG005|Overall Study|Continuing on expanded access|0|||
162223093|NCT04020185|585866550|FG006|Overall Study|Continuing on expanded access|1|||
162223094|NCT04020185|585866551|FG007|Overall Study|Continuing on expanded access|1|||
162223095|NCT00527787|585866553|FG000|Overall Study|Adverse Event|14|||
162223096|NCT00527787|585866554|FG001|Overall Study|Adverse Event|24|||
162223097|NCT00527787|585866553|FG000|Overall Study|Withdrawal by Subject|13|||
162223098|NCT00527787|585866554|FG001|Overall Study|Withdrawal by Subject|25|||
162223099|NCT00527787|585866553|FG000|Overall Study|Lost to Follow-up|5|||
162223100|NCT00527787|585866554|FG001|Overall Study|Lost to Follow-up|2|||
162223101|NCT00527787|585866553|FG000|Overall Study|Duodenal Ulcer|1|||
162223102|NCT00527787|585866554|FG001|Overall Study|Duodenal Ulcer|10|||
162223103|NCT00527787|585866553|FG000|Overall Study|misc|5|||
162223104|NCT00527787|585866554|FG001|Overall Study|misc|2|||
162223105|NCT01706705|585866557|FG000|Overall Study|Death|1|||
162223106|NCT01706705|585866557|FG000|Overall Study|Lack of Efficacy|13|||
162223107|NCT01706705|585866557|FG000|Overall Study|Non-clinical|6|||
162223108|NCT00608868|585866560|FG000|Overall Study|Withdrawal by Subject|7|||
162223109|NCT00608868|585866560|FG000|Overall Study|Protocol Violation|3|||
162223110|NCT00608868|585866560|FG000|Overall Study|Lost to Follow-up|2|||
162223111|NCT00608868|585866560|FG000|Overall Study|Adverse Event|1|||
162223112|NCT00608868|585866560|FG000|Overall Study|Physician Decision|2|||
162223113|NCT00702962|585866563|FG000|Overall Study|Progressive disease|0|||
162223114|NCT00702962|585866564|FG001|Overall Study|Progressive disease|1|||
162223115|NCT00702962|585866563|FG000|Overall Study|Hospitalized for other health disorder|1|||
162223116|NCT00702962|585866564|FG001|Overall Study|Hospitalized for other health disorder|0|||
162223117|NCT01252355|585866565|FG000|Overall Study|Adverse Event|9|||
162223118|NCT01252355|585866566|FG001|Overall Study|Adverse Event|17|||
162223119|NCT01252355|585866567|FG002|Overall Study|Adverse Event|22|||
162223120|NCT01252355|585866565|FG000|Overall Study|Lack of Efficacy|6|||
162223121|NCT01252355|585866566|FG001|Overall Study|Lack of Efficacy|4|||
162223122|NCT01252355|585866567|FG002|Overall Study|Lack of Efficacy|2|||
162223123|NCT01252355|585866565|FG000|Overall Study|Lost to Follow-up|0|||
162223124|NCT01252355|585866566|FG001|Overall Study|Lost to Follow-up|0|||
162223125|NCT01252355|585866567|FG002|Overall Study|Lost to Follow-up|1|||
162223126|NCT01252355|585866565|FG000|Overall Study|Poor Compliance to Protocol|1|||
162223127|NCT01252355|585866566|FG001|Overall Study|Poor Compliance to Protocol|1|||
162223128|NCT01252355|585866567|FG002|Overall Study|Poor Compliance to Protocol|1|||
162223129|NCT01252355|585866565|FG000|Overall Study|Progressive Disease|2|||
162223130|NCT01252355|585866566|FG001|Overall Study|Progressive Disease|0|||
162223131|NCT01252355|585866567|FG002|Overall Study|Progressive Disease|0|||
162223132|NCT01252355|585866565|FG000|Overall Study|Sponsor Early Termination of Study|149|||
162223133|NCT01252355|585866566|FG001|Overall Study|Sponsor Early Termination of Study|149|||
162223134|NCT01252355|585866567|FG002|Overall Study|Sponsor Early Termination of Study|146|||
162223135|NCT01252355|585866565|FG000|Overall Study|Randomized but not Treated|2|||
162223136|NCT01252355|585866566|FG001|Overall Study|Randomized but not Treated|0|||
162223137|NCT01252355|585866567|FG002|Overall Study|Randomized but not Treated|0|||
162223138|NCT01252355|585866565|FG000|Overall Study|Other Than Above|8|||
162223139|NCT01252355|585866566|FG001|Overall Study|Other Than Above|7|||
162223140|NCT01252355|585866567|FG002|Overall Study|Other Than Above|7|||
161829312|NCT00794417|584415747|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
162223141|NCT02175641|585866569|FG000|Overall Study|Death|3|||
162223142|NCT02175641|585866570|FG001|Overall Study|Death|4|||
162223143|NCT02175641|585866569|FG000|Overall Study|Lost to Follow-up|4|||
162223144|NCT02175641|585866570|FG001|Overall Study|Lost to Follow-up|4|||
162223145|NCT02175641|585866569|FG000|Overall Study|Withdrawal by Subject|7|||
162223146|NCT02175641|585866570|FG001|Overall Study|Withdrawal by Subject|4|||
162223147|NCT02175641|585866569|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
161829313|NCT00794417|584415748|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
162223148|NCT02175641|585866570|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
162223149|NCT02175641|585866569|FG000|Overall Study|Developed Contraindicated Condition|8|||
162223150|NCT02175641|585866570|FG001|Overall Study|Developed Contraindicated Condition|0|||
161829314|NCT00794417|584415749|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
161829315|NCT00794417|584415750|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
162223151|NCT01876901|585866573|FG000|Overall Study|Protocol Violation|10|||
162223152|NCT01876901|585866574|FG001|Overall Study|Protocol Violation|2|||
162223153|NCT01876901|585866573|FG000|Overall Study|No or other surgical intervention|7|||
162223154|NCT01876901|585866574|FG001|Overall Study|No or other surgical intervention|5|||
162223155|NCT02242097|585866577|FG000|Ibrutinib Treatment|Adverse Event|16|||
162223156|NCT02242097|585866577|FG000|Ibrutinib Treatment|Physician Decision|1|||
162223157|NCT02242097|585866577|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
162223158|NCT02242097|585866577|FG000|Ibrutinib Treatment|Death|1|||
162223159|NCT02242097|585866577|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
162223160|NCT02242097|585866577|FG000|Post Therapy Follow Up|Death|3|||
162223161|NCT02242097|585866577|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
162223162|NCT03031496|585866579|FG000|Period 1|Adverse Event|2|||
162223163|NCT03031496|585866580|FG001|Period 1|Adverse Event|0|||
162223164|NCT03031496|585866579|FG000|Period 1|Withdrawal by Subject|0|||
162223165|NCT03031496|585866580|FG001|Period 1|Withdrawal by Subject|2|||
162223166|NCT03868787|585866582|FG000|Overall Study|Withdrawal by Subject|2|||
162223167|NCT03868787|585866583|FG001|Overall Study|Withdrawal by Subject|1|||
162223168|NCT01399697|585866584|FG000|Overall Study|Adverse Event|13|||
162223169|NCT01399697|585866585|FG001|Overall Study|Adverse Event|3|||
162223170|NCT01399697|585866586|FG002|Overall Study|Adverse Event|1|||
162223171|NCT01399697|585866584|FG000|Overall Study|Lost to Follow-up|2|||
162223172|NCT01399697|585866585|FG001|Overall Study|Lost to Follow-up|0|||
162223173|NCT01399697|585866586|FG002|Overall Study|Lost to Follow-up|0|||
162223174|NCT01399697|585866584|FG000|Overall Study|Withdrawal by Subject|8|||
162223175|NCT01399697|585866585|FG001|Overall Study|Withdrawal by Subject|0|||
162223176|NCT01399697|585866586|FG002|Overall Study|Withdrawal by Subject|0|||
162223177|NCT01399697|585866584|FG000|Overall Study|Investigator Decisión|1|||
162223178|NCT01399697|585866585|FG001|Overall Study|Investigator Decisión|0|||
162223179|NCT01399697|585866586|FG002|Overall Study|Investigator Decisión|2|||
162223180|NCT01399697|585866584|FG000|Overall Study|Lack of Efficacy|9|||
162223181|NCT01399697|585866585|FG001|Overall Study|Lack of Efficacy|0|||
162223182|NCT01399697|585866586|FG002|Overall Study|Lack of Efficacy|1|||
162223183|NCT01399697|585866584|FG000|Overall Study|Protocol Violation|2|||
162223184|NCT01399697|585866585|FG001|Overall Study|Protocol Violation|0|||
162223185|NCT01399697|585866586|FG002|Overall Study|Protocol Violation|0|||
162223186|NCT01399697|585866584|FG000|Overall Study|Non-Compliant|1|||
162223187|NCT01399697|585866585|FG001|Overall Study|Non-Compliant|0|||
162223188|NCT01399697|585866586|FG002|Overall Study|Non-Compliant|0|||
162223189|NCT01399697|585866584|FG000|Overall Study|Inclusion Error|2|||
162223190|NCT01399697|585866585|FG001|Overall Study|Inclusion Error|0|||
162223191|NCT01399697|585866586|FG002|Overall Study|Inclusion Error|0|||
162223192|NCT01399697|585866584|FG000|Overall Study|Positive result for hepatitis B|1|||
162223193|NCT01399697|585866585|FG001|Overall Study|Positive result for hepatitis B|0|||
162223194|NCT01399697|585866586|FG002|Overall Study|Positive result for hepatitis B|0|||
162223195|NCT01399697|585866584|FG000|Overall Study|Clinical RA remission|1|||
162223196|NCT01399697|585866585|FG001|Overall Study|Clinical RA remission|0|||
162223197|NCT01399697|585866586|FG002|Overall Study|Clinical RA remission|0|||
162223198|NCT01399697|585866584|FG000|Overall Study|Sponsor Decision|1|||
162223199|NCT01399697|585866585|FG001|Overall Study|Sponsor Decision|0|||
162223200|NCT01399697|585866586|FG002|Overall Study|Sponsor Decision|0|||
162223201|NCT01712061|585866588|FG000|Overall Study|Adverse Event|4|||
162223202|NCT01712061|585866589|FG001|Overall Study|Adverse Event|9|||
162223203|NCT01712061|585866590|FG002|Overall Study|Adverse Event|5|||
162223204|NCT01712061|585866588|FG000|Overall Study|Death|0|||
162223205|NCT01712061|585866589|FG001|Overall Study|Death|0|||
162223206|NCT01712061|585866590|FG002|Overall Study|Death|1|||
162223207|NCT01712061|585866588|FG000|Overall Study|Lost to Follow-up|1|||
162223208|NCT01712061|585866589|FG001|Overall Study|Lost to Follow-up|0|||
162223209|NCT01712061|585866590|FG002|Overall Study|Lost to Follow-up|1|||
162223210|NCT01712061|585866588|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
162223211|NCT01712061|585866589|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
162223212|NCT01712061|585866590|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
162223213|NCT01712061|585866588|FG000|Overall Study|Medication Error Without Associated AE|0|||
162223214|NCT01712061|585866589|FG001|Overall Study|Medication Error Without Associated AE|1|||
162223215|NCT01712061|585866590|FG002|Overall Study|Medication Error Without Associated AE|0|||
162223216|NCT01712061|585866588|FG000|Overall Study|Withdrawal by Subject|1|||
162223217|NCT01712061|585866589|FG001|Overall Study|Withdrawal by Subject|7|||
162223218|NCT01712061|585866590|FG002|Overall Study|Withdrawal by Subject|1|||
162223219|NCT01712061|585866588|FG000|Overall Study|Other|0|||
162223220|NCT01712061|585866589|FG001|Overall Study|Other|3|||
162223221|NCT01712061|585866590|FG002|Overall Study|Other|0|||
162223222|NCT00504777|585866595|FG000|Overall Study|Adverse Event|1|||
162223223|NCT04868539|585866599|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
162223224|NCT04868539|585866600|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
162223225|NCT01572740|585866601|FG000|Overall Study|Adverse Event|1|||
162223226|NCT01572740|585866602|FG001|Overall Study|Adverse Event|1|||
162223227|NCT01572740|585866601|FG000|Overall Study|Withdrawal by Subject|1|||
162223228|NCT01572740|585866602|FG001|Overall Study|Withdrawal by Subject|1|||
162223229|NCT01572740|585866601|FG000|Overall Study|unclassified|4|||
162223230|NCT01572740|585866602|FG001|Overall Study|unclassified|3|||
162223231|NCT01401153|585866603|FG000|First Test Day|Learning disabilities; illness|1|||
162223232|NCT01401153|585866604|FG001|First Test Day|Learning disabilities; illness|10|||
162223233|NCT01401153|585866603|FG000|Second Test Day|illness|0|||
162223234|NCT01401153|585866604|FG001|Second Test Day|illness|5|||
162223235|NCT01677767|585866607|FG000|Overall Study|Adverse Event|1|||
162223236|NCT01677767|585866607|FG000|Overall Study|Death|4|||
161829316|NCT00794417|584415747|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
161829317|NCT00794417|584415748|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
161829318|NCT00794417|584415749|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
161829319|NCT00794417|584415750|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
161829320|NCT00794417|584415747|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
161829321|NCT00794417|584415748|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
161829322|NCT00794417|584415749|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
161829323|NCT00794417|584415750|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
161829324|NCT00794417|584415747|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
161829325|NCT00794417|584415748|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
161829326|NCT00794417|584415749|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
161829327|NCT00794417|584415750|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
161829328|NCT00794417|584415747|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
161829329|NCT00794417|584415748|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
161829330|NCT00794417|584415749|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
161829331|NCT00794417|584415750|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
161939571|NCT03685149|584828680|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
161939572|NCT03685149|584828679|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
162223237|NCT01677767|585866607|FG000|Overall Study|Protocol Violation|4|||
162223238|NCT01677767|585866607|FG000|Overall Study|Withdrawal by Subject|10|||
162223239|NCT01677767|585866607|FG000|Overall Study|Non-compliance by the participants|3|||
162223240|NCT00842244|585866608|FG000|Overall Study|Death|3|||
162223241|NCT00842244|585866608|FG000|Overall Study|Withdrawal by Subject|1|||
162223242|NCT00842244|585866608|FG000|Overall Study|Other|17|||
162223243|NCT01068665|585866613|FG000|Overall Study|Adverse Event|5|||
162223244|NCT01068665|585866614|FG001|Overall Study|Adverse Event|4|||
162223245|NCT01068665|585866613|FG000|Overall Study|Lack of Efficacy|0|||
162223246|NCT01068665|585866614|FG001|Overall Study|Lack of Efficacy|2|||
162223247|NCT01068665|585866613|FG000|Overall Study|Protocol Violation|5|||
162223248|NCT01068665|585866614|FG001|Overall Study|Protocol Violation|2|||
162223249|NCT01068665|585866613|FG000|Overall Study|Withdrawal Criteria|3|||
162223250|NCT01068665|585866614|FG001|Overall Study|Withdrawal Criteria|9|||
162223251|NCT01068665|585866613|FG000|Overall Study|Other|17|||
162223252|NCT01068665|585866614|FG001|Overall Study|Other|12|||
162223253|NCT02807272|585866615|FG000|Overall Study|Death|9|||
162223254|NCT02807272|585866616|FG001|Overall Study|Death|5|||
162223255|NCT02807272|585866617|FG002|Overall Study|Death|2|||
162223256|NCT02807272|585866618|FG003|Overall Study|Death|0|||
162223257|NCT02807272|585866619|FG004|Overall Study|Death|1|||
162223258|NCT02807272|585866615|FG000|Overall Study|Lost to Follow-up|1|||
162223259|NCT02807272|585866616|FG001|Overall Study|Lost to Follow-up|0|||
162223260|NCT02807272|585866617|FG002|Overall Study|Lost to Follow-up|0|||
162223261|NCT02807272|585866618|FG003|Overall Study|Lost to Follow-up|0|||
162223262|NCT02807272|585866619|FG004|Overall Study|Lost to Follow-up|0|||
162223263|NCT02807272|585866615|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
162223264|NCT02807272|585866616|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
162223265|NCT02807272|585866617|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
162223266|NCT02807272|585866618|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
162223267|NCT02807272|585866619|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
162223268|NCT02807272|585866615|FG000|Overall Study|Protocol-defined Disease Progression|0|||
162223269|NCT02807272|585866616|FG001|Overall Study|Protocol-defined Disease Progression|1|||
162223270|NCT02807272|585866617|FG002|Overall Study|Protocol-defined Disease Progression|0|||
162223271|NCT02807272|585866618|FG003|Overall Study|Protocol-defined Disease Progression|0|||
162223272|NCT02807272|585866619|FG004|Overall Study|Protocol-defined Disease Progression|1|||
162223273|NCT02807272|585866615|FG000|Overall Study|Study Terminated by Sponsor|1|||
162223274|NCT02807272|585866616|FG001|Overall Study|Study Terminated by Sponsor|0|||
162223275|NCT02807272|585866617|FG002|Overall Study|Study Terminated by Sponsor|0|||
162223276|NCT02807272|585866618|FG003|Overall Study|Study Terminated by Sponsor|1|||
162223277|NCT02807272|585866619|FG004|Overall Study|Study Terminated by Sponsor|0|||
162223278|NCT02807272|585866615|FG000|Overall Study|Other|1|||
162223279|NCT02807272|585866616|FG001|Overall Study|Other|0|||
161678718|NCT03024970|583876061|FG000|Second Intervention|Lost to Follow-up|1|||
161678719|NCT03024970|583876062|FG001|Second Intervention|Lost to Follow-up|0|||
161678720|NCT00131469|583876063|FG000|Overall Study|Withdrawal by Subject|3|||
161678721|NCT00131469|583876064|FG001|Overall Study|Withdrawal by Subject|4|||
161678722|NCT00131469|583876063|FG000|Overall Study|Protocol Violation|3|||
161678723|NCT00131469|583876064|FG001|Overall Study|Protocol Violation|1|||
162223280|NCT02807272|585866617|FG002|Overall Study|Other|0|||
162223281|NCT02807272|585866618|FG003|Overall Study|Other|0|||
162223282|NCT02807272|585866619|FG004|Overall Study|Other|1|||
161678724|NCT00131469|583876063|FG000|Overall Study|Death|0|||
162223283|NCT01162863|585866623|FG000|Overall Study|Lack of Efficacy|1|||
162223284|NCT01162863|585866624|FG001|Overall Study|Lack of Efficacy|0|||
162223285|NCT01162863|585866625|FG002|Overall Study|Lack of Efficacy|0|||
162223286|NCT01162863|585866623|FG000|Overall Study|Adverse Event|0|||
162223287|NCT01162863|585866624|FG001|Overall Study|Adverse Event|1|||
162223288|NCT01162863|585866625|FG002|Overall Study|Adverse Event|0|||
162223289|NCT00392925|585866626|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
162223290|NCT00392925|585866627|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
162223291|NCT00392925|585866628|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
162223292|NCT00392925|585866629|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
161678725|NCT00131469|583876064|FG001|Overall Study|Death|1|||
161678726|NCT00131469|583876063|FG000|Overall Study|Lost to Follow-up|0|||
162223293|NCT00392925|585866626|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
162223294|NCT00392925|585866627|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
162223295|NCT00392925|585866628|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
162223296|NCT00392925|585866629|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
162223297|NCT00392925|585866626|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
162223298|NCT00392925|585866627|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
162223299|NCT00392925|585866628|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
162223300|NCT00392925|585866629|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
162223301|NCT00392925|585866626|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
162223302|NCT00392925|585866627|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
162223303|NCT00392925|585866628|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
162223304|NCT00392925|585866629|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
162223305|NCT00392925|585866626|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
162223306|NCT00392925|585866627|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
162223307|NCT00392925|585866628|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
162223308|NCT00392925|585866629|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
162223309|NCT00392925|585866626|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
162223310|NCT00392925|585866627|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
162223311|NCT00392925|585866628|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
162223312|NCT00392925|585866629|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
162223313|NCT00392925|585866626|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
162223314|NCT00392925|585866627|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
162223315|NCT00392925|585866628|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
162223316|NCT00392925|585866629|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
162223317|NCT00392925|585866626|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
162223318|NCT00392925|585866627|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
162223319|NCT00392925|585866628|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
162223320|NCT00392925|585866629|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
162223321|NCT00392925|585866626|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
162223322|NCT00392925|585866627|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
162223323|NCT00392925|585866628|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
162223324|NCT00392925|585866629|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
162223325|NCT03552523|585866630|FG000|Overall Study|Withdrawal by Subject|1|||
162223326|NCT03552523|585866631|FG001|Overall Study|Withdrawal by Subject|1|||
162223327|NCT04145700|585866632|FG000|Overall Study|Withdrawal by Subject|8|||
162223328|NCT04145700|585866633|FG001|Overall Study|Withdrawal by Subject|3|||
162223329|NCT00780559|585866636|FG000|Overall Study|Lost to Follow-up|2|||
162223330|NCT00780559|585866637|FG001|Overall Study|Lost to Follow-up|7|||
162223331|NCT00780559|585866636|FG000|Overall Study|Death|1|||
162223332|NCT00780559|585866637|FG001|Overall Study|Death|0|||
162223333|NCT01840410|585866639|FG000|Overall Study|Physician Decision|1|||
162223334|NCT01840410|585866640|FG001|Overall Study|Physician Decision|2|||
162223335|NCT01840410|585866639|FG000|Overall Study|Pregnancy|1|||
162223336|NCT01840410|585866640|FG001|Overall Study|Pregnancy|0|||
162223337|NCT01840410|585866639|FG000|Overall Study|Protocol deviation|1|||
162223338|NCT01840410|585866640|FG001|Overall Study|Protocol deviation|0|||
162223339|NCT01840410|585866639|FG000|Overall Study|Lost to Follow-up|1|||
162223340|NCT01840410|585866640|FG001|Overall Study|Lost to Follow-up|0|||
162223341|NCT01840410|585866639|FG000|Overall Study|Withdrawal by Subject|2|||
162223342|NCT01840410|585866640|FG001|Overall Study|Withdrawal by Subject|1|||
162223343|NCT01840410|585866639|FG000|Overall Study|Adverse Event|1|||
162223344|NCT01840410|585866640|FG001|Overall Study|Adverse Event|1|||
162223345|NCT00839956|585866641|FG000|Overall Study|Adverse Event|2|||
162223346|NCT00839956|585866641|FG000|Overall Study|Lack of Efficacy|6|||
162223347|NCT00839956|585866641|FG000|Overall Study|Physician Decision|1|||
162223348|NCT00839956|585866641|FG000|Overall Study|Withdrawal by Subject|3|||
162223349|NCT00594880|585866642|FG000|Overall Study|Withdrawal by Subject|1|||
162223350|NCT00594880|585866643|FG001|Overall Study|Withdrawal by Subject|1|||
162223351|NCT00594880|585866642|FG000|Overall Study|Lost to Follow-up|1|||
162223352|NCT00594880|585866643|FG001|Overall Study|Lost to Follow-up|0|||
162223353|NCT02206061|585866644|FG000|Overall Study|Withdrawal by Subject|4|||
162223354|NCT02206061|585866645|FG001|Overall Study|Withdrawal by Subject|7|||
162223355|NCT02206061|585866646|FG002|Overall Study|Withdrawal by Subject|1|||
162223356|NCT02206061|585866644|FG000|Overall Study|Lost to Follow-up|14|||
162223357|NCT02206061|585866645|FG001|Overall Study|Lost to Follow-up|7|||
162223358|NCT02206061|585866646|FG002|Overall Study|Lost to Follow-up|20|||
162223359|NCT00694109|585866647|FG000|Overall Study|Physician Decision|3|||
162223360|NCT00694109|585866647|FG000|Overall Study|Adverse Event|74|||
162223361|NCT00694109|585866647|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
162223362|NCT00694109|585866647|FG000|Overall Study|Lack of Efficacy|2|||
162223363|NCT00694109|585866647|FG000|Overall Study|Withdrawal by Subject|13|||
162223364|NCT00694109|585866647|FG000|Overall Study|Pregnancy|1|||
162223365|NCT00694109|585866647|FG000|Overall Study|Enrolled but not treated|1|||
162223366|NCT00694109|585866647|FG000|Overall Study|Other|2|||
162223367|NCT00694109|585866647|FG000|Overall Study|Consented but no additional treatment|3|||
162223368|NCT04520659|585866650|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
162223369|NCT04520659|585866651|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
162223370|NCT04520659|585866652|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
162223371|NCT04520659|585866653|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
162223372|NCT04485611|585866654|FG000|Prehabilitation|Physician Decision|1|||
162223373|NCT03345576|585866656|FG000|Overall Study|Withdrawal by Subject|2|||
162223374|NCT03345576|585866657|FG001|Overall Study|Withdrawal by Subject|2|||
162223375|NCT03345576|585866656|FG000|Overall Study|Adverse Event|1|||
162223376|NCT03345576|585866657|FG001|Overall Study|Adverse Event|0|||
162223377|NCT05718466|585868598|FG000|Overall Study|Withdrawal by Subject|1|||
162223378|NCT05718466|585868599|FG001|Overall Study|Withdrawal by Subject|2|||
162223379|NCT05718466|585868598|FG000|Overall Study|Death|0|||
162223380|NCT05718466|585868599|FG001|Overall Study|Death|1|||
162223381|NCT01253135|585868602|FG000|Original Protocol|Protocol Amendment|15|||
162223382|NCT01253135|585868602|FG000|Amended Protocol|Non-compliance|1|||
162223383|NCT00833261|585868609|FG000|Overall Study|Withdrawal by Subject|4|||
162223384|NCT01255631|585868613|FG000|Overall Study|poor enrollment, no data analyzed|9|||
162223385|NCT01255631|585868614|FG001|Overall Study|poor enrollment, no data analyzed|6|||
162223386|NCT00264303|585868622|FG000|Overall Study|Adverse Event|4|||
162223387|NCT00264303|585868623|FG001|Overall Study|Adverse Event|3|||
162223388|NCT00264303|585868622|FG000|Overall Study|Lack of Efficacy|10|||
162223389|NCT00264303|585868623|FG001|Overall Study|Lack of Efficacy|13|||
162223390|NCT00264303|585868622|FG000|Overall Study|Lost to Follow-up|3|||
162223391|NCT00264303|585868623|FG001|Overall Study|Lost to Follow-up|3|||
162223392|NCT00264303|585868622|FG000|Overall Study|Withdrawal by Subject|2|||
162223393|NCT00264303|585868623|FG001|Overall Study|Withdrawal by Subject|3|||
162223394|NCT00264303|585868622|FG000|Overall Study|Various reasons listed in study report|6|||
162223395|NCT00264303|585868623|FG001|Overall Study|Various reasons listed in study report|7|||
162223396|NCT02815579|585868624|FG000|Overall Study|Non-payment of loan down-payment|16|||
162223397|NCT02815579|585868625|FG001|Overall Study|Non-payment of loan down-payment|0|||
162223398|NCT02815579|585868624|FG000|Overall Study|Withdrawal by Subject|7|||
162223399|NCT02815579|585868625|FG001|Overall Study|Withdrawal by Subject|1|||
162223400|NCT02815579|585868624|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
162223401|NCT02815579|585868625|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
162223402|NCT02815579|585868624|FG000|Overall Study|Lost to Follow-up|7|||
162223403|NCT02815579|585868625|FG001|Overall Study|Lost to Follow-up|4|||
162223404|NCT02815579|585868624|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
162223405|NCT02815579|585868625|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
162223406|NCT02815579|585868624|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
162223407|NCT02815579|585868625|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
162223408|NCT02815579|585868624|FG000|Overall Study|Death|5|||
162223409|NCT02815579|585868625|FG001|Overall Study|Death|4|||
162223410|NCT02815579|585868624|FG000|Overall Study|Imprisoned|0|||
162223411|NCT02815579|585868625|FG001|Overall Study|Imprisoned|2|||
162223412|NCT02815579|585868624|FG000|Overall Study|Did not meet enrollment criteria|0|||
162223413|NCT02815579|585868625|FG001|Overall Study|Did not meet enrollment criteria|1|||
162223414|NCT02389452|585868626|FG000|Overall Study|Lost to Follow-up|13|||
162223415|NCT02389452|585868626|FG000|Overall Study|Adverse Event|1|||
162223416|NCT02389452|585868626|FG000|Overall Study|Withdrawal by Subject|5|||
162223417|NCT02389452|585868626|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
162223418|NCT02311673|585868627|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
162223419|NCT02311673|585868628|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
162223420|NCT02311673|585868629|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
162223421|NCT02311673|585868630|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
162223422|NCT00414908|585868636|FG000|Overall Study|Protocol Violation|1|||
162223423|NCT00414908|585868637|FG001|Overall Study|Protocol Violation|1|||
162223424|NCT00818168|585868638|FG000|Overall Study|Lack of Efficacy|18|||
162223425|NCT00818168|585868638|FG000|Overall Study|Pregnancy|2|||
162223426|NCT00818168|585868638|FG000|Overall Study|Withdrawal by Subject|16|||
162223427|NCT00818168|585868638|FG000|Overall Study|Lost to Follow-up|7|||
162223428|NCT00818168|585868638|FG000|Overall Study|Adverse Event|19|||
162223429|NCT00818168|585868638|FG000|Overall Study|Reason for Non-completion Not reported|6|||
162223430|NCT00818168|585868638|FG000|Overall Study|Participant Moved|2|||
162223431|NCT01977677|585868639|FG000|Overall Study|Unrelated Adverse Event|0|||
162223432|NCT01977677|585868640|FG001|Overall Study|Unrelated Adverse Event|0|||
162223433|NCT01977677|585868641|FG002|Overall Study|Unrelated Adverse Event|1|||
162223434|NCT00667225|585868642|FG000|Overall Study|Subject had no more lesions to treat.|1|||
162223435|NCT00667225|585868643|FG001|Overall Study|Subject had no more lesions to treat.|0|||
162223436|NCT00667225|585868642|FG000|Overall Study|Lost to Follow-up|0|||
162223437|NCT00667225|585868643|FG001|Overall Study|Lost to Follow-up|1|||
162223438|NCT03563157|585868648|FG000|Overall Study|Progressive Disease|2|||
162223439|NCT02248818|585868649|FG000|Screening|Protocol Violation|0|||
162223440|NCT02248818|585868650|FG001|Screening|Protocol Violation|0|||
162223441|NCT02248818|585868651|FG002|Screening|Protocol Violation|0|||
162223442|NCT02248818|585868652|FG003|Screening|Protocol Violation|0|||
162223443|NCT02248818|585868653|FG004|Screening|Protocol Violation|0|||
162223444|NCT02248818|585868654|FG005|Screening|Protocol Violation|0|||
162223445|NCT02248818|585868655|FG006|Screening|Protocol Violation|0|||
162223446|NCT02248818|585868656|FG007|Screening|Protocol Violation|0|||
162223447|NCT02248818|585868657|FG008|Screening|Protocol Violation|7|||
162223448|NCT02248818|585868649|FG000|Screening|Study fully enrolled|0|||
162223449|NCT02248818|585868650|FG001|Screening|Study fully enrolled|0|||
162223450|NCT02248818|585868651|FG002|Screening|Study fully enrolled|0|||
162223451|NCT02248818|585868652|FG003|Screening|Study fully enrolled|0|||
162223452|NCT02248818|585868653|FG004|Screening|Study fully enrolled|0|||
162223453|NCT02248818|585868654|FG005|Screening|Study fully enrolled|0|||
162223454|NCT02248818|585868655|FG006|Screening|Study fully enrolled|0|||
162223455|NCT02248818|585868656|FG007|Screening|Study fully enrolled|0|||
162223456|NCT02248818|585868657|FG008|Screening|Study fully enrolled|14|||
162223457|NCT02248818|585868649|FG000|Screening|Physician Decision|0|||
162223458|NCT02248818|585868650|FG001|Screening|Physician Decision|0|||
162223459|NCT02248818|585868651|FG002|Screening|Physician Decision|0|||
162223460|NCT02248818|585868652|FG003|Screening|Physician Decision|0|||
162223461|NCT02248818|585868653|FG004|Screening|Physician Decision|0|||
162223462|NCT02248818|585868654|FG005|Screening|Physician Decision|0|||
162223463|NCT02248818|585868655|FG006|Screening|Physician Decision|0|||
162223464|NCT02248818|585868656|FG007|Screening|Physician Decision|0|||
162223465|NCT02248818|585868657|FG008|Screening|Physician Decision|73|||
162223466|NCT02248818|585868649|FG000|Screening|Withdrawal by Subject|0|||
162223467|NCT02248818|585868650|FG001|Screening|Withdrawal by Subject|0|||
162223468|NCT02248818|585868651|FG002|Screening|Withdrawal by Subject|0|||
162223469|NCT02248818|585868652|FG003|Screening|Withdrawal by Subject|0|||
162223470|NCT02248818|585868653|FG004|Screening|Withdrawal by Subject|0|||
162223471|NCT02248818|585868654|FG005|Screening|Withdrawal by Subject|0|||
162223472|NCT02248818|585868655|FG006|Screening|Withdrawal by Subject|0|||
162223473|NCT02248818|585868656|FG007|Screening|Withdrawal by Subject|0|||
162223474|NCT02248818|585868657|FG008|Screening|Withdrawal by Subject|6|||
162223475|NCT02248818|585868649|FG000|Screening|Lost to Follow-up|0|||
162223476|NCT02248818|585868650|FG001|Screening|Lost to Follow-up|0|||
162223477|NCT02248818|585868651|FG002|Screening|Lost to Follow-up|0|||
162223478|NCT02248818|585868652|FG003|Screening|Lost to Follow-up|0|||
162223479|NCT02248818|585868653|FG004|Screening|Lost to Follow-up|0|||
162223480|NCT02248818|585868654|FG005|Screening|Lost to Follow-up|0|||
162223481|NCT02248818|585868655|FG006|Screening|Lost to Follow-up|0|||
162223482|NCT02248818|585868656|FG007|Screening|Lost to Follow-up|0|||
162223483|NCT02248818|585868657|FG008|Screening|Lost to Follow-up|7|||
162223484|NCT02248818|585868649|FG000|Randomised Study|Administrative - randomization error|0|||
162223485|NCT02248818|585868650|FG001|Randomised Study|Administrative - randomization error|0|||
162223486|NCT02248818|585868651|FG002|Randomised Study|Administrative - randomization error|0|||
162223487|NCT02248818|585868652|FG003|Randomised Study|Administrative - randomization error|0|||
162223488|NCT02248818|585868653|FG004|Randomised Study|Administrative - randomization error|0|||
162223489|NCT02248818|585868654|FG005|Randomised Study|Administrative - randomization error|8|||
162223490|NCT02248818|585868655|FG006|Randomised Study|Administrative - randomization error|0|||
162223491|NCT02248818|585868656|FG007|Randomised Study|Administrative - randomization error|0|||
162223492|NCT02248818|585868657|FG008|Randomised Study|Administrative - randomization error|0|||
162223493|NCT04313608|585868660|FG000|Overall Study|Death|12|||
162223494|NCT04313608|585868661|FG001|Overall Study|Death|3|||
162223495|NCT01867333|585868662|FG000|Overall Study|Withdrawal by Subject|1|||
162223496|NCT01867333|585868663|FG001|Overall Study|Withdrawal by Subject|0|||
162223497|NCT01867333|585868662|FG000|Overall Study|Adverse Event|1|||
162223498|NCT01867333|585868663|FG001|Overall Study|Adverse Event|0|||
162223499|NCT01867333|585868662|FG000|Overall Study|Participant choice|1|||
162223500|NCT01867333|585868663|FG001|Overall Study|Participant choice|2|||
162223501|NCT01867333|585868662|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
162223502|NCT01867333|585868663|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
162223503|NCT01867333|585868662|FG000|Overall Study|Death|0|||
162223504|NCT01867333|585868663|FG001|Overall Study|Death|1|||
162223505|NCT01867333|585868662|FG000|Overall Study|Physician Decision|3|||
162223506|NCT01867333|585868663|FG001|Overall Study|Physician Decision|2|||
162223507|NCT01867333|585868662|FG000|Overall Study|Switched to alternative treatment|1|||
162223508|NCT01867333|585868663|FG001|Overall Study|Switched to alternative treatment|0|||
162223509|NCT01145898|585868664|FG000|3-year Treatment|medication change by treating physician|3|||
162223510|NCT01145898|585868665|FG001|3-year Treatment|medication change by treating physician|16|||
162223511|NCT00879775|585868666|FG000|Overall Study|Lost to Follow-up|2|||
162223512|NCT00879775|585868667|FG001|Overall Study|Lost to Follow-up|1|||
162223513|NCT04343976|585868672|FG000|Overall Study|Withdrawal by Subject|0|||
162223514|NCT04343976|585868673|FG001|Overall Study|Withdrawal by Subject|1|||
162223515|NCT02807883|585868674|FG000|Overall Study|Withdrawal by Subject|2|||
162223516|NCT04608773|585868675|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
162223517|NCT04608773|585868676|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
162223518|NCT04608773|585868675|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
162223519|NCT04608773|585868676|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
162223520|NCT04608773|585868675|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
162223521|NCT04608773|585868676|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
162223522|NCT04608773|585868675|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
162223523|NCT04608773|585868676|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
162223524|NCT04608773|585868675|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
162223525|NCT04608773|585868676|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
162223526|NCT02833077|585868677|FG000|Overall Study|Adverse Event|1|||
162223527|NCT02833077|585868678|FG001|Overall Study|Adverse Event|2|||
162223528|NCT02833077|585868677|FG000|Overall Study|Lost to Follow-up|10|||
162223529|NCT02833077|585868678|FG001|Overall Study|Lost to Follow-up|1|||
162223530|NCT02833077|585868677|FG000|Overall Study|Personal Reasons|6|||
162223531|NCT02833077|585868678|FG001|Overall Study|Personal Reasons|4|||
161678727|NCT00131469|583876064|FG001|Overall Study|Lost to Follow-up|1|||
161678728|NCT00131469|583876063|FG000|Overall Study|scan not analyzable|3|||
161678729|NCT00131469|583876064|FG001|Overall Study|scan not analyzable|6|||
161678730|NCT00574288|583876065|FG000|Overall Study|Adverse Event|2|||
161678731|NCT00574288|583876066|FG001|Overall Study|Adverse Event|0|||
161678732|NCT00574288|583876067|FG002|Overall Study|Adverse Event|0|||
161678733|NCT00574288|583876068|FG003|Overall Study|Adverse Event|0|||
162223532|NCT02833077|585868677|FG000|Overall Study|Protocol Deviation|0|||
162223533|NCT02833077|585868678|FG001|Overall Study|Protocol Deviation|1|||
162223534|NCT01077518|585868681|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
162223535|NCT01077518|585868682|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
162223536|NCT01077518|585868683|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
162223537|NCT01077518|585868681|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
162223538|NCT01077518|585868682|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
162223539|NCT01077518|585868683|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
162223540|NCT01077518|585868681|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
162223541|NCT01077518|585868682|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
162223542|NCT01077518|585868683|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
162223543|NCT01077518|585868681|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
162223544|NCT01077518|585868682|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
161678734|NCT00574288|583876069|FG004|Overall Study|Adverse Event|1|||
161678735|NCT00574288|583876070|FG005|Overall Study|Adverse Event|0|||
161678736|NCT00574288|583876071|FG006|Overall Study|Adverse Event|0|||
161678737|NCT00574288|583876065|FG000|Overall Study|Death|0|||
161678738|NCT00574288|583876066|FG001|Overall Study|Death|0|||
161678739|NCT00574288|583876067|FG002|Overall Study|Death|0|||
161678740|NCT00574288|583876068|FG003|Overall Study|Death|0|||
161678741|NCT00574288|583876069|FG004|Overall Study|Death|0|||
162223545|NCT01077518|585868683|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
162223546|NCT01077518|585868681|FG000|Optional Ofa Phase|Physician Decision|0|||
162223547|NCT01077518|585868682|FG001|Optional Ofa Phase|Physician Decision|0|||
162223548|NCT01077518|585868683|FG002|Optional Ofa Phase|Physician Decision|1|||
162223549|NCT01077518|585868681|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
162223550|NCT01077518|585868682|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
162223551|NCT01077518|585868683|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
162223552|NCT01077518|585868681|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
162223553|NCT01077518|585868682|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
162223554|NCT01077518|585868683|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
162223555|NCT00972322|585868684|FG000|Overall Study|Adverse Event|2|||
162223556|NCT00972322|585868685|FG001|Overall Study|Adverse Event|1|||
162223557|NCT00972322|585868684|FG000|Overall Study|Positive drug screen|0|||
162223558|NCT00972322|585868685|FG001|Overall Study|Positive drug screen|1|||
162223559|NCT00972322|585868684|FG000|Overall Study|Lost to Follow-up|0|||
162223560|NCT00972322|585868685|FG001|Overall Study|Lost to Follow-up|1|||
162223561|NCT00972322|585868684|FG000|Overall Study|Consistently high glucose values|1|||
162223562|NCT00972322|585868685|FG001|Overall Study|Consistently high glucose values|0|||
162223563|NCT04958200|585868686|FG000|Overall Study|Withdrawal by Subject|0|||
162223564|NCT04958200|585868687|FG001|Overall Study|Withdrawal by Subject|2|||
162223565|NCT04958200|585868686|FG000|Overall Study|Lost to Follow-up|3|||
162223566|NCT04958200|585868687|FG001|Overall Study|Lost to Follow-up|2|||
162223567|NCT00316017|585868690|FG000|Overall Study|Protocol Violation|11|||
162223568|NCT00316017|585868691|FG001|Overall Study|Protocol Violation|13|||
162223569|NCT00316017|585868692|FG002|Overall Study|Protocol Violation|19|||
162223570|NCT04157400|585868693|FG000|Overall Study|Withdrawal by Subject|1|||
162223571|NCT04157400|585868693|FG000|Overall Study|Lost to Follow-up|3|||
162223572|NCT00623805|585868699|FG000|Overall Study|Adverse Event|9|||
162223573|NCT00623805|585868700|FG001|Overall Study|Adverse Event|6|||
162223574|NCT00623805|585868699|FG000|Overall Study|Death|2|||
162223575|NCT00623805|585868700|FG001|Overall Study|Death|0|||
162223576|NCT00623805|585868699|FG000|Overall Study|Lack of Efficacy|3|||
162223577|NCT00623805|585868700|FG001|Overall Study|Lack of Efficacy|7|||
162223578|NCT00623805|585868699|FG000|Overall Study|Lost to Follow-up|2|||
162223579|NCT00623805|585868700|FG001|Overall Study|Lost to Follow-up|2|||
162223580|NCT00623805|585868699|FG000|Overall Study|Protocol Violation|1|||
162223581|NCT00623805|585868700|FG001|Overall Study|Protocol Violation|1|||
162223582|NCT00623805|585868699|FG000|Overall Study|Reason not Specified|3|||
162223583|NCT00623805|585868700|FG001|Overall Study|Reason not Specified|6|||
162223584|NCT02671500|585868703|FG000|Overall Study|Lack of Efficacy|12|||
162223585|NCT02671500|585868703|FG000|Overall Study|Lost to Follow-up|2|||
162223586|NCT05235269|585868705|FG000|Overall Study|Adverse Event|1|||
162223587|NCT05235269|585868705|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
162223588|NCT05235269|585868705|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
162223589|NCT03361865|585868706|FG000|Overall Study|Death|17|||
162223590|NCT03361865|585868707|FG001|Overall Study|Death|18|||
162223591|NCT03361865|585868706|FG000|Overall Study|Physician Decision|1|||
162223592|NCT03361865|585868707|FG001|Overall Study|Physician Decision|9|||
162223593|NCT03361865|585868706|FG000|Overall Study|Withdrawal by Subject|1|||
162223594|NCT03361865|585868707|FG001|Overall Study|Withdrawal by Subject|0|||
162223595|NCT03852719|585868709|FG000|Overall Study|Withdrawal of consent|8|||
162223596|NCT03852719|585868710|FG001|Overall Study|Withdrawal of consent|8|||
162223597|NCT03852719|585868711|FG002|Overall Study|Withdrawal of consent|9|||
162223598|NCT03852719|585868709|FG000|Overall Study|Physician Decision|5|||
162223599|NCT03852719|585868710|FG001|Overall Study|Physician Decision|4|||
162223600|NCT03852719|585868711|FG002|Overall Study|Physician Decision|1|||
162223601|NCT03852719|585868709|FG000|Overall Study|Pregnancy|2|||
162223602|NCT03852719|585868710|FG001|Overall Study|Pregnancy|1|||
162223603|NCT03852719|585868711|FG002|Overall Study|Pregnancy|0|||
162223604|NCT03852719|585868709|FG000|Overall Study|Death|1|||
162223605|NCT03852719|585868710|FG001|Overall Study|Death|0|||
162223606|NCT03852719|585868711|FG002|Overall Study|Death|0|||
162223607|NCT03852719|585868709|FG000|Overall Study|Reason not Specified|3|||
162223608|NCT03852719|585868710|FG001|Overall Study|Reason not Specified|3|||
162223609|NCT03852719|585868711|FG002|Overall Study|Reason not Specified|5|||
162223610|NCT03852719|585868709|FG000|Overall Study|Adverse Event|2|||
162223611|NCT03852719|585868710|FG001|Overall Study|Adverse Event|1|||
162223612|NCT03852719|585868711|FG002|Overall Study|Adverse Event|4|||
162223613|NCT03852719|585868709|FG000|Overall Study|Progressive disease|1|||
162223614|NCT03852719|585868710|FG001|Overall Study|Progressive disease|4|||
162223615|NCT03852719|585868711|FG002|Overall Study|Progressive disease|1|||
162223616|NCT03852719|585868709|FG000|Overall Study|Lost to Follow-up|1|||
162223617|NCT03852719|585868710|FG001|Overall Study|Lost to Follow-up|0|||
161939573|NCT03685149|584828680|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161939574|NCT03685149|584828679|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
162223618|NCT03852719|585868711|FG002|Overall Study|Lost to Follow-up|0|||
162223619|NCT03810235|585868712|FG000|Overall Study|Withdrawal by Subject|2|||
162223620|NCT03810235|585868713|FG001|Overall Study|Withdrawal by Subject|0|||
162223621|NCT04201262|585868714|FG000|Primary Treatment Period|Adverse Event|1|||
162223622|NCT04201262|585868715|FG001|Primary Treatment Period|Adverse Event|2|||
162223623|NCT04201262|585868714|FG000|Primary Treatment Period|Physician Decision|1|||
162223624|NCT04201262|585868715|FG001|Primary Treatment Period|Physician Decision|1|||
162223625|NCT04201262|585868714|FG000|Long-term Extension Period|Death|1|||
162223626|NCT04201262|585868715|FG001|Long-term Extension Period|Death|0|||
161939575|NCT03685149|584828680|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
161939576|NCT02034565|584828685|FG000|Overall Study|Adverse Event|1|||
161939577|NCT02034565|584828686|FG001|Overall Study|Adverse Event|0|||
161939578|NCT00581919|584828687|FG000|Overall Study|Adverse Event|8|||
162223627|NCT01647542|585868717|FG000|Overall Study|Major Protocol Deviation|1|||
162223628|NCT01647542|585868718|FG001|Overall Study|Major Protocol Deviation|0|||
162223629|NCT01647542|585868719|FG002|Overall Study|Major Protocol Deviation|0|||
162223630|NCT01647542|585868717|FG000|Overall Study|Adverse Event|4|||
162223631|NCT01647542|585868718|FG001|Overall Study|Adverse Event|5|||
162223632|NCT01647542|585868719|FG002|Overall Study|Adverse Event|4|||
162223633|NCT01647542|585868717|FG000|Overall Study|Lost to Follow-up|0|||
162223634|NCT01647542|585868718|FG001|Overall Study|Lost to Follow-up|2|||
162223635|NCT01647542|585868719|FG002|Overall Study|Lost to Follow-up|2|||
162223636|NCT01647542|585868717|FG000|Overall Study|Withdrawal by Subject|6|||
162223637|NCT01647542|585868718|FG001|Overall Study|Withdrawal by Subject|4|||
162223638|NCT01647542|585868719|FG002|Overall Study|Withdrawal by Subject|0|||
162223639|NCT01647542|585868717|FG000|Overall Study|Study Termination|64|||
162223640|NCT01647542|585868718|FG001|Overall Study|Study Termination|61|||
162223641|NCT01647542|585868719|FG002|Overall Study|Study Termination|65|||
162223642|NCT01647542|585868717|FG000|Overall Study|Lack of Efficacy|1|||
162223643|NCT01647542|585868718|FG001|Overall Study|Lack of Efficacy|1|||
162223644|NCT01647542|585868719|FG002|Overall Study|Lack of Efficacy|0|||
162223645|NCT01647542|585868717|FG000|Overall Study|Death|0|||
162223646|NCT01647542|585868718|FG001|Overall Study|Death|0|||
161939579|NCT00581919|584828687|FG000|Overall Study|Death|1|||
161939580|NCT00581919|584828687|FG000|Overall Study|Disease Progression|10|||
161939581|NCT00581919|584828687|FG000|Overall Study|Physician Decision|1|||
161939582|NCT00581919|584828687|FG000|Overall Study|Other Complicating Disease|1|||
161939583|NCT00581919|584828687|FG000|Overall Study|Started Non-Protocol Therapy|2|||
161939584|NCT00581919|584828687|FG000|Overall Study|Withdrawal by Subject|1|||
161939585|NCT03232567|584828690|FG000|Overall Study|Withdrawal by Subject|0|||
161939586|NCT03232567|584828691|FG001|Overall Study|Withdrawal by Subject|1|||
161939587|NCT03232567|584828692|FG002|Overall Study|Withdrawal by Subject|0|||
161939588|NCT03232567|584828693|FG003|Overall Study|Withdrawal by Subject|0|||
161939589|NCT02655601|584828694|FG000|Overall Study|Adverse Event|0|||
161939590|NCT02655601|584828695|FG001|Overall Study|Adverse Event|0|||
161939591|NCT02655601|584828696|FG002|Overall Study|Adverse Event|0|||
161939592|NCT02655601|584828697|FG003|Overall Study|Adverse Event|1|||
161939593|NCT02655601|584828698|FG004|Overall Study|Adverse Event|1|||
161939594|NCT02655601|584828699|FG005|Overall Study|Adverse Event|0|||
162223647|NCT01647542|585868719|FG002|Overall Study|Death|1|||
162223648|NCT02819024|585868720|FG000|Overall Study|Withdrawal by Subject|1|||
162223649|NCT05217641|585868724|FG000|Overall Study|Lost to Follow-up|1|||
162223650|NCT05217641|585868725|FG001|Overall Study|Lost to Follow-up|1|||
162223651|NCT05217641|585868726|FG002|Overall Study|Lost to Follow-up|0|||
161939595|NCT02655601|584828694|FG000|Overall Study|Physician Decision|0|||
161939596|NCT02655601|584828695|FG001|Overall Study|Physician Decision|0|||
161939597|NCT02655601|584828696|FG002|Overall Study|Physician Decision|0|||
161939598|NCT02655601|584828697|FG003|Overall Study|Physician Decision|0|||
161939599|NCT02655601|584828698|FG004|Overall Study|Physician Decision|1|||
162223652|NCT05217641|585868727|FG003|Overall Study|Lost to Follow-up|1|||
162223653|NCT05217641|585868728|FG004|Overall Study|Lost to Follow-up|1|||
162223654|NCT05217641|585868729|FG005|Overall Study|Lost to Follow-up|0|||
162223655|NCT05217641|585868724|FG000|Overall Study|Withdrawal by Subject|0|||
162223656|NCT05217641|585868725|FG001|Overall Study|Withdrawal by Subject|0|||
162223657|NCT05217641|585868726|FG002|Overall Study|Withdrawal by Subject|0|||
162223658|NCT05217641|585868727|FG003|Overall Study|Withdrawal by Subject|3|||
162223659|NCT05217641|585868728|FG004|Overall Study|Withdrawal by Subject|1|||
161939600|NCT02655601|584828699|FG005|Overall Study|Physician Decision|1|||
161939601|NCT02655601|584828694|FG000|Overall Study|Withdrawal by Subject|0|||
161939602|NCT02655601|584828695|FG001|Overall Study|Withdrawal by Subject|0|||
161939603|NCT02655601|584828696|FG002|Overall Study|Withdrawal by Subject|0|||
161939604|NCT02655601|584828697|FG003|Overall Study|Withdrawal by Subject|0|||
161939605|NCT02655601|584828698|FG004|Overall Study|Withdrawal by Subject|4|||
161939606|NCT02655601|584828699|FG005|Overall Study|Withdrawal by Subject|8|||
161939607|NCT02655601|584828694|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
161939608|NCT02655601|584828695|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
161939609|NCT02655601|584828696|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
161939610|NCT02655601|584828697|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
161939611|NCT02655601|584828698|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
161939612|NCT02655601|584828699|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
161939613|NCT05837481|584828700|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
161939614|NCT05837481|584828701|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
161939615|NCT02014376|584828702|FG000|Overall Study|Adverse Event|1|||
161939616|NCT02014376|584828703|FG001|Overall Study|Adverse Event|1|||
161939617|NCT02014376|584828704|FG002|Overall Study|Adverse Event|0|||
161939618|NCT02014376|584828702|FG000|Overall Study|Lost to Follow-up|2|||
161939619|NCT02014376|584828703|FG001|Overall Study|Lost to Follow-up|0|||
161939620|NCT02014376|584828704|FG002|Overall Study|Lost to Follow-up|0|||
161939621|NCT00759395|584828707|FG000|Overall Study|Adverse Event|1|||
161939622|NCT00759395|584828708|FG001|Overall Study|Adverse Event|0|||
161939623|NCT00759395|584828707|FG000|Overall Study|Withdrawal by Subject|1|||
161939624|NCT00759395|584828708|FG001|Overall Study|Withdrawal by Subject|0|||
161939625|NCT00759395|584828707|FG000|Overall Study|Lack of Efficacy|0|||
161939626|NCT00759395|584828708|FG001|Overall Study|Lack of Efficacy|2|||
161939627|NCT00086515|584828709|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
161939628|NCT00086515|584828710|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
161939629|NCT00086515|584828709|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
161939630|NCT00086515|584828710|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
161939631|NCT00086515|584828709|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
161939632|NCT00086515|584828710|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
161939633|NCT00086515|584828709|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
161939634|NCT00086515|584828710|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
161939635|NCT00086515|584828709|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
161939636|NCT00086515|584828710|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
162223660|NCT05217641|585868729|FG005|Overall Study|Withdrawal by Subject|0|||
162223661|NCT05217641|585868724|FG000|Overall Study|Other: participant did not specify reason|0|||
162223662|NCT05217641|585868725|FG001|Overall Study|Other: participant did not specify reason|0|||
162223663|NCT05217641|585868726|FG002|Overall Study|Other: participant did not specify reason|0|||
162223664|NCT05217641|585868727|FG003|Overall Study|Other: participant did not specify reason|0|||
162223665|NCT05217641|585868728|FG004|Overall Study|Other: participant did not specify reason|1|||
162223666|NCT05217641|585868729|FG005|Overall Study|Other: participant did not specify reason|0|||
162223667|NCT05217641|585868724|FG000|Overall Study|Extended Follow up|1|||
162223668|NCT05217641|585868725|FG001|Overall Study|Extended Follow up|1|||
162223669|NCT05217641|585868726|FG002|Overall Study|Extended Follow up|0|||
162223670|NCT05217641|585868727|FG003|Overall Study|Extended Follow up|0|||
162223671|NCT05217641|585868728|FG004|Overall Study|Extended Follow up|1|||
162223672|NCT05217641|585868729|FG005|Overall Study|Extended Follow up|0|||
162223673|NCT03548220|585868731|FG000|Overall Study|Lost to Follow-up|1|||
162223674|NCT03548220|585868732|FG001|Overall Study|Lost to Follow-up|0|||
162223675|NCT03548220|585868733|FG002|Overall Study|Lost to Follow-up|0|||
162223676|NCT03548220|585868734|FG003|Overall Study|Lost to Follow-up|0|||
162223677|NCT02397447|585868735|FG000|Overall Study|Lost to Follow-up|2|||
162223678|NCT02397447|585868736|FG001|Overall Study|Lost to Follow-up|2|||
161939637|NCT00086515|584828709|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
161939638|NCT00086515|584828710|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
161939639|NCT00086515|584828709|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
162023412|NCT02152956|585142689|FG004|Overall Study|Withdrawal by Subject|2|||
162023413|NCT02152956|585142690|FG005|Overall Study|Withdrawal by Subject|2|||
162023414|NCT02152956|585142691|FG006|Overall Study|Withdrawal by Subject|0|||
162223679|NCT02994069|585868739|FG000|Overall Study|Death|7|||
162223680|NCT02994069|585868740|FG001|Overall Study|Death|13|||
162223681|NCT02994069|585868739|FG000|Overall Study|Adverse Event|1|||
162223682|NCT02994069|585868740|FG001|Overall Study|Adverse Event|0|||
162223683|NCT02994069|585868739|FG000|Overall Study|Other|2|||
162223684|NCT02994069|585868740|FG001|Overall Study|Other|0|||
162223685|NCT02994069|585868739|FG000|Overall Study|still on follow up/treatment|5|||
162223686|NCT02994069|585868740|FG001|Overall Study|still on follow up/treatment|6|||
162223687|NCT06926673|585868741|FG000|Overall Study|Lost to Follow-up|0|||
162223688|NCT06926673|585868742|FG001|Overall Study|Lost to Follow-up|0|||
162223689|NCT06926673|585868743|FG002|Overall Study|Lost to Follow-up|0|||
162223690|NCT06926673|585868744|FG003|Overall Study|Lost to Follow-up|1|||
162223691|NCT06926673|585868745|FG004|Overall Study|Lost to Follow-up|0|||
161939640|NCT00086515|584828710|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
161939641|NCT00086515|584828709|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
161939642|NCT00086515|584828710|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
161939643|NCT00086515|584828709|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
161939644|NCT00086515|584828710|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
161939645|NCT00086515|584828709|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
161939646|NCT00086515|584828710|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
161939647|NCT00086515|584828709|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
161939648|NCT00086515|584828710|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
161939649|NCT00086515|584828709|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
162223692|NCT06926673|585868746|FG005|Overall Study|Lost to Follow-up|0|||
162223693|NCT06926673|585868747|FG006|Overall Study|Lost to Follow-up|0|||
162223694|NCT06926673|585868741|FG000|Overall Study|Physician Decision|0|||
162223695|NCT06926673|585868742|FG001|Overall Study|Physician Decision|0|||
162223696|NCT06926673|585868743|FG002|Overall Study|Physician Decision|0|||
162223697|NCT06926673|585868744|FG003|Overall Study|Physician Decision|0|||
162223698|NCT06926673|585868745|FG004|Overall Study|Physician Decision|0|||
162223699|NCT06926673|585868746|FG005|Overall Study|Physician Decision|0|||
162223700|NCT06926673|585868747|FG006|Overall Study|Physician Decision|1|||
161939650|NCT00086515|584828710|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
161939651|NCT00086515|584828709|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
161939652|NCT00086515|584828710|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
161939653|NCT00086515|584828709|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
161939654|NCT00086515|584828710|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
162223701|NCT06926673|585868741|FG000|Overall Study|Withdrawal by Subject|0|||
162223702|NCT06926673|585868742|FG001|Overall Study|Withdrawal by Subject|3|||
161939655|NCT00086515|584828709|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
161939656|NCT00086515|584828710|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
161939657|NCT00086515|584828709|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
161939658|NCT00086515|584828710|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
161939659|NCT00086515|584828709|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
161939660|NCT00086515|584828710|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
161939661|NCT00086515|584828709|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
161939662|NCT00086515|584828710|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
161939663|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
161939664|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
161939665|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
161939666|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
161939667|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
161939668|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
161939669|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
162223703|NCT06926673|585868743|FG002|Overall Study|Withdrawal by Subject|2|||
162223704|NCT06926673|585868744|FG003|Overall Study|Withdrawal by Subject|1|||
162223705|NCT06926673|585868745|FG004|Overall Study|Withdrawal by Subject|0|||
162223706|NCT06926673|585868746|FG005|Overall Study|Withdrawal by Subject|2|||
162223707|NCT06926673|585868747|FG006|Overall Study|Withdrawal by Subject|0|||
162223708|NCT01076153|585869991|FG000|Overall Study|Symptoms improved/resolved|10|||
162223709|NCT01076153|585869991|FG000|Overall Study|Adverse Event|1|||
162223710|NCT04165031|585869992|FG000|Overall Study|Adverse Event|1|||
162223711|NCT04165031|585869993|FG001|Overall Study|Adverse Event|1|||
161939670|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
161939671|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
161939672|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
161939673|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
162223712|NCT04165031|585869994|FG002|Overall Study|Adverse Event|0|||
162223713|NCT04165031|585869995|FG003|Overall Study|Adverse Event|0|||
162223714|NCT04165031|585869996|FG004|Overall Study|Adverse Event|0|||
162223715|NCT04165031|585869997|FG005|Overall Study|Adverse Event|0|||
162223716|NCT04165031|585869992|FG000|Overall Study|Withdrawal by Subject|0|||
162223717|NCT04165031|585869993|FG001|Overall Study|Withdrawal by Subject|0|||
162223718|NCT04165031|585869994|FG002|Overall Study|Withdrawal by Subject|1|||
162223719|NCT04165031|585869995|FG003|Overall Study|Withdrawal by Subject|0|||
162223720|NCT04165031|585869996|FG004|Overall Study|Withdrawal by Subject|0|||
162223721|NCT04165031|585869997|FG005|Overall Study|Withdrawal by Subject|0|||
162223722|NCT02187159|585869998|FG000|Overall Study|Protocol Violation|4|||
162223723|NCT02187159|585869999|FG001|Overall Study|Protocol Violation|6|||
162223724|NCT02187159|585870000|FG002|Overall Study|Protocol Violation|3|||
162223725|NCT02187159|585870001|FG003|Overall Study|Protocol Violation|4|||
162223726|NCT02187159|585869998|FG000|Overall Study|Lack of Efficacy|10|||
162223727|NCT02187159|585869999|FG001|Overall Study|Lack of Efficacy|5|||
162223728|NCT02187159|585870000|FG002|Overall Study|Lack of Efficacy|4|||
162223729|NCT02187159|585870001|FG003|Overall Study|Lack of Efficacy|7|||
162223730|NCT02187159|585869998|FG000|Overall Study|Adverse Event|28|||
161939674|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
161939675|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
161939676|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
161939677|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
162223731|NCT02187159|585869999|FG001|Overall Study|Adverse Event|33|||
162223732|NCT02187159|585870000|FG002|Overall Study|Adverse Event|42|||
161939678|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
161939679|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
161939680|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
161939681|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
161939682|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
162223733|NCT02187159|585870001|FG003|Overall Study|Adverse Event|50|||
162223734|NCT02187159|585869998|FG000|Overall Study|Withdrawal by Subject|24|||
161939683|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
161939684|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
161939685|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
161939686|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
161939687|NCT00086515|584828709|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
161939688|NCT00086515|584828710|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
161939689|NCT02251041|584828711|FG000|Overall Study|Did not receive intervention|15|||
161939690|NCT02251041|584828712|FG001|Overall Study|Did not receive intervention|4|||
161939691|NCT01848457|584828715|FG000|Overall Study|Death|1|||
161939692|NCT01848457|584828716|FG001|Overall Study|Death|0|||
161939693|NCT01848457|584828717|FG002|Overall Study|Death|0|||
161939694|NCT01848457|584828718|FG003|Overall Study|Death|0|||
161939695|NCT02181413|584828720|FG000|Overall Study|Withdrawal by Subject|45|||
161939696|NCT02181413|584828721|FG001|Overall Study|Withdrawal by Subject|61|||
161939697|NCT02181413|584828720|FG000|Overall Study|Reason Not Specified|2|||
161939698|NCT02181413|584828721|FG001|Overall Study|Reason Not Specified|5|||
161939699|NCT02181413|584828720|FG000|Overall Study|Lost to Follow-up|8|||
161939700|NCT02181413|584828721|FG001|Overall Study|Lost to Follow-up|7|||
161939701|NCT02298946|584828723|FG000|Overall Study|Did not receive treatment|2|||
161939702|NCT02298946|584828724|FG001|Overall Study|Did not receive treatment|0|||
161939703|NCT02298946|584828723|FG000|Overall Study|Unevaluable|2|||
161939704|NCT02298946|584828724|FG001|Overall Study|Unevaluable|1|||
161939705|NCT00050011|584828725|FG000|Overall Study|Adverse Event|41|||
161939706|NCT00050011|584828726|FG001|Overall Study|Adverse Event|46|||
161939707|NCT00050011|584828725|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161939708|NCT00050011|584828726|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161939709|NCT00050011|584828725|FG000|Overall Study|Abnormal test procedure results|0|||
161939710|NCT00050011|584828726|FG001|Overall Study|Abnormal test procedure results|1|||
161939711|NCT00050011|584828725|FG000|Overall Study|Lack of Efficacy|16|||
161939712|NCT00050011|584828726|FG001|Overall Study|Lack of Efficacy|21|||
161939713|NCT00050011|584828725|FG000|Overall Study|Participant condition no longer required|1|||
161939714|NCT00050011|584828726|FG001|Overall Study|Participant condition no longer required|0|||
161939715|NCT00050011|584828725|FG000|Overall Study|Protocol Violation|4|||
161939716|NCT00050011|584828726|FG001|Overall Study|Protocol Violation|10|||
161939717|NCT00050011|584828725|FG000|Overall Study|Withdrawal by Subject|34|||
161939718|NCT00050011|584828726|FG001|Overall Study|Withdrawal by Subject|26|||
161939719|NCT00050011|584828725|FG000|Overall Study|Lost to Follow-up|7|||
161939720|NCT00050011|584828726|FG001|Overall Study|Lost to Follow-up|9|||
161939721|NCT00050011|584828725|FG000|Overall Study|Administrative problems|10|||
161939722|NCT00050011|584828726|FG001|Overall Study|Administrative problems|6|||
161939723|NCT00050011|584828725|FG000|Overall Study|Death|7|||
161939724|NCT00050011|584828726|FG001|Overall Study|Death|4|||
161939725|NCT00050011|584828725|FG000|Overall Study|Unknown - Reason is missing|0|||
161939726|NCT00050011|584828726|FG001|Overall Study|Unknown - Reason is missing|2|||
161939727|NCT03034044|584828727|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
161939728|NCT04042311|584828731|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
161939729|NCT04042311|584828731|FG000|Overall Study|Unable to tolerate|4|||
161939730|NCT04042311|584828731|FG000|Overall Study|Concurrent illness|2|||
161939731|NCT04042311|584828731|FG000|Overall Study|Adverse Event|2|||
161939732|NCT04042311|584828731|FG000|Overall Study|No longer meeting inclusion criteria|2|||
161939733|NCT04042311|584828731|FG000|Overall Study|No reason given|1|||
161939734|NCT04042311|584828731|FG000|Overall Study|Withdrawal by Subject|4|||
161939735|NCT03518060|584828732|FG000|Overall Study|Death|1|||
161939736|NCT03518060|584828732|FG000|Overall Study|Poor adherence|1|||
161939737|NCT03518060|584828732|FG000|Overall Study|Withdrawal of informed consent|2|||
161939738|NCT03518060|584828732|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
161939739|NCT03518060|584828732|FG000|Overall Study|Physician Decision|7|||
161939740|NCT03518060|584828732|FG000|Overall Study|Adverse drug reactions|23|||
161939741|NCT03518060|584828732|FG000|Overall Study|Withdrawal by Subject|25|||
161939742|NCT03518060|584828732|FG000|Overall Study|Lost to Follow-up|13|||
161939743|NCT00323622|584828733|FG000|Overall Study|Other|30|||
161939744|NCT00323622|584828734|FG001|Overall Study|Other|91|||
161939745|NCT00323622|584828735|FG002|Overall Study|Other|4|||
161939746|NCT00323622|584828736|FG003|Overall Study|Other|12|||
161939747|NCT00323622|584828737|FG004|Overall Study|Other|32|||
161939748|NCT00323622|584828738|FG005|Overall Study|Other|74|||
161939749|NCT00323622|584828739|FG006|Overall Study|Other|5|||
161939750|NCT00323622|584828740|FG007|Overall Study|Other|13|||
161939751|NCT00323622|584828733|FG000|Overall Study|Death|1|||
161939752|NCT00323622|584828734|FG001|Overall Study|Death|1|||
161939753|NCT00323622|584828735|FG002|Overall Study|Death|0|||
161939754|NCT00323622|584828736|FG003|Overall Study|Death|0|||
161939755|NCT00323622|584828737|FG004|Overall Study|Death|7|||
161939756|NCT00323622|584828738|FG005|Overall Study|Death|0|||
161939757|NCT00323622|584828739|FG006|Overall Study|Death|0|||
161939758|NCT00323622|584828740|FG007|Overall Study|Death|2|||
161939759|NCT03709472|584828741|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
161939760|NCT03709472|584828742|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
161939761|NCT03709472|584828741|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
161939762|NCT03709472|584828742|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
161939763|NCT01385995|584828750|FG000|Period 1, 2 Months|Physician Decision|1|||
161939764|NCT01385995|584828751|FG001|Period 1, 2 Months|Physician Decision|0|||
162223735|NCT02187159|585869999|FG001|Overall Study|Withdrawal by Subject|28|||
162223736|NCT02187159|585870000|FG002|Overall Study|Withdrawal by Subject|25|||
162223737|NCT02187159|585870001|FG003|Overall Study|Withdrawal by Subject|26|||
162223738|NCT02187159|585869998|FG000|Overall Study|Other|3|||
162223739|NCT02187159|585869999|FG001|Overall Study|Other|7|||
162223740|NCT02187159|585870000|FG002|Overall Study|Other|3|||
162223741|NCT02187159|585870001|FG003|Overall Study|Other|9|||
162223742|NCT01283152|585870002|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
162223743|NCT01283152|585870003|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
162223744|NCT01283152|585870002|FG000|Overall Study|Refused HESA|1|||
162223745|NCT01283152|585870003|FG001|Overall Study|Refused HESA|0|||
162223746|NCT03482466|585870004|FG000|Overall Study|Protocol Violation|2|||
162223747|NCT04833127|585870005|FG000|Overall Study|Lost to Follow-up|1|||
162223748|NCT04833127|585870006|FG001|Overall Study|Lost to Follow-up|1|||
162223749|NCT01736189|585870007|FG000|Overall Study|Violation of registration criteria|41|||
162223750|NCT01736189|585870007|FG000|Overall Study|Protocol Violation|4|||
162223751|NCT01736189|585870007|FG000|Overall Study|Criteria and protocol violations|1|||
162223752|NCT01499303|585870008|FG000|Overall Study|Ongoing|2|||
162223753|NCT01499303|585870009|FG001|Overall Study|Ongoing|1|||
162223754|NCT01499303|585870008|FG000|Overall Study|Withdrawal by Subject|0|||
162223755|NCT01499303|585870009|FG001|Overall Study|Withdrawal by Subject|1|||
162223756|NCT01499303|585870008|FG000|Overall Study|Adverse Event|1|||
162223757|NCT01499303|585870009|FG001|Overall Study|Adverse Event|4|||
161939765|NCT04976777|584830609|FG000|Overall Study|COVID-19 Infection|1|||
161939766|NCT04976777|584830610|FG001|Overall Study|COVID-19 Infection|0|||
161939767|NCT00462826|584830611|FG000|Overall Study|Ineligible - second primary|1|||
161939768|NCT00462826|584830611|FG000|Overall Study|Ineligible - wrong cell type|1|||
161939769|NCT00462826|584830611|FG000|Overall Study|Ineligible - wrong primary|2|||
161939770|NCT00462826|584830611|FG000|Overall Study|Never treated|1|||
161939771|NCT05654181|584830612|FG000|Overall Study|Adverse Event|1|||
161939772|NCT05654181|584830613|FG001|Overall Study|Adverse Event|0|||
161939773|NCT05654181|584830614|FG002|Overall Study|Adverse Event|0|||
161939774|NCT05654181|584830615|FG003|Overall Study|Adverse Event|0|||
161939775|NCT05654181|584830616|FG004|Overall Study|Adverse Event|0|||
161939776|NCT05654181|584830617|FG005|Overall Study|Adverse Event|0|||
161939777|NCT05654181|584830618|FG006|Overall Study|Adverse Event|0|||
161939778|NCT05654181|584830619|FG007|Overall Study|Adverse Event|1|||
161939779|NCT05654181|584830620|FG008|Overall Study|Adverse Event|0|||
161939780|NCT05654181|584830621|FG009|Overall Study|Adverse Event|0|||
161939781|NCT05654181|584830612|FG000|Overall Study|Withdrawal by Subject|0|||
161939782|NCT05654181|584830613|FG001|Overall Study|Withdrawal by Subject|0|||
161939783|NCT05654181|584830614|FG002|Overall Study|Withdrawal by Subject|0|||
161939784|NCT05654181|584830615|FG003|Overall Study|Withdrawal by Subject|0|||
161939785|NCT05654181|584830616|FG004|Overall Study|Withdrawal by Subject|0|||
161939786|NCT05654181|584830617|FG005|Overall Study|Withdrawal by Subject|0|||
161939787|NCT05654181|584830618|FG006|Overall Study|Withdrawal by Subject|0|||
161939788|NCT05654181|584830619|FG007|Overall Study|Withdrawal by Subject|1|||
161939789|NCT05654181|584830620|FG008|Overall Study|Withdrawal by Subject|0|||
161939790|NCT05654181|584830621|FG009|Overall Study|Withdrawal by Subject|0|||
161939791|NCT05654181|584830612|FG000|Overall Study|Other|0|||
161939792|NCT05654181|584830613|FG001|Overall Study|Other|0|||
161939793|NCT05654181|584830614|FG002|Overall Study|Other|0|||
161939794|NCT05654181|584830615|FG003|Overall Study|Other|0|||
161939795|NCT05654181|584830616|FG004|Overall Study|Other|1|||
161939796|NCT05654181|584830617|FG005|Overall Study|Other|1|||
161939797|NCT05654181|584830618|FG006|Overall Study|Other|0|||
161939798|NCT05654181|584830619|FG007|Overall Study|Other|0|||
162223758|NCT01499303|585870008|FG000|Overall Study|Other|0|||
162223759|NCT01499303|585870009|FG001|Overall Study|Other|1|||
162223760|NCT00461981|585870010|FG000|Overall Study|Lost to Follow-up|9|||
162223761|NCT00461981|585870011|FG001|Overall Study|Lost to Follow-up|6|||
162223762|NCT00461981|585870010|FG000|Overall Study|Withdrawal by Subject|2|||
162223763|NCT00461981|585870011|FG001|Overall Study|Withdrawal by Subject|3|||
161939799|NCT05654181|584830620|FG008|Overall Study|Other|0|||
161939800|NCT05654181|584830621|FG009|Overall Study|Other|0|||
162223764|NCT01896557|585870012|FG000|Clopidogrel Alone|Adverse Event|1|||
161939801|NCT00939185|584830625|FG000|Overall Study|Adverse Event|3|||
161939802|NCT00939185|584830625|FG000|Overall Study|Lack of Efficacy|1|||
161939803|NCT00939185|584830625|FG000|Overall Study|Lost to Follow-up|6|||
161939804|NCT00939185|584830625|FG000|Overall Study|Other|3|||
161939805|NCT00939185|584830625|FG000|Overall Study|Withdrawal by Subject|2|||
161939806|NCT00939185|584830625|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
161939807|NCT00363298|584830626|FG000|First Study Week|Lack of Efficacy|6|||
161939808|NCT00363298|584830627|FG001|First Study Week|Lack of Efficacy|5|||
161939809|NCT00363298|584830626|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
161939810|NCT00363298|584830627|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
161939811|NCT03033784|584830629|FG000|Overall Study|Anxiety related to MRI scanner|0|||
161939812|NCT03033784|584830630|FG001|Overall Study|Anxiety related to MRI scanner|1|||
162223765|NCT01896557|585870013|FG001|Clopidogrel Alone|Adverse Event|0|||
162223766|NCT01896557|585870012|FG000|Clopidogrel + GI Protector|low adherence|1|||
162223767|NCT01896557|585870013|FG001|Clopidogrel + GI Protector|low adherence|1|||
162223768|NCT01896557|585870012|FG000|Clopidogrel + GI Protector|Reading error|1|||
162223769|NCT01896557|585870013|FG001|Clopidogrel + GI Protector|Reading error|3|||
162223770|NCT02383940|585870014|FG000|Overall Study|Adverse Event|1|||
162223771|NCT02383940|585870015|FG001|Overall Study|Adverse Event|0|||
162223772|NCT02383940|585870014|FG000|Overall Study|Lost to Follow-up|2|||
162223773|NCT02383940|585870015|FG001|Overall Study|Lost to Follow-up|2|||
162223774|NCT02383940|585870014|FG000|Overall Study|Physician Decision|2|||
162223775|NCT02383940|585870015|FG001|Overall Study|Physician Decision|0|||
162223776|NCT02383940|585870014|FG000|Overall Study|Withdrawal by Subject|1|||
162223777|NCT02383940|585870015|FG001|Overall Study|Withdrawal by Subject|1|||
162223778|NCT02383940|585870014|FG000|Overall Study|Randomized but not treated|2|||
162223779|NCT02383940|585870015|FG001|Overall Study|Randomized but not treated|0|||
162223780|NCT02383940|585870014|FG000|Overall Study|Other than specified above|1|||
162223781|NCT02383940|585870015|FG001|Overall Study|Other than specified above|0|||
162223782|NCT01517295|585870016|FG000|Overall Study|Physician Decision|1|||
162223783|NCT01517295|585870017|FG001|Overall Study|Physician Decision|0|||
162223784|NCT00565773|585870018|FG000|Overall Study|Withdrawal by Subject|1|||
162223785|NCT00565773|585870018|FG000|Overall Study|Physician Decision|1|||
162223786|NCT03853551|585870019|FG000|Overall Study|Death|2|||
162223787|NCT03853551|585870019|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
162223788|NCT01923467|585870022|FG000|Overall Study|Lost to Follow-up|62|||
162223789|NCT01923467|585870022|FG000|Overall Study|Subject non-interest|479|||
162223790|NCT01075958|585870023|FG000|Overall Study|Blood sample could not be obtained|44|||
162223791|NCT01240915|585870026|FG000|Overall Study|Adverse Event|0|||
162223792|NCT01240915|585870027|FG001|Overall Study|Adverse Event|0|||
162223793|NCT01240915|585870028|FG002|Overall Study|Adverse Event|0|||
162223794|NCT01240915|585870029|FG003|Overall Study|Adverse Event|1|||
162223795|NCT01240915|585870030|FG004|Overall Study|Adverse Event|0|||
162223796|NCT01240915|585870031|FG005|Overall Study|Adverse Event|2|||
162223797|NCT01240915|585870032|FG006|Overall Study|Adverse Event|0|||
162223798|NCT01240915|585870033|FG007|Overall Study|Adverse Event|0|||
162223799|NCT01240915|585870034|FG008|Overall Study|Adverse Event|1|||
162223800|NCT01240915|585870026|FG000|Overall Study|Lost to Follow-up|0|||
162223801|NCT01240915|585870027|FG001|Overall Study|Lost to Follow-up|0|||
162223802|NCT01240915|585870028|FG002|Overall Study|Lost to Follow-up|0|||
162223803|NCT01240915|585870029|FG003|Overall Study|Lost to Follow-up|0|||
162223804|NCT01240915|585870030|FG004|Overall Study|Lost to Follow-up|1|||
162223805|NCT01240915|585870031|FG005|Overall Study|Lost to Follow-up|1|||
162223806|NCT01240915|585870032|FG006|Overall Study|Lost to Follow-up|0|||
162223807|NCT01240915|585870033|FG007|Overall Study|Lost to Follow-up|1|||
162223808|NCT01240915|585870034|FG008|Overall Study|Lost to Follow-up|1|||
162223809|NCT01240915|585870026|FG000|Overall Study|Withdrawal by Subject|2|||
162223810|NCT01240915|585870027|FG001|Overall Study|Withdrawal by Subject|1|||
162223811|NCT01240915|585870028|FG002|Overall Study|Withdrawal by Subject|0|||
162223812|NCT01240915|585870029|FG003|Overall Study|Withdrawal by Subject|2|||
161939813|NCT03033784|584830631|FG002|Overall Study|Anxiety related to MRI scanner|0|||
161939814|NCT03033784|584830632|FG003|Overall Study|Anxiety related to MRI scanner|0|||
161939815|NCT03033784|584830633|FG004|Overall Study|Anxiety related to MRI scanner|0|||
161939816|NCT03033784|584830634|FG005|Overall Study|Anxiety related to MRI scanner|0|||
161939817|NCT03033784|584830635|FG006|Overall Study|Anxiety related to MRI scanner|0|||
162223813|NCT01240915|585870030|FG004|Overall Study|Withdrawal by Subject|0|||
162223814|NCT01240915|585870031|FG005|Overall Study|Withdrawal by Subject|4|||
162223815|NCT01240915|585870032|FG006|Overall Study|Withdrawal by Subject|2|||
162223816|NCT01240915|585870033|FG007|Overall Study|Withdrawal by Subject|3|||
162223817|NCT01240915|585870034|FG008|Overall Study|Withdrawal by Subject|3|||
162223818|NCT01240915|585870026|FG000|Overall Study|Other|0|||
162223819|NCT01240915|585870027|FG001|Overall Study|Other|0|||
162223820|NCT01240915|585870028|FG002|Overall Study|Other|0|||
161939818|NCT03033784|584830636|FG007|Overall Study|Anxiety related to MRI scanner|0|||
162223821|NCT01240915|585870029|FG003|Overall Study|Other|0|||
162223822|NCT01240915|585870030|FG004|Overall Study|Other|2|||
162223823|NCT01240915|585870031|FG005|Overall Study|Other|0|||
162223824|NCT01240915|585870032|FG006|Overall Study|Other|0|||
161939819|NCT03033784|584830637|FG008|Overall Study|Anxiety related to MRI scanner|0|||
161939820|NCT03033784|584830638|FG009|Overall Study|Anxiety related to MRI scanner|0|||
162223825|NCT01240915|585870033|FG007|Overall Study|Other|0|||
162223826|NCT01240915|585870034|FG008|Overall Study|Other|0|||
161939821|NCT03033784|584830639|FG010|Overall Study|Anxiety related to MRI scanner|0|||
161939822|NCT03033784|584830640|FG011|Overall Study|Anxiety related to MRI scanner|0|||
161939823|NCT03033784|584830641|FG012|Overall Study|Anxiety related to MRI scanner|0|||
161939824|NCT03033784|584830629|FG000|Overall Study|Withdrawal by Subject|0|||
161939825|NCT03033784|584830630|FG001|Overall Study|Withdrawal by Subject|0|||
161939826|NCT03033784|584830631|FG002|Overall Study|Withdrawal by Subject|0|||
161939827|NCT03033784|584830632|FG003|Overall Study|Withdrawal by Subject|0|||
161939828|NCT03033784|584830633|FG004|Overall Study|Withdrawal by Subject|0|||
161939829|NCT03033784|584830634|FG005|Overall Study|Withdrawal by Subject|0|||
161939830|NCT03033784|584830635|FG006|Overall Study|Withdrawal by Subject|0|||
161939831|NCT03033784|584830636|FG007|Overall Study|Withdrawal by Subject|0|||
161939832|NCT03033784|584830637|FG008|Overall Study|Withdrawal by Subject|0|||
161939833|NCT03033784|584830638|FG009|Overall Study|Withdrawal by Subject|0|||
161939834|NCT03033784|584830639|FG010|Overall Study|Withdrawal by Subject|0|||
161939835|NCT03033784|584830640|FG011|Overall Study|Withdrawal by Subject|0|||
161939836|NCT03033784|584830641|FG012|Overall Study|Withdrawal by Subject|2|||
161939837|NCT00267488|584830642|FG000|Overall Study|Sponsor Terminated Study|9|||
161939838|NCT00267488|584830642|FG000|Overall Study|Protocol Violation|1|||
161939839|NCT00267488|584830642|FG000|Overall Study|Other (Disease Progression)|1|||
162223827|NCT01240915|585870026|FG000|Overall Study|Insufficient Clinical Response|0|||
162223828|NCT01240915|585870027|FG001|Overall Study|Insufficient Clinical Response|0|||
162223829|NCT01240915|585870028|FG002|Overall Study|Insufficient Clinical Response|0|||
161939840|NCT02093520|584830643|FG000|Overall Study|Not treated|6|||
161939841|NCT02093520|584830644|FG001|Overall Study|Not treated|22|||
161939842|NCT00851084|584830645|FG000|Overall Study|Randomized but not treated|1|||
162223830|NCT01240915|585870029|FG003|Overall Study|Insufficient Clinical Response|0|||
161939843|NCT00851084|584830646|FG001|Overall Study|Randomized but not treated|0|||
162223831|NCT01240915|585870030|FG004|Overall Study|Insufficient Clinical Response|1|||
162223832|NCT01240915|585870031|FG005|Overall Study|Insufficient Clinical Response|3|||
162223833|NCT01240915|585870032|FG006|Overall Study|Insufficient Clinical Response|6|||
162223834|NCT01240915|585870033|FG007|Overall Study|Insufficient Clinical Response|0|||
162223835|NCT01240915|585870034|FG008|Overall Study|Insufficient Clinical Response|3|||
162223836|NCT02574845|585870036|FG000|Overall Study|Consent withdrawn further participation|0|||
162223837|NCT02574845|585870037|FG001|Overall Study|Consent withdrawn further participation|0|||
162223838|NCT02574845|585870038|FG002|Overall Study|Consent withdrawn further participation|0|||
162223839|NCT02574845|585870039|FG003|Overall Study|Consent withdrawn further participation|0|||
162223840|NCT02574845|585870040|FG004|Overall Study|Consent withdrawn further participation|1|||
162223841|NCT02574845|585870041|FG005|Overall Study|Consent withdrawn further participation|0|||
162223842|NCT02574845|585870036|FG000|Overall Study|Adverse Event|0|||
162223843|NCT02574845|585870037|FG001|Overall Study|Adverse Event|1|||
162223844|NCT02574845|585870038|FG002|Overall Study|Adverse Event|0|||
162223845|NCT02574845|585870039|FG003|Overall Study|Adverse Event|0|||
162223846|NCT02574845|585870040|FG004|Overall Study|Adverse Event|0|||
162223847|NCT02574845|585870041|FG005|Overall Study|Adverse Event|1|||
162223848|NCT02440425|585870046|FG000|Overall Study|Death likely due to disease progression|1|||
162223849|NCT02440425|585870046|FG000|Overall Study|Withdrawal by Subject|2|||
162223850|NCT02440425|585870046|FG000|Overall Study|Adverse Event|1|||
162223851|NCT02440425|585870046|FG000|Overall Study|Adverse Event/Ineligible|1|||
162223852|NCT03101462|585870047|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
162223853|NCT03101462|585870048|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
162223854|NCT01696045|585870052|FG000|Overall Study|Study drug toxicity|1|||
162223855|NCT01696045|585870053|FG001|Overall Study|Study drug toxicity|5|||
162223856|NCT01696045|585870052|FG000|Overall Study|Disease progression|2|||
161939844|NCT00851084|584830645|FG000|Overall Study|Adverse Event|26|||
161939845|NCT00851084|584830646|FG001|Overall Study|Adverse Event|36|||
161939846|NCT00851084|584830645|FG000|Overall Study|Disease progression|52|||
161939847|NCT00851084|584830646|FG001|Overall Study|Disease progression|47|||
161939848|NCT00851084|584830645|FG000|Overall Study|Poor compliance to protocol|1|||
162223857|NCT01696045|585870053|FG001|Overall Study|Disease progression|2|||
162223858|NCT01559129|585870054|FG000|Treatment Phase|Adverse Event|0|||
162223859|NCT01559129|585870055|FG001|Treatment Phase|Adverse Event|2|||
162223860|NCT01559129|585870054|FG000|Treatment Phase|Progressive Disease|1|||
162223861|NCT01559129|585870055|FG001|Treatment Phase|Progressive Disease|1|||
161939849|NCT00851084|584830646|FG001|Overall Study|Poor compliance to protocol|1|||
161939850|NCT00851084|584830645|FG000|Overall Study|Physician Decision|13|||
161939851|NCT00851084|584830646|FG001|Overall Study|Physician Decision|14|||
161939852|NCT00851084|584830645|FG000|Overall Study|Consent withdrawn|0|||
162223862|NCT01559129|585870054|FG000|Treatment Phase|Lack of Efficacy|0|||
162223863|NCT01559129|585870055|FG001|Treatment Phase|Lack of Efficacy|1|||
162223864|NCT01559129|585870054|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
162223865|NCT01559129|585870055|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
162223866|NCT01559129|585870054|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
162223867|NCT01559129|585870055|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
162223868|NCT01559129|585870054|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
162223869|NCT01559129|585870055|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
162223870|NCT01559129|585870054|FG000|Open-label Extension Period|Adverse Event|1|||
162223871|NCT01559129|585870055|FG001|Open-label Extension Period|Adverse Event|0|||
162223872|NCT01559129|585870054|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
161829332|NCT00794417|584415747|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
161829333|NCT00794417|584415748|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
162223873|NCT01559129|585870055|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
162223874|NCT03525392|585870056|FG000|Overall Study|Adverse Event|1|||
162223875|NCT03525392|585870057|FG001|Overall Study|Adverse Event|0|||
162223876|NCT03525392|585870058|FG002|Overall Study|Adverse Event|2|||
162223877|NCT03525392|585870059|FG003|Overall Study|Adverse Event|0|||
162223878|NCT03525392|585870060|FG004|Overall Study|Adverse Event|0|||
162223879|NCT03525392|585870056|FG000|Overall Study|Progressive disease|0|||
162223880|NCT03525392|585870057|FG001|Overall Study|Progressive disease|1|||
162223881|NCT03525392|585870058|FG002|Overall Study|Progressive disease|1|||
162223882|NCT03525392|585870059|FG003|Overall Study|Progressive disease|3|||
162223883|NCT03525392|585870060|FG004|Overall Study|Progressive disease|1|||
162223884|NCT00831129|585870063|FG000|Overall Study|Adverse Event|0|||
162223885|NCT00831129|585870064|FG001|Overall Study|Adverse Event|1|||
162223886|NCT00831129|585870063|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
162223887|NCT00831129|585870064|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
161829334|NCT00794417|584415749|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
161829335|NCT00794417|584415750|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
161829336|NCT00317642|584415753|FG000|Overall Study|Not Received Either Study Drug|1|||
161829337|NCT00317642|584415754|FG001|Overall Study|Not Received Either Study Drug|3|||
161829338|NCT00317642|584415753|FG000|Overall Study|Physician Decision|15|||
161829339|NCT00317642|584415754|FG001|Overall Study|Physician Decision|7|||
161829340|NCT00317642|584415753|FG000|Overall Study|Participant declined treatment|14|||
161829341|NCT00317642|584415754|FG001|Overall Study|Participant declined treatment|3|||
161829342|NCT00317642|584415753|FG000|Overall Study|Adverse Event|17|||
161829343|NCT00317642|584415754|FG001|Overall Study|Adverse Event|5|||
161829344|NCT00317642|584415753|FG000|Overall Study|Treatment Failure|56|||
161829345|NCT00317642|584415754|FG001|Overall Study|Treatment Failure|102|||
161829346|NCT00317642|584415753|FG000|Overall Study|Disease Recurrence|1|||
161829347|NCT00317642|584415754|FG001|Overall Study|Disease Recurrence|2|||
161829348|NCT00317642|584415753|FG000|Overall Study|Death|14|||
161829349|NCT00317642|584415754|FG001|Overall Study|Death|7|||
161829350|NCT00317642|584415753|FG000|Overall Study|Not Continue to Consolidation|2|||
161829351|NCT00317642|584415754|FG001|Overall Study|Not Continue to Consolidation|0|||
161829352|NCT00317642|584415753|FG000|Overall Study|Withdrawal by Subject|0|||
161829353|NCT00317642|584415754|FG001|Overall Study|Withdrawal by Subject|1|||
161829354|NCT00317642|584415753|FG000|Overall Study|Referred For Transplantation|1|||
161829355|NCT00317642|584415754|FG001|Overall Study|Referred For Transplantation|0|||
161829356|NCT00317642|584415753|FG000|Overall Study|AML Not Centrally Confirmed|1|||
161829357|NCT00317642|584415754|FG001|Overall Study|AML Not Centrally Confirmed|5|||
161829358|NCT00255151|584415756|FG000|Overall Study|Adverse Event|10|||
161829359|NCT00255151|584415757|FG001|Overall Study|Adverse Event|6|||
161829360|NCT00255151|584415758|FG002|Overall Study|Adverse Event|9|||
161829361|NCT00255151|584415756|FG000|Overall Study|Lost to Follow-up|4|||
161829362|NCT00255151|584415757|FG001|Overall Study|Lost to Follow-up|3|||
161829363|NCT00255151|584415758|FG002|Overall Study|Lost to Follow-up|4|||
161829364|NCT00255151|584415756|FG000|Overall Study|Withdrawal by Subject|18|||
161829365|NCT00255151|584415757|FG001|Overall Study|Withdrawal by Subject|17|||
161829366|NCT00255151|584415758|FG002|Overall Study|Withdrawal by Subject|8|||
161829367|NCT00255151|584415756|FG000|Overall Study|Noncompliance|0|||
161829368|NCT00255151|584415757|FG001|Overall Study|Noncompliance|1|||
161829369|NCT00255151|584415758|FG002|Overall Study|Noncompliance|2|||
161829370|NCT00255151|584415756|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
161829371|NCT00255151|584415757|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
161829372|NCT00255151|584415758|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
161829373|NCT00255151|584415756|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
161829374|NCT00255151|584415757|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
161829375|NCT00255151|584415758|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
161829376|NCT00255151|584415756|FG000|Overall Study|Possible Barrett's Esophagus|1|||
161829377|NCT00255151|584415757|FG001|Overall Study|Possible Barrett's Esophagus|3|||
161829378|NCT00255151|584415758|FG002|Overall Study|Possible Barrett's Esophagus|8|||
162223888|NCT01669577|585870066|FG000|Overall Study|Death|22|||
162223889|NCT01669577|585870066|FG000|Overall Study|Lost to Follow-up|78|||
162223890|NCT01669577|585870066|FG000|Overall Study|Physician Decision|34|||
162223891|NCT04462289|585870069|FG000|Overall Study|Lost to Follow-up|4|||
162223892|NCT04462289|585870070|FG001|Overall Study|Lost to Follow-up|5|||
162223893|NCT04462289|585870069|FG000|Overall Study|Death|0|||
162223894|NCT04462289|585870070|FG001|Overall Study|Death|3|||
162223895|NCT04462289|585870069|FG000|Overall Study|Withdrawal by Subject|1|||
162223896|NCT04462289|585870070|FG001|Overall Study|Withdrawal by Subject|3|||
162223897|NCT00818779|585870071|FG000|Overall Study|Protocol Violation|1|||
162223898|NCT00818779|585870072|FG001|Overall Study|Protocol Violation|0|||
162223899|NCT00818779|585870071|FG000|Overall Study|Lost to Follow-up|1|||
162223900|NCT00818779|585870072|FG001|Overall Study|Lost to Follow-up|0|||
162223901|NCT00818779|585870071|FG000|Overall Study|Adverse Event|4|||
162223902|NCT00818779|585870072|FG001|Overall Study|Adverse Event|1|||
162223903|NCT01518153|585870073|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
162223904|NCT01518153|585870074|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
162223905|NCT01518153|585870075|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
162223906|NCT01518153|585870073|FG000|Stem Cell Transplant|Death|2|||
162223907|NCT01518153|585870074|FG001|Stem Cell Transplant|Death|0|||
162223908|NCT01518153|585870075|FG002|Stem Cell Transplant|Death|0|||
162223909|NCT01518153|585870073|FG000|Stem Cell Transplant|Secondary graft failure|1|||
162223910|NCT01518153|585870074|FG001|Stem Cell Transplant|Secondary graft failure|0|||
162223911|NCT01518153|585870075|FG002|Stem Cell Transplant|Secondary graft failure|0|||
162223912|NCT01518153|585870073|FG000|Stem Cell Transplant|Adverse Event|1|||
162223913|NCT01518153|585870074|FG001|Stem Cell Transplant|Adverse Event|0|||
162223914|NCT01518153|585870075|FG002|Stem Cell Transplant|Adverse Event|0|||
162223915|NCT01518153|585870073|FG000|Donor Lymphocyte Infusion|Death|0|||
162223916|NCT01518153|585870074|FG001|Donor Lymphocyte Infusion|Death|2|||
162223917|NCT01518153|585870075|FG002|Donor Lymphocyte Infusion|Death|1|||
162223918|NCT00132873|585870076|FG000|Overall Study|Adverse Event|3|||
162223919|NCT00132873|585870076|FG000|Overall Study|Lost to Follow-up|1|||
162223920|NCT00132873|585870076|FG000|Overall Study|Lack of Efficacy|1|||
161939853|NCT00851084|584830646|FG001|Overall Study|Consent withdrawn|2|||
161939854|NCT00851084|584830645|FG000|Overall Study|Withdrawal by Subject|11|||
161939855|NCT00851084|584830646|FG001|Overall Study|Withdrawal by Subject|12|||
161939856|NCT00851084|584830645|FG000|Overall Study|Metastatic surgery|6|||
161939857|NCT00851084|584830646|FG001|Overall Study|Metastatic surgery|6|||
161939858|NCT00851084|584830645|FG000|Overall Study|Other|7|||
161939859|NCT00851084|584830646|FG001|Overall Study|Other|1|||
161939860|NCT01892189|584830649|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
161939861|NCT01892189|584830650|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
161939862|NCT01892189|584830651|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
161939863|NCT01892189|584830652|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
161939864|NCT01892189|584830653|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
161939865|NCT01892189|584830654|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
161939866|NCT01892189|584830655|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
161939867|NCT01892189|584830656|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
161939868|NCT01892189|584830657|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
162223921|NCT00132873|585870076|FG000|Overall Study|Withdrawal by Subject|3|||
162223922|NCT00132873|585870076|FG000|Overall Study|Planned Pregnancy|1|||
162223923|NCT04276415|585870077|FG000|Overall Study|Adverse Event|0|||
162223924|NCT04276415|585870078|FG001|Overall Study|Adverse Event|0|||
162223925|NCT04276415|585870079|FG002|Overall Study|Adverse Event|0|||
162223926|NCT04276415|585870080|FG003|Overall Study|Adverse Event|3|||
162223927|NCT04276415|585870081|FG004|Overall Study|Adverse Event|0|||
162223928|NCT04276415|585870082|FG005|Overall Study|Adverse Event|0|||
162223929|NCT04276415|585870077|FG000|Overall Study|Clinical progression|1|||
162223930|NCT04276415|585870078|FG001|Overall Study|Clinical progression|1|||
162223931|NCT04276415|585870079|FG002|Overall Study|Clinical progression|0|||
162223932|NCT04276415|585870080|FG003|Overall Study|Clinical progression|0|||
162223933|NCT04276415|585870081|FG004|Overall Study|Clinical progression|1|||
162223934|NCT04276415|585870082|FG005|Overall Study|Clinical progression|0|||
162223935|NCT04276415|585870077|FG000|Overall Study|Other|0|||
161939869|NCT01892189|584830649|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162223936|NCT04276415|585870078|FG001|Overall Study|Other|0|||
162223937|NCT04276415|585870079|FG002|Overall Study|Other|0|||
162223938|NCT04276415|585870080|FG003|Overall Study|Other|1|||
162223939|NCT04276415|585870081|FG004|Overall Study|Other|0|||
162223940|NCT04276415|585870082|FG005|Overall Study|Other|0|||
162223941|NCT04276415|585870077|FG000|Overall Study|Physician Decision|0|||
162223942|NCT04276415|585870078|FG001|Overall Study|Physician Decision|0|||
162223943|NCT04276415|585870079|FG002|Overall Study|Physician Decision|1|||
162223944|NCT04276415|585870080|FG003|Overall Study|Physician Decision|3|||
162023415|NCT02152956|585142692|FG007|Overall Study|Withdrawal by Subject|0|||
161939870|NCT01892189|584830650|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
162223945|NCT04276415|585870081|FG004|Overall Study|Physician Decision|2|||
162223946|NCT04276415|585870082|FG005|Overall Study|Physician Decision|0|||
162223947|NCT04276415|585870077|FG000|Overall Study|Progressive disease|3|||
162223948|NCT04276415|585870078|FG001|Overall Study|Progressive disease|3|||
162223949|NCT04276415|585870079|FG002|Overall Study|Progressive disease|4|||
162223950|NCT04276415|585870080|FG003|Overall Study|Progressive disease|5|||
162223951|NCT04276415|585870081|FG004|Overall Study|Progressive disease|1|||
162223952|NCT04276415|585870082|FG005|Overall Study|Progressive disease|2|||
162223953|NCT04276415|585870077|FG000|Overall Study|Withdrawal by patient|0|||
162223954|NCT04276415|585870078|FG001|Overall Study|Withdrawal by patient|0|||
162223955|NCT04276415|585870079|FG002|Overall Study|Withdrawal by patient|0|||
162223956|NCT04276415|585870080|FG003|Overall Study|Withdrawal by patient|1|||
162223957|NCT04276415|585870081|FG004|Overall Study|Withdrawal by patient|2|||
162223958|NCT04276415|585870082|FG005|Overall Study|Withdrawal by patient|0|||
161939871|NCT01892189|584830651|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
161939872|NCT01892189|584830652|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161939873|NCT01892189|584830653|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161939874|NCT01892189|584830654|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161939875|NCT01892189|584830655|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161939876|NCT01892189|584830656|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161939877|NCT01892189|584830657|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161939878|NCT01892189|584830649|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161939879|NCT01892189|584830650|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161939880|NCT01892189|584830651|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161939881|NCT01892189|584830652|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161939882|NCT01892189|584830653|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161939883|NCT01892189|584830654|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
161939884|NCT01892189|584830655|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161939885|NCT01892189|584830656|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161939886|NCT01892189|584830657|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
161939887|NCT01497197|584830660|FG000|Overall Study|Lost to Follow-up|1|||
161939888|NCT01497197|584830661|FG001|Overall Study|Lost to Follow-up|0|||
161939889|NCT01497197|584830660|FG000|Overall Study|Protocol Violation|0|||
161939890|NCT01497197|584830661|FG001|Overall Study|Protocol Violation|2|||
161939891|NCT01497197|584830660|FG000|Overall Study|Withdrawal by Subject|2|||
161939892|NCT01497197|584830661|FG001|Overall Study|Withdrawal by Subject|1|||
161939893|NCT01497197|584830660|FG000|Overall Study|Excessive/lack of response to treatment|1|||
161939894|NCT01497197|584830661|FG001|Overall Study|Excessive/lack of response to treatment|0|||
161939895|NCT01497197|584830660|FG000|Overall Study|Risk of OHSS|1|||
161939896|NCT01497197|584830661|FG001|Overall Study|Risk of OHSS|0|||
161939897|NCT01497197|584830660|FG000|Overall Study|No oocytes retrieved|3|||
161939898|NCT01497197|584830661|FG001|Overall Study|No oocytes retrieved|2|||
161939899|NCT01497197|584830660|FG000|Overall Study|No fertilisation|6|||
161939900|NCT01497197|584830661|FG001|Overall Study|No fertilisation|5|||
161939901|NCT01497197|584830660|FG000|Overall Study|Intention to freeze all embryos|0|||
161939902|NCT01497197|584830661|FG001|Overall Study|Intention to freeze all embryos|1|||
161939903|NCT01497197|584830660|FG000|Overall Study|All embryos discarded|0|||
161939904|NCT01497197|584830661|FG001|Overall Study|All embryos discarded|3|||
161939905|NCT01497197|584830660|FG000|Overall Study|Other|3|||
161939906|NCT01497197|584830661|FG001|Overall Study|Other|1|||
161939907|NCT01425814|584830663|FG000|Period 1|Stability criteria not fulfilled|0|||
161939908|NCT01425814|584830664|FG001|Period 1|Stability criteria not fulfilled|1|||
161939909|NCT01425814|584830665|FG002|Period 1|Stability criteria not fulfilled|0|||
161939910|NCT01425814|584830666|FG003|Period 1|Stability criteria not fulfilled|0|||
161939911|NCT01425814|584830667|FG004|Period 1|Stability criteria not fulfilled|0|||
161939912|NCT01425814|584830668|FG005|Period 1|Stability criteria not fulfilled|0|||
161939913|NCT01425814|584830663|FG000|Period 2|Stability criteria not fulfilled|0|||
161939914|NCT01425814|584830664|FG001|Period 2|Stability criteria not fulfilled|1|||
161939915|NCT01425814|584830665|FG002|Period 2|Stability criteria not fulfilled|0|||
161939916|NCT01425814|584830666|FG003|Period 2|Stability criteria not fulfilled|0|||
161939917|NCT01425814|584830667|FG004|Period 2|Stability criteria not fulfilled|0|||
161939918|NCT01425814|584830668|FG005|Period 2|Stability criteria not fulfilled|0|||
161939919|NCT01425814|584830663|FG000|Period 3|Adverse Event|0|||
161939920|NCT01425814|584830664|FG001|Period 3|Adverse Event|0|||
161939921|NCT01425814|584830665|FG002|Period 3|Adverse Event|0|||
162223959|NCT03309813|585870083|FG000|Main Randomized Study|Withdrawal by Subject|1|||
161939922|NCT01425814|584830666|FG003|Period 3|Adverse Event|0|||
161939923|NCT01425814|584830667|FG004|Period 3|Adverse Event|0|||
161939924|NCT01425814|584830668|FG005|Period 3|Adverse Event|1|||
161939925|NCT01425814|584830663|FG000|Period 4|Adverse Event|1|||
161939926|NCT01425814|584830664|FG001|Period 4|Adverse Event|0|||
161939927|NCT01425814|584830665|FG002|Period 4|Adverse Event|1|||
161939928|NCT01425814|584830666|FG003|Period 4|Adverse Event|0|||
161939929|NCT01425814|584830667|FG004|Period 4|Adverse Event|0|||
161939930|NCT01425814|584830668|FG005|Period 4|Adverse Event|0|||
161939931|NCT01425814|584830663|FG000|Period 5|Stability criteria not fulfilled|0|||
162223960|NCT03309813|585870084|FG001|Main Randomized Study|Withdrawal by Subject|0|||
162223961|NCT01327846|585870085|FG000|Core Phase|Subject decision (vital status: missing)|1|||
162223962|NCT01327846|585870086|FG001|Core Phase|Subject decision (vital status: missing)|2|||
162223963|NCT01327846|585870087|FG002|Core Phase|Subject decision (vital status: missing)|2|||
162223964|NCT01327846|585870088|FG003|Core Phase|Subject decision (vital status: missing)|1|||
162223965|NCT01327846|585870085|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
162223966|NCT01327846|585870086|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
162223967|NCT01327846|585870087|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
162223968|NCT01327846|585870088|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
162223969|NCT01327846|585870085|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
162223970|NCT01327846|585870086|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
162223971|NCT01327846|585870087|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
162223972|NCT01327846|585870088|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
162223973|NCT01327846|585870085|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
162223974|NCT01327846|585870086|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
162223975|NCT01327846|585870087|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
162223976|NCT01327846|585870088|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
162223977|NCT01327846|585870085|FG000|Core Phase|Lost to Follow-up|3|||
162223978|NCT01327846|585870086|FG001|Core Phase|Lost to Follow-up|3|||
162223979|NCT01327846|585870087|FG002|Core Phase|Lost to Follow-up|4|||
162223980|NCT01327846|585870088|FG003|Core Phase|Lost to Follow-up|5|||
162223981|NCT01327846|585870085|FG000|Extension Phase|Study terminated by sponsor|1073|||
162223982|NCT01327846|585870086|FG001|Extension Phase|Study terminated by sponsor|1124|||
162223983|NCT01327846|585870087|FG002|Extension Phase|Study terminated by sponsor|1067|||
162223984|NCT01327846|585870088|FG003|Extension Phase|Study terminated by sponsor|1660|||
162223985|NCT01327846|585870085|FG000|Extension Phase|Withdrawal by Subject|20|||
162223986|NCT01327846|585870086|FG001|Extension Phase|Withdrawal by Subject|13|||
162223987|NCT01327846|585870087|FG002|Extension Phase|Withdrawal by Subject|19|||
162223988|NCT01327846|585870088|FG003|Extension Phase|Withdrawal by Subject|37|||
162223989|NCT01327846|585870085|FG000|Extension Phase|Lost to Follow-up|4|||
162223990|NCT01327846|585870086|FG001|Extension Phase|Lost to Follow-up|3|||
162223991|NCT01327846|585870087|FG002|Extension Phase|Lost to Follow-up|4|||
162223992|NCT01327846|585870088|FG003|Extension Phase|Lost to Follow-up|7|||
162223993|NCT01327846|585870085|FG000|Extension Phase|Technical Problems|2|||
162223994|NCT01327846|585870086|FG001|Extension Phase|Technical Problems|4|||
162223995|NCT01327846|585870087|FG002|Extension Phase|Technical Problems|2|||
162223996|NCT01327846|585870088|FG003|Extension Phase|Technical Problems|2|||
162223997|NCT04662931|585870089|FG000|Overall Study|Withdrawal by Subject|17|||
162223998|NCT04662931|585870089|FG000|Overall Study|Death|3|||
162223999|NCT04662931|585870089|FG000|Overall Study|Lost to Follow-up|3|||
162224000|NCT04662931|585870089|FG000|Overall Study|Guardian Decision|1|||
162224001|NCT03682185|585870097|FG000|Overall Study|Lost to Follow-up|4|||
162224002|NCT03682185|585870098|FG001|Overall Study|Lost to Follow-up|7|||
162224003|NCT03682185|585870099|FG002|Overall Study|Lost to Follow-up|4|||
162224004|NCT03682185|585870100|FG003|Overall Study|Lost to Follow-up|7|||
162224005|NCT03682185|585870101|FG004|Overall Study|Lost to Follow-up|1|||
162224006|NCT03682185|585870097|FG000|Overall Study|Withdrawal by Subject|7|||
162224007|NCT03682185|585870098|FG001|Overall Study|Withdrawal by Subject|3|||
162224008|NCT03682185|585870099|FG002|Overall Study|Withdrawal by Subject|7|||
162224009|NCT03682185|585870100|FG003|Overall Study|Withdrawal by Subject|3|||
162224010|NCT03682185|585870101|FG004|Overall Study|Withdrawal by Subject|0|||
162224011|NCT01967147|585871933|FG000|Overall Study|Adverse Event|5|||
162224012|NCT01967147|585871934|FG001|Overall Study|Adverse Event|2|||
162224013|NCT01967147|585871933|FG000|Overall Study|Lack of Efficacy|1|||
162224014|NCT01967147|585871934|FG001|Overall Study|Lack of Efficacy|4|||
162224015|NCT01967147|585871933|FG000|Overall Study|Lost to Follow-up|1|||
162224016|NCT01967147|585871934|FG001|Overall Study|Lost to Follow-up|2|||
162224017|NCT01967147|585871933|FG000|Overall Study|Withdrawal by Subject|2|||
162224018|NCT01967147|585871934|FG001|Overall Study|Withdrawal by Subject|4|||
162224019|NCT01967147|585871933|FG000|Overall Study|Non-compliance with Study Drug|0|||
162224020|NCT01967147|585871934|FG001|Overall Study|Non-compliance with Study Drug|3|||
162224021|NCT01967147|585871933|FG000|Overall Study|Other|4|||
162224022|NCT01967147|585871934|FG001|Overall Study|Other|5|||
162224023|NCT03843554|585871935|FG000|Overall Study|Physician Decision|0|||
162224024|NCT03843554|585871936|FG001|Overall Study|Physician Decision|2|||
162224025|NCT00387426|585871938|FG000|Overall Study|Lack of Response|7|||
162224026|NCT00387426|585871938|FG000|Overall Study|Toxicities|4|||
162224027|NCT00387426|585871938|FG000|Overall Study|Disease Progression|3|||
162224028|NCT02218606|585871939|FG000|Overall Study|Adverse Event|1|||
162224029|NCT02218606|585871940|FG001|Overall Study|Adverse Event|1|||
162224030|NCT02218606|585871939|FG000|Overall Study|Death|15|||
162224031|NCT02218606|585871940|FG001|Overall Study|Death|28|||
162224032|NCT02218606|585871939|FG000|Overall Study|Physician Decision|0|||
162224033|NCT02218606|585871940|FG001|Overall Study|Physician Decision|1|||
162224034|NCT02218606|585871939|FG000|Overall Study|Withdrawal by Subject|4|||
162224035|NCT02218606|585871940|FG001|Overall Study|Withdrawal by Subject|0|||
162224036|NCT02218606|585871939|FG000|Overall Study|Noncompliance|1|||
162224037|NCT02218606|585871940|FG001|Overall Study|Noncompliance|0|||
162224038|NCT02218606|585871939|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
162224039|NCT02218606|585871940|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
162224040|NCT02218606|585871939|FG000|Overall Study|Other|2|||
162224041|NCT02218606|585871940|FG001|Overall Study|Other|1|||
162224042|NCT02218606|585871939|FG000|Overall Study|Never started treatment|0|||
162224043|NCT02218606|585871940|FG001|Overall Study|Never started treatment|1|||
162224044|NCT03203473|585871941|FG000|Induction Phase|Never started primary treatment|2|||
162224045|NCT03203473|585871942|FG001|Induction Phase|Never started primary treatment|0|||
162224046|NCT03203473|585871943|FG002|Induction Phase|Never started primary treatment|0|||
162224047|NCT03203473|585871941|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
162224048|NCT03203473|585871942|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
162224049|NCT03203473|585871943|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
162224050|NCT03203473|585871941|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
162224051|NCT03203473|585871942|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
162224052|NCT03203473|585871943|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
162224053|NCT03203473|585871941|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
162224054|NCT03203473|585871942|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
162224055|NCT03203473|585871943|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
162224056|NCT03203473|585871941|FG000|Arm Allocation Phase|started salvage therapy|0|||
162224057|NCT03203473|585871942|FG001|Arm Allocation Phase|started salvage therapy|5|||
162224058|NCT03203473|585871943|FG002|Arm Allocation Phase|started salvage therapy|0|||
162224059|NCT03203473|585871941|FG000|Arm Allocation Phase|Disease progression|0|||
162224060|NCT03203473|585871942|FG001|Arm Allocation Phase|Disease progression|0|||
162224061|NCT03203473|585871943|FG002|Arm Allocation Phase|Disease progression|37|||
162224062|NCT03203473|585871941|FG000|Arm Allocation Phase|Adverse Event|0|||
162224063|NCT03203473|585871942|FG001|Arm Allocation Phase|Adverse Event|0|||
162224064|NCT03203473|585871943|FG002|Arm Allocation Phase|Adverse Event|11|||
162224065|NCT03203473|585871941|FG000|Arm Allocation Phase|Physician Decision|0|||
162224066|NCT03203473|585871942|FG001|Arm Allocation Phase|Physician Decision|0|||
162224067|NCT03203473|585871943|FG002|Arm Allocation Phase|Physician Decision|3|||
162224068|NCT03203473|585871941|FG000|Arm Allocation Phase|Death|0|||
162224069|NCT03203473|585871942|FG001|Arm Allocation Phase|Death|0|||
162224070|NCT03203473|585871943|FG002|Arm Allocation Phase|Death|1|||
162224071|NCT03203473|585871941|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
162224072|NCT03203473|585871942|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
162224073|NCT03203473|585871943|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
162224074|NCT03203473|585871941|FG000|Arm Allocation Phase|Intercurrent illness|0|||
162224075|NCT03203473|585871942|FG001|Arm Allocation Phase|Intercurrent illness|0|||
162224076|NCT03203473|585871943|FG002|Arm Allocation Phase|Intercurrent illness|1|||
162224077|NCT03203473|585871941|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
162224078|NCT03203473|585871942|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
162224079|NCT03203473|585871943|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
162224080|NCT00890695|585871944|FG000|Overall Study|Protocol Violation|1|||
162224081|NCT00890695|585871945|FG001|Overall Study|Protocol Violation|0|||
162224082|NCT04396366|585871948|FG000|Overall Study|Adverse Event|1|||
162224083|NCT04396366|585871949|FG001|Overall Study|Adverse Event|0|||
162224084|NCT01531673|585871950|FG000|Overall Study|Non-Compliance|0|||
162224085|NCT01531673|585871951|FG001|Overall Study|Non-Compliance|0|||
162224086|NCT01531673|585871952|FG002|Overall Study|Non-Compliance|0|||
161939932|NCT01425814|584830664|FG001|Period 5|Stability criteria not fulfilled|0|||
161939933|NCT01425814|584830665|FG002|Period 5|Stability criteria not fulfilled|1|||
161939934|NCT01425814|584830666|FG003|Period 5|Stability criteria not fulfilled|0|||
162224087|NCT01531673|585871953|FG003|Overall Study|Non-Compliance|0|||
162224088|NCT01531673|585871954|FG004|Overall Study|Non-Compliance|0|||
162224089|NCT01531673|585871955|FG005|Overall Study|Non-Compliance|1|||
162224090|NCT01531673|585871956|FG006|Overall Study|Non-Compliance|0|||
162224091|NCT01531673|585871957|FG007|Overall Study|Non-Compliance|0|||
162224092|NCT01531673|585871958|FG008|Overall Study|Non-Compliance|0|||
162224093|NCT01531673|585871959|FG009|Overall Study|Non-Compliance|0|||
162224094|NCT01531673|585871960|FG010|Overall Study|Non-Compliance|0|||
162224095|NCT01531673|585871961|FG011|Overall Study|Non-Compliance|0|||
162224096|NCT01531673|585871962|FG012|Overall Study|Non-Compliance|0|||
162224097|NCT01531673|585871950|FG000|Overall Study|Adverse Event|0|||
162224098|NCT01531673|585871951|FG001|Overall Study|Adverse Event|1|||
162224099|NCT01531673|585871952|FG002|Overall Study|Adverse Event|0|||
162224100|NCT01531673|585871953|FG003|Overall Study|Adverse Event|0|||
162224101|NCT01531673|585871954|FG004|Overall Study|Adverse Event|0|||
162224102|NCT01531673|585871955|FG005|Overall Study|Adverse Event|0|||
162224103|NCT01531673|585871956|FG006|Overall Study|Adverse Event|0|||
162224104|NCT01531673|585871957|FG007|Overall Study|Adverse Event|0|||
162224105|NCT01531673|585871958|FG008|Overall Study|Adverse Event|0|||
162224106|NCT01531673|585871959|FG009|Overall Study|Adverse Event|0|||
162224107|NCT01531673|585871960|FG010|Overall Study|Adverse Event|0|||
162224108|NCT01531673|585871961|FG011|Overall Study|Adverse Event|0|||
162224109|NCT01531673|585871962|FG012|Overall Study|Adverse Event|0|||
162224110|NCT01531673|585871950|FG000|Overall Study|Lost to Follow-up|0|||
162224111|NCT01531673|585871951|FG001|Overall Study|Lost to Follow-up|0|||
162224112|NCT01531673|585871952|FG002|Overall Study|Lost to Follow-up|0|||
162224113|NCT01531673|585871953|FG003|Overall Study|Lost to Follow-up|0|||
162224114|NCT01531673|585871954|FG004|Overall Study|Lost to Follow-up|1|||
162224115|NCT01531673|585871955|FG005|Overall Study|Lost to Follow-up|0|||
162224116|NCT01531673|585871956|FG006|Overall Study|Lost to Follow-up|0|||
162224117|NCT01531673|585871957|FG007|Overall Study|Lost to Follow-up|0|||
162224118|NCT01531673|585871958|FG008|Overall Study|Lost to Follow-up|0|||
162224119|NCT01531673|585871959|FG009|Overall Study|Lost to Follow-up|0|||
162224120|NCT01531673|585871960|FG010|Overall Study|Lost to Follow-up|0|||
162224121|NCT01531673|585871961|FG011|Overall Study|Lost to Follow-up|0|||
162224122|NCT01531673|585871962|FG012|Overall Study|Lost to Follow-up|0|||
162224123|NCT01531673|585871950|FG000|Overall Study|Other|0|||
162224124|NCT01531673|585871951|FG001|Overall Study|Other|0|||
162224125|NCT01531673|585871952|FG002|Overall Study|Other|0|||
162224126|NCT01531673|585871953|FG003|Overall Study|Other|1|||
162224127|NCT01531673|585871954|FG004|Overall Study|Other|0|||
162224128|NCT01531673|585871955|FG005|Overall Study|Other|0|||
162224129|NCT01531673|585871956|FG006|Overall Study|Other|0|||
162224130|NCT01531673|585871957|FG007|Overall Study|Other|0|||
162224131|NCT01531673|585871958|FG008|Overall Study|Other|0|||
162224132|NCT01531673|585871959|FG009|Overall Study|Other|1|||
162224133|NCT01531673|585871960|FG010|Overall Study|Other|0|||
162224134|NCT01531673|585871961|FG011|Overall Study|Other|0|||
162224135|NCT01531673|585871962|FG012|Overall Study|Other|0|||
162224136|NCT01014208|585871966|FG000|Overall Study|Lost to Follow-up|2|||
162224137|NCT01014208|585871967|FG001|Overall Study|Lost to Follow-up|5|||
162224138|NCT01014208|585871966|FG000|Overall Study|Participant Withdrew Consent|12|||
162224139|NCT01014208|585871967|FG001|Overall Study|Participant Withdrew Consent|12|||
162224140|NCT01014208|585871966|FG000|Overall Study|Did Not Receive Study Drug|2|||
162224141|NCT01014208|585871967|FG001|Overall Study|Did Not Receive Study Drug|0|||
162224142|NCT01014208|585871966|FG000|Overall Study|Study Closed/terminated|78|||
162224143|NCT01014208|585871967|FG001|Overall Study|Study Closed/terminated|83|||
162224144|NCT01008410|585871970|FG000|Overall Study|Adverse Event|13|||
162224145|NCT01008410|585871971|FG001|Overall Study|Adverse Event|7|||
162224146|NCT01008410|585871970|FG000|Overall Study|Withdrawal by Subject|6|||
162224147|NCT01008410|585871971|FG001|Overall Study|Withdrawal by Subject|2|||
162224148|NCT01008410|585871970|FG000|Overall Study|Lost to Follow-up|1|||
162224149|NCT01008410|585871971|FG001|Overall Study|Lost to Follow-up|0|||
162224150|NCT01008410|585871970|FG000|Overall Study|Noncompliance|1|||
162224151|NCT01008410|585871971|FG001|Overall Study|Noncompliance|0|||
162224152|NCT01008410|585871970|FG000|Overall Study|Low Cortisol|2|||
162224153|NCT01008410|585871971|FG001|Overall Study|Low Cortisol|0|||
162224154|NCT01008410|585871970|FG000|Overall Study|Lack of Efficacy|2|||
162224155|NCT01008410|585871971|FG001|Overall Study|Lack of Efficacy|6|||
162224156|NCT01008410|585871970|FG000|Overall Study|Met Exclusion Criterion|0|||
162224157|NCT01008410|585871971|FG001|Overall Study|Met Exclusion Criterion|1|||
162224158|NCT00297427|585871974|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
162224159|NCT00297427|585871975|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
161939935|NCT01425814|584830667|FG004|Period 5|Stability criteria not fulfilled|0|||
161939936|NCT01425814|584830668|FG005|Period 5|Stability criteria not fulfilled|1|||
161939937|NCT00565747|584830669|FG000|Overall Study|No embryo transfer|67|||
161939938|NCT00565747|584830670|FG001|Overall Study|No embryo transfer|73|||
162224160|NCT00297427|585871974|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
162224161|NCT00297427|585871975|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
162224162|NCT00297427|585871974|FG000|Phase 1: Initial Intervention|Death|0|||
162224163|NCT00297427|585871975|FG001|Phase 1: Initial Intervention|Death|1|||
162224164|NCT00297427|585871974|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
162224165|NCT00297427|585871975|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
162224166|NCT00297427|585871974|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
162224167|NCT00297427|585871975|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
162224168|NCT00297427|585871974|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
162224169|NCT00297427|585871975|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
162224170|NCT00297427|585871974|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
162224171|NCT00297427|585871975|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
162224172|NCT00297427|585871974|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
162224173|NCT00297427|585871975|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
162224174|NCT01127893|585871976|FG000|Overall Study|Study Termination by the Sponsor|1|||
162224175|NCT01262677|585871977|FG000|Overall Study|Does not meet entrance criteria|0|||
162224176|NCT01262677|585871978|FG001|Overall Study|Does not meet entrance criteria|2|||
162224177|NCT01262677|585871979|FG002|Overall Study|Does not meet entrance criteria|0|||
162224178|NCT01262677|585871977|FG000|Overall Study|Insufficient clinical response|0|||
162224179|NCT01262677|585871978|FG001|Overall Study|Insufficient clinical response|0|||
162224180|NCT01262677|585871979|FG002|Overall Study|Insufficient clinical response|1|||
162224181|NCT01262677|585871977|FG000|Overall Study|Lost to Follow-up|1|||
162224182|NCT01262677|585871978|FG001|Overall Study|Lost to Follow-up|0|||
161939939|NCT01052779|584830671|FG000|Overall Study|Adverse Event|1|||
161939940|NCT01052779|584830672|FG001|Overall Study|Adverse Event|4|||
161939941|NCT01052779|584830671|FG000|Overall Study|Withdrawal by Subject|1|||
161939942|NCT01052779|584830672|FG001|Overall Study|Withdrawal by Subject|2|||
161939943|NCT01052779|584830671|FG000|Overall Study|Other-Protocol Violation|1|||
161939944|NCT01052779|584830672|FG001|Overall Study|Other-Protocol Violation|1|||
161939945|NCT01052779|584830671|FG000|Overall Study|Other-Surgery|0|||
161939946|NCT01052779|584830672|FG001|Overall Study|Other-Surgery|2|||
161939947|NCT01052779|584830671|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
161939948|NCT01052779|584830672|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
162224183|NCT01262677|585871979|FG002|Overall Study|Lost to Follow-up|2|||
162224184|NCT01262677|585871977|FG000|Overall Study|No longer willing to participate|3|||
162224185|NCT01262677|585871978|FG001|Overall Study|No longer willing to participate|3|||
162224186|NCT01262677|585871979|FG002|Overall Study|No longer willing to participate|2|||
162224187|NCT01262677|585871977|FG000|Overall Study|Reason not provided|2|||
162224188|NCT01262677|585871978|FG001|Overall Study|Reason not provided|1|||
162224189|NCT01262677|585871979|FG002|Overall Study|Reason not provided|3|||
162224190|NCT01262677|585871977|FG000|Overall Study|Protocol Violation|0|||
162224191|NCT01262677|585871978|FG001|Overall Study|Protocol Violation|1|||
162224192|NCT01262677|585871979|FG002|Overall Study|Protocol Violation|1|||
162224193|NCT01262677|585871977|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
162224194|NCT01262677|585871978|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
162224195|NCT01262677|585871979|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
162224196|NCT02787044|585871982|FG000|Overall Study|Lost to Follow-up|15|||
162224197|NCT02787044|585871983|FG001|Overall Study|Lost to Follow-up|19|||
162224198|NCT00567567|585871984|FG000|Overall Study|Adverse Event|0|||
162224199|NCT00567567|585871985|FG001|Overall Study|Adverse Event|2|||
162224200|NCT00567567|585871986|FG002|Overall Study|Adverse Event|5|||
162224201|NCT00567567|585871984|FG000|Overall Study|Death|8|||
162224202|NCT00567567|585871985|FG001|Overall Study|Death|1|||
162224203|NCT00567567|585871986|FG002|Overall Study|Death|5|||
162224204|NCT00567567|585871984|FG000|Overall Study|Lack of Efficacy|16|||
162224205|NCT00567567|585871985|FG001|Overall Study|Lack of Efficacy|17|||
162224206|NCT00567567|585871986|FG002|Overall Study|Lack of Efficacy|48|||
162224207|NCT00567567|585871984|FG000|Overall Study|Lost to Follow-up|0|||
162224208|NCT00567567|585871985|FG001|Overall Study|Lost to Follow-up|0|||
162224209|NCT00567567|585871986|FG002|Overall Study|Lost to Follow-up|1|||
162224210|NCT00567567|585871984|FG000|Overall Study|Physician Decision|16|||
162224211|NCT00567567|585871985|FG001|Overall Study|Physician Decision|18|||
162224212|NCT00567567|585871986|FG002|Overall Study|Physician Decision|84|||
162224213|NCT00567567|585871984|FG000|Overall Study|Withdrawal by Subject|0|||
162224214|NCT00567567|585871985|FG001|Overall Study|Withdrawal by Subject|0|||
162224215|NCT00567567|585871986|FG002|Overall Study|Withdrawal by Subject|2|||
162224216|NCT00567567|585871984|FG000|Overall Study|Ineligible|4|||
162224217|NCT00567567|585871985|FG001|Overall Study|Ineligible|0|||
162224218|NCT00567567|585871986|FG002|Overall Study|Ineligible|9|||
162224219|NCT00567567|585871984|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
162224220|NCT00567567|585871985|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
162224221|NCT00567567|585871986|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
162224222|NCT00567567|585871984|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
162224223|NCT00567567|585871985|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
161939949|NCT03580044|584830673|FG000|Overall Study|Death|2|||
161939950|NCT03580044|584830674|FG001|Overall Study|Death|1|||
161939951|NCT03580044|584830673|FG000|Overall Study|Withdrawal by Subject|1|||
161939952|NCT03580044|584830674|FG001|Overall Study|Withdrawal by Subject|1|||
162224224|NCT00567567|585871986|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
162224225|NCT00567567|585871984|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
161939953|NCT03524157|584830675|FG000|Overall Study|cytology not readable|0|||
161939954|NCT03524157|584830676|FG001|Overall Study|cytology not readable|0|||
161939955|NCT03524157|584830677|FG002|Overall Study|cytology not readable|1|||
161939956|NCT02743962|584830678|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
162224226|NCT00567567|585871985|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
162224227|NCT00567567|585871986|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
162224228|NCT03433677|585871987|FG000|Period 1|Protocol Violation|1|||
162224229|NCT03433677|585871988|FG001|Period 1|Protocol Violation|0|||
162224230|NCT03433677|585871987|FG000|Period 2|Withdrawal by Subject|1|||
162224231|NCT03433677|585871988|FG001|Period 2|Withdrawal by Subject|1|||
162224232|NCT03330405|585871989|FG000|Overall Study|Other|1|||
161939957|NCT02743962|584830679|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
162224233|NCT03330405|585871990|FG001|Overall Study|Other|3|||
162224234|NCT03330405|585871991|FG002|Overall Study|Other|1|||
162224235|NCT03330405|585871992|FG003|Overall Study|Other|0|||
162224236|NCT03330405|585871993|FG004|Overall Study|Other|2|||
162224237|NCT03330405|585871994|FG005|Overall Study|Other|0|||
161939958|NCT06582732|584830683|FG000|Initial Study Period|Adverse Event|0|||
161939959|NCT06582732|584830684|FG001|Initial Study Period|Adverse Event|0|||
162224238|NCT03330405|585871995|FG006|Overall Study|Other|1|||
162224239|NCT03330405|585871996|FG007|Overall Study|Other|0|||
162224240|NCT03330405|585871997|FG008|Overall Study|Other|0|||
162224241|NCT03330405|585871998|FG009|Overall Study|Other|0|||
162224242|NCT03330405|585871999|FG010|Overall Study|Other|0|||
162224243|NCT03330405|585871989|FG000|Overall Study|Progressive disease|8|||
162224244|NCT03330405|585871990|FG001|Overall Study|Progressive disease|27|||
162224245|NCT03330405|585871991|FG002|Overall Study|Progressive disease|4|||
162224246|NCT03330405|585871992|FG003|Overall Study|Progressive disease|18|||
162224247|NCT03330405|585871993|FG004|Overall Study|Progressive disease|16|||
162224248|NCT03330405|585871994|FG005|Overall Study|Progressive disease|14|||
162224249|NCT03330405|585871995|FG006|Overall Study|Progressive disease|7|||
162224250|NCT03330405|585871996|FG007|Overall Study|Progressive disease|29|||
162224251|NCT03330405|585871997|FG008|Overall Study|Progressive disease|9|||
162224252|NCT03330405|585871998|FG009|Overall Study|Progressive disease|11|||
162224253|NCT03330405|585871999|FG010|Overall Study|Progressive disease|5|||
161939960|NCT06582732|584830685|FG002|Initial Study Period|Adverse Event|0|||
161939961|NCT06582732|584830686|FG003|Initial Study Period|Adverse Event|2|||
161939962|NCT06582732|584830687|FG004|Initial Study Period|Adverse Event|0|||
161939963|NCT06582732|584830688|FG005|Initial Study Period|Adverse Event|0|||
161939964|NCT06582732|584830689|FG006|Initial Study Period|Adverse Event|0|||
161939965|NCT06582732|584830683|FG000|Initial Study Period|Death|1|||
161939966|NCT06582732|584830684|FG001|Initial Study Period|Death|0|||
161939967|NCT06582732|584830685|FG002|Initial Study Period|Death|0|||
161939968|NCT06582732|584830686|FG003|Initial Study Period|Death|0|||
161939969|NCT06582732|584830687|FG004|Initial Study Period|Death|1|||
161939970|NCT06582732|584830688|FG005|Initial Study Period|Death|0|||
161939971|NCT06582732|584830689|FG006|Initial Study Period|Death|0|||
161939972|NCT06582732|584830683|FG000|Initial Study Period|Lost to Follow-up|0|||
161939973|NCT06582732|584830684|FG001|Initial Study Period|Lost to Follow-up|0|||
161939974|NCT06582732|584830685|FG002|Initial Study Period|Lost to Follow-up|2|||
161939975|NCT06582732|584830686|FG003|Initial Study Period|Lost to Follow-up|0|||
161939976|NCT06582732|584830687|FG004|Initial Study Period|Lost to Follow-up|0|||
161939977|NCT06582732|584830688|FG005|Initial Study Period|Lost to Follow-up|0|||
161939978|NCT06582732|584830689|FG006|Initial Study Period|Lost to Follow-up|0|||
161939979|NCT06582732|584830683|FG000|Initial Study Period|Withdrawal by Subject|0|||
161939980|NCT06582732|584830684|FG001|Initial Study Period|Withdrawal by Subject|1|||
161939981|NCT06582732|584830685|FG002|Initial Study Period|Withdrawal by Subject|0|||
161939982|NCT06582732|584830686|FG003|Initial Study Period|Withdrawal by Subject|1|||
161939983|NCT06582732|584830687|FG004|Initial Study Period|Withdrawal by Subject|3|||
161678742|NCT00574288|583876070|FG005|Overall Study|Death|25|||
161939984|NCT06582732|584830688|FG005|Initial Study Period|Withdrawal by Subject|1|||
161939985|NCT06582732|584830689|FG006|Initial Study Period|Withdrawal by Subject|2|||
161939986|NCT06582732|584830683|FG000|Initial Study Period|Moved Away|0|||
161939987|NCT06582732|584830684|FG001|Initial Study Period|Moved Away|0|||
162224254|NCT03330405|585871989|FG000|Overall Study|Withdrawal by Subject|1|||
162224255|NCT03330405|585871990|FG001|Overall Study|Withdrawal by Subject|4|||
161939988|NCT06582732|584830685|FG002|Initial Study Period|Moved Away|0|||
161939989|NCT06582732|584830686|FG003|Initial Study Period|Moved Away|0|||
161939990|NCT06582732|584830687|FG004|Initial Study Period|Moved Away|1|||
161939991|NCT06582732|584830688|FG005|Initial Study Period|Moved Away|0|||
161939992|NCT06582732|584830689|FG006|Initial Study Period|Moved Away|0|||
161939993|NCT03931330|584830690|FG000|Overall Study|Physician Decision|1|||
161939994|NCT03412929|584830691|FG000|Overall Study|Protocol Violation|3|||
161939995|NCT01381679|584830696|FG000|Overall Study|Adverse Event|3|||
161939996|NCT01381679|584830696|FG000|Overall Study|Lost to Follow-up|885|||
161939997|NCT02919618|584830697|FG000|Overall Study|Death|1|||
161939998|NCT03411044|584830698|FG000|Overall Study|Death|30|||
161939999|NCT03411044|584830698|FG000|Overall Study|Withdrawal by Subject|48|||
161940000|NCT03411044|584830698|FG000|Overall Study|Lost to Follow-up|78|||
161940001|NCT03411044|584830698|FG000|Overall Study|Adverse Event|30|||
161940002|NCT03411044|584830698|FG000|Overall Study|Missing status|4|||
161940003|NCT02135133|584830699|FG000|Overall Study|Adverse Event|10|||
161940004|NCT02135133|584830699|FG000|Overall Study|regulatory mandate|5|||
161940005|NCT02259231|584830700|FG000|Overall Study|Adverse Event|1|||
161940006|NCT02259231|584830701|FG001|Overall Study|Adverse Event|1|||
161940007|NCT02259231|584830702|FG002|Overall Study|Adverse Event|2|||
161940008|NCT02259231|584830703|FG003|Overall Study|Adverse Event|0|||
161940009|NCT02259231|584830704|FG004|Overall Study|Adverse Event|0|||
161940010|NCT02259231|584830705|FG005|Overall Study|Adverse Event|0|||
161940011|NCT02259231|584830706|FG006|Overall Study|Adverse Event|0|||
161940012|NCT02259231|584830700|FG000|Overall Study|Progressive Disease|4|||
161940013|NCT02259231|584830701|FG001|Overall Study|Progressive Disease|5|||
161940014|NCT02259231|584830702|FG002|Overall Study|Progressive Disease|4|||
161940015|NCT02259231|584830703|FG003|Overall Study|Progressive Disease|5|||
161940016|NCT02259231|584830704|FG004|Overall Study|Progressive Disease|4|||
161940017|NCT02259231|584830705|FG005|Overall Study|Progressive Disease|5|||
161940018|NCT02259231|584830706|FG006|Overall Study|Progressive Disease|4|||
161940019|NCT02259231|584830700|FG000|Overall Study|Sponsor termination of study|1|||
161940020|NCT02259231|584830701|FG001|Overall Study|Sponsor termination of study|0|||
162224256|NCT03330405|585871991|FG002|Overall Study|Withdrawal by Subject|0|||
162224257|NCT03330405|585871992|FG003|Overall Study|Withdrawal by Subject|1|||
162224258|NCT03330405|585871993|FG004|Overall Study|Withdrawal by Subject|1|||
162224259|NCT03330405|585871994|FG005|Overall Study|Withdrawal by Subject|1|||
162224260|NCT03330405|585871995|FG006|Overall Study|Withdrawal by Subject|0|||
162224261|NCT03330405|585871996|FG007|Overall Study|Withdrawal by Subject|2|||
161940021|NCT02259231|584830702|FG002|Overall Study|Sponsor termination of study|0|||
161940022|NCT02259231|584830703|FG003|Overall Study|Sponsor termination of study|1|||
161940023|NCT02259231|584830704|FG004|Overall Study|Sponsor termination of study|2|||
161940024|NCT02259231|584830705|FG005|Overall Study|Sponsor termination of study|1|||
161940025|NCT02259231|584830706|FG006|Overall Study|Sponsor termination of study|1|||
161940026|NCT03312543|584830717|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
161940027|NCT03312543|584830718|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
161940028|NCT03312543|584830717|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
161940029|NCT03312543|584830718|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
161940030|NCT03312543|584830717|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
161940031|NCT03312543|584830718|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
161940032|NCT03312543|584830717|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
161940033|NCT03312543|584830718|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
161940034|NCT03312543|584830717|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
161940035|NCT03312543|584830718|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
161940036|NCT03312543|584830717|FG000|Regression (Week 12 to Week 24)|Death|0|||
161940037|NCT03312543|584830718|FG001|Regression (Week 12 to Week 24)|Death|1|||
161940038|NCT04507269|584830719|FG000|Overall Study|Withdrawal by Subject|1|||
161940039|NCT04507269|584830720|FG001|Overall Study|Withdrawal by Subject|1|||
161940040|NCT04507269|584830721|FG002|Overall Study|Withdrawal by Subject|0|||
161940041|NCT04507269|584830722|FG003|Overall Study|Withdrawal by Subject|0|||
161940042|NCT04507269|584830723|FG004|Overall Study|Withdrawal by Subject|0|||
162224262|NCT03330405|585871997|FG008|Overall Study|Withdrawal by Subject|2|||
162224263|NCT03330405|585871998|FG009|Overall Study|Withdrawal by Subject|1|||
162224264|NCT03330405|585871999|FG010|Overall Study|Withdrawal by Subject|1|||
162224265|NCT03330405|585871989|FG000|Overall Study|Global deterioration of health status|2|||
162224266|NCT03330405|585871990|FG001|Overall Study|Global deterioration of health status|3|||
161940043|NCT04507269|584830724|FG005|Overall Study|Withdrawal by Subject|0|||
161940044|NCT04507269|584830719|FG000|Overall Study|Lost to Follow-up|0|||
161940045|NCT04507269|584830720|FG001|Overall Study|Lost to Follow-up|0|||
161940046|NCT04507269|584830721|FG002|Overall Study|Lost to Follow-up|0|||
161940047|NCT04507269|584830722|FG003|Overall Study|Lost to Follow-up|0|||
161940048|NCT04507269|584830723|FG004|Overall Study|Lost to Follow-up|1|||
161940049|NCT04507269|584830724|FG005|Overall Study|Lost to Follow-up|0|||
161940050|NCT05852340|584830725|FG000|Period 5|Not completing the meal|0|||
161940051|NCT05852340|584830726|FG001|Period 5|Not completing the meal|1|||
161940052|NCT05852340|584830727|FG002|Period 5|Not completing the meal|0|||
161940053|NCT05852340|584830728|FG003|Period 5|Not completing the meal|0|||
161940054|NCT05852340|584830725|FG000|Period 5|Adverse Event|0|||
161940055|NCT05852340|584830726|FG001|Period 5|Adverse Event|0|||
161940056|NCT05852340|584830727|FG002|Period 5|Adverse Event|0|||
161940057|NCT05852340|584830728|FG003|Period 5|Adverse Event|1|||
161940058|NCT00071032|584830731|FG000|Overall Study|Lost to Follow-up|1|||
161940059|NCT00071032|584830732|FG001|Overall Study|Lost to Follow-up|1|||
161940060|NCT00071032|584830731|FG000|Overall Study|Withdrawal by Subject|8|||
161940061|NCT00071032|584830732|FG001|Overall Study|Withdrawal by Subject|6|||
161940062|NCT00071032|584830731|FG000|Overall Study|Missing Primary Outcome|0|||
161940063|NCT00071032|584830732|FG001|Overall Study|Missing Primary Outcome|1|||
161940064|NCT04197583|584830733|FG000|Overall Study|Study Stent Replacement|34|||
161940065|NCT04197583|584830734|FG001|Overall Study|Study Stent Replacement|8|||
162023416|NCT02152956|585142693|FG008|Overall Study|Withdrawal by Subject|1|||
162224267|NCT03330405|585871991|FG002|Overall Study|Global deterioration of health status|0|||
162224268|NCT03330405|585871992|FG003|Overall Study|Global deterioration of health status|2|||
162224269|NCT03330405|585871993|FG004|Overall Study|Global deterioration of health status|3|||
162224270|NCT03330405|585871994|FG005|Overall Study|Global deterioration of health status|3|||
162224271|NCT03330405|585871995|FG006|Overall Study|Global deterioration of health status|0|||
162224272|NCT03330405|585871996|FG007|Overall Study|Global deterioration of health status|2|||
162224273|NCT03330405|585871997|FG008|Overall Study|Global deterioration of health status|8|||
162224274|NCT03330405|585871998|FG009|Overall Study|Global deterioration of health status|4|||
162224275|NCT03330405|585871999|FG010|Overall Study|Global deterioration of health status|1|||
162224276|NCT03330405|585871989|FG000|Overall Study|Adverse Event|0|||
162224277|NCT03330405|585871990|FG001|Overall Study|Adverse Event|1|||
162224278|NCT03330405|585871991|FG002|Overall Study|Adverse Event|0|||
162224279|NCT03330405|585871992|FG003|Overall Study|Adverse Event|1|||
162224280|NCT03330405|585871993|FG004|Overall Study|Adverse Event|1|||
162224281|NCT03330405|585871994|FG005|Overall Study|Adverse Event|1|||
162224282|NCT03330405|585871995|FG006|Overall Study|Adverse Event|3|||
162224283|NCT03330405|585871996|FG007|Overall Study|Adverse Event|4|||
162224284|NCT03330405|585871997|FG008|Overall Study|Adverse Event|2|||
162224285|NCT03330405|585871998|FG009|Overall Study|Adverse Event|2|||
162224286|NCT03330405|585871999|FG010|Overall Study|Adverse Event|2|||
162224287|NCT03330405|585871989|FG000|Overall Study|Death|0|||
162224288|NCT03330405|585871990|FG001|Overall Study|Death|4|||
162224289|NCT03330405|585871991|FG002|Overall Study|Death|0|||
162224290|NCT03330405|585871992|FG003|Overall Study|Death|0|||
162224291|NCT03330405|585871993|FG004|Overall Study|Death|0|||
162224292|NCT03330405|585871994|FG005|Overall Study|Death|1|||
162224293|NCT03330405|585871995|FG006|Overall Study|Death|0|||
162224294|NCT03330405|585871996|FG007|Overall Study|Death|2|||
162224295|NCT03330405|585871997|FG008|Overall Study|Death|0|||
162224296|NCT03330405|585871998|FG009|Overall Study|Death|0|||
162224297|NCT03330405|585871999|FG010|Overall Study|Death|0|||
162224298|NCT03330405|585871989|FG000|Overall Study|Physician Decision|0|||
162224299|NCT03330405|585871990|FG001|Overall Study|Physician Decision|0|||
162224300|NCT03330405|585871991|FG002|Overall Study|Physician Decision|0|||
162224301|NCT03330405|585871992|FG003|Overall Study|Physician Decision|0|||
162224302|NCT03330405|585871993|FG004|Overall Study|Physician Decision|0|||
162224303|NCT03330405|585871994|FG005|Overall Study|Physician Decision|0|||
162224304|NCT03330405|585871995|FG006|Overall Study|Physician Decision|0|||
162224305|NCT03330405|585871996|FG007|Overall Study|Physician Decision|1|||
162224306|NCT03330405|585871997|FG008|Overall Study|Physician Decision|0|||
162224307|NCT03330405|585871998|FG009|Overall Study|Physician Decision|0|||
162224308|NCT03330405|585871999|FG010|Overall Study|Physician Decision|0|||
162224309|NCT03889704|585872001|FG000|Overall Study|Study terminated due to pandemic|1|||
162224310|NCT04552899|585872004|FG000|Overall Study|Adverse Event|4|||
162224311|NCT04552899|585872005|FG001|Overall Study|Adverse Event|3|||
162224312|NCT04552899|585872004|FG000|Overall Study|Death|4|||
162224313|NCT04552899|585872005|FG001|Overall Study|Death|4|||
162224314|NCT04552899|585872004|FG000|Overall Study|Lost to Follow-up|8|||
162224315|NCT04552899|585872005|FG001|Overall Study|Lost to Follow-up|13|||
162224316|NCT04552899|585872004|FG000|Overall Study|Lung Transplant|4|||
162224317|NCT04552899|585872005|FG001|Overall Study|Lung Transplant|3|||
162224318|NCT04552899|585872004|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
162224319|NCT04552899|585872005|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
162224320|NCT04552899|585872004|FG000|Overall Study|Physician Decision|3|||
162224321|NCT04552899|585872005|FG001|Overall Study|Physician Decision|4|||
162224322|NCT04552899|585872004|FG000|Overall Study|Study Terminated By Sponsor|237|||
162023417|NCT02152956|585142694|FG009|Overall Study|Withdrawal by Subject|0|||
162224323|NCT04552899|585872005|FG001|Overall Study|Study Terminated By Sponsor|239|||
162224324|NCT04552899|585872004|FG000|Overall Study|Withdrawal by Subject|15|||
162224325|NCT04552899|585872005|FG001|Overall Study|Withdrawal by Subject|17|||
162224326|NCT02672852|585872010|FG000|Part A1|Disease Worsening|1|||
162224327|NCT02672852|585872011|FG001|Part A1|Disease Worsening|0|||
161678743|NCT00574288|583876071|FG006|Overall Study|Death|21|||
161940066|NCT04197583|584830733|FG000|Overall Study|Lost to Follow-up|14|||
161940067|NCT04197583|584830734|FG001|Overall Study|Lost to Follow-up|3|||
162224328|NCT02672852|585872012|FG002|Part A1|Disease Worsening|0|||
162224329|NCT02672852|585872013|FG003|Part A1|Disease Worsening|0|||
162224330|NCT02672852|585872014|FG004|Part A1|Disease Worsening|0|||
162224331|NCT02672852|585872015|FG005|Part A1|Disease Worsening|0|||
162224332|NCT02672852|585872016|FG006|Part A1|Disease Worsening|0|||
162224333|NCT02672852|585872010|FG000|Part A1|Adverse Event|0|||
162224334|NCT02672852|585872011|FG001|Part A1|Adverse Event|1|||
162224335|NCT02672852|585872012|FG002|Part A1|Adverse Event|0|||
162224336|NCT02672852|585872013|FG003|Part A1|Adverse Event|0|||
162224337|NCT02672852|585872014|FG004|Part A1|Adverse Event|0|||
162224338|NCT02672852|585872015|FG005|Part A1|Adverse Event|0|||
162224339|NCT02672852|585872016|FG006|Part A1|Adverse Event|0|||
162224340|NCT02672852|585872010|FG000|Part A1|Lost to Follow-up|1|||
162224341|NCT02672852|585872011|FG001|Part A1|Lost to Follow-up|2|||
162224342|NCT02672852|585872012|FG002|Part A1|Lost to Follow-up|0|||
162224343|NCT02672852|585872013|FG003|Part A1|Lost to Follow-up|0|||
162224344|NCT02672852|585872014|FG004|Part A1|Lost to Follow-up|0|||
162224345|NCT02672852|585872015|FG005|Part A1|Lost to Follow-up|0|||
162224346|NCT02672852|585872016|FG006|Part A1|Lost to Follow-up|0|||
162224347|NCT02672852|585872010|FG000|Part A1|Withdrawal by Subject|1|||
162224348|NCT02672852|585872011|FG001|Part A1|Withdrawal by Subject|1|||
162224349|NCT02672852|585872012|FG002|Part A1|Withdrawal by Subject|0|||
162224350|NCT02672852|585872013|FG003|Part A1|Withdrawal by Subject|0|||
162224351|NCT02672852|585872014|FG004|Part A1|Withdrawal by Subject|0|||
162224352|NCT02672852|585872015|FG005|Part A1|Withdrawal by Subject|0|||
162224353|NCT02672852|585872016|FG006|Part A1|Withdrawal by Subject|0|||
162224354|NCT02672852|585872010|FG000|Part A2|Disease worsening|0|||
162224355|NCT02672852|585872011|FG001|Part A2|Disease worsening|0|||
162224356|NCT02672852|585872012|FG002|Part A2|Disease worsening|1|||
162224357|NCT02672852|585872013|FG003|Part A2|Disease worsening|0|||
162224358|NCT02672852|585872014|FG004|Part A2|Disease worsening|0|||
162224359|NCT02672852|585872015|FG005|Part A2|Disease worsening|0|||
162224360|NCT02672852|585872016|FG006|Part A2|Disease worsening|0|||
162224361|NCT02672852|585872010|FG000|Part A2|Adverse Event|0|||
162224362|NCT02672852|585872011|FG001|Part A2|Adverse Event|0|||
162224363|NCT02672852|585872012|FG002|Part A2|Adverse Event|3|||
162224364|NCT02672852|585872013|FG003|Part A2|Adverse Event|0|||
162224365|NCT02672852|585872014|FG004|Part A2|Adverse Event|0|||
162224366|NCT02672852|585872015|FG005|Part A2|Adverse Event|0|||
162224367|NCT02672852|585872016|FG006|Part A2|Adverse Event|0|||
162224368|NCT02672852|585872010|FG000|Part A2|Lost to Follow-up|0|||
162224369|NCT02672852|585872011|FG001|Part A2|Lost to Follow-up|0|||
162224370|NCT02672852|585872012|FG002|Part A2|Lost to Follow-up|2|||
162224371|NCT02672852|585872013|FG003|Part A2|Lost to Follow-up|0|||
162224372|NCT02672852|585872014|FG004|Part A2|Lost to Follow-up|0|||
162224373|NCT02672852|585872015|FG005|Part A2|Lost to Follow-up|0|||
162224374|NCT02672852|585872016|FG006|Part A2|Lost to Follow-up|0|||
162224375|NCT02672852|585872010|FG000|Part A2|Withdrawal by Subject|0|||
162224376|NCT02672852|585872011|FG001|Part A2|Withdrawal by Subject|0|||
162224377|NCT02672852|585872012|FG002|Part A2|Withdrawal by Subject|1|||
162224378|NCT02672852|585872013|FG003|Part A2|Withdrawal by Subject|0|||
162224379|NCT02672852|585872014|FG004|Part A2|Withdrawal by Subject|0|||
162224380|NCT02672852|585872015|FG005|Part A2|Withdrawal by Subject|0|||
162224381|NCT02672852|585872016|FG006|Part A2|Withdrawal by Subject|0|||
162224382|NCT02672852|585872010|FG000|Part A2|Other|0|||
162224383|NCT02672852|585872011|FG001|Part A2|Other|0|||
162224384|NCT02672852|585872012|FG002|Part A2|Other|3|||
162224385|NCT02672852|585872013|FG003|Part A2|Other|0|||
162224386|NCT02672852|585872014|FG004|Part A2|Other|0|||
162224387|NCT02672852|585872015|FG005|Part A2|Other|0|||
162224388|NCT02672852|585872016|FG006|Part A2|Other|0|||
162224389|NCT02672852|585872010|FG000|Part A2|Not entered in Part B|0|||
162224390|NCT02672852|585872011|FG001|Part A2|Not entered in Part B|0|||
162224391|NCT02672852|585872012|FG002|Part A2|Not entered in Part B|0|||
162224392|NCT02672852|585872013|FG003|Part A2|Not entered in Part B|4|||
162224393|NCT02672852|585872014|FG004|Part A2|Not entered in Part B|0|||
162224394|NCT02672852|585872015|FG005|Part A2|Not entered in Part B|0|||
162224395|NCT02672852|585872016|FG006|Part A2|Not entered in Part B|0|||
162224396|NCT02672852|585872010|FG000|Part B|Disease worsening|0|||
162224397|NCT02672852|585872011|FG001|Part B|Disease worsening|0|||
162224398|NCT02672852|585872012|FG002|Part B|Disease worsening|0|||
162224399|NCT02672852|585872013|FG003|Part B|Disease worsening|0|||
162224400|NCT02672852|585872014|FG004|Part B|Disease worsening|1|||
162224401|NCT02672852|585872015|FG005|Part B|Disease worsening|0|||
162224402|NCT02672852|585872016|FG006|Part B|Disease worsening|1|||
162224403|NCT02672852|585872010|FG000|Part B|Worsening pre-existing condition|0|||
162224404|NCT02672852|585872011|FG001|Part B|Worsening pre-existing condition|0|||
162224405|NCT02672852|585872012|FG002|Part B|Worsening pre-existing condition|0|||
162224406|NCT02672852|585872013|FG003|Part B|Worsening pre-existing condition|0|||
162224407|NCT02672852|585872014|FG004|Part B|Worsening pre-existing condition|0|||
162224408|NCT02672852|585872015|FG005|Part B|Worsening pre-existing condition|1|||
162224409|NCT02672852|585872016|FG006|Part B|Worsening pre-existing condition|0|||
162224410|NCT02672852|585872010|FG000|Part B|Other adverse event|0|||
162224411|NCT02672852|585872011|FG001|Part B|Other adverse event|0|||
162224412|NCT02672852|585872012|FG002|Part B|Other adverse event|0|||
162224413|NCT02672852|585872013|FG003|Part B|Other adverse event|0|||
162224414|NCT02672852|585872014|FG004|Part B|Other adverse event|3|||
162224415|NCT02672852|585872015|FG005|Part B|Other adverse event|5|||
162224416|NCT02672852|585872016|FG006|Part B|Other adverse event|1|||
162224417|NCT02672852|585872010|FG000|Part B|Lost to Follow-up|0|||
162224418|NCT02672852|585872011|FG001|Part B|Lost to Follow-up|0|||
162224419|NCT02672852|585872012|FG002|Part B|Lost to Follow-up|0|||
162224420|NCT02672852|585872013|FG003|Part B|Lost to Follow-up|0|||
162224421|NCT02672852|585872014|FG004|Part B|Lost to Follow-up|3|||
162224422|NCT02672852|585872015|FG005|Part B|Lost to Follow-up|4|||
162224423|NCT02672852|585872016|FG006|Part B|Lost to Follow-up|1|||
162224424|NCT02672852|585872010|FG000|Part B|Withdrawal by Subject|0|||
162224425|NCT02672852|585872011|FG001|Part B|Withdrawal by Subject|0|||
162224426|NCT02672852|585872012|FG002|Part B|Withdrawal by Subject|0|||
162224427|NCT02672852|585872013|FG003|Part B|Withdrawal by Subject|0|||
162224428|NCT02672852|585872014|FG004|Part B|Withdrawal by Subject|5|||
162224429|NCT02672852|585872015|FG005|Part B|Withdrawal by Subject|0|||
162224430|NCT02672852|585872016|FG006|Part B|Withdrawal by Subject|7|||
162224431|NCT02672852|585872010|FG000|Part B|Other|0|||
162224432|NCT02672852|585872011|FG001|Part B|Other|0|||
162224433|NCT02672852|585872012|FG002|Part B|Other|0|||
162224434|NCT02672852|585872013|FG003|Part B|Other|0|||
162224435|NCT02672852|585872014|FG004|Part B|Other|4|||
162224436|NCT02672852|585872015|FG005|Part B|Other|1|||
162224437|NCT02672852|585872016|FG006|Part B|Other|2|||
162224438|NCT01353859|585872017|FG000|Overall Study|Adverse Event|3|||
162224439|NCT01353859|585872017|FG000|Overall Study|Lack of Efficacy|1|||
162224440|NCT01725126|585872020|FG000|Overall Study|Protocol Violation|0|||
162224441|NCT01725126|585872021|FG001|Overall Study|Protocol Violation|1|||
162224442|NCT01725126|585872022|FG002|Overall Study|Protocol Violation|0|||
162224443|NCT01725126|585872023|FG003|Overall Study|Protocol Violation|0|||
162224444|NCT01725126|585872024|FG004|Overall Study|Protocol Violation|0|||
162224445|NCT01725126|585872025|FG005|Overall Study|Protocol Violation|0|||
162224446|NCT01725126|585872020|FG000|Overall Study|Withdrawal by Subject|0|||
162224447|NCT01725126|585872021|FG001|Overall Study|Withdrawal by Subject|0|||
162224448|NCT01725126|585872022|FG002|Overall Study|Withdrawal by Subject|0|||
162224449|NCT01725126|585872023|FG003|Overall Study|Withdrawal by Subject|1|||
162224450|NCT01725126|585872024|FG004|Overall Study|Withdrawal by Subject|0|||
162224451|NCT01725126|585872025|FG005|Overall Study|Withdrawal by Subject|0|||
162224452|NCT00208325|585872026|FG000|Overall Study|Death|18|||
162224453|NCT00208325|585872027|FG001|Overall Study|Death|19|||
162224454|NCT00208325|585872028|FG002|Overall Study|Death|7|||
162224455|NCT00208325|585872029|FG003|Overall Study|Death|5|||
161678744|NCT00574288|583876065|FG000|Overall Study|Lost to Follow-up|0|||
161678745|NCT00574288|583876066|FG001|Overall Study|Lost to Follow-up|0|||
162224456|NCT00208325|585872026|FG000|Overall Study|Withdrawal by Subject|0|||
162224457|NCT00208325|585872027|FG001|Overall Study|Withdrawal by Subject|1|||
162224458|NCT00208325|585872028|FG002|Overall Study|Withdrawal by Subject|0|||
161678746|NCT00574288|583876067|FG002|Overall Study|Lost to Follow-up|0|||
162224459|NCT00208325|585872029|FG003|Overall Study|Withdrawal by Subject|0|||
162224460|NCT00208325|585872026|FG000|Overall Study|Revision|4|||
162224461|NCT00208325|585872027|FG001|Overall Study|Revision|1|||
162224462|NCT00208325|585872028|FG002|Overall Study|Revision|0|||
162224463|NCT00208325|585872029|FG003|Overall Study|Revision|4|||
162224464|NCT00208325|585872026|FG000|Overall Study|Lost to Follow-up|1|||
162224465|NCT00208325|585872027|FG001|Overall Study|Lost to Follow-up|0|||
162224466|NCT00208325|585872028|FG002|Overall Study|Lost to Follow-up|2|||
162224467|NCT00208325|585872029|FG003|Overall Study|Lost to Follow-up|0|||
162224468|NCT00208325|585872026|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
162224469|NCT00208325|585872027|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
162224470|NCT00208325|585872028|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
162224471|NCT00208325|585872029|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
162224472|NCT00208325|585872026|FG000|Overall Study|Does not wish to Continue in Study|5|||
162224473|NCT00208325|585872027|FG001|Overall Study|Does not wish to Continue in Study|8|||
162224474|NCT00208325|585872028|FG002|Overall Study|Does not wish to Continue in Study|3|||
162224475|NCT00208325|585872029|FG003|Overall Study|Does not wish to Continue in Study|2|||
162224476|NCT00208325|585872026|FG000|Overall Study|Other|2|||
162224477|NCT00208325|585872027|FG001|Overall Study|Other|1|||
162224478|NCT00208325|585872028|FG002|Overall Study|Other|1|||
162224479|NCT00208325|585872029|FG003|Overall Study|Other|0|||
162224480|NCT00208325|585872026|FG000|Overall Study|Mis-Randomized|17|||
162224481|NCT00208325|585872027|FG001|Overall Study|Mis-Randomized|20|||
162224482|NCT00208325|585872028|FG002|Overall Study|Mis-Randomized|0|||
162224483|NCT00208325|585872029|FG003|Overall Study|Mis-Randomized|0|||
162224484|NCT01254747|585872030|FG000|Overall Study|Unacceptable subjective vision|0|||
162224485|NCT01254747|585872031|FG001|Overall Study|Unacceptable subjective vision|0|||
162224486|NCT01254747|585872032|FG002|Overall Study|Unacceptable subjective vision|0|||
162224487|NCT01254747|585872033|FG003|Overall Study|Unacceptable subjective vision|2|||
162224488|NCT01254747|585872030|FG000|Overall Study|Difficult removal handling|0|||
162224489|NCT01254747|585872031|FG001|Overall Study|Difficult removal handling|0|||
162224490|NCT01254747|585872032|FG002|Overall Study|Difficult removal handling|1|||
162224491|NCT01254747|585872033|FG003|Overall Study|Difficult removal handling|0|||
162224492|NCT01254747|585872030|FG000|Overall Study|Symptoms and problems|0|||
162224493|NCT01254747|585872031|FG001|Overall Study|Symptoms and problems|2|||
162224494|NCT01254747|585872032|FG002|Overall Study|Symptoms and problems|1|||
162224495|NCT01254747|585872033|FG003|Overall Study|Symptoms and problems|0|||
162224496|NCT01254747|585872030|FG000|Overall Study|Lost to Follow-up|0|||
162224497|NCT01254747|585872031|FG001|Overall Study|Lost to Follow-up|0|||
162224498|NCT01254747|585872032|FG002|Overall Study|Lost to Follow-up|1|||
162224499|NCT01254747|585872033|FG003|Overall Study|Lost to Follow-up|0|||
162224500|NCT01254747|585872030|FG000|Overall Study|Biomicroscopy|0|||
162224501|NCT01254747|585872031|FG001|Overall Study|Biomicroscopy|0|||
162224502|NCT01254747|585872032|FG002|Overall Study|Biomicroscopy|1|||
162224503|NCT01254747|585872033|FG003|Overall Study|Biomicroscopy|0|||
162224504|NCT01254747|585872030|FG000|Overall Study|Discomfort|0|||
162224505|NCT01254747|585872031|FG001|Overall Study|Discomfort|4|||
162224506|NCT01254747|585872032|FG002|Overall Study|Discomfort|0|||
162224507|NCT01254747|585872033|FG003|Overall Study|Discomfort|0|||
162224508|NCT02406677|585872034|FG000|Overall Study|Death|16|||
162224509|NCT02406677|585872035|FG001|Overall Study|Death|8|||
162224510|NCT02406677|585872034|FG000|Overall Study|Discharged without P2Y12|1|||
162224511|NCT02406677|585872035|FG001|Overall Study|Discharged without P2Y12|3|||
162224512|NCT02406677|585872034|FG000|Overall Study|Discharged on prasugrel|283|||
162224513|NCT02406677|585872035|FG001|Overall Study|Discharged on prasugrel|587|||
162224514|NCT02406677|585872034|FG000|Overall Study|Withdrawal by Subject|1|||
162224515|NCT02406677|585872035|FG001|Overall Study|Withdrawal by Subject|0|||
162224516|NCT04531098|585872040|FG000|Stage I|Adverse Event|0|||
162224517|NCT04531098|585872041|FG001|Stage I|Adverse Event|0|||
162224518|NCT04531098|585872042|FG002|Stage I|Adverse Event|3|||
162224519|NCT04531098|585872040|FG000|Stage I|Protocol Violation|0|||
162224520|NCT04531098|585872041|FG001|Stage I|Protocol Violation|0|||
162224521|NCT04531098|585872042|FG002|Stage I|Protocol Violation|5|||
162224522|NCT04531098|585872040|FG000|Stage I|Withdrawal by Subject|0|||
162224523|NCT04531098|585872041|FG001|Stage I|Withdrawal by Subject|5|||
162224524|NCT04531098|585872042|FG002|Stage I|Withdrawal by Subject|10|||
162224525|NCT04531098|585872040|FG000|Stage II|Adverse Event|1|||
162224526|NCT04531098|585872041|FG001|Stage II|Adverse Event|2|||
162224527|NCT04531098|585872042|FG002|Stage II|Adverse Event|0|||
162224528|NCT04531098|585872040|FG000|Stage II|Protocol Violation|1|||
162224529|NCT04531098|585872041|FG001|Stage II|Protocol Violation|2|||
162224530|NCT04531098|585872042|FG002|Stage II|Protocol Violation|0|||
162224531|NCT04531098|585872040|FG000|Stage II|Withdrawal by Subject|3|||
162224532|NCT04531098|585872041|FG001|Stage II|Withdrawal by Subject|1|||
162224533|NCT04531098|585872042|FG002|Stage II|Withdrawal by Subject|0|||
162224534|NCT04531098|585872040|FG000|Stage II|Moved from study area|8|||
162224535|NCT04531098|585872041|FG001|Stage II|Moved from study area|5|||
162224536|NCT04531098|585872042|FG002|Stage II|Moved from study area|0|||
162224537|NCT02145468|585872043|FG000|Overall Study|Withdrawal by Subject|5|||
162224538|NCT02145468|585872044|FG001|Overall Study|Withdrawal by Subject|8|||
162224539|NCT01803282|585872048|FG000|Overall Study|Progressive Disease|4|||
162224540|NCT01803282|585872049|FG001|Overall Study|Progressive Disease|3|||
162224541|NCT01803282|585872050|FG002|Overall Study|Progressive Disease|6|||
162224542|NCT01803282|585872051|FG003|Overall Study|Progressive Disease|22|||
162224543|NCT01803282|585872052|FG004|Overall Study|Progressive Disease|5|||
162224544|NCT01803282|585872053|FG005|Overall Study|Progressive Disease|8|||
162224545|NCT01803282|585872054|FG006|Overall Study|Progressive Disease|23|||
162224546|NCT01803282|585872055|FG007|Overall Study|Progressive Disease|24|||
162224547|NCT01803282|585872056|FG008|Overall Study|Progressive Disease|3|||
162224548|NCT01803282|585872057|FG009|Overall Study|Progressive Disease|29|||
162224549|NCT01803282|585872058|FG010|Overall Study|Progressive Disease|6|||
162023418|NCT02152956|585142695|FG010|Overall Study|Withdrawal by Subject|0|||
162224550|NCT01803282|585872059|FG011|Overall Study|Progressive Disease|11|||
162224551|NCT01803282|585872048|FG000|Overall Study|Death|0|||
162224552|NCT01803282|585872049|FG001|Overall Study|Death|0|||
162224553|NCT01803282|585872050|FG002|Overall Study|Death|0|||
162224554|NCT01803282|585872051|FG003|Overall Study|Death|0|||
162224555|NCT01803282|585872052|FG004|Overall Study|Death|2|||
162224556|NCT01803282|585872053|FG005|Overall Study|Death|1|||
162224557|NCT01803282|585872054|FG006|Overall Study|Death|1|||
162023419|NCT02152956|585142696|FG011|Overall Study|Withdrawal by Subject|4|||
162224558|NCT01803282|585872055|FG007|Overall Study|Death|5|||
162224559|NCT01803282|585872056|FG008|Overall Study|Death|1|||
162224560|NCT01803282|585872057|FG009|Overall Study|Death|1|||
162224561|NCT01803282|585872058|FG010|Overall Study|Death|0|||
162224562|NCT01803282|585872059|FG011|Overall Study|Death|0|||
162224563|NCT01803282|585872048|FG000|Overall Study|Withdrew Consent|0|||
162224564|NCT01803282|585872049|FG001|Overall Study|Withdrew Consent|0|||
162224565|NCT01803282|585872050|FG002|Overall Study|Withdrew Consent|0|||
161678747|NCT00574288|583876068|FG003|Overall Study|Lost to Follow-up|0|||
162224566|NCT01803282|585872051|FG003|Overall Study|Withdrew Consent|6|||
162224567|NCT01803282|585872052|FG004|Overall Study|Withdrew Consent|1|||
162224568|NCT01803282|585872053|FG005|Overall Study|Withdrew Consent|0|||
162224569|NCT01803282|585872054|FG006|Overall Study|Withdrew Consent|8|||
162224570|NCT01803282|585872055|FG007|Overall Study|Withdrew Consent|3|||
162224571|NCT01803282|585872056|FG008|Overall Study|Withdrew Consent|1|||
162224572|NCT01803282|585872057|FG009|Overall Study|Withdrew Consent|5|||
162224573|NCT01803282|585872058|FG010|Overall Study|Withdrew Consent|0|||
162224574|NCT01803282|585872059|FG011|Overall Study|Withdrew Consent|1|||
162224575|NCT01803282|585872048|FG000|Overall Study|Investigator's Discretion|0|||
162224576|NCT01803282|585872049|FG001|Overall Study|Investigator's Discretion|0|||
162224577|NCT01803282|585872050|FG002|Overall Study|Investigator's Discretion|0|||
162224578|NCT01803282|585872051|FG003|Overall Study|Investigator's Discretion|7|||
162224579|NCT01803282|585872052|FG004|Overall Study|Investigator's Discretion|2|||
162224580|NCT01803282|585872053|FG005|Overall Study|Investigator's Discretion|1|||
162224581|NCT01803282|585872054|FG006|Overall Study|Investigator's Discretion|7|||
162224582|NCT01803282|585872055|FG007|Overall Study|Investigator's Discretion|10|||
162224583|NCT01803282|585872056|FG008|Overall Study|Investigator's Discretion|6|||
162224584|NCT01803282|585872057|FG009|Overall Study|Investigator's Discretion|7|||
162224585|NCT01803282|585872058|FG010|Overall Study|Investigator's Discretion|1|||
162224586|NCT01803282|585872059|FG011|Overall Study|Investigator's Discretion|0|||
162224587|NCT01803282|585872048|FG000|Overall Study|Adverse Event|0|||
162224588|NCT01803282|585872049|FG001|Overall Study|Adverse Event|0|||
162224589|NCT01803282|585872050|FG002|Overall Study|Adverse Event|0|||
162224590|NCT01803282|585872051|FG003|Overall Study|Adverse Event|0|||
162224591|NCT01803282|585872052|FG004|Overall Study|Adverse Event|0|||
162224592|NCT01803282|585872053|FG005|Overall Study|Adverse Event|0|||
162224593|NCT01803282|585872054|FG006|Overall Study|Adverse Event|1|||
162224594|NCT01803282|585872055|FG007|Overall Study|Adverse Event|2|||
162224595|NCT01803282|585872056|FG008|Overall Study|Adverse Event|0|||
162224596|NCT01803282|585872057|FG009|Overall Study|Adverse Event|1|||
162224597|NCT01803282|585872058|FG010|Overall Study|Adverse Event|0|||
162224598|NCT01803282|585872059|FG011|Overall Study|Adverse Event|3|||
162224599|NCT01803282|585872048|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162224600|NCT01803282|585872049|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162224601|NCT01803282|585872050|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162224602|NCT01803282|585872051|FG003|Overall Study|Non-Compliance with Study Drug|1|||
162224603|NCT01803282|585872052|FG004|Overall Study|Non-Compliance with Study Drug|0|||
162224604|NCT01803282|585872053|FG005|Overall Study|Non-Compliance with Study Drug|0|||
162224605|NCT01803282|585872054|FG006|Overall Study|Non-Compliance with Study Drug|0|||
162224606|NCT01803282|585872055|FG007|Overall Study|Non-Compliance with Study Drug|0|||
162224607|NCT01803282|585872056|FG008|Overall Study|Non-Compliance with Study Drug|0|||
162224608|NCT01803282|585872057|FG009|Overall Study|Non-Compliance with Study Drug|0|||
162224609|NCT01803282|585872058|FG010|Overall Study|Non-Compliance with Study Drug|0|||
162224610|NCT01803282|585872059|FG011|Overall Study|Non-Compliance with Study Drug|0|||
162224611|NCT01803282|585872048|FG000|Overall Study|Unknown Reason|0|||
162224612|NCT01803282|585872049|FG001|Overall Study|Unknown Reason|0|||
162224613|NCT01803282|585872050|FG002|Overall Study|Unknown Reason|0|||
162224614|NCT01803282|585872051|FG003|Overall Study|Unknown Reason|0|||
162224615|NCT01803282|585872052|FG004|Overall Study|Unknown Reason|0|||
162224616|NCT01803282|585872053|FG005|Overall Study|Unknown Reason|0|||
162224617|NCT01803282|585872054|FG006|Overall Study|Unknown Reason|0|||
162224618|NCT01803282|585872055|FG007|Overall Study|Unknown Reason|1|||
162224619|NCT01803282|585872056|FG008|Overall Study|Unknown Reason|0|||
162224620|NCT01803282|585872057|FG009|Overall Study|Unknown Reason|0|||
162224621|NCT01803282|585872058|FG010|Overall Study|Unknown Reason|0|||
162224622|NCT01803282|585872059|FG011|Overall Study|Unknown Reason|0|||
162224623|NCT01803282|585872048|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
162224624|NCT01803282|585872049|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
162224625|NCT01803282|585872050|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
162224626|NCT01803282|585872051|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
162224627|NCT01803282|585872052|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
162224628|NCT01803282|585872053|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
162224629|NCT01803282|585872054|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
162224630|NCT01803282|585872055|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
162224631|NCT01803282|585872056|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
162224632|NCT01803282|585872057|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
162224633|NCT01803282|585872058|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
162224634|NCT01803282|585872059|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
162224635|NCT01803282|585872048|FG000|Overall Study|Enrolled but Never Treated|0|||
162224636|NCT01803282|585872049|FG001|Overall Study|Enrolled but Never Treated|0|||
162224637|NCT01803282|585872050|FG002|Overall Study|Enrolled but Never Treated|0|||
162224638|NCT01803282|585872051|FG003|Overall Study|Enrolled but Never Treated|0|||
162224639|NCT01803282|585872052|FG004|Overall Study|Enrolled but Never Treated|1|||
162224640|NCT01803282|585872053|FG005|Overall Study|Enrolled but Never Treated|0|||
162224641|NCT01803282|585872054|FG006|Overall Study|Enrolled but Never Treated|1|||
162224642|NCT01803282|585872055|FG007|Overall Study|Enrolled but Never Treated|1|||
162224643|NCT01803282|585872056|FG008|Overall Study|Enrolled but Never Treated|0|||
162224644|NCT01803282|585872057|FG009|Overall Study|Enrolled but Never Treated|1|||
162224645|NCT01803282|585872058|FG010|Overall Study|Enrolled but Never Treated|0|||
162224646|NCT01803282|585872059|FG011|Overall Study|Enrolled but Never Treated|0|||
162224647|NCT05543707|585872068|FG000|Overall Study|Study drug non-compliance/|5|||
162224648|NCT05543707|585872069|FG001|Overall Study|Study drug non-compliance/|0|||
162224649|NCT05543707|585872068|FG000|Overall Study|Withdrawal by Subject|1|||
162224650|NCT05543707|585872069|FG001|Overall Study|Withdrawal by Subject|1|||
162224651|NCT05543707|585872068|FG000|Overall Study|Adverse Event|1|||
162224652|NCT05543707|585872069|FG001|Overall Study|Adverse Event|0|||
162224653|NCT05543707|585872068|FG000|Overall Study|concurrent illness|0|||
162224654|NCT05543707|585872069|FG001|Overall Study|concurrent illness|1|||
162224655|NCT05543707|585872068|FG000|Overall Study|Pregnancy|1|||
162224656|NCT05543707|585872069|FG001|Overall Study|Pregnancy|1|||
162224657|NCT05511038|585872070|FG000|Overall|Withdrawal by Subject|5|||
162224658|NCT05511038|585872071|FG001|Overall|Withdrawal by Subject|3|||
162224659|NCT05511038|585872070|FG000|Overall|Screen Failure|20|||
162224660|NCT05511038|585872071|FG001|Overall|Screen Failure|1|||
162224661|NCT05511038|585872070|FG000|Overall|Physician Decision|3|||
162224662|NCT05511038|585872071|FG001|Overall|Physician Decision|0|||
162224663|NCT05511038|585872070|FG000|Overall|Lost to Follow-up|3|||
162224664|NCT05511038|585872071|FG001|Overall|Lost to Follow-up|0|||
162224665|NCT05511038|585872070|FG000|Overall|Death|1|||
162224666|NCT05511038|585872071|FG001|Overall|Death|0|||
162224667|NCT05511038|585872070|FG000|Screening|Withdrawal by Subject|1|||
162224668|NCT05511038|585872071|FG001|Screening|Withdrawal by Subject|0|||
162224669|NCT05511038|585872070|FG000|Screening|Lost to Follow Up (1 participant)|1|||
162224670|NCT05511038|585872071|FG001|Screening|Lost to Follow Up (1 participant)|0|||
162224671|NCT05511038|585872070|FG000|Screening|Screen Failure|3|||
162224672|NCT05511038|585872071|FG001|Screening|Screen Failure|0|||
162224673|NCT05511038|585872070|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
162224674|NCT05511038|585872071|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
162224675|NCT05511038|585872070|FG000|Treatment|Withdrawal by Subject|5|||
162224676|NCT05511038|585872071|FG001|Treatment|Withdrawal by Subject|3|||
162224677|NCT05511038|585872070|FG000|Treatment|Physician Decision|4|||
162224678|NCT05511038|585872071|FG001|Treatment|Physician Decision|0|||
162224679|NCT05511038|585872070|FG000|Treatment|Lost to Follow-up|2|||
162224680|NCT05511038|585872071|FG001|Treatment|Lost to Follow-up|0|||
162224681|NCT05511038|585872070|FG000|Treatment|Death|1|||
162224682|NCT05511038|585872071|FG001|Treatment|Death|0|||
162224683|NCT05511038|585872070|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
162224684|NCT05511038|585872071|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
162224685|NCT05511038|585872070|FG000|Treatment|Refuse by subject|1|||
162224686|NCT05511038|585872071|FG001|Treatment|Refuse by subject|0|||
162224687|NCT05511038|585872070|FG000|Treatment|Subject did not go to the site for visit|1|||
162224688|NCT05511038|585872071|FG001|Treatment|Subject did not go to the site for visit|0|||
162224689|NCT02108964|585872072|FG000|Overall Study|Progressive disease|15|||
162224690|NCT02108964|585872073|FG001|Overall Study|Progressive disease|31|||
162224691|NCT02108964|585872074|FG002|Overall Study|Progressive disease|54|||
162224692|NCT02108964|585872075|FG003|Overall Study|Progressive disease|7|||
162224693|NCT02108964|585872076|FG004|Overall Study|Progressive disease|20|||
162224694|NCT02108964|585872077|FG005|Overall Study|Progressive disease|4|||
162224695|NCT02108964|585872078|FG006|Overall Study|Progressive disease|6|||
162224696|NCT02108964|585872079|FG007|Overall Study|Progressive disease|33|||
162224697|NCT02108964|585872072|FG000|Overall Study|Physician Decision|1|||
162224698|NCT02108964|585872073|FG001|Overall Study|Physician Decision|5|||
162224699|NCT02108964|585872074|FG002|Overall Study|Physician Decision|7|||
162224700|NCT02108964|585872075|FG003|Overall Study|Physician Decision|1|||
162224701|NCT02108964|585872076|FG004|Overall Study|Physician Decision|2|||
162224702|NCT02108964|585872077|FG005|Overall Study|Physician Decision|1|||
162224703|NCT02108964|585872078|FG006|Overall Study|Physician Decision|1|||
162224704|NCT02108964|585872079|FG007|Overall Study|Physician Decision|3|||
162224705|NCT02108964|585872072|FG000|Overall Study|Adverse Event|0|||
162224706|NCT02108964|585872073|FG001|Overall Study|Adverse Event|0|||
162224707|NCT02108964|585872074|FG002|Overall Study|Adverse Event|4|||
162224708|NCT02108964|585872075|FG003|Overall Study|Adverse Event|0|||
162224709|NCT02108964|585872076|FG004|Overall Study|Adverse Event|1|||
162224710|NCT02108964|585872077|FG005|Overall Study|Adverse Event|0|||
162224711|NCT02108964|585872078|FG006|Overall Study|Adverse Event|3|||
162224712|NCT02108964|585872079|FG007|Overall Study|Adverse Event|2|||
162224713|NCT02108964|585872072|FG000|Overall Study|Death|1|||
162224714|NCT02108964|585872073|FG001|Overall Study|Death|1|||
162224715|NCT02108964|585872074|FG002|Overall Study|Death|4|||
162224716|NCT02108964|585872075|FG003|Overall Study|Death|0|||
162224717|NCT02108964|585872076|FG004|Overall Study|Death|3|||
162224718|NCT02108964|585872077|FG005|Overall Study|Death|0|||
162224719|NCT02108964|585872078|FG006|Overall Study|Death|0|||
162224720|NCT02108964|585872079|FG007|Overall Study|Death|2|||
162224721|NCT02108964|585872072|FG000|Overall Study|Subject/Guardian decision|0|||
162224722|NCT02108964|585872073|FG001|Overall Study|Subject/Guardian decision|1|||
162224723|NCT02108964|585872074|FG002|Overall Study|Subject/Guardian decision|4|||
162224724|NCT02108964|585872075|FG003|Overall Study|Subject/Guardian decision|0|||
162224725|NCT02108964|585872076|FG004|Overall Study|Subject/Guardian decision|2|||
162224726|NCT02108964|585872077|FG005|Overall Study|Subject/Guardian decision|0|||
162224727|NCT02108964|585872078|FG006|Overall Study|Subject/Guardian decision|1|||
162224728|NCT02108964|585872079|FG007|Overall Study|Subject/Guardian decision|2|||
162224729|NCT02108964|585872072|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162224730|NCT02108964|585872073|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162224731|NCT02108964|585872074|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162224732|NCT02108964|585872075|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162224733|NCT02108964|585872076|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162224734|NCT02108964|585872077|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162224735|NCT02108964|585872078|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
162224736|NCT02108964|585872079|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
162224737|NCT00798434|585872082|FG000|Double-Blind|Adverse Event|22|||
162224738|NCT00798434|585872083|FG001|Double-Blind|Adverse Event|46|||
162224739|NCT00798434|585872082|FG000|Double-Blind|Death|0|||
162224740|NCT00798434|585872083|FG001|Double-Blind|Death|1|||
162224741|NCT00798434|585872082|FG000|Double-Blind|Lost to Follow-up|1|||
162224742|NCT00798434|585872083|FG001|Double-Blind|Lost to Follow-up|0|||
162224743|NCT00798434|585872082|FG000|Double-Blind|Lack of Efficacy|8|||
162224744|NCT00798434|585872083|FG001|Double-Blind|Lack of Efficacy|12|||
162224745|NCT00798434|585872082|FG000|Double-Blind|Withdrawal by Subject|17|||
162224746|NCT00798434|585872083|FG001|Double-Blind|Withdrawal by Subject|14|||
162224747|NCT00798434|585872082|FG000|Double-Blind|Protocol Violation|1|||
162224748|NCT00798434|585872083|FG001|Double-Blind|Protocol Violation|4|||
162224749|NCT00798434|585872082|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
162224750|NCT00798434|585872083|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
162224751|NCT00798434|585872082|FG000|Double-Blind|Other|1|||
162224752|NCT00798434|585872083|FG001|Double-Blind|Other|0|||
162224753|NCT00798434|585872082|FG000|Double-Blind|Not Treated|3|||
162224754|NCT00798434|585872083|FG001|Double-Blind|Not Treated|6|||
162224755|NCT00798434|585872082|FG000|Open-Label|Adverse Event|33|||
162224756|NCT00798434|585872083|FG001|Open-Label|Adverse Event|11|||
162224757|NCT00798434|585872082|FG000|Open-Label|Lack of Efficacy|5|||
162224758|NCT00798434|585872083|FG001|Open-Label|Lack of Efficacy|11|||
162224759|NCT00798434|585872082|FG000|Open-Label|Withdrawal by Subject|2|||
162224760|NCT00798434|585872083|FG001|Open-Label|Withdrawal by Subject|7|||
162224761|NCT00798434|585872082|FG000|Open-Label|Protocol Violation|1|||
162224762|NCT00798434|585872083|FG001|Open-Label|Protocol Violation|0|||
162224763|NCT00798434|585872082|FG000|Open-Label|Other|1|||
162224764|NCT00798434|585872083|FG001|Open-Label|Other|2|||
162224765|NCT00798434|585872082|FG000|Open-Label|Not Treated|0|||
162224766|NCT00798434|585872083|FG001|Open-Label|Not Treated|1|||
162224767|NCT01217437|585872087|FG000|Overall Study|Adverse Event|0|||
162224768|NCT01217437|585872088|FG001|Overall Study|Adverse Event|8|||
162224769|NCT01217437|585872087|FG000|Overall Study|Death|5|||
162224770|NCT01217437|585872088|FG001|Overall Study|Death|0|||
162224771|NCT01217437|585872087|FG000|Overall Study|Lack of Efficacy|29|||
162224772|NCT01217437|585872088|FG001|Overall Study|Lack of Efficacy|25|||
162224773|NCT01217437|585872087|FG000|Overall Study|Physician Decision|8|||
162224774|NCT01217437|585872088|FG001|Overall Study|Physician Decision|5|||
162224775|NCT01217437|585872087|FG000|Overall Study|Withdrawal by Subject|0|||
162224776|NCT01217437|585872088|FG001|Overall Study|Withdrawal by Subject|2|||
162224777|NCT01217437|585872087|FG000|Overall Study|Ineligible|1|||
162224778|NCT01217437|585872088|FG001|Overall Study|Ineligible|1|||
162224779|NCT04908631|585872089|FG000|Overall Study|Lost to Follow-up|1|||
162224780|NCT04908631|585872089|FG000|Overall Study|Physician Decision|1|||
162224781|NCT04908631|585872089|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
162224782|NCT03578887|585872094|FG000|Overall Study|Withdrawal by Subject|7|||
162224783|NCT03578887|585872095|FG001|Overall Study|Withdrawal by Subject|2|||
162224784|NCT03578887|585872096|FG002|Overall Study|Withdrawal by Subject|1|||
162224785|NCT03578887|585872094|FG000|Overall Study|Lost to Follow-up|13|||
162224786|NCT03578887|585872095|FG001|Overall Study|Lost to Follow-up|1|||
162224787|NCT03578887|585872096|FG002|Overall Study|Lost to Follow-up|4|||
162224788|NCT03578887|585872094|FG000|Overall Study|Physician Decision|0|||
162224789|NCT03578887|585872095|FG001|Overall Study|Physician Decision|1|||
162224790|NCT03578887|585872096|FG002|Overall Study|Physician Decision|1|||
162224791|NCT00095498|585873724|FG000|Overall Study|Physician Decision|9|||
161829379|NCT00255151|584415756|FG000|Overall Study|Esophageal Stricture|0|||
161829380|NCT00255151|584415757|FG001|Overall Study|Esophageal Stricture|0|||
161829381|NCT00255151|584415758|FG002|Overall Study|Esophageal Stricture|1|||
162224792|NCT00095498|585873725|FG001|Overall Study|Physician Decision|10|||
162224793|NCT00095498|585873726|FG002|Overall Study|Physician Decision|8|||
162224794|NCT00095498|585873724|FG000|Overall Study|Adverse Event|1|||
162224795|NCT00095498|585873725|FG001|Overall Study|Adverse Event|0|||
162224796|NCT00095498|585873726|FG002|Overall Study|Adverse Event|1|||
162224797|NCT00095498|585873724|FG000|Overall Study|Withdrawal by Subject|15|||
162224798|NCT00095498|585873725|FG001|Overall Study|Withdrawal by Subject|16|||
162224799|NCT00095498|585873726|FG002|Overall Study|Withdrawal by Subject|15|||
162224800|NCT00095498|585873724|FG000|Overall Study|Disease progression|0|||
162224801|NCT00095498|585873725|FG001|Overall Study|Disease progression|1|||
162224802|NCT00095498|585873726|FG002|Overall Study|Disease progression|1|||
162224803|NCT00095498|585873724|FG000|Overall Study|Ineligibility determined|3|||
162224804|NCT00095498|585873725|FG001|Overall Study|Ineligibility determined|0|||
162224805|NCT00095498|585873726|FG002|Overall Study|Ineligibility determined|2|||
162224806|NCT00095498|585873724|FG000|Overall Study|Lost to Follow-up|1|||
162224807|NCT00095498|585873725|FG001|Overall Study|Lost to Follow-up|1|||
162224808|NCT00095498|585873726|FG002|Overall Study|Lost to Follow-up|2|||
162224809|NCT00095498|585873724|FG000|Overall Study|Noncompliance|1|||
162224810|NCT00095498|585873725|FG001|Overall Study|Noncompliance|0|||
162224811|NCT00095498|585873726|FG002|Overall Study|Noncompliance|1|||
162224812|NCT00095498|585873724|FG000|Overall Study|Other|6|||
162224813|NCT00095498|585873725|FG001|Overall Study|Other|7|||
162224814|NCT00095498|585873726|FG002|Overall Study|Other|6|||
162224815|NCT00095498|585873724|FG000|Overall Study|Protocol Violation|0|||
162224816|NCT00095498|585873725|FG001|Overall Study|Protocol Violation|0|||
162224817|NCT00095498|585873726|FG002|Overall Study|Protocol Violation|1|||
162224818|NCT00095498|585873724|FG000|Overall Study|Requirement for alternative therapy|1|||
162224819|NCT00095498|585873725|FG001|Overall Study|Requirement for alternative therapy|0|||
162224820|NCT00095498|585873726|FG002|Overall Study|Requirement for alternative therapy|2|||
162224821|NCT05020327|585873728|FG000|Overall Study|Physician Decision|3|||
162224822|NCT05020327|585873729|FG001|Overall Study|Physician Decision|0|||
162224823|NCT05020327|585873730|FG002|Overall Study|Physician Decision|0|||
162224824|NCT05020327|585873728|FG000|Overall Study|Withdrawal by Subject|1|||
162224825|NCT05020327|585873729|FG001|Overall Study|Withdrawal by Subject|1|||
162224826|NCT05020327|585873730|FG002|Overall Study|Withdrawal by Subject|0|||
162224827|NCT05020327|585873728|FG000|Overall Study|personal/cultural, ineligible|12|||
162224828|NCT05020327|585873729|FG001|Overall Study|personal/cultural, ineligible|0|||
162224829|NCT05020327|585873730|FG002|Overall Study|personal/cultural, ineligible|0|||
162224830|NCT03002220|585873732|FG000|Overall Study|Lack of Efficacy|2|||
162224831|NCT03002220|585873732|FG000|Overall Study|Withdrawal by Subject|3|||
162224832|NCT03002220|585873732|FG000|Overall Study|Adverse Event|2|||
162224833|NCT03002220|585873732|FG000|Overall Study|Disease progression|13|||
162224834|NCT03002220|585873732|FG000|Overall Study|Physician Decision|1|||
162224835|NCT01015560|585873735|FG000|Overall Study|Adverse Event|1|||
162224836|NCT01015560|585873735|FG000|Overall Study|Not protocol specified|1|||
162224837|NCT01015560|585873735|FG000|Overall Study|Withdrawal by Subject|1|||
162224838|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
162224839|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
162224840|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
162224841|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
162224842|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
162224843|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
162224844|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
162224845|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
162224846|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
162224847|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
162224848|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
162224849|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
162224850|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Death|1|||
162224851|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Death|2|||
162224852|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Death|2|||
162224853|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Death|0|||
162224854|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Death|0|||
162224855|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Death|0|||
161829382|NCT00255151|584415756|FG000|Overall Study|Therapeutic Failure|11|||
162224856|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
162224857|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
162224858|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
162224859|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
162224860|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
162224861|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
162224862|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
162224863|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
162224864|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
162224865|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
162224866|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
162224867|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
162224868|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
162224869|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
162224870|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
162224871|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
162224872|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
162224873|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
162224874|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
162224875|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
162224876|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
162224877|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
162224878|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
162224879|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
162224880|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
162224881|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
162224882|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
162224883|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
162224884|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
162224885|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
162224886|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
162224887|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
162224888|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
162224889|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
162224890|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
162224891|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
162224892|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
162224893|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
162224894|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
162224895|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
162224896|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
162224897|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
162224898|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Site closure|0|||
162224899|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Site closure|0|||
162224900|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Site closure|1|||
162224901|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Site closure|0|||
162224902|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Site closure|0|||
162224903|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Site closure|0|||
162224904|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
162224905|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
162224906|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
162224907|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
162224908|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
162224909|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
162224910|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
162224911|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
162224912|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
162224913|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
162224914|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
161829383|NCT00255151|584415757|FG001|Overall Study|Therapeutic Failure|2|||
162224915|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
162224916|NCT03439254|585873736|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
162224917|NCT03439254|585873737|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
162224918|NCT03439254|585873738|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
162224919|NCT03439254|585873739|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
162224920|NCT03439254|585873740|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
162224921|NCT03439254|585873741|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
162224922|NCT03439254|585873736|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
162224923|NCT03439254|585873737|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
162224924|NCT03439254|585873738|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
162224925|NCT03439254|585873739|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
162224926|NCT03439254|585873740|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
162224927|NCT03439254|585873741|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
162224928|NCT03439254|585873736|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
162224929|NCT03439254|585873737|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
162224930|NCT03439254|585873738|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
162224931|NCT03439254|585873739|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
162224932|NCT03439254|585873740|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
162224933|NCT03439254|585873741|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
162224934|NCT03439254|585873736|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
162224935|NCT03439254|585873737|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
162224936|NCT03439254|585873738|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
162224937|NCT03439254|585873739|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
162224938|NCT03439254|585873740|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
162224939|NCT03439254|585873741|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
162224940|NCT03439254|585873736|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
162224941|NCT03439254|585873737|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
162224942|NCT03439254|585873738|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
162224943|NCT03439254|585873739|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
162224944|NCT03439254|585873740|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
162224945|NCT03439254|585873741|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
162224946|NCT03439254|585873736|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
162224947|NCT03439254|585873737|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
162224948|NCT03439254|585873738|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
162224949|NCT03439254|585873739|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
162224950|NCT03439254|585873740|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
162224951|NCT03439254|585873741|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
162224952|NCT03439254|585873736|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
162224953|NCT03439254|585873737|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
162224954|NCT03439254|585873738|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
162224955|NCT03439254|585873739|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
162224956|NCT03439254|585873740|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
162224957|NCT03439254|585873741|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
162224958|NCT03439254|585873736|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
162224959|NCT03439254|585873737|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
162224960|NCT03439254|585873738|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
162224961|NCT03439254|585873739|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
161678748|NCT00574288|583876069|FG004|Overall Study|Lost to Follow-up|0|||
161829384|NCT00255151|584415758|FG002|Overall Study|Therapeutic Failure|3|||
161829385|NCT00792623|584415759|FG000|Overall Study|Adverse Event|2|||
161829386|NCT00792623|584415759|FG000|Overall Study|Withdrawal by Subject|5|||
161829387|NCT00880087|584415768|FG000|Overall Study|Lost to Follow-up|0|||
161829388|NCT00880087|584415769|FG001|Overall Study|Lost to Follow-up|2|||
161829389|NCT00743509|584415770|FG000|Overall Study|Withdrawal by Subject|2|||
161829390|NCT00892281|584415775|FG000|Overall Study|Adverse Event|65|||
162224962|NCT03439254|585873740|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
162224963|NCT03439254|585873741|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
162224964|NCT03439254|585873736|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
162224965|NCT03439254|585873737|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
162224966|NCT03439254|585873738|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
162224967|NCT03439254|585873739|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
162224968|NCT03439254|585873740|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
162224969|NCT03439254|585873741|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
162224970|NCT03439254|585873736|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
162224971|NCT03439254|585873737|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
162224972|NCT03439254|585873738|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
162224973|NCT03439254|585873739|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
162224974|NCT03439254|585873740|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
162224975|NCT03439254|585873741|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
162224976|NCT00128102|585873744|FG000|Overall Study|Site Discontinued|3|||
162224977|NCT00128102|585873745|FG001|Overall Study|Site Discontinued|6|||
162224978|NCT00128102|585873744|FG000|Overall Study|Other|0|||
162224979|NCT00128102|585873745|FG001|Overall Study|Other|1|||
162224980|NCT00128102|585873744|FG000|Overall Study|Progressive Disease|255|||
162224981|NCT00128102|585873745|FG001|Overall Study|Progressive Disease|285|||
162224982|NCT00128102|585873744|FG000|Overall Study|Adverse Event|34|||
162224983|NCT00128102|585873745|FG001|Overall Study|Adverse Event|11|||
162224984|NCT00128102|585873744|FG000|Overall Study|Death|12|||
162224985|NCT00128102|585873745|FG001|Overall Study|Death|13|||
162224986|NCT00128102|585873744|FG000|Overall Study|Physician Decision|3|||
162224987|NCT00128102|585873745|FG001|Overall Study|Physician Decision|3|||
162224988|NCT00128102|585873744|FG000|Overall Study|Withdrawal by Subject|19|||
162224989|NCT00128102|585873745|FG001|Overall Study|Withdrawal by Subject|11|||
162224990|NCT00128102|585873744|FG000|Overall Study|Protocol Violation|2|||
162224991|NCT00128102|585873745|FG001|Overall Study|Protocol Violation|2|||
162224992|NCT00568178|585873746|FG000|Double Blind Base Study|Adverse Event|0|||
162224993|NCT00568178|585873747|FG001|Double Blind Base Study|Adverse Event|2|||
162224994|NCT00568178|585873748|FG002|Double Blind Base Study|Adverse Event|1|||
162224995|NCT00568178|585873749|FG003|Double Blind Base Study|Adverse Event|2|||
162224996|NCT00568178|585873750|FG004|Double Blind Base Study|Adverse Event|0|||
162224997|NCT00568178|585873751|FG005|Double Blind Base Study|Adverse Event|0|||
162224998|NCT00568178|585873746|FG000|Double Blind Base Study|Lost to Follow-up|1|||
162224999|NCT00568178|585873747|FG001|Double Blind Base Study|Lost to Follow-up|0|||
162225000|NCT00568178|585873748|FG002|Double Blind Base Study|Lost to Follow-up|0|||
162225001|NCT00568178|585873749|FG003|Double Blind Base Study|Lost to Follow-up|1|||
162225002|NCT00568178|585873750|FG004|Double Blind Base Study|Lost to Follow-up|0|||
162225003|NCT00568178|585873751|FG005|Double Blind Base Study|Lost to Follow-up|0|||
162225004|NCT00568178|585873746|FG000|Double Blind Base Study|Physician Decision|1|||
162225005|NCT00568178|585873747|FG001|Double Blind Base Study|Physician Decision|1|||
162225006|NCT00568178|585873748|FG002|Double Blind Base Study|Physician Decision|0|||
162225007|NCT00568178|585873749|FG003|Double Blind Base Study|Physician Decision|1|||
162225008|NCT00568178|585873750|FG004|Double Blind Base Study|Physician Decision|0|||
162225009|NCT00568178|585873751|FG005|Double Blind Base Study|Physician Decision|0|||
162225010|NCT00568178|585873746|FG000|Double Blind Base Study|Protocol Violation|3|||
162225011|NCT00568178|585873747|FG001|Double Blind Base Study|Protocol Violation|2|||
162225012|NCT00568178|585873748|FG002|Double Blind Base Study|Protocol Violation|0|||
162225013|NCT00568178|585873749|FG003|Double Blind Base Study|Protocol Violation|0|||
162225014|NCT00568178|585873750|FG004|Double Blind Base Study|Protocol Violation|0|||
162225015|NCT00568178|585873751|FG005|Double Blind Base Study|Protocol Violation|0|||
162225016|NCT00568178|585873746|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
162225017|NCT00568178|585873747|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
162225018|NCT00568178|585873748|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
162225019|NCT00568178|585873749|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
162225020|NCT00568178|585873750|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
162225021|NCT00568178|585873751|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
162225022|NCT00568178|585873746|FG000|Double Blind Base Study|Progressive Disease|0|||
162225023|NCT00568178|585873747|FG001|Double Blind Base Study|Progressive Disease|0|||
162225024|NCT00568178|585873748|FG002|Double Blind Base Study|Progressive Disease|0|||
162225025|NCT00568178|585873749|FG003|Double Blind Base Study|Progressive Disease|1|||
162225026|NCT00568178|585873750|FG004|Double Blind Base Study|Progressive Disease|0|||
162225027|NCT00568178|585873751|FG005|Double Blind Base Study|Progressive Disease|0|||
162225028|NCT00568178|585873746|FG000|Open Label Extension|Adverse Event|0|||
162225029|NCT00568178|585873747|FG001|Open Label Extension|Adverse Event|0|||
162225030|NCT00568178|585873748|FG002|Open Label Extension|Adverse Event|0|||
162225031|NCT00568178|585873749|FG003|Open Label Extension|Adverse Event|0|||
162225032|NCT00568178|585873750|FG004|Open Label Extension|Adverse Event|11|||
162225033|NCT00568178|585873751|FG005|Open Label Extension|Adverse Event|8|||
162225034|NCT00568178|585873746|FG000|Open Label Extension|Protocol Violation|0|||
162225035|NCT00568178|585873747|FG001|Open Label Extension|Protocol Violation|0|||
162225036|NCT00568178|585873748|FG002|Open Label Extension|Protocol Violation|0|||
162225037|NCT00568178|585873749|FG003|Open Label Extension|Protocol Violation|0|||
162225038|NCT00568178|585873750|FG004|Open Label Extension|Protocol Violation|1|||
162225039|NCT00568178|585873751|FG005|Open Label Extension|Protocol Violation|0|||
162225040|NCT00568178|585873746|FG000|Open Label Extension|Lost to Follow-up|0|||
162225041|NCT00568178|585873747|FG001|Open Label Extension|Lost to Follow-up|0|||
162225042|NCT00568178|585873748|FG002|Open Label Extension|Lost to Follow-up|0|||
162225043|NCT00568178|585873749|FG003|Open Label Extension|Lost to Follow-up|0|||
162225044|NCT00568178|585873750|FG004|Open Label Extension|Lost to Follow-up|6|||
162225045|NCT00568178|585873751|FG005|Open Label Extension|Lost to Follow-up|11|||
162225046|NCT00568178|585873746|FG000|Open Label Extension|Physician Decision|0|||
162225047|NCT00568178|585873747|FG001|Open Label Extension|Physician Decision|0|||
162225048|NCT00568178|585873748|FG002|Open Label Extension|Physician Decision|0|||
162225049|NCT00568178|585873749|FG003|Open Label Extension|Physician Decision|0|||
162225050|NCT00568178|585873750|FG004|Open Label Extension|Physician Decision|9|||
162225051|NCT00568178|585873751|FG005|Open Label Extension|Physician Decision|8|||
162225052|NCT00568178|585873746|FG000|Open Label Extension|Pregnancy|0|||
162225053|NCT00568178|585873747|FG001|Open Label Extension|Pregnancy|0|||
162225054|NCT00568178|585873748|FG002|Open Label Extension|Pregnancy|0|||
162225055|NCT00568178|585873749|FG003|Open Label Extension|Pregnancy|0|||
162225056|NCT00568178|585873750|FG004|Open Label Extension|Pregnancy|0|||
162225057|NCT00568178|585873751|FG005|Open Label Extension|Pregnancy|1|||
162225058|NCT00568178|585873746|FG000|Open Label Extension|Progressive Disease|0|||
162225059|NCT00568178|585873747|FG001|Open Label Extension|Progressive Disease|0|||
162225060|NCT00568178|585873748|FG002|Open Label Extension|Progressive Disease|0|||
162225061|NCT00568178|585873749|FG003|Open Label Extension|Progressive Disease|0|||
162225062|NCT00568178|585873750|FG004|Open Label Extension|Progressive Disease|3|||
162225063|NCT00568178|585873751|FG005|Open Label Extension|Progressive Disease|1|||
162225064|NCT00568178|585873746|FG000|Open Label Extension|Termination of Trial|0|||
162225065|NCT00568178|585873747|FG001|Open Label Extension|Termination of Trial|0|||
162225066|NCT00568178|585873748|FG002|Open Label Extension|Termination of Trial|0|||
162225067|NCT00568178|585873749|FG003|Open Label Extension|Termination of Trial|0|||
162225068|NCT00568178|585873750|FG004|Open Label Extension|Termination of Trial|45|||
162225069|NCT00568178|585873751|FG005|Open Label Extension|Termination of Trial|47|||
162225070|NCT00568178|585873746|FG000|Open Label Extension|Withdrawal by Subject|0|||
162225071|NCT00568178|585873747|FG001|Open Label Extension|Withdrawal by Subject|0|||
162225072|NCT00568178|585873748|FG002|Open Label Extension|Withdrawal by Subject|0|||
162225073|NCT00568178|585873749|FG003|Open Label Extension|Withdrawal by Subject|0|||
162225074|NCT00568178|585873750|FG004|Open Label Extension|Withdrawal by Subject|4|||
162225075|NCT00568178|585873751|FG005|Open Label Extension|Withdrawal by Subject|4|||
162225076|NCT01332630|585873752|FG000|Overall Study|Withdrawal by Subject|3|||
162225077|NCT04476251|585873755|FG000|Overall Study|Not treated|1|||
162225078|NCT01008553|585873756|FG000|Period 1 (Titration Period)|Physician Decision|2|||
162225079|NCT01008553|585873757|FG001|Period 1 (Titration Period)|Physician Decision|0|||
162225080|NCT01008553|585873758|FG002|Period 1 (Titration Period)|Physician Decision|0|||
162225081|NCT01008553|585873756|FG000|Period 1 (Titration Period)|Adverse Event|33|||
162225082|NCT01008553|585873757|FG001|Period 1 (Titration Period)|Adverse Event|0|||
162225083|NCT01008553|585873758|FG002|Period 1 (Titration Period)|Adverse Event|0|||
162225084|NCT01008553|585873756|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
162225085|NCT01008553|585873757|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
162225086|NCT01008553|585873758|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
162225087|NCT01008553|585873756|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
162225088|NCT01008553|585873757|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
162225089|NCT01008553|585873758|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
162225090|NCT01008553|585873756|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
162225091|NCT01008553|585873757|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
162225092|NCT01008553|585873758|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
162225093|NCT01008553|585873756|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
162225094|NCT01008553|585873757|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
162225095|NCT01008553|585873758|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
162225096|NCT01008553|585873756|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
162225097|NCT01008553|585873757|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
162225098|NCT01008553|585873758|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
162225099|NCT01008553|585873756|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
162225100|NCT01008553|585873757|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
162225101|NCT01008553|585873758|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
162225102|NCT01008553|585873756|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
162225103|NCT01008553|585873757|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
162225104|NCT01008553|585873758|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
162225105|NCT01008553|585873756|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
162225106|NCT01008553|585873757|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
162225107|NCT01008553|585873758|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
162225108|NCT01008553|585873756|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
162225109|NCT01008553|585873757|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
162225110|NCT01008553|585873758|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
162225111|NCT01008553|585873756|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
162225112|NCT01008553|585873757|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
162225113|NCT01008553|585873758|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
162225114|NCT01008553|585873756|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
162225115|NCT01008553|585873757|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
162225116|NCT01008553|585873758|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
162225117|NCT01008553|585873756|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
162225118|NCT01008553|585873757|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
162225119|NCT01008553|585873758|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
162225120|NCT00574873|585873761|FG000|Overall Study|Withdrawal by Subject|18|||
162225121|NCT00574873|585873762|FG001|Overall Study|Withdrawal by Subject|19|||
162225122|NCT00574873|585873761|FG000|Overall Study|Investigator request|18|||
162225123|NCT00574873|585873762|FG001|Overall Study|Investigator request|8|||
162225124|NCT00574873|585873761|FG000|Overall Study|Death|15|||
162225125|NCT00574873|585873762|FG001|Overall Study|Death|14|||
162225126|NCT00574873|585873761|FG000|Overall Study|Lost to Follow-up|14|||
162225127|NCT00574873|585873762|FG001|Overall Study|Lost to Follow-up|5|||
162225128|NCT00574873|585873761|FG000|Overall Study|Other|40|||
162225129|NCT00574873|585873762|FG001|Overall Study|Other|4|||
162225130|NCT00574873|585873761|FG000|Overall Study|Discontinuation of study by sponsor|5|||
162225131|NCT00574873|585873762|FG001|Overall Study|Discontinuation of study by sponsor|199|||
162225132|NCT00574873|585873761|FG000|Overall Study|Blank, site closed per local regulations|2|||
162225133|NCT00574873|585873762|FG001|Overall Study|Blank, site closed per local regulations|2|||
162225134|NCT00574873|585873761|FG000|Overall Study|Extension Study|126|||
162225135|NCT00574873|585873762|FG001|Overall Study|Extension Study|0|||
162225136|NCT00581555|585873763|FG000|Overall Study|Adverse Event|4|||
162225137|NCT00581555|585873764|FG001|Overall Study|Adverse Event|3|||
162225138|NCT00581555|585873763|FG000|Overall Study|Physician Decision|3|||
162225139|NCT00581555|585873764|FG001|Overall Study|Physician Decision|2|||
162225140|NCT00581555|585873763|FG000|Overall Study|Withdrawal by Subject|18|||
162225141|NCT00581555|585873764|FG001|Overall Study|Withdrawal by Subject|9|||
162225142|NCT00581555|585873763|FG000|Overall Study|Lost to Follow-up|2|||
162225143|NCT00581555|585873764|FG001|Overall Study|Lost to Follow-up|2|||
162225144|NCT00581555|585873763|FG000|Overall Study|Other reasons|16|||
162225145|NCT00581555|585873764|FG001|Overall Study|Other reasons|4|||
162225146|NCT01638429|585873765|FG000|Overall Study|Withdrawal by Subject|1|||
162225147|NCT02040584|585873766|FG000|Overall Study|Adverse Event|13|||
162225148|NCT02040584|585873767|FG001|Overall Study|Adverse Event|6|||
162225149|NCT02040584|585873766|FG000|Overall Study|Protocol Violation|9|||
162225150|NCT02040584|585873767|FG001|Overall Study|Protocol Violation|11|||
162225151|NCT02040584|585873766|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162225152|NCT02040584|585873767|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162225153|NCT02040584|585873766|FG000|Overall Study|Death|6|||
162225154|NCT02040584|585873767|FG001|Overall Study|Death|3|||
162225155|NCT02040584|585873766|FG000|Overall Study|Transplant rejection/retransplant|0|||
162225156|NCT02040584|585873767|FG001|Overall Study|Transplant rejection/retransplant|1|||
162225157|NCT02040584|585873766|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
162225158|NCT02040584|585873767|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
162225159|NCT02591953|585873768|FG000|Overall Study|Lost to Follow-up|6|||
162225160|NCT02591953|585873769|FG001|Overall Study|Lost to Follow-up|6|||
162225161|NCT02060370|585873770|FG000|Overall Study|Physician Decision|1|||
162225162|NCT00731133|585873771|FG000|Overall Study|Withdrawal by Subject|10|||
162225163|NCT00943852|585873772|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162225164|NCT00943852|585873773|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162225165|NCT00943852|585873774|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162225166|NCT00943852|585873775|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
162225167|NCT00943852|585873776|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162225168|NCT00943852|585873777|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162225169|NCT00943852|585873778|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162225170|NCT00943852|585873779|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162225171|NCT00943852|585873780|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162225172|NCT00943852|585873781|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
162225173|NCT00943852|585873772|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162225174|NCT00943852|585873773|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162225175|NCT00943852|585873774|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162225176|NCT00943852|585873775|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162225177|NCT00943852|585873776|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162225178|NCT00943852|585873777|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
162225179|NCT00943852|585873778|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162225180|NCT00943852|585873779|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162225181|NCT00943852|585873780|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162225182|NCT00943852|585873781|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
162225183|NCT00943852|585873772|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162225184|NCT00943852|585873773|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162225185|NCT00943852|585873774|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162225186|NCT00943852|585873775|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162225187|NCT00943852|585873776|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162225188|NCT00943852|585873777|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162225189|NCT00943852|585873778|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
162225190|NCT00943852|585873779|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162225191|NCT00943852|585873780|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162225192|NCT00943852|585873781|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
162225193|NCT00943852|585873772|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162225194|NCT00943852|585873773|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162225195|NCT00943852|585873774|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162225196|NCT00943852|585873775|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162225197|NCT00943852|585873776|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162225198|NCT00943852|585873777|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162225199|NCT00943852|585873778|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162225200|NCT00943852|585873779|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
162225201|NCT00943852|585873780|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162225202|NCT00943852|585873781|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
162225203|NCT00943852|585873772|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
162225204|NCT00943852|585873773|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
162225205|NCT00943852|585873774|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
162225206|NCT00943852|585873775|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
162225207|NCT00943852|585873776|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
162225208|NCT00943852|585873777|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
162225209|NCT00943852|585873778|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
162225210|NCT00943852|585873779|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
162225211|NCT00943852|585873780|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
162225212|NCT00943852|585873781|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
162225213|NCT02530970|585873801|FG000|Overall Study|Adverse Event|8|||
162225214|NCT02530970|585873801|FG000|Overall Study|Lost to Follow-up|88|||
162225215|NCT02530970|585873801|FG000|Overall Study|Physician Decision|5|||
162225216|NCT02530970|585873801|FG000|Overall Study|Withdrawal by Subject|14|||
162225217|NCT02530970|585873801|FG000|Overall Study|Death|6|||
162225218|NCT02530970|585873801|FG000|Overall Study|Hospitalization|1|||
162225219|NCT02530970|585873801|FG000|Overall Study|Insurance|2|||
162225220|NCT02530970|585873801|FG000|Overall Study|Explant|2|||
162225221|NCT02530970|585873801|FG000|Overall Study|Change in Provider|5|||
162225222|NCT02530970|585873801|FG000|Overall Study|Relocation|3|||
162225223|NCT02636725|585873805|FG000|Overall Study|Adverse Event|1|||
162225224|NCT00743431|585873814|FG000|Overall Study|Toxicity|6|||
162225225|NCT00743431|585873814|FG000|Overall Study|Tumor progression|56|||
162225226|NCT00743431|585873814|FG000|Overall Study|Withdrawal by Subject|13|||
162225227|NCT00743431|585873814|FG000|Overall Study|Death|9|||
162225228|NCT00743431|585873814|FG000|Overall Study|Reason for discontinuation not specified|29|||
162225229|NCT00743431|585873814|FG000|Overall Study|No documentation available|13|||
162225230|NCT03291288|585873815|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
162225231|NCT03291288|585873816|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
162225232|NCT03291288|585873815|FG000|Drug-drug Interaction Phase|Disease progression|1|||
162225233|NCT03291288|585873816|FG001|Drug-drug Interaction Phase|Disease progression|0|||
161940068|NCT04197583|584830733|FG000|Overall Study|Death|3|||
161940069|NCT04197583|584830734|FG001|Overall Study|Death|0|||
161940070|NCT04197583|584830733|FG000|Overall Study|Physician Decision|1|||
161940071|NCT04197583|584830734|FG001|Overall Study|Physician Decision|0|||
162225234|NCT03291288|585873815|FG000|Drug-drug Interaction Phase|Other|3|||
162225235|NCT03291288|585873816|FG001|Drug-drug Interaction Phase|Other|0|||
162225236|NCT03291288|585873815|FG000|Pexidartinib Only|Ongoing|0|||
162225237|NCT03291288|585873816|FG001|Pexidartinib Only|Ongoing|2|||
162225238|NCT04978493|585873817|FG000|Overall Study|No reason available|0|||
162225239|NCT04978493|585873818|FG001|Overall Study|No reason available|1|||
161678749|NCT00574288|583876070|FG005|Overall Study|Lost to Follow-up|1|||
161940072|NCT04197583|584830733|FG000|Overall Study|Withdrawal by Subject|1|||
161940073|NCT04197583|584830734|FG001|Overall Study|Withdrawal by Subject|1|||
161940074|NCT04197583|584830733|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
161940075|NCT04197583|584830734|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
162225240|NCT04978493|585873817|FG000|Overall Study|Adverse Event|1|||
162225241|NCT04978493|585873818|FG001|Overall Study|Adverse Event|0|||
162225242|NCT01896726|585873819|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
162225243|NCT01896726|585873819|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
162225244|NCT01128114|585873820|FG000|Overall Study|Treatment Withdrawn|6|||
162225245|NCT01128114|585873820|FG000|Overall Study|Screening Failed|2|||
161940076|NCT04197583|584830733|FG000|Overall Study|Screen Failure|0|||
162225246|NCT02336451|585873821|FG000|Overall Study|Adverse Event|1|||
162225247|NCT02336451|585873822|FG001|Overall Study|Adverse Event|2|||
162225248|NCT02336451|585873823|FG002|Overall Study|Adverse Event|0|||
162225249|NCT02336451|585873824|FG003|Overall Study|Adverse Event|6|||
162225250|NCT02336451|585873825|FG004|Overall Study|Adverse Event|4|||
162225251|NCT02336451|585873821|FG000|Overall Study|Death|6|||
162225252|NCT02336451|585873822|FG001|Overall Study|Death|2|||
162225253|NCT02336451|585873823|FG002|Overall Study|Death|3|||
162225254|NCT02336451|585873824|FG003|Overall Study|Death|6|||
162225255|NCT02336451|585873825|FG004|Overall Study|Death|6|||
162225256|NCT02336451|585873821|FG000|Overall Study|Physician Decision|9|||
162225257|NCT02336451|585873822|FG001|Overall Study|Physician Decision|6|||
162225258|NCT02336451|585873823|FG002|Overall Study|Physician Decision|7|||
162225259|NCT02336451|585873824|FG003|Overall Study|Physician Decision|16|||
162225260|NCT02336451|585873825|FG004|Overall Study|Physician Decision|3|||
162225261|NCT02336451|585873821|FG000|Overall Study|Progressive disease|23|||
162225262|NCT02336451|585873822|FG001|Overall Study|Progressive disease|26|||
162225263|NCT02336451|585873823|FG002|Overall Study|Progressive disease|2|||
162225264|NCT02336451|585873824|FG003|Overall Study|Progressive disease|14|||
162225265|NCT02336451|585873825|FG004|Overall Study|Progressive disease|4|||
162225266|NCT02336451|585873821|FG000|Overall Study|Protocol Violation|1|||
162225267|NCT02336451|585873822|FG001|Overall Study|Protocol Violation|0|||
162225268|NCT02336451|585873823|FG002|Overall Study|Protocol Violation|0|||
162225269|NCT02336451|585873824|FG003|Overall Study|Protocol Violation|0|||
162225270|NCT02336451|585873825|FG004|Overall Study|Protocol Violation|0|||
162225271|NCT02336451|585873821|FG000|Overall Study|Patient/guardian decision|2|||
162225272|NCT02336451|585873822|FG001|Overall Study|Patient/guardian decision|4|||
162225273|NCT02336451|585873823|FG002|Overall Study|Patient/guardian decision|0|||
162225274|NCT02336451|585873824|FG003|Overall Study|Patient/guardian decision|2|||
162225275|NCT02336451|585873825|FG004|Overall Study|Patient/guardian decision|1|||
162225276|NCT06655558|585873828|FG000|Overall Study|Protocol Violation|1|||
162225277|NCT04998812|585873834|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
162225278|NCT04998812|585873835|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
162225279|NCT04998812|585873834|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
162225280|NCT04998812|585873835|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
162225281|NCT04998812|585873834|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
162225282|NCT04998812|585873835|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
162225283|NCT04998812|585873834|FG000|Vaccination Period|Ongoing in study|23|||
162225284|NCT04998812|585873835|FG001|Vaccination Period|Ongoing in study|23|||
162225285|NCT03524092|585873841|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
162225286|NCT03524092|585873842|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
162225287|NCT03524092|585873843|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
162225288|NCT03524092|585873844|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
162225289|NCT03524092|585873845|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
162225290|NCT03524092|585873846|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
162225291|NCT03524092|585873841|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
162225292|NCT03524092|585873842|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
162225293|NCT03524092|585873843|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
162225294|NCT03524092|585873844|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
162225295|NCT03524092|585873845|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
162225296|NCT03524092|585873846|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
162225297|NCT03524092|585873841|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
162225298|NCT03524092|585873842|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
162225299|NCT03524092|585873843|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
162225300|NCT03524092|585873844|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
162225301|NCT03524092|585873845|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
162225302|NCT03524092|585873846|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
162225303|NCT03524092|585873841|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
162225304|NCT03524092|585873842|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
162225305|NCT03524092|585873843|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
162225306|NCT03524092|585873844|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
162225307|NCT03524092|585873845|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
162225308|NCT03524092|585873846|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
162225309|NCT03524092|585873841|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
162225310|NCT03524092|585873842|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
162225311|NCT03524092|585873843|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
162225312|NCT03524092|585873844|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
162225313|NCT03524092|585873845|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
162225314|NCT03524092|585873846|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
162225315|NCT03524092|585873841|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
162225316|NCT03524092|585873842|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
162225317|NCT03524092|585873843|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
162225318|NCT03524092|585873844|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
162225319|NCT03524092|585873845|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
162225320|NCT03524092|585873846|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
162225321|NCT03524092|585873841|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
162225322|NCT03524092|585873842|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
162225323|NCT03524092|585873843|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
162225324|NCT03524092|585873844|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
162225325|NCT03524092|585873845|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
162225326|NCT03524092|585873846|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
162225327|NCT03524092|585873841|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
162225328|NCT03524092|585873842|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
162225329|NCT03524092|585873843|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
162225330|NCT03524092|585873844|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
162225331|NCT03524092|585873845|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
162225332|NCT03524092|585873846|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
162225333|NCT03524092|585873841|FG000|Loss of Response Rescue Period|Adverse Event|0|||
162225334|NCT03524092|585873842|FG001|Loss of Response Rescue Period|Adverse Event|0|||
162225335|NCT03524092|585873843|FG002|Loss of Response Rescue Period|Adverse Event|0|||
162225336|NCT03524092|585873844|FG003|Loss of Response Rescue Period|Adverse Event|2|||
162225337|NCT03524092|585873845|FG004|Loss of Response Rescue Period|Adverse Event|0|||
162225338|NCT03524092|585873846|FG005|Loss of Response Rescue Period|Adverse Event|0|||
162225339|NCT03524092|585873841|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
162225340|NCT03524092|585873842|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
162225341|NCT03524092|585873843|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
162225342|NCT03524092|585873844|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
162225343|NCT03524092|585873845|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
162225344|NCT03524092|585873846|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
162225345|NCT03524092|585873841|FG000|Loss of Response Rescue Period|Pregnancy|0|||
162225346|NCT03524092|585873842|FG001|Loss of Response Rescue Period|Pregnancy|0|||
162225347|NCT03524092|585873843|FG002|Loss of Response Rescue Period|Pregnancy|0|||
162225348|NCT03524092|585873844|FG003|Loss of Response Rescue Period|Pregnancy|1|||
162225349|NCT03524092|585873845|FG004|Loss of Response Rescue Period|Pregnancy|0|||
162225350|NCT03524092|585873846|FG005|Loss of Response Rescue Period|Pregnancy|0|||
162225351|NCT03524092|585873841|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
162225352|NCT03524092|585873842|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
162225353|NCT03524092|585873843|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
162225354|NCT03524092|585873844|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
162225355|NCT03524092|585873845|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
162225356|NCT03524092|585873846|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
162225357|NCT03524092|585873841|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
162225358|NCT03524092|585873842|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
162225359|NCT03524092|585873843|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
162225360|NCT03524092|585873844|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
162225361|NCT03524092|585873845|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
162225362|NCT03524092|585873846|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
162225363|NCT03524092|585873841|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
162225364|NCT03524092|585873842|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
162236709|NCT01395888|585917035|FG002|2-week Run-in Period|Lost to Follow-up|0|||
162236710|NCT01395888|585917033|FG000|2-week Run-in Period|Protocol Violation|2|||
162236711|NCT01395888|585917034|FG001|2-week Run-in Period|Protocol Violation|0|||
162236712|NCT01395888|585917035|FG002|2-week Run-in Period|Protocol Violation|0|||
162236713|NCT01395888|585917033|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
162236714|NCT01395888|585917034|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
162236715|NCT01395888|585917035|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
162236716|NCT01395888|585917033|FG000|Treatment Period (TP)|Adverse Event|0|||
162236717|NCT01395888|585917034|FG001|Treatment Period (TP)|Adverse Event|7|||
162225365|NCT03524092|585873843|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
162225366|NCT03524092|585873844|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
162225367|NCT03524092|585873845|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
162225368|NCT03524092|585873846|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
162225369|NCT03524092|585873841|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
162225370|NCT03524092|585873842|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
162225371|NCT03524092|585873843|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
162225372|NCT03524092|585873844|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
162225373|NCT03524092|585873845|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
162225374|NCT03524092|585873846|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
162225375|NCT03524092|585873841|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
162225376|NCT03524092|585873842|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
162225377|NCT03524092|585873843|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
162225378|NCT03524092|585873844|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
162225379|NCT03524092|585873845|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
162225380|NCT03524092|585873846|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
162225381|NCT03524092|585873841|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
162225382|NCT03524092|585873842|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
162225383|NCT03524092|585873843|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
162225384|NCT03524092|585873844|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
162225385|NCT03524092|585873845|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
162225386|NCT03524092|585873846|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
162225387|NCT03524092|585873841|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
162225388|NCT03524092|585873842|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
162225389|NCT03524092|585873843|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
162225390|NCT03524092|585873844|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
162225391|NCT03524092|585873845|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
162225392|NCT03524092|585873846|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
162225393|NCT03524092|585873841|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
162225394|NCT03524092|585873842|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
162225395|NCT03524092|585873843|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
162225396|NCT03524092|585873844|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
162225397|NCT03524092|585873845|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
162225398|NCT03524092|585873846|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
162225399|NCT03524092|585873841|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
162225400|NCT03524092|585873842|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
162225401|NCT03524092|585873843|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
162225402|NCT03524092|585873844|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
162225403|NCT03524092|585873845|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
162225404|NCT03524092|585873846|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
162225405|NCT03524092|585873841|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
162225406|NCT03524092|585873842|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
162225407|NCT03524092|585873843|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
162225408|NCT03524092|585873844|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
162225409|NCT03524092|585873845|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
162225410|NCT03524092|585873846|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
162225411|NCT03524092|585873841|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
162225412|NCT03524092|585873842|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
162225413|NCT03524092|585873843|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
162225414|NCT03524092|585873844|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
162225415|NCT03524092|585873845|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
162225416|NCT03524092|585873846|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
162225417|NCT03524092|585873841|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
162225418|NCT03524092|585873842|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
161829391|NCT00892281|584415776|FG001|Overall Study|Adverse Event|8|||
161829392|NCT00892281|584415775|FG000|Overall Study|Lost to Follow-up|81|||
161829393|NCT00892281|584415776|FG001|Overall Study|Lost to Follow-up|8|||
162225419|NCT03524092|585873843|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
162225420|NCT03524092|585873844|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
162023420|NCT02152956|585142697|FG012|Overall Study|Withdrawal by Subject|0|||
161829394|NCT00892281|584415775|FG000|Overall Study|Pregnancy|1|||
161829395|NCT00892281|584415776|FG001|Overall Study|Pregnancy|0|||
162225421|NCT03524092|585873845|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
162225422|NCT03524092|585873846|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
162225423|NCT04303780|585873847|FG000|Overall Study|Death|104|||
162225424|NCT04303780|585873848|FG001|Overall Study|Death|85|||
162225425|NCT04303780|585873847|FG000|Overall Study|Lost to Follow-up|5|||
162225426|NCT04303780|585873848|FG001|Overall Study|Lost to Follow-up|2|||
162225427|NCT04303780|585873847|FG000|Overall Study|Withdrawal by Subject|12|||
162225428|NCT04303780|585873848|FG001|Overall Study|Withdrawal by Subject|39|||
162225429|NCT04303780|585873847|FG000|Overall Study|Ongoing in study|50|||
162225430|NCT04303780|585873848|FG001|Overall Study|Ongoing in study|45|||
162225431|NCT03826030|585873849|FG000|Overall Study|Withdrawal by Subject|2|||
162225432|NCT03826030|585873850|FG001|Overall Study|Withdrawal by Subject|0|||
162225433|NCT03826030|585873851|FG002|Overall Study|Withdrawal by Subject|1|||
162225434|NCT03826030|585873849|FG000|Overall Study|Lost to Follow-up|1|||
162225435|NCT03826030|585873850|FG001|Overall Study|Lost to Follow-up|1|||
162225436|NCT03826030|585873851|FG002|Overall Study|Lost to Follow-up|1|||
162225437|NCT03826030|585873849|FG000|Overall Study|Too busy to return for visits|1|||
162225438|NCT03826030|585873850|FG001|Overall Study|Too busy to return for visits|0|||
162225439|NCT03826030|585873851|FG002|Overall Study|Too busy to return for visits|0|||
162225440|NCT04893460|585873852|FG000|Overall Study|Lost to Follow-up|18|||
162225441|NCT01099215|585875380|FG000|Overall Study|Withdrawal by Subject|1|||
162225442|NCT01099215|585875381|FG001|Overall Study|Withdrawal by Subject|0|||
162225443|NCT01099215|585875380|FG000|Overall Study|Adverse Event|0|||
162225444|NCT01099215|585875381|FG001|Overall Study|Adverse Event|1|||
162225445|NCT01901432|585875385|FG000|Overall Study|Adverse Event|0|||
162225446|NCT01901432|585875386|FG001|Overall Study|Adverse Event|1|||
162225447|NCT01901432|585875387|FG002|Overall Study|Adverse Event|1|||
162225448|NCT01901432|585875388|FG003|Overall Study|Adverse Event|0|||
162225449|NCT01901432|585875389|FG004|Overall Study|Adverse Event|1|||
162225450|NCT01901432|585875385|FG000|Overall Study|Withdrawal by Subject|0|||
162225451|NCT01901432|585875386|FG001|Overall Study|Withdrawal by Subject|0|||
162225452|NCT01901432|585875387|FG002|Overall Study|Withdrawal by Subject|1|||
162225453|NCT01901432|585875388|FG003|Overall Study|Withdrawal by Subject|0|||
162225454|NCT01901432|585875389|FG004|Overall Study|Withdrawal by Subject|5|||
162225455|NCT01901432|585875385|FG000|Overall Study|Physician Decision|0|||
162225456|NCT01901432|585875386|FG001|Overall Study|Physician Decision|0|||
162225457|NCT01901432|585875387|FG002|Overall Study|Physician Decision|0|||
162225458|NCT01901432|585875388|FG003|Overall Study|Physician Decision|0|||
162225459|NCT01901432|585875389|FG004|Overall Study|Physician Decision|2|||
162225460|NCT01901432|585875385|FG000|Overall Study|Patient decision to stop study drug|0|||
162225461|NCT01901432|585875386|FG001|Overall Study|Patient decision to stop study drug|0|||
162225462|NCT01901432|585875387|FG002|Overall Study|Patient decision to stop study drug|0|||
162225463|NCT01901432|585875388|FG003|Overall Study|Patient decision to stop study drug|0|||
162225464|NCT01901432|585875389|FG004|Overall Study|Patient decision to stop study drug|1|||
162225465|NCT01077271|585875395|FG000|Overall Study|Parental desire|8|||
162225466|NCT01077271|585875395|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
162225467|NCT01077271|585875395|FG000|Overall Study|Noncompliance|2|||
162225468|NCT01077271|585875395|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
162225469|NCT01077271|585875395|FG000|Overall Study|Changed doctors|2|||
162225470|NCT01077271|585875395|FG000|Overall Study|Parents thought too many injections|2|||
162225471|NCT01077271|585875395|FG000|Overall Study|End of RSV season nearly reached|1|||
162225472|NCT01077271|585875395|FG000|Overall Study|Mother unconvinced of the necessity|1|||
162225473|NCT00215137|585875396|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
162225474|NCT00215137|585875397|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
162225475|NCT00215137|585875398|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
162225476|NCT00215137|585875396|FG000|Randomization Period|Lost to Follow-up|0|||
162225477|NCT00215137|585875397|FG001|Randomization Period|Lost to Follow-up|1|||
162225478|NCT00215137|585875398|FG002|Randomization Period|Lost to Follow-up|0|||
162225479|NCT00215137|585875396|FG000|Randomization Period|Withdrawal by Subject|0|||
162225480|NCT00215137|585875397|FG001|Randomization Period|Withdrawal by Subject|1|||
162225481|NCT00215137|585875398|FG002|Randomization Period|Withdrawal by Subject|0|||
162225482|NCT03333876|585875399|FG000|Screening Period|Screen Failure|4|||
162225483|NCT03333876|585875399|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
162225484|NCT03333876|585875399|FG000|Mandibular Advancement|Adverse Event|2|||
162225485|NCT03333876|585875399|FG000|Mandibular Advancement|Product Damage|2|||
162225486|NCT00166712|585875401|FG000|Overall Study|Death|0|||
162225487|NCT00166712|585875402|FG001|Overall Study|Death|1|||
162225488|NCT00166712|585875401|FG000|Overall Study|Adverse Event|1|||
162225489|NCT00166712|585875402|FG001|Overall Study|Adverse Event|0|||
162225490|NCT00166712|585875401|FG000|Overall Study|Withdrawal by Subject|1|||
162225491|NCT00166712|585875402|FG001|Overall Study|Withdrawal by Subject|2|||
162225492|NCT00166712|585875401|FG000|Overall Study|Physician Decision|0|||
162225493|NCT00166712|585875402|FG001|Overall Study|Physician Decision|2|||
162225494|NCT04684394|585875403|FG000|Overall Study|Death|1|||
162225495|NCT04684394|585875404|FG001|Overall Study|Death|2|||
162225496|NCT04684394|585875403|FG000|Overall Study|Lost to Follow-up|1|||
162225497|NCT04684394|585875404|FG001|Overall Study|Lost to Follow-up|0|||
162225498|NCT04684394|585875403|FG000|Overall Study|Withdrawal by Subject|2|||
162225499|NCT04684394|585875404|FG001|Overall Study|Withdrawal by Subject|0|||
162225500|NCT04684394|585875403|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
162225501|NCT04684394|585875404|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
162225502|NCT03986944|585875405|FG000|Overall Study|Adverse Event|1|||
162225503|NCT03986944|585875406|FG001|Overall Study|Adverse Event|2|||
162225504|NCT03986944|585875407|FG002|Overall Study|Adverse Event|3|||
162225505|NCT03986944|585875405|FG000|Overall Study|Protocol Violation|0|||
162225506|NCT03986944|585875406|FG001|Overall Study|Protocol Violation|1|||
162225507|NCT03986944|585875407|FG002|Overall Study|Protocol Violation|1|||
162225508|NCT03986944|585875405|FG000|Overall Study|Withdrawal by Subject|3|||
162225509|NCT03986944|585875406|FG001|Overall Study|Withdrawal by Subject|5|||
162225510|NCT03986944|585875407|FG002|Overall Study|Withdrawal by Subject|5|||
162225511|NCT03986944|585875405|FG000|Overall Study|Study termination|10|||
162225512|NCT03986944|585875406|FG001|Overall Study|Study termination|10|||
162225513|NCT03986944|585875407|FG002|Overall Study|Study termination|10|||
162225514|NCT03986944|585875405|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
162225515|NCT03986944|585875406|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
162225516|NCT03986944|585875407|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
162225517|NCT03986944|585875405|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
162225518|NCT03986944|585875406|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
162225519|NCT03986944|585875407|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
162225520|NCT05816330|585875414|FG000|Overall Study|Withdrawal by Subject|4|||
162225521|NCT05816330|585875415|FG001|Overall Study|Withdrawal by Subject|1|||
162225522|NCT00201643|585875416|FG000|Overall Study|Withdrawal by Subject|5|||
162225523|NCT00201643|585875417|FG001|Overall Study|Withdrawal by Subject|4|||
162225524|NCT03446781|585875418|FG000|Overall Study|Lost to Follow-up|11|||
162225525|NCT03446781|585875419|FG001|Overall Study|Lost to Follow-up|5|||
162225526|NCT03446781|585875418|FG000|Overall Study|Withdrawal by Subject|9|||
162225527|NCT03446781|585875419|FG001|Overall Study|Withdrawal by Subject|7|||
162225528|NCT03446781|585875418|FG000|Overall Study|Adverse Event|8|||
162225529|NCT03446781|585875419|FG001|Overall Study|Adverse Event|2|||
162225530|NCT03446781|585875418|FG000|Overall Study|Protocol Violation|0|||
162225531|NCT03446781|585875419|FG001|Overall Study|Protocol Violation|3|||
162225532|NCT02898077|585875426|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
162225533|NCT02898077|585875427|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
162225534|NCT02898077|585875426|FG000|Overall Study|Lost to Follow-up|4|||
162225535|NCT02898077|585875427|FG001|Overall Study|Lost to Follow-up|3|||
162225536|NCT02898077|585875426|FG000|Overall Study|Physician Decision|0|||
162225537|NCT02898077|585875427|FG001|Overall Study|Physician Decision|2|||
162225538|NCT02898077|585875426|FG000|Overall Study|Sponsor Decision|32|||
162225539|NCT02898077|585875427|FG001|Overall Study|Sponsor Decision|13|||
162225540|NCT02898077|585875426|FG000|Overall Study|Withdrawal by Subject|6|||
162225541|NCT02898077|585875427|FG001|Overall Study|Withdrawal by Subject|3|||
162225542|NCT02898077|585875426|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
162225543|NCT02898077|585875427|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
162225544|NCT02898077|585875426|FG000|Overall Study|Ended extension period|3|||
162225545|NCT02898077|585875427|FG001|Overall Study|Ended extension period|0|||
162225546|NCT00996476|585875428|FG000|Overall Study|Withdrawal by Subject|1|||
162225547|NCT00996476|585875429|FG001|Overall Study|Withdrawal by Subject|2|||
162225548|NCT00996476|585875430|FG002|Overall Study|Withdrawal by Subject|1|||
162225549|NCT00996476|585875431|FG003|Overall Study|Withdrawal by Subject|0|||
162225550|NCT00996476|585875432|FG004|Overall Study|Withdrawal by Subject|1|||
162225551|NCT00996476|585875428|FG000|Overall Study|Adverse Event|0|||
162225552|NCT00996476|585875429|FG001|Overall Study|Adverse Event|1|||
162225553|NCT00996476|585875430|FG002|Overall Study|Adverse Event|0|||
162225554|NCT00996476|585875431|FG003|Overall Study|Adverse Event|0|||
162225555|NCT00996476|585875432|FG004|Overall Study|Adverse Event|1|||
162225556|NCT01940939|585875433|FG000|Overall Study|Withdrawal by Subject|2|||
162225557|NCT01940939|585875434|FG001|Overall Study|Withdrawal by Subject|8|||
162225558|NCT01470001|585875435|FG000|Overall Study|Lost to Follow-up|1|||
162225559|NCT01470001|585875436|FG001|Overall Study|Lost to Follow-up|1|||
162225560|NCT01470001|585875435|FG000|Overall Study|Physician Decision|2|||
162225561|NCT01470001|585875436|FG001|Overall Study|Physician Decision|0|||
162225562|NCT01470001|585875435|FG000|Overall Study|Withdrawal by Subject|2|||
162225563|NCT01470001|585875436|FG001|Overall Study|Withdrawal by Subject|1|||
162225564|NCT04939701|585875440|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
162225565|NCT04939701|585875441|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
162225566|NCT04939701|585875442|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
162225567|NCT04939701|585875440|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
162225568|NCT04939701|585875441|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
162225569|NCT04939701|585875442|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
162225570|NCT04939701|585875440|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
162225571|NCT04939701|585875441|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
162225572|NCT04939701|585875442|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
162225573|NCT04939701|585875440|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
162225574|NCT04939701|585875441|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
162225575|NCT04939701|585875442|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
162225576|NCT04939701|585875440|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
162225577|NCT04939701|585875441|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
162225578|NCT04939701|585875442|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
162225579|NCT04939701|585875440|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
162225580|NCT04939701|585875441|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
162225581|NCT04939701|585875442|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
162225582|NCT04939701|585875440|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
162225583|NCT04939701|585875441|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
162225584|NCT04939701|585875442|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
162225585|NCT01283516|585875447|FG000|Overall Study|Adverse Event|0|||
162225586|NCT01283516|585875448|FG001|Overall Study|Adverse Event|0|||
162225587|NCT01283516|585875449|FG002|Overall Study|Adverse Event|0|||
162225588|NCT01283516|585875450|FG003|Overall Study|Adverse Event|0|||
162225589|NCT01283516|585875451|FG004|Overall Study|Adverse Event|0|||
162225590|NCT01283516|585875452|FG005|Overall Study|Adverse Event|0|||
162225591|NCT01283516|585875453|FG006|Overall Study|Adverse Event|2|||
162225592|NCT01283516|585875454|FG007|Overall Study|Adverse Event|0|||
162225593|NCT01283516|585875455|FG008|Overall Study|Adverse Event|28|||
162225594|NCT01283516|585875447|FG000|Overall Study|Death|0|||
162225595|NCT01283516|585875448|FG001|Overall Study|Death|0|||
162225596|NCT01283516|585875449|FG002|Overall Study|Death|0|||
162225597|NCT01283516|585875450|FG003|Overall Study|Death|0|||
162225598|NCT01283516|585875451|FG004|Overall Study|Death|0|||
162225599|NCT01283516|585875452|FG005|Overall Study|Death|1|||
162225600|NCT01283516|585875453|FG006|Overall Study|Death|0|||
162225601|NCT01283516|585875454|FG007|Overall Study|Death|1|||
162225602|NCT01283516|585875455|FG008|Overall Study|Death|12|||
162225603|NCT01283516|585875447|FG000|Overall Study|Disease Progression|2|||
162225604|NCT01283516|585875448|FG001|Overall Study|Disease Progression|2|||
162225605|NCT01283516|585875449|FG002|Overall Study|Disease Progression|3|||
162225606|NCT01283516|585875450|FG003|Overall Study|Disease Progression|3|||
162225607|NCT01283516|585875451|FG004|Overall Study|Disease Progression|13|||
162225608|NCT01283516|585875452|FG005|Overall Study|Disease Progression|8|||
162225609|NCT01283516|585875453|FG006|Overall Study|Disease Progression|6|||
162225610|NCT01283516|585875454|FG007|Overall Study|Disease Progression|3|||
162225611|NCT01283516|585875455|FG008|Overall Study|Disease Progression|139|||
162225612|NCT01283516|585875447|FG000|Overall Study|Withdrawal by Subject|0|||
162225613|NCT01283516|585875448|FG001|Overall Study|Withdrawal by Subject|0|||
162225614|NCT01283516|585875449|FG002|Overall Study|Withdrawal by Subject|0|||
162225615|NCT01283516|585875450|FG003|Overall Study|Withdrawal by Subject|0|||
162225616|NCT01283516|585875451|FG004|Overall Study|Withdrawal by Subject|1|||
162225617|NCT01283516|585875452|FG005|Overall Study|Withdrawal by Subject|0|||
162225618|NCT01283516|585875453|FG006|Overall Study|Withdrawal by Subject|1|||
162225619|NCT01283516|585875454|FG007|Overall Study|Withdrawal by Subject|0|||
162225620|NCT01283516|585875455|FG008|Overall Study|Withdrawal by Subject|36|||
162225621|NCT01283516|585875447|FG000|Overall Study|Administrative problems|0|||
162225622|NCT01283516|585875448|FG001|Overall Study|Administrative problems|0|||
162225623|NCT01283516|585875449|FG002|Overall Study|Administrative problems|0|||
162225624|NCT01283516|585875450|FG003|Overall Study|Administrative problems|0|||
162225625|NCT01283516|585875451|FG004|Overall Study|Administrative problems|0|||
162225626|NCT01283516|585875452|FG005|Overall Study|Administrative problems|1|||
162225627|NCT01283516|585875453|FG006|Overall Study|Administrative problems|1|||
162225628|NCT01283516|585875454|FG007|Overall Study|Administrative problems|1|||
162225629|NCT01283516|585875455|FG008|Overall Study|Administrative problems|39|||
162225630|NCT01283516|585875447|FG000|Overall Study|Lost to Follow-up|0|||
162225631|NCT01283516|585875448|FG001|Overall Study|Lost to Follow-up|0|||
162225632|NCT01283516|585875449|FG002|Overall Study|Lost to Follow-up|0|||
162225633|NCT01283516|585875450|FG003|Overall Study|Lost to Follow-up|0|||
162225634|NCT01283516|585875451|FG004|Overall Study|Lost to Follow-up|0|||
162225635|NCT01283516|585875452|FG005|Overall Study|Lost to Follow-up|0|||
162225636|NCT01283516|585875453|FG006|Overall Study|Lost to Follow-up|0|||
162225637|NCT01283516|585875454|FG007|Overall Study|Lost to Follow-up|0|||
162225638|NCT01283516|585875455|FG008|Overall Study|Lost to Follow-up|1|||
162225639|NCT00444275|585875458|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
162225640|NCT00444275|585875459|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
162225641|NCT00444275|585875460|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
162225642|NCT00444275|585875461|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
162225643|NCT00444275|585875462|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
162225644|NCT00444275|585875458|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
162225645|NCT00444275|585875459|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
162225646|NCT00444275|585875460|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
162225647|NCT00444275|585875461|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
162225648|NCT00444275|585875462|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
162225649|NCT00444275|585875458|FG000|Maintenance Treatment Phase|Adverse Event|0|||
162225650|NCT00444275|585875459|FG001|Maintenance Treatment Phase|Adverse Event|0|||
162225651|NCT00444275|585875460|FG002|Maintenance Treatment Phase|Adverse Event|3|||
162225652|NCT00444275|585875461|FG003|Maintenance Treatment Phase|Adverse Event|2|||
162225653|NCT00444275|585875462|FG004|Maintenance Treatment Phase|Adverse Event|13|||
162225654|NCT00444275|585875458|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
162225655|NCT00444275|585875459|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
162225656|NCT00444275|585875460|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
162225657|NCT00444275|585875461|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
162225658|NCT00444275|585875462|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
162225659|NCT00444275|585875458|FG000|Maintenance Treatment Phase|Patient's wish|0|||
162225660|NCT00444275|585875459|FG001|Maintenance Treatment Phase|Patient's wish|0|||
162225661|NCT00444275|585875460|FG002|Maintenance Treatment Phase|Patient's wish|19|||
162225662|NCT00444275|585875461|FG003|Maintenance Treatment Phase|Patient's wish|9|||
162225663|NCT00444275|585875462|FG004|Maintenance Treatment Phase|Patient's wish|20|||
162225664|NCT00444275|585875458|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
162225665|NCT00444275|585875459|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
162225666|NCT00444275|585875460|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
162225667|NCT00444275|585875461|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
162225668|NCT00444275|585875462|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
162225669|NCT00444275|585875458|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
162225670|NCT00444275|585875459|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
162225671|NCT00444275|585875460|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
162225672|NCT00444275|585875461|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
162225673|NCT00444275|585875462|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
162225674|NCT04187326|585875463|FG000|Overall Study|Lost to Follow-up|2|||
162225675|NCT04187326|585875464|FG001|Overall Study|Lost to Follow-up|1|||
162225676|NCT04187326|585875463|FG000|Overall Study|Computer error- task was only partially completed.|0|||
162225677|NCT04187326|585875464|FG001|Overall Study|Computer error- task was only partially completed.|1|||
162225678|NCT02387970|585875465|FG000|Overall Study|Did not complete 1-year follow up|1|||
162225679|NCT02387970|585875466|FG001|Overall Study|Did not complete 1-year follow up|2|||
162225680|NCT02628028|585875467|FG000|Dosing Period|Withdrawal by Subject|0|||
162225681|NCT02628028|585875468|FG001|Dosing Period|Withdrawal by Subject|0|||
162225682|NCT02628028|585875469|FG002|Dosing Period|Withdrawal by Subject|1|||
162225683|NCT02628028|585875470|FG003|Dosing Period|Withdrawal by Subject|0|||
162225684|NCT02628028|585875471|FG004|Dosing Period|Withdrawal by Subject|2|||
162225685|NCT02628028|585875472|FG005|Dosing Period|Withdrawal by Subject|4|||
162225686|NCT02628028|585875473|FG006|Dosing Period|Withdrawal by Subject|1|||
162225687|NCT02628028|585875474|FG007|Dosing Period|Withdrawal by Subject|1|||
162225688|NCT02628028|585875467|FG000|Dosing Period|Adverse Event|0|||
162225689|NCT02628028|585875468|FG001|Dosing Period|Adverse Event|0|||
162225690|NCT02628028|585875469|FG002|Dosing Period|Adverse Event|0|||
162225691|NCT02628028|585875470|FG003|Dosing Period|Adverse Event|0|||
162225692|NCT02628028|585875471|FG004|Dosing Period|Adverse Event|2|||
162225693|NCT02628028|585875472|FG005|Dosing Period|Adverse Event|1|||
162225694|NCT02628028|585875473|FG006|Dosing Period|Adverse Event|3|||
162225695|NCT02628028|585875474|FG007|Dosing Period|Adverse Event|2|||
162225696|NCT02628028|585875467|FG000|Dosing Period|Death|0|||
162225697|NCT02628028|585875468|FG001|Dosing Period|Death|0|||
162225698|NCT02628028|585875469|FG002|Dosing Period|Death|0|||
162225699|NCT02628028|585875470|FG003|Dosing Period|Death|0|||
162225700|NCT02628028|585875471|FG004|Dosing Period|Death|0|||
162225701|NCT02628028|585875472|FG005|Dosing Period|Death|0|||
162225702|NCT02628028|585875473|FG006|Dosing Period|Death|0|||
162225703|NCT02628028|585875474|FG007|Dosing Period|Death|1|||
162225704|NCT02628028|585875467|FG000|Dosing Period|Lack of Efficacy|0|||
162225705|NCT02628028|585875468|FG001|Dosing Period|Lack of Efficacy|0|||
162225706|NCT02628028|585875469|FG002|Dosing Period|Lack of Efficacy|0|||
162225707|NCT02628028|585875470|FG003|Dosing Period|Lack of Efficacy|0|||
162225708|NCT02628028|585875471|FG004|Dosing Period|Lack of Efficacy|3|||
162225709|NCT02628028|585875472|FG005|Dosing Period|Lack of Efficacy|0|||
162225710|NCT02628028|585875473|FG006|Dosing Period|Lack of Efficacy|1|||
162225711|NCT02628028|585875474|FG007|Dosing Period|Lack of Efficacy|0|||
162225712|NCT02628028|585875467|FG000|Dosing Period|Study Terminated by Sponsor|0|||
162225713|NCT02628028|585875468|FG001|Dosing Period|Study Terminated by Sponsor|0|||
162225714|NCT02628028|585875469|FG002|Dosing Period|Study Terminated by Sponsor|0|||
162225715|NCT02628028|585875470|FG003|Dosing Period|Study Terminated by Sponsor|0|||
162225716|NCT02628028|585875471|FG004|Dosing Period|Study Terminated by Sponsor|7|||
162225717|NCT02628028|585875472|FG005|Dosing Period|Study Terminated by Sponsor|6|||
162225718|NCT02628028|585875473|FG006|Dosing Period|Study Terminated by Sponsor|7|||
162225719|NCT02628028|585875474|FG007|Dosing Period|Study Terminated by Sponsor|7|||
162225720|NCT02628028|585875467|FG000|Dosing Period|Physician Decision|0|||
162225721|NCT02628028|585875468|FG001|Dosing Period|Physician Decision|0|||
162225722|NCT02628028|585875469|FG002|Dosing Period|Physician Decision|0|||
162225723|NCT02628028|585875470|FG003|Dosing Period|Physician Decision|0|||
162225724|NCT02628028|585875471|FG004|Dosing Period|Physician Decision|0|||
162225725|NCT02628028|585875472|FG005|Dosing Period|Physician Decision|1|||
162225726|NCT02628028|585875473|FG006|Dosing Period|Physician Decision|0|||
162225727|NCT02628028|585875474|FG007|Dosing Period|Physician Decision|0|||
162225728|NCT02628028|585875467|FG000|Dosing Period|Site Terminated by Sponsor|0|||
162225729|NCT02628028|585875468|FG001|Dosing Period|Site Terminated by Sponsor|0|||
162225730|NCT02628028|585875469|FG002|Dosing Period|Site Terminated by Sponsor|0|||
162225731|NCT02628028|585875470|FG003|Dosing Period|Site Terminated by Sponsor|0|||
162225732|NCT02628028|585875471|FG004|Dosing Period|Site Terminated by Sponsor|0|||
162225733|NCT02628028|585875472|FG005|Dosing Period|Site Terminated by Sponsor|1|||
162225734|NCT02628028|585875473|FG006|Dosing Period|Site Terminated by Sponsor|1|||
162225735|NCT02628028|585875474|FG007|Dosing Period|Site Terminated by Sponsor|0|||
162225736|NCT02628028|585875467|FG000|Dosing Period|Lost to Follow-up|0|||
162225737|NCT02628028|585875468|FG001|Dosing Period|Lost to Follow-up|0|||
162225738|NCT02628028|585875469|FG002|Dosing Period|Lost to Follow-up|0|||
162225739|NCT02628028|585875470|FG003|Dosing Period|Lost to Follow-up|0|||
162225740|NCT02628028|585875471|FG004|Dosing Period|Lost to Follow-up|0|||
162225741|NCT02628028|585875472|FG005|Dosing Period|Lost to Follow-up|0|||
162225742|NCT02628028|585875473|FG006|Dosing Period|Lost to Follow-up|1|||
162225743|NCT02628028|585875474|FG007|Dosing Period|Lost to Follow-up|0|||
162225744|NCT02628028|585875467|FG000|Dosing Period|Other|0|||
162225745|NCT02628028|585875468|FG001|Dosing Period|Other|0|||
162225746|NCT02628028|585875469|FG002|Dosing Period|Other|0|||
162225747|NCT02628028|585875470|FG003|Dosing Period|Other|0|||
162225748|NCT02628028|585875471|FG004|Dosing Period|Other|2|||
162225749|NCT02628028|585875472|FG005|Dosing Period|Other|1|||
162225750|NCT02628028|585875473|FG006|Dosing Period|Other|2|||
162225751|NCT02628028|585875474|FG007|Dosing Period|Other|4|||
162225752|NCT02628028|585875467|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
162225753|NCT02628028|585875468|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
162225754|NCT02628028|585875469|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
162225755|NCT02628028|585875470|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
162225756|NCT02628028|585875471|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
162225757|NCT02628028|585875472|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
162225758|NCT02628028|585875473|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
162225759|NCT02628028|585875474|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
162225760|NCT02628028|585875467|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
162225761|NCT02628028|585875468|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
162225762|NCT02628028|585875469|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
162225763|NCT02628028|585875470|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
162225764|NCT02628028|585875471|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
162225765|NCT02628028|585875472|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
162225766|NCT02628028|585875473|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
162225767|NCT02628028|585875474|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
162225768|NCT02628028|585875467|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
162225769|NCT02628028|585875468|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
162225770|NCT02628028|585875469|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
162225771|NCT02628028|585875470|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
162225772|NCT02628028|585875471|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
162225773|NCT02628028|585875472|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
162225774|NCT02628028|585875473|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
162225775|NCT02628028|585875474|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
162225776|NCT02628028|585875467|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
162225777|NCT02628028|585875468|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
162023421|NCT02152956|585142685|FG000|Overall Study|Physician Decision|0|||
162225778|NCT02628028|585875469|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
162225779|NCT02628028|585875470|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
162225780|NCT02628028|585875471|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
162225781|NCT02628028|585875472|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
162225782|NCT02628028|585875473|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
162225783|NCT02628028|585875474|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
162225784|NCT02628028|585875467|FG000|Long-term Extension (LTE) Period|Other|0|||
162023422|NCT02152956|585142686|FG001|Overall Study|Physician Decision|0|||
162023423|NCT02152956|585142687|FG002|Overall Study|Physician Decision|0|||
162023424|NCT02152956|585142688|FG003|Overall Study|Physician Decision|0|||
162023425|NCT02152956|585142689|FG004|Overall Study|Physician Decision|0|||
162023426|NCT02152956|585142690|FG005|Overall Study|Physician Decision|0|||
162023427|NCT02152956|585142691|FG006|Overall Study|Physician Decision|0|||
162023428|NCT02152956|585142692|FG007|Overall Study|Physician Decision|0|||
162023429|NCT02152956|585142693|FG008|Overall Study|Physician Decision|0|||
162023430|NCT02152956|585142694|FG009|Overall Study|Physician Decision|0|||
162023431|NCT02152956|585142695|FG010|Overall Study|Physician Decision|0|||
162023432|NCT02152956|585142696|FG011|Overall Study|Physician Decision|1|||
162023433|NCT02152956|585142697|FG012|Overall Study|Physician Decision|0|||
162023434|NCT02152956|585142685|FG000|Overall Study|Study terminated by sponsor|0|||
162023435|NCT02152956|585142686|FG001|Overall Study|Study terminated by sponsor|0|||
162023436|NCT02152956|585142687|FG002|Overall Study|Study terminated by sponsor|0|||
162023437|NCT02152956|585142688|FG003|Overall Study|Study terminated by sponsor|0|||
162023438|NCT02152956|585142689|FG004|Overall Study|Study terminated by sponsor|0|||
162023439|NCT02152956|585142690|FG005|Overall Study|Study terminated by sponsor|0|||
162023440|NCT02152956|585142691|FG006|Overall Study|Study terminated by sponsor|0|||
162023441|NCT02152956|585142692|FG007|Overall Study|Study terminated by sponsor|0|||
162023442|NCT02152956|585142693|FG008|Overall Study|Study terminated by sponsor|0|||
162023443|NCT02152956|585142694|FG009|Overall Study|Study terminated by sponsor|0|||
162023444|NCT02152956|585142695|FG010|Overall Study|Study terminated by sponsor|0|||
162023445|NCT02152956|585142696|FG011|Overall Study|Study terminated by sponsor|29|||
162023446|NCT02152956|585142697|FG012|Overall Study|Study terminated by sponsor|0|||
162023447|NCT02152956|585142685|FG000|Overall Study|progressive disease|0|||
162023448|NCT02152956|585142686|FG001|Overall Study|progressive disease|0|||
162023449|NCT02152956|585142687|FG002|Overall Study|progressive disease|0|||
162023450|NCT02152956|585142688|FG003|Overall Study|progressive disease|0|||
162023451|NCT02152956|585142689|FG004|Overall Study|progressive disease|0|||
162023452|NCT02152956|585142690|FG005|Overall Study|progressive disease|0|||
162023453|NCT02152956|585142691|FG006|Overall Study|progressive disease|0|||
162023454|NCT02152956|585142692|FG007|Overall Study|progressive disease|0|||
162023455|NCT02152956|585142693|FG008|Overall Study|progressive disease|1|||
162023456|NCT02152956|585142694|FG009|Overall Study|progressive disease|0|||
162023457|NCT02152956|585142695|FG010|Overall Study|progressive disease|0|||
162023458|NCT02152956|585142696|FG011|Overall Study|progressive disease|1|||
162023459|NCT02152956|585142697|FG012|Overall Study|progressive disease|0|||
162023460|NCT05661851|585142698|FG000|Overall Study|Protocol Violation|1|||
162023461|NCT05661851|585142699|FG001|Overall Study|Protocol Violation|1|||
162023462|NCT05661851|585142698|FG000|Overall Study|Covid-19 Related|3|||
162023463|NCT05661851|585142699|FG001|Overall Study|Covid-19 Related|4|||
162023464|NCT05661851|585142698|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
162023465|NCT05661851|585142699|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
162023466|NCT05661851|585142698|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
162023467|NCT05661851|585142699|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
162023468|NCT01014910|585142700|FG000|Overall Study|Withdrawal by Subject|0|||
162023469|NCT01014910|585142701|FG001|Overall Study|Withdrawal by Subject|2|||
162023470|NCT03753789|585142702|FG000|Overall Study|Withdrawal by Subject|2|||
162023471|NCT00853567|585142705|FG000|Overall Study|Study prematurely terminated|71|||
162023472|NCT00782834|585142709|FG000|Treatment Phase|fibrous tumor not GIST|1|||
162023473|NCT02055118|585142710|FG000|Overall Study|Withdrawal by Subject|0|||
162023474|NCT02055118|585142711|FG001|Overall Study|Withdrawal by Subject|2|||
162023475|NCT02055118|585142712|FG002|Overall Study|Withdrawal by Subject|0|||
162023476|NCT02281383|585142714|FG000|Overall Study|Progressive Disease|1|||
162023477|NCT02281383|585142714|FG000|Overall Study|Withdrawal by Subject|6|||
162225785|NCT02628028|585875468|FG001|Long-term Extension (LTE) Period|Other|0|||
162023478|NCT02281383|585142714|FG000|Overall Study|Protocol Violation|2|||
162023479|NCT02281383|585142714|FG000|Overall Study|Death|1|||
162023480|NCT02281383|585142714|FG000|Overall Study|Adverse Event|2|||
162023481|NCT02252939|585142715|FG000|Overall Study|Lost to Follow-up|3|||
162023482|NCT04270370|585142716|FG000|Overall Study|Lost to Follow-up|1|||
162225786|NCT02628028|585875469|FG002|Long-term Extension (LTE) Period|Other|0|||
162225787|NCT02628028|585875470|FG003|Long-term Extension (LTE) Period|Other|0|||
162225788|NCT02628028|585875471|FG004|Long-term Extension (LTE) Period|Other|0|||
162023483|NCT04270370|585142717|FG001|Overall Study|Lost to Follow-up|0|||
162023484|NCT04270370|585142718|FG002|Overall Study|Lost to Follow-up|0|||
162023485|NCT04270370|585142719|FG003|Overall Study|Lost to Follow-up|0|||
162023486|NCT04270370|585142720|FG004|Overall Study|Lost to Follow-up|0|||
162225789|NCT02628028|585875472|FG005|Long-term Extension (LTE) Period|Other|3|||
162225790|NCT02628028|585875473|FG006|Long-term Extension (LTE) Period|Other|4|||
162225791|NCT02628028|585875474|FG007|Long-term Extension (LTE) Period|Other|3|||
162225792|NCT00586612|585875475|FG000|Primary Phase|Protocol Violation|1|||
162225793|NCT00586612|585875476|FG001|Primary Phase|Protocol Violation|0|||
162225794|NCT00586612|585875475|FG000|Primary Phase|Lost to Follow-up|0|||
162225795|NCT00586612|585875476|FG001|Primary Phase|Lost to Follow-up|1|||
162225796|NCT00586612|585875475|FG000|Primary Phase|Withdrawal by Subject|0|||
162225797|NCT00586612|585875476|FG001|Primary Phase|Withdrawal by Subject|2|||
162225798|NCT00586612|585875475|FG000|Booster Phase|Lost to Follow-up|3|||
162225799|NCT00586612|585875476|FG001|Booster Phase|Lost to Follow-up|1|||
162225800|NCT01743989|585875477|FG000|Treatment Phase|Unstable MR4.0|0|||
162225801|NCT01743989|585875478|FG001|Treatment Phase|Unstable MR4.0|6|||
162225802|NCT01743989|585875479|FG002|Treatment Phase|Unstable MR4.0|263|||
162225803|NCT01743989|585875477|FG000|Treatment Phase|Adverse Event|0|||
162225804|NCT01743989|585875478|FG001|Treatment Phase|Adverse Event|4|||
162225805|NCT01743989|585875479|FG002|Treatment Phase|Adverse Event|67|||
162225806|NCT01743989|585875477|FG000|Treatment Phase|Withdrawal by Subject|1|||
162225807|NCT01743989|585875478|FG001|Treatment Phase|Withdrawal by Subject|3|||
162225808|NCT01743989|585875479|FG002|Treatment Phase|Withdrawal by Subject|28|||
162225809|NCT01743989|585875477|FG000|Treatment Phase|Death|0|||
162225810|NCT01743989|585875478|FG001|Treatment Phase|Death|1|||
162225811|NCT01743989|585875479|FG002|Treatment Phase|Death|3|||
162225812|NCT01743989|585875477|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
162225813|NCT01743989|585875478|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
162225814|NCT01743989|585875479|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
162225815|NCT01743989|585875477|FG000|Treatment Phase|Protocol deviation|0|||
162225816|NCT01743989|585875478|FG001|Treatment Phase|Protocol deviation|0|||
162225817|NCT01743989|585875479|FG002|Treatment Phase|Protocol deviation|3|||
162225818|NCT01743989|585875477|FG000|Treatment Phase|Pregnancy|0|||
162225819|NCT01743989|585875478|FG001|Treatment Phase|Pregnancy|0|||
162225820|NCT01743989|585875479|FG002|Treatment Phase|Pregnancy|2|||
162225821|NCT01743989|585875477|FG000|Treatment Phase|Lost to Follow-up|0|||
162023487|NCT04270370|585142721|FG005|Overall Study|Lost to Follow-up|0|||
162023488|NCT04270370|585142722|FG006|Overall Study|Lost to Follow-up|0|||
162023489|NCT04270370|585142723|FG007|Overall Study|Lost to Follow-up|0|||
162023490|NCT04270370|585142724|FG008|Overall Study|Lost to Follow-up|1|||
162023491|NCT04270370|585142725|FG009|Overall Study|Lost to Follow-up|0|||
162023492|NCT04270370|585142726|FG010|Overall Study|Lost to Follow-up|0|||
162023493|NCT04270370|585142727|FG011|Overall Study|Lost to Follow-up|0|||
162023494|NCT01324141|585142728|FG000|Overall Study|Declined to participate before treatment started|1|||
162023495|NCT01324141|585142728|FG000|Overall Study|Disease progression on study|1|||
162023496|NCT01584440|585142736|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
162023497|NCT01584440|585142737|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
162023498|NCT01584440|585142738|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
162023499|NCT01584440|585142739|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
162023500|NCT01584440|585142740|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
162023501|NCT01584440|585142736|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
162225822|NCT01743989|585875478|FG001|Treatment Phase|Lost to Follow-up|0|||
162225823|NCT01743989|585875479|FG002|Treatment Phase|Lost to Follow-up|2|||
161678750|NCT00574288|583876071|FG006|Overall Study|Lost to Follow-up|2|||
162023502|NCT01584440|585142737|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
162023503|NCT01584440|585142738|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
162023504|NCT01584440|585142739|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
162023505|NCT01584440|585142740|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
162225824|NCT01743989|585875477|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
162225825|NCT01743989|585875478|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
162225826|NCT01743989|585875479|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
162225827|NCT01743989|585875477|FG000|Treatment Phase|Administrative problems|0|||
162225828|NCT01743989|585875478|FG001|Treatment Phase|Administrative problems|0|||
162225829|NCT01743989|585875479|FG002|Treatment Phase|Administrative problems|1|||
162225830|NCT01743989|585875477|FG000|Treatment Phase|New cancer (CML) therapy|0|||
162225831|NCT01743989|585875478|FG001|Treatment Phase|New cancer (CML) therapy|1|||
162225832|NCT01743989|585875479|FG002|Treatment Phase|New cancer (CML) therapy|0|||
162225833|NCT01743989|585875477|FG000|Treatment Phase|Physician Decision|0|||
162225834|NCT01743989|585875478|FG001|Treatment Phase|Physician Decision|0|||
162225835|NCT01743989|585875479|FG002|Treatment Phase|Physician Decision|3|||
162225836|NCT01743989|585875477|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
162225837|NCT01743989|585875478|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
162225838|NCT01743989|585875479|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
162225839|NCT01743989|585875477|FG000|Treatment Phase|Not randomized by mistake|0|||
162225840|NCT01743989|585875478|FG001|Treatment Phase|Not randomized by mistake|0|||
162225841|NCT01743989|585875479|FG002|Treatment Phase|Not randomized by mistake|1|||
162225842|NCT01743989|585875477|FG000|Treatment Phase|Included by mistake|0|||
162225843|NCT01743989|585875478|FG001|Treatment Phase|Included by mistake|0|||
162225844|NCT01743989|585875479|FG002|Treatment Phase|Included by mistake|1|||
162225845|NCT01743989|585875477|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
162225846|NCT01743989|585875478|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
162225847|NCT01743989|585875479|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
162225848|NCT01743989|585875477|FG000|TFR Phase|Adverse Event|0|||
162225849|NCT01743989|585875478|FG001|TFR Phase|Adverse Event|1|||
162225850|NCT01743989|585875479|FG002|TFR Phase|Adverse Event|0|||
162225851|NCT01743989|585875477|FG000|TFR Phase|Lost to Follow-up|0|||
162225852|NCT01743989|585875478|FG001|TFR Phase|Lost to Follow-up|2|||
162225853|NCT01743989|585875479|FG002|TFR Phase|Lost to Follow-up|0|||
162225854|NCT01743989|585875477|FG000|TFR Phase|Physician Decision|0|||
162225855|NCT01743989|585875478|FG001|TFR Phase|Physician Decision|1|||
162225856|NCT01743989|585875479|FG002|TFR Phase|Physician Decision|0|||
162225857|NCT01743989|585875477|FG000|TFR Phase|Logistical problems|0|||
162225858|NCT01743989|585875478|FG001|TFR Phase|Logistical problems|2|||
162225859|NCT01743989|585875479|FG002|TFR Phase|Logistical problems|0|||
162225860|NCT01743989|585875477|FG000|TFR Phase|Protocol deviation|0|||
162225861|NCT01743989|585875478|FG001|TFR Phase|Protocol deviation|1|||
162225862|NCT01743989|585875479|FG002|TFR Phase|Protocol deviation|0|||
162225863|NCT01743989|585875477|FG000|TFR Phase|Withdrawal by Subject|0|||
162225864|NCT01743989|585875478|FG001|TFR Phase|Withdrawal by Subject|2|||
162225865|NCT01743989|585875479|FG002|TFR Phase|Withdrawal by Subject|0|||
162225866|NCT01743989|585875477|FG000|Re-treatment Phase|Adverse Event|8|||
162225867|NCT01743989|585875478|FG001|Re-treatment Phase|Adverse Event|4|||
162225868|NCT01743989|585875479|FG002|Re-treatment Phase|Adverse Event|0|||
162225869|NCT01743989|585875477|FG000|Re-treatment Phase|Death|1|||
162225870|NCT01743989|585875478|FG001|Re-treatment Phase|Death|1|||
162225871|NCT01743989|585875479|FG002|Re-treatment Phase|Death|0|||
162225872|NCT01743989|585875477|FG000|Re-treatment Phase|Administrative problems|1|||
162225873|NCT01743989|585875478|FG001|Re-treatment Phase|Administrative problems|1|||
162225874|NCT01743989|585875479|FG002|Re-treatment Phase|Administrative problems|0|||
162225875|NCT01743989|585875477|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
162225876|NCT01743989|585875478|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
162225877|NCT01743989|585875479|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
162225878|NCT01743989|585875477|FG000|Re-treatment Phase|Unstable MR|1|||
162225879|NCT01743989|585875478|FG001|Re-treatment Phase|Unstable MR|0|||
162225880|NCT01743989|585875479|FG002|Re-treatment Phase|Unstable MR|0|||
162225881|NCT01743989|585875477|FG000|Re-treatment Phase|Physician Decision|0|||
162225882|NCT01743989|585875478|FG001|Re-treatment Phase|Physician Decision|1|||
162225883|NCT01743989|585875479|FG002|Re-treatment Phase|Physician Decision|0|||
162225884|NCT01743989|585875477|FG000|Re-treatment Phase|Lost to Follow-up|0|||
162225885|NCT01743989|585875478|FG001|Re-treatment Phase|Lost to Follow-up|1|||
162225886|NCT01743989|585875479|FG002|Re-treatment Phase|Lost to Follow-up|0|||
162225887|NCT02235311|585875482|FG000|Overall Study|Lost to Follow-up|0|||
162225888|NCT02235311|585875483|FG001|Overall Study|Lost to Follow-up|1|||
162225889|NCT02235311|585875482|FG000|Overall Study|Protocol Violation|0|||
162225890|NCT02235311|585875483|FG001|Overall Study|Protocol Violation|1|||
162225891|NCT04655027|585875484|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
162225892|NCT04655027|585875485|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
162225893|NCT00658788|585875486|FG000|Overall Study|Adverse Event|11|||
162225894|NCT00658788|585875486|FG000|Overall Study|Withdrawal by Subject|13|||
162225895|NCT00658788|585875486|FG000|Overall Study|Lost to Follow-up|18|||
162225896|NCT00658788|585875486|FG000|Overall Study|Treatment Discontinuation|32|||
162225897|NCT00653523|585875487|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
162225898|NCT00653523|585875487|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
162225899|NCT00653523|585875487|FG000|Overall Study|Adverse Event|7|||
162225900|NCT00653523|585875487|FG000|Overall Study|Withdrawal by Subject|6|||
162225901|NCT00653523|585875487|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
162225902|NCT00653523|585875487|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
162225903|NCT00186888|585875490|FG000|Overall Study|Toxicity|0|||
162225904|NCT00186888|585875491|FG001|Overall Study|Toxicity|1|||
162225905|NCT00186888|585875492|FG002|Overall Study|Toxicity|0|||
162225906|NCT00186888|585875490|FG000|Overall Study|Relapse or progression of disease|4|||
162225907|NCT00186888|585875491|FG001|Overall Study|Relapse or progression of disease|2|||
162225908|NCT00186888|585875492|FG002|Overall Study|Relapse or progression of disease|0|||
162225909|NCT03006848|585875493|FG000|Overall Study|Adverse Event|1|||
162225910|NCT03006848|585875493|FG000|Overall Study|Physician Decision|1|||
162225911|NCT03006848|585875493|FG000|Overall Study|Lack of Efficacy|16|||
162225912|NCT05543187|585875494|FG000|Overall Study|Ongoing|3|||
162225913|NCT05543187|585875495|FG001|Overall Study|Ongoing|2|||
162225914|NCT04777864|585875496|FG000|Overall Study|Lost to Follow-up|8|||
162023506|NCT01584440|585142736|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
162023507|NCT01584440|585142737|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
162023508|NCT01584440|585142738|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
162023509|NCT01584440|585142739|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
162023510|NCT01584440|585142740|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
162023511|NCT01584440|585142736|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
162023512|NCT01584440|585142737|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
162023513|NCT01584440|585142738|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
162023514|NCT01584440|585142739|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
162225915|NCT04777864|585875497|FG001|Overall Study|Lost to Follow-up|19|||
162225916|NCT03086655|585875498|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
162225917|NCT03086655|585875499|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
162225918|NCT03086655|585875498|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
162225919|NCT03086655|585875499|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
162225920|NCT03086655|585875498|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
162225921|NCT03086655|585875499|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
162225922|NCT03086655|585875498|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
162225923|NCT03086655|585875499|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
162225924|NCT03086655|585875498|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
162225925|NCT03086655|585875499|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
162225926|NCT03086655|585875498|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
162023515|NCT01584440|585142740|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
162023516|NCT01584440|585142736|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
162023517|NCT01584440|585142737|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
162023518|NCT01584440|585142738|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
162023519|NCT01584440|585142739|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
162023520|NCT01584440|585142740|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
162023521|NCT01584440|585142736|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
162023522|NCT01584440|585142737|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
162023523|NCT01584440|585142738|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
162023524|NCT01584440|585142739|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
162023525|NCT01584440|585142740|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
162023526|NCT01584440|585142736|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
162023527|NCT01584440|585142737|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
162023528|NCT01584440|585142738|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
162023529|NCT01584440|585142739|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
162023530|NCT01584440|585142740|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
162023531|NCT01584440|585142736|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
162023532|NCT01584440|585142737|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
162023533|NCT01584440|585142738|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
162023534|NCT01584440|585142739|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
162023535|NCT01584440|585142740|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
162225927|NCT03086655|585875499|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
162225928|NCT03086655|585875498|FG000|12 Month Follow-up = Final Assessment|Death|0|||
162225929|NCT03086655|585875499|FG001|12 Month Follow-up = Final Assessment|Death|1|||
162023536|NCT01584440|585142736|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
162023537|NCT01584440|585142737|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
162225930|NCT00384397|585875500|FG000|Overall Study|Adverse Event|0|||
162225931|NCT00384397|585875501|FG001|Overall Study|Adverse Event|1|||
162225932|NCT00384397|585875502|FG002|Overall Study|Adverse Event|2|||
162225933|NCT00384397|585875500|FG000|Overall Study|Protocol Violation|7|||
162225934|NCT00384397|585875501|FG001|Overall Study|Protocol Violation|15|||
162225935|NCT00384397|585875502|FG002|Overall Study|Protocol Violation|13|||
162225936|NCT00384397|585875500|FG000|Overall Study|Lost to Follow-up|11|||
162225937|NCT00384397|585875501|FG001|Overall Study|Lost to Follow-up|13|||
162023538|NCT01584440|585142738|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
162023539|NCT01584440|585142739|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
162023540|NCT01584440|585142740|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
162023541|NCT04237116|585142741|FG000|Overall Study|Adverse Event|0|||
162225938|NCT00384397|585875502|FG002|Overall Study|Lost to Follow-up|3|||
162225939|NCT00384397|585875500|FG000|Overall Study|Withdrawal by Subject|14|||
162023542|NCT04237116|585142742|FG001|Overall Study|Adverse Event|1|||
162023543|NCT04237116|585142741|FG000|Overall Study|Study terminated by Sponsor|4|||
162225940|NCT00384397|585875501|FG001|Overall Study|Withdrawal by Subject|17|||
162225941|NCT00384397|585875502|FG002|Overall Study|Withdrawal by Subject|15|||
162225942|NCT04531982|585875503|FG000|Overall Study|Withdrawal by Subject|10|||
162225943|NCT04531982|585875504|FG001|Overall Study|Withdrawal by Subject|11|||
162225944|NCT04531982|585875503|FG000|Overall Study|Adverse Event|6|||
162225945|NCT04531982|585875504|FG001|Overall Study|Adverse Event|14|||
162225946|NCT04531982|585875503|FG000|Overall Study|Protocol Violation|6|||
162225947|NCT04531982|585875504|FG001|Overall Study|Protocol Violation|9|||
162225948|NCT04531982|585875503|FG000|Overall Study|Non-compliance with study drug|3|||
162225949|NCT04531982|585875504|FG001|Overall Study|Non-compliance with study drug|2|||
162225950|NCT04531982|585875503|FG000|Overall Study|Use of prohibited medication|2|||
162225951|NCT04531982|585875504|FG001|Overall Study|Use of prohibited medication|0|||
162225952|NCT04531982|585875503|FG000|Overall Study|Lost to Follow-up|0|||
162225953|NCT04531982|585875504|FG001|Overall Study|Lost to Follow-up|1|||
162225954|NCT04531982|585875503|FG000|Overall Study|Geopolitical conflict|2|||
162225955|NCT04531982|585875504|FG001|Overall Study|Geopolitical conflict|0|||
162225956|NCT04531982|585875503|FG000|Overall Study|Lack of Efficacy|3|||
162225957|NCT04531982|585875504|FG001|Overall Study|Lack of Efficacy|1|||
162225958|NCT06748729|585875506|FG000|Overall Study|Withdrawal by Subject|1|||
162225959|NCT01732822|585877563|FG000|Overall Study|Withdrawal by Subject|123|||
162225960|NCT01732822|585877564|FG001|Overall Study|Withdrawal by Subject|113|||
162225961|NCT02314780|585877565|FG000|Overall Study|organizational reasons|0|||
162225962|NCT02314780|585877566|FG001|Overall Study|organizational reasons|2|||
162225963|NCT02314780|585877567|FG002|Overall Study|organizational reasons|0|||
162225964|NCT02314780|585877565|FG000|Overall Study|Adverse Event|0|||
162225965|NCT02314780|585877566|FG001|Overall Study|Adverse Event|1|||
162225966|NCT02314780|585877567|FG002|Overall Study|Adverse Event|0|||
162225967|NCT00379288|585877568|FG000|Overall Study|Adverse Event|5|||
162225968|NCT00379288|585877569|FG001|Overall Study|Adverse Event|6|||
162225969|NCT00379288|585877570|FG002|Overall Study|Adverse Event|2|||
162225970|NCT00379288|585877571|FG003|Overall Study|Adverse Event|0|||
162225971|NCT00379288|585877568|FG000|Overall Study|Treatment Failure|0|||
162225972|NCT00379288|585877569|FG001|Overall Study|Treatment Failure|1|||
162225973|NCT00379288|585877570|FG002|Overall Study|Treatment Failure|0|||
162225974|NCT00379288|585877571|FG003|Overall Study|Treatment Failure|1|||
162225975|NCT00379288|585877568|FG000|Overall Study|Lost to Follow-up|3|||
162225976|NCT00379288|585877569|FG001|Overall Study|Lost to Follow-up|3|||
162225977|NCT00379288|585877570|FG002|Overall Study|Lost to Follow-up|2|||
162225978|NCT00379288|585877571|FG003|Overall Study|Lost to Follow-up|0|||
162225979|NCT00379288|585877568|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
162225980|NCT00379288|585877569|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
162225981|NCT00379288|585877570|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
162225982|NCT00379288|585877571|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
162225983|NCT00379288|585877568|FG000|Overall Study|Subject withdrew-related to study drug|1|||
162225984|NCT00379288|585877569|FG001|Overall Study|Subject withdrew-related to study drug|0|||
162225985|NCT00379288|585877570|FG002|Overall Study|Subject withdrew-related to study drug|0|||
162225986|NCT00379288|585877571|FG003|Overall Study|Subject withdrew-related to study drug|1|||
162225987|NCT00379288|585877568|FG000|Overall Study|Noncompliance with protocol|8|||
162225988|NCT00379288|585877569|FG001|Overall Study|Noncompliance with protocol|6|||
162225989|NCT00379288|585877570|FG002|Overall Study|Noncompliance with protocol|2|||
162225990|NCT00379288|585877571|FG003|Overall Study|Noncompliance with protocol|1|||
162225991|NCT00379288|585877568|FG000|Overall Study|Did not meet protocol eligibility|0|||
162225992|NCT00379288|585877569|FG001|Overall Study|Did not meet protocol eligibility|1|||
162225993|NCT00379288|585877570|FG002|Overall Study|Did not meet protocol eligibility|0|||
162225994|NCT00379288|585877571|FG003|Overall Study|Did not meet protocol eligibility|2|||
162225995|NCT00379288|585877568|FG000|Overall Study|Administrative|2|||
162225996|NCT00379288|585877569|FG001|Overall Study|Administrative|2|||
162225997|NCT00379288|585877570|FG002|Overall Study|Administrative|0|||
162225998|NCT00379288|585877571|FG003|Overall Study|Administrative|1|||
162225999|NCT01183260|585877572|FG000|Overall Study|Intraop screen failure|2|||
162023544|NCT04237116|585142742|FG001|Overall Study|Study terminated by Sponsor|1|||
162023545|NCT00899431|585142743|FG000|Overall Study|Physician Decision|1|||
162023546|NCT00899431|585142744|FG001|Overall Study|Physician Decision|0|||
162023547|NCT00899431|585142745|FG002|Overall Study|Physician Decision|0|||
162226000|NCT01183260|585877573|FG001|Overall Study|Intraop screen failure|0|||
162226001|NCT01183260|585877572|FG000|Overall Study|Withdrawal by Subject|1|||
162226002|NCT01183260|585877573|FG001|Overall Study|Withdrawal by Subject|1|||
162226003|NCT01183260|585877572|FG000|Overall Study|Revised within 30 days|0|||
162226004|NCT01183260|585877573|FG001|Overall Study|Revised within 30 days|1|||
162226005|NCT01183260|585877572|FG000|Overall Study|Death|1|||
162226006|NCT01183260|585877573|FG001|Overall Study|Death|0|||
162226007|NCT00095056|585877576|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
162226008|NCT00095056|585877577|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
162226009|NCT00095056|585877576|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
162226010|NCT00095056|585877577|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
162226011|NCT00095056|585877576|FG000|Phase A (Weeks 0-12)|Death|1|||
162226012|NCT00095056|585877577|FG001|Phase A (Weeks 0-12)|Death|0|||
162226013|NCT00095056|585877576|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
162226014|NCT00095056|585877577|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
162226015|NCT00095056|585877576|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
162226016|NCT00095056|585877577|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
162226017|NCT00095056|585877576|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
162226018|NCT00095056|585877577|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
162226019|NCT00095056|585877576|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
162226020|NCT00095056|585877577|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
162226021|NCT00095056|585877576|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
162226022|NCT00095056|585877577|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
162226023|NCT00095056|585877576|FG000|Phase B (Weeks 12-54)|Death|3|||
162226024|NCT00095056|585877577|FG001|Phase B (Weeks 12-54)|Death|1|||
162226025|NCT00095056|585877576|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
162226026|NCT00095056|585877577|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
162226027|NCT00095056|585877576|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
162226028|NCT00095056|585877577|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
162226029|NCT02735577|585877581|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
162226030|NCT02735577|585877581|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
162226031|NCT00833833|585877582|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
162226032|NCT00833833|585877583|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
162226033|NCT00833833|585877584|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
162226034|NCT00833833|585877585|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
162226035|NCT00833833|585877586|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
162226036|NCT00833833|585877587|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
162226037|NCT00833833|585877582|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
162226038|NCT00833833|585877583|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
162226039|NCT00833833|585877584|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
162226040|NCT00833833|585877585|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
162226041|NCT00833833|585877586|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
162226042|NCT00833833|585877587|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
162226043|NCT00833833|585877582|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
162226044|NCT00833833|585877583|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
162226045|NCT00833833|585877584|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
162226046|NCT00833833|585877585|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
162226047|NCT00833833|585877586|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
162226048|NCT00833833|585877587|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
162226049|NCT00833833|585877582|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
162226050|NCT00833833|585877583|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
162226051|NCT00833833|585877584|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
162226052|NCT00833833|585877585|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
162226053|NCT00833833|585877586|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
162226054|NCT00833833|585877587|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
162226055|NCT00833833|585877582|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
162226056|NCT00833833|585877583|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162226057|NCT00833833|585877584|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
162226058|NCT00833833|585877585|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162226059|NCT00833833|585877586|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162226060|NCT00833833|585877587|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162226061|NCT00833833|585877582|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
162226062|NCT00833833|585877583|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
162226063|NCT00833833|585877584|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
162226064|NCT00833833|585877585|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
162226065|NCT00833833|585877586|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
162226066|NCT00833833|585877587|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
162226067|NCT00833833|585877582|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
162226068|NCT00833833|585877583|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
162226069|NCT00833833|585877584|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
162226070|NCT00833833|585877585|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
162226071|NCT00833833|585877586|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
162226072|NCT00833833|585877587|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
162226073|NCT00833833|585877582|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
162226074|NCT00833833|585877583|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
162226075|NCT00833833|585877584|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
162226076|NCT00833833|585877585|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
162226077|NCT00833833|585877586|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
162226078|NCT00833833|585877587|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
162226079|NCT00833833|585877582|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
162226080|NCT00833833|585877583|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
162226081|NCT00833833|585877584|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
162226082|NCT00833833|585877585|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
162226083|NCT00833833|585877586|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
162226084|NCT00833833|585877587|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
162226085|NCT00833833|585877582|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162226086|NCT00833833|585877583|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162226087|NCT00833833|585877584|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162226088|NCT00833833|585877585|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
162226089|NCT00833833|585877586|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
162226090|NCT00833833|585877587|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
162226091|NCT00833833|585877582|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
162226092|NCT00833833|585877583|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
162226093|NCT00833833|585877584|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
162226094|NCT00833833|585877585|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
162226095|NCT00833833|585877586|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
162226096|NCT00833833|585877587|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
162226097|NCT00833833|585877582|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
162226098|NCT00833833|585877583|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
162226099|NCT00833833|585877584|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
162226100|NCT00833833|585877585|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
162226101|NCT00833833|585877586|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
162226102|NCT00833833|585877587|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
162226103|NCT00833833|585877582|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
162226104|NCT00833833|585877583|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
162226105|NCT00833833|585877584|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
162226106|NCT00833833|585877585|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
162226107|NCT00833833|585877586|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
162226108|NCT00833833|585877587|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
162226109|NCT02040259|585877588|FG000|Overall Study|Death|280|||
162226110|NCT02040259|585877588|FG000|Overall Study|Lost to Follow-up|76|||
162226111|NCT02040259|585877588|FG000|Overall Study|Assessment not completed|3|||
162226112|NCT02040259|585877588|FG000|Overall Study|Withdrawal by Subject|4|||
162226113|NCT00316602|585877598|FG000|Overall Study|Withdrawal by Subject|3|||
162226114|NCT00316602|585877599|FG001|Overall Study|Withdrawal by Subject|2|||
162226115|NCT00316602|585877598|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
162226116|NCT00316602|585877599|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
162226117|NCT00316602|585877598|FG000|Overall Study|Adverse Event|1|||
162226118|NCT00316602|585877599|FG001|Overall Study|Adverse Event|0|||
162226119|NCT00316602|585877598|FG000|Overall Study|Other|3|||
162226120|NCT00316602|585877599|FG001|Overall Study|Other|6|||
162226121|NCT01142232|585877600|FG000|Overall Study|Adverse Event|1|||
162226122|NCT01142232|585877601|FG001|Overall Study|Adverse Event|2|||
162226123|NCT01142232|585877602|FG002|Overall Study|Adverse Event|1|||
162226124|NCT01142232|585877603|FG003|Overall Study|Adverse Event|0|||
162226125|NCT01142232|585877604|FG004|Overall Study|Adverse Event|4|||
162226126|NCT01142232|585877600|FG000|Overall Study|Death|0|||
162226127|NCT01142232|585877601|FG001|Overall Study|Death|0|||
162226128|NCT01142232|585877602|FG002|Overall Study|Death|0|||
162226129|NCT01142232|585877603|FG003|Overall Study|Death|0|||
162226130|NCT01142232|585877604|FG004|Overall Study|Death|1|||
162226131|NCT01142232|585877600|FG000|Overall Study|Disease Progression|2|||
162226132|NCT01142232|585877601|FG001|Overall Study|Disease Progression|0|||
162226133|NCT01142232|585877602|FG002|Overall Study|Disease Progression|1|||
162023548|NCT03212144|585142746|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
162226134|NCT01142232|585877603|FG003|Overall Study|Disease Progression|2|||
162226135|NCT01142232|585877604|FG004|Overall Study|Disease Progression|12|||
162226136|NCT01142232|585877600|FG000|Overall Study|Withdrawal by Subject|0|||
162226137|NCT01142232|585877601|FG001|Overall Study|Withdrawal by Subject|0|||
162226138|NCT01142232|585877602|FG002|Overall Study|Withdrawal by Subject|0|||
162226139|NCT01142232|585877603|FG003|Overall Study|Withdrawal by Subject|1|||
162226140|NCT01142232|585877604|FG004|Overall Study|Withdrawal by Subject|3|||
162226141|NCT01142232|585877600|FG000|Overall Study|Physician Decision|0|||
162226142|NCT01142232|585877601|FG001|Overall Study|Physician Decision|1|||
162226143|NCT01142232|585877602|FG002|Overall Study|Physician Decision|0|||
162226144|NCT01142232|585877603|FG003|Overall Study|Physician Decision|2|||
162226145|NCT01142232|585877604|FG004|Overall Study|Physician Decision|10|||
162226146|NCT01142232|585877600|FG000|Overall Study|Alternative Therapy|0|||
162226147|NCT01142232|585877601|FG001|Overall Study|Alternative Therapy|1|||
162226148|NCT01142232|585877602|FG002|Overall Study|Alternative Therapy|1|||
162226149|NCT01142232|585877603|FG003|Overall Study|Alternative Therapy|0|||
162226150|NCT01142232|585877604|FG004|Overall Study|Alternative Therapy|1|||
162226151|NCT01142232|585877600|FG000|Overall Study|Off Trt for other complicating disease|0|||
162226152|NCT01142232|585877601|FG001|Overall Study|Off Trt for other complicating disease|0|||
162226153|NCT01142232|585877602|FG002|Overall Study|Off Trt for other complicating disease|0|||
162226154|NCT01142232|585877603|FG003|Overall Study|Off Trt for other complicating disease|0|||
162226155|NCT01142232|585877604|FG004|Overall Study|Off Trt for other complicating disease|1|||
162226156|NCT01142232|585877600|FG000|Overall Study|Noncompliance|0|||
162226157|NCT01142232|585877601|FG001|Overall Study|Noncompliance|0|||
162226158|NCT01142232|585877602|FG002|Overall Study|Noncompliance|0|||
162226159|NCT01142232|585877603|FG003|Overall Study|Noncompliance|0|||
162226160|NCT01142232|585877604|FG004|Overall Study|Noncompliance|2|||
162226161|NCT00626990|585877605|FG000|Overall Study|Lack of Efficacy|6|||
162226162|NCT00626990|585877606|FG001|Overall Study|Lack of Efficacy|7|||
162226163|NCT00626990|585877607|FG002|Overall Study|Lack of Efficacy|49|||
162226164|NCT00626990|585877608|FG003|Overall Study|Lack of Efficacy|40|||
162226165|NCT00626990|585877605|FG000|Overall Study|Adverse Event|1|||
162226166|NCT00626990|585877606|FG001|Overall Study|Adverse Event|7|||
162226167|NCT00626990|585877607|FG002|Overall Study|Adverse Event|14|||
162226168|NCT00626990|585877608|FG003|Overall Study|Adverse Event|28|||
162226169|NCT00626990|585877605|FG000|Overall Study|Death|0|||
162226170|NCT00626990|585877606|FG001|Overall Study|Death|1|||
162226171|NCT00626990|585877607|FG002|Overall Study|Death|0|||
162226172|NCT00626990|585877608|FG003|Overall Study|Death|0|||
162226173|NCT00626990|585877605|FG000|Overall Study|Withdrawal by Subject|3|||
162226174|NCT00626990|585877606|FG001|Overall Study|Withdrawal by Subject|1|||
162226175|NCT00626990|585877607|FG002|Overall Study|Withdrawal by Subject|5|||
162226176|NCT00626990|585877608|FG003|Overall Study|Withdrawal by Subject|11|||
162226177|NCT00626990|585877605|FG000|Overall Study|Protocol Violation|0|||
162226178|NCT00626990|585877606|FG001|Overall Study|Protocol Violation|1|||
162226179|NCT00626990|585877607|FG002|Overall Study|Protocol Violation|1|||
162226180|NCT00626990|585877608|FG003|Overall Study|Protocol Violation|0|||
162226181|NCT00626990|585877605|FG000|Overall Study|Various different reasons/missing|4|||
162226182|NCT00626990|585877606|FG001|Overall Study|Various different reasons/missing|8|||
162226183|NCT00626990|585877607|FG002|Overall Study|Various different reasons/missing|8|||
162226184|NCT00626990|585877608|FG003|Overall Study|Various different reasons/missing|16|||
162226185|NCT01802567|585877611|FG000|Overall Study|Withdrawal by Subject|2|||
162226186|NCT01802567|585877611|FG000|Overall Study|Physician Decision|1|||
162226187|NCT01802567|585877611|FG000|Overall Study|Lack of Efficacy|7|||
162226188|NCT01802567|585877611|FG000|Overall Study|Consented but did not start therapy|7|||
162226189|NCT01802567|585877611|FG000|Overall Study|Protocol Violation|1|||
162226190|NCT01895101|585877612|FG000|Overall Study|OPCAB procedure|1|||
162226191|NCT01895101|585877613|FG001|Overall Study|OPCAB procedure|1|||
162226192|NCT01895101|585877614|FG002|Overall Study|OPCAB procedure|3|||
162226193|NCT01895101|585877612|FG000|Overall Study|Withdrawal by Subject|0|||
162226194|NCT01895101|585877613|FG001|Overall Study|Withdrawal by Subject|1|||
162226195|NCT01895101|585877614|FG002|Overall Study|Withdrawal by Subject|2|||
162226196|NCT01895101|585877612|FG000|Overall Study|another study, enrolled in other study|0|||
162226197|NCT01895101|585877613|FG001|Overall Study|another study, enrolled in other study|1|||
162226198|NCT01895101|585877614|FG002|Overall Study|another study, enrolled in other study|0|||
162226199|NCT01895101|585877612|FG000|Overall Study|Death|0|||
162226200|NCT01895101|585877613|FG001|Overall Study|Death|1|||
162226201|NCT01895101|585877614|FG002|Overall Study|Death|0|||
162226202|NCT01895101|585877612|FG000|Overall Study|coagulation disorder|0|||
162226203|NCT01895101|585877613|FG001|Overall Study|coagulation disorder|1|||
162226204|NCT01895101|585877614|FG002|Overall Study|coagulation disorder|0|||
162226205|NCT03268603|585877615|FG000|Overall Study|Withdrawal by Subject|6|||
162226206|NCT03268603|585877615|FG000|Overall Study|Physician Decision|1|||
162226207|NCT03268603|585877615|FG000|Overall Study|Withdrawn due to disease progression|2|||
162226208|NCT03248882|585877616|FG000|Overall Study|Adverse Event|3|||
162226209|NCT03248882|585877617|FG001|Overall Study|Adverse Event|3|||
162226210|NCT03248882|585877618|FG002|Overall Study|Adverse Event|2|||
162226211|NCT03248882|585877619|FG003|Overall Study|Adverse Event|6|||
162226212|NCT03248882|585877620|FG004|Overall Study|Adverse Event|9|||
162226213|NCT03248882|585877616|FG000|Overall Study|Lost to Follow-up|0|||
162226214|NCT03248882|585877617|FG001|Overall Study|Lost to Follow-up|0|||
162226215|NCT03248882|585877618|FG002|Overall Study|Lost to Follow-up|0|||
162226216|NCT03248882|585877619|FG003|Overall Study|Lost to Follow-up|0|||
161829396|NCT00892281|584415775|FG000|Overall Study|Protocol Violation|7|||
162226217|NCT03248882|585877620|FG004|Overall Study|Lost to Follow-up|1|||
162226218|NCT03248882|585877616|FG000|Overall Study|Protocol Violation|2|||
162226219|NCT03248882|585877617|FG001|Overall Study|Protocol Violation|0|||
162226220|NCT03248882|585877618|FG002|Overall Study|Protocol Violation|2|||
162226221|NCT03248882|585877619|FG003|Overall Study|Protocol Violation|0|||
162226222|NCT03248882|585877620|FG004|Overall Study|Protocol Violation|1|||
162226223|NCT03248882|585877616|FG000|Overall Study|Withdrawal by Subject|2|||
162226224|NCT03248882|585877617|FG001|Overall Study|Withdrawal by Subject|2|||
162226225|NCT03248882|585877618|FG002|Overall Study|Withdrawal by Subject|3|||
162226226|NCT03248882|585877619|FG003|Overall Study|Withdrawal by Subject|4|||
162226227|NCT03248882|585877620|FG004|Overall Study|Withdrawal by Subject|2|||
162226228|NCT02182947|585877621|FG000|Overall Study|Withdrawal by Subject|7|||
162226229|NCT02182947|585877621|FG000|Overall Study|Lost to Follow-up|3|||
162226230|NCT02182947|585877621|FG000|Overall Study|Failed screening activities|8|||
162226231|NCT02236988|585877622|FG000|Overall Study|Lost to Follow-up|0|||
162226232|NCT02236988|585877623|FG001|Overall Study|Lost to Follow-up|0|||
162226233|NCT02236988|585877624|FG002|Overall Study|Lost to Follow-up|0|||
162226234|NCT02236988|585877625|FG003|Overall Study|Lost to Follow-up|1|||
162226235|NCT02236988|585877622|FG000|Overall Study|Unable to Comply with Study Visits|0|||
162226236|NCT02236988|585877623|FG001|Overall Study|Unable to Comply with Study Visits|0|||
162226237|NCT02236988|585877624|FG002|Overall Study|Unable to Comply with Study Visits|0|||
162226238|NCT02236988|585877625|FG003|Overall Study|Unable to Comply with Study Visits|2|||
162226239|NCT04308590|585877626|FG000|Overall Study|Adverse Event|12|||
162226240|NCT04308590|585877627|FG001|Overall Study|Adverse Event|2|||
162226241|NCT04308590|585877626|FG000|Overall Study|Withdrawal by Subject|10|||
162226242|NCT04308590|585877627|FG001|Overall Study|Withdrawal by Subject|4|||
162226243|NCT04308590|585877626|FG000|Overall Study|Death|1|||
162226244|NCT04308590|585877627|FG001|Overall Study|Death|0|||
162226245|NCT04308590|585877626|FG000|Overall Study|Lost to Follow-up|1|||
162226246|NCT04308590|585877627|FG001|Overall Study|Lost to Follow-up|1|||
162226247|NCT04308590|585877626|FG000|Overall Study|Physician Decision|1|||
162226248|NCT04308590|585877627|FG001|Overall Study|Physician Decision|0|||
162226249|NCT04308590|585877626|FG000|Overall Study|Subject does not want to continue with Pi|0|||
162226250|NCT04308590|585877627|FG001|Overall Study|Subject does not want to continue with Pi|1|||
162226251|NCT01156376|585877629|FG000|Overall Study|Adverse Event|1|||
162226252|NCT01156376|585877630|FG001|Overall Study|Adverse Event|0|||
162226253|NCT01156376|585877631|FG002|Overall Study|Adverse Event|1|||
162226254|NCT01156376|585877629|FG000|Overall Study|Withdrawal by Subject|0|||
162226255|NCT01156376|585877630|FG001|Overall Study|Withdrawal by Subject|0|||
162226256|NCT01156376|585877631|FG002|Overall Study|Withdrawal by Subject|3|||
162226257|NCT01493427|585877632|FG000|Overall Study|Adverse Event|10|||
162226258|NCT01493427|585877632|FG000|Overall Study|Personal Reasons|4|||
162226259|NCT01493427|585877632|FG000|Overall Study|Lost to Follow-up|2|||
162023549|NCT03212144|585142747|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
162023550|NCT03212144|585142746|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
162023551|NCT03212144|585142747|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
162023552|NCT00661427|585142750|FG000|Overall Study|Adverse Event|5|||
162023553|NCT00661427|585142751|FG001|Overall Study|Adverse Event|5|||
162023554|NCT00661427|585142750|FG000|Overall Study|Patient not treated|0|||
162023555|NCT00661427|585142751|FG001|Overall Study|Patient not treated|2|||
162023556|NCT01821560|585142752|FG000|Overall Study|Lost to Follow-up|5|||
162023557|NCT01821560|585142753|FG001|Overall Study|Lost to Follow-up|5|||
162023558|NCT01821560|585142752|FG000|Overall Study|Withdrawal by Subject|1|||
162023559|NCT01821560|585142753|FG001|Overall Study|Withdrawal by Subject|1|||
162023560|NCT01821560|585142752|FG000|Overall Study|Protocol Violation|0|||
162023561|NCT01821560|585142753|FG001|Overall Study|Protocol Violation|1|||
162023562|NCT01338298|585142754|FG000|Overall Study|Withdrawal by Subject|1|||
162023563|NCT01338298|585142755|FG001|Overall Study|Withdrawal by Subject|1|||
162023564|NCT01338298|585142754|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
162023565|NCT01338298|585142755|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
162226260|NCT01493427|585877632|FG000|Overall Study|Inability to Follow Instructions|2|||
162226261|NCT01493427|585877632|FG000|Overall Study|Other|2|||
162226262|NCT05775991|585877633|FG000|Overall Study|Withdrawal by Subject|0|||
162226263|NCT05775991|585877634|FG001|Overall Study|Withdrawal by Subject|0|||
162226264|NCT05775991|585877635|FG002|Overall Study|Withdrawal by Subject|2|||
162226265|NCT00939822|585877642|FG000|Overall Study|Lost to Follow-up|1|||
162226266|NCT00939822|585877643|FG001|Overall Study|Lost to Follow-up|0|||
162226267|NCT00939822|585877642|FG000|Overall Study|withdrew from study due to busy schedule|1|||
162226268|NCT00939822|585877643|FG001|Overall Study|withdrew from study due to busy schedule|1|||
162226269|NCT00939822|585877642|FG000|Overall Study|Mental health issues|0|||
162023566|NCT01338298|585142754|FG000|Overall Study|Administrative error|0|||
162023567|NCT01338298|585142755|FG001|Overall Study|Administrative error|1|||
162023568|NCT01338298|585142754|FG000|Overall Study|Positive symptom worsening|1|||
162023569|NCT01338298|585142755|FG001|Overall Study|Positive symptom worsening|0|||
162226270|NCT00939822|585877643|FG001|Overall Study|Mental health issues|2|||
162226271|NCT01072630|585877644|FG000|Overall Study|Adverse Event|11|||
162226272|NCT01072630|585877645|FG001|Overall Study|Adverse Event|19|||
162226273|NCT01072630|585877646|FG002|Overall Study|Adverse Event|2|||
162226274|NCT01072630|585877644|FG000|Overall Study|Lack of Efficacy|10|||
162226275|NCT01072630|585877645|FG001|Overall Study|Lack of Efficacy|10|||
162226276|NCT01072630|585877646|FG002|Overall Study|Lack of Efficacy|1|||
162226277|NCT01072630|585877644|FG000|Overall Study|Withdrawal by Subject|8|||
162226278|NCT01072630|585877645|FG001|Overall Study|Withdrawal by Subject|7|||
162226279|NCT01072630|585877646|FG002|Overall Study|Withdrawal by Subject|2|||
162226280|NCT01072630|585877644|FG000|Overall Study|Protocol Violation|10|||
162226281|NCT01072630|585877645|FG001|Overall Study|Protocol Violation|8|||
162226282|NCT01072630|585877646|FG002|Overall Study|Protocol Violation|4|||
162226283|NCT01072630|585877644|FG000|Overall Study|Lost to Follow-up|11|||
162226284|NCT01072630|585877645|FG001|Overall Study|Lost to Follow-up|11|||
162226285|NCT01072630|585877646|FG002|Overall Study|Lost to Follow-up|1|||
162226286|NCT01072630|585877644|FG000|Overall Study|Noncompliance with study medication|1|||
162226287|NCT01072630|585877645|FG001|Overall Study|Noncompliance with study medication|1|||
162226288|NCT01072630|585877646|FG002|Overall Study|Noncompliance with study medication|1|||
162226289|NCT01072630|585877644|FG000|Overall Study|Noncompliance with study procedures|1|||
162226290|NCT01072630|585877645|FG001|Overall Study|Noncompliance with study procedures|2|||
162226291|NCT01072630|585877646|FG002|Overall Study|Noncompliance with study procedures|1|||
162226292|NCT01072630|585877644|FG000|Overall Study|Other|3|||
162226293|NCT01072630|585877645|FG001|Overall Study|Other|2|||
162226294|NCT01072630|585877646|FG002|Overall Study|Other|1|||
162226295|NCT05032872|585877647|FG000|Overall Study|Adverse Event|1|||
162226296|NCT05032872|585877648|FG001|Overall Study|Adverse Event|0|||
162226297|NCT05032872|585877647|FG000|Overall Study|Lost to Follow-up|2|||
162226298|NCT05032872|585877648|FG001|Overall Study|Lost to Follow-up|4|||
162226299|NCT05032872|585877647|FG000|Overall Study|Withdrawal by Subject|4|||
162226300|NCT05032872|585877648|FG001|Overall Study|Withdrawal by Subject|3|||
162226301|NCT00338962|585877649|FG000|Overall Study|Lost to Follow-up|3|||
162226302|NCT00338962|585877650|FG001|Overall Study|Lost to Follow-up|3|||
162226303|NCT00338962|585877651|FG002|Overall Study|Lost to Follow-up|2|||
162226304|NCT00338962|585877652|FG003|Overall Study|Lost to Follow-up|3|||
162226305|NCT00338962|585877649|FG000|Overall Study|Withdrawal by Subject|1|||
162226306|NCT00338962|585877650|FG001|Overall Study|Withdrawal by Subject|0|||
162226307|NCT00338962|585877651|FG002|Overall Study|Withdrawal by Subject|0|||
162226308|NCT00338962|585877652|FG003|Overall Study|Withdrawal by Subject|0|||
162226309|NCT00338962|585877649|FG000|Overall Study|No Transportation|2|||
162226310|NCT00338962|585877650|FG001|Overall Study|No Transportation|0|||
162226311|NCT00338962|585877651|FG002|Overall Study|No Transportation|0|||
162226312|NCT00338962|585877652|FG003|Overall Study|No Transportation|0|||
162226313|NCT00338962|585877649|FG000|Overall Study|Time Constraint|2|||
162226314|NCT00338962|585877650|FG001|Overall Study|Time Constraint|0|||
162226315|NCT00338962|585877651|FG002|Overall Study|Time Constraint|0|||
162226316|NCT00338962|585877652|FG003|Overall Study|Time Constraint|0|||
162226317|NCT00338962|585877649|FG000|Overall Study|Moved|0|||
162226318|NCT00338962|585877650|FG001|Overall Study|Moved|1|||
162226319|NCT00338962|585877651|FG002|Overall Study|Moved|0|||
162226320|NCT00338962|585877652|FG003|Overall Study|Moved|0|||
162226321|NCT00338962|585877649|FG000|Overall Study|Adverse Event|0|||
162226322|NCT00338962|585877650|FG001|Overall Study|Adverse Event|0|||
162226323|NCT00338962|585877651|FG002|Overall Study|Adverse Event|2|||
162226324|NCT00338962|585877652|FG003|Overall Study|Adverse Event|0|||
162226325|NCT00338962|585877649|FG000|Overall Study|Poor Compliance|0|||
162226326|NCT00338962|585877650|FG001|Overall Study|Poor Compliance|0|||
162226327|NCT00338962|585877651|FG002|Overall Study|Poor Compliance|2|||
162226328|NCT00338962|585877652|FG003|Overall Study|Poor Compliance|0|||
162226329|NCT03733314|585877653|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
162226330|NCT03733314|585877654|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
162226331|NCT03733314|585877653|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
162226332|NCT03733314|585877654|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
162226333|NCT03733314|585877653|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
162226334|NCT03733314|585877654|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
162226335|NCT03733314|585877653|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
162226336|NCT03733314|585877654|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
162226337|NCT03733314|585877653|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
162226338|NCT03733314|585877654|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
162226339|NCT03733314|585877653|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
162226340|NCT03733314|585877654|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
162226341|NCT01598662|585877655|FG000|Overall Study|Lost to Follow-up|10|||
162226342|NCT01598662|585877656|FG001|Overall Study|Lost to Follow-up|17|||
161829397|NCT00892281|584415776|FG001|Overall Study|Protocol Violation|2|||
162226343|NCT01598662|585877655|FG000|Overall Study|Physician Decision|1|||
162226344|NCT01598662|585877656|FG001|Overall Study|Physician Decision|2|||
162226345|NCT01598662|585877655|FG000|Overall Study|IUD expelled before month 6|0|||
162226346|NCT01598662|585877656|FG001|Overall Study|IUD expelled before month 6|2|||
162226347|NCT00910039|585877657|FG000|Overall Study|Physician Decision|1|||
162226348|NCT04155047|585877662|FG000|Overall Study|Adverse Event|1|||
162226349|NCT04155047|585877663|FG001|Overall Study|Adverse Event|0|||
162226350|NCT04155047|585877662|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
162226351|NCT04155047|585877663|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
162226352|NCT04514510|585877664|FG000|Overall Study|Lost to Follow-up|0|||
162226353|NCT04514510|585877665|FG001|Overall Study|Lost to Follow-up|1|||
162226354|NCT04514510|585877664|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
162226355|NCT04514510|585877665|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
162226356|NCT00821587|585877666|FG000|Overall Study|Physician Decision|0|||
162226357|NCT00821587|585877667|FG001|Overall Study|Physician Decision|1|||
162226358|NCT02781090|585877670|FG000|3-Month Follow-Up|Missed Visit|20|||
162226359|NCT02781090|585877671|FG001|3-Month Follow-Up|Missed Visit|20|||
162226360|NCT02781090|585877670|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
162226361|NCT02781090|585877671|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
162226362|NCT02781090|585877670|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
162226363|NCT02781090|585877671|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
162226364|NCT02781090|585877670|FG000|3-Month Follow-Up|Death|1|||
162226365|NCT02781090|585877671|FG001|3-Month Follow-Up|Death|0|||
162226366|NCT02781090|585877670|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
162226367|NCT02781090|585877671|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
162226368|NCT02781090|585877670|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
162226369|NCT02781090|585877671|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
162226370|NCT02781090|585877670|FG000|6-Month Follow-Up|Death|0|||
162226371|NCT02781090|585877671|FG001|6-Month Follow-Up|Death|1|||
162226372|NCT00643617|585877672|FG000|Overall Study|Death|6|||
162226373|NCT00643617|585877673|FG001|Overall Study|Death|9|||
162226374|NCT00643617|585877672|FG000|Overall Study|Lost to Follow-up|42|||
162226375|NCT00643617|585877673|FG001|Overall Study|Lost to Follow-up|51|||
162226376|NCT02075073|585877674|FG000|Overall Study|Withdrawal by Subject|0|||
162226377|NCT02075073|585877675|FG001|Overall Study|Withdrawal by Subject|1|||
162226378|NCT02075073|585877676|FG002|Overall Study|Withdrawal by Subject|0|||
162226379|NCT01208103|585877683|FG000|Overall Study|Adverse Event|1|||
162226380|NCT01208103|585877683|FG000|Overall Study|Withdrawal by Subject|1|||
162226381|NCT02683785|585877686|FG000|Overall Study|Withdrawal by Subject|1|||
162226382|NCT02683785|585877687|FG001|Overall Study|Withdrawal by Subject|1|||
162226383|NCT02683785|585877686|FG000|Overall Study|Lost to Follow-up|0|||
162226384|NCT02683785|585877687|FG001|Overall Study|Lost to Follow-up|1|||
162226385|NCT02683785|585877686|FG000|Overall Study|Adverse Event|0|||
162226386|NCT02683785|585877687|FG001|Overall Study|Adverse Event|2|||
162226387|NCT00416195|585877688|FG000|Overall Study|Adverse Event|1|||
162226388|NCT00416195|585877689|FG001|Overall Study|Adverse Event|2|||
162226389|NCT00416195|585877688|FG000|Overall Study|Protocol Violation|1|||
162226390|NCT00416195|585877689|FG001|Overall Study|Protocol Violation|1|||
162226391|NCT00416195|585877688|FG000|Overall Study|Other|0|||
162226392|NCT00416195|585877689|FG001|Overall Study|Other|1|||
162226393|NCT01305408|585877694|FG000|Overall Study|Adverse Event|10|||
162226394|NCT01305408|585877695|FG001|Overall Study|Adverse Event|7|||
162226395|NCT01305408|585877694|FG000|Overall Study|Lack of Efficacy|3|||
162226396|NCT01305408|585877695|FG001|Overall Study|Lack of Efficacy|4|||
162226397|NCT01305408|585877694|FG000|Overall Study|Withdrawal by Subject|9|||
162226398|NCT01305408|585877695|FG001|Overall Study|Withdrawal by Subject|9|||
162226399|NCT01305408|585877694|FG000|Overall Study|Protocol Violation|4|||
162226400|NCT01305408|585877695|FG001|Overall Study|Protocol Violation|6|||
162226401|NCT01305408|585877694|FG000|Overall Study|Lost to Follow-up|5|||
162226402|NCT01305408|585877695|FG001|Overall Study|Lost to Follow-up|3|||
162226403|NCT01305408|585877694|FG000|Overall Study|Noncompliance with study medication|0|||
162226404|NCT01305408|585877695|FG001|Overall Study|Noncompliance with study medication|1|||
162226405|NCT01305408|585877694|FG000|Overall Study|Noncompliance with study procedures|0|||
162226406|NCT01305408|585877695|FG001|Overall Study|Noncompliance with study procedures|1|||
162226407|NCT01305408|585877694|FG000|Overall Study|Other|1|||
162226408|NCT01305408|585877695|FG001|Overall Study|Other|0|||
162226409|NCT02770612|585877696|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
162226410|NCT02233803|585877697|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
162226411|NCT02233803|585877698|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
162226412|NCT02233803|585877697|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
162226413|NCT02233803|585877698|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
162226414|NCT02233803|585877697|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
162226415|NCT02233803|585877698|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
162226416|NCT02233803|585877697|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
162226417|NCT02233803|585877698|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
162226418|NCT02233803|585877697|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
162226419|NCT02233803|585877698|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
162226420|NCT02233803|585877697|FG000|Washout Period (4-Wks)|Physician Decision|1|||
162226421|NCT02233803|585877698|FG001|Washout Period (4-Wks)|Physician Decision|0|||
162226422|NCT02233803|585877697|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
162226423|NCT02233803|585877698|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
162226424|NCT02233803|585877697|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
162226425|NCT02233803|585877698|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
162226426|NCT02233803|585877697|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
162226427|NCT02233803|585877698|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
162226428|NCT03846453|585877699|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
162226429|NCT03846453|585877700|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
162226430|NCT03846453|585877701|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
162226431|NCT03846453|585877699|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
162226432|NCT03846453|585877700|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
162226433|NCT03846453|585877701|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
162226434|NCT03846453|585877699|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
162226435|NCT03846453|585877700|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
162226436|NCT03846453|585877701|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
162226437|NCT03846453|585877699|FG000|Placebo Run-in (14 Days)|Other|2|||
162226438|NCT03846453|585877700|FG001|Placebo Run-in (14 Days)|Other|0|||
162226439|NCT03846453|585877701|FG002|Placebo Run-in (14 Days)|Other|0|||
162226440|NCT03846453|585877699|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
162226441|NCT03846453|585877700|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
162226442|NCT03846453|585877701|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
162226443|NCT03846453|585877699|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
162226444|NCT03846453|585877700|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
162226445|NCT03846453|585877701|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
162226446|NCT03846453|585877699|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
162226447|NCT03846453|585877700|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
162226448|NCT03846453|585877701|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
162226449|NCT03846453|585877699|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
162226450|NCT03846453|585877700|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
162226451|NCT03846453|585877701|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
162226452|NCT03846453|585877699|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
162226453|NCT03846453|585877700|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
162226454|NCT03846453|585877701|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
162226455|NCT00468143|585877702|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
162226456|NCT00468143|585877703|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
162226457|NCT00468143|585877702|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
162226458|NCT00468143|585877703|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
162226459|NCT01606670|585877706|FG000|Overall Study|Adverse Event|6|||
162226460|NCT01606670|585877706|FG000|Overall Study|Lack of Efficacy|2|||
162226461|NCT01606670|585877706|FG000|Overall Study|Lost to Follow-up|3|||
162226462|NCT01606670|585877706|FG000|Overall Study|Withdrawal by Subject|3|||
162226463|NCT01606670|585877706|FG000|Overall Study|Other Reason|2|||
162226464|NCT00886795|585877711|FG000|Overall Study|Lack of Efficacy|1|||
162226465|NCT01877239|585877714|FG000|Overall Study|Adverse Event|4|||
162226466|NCT01877239|585877714|FG000|Overall Study|Disease Remission|1|||
162226467|NCT01877239|585877714|FG000|Overall Study|Withdrawal by Subject|4|||
162226468|NCT01877239|585877714|FG000|Overall Study|Other|2|||
162226469|NCT01877239|585877714|FG000|Overall Study|Lack of Efficacy|4|||
161940077|NCT04197583|584830734|FG001|Overall Study|Screen Failure|20|||
161940078|NCT04134936|584830738|FG000|Overall Study|Adverse Event|3|||
161940079|NCT04134936|584830739|FG001|Overall Study|Adverse Event|2|||
161940080|NCT04134936|584830738|FG000|Overall Study|Withdrawal by Subject|2|||
161940081|NCT04134936|584830739|FG001|Overall Study|Withdrawal by Subject|3|||
161940082|NCT04134936|584830738|FG000|Overall Study|Physician Decision|0|||
161940083|NCT04134936|584830739|FG001|Overall Study|Physician Decision|1|||
161940084|NCT04134936|584830738|FG000|Overall Study|Progressive disease, joined another trial|1|||
161940085|NCT04134936|584830739|FG001|Overall Study|Progressive disease, joined another trial|0|||
161940086|NCT04134936|584830738|FG000|Overall Study|Progressive disease|1|||
161940087|NCT04134936|584830739|FG001|Overall Study|Progressive disease|0|||
161940088|NCT04629196|584830740|FG000|Overall Study|Subject discontinued study drug|1|||
161940089|NCT04629196|584830741|FG001|Overall Study|Subject discontinued study drug|0|||
161940090|NCT04629196|584830740|FG000|Overall Study|Subject study drug dosing increased|1|||
161940091|NCT04629196|584830741|FG001|Overall Study|Subject study drug dosing increased|1|||
162226470|NCT01877239|585877714|FG000|Overall Study|Data not available|35|||
162226471|NCT01989169|585877717|FG000|Period 2|Adverse Event|0|||
162226472|NCT01989169|585877718|FG001|Period 2|Adverse Event|1|||
162226473|NCT01114880|585877719|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
162226474|NCT01114880|585877720|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
162226475|NCT01114880|585877719|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
162226476|NCT01114880|585877720|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
162226477|NCT01114880|585877719|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
162226478|NCT01114880|585877720|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
162226479|NCT01114880|585877719|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
162226480|NCT01114880|585877720|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
162226481|NCT01114880|585877719|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
162226482|NCT01114880|585877720|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
162226483|NCT01114880|585877719|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
162226484|NCT01114880|585877720|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
162226485|NCT04531904|585877722|FG000|Overall Study|Lost to Follow-up|1|||
162226486|NCT04531904|585877722|FG000|Overall Study|Death|14|||
162226487|NCT00283244|585877723|FG000|Overall Study|Adverse Event|0|||
162226488|NCT00283244|585877724|FG001|Overall Study|Adverse Event|8|||
162226489|NCT00283244|585877725|FG002|Overall Study|Adverse Event|11|||
162226490|NCT00283244|585877723|FG000|Overall Study|Death|4|||
162226491|NCT00283244|585877724|FG001|Overall Study|Death|3|||
162226492|NCT00283244|585877725|FG002|Overall Study|Death|2|||
162226493|NCT00283244|585877723|FG000|Overall Study|Lack of Efficacy|8|||
162226494|NCT00283244|585877724|FG001|Overall Study|Lack of Efficacy|32|||
162226495|NCT00283244|585877725|FG002|Overall Study|Lack of Efficacy|26|||
162226496|NCT00283244|585877723|FG000|Overall Study|Withdrawal by Subject|1|||
162226497|NCT00283244|585877724|FG001|Overall Study|Withdrawal by Subject|2|||
162226498|NCT00283244|585877725|FG002|Overall Study|Withdrawal by Subject|2|||
162226499|NCT00283244|585877723|FG000|Overall Study|Physician Decision|0|||
162226500|NCT00283244|585877724|FG001|Overall Study|Physician Decision|0|||
162226501|NCT00283244|585877725|FG002|Overall Study|Physician Decision|1|||
162226502|NCT00283244|585877723|FG000|Overall Study|Medical illness (other complicating dz)|4|||
162226503|NCT00283244|585877724|FG001|Overall Study|Medical illness (other complicating dz)|3|||
162226504|NCT00283244|585877725|FG002|Overall Study|Medical illness (other complicating dz)|6|||
162226505|NCT00283244|585877723|FG000|Overall Study|Clinical deterioration|1|||
162226506|NCT00283244|585877724|FG001|Overall Study|Clinical deterioration|3|||
162226507|NCT00283244|585877725|FG002|Overall Study|Clinical deterioration|3|||
162226508|NCT02738853|585877728|FG000|Enrollment|Inclusion/Exclusion not met|21|||
162226509|NCT02738853|585877728|FG000|Enrollment|Withdrawal by Subject|3|||
162226510|NCT02738853|585877728|FG000|Enrollment|Subject treated with commercially available device|6|||
162226511|NCT02738853|585877728|FG000|Enrollment|Study Enrollment Closed|3|||
162226512|NCT02738853|585877728|FG000|Procedure|Death|1|||
162226513|NCT02738853|585877728|FG000|1 Month|Death|2|||
162226514|NCT02738853|585877728|FG000|6 Month|Death|4|||
162226515|NCT02738853|585877728|FG000|6 Month|Withdrawal by Subject|2|||
162226516|NCT02738853|585877728|FG000|1 Year|Death|6|||
162226517|NCT02738853|585877728|FG000|1 Year|Withdrawal by Subject|1|||
162226518|NCT02738853|585877728|FG000|2 Year|Death|2|||
162226519|NCT02738853|585877728|FG000|2 Year|Lost to Follow-up|1|||
162226520|NCT02738853|585877728|FG000|3 Year|Death|2|||
162226521|NCT02738853|585877728|FG000|3 Year|Withdrawal by Subject|1|||
162226522|NCT02738853|585877728|FG000|4 Year|Death|9|||
162226523|NCT02738853|585877728|FG000|5 Year|Lost to Follow-up|4|||
162226524|NCT03519997|585877729|FG000|Overall Study|Adverse Event|4|||
162226525|NCT03519997|585877729|FG000|Overall Study|Withdrawal by Subject|2|||
162226526|NCT03519997|585877729|FG000|Overall Study|Protocol Violation|1|||
162226527|NCT03361605|585877730|FG000|Overall Study|Analyzable data not available|3|||
162226528|NCT03520712|585877731|FG000|Overall Study|Early termination of the study by Sponsor|2|||
162226529|NCT04372121|585877732|FG000|Overall Study|Lost to Follow-up|0|||
162226530|NCT04372121|585877733|FG001|Overall Study|Lost to Follow-up|0|||
162023570|NCT01338298|585142754|FG000|Overall Study|Depressive symptoms and nausea|1|||
162023571|NCT01338298|585142755|FG001|Overall Study|Depressive symptoms and nausea|0|||
162023572|NCT01338298|585142754|FG000|Overall Study|Non-adherence|1|||
162023573|NCT01338298|585142755|FG001|Overall Study|Non-adherence|0|||
162226531|NCT04372121|585877734|FG002|Overall Study|Lost to Follow-up|0|||
162226532|NCT04372121|585877735|FG003|Overall Study|Lost to Follow-up|1|||
162226533|NCT04372121|585877732|FG000|Overall Study|Protocol Violation|0|||
162226534|NCT04372121|585877733|FG001|Overall Study|Protocol Violation|0|||
162226535|NCT04372121|585877734|FG002|Overall Study|Protocol Violation|1|||
162226536|NCT04372121|585877735|FG003|Overall Study|Protocol Violation|0|||
162226537|NCT04372121|585877732|FG000|Overall Study|Withdrawal by Subject|3|||
162226538|NCT04372121|585877733|FG001|Overall Study|Withdrawal by Subject|1|||
162226539|NCT04372121|585877734|FG002|Overall Study|Withdrawal by Subject|0|||
162226540|NCT04372121|585877735|FG003|Overall Study|Withdrawal by Subject|0|||
162226541|NCT04372121|585877732|FG000|Overall Study|Study termination|6|||
162226542|NCT04372121|585877733|FG001|Overall Study|Study termination|5|||
162226543|NCT04372121|585877734|FG002|Overall Study|Study termination|1|||
162226544|NCT04372121|585877735|FG003|Overall Study|Study termination|1|||
162226545|NCT04372121|585877732|FG000|Overall Study|Hysterectomy planned|1|||
162226546|NCT04372121|585877733|FG001|Overall Study|Hysterectomy planned|0|||
162226547|NCT04372121|585877734|FG002|Overall Study|Hysterectomy planned|0|||
162226548|NCT04372121|585877735|FG003|Overall Study|Hysterectomy planned|0|||
162226549|NCT02344290|585877739|FG000|Overall Study|Withdrawal by Subject|315|||
162226550|NCT02344290|585877740|FG001|Overall Study|Withdrawal by Subject|324|||
162226551|NCT02344290|585877739|FG000|Overall Study|Lost to Follow-up|258|||
162226552|NCT02344290|585877740|FG001|Overall Study|Lost to Follow-up|249|||
162226553|NCT02344290|585877739|FG000|Overall Study|Unable to get to clinic|69|||
162226554|NCT02344290|585877740|FG001|Overall Study|Unable to get to clinic|60|||
162226555|NCT02344290|585877739|FG000|Overall Study|Physician Decision|25|||
162226556|NCT02344290|585877740|FG001|Overall Study|Physician Decision|25|||
162226557|NCT02344290|585877739|FG000|Overall Study|Site Closure|15|||
162226558|NCT02344290|585877740|FG001|Overall Study|Site Closure|19|||
162226559|NCT02344290|585877739|FG000|Overall Study|Other|5|||
162226560|NCT02344290|585877740|FG001|Overall Study|Other|3|||
162226561|NCT00591370|585879209|FG000|Overall Study|Not Treated|2|||
162226562|NCT01202903|585879211|FG000|Overall Study|Administrative Probelms|1|||
162226563|NCT01202903|585879212|FG001|Overall Study|Administrative Probelms|4|||
162226564|NCT01202903|585879211|FG000|Overall Study|Protocol Violation|0|||
162226565|NCT01202903|585879212|FG001|Overall Study|Protocol Violation|1|||
162226566|NCT01202903|585879211|FG000|Overall Study|Death|1|||
162226567|NCT01202903|585879212|FG001|Overall Study|Death|0|||
162226568|NCT01202903|585879211|FG000|Overall Study|Lost to Follow-up|1|||
162226569|NCT01202903|585879212|FG001|Overall Study|Lost to Follow-up|1|||
162226570|NCT01202903|585879211|FG000|Overall Study|Lack of Efficacy|1|||
162226571|NCT01202903|585879212|FG001|Overall Study|Lack of Efficacy|3|||
162226572|NCT01202903|585879211|FG000|Overall Study|Adverse Event|3|||
162226573|NCT01202903|585879212|FG001|Overall Study|Adverse Event|3|||
162226574|NCT01202903|585879211|FG000|Overall Study|Withdrawal by Subject|4|||
162226575|NCT01202903|585879212|FG001|Overall Study|Withdrawal by Subject|4|||
162226576|NCT01302080|585879213|FG000|Overall Study|Withdrew Consent|92|||
162226577|NCT01302080|585879214|FG001|Overall Study|Withdrew Consent|39|||
162226578|NCT01302080|585879213|FG000|Overall Study|Patient/Family Moved|28|||
162226579|NCT01302080|585879214|FG001|Overall Study|Patient/Family Moved|3|||
162226580|NCT01302080|585879213|FG000|Overall Study|Lost to Follow-up|192|||
162226581|NCT01302080|585879214|FG001|Overall Study|Lost to Follow-up|93|||
162226582|NCT01302080|585879213|FG000|Overall Study|Death|1|||
162226583|NCT01302080|585879214|FG001|Overall Study|Death|0|||
162226584|NCT01302080|585879213|FG000|Overall Study|Other|52|||
162226585|NCT01302080|585879214|FG001|Overall Study|Other|8|||
162226586|NCT01302080|585879213|FG000|Overall Study|Reason Missing For Discontinuation|1|||
162226587|NCT01302080|585879214|FG001|Overall Study|Reason Missing For Discontinuation|0|||
162226588|NCT00837694|585879215|FG000|Overall Study|Lost to Follow-up|2|||
162226589|NCT00837694|585879216|FG001|Overall Study|Lost to Follow-up|0|||
162226590|NCT00837694|585879217|FG002|Overall Study|Lost to Follow-up|2|||
162226591|NCT00837694|585879218|FG003|Overall Study|Lost to Follow-up|1|||
162226592|NCT00837694|585879219|FG004|Overall Study|Lost to Follow-up|1|||
162226593|NCT00837694|585879220|FG005|Overall Study|Lost to Follow-up|1|||
162226594|NCT00306670|585879221|FG000|Overall Study|patients recruited; Genentech, the st|0|||
162226595|NCT00306670|585879222|FG001|Overall Study|patients recruited; Genentech, the st|2|||
162226596|NCT00503139|585879223|FG000|Overall Study|Case Report Forms were not collected|4|||
162226597|NCT00503139|585879223|FG000|Overall Study|Protocol Violation|4|||
162226598|NCT00091169|585879227|FG000|Overall Study|Disease progression|3|||
162226599|NCT00091169|585879228|FG001|Overall Study|Disease progression|1|||
162226600|NCT00091169|585879227|FG000|Overall Study|Adverse Event|11|||
162226601|NCT00091169|585879228|FG001|Overall Study|Adverse Event|17|||
162226602|NCT00091169|585879227|FG000|Overall Study|Death|4|||
162226603|NCT00091169|585879228|FG001|Overall Study|Death|1|||
162226604|NCT00091169|585879227|FG000|Overall Study|Withdrawal by Subject|10|||
162226605|NCT00091169|585879228|FG001|Overall Study|Withdrawal by Subject|13|||
162226606|NCT00091169|585879227|FG000|Overall Study|Other|3|||
162226607|NCT00091169|585879228|FG001|Overall Study|Other|4|||
162226608|NCT00091169|585879227|FG000|Overall Study|Not start protocol therapy|26|||
162226609|NCT00091169|585879228|FG001|Overall Study|Not start protocol therapy|17|||
162226610|NCT04138576|585879233|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
161940092|NCT04629196|584830740|FG000|Overall Study|Withdrawal by Subject|1|||
161940093|NCT04629196|584830741|FG001|Overall Study|Withdrawal by Subject|2|||
162226611|NCT04410523|585879237|FG000|Overall Study|Study terminated by sponsor|1|||
162226612|NCT04410523|585879238|FG001|Overall Study|Study terminated by sponsor|3|||
162226613|NCT04410523|585879239|FG002|Overall Study|Study terminated by sponsor|2|||
162226614|NCT04410523|585879240|FG003|Overall Study|Study terminated by sponsor|6|||
162226615|NCT04410523|585879241|FG004|Overall Study|Study terminated by sponsor|3|||
162226616|NCT04410523|585879242|FG005|Overall Study|Study terminated by sponsor|4|||
162226617|NCT04410523|585879237|FG000|Overall Study|Adverse Event|1|||
162226618|NCT04410523|585879238|FG001|Overall Study|Adverse Event|0|||
162226619|NCT04410523|585879239|FG002|Overall Study|Adverse Event|0|||
162226620|NCT04410523|585879240|FG003|Overall Study|Adverse Event|0|||
162226621|NCT04410523|585879241|FG004|Overall Study|Adverse Event|0|||
162226622|NCT04410523|585879242|FG005|Overall Study|Adverse Event|2|||
162226623|NCT04410523|585879237|FG000|Overall Study|Lost to Follow-up|0|||
162226624|NCT04410523|585879238|FG001|Overall Study|Lost to Follow-up|1|||
162226625|NCT04410523|585879239|FG002|Overall Study|Lost to Follow-up|0|||
162226626|NCT04410523|585879240|FG003|Overall Study|Lost to Follow-up|0|||
162226627|NCT04410523|585879241|FG004|Overall Study|Lost to Follow-up|0|||
162226628|NCT04410523|585879242|FG005|Overall Study|Lost to Follow-up|0|||
162226629|NCT04410523|585879237|FG000|Overall Study|Physician Decision|0|||
162226630|NCT04410523|585879238|FG001|Overall Study|Physician Decision|1|||
162226631|NCT04410523|585879239|FG002|Overall Study|Physician Decision|0|||
162226632|NCT04410523|585879240|FG003|Overall Study|Physician Decision|0|||
162226633|NCT04410523|585879241|FG004|Overall Study|Physician Decision|0|||
162226634|NCT04410523|585879242|FG005|Overall Study|Physician Decision|0|||
162226635|NCT04410523|585879237|FG000|Overall Study|Pregnancy|0|||
162226636|NCT04410523|585879238|FG001|Overall Study|Pregnancy|0|||
162226637|NCT04410523|585879239|FG002|Overall Study|Pregnancy|0|||
162226638|NCT04410523|585879240|FG003|Overall Study|Pregnancy|0|||
162226639|NCT04410523|585879241|FG004|Overall Study|Pregnancy|0|||
162226640|NCT04410523|585879242|FG005|Overall Study|Pregnancy|1|||
162226641|NCT04410523|585879237|FG000|Overall Study|Protocol deviation|0|||
162226642|NCT04410523|585879238|FG001|Overall Study|Protocol deviation|0|||
162226643|NCT04410523|585879239|FG002|Overall Study|Protocol deviation|0|||
162226644|NCT04410523|585879240|FG003|Overall Study|Protocol deviation|0|||
162226645|NCT04410523|585879241|FG004|Overall Study|Protocol deviation|0|||
162226646|NCT04410523|585879242|FG005|Overall Study|Protocol deviation|2|||
162226647|NCT04410523|585879237|FG000|Overall Study|Subject decision|2|||
162226648|NCT04410523|585879238|FG001|Overall Study|Subject decision|0|||
162226649|NCT04410523|585879239|FG002|Overall Study|Subject decision|0|||
162226650|NCT04410523|585879240|FG003|Overall Study|Subject decision|1|||
162226651|NCT04410523|585879241|FG004|Overall Study|Subject decision|0|||
162226652|NCT04410523|585879242|FG005|Overall Study|Subject decision|1|||
162226653|NCT00490490|585879243|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
162226654|NCT00490490|585879243|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
162226655|NCT00772330|585879244|FG000|Overall Study|Lost to Follow-up|3|||
162226656|NCT00734591|585879245|FG000|Screening for Prospective Period|Site did not participate|1604|||
162226657|NCT00734591|585879246|FG001|Screening for Prospective Period|Site did not participate|1488|||
162226658|NCT00734591|585879245|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
162226659|NCT00734591|585879246|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
162226660|NCT00734591|585879245|FG000|Prospective Period|Withdrawal by Subject|11|||
162226661|NCT00734591|585879246|FG001|Prospective Period|Withdrawal by Subject|9|||
162226662|NCT00734591|585879245|FG000|Prospective Period|Lost to Follow-up|37|||
162226663|NCT00734591|585879246|FG001|Prospective Period|Lost to Follow-up|33|||
162226664|NCT00734591|585879245|FG000|Prospective Period|Study Terminated|1|||
162226665|NCT00734591|585879246|FG001|Prospective Period|Study Terminated|0|||
162226666|NCT00734591|585879245|FG000|Prospective Period|Other|2|||
162226667|NCT00734591|585879246|FG001|Prospective Period|Other|2|||
162226668|NCT01656200|585879249|FG000|Overall Study|Withdrawal by Subject|1|||
162226669|NCT01461811|585879250|FG000|Overall Study|Adverse Event|2|||
162226670|NCT01461811|585879251|FG001|Overall Study|Adverse Event|1|||
162226671|NCT01461811|585879250|FG000|Overall Study|Subject decision unrelated to an AE|1|||
162226672|NCT01461811|585879251|FG001|Overall Study|Subject decision unrelated to an AE|1|||
162226673|NCT01461811|585879250|FG000|Overall Study|Noncompliance|1|||
162226674|NCT01461811|585879251|FG001|Overall Study|Noncompliance|1|||
162226675|NCT03015129|585879252|FG000|Overall Study|Death|2|||
162226676|NCT03015129|585879253|FG001|Overall Study|Death|2|||
162226677|NCT03015129|585879252|FG000|Overall Study|Lost to Follow-up|0|||
162226678|NCT03015129|585879253|FG001|Overall Study|Lost to Follow-up|1|||
162226679|NCT03015129|585879252|FG000|Overall Study|Progression of disease|38|||
162226680|NCT03015129|585879253|FG001|Overall Study|Progression of disease|33|||
162226681|NCT03015129|585879252|FG000|Overall Study|Adverse Event|0|||
162226682|NCT03015129|585879253|FG001|Overall Study|Adverse Event|4|||
162226683|NCT03192475|585879260|FG000|Overall Study|Death|0|||
162226684|NCT03192475|585879261|FG001|Overall Study|Death|1|||
162226685|NCT03192475|585879260|FG000|Overall Study|Lost to Follow-up|13|||
162226686|NCT03192475|585879261|FG001|Overall Study|Lost to Follow-up|8|||
162226687|NCT00798590|585879262|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
162226688|NCT00798590|585879263|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
162226689|NCT03653208|585879268|FG000|Overall Study|Withdrawal by Subject|0|||
162226690|NCT03653208|585879269|FG001|Overall Study|Withdrawal by Subject|0|||
162226691|NCT03653208|585879270|FG002|Overall Study|Withdrawal by Subject|0|||
162226692|NCT03653208|585879271|FG003|Overall Study|Withdrawal by Subject|0|||
162226693|NCT03653208|585879272|FG004|Overall Study|Withdrawal by Subject|1|||
162226694|NCT03653208|585879273|FG005|Overall Study|Withdrawal by Subject|0|||
162226695|NCT03653208|585879274|FG006|Overall Study|Withdrawal by Subject|0|||
162226696|NCT03653208|585879275|FG007|Overall Study|Withdrawal by Subject|1|||
161829398|NCT00892281|584415775|FG000|Overall Study|Withdrawal by Subject|86|||
161829399|NCT00892281|584415776|FG001|Overall Study|Withdrawal by Subject|14|||
162226697|NCT03653208|585879276|FG008|Overall Study|Withdrawal by Subject|1|||
162226698|NCT00368927|585879277|FG000|Overall Study|Lost to Follow-up|2|||
162226699|NCT00368927|585879278|FG001|Overall Study|Lost to Follow-up|0|||
162226700|NCT00368927|585879277|FG000|Overall Study|Adverse Event|1|||
162226701|NCT00368927|585879278|FG001|Overall Study|Adverse Event|1|||
162226702|NCT00368927|585879277|FG000|Overall Study|Withdrawal by Subject|1|||
162226703|NCT00368927|585879278|FG001|Overall Study|Withdrawal by Subject|2|||
162226704|NCT00368927|585879277|FG000|Overall Study|Physician Decision|1|||
162226705|NCT00368927|585879278|FG001|Overall Study|Physician Decision|0|||
162226706|NCT01204710|585879279|FG000|Randomization Treatment|Lost to Follow-up|1|||
162226707|NCT01204710|585879280|FG001|Randomization Treatment|Lost to Follow-up|0|||
162226708|NCT01204710|585879279|FG000|Randomization Treatment|Withdrawal by Subject|6|||
162226709|NCT01204710|585879280|FG001|Randomization Treatment|Withdrawal by Subject|5|||
162226710|NCT01204710|585879279|FG000|Randomization Treatment|Physician Decision|3|||
162226711|NCT01204710|585879280|FG001|Randomization Treatment|Physician Decision|2|||
162226712|NCT01204710|585879279|FG000|Randomization Treatment|Entry criteria not met|0|||
162226713|NCT01204710|585879280|FG001|Randomization Treatment|Entry criteria not met|1|||
162226714|NCT01204710|585879279|FG000|Randomization Treatment|Adverse Event|4|||
162226715|NCT01204710|585879280|FG001|Randomization Treatment|Adverse Event|2|||
162226716|NCT01204710|585879279|FG000|Randomization Treatment|Sponsor Decision|0|||
162226717|NCT01204710|585879280|FG001|Randomization Treatment|Sponsor Decision|1|||
162226718|NCT01204710|585879279|FG000|Randomization Treatment|Worsening of General condition|0|||
162226719|NCT01204710|585879280|FG001|Randomization Treatment|Worsening of General condition|1|||
162226720|NCT01204710|585879279|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
162226721|NCT01204710|585879280|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
162226722|NCT01204710|585879279|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
162226723|NCT01204710|585879280|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
162226724|NCT01204710|585879279|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
162226725|NCT01204710|585879280|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
162226726|NCT01204710|585879279|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
162226727|NCT01204710|585879280|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
162226728|NCT03898167|585879281|FG000|Overall Study|Terminated phone call early|7|||
162226729|NCT03898167|585879282|FG001|Overall Study|Terminated phone call early|0|||
162226730|NCT03898167|585879283|FG002|Overall Study|Terminated phone call early|0|||
162226731|NCT03898167|585879281|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
162226732|NCT03898167|585879282|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
162226733|NCT03898167|585879283|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
162226734|NCT00151281|585879284|FG000|Overall Study|Not evaluable|3|||
162226735|NCT02906007|585879287|FG000|Overall Study|Physician Decision|0|||
162226736|NCT02906007|585879288|FG001|Overall Study|Physician Decision|0|||
162226737|NCT02906007|585879289|FG002|Overall Study|Physician Decision|1|||
162226738|NCT02906007|585879287|FG000|Overall Study|Died|1|||
162226739|NCT02906007|585879288|FG001|Overall Study|Died|0|||
162226740|NCT02906007|585879289|FG002|Overall Study|Died|0|||
162226741|NCT04696653|585879290|FG000|Overall Study|left organization|18|||
162226742|NCT04696653|585879290|FG000|Overall Study|Lost to Follow-up|3|||
162226743|NCT04047862|585879297|FG000|Overall Study|Death|0|||
162226744|NCT04047862|585879298|FG001|Overall Study|Death|0|||
162226745|NCT04047862|585879299|FG002|Overall Study|Death|4|||
162226746|NCT04047862|585879300|FG003|Overall Study|Death|7|||
162226747|NCT04047862|585879301|FG004|Overall Study|Death|2|||
162226748|NCT04047862|585879302|FG005|Overall Study|Death|4|||
162226749|NCT04047862|585879303|FG006|Overall Study|Death|3|||
162226750|NCT04047862|585879304|FG007|Overall Study|Death|24|||
162226751|NCT04047862|585879305|FG008|Overall Study|Death|24|||
162226752|NCT04047862|585879306|FG009|Overall Study|Death|22|||
162226753|NCT04047862|585879307|FG010|Overall Study|Death|35|||
162226754|NCT04047862|585879308|FG011|Overall Study|Death|18|||
162226755|NCT04047862|585879309|FG012|Overall Study|Death|14|||
162226756|NCT04047862|585879310|FG013|Overall Study|Death|6|||
162226757|NCT04047862|585879311|FG014|Overall Study|Death|19|||
162226758|NCT04047862|585879312|FG015|Overall Study|Death|42|||
162226759|NCT04047862|585879313|FG016|Overall Study|Death|9|||
162226760|NCT04047862|585879314|FG017|Overall Study|Death|8|||
162226761|NCT04047862|585879315|FG018|Overall Study|Death|10|||
162226762|NCT04047862|585879297|FG000|Overall Study|Withdrawal by Subject|0|||
162226763|NCT04047862|585879298|FG001|Overall Study|Withdrawal by Subject|0|||
162226764|NCT04047862|585879299|FG002|Overall Study|Withdrawal by Subject|0|||
162226765|NCT04047862|585879300|FG003|Overall Study|Withdrawal by Subject|5|||
162226766|NCT04047862|585879301|FG004|Overall Study|Withdrawal by Subject|2|||
162226767|NCT04047862|585879302|FG005|Overall Study|Withdrawal by Subject|0|||
162226768|NCT04047862|585879303|FG006|Overall Study|Withdrawal by Subject|1|||
162226769|NCT04047862|585879304|FG007|Overall Study|Withdrawal by Subject|0|||
162226770|NCT04047862|585879305|FG008|Overall Study|Withdrawal by Subject|4|||
162226771|NCT04047862|585879306|FG009|Overall Study|Withdrawal by Subject|4|||
162226772|NCT04047862|585879307|FG010|Overall Study|Withdrawal by Subject|4|||
162226773|NCT04047862|585879308|FG011|Overall Study|Withdrawal by Subject|2|||
162226774|NCT04047862|585879309|FG012|Overall Study|Withdrawal by Subject|3|||
162226775|NCT04047862|585879310|FG013|Overall Study|Withdrawal by Subject|0|||
162226776|NCT04047862|585879311|FG014|Overall Study|Withdrawal by Subject|9|||
162226777|NCT04047862|585879312|FG015|Overall Study|Withdrawal by Subject|5|||
162226778|NCT04047862|585879313|FG016|Overall Study|Withdrawal by Subject|1|||
162226779|NCT04047862|585879314|FG017|Overall Study|Withdrawal by Subject|3|||
162226780|NCT04047862|585879315|FG018|Overall Study|Withdrawal by Subject|1|||
162226781|NCT04047862|585879297|FG000|Overall Study|Lost to Follow-up|0|||
162226782|NCT04047862|585879298|FG001|Overall Study|Lost to Follow-up|0|||
162226783|NCT04047862|585879299|FG002|Overall Study|Lost to Follow-up|1|||
162226784|NCT04047862|585879300|FG003|Overall Study|Lost to Follow-up|0|||
162226785|NCT04047862|585879301|FG004|Overall Study|Lost to Follow-up|0|||
162226786|NCT04047862|585879302|FG005|Overall Study|Lost to Follow-up|0|||
162226787|NCT04047862|585879303|FG006|Overall Study|Lost to Follow-up|0|||
162226788|NCT04047862|585879304|FG007|Overall Study|Lost to Follow-up|1|||
162226789|NCT04047862|585879305|FG008|Overall Study|Lost to Follow-up|0|||
162226790|NCT04047862|585879306|FG009|Overall Study|Lost to Follow-up|1|||
162226791|NCT04047862|585879307|FG010|Overall Study|Lost to Follow-up|0|||
162226792|NCT04047862|585879308|FG011|Overall Study|Lost to Follow-up|3|||
162226793|NCT04047862|585879309|FG012|Overall Study|Lost to Follow-up|0|||
162226794|NCT04047862|585879310|FG013|Overall Study|Lost to Follow-up|0|||
162226795|NCT04047862|585879311|FG014|Overall Study|Lost to Follow-up|2|||
162226796|NCT04047862|585879312|FG015|Overall Study|Lost to Follow-up|2|||
162226797|NCT04047862|585879313|FG016|Overall Study|Lost to Follow-up|1|||
162226798|NCT04047862|585879314|FG017|Overall Study|Lost to Follow-up|0|||
162226799|NCT04047862|585879315|FG018|Overall Study|Lost to Follow-up|0|||
162226800|NCT04047862|585879297|FG000|Overall Study|Physician Decision|0|||
162226801|NCT04047862|585879298|FG001|Overall Study|Physician Decision|0|||
162226802|NCT04047862|585879299|FG002|Overall Study|Physician Decision|0|||
162226803|NCT04047862|585879300|FG003|Overall Study|Physician Decision|1|||
162226804|NCT04047862|585879301|FG004|Overall Study|Physician Decision|0|||
162226805|NCT04047862|585879302|FG005|Overall Study|Physician Decision|0|||
162226806|NCT04047862|585879303|FG006|Overall Study|Physician Decision|0|||
162226807|NCT04047862|585879304|FG007|Overall Study|Physician Decision|0|||
162226808|NCT04047862|585879305|FG008|Overall Study|Physician Decision|0|||
162226809|NCT04047862|585879306|FG009|Overall Study|Physician Decision|0|||
162226810|NCT04047862|585879307|FG010|Overall Study|Physician Decision|0|||
162226811|NCT04047862|585879308|FG011|Overall Study|Physician Decision|0|||
162226812|NCT04047862|585879309|FG012|Overall Study|Physician Decision|0|||
162226813|NCT04047862|585879310|FG013|Overall Study|Physician Decision|0|||
162226814|NCT04047862|585879311|FG014|Overall Study|Physician Decision|1|||
162226815|NCT04047862|585879312|FG015|Overall Study|Physician Decision|0|||
162226816|NCT04047862|585879313|FG016|Overall Study|Physician Decision|1|||
161678751|NCT00574288|583876065|FG000|Overall Study|Study Terminated By Sponsor|0|||
162226817|NCT04047862|585879314|FG017|Overall Study|Physician Decision|0|||
162226818|NCT04047862|585879315|FG018|Overall Study|Physician Decision|0|||
162226819|NCT04047862|585879297|FG000|Overall Study|Completed all Assessments|1|||
162226820|NCT04047862|585879298|FG001|Overall Study|Completed all Assessments|3|||
162226821|NCT04047862|585879299|FG002|Overall Study|Completed all Assessments|1|||
162226822|NCT04047862|585879300|FG003|Overall Study|Completed all Assessments|3|||
162226823|NCT04047862|585879301|FG004|Overall Study|Completed all Assessments|2|||
162226824|NCT04047862|585879302|FG005|Overall Study|Completed all Assessments|5|||
162226825|NCT04047862|585879303|FG006|Overall Study|Completed all Assessments|7|||
162226826|NCT04047862|585879304|FG007|Overall Study|Completed all Assessments|0|||
162226827|NCT04047862|585879305|FG008|Overall Study|Completed all Assessments|0|||
162226828|NCT04047862|585879306|FG009|Overall Study|Completed all Assessments|0|||
162226829|NCT04047862|585879307|FG010|Overall Study|Completed all Assessments|0|||
162226830|NCT04047862|585879308|FG011|Overall Study|Completed all Assessments|0|||
162226831|NCT04047862|585879309|FG012|Overall Study|Completed all Assessments|0|||
162226832|NCT04047862|585879310|FG013|Overall Study|Completed all Assessments|0|||
162226833|NCT04047862|585879311|FG014|Overall Study|Completed all Assessments|0|||
162226834|NCT04047862|585879312|FG015|Overall Study|Completed all Assessments|0|||
162226835|NCT04047862|585879313|FG016|Overall Study|Completed all Assessments|0|||
162226836|NCT04047862|585879314|FG017|Overall Study|Completed all Assessments|0|||
162226837|NCT04047862|585879315|FG018|Overall Study|Completed all Assessments|0|||
162226838|NCT04047862|585879297|FG000|Overall Study|Sponsor Decision|0|||
162226839|NCT04047862|585879298|FG001|Overall Study|Sponsor Decision|0|||
162226840|NCT04047862|585879299|FG002|Overall Study|Sponsor Decision|0|||
162226841|NCT04047862|585879300|FG003|Overall Study|Sponsor Decision|0|||
162226842|NCT04047862|585879301|FG004|Overall Study|Sponsor Decision|0|||
162226843|NCT04047862|585879302|FG005|Overall Study|Sponsor Decision|0|||
162226844|NCT04047862|585879303|FG006|Overall Study|Sponsor Decision|0|||
162226845|NCT04047862|585879304|FG007|Overall Study|Sponsor Decision|13|||
162226846|NCT04047862|585879305|FG008|Overall Study|Sponsor Decision|10|||
162226847|NCT04047862|585879306|FG009|Overall Study|Sponsor Decision|18|||
162226848|NCT04047862|585879307|FG010|Overall Study|Sponsor Decision|3|||
162226849|NCT04047862|585879308|FG011|Overall Study|Sponsor Decision|3|||
162226850|NCT04047862|585879309|FG012|Overall Study|Sponsor Decision|4|||
162226851|NCT04047862|585879310|FG013|Overall Study|Sponsor Decision|0|||
162226852|NCT04047862|585879311|FG014|Overall Study|Sponsor Decision|7|||
162226853|NCT04047862|585879312|FG015|Overall Study|Sponsor Decision|8|||
162226854|NCT04047862|585879313|FG016|Overall Study|Sponsor Decision|9|||
162226855|NCT04047862|585879314|FG017|Overall Study|Sponsor Decision|7|||
162226856|NCT04047862|585879315|FG018|Overall Study|Sponsor Decision|8|||
162226857|NCT04047862|585879297|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162226858|NCT04047862|585879298|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162226859|NCT04047862|585879299|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162226860|NCT04047862|585879300|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162226861|NCT04047862|585879301|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162226862|NCT04047862|585879302|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162226863|NCT04047862|585879303|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162226864|NCT04047862|585879304|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
162226865|NCT04047862|585879305|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
162226866|NCT04047862|585879306|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162226867|NCT04047862|585879307|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
162226868|NCT04047862|585879308|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162226869|NCT04047862|585879309|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162226870|NCT04047862|585879310|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
162226871|NCT04047862|585879311|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
162226872|NCT04047862|585879312|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
162226873|NCT04047862|585879313|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
162226874|NCT04047862|585879314|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
162226875|NCT04047862|585879315|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
162226876|NCT04047862|585879297|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226877|NCT04047862|585879298|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226878|NCT04047862|585879299|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226879|NCT04047862|585879300|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226880|NCT04047862|585879301|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226881|NCT04047862|585879302|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226882|NCT04047862|585879303|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226883|NCT04047862|585879304|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226884|NCT04047862|585879305|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226885|NCT04047862|585879306|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226886|NCT04047862|585879307|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226887|NCT04047862|585879308|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226888|NCT04047862|585879309|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226889|NCT04047862|585879310|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226890|NCT04047862|585879311|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161678752|NCT00574288|583876066|FG001|Overall Study|Study Terminated By Sponsor|0|||
161678753|NCT00574288|583876067|FG002|Overall Study|Study Terminated By Sponsor|0|||
162226891|NCT04047862|585879312|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
162226892|NCT04047862|585879313|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226893|NCT04047862|585879314|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
162226894|NCT04047862|585879315|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
162226895|NCT04047862|585879297|FG000|Overall Study|Other|0|||
162226896|NCT04047862|585879298|FG001|Overall Study|Other|0|||
162226897|NCT04047862|585879299|FG002|Overall Study|Other|0|||
162226898|NCT04047862|585879300|FG003|Overall Study|Other|0|||
162226899|NCT04047862|585879301|FG004|Overall Study|Other|0|||
162226900|NCT04047862|585879302|FG005|Overall Study|Other|0|||
162226901|NCT04047862|585879303|FG006|Overall Study|Other|0|||
162226902|NCT04047862|585879304|FG007|Overall Study|Other|0|||
162226903|NCT04047862|585879305|FG008|Overall Study|Other|0|||
162226904|NCT04047862|585879306|FG009|Overall Study|Other|0|||
162226905|NCT04047862|585879307|FG010|Overall Study|Other|0|||
162226906|NCT04047862|585879308|FG011|Overall Study|Other|0|||
162226907|NCT04047862|585879309|FG012|Overall Study|Other|0|||
162226908|NCT04047862|585879310|FG013|Overall Study|Other|0|||
162226909|NCT04047862|585879311|FG014|Overall Study|Other|2|||
162226910|NCT04047862|585879312|FG015|Overall Study|Other|1|||
162226911|NCT04047862|585879313|FG016|Overall Study|Other|1|||
162226912|NCT04047862|585879314|FG017|Overall Study|Other|1|||
162226913|NCT04047862|585879315|FG018|Overall Study|Other|0|||
162226914|NCT04349631|585879320|FG000|Overall Study|Lost to Follow-up|3|||
162226915|NCT04349631|585879320|FG000|Overall Study|Withdrawal by Subject|7|||
162226916|NCT00640133|585881510|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
162226917|NCT00640133|585881511|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
162226918|NCT00640133|585881510|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
162226919|NCT00640133|585881511|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
162226920|NCT00640133|585881510|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
162226921|NCT00640133|585881511|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
162226922|NCT01994837|585881513|FG000|Overall Study|Progressive disease per protocol|23|||
162226923|NCT01994837|585881513|FG000|Overall Study|Adv event related to progressive disease|3|||
162226924|NCT01994837|585881513|FG000|Overall Study|Fatal progressive disease|2|||
162226925|NCT01994837|585881513|FG000|Overall Study|Adverse event not related to progression|1|||
162226926|NCT01994837|585881513|FG000|Overall Study|Chose palliative care|1|||
162226927|NCT01994837|585881513|FG000|Overall Study|Proceeded to transplant|1|||
162226928|NCT01994837|585881513|FG000|Overall Study|Removed from study due to no response|1|||
162226929|NCT03900416|585881515|FG000|Six Week Follow-up|Lost to Follow-up|1|||
162226930|NCT03900416|585881516|FG001|Six Week Follow-up|Lost to Follow-up|0|||
162226931|NCT03900416|585881515|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
162226932|NCT03900416|585881516|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
162226933|NCT03900416|585881515|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
162226934|NCT03900416|585881516|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
162226935|NCT03900416|585881515|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
162226936|NCT03900416|585881516|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
162226937|NCT03900416|585881515|FG000|Twelve Week Follow-up|Adverse Event|1|||
162226938|NCT03900416|585881516|FG001|Twelve Week Follow-up|Adverse Event|1|||
162226939|NCT03900416|585881515|FG000|Six Month Follow-up|Lost to Follow-up|4|||
162226940|NCT03900416|585881516|FG001|Six Month Follow-up|Lost to Follow-up|3|||
162226941|NCT03900416|585881515|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
162226942|NCT03900416|585881516|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
162226943|NCT03207451|585881519|FG000|Overall Study|scheduling conflict|1|||
162226944|NCT03207451|585881520|FG001|Overall Study|scheduling conflict|0|||
162226945|NCT03207451|585881521|FG002|Overall Study|scheduling conflict|2|||
162226946|NCT03207451|585881522|FG003|Overall Study|scheduling conflict|2|||
162226947|NCT03207451|585881519|FG000|Overall Study|Adverse Event|0|||
162226948|NCT03207451|585881520|FG001|Overall Study|Adverse Event|0|||
162226949|NCT03207451|585881521|FG002|Overall Study|Adverse Event|0|||
162226950|NCT03207451|585881522|FG003|Overall Study|Adverse Event|1|||
162226951|NCT03896152|585881523|FG000|Overall Study|Patient/guardian decision|1|||
162226952|NCT03896152|585881524|FG001|Overall Study|Patient/guardian decision|1|||
162226953|NCT03896152|585881523|FG000|Overall Study|Adverse Event|0|||
162226954|NCT03896152|585881524|FG001|Overall Study|Adverse Event|1|||
162226955|NCT03896152|585881523|FG000|Overall Study|Physician Decision|1|||
162226956|NCT03896152|585881524|FG001|Overall Study|Physician Decision|0|||
162226957|NCT03896152|585881523|FG000|Overall Study|Technical problems|1|||
162226958|NCT03896152|585881524|FG001|Overall Study|Technical problems|0|||
162226959|NCT00436852|585881525|FG000|Overall Study|Death|23|||
162226960|NCT00436852|585881526|FG001|Overall Study|Death|34|||
162226961|NCT00436852|585881525|FG000|Overall Study|Lack of Efficacy|9|||
162226962|NCT00436852|585881526|FG001|Overall Study|Lack of Efficacy|7|||
162226963|NCT00436852|585881525|FG000|Overall Study|Withdrawal by Subject|2|||
162226964|NCT00436852|585881526|FG001|Overall Study|Withdrawal by Subject|4|||
162226965|NCT00436852|585881525|FG000|Overall Study|Ineligible|1|||
162226966|NCT00436852|585881526|FG001|Overall Study|Ineligible|0|||
162226967|NCT00370682|585881527|FG000|Overall Study|Moved from area|0|||
162226968|NCT00370682|585881528|FG001|Overall Study|Moved from area|2|||
162226969|NCT00370682|585881529|FG002|Overall Study|Moved from area|0|||
162226970|NCT00370682|585881527|FG000|Overall Study|Lost to Follow-up|0|||
162226971|NCT00370682|585881528|FG001|Overall Study|Lost to Follow-up|1|||
162226972|NCT00370682|585881529|FG002|Overall Study|Lost to Follow-up|1|||
162226973|NCT03167359|585881530|FG000|Overall Study|Physician Decision|1|||
162226974|NCT03167359|585881530|FG000|Overall Study|Lost to Follow-up|1|||
162226975|NCT03339583|585881531|FG000|First Intervention (14 Days)|Adverse Event|1|||
162226976|NCT03339583|585881532|FG001|First Intervention (14 Days)|Adverse Event|0|||
162226977|NCT03339583|585881531|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
162226978|NCT03339583|585881532|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
162226979|NCT03339583|585881531|FG000|Second Intervention (14 Days)|Adverse Event|0|||
162226980|NCT03339583|585881532|FG001|Second Intervention (14 Days)|Adverse Event|1|||
162226981|NCT03339583|585881531|FG000|Follow-up (14 Days)|Physician Decision|6|||
162226982|NCT03339583|585881532|FG001|Follow-up (14 Days)|Physician Decision|3|||
162226983|NCT02141620|585881533|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
162226984|NCT02141620|585881534|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
162226985|NCT03651622|585881535|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
162226986|NCT03651622|585881536|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
162226987|NCT03651622|585881537|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
162226988|NCT03651622|585881535|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
162226989|NCT03651622|585881536|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
162226990|NCT03651622|585881537|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
162226991|NCT03651622|585881535|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
162226992|NCT03651622|585881536|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
162226993|NCT03651622|585881537|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
162226994|NCT03651622|585881535|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
162226995|NCT03651622|585881536|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
162226996|NCT03651622|585881537|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
162226997|NCT03651622|585881535|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
162226998|NCT03651622|585881536|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
162226999|NCT03651622|585881537|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
162227000|NCT01519089|585881538|FG000|Overall Study|Adverse Event|4|||
162227001|NCT01519089|585881539|FG001|Overall Study|Adverse Event|4|||
162227002|NCT01519089|585881538|FG000|Overall Study|Lack of Efficacy|0|||
162227003|NCT01519089|585881539|FG001|Overall Study|Lack of Efficacy|2|||
162227004|NCT01519089|585881538|FG000|Overall Study|Lost to Follow-up|1|||
162227005|NCT01519089|585881539|FG001|Overall Study|Lost to Follow-up|0|||
162227006|NCT01519089|585881538|FG000|Overall Study|Withdrawal by Subject|0|||
162227007|NCT01519089|585881539|FG001|Overall Study|Withdrawal by Subject|2|||
162227008|NCT01519089|585881538|FG000|Overall Study|Other|2|||
162227009|NCT01519089|585881539|FG001|Overall Study|Other|6|||
162227010|NCT01519089|585881538|FG000|Overall Study|Not received study drug|0|||
162227011|NCT01519089|585881539|FG001|Overall Study|Not received study drug|1|||
162227012|NCT00307684|585881540|FG000|Open Label Phase|Lack of Efficacy|0|||
162227013|NCT00307684|585881541|FG001|Open Label Phase|Lack of Efficacy|0|||
162227014|NCT00307684|585881542|FG002|Open Label Phase|Lack of Efficacy|3|||
162227015|NCT00307684|585881540|FG000|Open Label Phase|Adverse Event|0|||
161940094|NCT02061085|584830747|FG000|Overall Study|Adverse Event|8|||
161940095|NCT05487378|584830754|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
161940096|NCT05487378|584830755|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
161940097|NCT05487378|584830754|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
161940098|NCT05487378|584830755|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
161940099|NCT02414841|584830757|FG000|Overall Study|Withdrawal by Subject|7|||
161940100|NCT02414841|584830758|FG001|Overall Study|Withdrawal by Subject|5|||
161940101|NCT02414841|584830757|FG000|Overall Study|Lost to Follow-up|13|||
161940102|NCT02414841|584830758|FG001|Overall Study|Lost to Follow-up|6|||
161940103|NCT02414841|584830757|FG000|Overall Study|Death|17|||
161940104|NCT02414841|584830758|FG001|Overall Study|Death|14|||
161940105|NCT02414841|584830757|FG000|Overall Study|Received a Kidney Transplant|13|||
161940106|NCT02414841|584830758|FG001|Overall Study|Received a Kidney Transplant|4|||
161940107|NCT02414841|584830757|FG000|Overall Study|Randomized But Not Treated|6|||
161940108|NCT02414841|584830758|FG001|Overall Study|Randomized But Not Treated|4|||
161940109|NCT00112385|584830759|FG000|Overall Study|Lost to Follow-up|1|||
161940110|NCT00112385|584830760|FG001|Overall Study|Lost to Follow-up|0|||
161940111|NCT00112385|584830759|FG000|Overall Study|Withdrawal by Subject|0|||
161940112|NCT00112385|584830760|FG001|Overall Study|Withdrawal by Subject|1|||
161940113|NCT02613507|584830766|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
161940114|NCT02613507|584830767|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
161940115|NCT02613507|584830766|FG000|Pre-Treamtent|Participant withdrew consent|0|||
161940116|NCT02613507|584830767|FG001|Pre-Treamtent|Participant withdrew consent|4|||
162023574|NCT00531427|585142756|FG000|Overall Study|Withdrawal by Subject|7|||
162227016|NCT00307684|585881541|FG001|Open Label Phase|Adverse Event|0|||
162227017|NCT00307684|585881542|FG002|Open Label Phase|Adverse Event|16|||
162227018|NCT00307684|585881540|FG000|Open Label Phase|Withdrawal by Subject|0|||
162227019|NCT00307684|585881541|FG001|Open Label Phase|Withdrawal by Subject|0|||
162227020|NCT00307684|585881542|FG002|Open Label Phase|Withdrawal by Subject|15|||
162227021|NCT00307684|585881540|FG000|Open Label Phase|Lost to Follow-up|0|||
162227022|NCT00307684|585881541|FG001|Open Label Phase|Lost to Follow-up|0|||
162227023|NCT00307684|585881542|FG002|Open Label Phase|Lost to Follow-up|11|||
161678754|NCT00574288|583876068|FG003|Overall Study|Study Terminated By Sponsor|0|||
162227024|NCT00307684|585881540|FG000|Open Label Phase|non compliance|0|||
162227025|NCT00307684|585881541|FG001|Open Label Phase|non compliance|0|||
162227026|NCT00307684|585881542|FG002|Open Label Phase|non compliance|5|||
162227027|NCT00307684|585881540|FG000|Open Label Phase|other|0|||
162227028|NCT00307684|585881541|FG001|Open Label Phase|other|0|||
162227029|NCT00307684|585881542|FG002|Open Label Phase|other|6|||
162227030|NCT00307684|585881540|FG000|Double Blind Phase|Lack of Efficacy|2|||
162227031|NCT00307684|585881541|FG001|Double Blind Phase|Lack of Efficacy|5|||
162227032|NCT00307684|585881542|FG002|Double Blind Phase|Lack of Efficacy|0|||
162227033|NCT00224887|585881543|FG000|Overall Study|Pregnancy|6|||
162227034|NCT00224887|585881544|FG001|Overall Study|Pregnancy|6|||
162227035|NCT00730275|585881545|FG000|Overall Study|Withdrawal by Subject|0|||
162227036|NCT00730275|585881546|FG001|Overall Study|Withdrawal by Subject|0|||
162227037|NCT00730275|585881547|FG002|Overall Study|Withdrawal by Subject|0|||
162227038|NCT00730275|585881548|FG003|Overall Study|Withdrawal by Subject|1|||
162227039|NCT00356408|585881549|FG000|Overall Study|Adverse Event|9|||
162227040|NCT00356408|585881549|FG000|Overall Study|Lack of Efficacy|36|||
162227041|NCT00356408|585881549|FG000|Overall Study|Lost to Follow-up|2|||
162227042|NCT00356408|585881549|FG000|Overall Study|Withdrawal by Subject|6|||
162227043|NCT00356408|585881549|FG000|Overall Study|Other: Principal investigator discretion|3|||
162227044|NCT00356408|585881549|FG000|Overall Study|Other: Sponsor request|1|||
162227045|NCT00356408|585881549|FG000|Overall Study|Other: Azathioprine stopped|1|||
162227046|NCT00356408|585881549|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
162227047|NCT00356408|585881549|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
162227048|NCT05487586|585881554|FG000|Overall Study|Death|22|||
162227049|NCT05487586|585881554|FG000|Overall Study|Physician Decision|1|||
162227050|NCT05487586|585881554|FG000|Overall Study|Transfer to another hospital|4|||
162227051|NCT05487586|585881554|FG000|Overall Study|Other|1|||
162227052|NCT03921723|585881555|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
162227053|NCT03921723|585881555|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
162227054|NCT03046121|585881557|FG000|Overall Study|Death|32|||
162227055|NCT03046121|585881558|FG001|Overall Study|Death|60|||
162227056|NCT03046121|585881557|FG000|Overall Study|Withdrawal by Subject|14|||
162227057|NCT03046121|585881558|FG001|Overall Study|Withdrawal by Subject|12|||
162227058|NCT03214640|585881559|FG000|Overall Study|Protocol Violation|1|||
162227059|NCT03214640|585881560|FG001|Overall Study|Protocol Violation|2|||
162227060|NCT03214640|585881561|FG002|Overall Study|Protocol Violation|1|||
162227061|NCT03214640|585881562|FG003|Overall Study|Protocol Violation|4|||
162227062|NCT00406692|585881570|FG000|Overall Study|Withdrawal by Subject|4|||
162227063|NCT00406692|585881570|FG000|Overall Study|Physician Decision|1|||
162227064|NCT00406692|585881570|FG000|Overall Study|Adverse Event|1|||
162227065|NCT00406692|585881570|FG000|Overall Study|Lack of Efficacy|1|||
162227066|NCT04488770|585881571|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162227067|NCT04488770|585881572|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162227068|NCT04488770|585881573|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162227069|NCT04488770|585881574|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
162227070|NCT04488770|585881575|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162227071|NCT04488770|585881576|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162227072|NCT04488770|585881577|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162227073|NCT04488770|585881578|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162227074|NCT04488770|585881579|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162227075|NCT04488770|585881580|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162227076|NCT04488770|585881581|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162227077|NCT04488770|585881582|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162227078|NCT04488770|585881583|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
162023575|NCT00531427|585142757|FG001|Overall Study|Withdrawal by Subject|13|||
162227079|NCT04488770|585881571|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
162227080|NCT04488770|585881572|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162227081|NCT04488770|585881573|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162227082|NCT04488770|585881574|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162227083|NCT04488770|585881575|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161678755|NCT00574288|583876069|FG004|Overall Study|Study Terminated By Sponsor|0|||
161678756|NCT00574288|583876070|FG005|Overall Study|Study Terminated By Sponsor|0|||
162227084|NCT04488770|585881576|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162227085|NCT04488770|585881577|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162227086|NCT04488770|585881578|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162227087|NCT04488770|585881579|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162227088|NCT04488770|585881580|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162227089|NCT04488770|585881581|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162227090|NCT04488770|585881582|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162227091|NCT04488770|585881583|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
162227092|NCT04488770|585881571|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162227093|NCT04488770|585881572|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162227094|NCT04488770|585881573|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162227095|NCT04488770|585881574|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162227096|NCT04488770|585881575|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162227097|NCT04488770|585881576|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
162227098|NCT04488770|585881577|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
162227099|NCT04488770|585881578|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162227100|NCT04488770|585881579|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162227101|NCT04488770|585881580|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162227102|NCT04488770|585881581|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162227103|NCT04488770|585881582|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162227104|NCT04488770|585881583|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162227105|NCT04488770|585881571|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162227106|NCT04488770|585881572|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162227107|NCT04488770|585881573|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162227108|NCT04488770|585881574|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162227109|NCT04488770|585881575|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
162227110|NCT04488770|585881576|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161940117|NCT02613507|584830766|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
161940118|NCT02613507|584830767|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
161940119|NCT02613507|584830766|FG000|Treatment|Not reported|3|||
161940120|NCT02613507|584830767|FG001|Treatment|Not reported|0|||
161940121|NCT02613507|584830766|FG000|Treatment|Other reasons|8|||
162227111|NCT04488770|585881577|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162227112|NCT04488770|585881578|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162227113|NCT04488770|585881579|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162227114|NCT04488770|585881580|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162227115|NCT04488770|585881581|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162227116|NCT04488770|585881582|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162227117|NCT04488770|585881583|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
162227118|NCT03547739|585881584|FG000|Overall Study|Death|0|||
162227119|NCT03547739|585881585|FG001|Overall Study|Death|1|||
162227120|NCT03547739|585881586|FG002|Overall Study|Death|5|||
162227121|NCT03547739|585881584|FG000|Overall Study|Adverse Event|24|||
162227122|NCT03547739|585881585|FG001|Overall Study|Adverse Event|11|||
162227123|NCT03547739|585881586|FG002|Overall Study|Adverse Event|13|||
162227124|NCT03547739|585881584|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
162227125|NCT03547739|585881585|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
162227126|NCT03547739|585881586|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
162227127|NCT03547739|585881584|FG000|Overall Study|Lost to Follow-up|80|||
162227128|NCT03547739|585881585|FG001|Overall Study|Lost to Follow-up|84|||
162227129|NCT03547739|585881586|FG002|Overall Study|Lost to Follow-up|116|||
162227130|NCT01696955|585881587|FG000|Main Study|Protocol Violation|1|||
162227131|NCT01696955|585881588|FG001|Main Study|Protocol Violation|0|||
161829400|NCT00892281|584415775|FG000|Overall Study|Subject failed to return for final visit|2|||
161829401|NCT00892281|584415776|FG001|Overall Study|Subject failed to return for final visit|0|||
161829402|NCT00892281|584415775|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
161829403|NCT00892281|584415776|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
161829404|NCT00892281|584415775|FG000|Overall Study|Final visit completed 4 weeks late|0|||
161829405|NCT00892281|584415776|FG001|Overall Study|Final visit completed 4 weeks late|1|||
161829406|NCT00892281|584415775|FG000|Overall Study|Subject completed day after study closed|1|||
161829407|NCT00892281|584415776|FG001|Overall Study|Subject completed day after study closed|0|||
161829408|NCT00892281|584415775|FG000|Overall Study|Family emergency|1|||
162227132|NCT01696955|585881587|FG000|Main Study|Withdrawal by Subject|1|||
162227133|NCT01696955|585881588|FG001|Main Study|Withdrawal by Subject|1|||
162227134|NCT01641159|585881589|FG000|Overall Study|Lost to Follow-up|2|||
162227135|NCT01641159|585881590|FG001|Overall Study|Lost to Follow-up|1|||
162227136|NCT01641159|585881589|FG000|Overall Study|Withdrawal by Subject|0|||
162227137|NCT01641159|585881590|FG001|Overall Study|Withdrawal by Subject|1|||
162227138|NCT03980808|585881591|FG000|Overall Study|Lost to Follow-up|2|||
162227139|NCT03980808|585881592|FG001|Overall Study|Lost to Follow-up|2|||
162227140|NCT05330676|585881593|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
162227141|NCT05330676|585881594|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
162227142|NCT00436605|585881595|FG000|Overall Study|Protocol Violation|3|||
162227143|NCT00573859|585881600|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
162227144|NCT00573859|585881600|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
162227145|NCT02416453|585881601|FG000|Overall Study|Adverse Event|0|||
162227146|NCT02416453|585881602|FG001|Overall Study|Adverse Event|0|||
162227147|NCT02416453|585881603|FG002|Overall Study|Adverse Event|0|||
162227148|NCT02416453|585881604|FG003|Overall Study|Adverse Event|2|||
162227149|NCT02416453|585881605|FG004|Overall Study|Adverse Event|0|||
162227150|NCT02416453|585881606|FG005|Overall Study|Adverse Event|1|||
162227151|NCT02416453|585881607|FG006|Overall Study|Adverse Event|0|||
162227152|NCT02416453|585881608|FG007|Overall Study|Adverse Event|0|||
162227153|NCT02416453|585881609|FG008|Overall Study|Adverse Event|0|||
162227154|NCT02416453|585881610|FG009|Overall Study|Adverse Event|0|||
162227155|NCT02416453|585881611|FG010|Overall Study|Adverse Event|0|||
162023576|NCT00531427|585142756|FG000|Overall Study|Adverse Event|44|||
162023577|NCT00531427|585142757|FG001|Overall Study|Adverse Event|30|||
162227156|NCT02416453|585881601|FG000|Overall Study|Lost to Follow-up|1|||
162227157|NCT02416453|585881602|FG001|Overall Study|Lost to Follow-up|3|||
162227158|NCT02416453|585881603|FG002|Overall Study|Lost to Follow-up|0|||
161829409|NCT00892281|584415776|FG001|Overall Study|Family emergency|0|||
161829410|NCT00892281|584415775|FG000|Overall Study|Last visit not done - death in family|1|||
162227159|NCT02416453|585881604|FG003|Overall Study|Lost to Follow-up|8|||
162227160|NCT02416453|585881605|FG004|Overall Study|Lost to Follow-up|0|||
161829411|NCT00892281|584415776|FG001|Overall Study|Last visit not done - death in family|0|||
161829412|NCT00892281|584415775|FG000|Overall Study|Did not meet incl/excl criteria|1|||
162227161|NCT02416453|585881606|FG005|Overall Study|Lost to Follow-up|5|||
162227162|NCT02416453|585881607|FG006|Overall Study|Lost to Follow-up|1|||
162227163|NCT02416453|585881608|FG007|Overall Study|Lost to Follow-up|3|||
162227164|NCT02416453|585881609|FG008|Overall Study|Lost to Follow-up|1|||
162227165|NCT02416453|585881610|FG009|Overall Study|Lost to Follow-up|0|||
162227166|NCT02416453|585881611|FG010|Overall Study|Lost to Follow-up|0|||
162227167|NCT02416453|585881601|FG000|Overall Study|Physician Decision|0|||
162227168|NCT02416453|585881602|FG001|Overall Study|Physician Decision|0|||
162227169|NCT02416453|585881603|FG002|Overall Study|Physician Decision|0|||
162227170|NCT02416453|585881604|FG003|Overall Study|Physician Decision|0|||
162227171|NCT02416453|585881605|FG004|Overall Study|Physician Decision|0|||
162227172|NCT02416453|585881606|FG005|Overall Study|Physician Decision|1|||
162227173|NCT02416453|585881607|FG006|Overall Study|Physician Decision|1|||
162227174|NCT02416453|585881608|FG007|Overall Study|Physician Decision|1|||
162227175|NCT02416453|585881609|FG008|Overall Study|Physician Decision|0|||
162227176|NCT02416453|585881610|FG009|Overall Study|Physician Decision|0|||
162227177|NCT02416453|585881611|FG010|Overall Study|Physician Decision|0|||
162227178|NCT02416453|585881601|FG000|Overall Study|Withdrawal by Subject|2|||
162227179|NCT02416453|585881602|FG001|Overall Study|Withdrawal by Subject|0|||
162227180|NCT02416453|585881603|FG002|Overall Study|Withdrawal by Subject|0|||
162227181|NCT02416453|585881604|FG003|Overall Study|Withdrawal by Subject|5|||
162227182|NCT02416453|585881605|FG004|Overall Study|Withdrawal by Subject|1|||
162227183|NCT02416453|585881606|FG005|Overall Study|Withdrawal by Subject|8|||
162227184|NCT02416453|585881607|FG006|Overall Study|Withdrawal by Subject|0|||
162227185|NCT02416453|585881608|FG007|Overall Study|Withdrawal by Subject|8|||
162227186|NCT02416453|585881609|FG008|Overall Study|Withdrawal by Subject|4|||
162227187|NCT02416453|585881610|FG009|Overall Study|Withdrawal by Subject|0|||
162227188|NCT02416453|585881611|FG010|Overall Study|Withdrawal by Subject|0|||
162227189|NCT02416453|585881601|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162227190|NCT02416453|585881602|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162227191|NCT02416453|585881603|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
162227192|NCT02416453|585881604|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162227193|NCT02416453|585881605|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162227194|NCT02416453|585881606|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162227195|NCT02416453|585881607|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162227196|NCT02416453|585881608|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162227197|NCT02416453|585881609|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162227198|NCT02416453|585881610|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162227199|NCT02416453|585881611|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
162227200|NCT02416453|585881601|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162227201|NCT02416453|585881602|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162227202|NCT02416453|585881603|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162227203|NCT02416453|585881604|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162227204|NCT02416453|585881605|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162227205|NCT02416453|585881606|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
162227206|NCT02416453|585881607|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162227207|NCT02416453|585881608|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162227208|NCT02416453|585881609|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162227209|NCT02416453|585881610|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161829413|NCT00892281|584415776|FG001|Overall Study|Did not meet incl/excl criteria|0|||
161829414|NCT00892281|584415775|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
161940122|NCT02613507|584830767|FG001|Treatment|Other reasons|0|||
161940123|NCT02613507|584830766|FG000|Treatment|Participant no longer meets criteria|3|||
161940124|NCT02613507|584830767|FG001|Treatment|Participant no longer meets criteria|0|||
161940125|NCT02613507|584830766|FG000|Treatment|Maximum clinical benefit|5|||
162227210|NCT02416453|585881611|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
162227211|NCT01152814|585881612|FG000|Overall Study|Lost to Follow-up|2|||
162227212|NCT02729831|585881614|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
162227213|NCT02729831|585881615|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
162227214|NCT02729831|585881616|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
162227215|NCT02729831|585881617|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
162227216|NCT02729831|585881614|FG000|1 Week Post-visit|Lost to Follow-up|43|||
162227217|NCT02729831|585881615|FG001|1 Week Post-visit|Lost to Follow-up|40|||
162227218|NCT02729831|585881616|FG002|1 Week Post-visit|Lost to Follow-up|38|||
162227219|NCT02729831|585881617|FG003|1 Week Post-visit|Lost to Follow-up|36|||
162227220|NCT02729831|585881614|FG000|6 Month Follow-up|Lost to Follow-up|54|||
162227221|NCT02729831|585881615|FG001|6 Month Follow-up|Lost to Follow-up|51|||
162227222|NCT02729831|585881616|FG002|6 Month Follow-up|Lost to Follow-up|48|||
162227223|NCT02729831|585881617|FG003|6 Month Follow-up|Lost to Follow-up|42|||
162227224|NCT02729831|585881614|FG000|6 Month Follow-up|Death|1|||
162227225|NCT02729831|585881615|FG001|6 Month Follow-up|Death|3|||
162227226|NCT02729831|585881616|FG002|6 Month Follow-up|Death|0|||
162227227|NCT02729831|585881617|FG003|6 Month Follow-up|Death|1|||
162227228|NCT00864253|585881618|FG000|Overall Study|Adverse Event|56|||
162227229|NCT00864253|585881619|FG001|Overall Study|Adverse Event|11|||
162227230|NCT00864253|585881618|FG000|Overall Study|Unrelated Adverse Event|3|||
162227231|NCT00864253|585881619|FG001|Overall Study|Unrelated Adverse Event|1|||
162227232|NCT00864253|585881618|FG000|Overall Study|Physician Decision|11|||
162227233|NCT00864253|585881619|FG001|Overall Study|Physician Decision|15|||
162227234|NCT00864253|585881618|FG000|Overall Study|Protocol Violation|0|||
162227235|NCT00864253|585881619|FG001|Overall Study|Protocol Violation|2|||
162227236|NCT00864253|585881618|FG000|Overall Study|Lost to Follow-up|1|||
162227237|NCT00864253|585881619|FG001|Overall Study|Lost to Follow-up|1|||
162227238|NCT00864253|585881618|FG000|Overall Study|Withdrawal by Subject|18|||
162227239|NCT00864253|585881619|FG001|Overall Study|Withdrawal by Subject|18|||
162227240|NCT00864253|585881618|FG000|Overall Study|Death|1|||
162227241|NCT00864253|585881619|FG001|Overall Study|Death|0|||
162227242|NCT00864253|585881618|FG000|Overall Study|Ongoing|2|||
162227243|NCT00864253|585881619|FG001|Overall Study|Ongoing|3|||
162227244|NCT00864253|585881618|FG000|Overall Study|Untreated|7|||
162227245|NCT00864253|585881619|FG001|Overall Study|Untreated|7|||
162227246|NCT01111240|585881620|FG000|Overall Study|Adverse Event|190|||
162227247|NCT01111240|585881620|FG000|Overall Study|Lack of Efficacy|545|||
162227248|NCT01111240|585881620|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
162227249|NCT01111240|585881620|FG000|Overall Study|Other|312|||
162227250|NCT01747551|585881621|FG000|Overall Study|Progressive Disease|24|||
162227251|NCT01747551|585881622|FG001|Overall Study|Progressive Disease|17|||
162227252|NCT01747551|585881621|FG000|Overall Study|Death|3|||
162227253|NCT01747551|585881622|FG001|Overall Study|Death|1|||
162227254|NCT01747551|585881621|FG000|Overall Study|Adverse Event|7|||
162227255|NCT01747551|585881622|FG001|Overall Study|Adverse Event|1|||
162227256|NCT01747551|585881621|FG000|Overall Study|Prolonged Treatment Delay|2|||
162227257|NCT01747551|585881622|FG001|Overall Study|Prolonged Treatment Delay|0|||
162227258|NCT01747551|585881621|FG000|Overall Study|Withdrawal by Subject|3|||
162227259|NCT01747551|585881622|FG001|Overall Study|Withdrawal by Subject|1|||
162227260|NCT01747551|585881621|FG000|Overall Study|Physician Decision|2|||
162227261|NCT01747551|585881622|FG001|Overall Study|Physician Decision|1|||
162227262|NCT01747551|585881621|FG000|Overall Study|Other|2|||
162227263|NCT01747551|585881622|FG001|Overall Study|Other|0|||
162227264|NCT01609062|585881623|FG000|Extension Phase|Terminated by Sponsor|14|||
162227265|NCT01609062|585881624|FG001|Extension Phase|Terminated by Sponsor|9|||
162227266|NCT01609062|585881623|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
162227267|NCT01609062|585881624|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
162227268|NCT01609062|585881623|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
162227269|NCT01609062|585881624|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
162227270|NCT00680992|585881625|FG000|Overall Study|Complete Resection (as per protocol)|25|||
162227271|NCT00680992|585881626|FG001|Overall Study|Complete Resection (as per protocol)|121|||
162227272|NCT00680992|585881627|FG002|Overall Study|Complete Resection (as per protocol)|0|||
162227273|NCT00680992|585881625|FG000|Overall Study|Administrative Decision|83|||
162227274|NCT00680992|585881626|FG001|Overall Study|Administrative Decision|42|||
162227275|NCT00680992|585881627|FG002|Overall Study|Administrative Decision|5|||
162227276|NCT00680992|585881625|FG000|Overall Study|End of Trial|32|||
162227277|NCT00680992|585881626|FG001|Overall Study|End of Trial|12|||
161829415|NCT00892281|584415776|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
162227278|NCT00680992|585881627|FG002|Overall Study|End of Trial|3|||
162227279|NCT00680992|585881625|FG000|Overall Study|Withdrawal by Subject|33|||
162227280|NCT00680992|585881626|FG001|Overall Study|Withdrawal by Subject|11|||
162227281|NCT00680992|585881627|FG002|Overall Study|Withdrawal by Subject|1|||
162227282|NCT00680992|585881625|FG000|Overall Study|Adverse Event|21|||
162227283|NCT00680992|585881626|FG001|Overall Study|Adverse Event|19|||
162227284|NCT00680992|585881627|FG002|Overall Study|Adverse Event|1|||
162227285|NCT00680992|585881625|FG000|Overall Study|Other|19|||
162023578|NCT00531427|585142756|FG000|Overall Study|Lost to Follow-up|4|||
162023579|NCT00531427|585142757|FG001|Overall Study|Lost to Follow-up|3|||
162023580|NCT00531427|585142756|FG000|Overall Study|Lack of Efficacy|14|||
162023581|NCT00531427|585142757|FG001|Overall Study|Lack of Efficacy|39|||
162023582|NCT00531427|585142756|FG000|Overall Study|Administrative|4|||
162023583|NCT00531427|585142757|FG001|Overall Study|Administrative|9|||
162023584|NCT05477108|585142758|FG000|Overall Study|Participants randomized, not treated|1|||
162023585|NCT05477108|585142759|FG001|Overall Study|Participants randomized, not treated|1|||
162023586|NCT05477108|585142760|FG002|Overall Study|Participants randomized, not treated|1|||
162023587|NCT05477108|585142758|FG000|Overall Study|Physician Decision|0|||
162023588|NCT05477108|585142759|FG001|Overall Study|Physician Decision|0|||
162023589|NCT05477108|585142760|FG002|Overall Study|Physician Decision|1|||
162023590|NCT05477108|585142758|FG000|Overall Study|withdrawn from study|0|||
162023591|NCT05477108|585142759|FG001|Overall Study|withdrawn from study|0|||
162023592|NCT05477108|585142760|FG002|Overall Study|withdrawn from study|1|||
162023593|NCT01253577|585142761|FG000|Overall Study|Lost to Follow-up|3|||
162023594|NCT00488683|585142762|FG000|Overall Study|Withdrawal by Subject|1|||
162023595|NCT00488683|585142763|FG001|Overall Study|Withdrawal by Subject|2|||
162023596|NCT00488683|585142764|FG002|Overall Study|Withdrawal by Subject|2|||
162023597|NCT00488683|585142762|FG000|Overall Study|Lost to Follow-up|5|||
162023598|NCT00488683|585142763|FG001|Overall Study|Lost to Follow-up|3|||
162023599|NCT00488683|585142764|FG002|Overall Study|Lost to Follow-up|0|||
162023600|NCT00488683|585142762|FG000|Overall Study|Protocol Violation|5|||
162023601|NCT00488683|585142763|FG001|Overall Study|Protocol Violation|1|||
162023602|NCT00488683|585142764|FG002|Overall Study|Protocol Violation|0|||
162023603|NCT00488683|585142762|FG000|Overall Study|Unable to Classify|1|||
162023604|NCT00488683|585142763|FG001|Overall Study|Unable to Classify|0|||
162023605|NCT00488683|585142764|FG002|Overall Study|Unable to Classify|0|||
162023606|NCT00336856|585144465|FG000|Overall Study|Withdrawal by Subject|3|||
162023607|NCT00336856|585144465|FG000|Overall Study|Found ineligible at time of analysis|1|||
162023608|NCT00843778|585144478|FG000|Overall Study|Adverse Event|15|||
162023609|NCT00843778|585144478|FG000|Overall Study|Lack of Efficacy|14|||
162023610|NCT00843778|585144478|FG000|Overall Study|Loss of efficacy|2|||
162023611|NCT00843778|585144478|FG000|Overall Study|Withdrawal by Subject|4|||
162023612|NCT00830869|585144481|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
162023613|NCT00830869|585144482|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
162023614|NCT00830869|585144483|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
162023615|NCT00830869|585144484|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
162023616|NCT00830869|585144485|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
162023617|NCT00830869|585144486|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
162023618|NCT00830869|585144487|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
162023619|NCT00830869|585144488|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
162023620|NCT00830869|585144489|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
162023621|NCT00830869|585144490|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
162023622|NCT00830869|585144491|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
162023623|NCT00830869|585144492|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
162023624|NCT00830869|585144481|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
162023625|NCT00830869|585144482|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
162023626|NCT00830869|585144483|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
162023627|NCT00830869|585144484|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
162023628|NCT00830869|585144485|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
162023629|NCT00830869|585144486|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
162227286|NCT00680992|585881626|FG001|Overall Study|Other|14|||
162227287|NCT00680992|585881627|FG002|Overall Study|Other|1|||
162227288|NCT00680992|585881625|FG000|Overall Study|Disease Progression|21|||
162227289|NCT00680992|585881626|FG001|Overall Study|Disease Progression|9|||
162227290|NCT00680992|585881627|FG002|Overall Study|Disease Progression|0|||
162227291|NCT00680992|585881625|FG000|Overall Study|Lost to Follow-up|12|||
162227292|NCT00680992|585881626|FG001|Overall Study|Lost to Follow-up|14|||
162227293|NCT00680992|585881627|FG002|Overall Study|Lost to Follow-up|0|||
162227294|NCT00680992|585881625|FG000|Overall Study|Noncompliance|4|||
162227295|NCT00680992|585881626|FG001|Overall Study|Noncompliance|6|||
162227296|NCT00680992|585881627|FG002|Overall Study|Noncompliance|0|||
162227297|NCT00680992|585881625|FG000|Overall Study|Requirement for Alternative Therapy|8|||
162227298|NCT00680992|585881626|FG001|Overall Study|Requirement for Alternative Therapy|2|||
162023630|NCT00830869|585144487|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
162023631|NCT00830869|585144488|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
162023632|NCT00830869|585144489|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
162023633|NCT00830869|585144490|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
162023634|NCT00830869|585144491|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
162023635|NCT00830869|585144492|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
162023636|NCT00830869|585144481|FG000|Period 1: Part 1|Adverse Event|0|||
162023637|NCT00830869|585144482|FG001|Period 1: Part 1|Adverse Event|0|||
162023638|NCT00830869|585144483|FG002|Period 1: Part 1|Adverse Event|0|||
162023639|NCT00830869|585144484|FG003|Period 1: Part 1|Adverse Event|0|||
161829416|NCT00892281|584415775|FG000|Overall Study|Unable to redeem the drug voucher|1|||
161829417|NCT00892281|584415776|FG001|Overall Study|Unable to redeem the drug voucher|0|||
162227299|NCT00680992|585881627|FG002|Overall Study|Requirement for Alternative Therapy|0|||
161829418|NCT00892281|584415775|FG000|Overall Study|Subject not good candidate for study|1|||
162227300|NCT00680992|585881625|FG000|Overall Study|Pregnancy|5|||
162227301|NCT00680992|585881626|FG001|Overall Study|Pregnancy|0|||
162227302|NCT00680992|585881627|FG002|Overall Study|Pregnancy|1|||
162227303|NCT00680992|585881625|FG000|Overall Study|Death|5|||
162227304|NCT00680992|585881626|FG001|Overall Study|Death|1|||
162227305|NCT00680992|585881627|FG002|Overall Study|Death|0|||
162227306|NCT00680992|585881625|FG000|Overall Study|Ineligibility Determined|0|||
162227307|NCT00680992|585881626|FG001|Overall Study|Ineligibility Determined|1|||
162227308|NCT00680992|585881627|FG002|Overall Study|Ineligibility Determined|0|||
162227309|NCT03842358|585881632|FG000|Overall Study|Poor DOT probe contact with breast|2|||
162227310|NCT03842358|585881632|FG000|Overall Study|DOT system problem|1|||
162227311|NCT03842358|585881632|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
162227312|NCT03842358|585881632|FG000|Overall Study|No biopsy after physician review|4|||
162227313|NCT03842358|585881632|FG000|Overall Study|Patient withdrew|2|||
162227314|NCT05384938|585881633|FG000|Overall Study|Withdrawal by Subject|8|||
162227315|NCT05384938|585881633|FG000|Overall Study|Lost to Follow-up|6|||
162227316|NCT05384938|585881633|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
162227317|NCT02626455|585881634|FG000|Overall Study|Other|1|||
162227318|NCT02626455|585881635|FG001|Overall Study|Other|1|||
162227319|NCT02626455|585881636|FG002|Overall Study|Other|0|||
162227320|NCT02626455|585881637|FG003|Overall Study|Other|0|||
162227321|NCT02626455|585881638|FG004|Overall Study|Other|0|||
162227322|NCT02626455|585881639|FG005|Overall Study|Other|17|||
162227323|NCT02626455|585881640|FG006|Overall Study|Other|23|||
162227324|NCT02626455|585881634|FG000|Overall Study|Withdrawal by Subject|1|||
162227325|NCT02626455|585881635|FG001|Overall Study|Withdrawal by Subject|0|||
162227326|NCT02626455|585881636|FG002|Overall Study|Withdrawal by Subject|0|||
162227327|NCT02626455|585881637|FG003|Overall Study|Withdrawal by Subject|0|||
161829419|NCT00892281|584415776|FG001|Overall Study|Subject not good candidate for study|0|||
162023640|NCT00830869|585144485|FG004|Period 1: Part 1|Adverse Event|0|||
162227328|NCT02626455|585881638|FG004|Overall Study|Withdrawal by Subject|0|||
162227329|NCT02626455|585881639|FG005|Overall Study|Withdrawal by Subject|10|||
162227330|NCT02626455|585881640|FG006|Overall Study|Withdrawal by Subject|6|||
162227331|NCT02626455|585881634|FG000|Overall Study|Physician Decision|0|||
162227332|NCT02626455|585881635|FG001|Overall Study|Physician Decision|2|||
162227333|NCT02626455|585881636|FG002|Overall Study|Physician Decision|2|||
162227334|NCT02626455|585881637|FG003|Overall Study|Physician Decision|2|||
162227335|NCT02626455|585881638|FG004|Overall Study|Physician Decision|1|||
162227336|NCT02626455|585881639|FG005|Overall Study|Physician Decision|10|||
162227337|NCT02626455|585881640|FG006|Overall Study|Physician Decision|3|||
162227338|NCT02626455|585881634|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162227339|NCT02626455|585881635|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162227340|NCT02626455|585881636|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162227341|NCT02626455|585881637|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162227342|NCT02626455|585881638|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162227343|NCT02626455|585881639|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
162227344|NCT02626455|585881640|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
162227345|NCT02626455|585881634|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
162227346|NCT02626455|585881635|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
162227347|NCT02626455|585881636|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
162227348|NCT02626455|585881637|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
162227349|NCT02626455|585881638|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
162227350|NCT02626455|585881639|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
162227351|NCT02626455|585881640|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
162227352|NCT02626455|585881634|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
162227353|NCT02626455|585881635|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
162227354|NCT02626455|585881636|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
162227355|NCT02626455|585881637|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
162227356|NCT02626455|585881638|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
161829420|NCT00892281|584415775|FG000|Overall Study|Subject did not return for any visits|1|||
161829421|NCT00892281|584415776|FG001|Overall Study|Subject did not return for any visits|0|||
161829422|NCT00892281|584415775|FG000|Overall Study|Subject missed several visits/lost meds|1|||
161829423|NCT00892281|584415776|FG001|Overall Study|Subject missed several visits/lost meds|0|||
161829424|NCT00892281|584415775|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
161829425|NCT00892281|584415776|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
161829426|NCT00892281|584415775|FG000|Overall Study|Scheduled for knee replacement|0|||
161829427|NCT00892281|584415776|FG001|Overall Study|Scheduled for knee replacement|1|||
161829428|NCT00892281|584415775|FG000|Overall Study|PI complained of inadequate compensation|3|||
161829429|NCT00892281|584415776|FG001|Overall Study|PI complained of inadequate compensation|0|||
161829430|NCT00892281|584415775|FG000|Overall Study|Subject lost interest in program|0|||
161829431|NCT00892281|584415776|FG001|Overall Study|Subject lost interest in program|1|||
161829432|NCT00892281|584415775|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
161829433|NCT00892281|584415776|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
161829434|NCT00892281|584415775|FG000|Overall Study|Death in family|1|||
161829435|NCT00892281|584415776|FG001|Overall Study|Death in family|0|||
161829436|NCT00892281|584415775|FG000|Overall Study|Lack of efficacy of study product|2|||
161829437|NCT00892281|584415776|FG001|Overall Study|Lack of efficacy of study product|0|||
162227357|NCT02626455|585881639|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
162227358|NCT02626455|585881640|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
162227359|NCT02626455|585881634|FG000|Overall Study|Patient decision|0|||
162227360|NCT02626455|585881635|FG001|Overall Study|Patient decision|1|||
162227361|NCT02626455|585881636|FG002|Overall Study|Patient decision|0|||
162227362|NCT02626455|585881637|FG003|Overall Study|Patient decision|0|||
162227363|NCT02626455|585881638|FG004|Overall Study|Patient decision|1|||
162227364|NCT02626455|585881639|FG005|Overall Study|Patient decision|36|||
162227365|NCT02626455|585881640|FG006|Overall Study|Patient decision|22|||
162227366|NCT02626455|585881634|FG000|Overall Study|Protocol Violation|0|||
162227367|NCT02626455|585881635|FG001|Overall Study|Protocol Violation|0|||
162227368|NCT02626455|585881636|FG002|Overall Study|Protocol Violation|0|||
162227369|NCT02626455|585881637|FG003|Overall Study|Protocol Violation|0|||
162227370|NCT02626455|585881638|FG004|Overall Study|Protocol Violation|0|||
162227371|NCT02626455|585881639|FG005|Overall Study|Protocol Violation|0|||
162227372|NCT02626455|585881640|FG006|Overall Study|Protocol Violation|1|||
162227373|NCT02626455|585881634|FG000|Overall Study|Progressive disease - radiological progression|0|||
162227374|NCT02626455|585881635|FG001|Overall Study|Progressive disease - radiological progression|0|||
162227375|NCT02626455|585881636|FG002|Overall Study|Progressive disease - radiological progression|0|||
162227376|NCT02626455|585881637|FG003|Overall Study|Progressive disease - radiological progression|0|||
162227377|NCT02626455|585881638|FG004|Overall Study|Progressive disease - radiological progression|0|||
162227378|NCT02626455|585881639|FG005|Overall Study|Progressive disease - radiological progression|11|||
162227379|NCT02626455|585881640|FG006|Overall Study|Progressive disease - radiological progression|22|||
162227380|NCT02626455|585881634|FG000|Overall Study|Progressive disease - clinical progression|0|||
162227381|NCT02626455|585881635|FG001|Overall Study|Progressive disease - clinical progression|0|||
162227382|NCT02626455|585881636|FG002|Overall Study|Progressive disease - clinical progression|0|||
162227383|NCT02626455|585881637|FG003|Overall Study|Progressive disease - clinical progression|0|||
162227384|NCT02626455|585881638|FG004|Overall Study|Progressive disease - clinical progression|0|||
162227385|NCT02626455|585881639|FG005|Overall Study|Progressive disease - clinical progression|1|||
162227386|NCT02626455|585881640|FG006|Overall Study|Progressive disease - clinical progression|2|||
162227387|NCT02626455|585881634|FG000|Overall Study|Lost to Follow-up|0|||
162227388|NCT02626455|585881635|FG001|Overall Study|Lost to Follow-up|0|||
162227389|NCT02626455|585881636|FG002|Overall Study|Lost to Follow-up|0|||
162227390|NCT02626455|585881637|FG003|Overall Study|Lost to Follow-up|0|||
162227391|NCT02626455|585881638|FG004|Overall Study|Lost to Follow-up|0|||
162227392|NCT02626455|585881639|FG005|Overall Study|Lost to Follow-up|1|||
162227393|NCT02626455|585881640|FG006|Overall Study|Lost to Follow-up|0|||
162227394|NCT02626455|585881634|FG000|Overall Study|AE not associated with clinical disease progression|1|||
162227395|NCT02626455|585881635|FG001|Overall Study|AE not associated with clinical disease progression|1|||
162227396|NCT02626455|585881636|FG002|Overall Study|AE not associated with clinical disease progression|0|||
162227397|NCT02626455|585881637|FG003|Overall Study|AE not associated with clinical disease progression|2|||
162227398|NCT02626455|585881638|FG004|Overall Study|AE not associated with clinical disease progression|1|||
162227399|NCT02626455|585881639|FG005|Overall Study|AE not associated with clinical disease progression|65|||
162227400|NCT02626455|585881640|FG006|Overall Study|AE not associated with clinical disease progression|21|||
162227401|NCT02626455|585881634|FG000|Overall Study|AE associated with clinical disease progression|0|||
162227402|NCT02626455|585881635|FG001|Overall Study|AE associated with clinical disease progression|0|||
162227403|NCT02626455|585881636|FG002|Overall Study|AE associated with clinical disease progression|0|||
162227404|NCT02626455|585881637|FG003|Overall Study|AE associated with clinical disease progression|0|||
162227405|NCT02626455|585881638|FG004|Overall Study|AE associated with clinical disease progression|0|||
162227406|NCT02626455|585881639|FG005|Overall Study|AE associated with clinical disease progression|1|||
162227407|NCT02626455|585881640|FG006|Overall Study|AE associated with clinical disease progression|2|||
162227408|NCT02626455|585881634|FG000|Overall Study|Study intervention never administered|0|||
162227409|NCT02626455|585881635|FG001|Overall Study|Study intervention never administered|0|||
162227410|NCT02626455|585881636|FG002|Overall Study|Study intervention never administered|0|||
162227411|NCT02626455|585881637|FG003|Overall Study|Study intervention never administered|0|||
162227412|NCT02626455|585881638|FG004|Overall Study|Study intervention never administered|0|||
162227413|NCT02626455|585881639|FG005|Overall Study|Study intervention never administered|1|||
162227414|NCT02626455|585881640|FG006|Overall Study|Study intervention never administered|3|||
162227415|NCT06665919|585881641|FG000|Overall Study|Withdrawal by Subject|4|||
162227416|NCT06665919|585881642|FG001|Overall Study|Withdrawal by Subject|4|||
162227417|NCT06665919|585881643|FG002|Overall Study|Withdrawal by Subject|4|||
162227418|NCT06665919|585881641|FG000|Overall Study|Non-compliance to Treatment|4|||
162227419|NCT06665919|585881642|FG001|Overall Study|Non-compliance to Treatment|1|||
162227420|NCT06665919|585881643|FG002|Overall Study|Non-compliance to Treatment|6|||
162227421|NCT06665919|585881641|FG000|Overall Study|Lost to Follow-up|3|||
162227422|NCT06665919|585881642|FG001|Overall Study|Lost to Follow-up|0|||
162227423|NCT06665919|585881643|FG002|Overall Study|Lost to Follow-up|2|||
162227424|NCT06665919|585881641|FG000|Overall Study|Physician Decision|4|||
162227425|NCT06665919|585881642|FG001|Overall Study|Physician Decision|0|||
162227426|NCT06665919|585881643|FG002|Overall Study|Physician Decision|1|||
162227427|NCT05148962|585881644|FG000|Overall Study|Withdrawal by Subject|1|||
162227428|NCT05148962|585881645|FG001|Overall Study|Withdrawal by Subject|1|||
162227429|NCT05148962|585881646|FG002|Overall Study|Withdrawal by Subject|0|||
162227430|NCT05148962|585881647|FG003|Overall Study|Withdrawal by Subject|1|||
162227431|NCT05148962|585881648|FG004|Overall Study|Withdrawal by Subject|0|||
162227432|NCT05148962|585881644|FG000|Overall Study|Participant was early terminated per protocol|0|||
162227433|NCT05148962|585881645|FG001|Overall Study|Participant was early terminated per protocol|0|||
162227434|NCT05148962|585881646|FG002|Overall Study|Participant was early terminated per protocol|3|||
162227435|NCT05148962|585881647|FG003|Overall Study|Participant was early terminated per protocol|5|||
162227436|NCT05148962|585881648|FG004|Overall Study|Participant was early terminated per protocol|2|||
162227437|NCT05148962|585881644|FG000|Overall Study|Miscellaneous|0|||
162227438|NCT05148962|585881645|FG001|Overall Study|Miscellaneous|0|||
162227439|NCT05148962|585881646|FG002|Overall Study|Miscellaneous|0|||
162227440|NCT05148962|585881647|FG003|Overall Study|Miscellaneous|1|||
162227441|NCT05148962|585881648|FG004|Overall Study|Miscellaneous|0|||
162227442|NCT01200290|585881650|FG000|Treatment Period|Adverse Event|1|||
162227443|NCT01200290|585881650|FG000|Post-Treatment Follow-Up Period|Death|2|||
162227444|NCT01525238|585881651|FG000|Overall Study|Withdrawal by Subject|1|||
162227445|NCT01525238|585881652|FG001|Overall Study|Withdrawal by Subject|0|||
162227446|NCT01525238|585881653|FG002|Overall Study|Withdrawal by Subject|0|||
162227447|NCT00607724|585881654|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
162227448|NCT00607724|585881655|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
162227449|NCT00607724|585881656|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
162227450|NCT00607724|585881657|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
162227451|NCT00607724|585881658|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
162227452|NCT00607724|585881659|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
162227453|NCT00607724|585881660|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
162227454|NCT00607724|585881654|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
162227455|NCT00607724|585881655|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
162227456|NCT00607724|585881656|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
162227457|NCT00607724|585881657|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
162227458|NCT00607724|585881658|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
162227459|NCT00607724|585881659|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
162227460|NCT00607724|585881660|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
162227461|NCT00607724|585881654|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
162227462|NCT00607724|585881655|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
162227463|NCT00607724|585881656|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
162227464|NCT00607724|585881657|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
162227465|NCT00607724|585881658|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
162227466|NCT00607724|585881659|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
162227467|NCT00607724|585881660|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
162227468|NCT00607724|585881654|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
162227469|NCT00607724|585881655|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
162227470|NCT00607724|585881656|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
162227471|NCT00607724|585881657|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
162227472|NCT00607724|585881658|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
162227473|NCT00607724|585881659|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
162227474|NCT00607724|585881660|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
162227475|NCT00607724|585881654|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
162227476|NCT00607724|585881655|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
162227477|NCT00607724|585881656|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
162227478|NCT00607724|585881657|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
162227479|NCT00607724|585881658|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
162227480|NCT00607724|585881659|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
162227481|NCT00607724|585881660|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
162227482|NCT00775463|585883186|FG000|Overall Study|Withdrawal by Subject|0|||
162227483|NCT00775463|585883187|FG001|Overall Study|Withdrawal by Subject|1|||
162227484|NCT00775463|585883186|FG000|Overall Study|Adverse Event|7|||
162227485|NCT00775463|585883187|FG001|Overall Study|Adverse Event|9|||
162227486|NCT00775463|585883186|FG000|Overall Study|Protocol Violation|2|||
162227487|NCT00775463|585883187|FG001|Overall Study|Protocol Violation|2|||
162227488|NCT00775463|585883186|FG000|Overall Study|Lost to Follow-up|1|||
162227489|NCT00775463|585883187|FG001|Overall Study|Lost to Follow-up|0|||
162227490|NCT00775463|585883186|FG000|Overall Study|Lack of Efficacy|1|||
162227491|NCT00775463|585883187|FG001|Overall Study|Lack of Efficacy|1|||
162227492|NCT01789567|585883188|FG000|Overall Study|Death|6|||
162227493|NCT04032613|585883189|FG000|Overall Study|Did not complete post-program assessment|5|||
162227494|NCT04032613|585883190|FG001|Overall Study|Did not complete post-program assessment|2|||
162227495|NCT01659853|585883191|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
162227496|NCT01659853|585883192|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
162227497|NCT01659853|585883191|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
162227498|NCT01659853|585883192|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
162227499|NCT01744392|585883196|FG000|Overall Study|Physician Decision|1|||
162227500|NCT00299494|585883197|FG000|Overall Study|Withdrawal by Subject|0|||
162227501|NCT00299494|585883198|FG001|Overall Study|Withdrawal by Subject|0|||
162227502|NCT00299494|585883199|FG002|Overall Study|Withdrawal by Subject|0|||
162227503|NCT00299494|585883200|FG003|Overall Study|Withdrawal by Subject|3|||
162227504|NCT00299494|585883201|FG004|Overall Study|Withdrawal by Subject|1|||
162227505|NCT00299494|585883202|FG005|Overall Study|Withdrawal by Subject|4|||
162227506|NCT00299494|585883197|FG000|Overall Study|Physician Decision|0|||
162227507|NCT00299494|585883198|FG001|Overall Study|Physician Decision|0|||
162227508|NCT00299494|585883199|FG002|Overall Study|Physician Decision|0|||
162227509|NCT00299494|585883200|FG003|Overall Study|Physician Decision|0|||
162227510|NCT00299494|585883201|FG004|Overall Study|Physician Decision|1|||
162227511|NCT00299494|585883202|FG005|Overall Study|Physician Decision|0|||
162227512|NCT00299494|585883197|FG000|Overall Study|Death|3|||
162227513|NCT00299494|585883198|FG001|Overall Study|Death|1|||
162227514|NCT00299494|585883199|FG002|Overall Study|Death|4|||
162227515|NCT00299494|585883200|FG003|Overall Study|Death|6|||
162227516|NCT00299494|585883201|FG004|Overall Study|Death|18|||
162227517|NCT00299494|585883202|FG005|Overall Study|Death|19|||
162227518|NCT00299494|585883197|FG000|Overall Study|Lost to Follow-up|0|||
162227519|NCT00299494|585883198|FG001|Overall Study|Lost to Follow-up|0|||
162227520|NCT00299494|585883199|FG002|Overall Study|Lost to Follow-up|0|||
162227521|NCT00299494|585883200|FG003|Overall Study|Lost to Follow-up|0|||
162227522|NCT00299494|585883201|FG004|Overall Study|Lost to Follow-up|3|||
162227523|NCT00299494|585883202|FG005|Overall Study|Lost to Follow-up|1|||
162227524|NCT00299494|585883197|FG000|Overall Study|Other - Unspecified|0|||
162227525|NCT00299494|585883198|FG001|Overall Study|Other - Unspecified|0|||
162227526|NCT00299494|585883199|FG002|Overall Study|Other - Unspecified|0|||
162227527|NCT00299494|585883200|FG003|Overall Study|Other - Unspecified|0|||
162227528|NCT00299494|585883201|FG004|Overall Study|Other - Unspecified|3|||
162227529|NCT00299494|585883202|FG005|Overall Study|Other - Unspecified|1|||
162227530|NCT00299494|585883197|FG000|Overall Study|Other - site closure|0|||
162227531|NCT00299494|585883198|FG001|Overall Study|Other - site closure|0|||
162227532|NCT00299494|585883199|FG002|Overall Study|Other - site closure|0|||
162227533|NCT00299494|585883200|FG003|Overall Study|Other - site closure|1|||
161940126|NCT02613507|584830767|FG001|Treatment|Maximum clinical benefit|10|||
161940127|NCT02613507|584830766|FG000|Treatment|Lost to Follow-up|1|||
162227534|NCT00299494|585883201|FG004|Overall Study|Other - site closure|1|||
162227535|NCT00299494|585883202|FG005|Overall Study|Other - site closure|1|||
162227536|NCT01417104|585883206|FG000|Overall Study|Withdrawal by Subject|5|||
162227537|NCT01417104|585883207|FG001|Overall Study|Withdrawal by Subject|1|||
162227538|NCT01417104|585883206|FG000|Overall Study|Failure to make contact|0|||
161940128|NCT02613507|584830767|FG001|Treatment|Lost to Follow-up|0|||
162227539|NCT01417104|585883207|FG001|Overall Study|Failure to make contact|1|||
162227540|NCT01417104|585883206|FG000|Overall Study|Adverse Event|1|||
162227541|NCT01417104|585883207|FG001|Overall Study|Adverse Event|0|||
162227542|NCT01365481|585883213|FG000|Overall Study|Adverse Event|6|||
162227543|NCT01365481|585883214|FG001|Overall Study|Adverse Event|9|||
162227544|NCT01365481|585883215|FG002|Overall Study|Adverse Event|0|||
162227545|NCT01365481|585883216|FG003|Overall Study|Adverse Event|2|||
162227546|NCT01365481|585883213|FG000|Overall Study|Withdrawal by Subject|0|||
162227547|NCT01365481|585883214|FG001|Overall Study|Withdrawal by Subject|2|||
162227548|NCT01365481|585883215|FG002|Overall Study|Withdrawal by Subject|1|||
162227549|NCT01365481|585883216|FG003|Overall Study|Withdrawal by Subject|1|||
162227550|NCT01365481|585883213|FG000|Overall Study|Lost to Follow-up|1|||
162227551|NCT01365481|585883214|FG001|Overall Study|Lost to Follow-up|1|||
162227552|NCT01365481|585883215|FG002|Overall Study|Lost to Follow-up|2|||
162227553|NCT01365481|585883216|FG003|Overall Study|Lost to Follow-up|3|||
162227554|NCT01365481|585883213|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162227555|NCT01365481|585883214|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162227556|NCT01365481|585883215|FG002|Overall Study|Abnormal laboratory value(s)|0|||
162227557|NCT01365481|585883216|FG003|Overall Study|Abnormal laboratory value(s)|0|||
162227558|NCT01365481|585883213|FG000|Overall Study|Administrative problems|0|||
162227559|NCT01365481|585883214|FG001|Overall Study|Administrative problems|1|||
162227560|NCT01365481|585883215|FG002|Overall Study|Administrative problems|0|||
162227561|NCT01365481|585883216|FG003|Overall Study|Administrative problems|0|||
162227562|NCT01365481|585883213|FG000|Overall Study|Protocol deviation|0|||
162227563|NCT01365481|585883214|FG001|Overall Study|Protocol deviation|1|||
162227564|NCT01365481|585883215|FG002|Overall Study|Protocol deviation|0|||
162227565|NCT01365481|585883216|FG003|Overall Study|Protocol deviation|1|||
162227566|NCT01365481|585883213|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162227567|NCT01365481|585883214|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162227568|NCT01365481|585883215|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
162227569|NCT01365481|585883216|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
162227570|NCT00757627|585883217|FG000|Overall Study|Adverse Event|15|||
162227571|NCT00757627|585883217|FG000|Overall Study|Lack of Efficacy|10|||
162227572|NCT00757627|585883217|FG000|Overall Study|Lost to Follow-up|28|||
162227573|NCT00757627|585883217|FG000|Overall Study|Withdrawal by Subject|27|||
162227574|NCT00757627|585883217|FG000|Overall Study|Other|1|||
162227575|NCT00635661|585883222|FG000|Overall Study|Withdrawal by Subject|4|||
162227576|NCT00403767|585883228|FG000|Overall Study|Adverse Event|993|||
162227577|NCT00403767|585883229|FG001|Overall Study|Adverse Event|919|||
162227578|NCT00403767|585883228|FG000|Overall Study|Non-compliant with study medication|134|||
162227579|NCT00403767|585883229|FG001|Overall Study|Non-compliant with study medication|164|||
162227580|NCT00403767|585883228|FG000|Overall Study|Consent withdrawn|671|||
162227581|NCT00403767|585883229|FG001|Overall Study|Consent withdrawn|673|||
162227582|NCT00403767|585883228|FG000|Overall Study|Investigator dec./not protocol-related|191|||
162227583|NCT00403767|585883229|FG001|Overall Study|Investigator dec./not protocol-related|178|||
162227584|NCT00403767|585883228|FG000|Overall Study|Lost to Follow-up|6|||
162227585|NCT00403767|585883229|FG001|Overall Study|Lost to Follow-up|8|||
162227586|NCT00403767|585883228|FG000|Overall Study|Protocol Violation|142|||
162227587|NCT00403767|585883229|FG001|Overall Study|Protocol Violation|124|||
162227588|NCT00403767|585883228|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
162227589|NCT00403767|585883229|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
162227590|NCT00403767|585883228|FG000|Overall Study|Study terminated by sponsor|82|||
162227591|NCT00403767|585883229|FG001|Overall Study|Study terminated by sponsor|69|||
162227592|NCT00403767|585883228|FG000|Overall Study|Missing/incomplete data|1|||
162227593|NCT00403767|585883229|FG001|Overall Study|Missing/incomplete data|1|||
162227594|NCT02755818|585883230|FG000|Overall Study|Withdrawal by Subject|0|||
162227595|NCT02755818|585883231|FG001|Overall Study|Withdrawal by Subject|0|||
162227596|NCT02755818|585883232|FG002|Overall Study|Withdrawal by Subject|0|||
162227597|NCT02755818|585883233|FG003|Overall Study|Withdrawal by Subject|2|||
162227598|NCT02755818|585883230|FG000|Overall Study|withdrawal by PI|0|||
162227599|NCT02755818|585883231|FG001|Overall Study|withdrawal by PI|0|||
162227600|NCT02755818|585883232|FG002|Overall Study|withdrawal by PI|1|||
161940129|NCT02613507|584830766|FG000|Treatment|Participant withdrew consent|0|||
161940130|NCT02613507|584830767|FG001|Treatment|Participant withdrew consent|2|||
162227601|NCT02755818|585883233|FG003|Overall Study|withdrawal by PI|1|||
162227602|NCT03014011|585883234|FG000|First Intervention|Withdrawal by Subject|1|||
162227603|NCT03014011|585883235|FG001|First Intervention|Withdrawal by Subject|0|||
162227604|NCT03014011|585883234|FG000|Washout|Withdrawal by Subject|1|||
162227605|NCT03014011|585883235|FG001|Washout|Withdrawal by Subject|0|||
161678757|NCT00574288|583876071|FG006|Overall Study|Study Terminated By Sponsor|5|||
162227606|NCT03223662|585883242|FG000|Overall Study|Physician Decision|1|||
162227607|NCT03223662|585883242|FG000|Overall Study|Study closure|1|||
162227608|NCT01280357|585883247|FG000|Overall Study|Excluded no internal monitoring|14|||
162227609|NCT01280357|585883247|FG000|Overall Study|IInsufficient data/No data supplied|12|||
162227610|NCT02229851|585883248|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
162023641|NCT00830869|585144486|FG005|Period 1: Part 1|Adverse Event|1|||
161829438|NCT00892281|584415775|FG000|Overall Study|Subject not seen by PI at final visit|1|||
161829439|NCT00892281|584415776|FG001|Overall Study|Subject not seen by PI at final visit|0|||
161829440|NCT00892281|584415775|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
161829441|NCT00892281|584415776|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
161829442|NCT00892281|584415775|FG000|Overall Study|Missed multiple visits|1|||
161829443|NCT00892281|584415776|FG001|Overall Study|Missed multiple visits|0|||
161829444|NCT00892281|584415775|FG000|Overall Study|Missed visits rescheduled out of window|1|||
161829445|NCT00892281|584415776|FG001|Overall Study|Missed visits rescheduled out of window|0|||
161829446|NCT00892281|584415775|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
161829447|NCT00892281|584415776|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
162227611|NCT02229851|585883249|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
162227612|NCT02229851|585883250|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
162227613|NCT02229851|585883251|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
162227614|NCT02229851|585883252|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
162227615|NCT02229851|585883253|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
162227616|NCT02229851|585883254|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
162227617|NCT02229851|585883248|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
162227618|NCT02229851|585883249|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
162227619|NCT02229851|585883250|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
162227620|NCT02229851|585883251|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
162227621|NCT02229851|585883252|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
162227622|NCT02229851|585883253|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
162227623|NCT02229851|585883254|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
162227624|NCT02229851|585883248|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
162227625|NCT02229851|585883249|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
162227626|NCT02229851|585883250|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
161829448|NCT00892281|584415775|FG000|Overall Study|Subject had history of drug abuse|1|||
161829449|NCT00892281|584415776|FG001|Overall Study|Subject had history of drug abuse|0|||
161829450|NCT00892281|584415775|FG000|Overall Study|Rash on hand|1|||
162227627|NCT02229851|585883251|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
162227628|NCT02229851|585883252|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
162227629|NCT02229851|585883253|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
162227630|NCT02229851|585883254|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
162227631|NCT02229851|585883248|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
162227632|NCT02229851|585883249|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
162227633|NCT02229851|585883250|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
162227634|NCT02229851|585883251|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
162227635|NCT02229851|585883252|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
162227636|NCT02229851|585883253|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
162227637|NCT02229851|585883254|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
162227638|NCT02229851|585883248|FG000|Main Phase (Double-blind Phase)|Death|1|||
162227639|NCT02229851|585883249|FG001|Main Phase (Double-blind Phase)|Death|1|||
162227640|NCT02229851|585883250|FG002|Main Phase (Double-blind Phase)|Death|0|||
162227641|NCT02229851|585883251|FG003|Main Phase (Double-blind Phase)|Death|0|||
162227642|NCT02229851|585883252|FG004|Main Phase (Double-blind Phase)|Death|0|||
162227643|NCT02229851|585883253|FG005|Main Phase (Double-blind Phase)|Death|0|||
162227644|NCT02229851|585883254|FG006|Main Phase (Double-blind Phase)|Death|0|||
162227645|NCT02229851|585883248|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
162227646|NCT02229851|585883249|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
162227647|NCT02229851|585883250|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
162227648|NCT02229851|585883251|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
162227649|NCT02229851|585883252|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
162227650|NCT02229851|585883253|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
162227651|NCT02229851|585883254|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
162227652|NCT02229851|585883248|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
162227653|NCT02229851|585883249|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
162227654|NCT02229851|585883250|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
162227655|NCT02229851|585883251|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
162227656|NCT02229851|585883252|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
162227657|NCT02229851|585883253|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
162227658|NCT02229851|585883254|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
162227659|NCT02229851|585883248|FG000|Extension Phase (Open-label Phase)|Death|0|||
162227660|NCT02229851|585883249|FG001|Extension Phase (Open-label Phase)|Death|0|||
162227661|NCT02229851|585883250|FG002|Extension Phase (Open-label Phase)|Death|0|||
162227662|NCT02229851|585883251|FG003|Extension Phase (Open-label Phase)|Death|1|||
162227663|NCT02229851|585883252|FG004|Extension Phase (Open-label Phase)|Death|0|||
162227664|NCT02229851|585883253|FG005|Extension Phase (Open-label Phase)|Death|1|||
162227665|NCT02229851|585883254|FG006|Extension Phase (Open-label Phase)|Death|1|||
162227666|NCT03284203|585883255|FG000|Overall Study|Lost to Follow-up|3|||
162227667|NCT00528931|585883256|FG000|Overall Study|Lost to Follow-up|1|||
162227668|NCT00992225|585883259|FG000|Overall Study|Entry Criteria Not Met|8|||
162227669|NCT00992225|585883259|FG000|Overall Study|Adverse Event|2|||
162227670|NCT03122223|585883260|FG000|Overall Study|Withdrawal by Subject|2|||
162227671|NCT03122223|585883261|FG001|Overall Study|Withdrawal by Subject|2|||
162227672|NCT03122223|585883262|FG002|Overall Study|Withdrawal by Subject|1|||
162227673|NCT03122223|585883263|FG003|Overall Study|Withdrawal by Subject|0|||
162227674|NCT03122223|585883260|FG000|Overall Study|Lost to Follow-up|0|||
162227675|NCT03122223|585883261|FG001|Overall Study|Lost to Follow-up|2|||
162227676|NCT03122223|585883262|FG002|Overall Study|Lost to Follow-up|2|||
162227677|NCT03122223|585883263|FG003|Overall Study|Lost to Follow-up|0|||
162227678|NCT03122223|585883260|FG000|Overall Study|Participant unable to adhere|1|||
162227679|NCT03122223|585883261|FG001|Overall Study|Participant unable to adhere|1|||
162227680|NCT03122223|585883262|FG002|Overall Study|Participant unable to adhere|1|||
162227681|NCT03122223|585883263|FG003|Overall Study|Participant unable to adhere|0|||
162023642|NCT00830869|585144487|FG006|Period 1: Part 1|Adverse Event|1|||
162023643|NCT00830869|585144488|FG007|Period 1: Part 1|Adverse Event|0|||
162023644|NCT00830869|585144489|FG008|Period 1: Part 1|Adverse Event|0|||
162023645|NCT00830869|585144490|FG009|Period 1: Part 1|Adverse Event|0|||
162023646|NCT00830869|585144491|FG010|Period 1: Part 1|Adverse Event|0|||
162023647|NCT00830869|585144492|FG011|Period 1: Part 1|Adverse Event|0|||
162023648|NCT00830869|585144481|FG000|Period 1: Part 1|Progressive disease|1|||
162023649|NCT00830869|585144482|FG001|Period 1: Part 1|Progressive disease|0|||
162023650|NCT00830869|585144483|FG002|Period 1: Part 1|Progressive disease|1|||
162023651|NCT00830869|585144484|FG003|Period 1: Part 1|Progressive disease|6|||
162023652|NCT00830869|585144485|FG004|Period 1: Part 1|Progressive disease|4|||
162023653|NCT00830869|585144486|FG005|Period 1: Part 1|Progressive disease|4|||
162023654|NCT00830869|585144487|FG006|Period 1: Part 1|Progressive disease|1|||
162227682|NCT03466073|585883264|FG000|Overall Study|Death|1|||
162227683|NCT03466073|585883265|FG001|Overall Study|Death|0|||
162227684|NCT03466073|585883266|FG002|Overall Study|Death|0|||
162227685|NCT03466073|585883267|FG003|Overall Study|Death|0|||
162227686|NCT03466073|585883268|FG004|Overall Study|Death|0|||
162227687|NCT03466073|585883269|FG005|Overall Study|Death|1|||
162227688|NCT03682302|585883270|FG000|Overall Study|Lost to Follow-up|1|||
162227689|NCT03682302|585883271|FG001|Overall Study|Lost to Follow-up|2|||
162227690|NCT03682302|585883272|FG002|Overall Study|Lost to Follow-up|0|||
162227691|NCT03682302|585883273|FG003|Overall Study|Lost to Follow-up|1|||
162227692|NCT03682302|585883270|FG000|Overall Study|Study drug was not administered|0|||
162227693|NCT03682302|585883271|FG001|Overall Study|Study drug was not administered|0|||
162227694|NCT03682302|585883272|FG002|Overall Study|Study drug was not administered|1|||
162227695|NCT03682302|585883273|FG003|Overall Study|Study drug was not administered|1|||
162227696|NCT01489891|585883276|FG000|Overall Study|Endoscopy failure|1|||
162227697|NCT01489891|585883277|FG001|Overall Study|Endoscopy failure|0|||
162227698|NCT00532493|585883278|FG000|Overall Study|Death|1|||
162227699|NCT00532493|585883279|FG001|Overall Study|Death|1|||
162227700|NCT00532493|585883278|FG000|Overall Study|Lost to Follow-up|10|||
162227701|NCT00532493|585883279|FG001|Overall Study|Lost to Follow-up|7|||
162227702|NCT00532493|585883278|FG000|Overall Study|Withdrawal by Subject|7|||
162227703|NCT00532493|585883279|FG001|Overall Study|Withdrawal by Subject|9|||
162227704|NCT00532493|585883278|FG000|Overall Study|Physician Decision|1|||
162227705|NCT00532493|585883279|FG001|Overall Study|Physician Decision|6|||
162227706|NCT00532493|585883278|FG000|Overall Study|Adverse Event|6|||
162227707|NCT00532493|585883279|FG001|Overall Study|Adverse Event|5|||
162227708|NCT00532493|585883278|FG000|Overall Study|Protocol Deviation|1|||
162227709|NCT00532493|585883279|FG001|Overall Study|Protocol Deviation|0|||
162227710|NCT00532493|585883278|FG000|Overall Study|Subject Moved Away|3|||
162227711|NCT00532493|585883279|FG001|Overall Study|Subject Moved Away|1|||
162227712|NCT00532493|585883278|FG000|Overall Study|Contraindicative Medication|1|||
162227713|NCT00532493|585883279|FG001|Overall Study|Contraindicative Medication|0|||
162227714|NCT02045875|585883283|FG000|Overall Study|Lost to Follow-up|3|||
162227715|NCT02045875|585883284|FG001|Overall Study|Lost to Follow-up|0|||
162227716|NCT02045875|585883283|FG000|Overall Study|Withdrawal by Subject|4|||
162227717|NCT02045875|585883284|FG001|Overall Study|Withdrawal by Subject|3|||
162227718|NCT03459443|585883287|FG000|Overall Study|Lack of Efficacy|3|||
162227719|NCT03459443|585883287|FG000|Overall Study|Adverse Event|1|||
162227720|NCT03459443|585883287|FG000|Overall Study|Sponsor's decision to close the study|18|||
162227721|NCT02153073|585883288|FG000|Overall Study|Case Report Forms Uncollected|230|||
162227722|NCT02153073|585883288|FG000|Overall Study|Protocol Deviation|68|||
162227723|NCT03189745|585883289|FG000|Overall Study|Conflict in work schedule of participant|1|||
162227724|NCT03189745|585883290|FG001|Overall Study|Conflict in work schedule of participant|1|||
162227725|NCT03702231|585883291|FG000|Overall Study|Withdrawal by Subject|1|||
162227726|NCT03702231|585883292|FG001|Overall Study|Withdrawal by Subject|0|||
162227727|NCT03702231|585883293|FG002|Overall Study|Withdrawal by Subject|0|||
162227728|NCT03702231|585883291|FG000|Overall Study|Protocol Violation|0|||
162227729|NCT03702231|585883292|FG001|Overall Study|Protocol Violation|0|||
162227730|NCT03702231|585883293|FG002|Overall Study|Protocol Violation|1|||
162227731|NCT03702231|585883291|FG000|Overall Study|Change in CLL Treatment|0|||
162227732|NCT03702231|585883292|FG001|Overall Study|Change in CLL Treatment|0|||
162227733|NCT03702231|585883293|FG002|Overall Study|Change in CLL Treatment|1|||
162227734|NCT03702231|585883291|FG000|Overall Study|COVID Pandemic|1|||
162227735|NCT03702231|585883292|FG001|Overall Study|COVID Pandemic|4|||
162227736|NCT03702231|585883293|FG002|Overall Study|COVID Pandemic|1|||
162227737|NCT03702231|585883291|FG000|Overall Study|Non-compliance|0|||
162227738|NCT03702231|585883292|FG001|Overall Study|Non-compliance|0|||
162227739|NCT03702231|585883293|FG002|Overall Study|Non-compliance|1|||
162227740|NCT01276379|585883294|FG000|Overall Study|Screening failure|40|||
162227741|NCT01278173|585883295|FG000|Overall Study|Lack of Efficacy|13|||
162227742|NCT01278173|585883295|FG000|Overall Study|Adverse Event|8|||
162227743|NCT01278173|585883295|FG000|Overall Study|Administrative or other reason|4|||
162227744|NCT01278173|585883295|FG000|Overall Study|Protocol Violation|1|||
161829451|NCT00892281|584415776|FG001|Overall Study|Rash on hand|0|||
161829452|NCT00892281|584415775|FG000|Overall Study|Visit 4 date out of window|1|||
162227745|NCT01278173|585883295|FG000|Overall Study|Withdrawal by Subject|1|||
162227746|NCT04445987|585883298|FG000|Overall Study|Adverse Event|0|||
162227747|NCT04445987|585883299|FG001|Overall Study|Adverse Event|0|||
162227748|NCT04445987|585883300|FG002|Overall Study|Adverse Event|1|||
162227749|NCT04445987|585883301|FG003|Overall Study|Adverse Event|0|||
161829453|NCT00892281|584415776|FG001|Overall Study|Visit 4 date out of window|0|||
161829454|NCT01534078|584415777|FG000|Overall Study|Death|1|||
162227750|NCT04445987|585883302|FG004|Overall Study|Adverse Event|4|||
162227751|NCT04445987|585883303|FG005|Overall Study|Adverse Event|0|||
162227752|NCT04445987|585883298|FG000|Overall Study|Lost to Follow-up|4|||
162227753|NCT04445987|585883299|FG001|Overall Study|Lost to Follow-up|3|||
162227754|NCT04445987|585883300|FG002|Overall Study|Lost to Follow-up|1|||
162227755|NCT04445987|585883301|FG003|Overall Study|Lost to Follow-up|1|||
162227756|NCT04445987|585883302|FG004|Overall Study|Lost to Follow-up|29|||
162227757|NCT04445987|585883303|FG005|Overall Study|Lost to Follow-up|0|||
162227758|NCT04445987|585883298|FG000|Overall Study|Physician Decision|0|||
162227759|NCT04445987|585883299|FG001|Overall Study|Physician Decision|0|||
162227760|NCT04445987|585883300|FG002|Overall Study|Physician Decision|0|||
162227761|NCT04445987|585883301|FG003|Overall Study|Physician Decision|0|||
162227762|NCT04445987|585883302|FG004|Overall Study|Physician Decision|1|||
162227763|NCT04445987|585883303|FG005|Overall Study|Physician Decision|0|||
162227764|NCT04445987|585883298|FG000|Overall Study|Protocol Violation|1|||
162227765|NCT04445987|585883299|FG001|Overall Study|Protocol Violation|0|||
162227766|NCT04445987|585883300|FG002|Overall Study|Protocol Violation|0|||
162227767|NCT04445987|585883301|FG003|Overall Study|Protocol Violation|0|||
162227768|NCT04445987|585883302|FG004|Overall Study|Protocol Violation|2|||
162227769|NCT04445987|585883303|FG005|Overall Study|Protocol Violation|0|||
162227770|NCT04445987|585883298|FG000|Overall Study|Withdrawal by Subject|4|||
162227771|NCT04445987|585883299|FG001|Overall Study|Withdrawal by Subject|0|||
162227772|NCT04445987|585883300|FG002|Overall Study|Withdrawal by Subject|1|||
162227773|NCT04445987|585883301|FG003|Overall Study|Withdrawal by Subject|0|||
162227774|NCT04445987|585883302|FG004|Overall Study|Withdrawal by Subject|18|||
162227775|NCT04445987|585883303|FG005|Overall Study|Withdrawal by Subject|1|||
162227776|NCT04445987|585883298|FG000|Overall Study|Other reason|0|||
162227777|NCT04445987|585883299|FG001|Overall Study|Other reason|0|||
162227778|NCT04445987|585883300|FG002|Overall Study|Other reason|1|||
162227779|NCT04445987|585883301|FG003|Overall Study|Other reason|0|||
162227780|NCT04445987|585883302|FG004|Overall Study|Other reason|2|||
162227781|NCT04445987|585883303|FG005|Overall Study|Other reason|0|||
162227782|NCT01133418|585883304|FG000|Overall Study|Lost to Follow-up|5|||
162227783|NCT01133418|585883305|FG001|Overall Study|Lost to Follow-up|6|||
162227784|NCT04150068|585883311|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
162227785|NCT04150068|585883312|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
162227786|NCT04150068|585883313|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
162227787|NCT04150068|585883311|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
162227788|NCT04150068|585883312|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
162227789|NCT04150068|585883313|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
162227790|NCT05316701|585883314|FG000|Overall Study|Adverse Event|0|||
162227791|NCT05316701|585883315|FG001|Overall Study|Adverse Event|1|||
162227792|NCT05316701|585883314|FG000|Overall Study|Death|3|||
162227793|NCT05316701|585883315|FG001|Overall Study|Death|9|||
162227794|NCT05316701|585883314|FG000|Overall Study|Lost to Follow-up|1|||
162227795|NCT05316701|585883315|FG001|Overall Study|Lost to Follow-up|0|||
162227796|NCT05316701|585883314|FG000|Overall Study|Physician Decision|1|||
162227797|NCT05316701|585883315|FG001|Overall Study|Physician Decision|4|||
162227798|NCT05316701|585883314|FG000|Overall Study|Withdrawal by Subject|3|||
162227799|NCT05316701|585883315|FG001|Overall Study|Withdrawal by Subject|5|||
162227800|NCT05316701|585883314|FG000|Overall Study|Progression/Relapse|14|||
162227801|NCT05316701|585883315|FG001|Overall Study|Progression/Relapse|9|||
162227802|NCT05316701|585883314|FG000|Overall Study|Received Standard of Care|1|||
162227803|NCT05316701|585883315|FG001|Overall Study|Received Standard of Care|0|||
162227804|NCT05316701|585883314|FG000|Overall Study|Ongoing|70|||
162227805|NCT05316701|585883315|FG001|Overall Study|Ongoing|64|||
162227806|NCT01946529|585883316|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
162227807|NCT01946529|585883317|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
162227808|NCT01946529|585883318|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
162227809|NCT01946529|585883316|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
162227810|NCT01946529|585883317|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
162227811|NCT01946529|585883318|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
162227812|NCT04679935|585883319|FG000|Overall Study|Death|0|||
162227813|NCT04679935|585883320|FG001|Overall Study|Death|1|||
162227814|NCT02980731|585884424|FG000|Overall Study|Death|63|||
162227815|NCT02980731|585884424|FG000|Overall Study|Withdrawal by Subject|6|||
162227816|NCT02980731|585884424|FG000|Overall Study|Lost to Follow-up|5|||
162227817|NCT02980731|585884424|FG000|Overall Study|Study terminated by Sponsor|4|||
162227818|NCT02980731|585884424|FG000|Overall Study|Completed survival follow-up period|65|||
162227819|NCT02980731|585884424|FG000|Overall Study|COVID-19 infection|1|||
162227820|NCT02980731|585884424|FG000|Overall Study|Other, not specified|66|||
162227821|NCT03037931|585884425|FG000|Overall Study|Death|354|||
162227822|NCT03037931|585884426|FG001|Overall Study|Death|367|||
162227823|NCT03037931|585884425|FG000|Overall Study|Lost to Follow-up|7|||
162227824|NCT03037931|585884426|FG001|Overall Study|Lost to Follow-up|4|||
162227825|NCT03037931|585884425|FG000|Overall Study|Withdrawal by Subject|48|||
162227826|NCT03037931|585884426|FG001|Overall Study|Withdrawal by Subject|41|||
162227827|NCT02075476|585884427|FG000|Overall Study|Death|2|||
162227828|NCT02075476|585884428|FG001|Overall Study|Death|2|||
162227829|NCT02075476|585884427|FG000|Overall Study|Lost to Follow-up|1|||
162227830|NCT02075476|585884428|FG001|Overall Study|Lost to Follow-up|3|||
162227831|NCT01850446|585884429|FG000|Overall Study|Lack of Efficacy|1|||
162227832|NCT01850446|585884430|FG001|Overall Study|Lack of Efficacy|0|||
162227833|NCT01850446|585884429|FG000|Overall Study|Withdrawal by Subject|4|||
162227834|NCT01850446|585884430|FG001|Overall Study|Withdrawal by Subject|0|||
162227835|NCT01850446|585884429|FG000|Overall Study|Protocol Violation|0|||
162227836|NCT01850446|585884430|FG001|Overall Study|Protocol Violation|2|||
162227837|NCT00591721|585884431|FG000|Overall Study|Withdrawal by Subject|10|||
162227838|NCT00591721|585884432|FG001|Overall Study|Withdrawal by Subject|10|||
162227839|NCT00591721|585884431|FG000|Overall Study|Lost to Follow-up|1|||
162227840|NCT00591721|585884432|FG001|Overall Study|Lost to Follow-up|4|||
162227841|NCT00591721|585884431|FG000|Overall Study|Intervention not received|10|||
162227842|NCT00591721|585884432|FG001|Overall Study|Intervention not received|8|||
162227843|NCT03527550|585884439|FG000|Overall Study|Lost to Follow-up|4|||
162227844|NCT03527550|585884440|FG001|Overall Study|Lost to Follow-up|2|||
162227845|NCT03527550|585884439|FG000|Overall Study|Withdrawal by Subject|4|||
162227846|NCT03527550|585884440|FG001|Overall Study|Withdrawal by Subject|1|||
162227847|NCT03527550|585884439|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
162227848|NCT03527550|585884440|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
162227849|NCT03053518|585884442|FG000|Overall Study|Withdrawal by Subject|3|||
162227850|NCT03053518|585884442|FG000|Overall Study|Lost to Follow-up|2|||
162227851|NCT03053518|585884442|FG000|Overall Study|Ineligible|5|||
162227852|NCT02683876|585884443|FG000|Overall Study|samples damaged during shipping|2|||
162227853|NCT02683876|585884444|FG001|Overall Study|samples damaged during shipping|0|||
162227854|NCT01232738|585884445|FG000|Overall Study|Death|3|||
162227855|NCT01232738|585884445|FG000|Overall Study|Physician Decision|2|||
162227856|NCT01232738|585884445|FG000|Overall Study|Lost to Follow-up|1|||
162227857|NCT01232738|585884445|FG000|Overall Study|Withdrawal by Subject|2|||
162227858|NCT01232738|585884445|FG000|Overall Study|Adverse Event|5|||
162227859|NCT00859222|585884450|FG000|Overall Study|Adverse Event|2|||
162227860|NCT00859222|585884451|FG001|Overall Study|Adverse Event|3|||
162227861|NCT00859222|585884452|FG002|Overall Study|Adverse Event|6|||
162227862|NCT00859222|585884453|FG003|Overall Study|Adverse Event|24|||
162227863|NCT00859222|585884454|FG004|Overall Study|Adverse Event|15|||
162227864|NCT00859222|585884450|FG000|Overall Study|DLT|1|||
162227865|NCT00859222|585884451|FG001|Overall Study|DLT|0|||
162227866|NCT00859222|585884452|FG002|Overall Study|DLT|0|||
162227867|NCT00859222|585884453|FG003|Overall Study|DLT|0|||
162227868|NCT00859222|585884454|FG004|Overall Study|DLT|0|||
162227869|NCT00488475|585884455|FG000|Overall Study|Other|1754|||
162227870|NCT00400725|585884466|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
162227871|NCT00400725|585884467|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
162227872|NCT00400725|585884468|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
162227873|NCT00400725|585884466|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
162227874|NCT00400725|585884467|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
162227875|NCT00400725|585884468|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
162227876|NCT00400725|585884466|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
162227877|NCT00400725|585884467|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
162227878|NCT00400725|585884468|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
161829455|NCT01534078|584415777|FG000|Overall Study|Withdrawal by Subject|1|||
162227879|NCT00400725|585884466|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
162227880|NCT00400725|585884467|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
162227881|NCT00400725|585884468|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
162227882|NCT00400725|585884466|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
162227883|NCT00400725|585884467|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
162227884|NCT00400725|585884468|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
161829456|NCT01280617|584415781|FG000|Overall Study|Adverse Event|0|||
161829457|NCT01280617|584415782|FG001|Overall Study|Adverse Event|1|||
161829458|NCT00986570|584415783|FG000|Overall Study|Lost to Follow-up|6|||
161829459|NCT00986570|584415783|FG000|Overall Study|Potential bias for objective assessment|1|||
161829460|NCT02225665|584415784|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
161829461|NCT02225665|584415785|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
161829462|NCT02225665|584415784|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
161829463|NCT02225665|584415785|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
161829464|NCT01311557|584415786|FG000|Overall Study|Serious adverse event|0|||
161829465|NCT01311557|584415787|FG001|Overall Study|Serious adverse event|1|||
161829466|NCT01311557|584415786|FG000|Overall Study|Protocol Violation|4|||
161829467|NCT01311557|584415787|FG001|Overall Study|Protocol Violation|2|||
161829468|NCT01311557|584415786|FG000|Overall Study|Lost to Follow-up|0|||
161829469|NCT01311557|584415787|FG001|Overall Study|Lost to Follow-up|1|||
161829470|NCT01311557|584415786|FG000|Overall Study|Withdrawal by Subject|1|||
161829471|NCT01311557|584415787|FG001|Overall Study|Withdrawal by Subject|2|||
161829472|NCT00608517|584415788|FG000|Overall Study|Death|1|||
161829473|NCT00608517|584415789|FG001|Overall Study|Death|0|||
162023655|NCT00830869|585144488|FG007|Period 1: Part 1|Progressive disease|0|||
162227885|NCT00400725|585884466|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
162227886|NCT00400725|585884467|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
162227887|NCT00400725|585884468|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
162227888|NCT00400725|585884466|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
162227889|NCT00400725|585884467|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
162227890|NCT00400725|585884468|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
162227891|NCT00400725|585884466|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
162227892|NCT00400725|585884467|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
162227893|NCT00400725|585884468|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
162227894|NCT00400725|585884466|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
162227895|NCT00400725|585884467|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
162227896|NCT00400725|585884468|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
162227897|NCT02797080|585884472|FG000|Overall Study|Lost to Follow-up|1|||
162227898|NCT02797080|585884472|FG000|Overall Study|Withdrawal by Subject|1|||
162227899|NCT00744757|585884475|FG000|Overall Study|Objective disease progression|7|||
162227900|NCT00744757|585884475|FG000|Overall Study|Physician Decision|5|||
162227901|NCT00744757|585884475|FG000|Overall Study|Withdrawal by Subject|1|||
162227902|NCT00744757|585884475|FG000|Overall Study|Death|6|||
162227903|NCT00744757|585884475|FG000|Overall Study|Adverse Event|2|||
161829474|NCT00608517|584415790|FG002|Overall Study|Death|0|||
162227904|NCT02285153|585884476|FG000|Overall Study|Adverse Event|1|||
162227905|NCT02285153|585884477|FG001|Overall Study|Adverse Event|0|||
161829475|NCT00572039|584415791|FG000|Overall Study|Withdrawal by Subject|9|||
162227906|NCT00548262|585884478|FG000|Overall Study|Death|21|||
162227907|NCT00548262|585884478|FG000|Overall Study|Adverse Event|2|||
162227908|NCT00548262|585884478|FG000|Overall Study|Lack of Efficacy|4|||
162227909|NCT00548262|585884478|FG000|Overall Study|Lost to Follow-up|1|||
162227910|NCT00548262|585884478|FG000|Overall Study|Other|3|||
162227911|NCT00548262|585884478|FG000|Overall Study|Withdrawal by Subject|1|||
162227912|NCT01712659|585884479|FG000|Dose Escalation|Physician Decision|0|||
162227913|NCT01712659|585884480|FG001|Dose Escalation|Physician Decision|1|||
162227914|NCT01712659|585884481|FG002|Dose Escalation|Physician Decision|0|||
162227915|NCT01712659|585884482|FG003|Dose Escalation|Physician Decision|0|||
162227916|NCT01712659|585884483|FG004|Dose Escalation|Physician Decision|0|||
162227917|NCT01712659|585884479|FG000|Dose Escalation|Unable to take study drug|0|||
162227918|NCT01712659|585884480|FG001|Dose Escalation|Unable to take study drug|1|||
162227919|NCT01712659|585884481|FG002|Dose Escalation|Unable to take study drug|0|||
162227920|NCT01712659|585884482|FG003|Dose Escalation|Unable to take study drug|0|||
162227921|NCT01712659|585884483|FG004|Dose Escalation|Unable to take study drug|0|||
162227922|NCT01712659|585884479|FG000|Dose Expansion|Early disease progression|1|||
162227923|NCT01712659|585884480|FG001|Dose Expansion|Early disease progression|0|||
162227924|NCT01712659|585884481|FG002|Dose Expansion|Early disease progression|0|||
162227925|NCT01712659|585884482|FG003|Dose Expansion|Early disease progression|0|||
162227926|NCT01712659|585884483|FG004|Dose Expansion|Early disease progression|0|||
162227927|NCT01712659|585884479|FG000|Dose Expansion|Physician Decision|1|||
162227928|NCT01712659|585884480|FG001|Dose Expansion|Physician Decision|0|||
162227929|NCT01712659|585884481|FG002|Dose Expansion|Physician Decision|0|||
162227930|NCT01712659|585884482|FG003|Dose Expansion|Physician Decision|0|||
162227931|NCT01712659|585884483|FG004|Dose Expansion|Physician Decision|0|||
162227932|NCT00948766|585884484|FG000|Core Study|Adverse Event|73|||
162227933|NCT00948766|585884485|FG001|Core Study|Adverse Event|51|||
162227934|NCT00948766|585884484|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
162227935|NCT00948766|585884485|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
162227936|NCT00948766|585884484|FG000|Core Study|Patient Withdrew Consent|27|||
162227937|NCT00948766|585884485|FG001|Core Study|Patient Withdrew Consent|46|||
162227938|NCT00948766|585884484|FG000|Core Study|Lost to Follow-up|3|||
162227939|NCT00948766|585884485|FG001|Core Study|Lost to Follow-up|2|||
162227940|NCT00948766|585884484|FG000|Core Study|Administrative Problems|2|||
162227941|NCT00948766|585884485|FG001|Core Study|Administrative Problems|2|||
162227942|NCT00948766|585884484|FG000|Core Study|Death|1|||
162227943|NCT00948766|585884485|FG001|Core Study|Death|1|||
162227944|NCT00948766|585884484|FG000|Core Study|Protocol Deviation|8|||
162227945|NCT00948766|585884485|FG001|Core Study|Protocol Deviation|10|||
162227946|NCT00948766|585884484|FG000|Extension Study|Adverse Event|43|||
162227947|NCT00948766|585884485|FG001|Extension Study|Adverse Event|0|||
162227948|NCT00948766|585884484|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
162227949|NCT00948766|585884485|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
162227950|NCT00948766|585884484|FG000|Extension Study|Study Drug No Longer Required|1|||
162227951|NCT00948766|585884485|FG001|Extension Study|Study Drug No Longer Required|0|||
162227952|NCT00948766|585884484|FG000|Extension Study|Patient Withdrew Consent|32|||
162227953|NCT00948766|585884485|FG001|Extension Study|Patient Withdrew Consent|0|||
162227954|NCT00948766|585884484|FG000|Extension Study|Lost to Follow-up|8|||
162227955|NCT00948766|585884485|FG001|Extension Study|Lost to Follow-up|0|||
162227956|NCT00948766|585884484|FG000|Extension Study|Administrative Problems|1|||
162227957|NCT00948766|585884485|FG001|Extension Study|Administrative Problems|0|||
162227958|NCT00948766|585884484|FG000|Extension Study|Death|4|||
162227959|NCT00948766|585884485|FG001|Extension Study|Death|0|||
162227960|NCT01769326|585884489|FG000|Overall Study|Lost to Follow-up|1|||
162227961|NCT01769326|585884490|FG001|Overall Study|Lost to Follow-up|2|||
162227962|NCT01769326|585884491|FG002|Overall Study|Lost to Follow-up|0|||
162227963|NCT01769326|585884492|FG003|Overall Study|Lost to Follow-up|0|||
162227964|NCT01769326|585884489|FG000|Overall Study|unrelated injry|1|||
162227965|NCT01769326|585884490|FG001|Overall Study|unrelated injry|1|||
162227966|NCT01769326|585884491|FG002|Overall Study|unrelated injry|0|||
162227967|NCT01769326|585884492|FG003|Overall Study|unrelated injry|0|||
162227968|NCT01769326|585884489|FG000|Overall Study|got a job|0|||
162227969|NCT01769326|585884490|FG001|Overall Study|got a job|1|||
161829476|NCT00572039|584415792|FG001|Overall Study|Withdrawal by Subject|6|||
162227970|NCT01769326|585884491|FG002|Overall Study|got a job|0|||
162227971|NCT01769326|585884492|FG003|Overall Study|got a job|0|||
162227972|NCT01769326|585884489|FG000|Overall Study|Got sick and could not complete study|0|||
162227973|NCT01769326|585884490|FG001|Overall Study|Got sick and could not complete study|0|||
162227974|NCT01769326|585884491|FG002|Overall Study|Got sick and could not complete study|1|||
162227975|NCT01769326|585884492|FG003|Overall Study|Got sick and could not complete study|0|||
162227976|NCT01036438|585884493|FG000|Overall Study|Adverse Event|7|||
162227977|NCT01036438|585884494|FG001|Overall Study|Adverse Event|8|||
162227978|NCT01036438|585884493|FG000|Overall Study|Death|0|||
162227979|NCT01036438|585884494|FG001|Overall Study|Death|1|||
162227980|NCT01036438|585884493|FG000|Overall Study|No effect of study treatment|3|||
162227981|NCT01036438|585884494|FG001|Overall Study|No effect of study treatment|1|||
162227982|NCT00888927|585884495|FG000|Overall Study|Adverse Event|0|||
162023656|NCT00830869|585144489|FG008|Period 1: Part 1|Progressive disease|0|||
162023657|NCT00830869|585144490|FG009|Period 1: Part 1|Progressive disease|0|||
162023658|NCT00830869|585144491|FG010|Period 1: Part 1|Progressive disease|0|||
162023659|NCT00830869|585144492|FG011|Period 1: Part 1|Progressive disease|0|||
162023660|NCT00830869|585144481|FG000|Period 2: Part 2|Protocol Violation|0|||
162023661|NCT00830869|585144482|FG001|Period 2: Part 2|Protocol Violation|0|||
162023662|NCT00830869|585144483|FG002|Period 2: Part 2|Protocol Violation|0|||
162023663|NCT00830869|585144484|FG003|Period 2: Part 2|Protocol Violation|0|||
162023664|NCT00830869|585144485|FG004|Period 2: Part 2|Protocol Violation|0|||
162023665|NCT00830869|585144486|FG005|Period 2: Part 2|Protocol Violation|0|||
162023666|NCT00830869|585144487|FG006|Period 2: Part 2|Protocol Violation|0|||
162023667|NCT00830869|585144488|FG007|Period 2: Part 2|Protocol Violation|1|||
162023668|NCT00830869|585144489|FG008|Period 2: Part 2|Protocol Violation|0|||
162023669|NCT00830869|585144490|FG009|Period 2: Part 2|Protocol Violation|1|||
162023670|NCT00830869|585144491|FG010|Period 2: Part 2|Protocol Violation|0|||
162023671|NCT00830869|585144492|FG011|Period 2: Part 2|Protocol Violation|0|||
162023672|NCT00830869|585144481|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
162227983|NCT00888927|585884496|FG001|Overall Study|Adverse Event|0|||
162227984|NCT00888927|585884497|FG002|Overall Study|Adverse Event|0|||
162227985|NCT00888927|585884498|FG003|Overall Study|Adverse Event|1|||
162227986|NCT00888927|585884495|FG000|Overall Study|Withdrawal of consent|0|||
162227987|NCT00888927|585884496|FG001|Overall Study|Withdrawal of consent|0|||
162227988|NCT00888927|585884497|FG002|Overall Study|Withdrawal of consent|0|||
162227989|NCT00888927|585884498|FG003|Overall Study|Withdrawal of consent|1|||
162227990|NCT02270515|585884499|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
162227991|NCT02270515|585884499|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
162227992|NCT02270515|585884499|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
162227993|NCT02270515|585884499|FG000|Intervention Period 1: 0-6 Months|Death|7|||
162227994|NCT02270515|585884499|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
162227995|NCT02270515|585884499|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
162227996|NCT02270515|585884499|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
162227997|NCT02270515|585884499|FG000|Intervention Period 2: 6-12 Months|Death|5|||
162227998|NCT02270515|585884499|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
162227999|NCT02270515|585884499|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
162228000|NCT02270515|585884499|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
162228001|NCT02270515|585884499|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
162228002|NCT02270515|585884499|FG000|Intervention Period 3: 12-18 Months|Death|3|||
162228003|NCT02270515|585884499|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
162228004|NCT01607476|585884501|FG000|Overall Study|Withdrawal by Subject|1|||
162228005|NCT01607476|585884502|FG001|Overall Study|Withdrawal by Subject|0|||
162228006|NCT01607476|585884503|FG002|Overall Study|Withdrawal by Subject|1|||
162228007|NCT01607476|585884501|FG000|Overall Study|Lost to Follow-up|0|||
162228008|NCT01607476|585884502|FG001|Overall Study|Lost to Follow-up|0|||
162228009|NCT01607476|585884503|FG002|Overall Study|Lost to Follow-up|2|||
162228010|NCT02091206|585884504|FG000|Treatment Period|Adverse Event|0|||
162228011|NCT02091206|585884505|FG001|Treatment Period|Adverse Event|1|||
162228012|NCT02091206|585884506|FG002|Treatment Period|Adverse Event|0|||
162228013|NCT02091206|585884507|FG003|Treatment Period|Adverse Event|0|||
162228014|NCT02091206|585884504|FG000|Treatment Period|Met withdrawal criteria|0|||
162228015|NCT02091206|585884505|FG001|Treatment Period|Met withdrawal criteria|0|||
162228016|NCT02091206|585884506|FG002|Treatment Period|Met withdrawal criteria|1|||
162228017|NCT02091206|585884507|FG003|Treatment Period|Met withdrawal criteria|0|||
162228018|NCT02091206|585884504|FG000|Taper Period|Participant refused study drug|1|||
162228019|NCT02091206|585884505|FG001|Taper Period|Participant refused study drug|0|||
162228020|NCT02091206|585884506|FG002|Taper Period|Participant refused study drug|0|||
162228021|NCT02091206|585884507|FG003|Taper Period|Participant refused study drug|1|||
162228022|NCT02091206|585884504|FG000|Taper Period|Lost to Follow-up|0|||
162228023|NCT02091206|585884505|FG001|Taper Period|Lost to Follow-up|0|||
162228024|NCT02091206|585884506|FG002|Taper Period|Lost to Follow-up|0|||
162228025|NCT02091206|585884507|FG003|Taper Period|Lost to Follow-up|1|||
162228026|NCT03772587|585884513|FG000|Overall Study|COVID-19|0|||
162228027|NCT03772587|585884514|FG001|Overall Study|COVID-19|0|||
162228028|NCT03772587|585884515|FG002|Overall Study|COVID-19|1|||
162228029|NCT03772587|585884516|FG003|Overall Study|COVID-19|1|||
162228030|NCT03772587|585884517|FG004|Overall Study|COVID-19|0|||
162228031|NCT03772587|585884513|FG000|Overall Study|Withdrawal by Subject|1|||
162228032|NCT03772587|585884514|FG001|Overall Study|Withdrawal by Subject|0|||
162228033|NCT03772587|585884515|FG002|Overall Study|Withdrawal by Subject|0|||
162023673|NCT00830869|585144482|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
162023674|NCT00830869|585144483|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
162023675|NCT00830869|585144484|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
162023676|NCT00830869|585144485|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
162023677|NCT00830869|585144486|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
162228034|NCT03772587|585884516|FG003|Overall Study|Withdrawal by Subject|0|||
162228035|NCT03772587|585884517|FG004|Overall Study|Withdrawal by Subject|0|||
162228036|NCT02297139|585884518|FG000|Overall Study|Disease progression|0|||
162228037|NCT02297139|585884519|FG001|Overall Study|Disease progression|1|||
162228038|NCT02297139|585884518|FG000|Overall Study|Study drug toxicity|0|||
162228039|NCT02297139|585884519|FG001|Overall Study|Study drug toxicity|4|||
162228040|NCT02297139|585884518|FG000|Overall Study|Participant request to discontinue study treatment|0|||
162228041|NCT02297139|585884519|FG001|Overall Study|Participant request to discontinue study treatment|1|||
162228042|NCT02297139|585884518|FG000|Overall Study|Maximum clinical benefit|1|||
162228043|NCT02297139|585884519|FG001|Overall Study|Maximum clinical benefit|0|||
162228044|NCT02297139|585884518|FG000|Overall Study|Administrative reason by sponsor|0|||
162228045|NCT02297139|585884519|FG001|Overall Study|Administrative reason by sponsor|2|||
162228046|NCT02297139|585884518|FG000|Overall Study|Other reasons|0|||
162228047|NCT02297139|585884519|FG001|Overall Study|Other reasons|8|||
162228048|NCT05051462|585884525|FG000|Overall Study|Lost to Follow-up|1|||
162228049|NCT05051462|585884526|FG001|Overall Study|Lost to Follow-up|8|||
162228050|NCT05051462|585884525|FG000|Overall Study|Withdrawal by Subject|1|||
162228051|NCT05051462|585884526|FG001|Overall Study|Withdrawal by Subject|0|||
162228052|NCT05051462|585884525|FG000|Overall Study|Protocol Violation|0|||
162228053|NCT05051462|585884526|FG001|Overall Study|Protocol Violation|2|||
162228054|NCT02425904|585884527|FG000|Overall Study|Lost to Follow-up|1|||
162228055|NCT02425904|585884528|FG001|Overall Study|Lost to Follow-up|0|||
162228056|NCT02425904|585884527|FG000|Overall Study|Withdrawal by Subject|2|||
162228057|NCT02425904|585884528|FG001|Overall Study|Withdrawal by Subject|0|||
162228058|NCT02425904|585884527|FG000|Overall Study|Death|0|||
162228059|NCT02425904|585884528|FG001|Overall Study|Death|3|||
162228060|NCT05260021|585884529|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
162228061|NCT05260021|585884530|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
162228062|NCT05260021|585884531|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
162228063|NCT05260021|585884529|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
162228064|NCT05260021|585884530|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
162228065|NCT05260021|585884531|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
162228066|NCT05260021|585884529|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
162228067|NCT05260021|585884530|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
162228068|NCT05260021|585884531|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
162228069|NCT05260021|585884529|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
162228070|NCT05260021|585884530|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
162228071|NCT05260021|585884531|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
162228072|NCT05260021|585884529|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
162228073|NCT05260021|585884530|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
162228074|NCT05260021|585884531|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
162228075|NCT05597787|585884532|FG000|Overall Study|Withdrawal by Subject|0|||
162228076|NCT05597787|585884533|FG001|Overall Study|Withdrawal by Subject|0|||
162228077|NCT05597787|585884534|FG002|Overall Study|Withdrawal by Subject|1|||
162228078|NCT01144377|585884535|FG000|52 Week Treatment Period|Adverse Event|0|||
162228079|NCT01144377|585884536|FG001|52 Week Treatment Period|Adverse Event|0|||
162228080|NCT01144377|585884537|FG002|52 Week Treatment Period|Adverse Event|3|||
162228081|NCT01144377|585884538|FG003|52 Week Treatment Period|Adverse Event|2|||
162228082|NCT01144377|585884539|FG004|52 Week Treatment Period|Adverse Event|1|||
162228083|NCT01144377|585884535|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
162228084|NCT01144377|585884536|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
162228085|NCT01144377|585884537|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
162228086|NCT01144377|585884538|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
162228087|NCT01144377|585884539|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
162228088|NCT01144377|585884535|FG000|52 Week Treatment Period|Protocol Violation|0|||
162228089|NCT01144377|585884536|FG001|52 Week Treatment Period|Protocol Violation|0|||
162228090|NCT01144377|585884537|FG002|52 Week Treatment Period|Protocol Violation|0|||
162228091|NCT01144377|585884538|FG003|52 Week Treatment Period|Protocol Violation|0|||
162228092|NCT01144377|585884539|FG004|52 Week Treatment Period|Protocol Violation|1|||
162228093|NCT01144377|585884535|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
162228094|NCT01144377|585884536|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
162228095|NCT01144377|585884537|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
162228096|NCT01144377|585884538|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
162228097|NCT01144377|585884539|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
162228098|NCT01144377|585884535|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
162228099|NCT01144377|585884536|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
162228100|NCT01144377|585884537|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
162228101|NCT01144377|585884538|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
162228102|NCT01144377|585884539|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
162228103|NCT01144377|585884535|FG000|52 Week Treatment Period|Sponsor Decision|0|||
162228104|NCT01144377|585884536|FG001|52 Week Treatment Period|Sponsor Decision|0|||
162228105|NCT01144377|585884537|FG002|52 Week Treatment Period|Sponsor Decision|0|||
162228106|NCT01144377|585884538|FG003|52 Week Treatment Period|Sponsor Decision|0|||
162228107|NCT01144377|585884539|FG004|52 Week Treatment Period|Sponsor Decision|1|||
162228108|NCT01144377|585884535|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
162228109|NCT01144377|585884536|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
162228110|NCT01144377|585884537|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
162228111|NCT01144377|585884538|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
162228112|NCT01144377|585884539|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
162228113|NCT01144377|585884535|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
162228114|NCT01144377|585884536|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
162228115|NCT01144377|585884537|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
162228116|NCT01144377|585884538|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
162228117|NCT01144377|585884539|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
162228118|NCT01144377|585884535|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
162228119|NCT01144377|585884536|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
162228120|NCT01144377|585884537|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
162228121|NCT01144377|585884538|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
162228122|NCT01144377|585884539|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
162228123|NCT01214642|585884541|FG000|Overall Study|Progressive Disease|3|||
162228124|NCT01214642|585884542|FG001|Overall Study|Progressive Disease|2|||
162228125|NCT01214642|585884543|FG002|Overall Study|Progressive Disease|3|||
162228126|NCT01214642|585884544|FG003|Overall Study|Progressive Disease|5|||
162228127|NCT01214642|585884545|FG004|Overall Study|Progressive Disease|5|||
162228128|NCT01214642|585884546|FG005|Overall Study|Progressive Disease|3|||
162228129|NCT01214642|585884547|FG006|Overall Study|Progressive Disease|5|||
162228130|NCT01214642|585884548|FG007|Overall Study|Progressive Disease|3|||
162228131|NCT01214642|585884549|FG008|Overall Study|Progressive Disease|10|||
162228132|NCT01214642|585884550|FG009|Overall Study|Progressive Disease|2|||
162228133|NCT01214642|585884551|FG010|Overall Study|Progressive Disease|1|||
161678758|NCT00574288|583876065|FG000|Overall Study|Progressive Disease|17|||
161678759|NCT00574288|583876066|FG001|Overall Study|Progressive Disease|2|||
161678760|NCT00574288|583876067|FG002|Overall Study|Progressive Disease|3|||
161678761|NCT00574288|583876068|FG003|Overall Study|Progressive Disease|2|||
161678762|NCT00574288|583876069|FG004|Overall Study|Progressive Disease|1|||
161678763|NCT00574288|583876070|FG005|Overall Study|Progressive Disease|0|||
161678764|NCT00574288|583876071|FG006|Overall Study|Progressive Disease|0|||
161678765|NCT00574288|583876065|FG000|Overall Study|Other|1|||
161678766|NCT00574288|583876066|FG001|Overall Study|Other|1|||
161678767|NCT00574288|583876067|FG002|Overall Study|Other|0|||
161678768|NCT00574288|583876068|FG003|Overall Study|Other|0|||
161678769|NCT00574288|583876069|FG004|Overall Study|Other|0|||
161678770|NCT00574288|583876070|FG005|Overall Study|Other|0|||
161678771|NCT00574288|583876071|FG006|Overall Study|Other|0|||
161678772|NCT01106027|583876072|FG000|Overall Study|Lost graft early, discontinued|1|||
161678773|NCT00356889|583876073|FG000|Overall Study|Protocol Violation|2|||
161678774|NCT00356889|583876073|FG000|Overall Study|Adverse Event|1|||
161678775|NCT02361944|583876074|FG000|Overall Study|surgery cancellation|0|||
161678776|NCT02361944|583876075|FG001|Overall Study|surgery cancellation|1|||
161678777|NCT03123250|583876076|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
161678778|NCT00773136|583876103|FG000|Overall Study|Physician Decision|2|||
161678779|NCT02463071|583876110|FG000|Overall Study|Adverse Event|3|||
161678780|NCT02463071|583876111|FG001|Overall Study|Adverse Event|5|||
161678781|NCT02463071|583876112|FG002|Overall Study|Adverse Event|1|||
161678782|NCT02463071|583876110|FG000|Overall Study|Death|1|||
161678783|NCT02463071|583876111|FG001|Overall Study|Death|0|||
161678784|NCT02463071|583876112|FG002|Overall Study|Death|0|||
161678785|NCT02463071|583876110|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
161678786|NCT02463071|583876111|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161678787|NCT02463071|583876112|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
161678788|NCT02463071|583876110|FG000|Overall Study|Reason not specified|7|||
161678789|NCT02463071|583876111|FG001|Overall Study|Reason not specified|9|||
161678790|NCT02463071|583876112|FG002|Overall Study|Reason not specified|4|||
161678791|NCT02463071|583876110|FG000|Overall Study|Protocol Violation|0|||
161678792|NCT02463071|583876111|FG001|Overall Study|Protocol Violation|2|||
161678793|NCT02463071|583876112|FG002|Overall Study|Protocol Violation|0|||
161678794|NCT02463071|583876110|FG000|Overall Study|Lost to Follow-up|0|||
161678795|NCT02463071|583876111|FG001|Overall Study|Lost to Follow-up|0|||
161678796|NCT02463071|583876112|FG002|Overall Study|Lost to Follow-up|1|||
161678797|NCT00175877|583876128|FG000|Overall Study|Adverse Event|136|||
161678798|NCT00175877|583876128|FG000|Overall Study|Withdrawal by Subject|141|||
161678799|NCT00175877|583876128|FG000|Overall Study|Lost to Follow-up|9|||
161678800|NCT00175877|583876128|FG000|Overall Study|Lack of Efficacy|26|||
161678801|NCT00175877|583876128|FG000|Overall Study|Protocol Violation|15|||
161678802|NCT00175877|583876128|FG000|Overall Study|Other Reason|20|||
161678803|NCT00175877|583876128|FG000|Overall Study|AE & Other|1|||
161678804|NCT00175877|583876128|FG000|Overall Study|Withdrawal by subject & Other|1|||
161678805|NCT02054325|583876132|FG000|Overall Study|Lost to Follow-up|8|||
162228134|NCT01214642|585884552|FG011|Overall Study|Progressive Disease|4|||
162228135|NCT01214642|585884541|FG000|Overall Study|Adverse Event|0|||
162228136|NCT01214642|585884542|FG001|Overall Study|Adverse Event|1|||
162228137|NCT01214642|585884543|FG002|Overall Study|Adverse Event|0|||
162228138|NCT01214642|585884544|FG003|Overall Study|Adverse Event|0|||
162228139|NCT01214642|585884545|FG004|Overall Study|Adverse Event|0|||
162228140|NCT01214642|585884546|FG005|Overall Study|Adverse Event|0|||
162228141|NCT01214642|585884547|FG006|Overall Study|Adverse Event|1|||
162228142|NCT01214642|585884548|FG007|Overall Study|Adverse Event|0|||
162228143|NCT01214642|585884549|FG008|Overall Study|Adverse Event|0|||
162228144|NCT01214642|585884550|FG009|Overall Study|Adverse Event|1|||
162228145|NCT01214642|585884551|FG010|Overall Study|Adverse Event|1|||
162228146|NCT01214642|585884552|FG011|Overall Study|Adverse Event|0|||
162228147|NCT01214642|585884541|FG000|Overall Study|Death|0|||
162228148|NCT01214642|585884542|FG001|Overall Study|Death|0|||
162228149|NCT01214642|585884543|FG002|Overall Study|Death|1|||
162228150|NCT01214642|585884544|FG003|Overall Study|Death|0|||
162228151|NCT01214642|585884545|FG004|Overall Study|Death|0|||
162228152|NCT01214642|585884546|FG005|Overall Study|Death|0|||
162228153|NCT01214642|585884547|FG006|Overall Study|Death|0|||
162228154|NCT01214642|585884548|FG007|Overall Study|Death|0|||
162228155|NCT01214642|585884549|FG008|Overall Study|Death|0|||
162228156|NCT01214642|585884550|FG009|Overall Study|Death|0|||
162228157|NCT01214642|585884551|FG010|Overall Study|Death|1|||
162228158|NCT01214642|585884552|FG011|Overall Study|Death|0|||
162228159|NCT01214642|585884541|FG000|Overall Study|Withdrawal by Subject|0|||
162228160|NCT01214642|585884542|FG001|Overall Study|Withdrawal by Subject|0|||
162228161|NCT01214642|585884543|FG002|Overall Study|Withdrawal by Subject|1|||
162228162|NCT01214642|585884544|FG003|Overall Study|Withdrawal by Subject|0|||
162228163|NCT01214642|585884545|FG004|Overall Study|Withdrawal by Subject|0|||
162228164|NCT01214642|585884546|FG005|Overall Study|Withdrawal by Subject|0|||
162228165|NCT01214642|585884547|FG006|Overall Study|Withdrawal by Subject|0|||
162228166|NCT01214642|585884548|FG007|Overall Study|Withdrawal by Subject|0|||
162228167|NCT01214642|585884549|FG008|Overall Study|Withdrawal by Subject|3|||
162228168|NCT01214642|585884550|FG009|Overall Study|Withdrawal by Subject|1|||
162228169|NCT01214642|585884551|FG010|Overall Study|Withdrawal by Subject|1|||
162228170|NCT01214642|585884552|FG011|Overall Study|Withdrawal by Subject|0|||
162228171|NCT01214642|585884541|FG000|Overall Study|Physician Decision|0|||
162228172|NCT01214642|585884542|FG001|Overall Study|Physician Decision|0|||
162228173|NCT01214642|585884543|FG002|Overall Study|Physician Decision|1|||
162228174|NCT01214642|585884544|FG003|Overall Study|Physician Decision|1|||
162228175|NCT01214642|585884545|FG004|Overall Study|Physician Decision|1|||
162228176|NCT01214642|585884546|FG005|Overall Study|Physician Decision|0|||
162228177|NCT01214642|585884547|FG006|Overall Study|Physician Decision|0|||
162228178|NCT01214642|585884548|FG007|Overall Study|Physician Decision|0|||
162228179|NCT01214642|585884549|FG008|Overall Study|Physician Decision|0|||
162228180|NCT01214642|585884550|FG009|Overall Study|Physician Decision|0|||
162228181|NCT01214642|585884551|FG010|Overall Study|Physician Decision|0|||
162228182|NCT01214642|585884552|FG011|Overall Study|Physician Decision|2|||
162228183|NCT01241604|585884553|FG000|Screening Period|Screen Failure|3|||
162228184|NCT01241604|585884554|FG001|Screening Period|Screen Failure|0|||
162228185|NCT01241604|585884555|FG002|Screening Period|Screen Failure|0|||
162228186|NCT01593787|585884556|FG000|Overall Study|Adverse Event|1|||
162228187|NCT01593787|585884557|FG001|Overall Study|Adverse Event|0|||
162228188|NCT01593787|585884558|FG002|Overall Study|Adverse Event|0|||
162228189|NCT02914275|585886390|FG000|Overall Study|Lost to Follow-up|84|||
162228190|NCT02914275|585886391|FG001|Overall Study|Lost to Follow-up|29|||
162228191|NCT02914275|585886390|FG000|Overall Study|Withdrawal by Subject|26|||
162228192|NCT02914275|585886391|FG001|Overall Study|Withdrawal by Subject|10|||
162228193|NCT02914275|585886390|FG000|Overall Study|Protocol Violation|1|||
162228194|NCT02914275|585886391|FG001|Overall Study|Protocol Violation|1|||
162228195|NCT02914275|585886390|FG000|Overall Study|Physician Decision|3|||
162228196|NCT02914275|585886391|FG001|Overall Study|Physician Decision|1|||
162228197|NCT02914275|585886390|FG000|Overall Study|Other|4|||
162228198|NCT02914275|585886391|FG001|Overall Study|Other|1|||
162228199|NCT02914275|585886390|FG000|Overall Study|Excluded due to invalid informed consent|3|||
162228200|NCT02914275|585886391|FG001|Overall Study|Excluded due to invalid informed consent|0|||
162228201|NCT02731690|585886392|FG000|Overall Study|Adverse Event|1|||
162228202|NCT02731690|585886392|FG000|Overall Study|Withdrawal by Subject|3|||
162228203|NCT02731690|585886392|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
162228204|NCT00872989|585886393|FG000|Overall Study|Adverse Event|7|||
161678806|NCT02054325|583876133|FG001|Overall Study|Lost to Follow-up|5|||
161678807|NCT02003014|583876134|FG000|Overall Study|Case report forms uncollected|9|||
161678808|NCT02003014|583876134|FG000|Overall Study|Treatment started after contract period|1|||
161678809|NCT02003014|583876134|FG000|Overall Study|Patient did not visit the study site|5|||
161678810|NCT02003014|583876134|FG000|Overall Study|Investigator's transfer|4|||
161678811|NCT03007979|583876137|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
161678812|NCT03734016|583876138|FG000|Overall Study|Sponsor Ended Study|225|||
161678813|NCT03734016|583876139|FG001|Overall Study|Sponsor Ended Study|200|||
161678814|NCT03734016|583876138|FG000|Overall Study|Death|69|||
161678815|NCT03734016|583876139|FG001|Overall Study|Death|83|||
161678816|NCT03734016|583876138|FG000|Overall Study|Withdrawal by Subject|21|||
161678817|NCT03734016|583876139|FG001|Overall Study|Withdrawal by Subject|27|||
161678818|NCT03734016|583876138|FG000|Overall Study|Physician Decision|1|||
161678819|NCT03734016|583876139|FG001|Overall Study|Physician Decision|12|||
161678820|NCT03734016|583876138|FG000|Overall Study|Lost to Follow-up|6|||
161678821|NCT03734016|583876139|FG001|Overall Study|Lost to Follow-up|2|||
161678822|NCT03734016|583876138|FG000|Overall Study|Miscellaneous|5|||
161678823|NCT03734016|583876139|FG001|Overall Study|Miscellaneous|1|||
161678824|NCT01624259|583876142|FG000|Overall Study|Adverse Event|18|||
161678825|NCT01624259|583876143|FG001|Overall Study|Adverse Event|18|||
161678826|NCT01624259|583876142|FG000|Overall Study|Protocol Violation|1|||
161678827|NCT01624259|583876143|FG001|Overall Study|Protocol Violation|2|||
161678828|NCT01624259|583876142|FG000|Overall Study|Withdrawal by Subject|5|||
161678829|NCT01624259|583876143|FG001|Overall Study|Withdrawal by Subject|7|||
161678830|NCT01624259|583876142|FG000|Overall Study|Physician Decision|1|||
161678831|NCT01624259|583876143|FG001|Overall Study|Physician Decision|1|||
161678832|NCT01624259|583876142|FG000|Overall Study|Lost to Follow-up|2|||
161678833|NCT01624259|583876143|FG001|Overall Study|Lost to Follow-up|3|||
161678834|NCT01624259|583876142|FG000|Overall Study|Abnormal laboratory measure|3|||
161678835|NCT01624259|583876143|FG001|Overall Study|Abnormal laboratory measure|0|||
161678836|NCT01298518|583876144|FG000|Overall Study|Withdrawal by Subject|0|||
161678837|NCT01298518|583876145|FG001|Overall Study|Withdrawal by Subject|0|||
161678838|NCT01298518|583876146|FG002|Overall Study|Withdrawal by Subject|1|||
161678839|NCT02273726|583876147|FG000|Overall Study|Death|70|||
161678840|NCT02273726|583876148|FG001|Overall Study|Death|62|||
161678841|NCT02273726|583876147|FG000|Overall Study|Withdrawal by Subject|41|||
161678842|NCT02273726|583876148|FG001|Overall Study|Withdrawal by Subject|29|||
161678843|NCT02273726|583876147|FG000|Overall Study|Kidney transplant|31|||
161678844|NCT02273726|583876148|FG001|Overall Study|Kidney transplant|39|||
161678845|NCT02273726|583876147|FG000|Overall Study|Physician Decision|30|||
161678846|NCT02273726|583876148|FG001|Overall Study|Physician Decision|15|||
161678847|NCT02273726|583876147|FG000|Overall Study|Adverse Event|27|||
161678848|NCT02273726|583876148|FG001|Overall Study|Adverse Event|9|||
161678849|NCT02273726|583876147|FG000|Overall Study|Lost to Follow-up|6|||
161678850|NCT02273726|583876148|FG001|Overall Study|Lost to Follow-up|3|||
161678851|NCT02273726|583876147|FG000|Overall Study|Lack of Efficacy|6|||
162228205|NCT00872989|585886394|FG001|Overall Study|Adverse Event|15|||
162228206|NCT00872989|585886393|FG000|Overall Study|Withdrawal by Subject|8|||
162228207|NCT00872989|585886394|FG001|Overall Study|Withdrawal by Subject|5|||
162228208|NCT00872989|585886393|FG000|Overall Study|Progression/relapse|47|||
162228209|NCT00872989|585886394|FG001|Overall Study|Progression/relapse|35|||
162228210|NCT00872989|585886393|FG000|Overall Study|Not protocol specified|3|||
162228211|NCT00872989|585886394|FG001|Overall Study|Not protocol specified|8|||
162228212|NCT02407990|585886395|FG000|Overall Study|Death|2|||
162228213|NCT02407990|585886396|FG001|Overall Study|Death|22|||
162228214|NCT02407990|585886397|FG002|Overall Study|Death|23|||
161678852|NCT02273726|583876148|FG001|Overall Study|Lack of Efficacy|1|||
161678853|NCT02273726|583876147|FG000|Overall Study|Protocol Violation|4|||
161678854|NCT02273726|583876148|FG001|Overall Study|Protocol Violation|0|||
161678855|NCT02273726|583876147|FG000|Overall Study|Other than specified|28|||
161678856|NCT02273726|583876148|FG001|Overall Study|Other than specified|30|||
161678857|NCT01979835|583876149|FG000|Primary Outcome SA Measurment|failed insertion|18|||
161678858|NCT01979835|583876149|FG000|Follow-up|Lost to Follow-up|32|||
161678859|NCT03697720|583877722|FG000|Overall Study|Lost to Follow-up|7|||
161678860|NCT00382720|583877727|FG000|Overall Study|Adverse Event|21|||
161678861|NCT00382720|583877728|FG001|Overall Study|Adverse Event|23|||
161678862|NCT00382720|583877729|FG002|Overall Study|Adverse Event|15|||
161678863|NCT00382720|583877727|FG000|Overall Study|Protocol Violation|2|||
161678864|NCT00382720|583877728|FG001|Overall Study|Protocol Violation|5|||
161678865|NCT00382720|583877729|FG002|Overall Study|Protocol Violation|1|||
161678866|NCT00382720|583877727|FG000|Overall Study|Death|0|||
161678867|NCT00382720|583877728|FG001|Overall Study|Death|1|||
161678868|NCT00382720|583877729|FG002|Overall Study|Death|2|||
161678869|NCT00382720|583877727|FG000|Overall Study|Progressive disease|37|||
161678870|NCT00382720|583877728|FG001|Overall Study|Progressive disease|28|||
161678871|NCT00382720|583877729|FG002|Overall Study|Progressive disease|38|||
161678872|NCT00382720|583877727|FG000|Overall Study|Withdrew consent|1|||
161678873|NCT00382720|583877728|FG001|Overall Study|Withdrew consent|1|||
161678874|NCT00382720|583877729|FG002|Overall Study|Withdrew consent|2|||
162228215|NCT02407990|585886398|FG003|Overall Study|Death|7|||
162228216|NCT02407990|585886399|FG004|Overall Study|Death|17|||
162228217|NCT02407990|585886400|FG005|Overall Study|Death|16|||
162228218|NCT02407990|585886401|FG006|Overall Study|Death|10|||
162228219|NCT02407990|585886402|FG007|Overall Study|Death|248|||
162228220|NCT02407990|585886395|FG000|Overall Study|Lost to Follow-up|0|||
162228221|NCT02407990|585886396|FG001|Overall Study|Lost to Follow-up|1|||
162228222|NCT02407990|585886397|FG002|Overall Study|Lost to Follow-up|0|||
162228223|NCT02407990|585886398|FG003|Overall Study|Lost to Follow-up|0|||
162228224|NCT02407990|585886399|FG004|Overall Study|Lost to Follow-up|0|||
162228225|NCT02407990|585886400|FG005|Overall Study|Lost to Follow-up|0|||
162228226|NCT02407990|585886401|FG006|Overall Study|Lost to Follow-up|0|||
162228227|NCT02407990|585886402|FG007|Overall Study|Lost to Follow-up|17|||
162228228|NCT02407990|585886395|FG000|Overall Study|Progressive Disease|0|||
162228229|NCT02407990|585886396|FG001|Overall Study|Progressive Disease|0|||
162228230|NCT02407990|585886397|FG002|Overall Study|Progressive Disease|0|||
162228231|NCT02407990|585886398|FG003|Overall Study|Progressive Disease|0|||
162228232|NCT02407990|585886399|FG004|Overall Study|Progressive Disease|0|||
162228233|NCT02407990|585886400|FG005|Overall Study|Progressive Disease|0|||
161678875|NCT00382720|583877727|FG000|Overall Study|Withdrawal by Subject|11|||
161678876|NCT00382720|583877728|FG001|Overall Study|Withdrawal by Subject|20|||
161678877|NCT00382720|583877729|FG002|Overall Study|Withdrawal by Subject|12|||
161678878|NCT00382720|583877727|FG000|Overall Study|Surgery|1|||
161678879|NCT00382720|583877728|FG001|Overall Study|Surgery|1|||
161678880|NCT00382720|583877729|FG002|Overall Study|Surgery|4|||
161678881|NCT00382720|583877727|FG000|Overall Study|Patient did not receive study medication|1|||
161678882|NCT00382720|583877728|FG001|Overall Study|Patient did not receive study medication|1|||
161678883|NCT00382720|583877729|FG002|Overall Study|Patient did not receive study medication|4|||
161678884|NCT00382720|583877727|FG000|Overall Study|Clinically progressive disease|0|||
161678885|NCT00382720|583877728|FG001|Overall Study|Clinically progressive disease|1|||
161678886|NCT00382720|583877729|FG002|Overall Study|Clinically progressive disease|0|||
161678887|NCT00382720|583877727|FG000|Overall Study|Good prognosis|0|||
161678888|NCT00382720|583877728|FG001|Overall Study|Good prognosis|1|||
161678889|NCT00382720|583877729|FG002|Overall Study|Good prognosis|0|||
161678890|NCT00382720|583877727|FG000|Overall Study|Investigator/Clinical decision|5|||
161678891|NCT00382720|583877728|FG001|Overall Study|Investigator/Clinical decision|6|||
161678892|NCT00382720|583877729|FG002|Overall Study|Investigator/Clinical decision|6|||
161678893|NCT00382720|583877727|FG000|Overall Study|Discontinued at end of study|0|||
161678894|NCT00382720|583877728|FG001|Overall Study|Discontinued at end of study|1|||
161678895|NCT00382720|583877729|FG002|Overall Study|Discontinued at end of study|2|||
161678896|NCT01183143|583877732|FG000|Overall Study|Protocol Violation|115|||
161678897|NCT01183143|583877732|FG000|Overall Study|Withdrawal by Subject|19|||
161678898|NCT01183143|583877732|FG000|Overall Study|Subject Questionnaires not returned|5|||
161678899|NCT01183143|583877732|FG000|Overall Study|Subjects enrolled, but not treated|11|||
161678900|NCT01704287|583877733|FG000|Initial Treatment Period|Death|139|||
161678901|NCT01704287|583877734|FG001|Initial Treatment Period|Death|129|||
161678902|NCT01704287|583877735|FG002|Initial Treatment Period|Death|71|||
161678903|NCT01704287|583877736|FG003|Initial Treatment Period|Death|0|||
161678904|NCT01704287|583877737|FG004|Initial Treatment Period|Death|0|||
161678905|NCT01704287|583877733|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
161678906|NCT01704287|583877734|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
161678907|NCT01704287|583877735|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
161678908|NCT01704287|583877736|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
161678909|NCT01704287|583877737|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
161678910|NCT01704287|583877733|FG000|Initial Treatment Period|Lost to Follow-up|5|||
161678911|NCT01704287|583877734|FG001|Initial Treatment Period|Lost to Follow-up|3|||
161678912|NCT01704287|583877735|FG002|Initial Treatment Period|Lost to Follow-up|0|||
161678913|NCT01704287|583877736|FG003|Initial Treatment Period|Lost to Follow-up|0|||
161678914|NCT01704287|583877737|FG004|Initial Treatment Period|Lost to Follow-up|0|||
161678915|NCT01704287|583877733|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
161678916|NCT01704287|583877734|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
161678917|NCT01704287|583877735|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
161678918|NCT01704287|583877736|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
161678919|NCT01704287|583877737|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
161678920|NCT01704287|583877733|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
161678921|NCT01704287|583877734|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
161678922|NCT01704287|583877735|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
161678923|NCT01704287|583877736|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
161678924|NCT01704287|583877737|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
161678925|NCT01704287|583877733|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
161678926|NCT01704287|583877734|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
161678927|NCT01704287|583877735|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
161678928|NCT01704287|583877736|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
161678929|NCT01704287|583877737|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
161678930|NCT01704287|583877733|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
161678931|NCT01704287|583877734|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
161678932|NCT01704287|583877735|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
161678933|NCT01704287|583877736|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
161678934|NCT01704287|583877737|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
161678935|NCT04042740|583877738|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
161678936|NCT04042740|583877738|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
161678937|NCT01717287|583877739|FG000|Overall Study|Lost to Follow-up|0|||
161678938|NCT01717287|583877740|FG001|Overall Study|Lost to Follow-up|2|||
161678939|NCT01717287|583877739|FG000|Overall Study|Protocol Violation|0|||
161678940|NCT01717287|583877740|FG001|Overall Study|Protocol Violation|1|||
161829477|NCT00572039|584415791|FG000|Overall Study|Death|2|||
161829478|NCT00572039|584415792|FG001|Overall Study|Death|3|||
161678941|NCT04024228|583877741|FG000|Overall Study|Adverse Event|1|||
161678942|NCT04024228|583877742|FG001|Overall Study|Adverse Event|0|||
161829479|NCT00572039|584415791|FG000|Overall Study|Ill|5|||
161829480|NCT00572039|584415792|FG001|Overall Study|Ill|1|||
162228234|NCT02407990|585886401|FG006|Overall Study|Progressive Disease|0|||
162228235|NCT02407990|585886402|FG007|Overall Study|Progressive Disease|1|||
162228236|NCT02407990|585886395|FG000|Overall Study|Withdrawal by Subject|0|||
162228237|NCT02407990|585886396|FG001|Overall Study|Withdrawal by Subject|0|||
162228238|NCT02407990|585886397|FG002|Overall Study|Withdrawal by Subject|0|||
162228239|NCT02407990|585886398|FG003|Overall Study|Withdrawal by Subject|0|||
162228240|NCT02407990|585886399|FG004|Overall Study|Withdrawal by Subject|1|||
162228241|NCT02407990|585886400|FG005|Overall Study|Withdrawal by Subject|0|||
162228242|NCT02407990|585886401|FG006|Overall Study|Withdrawal by Subject|0|||
162228243|NCT02407990|585886402|FG007|Overall Study|Withdrawal by Subject|30|||
162228244|NCT02407990|585886395|FG000|Overall Study|Study Terminated by Sponsor|1|||
162228245|NCT02407990|585886396|FG001|Overall Study|Study Terminated by Sponsor|3|||
162228246|NCT02407990|585886397|FG002|Overall Study|Study Terminated by Sponsor|3|||
162228247|NCT02407990|585886398|FG003|Overall Study|Study Terminated by Sponsor|0|||
162228248|NCT02407990|585886399|FG004|Overall Study|Study Terminated by Sponsor|3|||
162228249|NCT02407990|585886400|FG005|Overall Study|Study Terminated by Sponsor|4|||
162228250|NCT02407990|585886401|FG006|Overall Study|Study Terminated by Sponsor|3|||
162228251|NCT02407990|585886402|FG007|Overall Study|Study Terminated by Sponsor|37|||
162228252|NCT02407990|585886395|FG000|Overall Study|Logistics|0|||
162228253|NCT02407990|585886396|FG001|Overall Study|Logistics|0|||
162228254|NCT02407990|585886397|FG002|Overall Study|Logistics|0|||
162228255|NCT02407990|585886398|FG003|Overall Study|Logistics|0|||
162228256|NCT02407990|585886399|FG004|Overall Study|Logistics|0|||
162228257|NCT02407990|585886400|FG005|Overall Study|Logistics|0|||
162228258|NCT02407990|585886401|FG006|Overall Study|Logistics|0|||
162228259|NCT02407990|585886402|FG007|Overall Study|Logistics|1|||
162228260|NCT02407990|585886395|FG000|Overall Study|Rolled into long-term extension study|0|||
162228261|NCT02407990|585886396|FG001|Overall Study|Rolled into long-term extension study|0|||
162228262|NCT02407990|585886397|FG002|Overall Study|Rolled into long-term extension study|0|||
162228263|NCT02407990|585886398|FG003|Overall Study|Rolled into long-term extension study|0|||
162228264|NCT02407990|585886399|FG004|Overall Study|Rolled into long-term extension study|0|||
162228265|NCT02407990|585886400|FG005|Overall Study|Rolled into long-term extension study|0|||
162228266|NCT02407990|585886401|FG006|Overall Study|Rolled into long-term extension study|0|||
162228267|NCT02407990|585886402|FG007|Overall Study|Rolled into long-term extension study|1|||
162228268|NCT00923260|585886403|FG000|Overall Study|Lost to Follow-up|1|||
162228269|NCT00923260|585886404|FG001|Overall Study|Lost to Follow-up|1|||
162228270|NCT01238900|585886409|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
162228271|NCT01238900|585886409|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
162228272|NCT03241927|585886410|FG000|Overall Study|study terminated|1|||
162228273|NCT03241927|585886411|FG001|Overall Study|study terminated|0|||
162228274|NCT03573583|585886412|FG000|Overall Study|Lost to Follow-up|1|||
162228275|NCT03573583|585886413|FG001|Overall Study|Lost to Follow-up|0|||
162228276|NCT03573583|585886412|FG000|Overall Study|Withdrawal by Subject|1|||
162228277|NCT03573583|585886413|FG001|Overall Study|Withdrawal by Subject|1|||
162228278|NCT01198756|585886414|FG000|Overall Study|Adverse Event|0|||
162228279|NCT01198756|585886415|FG001|Overall Study|Adverse Event|0|||
162228280|NCT01198756|585886416|FG002|Overall Study|Adverse Event|0|||
162228281|NCT01198756|585886417|FG003|Overall Study|Adverse Event|1|||
162228282|NCT01198756|585886414|FG000|Overall Study|Protocol Violation|0|||
162228283|NCT01198756|585886415|FG001|Overall Study|Protocol Violation|0|||
162228284|NCT01198756|585886416|FG002|Overall Study|Protocol Violation|0|||
162228285|NCT01198756|585886417|FG003|Overall Study|Protocol Violation|2|||
162228286|NCT01198756|585886414|FG000|Overall Study|Withdrawal by Subject|9|||
162228287|NCT01198756|585886415|FG001|Overall Study|Withdrawal by Subject|4|||
162228288|NCT01198756|585886416|FG002|Overall Study|Withdrawal by Subject|7|||
162228289|NCT01198756|585886417|FG003|Overall Study|Withdrawal by Subject|5|||
162023678|NCT00830869|585144487|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
162228290|NCT01198756|585886414|FG000|Overall Study|Lost to Follow-up|29|||
162228291|NCT01198756|585886415|FG001|Overall Study|Lost to Follow-up|36|||
162228292|NCT01198756|585886416|FG002|Overall Study|Lost to Follow-up|23|||
162228293|NCT01198756|585886417|FG003|Overall Study|Lost to Follow-up|18|||
162228294|NCT02915302|585886420|FG000|Overall Study|Adverse Event|3|||
162228295|NCT02915302|585886421|FG001|Overall Study|Adverse Event|0|||
162228296|NCT02915302|585886420|FG000|Overall Study|Protocol Violation|20|||
162228297|NCT02915302|585886421|FG001|Overall Study|Protocol Violation|27|||
162228298|NCT02915302|585886420|FG000|Overall Study|Lost to Follow-up|19|||
162228299|NCT02915302|585886421|FG001|Overall Study|Lost to Follow-up|22|||
162228300|NCT02915302|585886420|FG000|Overall Study|Withdrawal by Subject|22|||
162228301|NCT02915302|585886421|FG001|Overall Study|Withdrawal by Subject|29|||
162228302|NCT02915302|585886420|FG000|Overall Study|Other|1|||
162228303|NCT02915302|585886421|FG001|Overall Study|Other|0|||
162228304|NCT04343872|585886424|FG000|Overall Study|Lost to Follow-up|6|||
162228305|NCT04343872|585886425|FG001|Overall Study|Lost to Follow-up|3|||
162228306|NCT02134977|585886426|FG000|Overall Study|Protocol Deviation|102|||
162228307|NCT01639495|585886427|FG000|Overall Study|Lost to Follow-up|6|||
162228308|NCT01639495|585886427|FG000|Overall Study|Consented but didn't have study catheter|4|||
162228309|NCT01639495|585886427|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
162228310|NCT01639495|585886427|FG000|Overall Study|No radiofrequency energy applied|2|||
162228311|NCT01119105|585886428|FG000|Overall Study|Withdrawal by Subject|1|||
162228312|NCT01119105|585886429|FG001|Overall Study|Withdrawal by Subject|1|||
162228313|NCT01119105|585886430|FG002|Overall Study|Withdrawal by Subject|1|||
162228314|NCT01119105|585886428|FG000|Overall Study|Lost to Follow-up|0|||
162228315|NCT01119105|585886429|FG001|Overall Study|Lost to Follow-up|2|||
162228316|NCT01119105|585886430|FG002|Overall Study|Lost to Follow-up|5|||
162228317|NCT01119105|585886428|FG000|Overall Study|Adverse Event|1|||
162228318|NCT01119105|585886429|FG001|Overall Study|Adverse Event|0|||
162228319|NCT01119105|585886430|FG002|Overall Study|Adverse Event|1|||
162228320|NCT01119105|585886428|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
162228321|NCT01119105|585886429|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
162228322|NCT01119105|585886430|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
162228323|NCT01119105|585886428|FG000|Overall Study|Other|1|||
162228324|NCT01119105|585886429|FG001|Overall Study|Other|1|||
162228325|NCT01119105|585886430|FG002|Overall Study|Other|0|||
162228326|NCT03507777|585886431|FG000|Overall Study|Lost to Follow-up|5|||
162228327|NCT03507777|585886432|FG001|Overall Study|Lost to Follow-up|7|||
161829481|NCT01098110|584415798|FG000|Overall Study|Withdrawal by Subject|14|||
162023679|NCT00830869|585144488|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
162228328|NCT03507777|585886431|FG000|Overall Study|Withdrawal by Subject|6|||
162228329|NCT03507777|585886432|FG001|Overall Study|Withdrawal by Subject|11|||
162228330|NCT03507777|585886431|FG000|Overall Study|Death|30|||
162228331|NCT03507777|585886432|FG001|Overall Study|Death|44|||
162228332|NCT03507777|585886431|FG000|Overall Study|Other Reasons|3|||
162228333|NCT03507777|585886432|FG001|Overall Study|Other Reasons|8|||
162228334|NCT02366468|585886434|FG000|Overall Study|Adverse Event|2|||
162228335|NCT02366468|585886435|FG001|Overall Study|Adverse Event|0|||
162228336|NCT02366468|585886434|FG000|Overall Study|Withdrawal by Subject|1|||
162228337|NCT02366468|585886435|FG001|Overall Study|Withdrawal by Subject|5|||
162228338|NCT02366468|585886434|FG000|Overall Study|Lost to Follow-up|2|||
162228339|NCT02366468|585886435|FG001|Overall Study|Lost to Follow-up|0|||
162228340|NCT02366468|585886434|FG000|Overall Study|Death|1|||
162228341|NCT02366468|585886435|FG001|Overall Study|Death|2|||
162228342|NCT02366468|585886434|FG000|Overall Study|Other|0|||
162228343|NCT02366468|585886435|FG001|Overall Study|Other|2|||
162228344|NCT00446043|585886436|FG000|Overall Study|Adverse Event|9|||
162228345|NCT00446043|585886436|FG000|Overall Study|Withdrawal by Subject|70|||
162228346|NCT00446043|585886436|FG000|Overall Study|Protocol Violation|2|||
162228347|NCT00446043|585886436|FG000|Overall Study|Lost to Follow-up|42|||
162228348|NCT00446043|585886436|FG000|Overall Study|Pregnancy|2|||
162228349|NCT05540717|585886439|FG000|Overall Study|Lost to Follow-up|2|||
162228350|NCT05540717|585886440|FG001|Overall Study|Lost to Follow-up|5|||
162228351|NCT05540717|585886439|FG000|Overall Study|Withdrawal by Subject|6|||
162228352|NCT05540717|585886440|FG001|Overall Study|Withdrawal by Subject|6|||
162228353|NCT05540717|585886439|FG000|Overall Study|Sponsor request|1|||
162228354|NCT05540717|585886440|FG001|Overall Study|Sponsor request|0|||
162228355|NCT05540717|585886439|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
162228356|NCT05540717|585886440|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
162228357|NCT05540717|585886439|FG000|Overall Study|Other|0|||
162228358|NCT05540717|585886440|FG001|Overall Study|Other|1|||
162228359|NCT01144052|585886441|FG000|Overall Study|Withdrawal by Subject|1|||
162228360|NCT01144052|585886442|FG001|Overall Study|Withdrawal by Subject|1|||
162228361|NCT03836716|585886446|FG000|Overall Study|Adverse Event|3|||
162228362|NCT03836716|585886446|FG000|Overall Study|Death|22|||
162228363|NCT03836716|585886446|FG000|Overall Study|Withdrawal by Subject|8|||
162228364|NCT03836716|585886446|FG000|Overall Study|Study terminated by sponsor|87|||
162228365|NCT01879722|585886447|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162228366|NCT01879722|585886448|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
162228367|NCT01879722|585886449|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
162228368|NCT01879722|585886450|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
162228369|NCT01879722|585886451|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
162228370|NCT01879722|585886452|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
162228371|NCT01879722|585886453|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
162228372|NCT01879722|585886454|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
162228373|NCT01879722|585886455|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
162023680|NCT00830869|585144489|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
162228374|NCT01879722|585886456|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
161678943|NCT04024228|583877741|FG000|Overall Study|Protocol Deviation|0|||
161678944|NCT04024228|583877742|FG001|Overall Study|Protocol Deviation|2|||
161678945|NCT04024228|583877741|FG000|Overall Study|Withdrawal by Subject|3|||
161678946|NCT04024228|583877742|FG001|Overall Study|Withdrawal by Subject|4|||
161678947|NCT04490395|583877746|FG000|Overall Study|Lost to Follow-up|0|||
161678948|NCT04490395|583877747|FG001|Overall Study|Lost to Follow-up|1|||
161678949|NCT00938717|583877748|FG000|Overall Study|Adverse Event|10|||
161678950|NCT00938717|583877749|FG001|Overall Study|Adverse Event|41|||
161678951|NCT00938717|583877748|FG000|Overall Study|Protocol Violation|11|||
161678952|NCT00938717|583877749|FG001|Overall Study|Protocol Violation|8|||
161678953|NCT00938717|583877748|FG000|Overall Study|Withdrawal by Subject|26|||
161678954|NCT00938717|583877749|FG001|Overall Study|Withdrawal by Subject|24|||
161678955|NCT00938717|583877748|FG000|Overall Study|Lost to Follow-up|13|||
161678956|NCT00938717|583877749|FG001|Overall Study|Lost to Follow-up|18|||
161678957|NCT00938717|583877748|FG000|Overall Study|Lack of Efficacy|33|||
161678958|NCT00938717|583877749|FG001|Overall Study|Lack of Efficacy|15|||
161678959|NCT00938717|583877748|FG000|Overall Study|Other reason|5|||
161678960|NCT00938717|583877749|FG001|Overall Study|Other reason|2|||
161678961|NCT01942148|583877754|FG000|Overall Study|Adverse Event|4|||
161678962|NCT01942148|583877754|FG000|Overall Study|Lack of Efficacy|2|||
162228375|NCT01879722|585886447|FG000|Overall Study|Voluntary Withdrawal|0|||
162228376|NCT01879722|585886448|FG001|Overall Study|Voluntary Withdrawal|0|||
162228377|NCT01879722|585886449|FG002|Overall Study|Voluntary Withdrawal|0|||
162228378|NCT01879722|585886450|FG003|Overall Study|Voluntary Withdrawal|0|||
162228379|NCT01879722|585886451|FG004|Overall Study|Voluntary Withdrawal|0|||
162228380|NCT01879722|585886452|FG005|Overall Study|Voluntary Withdrawal|0|||
162228381|NCT01879722|585886453|FG006|Overall Study|Voluntary Withdrawal|0|||
162228382|NCT01879722|585886454|FG007|Overall Study|Voluntary Withdrawal|0|||
162228383|NCT01879722|585886455|FG008|Overall Study|Voluntary Withdrawal|1|||
162228384|NCT01879722|585886456|FG009|Overall Study|Voluntary Withdrawal|0|||
162228385|NCT01983254|585886457|FG000|Overall Study|Death|6|||
162228386|NCT01983254|585886458|FG001|Overall Study|Death|6|||
162228387|NCT01983254|585886457|FG000|Overall Study|Lost to Follow-up|17|||
162228388|NCT01983254|585886458|FG001|Overall Study|Lost to Follow-up|16|||
162228389|NCT01983254|585886457|FG000|Overall Study|too ill|11|||
162228390|NCT01983254|585886458|FG001|Overall Study|too ill|8|||
162228391|NCT00037830|585886459|FG000|Overall Study|Adverse Event|2|||
162023681|NCT00830869|585144490|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
162228392|NCT00037830|585886460|FG001|Overall Study|Adverse Event|0|||
162228393|NCT00037830|585886461|FG002|Overall Study|Adverse Event|0|||
162228394|NCT00037830|585886459|FG000|Overall Study|Withdrawal by Subject|4|||
162228395|NCT00037830|585886460|FG001|Overall Study|Withdrawal by Subject|5|||
162228396|NCT00037830|585886461|FG002|Overall Study|Withdrawal by Subject|1|||
161678963|NCT01942148|583877754|FG000|Overall Study|Physician Decision|11|||
162228397|NCT00037830|585886459|FG000|Overall Study|Protocol Violation|2|||
162023682|NCT00830869|585144491|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
162023683|NCT00830869|585144492|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
162023684|NCT00830869|585144481|FG000|Period 2: Part 2|Adverse Event|0|||
161678964|NCT01942148|583877754|FG000|Overall Study|Protocol Violation|1|||
161678965|NCT01942148|583877754|FG000|Overall Study|Withdrawal by Subject|8|||
161678966|NCT01942148|583877754|FG000|Overall Study|Use of the prohibition medicine|1|||
161678967|NCT01838616|583877755|FG000|Titration Period|Adverse Event|18|||
161678968|NCT01838616|583877756|FG001|Titration Period|Adverse Event|48|||
161678969|NCT01838616|583877755|FG000|Titration Period|Lack of Efficacy|5|||
162228398|NCT00037830|585886460|FG001|Overall Study|Protocol Violation|2|||
162228399|NCT00037830|585886461|FG002|Overall Study|Protocol Violation|0|||
162228400|NCT00037830|585886459|FG000|Overall Study|Unrelated Medical Problem|2|||
162228401|NCT00037830|585886460|FG001|Overall Study|Unrelated Medical Problem|0|||
162228402|NCT00037830|585886461|FG002|Overall Study|Unrelated Medical Problem|0|||
162228403|NCT00127205|585886462|FG000|Overall Study|Adverse Event|228|||
162228404|NCT00127205|585886463|FG001|Overall Study|Adverse Event|387|||
162228405|NCT00127205|585886464|FG002|Overall Study|Adverse Event|273|||
162228406|NCT00127205|585886462|FG000|Overall Study|Death|8|||
162228407|NCT00127205|585886463|FG001|Overall Study|Death|6|||
162228408|NCT00127205|585886464|FG002|Overall Study|Death|5|||
162228409|NCT00127205|585886462|FG000|Overall Study|Withdrawal by Subject|318|||
162228410|NCT00127205|585886463|FG001|Overall Study|Withdrawal by Subject|310|||
162228411|NCT00127205|585886464|FG002|Overall Study|Withdrawal by Subject|172|||
162228412|NCT00127205|585886462|FG000|Overall Study|Other-non protocol specified|142|||
162228413|NCT00127205|585886463|FG001|Overall Study|Other-non protocol specified|129|||
162228414|NCT00127205|585886464|FG002|Overall Study|Other-non protocol specified|77|||
162228415|NCT00127205|585886462|FG000|Overall Study|Data not reported|6|||
162228416|NCT00127205|585886463|FG001|Overall Study|Data not reported|10|||
162228417|NCT00127205|585886464|FG002|Overall Study|Data not reported|1|||
162228418|NCT00127205|585886462|FG000|Overall Study|Progression|127|||
162228419|NCT00127205|585886463|FG001|Overall Study|Progression|131|||
162228420|NCT00127205|585886464|FG002|Overall Study|Progression|84|||
162228421|NCT01327495|585886465|FG000|Overall Study|Adverse Event|2|||
162228422|NCT01327495|585886466|FG001|Overall Study|Adverse Event|1|||
162228423|NCT01327495|585886467|FG002|Overall Study|Adverse Event|1|||
162228424|NCT01327495|585886468|FG003|Overall Study|Adverse Event|0|||
162228425|NCT01327495|585886469|FG004|Overall Study|Adverse Event|0|||
162228426|NCT01327495|585886470|FG005|Overall Study|Adverse Event|2|||
162228427|NCT01327495|585886465|FG000|Overall Study|Withdrawal by Subject|0|||
162228428|NCT01327495|585886466|FG001|Overall Study|Withdrawal by Subject|1|||
162228429|NCT01327495|585886467|FG002|Overall Study|Withdrawal by Subject|1|||
162228430|NCT01327495|585886468|FG003|Overall Study|Withdrawal by Subject|0|||
162228431|NCT01327495|585886469|FG004|Overall Study|Withdrawal by Subject|1|||
162228432|NCT01327495|585886470|FG005|Overall Study|Withdrawal by Subject|0|||
162228433|NCT01327495|585886465|FG000|Overall Study|Physician Decision|0|||
162228434|NCT01327495|585886466|FG001|Overall Study|Physician Decision|0|||
162228435|NCT01327495|585886467|FG002|Overall Study|Physician Decision|0|||
162228436|NCT01327495|585886468|FG003|Overall Study|Physician Decision|0|||
162228437|NCT01327495|585886469|FG004|Overall Study|Physician Decision|2|||
162228438|NCT01327495|585886470|FG005|Overall Study|Physician Decision|0|||
162228439|NCT03377699|585886471|FG000|Overall Study|Withdrawal by Subject|2|||
162228440|NCT03377699|585886472|FG001|Overall Study|Withdrawal by Subject|9|||
162228441|NCT03377699|585886471|FG000|Overall Study|Lost to Follow-up|1|||
162228442|NCT03377699|585886472|FG001|Overall Study|Lost to Follow-up|1|||
162228443|NCT03377699|585886471|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
162228444|NCT03377699|585886472|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
162228445|NCT03377699|585886471|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
162228446|NCT03377699|585886472|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
162228447|NCT03377699|585886471|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
162228448|NCT03377699|585886472|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
162228449|NCT03377699|585886471|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
162228450|NCT03377699|585886472|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
162228451|NCT02580305|585886476|FG000|Overall Study|Adverse Event|15|||
162228452|NCT02580305|585886477|FG001|Overall Study|Adverse Event|19|||
161678970|NCT01838616|583877756|FG001|Titration Period|Lack of Efficacy|12|||
162228453|NCT02580305|585886478|FG002|Overall Study|Adverse Event|10|||
161678971|NCT01838616|583877755|FG000|Titration Period|Withdrawal by Subject|5|||
162228454|NCT02580305|585886476|FG000|Overall Study|Lack of Efficacy|5|||
162228455|NCT02580305|585886477|FG001|Overall Study|Lack of Efficacy|0|||
162228456|NCT02580305|585886478|FG002|Overall Study|Lack of Efficacy|2|||
162228457|NCT02580305|585886476|FG000|Overall Study|Protocol Violation|4|||
162228458|NCT02580305|585886477|FG001|Overall Study|Protocol Violation|9|||
162228459|NCT02580305|585886478|FG002|Overall Study|Protocol Violation|6|||
162228460|NCT02580305|585886476|FG000|Overall Study|Lost to Follow-up|4|||
162228461|NCT02580305|585886477|FG001|Overall Study|Lost to Follow-up|4|||
162228462|NCT02580305|585886478|FG002|Overall Study|Lost to Follow-up|2|||
161678972|NCT01838616|583877756|FG001|Titration Period|Withdrawal by Subject|5|||
161678973|NCT01838616|583877755|FG000|Titration Period|Technical problems|1|||
162228463|NCT02580305|585886476|FG000|Overall Study|Withdrawal by Subject|11|||
162228464|NCT02580305|585886477|FG001|Overall Study|Withdrawal by Subject|9|||
162228465|NCT02580305|585886478|FG002|Overall Study|Withdrawal by Subject|7|||
162228466|NCT02580305|585886476|FG000|Overall Study|Randomized in error and never treated|4|||
162228467|NCT02580305|585886477|FG001|Overall Study|Randomized in error and never treated|8|||
162228468|NCT02580305|585886478|FG002|Overall Study|Randomized in error and never treated|5|||
162228469|NCT03582943|585886479|FG000|Allocated to Groups|Withdrawal by Subject|1|||
162228470|NCT03582943|585886480|FG001|Allocated to Groups|Withdrawal by Subject|1|||
162228471|NCT03582943|585886479|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
162228472|NCT03582943|585886480|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
162228473|NCT03582943|585886479|FG000|Analyzed|Protocol Violation|4|||
162228474|NCT03582943|585886480|FG001|Analyzed|Protocol Violation|1|||
162228475|NCT01631227|585886483|FG000|Overall Study|withdrawn consent|27|||
162228476|NCT01631227|585886484|FG001|Overall Study|withdrawn consent|21|||
161678974|NCT01838616|583877756|FG001|Titration Period|Technical problems|0|||
161678975|NCT01838616|583877755|FG000|Titration Period|Other|1|||
161678976|NCT01838616|583877756|FG001|Titration Period|Other|0|||
161829482|NCT01098110|584415799|FG001|Overall Study|Withdrawal by Subject|24|||
161829483|NCT01098110|584415800|FG002|Overall Study|Withdrawal by Subject|19|||
162228477|NCT01631227|585886483|FG000|Overall Study|Adverse Event|1|||
162228478|NCT01631227|585886484|FG001|Overall Study|Adverse Event|0|||
162228479|NCT01631227|585886483|FG000|Overall Study|administrative|2|||
162228480|NCT01631227|585886484|FG001|Overall Study|administrative|1|||
162228481|NCT01153321|585886485|FG000|Overall Study|Development of study withdrawal criteria|0|||
162228482|NCT01153321|585886486|FG001|Overall Study|Development of study withdrawal criteria|1|||
162228483|NCT01153321|585886485|FG000|Overall Study|Withdrawal by Subject|0|||
162228484|NCT01153321|585886486|FG001|Overall Study|Withdrawal by Subject|1|||
162228485|NCT01153321|585886485|FG000|Overall Study|Adverse Event|1|||
162228486|NCT01153321|585886486|FG001|Overall Study|Adverse Event|1|||
162228487|NCT01177800|585886488|FG000|Overall Study|Adverse Event|9|||
162228488|NCT01177800|585886489|FG001|Overall Study|Adverse Event|3|||
162228489|NCT01177800|585886488|FG000|Overall Study|Protocol Violation|0|||
162228490|NCT01177800|585886489|FG001|Overall Study|Protocol Violation|1|||
162228491|NCT01177800|585886488|FG000|Overall Study|Physician Decision|1|||
162228492|NCT01177800|585886489|FG001|Overall Study|Physician Decision|0|||
162228493|NCT01177800|585886488|FG000|Overall Study|Withdrawal of informed consent|0|||
162228494|NCT01177800|585886489|FG001|Overall Study|Withdrawal of informed consent|1|||
162228495|NCT05560243|585886493|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
162228496|NCT05870228|585886495|FG000|Overall Study|Lost to Follow-up|2|||
162228497|NCT05870228|585886496|FG001|Overall Study|Lost to Follow-up|0|||
162228498|NCT05870228|585886495|FG000|Overall Study|Withdrawal by Subject|1|||
162228499|NCT05870228|585886496|FG001|Overall Study|Withdrawal by Subject|0|||
162228500|NCT03231800|585886498|FG000|Overall Study|Lost to Follow-up|0|||
162228501|NCT03231800|585886499|FG001|Overall Study|Lost to Follow-up|2|||
162228502|NCT03231800|585886498|FG000|Overall Study|Protocol Violation|1|||
162228503|NCT03231800|585886499|FG001|Overall Study|Protocol Violation|1|||
162228504|NCT03231800|585886498|FG000|Overall Study|reason not provided|2|||
162228505|NCT03231800|585886499|FG001|Overall Study|reason not provided|0|||
162228506|NCT03500159|585886504|FG000|Overall Study|Study Terminated|2|||
162228507|NCT03500159|585886505|FG001|Overall Study|Study Terminated|1|||
162228508|NCT04075994|585886508|FG000|Overall Study|Withdrawal by Subject|8|||
162228509|NCT04075994|585886509|FG001|Overall Study|Withdrawal by Subject|9|||
162228510|NCT04075994|585886508|FG000|Overall Study|Adverse Event|2|||
162228511|NCT04075994|585886509|FG001|Overall Study|Adverse Event|2|||
162228512|NCT04075994|585886508|FG000|Overall Study|Investigator withdrew|3|||
162228513|NCT04075994|585886509|FG001|Overall Study|Investigator withdrew|1|||
162228514|NCT00252577|585886515|FG000|Overall Study|Lost to Follow-up|20|||
162228515|NCT00560066|585886516|FG000|Overall Study|Death|2|||
162228516|NCT00560066|585886517|FG001|Overall Study|Death|1|||
162228517|NCT00560066|585886516|FG000|Overall Study|Withdrawal by Subject|0|||
162228518|NCT00560066|585886517|FG001|Overall Study|Withdrawal by Subject|3|||
162228519|NCT00560066|585886516|FG000|Overall Study|Lost to Follow-up|4|||
162228520|NCT00560066|585886517|FG001|Overall Study|Lost to Follow-up|10|||
162228521|NCT00560066|585886516|FG000|Overall Study|Protocol Violation|0|||
162228522|NCT00560066|585886517|FG001|Overall Study|Protocol Violation|1|||
162228523|NCT00560066|585886516|FG000|Overall Study|Administrative reason|0|||
162228524|NCT00560066|585886517|FG001|Overall Study|Administrative reason|5|||
162228525|NCT00560066|585886516|FG000|Overall Study|Missing primary reason|0|||
162228526|NCT00560066|585886517|FG001|Overall Study|Missing primary reason|2|||
162228527|NCT04035499|585886518|FG000|Overall Study|Death|2|||
162228528|NCT04035499|585886518|FG000|Overall Study|Withdrawal by Subject|1|||
162228529|NCT00951015|585886519|FG000|Randomization Phase 96 Week|Adverse Event|1|||
162228530|NCT00951015|585886520|FG001|Randomization Phase 96 Week|Adverse Event|1|||
162228531|NCT00951015|585886521|FG002|Randomization Phase 96 Week|Adverse Event|2|||
162228532|NCT00951015|585886522|FG003|Randomization Phase 96 Week|Adverse Event|5|||
162228533|NCT00951015|585886523|FG004|Randomization Phase 96 Week|Adverse Event|0|||
162228534|NCT00951015|585886519|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
162228535|NCT00951015|585886520|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
161829484|NCT01098110|584415798|FG000|Overall Study|Adverse Event|30|||
162228536|NCT00951015|585886521|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
162228537|NCT00951015|585886522|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
162228538|NCT00951015|585886523|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
162228539|NCT00951015|585886519|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
162228540|NCT00951015|585886520|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
162228541|NCT00951015|585886521|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
162228542|NCT00951015|585886522|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
162228543|NCT00951015|585886523|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
162228544|NCT00951015|585886519|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
162228545|NCT00951015|585886520|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
161678977|NCT01838616|583877755|FG000|Titration Period|Protocol Violation|0|||
161829485|NCT01098110|584415799|FG001|Overall Study|Adverse Event|32|||
162228546|NCT00951015|585886521|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
162228547|NCT00951015|585886522|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
162228548|NCT00951015|585886523|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
162228549|NCT00951015|585886519|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
162228550|NCT00951015|585886520|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
162228551|NCT00951015|585886521|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
162228552|NCT00951015|585886522|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
161829486|NCT01098110|584415800|FG002|Overall Study|Adverse Event|43|||
161829487|NCT01098110|584415798|FG000|Overall Study|Lack of Efficacy|13|||
161829488|NCT01098110|584415799|FG001|Overall Study|Lack of Efficacy|9|||
161829489|NCT01098110|584415800|FG002|Overall Study|Lack of Efficacy|27|||
161829490|NCT01098110|584415798|FG000|Overall Study|Other|4|||
162228553|NCT00951015|585886523|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
161829491|NCT01098110|584415799|FG001|Overall Study|Other|7|||
161829492|NCT01098110|584415800|FG002|Overall Study|Other|5|||
161829493|NCT01098110|584415798|FG000|Overall Study|Untreated|1|||
161829494|NCT01098110|584415799|FG001|Overall Study|Untreated|1|||
161829495|NCT01098110|584415800|FG002|Overall Study|Untreated|0|||
161829496|NCT00089076|584415807|FG000|Overall Study|Alternate Therapy|1|||
161829497|NCT00089076|584415807|FG000|Overall Study|Withdrawal by Subject|2|||
161829498|NCT00089076|584415807|FG000|Overall Study|Progression|7|||
161829499|NCT00931463|584415808|FG000|Overall Study|Death|8|||
161678978|NCT01838616|583877756|FG001|Titration Period|Protocol Violation|1|||
161678979|NCT01838616|583877755|FG000|Continuation Period|Lack of Efficacy|3|||
161678980|NCT01838616|583877756|FG001|Continuation Period|Lack of Efficacy|5|||
161678981|NCT01838616|583877755|FG000|Continuation Period|Adverse Event|8|||
161829500|NCT00931463|584415809|FG001|Overall Study|Death|4|||
161829501|NCT00931463|584415808|FG000|Overall Study|Withdrawal by Subject|5|||
161829502|NCT00931463|584415809|FG001|Overall Study|Withdrawal by Subject|0|||
161829503|NCT00931463|584415808|FG000|Overall Study|Lost to Follow-up|4|||
162023685|NCT00830869|585144482|FG001|Period 2: Part 2|Adverse Event|0|||
161678982|NCT01838616|583877756|FG001|Continuation Period|Adverse Event|4|||
161678983|NCT01838616|583877755|FG000|Continuation Period|Protocol Violation|2|||
161678984|NCT01838616|583877756|FG001|Continuation Period|Protocol Violation|0|||
161678985|NCT01838616|583877755|FG000|Continuation Period|Lost to Follow-up|1|||
161678986|NCT01838616|583877756|FG001|Continuation Period|Lost to Follow-up|0|||
161678987|NCT01838616|583877755|FG000|Continuation Period|Withdrawal by Subject|0|||
161678988|NCT01838616|583877756|FG001|Continuation Period|Withdrawal by Subject|4|||
161678989|NCT01838616|583877755|FG000|Continuation Period|Technical problems|0|||
161678990|NCT01838616|583877756|FG001|Continuation Period|Technical problems|1|||
161678991|NCT01838616|583877755|FG000|Pick-up Arm|Lack of Efficacy|4|||
161678992|NCT01838616|583877756|FG001|Pick-up Arm|Lack of Efficacy|0|||
161678993|NCT01838616|583877755|FG000|Pick-up Arm|Adverse Event|9|||
161678994|NCT01838616|583877756|FG001|Pick-up Arm|Adverse Event|0|||
161678995|NCT01838616|583877755|FG000|Pick-up Arm|Withdrawal by Subject|1|||
161678996|NCT01838616|583877756|FG001|Pick-up Arm|Withdrawal by Subject|0|||
161678997|NCT01838616|583877755|FG000|Pick-up Arm|Technical problems|1|||
161678998|NCT01838616|583877756|FG001|Pick-up Arm|Technical problems|0|||
161678999|NCT00257725|583877757|FG000|Overall Study|Adverse Event|3|||
161679000|NCT02573870|583877758|FG000|Overall Study|Adverse Event|0|||
161679001|NCT02573870|583877759|FG001|Overall Study|Adverse Event|2|||
161679002|NCT02573870|583877758|FG000|Overall Study|Lack of Efficacy|0|||
161679003|NCT02573870|583877759|FG001|Overall Study|Lack of Efficacy|1|||
161679004|NCT02573870|583877758|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
161679005|NCT02573870|583877759|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
161679006|NCT02573870|583877758|FG000|Overall Study|Lost to Follow-up|0|||
161679007|NCT02573870|583877759|FG001|Overall Study|Lost to Follow-up|1|||
161679008|NCT02573870|583877758|FG000|Overall Study|Other: Fail to Meet Visit|0|||
161679009|NCT02573870|583877759|FG001|Overall Study|Other: Fail to Meet Visit|2|||
161679010|NCT00514514|583877760|FG000|Pre-phase|Death|10|||
161679011|NCT00514514|583877761|FG001|Pre-phase|Death|0|||
161679012|NCT00514514|583877762|FG002|Pre-phase|Death|0|||
161679013|NCT00514514|583877760|FG000|Pre-phase|administrative problems|2|||
161679014|NCT00514514|583877761|FG001|Pre-phase|administrative problems|0|||
161679015|NCT00514514|583877762|FG002|Pre-phase|administrative problems|0|||
161679016|NCT00514514|583877760|FG000|Pre-phase|Protocol Violation|6|||
161679017|NCT00514514|583877761|FG001|Pre-phase|Protocol Violation|0|||
161679018|NCT00514514|583877762|FG002|Pre-phase|Protocol Violation|0|||
161679019|NCT00514514|583877760|FG000|Pre-phase|condition no longer requires study drug|7|||
161679020|NCT00514514|583877761|FG001|Pre-phase|condition no longer requires study drug|0|||
161679021|NCT00514514|583877762|FG002|Pre-phase|condition no longer requires study drug|0|||
161829504|NCT00931463|584415809|FG001|Overall Study|Lost to Follow-up|1|||
161829505|NCT00808509|584415810|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
162023686|NCT00830869|585144483|FG002|Period 2: Part 2|Adverse Event|0|||
162023687|NCT00830869|585144484|FG003|Period 2: Part 2|Adverse Event|0|||
162228554|NCT00951015|585886519|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
162228555|NCT00951015|585886520|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
162228556|NCT00951015|585886521|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
162228557|NCT00951015|585886522|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
162228558|NCT00951015|585886523|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
162228559|NCT00951015|585886519|FG000|Open-label Phase|Adverse Event|0|||
162228560|NCT00951015|585886520|FG001|Open-label Phase|Adverse Event|0|||
162228561|NCT00951015|585886521|FG002|Open-label Phase|Adverse Event|0|||
162228562|NCT00951015|585886522|FG003|Open-label Phase|Adverse Event|0|||
162228563|NCT00951015|585886523|FG004|Open-label Phase|Adverse Event|3|||
162228564|NCT00951015|585886519|FG000|Open-label Phase|Lack of Efficacy|0|||
162228565|NCT00951015|585886520|FG001|Open-label Phase|Lack of Efficacy|0|||
162228566|NCT00951015|585886521|FG002|Open-label Phase|Lack of Efficacy|0|||
162228567|NCT00951015|585886522|FG003|Open-label Phase|Lack of Efficacy|0|||
162228568|NCT00951015|585886523|FG004|Open-label Phase|Lack of Efficacy|1|||
162228569|NCT00951015|585886519|FG000|Open-label Phase|Protocol Violation|0|||
162228570|NCT00951015|585886520|FG001|Open-label Phase|Protocol Violation|0|||
161679022|NCT00514514|583877760|FG000|Pre-phase|abnormal test procedure results|15|||
161679023|NCT00514514|583877761|FG001|Pre-phase|abnormal test procedure results|0|||
161679024|NCT00514514|583877762|FG002|Pre-phase|abnormal test procedure results|0|||
161679025|NCT00514514|583877760|FG000|Pre-phase|Lost to Follow-up|2|||
161679026|NCT00514514|583877761|FG001|Pre-phase|Lost to Follow-up|0|||
161679027|NCT00514514|583877762|FG002|Pre-phase|Lost to Follow-up|0|||
161679028|NCT00514514|583877760|FG000|Pre-phase|abnormal lab values|23|||
161679029|NCT00514514|583877761|FG001|Pre-phase|abnormal lab values|0|||
161679030|NCT00514514|583877762|FG002|Pre-phase|abnormal lab values|0|||
161679031|NCT00514514|583877760|FG000|Pre-phase|Lack of Efficacy|35|||
161679032|NCT00514514|583877761|FG001|Pre-phase|Lack of Efficacy|0|||
161679033|NCT00514514|583877762|FG002|Pre-phase|Lack of Efficacy|0|||
161679034|NCT00514514|583877760|FG000|Pre-phase|Adverse Event|137|||
161679035|NCT00514514|583877761|FG001|Pre-phase|Adverse Event|0|||
161679036|NCT00514514|583877762|FG002|Pre-phase|Adverse Event|0|||
161679037|NCT00514514|583877760|FG000|Pre-phase|Withdrawal by Subject|66|||
161679038|NCT00514514|583877761|FG001|Pre-phase|Withdrawal by Subject|0|||
161679039|NCT00514514|583877762|FG002|Pre-phase|Withdrawal by Subject|0|||
161679040|NCT00514514|583877760|FG000|Randomized - 9 Month|Death|3|||
161679041|NCT00514514|583877761|FG001|Randomized - 9 Month|Death|2|||
161679042|NCT00514514|583877762|FG002|Randomized - 9 Month|Death|2|||
161679043|NCT00514514|583877760|FG000|Randomized - 9 Month|Administrative problems|1|||
161679044|NCT00514514|583877761|FG001|Randomized - 9 Month|Administrative problems|1|||
161679045|NCT00514514|583877762|FG002|Randomized - 9 Month|Administrative problems|2|||
161679046|NCT00514514|583877760|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
161679047|NCT00514514|583877761|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
161679048|NCT00514514|583877762|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
161679049|NCT00514514|583877760|FG000|Randomized - 9 Month|Protocol Violation|1|||
161679050|NCT00514514|583877761|FG001|Randomized - 9 Month|Protocol Violation|1|||
161679051|NCT00514514|583877762|FG002|Randomized - 9 Month|Protocol Violation|0|||
161679052|NCT00514514|583877760|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
161679053|NCT00514514|583877761|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
161679054|NCT00514514|583877762|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
161679055|NCT00514514|583877760|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
161679056|NCT00514514|583877761|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
161679057|NCT00514514|583877762|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
161679058|NCT00514514|583877760|FG000|Randomized - 9 Month|Adverse Event|25|||
161679059|NCT00514514|583877761|FG001|Randomized - 9 Month|Adverse Event|44|||
161679060|NCT00514514|583877762|FG002|Randomized - 9 Month|Adverse Event|27|||
161679061|NCT00514514|583877760|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
161679062|NCT00514514|583877761|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
161679063|NCT00514514|583877762|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
161679064|NCT00514514|583877760|FG000|Extension - 4 Years|Lost to Follow-up|12|||
161679065|NCT00514514|583877761|FG001|Extension - 4 Years|Lost to Follow-up|10|||
161679066|NCT00514514|583877762|FG002|Extension - 4 Years|Lost to Follow-up|9|||
161679067|NCT00514514|583877760|FG000|Extension - 4 Years|Administrative problems|3|||
161679068|NCT00514514|583877761|FG001|Extension - 4 Years|Administrative problems|1|||
161679069|NCT00514514|583877762|FG002|Extension - 4 Years|Administrative problems|1|||
161679070|NCT00514514|583877760|FG000|Extension - 4 Years|Death|8|||
161679071|NCT00514514|583877761|FG001|Extension - 4 Years|Death|3|||
161679072|NCT00514514|583877762|FG002|Extension - 4 Years|Death|6|||
161679073|NCT00514514|583877760|FG000|Extension - 4 Years|Adverse Event|9|||
161679074|NCT00514514|583877761|FG001|Extension - 4 Years|Adverse Event|6|||
161679075|NCT00514514|583877762|FG002|Extension - 4 Years|Adverse Event|3|||
162023688|NCT00830869|585144485|FG004|Period 2: Part 2|Adverse Event|0|||
162023689|NCT00830869|585144486|FG005|Period 2: Part 2|Adverse Event|0|||
161679076|NCT01480284|583877764|FG000|Overall Study|Withdrawal by Subject|2|||
161679077|NCT01480284|583877765|FG001|Overall Study|Withdrawal by Subject|0|||
161679078|NCT01480284|583877764|FG000|Overall Study|Adverse Event|1|||
161679079|NCT01480284|583877765|FG001|Overall Study|Adverse Event|0|||
161679080|NCT01480284|583877764|FG000|Overall Study|Study closed/terminated|3|||
161679081|NCT01480284|583877765|FG001|Overall Study|Study closed/terminated|0|||
161679082|NCT01480284|583877764|FG000|Overall Study|Lost to Follow-up|1|||
161679083|NCT01480284|583877765|FG001|Overall Study|Lost to Follow-up|0|||
161679084|NCT01480284|583877764|FG000|Overall Study|Physician Decision|1|||
161679085|NCT01480284|583877765|FG001|Overall Study|Physician Decision|0|||
161679086|NCT03374995|583877769|FG000|Overall Study|Withdrawal by Subject|0|||
161679087|NCT03374995|583877770|FG001|Overall Study|Withdrawal by Subject|1|||
161679088|NCT01383096|583877773|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
161679089|NCT01383096|583877774|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
161679090|NCT01383096|583877775|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
161679091|NCT01383096|583877773|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
161829506|NCT00808509|584415811|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
161679092|NCT01383096|583877774|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
162023690|NCT00830869|585144487|FG006|Period 2: Part 2|Adverse Event|0|||
162228571|NCT00951015|585886521|FG002|Open-label Phase|Protocol Violation|0|||
161679093|NCT01383096|583877775|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
161679094|NCT01383096|583877773|FG000|Third Intervention (8 Days)|Elevated AST|0|||
161679095|NCT01383096|583877774|FG001|Third Intervention (8 Days)|Elevated AST|1|||
161679096|NCT01383096|583877775|FG002|Third Intervention (8 Days)|Elevated AST|0|||
161679097|NCT01383096|583877773|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
161679098|NCT01383096|583877774|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
161679099|NCT01383096|583877775|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
161679100|NCT01383096|583877773|FG000|Third Intervention (8 Days)|Adverse Event|1|||
161679101|NCT01383096|583877774|FG001|Third Intervention (8 Days)|Adverse Event|0|||
161679102|NCT01383096|583877775|FG002|Third Intervention (8 Days)|Adverse Event|0|||
161679103|NCT01383096|583877773|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
161679104|NCT01383096|583877774|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
161679105|NCT01383096|583877775|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
161679106|NCT01383096|583877773|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
161679107|NCT01383096|583877774|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
161679108|NCT01383096|583877775|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
161679109|NCT01383096|583877773|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
161679110|NCT01383096|583877774|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
161679111|NCT01383096|583877775|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
161679112|NCT01383096|583877773|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
161679113|NCT01383096|583877774|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
161679114|NCT01383096|583877775|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
161679115|NCT01383096|583877773|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
161679116|NCT01383096|583877774|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
161679117|NCT01383096|583877775|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
161679118|NCT01383096|583877773|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
161679119|NCT01383096|583877774|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
161679120|NCT01383096|583877775|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
161679121|NCT01211535|583877776|FG000|Overall Study|Adverse Event|0|||
161679122|NCT01211535|583877777|FG001|Overall Study|Adverse Event|1|||
161679123|NCT03593850|583877783|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
161679124|NCT03593850|583877784|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
161679125|NCT02490475|583877785|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
161679126|NCT02490475|583877786|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
161679127|NCT02490475|583877787|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
161679128|NCT02490475|583877788|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
161679129|NCT02490475|583877785|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
161679130|NCT02490475|583877786|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
161679131|NCT02490475|583877787|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
161679132|NCT02490475|583877788|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
161679133|NCT02490475|583877785|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
161679134|NCT02490475|583877786|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
161679135|NCT02490475|583877787|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
161679136|NCT02490475|583877788|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
161679137|NCT02490475|583877785|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
161679138|NCT02490475|583877786|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
161679139|NCT02490475|583877787|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
161679140|NCT02490475|583877788|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
161679141|NCT02490475|583877785|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
161679142|NCT02490475|583877786|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
161679143|NCT02490475|583877787|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
161679144|NCT02490475|583877788|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
161679145|NCT02490475|583877785|FG000|Period 2: Extension Phase|Refused Treatment|0|||
161679146|NCT02490475|583877786|FG001|Period 2: Extension Phase|Refused Treatment|0|||
161679147|NCT02490475|583877787|FG002|Period 2: Extension Phase|Refused Treatment|0|||
161679148|NCT02490475|583877788|FG003|Period 2: Extension Phase|Refused Treatment|1|||
161679149|NCT02490475|583877785|FG000|Period 2: Extension Phase|Adverse Event|0|||
161679150|NCT02490475|583877786|FG001|Period 2: Extension Phase|Adverse Event|0|||
161829507|NCT00808509|584415810|FG000|Randomized Phase|Reduced methotrexate dose|1|||
161829508|NCT00808509|584415811|FG001|Randomized Phase|Reduced methotrexate dose|2|||
161829509|NCT00808509|584415810|FG000|Randomized Phase|Patient refused rescue therapy|0|||
161679151|NCT02490475|583877787|FG002|Period 2: Extension Phase|Adverse Event|1|||
161679152|NCT02490475|583877788|FG003|Period 2: Extension Phase|Adverse Event|0|||
161679153|NCT00616434|583877790|FG000|Overall Study|Adverse Event|5|||
161679154|NCT00616434|583877791|FG001|Overall Study|Adverse Event|2|||
161829510|NCT00808509|584415811|FG001|Randomized Phase|Patient refused rescue therapy|3|||
161829511|NCT00436917|584415812|FG000|Overall Study|Withdrawal by Subject|13|||
161829512|NCT00436917|584415812|FG000|Overall Study|Adverse Event|2|||
162228572|NCT00951015|585886522|FG003|Open-label Phase|Protocol Violation|0|||
162228573|NCT00951015|585886523|FG004|Open-label Phase|Protocol Violation|12|||
162228574|NCT00951015|585886519|FG000|Open-label Phase|Lost to Follow-up|0|||
162228575|NCT00951015|585886520|FG001|Open-label Phase|Lost to Follow-up|0|||
162228576|NCT00951015|585886521|FG002|Open-label Phase|Lost to Follow-up|0|||
162228577|NCT00951015|585886522|FG003|Open-label Phase|Lost to Follow-up|0|||
162228578|NCT00951015|585886523|FG004|Open-label Phase|Lost to Follow-up|12|||
162228579|NCT00951015|585886519|FG000|Open-label Phase|Withdrawal by Subject|0|||
162228580|NCT00951015|585886520|FG001|Open-label Phase|Withdrawal by Subject|0|||
162228581|NCT00951015|585886521|FG002|Open-label Phase|Withdrawal by Subject|0|||
162228582|NCT00951015|585886522|FG003|Open-label Phase|Withdrawal by Subject|0|||
162228583|NCT00951015|585886523|FG004|Open-label Phase|Withdrawal by Subject|14|||
162228584|NCT00951015|585886519|FG000|Open-label Phase|Physician Decision|0|||
162228585|NCT00951015|585886520|FG001|Open-label Phase|Physician Decision|0|||
162228586|NCT00951015|585886521|FG002|Open-label Phase|Physician Decision|0|||
162228587|NCT00951015|585886522|FG003|Open-label Phase|Physician Decision|0|||
162228588|NCT00951015|585886523|FG004|Open-label Phase|Physician Decision|8|||
162228589|NCT01416389|585886524|FG000|Overall Study|Lost to Follow-up|1|||
162228590|NCT01416389|585886525|FG001|Overall Study|Lost to Follow-up|0|||
162228591|NCT01416389|585886524|FG000|Overall Study|Started New Therapy|2|||
162228592|NCT01416389|585886525|FG001|Overall Study|Started New Therapy|0|||
162228593|NCT00958841|585886526|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162228594|NCT00958841|585886526|FG000|Overall Study|Abnormal test procedure result(s)|3|||
162228595|NCT00958841|585886526|FG000|Overall Study|Administrative problems|1|||
162228596|NCT00958841|585886526|FG000|Overall Study|Adverse Event|8|||
162228597|NCT00958841|585886526|FG000|Overall Study|New cancer therapy|5|||
162228598|NCT00958841|585886526|FG000|Overall Study|Withdrawal by Subject|1|||
162228599|NCT00958841|585886526|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
162228600|NCT00958841|585886526|FG000|Overall Study|Completed M6/did not enter extension|27|||
162228601|NCT00958841|585886526|FG000|Overall Study|Discontinued prior to M*|28|||
162228602|NCT02535091|585886533|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
162228603|NCT02535091|585886534|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
162228604|NCT02535091|585886535|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
162228605|NCT02535091|585886533|FG000|Overall Study|Withdrawal by Subject|14|||
162228606|NCT02535091|585886534|FG001|Overall Study|Withdrawal by Subject|5|||
162228607|NCT02535091|585886535|FG002|Overall Study|Withdrawal by Subject|121|||
162228608|NCT02535091|585886533|FG000|Overall Study|Adverse Event|9|||
162228609|NCT02535091|585886534|FG001|Overall Study|Adverse Event|4|||
162228610|NCT02535091|585886535|FG002|Overall Study|Adverse Event|170|||
162228611|NCT02535091|585886533|FG000|Overall Study|Other|4|||
162228612|NCT02535091|585886534|FG001|Overall Study|Other|3|||
162228613|NCT02535091|585886535|FG002|Overall Study|Other|81|||
162228614|NCT02535091|585886533|FG000|Overall Study|Lost to Follow-up|0|||
162228615|NCT02535091|585886534|FG001|Overall Study|Lost to Follow-up|1|||
162228616|NCT02535091|585886535|FG002|Overall Study|Lost to Follow-up|19|||
162228617|NCT02535091|585886533|FG000|Overall Study|Protocol Violation|0|||
162228618|NCT02535091|585886534|FG001|Overall Study|Protocol Violation|1|||
162228619|NCT02535091|585886535|FG002|Overall Study|Protocol Violation|11|||
162228620|NCT02535091|585886533|FG000|Overall Study|Pregnancy|0|||
162228621|NCT02535091|585886534|FG001|Overall Study|Pregnancy|0|||
162228622|NCT02535091|585886535|FG002|Overall Study|Pregnancy|7|||
162228623|NCT01259089|585886540|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
162228624|NCT01259089|585886541|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
162228625|NCT01259089|585886542|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
162228626|NCT01259089|585886543|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
162228627|NCT01259089|585886544|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
162228628|NCT01259089|585886545|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
162228629|NCT01259089|585886540|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
162228630|NCT01259089|585886541|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
162228631|NCT01259089|585886542|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
162228632|NCT01259089|585886543|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
162228633|NCT01259089|585886544|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
162228634|NCT01259089|585886545|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
162228635|NCT01259089|585886540|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
162228636|NCT01259089|585886541|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
162228637|NCT01259089|585886542|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
162228638|NCT01259089|585886543|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
162228639|NCT01259089|585886544|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
162228640|NCT01259089|585886545|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
162228641|NCT01259089|585886540|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
162228642|NCT01259089|585886541|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
161679155|NCT00616434|583877790|FG000|Overall Study|Physician Decision|0|||
161679156|NCT00616434|583877791|FG001|Overall Study|Physician Decision|4|||
161679157|NCT00616434|583877790|FG000|Overall Study|Withdrawal by Subject|1|||
161679158|NCT00616434|583877791|FG001|Overall Study|Withdrawal by Subject|1|||
161679159|NCT00616434|583877790|FG000|Overall Study|Protocol deviation|0|||
161679160|NCT00616434|583877791|FG001|Overall Study|Protocol deviation|1|||
161679161|NCT04784897|583877797|FG000|Overall Study|Death|4|||
161679162|NCT04784897|583877798|FG001|Overall Study|Death|2|||
161679163|NCT04784897|583877799|FG002|Overall Study|Death|1|||
161679164|NCT04784897|583877797|FG000|Overall Study|Withdrawal by Subject|0|||
161679165|NCT04784897|583877798|FG001|Overall Study|Withdrawal by Subject|0|||
161679166|NCT04784897|583877799|FG002|Overall Study|Withdrawal by Subject|1|||
161679167|NCT02319668|583877800|FG000|Overall Study|Other (Not specified)|0|||
161679168|NCT02319668|583877801|FG001|Overall Study|Other (Not specified)|2|||
161679169|NCT01161043|583877802|FG000|Overall Study|Withdrawal by Subject|3|||
161679170|NCT02164929|583877803|FG000|Overall Study|Converted to open procedure|1|||
161679171|NCT02164929|583877804|FG001|Overall Study|Converted to open procedure|0|||
161679172|NCT02164929|583877805|FG002|Overall Study|Converted to open procedure|0|||
161679173|NCT02164929|583877806|FG003|Overall Study|Converted to open procedure|2|||
161679174|NCT02164929|583877803|FG000|Overall Study|Failed regional block|0|||
161679175|NCT02164929|583877804|FG001|Overall Study|Failed regional block|0|||
161679176|NCT02164929|583877805|FG002|Overall Study|Failed regional block|1|||
161679177|NCT02164929|583877806|FG003|Overall Study|Failed regional block|0|||
161679178|NCT00365456|583877810|FG000|Trial Period I (12 Months)|Adverse Event|84|||
161679179|NCT00365456|583877811|FG001|Trial Period I (12 Months)|Adverse Event|0|||
161679180|NCT00365456|583877810|FG000|Trial Period I (12 Months)|Non-compliance|3|||
162228643|NCT01259089|585886542|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
162228644|NCT01259089|585886543|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
162228645|NCT01259089|585886544|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
162228646|NCT01259089|585886545|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
162228647|NCT01259089|585886540|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
162228648|NCT01259089|585886541|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
162228649|NCT01259089|585886542|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
162228650|NCT01259089|585886543|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
162228651|NCT01259089|585886544|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
162228652|NCT01259089|585886545|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
162228653|NCT01259089|585886540|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
162228654|NCT01259089|585886541|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
162228655|NCT01259089|585886542|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
162228656|NCT01259089|585886543|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
162228657|NCT01259089|585886544|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
162228658|NCT01259089|585886545|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
162228659|NCT01259089|585886540|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
162228660|NCT01259089|585886541|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
162228661|NCT01259089|585886542|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
161679181|NCT00365456|583877811|FG001|Trial Period I (12 Months)|Non-compliance|0|||
161679182|NCT00365456|583877810|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
161679183|NCT00365456|583877811|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
161679184|NCT00365456|583877810|FG000|Trial Period I (12 Months)|Other|11|||
161679185|NCT00365456|583877811|FG001|Trial Period I (12 Months)|Other|0|||
161679186|NCT00365456|583877810|FG000|Trial Period II (12 Months)|Adverse Event|0|||
161679187|NCT00365456|583877811|FG001|Trial Period II (12 Months)|Adverse Event|6|||
162228662|NCT01259089|585886543|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
162228663|NCT01259089|585886544|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
161679188|NCT00365456|583877810|FG000|Trial Period II (12 Months)|Non-compliance|0|||
161679189|NCT00365456|583877811|FG001|Trial Period II (12 Months)|Non-compliance|2|||
161679190|NCT00365456|583877810|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
161679191|NCT00365456|583877811|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
161679192|NCT00365456|583877810|FG000|Trial Period II (12 Months)|Other|0|||
161679193|NCT00365456|583877811|FG001|Trial Period II (12 Months)|Other|1|||
162228664|NCT01259089|585886545|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
162228665|NCT01259089|585886540|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
161679194|NCT00365456|583877810|FG000|Trial Period III (12 Months)|Adverse Event|13|||
161679195|NCT00365456|583877811|FG001|Trial Period III (12 Months)|Adverse Event|3|||
162023691|NCT00830869|585144488|FG007|Period 2: Part 2|Adverse Event|4|||
162228666|NCT01259089|585886541|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
162228667|NCT01259089|585886542|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
162228668|NCT01259089|585886543|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
161679196|NCT00365456|583877810|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
161679197|NCT00365456|583877811|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
161679198|NCT00365456|583877810|FG000|Trial Period III (12 Months)|Other|1|||
161679199|NCT00365456|583877811|FG001|Trial Period III (12 Months)|Other|1|||
161679200|NCT04754802|583877814|FG000|Overall Study|Lost to Follow-up|0|||
162228669|NCT01259089|585886544|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
161679201|NCT04754802|583877815|FG001|Overall Study|Lost to Follow-up|2|||
161679202|NCT04754802|583877814|FG000|Overall Study|Withdrawal by Subject|2|||
161679203|NCT04754802|583877815|FG001|Overall Study|Withdrawal by Subject|0|||
161679204|NCT00701090|583877816|FG000|Overall Study|Adverse Event|11|||
161679205|NCT00701090|583877817|FG001|Overall Study|Adverse Event|2|||
161679206|NCT00701090|583877816|FG000|Overall Study|Death|0|||
161679207|NCT00701090|583877817|FG001|Overall Study|Death|1|||
161679208|NCT00701090|583877816|FG000|Overall Study|Lack of Efficacy|5|||
161679209|NCT00701090|583877817|FG001|Overall Study|Lack of Efficacy|4|||
161679210|NCT00701090|583877816|FG000|Overall Study|Lost to Follow-up|9|||
161679211|NCT00701090|583877817|FG001|Overall Study|Lost to Follow-up|9|||
161679212|NCT00701090|583877816|FG000|Overall Study|Physician Decision|3|||
161679213|NCT00701090|583877817|FG001|Overall Study|Physician Decision|4|||
161679214|NCT00701090|583877816|FG000|Overall Study|Protocol Violation|2|||
161679215|NCT00701090|583877817|FG001|Overall Study|Protocol Violation|3|||
161679216|NCT00701090|583877816|FG000|Overall Study|Withdrawal by Subject|11|||
161679217|NCT00701090|583877817|FG001|Overall Study|Withdrawal by Subject|16|||
161679218|NCT00701090|583877816|FG000|Overall Study|Other|7|||
161679219|NCT00701090|583877817|FG001|Overall Study|Other|12|||
161679220|NCT01299376|583877824|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
161679221|NCT01299376|583877825|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
161679222|NCT01299376|583877824|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
161679223|NCT01299376|583877825|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
161679224|NCT01299376|583877824|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
161679225|NCT01299376|583877825|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
161679226|NCT01299376|583877824|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
162228670|NCT01259089|585886545|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
161679227|NCT01299376|583877825|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
161679228|NCT01299376|583877824|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
161679229|NCT01299376|583877825|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
161679230|NCT01299376|583877824|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
161679231|NCT01299376|583877825|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
161679232|NCT01299376|583877824|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
161679233|NCT01299376|583877825|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
161679234|NCT01299376|583877824|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
161679235|NCT01299376|583877825|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
161679236|NCT01299376|583877824|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
161679237|NCT01299376|583877825|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
161679238|NCT01299376|583877824|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
161679239|NCT01299376|583877825|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
161679240|NCT01299376|583877824|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
161679241|NCT01299376|583877825|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
161679242|NCT00617604|583877831|FG000|Overall Study|Death|2|||
161679243|NCT00617604|583877832|FG001|Overall Study|Death|1|||
161679244|NCT00617604|583877831|FG000|Overall Study|Lost to Follow-up|1|||
161679245|NCT00617604|583877832|FG001|Overall Study|Lost to Follow-up|0|||
161679246|NCT00617604|583877831|FG000|Overall Study|Miscellaneous Reasons|8|||
161679247|NCT00617604|583877832|FG001|Overall Study|Miscellaneous Reasons|10|||
161679248|NCT00617604|583877831|FG000|Overall Study|Withdrawal by Subject|4|||
161679249|NCT00617604|583877832|FG001|Overall Study|Withdrawal by Subject|6|||
161679250|NCT00617604|583877831|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
161679251|NCT00617604|583877832|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
161679252|NCT02303704|583877833|FG000|Overall Study|Protocol Violation|5|||
161679253|NCT02303704|583877834|FG001|Overall Study|Protocol Violation|9|||
161679254|NCT00805025|583877835|FG000|Overall Study|Screened but not enrolled/treated|42|||
161679255|NCT00805025|583877835|FG000|Overall Study|Adverse Event|4|||
161679256|NCT00805025|583877835|FG000|Overall Study|Withdrawal by Subject|2|||
161679257|NCT00805025|583877835|FG000|Overall Study|Physician Decision|1|||
161679258|NCT04029961|583877841|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
161679259|NCT04029961|583877842|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
161679260|NCT04029961|583877841|FG000|Overall Study|Change in Treatment Course|0|||
161679261|NCT04029961|583877842|FG001|Overall Study|Change in Treatment Course|1|||
161679262|NCT01721876|583877843|FG000|Overall Study|Not treated|1|||
161679263|NCT01721876|583877844|FG001|Overall Study|Not treated|4|||
161679264|NCT01721876|583877843|FG000|Overall Study|Disease progression / relapse|123|||
162228671|NCT01259089|585886540|FG000|Survival Follow up for Two Years|Death|3|||
161679265|NCT01721876|583877844|FG001|Overall Study|Disease progression / relapse|156|||
161829513|NCT00436917|584415812|FG000|Overall Study|Physician Decision|1|||
162228672|NCT01259089|585886541|FG001|Survival Follow up for Two Years|Death|2|||
161679266|NCT01721876|583877843|FG000|Overall Study|Death|6|||
161679267|NCT01721876|583877844|FG001|Overall Study|Death|13|||
161679268|NCT01721876|583877843|FG000|Overall Study|Adverse Event|41|||
162228673|NCT01259089|585886542|FG002|Survival Follow up for Two Years|Death|2|||
162228674|NCT01259089|585886543|FG003|Survival Follow up for Two Years|Death|3|||
162228675|NCT01259089|585886544|FG004|Survival Follow up for Two Years|Death|6|||
162228676|NCT01259089|585886545|FG005|Survival Follow up for Two Years|Death|13|||
162228677|NCT01259089|585886540|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
162228678|NCT01259089|585886541|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
162228679|NCT01259089|585886542|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
162228680|NCT01259089|585886543|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
162228681|NCT01259089|585886544|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
162228682|NCT01259089|585886545|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
162228683|NCT01259089|585886540|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
162228684|NCT01259089|585886541|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
162228685|NCT01259089|585886542|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
162228686|NCT01259089|585886543|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
162228687|NCT01259089|585886544|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
162228688|NCT01259089|585886545|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
162228689|NCT00688870|585886546|FG000|Infant Series|Parent or legal guardian request|4|||
162228690|NCT00688870|585886547|FG001|Infant Series|Parent or legal guardian request|0|||
162228691|NCT01151410|585886548|FG000|Overall Study|Withdrawal by Subject|3|||
162228692|NCT01151410|585886549|FG001|Overall Study|Withdrawal by Subject|5|||
162228693|NCT01151410|585886548|FG000|Overall Study|Lost to Follow-up|3|||
162228694|NCT01151410|585886549|FG001|Overall Study|Lost to Follow-up|4|||
162228695|NCT01151410|585886548|FG000|Overall Study|Adverse Event|1|||
162228696|NCT01151410|585886549|FG001|Overall Study|Adverse Event|2|||
162228697|NCT01151410|585886548|FG000|Overall Study|Protocol deviation|2|||
162228698|NCT01151410|585886549|FG001|Overall Study|Protocol deviation|1|||
162228699|NCT01151410|585886548|FG000|Overall Study|Administrative problems|1|||
162228700|NCT01151410|585886549|FG001|Overall Study|Administrative problems|1|||
162228701|NCT01151410|585886548|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162228702|NCT01151410|585886549|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162228703|NCT01151410|585886548|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162228704|NCT01151410|585886549|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162228705|NCT01253018|585886550|FG000|Overall Study|Lost to Follow-up|1|||
162228706|NCT01253018|585886551|FG001|Overall Study|Lost to Follow-up|1|||
162228707|NCT01253018|585886550|FG000|Overall Study|Robot Repair Issues|2|||
162228708|NCT01253018|585886551|FG001|Overall Study|Robot Repair Issues|0|||
162228709|NCT01253018|585886550|FG000|Overall Study|Withdrawal by Subject|1|||
162228710|NCT01253018|585886551|FG001|Overall Study|Withdrawal by Subject|1|||
162228711|NCT00969709|585888395|FG000|Overall Study|Adverse Event|3|||
162228712|NCT00969709|585888396|FG001|Overall Study|Adverse Event|13|||
162228713|NCT00969709|585888397|FG002|Overall Study|Adverse Event|26|||
162228714|NCT00969709|585888398|FG003|Overall Study|Adverse Event|12|||
162228715|NCT00969709|585888395|FG000|Overall Study|Lack of Efficacy|7|||
162228716|NCT00969709|585888396|FG001|Overall Study|Lack of Efficacy|4|||
162228717|NCT00969709|585888397|FG002|Overall Study|Lack of Efficacy|1|||
162228718|NCT00969709|585888398|FG003|Overall Study|Lack of Efficacy|3|||
162228719|NCT00969709|585888395|FG000|Overall Study|Protocol Violation|9|||
162228720|NCT00969709|585888396|FG001|Overall Study|Protocol Violation|5|||
162228721|NCT00969709|585888397|FG002|Overall Study|Protocol Violation|9|||
162228722|NCT00969709|585888398|FG003|Overall Study|Protocol Violation|10|||
162228723|NCT00969709|585888395|FG000|Overall Study|Withdrawal by Subject|9|||
162228724|NCT00969709|585888396|FG001|Overall Study|Withdrawal by Subject|12|||
162228725|NCT00969709|585888397|FG002|Overall Study|Withdrawal by Subject|11|||
162228726|NCT00969709|585888398|FG003|Overall Study|Withdrawal by Subject|23|||
162228727|NCT00969709|585888395|FG000|Overall Study|Lost to Follow-up|10|||
162228728|NCT00969709|585888396|FG001|Overall Study|Lost to Follow-up|14|||
162228729|NCT00969709|585888397|FG002|Overall Study|Lost to Follow-up|8|||
162228730|NCT00969709|585888398|FG003|Overall Study|Lost to Follow-up|15|||
162228731|NCT00969709|585888395|FG000|Overall Study|Other reasons|0|||
162228732|NCT00969709|585888396|FG001|Overall Study|Other reasons|0|||
162228733|NCT00969709|585888397|FG002|Overall Study|Other reasons|3|||
162228734|NCT00969709|585888398|FG003|Overall Study|Other reasons|0|||
162228735|NCT02516332|585888399|FG000|Overall Study|Withdrawal by Subject|2|||
162228736|NCT02516332|585888400|FG001|Overall Study|Withdrawal by Subject|1|||
161679269|NCT01721876|583877844|FG001|Overall Study|Adverse Event|165|||
161679270|NCT01721876|583877843|FG000|Overall Study|Protocol Violation|2|||
161679271|NCT01721876|583877844|FG001|Overall Study|Protocol Violation|1|||
161679272|NCT01721876|583877843|FG000|Overall Study|Withdrawal by Subject|15|||
161679273|NCT01721876|583877844|FG001|Overall Study|Withdrawal by Subject|38|||
161679274|NCT01721876|583877843|FG000|Overall Study|Reason not listed|34|||
161679275|NCT01721876|583877844|FG001|Overall Study|Reason not listed|63|||
161679276|NCT01721876|583877843|FG000|Overall Study|Sponsor terminated trial|0|||
161679277|NCT01721876|583877844|FG001|Overall Study|Sponsor terminated trial|4|||
161679278|NCT01252810|583877847|FG000|Overall Study|Withdrawal by Subject|4|||
162228737|NCT02516332|585888401|FG002|Overall Study|Withdrawal by Subject|2|||
162228738|NCT03695237|585888402|FG000|Overall Study|Withdrawal by Subject|1|||
162228739|NCT03695237|585888403|FG001|Overall Study|Withdrawal by Subject|3|||
162228740|NCT03695237|585888402|FG000|Overall Study|Lost to Follow-up|1|||
162228741|NCT03695237|585888403|FG001|Overall Study|Lost to Follow-up|2|||
161679279|NCT01252810|583877848|FG001|Overall Study|Withdrawal by Subject|1|||
161679280|NCT01252810|583877847|FG000|Overall Study|Lost to Follow-up|0|||
161679281|NCT01252810|583877848|FG001|Overall Study|Lost to Follow-up|1|||
162228742|NCT03695237|585888402|FG000|Overall Study|Other, Not Specified|8|||
162228743|NCT03695237|585888403|FG001|Overall Study|Other, Not Specified|2|||
162228744|NCT00055601|585888404|FG000|Overall Study|Protocol Violation|1|||
162228745|NCT00055601|585888405|FG001|Overall Study|Protocol Violation|1|||
162228746|NCT00055601|585888404|FG000|Overall Study|No protocol treatment received|1|||
162228747|NCT00055601|585888405|FG001|Overall Study|No protocol treatment received|1|||
162228748|NCT02217332|585888406|FG000|Overall Study|Adverse Event|3|||
162228749|NCT02217332|585888406|FG000|Overall Study|Dose interruption >1 month|1|||
162228750|NCT02217332|585888406|FG000|Overall Study|Protocol Violation (eligibility)|1|||
162228751|NCT02217332|585888406|FG000|Overall Study|Withdrawal by Subject|1|||
162228752|NCT02217332|585888406|FG000|Overall Study|Lost to Follow-up|1|||
162228753|NCT03828747|585888415|FG000|Double-Blind Treatment Period|Adverse Event|6|||
162228754|NCT03828747|585888416|FG001|Double-Blind Treatment Period|Adverse Event|6|||
162228755|NCT03828747|585888415|FG000|Double-Blind Treatment Period|Death|1|||
161679282|NCT01252810|583877847|FG000|Overall Study|Physician Decision|2|||
161679283|NCT01252810|583877848|FG001|Overall Study|Physician Decision|1|||
161679284|NCT01252810|583877847|FG000|Overall Study|Various reasons|8|||
161679285|NCT01252810|583877848|FG001|Overall Study|Various reasons|0|||
161679286|NCT02811549|583877850|FG000|Overall Study|Lost to Follow-up|1|||
161679287|NCT02811549|583877850|FG000|Overall Study|Withdrawal by Subject|3|||
161679288|NCT02811549|583877850|FG000|Overall Study|Subject screen failed|4|||
161679289|NCT02811549|583877850|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
161679290|NCT05293743|583877851|FG000|Overall Study|Withdrawal by Subject|1|||
161679291|NCT05293743|583877852|FG001|Overall Study|Withdrawal by Subject|0|||
161679292|NCT00688155|583877853|FG000|Overall Study|Withdrawal by Subject|2|||
161679293|NCT00688155|583877854|FG001|Overall Study|Withdrawal by Subject|2|||
161679294|NCT00688155|583877855|FG002|Overall Study|Withdrawal by Subject|1|||
161679295|NCT00688155|583877856|FG003|Overall Study|Withdrawal by Subject|1|||
161679296|NCT00445224|583877859|FG000|Specific Exercises|Withdrawal by Subject|3|||
161679297|NCT00445224|583877860|FG001|Specific Exercises|Withdrawal by Subject|3|||
161679298|NCT00445224|583877859|FG000|Specific Exercises|Withdrawal by Subject|1|||
161679299|NCT00445224|583877860|FG001|Specific Exercises|Withdrawal by Subject|0|||
161679300|NCT03184077|583877863|FG000|Overall Study|Lost to Follow-up|21|||
161679301|NCT03184077|583877864|FG001|Overall Study|Lost to Follow-up|21|||
161679302|NCT04136184|583877865|FG000|Overall Study|Lost to Follow-up|0|||
161679303|NCT04136184|583877866|FG001|Overall Study|Lost to Follow-up|3|||
161679304|NCT04136184|583877865|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
161679305|NCT04136184|583877866|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
161679306|NCT03318978|583877870|FG000|Overall Study|Withdrawal by Subject|1|||
161679307|NCT01200238|583877873|FG000|Overall Study|Adverse Event|2|||
161679308|NCT01200238|583877874|FG001|Overall Study|Adverse Event|1|||
161679309|NCT01200238|583877873|FG000|Overall Study|Progressive Disease|5|||
162228756|NCT03828747|585888416|FG001|Double-Blind Treatment Period|Death|1|||
162228757|NCT03828747|585888415|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162228758|NCT03828747|585888416|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
162228759|NCT03828747|585888415|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
162228760|NCT03828747|585888416|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
162228761|NCT03828747|585888415|FG000|Double-Blind Treatment Period|Physician Decision|1|||
162228762|NCT03828747|585888416|FG001|Double-Blind Treatment Period|Physician Decision|4|||
162228763|NCT03828747|585888415|FG000|Double-Blind Treatment Period|Various reasons|5|||
162228764|NCT03828747|585888416|FG001|Double-Blind Treatment Period|Various reasons|3|||
162228765|NCT03828747|585888415|FG000|Open-Label Extension|Adverse Event|9|||
162228766|NCT03828747|585888416|FG001|Open-Label Extension|Adverse Event|7|||
162228767|NCT03828747|585888415|FG000|Open-Label Extension|Death|0|||
162228768|NCT03828747|585888416|FG001|Open-Label Extension|Death|2|||
162228769|NCT03828747|585888415|FG000|Open-Label Extension|Lost to Follow-up|4|||
162228770|NCT03828747|585888416|FG001|Open-Label Extension|Lost to Follow-up|0|||
162228771|NCT03828747|585888415|FG000|Open-Label Extension|Withdrawal by Subject|31|||
162228772|NCT03828747|585888416|FG001|Open-Label Extension|Withdrawal by Subject|30|||
162228773|NCT03828747|585888415|FG000|Open-Label Extension|Various reasons|4|||
162228774|NCT03828747|585888416|FG001|Open-Label Extension|Various reasons|4|||
162228775|NCT03828747|585888415|FG000|Open-Label Extension|Physician Decision|6|||
162228776|NCT03828747|585888416|FG001|Open-Label Extension|Physician Decision|2|||
162228777|NCT01658150|585888417|FG000|Overall Study|Withdrawal by Subject|1|||
162228778|NCT04187989|585888418|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
162228779|NCT04187989|585888419|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
162228780|NCT04187989|585888418|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
162228781|NCT04187989|585888419|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
162228782|NCT03646656|585888420|FG000|Overall Study|Lost to Follow-up|1|||
162228783|NCT03646656|585888421|FG001|Overall Study|Lost to Follow-up|0|||
162228784|NCT03646656|585888420|FG000|Overall Study|Withdrawal by Subject|2|||
162228785|NCT03646656|585888421|FG001|Overall Study|Withdrawal by Subject|0|||
162228786|NCT02245737|585888422|FG000|Overall Study|Adverse Event|23|||
162228787|NCT02245737|585888423|FG001|Overall Study|Adverse Event|26|||
162228788|NCT02245737|585888424|FG002|Overall Study|Adverse Event|33|||
162228789|NCT02245737|585888422|FG000|Overall Study|Condition Worsened|9|||
162228790|NCT02245737|585888423|FG001|Overall Study|Condition Worsened|10|||
162228791|NCT02245737|585888424|FG002|Overall Study|Condition Worsened|9|||
162228792|NCT02245737|585888422|FG000|Overall Study|Death|2|||
162228793|NCT02245737|585888423|FG001|Overall Study|Death|4|||
162228794|NCT02245737|585888424|FG002|Overall Study|Death|4|||
162228795|NCT02245737|585888422|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
162228796|NCT02245737|585888423|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
162228797|NCT02245737|585888424|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
162228798|NCT02245737|585888422|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
162228799|NCT02245737|585888423|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
162228800|NCT02245737|585888424|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
162228801|NCT02245737|585888422|FG000|Overall Study|Lost to Follow-up|2|||
162228802|NCT02245737|585888423|FG001|Overall Study|Lost to Follow-up|5|||
162228803|NCT02245737|585888424|FG002|Overall Study|Lost to Follow-up|4|||
162228804|NCT02245737|585888422|FG000|Overall Study|Other-determined by Investigator|9|||
162228805|NCT02245737|585888423|FG001|Overall Study|Other-determined by Investigator|10|||
162228806|NCT02245737|585888424|FG002|Overall Study|Other-determined by Investigator|10|||
162228807|NCT02245737|585888422|FG000|Overall Study|Physician Decision|6|||
162228808|NCT02245737|585888423|FG001|Overall Study|Physician Decision|3|||
162228809|NCT02245737|585888424|FG002|Overall Study|Physician Decision|6|||
162228810|NCT02245737|585888422|FG000|Overall Study|Protocol Violation|3|||
162228811|NCT02245737|585888423|FG001|Overall Study|Protocol Violation|2|||
162228812|NCT02245737|585888424|FG002|Overall Study|Protocol Violation|3|||
162228813|NCT02245737|585888422|FG000|Overall Study|Withdrawal by Subject|40|||
162228814|NCT02245737|585888423|FG001|Overall Study|Withdrawal by Subject|41|||
162228815|NCT02245737|585888424|FG002|Overall Study|Withdrawal by Subject|44|||
162228816|NCT02245737|585888422|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
162228817|NCT02245737|585888423|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
162228818|NCT02245737|585888424|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
162228819|NCT02245737|585888422|FG000|Overall Study|Sponsor Decision|445|||
162228820|NCT02245737|585888423|FG001|Overall Study|Sponsor Decision|430|||
162228821|NCT02245737|585888424|FG002|Overall Study|Sponsor Decision|432|||
161829514|NCT00436917|584415812|FG000|Overall Study|Death|1|||
161829515|NCT00436917|584415812|FG000|Overall Study|Lost to Follow-up|1|||
162228822|NCT01699503|585888428|FG000|Overall Study|Death|31|||
162228823|NCT01699503|585888429|FG001|Overall Study|Death|40|||
162228824|NCT01699503|585888428|FG000|Overall Study|Withdrawal by Subject|65|||
162228825|NCT01699503|585888429|FG001|Overall Study|Withdrawal by Subject|57|||
162228826|NCT01699503|585888428|FG000|Overall Study|Lost to Follow-up|121|||
162228827|NCT01699503|585888429|FG001|Overall Study|Lost to Follow-up|117|||
162228828|NCT01699503|585888428|FG000|Overall Study|Excluded due to quality|783|||
162228829|NCT01699503|585888429|FG001|Overall Study|Excluded due to quality|791|||
162228830|NCT01639560|585888430|FG000|Overall Study|Withdrawal by Subject|9|||
162228831|NCT01639560|585888431|FG001|Overall Study|Withdrawal by Subject|14|||
162228832|NCT01639560|585888430|FG000|Overall Study|Lack of Efficacy|1|||
162228833|NCT01639560|585888431|FG001|Overall Study|Lack of Efficacy|2|||
162228834|NCT01639560|585888430|FG000|Overall Study|Lost to Follow-up|9|||
162228835|NCT01639560|585888431|FG001|Overall Study|Lost to Follow-up|11|||
162228836|NCT01639560|585888430|FG000|Overall Study|Adverse Event|0|||
162228837|NCT01639560|585888431|FG001|Overall Study|Adverse Event|2|||
162228838|NCT00774930|585888432|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
162228839|NCT00774930|585888433|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
162228840|NCT00774930|585888432|FG000|DB Phase|Adverse Event|1|||
162228841|NCT00774930|585888433|FG001|DB Phase|Adverse Event|2|||
162228842|NCT00774930|585888432|FG000|DB Phase|Subject Decision|1|||
162228843|NCT00774930|585888433|FG001|DB Phase|Subject Decision|5|||
162228844|NCT00774930|585888432|FG000|DB Phase|Sponsor Decision|0|||
162228845|NCT00774930|585888433|FG001|DB Phase|Sponsor Decision|1|||
162228846|NCT00774930|585888432|FG000|DB Phase|Disease Progression|1|||
162228847|NCT00774930|585888433|FG001|DB Phase|Disease Progression|1|||
162023692|NCT00830869|585144489|FG008|Period 2: Part 2|Adverse Event|3|||
162228848|NCT00774930|585888432|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
162228849|NCT00774930|585888433|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
162228850|NCT00774930|585888432|FG000|IOL Phase|Adverse Event|1|||
162228851|NCT00774930|585888433|FG001|IOL Phase|Adverse Event|1|||
162023693|NCT00830869|585144490|FG009|Period 2: Part 2|Adverse Event|2|||
162228852|NCT00774930|585888432|FG000|IOL Phase|Subject Decision|4|||
162228853|NCT00774930|585888433|FG001|IOL Phase|Subject Decision|3|||
162228854|NCT00774930|585888432|FG000|IOL Phase|Physician Decision|3|||
162228855|NCT00774930|585888433|FG001|IOL Phase|Physician Decision|2|||
162228856|NCT00774930|585888432|FG000|IOL Phase|Sponsor Decision|1|||
162228857|NCT00774930|585888433|FG001|IOL Phase|Sponsor Decision|0|||
162228858|NCT00774930|585888432|FG000|IOL Phase|Disease Progression|2|||
162228859|NCT00774930|585888433|FG001|IOL Phase|Disease Progression|1|||
162228860|NCT00774930|585888432|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
162228861|NCT00774930|585888433|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
162228862|NCT00774930|585888432|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
162228863|NCT00774930|585888433|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
162228864|NCT00774930|585888432|FG000|IOL Phase|Other|1|||
162228865|NCT00774930|585888433|FG001|IOL Phase|Other|0|||
162228866|NCT00774930|585888432|FG000|IOL Phase|Brain radiation|0|||
162228867|NCT00774930|585888433|FG001|IOL Phase|Brain radiation|1|||
162228868|NCT00774930|585888432|FG000|LTOLE Phase|Adverse Event|7|||
162228869|NCT00774930|585888433|FG001|LTOLE Phase|Adverse Event|3|||
162228870|NCT00774930|585888432|FG000|LTOLE Phase|Subject decision|0|||
162228871|NCT00774930|585888433|FG001|LTOLE Phase|Subject decision|5|||
162228872|NCT00774930|585888432|FG000|LTOLE Phase|Physician Decision|4|||
162228873|NCT00774930|585888433|FG001|LTOLE Phase|Physician Decision|1|||
161679310|NCT01200238|583877874|FG001|Overall Study|Progressive Disease|8|||
161679311|NCT01200238|583877873|FG000|Overall Study|Withdrawal by Subject|0|||
161679312|NCT01200238|583877874|FG001|Overall Study|Withdrawal by Subject|1|||
161679313|NCT02717754|583877875|FG000|Overall Study|Incorrect Infusion Duration|0|||
161679314|NCT02717754|583877876|FG001|Overall Study|Incorrect Infusion Duration|0|||
161679315|NCT02717754|583877877|FG002|Overall Study|Incorrect Infusion Duration|0|||
161679316|NCT02717754|583877878|FG003|Overall Study|Incorrect Infusion Duration|10|||
161679317|NCT02717754|583877879|FG004|Overall Study|Incorrect Infusion Duration|20|||
161679318|NCT02717754|583877880|FG005|Overall Study|Incorrect Infusion Duration|20|||
161679319|NCT00482703|583877881|FG000|Overall Study|Poor compliance|1|||
161679320|NCT00482703|583877882|FG001|Overall Study|Poor compliance|0|||
161679321|NCT00667823|583877884|FG000|Overall Study|Lost to Follow-up|5|||
161679322|NCT00667823|583877884|FG000|Overall Study|Adverse Event|7|||
161679323|NCT00667823|583877884|FG000|Overall Study|Death|182|||
161679324|NCT00667823|583877884|FG000|Overall Study|Withdrawal by Subject|12|||
161679325|NCT00667823|583877884|FG000|Overall Study|Other|8|||
161679326|NCT00667823|583877884|FG000|Overall Study|Missing (completion page missing)|2|||
161829516|NCT00436917|584415812|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
161829517|NCT00436917|584415812|FG000|Overall Study|Increased creatinine|1|||
161829518|NCT00436917|584415812|FG000|Overall Study|Personal conflicts of patient|1|||
162228874|NCT00774930|585888432|FG000|LTOLE Phase|Sponsor decision|2|||
162228875|NCT00774930|585888433|FG001|LTOLE Phase|Sponsor decision|1|||
162228876|NCT00774930|585888432|FG000|LTOLE Phase|Disease Progression|2|||
162228877|NCT00774930|585888433|FG001|LTOLE Phase|Disease Progression|5|||
162228878|NCT00774930|585888432|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
162228879|NCT00774930|585888433|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
162228880|NCT00774930|585888432|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
162228881|NCT00774930|585888433|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
162228882|NCT00766363|585888439|FG000|Overall Study|Withdrawal by Subject|1|||
162228883|NCT00766363|585888440|FG001|Overall Study|Withdrawal by Subject|0|||
162228884|NCT00766363|585888441|FG002|Overall Study|Withdrawal by Subject|0|||
162228885|NCT00766363|585888442|FG003|Overall Study|Withdrawal by Subject|0|||
162228886|NCT00766363|585888439|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
162228887|NCT00766363|585888440|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
162228888|NCT00766363|585888441|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
162228889|NCT00766363|585888442|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
162228890|NCT03020576|585888443|FG000|Overall Study|Withdrawal by Subject|1|||
162228891|NCT03020576|585888444|FG001|Overall Study|Withdrawal by Subject|2|||
162228892|NCT03292432|585888445|FG000|Overall Study|Lost to Follow-up|11|||
162228893|NCT03292432|585888446|FG001|Overall Study|Lost to Follow-up|8|||
162228894|NCT03292432|585888445|FG000|Overall Study|Death|2|||
162228895|NCT03292432|585888446|FG001|Overall Study|Death|1|||
162228896|NCT03292432|585888445|FG000|Overall Study|Withdrawal by Subject|1|||
162228897|NCT03292432|585888446|FG001|Overall Study|Withdrawal by Subject|2|||
162228898|NCT03292432|585888445|FG000|Overall Study|Site closed before any data collected|1|||
162228899|NCT03292432|585888446|FG001|Overall Study|Site closed before any data collected|0|||
162228900|NCT00911937|585888447|FG000|Overall Study|Death|1|||
162228901|NCT00911937|585888448|FG001|Overall Study|Death|0|||
162228902|NCT00911937|585888447|FG000|Overall Study|Lost to Follow-up|8|||
162228903|NCT00911937|585888448|FG001|Overall Study|Lost to Follow-up|5|||
162228904|NCT00911937|585888447|FG000|Overall Study|Withdrawal by Subject|10|||
162228905|NCT00911937|585888448|FG001|Overall Study|Withdrawal by Subject|7|||
162228906|NCT00911937|585888447|FG000|Overall Study|Withdrawn due to pregnancy|1|||
162228907|NCT00911937|585888448|FG001|Overall Study|Withdrawn due to pregnancy|0|||
162228908|NCT00911937|585888447|FG000|Overall Study|Adverse Event|11|||
162228909|NCT00911937|585888448|FG001|Overall Study|Adverse Event|25|||
162228910|NCT00911937|585888447|FG000|Overall Study|Lack of Efficacy|11|||
162228911|NCT00911937|585888448|FG001|Overall Study|Lack of Efficacy|6|||
162228912|NCT00911937|585888447|FG000|Overall Study|Did not meet inclusion criteria|9|||
162228913|NCT00911937|585888448|FG001|Overall Study|Did not meet inclusion criteria|11|||
162228914|NCT00911937|585888447|FG000|Overall Study|Protocol Violation|14|||
162228915|NCT00911937|585888448|FG001|Overall Study|Protocol Violation|23|||
162228916|NCT00911937|585888447|FG000|Overall Study|Randomized but not treated|13|||
162228917|NCT00911937|585888448|FG001|Overall Study|Randomized but not treated|13|||
162228918|NCT00911937|585888447|FG000|Overall Study|Other|9|||
162228919|NCT00911937|585888448|FG001|Overall Study|Other|5|||
162228920|NCT01498679|585888449|FG000|Overall Study|Adverse Event|1|||
162228921|NCT01498679|585888450|FG001|Overall Study|Adverse Event|4|||
162228922|NCT01498679|585888449|FG000|Overall Study|Lack of Efficacy|72|||
161679327|NCT03496012|583879068|FG000|Overall Study|Withdrawal by Subject|2|||
161679328|NCT03496012|583879069|FG001|Overall Study|Withdrawal by Subject|0|||
161679329|NCT03496012|583879070|FG002|Overall Study|Withdrawal by Subject|2|||
161679330|NCT03496012|583879068|FG000|Overall Study|Adverse Event|0|||
161679331|NCT03496012|583879069|FG001|Overall Study|Adverse Event|0|||
161679332|NCT03496012|583879070|FG002|Overall Study|Adverse Event|1|||
161679333|NCT03496012|583879068|FG000|Overall Study|Reason Not Specified|2|||
161829519|NCT02169791|584415815|FG000|Overall Study|Death|6|||
162023694|NCT00830869|585144491|FG010|Period 2: Part 2|Adverse Event|2|||
162228923|NCT01498679|585888450|FG001|Overall Study|Lack of Efficacy|12|||
162228924|NCT01498679|585888449|FG000|Overall Study|Protocol Violation|4|||
162228925|NCT01498679|585888450|FG001|Overall Study|Protocol Violation|0|||
162228926|NCT01498679|585888449|FG000|Overall Study|Physician Decision|0|||
161829520|NCT02169791|584415815|FG000|Overall Study|patient withdrew consent|1|||
162228927|NCT01498679|585888450|FG001|Overall Study|Physician Decision|2|||
162228928|NCT01498679|585888449|FG000|Overall Study|Withdrawal by Subject|12|||
162228929|NCT01498679|585888450|FG001|Overall Study|Withdrawal by Subject|4|||
162228930|NCT00700427|585888451|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
162228931|NCT00700427|585888452|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
162228932|NCT00700427|585888453|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
162228933|NCT00700427|585888454|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
162228934|NCT00700427|585888455|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
162228935|NCT00700427|585888451|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
162228936|NCT00700427|585888452|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
162228937|NCT00700427|585888453|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
161829521|NCT03170869|584415816|FG000|Overall Study|Protocol Violation|5|||
162023695|NCT00830869|585144492|FG011|Period 2: Part 2|Adverse Event|0|||
162228938|NCT00700427|585888454|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
162228939|NCT00700427|585888455|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
162228940|NCT00700427|585888451|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
162228941|NCT00700427|585888452|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
162228942|NCT00700427|585888453|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
162228943|NCT00700427|585888454|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
162228944|NCT00700427|585888455|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
162228945|NCT00700427|585888451|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
162228946|NCT00700427|585888452|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
162228947|NCT00700427|585888453|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
162228948|NCT00700427|585888454|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
162228949|NCT00700427|585888455|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
162228950|NCT00700427|585888451|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
162228951|NCT00700427|585888452|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
162228952|NCT00700427|585888453|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
162228953|NCT00700427|585888454|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
162228954|NCT00700427|585888455|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
162228955|NCT00700427|585888451|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
162228956|NCT00700427|585888452|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
162228957|NCT00700427|585888453|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
162228958|NCT00700427|585888454|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
162228959|NCT00700427|585888455|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
162228960|NCT00700427|585888451|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
162228961|NCT00700427|585888452|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
162228962|NCT00700427|585888453|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
162228963|NCT00700427|585888454|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
162228964|NCT00700427|585888455|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
162228965|NCT00700427|585888451|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
162228966|NCT00700427|585888452|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
162228967|NCT00700427|585888453|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
162228968|NCT00700427|585888454|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
162228969|NCT00700427|585888455|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
162228970|NCT00700427|585888451|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
162228971|NCT00700427|585888452|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
162228972|NCT00700427|585888453|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
162228973|NCT00700427|585888454|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
162228974|NCT00700427|585888455|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
162228975|NCT00700427|585888451|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
162228976|NCT00700427|585888452|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
162228977|NCT00700427|585888453|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
162228978|NCT00700427|585888454|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
162228979|NCT00700427|585888455|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
162228980|NCT00700427|585888451|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
162023696|NCT00830869|585144481|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
162228981|NCT00700427|585888452|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
162228982|NCT00700427|585888453|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
162228983|NCT00700427|585888454|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
162228984|NCT00700427|585888455|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
162228985|NCT00700427|585888451|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
162228986|NCT00700427|585888452|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
162228987|NCT00700427|585888453|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
162228988|NCT00700427|585888454|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
162228989|NCT00700427|585888455|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
162228990|NCT00700427|585888451|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
162228991|NCT00700427|585888452|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
162228992|NCT00700427|585888453|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
162228993|NCT00700427|585888454|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
162228994|NCT00700427|585888455|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
162228995|NCT00700427|585888451|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
162228996|NCT00700427|585888452|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
162228997|NCT00700427|585888453|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
162228998|NCT00700427|585888454|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
162228999|NCT00700427|585888455|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
162229000|NCT00700427|585888451|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
162229001|NCT00700427|585888452|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
162229002|NCT00700427|585888453|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
162229003|NCT00700427|585888454|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
162229004|NCT00700427|585888455|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
162229005|NCT00700427|585888451|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
162229006|NCT00700427|585888452|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
162229007|NCT00700427|585888453|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
162229008|NCT00700427|585888454|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
162229009|NCT00700427|585888455|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
162229010|NCT00700427|585888451|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
162229011|NCT00700427|585888452|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
162229012|NCT00700427|585888453|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
162229013|NCT00700427|585888454|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
162229014|NCT00700427|585888455|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
162229015|NCT00700427|585888451|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
162229016|NCT00700427|585888452|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
162229017|NCT00700427|585888453|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
162229018|NCT00700427|585888454|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
162229019|NCT00700427|585888455|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
162229020|NCT00700427|585888451|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
162229021|NCT00700427|585888452|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
162229022|NCT00700427|585888453|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
162229023|NCT00700427|585888454|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
162229024|NCT00700427|585888455|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
162229025|NCT00700427|585888451|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
162229026|NCT00700427|585888452|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
162229027|NCT00700427|585888453|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
162229028|NCT00700427|585888454|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
162229029|NCT00700427|585888455|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
162229030|NCT00700427|585888451|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
162229031|NCT00700427|585888452|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
162229032|NCT00700427|585888453|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
162229033|NCT00700427|585888454|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
162229034|NCT00700427|585888455|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
162229035|NCT00700427|585888451|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
162229036|NCT00700427|585888452|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
162229037|NCT00700427|585888453|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
162229038|NCT00700427|585888454|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
162229039|NCT00700427|585888455|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
162229040|NCT00700427|585888451|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
162229041|NCT00700427|585888452|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
162229042|NCT00700427|585888453|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
162229043|NCT00700427|585888454|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
162229044|NCT00700427|585888455|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
162229045|NCT00700427|585888451|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
162229046|NCT00700427|585888452|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
162229047|NCT00700427|585888453|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
162229048|NCT00700427|585888454|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
162229049|NCT00700427|585888455|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
162229050|NCT00700427|585888451|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
162229051|NCT00700427|585888452|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
162229052|NCT00700427|585888453|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
162229053|NCT00700427|585888454|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
162229054|NCT00700427|585888455|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
162229055|NCT00700427|585888451|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
162229056|NCT00700427|585888452|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
162229057|NCT00700427|585888453|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
162229058|NCT00700427|585888454|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
162229059|NCT00700427|585888455|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
162229060|NCT00700427|585888451|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
162229061|NCT00700427|585888452|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
162229062|NCT00700427|585888453|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
162229063|NCT00700427|585888454|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
162229064|NCT00700427|585888455|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
162229065|NCT00700427|585888451|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
162229066|NCT00700427|585888452|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
162229067|NCT00700427|585888453|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
162229068|NCT00700427|585888454|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
162229069|NCT00700427|585888455|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
162229070|NCT00700427|585888451|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
162229071|NCT00700427|585888452|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
162229072|NCT00700427|585888453|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
162229073|NCT00700427|585888454|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
162229074|NCT00700427|585888455|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
162229075|NCT00700427|585888451|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
162229076|NCT00700427|585888452|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
162229077|NCT00700427|585888453|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
162229078|NCT00700427|585888454|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
162229079|NCT00700427|585888455|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
162229080|NCT00700427|585888451|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
162229081|NCT00700427|585888452|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
162229082|NCT00700427|585888453|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
162229083|NCT00700427|585888454|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
162229084|NCT00700427|585888455|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
162229085|NCT00700427|585888451|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
162229086|NCT00700427|585888452|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
162229087|NCT00700427|585888453|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
162229088|NCT00700427|585888454|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
162229089|NCT00700427|585888455|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
162229090|NCT00700427|585888451|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
162229091|NCT00700427|585888452|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
162229092|NCT00700427|585888453|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
162229093|NCT00700427|585888454|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
162229094|NCT00700427|585888455|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
162229095|NCT00700427|585888451|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
162229096|NCT00700427|585888452|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
162229097|NCT00700427|585888453|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
162229098|NCT00700427|585888454|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
162229099|NCT00700427|585888455|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
161679334|NCT03496012|583879069|FG001|Overall Study|Reason Not Specified|0|||
161679335|NCT03496012|583879070|FG002|Overall Study|Reason Not Specified|1|||
161679336|NCT02322125|583879071|FG000|Overall Study|Withdrawal by Subject|2|||
161679337|NCT04096274|583879074|FG000|Phase I|Lost to Follow-up|5|||
161679338|NCT04096274|583879075|FG001|Phase I|Lost to Follow-up|5|||
161679339|NCT04096274|583879074|FG000|Phase II|Lost to Follow-up|11|||
161679340|NCT04096274|583879075|FG001|Phase II|Lost to Follow-up|11|||
161679341|NCT05092919|583879076|FG000|Overall Study|Lost to Follow-up|7|||
161679342|NCT05092919|583879076|FG000|Overall Study|Withdrawal by Subject|2|||
161679343|NCT02248259|583879078|FG000|Treatment Period 1|Adverse Event|0|||
161679344|NCT02248259|583879079|FG001|Treatment Period 1|Adverse Event|0|||
161679345|NCT02248259|583879080|FG002|Treatment Period 1|Adverse Event|1|||
161679346|NCT02248259|583879081|FG003|Treatment Period 1|Adverse Event|0|||
161679347|NCT01543152|583879082|FG000|Overall Study|Withdrawal by Subject|0|||
161679348|NCT01543152|583879083|FG001|Overall Study|Withdrawal by Subject|2|||
161679349|NCT01543152|583879084|FG002|Overall Study|Withdrawal by Subject|0|||
161679350|NCT01543152|583879085|FG003|Overall Study|Withdrawal by Subject|0|||
161679351|NCT01543152|583879086|FG004|Overall Study|Withdrawal by Subject|0|||
161679352|NCT00096785|583879087|FG000|Overall Study|Lost to Follow-up|1|||
161679353|NCT00096785|583879088|FG001|Overall Study|Lost to Follow-up|0|||
161679354|NCT00096785|583879087|FG000|Overall Study|Withdrawal by Subject|0|||
161679355|NCT00096785|583879088|FG001|Overall Study|Withdrawal by Subject|1|||
161679356|NCT00096785|583879087|FG000|Overall Study|Relocated|1|||
161679357|NCT00096785|583879088|FG001|Overall Study|Relocated|0|||
161679358|NCT00762892|583879090|FG000|Overall Study|Lost to Follow-up|2|||
161679359|NCT00762892|583879091|FG001|Overall Study|Lost to Follow-up|5|||
161829522|NCT03170869|584415816|FG000|Overall Study|Early study termination|3|||
161829523|NCT00373425|584415820|FG000|Overall Study|Relapse of NSCLC|116|||
161829524|NCT00373425|584415821|FG001|Overall Study|Relapse of NSCLC|104|||
161829525|NCT00373425|584415822|FG002|Overall Study|Relapse of NSCLC|19|||
161829526|NCT00373425|584415823|FG003|Overall Study|Relapse of NSCLC|2|||
161829527|NCT00373425|584415824|FG004|Overall Study|Relapse of NSCLC|26|||
161829528|NCT00373425|584415820|FG000|Overall Study|Adverse Event|191|||
161829529|NCT00373425|584415821|FG001|Overall Study|Adverse Event|22|||
161829530|NCT00373425|584415822|FG002|Overall Study|Adverse Event|59|||
161829531|NCT00373425|584415823|FG003|Overall Study|Adverse Event|0|||
161829532|NCT00373425|584415824|FG004|Overall Study|Adverse Event|34|||
161829533|NCT00373425|584415820|FG000|Overall Study|Patient request|35|||
161829534|NCT00373425|584415821|FG001|Overall Study|Patient request|18|||
161829535|NCT00373425|584415822|FG002|Overall Study|Patient request|43|||
161829536|NCT00373425|584415823|FG003|Overall Study|Patient request|6|||
161829537|NCT00373425|584415824|FG004|Overall Study|Patient request|7|||
161829538|NCT00373425|584415820|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
161829539|NCT00373425|584415821|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
161829540|NCT00373425|584415822|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
161829541|NCT00373425|584415823|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
161829542|NCT00373425|584415824|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
161829543|NCT00373425|584415820|FG000|Overall Study|Death|7|||
161829544|NCT00373425|584415821|FG001|Overall Study|Death|0|||
161829545|NCT00373425|584415822|FG002|Overall Study|Death|3|||
161829546|NCT00373425|584415823|FG003|Overall Study|Death|1|||
161829547|NCT00373425|584415824|FG004|Overall Study|Death|0|||
161829548|NCT00551616|584415827|FG000|Overall Study|Lost to Follow-up|48|||
161829549|NCT00551616|584415828|FG001|Overall Study|Lost to Follow-up|40|||
161829550|NCT02808819|584415829|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
161829551|NCT02808819|584415830|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
161829552|NCT02808819|584415829|FG000|Overall Study|Withdrawal by Subject|10|||
161829553|NCT02808819|584415830|FG001|Overall Study|Withdrawal by Subject|13|||
161679360|NCT00762892|583879090|FG000|Overall Study|Withdrawal by Subject|0|||
161679361|NCT00762892|583879091|FG001|Overall Study|Withdrawal by Subject|1|||
161679362|NCT00762892|583879090|FG000|Overall Study|Death|1|||
161829554|NCT02808819|584415829|FG000|Overall Study|Site terminated by sponsor|2|||
161829555|NCT02808819|584415830|FG001|Overall Study|Site terminated by sponsor|0|||
161829556|NCT02808819|584415829|FG000|Overall Study|Pregnancy|1|||
161829557|NCT02808819|584415830|FG001|Overall Study|Pregnancy|0|||
161829558|NCT02808819|584415829|FG000|Overall Study|Lost to Follow-up|1|||
161829559|NCT02808819|584415830|FG001|Overall Study|Lost to Follow-up|6|||
161829560|NCT02808819|584415829|FG000|Overall Study|Protocol Violation|0|||
161829561|NCT02808819|584415830|FG001|Overall Study|Protocol Violation|1|||
161829562|NCT02808819|584415829|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
161679363|NCT00762892|583879091|FG001|Overall Study|Death|0|||
161679364|NCT00762892|583879090|FG000|Overall Study|Pregnancy|1|||
161679365|NCT00762892|583879091|FG001|Overall Study|Pregnancy|0|||
161679366|NCT00762892|583879090|FG000|Overall Study|Incarceration|1|||
161679367|NCT00762892|583879091|FG001|Overall Study|Incarceration|0|||
161679368|NCT02234479|583879092|FG000|Overall Study|Withdrawal by Subject|1|||
161679369|NCT02234479|583879093|FG001|Overall Study|Withdrawal by Subject|3|||
161679370|NCT00914927|583879094|FG000|Overall Study|Adverse Event|0|||
161829563|NCT02808819|584415830|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
161829564|NCT02808819|584415829|FG000|Overall Study|Death|1|||
162229100|NCT00700427|585888451|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
162229101|NCT00700427|585888452|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
162229102|NCT00700427|585888453|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
162229103|NCT00700427|585888454|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
162229104|NCT00700427|585888455|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
162229105|NCT00700427|585888451|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
162229106|NCT00700427|585888452|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
162229107|NCT00700427|585888453|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
162229108|NCT00700427|585888454|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
162229109|NCT00700427|585888455|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
162229110|NCT00700427|585888451|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
162229111|NCT00700427|585888452|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
162229112|NCT00700427|585888453|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
162229113|NCT00700427|585888454|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
162229114|NCT00700427|585888455|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
162229115|NCT00700427|585888451|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
162229116|NCT00700427|585888452|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
162229117|NCT00700427|585888453|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
162229118|NCT00700427|585888454|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
162229119|NCT00700427|585888455|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
162229120|NCT00424385|585888458|FG000|Cohort 0|Withdrawal by Subject|5|||
162229121|NCT00424385|585888458|FG000|Cohort 0|Physician Decision|1|||
161679371|NCT00914927|583879095|FG001|Overall Study|Adverse Event|0|||
162229122|NCT00424385|585888458|FG000|Cohort 1|Withdrawal by Subject|1|||
162229123|NCT02057523|585888461|FG000|Overall Study|Withdrawal by Subject|1|||
162229124|NCT02057523|585888461|FG000|Overall Study|Lack of Efficacy|1|||
162229125|NCT02071290|585888462|FG000|Overall Study|Death|1|||
162229126|NCT02071290|585888463|FG001|Overall Study|Death|0|||
162229127|NCT02071290|585888462|FG000|Overall Study|Withdrawal by Subject|0|||
162229128|NCT02071290|585888463|FG001|Overall Study|Withdrawal by Subject|1|||
162229129|NCT02071290|585888462|FG000|Overall Study|Protocol Violation|3|||
162229130|NCT02071290|585888463|FG001|Overall Study|Protocol Violation|5|||
162229131|NCT02071290|585888462|FG000|Overall Study|Physician Decision|0|||
162229132|NCT02071290|585888463|FG001|Overall Study|Physician Decision|1|||
162229133|NCT00964886|585888468|FG000|Overall Study|Lost to Follow-up|2|||
162229134|NCT00964886|585888469|FG001|Overall Study|Lost to Follow-up|2|||
161679372|NCT00914927|583879096|FG002|Overall Study|Adverse Event|0|||
161679373|NCT00914927|583879097|FG003|Overall Study|Adverse Event|0|||
161679374|NCT00914927|583879098|FG004|Overall Study|Adverse Event|1|||
161679375|NCT00914927|583879099|FG005|Overall Study|Adverse Event|0|||
161679376|NCT00914927|583879100|FG006|Overall Study|Adverse Event|0|||
161679377|NCT00914927|583879094|FG000|Overall Study|Withdrawal by Subject|0|||
161679378|NCT00914927|583879095|FG001|Overall Study|Withdrawal by Subject|1|||
161679379|NCT00914927|583879096|FG002|Overall Study|Withdrawal by Subject|0|||
161679380|NCT00914927|583879097|FG003|Overall Study|Withdrawal by Subject|1|||
161679381|NCT00914927|583879098|FG004|Overall Study|Withdrawal by Subject|0|||
161679382|NCT00914927|583879099|FG005|Overall Study|Withdrawal by Subject|0|||
161679383|NCT00914927|583879100|FG006|Overall Study|Withdrawal by Subject|0|||
161679384|NCT00914927|583879094|FG000|Overall Study|Lost to Follow-up|0|||
161679385|NCT00914927|583879095|FG001|Overall Study|Lost to Follow-up|0|||
161679386|NCT00914927|583879096|FG002|Overall Study|Lost to Follow-up|0|||
161679387|NCT00914927|583879097|FG003|Overall Study|Lost to Follow-up|1|||
161679388|NCT00914927|583879098|FG004|Overall Study|Lost to Follow-up|0|||
161679389|NCT00914927|583879099|FG005|Overall Study|Lost to Follow-up|0|||
161679390|NCT00914927|583879100|FG006|Overall Study|Lost to Follow-up|0|||
161679391|NCT00914927|583879094|FG000|Overall Study|Administrative/Other|2|||
161679392|NCT00914927|583879095|FG001|Overall Study|Administrative/Other|1|||
161679393|NCT00914927|583879096|FG002|Overall Study|Administrative/Other|0|||
161679394|NCT00914927|583879097|FG003|Overall Study|Administrative/Other|0|||
161679395|NCT00914927|583879098|FG004|Overall Study|Administrative/Other|1|||
161679396|NCT00914927|583879099|FG005|Overall Study|Administrative/Other|0|||
161679397|NCT00914927|583879100|FG006|Overall Study|Administrative/Other|0|||
161679398|NCT01490814|583879101|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
161679399|NCT01490814|583879102|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
161679400|NCT01490814|583879101|FG000|Overall Study|Physician Decision|1|||
161679401|NCT01490814|583879102|FG001|Overall Study|Physician Decision|0|||
161679402|NCT01490814|583879101|FG000|Overall Study|Withdrawal by Subject|0|||
161679403|NCT01490814|583879102|FG001|Overall Study|Withdrawal by Subject|5|||
161679404|NCT01537198|583879103|FG000|Overall Study|RSV infection|2|||
161679405|NCT01537198|583879103|FG000|Overall Study|Adverse Event|4|||
161679406|NCT01537198|583879103|FG000|Overall Study|No Further Visits to the Clinic|37|||
161679407|NCT01537198|583879103|FG000|Overall Study|Other|111|||
161679408|NCT00496730|583879105|FG000|Overall Study|Lost to Follow-up|4|||
161679409|NCT00496730|583879106|FG001|Overall Study|Lost to Follow-up|3|||
161679410|NCT00496730|583879105|FG000|Overall Study|Withdrawal by Subject|2|||
161679411|NCT00496730|583879106|FG001|Overall Study|Withdrawal by Subject|2|||
161679412|NCT03962738|583879113|FG000|Overall Study|Protocol Deviation|3|||
162229135|NCT00964886|585888470|FG002|Overall Study|Lost to Follow-up|6|||
162229136|NCT00964886|585888471|FG003|Overall Study|Lost to Follow-up|4|||
161679413|NCT03962738|583879114|FG001|Overall Study|Protocol Deviation|0|||
161679414|NCT03962738|583879115|FG002|Overall Study|Protocol Deviation|1|||
161679415|NCT03962738|583879116|FG003|Overall Study|Protocol Deviation|1|||
161679416|NCT03962738|583879113|FG000|Overall Study|Withdrawal by Subject|4|||
162023697|NCT00830869|585144482|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
162229137|NCT00964886|585888468|FG000|Overall Study|Withdrawal by Subject|6|||
162229138|NCT00964886|585888469|FG001|Overall Study|Withdrawal by Subject|2|||
162229139|NCT00964886|585888470|FG002|Overall Study|Withdrawal by Subject|5|||
161679417|NCT03962738|583879114|FG001|Overall Study|Withdrawal by Subject|0|||
161679418|NCT03962738|583879115|FG002|Overall Study|Withdrawal by Subject|0|||
161679419|NCT03962738|583879116|FG003|Overall Study|Withdrawal by Subject|0|||
161679420|NCT03962738|583879113|FG000|Overall Study|Lost to Follow-up|0|||
162023698|NCT00830869|585144483|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
162229140|NCT00964886|585888471|FG003|Overall Study|Withdrawal by Subject|3|||
161679421|NCT03962738|583879114|FG001|Overall Study|Lost to Follow-up|0|||
161679422|NCT03962738|583879115|FG002|Overall Study|Lost to Follow-up|1|||
161679423|NCT03962738|583879116|FG003|Overall Study|Lost to Follow-up|0|||
161679424|NCT02170779|583879117|FG000|Overall Study|Withdrawal by Subject|1|||
162229141|NCT00964886|585888468|FG000|Overall Study|Adverse Event|3|||
162229142|NCT00964886|585888469|FG001|Overall Study|Adverse Event|1|||
161679425|NCT02170779|583879118|FG001|Overall Study|Withdrawal by Subject|0|||
161679426|NCT02170779|583879117|FG000|Overall Study|Lost to Follow-up|0|||
161679427|NCT02170779|583879118|FG001|Overall Study|Lost to Follow-up|1|||
161679428|NCT04556136|583879121|FG000|Overall Study|Lost to Follow-up|6|||
161679429|NCT04556136|583879122|FG001|Overall Study|Lost to Follow-up|6|||
161679430|NCT04556136|583879121|FG000|Overall Study|Physician Decision|2|||
161679431|NCT04556136|583879122|FG001|Overall Study|Physician Decision|1|||
161679432|NCT04556136|583879121|FG000|Overall Study|Withdrawal by Subject|2|||
161679433|NCT04556136|583879122|FG001|Overall Study|Withdrawal by Subject|1|||
161679434|NCT00935272|583879125|FG000|Overall Study|Lost to Follow-up|10|||
161679435|NCT00935272|583879126|FG001|Overall Study|Lost to Follow-up|3|||
161679436|NCT00935272|583879125|FG000|Overall Study|Withdrawal by Subject|8|||
161679437|NCT00935272|583879126|FG001|Overall Study|Withdrawal by Subject|2|||
161679438|NCT00935272|583879125|FG000|Overall Study|Physician Decision|1|||
161679439|NCT00935272|583879126|FG001|Overall Study|Physician Decision|0|||
161829565|NCT02808819|584415830|FG001|Overall Study|Death|0|||
162023699|NCT00830869|585144484|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
162229143|NCT00964886|585888470|FG002|Overall Study|Adverse Event|5|||
162229144|NCT00964886|585888471|FG003|Overall Study|Adverse Event|2|||
162229145|NCT00964886|585888468|FG000|Overall Study|Protocol Violation|0|||
162229146|NCT00964886|585888469|FG001|Overall Study|Protocol Violation|2|||
162229147|NCT00964886|585888470|FG002|Overall Study|Protocol Violation|0|||
162229148|NCT00964886|585888471|FG003|Overall Study|Protocol Violation|0|||
162229149|NCT01941719|585888473|FG000|Overall Study|Lost to Follow-up|20|||
162229150|NCT01941719|585888474|FG001|Overall Study|Lost to Follow-up|19|||
162229151|NCT03819634|585888476|FG000|Overall Study|Physician Decision|2|||
162229152|NCT01125514|585888478|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
162229153|NCT01125514|585888478|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
162229154|NCT01125514|585888478|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
162229155|NCT01125514|585888478|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
162229156|NCT01125514|585888478|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
162229157|NCT01125514|585888478|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
162229158|NCT00858364|585888479|FG000|Overall Study|Administrative Decision|3|||
162229159|NCT00858364|585888480|FG001|Overall Study|Administrative Decision|2|||
162229160|NCT00858364|585888479|FG000|Overall Study|Adverse Event|5|||
162229161|NCT00858364|585888480|FG001|Overall Study|Adverse Event|2|||
162229162|NCT00858364|585888479|FG000|Overall Study|Withdrawal by Subject|44|||
162229163|NCT00858364|585888480|FG001|Overall Study|Withdrawal by Subject|118|||
162229164|NCT00858364|585888479|FG000|Overall Study|Ineligibility Determined|1|||
162229165|NCT00858364|585888480|FG001|Overall Study|Ineligibility Determined|10|||
162229166|NCT00858364|585888479|FG000|Overall Study|Lost to Follow-up|24|||
162229167|NCT00858364|585888480|FG001|Overall Study|Lost to Follow-up|54|||
162229168|NCT00858364|585888479|FG000|Overall Study|Noncompliance|3|||
162229169|NCT00858364|585888480|FG001|Overall Study|Noncompliance|4|||
162229170|NCT00858364|585888479|FG000|Overall Study|Protocol Deviation|0|||
162229171|NCT00858364|585888480|FG001|Overall Study|Protocol Deviation|2|||
162229172|NCT00858364|585888479|FG000|Overall Study|Other|9|||
162229173|NCT00858364|585888480|FG001|Overall Study|Other|17|||
162229174|NCT00858364|585888479|FG000|Overall Study|Missing|1|||
162229175|NCT00858364|585888480|FG001|Overall Study|Missing|1|||
162229176|NCT00858364|585888479|FG000|Overall Study|Still on-study|114|||
162229177|NCT00858364|585888480|FG001|Overall Study|Still on-study|247|||
162229178|NCT01655693|585888484|FG000|Overall Study|Progression of Disease|92|||
162229179|NCT01655693|585888485|FG001|Overall Study|Progression of Disease|76|||
162229180|NCT01655693|585888486|FG002|Overall Study|Progression of Disease|58|||
162229181|NCT01655693|585888484|FG000|Overall Study|Death|8|||
162229182|NCT01655693|585888485|FG001|Overall Study|Death|9|||
162229183|NCT01655693|585888486|FG002|Overall Study|Death|12|||
162229184|NCT01655693|585888484|FG000|Overall Study|Serious Adverse Event|3|||
162229185|NCT01655693|585888485|FG001|Overall Study|Serious Adverse Event|15|||
162229186|NCT01655693|585888486|FG002|Overall Study|Serious Adverse Event|11|||
162229187|NCT01655693|585888484|FG000|Overall Study|Withdrawal by Subject|3|||
162229188|NCT01655693|585888485|FG001|Overall Study|Withdrawal by Subject|2|||
162229189|NCT01655693|585888486|FG002|Overall Study|Withdrawal by Subject|20|||
162229190|NCT01655693|585888484|FG000|Overall Study|Adverse Event|3|||
162229191|NCT01655693|585888485|FG001|Overall Study|Adverse Event|11|||
162229192|NCT01655693|585888486|FG002|Overall Study|Adverse Event|3|||
162229193|NCT01655693|585888484|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
161679440|NCT00935272|583879125|FG000|Overall Study|Protocol Violation|0|||
161829566|NCT02808819|584415829|FG000|Overall Study|Adverse Event|3|||
161829567|NCT02808819|584415830|FG001|Overall Study|Adverse Event|4|||
161829568|NCT03297294|584415831|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
161829569|NCT03297294|584415832|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
161829570|NCT03297294|584415833|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161829571|NCT03297294|584415834|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161679441|NCT00935272|583879126|FG001|Overall Study|Protocol Violation|1|||
161679442|NCT03492554|583879127|FG000|Overall Study|Protocol Violation|0|||
161679443|NCT03492554|583879128|FG001|Overall Study|Protocol Violation|14|||
161679444|NCT01478360|583879129|FG000|Overall Study|Lost to Follow-up|1|||
161679445|NCT01478360|583879130|FG001|Overall Study|Lost to Follow-up|0|||
161679446|NCT01478360|583879129|FG000|Overall Study|Adverse Event|0|||
161679447|NCT01478360|583879130|FG001|Overall Study|Adverse Event|1|||
161679448|NCT01478360|583879129|FG000|Overall Study|Administrative problems|1|||
161679449|NCT01478360|583879130|FG001|Overall Study|Administrative problems|2|||
161679450|NCT04340557|583879134|FG000|Overall Study|Transferred to ICU and/or death|1|||
161679451|NCT04340557|583879135|FG001|Overall Study|Transferred to ICU and/or death|2|||
161679452|NCT01221727|583879136|FG000|Overall Study|Physician Decision|2|||
161679453|NCT01221727|583879137|FG001|Overall Study|Physician Decision|0|||
161679454|NCT01221727|583879136|FG000|Overall Study|Withdrawal by Subject|1|||
161679455|NCT01221727|583879137|FG001|Overall Study|Withdrawal by Subject|1|||
161679456|NCT02566577|583879138|FG000|Overall Study|Withdrawal by Subject|1|||
161679457|NCT02566577|583879139|FG001|Overall Study|Withdrawal by Subject|1|||
161679458|NCT02566577|583879138|FG000|Overall Study|Equipment failure|1|||
161679459|NCT02566577|583879139|FG001|Overall Study|Equipment failure|1|||
161679460|NCT02566577|583879138|FG000|Overall Study|Physical limitation|1|||
161679461|NCT02566577|583879139|FG001|Overall Study|Physical limitation|0|||
161679462|NCT00529451|583879140|FG000|Overall Study|Subject withdrew consent|16|||
161679463|NCT00529451|583879141|FG001|Overall Study|Subject withdrew consent|21|||
161679464|NCT00529451|583879142|FG002|Overall Study|Subject withdrew consent|13|||
161679465|NCT00529451|583879143|FG003|Overall Study|Subject withdrew consent|12|||
161679466|NCT00529451|583879140|FG000|Overall Study|Adverse Event|9|||
161679467|NCT00529451|583879141|FG001|Overall Study|Adverse Event|16|||
161679468|NCT00529451|583879142|FG002|Overall Study|Adverse Event|14|||
161679469|NCT00529451|583879143|FG003|Overall Study|Adverse Event|8|||
161679470|NCT00529451|583879140|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
161679471|NCT00529451|583879141|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
161679472|NCT00529451|583879142|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
161679473|NCT00529451|583879143|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
161679474|NCT00529451|583879140|FG000|Overall Study|Lost to Follow-up|4|||
161679475|NCT00529451|583879141|FG001|Overall Study|Lost to Follow-up|7|||
161679476|NCT00529451|583879142|FG002|Overall Study|Lost to Follow-up|4|||
161679477|NCT00529451|583879143|FG003|Overall Study|Lost to Follow-up|4|||
161679478|NCT00529451|583879140|FG000|Overall Study|Protocol deviation|1|||
161679479|NCT00529451|583879141|FG001|Overall Study|Protocol deviation|1|||
161679480|NCT00529451|583879142|FG002|Overall Study|Protocol deviation|4|||
161679481|NCT00529451|583879143|FG003|Overall Study|Protocol deviation|1|||
161679482|NCT00529451|583879140|FG000|Overall Study|Administrative problems|1|||
161679483|NCT00529451|583879141|FG001|Overall Study|Administrative problems|1|||
161679484|NCT00529451|583879142|FG002|Overall Study|Administrative problems|0|||
161679485|NCT00529451|583879143|FG003|Overall Study|Administrative problems|2|||
161679486|NCT01010633|583879144|FG000|Overall Study|Adverse Event|1|||
161679487|NCT01010633|583879145|FG001|Overall Study|Adverse Event|1|||
161679488|NCT01010633|583879144|FG000|Overall Study|Protocol Violation|1|||
161679489|NCT01010633|583879145|FG001|Overall Study|Protocol Violation|2|||
161679490|NCT01010633|583879144|FG000|Overall Study|Withdrawal by Subject|2|||
161679491|NCT01010633|583879145|FG001|Overall Study|Withdrawal by Subject|1|||
161679492|NCT01010633|583879144|FG000|Overall Study|Investigator decision|0|||
161679493|NCT01010633|583879145|FG001|Overall Study|Investigator decision|1|||
161679494|NCT02941926|583879146|FG000|Core Phase|Progressive disease|1109|||
161679495|NCT02941926|583879146|FG000|Core Phase|Adverse Event|504|||
161679496|NCT02941926|583879146|FG000|Core Phase|Subject/guardian decision|127|||
162229194|NCT01655693|585888485|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
162229195|NCT01655693|585888486|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
162229196|NCT01655693|585888484|FG000|Overall Study|Non-Compliance|0|||
162229197|NCT01655693|585888485|FG001|Overall Study|Non-Compliance|0|||
161679497|NCT02941926|583879146|FG000|Core Phase|Physician Decision|112|||
161679498|NCT02941926|583879146|FG000|Core Phase|Death|46|||
161679499|NCT02941926|583879146|FG000|Core Phase|Protocol deviation|34|||
161679500|NCT02941926|583879146|FG000|Core Phase|Lost to Follow-up|8|||
161679501|NCT02941926|583879146|FG000|Core Phase|Technical problems|5|||
161679502|NCT02941926|583879146|FG000|Extension Phase|Physician Decision|155|||
161679503|NCT02941926|583879146|FG000|Extension Phase|Progressive disease|115|||
161679504|NCT02941926|583879146|FG000|Extension Phase|Adverse Event|13|||
161679505|NCT02941926|583879146|FG000|Extension Phase|Subject/Guardian decision|12|||
161679506|NCT02941926|583879146|FG000|Extension Phase|Death|6|||
161679507|NCT00097773|583879147|FG000|Overall Study|Lost to Follow-up|2|||
161679508|NCT00097773|583879148|FG001|Overall Study|Lost to Follow-up|2|||
161679509|NCT00097773|583879149|FG002|Overall Study|Lost to Follow-up|0|||
161679510|NCT00097773|583879150|FG003|Overall Study|Lost to Follow-up|1|||
161679511|NCT00097773|583879147|FG000|Overall Study|Physician Decision|2|||
161679512|NCT00097773|583879148|FG001|Overall Study|Physician Decision|2|||
161679513|NCT00097773|583879149|FG002|Overall Study|Physician Decision|3|||
162229198|NCT01655693|585888486|FG002|Overall Study|Non-Compliance|7|||
161940131|NCT02613507|584830766|FG000|Treatment|Participant request to discontinue study treatment|13|||
161940132|NCT02613507|584830767|FG001|Treatment|Participant request to discontinue study treatment|17|||
161940133|NCT02613507|584830766|FG000|Treatment|Adverse event unrelated to study drug|20|||
161940134|NCT02613507|584830767|FG001|Treatment|Adverse event unrelated to study drug|3|||
161940135|NCT02613507|584830766|FG000|Treatment|Death|2|||
161940136|NCT02613507|584830767|FG001|Treatment|Death|0|||
161940137|NCT02613507|584830766|FG000|Treatment|Study drug toxicity|19|||
162229199|NCT01655693|585888484|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
162229200|NCT01655693|585888485|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
162229201|NCT01655693|585888486|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
162229202|NCT01655693|585888484|FG000|Overall Study|Protocol Violation|1|||
162229203|NCT01655693|585888485|FG001|Overall Study|Protocol Violation|0|||
162229204|NCT01655693|585888486|FG002|Overall Study|Protocol Violation|3|||
162229205|NCT01655693|585888484|FG000|Overall Study|Lost to Follow-up|1|||
162229206|NCT01655693|585888485|FG001|Overall Study|Lost to Follow-up|0|||
162229207|NCT01655693|585888486|FG002|Overall Study|Lost to Follow-up|1|||
162229208|NCT01655693|585888484|FG000|Overall Study|Screening Failure|1|||
162229209|NCT01655693|585888485|FG001|Overall Study|Screening Failure|0|||
162229210|NCT01655693|585888486|FG002|Overall Study|Screening Failure|0|||
162229211|NCT01655693|585888484|FG000|Overall Study|Other|8|||
162229212|NCT01655693|585888485|FG001|Overall Study|Other|6|||
162229213|NCT01655693|585888486|FG002|Overall Study|Other|15|||
162229214|NCT00929110|585888489|FG000|Overall Study|Adverse Event|40|||
162229215|NCT00929110|585888490|FG001|Overall Study|Adverse Event|29|||
162229216|NCT00929110|585888491|FG002|Overall Study|Adverse Event|18|||
162229217|NCT00929110|585888489|FG000|Overall Study|Subject withdrew consent|40|||
162229218|NCT00929110|585888490|FG001|Overall Study|Subject withdrew consent|23|||
162229219|NCT00929110|585888491|FG002|Overall Study|Subject withdrew consent|26|||
162229220|NCT00929110|585888489|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
162229221|NCT00929110|585888490|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
162229222|NCT00929110|585888491|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
162229223|NCT00929110|585888489|FG000|Overall Study|Lost to Follow-up|7|||
162229224|NCT00929110|585888490|FG001|Overall Study|Lost to Follow-up|7|||
162229225|NCT00929110|585888491|FG002|Overall Study|Lost to Follow-up|3|||
162229226|NCT00929110|585888489|FG000|Overall Study|Protocol deviation|5|||
162229227|NCT00929110|585888490|FG001|Overall Study|Protocol deviation|2|||
162229228|NCT00929110|585888491|FG002|Overall Study|Protocol deviation|4|||
162229229|NCT00929110|585888489|FG000|Overall Study|Administrative problems|4|||
162229230|NCT00929110|585888490|FG001|Overall Study|Administrative problems|1|||
162229231|NCT00929110|585888491|FG002|Overall Study|Administrative problems|2|||
162229232|NCT00929110|585888489|FG000|Overall Study|Death|2|||
162229233|NCT00929110|585888490|FG001|Overall Study|Death|2|||
162229234|NCT00929110|585888491|FG002|Overall Study|Death|2|||
162229235|NCT00929110|585888489|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162229236|NCT00929110|585888490|FG001|Overall Study|Abnormal laboratory value(s)|1|||
162229237|NCT00929110|585888491|FG002|Overall Study|Abnormal laboratory value(s)|0|||
162229238|NCT00929110|585888489|FG000|Overall Study|Abnormal test procedure result(s)|0|||
162229239|NCT00929110|585888490|FG001|Overall Study|Abnormal test procedure result(s)|1|||
162229240|NCT00929110|585888491|FG002|Overall Study|Abnormal test procedure result(s)|1|||
162229241|NCT00929110|585888489|FG000|Overall Study|Patient inability to use the device|0|||
162229242|NCT00929110|585888490|FG001|Overall Study|Patient inability to use the device|1|||
162229243|NCT00929110|585888491|FG002|Overall Study|Patient inability to use the device|0|||
162229244|NCT01163292|585888495|FG000|Overall Study|Lack of Efficacy|9|||
162229245|NCT01163292|585888496|FG001|Overall Study|Lack of Efficacy|0|||
162229246|NCT01163292|585888495|FG000|Overall Study|Adverse Event|6|||
162229247|NCT01163292|585888496|FG001|Overall Study|Adverse Event|0|||
162229248|NCT01163292|585888495|FG000|Overall Study|Initiation of biological therapy|0|||
162229249|NCT01163292|585888496|FG001|Overall Study|Initiation of biological therapy|15|||
162229250|NCT01163292|585888495|FG000|Overall Study|Sufficient response to adalimumab|8|||
162229251|NCT01163292|585888496|FG001|Overall Study|Sufficient response to adalimumab|0|||
162229252|NCT01163292|585888495|FG000|Overall Study|Refusal to receive adalimumab|7|||
162229253|NCT01163292|585888496|FG001|Overall Study|Refusal to receive adalimumab|0|||
162229254|NCT01163292|585888495|FG000|Overall Study|Economic reasons|6|||
162229255|NCT01163292|585888496|FG001|Overall Study|Economic reasons|0|||
162229256|NCT01163292|585888495|FG000|Overall Study|No further visits|5|||
162229257|NCT01163292|585888496|FG001|Overall Study|No further visits|7|||
162229258|NCT02643472|585888500|FG000|Overall Study|Death|2|||
162229259|NCT02643472|585888501|FG001|Overall Study|Death|5|||
162229260|NCT02643472|585888500|FG000|Overall Study|Withdrawal by Subject|3|||
162229261|NCT02643472|585888501|FG001|Overall Study|Withdrawal by Subject|2|||
162229262|NCT02643472|585888500|FG000|Overall Study|Protocol Violation|0|||
162229263|NCT02643472|585888501|FG001|Overall Study|Protocol Violation|1|||
162229264|NCT02643472|585888500|FG000|Overall Study|Lost to Follow-up|22|||
162229265|NCT02643472|585888501|FG001|Overall Study|Lost to Follow-up|26|||
162229266|NCT01258595|585888502|FG000|Overall Study|Lost to Follow-up|1|||
161940138|NCT02613507|584830767|FG001|Treatment|Study drug toxicity|14|||
161940139|NCT02613507|584830766|FG000|Treatment|Disease progression|263|||
161829572|NCT03297294|584415835|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
162229267|NCT01258595|585888503|FG001|Overall Study|Lost to Follow-up|0|||
162229268|NCT01258595|585888502|FG000|Overall Study|Withdrawal by Subject|0|||
162229269|NCT01258595|585888503|FG001|Overall Study|Withdrawal by Subject|1|||
162229270|NCT01215188|585888504|FG000|Overall Study|Lost to Follow-up|22|||
162229271|NCT01215188|585888505|FG001|Overall Study|Lost to Follow-up|22|||
162229272|NCT01215188|585888506|FG002|Overall Study|Lost to Follow-up|16|||
162229273|NCT01215188|585888504|FG000|Overall Study|Adverse Event|1|||
162229274|NCT01215188|585888505|FG001|Overall Study|Adverse Event|1|||
162229275|NCT01215188|585888506|FG002|Overall Study|Adverse Event|3|||
162229276|NCT01215188|585888504|FG000|Overall Study|Physician Decision|2|||
162229277|NCT01215188|585888505|FG001|Overall Study|Physician Decision|1|||
162229278|NCT01215188|585888506|FG002|Overall Study|Physician Decision|0|||
162229279|NCT01215188|585888504|FG000|Overall Study|Lack of Efficacy|0|||
162229280|NCT01215188|585888505|FG001|Overall Study|Lack of Efficacy|0|||
162229281|NCT01215188|585888506|FG002|Overall Study|Lack of Efficacy|1|||
162229282|NCT01215188|585888504|FG000|Overall Study|Protocol Violation|1|||
162229283|NCT01215188|585888505|FG001|Overall Study|Protocol Violation|1|||
162229284|NCT01215188|585888506|FG002|Overall Study|Protocol Violation|1|||
162229285|NCT01215188|585888504|FG000|Overall Study|Withdrawal by Subject|32|||
162229286|NCT01215188|585888505|FG001|Overall Study|Withdrawal by Subject|34|||
162229287|NCT01215188|585888506|FG002|Overall Study|Withdrawal by Subject|31|||
162229288|NCT02310100|585888507|FG000|Overall Study|Physician Decision|3|||
162229289|NCT02310100|585888507|FG000|Overall Study|Withdrawal by Subject|10|||
162229290|NCT02310100|585888507|FG000|Overall Study|Enrollment closure|1|||
162229291|NCT02310100|585888507|FG000|Overall Study|Unapproved ablation operator|1|||
162229292|NCT02310100|585888507|FG000|Overall Study|Visit compliance|1|||
162229293|NCT02310100|585888507|FG000|Overall Study|Lost to Follow-up|2|||
162229294|NCT01820585|585888514|FG000|Overall Study|Adverse Event|9|||
162229295|NCT01820585|585888515|FG001|Overall Study|Adverse Event|13|||
162229296|NCT01820585|585888516|FG002|Overall Study|Adverse Event|23|||
162229297|NCT01820585|585888517|FG003|Overall Study|Adverse Event|34|||
162229298|NCT01820585|585888514|FG000|Overall Study|Lack of Efficacy|9|||
162229299|NCT01820585|585888515|FG001|Overall Study|Lack of Efficacy|7|||
162229300|NCT01820585|585888516|FG002|Overall Study|Lack of Efficacy|5|||
162229301|NCT01820585|585888517|FG003|Overall Study|Lack of Efficacy|1|||
162229302|NCT01820585|585888514|FG000|Overall Study|Withdrawal by Subject|3|||
162229303|NCT01820585|585888515|FG001|Overall Study|Withdrawal by Subject|7|||
162229304|NCT01820585|585888516|FG002|Overall Study|Withdrawal by Subject|3|||
162229305|NCT01820585|585888517|FG003|Overall Study|Withdrawal by Subject|8|||
162229306|NCT01820585|585888514|FG000|Overall Study|Lost to Follow-up|3|||
162229307|NCT01820585|585888515|FG001|Overall Study|Lost to Follow-up|3|||
162229308|NCT01820585|585888516|FG002|Overall Study|Lost to Follow-up|0|||
162229309|NCT01820585|585888517|FG003|Overall Study|Lost to Follow-up|3|||
162229310|NCT01820585|585888514|FG000|Overall Study|Protocol Violation|3|||
162229311|NCT01820585|585888515|FG001|Overall Study|Protocol Violation|1|||
162229312|NCT01820585|585888516|FG002|Overall Study|Protocol Violation|1|||
162229313|NCT01820585|585888517|FG003|Overall Study|Protocol Violation|1|||
162229314|NCT01820585|585888514|FG000|Overall Study|Subject non-compliance|0|||
162229315|NCT01820585|585888515|FG001|Overall Study|Subject non-compliance|0|||
162229316|NCT01820585|585888516|FG002|Overall Study|Subject non-compliance|1|||
162229317|NCT01820585|585888517|FG003|Overall Study|Subject non-compliance|2|||
162229318|NCT01820585|585888514|FG000|Overall Study|at sponsor request|0|||
162229319|NCT01820585|585888515|FG001|Overall Study|at sponsor request|0|||
162229320|NCT01820585|585888516|FG002|Overall Study|at sponsor request|1|||
162229321|NCT01820585|585888517|FG003|Overall Study|at sponsor request|0|||
162229322|NCT01820585|585888514|FG000|Overall Study|Pregnancy|0|||
162229323|NCT01820585|585888515|FG001|Overall Study|Pregnancy|1|||
162229324|NCT01820585|585888516|FG002|Overall Study|Pregnancy|0|||
162229325|NCT01820585|585888517|FG003|Overall Study|Pregnancy|0|||
162229326|NCT03592745|585888520|FG000|Overall Study|Adverse Event|0|||
162229327|NCT03592745|585888521|FG001|Overall Study|Adverse Event|2|||
162229328|NCT03592745|585888520|FG000|Overall Study|Lost to Follow-up|2|||
162229329|NCT03592745|585888521|FG001|Overall Study|Lost to Follow-up|0|||
162229330|NCT03592745|585888520|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
162229331|NCT03592745|585888521|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
162229332|NCT00293059|585888522|FG000|Overall Study|Adverse Event|12|||
162229333|NCT00293059|585888523|FG001|Overall Study|Adverse Event|4|||
162229334|NCT00293059|585888522|FG000|Overall Study|Lack of Efficacy|2|||
162229335|NCT00293059|585888523|FG001|Overall Study|Lack of Efficacy|0|||
162229336|NCT00293059|585888522|FG000|Overall Study|Lost to Follow-up|2|||
162229337|NCT00293059|585888523|FG001|Overall Study|Lost to Follow-up|3|||
162229338|NCT00293059|585888522|FG000|Overall Study|Pregnancy|1|||
162229339|NCT00293059|585888523|FG001|Overall Study|Pregnancy|1|||
162229340|NCT00293059|585888522|FG000|Overall Study|Protocol Violation|2|||
161829573|NCT03297294|584415831|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
161829574|NCT03297294|584415832|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
162229341|NCT00293059|585888523|FG001|Overall Study|Protocol Violation|0|||
162229342|NCT00293059|585888522|FG000|Overall Study|Withdrawal by Subject|11|||
162229343|NCT00293059|585888523|FG001|Overall Study|Withdrawal by Subject|5|||
161940140|NCT02613507|584830767|FG001|Treatment|Disease progression|110|||
161940141|NCT03648372|584830776|FG000|Overall Study|Withdrawal by Subject|2|||
161940142|NCT03648372|584830777|FG001|Overall Study|Withdrawal by Subject|0|||
161940143|NCT03648372|584830778|FG002|Overall Study|Withdrawal by Subject|0|||
161940144|NCT03648372|584830779|FG003|Overall Study|Withdrawal by Subject|0|||
161940145|NCT03648372|584830780|FG004|Overall Study|Withdrawal by Subject|0|||
161940146|NCT03648372|584830781|FG005|Overall Study|Withdrawal by Subject|1|||
161940147|NCT03648372|584830782|FG006|Overall Study|Withdrawal by Subject|2|||
161940148|NCT03648372|584830783|FG007|Overall Study|Withdrawal by Subject|0|||
161940149|NCT03648372|584830784|FG008|Overall Study|Withdrawal by Subject|0|||
162229344|NCT00293059|585888522|FG000|Overall Study|Participant moved out of state|1|||
162229345|NCT00293059|585888523|FG001|Overall Study|Participant moved out of state|0|||
162229346|NCT00293059|585888522|FG000|Overall Study|Participant stopped study drug|1|||
162229347|NCT00293059|585888523|FG001|Overall Study|Participant stopped study drug|0|||
162229348|NCT00293059|585888522|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
162229349|NCT00293059|585888523|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
162229350|NCT00293059|585888522|FG000|Overall Study|missing|3|||
162229351|NCT00293059|585888523|FG001|Overall Study|missing|5|||
162229352|NCT04362189|585888527|FG000|Overall Study|Lost to Follow-up|0|||
162229353|NCT04362189|585888528|FG001|Overall Study|Lost to Follow-up|1|||
162229354|NCT04362189|585888527|FG000|Overall Study|Withdrawal by Subject|1|||
162229355|NCT04362189|585888528|FG001|Overall Study|Withdrawal by Subject|0|||
162229356|NCT04362189|585888527|FG000|Overall Study|FDA Clinical Hold|7|||
162229357|NCT04362189|585888528|FG001|Overall Study|FDA Clinical Hold|2|||
162229358|NCT04362189|585888527|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
162229359|NCT04362189|585888528|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
162229360|NCT04362189|585888527|FG000|Overall Study|Adverse Event|0|||
162229361|NCT04362189|585888528|FG001|Overall Study|Adverse Event|2|||
162229362|NCT04362189|585888527|FG000|Overall Study|Death|4|||
162229363|NCT04362189|585888528|FG001|Overall Study|Death|1|||
162229364|NCT02111681|585888529|FG000|Overall Study|Death|5|||
162229365|NCT02111681|585888529|FG000|Overall Study|Lack of Efficacy|2|||
162229366|NCT02111681|585888529|FG000|Overall Study|Progression of disease|4|||
162229367|NCT03981861|585888530|FG000|Overall Study|Withdrawal by Subject|3|||
162229368|NCT01227577|585890448|FG000|Overall Study|Protocol deviation|3|||
162229369|NCT01227577|585890448|FG000|Overall Study|Death|3|||
162229370|NCT01227577|585890448|FG000|Overall Study|Administrative problems|2|||
162229371|NCT01227577|585890448|FG000|Overall Study|Lost to Follow-up|1|||
162229372|NCT01227577|585890448|FG000|Overall Study|Withdrawal by Subject|4|||
162229373|NCT01227577|585890448|FG000|Overall Study|Lack of Efficacy|5|||
162229374|NCT01227577|585890448|FG000|Overall Study|Adverse Event|17|||
162229375|NCT03809429|585890449|FG000|Overall Study|Withdrawal by Subject|7|||
162229376|NCT03809429|585890450|FG001|Overall Study|Withdrawal by Subject|3|||
162229377|NCT03809429|585890449|FG000|Overall Study|Adverse Event|6|||
162229378|NCT03809429|585890450|FG001|Overall Study|Adverse Event|9|||
162229379|NCT03809429|585890449|FG000|Overall Study|COVID-19|3|||
162229380|NCT03809429|585890450|FG001|Overall Study|COVID-19|1|||
162229381|NCT03809429|585890449|FG000|Overall Study|Participant was discontinued by investigator|12|||
162229382|NCT03809429|585890450|FG001|Overall Study|Participant was discontinued by investigator|7|||
162229383|NCT00836745|585890451|FG000|Overall Study|Death|2|||
162229384|NCT00836745|585890451|FG000|Overall Study|Lost to Follow-up|10|||
162229385|NCT00836745|585890451|FG000|Overall Study|Adverse Event|3|||
162229386|NCT00836745|585890451|FG000|Overall Study|Objective progression or relapse|4|||
162229387|NCT00836745|585890451|FG000|Overall Study|Other|2|||
162229388|NCT01239043|585890454|FG000|Overall Study|Protocol Violation|2|||
162229389|NCT01239043|585890455|FG001|Overall Study|Protocol Violation|1|||
162229390|NCT02929329|585890458|FG000|Overall Study|Withdrawal by Subject|24|||
162229391|NCT02929329|585890459|FG001|Overall Study|Withdrawal by Subject|21|||
162229392|NCT02929329|585890458|FG000|Overall Study|Lost to Follow-up|26|||
162229393|NCT02929329|585890459|FG001|Overall Study|Lost to Follow-up|20|||
162229394|NCT02929329|585890458|FG000|Overall Study|Death|1054|||
162229395|NCT02929329|585890459|FG001|Overall Study|Death|1051|||
161940150|NCT03648372|584830785|FG009|Overall Study|Withdrawal by Subject|0|||
162229396|NCT02121301|585890460|FG000|Overall Study|Protocol Violation|1|||
162229397|NCT02121301|585890461|FG001|Overall Study|Protocol Violation|4|||
162229398|NCT02121301|585890462|FG002|Overall Study|Protocol Violation|1|||
162229399|NCT00434213|585890468|FG000|Overall Study|Adverse Event|12|||
162229400|NCT00434213|585890468|FG000|Overall Study|Lack of Efficacy|9|||
162229401|NCT00434213|585890468|FG000|Overall Study|Lost to Follow-up|14|||
162229402|NCT00434213|585890468|FG000|Overall Study|Withdrawal by Subject|7|||
162229403|NCT00434213|585890468|FG000|Overall Study|Protocol Violation|3|||
162229404|NCT00434213|585890468|FG000|Overall Study|Unable to comply with study visit window|2|||
161829575|NCT03297294|584415833|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161829576|NCT03297294|584415834|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161829577|NCT03297294|584415835|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
162229405|NCT00434213|585890468|FG000|Overall Study|Application site reaction|1|||
162229406|NCT00434213|585890468|FG000|Overall Study|Non-compliant to study schedule|1|||
162229407|NCT01871805|585890479|FG000|Phase I|Death|7|||
162229408|NCT01871805|585890480|FG001|Phase I|Death|4|||
162229409|NCT01871805|585890481|FG002|Phase I|Death|6|||
162229410|NCT01871805|585890482|FG003|Phase I|Death|2|||
162229411|NCT01871805|585890483|FG004|Phase I|Death|9|||
162229412|NCT01871805|585890484|FG005|Phase I|Death|0|||
162229413|NCT01871805|585890479|FG000|Phase I|Alive in Survival Follow-up|0|||
162229414|NCT01871805|585890480|FG001|Phase I|Alive in Survival Follow-up|2|||
162229415|NCT01871805|585890481|FG002|Phase I|Alive in Survival Follow-up|4|||
162229416|NCT01871805|585890482|FG003|Phase I|Alive in Survival Follow-up|5|||
162229417|NCT01871805|585890483|FG004|Phase I|Alive in Survival Follow-up|4|||
162229418|NCT01871805|585890484|FG005|Phase I|Alive in Survival Follow-up|0|||
162229419|NCT01871805|585890479|FG000|Phase I|Lost to Follow-up|0|||
162229420|NCT01871805|585890480|FG001|Phase I|Lost to Follow-up|1|||
162229421|NCT01871805|585890481|FG002|Phase I|Lost to Follow-up|3|||
162229422|NCT01871805|585890482|FG003|Phase I|Lost to Follow-up|0|||
162229423|NCT01871805|585890483|FG004|Phase I|Lost to Follow-up|0|||
162229424|NCT01871805|585890484|FG005|Phase I|Lost to Follow-up|0|||
162229425|NCT01871805|585890479|FG000|Phase II|Death|0|||
162229426|NCT01871805|585890480|FG001|Phase II|Death|0|||
162229427|NCT01871805|585890481|FG002|Phase II|Death|0|||
162229428|NCT01871805|585890482|FG003|Phase II|Death|0|||
162229429|NCT01871805|585890483|FG004|Phase II|Death|0|||
162229430|NCT01871805|585890484|FG005|Phase II|Death|45|||
162229431|NCT01871805|585890479|FG000|Phase II|Alive in Survival Follow-up|0|||
162229432|NCT01871805|585890480|FG001|Phase II|Alive in Survival Follow-up|0|||
162229433|NCT01871805|585890481|FG002|Phase II|Alive in Survival Follow-up|0|||
162229434|NCT01871805|585890482|FG003|Phase II|Alive in Survival Follow-up|0|||
162229435|NCT01871805|585890483|FG004|Phase II|Alive in Survival Follow-up|0|||
162229436|NCT01871805|585890484|FG005|Phase II|Alive in Survival Follow-up|29|||
162229437|NCT01871805|585890479|FG000|Phase II|Lost to Follow-up|0|||
162229438|NCT01871805|585890480|FG001|Phase II|Lost to Follow-up|0|||
162229439|NCT01871805|585890481|FG002|Phase II|Lost to Follow-up|0|||
162229440|NCT01871805|585890482|FG003|Phase II|Lost to Follow-up|0|||
162229441|NCT01871805|585890483|FG004|Phase II|Lost to Follow-up|0|||
162229442|NCT01871805|585890484|FG005|Phase II|Lost to Follow-up|13|||
162229443|NCT00941070|585890489|FG000|Overall Study|Patient non-compliant|1|||
162229444|NCT03174431|585890490|FG000|Overall Study|Withdrawal by Subject|14|||
162229445|NCT03174431|585890491|FG001|Overall Study|Withdrawal by Subject|11|||
162229446|NCT03174431|585890490|FG000|Overall Study|alternative treatment|2|||
162229447|NCT03174431|585890491|FG001|Overall Study|alternative treatment|0|||
162229448|NCT03174431|585890490|FG000|Overall Study|Lost to Follow-up|1|||
162229449|NCT03174431|585890491|FG001|Overall Study|Lost to Follow-up|5|||
162229450|NCT03484273|585890496|FG000|Overall Study|Equipment Malfunction|1|||
162229451|NCT03484273|585890496|FG000|Overall Study|Data excluded from analysis|1|||
162229452|NCT00468104|585890502|FG000|First Intervention|Protocol Violation|2|||
162229453|NCT00468104|585890503|FG001|First Intervention|Protocol Violation|1|||
162229454|NCT00468104|585890502|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
162229455|NCT00468104|585890503|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
162229456|NCT00468104|585890502|FG000|First Intervention|died within 3 weeks|1|||
162229457|NCT00468104|585890503|FG001|First Intervention|died within 3 weeks|0|||
162229458|NCT00468104|585890502|FG000|First Intervention|malposition/blocked chest tube tube|2|||
162229459|NCT00468104|585890503|FG001|First Intervention|malposition/blocked chest tube tube|0|||
162229460|NCT00468104|585890502|FG000|First Intervention|large lung mass with minimal effusion|1|||
162229461|NCT00468104|585890503|FG001|First Intervention|large lung mass with minimal effusion|0|||
161829578|NCT03297294|584415831|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
161829579|NCT03297294|584415832|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
161829580|NCT03297294|584415833|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161829581|NCT03297294|584415834|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161829582|NCT03297294|584415835|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161829583|NCT03297294|584415831|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
161829584|NCT03297294|584415832|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
161829585|NCT03297294|584415833|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161829586|NCT03297294|584415834|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161829587|NCT03297294|584415835|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161829588|NCT03297294|584415831|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
161829589|NCT03297294|584415832|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
161829590|NCT03297294|584415833|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
161829591|NCT03297294|584415834|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
161829592|NCT03297294|584415835|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
162229462|NCT00468104|585890502|FG000|First Intervention|associated prolonged pneumothorax|1|||
162229463|NCT00468104|585890503|FG001|First Intervention|associated prolonged pneumothorax|0|||
162229464|NCT00468104|585890502|FG000|First Intervention|trapped lung|1|||
162229465|NCT00468104|585890503|FG001|First Intervention|trapped lung|0|||
162229466|NCT00468104|585890502|FG000|Second Intervention|Withdrawal by Subject|5|||
162229467|NCT00468104|585890503|FG001|Second Intervention|Withdrawal by Subject|2|||
162229468|NCT00468104|585890502|FG000|Second Intervention|discarded for malposition of chest tube|0|||
162229469|NCT00468104|585890503|FG001|Second Intervention|discarded for malposition of chest tube|2|||
162229470|NCT01263665|585890504|FG000|Overall Study|Withdrew Consent|1|||
162229471|NCT01263665|585890504|FG000|Overall Study|Lost to Follow-up|3|||
162229472|NCT01263665|585890504|FG000|Overall Study|Death|2|||
162229473|NCT01263665|585890504|FG000|Overall Study|Amputation above the ankle|1|||
162229474|NCT01263665|585890504|FG000|Overall Study|Surgical Bypass|2|||
162229475|NCT02706899|585890509|FG000|Overall Study|Withdrawal by Subject|1|||
162229476|NCT02706899|585890510|FG001|Overall Study|Withdrawal by Subject|0|||
162229477|NCT02706899|585890509|FG000|Overall Study|Death|8|||
162229478|NCT02706899|585890510|FG001|Overall Study|Death|0|||
162229479|NCT02706899|585890509|FG000|Overall Study|Study Termination by Sponsor|4|||
162229480|NCT02706899|585890510|FG001|Overall Study|Study Termination by Sponsor|6|||
162229481|NCT00324675|585890511|FG000|Overall Study|Adverse Event|1|||
162229482|NCT00324675|585890512|FG001|Overall Study|Adverse Event|0|||
162229483|NCT00381615|585890513|FG000|Overall Study|Withdrawal by Subject|1|||
162229484|NCT00381615|585890514|FG001|Overall Study|Withdrawal by Subject|3|||
162229485|NCT00381615|585890515|FG002|Overall Study|Withdrawal by Subject|0|||
162229486|NCT00381615|585890516|FG003|Overall Study|Withdrawal by Subject|1|||
162229487|NCT00381615|585890513|FG000|Overall Study|Lost to Follow-up|3|||
162229488|NCT00381615|585890514|FG001|Overall Study|Lost to Follow-up|2|||
162229489|NCT00381615|585890515|FG002|Overall Study|Lost to Follow-up|0|||
162229490|NCT00381615|585890516|FG003|Overall Study|Lost to Follow-up|1|||
162229491|NCT00381615|585890513|FG000|Overall Study|Protocol Violation|0|||
162229492|NCT00381615|585890514|FG001|Overall Study|Protocol Violation|0|||
162229493|NCT00381615|585890515|FG002|Overall Study|Protocol Violation|1|||
162229494|NCT00381615|585890516|FG003|Overall Study|Protocol Violation|0|||
161940151|NCT03648372|584830786|FG010|Overall Study|Withdrawal by Subject|2|||
161940152|NCT03648372|584830787|FG011|Overall Study|Withdrawal by Subject|0|||
161940153|NCT03648372|584830788|FG012|Overall Study|Withdrawal by Subject|2|||
161940154|NCT03648372|584830789|FG013|Overall Study|Withdrawal by Subject|0|||
161940155|NCT03648372|584830790|FG014|Overall Study|Withdrawal by Subject|0|||
161940156|NCT03648372|584830791|FG015|Overall Study|Withdrawal by Subject|0|||
161940157|NCT03648372|584830792|FG016|Overall Study|Withdrawal by Subject|1|||
162229495|NCT01012414|585890518|FG000|Overall Study|Withdrawal by Subject|2|||
162229496|NCT01012414|585890518|FG000|Overall Study|Lost to Follow-up|1|||
162229497|NCT01012414|585890518|FG000|Overall Study|Trial was stopped before completed|7|||
162229498|NCT02601300|585890519|FG000|Induction Phase|Lack of Efficacy|2|||
162229499|NCT02601300|585890519|FG000|Induction Phase|Protocol Violation|1|||
161940158|NCT03648372|584830793|FG017|Overall Study|Withdrawal by Subject|0|||
162229500|NCT02601300|585890519|FG000|Extension Phase|Withdrawal by Subject|3|||
162229501|NCT02601300|585890519|FG000|Extension Phase|Adverse Event|4|||
162229502|NCT02601300|585890519|FG000|Extension Phase|Lack of Efficacy|10|||
162229503|NCT00291642|585890524|FG000|Overall Study|Adverse Event|1|||
162229504|NCT00291642|585890525|FG001|Overall Study|Adverse Event|0|||
162229505|NCT00291642|585890526|FG002|Overall Study|Adverse Event|1|||
162229506|NCT00291642|585890527|FG003|Overall Study|Adverse Event|0|||
162229507|NCT00291642|585890528|FG004|Overall Study|Adverse Event|1|||
162229508|NCT00291642|585890524|FG000|Overall Study|Patient missed visit|0|||
162229509|NCT00291642|585890525|FG001|Overall Study|Patient missed visit|0|||
162229510|NCT00291642|585890526|FG002|Overall Study|Patient missed visit|1|||
162229511|NCT00291642|585890527|FG003|Overall Study|Patient missed visit|0|||
162229512|NCT00291642|585890528|FG004|Overall Study|Patient missed visit|0|||
162229513|NCT00291642|585890524|FG000|Overall Study|Intake of prohibited medication|1|||
162229514|NCT00291642|585890525|FG001|Overall Study|Intake of prohibited medication|0|||
162229515|NCT00291642|585890526|FG002|Overall Study|Intake of prohibited medication|0|||
162229516|NCT00291642|585890527|FG003|Overall Study|Intake of prohibited medication|0|||
162229517|NCT00291642|585890528|FG004|Overall Study|Intake of prohibited medication|0|||
162229518|NCT02544451|585890532|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
162229519|NCT02544451|585890533|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
162229520|NCT02544451|585890534|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
162229521|NCT02544451|585890535|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
162229522|NCT02544451|585890532|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
162229523|NCT02544451|585890533|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
162229524|NCT02544451|585890534|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
162229525|NCT02544451|585890535|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
162229526|NCT02544451|585890532|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
162229527|NCT02544451|585890533|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
162229528|NCT02544451|585890534|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
162229529|NCT02544451|585890535|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
162229530|NCT02544451|585890532|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
162229531|NCT02544451|585890533|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
162229532|NCT02544451|585890534|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
162229533|NCT02544451|585890535|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
162229534|NCT02544451|585890532|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
162229535|NCT02544451|585890533|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
162229536|NCT02544451|585890534|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
162229537|NCT02544451|585890535|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
162229538|NCT02544451|585890532|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
162229539|NCT02544451|585890533|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
162229540|NCT02544451|585890534|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
162229541|NCT02544451|585890535|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
162229542|NCT04602221|585890539|FG000|Overall Study|Discontinuation of trial treatment|0|||
162229543|NCT04602221|585890540|FG001|Overall Study|Discontinuation of trial treatment|0|||
162229544|NCT04602221|585890541|FG002|Overall Study|Discontinuation of trial treatment|1|||
162229545|NCT04602221|585890542|FG003|Overall Study|Discontinuation of trial treatment|0|||
162229546|NCT04602221|585890543|FG004|Overall Study|Discontinuation of trial treatment|0|||
162229547|NCT04602221|585890544|FG005|Overall Study|Discontinuation of trial treatment|0|||
162229548|NCT04602221|585890545|FG006|Overall Study|Discontinuation of trial treatment|0|||
162229549|NCT04602221|585890546|FG007|Overall Study|Discontinuation of trial treatment|0|||
162229550|NCT04602221|585890547|FG008|Overall Study|Discontinuation of trial treatment|0|||
162229551|NCT04602221|585890548|FG009|Overall Study|Discontinuation of trial treatment|0|||
162229552|NCT04602221|585890549|FG010|Overall Study|Discontinuation of trial treatment|0|||
162229553|NCT04602221|585890550|FG011|Overall Study|Discontinuation of trial treatment|0|||
162229554|NCT04602221|585890551|FG012|Overall Study|Discontinuation of trial treatment|0|||
162229555|NCT04602221|585890552|FG013|Overall Study|Discontinuation of trial treatment|0|||
162229556|NCT04602221|585890553|FG014|Overall Study|Discontinuation of trial treatment|0|||
162229557|NCT04602221|585890554|FG015|Overall Study|Discontinuation of trial treatment|0|||
162229558|NCT04602221|585890555|FG016|Overall Study|Discontinuation of trial treatment|0|||
162229559|NCT04602221|585890556|FG017|Overall Study|Discontinuation of trial treatment|0|||
162229560|NCT04602221|585890539|FG000|Overall Study|Other than listed|0|||
162229561|NCT04602221|585890540|FG001|Overall Study|Other than listed|0|||
162229562|NCT04602221|585890541|FG002|Overall Study|Other than listed|0|||
162229563|NCT04602221|585890542|FG003|Overall Study|Other than listed|0|||
162229564|NCT04602221|585890543|FG004|Overall Study|Other than listed|0|||
162229565|NCT04602221|585890544|FG005|Overall Study|Other than listed|0|||
162229566|NCT04602221|585890545|FG006|Overall Study|Other than listed|0|||
161940159|NCT03648372|584830794|FG018|Overall Study|Withdrawal by Subject|0|||
162229567|NCT04602221|585890546|FG007|Overall Study|Other than listed|0|||
162229568|NCT04602221|585890547|FG008|Overall Study|Other than listed|0|||
162229569|NCT04602221|585890548|FG009|Overall Study|Other than listed|0|||
162229570|NCT04602221|585890549|FG010|Overall Study|Other than listed|0|||
162229571|NCT04602221|585890550|FG011|Overall Study|Other than listed|0|||
162229572|NCT04602221|585890551|FG012|Overall Study|Other than listed|0|||
162229573|NCT04602221|585890552|FG013|Overall Study|Other than listed|0|||
162229574|NCT04602221|585890553|FG014|Overall Study|Other than listed|0|||
162229575|NCT04602221|585890554|FG015|Overall Study|Other than listed|1|||
162229576|NCT04602221|585890555|FG016|Overall Study|Other than listed|0|||
162229577|NCT04602221|585890556|FG017|Overall Study|Other than listed|1|||
162229578|NCT04602221|585890539|FG000|Overall Study|Withdrawal by Subject|0|||
162229579|NCT04602221|585890540|FG001|Overall Study|Withdrawal by Subject|0|||
162229580|NCT04602221|585890541|FG002|Overall Study|Withdrawal by Subject|0|||
162229581|NCT04602221|585890542|FG003|Overall Study|Withdrawal by Subject|0|||
162229582|NCT04602221|585890543|FG004|Overall Study|Withdrawal by Subject|0|||
162229583|NCT04602221|585890544|FG005|Overall Study|Withdrawal by Subject|0|||
162229584|NCT04602221|585890545|FG006|Overall Study|Withdrawal by Subject|0|||
162229585|NCT04602221|585890546|FG007|Overall Study|Withdrawal by Subject|0|||
162229586|NCT04602221|585890547|FG008|Overall Study|Withdrawal by Subject|0|||
162229587|NCT04602221|585890548|FG009|Overall Study|Withdrawal by Subject|0|||
162229588|NCT04602221|585890549|FG010|Overall Study|Withdrawal by Subject|0|||
162229589|NCT04602221|585890550|FG011|Overall Study|Withdrawal by Subject|0|||
162229590|NCT04602221|585890551|FG012|Overall Study|Withdrawal by Subject|1|||
162229591|NCT04602221|585890552|FG013|Overall Study|Withdrawal by Subject|0|||
162229592|NCT04602221|585890553|FG014|Overall Study|Withdrawal by Subject|0|||
162229593|NCT04602221|585890554|FG015|Overall Study|Withdrawal by Subject|0|||
162229594|NCT04602221|585890555|FG016|Overall Study|Withdrawal by Subject|0|||
162229595|NCT04602221|585890556|FG017|Overall Study|Withdrawal by Subject|0|||
162229596|NCT04602221|585890539|FG000|Overall Study|Lost to Follow-up|0|||
161679514|NCT00097773|583879150|FG003|Overall Study|Physician Decision|1|||
161679515|NCT00097773|583879147|FG000|Overall Study|Withdrawal by Subject|3|||
161679516|NCT00097773|583879148|FG001|Overall Study|Withdrawal by Subject|3|||
161679517|NCT00097773|583879149|FG002|Overall Study|Withdrawal by Subject|3|||
161679518|NCT00097773|583879150|FG003|Overall Study|Withdrawal by Subject|1|||
161679519|NCT00097773|583879147|FG000|Overall Study|Adverse Event|0|||
161679520|NCT00097773|583879148|FG001|Overall Study|Adverse Event|1|||
161679521|NCT00097773|583879149|FG002|Overall Study|Adverse Event|0|||
161679522|NCT00097773|583879150|FG003|Overall Study|Adverse Event|0|||
161679523|NCT00097773|583879147|FG000|Overall Study|Other|1|||
161679524|NCT00097773|583879148|FG001|Overall Study|Other|0|||
161679525|NCT00097773|583879149|FG002|Overall Study|Other|2|||
161679526|NCT00097773|583879150|FG003|Overall Study|Other|0|||
161679527|NCT01494350|583879151|FG000|Overall Study|Worsening of lesion|1|||
161679528|NCT00474708|583879152|FG000|Overall Study|Lack of Efficacy|11|||
161679529|NCT00474708|583879153|FG001|Overall Study|Lack of Efficacy|5|||
161679530|NCT00474708|583879152|FG000|Overall Study|Suicide ideation/behavior|0|||
161679531|NCT00474708|583879153|FG001|Overall Study|Suicide ideation/behavior|1|||
161679532|NCT00474708|583879152|FG000|Overall Study|Withdrawal by Subject|7|||
161679533|NCT00474708|583879153|FG001|Overall Study|Withdrawal by Subject|0|||
161679534|NCT00474708|583879152|FG000|Overall Study|Lack of compliance|12|||
161679535|NCT00474708|583879153|FG001|Overall Study|Lack of compliance|4|||
161679536|NCT00474708|583879152|FG000|Overall Study|Lost to Follow-up|18|||
161679537|NCT00474708|583879153|FG001|Overall Study|Lost to Follow-up|9|||
161679538|NCT00474708|583879152|FG000|Overall Study|Physician Decision|9|||
161679539|NCT00474708|583879153|FG001|Overall Study|Physician Decision|6|||
161679540|NCT03700320|583879154|FG000|Overall Study|Adverse Event|5|||
161679541|NCT03700320|583879155|FG001|Overall Study|Adverse Event|31|||
161679542|NCT03700320|583879154|FG000|Overall Study|Lack of Efficacy|2|||
161679543|NCT03700320|583879155|FG001|Overall Study|Lack of Efficacy|5|||
161679544|NCT03700320|583879154|FG000|Overall Study|Withdrawal by Subject|29|||
161679545|NCT03700320|583879155|FG001|Overall Study|Withdrawal by Subject|75|||
161679546|NCT03700320|583879154|FG000|Overall Study|Lost to Follow-up|16|||
161679547|NCT03700320|583879155|FG001|Overall Study|Lost to Follow-up|23|||
161679548|NCT03700320|583879154|FG000|Overall Study|Pregnancy|2|||
161679549|NCT03700320|583879155|FG001|Overall Study|Pregnancy|4|||
161679550|NCT03700320|583879154|FG000|Overall Study|Protocol Deviation|7|||
161679551|NCT03700320|583879155|FG001|Overall Study|Protocol Deviation|31|||
161679552|NCT03700320|583879154|FG000|Overall Study|Non-compliance with Study Drug|1|||
161679553|NCT03700320|583879155|FG001|Overall Study|Non-compliance with Study Drug|3|||
161679554|NCT03700320|583879154|FG000|Overall Study|Reason not Specified|0|||
161679555|NCT03700320|583879155|FG001|Overall Study|Reason not Specified|1|||
162229597|NCT04602221|585890540|FG001|Overall Study|Lost to Follow-up|0|||
162229598|NCT04602221|585890541|FG002|Overall Study|Lost to Follow-up|0|||
162229599|NCT04602221|585890542|FG003|Overall Study|Lost to Follow-up|0|||
162229600|NCT04602221|585890543|FG004|Overall Study|Lost to Follow-up|0|||
162229601|NCT04602221|585890544|FG005|Overall Study|Lost to Follow-up|1|||
162229602|NCT04602221|585890545|FG006|Overall Study|Lost to Follow-up|0|||
162229603|NCT04602221|585890546|FG007|Overall Study|Lost to Follow-up|0|||
162229604|NCT04602221|585890547|FG008|Overall Study|Lost to Follow-up|0|||
162229605|NCT04602221|585890548|FG009|Overall Study|Lost to Follow-up|0|||
162229606|NCT04602221|585890549|FG010|Overall Study|Lost to Follow-up|0|||
162229607|NCT04602221|585890550|FG011|Overall Study|Lost to Follow-up|0|||
162229608|NCT04602221|585890551|FG012|Overall Study|Lost to Follow-up|0|||
162229609|NCT04602221|585890552|FG013|Overall Study|Lost to Follow-up|0|||
162229610|NCT04602221|585890553|FG014|Overall Study|Lost to Follow-up|0|||
162229611|NCT04602221|585890554|FG015|Overall Study|Lost to Follow-up|0|||
162229612|NCT04602221|585890555|FG016|Overall Study|Lost to Follow-up|0|||
162229613|NCT04602221|585890556|FG017|Overall Study|Lost to Follow-up|0|||
162229614|NCT03001076|585890558|FG000|Overall Study|Withdrawal by patient|2|||
161679556|NCT04305275|583879156|FG000|Overall Study|Adverse Event|4|||
161679557|NCT04305275|583879157|FG001|Overall Study|Adverse Event|0|||
161679558|NCT04305275|583879156|FG000|Overall Study|Lost to Follow-up|1|||
161679559|NCT04305275|583879157|FG001|Overall Study|Lost to Follow-up|1|||
161679560|NCT04305275|583879156|FG000|Overall Study|Withdrawal by Participant|8|||
161679561|NCT04305275|583879157|FG001|Overall Study|Withdrawal by Participant|1|||
161679562|NCT03061175|583879160|FG000|Baseline|Participant was deemed ineligible|1|||
161679563|NCT03061175|583879161|FG001|Baseline|Participant was deemed ineligible|0|||
161679564|NCT03061175|583879160|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
161679565|NCT03061175|583879161|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
161679566|NCT03061175|583879160|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
161829593|NCT02692482|584415836|FG000|Overall Study|Death|2|||
161829594|NCT02692482|584415837|FG001|Overall Study|Death|2|||
161829595|NCT02692482|584415836|FG000|Overall Study|Withdrawal by Subject|1|||
161829596|NCT02692482|584415837|FG001|Overall Study|Withdrawal by Subject|2|||
161829597|NCT00127166|584415840|FG000|Period I|Protocol Violation|0|||
161829598|NCT00127166|584415841|FG001|Period I|Protocol Violation|2|||
161829599|NCT00127166|584415840|FG000|Period I|Withdrawal by Subject|2|||
161829600|NCT00127166|584415841|FG001|Period I|Withdrawal by Subject|0|||
162229615|NCT03001076|585890559|FG001|Overall Study|Withdrawal by patient|0|||
162229616|NCT03001076|585890558|FG000|Overall Study|Other|1|||
162229617|NCT03001076|585890559|FG001|Overall Study|Other|0|||
162229618|NCT03001076|585890558|FG000|Overall Study|Adverse Event|3|||
162229619|NCT03001076|585890559|FG001|Overall Study|Adverse Event|3|||
162229620|NCT03001076|585890558|FG000|Overall Study|Sponsor decision|1|||
162229621|NCT03001076|585890559|FG001|Overall Study|Sponsor decision|0|||
162229622|NCT03001076|585890558|FG000|Overall Study|Lost to Follow-up|0|||
162229623|NCT03001076|585890559|FG001|Overall Study|Lost to Follow-up|2|||
162229624|NCT00844532|585890560|FG000|Overall Study|Death|16|||
162229625|NCT00844532|585890560|FG000|Overall Study|Withdrawal by Subject|16|||
162229626|NCT00844532|585890560|FG000|Overall Study|Lost to Follow-up|7|||
162229627|NCT02576587|585890561|FG000|Baseline|Equipment failure|0|||
162229628|NCT02576587|585890562|FG001|Baseline|Equipment failure|1|||
162229629|NCT02576587|585890561|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
162229630|NCT02576587|585890562|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
162229631|NCT02576587|585890561|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
162229632|NCT02576587|585890562|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
162229633|NCT02576587|585890561|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
162229634|NCT02576587|585890562|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
162229635|NCT01080716|585890563|FG000|Part 1|Physician Decision|1|||
162229636|NCT01080716|585890564|FG001|Part 1|Physician Decision|0|||
162229637|NCT01080716|585890565|FG002|Part 1|Physician Decision|0|||
162229638|NCT01080716|585890566|FG003|Part 1|Physician Decision|0|||
162229639|NCT01056718|585890567|FG000|Overall Study|Withdrawal by Subject|2|||
162229640|NCT01056718|585890567|FG000|Overall Study|Ischemia on baseline stress test|1|||
162229641|NCT03590366|585890568|FG000|Overall Study|Adverse Event|0|||
162229642|NCT03590366|585890569|FG001|Overall Study|Adverse Event|3|||
162229643|NCT03590366|585890568|FG000|Overall Study|Lost to Follow-up|3|||
162023700|NCT00830869|585144485|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
162229644|NCT03590366|585890569|FG001|Overall Study|Lost to Follow-up|3|||
162229645|NCT03590366|585890568|FG000|Overall Study|Withdrawal by Subject|0|||
162229646|NCT03590366|585890569|FG001|Overall Study|Withdrawal by Subject|2|||
162229647|NCT00738894|585890570|FG000|Overall Study|Lost to Follow-up|23|||
162229648|NCT00738894|585890571|FG001|Overall Study|Lost to Follow-up|13|||
162229649|NCT00738894|585890570|FG000|Overall Study|Withdrawal by Subject|10|||
162229650|NCT00738894|585890571|FG001|Overall Study|Withdrawal by Subject|15|||
162229651|NCT00738894|585890570|FG000|Overall Study|Physician Decision|4|||
162229652|NCT00738894|585890571|FG001|Overall Study|Physician Decision|5|||
162229653|NCT00738894|585890570|FG000|Overall Study|Death|2|||
162229654|NCT00738894|585890571|FG001|Overall Study|Death|0|||
162229655|NCT05017103|585890572|FG000|Overall Study|Death|2|||
162229656|NCT02656329|585890573|FG000|Overall Study|Lost to Follow-up|2|||
162229657|NCT02656329|585890574|FG001|Overall Study|Lost to Follow-up|3|||
162229658|NCT02656329|585890573|FG000|Overall Study|Withdrawal by Subject|7|||
162229659|NCT02656329|585890574|FG001|Overall Study|Withdrawal by Subject|6|||
162229660|NCT02656329|585890573|FG000|Overall Study|Study termination by Sponsor|150|||
162229661|NCT02656329|585890574|FG001|Overall Study|Study termination by Sponsor|142|||
162229662|NCT02656329|585890573|FG000|Overall Study|Other than specified above|5|||
162229663|NCT02656329|585890574|FG001|Overall Study|Other than specified above|6|||
162229664|NCT01081665|585890576|FG000|Overall Study|Death|41|||
162229665|NCT01081665|585890576|FG000|Overall Study|Lost to Follow-up|18|||
162229666|NCT01081665|585890576|FG000|Overall Study|Withdrawal by Subject|17|||
162229667|NCT01081665|585890576|FG000|Overall Study|Change of dialysis unit|10|||
162229668|NCT01081665|585890576|FG000|Overall Study|Regulation of iPTH|5|||
162229669|NCT01081665|585890576|FG000|Overall Study|Change in renal replacement therapy|2|||
162229670|NCT01081665|585890576|FG000|Overall Study|Adverse Event|1|||
162229671|NCT01081665|585890576|FG000|Overall Study|Lack of Efficacy|1|||
162229672|NCT01413503|585890589|FG000|Overall Study|Lost to Follow-up|1|||
162229673|NCT02546921|585890590|FG000|Overall Study|Adverse Event|0|||
162229674|NCT02546921|585890591|FG001|Overall Study|Adverse Event|5|||
162229675|NCT02546921|585890592|FG002|Overall Study|Adverse Event|2|||
162229676|NCT02546921|585890593|FG003|Overall Study|Adverse Event|0|||
162229677|NCT02546921|585890594|FG004|Overall Study|Adverse Event|0|||
162229678|NCT02546921|585890595|FG005|Overall Study|Adverse Event|0|||
161940160|NCT03648372|584830795|FG019|Overall Study|Withdrawal by Subject|0|||
162229679|NCT02546921|585890596|FG006|Overall Study|Adverse Event|0|||
161940161|NCT03648372|584830796|FG020|Overall Study|Withdrawal by Subject|0|||
161940162|NCT03648372|584830776|FG000|Overall Study|Progressive Disease|2|||
162229680|NCT02546921|585890590|FG000|Overall Study|Evidence of Disease Progression|1|||
162229681|NCT02546921|585890591|FG001|Overall Study|Evidence of Disease Progression|0|||
161829601|NCT00127166|584415840|FG000|Period I|Patient did not meet inclusion criteria|1|||
162229682|NCT02546921|585890592|FG002|Overall Study|Evidence of Disease Progression|0|||
162229683|NCT02546921|585890593|FG003|Overall Study|Evidence of Disease Progression|0|||
162229684|NCT02546921|585890594|FG004|Overall Study|Evidence of Disease Progression|1|||
162229685|NCT02546921|585890595|FG005|Overall Study|Evidence of Disease Progression|0|||
162229686|NCT02546921|585890596|FG006|Overall Study|Evidence of Disease Progression|0|||
162229687|NCT02546921|585890590|FG000|Overall Study|Patient Choice|0|||
162229688|NCT02546921|585890591|FG001|Overall Study|Patient Choice|1|||
162229689|NCT02546921|585890592|FG002|Overall Study|Patient Choice|0|||
162229690|NCT02546921|585890593|FG003|Overall Study|Patient Choice|0|||
162229691|NCT02546921|585890594|FG004|Overall Study|Patient Choice|0|||
162229692|NCT02546921|585890595|FG005|Overall Study|Patient Choice|1|||
162229693|NCT02546921|585890596|FG006|Overall Study|Patient Choice|0|||
162229694|NCT01373151|585890597|FG000|Period 1|Lack of Efficacy|3|||
162229695|NCT01373151|585890598|FG001|Period 1|Lack of Efficacy|0|||
162229696|NCT01373151|585890599|FG002|Period 1|Lack of Efficacy|0|||
162229697|NCT01373151|585890600|FG003|Period 1|Lack of Efficacy|0|||
162229698|NCT01373151|585890601|FG004|Period 1|Lack of Efficacy|1|||
162229699|NCT01373151|585890602|FG005|Period 1|Lack of Efficacy|0|||
162229700|NCT01373151|585890603|FG006|Period 1|Lack of Efficacy|0|||
162229701|NCT01373151|585890597|FG000|Period 1|Adverse Event|0|||
162229702|NCT01373151|585890598|FG001|Period 1|Adverse Event|0|||
162229703|NCT01373151|585890599|FG002|Period 1|Adverse Event|1|||
162229704|NCT01373151|585890600|FG003|Period 1|Adverse Event|0|||
162229705|NCT01373151|585890601|FG004|Period 1|Adverse Event|4|||
162229706|NCT01373151|585890602|FG005|Period 1|Adverse Event|3|||
162229707|NCT01373151|585890603|FG006|Period 1|Adverse Event|0|||
162229708|NCT01373151|585890597|FG000|Period 1|Withdrawal by Subject|2|||
162229709|NCT01373151|585890598|FG001|Period 1|Withdrawal by Subject|0|||
162229710|NCT01373151|585890599|FG002|Period 1|Withdrawal by Subject|3|||
162229711|NCT01373151|585890600|FG003|Period 1|Withdrawal by Subject|1|||
162229712|NCT01373151|585890601|FG004|Period 1|Withdrawal by Subject|0|||
162229713|NCT01373151|585890602|FG005|Period 1|Withdrawal by Subject|1|||
162229714|NCT01373151|585890603|FG006|Period 1|Withdrawal by Subject|0|||
162229715|NCT01373151|585890597|FG000|Period 2|Lack of Efficacy|9|||
162229716|NCT01373151|585890598|FG001|Period 2|Lack of Efficacy|0|||
162229717|NCT01373151|585890599|FG002|Period 2|Lack of Efficacy|0|||
162229718|NCT01373151|585890600|FG003|Period 2|Lack of Efficacy|1|||
162229719|NCT01373151|585890601|FG004|Period 2|Lack of Efficacy|2|||
162229720|NCT01373151|585890602|FG005|Period 2|Lack of Efficacy|0|||
162229721|NCT01373151|585890603|FG006|Period 2|Lack of Efficacy|3|||
162229722|NCT01373151|585890597|FG000|Period 2|Adverse Event|0|||
162229723|NCT01373151|585890598|FG001|Period 2|Adverse Event|0|||
162229724|NCT01373151|585890599|FG002|Period 2|Adverse Event|3|||
162229725|NCT01373151|585890600|FG003|Period 2|Adverse Event|3|||
162229726|NCT01373151|585890601|FG004|Period 2|Adverse Event|0|||
162229727|NCT01373151|585890602|FG005|Period 2|Adverse Event|0|||
162229728|NCT01373151|585890603|FG006|Period 2|Adverse Event|1|||
161679567|NCT03061175|583879161|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
162023701|NCT00830869|585144486|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
162229729|NCT01373151|585890597|FG000|Period 2|subject request to discontinue|0|||
162229730|NCT01373151|585890598|FG001|Period 2|subject request to discontinue|1|||
162229731|NCT01373151|585890599|FG002|Period 2|subject request to discontinue|0|||
162229732|NCT01373151|585890600|FG003|Period 2|subject request to discontinue|0|||
162229733|NCT01373151|585890601|FG004|Period 2|subject request to discontinue|0|||
162229734|NCT01373151|585890602|FG005|Period 2|subject request to discontinue|0|||
162229735|NCT01373151|585890603|FG006|Period 2|subject request to discontinue|0|||
162229736|NCT01373151|585890597|FG000|Period 2|Withdrawal by Subject|0|||
162229737|NCT01373151|585890598|FG001|Period 2|Withdrawal by Subject|0|||
162229738|NCT01373151|585890599|FG002|Period 2|Withdrawal by Subject|0|||
162229739|NCT01373151|585890600|FG003|Period 2|Withdrawal by Subject|1|||
162229740|NCT01373151|585890601|FG004|Period 2|Withdrawal by Subject|0|||
161829602|NCT00127166|584415841|FG001|Period I|Patient did not meet inclusion criteria|0|||
161829603|NCT00127166|584415840|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
161940163|NCT03648372|584830777|FG001|Overall Study|Progressive Disease|3|||
161679568|NCT03061175|583879160|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
161829604|NCT00127166|584415841|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
161829605|NCT00127166|584415840|FG000|Period II|Withdrawal by Subject|2|||
161829606|NCT00127166|584415841|FG001|Period II|Withdrawal by Subject|0|||
161829607|NCT00127166|584415840|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
162229741|NCT01373151|585890602|FG005|Period 2|Withdrawal by Subject|0|||
162229742|NCT01373151|585890603|FG006|Period 2|Withdrawal by Subject|0|||
162229743|NCT01373151|585890597|FG000|Period 2|Other|0|||
162229744|NCT01373151|585890598|FG001|Period 2|Other|0|||
162229745|NCT01373151|585890599|FG002|Period 2|Other|1|||
162229746|NCT01373151|585890600|FG003|Period 2|Other|0|||
162229747|NCT01373151|585890601|FG004|Period 2|Other|0|||
162229748|NCT01373151|585890602|FG005|Period 2|Other|0|||
162229749|NCT01373151|585890603|FG006|Period 2|Other|1|||
162229750|NCT03026075|585890607|FG000|Overall Study|Physician Decision|1|||
162229751|NCT03381339|585890608|FG000|Overall Study|Protocol Violation|4|||
162229752|NCT03381339|585890609|FG001|Overall Study|Protocol Violation|3|||
162229753|NCT03381339|585890608|FG000|Overall Study|Lost to Follow-up|0|||
162229754|NCT03381339|585890609|FG001|Overall Study|Lost to Follow-up|1|||
162229755|NCT02001064|585890611|FG000|Overall Study|Withdrawal by Subject|2|||
162229756|NCT02001064|585890612|FG001|Overall Study|Withdrawal by Subject|1|||
162229757|NCT00545753|585890613|FG000|Overall Study|Withdrawal by Subject|0|||
162229758|NCT00545753|585890614|FG001|Overall Study|Withdrawal by Subject|1|||
162229759|NCT00545753|585890615|FG002|Overall Study|Withdrawal by Subject|10|||
162229760|NCT00545753|585890613|FG000|Overall Study|Lost to Follow-up|13|||
162229761|NCT00545753|585890614|FG001|Overall Study|Lost to Follow-up|3|||
162229762|NCT00545753|585890615|FG002|Overall Study|Lost to Follow-up|12|||
162229763|NCT00545753|585890613|FG000|Overall Study|Protocol Violation|3|||
162229764|NCT00545753|585890614|FG001|Overall Study|Protocol Violation|1|||
162229765|NCT00545753|585890615|FG002|Overall Study|Protocol Violation|4|||
162229766|NCT01011153|585890616|FG000|Overall Study|Less than 78 cases completed|8|||
162229767|NCT01011153|585890617|FG001|Overall Study|Less than 78 cases completed|11|||
162229768|NCT01011153|585890618|FG002|Overall Study|Less than 78 cases completed|9|||
162229769|NCT03014479|585890623|FG000|Overall Study|Adverse Event|0|||
162229770|NCT03014479|585890624|FG001|Overall Study|Adverse Event|1|||
162229771|NCT03014479|585890623|FG000|Overall Study|Voluntary Withdrawal|0|||
162229772|NCT03014479|585890624|FG001|Overall Study|Voluntary Withdrawal|2|||
162229773|NCT03014479|585890623|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
162229774|NCT03014479|585890624|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
162229775|NCT01081132|585890630|FG000|Overall Study|Lack of Efficacy|25|||
162229776|NCT01081132|585890631|FG001|Overall Study|Lack of Efficacy|9|||
162229777|NCT01081132|585890630|FG000|Overall Study|Withdrawal by Subject|13|||
162229778|NCT01081132|585890631|FG001|Overall Study|Withdrawal by Subject|16|||
162229779|NCT01081132|585890630|FG000|Overall Study|Lost to Follow-up|4|||
162229780|NCT01081132|585890631|FG001|Overall Study|Lost to Follow-up|11|||
162229781|NCT01081132|585890630|FG000|Overall Study|Adverse Event|3|||
162229782|NCT01081132|585890631|FG001|Overall Study|Adverse Event|9|||
162229783|NCT01081132|585890630|FG000|Overall Study|Non Compliance|4|||
162229784|NCT01081132|585890631|FG001|Overall Study|Non Compliance|2|||
162229785|NCT01081132|585890630|FG000|Overall Study|Lack Of Compliance|0|||
162229786|NCT01081132|585890631|FG001|Overall Study|Lack Of Compliance|1|||
162229787|NCT01081132|585890630|FG000|Overall Study|Missed Visits|1|||
162229788|NCT01081132|585890631|FG001|Overall Study|Missed Visits|1|||
162229789|NCT01081132|585890630|FG000|Overall Study|Stopped Taking Meds|2|||
162229790|NCT01081132|585890631|FG001|Overall Study|Stopped Taking Meds|0|||
162229791|NCT01081132|585890630|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
162229792|NCT01081132|585890631|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
162229793|NCT01081132|585890630|FG000|Overall Study|Declined Taper Phase|0|||
162229794|NCT01081132|585890631|FG001|Overall Study|Declined Taper Phase|1|||
162229795|NCT01081132|585890630|FG000|Overall Study|Protocol Violation|3|||
162229796|NCT01081132|585890631|FG001|Overall Study|Protocol Violation|1|||
162229797|NCT02101385|585890632|FG000|Study Treatment|Disease Progression|9|||
162229798|NCT02101385|585890633|FG001|Study Treatment|Disease Progression|3|||
162229799|NCT02101385|585890632|FG000|Study Treatment|Alternative therapy|0|||
162229800|NCT02101385|585890633|FG001|Study Treatment|Alternative therapy|1|||
162229801|NCT02101385|585890632|FG000|Study Treatment|No treatment, per protocol criteria|0|||
162229802|NCT02101385|585890633|FG001|Study Treatment|No treatment, per protocol criteria|4|||
162229803|NCT02101385|585890632|FG000|Study Treatment|Patient Non compliance|0|||
162229804|NCT02101385|585890633|FG001|Study Treatment|Patient Non compliance|2|||
162229805|NCT02101385|585890632|FG000|Study Treatment|Withdrawal by Subject|5|||
162229806|NCT02101385|585890633|FG001|Study Treatment|Withdrawal by Subject|2|||
162229807|NCT02101385|585890632|FG000|Study Treatment|screen failure|1|||
162229808|NCT02101385|585890633|FG001|Study Treatment|screen failure|0|||
162229809|NCT02101385|585890632|FG000|Study Treatment|AE/Side Effects/Complications|8|||
162229810|NCT02101385|585890633|FG001|Study Treatment|AE/Side Effects/Complications|0|||
162229811|NCT02101385|585890632|FG000|Study Treatment|Lost to Follow-up|1|||
162229812|NCT02101385|585890633|FG001|Study Treatment|Lost to Follow-up|0|||
162229813|NCT02101385|585890632|FG000|Study Treatment|Disease Progression before treatment|1|||
162229814|NCT02101385|585890633|FG001|Study Treatment|Disease Progression before treatment|0|||
162229815|NCT02101385|585890632|FG000|Study Treatment|Death|1|||
162229816|NCT02101385|585890633|FG001|Study Treatment|Death|0|||
162229817|NCT02101385|585890632|FG000|Follow up|Lost to Follow-up|4|||
162229818|NCT02101385|585890633|FG001|Follow up|Lost to Follow-up|9|||
162229819|NCT02101385|585890632|FG000|Follow up|Refused to follow up|5|||
162229820|NCT02101385|585890633|FG001|Follow up|Refused to follow up|4|||
162229821|NCT02101385|585890632|FG000|Follow up|Death|21|||
162229822|NCT02101385|585890633|FG001|Follow up|Death|39|||
162229823|NCT02101385|585890632|FG000|Follow up|study completed|33|||
162229824|NCT02101385|585890633|FG001|Follow up|study completed|52|||
162229825|NCT02101385|585890632|FG000|Follow up|screen failure|2|||
162229826|NCT02101385|585890633|FG001|Follow up|screen failure|0|||
162229827|NCT02101385|585890632|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
162229828|NCT02101385|585890633|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
162229829|NCT02101385|585890632|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
162229830|NCT02101385|585890633|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
162229831|NCT02101385|585890632|FG000|Follow up|Withdrawal by Subject|2|||
162229832|NCT02101385|585890633|FG001|Follow up|Withdrawal by Subject|2|||
162229833|NCT02101385|585890632|FG000|Follow up|PI requested closure of site|0|||
162229834|NCT02101385|585890633|FG001|Follow up|PI requested closure of site|5|||
162229835|NCT03973931|585890640|FG000|Overall Study|Lost to Follow-up|47|||
162229836|NCT03973931|585890641|FG001|Overall Study|Lost to Follow-up|63|||
162229837|NCT03973931|585890642|FG002|Overall Study|Lost to Follow-up|51|||
162229838|NCT03973931|585890643|FG003|Overall Study|Lost to Follow-up|54|||
161940164|NCT03648372|584830778|FG002|Overall Study|Progressive Disease|4|||
162229839|NCT03973931|585890640|FG000|Overall Study|opted out|6|||
162229840|NCT03973931|585890641|FG001|Overall Study|opted out|5|||
162229841|NCT03973931|585890642|FG002|Overall Study|opted out|5|||
162229842|NCT03973931|585890643|FG003|Overall Study|opted out|1|||
162229843|NCT03541174|585891838|FG000|Part 1 Double-Blind|Adverse Event|6|||
162229844|NCT03541174|585891839|FG001|Part 1 Double-Blind|Adverse Event|5|||
162229845|NCT03541174|585891840|FG002|Part 1 Double-Blind|Adverse Event|2|||
162229846|NCT03541174|585891841|FG003|Part 1 Double-Blind|Adverse Event|0|||
162229847|NCT03541174|585891842|FG004|Part 1 Double-Blind|Adverse Event|0|||
162229848|NCT03541174|585891843|FG005|Part 1 Double-Blind|Adverse Event|0|||
162229849|NCT03541174|585891838|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
162229850|NCT03541174|585891839|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
162229851|NCT03541174|585891840|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
162229852|NCT03541174|585891841|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
162229853|NCT03541174|585891842|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
162229854|NCT03541174|585891843|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
162229855|NCT03541174|585891838|FG000|Part 1 Double-Blind|Other reasons|3|||
162229856|NCT03541174|585891839|FG001|Part 1 Double-Blind|Other reasons|2|||
162229857|NCT03541174|585891840|FG002|Part 1 Double-Blind|Other reasons|3|||
162229858|NCT03541174|585891841|FG003|Part 1 Double-Blind|Other reasons|0|||
162229859|NCT03541174|585891842|FG004|Part 1 Double-Blind|Other reasons|0|||
162229860|NCT03541174|585891843|FG005|Part 1 Double-Blind|Other reasons|0|||
162229861|NCT03541174|585891838|FG000|Part 2 Single-Blind|Adverse Event|0|||
162229862|NCT03541174|585891839|FG001|Part 2 Single-Blind|Adverse Event|0|||
162229863|NCT03541174|585891840|FG002|Part 2 Single-Blind|Adverse Event|0|||
162229864|NCT03541174|585891841|FG003|Part 2 Single-Blind|Adverse Event|25|||
162229865|NCT03541174|585891842|FG004|Part 2 Single-Blind|Adverse Event|0|||
162229866|NCT03541174|585891843|FG005|Part 2 Single-Blind|Adverse Event|0|||
162229867|NCT03541174|585891838|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
162229868|NCT03541174|585891839|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
162229869|NCT03541174|585891840|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
162229870|NCT03541174|585891841|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
162229871|NCT03541174|585891842|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
162229872|NCT03541174|585891843|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
162229873|NCT03541174|585891838|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
162229874|NCT03541174|585891839|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
162229875|NCT03541174|585891840|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
162229876|NCT03541174|585891841|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
162229877|NCT03541174|585891842|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
162229878|NCT03541174|585891843|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
162229879|NCT03541174|585891838|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
162229880|NCT03541174|585891839|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
162229881|NCT03541174|585891840|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
162229882|NCT03541174|585891841|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
162229883|NCT03541174|585891842|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
162229884|NCT03541174|585891843|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
162229885|NCT03541174|585891838|FG000|Part 2 Single-Blind|Death|0|||
162229886|NCT03541174|585891839|FG001|Part 2 Single-Blind|Death|0|||
162229887|NCT03541174|585891840|FG002|Part 2 Single-Blind|Death|0|||
162229888|NCT03541174|585891841|FG003|Part 2 Single-Blind|Death|5|||
162229889|NCT03541174|585891842|FG004|Part 2 Single-Blind|Death|0|||
162229890|NCT03541174|585891843|FG005|Part 2 Single-Blind|Death|0|||
162229891|NCT03541174|585891838|FG000|Part 2 Single-Blind|Pregnancy|0|||
162229892|NCT03541174|585891839|FG001|Part 2 Single-Blind|Pregnancy|0|||
162229893|NCT03541174|585891840|FG002|Part 2 Single-Blind|Pregnancy|0|||
162229894|NCT03541174|585891841|FG003|Part 2 Single-Blind|Pregnancy|1|||
162229895|NCT03541174|585891842|FG004|Part 2 Single-Blind|Pregnancy|0|||
162229896|NCT03541174|585891843|FG005|Part 2 Single-Blind|Pregnancy|0|||
162229897|NCT03541174|585891838|FG000|Part 2 Single-Blind|Other reasons|0|||
162229898|NCT03541174|585891839|FG001|Part 2 Single-Blind|Other reasons|0|||
162229899|NCT03541174|585891840|FG002|Part 2 Single-Blind|Other reasons|0|||
162229900|NCT03541174|585891841|FG003|Part 2 Single-Blind|Other reasons|32|||
162229901|NCT03541174|585891842|FG004|Part 2 Single-Blind|Other reasons|0|||
162229902|NCT03541174|585891843|FG005|Part 2 Single-Blind|Other reasons|0|||
162229903|NCT03541174|585891838|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
162229904|NCT03541174|585891839|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
162229905|NCT03541174|585891840|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
162229906|NCT03541174|585891841|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
162229907|NCT03541174|585891842|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
162229908|NCT03541174|585891843|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
162229909|NCT03541174|585891838|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
162229910|NCT03541174|585891839|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
162229911|NCT03541174|585891840|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
162229912|NCT03541174|585891841|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
162229913|NCT03541174|585891842|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
162229914|NCT03541174|585891843|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
162229915|NCT03541174|585891838|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
162229916|NCT03541174|585891839|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
162229917|NCT03541174|585891840|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
162229918|NCT03541174|585891841|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
162229919|NCT03541174|585891842|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
162229920|NCT03541174|585891843|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
162229921|NCT03541174|585891838|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
162229922|NCT03541174|585891839|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
162229923|NCT03541174|585891840|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
162229924|NCT03541174|585891841|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
162229925|NCT03541174|585891842|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
162229926|NCT03541174|585891843|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
162229927|NCT03541174|585891838|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
162229928|NCT03541174|585891839|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
162229929|NCT03541174|585891840|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
162229930|NCT03541174|585891841|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
162229931|NCT03541174|585891842|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
162229932|NCT03541174|585891843|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
162229933|NCT00605215|585891844|FG000|Overall Study|Death|0|||
162229934|NCT00605215|585891845|FG001|Overall Study|Death|0|||
162229935|NCT00605215|585891846|FG002|Overall Study|Death|1|||
162229936|NCT00605215|585891844|FG000|Overall Study|Adverse Event|19|||
162229937|NCT00605215|585891845|FG001|Overall Study|Adverse Event|21|||
162229938|NCT00605215|585891846|FG002|Overall Study|Adverse Event|26|||
162229939|NCT00605215|585891844|FG000|Overall Study|Refusal to sign the re-consent form|8|||
162229940|NCT00605215|585891845|FG001|Overall Study|Refusal to sign the re-consent form|3|||
162229941|NCT00605215|585891846|FG002|Overall Study|Refusal to sign the re-consent form|3|||
162229942|NCT00605215|585891844|FG000|Overall Study|Withdrawal by Subject|39|||
162229943|NCT00605215|585891845|FG001|Overall Study|Withdrawal by Subject|37|||
162229944|NCT00605215|585891846|FG002|Overall Study|Withdrawal by Subject|27|||
162229945|NCT00605215|585891844|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
162229946|NCT00605215|585891845|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
162229947|NCT00605215|585891846|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
162229948|NCT00605215|585891844|FG000|Overall Study|Protocol Violation|3|||
162229949|NCT00605215|585891845|FG001|Overall Study|Protocol Violation|4|||
162229950|NCT00605215|585891846|FG002|Overall Study|Protocol Violation|1|||
162229951|NCT00605215|585891844|FG000|Overall Study|Pregnancy|8|||
162229952|NCT00605215|585891845|FG001|Overall Study|Pregnancy|5|||
162229953|NCT00605215|585891846|FG002|Overall Study|Pregnancy|4|||
162229954|NCT00605215|585891844|FG000|Overall Study|Lost to Follow-up|8|||
162229955|NCT00605215|585891845|FG001|Overall Study|Lost to Follow-up|5|||
162229956|NCT00605215|585891846|FG002|Overall Study|Lost to Follow-up|2|||
162229957|NCT00605215|585891844|FG000|Overall Study|Other than specified|0|||
161829608|NCT00127166|584415841|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
161829609|NCT00105157|584415842|FG000|Double-Blind (DB)|Never Treated|1|||
162229958|NCT00605215|585891845|FG001|Overall Study|Other than specified|2|||
162229959|NCT00605215|585891846|FG002|Overall Study|Other than specified|1|||
162229960|NCT00275262|585891853|FG000|Overall Study|Adverse Event|2|||
162229961|NCT00275262|585891854|FG001|Overall Study|Adverse Event|0|||
162229962|NCT00275262|585891853|FG000|Overall Study|Disease progression|2|||
162229963|NCT00275262|585891854|FG001|Overall Study|Disease progression|5|||
162229964|NCT00275262|585891853|FG000|Overall Study|Lost to Follow-up|0|||
161829610|NCT00105157|584415843|FG001|Double-Blind (DB)|Never Treated|0|||
162229965|NCT00275262|585891854|FG001|Overall Study|Lost to Follow-up|2|||
162229966|NCT00275262|585891853|FG000|Overall Study|Protocol Violation|0|||
162229967|NCT00275262|585891854|FG001|Overall Study|Protocol Violation|2|||
162229968|NCT00275262|585891853|FG000|Overall Study|Death|1|||
162229969|NCT00275262|585891854|FG001|Overall Study|Death|0|||
162229970|NCT00275262|585891853|FG000|Overall Study|Started Chemotherapy|1|||
162229971|NCT00275262|585891854|FG001|Overall Study|Started Chemotherapy|0|||
162229972|NCT04058366|585891857|FG000|Overall Study|Adverse Event|14|||
162229973|NCT04058366|585891857|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
162229974|NCT04058366|585891857|FG000|Overall Study|Commercial drug is available for participants|6|||
162229975|NCT04058366|585891857|FG000|Overall Study|Death|1|||
162229976|NCT04058366|585891857|FG000|Overall Study|Other non-compliance|2|||
162229977|NCT04058366|585891857|FG000|Overall Study|Other|6|||
162229978|NCT02738203|585891858|FG000|Overall Study|Failed IUD Insertion|2|||
162229979|NCT02738203|585891859|FG001|Overall Study|Failed IUD Insertion|2|||
162229980|NCT02738203|585891858|FG000|Overall Study|Protocol Violation|0|||
162229981|NCT02738203|585891859|FG001|Overall Study|Protocol Violation|1|||
162229982|NCT05087979|585891860|FG000|Overall Study|Converted to general anesthesia|1|||
162229983|NCT05087979|585891861|FG001|Overall Study|Converted to general anesthesia|0|||
162229984|NCT00194987|585891862|FG000|Overall Study|Withdrawal by Subject|0|||
162229985|NCT00194987|585891863|FG001|Overall Study|Withdrawal by Subject|3|||
162229986|NCT01664598|585891864|FG000|Overall Study|Sponsor Decision|1|||
162229987|NCT01664598|585891864|FG000|Overall Study|Withdrawal of Informed Consent|4|||
162229988|NCT01664598|585891864|FG000|Overall Study|Adverse Event|1|||
162229989|NCT04988867|585891871|FG000|Overall Study|Study terminated by Sponsor|12|||
162229990|NCT04988867|585891871|FG000|Overall Study|Adverse Event|2|||
162229991|NCT04988867|585891871|FG000|Overall Study|Study drug noncompliance|1|||
162229992|NCT01097707|585891872|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162229993|NCT01097707|585891873|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
162229994|NCT01097707|585891874|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
162229995|NCT01097707|585891875|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
162229996|NCT01097707|585891876|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
162229997|NCT01097707|585891872|FG000|Overall Study|Adverse Event|4|||
162229998|NCT01097707|585891873|FG001|Overall Study|Adverse Event|2|||
162229999|NCT01097707|585891874|FG002|Overall Study|Adverse Event|3|||
162230000|NCT01097707|585891875|FG003|Overall Study|Adverse Event|1|||
162230001|NCT01097707|585891876|FG004|Overall Study|Adverse Event|3|||
162230002|NCT01097707|585891872|FG000|Overall Study|Entry Criteria Not Met|2|||
162230003|NCT01097707|585891873|FG001|Overall Study|Entry Criteria Not Met|1|||
162230004|NCT01097707|585891874|FG002|Overall Study|Entry Criteria Not Met|1|||
162230005|NCT01097707|585891875|FG003|Overall Study|Entry Criteria Not Met|0|||
162230006|NCT01097707|585891876|FG004|Overall Study|Entry Criteria Not Met|1|||
162230007|NCT01097707|585891872|FG000|Overall Study|Lack of Efficacy|1|||
162230008|NCT01097707|585891873|FG001|Overall Study|Lack of Efficacy|0|||
162230009|NCT01097707|585891874|FG002|Overall Study|Lack of Efficacy|0|||
162230010|NCT01097707|585891875|FG003|Overall Study|Lack of Efficacy|1|||
162230011|NCT01097707|585891876|FG004|Overall Study|Lack of Efficacy|0|||
162230012|NCT01097707|585891872|FG000|Overall Study|Lost to Follow-up|1|||
162230013|NCT01097707|585891873|FG001|Overall Study|Lost to Follow-up|1|||
162230014|NCT01097707|585891874|FG002|Overall Study|Lost to Follow-up|2|||
162230015|NCT01097707|585891875|FG003|Overall Study|Lost to Follow-up|0|||
162230016|NCT01097707|585891876|FG004|Overall Study|Lost to Follow-up|3|||
162230017|NCT01097707|585891872|FG000|Overall Study|Protocol Violation|2|||
162230018|NCT01097707|585891873|FG001|Overall Study|Protocol Violation|2|||
162230019|NCT01097707|585891874|FG002|Overall Study|Protocol Violation|3|||
162230020|NCT01097707|585891875|FG003|Overall Study|Protocol Violation|2|||
162230021|NCT01097707|585891876|FG004|Overall Study|Protocol Violation|2|||
161829611|NCT00105157|584415844|FG002|Double-Blind (DB)|Never Treated|0|||
161829612|NCT00105157|584415845|FG003|Double-Blind (DB)|Never Treated|0|||
161829613|NCT00105157|584415842|FG000|Double-Blind (DB)|Adverse Event|2|||
161829614|NCT00105157|584415843|FG001|Double-Blind (DB)|Adverse Event|0|||
161829615|NCT00105157|584415844|FG002|Double-Blind (DB)|Adverse Event|1|||
161829616|NCT00105157|584415845|FG003|Double-Blind (DB)|Adverse Event|1|||
161829617|NCT00105157|584415842|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
161829618|NCT00105157|584415843|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
161829619|NCT00105157|584415844|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
162230022|NCT01097707|585891872|FG000|Overall Study|Sponsor Decision|31|||
162230023|NCT01097707|585891873|FG001|Overall Study|Sponsor Decision|31|||
162230024|NCT01097707|585891874|FG002|Overall Study|Sponsor Decision|34|||
162230025|NCT01097707|585891875|FG003|Overall Study|Sponsor Decision|35|||
161829620|NCT00105157|584415845|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
161829621|NCT00105157|584415842|FG000|Open-Label Continuation of DB|Adverse Event|3|||
162230026|NCT01097707|585891876|FG004|Overall Study|Sponsor Decision|36|||
162230027|NCT01097707|585891872|FG000|Overall Study|Withdrawal by Subject|3|||
162230028|NCT01097707|585891873|FG001|Overall Study|Withdrawal by Subject|6|||
162230029|NCT01097707|585891874|FG002|Overall Study|Withdrawal by Subject|1|||
162230030|NCT01097707|585891875|FG003|Overall Study|Withdrawal by Subject|4|||
162230031|NCT01097707|585891876|FG004|Overall Study|Withdrawal by Subject|3|||
162230032|NCT01097707|585891872|FG000|Overall Study|Reason unknown|0|||
162230033|NCT01097707|585891873|FG001|Overall Study|Reason unknown|0|||
162230034|NCT01097707|585891874|FG002|Overall Study|Reason unknown|0|||
162230035|NCT01097707|585891875|FG003|Overall Study|Reason unknown|0|||
162230036|NCT01097707|585891876|FG004|Overall Study|Reason unknown|1|||
162230037|NCT04811131|585891881|FG000|Overall Study|Adverse Event|0|||
162230038|NCT04811131|585891882|FG001|Overall Study|Adverse Event|0|||
162230039|NCT04811131|585891883|FG002|Overall Study|Adverse Event|1|||
162230040|NCT04811131|585891884|FG003|Overall Study|Adverse Event|0|||
162230041|NCT04811131|585891881|FG000|Overall Study|Lack of Efficacy|0|||
162230042|NCT04811131|585891882|FG001|Overall Study|Lack of Efficacy|0|||
162230043|NCT04811131|585891883|FG002|Overall Study|Lack of Efficacy|0|||
162230044|NCT04811131|585891884|FG003|Overall Study|Lack of Efficacy|1|||
162230045|NCT04811131|585891881|FG000|Overall Study|Lost to Follow-up|0|||
162230046|NCT04811131|585891882|FG001|Overall Study|Lost to Follow-up|1|||
162230047|NCT04811131|585891883|FG002|Overall Study|Lost to Follow-up|0|||
162230048|NCT04811131|585891884|FG003|Overall Study|Lost to Follow-up|0|||
162230049|NCT04811131|585891881|FG000|Overall Study|Sponsor request|31|||
162230050|NCT04811131|585891882|FG001|Overall Study|Sponsor request|35|||
162230051|NCT04811131|585891883|FG002|Overall Study|Sponsor request|27|||
162230052|NCT04811131|585891884|FG003|Overall Study|Sponsor request|10|||
162230053|NCT04811131|585891881|FG000|Overall Study|Withdrawal by Subject|3|||
162230054|NCT04811131|585891882|FG001|Overall Study|Withdrawal by Subject|1|||
162230055|NCT04811131|585891883|FG002|Overall Study|Withdrawal by Subject|3|||
162230056|NCT04811131|585891884|FG003|Overall Study|Withdrawal by Subject|1|||
162230057|NCT01127763|585891887|FG000|Overall Study|Adverse Event|2|||
162230058|NCT01127763|585891887|FG000|Overall Study|Withdrawal by Subject|1|||
162230059|NCT01127763|585891887|FG000|Overall Study|Physician Decision|2|||
162230060|NCT03181789|585891889|FG000|Overall Study|Withdrawal by Subject|0|||
162230061|NCT03181789|585891890|FG001|Overall Study|Withdrawal by Subject|1|||
162230062|NCT03181789|585891891|FG002|Overall Study|Withdrawal by Subject|1|||
162230063|NCT03181789|585891892|FG003|Overall Study|Withdrawal by Subject|0|||
162230064|NCT03181789|585891889|FG000|Overall Study|Lost to Follow-up|7|||
162230065|NCT03181789|585891890|FG001|Overall Study|Lost to Follow-up|1|||
162230066|NCT03181789|585891891|FG002|Overall Study|Lost to Follow-up|0|||
162230067|NCT03181789|585891892|FG003|Overall Study|Lost to Follow-up|0|||
162230068|NCT03181789|585891889|FG000|Overall Study|Participant unable to adhere to visit|0|||
162230069|NCT03181789|585891890|FG001|Overall Study|Participant unable to adhere to visit|1|||
162230070|NCT03181789|585891891|FG002|Overall Study|Participant unable to adhere to visit|0|||
162230071|NCT03181789|585891892|FG003|Overall Study|Participant unable to adhere to visit|0|||
162230072|NCT01131182|585891893|FG000|Overall Study|Withdrawal by Subject|1|||
162230073|NCT01131182|585891894|FG001|Overall Study|Withdrawal by Subject|1|||
162230074|NCT01131182|585891893|FG000|Overall Study|Lost to Follow-up|14|||
162230075|NCT01131182|585891894|FG001|Overall Study|Lost to Follow-up|15|||
162230076|NCT01131182|585891893|FG000|Overall Study|Other Reason|1|||
162230077|NCT01131182|585891894|FG001|Overall Study|Other Reason|0|||
162230078|NCT00735475|585891895|FG000|Overall Study|Adverse Event|0|||
162230079|NCT00735475|585891896|FG001|Overall Study|Adverse Event|1|||
162230080|NCT00735475|585891895|FG000|Overall Study|Death|1|||
162230081|NCT00735475|585891896|FG001|Overall Study|Death|1|||
162230082|NCT00735475|585891895|FG000|Overall Study|Lost to Follow-up|3|||
162230083|NCT00735475|585891896|FG001|Overall Study|Lost to Follow-up|3|||
162230084|NCT00735475|585891895|FG000|Overall Study|Physician Decision|0|||
162230085|NCT00735475|585891896|FG001|Overall Study|Physician Decision|1|||
162230086|NCT00735475|585891895|FG000|Overall Study|Withdrawal by Subject|4|||
162230087|NCT00735475|585891896|FG001|Overall Study|Withdrawal by Subject|5|||
162230088|NCT05086276|585891897|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
162230089|NCT05086276|585891898|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
162230090|NCT00777088|585891899|FG000|Overall Study|PED Treatment not attempted|1|||
162230091|NCT00633880|585891900|FG000|Open Label Titration|Lack of Efficacy|1|||
162230092|NCT00633880|585891901|FG001|Open Label Titration|Lack of Efficacy|0|||
162230093|NCT00633880|585891902|FG002|Open Label Titration|Lack of Efficacy|0|||
162230094|NCT00633880|585891900|FG000|Open Label Titration|Adverse Event|13|||
162230095|NCT00633880|585891901|FG001|Open Label Titration|Adverse Event|0|||
162230096|NCT00633880|585891902|FG002|Open Label Titration|Adverse Event|0|||
162230097|NCT00633880|585891900|FG000|Open Label Titration|Treatment Failure|55|||
162230098|NCT00633880|585891901|FG001|Open Label Titration|Treatment Failure|0|||
162230099|NCT00633880|585891902|FG002|Open Label Titration|Treatment Failure|0|||
162230100|NCT00633880|585891900|FG000|Open Label Titration|Protocol Violation|6|||
162230101|NCT00633880|585891901|FG001|Open Label Titration|Protocol Violation|0|||
162230102|NCT00633880|585891902|FG002|Open Label Titration|Protocol Violation|0|||
162230103|NCT00633880|585891900|FG000|Open Label Titration|Physician Decision|1|||
162230104|NCT00633880|585891901|FG001|Open Label Titration|Physician Decision|0|||
162230105|NCT00633880|585891902|FG002|Open Label Titration|Physician Decision|0|||
162230106|NCT00633880|585891900|FG000|Open Label Titration|Withdrawal by Subject|4|||
162230107|NCT00633880|585891901|FG001|Open Label Titration|Withdrawal by Subject|0|||
162230108|NCT00633880|585891902|FG002|Open Label Titration|Withdrawal by Subject|0|||
162230109|NCT03117998|585891905|FG000|Overall Study|Adverse Event|1|||
162230110|NCT03117998|585891906|FG001|Overall Study|Adverse Event|0|||
162230111|NCT03117998|585891907|FG002|Overall Study|Adverse Event|0|||
162230112|NCT03117998|585891908|FG003|Overall Study|Adverse Event|0|||
162230113|NCT03117998|585891909|FG004|Overall Study|Adverse Event|0|||
162230114|NCT03117998|585891910|FG005|Overall Study|Adverse Event|0|||
162230115|NCT03117998|585891905|FG000|Overall Study|Withdrawal by Subject|0|||
162230116|NCT03117998|585891906|FG001|Overall Study|Withdrawal by Subject|0|||
162230117|NCT03117998|585891907|FG002|Overall Study|Withdrawal by Subject|2|||
162230118|NCT03117998|585891908|FG003|Overall Study|Withdrawal by Subject|3|||
162230119|NCT03117998|585891909|FG004|Overall Study|Withdrawal by Subject|3|||
162230120|NCT03117998|585891910|FG005|Overall Study|Withdrawal by Subject|0|||
162230121|NCT03117998|585891905|FG000|Overall Study|Physician Decision|0|||
162230122|NCT03117998|585891906|FG001|Overall Study|Physician Decision|1|||
162230123|NCT03117998|585891907|FG002|Overall Study|Physician Decision|1|||
162230124|NCT03117998|585891908|FG003|Overall Study|Physician Decision|0|||
162230125|NCT03117998|585891909|FG004|Overall Study|Physician Decision|0|||
162230126|NCT03117998|585891910|FG005|Overall Study|Physician Decision|0|||
162230127|NCT03117998|585891905|FG000|Overall Study|Lost to Follow-up|0|||
162230128|NCT03117998|585891906|FG001|Overall Study|Lost to Follow-up|0|||
162230129|NCT03117998|585891907|FG002|Overall Study|Lost to Follow-up|0|||
162230130|NCT03117998|585891908|FG003|Overall Study|Lost to Follow-up|1|||
162230131|NCT03117998|585891909|FG004|Overall Study|Lost to Follow-up|4|||
162230132|NCT03117998|585891910|FG005|Overall Study|Lost to Follow-up|0|||
162230133|NCT03117998|585891905|FG000|Overall Study|Subject noncompliance|0|||
162230134|NCT03117998|585891906|FG001|Overall Study|Subject noncompliance|0|||
162230135|NCT03117998|585891907|FG002|Overall Study|Subject noncompliance|1|||
162230136|NCT03117998|585891908|FG003|Overall Study|Subject noncompliance|0|||
162230137|NCT03117998|585891909|FG004|Overall Study|Subject noncompliance|0|||
162230138|NCT03117998|585891910|FG005|Overall Study|Subject noncompliance|2|||
162230139|NCT03117998|585891905|FG000|Overall Study|Protocol Violation|0|||
162230140|NCT03117998|585891906|FG001|Overall Study|Protocol Violation|0|||
162230141|NCT03117998|585891907|FG002|Overall Study|Protocol Violation|0|||
162230142|NCT03117998|585891908|FG003|Overall Study|Protocol Violation|0|||
162230143|NCT03117998|585891909|FG004|Overall Study|Protocol Violation|0|||
162230144|NCT03117998|585891910|FG005|Overall Study|Protocol Violation|1|||
162230145|NCT04927247|585891911|FG000|Overall Study|Other|2|||
162230146|NCT04927247|585891912|FG001|Overall Study|Other|1|||
162230147|NCT04927247|585891911|FG000|Overall Study|Physician Decision|0|||
162230148|NCT04927247|585891912|FG001|Overall Study|Physician Decision|1|||
162230149|NCT04927247|585891911|FG000|Overall Study|Adverse Event|1|||
162230150|NCT04927247|585891912|FG001|Overall Study|Adverse Event|0|||
162230151|NCT01468181|585891914|FG000|Overall Study|Adverse Event|8|||
162230152|NCT01468181|585891915|FG001|Overall Study|Adverse Event|1|||
162230153|NCT01468181|585891916|FG002|Overall Study|Adverse Event|6|||
162230154|NCT01468181|585891917|FG003|Overall Study|Adverse Event|2|||
162230155|NCT01468181|585891918|FG004|Overall Study|Adverse Event|2|||
162230156|NCT01468181|585891914|FG000|Overall Study|Protocol Violation|2|||
162230157|NCT01468181|585891915|FG001|Overall Study|Protocol Violation|0|||
162230158|NCT01468181|585891916|FG002|Overall Study|Protocol Violation|1|||
162230159|NCT01468181|585891917|FG003|Overall Study|Protocol Violation|0|||
162230160|NCT01468181|585891918|FG004|Overall Study|Protocol Violation|1|||
161829622|NCT00105157|584415843|FG001|Open-Label Continuation of DB|Adverse Event|1|||
162230161|NCT01468181|585891914|FG000|Overall Study|Physician Decision|0|||
162230162|NCT01468181|585891915|FG001|Overall Study|Physician Decision|0|||
162230163|NCT01468181|585891916|FG002|Overall Study|Physician Decision|0|||
162230164|NCT01468181|585891917|FG003|Overall Study|Physician Decision|1|||
162230165|NCT01468181|585891918|FG004|Overall Study|Physician Decision|1|||
162230166|NCT01468181|585891914|FG000|Overall Study|Lost to Follow-up|0|||
162230167|NCT01468181|585891915|FG001|Overall Study|Lost to Follow-up|0|||
162230168|NCT01468181|585891916|FG002|Overall Study|Lost to Follow-up|1|||
162230169|NCT01468181|585891917|FG003|Overall Study|Lost to Follow-up|0|||
162230170|NCT01468181|585891918|FG004|Overall Study|Lost to Follow-up|1|||
162230171|NCT01468181|585891914|FG000|Overall Study|Withdrawal by Subject|0|||
162230172|NCT01468181|585891915|FG001|Overall Study|Withdrawal by Subject|1|||
162230173|NCT01468181|585891916|FG002|Overall Study|Withdrawal by Subject|0|||
162230174|NCT01468181|585891917|FG003|Overall Study|Withdrawal by Subject|0|||
162230175|NCT01468181|585891918|FG004|Overall Study|Withdrawal by Subject|0|||
162230176|NCT00513305|585891922|FG000|Overall Study|Adverse Event|6|||
162230177|NCT00513305|585891923|FG001|Overall Study|Adverse Event|2|||
162230178|NCT00513305|585891922|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
162230179|NCT00513305|585891923|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
162230180|NCT00513305|585891922|FG000|Overall Study|Lack of Efficacy|8|||
162230181|NCT00513305|585891923|FG001|Overall Study|Lack of Efficacy|13|||
162230182|NCT00513305|585891922|FG000|Overall Study|Withdrawal by Subject|1|||
162230183|NCT00513305|585891923|FG001|Overall Study|Withdrawal by Subject|2|||
162230184|NCT00513305|585891922|FG000|Overall Study|Disease progression|8|||
162230185|NCT00513305|585891923|FG001|Overall Study|Disease progression|5|||
162230186|NCT00513305|585891922|FG000|Overall Study|Eligible for stem cell transplant|1|||
162230187|NCT00513305|585891923|FG001|Overall Study|Eligible for stem cell transplant|0|||
162230188|NCT00513305|585891922|FG000|Overall Study|Hematologic counts did not recover|1|||
162230189|NCT00513305|585891923|FG001|Overall Study|Hematologic counts did not recover|0|||
162230190|NCT00513305|585891922|FG000|Overall Study|Physician Decision|1|||
162230191|NCT00513305|585891923|FG001|Overall Study|Physician Decision|0|||
162230192|NCT00513305|585891922|FG000|Overall Study|Persistent hypocellularity|0|||
162230193|NCT00513305|585891923|FG001|Overall Study|Persistent hypocellularity|1|||
162023702|NCT00830869|585144487|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
162023703|NCT00830869|585144488|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
162023704|NCT00830869|585144489|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
162023705|NCT00830869|585144490|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
162023706|NCT00830869|585144491|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
162023707|NCT00830869|585144492|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
162023708|NCT00830869|585144481|FG000|Period 2: Part 2|Progressive disease|0|||
162023709|NCT00830869|585144482|FG001|Period 2: Part 2|Progressive disease|0|||
162230194|NCT00513305|585891922|FG000|Overall Study|Sponsor Decision|0|||
162230195|NCT00513305|585891923|FG001|Overall Study|Sponsor Decision|2|||
162230196|NCT01262027|585891925|FG000|Overall Study|Adverse Event|1|||
162230197|NCT01262027|585891925|FG000|Overall Study|Withdrawal by Subject|3|||
162230198|NCT01262027|585891925|FG000|Overall Study|Protocol Violation|1|||
162230199|NCT02489968|585891929|FG000|Open-label Treatment Period|Adverse Event|14|||
162023710|NCT00830869|585144483|FG002|Period 2: Part 2|Progressive disease|0|||
162023711|NCT00830869|585144484|FG003|Period 2: Part 2|Progressive disease|0|||
162023712|NCT00830869|585144485|FG004|Period 2: Part 2|Progressive disease|0|||
162023713|NCT00830869|585144486|FG005|Period 2: Part 2|Progressive disease|0|||
162023714|NCT00830869|585144487|FG006|Period 2: Part 2|Progressive disease|0|||
162230200|NCT02489968|585891930|FG001|Open-label Treatment Period|Adverse Event|7|||
162230201|NCT02489968|585891931|FG002|Open-label Treatment Period|Adverse Event|0|||
162230202|NCT02489968|585891932|FG003|Open-label Treatment Period|Adverse Event|0|||
162230203|NCT02489968|585891933|FG004|Open-label Treatment Period|Adverse Event|0|||
162230204|NCT02489968|585891934|FG005|Open-label Treatment Period|Adverse Event|0|||
162230205|NCT02489968|585891929|FG000|Open-label Treatment Period|Protocol Violation|2|||
162230206|NCT02489968|585891930|FG001|Open-label Treatment Period|Protocol Violation|2|||
162230207|NCT02489968|585891931|FG002|Open-label Treatment Period|Protocol Violation|0|||
162230208|NCT02489968|585891932|FG003|Open-label Treatment Period|Protocol Violation|0|||
162230209|NCT02489968|585891933|FG004|Open-label Treatment Period|Protocol Violation|0|||
162230210|NCT02489968|585891934|FG005|Open-label Treatment Period|Protocol Violation|0|||
162230211|NCT02489968|585891929|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
162230212|NCT02489968|585891930|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
162230213|NCT02489968|585891931|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
162230214|NCT02489968|585891932|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
162230215|NCT02489968|585891933|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
162230216|NCT02489968|585891934|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
162230217|NCT02489968|585891929|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
162230218|NCT02489968|585891930|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
162230219|NCT02489968|585891931|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
162230220|NCT02489968|585891932|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
162230221|NCT02489968|585891933|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
162230222|NCT02489968|585891934|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
162230223|NCT02489968|585891929|FG000|Open-label Treatment Period|Other than specified above|204|||
162230224|NCT02489968|585891930|FG001|Open-label Treatment Period|Other than specified above|189|||
162230225|NCT02489968|585891931|FG002|Open-label Treatment Period|Other than specified above|0|||
161829623|NCT00105157|584415844|FG002|Open-Label Continuation of DB|Adverse Event|0|||
162023715|NCT00830869|585144488|FG007|Period 2: Part 2|Progressive disease|14|||
161829624|NCT00105157|584415845|FG003|Open-Label Continuation of DB|Adverse Event|0|||
161829625|NCT00105157|584415842|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
161829626|NCT00105157|584415843|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
161829627|NCT00105157|584415844|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
162023716|NCT00830869|585144489|FG008|Period 2: Part 2|Progressive disease|11|||
162230226|NCT02489968|585891932|FG003|Open-label Treatment Period|Other than specified above|0|||
162230227|NCT02489968|585891933|FG004|Open-label Treatment Period|Other than specified above|0|||
162230228|NCT02489968|585891934|FG005|Open-label Treatment Period|Other than specified above|0|||
162230229|NCT02489968|585891929|FG000|Double-blind Treatment Period|Adverse Event|0|||
162023717|NCT00830869|585144490|FG009|Period 2: Part 2|Progressive disease|12|||
162023718|NCT00830869|585144491|FG010|Period 2: Part 2|Progressive disease|8|||
162023719|NCT00830869|585144492|FG011|Period 2: Part 2|Progressive disease|15|||
162023720|NCT00830869|585144481|FG000|Period 2: Part 2|Other|0|||
162230230|NCT02489968|585891930|FG001|Double-blind Treatment Period|Adverse Event|0|||
162230231|NCT02489968|585891931|FG002|Double-blind Treatment Period|Adverse Event|2|||
162230232|NCT02489968|585891932|FG003|Double-blind Treatment Period|Adverse Event|6|||
162230233|NCT02489968|585891933|FG004|Double-blind Treatment Period|Adverse Event|4|||
162230234|NCT02489968|585891934|FG005|Double-blind Treatment Period|Adverse Event|5|||
162230235|NCT02489968|585891929|FG000|Double-blind Treatment Period|Protocol Violation|0|||
162230236|NCT02489968|585891930|FG001|Double-blind Treatment Period|Protocol Violation|0|||
162230237|NCT02489968|585891931|FG002|Double-blind Treatment Period|Protocol Violation|0|||
162230238|NCT02489968|585891932|FG003|Double-blind Treatment Period|Protocol Violation|0|||
162230239|NCT02489968|585891933|FG004|Double-blind Treatment Period|Protocol Violation|1|||
162230240|NCT02489968|585891934|FG005|Double-blind Treatment Period|Protocol Violation|1|||
162230241|NCT02489968|585891929|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
162230242|NCT02489968|585891930|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
162230243|NCT02489968|585891931|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
162230244|NCT02489968|585891932|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
162230245|NCT02489968|585891933|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
162230246|NCT02489968|585891934|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
162230247|NCT02489968|585891929|FG000|Double-blind Treatment Period|Other than specified above|0|||
162230248|NCT02489968|585891930|FG001|Double-blind Treatment Period|Other than specified above|0|||
162230249|NCT02489968|585891931|FG002|Double-blind Treatment Period|Other than specified above|0|||
162230250|NCT02489968|585891932|FG003|Double-blind Treatment Period|Other than specified above|0|||
162230251|NCT02489968|585891933|FG004|Double-blind Treatment Period|Other than specified above|1|||
162230252|NCT02489968|585891934|FG005|Double-blind Treatment Period|Other than specified above|0|||
162230253|NCT03738423|585891935|FG000|Overall Study|Withdrawal by Subject|9|||
161940165|NCT03648372|584830779|FG003|Overall Study|Progressive Disease|3|||
161940166|NCT03648372|584830780|FG004|Overall Study|Progressive Disease|2|||
161940167|NCT03648372|584830781|FG005|Overall Study|Progressive Disease|2|||
161940168|NCT03648372|584830782|FG006|Overall Study|Progressive Disease|3|||
161940169|NCT03648372|584830783|FG007|Overall Study|Progressive Disease|3|||
161940170|NCT03648372|584830784|FG008|Overall Study|Progressive Disease|5|||
161940171|NCT03648372|584830785|FG009|Overall Study|Progressive Disease|5|||
161940172|NCT03648372|584830786|FG010|Overall Study|Progressive Disease|2|||
161940173|NCT03648372|584830787|FG011|Overall Study|Progressive Disease|3|||
161940174|NCT03648372|584830788|FG012|Overall Study|Progressive Disease|3|||
161940175|NCT03648372|584830789|FG013|Overall Study|Progressive Disease|3|||
162230254|NCT03738423|585891936|FG001|Overall Study|Withdrawal by Subject|12|||
162230255|NCT03738423|585891937|FG002|Overall Study|Withdrawal by Subject|9|||
162230256|NCT03738423|585891938|FG003|Overall Study|Withdrawal by Subject|12|||
162230257|NCT03738423|585891939|FG004|Overall Study|Withdrawal by Subject|10|||
162230258|NCT03738423|585891935|FG000|Overall Study|Lack of Efficacy|3|||
162230259|NCT03738423|585891936|FG001|Overall Study|Lack of Efficacy|1|||
162230260|NCT03738423|585891937|FG002|Overall Study|Lack of Efficacy|1|||
162230261|NCT03738423|585891938|FG003|Overall Study|Lack of Efficacy|1|||
162230262|NCT03738423|585891939|FG004|Overall Study|Lack of Efficacy|2|||
162230263|NCT03738423|585891935|FG000|Overall Study|Lost to Follow-up|1|||
162230264|NCT03738423|585891936|FG001|Overall Study|Lost to Follow-up|0|||
162230265|NCT03738423|585891937|FG002|Overall Study|Lost to Follow-up|1|||
162230266|NCT03738423|585891938|FG003|Overall Study|Lost to Follow-up|1|||
162230267|NCT03738423|585891939|FG004|Overall Study|Lost to Follow-up|0|||
162230268|NCT03738423|585891935|FG000|Overall Study|Protocol Violation|1|||
162230269|NCT03738423|585891936|FG001|Overall Study|Protocol Violation|0|||
161940176|NCT03648372|584830790|FG014|Overall Study|Progressive Disease|6|||
161940177|NCT03648372|584830791|FG015|Overall Study|Progressive Disease|0|||
161940178|NCT03648372|584830792|FG016|Overall Study|Progressive Disease|0|||
161940179|NCT03648372|584830793|FG017|Overall Study|Progressive Disease|0|||
161940180|NCT03648372|584830794|FG018|Overall Study|Progressive Disease|0|||
161940181|NCT03648372|584830795|FG019|Overall Study|Progressive Disease|0|||
161940182|NCT03648372|584830796|FG020|Overall Study|Progressive Disease|0|||
162230270|NCT03738423|585891937|FG002|Overall Study|Protocol Violation|0|||
162230271|NCT03738423|585891938|FG003|Overall Study|Protocol Violation|0|||
162230272|NCT03738423|585891939|FG004|Overall Study|Protocol Violation|1|||
162230273|NCT03738423|585891935|FG000|Overall Study|Physician Decision|0|||
162230274|NCT03738423|585891936|FG001|Overall Study|Physician Decision|0|||
162230275|NCT03738423|585891937|FG002|Overall Study|Physician Decision|1|||
162230276|NCT03738423|585891938|FG003|Overall Study|Physician Decision|0|||
162230277|NCT03738423|585891939|FG004|Overall Study|Physician Decision|1|||
162230278|NCT03738423|585891935|FG000|Overall Study|Death|0|||
162230279|NCT03738423|585891936|FG001|Overall Study|Death|0|||
162230280|NCT03738423|585891937|FG002|Overall Study|Death|0|||
162230281|NCT03738423|585891938|FG003|Overall Study|Death|0|||
162230282|NCT03738423|585891939|FG004|Overall Study|Death|1|||
162230283|NCT03738423|585891935|FG000|Overall Study|Randomized but never treated|0|||
162230284|NCT03738423|585891936|FG001|Overall Study|Randomized but never treated|0|||
162230285|NCT03738423|585891937|FG002|Overall Study|Randomized but never treated|1|||
162230286|NCT03738423|585891938|FG003|Overall Study|Randomized but never treated|1|||
162230287|NCT03738423|585891939|FG004|Overall Study|Randomized but never treated|0|||
162230288|NCT02592876|585891945|FG000|Overall Study|Withdrawal by Subject|3|||
162230289|NCT02592876|585891946|FG001|Overall Study|Withdrawal by Subject|3|||
162230290|NCT02592876|585891945|FG000|Overall Study|Study Termination by Sponsor|32|||
162230291|NCT02592876|585891946|FG001|Overall Study|Study Termination by Sponsor|27|||
162230292|NCT02592876|585891945|FG000|Overall Study|Lost to Follow-up|0|||
162230293|NCT02592876|585891946|FG001|Overall Study|Lost to Follow-up|1|||
162230294|NCT02592876|585891945|FG000|Overall Study|Death|6|||
162230295|NCT02592876|585891946|FG001|Overall Study|Death|9|||
162230296|NCT01865747|585891947|FG000|Overall Study (ITT)|Adverse Event|32|||
162230297|NCT01865747|585891948|FG001|Overall Study (ITT)|Adverse Event|31|||
162230298|NCT01865747|585891947|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
162230299|NCT01865747|585891948|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
162230300|NCT01865747|585891947|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
162230301|NCT01865747|585891948|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
162230302|NCT01865747|585891947|FG000|Overall Study (ITT)|Protocol Violation|1|||
162230303|NCT01865747|585891948|FG001|Overall Study (ITT)|Protocol Violation|1|||
162230304|NCT01865747|585891947|FG000|Overall Study (ITT)|Physician Decision|5|||
162230305|NCT01865747|585891948|FG001|Overall Study (ITT)|Physician Decision|2|||
162230306|NCT01865747|585891947|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
162230307|NCT01865747|585891948|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
162230308|NCT01865747|585891947|FG000|Overall Study (ITT)|Sponsor Decision|0|||
162230309|NCT01865747|585891948|FG001|Overall Study (ITT)|Sponsor Decision|1|||
162230310|NCT01865747|585891947|FG000|Overall Study (ITT)|Progressive Disease|122|||
162230311|NCT01865747|585891948|FG001|Overall Study (ITT)|Progressive Disease|158|||
162230312|NCT01865747|585891947|FG000|Overall Study (ITT)|Reason Not Provided|0|||
162230313|NCT01865747|585891948|FG001|Overall Study (ITT)|Reason Not Provided|1|||
162230314|NCT01865747|585891947|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
162230315|NCT01865747|585891948|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
162230316|NCT01865747|585891947|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
162230317|NCT01865747|585891948|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
162230318|NCT01865747|585891947|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
162230319|NCT01865747|585891948|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
162230320|NCT01865747|585891947|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
162230321|NCT01865747|585891948|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
162230322|NCT01865747|585891947|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
162230323|NCT01865747|585891948|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
162230324|NCT01865747|585891947|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
162230325|NCT01865747|585891948|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
162230326|NCT01865747|585891947|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
162230327|NCT01865747|585891948|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
162230328|NCT01865747|585891947|FG000|Primary Intent to Treat (PITT)|Other|0|||
162230329|NCT01865747|585891948|FG001|Primary Intent to Treat (PITT)|Other|1|||
162230330|NCT00867308|585891949|FG000|Overall Study|Death|1|||
162230331|NCT00867308|585891950|FG001|Overall Study|Death|0|||
162230332|NCT00867308|585891949|FG000|Overall Study|Adverse Event|1|||
161829628|NCT00105157|584415845|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
161829629|NCT00105157|584415842|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
162230333|NCT00867308|585891950|FG001|Overall Study|Adverse Event|4|||
161829630|NCT00105157|584415843|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
162230334|NCT00867308|585891949|FG000|Overall Study|Lack of Efficacy|6|||
162230335|NCT00867308|585891950|FG001|Overall Study|Lack of Efficacy|12|||
161829631|NCT00105157|584415844|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
161829632|NCT00105157|584415845|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
161829633|NCT00105157|584415842|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
161829634|NCT00105157|584415843|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
161829635|NCT00105157|584415844|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
161829636|NCT00105157|584415845|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
161679569|NCT03061175|583879161|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
161679570|NCT00199836|583879162|FG000|Overall Study|Progressive Disease|5|||
161679571|NCT00199836|583879162|FG000|Overall Study|Death|1|||
162230336|NCT00867308|585891949|FG000|Overall Study|Withdrawal by Subject|1|||
162230337|NCT00867308|585891950|FG001|Overall Study|Withdrawal by Subject|2|||
162230338|NCT00611975|585891953|FG000|Overall Study|Withdrawal by Subject|3|||
162230339|NCT00611975|585891954|FG001|Overall Study|Withdrawal by Subject|7|||
162230340|NCT00611975|585891953|FG000|Overall Study|Pregnancy|2|||
162230341|NCT00611975|585891954|FG001|Overall Study|Pregnancy|1|||
162230342|NCT04625413|585891955|FG000|Overall Study|Hospice|2|||
162230343|NCT04625413|585891955|FG000|Overall Study|Distress|1|||
162230344|NCT04625413|585891955|FG000|Overall Study|Not feeling well|1|||
162230345|NCT01982448|585891959|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
162230346|NCT01982448|585891960|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
162230347|NCT01982448|585891959|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
162230348|NCT01982448|585891960|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
162230349|NCT01982448|585891959|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
162230350|NCT01982448|585891960|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
162230351|NCT01982448|585891959|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
161940183|NCT03648372|584830776|FG000|Overall Study|Other|0|||
161940184|NCT03648372|584830777|FG001|Overall Study|Other|0|||
162230352|NCT01982448|585891960|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
161940185|NCT03648372|584830778|FG002|Overall Study|Other|0|||
161940186|NCT03648372|584830779|FG003|Overall Study|Other|0|||
162230353|NCT00432666|585893362|FG000|Main Period|Adverse Event|1|||
162230354|NCT00432666|585893363|FG001|Main Period|Adverse Event|1|||
162230355|NCT00432666|585893362|FG000|Main Period|Consent Withdrawn|1|||
161940187|NCT03648372|584830780|FG004|Overall Study|Other|1|||
162230356|NCT00432666|585893363|FG001|Main Period|Consent Withdrawn|0|||
162230357|NCT00432666|585893362|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
162230358|NCT00432666|585893363|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
162230359|NCT00432666|585893362|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
162230360|NCT00432666|585893363|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
162230361|NCT00432666|585893362|FG000|Open-Label Extension Period|Adverse Event|5|||
162230362|NCT00432666|585893363|FG001|Open-Label Extension Period|Adverse Event|0|||
162230363|NCT00432666|585893362|FG000|Open-Label Extension Period|Consent withdrawn|10|||
162230364|NCT00432666|585893363|FG001|Open-Label Extension Period|Consent withdrawn|0|||
162230365|NCT00432666|585893362|FG000|Open-Label Extension Period|Physician Decision|3|||
162230366|NCT00432666|585893363|FG001|Open-Label Extension Period|Physician Decision|0|||
162230367|NCT00978627|585893364|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
162230368|NCT00978627|585893365|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
162230369|NCT00978627|585893364|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
162230370|NCT00978627|585893365|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
162230371|NCT00978627|585893364|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
162230372|NCT00978627|585893365|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
162230373|NCT00978627|585893364|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
162230374|NCT00978627|585893365|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
162230375|NCT00978627|585893364|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
162230376|NCT00978627|585893365|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
162230377|NCT00978627|585893364|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
162230378|NCT00978627|585893365|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
162230379|NCT00978627|585893364|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
162230380|NCT00978627|585893365|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
162230381|NCT00978627|585893364|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
162230382|NCT00978627|585893365|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
162230383|NCT00978627|585893364|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
162230384|NCT00978627|585893365|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
162230385|NCT01506453|585893366|FG000|Overall Study|Withdrawal prior to treatment|0|||
162230386|NCT01506453|585893367|FG001|Overall Study|Withdrawal prior to treatment|2|||
162230387|NCT00603304|585893378|FG000|Overall Study|Lost to Follow-up|5|||
162230388|NCT00603304|585893379|FG001|Overall Study|Lost to Follow-up|7|||
162230389|NCT00603304|585893378|FG000|Overall Study|Withdrawal by Subject|8|||
162230390|NCT00603304|585893379|FG001|Overall Study|Withdrawal by Subject|5|||
162230391|NCT00603304|585893378|FG000|Overall Study|Protocol Violation|1|||
162230392|NCT00603304|585893379|FG001|Overall Study|Protocol Violation|0|||
162230393|NCT00603304|585893378|FG000|Overall Study|Adverse Event|4|||
162230394|NCT00603304|585893379|FG001|Overall Study|Adverse Event|2|||
162230395|NCT00603304|585893378|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
162230396|NCT00603304|585893379|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
162230397|NCT00603304|585893378|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
162230398|NCT00603304|585893379|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
162230399|NCT00603304|585893378|FG000|Overall Study|Exclusionary Medication|2|||
162230400|NCT00603304|585893379|FG001|Overall Study|Exclusionary Medication|3|||
162230401|NCT00603304|585893378|FG000|Overall Study|Non-Compliant|0|||
162230402|NCT00603304|585893379|FG001|Overall Study|Non-Compliant|1|||
162230403|NCT00603304|585893378|FG000|Overall Study|Moved Away|0|||
162230404|NCT00603304|585893379|FG001|Overall Study|Moved Away|2|||
162230405|NCT00603304|585893378|FG000|Overall Study|Other|2|||
162230406|NCT00603304|585893379|FG001|Overall Study|Other|0|||
162230407|NCT00603304|585893378|FG000|Overall Study|Patient Decision|2|||
162230408|NCT00603304|585893379|FG001|Overall Study|Patient Decision|0|||
162230409|NCT01076192|585893380|FG000|Overall Study|Other|197|||
162230410|NCT01290315|585893381|FG000|Overall Study|Adverse Event|0|||
162230411|NCT01290315|585893382|FG001|Overall Study|Adverse Event|0|||
162230412|NCT01290315|585893383|FG002|Overall Study|Adverse Event|0|||
162230413|NCT01290315|585893384|FG003|Overall Study|Adverse Event|3|||
162230414|NCT01290315|585893381|FG000|Overall Study|Selection criteria/compliance|2|||
162230415|NCT01290315|585893382|FG001|Overall Study|Selection criteria/compliance|1|||
161679572|NCT00760669|583879163|FG000|Overall Study|Not assessed for overall improvement|18|||
161679573|NCT00760669|583879163|FG000|Overall Study|Participants missing efficacy assessment|6|||
162230416|NCT01290315|585893383|FG002|Overall Study|Selection criteria/compliance|0|||
162230417|NCT01290315|585893384|FG003|Overall Study|Selection criteria/compliance|2|||
162230418|NCT01290315|585893381|FG000|Overall Study|Lost to Follow-up|0|||
162230419|NCT01290315|585893382|FG001|Overall Study|Lost to Follow-up|1|||
162230420|NCT01290315|585893383|FG002|Overall Study|Lost to Follow-up|0|||
162230421|NCT01290315|585893384|FG003|Overall Study|Lost to Follow-up|0|||
162230422|NCT01290315|585893381|FG000|Overall Study|Withdrawal by Subject|1|||
162230423|NCT01290315|585893382|FG001|Overall Study|Withdrawal by Subject|1|||
162230424|NCT01290315|585893383|FG002|Overall Study|Withdrawal by Subject|0|||
162230425|NCT01290315|585893384|FG003|Overall Study|Withdrawal by Subject|0|||
162230426|NCT03725085|585893385|FG000|Overall Study|Lost to Follow-up|2|||
162230427|NCT00705679|585893386|FG000|Overall Study|Adverse Event|1|||
162230428|NCT00705679|585893387|FG001|Overall Study|Adverse Event|1|||
162230429|NCT00705679|585893388|FG002|Overall Study|Adverse Event|0|||
162230430|NCT00705679|585893389|FG003|Overall Study|Adverse Event|0|||
162230431|NCT00705679|585893390|FG004|Overall Study|Adverse Event|0|||
162230432|NCT00705679|585893386|FG000|Overall Study|Death|0|||
162230433|NCT00705679|585893387|FG001|Overall Study|Death|0|||
162230434|NCT00705679|585893388|FG002|Overall Study|Death|3|||
162230435|NCT00705679|585893389|FG003|Overall Study|Death|2|||
162230436|NCT00705679|585893390|FG004|Overall Study|Death|1|||
162230437|NCT00705679|585893386|FG000|Overall Study|Lost to Follow-up|32|||
162230438|NCT00705679|585893387|FG001|Overall Study|Lost to Follow-up|60|||
162230439|NCT00705679|585893388|FG002|Overall Study|Lost to Follow-up|44|||
162230440|NCT00705679|585893389|FG003|Overall Study|Lost to Follow-up|30|||
162230441|NCT00705679|585893390|FG004|Overall Study|Lost to Follow-up|35|||
162230442|NCT00705679|585893386|FG000|Overall Study|Physician Decision|0|||
162230443|NCT00705679|585893387|FG001|Overall Study|Physician Decision|1|||
162230444|NCT00705679|585893388|FG002|Overall Study|Physician Decision|0|||
162230445|NCT00705679|585893389|FG003|Overall Study|Physician Decision|1|||
162230446|NCT00705679|585893390|FG004|Overall Study|Physician Decision|0|||
162230447|NCT00705679|585893386|FG000|Overall Study|Withdrawal by Subject|32|||
162230448|NCT00705679|585893387|FG001|Overall Study|Withdrawal by Subject|77|||
162230449|NCT00705679|585893388|FG002|Overall Study|Withdrawal by Subject|68|||
162230450|NCT00705679|585893389|FG003|Overall Study|Withdrawal by Subject|47|||
162230451|NCT00705679|585893390|FG004|Overall Study|Withdrawal by Subject|33|||
162230452|NCT03527173|585893391|FG000|Overall Study|Lost to Follow-up|4|||
161679574|NCT00760669|583879163|FG000|Overall Study|Participants with overlapping cases|1|||
161679575|NCT00760669|583879163|FG000|Overall Study|Took drug before entering in contract|5|||
161679576|NCT02456662|583879172|FG000|Overall Study|Lost to Follow-up|2|||
161679577|NCT02456662|583879173|FG001|Overall Study|Lost to Follow-up|1|||
161679578|NCT00504153|583879178|FG000|Overall Study|Withdrawal by Subject|1|||
162230453|NCT03527173|585893392|FG001|Overall Study|Lost to Follow-up|2|||
162230454|NCT03527173|585893391|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
162230455|NCT03527173|585893392|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
162230456|NCT03527173|585893391|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
162230457|NCT03527173|585893392|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
162230458|NCT03527173|585893391|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
162230459|NCT03527173|585893392|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
162230460|NCT02704754|585893393|FG000|Overall Study|Lost to Follow-up|1|||
162230461|NCT02704754|585893394|FG001|Overall Study|Lost to Follow-up|1|||
162230462|NCT02704754|585893393|FG000|Overall Study|Lack of Efficacy|1|||
162230463|NCT02704754|585893394|FG001|Overall Study|Lack of Efficacy|0|||
161679579|NCT00504153|583879178|FG000|Overall Study|Adverse Event|4|||
162230464|NCT02704754|585893393|FG000|Overall Study|Withdrawal by Subject|1|||
162230465|NCT02704754|585893394|FG001|Overall Study|Withdrawal by Subject|0|||
162230466|NCT00423943|585893397|FG000|Overall Study|Withdrawal by Subject|3|||
162230467|NCT00423943|585893398|FG001|Overall Study|Withdrawal by Subject|1|||
162230468|NCT03730480|585893399|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
162230469|NCT01248780|585893400|FG000|Overall Study|Lack of Efficacy|2|||
162230470|NCT01248780|585893401|FG001|Overall Study|Lack of Efficacy|0|||
162230471|NCT01248780|585893400|FG000|Overall Study|Lost to Follow-up|0|||
162230472|NCT01248780|585893401|FG001|Overall Study|Lost to Follow-up|1|||
162230473|NCT01248780|585893400|FG000|Overall Study|Death|0|||
162230474|NCT01248780|585893401|FG001|Overall Study|Death|1|||
162230475|NCT01248780|585893400|FG000|Overall Study|Adverse Event|2|||
162230476|NCT01248780|585893401|FG001|Overall Study|Adverse Event|7|||
162230477|NCT01248780|585893400|FG000|Overall Study|Protocol Violation|1|||
162230478|NCT01248780|585893401|FG001|Overall Study|Protocol Violation|1|||
162230479|NCT01248780|585893400|FG000|Overall Study|Withdrawal by Subject|4|||
162230480|NCT01248780|585893401|FG001|Overall Study|Withdrawal by Subject|4|||
162230481|NCT01248780|585893400|FG000|Overall Study|Not treated|0|||
162230482|NCT01248780|585893401|FG001|Overall Study|Not treated|1|||
162230483|NCT00107120|585893405|FG000|Overall Study|Adverse Event|4|||
162230484|NCT00107120|585893406|FG001|Overall Study|Adverse Event|1|||
162230485|NCT00107120|585893405|FG000|Overall Study|Lack of Efficacy|5|||
162230486|NCT00107120|585893406|FG001|Overall Study|Lack of Efficacy|5|||
162230487|NCT00107120|585893405|FG000|Overall Study|Protocol Violation|3|||
162230488|NCT00107120|585893406|FG001|Overall Study|Protocol Violation|0|||
162230489|NCT00107120|585893405|FG000|Overall Study|Withdrawal by Subject|8|||
162230490|NCT00107120|585893406|FG001|Overall Study|Withdrawal by Subject|9|||
162230491|NCT00107120|585893405|FG000|Overall Study|Lost to Follow-up|8|||
162230492|NCT00107120|585893406|FG001|Overall Study|Lost to Follow-up|6|||
162230493|NCT00107120|585893405|FG000|Overall Study|Pregnancy|0|||
162230494|NCT00107120|585893406|FG001|Overall Study|Pregnancy|1|||
162230495|NCT00107120|585893405|FG000|Overall Study|moving away from site|1|||
162230496|NCT00107120|585893406|FG001|Overall Study|moving away from site|1|||
162230497|NCT00107120|585893405|FG000|Overall Study|death of parent|0|||
162230498|NCT00107120|585893406|FG001|Overall Study|death of parent|1|||
162230499|NCT04214600|585893409|FG000|Overall Study|Lost to Follow-up|9|||
162230500|NCT04214600|585893410|FG001|Overall Study|Lost to Follow-up|14|||
162230501|NCT00896051|585893411|FG000|Overall Study|Adverse Event|2|||
162230502|NCT00896051|585893412|FG001|Overall Study|Adverse Event|1|||
162230503|NCT00896051|585893411|FG000|Overall Study|Lost to Follow-up|3|||
162230504|NCT00896051|585893412|FG001|Overall Study|Lost to Follow-up|2|||
162230505|NCT00896051|585893411|FG000|Overall Study|Withdrawal by Subject|3|||
162230506|NCT00896051|585893412|FG001|Overall Study|Withdrawal by Subject|2|||
162230507|NCT00896051|585893411|FG000|Overall Study|Subject noncompliant|1|||
162230508|NCT00896051|585893412|FG001|Overall Study|Subject noncompliant|3|||
162230509|NCT00896051|585893411|FG000|Overall Study|Other|1|||
162230510|NCT00896051|585893412|FG001|Overall Study|Other|1|||
162230511|NCT02935452|585893413|FG000|Overall Study|work and life commintment|3|||
162230512|NCT02935452|585893414|FG001|Overall Study|work and life commintment|1|||
162230513|NCT01635920|585893416|FG000|Overall Study|Adverse Event|1|||
162230514|NCT01635920|585893417|FG001|Overall Study|Adverse Event|0|||
162230515|NCT01635920|585893416|FG000|Overall Study|Lost to Follow-up|0|||
162230516|NCT01635920|585893417|FG001|Overall Study|Lost to Follow-up|1|||
162230517|NCT01635920|585893416|FG000|Overall Study|Subject decision|2|||
162230518|NCT01635920|585893417|FG001|Overall Study|Subject decision|0|||
161679580|NCT00504153|583879178|FG000|Overall Study|Death|1|||
161679581|NCT01034540|583879179|FG000|Overall Study|Adverse Event|0|||
161679582|NCT01034540|583879180|FG001|Overall Study|Adverse Event|1|||
161679583|NCT00932425|583879183|FG000|Overall Study|Lost to Follow-up|0|||
161940188|NCT03648372|584830781|FG005|Overall Study|Other|0|||
162230519|NCT01813929|585893418|FG000|Overall Study|Withdrawal by Subject|0|||
162230520|NCT01813929|585893419|FG001|Overall Study|Withdrawal by Subject|1|||
162230521|NCT00007345|585893420|FG000|Overall Study|Refused further treatment|0|||
162230522|NCT00007345|585893421|FG001|Overall Study|Refused further treatment|7|||
162230523|NCT00007345|585893420|FG000|Overall Study|Switched to alternative treatment|0|||
161679584|NCT00932425|583879184|FG001|Overall Study|Lost to Follow-up|1|||
161679585|NCT00932425|583879183|FG000|Overall Study|Withdrawal by Subject|0|||
161940189|NCT03648372|584830782|FG006|Overall Study|Other|0|||
162230524|NCT00007345|585893421|FG001|Overall Study|Switched to alternative treatment|3|||
162230525|NCT00007345|585893420|FG000|Overall Study|Intercurrent illness|1|||
162230526|NCT00007345|585893421|FG001|Overall Study|Intercurrent illness|0|||
162230527|NCT00007345|585893420|FG000|Overall Study|Death on study|1|||
162230528|NCT00007345|585893421|FG001|Overall Study|Death on study|1|||
162230529|NCT04433585|585893422|FG000|Overall Study|Withdrawal by Subject|15|||
162230530|NCT04433585|585893423|FG001|Overall Study|Withdrawal by Subject|3|||
162230531|NCT04433585|585893424|FG002|Overall Study|Withdrawal by Subject|15|||
162230532|NCT04433585|585893425|FG003|Overall Study|Withdrawal by Subject|6|||
162230533|NCT04433585|585893422|FG000|Overall Study|Adverse Event|10|||
161679586|NCT00932425|583879184|FG001|Overall Study|Withdrawal by Subject|1|||
161679587|NCT03805750|583879185|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
161679588|NCT03805750|583879186|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
161940190|NCT03648372|584830783|FG007|Overall Study|Other|0|||
162230534|NCT04433585|585893423|FG001|Overall Study|Adverse Event|4|||
162230535|NCT04433585|585893424|FG002|Overall Study|Adverse Event|1|||
162230536|NCT04433585|585893425|FG003|Overall Study|Adverse Event|0|||
162230537|NCT04433585|585893422|FG000|Overall Study|Due to the conflict in Ukraine|2|||
162230538|NCT04433585|585893423|FG001|Overall Study|Due to the conflict in Ukraine|1|||
162230539|NCT04433585|585893424|FG002|Overall Study|Due to the conflict in Ukraine|1|||
162230540|NCT04433585|585893425|FG003|Overall Study|Due to the conflict in Ukraine|2|||
162230541|NCT04433585|585893422|FG000|Overall Study|Physician Decision|1|||
162230542|NCT04433585|585893423|FG001|Overall Study|Physician Decision|2|||
162230543|NCT04433585|585893424|FG002|Overall Study|Physician Decision|0|||
162230544|NCT04433585|585893425|FG003|Overall Study|Physician Decision|0|||
162230545|NCT04433585|585893422|FG000|Overall Study|Lost to Follow-up|1|||
162230546|NCT04433585|585893423|FG001|Overall Study|Lost to Follow-up|1|||
162230547|NCT04433585|585893424|FG002|Overall Study|Lost to Follow-up|1|||
162230548|NCT04433585|585893425|FG003|Overall Study|Lost to Follow-up|0|||
162230549|NCT04433585|585893422|FG000|Overall Study|Lack of Efficacy|0|||
162230550|NCT04433585|585893423|FG001|Overall Study|Lack of Efficacy|1|||
162230551|NCT04433585|585893424|FG002|Overall Study|Lack of Efficacy|1|||
162230552|NCT04433585|585893425|FG003|Overall Study|Lack of Efficacy|1|||
162230553|NCT04433585|585893422|FG000|Overall Study|Death|0|||
162230554|NCT04433585|585893423|FG001|Overall Study|Death|1|||
162230555|NCT04433585|585893424|FG002|Overall Study|Death|0|||
162230556|NCT04433585|585893425|FG003|Overall Study|Death|0|||
162230557|NCT03212989|585893440|FG000|Overall Study|Physician Decision|8|||
162230558|NCT03775434|585893441|FG000|Overall Study|Adverse Event|2|||
162230559|NCT03775434|585893441|FG000|Overall Study|Withdrawal by Subject|1|||
162230560|NCT03047395|585893442|FG000|Overall Study|Adverse Event|142|||
162230561|NCT03047395|585893442|FG000|Overall Study|Withdrawal by Subject|155|||
162230562|NCT03047395|585893442|FG000|Overall Study|Lost to Follow-up|144|||
162230563|NCT03047395|585893442|FG000|Overall Study|COVID-19 Infection|2|||
162230564|NCT03047395|585893442|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
162230565|NCT03047395|585893442|FG000|Overall Study|Other, Not Specified|117|||
162230566|NCT00620282|585893450|FG000|Overall Study|Adverse Event|0|||
162230567|NCT00620282|585893451|FG001|Overall Study|Adverse Event|1|||
162230568|NCT00620282|585893452|FG002|Overall Study|Adverse Event|0|||
162230569|NCT00620282|585893450|FG000|Overall Study|Arterial line unable to be placed|0|||
162230570|NCT00620282|585893451|FG001|Overall Study|Arterial line unable to be placed|0|||
162230571|NCT00620282|585893452|FG002|Overall Study|Arterial line unable to be placed|1|||
162230572|NCT00620282|585893450|FG000|Overall Study|Withdrawal by Subject|0|||
162230573|NCT00620282|585893451|FG001|Overall Study|Withdrawal by Subject|1|||
162230574|NCT00620282|585893452|FG002|Overall Study|Withdrawal by Subject|0|||
162230575|NCT02217475|585893453|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
162230576|NCT02217475|585893454|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
162230577|NCT02217475|585893455|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
162230578|NCT02217475|585893453|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
162230579|NCT02217475|585893454|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
162230580|NCT02217475|585893455|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
162230581|NCT02217475|585893453|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
162230582|NCT02217475|585893454|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
162230583|NCT02217475|585893455|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
162230584|NCT02217475|585893453|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
162230585|NCT02217475|585893454|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
162230586|NCT02217475|585893455|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
162230587|NCT02217475|585893453|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
162230588|NCT02217475|585893454|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
162230589|NCT02217475|585893455|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
162230590|NCT02217475|585893453|FG000|Discontinued After Period 1|Adverse Event|1|||
162230591|NCT02217475|585893454|FG001|Discontinued After Period 1|Adverse Event|2|||
162230592|NCT02217475|585893455|FG002|Discontinued After Period 1|Adverse Event|0|||
162230593|NCT02217475|585893453|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
162230594|NCT02217475|585893454|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
162230595|NCT02217475|585893455|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
162230596|NCT02217475|585893453|FG000|Discontinued After Period 1|Physician Decision|0|||
161940191|NCT03648372|584830784|FG008|Overall Study|Other|0|||
161940192|NCT03648372|584830785|FG009|Overall Study|Other|0|||
161940193|NCT03648372|584830786|FG010|Overall Study|Other|1|||
161940194|NCT03648372|584830787|FG011|Overall Study|Other|2|||
161940195|NCT03648372|584830788|FG012|Overall Study|Other|1|||
161940196|NCT03648372|584830789|FG013|Overall Study|Other|3|||
161940197|NCT03648372|584830790|FG014|Overall Study|Other|0|||
161940198|NCT03648372|584830791|FG015|Overall Study|Other|5|||
161940199|NCT03648372|584830792|FG016|Overall Study|Other|1|||
161940200|NCT03648372|584830793|FG017|Overall Study|Other|5|||
161940201|NCT03648372|584830794|FG018|Overall Study|Other|0|||
161940202|NCT03648372|584830795|FG019|Overall Study|Other|1|||
161940203|NCT03648372|584830796|FG020|Overall Study|Other|0|||
162230597|NCT02217475|585893454|FG001|Discontinued After Period 1|Physician Decision|0|||
162230598|NCT02217475|585893455|FG002|Discontinued After Period 1|Physician Decision|1|||
162230599|NCT02217475|585893453|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
162230600|NCT02217475|585893454|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
162230601|NCT02217475|585893455|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
162230602|NCT02217475|585893453|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
162230603|NCT02217475|585893454|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
162230604|NCT02217475|585893455|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
162230605|NCT02217475|585893453|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
162230606|NCT02217475|585893454|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
162230607|NCT02217475|585893455|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
162230608|NCT02217475|585893453|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
162230609|NCT02217475|585893454|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
162230610|NCT02217475|585893455|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
162230611|NCT02217475|585893453|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
162230612|NCT02217475|585893454|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
162230613|NCT02217475|585893455|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
162230614|NCT04738292|585893460|FG000|Overall Study|Death|1|||
162230615|NCT02442336|585893461|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
162230616|NCT02442336|585893461|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
162230617|NCT02442336|585893461|FG000|Overall Study|Lost to Follow-up|11|||
162230618|NCT01237587|585893462|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
162230619|NCT01237587|585893463|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
162230620|NCT01237587|585893462|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
162230621|NCT01237587|585893463|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
162230622|NCT01237587|585893462|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
162230623|NCT01237587|585893463|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
162230624|NCT01237587|585893462|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
162230625|NCT01237587|585893463|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
162230626|NCT01237587|585893462|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
162230627|NCT01237587|585893463|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
162230628|NCT01237587|585893462|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
162230629|NCT01237587|585893463|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
162230630|NCT01237587|585893462|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
162230631|NCT01237587|585893463|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
162230632|NCT01237587|585893462|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
162230633|NCT01237587|585893463|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
162230634|NCT01237587|585893462|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
162230635|NCT01237587|585893463|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
162230636|NCT01237587|585893462|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
162230637|NCT01237587|585893463|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
162230638|NCT01237587|585893462|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
162230639|NCT01237587|585893463|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
162230640|NCT01237587|585893462|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
162230641|NCT01237587|585893463|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
162230642|NCT01237587|585893462|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
162230643|NCT01237587|585893463|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
162230644|NCT01237587|585893462|FG000|Taper Phase|Adverse Event|0|||
162230645|NCT01237587|585893463|FG001|Taper Phase|Adverse Event|2|||
162230646|NCT01237587|585893462|FG000|Taper Phase|Protocol Violation|2|||
162230647|NCT01237587|585893463|FG001|Taper Phase|Protocol Violation|0|||
162230648|NCT01237587|585893462|FG000|Taper Phase|Lack of Efficacy|2|||
162230649|NCT01237587|585893463|FG001|Taper Phase|Lack of Efficacy|5|||
161831579|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
161831580|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
161831581|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
161831582|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
161831583|NCT00384293|584424836|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
161831584|NCT00384293|584424837|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
161831585|NCT00384293|584424838|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
161831586|NCT00384293|584424836|FG000|Post-randomization Period|Adverse Event|0|||
161831587|NCT00384293|584424837|FG001|Post-randomization Period|Adverse Event|23|||
161831588|NCT00384293|584424838|FG002|Post-randomization Period|Adverse Event|7|||
161831589|NCT00384293|584424836|FG000|Post-randomization Period|Lost to Follow-up|0|||
161831590|NCT00384293|584424837|FG001|Post-randomization Period|Lost to Follow-up|2|||
161831591|NCT00384293|584424838|FG002|Post-randomization Period|Lost to Follow-up|1|||
162230650|NCT01237587|585893462|FG000|Taper Phase|Parent/Guardian Decision|0|||
162230651|NCT01237587|585893463|FG001|Taper Phase|Parent/Guardian Decision|2|||
162230652|NCT01237587|585893462|FG000|Taper Phase|Sponsor Decision|1|||
162230653|NCT01237587|585893463|FG001|Taper Phase|Sponsor Decision|0|||
162230654|NCT01237587|585893462|FG000|Taper Phase|Withdrawal by Subject|0|||
162230655|NCT01237587|585893463|FG001|Taper Phase|Withdrawal by Subject|1|||
162230656|NCT01011387|585893464|FG000|Overall Study|Withdrawal by Subject|3|||
162230657|NCT01011387|585893464|FG000|Overall Study|Adverse Event|2|||
162230658|NCT01011387|585893464|FG000|Overall Study|Protocol Violation|1|||
162230659|NCT01139580|585893465|FG000|Overall Study|Adverse Event|5|||
162230660|NCT01139580|585893466|FG001|Overall Study|Adverse Event|4|||
162230661|NCT01139580|585893465|FG000|Overall Study|Lost to Follow-up|9|||
162230662|NCT01139580|585893466|FG001|Overall Study|Lost to Follow-up|1|||
162230663|NCT01139580|585893465|FG000|Overall Study|Lack of Efficacy|0|||
162230664|NCT01139580|585893466|FG001|Overall Study|Lack of Efficacy|2|||
162230665|NCT01139580|585893465|FG000|Overall Study|Withdrawal by Subject|6|||
162230666|NCT01139580|585893466|FG001|Overall Study|Withdrawal by Subject|9|||
162230667|NCT01139580|585893465|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
162230668|NCT01139580|585893466|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
162230669|NCT01139580|585893465|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
162230670|NCT01139580|585893466|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
162230671|NCT01139580|585893465|FG000|Overall Study|Misrandomized|1|||
162230672|NCT01139580|585893466|FG001|Overall Study|Misrandomized|0|||
162230673|NCT01139580|585893465|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
162230674|NCT01139580|585893466|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
162230675|NCT01139580|585893465|FG000|Overall Study|Participant Randomization in Error|0|||
162230676|NCT01139580|585893466|FG001|Overall Study|Participant Randomization in Error|1|||
162230677|NCT01285609|585893467|FG000|Randomized|Progressive Disease|41|||
162230678|NCT01285609|585893468|FG001|Randomized|Progressive Disease|61|||
162230679|NCT01285609|585893467|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
162230680|NCT01285609|585893468|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
162230681|NCT01285609|585893467|FG000|Randomized|Study Drug Toxicity|13|||
162230682|NCT01285609|585893468|FG001|Randomized|Study Drug Toxicity|14|||
162230683|NCT01285609|585893467|FG000|Randomized|Death|5|||
162230684|NCT01285609|585893468|FG001|Randomized|Death|7|||
162230685|NCT01285609|585893467|FG000|Randomized|Withdrawal by Subject|8|||
162230686|NCT01285609|585893468|FG001|Randomized|Withdrawal by Subject|11|||
162230687|NCT01285609|585893467|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
162230688|NCT01285609|585893468|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
162230689|NCT01285609|585893467|FG000|Randomized|Undisclosed Reasons|1|||
162230690|NCT01285609|585893468|FG001|Randomized|Undisclosed Reasons|0|||
162230691|NCT01285609|585893467|FG000|Randomized|Randomized but not Treated|4|||
162230692|NCT01285609|585893468|FG001|Randomized|Randomized but not Treated|4|||
162230693|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
162230694|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
162230695|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
162230696|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
162230697|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
162230698|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
162230699|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
162230700|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
162230701|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Death|11|||
162230702|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Death|3|||
161831592|NCT00384293|584424836|FG000|Post-randomization Period|Protocol Violation|0|||
162230703|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
162230704|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
162230705|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Not Reported|0|||
162230706|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Not Reported|2|||
162230707|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
162230708|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
162230709|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
162230710|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
162230711|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
162230712|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
162230713|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
162230714|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
162230715|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
162230716|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
162230717|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
162230718|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
162230719|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
162230720|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
162230721|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
162230722|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
162230723|NCT01285609|585893467|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
162230724|NCT01285609|585893468|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
162230725|NCT01285609|585893467|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
162230726|NCT01285609|585893468|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
162230727|NCT01142115|585893469|FG000|First Intervention|Lack of Efficacy|1|||
162230728|NCT01142115|585893470|FG001|First Intervention|Lack of Efficacy|1|||
162230729|NCT01142115|585893469|FG000|First Intervention|Adverse Event|1|||
162230730|NCT01142115|585893470|FG001|First Intervention|Adverse Event|0|||
162230731|NCT00320528|585893473|FG000|Study Period II|Adverse Event|3|||
162230732|NCT00320528|585893474|FG001|Study Period II|Adverse Event|4|||
162230733|NCT00320528|585893475|FG002|Study Period II|Adverse Event|8|||
162230734|NCT00320528|585893473|FG000|Study Period II|Parent/Caregiver Decision|8|||
162230735|NCT00320528|585893474|FG001|Study Period II|Parent/Caregiver Decision|3|||
162230736|NCT00320528|585893475|FG002|Study Period II|Parent/Caregiver Decision|11|||
162230737|NCT00320528|585893473|FG000|Study Period II|Withdrawal by Subject|0|||
162230738|NCT00320528|585893474|FG001|Study Period II|Withdrawal by Subject|1|||
162230739|NCT00320528|585893475|FG002|Study Period II|Withdrawal by Subject|1|||
162230740|NCT00320528|585893473|FG000|Study Period II|Entry Criteria Exclusion|0|||
162230741|NCT00320528|585893474|FG001|Study Period II|Entry Criteria Exclusion|2|||
162230742|NCT00320528|585893475|FG002|Study Period II|Entry Criteria Exclusion|2|||
162230743|NCT00320528|585893473|FG000|Study Period III|Adverse Event|1|||
162230744|NCT00320528|585893474|FG001|Study Period III|Adverse Event|0|||
162230745|NCT00320528|585893475|FG002|Study Period III|Adverse Event|0|||
162230746|NCT00320528|585893473|FG000|Study Period III|Lost to Follow-up|1|||
162230747|NCT00320528|585893474|FG001|Study Period III|Lost to Follow-up|0|||
162230748|NCT00320528|585893475|FG002|Study Period III|Lost to Follow-up|0|||
162230749|NCT00320528|585893473|FG000|Study Period III|Withdrawal by Subject|1|||
162230750|NCT00320528|585893474|FG001|Study Period III|Withdrawal by Subject|1|||
162230751|NCT00320528|585893475|FG002|Study Period III|Withdrawal by Subject|2|||
162230752|NCT00320528|585893473|FG000|Study Period III|Lack of Efficacy|2|||
162230753|NCT00320528|585893474|FG001|Study Period III|Lack of Efficacy|0|||
162230754|NCT00320528|585893475|FG002|Study Period III|Lack of Efficacy|0|||
162230755|NCT00320528|585893473|FG000|Study Period III|Parent/Caregiver Decision|14|||
162230756|NCT00320528|585893474|FG001|Study Period III|Parent/Caregiver Decision|3|||
162230757|NCT00320528|585893475|FG002|Study Period III|Parent/Caregiver Decision|11|||
162230758|NCT00320528|585893473|FG000|Study Period III|Protocol Violation|0|||
162230759|NCT00320528|585893474|FG001|Study Period III|Protocol Violation|1|||
162230760|NCT00320528|585893475|FG002|Study Period III|Protocol Violation|0|||
162230761|NCT00320528|585893473|FG000|Study Period III|Physician Decision|0|||
162230762|NCT00320528|585893474|FG001|Study Period III|Physician Decision|1|||
162230763|NCT00320528|585893475|FG002|Study Period III|Physician Decision|2|||
162230764|NCT00320528|585893473|FG000|Study Period III|Sponsor Decision|0|||
162230765|NCT00320528|585893474|FG001|Study Period III|Sponsor Decision|0|||
162230766|NCT00320528|585893475|FG002|Study Period III|Sponsor Decision|1|||
162230767|NCT00320528|585893473|FG000|Study Period III|Atomoxetine Commercially Available|68|||
162023721|NCT00830869|585144482|FG001|Period 2: Part 2|Other|0|||
162230768|NCT00320528|585893474|FG001|Study Period III|Atomoxetine Commercially Available|25|||
162230769|NCT00320528|585893475|FG002|Study Period III|Atomoxetine Commercially Available|90|||
162230770|NCT04828837|585893476|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
162230771|NCT04828837|585893477|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
162230772|NCT04828837|585893476|FG000|Overall Study|Lost to Follow-up|2|||
162230773|NCT04828837|585893477|FG001|Overall Study|Lost to Follow-up|6|||
162230774|NCT04828837|585893476|FG000|Overall Study|Lack of Efficacy|1|||
162230775|NCT04828837|585893477|FG001|Overall Study|Lack of Efficacy|0|||
162230776|NCT04828837|585893476|FG000|Overall Study|Admitted due to pneumothorax.|1|||
162230777|NCT04828837|585893477|FG001|Overall Study|Admitted due to pneumothorax.|0|||
162230778|NCT04828837|585893476|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
162230779|NCT04828837|585893477|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
162230780|NCT01397422|585893478|FG000|Overall Study|Adverse Event|0|||
162230781|NCT01397422|585893479|FG001|Overall Study|Adverse Event|3|||
162230782|NCT01397422|585893480|FG002|Overall Study|Adverse Event|3|||
162230783|NCT01397422|585893481|FG003|Overall Study|Adverse Event|8|||
162230784|NCT01397422|585893478|FG000|Overall Study|Withdrawal by Subject|1|||
162230785|NCT01397422|585893479|FG001|Overall Study|Withdrawal by Subject|0|||
162230786|NCT01397422|585893480|FG002|Overall Study|Withdrawal by Subject|0|||
162230787|NCT01397422|585893481|FG003|Overall Study|Withdrawal by Subject|0|||
162230788|NCT01397422|585893478|FG000|Overall Study|Increased bradykinesia related to PD|1|||
162230789|NCT01397422|585893479|FG001|Overall Study|Increased bradykinesia related to PD|0|||
162230790|NCT01397422|585893480|FG002|Overall Study|Increased bradykinesia related to PD|0|||
162230791|NCT01397422|585893481|FG003|Overall Study|Increased bradykinesia related to PD|0|||
162230792|NCT03762200|585893494|FG000|Overall Study|Death|2|||
162230793|NCT05618912|585893495|FG000|Overall Study|Lost to Follow-up|14|||
162230794|NCT05618912|585893496|FG001|Overall Study|Lost to Follow-up|19|||
162230795|NCT02594163|585895282|FG000|Treatment Period|Progressive disease|2|||
162230796|NCT02594163|585895283|FG001|Treatment Period|Progressive disease|3|||
162230797|NCT02594163|585895282|FG000|Treatment Period|Adverse Event|1|||
162230798|NCT02594163|585895283|FG001|Treatment Period|Adverse Event|5|||
162230799|NCT02594163|585895282|FG000|Treatment Period|Physician Decision|1|||
162230800|NCT02594163|585895283|FG001|Treatment Period|Physician Decision|3|||
162230801|NCT02594163|585895282|FG000|Treatment Period|Study termination by sponsor|2|||
162230802|NCT02594163|585895283|FG001|Treatment Period|Study termination by sponsor|1|||
162230803|NCT02594163|585895282|FG000|Treatment Period|Other, Non-AE|1|||
161679589|NCT00493220|583879187|FG000|Third Intervention|Withdrawal by Subject|1|||
161829637|NCT00105157|584415842|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
161829638|NCT00105157|584415843|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
161829639|NCT00105157|584415844|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
161679590|NCT00493220|583879188|FG001|Third Intervention|Withdrawal by Subject|0|||
161679591|NCT00493220|583879189|FG002|Third Intervention|Withdrawal by Subject|0|||
162230804|NCT02594163|585895283|FG001|Treatment Period|Other, Non-AE|0|||
162230805|NCT02594163|585895282|FG000|Follow-up Period|Withdrawal by Subject|0|||
162230806|NCT02594163|585895283|FG001|Follow-up Period|Withdrawal by Subject|1|||
162230807|NCT02594163|585895282|FG000|Follow-up Period|Study Termination by Sponsor|6|||
162230808|NCT02594163|585895283|FG001|Follow-up Period|Study Termination by Sponsor|4|||
162230809|NCT02594163|585895282|FG000|Follow-up Period|Lost to Follow-up|1|||
162230810|NCT02594163|585895283|FG001|Follow-up Period|Lost to Follow-up|0|||
162230811|NCT02594163|585895282|FG000|Follow-up Period|Death|2|||
162230812|NCT02594163|585895283|FG001|Follow-up Period|Death|5|||
162230813|NCT02594163|585895282|FG000|Follow-up Period|Adverse Event|0|||
162230814|NCT02594163|585895283|FG001|Follow-up Period|Adverse Event|1|||
161679592|NCT00493220|583879190|FG003|Third Intervention|Withdrawal by Subject|0|||
161679593|NCT00493220|583879191|FG004|Third Intervention|Withdrawal by Subject|0|||
161679594|NCT00493220|583879192|FG005|Third Intervention|Withdrawal by Subject|0|||
161679595|NCT00310804|583879193|FG000|Overall Study|Lost to Follow-up|2|||
162230815|NCT02594163|585895282|FG000|Follow-up Period|Progressive Disease|2|||
162230816|NCT02594163|585895283|FG001|Follow-up Period|Progressive Disease|0|||
162230817|NCT02594163|585895282|FG000|Follow-up Period|Physician Decision|0|||
162230818|NCT02594163|585895283|FG001|Follow-up Period|Physician Decision|1|||
162230819|NCT01342341|585895284|FG000|Overall Study|Lost to Follow-up|4|||
162230820|NCT01342341|585895285|FG001|Overall Study|Lost to Follow-up|4|||
162230821|NCT01022268|585895288|FG000|Overall Study|Withdrawal by Subject|1|||
162230822|NCT01022268|585895289|FG001|Overall Study|Withdrawal by Subject|0|||
162230823|NCT01022268|585895288|FG000|Overall Study|Withdrawal by Subject|1|||
162230824|NCT01022268|585895289|FG001|Overall Study|Withdrawal by Subject|0|||
162230825|NCT01034176|585895290|FG000|Overall Study|Physician Decision|2|||
162230826|NCT01034176|585895291|FG001|Overall Study|Physician Decision|0|||
162230827|NCT01034176|585895290|FG000|Overall Study|Withdrawal by Subject|0|||
162230828|NCT01034176|585895291|FG001|Overall Study|Withdrawal by Subject|1|||
162230829|NCT01034176|585895290|FG000|Overall Study|Lost to Follow-up|0|||
162230830|NCT01034176|585895291|FG001|Overall Study|Lost to Follow-up|1|||
162230831|NCT00266227|585895294|FG000|Initial Treatment|Adverse Event|0|||
162230832|NCT00266227|585895295|FG001|Initial Treatment|Adverse Event|0|||
162230833|NCT00266227|585895296|FG002|Initial Treatment|Adverse Event|13|||
162230834|NCT00266227|585895294|FG000|Initial Treatment|Lost to Follow-up|0|||
162230835|NCT00266227|585895295|FG001|Initial Treatment|Lost to Follow-up|0|||
162230836|NCT00266227|585895296|FG002|Initial Treatment|Lost to Follow-up|6|||
162230837|NCT00266227|585895294|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
162230838|NCT00266227|585895295|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
162230839|NCT00266227|585895296|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
162230840|NCT00266227|585895294|FG000|Initial Treatment|Physician decision to withdraw|0|||
162230841|NCT00266227|585895295|FG001|Initial Treatment|Physician decision to withdraw|0|||
162230842|NCT00266227|585895296|FG002|Initial Treatment|Physician decision to withdraw|12|||
162230843|NCT00266227|585895294|FG000|Initial Treatment|Pregnancy|0|||
162230844|NCT00266227|585895295|FG001|Initial Treatment|Pregnancy|0|||
162230845|NCT00266227|585895296|FG002|Initial Treatment|Pregnancy|1|||
162230846|NCT00266227|585895294|FG000|Retreatment: Up to Week 48|Death|1|||
162230847|NCT00266227|585895295|FG001|Retreatment: Up to Week 48|Death|0|||
162230848|NCT00266227|585895296|FG002|Retreatment: Up to Week 48|Death|0|||
162230849|NCT00266227|585895294|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
162230850|NCT00266227|585895295|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
162230851|NCT00266227|585895296|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
162230852|NCT00266227|585895294|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
162230853|NCT00266227|585895295|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
162230854|NCT00266227|585895296|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
162230855|NCT00266227|585895294|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
162230856|NCT00266227|585895295|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
162230857|NCT00266227|585895296|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
162230858|NCT00266227|585895294|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
162230859|NCT00266227|585895295|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
162230860|NCT00266227|585895296|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
162230861|NCT00266227|585895294|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
161829640|NCT00105157|584415845|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
162230862|NCT00266227|585895295|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
161829641|NCT00105157|584415842|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
161829642|NCT00105157|584415843|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
161829643|NCT00105157|584415844|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
161829644|NCT00105157|584415845|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
161829645|NCT00105157|584415842|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
161829646|NCT00105157|584415843|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
161829647|NCT00105157|584415844|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
161829648|NCT00105157|584415845|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
161829649|NCT00105157|584415842|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
161829650|NCT00105157|584415843|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
161940204|NCT03648372|584830776|FG000|Overall Study|Lost to Follow-up|0|||
161940205|NCT03648372|584830777|FG001|Overall Study|Lost to Follow-up|0|||
161940206|NCT03648372|584830778|FG002|Overall Study|Lost to Follow-up|0|||
161940207|NCT03648372|584830779|FG003|Overall Study|Lost to Follow-up|0|||
161940208|NCT03648372|584830780|FG004|Overall Study|Lost to Follow-up|0|||
161940209|NCT03648372|584830781|FG005|Overall Study|Lost to Follow-up|0|||
161940210|NCT03648372|584830782|FG006|Overall Study|Lost to Follow-up|0|||
161940211|NCT03648372|584830783|FG007|Overall Study|Lost to Follow-up|0|||
161940212|NCT03648372|584830784|FG008|Overall Study|Lost to Follow-up|0|||
161940213|NCT03648372|584830785|FG009|Overall Study|Lost to Follow-up|0|||
161940214|NCT03648372|584830786|FG010|Overall Study|Lost to Follow-up|0|||
161940215|NCT03648372|584830787|FG011|Overall Study|Lost to Follow-up|0|||
161940216|NCT03648372|584830788|FG012|Overall Study|Lost to Follow-up|0|||
161940217|NCT03648372|584830789|FG013|Overall Study|Lost to Follow-up|1|||
161940218|NCT03648372|584830790|FG014|Overall Study|Lost to Follow-up|0|||
161940219|NCT03648372|584830791|FG015|Overall Study|Lost to Follow-up|1|||
162230863|NCT00266227|585895296|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
162230864|NCT00266227|585895294|FG000|Retreatment: Week 48 to Week 72|Death|1|||
162230865|NCT00266227|585895295|FG001|Retreatment: Week 48 to Week 72|Death|1|||
162230866|NCT00266227|585895296|FG002|Retreatment: Week 48 to Week 72|Death|0|||
162230867|NCT00266227|585895294|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
162230868|NCT00266227|585895295|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
162023722|NCT00830869|585144483|FG002|Period 2: Part 2|Other|0|||
162023723|NCT00830869|585144484|FG003|Period 2: Part 2|Other|0|||
162023724|NCT00830869|585144485|FG004|Period 2: Part 2|Other|0|||
162023725|NCT00830869|585144486|FG005|Period 2: Part 2|Other|0|||
162023726|NCT00830869|585144487|FG006|Period 2: Part 2|Other|0|||
162023727|NCT00830869|585144488|FG007|Period 2: Part 2|Other|0|||
162023728|NCT00830869|585144489|FG008|Period 2: Part 2|Other|0|||
162023729|NCT00830869|585144490|FG009|Period 2: Part 2|Other|1|||
162023730|NCT00830869|585144491|FG010|Period 2: Part 2|Other|0|||
162023731|NCT00830869|585144492|FG011|Period 2: Part 2|Other|0|||
162023732|NCT00507728|585144493|FG000|Randomization to Month 3|Lost to Follow-up|15|||
162023733|NCT00507728|585144494|FG001|Randomization to Month 3|Lost to Follow-up|14|||
162023734|NCT00507728|585144495|FG002|Randomization to Month 3|Lost to Follow-up|20|||
162023735|NCT00507728|585144493|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
162023736|NCT00507728|585144494|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
162023737|NCT00507728|585144495|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
162023738|NCT00730028|585144497|FG000|Overall Study|Adverse Event|23|||
162023739|NCT00730028|585144498|FG001|Overall Study|Adverse Event|26|||
162023740|NCT00730028|585144499|FG002|Overall Study|Adverse Event|16|||
162023741|NCT00730028|585144500|FG003|Overall Study|Adverse Event|20|||
162023742|NCT00730028|585144501|FG004|Overall Study|Adverse Event|43|||
162023743|NCT00730028|585144497|FG000|Overall Study|Lost to Follow-up|13|||
162023744|NCT00730028|585144498|FG001|Overall Study|Lost to Follow-up|26|||
162023745|NCT00730028|585144499|FG002|Overall Study|Lost to Follow-up|22|||
162023746|NCT00730028|585144500|FG003|Overall Study|Lost to Follow-up|26|||
162023747|NCT00730028|585144501|FG004|Overall Study|Lost to Follow-up|25|||
162023748|NCT00730028|585144497|FG000|Overall Study|Protocol Violation|6|||
162023749|NCT00730028|585144498|FG001|Overall Study|Protocol Violation|1|||
162023750|NCT00730028|585144499|FG002|Overall Study|Protocol Violation|1|||
162023751|NCT00730028|585144500|FG003|Overall Study|Protocol Violation|2|||
162023752|NCT00730028|585144501|FG004|Overall Study|Protocol Violation|0|||
162023753|NCT00730028|585144497|FG000|Overall Study|Withdrawal by Subject|9|||
162023754|NCT00730028|585144498|FG001|Overall Study|Withdrawal by Subject|5|||
162023755|NCT00730028|585144499|FG002|Overall Study|Withdrawal by Subject|4|||
162023756|NCT00730028|585144500|FG003|Overall Study|Withdrawal by Subject|5|||
162023757|NCT00730028|585144501|FG004|Overall Study|Withdrawal by Subject|9|||
162023758|NCT00730028|585144497|FG000|Overall Study|Physician Decision|3|||
162023759|NCT00730028|585144498|FG001|Overall Study|Physician Decision|3|||
162023760|NCT00730028|585144499|FG002|Overall Study|Physician Decision|2|||
162023761|NCT00730028|585144500|FG003|Overall Study|Physician Decision|3|||
162023762|NCT00730028|585144501|FG004|Overall Study|Physician Decision|2|||
162023763|NCT00730028|585144497|FG000|Overall Study|Treatment Failure|5|||
162023764|NCT00730028|585144498|FG001|Overall Study|Treatment Failure|5|||
162023765|NCT00730028|585144499|FG002|Overall Study|Treatment Failure|0|||
162023766|NCT00730028|585144500|FG003|Overall Study|Treatment Failure|0|||
162023767|NCT00730028|585144501|FG004|Overall Study|Treatment Failure|1|||
162023768|NCT00730028|585144497|FG000|Overall Study|Randomization Error|1|||
162023769|NCT00730028|585144498|FG001|Overall Study|Randomization Error|0|||
162023770|NCT00730028|585144499|FG002|Overall Study|Randomization Error|0|||
162023771|NCT00730028|585144500|FG003|Overall Study|Randomization Error|0|||
162023772|NCT00730028|585144501|FG004|Overall Study|Randomization Error|2|||
162023773|NCT00615901|585144502|FG000|Overall Study|Withdrawal by Subject|2|||
162023774|NCT00615901|585144502|FG000|Overall Study|Adverse Event|7|||
162023775|NCT01250496|585144503|FG000|Overall Study|Study terminated|124|||
162023776|NCT01250496|585144504|FG001|Overall Study|Study terminated|124|||
162023777|NCT01425463|585144510|FG000|Overall Study|Adverse Event|5|||
162023778|NCT01425463|585144511|FG001|Overall Study|Adverse Event|7|||
162023779|NCT01425463|585144510|FG000|Overall Study|Lack of Efficacy|1|||
162023780|NCT01425463|585144511|FG001|Overall Study|Lack of Efficacy|1|||
162023781|NCT01425463|585144510|FG000|Overall Study|Protocol Violation|2|||
162023782|NCT01425463|585144511|FG001|Overall Study|Protocol Violation|2|||
162023783|NCT01425463|585144510|FG000|Overall Study|Lost to Follow-up|5|||
162023784|NCT01425463|585144511|FG001|Overall Study|Lost to Follow-up|2|||
162023785|NCT01425463|585144510|FG000|Overall Study|Withdrawal by Subject|7|||
162023786|NCT01425463|585144511|FG001|Overall Study|Withdrawal by Subject|5|||
162023787|NCT01425463|585144510|FG000|Overall Study|Unknown Reason|4|||
162023788|NCT01425463|585144511|FG001|Overall Study|Unknown Reason|7|||
162023789|NCT01332799|585144512|FG000|Overall Study|Insufficient funding|10|||
162023790|NCT01332799|585144513|FG001|Overall Study|Insufficient funding|10|||
162023791|NCT03467152|585144514|FG000|Overall Study|Adverse Event|4|||
162023792|NCT03467152|585144515|FG001|Overall Study|Adverse Event|5|||
162023793|NCT03467152|585144516|FG002|Overall Study|Adverse Event|0|||
162023794|NCT03467152|585144514|FG000|Overall Study|Subject Choice|1|||
162023795|NCT03467152|585144515|FG001|Overall Study|Subject Choice|3|||
162023796|NCT03467152|585144516|FG002|Overall Study|Subject Choice|0|||
162023797|NCT03467152|585144514|FG000|Overall Study|Lost to Follow-up|1|||
162023798|NCT03467152|585144515|FG001|Overall Study|Lost to Follow-up|0|||
162023799|NCT03467152|585144516|FG002|Overall Study|Lost to Follow-up|0|||
162023800|NCT03467152|585144514|FG000|Overall Study|Withdrawal by Subject|4|||
162023801|NCT03467152|585144515|FG001|Overall Study|Withdrawal by Subject|2|||
162023802|NCT03467152|585144516|FG002|Overall Study|Withdrawal by Subject|0|||
162023803|NCT03467152|585144514|FG000|Overall Study|Others|3|||
162023804|NCT03467152|585144515|FG001|Overall Study|Others|0|||
162023805|NCT03467152|585144516|FG002|Overall Study|Others|0|||
162023806|NCT03467152|585144514|FG000|Overall Study|Not treated|3|||
162023807|NCT03467152|585144515|FG001|Overall Study|Not treated|1|||
162023808|NCT03467152|585144516|FG002|Overall Study|Not treated|6|||
162023809|NCT00945906|585144518|FG000|Overall Study|Withdrawal by Subject|1|||
162023810|NCT00945906|585144518|FG000|Overall Study|Did not want to return for last visit|2|||
162023811|NCT00945906|585144518|FG000|Overall Study|Unable to return for last visit|2|||
162023812|NCT00945906|585144518|FG000|Overall Study|Moved to another country|2|||
162023813|NCT01236547|585144519|FG000|Overall Study|Protocol Violation|0|||
162023814|NCT01236547|585144520|FG001|Overall Study|Protocol Violation|1|||
162023815|NCT01236547|585144521|FG002|Overall Study|Protocol Violation|1|||
162023816|NCT01236547|585144522|FG003|Overall Study|Protocol Violation|6|||
162023817|NCT01236547|585144523|FG004|Overall Study|Protocol Violation|12|||
162023818|NCT01120782|585144524|FG000|Overall Study|Test article shipping error|11|||
162023819|NCT04022733|585144525|FG000|Overall Study|conversion to open surgery|3|||
162023820|NCT04022733|585144526|FG001|Overall Study|conversion to open surgery|2|||
162023821|NCT04022733|585144525|FG000|Overall Study|bradycardia|0|||
162023822|NCT04022733|585144526|FG001|Overall Study|bradycardia|1|||
162023823|NCT01541397|585144527|FG000|Overall Study|Study ended prior to data collection|4|||
162023824|NCT01541397|585144528|FG001|Overall Study|Study ended prior to data collection|2|||
162023825|NCT00233454|585144529|FG000|Overall Study|Death|6|||
162023826|NCT04224688|585144530|FG000|Overall Study|Withdrawal by Subject|1|||
162023827|NCT04224688|585144531|FG001|Overall Study|Withdrawal by Subject|3|||
162023828|NCT04224688|585144530|FG000|Overall Study|Lack of Efficacy|1|||
162023829|NCT04224688|585144531|FG001|Overall Study|Lack of Efficacy|1|||
162023830|NCT04224688|585144530|FG000|Overall Study|Adverse event, not fatal|0|||
162023831|NCT04224688|585144531|FG001|Overall Study|Adverse event, not fatal|2|||
162023832|NCT04224688|585144530|FG000|Overall Study|COVID-19|0|||
162023833|NCT04224688|585144531|FG001|Overall Study|COVID-19|1|||
162023834|NCT03083990|585144532|FG000|Overall Study|Adverse Event|1|||
162023835|NCT03083990|585144533|FG001|Overall Study|Adverse Event|0|||
162023836|NCT01853839|585144534|FG000|Overall Study|Violated inclusion criteria|2|||
162023837|NCT01853839|585144534|FG000|Overall Study|Not meet ITT population definition|58|||
162023838|NCT01853839|585144534|FG000|Overall Study|End of treatment visit too early|33|||
162023839|NCT01853839|585144534|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
162023840|NCT01640314|585144535|FG000|Overall Study|Protocol Violation|0|||
162023841|NCT01640314|585144536|FG001|Overall Study|Protocol Violation|1|||
162023842|NCT02709538|585144538|FG000|Overall Study|Adverse Event|13|||
162023843|NCT02709538|585144539|FG001|Overall Study|Adverse Event|2|||
162023844|NCT02709538|585144540|FG002|Overall Study|Adverse Event|3|||
162023845|NCT02709538|585144538|FG000|Overall Study|Lack of Efficacy|1|||
162023846|NCT02709538|585144539|FG001|Overall Study|Lack of Efficacy|0|||
162023847|NCT02709538|585144540|FG002|Overall Study|Lack of Efficacy|0|||
162023848|NCT02709538|585144538|FG000|Overall Study|Lost to Follow-up|24|||
162023849|NCT02709538|585144539|FG001|Overall Study|Lost to Follow-up|8|||
162023850|NCT02709538|585144540|FG002|Overall Study|Lost to Follow-up|4|||
162023851|NCT02709538|585144538|FG000|Overall Study|Physician Decision|1|||
162023852|NCT02709538|585144539|FG001|Overall Study|Physician Decision|0|||
162023853|NCT02709538|585144540|FG002|Overall Study|Physician Decision|0|||
162023854|NCT02709538|585144538|FG000|Overall Study|Withdrawal by Subject|40|||
162023855|NCT02709538|585144539|FG001|Overall Study|Withdrawal by Subject|7|||
162023856|NCT02709538|585144540|FG002|Overall Study|Withdrawal by Subject|4|||
162023857|NCT02709538|585144538|FG000|Overall Study|Non-compliance with study procedures|5|||
162023858|NCT02709538|585144539|FG001|Overall Study|Non-compliance with study procedures|0|||
162023859|NCT02709538|585144540|FG002|Overall Study|Non-compliance with study procedures|0|||
162023860|NCT02709538|585144538|FG000|Overall Study|Non-compliance with study drug|2|||
162023861|NCT02709538|585144539|FG001|Overall Study|Non-compliance with study drug|0|||
162023862|NCT02709538|585144540|FG002|Overall Study|Non-compliance with study drug|0|||
162023863|NCT02709538|585144538|FG000|Overall Study|Protocol deviation|10|||
162023864|NCT02709538|585144539|FG001|Overall Study|Protocol deviation|4|||
162023865|NCT02709538|585144540|FG002|Overall Study|Protocol deviation|4|||
162023866|NCT02709538|585144538|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
162023867|NCT02709538|585144539|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
162023868|NCT02709538|585144540|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
162023869|NCT02709538|585144538|FG000|Overall Study|Other|16|||
162023870|NCT02709538|585144539|FG001|Overall Study|Other|7|||
162023871|NCT02709538|585144540|FG002|Overall Study|Other|5|||
162023872|NCT00835211|585144542|FG000|First Intervention|Withdrawal by Subject|0|||
162023873|NCT00835211|585144543|FG001|First Intervention|Withdrawal by Subject|1|||
162023874|NCT00835211|585144542|FG000|Washout: 7 Days|Adverse Event|2|||
162023875|NCT00835211|585144543|FG001|Washout: 7 Days|Adverse Event|1|||
162023876|NCT00835211|585144542|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
162023877|NCT00835211|585144543|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
162023878|NCT02343549|585144544|FG000|Overall Study|Death|11|||
162023879|NCT02343549|585144544|FG000|Overall Study|Withdrawal by Subject|2|||
162230869|NCT00266227|585895296|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
162230870|NCT00266227|585895294|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
162230871|NCT00266227|585895295|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
162230872|NCT00266227|585895296|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
162230873|NCT00266227|585895294|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
162230874|NCT00266227|585895295|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
162230875|NCT00266227|585895296|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
162230876|NCT00266227|585895294|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
162230877|NCT00266227|585895295|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
162230878|NCT00266227|585895296|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
162230879|NCT02680002|585895298|FG000|Overall Study|Lost to Follow-up|5|||
162230880|NCT02680002|585895299|FG001|Overall Study|Lost to Follow-up|1|||
162230881|NCT02680002|585895300|FG002|Overall Study|Lost to Follow-up|4|||
162230882|NCT02680002|585895301|FG003|Overall Study|Lost to Follow-up|2|||
162230883|NCT02680002|585895302|FG004|Overall Study|Lost to Follow-up|0|||
162230884|NCT02680002|585895303|FG005|Overall Study|Lost to Follow-up|2|||
162230885|NCT02680002|585895298|FG000|Overall Study|Physician Decision|5|||
162230886|NCT02680002|585895299|FG001|Overall Study|Physician Decision|1|||
162230887|NCT02680002|585895300|FG002|Overall Study|Physician Decision|1|||
162230888|NCT02680002|585895301|FG003|Overall Study|Physician Decision|1|||
162230889|NCT02680002|585895302|FG004|Overall Study|Physician Decision|1|||
162230890|NCT02680002|585895303|FG005|Overall Study|Physician Decision|1|||
162230891|NCT02680002|585895298|FG000|Overall Study|Protocol Violation|1|||
162230892|NCT02680002|585895299|FG001|Overall Study|Protocol Violation|0|||
162230893|NCT02680002|585895300|FG002|Overall Study|Protocol Violation|1|||
162230894|NCT02680002|585895301|FG003|Overall Study|Protocol Violation|0|||
162230895|NCT02680002|585895302|FG004|Overall Study|Protocol Violation|1|||
162230896|NCT02680002|585895303|FG005|Overall Study|Protocol Violation|2|||
161829651|NCT00105157|584415844|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
161829652|NCT00105157|584415845|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
161829653|NCT00105157|584415842|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
162230897|NCT02680002|585895298|FG000|Overall Study|Withdrawal by Subject|0|||
162230898|NCT02680002|585895299|FG001|Overall Study|Withdrawal by Subject|0|||
162230899|NCT02680002|585895300|FG002|Overall Study|Withdrawal by Subject|1|||
161829654|NCT00105157|584415843|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
161829655|NCT00105157|584415844|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
161829656|NCT00105157|584415845|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
161829657|NCT00105157|584415842|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
161829658|NCT00105157|584415843|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
161829659|NCT00105157|584415844|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
161829660|NCT00105157|584415845|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
161829661|NCT00105157|584415842|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
161829662|NCT00105157|584415843|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
161829663|NCT00105157|584415844|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
161829664|NCT00105157|584415845|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
161829665|NCT01396421|584415848|FG000|Overall Study|Lost to Follow-up|0|||
161829666|NCT01396421|584415849|FG001|Overall Study|Lost to Follow-up|0|||
161829667|NCT01396421|584415850|FG002|Overall Study|Lost to Follow-up|0|||
161829668|NCT01396421|584415851|FG003|Overall Study|Lost to Follow-up|1|||
161829669|NCT01396421|584415848|FG000|Overall Study|Adverse Event|17|||
161829670|NCT01396421|584415849|FG001|Overall Study|Adverse Event|15|||
161829671|NCT01396421|584415850|FG002|Overall Study|Adverse Event|12|||
161829672|NCT01396421|584415851|FG003|Overall Study|Adverse Event|32|||
161829673|NCT01396421|584415848|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
161829674|NCT01396421|584415849|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
161829675|NCT01396421|584415850|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
161829676|NCT01396421|584415851|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
161829677|NCT01396421|584415848|FG000|Overall Study|Physician Decision|1|||
161829678|NCT01396421|584415849|FG001|Overall Study|Physician Decision|1|||
162230900|NCT02680002|585895301|FG003|Overall Study|Withdrawal by Subject|0|||
162230901|NCT02680002|585895302|FG004|Overall Study|Withdrawal by Subject|2|||
162230902|NCT02680002|585895303|FG005|Overall Study|Withdrawal by Subject|2|||
162230903|NCT02680002|585895298|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
162230904|NCT02680002|585895299|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
162230905|NCT02680002|585895300|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
162230906|NCT02680002|585895301|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
161829679|NCT01396421|584415850|FG002|Overall Study|Physician Decision|0|||
161829680|NCT01396421|584415851|FG003|Overall Study|Physician Decision|3|||
161940220|NCT03648372|584830792|FG016|Overall Study|Lost to Follow-up|0|||
161829681|NCT01396421|584415848|FG000|Overall Study|Withdrawal by Subject|31|||
161829682|NCT01396421|584415849|FG001|Overall Study|Withdrawal by Subject|24|||
161829683|NCT01396421|584415850|FG002|Overall Study|Withdrawal by Subject|13|||
161829684|NCT01396421|584415851|FG003|Overall Study|Withdrawal by Subject|21|||
161829685|NCT01396421|584415848|FG000|Overall Study|Protocol Deviation|2|||
161829686|NCT01396421|584415849|FG001|Overall Study|Protocol Deviation|1|||
161829687|NCT01396421|584415850|FG002|Overall Study|Protocol Deviation|1|||
161829688|NCT01396421|584415851|FG003|Overall Study|Protocol Deviation|0|||
161829689|NCT01396421|584415848|FG000|Overall Study|Lack of Efficacy|7|||
161829690|NCT01396421|584415849|FG001|Overall Study|Lack of Efficacy|17|||
161829691|NCT01396421|584415850|FG002|Overall Study|Lack of Efficacy|7|||
161829692|NCT01396421|584415851|FG003|Overall Study|Lack of Efficacy|18|||
161829693|NCT01610063|584415860|FG000|Overall Study|Lost to Follow-up|42|||
161829694|NCT01610063|584415861|FG001|Overall Study|Lost to Follow-up|20|||
161829695|NCT03314662|584415862|FG000|Overall Study|Withdrawal by Subject|1|||
161829696|NCT03314662|584415863|FG001|Overall Study|Withdrawal by Subject|1|||
161829697|NCT03314662|584415864|FG002|Overall Study|Withdrawal by Subject|1|||
161940221|NCT03648372|584830793|FG017|Overall Study|Lost to Follow-up|1|||
161940222|NCT03648372|584830794|FG018|Overall Study|Lost to Follow-up|0|||
161940223|NCT03648372|584830795|FG019|Overall Study|Lost to Follow-up|0|||
161940224|NCT03648372|584830796|FG020|Overall Study|Lost to Follow-up|0|||
161940225|NCT03648372|584830776|FG000|Overall Study|Start of a New Systemic Treatment|0|||
161940226|NCT03648372|584830777|FG001|Overall Study|Start of a New Systemic Treatment|0|||
161940227|NCT03648372|584830778|FG002|Overall Study|Start of a New Systemic Treatment|0|||
161940228|NCT03648372|584830779|FG003|Overall Study|Start of a New Systemic Treatment|0|||
161940229|NCT03648372|584830780|FG004|Overall Study|Start of a New Systemic Treatment|0|||
161940230|NCT03648372|584830781|FG005|Overall Study|Start of a New Systemic Treatment|0|||
161940231|NCT03648372|584830782|FG006|Overall Study|Start of a New Systemic Treatment|0|||
161940232|NCT03648372|584830783|FG007|Overall Study|Start of a New Systemic Treatment|2|||
161940233|NCT03648372|584830784|FG008|Overall Study|Start of a New Systemic Treatment|0|||
161940234|NCT03648372|584830785|FG009|Overall Study|Start of a New Systemic Treatment|0|||
162230907|NCT02680002|585895302|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
162230908|NCT02680002|585895303|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
162230909|NCT02680002|585895298|FG000|Overall Study|Other|0|||
162230910|NCT02680002|585895299|FG001|Overall Study|Other|1|||
162230911|NCT02680002|585895300|FG002|Overall Study|Other|0|||
162230912|NCT02680002|585895301|FG003|Overall Study|Other|0|||
162230913|NCT02680002|585895302|FG004|Overall Study|Other|1|||
162230914|NCT02680002|585895303|FG005|Overall Study|Other|0|||
161829698|NCT03314662|584415862|FG000|Overall Study|Lost to Follow-up|5|||
161829699|NCT03314662|584415863|FG001|Overall Study|Lost to Follow-up|4|||
161829700|NCT03314662|584415864|FG002|Overall Study|Lost to Follow-up|4|||
161829701|NCT03314662|584415862|FG000|Overall Study|Death|2|||
161829702|NCT03314662|584415863|FG001|Overall Study|Death|0|||
161940235|NCT03648372|584830786|FG010|Overall Study|Start of a New Systemic Treatment|1|||
161940236|NCT03648372|584830787|FG011|Overall Study|Start of a New Systemic Treatment|0|||
162230915|NCT02680002|585895298|FG000|Overall Study|Adverse Event|0|||
162230916|NCT02680002|585895299|FG001|Overall Study|Adverse Event|0|||
162230917|NCT02680002|585895300|FG002|Overall Study|Adverse Event|0|||
162230918|NCT02680002|585895301|FG003|Overall Study|Adverse Event|0|||
162230919|NCT02680002|585895302|FG004|Overall Study|Adverse Event|1|||
162230920|NCT02680002|585895303|FG005|Overall Study|Adverse Event|2|||
162230921|NCT04097301|585895306|FG000|Overall Study|Death|1|||
162230922|NCT04097301|585895306|FG000|Overall Study|Withdrawal by Subject|1|||
162230923|NCT04097301|585895306|FG000|Overall Study|Screening Failure|5|||
162230924|NCT01403610|585895310|FG000|Overall Study|Withdrawal by Subject|2|||
162230925|NCT01403610|585895311|FG001|Overall Study|Withdrawal by Subject|0|||
162230926|NCT01403610|585895312|FG002|Overall Study|Withdrawal by Subject|0|||
162230927|NCT01403610|585895313|FG003|Overall Study|Withdrawal by Subject|0|||
162230928|NCT01403610|585895310|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
162230929|NCT01403610|585895311|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
162230930|NCT01403610|585895312|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
162230931|NCT01403610|585895313|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
162230932|NCT00901186|585895314|FG000|Overall Study|Lack of Efficacy|0|||
162230933|NCT00901186|585895315|FG001|Overall Study|Lack of Efficacy|1|||
162230934|NCT00901186|585895314|FG000|Overall Study|Abnormal laboratory values|0|||
162230935|NCT00901186|585895315|FG001|Overall Study|Abnormal laboratory values|1|||
162230936|NCT00901186|585895314|FG000|Overall Study|Lost to Follow-up|2|||
162230937|NCT00901186|585895315|FG001|Overall Study|Lost to Follow-up|0|||
162230938|NCT00901186|585895314|FG000|Overall Study|Adverse Event|2|||
162230939|NCT00901186|585895315|FG001|Overall Study|Adverse Event|4|||
162230940|NCT00901186|585895314|FG000|Overall Study|Administration problems|0|||
162230941|NCT00901186|585895315|FG001|Overall Study|Administration problems|1|||
162230942|NCT00901186|585895314|FG000|Overall Study|Protocol deviations|5|||
162230943|NCT00901186|585895315|FG001|Overall Study|Protocol deviations|4|||
162230944|NCT02383056|585895316|FG000|Overall Study|Adverse Event|1|||
162230945|NCT02383056|585895317|FG001|Overall Study|Adverse Event|0|||
162230946|NCT02383056|585895316|FG000|Overall Study|Lost to Follow-up|0|||
162230947|NCT02383056|585895317|FG001|Overall Study|Lost to Follow-up|2|||
162230948|NCT01775475|585895318|FG000|Overall Study|Death|3|||
162230949|NCT01775475|585895319|FG001|Overall Study|Death|3|||
162230950|NCT02074553|585895323|FG000|Intervention Period 1|Family Emergency|0|||
162230951|NCT02074553|585895324|FG001|Intervention Period 1|Family Emergency|0|||
162230952|NCT02074553|585895325|FG002|Intervention Period 1|Family Emergency|0|||
162230953|NCT02074553|585895326|FG003|Intervention Period 1|Family Emergency|1|||
162230954|NCT02074553|585895327|FG004|Intervention Period 1|Family Emergency|0|||
162230955|NCT02074553|585895328|FG005|Intervention Period 1|Family Emergency|0|||
162230956|NCT02074553|585895329|FG006|Intervention Period 1|Family Emergency|0|||
162230957|NCT02074553|585895330|FG007|Intervention Period 1|Family Emergency|0|||
162230958|NCT02074553|585895323|FG000|Washout Period 1|Adverse Event|1|||
162230959|NCT02074553|585895324|FG001|Washout Period 1|Adverse Event|0|||
162230960|NCT02074553|585895325|FG002|Washout Period 1|Adverse Event|0|||
162230961|NCT02074553|585895326|FG003|Washout Period 1|Adverse Event|0|||
162230962|NCT02074553|585895327|FG004|Washout Period 1|Adverse Event|0|||
162230963|NCT02074553|585895328|FG005|Washout Period 1|Adverse Event|0|||
162230964|NCT02074553|585895329|FG006|Washout Period 1|Adverse Event|0|||
162230965|NCT02074553|585895330|FG007|Washout Period 1|Adverse Event|0|||
162230966|NCT02074553|585895323|FG000|Washout Period 1|Physician Decision|0|||
162230967|NCT02074553|585895324|FG001|Washout Period 1|Physician Decision|0|||
162230968|NCT02074553|585895325|FG002|Washout Period 1|Physician Decision|0|||
162230969|NCT02074553|585895326|FG003|Washout Period 1|Physician Decision|1|||
162230970|NCT02074553|585895327|FG004|Washout Period 1|Physician Decision|0|||
162230971|NCT02074553|585895328|FG005|Washout Period 1|Physician Decision|0|||
162230972|NCT02074553|585895329|FG006|Washout Period 1|Physician Decision|0|||
162230973|NCT02074553|585895330|FG007|Washout Period 1|Physician Decision|0|||
162230974|NCT02074553|585895323|FG000|Washout Period 1|Other|0|||
162023880|NCT03087617|585144545|FG000|Overall Study|Lost to Follow-up|32|||
162230975|NCT02074553|585895324|FG001|Washout Period 1|Other|0|||
162230976|NCT02074553|585895325|FG002|Washout Period 1|Other|0|||
162230977|NCT02074553|585895326|FG003|Washout Period 1|Other|0|||
162230978|NCT02074553|585895327|FG004|Washout Period 1|Other|0|||
162230979|NCT02074553|585895328|FG005|Washout Period 1|Other|1|||
162230980|NCT02074553|585895329|FG006|Washout Period 1|Other|0|||
162230981|NCT02074553|585895330|FG007|Washout Period 1|Other|0|||
162230982|NCT02074553|585895323|FG000|Washout Period 2|Adverse Event|0|||
161829703|NCT03314662|584415864|FG002|Overall Study|Death|0|||
161829704|NCT01117766|584415869|FG000|First Intervention|Adverse Event|0|||
161829705|NCT01117766|584415870|FG001|First Intervention|Adverse Event|1|||
161829706|NCT01117766|584415869|FG000|First Intervention|Protocol Violation|1|||
161829707|NCT01117766|584415870|FG001|First Intervention|Protocol Violation|0|||
162230983|NCT02074553|585895324|FG001|Washout Period 2|Adverse Event|0|||
162230984|NCT02074553|585895325|FG002|Washout Period 2|Adverse Event|0|||
162230985|NCT02074553|585895326|FG003|Washout Period 2|Adverse Event|0|||
162230986|NCT02074553|585895327|FG004|Washout Period 2|Adverse Event|0|||
162023881|NCT03087617|585144546|FG001|Overall Study|Lost to Follow-up|30|||
162230987|NCT02074553|585895328|FG005|Washout Period 2|Adverse Event|0|||
162230988|NCT02074553|585895329|FG006|Washout Period 2|Adverse Event|1|||
162230989|NCT02074553|585895330|FG007|Washout Period 2|Adverse Event|0|||
162230990|NCT02074553|585895323|FG000|Washout Period 2|Physician Decision|0|||
162230991|NCT02074553|585895324|FG001|Washout Period 2|Physician Decision|0|||
162230992|NCT02074553|585895325|FG002|Washout Period 2|Physician Decision|0|||
162230993|NCT02074553|585895326|FG003|Washout Period 2|Physician Decision|0|||
162230994|NCT02074553|585895327|FG004|Washout Period 2|Physician Decision|0|||
162230995|NCT02074553|585895328|FG005|Washout Period 2|Physician Decision|1|||
162230996|NCT02074553|585895329|FG006|Washout Period 2|Physician Decision|0|||
162230997|NCT02074553|585895330|FG007|Washout Period 2|Physician Decision|0|||
162230998|NCT02074553|585895323|FG000|Washout Period 2|Lost to Follow-up|0|||
162230999|NCT02074553|585895324|FG001|Washout Period 2|Lost to Follow-up|0|||
162231000|NCT02074553|585895325|FG002|Washout Period 2|Lost to Follow-up|1|||
162231001|NCT02074553|585895326|FG003|Washout Period 2|Lost to Follow-up|0|||
162231002|NCT02074553|585895327|FG004|Washout Period 2|Lost to Follow-up|0|||
162231003|NCT02074553|585895328|FG005|Washout Period 2|Lost to Follow-up|0|||
162231004|NCT02074553|585895329|FG006|Washout Period 2|Lost to Follow-up|0|||
162231005|NCT02074553|585895330|FG007|Washout Period 2|Lost to Follow-up|0|||
162231006|NCT02074553|585895323|FG000|Washout Period 3|Physician Decision|0|||
162231007|NCT02074553|585895324|FG001|Washout Period 3|Physician Decision|0|||
162231008|NCT02074553|585895325|FG002|Washout Period 3|Physician Decision|0|||
162231009|NCT02074553|585895326|FG003|Washout Period 3|Physician Decision|0|||
162231010|NCT02074553|585895327|FG004|Washout Period 3|Physician Decision|0|||
161679596|NCT00310804|583879194|FG001|Overall Study|Lost to Follow-up|0|||
161679597|NCT00310804|583879193|FG000|Overall Study|Withdrawal by Subject|3|||
161679598|NCT00310804|583879194|FG001|Overall Study|Withdrawal by Subject|0|||
161679599|NCT01889238|583879197|FG000|Overall Study|Death|1|||
161829708|NCT01117766|584415869|FG000|Washout Period|Protocol Violation|0|||
161829709|NCT01117766|584415870|FG001|Washout Period|Protocol Violation|2|||
161829710|NCT01117766|584415869|FG000|Second Intervention|Lost to Follow-up|1|||
161829711|NCT01117766|584415870|FG001|Second Intervention|Lost to Follow-up|0|||
162231011|NCT02074553|585895328|FG005|Washout Period 3|Physician Decision|0|||
162231012|NCT02074553|585895329|FG006|Washout Period 3|Physician Decision|0|||
162231013|NCT02074553|585895330|FG007|Washout Period 3|Physician Decision|1|||
162231014|NCT02342743|585895331|FG000|Baseline Period|Withdrawal by Subject|3|||
161829712|NCT01117766|584415869|FG000|Second Intervention|Other|1|||
161829713|NCT01117766|584415870|FG001|Second Intervention|Other|2|||
161829714|NCT01117766|584415869|FG000|Second Intervention|Adverse Event|0|||
161829715|NCT01117766|584415870|FG001|Second Intervention|Adverse Event|2|||
161829716|NCT01117766|584415869|FG000|Second Intervention|Withdrawal by Subject|0|||
161829717|NCT01117766|584415870|FG001|Second Intervention|Withdrawal by Subject|1|||
161829718|NCT04405739|584415871|FG000|Overall Study|Adverse Event|0|||
161829719|NCT04405739|584415872|FG001|Overall Study|Adverse Event|1|||
161829720|NCT04405739|584415873|FG002|Overall Study|Adverse Event|0|||
161829721|NCT04405739|584415874|FG003|Overall Study|Adverse Event|0|||
161829722|NCT04405739|584415871|FG000|Overall Study|Lost to Follow-up|0|||
161829723|NCT04405739|584415872|FG001|Overall Study|Lost to Follow-up|2|||
161829724|NCT04405739|584415873|FG002|Overall Study|Lost to Follow-up|1|||
161829725|NCT04405739|584415874|FG003|Overall Study|Lost to Follow-up|3|||
161829726|NCT04405739|584415871|FG000|Overall Study|Withdrawal by Subject|0|||
162231015|NCT02342743|585895331|FG000|Baseline Period|Lost to Follow-up|2|||
162231016|NCT02342743|585895331|FG000|Baseline Period|Change in prophylactic medication|3|||
162231017|NCT02342743|585895331|FG000|Baseline Period|Screening failure regarding baseline|7|||
162231018|NCT02342743|585895331|FG000|Treatment Period|Withdrawal by Subject|2|||
162231019|NCT02342743|585895331|FG000|Treatment Period|Lost to Follow-up|8|||
162231020|NCT02342743|585895331|FG000|Treatment Period|Change in prophylactic medication|1|||
162231021|NCT00686725|585895332|FG000|Overall Study|Adverse Event|1|||
162231022|NCT00686725|585895333|FG001|Overall Study|Adverse Event|1|||
162231023|NCT00686725|585895332|FG000|Overall Study|Progressive Disease|17|||
162231024|NCT00686725|585895333|FG001|Overall Study|Progressive Disease|23|||
162231025|NCT00686725|585895332|FG000|Overall Study|Lost to Follow-up|7|||
162231026|NCT00686725|585895333|FG001|Overall Study|Lost to Follow-up|5|||
162231027|NCT00686725|585895332|FG000|Overall Study|Death|6|||
162231028|NCT00686725|585895333|FG001|Overall Study|Death|3|||
162231029|NCT00686725|585895332|FG000|Overall Study|Withdrawal by Subject|13|||
162231030|NCT00686725|585895333|FG001|Overall Study|Withdrawal by Subject|4|||
162231031|NCT00686725|585895332|FG000|Overall Study|Protocol Violation|1|||
162231032|NCT00686725|585895333|FG001|Overall Study|Protocol Violation|3|||
162231033|NCT00686725|585895332|FG000|Overall Study|Other|1|||
162231034|NCT00686725|585895333|FG001|Overall Study|Other|3|||
162231035|NCT03602066|585895334|FG000|Overall Study|Withdrawal by Subject|2|||
162231036|NCT03602066|585895335|FG001|Overall Study|Withdrawal by Subject|0|||
162231037|NCT03602066|585895334|FG000|Overall Study|Physician Decision|1|||
162231038|NCT03602066|585895335|FG001|Overall Study|Physician Decision|0|||
162231039|NCT00092495|585895336|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
162231040|NCT00092495|585895337|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
162023882|NCT03087617|585144547|FG002|Overall Study|Lost to Follow-up|30|||
162023883|NCT03087617|585144548|FG003|Overall Study|Lost to Follow-up|39|||
162023884|NCT02160041|585144550|FG000|Overall Study|Adverse Event|11|||
162023885|NCT02160041|585144550|FG000|Overall Study|Death|2|||
162023886|NCT02160041|585144550|FG000|Overall Study|disease progression|57|||
162023887|NCT02160041|585144550|FG000|Overall Study|Protocol Violation|1|||
162023888|NCT02160041|585144550|FG000|Overall Study|non-compliance with study|1|||
162023889|NCT02160041|585144550|FG000|Overall Study|Physician Decision|3|||
162023890|NCT02160041|585144550|FG000|Overall Study|Withdrawal by Subject|8|||
162023891|NCT02160041|585144550|FG000|Overall Study|study terminated by by sponsor|1|||
162023892|NCT04450381|585144551|FG000|Overall Study|Protocol Violation|4|||
162023893|NCT04450381|585144551|FG000|Overall Study|Wrong device setting|2|||
162023894|NCT00006409|585144557|FG000|Baseline|Protocol Violation|48|||
162023895|NCT00006409|585144558|FG001|Baseline|Protocol Violation|70|||
162023896|NCT00006409|585144559|FG002|Baseline|Protocol Violation|0|||
162023897|NCT00006409|585144560|FG003|Baseline|Protocol Violation|0|||
162023898|NCT00006409|585144561|FG004|Baseline|Protocol Violation|0|||
162023899|NCT00006409|585144562|FG005|Baseline|Protocol Violation|0|||
162023900|NCT00006409|585144557|FG000|Post-2 Year Intervention|Protocol Violation|0|||
162023901|NCT00006409|585144558|FG001|Post-2 Year Intervention|Protocol Violation|0|||
162023902|NCT00006409|585144559|FG002|Post-2 Year Intervention|Protocol Violation|251|||
162023903|NCT00006409|585144560|FG003|Post-2 Year Intervention|Protocol Violation|168|||
162023904|NCT00006409|585144561|FG004|Post-2 Year Intervention|Protocol Violation|0|||
162023905|NCT00006409|585144562|FG005|Post-2 Year Intervention|Protocol Violation|0|||
162023906|NCT00006409|585144557|FG000|Post-3 Year Intervention|Protocol Violation|0|||
162023907|NCT00006409|585144558|FG001|Post-3 Year Intervention|Protocol Violation|0|||
162023908|NCT00006409|585144559|FG002|Post-3 Year Intervention|Protocol Violation|0|||
162023909|NCT00006409|585144560|FG003|Post-3 Year Intervention|Protocol Violation|0|||
162023910|NCT00006409|585144561|FG004|Post-3 Year Intervention|Protocol Violation|62|||
162023911|NCT00006409|585144562|FG005|Post-3 Year Intervention|Protocol Violation|62|||
162023912|NCT02059291|585144563|FG000|Epoch 2|Lack of Efficacy|0|||
162023913|NCT02059291|585144564|FG001|Epoch 2|Lack of Efficacy|0|||
162023914|NCT02059291|585144565|FG002|Epoch 2|Lack of Efficacy|0|||
162023915|NCT02059291|585144566|FG003|Epoch 2|Lack of Efficacy|1|||
162023916|NCT02059291|585144567|FG004|Epoch 2|Lack of Efficacy|0|||
162023917|NCT02059291|585144568|FG005|Epoch 2|Lack of Efficacy|1|||
162023918|NCT02059291|585144569|FG006|Epoch 2|Lack of Efficacy|0|||
162023919|NCT02059291|585144570|FG007|Epoch 2|Lack of Efficacy|0|||
162023920|NCT02059291|585144571|FG008|Epoch 2|Lack of Efficacy|0|||
162023921|NCT02059291|585144572|FG009|Epoch 2|Lack of Efficacy|0|||
162023922|NCT02059291|585144573|FG010|Epoch 2|Lack of Efficacy|0|||
162023923|NCT02059291|585144574|FG011|Epoch 2|Lack of Efficacy|0|||
162023924|NCT02059291|585144575|FG012|Epoch 2|Lack of Efficacy|0|||
162023925|NCT02059291|585144576|FG013|Epoch 2|Lack of Efficacy|0|||
162023926|NCT02059291|585144577|FG014|Epoch 2|Lack of Efficacy|0|||
162023927|NCT02059291|585144578|FG015|Epoch 2|Lack of Efficacy|0|||
162023928|NCT02059291|585144579|FG016|Epoch 2|Lack of Efficacy|0|||
162023929|NCT02059291|585144580|FG017|Epoch 2|Lack of Efficacy|0|||
162023930|NCT02059291|585144581|FG018|Epoch 2|Lack of Efficacy|0|||
162023931|NCT02059291|585144582|FG019|Epoch 2|Lack of Efficacy|0|||
162023932|NCT02059291|585144583|FG020|Epoch 2|Lack of Efficacy|0|||
162023933|NCT02059291|585144584|FG021|Epoch 2|Lack of Efficacy|0|||
162023934|NCT02059291|585144585|FG022|Epoch 2|Lack of Efficacy|0|||
162023935|NCT02059291|585144586|FG023|Epoch 2|Lack of Efficacy|0|||
162023936|NCT02059291|585144587|FG024|Epoch 2|Lack of Efficacy|0|||
162231041|NCT00092495|585895338|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
162231042|NCT00092495|585895339|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
162231043|NCT00092495|585895340|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
162231044|NCT00092495|585895336|FG000|Base Study Vaccination Period|Extended|0|||
162231045|NCT00092495|585895337|FG001|Base Study Vaccination Period|Extended|0|||
162231046|NCT00092495|585895338|FG002|Base Study Vaccination Period|Extended|0|||
162231047|NCT00092495|585895339|FG003|Base Study Vaccination Period|Extended|1|||
162231048|NCT00092495|585895340|FG004|Base Study Vaccination Period|Extended|0|||
162231049|NCT00092495|585895336|FG000|Base Study Vaccination Period|*Clinical AE|1|||
162231050|NCT00092495|585895337|FG001|Base Study Vaccination Period|*Clinical AE|0|||
162231051|NCT00092495|585895338|FG002|Base Study Vaccination Period|*Clinical AE|1|||
162023937|NCT02059291|585144563|FG000|Epoch 2|Adverse Event|0|||
162023938|NCT02059291|585144564|FG001|Epoch 2|Adverse Event|0|||
162023939|NCT02059291|585144565|FG002|Epoch 2|Adverse Event|1|||
162023940|NCT02059291|585144566|FG003|Epoch 2|Adverse Event|1|||
162023941|NCT02059291|585144567|FG004|Epoch 2|Adverse Event|0|||
162023942|NCT02059291|585144568|FG005|Epoch 2|Adverse Event|0|||
162023943|NCT02059291|585144569|FG006|Epoch 2|Adverse Event|0|||
162023944|NCT02059291|585144570|FG007|Epoch 2|Adverse Event|1|||
162023945|NCT02059291|585144571|FG008|Epoch 2|Adverse Event|1|||
162023946|NCT02059291|585144572|FG009|Epoch 2|Adverse Event|0|||
162023947|NCT02059291|585144573|FG010|Epoch 2|Adverse Event|0|||
162023948|NCT02059291|585144574|FG011|Epoch 2|Adverse Event|0|||
162023949|NCT02059291|585144575|FG012|Epoch 2|Adverse Event|0|||
161679600|NCT01889238|583879197|FG000|Overall Study|Withdrawal by Subject|1|||
161679601|NCT01889238|583879197|FG000|Overall Study|Adverse Event|6|||
161679602|NCT01889238|583879197|FG000|Overall Study|Disease Progression|104|||
161679603|NCT01889238|583879197|FG000|Overall Study|Other|6|||
161679604|NCT02844816|583879198|FG000|Overall Study|No protocol treatment received|5|||
161679605|NCT02844816|583879199|FG001|Overall Study|No protocol treatment received|1|||
161679606|NCT02844816|583879198|FG000|Overall Study|Ineligible|22|||
161679607|NCT02844816|583879199|FG001|Overall Study|Ineligible|15|||
161679608|NCT02844816|583879198|FG000|Overall Study|Participant refusal|5|||
161679609|NCT02844816|583879199|FG001|Overall Study|Participant refusal|5|||
161679610|NCT02844816|583879198|FG000|Overall Study|Adverse Event|5|||
161679611|NCT02844816|583879199|FG001|Overall Study|Adverse Event|4|||
161679612|NCT02844816|583879198|FG000|Overall Study|Death|0|||
161679613|NCT02844816|583879199|FG001|Overall Study|Death|1|||
161679614|NCT02844816|583879198|FG000|Overall Study|Disease progression/recurrence|50|||
161679615|NCT02844816|583879199|FG001|Overall Study|Disease progression/recurrence|24|||
161679616|NCT02844816|583879198|FG000|Overall Study|Physician Decision|1|||
161679617|NCT02844816|583879199|FG001|Overall Study|Physician Decision|1|||
161679618|NCT06156215|583879200|FG000|Overall Study|Withdrawal by Subject|2|||
161679619|NCT06156215|583879201|FG001|Overall Study|Withdrawal by Subject|4|||
161679620|NCT06156215|583879202|FG002|Overall Study|Withdrawal by Subject|4|||
161679621|NCT06156215|583879203|FG003|Overall Study|Withdrawal by Subject|0|||
161679622|NCT06156215|583879204|FG004|Overall Study|Withdrawal by Subject|2|||
161679623|NCT06156215|583879205|FG005|Overall Study|Withdrawal by Subject|2|||
161679624|NCT06156215|583879200|FG000|Overall Study|Left ED without completing study|9|||
161679625|NCT06156215|583879201|FG001|Overall Study|Left ED without completing study|3|||
161679626|NCT06156215|583879202|FG002|Overall Study|Left ED without completing study|9|||
161679627|NCT06156215|583879203|FG003|Overall Study|Left ED without completing study|0|||
161679628|NCT06156215|583879204|FG004|Overall Study|Left ED without completing study|8|||
161679629|NCT06156215|583879205|FG005|Overall Study|Left ED without completing study|16|||
161679630|NCT06156215|583879200|FG000|Overall Study|Physician Decision|1|||
161679631|NCT06156215|583879201|FG001|Overall Study|Physician Decision|0|||
161679632|NCT06156215|583879202|FG002|Overall Study|Physician Decision|0|||
161679633|NCT06156215|583879203|FG003|Overall Study|Physician Decision|0|||
161679634|NCT06156215|583879204|FG004|Overall Study|Physician Decision|0|||
161679635|NCT06156215|583879205|FG005|Overall Study|Physician Decision|0|||
161679636|NCT06156215|583879200|FG000|Overall Study|Became or found ineligible|2|||
161679637|NCT06156215|583879201|FG001|Overall Study|Became or found ineligible|0|||
161679638|NCT06156215|583879202|FG002|Overall Study|Became or found ineligible|2|||
161679639|NCT06156215|583879203|FG003|Overall Study|Became or found ineligible|0|||
161679640|NCT06156215|583879204|FG004|Overall Study|Became or found ineligible|1|||
161679641|NCT06156215|583879205|FG005|Overall Study|Became or found ineligible|2|||
161679642|NCT04360551|583881346|FG000|Overall Study|Withdrawal by Subject|1|||
161679643|NCT04360551|583881347|FG001|Overall Study|Withdrawal by Subject|0|||
161679644|NCT01524198|583881354|FG000|Overall Study|Protocol Violation|8|||
161679645|NCT01524198|583881355|FG001|Overall Study|Protocol Violation|6|||
161679646|NCT01524198|583881354|FG000|Overall Study|Withdrawal by Subject|15|||
161679647|NCT01524198|583881355|FG001|Overall Study|Withdrawal by Subject|10|||
161679648|NCT02232802|583881356|FG000|Period 1|Sponsor request|1|||
161679649|NCT02232802|583881357|FG001|Period 1|Sponsor request|0|||
161679650|NCT02232802|583881356|FG000|Period 1|Adverse Event|1|||
161679651|NCT02232802|583881357|FG001|Period 1|Adverse Event|1|||
161679652|NCT00885703|583881363|FG000|Overall Study|Death|9|||
161679653|NCT00885703|583881364|FG001|Overall Study|Death|7|||
161679654|NCT00885703|583881365|FG002|Overall Study|Death|8|||
161679655|NCT00885703|583881366|FG003|Overall Study|Death|7|||
161679656|NCT00885703|583881367|FG004|Overall Study|Death|7|||
161679657|NCT00885703|583881368|FG005|Overall Study|Death|8|||
161679658|NCT00885703|583881369|FG006|Overall Study|Death|4|||
161679659|NCT00885703|583881363|FG000|Overall Study|Lost to Follow-up|0|||
161679660|NCT00885703|583881364|FG001|Overall Study|Lost to Follow-up|0|||
161679661|NCT00885703|583881365|FG002|Overall Study|Lost to Follow-up|1|||
161679662|NCT00885703|583881366|FG003|Overall Study|Lost to Follow-up|0|||
161679663|NCT00885703|583881367|FG004|Overall Study|Lost to Follow-up|0|||
161679664|NCT00885703|583881368|FG005|Overall Study|Lost to Follow-up|1|||
161679665|NCT00885703|583881369|FG006|Overall Study|Lost to Follow-up|0|||
161829727|NCT04405739|584415872|FG001|Overall Study|Withdrawal by Subject|2|||
161679666|NCT00885703|583881363|FG000|Overall Study|Withdrawal by Subject|0|||
161679667|NCT00885703|583881364|FG001|Overall Study|Withdrawal by Subject|0|||
161679668|NCT00885703|583881365|FG002|Overall Study|Withdrawal by Subject|0|||
161679669|NCT00885703|583881366|FG003|Overall Study|Withdrawal by Subject|1|||
161679670|NCT00885703|583881367|FG004|Overall Study|Withdrawal by Subject|3|||
161829728|NCT04405739|584415873|FG002|Overall Study|Withdrawal by Subject|1|||
161679671|NCT00885703|583881368|FG005|Overall Study|Withdrawal by Subject|1|||
161679672|NCT00885703|583881369|FG006|Overall Study|Withdrawal by Subject|1|||
161679673|NCT00885703|583881363|FG000|Overall Study|Ineligible (no CM)|1|||
161679674|NCT00885703|583881364|FG001|Overall Study|Ineligible (no CM)|3|||
161679675|NCT00885703|583881365|FG002|Overall Study|Ineligible (no CM)|2|||
161829729|NCT04405739|584415874|FG003|Overall Study|Withdrawal by Subject|1|||
162231052|NCT00092495|585895339|FG003|Base Study Vaccination Period|*Clinical AE|2|||
162231053|NCT00092495|585895340|FG004|Base Study Vaccination Period|*Clinical AE|0|||
162231054|NCT00092495|585895336|FG000|Base Study Vaccination Period|*Other reasons|1|||
162231055|NCT00092495|585895337|FG001|Base Study Vaccination Period|*Other reasons|0|||
162231056|NCT00092495|585895338|FG002|Base Study Vaccination Period|*Other reasons|0|||
162231057|NCT00092495|585895339|FG003|Base Study Vaccination Period|*Other reasons|1|||
162231058|NCT00092495|585895340|FG004|Base Study Vaccination Period|*Other reasons|0|||
162231059|NCT00092495|585895336|FG000|Base Study Vaccination Period|*Pregnancy|0|||
161940237|NCT03648372|584830788|FG012|Overall Study|Start of a New Systemic Treatment|0|||
161940238|NCT03648372|584830789|FG013|Overall Study|Start of a New Systemic Treatment|0|||
161940239|NCT03648372|584830790|FG014|Overall Study|Start of a New Systemic Treatment|0|||
161940240|NCT03648372|584830791|FG015|Overall Study|Start of a New Systemic Treatment|0|||
161940241|NCT03648372|584830792|FG016|Overall Study|Start of a New Systemic Treatment|0|||
162231060|NCT00092495|585895337|FG001|Base Study Vaccination Period|*Pregnancy|2|||
161679676|NCT00885703|583881366|FG003|Overall Study|Ineligible (no CM)|1|||
161679677|NCT00885703|583881367|FG004|Overall Study|Ineligible (no CM)|2|||
161679678|NCT00885703|583881368|FG005|Overall Study|Ineligible (no CM)|3|||
161679679|NCT00885703|583881369|FG006|Overall Study|Ineligible (no CM)|1|||
161679680|NCT01490450|583881372|FG000|Period 1|Lack of Efficacy|2|||
161679681|NCT01490450|583881373|FG001|Period 1|Lack of Efficacy|0|||
161679682|NCT01490450|583881374|FG002|Period 1|Lack of Efficacy|3|||
161679683|NCT01490450|583881375|FG003|Period 1|Lack of Efficacy|0|||
161679684|NCT01490450|583881372|FG000|Period 1|Adverse Event|0|||
161679685|NCT01490450|583881373|FG001|Period 1|Adverse Event|0|||
161679686|NCT01490450|583881374|FG002|Period 1|Adverse Event|0|||
161679687|NCT01490450|583881375|FG003|Period 1|Adverse Event|5|||
161679688|NCT01490450|583881372|FG000|Period 1|Request to discontinue treatment|1|||
161679689|NCT01490450|583881373|FG001|Period 1|Request to discontinue treatment|0|||
161679690|NCT01490450|583881374|FG002|Period 1|Request to discontinue treatment|0|||
161679691|NCT01490450|583881375|FG003|Period 1|Request to discontinue treatment|0|||
161679692|NCT01490450|583881372|FG000|Period 1|Withdrawal by Subject|0|||
161679693|NCT01490450|583881373|FG001|Period 1|Withdrawal by Subject|0|||
161679694|NCT01490450|583881374|FG002|Period 1|Withdrawal by Subject|0|||
161679695|NCT01490450|583881375|FG003|Period 1|Withdrawal by Subject|3|||
161679696|NCT01490450|583881372|FG000|Period 1|No longer met study criteria|0|||
161679697|NCT01490450|583881373|FG001|Period 1|No longer met study criteria|1|||
161679698|NCT01490450|583881374|FG002|Period 1|No longer met study criteria|1|||
161679699|NCT01490450|583881375|FG003|Period 1|No longer met study criteria|0|||
161679700|NCT01490450|583881372|FG000|Period 2|Lack of Efficacy|0|||
161679701|NCT01490450|583881373|FG001|Period 2|Lack of Efficacy|0|||
161679702|NCT01490450|583881374|FG002|Period 2|Lack of Efficacy|0|||
161679703|NCT01490450|583881375|FG003|Period 2|Lack of Efficacy|1|||
161679704|NCT01490450|583881372|FG000|Period 2|Adverse Event|1|||
161679705|NCT01490450|583881373|FG001|Period 2|Adverse Event|1|||
161679706|NCT01490450|583881374|FG002|Period 2|Adverse Event|0|||
161679707|NCT01490450|583881375|FG003|Period 2|Adverse Event|1|||
161679708|NCT01490450|583881372|FG000|Period 2|Withdrawal by Subject|1|||
161679709|NCT01490450|583881373|FG001|Period 2|Withdrawal by Subject|0|||
161679710|NCT01490450|583881374|FG002|Period 2|Withdrawal by Subject|0|||
161679711|NCT01490450|583881375|FG003|Period 2|Withdrawal by Subject|0|||
161679712|NCT01490450|583881372|FG000|Period 2|Lost to Follow-up|0|||
161679713|NCT01490450|583881373|FG001|Period 2|Lost to Follow-up|0|||
161679714|NCT01490450|583881374|FG002|Period 2|Lost to Follow-up|0|||
161679715|NCT01490450|583881375|FG003|Period 2|Lost to Follow-up|2|||
161679716|NCT00404820|583881376|FG000|Overall Study|Adverse Event|4|||
161679717|NCT00404820|583881377|FG001|Overall Study|Adverse Event|16|||
161679718|NCT00404820|583881376|FG000|Overall Study|Withdrawal by Subject|5|||
161679719|NCT00404820|583881377|FG001|Overall Study|Withdrawal by Subject|3|||
161679720|NCT00404820|583881376|FG000|Overall Study|Lost to Follow-up|7|||
161679721|NCT00404820|583881377|FG001|Overall Study|Lost to Follow-up|3|||
161679722|NCT00404820|583881376|FG000|Overall Study|Administrative problems|2|||
161679723|NCT00404820|583881377|FG001|Overall Study|Administrative problems|0|||
161679724|NCT00404820|583881376|FG000|Overall Study|Death|1|||
161940242|NCT03648372|584830793|FG017|Overall Study|Start of a New Systemic Treatment|0|||
161940243|NCT03648372|584830794|FG018|Overall Study|Start of a New Systemic Treatment|0|||
162231061|NCT00092495|585895338|FG002|Base Study Vaccination Period|*Pregnancy|5|||
162231062|NCT00092495|585895339|FG003|Base Study Vaccination Period|*Pregnancy|7|||
161679725|NCT00404820|583881377|FG001|Overall Study|Death|0|||
161679726|NCT00404820|583881376|FG000|Overall Study|Other|0|||
161679727|NCT00404820|583881377|FG001|Overall Study|Other|2|||
161679728|NCT01462435|583881378|FG000|Overall Study|Lack of Efficacy|1|||
161679729|NCT01462435|583881379|FG001|Overall Study|Lack of Efficacy|0|||
161679730|NCT01462435|583881380|FG002|Overall Study|Lack of Efficacy|0|||
161679731|NCT01462435|583881381|FG003|Overall Study|Lack of Efficacy|3|||
161679732|NCT01462435|583881378|FG000|Overall Study|Physician Decision|0|||
161679733|NCT01462435|583881379|FG001|Overall Study|Physician Decision|0|||
161679734|NCT01462435|583881380|FG002|Overall Study|Physician Decision|1|||
161679735|NCT01462435|583881381|FG003|Overall Study|Physician Decision|0|||
161679736|NCT01462435|583881378|FG000|Overall Study|Withdrawal by Subject|0|||
161679737|NCT01462435|583881379|FG001|Overall Study|Withdrawal by Subject|0|||
161679738|NCT01462435|583881380|FG002|Overall Study|Withdrawal by Subject|0|||
161679739|NCT01462435|583881381|FG003|Overall Study|Withdrawal by Subject|1|||
161679740|NCT01462435|583881378|FG000|Overall Study|Lost to Follow-up|0|||
161679741|NCT01462435|583881379|FG001|Overall Study|Lost to Follow-up|0|||
161679742|NCT01462435|583881380|FG002|Overall Study|Lost to Follow-up|0|||
161679743|NCT01462435|583881381|FG003|Overall Study|Lost to Follow-up|1|||
161679744|NCT02053168|583881386|FG000|Overall Study|Withdrawal by Subject|1|||
161679745|NCT02053168|583881386|FG000|Overall Study|Physician Decision|1|||
161679746|NCT02053168|583881386|FG000|Overall Study|Lost to Follow-up|1|||
161679747|NCT02687542|583881389|FG000|Overall Study|Medication error without associated AEs|0|||
161679748|NCT02687542|583881390|FG001|Overall Study|Medication error without associated AEs|0|||
161679749|NCT02687542|583881391|FG002|Overall Study|Medication error without associated AEs|0|||
161679750|NCT02687542|583881392|FG003|Overall Study|Medication error without associated AEs|0|||
161679751|NCT02687542|583881393|FG004|Overall Study|Medication error without associated AEs|1|||
161679752|NCT02687542|583881389|FG000|Overall Study|Lost to Follow-up|0|||
161679753|NCT02687542|583881390|FG001|Overall Study|Lost to Follow-up|0|||
161679754|NCT02687542|583881391|FG002|Overall Study|Lost to Follow-up|0|||
161679755|NCT02687542|583881392|FG003|Overall Study|Lost to Follow-up|0|||
161679756|NCT02687542|583881393|FG004|Overall Study|Lost to Follow-up|1|||
161679757|NCT02687542|583881389|FG000|Overall Study|Protocol Violation|0|||
161679758|NCT02687542|583881390|FG001|Overall Study|Protocol Violation|1|||
161679759|NCT02687542|583881391|FG002|Overall Study|Protocol Violation|0|||
161679760|NCT02687542|583881392|FG003|Overall Study|Protocol Violation|0|||
161679761|NCT02687542|583881393|FG004|Overall Study|Protocol Violation|0|||
161679762|NCT02687542|583881389|FG000|Overall Study|Other|5|||
161679763|NCT02687542|583881390|FG001|Overall Study|Other|9|||
161679764|NCT02687542|583881391|FG002|Overall Study|Other|10|||
161679765|NCT02687542|583881392|FG003|Overall Study|Other|6|||
161679766|NCT02687542|583881393|FG004|Overall Study|Other|5|||
161679767|NCT02687542|583881389|FG000|Overall Study|Adverse Event|3|||
161679768|NCT02687542|583881390|FG001|Overall Study|Adverse Event|1|||
161679769|NCT02687542|583881391|FG002|Overall Study|Adverse Event|3|||
161679770|NCT02687542|583881392|FG003|Overall Study|Adverse Event|2|||
161679771|NCT02687542|583881393|FG004|Overall Study|Adverse Event|9|||
161679772|NCT02687542|583881389|FG000|Overall Study|Withdrawal by Subject|0|||
161679773|NCT02687542|583881390|FG001|Overall Study|Withdrawal by Subject|1|||
161679774|NCT02687542|583881391|FG002|Overall Study|Withdrawal by Subject|1|||
161679775|NCT02687542|583881392|FG003|Overall Study|Withdrawal by Subject|2|||
161679776|NCT02687542|583881393|FG004|Overall Study|Withdrawal by Subject|4|||
161679777|NCT00636675|583881395|FG000|Overall Study|Lost to Follow-up|121|||
161679778|NCT00636675|583881396|FG001|Overall Study|Lost to Follow-up|31|||
161679779|NCT00636675|583881395|FG000|Overall Study|Withdrawal by Subject|19|||
161679780|NCT00636675|583881396|FG001|Overall Study|Withdrawal by Subject|10|||
161679781|NCT03785925|583881398|FG000|Overall Study|Withdrawal by Subject|15|||
161679782|NCT03785925|583881398|FG000|Overall Study|Lost to Follow-up|1|||
161679783|NCT00176605|583881399|FG000|Overall Study|Withdrawal by Subject|2|||
161679784|NCT01227187|583881400|FG000|Overall Study|Physician Decision|0|||
161679785|NCT01227187|583881401|FG001|Overall Study|Physician Decision|0|||
161679786|NCT01227187|583881402|FG002|Overall Study|Physician Decision|0|||
161679787|NCT01227187|583881403|FG003|Overall Study|Physician Decision|1|||
161679788|NCT01566773|583881405|FG000|Overall Study|Protocol specified criteria|4|||
161679789|NCT01566773|583881405|FG000|Overall Study|Protocol Violation|4|||
161679790|NCT01566773|583881405|FG000|Overall Study|Withdrawal by Subject|9|||
161679791|NCT01566773|583881405|FG000|Overall Study|Administrative reason|1|||
161679792|NCT01566773|583881405|FG000|Overall Study|Adverse Event|10|||
161679793|NCT01566773|583881405|FG000|Overall Study|Physician Decision|2|||
161679794|NCT00833053|583881406|FG000|Overall Study|Adverse Event|4|||
161679795|NCT00833053|583881407|FG001|Overall Study|Adverse Event|0|||
161679796|NCT00833053|583881406|FG000|Overall Study|Treatment Failure|3|||
161679797|NCT00833053|583881407|FG001|Overall Study|Treatment Failure|1|||
161679798|NCT00833053|583881406|FG000|Overall Study|Withdrawal by Subject|0|||
161679799|NCT00833053|583881407|FG001|Overall Study|Withdrawal by Subject|1|||
161679800|NCT00833053|583881406|FG000|Overall Study|Protocol Violation|2|||
161679801|NCT00833053|583881407|FG001|Overall Study|Protocol Violation|1|||
161679802|NCT02187471|583881408|FG000|Overall Study|Protocol Violation|4|||
161679803|NCT02187471|583881409|FG001|Overall Study|Protocol Violation|5|||
161679804|NCT02187471|583881410|FG002|Overall Study|Protocol Violation|4|||
161679805|NCT02187471|583881411|FG003|Overall Study|Protocol Violation|4|||
161679806|NCT02187471|583881408|FG000|Overall Study|Missing|0|||
161679807|NCT02187471|583881409|FG001|Overall Study|Missing|0|||
161679808|NCT02187471|583881410|FG002|Overall Study|Missing|0|||
161679809|NCT02187471|583881411|FG003|Overall Study|Missing|1|||
161679810|NCT02187471|583881408|FG000|Overall Study|Lack of Efficacy|18|||
161679811|NCT02187471|583881409|FG001|Overall Study|Lack of Efficacy|9|||
161679812|NCT02187471|583881410|FG002|Overall Study|Lack of Efficacy|13|||
161679813|NCT02187471|583881411|FG003|Overall Study|Lack of Efficacy|11|||
161679814|NCT02187471|583881408|FG000|Overall Study|Adverse Event|24|||
161679815|NCT02187471|583881409|FG001|Overall Study|Adverse Event|34|||
162023950|NCT02059291|585144576|FG013|Epoch 2|Adverse Event|0|||
162023951|NCT02059291|585144577|FG014|Epoch 2|Adverse Event|0|||
162023952|NCT02059291|585144578|FG015|Epoch 2|Adverse Event|0|||
162023953|NCT02059291|585144579|FG016|Epoch 2|Adverse Event|0|||
162023954|NCT02059291|585144580|FG017|Epoch 2|Adverse Event|0|||
162023955|NCT02059291|585144581|FG018|Epoch 2|Adverse Event|0|||
162231063|NCT00092495|585895340|FG004|Base Study Vaccination Period|*Pregnancy|0|||
162231064|NCT00092495|585895336|FG000|Base Study Vaccination Period|Adverse Event|1|||
162231065|NCT00092495|585895337|FG001|Base Study Vaccination Period|Adverse Event|0|||
162231066|NCT00092495|585895338|FG002|Base Study Vaccination Period|Adverse Event|0|||
162231067|NCT00092495|585895339|FG003|Base Study Vaccination Period|Adverse Event|3|||
162023956|NCT02059291|585144582|FG019|Epoch 2|Adverse Event|0|||
162023957|NCT02059291|585144583|FG020|Epoch 2|Adverse Event|0|||
162023958|NCT02059291|585144584|FG021|Epoch 2|Adverse Event|0|||
162023959|NCT02059291|585144585|FG022|Epoch 2|Adverse Event|0|||
162023960|NCT02059291|585144586|FG023|Epoch 2|Adverse Event|0|||
162023961|NCT02059291|585144587|FG024|Epoch 2|Adverse Event|0|||
162231068|NCT00092495|585895340|FG004|Base Study Vaccination Period|Adverse Event|0|||
161679816|NCT02187471|583881410|FG002|Overall Study|Adverse Event|44|||
162023962|NCT02059291|585144563|FG000|Epoch 2|Withdrawal by Subject|0|||
162023963|NCT02059291|585144564|FG001|Epoch 2|Withdrawal by Subject|1|||
161679817|NCT02187471|583881411|FG003|Overall Study|Adverse Event|36|||
161679818|NCT02187471|583881408|FG000|Overall Study|Withdrawal by Subject|23|||
161679819|NCT02187471|583881409|FG001|Overall Study|Withdrawal by Subject|29|||
161679820|NCT02187471|583881410|FG002|Overall Study|Withdrawal by Subject|22|||
161679821|NCT02187471|583881411|FG003|Overall Study|Withdrawal by Subject|24|||
161679822|NCT02187471|583881408|FG000|Overall Study|Other|7|||
161679823|NCT02187471|583881409|FG001|Overall Study|Other|5|||
161679824|NCT02187471|583881410|FG002|Overall Study|Other|3|||
161679825|NCT02187471|583881411|FG003|Overall Study|Other|4|||
161679826|NCT00957528|583881414|FG000|Overall Study|Protocol Violation|0|||
161679827|NCT00957528|583881415|FG001|Overall Study|Protocol Violation|1|||
161679828|NCT00957528|583881416|FG002|Overall Study|Protocol Violation|0|||
161679829|NCT00957528|583881414|FG000|Overall Study|Withdrawal by Subject|0|||
161679830|NCT00957528|583881415|FG001|Overall Study|Withdrawal by Subject|0|||
161679831|NCT00957528|583881416|FG002|Overall Study|Withdrawal by Subject|1|||
161679832|NCT02318667|583881417|FG000|Overall Study|Adverse Event|1|||
161679833|NCT02318667|583881417|FG000|Overall Study|Lack of Efficacy|6|||
161679834|NCT02318667|583881417|FG000|Overall Study|Protocol Violation|2|||
161679835|NCT01101438|583881419|FG000|Overall Study|Withdrawal by Subject|8|||
161679836|NCT01101438|583881420|FG001|Overall Study|Withdrawal by Subject|9|||
161679837|NCT02289742|583881429|FG000|First Wear Period|Adverse event prior to treatment|0|||
161679838|NCT02289742|583881430|FG001|First Wear Period|Adverse event prior to treatment|1|||
161679839|NCT02289742|583881431|FG002|First Wear Period|Adverse event prior to treatment|0|||
161679840|NCT02289742|583881432|FG003|First Wear Period|Adverse event prior to treatment|0|||
161679841|NCT02289742|583881429|FG000|First Wear Period|Adverse Event|0|||
161679842|NCT02289742|583881430|FG001|First Wear Period|Adverse Event|0|||
161679843|NCT02289742|583881431|FG002|First Wear Period|Adverse Event|1|||
161679844|NCT02289742|583881432|FG003|First Wear Period|Adverse Event|0|||
161679845|NCT02289742|583881429|FG000|First Wear Period|Other prior to treatment|0|||
161679846|NCT02289742|583881430|FG001|First Wear Period|Other prior to treatment|0|||
161679847|NCT02289742|583881431|FG002|First Wear Period|Other prior to treatment|0|||
161679848|NCT02289742|583881432|FG003|First Wear Period|Other prior to treatment|1|||
161679849|NCT02289742|583881429|FG000|Third Wear Period|Adverse Event|0|||
161679850|NCT02289742|583881430|FG001|Third Wear Period|Adverse Event|1|||
161679851|NCT02289742|583881431|FG002|Third Wear Period|Adverse Event|0|||
161679852|NCT02289742|583881432|FG003|Third Wear Period|Adverse Event|0|||
161679853|NCT02289742|583881429|FG000|Third Wear Period|Reason not given|0|||
161679854|NCT02289742|583881430|FG001|Third Wear Period|Reason not given|0|||
161679855|NCT02289742|583881431|FG002|Third Wear Period|Reason not given|0|||
161679856|NCT02289742|583881432|FG003|Third Wear Period|Reason not given|1|||
161679857|NCT00709111|583881433|FG000|Overall Study|Withdrawal by Subject|1|||
161679858|NCT00709111|583881433|FG000|Overall Study|Unable to attend clinic visits|1|||
161679859|NCT02865018|583881434|FG000|Overall Study|Withdrawal by Subject|1|||
161679860|NCT01735279|583881437|FG000|Overall Study|Lost to Follow-up|11|||
161679861|NCT01735279|583881438|FG001|Overall Study|Lost to Follow-up|8|||
161679862|NCT00806195|583881439|FG000|Overall Study|Death|6|||
162023964|NCT02059291|585144565|FG002|Epoch 2|Withdrawal by Subject|0|||
162023965|NCT02059291|585144566|FG003|Epoch 2|Withdrawal by Subject|0|||
162023966|NCT02059291|585144567|FG004|Epoch 2|Withdrawal by Subject|0|||
162023967|NCT02059291|585144568|FG005|Epoch 2|Withdrawal by Subject|1|||
161679863|NCT00806195|583881440|FG001|Overall Study|Death|0|||
161679864|NCT00806195|583881441|FG002|Overall Study|Death|1|||
161679865|NCT00806195|583881442|FG003|Overall Study|Death|0|||
161679866|NCT00806195|583881439|FG000|Overall Study|Adverse Event|25|||
161679867|NCT00806195|583881440|FG001|Overall Study|Adverse Event|5|||
162023968|NCT02059291|585144569|FG006|Epoch 2|Withdrawal by Subject|0|||
162023969|NCT02059291|585144570|FG007|Epoch 2|Withdrawal by Subject|0|||
162023970|NCT02059291|585144571|FG008|Epoch 2|Withdrawal by Subject|1|||
162231069|NCT00092495|585895336|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
162231070|NCT00092495|585895337|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
162231071|NCT00092495|585895338|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
162231072|NCT00092495|585895339|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
162231073|NCT00092495|585895340|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
162231074|NCT00092495|585895336|FG000|Base Study Vaccination Period|Moved|3|||
162231075|NCT00092495|585895337|FG001|Base Study Vaccination Period|Moved|1|||
162231076|NCT00092495|585895338|FG002|Base Study Vaccination Period|Moved|2|||
162231077|NCT00092495|585895339|FG003|Base Study Vaccination Period|Moved|2|||
162231078|NCT00092495|585895340|FG004|Base Study Vaccination Period|Moved|0|||
162231079|NCT00092495|585895336|FG000|Base Study Vaccination Period|Other|1|||
161679868|NCT00806195|583881441|FG002|Overall Study|Adverse Event|11|||
161679869|NCT00806195|583881442|FG003|Overall Study|Adverse Event|2|||
161679870|NCT00806195|583881439|FG000|Overall Study|Withdrawal by Subject|119|||
161679871|NCT00806195|583881440|FG001|Overall Study|Withdrawal by Subject|31|||
161679872|NCT00806195|583881441|FG002|Overall Study|Withdrawal by Subject|76|||
161940244|NCT03648372|584830795|FG019|Overall Study|Start of a New Systemic Treatment|0|||
161940245|NCT03648372|584830796|FG020|Overall Study|Start of a New Systemic Treatment|0|||
161940246|NCT02471144|584832040|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
162231080|NCT00092495|585895337|FG001|Base Study Vaccination Period|Other|1|||
161679873|NCT00806195|583881442|FG003|Overall Study|Withdrawal by Subject|35|||
161679874|NCT00806195|583881439|FG000|Overall Study|Lost to Follow-up|217|||
161829730|NCT04405739|584415871|FG000|Overall Study|Death|0|||
161829731|NCT04405739|584415872|FG001|Overall Study|Death|0|||
161829732|NCT04405739|584415873|FG002|Overall Study|Death|1|||
161829733|NCT04405739|584415874|FG003|Overall Study|Death|0|||
161829734|NCT04405739|584415871|FG000|Overall Study|Transferred to rehab|0|||
161829735|NCT04405739|584415872|FG001|Overall Study|Transferred to rehab|0|||
161829736|NCT04405739|584415873|FG002|Overall Study|Transferred to rehab|0|||
161829737|NCT04405739|584415874|FG003|Overall Study|Transferred to rehab|1|||
161829738|NCT04405739|584415871|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
161829739|NCT04405739|584415872|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
161829740|NCT04405739|584415873|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
161829741|NCT04405739|584415874|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
161829742|NCT00438659|584415875|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
161829743|NCT00438659|584415876|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
161829744|NCT00438659|584415875|FG000|Overall Study|Cancel|5|||
161829745|NCT00438659|584415876|FG001|Overall Study|Cancel|2|||
161829746|NCT05766787|584415877|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
161829747|NCT05766787|584415878|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
161829748|NCT05766787|584415877|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
161679875|NCT00806195|583881440|FG001|Overall Study|Lost to Follow-up|66|||
161679876|NCT00806195|583881441|FG002|Overall Study|Lost to Follow-up|90|||
161679877|NCT00806195|583881442|FG003|Overall Study|Lost to Follow-up|34|||
161679878|NCT00806195|583881439|FG000|Overall Study|Inappropriate Enrollment|0|||
161679879|NCT00806195|583881440|FG001|Overall Study|Inappropriate Enrollment|1|||
161679880|NCT00806195|583881441|FG002|Overall Study|Inappropriate Enrollment|0|||
161679881|NCT00806195|583881442|FG003|Overall Study|Inappropriate Enrollment|0|||
161679882|NCT00806195|583881439|FG000|Overall Study|Administrative Reason|113|||
161679883|NCT00806195|583881440|FG001|Overall Study|Administrative Reason|35|||
161679884|NCT00806195|583881441|FG002|Overall Study|Administrative Reason|66|||
161679885|NCT00806195|583881442|FG003|Overall Study|Administrative Reason|26|||
161679886|NCT00806195|583881439|FG000|Overall Study|Protocol Violation|34|||
161679887|NCT00806195|583881440|FG001|Overall Study|Protocol Violation|24|||
161679888|NCT00806195|583881441|FG002|Overall Study|Protocol Violation|26|||
161679889|NCT00806195|583881442|FG003|Overall Study|Protocol Violation|9|||
161679890|NCT01519934|583881448|FG000|Overall Study|Lost to Follow-up|3|||
161679891|NCT00922480|583881449|FG000|Main Study|Protocol Violation|3|||
161679892|NCT00922480|583881450|FG001|Main Study|Protocol Violation|6|||
161679893|NCT00922480|583881449|FG000|Main Study|Adverse Event|6|||
161679894|NCT00922480|583881450|FG001|Main Study|Adverse Event|7|||
161679895|NCT00922480|583881449|FG000|Main Study|Lack of Efficacy|3|||
161679896|NCT00922480|583881450|FG001|Main Study|Lack of Efficacy|0|||
161679897|NCT00922480|583881449|FG000|Main Study|Withdrawal by Subject|20|||
161679898|NCT00922480|583881450|FG001|Main Study|Withdrawal by Subject|15|||
161679899|NCT00922480|583881449|FG000|Main Study|Lost to Follow-up|5|||
161679900|NCT00922480|583881450|FG001|Main Study|Lost to Follow-up|0|||
161679901|NCT00922480|583881449|FG000|Main Study|Physician Decision|0|||
161679902|NCT00922480|583881450|FG001|Main Study|Physician Decision|1|||
161679903|NCT00922480|583881449|FG000|Extension Study|Protocol Violation|3|||
161679904|NCT00922480|583881450|FG001|Extension Study|Protocol Violation|0|||
161679905|NCT00922480|583881449|FG000|Extension Study|Adverse Event|1|||
161679906|NCT00922480|583881450|FG001|Extension Study|Adverse Event|1|||
161679907|NCT00922480|583881449|FG000|Extension Study|Withdrawal by Subject|1|||
161679908|NCT00922480|583881450|FG001|Extension Study|Withdrawal by Subject|1|||
161679909|NCT00922480|583881449|FG000|Extension Study|Others|0|||
161679910|NCT00922480|583881450|FG001|Extension Study|Others|1|||
161679911|NCT00326209|583881457|FG000|Overall Study|Adverse Event|28|||
161679912|NCT00326209|583881457|FG000|Overall Study|Withdrawal by Subject|22|||
161679913|NCT00326209|583881457|FG000|Overall Study|Lack of Efficacy|31|||
161679914|NCT00326209|583881457|FG000|Overall Study|Lost to Follow-up|18|||
161679915|NCT00326209|583881457|FG000|Overall Study|Participant non-compliant|6|||
161679916|NCT00326209|583881457|FG000|Overall Study|Sponsor closed study|173|||
161679917|NCT00326209|583881457|FG000|Overall Study|Prohibited medication use|1|||
161679918|NCT00326209|583881457|FG000|Overall Study|Violation of entry criteria|1|||
161679919|NCT00326209|583881457|FG000|Overall Study|Withdrawn in error|1|||
161679920|NCT00326209|583881457|FG000|Overall Study|Pregnancy|1|||
161679921|NCT02138617|583881458|FG000|Overall Study|Death|1|||
161679922|NCT02138617|583881459|FG001|Overall Study|Death|2|||
161679923|NCT02138617|583881460|FG002|Overall Study|Death|2|||
161679924|NCT02138617|583881458|FG000|Overall Study|Adverse Event|8|||
161829749|NCT05766787|584415878|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
162023971|NCT02059291|585144572|FG009|Epoch 2|Withdrawal by Subject|0|||
161679925|NCT02138617|583881459|FG001|Overall Study|Adverse Event|5|||
161679926|NCT02138617|583881460|FG002|Overall Study|Adverse Event|2|||
161679927|NCT02138617|583881458|FG000|Overall Study|Disease Progression|20|||
161679928|NCT02138617|583881459|FG001|Overall Study|Disease Progression|13|||
161679929|NCT02138617|583881460|FG002|Overall Study|Disease Progression|4|||
161679930|NCT02138617|583881458|FG000|Overall Study|Withdrawal by Subject|7|||
161679931|NCT02138617|583881459|FG001|Overall Study|Withdrawal by Subject|10|||
161679932|NCT02138617|583881460|FG002|Overall Study|Withdrawal by Subject|2|||
161679933|NCT02138617|583881458|FG000|Overall Study|other complicating disease|0|||
161829750|NCT05766787|584415877|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
161829751|NCT05766787|584415878|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
161829752|NCT01867606|584415879|FG000|Overall Study|Withdrawal by Subject|10|||
161829753|NCT01867606|584415880|FG001|Overall Study|Withdrawal by Subject|14|||
161829754|NCT01867606|584415879|FG000|Overall Study|Protocol Violation|0|||
161829755|NCT01867606|584415880|FG001|Overall Study|Protocol Violation|1|||
161829756|NCT00206102|584415881|FG000|Overall Study|Adverse Event|119|||
161829757|NCT00206102|584415882|FG001|Overall Study|Adverse Event|82|||
161829758|NCT00206102|584415881|FG000|Overall Study|Protocol Violation|0|||
161829759|NCT00206102|584415882|FG001|Overall Study|Protocol Violation|2|||
161829760|NCT00206102|584415881|FG000|Overall Study|Lack of therapeutic response|16|||
161829761|NCT00206102|584415882|FG001|Overall Study|Lack of therapeutic response|11|||
161829762|NCT00206102|584415881|FG000|Overall Study|Lost to Follow-up|95|||
161829763|NCT00206102|584415882|FG001|Overall Study|Lost to Follow-up|66|||
161829764|NCT00206102|584415881|FG000|Overall Study|Withdrawal by Subject|118|||
161829765|NCT00206102|584415882|FG001|Overall Study|Withdrawal by Subject|101|||
161829766|NCT00206102|584415881|FG000|Overall Study|Study-specific discontinuation criteria|18|||
162023972|NCT02059291|585144573|FG010|Epoch 2|Withdrawal by Subject|0|||
162023973|NCT02059291|585144574|FG011|Epoch 2|Withdrawal by Subject|0|||
162023974|NCT02059291|585144575|FG012|Epoch 2|Withdrawal by Subject|0|||
162023975|NCT02059291|585144576|FG013|Epoch 2|Withdrawal by Subject|0|||
162023976|NCT02059291|585144577|FG014|Epoch 2|Withdrawal by Subject|0|||
162023977|NCT02059291|585144578|FG015|Epoch 2|Withdrawal by Subject|0|||
162023978|NCT02059291|585144579|FG016|Epoch 2|Withdrawal by Subject|0|||
162023979|NCT02059291|585144580|FG017|Epoch 2|Withdrawal by Subject|0|||
162023980|NCT02059291|585144581|FG018|Epoch 2|Withdrawal by Subject|0|||
162023981|NCT02059291|585144582|FG019|Epoch 2|Withdrawal by Subject|0|||
162023982|NCT02059291|585144583|FG020|Epoch 2|Withdrawal by Subject|0|||
162023983|NCT02059291|585144584|FG021|Epoch 2|Withdrawal by Subject|0|||
162023984|NCT02059291|585144585|FG022|Epoch 2|Withdrawal by Subject|0|||
161679934|NCT02138617|583881459|FG001|Overall Study|other complicating disease|2|||
161679935|NCT02138617|583881460|FG002|Overall Study|other complicating disease|0|||
161679936|NCT02138617|583881458|FG000|Overall Study|Protocol Violation|1|||
161679937|NCT02138617|583881459|FG001|Overall Study|Protocol Violation|0|||
161679938|NCT02138617|583881460|FG002|Overall Study|Protocol Violation|0|||
161679939|NCT02138617|583881458|FG000|Overall Study|Physician Decision|7|||
161679940|NCT02138617|583881459|FG001|Overall Study|Physician Decision|6|||
161679941|NCT02138617|583881460|FG002|Overall Study|Physician Decision|0|||
161679942|NCT02138617|583881458|FG000|Overall Study|financial reason|0|||
161679943|NCT02138617|583881459|FG001|Overall Study|financial reason|1|||
161679944|NCT02138617|583881460|FG002|Overall Study|financial reason|0|||
161679945|NCT02138617|583881458|FG000|Overall Study|other therapy|3|||
161679946|NCT02138617|583881459|FG001|Overall Study|other therapy|4|||
161679947|NCT02138617|583881460|FG002|Overall Study|other therapy|0|||
161679948|NCT01671111|583881462|FG000|Overall Study|Adverse Event|2|||
161679949|NCT01671111|583881462|FG000|Overall Study|Lack of Efficacy|1|||
161679950|NCT01671111|583881462|FG000|Overall Study|Withdrawal by Subject|2|||
161679951|NCT01671111|583881462|FG000|Overall Study|Physician Decision|1|||
161679952|NCT01671111|583881462|FG000|Overall Study|Other|24|||
161679953|NCT00113074|583881472|FG000|Overall Study|Lost to Follow-up|10|||
161679954|NCT00113074|583881473|FG001|Overall Study|Lost to Follow-up|10|||
161679955|NCT00113074|583881474|FG002|Overall Study|Lost to Follow-up|14|||
161679956|NCT03680911|583881475|FG000|At Home Treatment|Study Termination|3|||
161679957|NCT03680911|583881476|FG001|At Home Treatment|Study Termination|0|||
161679958|NCT03680911|583881475|FG000|At Home Treatment|Lost to Follow-up|0|||
161679959|NCT03680911|583881476|FG001|At Home Treatment|Lost to Follow-up|1|||
161679960|NCT03680911|583881475|FG000|At Home Treatment|Withdrawal by Subject|0|||
161679961|NCT03680911|583881476|FG001|At Home Treatment|Withdrawal by Subject|2|||
161679962|NCT03680911|583881475|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
161679963|NCT03680911|583881476|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
161679964|NCT03716050|583881480|FG000|Overall Study|Lost to Follow-up|0|||
161679965|NCT03716050|583881481|FG001|Overall Study|Lost to Follow-up|0|||
161679966|NCT03716050|583881482|FG002|Overall Study|Lost to Follow-up|1|||
161679967|NCT03716050|583881483|FG003|Overall Study|Lost to Follow-up|0|||
161679968|NCT03716050|583881484|FG004|Overall Study|Lost to Follow-up|0|||
161679969|NCT03716050|583881485|FG005|Overall Study|Lost to Follow-up|0|||
161679970|NCT03716050|583881486|FG006|Overall Study|Lost to Follow-up|0|||
161679971|NCT03716050|583881487|FG007|Overall Study|Lost to Follow-up|0|||
161679972|NCT03716050|583881480|FG000|Overall Study|Physician Decision|0|||
161679973|NCT03716050|583881481|FG001|Overall Study|Physician Decision|0|||
161679974|NCT03716050|583881482|FG002|Overall Study|Physician Decision|0|||
161679975|NCT03716050|583881483|FG003|Overall Study|Physician Decision|1|||
161679976|NCT03716050|583881484|FG004|Overall Study|Physician Decision|0|||
162231081|NCT00092495|585895338|FG002|Base Study Vaccination Period|Other|0|||
162231082|NCT00092495|585895339|FG003|Base Study Vaccination Period|Other|2|||
162231083|NCT00092495|585895340|FG004|Base Study Vaccination Period|Other|0|||
162231084|NCT00092495|585895336|FG000|Base Study Vaccination Period|Pregnancy|2|||
162231085|NCT00092495|585895337|FG001|Base Study Vaccination Period|Pregnancy|0|||
162231086|NCT00092495|585895338|FG002|Base Study Vaccination Period|Pregnancy|0|||
162231087|NCT00092495|585895339|FG003|Base Study Vaccination Period|Pregnancy|0|||
161679977|NCT03716050|583881485|FG005|Overall Study|Physician Decision|0|||
161679978|NCT03716050|583881486|FG006|Overall Study|Physician Decision|0|||
161679979|NCT03716050|583881487|FG007|Overall Study|Physician Decision|0|||
161679980|NCT03716050|583881480|FG000|Overall Study|Protocol Violation|0|||
161679981|NCT03716050|583881481|FG001|Overall Study|Protocol Violation|0|||
161679982|NCT03716050|583881482|FG002|Overall Study|Protocol Violation|0|||
161679983|NCT03716050|583881483|FG003|Overall Study|Protocol Violation|1|||
161679984|NCT03716050|583881484|FG004|Overall Study|Protocol Violation|0|||
162023985|NCT02059291|585144586|FG023|Epoch 2|Withdrawal by Subject|0|||
162023986|NCT02059291|585144587|FG024|Epoch 2|Withdrawal by Subject|0|||
161679985|NCT03716050|583881485|FG005|Overall Study|Protocol Violation|0|||
162023987|NCT02059291|585144563|FG000|Epoch 3|Physician Decision|0|||
162023988|NCT02059291|585144564|FG001|Epoch 3|Physician Decision|0|||
161679986|NCT03716050|583881486|FG006|Overall Study|Protocol Violation|0|||
161679987|NCT03716050|583881487|FG007|Overall Study|Protocol Violation|2|||
161679988|NCT01289821|583881488|FG000|Treatment Period|Withdrawal by Subject|1|||
162231088|NCT00092495|585895340|FG004|Base Study Vaccination Period|Pregnancy|0|||
162231089|NCT00092495|585895336|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
162231090|NCT00092495|585895337|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
162231091|NCT00092495|585895338|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
162231092|NCT00092495|585895339|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
161940247|NCT02471144|584832041|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
161940248|NCT02471144|584832042|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
161940249|NCT02471144|584832043|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
161940250|NCT02471144|584832044|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
161940251|NCT02471144|584832045|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
161940252|NCT02471144|584832046|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
161940253|NCT02471144|584832047|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
161940254|NCT02471144|584832048|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
161940255|NCT02471144|584832049|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
161940256|NCT02471144|584832050|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
161940257|NCT02471144|584832040|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161940258|NCT02471144|584832041|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161940259|NCT02471144|584832042|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161940260|NCT02471144|584832043|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
161940261|NCT02471144|584832044|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161940262|NCT02471144|584832045|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161940263|NCT02471144|584832046|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161940264|NCT02471144|584832047|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161940265|NCT02471144|584832048|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161940266|NCT02471144|584832049|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161940267|NCT02471144|584832050|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
161940268|NCT02471144|584832040|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161940269|NCT02471144|584832041|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161940270|NCT02471144|584832042|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
161940271|NCT02471144|584832043|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161940272|NCT02471144|584832044|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161940273|NCT02471144|584832045|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161940274|NCT02471144|584832046|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161940275|NCT02471144|584832047|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161940276|NCT02471144|584832048|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161940277|NCT02471144|584832049|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161940278|NCT02471144|584832050|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
161940279|NCT02471144|584832040|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
161940280|NCT02471144|584832041|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
161940281|NCT02471144|584832042|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161940282|NCT02471144|584832043|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161940283|NCT02471144|584832044|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161940284|NCT02471144|584832045|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161940285|NCT02471144|584832046|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161940286|NCT02471144|584832047|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161940287|NCT02471144|584832048|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161940288|NCT02471144|584832049|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161940289|NCT02471144|584832050|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
161940290|NCT02471144|584832040|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
162023989|NCT02059291|585144565|FG002|Epoch 3|Physician Decision|0|||
162023990|NCT02059291|585144566|FG003|Epoch 3|Physician Decision|0|||
162023991|NCT02059291|585144567|FG004|Epoch 3|Physician Decision|0|||
162023992|NCT02059291|585144568|FG005|Epoch 3|Physician Decision|0|||
162231093|NCT00092495|585895340|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
162231094|NCT00092495|585895336|FG000|Base Study Vaccination Period|Protocol Violation|1|||
162231095|NCT00092495|585895337|FG001|Base Study Vaccination Period|Protocol Violation|0|||
162231096|NCT00092495|585895338|FG002|Base Study Vaccination Period|Protocol Violation|0|||
162231097|NCT00092495|585895339|FG003|Base Study Vaccination Period|Protocol Violation|0|||
162231098|NCT00092495|585895340|FG004|Base Study Vaccination Period|Protocol Violation|0|||
162231099|NCT00092495|585895336|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
162231100|NCT00092495|585895337|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
162231101|NCT00092495|585895338|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
162231102|NCT00092495|585895339|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
162231103|NCT00092495|585895340|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
161940291|NCT02471144|584832041|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161940292|NCT02471144|584832042|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
162023993|NCT02059291|585144569|FG006|Epoch 3|Physician Decision|0|||
162023994|NCT02059291|585144570|FG007|Epoch 3|Physician Decision|0|||
162023995|NCT02059291|585144571|FG008|Epoch 3|Physician Decision|0|||
162023996|NCT02059291|585144572|FG009|Epoch 3|Physician Decision|0|||
162023997|NCT02059291|585144573|FG010|Epoch 3|Physician Decision|0|||
162023998|NCT02059291|585144574|FG011|Epoch 3|Physician Decision|0|||
162023999|NCT02059291|585144575|FG012|Epoch 3|Physician Decision|0|||
162024000|NCT02059291|585144576|FG013|Epoch 3|Physician Decision|1|||
162024001|NCT02059291|585144577|FG014|Epoch 3|Physician Decision|0|||
162024002|NCT02059291|585144578|FG015|Epoch 3|Physician Decision|1|||
162024003|NCT02059291|585144579|FG016|Epoch 3|Physician Decision|0|||
162024004|NCT02059291|585144580|FG017|Epoch 3|Physician Decision|0|||
162024005|NCT02059291|585144581|FG018|Epoch 3|Physician Decision|0|||
162024006|NCT02059291|585144582|FG019|Epoch 3|Physician Decision|0|||
162024007|NCT02059291|585144583|FG020|Epoch 3|Physician Decision|0|||
162024008|NCT02059291|585144584|FG021|Epoch 3|Physician Decision|0|||
162024009|NCT02059291|585144585|FG022|Epoch 3|Physician Decision|0|||
162024010|NCT02059291|585144586|FG023|Epoch 3|Physician Decision|0|||
162024011|NCT02059291|585144587|FG024|Epoch 3|Physician Decision|0|||
162024012|NCT02059291|585144563|FG000|Epoch 3|Adverse Event|0|||
162024013|NCT02059291|585144564|FG001|Epoch 3|Adverse Event|0|||
162024014|NCT02059291|585144565|FG002|Epoch 3|Adverse Event|0|||
162024015|NCT02059291|585144566|FG003|Epoch 3|Adverse Event|0|||
162024016|NCT02059291|585144567|FG004|Epoch 3|Adverse Event|0|||
162024017|NCT02059291|585144568|FG005|Epoch 3|Adverse Event|0|||
162024018|NCT02059291|585144569|FG006|Epoch 3|Adverse Event|0|||
162024019|NCT02059291|585144570|FG007|Epoch 3|Adverse Event|0|||
162024020|NCT02059291|585144571|FG008|Epoch 3|Adverse Event|0|||
162024021|NCT02059291|585144572|FG009|Epoch 3|Adverse Event|0|||
162024022|NCT02059291|585144573|FG010|Epoch 3|Adverse Event|0|||
162024023|NCT02059291|585144574|FG011|Epoch 3|Adverse Event|0|||
162024024|NCT02059291|585144575|FG012|Epoch 3|Adverse Event|0|||
162024025|NCT02059291|585144576|FG013|Epoch 3|Adverse Event|0|||
162024026|NCT02059291|585144577|FG014|Epoch 3|Adverse Event|0|||
162024027|NCT02059291|585144578|FG015|Epoch 3|Adverse Event|1|||
162024028|NCT02059291|585144579|FG016|Epoch 3|Adverse Event|0|||
162024029|NCT02059291|585144580|FG017|Epoch 3|Adverse Event|0|||
162024030|NCT02059291|585144581|FG018|Epoch 3|Adverse Event|0|||
162024031|NCT02059291|585144582|FG019|Epoch 3|Adverse Event|0|||
162024032|NCT02059291|585144583|FG020|Epoch 3|Adverse Event|0|||
162024033|NCT02059291|585144584|FG021|Epoch 3|Adverse Event|0|||
162024034|NCT02059291|585144585|FG022|Epoch 3|Adverse Event|0|||
162024035|NCT02059291|585144586|FG023|Epoch 3|Adverse Event|0|||
162024036|NCT02059291|585144587|FG024|Epoch 3|Adverse Event|0|||
162024037|NCT02059291|585144563|FG000|Epoch 3|Lack of Efficacy|0|||
162024038|NCT02059291|585144564|FG001|Epoch 3|Lack of Efficacy|0|||
162024039|NCT02059291|585144565|FG002|Epoch 3|Lack of Efficacy|0|||
162024040|NCT02059291|585144566|FG003|Epoch 3|Lack of Efficacy|0|||
162024041|NCT02059291|585144567|FG004|Epoch 3|Lack of Efficacy|0|||
162024042|NCT02059291|585144568|FG005|Epoch 3|Lack of Efficacy|0|||
162024043|NCT02059291|585144569|FG006|Epoch 3|Lack of Efficacy|0|||
162024044|NCT02059291|585144570|FG007|Epoch 3|Lack of Efficacy|0|||
162024045|NCT02059291|585144571|FG008|Epoch 3|Lack of Efficacy|0|||
162024046|NCT02059291|585144572|FG009|Epoch 3|Lack of Efficacy|0|||
162024047|NCT02059291|585144573|FG010|Epoch 3|Lack of Efficacy|0|||
162024048|NCT02059291|585144574|FG011|Epoch 3|Lack of Efficacy|0|||
162024049|NCT02059291|585144575|FG012|Epoch 3|Lack of Efficacy|0|||
162024050|NCT02059291|585144576|FG013|Epoch 3|Lack of Efficacy|0|||
162024051|NCT02059291|585144577|FG014|Epoch 3|Lack of Efficacy|0|||
162024052|NCT02059291|585144578|FG015|Epoch 3|Lack of Efficacy|3|||
162024053|NCT02059291|585144579|FG016|Epoch 3|Lack of Efficacy|0|||
162024054|NCT02059291|585144580|FG017|Epoch 3|Lack of Efficacy|0|||
162024055|NCT02059291|585144581|FG018|Epoch 3|Lack of Efficacy|0|||
162024056|NCT02059291|585144582|FG019|Epoch 3|Lack of Efficacy|0|||
162024057|NCT02059291|585144583|FG020|Epoch 3|Lack of Efficacy|0|||
162231104|NCT00092495|585895336|FG000|Base Study Follow-up Period|Extended|0|||
162231105|NCT00092495|585895337|FG001|Base Study Follow-up Period|Extended|0|||
162231106|NCT00092495|585895338|FG002|Base Study Follow-up Period|Extended|1|||
162024058|NCT02059291|585144584|FG021|Epoch 3|Lack of Efficacy|0|||
162024059|NCT02059291|585144585|FG022|Epoch 3|Lack of Efficacy|0|||
162024060|NCT02059291|585144586|FG023|Epoch 3|Lack of Efficacy|0|||
162024061|NCT02059291|585144587|FG024|Epoch 3|Lack of Efficacy|0|||
162024062|NCT02059291|585144563|FG000|Epoch 3|Withdrawal by Subject|0|||
162024063|NCT02059291|585144564|FG001|Epoch 3|Withdrawal by Subject|0|||
162024064|NCT02059291|585144565|FG002|Epoch 3|Withdrawal by Subject|0|||
162231107|NCT00092495|585895339|FG003|Base Study Follow-up Period|Extended|2|||
162231108|NCT00092495|585895340|FG004|Base Study Follow-up Period|Extended|0|||
162024065|NCT02059291|585144566|FG003|Epoch 3|Withdrawal by Subject|0|||
162024066|NCT02059291|585144567|FG004|Epoch 3|Withdrawal by Subject|0|||
162024067|NCT02059291|585144568|FG005|Epoch 3|Withdrawal by Subject|0|||
162024068|NCT02059291|585144569|FG006|Epoch 3|Withdrawal by Subject|0|||
162024069|NCT02059291|585144570|FG007|Epoch 3|Withdrawal by Subject|0|||
162024070|NCT02059291|585144571|FG008|Epoch 3|Withdrawal by Subject|0|||
162024071|NCT02059291|585144572|FG009|Epoch 3|Withdrawal by Subject|0|||
162024072|NCT02059291|585144573|FG010|Epoch 3|Withdrawal by Subject|0|||
162024073|NCT02059291|585144574|FG011|Epoch 3|Withdrawal by Subject|0|||
162024074|NCT02059291|585144575|FG012|Epoch 3|Withdrawal by Subject|0|||
162024075|NCT02059291|585144576|FG013|Epoch 3|Withdrawal by Subject|0|||
162024076|NCT02059291|585144577|FG014|Epoch 3|Withdrawal by Subject|0|||
162024077|NCT02059291|585144578|FG015|Epoch 3|Withdrawal by Subject|1|||
162024078|NCT02059291|585144579|FG016|Epoch 3|Withdrawal by Subject|0|||
162024079|NCT02059291|585144580|FG017|Epoch 3|Withdrawal by Subject|0|||
162024080|NCT02059291|585144581|FG018|Epoch 3|Withdrawal by Subject|0|||
162024081|NCT02059291|585144582|FG019|Epoch 3|Withdrawal by Subject|0|||
162024082|NCT02059291|585144583|FG020|Epoch 3|Withdrawal by Subject|0|||
162024083|NCT02059291|585144584|FG021|Epoch 3|Withdrawal by Subject|0|||
162024084|NCT02059291|585144585|FG022|Epoch 3|Withdrawal by Subject|0|||
162024085|NCT02059291|585144586|FG023|Epoch 3|Withdrawal by Subject|0|||
162024086|NCT02059291|585144587|FG024|Epoch 3|Withdrawal by Subject|0|||
162024087|NCT02059291|585144563|FG000|Epoch 4|Adverse Event|0|||
162024088|NCT02059291|585144564|FG001|Epoch 4|Adverse Event|0|||
162024089|NCT02059291|585144565|FG002|Epoch 4|Adverse Event|0|||
162024090|NCT02059291|585144566|FG003|Epoch 4|Adverse Event|0|||
162024091|NCT02059291|585144567|FG004|Epoch 4|Adverse Event|0|||
162024092|NCT02059291|585144568|FG005|Epoch 4|Adverse Event|0|||
162024093|NCT02059291|585144569|FG006|Epoch 4|Adverse Event|0|||
162024094|NCT02059291|585144570|FG007|Epoch 4|Adverse Event|0|||
162024095|NCT02059291|585144571|FG008|Epoch 4|Adverse Event|0|||
162024096|NCT02059291|585144572|FG009|Epoch 4|Adverse Event|0|||
162024097|NCT02059291|585144573|FG010|Epoch 4|Adverse Event|0|||
162024098|NCT02059291|585144574|FG011|Epoch 4|Adverse Event|0|||
162024099|NCT02059291|585144575|FG012|Epoch 4|Adverse Event|0|||
162024100|NCT02059291|585144576|FG013|Epoch 4|Adverse Event|0|||
162024101|NCT02059291|585144577|FG014|Epoch 4|Adverse Event|0|||
162024102|NCT02059291|585144578|FG015|Epoch 4|Adverse Event|0|||
162024103|NCT02059291|585144579|FG016|Epoch 4|Adverse Event|1|||
162024104|NCT02059291|585144580|FG017|Epoch 4|Adverse Event|0|||
162024105|NCT02059291|585144581|FG018|Epoch 4|Adverse Event|0|||
162024106|NCT02059291|585144582|FG019|Epoch 4|Adverse Event|0|||
162024107|NCT02059291|585144583|FG020|Epoch 4|Adverse Event|0|||
162024108|NCT02059291|585144584|FG021|Epoch 4|Adverse Event|0|||
162024109|NCT02059291|585144585|FG022|Epoch 4|Adverse Event|1|||
162024110|NCT02059291|585144586|FG023|Epoch 4|Adverse Event|0|||
162024111|NCT02059291|585144587|FG024|Epoch 4|Adverse Event|0|||
162024112|NCT02059291|585144563|FG000|Epoch 4|Pregnancy|0|||
162024113|NCT02059291|585144564|FG001|Epoch 4|Pregnancy|0|||
162024114|NCT02059291|585144565|FG002|Epoch 4|Pregnancy|0|||
162024115|NCT02059291|585144566|FG003|Epoch 4|Pregnancy|0|||
162024116|NCT02059291|585144567|FG004|Epoch 4|Pregnancy|0|||
162024117|NCT02059291|585144568|FG005|Epoch 4|Pregnancy|0|||
162024118|NCT02059291|585144569|FG006|Epoch 4|Pregnancy|0|||
162024119|NCT02059291|585144570|FG007|Epoch 4|Pregnancy|0|||
162024120|NCT02059291|585144571|FG008|Epoch 4|Pregnancy|0|||
162024121|NCT02059291|585144572|FG009|Epoch 4|Pregnancy|0|||
162024122|NCT02059291|585144573|FG010|Epoch 4|Pregnancy|0|||
162024123|NCT02059291|585144574|FG011|Epoch 4|Pregnancy|0|||
162024124|NCT02059291|585144575|FG012|Epoch 4|Pregnancy|0|||
162024125|NCT02059291|585144576|FG013|Epoch 4|Pregnancy|0|||
162024126|NCT02059291|585144577|FG014|Epoch 4|Pregnancy|0|||
162024127|NCT02059291|585144578|FG015|Epoch 4|Pregnancy|0|||
162024128|NCT02059291|585144579|FG016|Epoch 4|Pregnancy|1|||
162024129|NCT02059291|585144580|FG017|Epoch 4|Pregnancy|0|||
162024130|NCT02059291|585144581|FG018|Epoch 4|Pregnancy|0|||
162024131|NCT02059291|585144582|FG019|Epoch 4|Pregnancy|0|||
162024132|NCT02059291|585144583|FG020|Epoch 4|Pregnancy|0|||
162231109|NCT00092495|585895336|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
162231110|NCT00092495|585895337|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
162231111|NCT00092495|585895338|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
162231112|NCT00092495|585895339|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
162024133|NCT02059291|585144584|FG021|Epoch 4|Pregnancy|0|||
162024134|NCT02059291|585144585|FG022|Epoch 4|Pregnancy|0|||
162024135|NCT02059291|585144586|FG023|Epoch 4|Pregnancy|0|||
162024136|NCT02059291|585144587|FG024|Epoch 4|Pregnancy|0|||
162024137|NCT02059291|585144563|FG000|Epoch 4|Withdrawal by Subject|0|||
162024138|NCT02059291|585144564|FG001|Epoch 4|Withdrawal by Subject|0|||
162024139|NCT02059291|585144565|FG002|Epoch 4|Withdrawal by Subject|0|||
162024140|NCT02059291|585144566|FG003|Epoch 4|Withdrawal by Subject|0|||
162024141|NCT02059291|585144567|FG004|Epoch 4|Withdrawal by Subject|0|||
162024142|NCT02059291|585144568|FG005|Epoch 4|Withdrawal by Subject|0|||
162024143|NCT02059291|585144569|FG006|Epoch 4|Withdrawal by Subject|0|||
162024144|NCT02059291|585144570|FG007|Epoch 4|Withdrawal by Subject|0|||
162024145|NCT02059291|585144571|FG008|Epoch 4|Withdrawal by Subject|0|||
162024146|NCT02059291|585144572|FG009|Epoch 4|Withdrawal by Subject|0|||
162024147|NCT02059291|585144573|FG010|Epoch 4|Withdrawal by Subject|0|||
162024148|NCT02059291|585144574|FG011|Epoch 4|Withdrawal by Subject|0|||
162024149|NCT02059291|585144575|FG012|Epoch 4|Withdrawal by Subject|0|||
162024150|NCT02059291|585144576|FG013|Epoch 4|Withdrawal by Subject|0|||
162024151|NCT02059291|585144577|FG014|Epoch 4|Withdrawal by Subject|0|||
162024152|NCT02059291|585144578|FG015|Epoch 4|Withdrawal by Subject|0|||
162024153|NCT02059291|585144579|FG016|Epoch 4|Withdrawal by Subject|0|||
162024154|NCT02059291|585144580|FG017|Epoch 4|Withdrawal by Subject|0|||
162024155|NCT02059291|585144581|FG018|Epoch 4|Withdrawal by Subject|0|||
162024156|NCT02059291|585144582|FG019|Epoch 4|Withdrawal by Subject|0|||
162024157|NCT02059291|585144583|FG020|Epoch 4|Withdrawal by Subject|1|||
162024158|NCT02059291|585144584|FG021|Epoch 4|Withdrawal by Subject|0|||
162024159|NCT02059291|585144585|FG022|Epoch 4|Withdrawal by Subject|0|||
162024160|NCT02059291|585144586|FG023|Epoch 4|Withdrawal by Subject|0|||
162024161|NCT02059291|585144587|FG024|Epoch 4|Withdrawal by Subject|0|||
162024162|NCT02059291|585144563|FG000|Epoch 4|Lack of Efficacy|0|||
162024163|NCT02059291|585144564|FG001|Epoch 4|Lack of Efficacy|0|||
162024164|NCT02059291|585144565|FG002|Epoch 4|Lack of Efficacy|0|||
162024165|NCT02059291|585144566|FG003|Epoch 4|Lack of Efficacy|0|||
162024166|NCT02059291|585144567|FG004|Epoch 4|Lack of Efficacy|0|||
162024167|NCT02059291|585144568|FG005|Epoch 4|Lack of Efficacy|0|||
162024168|NCT02059291|585144569|FG006|Epoch 4|Lack of Efficacy|0|||
162024169|NCT02059291|585144570|FG007|Epoch 4|Lack of Efficacy|0|||
162024170|NCT02059291|585144571|FG008|Epoch 4|Lack of Efficacy|0|||
162024171|NCT02059291|585144572|FG009|Epoch 4|Lack of Efficacy|0|||
162024172|NCT02059291|585144573|FG010|Epoch 4|Lack of Efficacy|0|||
162024173|NCT02059291|585144574|FG011|Epoch 4|Lack of Efficacy|0|||
162024174|NCT02059291|585144575|FG012|Epoch 4|Lack of Efficacy|0|||
162024175|NCT02059291|585144576|FG013|Epoch 4|Lack of Efficacy|0|||
162024176|NCT02059291|585144577|FG014|Epoch 4|Lack of Efficacy|0|||
162024177|NCT02059291|585144578|FG015|Epoch 4|Lack of Efficacy|0|||
162024178|NCT02059291|585144579|FG016|Epoch 4|Lack of Efficacy|0|||
162024179|NCT02059291|585144580|FG017|Epoch 4|Lack of Efficacy|0|||
162024180|NCT02059291|585144581|FG018|Epoch 4|Lack of Efficacy|0|||
162024181|NCT02059291|585144582|FG019|Epoch 4|Lack of Efficacy|0|||
162024182|NCT02059291|585144583|FG020|Epoch 4|Lack of Efficacy|0|||
162024183|NCT02059291|585144584|FG021|Epoch 4|Lack of Efficacy|0|||
162024184|NCT02059291|585144585|FG022|Epoch 4|Lack of Efficacy|0|||
162024185|NCT02059291|585144586|FG023|Epoch 4|Lack of Efficacy|1|||
162024186|NCT02059291|585144587|FG024|Epoch 4|Lack of Efficacy|0|||
162024187|NCT01276054|585144592|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
162024188|NCT01276054|585144593|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
162024189|NCT00787267|585144594|FG000|Overall Study|Screen failure/Ineligible|10|||
162024190|NCT00787267|585144594|FG000|Overall Study|No Reason Provided|1|||
162024191|NCT00787267|585144594|FG000|Overall Study|Withdrawal by Subject|1|||
162024192|NCT04343235|585144595|FG000|Overall Study|Lost to Follow-up|3|||
162024193|NCT04343235|585144596|FG001|Overall Study|Lost to Follow-up|2|||
162024194|NCT01763996|585144597|FG000|Treatment Period 2|Adverse Event|0|||
162024195|NCT01763996|585144598|FG001|Treatment Period 2|Adverse Event|1|||
162024196|NCT05405257|585144602|FG000|Overall Study|Withdrawal by Subject|1|||
162024197|NCT00776919|585144605|FG000|Overall Study|Withdrawal by Subject|16|||
162024198|NCT00776919|585144606|FG001|Overall Study|Withdrawal by Subject|14|||
162024199|NCT00776919|585144607|FG002|Overall Study|Withdrawal by Subject|15|||
162024200|NCT00776919|585144608|FG003|Overall Study|Withdrawal by Subject|26|||
162024201|NCT00776919|585144605|FG000|Overall Study|Lost to Follow-up|8|||
162024202|NCT00776919|585144606|FG001|Overall Study|Lost to Follow-up|12|||
162024203|NCT00776919|585144607|FG002|Overall Study|Lost to Follow-up|11|||
162024204|NCT00776919|585144608|FG003|Overall Study|Lost to Follow-up|8|||
162024205|NCT00776919|585144605|FG000|Overall Study|Adverse Event|1|||
162024206|NCT00776919|585144606|FG001|Overall Study|Adverse Event|0|||
162024207|NCT00776919|585144607|FG002|Overall Study|Adverse Event|2|||
162024208|NCT00776919|585144608|FG003|Overall Study|Adverse Event|2|||
162024209|NCT00776919|585144605|FG000|Overall Study|Protocol Violation|1|||
162024210|NCT00776919|585144606|FG001|Overall Study|Protocol Violation|2|||
162024211|NCT00776919|585144607|FG002|Overall Study|Protocol Violation|0|||
162024212|NCT00776919|585144608|FG003|Overall Study|Protocol Violation|1|||
162024213|NCT00776919|585144605|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
162024214|NCT00776919|585144606|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
162024215|NCT00776919|585144607|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
162024216|NCT00776919|585144608|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
162024217|NCT01788215|585144609|FG000|Overall Study|Withdrawal by Subject|0|||
162024218|NCT01788215|585144610|FG001|Overall Study|Withdrawal by Subject|1|||
162024219|NCT01788215|585144609|FG000|Overall Study|Lost to Follow-up|2|||
162024220|NCT01788215|585144610|FG001|Overall Study|Lost to Follow-up|0|||
162024221|NCT03116152|585144611|FG000|Overall Study|Disease Progression|49|||
162024222|NCT03116152|585144612|FG001|Overall Study|Disease Progression|47|||
162024223|NCT03116152|585144611|FG000|Overall Study|Death|5|||
162024224|NCT03116152|585144612|FG001|Overall Study|Death|2|||
162024225|NCT03116152|585144611|FG000|Overall Study|Adverse Event|21|||
162024226|NCT03116152|585144612|FG001|Overall Study|Adverse Event|7|||
162024227|NCT03116152|585144611|FG000|Overall Study|Protocol Violation|2|||
162024228|NCT03116152|585144612|FG001|Overall Study|Protocol Violation|2|||
161679989|NCT01289821|583881488|FG000|Treatment Period|Physician Decision|3|||
161679990|NCT01289821|583881488|FG000|Treatment Period|Adverse Event|4|||
161679991|NCT01289821|583881488|FG000|Treatment Period|Radiological Progression|43|||
161679992|NCT01289821|583881488|FG000|Treatment Period|Clinical Progression|2|||
161679993|NCT01289821|583881488|FG000|Treatment Period|Therapeutic procedure required|1|||
161679994|NCT01289821|583881488|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
161679995|NCT01289821|583881488|FG000|Safety Follow-up Period|Protocol Violation|3|||
161679996|NCT01289821|583881488|FG000|Safety Follow-up Period|Unspecified reason|1|||
161679997|NCT01289821|583881488|FG000|Survival Follow-up Period|Protocol Violation|1|||
161679998|NCT01289821|583881488|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
161679999|NCT01289821|583881488|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
161680000|NCT01009034|583881489|FG000|Overall Study|Lost to Follow-up|2|||
161680001|NCT01009034|583881489|FG000|Overall Study|Withdrawal by Subject|2|||
161680002|NCT02243865|583881492|FG000|Overall Study|Protocol Violation|1|||
161680003|NCT02243865|583881493|FG001|Overall Study|Protocol Violation|3|||
161680004|NCT02243865|583881492|FG000|Overall Study|Lost to Follow-up|1|||
161680005|NCT02243865|583881493|FG001|Overall Study|Lost to Follow-up|1|||
161680006|NCT02243865|583881492|FG000|Overall Study|Withdrawal by Subject|1|||
161680007|NCT02243865|583881493|FG001|Overall Study|Withdrawal by Subject|0|||
161680008|NCT02243865|583881492|FG000|Overall Study|Adverse Event|1|||
161680009|NCT02243865|583881493|FG001|Overall Study|Adverse Event|1|||
161680010|NCT05093322|583881494|FG000|Overall Study|Death|6|||
161680011|NCT05093322|583881495|FG001|Overall Study|Death|2|||
161680012|NCT05093322|583881494|FG000|Overall Study|Other|4|||
161680013|NCT05093322|583881495|FG001|Overall Study|Other|1|||
161680014|NCT00898443|583881496|FG000|Overall Study|Withdrawal by Subject|1|||
161680015|NCT00898443|583881497|FG001|Overall Study|Withdrawal by Subject|0|||
161680016|NCT00074581|583881499|FG000|Overall Study|Death|15|||
161680017|NCT00074581|583881500|FG001|Overall Study|Death|16|||
161680018|NCT00074581|583881499|FG000|Overall Study|Withdrawal by Subject|50|||
161680019|NCT00074581|583881500|FG001|Overall Study|Withdrawal by Subject|49|||
161680020|NCT00074581|583881499|FG000|Overall Study|Unable to adhere to visit schedule|13|||
161680021|NCT00074581|583881500|FG001|Overall Study|Unable to adhere to visit schedule|14|||
161680022|NCT00074581|583881499|FG000|Overall Study|Relocated|14|||
161680023|NCT00074581|583881500|FG001|Overall Study|Relocated|9|||
161680024|NCT00074581|583881499|FG000|Overall Study|Were withdrawn by investigator|5|||
161680025|NCT00074581|583881500|FG001|Overall Study|Were withdrawn by investigator|2|||
161680026|NCT00074581|583881499|FG000|Overall Study|Lost to Follow-up|16|||
161680027|NCT00074581|583881500|FG001|Overall Study|Lost to Follow-up|11|||
161680028|NCT00074581|583881499|FG000|Overall Study|Ended relationship w. index participant|117|||
161680029|NCT00074581|583881500|FG001|Overall Study|Ended relationship w. index participant|106|||
161680030|NCT00074581|583881499|FG000|Overall Study|Other|14|||
161680031|NCT00074581|583881500|FG001|Overall Study|Other|19|||
161680032|NCT01770912|583881501|FG000|Overall Study|Lost to Follow-up|2|||
161680033|NCT01770912|583881502|FG001|Overall Study|Lost to Follow-up|0|||
161680034|NCT03250832|583881503|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
161680035|NCT03250832|583881504|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
161680036|NCT03250832|583881505|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
161680037|NCT03250832|583881506|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
161680038|NCT03250832|583881507|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
161680039|NCT03250832|583881508|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
161680040|NCT03250832|583881509|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
161680041|NCT03250832|583881510|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
161680042|NCT03250832|583881511|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
161680043|NCT03250832|583881512|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
161680044|NCT03250832|583881513|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
161680045|NCT03250832|583881514|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
161680046|NCT03250832|583881503|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
161680047|NCT03250832|583881504|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
161680048|NCT03250832|583881505|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
161680049|NCT03250832|583881506|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
161680050|NCT03250832|583881507|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
161680051|NCT03250832|583881508|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
161680052|NCT03250832|583881509|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
161680053|NCT03250832|583881510|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161680054|NCT03250832|583881511|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161680055|NCT03250832|583881512|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161680056|NCT03250832|583881513|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161680057|NCT03250832|583881514|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161680058|NCT03250832|583881503|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680059|NCT03250832|583881504|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680060|NCT03250832|583881505|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
161680061|NCT03250832|583881506|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680062|NCT03250832|583881507|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680063|NCT03250832|583881508|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680064|NCT03250832|583881509|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680065|NCT03250832|583881510|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680066|NCT03250832|583881511|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680067|NCT03250832|583881512|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162024229|NCT03116152|585144611|FG000|Overall Study|Withdrawal by Subject|0|||
162024230|NCT03116152|585144612|FG001|Overall Study|Withdrawal by Subject|1|||
162024231|NCT03116152|585144611|FG000|Overall Study|Physician Decision|3|||
162024232|NCT03116152|585144612|FG001|Overall Study|Physician Decision|2|||
162024233|NCT03116152|585144611|FG000|Overall Study|other|11|||
162024234|NCT03116152|585144612|FG001|Overall Study|other|34|||
162024235|NCT01396057|585144621|FG000|Overall Study|Adverse Event|2|||
162024236|NCT01396057|585144622|FG001|Overall Study|Adverse Event|6|||
162024237|NCT01396057|585144621|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162024238|NCT01396057|585144622|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
162024239|NCT01396057|585144621|FG000|Overall Study|Protocol deviation|4|||
162024240|NCT01396057|585144622|FG001|Overall Study|Protocol deviation|4|||
162024241|NCT01396057|585144621|FG000|Overall Study|Consent withdrawn|3|||
162024242|NCT01396057|585144622|FG001|Overall Study|Consent withdrawn|2|||
162024243|NCT00884741|585144627|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
162024244|NCT00884741|585144628|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
162024245|NCT00884741|585144629|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
162024246|NCT00884741|585144630|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
162024247|NCT00884741|585144627|FG000|Step 1 Registration: Tissue Screening|Death|3|||
162024248|NCT00884741|585144628|FG001|Step 1 Registration: Tissue Screening|Death|0|||
162024249|NCT00884741|585144629|FG002|Step 1 Registration: Tissue Screening|Death|0|||
162024250|NCT00884741|585144630|FG003|Step 1 Registration: Tissue Screening|Death|0|||
162024251|NCT00884741|585144627|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
162024252|NCT00884741|585144628|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
162024253|NCT00884741|585144629|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
162024254|NCT00884741|585144630|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
162024255|NCT00884741|585144627|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
162024256|NCT00884741|585144628|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
162024257|NCT00884741|585144629|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
162024258|NCT00884741|585144630|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
162024259|NCT00884741|585144627|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
162024260|NCT00884741|585144628|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
162024261|NCT00884741|585144629|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
162024262|NCT00884741|585144630|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
162024263|NCT00884741|585144627|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
162024264|NCT00884741|585144628|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
162024265|NCT00884741|585144629|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
162024266|NCT00884741|585144630|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
162024267|NCT00884741|585144627|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
162024268|NCT00884741|585144628|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
162024269|NCT00884741|585144629|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
162024270|NCT00884741|585144630|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
162024271|NCT00884741|585144627|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
162024272|NCT00884741|585144628|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
162024273|NCT00884741|585144629|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
162024274|NCT00884741|585144630|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
162024275|NCT00884741|585144627|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
162024276|NCT00884741|585144628|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
162024277|NCT00884741|585144629|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
162024278|NCT00884741|585144630|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
162024279|NCT00884741|585144627|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
162024280|NCT00884741|585144628|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
162024281|NCT00884741|585144629|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
162024282|NCT00884741|585144630|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
162024283|NCT00884741|585144627|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
162024284|NCT00884741|585144628|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
162024285|NCT00884741|585144629|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
162024286|NCT00884741|585144630|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
162024287|NCT00884741|585144627|FG000|Randomization|Protocol Violation|0|||
162024288|NCT00884741|585144628|FG001|Randomization|Protocol Violation|0|||
162024289|NCT00884741|585144629|FG002|Randomization|Protocol Violation|8|||
162231113|NCT00092495|585895340|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
162231114|NCT00092495|585895336|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
162231115|NCT00092495|585895337|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
162231116|NCT00092495|585895338|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
162024290|NCT00884741|585144630|FG003|Randomization|Protocol Violation|8|||
162024291|NCT01324401|585144631|FG000|Overall Study|Withdrawn before any treatment|0|||
162024292|NCT01324401|585144632|FG001|Overall Study|Withdrawn before any treatment|3|||
162024293|NCT01324401|585144631|FG000|Overall Study|Adverse Event|1|||
162024294|NCT01324401|585144632|FG001|Overall Study|Adverse Event|3|||
161680068|NCT03250832|583881513|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
162024295|NCT02969655|585144633|FG000|Overall Study|Withdrawal by Subject|3|||
162024296|NCT02969655|585144634|FG001|Overall Study|Withdrawal by Subject|2|||
162024297|NCT02969655|585144633|FG000|Overall Study|Physician Decision|4|||
162024298|NCT02969655|585144634|FG001|Overall Study|Physician Decision|3|||
162024299|NCT02969655|585144633|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
162024300|NCT02969655|585144634|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
162024301|NCT02969655|585144633|FG000|Overall Study|Adverse Event|10|||
162024302|NCT02969655|585144634|FG001|Overall Study|Adverse Event|8|||
162024303|NCT00335764|585144635|FG000|Overall Study|wrong histology|1|||
162024304|NCT00335764|585144636|FG001|Overall Study|wrong histology|0|||
162024305|NCT00335764|585144637|FG002|Overall Study|wrong histology|0|||
162024306|NCT00335764|585144638|FG003|Overall Study|wrong histology|0|||
162024307|NCT00335764|585144639|FG004|Overall Study|wrong histology|1|||
162024308|NCT01578850|585144641|FG000|Period 1|Insufficient Clinical Response|1|||
162024309|NCT01578850|585144642|FG001|Period 1|Insufficient Clinical Response|0|||
162024310|NCT01578850|585144643|FG002|Period 1|Insufficient Clinical Response|0|||
162024311|NCT01578850|585144641|FG000|Period 1|Adverse Event|11|||
162024312|NCT01578850|585144642|FG001|Period 1|Adverse Event|0|||
162024313|NCT01578850|585144643|FG002|Period 1|Adverse Event|0|||
162024314|NCT01578850|585144641|FG000|Period 1|Death|1|||
162024315|NCT01578850|585144642|FG001|Period 1|Death|0|||
162024316|NCT01578850|585144643|FG002|Period 1|Death|0|||
162024317|NCT01578850|585144641|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
162024318|NCT01578850|585144642|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
162024319|NCT01578850|585144643|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
162024320|NCT01578850|585144641|FG000|Period 1|Withdrawal by Subject|9|||
162024321|NCT01578850|585144642|FG001|Period 1|Withdrawal by Subject|0|||
161680069|NCT03250832|583881514|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161680070|NCT03250832|583881503|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680071|NCT03250832|583881504|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680072|NCT03250832|583881505|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680073|NCT03250832|583881506|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680074|NCT03250832|583881507|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680075|NCT03250832|583881508|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680076|NCT03250832|583881509|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680077|NCT03250832|583881510|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
161680078|NCT03250832|583881511|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680079|NCT03250832|583881512|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680080|NCT03250832|583881513|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680081|NCT03250832|583881514|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
161680082|NCT03250832|583881503|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680083|NCT03250832|583881504|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680084|NCT03250832|583881505|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680085|NCT03250832|583881506|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680086|NCT03250832|583881507|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680087|NCT03250832|583881508|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680088|NCT03250832|583881509|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680089|NCT03250832|583881510|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
161680090|NCT03250832|583881511|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680091|NCT03250832|583881512|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680092|NCT03250832|583881513|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680093|NCT03250832|583881514|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161680094|NCT03250832|583881503|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680095|NCT03250832|583881504|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680096|NCT03250832|583881505|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680097|NCT03250832|583881506|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680098|NCT03250832|583881507|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680099|NCT03250832|583881508|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680100|NCT03250832|583881509|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680101|NCT03250832|583881510|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
161829767|NCT00206102|584415882|FG001|Overall Study|Study-specific discontinuation criteria|17|||
161829768|NCT00206102|584415881|FG000|Overall Study|None of those categories|42|||
161829769|NCT00206102|584415882|FG001|Overall Study|None of those categories|36|||
162024322|NCT01578850|585144643|FG002|Period 1|Withdrawal by Subject|0|||
162024323|NCT01578850|585144641|FG000|Period 1|Study Terminated by Sponsor|3|||
162024324|NCT01578850|585144642|FG001|Period 1|Study Terminated by Sponsor|0|||
161829770|NCT01917968|584415883|FG000|Overall Study|Death|3|||
161829771|NCT01917968|584415884|FG001|Overall Study|Death|2|||
162024325|NCT01578850|585144643|FG002|Period 1|Study Terminated by Sponsor|0|||
162024326|NCT01578850|585144641|FG000|Period 2|Insufficient Clinical Response|0|||
162024327|NCT01578850|585144642|FG001|Period 2|Insufficient Clinical Response|1|||
162024328|NCT01578850|585144643|FG002|Period 2|Insufficient Clinical Response|0|||
162024329|NCT01578850|585144641|FG000|Period 2|Adverse Event|0|||
162024330|NCT01578850|585144642|FG001|Period 2|Adverse Event|3|||
162024331|NCT01578850|585144643|FG002|Period 2|Adverse Event|6|||
162024332|NCT01578850|585144641|FG000|Period 2|Lost to Follow-up|0|||
162024333|NCT01578850|585144642|FG001|Period 2|Lost to Follow-up|1|||
162024334|NCT01578850|585144643|FG002|Period 2|Lost to Follow-up|2|||
162024335|NCT01578850|585144641|FG000|Period 2|Withdrawal by Subject|0|||
162024336|NCT01578850|585144642|FG001|Period 2|Withdrawal by Subject|2|||
162024337|NCT01578850|585144643|FG002|Period 2|Withdrawal by Subject|2|||
162024338|NCT01578850|585144641|FG000|Period 2|Study Terminated by Sponsor|0|||
162024339|NCT01578850|585144642|FG001|Period 2|Study Terminated by Sponsor|5|||
162024340|NCT01578850|585144643|FG002|Period 2|Study Terminated by Sponsor|4|||
162024341|NCT01578850|585144641|FG000|Period 2|Unspecified Reasons|0|||
162024342|NCT01578850|585144642|FG001|Period 2|Unspecified Reasons|1|||
162024343|NCT01578850|585144643|FG002|Period 2|Unspecified Reasons|0|||
162024344|NCT01215097|585144655|FG000|Overall Study|Adverse Event|1|||
162024345|NCT01215097|585144656|FG001|Overall Study|Adverse Event|3|||
162024346|NCT01215097|585144655|FG000|Overall Study|Protocol Violation|0|||
162024347|NCT01215097|585144656|FG001|Overall Study|Protocol Violation|2|||
162024348|NCT01215097|585144655|FG000|Overall Study|Lost to Follow-up|2|||
162024349|NCT01215097|585144656|FG001|Overall Study|Lost to Follow-up|0|||
162024350|NCT01215097|585144655|FG000|Overall Study|Withdrawal by Subject|6|||
162024351|NCT01215097|585144656|FG001|Overall Study|Withdrawal by Subject|3|||
162024352|NCT01215097|585144655|FG000|Overall Study|Lack of Efficacy|0|||
162024353|NCT01215097|585144656|FG001|Overall Study|Lack of Efficacy|3|||
162024354|NCT01215097|585144655|FG000|Overall Study|patient's refusal to come|2|||
162024355|NCT01215097|585144656|FG001|Overall Study|patient's refusal to come|2|||
162024356|NCT01215097|585144655|FG000|Overall Study|patient's private reason|1|||
162024357|NCT01215097|585144656|FG001|Overall Study|patient's private reason|1|||
162024358|NCT02703337|585144657|FG000|Period One (Part A)|Withdrawal by Subject|0|||
162024359|NCT02703337|585144658|FG001|Period One (Part A)|Withdrawal by Subject|0|||
162024360|NCT02703337|585144659|FG002|Period One (Part A)|Withdrawal by Subject|0|||
162024361|NCT02703337|585144660|FG003|Period One (Part A)|Withdrawal by Subject|0|||
162024362|NCT02703337|585144661|FG004|Period One (Part A)|Withdrawal by Subject|1|||
162024363|NCT02703337|585144662|FG005|Period One (Part A)|Withdrawal by Subject|0|||
162024364|NCT02703337|585144663|FG006|Period One (Part A)|Withdrawal by Subject|0|||
162024365|NCT02703337|585144664|FG007|Period One (Part A)|Withdrawal by Subject|0|||
162024366|NCT01001325|585144669|FG000|Overall Study|Lost to Follow-up|16|||
162024367|NCT01001325|585144670|FG001|Overall Study|Lost to Follow-up|10|||
162024368|NCT01001325|585144669|FG000|Overall Study|Protocol Violation|2|||
162024369|NCT01001325|585144670|FG001|Overall Study|Protocol Violation|0|||
162024370|NCT02872285|585144672|FG000|Overall Study|Withdrawal by Subject|2|||
162024371|NCT02872285|585144673|FG001|Overall Study|Withdrawal by Subject|0|||
162024372|NCT02872285|585144672|FG000|Overall Study|Lost to Follow-up|2|||
162024373|NCT02872285|585144673|FG001|Overall Study|Lost to Follow-up|2|||
162024374|NCT02872285|585144672|FG000|Overall Study|Discontinued due to back surgery|1|||
162024375|NCT02872285|585144673|FG001|Overall Study|Discontinued due to back surgery|0|||
162024376|NCT05688670|585144674|FG000|Overall Study|Change in surgery plan|1|||
162024377|NCT05688670|585144675|FG001|Overall Study|Change in surgery plan|4|||
162024378|NCT05688670|585144674|FG000|Overall Study|Inability to extubate|1|||
162024379|NCT05688670|585144675|FG001|Overall Study|Inability to extubate|2|||
162024380|NCT05688670|585144674|FG000|Overall Study|Day of surgery cancellation|0|||
162024381|NCT05688670|585144675|FG001|Overall Study|Day of surgery cancellation|1|||
162024382|NCT05688670|585144674|FG000|Overall Study|Reintubated on PCICU arrival|0|||
162024383|NCT05688670|585144675|FG001|Overall Study|Reintubated on PCICU arrival|1|||
162024384|NCT00361634|585146436|FG000|Overall Study|Lost to Follow-up|1|||
162024385|NCT00361634|585146436|FG000|Overall Study|Withdrawal by Subject|1|||
162024386|NCT05315908|585146437|FG000|Overall Study|Lost to Follow-up|4477|||
162024387|NCT05315908|585146438|FG001|Overall Study|Lost to Follow-up|4606|||
162024388|NCT00505076|585146447|FG000|Overall Study|Adverse Event|1|||
162024389|NCT00505076|585146448|FG001|Overall Study|Adverse Event|0|||
162024390|NCT00505076|585146449|FG002|Overall Study|Adverse Event|1|||
162024391|NCT00505076|585146447|FG000|Overall Study|Protocol Violation|2|||
162024392|NCT00505076|585146448|FG001|Overall Study|Protocol Violation|1|||
162024393|NCT00505076|585146449|FG002|Overall Study|Protocol Violation|2|||
162024394|NCT00505076|585146447|FG000|Overall Study|Withdrawal by Subject|0|||
162024395|NCT00505076|585146448|FG001|Overall Study|Withdrawal by Subject|1|||
162231117|NCT00092495|585895339|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
162024396|NCT00505076|585146449|FG002|Overall Study|Withdrawal by Subject|2|||
162024397|NCT01128621|585146452|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
162024398|NCT01128621|585146453|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
162024399|NCT04074161|585146454|FG000|Overall Study|Withdrawal by Subject|2|||
162024400|NCT04074161|585146455|FG001|Overall Study|Withdrawal by Subject|4|||
162024401|NCT04074161|585146456|FG002|Overall Study|Withdrawal by Subject|1|||
162024402|NCT04074161|585146454|FG000|Overall Study|Lost to Follow-up|4|||
162024403|NCT04074161|585146455|FG001|Overall Study|Lost to Follow-up|5|||
162024404|NCT04074161|585146456|FG002|Overall Study|Lost to Follow-up|3|||
162024405|NCT03595228|585146459|FG000|Overall Study|Death|2|||
161680102|NCT03250832|583881511|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680103|NCT03250832|583881512|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161829772|NCT01917968|584415883|FG000|Overall Study|Lost to Follow-up|21|||
161829773|NCT01917968|584415884|FG001|Overall Study|Lost to Follow-up|39|||
161829774|NCT01917968|584415883|FG000|Overall Study|Physician Decision|1|||
161829775|NCT01917968|584415884|FG001|Overall Study|Physician Decision|2|||
161829776|NCT01917968|584415883|FG000|Overall Study|Withdrawal by Subject|20|||
161829777|NCT01917968|584415884|FG001|Overall Study|Withdrawal by Subject|35|||
161829778|NCT01917968|584415883|FG000|Overall Study|Subject Relocation|5|||
161829779|NCT01917968|584415884|FG001|Overall Study|Subject Relocation|1|||
161829780|NCT01917968|584415883|FG000|Overall Study|36M Missed Visit|3|||
161829781|NCT01917968|584415884|FG001|Overall Study|36M Missed Visit|2|||
161829782|NCT01917968|584415883|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
161829783|NCT01917968|584415884|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
161829784|NCT01917968|584415883|FG000|Overall Study|Change in Family Circumstances|0|||
161829785|NCT01917968|584415884|FG001|Overall Study|Change in Family Circumstances|1|||
161829786|NCT01917968|584415883|FG000|Overall Study|No Data Available|0|||
161829787|NCT01917968|584415884|FG001|Overall Study|No Data Available|2|||
161829788|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
161829789|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
161829790|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
161829791|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
161829792|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
161829793|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
161829794|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
161829795|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
161829796|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
161829797|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
161829798|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
161829799|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
161829800|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
161829801|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
161829802|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
161829803|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
161829804|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
161829805|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
161829806|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
161829807|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
161829808|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
161829809|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
161829810|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
161829811|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
161829812|NCT01435928|584415886|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
161829813|NCT01435928|584415887|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
161829814|NCT01435928|584415888|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
161829815|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
161829816|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
161829817|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
161829818|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
161829819|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
161829820|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
161829821|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
161829822|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
161829823|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
161829824|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
161829825|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
161829826|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
161829827|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
161829828|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
161829829|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
161829830|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
161829831|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
161829832|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
161829833|NCT01435928|584415886|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
161829834|NCT01435928|584415887|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
161829835|NCT01435928|584415888|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
162024406|NCT03595228|585146459|FG000|Overall Study|Lack of Efficacy|13|||
162024407|NCT03595228|585146459|FG000|Overall Study|Withdrawal by Subject|3|||
162024408|NCT03595228|585146459|FG000|Overall Study|Withdrawal by Sponsor|1|||
162024409|NCT01639729|585146460|FG000|Overall Study|Withdrawal by Subject|1|||
162024410|NCT01639729|585146461|FG001|Overall Study|Withdrawal by Subject|0|||
162024411|NCT01639729|585146462|FG002|Overall Study|Withdrawal by Subject|1|||
162024412|NCT01639729|585146463|FG003|Overall Study|Withdrawal by Subject|1|||
162024413|NCT01639729|585146464|FG004|Overall Study|Withdrawal by Subject|0|||
162024414|NCT01639729|585146465|FG005|Overall Study|Withdrawal by Subject|0|||
162024415|NCT03232333|585146466|FG000|Overall Study|Infection or Osteomyelitis|9|||
162024416|NCT03232333|585146466|FG000|Overall Study|Lost to Follow-up|4|||
162024417|NCT03232333|585146466|FG000|Overall Study|Withdrawal by Subject|2|||
162024418|NCT01155011|585146467|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
162024419|NCT01155011|585146468|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
162024420|NCT01155011|585146467|FG000|Baseline to 6 Months|investigator decision, moved|4|||
162024421|NCT01155011|585146468|FG001|Baseline to 6 Months|investigator decision, moved|5|||
162024422|NCT01155011|585146467|FG000|Baseline to 6 Months|Death|0|||
162024423|NCT01155011|585146468|FG001|Baseline to 6 Months|Death|1|||
162024424|NCT01155011|585146467|FG000|6 to 12 Months|Withdrawal by Subject|8|||
162024425|NCT01155011|585146468|FG001|6 to 12 Months|Withdrawal by Subject|5|||
162024426|NCT01155011|585146467|FG000|6 to 12 Months|Death|1|||
162024427|NCT01155011|585146468|FG001|6 to 12 Months|Death|5|||
162024428|NCT01253811|585146469|FG000|Overall Study|Withdrawal criteria|1|||
162024429|NCT01087736|585146470|FG000|Overall Study|Lost to Follow-up|1|||
162024430|NCT01087736|585146471|FG001|Overall Study|Lost to Follow-up|0|||
162024431|NCT01087736|585146470|FG000|Overall Study|Death|0|||
162024432|NCT01087736|585146471|FG001|Overall Study|Death|1|||
162024433|NCT01087736|585146470|FG000|Overall Study|Withdrawal by Subject|0|||
162024434|NCT01087736|585146471|FG001|Overall Study|Withdrawal by Subject|1|||
162024435|NCT00759564|585146472|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
162024436|NCT00759564|585146473|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
162024437|NCT00759564|585146474|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
162024438|NCT00759564|585146475|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
162024439|NCT00759564|585146476|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
162024440|NCT01565343|585146479|FG000|Overall Study|Administrative decision/technical issues|1|||
162024441|NCT01565343|585146480|FG001|Overall Study|Administrative decision/technical issues|0|||
162024442|NCT01565343|585146481|FG002|Overall Study|Administrative decision/technical issues|0|||
162024443|NCT04975438|585146484|FG000|Overall Study|Lost to Follow-up|1|||
162024444|NCT04975438|585146485|FG001|Overall Study|Lost to Follow-up|0|||
162024445|NCT04975438|585146486|FG002|Overall Study|Lost to Follow-up|1|||
162024446|NCT04975438|585146487|FG003|Overall Study|Lost to Follow-up|0|||
162024447|NCT04975438|585146484|FG000|Overall Study|Withdrawal by Subject|1|||
162024448|NCT04975438|585146485|FG001|Overall Study|Withdrawal by Subject|0|||
162024449|NCT04975438|585146486|FG002|Overall Study|Withdrawal by Subject|0|||
162024450|NCT04975438|585146487|FG003|Overall Study|Withdrawal by Subject|0|||
162024451|NCT03500224|585146493|FG000|Overall Study|Withdrawal by Subject|2|||
162024452|NCT00929643|585146494|FG000|Overall Study|Protocol Violation|2|||
162024453|NCT00145977|585146495|FG000|Overall Study|Lack of Efficacy|0|||
162024454|NCT00145977|585146496|FG001|Overall Study|Lack of Efficacy|4|||
162024455|NCT00145977|585146495|FG000|Overall Study|Lost to Follow-up|1|||
162024456|NCT00145977|585146496|FG001|Overall Study|Lost to Follow-up|0|||
162024457|NCT00145977|585146495|FG000|Overall Study|Withdrawal by Subject|1|||
162024458|NCT00145977|585146496|FG001|Overall Study|Withdrawal by Subject|0|||
162024459|NCT02717832|585146499|FG000|Overall Study|Inability to place IV|3|||
162024460|NCT02259088|585146500|FG000|Overall Study|Adverse Event|6|||
162024461|NCT02259088|585146501|FG001|Overall Study|Adverse Event|4|||
162024462|NCT02259088|585146500|FG000|Overall Study|Lost to Follow-up|2|||
162024463|NCT02259088|585146501|FG001|Overall Study|Lost to Follow-up|0|||
162024464|NCT02259088|585146500|FG000|Overall Study|Death|2|||
162024465|NCT02259088|585146501|FG001|Overall Study|Death|0|||
162024466|NCT02259088|585146500|FG000|Overall Study|Physician Decision|5|||
162231118|NCT00092495|585895340|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
162231119|NCT00938470|585895341|FG000|Overall Study|Disease Progression|3|||
162231120|NCT00938470|585895342|FG001|Overall Study|Disease Progression|0|||
162231121|NCT00938470|585895341|FG000|Overall Study|Alternate Treatment|1|||
162231122|NCT00938470|585895342|FG001|Overall Study|Alternate Treatment|0|||
162231123|NCT00938470|585895341|FG000|Overall Study|Death|3|||
162024467|NCT02259088|585146501|FG001|Overall Study|Physician Decision|2|||
162024468|NCT02259088|585146500|FG000|Overall Study|Protocol deviation|5|||
162024469|NCT02259088|585146501|FG001|Overall Study|Protocol deviation|0|||
162024470|NCT02259088|585146500|FG000|Overall Study|Subject/guardian decision|8|||
162024471|NCT02259088|585146501|FG001|Overall Study|Subject/guardian decision|8|||
162024472|NCT01818752|585146503|FG000|Overall Study|Adverse Event|64|||
162024473|NCT01818752|585146504|FG001|Overall Study|Adverse Event|74|||
162024474|NCT01818752|585146503|FG000|Overall Study|Death|14|||
162024475|NCT01818752|585146504|FG001|Overall Study|Death|18|||
162024476|NCT01818752|585146503|FG000|Overall Study|Non-compliance|16|||
162024477|NCT01818752|585146504|FG001|Overall Study|Non-compliance|20|||
162231124|NCT00938470|585895342|FG001|Overall Study|Death|2|||
161940293|NCT02471144|584832043|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161940294|NCT02471144|584832044|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
161940295|NCT02471144|584832045|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161940296|NCT02471144|584832046|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
161940297|NCT02471144|584832047|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161940298|NCT02471144|584832048|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
161940299|NCT02471144|584832049|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161940300|NCT02471144|584832050|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161940301|NCT02471144|584832040|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161940302|NCT02471144|584832041|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161940303|NCT02471144|584832042|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161940304|NCT02471144|584832043|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161940305|NCT02471144|584832044|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161940306|NCT02471144|584832045|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
161940307|NCT02471144|584832046|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161940308|NCT02471144|584832047|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161940309|NCT02471144|584832048|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
161940310|NCT02471144|584832049|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161940311|NCT02471144|584832050|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
161940312|NCT02471144|584832040|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161940313|NCT02471144|584832041|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161940314|NCT02471144|584832042|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161940315|NCT02471144|584832043|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161940316|NCT02471144|584832044|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161940317|NCT02471144|584832045|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161940318|NCT02471144|584832046|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161940319|NCT02471144|584832047|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161940320|NCT02471144|584832048|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
161940321|NCT02471144|584832049|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161940322|NCT02471144|584832050|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161940323|NCT02471144|584832040|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161940324|NCT02471144|584832041|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161940325|NCT02471144|584832042|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161940326|NCT02471144|584832043|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161940327|NCT02471144|584832044|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161940328|NCT02471144|584832045|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161940329|NCT02471144|584832046|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161940330|NCT02471144|584832047|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
161940331|NCT02471144|584832048|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
161940332|NCT02471144|584832049|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161940333|NCT02471144|584832050|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
161940334|NCT02471144|584832040|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161940335|NCT02471144|584832041|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161940336|NCT02471144|584832042|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161940337|NCT02471144|584832043|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161940338|NCT02471144|584832044|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161940339|NCT02471144|584832045|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161940340|NCT02471144|584832046|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161940341|NCT02471144|584832047|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161940342|NCT02471144|584832048|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
161940343|NCT02471144|584832049|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
161940344|NCT02471144|584832050|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
161940345|NCT02471144|584832040|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161940346|NCT02471144|584832041|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161940347|NCT02471144|584832042|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161940348|NCT02471144|584832043|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161940349|NCT02471144|584832044|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161940350|NCT02471144|584832045|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161940351|NCT02471144|584832046|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161940352|NCT02471144|584832047|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161940353|NCT02471144|584832048|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161940354|NCT02471144|584832049|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
161940355|NCT02471144|584832050|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
161940356|NCT02471144|584832040|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161940357|NCT02471144|584832041|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
162231125|NCT00938470|585895341|FG000|Overall Study|Other Reason|0|||
161940358|NCT02471144|584832042|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161940359|NCT02471144|584832043|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161940360|NCT02471144|584832044|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161940361|NCT02471144|584832045|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161940362|NCT02471144|584832046|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161940363|NCT02471144|584832047|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161940364|NCT02471144|584832048|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161940365|NCT02471144|584832049|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
161940366|NCT02471144|584832050|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
161940367|NCT02471144|584832040|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161940368|NCT02471144|584832041|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161940369|NCT02471144|584832042|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161940370|NCT02471144|584832043|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161940371|NCT02471144|584832044|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161940372|NCT02471144|584832045|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161940373|NCT02471144|584832046|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161940374|NCT02471144|584832047|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161940375|NCT02471144|584832048|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
161940376|NCT02471144|584832049|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
161940377|NCT02471144|584832050|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
161940378|NCT02471144|584832040|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161940379|NCT02471144|584832041|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161940380|NCT02471144|584832042|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161940381|NCT02471144|584832043|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161940382|NCT02471144|584832044|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161940383|NCT02471144|584832045|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161940384|NCT02471144|584832046|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161940385|NCT02471144|584832047|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161940386|NCT02471144|584832048|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161940387|NCT02471144|584832049|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
161940388|NCT02471144|584832050|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
161940389|NCT02471144|584832040|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161940390|NCT02471144|584832041|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161940391|NCT02471144|584832042|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161940392|NCT02471144|584832043|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161940393|NCT02471144|584832044|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161940394|NCT02471144|584832045|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161940395|NCT02471144|584832046|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161940396|NCT02471144|584832047|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161940397|NCT02471144|584832048|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
161940398|NCT02471144|584832049|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
161940399|NCT02471144|584832050|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
161940400|NCT03977155|584832054|FG000|Overall Study|Adverse Event|3|||
161940401|NCT03977155|584832055|FG001|Overall Study|Adverse Event|0|||
161940402|NCT03977155|584832056|FG002|Overall Study|Adverse Event|0|||
161940403|NCT03977155|584832054|FG000|Overall Study|Lost to Follow-up|0|||
161940404|NCT03977155|584832055|FG001|Overall Study|Lost to Follow-up|1|||
161940405|NCT03977155|584832056|FG002|Overall Study|Lost to Follow-up|0|||
161940406|NCT03977155|584832054|FG000|Overall Study|Withdrawal by Subject|1|||
161940407|NCT03977155|584832055|FG001|Overall Study|Withdrawal by Subject|1|||
161940408|NCT03977155|584832056|FG002|Overall Study|Withdrawal by Subject|2|||
161940409|NCT03977155|584832054|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
161940410|NCT03977155|584832055|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
161940411|NCT03977155|584832056|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
161940412|NCT00936936|584832057|FG000|Overall Study|Adverse Event|7|||
161940413|NCT00936936|584832058|FG001|Overall Study|Adverse Event|1|||
161940414|NCT00936936|584832057|FG000|Overall Study|Disease Progression|2|||
161940415|NCT00936936|584832058|FG001|Overall Study|Disease Progression|2|||
161940416|NCT00936936|584832057|FG000|Overall Study|Unrelated|3|||
161940417|NCT00936936|584832058|FG001|Overall Study|Unrelated|1|||
161940418|NCT03440385|584832067|FG000|Overall Study|Other Reason|4|||
161940419|NCT03440385|584832068|FG001|Overall Study|Other Reason|1|||
161940420|NCT03440385|584832067|FG000|Overall Study|Site Closed|1|||
161940421|NCT03440385|584832068|FG001|Overall Study|Site Closed|0|||
161940422|NCT03440385|584832067|FG000|Overall Study|Lost to Follow-up|2|||
161940423|NCT03440385|584832068|FG001|Overall Study|Lost to Follow-up|0|||
161940424|NCT03440385|584832067|FG000|Overall Study|Withdrawal by Subject|12|||
161940425|NCT03440385|584832068|FG001|Overall Study|Withdrawal by Subject|6|||
161940426|NCT03440385|584832067|FG000|Overall Study|Lack of Efficacy|9|||
161680104|NCT03250832|583881513|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680105|NCT03250832|583881514|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161680106|NCT03250832|583881503|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680107|NCT03250832|583881504|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680108|NCT03250832|583881505|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680109|NCT03250832|583881506|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680110|NCT03250832|583881507|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680111|NCT03250832|583881508|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680112|NCT03250832|583881509|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680113|NCT03250832|583881510|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
161680114|NCT03250832|583881511|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680115|NCT03250832|583881512|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680116|NCT03250832|583881513|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680117|NCT03250832|583881514|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161680118|NCT03250832|583881503|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680119|NCT03250832|583881504|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680120|NCT03250832|583881505|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680121|NCT03250832|583881506|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680122|NCT03250832|583881507|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680123|NCT03250832|583881508|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680124|NCT03250832|583881509|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680125|NCT03250832|583881510|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
161680126|NCT03250832|583881511|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680127|NCT03250832|583881512|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680128|NCT03250832|583881513|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680129|NCT03250832|583881514|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
161680130|NCT03250832|583881503|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680131|NCT03250832|583881504|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680132|NCT03250832|583881505|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680133|NCT03250832|583881506|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680134|NCT03250832|583881507|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680135|NCT03250832|583881508|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680136|NCT03250832|583881509|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680137|NCT03250832|583881510|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680138|NCT03250832|583881511|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
161680139|NCT03250832|583881512|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
161680140|NCT03250832|583881513|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680141|NCT03250832|583881514|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
161680142|NCT03250832|583881503|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680143|NCT03250832|583881504|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680144|NCT03250832|583881505|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680145|NCT03250832|583881506|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
162231126|NCT00938470|585895342|FG001|Overall Study|Other Reason|1|||
162231127|NCT01552603|585895343|FG000|Overall Study|Physician Decision|1|||
161829836|NCT00576303|584415892|FG000|Dose Titration Period|Early withdrawal|17|||
161829837|NCT00576303|584415892|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
161829838|NCT00576303|584415892|FG000|Long Term Safety Period|Early withdrawal|16|||
161829839|NCT02843659|584415896|FG000|Overall Study|Subject Withdrew Consent|0|||
161829840|NCT02843659|584415897|FG001|Overall Study|Subject Withdrew Consent|0|||
161829841|NCT02843659|584415898|FG002|Overall Study|Subject Withdrew Consent|1|||
161829842|NCT02843659|584415896|FG000|Overall Study|Administrative Reason by Sponsor|4|||
161829843|NCT02843659|584415897|FG001|Overall Study|Administrative Reason by Sponsor|5|||
161829844|NCT02843659|584415898|FG002|Overall Study|Administrative Reason by Sponsor|4|||
161829845|NCT02843659|584415896|FG000|Overall Study|Adverse Event|0|||
161829846|NCT02843659|584415897|FG001|Overall Study|Adverse Event|1|||
161829847|NCT02843659|584415898|FG002|Overall Study|Adverse Event|0|||
161829848|NCT03203642|584415899|FG000|Overall Study|Adverse Event|3|||
161829849|NCT03203642|584415900|FG001|Overall Study|Adverse Event|1|||
161829850|NCT03203642|584415899|FG000|Overall Study|Withdrawal by Subject|6|||
161829851|NCT03203642|584415900|FG001|Overall Study|Withdrawal by Subject|6|||
161829852|NCT03203642|584415899|FG000|Overall Study|Lost to Follow-up|2|||
161829853|NCT03203642|584415900|FG001|Overall Study|Lost to Follow-up|1|||
161829854|NCT03203642|584415899|FG000|Overall Study|Termination of the study by sponsor|1|||
161829855|NCT03203642|584415900|FG001|Overall Study|Termination of the study by sponsor|1|||
161829856|NCT03203642|584415899|FG000|Overall Study|Participant moved|0|||
161829857|NCT03203642|584415900|FG001|Overall Study|Participant moved|1|||
161829858|NCT03203642|584415899|FG000|Overall Study|Investigator's decision|3|||
161829859|NCT03203642|584415900|FG001|Overall Study|Investigator's decision|0|||
161829860|NCT03203642|584415899|FG000|Overall Study|Other than above specified|0|||
161829861|NCT03203642|584415900|FG001|Overall Study|Other than above specified|1|||
162024478|NCT01818752|585146503|FG000|Overall Study|Withdrawal by Subject|15|||
162024479|NCT01818752|585146504|FG001|Overall Study|Withdrawal by Subject|14|||
162024480|NCT01818752|585146503|FG000|Overall Study|Physician Decision|9|||
162024481|NCT01818752|585146504|FG001|Overall Study|Physician Decision|8|||
162024482|NCT01818752|585146503|FG000|Overall Study|Disease Progression|54|||
162024483|NCT01818752|585146504|FG001|Overall Study|Disease Progression|48|||
162024484|NCT01818752|585146503|FG000|Overall Study|Other|7|||
162024485|NCT01818752|585146504|FG001|Overall Study|Other|8|||
162024486|NCT01818752|585146503|FG000|Overall Study|Continuing Treatment|1|||
162024487|NCT01818752|585146504|FG001|Overall Study|Continuing Treatment|4|||
162024488|NCT01818752|585146503|FG000|Overall Study|Randomized but not Dosed|7|||
162024489|NCT01818752|585146504|FG001|Overall Study|Randomized but not Dosed|4|||
162024490|NCT03060551|585146505|FG000|Overall Study|Withdrawal by Subject|1|||
162024491|NCT03060551|585146505|FG000|Overall Study|Adverse Event|1|||
162024492|NCT04629066|585146506|FG000|Overall Study|Lost to Follow-up|3|||
162024493|NCT04629066|585146507|FG001|Overall Study|Lost to Follow-up|2|||
162024494|NCT00282308|585146510|FG000|Treatment Period|Lost to Follow-up|1|||
162024495|NCT00282308|585146511|FG001|Treatment Period|Lost to Follow-up|0|||
162024496|NCT00282308|585146512|FG002|Treatment Period|Lost to Follow-up|0|||
162024497|NCT00282308|585146510|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
162024498|NCT00282308|585146511|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
162024499|NCT00282308|585146512|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
162024500|NCT00282308|585146510|FG000|Treatment Period|Adverse Event|0|||
162024501|NCT00282308|585146511|FG001|Treatment Period|Adverse Event|2|||
162024502|NCT00282308|585146512|FG002|Treatment Period|Adverse Event|0|||
162024503|NCT00282308|585146510|FG000|Treatment Period|Not Treated with Study Drug|1|||
162024504|NCT00282308|585146511|FG001|Treatment Period|Not Treated with Study Drug|0|||
162024505|NCT00282308|585146512|FG002|Treatment Period|Not Treated with Study Drug|0|||
162024506|NCT00282308|585146510|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
162024507|NCT00282308|585146511|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
162024508|NCT00282308|585146512|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
162024509|NCT00282308|585146510|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
162024510|NCT00282308|585146511|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
162024511|NCT00282308|585146512|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
162024512|NCT00282308|585146510|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
162024513|NCT00282308|585146511|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
162024514|NCT00282308|585146512|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
162024515|NCT00282308|585146510|FG000|Safety Follow-up Period|Adverse Event|0|||
162024516|NCT00282308|585146511|FG001|Safety Follow-up Period|Adverse Event|0|||
162024517|NCT00282308|585146512|FG002|Safety Follow-up Period|Adverse Event|1|||
162024518|NCT00282308|585146510|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
162024519|NCT00282308|585146511|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
162024520|NCT00282308|585146512|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
162024521|NCT00282308|585146510|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
162024522|NCT00282308|585146511|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
162024523|NCT00282308|585146512|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
162024524|NCT00282308|585146510|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
162024525|NCT00282308|585146511|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
162024526|NCT00282308|585146512|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
162024527|NCT02660983|585146513|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
162024528|NCT02660983|585146514|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
162024529|NCT02660983|585146513|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
162024530|NCT02660983|585146514|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
162024531|NCT02660983|585146513|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
162024532|NCT02660983|585146514|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
162024533|NCT02660983|585146513|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
162024534|NCT02660983|585146514|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
162024535|NCT02660983|585146513|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
162024536|NCT02660983|585146514|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
162024537|NCT02660983|585146513|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
161680146|NCT03250832|583881507|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
162024538|NCT02660983|585146514|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
162024539|NCT02660983|585146513|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
162024540|NCT02660983|585146514|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
162024541|NCT00721968|585146517|FG000|Overall Study|Lost to Follow-up|2|||
162024542|NCT00721968|585146518|FG001|Overall Study|Lost to Follow-up|0|||
162024543|NCT04303195|585146519|FG000|Overall Study|Adverse Event|1|||
162024544|NCT04303195|585146520|FG001|Overall Study|Adverse Event|3|||
162024545|NCT04303195|585146521|FG002|Overall Study|Adverse Event|7|||
162024546|NCT04303195|585146522|FG003|Overall Study|Adverse Event|0|||
162024547|NCT04303195|585146519|FG000|Overall Study|Lost to Follow-up|1|||
162024548|NCT04303195|585146520|FG001|Overall Study|Lost to Follow-up|0|||
162024549|NCT04303195|585146521|FG002|Overall Study|Lost to Follow-up|1|||
162024550|NCT04303195|585146522|FG003|Overall Study|Lost to Follow-up|4|||
162024551|NCT04303195|585146519|FG000|Overall Study|Withdrawal by Subject|3|||
162024552|NCT04303195|585146520|FG001|Overall Study|Withdrawal by Subject|1|||
162231128|NCT00618618|585895344|FG000|Overall Study|Patient Request|0|||
161680147|NCT03250832|583881508|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161829862|NCT01546142|584418015|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
161829863|NCT01546142|584418016|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
162231129|NCT00618618|585895345|FG001|Overall Study|Patient Request|0|||
162231130|NCT00618618|585895346|FG002|Overall Study|Patient Request|2|||
162231131|NCT00618618|585895347|FG003|Overall Study|Patient Request|0|||
162231132|NCT00618618|585895344|FG000|Overall Study|Inability to Complete Study Procedures|0|||
162231133|NCT00618618|585895345|FG001|Overall Study|Inability to Complete Study Procedures|1|||
162231134|NCT00618618|585895346|FG002|Overall Study|Inability to Complete Study Procedures|0|||
161829864|NCT01546142|584418015|FG000|Overall Study|Subject Noncompliance|1|||
162024553|NCT04303195|585146521|FG002|Overall Study|Withdrawal by Subject|1|||
162024554|NCT04303195|585146522|FG003|Overall Study|Withdrawal by Subject|1|||
162231135|NCT00618618|585895347|FG003|Overall Study|Inability to Complete Study Procedures|0|||
162231136|NCT00618618|585895344|FG000|Overall Study|Lost to Follow-up|3|||
162231137|NCT00618618|585895345|FG001|Overall Study|Lost to Follow-up|0|||
162231138|NCT00618618|585895346|FG002|Overall Study|Lost to Follow-up|0|||
162231139|NCT00618618|585895347|FG003|Overall Study|Lost to Follow-up|1|||
162231140|NCT00618618|585895344|FG000|Overall Study|Non-compliance|1|||
162231141|NCT00618618|585895345|FG001|Overall Study|Non-compliance|1|||
162231142|NCT00618618|585895346|FG002|Overall Study|Non-compliance|0|||
162231143|NCT00618618|585895347|FG003|Overall Study|Non-compliance|0|||
162231144|NCT00618618|585895344|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
162231145|NCT00618618|585895345|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
162231146|NCT00618618|585895346|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
162231147|NCT00618618|585895347|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
162231148|NCT00618618|585895344|FG000|Overall Study|Death|0|||
162231149|NCT00618618|585895345|FG001|Overall Study|Death|1|||
162231150|NCT00618618|585895346|FG002|Overall Study|Death|0|||
161940427|NCT03440385|584832068|FG001|Overall Study|Lack of Efficacy|2|||
161940428|NCT03440385|584832067|FG000|Overall Study|Adverse Event|15|||
161940429|NCT03440385|584832068|FG001|Overall Study|Adverse Event|11|||
161940430|NCT00488293|584832069|FG000|Overall Study|Lost to Follow-up|28|||
161940431|NCT00488293|584832070|FG001|Overall Study|Lost to Follow-up|25|||
161940432|NCT00488293|584832069|FG000|Overall Study|Withdrawal by Subject|5|||
161940433|NCT00488293|584832070|FG001|Overall Study|Withdrawal by Subject|3|||
161940434|NCT00488293|584832069|FG000|Overall Study|Death|2|||
161940435|NCT00488293|584832070|FG001|Overall Study|Death|1|||
161940436|NCT00488293|584832069|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
161940437|NCT00488293|584832070|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
161940438|NCT02374255|584832071|FG000|Overall Study|Withdrawal by Subject|2|||
161940439|NCT02374255|584832072|FG001|Overall Study|Withdrawal by Subject|0|||
161940440|NCT02374255|584832073|FG002|Overall Study|Withdrawal by Subject|0|||
161940441|NCT02374255|584832074|FG003|Overall Study|Withdrawal by Subject|0|||
161940442|NCT00730327|584832075|FG000|Overall Study|Lost to Follow-up|14|||
161940443|NCT00730327|584832076|FG001|Overall Study|Lost to Follow-up|16|||
161940444|NCT00730327|584832075|FG000|Overall Study|Adverse Event|8|||
161940445|NCT00730327|584832076|FG001|Overall Study|Adverse Event|1|||
161940446|NCT00730327|584832075|FG000|Overall Study|Withdrawal by Subject|3|||
161940447|NCT00730327|584832076|FG001|Overall Study|Withdrawal by Subject|13|||
161940448|NCT00730327|584832075|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
161940449|NCT00730327|584832076|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
161940450|NCT00095576|584832077|FG000|Overall Study|Adverse Event|5|||
161940451|NCT00095576|584832078|FG001|Overall Study|Adverse Event|3|||
161940452|NCT00095576|584832077|FG000|Overall Study|Lost to Follow-up|233|||
161940453|NCT00095576|584832078|FG001|Overall Study|Lost to Follow-up|229|||
161940454|NCT00095576|584832077|FG000|Overall Study|Protocol Violation|1|||
161940455|NCT00095576|584832078|FG001|Overall Study|Protocol Violation|0|||
161940456|NCT00095576|584832077|FG000|Overall Study|Withdrawal by Subject|34|||
161940457|NCT00095576|584832078|FG001|Overall Study|Withdrawal by Subject|47|||
161940458|NCT00095576|584832077|FG000|Overall Study|Option to switch to a rollover study|1097|||
161940459|NCT00095576|584832078|FG001|Overall Study|Option to switch to a rollover study|1099|||
161940460|NCT00095576|584832077|FG000|Overall Study|Site terminated|75|||
161940461|NCT00095576|584832078|FG001|Overall Study|Site terminated|67|||
161940462|NCT00095576|584832077|FG000|Overall Study|Subject moved|30|||
161940463|NCT00095576|584832078|FG001|Overall Study|Subject moved|36|||
161940464|NCT01358734|584832081|FG000|Overall Study|Adverse Event|4|||
161940465|NCT01358734|584832082|FG001|Overall Study|Adverse Event|7|||
161940466|NCT01358734|584832083|FG002|Overall Study|Adverse Event|3|||
161940467|NCT01358734|584832081|FG000|Overall Study|Lack of Efficacy|0|||
161940468|NCT01358734|584832082|FG001|Overall Study|Lack of Efficacy|1|||
161940469|NCT01358734|584832083|FG002|Overall Study|Lack of Efficacy|3|||
161940470|NCT01358734|584832081|FG000|Overall Study|Withdrawal by Subject|1|||
161940471|NCT01358734|584832082|FG001|Overall Study|Withdrawal by Subject|6|||
161940472|NCT01358734|584832083|FG002|Overall Study|Withdrawal by Subject|3|||
161940473|NCT01358734|584832081|FG000|Overall Study|Death|3|||
161940474|NCT01358734|584832082|FG001|Overall Study|Death|7|||
161940475|NCT01358734|584832083|FG002|Overall Study|Death|2|||
161940476|NCT01358734|584832081|FG000|Overall Study|Progressive Disease|5|||
161940477|NCT01358734|584832082|FG001|Overall Study|Progressive Disease|13|||
161940478|NCT01358734|584832083|FG002|Overall Study|Progressive Disease|16|||
161940479|NCT01358734|584832081|FG000|Overall Study|Non-compliance with study drug|0|||
161940480|NCT01358734|584832082|FG001|Overall Study|Non-compliance with study drug|0|||
161940481|NCT01358734|584832083|FG002|Overall Study|Non-compliance with study drug|1|||
161940482|NCT01358734|584832081|FG000|Overall Study|Other|2|||
161940483|NCT01358734|584832082|FG001|Overall Study|Other|5|||
161940484|NCT01358734|584832083|FG002|Overall Study|Other|4|||
161940485|NCT01358734|584832081|FG000|Overall Study|Protocol Violation|0|||
161940486|NCT01358734|584832082|FG001|Overall Study|Protocol Violation|0|||
161940487|NCT01358734|584832083|FG002|Overall Study|Protocol Violation|2|||
161940488|NCT01905540|584832086|FG000|Period 3|Other|1|||
161940489|NCT01905540|584832087|FG001|Period 3|Other|0|||
162231151|NCT00618618|585895347|FG003|Overall Study|Death|0|||
162231152|NCT01236365|585895351|FG000|Overall Study|Lost to Follow-up|0|||
162231153|NCT01236365|585895352|FG001|Overall Study|Lost to Follow-up|2|||
162231154|NCT01236365|585895351|FG000|Overall Study|Moved Out of State|1|||
162231155|NCT01236365|585895352|FG001|Overall Study|Moved Out of State|0|||
162231156|NCT01236365|585895351|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
162231157|NCT01236365|585895352|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
162231158|NCT00006011|585895358|FG000|Overall Study|Disease progression|13|||
162231159|NCT00006011|585895359|FG001|Overall Study|Disease progression|6|||
162231160|NCT00006011|585895360|FG002|Overall Study|Disease progression|26|||
162231161|NCT00006011|585895358|FG000|Overall Study|Refused further treatment|15|||
162231162|NCT00006011|585895359|FG001|Overall Study|Refused further treatment|13|||
162231163|NCT00006011|585895360|FG002|Overall Study|Refused further treatment|26|||
162231164|NCT00006011|585895358|FG000|Overall Study|Adverse Event|15|||
162231165|NCT00006011|585895359|FG001|Overall Study|Adverse Event|39|||
162231166|NCT00006011|585895360|FG002|Overall Study|Adverse Event|5|||
162231167|NCT00006011|585895358|FG000|Overall Study|Death|0|||
161940490|NCT01905540|584832088|FG002|Period 3|Other|1|||
162231168|NCT00006011|585895359|FG001|Overall Study|Death|1|||
162231169|NCT00006011|585895360|FG002|Overall Study|Death|2|||
162231170|NCT00006011|585895358|FG000|Overall Study|Other|4|||
161940491|NCT01905540|584832089|FG003|Period 3|Other|1|||
162231171|NCT00006011|585895359|FG001|Overall Study|Other|2|||
162231172|NCT00006011|585895360|FG002|Overall Study|Other|5|||
162231173|NCT00006011|585895358|FG000|Overall Study|Ineligible|18|||
162231174|NCT00006011|585895359|FG001|Overall Study|Ineligible|16|||
162231175|NCT00006011|585895360|FG002|Overall Study|Ineligible|9|||
162231176|NCT01236534|585895366|FG000|Overall Study|Adverse Event|3|||
162231177|NCT01236534|585895367|FG001|Overall Study|Adverse Event|0|||
162231178|NCT01844687|585895370|FG000|Visit 1|Protocol Violation|3|||
162231179|NCT01844687|585895370|FG000|Visit 1|Lost to Follow-up|5|||
162231180|NCT01844687|585895370|FG000|Visit 2|Withdrawal by Subject|1|||
162231181|NCT01844687|585895370|FG000|Visit 2|Protocol Violation|1|||
162231182|NCT01844687|585895370|FG000|Visit 3|Lost to Follow-up|1|||
162231183|NCT01844687|585895370|FG000|Visit 3|Withdrawal by Subject|3|||
162231184|NCT01844687|585895370|FG000|Visit 3|child care problems|1|||
162231185|NCT01844687|585895370|FG000|Visit 4|Pregnancy|1|||
162231186|NCT01844687|585895370|FG000|Visit 4|Lost to Follow-up|1|||
162231187|NCT01844687|585895370|FG000|Visit 4|Withdrawal by Subject|2|||
162231188|NCT00158860|585895385|FG000|Overall Study|Adverse Event|3|||
162231189|NCT00158860|585895386|FG001|Overall Study|Adverse Event|6|||
162231190|NCT00158860|585895385|FG000|Overall Study|Lost to Follow-up|11|||
162231191|NCT00158860|585895386|FG001|Overall Study|Lost to Follow-up|17|||
162231192|NCT00158860|585895385|FG000|Overall Study|Protocol Violation|8|||
162231193|NCT00158860|585895386|FG001|Overall Study|Protocol Violation|23|||
162231194|NCT00158860|585895385|FG000|Overall Study|Withdrawal by Subject|7|||
162231195|NCT00158860|585895386|FG001|Overall Study|Withdrawal by Subject|17|||
162231196|NCT00158860|585895385|FG000|Overall Study|MOVING OUT OF STATE|1|||
162231197|NCT00158860|585895386|FG001|Overall Study|MOVING OUT OF STATE|0|||
162231198|NCT00158860|585895385|FG000|Overall Study|Pregnancy|3|||
162231199|NCT00158860|585895386|FG001|Overall Study|Pregnancy|3|||
162231200|NCT00158860|585895385|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
162231201|NCT00158860|585895386|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
162231202|NCT00158860|585895385|FG000|Overall Study|SPONSOR REQUEST|0|||
162231203|NCT00158860|585895386|FG001|Overall Study|SPONSOR REQUEST|1|||
162231204|NCT00158860|585895385|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
162231205|NCT00158860|585895386|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
162231206|NCT00158860|585895385|FG000|Overall Study|Closed per sponsor|0|||
162231207|NCT00158860|585895386|FG001|Overall Study|Closed per sponsor|1|||
162231208|NCT04638920|585895387|FG000|Overall Study|Withdrawal by Subject|5|||
162231209|NCT01801735|585895388|FG000|Overall Study|Adverse Event|79|||
162231210|NCT01801735|585895388|FG000|Overall Study|Lack of Efficacy|28|||
162231211|NCT01801735|585895388|FG000|Overall Study|Withdrawal by Subject|27|||
162231212|NCT01801735|585895388|FG000|Overall Study|Protocol Violation|25|||
162231213|NCT01801735|585895388|FG000|Overall Study|Lost to Follow-up|15|||
162231214|NCT01801735|585895388|FG000|Overall Study|Non-compliance with Trial Drug|13|||
161940492|NCT03427619|584832090|FG000|Overall Study|Physician Decision|3|||
161940493|NCT03427619|584832090|FG000|Overall Study|Withdrawal by Subject|4|||
161940494|NCT03427619|584832090|FG000|Overall Study|Lost to Follow-up|5|||
162231215|NCT01801735|585895388|FG000|Overall Study|Physician Decision|3|||
162231216|NCT01801735|585895388|FG000|Overall Study|Death|1|||
162231217|NCT01801735|585895388|FG000|Overall Study|Other, including site closure|19|||
162231218|NCT01435616|585895389|FG000|Overall Study|Adverse Event|39|||
162231219|NCT01435616|585895390|FG001|Overall Study|Adverse Event|21|||
162231220|NCT01435616|585895389|FG000|Overall Study|Death|7|||
162231221|NCT01435616|585895390|FG001|Overall Study|Death|2|||
162231222|NCT01435616|585895389|FG000|Overall Study|Lost to Follow-up|22|||
161940495|NCT03427619|584832090|FG000|Overall Study|Administrative|4|||
162231223|NCT01435616|585895390|FG001|Overall Study|Lost to Follow-up|13|||
162231224|NCT01435616|585895389|FG000|Overall Study|Protocol Violation|16|||
162231225|NCT01435616|585895390|FG001|Overall Study|Protocol Violation|13|||
162231226|NCT01435616|585895389|FG000|Overall Study|Withdrawal by Subject|66|||
162231227|NCT01435616|585895390|FG001|Overall Study|Withdrawal by Subject|24|||
162231228|NCT01435616|585895389|FG000|Overall Study|Physician Decision|20|||
162231229|NCT01435616|585895390|FG001|Overall Study|Physician Decision|7|||
162231230|NCT01435616|585895389|FG000|Overall Study|Sponsor Decision|1|||
162231231|NCT01435616|585895390|FG001|Overall Study|Sponsor Decision|0|||
162231232|NCT00371683|585895392|FG000|DB Treatment Period-Randomized Patients|Death|1|||
162231233|NCT00371683|585895393|FG001|DB Treatment Period-Randomized Patients|Death|1|||
162231234|NCT00371683|585895392|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
162231235|NCT00371683|585895393|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
162231236|NCT00371683|585895392|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
162231237|NCT00371683|585895393|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
162231238|NCT00371683|585895392|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
162231239|NCT00371683|585895393|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
162231240|NCT00371683|585895392|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
162231241|NCT00371683|585895393|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
162231242|NCT00371683|585895392|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
162231243|NCT00371683|585895393|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
162231244|NCT00371683|585895392|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
162231245|NCT00371683|585895393|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
162231246|NCT00371683|585895392|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
162231247|NCT00371683|585895393|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
162231248|NCT00371683|585895392|FG000|Follow-Up Period - Randomized Patients|Death|0|||
162231249|NCT00371683|585895393|FG001|Follow-Up Period - Randomized Patients|Death|2|||
162231250|NCT00371683|585895392|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
162231251|NCT00371683|585895393|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
162231252|NCT00371683|585895392|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
162231253|NCT00371683|585895393|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
162231254|NCT03208036|585895395|FG000|Baseline Assessment|Withdrawal by Subject|1|||
162231255|NCT03208036|585895396|FG001|Baseline Assessment|Withdrawal by Subject|1|||
162231256|NCT03208036|585895395|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
162231257|NCT03208036|585895396|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
162231258|NCT03208036|585895395|FG000|Intervention|Withdrawal by Subject|3|||
162231259|NCT03208036|585895396|FG001|Intervention|Withdrawal by Subject|2|||
162231260|NCT03208036|585895395|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
162231261|NCT03208036|585895396|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
162231262|NCT00700778|585895397|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
162231263|NCT00350103|585895401|FG000|Overall Study|Adverse Event|12|||
162231264|NCT00350103|585895402|FG001|Overall Study|Adverse Event|29|||
162231265|NCT00350103|585895403|FG002|Overall Study|Adverse Event|17|||
162231266|NCT00350103|585895401|FG000|Overall Study|Lack of Efficacy|5|||
162231267|NCT00350103|585895402|FG001|Overall Study|Lack of Efficacy|1|||
162231268|NCT00350103|585895403|FG002|Overall Study|Lack of Efficacy|3|||
162231269|NCT00350103|585895401|FG000|Overall Study|Withdrawal by Subject|6|||
162231270|NCT00350103|585895402|FG001|Overall Study|Withdrawal by Subject|6|||
162231271|NCT00350103|585895403|FG002|Overall Study|Withdrawal by Subject|8|||
162231272|NCT00350103|585895401|FG000|Overall Study|Protocol Violation|0|||
162231273|NCT00350103|585895402|FG001|Overall Study|Protocol Violation|0|||
162231274|NCT00350103|585895403|FG002|Overall Study|Protocol Violation|1|||
162231275|NCT00350103|585895401|FG000|Overall Study|Unsatisfactory Compliance|2|||
162231276|NCT00350103|585895402|FG001|Overall Study|Unsatisfactory Compliance|2|||
162231277|NCT00350103|585895403|FG002|Overall Study|Unsatisfactory Compliance|1|||
162231278|NCT00350103|585895401|FG000|Overall Study|Investigator´s decision|1|||
162231279|NCT00350103|585895402|FG001|Overall Study|Investigator´s decision|1|||
162231280|NCT00350103|585895403|FG002|Overall Study|Investigator´s decision|0|||
162231281|NCT00350103|585895401|FG000|Overall Study|Exclusion criteria met|0|||
162231282|NCT00350103|585895402|FG001|Overall Study|Exclusion criteria met|0|||
162231283|NCT00350103|585895403|FG002|Overall Study|Exclusion criteria met|1|||
162231284|NCT00350103|585895401|FG000|Overall Study|Patient relocated|0|||
162231285|NCT00350103|585895402|FG001|Overall Study|Patient relocated|0|||
162231286|NCT00350103|585895403|FG002|Overall Study|Patient relocated|1|||
162231287|NCT00350103|585895401|FG000|Overall Study|Need for prohibited medication|1|||
162231288|NCT00350103|585895402|FG001|Overall Study|Need for prohibited medication|0|||
162231289|NCT00350103|585895403|FG002|Overall Study|Need for prohibited medication|0|||
162231290|NCT00350103|585895401|FG000|Overall Study|Personal reasons|0|||
162231291|NCT00350103|585895402|FG001|Overall Study|Personal reasons|0|||
162231292|NCT00350103|585895403|FG002|Overall Study|Personal reasons|1|||
162231293|NCT00350103|585895401|FG000|Overall Study|Patient stopped feeling pain|1|||
162231294|NCT00350103|585895402|FG001|Overall Study|Patient stopped feeling pain|0|||
162231295|NCT00350103|585895403|FG002|Overall Study|Patient stopped feeling pain|0|||
162231296|NCT00350103|585895401|FG000|Overall Study|PR greater than 250ms|0|||
162231297|NCT00350103|585895402|FG001|Overall Study|PR greater than 250ms|0|||
162231298|NCT00350103|585895403|FG002|Overall Study|PR greater than 250ms|1|||
162231299|NCT00350103|585895401|FG000|Overall Study|Wrong calculation of QT interval|0|||
162231300|NCT00350103|585895402|FG001|Overall Study|Wrong calculation of QT interval|0|||
162231301|NCT00350103|585895403|FG002|Overall Study|Wrong calculation of QT interval|1|||
162231302|NCT00350103|585895401|FG000|Overall Study|Sponsor mistake|1|||
162231303|NCT00350103|585895402|FG001|Overall Study|Sponsor mistake|0|||
162231304|NCT00350103|585895403|FG002|Overall Study|Sponsor mistake|0|||
162231305|NCT00350103|585895401|FG000|Overall Study|Randomization mistake|0|||
162231306|NCT00350103|585895402|FG001|Overall Study|Randomization mistake|1|||
162231307|NCT00350103|585895403|FG002|Overall Study|Randomization mistake|1|||
162231308|NCT00350103|585895401|FG000|Overall Study|Sponsor´s decision|0|||
162231309|NCT00350103|585895402|FG001|Overall Study|Sponsor´s decision|1|||
162231310|NCT00350103|585895403|FG002|Overall Study|Sponsor´s decision|0|||
162231311|NCT00350103|585895401|FG000|Overall Study|Lost, Reason unknown|1|||
162231312|NCT00350103|585895402|FG001|Overall Study|Lost, Reason unknown|1|||
162231313|NCT00350103|585895403|FG002|Overall Study|Lost, Reason unknown|0|||
162231314|NCT01879553|585895404|FG000|Overall Study|Withdrawal by Subject|1|||
162231315|NCT01879553|585895405|FG001|Overall Study|Withdrawal by Subject|0|||
162231316|NCT02559895|585895406|FG000|Overall Study|Adverse Event|3|||
162231317|NCT02559895|585895407|FG001|Overall Study|Adverse Event|3|||
162231318|NCT02559895|585895408|FG002|Overall Study|Adverse Event|2|||
162231319|NCT02559895|585895409|FG003|Overall Study|Adverse Event|1|||
162231320|NCT02559895|585895406|FG000|Overall Study|Lack of Efficacy|2|||
162231321|NCT02559895|585895407|FG001|Overall Study|Lack of Efficacy|3|||
162231322|NCT02559895|585895408|FG002|Overall Study|Lack of Efficacy|2|||
162231323|NCT02559895|585895409|FG003|Overall Study|Lack of Efficacy|8|||
162231324|NCT02559895|585895406|FG000|Overall Study|Lost to Follow-up|22|||
162231325|NCT02559895|585895407|FG001|Overall Study|Lost to Follow-up|16|||
162231326|NCT02559895|585895408|FG002|Overall Study|Lost to Follow-up|12|||
162231327|NCT02559895|585895409|FG003|Overall Study|Lost to Follow-up|17|||
162231328|NCT02559895|585895406|FG000|Overall Study|Physician Decision|1|||
162231329|NCT02559895|585895407|FG001|Overall Study|Physician Decision|1|||
162231330|NCT02559895|585895408|FG002|Overall Study|Physician Decision|3|||
162231331|NCT02559895|585895409|FG003|Overall Study|Physician Decision|0|||
162231332|NCT02559895|585895406|FG000|Overall Study|Withdrawal by Subject|16|||
162231333|NCT02559895|585895407|FG001|Overall Study|Withdrawal by Subject|9|||
162231334|NCT02559895|585895408|FG002|Overall Study|Withdrawal by Subject|20|||
162231335|NCT02559895|585895409|FG003|Overall Study|Withdrawal by Subject|9|||
162231336|NCT02559895|585895406|FG000|Overall Study|Study Burden|10|||
162231337|NCT02559895|585895407|FG001|Overall Study|Study Burden|16|||
162231338|NCT02559895|585895408|FG002|Overall Study|Study Burden|12|||
162231339|NCT02559895|585895409|FG003|Overall Study|Study Burden|22|||
162231340|NCT02559895|585895406|FG000|Overall Study|Other|1|||
162231341|NCT02559895|585895407|FG001|Overall Study|Other|5|||
162231342|NCT02559895|585895408|FG002|Overall Study|Other|3|||
162231343|NCT02559895|585895409|FG003|Overall Study|Other|3|||
162231344|NCT00760474|585895410|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
162231345|NCT00760474|585895411|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
162231346|NCT00760474|585895410|FG000|Placebo Washout Period|Other|0|||
162231347|NCT00760474|585895411|FG001|Placebo Washout Period|Other|1|||
162231348|NCT00760474|585895410|FG000|Period 2 (P2)|Lost to Follow-up|1|||
162231349|NCT00760474|585895411|FG001|Period 2 (P2)|Lost to Follow-up|0|||
162231350|NCT00760474|585895410|FG000|Period 2 (P2)|Adverse Event|0|||
161940496|NCT03427619|584832090|FG000|Overall Study|Other|2|||
161940497|NCT03427619|584832090|FG000|Overall Study|Unknown or Missing Completion Status|48|||
161940498|NCT03729609|584832097|FG000|Overall Study|Protocol Violation|1|||
161940499|NCT01055028|584832102|FG000|Screening|Screen Failure|1|||
161940500|NCT01055028|584832103|FG001|Screening|Screen Failure|1|||
161940501|NCT01055028|584832102|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
161940502|NCT01055028|584832103|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
161940503|NCT01055028|584832102|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
161940504|NCT01055028|584832103|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
161940505|NCT01055028|584832102|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
161940506|NCT01055028|584832103|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
161940507|NCT03528902|584832107|FG000|Overall Study|Adverse Event|1|||
161940508|NCT03528902|584832108|FG001|Overall Study|Adverse Event|0|||
161940509|NCT04620668|584832109|FG000|Overall Study|Withdrawal by Subject|2|||
161940510|NCT04620668|584832110|FG001|Overall Study|Withdrawal by Subject|0|||
162231351|NCT00760474|585895411|FG001|Period 2 (P2)|Adverse Event|1|||
162231352|NCT04540887|585895412|FG000|Overall Study|Withdrawal by Subject|2|||
162231353|NCT04664400|585895413|FG000|Overall Study|Withdrawal by Subject|2|||
162231354|NCT02217501|585895420|FG000|Overall Study|Death|3|||
161940511|NCT04620668|584832109|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
161940512|NCT04620668|584832110|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
162024555|NCT04303195|585146519|FG000|Overall Study|No study drug administered or protocol deviation|0|||
162024556|NCT04303195|585146520|FG001|Overall Study|No study drug administered or protocol deviation|2|||
161940513|NCT04620668|584832109|FG000|Overall Study|Removed before analysis: missing data|2|||
161940514|NCT04620668|584832110|FG001|Overall Study|Removed before analysis: missing data|0|||
161940515|NCT04620668|584832109|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
161940516|NCT04620668|584832110|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
161940517|NCT04620668|584832109|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
161940518|NCT04620668|584832110|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
161940519|NCT00427700|584832119|FG000|Overall Study|Lost to Follow-up|2|||
162024557|NCT04303195|585146521|FG002|Overall Study|No study drug administered or protocol deviation|0|||
162024558|NCT04303195|585146522|FG003|Overall Study|No study drug administered or protocol deviation|2|||
162024559|NCT01064947|585146523|FG000|Overall Study|negative culture|41|||
162024560|NCT02970942|585146524|FG000|Overall Study|Death|0|||
162024561|NCT02970942|585146525|FG001|Overall Study|Death|1|||
162024562|NCT02970942|585146526|FG002|Overall Study|Death|0|||
162024563|NCT02970942|585146527|FG003|Overall Study|Death|0|||
162024564|NCT02970942|585146524|FG000|Overall Study|Lost to Follow-up|1|||
162024565|NCT02970942|585146525|FG001|Overall Study|Lost to Follow-up|0|||
162024566|NCT02970942|585146526|FG002|Overall Study|Lost to Follow-up|2|||
162024567|NCT02970942|585146527|FG003|Overall Study|Lost to Follow-up|1|||
162024568|NCT02970942|585146524|FG000|Overall Study|Withdrawal by Subject|3|||
162024569|NCT02970942|585146525|FG001|Overall Study|Withdrawal by Subject|5|||
162024570|NCT02970942|585146526|FG002|Overall Study|Withdrawal by Subject|3|||
162024571|NCT02970942|585146527|FG003|Overall Study|Withdrawal by Subject|2|||
162024572|NCT06457204|585146530|FG000|Washout|Adverse Event|0|||
162024573|NCT06457204|585146531|FG001|Washout|Adverse Event|2|||
162024574|NCT01065454|585146534|FG000|Treatment|Adverse Event|7|||
162024575|NCT01065454|585146535|FG001|Treatment|Adverse Event|4|||
161940520|NCT00427700|584832120|FG001|Overall Study|Lost to Follow-up|5|||
161940521|NCT00427700|584832119|FG000|Overall Study|no induction of menses|1|||
161940522|NCT00427700|584832120|FG001|Overall Study|no induction of menses|4|||
161940523|NCT00427700|584832119|FG000|Overall Study|Pregnancy|0|||
161940524|NCT00427700|584832120|FG001|Overall Study|Pregnancy|2|||
162231355|NCT02217501|585895421|FG001|Overall Study|Death|4|||
162231356|NCT01394978|585895422|FG000|Overall Study|Withdrawal by Subject|2|||
162231357|NCT01394978|585895423|FG001|Overall Study|Withdrawal by Subject|4|||
162231358|NCT01394978|585895422|FG000|Overall Study|Lost to Follow-up|13|||
161940525|NCT04581395|584832121|FG000|Overall Study|Protocol Violation|4|||
161940526|NCT04581395|584832122|FG001|Overall Study|Protocol Violation|3|||
162024576|NCT01065454|585146536|FG002|Treatment|Adverse Event|3|||
162024577|NCT01065454|585146537|FG003|Treatment|Adverse Event|6|||
162024578|NCT01065454|585146534|FG000|Treatment|Death|1|||
162231359|NCT01394978|585895423|FG001|Overall Study|Lost to Follow-up|20|||
162231360|NCT01394978|585895422|FG000|Overall Study|Death|6|||
162231361|NCT01394978|585895423|FG001|Overall Study|Death|7|||
162231362|NCT02019667|585895424|FG000|First Intervention (6 Months)|Adverse Event|0|||
162231363|NCT02019667|585895425|FG001|First Intervention (6 Months)|Adverse Event|1|||
162231364|NCT02019667|585895424|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
162231365|NCT02019667|585895425|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
162231366|NCT02019667|585895424|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
162231367|NCT02019667|585895425|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
162231368|NCT05038163|585895434|FG000|Stage 1|Did not complete survey|374|||
162231369|NCT05038163|585895435|FG001|Stage 1|Did not complete survey|0|||
162231370|NCT05038163|585895436|FG002|Stage 1|Did not complete survey|0|||
162231371|NCT05038163|585895437|FG003|Stage 1|Did not complete survey|0|||
162231372|NCT05038163|585895438|FG004|Stage 1|Did not complete survey|0|||
162231373|NCT05038163|585895439|FG005|Stage 1|Did not complete survey|0|||
162231374|NCT05038163|585895434|FG000|Stage 2|Did not complete Stage 2 survey|0|||
162231375|NCT05038163|585895435|FG001|Stage 2|Did not complete Stage 2 survey|29|||
162231376|NCT05038163|585895436|FG002|Stage 2|Did not complete Stage 2 survey|30|||
162231377|NCT05038163|585895437|FG003|Stage 2|Did not complete Stage 2 survey|24|||
162231378|NCT05038163|585895438|FG004|Stage 2|Did not complete Stage 2 survey|21|||
162231379|NCT05038163|585895439|FG005|Stage 2|Did not complete Stage 2 survey|100|||
162231380|NCT05453201|585895441|FG000|Overall Study|Withdrawal by Subject|1|||
162231381|NCT03562975|585895442|FG000|Overall Study|Death|1|||
162231382|NCT03562975|585895442|FG000|Overall Study|Lost to Follow-up|1|||
162231383|NCT03562975|585895442|FG000|Overall Study|Withdrawal by Subject|1|||
162231384|NCT01934790|585895443|FG000|Treatment|Adverse Event|3|||
162231385|NCT01934790|585895443|FG000|Treatment|Clinical progression|6|||
162231386|NCT01934790|585895443|FG000|Treatment|Radiological progression|4|||
162231387|NCT01934790|585895443|FG000|Treatment|Withdrawal by Subject|2|||
162231388|NCT01934790|585895443|FG000|Treatment|Study drug never administered|1|||
162024579|NCT01065454|585146535|FG001|Treatment|Death|0|||
161940527|NCT04581395|584832123|FG002|Overall Study|Protocol Violation|2|||
161940528|NCT04581395|584832121|FG000|Overall Study|Physician Decision|0|||
162024580|NCT01065454|585146536|FG002|Treatment|Death|0|||
162024581|NCT01065454|585146537|FG003|Treatment|Death|0|||
162024582|NCT01065454|585146534|FG000|Treatment|Non-compliance|1|||
161940529|NCT04581395|584832122|FG001|Overall Study|Physician Decision|1|||
161940530|NCT04581395|584832123|FG002|Overall Study|Physician Decision|0|||
161680148|NCT03250832|583881509|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680149|NCT03250832|583881510|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680150|NCT03250832|583881511|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
161680151|NCT03250832|583881512|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
161680152|NCT03250832|583881513|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680153|NCT03250832|583881514|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161680154|NCT03250832|583881503|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680155|NCT03250832|583881504|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680156|NCT03250832|583881505|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680157|NCT03250832|583881506|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680158|NCT03250832|583881507|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680159|NCT03250832|583881508|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680160|NCT03250832|583881509|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680161|NCT03250832|583881510|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680162|NCT03250832|583881511|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
161680163|NCT03250832|583881512|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
161680164|NCT03250832|583881513|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680165|NCT03250832|583881514|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161680166|NCT03250832|583881503|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680167|NCT03250832|583881504|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680168|NCT03250832|583881505|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680169|NCT03250832|583881506|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680170|NCT03250832|583881507|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680171|NCT03250832|583881508|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680172|NCT03250832|583881509|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680173|NCT03250832|583881510|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680174|NCT03250832|583881511|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680175|NCT03250832|583881512|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680176|NCT03250832|583881513|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161680177|NCT03250832|583881514|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
161680178|NCT01708291|583881515|FG000|Overall Study|fighting|2|||
161680179|NCT01708291|583881516|FG001|Overall Study|fighting|1|||
161680180|NCT04411628|583881518|FG000|Overall Study|Withdrawal by Subject|1|||
161680181|NCT04411628|583881519|FG001|Overall Study|Withdrawal by Subject|1|||
161680182|NCT04411628|583881520|FG002|Overall Study|Withdrawal by Subject|2|||
161680183|NCT04411628|583881521|FG003|Overall Study|Withdrawal by Subject|0|||
161680184|NCT04411628|583881518|FG000|Overall Study|Lost to Follow-up|0|||
161680185|NCT04411628|583881519|FG001|Overall Study|Lost to Follow-up|1|||
161680186|NCT04411628|583881520|FG002|Overall Study|Lost to Follow-up|0|||
161680187|NCT04411628|583881521|FG003|Overall Study|Lost to Follow-up|0|||
161680188|NCT01428661|583881522|FG000|Double-Masked Phase|Protocol Violation|9|||
161680189|NCT01428661|583881523|FG001|Double-Masked Phase|Protocol Violation|4|||
161680190|NCT01428661|583881524|FG002|Double-Masked Phase|Protocol Violation|0|||
161680191|NCT01428661|583881522|FG000|Double-Masked Phase|Adverse Event|13|||
161680192|NCT01428661|583881523|FG001|Double-Masked Phase|Adverse Event|4|||
161680193|NCT01428661|583881524|FG002|Double-Masked Phase|Adverse Event|0|||
161680194|NCT01428661|583881522|FG000|Double-Masked Phase|Lost to Follow-up|14|||
161680195|NCT01428661|583881523|FG001|Double-Masked Phase|Lost to Follow-up|14|||
161680196|NCT01428661|583881524|FG002|Double-Masked Phase|Lost to Follow-up|0|||
161680197|NCT01428661|583881522|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
161680198|NCT01428661|583881523|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
161680199|NCT01428661|583881524|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
161680200|NCT01428661|583881522|FG000|Double-Masked Phase|Lack of Efficacy|2|||
161680201|NCT01428661|583881523|FG001|Double-Masked Phase|Lack of Efficacy|1|||
161680202|NCT01428661|583881524|FG002|Double-Masked Phase|Lack of Efficacy|0|||
161680203|NCT01428661|583881522|FG000|Double-Masked Phase|*Various|1|||
161680204|NCT01428661|583881523|FG001|Double-Masked Phase|*Various|6|||
161680205|NCT01428661|583881524|FG002|Double-Masked Phase|*Various|0|||
161680206|NCT01428661|583881522|FG000|Open Label Extension|Protocol Violation|0|||
161680207|NCT01428661|583881523|FG001|Open Label Extension|Protocol Violation|0|||
161680208|NCT01428661|583881524|FG002|Open Label Extension|Protocol Violation|9|||
161680209|NCT01428661|583881522|FG000|Open Label Extension|Adverse Event|0|||
161680210|NCT01428661|583881523|FG001|Open Label Extension|Adverse Event|0|||
161680211|NCT01428661|583881524|FG002|Open Label Extension|Adverse Event|15|||
161680212|NCT01428661|583881522|FG000|Open Label Extension|Lost to Follow-up|0|||
161680213|NCT01428661|583881523|FG001|Open Label Extension|Lost to Follow-up|0|||
161940531|NCT00815633|584832130|FG000|Overall Study|study terminated|1|||
161940532|NCT01362790|584832131|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
162024583|NCT01065454|585146535|FG001|Treatment|Non-compliance|0|||
162024584|NCT01065454|585146536|FG002|Treatment|Non-compliance|0|||
162024585|NCT01065454|585146537|FG003|Treatment|Non-compliance|1|||
162024586|NCT01065454|585146534|FG000|Treatment|Protocol Decision|0|||
162024587|NCT01065454|585146535|FG001|Treatment|Protocol Decision|0|||
162024588|NCT01065454|585146536|FG002|Treatment|Protocol Decision|3|||
162024589|NCT01065454|585146537|FG003|Treatment|Protocol Decision|2|||
162024590|NCT01065454|585146534|FG000|Treatment|Protocol Violation|1|||
162024591|NCT01065454|585146535|FG001|Treatment|Protocol Violation|0|||
162024592|NCT01065454|585146536|FG002|Treatment|Protocol Violation|1|||
162024593|NCT01065454|585146537|FG003|Treatment|Protocol Violation|0|||
162024594|NCT01065454|585146534|FG000|Treatment|Withdrawal by Subject|3|||
162024595|NCT01065454|585146535|FG001|Treatment|Withdrawal by Subject|1|||
162024596|NCT01065454|585146536|FG002|Treatment|Withdrawal by Subject|2|||
161680214|NCT01428661|583881524|FG002|Open Label Extension|Lost to Follow-up|38|||
161680215|NCT01428661|583881522|FG000|Open Label Extension|Withdrawal by Subject|0|||
161680216|NCT01428661|583881523|FG001|Open Label Extension|Withdrawal by Subject|0|||
161680217|NCT01428661|583881524|FG002|Open Label Extension|Withdrawal by Subject|49|||
161680218|NCT01428661|583881522|FG000|Open Label Extension|Lack of Efficacy|0|||
161680219|NCT01428661|583881523|FG001|Open Label Extension|Lack of Efficacy|0|||
161680220|NCT01428661|583881524|FG002|Open Label Extension|Lack of Efficacy|24|||
162024597|NCT01065454|585146537|FG003|Treatment|Withdrawal by Subject|3|||
162231389|NCT01934790|585895443|FG000|Active Follow up|Death|20|||
162231390|NCT01934790|585895443|FG000|Active Follow up|Physician Decision|2|||
162231391|NCT01934790|585895443|FG000|Active Follow up|Progressive disease|1|||
162231392|NCT01934790|585895443|FG000|Active Follow up|Other reason|1|||
162231393|NCT00552929|585895446|FG000|Overall Study|Lost to Follow-up|0|||
162231394|NCT00552929|585895447|FG001|Overall Study|Lost to Follow-up|0|||
162231395|NCT00552929|585895448|FG002|Overall Study|Lost to Follow-up|0|||
162231396|NCT00552929|585895449|FG003|Overall Study|Lost to Follow-up|0|||
162231397|NCT00552929|585895450|FG004|Overall Study|Lost to Follow-up|0|||
162231398|NCT00552929|585895451|FG005|Overall Study|Lost to Follow-up|0|||
162231399|NCT00552929|585895452|FG006|Overall Study|Lost to Follow-up|0|||
162231400|NCT00552929|585895453|FG007|Overall Study|Lost to Follow-up|0|||
162231401|NCT00552929|585895454|FG008|Overall Study|Lost to Follow-up|1|||
162231402|NCT00552929|585895455|FG009|Overall Study|Lost to Follow-up|0|||
162231403|NCT00552929|585895446|FG000|Overall Study|Not Eligible|0|||
162231404|NCT00552929|585895447|FG001|Overall Study|Not Eligible|0|||
162231405|NCT00552929|585895448|FG002|Overall Study|Not Eligible|0|||
162231406|NCT00552929|585895449|FG003|Overall Study|Not Eligible|0|||
162231407|NCT00552929|585895450|FG004|Overall Study|Not Eligible|0|||
161680221|NCT01428661|583881522|FG000|Open Label Extension|**Various|0|||
161680222|NCT01428661|583881523|FG001|Open Label Extension|**Various|0|||
162231408|NCT00552929|585895451|FG005|Overall Study|Not Eligible|1|||
162231409|NCT00552929|585895452|FG006|Overall Study|Not Eligible|0|||
162231410|NCT00552929|585895453|FG007|Overall Study|Not Eligible|0|||
162231411|NCT00552929|585895454|FG008|Overall Study|Not Eligible|0|||
162024598|NCT01065454|585146534|FG000|Follow up|Adverse Event|1|||
162024599|NCT01065454|585146535|FG001|Follow up|Adverse Event|0|||
162024600|NCT01065454|585146536|FG002|Follow up|Adverse Event|0|||
162024601|NCT01065454|585146537|FG003|Follow up|Adverse Event|1|||
162231412|NCT00552929|585895455|FG009|Overall Study|Not Eligible|0|||
161829865|NCT01546142|584418016|FG001|Overall Study|Subject Noncompliance|1|||
162231413|NCT01758900|585895458|FG000|Overall Study|difficulty for further intubation|7|||
162231414|NCT01758900|585895459|FG001|Overall Study|difficulty for further intubation|8|||
162231415|NCT04577001|585895460|FG000|Overall Study|Subject became ineligible|0|||
162231416|NCT04577001|585895461|FG001|Overall Study|Subject became ineligible|1|||
162231417|NCT00734097|585897521|FG000|Screening|Protocol Violation|12|||
162231418|NCT00734097|585897521|FG000|Screening|Withdrawal by Subject|5|||
162231419|NCT00734097|585897521|FG000|Screening|Lost to Follow-up|2|||
162231420|NCT00734097|585897521|FG000|Screening|Unconfirmed pregnancy|1|||
162231421|NCT00734097|585897521|FG000|Open Label|Lost to Follow-up|7|||
162231422|NCT00734097|585897521|FG000|Open Label|Withdrawal by Subject|5|||
162231423|NCT00734097|585897521|FG000|Open Label|Protocol Violation|4|||
162231424|NCT02233543|585897524|FG000|Period 1|Withdrawal by Subject|1|||
162231425|NCT02233543|585897525|FG001|Period 1|Withdrawal by Subject|0|||
162231426|NCT02233543|585897524|FG000|Period 1|Participants required other treatment.|2|||
162231427|NCT02233543|585897525|FG001|Period 1|Participants required other treatment.|3|||
162231428|NCT02233543|585897524|FG000|Period 2|Adverse Event|1|||
162231429|NCT02233543|585897525|FG001|Period 2|Adverse Event|0|||
162231430|NCT02233543|585897524|FG000|Period 2|Participant required other treatment.|0|||
162231431|NCT02233543|585897525|FG001|Period 2|Participant required other treatment.|1|||
162231432|NCT02233543|585897524|FG000|Period 2|COPD exacerbation|1|||
162231433|NCT02233543|585897525|FG001|Period 2|COPD exacerbation|0|||
162231434|NCT01302067|585897526|FG000|Overall Study|Death|0|||
162231435|NCT01302067|585897527|FG001|Overall Study|Death|0|||
162231436|NCT01302067|585897528|FG002|Overall Study|Death|1|||
162231437|NCT01302067|585897526|FG000|Overall Study|Physician Decision|9|||
162231438|NCT01302067|585897527|FG001|Overall Study|Physician Decision|5|||
162231439|NCT01302067|585897528|FG002|Overall Study|Physician Decision|14|||
162231440|NCT01302067|585897526|FG000|Overall Study|Lack of Efficacy|8|||
162231441|NCT01302067|585897527|FG001|Overall Study|Lack of Efficacy|4|||
162231442|NCT01302067|585897528|FG002|Overall Study|Lack of Efficacy|2|||
162231443|NCT01302067|585897526|FG000|Overall Study|Lost to Follow-up|9|||
162231444|NCT01302067|585897527|FG001|Overall Study|Lost to Follow-up|4|||
162231445|NCT01302067|585897528|FG002|Overall Study|Lost to Follow-up|15|||
162231446|NCT01302067|585897526|FG000|Overall Study|Withdrawal by Subject|13|||
162231447|NCT01302067|585897527|FG001|Overall Study|Withdrawal by Subject|6|||
162231448|NCT01302067|585897528|FG002|Overall Study|Withdrawal by Subject|10|||
162231449|NCT01302067|585897526|FG000|Overall Study|Other|1|||
162231450|NCT01302067|585897527|FG001|Overall Study|Other|1|||
162231451|NCT01302067|585897528|FG002|Overall Study|Other|3|||
162231452|NCT01302067|585897526|FG000|Overall Study|Protocol Violation|11|||
162231453|NCT01302067|585897527|FG001|Overall Study|Protocol Violation|0|||
162231454|NCT01302067|585897528|FG002|Overall Study|Protocol Violation|8|||
162231455|NCT01302067|585897526|FG000|Overall Study|Adverse Event|27|||
162231456|NCT01302067|585897527|FG001|Overall Study|Adverse Event|14|||
162231457|NCT01302067|585897528|FG002|Overall Study|Adverse Event|45|||
162231458|NCT02924428|585897529|FG000|Overall Study|Adverse Event|1|||
162231459|NCT02924428|585897530|FG001|Overall Study|Adverse Event|0|||
162231460|NCT02924428|585897529|FG000|Overall Study|Physician Decision|1|||
162231461|NCT02924428|585897530|FG001|Overall Study|Physician Decision|0|||
162024602|NCT01065454|585146534|FG000|Follow up|Death|0|||
162231462|NCT02924428|585897529|FG000|Overall Study|Lost to Follow-up|2|||
162231463|NCT02924428|585897530|FG001|Overall Study|Lost to Follow-up|4|||
162231464|NCT02924428|585897529|FG000|Overall Study|Pregnancy|0|||
162231465|NCT02924428|585897530|FG001|Overall Study|Pregnancy|1|||
162231466|NCT02480153|585897531|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
162231467|NCT02480153|585897532|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
162231468|NCT02480153|585897533|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
162231469|NCT02480153|585897531|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
162231470|NCT02480153|585897532|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
162231471|NCT02480153|585897533|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
162231472|NCT02480153|585897531|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
162231473|NCT02480153|585897532|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
162231474|NCT02480153|585897533|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
162231475|NCT02480153|585897531|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
161829866|NCT01546142|584418015|FG000|Overall Study|Adverse Event|6|||
161829867|NCT01546142|584418016|FG001|Overall Study|Adverse Event|3|||
161829868|NCT01546142|584418015|FG000|Overall Study|Lost to Follow-up|20|||
162231476|NCT02480153|585897532|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
162231477|NCT02480153|585897533|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
162231478|NCT02480153|585897531|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
162231479|NCT02480153|585897532|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
162231480|NCT02480153|585897533|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
162231481|NCT02480153|585897531|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
162231482|NCT02480153|585897532|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
162231483|NCT02480153|585897533|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
162231484|NCT02480153|585897531|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
162231485|NCT02480153|585897532|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
162231486|NCT02480153|585897533|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
161829869|NCT01546142|584418016|FG001|Overall Study|Lost to Follow-up|15|||
161829870|NCT01546142|584418015|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
161829871|NCT01546142|584418016|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
161829872|NCT01546142|584418015|FG000|Overall Study|Subject Randomized but Not Treated|1|||
161829873|NCT01546142|584418016|FG001|Overall Study|Subject Randomized but Not Treated|0|||
161829874|NCT01213836|584418017|FG000|Period 1, First Intervention|Adverse Event|2|||
161829875|NCT01213836|584418018|FG001|Period 1, First Intervention|Adverse Event|1|||
161829876|NCT01213836|584418017|FG000|Period 1, First Intervention|Protocol Violation|0|||
161829877|NCT01213836|584418018|FG001|Period 1, First Intervention|Protocol Violation|1|||
161829878|NCT01213836|584418017|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
161829879|NCT01213836|584418018|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
161829880|NCT01470417|584418019|FG000|Overall Study|Disease progression|0|||
161829881|NCT01470417|584418020|FG001|Overall Study|Disease progression|2|||
161829882|NCT02973321|584418021|FG000|Overall Study|Other than specified|0|||
161829883|NCT02973321|584418022|FG001|Overall Study|Other than specified|5|||
161829884|NCT02973321|584418023|FG002|Overall Study|Other than specified|3|||
161829885|NCT02973321|584418024|FG003|Overall Study|Other than specified|3|||
161829886|NCT02973321|584418025|FG004|Overall Study|Other than specified|1|||
161829887|NCT02973321|584418021|FG000|Overall Study|Lack of Efficacy|0|||
161829888|NCT02973321|584418022|FG001|Overall Study|Lack of Efficacy|0|||
161829889|NCT02973321|584418023|FG002|Overall Study|Lack of Efficacy|0|||
161829890|NCT02973321|584418024|FG003|Overall Study|Lack of Efficacy|0|||
161829891|NCT02973321|584418025|FG004|Overall Study|Lack of Efficacy|1|||
161829892|NCT02973321|584418021|FG000|Overall Study|Adverse Event|1|||
161829893|NCT02973321|584418022|FG001|Overall Study|Adverse Event|10|||
161829894|NCT02973321|584418023|FG002|Overall Study|Adverse Event|11|||
161829895|NCT02973321|584418024|FG003|Overall Study|Adverse Event|13|||
161829896|NCT02973321|584418025|FG004|Overall Study|Adverse Event|3|||
161829897|NCT01355302|584418029|FG000|Phase 1b|Death|4|||
161829898|NCT01355302|584418030|FG001|Phase 1b|Death|0|||
161829899|NCT01355302|584418031|FG002|Phase 1b|Death|0|||
161829900|NCT01355302|584418029|FG000|Phase 1b|Study terminated by sponsor|2|||
161940533|NCT01362790|584832132|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
161940534|NCT01362790|584832133|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
161829901|NCT01355302|584418030|FG001|Phase 1b|Study terminated by sponsor|0|||
161829902|NCT01355302|584418031|FG002|Phase 1b|Study terminated by sponsor|0|||
161829903|NCT00263887|584418032|FG000|Overall Study|Withdrawal by Subject|1|||
161829904|NCT00263887|584418033|FG001|Overall Study|Withdrawal by Subject|1|||
161829905|NCT00263887|584418032|FG000|Overall Study|Lung transplantation|1|||
161829906|NCT00263887|584418033|FG001|Overall Study|Lung transplantation|2|||
161829907|NCT00263887|584418032|FG000|Overall Study|Too ill to attend visit|1|||
161829908|NCT00263887|584418033|FG001|Overall Study|Too ill to attend visit|0|||
162231487|NCT02480153|585897531|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
162231488|NCT02480153|585897532|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
162231489|NCT02480153|585897533|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
162231490|NCT02480153|585897531|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
162231491|NCT02480153|585897532|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
162231492|NCT02480153|585897533|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
162231493|NCT02480153|585897531|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
162231494|NCT02480153|585897532|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
162231495|NCT02480153|585897533|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
162231496|NCT02480153|585897531|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
162231497|NCT02480153|585897532|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
162231498|NCT02480153|585897533|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
162231499|NCT02480153|585897531|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
162231500|NCT02480153|585897532|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
162231501|NCT02480153|585897533|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
162231502|NCT02480153|585897531|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
162231503|NCT02480153|585897532|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
162231504|NCT02480153|585897533|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
161940535|NCT01362790|584832134|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
161940536|NCT01362790|584832135|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
161940537|NCT01362790|584832136|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
161940538|NCT01362790|584832137|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
161940539|NCT01362790|584832131|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
161940540|NCT01362790|584832132|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
161940541|NCT01362790|584832133|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
161940542|NCT01362790|584832134|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
161940543|NCT01362790|584832135|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
161940544|NCT01362790|584832136|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
161940545|NCT01362790|584832137|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
161940546|NCT01362790|584832131|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
161940547|NCT01362790|584832132|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
161940548|NCT01362790|584832133|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
161940549|NCT01362790|584832134|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
161940550|NCT01362790|584832135|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
161940551|NCT01362790|584832136|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
161940552|NCT01362790|584832137|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
161940553|NCT01362790|584832131|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
161940554|NCT01362790|584832132|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
161940555|NCT01362790|584832133|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
161940556|NCT01362790|584832134|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
161940557|NCT01362790|584832135|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
161940558|NCT01362790|584832136|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
161940559|NCT01362790|584832137|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
161940560|NCT01362790|584832131|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
161940561|NCT01362790|584832132|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
161940562|NCT01362790|584832133|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
161940563|NCT01362790|584832134|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
161940564|NCT01362790|584832135|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
161940565|NCT01362790|584832136|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
161940566|NCT01362790|584832137|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
161940567|NCT01362790|584832131|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
161940568|NCT01362790|584832132|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
161940569|NCT01362790|584832133|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
161940570|NCT01362790|584832134|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
161940571|NCT01362790|584832135|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
161940572|NCT01362790|584832136|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
161940573|NCT01362790|584832137|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
161940574|NCT01362790|584832131|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
162024603|NCT01065454|585146535|FG001|Follow up|Death|1|||
161940575|NCT01362790|584832132|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
161940576|NCT01362790|584832133|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
161940577|NCT01362790|584832134|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
161940578|NCT01362790|584832135|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
161940579|NCT01362790|584832136|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
161940580|NCT01362790|584832137|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
161940581|NCT01362790|584832131|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
161940582|NCT01362790|584832132|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
161940583|NCT01362790|584832133|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
162231505|NCT02480153|585897531|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
162231506|NCT02480153|585897532|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
162231507|NCT02480153|585897533|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
162231508|NCT02480153|585897531|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
162231509|NCT02480153|585897532|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
162231510|NCT02480153|585897533|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
162231511|NCT02480153|585897531|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
162231512|NCT02480153|585897532|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
162231513|NCT02480153|585897533|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
162231514|NCT02480153|585897531|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
162231515|NCT02480153|585897532|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
162231516|NCT02480153|585897533|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
162231517|NCT02480153|585897531|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
161940584|NCT01362790|584832134|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
161940585|NCT01362790|584832135|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
161940586|NCT01362790|584832136|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
161940587|NCT01362790|584832137|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
161940588|NCT01362790|584832131|FG000|Pilot Phase & Phase 2|Death on study|0|||
161940589|NCT01362790|584832132|FG001|Pilot Phase & Phase 2|Death on study|0|||
161940590|NCT01362790|584832133|FG002|Pilot Phase & Phase 2|Death on study|0|||
161940591|NCT01362790|584832134|FG003|Pilot Phase & Phase 2|Death on study|1|||
161940592|NCT01362790|584832135|FG004|Pilot Phase & Phase 2|Death on study|0|||
161940593|NCT01362790|584832136|FG005|Pilot Phase & Phase 2|Death on study|0|||
161940594|NCT01362790|584832137|FG006|Pilot Phase & Phase 2|Death on study|0|||
161940595|NCT01362790|584832131|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
161940596|NCT01362790|584832132|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
161940597|NCT01362790|584832133|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
161940598|NCT01362790|584832134|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
161940599|NCT01362790|584832135|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
161940600|NCT01362790|584832136|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
161940601|NCT01362790|584832137|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
161940602|NCT01362790|584832131|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
161940603|NCT01362790|584832132|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
161940604|NCT01362790|584832133|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
161940605|NCT01362790|584832134|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
161940606|NCT01362790|584832135|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
161940607|NCT01362790|584832136|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
161940608|NCT01362790|584832137|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
161940609|NCT01362790|584832131|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
161940610|NCT01362790|584832132|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
161940611|NCT01362790|584832133|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
161940612|NCT01362790|584832134|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
161940613|NCT01362790|584832135|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
161940614|NCT01362790|584832136|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
162231518|NCT02480153|585897532|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
162231519|NCT02480153|585897533|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
162231520|NCT03241225|585897537|FG000|Overall Study|Lost to Follow-up|2|||
162231521|NCT03241225|585897538|FG001|Overall Study|Lost to Follow-up|1|||
162231522|NCT03241225|585897537|FG000|Overall Study|Protocol Violation|4|||
162231523|NCT03241225|585897538|FG001|Overall Study|Protocol Violation|1|||
162231524|NCT03241225|585897537|FG000|Overall Study|Withdrawal by Subject|1|||
162231525|NCT03241225|585897538|FG001|Overall Study|Withdrawal by Subject|0|||
162231526|NCT00852540|585897539|FG000|Overall Study|Adverse Event|10|||
162231527|NCT00852540|585897540|FG001|Overall Study|Adverse Event|3|||
162231528|NCT00852540|585897539|FG000|Overall Study|Lack of Efficacy|15|||
162231529|NCT00852540|585897540|FG001|Overall Study|Lack of Efficacy|3|||
162231530|NCT00852540|585897539|FG000|Overall Study|Protocol Violation|1|||
162231531|NCT00852540|585897540|FG001|Overall Study|Protocol Violation|2|||
162231532|NCT00852540|585897539|FG000|Overall Study|Lost to Follow-up|2|||
162231533|NCT00852540|585897540|FG001|Overall Study|Lost to Follow-up|3|||
162231534|NCT00852540|585897539|FG000|Overall Study|Investigator Discretion|2|||
162231535|NCT00852540|585897540|FG001|Overall Study|Investigator Discretion|3|||
162231536|NCT00852540|585897539|FG000|Overall Study|Withdrawal by Subject|3|||
162231537|NCT00852540|585897540|FG001|Overall Study|Withdrawal by Subject|1|||
162231538|NCT00852540|585897539|FG000|Overall Study|Did Not Receive Study Drug|3|||
162231539|NCT00852540|585897540|FG001|Overall Study|Did Not Receive Study Drug|3|||
161940615|NCT01362790|584832137|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
161940616|NCT03485157|584832138|FG000|Double Blind Phase|Lost to Follow-up|4|||
161940617|NCT03485157|584832139|FG001|Double Blind Phase|Lost to Follow-up|4|||
162231540|NCT04875676|585897550|FG000|Overall Study|Lost to Follow-up|1|||
162231541|NCT04875676|585897551|FG001|Overall Study|Lost to Follow-up|0|||
162231542|NCT04875676|585897552|FG002|Overall Study|Lost to Follow-up|0|||
162231543|NCT03064035|585897553|FG000|Overall Study|Did not receive allocated intervention|4|||
162231544|NCT03064035|585897554|FG001|Overall Study|Did not receive allocated intervention|2|||
162231545|NCT03064035|585897553|FG000|Overall Study|Lost to Follow-up|1|||
161829909|NCT00263887|584418032|FG000|Overall Study|Adverse Event|0|||
161829910|NCT00263887|584418033|FG001|Overall Study|Adverse Event|2|||
161680223|NCT01428661|583881524|FG002|Open Label Extension|**Various|185|||
161829911|NCT00263887|584418032|FG000|Overall Study|Disease progression|0|||
161829912|NCT00263887|584418033|FG001|Overall Study|Disease progression|1|||
161829913|NCT00263887|584418032|FG000|Overall Study|Lack of Efficacy|0|||
161829914|NCT00263887|584418033|FG001|Overall Study|Lack of Efficacy|1|||
161829915|NCT02274948|584418036|FG000|Overall Study|Lost to Follow-up|28|||
161829916|NCT02274948|584418037|FG001|Overall Study|Lost to Follow-up|25|||
161829917|NCT02274948|584418036|FG000|Overall Study|Withdrawal by Subject|64|||
161829918|NCT02274948|584418037|FG001|Overall Study|Withdrawal by Subject|58|||
161829919|NCT02274948|584418036|FG000|Overall Study|Stopped on family Practitioner advice|2|||
161829920|NCT02274948|584418037|FG001|Overall Study|Stopped on family Practitioner advice|5|||
161829921|NCT02274948|584418036|FG000|Overall Study|Left the area|4|||
161829922|NCT02274948|584418037|FG001|Overall Study|Left the area|3|||
161829923|NCT00707434|584418038|FG000|Overall Study|Adverse Event|1|||
161829924|NCT05212883|584418039|FG000|Overall Study|Invalid test result|125|||
161829925|NCT02502734|584418040|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
161829926|NCT02502734|584418041|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
161829927|NCT02502734|584418040|FG000|Washout Period|Adverse Event|1|||
161829928|NCT02502734|584418041|FG001|Washout Period|Adverse Event|0|||
161829929|NCT00614822|584418042|FG000|Overall Study|Adverse Event|3|||
161829930|NCT00865514|584418051|FG000|Overall Study|Infusion cost exceeded funding|2|||
161829931|NCT03649412|584418052|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
161829932|NCT03649412|584418053|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
161829933|NCT03649412|584418052|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
161829934|NCT03649412|584418053|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
161829935|NCT03649412|584418052|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
161829936|NCT03649412|584418053|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161829937|NCT03649412|584418052|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
161829938|NCT03649412|584418053|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
161829939|NCT03649412|584418052|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
161829940|NCT03649412|584418053|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
161829941|NCT03649412|584418052|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
161829942|NCT03649412|584418053|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
161829943|NCT03095118|584418054|FG000|Overall Study|Adverse Event|1|||
161829944|NCT03095118|584418054|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
161829945|NCT02865395|584418055|FG000|Overall Study|Physician Decision|6|||
161829946|NCT02865395|584418056|FG001|Overall Study|Physician Decision|10|||
161829947|NCT02865395|584418057|FG002|Overall Study|Physician Decision|7|||
161829948|NCT00530348|584418058|FG000|Overall Study|Adverse Event|5|||
161829949|NCT00530348|584418059|FG001|Overall Study|Adverse Event|1|||
161829950|NCT00530348|584418058|FG000|Overall Study|Death|0|||
161829951|NCT00530348|584418059|FG001|Overall Study|Death|1|||
161829952|NCT00530348|584418058|FG000|Overall Study|Lack of Efficacy|2|||
161829953|NCT00530348|584418059|FG001|Overall Study|Lack of Efficacy|0|||
161829954|NCT00530348|584418058|FG000|Overall Study|Lost to Follow-up|0|||
161829955|NCT00530348|584418059|FG001|Overall Study|Lost to Follow-up|2|||
161829956|NCT00530348|584418058|FG000|Overall Study|Physician Decision|1|||
161829957|NCT00530348|584418059|FG001|Overall Study|Physician Decision|2|||
161829958|NCT00530348|584418058|FG000|Overall Study|Pregnancy|1|||
161829959|NCT00530348|584418059|FG001|Overall Study|Pregnancy|0|||
161829960|NCT00530348|584418058|FG000|Overall Study|Withdrawal by Subject|12|||
161829961|NCT00530348|584418059|FG001|Overall Study|Withdrawal by Subject|12|||
161829962|NCT00530348|584418058|FG000|Overall Study|Randomised in error|1|||
161829963|NCT00530348|584418059|FG001|Overall Study|Randomised in error|0|||
161829964|NCT00530348|584418058|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
161829965|NCT00530348|584418059|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
161829966|NCT04364763|584418060|FG000|Overall Study|Death|1|||
161829967|NCT04364763|584418061|FG001|Overall Study|Death|2|||
161829968|NCT04364763|584418060|FG000|Overall Study|Lost to Follow-up|1|||
161829969|NCT04364763|584418061|FG001|Overall Study|Lost to Follow-up|0|||
161829970|NCT01256060|584418063|FG000|Overall Study|Lost to Follow-up|0|||
161829971|NCT01256060|584418064|FG001|Overall Study|Lost to Follow-up|1|||
161829972|NCT01256060|584418065|FG002|Overall Study|Lost to Follow-up|0|||
161829973|NCT01256060|584418066|FG003|Overall Study|Lost to Follow-up|0|||
161829974|NCT00985231|584418069|FG000|Overall Study|ineligible|1|||
161829975|NCT00985231|584418070|FG001|Overall Study|ineligible|0|||
161829976|NCT00985231|584418069|FG000|Overall Study|Protocol Violation|1|||
161829977|NCT00985231|584418070|FG001|Overall Study|Protocol Violation|0|||
161829978|NCT00985231|584418069|FG000|Overall Study|Withdrawal by Subject|1|||
162024604|NCT01065454|585146536|FG002|Follow up|Death|1|||
162024605|NCT01065454|585146537|FG003|Follow up|Death|0|||
162024606|NCT01065454|585146534|FG000|Follow up|Lost to Follow-up|0|||
162024607|NCT01065454|585146535|FG001|Follow up|Lost to Follow-up|0|||
162024608|NCT01065454|585146536|FG002|Follow up|Lost to Follow-up|0|||
162024609|NCT01065454|585146537|FG003|Follow up|Lost to Follow-up|1|||
162024610|NCT01065454|585146534|FG000|Follow up|Progressive disease|0|||
162231546|NCT03064035|585897554|FG001|Overall Study|Lost to Follow-up|1|||
162231547|NCT03103763|585897557|FG000|Overall Study|Death|15|||
162231548|NCT03103763|585897558|FG001|Overall Study|Death|5|||
162231549|NCT03103763|585897559|FG002|Overall Study|Death|5|||
162024611|NCT01065454|585146535|FG001|Follow up|Progressive disease|0|||
162024612|NCT01065454|585146536|FG002|Follow up|Progressive disease|0|||
162024613|NCT01065454|585146537|FG003|Follow up|Progressive disease|1|||
162024614|NCT01065454|585146534|FG000|Follow up|Withdrawal by Subject|1|||
162024615|NCT01065454|585146535|FG001|Follow up|Withdrawal by Subject|1|||
162024616|NCT01065454|585146536|FG002|Follow up|Withdrawal by Subject|1|||
162231550|NCT03103763|585897557|FG000|Overall Study|Withdrawal by Subject|0|||
162231551|NCT03103763|585897558|FG001|Overall Study|Withdrawal by Subject|3|||
162231552|NCT03103763|585897559|FG002|Overall Study|Withdrawal by Subject|2|||
162231553|NCT02336178|585897560|FG000|Overall Study|Lost to Follow-up|1|||
162231554|NCT02336178|585897560|FG000|Overall Study|Protocol Violation|1|||
162231555|NCT02336178|585897560|FG000|Overall Study|Withdrawal by Subject|1|||
162231556|NCT02336178|585897560|FG000|Overall Study|Other|1|||
162231557|NCT03245151|585897561|FG000|Overall Study|Withdrawal by Subject|2|||
162231558|NCT03245151|585897562|FG001|Overall Study|Withdrawal by Subject|0|||
162231559|NCT03245151|585897563|FG002|Overall Study|Withdrawal by Subject|0|||
162231560|NCT03245151|585897564|FG003|Overall Study|Withdrawal by Subject|2|||
162231561|NCT03245151|585897565|FG004|Overall Study|Withdrawal by Subject|1|||
162231562|NCT03245151|585897561|FG000|Overall Study|Death|3|||
162231563|NCT03245151|585897562|FG001|Overall Study|Death|14|||
162231564|NCT03245151|585897563|FG002|Overall Study|Death|9|||
162231565|NCT03245151|585897564|FG003|Overall Study|Death|16|||
162231566|NCT03245151|585897565|FG004|Overall Study|Death|7|||
162024617|NCT01065454|585146537|FG003|Follow up|Withdrawal by Subject|0|||
162024618|NCT01065454|585146534|FG000|Follow up|study ongoing|37|||
162024619|NCT01065454|585146535|FG001|Follow up|study ongoing|22|||
162024620|NCT01065454|585146536|FG002|Follow up|study ongoing|15|||
162231567|NCT03245151|585897561|FG000|Overall Study|Sponsor's decision|0|||
162231568|NCT03245151|585897562|FG001|Overall Study|Sponsor's decision|1|||
162231569|NCT03245151|585897563|FG002|Overall Study|Sponsor's decision|0|||
162231570|NCT03245151|585897564|FG003|Overall Study|Sponsor's decision|0|||
162231571|NCT03245151|585897565|FG004|Overall Study|Sponsor's decision|0|||
162231572|NCT01970345|585897566|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
162231573|NCT01970345|585897567|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
162231574|NCT01970345|585897566|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
161680224|NCT03828292|583881525|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161680225|NCT03828292|583881526|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
161680226|NCT03828292|583881527|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161680227|NCT03828292|583881528|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161680228|NCT03828292|583881529|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161680229|NCT03828292|583881530|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161680230|NCT03828292|583881525|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161680231|NCT03828292|583881526|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161680232|NCT03828292|583881527|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
161680233|NCT03828292|583881528|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161680234|NCT03828292|583881529|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161680235|NCT03828292|583881530|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161680236|NCT03828292|583881525|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
162024621|NCT01065454|585146537|FG003|Follow up|study ongoing|41|||
162024622|NCT03374202|585146538|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
162024623|NCT03374202|585146539|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
162024624|NCT03374202|585146540|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
162024625|NCT03374202|585146538|FG000|Five Year Long Term Follow Up|Death|0|||
162024626|NCT03374202|585146539|FG001|Five Year Long Term Follow Up|Death|1|||
162231575|NCT01970345|585897567|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
162231576|NCT01346475|585897568|FG000|First Intervention|Lost to Follow-up|4|||
162024627|NCT03374202|585146540|FG002|Five Year Long Term Follow Up|Death|0|||
162024628|NCT01948193|585148667|FG000|Overall Study|Serious event|2|||
162024629|NCT01948193|585148667|FG000|Overall Study|Lost to Follow-up|7|||
162024630|NCT01325337|585148668|FG000|Overall Study|Adverse Event|0|||
162024631|NCT01325337|585148669|FG001|Overall Study|Adverse Event|2|||
162231577|NCT01346475|585897569|FG001|First Intervention|Lost to Follow-up|3|||
162231578|NCT00621777|585897570|FG000|Open Phase|Adverse Event|20|||
162231579|NCT00621777|585897571|FG001|Open Phase|Adverse Event|0|||
162231580|NCT00621777|585897570|FG000|Open Phase|Did not abstain during open phase|56|||
162231581|NCT00621777|585897571|FG001|Open Phase|Did not abstain during open phase|0|||
162231582|NCT00621777|585897570|FG000|Open Phase|Withdrawal by Subject|17|||
162231583|NCT00621777|585897571|FG001|Open Phase|Withdrawal by Subject|0|||
162231584|NCT00621777|585897570|FG000|Open Phase|administrative|13|||
162231585|NCT00621777|585897571|FG001|Open Phase|administrative|0|||
162231586|NCT00621777|585897570|FG000|Open Phase|Lost to Follow-up|10|||
161680237|NCT03828292|583881526|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161680238|NCT03828292|583881527|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161680239|NCT03828292|583881528|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
161680240|NCT03828292|583881529|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161680241|NCT03828292|583881530|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161680242|NCT03828292|583881525|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161680243|NCT03828292|583881526|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161680244|NCT03828292|583881527|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161680245|NCT03828292|583881528|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
161680246|NCT03828292|583881529|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161680247|NCT03828292|583881530|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161680248|NCT03828292|583881525|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
161680249|NCT03828292|583881526|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
161680250|NCT03828292|583881527|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
161680251|NCT03828292|583881528|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
161680252|NCT03828292|583881529|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
161680253|NCT03828292|583881530|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
161680254|NCT04376827|583881531|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
161680255|NCT04376827|583881532|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
161680256|NCT04376827|583881531|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
161680257|NCT04376827|583881532|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
161680258|NCT04376827|583881531|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
161680259|NCT04376827|583881532|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
161680260|NCT04376827|583881531|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
161680261|NCT04376827|583881532|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
161680262|NCT04376827|583881531|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
161680263|NCT04376827|583881532|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
161680264|NCT00346073|583882868|FG000|Overall Study|Serious Adverse Event|2|||
161680265|NCT00346073|583882869|FG001|Overall Study|Serious Adverse Event|0|||
161680266|NCT00346073|583882868|FG000|Overall Study|Lost to Follow-up|39|||
161680267|NCT00346073|583882869|FG001|Overall Study|Lost to Follow-up|24|||
161680268|NCT00980200|583882871|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
161680269|NCT00980200|583882872|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
161680270|NCT00980200|583882873|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
161680271|NCT00980200|583882874|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
161680272|NCT00980200|583882875|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
161680273|NCT00980200|583882871|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
161680274|NCT00980200|583882872|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
161680275|NCT00980200|583882873|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
161680276|NCT00980200|583882874|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
161680277|NCT00980200|583882875|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
161680278|NCT01617460|583882876|FG000|Overall Study|Adverse Event|10|||
161680279|NCT01617460|583882876|FG000|Overall Study|Physician Decision|16|||
161680280|NCT01617460|583882876|FG000|Overall Study|Protocol Violation|5|||
161680281|NCT01617460|583882876|FG000|Overall Study|Withdrawal by Subject|9|||
161680282|NCT00915772|583882878|FG000|Overall Study|Adverse Event|12|||
161680283|NCT00915772|583882879|FG001|Overall Study|Adverse Event|13|||
161680284|NCT00915772|583882880|FG002|Overall Study|Adverse Event|11|||
161680285|NCT00915772|583882878|FG000|Overall Study|Protocol Violation|4|||
161680286|NCT00915772|583882879|FG001|Overall Study|Protocol Violation|1|||
161680287|NCT00915772|583882880|FG002|Overall Study|Protocol Violation|2|||
161680288|NCT00915772|583882878|FG000|Overall Study|Lost to Follow-up|1|||
161680289|NCT00915772|583882879|FG001|Overall Study|Lost to Follow-up|2|||
161680290|NCT00915772|583882880|FG002|Overall Study|Lost to Follow-up|2|||
161680291|NCT00915772|583882878|FG000|Overall Study|Lack of Efficacy|9|||
161680292|NCT00915772|583882879|FG001|Overall Study|Lack of Efficacy|15|||
162231587|NCT00621777|585897571|FG001|Open Phase|Lost to Follow-up|0|||
161680293|NCT00915772|583882880|FG002|Overall Study|Lack of Efficacy|3|||
161680294|NCT00915772|583882878|FG000|Overall Study|Refused to continue trial medication|6|||
161680295|NCT00915772|583882879|FG001|Overall Study|Refused to continue trial medication|8|||
161680296|NCT00915772|583882880|FG002|Overall Study|Refused to continue trial medication|4|||
162231588|NCT00621777|585897570|FG000|Randomized Phase|Adverse Event|3|||
162231589|NCT00621777|585897571|FG001|Randomized Phase|Adverse Event|3|||
162231590|NCT00621777|585897570|FG000|Randomized Phase|Lost to Follow-up|3|||
162231591|NCT00621777|585897571|FG001|Randomized Phase|Lost to Follow-up|3|||
162231592|NCT00621777|585897570|FG000|Randomized Phase|Withdrawal by Subject|1|||
162231593|NCT00621777|585897571|FG001|Randomized Phase|Withdrawal by Subject|9|||
162231594|NCT00621777|585897570|FG000|Randomized Phase|administrative|0|||
162231595|NCT00621777|585897571|FG001|Randomized Phase|administrative|3|||
162231596|NCT00621777|585897570|FG000|Randomized Phase|Death|0|||
162231597|NCT00621777|585897571|FG001|Randomized Phase|Death|1|||
162231598|NCT00558259|585897572|FG000|Overall Study|Adverse Event|50|||
162231599|NCT00558259|585897573|FG001|Overall Study|Adverse Event|81|||
162231600|NCT00558259|585897572|FG000|Overall Study|Protocol Violation|9|||
162231601|NCT00558259|585897573|FG001|Overall Study|Protocol Violation|5|||
162231602|NCT00558259|585897572|FG000|Overall Study|Withdrawal by Subject|12|||
162231603|NCT00558259|585897573|FG001|Overall Study|Withdrawal by Subject|13|||
162231604|NCT00700258|585897580|FG000|Overall Study|Premature discontinuation of documentation|136|||
162231605|NCT00700258|585897580|FG000|Overall Study|Type of study end not documented|1|||
162231606|NCT00700258|585897580|FG000|Overall Study|Lost to Follow-up|81|||
162231607|NCT00700258|585897580|FG000|Overall Study|Premature discontinuation of therapy|1013|||
162231608|NCT00473265|585897581|FG000|Overall Study|Unrelated adverse event|5|||
162231609|NCT00473265|585897581|FG000|Overall Study|Off treatment early|15|||
162231610|NCT02663518|585897584|FG000|Part 1: Phase 1a Escalation|Death|0|||
162231611|NCT02663518|585897585|FG001|Part 1: Phase 1a Escalation|Death|0|||
162231612|NCT02663518|585897586|FG002|Part 1: Phase 1a Escalation|Death|1|||
162231613|NCT02663518|585897587|FG003|Part 1: Phase 1a Escalation|Death|0|||
162231614|NCT02663518|585897588|FG004|Part 1: Phase 1a Escalation|Death|0|||
162231615|NCT02663518|585897589|FG005|Part 1: Phase 1a Escalation|Death|0|||
162231616|NCT02663518|585897590|FG006|Part 1: Phase 1a Escalation|Death|0|||
162231617|NCT02663518|585897591|FG007|Part 1: Phase 1a Escalation|Death|0|||
162231618|NCT02663518|585897592|FG008|Part 1: Phase 1a Escalation|Death|0|||
162231619|NCT02663518|585897593|FG009|Part 1: Phase 1a Escalation|Death|0|||
162231620|NCT02663518|585897594|FG010|Part 1: Phase 1a Escalation|Death|0|||
162231621|NCT02663518|585897595|FG011|Part 1: Phase 1a Escalation|Death|0|||
162231622|NCT02663518|585897596|FG012|Part 1: Phase 1a Escalation|Death|0|||
162231623|NCT02663518|585897597|FG013|Part 1: Phase 1a Escalation|Death|0|||
162231624|NCT02663518|585897584|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231625|NCT02663518|585897585|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231626|NCT02663518|585897586|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
162231627|NCT02663518|585897587|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231628|NCT02663518|585897588|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231629|NCT02663518|585897589|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231630|NCT02663518|585897590|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231631|NCT02663518|585897591|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231632|NCT02663518|585897592|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231633|NCT02663518|585897593|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231634|NCT02663518|585897594|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231635|NCT02663518|585897595|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231636|NCT02663518|585897596|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231637|NCT02663518|585897597|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
162231638|NCT02663518|585897584|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
162231639|NCT02663518|585897585|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
162231640|NCT02663518|585897586|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
162231641|NCT02663518|585897587|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
162231642|NCT02663518|585897588|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162231643|NCT02663518|585897589|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162231644|NCT02663518|585897590|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162231645|NCT02663518|585897591|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162231646|NCT02663518|585897592|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162231647|NCT02663518|585897593|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162231648|NCT02663518|585897594|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162231649|NCT02663518|585897595|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162231650|NCT02663518|585897596|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162231651|NCT02663518|585897597|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
162231652|NCT02663518|585897584|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
162231653|NCT02663518|585897585|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162231654|NCT02663518|585897586|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
162231655|NCT02663518|585897587|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
162231656|NCT02663518|585897588|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162231657|NCT02663518|585897589|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162231658|NCT02663518|585897590|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162231659|NCT02663518|585897591|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162231660|NCT02663518|585897592|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162231661|NCT02663518|585897593|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162231662|NCT02663518|585897594|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162231663|NCT02663518|585897595|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161680297|NCT00915772|583882878|FG000|Overall Study|Any other reason|4|||
161829979|NCT00985231|584418070|FG001|Overall Study|Withdrawal by Subject|0|||
161829980|NCT00985231|584418069|FG000|Overall Study|Lost to Follow-up|0|||
161829981|NCT00985231|584418070|FG001|Overall Study|Lost to Follow-up|1|||
161829982|NCT00985231|584418069|FG000|Overall Study|Study related symptoms & complaints|0|||
161829983|NCT00985231|584418070|FG001|Overall Study|Study related symptoms & complaints|2|||
162231664|NCT02663518|585897596|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161680298|NCT00915772|583882879|FG001|Overall Study|Any other reason|7|||
161680299|NCT00915772|583882880|FG002|Overall Study|Any other reason|7|||
161680300|NCT00294060|583882885|FG000|Overall Study|Death|225|||
161680301|NCT00294060|583882885|FG000|Overall Study|Other|59|||
161680302|NCT00294060|583882885|FG000|Overall Study|Lost to Follow-up|55|||
161680303|NCT00294060|583882885|FG000|Overall Study|Withdrawal by Subject|11|||
161680304|NCT00294060|583882885|FG000|Overall Study|Physician Decision|797|||
161680305|NCT00294060|583882885|FG000|Overall Study|Medical condition|3|||
161680306|NCT00294060|583882885|FG000|Overall Study|Device explanted/not replaced|23|||
161680307|NCT00139776|583882886|FG000|Period I|Did not enter Period II|575|||
161680308|NCT00139776|583882887|FG001|Period I|Did not enter Period II|0|||
161680309|NCT00139776|583882888|FG002|Period I|Did not enter Period II|0|||
161680310|NCT00139776|583882889|FG003|Period I|Did not enter Period II|0|||
161680311|NCT00139776|583882886|FG000|Period II|Not Randomized into Period III|0|||
161829984|NCT01009515|584418072|FG000|Overall Study|Withdrawal by Subject|3|||
161829985|NCT01501110|584418074|FG000|Overall Study|Death|0|||
162231665|NCT02663518|585897597|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
162231666|NCT02663518|585897584|FG000|Part 1: Phase 1a Escalation|Other|0|||
162231667|NCT02663518|585897585|FG001|Part 1: Phase 1a Escalation|Other|0|||
162231668|NCT02663518|585897586|FG002|Part 1: Phase 1a Escalation|Other|2|||
162231669|NCT02663518|585897587|FG003|Part 1: Phase 1a Escalation|Other|0|||
162231670|NCT02663518|585897588|FG004|Part 1: Phase 1a Escalation|Other|0|||
162231671|NCT02663518|585897589|FG005|Part 1: Phase 1a Escalation|Other|0|||
162231672|NCT02663518|585897590|FG006|Part 1: Phase 1a Escalation|Other|0|||
162231673|NCT02663518|585897591|FG007|Part 1: Phase 1a Escalation|Other|0|||
162231674|NCT02663518|585897592|FG008|Part 1: Phase 1a Escalation|Other|0|||
162231675|NCT02663518|585897593|FG009|Part 1: Phase 1a Escalation|Other|0|||
162231676|NCT02663518|585897594|FG010|Part 1: Phase 1a Escalation|Other|0|||
162231677|NCT02663518|585897595|FG011|Part 1: Phase 1a Escalation|Other|0|||
162231678|NCT02663518|585897596|FG012|Part 1: Phase 1a Escalation|Other|0|||
162231679|NCT02663518|585897597|FG013|Part 1: Phase 1a Escalation|Other|0|||
162231680|NCT02663518|585897584|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
162231681|NCT02663518|585897585|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
162231682|NCT02663518|585897586|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
162231683|NCT02663518|585897587|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
162231684|NCT02663518|585897588|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
162231685|NCT02663518|585897589|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
161680312|NCT00139776|583882887|FG001|Period II|Not Randomized into Period III|322|||
161680313|NCT00139776|583882888|FG002|Period II|Not Randomized into Period III|0|||
161680314|NCT00139776|583882889|FG003|Period II|Not Randomized into Period III|0|||
162231686|NCT02663518|585897590|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
162231687|NCT02663518|585897591|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
161829986|NCT01501110|584418075|FG001|Overall Study|Death|1|||
162231688|NCT02663518|585897592|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
162231689|NCT02663518|585897593|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
162231690|NCT02663518|585897594|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
162231691|NCT02663518|585897595|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
162024632|NCT01325337|585148670|FG002|Overall Study|Adverse Event|2|||
162024633|NCT01325337|585148671|FG003|Overall Study|Adverse Event|1|||
162231692|NCT02663518|585897596|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
162231693|NCT02663518|585897597|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
162231694|NCT02663518|585897584|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162231695|NCT02663518|585897585|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162231696|NCT02663518|585897586|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162231697|NCT02663518|585897587|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162231698|NCT02663518|585897588|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
162231699|NCT02663518|585897589|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162231700|NCT02663518|585897590|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
162231701|NCT02663518|585897591|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
162231702|NCT02663518|585897592|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162231703|NCT02663518|585897593|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162231704|NCT02663518|585897594|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162231705|NCT02663518|585897595|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162231706|NCT02663518|585897596|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162231707|NCT02663518|585897597|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
162231708|NCT02663518|585897584|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231709|NCT02663518|585897585|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231710|NCT02663518|585897586|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231711|NCT02663518|585897587|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231712|NCT02663518|585897588|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
162231713|NCT02663518|585897589|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231714|NCT02663518|585897590|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231715|NCT02663518|585897591|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231716|NCT02663518|585897592|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231717|NCT02663518|585897593|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231718|NCT02663518|585897594|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231719|NCT02663518|585897595|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231720|NCT02663518|585897596|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231721|NCT02663518|585897597|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
162231722|NCT02663518|585897584|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162231723|NCT02663518|585897585|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162231724|NCT02663518|585897586|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162024634|NCT01325337|585148672|FG004|Overall Study|Adverse Event|2|||
162024635|NCT01325337|585148668|FG000|Overall Study|Lost to Follow-up|2|||
162024636|NCT01325337|585148669|FG001|Overall Study|Lost to Follow-up|2|||
162024637|NCT01325337|585148670|FG002|Overall Study|Lost to Follow-up|2|||
162024638|NCT01325337|585148671|FG003|Overall Study|Lost to Follow-up|1|||
162024639|NCT01325337|585148672|FG004|Overall Study|Lost to Follow-up|2|||
162024640|NCT01325337|585148668|FG000|Overall Study|Personal Reasons|2|||
162024641|NCT01325337|585148669|FG001|Overall Study|Personal Reasons|5|||
162024642|NCT01325337|585148670|FG002|Overall Study|Personal Reasons|4|||
162024643|NCT01325337|585148671|FG003|Overall Study|Personal Reasons|8|||
162024644|NCT01325337|585148672|FG004|Overall Study|Personal Reasons|3|||
162024645|NCT01325337|585148668|FG000|Overall Study|Withdrawal by Subject|1|||
162024646|NCT01325337|585148669|FG001|Overall Study|Withdrawal by Subject|0|||
162024647|NCT01325337|585148670|FG002|Overall Study|Withdrawal by Subject|1|||
162024648|NCT01325337|585148671|FG003|Overall Study|Withdrawal by Subject|0|||
162024649|NCT01325337|585148672|FG004|Overall Study|Withdrawal by Subject|1|||
162024650|NCT01604278|585148679|FG000|Overall Study|Lack of Efficacy|0|||
162024651|NCT01604278|585148680|FG001|Overall Study|Lack of Efficacy|1|||
162024652|NCT01604278|585148679|FG000|Overall Study|Lost to Follow-up|1|||
162024653|NCT01604278|585148680|FG001|Overall Study|Lost to Follow-up|0|||
162231725|NCT02663518|585897587|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161680315|NCT00139776|583882886|FG000|Period III|Adverse Event|0|||
162024654|NCT01604278|585148679|FG000|Overall Study|Administrative problems|2|||
162024655|NCT01604278|585148680|FG001|Overall Study|Administrative problems|1|||
162024656|NCT01604278|585148679|FG000|Overall Study|Withdrawal by Subject|3|||
162024657|NCT01604278|585148680|FG001|Overall Study|Withdrawal by Subject|3|||
162024658|NCT01604278|585148679|FG000|Overall Study|Adverse Event|3|||
162024659|NCT01604278|585148680|FG001|Overall Study|Adverse Event|5|||
162024660|NCT01604278|585148679|FG000|Overall Study|Protocol Deviation|5|||
162024661|NCT01604278|585148680|FG001|Overall Study|Protocol Deviation|3|||
162024662|NCT00668733|585148688|FG000|Overall Study|Lost to Follow-up|2|||
162024663|NCT00668733|585148689|FG001|Overall Study|Lost to Follow-up|3|||
162024664|NCT00668733|585148688|FG000|Overall Study|Withdrawal by Subject|0|||
162024665|NCT00668733|585148689|FG001|Overall Study|Withdrawal by Subject|4|||
162024666|NCT01122264|585148692|FG000|Overall Study|Adverse Event|6|||
162024667|NCT01122264|585148693|FG001|Overall Study|Adverse Event|5|||
162024668|NCT01122264|585148694|FG002|Overall Study|Adverse Event|7|||
162024669|NCT01122264|585148692|FG000|Overall Study|Death|1|||
162024670|NCT01122264|585148693|FG001|Overall Study|Death|0|||
162024671|NCT01122264|585148694|FG002|Overall Study|Death|0|||
162024672|NCT01122264|585148692|FG000|Overall Study|Lost to Follow-up|5|||
162024673|NCT01122264|585148693|FG001|Overall Study|Lost to Follow-up|9|||
162024674|NCT01122264|585148694|FG002|Overall Study|Lost to Follow-up|13|||
162024675|NCT01122264|585148692|FG000|Overall Study|Entry Criteria Not Met|1|||
162024676|NCT01122264|585148693|FG001|Overall Study|Entry Criteria Not Met|0|||
162024677|NCT01122264|585148694|FG002|Overall Study|Entry Criteria Not Met|0|||
162024678|NCT01122264|585148692|FG000|Overall Study|Protocol Violation|7|||
162024679|NCT01122264|585148693|FG001|Overall Study|Protocol Violation|7|||
162024680|NCT01122264|585148694|FG002|Overall Study|Protocol Violation|9|||
162024681|NCT01122264|585148692|FG000|Overall Study|Withdrawal by Subject|6|||
162024682|NCT01122264|585148693|FG001|Overall Study|Withdrawal by Subject|6|||
162024683|NCT01122264|585148694|FG002|Overall Study|Withdrawal by Subject|16|||
162024684|NCT01122264|585148692|FG000|Overall Study|Physician Decision|3|||
162024685|NCT01122264|585148693|FG001|Overall Study|Physician Decision|1|||
162024686|NCT01122264|585148694|FG002|Overall Study|Physician Decision|1|||
162024687|NCT01122264|585148692|FG000|Overall Study|Lack of Efficacy|3|||
162024688|NCT01122264|585148693|FG001|Overall Study|Lack of Efficacy|1|||
162024689|NCT01122264|585148694|FG002|Overall Study|Lack of Efficacy|1|||
162024690|NCT00097981|585148703|FG000|Overall Study|Adverse Event|31|||
162024691|NCT00097981|585148704|FG001|Overall Study|Adverse Event|44|||
162024692|NCT00097981|585148703|FG000|Overall Study|Withdrawal by Subject|10|||
162024693|NCT00097981|585148704|FG001|Overall Study|Withdrawal by Subject|8|||
162024694|NCT00097981|585148703|FG000|Overall Study|Protocol Violation|1|||
162024695|NCT00097981|585148704|FG001|Overall Study|Protocol Violation|1|||
162024696|NCT00097981|585148703|FG000|Overall Study|Death|2|||
162024697|NCT00097981|585148704|FG001|Overall Study|Death|4|||
162024698|NCT00097981|585148703|FG000|Overall Study|Physician Decision|7|||
162024699|NCT00097981|585148704|FG001|Overall Study|Physician Decision|1|||
162024700|NCT00097981|585148703|FG000|Overall Study|Disease Progression|8|||
162024701|NCT00097981|585148704|FG001|Overall Study|Disease Progression|2|||
162024702|NCT00097981|585148703|FG000|Overall Study|Transplant planned|28|||
162024703|NCT00097981|585148704|FG001|Overall Study|Transplant planned|27|||
162024704|NCT00097981|585148703|FG000|Overall Study|Other|19|||
162024705|NCT00097981|585148704|FG001|Overall Study|Other|13|||
162024706|NCT00796445|585148713|FG000|Overall Study|Protocol Violation|5|||
162024707|NCT00796445|585148714|FG001|Overall Study|Protocol Violation|3|||
162024708|NCT00796445|585148713|FG000|Overall Study|Adverse event, serious fatal|10|||
162024709|NCT00796445|585148714|FG001|Overall Study|Adverse event, serious fatal|5|||
162024710|NCT00796445|585148713|FG000|Overall Study|Adverse event, non-fatal|4|||
162024711|NCT00796445|585148714|FG001|Overall Study|Adverse event, non-fatal|0|||
162024712|NCT00796445|585148713|FG000|Overall Study|Disease progression/recurrence|537|||
162024713|NCT00796445|585148714|FG001|Overall Study|Disease progression/recurrence|268|||
162024714|NCT00796445|585148713|FG000|Overall Study|Other|10|||
162024715|NCT00796445|585148714|FG001|Overall Study|Other|7|||
162024716|NCT00796445|585148713|FG000|Overall Study|Withdrawal by Subject|18|||
162024717|NCT00796445|585148714|FG001|Overall Study|Withdrawal by Subject|9|||
162024718|NCT00796445|585148713|FG000|Overall Study|Invalid Informed Consent Form|1|||
162024719|NCT00796445|585148714|FG001|Overall Study|Invalid Informed Consent Form|0|||
162024720|NCT00388583|585148715|FG000|Overall Study|Protocol Violation|1|||
162024721|NCT00388583|585148716|FG001|Overall Study|Protocol Violation|0|||
162024722|NCT00388583|585148715|FG000|Overall Study|Withdrawal by Subject|3|||
162024723|NCT00388583|585148716|FG001|Overall Study|Withdrawal by Subject|3|||
162024724|NCT00388583|585148715|FG000|Overall Study|Serious Adverse Event|2|||
162024725|NCT00388583|585148716|FG001|Overall Study|Serious Adverse Event|0|||
162024726|NCT00388583|585148715|FG000|Overall Study|Did not receive vaccine|0|||
162024727|NCT00388583|585148716|FG001|Overall Study|Did not receive vaccine|1|||
162024728|NCT05194579|585148719|FG000|Overall Study|Lost to Follow-up|2|||
162024729|NCT05194579|585148720|FG001|Overall Study|Lost to Follow-up|3|||
162024730|NCT05194579|585148719|FG000|Overall Study|Withdrawal by Subject|3|||
162024731|NCT05194579|585148720|FG001|Overall Study|Withdrawal by Subject|4|||
162024732|NCT05194579|585148719|FG000|Overall Study|Refused further study procedures|0|||
162024733|NCT05194579|585148720|FG001|Overall Study|Refused further study procedures|1|||
162231726|NCT02663518|585897588|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
162231727|NCT02663518|585897589|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
162231728|NCT02663518|585897590|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
162231729|NCT02663518|585897591|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
162231730|NCT02663518|585897592|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162231731|NCT02663518|585897593|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162231732|NCT02663518|585897594|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162231733|NCT02663518|585897595|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162231734|NCT02663518|585897596|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162231735|NCT02663518|585897597|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
162231736|NCT02663518|585897584|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
162231737|NCT02663518|585897585|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
162231738|NCT02663518|585897586|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
162231739|NCT02663518|585897587|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
162231740|NCT02663518|585897588|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
162231741|NCT02663518|585897589|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
161940618|NCT03485157|584832138|FG000|Double Blind Phase|Adverse Event|2|||
161940619|NCT03485157|584832139|FG001|Double Blind Phase|Adverse Event|1|||
161940620|NCT03485157|584832138|FG000|Double Blind Phase|Withdrawal by Subject|6|||
161940621|NCT03485157|584832139|FG001|Double Blind Phase|Withdrawal by Subject|9|||
161940622|NCT03485157|584832138|FG000|Double Blind Phase|Removal by PI|3|||
161940623|NCT03485157|584832139|FG001|Double Blind Phase|Removal by PI|7|||
161940624|NCT03485157|584832138|FG000|Open Label Phase|Lost to Follow-up|1|||
161940625|NCT03485157|584832139|FG001|Open Label Phase|Lost to Follow-up|2|||
161940626|NCT03485157|584832138|FG000|Open Label Phase|Adverse Event|0|||
161940627|NCT03485157|584832139|FG001|Open Label Phase|Adverse Event|1|||
161940628|NCT03485157|584832138|FG000|Open Label Phase|Withdrawal by Subject|1|||
161940629|NCT03485157|584832139|FG001|Open Label Phase|Withdrawal by Subject|2|||
161940630|NCT03485157|584832138|FG000|Open Label Phase|Removal by PI|2|||
161940631|NCT03485157|584832139|FG001|Open Label Phase|Removal by PI|0|||
161940632|NCT02607722|584832148|FG000|Overall Study|No data reliability|1|||
161940633|NCT02607722|584832148|FG000|Overall Study|no patient visit|18|||
161940634|NCT02607722|584832148|FG000|Overall Study|missing info in CRF|13|||
161940635|NCT02607722|584832148|FG000|Overall Study|Withdrawal by Subject|616|||
161940636|NCT02607722|584832148|FG000|Overall Study|Lost to Follow-up|312|||
161940637|NCT02607722|584832148|FG000|Overall Study|Improved|22|||
161940638|NCT02607722|584832148|FG000|Overall Study|Lack of Efficacy|316|||
161940639|NCT02607722|584832148|FG000|Overall Study|Adverse Event|2553|||
161940640|NCT02607722|584832148|FG000|Overall Study|Not treated|1|||
161940641|NCT02607722|584832148|FG000|Overall Study|No CRF collected|138|||
161940642|NCT02607722|584832148|FG000|Overall Study|without CRF|4225|||
161940643|NCT02607722|584832148|FG000|Overall Study|Physician Decision|367|||
161940644|NCT04347538|584832149|FG000|Overall Study|Lost to Follow-up|4|||
161940645|NCT04347538|584832150|FG001|Overall Study|Lost to Follow-up|5|||
161940646|NCT04347538|584832151|FG002|Overall Study|Lost to Follow-up|7|||
161940647|NCT02871219|584832152|FG000|Overall Study|Adverse Event|15|||
161940648|NCT02871219|584832152|FG000|Overall Study|Death|3|||
161940649|NCT02871219|584832152|FG000|Overall Study|Progression|3|||
161940650|NCT02871219|584832152|FG000|Overall Study|Infections|7|||
161940651|NCT02871219|584832152|FG000|Overall Study|Infusion Related|4|||
161940652|NCT03238196|584832153|FG000|Overall Study|Adverse Event|3|||
161940653|NCT03238196|584832154|FG001|Overall Study|Adverse Event|0|||
161940654|NCT03238196|584832155|FG002|Overall Study|Adverse Event|2|||
161940655|NCT03238196|584832156|FG003|Overall Study|Adverse Event|2|||
161940656|NCT03238196|584832153|FG000|Overall Study|Withdrawal by Subject|4|||
161940657|NCT03238196|584832154|FG001|Overall Study|Withdrawal by Subject|1|||
161940658|NCT03238196|584832155|FG002|Overall Study|Withdrawal by Subject|1|||
161940659|NCT03238196|584832156|FG003|Overall Study|Withdrawal by Subject|0|||
161940660|NCT03238196|584832153|FG000|Overall Study|Disease progression|14|||
161940661|NCT03238196|584832154|FG001|Overall Study|Disease progression|2|||
161940662|NCT03238196|584832155|FG002|Overall Study|Disease progression|3|||
161940663|NCT03238196|584832156|FG003|Overall Study|Disease progression|2|||
161940664|NCT03238196|584832153|FG000|Overall Study|Still on treatment|1|||
161940665|NCT03238196|584832154|FG001|Overall Study|Still on treatment|0|||
161940666|NCT03238196|584832155|FG002|Overall Study|Still on treatment|0|||
161940667|NCT03238196|584832156|FG003|Overall Study|Still on treatment|0|||
161940668|NCT05081843|584832157|FG000|Overall Study|Lost to Follow-up|135|||
161940669|NCT05081843|584832158|FG001|Overall Study|Lost to Follow-up|145|||
161940670|NCT00835354|584832159|FG000|First Intervention|Adverse Event|0|||
161940671|NCT00835354|584832160|FG001|First Intervention|Adverse Event|1|||
161940672|NCT02457793|584832166|FG000|Overall Study|Reason not specified|0|||
161940673|NCT02457793|584832167|FG001|Overall Study|Reason not specified|0|||
161940674|NCT02457793|584832168|FG002|Overall Study|Reason not specified|0|||
161940675|NCT02457793|584832169|FG003|Overall Study|Reason not specified|1|||
161940676|NCT02457793|584832170|FG004|Overall Study|Reason not specified|1|||
161940677|NCT02457793|584832171|FG005|Overall Study|Reason not specified|1|||
161940678|NCT02457793|584832166|FG000|Overall Study|Withdrawal by Subject|0|||
161940679|NCT02457793|584832167|FG001|Overall Study|Withdrawal by Subject|4|||
161940680|NCT02457793|584832168|FG002|Overall Study|Withdrawal by Subject|2|||
161940681|NCT02457793|584832169|FG003|Overall Study|Withdrawal by Subject|2|||
161940682|NCT02457793|584832170|FG004|Overall Study|Withdrawal by Subject|2|||
161940683|NCT02457793|584832171|FG005|Overall Study|Withdrawal by Subject|2|||
161940684|NCT02457793|584832166|FG000|Overall Study|Adverse Event|0|||
161940685|NCT02457793|584832167|FG001|Overall Study|Adverse Event|0|||
161940686|NCT02457793|584832168|FG002|Overall Study|Adverse Event|0|||
161940687|NCT02457793|584832169|FG003|Overall Study|Adverse Event|1|||
161940688|NCT02457793|584832170|FG004|Overall Study|Adverse Event|0|||
161940689|NCT02457793|584832171|FG005|Overall Study|Adverse Event|0|||
161940690|NCT02457793|584832166|FG000|Overall Study|Physician Decision|1|||
161940691|NCT02457793|584832167|FG001|Overall Study|Physician Decision|0|||
161940692|NCT02457793|584832168|FG002|Overall Study|Physician Decision|1|||
161940693|NCT02457793|584832169|FG003|Overall Study|Physician Decision|1|||
161940694|NCT02457793|584832170|FG004|Overall Study|Physician Decision|1|||
161940695|NCT02457793|584832171|FG005|Overall Study|Physician Decision|3|||
161940696|NCT00835172|584832176|FG000|Washout|Protocol Violation|0|||
161940697|NCT00835172|584832177|FG001|Washout|Protocol Violation|1|||
161940698|NCT03164356|584832178|FG000|Overall Study|Lost to Follow-up|1|||
161940699|NCT03164356|584832179|FG001|Overall Study|Lost to Follow-up|1|||
161940700|NCT03164356|584832180|FG002|Overall Study|Lost to Follow-up|2|||
161940701|NCT03164356|584832181|FG003|Overall Study|Lost to Follow-up|1|||
161940702|NCT03164356|584832178|FG000|Overall Study|Physician Decision|0|||
161940703|NCT03164356|584832179|FG001|Overall Study|Physician Decision|0|||
161940704|NCT03164356|584832180|FG002|Overall Study|Physician Decision|3|||
161940705|NCT03164356|584832181|FG003|Overall Study|Physician Decision|0|||
161940706|NCT03164356|584832178|FG000|Overall Study|Protocol Violation|2|||
161940707|NCT03164356|584832179|FG001|Overall Study|Protocol Violation|1|||
161940708|NCT03164356|584832180|FG002|Overall Study|Protocol Violation|0|||
161940709|NCT03164356|584832181|FG003|Overall Study|Protocol Violation|0|||
161940710|NCT03164356|584832178|FG000|Overall Study|Withdrawal by Subject|1|||
161940711|NCT03164356|584832179|FG001|Overall Study|Withdrawal by Subject|0|||
161940712|NCT03164356|584832180|FG002|Overall Study|Withdrawal by Subject|0|||
161940713|NCT03164356|584832181|FG003|Overall Study|Withdrawal by Subject|0|||
161940714|NCT03164356|584832178|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
161940715|NCT03164356|584832179|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
161940716|NCT03164356|584832180|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
161940717|NCT03164356|584832181|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
161940718|NCT03164356|584832178|FG000|Overall Study|Subject Incarcerated|0|||
161940719|NCT03164356|584832179|FG001|Overall Study|Subject Incarcerated|1|||
161940720|NCT03164356|584832180|FG002|Overall Study|Subject Incarcerated|0|||
161940721|NCT03164356|584832181|FG003|Overall Study|Subject Incarcerated|0|||
161940722|NCT03164356|584832178|FG000|Overall Study|Prosthetist unable to participate|0|||
161940723|NCT03164356|584832179|FG001|Overall Study|Prosthetist unable to participate|2|||
161940724|NCT03164356|584832180|FG002|Overall Study|Prosthetist unable to participate|1|||
161940725|NCT03164356|584832181|FG003|Overall Study|Prosthetist unable to participate|0|||
161940726|NCT00791648|584833668|FG000|Overall Study|Physician Decision|0|||
161940727|NCT00791648|584833669|FG001|Overall Study|Physician Decision|1|||
161940728|NCT00791648|584833668|FG000|Overall Study|Withdrawal by Subject|0|||
161940729|NCT00791648|584833669|FG001|Overall Study|Withdrawal by Subject|1|||
161940730|NCT04123704|584833680|FG000|Overall Study|Disease progression|2|||
161940731|NCT03332056|584833686|FG000|Overall Study|Incomplete questionnaires|8|||
161940732|NCT03332056|584833687|FG001|Overall Study|Incomplete questionnaires|9|||
161940733|NCT03332056|584833686|FG000|Overall Study|Passed stone prior to surgery date|1|||
161940734|NCT03332056|584833687|FG001|Overall Study|Passed stone prior to surgery date|0|||
161940735|NCT03332056|584833686|FG000|Overall Study|Did not require a ureteral stent|0|||
161940736|NCT03332056|584833687|FG001|Overall Study|Did not require a ureteral stent|1|||
161940737|NCT03360344|584833690|FG000|Overall Study|Withdrawal by Subject|0|||
161940738|NCT03360344|584833691|FG001|Overall Study|Withdrawal by Subject|1|||
162024734|NCT05194579|585148719|FG000|Overall Study|Protocol deviation|1|||
162024735|NCT05194579|585148720|FG001|Overall Study|Protocol deviation|0|||
162024736|NCT02500056|585148725|FG000|Overall Study|Lost to Follow-up|3|||
162024737|NCT02500056|585148726|FG001|Overall Study|Lost to Follow-up|7|||
162024738|NCT02500056|585148725|FG000|Overall Study|Recurrence|1|||
162024739|NCT02500056|585148726|FG001|Overall Study|Recurrence|0|||
162024740|NCT02500056|585148725|FG000|Overall Study|Death|3|||
162024741|NCT02500056|585148726|FG001|Overall Study|Death|1|||
162024742|NCT00638183|585148729|FG000|Overall Study|Adverse Event|23|||
162024743|NCT00638183|585148729|FG000|Overall Study|Lack of Efficacy|14|||
162024744|NCT00638183|585148729|FG000|Overall Study|Physician Decision|9|||
162024745|NCT00638183|585148729|FG000|Overall Study|Lost to Follow-up|46|||
162024746|NCT00638183|585148729|FG000|Overall Study|Other reason not defined above|27|||
162024747|NCT03180619|585148730|FG000|Overall Study|Withdrew Consent|5|||
162024748|NCT03180619|585148731|FG001|Overall Study|Withdrew Consent|0|||
162024749|NCT03180619|585148732|FG002|Overall Study|Withdrew Consent|2|||
162024750|NCT03180619|585148730|FG000|Overall Study|Death|2|||
162024751|NCT03180619|585148731|FG001|Overall Study|Death|1|||
162024752|NCT03180619|585148732|FG002|Overall Study|Death|2|||
162024753|NCT03180619|585148730|FG000|Overall Study|Adverse Event|2|||
162024754|NCT03180619|585148731|FG001|Overall Study|Adverse Event|0|||
162024755|NCT03180619|585148732|FG002|Overall Study|Adverse Event|1|||
162024756|NCT03180619|585148730|FG000|Overall Study|Investigator's discretion|2|||
162024757|NCT03180619|585148731|FG001|Overall Study|Investigator's discretion|0|||
162024758|NCT03180619|585148732|FG002|Overall Study|Investigator's discretion|1|||
162024759|NCT01989208|585148735|FG000|200 mg (7 Days)|Protocol Violation|0|||
162024760|NCT01989208|585148736|FG001|200 mg (7 Days)|Protocol Violation|1|||
162024761|NCT04973436|585148737|FG000|Overall Study|Lost to Follow-up|3|||
162024762|NCT04973436|585148737|FG000|Overall Study|Withdrawal by Subject|1|||
162024763|NCT04973436|585148737|FG000|Overall Study|Death|2|||
162024764|NCT00275340|585148738|FG000|Overall Study|Lost to Follow-up|2|||
162024765|NCT00275340|585148739|FG001|Overall Study|Lost to Follow-up|4|||
162024766|NCT00862641|585148742|FG000|Overall Study|Randomized, but drug not received|1|||
162024767|NCT00862641|585148743|FG001|Overall Study|Randomized, but drug not received|4|||
162024768|NCT00862641|585148744|FG002|Overall Study|Randomized, but drug not received|1|||
161940739|NCT03360344|584833692|FG002|Overall Study|Withdrawal by Subject|1|||
161940740|NCT00133705|584833697|FG000|Overall Study|Withdrawal by Subject|2|||
161940741|NCT00133705|584833698|FG001|Overall Study|Withdrawal by Subject|3|||
161940742|NCT00959049|584833699|FG000|Overall Study|Adverse Event|1|||
161940743|NCT00959049|584833700|FG001|Overall Study|Adverse Event|0|||
161940744|NCT00959049|584833701|FG002|Overall Study|Adverse Event|0|||
161940745|NCT00959049|584833702|FG003|Overall Study|Adverse Event|0|||
161940746|NCT00959049|584833703|FG004|Overall Study|Adverse Event|0|||
161940747|NCT00959049|584833704|FG005|Overall Study|Adverse Event|0|||
161940748|NCT00959049|584833699|FG000|Overall Study|Lost to Follow-up|17|||
161940749|NCT00959049|584833700|FG001|Overall Study|Lost to Follow-up|5|||
161940750|NCT00959049|584833701|FG002|Overall Study|Lost to Follow-up|1|||
161940751|NCT00959049|584833702|FG003|Overall Study|Lost to Follow-up|10|||
161940752|NCT00959049|584833703|FG004|Overall Study|Lost to Follow-up|9|||
161940753|NCT00959049|584833704|FG005|Overall Study|Lost to Follow-up|1|||
161940754|NCT00959049|584833699|FG000|Overall Study|Contraindicated medication|0|||
161940755|NCT00959049|584833700|FG001|Overall Study|Contraindicated medication|0|||
161940756|NCT00959049|584833701|FG002|Overall Study|Contraindicated medication|0|||
161940757|NCT00959049|584833702|FG003|Overall Study|Contraindicated medication|1|||
161940758|NCT00959049|584833703|FG004|Overall Study|Contraindicated medication|0|||
161940759|NCT00959049|584833704|FG005|Overall Study|Contraindicated medication|0|||
161940760|NCT00959049|584833699|FG000|Overall Study|Withdrawal by Subject|0|||
161940761|NCT00959049|584833700|FG001|Overall Study|Withdrawal by Subject|2|||
161940762|NCT00959049|584833701|FG002|Overall Study|Withdrawal by Subject|0|||
161940763|NCT00959049|584833702|FG003|Overall Study|Withdrawal by Subject|0|||
161940764|NCT00959049|584833703|FG004|Overall Study|Withdrawal by Subject|0|||
161940765|NCT00959049|584833704|FG005|Overall Study|Withdrawal by Subject|0|||
161940766|NCT00836706|584833712|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
161940767|NCT00836706|584833713|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
162024769|NCT00862641|585148745|FG003|Overall Study|Randomized, but drug not received|4|||
162024770|NCT02365480|585148746|FG000|Overall Study|Withdrawal by Subject|2|||
162024771|NCT02365480|585148747|FG001|Overall Study|Withdrawal by Subject|0|||
162024772|NCT01419197|585148752|FG000|Overall Study|Death|247|||
162024773|NCT01419197|585148753|FG001|Overall Study|Death|122|||
162024774|NCT01419197|585148752|FG000|Overall Study|Physician Decision|4|||
162024775|NCT01419197|585148753|FG001|Overall Study|Physician Decision|4|||
161940768|NCT02989857|584833714|FG000|Randomization Phase|Not Treated|3|||
161940769|NCT02989857|584833715|FG001|Randomization Phase|Not Treated|2|||
162024776|NCT01419197|585148752|FG000|Overall Study|Non-compliance|3|||
162024777|NCT01419197|585148753|FG001|Overall Study|Non-compliance|1|||
162024778|NCT01419197|585148752|FG000|Overall Study|Withdrawal by Subject|33|||
162024779|NCT01419197|585148753|FG001|Overall Study|Withdrawal by Subject|32|||
162024780|NCT01419197|585148752|FG000|Overall Study|Study Completed by Sponsor|103|||
162024781|NCT01419197|585148753|FG001|Overall Study|Study Completed by Sponsor|34|||
162024782|NCT01419197|585148752|FG000|Overall Study|Reason Not Specified|0|||
162024783|NCT01419197|585148753|FG001|Overall Study|Reason Not Specified|1|||
162024784|NCT01419197|585148752|FG000|Overall Study|Lost to Follow-up|14|||
162024785|NCT01419197|585148753|FG001|Overall Study|Lost to Follow-up|4|||
162024786|NCT01781299|585148754|FG000|Overall Study|Withdrawal by Subject|0|||
162024787|NCT01781299|585148755|FG001|Overall Study|Withdrawal by Subject|1|||
162024788|NCT00146848|585148759|FG000|Pre-randomization|Death|19|||
162024789|NCT00146848|585148760|FG001|Pre-randomization|Death|0|||
162024790|NCT00146848|585148761|FG002|Pre-randomization|Death|0|||
162024791|NCT00146848|585148759|FG000|Pre-randomization|Lost to Follow-up|70|||
162024792|NCT00146848|585148760|FG001|Pre-randomization|Lost to Follow-up|0|||
162024793|NCT00146848|585148761|FG002|Pre-randomization|Lost to Follow-up|0|||
162024794|NCT00146848|585148759|FG000|Pre-randomization|Physician Decision|8|||
162024795|NCT00146848|585148760|FG001|Pre-randomization|Physician Decision|0|||
162024796|NCT00146848|585148761|FG002|Pre-randomization|Physician Decision|0|||
162024797|NCT00146848|585148759|FG000|Pre-randomization|Protocol Violation|172|||
162024798|NCT00146848|585148760|FG001|Pre-randomization|Protocol Violation|0|||
162024799|NCT00146848|585148761|FG002|Pre-randomization|Protocol Violation|0|||
162024800|NCT00146848|585148759|FG000|Pre-randomization|Withdrawal by Subject|40|||
162024801|NCT00146848|585148760|FG001|Pre-randomization|Withdrawal by Subject|0|||
162024802|NCT00146848|585148761|FG002|Pre-randomization|Withdrawal by Subject|0|||
162024803|NCT00146848|585148759|FG000|Post-randomization|Lost to Follow-up|12|||
162024804|NCT00146848|585148760|FG001|Post-randomization|Lost to Follow-up|15|||
162024805|NCT00146848|585148761|FG002|Post-randomization|Lost to Follow-up|12|||
162024806|NCT00146848|585148759|FG000|Post-randomization|Withdrawn|26|||
162024807|NCT00146848|585148760|FG001|Post-randomization|Withdrawn|32|||
162024808|NCT00146848|585148761|FG002|Post-randomization|Withdrawn|27|||
162024809|NCT01798849|585148762|FG000|Overall Study|Physician Decision|0|||
162024810|NCT01798849|585148763|FG001|Overall Study|Physician Decision|0|||
162024811|NCT01798849|585148764|FG002|Overall Study|Physician Decision|1|||
162024812|NCT02395172|585148765|FG000|Overall Study|Participants randomized but not treated|3|||
162024813|NCT02395172|585148766|FG001|Overall Study|Participants randomized but not treated|31|||
162024814|NCT00653939|585148767|FG000|Overall Study|Adverse Event|1|||
162024815|NCT00653939|585148768|FG001|Overall Study|Adverse Event|3|||
162024816|NCT00653939|585148767|FG000|Overall Study|Withdrawal by Subject|3|||
162024817|NCT00653939|585148768|FG001|Overall Study|Withdrawal by Subject|3|||
162024818|NCT00653939|585148767|FG000|Overall Study|Physician Decision|4|||
162024819|NCT00653939|585148768|FG001|Overall Study|Physician Decision|0|||
162024820|NCT00653939|585148767|FG000|Overall Study|Disease Progression|2|||
162024821|NCT00653939|585148768|FG001|Overall Study|Disease Progression|3|||
162024822|NCT00653939|585148767|FG000|Overall Study|Other|2|||
162024823|NCT00653939|585148768|FG001|Overall Study|Other|6|||
162024824|NCT02032238|585148769|FG000|Overall Study|Lost to Follow-up|2|||
162024825|NCT02032238|585148770|FG001|Overall Study|Lost to Follow-up|0|||
162024826|NCT00717236|585148771|FG000|Double-Blind Period|Adverse Event|33|||
162024827|NCT00717236|585148772|FG001|Double-Blind Period|Adverse Event|6|||
162024828|NCT00717236|585148771|FG000|Double-Blind Period|Lack of Efficacy|6|||
162024829|NCT00717236|585148772|FG001|Double-Blind Period|Lack of Efficacy|6|||
162024830|NCT00717236|585148771|FG000|Double-Blind Period|Lost to Follow-up|3|||
162024831|NCT00717236|585148772|FG001|Double-Blind Period|Lost to Follow-up|5|||
162024832|NCT00717236|585148771|FG000|Double-Blind Period|Withdrawal by Subject|10|||
162024833|NCT00717236|585148772|FG001|Double-Blind Period|Withdrawal by Subject|2|||
162024834|NCT00717236|585148771|FG000|Double-Blind Period|Loss of efficacy|3|||
162024835|NCT00717236|585148772|FG001|Double-Blind Period|Loss of efficacy|0|||
162024836|NCT00717236|585148771|FG000|Double-Blind Period|Other: Death|1|||
162024837|NCT00717236|585148772|FG001|Double-Blind Period|Other: Death|0|||
162024838|NCT00717236|585148771|FG000|Double-Blind Period|Other: Pregnancy|1|||
162024839|NCT00717236|585148772|FG001|Double-Blind Period|Other: Pregnancy|0|||
162024840|NCT00717236|585148771|FG000|Double-Blind Period|Other: Protocol Violation|2|||
162024841|NCT00717236|585148772|FG001|Double-Blind Period|Other: Protocol Violation|0|||
162024842|NCT00717236|585148771|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
162024843|NCT00717236|585148772|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
162024844|NCT00717236|585148771|FG000|Double-Blind Period|Other: Site withdrew|2|||
162024845|NCT00717236|585148772|FG001|Double-Blind Period|Other: Site withdrew|0|||
162024846|NCT00717236|585148771|FG000|Double-Blind Period|Other: Screening failure|1|||
162024847|NCT00717236|585148772|FG001|Double-Blind Period|Other: Screening failure|0|||
162024848|NCT00717236|585148771|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
162024849|NCT00717236|585148772|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
162024850|NCT00717236|585148771|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
162024851|NCT00717236|585148772|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
162024852|NCT00717236|585148771|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
162024853|NCT00717236|585148772|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
162024854|NCT00717236|585148771|FG000|Double-Blind Period|Other: History of cancer|1|||
162024855|NCT00717236|585148772|FG001|Double-Blind Period|Other: History of cancer|0|||
161680316|NCT00139776|583882887|FG001|Period III|Adverse Event|0|||
161680317|NCT00139776|583882888|FG002|Period III|Adverse Event|22|||
161680318|NCT00139776|583882889|FG003|Period III|Adverse Event|23|||
161680319|NCT00139776|583882886|FG000|Period III|Other|0|||
161680320|NCT00139776|583882887|FG001|Period III|Other|0|||
161680321|NCT00139776|583882888|FG002|Period III|Other|23|||
161680322|NCT00139776|583882889|FG003|Period III|Other|34|||
161680323|NCT00139776|583882886|FG000|Period III|Lack of Efficacy|0|||
161680324|NCT00139776|583882887|FG001|Period III|Lack of Efficacy|0|||
161680325|NCT00139776|583882888|FG002|Period III|Lack of Efficacy|10|||
161680326|NCT00139776|583882889|FG003|Period III|Lack of Efficacy|24|||
161680327|NCT00139776|583882886|FG000|Period III|Lost to Follow-up|0|||
161680328|NCT00139776|583882887|FG001|Period III|Lost to Follow-up|0|||
161680329|NCT00139776|583882888|FG002|Period III|Lost to Follow-up|5|||
161680330|NCT00139776|583882889|FG003|Period III|Lost to Follow-up|4|||
161680331|NCT00139776|583882886|FG000|Period III|Withdrawal by Subject|0|||
161680332|NCT00139776|583882887|FG001|Period III|Withdrawal by Subject|0|||
161680333|NCT00139776|583882888|FG002|Period III|Withdrawal by Subject|16|||
161680334|NCT00139776|583882889|FG003|Period III|Withdrawal by Subject|21|||
161680335|NCT00187096|583882890|FG000|Overall Study|unacceptable toxicity|0|||
161680336|NCT00187096|583882891|FG001|Overall Study|unacceptable toxicity|0|||
161680337|NCT00187096|583882892|FG002|Overall Study|unacceptable toxicity|1|||
161680338|NCT00971178|583882907|FG000|Overall Study|Lost to Follow-up|2|||
161680339|NCT00971178|583882908|FG001|Overall Study|Lost to Follow-up|2|||
161680340|NCT00971178|583882909|FG002|Overall Study|Lost to Follow-up|2|||
161680341|NCT02161575|583882910|FG000|Overall Study|Protocol Violation|8|||
161680342|NCT02161575|583882910|FG000|Overall Study|Lack of Efficacy|1|||
161680343|NCT02161575|583882910|FG000|Overall Study|Adverse Event|2|||
161680344|NCT00714285|583882911|FG000|Overall Study|Lost to Follow-up|0|||
161680345|NCT00714285|583882912|FG001|Overall Study|Lost to Follow-up|2|||
161680346|NCT00714285|583882913|FG002|Overall Study|Lost to Follow-up|0|||
161680347|NCT00714285|583882914|FG003|Overall Study|Lost to Follow-up|1|||
161680348|NCT00714285|583882911|FG000|Overall Study|Migrated/moved from study area|0|||
161680349|NCT00714285|583882912|FG001|Overall Study|Migrated/moved from study area|1|||
161680350|NCT00714285|583882913|FG002|Overall Study|Migrated/moved from study area|0|||
161680351|NCT00714285|583882914|FG003|Overall Study|Migrated/moved from study area|0|||
161680352|NCT01816061|583882916|FG000|Overall Study|Lost to Follow-up|13|||
161680353|NCT01816061|583882917|FG001|Overall Study|Lost to Follow-up|24|||
161680354|NCT01970488|583882918|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
161680355|NCT01970488|583882919|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
161680356|NCT01970488|583882920|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
161680357|NCT01970488|583882921|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
161680358|NCT01970488|583882922|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
161680359|NCT01970488|583882918|FG000|Part 1: Through Week 16|Protocol Violation|1|||
161680360|NCT01970488|583882919|FG001|Part 1: Through Week 16|Protocol Violation|2|||
161680361|NCT01970488|583882920|FG002|Part 1: Through Week 16|Protocol Violation|0|||
161680362|NCT01970488|583882921|FG003|Part 1: Through Week 16|Protocol Violation|0|||
161680363|NCT01970488|583882922|FG004|Part 1: Through Week 16|Protocol Violation|0|||
161680364|NCT01970488|583882918|FG000|Part 1: Through Week 16|Adverse Event|6|||
161680365|NCT01970488|583882919|FG001|Part 1: Through Week 16|Adverse Event|5|||
161680366|NCT01970488|583882920|FG002|Part 1: Through Week 16|Adverse Event|0|||
161680367|NCT01970488|583882921|FG003|Part 1: Through Week 16|Adverse Event|0|||
161680368|NCT01970488|583882922|FG004|Part 1: Through Week 16|Adverse Event|0|||
161680369|NCT01970488|583882918|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
161680370|NCT01970488|583882919|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
161680371|NCT01970488|583882920|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
161680372|NCT01970488|583882921|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
161680373|NCT01970488|583882922|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
161680374|NCT01970488|583882918|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
161680375|NCT01970488|583882919|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
161680376|NCT01970488|583882920|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
161680377|NCT01970488|583882921|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
161680378|NCT01970488|583882922|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
161680379|NCT01970488|583882918|FG000|Part 2: Post Week 16|Physician Decision|0|||
161680380|NCT01970488|583882919|FG001|Part 2: Post Week 16|Physician Decision|0|||
161680381|NCT01970488|583882920|FG002|Part 2: Post Week 16|Physician Decision|0|||
161680382|NCT01970488|583882921|FG003|Part 2: Post Week 16|Physician Decision|0|||
162231742|NCT02663518|585897590|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
162231743|NCT02663518|585897591|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
161680383|NCT01970488|583882922|FG004|Part 2: Post Week 16|Physician Decision|1|||
161680384|NCT01970488|583882918|FG000|Part 2: Post Week 16|Non-compliance|0|||
161680385|NCT01970488|583882919|FG001|Part 2: Post Week 16|Non-compliance|0|||
161680386|NCT01970488|583882920|FG002|Part 2: Post Week 16|Non-compliance|1|||
161680387|NCT01970488|583882921|FG003|Part 2: Post Week 16|Non-compliance|0|||
161680388|NCT01970488|583882922|FG004|Part 2: Post Week 16|Non-compliance|0|||
161680389|NCT01970488|583882918|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
161829987|NCT02075606|584418079|FG000|Overall Study|Adverse Event|5|||
162024856|NCT00717236|585148771|FG000|Double-Blind Period|Other: Sponsor request|1|||
162024857|NCT00717236|585148772|FG001|Double-Blind Period|Other: Sponsor request|0|||
162024858|NCT00717236|585148771|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
162024859|NCT00717236|585148772|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
162024860|NCT00717236|585148771|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
162024861|NCT00717236|585148772|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
162024862|NCT00717236|585148771|FG000|Double-Blind Period|Other: Subject moved|1|||
162024863|NCT00717236|585148772|FG001|Double-Blind Period|Other: Subject moved|1|||
162024864|NCT00717236|585148771|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
162024865|NCT00717236|585148772|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
162024866|NCT00717236|585148771|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
162024867|NCT00717236|585148772|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
162024868|NCT00717236|585148771|FG000|Double-Blind Period|Other: Transportation problems|0|||
162024869|NCT00717236|585148772|FG001|Double-Blind Period|Other: Transportation problems|1|||
162024870|NCT00717236|585148771|FG000|Double-Blind Period|Other: Investigator Decision|0|||
162024871|NCT00717236|585148772|FG001|Double-Blind Period|Other: Investigator Decision|1|||
162024872|NCT00717236|585148771|FG000|Open-Label Period|Adverse Event|29|||
162024873|NCT00717236|585148772|FG001|Open-Label Period|Adverse Event|4|||
162024874|NCT00717236|585148771|FG000|Open-Label Period|Lack of Efficacy|30|||
162024875|NCT00717236|585148772|FG001|Open-Label Period|Lack of Efficacy|8|||
162024876|NCT00717236|585148771|FG000|Open-Label Period|Lost to Follow-up|28|||
162024877|NCT00717236|585148772|FG001|Open-Label Period|Lost to Follow-up|4|||
162024878|NCT00717236|585148771|FG000|Open-Label Period|Withdrawal by Subject|20|||
162024879|NCT00717236|585148772|FG001|Open-Label Period|Withdrawal by Subject|2|||
162024880|NCT00717236|585148771|FG000|Open-Label Period|Loss of Efficacy|6|||
162024881|NCT00717236|585148772|FG001|Open-Label Period|Loss of Efficacy|1|||
162024882|NCT00717236|585148771|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
162024883|NCT00717236|585148772|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
162024884|NCT00717236|585148771|FG000|Open-Label Period|Other: Lack of Compliance|1|||
162024885|NCT00717236|585148772|FG001|Open-Label Period|Other: Lack of Compliance|1|||
162024886|NCT00717236|585148771|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
162024887|NCT00717236|585148772|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
162024888|NCT00717236|585148771|FG000|Open-Label Period|Other: Moved|1|||
162024889|NCT00717236|585148772|FG001|Open-Label Period|Other: Moved|0|||
162024890|NCT00717236|585148771|FG000|Open-Label Period|Other: Investigator Decision|1|||
162024891|NCT00717236|585148772|FG001|Open-Label Period|Other: Investigator Decision|0|||
162024892|NCT00717236|585148771|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
162024893|NCT00717236|585148772|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
162024894|NCT00717236|585148771|FG000|Open-Label Period|Other: Sponsor Request|3|||
162024895|NCT00717236|585148772|FG001|Open-Label Period|Other: Sponsor Request|0|||
162024896|NCT00717236|585148771|FG000|Open-Label Period|Other: Cataract Surgery|1|||
162024897|NCT00717236|585148772|FG001|Open-Label Period|Other: Cataract Surgery|0|||
162024898|NCT00717236|585148771|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
162024899|NCT00717236|585148772|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
162024900|NCT00717236|585148771|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
162024901|NCT00717236|585148772|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
162024902|NCT00717236|585148771|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
162024903|NCT00717236|585148772|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
162024904|NCT00612105|585148773|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
162024905|NCT00612105|585148774|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
162024906|NCT00612105|585148773|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
162024907|NCT00612105|585148774|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
162024908|NCT00612105|585148773|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
162024909|NCT00612105|585148774|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
162024910|NCT00612105|585148773|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
162024911|NCT00612105|585148774|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
162024912|NCT00612105|585148773|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
162024913|NCT00612105|585148774|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
162024914|NCT00612105|585148773|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
162024915|NCT00612105|585148774|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
162024916|NCT00612105|585148773|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
162024917|NCT00612105|585148774|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
162024918|NCT00612105|585148773|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
162024919|NCT00612105|585148774|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
162024920|NCT00612105|585148773|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
162024921|NCT00612105|585148774|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
162024922|NCT00612105|585148773|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
162024923|NCT00612105|585148774|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
162024924|NCT00612105|585148773|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
162024925|NCT00612105|585148774|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
162024926|NCT00612105|585148773|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
162024927|NCT00612105|585148774|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
162024928|NCT00475982|585148775|FG000|Overall Study|surgery rescheduled|7|||
162024929|NCT00475982|585148776|FG001|Overall Study|surgery rescheduled|3|||
162024930|NCT01105767|585148777|FG000|Overall Study|Lost to Follow-up|1160|||
162024931|NCT01105767|585148778|FG001|Overall Study|Lost to Follow-up|1614|||
162024932|NCT01105767|585148779|FG002|Overall Study|Lost to Follow-up|1184|||
162024933|NCT00743106|585148780|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
162024934|NCT00743106|585148781|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
162024935|NCT02410343|585148786|FG000|Core Period (24 Weeks)|Adverse Event|1|||
162024936|NCT02410343|585148787|FG001|Core Period (24 Weeks)|Adverse Event|0|||
162024937|NCT02410343|585148786|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
162024938|NCT02410343|585148787|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
162024939|NCT02410343|585148786|FG000|Extension Period (12 Months)|Adverse Event|1|||
162024940|NCT02410343|585148787|FG001|Extension Period (12 Months)|Adverse Event|0|||
162024941|NCT02410343|585148786|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
162024942|NCT02410343|585148787|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
162024943|NCT00029146|585148788|FG000|Overall Study|Lost to Follow-up|2|||
162024944|NCT00029146|585148789|FG001|Overall Study|Lost to Follow-up|1|||
162024945|NCT00946985|585148792|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
162024946|NCT00946985|585148792|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
162024947|NCT00946985|585148792|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
162024948|NCT00946985|585148792|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
162024949|NCT00946985|585148792|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
162024950|NCT00946985|585148792|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
162024951|NCT00946985|585148792|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
162024952|NCT00946985|585148792|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
162024953|NCT00946985|585148792|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
162024954|NCT00271505|585148793|FG000|Overall Study|Screen Failure|3|||
162024955|NCT00271505|585148793|FG000|Overall Study|Adverse Event|1|||
162024956|NCT00271505|585148793|FG000|Overall Study|Death|1|||
162024957|NCT04556383|585148794|FG000|PCP|Lack of Efficacy|28|||
162024958|NCT04556383|585148795|FG001|PCP|Lack of Efficacy|23|||
162024959|NCT04556383|585148796|FG002|PCP|Lack of Efficacy|23|||
162024960|NCT04556383|585148797|FG003|PCP|Lack of Efficacy|0|||
162024961|NCT04556383|585148794|FG000|PCP|Study terminated by sponsor|15|||
162024962|NCT04556383|585148795|FG001|PCP|Study terminated by sponsor|13|||
162024963|NCT04556383|585148796|FG002|PCP|Study terminated by sponsor|16|||
162024964|NCT04556383|585148797|FG003|PCP|Study terminated by sponsor|0|||
162024965|NCT04556383|585148794|FG000|PCP|Withdrawal by Subject|8|||
162024966|NCT04556383|585148795|FG001|PCP|Withdrawal by Subject|6|||
162024967|NCT04556383|585148796|FG002|PCP|Withdrawal by Subject|6|||
162024968|NCT04556383|585148797|FG003|PCP|Withdrawal by Subject|0|||
162024969|NCT04556383|585148794|FG000|PCP|Adverse Event|1|||
162024970|NCT04556383|585148795|FG001|PCP|Adverse Event|7|||
162024971|NCT04556383|585148796|FG002|PCP|Adverse Event|7|||
162024972|NCT04556383|585148797|FG003|PCP|Adverse Event|0|||
162024973|NCT04556383|585148794|FG000|PCP|Other, Not Specified|1|||
162024974|NCT04556383|585148795|FG001|PCP|Other, Not Specified|2|||
162024975|NCT04556383|585148796|FG002|PCP|Other, Not Specified|1|||
162024976|NCT04556383|585148797|FG003|PCP|Other, Not Specified|0|||
162024977|NCT04556383|585148794|FG000|PCP|Protocol Violation|1|||
162024978|NCT04556383|585148795|FG001|PCP|Protocol Violation|0|||
162024979|NCT04556383|585148796|FG002|PCP|Protocol Violation|1|||
162024980|NCT04556383|585148797|FG003|PCP|Protocol Violation|0|||
162024981|NCT04556383|585148794|FG000|PCP|Lost to Follow-up|1|||
162024982|NCT04556383|585148795|FG001|PCP|Lost to Follow-up|0|||
162024983|NCT04556383|585148796|FG002|PCP|Lost to Follow-up|0|||
162024984|NCT04556383|585148797|FG003|PCP|Lost to Follow-up|0|||
162024985|NCT04556383|585148794|FG000|PCP|Physician Decision|0|||
162024986|NCT04556383|585148795|FG001|PCP|Physician Decision|1|||
162024987|NCT04556383|585148796|FG002|PCP|Physician Decision|0|||
162024988|NCT04556383|585148797|FG003|PCP|Physician Decision|0|||
162024989|NCT04556383|585148794|FG000|PCP|Site terminated by sponsor|0|||
162024990|NCT04556383|585148795|FG001|PCP|Site terminated by sponsor|1|||
162024991|NCT04556383|585148796|FG002|PCP|Site terminated by sponsor|0|||
162024992|NCT04556383|585148797|FG003|PCP|Site terminated by sponsor|0|||
162024993|NCT04556383|585148794|FG000|OLE|Study terminated by sponsor|0|||
162024994|NCT04556383|585148795|FG001|OLE|Study terminated by sponsor|0|||
162024995|NCT04556383|585148796|FG002|OLE|Study terminated by sponsor|0|||
162024996|NCT04556383|585148797|FG003|OLE|Study terminated by sponsor|68|||
162024997|NCT04556383|585148794|FG000|OLE|Withdrawal by Subject|0|||
162024998|NCT04556383|585148795|FG001|OLE|Withdrawal by Subject|0|||
162024999|NCT04556383|585148796|FG002|OLE|Withdrawal by Subject|0|||
162025000|NCT04556383|585148797|FG003|OLE|Withdrawal by Subject|10|||
162025001|NCT04556383|585148794|FG000|OLE|Lack of Efficacy|0|||
162025002|NCT04556383|585148795|FG001|OLE|Lack of Efficacy|0|||
162025003|NCT04556383|585148796|FG002|OLE|Lack of Efficacy|0|||
162025004|NCT04556383|585148797|FG003|OLE|Lack of Efficacy|7|||
162025005|NCT04556383|585148794|FG000|OLE|Adverse Event|0|||
162025006|NCT04556383|585148795|FG001|OLE|Adverse Event|0|||
162025007|NCT04556383|585148796|FG002|OLE|Adverse Event|0|||
162025008|NCT04556383|585148797|FG003|OLE|Adverse Event|2|||
162025009|NCT04556383|585148794|FG000|OLE|Other, Not Specified|0|||
162025010|NCT04556383|585148795|FG001|OLE|Other, Not Specified|0|||
162025011|NCT04556383|585148796|FG002|OLE|Other, Not Specified|0|||
162025012|NCT04556383|585148797|FG003|OLE|Other, Not Specified|2|||
162025013|NCT04556383|585148794|FG000|OLE|Death|0|||
162025014|NCT04556383|585148795|FG001|OLE|Death|0|||
162025015|NCT04556383|585148796|FG002|OLE|Death|0|||
162025016|NCT04556383|585148797|FG003|OLE|Death|1|||
162025017|NCT04556383|585148794|FG000|OLE|Lost to Follow-up|0|||
162025018|NCT04556383|585148795|FG001|OLE|Lost to Follow-up|0|||
162025019|NCT04556383|585148796|FG002|OLE|Lost to Follow-up|0|||
162025020|NCT04556383|585148797|FG003|OLE|Lost to Follow-up|1|||
162025021|NCT03704636|585148803|FG000|Overall Study|Inadequate Venous Flow|3|||
162025022|NCT02720042|585148804|FG000|Overall Study|Death|3|||
162025023|NCT02720042|585148804|FG000|Overall Study|Lost to Follow-up|4|||
162025024|NCT02720042|585148804|FG000|Overall Study|Withdrawal by Subject|1|||
162025025|NCT02720042|585148804|FG000|Overall Study|Physician Decision|3|||
162025026|NCT02720042|585148804|FG000|Overall Study|Phasix Mesh explanted|1|||
162025027|NCT02720042|585148804|FG000|Overall Study|unable due to non-study-related illness|3|||
162025028|NCT00539188|585148805|FG000|Overall Study|Withdrawal by Subject|1|||
162025029|NCT00539188|585148806|FG001|Overall Study|Withdrawal by Subject|0|||
162025030|NCT00539188|585148805|FG000|Overall Study|Lost to Follow-up|2|||
162025031|NCT00539188|585148806|FG001|Overall Study|Lost to Follow-up|1|||
161829988|NCT02075606|584418079|FG000|Overall Study|Withdrawal by Subject|1|||
161829989|NCT02075606|584418079|FG000|Overall Study|Death|1|||
161829990|NCT02075606|584418079|FG000|Overall Study|Investigator's decision|1|||
162025032|NCT04784442|585148807|FG000|Overall Study|Adverse Event|1|||
162025033|NCT04784442|585148808|FG001|Overall Study|Adverse Event|0|||
162025034|NCT04784442|585148809|FG002|Overall Study|Adverse Event|2|||
162025035|NCT04784442|585148810|FG003|Overall Study|Adverse Event|1|||
161829991|NCT02075606|584418079|FG000|Overall Study|Symptom management|1|||
162025036|NCT04784442|585148807|FG000|Overall Study|Protocol Violation|1|||
161829992|NCT02075606|584418079|FG000|Overall Study|Increasing Symptoms|1|||
162025037|NCT04784442|585148808|FG001|Overall Study|Protocol Violation|0|||
162025038|NCT04784442|585148809|FG002|Overall Study|Protocol Violation|0|||
162025039|NCT04784442|585148810|FG003|Overall Study|Protocol Violation|0|||
162025040|NCT04784442|585148807|FG000|Overall Study|Non-compliance with study drug|1|||
162025041|NCT04784442|585148808|FG001|Overall Study|Non-compliance with study drug|0|||
162025042|NCT04784442|585148809|FG002|Overall Study|Non-compliance with study drug|0|||
162025043|NCT04784442|585148810|FG003|Overall Study|Non-compliance with study drug|0|||
162025044|NCT00509145|585148811|FG000|Overall Study|Death|0|||
162025045|NCT00509145|585148812|FG001|Overall Study|Death|2|||
162025046|NCT00509145|585148811|FG000|Overall Study|Adverse Event|42|||
162025047|NCT00509145|585148812|FG001|Overall Study|Adverse Event|28|||
162025048|NCT00509145|585148811|FG000|Overall Study|Withdrawal by Subject|32|||
162025049|NCT00509145|585148812|FG001|Overall Study|Withdrawal by Subject|38|||
162025050|NCT00509145|585148811|FG000|Overall Study|Physician Decision|11|||
162025051|NCT00509145|585148812|FG001|Overall Study|Physician Decision|14|||
162025052|NCT00509145|585148811|FG000|Overall Study|Protocol Violation|1|||
162025053|NCT00509145|585148812|FG001|Overall Study|Protocol Violation|6|||
162025054|NCT00509145|585148811|FG000|Overall Study|Pregnancy|3|||
162025055|NCT00509145|585148812|FG001|Overall Study|Pregnancy|8|||
162025056|NCT00509145|585148811|FG000|Overall Study|Lost to Follow-up|6|||
162025057|NCT00509145|585148812|FG001|Overall Study|Lost to Follow-up|5|||
161680390|NCT01970488|583882919|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
161680391|NCT01970488|583882920|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
161680392|NCT01970488|583882921|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
161680393|NCT01970488|583882922|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
161680394|NCT01970488|583882918|FG000|Part 2: Post Week 16|Adverse Event|0|||
161680395|NCT01970488|583882919|FG001|Part 2: Post Week 16|Adverse Event|0|||
161680396|NCT01970488|583882920|FG002|Part 2: Post Week 16|Adverse Event|5|||
161680397|NCT01970488|583882921|FG003|Part 2: Post Week 16|Adverse Event|1|||
161680398|NCT01970488|583882922|FG004|Part 2: Post Week 16|Adverse Event|1|||
161680399|NCT01970488|583882918|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
161680400|NCT01970488|583882919|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
161680401|NCT01970488|583882920|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
161680402|NCT01970488|583882921|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
161680403|NCT01970488|583882922|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
161680404|NCT01970488|583882918|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
161680405|NCT01970488|583882919|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
161680406|NCT01970488|583882920|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
161680407|NCT01970488|583882921|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
161680408|NCT01970488|583882922|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
161680409|NCT05525689|583882924|FG000|Overall Study|Lost to Follow-up|1|||
161680410|NCT05525689|583882925|FG001|Overall Study|Lost to Follow-up|0|||
161680411|NCT01231659|583882926|FG000|Overall Study|Adverse Event|9|||
161680412|NCT01231659|583882926|FG000|Overall Study|Disease Progression|48|||
161680413|NCT01231659|583882926|FG000|Overall Study|Death|2|||
161680414|NCT01231659|583882926|FG000|Overall Study|Patient refused to complete study visit|1|||
161940770|NCT02989857|584833716|FG002|Randomization Phase|Not Treated|0|||
161680415|NCT01231659|583882926|FG000|Overall Study|Other protocol defined criteria|12|||
161680416|NCT01075412|583882927|FG000|Overall Study|Withdrawal by Subject|0|||
161680417|NCT01075412|583882928|FG001|Overall Study|Withdrawal by Subject|1|||
161680418|NCT00509067|583882929|FG000|Overall Study|Lost to Follow-up|1|||
161680419|NCT00509067|583882930|FG001|Overall Study|Lost to Follow-up|1|||
161680420|NCT00509067|583882929|FG000|Overall Study|Adverse Event|3|||
161680421|NCT00509067|583882930|FG001|Overall Study|Adverse Event|1|||
161680422|NCT00509067|583882929|FG000|Overall Study|Protocol Violation|0|||
161680423|NCT00509067|583882930|FG001|Overall Study|Protocol Violation|3|||
161680424|NCT00702325|583882942|FG000|Overall Study|Adverse Event|1|||
161680425|NCT00702325|583882943|FG001|Overall Study|Adverse Event|0|||
161680426|NCT00702325|583882942|FG000|Overall Study|Withdrawal by Subject|7|||
161680427|NCT00702325|583882943|FG001|Overall Study|Withdrawal by Subject|7|||
161680428|NCT00702325|583882942|FG000|Overall Study|Lost to Follow-up|3|||
161680429|NCT00702325|583882943|FG001|Overall Study|Lost to Follow-up|4|||
161940771|NCT01992757|584833717|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
161940772|NCT00688740|584833721|FG000|Overall Study|Adverse Event|45|||
161940773|NCT00688740|584833722|FG001|Overall Study|Adverse Event|8|||
161940774|NCT00688740|584833721|FG000|Overall Study|Death|2|||
161940775|NCT00688740|584833722|FG001|Overall Study|Death|2|||
161940776|NCT00688740|584833721|FG000|Overall Study|Lost to Follow-up|0|||
161940777|NCT00688740|584833722|FG001|Overall Study|Lost to Follow-up|1|||
161940778|NCT00688740|584833721|FG000|Overall Study|Consent Withdrawn|17|||
161940779|NCT00688740|584833722|FG001|Overall Study|Consent Withdrawn|17|||
161940780|NCT00688740|584833721|FG000|Overall Study|Breast Cancer Relapse|1|||
161940781|NCT00688740|584833722|FG001|Overall Study|Breast Cancer Relapse|4|||
161940782|NCT00688740|584833721|FG000|Overall Study|Violation of Inclusion Criteria|1|||
161940783|NCT00688740|584833722|FG001|Overall Study|Violation of Inclusion Criteria|3|||
161940784|NCT01344356|584833723|FG000|Overall Study|Physician Decision|0|||
161940785|NCT01344356|584833724|FG001|Overall Study|Physician Decision|3|||
161940786|NCT01344356|584833723|FG000|Overall Study|Lost to Follow-up|0|||
161940787|NCT01344356|584833724|FG001|Overall Study|Lost to Follow-up|6|||
161940788|NCT04484857|584833725|FG000|Overall Study|Adverse Event|2|||
161940789|NCT04484857|584833725|FG000|Overall Study|Death|10|||
161940790|NCT04484857|584833725|FG000|Overall Study|Withdrawal by Subject|3|||
161940791|NCT04484857|584833725|FG000|Overall Study|Transferred/Relocation|5|||
161940792|NCT04484857|584833725|FG000|Overall Study|Kidney Transplant|7|||
161940793|NCT04484857|584833725|FG000|Overall Study|Other than specified|4|||
161940794|NCT04484857|584833725|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
161940795|NCT02390076|584833728|FG000|Overall Study|Lost to Follow-up|2|||
161940796|NCT02390076|584833729|FG001|Overall Study|Lost to Follow-up|1|||
161680430|NCT00702325|583882942|FG000|Overall Study|Incorrect enrollment|5|||
161940797|NCT02390076|584833730|FG002|Overall Study|Lost to Follow-up|4|||
161940798|NCT04507204|584833731|FG000|Overall Study|Adverse Event|8|||
161940799|NCT04507204|584833732|FG001|Overall Study|Adverse Event|13|||
161680431|NCT00702325|583882943|FG001|Overall Study|Incorrect enrollment|7|||
161680432|NCT00702325|583882942|FG000|Overall Study|Developed study discontinuation criteria|18|||
161680433|NCT00702325|583882943|FG001|Overall Study|Developed study discontinuation criteria|28|||
161680434|NCT00702325|583882942|FG000|Overall Study|Severe noncompliance to protocol|3|||
161680435|NCT00702325|583882943|FG001|Overall Study|Severe noncompliance to protocol|3|||
162231744|NCT02663518|585897592|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
162231745|NCT02663518|585897593|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
162231746|NCT02663518|585897594|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
162231747|NCT02663518|585897595|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
162231748|NCT02663518|585897596|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
162231749|NCT02663518|585897597|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
162231750|NCT02663518|585897584|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231751|NCT02663518|585897585|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231752|NCT02663518|585897586|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231753|NCT02663518|585897587|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231754|NCT02663518|585897588|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231755|NCT02663518|585897589|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231756|NCT02663518|585897590|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
162231757|NCT02663518|585897591|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231758|NCT02663518|585897592|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231759|NCT02663518|585897593|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231760|NCT02663518|585897594|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231761|NCT02663518|585897595|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231762|NCT02663518|585897596|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231763|NCT02663518|585897597|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
162231764|NCT02663518|585897584|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
162231765|NCT02663518|585897585|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
162231766|NCT02663518|585897586|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
162231767|NCT02663518|585897587|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
162231768|NCT02663518|585897588|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
162231769|NCT02663518|585897589|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
162231770|NCT02663518|585897590|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
162231771|NCT02663518|585897591|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
162231772|NCT02663518|585897592|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
162231773|NCT02663518|585897593|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
162231774|NCT02663518|585897594|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
161680436|NCT00702325|583882942|FG000|Overall Study|Termination due to lab results|1|||
161940800|NCT04507204|584833731|FG000|Overall Study|Death|0|||
161940801|NCT04507204|584833732|FG001|Overall Study|Death|1|||
162231775|NCT02663518|585897595|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
162231776|NCT02663518|585897596|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
162231777|NCT02663518|585897597|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
162231778|NCT02663518|585897584|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162231779|NCT02663518|585897585|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162231780|NCT02663518|585897586|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162231781|NCT02663518|585897587|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162231782|NCT02663518|585897588|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162231783|NCT02663518|585897589|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162231784|NCT02663518|585897590|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162231785|NCT02663518|585897591|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161940802|NCT04507204|584833731|FG000|Overall Study|Lost to Follow-up|15|||
161940803|NCT04507204|584833732|FG001|Overall Study|Lost to Follow-up|14|||
161940804|NCT04507204|584833731|FG000|Overall Study|Poor Compliance with Protocol|2|||
162231786|NCT02663518|585897592|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162231787|NCT02663518|585897593|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162231788|NCT02663518|585897594|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161680437|NCT00702325|583882943|FG001|Overall Study|Termination due to lab results|0|||
162231789|NCT02663518|585897595|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162231790|NCT02663518|585897596|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
162231791|NCT02663518|585897597|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
162231792|NCT02663518|585897584|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231793|NCT02663518|585897585|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231794|NCT02663518|585897586|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231795|NCT02663518|585897587|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231796|NCT02663518|585897588|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231797|NCT02663518|585897589|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231798|NCT02663518|585897590|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231799|NCT02663518|585897591|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231800|NCT02663518|585897592|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231801|NCT02663518|585897593|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231802|NCT02663518|585897594|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231803|NCT02663518|585897595|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
162231804|NCT02663518|585897596|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231805|NCT02663518|585897597|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
162231806|NCT02663518|585897584|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162231807|NCT02663518|585897585|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162231808|NCT02663518|585897586|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162231809|NCT02663518|585897587|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162231810|NCT02663518|585897588|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162231811|NCT02663518|585897589|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162231812|NCT02663518|585897590|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162231813|NCT02663518|585897591|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162231814|NCT02663518|585897592|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
162231815|NCT02663518|585897593|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
162231816|NCT02663518|585897594|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161680438|NCT00702325|583882942|FG000|Overall Study|Didn't follow study medication dosage|0|||
161680439|NCT00702325|583882943|FG001|Overall Study|Didn't follow study medication dosage|2|||
161680440|NCT00702325|583882942|FG000|Overall Study|Withdrew consent|0|||
161680441|NCT00702325|583882943|FG001|Overall Study|Withdrew consent|1|||
161829993|NCT00983476|584418080|FG000|Overall Study|Did not receive intervention|17|||
161829994|NCT00983476|584418081|FG001|Overall Study|Did not receive intervention|22|||
161680442|NCT00702325|583882942|FG000|Overall Study|Incorrectly Discontinued|0|||
161829995|NCT00983476|584418082|FG002|Overall Study|Did not receive intervention|0|||
161829996|NCT01439724|584418084|FG000|Overall Study|missing consultation|9|||
161829997|NCT01439724|584418085|FG001|Overall Study|missing consultation|8|||
161829998|NCT00575380|584418090|FG000|Overall Study|Withdrawal by Subject|1|||
161829999|NCT00575380|584418091|FG001|Overall Study|Withdrawal by Subject|0|||
161830000|NCT00575380|584418090|FG000|Overall Study|Adverse Event|0|||
161830001|NCT00575380|584418091|FG001|Overall Study|Adverse Event|1|||
161830002|NCT00575380|584418090|FG000|Overall Study|Various|0|||
161830003|NCT00575380|584418091|FG001|Overall Study|Various|2|||
161830004|NCT04019054|584418092|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
161830005|NCT04019054|584418093|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
161830006|NCT04019054|584418092|FG000|Overall Study|Withdrawal by Subject|3|||
161830007|NCT04019054|584418093|FG001|Overall Study|Withdrawal by Subject|1|||
161830008|NCT01040793|584418094|FG000|Overall Study|Adverse Event|5|||
161830009|NCT01040793|584418095|FG001|Overall Study|Adverse Event|3|||
161830010|NCT01040793|584418096|FG002|Overall Study|Adverse Event|0|||
161830011|NCT01040793|584418097|FG003|Overall Study|Adverse Event|2|||
161830012|NCT01040793|584418098|FG004|Overall Study|Adverse Event|2|||
161830013|NCT01040793|584418099|FG005|Overall Study|Adverse Event|1|||
161830014|NCT01040793|584418094|FG000|Overall Study|Protocol Violation|1|||
161830015|NCT01040793|584418095|FG001|Overall Study|Protocol Violation|1|||
161830016|NCT01040793|584418096|FG002|Overall Study|Protocol Violation|1|||
161830017|NCT01040793|584418097|FG003|Overall Study|Protocol Violation|0|||
161830018|NCT01040793|584418098|FG004|Overall Study|Protocol Violation|1|||
161830019|NCT01040793|584418099|FG005|Overall Study|Protocol Violation|0|||
161830020|NCT01040793|584418094|FG000|Overall Study|Lost to Follow-up|0|||
161830021|NCT01040793|584418095|FG001|Overall Study|Lost to Follow-up|1|||
161830022|NCT01040793|584418096|FG002|Overall Study|Lost to Follow-up|1|||
161830023|NCT01040793|584418097|FG003|Overall Study|Lost to Follow-up|0|||
161830024|NCT01040793|584418098|FG004|Overall Study|Lost to Follow-up|0|||
161830025|NCT01040793|584418099|FG005|Overall Study|Lost to Follow-up|0|||
161830026|NCT01040793|584418094|FG000|Overall Study|Withdrawal by Subject|0|||
161830027|NCT01040793|584418095|FG001|Overall Study|Withdrawal by Subject|0|||
161830028|NCT01040793|584418096|FG002|Overall Study|Withdrawal by Subject|0|||
162231817|NCT02663518|585897595|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
162231818|NCT02663518|585897596|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
162231819|NCT02663518|585897597|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
162231820|NCT02663518|585897584|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
162231821|NCT02663518|585897585|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
162231822|NCT02663518|585897586|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
162231823|NCT02663518|585897587|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
162231824|NCT02663518|585897588|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
162231825|NCT02663518|585897589|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
162231826|NCT02663518|585897590|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
162231827|NCT02663518|585897591|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
162231828|NCT02663518|585897592|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
162231829|NCT02663518|585897593|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
162231830|NCT02663518|585897594|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
162231831|NCT02663518|585897595|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
162231832|NCT02663518|585897596|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
162231833|NCT02663518|585897597|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
162231834|NCT02663518|585897584|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231835|NCT02663518|585897585|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231836|NCT02663518|585897586|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231837|NCT02663518|585897587|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231838|NCT02663518|585897588|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231839|NCT02663518|585897589|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231840|NCT02663518|585897590|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231841|NCT02663518|585897591|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231842|NCT02663518|585897592|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231843|NCT02663518|585897593|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231844|NCT02663518|585897594|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231845|NCT02663518|585897595|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231846|NCT02663518|585897596|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
162231847|NCT02663518|585897597|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
162231848|NCT01004848|585897598|FG000|Overall Study|Lost to Follow-up|55|||
162231849|NCT01004848|585897599|FG001|Overall Study|Lost to Follow-up|45|||
162231850|NCT03215810|585897600|FG000|Overall Study|Still responding to nivolumab|1|||
162231851|NCT03215810|585897600|FG000|Overall Study|Insufficient TIL growth|1|||
162231852|NCT03215810|585897600|FG000|Overall Study|Decline in performance status|1|||
162231853|NCT03215810|585897600|FG000|Overall Study|Withdrawal by Subject|1|||
162231854|NCT01157676|585897607|FG000|Randomization|Death|1|||
162231855|NCT01157676|585897608|FG001|Randomization|Death|1|||
162231856|NCT01157676|585897607|FG000|Randomization|unresectable|2|||
162231857|NCT01157676|585897608|FG001|Randomization|unresectable|3|||
162231858|NCT01157676|585897607|FG000|Randomization|Withdrawal by Subject|17|||
162231859|NCT01157676|585897608|FG001|Randomization|Withdrawal by Subject|13|||
162231860|NCT01157676|585897607|FG000|Randomization|Physician Decision|1|||
162231861|NCT01157676|585897608|FG001|Randomization|Physician Decision|0|||
162231862|NCT01157676|585897607|FG000|Surgery|underwent open cystectomy|0|||
162231863|NCT01157676|585897608|FG001|Surgery|underwent open cystectomy|4|||
162231864|NCT01157676|585897607|FG000|Surgery|converted to open procedure|0|||
162231865|NCT01157676|585897608|FG001|Surgery|converted to open procedure|5|||
162231866|NCT01157676|585897607|FG000|Surgery|underwent robotic cystectomy|1|||
162231867|NCT01157676|585897608|FG001|Surgery|underwent robotic cystectomy|0|||
162231868|NCT00682890|585897609|FG000|Overall Study|Lost to Follow-up|1|||
162231869|NCT00682890|585897610|FG001|Overall Study|Lost to Follow-up|1|||
162231870|NCT00682890|585897609|FG000|Overall Study|subject moved away|0|||
162231871|NCT00682890|585897610|FG001|Overall Study|subject moved away|1|||
162231872|NCT00682890|585897609|FG000|Overall Study|heavy menstrual bleeding|1|||
162231873|NCT00682890|585897610|FG001|Overall Study|heavy menstrual bleeding|0|||
162231874|NCT00141219|585897613|FG000|Overall Study|Protocol violations|5|||
162231875|NCT00141219|585897614|FG001|Overall Study|Protocol violations|4|||
162231876|NCT00141219|585897613|FG000|Overall Study|Adverse Event|8|||
162231877|NCT00141219|585897614|FG001|Overall Study|Adverse Event|6|||
162231878|NCT00141219|585897613|FG000|Overall Study|Lack of Efficacy|5|||
162231879|NCT00141219|585897614|FG001|Overall Study|Lack of Efficacy|4|||
162231880|NCT00141219|585897613|FG000|Overall Study|Withdrawal by Subject|6|||
162231881|NCT00141219|585897614|FG001|Overall Study|Withdrawal by Subject|2|||
162231882|NCT01577745|585897615|FG000|Overall Study|Withdrawal by Subject|0|||
162231883|NCT01577745|585897616|FG001|Overall Study|Withdrawal by Subject|1|||
162231884|NCT01577745|585897617|FG002|Overall Study|Withdrawal by Subject|0|||
162231885|NCT01577745|585897618|FG003|Overall Study|Withdrawal by Subject|3|||
162231886|NCT01577745|585897619|FG004|Overall Study|Withdrawal by Subject|2|||
162231887|NCT01577745|585897620|FG005|Overall Study|Withdrawal by Subject|0|||
162231888|NCT01577745|585897615|FG000|Overall Study|Death|3|||
162231889|NCT01577745|585897616|FG001|Overall Study|Death|2|||
162231890|NCT01577745|585897617|FG002|Overall Study|Death|2|||
162231891|NCT01577745|585897618|FG003|Overall Study|Death|1|||
162231892|NCT01577745|585897619|FG004|Overall Study|Death|1|||
162231893|NCT01577745|585897620|FG005|Overall Study|Death|3|||
162231894|NCT01577745|585897615|FG000|Overall Study|Physician Decision|0|||
162231895|NCT01577745|585897616|FG001|Overall Study|Physician Decision|0|||
162231896|NCT01577745|585897617|FG002|Overall Study|Physician Decision|0|||
162231897|NCT01577745|585897618|FG003|Overall Study|Physician Decision|1|||
162231898|NCT01577745|585897619|FG004|Overall Study|Physician Decision|1|||
162231899|NCT01577745|585897620|FG005|Overall Study|Physician Decision|0|||
162231900|NCT01577745|585897615|FG000|Overall Study|Lost to Follow-up|0|||
162231901|NCT01577745|585897616|FG001|Overall Study|Lost to Follow-up|0|||
162231902|NCT01577745|585897617|FG002|Overall Study|Lost to Follow-up|0|||
162231903|NCT01577745|585897618|FG003|Overall Study|Lost to Follow-up|0|||
162231904|NCT01577745|585897619|FG004|Overall Study|Lost to Follow-up|0|||
162231905|NCT01577745|585897620|FG005|Overall Study|Lost to Follow-up|1|||
162231906|NCT01577745|585897615|FG000|Overall Study|Alternative Therapy|0|||
162231907|NCT01577745|585897616|FG001|Overall Study|Alternative Therapy|0|||
162231908|NCT01577745|585897617|FG002|Overall Study|Alternative Therapy|0|||
162231909|NCT01577745|585897618|FG003|Overall Study|Alternative Therapy|1|||
162231910|NCT01577745|585897619|FG004|Overall Study|Alternative Therapy|1|||
162231911|NCT01577745|585897620|FG005|Overall Study|Alternative Therapy|0|||
162231912|NCT02971761|585897622|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
162231913|NCT02624791|585897623|FG000|Overall Study|Withdrawal by Subject|2|||
162231914|NCT02624791|585897624|FG001|Overall Study|Withdrawal by Subject|0|||
162231915|NCT02624791|585897625|FG002|Overall Study|Withdrawal by Subject|0|||
162231916|NCT02624791|585897626|FG003|Overall Study|Withdrawal by Subject|0|||
162231917|NCT02624791|585897627|FG004|Overall Study|Withdrawal by Subject|0|||
162231918|NCT02624791|585897628|FG005|Overall Study|Withdrawal by Subject|0|||
162231919|NCT01146782|585897632|FG000|Screening Cohort|Screen Failure|187|||
161940805|NCT04507204|584833732|FG001|Overall Study|Poor Compliance with Protocol|4|||
161940806|NCT04507204|584833731|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
161940807|NCT04507204|584833732|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
161940808|NCT04507204|584833731|FG000|Overall Study|Withdrawal of Patient Consent|21|||
161940809|NCT04507204|584833732|FG001|Overall Study|Withdrawal of Patient Consent|13|||
161940810|NCT01206517|584833733|FG000|Overall Study|Withdrawal by Subject|0|||
161940811|NCT01206517|584833734|FG001|Overall Study|Withdrawal by Subject|0|||
161940812|NCT01206517|584833735|FG002|Overall Study|Withdrawal by Subject|2|||
161940813|NCT01206517|584833736|FG003|Overall Study|Withdrawal by Subject|0|||
161940814|NCT01206517|584833737|FG004|Overall Study|Withdrawal by Subject|1|||
161940815|NCT01206517|584833738|FG005|Overall Study|Withdrawal by Subject|0|||
161940816|NCT04770285|584833744|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
161940817|NCT04770285|584833745|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
161940818|NCT04770285|584833744|FG000|Overall Study|Lack of Efficacy|0|||
161940819|NCT04770285|584833745|FG001|Overall Study|Lack of Efficacy|1|||
161940820|NCT04770285|584833744|FG000|Overall Study|Lost to Follow-up|11|||
161940821|NCT04770285|584833745|FG001|Overall Study|Lost to Follow-up|8|||
161940822|NCT04770285|584833744|FG000|Overall Study|Protocol Deviation|6|||
161940823|NCT04770285|584833745|FG001|Overall Study|Protocol Deviation|6|||
161940824|NCT04770285|584833744|FG000|Overall Study|Technical Problem|0|||
161940825|NCT04770285|584833745|FG001|Overall Study|Technical Problem|1|||
161940826|NCT04770285|584833744|FG000|Overall Study|Withdrawal by Subject|9|||
161940827|NCT04770285|584833745|FG001|Overall Study|Withdrawal by Subject|8|||
161940828|NCT04770285|584833744|FG000|Overall Study|Reason Not Specified|0|||
161940829|NCT04770285|584833745|FG001|Overall Study|Reason Not Specified|1|||
161940830|NCT00645658|584833746|FG000|Overall Study|Withdrawal by Subject|1|||
161940831|NCT00645658|584833747|FG001|Overall Study|Withdrawal by Subject|0|||
161940832|NCT00645658|584833746|FG000|Overall Study|Did not complete all assesments|0|||
161940833|NCT00645658|584833747|FG001|Overall Study|Did not complete all assesments|2|||
161940834|NCT03093415|584833750|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
161940835|NCT03093415|584833751|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
161940836|NCT03093415|584833752|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
161940837|NCT03093415|584833750|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
161940838|NCT03093415|584833751|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
161940839|NCT03093415|584833752|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
161940840|NCT03093415|584833750|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
162025058|NCT00509145|585148811|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
162231920|NCT01146782|585897632|FG000|Screening Cohort|Lost to Follow-up|4|||
162231921|NCT01146782|585897632|FG000|Screening Cohort|Physician Decision|1|||
162231922|NCT01146782|585897632|FG000|Screening Cohort|Withdrawal by Subject|29|||
162231923|NCT01146782|585897632|FG000|Safety Cohort|Screen Failure|61|||
162231924|NCT01146782|585897632|FG000|Safety Cohort|Withdrawal by Subject|4|||
162231925|NCT01146782|585897632|FG000|Safety Cohort|Control AHI <5|4|||
162231926|NCT01146782|585897632|FG000|Safety Cohort|TST <4 hrs|14|||
162231927|NCT01146782|585897632|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
162231928|NCT01146782|585897632|FG000|Primary Endpoint Cohort|Physician Decision|1|||
162231929|NCT01605916|585897633|FG000|Overall Study|Adverse Event|1|||
162231930|NCT01605916|585897634|FG001|Overall Study|Adverse Event|0|||
162231931|NCT01605916|585897635|FG002|Overall Study|Adverse Event|0|||
162231932|NCT01605916|585897636|FG003|Overall Study|Adverse Event|1|||
162231933|NCT01605916|585897637|FG004|Overall Study|Adverse Event|0|||
162231934|NCT01605916|585897633|FG000|Overall Study|Lack of Efficacy|2|||
162231935|NCT01605916|585897634|FG001|Overall Study|Lack of Efficacy|3|||
162231936|NCT01605916|585897635|FG002|Overall Study|Lack of Efficacy|3|||
162231937|NCT01605916|585897636|FG003|Overall Study|Lack of Efficacy|5|||
162231938|NCT01605916|585897637|FG004|Overall Study|Lack of Efficacy|4|||
162231939|NCT01605916|585897633|FG000|Overall Study|Withdrawal by Subject|1|||
162231940|NCT01605916|585897634|FG001|Overall Study|Withdrawal by Subject|1|||
162231941|NCT01605916|585897635|FG002|Overall Study|Withdrawal by Subject|0|||
162231942|NCT01605916|585897636|FG003|Overall Study|Withdrawal by Subject|0|||
162231943|NCT01605916|585897637|FG004|Overall Study|Withdrawal by Subject|2|||
162231944|NCT02842151|585897640|FG000|Overall Study|Adverse Event|1|||
162231945|NCT02842151|585897640|FG000|Overall Study|Subject moved too far away|1|||
162231946|NCT00438672|585897641|FG000|Overall Study|Lost to Follow-up|7|||
162231947|NCT00438672|585897642|FG001|Overall Study|Lost to Follow-up|9|||
162025059|NCT00509145|585148812|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
162231948|NCT03965351|585897645|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
162231949|NCT03965351|585897646|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
162231950|NCT03965351|585897645|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
162231951|NCT03965351|585897646|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
162231952|NCT02432196|585897649|FG000|Overall Study|Exit - did not receive study device|1|||
162231953|NCT02432196|585897649|FG000|Overall Study|Death|2|||
162231954|NCT02432196|585897649|FG000|Overall Study|Reoperation|3|||
162231955|NCT01942785|585897653|FG000|Overall Study|Adverse Event|2|||
162231956|NCT01942785|585897653|FG000|Overall Study|Withdrawal by Subject|1|||
162231957|NCT01942785|585897653|FG000|Overall Study|Protocol Violation|1|||
162231958|NCT01905150|585897657|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
162231959|NCT01905150|585897658|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
162231960|NCT01147536|585897659|FG000|Overall Study|Administrative study close|2|||
162231961|NCT01147536|585897659|FG000|Overall Study|Death|1|||
162231962|NCT00935818|585897660|FG000|Overall Study|Withdrawal by Subject|45|||
162231963|NCT00935818|585897661|FG001|Overall Study|Withdrawal by Subject|50|||
162231964|NCT00935818|585897660|FG000|Overall Study|Lost to Follow-up|40|||
162231965|NCT00935818|585897661|FG001|Overall Study|Lost to Follow-up|42|||
162231966|NCT00935818|585897660|FG000|Overall Study|Adverse Event|6|||
162231967|NCT00935818|585897661|FG001|Overall Study|Adverse Event|7|||
162231968|NCT00935818|585897660|FG000|Overall Study|Physician Decision|0|||
162231969|NCT00935818|585897661|FG001|Overall Study|Physician Decision|1|||
162231970|NCT02631577|585897662|FG000|Overall Study|Death|1|||
162231971|NCT02631577|585897663|FG001|Overall Study|Death|7|||
162231972|NCT02631577|585897662|FG000|Overall Study|Withdrawal by Subject|0|||
162231973|NCT02631577|585897663|FG001|Overall Study|Withdrawal by Subject|3|||
162231974|NCT00604825|585897666|FG000|Overall Study|Adverse Event|2|||
162231975|NCT00604825|585897667|FG001|Overall Study|Adverse Event|6|||
162231976|NCT00604825|585897668|FG002|Overall Study|Adverse Event|7|||
162231977|NCT00604825|585897669|FG003|Overall Study|Adverse Event|4|||
162025060|NCT00509145|585148811|FG000|Overall Study|Other|6|||
162025061|NCT00509145|585148812|FG001|Overall Study|Other|6|||
162231978|NCT00604825|585897666|FG000|Overall Study|Lost to Follow-up|0|||
162231979|NCT00604825|585897667|FG001|Overall Study|Lost to Follow-up|3|||
162231980|NCT00604825|585897668|FG002|Overall Study|Lost to Follow-up|1|||
162231981|NCT00604825|585897669|FG003|Overall Study|Lost to Follow-up|0|||
162231982|NCT00604825|585897666|FG000|Overall Study|Protocol Violation|0|||
162231983|NCT00604825|585897667|FG001|Overall Study|Protocol Violation|1|||
162231984|NCT00604825|585897668|FG002|Overall Study|Protocol Violation|0|||
162231985|NCT00604825|585897669|FG003|Overall Study|Protocol Violation|0|||
162025062|NCT01994889|585148815|FG000|Overall Study|Adverse Event|5|||
162025063|NCT01994889|585148816|FG001|Overall Study|Adverse Event|12|||
162025064|NCT01994889|585148817|FG002|Overall Study|Adverse Event|11|||
162231986|NCT00604825|585897666|FG000|Overall Study|Withdrawal by Subject|4|||
162231987|NCT00604825|585897667|FG001|Overall Study|Withdrawal by Subject|3|||
162231988|NCT00604825|585897668|FG002|Overall Study|Withdrawal by Subject|5|||
162231989|NCT00604825|585897669|FG003|Overall Study|Withdrawal by Subject|5|||
161680443|NCT00702325|583882943|FG001|Overall Study|Incorrectly Discontinued|1|||
162025065|NCT01994889|585148815|FG000|Overall Study|Cardiac Device Implantation|0|||
162025066|NCT01994889|585148816|FG001|Overall Study|Cardiac Device Implantation|2|||
162025067|NCT01994889|585148817|FG002|Overall Study|Cardiac Device Implantation|0|||
162231990|NCT00604825|585897666|FG000|Overall Study|Lack of Efficacy|3|||
162231991|NCT00604825|585897667|FG001|Overall Study|Lack of Efficacy|2|||
162231992|NCT00604825|585897668|FG002|Overall Study|Lack of Efficacy|1|||
162231993|NCT00604825|585897669|FG003|Overall Study|Lack of Efficacy|0|||
162231994|NCT00604825|585897666|FG000|Overall Study|Did not meet eligibility criteria|0|||
162231995|NCT00604825|585897667|FG001|Overall Study|Did not meet eligibility criteria|0|||
162231996|NCT00604825|585897668|FG002|Overall Study|Did not meet eligibility criteria|2|||
162231997|NCT00604825|585897669|FG003|Overall Study|Did not meet eligibility criteria|0|||
162231998|NCT00604825|585897666|FG000|Overall Study|Physician Decision|0|||
162231999|NCT00604825|585897667|FG001|Overall Study|Physician Decision|0|||
162232000|NCT00604825|585897668|FG002|Overall Study|Physician Decision|0|||
162232001|NCT00604825|585897669|FG003|Overall Study|Physician Decision|1|||
162232002|NCT00604825|585897666|FG000|Overall Study|Exclusion criterion met|0|||
162232003|NCT00604825|585897667|FG001|Overall Study|Exclusion criterion met|0|||
162232004|NCT00604825|585897668|FG002|Overall Study|Exclusion criterion met|0|||
162232005|NCT00604825|585897669|FG003|Overall Study|Exclusion criterion met|1|||
162232006|NCT03465904|585897670|FG000|Overall Study|Withdrawal by Subject|9|||
162232007|NCT03465904|585897671|FG001|Overall Study|Withdrawal by Subject|5|||
162232008|NCT03465904|585897670|FG000|Overall Study|Lost to Follow-up|11|||
162232009|NCT03465904|585897671|FG001|Overall Study|Lost to Follow-up|9|||
162232010|NCT03465904|585897670|FG000|Overall Study|Protocol Violation|20|||
162232011|NCT03465904|585897671|FG001|Overall Study|Protocol Violation|15|||
162232012|NCT05593445|585897672|FG000|12-Week DBVC Period|Adverse Event|1|||
162232013|NCT05593445|585897673|FG001|12-Week DBVC Period|Adverse Event|0|||
162232014|NCT05593445|585897674|FG002|12-Week DBVC Period|Adverse Event|0|||
162232015|NCT05593445|585897675|FG003|12-Week DBVC Period|Adverse Event|0|||
162232016|NCT05593445|585897672|FG000|12-Week DBVC Period|Physician Decision|0|||
162232017|NCT05593445|585897673|FG001|12-Week DBVC Period|Physician Decision|1|||
162232018|NCT05593445|585897674|FG002|12-Week DBVC Period|Physician Decision|0|||
162232019|NCT05593445|585897675|FG003|12-Week DBVC Period|Physician Decision|0|||
162232020|NCT05593445|585897672|FG000|12-Week DBVC Period|Protocol Violation|0|||
162232021|NCT05593445|585897673|FG001|12-Week DBVC Period|Protocol Violation|1|||
162232022|NCT05593445|585897674|FG002|12-Week DBVC Period|Protocol Violation|0|||
162232023|NCT05593445|585897675|FG003|12-Week DBVC Period|Protocol Violation|0|||
162232024|NCT05593445|585897672|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
162232025|NCT05593445|585897673|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
162232026|NCT05593445|585897674|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
161940841|NCT03093415|584833751|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
161940842|NCT03093415|584833752|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
161940843|NCT03093415|584833750|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
161940844|NCT03093415|584833751|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
161940845|NCT03093415|584833752|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
161940846|NCT03093415|584833750|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
161940847|NCT03093415|584833751|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
161940848|NCT03093415|584833752|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
161940849|NCT03093415|584833750|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
161940850|NCT03093415|584833751|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
161940851|NCT03093415|584833752|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
161940852|NCT03093415|584833750|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
161940853|NCT03093415|584833751|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
161940854|NCT03093415|584833752|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
161940855|NCT03093415|584833750|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
161940856|NCT03093415|584833751|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
161940857|NCT03093415|584833752|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
161940858|NCT03093415|584833750|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
161940859|NCT03093415|584833751|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
161940860|NCT03093415|584833752|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
161940861|NCT03093415|584833750|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
161940862|NCT03093415|584833751|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
161940863|NCT03093415|584833752|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
161940864|NCT03093415|584833750|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
161940865|NCT03093415|584833751|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
161940866|NCT03093415|584833752|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
161940867|NCT02457065|584833753|FG000|Overall Study|Lost to Follow-up|9|||
161940868|NCT02457065|584833754|FG001|Overall Study|Lost to Follow-up|11|||
161940869|NCT03038087|584833755|FG000|Overall Study|lost data|1|||
161940870|NCT00654355|584833756|FG000|Overall Study|Lost to Follow-up|2|||
162232027|NCT05593445|585897675|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
162232028|NCT05593445|585897672|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
162232029|NCT05593445|585897673|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
162232030|NCT05593445|585897674|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
162232031|NCT05593445|585897675|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
162232032|NCT05593445|585897672|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
162232033|NCT05593445|585897673|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
162232034|NCT05593445|585897674|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
162232035|NCT05593445|585897675|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
162232036|NCT05593445|585897672|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
162232037|NCT05593445|585897673|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
162232038|NCT05593445|585897674|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
162232039|NCT05593445|585897675|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
162232040|NCT05593445|585897672|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162232041|NCT05593445|585897673|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162232042|NCT05593445|585897674|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
162232043|NCT05593445|585897675|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162232044|NCT03694275|585899476|FG000|Overall Study|Adverse Event|0|||
162232045|NCT03694275|585899477|FG001|Overall Study|Adverse Event|1|||
162232046|NCT03694275|585899476|FG000|Overall Study|Reason not Specified|0|||
162232047|NCT03694275|585899477|FG001|Overall Study|Reason not Specified|1|||
162232048|NCT00910689|585899481|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
162232049|NCT00910689|585899482|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
162232050|NCT00910689|585899483|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
162232051|NCT00910689|585899484|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
162232052|NCT00910689|585899481|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
162232053|NCT00910689|585899482|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
162232054|NCT00910689|585899483|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
162232055|NCT00910689|585899484|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
162232056|NCT00910689|585899481|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
162232057|NCT00910689|585899482|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
162232058|NCT00910689|585899483|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
162232059|NCT00910689|585899484|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
162232060|NCT00910689|585899481|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
162232061|NCT00910689|585899482|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
162232062|NCT00910689|585899483|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
162232063|NCT00910689|585899484|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
162232064|NCT00910689|585899481|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
162232065|NCT00910689|585899482|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
162232066|NCT00910689|585899483|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
162232067|NCT00910689|585899484|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
162232068|NCT00910689|585899481|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
162232069|NCT00910689|585899482|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
162232070|NCT00910689|585899483|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
162232071|NCT00910689|585899484|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
162232072|NCT00910689|585899481|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
162232073|NCT00910689|585899482|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
162232074|NCT00910689|585899483|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
162232075|NCT00910689|585899484|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
162232076|NCT00910689|585899481|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
162232077|NCT00910689|585899482|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
162232078|NCT00910689|585899483|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
162232079|NCT00910689|585899484|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
162232080|NCT00910689|585899481|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
162232081|NCT00910689|585899482|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
162232082|NCT00910689|585899483|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
162232083|NCT00910689|585899484|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
162232084|NCT00910689|585899481|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
162232085|NCT00910689|585899482|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
162232086|NCT00910689|585899483|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
162232087|NCT00910689|585899484|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
162232088|NCT00910689|585899481|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
161680444|NCT03086057|583882946|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
161830029|NCT01040793|584418097|FG003|Overall Study|Withdrawal by Subject|2|||
161830030|NCT01040793|584418098|FG004|Overall Study|Withdrawal by Subject|0|||
161940871|NCT00654355|584833757|FG001|Overall Study|Lost to Follow-up|2|||
162232089|NCT00910689|585899482|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
162232090|NCT00910689|585899483|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
162232091|NCT00910689|585899484|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
162232092|NCT00910689|585899481|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
162232093|NCT00910689|585899482|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
162232094|NCT00910689|585899483|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
162232095|NCT00910689|585899484|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
161680445|NCT03086057|583882947|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
161830031|NCT01040793|584418099|FG005|Overall Study|Withdrawal by Subject|0|||
162232096|NCT00910689|585899481|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
162232097|NCT00910689|585899482|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
162232098|NCT00910689|585899483|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
162232099|NCT00910689|585899484|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
162232100|NCT00910689|585899481|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
162232101|NCT00910689|585899482|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
162232102|NCT00910689|585899483|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
162232103|NCT00910689|585899484|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
162232104|NCT00910689|585899481|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
162232105|NCT00910689|585899482|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
162232106|NCT00910689|585899483|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
162232107|NCT00910689|585899484|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
162232108|NCT00910689|585899481|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
162232109|NCT00910689|585899482|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
162232110|NCT00910689|585899483|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
162232111|NCT00910689|585899484|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
162232112|NCT00910689|585899481|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
162232113|NCT00910689|585899482|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
162232114|NCT00910689|585899483|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
162232115|NCT00910689|585899484|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
162232116|NCT00910689|585899481|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
162232117|NCT00910689|585899482|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
162232118|NCT00910689|585899483|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
162232119|NCT00910689|585899484|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
162232120|NCT00910689|585899481|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
162232121|NCT00910689|585899482|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
162232122|NCT00910689|585899483|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
162232123|NCT00910689|585899484|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
162232124|NCT00910689|585899481|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
162232125|NCT00910689|585899482|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
162232126|NCT00910689|585899483|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
162232127|NCT00910689|585899484|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
162232128|NCT00910689|585899481|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
162232129|NCT00910689|585899482|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
162232130|NCT00910689|585899483|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
162232131|NCT00910689|585899484|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
162232132|NCT01290029|585899485|FG000|Overall Study|Other|2|||
162232133|NCT00616902|585899488|FG000|Overall Study|Termination of study|6|||
162232134|NCT00616902|585899489|FG001|Overall Study|Termination of study|6|||
162232135|NCT01877837|585899490|FG000|Overall Study|Lost to Follow-up|1|||
162232136|NCT01877837|585899490|FG000|Overall Study|Ineligible|4|||
162232137|NCT00645801|585899491|FG000|Overall Study|unclear if patient took all the medication.|1|||
162025068|NCT01994889|585148815|FG000|Overall Study|Organ Transplantation|1|||
162025069|NCT01994889|585148816|FG001|Overall Study|Organ Transplantation|5|||
162025070|NCT01994889|585148817|FG002|Overall Study|Organ Transplantation|5|||
162025071|NCT01994889|585148815|FG000|Overall Study|No longer willing to participate|8|||
162025072|NCT01994889|585148816|FG001|Overall Study|No longer willing to participate|17|||
162025073|NCT01994889|585148817|FG002|Overall Study|No longer willing to participate|37|||
162025074|NCT01994889|585148815|FG000|Overall Study|Lost to Follow-up|0|||
162025075|NCT01994889|585148816|FG001|Overall Study|Lost to Follow-up|1|||
162025076|NCT01994889|585148817|FG002|Overall Study|Lost to Follow-up|0|||
162025077|NCT01994889|585148815|FG000|Overall Study|Protocol Violation|0|||
162025078|NCT01994889|585148816|FG001|Overall Study|Protocol Violation|1|||
162232138|NCT00645801|585899492|FG001|Overall Study|unclear if patient took all the medication.|0|||
162232139|NCT00645801|585899491|FG000|Overall Study|Lost to Follow-up|19|||
162232140|NCT00645801|585899492|FG001|Overall Study|Lost to Follow-up|15|||
162232141|NCT00759915|585899493|FG000|Overall Study|Withdrawal by Subject|1|||
162232142|NCT00759915|585899494|FG001|Overall Study|Withdrawal by Subject|0|||
162232143|NCT00759915|585899493|FG000|Overall Study|Adverse Event|0|||
162232144|NCT00759915|585899494|FG001|Overall Study|Adverse Event|1|||
162232145|NCT00932113|585899497|FG000|Overall Study|Lost to Follow-up|1|||
162232146|NCT00932113|585899498|FG001|Overall Study|Lost to Follow-up|0|||
162232147|NCT01773291|585899499|FG000|Overall Study|Protocol Violation|1|||
162232148|NCT01773291|585899500|FG001|Overall Study|Protocol Violation|0|||
162232149|NCT01773291|585899501|FG002|Overall Study|Protocol Violation|0|||
162232150|NCT01773291|585899499|FG000|Overall Study|Withdrawal by Subject|0|||
162025079|NCT01994889|585148817|FG002|Overall Study|Protocol Violation|1|||
162025080|NCT01994889|585148815|FG000|Overall Study|Death|14|||
162025081|NCT01994889|585148816|FG001|Overall Study|Death|25|||
162025082|NCT01994889|585148817|FG002|Overall Study|Death|38|||
162025083|NCT01711216|585148821|FG000|Overall Study|Adverse Event|4|||
162025084|NCT01711216|585148821|FG000|Overall Study|Pregnancy|56|||
162025085|NCT01711216|585148821|FG000|Overall Study|Withdrawal by Subject|6|||
162025086|NCT01711216|585148821|FG000|Overall Study|Lost to Follow-up|46|||
162025087|NCT01711216|585148821|FG000|Overall Study|variety of other minor reasons|83|||
162025088|NCT01711216|585148821|FG000|Overall Study|no reason specified|22|||
162025089|NCT01214395|585148827|FG000|Overall Study|All patients had infection|5|||
162232151|NCT01773291|585899500|FG001|Overall Study|Withdrawal by Subject|0|||
162232152|NCT01773291|585899501|FG002|Overall Study|Withdrawal by Subject|1|||
162232153|NCT00203476|585899502|FG000|Overall Study|Lost to Follow-up|1|||
162232154|NCT00203476|585899503|FG001|Overall Study|Lost to Follow-up|0|||
162232155|NCT00203476|585899504|FG002|Overall Study|Lost to Follow-up|0|||
162232156|NCT00203476|585899502|FG000|Overall Study|Withdrawal by Subject|0|||
162232157|NCT00203476|585899503|FG001|Overall Study|Withdrawal by Subject|1|||
162232158|NCT00203476|585899504|FG002|Overall Study|Withdrawal by Subject|0|||
162232159|NCT03310268|585899505|FG000|Overall Study|(Not specified)|1|||
162025090|NCT03698591|585148833|FG000|Overall Study|Withdrawal by Subject|2|||
162025091|NCT03698591|585148834|FG001|Overall Study|Withdrawal by Subject|2|||
162025092|NCT03698591|585148833|FG000|Overall Study|Failed drug screen|1|||
162025093|NCT03698591|585148834|FG001|Overall Study|Failed drug screen|1|||
162025094|NCT03698591|585148833|FG000|Overall Study|Failed health screen|0|||
162025095|NCT03698591|585148834|FG001|Overall Study|Failed health screen|1|||
162025096|NCT03698591|585148833|FG000|Overall Study|Ineligible for financial compensation|1|||
162025097|NCT03698591|585148834|FG001|Overall Study|Ineligible for financial compensation|0|||
162025098|NCT03698591|585148833|FG000|Overall Study|Equipment Error|1|||
162025099|NCT03698591|585148834|FG001|Overall Study|Equipment Error|0|||
162025100|NCT03698591|585148833|FG000|Overall Study|Could not establish TMS dosage|0|||
162025101|NCT03698591|585148834|FG001|Overall Study|Could not establish TMS dosage|1|||
162025102|NCT00334113|585148844|FG000|Overall Study|Lost to Follow-up|2|||
162025103|NCT00334113|585148845|FG001|Overall Study|Lost to Follow-up|2|||
162025104|NCT00334113|585148844|FG000|Overall Study|Withdrawal by Subject|0|||
162025105|NCT00334113|585148845|FG001|Overall Study|Withdrawal by Subject|1|||
162025106|NCT01457352|585148855|FG000|Period 1|Adverse Event|2|||
162025107|NCT01457352|585148856|FG001|Period 1|Adverse Event|0|||
162025108|NCT01457352|585148855|FG000|Period 1|Withdrawal by Subject|2|||
162025109|NCT01457352|585148856|FG001|Period 1|Withdrawal by Subject|0|||
162025110|NCT01457352|585148855|FG000|Period 1|Physician Decision|2|||
162025111|NCT01457352|585148856|FG001|Period 1|Physician Decision|0|||
162025112|NCT01457352|585148855|FG000|Period 1|MS related disease progression|1|||
162025113|NCT01457352|585148856|FG001|Period 1|MS related disease progression|0|||
162025114|NCT01457352|585148855|FG000|Period 1|Withdrawn|1|||
162025115|NCT01457352|585148856|FG001|Period 1|Withdrawn|0|||
162025116|NCT01457352|585148855|FG000|Period 1|withdrew per sponsor|1|||
162025117|NCT01457352|585148856|FG001|Period 1|withdrew per sponsor|0|||
162025118|NCT01457352|585148855|FG000|Period 1|Protocol Violation|4|||
162025119|NCT01457352|585148856|FG001|Period 1|Protocol Violation|0|||
162025120|NCT01457352|585148855|FG000|Period 1|Did not meet eligibility criteria|3|||
162025121|NCT01457352|585148856|FG001|Period 1|Did not meet eligibility criteria|0|||
162025122|NCT01457352|585148855|FG000|Period 2|Withdrawal by Subject|23|||
162025123|NCT01457352|585148856|FG001|Period 2|Withdrawal by Subject|0|||
162025124|NCT01457352|585148855|FG000|Period 2|Adverse Event|22|||
162025125|NCT01457352|585148856|FG001|Period 2|Adverse Event|0|||
162025126|NCT01457352|585148855|FG000|Period 2|no analysis|10|||
162025127|NCT01457352|585148856|FG001|Period 2|no analysis|0|||
162025128|NCT01457352|585148855|FG000|Period 2|Lack of Efficacy|8|||
162025129|NCT01457352|585148856|FG001|Period 2|Lack of Efficacy|0|||
162025130|NCT01457352|585148855|FG000|Period 2|Protocol Violation|4|||
162025131|NCT01457352|585148856|FG001|Period 2|Protocol Violation|0|||
162025132|NCT01457352|585148855|FG000|Period 2|Sponsor's withdrawal|7|||
162025133|NCT01457352|585148856|FG001|Period 2|Sponsor's withdrawal|0|||
162025134|NCT01457352|585148855|FG000|Period 2|Lost to Follow-up|1|||
162025135|NCT01457352|585148856|FG001|Period 2|Lost to Follow-up|0|||
162232160|NCT03310268|585899506|FG001|Overall Study|(Not specified)|5|||
162025136|NCT01457352|585148855|FG000|Period 2|dose change|1|||
162025137|NCT01457352|585148856|FG001|Period 2|dose change|0|||
162025138|NCT01457352|585148855|FG000|Period 2|Physician Decision|1|||
162025139|NCT01457352|585148856|FG001|Period 2|Physician Decision|0|||
162232161|NCT03310268|585899507|FG002|Overall Study|(Not specified)|0|||
162232162|NCT04797650|585899508|FG000|Overall Study|Reason Not Specified|5|||
162232163|NCT04797650|585899509|FG001|Overall Study|Reason Not Specified|12|||
162232164|NCT04797650|585899510|FG002|Overall Study|Reason Not Specified|5|||
162232165|NCT04797650|585899508|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
162232166|NCT04797650|585899509|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
162232167|NCT04797650|585899510|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
162232168|NCT04797650|585899508|FG000|Overall Study|Lack of Efficacy|1|||
162232169|NCT04797650|585899509|FG001|Overall Study|Lack of Efficacy|0|||
162232170|NCT04797650|585899510|FG002|Overall Study|Lack of Efficacy|1|||
162232171|NCT04797650|585899508|FG000|Overall Study|Non-compliance with Study Drug|0|||
162232172|NCT04797650|585899509|FG001|Overall Study|Non-compliance with Study Drug|0|||
162232173|NCT04797650|585899510|FG002|Overall Study|Non-compliance with Study Drug|2|||
162232174|NCT04797650|585899508|FG000|Overall Study|Lost to Follow-up|4|||
162232175|NCT04797650|585899509|FG001|Overall Study|Lost to Follow-up|6|||
162232176|NCT04797650|585899510|FG002|Overall Study|Lost to Follow-up|1|||
162232177|NCT04772898|585899513|FG000|Overall Study|Withdrawal by Subject|0|||
162232178|NCT04772898|585899514|FG001|Overall Study|Withdrawal by Subject|1|||
162232179|NCT00309959|585899516|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
162232180|NCT02937454|585899517|FG000|Overall Study|Adverse Event|0|||
162025140|NCT01457352|585148855|FG000|Period 2|Did not meet eligibility criteria|3|||
162232181|NCT02937454|585899518|FG001|Overall Study|Adverse Event|1|||
162232182|NCT02937454|585899517|FG000|Overall Study|Death|98|||
162232183|NCT02937454|585899518|FG001|Overall Study|Death|95|||
162232184|NCT02937454|585899517|FG000|Overall Study|Lost to Follow-up|1|||
162232185|NCT02937454|585899518|FG001|Overall Study|Lost to Follow-up|1|||
162232186|NCT02937454|585899517|FG000|Overall Study|Physician Decision|0|||
162025141|NCT01457352|585148856|FG001|Period 2|Did not meet eligibility criteria|0|||
162025142|NCT01457352|585148855|FG000|Period 3|Adverse Event|1|||
162025143|NCT01457352|585148856|FG001|Period 3|Adverse Event|1|||
162232187|NCT02937454|585899518|FG001|Overall Study|Physician Decision|1|||
162232188|NCT02937454|585899517|FG000|Overall Study|Protocol Violation|6|||
162232189|NCT02937454|585899518|FG001|Overall Study|Protocol Violation|10|||
162232190|NCT02937454|585899517|FG000|Overall Study|Withdrawal by Subject|27|||
162232191|NCT02937454|585899518|FG001|Overall Study|Withdrawal by Subject|15|||
162232192|NCT02937454|585899517|FG000|Overall Study|Other|8|||
162232193|NCT02937454|585899518|FG001|Overall Study|Other|5|||
162232194|NCT01253304|585899519|FG000|Overall Study|Adverse Event|0|||
162232195|NCT01253304|585899520|FG001|Overall Study|Adverse Event|0|||
162232196|NCT01253304|585899521|FG002|Overall Study|Adverse Event|0|||
162232197|NCT01253304|585899522|FG003|Overall Study|Adverse Event|1|||
162232198|NCT01888900|585899530|FG000|Overall Study|failed treatment|0|||
162232199|NCT01888900|585899531|FG001|Overall Study|failed treatment|2|||
162232200|NCT01160289|585899532|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
162232201|NCT01160289|585899533|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
162232202|NCT01160289|585899534|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
162232203|NCT01160289|585899535|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
162232204|NCT01160289|585899536|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
162232205|NCT01160289|585899537|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
162232206|NCT01160289|585899532|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
162232207|NCT01160289|585899533|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
162025144|NCT01457352|585148855|FG000|Period 3|Withdrawal by Subject|0|||
162232208|NCT01160289|585899534|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
162232209|NCT01160289|585899535|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
162232210|NCT01160289|585899536|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
162232211|NCT01160289|585899537|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
162232212|NCT01160289|585899532|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
162232213|NCT01160289|585899533|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
162232214|NCT01160289|585899534|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
162232215|NCT01160289|585899535|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
162232216|NCT01160289|585899536|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
162232217|NCT01160289|585899537|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
162232218|NCT01160289|585899532|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
162232219|NCT01160289|585899533|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
162232220|NCT01160289|585899534|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
162232221|NCT01160289|585899535|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
162025145|NCT01457352|585148856|FG001|Period 3|Withdrawal by Subject|2|||
162025146|NCT01457352|585148855|FG000|Period 3|incorrect treatment|0|||
162232222|NCT01160289|585899536|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
162232223|NCT01160289|585899537|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
162232224|NCT01160289|585899532|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
162232225|NCT01160289|585899533|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
162232226|NCT01160289|585899534|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
162232227|NCT01160289|585899535|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
162232228|NCT01160289|585899536|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
162232229|NCT01160289|585899537|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
162232230|NCT01160289|585899532|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
162232231|NCT01160289|585899533|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
162232232|NCT01160289|585899534|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
162232233|NCT01160289|585899535|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
162232234|NCT01160289|585899536|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
162232235|NCT01160289|585899537|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
162232236|NCT01160289|585899532|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
162232237|NCT01160289|585899533|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
162232238|NCT01160289|585899534|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
162232239|NCT01160289|585899535|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
162232240|NCT01160289|585899536|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
162232241|NCT01160289|585899537|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
162232242|NCT01160289|585899532|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
162232243|NCT01160289|585899533|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
162232244|NCT01160289|585899534|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
162232245|NCT01160289|585899535|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
162232246|NCT01160289|585899536|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
162232247|NCT01160289|585899537|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
162232248|NCT01160289|585899532|FG000|Post-Randomization Period|Adverse Event|0|||
162232249|NCT01160289|585899533|FG001|Post-Randomization Period|Adverse Event|4|||
162232250|NCT01160289|585899534|FG002|Post-Randomization Period|Adverse Event|4|||
162232251|NCT01160289|585899535|FG003|Post-Randomization Period|Adverse Event|2|||
162232252|NCT01160289|585899536|FG004|Post-Randomization Period|Adverse Event|0|||
162232253|NCT01160289|585899537|FG005|Post-Randomization Period|Adverse Event|0|||
162232254|NCT01160289|585899532|FG000|Post-Randomization Period|Death|0|||
162232255|NCT01160289|585899533|FG001|Post-Randomization Period|Death|0|||
162232256|NCT01160289|585899534|FG002|Post-Randomization Period|Death|0|||
162232257|NCT01160289|585899535|FG003|Post-Randomization Period|Death|1|||
162232258|NCT01160289|585899536|FG004|Post-Randomization Period|Death|0|||
162232259|NCT01160289|585899537|FG005|Post-Randomization Period|Death|0|||
162232260|NCT01160289|585899532|FG000|Post-Randomization Period|Lack of Efficacy|0|||
162232261|NCT01160289|585899533|FG001|Post-Randomization Period|Lack of Efficacy|1|||
162232262|NCT01160289|585899534|FG002|Post-Randomization Period|Lack of Efficacy|0|||
162232263|NCT01160289|585899535|FG003|Post-Randomization Period|Lack of Efficacy|3|||
162232264|NCT01160289|585899536|FG004|Post-Randomization Period|Lack of Efficacy|0|||
162232265|NCT01160289|585899537|FG005|Post-Randomization Period|Lack of Efficacy|0|||
162232266|NCT01160289|585899532|FG000|Post-Randomization Period|Lost to Follow-up|0|||
162232267|NCT01160289|585899533|FG001|Post-Randomization Period|Lost to Follow-up|3|||
162232268|NCT01160289|585899534|FG002|Post-Randomization Period|Lost to Follow-up|2|||
162232269|NCT01160289|585899535|FG003|Post-Randomization Period|Lost to Follow-up|5|||
162232270|NCT01160289|585899536|FG004|Post-Randomization Period|Lost to Follow-up|3|||
162232271|NCT01160289|585899537|FG005|Post-Randomization Period|Lost to Follow-up|4|||
162232272|NCT01160289|585899532|FG000|Post-Randomization Period|Physician Decision|0|||
162232273|NCT01160289|585899533|FG001|Post-Randomization Period|Physician Decision|0|||
162232274|NCT01160289|585899534|FG002|Post-Randomization Period|Physician Decision|1|||
162232275|NCT01160289|585899535|FG003|Post-Randomization Period|Physician Decision|0|||
162232276|NCT01160289|585899536|FG004|Post-Randomization Period|Physician Decision|0|||
162232277|NCT01160289|585899537|FG005|Post-Randomization Period|Physician Decision|0|||
162232278|NCT01160289|585899532|FG000|Post-Randomization Period|Protocol Violation|0|||
162232279|NCT01160289|585899533|FG001|Post-Randomization Period|Protocol Violation|4|||
162232280|NCT01160289|585899534|FG002|Post-Randomization Period|Protocol Violation|2|||
162232281|NCT01160289|585899535|FG003|Post-Randomization Period|Protocol Violation|0|||
162232282|NCT01160289|585899536|FG004|Post-Randomization Period|Protocol Violation|1|||
162232283|NCT01160289|585899537|FG005|Post-Randomization Period|Protocol Violation|3|||
162232284|NCT01160289|585899532|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
162232285|NCT01160289|585899533|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
162232286|NCT01160289|585899534|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
162232287|NCT01160289|585899535|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
162232288|NCT01160289|585899536|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
162232289|NCT01160289|585899537|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
162232290|NCT01160289|585899532|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
162232291|NCT01160289|585899533|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
162232292|NCT01160289|585899534|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
162232293|NCT01160289|585899535|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
162232294|NCT01160289|585899536|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
162232295|NCT01160289|585899537|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
162232296|NCT01160289|585899532|FG000|Post-Randomization Period|Sponsor Decision|0|||
162232297|NCT01160289|585899533|FG001|Post-Randomization Period|Sponsor Decision|1|||
162232298|NCT01160289|585899534|FG002|Post-Randomization Period|Sponsor Decision|0|||
162232299|NCT01160289|585899535|FG003|Post-Randomization Period|Sponsor Decision|0|||
162232300|NCT01160289|585899536|FG004|Post-Randomization Period|Sponsor Decision|0|||
162232301|NCT01160289|585899537|FG005|Post-Randomization Period|Sponsor Decision|0|||
162232302|NCT01156792|585899542|FG000|Overall Study|Adverse Event|1|||
162232303|NCT01156792|585899542|FG000|Overall Study|Lack of Efficacy|36|||
162232304|NCT01156792|585899542|FG000|Overall Study|Protocol Violation|6|||
162232305|NCT01156792|585899542|FG000|Overall Study|Lost to Follow-up|3|||
162232306|NCT01156792|585899542|FG000|Overall Study|Physician Decision|3|||
162232307|NCT01156792|585899542|FG000|Overall Study|Withdrawal by Subject|9|||
162232308|NCT01156792|585899542|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
162232309|NCT00768079|585899543|FG000|Overall Study|Lost to Follow-up|2|||
162232310|NCT00768079|585899544|FG001|Overall Study|Lost to Follow-up|0|||
162232311|NCT00768079|585899545|FG002|Overall Study|Lost to Follow-up|4|||
162232312|NCT00768079|585899543|FG000|Overall Study|Participant incarcerated|0|||
162232313|NCT00768079|585899544|FG001|Overall Study|Participant incarcerated|1|||
162232314|NCT00768079|585899545|FG002|Overall Study|Participant incarcerated|0|||
162232315|NCT03271021|585899546|FG000|Overall Study|Adverse Event|3|||
162232316|NCT03271021|585899547|FG001|Overall Study|Adverse Event|2|||
162232317|NCT03271021|585899546|FG000|Overall Study|Withdrawal by Subject|36|||
162232318|NCT03271021|585899547|FG001|Overall Study|Withdrawal by Subject|53|||
162232319|NCT03271021|585899546|FG000|Overall Study|Lost to Follow-up|34|||
162232320|NCT03271021|585899547|FG001|Overall Study|Lost to Follow-up|39|||
162232321|NCT03271021|585899546|FG000|Overall Study|Protocol Violation|6|||
162232322|NCT03271021|585899547|FG001|Overall Study|Protocol Violation|4|||
162232323|NCT03271021|585899546|FG000|Overall Study|Abnormal Lab Results|1|||
162232324|NCT03271021|585899547|FG001|Overall Study|Abnormal Lab Results|0|||
161680446|NCT03086057|583882948|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
161680447|NCT03086057|583882949|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
161680448|NCT03086057|583882946|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
161680449|NCT03086057|583882947|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
161680450|NCT03086057|583882948|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
161680451|NCT03086057|583882949|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
162232325|NCT03271021|585899546|FG000|Overall Study|Miscellaneous|9|||
162232326|NCT03271021|585899547|FG001|Overall Study|Miscellaneous|8|||
162232327|NCT01474434|585899548|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
162232328|NCT01474434|585899549|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
162232329|NCT01474434|585899550|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
162232330|NCT01474434|585899551|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
162232331|NCT01474434|585899548|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
162232332|NCT01474434|585899549|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
162232333|NCT01474434|585899550|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
162232334|NCT01474434|585899551|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
162232335|NCT01474434|585899548|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
162232336|NCT01474434|585899549|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
162232337|NCT01474434|585899550|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
162232338|NCT01474434|585899551|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
162232339|NCT00993668|585899554|FG000|Single-Blind Period|Adverse Event|1|||
161830032|NCT01040793|584418094|FG000|Overall Study|Other reasons not listed above|0|||
162232340|NCT00993668|585899555|FG001|Single-Blind Period|Adverse Event|1|||
161830033|NCT01040793|584418095|FG001|Overall Study|Other reasons not listed above|0|||
161830034|NCT01040793|584418096|FG002|Overall Study|Other reasons not listed above|1|||
162232341|NCT00993668|585899554|FG000|Single-Blind Period|Lack of Efficacy|0|||
162232342|NCT00993668|585899555|FG001|Single-Blind Period|Lack of Efficacy|1|||
162232343|NCT00993668|585899554|FG000|Single-Blind Period|Lost to Follow-up|3|||
162232344|NCT00993668|585899555|FG001|Single-Blind Period|Lost to Follow-up|1|||
162232345|NCT00993668|585899554|FG000|Open-Label Period|Adverse Event|9|||
162232346|NCT00993668|585899555|FG001|Open-Label Period|Adverse Event|8|||
162232347|NCT00993668|585899554|FG000|Open-Label Period|Lack of Efficacy|4|||
162232348|NCT00993668|585899555|FG001|Open-Label Period|Lack of Efficacy|3|||
162232349|NCT00993668|585899554|FG000|Open-Label Period|Withdrawal by Subject|4|||
162232350|NCT00993668|585899555|FG001|Open-Label Period|Withdrawal by Subject|3|||
162232351|NCT00993668|585899554|FG000|Open-Label Period|Lost to Follow-up|6|||
162232352|NCT00993668|585899555|FG001|Open-Label Period|Lost to Follow-up|1|||
162232353|NCT02207569|585899556|FG000|1-Month|Death|6|||
162232354|NCT02207569|585899556|FG000|1-Month|Withdrawal by Subject|2|||
162232355|NCT02207569|585899556|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
162232356|NCT02207569|585899556|FG000|6-Month|Death|8|||
162232357|NCT02207569|585899556|FG000|6-Month|Withdrawal by Subject|2|||
162232358|NCT02207569|585899556|FG000|12-Month|Death|14|||
162232359|NCT02207569|585899556|FG000|12-Month|Withdrawal by Subject|2|||
162232360|NCT02207569|585899556|FG000|24-Month|Death|23|||
162232361|NCT02207569|585899556|FG000|24-Month|Withdrawal by Subject|3|||
162232362|NCT02207569|585899556|FG000|36-Month|Death|23|||
162232363|NCT02207569|585899556|FG000|36-Month|Withdrawal by Subject|4|||
162232364|NCT02207569|585899556|FG000|48-Month|Death|25|||
162232365|NCT02207569|585899556|FG000|48-Month|Withdrawal by Subject|2|||
162232366|NCT02207569|585899556|FG000|48-Month|Lost to Follow-up|4|||
162232367|NCT02207569|585899556|FG000|60-Month|Death|1|||
162025147|NCT01457352|585148856|FG001|Period 3|incorrect treatment|1|||
162025148|NCT01457352|585148855|FG000|Period 3|Sponsor's withdrawal|0|||
162025149|NCT01457352|585148856|FG001|Period 3|Sponsor's withdrawal|1|||
162025150|NCT04614324|585148857|FG000|Overall Study|Lost to Follow-up|3|||
162025151|NCT04614324|585148857|FG000|Overall Study|Physician Decision|1|||
162025152|NCT04614324|585148857|FG000|Overall Study|Withdrawal by Subject|2|||
162025153|NCT04614324|585148857|FG000|Overall Study|Remaining in Follow up|123|||
162025154|NCT03472547|585148858|FG000|Overall Study|Withdrawal by Subject|30|||
162232368|NCT02207569|585899556|FG000|60-Month|Lost to Follow-up|1|||
162232369|NCT02207569|585899556|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
162232370|NCT02207569|585899556|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
162232371|NCT02585232|585899557|FG000|Overall Study|Lost to Follow-up|8|||
162232372|NCT02585232|585899558|FG001|Overall Study|Lost to Follow-up|8|||
162232373|NCT02585232|585899557|FG000|Overall Study|Withdrawal by Subject|4|||
162232374|NCT02585232|585899558|FG001|Overall Study|Withdrawal by Subject|8|||
162232375|NCT02313233|585899561|FG000|Overall Study|Withdrawal by Subject|1|||
162232376|NCT02313233|585899562|FG001|Overall Study|Withdrawal by Subject|2|||
162232377|NCT02313233|585899561|FG000|Overall Study|Administrative reason|1|||
162232378|NCT02313233|585899562|FG001|Overall Study|Administrative reason|1|||
162232379|NCT02095951|585899563|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
162232380|NCT02095951|585899564|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
162232381|NCT03618823|585899565|FG000|Overall Study|Lost to Follow-up|63|||
162232382|NCT03618823|585899566|FG001|Overall Study|Lost to Follow-up|61|||
162232383|NCT05383508|585899567|FG000|Overall Study|Withdrawal by Subject|1|||
162232384|NCT05383508|585899568|FG001|Overall Study|Withdrawal by Subject|0|||
162232385|NCT05383508|585899569|FG002|Overall Study|Withdrawal by Subject|1|||
162232386|NCT05383508|585899570|FG003|Overall Study|Withdrawal by Subject|1|||
162232387|NCT05383508|585899571|FG004|Overall Study|Withdrawal by Subject|2|||
162232388|NCT05383508|585899572|FG005|Overall Study|Withdrawal by Subject|0|||
162232389|NCT01621568|585899574|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
162232390|NCT01621568|585899575|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
162232391|NCT01621568|585899574|FG000|Week 5-6 No Treatment|Death|1|||
162025155|NCT05141448|585148859|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
161680452|NCT03086057|583882946|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
162232392|NCT01621568|585899575|FG001|Week 5-6 No Treatment|Death|0|||
162232393|NCT01859988|585899576|FG000|Overall Study|Withdrawal by Subject|6|||
162232394|NCT01859988|585899577|FG001|Overall Study|Withdrawal by Subject|3|||
162232395|NCT01859988|585899578|FG002|Overall Study|Withdrawal by Subject|4|||
162232396|NCT01859988|585899579|FG003|Overall Study|Withdrawal by Subject|3|||
162232397|NCT01859988|585899580|FG004|Overall Study|Withdrawal by Subject|2|||
162232398|NCT01859988|585899581|FG005|Overall Study|Withdrawal by Subject|2|||
162232399|NCT01859988|585899576|FG000|Overall Study|Lack of Efficacy|1|||
162232400|NCT01859988|585899577|FG001|Overall Study|Lack of Efficacy|1|||
162232401|NCT01859988|585899578|FG002|Overall Study|Lack of Efficacy|5|||
162232402|NCT01859988|585899579|FG003|Overall Study|Lack of Efficacy|0|||
162232403|NCT01859988|585899580|FG004|Overall Study|Lack of Efficacy|7|||
162232404|NCT01859988|585899581|FG005|Overall Study|Lack of Efficacy|9|||
162232405|NCT01859988|585899576|FG000|Overall Study|Physician Decision|1|||
162232406|NCT01859988|585899577|FG001|Overall Study|Physician Decision|3|||
162232407|NCT01859988|585899578|FG002|Overall Study|Physician Decision|1|||
162232408|NCT01859988|585899579|FG003|Overall Study|Physician Decision|3|||
162232409|NCT01859988|585899580|FG004|Overall Study|Physician Decision|4|||
162232410|NCT01859988|585899581|FG005|Overall Study|Physician Decision|1|||
162232411|NCT01859988|585899576|FG000|Overall Study|Adverse Event|2|||
162232412|NCT01859988|585899577|FG001|Overall Study|Adverse Event|1|||
162232413|NCT01859988|585899578|FG002|Overall Study|Adverse Event|3|||
162232414|NCT01859988|585899579|FG003|Overall Study|Adverse Event|1|||
162232415|NCT01859988|585899580|FG004|Overall Study|Adverse Event|2|||
162232416|NCT01859988|585899581|FG005|Overall Study|Adverse Event|2|||
162232417|NCT01859988|585899576|FG000|Overall Study|Lost to Follow-up|1|||
162232418|NCT01859988|585899577|FG001|Overall Study|Lost to Follow-up|2|||
162232419|NCT01859988|585899578|FG002|Overall Study|Lost to Follow-up|3|||
162232420|NCT01859988|585899579|FG003|Overall Study|Lost to Follow-up|0|||
162232421|NCT01859988|585899580|FG004|Overall Study|Lost to Follow-up|3|||
162232422|NCT01859988|585899581|FG005|Overall Study|Lost to Follow-up|2|||
162232423|NCT01859988|585899576|FG000|Overall Study|Protocol Violation|0|||
162232424|NCT01859988|585899577|FG001|Overall Study|Protocol Violation|0|||
162232425|NCT01859988|585899578|FG002|Overall Study|Protocol Violation|1|||
162232426|NCT01859988|585899579|FG003|Overall Study|Protocol Violation|0|||
162232427|NCT01859988|585899580|FG004|Overall Study|Protocol Violation|0|||
162232428|NCT01859988|585899581|FG005|Overall Study|Protocol Violation|0|||
162232429|NCT01859988|585899576|FG000|Overall Study|Other than specified above|0|||
162232430|NCT01859988|585899577|FG001|Overall Study|Other than specified above|2|||
162232431|NCT01859988|585899578|FG002|Overall Study|Other than specified above|11|||
162232432|NCT01859988|585899579|FG003|Overall Study|Other than specified above|3|||
162232433|NCT01859988|585899580|FG004|Overall Study|Other than specified above|5|||
162232434|NCT01859988|585899581|FG005|Overall Study|Other than specified above|3|||
162232435|NCT02930226|585899582|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
162232436|NCT02930226|585899583|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
162232437|NCT02930226|585899584|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
162232438|NCT02930226|585899585|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
162232439|NCT02930226|585899586|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
162232440|NCT02930226|585899587|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
162232441|NCT00652327|585899588|FG000|Overall Study|Adverse Event|0|||
162232442|NCT00652327|585899589|FG001|Overall Study|Adverse Event|2|||
162232443|NCT00652327|585899588|FG000|Overall Study|Lost to Follow-up|0|||
162232444|NCT00652327|585899589|FG001|Overall Study|Lost to Follow-up|3|||
162232445|NCT00635427|585899591|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
162232446|NCT00635427|585899592|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
162232447|NCT00635427|585899593|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
162232448|NCT00635427|585899594|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
162232449|NCT00635427|585899595|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
162232450|NCT00635427|585899591|FG000|Overall Study|Death|0|||
162232451|NCT00635427|585899592|FG001|Overall Study|Death|0|||
162232452|NCT00635427|585899593|FG002|Overall Study|Death|0|||
162232453|NCT00635427|585899594|FG003|Overall Study|Death|1|||
162232454|NCT00635427|585899595|FG004|Overall Study|Death|0|||
162232455|NCT00635427|585899591|FG000|Overall Study|Termination Of Study By Sponsor|12|||
162232456|NCT00635427|585899592|FG001|Overall Study|Termination Of Study By Sponsor|6|||
162232457|NCT00635427|585899593|FG002|Overall Study|Termination Of Study By Sponsor|10|||
161830035|NCT01040793|584418097|FG003|Overall Study|Other reasons not listed above|0|||
161830036|NCT01040793|584418098|FG004|Overall Study|Other reasons not listed above|1|||
161830037|NCT01040793|584418099|FG005|Overall Study|Other reasons not listed above|0|||
161830038|NCT02412722|584418104|FG000|Overall Study|Adverse Event|0|||
161830039|NCT02412722|584418105|FG001|Overall Study|Adverse Event|2|||
161830040|NCT02412722|584418106|FG002|Overall Study|Adverse Event|0|||
162232458|NCT00635427|585899594|FG003|Overall Study|Termination Of Study By Sponsor|6|||
161830041|NCT02412722|584418107|FG003|Overall Study|Adverse Event|3|||
162232459|NCT00635427|585899595|FG004|Overall Study|Termination Of Study By Sponsor|6|||
162232460|NCT00635427|585899591|FG000|Overall Study|Withdrawal Of Consent|0|||
162232461|NCT00635427|585899592|FG001|Overall Study|Withdrawal Of Consent|0|||
162232462|NCT00635427|585899593|FG002|Overall Study|Withdrawal Of Consent|0|||
162232463|NCT00635427|585899594|FG003|Overall Study|Withdrawal Of Consent|2|||
162232464|NCT00635427|585899595|FG004|Overall Study|Withdrawal Of Consent|2|||
162232465|NCT00564889|585899596|FG000|Overall Study|Death|7|||
162232466|NCT00564889|585899596|FG000|Overall Study|Adverse Event|12|||
162232467|NCT00564889|585899596|FG000|Overall Study|Alternative treatment|3|||
162232468|NCT00564889|585899596|FG000|Overall Study|Disease progression|3|||
162232469|NCT00564889|585899596|FG000|Overall Study|Other, not specified|4|||
162232470|NCT01506609|585899605|FG000|Overall Study|Adverse Event Related to Progression|0|||
162232471|NCT01506609|585899606|FG001|Overall Study|Adverse Event Related to Progression|0|||
162232472|NCT01506609|585899607|FG002|Overall Study|Adverse Event Related to Progression|0|||
162232473|NCT01506609|585899608|FG003|Overall Study|Adverse Event Related to Progression|3|||
162232474|NCT01506609|585899609|FG004|Overall Study|Adverse Event Related to Progression|7|||
162232475|NCT01506609|585899610|FG005|Overall Study|Adverse Event Related to Progression|3|||
162232476|NCT01506609|585899605|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
162232477|NCT01506609|585899606|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
162232478|NCT01506609|585899607|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
162232479|NCT01506609|585899608|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
162232480|NCT01506609|585899609|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
162232481|NCT01506609|585899610|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
162232482|NCT01506609|585899605|FG000|Overall Study|Withdrawal by Subject|0|||
162232483|NCT01506609|585899606|FG001|Overall Study|Withdrawal by Subject|0|||
162232484|NCT01506609|585899607|FG002|Overall Study|Withdrawal by Subject|0|||
162232485|NCT01506609|585899608|FG003|Overall Study|Withdrawal by Subject|9|||
162232486|NCT01506609|585899609|FG004|Overall Study|Withdrawal by Subject|7|||
162232487|NCT01506609|585899610|FG005|Overall Study|Withdrawal by Subject|7|||
162232488|NCT01506609|585899605|FG000|Overall Study|Lost to Follow-up|0|||
162232489|NCT01506609|585899606|FG001|Overall Study|Lost to Follow-up|0|||
162232490|NCT01506609|585899607|FG002|Overall Study|Lost to Follow-up|0|||
162232491|NCT01506609|585899608|FG003|Overall Study|Lost to Follow-up|1|||
162232492|NCT01506609|585899609|FG004|Overall Study|Lost to Follow-up|2|||
162232493|NCT01506609|585899610|FG005|Overall Study|Lost to Follow-up|0|||
162232494|NCT01506609|585899605|FG000|Overall Study|Sponsor Discontinued Study|0|||
162232495|NCT01506609|585899606|FG001|Overall Study|Sponsor Discontinued Study|0|||
162232496|NCT01506609|585899607|FG002|Overall Study|Sponsor Discontinued Study|0|||
162232497|NCT01506609|585899608|FG003|Overall Study|Sponsor Discontinued Study|2|||
162232498|NCT01506609|585899609|FG004|Overall Study|Sponsor Discontinued Study|2|||
162232499|NCT01506609|585899610|FG005|Overall Study|Sponsor Discontinued Study|0|||
162232500|NCT01506609|585899605|FG000|Overall Study|Progressive Disease per Protocol|1|||
162232501|NCT01506609|585899606|FG001|Overall Study|Progressive Disease per Protocol|0|||
162232502|NCT01506609|585899607|FG002|Overall Study|Progressive Disease per Protocol|0|||
162232503|NCT01506609|585899608|FG003|Overall Study|Progressive Disease per Protocol|64|||
162232504|NCT01506609|585899609|FG004|Overall Study|Progressive Disease per Protocol|57|||
162232505|NCT01506609|585899610|FG005|Overall Study|Progressive Disease per Protocol|74|||
162232506|NCT01506609|585899605|FG000|Overall Study|Other, Not Specified|0|||
162232507|NCT01506609|585899606|FG001|Overall Study|Other, Not Specified|0|||
162232508|NCT01506609|585899607|FG002|Overall Study|Other, Not Specified|0|||
162232509|NCT01506609|585899608|FG003|Overall Study|Other, Not Specified|10|||
162232510|NCT01506609|585899609|FG004|Overall Study|Other, Not Specified|7|||
162232511|NCT01506609|585899610|FG005|Overall Study|Other, Not Specified|3|||
162232512|NCT01506609|585899605|FG000|Overall Study|Missing / Unknown Reason|1|||
162232513|NCT01506609|585899606|FG001|Overall Study|Missing / Unknown Reason|0|||
162232514|NCT01506609|585899607|FG002|Overall Study|Missing / Unknown Reason|1|||
162232515|NCT01506609|585899608|FG003|Overall Study|Missing / Unknown Reason|4|||
162232516|NCT01506609|585899609|FG004|Overall Study|Missing / Unknown Reason|4|||
162232517|NCT01506609|585899610|FG005|Overall Study|Missing / Unknown Reason|2|||
162232518|NCT00577473|585899615|FG000|Overall Study|Protocol Violation|1|||
162232519|NCT00577473|585899616|FG001|Overall Study|Protocol Violation|4|||
162232520|NCT00577473|585899615|FG000|Overall Study|Adverse Event|8|||
161940872|NCT01435356|584833759|FG000|Overall Study|Adverse Event|2|||
161940873|NCT01435356|584833760|FG001|Overall Study|Adverse Event|0|||
161940874|NCT01435356|584833759|FG000|Overall Study|Disease progression/recurrence|17|||
161940875|NCT01435356|584833760|FG001|Overall Study|Disease progression/recurrence|10|||
161940876|NCT01435356|584833759|FG000|Overall Study|Protocol Violation|0|||
161940877|NCT01435356|584833760|FG001|Overall Study|Protocol Violation|1|||
161940878|NCT01435356|584833759|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
161940879|NCT01435356|584833760|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
161940880|NCT01435356|584833759|FG000|Overall Study|Withdrawal by Subject|1|||
161940881|NCT01435356|584833760|FG001|Overall Study|Withdrawal by Subject|1|||
162232521|NCT00577473|585899616|FG001|Overall Study|Adverse Event|5|||
162232522|NCT00577473|585899615|FG000|Overall Study|Withdrawal by Subject|2|||
162232523|NCT00577473|585899616|FG001|Overall Study|Withdrawal by Subject|6|||
162232524|NCT00577473|585899615|FG000|Overall Study|Physician Decision|2|||
162232525|NCT00577473|585899616|FG001|Overall Study|Physician Decision|2|||
162232526|NCT00577473|585899615|FG000|Overall Study|Lack of Efficacy|8|||
162232527|NCT00577473|585899616|FG001|Overall Study|Lack of Efficacy|7|||
162232528|NCT02595073|585899619|FG000|Overall Study|Progressive Disease|0|||
161940882|NCT01435356|584833759|FG000|Overall Study|Facial palsy|1|||
161940883|NCT01435356|584833760|FG001|Overall Study|Facial palsy|0|||
162232529|NCT02595073|585899620|FG001|Overall Study|Progressive Disease|1|||
162232530|NCT02595073|585899619|FG000|Overall Study|Protocol Violation|2|||
162232531|NCT02595073|585899620|FG001|Overall Study|Protocol Violation|0|||
162232532|NCT01990560|585899623|FG000|Overall Study|Withdrawal by Subject|1|||
162232533|NCT02884908|585899629|FG000|Overall Study|Lost to Follow-up|13|||
162232534|NCT02884908|585899630|FG001|Overall Study|Lost to Follow-up|18|||
161680453|NCT03086057|583882947|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
161680454|NCT03086057|583882948|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
162232535|NCT01324440|585899631|FG000|Overall Study|Subject moved|0|||
162232536|NCT01324440|585899632|FG001|Overall Study|Subject moved|1|||
162232537|NCT01293487|585899636|FG000|Overall Study|Lost to Follow-up|0|||
162232538|NCT01293487|585899637|FG001|Overall Study|Lost to Follow-up|0|||
162232539|NCT01293487|585899638|FG002|Overall Study|Lost to Follow-up|0|||
162232540|NCT01293487|585899639|FG003|Overall Study|Lost to Follow-up|1|||
162232541|NCT01293487|585899640|FG004|Overall Study|Lost to Follow-up|0|||
162232542|NCT01293487|585899641|FG005|Overall Study|Lost to Follow-up|0|||
162232543|NCT01293487|585899642|FG006|Overall Study|Lost to Follow-up|0|||
162232544|NCT01293487|585899643|FG007|Overall Study|Lost to Follow-up|0|||
162232545|NCT01293487|585899636|FG000|Overall Study|Withdrawal by Subject|0|||
162232546|NCT01293487|585899637|FG001|Overall Study|Withdrawal by Subject|0|||
162232547|NCT01293487|585899638|FG002|Overall Study|Withdrawal by Subject|0|||
162232548|NCT01293487|585899639|FG003|Overall Study|Withdrawal by Subject|0|||
162232549|NCT01293487|585899640|FG004|Overall Study|Withdrawal by Subject|0|||
162232550|NCT01293487|585899641|FG005|Overall Study|Withdrawal by Subject|0|||
162232551|NCT01293487|585899642|FG006|Overall Study|Withdrawal by Subject|0|||
162232552|NCT01293487|585899643|FG007|Overall Study|Withdrawal by Subject|2|||
162232553|NCT04860297|585899644|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
162232554|NCT04860297|585899645|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
162232555|NCT04860297|585899646|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
162232556|NCT04860297|585899647|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
162232557|NCT04860297|585899648|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
162232558|NCT04860297|585899649|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
162232559|NCT04860297|585899650|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
162232560|NCT04860297|585899651|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
162232561|NCT04860297|585899644|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
162232562|NCT04860297|585899645|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
162232563|NCT04860297|585899646|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
162232564|NCT04860297|585899647|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
162232565|NCT04860297|585899648|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
162232566|NCT04860297|585899649|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
162232567|NCT04860297|585899650|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
162232568|NCT04860297|585899651|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
162232569|NCT04860297|585899644|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
161830042|NCT02412722|584418108|FG004|Overall Study|Adverse Event|0|||
162232570|NCT04860297|585899645|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
162232571|NCT04860297|585899646|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
161830043|NCT02412722|584418109|FG005|Overall Study|Adverse Event|3|||
161830044|NCT02412722|584418104|FG000|Overall Study|Progressive Disease|6|||
162025156|NCT05141448|585148860|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
162232572|NCT04860297|585899647|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
162232573|NCT04860297|585899648|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
162232574|NCT04860297|585899649|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
162232575|NCT04860297|585899650|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
162232576|NCT04860297|585899651|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
162232577|NCT04860297|585899644|FG000|Part B (Booster Dose)|Other Than Specified|0|||
162232578|NCT04860297|585899645|FG001|Part B (Booster Dose)|Other Than Specified|0|||
162232579|NCT04860297|585899646|FG002|Part B (Booster Dose)|Other Than Specified|0|||
162232580|NCT04860297|585899647|FG003|Part B (Booster Dose)|Other Than Specified|0|||
162232581|NCT04860297|585899648|FG004|Part B (Booster Dose)|Other Than Specified|0|||
162232582|NCT04860297|585899649|FG005|Part B (Booster Dose)|Other Than Specified|1|||
162232583|NCT04860297|585899650|FG006|Part B (Booster Dose)|Other Than Specified|1|||
162232584|NCT04860297|585899651|FG007|Part B (Booster Dose)|Other Than Specified|0|||
161940884|NCT01435356|584833759|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
161940885|NCT01435356|584833760|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
161940886|NCT01435356|584833759|FG000|Overall Study|Physician Decision|1|||
161940887|NCT01435356|584833760|FG001|Overall Study|Physician Decision|0|||
161940888|NCT01435356|584833759|FG000|Overall Study|Patient decision|3|||
161940889|NCT01435356|584833760|FG001|Overall Study|Patient decision|0|||
161940890|NCT01435356|584833759|FG000|Overall Study|Patient moved to another city|1|||
161940891|NCT01435356|584833760|FG001|Overall Study|Patient moved to another city|1|||
161940892|NCT05360784|584833761|FG000|Overall Study|Discontinued|25|||
161940893|NCT05360784|584833762|FG001|Overall Study|Discontinued|11|||
161940894|NCT02796651|584833763|FG000|Overall Study|Adverse Event|6|||
161940895|NCT02796651|584833763|FG000|Overall Study|Lost to Follow-up|1|||
161940896|NCT02796651|584833763|FG000|Overall Study|Withdrawal by Subject|4|||
161940897|NCT02796651|584833763|FG000|Overall Study|Protocol Violation|4|||
161940898|NCT02796651|584833763|FG000|Overall Study|Lack of Efficacy|1|||
161940899|NCT02796651|584833763|FG000|Overall Study|Other|10|||
161940900|NCT00437073|584833764|FG000|Overall Study|Sponsor Terminated Study|1|||
161940901|NCT00437073|584833765|FG001|Overall Study|Sponsor Terminated Study|0|||
161940902|NCT00437073|584833764|FG000|Overall Study|Physician Decision|0|||
161940903|NCT00437073|584833765|FG001|Overall Study|Physician Decision|1|||
161940904|NCT04918771|584833766|FG000|Overall Study|Withdrawal by Subject|4|||
161940905|NCT04918771|584833767|FG001|Overall Study|Withdrawal by Subject|5|||
161940906|NCT04918771|584833766|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
161940907|NCT04918771|584833767|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
161940908|NCT02971163|584833768|FG000|Overall Study|Lost to Follow-up|4|||
161940909|NCT02971163|584833769|FG001|Overall Study|Lost to Follow-up|2|||
161940910|NCT01849276|584833770|FG000|Followed for Survival for 5 Years|Death|1|||
161940911|NCT01849276|584833770|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
161940912|NCT02657343|584833773|FG000|Overall Study|Death|0|||
161940913|NCT02657343|584833774|FG001|Overall Study|Death|2|||
161940914|NCT02657343|584833775|FG002|Overall Study|Death|0|||
161940915|NCT02657343|584833776|FG003|Overall Study|Death|0|||
161940916|NCT02657343|584833777|FG004|Overall Study|Death|0|||
161940917|NCT02657343|584833778|FG005|Overall Study|Death|0|||
161940918|NCT02657343|584833773|FG000|Overall Study|Patient went to hospice|1|||
161940919|NCT02657343|584833774|FG001|Overall Study|Patient went to hospice|0|||
161940920|NCT02657343|584833775|FG002|Overall Study|Patient went to hospice|0|||
161940921|NCT02657343|584833776|FG003|Overall Study|Patient went to hospice|0|||
161940922|NCT02657343|584833777|FG004|Overall Study|Patient went to hospice|0|||
161940923|NCT02657343|584833778|FG005|Overall Study|Patient went to hospice|0|||
161940924|NCT02657343|584833773|FG000|Overall Study|Withdrawal by Subject|0|||
161940925|NCT02657343|584833774|FG001|Overall Study|Withdrawal by Subject|0|||
161940926|NCT02657343|584833775|FG002|Overall Study|Withdrawal by Subject|0|||
161940927|NCT02657343|584833776|FG003|Overall Study|Withdrawal by Subject|0|||
162232585|NCT04860297|585899644|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
162232586|NCT04860297|585899645|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
162232587|NCT04860297|585899646|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
162232588|NCT04860297|585899647|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
162232589|NCT04860297|585899648|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
161940928|NCT02657343|584833777|FG004|Overall Study|Withdrawal by Subject|1|||
161940929|NCT02657343|584833778|FG005|Overall Study|Withdrawal by Subject|0|||
161940930|NCT01813357|584833785|FG000|Overall Study|Lost to Follow-up|5|||
161940931|NCT01813357|584833786|FG001|Overall Study|Lost to Follow-up|6|||
162232590|NCT04860297|585899649|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
161940932|NCT04938427|584833793|FG000|Overall Study|Adverse Event|5|||
161940933|NCT04938427|584833794|FG001|Overall Study|Adverse Event|19|||
161940934|NCT04938427|584833793|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161940935|NCT04938427|584833794|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161940936|NCT04938427|584833793|FG000|Overall Study|Withdrawal by Subject|1|||
161680455|NCT03086057|583882949|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
161680456|NCT03086057|583882946|FG000|Stage 1: PrEP Uptake|Death|1|||
162232591|NCT04860297|585899650|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
162232592|NCT04860297|585899651|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
162232593|NCT04860297|585899644|FG000|Part B (Booster Dose)|Death|0|||
162232594|NCT04860297|585899645|FG001|Part B (Booster Dose)|Death|0|||
162232595|NCT04860297|585899646|FG002|Part B (Booster Dose)|Death|0|||
162232596|NCT04860297|585899647|FG003|Part B (Booster Dose)|Death|0|||
162232597|NCT04860297|585899648|FG004|Part B (Booster Dose)|Death|1|||
162232598|NCT04860297|585899649|FG005|Part B (Booster Dose)|Death|2|||
162232599|NCT04860297|585899650|FG006|Part B (Booster Dose)|Death|1|||
162232600|NCT04860297|585899651|FG007|Part B (Booster Dose)|Death|0|||
162232601|NCT04860297|585899644|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
162232602|NCT04860297|585899645|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
162232603|NCT04860297|585899646|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
162232604|NCT04860297|585899647|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
162232605|NCT04860297|585899648|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
162232606|NCT04860297|585899649|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
162232607|NCT04860297|585899650|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
162232608|NCT04860297|585899651|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
162232609|NCT00468559|585899655|FG000|Open-label Treatment Phase|Adverse Event|5|||
162232610|NCT00468559|585899656|FG001|Open-label Treatment Phase|Adverse Event|0|||
162232611|NCT00468559|585899657|FG002|Open-label Treatment Phase|Adverse Event|0|||
162232612|NCT00468559|585899655|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
162232613|NCT00468559|585899656|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
162232614|NCT00468559|585899657|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
162232615|NCT00468559|585899655|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
162232616|NCT00468559|585899656|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
162232617|NCT00468559|585899657|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
162232618|NCT00468559|585899655|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
162232619|NCT00468559|585899656|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
162232620|NCT00468559|585899657|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
162232621|NCT00468559|585899655|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
162232622|NCT00468559|585899656|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
162232623|NCT00468559|585899657|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
162232624|NCT00862719|585899658|FG000|Overall Study|Disease Progression|5|||
162232625|NCT00862719|585899659|FG001|Overall Study|Disease Progression|0|||
162232626|NCT00862719|585899660|FG002|Overall Study|Disease Progression|1|||
162232627|NCT00862719|585899661|FG003|Overall Study|Disease Progression|0|||
162232628|NCT00862719|585899658|FG000|Overall Study|Death|5|||
162232629|NCT00862719|585899659|FG001|Overall Study|Death|6|||
162232630|NCT00862719|585899660|FG002|Overall Study|Death|1|||
162232631|NCT00862719|585899661|FG003|Overall Study|Death|1|||
162232632|NCT00862719|585899658|FG000|Overall Study|Engraftment failure|0|||
162232633|NCT00862719|585899659|FG001|Overall Study|Engraftment failure|0|||
162232634|NCT00862719|585899660|FG002|Overall Study|Engraftment failure|1|||
162232635|NCT00862719|585899661|FG003|Overall Study|Engraftment failure|0|||
162232636|NCT00862719|585899658|FG000|Overall Study|Veno-Occlusive Disease|0|||
162232637|NCT00862719|585899659|FG001|Overall Study|Veno-Occlusive Disease|0|||
162232638|NCT00862719|585899660|FG002|Overall Study|Veno-Occlusive Disease|1|||
162232639|NCT00862719|585899661|FG003|Overall Study|Veno-Occlusive Disease|0|||
161940937|NCT04938427|584833794|FG001|Overall Study|Withdrawal by Subject|0|||
162232640|NCT01153958|585899662|FG000|Overall Study|Study Terminated|36|||
162232641|NCT01153958|585899663|FG001|Overall Study|Study Terminated|32|||
162232642|NCT00925353|585899664|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
162232643|NCT03647488|585901351|FG000|Overall Study|Progressive disease|10|||
162232644|NCT03647488|585901352|FG001|Overall Study|Progressive disease|0|||
162232645|NCT03647488|585901353|FG002|Overall Study|Progressive disease|0|||
162232646|NCT03647488|585901351|FG000|Overall Study|Adverse Event|5|||
162232647|NCT03647488|585901352|FG001|Overall Study|Adverse Event|0|||
162232648|NCT03647488|585901353|FG002|Overall Study|Adverse Event|0|||
162232649|NCT03647488|585901351|FG000|Overall Study|Clinical progression|2|||
162232650|NCT03647488|585901352|FG001|Overall Study|Clinical progression|0|||
162232651|NCT03647488|585901353|FG002|Overall Study|Clinical progression|0|||
162232652|NCT03647488|585901351|FG000|Overall Study|Participant refused to take investigational product|1|||
161940938|NCT04938427|584833793|FG000|Overall Study|Reason Not Specified|2|||
161940939|NCT04938427|584833794|FG001|Overall Study|Reason Not Specified|1|||
162232653|NCT03647488|585901352|FG001|Overall Study|Participant refused to take investigational product|0|||
162232654|NCT03647488|585901353|FG002|Overall Study|Participant refused to take investigational product|0|||
162232655|NCT00812331|585901354|FG000|Overall Study|Adverse Event|1|||
162232656|NCT00812331|585901355|FG001|Overall Study|Adverse Event|0|||
161940940|NCT01107496|584833795|FG000|Overall Study|Adverse Event|1|||
162232657|NCT00812331|585901356|FG002|Overall Study|Adverse Event|0|||
162232658|NCT00812331|585901357|FG003|Overall Study|Adverse Event|0|||
162232659|NCT00812331|585901358|FG004|Overall Study|Adverse Event|0|||
161680457|NCT03086057|583882947|FG001|Stage 1: PrEP Uptake|Death|0|||
162232660|NCT02502799|585901359|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
162232661|NCT02502799|585901360|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
162232662|NCT02502799|585901361|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
162232663|NCT02502799|585901362|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
162232664|NCT02502799|585901359|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
162232665|NCT02502799|585901360|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
162232666|NCT02502799|585901361|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
162232667|NCT02502799|585901362|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
162232668|NCT02502799|585901359|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
162232669|NCT02502799|585901360|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
162232670|NCT02502799|585901361|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
162232671|NCT02502799|585901362|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
162232672|NCT02502799|585901359|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
162232673|NCT02502799|585901360|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
162232674|NCT02502799|585901361|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
162232675|NCT02502799|585901362|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
162232676|NCT02502799|585901359|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
162232677|NCT02502799|585901360|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
161680458|NCT03086057|583882948|FG002|Stage 1: PrEP Uptake|Death|0|||
161680459|NCT03086057|583882949|FG003|Stage 1: PrEP Uptake|Death|0|||
162232678|NCT02502799|585901361|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
162232679|NCT02502799|585901362|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
162232680|NCT00153062|585901372|FG000|Overall Study|Death|360|||
162232681|NCT00153062|585901373|FG001|Overall Study|Death|352|||
162232682|NCT00153062|585901374|FG002|Overall Study|Death|369|||
162232683|NCT00153062|585901375|FG003|Overall Study|Death|365|||
162232684|NCT00153062|585901372|FG000|Overall Study|Withdrawal by Subject|14|||
162232685|NCT00153062|585901373|FG001|Overall Study|Withdrawal by Subject|30|||
162232686|NCT00153062|585901374|FG002|Overall Study|Withdrawal by Subject|27|||
162232687|NCT00153062|585901375|FG003|Overall Study|Withdrawal by Subject|28|||
162232688|NCT00153062|585901372|FG000|Overall Study|Lost to Follow-up|12|||
162232689|NCT00153062|585901373|FG001|Overall Study|Lost to Follow-up|20|||
162232690|NCT00153062|585901374|FG002|Overall Study|Lost to Follow-up|15|||
162232691|NCT00153062|585901375|FG003|Overall Study|Lost to Follow-up|16|||
162232692|NCT00153062|585901372|FG000|Overall Study|Adverse Event|0|||
162232693|NCT00153062|585901373|FG001|Overall Study|Adverse Event|1|||
162232694|NCT00153062|585901374|FG002|Overall Study|Adverse Event|1|||
162232695|NCT00153062|585901375|FG003|Overall Study|Adverse Event|0|||
162232696|NCT00153062|585901372|FG000|Overall Study|Protocol Violation|0|||
162232697|NCT00153062|585901373|FG001|Overall Study|Protocol Violation|2|||
162232698|NCT00153062|585901374|FG002|Overall Study|Protocol Violation|1|||
162232699|NCT00153062|585901375|FG003|Overall Study|Protocol Violation|1|||
162232700|NCT00153062|585901372|FG000|Overall Study|No disposition data available|1|||
162232701|NCT00153062|585901373|FG001|Overall Study|No disposition data available|1|||
162232702|NCT00153062|585901374|FG002|Overall Study|No disposition data available|1|||
162232703|NCT00153062|585901375|FG003|Overall Study|No disposition data available|1|||
162232704|NCT00153062|585901372|FG000|Overall Study|Other|0|||
162232705|NCT00153062|585901373|FG001|Overall Study|Other|0|||
162232706|NCT00153062|585901374|FG002|Overall Study|Other|1|||
162232707|NCT00153062|585901375|FG003|Overall Study|Other|0|||
162232708|NCT02359877|585901376|FG000|Overall Study|Withdrawal by Subject|1|||
162232709|NCT02359877|585901377|FG001|Overall Study|Withdrawal by Subject|0|||
162232710|NCT02359877|585901378|FG002|Overall Study|Withdrawal by Subject|0|||
162232711|NCT02359877|585901379|FG003|Overall Study|Withdrawal by Subject|2|||
162232712|NCT02359877|585901376|FG000|Overall Study|Adverse Event|0|||
162232713|NCT02359877|585901377|FG001|Overall Study|Adverse Event|0|||
162232714|NCT02359877|585901378|FG002|Overall Study|Adverse Event|0|||
162232715|NCT02359877|585901379|FG003|Overall Study|Adverse Event|1|||
162232716|NCT01589237|585901392|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
162232717|NCT01589237|585901393|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
162232718|NCT01589237|585901394|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
162232719|NCT01589237|585901395|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
162232720|NCT01589237|585901392|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
162232721|NCT01589237|585901393|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
162232722|NCT01589237|585901394|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
162232723|NCT01589237|585901395|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
162232724|NCT01589237|585901392|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
162232725|NCT01589237|585901393|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
162232726|NCT01589237|585901394|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
162232727|NCT01589237|585901395|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
162232728|NCT01589237|585901392|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
162232729|NCT01589237|585901393|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
162232730|NCT01589237|585901394|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
162232731|NCT01589237|585901395|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
162232732|NCT00117845|585901396|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
162232733|NCT00189488|585901397|FG000|Overall Study|Ineligibility determined|1|||
162232734|NCT00189488|585901398|FG001|Overall Study|Ineligibility determined|0|||
162232735|NCT00189488|585901397|FG000|Overall Study|Protocol deviation|2|||
162232736|NCT00189488|585901398|FG001|Overall Study|Protocol deviation|1|||
162232737|NCT00189488|585901397|FG000|Overall Study|Adverse Event|2|||
162232738|NCT00189488|585901398|FG001|Overall Study|Adverse Event|1|||
162232739|NCT00189488|585901397|FG000|Overall Study|Withdrawal by Subject|2|||
162232740|NCT00189488|585901398|FG001|Overall Study|Withdrawal by Subject|6|||
162232741|NCT00189488|585901397|FG000|Overall Study|Disease progression|2|||
162232742|NCT00189488|585901398|FG001|Overall Study|Disease progression|4|||
162232743|NCT00189488|585901397|FG000|Overall Study|Administrative Decision|0|||
162232744|NCT00189488|585901398|FG001|Overall Study|Administrative Decision|2|||
162232745|NCT00189488|585901397|FG000|Overall Study|Death|5|||
161830045|NCT02412722|584418105|FG001|Overall Study|Progressive Disease|4|||
162232746|NCT00189488|585901398|FG001|Overall Study|Death|8|||
161830046|NCT02412722|584418106|FG002|Overall Study|Progressive Disease|4|||
161830047|NCT02412722|584418107|FG003|Overall Study|Progressive Disease|9|||
162232747|NCT00189488|585901397|FG000|Overall Study|Other|1|||
162232748|NCT00189488|585901398|FG001|Overall Study|Other|0|||
162232749|NCT02349425|585901399|FG000|Period 1|Adverse Event|1|||
162232750|NCT02349425|585901400|FG001|Period 1|Adverse Event|1|||
162232751|NCT02349425|585901401|FG002|Period 1|Adverse Event|0|||
162232752|NCT02349425|585901402|FG003|Period 1|Adverse Event|0|||
162232753|NCT02349425|585901399|FG000|Period 2|Adverse Event|0|||
162232754|NCT02349425|585901400|FG001|Period 2|Adverse Event|1|||
162232755|NCT02349425|585901401|FG002|Period 2|Adverse Event|1|||
162232756|NCT02349425|585901402|FG003|Period 2|Adverse Event|0|||
162232757|NCT03207009|585901403|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
162232758|NCT01491672|585901404|FG000|Overall Study|Lost to Follow-up|0|||
162232759|NCT01491672|585901405|FG001|Overall Study|Lost to Follow-up|4|||
162232760|NCT01491672|585901406|FG002|Overall Study|Lost to Follow-up|1|||
162232761|NCT01491672|585901404|FG000|Overall Study|Withdrawal by Subject|6|||
162232762|NCT01491672|585901405|FG001|Overall Study|Withdrawal by Subject|7|||
162232763|NCT01491672|585901406|FG002|Overall Study|Withdrawal by Subject|0|||
162232764|NCT01491672|585901404|FG000|Overall Study|Adverse Event|8|||
162232765|NCT01491672|585901405|FG001|Overall Study|Adverse Event|10|||
162232766|NCT01491672|585901406|FG002|Overall Study|Adverse Event|4|||
162232767|NCT01491672|585901404|FG000|Overall Study|Disease progression|42|||
162232768|NCT01491672|585901405|FG001|Overall Study|Disease progression|34|||
162232769|NCT01491672|585901406|FG002|Overall Study|Disease progression|6|||
162232770|NCT01491672|585901404|FG000|Overall Study|Protocol deviation|0|||
162232771|NCT01491672|585901405|FG001|Overall Study|Protocol deviation|1|||
162232772|NCT01491672|585901406|FG002|Overall Study|Protocol deviation|0|||
162232773|NCT01491672|585901404|FG000|Overall Study|Death|0|||
162232774|NCT01491672|585901405|FG001|Overall Study|Death|4|||
162232775|NCT01491672|585901406|FG002|Overall Study|Death|0|||
162232776|NCT01143038|585901407|FG000|Overall Study|Withdrawal by Subject|4|||
162232777|NCT01143038|585901407|FG000|Overall Study|Requirement for alternative therapy|5|||
162232778|NCT01143038|585901407|FG000|Overall Study|Adverse Event|3|||
162232779|NCT01143038|585901407|FG000|Overall Study|Lost to Follow-up|2|||
162232780|NCT01143038|585901407|FG000|Overall Study|Protocol Deviation|1|||
162232781|NCT01143038|585901407|FG000|Overall Study|Death|1|||
162232782|NCT00657020|585901410|FG000|PERIOD 1|Adverse Event|0|||
162232783|NCT00657020|585901411|FG001|PERIOD 1|Adverse Event|1|||
162232784|NCT01183234|585901412|FG000|First Intervention|Adverse Event|1|||
162232785|NCT01183234|585901413|FG001|First Intervention|Adverse Event|0|||
162232786|NCT02029846|585901416|FG000|Overall Study|n=1 each arm|1|||
162232787|NCT02029846|585901417|FG001|Overall Study|n=1 each arm|1|||
162232788|NCT02966301|585901418|FG000|Overall Study|Death|2|||
162232789|NCT02966301|585901418|FG000|Overall Study|Withdrawal by Subject|1|||
162232790|NCT00822172|585901422|FG000|Overall Study|Adverse Event|10|||
162232791|NCT00822172|585901423|FG001|Overall Study|Adverse Event|12|||
162232792|NCT00822172|585901422|FG000|Overall Study|Death|1|||
162232793|NCT00822172|585901423|FG001|Overall Study|Death|0|||
162232794|NCT00822172|585901422|FG000|Overall Study|Lost to Follow-up|3|||
162232795|NCT00822172|585901423|FG001|Overall Study|Lost to Follow-up|1|||
162232796|NCT00822172|585901422|FG000|Overall Study|Withdrawal by Subject|1|||
162232797|NCT00822172|585901423|FG001|Overall Study|Withdrawal by Subject|4|||
162232798|NCT00822172|585901422|FG000|Overall Study|site closed|0|||
162232799|NCT00822172|585901423|FG001|Overall Study|site closed|1|||
162232800|NCT00822172|585901422|FG000|Overall Study|Other|0|||
162232801|NCT00822172|585901423|FG001|Overall Study|Other|1|||
162232802|NCT00370331|585901424|FG000|Overall Study|Adverse Event|4|||
162232803|NCT00370331|585901425|FG001|Overall Study|Adverse Event|13|||
162232804|NCT00370331|585901424|FG000|Overall Study|Withdrawal by Subject|2|||
162232805|NCT00370331|585901425|FG001|Overall Study|Withdrawal by Subject|4|||
162232806|NCT00370331|585901424|FG000|Overall Study|Lost to Follow-up|0|||
162232807|NCT00370331|585901425|FG001|Overall Study|Lost to Follow-up|3|||
162232808|NCT00370331|585901424|FG000|Overall Study|Lack of Efficacy|0|||
162232809|NCT00370331|585901425|FG001|Overall Study|Lack of Efficacy|1|||
162232810|NCT00370331|585901424|FG000|Overall Study|Non-compliance|0|||
161940941|NCT01107496|584833796|FG001|Overall Study|Adverse Event|0|||
162232811|NCT00370331|585901425|FG001|Overall Study|Non-compliance|1|||
162232812|NCT00370331|585901424|FG000|Overall Study|Protocol Violation|1|||
162232813|NCT00370331|585901425|FG001|Overall Study|Protocol Violation|1|||
162232814|NCT02947087|585901427|FG000|Overall Study|Withdrawal by Subject|3|||
161830048|NCT02412722|584418108|FG004|Overall Study|Progressive Disease|3|||
161830049|NCT02412722|584418109|FG005|Overall Study|Progressive Disease|3|||
162232815|NCT02947087|585901428|FG001|Overall Study|Withdrawal by Subject|2|||
162232816|NCT02224690|585901433|FG000|Overall Study|Adverse Event|8|||
162232817|NCT02224690|585901434|FG001|Overall Study|Adverse Event|1|||
162232818|NCT02224690|585901433|FG000|Overall Study|Met Withdrawal Criteria|4|||
162232819|NCT02224690|585901434|FG001|Overall Study|Met Withdrawal Criteria|0|||
162232820|NCT02224690|585901433|FG000|Overall Study|Use of G-tube|1|||
162232821|NCT02224690|585901434|FG001|Overall Study|Use of G-tube|0|||
161940942|NCT01107496|584833795|FG000|Overall Study|Lack of Efficacy|1|||
161940943|NCT01107496|584833796|FG001|Overall Study|Lack of Efficacy|0|||
162232822|NCT02224690|585901433|FG000|Overall Study|Did not meet eligibility criteria|1|||
162232823|NCT02224690|585901434|FG001|Overall Study|Did not meet eligibility criteria|0|||
162232824|NCT05753670|585901435|FG000|Overall Study|Withdrawal by Subject|6|||
162232825|NCT05753670|585901436|FG001|Overall Study|Withdrawal by Subject|8|||
162232826|NCT05753670|585901435|FG000|Overall Study|Protocol Violation|3|||
162232827|NCT05753670|585901436|FG001|Overall Study|Protocol Violation|1|||
162232828|NCT02325557|585901437|FG000|Overall Study|Progressive disease|1|||
162232829|NCT02325557|585901438|FG001|Overall Study|Progressive disease|0|||
162232830|NCT02325557|585901439|FG002|Overall Study|Progressive disease|0|||
162232831|NCT02325557|585901440|FG003|Overall Study|Progressive disease|0|||
162232832|NCT02325557|585901437|FG000|Overall Study|Withdrawal by Subject|4|||
162232833|NCT02325557|585901438|FG001|Overall Study|Withdrawal by Subject|0|||
162232834|NCT02325557|585901439|FG002|Overall Study|Withdrawal by Subject|0|||
162232835|NCT02325557|585901440|FG003|Overall Study|Withdrawal by Subject|15|||
162232836|NCT02325557|585901437|FG000|Overall Study|Death|5|||
162232837|NCT02325557|585901438|FG001|Overall Study|Death|1|||
162232838|NCT02325557|585901439|FG002|Overall Study|Death|1|||
162232839|NCT02325557|585901440|FG003|Overall Study|Death|16|||
162232840|NCT02325557|585901437|FG000|Overall Study|Lost to Follow-up|0|||
162232841|NCT02325557|585901438|FG001|Overall Study|Lost to Follow-up|0|||
162232842|NCT02325557|585901439|FG002|Overall Study|Lost to Follow-up|1|||
162232843|NCT02325557|585901440|FG003|Overall Study|Lost to Follow-up|1|||
162232844|NCT02325557|585901437|FG000|Overall Study|Other|0|||
162232845|NCT02325557|585901438|FG001|Overall Study|Other|0|||
162232846|NCT02325557|585901439|FG002|Overall Study|Other|0|||
162232847|NCT02325557|585901440|FG003|Overall Study|Other|5|||
162232848|NCT02703259|585901441|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
162232849|NCT02703259|585901442|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
162232850|NCT02703259|585901441|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
162232851|NCT02703259|585901442|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
162232852|NCT02703259|585901441|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
162232853|NCT02703259|585901442|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
162232854|NCT01993927|585901444|FG000|Overall Study|Case Report Forms Uncollected|18|||
162232855|NCT01993927|585901444|FG000|Overall Study|Protocol Violation|11|||
162232856|NCT00895154|585901445|FG000|Overall Study|Lost to Follow-up|1|||
162232857|NCT00895154|585901446|FG001|Overall Study|Lost to Follow-up|1|||
162232858|NCT00895154|585901445|FG000|Overall Study|Withdrawal by Subject|0|||
162232859|NCT00895154|585901446|FG001|Overall Study|Withdrawal by Subject|1|||
162232860|NCT02414932|585901447|FG000|Overall Study|Withdrawal by Subject|2|||
162232861|NCT02414932|585901448|FG001|Overall Study|Withdrawal by Subject|3|||
162232862|NCT02414932|585901447|FG000|Overall Study|Adverse Event|1|||
162232863|NCT02414932|585901448|FG001|Overall Study|Adverse Event|0|||
162232864|NCT00470366|585901449|FG000|Overall Study|Adverse Event|3|||
162232865|NCT00470366|585901449|FG000|Overall Study|Poor compliance|1|||
162232866|NCT00540046|585901450|FG000|Overall Study|Lost to Follow-up|33|||
162232867|NCT00540046|585901451|FG001|Overall Study|Lost to Follow-up|23|||
162232868|NCT01021215|585901459|FG000|Overall Study|Lost to Follow-up|3|||
162232869|NCT01021215|585901460|FG001|Overall Study|Lost to Follow-up|0|||
162232870|NCT00185965|585901463|FG000|Overall Study|Adverse Event|0|||
162232871|NCT00185965|585901464|FG001|Overall Study|Adverse Event|1|||
162232872|NCT01103362|585901465|FG000|Overall Study|study terminated|596|||
162232873|NCT02533531|585901466|FG000|Overall Study|Device did not turn on|1|||
162232874|NCT03814187|585901467|FG000|Overall Study|Sponsor's Administrative Decision|0|||
162232875|NCT03814187|585901468|FG001|Overall Study|Sponsor's Administrative Decision|0|||
162232876|NCT03814187|585901469|FG002|Overall Study|Sponsor's Administrative Decision|272|||
162232877|NCT03814187|585901467|FG000|Overall Study|Death|80|||
162232878|NCT03814187|585901468|FG001|Overall Study|Death|81|||
162232879|NCT03814187|585901469|FG002|Overall Study|Death|4|||
162232880|NCT03814187|585901467|FG000|Overall Study|Withdrew Consent|77|||
162232881|NCT03814187|585901468|FG001|Overall Study|Withdrew Consent|78|||
162232882|NCT03814187|585901469|FG002|Overall Study|Withdrew Consent|2|||
161940944|NCT01107496|584833795|FG000|Overall Study|Protocol Violation|0|||
161940945|NCT01107496|584833796|FG001|Overall Study|Protocol Violation|1|||
162232883|NCT03814187|585901467|FG000|Overall Study|Lost to Follow-up|47|||
162232884|NCT03814187|585901468|FG001|Overall Study|Lost to Follow-up|52|||
162232885|NCT03814187|585901469|FG002|Overall Study|Lost to Follow-up|1|||
162232886|NCT03814187|585901467|FG000|Overall Study|Adverse Event|22|||
162232887|NCT03814187|585901468|FG001|Overall Study|Adverse Event|23|||
161940946|NCT01107496|584833795|FG000|Overall Study|Lost to Follow-up|0|||
161940947|NCT01107496|584833796|FG001|Overall Study|Lost to Follow-up|1|||
161940948|NCT03559556|584833797|FG000|Overall Study|Withdrawal by Subject|1|||
161940949|NCT02496000|584833798|FG000|Overall Study|Withdrawal by Subject|1|||
161940950|NCT02496000|584833799|FG001|Overall Study|Withdrawal by Subject|2|||
161940951|NCT02496000|584833800|FG002|Overall Study|Withdrawal by Subject|0|||
161940952|NCT02496000|584833798|FG000|Overall Study|Lost to Follow-up|1|||
161940953|NCT02496000|584833799|FG001|Overall Study|Lost to Follow-up|0|||
161940954|NCT02496000|584833800|FG002|Overall Study|Lost to Follow-up|1|||
161940955|NCT02496000|584833798|FG000|Overall Study|Protocol Violation|0|||
161940956|NCT02496000|584833799|FG001|Overall Study|Protocol Violation|0|||
161940957|NCT02496000|584833800|FG002|Overall Study|Protocol Violation|1|||
161940958|NCT02496000|584833798|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
161940959|NCT02496000|584833799|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
161940960|NCT02496000|584833800|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
161940961|NCT02496000|584833798|FG000|Overall Study|undetermined|0|||
161940962|NCT02496000|584833799|FG001|Overall Study|undetermined|1|||
161940963|NCT02496000|584833800|FG002|Overall Study|undetermined|0|||
161940964|NCT01877278|584833801|FG000|Overall Study|Lost to Follow-up|3|||
161940965|NCT01877278|584833802|FG001|Overall Study|Lost to Follow-up|3|||
161940966|NCT01969058|584833803|FG000|Overall Study|Withdrawal by Subject|2|||
161940967|NCT01969058|584833804|FG001|Overall Study|Withdrawal by Subject|0|||
161940968|NCT01969058|584833803|FG000|Overall Study|Adverse Event|1|||
161940969|NCT01969058|584833804|FG001|Overall Study|Adverse Event|0|||
161940970|NCT04090749|584833805|FG000|Open Label Pilot|Lost to Follow-up|1|||
161940971|NCT04090749|584833806|FG001|Open Label Pilot|Lost to Follow-up|0|||
161940972|NCT04090749|584833807|FG002|Open Label Pilot|Lost to Follow-up|0|||
161940973|NCT04090749|584833805|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
161940974|NCT04090749|584833806|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
161940975|NCT04090749|584833807|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
161940976|NCT04090749|584833805|FG000|Pilot Trial|Lost to Follow-up|0|||
161940977|NCT04090749|584833806|FG001|Pilot Trial|Lost to Follow-up|1|||
161940978|NCT04090749|584833807|FG002|Pilot Trial|Lost to Follow-up|1|||
161940979|NCT03510715|584833808|FG000|Overall Study|Adverse Event|1|||
161940980|NCT03510715|584833809|FG001|Overall Study|Adverse Event|0|||
161940981|NCT01972659|584833811|FG000|Overall Study|Protocol Violation|2|||
161940982|NCT01972659|584833812|FG001|Overall Study|Protocol Violation|2|||
161940983|NCT01972659|584833811|FG000|Overall Study|problems realted to acceleromyograph|2|||
161940984|NCT01972659|584833812|FG001|Overall Study|problems realted to acceleromyograph|1|||
161940985|NCT02757768|584833814|FG000|Overall Study|Randomized Never Received Study Drug|3|||
161940986|NCT02757768|584833815|FG001|Overall Study|Randomized Never Received Study Drug|4|||
161940987|NCT02757768|584833814|FG000|Overall Study|Adverse Event|5|||
161940988|NCT02757768|584833815|FG001|Overall Study|Adverse Event|3|||
161940989|NCT02757768|584833814|FG000|Overall Study|Lack of Efficacy|2|||
161940990|NCT02757768|584833815|FG001|Overall Study|Lack of Efficacy|1|||
162232888|NCT03814187|585901469|FG002|Overall Study|Adverse Event|0|||
162232889|NCT03814187|585901467|FG000|Overall Study|Physician Decision|7|||
162232890|NCT03814187|585901468|FG001|Overall Study|Physician Decision|4|||
162232891|NCT03814187|585901469|FG002|Overall Study|Physician Decision|2|||
162232892|NCT03814187|585901467|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
162232893|NCT03814187|585901468|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
162232894|NCT03814187|585901469|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
162232895|NCT03814187|585901467|FG000|Overall Study|Other reasons|34|||
162232896|NCT03814187|585901468|FG001|Overall Study|Other reasons|40|||
162232897|NCT03814187|585901469|FG002|Overall Study|Other reasons|2|||
162232898|NCT01014533|585901470|FG000|Overall Study|Protocol Violation|3|||
162232899|NCT01014533|585901471|FG001|Overall Study|Protocol Violation|2|||
162232900|NCT01014533|585901470|FG000|Overall Study|Withdrawal by Subject|2|||
162232901|NCT01014533|585901471|FG001|Overall Study|Withdrawal by Subject|0|||
162232902|NCT01014533|585901470|FG000|Overall Study|unable to come to appointment|0|||
162232903|NCT01014533|585901471|FG001|Overall Study|unable to come to appointment|3|||
162232904|NCT00513604|585901472|FG000|Overall Study|Not treated|2|||
162232905|NCT00513604|585901473|FG001|Overall Study|Not treated|0|||
162232906|NCT00513604|585901474|FG002|Overall Study|Not treated|1|||
162232907|NCT00513604|585901475|FG003|Overall Study|Not treated|0|||
162232908|NCT00513604|585901476|FG004|Overall Study|Not treated|0|||
162232909|NCT00513604|585901472|FG000|Overall Study|Death during treatment|0|||
162232910|NCT00513604|585901473|FG001|Overall Study|Death during treatment|3|||
162232911|NCT00513604|585901474|FG002|Overall Study|Death during treatment|2|||
162232912|NCT00513604|585901475|FG003|Overall Study|Death during treatment|0|||
162232913|NCT00513604|585901476|FG004|Overall Study|Death during treatment|0|||
162232914|NCT00412061|585901478|FG000|Double Blind Phase|Disease Progression|101|||
162232915|NCT00412061|585901479|FG001|Double Blind Phase|Disease Progression|154|||
162232916|NCT00412061|585901478|FG000|Double Blind Phase|Adverse Event|61|||
161680460|NCT03086057|583882946|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
161680461|NCT03086057|583882947|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
161680462|NCT03086057|583882948|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
161680463|NCT03086057|583882949|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
161680464|NCT03086057|583882946|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
161680465|NCT03086057|583882947|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
161680466|NCT03086057|583882948|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
161680467|NCT03086057|583882949|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
161680468|NCT03086057|583882946|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
161680469|NCT03086057|583882947|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
161680470|NCT03086057|583882948|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
161680471|NCT03086057|583882949|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
161680472|NCT03654976|583882952|FG000|Overall Study|Withdrawal by Subject|12|||
161680473|NCT03654976|583882953|FG001|Overall Study|Withdrawal by Subject|11|||
161680474|NCT03654976|583882952|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
161680475|NCT03654976|583882953|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
161680476|NCT03654976|583882952|FG000|Overall Study|Adverse Event|5|||
161680477|NCT03654976|583882953|FG001|Overall Study|Adverse Event|0|||
161680478|NCT03654976|583882952|FG000|Overall Study|Lost to Follow-up|2|||
161680479|NCT03654976|583882953|FG001|Overall Study|Lost to Follow-up|0|||
161680480|NCT03654976|583882952|FG000|Overall Study|Lack of Efficacy|0|||
161680481|NCT03654976|583882953|FG001|Overall Study|Lack of Efficacy|1|||
161680482|NCT00117598|583882954|FG000|Prior to Treatment Cross Over|Death|40|||
161680483|NCT00117598|583882955|FG001|Prior to Treatment Cross Over|Death|41|||
161680484|NCT00117598|583882956|FG002|Prior to Treatment Cross Over|Death|37|||
161680485|NCT00117598|583882957|FG003|Prior to Treatment Cross Over|Death|0|||
161680486|NCT00117598|583882958|FG004|Prior to Treatment Cross Over|Death|0|||
161680487|NCT00117598|583882954|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
161680488|NCT00117598|583882955|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
161680489|NCT00117598|583882956|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
161680490|NCT00117598|583882957|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
161680491|NCT00117598|583882958|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
161680492|NCT00117598|583882954|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
161680493|NCT00117598|583882955|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
161680494|NCT00117598|583882956|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
161680495|NCT00117598|583882957|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
161680496|NCT00117598|583882958|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
161680497|NCT00117598|583882954|FG000|Prior to Treatment Cross Over|Other|15|||
161680498|NCT00117598|583882955|FG001|Prior to Treatment Cross Over|Other|9|||
161680499|NCT00117598|583882956|FG002|Prior to Treatment Cross Over|Other|9|||
161680500|NCT00117598|583882957|FG003|Prior to Treatment Cross Over|Other|0|||
161680501|NCT00117598|583882958|FG004|Prior to Treatment Cross Over|Other|0|||
161680502|NCT00117598|583882954|FG000|After Treament Cross Over|Death|0|||
161680503|NCT00117598|583882955|FG001|After Treament Cross Over|Death|0|||
161680504|NCT00117598|583882956|FG002|After Treament Cross Over|Death|0|||
161680505|NCT00117598|583882957|FG003|After Treament Cross Over|Death|1|||
161680506|NCT00117598|583882958|FG004|After Treament Cross Over|Death|2|||
161680507|NCT00117598|583882954|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
161680508|NCT00117598|583882955|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
161680509|NCT00117598|583882956|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
161680510|NCT00117598|583882957|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
161680511|NCT00117598|583882958|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
162232917|NCT00412061|585901479|FG001|Double Blind Phase|Adverse Event|16|||
162232918|NCT00412061|585901478|FG000|Double Blind Phase|Final Primary Analysis|26|||
162232919|NCT00412061|585901479|FG001|Double Blind Phase|Final Primary Analysis|14|||
162232920|NCT00412061|585901478|FG000|Double Blind Phase|Withdrawal by Subject|18|||
162232921|NCT00412061|585901479|FG001|Double Blind Phase|Withdrawal by Subject|20|||
161680512|NCT00117598|583882954|FG000|After Treament Cross Over|Other|0|||
161680513|NCT00117598|583882955|FG001|After Treament Cross Over|Other|0|||
162232922|NCT00412061|585901478|FG000|Double Blind Phase|Death|6|||
162232923|NCT00412061|585901479|FG001|Double Blind Phase|Death|3|||
162232924|NCT00412061|585901478|FG000|Double Blind Phase|Protocol Violation|3|||
161680514|NCT00117598|583882956|FG002|After Treament Cross Over|Other|0|||
161680515|NCT00117598|583882957|FG003|After Treament Cross Over|Other|1|||
161680516|NCT00117598|583882958|FG004|After Treament Cross Over|Other|2|||
161680517|NCT01235793|583882959|FG000|Overall Study|Death|6|||
161680518|NCT03098836|583882960|FG000|Overall Study|Adverse Event|1|||
161680519|NCT03098836|583882961|FG001|Overall Study|Adverse Event|3|||
161680520|NCT03098836|583882960|FG000|Overall Study|Lack of Efficacy|30|||
161680521|NCT03098836|583882961|FG001|Overall Study|Lack of Efficacy|15|||
161680522|NCT03098836|583882960|FG000|Overall Study|Physician Decision|2|||
161680523|NCT03098836|583882961|FG001|Overall Study|Physician Decision|1|||
161680524|NCT03098836|583882960|FG000|Overall Study|Withdrawal by Subject|3|||
161680525|NCT03098836|583882961|FG001|Overall Study|Withdrawal by Subject|2|||
161680526|NCT03986866|583882962|FG000|Overall Study|Withdrawal by Subject|0|||
162232925|NCT00412061|585901479|FG001|Double Blind Phase|Protocol Violation|4|||
162232926|NCT00412061|585901478|FG000|Double Blind Phase|New Cander Therapy|1|||
162232927|NCT00412061|585901479|FG001|Double Blind Phase|New Cander Therapy|1|||
161830050|NCT02412722|584418104|FG000|Overall Study|Withdrawal by Subject|2|||
161830051|NCT02412722|584418105|FG001|Overall Study|Withdrawal by Subject|0|||
162232928|NCT00412061|585901478|FG000|Double Blind Phase|Lost to Follow-up|0|||
161830052|NCT02412722|584418106|FG002|Overall Study|Withdrawal by Subject|1|||
161830053|NCT02412722|584418107|FG003|Overall Study|Withdrawal by Subject|2|||
162025157|NCT05141448|585148861|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
162232929|NCT00412061|585901479|FG001|Double Blind Phase|Lost to Follow-up|1|||
162232930|NCT00412061|585901478|FG000|Open Label Phase|Disease Progression|0|||
162232931|NCT00412061|585901479|FG001|Open Label Phase|Disease Progression|86|||
162232932|NCT00412061|585901478|FG000|Open Label Phase|Adverse Event|0|||
162232933|NCT00412061|585901479|FG001|Open Label Phase|Adverse Event|46|||
162232934|NCT00412061|585901478|FG000|Open Label Phase|Withdrawal by Subject|0|||
162232935|NCT00412061|585901479|FG001|Open Label Phase|Withdrawal by Subject|15|||
162232936|NCT00412061|585901478|FG000|Open Label Phase|Administrative Problems|0|||
162232937|NCT00412061|585901479|FG001|Open Label Phase|Administrative Problems|13|||
162232938|NCT00412061|585901478|FG000|Open Label Phase|Death|0|||
162232939|NCT00412061|585901479|FG001|Open Label Phase|Death|7|||
162232940|NCT00412061|585901478|FG000|Open Label Phase|Lost to Follow-up|0|||
162232941|NCT00412061|585901479|FG001|Open Label Phase|Lost to Follow-up|2|||
162232942|NCT00412061|585901478|FG000|Open Label Phase|New Cancer Therapy|0|||
162232943|NCT00412061|585901479|FG001|Open Label Phase|New Cancer Therapy|1|||
162232944|NCT02689518|585901480|FG000|Overall Study|Withdrawal by Subject|3|||
162232945|NCT01688830|585901485|FG000|Overall Study|Lost to Follow-up|0|||
162232946|NCT01688830|585901486|FG001|Overall Study|Lost to Follow-up|0|||
162232947|NCT01688830|585901487|FG002|Overall Study|Lost to Follow-up|0|||
162232948|NCT01688830|585901488|FG003|Overall Study|Lost to Follow-up|0|||
162232949|NCT01688830|585901489|FG004|Overall Study|Lost to Follow-up|0|||
162232950|NCT01688830|585901490|FG005|Overall Study|Lost to Follow-up|0|||
162232951|NCT01688830|585901491|FG006|Overall Study|Lost to Follow-up|0|||
162232952|NCT01688830|585901492|FG007|Overall Study|Lost to Follow-up|0|||
162232953|NCT01688830|585901493|FG008|Overall Study|Lost to Follow-up|0|||
162232954|NCT01688830|585901494|FG009|Overall Study|Lost to Follow-up|0|||
162232955|NCT01688830|585901495|FG010|Overall Study|Lost to Follow-up|1|||
162232956|NCT01688830|585901496|FG011|Overall Study|Lost to Follow-up|0|||
162232957|NCT01688830|585901497|FG012|Overall Study|Lost to Follow-up|0|||
162232958|NCT01688830|585901498|FG013|Overall Study|Lost to Follow-up|0|||
162232959|NCT01688830|585901499|FG014|Overall Study|Lost to Follow-up|0|||
162232960|NCT01688830|585901500|FG015|Overall Study|Lost to Follow-up|0|||
162232961|NCT01688830|585901501|FG016|Overall Study|Lost to Follow-up|0|||
162232962|NCT01688830|585901502|FG017|Overall Study|Lost to Follow-up|0|||
162232963|NCT01688830|585901503|FG018|Overall Study|Lost to Follow-up|0|||
162232964|NCT01688830|585901504|FG019|Overall Study|Lost to Follow-up|0|||
162232965|NCT01688830|585901505|FG020|Overall Study|Lost to Follow-up|0|||
162232966|NCT04822597|585901506|FG000|Overall Study|Withdrawal by Subject|0|||
162232967|NCT04822597|585901507|FG001|Overall Study|Withdrawal by Subject|1|||
162232968|NCT04822597|585901508|FG002|Overall Study|Withdrawal by Subject|1|||
162232969|NCT04822597|585901509|FG003|Overall Study|Withdrawal by Subject|0|||
162232970|NCT04822597|585901506|FG000|Overall Study|Physician Decision|0|||
162232971|NCT04822597|585901507|FG001|Overall Study|Physician Decision|0|||
162232972|NCT04822597|585901508|FG002|Overall Study|Physician Decision|1|||
162232973|NCT04822597|585901509|FG003|Overall Study|Physician Decision|1|||
162232974|NCT04822597|585901506|FG000|Overall Study|Subject withdrawn after enrollment|0|||
161940991|NCT02757768|584833814|FG000|Overall Study|Lost to Follow-up|1|||
161680527|NCT03986866|583882963|FG001|Overall Study|Withdrawal by Subject|3|||
161680528|NCT03986866|583882962|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
161680529|NCT03986866|583882963|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
161680530|NCT00545064|583882966|FG000|Overall Study|Lost to Follow-up|3|||
161680531|NCT00545064|583882966|FG000|Overall Study|Withdrawal by Subject|2|||
161680532|NCT00545064|583882966|FG000|Overall Study|did not complete course of treatment|1|||
161680533|NCT00545064|583882966|FG000|Overall Study|cancel all appointments, no rebooking|1|||
161680534|NCT00545064|583882966|FG000|Overall Study|inclement weather|1|||
161680535|NCT01660451|583882967|FG000|Overall Study|Protocol Violation|0|||
161680536|NCT01660451|583882968|FG001|Overall Study|Protocol Violation|1|||
161680537|NCT01660451|583882969|FG002|Overall Study|Protocol Violation|1|||
161680538|NCT01660451|583882967|FG000|Overall Study|AE not associated with clinical disease progression|13|||
161680539|NCT01660451|583882968|FG001|Overall Study|AE not associated with clinical disease progression|10|||
161680540|NCT01660451|583882969|FG002|Overall Study|AE not associated with clinical disease progression|40|||
161680541|NCT01660451|583882967|FG000|Overall Study|AE associated with clinical disease progression|1|||
161680542|NCT01660451|583882968|FG001|Overall Study|AE associated with clinical disease progression|3|||
161680543|NCT01660451|583882969|FG002|Overall Study|AE associated with clinical disease progression|11|||
161680544|NCT01660451|583882967|FG000|Overall Study|Sponsor Decision|0|||
161680545|NCT01660451|583882968|FG001|Overall Study|Sponsor Decision|0|||
161680546|NCT01660451|583882969|FG002|Overall Study|Sponsor Decision|1|||
161680547|NCT01660451|583882967|FG000|Overall Study|Protocol Deviation|0|||
161680548|NCT01660451|583882968|FG001|Overall Study|Protocol Deviation|0|||
161680549|NCT01660451|583882969|FG002|Overall Study|Protocol Deviation|1|||
161680550|NCT01660451|583882967|FG000|Overall Study|Physician Decision|1|||
161680551|NCT01660451|583882968|FG001|Overall Study|Physician Decision|2|||
161940992|NCT02757768|584833815|FG001|Overall Study|Lost to Follow-up|0|||
161680552|NCT01660451|583882969|FG002|Overall Study|Physician Decision|5|||
161680553|NCT01660451|583882967|FG000|Overall Study|Withdrawal by Subject|1|||
161680554|NCT01660451|583882968|FG001|Overall Study|Withdrawal by Subject|1|||
161680555|NCT01660451|583882969|FG002|Overall Study|Withdrawal by Subject|20|||
161680556|NCT01660451|583882967|FG000|Overall Study|Trial closure.|0|||
161680557|NCT01660451|583882968|FG001|Overall Study|Trial closure.|0|||
161680558|NCT01660451|583882969|FG002|Overall Study|Trial closure.|1|||
162232975|NCT04822597|585901507|FG001|Overall Study|Subject withdrawn after enrollment|1|||
161680559|NCT01660451|583882967|FG000|Overall Study|Switching to other therapy|0|||
161680560|NCT01660451|583882968|FG001|Overall Study|Switching to other therapy|1|||
161680561|NCT01660451|583882969|FG002|Overall Study|Switching to other therapy|1|||
161680562|NCT01660451|583882967|FG000|Overall Study|Progressive disease - clinical progression|4|||
161680563|NCT01660451|583882968|FG001|Overall Study|Progressive disease - clinical progression|10|||
161680564|NCT01660451|583882969|FG002|Overall Study|Progressive disease - clinical progression|9|||
161680565|NCT01660451|583882967|FG000|Overall Study|Progressive disease - radiological progression|12|||
161680566|NCT01660451|583882968|FG001|Overall Study|Progressive disease - radiological progression|23|||
161680567|NCT01660451|583882969|FG002|Overall Study|Progressive disease - radiological progression|50|||
161680568|NCT01660451|583882967|FG000|Overall Study|Death|1|||
161680569|NCT01660451|583882968|FG001|Overall Study|Death|0|||
161680570|NCT01660451|583882969|FG002|Overall Study|Death|1|||
161680571|NCT01660451|583882967|FG000|Overall Study|Other|0|||
161680572|NCT01660451|583882968|FG001|Overall Study|Other|0|||
161680573|NCT01660451|583882969|FG002|Overall Study|Other|1|||
161680574|NCT04688775|583882970|FG000|Placebo-controlled Period|Randomized, not treated|1|||
161680575|NCT04688775|583882971|FG001|Placebo-controlled Period|Randomized, not treated|1|||
161680576|NCT04688775|583882972|FG002|Placebo-controlled Period|Randomized, not treated|0|||
161680577|NCT04688775|583882973|FG003|Placebo-controlled Period|Randomized, not treated|0|||
161680578|NCT04688775|583882970|FG000|Placebo-controlled Period|Adverse Event|2|||
161680579|NCT04688775|583882971|FG001|Placebo-controlled Period|Adverse Event|0|||
161680580|NCT04688775|583882972|FG002|Placebo-controlled Period|Adverse Event|0|||
161680581|NCT04688775|583882973|FG003|Placebo-controlled Period|Adverse Event|0|||
161680582|NCT04688775|583882970|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
161680583|NCT04688775|583882971|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
161680584|NCT04688775|583882972|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
161680585|NCT04688775|583882973|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
161680586|NCT04688775|583882970|FG000|Placebo-controlled Period|Protocol Violation|0|||
161680587|NCT04688775|583882971|FG001|Placebo-controlled Period|Protocol Violation|1|||
161680588|NCT04688775|583882972|FG002|Placebo-controlled Period|Protocol Violation|0|||
161680589|NCT04688775|583882973|FG003|Placebo-controlled Period|Protocol Violation|0|||
161680590|NCT04688775|583882970|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
161680591|NCT04688775|583882971|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
161680592|NCT04688775|583882972|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
161680593|NCT04688775|583882973|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
161680594|NCT04688775|583882970|FG000|Placebo-controlled Period|Other reasons|0|||
161680595|NCT04688775|583882971|FG001|Placebo-controlled Period|Other reasons|1|||
161680596|NCT04688775|583882972|FG002|Placebo-controlled Period|Other reasons|0|||
161680597|NCT04688775|583882973|FG003|Placebo-controlled Period|Other reasons|0|||
161680598|NCT04688775|583882970|FG000|Delayed Start Period|Adverse Event|0|||
161680599|NCT04688775|583882971|FG001|Delayed Start Period|Adverse Event|0|||
161680600|NCT04688775|583882972|FG002|Delayed Start Period|Adverse Event|1|||
161680601|NCT04688775|583882973|FG003|Delayed Start Period|Adverse Event|0|||
161680602|NCT04688775|583882970|FG000|Delayed Start Period|Lack of Efficacy|0|||
161680603|NCT04688775|583882971|FG001|Delayed Start Period|Lack of Efficacy|0|||
161680604|NCT04688775|583882972|FG002|Delayed Start Period|Lack of Efficacy|0|||
161680605|NCT04688775|583882973|FG003|Delayed Start Period|Lack of Efficacy|3|||
161680606|NCT04688775|583882970|FG000|Delayed Start Period|Withdrawal by Subject|0|||
161680607|NCT04688775|583882971|FG001|Delayed Start Period|Withdrawal by Subject|0|||
161680608|NCT04688775|583882972|FG002|Delayed Start Period|Withdrawal by Subject|2|||
161680609|NCT04688775|583882973|FG003|Delayed Start Period|Withdrawal by Subject|4|||
161680610|NCT04688775|583882970|FG000|Delayed Start Period|Lost to Follow-up|0|||
161680611|NCT04688775|583882971|FG001|Delayed Start Period|Lost to Follow-up|0|||
161680612|NCT04688775|583882972|FG002|Delayed Start Period|Lost to Follow-up|2|||
161680613|NCT04688775|583882973|FG003|Delayed Start Period|Lost to Follow-up|1|||
162232976|NCT04822597|585901508|FG002|Overall Study|Subject withdrawn after enrollment|0|||
162232977|NCT04822597|585901509|FG003|Overall Study|Subject withdrawn after enrollment|1|||
161680614|NCT04688775|583882970|FG000|Delayed Start Period|other reasons|0|||
161680615|NCT04688775|583882971|FG001|Delayed Start Period|other reasons|0|||
161680616|NCT04688775|583882972|FG002|Delayed Start Period|other reasons|1|||
161680617|NCT04688775|583882973|FG003|Delayed Start Period|other reasons|0|||
161680618|NCT01536951|583882980|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680619|NCT01536951|583882981|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680620|NCT01536951|583882982|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
161680621|NCT01536951|583882983|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680622|NCT01536951|583882984|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680623|NCT01536951|583882985|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680624|NCT01536951|583882986|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680625|NCT01536951|583882987|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161940993|NCT02757768|584833814|FG000|Overall Study|Protocol Deviation|2|||
161940994|NCT02757768|584833815|FG001|Overall Study|Protocol Deviation|9|||
162025158|NCT05141448|585148862|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
162025159|NCT05141448|585148863|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
162025160|NCT05141448|585148864|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
162025161|NCT05141448|585148859|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
162025162|NCT05141448|585148860|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
162025163|NCT05141448|585148861|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
162025164|NCT05141448|585148862|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
162232978|NCT04822597|585901506|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
162232979|NCT04822597|585901507|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
162232980|NCT04822597|585901508|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
162232981|NCT04822597|585901509|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
162232982|NCT02859324|585901510|FG000|Overall Study|Death|4|||
162232983|NCT02859324|585901511|FG001|Overall Study|Death|6|||
162232984|NCT02859324|585901512|FG002|Overall Study|Death|5|||
162232985|NCT02859324|585901510|FG000|Overall Study|Other reasons|3|||
162232986|NCT02859324|585901511|FG001|Overall Study|Other reasons|3|||
162232987|NCT02859324|585901512|FG002|Overall Study|Other reasons|0|||
162232988|NCT02665338|585901514|FG000|Overall Study|Withdrawal by Subject|0|||
162232989|NCT02665338|585901515|FG001|Overall Study|Withdrawal by Subject|1|||
162232990|NCT00998335|585901516|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
162232991|NCT00998335|585901517|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
162232992|NCT01305200|585901518|FG000|Overall Study|Physician Decision|4|||
162232993|NCT01305200|585901519|FG001|Overall Study|Physician Decision|6|||
162232994|NCT01305200|585901520|FG002|Overall Study|Physician Decision|1|||
162232995|NCT01305200|585901518|FG000|Overall Study|Withdrawal by Subject|24|||
162232996|NCT01305200|585901519|FG001|Overall Study|Withdrawal by Subject|21|||
162232997|NCT01305200|585901520|FG002|Overall Study|Withdrawal by Subject|1|||
162232998|NCT01305200|585901518|FG000|Overall Study|Ineligible|1|||
162232999|NCT01305200|585901519|FG001|Overall Study|Ineligible|2|||
162233000|NCT01305200|585901520|FG002|Overall Study|Ineligible|1|||
162233001|NCT01305200|585901518|FG000|Overall Study|Death|0|||
162233002|NCT01305200|585901519|FG001|Overall Study|Death|2|||
162233003|NCT01305200|585901520|FG002|Overall Study|Death|0|||
162233004|NCT05559476|585901521|FG000|Overall Study|Adverse Event|2|||
162233005|NCT05559476|585901522|FG001|Overall Study|Adverse Event|0|||
162233006|NCT05559476|585901521|FG000|Overall Study|Lost to Follow-up|13|||
162233007|NCT05559476|585901522|FG001|Overall Study|Lost to Follow-up|12|||
162233008|NCT05559476|585901521|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
162233009|NCT05559476|585901522|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
162233010|NCT05559476|585901521|FG000|Overall Study|Other|0|||
162233011|NCT05559476|585901522|FG001|Overall Study|Other|2|||
162233012|NCT05110690|585901523|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
162233013|NCT05110690|585901523|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
162233014|NCT05110690|585901523|FG000|Completion of Intervention|Lost to Follow-up|1|||
162233015|NCT05110690|585901523|FG000|Completion of Intervention|Death|1|||
162233016|NCT05110690|585901523|FG000|Completion of Intervention|Withdrawal by Subject|2|||
162233017|NCT01190514|585903785|FG000|First Intervention (Period 1)|Adverse Event|1|||
162233018|NCT01190514|585903786|FG001|First Intervention (Period 1)|Adverse Event|0|||
162233019|NCT01190514|585903787|FG002|First Intervention (Period 1)|Adverse Event|0|||
162233020|NCT01190514|585903788|FG003|First Intervention (Period 1)|Adverse Event|0|||
162233021|NCT01190514|585903785|FG000|Third Intervention (Period 3)|Adverse Event|1|||
162233022|NCT01190514|585903786|FG001|Third Intervention (Period 3)|Adverse Event|0|||
162233023|NCT01190514|585903787|FG002|Third Intervention (Period 3)|Adverse Event|0|||
162233024|NCT01190514|585903788|FG003|Third Intervention (Period 3)|Adverse Event|0|||
162233025|NCT00512317|585903789|FG000|Overall Study|Insufficient clinical response|36|||
162233026|NCT00512317|585903789|FG000|Overall Study|Withdrawal by Subject|23|||
162233027|NCT00512317|585903789|FG000|Overall Study|Sponsor closure of study|21|||
162233028|NCT00512317|585903789|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
162233029|NCT00512317|585903789|FG000|Overall Study|Adverse Event|13|||
162233030|NCT00512317|585903789|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
162233031|NCT00512317|585903789|FG000|Overall Study|Lost to Follow-up|2|||
162233032|NCT00512317|585903789|FG000|Overall Study|Other|2|||
162233033|NCT00706433|585903793|FG000|Overall Study|Lost to Follow-up|3|||
162233034|NCT00706433|585903794|FG001|Overall Study|Lost to Follow-up|1|||
162233035|NCT00706433|585903795|FG002|Overall Study|Lost to Follow-up|6|||
162233036|NCT00706433|585903796|FG003|Overall Study|Lost to Follow-up|0|||
162233037|NCT00706433|585903793|FG000|Overall Study|Withdrawal by Subject|1|||
162233038|NCT00706433|585903794|FG001|Overall Study|Withdrawal by Subject|2|||
162233039|NCT00706433|585903795|FG002|Overall Study|Withdrawal by Subject|3|||
162233040|NCT00706433|585903796|FG003|Overall Study|Withdrawal by Subject|1|||
162233041|NCT00706433|585903793|FG000|Overall Study|Adverse Event|0|||
162233042|NCT00706433|585903794|FG001|Overall Study|Adverse Event|0|||
162233043|NCT00706433|585903795|FG002|Overall Study|Adverse Event|1|||
162233044|NCT00706433|585903796|FG003|Overall Study|Adverse Event|0|||
162233045|NCT00706433|585903793|FG000|Overall Study|Protocol Violation|1|||
161680626|NCT01536951|583882988|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161680627|NCT01536951|583882980|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
161680628|NCT01536951|583882981|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
161680629|NCT01536951|583882982|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
161680630|NCT01536951|583882983|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
161680631|NCT01536951|583882984|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
161680632|NCT01536951|583882985|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
161680633|NCT01536951|583882986|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
161680634|NCT01536951|583882987|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
161680635|NCT01536951|583882988|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
161680636|NCT01843972|583882991|FG000|Overall Study|Withdrawal by Subject|0|||
161680637|NCT01843972|583882992|FG001|Overall Study|Withdrawal by Subject|0|||
161680638|NCT01843972|583882993|FG002|Overall Study|Withdrawal by Subject|0|||
161680639|NCT01843972|583882994|FG003|Overall Study|Withdrawal by Subject|0|||
161680640|NCT01843972|583882995|FG004|Overall Study|Withdrawal by Subject|1|||
162233046|NCT00706433|585903794|FG001|Overall Study|Protocol Violation|0|||
162233047|NCT00706433|585903795|FG002|Overall Study|Protocol Violation|0|||
162233048|NCT00706433|585903796|FG003|Overall Study|Protocol Violation|0|||
162233049|NCT00706433|585903793|FG000|Overall Study|new job|0|||
162233050|NCT00706433|585903794|FG001|Overall Study|new job|0|||
162233051|NCT00706433|585903795|FG002|Overall Study|new job|0|||
162233052|NCT00706433|585903796|FG003|Overall Study|new job|1|||
162233053|NCT04101318|585903798|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
162233054|NCT04101318|585903799|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
162233055|NCT04101318|585903798|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
162233056|NCT04101318|585903799|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
162233057|NCT04101318|585903798|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
162233058|NCT04101318|585903799|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
162233059|NCT00717067|585903800|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
162233060|NCT00717067|585903801|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
162233061|NCT00717067|585903802|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
162233062|NCT00717067|585903803|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
162233063|NCT00717067|585903804|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
162233064|NCT02090959|585903805|FG000|Overall Study|Withdrawal by Subject|10|||
162233065|NCT02090959|585903805|FG000|Overall Study|Adverse Event|1|||
162233066|NCT02090959|585903805|FG000|Overall Study|Investigator decision|2|||
162233067|NCT02090959|585903805|FG000|Overall Study|Study termination|6|||
162233068|NCT02090959|585903805|FG000|Overall Study|Enrolled but not treated|1|||
162233069|NCT02090959|585903805|FG000|Overall Study|Transfer for compassionate use medicine|4|||
162233070|NCT02090959|585903805|FG000|Overall Study|Move to medical need program|3|||
161940995|NCT02757768|584833814|FG000|Overall Study|Withdrawal by Subject|16|||
161940996|NCT02757768|584833815|FG001|Overall Study|Withdrawal by Subject|9|||
161940997|NCT02757768|584833814|FG000|Overall Study|Miscellaneous|4|||
161940998|NCT02757768|584833815|FG001|Overall Study|Miscellaneous|2|||
161680641|NCT01843972|583882996|FG005|Overall Study|Withdrawal by Subject|0|||
161940999|NCT00835367|584833816|FG000|Washout|Adverse Event|2|||
162233071|NCT02090959|585903805|FG000|Overall Study|Entered in to other study|34|||
162233072|NCT02090959|585903805|FG000|Overall Study|Switched to commercial supply|88|||
162233073|NCT02090959|585903805|FG000|Overall Study|Other than specified|2|||
162233074|NCT00522873|585903806|FG000|Overall Study|Adverse Event|41|||
162233075|NCT00522873|585903807|FG001|Overall Study|Adverse Event|26|||
162233076|NCT00522873|585903806|FG000|Overall Study|Withdrawal by Subject|20|||
162233077|NCT00522873|585903807|FG001|Overall Study|Withdrawal by Subject|9|||
162233078|NCT00522873|585903806|FG000|Overall Study|Protocol Violation|14|||
162233079|NCT00522873|585903807|FG001|Overall Study|Protocol Violation|4|||
162233080|NCT00522873|585903806|FG000|Overall Study|Lost to Follow-up|11|||
162233081|NCT00522873|585903807|FG001|Overall Study|Lost to Follow-up|3|||
162233082|NCT00522873|585903806|FG000|Overall Study|Personal Reasons|8|||
162233083|NCT00522873|585903807|FG001|Overall Study|Personal Reasons|1|||
162233084|NCT00522873|585903806|FG000|Overall Study|Medication Errors|1|||
162233085|NCT00522873|585903807|FG001|Overall Study|Medication Errors|1|||
162233086|NCT00522873|585903806|FG000|Overall Study|Never Received Medication|1|||
162233087|NCT00522873|585903807|FG001|Overall Study|Never Received Medication|0|||
162233088|NCT00545051|585903809|FG000|Overall Study|Adverse Event|7|||
162233089|NCT00545051|585903810|FG001|Overall Study|Adverse Event|3|||
162233090|NCT00545051|585903809|FG000|Overall Study|Death|1|||
162233091|NCT00545051|585903810|FG001|Overall Study|Death|0|||
162233092|NCT00545051|585903809|FG000|Overall Study|Violation of inclusion/exclusion|0|||
162233093|NCT00545051|585903810|FG001|Overall Study|Violation of inclusion/exclusion|2|||
162233094|NCT00545051|585903809|FG000|Overall Study|Protocol Violation|1|||
162233095|NCT00545051|585903810|FG001|Overall Study|Protocol Violation|0|||
162233096|NCT00545051|585903809|FG000|Overall Study|Withdrawal by Subject|0|||
162233097|NCT00545051|585903810|FG001|Overall Study|Withdrawal by Subject|1|||
162233098|NCT00545051|585903809|FG000|Overall Study|Administrative reasons|0|||
162233099|NCT00545051|585903810|FG001|Overall Study|Administrative reasons|1|||
162233100|NCT01375114|585903811|FG000|Overall Study|Lost to Follow-up|1|||
162233101|NCT01375114|585903812|FG001|Overall Study|Lost to Follow-up|0|||
162233102|NCT01375114|585903813|FG002|Overall Study|Lost to Follow-up|1|||
162233103|NCT01375114|585903811|FG000|Overall Study|Disease Progression|3|||
162233104|NCT01375114|585903812|FG001|Overall Study|Disease Progression|2|||
162233105|NCT01375114|585903813|FG002|Overall Study|Disease Progression|2|||
162233106|NCT01375114|585903811|FG000|Overall Study|Patient Changed Mind|0|||
162233107|NCT01375114|585903812|FG001|Overall Study|Patient Changed Mind|0|||
162233108|NCT01375114|585903813|FG002|Overall Study|Patient Changed Mind|2|||
162233109|NCT01375114|585903811|FG000|Overall Study|Pruritus|0|||
162233110|NCT01375114|585903812|FG001|Overall Study|Pruritus|0|||
162233111|NCT01375114|585903813|FG002|Overall Study|Pruritus|1|||
162233112|NCT01375114|585903811|FG000|Overall Study|Restlessness|0|||
162233113|NCT01375114|585903812|FG001|Overall Study|Restlessness|0|||
162233114|NCT01375114|585903813|FG002|Overall Study|Restlessness|1|||
162233115|NCT01375114|585903811|FG000|Overall Study|Diarrhea|0|||
162233116|NCT01375114|585903812|FG001|Overall Study|Diarrhea|0|||
162233117|NCT01375114|585903813|FG002|Overall Study|Diarrhea|1|||
162233118|NCT01375114|585903811|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
162233119|NCT01375114|585903812|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
162233120|NCT01375114|585903813|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
162233121|NCT01375114|585903811|FG000|Overall Study|Nausea|0|||
162233122|NCT01375114|585903812|FG001|Overall Study|Nausea|1|||
162233123|NCT01375114|585903813|FG002|Overall Study|Nausea|0|||
162233124|NCT01375114|585903811|FG000|Overall Study|Increased AST/ALT|0|||
162233125|NCT01375114|585903812|FG001|Overall Study|Increased AST/ALT|1|||
162233126|NCT01375114|585903813|FG002|Overall Study|Increased AST/ALT|0|||
162233127|NCT01375114|585903811|FG000|Overall Study|Vaginal Hemorrhage|0|||
162233128|NCT01375114|585903812|FG001|Overall Study|Vaginal Hemorrhage|1|||
162233129|NCT01375114|585903813|FG002|Overall Study|Vaginal Hemorrhage|0|||
162233130|NCT01375114|585903811|FG000|Overall Study|Family problem|0|||
162233131|NCT01375114|585903812|FG001|Overall Study|Family problem|1|||
162233132|NCT01375114|585903813|FG002|Overall Study|Family problem|0|||
162233133|NCT01375114|585903811|FG000|Overall Study|Protocol Violation|2|||
162233134|NCT01375114|585903812|FG001|Overall Study|Protocol Violation|0|||
162233135|NCT01375114|585903813|FG002|Overall Study|Protocol Violation|0|||
161680642|NCT01843972|583882997|FG006|Overall Study|Withdrawal by Subject|0|||
161680643|NCT01843972|583882998|FG007|Overall Study|Withdrawal by Subject|0|||
161680644|NCT01843972|583882999|FG008|Overall Study|Withdrawal by Subject|0|||
161680645|NCT01843972|583883000|FG009|Overall Study|Withdrawal by Subject|0|||
162233136|NCT00477334|585903814|FG000|Overall Study|Discontinued prior to taking study drug|106|||
161830054|NCT02412722|584418108|FG004|Overall Study|Withdrawal by Subject|1|||
162233137|NCT00477334|585903815|FG001|Overall Study|Discontinued prior to taking study drug|53|||
162233138|NCT00477334|585903814|FG000|Overall Study|Adverse Event|1|||
162233139|NCT00477334|585903815|FG001|Overall Study|Adverse Event|2|||
161680646|NCT01817751|583883006|FG000|Overall Study|Physician Decision|1|||
162233140|NCT00477334|585903814|FG000|Overall Study|Withdrawal by Subject|2|||
162233141|NCT00477334|585903815|FG001|Overall Study|Withdrawal by Subject|1|||
162233142|NCT00477334|585903814|FG000|Overall Study|Lost to Follow-up|15|||
162233143|NCT00477334|585903815|FG001|Overall Study|Lost to Follow-up|4|||
162233144|NCT00477334|585903814|FG000|Overall Study|Administrative Problems|39|||
162233145|NCT00477334|585903815|FG001|Overall Study|Administrative Problems|15|||
162233146|NCT00477334|585903814|FG000|Overall Study|Protocol Violation|7|||
162233147|NCT00477334|585903815|FG001|Overall Study|Protocol Violation|1|||
162233148|NCT04745026|585903816|FG000|Overall Study|Physician Decision|1|||
162233149|NCT04745026|585903817|FG001|Overall Study|Physician Decision|0|||
162233150|NCT04745026|585903816|FG000|Overall Study|Adverse Event|2|||
162233151|NCT04745026|585903817|FG001|Overall Study|Adverse Event|2|||
162233152|NCT04745026|585903816|FG000|Overall Study|Protocol Violation|1|||
162233153|NCT04745026|585903817|FG001|Overall Study|Protocol Violation|3|||
162233154|NCT04745026|585903816|FG000|Overall Study|Lost to Follow-up|4|||
162233155|NCT04745026|585903817|FG001|Overall Study|Lost to Follow-up|3|||
162233156|NCT04745026|585903816|FG000|Overall Study|Withdrawal by Subject|5|||
162233157|NCT04745026|585903817|FG001|Overall Study|Withdrawal by Subject|5|||
162233158|NCT01656733|585903818|FG000|Overall Study|No permission to collect birth outcomes|0|||
162233159|NCT01656733|585903819|FG001|Overall Study|No permission to collect birth outcomes|1|||
162233160|NCT01656733|585903818|FG000|Overall Study|Delivery at another hospital|0|||
162233161|NCT01656733|585903819|FG001|Overall Study|Delivery at another hospital|2|||
162233162|NCT01656733|585903818|FG000|Overall Study|Spontaneous abortion|0|||
162233163|NCT01656733|585903819|FG001|Overall Study|Spontaneous abortion|1|||
162233164|NCT01415531|585903820|FG000|Overall Study|Adverse Event|7|||
162233165|NCT01415531|585903821|FG001|Overall Study|Adverse Event|10|||
162233166|NCT01415531|585903820|FG000|Overall Study|Lack of Efficacy|3|||
162233167|NCT01415531|585903821|FG001|Overall Study|Lack of Efficacy|2|||
162233168|NCT01415531|585903820|FG000|Overall Study|Protocol Violation|0|||
162233169|NCT01415531|585903821|FG001|Overall Study|Protocol Violation|1|||
162233170|NCT01415531|585903820|FG000|Overall Study|Withdrawal by Subject|5|||
162233171|NCT01415531|585903821|FG001|Overall Study|Withdrawal by Subject|4|||
162233172|NCT01415531|585903820|FG000|Overall Study|Lost to Follow-up|6|||
162233173|NCT01415531|585903821|FG001|Overall Study|Lost to Follow-up|14|||
162233174|NCT01415531|585903820|FG000|Overall Study|Lack of Compliance|1|||
162233175|NCT01415531|585903821|FG001|Overall Study|Lack of Compliance|4|||
162025165|NCT05141448|585148863|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
162233176|NCT01415531|585903820|FG000|Overall Study|Other Reasons|3|||
162233177|NCT01415531|585903821|FG001|Overall Study|Other Reasons|2|||
162233178|NCT00122460|585903822|FG000|Overall Study|investigational study phase ongoing|7|||
162233179|NCT00122460|585903823|FG001|Overall Study|investigational study phase ongoing|1|||
162233180|NCT01236339|585903824|FG000|Overall Study|Termination of study by sponsor|11|||
162233181|NCT01236339|585903825|FG001|Overall Study|Termination of study by sponsor|13|||
162233182|NCT02084056|585903826|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
162233183|NCT02084056|585903827|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
162233184|NCT02084056|585903828|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
162233185|NCT02084056|585903829|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
162233186|NCT02084056|585903826|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
162233187|NCT02084056|585903827|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
162233188|NCT02084056|585903828|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
162233189|NCT02084056|585903829|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
162233190|NCT00938860|585903832|FG000|Overall Study|Adverse Event|2|||
162233191|NCT00938860|585903833|FG001|Overall Study|Adverse Event|1|||
162233192|NCT00938860|585903832|FG000|Overall Study|Abnormal laboratory values|2|||
162233193|NCT00938860|585903833|FG001|Overall Study|Abnormal laboratory values|2|||
162233194|NCT00938860|585903832|FG000|Overall Study|Withdrawal by Subject|11|||
162233195|NCT00938860|585903833|FG001|Overall Study|Withdrawal by Subject|8|||
162233196|NCT00938860|585903832|FG000|Overall Study|Lost to Follow-up|4|||
162233197|NCT00938860|585903833|FG001|Overall Study|Lost to Follow-up|4|||
162233198|NCT00938860|585903832|FG000|Overall Study|Administration problems|2|||
162233199|NCT00938860|585903833|FG001|Overall Study|Administration problems|0|||
162233200|NCT00938860|585903832|FG000|Overall Study|Death|1|||
162233201|NCT00938860|585903833|FG001|Overall Study|Death|1|||
162233202|NCT00938860|585903832|FG000|Overall Study|Protocol Violation|3|||
162233203|NCT00938860|585903833|FG001|Overall Study|Protocol Violation|1|||
162233204|NCT01605019|585903834|FG000|Overall Study|pt did not meet transplant endpoint|3|||
162233205|NCT01605019|585903835|FG001|Overall Study|pt did not meet transplant endpoint|0|||
162233206|NCT04223830|585903839|FG000|Overall Study|Lost to Follow-up|9|||
162233207|NCT04223830|585903839|FG000|Overall Study|Adverse Event|1|||
162233208|NCT00324116|585903840|FG000|Overall Study|Adverse Event|5|||
162233209|NCT00324116|585903840|FG000|Overall Study|Lack of Efficacy|17|||
162233210|NCT00324116|585903840|FG000|Overall Study|Withdrawal by Subject|5|||
162233211|NCT00324116|585903840|FG000|Overall Study|Other|5|||
162233212|NCT01806623|585903841|FG000|Overall Study|Withdrawal by Subject|1|||
162233213|NCT01806623|585903841|FG000|Overall Study|Adverse Event|1|||
162233214|NCT01806623|585903841|FG000|Overall Study|Did not meet the inclusion criteria|56|||
162233215|NCT01451827|585903842|FG000|Overall Study|Adverse Event|2|||
162233216|NCT01451827|585903843|FG001|Overall Study|Adverse Event|0|||
162233217|NCT01451827|585903844|FG002|Overall Study|Adverse Event|1|||
162233218|NCT01451827|585903845|FG003|Overall Study|Adverse Event|1|||
162233219|NCT01451827|585903842|FG000|Overall Study|Protocol deviation|1|||
162233220|NCT01451827|585903843|FG001|Overall Study|Protocol deviation|0|||
162233221|NCT01451827|585903844|FG002|Overall Study|Protocol deviation|0|||
162233222|NCT01451827|585903845|FG003|Overall Study|Protocol deviation|0|||
162233223|NCT01451827|585903842|FG000|Overall Study|Lost to Follow-up|0|||
162233224|NCT01451827|585903843|FG001|Overall Study|Lost to Follow-up|3|||
162233225|NCT01451827|585903844|FG002|Overall Study|Lost to Follow-up|0|||
162233226|NCT01451827|585903845|FG003|Overall Study|Lost to Follow-up|2|||
162233227|NCT01451827|585903842|FG000|Overall Study|Participant met withdrawal criteria|0|||
162233228|NCT01451827|585903843|FG001|Overall Study|Participant met withdrawal criteria|2|||
162233229|NCT01451827|585903844|FG002|Overall Study|Participant met withdrawal criteria|0|||
162233230|NCT01451827|585903845|FG003|Overall Study|Participant met withdrawal criteria|0|||
162233231|NCT01451827|585903842|FG000|Overall Study|Withdrawal by Subject|0|||
162233232|NCT01451827|585903843|FG001|Overall Study|Withdrawal by Subject|0|||
162233233|NCT01451827|585903844|FG002|Overall Study|Withdrawal by Subject|1|||
162233234|NCT01451827|585903845|FG003|Overall Study|Withdrawal by Subject|1|||
162233235|NCT01964924|585903846|FG000|Trametinib Monotherapy|Progression|19|||
162233236|NCT01964924|585903847|FG001|Trametinib Monotherapy|Progression|0|||
162233237|NCT01528345|585903848|FG000|Overall Study|Adverse Event|10|||
162233238|NCT01528345|585903849|FG001|Overall Study|Adverse Event|1|||
162233239|NCT01528345|585903848|FG000|Overall Study|Death|1|||
162233240|NCT01528345|585903849|FG001|Overall Study|Death|1|||
162233241|NCT01528345|585903848|FG000|Overall Study|Non-compliance with study treatment|1|||
162233242|NCT01528345|585903849|FG001|Overall Study|Non-compliance with study treatment|0|||
162233243|NCT01528345|585903848|FG000|Overall Study|Progressive Disease|26|||
162233244|NCT01528345|585903849|FG001|Overall Study|Progressive Disease|40|||
162233245|NCT01528345|585903848|FG000|Overall Study|Study Terminated by Sponsor|4|||
162233246|NCT01528345|585903849|FG001|Overall Study|Study Terminated by Sponsor|8|||
162233247|NCT01528345|585903848|FG000|Overall Study|Subject/Guardian Decision|5|||
162233248|NCT01528345|585903849|FG001|Overall Study|Subject/Guardian Decision|0|||
162233249|NCT01034163|585903850|FG000|Overall Study|Treatment completed as per protocol|8|||
162233250|NCT01034163|585903851|FG001|Overall Study|Treatment completed as per protocol|7|||
162233251|NCT01034163|585903850|FG000|Overall Study|Withdrawal by Subject|8|||
161680647|NCT00545402|583883007|FG000|Overall Study|Discontinuation of treatment|17|||
162233252|NCT01034163|585903851|FG001|Overall Study|Withdrawal by Subject|2|||
162233253|NCT01034163|585903850|FG000|Overall Study|Protocol deviation|1|||
162233254|NCT01034163|585903851|FG001|Overall Study|Protocol deviation|0|||
162233255|NCT01034163|585903850|FG000|Overall Study|Disease progression|3|||
162233256|NCT01034163|585903851|FG001|Overall Study|Disease progression|4|||
162233257|NCT01034163|585903850|FG000|Overall Study|Adverse Event|6|||
162233258|NCT01034163|585903851|FG001|Overall Study|Adverse Event|0|||
162233259|NCT01034163|585903850|FG000|Overall Study|Administrative problems|0|||
162233260|NCT01034163|585903851|FG001|Overall Study|Administrative problems|1|||
162233261|NCT01034163|585903850|FG000|Overall Study|Abnormal laboratory value|1|||
162233262|NCT01034163|585903851|FG001|Overall Study|Abnormal laboratory value|0|||
162233263|NCT00528645|585903852|FG000|Overall Study|Adverse Event|3|||
162233264|NCT01642251|585903853|FG000|Overall Study|Progressive disease|0|||
162233265|NCT01642251|585903854|FG001|Overall Study|Progressive disease|0|||
162233266|NCT01642251|585903855|FG002|Overall Study|Progressive disease|3|||
162233267|NCT01642251|585903856|FG003|Overall Study|Progressive disease|3|||
162233268|NCT01642251|585903853|FG000|Overall Study|Adverse Event|0|||
162233269|NCT01642251|585903854|FG001|Overall Study|Adverse Event|0|||
162233270|NCT01642251|585903855|FG002|Overall Study|Adverse Event|5|||
162233271|NCT01642251|585903856|FG003|Overall Study|Adverse Event|4|||
162233272|NCT01642251|585903853|FG000|Overall Study|Death|0|||
162233273|NCT01642251|585903854|FG001|Overall Study|Death|0|||
162233274|NCT01642251|585903855|FG002|Overall Study|Death|1|||
162233275|NCT01642251|585903856|FG003|Overall Study|Death|3|||
162233276|NCT01642251|585903853|FG000|Overall Study|Withdrawal by Subject|0|||
162233277|NCT01642251|585903854|FG001|Overall Study|Withdrawal by Subject|0|||
162233278|NCT01642251|585903855|FG002|Overall Study|Withdrawal by Subject|1|||
162233279|NCT01642251|585903856|FG003|Overall Study|Withdrawal by Subject|3|||
162233280|NCT01642251|585903853|FG000|Overall Study|Alternative therapy|0|||
162233281|NCT01642251|585903854|FG001|Overall Study|Alternative therapy|0|||
162233282|NCT01642251|585903855|FG002|Overall Study|Alternative therapy|0|||
162233283|NCT01642251|585903856|FG003|Overall Study|Alternative therapy|2|||
162233284|NCT01642251|585903853|FG000|Overall Study|Other complicating disease|0|||
162233285|NCT01642251|585903854|FG001|Overall Study|Other complicating disease|0|||
162233286|NCT01642251|585903855|FG002|Overall Study|Other complicating disease|1|||
162233287|NCT01642251|585903856|FG003|Overall Study|Other complicating disease|0|||
162233288|NCT01642251|585903853|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
162233289|NCT01642251|585903854|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
162233290|NCT01642251|585903855|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
162233291|NCT01642251|585903856|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
162233292|NCT00998790|585903857|FG000|Overall Study|Withdrawal by Subject|21|||
162233293|NCT00287690|585903860|FG000|Overall Study|Protocol Violation|20|||
162233294|NCT00287690|585903861|FG001|Overall Study|Protocol Violation|26|||
162233295|NCT02047903|585903862|FG000|Overall Study|Adverse Event|14|||
162233296|NCT02047903|585903862|FG000|Overall Study|Serious adverse event|10|||
162233297|NCT02047903|585903862|FG000|Overall Study|Withdrawal by Subject|16|||
162233298|NCT02047903|585903862|FG000|Overall Study|Lost to Follow-up|4|||
162233299|NCT02047903|585903862|FG000|Overall Study|Reason not listed|6|||
162233300|NCT02047903|585903862|FG000|Overall Study|Not Treated|9|||
162233301|NCT01942590|585903866|FG000|Overall Study|Withdrawal by Subject|0|||
162233302|NCT01942590|585903867|FG001|Overall Study|Withdrawal by Subject|1|||
162233303|NCT01942590|585903866|FG000|Overall Study|Adverse Event|1|||
162233304|NCT01942590|585903867|FG001|Overall Study|Adverse Event|0|||
162233305|NCT02433340|585903868|FG000|Overall Study|Adverse Event|0|||
162233306|NCT02433340|585903869|FG001|Overall Study|Adverse Event|0|||
162233307|NCT02433340|585903870|FG002|Overall Study|Adverse Event|1|||
162233308|NCT02433340|585903871|FG003|Overall Study|Adverse Event|0|||
162233309|NCT02433340|585903868|FG000|Overall Study|Withdrawal by Subject|1|||
162233310|NCT02433340|585903869|FG001|Overall Study|Withdrawal by Subject|0|||
162233311|NCT02433340|585903870|FG002|Overall Study|Withdrawal by Subject|1|||
162233312|NCT02433340|585903871|FG003|Overall Study|Withdrawal by Subject|2|||
162233313|NCT02433340|585903868|FG000|Overall Study|Lost to Follow-up|0|||
162233314|NCT02433340|585903869|FG001|Overall Study|Lost to Follow-up|1|||
162233315|NCT02433340|585903870|FG002|Overall Study|Lost to Follow-up|0|||
162233316|NCT02433340|585903871|FG003|Overall Study|Lost to Follow-up|0|||
162233317|NCT02433340|585903868|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
162233318|NCT02433340|585903869|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
162233319|NCT02433340|585903870|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
162233320|NCT02433340|585903871|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
162233321|NCT02433340|585903868|FG000|Overall Study|Other|0|||
162233322|NCT02433340|585903869|FG001|Overall Study|Other|1|||
162233323|NCT02433340|585903870|FG002|Overall Study|Other|0|||
162233324|NCT02433340|585903871|FG003|Overall Study|Other|0|||
162233325|NCT01226095|585903872|FG000|Overall Study|Poor compliance|1|||
162233326|NCT00911768|585903883|FG000|Overall Study|Protocol Violation|5|||
162233327|NCT00911768|585903884|FG001|Overall Study|Protocol Violation|4|||
162233328|NCT00911768|585903883|FG000|Overall Study|Withdrawal by Subject|1|||
162233329|NCT00911768|585903884|FG001|Overall Study|Withdrawal by Subject|0|||
162233330|NCT03406078|585903886|FG000|Overall Study|Death|1|||
161830055|NCT02412722|584418109|FG005|Overall Study|Withdrawal by Subject|1|||
162233331|NCT03406078|585903887|FG001|Overall Study|Death|0|||
162233332|NCT03406078|585903886|FG000|Overall Study|Lost to Follow-up|0|||
162233333|NCT03406078|585903887|FG001|Overall Study|Lost to Follow-up|1|||
162233334|NCT03406078|585903886|FG000|Overall Study|Withdrawal by Subject|5|||
162233335|NCT03406078|585903887|FG001|Overall Study|Withdrawal by Subject|2|||
162233336|NCT03616977|585903891|FG000|Period 1|Physician Decision|0|||
162233337|NCT03616977|585903892|FG001|Period 1|Physician Decision|1|||
162233338|NCT03616977|585903891|FG000|Period 3|Adverse Event|1|||
162233339|NCT03616977|585903892|FG001|Period 3|Adverse Event|1|||
162233340|NCT00591851|585903893|FG000|Overall Study|Withdrawal by Subject|3|||
162233341|NCT00591851|585903893|FG000|Overall Study|Adverse Event|2|||
162233342|NCT00591851|585903893|FG000|Overall Study|Progressive Disease|1|||
162233343|NCT00515853|585903894|FG000|Overall Study|Lost to Follow-up|9|||
162233344|NCT00515853|585903895|FG001|Overall Study|Lost to Follow-up|13|||
162233345|NCT00515853|585903894|FG000|Overall Study|Withdrawal by Subject|6|||
162233346|NCT00515853|585903895|FG001|Overall Study|Withdrawal by Subject|4|||
162233347|NCT00943111|585903900|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
162233348|NCT00943111|585903901|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
162233349|NCT00943111|585903902|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
162233350|NCT00943111|585903900|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
162233351|NCT00943111|585903901|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
162233352|NCT00943111|585903902|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
162233353|NCT00943111|585903900|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
162233354|NCT00943111|585903901|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
162233355|NCT00943111|585903902|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
162233356|NCT00943111|585903900|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
162233357|NCT00943111|585903901|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
162233358|NCT00943111|585903902|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
162233359|NCT00943111|585903900|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
162233360|NCT00943111|585903901|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
162233361|NCT00943111|585903902|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
162233362|NCT00943111|585903900|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
162233363|NCT00943111|585903901|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
162233364|NCT00943111|585903902|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
162233365|NCT00943111|585903900|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
162233366|NCT00943111|585903901|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
162233367|NCT00943111|585903902|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
162233368|NCT00943111|585903900|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
162233369|NCT00943111|585903901|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
162233370|NCT00943111|585903902|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
162233371|NCT03798691|585903903|FG000|Overall Study|Lost to Follow-up|2|||
162233372|NCT03798691|585903904|FG001|Overall Study|Lost to Follow-up|2|||
162233373|NCT00953407|585906031|FG000|Overall Study|Failed inclusion criteria|1|||
162233374|NCT00953407|585906032|FG001|Overall Study|Failed inclusion criteria|1|||
162233375|NCT00953407|585906033|FG002|Overall Study|Failed inclusion criteria|1|||
162233376|NCT00953407|585906034|FG003|Overall Study|Failed inclusion criteria|1|||
162233377|NCT00953407|585906035|FG004|Overall Study|Failed inclusion criteria|1|||
162233378|NCT00953407|585906031|FG000|Overall Study|Lost to Follow-up|0|||
162233379|NCT00953407|585906032|FG001|Overall Study|Lost to Follow-up|0|||
162233380|NCT00953407|585906033|FG002|Overall Study|Lost to Follow-up|0|||
162233381|NCT00953407|585906034|FG003|Overall Study|Lost to Follow-up|1|||
162233382|NCT00953407|585906035|FG004|Overall Study|Lost to Follow-up|0|||
162233383|NCT02502097|585906036|FG000|Period 1|Adverse Event|0|||
162233384|NCT02502097|585906037|FG001|Period 1|Adverse Event|0|||
162233385|NCT02502097|585906038|FG002|Period 1|Adverse Event|1|||
162233386|NCT02502097|585906039|FG003|Period 1|Adverse Event|0|||
162233387|NCT02502097|585906036|FG000|Wash Out Period|Adverse Event|0|||
162233388|NCT02502097|585906037|FG001|Wash Out Period|Adverse Event|1|||
162233389|NCT02502097|585906038|FG002|Wash Out Period|Adverse Event|1|||
162233390|NCT02502097|585906039|FG003|Wash Out Period|Adverse Event|1|||
162233391|NCT02502097|585906036|FG000|Period 2|Adverse Event|0|||
162233392|NCT02502097|585906037|FG001|Period 2|Adverse Event|0|||
162233393|NCT02502097|585906038|FG002|Period 2|Adverse Event|1|||
162233394|NCT02502097|585906039|FG003|Period 2|Adverse Event|0|||
162233395|NCT02186223|585906040|FG000|Overall Study|Not eligible for device placement|6|||
162233396|NCT02186223|585906040|FG000|Overall Study|Unable to obtain femoral access|3|||
162233397|NCT02186223|585906040|FG000|Overall Study|Death|3|||
162233398|NCT02186223|585906040|FG000|Overall Study|Device in place less than 48 hours|9|||
162233399|NCT01111474|585906041|FG000|Overall Study|Lost to Follow-up|12|||
162233400|NCT00618982|585906042|FG000|Overall Study|Adverse Event|23|||
162233401|NCT00618982|585906042|FG000|Overall Study|Withdrawal by Subject|1|||
162233402|NCT00618982|585906042|FG000|Overall Study|Protocol Violation|1|||
162233403|NCT00618982|585906042|FG000|Overall Study|ongoing, still treated with study med.|25|||
162233404|NCT00642772|585906044|FG000|Overall Study|Lost to Follow-up|3|||
162233405|NCT00642772|585906044|FG000|Overall Study|Withdrawal by Subject|7|||
162233406|NCT05398237|585906049|FG000|Overall Study|Withdrawal by Subject|1|||
162233407|NCT01312857|585906052|FG000|Overall Study|Adverse Event|1|||
162233408|NCT01312857|585906053|FG001|Overall Study|Adverse Event|1|||
162233409|NCT01312857|585906052|FG000|Overall Study|Lost to Follow-up|2|||
162233410|NCT01312857|585906053|FG001|Overall Study|Lost to Follow-up|0|||
162233411|NCT01312857|585906052|FG000|Overall Study|Physician Decision|3|||
162233412|NCT01312857|585906053|FG001|Overall Study|Physician Decision|0|||
162233413|NCT01312857|585906052|FG000|Overall Study|Withdrawal by Subject|2|||
162233414|NCT01312857|585906053|FG001|Overall Study|Withdrawal by Subject|0|||
162233415|NCT01248065|585906054|FG000|Overall Study|Lost to Follow-up|3|||
162233416|NCT01248065|585906055|FG001|Overall Study|Lost to Follow-up|5|||
162233417|NCT01248065|585906054|FG000|Overall Study|Withdrawal by Subject|14|||
162233418|NCT01248065|585906055|FG001|Overall Study|Withdrawal by Subject|11|||
162233419|NCT01248065|585906054|FG000|Overall Study|Adverse Event|3|||
162233420|NCT01248065|585906055|FG001|Overall Study|Adverse Event|0|||
162233421|NCT01248065|585906054|FG000|Overall Study|Third treatment failure event|3|||
162233422|NCT01248065|585906055|FG001|Overall Study|Third treatment failure event|1|||
162233423|NCT01248065|585906054|FG000|Overall Study|Other|3|||
162233424|NCT01248065|585906055|FG001|Overall Study|Other|5|||
162233425|NCT02781844|585906065|FG000|Treatment Period 1|Adverse Event|0|||
162233426|NCT02781844|585906066|FG001|Treatment Period 1|Adverse Event|0|||
162233427|NCT02781844|585906067|FG002|Treatment Period 1|Adverse Event|0|||
162233428|NCT02781844|585906068|FG003|Treatment Period 1|Adverse Event|0|||
162233429|NCT02781844|585906069|FG004|Treatment Period 1|Adverse Event|0|||
162233430|NCT02781844|585906070|FG005|Treatment Period 1|Adverse Event|1|||
162233431|NCT02781844|585906071|FG006|Treatment Period 1|Adverse Event|0|||
162233432|NCT02781844|585906072|FG007|Treatment Period 1|Adverse Event|0|||
162233433|NCT04256629|585906075|FG000|Overall Study|Adverse Event|0|||
162233434|NCT04256629|585906076|FG001|Overall Study|Adverse Event|0|||
162233435|NCT04256629|585906077|FG002|Overall Study|Adverse Event|0|||
162233436|NCT04256629|585906078|FG003|Overall Study|Adverse Event|0|||
162233437|NCT04256629|585906079|FG004|Overall Study|Adverse Event|0|||
162233438|NCT04256629|585906080|FG005|Overall Study|Adverse Event|1|||
162233439|NCT04256629|585906075|FG000|Overall Study|Protocol Violation|0|||
162233440|NCT04256629|585906076|FG001|Overall Study|Protocol Violation|1|||
162233441|NCT04256629|585906077|FG002|Overall Study|Protocol Violation|0|||
162233442|NCT04256629|585906078|FG003|Overall Study|Protocol Violation|0|||
162233443|NCT04256629|585906079|FG004|Overall Study|Protocol Violation|0|||
162233444|NCT04256629|585906080|FG005|Overall Study|Protocol Violation|0|||
162233445|NCT00321373|585906081|FG000|Overall Study|Adverse Event|0|||
162233446|NCT00321373|585906082|FG001|Overall Study|Adverse Event|0|||
162233447|NCT00321373|585906083|FG002|Overall Study|Adverse Event|1|||
162233448|NCT00321373|585906081|FG000|Overall Study|Lost to Follow-up|1|||
162233449|NCT00321373|585906082|FG001|Overall Study|Lost to Follow-up|0|||
162233450|NCT00321373|585906083|FG002|Overall Study|Lost to Follow-up|1|||
162233451|NCT00321373|585906081|FG000|Overall Study|Withdrawal by Subject|1|||
162233452|NCT00321373|585906082|FG001|Overall Study|Withdrawal by Subject|0|||
162233453|NCT00321373|585906083|FG002|Overall Study|Withdrawal by Subject|0|||
162233454|NCT00321373|585906081|FG000|Overall Study|Other|0|||
162233455|NCT00321373|585906082|FG001|Overall Study|Other|0|||
162233456|NCT00321373|585906083|FG002|Overall Study|Other|1|||
162233457|NCT01774487|585906084|FG000|Overall Study|Did not tolerate taste|4|||
162233458|NCT01774487|585906085|FG001|Overall Study|Did not tolerate taste|4|||
162233459|NCT01383499|585906086|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
162233460|NCT01383499|585906087|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
162233461|NCT01383499|585906088|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
162233462|NCT01383499|585906089|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
162233463|NCT02572882|585906094|FG000|Overall Study|Withdrawal by Subject|1|||
162233464|NCT02572882|585906094|FG000|Overall Study|Participant received kidney transplant|1|||
162233465|NCT04275089|585906097|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
162233466|NCT01079663|585906098|FG000|Overall Study|Adverse Event|0|||
162233467|NCT01079663|585906099|FG001|Overall Study|Adverse Event|2|||
162233468|NCT01079663|585906098|FG000|Overall Study|Protocol Violation|0|||
162233469|NCT01079663|585906099|FG001|Overall Study|Protocol Violation|2|||
162233470|NCT03606668|585906100|FG000|Overall Study|Screen Failure|1|||
162233471|NCT03606668|585906100|FG000|Overall Study|Lost to Follow-up|1|||
162233472|NCT02354508|585906104|FG000|Period 1: Core Phase|Adverse Event|1|||
162233473|NCT02354508|585906105|FG001|Period 1: Core Phase|Adverse Event|1|||
162233474|NCT02354508|585906106|FG002|Period 1: Core Phase|Adverse Event|2|||
162233475|NCT02354508|585906104|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
162233476|NCT02354508|585906105|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
162233477|NCT02354508|585906106|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
162233478|NCT02354508|585906104|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
162233479|NCT02354508|585906105|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
162233480|NCT02354508|585906106|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
162233481|NCT02354508|585906104|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
162233482|NCT02354508|585906105|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
162233483|NCT02354508|585906106|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
162233484|NCT02354508|585906104|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
162233485|NCT02354508|585906105|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
162233486|NCT02354508|585906106|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
162233487|NCT02354508|585906104|FG000|Period 2: Extension Phase|Physician Decision|5|||
162233488|NCT02354508|585906105|FG001|Period 2: Extension Phase|Physician Decision|0|||
162233489|NCT02354508|585906106|FG002|Period 2: Extension Phase|Physician Decision|1|||
162233490|NCT02354508|585906104|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
162233491|NCT02354508|585906105|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
162233492|NCT02354508|585906106|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
162233493|NCT02354508|585906104|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
162233494|NCT02354508|585906105|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
162233495|NCT02354508|585906106|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
162233496|NCT02354508|585906104|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
162233497|NCT02354508|585906105|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
162233498|NCT02354508|585906106|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
162233499|NCT01014143|585906108|FG000|Second Intervention|Lost to Follow-up|2|||
162233500|NCT01014143|585906109|FG001|Second Intervention|Lost to Follow-up|0|||
162233501|NCT01014143|585906110|FG002|Second Intervention|Lost to Follow-up|0|||
162233502|NCT00461032|585906111|FG000|Overall Study|Adverse Event|5|||
162233503|NCT00461032|585906112|FG001|Overall Study|Adverse Event|6|||
162233504|NCT00461032|585906111|FG000|Overall Study|Lack of Efficacy|5|||
162233505|NCT00461032|585906112|FG001|Overall Study|Lack of Efficacy|1|||
162233506|NCT00461032|585906111|FG000|Overall Study|Lost to Follow-up|7|||
162233507|NCT00461032|585906112|FG001|Overall Study|Lost to Follow-up|12|||
162233508|NCT00461032|585906111|FG000|Overall Study|Protocol Violation|4|||
162233509|NCT00461032|585906112|FG001|Overall Study|Protocol Violation|4|||
162233510|NCT00461032|585906111|FG000|Overall Study|Withdrawal by Subject|7|||
162233511|NCT00461032|585906112|FG001|Overall Study|Withdrawal by Subject|15|||
162233512|NCT00461032|585906111|FG000|Overall Study|Patient Moved or Relocated|2|||
162233513|NCT00461032|585906112|FG001|Overall Study|Patient Moved or Relocated|1|||
162233514|NCT00461032|585906111|FG000|Overall Study|Other|7|||
162233515|NCT00461032|585906112|FG001|Overall Study|Other|5|||
162233516|NCT04447846|585906113|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
162233517|NCT00297232|585906116|FG000|Overall Study|Lack of Efficacy|7|||
162233518|NCT00297232|585906116|FG000|Overall Study|Lost to Follow-up|10|||
162233519|NCT00297232|585906116|FG000|Overall Study|Adverse Event|63|||
162233520|NCT00297232|585906116|FG000|Overall Study|Voluntary Withdrawal|120|||
162233521|NCT00297232|585906116|FG000|Overall Study|Subject was Noncompliant|9|||
162233522|NCT00297232|585906116|FG000|Overall Study|Death|9|||
162233523|NCT00297232|585906116|FG000|Overall Study|Anti-natalizumab Positive|8|||
162233524|NCT00297232|585906116|FG000|Overall Study|Switched to Commercial Tysabri|22|||
162233525|NCT00297232|585906116|FG000|Overall Study|Disease Progression|8|||
162233526|NCT00297232|585906116|FG000|Overall Study|Fear of PML|10|||
162233527|NCT00297232|585906116|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
162233528|NCT00297232|585906116|FG000|Overall Study|Miscellaneous|5|||
162233529|NCT00297232|585906116|FG000|Overall Study|Sponsor Decision|34|||
162233530|NCT00297232|585906116|FG000|Overall Study|Subject Relocated|7|||
162233531|NCT00297232|585906116|FG000|Overall Study|Subject Withdrew Consent|37|||
162233532|NCT00297232|585906116|FG000|Overall Study|Persistently Positive Antibodies|11|||
162233533|NCT00297232|585906116|FG000|Overall Study|Investigator Withdrew From Program|19|||
162233534|NCT00297232|585906116|FG000|Overall Study|Did Not Enroll to Week 264|34|||
162233535|NCT00297232|585906116|FG000|Overall Study|Did Not Enroll to Week 480|17|||
162233536|NCT00297232|585906116|FG000|Overall Study|No data available after Week 264|161|||
162233537|NCT00297232|585906116|FG000|Overall Study|Other|1|||
162233538|NCT03536143|585906119|FG000|Overall Study|Early termination, Sponsor decision|1|||
162233539|NCT01878214|585906120|FG000|Overall Study|Withdrawal by Subject|18|||
162233540|NCT01878214|585906121|FG001|Overall Study|Withdrawal by Subject|7|||
162233541|NCT01878214|585906120|FG000|Overall Study|Death|0|||
162233542|NCT01878214|585906121|FG001|Overall Study|Death|1|||
162233543|NCT01878214|585906120|FG000|Overall Study|Lost to Follow-up|35|||
162233544|NCT01878214|585906121|FG001|Overall Study|Lost to Follow-up|36|||
162233545|NCT00495586|585906122|FG000|Overall Study|Withdrawal by Subject|4|||
162233546|NCT00495586|585906123|FG001|Overall Study|Withdrawal by Subject|4|||
162233547|NCT03038438|585906124|FG000|Overall Study|Death|3|||
162233548|NCT03038438|585906124|FG000|Overall Study|Lost to Follow-up|8|||
162233549|NCT03038438|585906124|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
162233550|NCT03038438|585906124|FG000|Overall Study|Withdrawal by Subject|5|||
162233551|NCT03038438|585906124|FG000|Overall Study|No 36-Month Follow-Up|18|||
162233552|NCT03406260|585906125|FG000|Period 1|Adverse Event|0|||
162233553|NCT03406260|585906126|FG001|Period 1|Adverse Event|0|||
162233554|NCT03406260|585906127|FG002|Period 1|Adverse Event|0|||
162233555|NCT03406260|585906128|FG003|Period 1|Adverse Event|0|||
162233556|NCT03406260|585906129|FG004|Period 1|Adverse Event|1|||
162233557|NCT03406260|585906130|FG005|Period 1|Adverse Event|0|||
162233558|NCT02647866|585906131|FG000|Overall Study|Adverse Event|0|||
162233559|NCT02647866|585906132|FG001|Overall Study|Adverse Event|0|||
162233560|NCT02647866|585906133|FG002|Overall Study|Adverse Event|2|||
162233561|NCT02647866|585906134|FG003|Overall Study|Adverse Event|2|||
162233562|NCT02647866|585906135|FG004|Overall Study|Adverse Event|1|||
162233563|NCT02647866|585906131|FG000|Overall Study|Disease Worsening|3|||
162233564|NCT02647866|585906132|FG001|Overall Study|Disease Worsening|1|||
162233565|NCT02647866|585906133|FG002|Overall Study|Disease Worsening|0|||
162233566|NCT02647866|585906134|FG003|Overall Study|Disease Worsening|0|||
162233567|NCT02647866|585906135|FG004|Overall Study|Disease Worsening|1|||
162233568|NCT02647866|585906131|FG000|Overall Study|Withdrawal by Subject|1|||
162233569|NCT02647866|585906132|FG001|Overall Study|Withdrawal by Subject|1|||
162233570|NCT02647866|585906133|FG002|Overall Study|Withdrawal by Subject|2|||
162233571|NCT02647866|585906134|FG003|Overall Study|Withdrawal by Subject|4|||
162233572|NCT02647866|585906135|FG004|Overall Study|Withdrawal by Subject|4|||
162233573|NCT02647866|585906131|FG000|Overall Study|Physician Decision|0|||
162233574|NCT02647866|585906132|FG001|Overall Study|Physician Decision|1|||
162233575|NCT02647866|585906133|FG002|Overall Study|Physician Decision|1|||
162233576|NCT02647866|585906134|FG003|Overall Study|Physician Decision|0|||
162233577|NCT02647866|585906135|FG004|Overall Study|Physician Decision|2|||
162233578|NCT02647866|585906131|FG000|Overall Study|Death|0|||
162233579|NCT02647866|585906132|FG001|Overall Study|Death|1|||
162233580|NCT02647866|585906133|FG002|Overall Study|Death|0|||
162233581|NCT02647866|585906134|FG003|Overall Study|Death|0|||
162233582|NCT02647866|585906135|FG004|Overall Study|Death|0|||
162233583|NCT02647866|585906131|FG000|Overall Study|Subject moved to different country|1|||
162233584|NCT02647866|585906132|FG001|Overall Study|Subject moved to different country|0|||
162233585|NCT02647866|585906133|FG002|Overall Study|Subject moved to different country|0|||
162233586|NCT02647866|585906134|FG003|Overall Study|Subject moved to different country|0|||
162233587|NCT02647866|585906135|FG004|Overall Study|Subject moved to different country|0|||
162025166|NCT05141448|585148864|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
162025167|NCT05141448|585148859|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
162025168|NCT05141448|585148860|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
162025169|NCT05141448|585148861|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
162025170|NCT05141448|585148862|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
162025171|NCT05141448|585148863|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
162025172|NCT05141448|585148864|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
162025173|NCT05141448|585148859|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
162025174|NCT05141448|585148860|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
162025175|NCT05141448|585148861|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
162025176|NCT05141448|585148862|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
162025177|NCT05141448|585148863|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
162025178|NCT05141448|585148864|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
162025179|NCT05141448|585148859|FG000|Period 2|COVID-19 Related|0|||
162025180|NCT05141448|585148860|FG001|Period 2|COVID-19 Related|0|||
162025181|NCT05141448|585148861|FG002|Period 2|COVID-19 Related|0|||
162025182|NCT05141448|585148862|FG003|Period 2|COVID-19 Related|1|||
162025183|NCT05141448|585148863|FG004|Period 2|COVID-19 Related|0|||
162025184|NCT05141448|585148864|FG005|Period 2|COVID-19 Related|1|||
162025185|NCT05141448|585148859|FG000|3|Covid-19 related|2|||
162025186|NCT05141448|585148860|FG001|3|Covid-19 related|0|||
162025187|NCT05141448|585148861|FG002|3|Covid-19 related|0|||
162233588|NCT02527343|585906139|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
162233589|NCT02527343|585906140|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
162233590|NCT02527343|585906141|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
162233591|NCT02527343|585906142|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
162233592|NCT02527343|585906143|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
162233593|NCT02527343|585906144|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
162233594|NCT02527343|585906139|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
162233595|NCT02527343|585906140|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
162233596|NCT02527343|585906141|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
162233597|NCT02527343|585906142|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
162233598|NCT02527343|585906143|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
162233599|NCT02527343|585906144|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
161830056|NCT02412722|584418104|FG000|Overall Study|Lost to Follow-up|0|||
161830057|NCT02412722|584418105|FG001|Overall Study|Lost to Follow-up|0|||
161830058|NCT02412722|584418106|FG002|Overall Study|Lost to Follow-up|0|||
161830059|NCT02412722|584418107|FG003|Overall Study|Lost to Follow-up|0|||
161830060|NCT02412722|584418108|FG004|Overall Study|Lost to Follow-up|1|||
161830061|NCT02412722|584418109|FG005|Overall Study|Lost to Follow-up|0|||
161941000|NCT00835367|584833817|FG001|Washout|Adverse Event|0|||
161941001|NCT00835367|584833816|FG000|Washout|Withdrawal by Subject|1|||
161941002|NCT00835367|584833817|FG001|Washout|Withdrawal by Subject|0|||
161941003|NCT00835367|584833816|FG000|Second Intervention|Adverse Event|1|||
161941004|NCT00835367|584833817|FG001|Second Intervention|Adverse Event|1|||
161941005|NCT03396445|584836059|FG000|Treatment Period|Death|2|||
161941006|NCT03396445|584836060|FG001|Treatment Period|Death|2|||
161941007|NCT03396445|584836061|FG002|Treatment Period|Death|1|||
161941008|NCT03396445|584836062|FG003|Treatment Period|Death|1|||
161941009|NCT03396445|584836063|FG004|Treatment Period|Death|3|||
161941010|NCT03396445|584836064|FG005|Treatment Period|Death|2|||
161941011|NCT03396445|584836065|FG006|Treatment Period|Death|5|||
161941012|NCT03396445|584836066|FG007|Treatment Period|Death|3|||
161941013|NCT03396445|584836067|FG008|Treatment Period|Death|3|||
161941014|NCT03396445|584836068|FG009|Treatment Period|Death|3|||
161941015|NCT03396445|584836069|FG010|Treatment Period|Death|7|||
161941016|NCT03396445|584836070|FG011|Treatment Period|Death|12|||
161941017|NCT03396445|584836071|FG012|Treatment Period|Death|28|||
161941018|NCT03396445|584836072|FG013|Treatment Period|Death|14|||
161941019|NCT03396445|584836073|FG014|Treatment Period|Death|10|||
161941020|NCT03396445|584836074|FG015|Treatment Period|Death|8|||
161941021|NCT03396445|584836075|FG016|Treatment Period|Death|18|||
161941022|NCT03396445|584836076|FG017|Treatment Period|Death|0|||
161941023|NCT03396445|584836077|FG018|Treatment Period|Death|0|||
161941024|NCT03396445|584836078|FG019|Treatment Period|Death|0|||
161941025|NCT03396445|584836079|FG020|Treatment Period|Death|0|||
161941026|NCT03396445|584836080|FG021|Treatment Period|Death|0|||
161941027|NCT03396445|584836081|FG022|Treatment Period|Death|0|||
161941028|NCT03396445|584836082|FG023|Treatment Period|Death|0|||
161941029|NCT03396445|584836083|FG024|Treatment Period|Death|0|||
161941030|NCT03396445|584836084|FG025|Treatment Period|Death|0|||
161941031|NCT03396445|584836059|FG000|Treatment Period|Lost to Follow-up|0|||
161941032|NCT03396445|584836060|FG001|Treatment Period|Lost to Follow-up|0|||
161941033|NCT03396445|584836061|FG002|Treatment Period|Lost to Follow-up|0|||
161941034|NCT03396445|584836062|FG003|Treatment Period|Lost to Follow-up|0|||
161941035|NCT03396445|584836063|FG004|Treatment Period|Lost to Follow-up|0|||
161941036|NCT03396445|584836064|FG005|Treatment Period|Lost to Follow-up|0|||
161941037|NCT03396445|584836065|FG006|Treatment Period|Lost to Follow-up|0|||
161941038|NCT03396445|584836066|FG007|Treatment Period|Lost to Follow-up|0|||
161941039|NCT03396445|584836067|FG008|Treatment Period|Lost to Follow-up|0|||
161941040|NCT03396445|584836068|FG009|Treatment Period|Lost to Follow-up|0|||
161941041|NCT03396445|584836069|FG010|Treatment Period|Lost to Follow-up|0|||
161941042|NCT03396445|584836070|FG011|Treatment Period|Lost to Follow-up|0|||
161941043|NCT03396445|584836071|FG012|Treatment Period|Lost to Follow-up|1|||
161941044|NCT03396445|584836072|FG013|Treatment Period|Lost to Follow-up|0|||
161941045|NCT03396445|584836073|FG014|Treatment Period|Lost to Follow-up|1|||
161941046|NCT03396445|584836074|FG015|Treatment Period|Lost to Follow-up|0|||
161941047|NCT03396445|584836075|FG016|Treatment Period|Lost to Follow-up|0|||
161941048|NCT03396445|584836076|FG017|Treatment Period|Lost to Follow-up|0|||
161941049|NCT03396445|584836077|FG018|Treatment Period|Lost to Follow-up|0|||
161941050|NCT03396445|584836078|FG019|Treatment Period|Lost to Follow-up|0|||
161941051|NCT03396445|584836079|FG020|Treatment Period|Lost to Follow-up|0|||
161941052|NCT03396445|584836080|FG021|Treatment Period|Lost to Follow-up|0|||
161941053|NCT03396445|584836081|FG022|Treatment Period|Lost to Follow-up|0|||
161941054|NCT03396445|584836082|FG023|Treatment Period|Lost to Follow-up|0|||
161941055|NCT03396445|584836083|FG024|Treatment Period|Lost to Follow-up|0|||
161941056|NCT03396445|584836084|FG025|Treatment Period|Lost to Follow-up|0|||
161941057|NCT03396445|584836059|FG000|Treatment Period|Physician Decision|0|||
161941058|NCT03396445|584836060|FG001|Treatment Period|Physician Decision|0|||
161941059|NCT03396445|584836061|FG002|Treatment Period|Physician Decision|0|||
161941060|NCT03396445|584836062|FG003|Treatment Period|Physician Decision|0|||
161941061|NCT03396445|584836063|FG004|Treatment Period|Physician Decision|1|||
161941062|NCT03396445|584836064|FG005|Treatment Period|Physician Decision|0|||
161941063|NCT03396445|584836065|FG006|Treatment Period|Physician Decision|0|||
161941064|NCT03396445|584836066|FG007|Treatment Period|Physician Decision|0|||
161941065|NCT03396445|584836067|FG008|Treatment Period|Physician Decision|0|||
161941066|NCT03396445|584836068|FG009|Treatment Period|Physician Decision|1|||
161941067|NCT03396445|584836069|FG010|Treatment Period|Physician Decision|0|||
161941068|NCT03396445|584836070|FG011|Treatment Period|Physician Decision|0|||
161941069|NCT03396445|584836071|FG012|Treatment Period|Physician Decision|0|||
161941070|NCT03396445|584836072|FG013|Treatment Period|Physician Decision|0|||
161830062|NCT02412722|584418104|FG000|Overall Study|Received drug in run-in and discontinued|0|||
161830063|NCT02412722|584418105|FG001|Overall Study|Received drug in run-in and discontinued|2|||
161830064|NCT02412722|584418106|FG002|Overall Study|Received drug in run-in and discontinued|0|||
161830065|NCT02412722|584418107|FG003|Overall Study|Received drug in run-in and discontinued|0|||
161830066|NCT02412722|584418108|FG004|Overall Study|Received drug in run-in and discontinued|0|||
161830067|NCT02412722|584418109|FG005|Overall Study|Received drug in run-in and discontinued|0|||
161830068|NCT02412722|584418104|FG000|Overall Study|Reason not Specified|3|||
162233600|NCT02527343|585906139|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
162233601|NCT02527343|585906140|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
162233602|NCT02527343|585906141|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
162233603|NCT02527343|585906142|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
162233604|NCT02527343|585906143|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
162233605|NCT02527343|585906144|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
162233606|NCT02527343|585906139|FG000|RT Period: Weeks 1 to 52|Other|4|||
162233607|NCT02527343|585906140|FG001|RT Period: Weeks 1 to 52|Other|3|||
162233608|NCT02527343|585906141|FG002|RT Period: Weeks 1 to 52|Other|0|||
162233609|NCT02527343|585906142|FG003|RT Period: Weeks 1 to 52|Other|0|||
162233610|NCT02527343|585906143|FG004|RT Period: Weeks 1 to 52|Other|0|||
162233611|NCT02527343|585906144|FG005|RT Period: Weeks 1 to 52|Other|0|||
162233612|NCT02527343|585906139|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
162233613|NCT02527343|585906140|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
162233614|NCT02527343|585906141|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
162233615|NCT02527343|585906142|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
162233616|NCT02527343|585906143|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
162233617|NCT02527343|585906144|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
162233618|NCT02527343|585906139|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
162233619|NCT02527343|585906140|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
162233620|NCT02527343|585906141|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
162233621|NCT02527343|585906142|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
162233622|NCT02527343|585906143|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
162233623|NCT02527343|585906144|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
162233624|NCT02527343|585906139|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
162233625|NCT02527343|585906140|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
162233626|NCT02527343|585906141|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
162233627|NCT02527343|585906142|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
162233628|NCT02527343|585906143|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
162233629|NCT02527343|585906144|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
162233630|NCT02527343|585906139|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
162233631|NCT02527343|585906140|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
162233632|NCT02527343|585906141|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
162233633|NCT02527343|585906142|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
162233634|NCT02527343|585906143|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
162233635|NCT02527343|585906144|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
162233636|NCT02527343|585906139|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
162233637|NCT02527343|585906140|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
162233638|NCT02527343|585906141|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
162233639|NCT02527343|585906142|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
162233640|NCT02527343|585906143|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
162233641|NCT02527343|585906144|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
162233642|NCT02527343|585906139|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
162233643|NCT02527343|585906140|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
162233644|NCT02527343|585906141|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
162233645|NCT02527343|585906142|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
162233646|NCT02527343|585906143|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
162233647|NCT02527343|585906144|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
162233648|NCT02527343|585906139|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
162233649|NCT02527343|585906140|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
162233650|NCT02527343|585906141|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
162233651|NCT02527343|585906142|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
162233652|NCT02527343|585906143|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
162233653|NCT02527343|585906144|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
162233654|NCT02527343|585906139|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
162233655|NCT02527343|585906140|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
162233656|NCT02527343|585906141|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
162233657|NCT02527343|585906142|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
162233658|NCT02527343|585906143|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
162233659|NCT02527343|585906144|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
162233660|NCT02527343|585906139|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
162233661|NCT02527343|585906140|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
162233662|NCT02527343|585906141|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
162233663|NCT02527343|585906142|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
162233664|NCT02527343|585906143|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
162233665|NCT02527343|585906144|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
162233666|NCT01029652|585906145|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
162233667|NCT01029652|585906146|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
162233668|NCT01029652|585906145|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
162233669|NCT01029652|585906146|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
162233670|NCT01029652|585906145|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
162233671|NCT01029652|585906146|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
162233672|NCT01029652|585906145|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
162233673|NCT01029652|585906146|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
162233674|NCT01029652|585906145|FG000|Core Study (0-12 Weeks)|Death|0|||
162233675|NCT01029652|585906146|FG001|Core Study (0-12 Weeks)|Death|1|||
162233676|NCT01029652|585906145|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
162233677|NCT01029652|585906146|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
162233678|NCT01029652|585906145|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
162233679|NCT01029652|585906146|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
162233680|NCT01029652|585906145|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
162233681|NCT01029652|585906146|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
162233682|NCT01029652|585906145|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
162233683|NCT01029652|585906146|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
162233684|NCT01029652|585906145|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
162233685|NCT01029652|585906146|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
162233686|NCT01029652|585906145|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
162233687|NCT01029652|585906146|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
162233688|NCT01029652|585906145|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
162233689|NCT01029652|585906146|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
162233690|NCT05767021|585906147|FG000|Overall Study|Adverse Event|2|||
162233691|NCT05767021|585906147|FG000|Overall Study|Protocol Deviation|1|||
162233692|NCT05767021|585906147|FG000|Overall Study|Withdrawal by Subject|1|||
162233693|NCT05767021|585906147|FG000|Overall Study|Physician Decision|1|||
162233694|NCT05767021|585906147|FG000|Overall Study|Lack of Efficacy|11|||
162233695|NCT05767021|585906147|FG000|Overall Study|Assigned Treatment by Mistake|1|||
162233696|NCT00523640|585906152|FG000|Overall Study|Death|1|||
162233697|NCT06377488|585906153|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
162233698|NCT06377488|585906153|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
162233699|NCT06377488|585906153|FG000|Overall Study|Protocol Violation|1|||
162233700|NCT06377488|585906153|FG000|Overall Study|Lost to Follow-up|1|||
162233701|NCT06377488|585906153|FG000|Overall Study|Incorrect Lens Dispensed|2|||
162233702|NCT02399254|585906156|FG000|Overall Study|Physician Decision|2|||
162233703|NCT02334423|585906157|FG000|Overall Study|Protocol Violation|10|||
162233704|NCT02334423|585906158|FG001|Overall Study|Protocol Violation|3|||
162233705|NCT01076647|585906161|FG000|Overall Study|Adverse Event|4|||
162233706|NCT01076647|585906162|FG001|Overall Study|Adverse Event|1|||
162233707|NCT01076647|585906161|FG000|Overall Study|Lack of Efficacy|0|||
162233708|NCT01076647|585906162|FG001|Overall Study|Lack of Efficacy|1|||
162233709|NCT01076647|585906161|FG000|Overall Study|Protocol Violation|7|||
162233710|NCT01076647|585906162|FG001|Overall Study|Protocol Violation|9|||
162233711|NCT01076647|585906161|FG000|Overall Study|Withdrawal criteria|2|||
162233712|NCT01076647|585906162|FG001|Overall Study|Withdrawal criteria|2|||
162233713|NCT01076647|585906161|FG000|Overall Study|Unclassified|12|||
162233714|NCT01076647|585906162|FG001|Overall Study|Unclassified|12|||
162233715|NCT04426851|585906167|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
162233716|NCT04426851|585906168|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
162233717|NCT04426851|585906167|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
162233718|NCT04426851|585906168|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
162233719|NCT02292927|585906169|FG000|Overall Study|Protocol Violation|13|||
162233720|NCT02292927|585906170|FG001|Overall Study|Protocol Violation|7|||
162233721|NCT02962960|585906173|FG000|Overall Study|Withdrawal by Subject|1|||
162233722|NCT02962960|585906174|FG001|Overall Study|Withdrawal by Subject|1|||
162233723|NCT02962960|585906175|FG002|Overall Study|Withdrawal by Subject|0|||
162233724|NCT02962960|585906173|FG000|Overall Study|Adverse Event|1|||
162233725|NCT02962960|585906174|FG001|Overall Study|Adverse Event|1|||
162233726|NCT02962960|585906175|FG002|Overall Study|Adverse Event|0|||
162233727|NCT02962960|585906173|FG000|Overall Study|Protocol Violation|1|||
162233728|NCT02962960|585906174|FG001|Overall Study|Protocol Violation|0|||
161941071|NCT03396445|584836073|FG014|Treatment Period|Physician Decision|0|||
162233729|NCT02962960|585906175|FG002|Overall Study|Protocol Violation|0|||
162233730|NCT02054741|585906176|FG000|Overall Study|Protocol Violation|13|||
162233731|NCT02054741|585906177|FG001|Overall Study|Protocol Violation|2|||
162233732|NCT02054741|585906176|FG000|Overall Study|Withdrawal by Subject|10|||
162233733|NCT02054741|585906177|FG001|Overall Study|Withdrawal by Subject|5|||
162233734|NCT02054741|585906176|FG000|Overall Study|Death|94|||
162233735|NCT02054741|585906177|FG001|Overall Study|Death|90|||
162233736|NCT02054741|585906176|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
162233737|NCT02054741|585906177|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
162233738|NCT00394082|585906178|FG000|Overall Study|Unacceptable toxicity|15|||
162233739|NCT00394082|585906178|FG000|Overall Study|Adverse Event|4|||
162233740|NCT00394082|585906178|FG000|Overall Study|Physician Decision|4|||
162233741|NCT00394082|585906178|FG000|Overall Study|Withdrawal by Subject|2|||
162233742|NCT00394082|585906178|FG000|Overall Study|Other|1|||
162233743|NCT02344004|585906180|FG000|Overall Study|Adverse Event|11|||
162233744|NCT02344004|585906181|FG001|Overall Study|Adverse Event|1|||
162233745|NCT02344004|585906180|FG000|Overall Study|Death|9|||
162233746|NCT02344004|585906181|FG001|Overall Study|Death|7|||
162233747|NCT02344004|585906180|FG000|Overall Study|Physician Decision|4|||
162233748|NCT02344004|585906181|FG001|Overall Study|Physician Decision|1|||
162233749|NCT02344004|585906180|FG000|Overall Study|Withdrawal by Subject|22|||
162233750|NCT02344004|585906181|FG001|Overall Study|Withdrawal by Subject|5|||
162233751|NCT02344004|585906180|FG000|Overall Study|Rescue Medication|2|||
162233752|NCT02344004|585906181|FG001|Overall Study|Rescue Medication|0|||
162233753|NCT02344004|585906180|FG000|Overall Study|Other Not Specified|12|||
162233754|NCT02344004|585906181|FG001|Overall Study|Other Not Specified|0|||
162233755|NCT02344004|585906180|FG000|Overall Study|Protocol Violation|1|||
162233756|NCT02344004|585906181|FG001|Overall Study|Protocol Violation|0|||
162233757|NCT01768117|585906182|FG000|Overall Study|Lost to Follow-up|1|||
162233758|NCT01768117|585906182|FG000|Overall Study|Withdrawal by Subject|2|||
162233759|NCT01768117|585906182|FG000|Overall Study|Protocol Violation|3|||
162233760|NCT01945060|585906183|FG000|Overall Study|Lost to follow up|1|||
162233761|NCT01945060|585906184|FG001|Overall Study|Lost to follow up|0|||
162233762|NCT01945060|585906183|FG000|Overall Study|Distress related to IV access|0|||
162233763|NCT01945060|585906184|FG001|Overall Study|Distress related to IV access|1|||
162233764|NCT00138671|585906185|FG000|Overall Study|Death|0|||
162233765|NCT00138671|585906186|FG001|Overall Study|Death|3|||
162233766|NCT00138671|585906185|FG000|Overall Study|Adverse Event|6|||
162233767|NCT00138671|585906186|FG001|Overall Study|Adverse Event|3|||
162233768|NCT00138671|585906185|FG000|Overall Study|Lost to Follow-up|1|||
162233769|NCT00138671|585906186|FG001|Overall Study|Lost to Follow-up|2|||
162233770|NCT00138671|585906185|FG000|Overall Study|Withdrawal by Subject|3|||
162233771|NCT00138671|585906186|FG001|Overall Study|Withdrawal by Subject|5|||
162233772|NCT00138671|585906185|FG000|Overall Study|Other|3|||
162233773|NCT00138671|585906186|FG001|Overall Study|Other|3|||
162233774|NCT01488487|585906187|FG000|Overall Study|Adverse Event|6|||
162233775|NCT01488487|585906187|FG000|Overall Study|Death|1|||
162233776|NCT01488487|585906187|FG000|Overall Study|Withdrawal by Subject|2|||
162233777|NCT00395460|585906190|FG000|Overall Study|Withdrawal by Subject|1|||
162233778|NCT00395460|585906191|FG001|Overall Study|Withdrawal by Subject|0|||
162233779|NCT01737827|585906197|FG000|Overall Study|Adverse Event|3|||
162233780|NCT01737827|585906198|FG001|Overall Study|Adverse Event|6|||
162233781|NCT01737827|585906199|FG002|Overall Study|Adverse Event|0|||
162233782|NCT01737827|585906197|FG000|Overall Study|Lost to Follow-up|0|||
162233783|NCT01737827|585906198|FG001|Overall Study|Lost to Follow-up|1|||
162233784|NCT01737827|585906199|FG002|Overall Study|Lost to Follow-up|0|||
162233785|NCT01737827|585906197|FG000|Overall Study|Physician Decision|0|||
162233786|NCT01737827|585906198|FG001|Overall Study|Physician Decision|2|||
161941072|NCT03396445|584836074|FG015|Treatment Period|Physician Decision|0|||
162233787|NCT01737827|585906199|FG002|Overall Study|Physician Decision|0|||
161941073|NCT03396445|584836075|FG016|Treatment Period|Physician Decision|0|||
161941074|NCT03396445|584836076|FG017|Treatment Period|Physician Decision|0|||
162233788|NCT01737827|585906197|FG000|Overall Study|Progressive Disease|5|||
162233789|NCT01737827|585906198|FG001|Overall Study|Progressive Disease|16|||
162233790|NCT01737827|585906199|FG002|Overall Study|Progressive Disease|2|||
162233791|NCT01737827|585906197|FG000|Overall Study|Study Terminated by Sponsor|0|||
162233792|NCT01737827|585906198|FG001|Overall Study|Study Terminated by Sponsor|1|||
162233793|NCT01737827|585906199|FG002|Overall Study|Study Terminated by Sponsor|0|||
162233794|NCT01737827|585906197|FG000|Overall Study|Subject/Guardian Decision|0|||
162233795|NCT01737827|585906198|FG001|Overall Study|Subject/Guardian Decision|2|||
162233796|NCT01737827|585906199|FG002|Overall Study|Subject/Guardian Decision|0|||
161830069|NCT02412722|584418105|FG001|Overall Study|Reason not Specified|0|||
161830070|NCT02412722|584418106|FG002|Overall Study|Reason not Specified|2|||
162233797|NCT00296400|585906200|FG000|Overall Study|Adverse Event|7|||
162233798|NCT00296400|585906201|FG001|Overall Study|Adverse Event|7|||
162233799|NCT00296400|585906202|FG002|Overall Study|Adverse Event|7|||
162233800|NCT00296400|585906200|FG000|Overall Study|Withdrawal by Subject|5|||
162233801|NCT00296400|585906201|FG001|Overall Study|Withdrawal by Subject|6|||
162233802|NCT00296400|585906202|FG002|Overall Study|Withdrawal by Subject|2|||
162233803|NCT00296400|585906200|FG000|Overall Study|Incorrect enrollment|2|||
162233804|NCT00296400|585906201|FG001|Overall Study|Incorrect enrollment|0|||
162233805|NCT00296400|585906202|FG002|Overall Study|Incorrect enrollment|0|||
162233806|NCT00296400|585906200|FG000|Overall Study|Protocol Violation|1|||
162233807|NCT00296400|585906201|FG001|Overall Study|Protocol Violation|1|||
162233808|NCT00296400|585906202|FG002|Overall Study|Protocol Violation|1|||
162233809|NCT00296400|585906200|FG000|Overall Study|Lost to Follow-up|1|||
162233810|NCT00296400|585906201|FG001|Overall Study|Lost to Follow-up|1|||
162233811|NCT00296400|585906202|FG002|Overall Study|Lost to Follow-up|2|||
162233812|NCT00296400|585906200|FG000|Overall Study|Study specific discontinuation criteria|0|||
162233813|NCT00296400|585906201|FG001|Overall Study|Study specific discontinuation criteria|0|||
162233814|NCT00296400|585906202|FG002|Overall Study|Study specific discontinuation criteria|1|||
162233815|NCT00296400|585906200|FG000|Overall Study|Visit 10 was performed earlier|0|||
162233816|NCT00296400|585906201|FG001|Overall Study|Visit 10 was performed earlier|1|||
162233817|NCT00296400|585906202|FG002|Overall Study|Visit 10 was performed earlier|0|||
162233818|NCT00296400|585906200|FG000|Overall Study|Pregnancy|1|||
162233819|NCT00296400|585906201|FG001|Overall Study|Pregnancy|2|||
162233820|NCT00296400|585906202|FG002|Overall Study|Pregnancy|0|||
162233821|NCT03538301|585906204|FG000|Overall Study|Adverse Event|1|||
162233822|NCT03538301|585906205|FG001|Overall Study|Adverse Event|4|||
162233823|NCT03538301|585906206|FG002|Overall Study|Adverse Event|4|||
162233824|NCT03538301|585906204|FG000|Overall Study|Death|1|||
162233825|NCT03538301|585906205|FG001|Overall Study|Death|1|||
162233826|NCT03538301|585906206|FG002|Overall Study|Death|0|||
162233827|NCT03538301|585906204|FG000|Overall Study|Physician Decision|0|||
162233828|NCT03538301|585906205|FG001|Overall Study|Physician Decision|1|||
162233829|NCT03538301|585906206|FG002|Overall Study|Physician Decision|0|||
162233830|NCT03538301|585906204|FG000|Overall Study|Protocol Violation|0|||
162233831|NCT03538301|585906205|FG001|Overall Study|Protocol Violation|0|||
162233832|NCT03538301|585906206|FG002|Overall Study|Protocol Violation|1|||
162233833|NCT03538301|585906204|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
162233834|NCT03538301|585906205|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
162233835|NCT03538301|585906206|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
162233836|NCT01586910|585908195|FG000|Overall Study|Death|4|||
162233837|NCT01586910|585908196|FG001|Overall Study|Death|4|||
162233838|NCT01586910|585908195|FG000|Overall Study|Withdrawal by Subject|6|||
162233839|NCT01586910|585908196|FG001|Overall Study|Withdrawal by Subject|43|||
162233840|NCT01586910|585908195|FG000|Overall Study|Physician withdrew Subject|5|||
162233841|NCT01586910|585908196|FG001|Overall Study|Physician withdrew Subject|24|||
162233842|NCT00252733|585908197|FG000|Overall Study|Withdrawal by Subject|73|||
162233843|NCT00252733|585908198|FG001|Overall Study|Withdrawal by Subject|67|||
162233844|NCT00252733|585908197|FG000|Overall Study|Death|7|||
162233845|NCT00252733|585908198|FG001|Overall Study|Death|5|||
162233846|NCT00252733|585908197|FG000|Overall Study|Lost to Follow-up|12|||
162233847|NCT00252733|585908198|FG001|Overall Study|Lost to Follow-up|6|||
162233848|NCT00252733|585908197|FG000|Overall Study|Multiple Reasons|14|||
162233849|NCT00252733|585908198|FG001|Overall Study|Multiple Reasons|14|||
162233850|NCT04289051|585908199|FG000|Overall Study|Lost to Follow-up|0|||
162233851|NCT04289051|585908200|FG001|Overall Study|Lost to Follow-up|0|||
162233852|NCT04289051|585908201|FG002|Overall Study|Lost to Follow-up|2|||
162233853|NCT00156819|585908204|FG000|Overall Study|Lost to Follow-up|1|||
162233854|NCT00156819|585908205|FG001|Overall Study|Lost to Follow-up|1|||
162233855|NCT00156819|585908206|FG002|Overall Study|Lost to Follow-up|3|||
162233856|NCT01689337|585908207|FG000|Overall Study|Study Discontinuation|1|||
162233857|NCT01174160|585908211|FG000|Overall Study|Adverse Event|1|||
161830071|NCT02412722|584418107|FG003|Overall Study|Reason not Specified|1|||
161830072|NCT02412722|584418108|FG004|Overall Study|Reason not Specified|2|||
161830073|NCT02412722|584418109|FG005|Overall Study|Reason not Specified|6|||
161830074|NCT02400476|584418110|FG000|Overall Study|Adverse Event|57|||
162233858|NCT01174160|585908212|FG001|Overall Study|Adverse Event|0|||
162233859|NCT01174160|585908211|FG000|Overall Study|Lost to Follow-up|1|||
162233860|NCT01174160|585908212|FG001|Overall Study|Lost to Follow-up|0|||
162233861|NCT01174160|585908211|FG000|Overall Study|Physician Decision|1|||
162233862|NCT01174160|585908212|FG001|Overall Study|Physician Decision|0|||
162233863|NCT01174160|585908211|FG000|Overall Study|Protocol Violation|4|||
162233864|NCT01174160|585908212|FG001|Overall Study|Protocol Violation|6|||
162233865|NCT01174160|585908211|FG000|Overall Study|Withdrawal by Subject|1|||
162233866|NCT01174160|585908212|FG001|Overall Study|Withdrawal by Subject|0|||
161680648|NCT00545402|583883008|FG001|Overall Study|Discontinuation of treatment|9|||
161680649|NCT00545402|583883007|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
161680650|NCT00545402|583883008|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
161680651|NCT00545402|583883007|FG000|Overall Study|Death|5|||
161680652|NCT00545402|583883008|FG001|Overall Study|Death|7|||
161680653|NCT00545402|583883007|FG000|Overall Study|Graft loss|2|||
161680654|NCT00545402|583883008|FG001|Overall Study|Graft loss|4|||
161680655|NCT00545402|583883007|FG000|Overall Study|Withdrawal by Subject|0|||
161680656|NCT00545402|583883008|FG001|Overall Study|Withdrawal by Subject|1|||
161680657|NCT00545402|583883007|FG000|Overall Study|Protocol Violation|1|||
161680658|NCT00545402|583883008|FG001|Overall Study|Protocol Violation|0|||
161680659|NCT00545402|583883007|FG000|Overall Study|Reason not specified|1|||
161680660|NCT00545402|583883008|FG001|Overall Study|Reason not specified|1|||
161680661|NCT00382018|583883009|FG000|Overall Study|Progression|0|||
161680662|NCT00382018|583883010|FG001|Overall Study|Progression|136|||
161680663|NCT00382018|583883011|FG002|Overall Study|Progression|51|||
161680664|NCT00382018|583883012|FG003|Overall Study|Progression|43|||
161680665|NCT00382018|583883009|FG000|Overall Study|Death|0|||
161680666|NCT00382018|583883010|FG001|Overall Study|Death|9|||
161680667|NCT00382018|583883011|FG002|Overall Study|Death|7|||
161680668|NCT00382018|583883012|FG003|Overall Study|Death|11|||
161680669|NCT00382018|583883009|FG000|Overall Study|Withdrawal by Subject|0|||
161680670|NCT00382018|583883010|FG001|Overall Study|Withdrawal by Subject|4|||
161680671|NCT00382018|583883011|FG002|Overall Study|Withdrawal by Subject|3|||
161680672|NCT00382018|583883012|FG003|Overall Study|Withdrawal by Subject|4|||
161680673|NCT00382018|583883009|FG000|Overall Study|Other, not protocol specified|0|||
161680674|NCT00382018|583883010|FG001|Overall Study|Other, not protocol specified|16|||
161680675|NCT00382018|583883011|FG002|Overall Study|Other, not protocol specified|3|||
161680676|NCT00382018|583883012|FG003|Overall Study|Other, not protocol specified|1|||
161680677|NCT01984164|583883013|FG000|Overall Study|Withdrawal by Subject|4|||
161680678|NCT01984164|583883014|FG001|Overall Study|Withdrawal by Subject|3|||
161680679|NCT01984164|583883013|FG000|Overall Study|Adverse Event|5|||
161680680|NCT01984164|583883014|FG001|Overall Study|Adverse Event|19|||
161680681|NCT01984164|583883013|FG000|Overall Study|Lost to Follow-up|1|||
161680682|NCT01984164|583883014|FG001|Overall Study|Lost to Follow-up|3|||
161680683|NCT00427349|583883018|FG000|Overall Study|Lack of Efficacy|23|||
161680684|NCT00427349|583883018|FG000|Overall Study|Adverse Event|14|||
161941075|NCT03396445|584836077|FG018|Treatment Period|Physician Decision|0|||
161680685|NCT00427349|583883018|FG000|Overall Study|Death|1|||
161680686|NCT00427349|583883018|FG000|Overall Study|Withdrawal by Subject|3|||
161680687|NCT00427349|583883018|FG000|Overall Study|Alternative therapy|1|||
161680688|NCT00427349|583883018|FG000|Overall Study|Other|2|||
161680689|NCT00427349|583883018|FG000|Overall Study|Ineligible|1|||
161680690|NCT00427349|583883018|FG000|Overall Study|Never started therapy|1|||
161680691|NCT00916279|583883021|FG000|Overall Study|Death|2|||
161680692|NCT00916279|583883021|FG000|Overall Study|Lost to Follow-up|2|||
161680693|NCT02592018|583883026|FG000|Overall Study|Adverse Event|1|||
162233867|NCT02038543|585908215|FG000|Overall Study|Screen Failure|0|||
162233868|NCT02038543|585908216|FG001|Overall Study|Screen Failure|0|||
162233869|NCT02038543|585908217|FG002|Overall Study|Screen Failure|0|||
161830075|NCT02400476|584418111|FG001|Overall Study|Adverse Event|10|||
161830076|NCT02400476|584418112|FG002|Overall Study|Adverse Event|22|||
161830077|NCT02400476|584418113|FG003|Overall Study|Adverse Event|19|||
161830078|NCT02400476|584418114|FG004|Overall Study|Adverse Event|5|||
161830079|NCT02400476|584418115|FG005|Overall Study|Adverse Event|8|||
161830080|NCT02400476|584418110|FG000|Overall Study|Withdrawal by Subject|4|||
161680694|NCT02592018|583883026|FG000|Overall Study|Lost to Follow-up|1|||
161680695|NCT00574145|583884291|FG000|Overall Study|Withdrawal by Subject|2|||
161680696|NCT00574145|583884292|FG001|Overall Study|Withdrawal by Subject|1|||
161680697|NCT03227471|583884293|FG000|Overall Study|Withdrawal by Subject|0|||
162233870|NCT02038543|585908218|FG003|Overall Study|Screen Failure|1|||
162233871|NCT02038543|585908215|FG000|Overall Study|Withdrawal by Subject|0|||
162233872|NCT02038543|585908216|FG001|Overall Study|Withdrawal by Subject|0|||
162233873|NCT02038543|585908217|FG002|Overall Study|Withdrawal by Subject|0|||
162233874|NCT02038543|585908218|FG003|Overall Study|Withdrawal by Subject|1|||
162233875|NCT00093808|585908219|FG000|Overall Study|Cancel participation before receiving tx|1|||
162233876|NCT00093808|585908219|FG000|Overall Study|Protocol Violation|1|||
162233877|NCT00871780|585908220|FG000|Overall Study|Enrolled But Not Treated|6|||
162233878|NCT00871780|585908220|FG000|Overall Study|Withdrawal by Subject|9|||
162233879|NCT00871780|585908220|FG000|Overall Study|Adverse Event|6|||
162233880|NCT00871780|585908220|FG000|Overall Study|Voluntary Discontinuation|4|||
162233881|NCT00871780|585908220|FG000|Overall Study|Death|1|||
162233882|NCT00871780|585908220|FG000|Overall Study|Physician Decision|1|||
162233883|NCT03545503|585908221|FG000|Overall Study|Protocol Violation|14|||
162233884|NCT03545503|585908222|FG001|Overall Study|Protocol Violation|16|||
162233885|NCT04494256|585908223|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
161680698|NCT03227471|583884294|FG001|Overall Study|Withdrawal by Subject|0|||
161680699|NCT03227471|583884295|FG002|Overall Study|Withdrawal by Subject|0|||
161680700|NCT03227471|583884296|FG003|Overall Study|Withdrawal by Subject|0|||
161680701|NCT03227471|583884297|FG004|Overall Study|Withdrawal by Subject|1|||
161680702|NCT03227471|583884298|FG005|Overall Study|Withdrawal by Subject|0|||
161680703|NCT03227471|583884299|FG006|Overall Study|Withdrawal by Subject|0|||
161680704|NCT03227471|583884300|FG007|Overall Study|Withdrawal by Subject|0|||
161680705|NCT03227471|583884301|FG008|Overall Study|Withdrawal by Subject|0|||
161680706|NCT03227471|583884302|FG009|Overall Study|Withdrawal by Subject|0|||
161680707|NCT03227471|583884303|FG010|Overall Study|Withdrawal by Subject|0|||
161680708|NCT03227471|583884304|FG011|Overall Study|Withdrawal by Subject|0|||
161680709|NCT03227471|583884305|FG012|Overall Study|Withdrawal by Subject|1|||
161680710|NCT03227471|583884306|FG013|Overall Study|Withdrawal by Subject|0|||
161680711|NCT03227471|583884307|FG014|Overall Study|Withdrawal by Subject|0|||
161680712|NCT03227471|583884293|FG000|Overall Study|Randomized, Never Dosed|0|||
161680713|NCT03227471|583884294|FG001|Overall Study|Randomized, Never Dosed|0|||
161680714|NCT03227471|583884295|FG002|Overall Study|Randomized, Never Dosed|0|||
161680715|NCT03227471|583884296|FG003|Overall Study|Randomized, Never Dosed|0|||
161680716|NCT03227471|583884297|FG004|Overall Study|Randomized, Never Dosed|0|||
162233886|NCT04494256|585908224|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
162233887|NCT04494256|585908225|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
161680717|NCT03227471|583884298|FG005|Overall Study|Randomized, Never Dosed|0|||
161830081|NCT02400476|584418111|FG001|Overall Study|Withdrawal by Subject|1|||
161830082|NCT02400476|584418112|FG002|Overall Study|Withdrawal by Subject|12|||
162233888|NCT04494256|585908226|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
162233889|NCT04494256|585908227|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
162233890|NCT04494256|585908228|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
162233891|NCT04494256|585908229|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
162233892|NCT04494256|585908223|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
162233893|NCT04494256|585908224|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
162233894|NCT04494256|585908225|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
162233895|NCT04494256|585908226|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
162233896|NCT04494256|585908227|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
162233897|NCT04494256|585908228|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
162233898|NCT04494256|585908229|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
162233899|NCT04494256|585908223|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
161830083|NCT02400476|584418113|FG003|Overall Study|Withdrawal by Subject|7|||
161830084|NCT02400476|584418114|FG004|Overall Study|Withdrawal by Subject|5|||
161830085|NCT02400476|584418115|FG005|Overall Study|Withdrawal by Subject|5|||
161830086|NCT02400476|584418110|FG000|Overall Study|Lost to Follow-up|0|||
161680718|NCT03227471|583884299|FG006|Overall Study|Randomized, Never Dosed|0|||
161680719|NCT03227471|583884300|FG007|Overall Study|Randomized, Never Dosed|0|||
161680720|NCT03227471|583884301|FG008|Overall Study|Randomized, Never Dosed|0|||
161830087|NCT02400476|584418111|FG001|Overall Study|Lost to Follow-up|0|||
162025188|NCT05141448|585148862|FG003|3|Covid-19 related|0|||
162025189|NCT05141448|585148863|FG004|3|Covid-19 related|0|||
162025190|NCT05141448|585148864|FG005|3|Covid-19 related|1|||
162025191|NCT05141448|585148859|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
162025192|NCT05141448|585148860|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
162025193|NCT05141448|585148861|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
162025194|NCT05141448|585148862|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
162025195|NCT05141448|585148863|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
162025196|NCT05141448|585148864|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
162025197|NCT03865316|585150698|FG000|Overall Study|Procedure Cancelled|4|||
162025198|NCT03865316|585150698|FG000|Overall Study|Equipment failure|4|||
162025199|NCT01836276|585150702|FG000|Overall Study|Lost to Follow-up|28|||
162025200|NCT01836276|585150703|FG001|Overall Study|Lost to Follow-up|51|||
162025201|NCT02208063|585150710|FG000|Overall Study|Death|3|||
162025202|NCT02208063|585150711|FG001|Overall Study|Death|5|||
162025203|NCT02208063|585150710|FG000|Overall Study|Not Specified in report|3|||
162025204|NCT02208063|585150711|FG001|Overall Study|Not Specified in report|4|||
162025205|NCT02208063|585150710|FG000|Overall Study|Withdrawal by Subject|5|||
162025206|NCT02208063|585150711|FG001|Overall Study|Withdrawal by Subject|2|||
162025207|NCT02208063|585150710|FG000|Overall Study|Lost to Follow-up|1|||
162025208|NCT02208063|585150711|FG001|Overall Study|Lost to Follow-up|0|||
162025209|NCT00913458|585150712|FG000|Phase 1|Non-Responder|54|||
162233900|NCT04494256|585908224|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
162233901|NCT04494256|585908225|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
162025210|NCT00913458|585150713|FG001|Phase 1|Non-Responder|0|||
162025211|NCT00913458|585150714|FG002|Phase 1|Non-Responder|0|||
162233902|NCT04494256|585908226|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
162233903|NCT04494256|585908227|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
162233904|NCT04494256|585908228|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
162025212|NCT00913458|585150715|FG003|Phase 1|Non-Responder|0|||
162025213|NCT00913458|585150716|FG004|Phase 1|Non-Responder|0|||
162025214|NCT00913458|585150717|FG005|Phase 1|Non-Responder|0|||
162025215|NCT00913458|585150718|FG006|Phase 1|Non-Responder|0|||
162233905|NCT04494256|585908229|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
162233906|NCT04494256|585908223|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162233907|NCT04494256|585908224|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162233908|NCT04494256|585908225|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162233909|NCT04494256|585908226|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
162233910|NCT04494256|585908227|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
162233911|NCT04494256|585908228|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162233912|NCT04494256|585908229|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162233913|NCT04494256|585908223|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
162233914|NCT04494256|585908224|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
162233915|NCT04494256|585908225|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
162233916|NCT04494256|585908226|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
162233917|NCT04494256|585908227|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
162233918|NCT04494256|585908228|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
162233919|NCT04494256|585908229|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
162233920|NCT04494256|585908223|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
162233921|NCT04494256|585908224|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
162233922|NCT04494256|585908225|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
162233923|NCT04494256|585908226|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
162233924|NCT04494256|585908227|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
162233925|NCT04494256|585908228|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
162233926|NCT04494256|585908229|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
162233927|NCT04494256|585908223|FG000|Part 2: Open Label Period|Death|0|||
162233928|NCT04494256|585908224|FG001|Part 2: Open Label Period|Death|0|||
162233929|NCT04494256|585908225|FG002|Part 2: Open Label Period|Death|0|||
162233930|NCT04494256|585908226|FG003|Part 2: Open Label Period|Death|0|||
162233931|NCT04494256|585908227|FG004|Part 2: Open Label Period|Death|0|||
162233932|NCT04494256|585908228|FG005|Part 2: Open Label Period|Death|4|||
162233933|NCT04494256|585908229|FG006|Part 2: Open Label Period|Death|2|||
162233934|NCT04494256|585908223|FG000|Part 2: Open Label Period|Adverse Event|0|||
162233935|NCT04494256|585908224|FG001|Part 2: Open Label Period|Adverse Event|0|||
162233936|NCT04494256|585908225|FG002|Part 2: Open Label Period|Adverse Event|0|||
162233937|NCT04494256|585908226|FG003|Part 2: Open Label Period|Adverse Event|0|||
162233938|NCT04494256|585908227|FG004|Part 2: Open Label Period|Adverse Event|0|||
162233939|NCT04494256|585908228|FG005|Part 2: Open Label Period|Adverse Event|0|||
162233940|NCT04494256|585908229|FG006|Part 2: Open Label Period|Adverse Event|2|||
162233941|NCT04494256|585908223|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
162233942|NCT04494256|585908224|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
162233943|NCT04494256|585908225|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
162233944|NCT04494256|585908226|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
162233945|NCT04494256|585908227|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
162233946|NCT04494256|585908228|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
162233947|NCT04494256|585908229|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
162233948|NCT04494256|585908223|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
162233949|NCT04494256|585908224|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
162233950|NCT04494256|585908225|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
162233951|NCT04494256|585908226|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
162233952|NCT04494256|585908227|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
162233953|NCT04494256|585908228|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
162233954|NCT04494256|585908229|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
162233955|NCT04494256|585908223|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
162233956|NCT04494256|585908224|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
162233957|NCT04494256|585908225|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
162233958|NCT04494256|585908226|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
162233959|NCT04494256|585908227|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
162233960|NCT04494256|585908228|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
162233961|NCT04494256|585908229|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
162233962|NCT04494256|585908223|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162233963|NCT04494256|585908224|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162233964|NCT04494256|585908225|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162233965|NCT04494256|585908226|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162233966|NCT04494256|585908227|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
162233967|NCT04494256|585908228|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
162233968|NCT04494256|585908229|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
162233969|NCT04494256|585908223|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
162233970|NCT04494256|585908224|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
162233971|NCT04494256|585908225|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
162233972|NCT04494256|585908226|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
162233973|NCT04494256|585908227|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
162233974|NCT04494256|585908228|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
162233975|NCT04494256|585908229|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
162233976|NCT00262951|585908230|FG000|Overall Study|Progressive disease/relapse|3|||
162233977|NCT00262951|585908230|FG000|Overall Study|Adverse Event|7|||
162233978|NCT00262951|585908230|FG000|Overall Study|Death|1|||
162233979|NCT00262951|585908230|FG000|Overall Study|Withdrawal by Subject|1|||
162233980|NCT00262951|585908230|FG000|Overall Study|Alternative treatment|3|||
162233981|NCT00262951|585908230|FG000|Overall Study|Off treatment for other disease|1|||
162233982|NCT02483585|585908231|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
162233983|NCT02483585|585908232|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
162233984|NCT02483585|585908231|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
162233985|NCT02483585|585908232|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
162233986|NCT02483585|585908231|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
162233987|NCT02483585|585908232|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
162233988|NCT02483585|585908231|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
162233989|NCT02483585|585908232|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
162233990|NCT02483585|585908231|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
162233991|NCT02483585|585908232|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
162233992|NCT02483585|585908231|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
162233993|NCT02483585|585908232|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
162233994|NCT02483585|585908231|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
162233995|NCT02483585|585908232|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
162233996|NCT00825916|585908236|FG000|Overall Study|Lost to Follow-up|4|||
162233997|NCT00825916|585908237|FG001|Overall Study|Lost to Follow-up|2|||
162233998|NCT00825916|585908238|FG002|Overall Study|Lost to Follow-up|1|||
162233999|NCT01778023|585908239|FG000|Overall Study|Withdrawal by Subject|0|||
162234000|NCT01778023|585908240|FG001|Overall Study|Withdrawal by Subject|3|||
162234001|NCT01098097|585908241|FG000|Overall Study|Adverse Event|17|||
162234002|NCT01098097|585908241|FG000|Overall Study|Lost to Follow-up|18|||
162234003|NCT01098097|585908241|FG000|Overall Study|Status unknown|16|||
162234004|NCT01098097|585908241|FG000|Overall Study|No reason reported|31|||
162234005|NCT01502631|585908244|FG000|Overall Study|Adverse Event|5|||
162234006|NCT01502631|585908245|FG001|Overall Study|Adverse Event|8|||
162234007|NCT01502631|585908244|FG000|Overall Study|Lost to Follow-up|2|||
162234008|NCT01502631|585908245|FG001|Overall Study|Lost to Follow-up|2|||
162234009|NCT01502631|585908244|FG000|Overall Study|Participant withdrew consent|2|||
162234010|NCT01502631|585908245|FG001|Overall Study|Participant withdrew consent|4|||
162234011|NCT01502631|585908244|FG000|Overall Study|Participant non-compliant|1|||
162234012|NCT01502631|585908245|FG001|Overall Study|Participant non-compliant|0|||
162234013|NCT01502631|585908244|FG000|Overall Study|Investigator's decision|0|||
162234014|NCT01502631|585908245|FG001|Overall Study|Investigator's decision|1|||
162234015|NCT01502631|585908244|FG000|Overall Study|Other|10|||
162234016|NCT01502631|585908245|FG001|Overall Study|Other|5|||
162234017|NCT01000636|585908248|FG000|Overall Study|Withdrawal by Subject|1|||
162234018|NCT01000636|585908248|FG000|Overall Study|Adverse Event|1|||
161830088|NCT02400476|584418112|FG002|Overall Study|Lost to Follow-up|0|||
162234019|NCT02319525|585908249|FG000|Overall Study|Withdrawal by Subject|2|||
161830089|NCT02400476|584418113|FG003|Overall Study|Lost to Follow-up|1|||
162234020|NCT02319525|585908250|FG001|Overall Study|Withdrawal by Subject|1|||
161830090|NCT02400476|584418114|FG004|Overall Study|Lost to Follow-up|3|||
162234021|NCT00577577|585908254|FG000|Overall Study|Adverse Event|3|||
162234022|NCT00577577|585908255|FG001|Overall Study|Adverse Event|2|||
162234023|NCT00577577|585908254|FG000|Overall Study|Lost to Follow-up|1|||
162234024|NCT00577577|585908255|FG001|Overall Study|Lost to Follow-up|0|||
162234025|NCT00577577|585908254|FG000|Overall Study|Protocol Violation|0|||
162234026|NCT00577577|585908255|FG001|Overall Study|Protocol Violation|3|||
162234027|NCT00577577|585908254|FG000|Overall Study|Transportation|1|||
162234028|NCT00577577|585908255|FG001|Overall Study|Transportation|0|||
162234029|NCT02424734|585908256|FG000|Overall Study|Treatment stopped to be discharged home|2|||
162234030|NCT02424734|585908257|FG001|Overall Study|Treatment stopped to be discharged home|2|||
162234031|NCT02424734|585908258|FG002|Overall Study|Treatment stopped to be discharged home|0|||
162234032|NCT01445301|585908259|FG000|Overall Study|Adverse Event|15|||
162234033|NCT01445301|585908260|FG001|Overall Study|Adverse Event|25|||
162234034|NCT01445301|585908261|FG002|Overall Study|Adverse Event|4|||
162234035|NCT01445301|585908259|FG000|Overall Study|Lack of Efficacy|0|||
162234036|NCT01445301|585908260|FG001|Overall Study|Lack of Efficacy|1|||
162234037|NCT01445301|585908261|FG002|Overall Study|Lack of Efficacy|0|||
162234038|NCT01445301|585908259|FG000|Overall Study|Protocol Violation|1|||
162234039|NCT01445301|585908260|FG001|Overall Study|Protocol Violation|0|||
162234040|NCT01445301|585908261|FG002|Overall Study|Protocol Violation|0|||
162234041|NCT01445301|585908259|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
162234042|NCT01445301|585908260|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
162234043|NCT01445301|585908261|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
162234044|NCT01445301|585908259|FG000|Overall Study|Physician Decision|0|||
162234045|NCT01445301|585908260|FG001|Overall Study|Physician Decision|2|||
162234046|NCT01445301|585908261|FG002|Overall Study|Physician Decision|0|||
162234047|NCT01445301|585908259|FG000|Overall Study|Withdrawal by Subject|5|||
162234048|NCT01445301|585908260|FG001|Overall Study|Withdrawal by Subject|6|||
162234049|NCT01445301|585908261|FG002|Overall Study|Withdrawal by Subject|4|||
162234050|NCT02729753|585908266|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
162234051|NCT02729753|585908267|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
162234052|NCT00190749|585908268|FG000|Overall Study|Lost to Follow-up|8|||
162234053|NCT00190749|585908269|FG001|Overall Study|Lost to Follow-up|11|||
162234054|NCT00190749|585908268|FG000|Overall Study|Withdrawal by Subject|10|||
162234055|NCT00190749|585908269|FG001|Overall Study|Withdrawal by Subject|6|||
162234056|NCT00190749|585908268|FG000|Overall Study|Protocol Violation|5|||
162234057|NCT00190749|585908269|FG001|Overall Study|Protocol Violation|4|||
162234058|NCT00190749|585908268|FG000|Overall Study|Adverse Event|0|||
162234059|NCT00190749|585908269|FG001|Overall Study|Adverse Event|5|||
162234060|NCT00190749|585908268|FG000|Overall Study|Lack of Efficacy|2|||
162234061|NCT00190749|585908269|FG001|Overall Study|Lack of Efficacy|3|||
162234062|NCT00190749|585908268|FG000|Overall Study|Reason Not Specified|0|||
162234063|NCT00190749|585908269|FG001|Overall Study|Reason Not Specified|2|||
162234064|NCT00190749|585908268|FG000|Overall Study|Sponsor Decision|1|||
162234065|NCT00190749|585908269|FG001|Overall Study|Sponsor Decision|0|||
162234066|NCT01090427|585908270|FG000|After Controlled Period|Death|0|||
162234067|NCT01090427|585908271|FG001|After Controlled Period|Death|0|||
162234068|NCT01090427|585908272|FG002|After Controlled Period|Death|0|||
162234069|NCT01090427|585908273|FG003|After Controlled Period|Death|0|||
162234070|NCT01090427|585908274|FG004|After Controlled Period|Death|0|||
162234071|NCT01090427|585908275|FG005|After Controlled Period|Death|1|||
162234072|NCT01090427|585908276|FG006|After Controlled Period|Death|0|||
162234073|NCT01090427|585908270|FG000|After Controlled Period|Lack of Efficacy|0|||
161941076|NCT03396445|584836078|FG019|Treatment Period|Physician Decision|0|||
161941077|NCT03396445|584836079|FG020|Treatment Period|Physician Decision|0|||
161941078|NCT03396445|584836080|FG021|Treatment Period|Physician Decision|0|||
161941079|NCT03396445|584836081|FG022|Treatment Period|Physician Decision|0|||
161941080|NCT03396445|584836082|FG023|Treatment Period|Physician Decision|0|||
161941081|NCT03396445|584836083|FG024|Treatment Period|Physician Decision|0|||
162234074|NCT01090427|585908271|FG001|After Controlled Period|Lack of Efficacy|0|||
162234075|NCT01090427|585908272|FG002|After Controlled Period|Lack of Efficacy|0|||
162234076|NCT01090427|585908273|FG003|After Controlled Period|Lack of Efficacy|0|||
162234077|NCT01090427|585908274|FG004|After Controlled Period|Lack of Efficacy|0|||
162234078|NCT01090427|585908275|FG005|After Controlled Period|Lack of Efficacy|3|||
162234079|NCT01090427|585908276|FG006|After Controlled Period|Lack of Efficacy|2|||
162234080|NCT01090427|585908270|FG000|After Controlled Period|Adverse Event|0|||
162234081|NCT01090427|585908271|FG001|After Controlled Period|Adverse Event|0|||
162234082|NCT01090427|585908272|FG002|After Controlled Period|Adverse Event|0|||
161941082|NCT03396445|584836084|FG025|Treatment Period|Physician Decision|0|||
162234083|NCT01090427|585908273|FG003|After Controlled Period|Adverse Event|2|||
162234084|NCT01090427|585908274|FG004|After Controlled Period|Adverse Event|0|||
162234085|NCT01090427|585908275|FG005|After Controlled Period|Adverse Event|1|||
162025216|NCT00913458|585150712|FG000|Phase 1|Subject Request|17|||
162025217|NCT00913458|585150713|FG001|Phase 1|Subject Request|0|||
162025218|NCT00913458|585150714|FG002|Phase 1|Subject Request|0|||
162025219|NCT00913458|585150715|FG003|Phase 1|Subject Request|0|||
162025220|NCT00913458|585150716|FG004|Phase 1|Subject Request|0|||
162025221|NCT00913458|585150717|FG005|Phase 1|Subject Request|0|||
162234086|NCT01090427|585908276|FG006|After Controlled Period|Adverse Event|0|||
162234087|NCT01154010|585908277|FG000|Overall Study|Lost to Follow-up|0|||
162025222|NCT00913458|585150718|FG006|Phase 1|Subject Request|0|||
162025223|NCT00913458|585150712|FG000|Phase 1|Adverse Event|20|||
162234088|NCT01154010|585908278|FG001|Overall Study|Lost to Follow-up|1|||
162234089|NCT00439231|585908279|FG000|Overall Study|Lack of Efficacy|28|||
162234090|NCT02413333|585908285|FG000|Period 1|Adverse Event|1|||
162234091|NCT02413333|585908286|FG001|Period 1|Adverse Event|0|||
162025224|NCT00913458|585150713|FG001|Phase 1|Adverse Event|0|||
162025225|NCT00913458|585150714|FG002|Phase 1|Adverse Event|0|||
162025226|NCT00913458|585150715|FG003|Phase 1|Adverse Event|0|||
162025227|NCT00913458|585150716|FG004|Phase 1|Adverse Event|0|||
162025228|NCT00913458|585150717|FG005|Phase 1|Adverse Event|0|||
162025229|NCT00913458|585150718|FG006|Phase 1|Adverse Event|0|||
162025230|NCT00913458|585150712|FG000|Phase 1|Lost to Follow-up|2|||
162025231|NCT00913458|585150713|FG001|Phase 1|Lost to Follow-up|0|||
162025232|NCT00913458|585150714|FG002|Phase 1|Lost to Follow-up|0|||
162025233|NCT00913458|585150715|FG003|Phase 1|Lost to Follow-up|0|||
162025234|NCT00913458|585150716|FG004|Phase 1|Lost to Follow-up|0|||
162025235|NCT00913458|585150717|FG005|Phase 1|Lost to Follow-up|0|||
162025236|NCT00913458|585150718|FG006|Phase 1|Lost to Follow-up|0|||
162025237|NCT00913458|585150712|FG000|Phase 1|Protocol Violation|10|||
162025238|NCT00913458|585150713|FG001|Phase 1|Protocol Violation|0|||
162025239|NCT00913458|585150714|FG002|Phase 1|Protocol Violation|0|||
162025240|NCT00913458|585150715|FG003|Phase 1|Protocol Violation|0|||
162025241|NCT00913458|585150716|FG004|Phase 1|Protocol Violation|0|||
162025242|NCT00913458|585150717|FG005|Phase 1|Protocol Violation|0|||
162025243|NCT00913458|585150718|FG006|Phase 1|Protocol Violation|0|||
162025244|NCT00913458|585150712|FG000|Phase 1|Sponsor|2|||
162025245|NCT00913458|585150713|FG001|Phase 1|Sponsor|0|||
162025246|NCT00913458|585150714|FG002|Phase 1|Sponsor|0|||
162025247|NCT00913458|585150715|FG003|Phase 1|Sponsor|0|||
162025248|NCT00913458|585150716|FG004|Phase 1|Sponsor|0|||
162025249|NCT00913458|585150717|FG005|Phase 1|Sponsor|0|||
162025250|NCT00913458|585150718|FG006|Phase 1|Sponsor|0|||
162025251|NCT00913458|585150712|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
162025252|NCT00913458|585150713|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
162234092|NCT02413333|585908285|FG000|Period 1|Reason Not Specified|0|||
162234093|NCT02413333|585908286|FG001|Period 1|Reason Not Specified|1|||
162234094|NCT02413333|585908285|FG000|Period 2|Protocol Deviation|1|||
162234095|NCT02413333|585908286|FG001|Period 2|Protocol Deviation|0|||
162234096|NCT01465347|585908287|FG000|Overall Study|Withdrawal by Subject|1|||
162234097|NCT01465347|585908288|FG001|Overall Study|Withdrawal by Subject|1|||
162234098|NCT01465347|585908287|FG000|Overall Study|Physician Decision|0|||
162234099|NCT01465347|585908288|FG001|Overall Study|Physician Decision|1|||
162234100|NCT01465347|585908287|FG000|Overall Study|Admitted to hospice|0|||
162234101|NCT01465347|585908288|FG001|Overall Study|Admitted to hospice|1|||
162234102|NCT00906945|585908289|FG000|Overall Study|Found to be not eligible|0|||
162234103|NCT00906945|585908290|FG001|Overall Study|Found to be not eligible|0|||
162234104|NCT00906945|585908291|FG002|Overall Study|Found to be not eligible|0|||
162234105|NCT00906945|585908292|FG003|Overall Study|Found to be not eligible|1|||
162234106|NCT00906945|585908293|FG004|Overall Study|Found to be not eligible|1|||
162234107|NCT00906945|585908294|FG005|Overall Study|Found to be not eligible|1|||
162234108|NCT00906945|585908289|FG000|Overall Study|Physician Decision|0|||
162234109|NCT00906945|585908290|FG001|Overall Study|Physician Decision|0|||
162025253|NCT00913458|585150714|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
162025254|NCT00913458|585150715|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
162234110|NCT00906945|585908291|FG002|Overall Study|Physician Decision|0|||
162025255|NCT00913458|585150716|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
162025256|NCT00913458|585150717|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
162025257|NCT00913458|585150718|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
162025258|NCT00913458|585150712|FG000|Phase 2|Non-Responder|0|||
162025259|NCT00913458|585150713|FG001|Phase 2|Non-Responder|5|||
162025260|NCT00913458|585150714|FG002|Phase 2|Non-Responder|7|||
162025261|NCT00913458|585150715|FG003|Phase 2|Non-Responder|12|||
162234111|NCT00906945|585908292|FG003|Overall Study|Physician Decision|0|||
162234112|NCT00906945|585908293|FG004|Overall Study|Physician Decision|0|||
161680721|NCT03227471|583884302|FG009|Overall Study|Randomized, Never Dosed|0|||
161680722|NCT03227471|583884303|FG010|Overall Study|Randomized, Never Dosed|0|||
161680723|NCT03227471|583884304|FG011|Overall Study|Randomized, Never Dosed|0|||
161680724|NCT03227471|583884305|FG012|Overall Study|Randomized, Never Dosed|0|||
161680725|NCT03227471|583884306|FG013|Overall Study|Randomized, Never Dosed|0|||
162234113|NCT00906945|585908294|FG005|Overall Study|Physician Decision|1|||
162234114|NCT02996474|585908296|FG000|Overall Study|Physician Decision|5|||
162234115|NCT01210664|585908297|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
162234116|NCT01210664|585908298|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
162234117|NCT01210664|585908299|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
161680726|NCT03227471|583884307|FG014|Overall Study|Randomized, Never Dosed|1|||
161680727|NCT00736255|583884315|FG000|Overall Study|Adverse Event|1|||
161680728|NCT00736255|583884316|FG001|Overall Study|Adverse Event|0|||
161680729|NCT00736255|583884315|FG000|Overall Study|Physician Decision|1|||
161680730|NCT00736255|583884316|FG001|Overall Study|Physician Decision|0|||
161680731|NCT00736255|583884315|FG000|Overall Study|Non-compliance|1|||
161680732|NCT00736255|583884316|FG001|Overall Study|Non-compliance|1|||
161680733|NCT00457015|583884317|FG000|Overall Study|Left study site against medical advice|0|||
161680734|NCT00457015|583884318|FG001|Overall Study|Left study site against medical advice|1|||
161680735|NCT03670953|583884319|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
161680736|NCT03670953|583884320|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
161680737|NCT03670953|583884321|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
161680738|NCT03670953|583884322|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
161680739|NCT03670953|583884319|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
161680740|NCT03670953|583884320|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
161680741|NCT03670953|583884321|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
161680742|NCT03670953|583884322|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
161680743|NCT03670953|583884319|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
161680744|NCT03670953|583884320|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
161680745|NCT03670953|583884321|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
161680746|NCT03670953|583884322|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
161680747|NCT03670953|583884319|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
161680748|NCT03670953|583884320|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
161680749|NCT03670953|583884321|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
161680750|NCT03670953|583884322|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
161680751|NCT03670953|583884319|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
161680752|NCT03670953|583884320|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
161680753|NCT03670953|583884321|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
161680754|NCT03670953|583884322|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
161680755|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
161680756|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
161680757|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
161680758|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
161680759|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
161680760|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
161680761|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
161680762|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
161680763|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
161680764|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
161680765|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
161680766|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
161680767|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
162234118|NCT01210664|585908300|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
162234119|NCT01210664|585908297|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
162234120|NCT01210664|585908298|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
162234121|NCT01210664|585908299|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
162234122|NCT01210664|585908300|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
161680768|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
161680769|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
161680770|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
161941083|NCT03396445|584836059|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
162234123|NCT01210664|585908297|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
161941084|NCT03396445|584836060|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161680771|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
161680772|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
161680773|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
161680774|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
161680775|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
161680776|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
162234124|NCT01210664|585908298|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
162234125|NCT01210664|585908299|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
162234126|NCT01210664|585908300|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
162234127|NCT04493502|585908301|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
162234128|NCT04493502|585908302|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
162234129|NCT04493502|585908301|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
162234130|NCT04493502|585908302|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
162234131|NCT04493502|585908301|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
162234132|NCT04493502|585908302|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
162234133|NCT04493502|585908301|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
162234134|NCT04493502|585908302|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
162234135|NCT04493502|585908301|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
162234136|NCT04493502|585908302|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
162234137|NCT04493502|585908301|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
162234138|NCT04493502|585908302|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
162234139|NCT04493502|585908301|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
162234140|NCT04493502|585908302|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
162234141|NCT04493502|585908301|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
162234142|NCT04493502|585908302|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
162234143|NCT04493502|585908301|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
162234144|NCT04493502|585908302|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
162234145|NCT04493502|585908301|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
162234146|NCT04493502|585908302|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
162234147|NCT04493502|585908301|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
162234148|NCT04493502|585908302|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
162234149|NCT04493502|585908301|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
162234150|NCT04493502|585908302|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
162234151|NCT04493502|585908301|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
162234152|NCT04493502|585908302|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
162234153|NCT01853644|585908303|FG000|Registration and Treatment Start|Did not start treatment|1|||
162234154|NCT01853644|585908303|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
162234155|NCT01853644|585908303|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
162234156|NCT01853644|585908303|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
162234157|NCT01853644|585908303|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
162234158|NCT01853644|585908303|FG000|Continued Treatment After First Response|Adverse Event|2|||
162234159|NCT01853644|585908303|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
162234160|NCT02891837|585908304|FG000|Overall Study|Lost to Follow-up|2|||
162234161|NCT02891837|585908305|FG001|Overall Study|Lost to Follow-up|0|||
162234162|NCT02891837|585908304|FG000|Overall Study|Withdrawal by Subject|1|||
162234163|NCT02891837|585908305|FG001|Overall Study|Withdrawal by Subject|0|||
162234164|NCT00709852|585908306|FG000|Period 1|Adverse Event|2|||
162234165|NCT00709852|585908307|FG001|Period 1|Adverse Event|0|||
162234166|NCT00709852|585908306|FG000|Period 1|Withdrawal by Subject|4|||
162234167|NCT00709852|585908307|FG001|Period 1|Withdrawal by Subject|2|||
162234168|NCT00709852|585908306|FG000|Period 1|Protocol Violation|1|||
162234169|NCT00709852|585908307|FG001|Period 1|Protocol Violation|0|||
162234170|NCT00709852|585908306|FG000|Period 1|Defective scanner|0|||
162234171|NCT00709852|585908307|FG001|Period 1|Defective scanner|1|||
162234172|NCT00709852|585908306|FG000|Period 1|Lost to Follow-up|1|||
162234173|NCT00709852|585908307|FG001|Period 1|Lost to Follow-up|0|||
162234174|NCT00709852|585908306|FG000|Period 2|Protocol Violation|4|||
162234175|NCT00709852|585908307|FG001|Period 2|Protocol Violation|1|||
162234176|NCT00709852|585908306|FG000|Period 2|Adverse Event|1|||
162234177|NCT00709852|585908307|FG001|Period 2|Adverse Event|1|||
162234178|NCT00709852|585908306|FG000|Period 2|Lost to Follow-up|1|||
162234179|NCT00709852|585908307|FG001|Period 2|Lost to Follow-up|0|||
162234180|NCT00709852|585908306|FG000|Period 2|No 72-hour follow-up|3|||
162234181|NCT00709852|585908307|FG001|Period 2|No 72-hour follow-up|0|||
162234182|NCT01048671|585908308|FG000|Overall Study|Protocol Violation|0|||
162234183|NCT01048671|585908309|FG001|Overall Study|Protocol Violation|1|||
162234184|NCT01048671|585908310|FG002|Overall Study|Protocol Violation|1|||
162234185|NCT01535560|585908312|FG000|Overall Study|Adverse Event|12|||
162234186|NCT01535560|585908313|FG001|Overall Study|Adverse Event|7|||
162234187|NCT01535560|585908312|FG000|Overall Study|Lost to Follow-up|1|||
162234188|NCT01535560|585908313|FG001|Overall Study|Lost to Follow-up|3|||
162234189|NCT01535560|585908312|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
162234190|NCT01535560|585908313|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
162234191|NCT01535560|585908312|FG000|Overall Study|Treatment Failure|21|||
162234192|NCT01535560|585908313|FG001|Overall Study|Treatment Failure|83|||
161830091|NCT02400476|584418115|FG005|Overall Study|Lost to Follow-up|1|||
162234193|NCT01535560|585908312|FG000|Overall Study|Other|0|||
162234194|NCT01535560|585908313|FG001|Overall Study|Other|1|||
162234195|NCT01535560|585908312|FG000|Overall Study|Randomized in Error|0|||
162234196|NCT01535560|585908313|FG001|Overall Study|Randomized in Error|1|||
162234197|NCT01178385|585908317|FG000|Overall Study|Withdrawal by Subject|2|||
162234198|NCT01178385|585908318|FG001|Overall Study|Withdrawal by Subject|0|||
162234199|NCT00985946|585908319|FG000|Overall Study|Lost to Follow-up|6|||
162234200|NCT00985946|585908319|FG000|Overall Study|Withdrawal by Subject|1|||
162234201|NCT00928018|585908324|FG000|Overall Study|Withdrawal by Subject|1|||
162234202|NCT00928018|585908325|FG001|Overall Study|Withdrawal by Subject|0|||
162234203|NCT02008877|585908326|FG000|Overall Study|Inevaluable|0|||
162234204|NCT02008877|585908327|FG001|Overall Study|Inevaluable|1|||
162234205|NCT02008877|585908328|FG002|Overall Study|Inevaluable|0|||
162234206|NCT00847808|585908329|FG000|Overall Study|Adverse Event|7|||
162234207|NCT00847808|585908329|FG000|Overall Study|Protocol Violation|1|||
162234208|NCT00847808|585908329|FG000|Overall Study|Lost to Follow-up|1|||
162234209|NCT00847808|585908329|FG000|Overall Study|Withdrawal by Subject|4|||
162234210|NCT00847808|585908329|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
162234211|NCT00847808|585908329|FG000|Overall Study|Participant Took Excluded Medication|1|||
162234212|NCT05000931|585908339|FG000|Overall Study|Lost to Follow-up|1|||
162234213|NCT05326815|585908340|FG000|Overall Study|Withdrawal by Subject|3|||
162234214|NCT05326815|585908340|FG000|Overall Study|Did not complete required labs|6|||
162234215|NCT05326815|585908340|FG000|Overall Study|Screen fail- abnormal labs|5|||
162234216|NCT00979134|585908341|FG000|Overall Study|Disease progression|18|||
162234217|NCT00979134|585908342|FG001|Overall Study|Disease progression|2|||
162234218|NCT00979134|585908343|FG002|Overall Study|Disease progression|5|||
162234219|NCT00979134|585908341|FG000|Overall Study|Adverse Event|0|||
162234220|NCT00979134|585908342|FG001|Overall Study|Adverse Event|0|||
162234221|NCT00979134|585908343|FG002|Overall Study|Adverse Event|2|||
162234222|NCT00979134|585908341|FG000|Overall Study|Withdrawal by Subject|1|||
162234223|NCT00979134|585908342|FG001|Overall Study|Withdrawal by Subject|1|||
162234224|NCT00979134|585908343|FG002|Overall Study|Withdrawal by Subject|2|||
162234225|NCT00979134|585908341|FG000|Overall Study|Lost to Follow-up|2|||
162234226|NCT00979134|585908342|FG001|Overall Study|Lost to Follow-up|2|||
162234227|NCT00979134|585908343|FG002|Overall Study|Lost to Follow-up|0|||
162234228|NCT00979134|585908341|FG000|Overall Study|Death|4|||
162234229|NCT00979134|585908342|FG001|Overall Study|Death|0|||
162234230|NCT00979134|585908343|FG002|Overall Study|Death|26|||
162234231|NCT00979134|585908341|FG000|Overall Study|Other|8|||
162234232|NCT00979134|585908342|FG001|Overall Study|Other|1|||
162234233|NCT00979134|585908343|FG002|Overall Study|Other|5|||
162234234|NCT05172050|585908344|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
162234235|NCT05172050|585908345|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
162234236|NCT05172050|585908346|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
162234237|NCT05172050|585908344|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
162234238|NCT05172050|585908345|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
162234239|NCT05172050|585908346|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
162234240|NCT05172050|585908344|FG000|Overall Study|Other|2|||
162234241|NCT05172050|585908345|FG001|Overall Study|Other|2|||
162234242|NCT05172050|585908346|FG002|Overall Study|Other|1|||
162234243|NCT04617275|585908351|FG000|Treatment Period|Adverse Event|1|||
162234244|NCT04617275|585908352|FG001|Treatment Period|Adverse Event|6|||
162234245|NCT04617275|585908353|FG002|Treatment Period|Adverse Event|4|||
162234246|NCT04617275|585908354|FG003|Treatment Period|Adverse Event|6|||
162234247|NCT04617275|585908355|FG004|Treatment Period|Adverse Event|7|||
162234248|NCT04617275|585908356|FG005|Treatment Period|Adverse Event|8|||
162234249|NCT04617275|585908357|FG006|Treatment Period|Adverse Event|0|||
162234250|NCT04617275|585908358|FG007|Treatment Period|Adverse Event|12|||
162234251|NCT04617275|585908351|FG000|Treatment Period|Lost to Follow-up|0|||
162234252|NCT04617275|585908352|FG001|Treatment Period|Lost to Follow-up|0|||
162234253|NCT04617275|585908353|FG002|Treatment Period|Lost to Follow-up|2|||
162234254|NCT04617275|585908354|FG003|Treatment Period|Lost to Follow-up|0|||
162234255|NCT04617275|585908355|FG004|Treatment Period|Lost to Follow-up|0|||
162234256|NCT04617275|585908356|FG005|Treatment Period|Lost to Follow-up|3|||
162234257|NCT04617275|585908357|FG006|Treatment Period|Lost to Follow-up|0|||
162234258|NCT04617275|585908358|FG007|Treatment Period|Lost to Follow-up|2|||
162234259|NCT04617275|585908351|FG000|Treatment Period|No longer meets eligibility criteria|0|||
162234260|NCT04617275|585908352|FG001|Treatment Period|No longer meets eligibility criteria|0|||
162234261|NCT04617275|585908353|FG002|Treatment Period|No longer meets eligibility criteria|0|||
162234262|NCT04617275|585908354|FG003|Treatment Period|No longer meets eligibility criteria|1|||
162234263|NCT04617275|585908355|FG004|Treatment Period|No longer meets eligibility criteria|0|||
162234264|NCT04617275|585908356|FG005|Treatment Period|No longer meets eligibility criteria|0|||
162234265|NCT04617275|585908357|FG006|Treatment Period|No longer meets eligibility criteria|0|||
162234266|NCT04617275|585908358|FG007|Treatment Period|No longer meets eligibility criteria|0|||
162234267|NCT04617275|585908351|FG000|Treatment Period|Other|0|||
162234268|NCT04617275|585908352|FG001|Treatment Period|Other|1|||
162234269|NCT04617275|585908353|FG002|Treatment Period|Other|0|||
161680777|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
161680778|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
162234270|NCT04617275|585908354|FG003|Treatment Period|Other|0|||
162234271|NCT04617275|585908355|FG004|Treatment Period|Other|0|||
162234272|NCT04617275|585908356|FG005|Treatment Period|Other|0|||
162234273|NCT04617275|585908357|FG006|Treatment Period|Other|0|||
162234274|NCT04617275|585908358|FG007|Treatment Period|Other|0|||
162234275|NCT04617275|585908351|FG000|Treatment Period|Withdrawal by Subject|2|||
162234276|NCT04617275|585908352|FG001|Treatment Period|Withdrawal by Subject|0|||
162234277|NCT04617275|585908353|FG002|Treatment Period|Withdrawal by Subject|0|||
162234278|NCT04617275|585908354|FG003|Treatment Period|Withdrawal by Subject|2|||
162234279|NCT04617275|585908355|FG004|Treatment Period|Withdrawal by Subject|2|||
162234280|NCT04617275|585908356|FG005|Treatment Period|Withdrawal by Subject|0|||
162234281|NCT04617275|585908357|FG006|Treatment Period|Withdrawal by Subject|1|||
162234282|NCT04617275|585908358|FG007|Treatment Period|Withdrawal by Subject|2|||
162234283|NCT04617275|585908351|FG000|Follow-up Period|Adverse Event|1|||
162234284|NCT04617275|585908352|FG001|Follow-up Period|Adverse Event|1|||
162234285|NCT04617275|585908353|FG002|Follow-up Period|Adverse Event|2|||
162234286|NCT04617275|585908354|FG003|Follow-up Period|Adverse Event|3|||
162234287|NCT04617275|585908355|FG004|Follow-up Period|Adverse Event|4|||
162234288|NCT04617275|585908356|FG005|Follow-up Period|Adverse Event|3|||
162234289|NCT04617275|585908357|FG006|Follow-up Period|Adverse Event|0|||
162234290|NCT04617275|585908358|FG007|Follow-up Period|Adverse Event|3|||
162234291|NCT04617275|585908351|FG000|Follow-up Period|Lost to Follow-up|0|||
162234292|NCT04617275|585908352|FG001|Follow-up Period|Lost to Follow-up|1|||
162234293|NCT04617275|585908353|FG002|Follow-up Period|Lost to Follow-up|2|||
162234294|NCT04617275|585908354|FG003|Follow-up Period|Lost to Follow-up|0|||
162234295|NCT04617275|585908355|FG004|Follow-up Period|Lost to Follow-up|0|||
162234296|NCT04617275|585908356|FG005|Follow-up Period|Lost to Follow-up|4|||
162234297|NCT04617275|585908357|FG006|Follow-up Period|Lost to Follow-up|0|||
162234298|NCT04617275|585908358|FG007|Follow-up Period|Lost to Follow-up|3|||
162234299|NCT04617275|585908351|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
162234300|NCT04617275|585908352|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
162234301|NCT04617275|585908353|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
162234302|NCT04617275|585908354|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
162234303|NCT04617275|585908355|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
162234304|NCT04617275|585908356|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
162234305|NCT04617275|585908357|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
162234306|NCT04617275|585908358|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
162234307|NCT04617275|585908351|FG000|Follow-up Period|Other|0|||
162234308|NCT04617275|585908352|FG001|Follow-up Period|Other|1|||
162234309|NCT04617275|585908353|FG002|Follow-up Period|Other|0|||
162234310|NCT04617275|585908354|FG003|Follow-up Period|Other|0|||
161680779|NCT03670953|583884319|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
161680780|NCT03670953|583884320|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
161680781|NCT03670953|583884321|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
161680782|NCT03670953|583884322|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
161680783|NCT03670953|583884319|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
161680784|NCT03670953|583884320|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
161680785|NCT03670953|583884321|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
161680786|NCT03670953|583884322|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
161941085|NCT03396445|584836061|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941086|NCT03396445|584836062|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941087|NCT03396445|584836063|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941088|NCT03396445|584836064|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
162234311|NCT04617275|585908355|FG004|Follow-up Period|Other|0|||
162234312|NCT04617275|585908356|FG005|Follow-up Period|Other|0|||
162234313|NCT04617275|585908357|FG006|Follow-up Period|Other|0|||
162234314|NCT04617275|585908358|FG007|Follow-up Period|Other|0|||
162234315|NCT04617275|585908351|FG000|Follow-up Period|Withdrawal by Subject|2|||
162234316|NCT04617275|585908352|FG001|Follow-up Period|Withdrawal by Subject|0|||
162234317|NCT04617275|585908353|FG002|Follow-up Period|Withdrawal by Subject|0|||
161941089|NCT03396445|584836065|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941090|NCT03396445|584836066|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941091|NCT03396445|584836067|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
162234318|NCT04617275|585908354|FG003|Follow-up Period|Withdrawal by Subject|2|||
162234319|NCT04617275|585908355|FG004|Follow-up Period|Withdrawal by Subject|2|||
162234320|NCT04617275|585908356|FG005|Follow-up Period|Withdrawal by Subject|0|||
162234321|NCT04617275|585908357|FG006|Follow-up Period|Withdrawal by Subject|1|||
162234322|NCT04617275|585908358|FG007|Follow-up Period|Withdrawal by Subject|2|||
162234323|NCT04227704|585908359|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
162234324|NCT04227704|585908360|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
161680787|NCT03670953|583884319|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
162234325|NCT04227704|585908361|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
162234326|NCT04227704|585908359|FG000|Overall Study|due to C/S being cancelled|1|||
162234327|NCT04227704|585908360|FG001|Overall Study|due to C/S being cancelled|0|||
162234328|NCT04227704|585908361|FG002|Overall Study|due to C/S being cancelled|0|||
162234329|NCT00729378|585910577|FG000|Baseline|Did not complete study measurements|72|||
162234330|NCT00729378|585910578|FG001|Baseline|Did not complete study measurements|33|||
162234331|NCT00729378|585910577|FG000|Baseline|Withdrawal by Subject|66|||
162234332|NCT00729378|585910578|FG001|Baseline|Withdrawal by Subject|59|||
162234333|NCT00729378|585910577|FG000|12-months|Lost to Follow-up|100|||
162234334|NCT00729378|585910578|FG001|12-months|Lost to Follow-up|65|||
162234335|NCT00729378|585910577|FG000|24-months|Lost to Follow-up|72|||
162234336|NCT00729378|585910578|FG001|24-months|Lost to Follow-up|51|||
162234337|NCT00729378|585910577|FG000|36-months|Lost to Follow-up|15|||
162234338|NCT00729378|585910578|FG001|36-months|Lost to Follow-up|6|||
162234339|NCT00484289|585910586|FG000|Long Term Phase|Adverse Event|1|||
162234340|NCT00484289|585910587|FG001|Long Term Phase|Adverse Event|17|||
162234341|NCT00484289|585910588|FG002|Long Term Phase|Adverse Event|5|||
162234342|NCT00484289|585910586|FG000|Long Term Phase|Withdrawal by Subject|0|||
162234343|NCT00484289|585910587|FG001|Long Term Phase|Withdrawal by Subject|7|||
162234344|NCT00484289|585910588|FG002|Long Term Phase|Withdrawal by Subject|6|||
162234345|NCT00484289|585910586|FG000|Long Term Phase|Inadequate response|2|||
162234346|NCT00484289|585910587|FG001|Long Term Phase|Inadequate response|7|||
162234347|NCT00484289|585910588|FG002|Long Term Phase|Inadequate response|4|||
162234348|NCT00484289|585910586|FG000|Long Term Phase|Other Reason|0|||
162234349|NCT00484289|585910587|FG001|Long Term Phase|Other Reason|5|||
162234350|NCT00484289|585910588|FG002|Long Term Phase|Other Reason|1|||
162234351|NCT00484289|585910586|FG000|Post Marketing Phase|Adverse Event|0|||
162234352|NCT00484289|585910587|FG001|Post Marketing Phase|Adverse Event|1|||
162234353|NCT00484289|585910588|FG002|Post Marketing Phase|Adverse Event|0|||
162234354|NCT00690443|585910589|FG000|Overall Study|Adverse Event|1|||
162234355|NCT00690443|585910590|FG001|Overall Study|Adverse Event|2|||
162234356|NCT02874924|585910593|FG000|Overall Study|Adverse Event|2|||
162234357|NCT02874924|585910594|FG001|Overall Study|Adverse Event|0|||
162234358|NCT02874924|585910595|FG002|Overall Study|Adverse Event|0|||
162234359|NCT02874924|585910593|FG000|Overall Study|Withdrawal by Subject|1|||
162234360|NCT02874924|585910594|FG001|Overall Study|Withdrawal by Subject|0|||
162234361|NCT02874924|585910595|FG002|Overall Study|Withdrawal by Subject|0|||
162234362|NCT02808143|585910596|FG000|Maintenance Phase|Disease recurrence|1|||
162234363|NCT02808143|585910597|FG001|Maintenance Phase|Disease recurrence|3|||
162234364|NCT02808143|585910596|FG000|Maintenance Phase|Disease progression|1|||
162234365|NCT02808143|585910597|FG001|Maintenance Phase|Disease progression|2|||
162234366|NCT02808143|585910596|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
162234367|NCT02808143|585910597|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
162234368|NCT02808143|585910596|FG000|Survival Follow-Up|Disease recurrence|0|||
162234369|NCT02808143|585910597|FG001|Survival Follow-Up|Disease recurrence|2|||
162234370|NCT02808143|585910596|FG000|Survival Follow-Up|Adverse Event|0|||
162234371|NCT02808143|585910597|FG001|Survival Follow-Up|Adverse Event|1|||
162234372|NCT02808143|585910596|FG000|Survival Follow-Up|Death|1|||
162234373|NCT02808143|585910597|FG001|Survival Follow-Up|Death|0|||
162234374|NCT01874431|585910598|FG000|Overall Study|Physician Decision|0|||
162234375|NCT01874431|585910599|FG001|Overall Study|Physician Decision|0|||
162234376|NCT01874431|585910600|FG002|Overall Study|Physician Decision|1|||
162234377|NCT01874431|585910601|FG003|Overall Study|Physician Decision|0|||
162234378|NCT01874431|585910602|FG004|Overall Study|Physician Decision|0|||
162234379|NCT01874431|585910603|FG005|Overall Study|Physician Decision|0|||
162234380|NCT01874431|585910604|FG006|Overall Study|Physician Decision|0|||
162234381|NCT01874431|585910605|FG007|Overall Study|Physician Decision|0|||
162234382|NCT01874431|585910598|FG000|Overall Study|Adverse Event|5|||
162234383|NCT01874431|585910599|FG001|Overall Study|Adverse Event|4|||
162234384|NCT01874431|585910600|FG002|Overall Study|Adverse Event|6|||
162234385|NCT01874431|585910601|FG003|Overall Study|Adverse Event|5|||
162234386|NCT01874431|585910602|FG004|Overall Study|Adverse Event|2|||
162234387|NCT01874431|585910603|FG005|Overall Study|Adverse Event|8|||
162234388|NCT01874431|585910604|FG006|Overall Study|Adverse Event|2|||
162234389|NCT01874431|585910605|FG007|Overall Study|Adverse Event|3|||
162234390|NCT01874431|585910598|FG000|Overall Study|Protocol Violation|1|||
162234391|NCT01874431|585910599|FG001|Overall Study|Protocol Violation|1|||
161830092|NCT02400476|584418110|FG000|Overall Study|Physician Decision|0|||
161830093|NCT02400476|584418111|FG001|Overall Study|Physician Decision|0|||
162234392|NCT01874431|585910600|FG002|Overall Study|Protocol Violation|1|||
162234393|NCT01874431|585910601|FG003|Overall Study|Protocol Violation|0|||
162234394|NCT01874431|585910602|FG004|Overall Study|Protocol Violation|3|||
162234395|NCT01874431|585910603|FG005|Overall Study|Protocol Violation|2|||
162234396|NCT01874431|585910604|FG006|Overall Study|Protocol Violation|1|||
162234397|NCT01874431|585910605|FG007|Overall Study|Protocol Violation|1|||
162234398|NCT01874431|585910598|FG000|Overall Study|Non-compliance|0|||
162234399|NCT01874431|585910599|FG001|Overall Study|Non-compliance|0|||
162234400|NCT01874431|585910600|FG002|Overall Study|Non-compliance|0|||
162234401|NCT01874431|585910601|FG003|Overall Study|Non-compliance|0|||
162234402|NCT01874431|585910602|FG004|Overall Study|Non-compliance|1|||
162234403|NCT01874431|585910603|FG005|Overall Study|Non-compliance|0|||
162234404|NCT01874431|585910604|FG006|Overall Study|Non-compliance|1|||
162234405|NCT01874431|585910605|FG007|Overall Study|Non-compliance|0|||
162234406|NCT01874431|585910598|FG000|Overall Study|Logistical difficulties|0|||
162234407|NCT01874431|585910599|FG001|Overall Study|Logistical difficulties|0|||
162234408|NCT01874431|585910600|FG002|Overall Study|Logistical difficulties|0|||
162234409|NCT01874431|585910601|FG003|Overall Study|Logistical difficulties|0|||
162234410|NCT01874431|585910602|FG004|Overall Study|Logistical difficulties|0|||
162234411|NCT01874431|585910603|FG005|Overall Study|Logistical difficulties|0|||
162234412|NCT01874431|585910604|FG006|Overall Study|Logistical difficulties|1|||
162234413|NCT01874431|585910605|FG007|Overall Study|Logistical difficulties|0|||
162234414|NCT01874431|585910598|FG000|Overall Study|Withdrawal by Subject|0|||
162234415|NCT01874431|585910599|FG001|Overall Study|Withdrawal by Subject|0|||
162234416|NCT01874431|585910600|FG002|Overall Study|Withdrawal by Subject|1|||
162234417|NCT01874431|585910601|FG003|Overall Study|Withdrawal by Subject|2|||
162234418|NCT01874431|585910602|FG004|Overall Study|Withdrawal by Subject|1|||
162234419|NCT01874431|585910603|FG005|Overall Study|Withdrawal by Subject|1|||
162234420|NCT01874431|585910604|FG006|Overall Study|Withdrawal by Subject|3|||
162234421|NCT01874431|585910605|FG007|Overall Study|Withdrawal by Subject|0|||
162234422|NCT01874431|585910598|FG000|Overall Study|Sponsor decision|0|||
162234423|NCT01874431|585910599|FG001|Overall Study|Sponsor decision|0|||
162234424|NCT01874431|585910600|FG002|Overall Study|Sponsor decision|0|||
162234425|NCT01874431|585910601|FG003|Overall Study|Sponsor decision|0|||
162234426|NCT01874431|585910602|FG004|Overall Study|Sponsor decision|1|||
162234427|NCT01874431|585910603|FG005|Overall Study|Sponsor decision|0|||
162234428|NCT01874431|585910604|FG006|Overall Study|Sponsor decision|0|||
162234429|NCT01874431|585910605|FG007|Overall Study|Sponsor decision|0|||
162234430|NCT01874431|585910598|FG000|Overall Study|Lost to Follow-up|0|||
162234431|NCT01874431|585910599|FG001|Overall Study|Lost to Follow-up|0|||
162234432|NCT01874431|585910600|FG002|Overall Study|Lost to Follow-up|1|||
162234433|NCT01874431|585910601|FG003|Overall Study|Lost to Follow-up|0|||
162234434|NCT01874431|585910602|FG004|Overall Study|Lost to Follow-up|0|||
162234435|NCT01874431|585910603|FG005|Overall Study|Lost to Follow-up|0|||
162234436|NCT01874431|585910604|FG006|Overall Study|Lost to Follow-up|0|||
162234437|NCT01874431|585910605|FG007|Overall Study|Lost to Follow-up|0|||
162234438|NCT03718533|585910607|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
162234439|NCT03718533|585910607|FG000|Overall Study|Protocol deviation|1|||
162234440|NCT03718533|585910607|FG000|Overall Study|Disease progression|1|||
162234441|NCT03718533|585910607|FG000|Overall Study|Relapse|1|||
162234442|NCT03718533|585910607|FG000|Overall Study|Physician Decision|2|||
162234443|NCT03718533|585910607|FG000|Overall Study|Physician Decision and Adverse Event|1|||
162234444|NCT02257567|585910608|FG000|Overall Study|Adverse Event|0|||
162234445|NCT02257567|585910609|FG001|Overall Study|Adverse Event|0|||
162234446|NCT02257567|585910610|FG002|Overall Study|Adverse Event|0|||
161830094|NCT02400476|584418112|FG002|Overall Study|Physician Decision|1|||
161830095|NCT02400476|584418113|FG003|Overall Study|Physician Decision|1|||
161830096|NCT02400476|584418114|FG004|Overall Study|Physician Decision|0|||
162234447|NCT02257567|585910611|FG003|Overall Study|Adverse Event|1|||
162234448|NCT02257567|585910612|FG004|Overall Study|Adverse Event|1|||
162234449|NCT02257567|585910613|FG005|Overall Study|Adverse Event|0|||
162234450|NCT02257567|585910614|FG006|Overall Study|Adverse Event|0|||
162234451|NCT02257567|585910615|FG007|Overall Study|Adverse Event|0|||
162234452|NCT02257567|585910616|FG008|Overall Study|Adverse Event|1|||
162234453|NCT02257567|585910617|FG009|Overall Study|Adverse Event|0|||
162234454|NCT02257567|585910618|FG010|Overall Study|Adverse Event|0|||
162234455|NCT02257567|585910608|FG000|Overall Study|Death|2|||
162234456|NCT02257567|585910609|FG001|Overall Study|Death|2|||
162234457|NCT02257567|585910610|FG002|Overall Study|Death|2|||
161830097|NCT02400476|584418115|FG005|Overall Study|Physician Decision|1|||
162234458|NCT02257567|585910611|FG003|Overall Study|Death|4|||
162234459|NCT02257567|585910612|FG004|Overall Study|Death|15|||
162234460|NCT02257567|585910613|FG005|Overall Study|Death|11|||
162234461|NCT02257567|585910614|FG006|Overall Study|Death|26|||
162234462|NCT02257567|585910615|FG007|Overall Study|Death|30|||
161830098|NCT02400476|584418110|FG000|Overall Study|Other, Disease Progression|0|||
162234463|NCT02257567|585910616|FG008|Overall Study|Death|2|||
162234464|NCT02257567|585910617|FG009|Overall Study|Death|18|||
161680788|NCT03670953|583884320|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
161680789|NCT03670953|583884321|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
161941092|NCT03396445|584836068|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
162234465|NCT02257567|585910618|FG010|Overall Study|Death|65|||
162234466|NCT02257567|585910608|FG000|Overall Study|Lost to Follow-up|0|||
162234467|NCT02257567|585910609|FG001|Overall Study|Lost to Follow-up|0|||
162234468|NCT02257567|585910610|FG002|Overall Study|Lost to Follow-up|0|||
162234469|NCT02257567|585910611|FG003|Overall Study|Lost to Follow-up|0|||
162234470|NCT02257567|585910612|FG004|Overall Study|Lost to Follow-up|2|||
162234471|NCT02257567|585910613|FG005|Overall Study|Lost to Follow-up|2|||
162234472|NCT02257567|585910614|FG006|Overall Study|Lost to Follow-up|0|||
162234473|NCT02257567|585910615|FG007|Overall Study|Lost to Follow-up|0|||
162234474|NCT02257567|585910616|FG008|Overall Study|Lost to Follow-up|0|||
162234475|NCT02257567|585910617|FG009|Overall Study|Lost to Follow-up|1|||
162234476|NCT02257567|585910618|FG010|Overall Study|Lost to Follow-up|1|||
162234477|NCT02257567|585910608|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162234478|NCT02257567|585910609|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162234479|NCT02257567|585910610|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162234480|NCT02257567|585910611|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162234481|NCT02257567|585910612|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
162234482|NCT02257567|585910613|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162234483|NCT02257567|585910614|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
162234484|NCT02257567|585910615|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162234485|NCT02257567|585910616|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162234486|NCT02257567|585910617|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162234487|NCT02257567|585910618|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
162234488|NCT02257567|585910608|FG000|Overall Study|Physician Decision|0|||
162234489|NCT02257567|585910609|FG001|Overall Study|Physician Decision|0|||
162234490|NCT02257567|585910610|FG002|Overall Study|Physician Decision|0|||
162234491|NCT02257567|585910611|FG003|Overall Study|Physician Decision|0|||
162234492|NCT02257567|585910612|FG004|Overall Study|Physician Decision|0|||
162234493|NCT02257567|585910613|FG005|Overall Study|Physician Decision|0|||
162234494|NCT02257567|585910614|FG006|Overall Study|Physician Decision|0|||
162025262|NCT00913458|585150716|FG004|Phase 2|Non-Responder|0|||
162025263|NCT00913458|585150717|FG005|Phase 2|Non-Responder|0|||
162025264|NCT00913458|585150718|FG006|Phase 2|Non-Responder|0|||
162025265|NCT00913458|585150712|FG000|Phase 2|Subject Request|0|||
162025266|NCT00913458|585150713|FG001|Phase 2|Subject Request|0|||
162025267|NCT00913458|585150714|FG002|Phase 2|Subject Request|1|||
162025268|NCT00913458|585150715|FG003|Phase 2|Subject Request|2|||
162025269|NCT00913458|585150716|FG004|Phase 2|Subject Request|0|||
162025270|NCT00913458|585150717|FG005|Phase 2|Subject Request|0|||
162025271|NCT00913458|585150718|FG006|Phase 2|Subject Request|0|||
162025272|NCT00913458|585150712|FG000|Phase 2|Adverse Event|0|||
162025273|NCT00913458|585150713|FG001|Phase 2|Adverse Event|3|||
162025274|NCT00913458|585150714|FG002|Phase 2|Adverse Event|0|||
162025275|NCT00913458|585150715|FG003|Phase 2|Adverse Event|1|||
162025276|NCT00913458|585150716|FG004|Phase 2|Adverse Event|0|||
162025277|NCT00913458|585150717|FG005|Phase 2|Adverse Event|0|||
162025278|NCT00913458|585150718|FG006|Phase 2|Adverse Event|0|||
162025279|NCT00913458|585150712|FG000|Phase 2|Lost to Follow-up|0|||
162025280|NCT00913458|585150713|FG001|Phase 2|Lost to Follow-up|0|||
162025281|NCT00913458|585150714|FG002|Phase 2|Lost to Follow-up|0|||
162025282|NCT00913458|585150715|FG003|Phase 2|Lost to Follow-up|1|||
162025283|NCT00913458|585150716|FG004|Phase 2|Lost to Follow-up|0|||
162025284|NCT00913458|585150717|FG005|Phase 2|Lost to Follow-up|0|||
162025285|NCT00913458|585150718|FG006|Phase 2|Lost to Follow-up|0|||
162025286|NCT00913458|585150712|FG000|Phase 2|Protocol Violation|0|||
162025287|NCT00913458|585150713|FG001|Phase 2|Protocol Violation|2|||
162025288|NCT00913458|585150714|FG002|Phase 2|Protocol Violation|0|||
162025289|NCT00913458|585150715|FG003|Phase 2|Protocol Violation|0|||
162025290|NCT00913458|585150716|FG004|Phase 2|Protocol Violation|0|||
162025291|NCT00913458|585150717|FG005|Phase 2|Protocol Violation|0|||
162025292|NCT00913458|585150718|FG006|Phase 2|Protocol Violation|0|||
162025293|NCT00913458|585150712|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
162025294|NCT00913458|585150713|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
162025295|NCT00913458|585150714|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
162025296|NCT00913458|585150715|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
162025297|NCT00913458|585150716|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
162025298|NCT00913458|585150717|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
162025299|NCT00913458|585150718|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
162025300|NCT00913458|585150712|FG000|Phase 3|Adverse Event|0|||
162025301|NCT00913458|585150713|FG001|Phase 3|Adverse Event|0|||
162025302|NCT00913458|585150714|FG002|Phase 3|Adverse Event|0|||
162025303|NCT00913458|585150715|FG003|Phase 3|Adverse Event|0|||
162025304|NCT00913458|585150716|FG004|Phase 3|Adverse Event|5|||
162025305|NCT00913458|585150717|FG005|Phase 3|Adverse Event|4|||
162025306|NCT00913458|585150718|FG006|Phase 3|Adverse Event|1|||
162025307|NCT00913458|585150712|FG000|Phase 3|Lost to Follow-up|0|||
162025308|NCT00913458|585150713|FG001|Phase 3|Lost to Follow-up|0|||
162025309|NCT00913458|585150714|FG002|Phase 3|Lost to Follow-up|0|||
162234495|NCT02257567|585910615|FG007|Overall Study|Physician Decision|2|||
162234496|NCT02257567|585910616|FG008|Overall Study|Physician Decision|0|||
162234497|NCT02257567|585910617|FG009|Overall Study|Physician Decision|1|||
162234498|NCT02257567|585910618|FG010|Overall Study|Physician Decision|0|||
162234499|NCT02257567|585910608|FG000|Overall Study|Withdrawal by Subject|0|||
162234500|NCT02257567|585910609|FG001|Overall Study|Withdrawal by Subject|0|||
162234501|NCT02257567|585910610|FG002|Overall Study|Withdrawal by Subject|2|||
162025310|NCT00913458|585150715|FG003|Phase 3|Lost to Follow-up|0|||
162025311|NCT00913458|585150716|FG004|Phase 3|Lost to Follow-up|2|||
162025312|NCT00913458|585150717|FG005|Phase 3|Lost to Follow-up|0|||
162025313|NCT00913458|585150718|FG006|Phase 3|Lost to Follow-up|0|||
162025314|NCT00913458|585150712|FG000|Phase 3|Non-Responder|0|||
162025315|NCT00913458|585150713|FG001|Phase 3|Non-Responder|0|||
162025316|NCT00913458|585150714|FG002|Phase 3|Non-Responder|0|||
162025317|NCT00913458|585150715|FG003|Phase 3|Non-Responder|0|||
162025318|NCT00913458|585150716|FG004|Phase 3|Non-Responder|0|||
162025319|NCT00913458|585150717|FG005|Phase 3|Non-Responder|1|||
162025320|NCT00913458|585150718|FG006|Phase 3|Non-Responder|3|||
162025321|NCT00913458|585150712|FG000|Phase 3|Withdrawal by Subject|0|||
162025322|NCT00913458|585150713|FG001|Phase 3|Withdrawal by Subject|0|||
162025323|NCT00913458|585150714|FG002|Phase 3|Withdrawal by Subject|0|||
162234502|NCT02257567|585910611|FG003|Overall Study|Withdrawal by Subject|0|||
162025324|NCT00913458|585150715|FG003|Phase 3|Withdrawal by Subject|0|||
162234503|NCT02257567|585910612|FG004|Overall Study|Withdrawal by Subject|0|||
162234504|NCT02257567|585910613|FG005|Overall Study|Withdrawal by Subject|6|||
162025325|NCT00913458|585150716|FG004|Phase 3|Withdrawal by Subject|1|||
162025326|NCT00913458|585150717|FG005|Phase 3|Withdrawal by Subject|2|||
162025327|NCT00913458|585150718|FG006|Phase 3|Withdrawal by Subject|0|||
162025328|NCT00913458|585150712|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
162025329|NCT00913458|585150713|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
162234505|NCT02257567|585910614|FG006|Overall Study|Withdrawal by Subject|6|||
162234506|NCT02257567|585910615|FG007|Overall Study|Withdrawal by Subject|6|||
162234507|NCT02257567|585910616|FG008|Overall Study|Withdrawal by Subject|1|||
162234508|NCT02257567|585910617|FG009|Overall Study|Withdrawal by Subject|1|||
162234509|NCT02257567|585910618|FG010|Overall Study|Withdrawal by Subject|10|||
162234510|NCT00946101|585910619|FG000|Overall Study|Lost to Follow-up|2|||
162234511|NCT00946101|585910620|FG001|Overall Study|Lost to Follow-up|1|||
162234512|NCT00946101|585910619|FG000|Overall Study|Withdrawal of consent|2|||
162234513|NCT00946101|585910620|FG001|Overall Study|Withdrawal of consent|0|||
162234514|NCT00946101|585910619|FG000|Overall Study|Physician Decision|0|||
162234515|NCT00946101|585910620|FG001|Overall Study|Physician Decision|1|||
162234516|NCT01590017|585910621|FG000|Overall Study|Adverse Event|1|||
162234517|NCT01590017|585910621|FG000|Overall Study|Withdrawal by Subject|1|||
162234518|NCT01590017|585910621|FG000|Overall Study|Lack of Efficacy|1|||
162234519|NCT01590017|585910621|FG000|Overall Study|Physician Decision|1|||
162234520|NCT03625895|585910622|FG000|Overall Study|Protocol Violation|585|||
162234521|NCT03256851|585910623|FG000|Overall Study|Withdrawal by Subject|1|||
162234522|NCT03256851|585910624|FG001|Overall Study|Withdrawal by Subject|0|||
162234523|NCT02081417|585910625|FG000|Overall Study|Lost to Follow-up|26|||
162234524|NCT02081417|585910626|FG001|Overall Study|Lost to Follow-up|23|||
162234525|NCT02081417|585910625|FG000|Overall Study|Moved Away|1|||
162234526|NCT02081417|585910626|FG001|Overall Study|Moved Away|2|||
162234527|NCT02081417|585910625|FG000|Overall Study|Incarcerated|2|||
162234528|NCT02081417|585910626|FG001|Overall Study|Incarcerated|2|||
162234529|NCT02081417|585910625|FG000|Overall Study|Death|4|||
162234530|NCT02081417|585910626|FG001|Overall Study|Death|3|||
162234531|NCT02081417|585910625|FG000|Overall Study|Withdrawal by Subject|4|||
162234532|NCT02081417|585910626|FG001|Overall Study|Withdrawal by Subject|0|||
162234533|NCT02081417|585910625|FG000|Overall Study|Admitted to Residential Treatment|2|||
162234534|NCT02081417|585910626|FG001|Overall Study|Admitted to Residential Treatment|0|||
162234535|NCT02081417|585910625|FG000|Overall Study|Did not start treatment|17|||
162234536|NCT02081417|585910626|FG001|Overall Study|Did not start treatment|21|||
162234537|NCT01065844|585910627|FG000|Overall Study|Adverse Event|5|||
162234538|NCT00752557|585910634|FG000|Overall Study|Withdrawal by Subject|4|||
162234539|NCT00752557|585910635|FG001|Overall Study|Withdrawal by Subject|3|||
162234540|NCT00752557|585910636|FG002|Overall Study|Withdrawal by Subject|3|||
162234541|NCT00752557|585910634|FG000|Overall Study|Unspecified resaons|0|||
162234542|NCT00752557|585910635|FG001|Overall Study|Unspecified resaons|2|||
162234543|NCT00752557|585910636|FG002|Overall Study|Unspecified resaons|2|||
162234544|NCT00752557|585910634|FG000|Overall Study|Lost to Follow-up|1|||
162234545|NCT00752557|585910635|FG001|Overall Study|Lost to Follow-up|0|||
161941093|NCT03396445|584836069|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941094|NCT03396445|584836070|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941095|NCT03396445|584836071|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
161941096|NCT03396445|584836072|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941097|NCT03396445|584836073|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
161941098|NCT03396445|584836074|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941099|NCT03396445|584836075|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941100|NCT03396445|584836076|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941101|NCT03396445|584836077|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941102|NCT03396445|584836078|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941103|NCT03396445|584836079|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941104|NCT03396445|584836080|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941105|NCT03396445|584836081|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941106|NCT03396445|584836082|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941107|NCT03396445|584836083|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941108|NCT03396445|584836084|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
161941109|NCT03396445|584836059|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
161941110|NCT03396445|584836060|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
162234546|NCT00752557|585910636|FG002|Overall Study|Lost to Follow-up|1|||
162234547|NCT02150343|585910637|FG000|Overall Study|Adverse Event|2|||
162234548|NCT02150343|585910638|FG001|Overall Study|Adverse Event|0|||
162234549|NCT02150343|585910639|FG002|Overall Study|Adverse Event|1|||
162234550|NCT02150343|585910640|FG003|Overall Study|Adverse Event|1|||
162234551|NCT02150343|585910637|FG000|Overall Study|Withdrawal by Subject|13|||
162234552|NCT02150343|585910638|FG001|Overall Study|Withdrawal by Subject|10|||
162234553|NCT02150343|585910639|FG002|Overall Study|Withdrawal by Subject|9|||
162234554|NCT02150343|585910640|FG003|Overall Study|Withdrawal by Subject|4|||
162234555|NCT02150343|585910637|FG000|Overall Study|Lost to Follow-up|4|||
161680790|NCT03670953|583884322|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
161680791|NCT03670953|583884319|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
161680792|NCT03670953|583884320|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
161680793|NCT03670953|583884321|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
161680794|NCT03670953|583884322|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
161680795|NCT03670953|583884319|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
161680796|NCT03670953|583884320|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
161680797|NCT03670953|583884321|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
161680798|NCT03670953|583884322|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
161680799|NCT03670953|583884319|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
161680800|NCT03670953|583884320|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
161680801|NCT03670953|583884321|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
161680802|NCT03670953|583884322|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
161680803|NCT03670953|583884319|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
161680804|NCT03670953|583884320|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
161680805|NCT03670953|583884321|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
161680806|NCT03670953|583884322|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
161680807|NCT00937937|583884323|FG000|Overall Study|Adverse Event|6|||
161680808|NCT00937937|583884323|FG000|Overall Study|Withdrawal by Subject|2|||
161680809|NCT00937937|583884323|FG000|Overall Study|Progression/relapse|61|||
161680810|NCT00937937|583884323|FG000|Overall Study|Death|1|||
161680811|NCT00937937|583884323|FG000|Overall Study|Other|2|||
161680812|NCT00362414|583884326|FG000|Overall Study|Death|2|||
161680813|NCT00362414|583884326|FG000|Overall Study|Adverse Event|1|||
161680814|NCT01365039|583884331|FG000|Overall Study|Study related symptoms and complaints|1|||
161680815|NCT01365039|583884332|FG001|Overall Study|Study related symptoms and complaints|0|||
161680816|NCT00549939|583884339|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
161680817|NCT00549939|583884340|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
161680818|NCT00549939|583884341|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
161680819|NCT00549939|583884339|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
161680820|NCT00549939|583884340|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
161680821|NCT00549939|583884341|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
161680822|NCT00549939|583884339|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
161680823|NCT00549939|583884340|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
161680824|NCT00549939|583884341|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
161680825|NCT00549939|583884339|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
161680826|NCT00549939|583884340|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
161680827|NCT00549939|583884341|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
161680828|NCT00549939|583884339|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
161680829|NCT00549939|583884340|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
161680830|NCT00549939|583884341|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
161680831|NCT00549939|583884339|FG000|40-week Open Label Treatment Period|Other|0|||
161680832|NCT00549939|583884340|FG001|40-week Open Label Treatment Period|Other|1|||
161680833|NCT00549939|583884341|FG002|40-week Open Label Treatment Period|Other|4|||
161680834|NCT03677596|583884342|FG000|Overall Study|Adverse Event|0|||
161680835|NCT03677596|583884343|FG001|Overall Study|Adverse Event|1|||
161680836|NCT03677596|583884342|FG000|Overall Study|Death|10|||
161680837|NCT03677596|583884343|FG001|Overall Study|Death|6|||
161680838|NCT03677596|583884342|FG000|Overall Study|Lost to Follow-up|0|||
161680839|NCT03677596|583884343|FG001|Overall Study|Lost to Follow-up|1|||
161680840|NCT03677596|583884342|FG000|Overall Study|Progressive Disease|8|||
161680841|NCT03677596|583884343|FG001|Overall Study|Progressive Disease|8|||
161680842|NCT03677596|583884342|FG000|Overall Study|Withdrawal by Subject|3|||
161680843|NCT03677596|583884343|FG001|Overall Study|Withdrawal by Subject|0|||
161680844|NCT03677596|583884342|FG000|Overall Study|Disease Relapse|2|||
161680845|NCT03677596|583884343|FG001|Overall Study|Disease Relapse|2|||
161680846|NCT03677596|583884342|FG000|Overall Study|Other|0|||
161680847|NCT03677596|583884343|FG001|Overall Study|Other|1|||
161680848|NCT01911442|583884344|FG000|Overall Study|Adverse Event|2|||
161680849|NCT01911442|583884345|FG001|Overall Study|Adverse Event|2|||
161680850|NCT01911442|583884346|FG002|Overall Study|Adverse Event|4|||
161830099|NCT02400476|584418111|FG001|Overall Study|Other, Disease Progression|1|||
161680851|NCT01911442|583884344|FG000|Overall Study|Lack of Efficacy|1|||
161680852|NCT01911442|583884345|FG001|Overall Study|Lack of Efficacy|1|||
161830100|NCT02400476|584418112|FG002|Overall Study|Other, Disease Progression|2|||
161830101|NCT02400476|584418113|FG003|Overall Study|Other, Disease Progression|1|||
161680853|NCT01911442|583884346|FG002|Overall Study|Lack of Efficacy|1|||
161680854|NCT01911442|583884344|FG000|Overall Study|Lost to Follow-up|2|||
161680855|NCT01911442|583884345|FG001|Overall Study|Lost to Follow-up|0|||
161680856|NCT01911442|583884346|FG002|Overall Study|Lost to Follow-up|1|||
161680857|NCT01911442|583884344|FG000|Overall Study|Withdrawal by Subject|1|||
161830102|NCT02400476|584418114|FG004|Overall Study|Other, Disease Progression|2|||
161680858|NCT01911442|583884345|FG001|Overall Study|Withdrawal by Subject|0|||
161680859|NCT01911442|583884346|FG002|Overall Study|Withdrawal by Subject|6|||
161680860|NCT01911442|583884344|FG000|Overall Study|Mother's Work Schedule|0|||
161680861|NCT01911442|583884345|FG001|Overall Study|Mother's Work Schedule|1|||
161680862|NCT01911442|583884346|FG002|Overall Study|Mother's Work Schedule|0|||
161680863|NCT00424749|583884350|FG000|Overall Study|Withdrawal by Subject|1|||
161680864|NCT01022502|583884355|FG000|Overall Study|Adverse Event|1|||
161680865|NCT01022502|583884355|FG000|Overall Study|employment related reasons|1|||
161680866|NCT01022502|583884355|FG000|Overall Study|Withdrawal by Subject|1|||
161680867|NCT00073528|583884365|FG000|Overall Study|Death|488|||
161680868|NCT00073528|583884366|FG001|Overall Study|Death|473|||
161680869|NCT00073528|583884365|FG000|Overall Study|Lost to Follow-up|52|||
161680870|NCT00073528|583884366|FG001|Overall Study|Lost to Follow-up|45|||
161680871|NCT00073528|583884365|FG000|Overall Study|Withdrawal by Subject|50|||
161680872|NCT00073528|583884366|FG001|Overall Study|Withdrawal by Subject|45|||
161680873|NCT00073528|583884365|FG000|Overall Study|Study terminated by Sponsor|10|||
161680874|NCT00073528|583884366|FG001|Overall Study|Study terminated by Sponsor|29|||
161680875|NCT00073528|583884365|FG000|Overall Study|Other|18|||
161680876|NCT00073528|583884366|FG001|Overall Study|Other|19|||
161680877|NCT00073528|583884365|FG000|Overall Study|Other|9|||
161680878|NCT00073528|583884366|FG001|Overall Study|Other|12|||
161680879|NCT00073528|583884365|FG000|Overall Study|Protocol Violation|3|||
161680880|NCT00073528|583884366|FG001|Overall Study|Protocol Violation|5|||
161680881|NCT03199040|583884369|FG000|Overall Study|Lack of Efficacy|2|||
161680882|NCT03199040|583884370|FG001|Overall Study|Lack of Efficacy|0|||
161680883|NCT03199040|583884369|FG000|Overall Study|Withdrawal by Subject|2|||
161680884|NCT03199040|583884370|FG001|Overall Study|Withdrawal by Subject|0|||
161680885|NCT03199040|583884369|FG000|Overall Study|Adverse Event|0|||
161680886|NCT03199040|583884370|FG001|Overall Study|Adverse Event|1|||
161680887|NCT03199040|583884369|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
161680888|NCT03199040|583884370|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
161680889|NCT01786603|583884371|FG000|Overall Study|Death|5|||
161680890|NCT01786603|583884372|FG001|Overall Study|Death|1|||
161680891|NCT01786603|583884371|FG000|Overall Study|Adverse Event|6|||
161680892|NCT01786603|583884372|FG001|Overall Study|Adverse Event|2|||
161680893|NCT01786603|583884371|FG000|Overall Study|Physician decision to withdraw|6|||
161680894|NCT01786603|583884372|FG001|Overall Study|Physician decision to withdraw|7|||
161680895|NCT01786603|583884371|FG000|Overall Study|Lost to Follow-up|1|||
161680896|NCT01786603|583884372|FG001|Overall Study|Lost to Follow-up|2|||
161680897|NCT01226459|583884373|FG000|Overall Study|Adverse Event|2|||
161680898|NCT01226459|583884374|FG001|Overall Study|Adverse Event|8|||
161680899|NCT01226459|583884373|FG000|Overall Study|Protocol Violation|4|||
161680900|NCT01226459|583884374|FG001|Overall Study|Protocol Violation|3|||
161680901|NCT01226459|583884373|FG000|Overall Study|Withdrawal by Subject|10|||
161680902|NCT01226459|583884374|FG001|Overall Study|Withdrawal by Subject|13|||
161680903|NCT01226459|583884373|FG000|Overall Study|Lost to Follow-up|4|||
161680904|NCT01226459|583884374|FG001|Overall Study|Lost to Follow-up|8|||
161680905|NCT01226459|583884373|FG000|Overall Study|Pregnancy|1|||
161680906|NCT01226459|583884374|FG001|Overall Study|Pregnancy|0|||
161680907|NCT01092143|583884382|FG000|Overall Study|Adverse Event|10|||
161680908|NCT01092143|583884383|FG001|Overall Study|Adverse Event|5|||
161680909|NCT01092143|583884384|FG002|Overall Study|Adverse Event|1|||
161680910|NCT01092143|583884385|FG003|Overall Study|Adverse Event|4|||
161680911|NCT01092143|583884386|FG004|Overall Study|Adverse Event|3|||
161680912|NCT01092143|583884382|FG000|Overall Study|Lost to Follow-up|1|||
161680913|NCT01092143|583884383|FG001|Overall Study|Lost to Follow-up|0|||
161680914|NCT01092143|583884384|FG002|Overall Study|Lost to Follow-up|1|||
161680915|NCT01092143|583884385|FG003|Overall Study|Lost to Follow-up|0|||
161680916|NCT01092143|583884386|FG004|Overall Study|Lost to Follow-up|0|||
161680917|NCT01092143|583884382|FG000|Overall Study|Consent withdrawn|2|||
161680918|NCT01092143|583884383|FG001|Overall Study|Consent withdrawn|1|||
161680919|NCT01092143|583884384|FG002|Overall Study|Consent withdrawn|0|||
161680920|NCT01092143|583884385|FG003|Overall Study|Consent withdrawn|1|||
161680921|NCT01092143|583884386|FG004|Overall Study|Consent withdrawn|3|||
161680922|NCT01092143|583884382|FG000|Overall Study|Not treated|0|||
161830103|NCT02400476|584418115|FG005|Overall Study|Other, Disease Progression|1|||
161680923|NCT01092143|583884383|FG001|Overall Study|Not treated|0|||
161680924|NCT01092143|583884384|FG002|Overall Study|Not treated|1|||
161680925|NCT01092143|583884385|FG003|Overall Study|Not treated|0|||
161680926|NCT01092143|583884386|FG004|Overall Study|Not treated|0|||
161680927|NCT01092143|583884382|FG000|Overall Study|did not reversibility criteria|0|||
161830104|NCT02400476|584418110|FG000|Overall Study|Other, Decreased Quality of Life|0|||
161830105|NCT02400476|584418111|FG001|Overall Study|Other, Decreased Quality of Life|0|||
161680928|NCT01092143|583884383|FG001|Overall Study|did not reversibility criteria|0|||
161680929|NCT01092143|583884384|FG002|Overall Study|did not reversibility criteria|1|||
161680930|NCT01092143|583884385|FG003|Overall Study|did not reversibility criteria|0|||
161680931|NCT01092143|583884386|FG004|Overall Study|did not reversibility criteria|0|||
161680932|NCT01092143|583884382|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
161680933|NCT01092143|583884383|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
161680934|NCT01092143|583884384|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
161680935|NCT01092143|583884385|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
161680936|NCT01092143|583884386|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
161680937|NCT01092143|583884382|FG000|Overall Study|Ineligible patient|1|||
161680938|NCT01092143|583884383|FG001|Overall Study|Ineligible patient|0|||
161680939|NCT01092143|583884384|FG002|Overall Study|Ineligible patient|0|||
161680940|NCT01092143|583884385|FG003|Overall Study|Ineligible patient|0|||
161680941|NCT01092143|583884386|FG004|Overall Study|Ineligible patient|0|||
161680942|NCT01092143|583884382|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
161680943|NCT01092143|583884383|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
161680944|NCT01092143|583884384|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
161680945|NCT01092143|583884385|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
161680946|NCT01092143|583884386|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
161680947|NCT01092143|583884382|FG000|Overall Study|Patient travel|0|||
161680948|NCT01092143|583884383|FG001|Overall Study|Patient travel|0|||
161680949|NCT01092143|583884384|FG002|Overall Study|Patient travel|0|||
162234556|NCT02150343|585910638|FG001|Overall Study|Lost to Follow-up|4|||
162234557|NCT02150343|585910639|FG002|Overall Study|Lost to Follow-up|2|||
162234558|NCT02150343|585910640|FG003|Overall Study|Lost to Follow-up|3|||
162234559|NCT02150343|585910637|FG000|Overall Study|Other|2|||
161680950|NCT01092143|583884385|FG003|Overall Study|Patient travel|0|||
161680951|NCT01092143|583884386|FG004|Overall Study|Patient travel|1|||
162234560|NCT02150343|585910638|FG001|Overall Study|Other|6|||
162234561|NCT02150343|585910639|FG002|Overall Study|Other|0|||
161680952|NCT01092143|583884382|FG000|Overall Study|Non compliance with study medication|0|||
161680953|NCT01092143|583884383|FG001|Overall Study|Non compliance with study medication|0|||
161680954|NCT01092143|583884384|FG002|Overall Study|Non compliance with study medication|0|||
161680955|NCT01092143|583884385|FG003|Overall Study|Non compliance with study medication|0|||
161680956|NCT01092143|583884386|FG004|Overall Study|Non compliance with study medication|1|||
161680957|NCT01092143|583884382|FG000|Overall Study|Randomized by mistake|0|||
161680958|NCT01092143|583884383|FG001|Overall Study|Randomized by mistake|0|||
161680959|NCT01092143|583884384|FG002|Overall Study|Randomized by mistake|0|||
161680960|NCT01092143|583884385|FG003|Overall Study|Randomized by mistake|1|||
161680961|NCT01092143|583884386|FG004|Overall Study|Randomized by mistake|0|||
161680962|NCT01092143|583884382|FG000|Overall Study|Pregnancy|0|||
161680963|NCT01092143|583884383|FG001|Overall Study|Pregnancy|0|||
161680964|NCT01092143|583884384|FG002|Overall Study|Pregnancy|0|||
161680965|NCT01092143|583884385|FG003|Overall Study|Pregnancy|1|||
161680966|NCT01092143|583884386|FG004|Overall Study|Pregnancy|0|||
161680967|NCT01854645|583884390|FG000|Overall Study|Protocol-Specified Criteria|13|||
161680968|NCT01854645|583884391|FG001|Overall Study|Protocol-Specified Criteria|10|||
161680969|NCT01854645|583884392|FG002|Overall Study|Protocol-Specified Criteria|8|||
161680970|NCT01854645|583884393|FG003|Overall Study|Protocol-Specified Criteria|5|||
161680971|NCT01854645|583884394|FG004|Overall Study|Protocol-Specified Criteria|7|||
161680972|NCT01854645|583884390|FG000|Overall Study|Administrative Reasons / Missing|0|||
161680973|NCT01854645|583884391|FG001|Overall Study|Administrative Reasons / Missing|0|||
161680974|NCT01854645|583884392|FG002|Overall Study|Administrative Reasons / Missing|0|||
161680975|NCT01854645|583884393|FG003|Overall Study|Administrative Reasons / Missing|1|||
161680976|NCT01854645|583884394|FG004|Overall Study|Administrative Reasons / Missing|1|||
161680977|NCT01854645|583884390|FG000|Overall Study|Protocol Violation|3|||
161680978|NCT01854645|583884391|FG001|Overall Study|Protocol Violation|0|||
161680979|NCT01854645|583884392|FG002|Overall Study|Protocol Violation|5|||
161680980|NCT01854645|583884393|FG003|Overall Study|Protocol Violation|4|||
161680981|NCT01854645|583884394|FG004|Overall Study|Protocol Violation|1|||
161680982|NCT01854645|583884390|FG000|Overall Study|Lost to Follow-up|10|||
161680983|NCT01854645|583884391|FG001|Overall Study|Lost to Follow-up|7|||
161680984|NCT01854645|583884392|FG002|Overall Study|Lost to Follow-up|8|||
161680985|NCT01854645|583884393|FG003|Overall Study|Lost to Follow-up|5|||
161680986|NCT01854645|583884394|FG004|Overall Study|Lost to Follow-up|0|||
161680987|NCT01854645|583884390|FG000|Overall Study|Physician Decision|1|||
161680988|NCT01854645|583884391|FG001|Overall Study|Physician Decision|5|||
161680989|NCT01854645|583884392|FG002|Overall Study|Physician Decision|3|||
161680990|NCT01854645|583884393|FG003|Overall Study|Physician Decision|3|||
161680991|NCT01854645|583884394|FG004|Overall Study|Physician Decision|7|||
161680992|NCT01854645|583884390|FG000|Overall Study|Withdrawal by Subject|31|||
161680993|NCT01854645|583884391|FG001|Overall Study|Withdrawal by Subject|41|||
161680994|NCT01854645|583884392|FG002|Overall Study|Withdrawal by Subject|30|||
161680995|NCT01854645|583884393|FG003|Overall Study|Withdrawal by Subject|21|||
161680996|NCT01854645|583884394|FG004|Overall Study|Withdrawal by Subject|24|||
161680997|NCT01854645|583884390|FG000|Overall Study|Lack of Efficacy|7|||
161680998|NCT01854645|583884391|FG001|Overall Study|Lack of Efficacy|12|||
161680999|NCT01854645|583884392|FG002|Overall Study|Lack of Efficacy|9|||
161681000|NCT01854645|583884393|FG003|Overall Study|Lack of Efficacy|3|||
161681001|NCT01854645|583884394|FG004|Overall Study|Lack of Efficacy|9|||
161681002|NCT01854645|583884390|FG000|Overall Study|Adverse Event|33|||
161681003|NCT01854645|583884391|FG001|Overall Study|Adverse Event|31|||
162234562|NCT02150343|585910640|FG003|Overall Study|Other|2|||
162234563|NCT02891408|585910641|FG000|Overall Study|Lost to Follow-up|0|||
162025330|NCT00913458|585150714|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
162234564|NCT02891408|585910642|FG001|Overall Study|Lost to Follow-up|0|||
162025331|NCT00913458|585150715|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
162234565|NCT02891408|585910643|FG002|Overall Study|Lost to Follow-up|1|||
162234566|NCT02891408|585910644|FG003|Overall Study|Lost to Follow-up|0|||
162234567|NCT02891408|585910645|FG004|Overall Study|Lost to Follow-up|0|||
162234568|NCT02891408|585910646|FG005|Overall Study|Lost to Follow-up|0|||
162234569|NCT02891408|585910647|FG006|Overall Study|Lost to Follow-up|0|||
162234570|NCT05249829|585910648|FG000|Overall Study|Participant Relocation|0|||
162234571|NCT05249829|585910649|FG001|Overall Study|Participant Relocation|1|||
162234572|NCT05249829|585910650|FG002|Overall Study|Participant Relocation|2|||
162234573|NCT05249829|585910651|FG003|Overall Study|Participant Relocation|2|||
162234574|NCT05249829|585910648|FG000|Overall Study|Withdrawal by Subject|9|||
162234575|NCT05249829|585910649|FG001|Overall Study|Withdrawal by Subject|17|||
162234576|NCT05249829|585910650|FG002|Overall Study|Withdrawal by Subject|40|||
162234577|NCT05249829|585910651|FG003|Overall Study|Withdrawal by Subject|35|||
162234578|NCT05249829|585910648|FG000|Overall Study|Physician Decision|1|||
162234579|NCT05249829|585910649|FG001|Overall Study|Physician Decision|0|||
162234580|NCT05249829|585910650|FG002|Overall Study|Physician Decision|0|||
162234581|NCT05249829|585910651|FG003|Overall Study|Physician Decision|0|||
162234582|NCT05249829|585910648|FG000|Overall Study|Lost to Follow-up|16|||
162234583|NCT05249829|585910649|FG001|Overall Study|Lost to Follow-up|16|||
162234584|NCT05249829|585910650|FG002|Overall Study|Lost to Follow-up|57|||
162234585|NCT05249829|585910651|FG003|Overall Study|Lost to Follow-up|60|||
162234586|NCT05249829|585910648|FG000|Overall Study|Adverse Event|2|||
162234587|NCT05249829|585910649|FG001|Overall Study|Adverse Event|2|||
162234588|NCT05249829|585910650|FG002|Overall Study|Adverse Event|2|||
162234589|NCT05249829|585910651|FG003|Overall Study|Adverse Event|2|||
162234590|NCT05249829|585910648|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
162234591|NCT05249829|585910649|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
162234592|NCT05249829|585910650|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
162234593|NCT05249829|585910651|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
162234594|NCT05249829|585910648|FG000|Overall Study|Protocol Violation|2|||
162234595|NCT05249829|585910649|FG001|Overall Study|Protocol Violation|0|||
162234596|NCT05249829|585910650|FG002|Overall Study|Protocol Violation|5|||
162234597|NCT05249829|585910651|FG003|Overall Study|Protocol Violation|3|||
162234598|NCT05249829|585910648|FG000|Overall Study|Death|0|||
162234599|NCT05249829|585910649|FG001|Overall Study|Death|1|||
162234600|NCT05249829|585910650|FG002|Overall Study|Death|2|||
162234601|NCT05249829|585910651|FG003|Overall Study|Death|4|||
162234602|NCT00196976|585910652|FG000|Primary Study|Migrated from study area|0|||
162234603|NCT00196976|585910653|FG001|Primary Study|Migrated from study area|0|||
162234604|NCT00196976|585910654|FG002|Primary Study|Migrated from study area|0|||
162234605|NCT00196976|585910655|FG003|Primary Study|Migrated from study area|0|||
162234606|NCT00196976|585910656|FG004|Primary Study|Migrated from study area|0|||
162234607|NCT00196976|585910657|FG005|Primary Study|Migrated from study area|0|||
162234608|NCT00196976|585910658|FG006|Primary Study|Migrated from study area|0|||
162234609|NCT00196976|585910659|FG007|Primary Study|Migrated from study area|1|||
162234610|NCT00196976|585910660|FG008|Primary Study|Migrated from study area|0|||
162234611|NCT00196976|585910661|FG009|Primary Study|Migrated from study area|0|||
162234612|NCT00196976|585910662|FG010|Primary Study|Migrated from study area|0|||
162234613|NCT00196976|585910663|FG011|Primary Study|Migrated from study area|0|||
162234614|NCT00196976|585910664|FG012|Primary Study|Migrated from study area|0|||
162234615|NCT00196976|585910665|FG013|Primary Study|Migrated from study area|0|||
162234616|NCT00196976|585910652|FG000|Primary Study|Protocol Violation|0|||
162234617|NCT00196976|585910653|FG001|Primary Study|Protocol Violation|1|||
162234618|NCT00196976|585910654|FG002|Primary Study|Protocol Violation|1|||
162234619|NCT00196976|585910655|FG003|Primary Study|Protocol Violation|0|||
162234620|NCT00196976|585910656|FG004|Primary Study|Protocol Violation|0|||
162234621|NCT00196976|585910657|FG005|Primary Study|Protocol Violation|0|||
162234622|NCT00196976|585910658|FG006|Primary Study|Protocol Violation|0|||
162234623|NCT00196976|585910659|FG007|Primary Study|Protocol Violation|0|||
162234624|NCT00196976|585910660|FG008|Primary Study|Protocol Violation|0|||
162234625|NCT00196976|585910661|FG009|Primary Study|Protocol Violation|0|||
162234626|NCT00196976|585910662|FG010|Primary Study|Protocol Violation|0|||
162234627|NCT00196976|585910663|FG011|Primary Study|Protocol Violation|0|||
161830106|NCT02400476|584418112|FG002|Overall Study|Other, Decreased Quality of Life|2|||
161830107|NCT02400476|584418113|FG003|Overall Study|Other, Decreased Quality of Life|0|||
162234628|NCT00196976|585910664|FG012|Primary Study|Protocol Violation|0|||
162234629|NCT00196976|585910665|FG013|Primary Study|Protocol Violation|0|||
162234630|NCT00196976|585910652|FG000|Primary Study|Withdrawal by Subject|1|||
162234631|NCT00196976|585910653|FG001|Primary Study|Withdrawal by Subject|0|||
162234632|NCT00196976|585910654|FG002|Primary Study|Withdrawal by Subject|1|||
162234633|NCT00196976|585910655|FG003|Primary Study|Withdrawal by Subject|1|||
162234634|NCT00196976|585910656|FG004|Primary Study|Withdrawal by Subject|2|||
162234635|NCT00196976|585910657|FG005|Primary Study|Withdrawal by Subject|1|||
162234636|NCT00196976|585910658|FG006|Primary Study|Withdrawal by Subject|0|||
162234637|NCT00196976|585910659|FG007|Primary Study|Withdrawal by Subject|0|||
162234638|NCT00196976|585910660|FG008|Primary Study|Withdrawal by Subject|0|||
162234639|NCT00196976|585910661|FG009|Primary Study|Withdrawal by Subject|1|||
162234640|NCT00196976|585910662|FG010|Primary Study|Withdrawal by Subject|0|||
162234641|NCT00196976|585910663|FG011|Primary Study|Withdrawal by Subject|0|||
162234642|NCT00196976|585910664|FG012|Primary Study|Withdrawal by Subject|0|||
162234643|NCT00196976|585910665|FG013|Primary Study|Withdrawal by Subject|0|||
162234644|NCT00196976|585910652|FG000|Primary Study|Lost to Follow-up|0|||
162234645|NCT00196976|585910653|FG001|Primary Study|Lost to Follow-up|0|||
162234646|NCT00196976|585910654|FG002|Primary Study|Lost to Follow-up|0|||
162234647|NCT00196976|585910655|FG003|Primary Study|Lost to Follow-up|0|||
162234648|NCT00196976|585910656|FG004|Primary Study|Lost to Follow-up|1|||
162234649|NCT00196976|585910657|FG005|Primary Study|Lost to Follow-up|1|||
162234650|NCT00196976|585910658|FG006|Primary Study|Lost to Follow-up|0|||
162234651|NCT00196976|585910659|FG007|Primary Study|Lost to Follow-up|2|||
162234652|NCT00196976|585910660|FG008|Primary Study|Lost to Follow-up|0|||
162234653|NCT00196976|585910661|FG009|Primary Study|Lost to Follow-up|0|||
162234654|NCT00196976|585910662|FG010|Primary Study|Lost to Follow-up|0|||
162234655|NCT00196976|585910663|FG011|Primary Study|Lost to Follow-up|0|||
162234656|NCT00196976|585910664|FG012|Primary Study|Lost to Follow-up|0|||
162234657|NCT00196976|585910665|FG013|Primary Study|Lost to Follow-up|0|||
162234658|NCT00196976|585910652|FG000|Primary Study|Other|0|||
162234659|NCT00196976|585910653|FG001|Primary Study|Other|0|||
162234660|NCT00196976|585910654|FG002|Primary Study|Other|2|||
162234661|NCT00196976|585910655|FG003|Primary Study|Other|0|||
162234662|NCT00196976|585910656|FG004|Primary Study|Other|0|||
162234663|NCT00196976|585910657|FG005|Primary Study|Other|0|||
162234664|NCT00196976|585910658|FG006|Primary Study|Other|0|||
162234665|NCT00196976|585910659|FG007|Primary Study|Other|0|||
162234666|NCT00196976|585910660|FG008|Primary Study|Other|0|||
162234667|NCT00196976|585910661|FG009|Primary Study|Other|0|||
162234668|NCT00196976|585910662|FG010|Primary Study|Other|0|||
162234669|NCT00196976|585910663|FG011|Primary Study|Other|0|||
162234670|NCT00196976|585910664|FG012|Primary Study|Other|0|||
162234671|NCT00196976|585910665|FG013|Primary Study|Other|0|||
162234672|NCT00196976|585910652|FG000|Booster Study|Withdrawal by Subject|0|||
162234673|NCT00196976|585910653|FG001|Booster Study|Withdrawal by Subject|0|||
162234674|NCT00196976|585910654|FG002|Booster Study|Withdrawal by Subject|0|||
162234675|NCT00196976|585910655|FG003|Booster Study|Withdrawal by Subject|0|||
162234676|NCT00196976|585910656|FG004|Booster Study|Withdrawal by Subject|0|||
162234677|NCT00196976|585910657|FG005|Booster Study|Withdrawal by Subject|0|||
162234678|NCT00196976|585910658|FG006|Booster Study|Withdrawal by Subject|0|||
162234679|NCT00196976|585910659|FG007|Booster Study|Withdrawal by Subject|0|||
162234680|NCT00196976|585910660|FG008|Booster Study|Withdrawal by Subject|0|||
162234681|NCT00196976|585910661|FG009|Booster Study|Withdrawal by Subject|0|||
162234682|NCT00196976|585910662|FG010|Booster Study|Withdrawal by Subject|1|||
162234683|NCT00196976|585910663|FG011|Booster Study|Withdrawal by Subject|0|||
162234684|NCT00196976|585910664|FG012|Booster Study|Withdrawal by Subject|0|||
162234685|NCT00196976|585910665|FG013|Booster Study|Withdrawal by Subject|0|||
162234686|NCT00196976|585910652|FG000|Booster Study|Lost to Follow-up|0|||
162234687|NCT00196976|585910653|FG001|Booster Study|Lost to Follow-up|0|||
162234688|NCT00196976|585910654|FG002|Booster Study|Lost to Follow-up|0|||
162234689|NCT00196976|585910655|FG003|Booster Study|Lost to Follow-up|0|||
162234690|NCT00196976|585910656|FG004|Booster Study|Lost to Follow-up|0|||
162234691|NCT00196976|585910657|FG005|Booster Study|Lost to Follow-up|0|||
162234692|NCT00196976|585910658|FG006|Booster Study|Lost to Follow-up|0|||
162234693|NCT00196976|585910659|FG007|Booster Study|Lost to Follow-up|0|||
162234694|NCT00196976|585910660|FG008|Booster Study|Lost to Follow-up|0|||
162234695|NCT00196976|585910661|FG009|Booster Study|Lost to Follow-up|0|||
162234696|NCT00196976|585910662|FG010|Booster Study|Lost to Follow-up|1|||
162234697|NCT00196976|585910663|FG011|Booster Study|Lost to Follow-up|2|||
162234698|NCT00196976|585910664|FG012|Booster Study|Lost to Follow-up|0|||
162234699|NCT00196976|585910665|FG013|Booster Study|Lost to Follow-up|0|||
162234700|NCT02009761|585910666|FG000|Overall Study|Adverse Event|4|||
162234701|NCT02842827|585910667|FG000|Overall Study|Adverse Event|0|||
162234702|NCT02842827|585910668|FG001|Overall Study|Adverse Event|1|||
162234703|NCT02842827|585910669|FG002|Overall Study|Adverse Event|0|||
162234704|NCT02842827|585910670|FG003|Overall Study|Adverse Event|1|||
162234705|NCT02842827|585910671|FG004|Overall Study|Adverse Event|0|||
162234706|NCT02842827|585910672|FG005|Overall Study|Adverse Event|1|||
162234707|NCT02842827|585910673|FG006|Overall Study|Adverse Event|0|||
162234708|NCT02842827|585910674|FG007|Overall Study|Adverse Event|0|||
162234709|NCT02842827|585910667|FG000|Overall Study|Death|1|||
162234710|NCT02842827|585910668|FG001|Overall Study|Death|0|||
162234711|NCT02842827|585910669|FG002|Overall Study|Death|2|||
162234712|NCT02842827|585910670|FG003|Overall Study|Death|3|||
162234713|NCT02842827|585910671|FG004|Overall Study|Death|2|||
162234714|NCT02842827|585910672|FG005|Overall Study|Death|1|||
162234715|NCT02842827|585910673|FG006|Overall Study|Death|0|||
162234716|NCT02842827|585910674|FG007|Overall Study|Death|4|||
162234717|NCT02842827|585910667|FG000|Overall Study|Physician Decision|1|||
162234718|NCT02842827|585910668|FG001|Overall Study|Physician Decision|3|||
162234719|NCT02842827|585910669|FG002|Overall Study|Physician Decision|0|||
162234720|NCT02842827|585910670|FG003|Overall Study|Physician Decision|0|||
162234721|NCT02842827|585910671|FG004|Overall Study|Physician Decision|1|||
162234722|NCT02842827|585910672|FG005|Overall Study|Physician Decision|4|||
162234723|NCT02842827|585910673|FG006|Overall Study|Physician Decision|2|||
162234724|NCT02842827|585910674|FG007|Overall Study|Physician Decision|1|||
162234725|NCT02842827|585910667|FG000|Overall Study|Protocol Defined Disease Progression|0|||
162234726|NCT02842827|585910668|FG001|Overall Study|Protocol Defined Disease Progression|0|||
162234727|NCT02842827|585910669|FG002|Overall Study|Protocol Defined Disease Progression|0|||
162234728|NCT02842827|585910670|FG003|Overall Study|Protocol Defined Disease Progression|0|||
162234729|NCT02842827|585910671|FG004|Overall Study|Protocol Defined Disease Progression|0|||
162234730|NCT02842827|585910672|FG005|Overall Study|Protocol Defined Disease Progression|1|||
162234731|NCT02842827|585910673|FG006|Overall Study|Protocol Defined Disease Progression|0|||
162234732|NCT02842827|585910674|FG007|Overall Study|Protocol Defined Disease Progression|0|||
162234733|NCT02842827|585910667|FG000|Overall Study|Participant Withdrawal of Consent|1|||
162234734|NCT02842827|585910668|FG001|Overall Study|Participant Withdrawal of Consent|2|||
162234735|NCT02842827|585910669|FG002|Overall Study|Participant Withdrawal of Consent|2|||
162234736|NCT02842827|585910670|FG003|Overall Study|Participant Withdrawal of Consent|2|||
162234737|NCT02842827|585910671|FG004|Overall Study|Participant Withdrawal of Consent|2|||
162234738|NCT02842827|585910672|FG005|Overall Study|Participant Withdrawal of Consent|1|||
161681004|NCT01854645|583884392|FG002|Overall Study|Adverse Event|19|||
161681005|NCT01854645|583884393|FG003|Overall Study|Adverse Event|20|||
161681006|NCT01854645|583884394|FG004|Overall Study|Adverse Event|11|||
161681007|NCT00555477|583884395|FG000|Overall Study|Adverse Event|0|||
161681008|NCT00555477|583884396|FG001|Overall Study|Adverse Event|9|||
162234739|NCT02842827|585910673|FG006|Overall Study|Participant Withdrawal of Consent|2|||
162234740|NCT02842827|585910674|FG007|Overall Study|Participant Withdrawal of Consent|1|||
162234741|NCT01815138|585910675|FG000|Overall Study|Withdrawal by Subject|0|||
162234742|NCT01815138|585910676|FG001|Overall Study|Withdrawal by Subject|1|||
162234743|NCT01815138|585910675|FG000|Overall Study|Physician Decision|8|||
161681009|NCT00555477|583884395|FG000|Overall Study|Withdrawal by Subject|1|||
161681010|NCT00555477|583884396|FG001|Overall Study|Withdrawal by Subject|2|||
161681011|NCT00555477|583884395|FG000|Overall Study|Physician Decision|1|||
161681012|NCT00555477|583884396|FG001|Overall Study|Physician Decision|2|||
161681013|NCT04702737|583884397|FG000|Overall Study|Decision by Sponsor|1|||
161681014|NCT04702737|583884397|FG000|Overall Study|Withdrawal of Consent from Study|3|||
161681015|NCT04702737|583884397|FG000|Overall Study|Lost to Follow-up|1|||
161681016|NCT04702737|583884397|FG000|Overall Study|Death|35|||
161681017|NCT01977820|583884400|FG000|Overall Study|Sponsor terminated the study|1|||
161681018|NCT01977820|583884401|FG001|Overall Study|Sponsor terminated the study|1|||
161681019|NCT00475722|583884402|FG000|Overall Study|Withdrawal by Subject|12|||
161681020|NCT00475722|583884403|FG001|Overall Study|Withdrawal by Subject|12|||
161681021|NCT00475722|583884402|FG000|Overall Study|Protocol Violation|3|||
161681022|NCT00475722|583884403|FG001|Overall Study|Protocol Violation|0|||
161681023|NCT00698997|583884404|FG000|Overall Study|Lost to Follow-up|3|||
161941111|NCT03396445|584836061|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
162234744|NCT01815138|585910676|FG001|Overall Study|Physician Decision|5|||
162234745|NCT00825825|585910677|FG000|First Medication Period (14 Days)|Adverse Event|1|||
162234746|NCT00825825|585910678|FG001|First Medication Period (14 Days)|Adverse Event|0|||
162234747|NCT00825825|585910679|FG002|First Medication Period (14 Days)|Adverse Event|0|||
162234748|NCT00825825|585910680|FG003|First Medication Period (14 Days)|Adverse Event|0|||
162234749|NCT00825825|585910681|FG004|First Medication Period (14 Days)|Adverse Event|0|||
162234750|NCT00825825|585910682|FG005|First Medication Period (14 Days)|Adverse Event|1|||
162234751|NCT00825825|585910677|FG000|First Medication Period (14 Days)|Physician Decision|2|||
162234752|NCT00825825|585910678|FG001|First Medication Period (14 Days)|Physician Decision|0|||
162234753|NCT00825825|585910679|FG002|First Medication Period (14 Days)|Physician Decision|1|||
162234754|NCT00825825|585910680|FG003|First Medication Period (14 Days)|Physician Decision|0|||
162234755|NCT00825825|585910681|FG004|First Medication Period (14 Days)|Physician Decision|0|||
162234756|NCT00825825|585910682|FG005|First Medication Period (14 Days)|Physician Decision|1|||
162234757|NCT00825825|585910677|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
162234758|NCT00825825|585910678|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
162234759|NCT00825825|585910679|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
161681024|NCT00698997|583884405|FG001|Overall Study|Lost to Follow-up|0|||
161681025|NCT00698997|583884404|FG000|Overall Study|Withdrawal by Subject|7|||
161681026|NCT00698997|583884405|FG001|Overall Study|Withdrawal by Subject|27|||
161681027|NCT05082376|583884408|FG000|Overall Study|Lost to Follow-up|2|||
161681028|NCT02568475|583884409|FG000|Overall Study|Lost to Follow-up|40|||
161681029|NCT02568475|583884410|FG001|Overall Study|Lost to Follow-up|39|||
161681030|NCT02568475|583884409|FG000|Overall Study|Withdrawal by Subject|2|||
161681031|NCT02568475|583884410|FG001|Overall Study|Withdrawal by Subject|0|||
161681032|NCT02568475|583884409|FG000|Overall Study|Discharged home|4|||
161681033|NCT02568475|583884410|FG001|Overall Study|Discharged home|4|||
162234760|NCT00825825|585910680|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
162234761|NCT00825825|585910681|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
162234762|NCT00825825|585910682|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
162234763|NCT00825825|585910677|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
162234764|NCT00825825|585910678|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
162234765|NCT00825825|585910679|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
162234766|NCT00825825|585910680|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
162234767|NCT00825825|585910681|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
162234768|NCT00825825|585910682|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
162234769|NCT00825825|585910677|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
162234770|NCT00825825|585910678|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
162234771|NCT00825825|585910679|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
162234772|NCT00825825|585910680|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
162234773|NCT00825825|585910681|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
162234774|NCT00825825|585910682|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
162234775|NCT00825825|585910677|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
162234776|NCT00825825|585910678|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
162234777|NCT00825825|585910679|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
162234778|NCT00825825|585910680|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
162234779|NCT00825825|585910681|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
162234780|NCT00825825|585910682|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
162234781|NCT00825825|585910677|FG000|Third Medication Period (14 Days)|poor data quality|0|||
162234782|NCT00825825|585910678|FG001|Third Medication Period (14 Days)|poor data quality|1|||
162234783|NCT00825825|585910679|FG002|Third Medication Period (14 Days)|poor data quality|0|||
162234784|NCT00825825|585910680|FG003|Third Medication Period (14 Days)|poor data quality|0|||
162234785|NCT00825825|585910681|FG004|Third Medication Period (14 Days)|poor data quality|0|||
162234786|NCT00825825|585910682|FG005|Third Medication Period (14 Days)|poor data quality|0|||
162234787|NCT02649946|585910688|FG000|Overall Study|Withdrawal by Subject|1|||
162234788|NCT02649946|585910689|FG001|Overall Study|Withdrawal by Subject|1|||
162234789|NCT02649946|585910688|FG000|Overall Study|Death|7|||
162234790|NCT02649946|585910689|FG001|Overall Study|Death|9|||
162234791|NCT02649946|585910688|FG000|Overall Study|Physician Decision|1|||
162234792|NCT02649946|585910689|FG001|Overall Study|Physician Decision|0|||
162234793|NCT02649946|585910688|FG000|Overall Study|Lost to Follow-up|2|||
162234794|NCT02649946|585910689|FG001|Overall Study|Lost to Follow-up|1|||
162234795|NCT02649946|585910688|FG000|Overall Study|Erroneously enrolled|1|||
162234796|NCT02649946|585910689|FG001|Overall Study|Erroneously enrolled|0|||
162234797|NCT02649946|585910688|FG000|Overall Study|Missed 6-month follow-up visit|0|||
162234798|NCT02649946|585910689|FG001|Overall Study|Missed 6-month follow-up visit|4|||
162234799|NCT00950950|585910690|FG000|Overall Study|Adverse Event|1|||
162234800|NCT00950950|585910691|FG001|Overall Study|Adverse Event|0|||
162234801|NCT00950950|585910690|FG000|Overall Study|Withdrawal by Subject|0|||
162234802|NCT00950950|585910691|FG001|Overall Study|Withdrawal by Subject|1|||
162234803|NCT01047293|585910692|FG000|Overall Study|DLT criteria not fulfilled|1|||
162234804|NCT01047293|585910693|FG001|Overall Study|DLT criteria not fulfilled|1|||
162234805|NCT01047293|585910694|FG002|Overall Study|DLT criteria not fulfilled|0|||
162234806|NCT01047293|585910695|FG003|Overall Study|DLT criteria not fulfilled|0|||
162234807|NCT00757783|585910696|FG000|Overall Study|Adverse Event|0|||
162234808|NCT00757783|585910697|FG001|Overall Study|Adverse Event|2|||
162234809|NCT00757783|585910696|FG000|Overall Study|Lost to Follow-up|1|||
162234810|NCT00757783|585910697|FG001|Overall Study|Lost to Follow-up|1|||
162234811|NCT00757783|585910696|FG000|Overall Study|Protocol Violation|1|||
162234812|NCT00757783|585910697|FG001|Overall Study|Protocol Violation|0|||
162234813|NCT00757783|585910696|FG000|Overall Study|Withdrawal by Subject|2|||
162234814|NCT00757783|585910697|FG001|Overall Study|Withdrawal by Subject|1|||
162234815|NCT00757783|585910696|FG000|Overall Study|Other|1|||
162234816|NCT00757783|585910697|FG001|Overall Study|Other|2|||
162234817|NCT02372136|585910698|FG000|Overall Study|Death|3|||
162234818|NCT02372136|585910699|FG001|Overall Study|Death|1|||
162234819|NCT02679508|585910700|FG000|Healing Phase|Protocol Violation|1|||
162234820|NCT02679508|585910701|FG001|Healing Phase|Protocol Violation|1|||
162234821|NCT02679508|585910700|FG000|Healing Phase|Lost to Follow-up|1|||
162234822|NCT02679508|585910701|FG001|Healing Phase|Lost to Follow-up|0|||
162234823|NCT02679508|585910700|FG000|Maintenance Phase|Adverse Event|12|||
162234824|NCT02679508|585910701|FG001|Maintenance Phase|Adverse Event|2|||
162234825|NCT02679508|585910700|FG000|Maintenance Phase|Lost to Follow-up|0|||
162234826|NCT02679508|585910701|FG001|Maintenance Phase|Lost to Follow-up|1|||
161681034|NCT02568475|583884409|FG000|Overall Study|Short-term: Discharge location unknown|4|||
161681035|NCT02568475|583884410|FG001|Overall Study|Short-term: Discharge location unknown|0|||
161681036|NCT02568475|583884409|FG000|Overall Study|Transferred to another facility|1|||
161681037|NCT02568475|583884410|FG001|Overall Study|Transferred to another facility|0|||
161681038|NCT02625233|583884411|FG000|Overall Study|Adverse Event|2|||
161681039|NCT02625233|583884412|FG001|Overall Study|Adverse Event|0|||
161681040|NCT00290186|583884413|FG000|Overall Study|Adverse Event|1|||
161681041|NCT00290186|583884414|FG001|Overall Study|Adverse Event|1|||
161681042|NCT00290186|583884413|FG000|Overall Study|Lost to Follow-up|3|||
161681043|NCT00290186|583884414|FG001|Overall Study|Lost to Follow-up|2|||
161681044|NCT00290186|583884413|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
161681045|NCT00290186|583884414|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
161681046|NCT00290186|583884413|FG000|Overall Study|Withdrawal by Subject|0|||
161681047|NCT00290186|583884414|FG001|Overall Study|Withdrawal by Subject|1|||
161681048|NCT02710136|583884415|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
161681049|NCT02710136|583884416|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
161681050|NCT02269787|583884417|FG000|Overall Study|Lost to Follow-up|20|||
161681051|NCT02269787|583884418|FG001|Overall Study|Lost to Follow-up|6|||
161681052|NCT02269787|583884417|FG000|Overall Study|Death|2|||
161681053|NCT02269787|583884418|FG001|Overall Study|Death|3|||
161681054|NCT02269787|583884417|FG000|Overall Study|Incapacitated|0|||
161681055|NCT02269787|583884418|FG001|Overall Study|Incapacitated|1|||
161681056|NCT00798135|583884419|FG000|Overall Study|Disease progression, relapse|11|||
161681057|NCT00798135|583884419|FG000|Overall Study|Disease progression, refractory|1|||
161681058|NCT00798135|583884419|FG000|Overall Study|Physician Decision|1|||
161681059|NCT02228720|583884420|FG000|Open Label - Day 30|Lost to Follow-up|1|||
161681060|NCT00282295|583884421|FG000|Overall Study|Adverse Event|0|||
161681061|NCT00282295|583884422|FG001|Overall Study|Adverse Event|1|||
161681062|NCT00282295|583884423|FG002|Overall Study|Adverse Event|0|||
161681063|NCT00282295|583884421|FG000|Overall Study|Serious Adverse Events|0|||
161681064|NCT00282295|583884422|FG001|Overall Study|Serious Adverse Events|0|||
161681065|NCT00282295|583884423|FG002|Overall Study|Serious Adverse Events|1|||
161681066|NCT00282295|583884421|FG000|Overall Study|Protocol Violation|0|||
161681067|NCT00282295|583884422|FG001|Overall Study|Protocol Violation|2|||
161681068|NCT00282295|583884423|FG002|Overall Study|Protocol Violation|1|||
161681069|NCT00282295|583884421|FG000|Overall Study|Withdrawal by Subject|2|||
161681070|NCT00282295|583884422|FG001|Overall Study|Withdrawal by Subject|6|||
161681071|NCT00282295|583884423|FG002|Overall Study|Withdrawal by Subject|4|||
161681072|NCT00282295|583884421|FG000|Overall Study|Lost to Follow-up|1|||
161681073|NCT00282295|583884422|FG001|Overall Study|Lost to Follow-up|7|||
161681074|NCT00282295|583884423|FG002|Overall Study|Lost to Follow-up|2|||
161681075|NCT00282295|583884421|FG000|Overall Study|Other|0|||
161681076|NCT00282295|583884422|FG001|Overall Study|Other|1|||
161681077|NCT00282295|583884423|FG002|Overall Study|Other|0|||
161681078|NCT03337542|583884426|FG000|Overall Study|Withdrew Consent|17|||
161681079|NCT03337542|583884426|FG000|Overall Study|Allergic Adverse Event|1|||
161681080|NCT03337542|583884426|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
161681081|NCT03337542|583884426|FG000|Overall Study|Lost to Follow-up|1|||
161681082|NCT03337542|583884426|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
161681083|NCT01401842|583884427|FG000|Overall Study|Withdrawal by Subject|3|||
161681084|NCT01401842|583884428|FG001|Overall Study|Withdrawal by Subject|2|||
161681085|NCT01401842|583884427|FG000|Overall Study|academic reason|4|||
161681086|NCT01401842|583884428|FG001|Overall Study|academic reason|1|||
161681087|NCT01401842|583884427|FG000|Overall Study|changed companies|20|||
161681088|NCT01401842|583884428|FG001|Overall Study|changed companies|34|||
161681089|NCT01401842|583884427|FG000|Overall Study|discharged from US Army|3|||
161681090|NCT01401842|583884428|FG001|Overall Study|discharged from US Army|4|||
161681091|NCT01401842|583884427|FG000|Overall Study|invalid follow-up strength data|1|||
161681092|NCT01401842|583884428|FG001|Overall Study|invalid follow-up strength data|4|||
161681093|NCT01401842|583884427|FG000|Overall Study|on profile|9|||
161681094|NCT01401842|583884428|FG001|Overall Study|on profile|5|||
161681095|NCT01401842|583884427|FG000|Overall Study|other/unknown|28|||
161681096|NCT01401842|583884428|FG001|Overall Study|other/unknown|17|||
161681097|NCT04183790|583886112|FG000|Overall Study|Participants did not rollover to Part B|12|||
161681098|NCT04183790|583886113|FG001|Overall Study|Participants did not rollover to Part B|0|||
161681099|NCT04183790|583886112|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
161681100|NCT04183790|583886113|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
161681101|NCT04183790|583886112|FG000|Overall Study|Commercial drug is available for participant|6|||
161681102|NCT04183790|583886113|FG001|Overall Study|Commercial drug is available for participant|0|||
161681103|NCT04183790|583886112|FG000|Overall Study|Adverse Event|1|||
161681104|NCT04183790|583886113|FG001|Overall Study|Adverse Event|0|||
161681105|NCT04183790|583886112|FG000|Overall Study|Not enrolled in 107 study|0|||
161681106|NCT04183790|583886113|FG001|Overall Study|Not enrolled in 107 study|2|||
161681107|NCT01251653|583886114|FG000|Overall Study|Progressive Disease|1|||
161681108|NCT01251653|583886115|FG001|Overall Study|Progressive Disease|7|||
161681109|NCT01251653|583886116|FG002|Overall Study|Progressive Disease|16|||
161681110|NCT01251653|583886117|FG003|Overall Study|Progressive Disease|4|||
161681111|NCT01251653|583886118|FG004|Overall Study|Progressive Disease|0|||
161681112|NCT01251653|583886119|FG005|Overall Study|Progressive Disease|17|||
161681113|NCT01251653|583886120|FG006|Overall Study|Progressive Disease|14|||
161681114|NCT01251653|583886121|FG007|Overall Study|Progressive Disease|7|||
161681115|NCT01251653|583886122|FG008|Overall Study|Progressive Disease|5|||
161681116|NCT01251653|583886114|FG000|Overall Study|Dose-limiting toxicity|0|||
161681117|NCT01251653|583886115|FG001|Overall Study|Dose-limiting toxicity|1|||
161681118|NCT01251653|583886116|FG002|Overall Study|Dose-limiting toxicity|1|||
161681119|NCT01251653|583886117|FG003|Overall Study|Dose-limiting toxicity|1|||
161681120|NCT01251653|583886118|FG004|Overall Study|Dose-limiting toxicity|0|||
161681121|NCT01251653|583886119|FG005|Overall Study|Dose-limiting toxicity|0|||
161681122|NCT01251653|583886120|FG006|Overall Study|Dose-limiting toxicity|2|||
161681123|NCT01251653|583886121|FG007|Overall Study|Dose-limiting toxicity|0|||
161681124|NCT01251653|583886122|FG008|Overall Study|Dose-limiting toxicity|0|||
161681125|NCT01251653|583886114|FG000|Overall Study|Adverse Event|1|||
161681126|NCT01251653|583886115|FG001|Overall Study|Adverse Event|0|||
161681127|NCT01251653|583886116|FG002|Overall Study|Adverse Event|2|||
161681128|NCT01251653|583886117|FG003|Overall Study|Adverse Event|1|||
161681129|NCT01251653|583886118|FG004|Overall Study|Adverse Event|1|||
161830108|NCT02400476|584418114|FG004|Overall Study|Other, Decreased Quality of Life|0|||
161830109|NCT02400476|584418115|FG005|Overall Study|Other, Decreased Quality of Life|0|||
161830110|NCT02400476|584418110|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
161830111|NCT02400476|584418111|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
162234827|NCT02679508|585910700|FG000|Maintenance Phase|Withdrawal by Subject|15|||
162234828|NCT02679508|585910701|FG001|Maintenance Phase|Withdrawal by Subject|8|||
162234829|NCT02679508|585910700|FG000|Maintenance Phase|Other|5|||
162234830|NCT02679508|585910701|FG001|Maintenance Phase|Other|4|||
162234831|NCT01588496|585910702|FG000|Overall Study|Withdrawal by Subject|0|||
162234832|NCT01588496|585910703|FG001|Overall Study|Withdrawal by Subject|1|||
162234833|NCT01588496|585910704|FG002|Overall Study|Withdrawal by Subject|0|||
162234834|NCT03143166|585910705|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
162234835|NCT05924945|585910706|FG000|Overall Study|Withdrawal by Subject|3|||
162234836|NCT05924945|585910707|FG001|Overall Study|Withdrawal by Subject|4|||
162234837|NCT02003573|585910722|FG000|Overall Study|Progressive disease|2|||
162234838|NCT02003573|585910723|FG001|Overall Study|Progressive disease|0|||
162234839|NCT02003573|585910724|FG002|Overall Study|Progressive disease|1|||
162234840|NCT02003573|585910722|FG000|Overall Study|Other Adverse event|0|||
162234841|NCT02003573|585910723|FG001|Overall Study|Other Adverse event|1|||
162234842|NCT02003573|585910724|FG002|Overall Study|Other Adverse event|1|||
162234843|NCT02003573|585910722|FG000|Overall Study|Refuse to take trial medication|0|||
162234844|NCT02003573|585910723|FG001|Overall Study|Refuse to take trial medication|1|||
162234845|NCT02003573|585910724|FG002|Overall Study|Refuse to take trial medication|1|||
162234846|NCT02003573|585910722|FG000|Overall Study|Other than specified|1|||
162234847|NCT02003573|585910723|FG001|Overall Study|Other than specified|2|||
162234848|NCT02003573|585910724|FG002|Overall Study|Other than specified|3|||
162234849|NCT03683823|585910731|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
162234850|NCT03683823|585910732|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
162234851|NCT03683823|585910731|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
162234852|NCT03683823|585910732|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
162234853|NCT03683823|585910731|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
162234854|NCT03683823|585910732|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
162234855|NCT05026710|585910734|FG000|Overall Study|No longer met eligibility criteria|3|||
162234856|NCT05026710|585910735|FG001|Overall Study|No longer met eligibility criteria|1|||
162234857|NCT00126503|585910736|FG000|Overall Study|disease progression|23|||
162234858|NCT00126503|585910737|FG001|Overall Study|disease progression|14|||
161681130|NCT01251653|583886119|FG005|Overall Study|Adverse Event|0|||
161830112|NCT02400476|584418112|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
162234859|NCT00126503|585910736|FG000|Overall Study|Withdrawal by Subject|0|||
162234860|NCT00126503|585910737|FG001|Overall Study|Withdrawal by Subject|1|||
162234861|NCT00126503|585910736|FG000|Overall Study|alternative therapy|1|||
162234862|NCT00126503|585910737|FG001|Overall Study|alternative therapy|1|||
162234863|NCT00126503|585910736|FG000|Overall Study|other complicating disease|4|||
161681131|NCT01251653|583886120|FG006|Overall Study|Adverse Event|2|||
161681132|NCT01251653|583886121|FG007|Overall Study|Adverse Event|2|||
161681133|NCT01251653|583886122|FG008|Overall Study|Adverse Event|1|||
162234864|NCT00126503|585910737|FG001|Overall Study|other complicating disease|1|||
162234865|NCT00126503|585910736|FG000|Overall Study|Death|3|||
161681134|NCT01251653|583886114|FG000|Overall Study|Withdrawal by Subject|1|||
162234866|NCT00126503|585910737|FG001|Overall Study|Death|0|||
162234867|NCT00126503|585910736|FG000|Overall Study|Adverse Event|13|||
162234868|NCT00126503|585910737|FG001|Overall Study|Adverse Event|3|||
162234869|NCT00126503|585910736|FG000|Overall Study|non-compliant|1|||
162234870|NCT00126503|585910737|FG001|Overall Study|non-compliant|0|||
161681135|NCT01251653|583886115|FG001|Overall Study|Withdrawal by Subject|0|||
161681136|NCT01251653|583886116|FG002|Overall Study|Withdrawal by Subject|1|||
161681137|NCT01251653|583886117|FG003|Overall Study|Withdrawal by Subject|0|||
161681138|NCT01251653|583886118|FG004|Overall Study|Withdrawal by Subject|1|||
161681139|NCT01251653|583886119|FG005|Overall Study|Withdrawal by Subject|1|||
161681140|NCT01251653|583886120|FG006|Overall Study|Withdrawal by Subject|0|||
161681141|NCT01251653|583886121|FG007|Overall Study|Withdrawal by Subject|1|||
161681142|NCT01251653|583886122|FG008|Overall Study|Withdrawal by Subject|0|||
161681143|NCT01251653|583886114|FG000|Overall Study|Other reason not mentioned above|0|||
161681144|NCT01251653|583886115|FG001|Overall Study|Other reason not mentioned above|0|||
161681145|NCT01251653|583886116|FG002|Overall Study|Other reason not mentioned above|0|||
161681146|NCT01251653|583886117|FG003|Overall Study|Other reason not mentioned above|0|||
161681147|NCT01251653|583886118|FG004|Overall Study|Other reason not mentioned above|0|||
161681148|NCT01251653|583886119|FG005|Overall Study|Other reason not mentioned above|0|||
161681149|NCT01251653|583886120|FG006|Overall Study|Other reason not mentioned above|0|||
161681150|NCT01251653|583886121|FG007|Overall Study|Other reason not mentioned above|2|||
161681151|NCT01251653|583886122|FG008|Overall Study|Other reason not mentioned above|0|||
161681152|NCT00847145|583886123|FG000|Overall Study|AE or Death|0|||
162234871|NCT00126503|585910736|FG000|Overall Study|Physician Decision|2|||
162234872|NCT00126503|585910737|FG001|Overall Study|Physician Decision|1|||
162234873|NCT02495792|585910738|FG000|Overall Study|Lost to Follow-up|5|||
162234874|NCT02495792|585910739|FG001|Overall Study|Lost to Follow-up|9|||
162234875|NCT02495792|585910738|FG000|Overall Study|Protocol Violation|32|||
162234876|NCT02495792|585910739|FG001|Overall Study|Protocol Violation|31|||
162234877|NCT03519971|585910740|FG000|Overall Study|Death|142|||
162234878|NCT03519971|585910741|FG001|Overall Study|Death|69|||
162234879|NCT03519971|585910740|FG000|Overall Study|Lost to Follow-up|0|||
162234880|NCT03519971|585910741|FG001|Overall Study|Lost to Follow-up|1|||
162234881|NCT03519971|585910740|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
162234882|NCT03519971|585910741|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
162234883|NCT03519971|585910740|FG000|Overall Study|Withdrawal by Subject|3|||
162234884|NCT03519971|585910741|FG001|Overall Study|Withdrawal by Subject|2|||
162234885|NCT03519971|585910740|FG000|Overall Study|Other|1|||
162234886|NCT03519971|585910741|FG001|Overall Study|Other|0|||
162234887|NCT00925132|585910742|FG000|Overall Study|Withdrawal by Subject|2|||
162234888|NCT00925132|585910743|FG001|Overall Study|Withdrawal by Subject|0|||
162234889|NCT00925132|585910744|FG002|Overall Study|Withdrawal by Subject|0|||
162234890|NCT00925132|585910745|FG003|Overall Study|Withdrawal by Subject|0|||
162234891|NCT00925132|585910746|FG004|Overall Study|Withdrawal by Subject|1|||
162234892|NCT00925132|585910742|FG000|Overall Study|Removed due to disease progression|0|||
162234893|NCT00925132|585910743|FG001|Overall Study|Removed due to disease progression|0|||
162234894|NCT00925132|585910744|FG002|Overall Study|Removed due to disease progression|0|||
162234895|NCT00925132|585910745|FG003|Overall Study|Removed due to disease progression|0|||
162234896|NCT00925132|585910746|FG004|Overall Study|Removed due to disease progression|4|||
162234897|NCT02545933|585910747|FG000|Overall Study|Adverse Event|3|||
162234898|NCT02545933|585910748|FG001|Overall Study|Adverse Event|0|||
162234899|NCT02545933|585910749|FG002|Overall Study|Adverse Event|0|||
162234900|NCT02545933|585910747|FG000|Overall Study|Withdrawal by Subject|2|||
162234901|NCT02545933|585910748|FG001|Overall Study|Withdrawal by Subject|3|||
162234902|NCT02545933|585910749|FG002|Overall Study|Withdrawal by Subject|3|||
162234903|NCT02545933|585910747|FG000|Overall Study|Protocol Violation|1|||
162234904|NCT02545933|585910748|FG001|Overall Study|Protocol Violation|0|||
162234905|NCT02545933|585910749|FG002|Overall Study|Protocol Violation|1|||
162234906|NCT03149549|585910750|FG000|Study Discontinuation--Treatment Period|Death|0|||
162234907|NCT03149549|585910751|FG001|Study Discontinuation--Treatment Period|Death|0|||
162234908|NCT03149549|585910752|FG002|Study Discontinuation--Treatment Period|Death|0|||
162234909|NCT03149549|585910753|FG003|Study Discontinuation--Treatment Period|Death|1|||
162234910|NCT03149549|585910754|FG004|Study Discontinuation--Treatment Period|Death|2|||
162234911|NCT03149549|585910755|FG005|Study Discontinuation--Treatment Period|Death|1|||
162234912|NCT03149549|585910756|FG006|Study Discontinuation--Treatment Period|Death|1|||
162234913|NCT03149549|585910757|FG007|Study Discontinuation--Treatment Period|Death|2|||
162234914|NCT03149549|585910758|FG008|Study Discontinuation--Treatment Period|Death|4|||
162234915|NCT03149549|585910759|FG009|Study Discontinuation--Treatment Period|Death|1|||
162234916|NCT03149549|585910760|FG010|Study Discontinuation--Treatment Period|Death|0|||
161681153|NCT00847145|583886124|FG001|Overall Study|AE or Death|1|||
161681154|NCT00847145|583886125|FG002|Overall Study|AE or Death|1|||
162234917|NCT03149549|585910761|FG011|Study Discontinuation--Treatment Period|Death|0|||
162234918|NCT03149549|585910762|FG012|Study Discontinuation--Treatment Period|Death|1|||
162234919|NCT03149549|585910750|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162234920|NCT03149549|585910751|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162234921|NCT03149549|585910752|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162234922|NCT03149549|585910753|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162234923|NCT03149549|585910754|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162234924|NCT03149549|585910755|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161681155|NCT00847145|583886126|FG003|Overall Study|AE or Death|0|||
162234925|NCT03149549|585910756|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162234926|NCT03149549|585910757|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
162234927|NCT03149549|585910758|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162234928|NCT03149549|585910759|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162234929|NCT03149549|585910760|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162234930|NCT03149549|585910761|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
162234931|NCT03149549|585910762|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
162234932|NCT03149549|585910750|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162234933|NCT03149549|585910751|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162234934|NCT03149549|585910752|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162234935|NCT03149549|585910753|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
162234936|NCT03149549|585910754|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
162234937|NCT03149549|585910755|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
162234938|NCT03149549|585910756|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
162234939|NCT03149549|585910757|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162234940|NCT03149549|585910758|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
162234941|NCT03149549|585910759|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162234942|NCT03149549|585910760|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162234943|NCT03149549|585910761|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162234944|NCT03149549|585910762|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
162234945|NCT03149549|585910750|FG000|Study Discontinuation--Treatment Period|Other|0|||
162234946|NCT03149549|585910751|FG001|Study Discontinuation--Treatment Period|Other|0|||
162234947|NCT03149549|585910752|FG002|Study Discontinuation--Treatment Period|Other|0|||
162234948|NCT03149549|585910753|FG003|Study Discontinuation--Treatment Period|Other|0|||
162234949|NCT03149549|585910754|FG004|Study Discontinuation--Treatment Period|Other|0|||
162234950|NCT03149549|585910755|FG005|Study Discontinuation--Treatment Period|Other|0|||
162234951|NCT03149549|585910756|FG006|Study Discontinuation--Treatment Period|Other|0|||
162234952|NCT03149549|585910757|FG007|Study Discontinuation--Treatment Period|Other|1|||
162234953|NCT03149549|585910758|FG008|Study Discontinuation--Treatment Period|Other|0|||
162234954|NCT03149549|585910759|FG009|Study Discontinuation--Treatment Period|Other|1|||
162234955|NCT03149549|585910760|FG010|Study Discontinuation--Treatment Period|Other|0|||
161681156|NCT00847145|583886127|FG004|Overall Study|AE or Death|0|||
162025332|NCT00913458|585150716|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
162025333|NCT00913458|585150717|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
162025334|NCT00913458|585150718|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
162025335|NCT02366091|585150719|FG000|Overall Study|Withdrawal by Subject|3|||
162025336|NCT02366091|585150720|FG001|Overall Study|Withdrawal by Subject|7|||
162025337|NCT02366091|585150721|FG002|Overall Study|Withdrawal by Subject|3|||
162025338|NCT02366091|585150722|FG003|Overall Study|Withdrawal by Subject|1|||
162025339|NCT02338232|585150723|FG000|Overall Study|Screen Failure|3|||
162025340|NCT02338232|585150723|FG000|Overall Study|Withdrawal by Subject|6|||
162025341|NCT02338232|585150723|FG000|Overall Study|Adverse Event|2|||
162025342|NCT03890666|585150724|FG000|Overall Study|Withdrawal by Subject|0|||
162025343|NCT03890666|585150725|FG001|Overall Study|Withdrawal by Subject|1|||
162025344|NCT03890666|585150724|FG000|Overall Study|Protocol deviation|1|||
162025345|NCT03890666|585150725|FG001|Overall Study|Protocol deviation|4|||
162025346|NCT03890666|585150724|FG000|Overall Study|Lost to Follow-up|2|||
162025347|NCT03890666|585150725|FG001|Overall Study|Lost to Follow-up|5|||
162025348|NCT03890666|585150724|FG000|Overall Study|Other than specified|1|||
162025349|NCT03890666|585150725|FG001|Overall Study|Other than specified|8|||
162025350|NCT01105065|585150726|FG000|Overall Study|Adverse Event|5|||
162025351|NCT01105065|585150726|FG000|Overall Study|Technical Problems|1|||
162025352|NCT02122783|585150730|FG000|Overall Study|Adverse Event|0|||
162025353|NCT02122783|585150731|FG001|Overall Study|Adverse Event|1|||
162025354|NCT00322621|585150732|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
162025355|NCT00322621|585150733|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
162025356|NCT00322621|585150734|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
162025357|NCT00322621|585150732|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
162025358|NCT00322621|585150733|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
162025359|NCT00322621|585150734|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
162025360|NCT00322621|585150732|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
162025361|NCT00322621|585150733|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
162025362|NCT00322621|585150734|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
162025363|NCT00322621|585150732|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
162025364|NCT00322621|585150733|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
162025365|NCT00322621|585150734|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
162025366|NCT00322621|585150732|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
162025367|NCT00322621|585150733|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
162025368|NCT00322621|585150734|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
162025369|NCT00322621|585150732|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
162025370|NCT00322621|585150733|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
162025371|NCT00322621|585150734|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
162025372|NCT00322621|585150732|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
162025373|NCT00322621|585150733|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
162025374|NCT00322621|585150734|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
162025375|NCT00322621|585150732|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
162025376|NCT00322621|585150733|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
162025377|NCT00322621|585150734|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
162025378|NCT00322621|585150732|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
162025379|NCT00322621|585150733|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
162025380|NCT00322621|585150734|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
162025381|NCT00322621|585150732|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
162025382|NCT00322621|585150733|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
162025383|NCT00322621|585150734|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
162025384|NCT00322621|585150732|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
162025385|NCT00322621|585150733|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
162025386|NCT00322621|585150734|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
162025387|NCT02213133|585150739|FG000|Overall Study|Participant discontinued study therapy|2|||
162025388|NCT02213133|585150740|FG001|Overall Study|Participant discontinued study therapy|0|||
162234956|NCT03149549|585910761|FG011|Study Discontinuation--Treatment Period|Other|0|||
162234957|NCT03149549|585910762|FG012|Study Discontinuation--Treatment Period|Other|0|||
162234958|NCT03149549|585910750|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162234959|NCT03149549|585910751|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162234960|NCT03149549|585910752|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162234961|NCT03149549|585910753|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162234962|NCT03149549|585910754|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162234963|NCT03149549|585910755|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
162234964|NCT03149549|585910756|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
162234965|NCT03149549|585910757|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162234966|NCT03149549|585910758|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
162234967|NCT03149549|585910759|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162234968|NCT03149549|585910760|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162234969|NCT03149549|585910761|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162234970|NCT03149549|585910762|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
162234971|NCT03149549|585910750|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162234972|NCT03149549|585910751|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162234973|NCT03149549|585910752|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161681157|NCT00847145|583886128|FG005|Overall Study|AE or Death|0|||
161681158|NCT00847145|583886129|FG006|Overall Study|AE or Death|0|||
161681159|NCT00847145|583886130|FG007|Overall Study|AE or Death|0|||
161681160|NCT00847145|583886123|FG000|Overall Study|Withdrawal by Subject|3|||
161681161|NCT00847145|583886124|FG001|Overall Study|Withdrawal by Subject|4|||
161681162|NCT00847145|583886125|FG002|Overall Study|Withdrawal by Subject|6|||
161681163|NCT00847145|583886126|FG003|Overall Study|Withdrawal by Subject|1|||
161681164|NCT00847145|583886127|FG004|Overall Study|Withdrawal by Subject|0|||
161681165|NCT00847145|583886128|FG005|Overall Study|Withdrawal by Subject|0|||
161681166|NCT00847145|583886129|FG006|Overall Study|Withdrawal by Subject|1|||
161681167|NCT00847145|583886130|FG007|Overall Study|Withdrawal by Subject|1|||
161681168|NCT00847145|583886123|FG000|Overall Study|Lost to Follow-up|3|||
161681169|NCT00847145|583886124|FG001|Overall Study|Lost to Follow-up|1|||
162234974|NCT03149549|585910753|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162234975|NCT03149549|585910754|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
162234976|NCT03149549|585910755|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162234977|NCT03149549|585910756|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162234978|NCT03149549|585910757|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
162234979|NCT03149549|585910758|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
162234980|NCT03149549|585910759|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162234981|NCT03149549|585910760|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
162234982|NCT03149549|585910761|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
162234983|NCT03149549|585910762|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
162234984|NCT03149549|585910750|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162234985|NCT03149549|585910751|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162234986|NCT03149549|585910752|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161681170|NCT00847145|583886125|FG002|Overall Study|Lost to Follow-up|1|||
161681171|NCT00847145|583886126|FG003|Overall Study|Lost to Follow-up|0|||
161681172|NCT00847145|583886127|FG004|Overall Study|Lost to Follow-up|4|||
161681173|NCT00847145|583886128|FG005|Overall Study|Lost to Follow-up|4|||
161681174|NCT00847145|583886129|FG006|Overall Study|Lost to Follow-up|8|||
161681175|NCT00847145|583886130|FG007|Overall Study|Lost to Follow-up|2|||
162025389|NCT02213133|585150741|FG002|Overall Study|Participant discontinued study therapy|0|||
162025390|NCT02213133|585150739|FG000|Overall Study|Participant withdrew informed consent|2|||
161681176|NCT00847145|583886123|FG000|Overall Study|Inappropriate enrollment|0|||
161681177|NCT00847145|583886124|FG001|Overall Study|Inappropriate enrollment|0|||
161681178|NCT00847145|583886125|FG002|Overall Study|Inappropriate enrollment|0|||
161681179|NCT00847145|583886126|FG003|Overall Study|Inappropriate enrollment|0|||
161681180|NCT00847145|583886127|FG004|Overall Study|Inappropriate enrollment|1|||
161681181|NCT00847145|583886128|FG005|Overall Study|Inappropriate enrollment|0|||
161681182|NCT00847145|583886129|FG006|Overall Study|Inappropriate enrollment|0|||
161681183|NCT00847145|583886130|FG007|Overall Study|Inappropriate enrollment|0|||
162234987|NCT03149549|585910753|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162234988|NCT03149549|585910754|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
162234989|NCT03149549|585910755|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162234990|NCT03149549|585910756|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162234991|NCT03149549|585910757|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
162234992|NCT03149549|585910758|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
162234993|NCT03149549|585910759|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
162234994|NCT03149549|585910760|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
162234995|NCT03149549|585910761|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
162234996|NCT03149549|585910762|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
162234997|NCT03149549|585910750|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
162234998|NCT03149549|585910751|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
162234999|NCT03149549|585910752|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
162235000|NCT03149549|585910753|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
162235001|NCT03149549|585910754|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
162235002|NCT03149549|585910755|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
162235003|NCT03149549|585910756|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
162235004|NCT03149549|585910757|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
162235005|NCT03149549|585910758|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
162235006|NCT03149549|585910759|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
162235007|NCT03149549|585910760|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
162235008|NCT03149549|585910761|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
162235009|NCT03149549|585910762|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
161681184|NCT00847145|583886123|FG000|Overall Study|Protocol Violation|0|||
161681185|NCT00847145|583886124|FG001|Overall Study|Protocol Violation|0|||
161681186|NCT00847145|583886125|FG002|Overall Study|Protocol Violation|3|||
161681187|NCT00847145|583886126|FG003|Overall Study|Protocol Violation|0|||
161681188|NCT00847145|583886127|FG004|Overall Study|Protocol Violation|1|||
161681189|NCT00847145|583886128|FG005|Overall Study|Protocol Violation|0|||
161681190|NCT00847145|583886129|FG006|Overall Study|Protocol Violation|0|||
161681191|NCT00847145|583886130|FG007|Overall Study|Protocol Violation|1|||
161681192|NCT02833974|583886131|FG000|Overall Study|Lost to Follow-up|1|||
161681193|NCT02833974|583886132|FG001|Overall Study|Lost to Follow-up|0|||
161681194|NCT02833974|583886131|FG000|Overall Study|Adverse Event|0|||
161681195|NCT02833974|583886132|FG001|Overall Study|Adverse Event|3|||
161681196|NCT04419610|583886133|FG000|Overall Study|Withdrawal by Subject|3|||
161681197|NCT04419610|583886134|FG001|Overall Study|Withdrawal by Subject|1|||
161681198|NCT04419610|583886133|FG000|Overall Study|Adverse Event|1|||
161681199|NCT04419610|583886134|FG001|Overall Study|Adverse Event|0|||
161681200|NCT04419610|583886133|FG000|Overall Study|discharged early|1|||
161681201|NCT04419610|583886134|FG001|Overall Study|discharged early|1|||
161681202|NCT01439282|583886135|FG000|Overall Study|Adverse Event|5|||
161681203|NCT01439282|583886136|FG001|Overall Study|Adverse Event|0|||
161681204|NCT01439282|583886135|FG000|Overall Study|Withdrawal by Subject|2|||
161830113|NCT02400476|584418113|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
161830114|NCT02400476|584418114|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
161830115|NCT02400476|584418115|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
161681205|NCT01439282|583886136|FG001|Overall Study|Withdrawal by Subject|0|||
161681206|NCT01439282|583886135|FG000|Overall Study|Other|1|||
161681207|NCT01439282|583886136|FG001|Overall Study|Other|1|||
162235010|NCT03149549|585910750|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
162235011|NCT03149549|585910751|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
162235012|NCT03149549|585910752|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
162235013|NCT03149549|585910753|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
162235014|NCT03149549|585910754|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
162235015|NCT03149549|585910755|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
162235016|NCT03149549|585910756|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
162235017|NCT03149549|585910757|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
162235018|NCT03149549|585910758|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
162235019|NCT03149549|585910759|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
162235020|NCT03149549|585910760|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
162235021|NCT03149549|585910761|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
162235022|NCT03149549|585910762|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
162235023|NCT05917470|585910763|FG000|Overall Study|Progressive Disease|1|||
162235024|NCT05917470|585910764|FG001|Overall Study|Progressive Disease|1|||
162235025|NCT05917470|585910765|FG002|Overall Study|Progressive Disease|2|||
162235026|NCT05917470|585910766|FG003|Overall Study|Progressive Disease|3|||
162235027|NCT05917470|585910767|FG004|Overall Study|Progressive Disease|1|||
162235028|NCT05917470|585910768|FG005|Overall Study|Progressive Disease|1|||
162235029|NCT05917470|585910769|FG006|Overall Study|Progressive Disease|0|||
162235030|NCT05917470|585910770|FG007|Overall Study|Progressive Disease|0|||
162235031|NCT05917470|585910763|FG000|Overall Study|Withdrawal by Subject|0|||
162235032|NCT05917470|585910764|FG001|Overall Study|Withdrawal by Subject|0|||
162235033|NCT05917470|585910765|FG002|Overall Study|Withdrawal by Subject|1|||
162235034|NCT05917470|585910766|FG003|Overall Study|Withdrawal by Subject|0|||
162235035|NCT05917470|585910767|FG004|Overall Study|Withdrawal by Subject|0|||
162235036|NCT05917470|585910768|FG005|Overall Study|Withdrawal by Subject|0|||
162235037|NCT05917470|585910769|FG006|Overall Study|Withdrawal by Subject|0|||
162235038|NCT05917470|585910770|FG007|Overall Study|Withdrawal by Subject|0|||
162235039|NCT05917470|585910763|FG000|Overall Study|Sponsor Decision|0|||
162235040|NCT05917470|585910764|FG001|Overall Study|Sponsor Decision|0|||
162235041|NCT05917470|585910765|FG002|Overall Study|Sponsor Decision|1|||
162235042|NCT05917470|585910766|FG003|Overall Study|Sponsor Decision|0|||
162235043|NCT05917470|585910767|FG004|Overall Study|Sponsor Decision|2|||
162235044|NCT05917470|585910768|FG005|Overall Study|Sponsor Decision|1|||
162235045|NCT05917470|585910769|FG006|Overall Study|Sponsor Decision|3|||
162235046|NCT05917470|585910770|FG007|Overall Study|Sponsor Decision|3|||
162235047|NCT05917470|585910763|FG000|Overall Study|Adverse Event|0|||
162235048|NCT05917470|585910764|FG001|Overall Study|Adverse Event|0|||
162235049|NCT05917470|585910765|FG002|Overall Study|Adverse Event|0|||
162235050|NCT05917470|585910766|FG003|Overall Study|Adverse Event|0|||
162235051|NCT05917470|585910767|FG004|Overall Study|Adverse Event|0|||
162235052|NCT05917470|585910768|FG005|Overall Study|Adverse Event|1|||
162235053|NCT05917470|585910769|FG006|Overall Study|Adverse Event|0|||
162235054|NCT05917470|585910770|FG007|Overall Study|Adverse Event|0|||
162235055|NCT02317432|585910771|FG000|Overall Study|Death|4|||
162235056|NCT02317432|585910772|FG001|Overall Study|Death|1|||
161681208|NCT04179734|583886140|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
161681209|NCT04179734|583886141|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
161681210|NCT04179734|583886140|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
161681211|NCT04179734|583886141|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
162235057|NCT02317432|585910771|FG000|Overall Study|Lost to Follow-up|0|||
161681212|NCT03197493|583886143|FG000|Overall Study|Withdrawal by Subject|5|||
161681213|NCT00054704|583886144|FG000|Overall Study|Lack of Efficacy|2|||
161681214|NCT00054704|583886145|FG001|Overall Study|Lack of Efficacy|3|||
161681215|NCT00054704|583886144|FG000|Overall Study|Adverse Event|3|||
161681216|NCT00054704|583886145|FG001|Overall Study|Adverse Event|1|||
161681217|NCT00054704|583886144|FG000|Overall Study|Lost to Follow-up|0|||
161681218|NCT00054704|583886145|FG001|Overall Study|Lost to Follow-up|1|||
162235058|NCT02317432|585910772|FG001|Overall Study|Lost to Follow-up|5|||
162235059|NCT02317432|585910771|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
162235060|NCT02317432|585910772|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
162235061|NCT01328717|585913004|FG000|Overall Study|Adverse Event|1|||
162235062|NCT00346268|585913005|FG000|Overall Study|Adverse Event|1|||
161681219|NCT01469182|583886148|FG000|Overall Study|Adverse Event|21|||
161830116|NCT00124462|584418116|FG000|Overall Study|Lost to Follow-up|3|||
161830117|NCT00124462|584418117|FG001|Overall Study|Lost to Follow-up|3|||
161681220|NCT01469182|583886149|FG001|Overall Study|Adverse Event|3|||
161681221|NCT01469182|583886148|FG000|Overall Study|Lost to Follow-up|3|||
162235063|NCT00346268|585913006|FG001|Overall Study|Adverse Event|0|||
162235064|NCT00346268|585913005|FG000|Overall Study|Protocol Violation|1|||
162235065|NCT00346268|585913006|FG001|Overall Study|Protocol Violation|0|||
162235066|NCT00346268|585913005|FG000|Overall Study|Participant refused|0|||
162235067|NCT00346268|585913006|FG001|Overall Study|Participant refused|3|||
162235068|NCT01557283|585913014|FG000|Overall Study|Lost to Follow-up|7|||
162235069|NCT01557283|585913014|FG000|Overall Study|Non-responder|19|||
162235070|NCT01557283|585913014|FG000|Overall Study|Adverse Event|7|||
162235071|NCT01557283|585913014|FG000|Overall Study|Lack of Efficacy|1|||
162235072|NCT01557283|585913014|FG000|Overall Study|Non-compliance|1|||
162235073|NCT01557283|585913014|FG000|Overall Study|Withdrawal by Subject|1|||
162235074|NCT01557283|585913014|FG000|Overall Study|Participant's weight too high for dose|1|||
162235075|NCT01557283|585913014|FG000|Overall Study|Worsening of psoriasis|1|||
162235076|NCT01557283|585913014|FG000|Overall Study|Other|6|||
162235077|NCT01765192|585913015|FG000|Treatment Period 1|Adverse Event|0|||
162235078|NCT01765192|585913016|FG001|Treatment Period 1|Adverse Event|1|||
162235079|NCT01765192|585913015|FG000|Washout Period|Voluntary Withdrawal|1|||
161830118|NCT00124462|584418116|FG000|Overall Study|Physician Decision|3|||
161830119|NCT00124462|584418117|FG001|Overall Study|Physician Decision|4|||
161830120|NCT00124462|584418116|FG000|Overall Study|Withdrawal by Subject|4|||
161830121|NCT00124462|584418117|FG001|Overall Study|Withdrawal by Subject|5|||
161830122|NCT00124462|584418116|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
161830123|NCT00124462|584418117|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
161830124|NCT00003531|584418118|FG000|Overall Study|Not evaluable|10|||
161830125|NCT00588731|584418119|FG000|Overall Study|Withdrawal by Subject|3|||
161830126|NCT00588731|584418120|FG001|Overall Study|Withdrawal by Subject|2|||
161830127|NCT00346164|584418121|FG000|Overall Study|Adverse Event|0|||
161830128|NCT00346164|584418122|FG001|Overall Study|Adverse Event|0|||
161830129|NCT00346164|584418123|FG002|Overall Study|Adverse Event|0|||
161830130|NCT00346164|584418124|FG003|Overall Study|Adverse Event|1|||
161830131|NCT00346164|584418121|FG000|Overall Study|Lack of Efficacy|0|||
161830132|NCT00346164|584418122|FG001|Overall Study|Lack of Efficacy|1|||
162025391|NCT02213133|585150740|FG001|Overall Study|Participant withdrew informed consent|1|||
162025392|NCT02213133|585150741|FG002|Overall Study|Participant withdrew informed consent|2|||
162235080|NCT01765192|585913016|FG001|Washout Period|Voluntary Withdrawal|1|||
161830133|NCT00346164|584418123|FG002|Overall Study|Lack of Efficacy|7|||
161830134|NCT00346164|584418124|FG003|Overall Study|Lack of Efficacy|25|||
161830135|NCT00346164|584418121|FG000|Overall Study|Physician Decision|0|||
161830136|NCT00346164|584418122|FG001|Overall Study|Physician Decision|1|||
161830137|NCT00346164|584418123|FG002|Overall Study|Physician Decision|2|||
161830138|NCT00346164|584418124|FG003|Overall Study|Physician Decision|27|||
162235081|NCT01765192|585913015|FG000|Washout Period|Reason not specified|1|||
162235082|NCT01765192|585913016|FG001|Washout Period|Reason not specified|0|||
162235083|NCT01765192|585913015|FG000|Treatment Period 2|Reason not specified|0|||
162235084|NCT01765192|585913016|FG001|Treatment Period 2|Reason not specified|2|||
162235085|NCT01765192|585913015|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
162235086|NCT01765192|585913016|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
162235087|NCT01016977|585913017|FG000|Overall Study|Lost to Follow-up|1|||
162235088|NCT01016977|585913018|FG001|Overall Study|Lost to Follow-up|0|||
162235089|NCT01016977|585913017|FG000|Overall Study|Withdrawal by Subject|2|||
162235090|NCT01016977|585913018|FG001|Overall Study|Withdrawal by Subject|2|||
162235091|NCT02080221|585913019|FG000|Overall Study|Withdrawal by Subject|1|||
162235092|NCT02080221|585913019|FG000|Overall Study|Clinical Progression of Disease|1|||
162235093|NCT03184870|585913025|FG000|Initial Treatment|Death|6|||
162235094|NCT03184870|585913026|FG001|Initial Treatment|Death|6|||
162235095|NCT03184870|585913027|FG002|Initial Treatment|Death|8|||
162235096|NCT03184870|585913028|FG003|Initial Treatment|Death|8|||
162235097|NCT03184870|585913029|FG004|Initial Treatment|Death|6|||
162235098|NCT03184870|585913030|FG005|Initial Treatment|Death|6|||
162235099|NCT03184870|585913031|FG006|Initial Treatment|Death|6|||
162235100|NCT03184870|585913032|FG007|Initial Treatment|Death|7|||
162235101|NCT03184870|585913033|FG008|Initial Treatment|Death|1|||
162235102|NCT03184870|585913034|FG009|Initial Treatment|Death|2|||
162235103|NCT03184870|585913035|FG010|Initial Treatment|Death|26|||
162235104|NCT03184870|585913036|FG011|Initial Treatment|Death|28|||
162235105|NCT03184870|585913037|FG012|Initial Treatment|Death|10|||
162235106|NCT03184870|585913038|FG013|Initial Treatment|Death|33|||
161830139|NCT00346164|584418121|FG000|Overall Study|Protocol Violation|6|||
161830140|NCT00346164|584418122|FG001|Overall Study|Protocol Violation|2|||
161830141|NCT00346164|584418123|FG002|Overall Study|Protocol Violation|10|||
161830142|NCT00346164|584418124|FG003|Overall Study|Protocol Violation|4|||
161830143|NCT00346164|584418121|FG000|Overall Study|Withdrawal by Subject|0|||
161830144|NCT00346164|584418122|FG001|Overall Study|Withdrawal by Subject|0|||
161830145|NCT00346164|584418123|FG002|Overall Study|Withdrawal by Subject|2|||
162235107|NCT03184870|585913039|FG014|Initial Treatment|Death|34|||
162235108|NCT03184870|585913040|FG015|Initial Treatment|Death|26|||
162235109|NCT03184870|585913041|FG016|Initial Treatment|Death|20|||
162235110|NCT03184870|585913042|FG017|Initial Treatment|Death|18|||
162235111|NCT03184870|585913025|FG000|Initial Treatment|Other Reasons|2|||
161681222|NCT01469182|583886149|FG001|Overall Study|Lost to Follow-up|0|||
161681223|NCT01469182|583886148|FG000|Overall Study|Withdrawal by Subject|4|||
162235112|NCT03184870|585913026|FG001|Initial Treatment|Other Reasons|2|||
162235113|NCT03184870|585913027|FG002|Initial Treatment|Other Reasons|0|||
162235114|NCT03184870|585913028|FG003|Initial Treatment|Other Reasons|1|||
162235115|NCT03184870|585913029|FG004|Initial Treatment|Other Reasons|0|||
162235116|NCT03184870|585913030|FG005|Initial Treatment|Other Reasons|0|||
162235117|NCT03184870|585913031|FG006|Initial Treatment|Other Reasons|0|||
162235118|NCT03184870|585913032|FG007|Initial Treatment|Other Reasons|2|||
162235119|NCT03184870|585913033|FG008|Initial Treatment|Other Reasons|0|||
162235120|NCT03184870|585913034|FG009|Initial Treatment|Other Reasons|0|||
162235121|NCT03184870|585913035|FG010|Initial Treatment|Other Reasons|4|||
162235122|NCT03184870|585913036|FG011|Initial Treatment|Other Reasons|2|||
162235123|NCT03184870|585913037|FG012|Initial Treatment|Other Reasons|2|||
162235124|NCT03184870|585913038|FG013|Initial Treatment|Other Reasons|0|||
162235125|NCT03184870|585913039|FG014|Initial Treatment|Other Reasons|0|||
162235126|NCT03184870|585913040|FG015|Initial Treatment|Other Reasons|1|||
162235127|NCT03184870|585913041|FG016|Initial Treatment|Other Reasons|0|||
162235128|NCT03184870|585913042|FG017|Initial Treatment|Other Reasons|2|||
162235129|NCT03184870|585913025|FG000|Initial Treatment|Lost to Follow-up|2|||
161681224|NCT01469182|583886149|FG001|Overall Study|Withdrawal by Subject|1|||
161681225|NCT01469182|583886148|FG000|Overall Study|Protocol Violation|4|||
161681226|NCT01469182|583886149|FG001|Overall Study|Protocol Violation|2|||
161681227|NCT01469182|583886148|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
161681228|NCT01469182|583886149|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
161681229|NCT02236520|583886151|FG000|Overall Study|Physician Decision|0|||
161681230|NCT02236520|583886152|FG001|Overall Study|Physician Decision|5|||
161681231|NCT02236520|583886153|FG002|Overall Study|Physician Decision|0|||
161681232|NCT02236520|583886154|FG003|Overall Study|Physician Decision|0|||
162235130|NCT03184870|585913026|FG001|Initial Treatment|Lost to Follow-up|0|||
161681233|NCT02236520|583886151|FG000|Overall Study|Withdrawal by Subject|1|||
161681234|NCT02236520|583886152|FG001|Overall Study|Withdrawal by Subject|0|||
161681235|NCT02236520|583886153|FG002|Overall Study|Withdrawal by Subject|0|||
161681236|NCT02236520|583886154|FG003|Overall Study|Withdrawal by Subject|1|||
161681237|NCT02236520|583886151|FG000|Overall Study|Pregnancy|1|||
161681238|NCT02236520|583886152|FG001|Overall Study|Pregnancy|0|||
161681239|NCT02236520|583886153|FG002|Overall Study|Pregnancy|0|||
161681240|NCT02236520|583886154|FG003|Overall Study|Pregnancy|0|||
161681241|NCT01785160|583886155|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
161681242|NCT01785160|583886155|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
161681243|NCT01033734|583886156|FG000|Overall Study|Withdrawal by Subject|1|||
161681244|NCT01360554|583886159|FG000|Overall Study|Death|359|||
161681245|NCT01360554|583886160|FG001|Overall Study|Death|371|||
161681246|NCT01360554|583886159|FG000|Overall Study|Lost to Follow-up|4|||
161681247|NCT01360554|583886160|FG001|Overall Study|Lost to Follow-up|4|||
161681248|NCT01360554|583886159|FG000|Overall Study|Withdrawal by Subject|23|||
161681249|NCT01360554|583886160|FG001|Overall Study|Withdrawal by Subject|24|||
161681250|NCT01360554|583886159|FG000|Overall Study|Study terminated by sponsor|49|||
161681251|NCT01360554|583886160|FG001|Overall Study|Study terminated by sponsor|37|||
161681252|NCT01360554|583886159|FG000|Overall Study|Other, not specified|1|||
162235131|NCT03184870|585913027|FG002|Initial Treatment|Lost to Follow-up|0|||
162235132|NCT03184870|585913028|FG003|Initial Treatment|Lost to Follow-up|1|||
162235133|NCT03184870|585913029|FG004|Initial Treatment|Lost to Follow-up|1|||
162235134|NCT03184870|585913030|FG005|Initial Treatment|Lost to Follow-up|1|||
162235135|NCT03184870|585913031|FG006|Initial Treatment|Lost to Follow-up|0|||
162235136|NCT03184870|585913032|FG007|Initial Treatment|Lost to Follow-up|2|||
161681253|NCT01360554|583886160|FG001|Overall Study|Other, not specified|0|||
162235137|NCT03184870|585913033|FG008|Initial Treatment|Lost to Follow-up|0|||
162235138|NCT03184870|585913034|FG009|Initial Treatment|Lost to Follow-up|0|||
161681254|NCT01360554|583886159|FG000|Overall Study|Randomized but not treated.|3|||
161681255|NCT01360554|583886160|FG001|Overall Study|Randomized but not treated.|3|||
161681256|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
161681257|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
161681258|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
162235139|NCT03184870|585913035|FG010|Initial Treatment|Lost to Follow-up|2|||
162235140|NCT03184870|585913036|FG011|Initial Treatment|Lost to Follow-up|0|||
162235141|NCT03184870|585913037|FG012|Initial Treatment|Lost to Follow-up|2|||
162235142|NCT03184870|585913038|FG013|Initial Treatment|Lost to Follow-up|2|||
162235143|NCT03184870|585913039|FG014|Initial Treatment|Lost to Follow-up|0|||
162235144|NCT03184870|585913040|FG015|Initial Treatment|Lost to Follow-up|0|||
162235145|NCT03184870|585913041|FG016|Initial Treatment|Lost to Follow-up|2|||
162235146|NCT03184870|585913042|FG017|Initial Treatment|Lost to Follow-up|2|||
162235147|NCT03184870|585913025|FG000|Initial Treatment|Withdrawal by Subject|0|||
162235148|NCT03184870|585913026|FG001|Initial Treatment|Withdrawal by Subject|0|||
162235149|NCT03184870|585913027|FG002|Initial Treatment|Withdrawal by Subject|2|||
162235150|NCT03184870|585913028|FG003|Initial Treatment|Withdrawal by Subject|1|||
162235151|NCT03184870|585913029|FG004|Initial Treatment|Withdrawal by Subject|1|||
162235152|NCT03184870|585913030|FG005|Initial Treatment|Withdrawal by Subject|0|||
162235153|NCT03184870|585913031|FG006|Initial Treatment|Withdrawal by Subject|1|||
162235154|NCT03184870|585913032|FG007|Initial Treatment|Withdrawal by Subject|0|||
162235155|NCT03184870|585913033|FG008|Initial Treatment|Withdrawal by Subject|0|||
162235156|NCT03184870|585913034|FG009|Initial Treatment|Withdrawal by Subject|0|||
162235157|NCT03184870|585913035|FG010|Initial Treatment|Withdrawal by Subject|0|||
162235158|NCT03184870|585913036|FG011|Initial Treatment|Withdrawal by Subject|2|||
162235159|NCT03184870|585913037|FG012|Initial Treatment|Withdrawal by Subject|3|||
162235160|NCT03184870|585913038|FG013|Initial Treatment|Withdrawal by Subject|0|||
162235161|NCT03184870|585913039|FG014|Initial Treatment|Withdrawal by Subject|1|||
162235162|NCT03184870|585913040|FG015|Initial Treatment|Withdrawal by Subject|5|||
162235163|NCT03184870|585913041|FG016|Initial Treatment|Withdrawal by Subject|2|||
162235164|NCT03184870|585913042|FG017|Initial Treatment|Withdrawal by Subject|2|||
162235165|NCT03184870|585913025|FG000|Initial Treatment|Moved to crossover treatment|0|||
162235166|NCT03184870|585913026|FG001|Initial Treatment|Moved to crossover treatment|0|||
162235167|NCT03184870|585913027|FG002|Initial Treatment|Moved to crossover treatment|0|||
162235168|NCT03184870|585913028|FG003|Initial Treatment|Moved to crossover treatment|0|||
162235169|NCT03184870|585913029|FG004|Initial Treatment|Moved to crossover treatment|0|||
162235170|NCT03184870|585913030|FG005|Initial Treatment|Moved to crossover treatment|0|||
162235171|NCT03184870|585913031|FG006|Initial Treatment|Moved to crossover treatment|0|||
162235172|NCT03184870|585913032|FG007|Initial Treatment|Moved to crossover treatment|0|||
162235173|NCT03184870|585913033|FG008|Initial Treatment|Moved to crossover treatment|0|||
162235174|NCT03184870|585913034|FG009|Initial Treatment|Moved to crossover treatment|0|||
162235175|NCT03184870|585913035|FG010|Initial Treatment|Moved to crossover treatment|0|||
162235176|NCT03184870|585913036|FG011|Initial Treatment|Moved to crossover treatment|0|||
162235177|NCT03184870|585913037|FG012|Initial Treatment|Moved to crossover treatment|9|||
162235178|NCT03184870|585913038|FG013|Initial Treatment|Moved to crossover treatment|0|||
162235179|NCT03184870|585913039|FG014|Initial Treatment|Moved to crossover treatment|0|||
162235180|NCT03184870|585913040|FG015|Initial Treatment|Moved to crossover treatment|0|||
162235181|NCT03184870|585913041|FG016|Initial Treatment|Moved to crossover treatment|0|||
162235182|NCT03184870|585913042|FG017|Initial Treatment|Moved to crossover treatment|0|||
162235183|NCT03184870|585913025|FG000|Crossover Treatment|Other reasons|0|||
162235184|NCT03184870|585913026|FG001|Crossover Treatment|Other reasons|0|||
162235185|NCT03184870|585913027|FG002|Crossover Treatment|Other reasons|0|||
162235186|NCT03184870|585913028|FG003|Crossover Treatment|Other reasons|0|||
161941112|NCT03396445|584836062|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
161941113|NCT03396445|584836063|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
162235187|NCT03184870|585913029|FG004|Crossover Treatment|Other reasons|0|||
162235188|NCT03184870|585913030|FG005|Crossover Treatment|Other reasons|0|||
162235189|NCT03184870|585913031|FG006|Crossover Treatment|Other reasons|0|||
162235190|NCT03184870|585913032|FG007|Crossover Treatment|Other reasons|0|||
162235191|NCT03184870|585913033|FG008|Crossover Treatment|Other reasons|0|||
162235192|NCT03184870|585913034|FG009|Crossover Treatment|Other reasons|0|||
162235193|NCT03184870|585913035|FG010|Crossover Treatment|Other reasons|0|||
162235194|NCT03184870|585913036|FG011|Crossover Treatment|Other reasons|0|||
162235195|NCT03184870|585913037|FG012|Crossover Treatment|Other reasons|0|||
162235196|NCT03184870|585913038|FG013|Crossover Treatment|Other reasons|0|||
162235197|NCT03184870|585913039|FG014|Crossover Treatment|Other reasons|0|||
162235198|NCT03184870|585913040|FG015|Crossover Treatment|Other reasons|0|||
162235199|NCT03184870|585913041|FG016|Crossover Treatment|Other reasons|0|||
162235200|NCT03184870|585913042|FG017|Crossover Treatment|Other reasons|2|||
162235201|NCT03184870|585913025|FG000|Crossover Treatment|Death|0|||
162235202|NCT03184870|585913026|FG001|Crossover Treatment|Death|0|||
162235203|NCT03184870|585913027|FG002|Crossover Treatment|Death|0|||
162235204|NCT03184870|585913028|FG003|Crossover Treatment|Death|0|||
162235205|NCT03184870|585913029|FG004|Crossover Treatment|Death|0|||
162235206|NCT03184870|585913030|FG005|Crossover Treatment|Death|0|||
162235207|NCT03184870|585913031|FG006|Crossover Treatment|Death|0|||
162235208|NCT03184870|585913032|FG007|Crossover Treatment|Death|0|||
162235209|NCT03184870|585913033|FG008|Crossover Treatment|Death|0|||
162235210|NCT03184870|585913034|FG009|Crossover Treatment|Death|0|||
162235211|NCT03184870|585913035|FG010|Crossover Treatment|Death|0|||
162235212|NCT03184870|585913036|FG011|Crossover Treatment|Death|0|||
162235213|NCT03184870|585913037|FG012|Crossover Treatment|Death|0|||
162235214|NCT03184870|585913038|FG013|Crossover Treatment|Death|0|||
162235215|NCT03184870|585913039|FG014|Crossover Treatment|Death|0|||
161681259|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
161681260|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
162235216|NCT03184870|585913040|FG015|Crossover Treatment|Death|0|||
162235217|NCT03184870|585913041|FG016|Crossover Treatment|Death|0|||
162235218|NCT03184870|585913042|FG017|Crossover Treatment|Death|7|||
162235219|NCT05081388|585913043|FG000|Overall Study|Adverse Event|1|||
162235220|NCT05081388|585913044|FG001|Overall Study|Adverse Event|0|||
162235221|NCT05081388|585913045|FG002|Overall Study|Adverse Event|0|||
162235222|NCT05081388|585913046|FG003|Overall Study|Adverse Event|0|||
162235223|NCT05081388|585913047|FG004|Overall Study|Adverse Event|0|||
162235224|NCT05081388|585913043|FG000|Overall Study|Lost to Follow-up|0|||
162235225|NCT05081388|585913044|FG001|Overall Study|Lost to Follow-up|1|||
162235226|NCT05081388|585913045|FG002|Overall Study|Lost to Follow-up|0|||
162235227|NCT05081388|585913046|FG003|Overall Study|Lost to Follow-up|0|||
162235228|NCT05081388|585913047|FG004|Overall Study|Lost to Follow-up|0|||
162235229|NCT05081388|585913043|FG000|Overall Study|Subject decision|0|||
162235230|NCT05081388|585913044|FG001|Overall Study|Subject decision|0|||
162235231|NCT05081388|585913045|FG002|Overall Study|Subject decision|0|||
161681261|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
161681262|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
161681263|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
161681264|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
161681265|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
161681266|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
161681267|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
161941114|NCT03396445|584836064|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
162235232|NCT05081388|585913046|FG003|Overall Study|Subject decision|1|||
162235233|NCT05081388|585913047|FG004|Overall Study|Subject decision|0|||
162235234|NCT03786783|585913048|FG000|Overall Study|Death|1|||
162235235|NCT03786783|585913048|FG000|Overall Study|Physician Decision|6|||
162235236|NCT03786783|585913048|FG000|Overall Study|Withdrawal by Subject|2|||
162235237|NCT03786783|585913048|FG000|Overall Study|Disease Progression|7|||
162235238|NCT03786783|585913048|FG000|Overall Study|Patient/Parent Refusal|4|||
162235239|NCT01776541|585913049|FG000|Overall Study|Administrative Reason|6|||
162235240|NCT01776541|585913050|FG001|Overall Study|Administrative Reason|2|||
162235241|NCT01776541|585913049|FG000|Overall Study|Death|4|||
162235242|NCT01776541|585913050|FG001|Overall Study|Death|0|||
162235243|NCT01776541|585913049|FG000|Overall Study|Lost to Follow-up|27|||
162235244|NCT01776541|585913050|FG001|Overall Study|Lost to Follow-up|48|||
162235245|NCT01776541|585913049|FG000|Overall Study|Unclassified|5|||
162235246|NCT01776541|585913050|FG001|Overall Study|Unclassified|4|||
162235247|NCT01776541|585913049|FG000|Overall Study|Protocol Violation|2|||
162235248|NCT01776541|585913050|FG001|Overall Study|Protocol Violation|1|||
162235249|NCT01776541|585913049|FG000|Overall Study|Withdrawal by Subject|12|||
162235250|NCT01776541|585913050|FG001|Overall Study|Withdrawal by Subject|20|||
162235251|NCT04279392|585913053|FG000|Overall Study|Physician Decision|1|||
162235252|NCT04279392|585913054|FG001|Overall Study|Physician Decision|0|||
162235253|NCT01981473|585913055|FG000|Overall Study|Incorrect diagnosis of RA|0|||
162235254|NCT01981473|585913056|FG001|Overall Study|Incorrect diagnosis of RA|0|||
162235255|NCT01981473|585913057|FG002|Overall Study|Incorrect diagnosis of RA|1|||
162235256|NCT01981473|585913055|FG000|Overall Study|Received treatment for < 6 months|0|||
162235257|NCT01981473|585913056|FG001|Overall Study|Received treatment for < 6 months|0|||
162235258|NCT01981473|585913057|FG002|Overall Study|Received treatment for < 6 months|1|||
162235259|NCT01981473|585913055|FG000|Overall Study|Received treatment for >24 months|2|||
162235260|NCT01981473|585913056|FG001|Overall Study|Received treatment for >24 months|0|||
162235261|NCT01981473|585913057|FG002|Overall Study|Received treatment for >24 months|6|||
162235262|NCT00738582|585913058|FG000|Combination Therapy|Completed Combination Therapy|1|||
162235263|NCT00738582|585913059|FG001|Combination Therapy|Completed Combination Therapy|0|||
162235264|NCT00738582|585913058|FG000|Combination Therapy|Physician Decision|1|||
162235265|NCT00738582|585913059|FG001|Combination Therapy|Physician Decision|0|||
162235266|NCT00738582|585913058|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
162235267|NCT00738582|585913059|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
162235268|NCT00738582|585913058|FG000|Combination Therapy|Other|5|||
162235269|NCT00738582|585913059|FG001|Combination Therapy|Other|0|||
162235270|NCT00738582|585913058|FG000|Combination Therapy|Adverse Event|16|||
161942342|NCT02303821|584838370|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
162235271|NCT00738582|585913059|FG001|Combination Therapy|Adverse Event|0|||
162235272|NCT00738582|585913058|FG000|Combination Therapy|Progressive Disease|9|||
162235273|NCT00738582|585913059|FG001|Combination Therapy|Progressive Disease|0|||
162235274|NCT00738582|585913058|FG000|Maintenance Therapy|Other|0|||
162235275|NCT00738582|585913059|FG001|Maintenance Therapy|Other|2|||
162235276|NCT00738582|585913058|FG000|Maintenance Therapy|Adverse Event|0|||
162235277|NCT00738582|585913059|FG001|Maintenance Therapy|Adverse Event|6|||
162235278|NCT00738582|585913058|FG000|Maintenance Therapy|Progressive Disease|0|||
162235279|NCT00738582|585913059|FG001|Maintenance Therapy|Progressive Disease|47|||
162235280|NCT00738582|585913058|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
162235281|NCT00738582|585913059|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
162025393|NCT02213133|585150739|FG000|Overall Study|Disease progression|11|||
162025394|NCT02213133|585150740|FG001|Overall Study|Disease progression|2|||
162025395|NCT02213133|585150741|FG002|Overall Study|Disease progression|0|||
162025396|NCT02213133|585150739|FG000|Overall Study|Adverse Event (AE)|1|||
162025397|NCT02213133|585150740|FG001|Overall Study|Adverse Event (AE)|0|||
162025398|NCT02213133|585150741|FG002|Overall Study|Adverse Event (AE)|0|||
162025399|NCT02213133|585150739|FG000|Overall Study|Death|16|||
162025400|NCT02213133|585150740|FG001|Overall Study|Death|2|||
162025401|NCT02213133|585150741|FG002|Overall Study|Death|1|||
162025402|NCT02213133|585150739|FG000|Overall Study|Other|5|||
162025403|NCT02213133|585150740|FG001|Overall Study|Other|0|||
162025404|NCT02213133|585150741|FG002|Overall Study|Other|0|||
162025405|NCT02743611|585150742|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
162025406|NCT02743611|585150743|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
162025407|NCT02743611|585150744|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
162025408|NCT02743611|585150745|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
162025409|NCT00729469|585150746|FG000|Overall Study|Adverse Event|14|||
162025410|NCT00729469|585150747|FG001|Overall Study|Adverse Event|25|||
162025411|NCT00729469|585150746|FG000|Overall Study|Lost to Follow-up|9|||
162025412|NCT00729469|585150747|FG001|Overall Study|Lost to Follow-up|9|||
162025413|NCT00729469|585150746|FG000|Overall Study|Protocol Violation|2|||
162025414|NCT00729469|585150747|FG001|Overall Study|Protocol Violation|1|||
162025415|NCT00729469|585150746|FG000|Overall Study|Withdrawal by Subject|19|||
162025416|NCT00729469|585150747|FG001|Overall Study|Withdrawal by Subject|8|||
162025417|NCT00729469|585150746|FG000|Overall Study|Other-Not mentioned|9|||
162025418|NCT00729469|585150747|FG001|Overall Study|Other-Not mentioned|4|||
162025419|NCT00566696|585150748|FG000|Overall Study|Met Exclusion Criteria|2|||
162025420|NCT00566696|585150748|FG000|Overall Study|Muromonab not available|1|||
162025421|NCT00566696|585150748|FG000|Overall Study|Health Status Change|1|||
162025422|NCT00566696|585150748|FG000|Overall Study|Physician Decision|1|||
162025423|NCT00566696|585150748|FG000|Overall Study|Non-Patient Donors|37|||
162025424|NCT00706342|585150749|FG000|Overall Study|Adverse Event|3|||
162025425|NCT00706342|585150749|FG000|Overall Study|Not responding to treatment|2|||
162025426|NCT00706342|585150749|FG000|Overall Study|Withdrawn due to failure to respond|1|||
162025427|NCT00706342|585150749|FG000|Overall Study|Death|1|||
162025428|NCT00706342|585150749|FG000|Overall Study|Withdrew from the study on his own.|1|||
162025429|NCT00706342|585150749|FG000|Overall Study|Investigator discretion|2|||
162025430|NCT00706342|585150749|FG000|Overall Study|Non-responder Week 12|1|||
162025431|NCT00706342|585150749|FG000|Overall Study|Ongoing|6|||
162025432|NCT00706342|585150749|FG000|Overall Study|WIthdrawal of consent|1|||
162235282|NCT00903006|585913065|FG000|Overall Study|Withdrawal by Subject|2|||
162235283|NCT00903006|585913066|FG001|Overall Study|Withdrawal by Subject|0|||
162235284|NCT00903006|585913067|FG002|Overall Study|Withdrawal by Subject|0|||
162235285|NCT00903006|585913068|FG003|Overall Study|Withdrawal by Subject|0|||
162235286|NCT00903006|585913065|FG000|Overall Study|Progressive Disease|0|||
162235287|NCT00903006|585913066|FG001|Overall Study|Progressive Disease|3|||
162235288|NCT00903006|585913067|FG002|Overall Study|Progressive Disease|1|||
162235289|NCT00903006|585913068|FG003|Overall Study|Progressive Disease|0|||
162235290|NCT03405792|585913069|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
162235291|NCT03405792|585913070|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
162235292|NCT03405792|585913069|FG000|Overall Study|o Did not receive pembrolizumab|1|||
162235293|NCT03405792|585913070|FG001|Overall Study|o Did not receive pembrolizumab|0|||
162235294|NCT02518490|585913074|FG000|Overall Study|Withdrawal by Subject|1|||
162235295|NCT02518490|585913075|FG001|Overall Study|Withdrawal by Subject|1|||
162235296|NCT00346632|585913076|FG000|Overall Study|Progressive Disease|2|||
162235297|NCT00346632|585913077|FG001|Overall Study|Progressive Disease|2|||
162235298|NCT00346632|585913078|FG002|Overall Study|Progressive Disease|4|||
162235299|NCT00346632|585913079|FG003|Overall Study|Progressive Disease|3|||
162235300|NCT00346632|585913080|FG004|Overall Study|Progressive Disease|3|||
162235301|NCT00346632|585913081|FG005|Overall Study|Progressive Disease|1|||
162235302|NCT00346632|585913082|FG006|Overall Study|Progressive Disease|2|||
162235303|NCT00346632|585913083|FG007|Overall Study|Progressive Disease|2|||
162235304|NCT00346632|585913084|FG008|Overall Study|Progressive Disease|2|||
162025433|NCT00119678|585150751|FG000|Double-blind Treatment Period|Death|1|||
162025434|NCT00119678|585150752|FG001|Double-blind Treatment Period|Death|0|||
162025435|NCT00119678|585150751|FG000|Double-blind Treatment Period|Adverse Event|7|||
162025436|NCT00119678|585150752|FG001|Double-blind Treatment Period|Adverse Event|1|||
162025437|NCT00119678|585150751|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
162025438|NCT00119678|585150752|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
162025439|NCT00119678|585150751|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
162025440|NCT00119678|585150752|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
162025441|NCT00119678|585150751|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
162235305|NCT00346632|585913085|FG009|Overall Study|Progressive Disease|2|||
161830146|NCT00346164|584418124|FG003|Overall Study|Withdrawal by Subject|0|||
161830147|NCT00346164|584418121|FG000|Overall Study|Ineligible|11|||
161830148|NCT00346164|584418122|FG001|Overall Study|Ineligible|2|||
161830149|NCT00346164|584418123|FG002|Overall Study|Ineligible|2|||
161830150|NCT00346164|584418124|FG003|Overall Study|Ineligible|23|||
161830151|NCT00346164|584418121|FG000|Overall Study|Refusal of further protocol therapy|0|||
161830152|NCT00346164|584418122|FG001|Overall Study|Refusal of further protocol therapy|1|||
161830153|NCT00346164|584418123|FG002|Overall Study|Refusal of further protocol therapy|3|||
161830154|NCT00346164|584418124|FG003|Overall Study|Refusal of further protocol therapy|15|||
161830155|NCT00346164|584418121|FG000|Overall Study|Inability to start week 16 tx on time|0|||
161830156|NCT00346164|584418122|FG001|Overall Study|Inability to start week 16 tx on time|0|||
161830157|NCT00346164|584418123|FG002|Overall Study|Inability to start week 16 tx on time|0|||
161830158|NCT00346164|584418124|FG003|Overall Study|Inability to start week 16 tx on time|11|||
161830159|NCT01684878|584418125|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
161830160|NCT01684878|584418126|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
161830161|NCT01684878|584418127|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
161830162|NCT01684878|584418128|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
161830163|NCT01684878|584418125|FG000|Part 1: Safety Run in Phase|Death|15|||
161830164|NCT01684878|584418126|FG001|Part 1: Safety Run in Phase|Death|20|||
161830165|NCT01684878|584418127|FG002|Part 1: Safety Run in Phase|Death|0|||
161830166|NCT01684878|584418128|FG003|Part 1: Safety Run in Phase|Death|0|||
161830167|NCT01684878|584418125|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
161830168|NCT01684878|584418126|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
161830169|NCT01684878|584418127|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
162235306|NCT00346632|585913076|FG000|Overall Study|Adverse Event|0|||
162235307|NCT00346632|585913077|FG001|Overall Study|Adverse Event|0|||
162235308|NCT00346632|585913078|FG002|Overall Study|Adverse Event|0|||
162235309|NCT00346632|585913079|FG003|Overall Study|Adverse Event|0|||
162235310|NCT00346632|585913080|FG004|Overall Study|Adverse Event|1|||
162235311|NCT00346632|585913081|FG005|Overall Study|Adverse Event|1|||
162235312|NCT00346632|585913082|FG006|Overall Study|Adverse Event|1|||
162235313|NCT00346632|585913083|FG007|Overall Study|Adverse Event|0|||
162235314|NCT00346632|585913084|FG008|Overall Study|Adverse Event|0|||
162235315|NCT00346632|585913085|FG009|Overall Study|Adverse Event|0|||
162235316|NCT00346632|585913076|FG000|Overall Study|Death|0|||
162235317|NCT00346632|585913077|FG001|Overall Study|Death|0|||
162235318|NCT00346632|585913078|FG002|Overall Study|Death|1|||
162235319|NCT00346632|585913079|FG003|Overall Study|Death|0|||
162235320|NCT00346632|585913080|FG004|Overall Study|Death|0|||
162235321|NCT00346632|585913081|FG005|Overall Study|Death|0|||
162235322|NCT00346632|585913082|FG006|Overall Study|Death|0|||
162235323|NCT00346632|585913083|FG007|Overall Study|Death|0|||
162235324|NCT00346632|585913084|FG008|Overall Study|Death|0|||
162235325|NCT00346632|585913085|FG009|Overall Study|Death|0|||
162235326|NCT00346632|585913076|FG000|Overall Study|Protocol Violation|0|||
162235327|NCT00346632|585913077|FG001|Overall Study|Protocol Violation|0|||
162235328|NCT00346632|585913078|FG002|Overall Study|Protocol Violation|0|||
162235329|NCT00346632|585913079|FG003|Overall Study|Protocol Violation|0|||
162235330|NCT00346632|585913080|FG004|Overall Study|Protocol Violation|0|||
162235331|NCT00346632|585913081|FG005|Overall Study|Protocol Violation|0|||
162235332|NCT00346632|585913082|FG006|Overall Study|Protocol Violation|1|||
162235333|NCT00346632|585913083|FG007|Overall Study|Protocol Violation|0|||
162235334|NCT00346632|585913084|FG008|Overall Study|Protocol Violation|0|||
162235335|NCT00346632|585913085|FG009|Overall Study|Protocol Violation|0|||
162235336|NCT00346632|585913076|FG000|Overall Study|Withdrawal by Subject|0|||
162235337|NCT00346632|585913077|FG001|Overall Study|Withdrawal by Subject|0|||
162235338|NCT00346632|585913078|FG002|Overall Study|Withdrawal by Subject|0|||
162235339|NCT00346632|585913079|FG003|Overall Study|Withdrawal by Subject|0|||
162235340|NCT00346632|585913080|FG004|Overall Study|Withdrawal by Subject|0|||
162235341|NCT00346632|585913081|FG005|Overall Study|Withdrawal by Subject|0|||
162235342|NCT00346632|585913082|FG006|Overall Study|Withdrawal by Subject|1|||
162235343|NCT00346632|585913083|FG007|Overall Study|Withdrawal by Subject|0|||
162235344|NCT00346632|585913084|FG008|Overall Study|Withdrawal by Subject|0|||
162235345|NCT00346632|585913085|FG009|Overall Study|Withdrawal by Subject|0|||
162235346|NCT00346632|585913076|FG000|Overall Study|Switched to alternative treatment|0|||
162235347|NCT00346632|585913077|FG001|Overall Study|Switched to alternative treatment|0|||
162235348|NCT00346632|585913078|FG002|Overall Study|Switched to alternative treatment|1|||
162235349|NCT00346632|585913079|FG003|Overall Study|Switched to alternative treatment|0|||
162235350|NCT00346632|585913080|FG004|Overall Study|Switched to alternative treatment|0|||
162235351|NCT00346632|585913081|FG005|Overall Study|Switched to alternative treatment|0|||
162235352|NCT00346632|585913082|FG006|Overall Study|Switched to alternative treatment|0|||
162235353|NCT00346632|585913083|FG007|Overall Study|Switched to alternative treatment|0|||
162235354|NCT00346632|585913084|FG008|Overall Study|Switched to alternative treatment|0|||
162235355|NCT00346632|585913085|FG009|Overall Study|Switched to alternative treatment|0|||
162235356|NCT00346632|585913076|FG000|Overall Study|Not Stated|1|||
162235357|NCT00346632|585913077|FG001|Overall Study|Not Stated|1|||
162235358|NCT00346632|585913078|FG002|Overall Study|Not Stated|0|||
162235359|NCT00346632|585913079|FG003|Overall Study|Not Stated|0|||
162235360|NCT00346632|585913080|FG004|Overall Study|Not Stated|0|||
162235361|NCT00346632|585913081|FG005|Overall Study|Not Stated|0|||
162235362|NCT00346632|585913082|FG006|Overall Study|Not Stated|0|||
162235363|NCT00346632|585913083|FG007|Overall Study|Not Stated|2|||
162235364|NCT00346632|585913084|FG008|Overall Study|Not Stated|2|||
162235365|NCT00346632|585913085|FG009|Overall Study|Not Stated|1|||
162235366|NCT04882995|585913086|FG000|Overall Study|Withdrawal by Subject|1|||
162235367|NCT04882995|585913087|FG001|Overall Study|Withdrawal by Subject|2|||
162235368|NCT04882995|585913086|FG000|Overall Study|Protocol Violation|4|||
162235369|NCT04882995|585913087|FG001|Overall Study|Protocol Violation|4|||
162235370|NCT04882995|585913086|FG000|Overall Study|Surgery postponed due to COVID|1|||
162235371|NCT04882995|585913087|FG001|Overall Study|Surgery postponed due to COVID|1|||
162235372|NCT03587974|585913088|FG000|Overall Study|caregiver demented, care recipient died|3|||
162235373|NCT03587974|585913089|FG001|Overall Study|caregiver demented, care recipient died|3|||
162235374|NCT03587974|585913088|FG000|Overall Study|Withdrawal by Subject|2|||
162235375|NCT03587974|585913089|FG001|Overall Study|Withdrawal by Subject|1|||
162235376|NCT03486457|585913090|FG000|Up to Month 3|Adverse Event|2|||
162235377|NCT03486457|585913091|FG001|Up to Month 3|Adverse Event|5|||
162235378|NCT03486457|585913090|FG000|Up to Month 3|Lack of Efficacy|1|||
162235379|NCT03486457|585913091|FG001|Up to Month 3|Lack of Efficacy|0|||
162235380|NCT03486457|585913090|FG000|Up to Month 3|Withdrawal by Subject|1|||
162025442|NCT00119678|585150752|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
162025443|NCT00119678|585150751|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
162025444|NCT00119678|585150752|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
162235381|NCT03486457|585913091|FG001|Up to Month 3|Withdrawal by Subject|0|||
162235382|NCT03486457|585913090|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
162235383|NCT03486457|585913091|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
162235384|NCT03486457|585913090|FG000|Up to Month 3|Other|1|||
162235385|NCT03486457|585913091|FG001|Up to Month 3|Other|0|||
162235386|NCT03486457|585913090|FG000|Month 3 to Month 6|Adverse Event|2|||
162235387|NCT03486457|585913091|FG001|Month 3 to Month 6|Adverse Event|0|||
162235388|NCT03486457|585913090|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
162235389|NCT03486457|585913091|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
162235390|NCT03486457|585913090|FG000|Month 3 to Month 6|Pregnancy|0|||
162235391|NCT03486457|585913091|FG001|Month 3 to Month 6|Pregnancy|1|||
162235392|NCT03486457|585913090|FG000|Month 3 to Month 6|Other|1|||
162235393|NCT03486457|585913091|FG001|Month 3 to Month 6|Other|0|||
162235394|NCT00372229|585913092|FG000|Study Phase|Graft loss|0|||
162235395|NCT00372229|585913093|FG001|Study Phase|Graft loss|3|||
162235396|NCT00372229|585913092|FG000|Study Phase|Protocol Violation|3|||
162235397|NCT00372229|585913093|FG001|Study Phase|Protocol Violation|4|||
162235398|NCT00372229|585913092|FG000|Study Phase|Consent withdrawn|16|||
162235399|NCT00372229|585913093|FG001|Study Phase|Consent withdrawn|14|||
162235400|NCT00372229|585913092|FG000|Study Phase|Refused treatment/did not cooperate|3|||
162235401|NCT00372229|585913093|FG001|Study Phase|Refused treatment/did not cooperate|1|||
162235402|NCT00372229|585913092|FG000|Study Phase|Death|3|||
162235403|NCT00372229|585913093|FG001|Study Phase|Death|2|||
162235404|NCT00372229|585913092|FG000|Study Phase|Reason not specified|3|||
162235405|NCT00372229|585913093|FG001|Study Phase|Reason not specified|2|||
162235406|NCT00372229|585913092|FG000|Study Phase|Lost to Follow-up|3|||
162235407|NCT00372229|585913093|FG001|Study Phase|Lost to Follow-up|3|||
162235408|NCT00372229|585913092|FG000|Follow-Up Phase|Graft loss|8|||
162235409|NCT00372229|585913093|FG001|Follow-Up Phase|Graft loss|7|||
162235410|NCT00372229|585913092|FG000|Follow-Up Phase|Consent withdrawn|13|||
162235411|NCT00372229|585913093|FG001|Follow-Up Phase|Consent withdrawn|19|||
162235412|NCT00372229|585913092|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
162235413|NCT00372229|585913093|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
162235414|NCT00372229|585913092|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
162235415|NCT00372229|585913093|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
162235416|NCT00372229|585913092|FG000|Follow-Up Phase|Death|9|||
162235417|NCT00372229|585913093|FG001|Follow-Up Phase|Death|12|||
162235418|NCT00372229|585913092|FG000|Follow-Up Phase|Administrative|1|||
162235419|NCT00372229|585913093|FG001|Follow-Up Phase|Administrative|0|||
162235420|NCT00372229|585913092|FG000|Follow-Up Phase|Reason not specified|2|||
162235421|NCT00372229|585913093|FG001|Follow-Up Phase|Reason not specified|3|||
162235422|NCT00372229|585913092|FG000|Follow-Up Phase|Lost to Follow-up|12|||
162235423|NCT00372229|585913093|FG001|Follow-Up Phase|Lost to Follow-up|10|||
162235424|NCT01347762|585913094|FG000|Overall Study|Lost to Follow-up|0|||
162235425|NCT01347762|585913095|FG001|Overall Study|Lost to Follow-up|1|||
162235426|NCT01347762|585913096|FG002|Overall Study|Lost to Follow-up|6|||
162235427|NCT01347762|585913097|FG003|Overall Study|Lost to Follow-up|5|||
162235428|NCT01347762|585913094|FG000|Overall Study|Withdrawal by Subject|4|||
162235429|NCT01347762|585913095|FG001|Overall Study|Withdrawal by Subject|1|||
162235430|NCT01347762|585913096|FG002|Overall Study|Withdrawal by Subject|3|||
162235431|NCT01347762|585913097|FG003|Overall Study|Withdrawal by Subject|3|||
162235432|NCT03235284|585913098|FG000|Overall Study|Adverse Event|1|||
162235433|NCT03235284|585913099|FG001|Overall Study|Adverse Event|2|||
162235434|NCT03235284|585913100|FG002|Overall Study|Adverse Event|1|||
162025445|NCT00119678|585150751|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
162025446|NCT00119678|585150752|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
162025447|NCT00119678|585150751|FG000|Double-blind Treatment Period|Pregnancy|0|||
162025448|NCT00119678|585150752|FG001|Double-blind Treatment Period|Pregnancy|2|||
162235435|NCT01382706|585913101|FG000|Overall Study|Adverse Event|1|||
162235436|NCT01382706|585913101|FG000|Overall Study|Withdrawal by Subject|1|||
162235437|NCT04055090|585913102|FG000|Overall Study|screen failure|1|||
162025449|NCT00119678|585150751|FG000|Double-blind Treatment Period|Not treated|1|||
162235438|NCT04055090|585913103|FG001|Overall Study|screen failure|0|||
162235439|NCT04055090|585913102|FG000|Overall Study|Withdrawal by Subject|1|||
162235440|NCT04055090|585913103|FG001|Overall Study|Withdrawal by Subject|0|||
162235441|NCT05478499|585913106|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
162235442|NCT05478499|585913107|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
162235443|NCT05478499|585913106|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
162235444|NCT05478499|585913107|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
161681268|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
161681269|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
161681270|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
161681271|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
161681272|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
161681273|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
161681274|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
161681275|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
161681276|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
161681277|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
161830170|NCT01684878|584418128|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
161681278|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
161681279|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
161681280|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
161681281|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
161681282|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
161681283|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
161681284|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
161681285|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
161830171|NCT01684878|584418125|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
161830172|NCT01684878|584418126|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
161830173|NCT01684878|584418127|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
161830174|NCT01684878|584418128|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
161830175|NCT01684878|584418125|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
161681286|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161681287|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161681288|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161681289|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161681290|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161681291|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161681292|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
161681293|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
161681294|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
161681295|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
161683068|NCT01148537|583891235|FG002|Overall Study|Withdrawal by Subject|2|||
161830176|NCT01684878|584418126|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
161941115|NCT03396445|584836065|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
161941116|NCT03396445|584836066|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941117|NCT03396445|584836067|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941118|NCT03396445|584836068|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941119|NCT03396445|584836069|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941120|NCT03396445|584836070|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941121|NCT03396445|584836071|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941122|NCT03396445|584836072|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941123|NCT03396445|584836073|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941124|NCT03396445|584836074|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941125|NCT03396445|584836075|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941126|NCT03396445|584836076|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941127|NCT03396445|584836077|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941128|NCT03396445|584836078|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941129|NCT03396445|584836079|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941130|NCT03396445|584836080|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
162025450|NCT00119678|585150752|FG001|Double-blind Treatment Period|Not treated|2|||
162235445|NCT05478499|585913106|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
162235446|NCT05478499|585913107|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
162235447|NCT05478499|585913106|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
162235448|NCT05478499|585913107|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
161830177|NCT01684878|584418127|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
161830178|NCT01684878|584418128|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
162025451|NCT00119678|585150751|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
162025452|NCT00119678|585150752|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
162025453|NCT00119678|585150751|FG000|Open-label Treatment Period|Death|1|||
162025454|NCT00119678|585150752|FG001|Open-label Treatment Period|Death|0|||
162025455|NCT00119678|585150751|FG000|Open-label Treatment Period|Adverse Event|3|||
162025456|NCT00119678|585150752|FG001|Open-label Treatment Period|Adverse Event|0|||
162025457|NCT00119678|585150751|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
162025458|NCT00119678|585150752|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
162025459|NCT00119678|585150751|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
162025460|NCT00119678|585150752|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
162025461|NCT00119678|585150751|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
162025462|NCT00119678|585150752|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
162025463|NCT00119678|585150751|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
162025464|NCT00119678|585150752|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
162025465|NCT00119678|585150751|FG000|Open-label Treatment Period|Pregnancy|1|||
162025466|NCT00119678|585150752|FG001|Open-label Treatment Period|Pregnancy|0|||
162025467|NCT00119678|585150751|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
162025468|NCT00119678|585150752|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
162025469|NCT03567343|585150753|FG000|Overall Study|Lost to Follow-up|2|||
162025470|NCT03567343|585150754|FG001|Overall Study|Lost to Follow-up|1|||
162025471|NCT03567343|585150753|FG000|Overall Study|No longer eligible|2|||
162025472|NCT03567343|585150754|FG001|Overall Study|No longer eligible|1|||
162025473|NCT03567343|585150753|FG000|Overall Study|Adverse Event|1|||
162025474|NCT03567343|585150754|FG001|Overall Study|Adverse Event|0|||
162025475|NCT03567343|585150753|FG000|Overall Study|Protocol Violation|1|||
162025476|NCT03567343|585150754|FG001|Overall Study|Protocol Violation|1|||
162025477|NCT01134705|585150755|FG000|Overall Study|Adverse Event|1|||
162025478|NCT01134705|585150756|FG001|Overall Study|Adverse Event|7|||
162025479|NCT01134705|585150755|FG000|Overall Study|Withdrawal by Subject|6|||
162025480|NCT01134705|585150756|FG001|Overall Study|Withdrawal by Subject|6|||
162025481|NCT01134705|585150755|FG000|Overall Study|Pregnancy|1|||
162025482|NCT01134705|585150756|FG001|Overall Study|Pregnancy|0|||
162025483|NCT01134705|585150755|FG000|Overall Study|Lost to Follow-up|5|||
161681296|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
161681297|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
161681298|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
161681299|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
161681300|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
161681301|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
161681302|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
161681303|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
161681304|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
161681305|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161941131|NCT03396445|584836081|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941132|NCT03396445|584836082|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941133|NCT03396445|584836083|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941134|NCT03396445|584836084|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
161941135|NCT03396445|584836059|FG000|Treatment Period|Withdrawal by Subject|0|||
161941136|NCT03396445|584836060|FG001|Treatment Period|Withdrawal by Subject|0|||
161941137|NCT03396445|584836061|FG002|Treatment Period|Withdrawal by Subject|0|||
161941138|NCT03396445|584836062|FG003|Treatment Period|Withdrawal by Subject|0|||
161941139|NCT03396445|584836063|FG004|Treatment Period|Withdrawal by Subject|0|||
161941140|NCT03396445|584836064|FG005|Treatment Period|Withdrawal by Subject|0|||
161941141|NCT03396445|584836065|FG006|Treatment Period|Withdrawal by Subject|0|||
161941142|NCT03396445|584836066|FG007|Treatment Period|Withdrawal by Subject|0|||
161941143|NCT03396445|584836067|FG008|Treatment Period|Withdrawal by Subject|0|||
162025484|NCT01134705|585150756|FG001|Overall Study|Lost to Follow-up|2|||
162025485|NCT01134705|585150755|FG000|Overall Study|Protocol Violation|1|||
162025486|NCT01134705|585150756|FG001|Overall Study|Protocol Violation|1|||
161681306|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161941144|NCT03396445|584836068|FG009|Treatment Period|Withdrawal by Subject|0|||
161941145|NCT03396445|584836069|FG010|Treatment Period|Withdrawal by Subject|0|||
161941146|NCT03396445|584836070|FG011|Treatment Period|Withdrawal by Subject|0|||
161941147|NCT03396445|584836071|FG012|Treatment Period|Withdrawal by Subject|0|||
161941148|NCT03396445|584836072|FG013|Treatment Period|Withdrawal by Subject|0|||
162025487|NCT01134705|585150755|FG000|Overall Study|Other|1|||
162025488|NCT01134705|585150756|FG001|Overall Study|Other|6|||
162025489|NCT00486811|585150760|FG000|Overall Study|Adverse Event|28|||
162025490|NCT00486811|585150761|FG001|Overall Study|Adverse Event|60|||
162025491|NCT00486811|585150762|FG002|Overall Study|Adverse Event|135|||
161941149|NCT03396445|584836073|FG014|Treatment Period|Withdrawal by Subject|1|||
161941150|NCT03396445|584836074|FG015|Treatment Period|Withdrawal by Subject|0|||
161941151|NCT03396445|584836075|FG016|Treatment Period|Withdrawal by Subject|1|||
161941152|NCT03396445|584836076|FG017|Treatment Period|Withdrawal by Subject|0|||
161941153|NCT03396445|584836077|FG018|Treatment Period|Withdrawal by Subject|0|||
161941154|NCT03396445|584836078|FG019|Treatment Period|Withdrawal by Subject|0|||
161941155|NCT03396445|584836079|FG020|Treatment Period|Withdrawal by Subject|0|||
161941156|NCT03396445|584836080|FG021|Treatment Period|Withdrawal by Subject|0|||
161941157|NCT03396445|584836081|FG022|Treatment Period|Withdrawal by Subject|0|||
161941158|NCT03396445|584836082|FG023|Treatment Period|Withdrawal by Subject|0|||
161941159|NCT03396445|584836083|FG024|Treatment Period|Withdrawal by Subject|0|||
161941160|NCT03396445|584836084|FG025|Treatment Period|Withdrawal by Subject|0|||
161941161|NCT03396445|584836059|FG000|Switch-over Period|Death|0|||
161941162|NCT03396445|584836060|FG001|Switch-over Period|Death|0|||
161941163|NCT03396445|584836061|FG002|Switch-over Period|Death|0|||
161941164|NCT03396445|584836062|FG003|Switch-over Period|Death|0|||
161941165|NCT03396445|584836063|FG004|Switch-over Period|Death|0|||
161941166|NCT03396445|584836064|FG005|Switch-over Period|Death|0|||
161941167|NCT03396445|584836065|FG006|Switch-over Period|Death|0|||
161941168|NCT03396445|584836066|FG007|Switch-over Period|Death|0|||
161941169|NCT03396445|584836067|FG008|Switch-over Period|Death|0|||
161941170|NCT03396445|584836068|FG009|Switch-over Period|Death|0|||
161941171|NCT03396445|584836069|FG010|Switch-over Period|Death|0|||
161941172|NCT03396445|584836070|FG011|Switch-over Period|Death|0|||
161941173|NCT03396445|584836071|FG012|Switch-over Period|Death|0|||
161941174|NCT03396445|584836072|FG013|Switch-over Period|Death|0|||
161941175|NCT03396445|584836073|FG014|Switch-over Period|Death|0|||
161941176|NCT03396445|584836074|FG015|Switch-over Period|Death|0|||
161941177|NCT03396445|584836075|FG016|Switch-over Period|Death|0|||
161941178|NCT03396445|584836076|FG017|Switch-over Period|Death|0|||
161941179|NCT03396445|584836077|FG018|Switch-over Period|Death|1|||
161941180|NCT03396445|584836078|FG019|Switch-over Period|Death|2|||
161941181|NCT03396445|584836079|FG020|Switch-over Period|Death|2|||
161941182|NCT03396445|584836080|FG021|Switch-over Period|Death|1|||
161941183|NCT03396445|584836081|FG022|Switch-over Period|Death|2|||
161941184|NCT03396445|584836082|FG023|Switch-over Period|Death|0|||
161941185|NCT03396445|584836083|FG024|Switch-over Period|Death|1|||
162025492|NCT00486811|585150760|FG000|Overall Study|Lack of Efficacy|34|||
162235449|NCT05478499|585913106|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
162235450|NCT05478499|585913107|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
162235451|NCT05478499|585913106|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
162235452|NCT05478499|585913107|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
162235453|NCT05478499|585913106|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
162235454|NCT05478499|585913107|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
162235455|NCT05478499|585913106|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
162235456|NCT05478499|585913107|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
162235457|NCT05478499|585913106|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
162235458|NCT05478499|585913107|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
162235459|NCT05478499|585913106|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
162235460|NCT05478499|585913107|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
162235461|NCT05478499|585913106|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
162235462|NCT05478499|585913107|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
162235463|NCT00249002|585913111|FG000|Overall Study|Adverse Event|2|||
162235464|NCT00249002|585913111|FG000|Overall Study|Study cancellation|3|||
162235465|NCT00249002|585913111|FG000|Overall Study|Other|2|||
162235466|NCT00552240|585913112|FG000|Overall Study|Adverse Event|9|||
162235467|NCT00552240|585913113|FG001|Overall Study|Adverse Event|9|||
162235468|NCT00552240|585913112|FG000|Overall Study|Protocol Violation|1|||
162235469|NCT00552240|585913113|FG001|Overall Study|Protocol Violation|1|||
162235470|NCT00552240|585913112|FG000|Overall Study|Lost to Follow-up|5|||
162235471|NCT00552240|585913113|FG001|Overall Study|Lost to Follow-up|6|||
162235472|NCT00552240|585913112|FG000|Overall Study|Withdrawal by Subject|2|||
162235473|NCT00552240|585913113|FG001|Overall Study|Withdrawal by Subject|2|||
162235474|NCT00552240|585913112|FG000|Overall Study|Lack of Efficacy|6|||
162235475|NCT00552240|585913113|FG001|Overall Study|Lack of Efficacy|0|||
162235476|NCT00552240|585913112|FG000|Overall Study|Other|1|||
162235477|NCT00552240|585913113|FG001|Overall Study|Other|0|||
162235478|NCT02679573|585913114|FG000|Overall Study|Adverse Event|13|||
161941186|NCT03396445|584836084|FG025|Switch-over Period|Death|6|||
161941187|NCT03396445|584836059|FG000|Switch-over Period|Lost to Follow-up|0|||
161941188|NCT03396445|584836060|FG001|Switch-over Period|Lost to Follow-up|0|||
161941189|NCT03396445|584836061|FG002|Switch-over Period|Lost to Follow-up|0|||
161941190|NCT03396445|584836062|FG003|Switch-over Period|Lost to Follow-up|0|||
161941191|NCT03396445|584836063|FG004|Switch-over Period|Lost to Follow-up|0|||
161941192|NCT03396445|584836064|FG005|Switch-over Period|Lost to Follow-up|0|||
161941193|NCT03396445|584836065|FG006|Switch-over Period|Lost to Follow-up|0|||
161941194|NCT03396445|584836066|FG007|Switch-over Period|Lost to Follow-up|0|||
161941195|NCT03396445|584836067|FG008|Switch-over Period|Lost to Follow-up|0|||
161941196|NCT03396445|584836068|FG009|Switch-over Period|Lost to Follow-up|0|||
162235479|NCT02679573|585913115|FG001|Overall Study|Adverse Event|6|||
162235480|NCT02679573|585913114|FG000|Overall Study|Lack of Efficacy|12|||
162235481|NCT02679573|585913115|FG001|Overall Study|Lack of Efficacy|15|||
162235482|NCT02679573|585913114|FG000|Overall Study|Could not complete required study visits|6|||
162235483|NCT02679573|585913115|FG001|Overall Study|Could not complete required study visits|2|||
162235484|NCT02679573|585913114|FG000|Overall Study|Withdrawal by Subject|2|||
162235485|NCT02679573|585913115|FG001|Overall Study|Withdrawal by Subject|9|||
162235486|NCT02679573|585913114|FG000|Overall Study|Death|2|||
162235487|NCT02679573|585913115|FG001|Overall Study|Death|0|||
162235488|NCT02679573|585913114|FG000|Overall Study|Physician Decision|2|||
162235489|NCT02679573|585913115|FG001|Overall Study|Physician Decision|4|||
162235490|NCT02679573|585913114|FG000|Overall Study|Lost to Follow-up|0|||
162235491|NCT02679573|585913115|FG001|Overall Study|Lost to Follow-up|3|||
162235492|NCT02476279|585913116|FG000|Overall Study|Lost to Follow-up|1|||
162235493|NCT02476279|585913117|FG001|Overall Study|Lost to Follow-up|1|||
162235494|NCT02128542|585913118|FG000|Overall Study|Lost to Follow-up|3|||
162235495|NCT02128542|585913119|FG001|Overall Study|Lost to Follow-up|0|||
162235496|NCT02128542|585913118|FG000|Overall Study|Withdrew Consent|1|||
162235497|NCT02128542|585913119|FG001|Overall Study|Withdrew Consent|0|||
162235498|NCT03451162|585913125|FG000|Overall Study|Lost to Follow-up|1|||
162235499|NCT03451162|585913126|FG001|Overall Study|Lost to Follow-up|0|||
162235500|NCT03451162|585913127|FG002|Overall Study|Lost to Follow-up|0|||
162235501|NCT03451162|585913128|FG003|Overall Study|Lost to Follow-up|0|||
162235502|NCT03451162|585913129|FG004|Overall Study|Lost to Follow-up|0|||
162235503|NCT03451162|585913125|FG000|Overall Study|Physician Decision|0|||
162235504|NCT03451162|585913126|FG001|Overall Study|Physician Decision|1|||
162235505|NCT03451162|585913127|FG002|Overall Study|Physician Decision|0|||
162235506|NCT03451162|585913128|FG003|Overall Study|Physician Decision|0|||
162235507|NCT03451162|585913129|FG004|Overall Study|Physician Decision|0|||
162235508|NCT03451162|585913125|FG000|Overall Study|Withdrawal by Subject|1|||
162235509|NCT03451162|585913126|FG001|Overall Study|Withdrawal by Subject|1|||
162235510|NCT03451162|585913127|FG002|Overall Study|Withdrawal by Subject|0|||
162235511|NCT03451162|585913128|FG003|Overall Study|Withdrawal by Subject|0|||
162235512|NCT03451162|585913129|FG004|Overall Study|Withdrawal by Subject|0|||
162235513|NCT01952054|585913130|FG000|Overall Study|Physician Decision|1|||
162235514|NCT00232544|585913131|FG000|Overall Study|Lost to Follow-up|20|||
162235515|NCT00232544|585913132|FG001|Overall Study|Lost to Follow-up|15|||
162235516|NCT00116753|585913133|FG000|Overall Study|Adverse Event|16|||
162235517|NCT00116753|585913134|FG001|Overall Study|Adverse Event|10|||
162235518|NCT00116753|585913135|FG002|Overall Study|Adverse Event|7|||
162235519|NCT00116753|585913133|FG000|Overall Study|Withdrawal by Subject|11|||
162235520|NCT00116753|585913134|FG001|Overall Study|Withdrawal by Subject|12|||
162235521|NCT00116753|585913135|FG002|Overall Study|Withdrawal by Subject|8|||
162235522|NCT00116753|585913133|FG000|Overall Study|Lost to Follow-up|0|||
162235523|NCT00116753|585913134|FG001|Overall Study|Lost to Follow-up|2|||
162235524|NCT00116753|585913135|FG002|Overall Study|Lost to Follow-up|1|||
161941197|NCT03396445|584836069|FG010|Switch-over Period|Lost to Follow-up|0|||
162025493|NCT00486811|585150761|FG001|Overall Study|Lack of Efficacy|14|||
162235525|NCT00116753|585913133|FG000|Overall Study|Protocol Violation|0|||
162235526|NCT00116753|585913134|FG001|Overall Study|Protocol Violation|0|||
162235527|NCT00116753|585913135|FG002|Overall Study|Protocol Violation|1|||
162235528|NCT00116753|585913133|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
162235529|NCT00116753|585913134|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
162235530|NCT00116753|585913135|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
162235531|NCT00116753|585913133|FG000|Overall Study|Disease Progression|3|||
162235532|NCT00116753|585913134|FG001|Overall Study|Disease Progression|4|||
161683069|NCT01148537|583891233|FG000|Overall Study|Adverse Event|2|||
162235533|NCT00116753|585913135|FG002|Overall Study|Disease Progression|3|||
162235534|NCT00116753|585913133|FG000|Overall Study|Abnormal Echocardiogram|0|||
162235535|NCT00116753|585913134|FG001|Overall Study|Abnormal Echocardiogram|0|||
162235536|NCT00116753|585913135|FG002|Overall Study|Abnormal Echocardiogram|1|||
162235537|NCT00116753|585913133|FG000|Overall Study|Progressive Parkinson's Disease|1|||
162235538|NCT00116753|585913134|FG001|Overall Study|Progressive Parkinson's Disease|0|||
162235539|NCT00116753|585913135|FG002|Overall Study|Progressive Parkinson's Disease|0|||
162235540|NCT00116753|585913133|FG000|Overall Study|Dosing Error|0|||
162235541|NCT00116753|585913134|FG001|Overall Study|Dosing Error|1|||
162235542|NCT00116753|585913135|FG002|Overall Study|Dosing Error|0|||
162235543|NCT01200589|585913136|FG000|Overall Study|Withdrawal by Subject|13|||
162235544|NCT01200589|585913137|FG001|Overall Study|Withdrawal by Subject|11|||
162235545|NCT01200589|585913136|FG000|Overall Study|Physician Decision|2|||
162235546|NCT01200589|585913137|FG001|Overall Study|Physician Decision|2|||
162235547|NCT01200589|585913136|FG000|Overall Study|Lost to Follow-up|5|||
162235548|NCT01200589|585913137|FG001|Overall Study|Lost to Follow-up|4|||
162235549|NCT01200589|585913136|FG000|Overall Study|Study terminated|170|||
162235550|NCT01200589|585913137|FG001|Overall Study|Study terminated|172|||
162235551|NCT00986973|585913138|FG000|Overall Study|Withdrawn by study team|1|||
162235552|NCT00598273|585913139|FG000|Overall Study|Adverse Event|4|||
162235553|NCT00598273|585913140|FG001|Overall Study|Adverse Event|5|||
162235554|NCT00598273|585913141|FG002|Overall Study|Adverse Event|2|||
162235555|NCT00598273|585913139|FG000|Overall Study|Death|6|||
162235556|NCT00598273|585913140|FG001|Overall Study|Death|12|||
162235557|NCT00598273|585913141|FG002|Overall Study|Death|8|||
162235558|NCT00598273|585913139|FG000|Overall Study|Lost to Follow-up|8|||
162235559|NCT00598273|585913140|FG001|Overall Study|Lost to Follow-up|3|||
162235560|NCT00598273|585913141|FG002|Overall Study|Lost to Follow-up|5|||
162235561|NCT00598273|585913139|FG000|Overall Study|Physician Decision|0|||
162235562|NCT00598273|585913140|FG001|Overall Study|Physician Decision|0|||
162235563|NCT00598273|585913141|FG002|Overall Study|Physician Decision|1|||
162235564|NCT00598273|585913139|FG000|Overall Study|Withdrawal by Subject|12|||
162235565|NCT00598273|585913140|FG001|Overall Study|Withdrawal by Subject|10|||
162235566|NCT00598273|585913141|FG002|Overall Study|Withdrawal by Subject|10|||
162235567|NCT00598273|585913139|FG000|Overall Study|Noncompliance|3|||
162235568|NCT00598273|585913140|FG001|Overall Study|Noncompliance|2|||
162235569|NCT00598273|585913141|FG002|Overall Study|Noncompliance|3|||
162235570|NCT00598273|585913139|FG000|Overall Study|Relocation|0|||
162235571|NCT00598273|585913140|FG001|Overall Study|Relocation|2|||
162235572|NCT00598273|585913141|FG002|Overall Study|Relocation|4|||
162235573|NCT00598273|585913139|FG000|Overall Study|Renal transplant|1|||
162235574|NCT00598273|585913140|FG001|Overall Study|Renal transplant|0|||
162235575|NCT00598273|585913141|FG002|Overall Study|Renal transplant|1|||
162235576|NCT00598273|585913139|FG000|Overall Study|Site elected to close|1|||
162235577|NCT00598273|585913140|FG001|Overall Study|Site elected to close|0|||
162235578|NCT00598273|585913141|FG002|Overall Study|Site elected to close|0|||
162235579|NCT00598273|585913139|FG000|Overall Study|Started dialysis|6|||
162235580|NCT00598273|585913140|FG001|Overall Study|Started dialysis|4|||
162235581|NCT00598273|585913141|FG002|Overall Study|Started dialysis|5|||
162235582|NCT01590082|585913142|FG000|Overall Study|Withdrawal by Subject|1|||
162235583|NCT01590082|585913143|FG001|Overall Study|Withdrawal by Subject|0|||
162235584|NCT01590082|585913142|FG000|Overall Study|Ineligible|1|||
162235585|NCT01590082|585913143|FG001|Overall Study|Ineligible|0|||
162235586|NCT02549196|585913144|FG000|Overall Study|Protocol Violation|0|||
162235587|NCT02549196|585913145|FG001|Overall Study|Protocol Violation|0|||
162235588|NCT02549196|585913146|FG002|Overall Study|Protocol Violation|0|||
162235589|NCT02549196|585913147|FG003|Overall Study|Protocol Violation|1|||
162025494|NCT00486811|585150762|FG002|Overall Study|Lack of Efficacy|7|||
162235590|NCT02549196|585913144|FG000|Overall Study|Withdrawal by Subject|1|||
162235591|NCT02549196|585913145|FG001|Overall Study|Withdrawal by Subject|0|||
162235592|NCT02549196|585913146|FG002|Overall Study|Withdrawal by Subject|1|||
162235593|NCT02549196|585913147|FG003|Overall Study|Withdrawal by Subject|0|||
162235594|NCT01442779|585913148|FG000|Overall Study|Withdrawal by Subject|3|||
162235595|NCT01442779|585913148|FG000|Overall Study|Death|3|||
162235596|NCT01442779|585913148|FG000|Overall Study|Non-compliance|1|||
162235597|NCT01323972|585913149|FG000|Overall Study|Withdrawal by Subject|1|||
161941198|NCT03396445|584836070|FG011|Switch-over Period|Lost to Follow-up|0|||
161941199|NCT03396445|584836071|FG012|Switch-over Period|Lost to Follow-up|0|||
161941200|NCT03396445|584836072|FG013|Switch-over Period|Lost to Follow-up|0|||
161941201|NCT03396445|584836073|FG014|Switch-over Period|Lost to Follow-up|0|||
161941202|NCT03396445|584836074|FG015|Switch-over Period|Lost to Follow-up|0|||
161941203|NCT03396445|584836075|FG016|Switch-over Period|Lost to Follow-up|0|||
161941204|NCT03396445|584836076|FG017|Switch-over Period|Lost to Follow-up|0|||
161941205|NCT03396445|584836077|FG018|Switch-over Period|Lost to Follow-up|0|||
161681307|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161681308|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161681309|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161681310|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161681311|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
161681312|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161681313|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161681314|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161681315|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161681316|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161681317|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
161681318|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161681319|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161681320|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161681321|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161681322|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161681323|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
161681324|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161681325|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161681326|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161681327|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161681328|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161681329|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
161681330|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161681331|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161681332|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161681333|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161681334|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161681335|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161681336|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161681337|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
161681338|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161681339|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161681340|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161681341|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161681342|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161681343|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
161681344|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161681345|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161681346|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161681347|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161681348|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161681349|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161681350|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
161681351|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161681352|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161681353|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161681354|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161681355|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161681356|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
161941206|NCT03396445|584836078|FG019|Switch-over Period|Lost to Follow-up|0|||
161941207|NCT03396445|584836079|FG020|Switch-over Period|Lost to Follow-up|0|||
161941208|NCT03396445|584836080|FG021|Switch-over Period|Lost to Follow-up|0|||
161941209|NCT03396445|584836081|FG022|Switch-over Period|Lost to Follow-up|0|||
162025495|NCT00486811|585150760|FG000|Overall Study|Lost to Follow-up|4|||
161830179|NCT01684878|584418125|FG000|Part 2: Randomized Phase|Death|0|||
161830180|NCT01684878|584418126|FG001|Part 2: Randomized Phase|Death|0|||
161830181|NCT01684878|584418127|FG002|Part 2: Randomized Phase|Death|62|||
161830182|NCT01684878|584418128|FG003|Part 2: Randomized Phase|Death|68|||
161941210|NCT03396445|584836082|FG023|Switch-over Period|Lost to Follow-up|1|||
161830183|NCT01684878|584418125|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
161830184|NCT01684878|584418126|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
161830185|NCT01684878|584418127|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
161830186|NCT01684878|584418128|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
161830187|NCT01684878|584418125|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
161830188|NCT01684878|584418126|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
161830189|NCT01684878|584418127|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
161830190|NCT01684878|584418128|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
161830191|NCT02087176|584418132|FG000|Overall Study|Withdrawal by Subject|1|||
161830192|NCT02087176|584418132|FG000|Overall Study|Death|10|||
161830193|NCT02087176|584418132|FG000|Overall Study|Censored|19|||
161830194|NCT02087176|584418132|FG000|Overall Study|Study Terminated by Sponsor|2|||
161830195|NCT02927834|584418133|FG000|Overall Study|Lost to Follow-up|1|||
161830196|NCT02927834|584418134|FG001|Overall Study|Lost to Follow-up|2|||
161830197|NCT02927834|584418135|FG002|Overall Study|Lost to Follow-up|2|||
161830198|NCT03812991|584418137|FG000|Overall Study|Lost to Follow-up|3|||
161830199|NCT03812991|584418138|FG001|Overall Study|Lost to Follow-up|1|||
161830200|NCT03942211|584418139|FG000|Overall Study|Death|1|||
161830201|NCT03942211|584418140|FG001|Overall Study|Death|0|||
161830202|NCT03942211|584418139|FG000|Overall Study|Study terminated by sponsor|5|||
161830203|NCT03942211|584418140|FG001|Overall Study|Study terminated by sponsor|3|||
161941211|NCT03396445|584836083|FG024|Switch-over Period|Lost to Follow-up|0|||
161941212|NCT03396445|584836084|FG025|Switch-over Period|Lost to Follow-up|0|||
161941213|NCT00366457|584836098|FG000|Overall Study|never began study therapy|2|||
161941214|NCT02829996|584836099|FG000|Overall Study|Withdrawal by Subject|1|||
161941215|NCT02829996|584836100|FG001|Overall Study|Withdrawal by Subject|0|||
161941216|NCT02829996|584836101|FG002|Overall Study|Withdrawal by Subject|0|||
161941217|NCT02829996|584836102|FG003|Overall Study|Withdrawal by Subject|0|||
161941218|NCT02829996|584836103|FG004|Overall Study|Withdrawal by Subject|0|||
161941219|NCT02095106|584836112|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
161941220|NCT02095106|584836113|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
161941221|NCT00553254|584836121|FG000|Overall Study|Death|3|||
161941222|NCT00553254|584836122|FG001|Overall Study|Death|6|||
161941223|NCT00553254|584836123|FG002|Overall Study|Death|25|||
161941224|NCT00553254|584836121|FG000|Overall Study|Lost to Follow-up|0|||
161941225|NCT00553254|584836122|FG001|Overall Study|Lost to Follow-up|0|||
161941226|NCT00553254|584836123|FG002|Overall Study|Lost to Follow-up|2|||
161941227|NCT00553254|584836121|FG000|Overall Study|Withdrawal by Subject|2|||
161941228|NCT00553254|584836122|FG001|Overall Study|Withdrawal by Subject|0|||
161941229|NCT00553254|584836123|FG002|Overall Study|Withdrawal by Subject|2|||
161941230|NCT00553254|584836121|FG000|Overall Study|Study terminated by Sponsor|0|||
161941231|NCT00553254|584836122|FG001|Overall Study|Study terminated by Sponsor|0|||
161941232|NCT00553254|584836123|FG002|Overall Study|Study terminated by Sponsor|1|||
161941233|NCT00553254|584836121|FG000|Overall Study|Other|1|||
161941234|NCT00553254|584836122|FG001|Overall Study|Other|0|||
161941235|NCT00553254|584836123|FG002|Overall Study|Other|13|||
161681357|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161830204|NCT03942211|584418139|FG000|Overall Study|Adverse Event|0|||
161830205|NCT03942211|584418140|FG001|Overall Study|Adverse Event|1|||
161830206|NCT01148225|584418141|FG000|Overall Study|Other|185|||
161941236|NCT02314923|584836126|FG000|Overall Study|Death|0|||
161941237|NCT02314923|584836127|FG001|Overall Study|Death|0|||
161941238|NCT02314923|584836128|FG002|Overall Study|Death|0|||
161941239|NCT02314923|584836129|FG003|Overall Study|Death|1|||
161830207|NCT01955044|584418142|FG000|Overall Study|Death|1|||
161830208|NCT01955044|584418143|FG001|Overall Study|Death|1|||
161830209|NCT01955044|584418144|FG002|Overall Study|Death|0|||
161830210|NCT00925301|584418148|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
161830211|NCT00925301|584418149|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
161830212|NCT00925301|584418150|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
161830213|NCT00925301|584418151|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
161830214|NCT00925301|584418148|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
161830215|NCT00925301|584418149|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
161830216|NCT00925301|584418150|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
161830217|NCT00925301|584418151|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
161830218|NCT00925301|584418148|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
161830219|NCT00925301|584418149|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
161830220|NCT00925301|584418150|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
161941240|NCT02314923|584836130|FG004|Overall Study|Death|0|||
161941241|NCT02314923|584836131|FG005|Overall Study|Death|0|||
161941242|NCT02314923|584836132|FG006|Overall Study|Death|0|||
161830221|NCT00925301|584418151|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
161941243|NCT02314923|584836133|FG007|Overall Study|Death|0|||
161941244|NCT02314923|584836134|FG008|Overall Study|Death|0|||
161941245|NCT02314923|584836135|FG009|Overall Study|Death|0|||
161941246|NCT02314923|584836126|FG000|Overall Study|Lost to Follow-up|2|||
161941247|NCT02314923|584836127|FG001|Overall Study|Lost to Follow-up|3|||
161830222|NCT00925301|584418148|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
161830223|NCT00925301|584418149|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
161830224|NCT00925301|584418150|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
161830225|NCT00925301|584418151|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
161830226|NCT00925301|584418148|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
161830227|NCT00925301|584418149|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
161830228|NCT00925301|584418150|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
161941248|NCT02314923|584836128|FG002|Overall Study|Lost to Follow-up|1|||
161941249|NCT02314923|584836129|FG003|Overall Study|Lost to Follow-up|0|||
161941250|NCT02314923|584836130|FG004|Overall Study|Lost to Follow-up|0|||
161941251|NCT02314923|584836131|FG005|Overall Study|Lost to Follow-up|0|||
161941252|NCT02314923|584836132|FG006|Overall Study|Lost to Follow-up|3|||
161941253|NCT02314923|584836133|FG007|Overall Study|Lost to Follow-up|4|||
161941254|NCT02314923|584836134|FG008|Overall Study|Lost to Follow-up|2|||
161941255|NCT02314923|584836135|FG009|Overall Study|Lost to Follow-up|0|||
161941256|NCT02314923|584836126|FG000|Overall Study|Withdrawal by Subject|0|||
161941257|NCT02314923|584836127|FG001|Overall Study|Withdrawal by Subject|0|||
161941258|NCT02314923|584836128|FG002|Overall Study|Withdrawal by Subject|1|||
161941259|NCT02314923|584836129|FG003|Overall Study|Withdrawal by Subject|0|||
161941260|NCT02314923|584836130|FG004|Overall Study|Withdrawal by Subject|1|||
161941261|NCT02314923|584836131|FG005|Overall Study|Withdrawal by Subject|0|||
161941262|NCT02314923|584836132|FG006|Overall Study|Withdrawal by Subject|1|||
161941263|NCT02314923|584836133|FG007|Overall Study|Withdrawal by Subject|0|||
161941264|NCT02314923|584836134|FG008|Overall Study|Withdrawal by Subject|0|||
161941265|NCT02314923|584836135|FG009|Overall Study|Withdrawal by Subject|0|||
161941266|NCT02314923|584836126|FG000|Overall Study|Physician Decision|0|||
161941267|NCT02314923|584836127|FG001|Overall Study|Physician Decision|1|||
161941268|NCT02314923|584836128|FG002|Overall Study|Physician Decision|0|||
161941269|NCT02314923|584836129|FG003|Overall Study|Physician Decision|0|||
161941270|NCT02314923|584836130|FG004|Overall Study|Physician Decision|0|||
161941271|NCT02314923|584836131|FG005|Overall Study|Physician Decision|0|||
161941272|NCT02314923|584836132|FG006|Overall Study|Physician Decision|0|||
161941273|NCT02314923|584836133|FG007|Overall Study|Physician Decision|0|||
161941274|NCT02314923|584836134|FG008|Overall Study|Physician Decision|0|||
161941275|NCT02314923|584836135|FG009|Overall Study|Physician Decision|0|||
161941276|NCT02314923|584836126|FG000|Overall Study|Participant unavailable|0|||
161941277|NCT02314923|584836127|FG001|Overall Study|Participant unavailable|0|||
161941278|NCT02314923|584836128|FG002|Overall Study|Participant unavailable|0|||
161941279|NCT02314923|584836129|FG003|Overall Study|Participant unavailable|0|||
161941280|NCT02314923|584836130|FG004|Overall Study|Participant unavailable|0|||
161941281|NCT02314923|584836131|FG005|Overall Study|Participant unavailable|1|||
161941282|NCT02314923|584836132|FG006|Overall Study|Participant unavailable|0|||
161941283|NCT02314923|584836133|FG007|Overall Study|Participant unavailable|0|||
161830229|NCT00925301|584418151|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
161681358|NCT00111800|583886163|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161681359|NCT00111800|583886164|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161681360|NCT00111800|583886165|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161681361|NCT00111800|583886166|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161681362|NCT00111800|583886167|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161681363|NCT00111800|583886168|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
161681364|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
161681365|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
161681366|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
161681367|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
161681368|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
161830230|NCT00925301|584418148|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
161830231|NCT00925301|584418149|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
161830232|NCT00925301|584418150|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
161830233|NCT00925301|584418151|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
161830234|NCT00925301|584418148|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
161830235|NCT00925301|584418149|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
161830236|NCT00925301|584418150|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
161830237|NCT00925301|584418151|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
161941284|NCT02314923|584836134|FG008|Overall Study|Participant unavailable|0|||
161941285|NCT02314923|584836135|FG009|Overall Study|Participant unavailable|0|||
161941286|NCT02314923|584836126|FG000|Overall Study|Screen failure|0|||
161681369|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
161681370|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
161681371|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
161681372|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
161681373|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
161681374|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
161681375|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
161681376|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
161681377|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
161941287|NCT02314923|584836127|FG001|Overall Study|Screen failure|0|||
161941288|NCT02314923|584836128|FG002|Overall Study|Screen failure|0|||
161941289|NCT02314923|584836129|FG003|Overall Study|Screen failure|0|||
161941290|NCT02314923|584836130|FG004|Overall Study|Screen failure|0|||
161941291|NCT02314923|584836131|FG005|Overall Study|Screen failure|0|||
161941292|NCT02314923|584836132|FG006|Overall Study|Screen failure|1|||
161941293|NCT02314923|584836133|FG007|Overall Study|Screen failure|0|||
161941294|NCT02314923|584836134|FG008|Overall Study|Screen failure|0|||
161941295|NCT02314923|584836135|FG009|Overall Study|Screen failure|0|||
161941296|NCT02314923|584836126|FG000|Overall Study|Participant relocation|1|||
161830238|NCT03043560|584418152|FG000|Overall Study|Discontinued Intervention|1|||
161830239|NCT03043560|584418153|FG001|Overall Study|Discontinued Intervention|2|||
161830240|NCT03043560|584418152|FG000|Overall Study|Lost to Follow-up|0|||
161830241|NCT03043560|584418153|FG001|Overall Study|Lost to Follow-up|1|||
161830242|NCT00442546|584418154|FG000|Overall Study|Adverse Event|11|||
161830243|NCT00442546|584418155|FG001|Overall Study|Adverse Event|17|||
161830244|NCT00442546|584418156|FG002|Overall Study|Adverse Event|13|||
161830245|NCT00442546|584418154|FG000|Overall Study|Lost to Follow-up|1|||
161830246|NCT00442546|584418155|FG001|Overall Study|Lost to Follow-up|2|||
161830247|NCT00442546|584418156|FG002|Overall Study|Lost to Follow-up|1|||
161830248|NCT00442546|584418154|FG000|Overall Study|Other|4|||
161830249|NCT00442546|584418155|FG001|Overall Study|Other|9|||
161830250|NCT00442546|584418156|FG002|Overall Study|Other|6|||
161830251|NCT00442546|584418154|FG000|Overall Study|Withdrawal by Subject|5|||
161830252|NCT00442546|584418155|FG001|Overall Study|Withdrawal by Subject|5|||
161830253|NCT00442546|584418156|FG002|Overall Study|Withdrawal by Subject|7|||
161830254|NCT00442546|584418154|FG000|Overall Study|Randomized But Not Treated|5|||
161830255|NCT00442546|584418155|FG001|Overall Study|Randomized But Not Treated|4|||
161681378|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
161681379|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
161681380|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
161681381|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
161681382|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
161681383|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
161681384|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
161681385|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
161681386|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
161681387|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
161681388|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161681389|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161830256|NCT00442546|584418156|FG002|Overall Study|Randomized But Not Treated|6|||
162235598|NCT01323972|585913150|FG001|Overall Study|Withdrawal by Subject|0|||
162235599|NCT01323972|585913151|FG002|Overall Study|Withdrawal by Subject|1|||
162235600|NCT01323972|585913152|FG003|Overall Study|Withdrawal by Subject|0|||
162235601|NCT01323972|585913149|FG000|Overall Study|Migrated/moved from study area|1|||
161830257|NCT01557582|584418158|FG000|Overall Study|Protocol Violation|4|||
162235602|NCT01323972|585913150|FG001|Overall Study|Migrated/moved from study area|2|||
162235603|NCT01323972|585913151|FG002|Overall Study|Migrated/moved from study area|0|||
162235604|NCT01323972|585913152|FG003|Overall Study|Migrated/moved from study area|0|||
162235605|NCT01323972|585913149|FG000|Overall Study|Lost to Follow-up|0|||
162235606|NCT01323972|585913150|FG001|Overall Study|Lost to Follow-up|1|||
162235607|NCT01323972|585913151|FG002|Overall Study|Lost to Follow-up|1|||
162235608|NCT01323972|585913152|FG003|Overall Study|Lost to Follow-up|1|||
162235609|NCT00994682|585913153|FG000|Double Bilnd|Withdrawal by Subject|5|||
162235610|NCT00994682|585913154|FG001|Double Bilnd|Withdrawal by Subject|6|||
162235611|NCT00994682|585913153|FG000|Double Bilnd|Lost to Follow-up|3|||
162235612|NCT00994682|585913154|FG001|Double Bilnd|Lost to Follow-up|3|||
162235613|NCT00994682|585913153|FG000|Double Bilnd|Adverse Event|1|||
162235614|NCT00994682|585913154|FG001|Double Bilnd|Adverse Event|0|||
162235615|NCT00994682|585913153|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
162235616|NCT00994682|585913154|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
162235617|NCT00994682|585913153|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
162235618|NCT00994682|585913154|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
161683070|NCT01148537|583891234|FG001|Overall Study|Adverse Event|0|||
161830258|NCT01557582|584418158|FG000|Overall Study|Operator error|2|||
162235619|NCT00994682|585913153|FG000|Pioglitazone Open Label|Physician Decision|6|||
162235620|NCT00994682|585913154|FG001|Pioglitazone Open Label|Physician Decision|1|||
162235621|NCT03218397|585913155|FG000|Overall Study|Prior positive blood culture|8|||
162235622|NCT03218397|585913156|FG001|Overall Study|Prior positive blood culture|13|||
162235623|NCT03218397|585913155|FG000|Overall Study|Comfort care|8|||
162235624|NCT03218397|585913156|FG001|Overall Study|Comfort care|5|||
162235625|NCT03218397|585913155|FG000|Overall Study|Comfort care and positive blood culture|1|||
162235626|NCT03218397|585913156|FG001|Overall Study|Comfort care and positive blood culture|0|||
162235627|NCT03218397|585913155|FG000|Overall Study|Comfort care and mixed culture|0|||
162235628|NCT03218397|585913156|FG001|Overall Study|Comfort care and mixed culture|1|||
162235629|NCT03218397|585913155|FG000|Overall Study|Mixed culture|2|||
162235630|NCT03218397|585913156|FG001|Overall Study|Mixed culture|2|||
162235631|NCT03218397|585913155|FG000|Overall Study|Inaccessible hospital records|2|||
162235632|NCT03218397|585913156|FG001|Overall Study|Inaccessible hospital records|5|||
162235633|NCT03218397|585913155|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
162235634|NCT03218397|585913156|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
162235635|NCT03218397|585913155|FG000|Overall Study|Randomized during laboratory off hours|2|||
162235636|NCT03218397|585913156|FG001|Overall Study|Randomized during laboratory off hours|1|||
162235637|NCT01796548|585913159|FG000|Overall Study|Lost to Follow-up|1|||
162235638|NCT01796548|585913159|FG000|Overall Study|Other|2|||
162235639|NCT01049217|585913162|FG000|Overall Study|Adverse Event|2|||
162235640|NCT01049217|585913163|FG001|Overall Study|Adverse Event|1|||
162235641|NCT01049217|585913162|FG000|Overall Study|Lack of Efficacy|1|||
162235642|NCT01049217|585913163|FG001|Overall Study|Lack of Efficacy|1|||
162235643|NCT01049217|585913162|FG000|Overall Study|Lost to Follow-up|3|||
162235644|NCT01049217|585913163|FG001|Overall Study|Lost to Follow-up|8|||
162235645|NCT01049217|585913162|FG000|Overall Study|Withdrawal by Subject|4|||
162235646|NCT01049217|585913163|FG001|Overall Study|Withdrawal by Subject|3|||
162235647|NCT01049217|585913162|FG000|Overall Study|Protocol Violation|1|||
162235648|NCT01049217|585913163|FG001|Overall Study|Protocol Violation|3|||
162235649|NCT01049217|585913162|FG000|Overall Study|Pregnancy|1|||
162235650|NCT01049217|585913163|FG001|Overall Study|Pregnancy|0|||
162235651|NCT01049217|585913162|FG000|Overall Study|Study Terminated by Sponsor|43|||
162235652|NCT01049217|585913163|FG001|Overall Study|Study Terminated by Sponsor|43|||
162235653|NCT01049217|585913162|FG000|Overall Study|Other|1|||
162235654|NCT01049217|585913163|FG001|Overall Study|Other|2|||
162235655|NCT01049217|585913162|FG000|Overall Study|Randomized but not Treated|0|||
162235656|NCT01049217|585913163|FG001|Overall Study|Randomized but not Treated|2|||
162235657|NCT00589121|585913164|FG000|Overall Study|Protocol Violation|2|||
162235658|NCT00589121|585913165|FG001|Overall Study|Protocol Violation|6|||
162235659|NCT00589121|585913164|FG000|Overall Study|No protocol treatment received|0|||
162235660|NCT00589121|585913165|FG001|Overall Study|No protocol treatment received|1|||
161830259|NCT00546910|584420031|FG000|Overall Study|Adverse Event|2|||
161830260|NCT00546910|584420032|FG001|Overall Study|Adverse Event|3|||
161830261|NCT00546910|584420031|FG000|Overall Study|Lack of Efficacy|5|||
161830262|NCT00546910|584420032|FG001|Overall Study|Lack of Efficacy|7|||
161830263|NCT00546910|584420031|FG000|Overall Study|Physician Decision|0|||
161830264|NCT00546910|584420032|FG001|Overall Study|Physician Decision|1|||
161830265|NCT00546910|584420031|FG000|Overall Study|Withdrawal by Subject|2|||
161830266|NCT00546910|584420032|FG001|Overall Study|Withdrawal by Subject|0|||
161830267|NCT01301482|584420033|FG000|Overall Study|Withdrawal by Subject|1|||
161830268|NCT04086641|584420041|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
161830269|NCT04086641|584420042|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
161830270|NCT00706095|584420043|FG000|Overall Study|Progressive Disease|4|||
161830271|NCT00706095|584420044|FG001|Overall Study|Progressive Disease|5|||
161830272|NCT00706095|584420045|FG002|Overall Study|Progressive Disease|3|||
161830273|NCT00706095|584420043|FG000|Overall Study|Clinical Progression|1|||
161830274|NCT00706095|584420044|FG001|Overall Study|Clinical Progression|2|||
161830275|NCT00706095|584420045|FG002|Overall Study|Clinical Progression|2|||
161830276|NCT00706095|584420043|FG000|Overall Study|Withdrawal by Subject|1|||
161830277|NCT00706095|584420044|FG001|Overall Study|Withdrawal by Subject|0|||
161830278|NCT00706095|584420045|FG002|Overall Study|Withdrawal by Subject|0|||
161830279|NCT01011556|584420051|FG000|Overall Study|Adverse Event|1|||
161830280|NCT01011556|584420052|FG001|Overall Study|Adverse Event|3|||
161830281|NCT01011556|584420053|FG002|Overall Study|Adverse Event|2|||
161830282|NCT01011556|584420054|FG003|Overall Study|Adverse Event|1|||
161830283|NCT01011556|584420051|FG000|Overall Study|Lost to Follow-up|1|||
161830284|NCT01011556|584420052|FG001|Overall Study|Lost to Follow-up|0|||
161830285|NCT01011556|584420053|FG002|Overall Study|Lost to Follow-up|0|||
161681390|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161681391|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161681392|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161681393|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161681394|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161681395|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
161681396|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161681397|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161681398|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161681399|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161830286|NCT01011556|584420054|FG003|Overall Study|Lost to Follow-up|0|||
161830287|NCT01011556|584420051|FG000|Overall Study|Physician Decision|1|||
161830288|NCT01011556|584420052|FG001|Overall Study|Physician Decision|0|||
161830289|NCT01011556|584420053|FG002|Overall Study|Physician Decision|0|||
161830290|NCT01011556|584420054|FG003|Overall Study|Physician Decision|1|||
161830291|NCT01011556|584420051|FG000|Overall Study|Protocol Violation|0|||
161830292|NCT01011556|584420052|FG001|Overall Study|Protocol Violation|1|||
161830293|NCT01011556|584420053|FG002|Overall Study|Protocol Violation|0|||
161830294|NCT01011556|584420054|FG003|Overall Study|Protocol Violation|0|||
161830295|NCT01011556|584420051|FG000|Overall Study|Withdrawal by Subject|1|||
161830296|NCT01011556|584420052|FG001|Overall Study|Withdrawal by Subject|2|||
161830297|NCT01011556|584420053|FG002|Overall Study|Withdrawal by Subject|4|||
161830298|NCT01011556|584420054|FG003|Overall Study|Withdrawal by Subject|4|||
161681400|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161683071|NCT01148537|583891235|FG002|Overall Study|Adverse Event|1|||
161830299|NCT01011556|584420051|FG000|Overall Study|Sponsor decision|0|||
161830300|NCT01011556|584420052|FG001|Overall Study|Sponsor decision|1|||
161830301|NCT01011556|584420053|FG002|Overall Study|Sponsor decision|1|||
161830302|NCT01011556|584420054|FG003|Overall Study|Sponsor decision|2|||
161830303|NCT01011556|584420051|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
161830304|NCT01011556|584420052|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
161830305|NCT01011556|584420053|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
161830306|NCT01011556|584420054|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
161830307|NCT03920280|584420055|FG000|Overall Study|Adverse Event|2|||
161830308|NCT03920280|584420056|FG001|Overall Study|Adverse Event|3|||
161830309|NCT03920280|584420055|FG000|Overall Study|Lost to Follow-up|0|||
161830310|NCT03920280|584420056|FG001|Overall Study|Lost to Follow-up|1|||
161681401|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
162025496|NCT00486811|585150761|FG001|Overall Study|Lost to Follow-up|6|||
161830311|NCT03920280|584420055|FG000|Overall Study|Withdrawal by Subject|1|||
161830312|NCT03920280|584420056|FG001|Overall Study|Withdrawal by Subject|1|||
161830313|NCT03920280|584420055|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
162235661|NCT03141905|585913166|FG000|Overall Study|Death|3|||
162235662|NCT03141905|585913167|FG001|Overall Study|Death|2|||
162235663|NCT03141905|585913166|FG000|Overall Study|Withdrawal by Subject|1|||
162235664|NCT03141905|585913167|FG001|Overall Study|Withdrawal by Subject|0|||
162235665|NCT03141905|585913166|FG000|Overall Study|Lost to Follow-up|3|||
162235666|NCT03141905|585913167|FG001|Overall Study|Lost to Follow-up|7|||
162235667|NCT03141905|585913166|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
162235668|NCT03141905|585913167|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
162235669|NCT05180500|585913168|FG000|Overall Study|Adverse Event|1|||
162235670|NCT05180500|585913169|FG001|Overall Study|Adverse Event|0|||
162235671|NCT05180500|585913168|FG000|Overall Study|Withdrawal by Subject|2|||
162235672|NCT05180500|585913169|FG001|Overall Study|Withdrawal by Subject|0|||
162235673|NCT04927884|585913174|FG000|Overall Study|Progressive Disease|2|||
162235674|NCT01775124|585913175|FG000|Core Period|Disease Progression|0|||
162235675|NCT01775124|585913176|FG001|Core Period|Disease Progression|1|||
162235676|NCT01775124|585913175|FG000|Core Period|Physician Decision|1|||
162235677|NCT01775124|585913176|FG001|Core Period|Physician Decision|1|||
162235678|NCT01775124|585913175|FG000|Core Period|Death|0|||
162235679|NCT01775124|585913176|FG001|Core Period|Death|1|||
162235680|NCT01775124|585913175|FG000|Core Period|Administrative problems|1|||
162235681|NCT01775124|585913176|FG001|Core Period|Administrative problems|0|||
162235682|NCT01775124|585913175|FG000|Core Period|Withdrawal by Subject|4|||
162235683|NCT01775124|585913176|FG001|Core Period|Withdrawal by Subject|2|||
162235684|NCT01775124|585913175|FG000|Core Period|Adverse Event|5|||
162235685|NCT01775124|585913176|FG001|Core Period|Adverse Event|5|||
162235686|NCT01775124|585913175|FG000|Extension Period|Adverse Event|3|||
162235687|NCT01775124|585913176|FG001|Extension Period|Adverse Event|2|||
162235688|NCT01775124|585913175|FG000|Extension Period|Physician Decision|0|||
162235689|NCT01775124|585913176|FG001|Extension Period|Physician Decision|2|||
162235690|NCT01775124|585913175|FG000|Extension Period|Administrative problems|0|||
162235691|NCT01775124|585913176|FG001|Extension Period|Administrative problems|1|||
162235692|NCT01775124|585913175|FG000|Extension Period|Lost to Follow-up|0|||
162235693|NCT01775124|585913176|FG001|Extension Period|Lost to Follow-up|1|||
162235694|NCT01775124|585913175|FG000|Extension Period|Withdrawal by Subject|9|||
162235695|NCT01775124|585913176|FG001|Extension Period|Withdrawal by Subject|12|||
162235696|NCT00727311|585913177|FG000|Overall Study|Did not receive drug|316|||
162235697|NCT00727311|585913177|FG000|Overall Study|Missing end of therapy data|205|||
162235698|NCT00727311|585913177|FG000|Overall Study|Adverse Event|58|||
162235699|NCT00727311|585913177|FG000|Overall Study|Lack of Efficacy|242|||
162235700|NCT00727311|585913177|FG000|Overall Study|Lost to Follow-up|73|||
162235701|NCT00727311|585913177|FG000|Overall Study|Withdrawal by Subject|77|||
162235702|NCT00727311|585913177|FG000|Overall Study|Other|97|||
162235703|NCT00727311|585913177|FG000|Overall Study|Multiple reasons|39|||
162235704|NCT03992846|585913178|FG000|Overall Study|Adverse Event|8|||
162235705|NCT03992846|585913179|FG001|Overall Study|Adverse Event|6|||
162235706|NCT03992846|585913180|FG002|Overall Study|Adverse Event|3|||
162235707|NCT03992846|585913178|FG000|Overall Study|Lost to Follow-up|0|||
162235708|NCT03992846|585913179|FG001|Overall Study|Lost to Follow-up|1|||
162235709|NCT03992846|585913180|FG002|Overall Study|Lost to Follow-up|1|||
162235710|NCT03992846|585913178|FG000|Overall Study|Pregnancy|2|||
162235711|NCT03992846|585913179|FG001|Overall Study|Pregnancy|0|||
162235712|NCT03992846|585913180|FG002|Overall Study|Pregnancy|1|||
162235713|NCT03992846|585913178|FG000|Overall Study|Protocol Violation|1|||
162235714|NCT03992846|585913179|FG001|Overall Study|Protocol Violation|2|||
162235715|NCT03992846|585913180|FG002|Overall Study|Protocol Violation|0|||
162235716|NCT03992846|585913178|FG000|Overall Study|Withdrawal by Subject|8|||
162235717|NCT03992846|585913179|FG001|Overall Study|Withdrawal by Subject|10|||
162235718|NCT03992846|585913180|FG002|Overall Study|Withdrawal by Subject|20|||
162235719|NCT03992846|585913178|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
162235720|NCT03992846|585913179|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
162235721|NCT03992846|585913180|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
162235722|NCT00031551|585914848|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
162235723|NCT00031551|585914849|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
162235724|NCT01919814|585914852|FG000|Overall Study|Adverse Event|1|||
162235725|NCT01919814|585914853|FG001|Overall Study|Adverse Event|0|||
162235726|NCT01919814|585914852|FG000|Overall Study|Protocol Violation|1|||
162235727|NCT01919814|585914853|FG001|Overall Study|Protocol Violation|0|||
162235728|NCT01919814|585914852|FG000|Overall Study|Withdrawal by Subject|1|||
162235729|NCT01919814|585914853|FG001|Overall Study|Withdrawal by Subject|0|||
162235730|NCT02164383|585914854|FG000|Overall Study|Lost to Follow-up|1|||
162235731|NCT02164383|585914855|FG001|Overall Study|Lost to Follow-up|0|||
162235732|NCT01036763|585914856|FG000|Overall Study|Adverse Event|25|||
162235733|NCT01036763|585914856|FG000|Overall Study|Lost to Follow-up|28|||
162235734|NCT01036763|585914856|FG000|Overall Study|Other reason (not specified)|40|||
161830314|NCT03920280|584420056|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
161830315|NCT00271024|584420067|FG000|Overall Study|Lost Interest|3|||
161830316|NCT00271024|584420068|FG001|Overall Study|Lost Interest|4|||
161830317|NCT00271024|584420069|FG002|Overall Study|Lost Interest|2|||
161830318|NCT00271024|584420070|FG003|Overall Study|Lost Interest|3|||
161830319|NCT00271024|584420067|FG000|Overall Study|Unknown/Unspecified|11|||
161830320|NCT00271024|584420068|FG001|Overall Study|Unknown/Unspecified|11|||
161830321|NCT00271024|584420069|FG002|Overall Study|Unknown/Unspecified|8|||
161830322|NCT00271024|584420070|FG003|Overall Study|Unknown/Unspecified|4|||
161830323|NCT00271024|584420067|FG000|Overall Study|Protocol Violation|1|||
161830324|NCT00271024|584420068|FG001|Overall Study|Protocol Violation|6|||
161830325|NCT00271024|584420069|FG002|Overall Study|Protocol Violation|5|||
161830326|NCT00271024|584420070|FG003|Overall Study|Protocol Violation|11|||
161830327|NCT00271024|584420067|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
161830328|NCT00271024|584420068|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
161830329|NCT00271024|584420069|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
161830330|NCT00271024|584420070|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
161830331|NCT00271024|584420067|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
161830332|NCT00271024|584420068|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
161830333|NCT00271024|584420069|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
161830334|NCT00271024|584420070|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
161830335|NCT04449341|584420071|FG000|Overall Study|Protocol Violation|1|||
161830336|NCT04449341|584420072|FG001|Overall Study|Protocol Violation|0|||
161830337|NCT04499482|584420073|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
161830338|NCT01020526|584420075|FG000|Overall Study|Withdrawal by Subject|5|||
161830339|NCT01020526|584420075|FG000|Overall Study|Other reasons|3|||
161830340|NCT01020526|584420075|FG000|Overall Study|Insufficient clinical response|3|||
161830341|NCT01020526|584420075|FG000|Overall Study|Lost to Follow-up|1|||
161830342|NCT01020526|584420075|FG000|Overall Study|Adverse Event|2|||
161830343|NCT03573817|584420076|FG000|Overall Study|Adverse Event|0|||
161830344|NCT03573817|584420077|FG001|Overall Study|Adverse Event|2|||
161830345|NCT03573817|584420076|FG000|Overall Study|Protocol Violation|0|||
161830346|NCT03573817|584420077|FG001|Overall Study|Protocol Violation|1|||
161830347|NCT03573817|584420076|FG000|Overall Study|Withdrawal by Subject|1|||
161830348|NCT03573817|584420077|FG001|Overall Study|Withdrawal by Subject|1|||
161830349|NCT01083680|584420086|FG000|Overall Study|Lost to Follow-up|2758|||
161830350|NCT01083680|584420086|FG000|Overall Study|Withdrawal by Subject|1086|||
161830351|NCT00508027|584420087|FG000|Dose Level 1|Lost to Follow-up|4|||
161830352|NCT00508027|584420087|FG000|Dose Level 1|Withdrawal by Subject|2|||
161830353|NCT00508027|584420087|FG000|Dose Level 1|Physician Decision|2|||
161830354|NCT00508027|584420087|FG000|Dose Level 2|Lost to Follow-up|2|||
161830355|NCT00508027|584420087|FG000|Dose Level 2|Withdrawal by Subject|2|||
161830356|NCT01719562|584420088|FG000|Overall Study|Lost to Follow-up|1|||
161830357|NCT01719562|584420089|FG001|Overall Study|Lost to Follow-up|0|||
161830358|NCT01719562|584420088|FG000|Overall Study|Death|1|||
161830359|NCT01719562|584420089|FG001|Overall Study|Death|0|||
161830360|NCT01719562|584420088|FG000|Overall Study|New cancer diagnosis|1|||
161830361|NCT01719562|584420089|FG001|Overall Study|New cancer diagnosis|0|||
161830362|NCT03877926|584420090|FG000|Overall Study|Adverse Event|1|||
161830363|NCT03877926|584420091|FG001|Overall Study|Adverse Event|0|||
161830364|NCT03877926|584420092|FG002|Overall Study|Adverse Event|0|||
161830365|NCT03877926|584420093|FG003|Overall Study|Adverse Event|0|||
161830366|NCT03877926|584420090|FG000|Overall Study|Death|2|||
161830367|NCT03877926|584420091|FG001|Overall Study|Death|2|||
161830368|NCT03877926|584420092|FG002|Overall Study|Death|2|||
161830369|NCT03877926|584420093|FG003|Overall Study|Death|0|||
161830370|NCT03877926|584420090|FG000|Overall Study|Lost to Follow-up|41|||
162235735|NCT01672723|585914857|FG000|First Intervention|Adverse Event|3|||
161681402|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
161681403|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161681404|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161681405|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161681406|NCT00111800|583886163|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161681407|NCT00111800|583886164|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161681408|NCT00111800|583886165|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
161681409|NCT00111800|583886166|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161830371|NCT03877926|584420091|FG001|Overall Study|Lost to Follow-up|52|||
161830372|NCT03877926|584420092|FG002|Overall Study|Lost to Follow-up|45|||
161830373|NCT03877926|584420093|FG003|Overall Study|Lost to Follow-up|17|||
161830374|NCT03877926|584420090|FG000|Overall Study|Physician Decision|2|||
161830375|NCT03877926|584420091|FG001|Overall Study|Physician Decision|0|||
161830376|NCT03877926|584420092|FG002|Overall Study|Physician Decision|2|||
161830377|NCT03877926|584420093|FG003|Overall Study|Physician Decision|0|||
161830378|NCT03877926|584420090|FG000|Overall Study|Withdrawal by Subject|18|||
161830379|NCT03877926|584420091|FG001|Overall Study|Withdrawal by Subject|21|||
162235736|NCT01672723|585914858|FG001|First Intervention|Adverse Event|0|||
162235737|NCT00743275|585914859|FG000|Overall Study|Protocol Violation|0|||
162235738|NCT00743275|585914860|FG001|Overall Study|Protocol Violation|1|||
162235739|NCT01177722|585914866|FG000|Overall Study|Serious Adverse Event|0|||
162235740|NCT01177722|585914867|FG001|Overall Study|Serious Adverse Event|0|||
162235741|NCT01177722|585914868|FG002|Overall Study|Serious Adverse Event|1|||
162235742|NCT01177722|585914869|FG003|Overall Study|Serious Adverse Event|0|||
162235743|NCT01177722|585914866|FG000|Overall Study|Protocol Violation|0|||
162235744|NCT01177722|585914867|FG001|Overall Study|Protocol Violation|0|||
162235745|NCT01177722|585914868|FG002|Overall Study|Protocol Violation|1|||
162235746|NCT01177722|585914869|FG003|Overall Study|Protocol Violation|0|||
162235747|NCT01177722|585914866|FG000|Overall Study|Lost to Follow-up|3|||
162235748|NCT01177722|585914867|FG001|Overall Study|Lost to Follow-up|4|||
162235749|NCT01177722|585914868|FG002|Overall Study|Lost to Follow-up|3|||
162235750|NCT01177722|585914869|FG003|Overall Study|Lost to Follow-up|1|||
162235751|NCT01177722|585914866|FG000|Overall Study|Withdrawal by Subject|10|||
162235752|NCT01177722|585914867|FG001|Overall Study|Withdrawal by Subject|6|||
162235753|NCT01177722|585914868|FG002|Overall Study|Withdrawal by Subject|4|||
162235754|NCT01177722|585914869|FG003|Overall Study|Withdrawal by Subject|6|||
162235755|NCT02831387|585914870|FG000|Overall Study|Withdrawal by Subject|1|||
162235756|NCT02831387|585914871|FG001|Overall Study|Withdrawal by Subject|1|||
162235757|NCT02831387|585914870|FG000|Overall Study|Discontinued due to stock recovery|0|||
162235758|NCT02831387|585914871|FG001|Overall Study|Discontinued due to stock recovery|1|||
162235759|NCT00192647|585914872|FG000|Overall Study|Death|1|||
162235760|NCT00192647|585914873|FG001|Overall Study|Death|1|||
162235761|NCT00192647|585914872|FG000|Overall Study|Adverse Event|35|||
162235762|NCT00192647|585914873|FG001|Overall Study|Adverse Event|29|||
162235763|NCT00192647|585914872|FG000|Overall Study|Laboratory Test Abnormality|4|||
162235764|NCT00192647|585914873|FG001|Overall Study|Laboratory Test Abnormality|2|||
162235765|NCT00192647|585914872|FG000|Overall Study|Insufficient Therapeutic Response|53|||
162235766|NCT00192647|585914873|FG001|Overall Study|Insufficient Therapeutic Response|83|||
162235767|NCT00192647|585914872|FG000|Overall Study|Entry Criteria Violation|6|||
162235768|NCT00192647|585914873|FG001|Overall Study|Entry Criteria Violation|6|||
162235769|NCT00192647|585914872|FG000|Overall Study|Protocol Violation|3|||
162235770|NCT00192647|585914873|FG001|Overall Study|Protocol Violation|1|||
162235771|NCT00192647|585914872|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
162235772|NCT00192647|585914873|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
162235773|NCT00192647|585914872|FG000|Overall Study|Failure to Return|11|||
162235774|NCT00192647|585914873|FG001|Overall Study|Failure to Return|13|||
162235775|NCT00192647|585914872|FG000|Overall Study|Other/Administrative|5|||
162235776|NCT00192647|585914873|FG001|Overall Study|Other/Administrative|3|||
162235777|NCT01828073|585914874|FG000|Overall Study|Lost to Follow-up|1|||
162235778|NCT01828073|585914875|FG001|Overall Study|Lost to Follow-up|2|||
162235779|NCT01201317|585914883|FG000|Overall Study|Withdrawal by Subject|5|||
162235780|NCT01201317|585914884|FG001|Overall Study|Withdrawal by Subject|0|||
162235781|NCT01201317|585914885|FG002|Overall Study|Withdrawal by Subject|3|||
162235782|NCT01201317|585914883|FG000|Overall Study|Adverse Event|2|||
162235783|NCT01201317|585914884|FG001|Overall Study|Adverse Event|2|||
162235784|NCT01201317|585914885|FG002|Overall Study|Adverse Event|2|||
162235785|NCT01201317|585914883|FG000|Overall Study|Screen failure|1|||
162235786|NCT01201317|585914884|FG001|Overall Study|Screen failure|1|||
162235787|NCT01201317|585914885|FG002|Overall Study|Screen failure|0|||
162235788|NCT01201317|585914883|FG000|Overall Study|Protocol Violation|0|||
162235789|NCT01201317|585914884|FG001|Overall Study|Protocol Violation|1|||
162235790|NCT01201317|585914885|FG002|Overall Study|Protocol Violation|1|||
162235791|NCT01201317|585914883|FG000|Overall Study|Death|0|||
162235792|NCT01201317|585914884|FG001|Overall Study|Death|1|||
162235793|NCT01201317|585914885|FG002|Overall Study|Death|0|||
162235794|NCT01201317|585914883|FG000|Overall Study|Study-specific withdrawal criteria|0|||
162235795|NCT01201317|585914884|FG001|Overall Study|Study-specific withdrawal criteria|0|||
162235796|NCT01201317|585914885|FG002|Overall Study|Study-specific withdrawal criteria|1|||
162235797|NCT01201317|585914883|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
161681410|NCT00111800|583886167|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161681411|NCT00111800|583886168|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161681412|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
161681413|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
161681414|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
161681415|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
161681416|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
161681417|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
162025497|NCT00486811|585150762|FG002|Overall Study|Lost to Follow-up|4|||
161830380|NCT03877926|584420092|FG002|Overall Study|Withdrawal by Subject|12|||
161830381|NCT03877926|584420093|FG003|Overall Study|Withdrawal by Subject|4|||
161830382|NCT03877926|584420090|FG000|Overall Study|Other - Various|4|||
161830383|NCT03877926|584420091|FG001|Overall Study|Other - Various|1|||
161830384|NCT03877926|584420092|FG002|Overall Study|Other - Various|1|||
161830385|NCT03877926|584420093|FG003|Overall Study|Other - Various|0|||
161830386|NCT03877926|584420090|FG000|Overall Study|Not Treated|3|||
161830387|NCT03877926|584420091|FG001|Overall Study|Not Treated|1|||
161830388|NCT03877926|584420092|FG002|Overall Study|Not Treated|1|||
161830389|NCT03877926|584420093|FG003|Overall Study|Not Treated|0|||
161830390|NCT03546647|584420094|FG000|Overall Study|Adverse Event|1|||
162235798|NCT01201317|585914884|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
162235799|NCT01201317|585914885|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
161681418|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
161681419|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
161681420|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
161681421|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
161681422|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
161681423|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
161681424|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
161681425|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
161830391|NCT03546647|584420095|FG001|Overall Study|Adverse Event|0|||
161830392|NCT02487082|584420096|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
162235800|NCT01201317|585914883|FG000|Overall Study|Decrease in renal function|0|||
161830393|NCT02487082|584420097|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
161830394|NCT02487082|584420096|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
161830395|NCT02487082|584420097|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
162235801|NCT01201317|585914884|FG001|Overall Study|Decrease in renal function|1|||
162235802|NCT01201317|585914885|FG002|Overall Study|Decrease in renal function|0|||
162235803|NCT01201317|585914883|FG000|Overall Study|Lack of Efficacy|1|||
162235804|NCT01201317|585914884|FG001|Overall Study|Lack of Efficacy|0|||
162235805|NCT01201317|585914885|FG002|Overall Study|Lack of Efficacy|0|||
162235806|NCT01201317|585914883|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
161681426|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
161681427|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
161681428|NCT00094770|583886169|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
161681429|NCT00094770|583886170|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
161681430|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
161681431|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
161681432|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
161681433|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
161681434|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
161681435|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
161681436|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
161681437|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
161681438|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
161681439|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
161681440|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
161681441|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
161681442|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
161681443|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
161681444|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
161681445|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
161681446|NCT00094770|583886169|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
161681447|NCT00094770|583886170|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
161681448|NCT02752035|583886171|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
161681449|NCT02752035|583886172|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
161681450|NCT02752035|583886173|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
161681451|NCT02752035|583886174|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
161681452|NCT02752035|583886171|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
161681453|NCT02752035|583886172|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
161681454|NCT02752035|583886173|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
161681455|NCT02752035|583886174|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
161681456|NCT02752035|583886171|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
161681457|NCT02752035|583886172|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
161681458|NCT02752035|583886173|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
161681459|NCT02752035|583886174|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
161681460|NCT02752035|583886171|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
161681461|NCT02752035|583886172|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
161681462|NCT02752035|583886173|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
161681463|NCT02752035|583886174|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
161681464|NCT02752035|583886171|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
161681465|NCT02752035|583886172|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
161681466|NCT02752035|583886173|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
161681467|NCT02752035|583886174|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
161681468|NCT02752035|583886171|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
161681469|NCT02752035|583886172|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
161681470|NCT02752035|583886173|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
161681471|NCT02752035|583886174|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
161681472|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
161681473|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
161681474|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
161681475|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
161681476|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
161681477|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
161681478|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
161681479|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
161681480|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
161681481|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
161830396|NCT00612677|584420099|FG000|Overall Study|study closed before treatment started|1|||
161830397|NCT00268892|584420103|FG000|Overall Study|Adverse Event|14|||
161830398|NCT00268892|584420104|FG001|Overall Study|Adverse Event|17|||
161830399|NCT00268892|584420105|FG002|Overall Study|Adverse Event|20|||
161830400|NCT00268892|584420103|FG000|Overall Study|Lack of Efficacy|1|||
161830401|NCT00268892|584420104|FG001|Overall Study|Lack of Efficacy|3|||
161830402|NCT00268892|584420105|FG002|Overall Study|Lack of Efficacy|0|||
161830403|NCT00268892|584420103|FG000|Overall Study|Withdrawal by Subject|14|||
161830404|NCT00268892|584420104|FG001|Overall Study|Withdrawal by Subject|15|||
161830405|NCT00268892|584420105|FG002|Overall Study|Withdrawal by Subject|13|||
161830406|NCT00268892|584420103|FG000|Overall Study|Physician Decision|0|||
161830407|NCT00268892|584420104|FG001|Overall Study|Physician Decision|1|||
161830408|NCT00268892|584420105|FG002|Overall Study|Physician Decision|0|||
161830409|NCT00268892|584420103|FG000|Overall Study|Lost to Follow-up|5|||
161830410|NCT00268892|584420104|FG001|Overall Study|Lost to Follow-up|2|||
161830411|NCT00268892|584420105|FG002|Overall Study|Lost to Follow-up|4|||
161830412|NCT00268892|584420103|FG000|Overall Study|Protocol Violation|0|||
161830413|NCT00268892|584420104|FG001|Overall Study|Protocol Violation|1|||
161830414|NCT00268892|584420105|FG002|Overall Study|Protocol Violation|0|||
161830415|NCT00268892|584420103|FG000|Overall Study|Disease Progression|1|||
161830416|NCT00268892|584420104|FG001|Overall Study|Disease Progression|1|||
161830417|NCT00268892|584420105|FG002|Overall Study|Disease Progression|0|||
161830418|NCT00268892|584420103|FG000|Overall Study|Trial Site Closed|4|||
161830419|NCT00268892|584420104|FG001|Overall Study|Trial Site Closed|2|||
161830420|NCT00268892|584420105|FG002|Overall Study|Trial Site Closed|2|||
161830421|NCT04569786|584420109|FG000|Overall Study|Lost to Follow-up|1|||
161830422|NCT04569786|584420110|FG001|Overall Study|Lost to Follow-up|0|||
161830423|NCT04569786|584420111|FG002|Overall Study|Lost to Follow-up|4|||
161830424|NCT04569786|584420112|FG003|Overall Study|Lost to Follow-up|1|||
162235807|NCT01201317|585914884|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
161830425|NCT04569786|584420113|FG004|Overall Study|Lost to Follow-up|0|||
161830426|NCT04569786|584420109|FG000|Overall Study|Withdrawal by Subject|0|||
161830427|NCT04569786|584420110|FG001|Overall Study|Withdrawal by Subject|0|||
161830428|NCT04569786|584420111|FG002|Overall Study|Withdrawal by Subject|0|||
161830429|NCT04569786|584420112|FG003|Overall Study|Withdrawal by Subject|5|||
161830430|NCT04569786|584420113|FG004|Overall Study|Withdrawal by Subject|1|||
161830431|NCT04569786|584420109|FG000|Overall Study|Physician Decision|0|||
161830432|NCT04569786|584420110|FG001|Overall Study|Physician Decision|0|||
161830433|NCT04569786|584420111|FG002|Overall Study|Physician Decision|0|||
161830434|NCT04569786|584420112|FG003|Overall Study|Physician Decision|1|||
161830435|NCT04569786|584420113|FG004|Overall Study|Physician Decision|0|||
161830436|NCT01640184|584420122|FG000|Overall Study|Death|1|||
161830437|NCT01640184|584420123|FG001|Overall Study|Death|0|||
161830438|NCT01640184|584420124|FG002|Overall Study|Death|0|||
161830439|NCT01640184|584420122|FG000|Overall Study|Lost to Follow-up|4|||
162235808|NCT01201317|585914885|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
162235809|NCT00876928|585914887|FG000|Overall Study|Lost to Follow-up|2|||
162235810|NCT00876928|585914888|FG001|Overall Study|Lost to Follow-up|5|||
162235811|NCT00876928|585914887|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
162235812|NCT00876928|585914888|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
162235813|NCT02795429|585914889|FG000|Overall Study|Adverse Event|1|||
162235814|NCT02795429|585914890|FG001|Overall Study|Adverse Event|2|||
162235815|NCT02795429|585914891|FG002|Overall Study|Adverse Event|1|||
162235816|NCT02795429|585914892|FG003|Overall Study|Adverse Event|2|||
162235817|NCT02795429|585914893|FG004|Overall Study|Adverse Event|1|||
162235818|NCT02795429|585914889|FG000|Overall Study|Death|1|||
162235819|NCT02795429|585914890|FG001|Overall Study|Death|0|||
162235820|NCT02795429|585914891|FG002|Overall Study|Death|1|||
162235821|NCT02795429|585914892|FG003|Overall Study|Death|2|||
162235822|NCT02795429|585914893|FG004|Overall Study|Death|1|||
162235823|NCT02795429|585914889|FG000|Overall Study|Physician Decision|0|||
162235824|NCT02795429|585914890|FG001|Overall Study|Physician Decision|0|||
162235825|NCT02795429|585914891|FG002|Overall Study|Physician Decision|2|||
162235826|NCT02795429|585914892|FG003|Overall Study|Physician Decision|1|||
162235827|NCT02795429|585914893|FG004|Overall Study|Physician Decision|5|||
162235828|NCT02795429|585914889|FG000|Overall Study|Progressive disease|3|||
162235829|NCT02795429|585914890|FG001|Overall Study|Progressive disease|7|||
162235830|NCT02795429|585914891|FG002|Overall Study|Progressive disease|6|||
162235831|NCT02795429|585914892|FG003|Overall Study|Progressive disease|26|||
162235832|NCT02795429|585914893|FG004|Overall Study|Progressive disease|20|||
162235833|NCT02795429|585914889|FG000|Overall Study|Subject/guardian decision|1|||
162235834|NCT02795429|585914890|FG001|Overall Study|Subject/guardian decision|1|||
162235835|NCT02795429|585914891|FG002|Overall Study|Subject/guardian decision|1|||
162235836|NCT02795429|585914892|FG003|Overall Study|Subject/guardian decision|1|||
162235837|NCT02795429|585914893|FG004|Overall Study|Subject/guardian decision|3|||
162235838|NCT05220254|585914894|FG000|Overall Study|Withdrawal by Subject|4|||
162235839|NCT05220254|585914894|FG000|Overall Study|Removed due to ineligibility|1|||
162235840|NCT05220254|585914894|FG000|Overall Study|Lost to Follow-up|7|||
162235841|NCT00918580|585914897|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
162235842|NCT00918580|585914897|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
162235843|NCT00918580|585914897|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
162235844|NCT00918580|585914897|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
161941297|NCT02314923|584836127|FG001|Overall Study|Participant relocation|0|||
161941298|NCT02314923|584836128|FG002|Overall Study|Participant relocation|0|||
161941299|NCT02314923|584836129|FG003|Overall Study|Participant relocation|0|||
161941300|NCT02314923|584836130|FG004|Overall Study|Participant relocation|0|||
161941301|NCT02314923|584836131|FG005|Overall Study|Participant relocation|0|||
161941302|NCT02314923|584836132|FG006|Overall Study|Participant relocation|0|||
161941303|NCT02314923|584836133|FG007|Overall Study|Participant relocation|1|||
161941304|NCT02314923|584836134|FG008|Overall Study|Participant relocation|0|||
161941305|NCT02314923|584836135|FG009|Overall Study|Participant relocation|0|||
161941306|NCT00725985|584836136|FG000|ITP- Treatment Disposition|Adverse Event|20|||
161941307|NCT00725985|584836137|FG001|ITP- Treatment Disposition|Adverse Event|10|||
161941308|NCT00725985|584836138|FG002|ITP- Treatment Disposition|Adverse Event|5|||
161941309|NCT00725985|584836139|FG003|ITP- Treatment Disposition|Adverse Event|0|||
161941310|NCT00725985|584836140|FG004|ITP- Treatment Disposition|Adverse Event|0|||
162235845|NCT00918580|585914897|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
162235846|NCT00918580|585914897|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
162235847|NCT00918580|585914897|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
162235848|NCT01411215|585914898|FG000|Overall Study|Adverse Event|1|||
162235849|NCT01411215|585914899|FG001|Overall Study|Adverse Event|2|||
162235850|NCT01411215|585914898|FG000|Overall Study|Lack of Efficacy|2|||
162235851|NCT01411215|585914899|FG001|Overall Study|Lack of Efficacy|4|||
162235852|NCT01411215|585914898|FG000|Overall Study|Lost to Follow-up|12|||
162235853|NCT01411215|585914899|FG001|Overall Study|Lost to Follow-up|18|||
162235854|NCT01411215|585914898|FG000|Overall Study|Did not meet entrance criteria|0|||
162235855|NCT01411215|585914899|FG001|Overall Study|Did not meet entrance criteria|1|||
162235856|NCT01411215|585914898|FG000|Overall Study|Study terminated by sponsor|2|||
162235857|NCT01411215|585914899|FG001|Overall Study|Study terminated by sponsor|15|||
162235858|NCT01411215|585914898|FG000|Overall Study|Protocol Violation|3|||
162235859|NCT01411215|585914899|FG001|Overall Study|Protocol Violation|5|||
162235860|NCT01411215|585914898|FG000|Overall Study|Withdrawal by Subject|34|||
162235861|NCT01411215|585914899|FG001|Overall Study|Withdrawal by Subject|21|||
162235862|NCT01411215|585914898|FG000|Overall Study|Other|12|||
162235863|NCT01411215|585914899|FG001|Overall Study|Other|17|||
162235864|NCT01411215|585914898|FG000|Overall Study|Screen failure|0|||
162235865|NCT01411215|585914899|FG001|Overall Study|Screen failure|1|||
162235866|NCT01100034|585914900|FG000|Overall Study|Lost to Follow-up|11|||
162235867|NCT01100034|585914900|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
162235868|NCT01100034|585914900|FG000|Overall Study|Withdrawal by Subject|4|||
162235869|NCT01100034|585914900|FG000|Overall Study|Sponsor decision|21|||
162235870|NCT01100034|585914900|FG000|Overall Study|Participated in another clinical trial|1|||
162235871|NCT01100034|585914900|FG000|Overall Study|Participants moved to another hospital|4|||
162235872|NCT01100034|585914900|FG000|Overall Study|Site closed due to non-responsiveness|1|||
162235873|NCT00402597|585914901|FG000|Overall Study|Death|15|||
162235874|NCT00402597|585914902|FG001|Overall Study|Death|7|||
162235875|NCT00402597|585914903|FG002|Overall Study|Death|6|||
162235876|NCT00402597|585914904|FG003|Overall Study|Death|4|||
161941311|NCT00725985|584836141|FG005|ITP- Treatment Disposition|Adverse Event|0|||
161941312|NCT00725985|584836142|FG006|ITP- Treatment Disposition|Adverse Event|0|||
161941313|NCT00725985|584836143|FG007|ITP- Treatment Disposition|Adverse Event|0|||
161941314|NCT00725985|584836144|FG008|ITP- Treatment Disposition|Adverse Event|0|||
161941315|NCT00725985|584836145|FG009|ITP- Treatment Disposition|Adverse Event|0|||
161941316|NCT00725985|584836146|FG010|ITP- Treatment Disposition|Adverse Event|0|||
161941317|NCT00725985|584836147|FG011|ITP- Treatment Disposition|Adverse Event|0|||
161941318|NCT00725985|584836136|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
161941319|NCT00725985|584836137|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
161681482|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
161681483|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
161681484|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
161681485|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
161681486|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
161681487|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
161681488|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
161681489|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
161681490|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
161681491|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
161681492|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Death|0|||
161681493|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Death|25|||
161681494|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Death|13|||
161681495|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Death|4|||
161681496|NCT02752035|583886171|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
161681497|NCT02752035|583886172|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
161681498|NCT02752035|583886173|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
161681499|NCT02752035|583886174|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
161681500|NCT02752035|583886171|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
161681501|NCT02752035|583886172|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
161681502|NCT02752035|583886173|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
161681503|NCT02752035|583886174|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
161681504|NCT02752035|583886171|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
161681505|NCT02752035|583886172|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
161681506|NCT02752035|583886173|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
161681507|NCT02752035|583886174|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
161681508|NCT02752035|583886171|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
161681509|NCT02752035|583886172|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
161681510|NCT02752035|583886173|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
161681511|NCT02752035|583886174|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
161681512|NCT02752035|583886171|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
161681513|NCT02752035|583886172|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
161681514|NCT02752035|583886173|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
161681515|NCT02752035|583886174|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
161681516|NCT03668600|583886177|FG000|Overall Study|Study Terminated by the Sponsor|157|||
161681517|NCT03668600|583886177|FG000|Overall Study|Protocol Violation|1|||
161681518|NCT03668600|583886177|FG000|Overall Study|Pregnancy|1|||
161681519|NCT03668600|583886177|FG000|Overall Study|Lost to Follow-up|7|||
161681520|NCT03668600|583886177|FG000|Overall Study|Withdrawal by Subject|56|||
161681521|NCT03668600|583886177|FG000|Overall Study|Lack of Efficacy|7|||
161681522|NCT03668600|583886177|FG000|Overall Study|Adverse Event|1|||
161681523|NCT01263483|583886179|FG000|Overall Study|Adverse Event|4|||
161681524|NCT01263483|583886180|FG001|Overall Study|Adverse Event|0|||
161681525|NCT01263483|583886181|FG002|Overall Study|Adverse Event|3|||
161681526|NCT01263483|583886179|FG000|Overall Study|Withdrawal by Subject|1|||
161681527|NCT01263483|583886180|FG001|Overall Study|Withdrawal by Subject|0|||
161681528|NCT01263483|583886181|FG002|Overall Study|Withdrawal by Subject|0|||
161681529|NCT01263483|583886179|FG000|Overall Study|Lack of Efficacy|2|||
161681530|NCT01263483|583886180|FG001|Overall Study|Lack of Efficacy|0|||
161681531|NCT01263483|583886181|FG002|Overall Study|Lack of Efficacy|0|||
161681532|NCT01263483|583886179|FG000|Overall Study|Protocol Violation|0|||
161681533|NCT01263483|583886180|FG001|Overall Study|Protocol Violation|1|||
161681534|NCT01263483|583886181|FG002|Overall Study|Protocol Violation|1|||
161941320|NCT00725985|584836138|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
161941321|NCT00725985|584836139|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
161941322|NCT00725985|584836140|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
161941323|NCT00725985|584836141|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
161681535|NCT01263483|583886179|FG000|Overall Study|Participant Unavailability|0|||
161681536|NCT01263483|583886180|FG001|Overall Study|Participant Unavailability|1|||
161681537|NCT01263483|583886181|FG002|Overall Study|Participant Unavailability|1|||
161941324|NCT00725985|584836142|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
161941325|NCT00725985|584836143|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
162235877|NCT00402597|585914905|FG004|Overall Study|Death|6|||
161681538|NCT01131676|583886186|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
161681539|NCT01131676|583886187|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
161681540|NCT01131676|583886188|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
161681541|NCT01131676|583886186|FG000|Discontinuation From Treatment|Not treated|4|||
161681542|NCT01131676|583886187|FG001|Discontinuation From Treatment|Not treated|2|||
161681543|NCT01131676|583886188|FG002|Discontinuation From Treatment|Not treated|2|||
161941326|NCT00725985|584836144|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
161941327|NCT00725985|584836145|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
161941328|NCT00725985|584836146|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
161681544|NCT01131676|583886186|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
161681545|NCT01131676|583886187|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
161681546|NCT01131676|583886188|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
161681547|NCT01131676|583886186|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
161941329|NCT00725985|584836147|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
161941330|NCT00725985|584836136|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
161941331|NCT00725985|584836137|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
161941332|NCT00725985|584836138|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
161941333|NCT00725985|584836139|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
161941334|NCT00725985|584836140|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
161941335|NCT00725985|584836141|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
161941336|NCT00725985|584836142|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
161681548|NCT01131676|583886187|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
161681549|NCT01131676|583886188|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
161681550|NCT01131676|583886186|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
161681551|NCT01131676|583886187|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
161681552|NCT01131676|583886188|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
161681553|NCT01131676|583886186|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
161681554|NCT01131676|583886187|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
161681555|NCT01131676|583886188|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
161681556|NCT01131676|583886186|FG000|Discontinuation From Treatment|Other than those specified|162|||
161681557|NCT01131676|583886187|FG001|Discontinuation From Treatment|Other than those specified|142|||
161681558|NCT01131676|583886188|FG002|Discontinuation From Treatment|Other than those specified|125|||
161681559|NCT01131676|583886186|FG000|Discontinuation From Treatment|Adverse Event|303|||
161681560|NCT01131676|583886187|FG001|Discontinuation From Treatment|Adverse Event|267|||
161681561|NCT01131676|583886188|FG002|Discontinuation From Treatment|Adverse Event|273|||
161681562|NCT01131676|583886186|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
161941337|NCT00725985|584836143|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
161941338|NCT00725985|584836144|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
161941339|NCT00725985|584836145|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
161941340|NCT00725985|584836146|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
161941341|NCT00725985|584836147|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
161941342|NCT00725985|584836136|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
161941343|NCT00725985|584836137|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
161681563|NCT01131676|583886187|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
161681564|NCT01131676|583886188|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
161681565|NCT01131676|583886186|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
161681566|NCT01131676|583886187|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
161681567|NCT01131676|583886188|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
161681568|NCT01131676|583886186|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
161683072|NCT01843842|583891239|FG000|Overall Study|Do not meet inclusion criteria|1|||
161941344|NCT00725985|584836138|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
161681569|NCT01131676|583886187|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
162025498|NCT00486811|585150760|FG000|Overall Study|Withdrawal by Subject|33|||
161681570|NCT01131676|583886188|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
161681571|NCT01131676|583886186|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
162025499|NCT00486811|585150761|FG001|Overall Study|Withdrawal by Subject|44|||
162025500|NCT00486811|585150762|FG002|Overall Study|Withdrawal by Subject|58|||
161830440|NCT01640184|584420123|FG001|Overall Study|Lost to Follow-up|1|||
161830441|NCT01640184|584420124|FG002|Overall Study|Lost to Follow-up|0|||
161830442|NCT01640184|584420122|FG000|Overall Study|Physician Decision|3|||
161830443|NCT01640184|584420123|FG001|Overall Study|Physician Decision|0|||
161830444|NCT01640184|584420124|FG002|Overall Study|Physician Decision|0|||
161830445|NCT01640184|584420122|FG000|Overall Study|Withdrawal by Subject|0|||
161830446|NCT01640184|584420123|FG001|Overall Study|Withdrawal by Subject|1|||
161830447|NCT01640184|584420124|FG002|Overall Study|Withdrawal by Subject|1|||
161830448|NCT01640184|584420122|FG000|Overall Study|Protocol Violation|0|||
161830449|NCT01640184|584420123|FG001|Overall Study|Protocol Violation|0|||
161830450|NCT01640184|584420124|FG002|Overall Study|Protocol Violation|1|||
161830451|NCT01876368|584420127|FG000|Overall Study|Adverse Event|2|||
161830452|NCT01876368|584420128|FG001|Overall Study|Adverse Event|5|||
161830453|NCT01876368|584420127|FG000|Overall Study|Lack of Efficacy|1|||
161830454|NCT01876368|584420128|FG001|Overall Study|Lack of Efficacy|0|||
161830455|NCT01876368|584420127|FG000|Overall Study|Lost to Follow-up|0|||
161830456|NCT01876368|584420128|FG001|Overall Study|Lost to Follow-up|1|||
161830457|NCT01876368|584420127|FG000|Overall Study|Non-compliance with study treatment|0|||
161830458|NCT01876368|584420128|FG001|Overall Study|Non-compliance with study treatment|1|||
161830459|NCT01876368|584420127|FG000|Overall Study|Physician Decision|0|||
161830460|NCT01876368|584420128|FG001|Overall Study|Physician Decision|2|||
161830461|NCT01876368|584420127|FG000|Overall Study|Protocol deviation|3|||
161830462|NCT01876368|584420128|FG001|Overall Study|Protocol deviation|3|||
161830463|NCT01876368|584420127|FG000|Overall Study|Subject/guardian decision|3|||
161830464|NCT01876368|584420128|FG001|Overall Study|Subject/guardian decision|1|||
161830465|NCT02260258|584420129|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
161831593|NCT00384293|584424837|FG001|Post-randomization Period|Protocol Violation|1|||
161681572|NCT01131676|583886187|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
161681573|NCT01131676|583886188|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
161681574|NCT01131676|583886186|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
161681575|NCT01131676|583886187|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
161830466|NCT02260258|584420130|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
161830467|NCT01644149|584420131|FG000|Overall Study|Withdrawal by Subject|1|||
161830468|NCT01644149|584420132|FG001|Overall Study|Withdrawal by Subject|0|||
161830469|NCT01644149|584420131|FG000|Overall Study|Lost to Follow-up|3|||
161681576|NCT01131676|583886188|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
161681577|NCT01131676|583886186|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
161681578|NCT01131676|583886187|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
161681579|NCT01131676|583886188|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
161681580|NCT04109222|583886189|FG000|Overall Study|Adverse Event|1|||
161681581|NCT04109222|583886190|FG001|Overall Study|Adverse Event|0|||
161681582|NCT04109222|583886191|FG002|Overall Study|Adverse Event|0|||
161681583|NCT02577406|583886192|FG000|Randomized Period|Death|1|||
161681584|NCT02577406|583886193|FG001|Randomized Period|Death|0|||
161681585|NCT02577406|583886192|FG000|Randomized Period|Other reasons|0|||
162235878|NCT00402597|585914901|FG000|Overall Study|Adverse Event|81|||
161681586|NCT02577406|583886193|FG001|Randomized Period|Other reasons|20|||
161681587|NCT02577406|583886192|FG000|Treatment Period|Death|38|||
161681588|NCT02577406|583886193|FG001|Treatment Period|Death|23|||
162235879|NCT00402597|585914902|FG001|Overall Study|Adverse Event|18|||
162235880|NCT00402597|585914903|FG002|Overall Study|Adverse Event|106|||
162235881|NCT00402597|585914904|FG003|Overall Study|Adverse Event|39|||
162235882|NCT00402597|585914905|FG004|Overall Study|Adverse Event|71|||
162235883|NCT00402597|585914901|FG000|Overall Study|Lost to Follow-up|8|||
162235884|NCT00402597|585914902|FG001|Overall Study|Lost to Follow-up|1|||
162235885|NCT00402597|585914903|FG002|Overall Study|Lost to Follow-up|8|||
162235886|NCT00402597|585914904|FG003|Overall Study|Lost to Follow-up|2|||
162235887|NCT00402597|585914905|FG004|Overall Study|Lost to Follow-up|3|||
162235888|NCT00402597|585914901|FG000|Overall Study|Withdrawal by Subject|57|||
162235889|NCT00402597|585914902|FG001|Overall Study|Withdrawal by Subject|16|||
162235890|NCT00402597|585914903|FG002|Overall Study|Withdrawal by Subject|65|||
162235891|NCT00402597|585914904|FG003|Overall Study|Withdrawal by Subject|15|||
162235892|NCT00402597|585914905|FG004|Overall Study|Withdrawal by Subject|24|||
162235893|NCT00402597|585914901|FG000|Overall Study|reason not specified|30|||
162235894|NCT00402597|585914902|FG001|Overall Study|reason not specified|4|||
162235895|NCT00402597|585914903|FG002|Overall Study|reason not specified|27|||
162235896|NCT00402597|585914904|FG003|Overall Study|reason not specified|14|||
162235897|NCT00402597|585914905|FG004|Overall Study|reason not specified|20|||
162235898|NCT01831856|585914906|FG000|Overall Study|Adverse Event|5|||
162235899|NCT01831856|585914907|FG001|Overall Study|Adverse Event|8|||
162235900|NCT01831856|585914906|FG000|Overall Study|Lack of Efficacy|13|||
162235901|NCT01831856|585914907|FG001|Overall Study|Lack of Efficacy|11|||
162235902|NCT01831856|585914906|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
162025501|NCT00486811|585150760|FG000|Overall Study|Study drug non-compliant|5|||
162025502|NCT00486811|585150761|FG001|Overall Study|Study drug non-compliant|6|||
161941345|NCT00725985|584836139|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
161941346|NCT00725985|584836140|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
161941347|NCT00725985|584836141|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
161941348|NCT00725985|584836142|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
161941349|NCT00725985|584836143|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
161681589|NCT02577406|583886192|FG000|Treatment Period|Adverse Event|17|||
161681590|NCT02577406|583886193|FG001|Treatment Period|Adverse Event|12|||
161681591|NCT02577406|583886192|FG000|Treatment Period|Progressive Disease|53|||
161681592|NCT02577406|583886193|FG001|Treatment Period|Progressive Disease|37|||
161681593|NCT02577406|583886192|FG000|Treatment Period|Withdrawal by Subject|10|||
161681594|NCT02577406|583886193|FG001|Treatment Period|Withdrawal by Subject|24|||
161681595|NCT02577406|583886192|FG000|Treatment Period|Lost to Follow-up|0|||
161681596|NCT02577406|583886193|FG001|Treatment Period|Lost to Follow-up|1|||
161681597|NCT02577406|583886192|FG000|Treatment Period|Transition to commercially available treatment|1|||
161681598|NCT02577406|583886193|FG001|Treatment Period|Transition to commercially available treatment|1|||
161681599|NCT02577406|583886192|FG000|Treatment Period|Physician Decision|1|||
161681600|NCT02577406|583886193|FG001|Treatment Period|Physician Decision|0|||
161681601|NCT02577406|583886192|FG000|Treatment Period|Disease Relapse|28|||
161681602|NCT02577406|583886193|FG001|Treatment Period|Disease Relapse|1|||
161681603|NCT02577406|583886192|FG000|Treatment Period|Protocol Violation|0|||
161681604|NCT02577406|583886193|FG001|Treatment Period|Protocol Violation|1|||
161681605|NCT02577406|583886192|FG000|Treatment Period|Other Reasons|3|||
161681606|NCT02577406|583886193|FG001|Treatment Period|Other Reasons|39|||
161681607|NCT02577406|583886192|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
161681608|NCT02577406|583886193|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
161681609|NCT01111851|583886199|FG000|Overall Study|All planned PET scans were not obtained.|2|||
161681610|NCT01111851|583886200|FG001|Overall Study|All planned PET scans were not obtained.|0|||
161681611|NCT05500274|583886201|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
161681612|NCT05500274|583886202|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
161681613|NCT05500274|583886201|FG000|Overall Study|Lost to Follow-up|76|||
161681614|NCT05500274|583886202|FG001|Overall Study|Lost to Follow-up|51|||
161681615|NCT01555151|583886203|FG000|Overall Study|Withdrawal by Subject|6|||
161681616|NCT01555151|583886204|FG001|Overall Study|Withdrawal by Subject|2|||
161681617|NCT01555151|583886205|FG002|Overall Study|Withdrawal by Subject|0|||
161681618|NCT01555151|583886206|FG003|Overall Study|Withdrawal by Subject|2|||
161681619|NCT01555151|583886203|FG000|Overall Study|Administrative|3|||
161681620|NCT01555151|583886204|FG001|Overall Study|Administrative|1|||
161681621|NCT01555151|583886205|FG002|Overall Study|Administrative|2|||
161681622|NCT01555151|583886206|FG003|Overall Study|Administrative|0|||
161681623|NCT01555151|583886203|FG000|Overall Study|Protocol Violation|3|||
161681624|NCT01555151|583886204|FG001|Overall Study|Protocol Violation|3|||
161681625|NCT01555151|583886205|FG002|Overall Study|Protocol Violation|3|||
161681626|NCT01555151|583886206|FG003|Overall Study|Protocol Violation|5|||
161681627|NCT01555151|583886203|FG000|Overall Study|Adverse Event|1|||
161681628|NCT01555151|583886204|FG001|Overall Study|Adverse Event|2|||
161681629|NCT01555151|583886205|FG002|Overall Study|Adverse Event|1|||
161681630|NCT01555151|583886206|FG003|Overall Study|Adverse Event|2|||
161681631|NCT01555151|583886203|FG000|Overall Study|Lost to Follow-up|0|||
161681632|NCT01555151|583886204|FG001|Overall Study|Lost to Follow-up|0|||
161681633|NCT01555151|583886205|FG002|Overall Study|Lost to Follow-up|0|||
161681634|NCT01555151|583886206|FG003|Overall Study|Lost to Follow-up|1|||
161681635|NCT01961349|583886207|FG000|Overall Study|Withdrawal by Subject|1|||
161681636|NCT01961349|583886208|FG001|Overall Study|Withdrawal by Subject|4|||
161681637|NCT01961349|583886209|FG002|Overall Study|Withdrawal by Subject|0|||
161681638|NCT01961349|583886207|FG000|Overall Study|Adverse Event|0|||
161681639|NCT01961349|583886208|FG001|Overall Study|Adverse Event|0|||
161681640|NCT01961349|583886209|FG002|Overall Study|Adverse Event|1|||
161681641|NCT01961349|583886207|FG000|Overall Study|registration error, personal reason etc|2|||
161681642|NCT01961349|583886208|FG001|Overall Study|registration error, personal reason etc|2|||
161681643|NCT01961349|583886209|FG002|Overall Study|registration error, personal reason etc|1|||
161681644|NCT02343159|583886211|FG000|Overall Study|Early Study Termination|16|||
161681645|NCT02343159|583886212|FG001|Overall Study|Early Study Termination|19|||
161681646|NCT02343159|583886213|FG002|Overall Study|Early Study Termination|23|||
161681647|NCT02343159|583886211|FG000|Overall Study|Physician Decision|2|||
161681648|NCT02343159|583886212|FG001|Overall Study|Physician Decision|0|||
161681649|NCT02343159|583886213|FG002|Overall Study|Physician Decision|1|||
161681650|NCT02343159|583886211|FG000|Overall Study|Withdrawal by Subject|3|||
161830470|NCT01644149|584420132|FG001|Overall Study|Lost to Follow-up|1|||
161681651|NCT02343159|583886212|FG001|Overall Study|Withdrawal by Subject|0|||
161681652|NCT02343159|583886213|FG002|Overall Study|Withdrawal by Subject|2|||
161681653|NCT02343159|583886211|FG000|Overall Study|Lost to Follow-up|0|||
161681654|NCT02343159|583886212|FG001|Overall Study|Lost to Follow-up|2|||
161681655|NCT02343159|583886213|FG002|Overall Study|Lost to Follow-up|2|||
161681656|NCT02343159|583886211|FG000|Overall Study|Adverse Event|4|||
161681657|NCT02343159|583886212|FG001|Overall Study|Adverse Event|4|||
161681658|NCT02343159|583886213|FG002|Overall Study|Adverse Event|2|||
161681659|NCT02343159|583886211|FG000|Overall Study|Sponsor Decision|0|||
161681660|NCT02343159|583886212|FG001|Overall Study|Sponsor Decision|1|||
161681661|NCT02343159|583886213|FG002|Overall Study|Sponsor Decision|0|||
161681662|NCT02343159|583886211|FG000|Overall Study|Enrollment Error|1|||
161681663|NCT02343159|583886212|FG001|Overall Study|Enrollment Error|0|||
161681664|NCT02343159|583886213|FG002|Overall Study|Enrollment Error|0|||
161681665|NCT02114268|583886216|FG000|Overall Study|Lost to Follow-up|4|||
161681666|NCT02114268|583886217|FG001|Overall Study|Lost to Follow-up|1|||
161681667|NCT02114268|583886218|FG002|Overall Study|Lost to Follow-up|1|||
161830471|NCT00690482|584420133|FG000|Overall Study|Adverse Event|2|||
161830472|NCT00690482|584420134|FG001|Overall Study|Adverse Event|1|||
161830473|NCT00690482|584420133|FG000|Overall Study|Incorrect enrolment|0|||
161830474|NCT00690482|584420134|FG001|Overall Study|Incorrect enrolment|1|||
161830475|NCT00690482|584420133|FG000|Overall Study|Study-specific discontinuation criteria|1|||
161830476|NCT00690482|584420134|FG001|Overall Study|Study-specific discontinuation criteria|0|||
161830477|NCT00690482|584420133|FG000|Overall Study|Intake of prohibited medicine|1|||
161830478|NCT00690482|584420134|FG001|Overall Study|Intake of prohibited medicine|0|||
161681668|NCT02114268|583886219|FG003|Overall Study|Lost to Follow-up|0|||
161681669|NCT02114268|583886220|FG004|Overall Study|Lost to Follow-up|0|||
161681670|NCT02114268|583886221|FG005|Overall Study|Lost to Follow-up|2|||
161681671|NCT02114268|583886216|FG000|Overall Study|Withdrawal by Subject|1|||
161681672|NCT02114268|583886217|FG001|Overall Study|Withdrawal by Subject|0|||
161681673|NCT02114268|583886218|FG002|Overall Study|Withdrawal by Subject|0|||
161681674|NCT02114268|583886219|FG003|Overall Study|Withdrawal by Subject|0|||
161681675|NCT02114268|583886220|FG004|Overall Study|Withdrawal by Subject|0|||
161681676|NCT02114268|583886221|FG005|Overall Study|Withdrawal by Subject|1|||
161681677|NCT02114268|583886216|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
161681678|NCT02114268|583886217|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
161681679|NCT02114268|583886218|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
161681680|NCT02114268|583886219|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
161681681|NCT02114268|583886220|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
161681682|NCT02114268|583886221|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
161681683|NCT02790138|583886222|FG000|Overall Study|Adverse Event|5|||
161681684|NCT02790138|583886223|FG001|Overall Study|Adverse Event|2|||
161681685|NCT02790138|583886222|FG000|Overall Study|Significant Protocol Deviation|0|||
161681686|NCT02790138|583886223|FG001|Overall Study|Significant Protocol Deviation|1|||
161681687|NCT02790138|583886222|FG000|Overall Study|Lost to Follow-up|1|||
161681688|NCT02790138|583886223|FG001|Overall Study|Lost to Follow-up|0|||
161681689|NCT02790138|583886222|FG000|Overall Study|Voluntary Withdrawal|8|||
161830479|NCT00690482|584420133|FG000|Overall Study|withdrew consent at rand.day|0|||
161681690|NCT02790138|583886223|FG001|Overall Study|Voluntary Withdrawal|9|||
161681691|NCT02790138|583886222|FG000|Overall Study|Lack of Efficacy|6|||
161681692|NCT02790138|583886223|FG001|Overall Study|Lack of Efficacy|7|||
161681693|NCT02790138|583886222|FG000|Overall Study|Reason not Specified|1|||
161941350|NCT00725985|584836144|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
161681694|NCT02790138|583886223|FG001|Overall Study|Reason not Specified|0|||
161681695|NCT04037748|583886224|FG000|Treatment Period 1|Withdrawal by Subject|3|||
161681696|NCT04037748|583886225|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161681697|NCT04037748|583886224|FG000|Treatment Period 1|Adverse Event|1|||
161681698|NCT04037748|583886225|FG001|Treatment Period 1|Adverse Event|1|||
161681699|NCT04037748|583886224|FG000|Treatment Period 1|Protocol Violation|4|||
161830480|NCT00690482|584420134|FG001|Overall Study|withdrew consent at rand.day|1|||
161681700|NCT04037748|583886225|FG001|Treatment Period 1|Protocol Violation|5|||
161681701|NCT04037748|583886224|FG000|Treatment Period 2|Adverse Event|0|||
161681702|NCT04037748|583886225|FG001|Treatment Period 2|Adverse Event|1|||
161681703|NCT04037748|583886224|FG000|Treatment Period 2|Protocol Violation|2|||
161681704|NCT04037748|583886225|FG001|Treatment Period 2|Protocol Violation|0|||
161681705|NCT02064920|583886228|FG000|Overall Study|Adverse Event|0|||
161681706|NCT02064920|583886229|FG001|Overall Study|Adverse Event|4|||
161681707|NCT02064920|583886228|FG000|Overall Study|Physician Decision|0|||
161941351|NCT00725985|584836145|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
161941352|NCT00725985|584836146|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
161941353|NCT00725985|584836147|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
161941354|NCT00725985|584836136|FG000|ITP- Treatment Disposition|Other|50|||
161830481|NCT04798482|584420135|FG000|Overall Study|Physician Decision|1|||
161681708|NCT02064920|583886229|FG001|Overall Study|Physician Decision|1|||
161830482|NCT04798482|584420135|FG000|Overall Study|Lost eligibility|1|||
161681709|NCT02064920|583886228|FG000|Overall Study|Technical Problems|0|||
161681710|NCT02064920|583886229|FG001|Overall Study|Technical Problems|1|||
161681711|NCT02064920|583886228|FG000|Overall Study|Withdrawal by Subject|1|||
161830483|NCT00605917|584420140|FG000|Overall Study|Protocol Violation|79|||
161830484|NCT01506908|584420141|FG000|Overall Study|Adverse Event|1|||
161830485|NCT01506908|584420142|FG001|Overall Study|Adverse Event|0|||
161830486|NCT00292227|584420145|FG000|Patch Period|Adverse Event|1|||
162025503|NCT00486811|585150762|FG002|Overall Study|Study drug non-compliant|3|||
162025504|NCT00486811|585150760|FG000|Overall Study|All other|18|||
161830487|NCT00292227|584420146|FG001|Patch Period|Adverse Event|0|||
161830488|NCT00292227|584420147|FG002|Patch Period|Adverse Event|2|||
161830489|NCT00292227|584420145|FG000|Patch Period|Withdrawal by Subject|0|||
161830490|NCT00292227|584420146|FG001|Patch Period|Withdrawal by Subject|0|||
161830491|NCT00292227|584420147|FG002|Patch Period|Withdrawal by Subject|1|||
161830492|NCT04232540|584420151|FG000|Overall Study|Lost to Follow-up|1|||
161830493|NCT04232540|584420152|FG001|Overall Study|Lost to Follow-up|0|||
161830494|NCT00537017|584420153|FG000|Treatment Phase|Adverse Event|19|||
161830495|NCT00537017|584420153|FG000|Treatment Phase|Withdrawal by Subject|13|||
161830496|NCT00537017|584420153|FG000|Treatment Phase|Protocol Violation|2|||
161830497|NCT00537017|584420153|FG000|Follow-up Phase|Withdrawal by Subject|9|||
161830498|NCT03234608|584420155|FG000|Overall Study|Lost to Follow-up|23|||
161830499|NCT03234608|584420156|FG001|Overall Study|Lost to Follow-up|21|||
161830500|NCT02105701|584420157|FG000|Overall Study|Lost to Follow-up|1|||
161830501|NCT02105701|584420158|FG001|Overall Study|Lost to Follow-up|0|||
161830502|NCT02105701|584420159|FG002|Overall Study|Lost to Follow-up|2|||
161830503|NCT02105701|584420160|FG003|Overall Study|Lost to Follow-up|1|||
161830504|NCT02105701|584420157|FG000|Overall Study|Protocol Violation|0|||
161830505|NCT02105701|584420158|FG001|Overall Study|Protocol Violation|0|||
161941355|NCT00725985|584836137|FG001|ITP- Treatment Disposition|Other|38|||
161941356|NCT00725985|584836138|FG002|ITP- Treatment Disposition|Other|24|||
161941357|NCT00725985|584836139|FG003|ITP- Treatment Disposition|Other|0|||
161941358|NCT00725985|584836140|FG004|ITP- Treatment Disposition|Other|0|||
161941359|NCT00725985|584836141|FG005|ITP- Treatment Disposition|Other|0|||
161830506|NCT02105701|584420159|FG002|Overall Study|Protocol Violation|1|||
161830507|NCT02105701|584420160|FG003|Overall Study|Protocol Violation|0|||
161830508|NCT02105701|584420157|FG000|Overall Study|Withdrawal by Subject|2|||
161830509|NCT02105701|584420158|FG001|Overall Study|Withdrawal by Subject|1|||
161830510|NCT02105701|584420159|FG002|Overall Study|Withdrawal by Subject|0|||
161830511|NCT02105701|584420160|FG003|Overall Study|Withdrawal by Subject|1|||
161830512|NCT02105701|584420157|FG000|Overall Study|Death|1|||
161830513|NCT02105701|584420158|FG001|Overall Study|Death|0|||
161830514|NCT02105701|584420159|FG002|Overall Study|Death|0|||
161830515|NCT02105701|584420160|FG003|Overall Study|Death|0|||
161830516|NCT02329431|584420161|FG000|Overall Study|Lost to Follow-up|20|||
161830517|NCT02329431|584420162|FG001|Overall Study|Lost to Follow-up|13|||
161830518|NCT03693950|584420163|FG000|Overall Study|Withdrawal by Subject|1|||
161830519|NCT03693950|584420164|FG001|Overall Study|Withdrawal by Subject|0|||
161830520|NCT01362296|584420165|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
161830521|NCT01362296|584420166|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
161830522|NCT01362296|584420167|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
161830523|NCT01362296|584420168|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
161830524|NCT01362296|584420165|FG000|Randomized Phase (RP)|Physician Decision|1|||
161830525|NCT01362296|584420166|FG001|Randomized Phase (RP)|Physician Decision|9|||
161830526|NCT01362296|584420167|FG002|Randomized Phase (RP)|Physician Decision|0|||
161830527|NCT01362296|584420168|FG003|Randomized Phase (RP)|Physician Decision|0|||
161830528|NCT01362296|584420165|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
161830529|NCT01362296|584420166|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
161830530|NCT01362296|584420167|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
161830531|NCT01362296|584420168|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
161830532|NCT01362296|584420165|FG000|Randomized Phase (RP)|Adverse Event|20|||
161830533|NCT01362296|584420166|FG001|Randomized Phase (RP)|Adverse Event|4|||
161830534|NCT01362296|584420167|FG002|Randomized Phase (RP)|Adverse Event|0|||
161830535|NCT01362296|584420168|FG003|Randomized Phase (RP)|Adverse Event|0|||
161830536|NCT01362296|584420165|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
161830537|NCT01362296|584420166|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
161830538|NCT01362296|584420167|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
161830539|NCT01362296|584420168|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
161830540|NCT01362296|584420165|FG000|Crossover Phase|PD including Death due to PD|0|||
161830541|NCT01362296|584420166|FG001|Crossover Phase|PD including Death due to PD|0|||
161830542|NCT01362296|584420167|FG002|Crossover Phase|PD including Death due to PD|16|||
161830543|NCT01362296|584420168|FG003|Crossover Phase|PD including Death due to PD|1|||
161830544|NCT01362296|584420165|FG000|Crossover Phase|Withdrawal by Subject|0|||
161830545|NCT01362296|584420166|FG001|Crossover Phase|Withdrawal by Subject|0|||
161830546|NCT01362296|584420167|FG002|Crossover Phase|Withdrawal by Subject|2|||
161830547|NCT01362296|584420168|FG003|Crossover Phase|Withdrawal by Subject|1|||
161830548|NCT01362296|584420165|FG000|Crossover Phase|Adverse Event|0|||
161830549|NCT01362296|584420166|FG001|Crossover Phase|Adverse Event|0|||
161830550|NCT01362296|584420167|FG002|Crossover Phase|Adverse Event|4|||
161830551|NCT01362296|584420168|FG003|Crossover Phase|Adverse Event|0|||
161830552|NCT01362296|584420165|FG000|Crossover Phase|Study Closed/Terminated|0|||
161830553|NCT01362296|584420166|FG001|Crossover Phase|Study Closed/Terminated|0|||
161830554|NCT01362296|584420167|FG002|Crossover Phase|Study Closed/Terminated|1|||
161830555|NCT01362296|584420168|FG003|Crossover Phase|Study Closed/Terminated|0|||
161830556|NCT04230876|584420169|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
161830557|NCT04230876|584420170|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
161830558|NCT01662362|584420172|FG000|Overall Study|Lost to Follow-up|38|||
162025505|NCT00486811|585150761|FG001|Overall Study|All other|11|||
161830559|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
161830560|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
161830561|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
161830562|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
161830563|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
161681712|NCT02064920|583886229|FG001|Overall Study|Withdrawal by Subject|3|||
161681713|NCT02109562|583886230|FG000|Overall Study|Insufficient clinical response|2|||
161681714|NCT02109562|583886231|FG001|Overall Study|Insufficient clinical response|0|||
161681715|NCT02109562|583886232|FG002|Overall Study|Insufficient clinical response|4|||
161681716|NCT02109562|583886230|FG000|Overall Study|Adverse Event|0|||
161681717|NCT02109562|583886231|FG001|Overall Study|Adverse Event|2|||
161681718|NCT02109562|583886232|FG002|Overall Study|Adverse Event|3|||
161681719|NCT02109562|583886230|FG000|Overall Study|Lost to Follow-up|1|||
161681720|NCT02109562|583886231|FG001|Overall Study|Lost to Follow-up|0|||
161681721|NCT02109562|583886232|FG002|Overall Study|Lost to Follow-up|1|||
161681722|NCT02109562|583886230|FG000|Overall Study|Protocol Violation|0|||
161681723|NCT02109562|583886231|FG001|Overall Study|Protocol Violation|3|||
161681724|NCT02109562|583886232|FG002|Overall Study|Protocol Violation|1|||
161681725|NCT02109562|583886230|FG000|Overall Study|Withdrawal by Subject|20|||
161681726|NCT02109562|583886231|FG001|Overall Study|Withdrawal by Subject|25|||
161681727|NCT02109562|583886232|FG002|Overall Study|Withdrawal by Subject|21|||
161681728|NCT02109562|583886230|FG000|Overall Study|Physician Decision|3|||
161681729|NCT02109562|583886231|FG001|Overall Study|Physician Decision|4|||
161681730|NCT02109562|583886232|FG002|Overall Study|Physician Decision|5|||
161681731|NCT00262522|583886244|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
161681732|NCT00262522|583886245|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
161681733|NCT00262522|583886246|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
161681734|NCT00262522|583886247|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
161681735|NCT00262522|583886244|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
161681736|NCT00262522|583886245|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
161681737|NCT00262522|583886246|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
161681738|NCT00262522|583886247|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
161681739|NCT00262522|583886244|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
161681740|NCT00262522|583886245|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
161681741|NCT00262522|583886246|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
161681742|NCT00262522|583886247|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
161681743|NCT00262522|583886244|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
161681744|NCT00262522|583886245|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
161941360|NCT00725985|584836142|FG006|ITP- Treatment Disposition|Other|0|||
161941361|NCT00725985|584836143|FG007|ITP- Treatment Disposition|Other|0|||
161941362|NCT00725985|584836144|FG008|ITP- Treatment Disposition|Other|0|||
161941363|NCT00725985|584836145|FG009|ITP- Treatment Disposition|Other|0|||
161681745|NCT00262522|583886246|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
161681746|NCT00262522|583886247|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
161941364|NCT00725985|584836146|FG010|ITP- Treatment Disposition|Other|0|||
161941365|NCT00725985|584836147|FG011|ITP- Treatment Disposition|Other|0|||
161681747|NCT00262522|583886244|FG000|Study Start Through 8 Weeks|Death|1|||
161941366|NCT00725985|584836136|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161681748|NCT00262522|583886245|FG001|Study Start Through 8 Weeks|Death|0|||
161681749|NCT00262522|583886246|FG002|Study Start Through 8 Weeks|Death|0|||
161681750|NCT00262522|583886247|FG003|Study Start Through 8 Weeks|Death|0|||
161681751|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
161681752|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
161681753|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
161681754|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
161681755|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
161681756|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
161941367|NCT00725985|584836137|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161941368|NCT00725985|584836138|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161941369|NCT00725985|584836139|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
161941370|NCT00725985|584836140|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
161941371|NCT00725985|584836141|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
161941372|NCT00725985|584836142|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161941373|NCT00725985|584836143|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161941374|NCT00725985|584836144|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161941375|NCT00725985|584836145|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161941376|NCT00725985|584836146|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161941377|NCT00725985|584836147|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
161830564|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
161830565|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
161830566|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
161830567|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
161830568|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
161830569|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
161830570|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
161830571|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Death|0|||
161830572|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Death|1|||
161830573|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Death|0|||
161830574|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Death|0|||
161830575|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
161830576|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
161830577|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
161830578|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
161830579|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
161830580|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
161830581|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
162235903|NCT01831856|585914907|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
162235904|NCT05208866|585914909|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
162235905|NCT00836095|585914912|FG000|Overall Study|Physician Decision|0|||
162235906|NCT00836095|585914913|FG001|Overall Study|Physician Decision|3|||
162235907|NCT01602562|585914914|FG000|Overall Study|Adverse Event|3|||
162235908|NCT01602562|585914915|FG001|Overall Study|Adverse Event|1|||
162235909|NCT01602562|585914914|FG000|Overall Study|Physician Decision|1|||
162235910|NCT01602562|585914915|FG001|Overall Study|Physician Decision|1|||
162235911|NCT01602562|585914914|FG000|Overall Study|Withdrawal by Subject|1|||
162235912|NCT01602562|585914915|FG001|Overall Study|Withdrawal by Subject|1|||
162235913|NCT04964414|585914917|FG000|Overall Study|Lost to Follow-up|10|||
161681757|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
161681758|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
161681759|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
161681760|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
161681761|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
161681762|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
161681763|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
161681764|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
161681765|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
161681766|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
161681767|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Death|2|||
161681768|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Death|0|||
161681769|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Death|1|||
161681770|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Death|0|||
161681771|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
161681772|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
161681773|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
161681774|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
161681775|NCT00262522|583886244|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
161681776|NCT00262522|583886245|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
161681777|NCT00262522|583886246|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
161681778|NCT00262522|583886247|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
161681779|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
161681780|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
161681781|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
161681782|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
161681783|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
161681784|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
161681785|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
162235914|NCT04964414|585914918|FG001|Overall Study|Lost to Follow-up|8|||
162235915|NCT04964414|585914917|FG000|Overall Study|Withdrawal by Subject|1|||
162235916|NCT04964414|585914918|FG001|Overall Study|Withdrawal by Subject|1|||
161681786|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
161830582|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
161830583|NCT00545688|584420174|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
162235917|NCT03881553|585914919|FG000|Overall Study|Discharged prior to participation|1|||
162235918|NCT03881553|585914920|FG001|Overall Study|Discharged prior to participation|1|||
162235919|NCT03881553|585914921|FG002|Overall Study|Discharged prior to participation|0|||
162235920|NCT03881553|585914919|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
162235921|NCT03881553|585914920|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
162235922|NCT03881553|585914921|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
162235923|NCT00336895|585914926|FG000|Overall Study|diarrhea|1|||
162235924|NCT00336895|585914926|FG000|Overall Study|nausea and upset stomach|1|||
162235925|NCT00336895|585914926|FG000|Overall Study|Physician Decision|1|||
162235926|NCT00336895|585914926|FG000|Overall Study|screen failed|1|||
162235927|NCT01959334|585914927|FG000|Second Dose|Adverse Event|1|||
162235928|NCT01959334|585914928|FG001|Second Dose|Adverse Event|0|||
162235929|NCT01959334|585914927|FG000|Third Dose|Adverse Event|0|||
162235930|NCT01959334|585914928|FG001|Third Dose|Adverse Event|1|||
162235931|NCT01313689|585914929|FG000|24-Week Randomization 1|Adverse Event|10|||
162235932|NCT01313689|585914930|FG001|24-Week Randomization 1|Adverse Event|5|||
162235933|NCT01313689|585914931|FG002|24-Week Randomization 1|Adverse Event|0|||
162235934|NCT01313689|585914932|FG003|24-Week Randomization 1|Adverse Event|0|||
162235935|NCT01313689|585914933|FG004|24-Week Randomization 1|Adverse Event|0|||
162235936|NCT01313689|585914929|FG000|24-Week Randomization 1|Physician Decision|4|||
162235937|NCT01313689|585914930|FG001|24-Week Randomization 1|Physician Decision|5|||
162235938|NCT01313689|585914931|FG002|24-Week Randomization 1|Physician Decision|0|||
162235939|NCT01313689|585914932|FG003|24-Week Randomization 1|Physician Decision|0|||
161830584|NCT00545688|584420175|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
162235940|NCT01313689|585914933|FG004|24-Week Randomization 1|Physician Decision|0|||
161941378|NCT00725985|584836136|FG000|OLMP (Up to 96 Weeks)|Death|0|||
162025506|NCT00486811|585150762|FG002|Overall Study|All other|7|||
161681787|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
162025507|NCT00852371|585150763|FG000|Overall Study|Lost to Follow-up|2|||
161681788|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
161681789|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
161681790|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
161681791|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
161941379|NCT00725985|584836137|FG001|OLMP (Up to 96 Weeks)|Death|0|||
161681792|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
161681793|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
161681794|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
161681795|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Death|2|||
161681796|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Death|0|||
161681797|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Death|2|||
161681798|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Death|0|||
161681799|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
161681800|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
161681801|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
161681802|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
161681803|NCT00262522|583886244|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
161681804|NCT00262522|583886245|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
161941380|NCT00725985|584836138|FG002|OLMP (Up to 96 Weeks)|Death|0|||
161941381|NCT00725985|584836139|FG003|OLMP (Up to 96 Weeks)|Death|0|||
161830585|NCT00545688|584420176|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
161830586|NCT00545688|584420177|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
161830587|NCT00545688|584420174|FG000|Adjuvant Treatment Period|Disease Progression|3|||
161830588|NCT00545688|584420175|FG001|Adjuvant Treatment Period|Disease Progression|3|||
161830589|NCT00545688|584420176|FG002|Adjuvant Treatment Period|Disease Progression|0|||
161830590|NCT00545688|584420177|FG003|Adjuvant Treatment Period|Disease Progression|7|||
161830591|NCT00545688|584420174|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
161830592|NCT00545688|584420175|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
161830593|NCT00545688|584420176|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
161830594|NCT00545688|584420177|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
161681805|NCT00262522|583886246|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
161681806|NCT00262522|583886247|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
161681807|NCT05318937|583886252|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161830595|NCT00545688|584420174|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
161830596|NCT00545688|584420175|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
161830597|NCT00545688|584420176|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
161830598|NCT00545688|584420177|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
161681808|NCT05318937|583886253|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161681809|NCT05318937|583886252|FG000|Overall Study|Lost to Follow-up|0|||
161681810|NCT05318937|583886253|FG001|Overall Study|Lost to Follow-up|1|||
161681811|NCT05318937|583886252|FG000|Overall Study|Withdrawal by Subject|0|||
161830599|NCT00545688|584420174|FG000|Adjuvant Treatment Period|Adverse Event|0|||
161941382|NCT00725985|584836140|FG004|OLMP (Up to 96 Weeks)|Death|1|||
161941383|NCT00725985|584836141|FG005|OLMP (Up to 96 Weeks)|Death|0|||
161941384|NCT00725985|584836142|FG006|OLMP (Up to 96 Weeks)|Death|0|||
161941385|NCT00725985|584836143|FG007|OLMP (Up to 96 Weeks)|Death|0|||
161941386|NCT00725985|584836144|FG008|OLMP (Up to 96 Weeks)|Death|0|||
161941387|NCT00725985|584836145|FG009|OLMP (Up to 96 Weeks)|Death|0|||
162025508|NCT00852371|585150764|FG001|Overall Study|Lost to Follow-up|3|||
162025509|NCT00852371|585150765|FG002|Overall Study|Lost to Follow-up|4|||
162025510|NCT00852371|585150766|FG003|Overall Study|Lost to Follow-up|2|||
162025511|NCT04525885|585150767|FG000|Overall Study|Screen Failure|1|||
161941388|NCT00725985|584836146|FG010|OLMP (Up to 96 Weeks)|Death|0|||
161681812|NCT05318937|583886253|FG001|Overall Study|Withdrawal by Subject|2|||
161681813|NCT05318937|583886252|FG000|Overall Study|Protocol Violation|0|||
161681814|NCT05318937|583886253|FG001|Overall Study|Protocol Violation|1|||
161681815|NCT04722042|583886254|FG000|Overall Study|Withdrawal by Subject|2|||
161681816|NCT04722042|583886255|FG001|Overall Study|Withdrawal by Subject|1|||
161681817|NCT04722042|583886256|FG002|Overall Study|Withdrawal by Subject|0|||
161681818|NCT01877915|583886264|FG000|Overall Study|Lost to Follow-up|10|||
161681819|NCT01877915|583886265|FG001|Overall Study|Lost to Follow-up|9|||
161681820|NCT01877915|583886264|FG000|Overall Study|Withdrawal by Subject|42|||
161681821|NCT01877915|583886265|FG001|Overall Study|Withdrawal by Subject|55|||
161681822|NCT01877915|583886264|FG000|Overall Study|Other|2|||
161681823|NCT01877915|583886265|FG001|Overall Study|Other|4|||
161681824|NCT01045798|583886270|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
161681825|NCT01045798|583886271|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
161681826|NCT01045798|583886270|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
161681827|NCT01045798|583886271|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
161681828|NCT01045798|583886270|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
161681829|NCT01045798|583886271|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
161681830|NCT01045798|583886270|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
161681831|NCT01045798|583886271|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
161681832|NCT01449461|583886272|FG000|Overall Study|Adverse Event|0|||
161681833|NCT01449461|583886273|FG001|Overall Study|Adverse Event|3|||
161941389|NCT00725985|584836147|FG011|OLMP (Up to 96 Weeks)|Death|0|||
161681834|NCT01449461|583886274|FG002|Overall Study|Adverse Event|2|||
161681835|NCT01449461|583886275|FG003|Overall Study|Adverse Event|3|||
161681836|NCT01449461|583886276|FG004|Overall Study|Adverse Event|4|||
161941390|NCT00725985|584836136|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161681837|NCT01449461|583886277|FG005|Overall Study|Adverse Event|4|||
161681838|NCT01449461|583886272|FG000|Overall Study|Death|0|||
161681839|NCT01449461|583886273|FG001|Overall Study|Death|2|||
161681840|NCT01449461|583886274|FG002|Overall Study|Death|0|||
161681841|NCT01449461|583886275|FG003|Overall Study|Death|0|||
161681842|NCT01449461|583886276|FG004|Overall Study|Death|7|||
161681843|NCT01449461|583886277|FG005|Overall Study|Death|1|||
162025512|NCT04525885|585150768|FG001|Overall Study|Screen Failure|0|||
161681844|NCT01449461|583886272|FG000|Overall Study|Physician Decision|0|||
161681845|NCT01449461|583886273|FG001|Overall Study|Physician Decision|1|||
161681846|NCT01449461|583886274|FG002|Overall Study|Physician Decision|0|||
161681847|NCT01449461|583886275|FG003|Overall Study|Physician Decision|4|||
161681848|NCT01449461|583886276|FG004|Overall Study|Physician Decision|1|||
161681849|NCT01449461|583886277|FG005|Overall Study|Physician Decision|0|||
161681850|NCT01449461|583886272|FG000|Overall Study|Documented Progressive Disease|4|||
161681851|NCT01449461|583886273|FG001|Overall Study|Documented Progressive Disease|7|||
161681852|NCT01449461|583886274|FG002|Overall Study|Documented Progressive Disease|14|||
161681853|NCT01449461|583886275|FG003|Overall Study|Documented Progressive Disease|15|||
161681854|NCT01449461|583886276|FG004|Overall Study|Documented Progressive Disease|24|||
161681855|NCT01449461|583886277|FG005|Overall Study|Documented Progressive Disease|5|||
161681856|NCT01449461|583886272|FG000|Overall Study|Clinical Progressive Disease|2|||
161681857|NCT01449461|583886273|FG001|Overall Study|Clinical Progressive Disease|2|||
161681858|NCT01449461|583886274|FG002|Overall Study|Clinical Progressive Disease|0|||
161681859|NCT01449461|583886275|FG003|Overall Study|Clinical Progressive Disease|3|||
161681860|NCT01449461|583886276|FG004|Overall Study|Clinical Progressive Disease|4|||
161681861|NCT01449461|583886277|FG005|Overall Study|Clinical Progressive Disease|2|||
161681862|NCT01449461|583886272|FG000|Overall Study|Protocol Violation|0|||
161681863|NCT01449461|583886273|FG001|Overall Study|Protocol Violation|0|||
161681864|NCT01449461|583886274|FG002|Overall Study|Protocol Violation|0|||
161681865|NCT01449461|583886275|FG003|Overall Study|Protocol Violation|1|||
161681866|NCT01449461|583886276|FG004|Overall Study|Protocol Violation|0|||
161681867|NCT01449461|583886277|FG005|Overall Study|Protocol Violation|0|||
161681868|NCT01449461|583886272|FG000|Overall Study|Site Terminated by Sponsor|0|||
161681869|NCT01449461|583886273|FG001|Overall Study|Site Terminated by Sponsor|1|||
161681870|NCT01449461|583886274|FG002|Overall Study|Site Terminated by Sponsor|2|||
161681871|NCT01449461|583886275|FG003|Overall Study|Site Terminated by Sponsor|3|||
161681872|NCT01449461|583886276|FG004|Overall Study|Site Terminated by Sponsor|4|||
161681873|NCT01449461|583886277|FG005|Overall Study|Site Terminated by Sponsor|1|||
161681874|NCT01449461|583886272|FG000|Overall Study|Withdrawal by Subject|0|||
161681875|NCT01449461|583886273|FG001|Overall Study|Withdrawal by Subject|1|||
161681876|NCT01449461|583886274|FG002|Overall Study|Withdrawal by Subject|0|||
161681877|NCT01449461|583886275|FG003|Overall Study|Withdrawal by Subject|0|||
161681878|NCT01449461|583886276|FG004|Overall Study|Withdrawal by Subject|2|||
161681879|NCT01449461|583886277|FG005|Overall Study|Withdrawal by Subject|1|||
161681880|NCT01449461|583886272|FG000|Overall Study|Reason not Specified|0|||
161681881|NCT01449461|583886273|FG001|Overall Study|Reason not Specified|1|||
161681882|NCT01449461|583886274|FG002|Overall Study|Reason not Specified|0|||
161681883|NCT01449461|583886275|FG003|Overall Study|Reason not Specified|3|||
161681884|NCT01449461|583886276|FG004|Overall Study|Reason not Specified|2|||
161681885|NCT01449461|583886277|FG005|Overall Study|Reason not Specified|1|||
161681886|NCT05314517|583886278|FG000|Double-blind Period|Adverse Event|4|||
161681887|NCT05314517|583886279|FG001|Double-blind Period|Adverse Event|0|||
161681888|NCT05314517|583886280|FG002|Double-blind Period|Adverse Event|0|||
161681889|NCT05314517|583886281|FG003|Double-blind Period|Adverse Event|0|||
161681890|NCT05314517|583886278|FG000|Double-blind Period|Noncompliance|0|||
161681891|NCT05314517|583886279|FG001|Double-blind Period|Noncompliance|1|||
161681892|NCT05314517|583886280|FG002|Double-blind Period|Noncompliance|0|||
161681893|NCT05314517|583886281|FG003|Double-blind Period|Noncompliance|0|||
161681894|NCT05314517|583886278|FG000|Double-blind Period|Randomized, not treated|1|||
161681895|NCT05314517|583886279|FG001|Double-blind Period|Randomized, not treated|0|||
161681896|NCT05314517|583886280|FG002|Double-blind Period|Randomized, not treated|0|||
161681897|NCT05314517|583886281|FG003|Double-blind Period|Randomized, not treated|0|||
161681898|NCT05314517|583886278|FG000|Open-label Extension|Adverse Event|0|||
161681899|NCT05314517|583886279|FG001|Open-label Extension|Adverse Event|0|||
161681900|NCT05314517|583886280|FG002|Open-label Extension|Adverse Event|1|||
161681901|NCT05314517|583886281|FG003|Open-label Extension|Adverse Event|2|||
161681902|NCT05314517|583886278|FG000|Open-label Extension|Investigator decision|0|||
161681903|NCT05314517|583886279|FG001|Open-label Extension|Investigator decision|0|||
162025513|NCT04525885|585150769|FG002|Overall Study|Screen Failure|0|||
162025514|NCT04525885|585150767|FG000|Overall Study|Withdrawal by Subject|14|||
161681904|NCT05314517|583886280|FG002|Open-label Extension|Investigator decision|1|||
161681905|NCT05314517|583886281|FG003|Open-label Extension|Investigator decision|0|||
161681906|NCT05314517|583886278|FG000|Open-label Extension|Lost to Follow-up|0|||
161681907|NCT05314517|583886279|FG001|Open-label Extension|Lost to Follow-up|0|||
161681908|NCT05314517|583886280|FG002|Open-label Extension|Lost to Follow-up|0|||
161681909|NCT05314517|583886281|FG003|Open-label Extension|Lost to Follow-up|1|||
161681910|NCT05314517|583886278|FG000|Open-label Extension|Withdrawal by Subject|0|||
161681911|NCT05314517|583886279|FG001|Open-label Extension|Withdrawal by Subject|0|||
161681912|NCT05314517|583886280|FG002|Open-label Extension|Withdrawal by Subject|1|||
161681913|NCT05314517|583886281|FG003|Open-label Extension|Withdrawal by Subject|2|||
161681914|NCT05314517|583886278|FG000|Open-label Extension|Use of prohibited medication|0|||
161681915|NCT05314517|583886279|FG001|Open-label Extension|Use of prohibited medication|0|||
162025515|NCT04525885|585150768|FG001|Overall Study|Withdrawal by Subject|6|||
162025516|NCT04525885|585150769|FG002|Overall Study|Withdrawal by Subject|20|||
162025517|NCT04525885|585150767|FG000|Overall Study|Physician Decision|1|||
162025518|NCT04525885|585150768|FG001|Overall Study|Physician Decision|0|||
162025519|NCT04525885|585150769|FG002|Overall Study|Physician Decision|1|||
161681916|NCT05314517|583886280|FG002|Open-label Extension|Use of prohibited medication|1|||
161681917|NCT05314517|583886281|FG003|Open-label Extension|Use of prohibited medication|0|||
161681918|NCT05314517|583886278|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
161681919|NCT05314517|583886279|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
161681920|NCT05314517|583886280|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
161681921|NCT05314517|583886281|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
161681922|NCT04198623|583887402|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
161681923|NCT05050318|583887408|FG000|Overall Study|Protocol Deviation|1|||
161681924|NCT05050318|583887409|FG001|Overall Study|Protocol Deviation|0|||
161681925|NCT05050318|583887410|FG002|Overall Study|Protocol Deviation|0|||
161681926|NCT04259411|583887411|FG000|Overall Study|Death|1|||
161681927|NCT04259411|583887411|FG000|Overall Study|Missed visit|2|||
161681928|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
161681929|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
161681930|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
161681931|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
161681932|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
161681933|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
161681934|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Death|2|||
161681935|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Death|0|||
161681936|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
161681937|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
161681938|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
161681939|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
161681940|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
161681941|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
161681942|NCT02603120|583887417|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
161681943|NCT02603120|583887418|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
161681944|NCT02603120|583887417|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
161681945|NCT02603120|583887418|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
161681946|NCT02603120|583887417|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
161681947|NCT02603120|583887418|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
161681948|NCT02603120|583887417|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
161681949|NCT02603120|583887418|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
161681950|NCT02603120|583887417|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
161681951|NCT02603120|583887418|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
161681952|NCT02603120|583887417|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
161681953|NCT02603120|583887418|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
161681954|NCT02603120|583887417|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
161681955|NCT02603120|583887418|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
161681956|NCT00916357|583887420|FG000|Period 1|Withdrawal by Subject|1|||
161681957|NCT00916357|583887421|FG001|Period 1|Withdrawal by Subject|0|||
161681958|NCT00916357|583887422|FG002|Period 1|Withdrawal by Subject|0|||
161681959|NCT00916357|583887423|FG003|Period 1|Withdrawal by Subject|0|||
161681960|NCT00916357|583887424|FG004|Period 1|Withdrawal by Subject|0|||
161681961|NCT00916357|583887425|FG005|Period 1|Withdrawal by Subject|0|||
161681962|NCT00916357|583887420|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
161681963|NCT00916357|583887421|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
161681964|NCT00916357|583887422|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
161681965|NCT00916357|583887423|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
161681966|NCT00916357|583887424|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
161681967|NCT00916357|583887425|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
161681968|NCT03807349|583887428|FG000|Overall Study|Early Study Termination|9|||
161681969|NCT05807464|583887431|FG000|Overall Study|Adverse Event|1|||
161681970|NCT04451161|583887432|FG000|Overall Study|Lost to Follow-up|28|||
161681971|NCT04451161|583887433|FG001|Overall Study|Lost to Follow-up|37|||
161681972|NCT04451161|583887434|FG002|Overall Study|Lost to Follow-up|22|||
161681973|NCT04451161|583887435|FG003|Overall Study|Lost to Follow-up|13|||
161681974|NCT04451161|583887436|FG004|Overall Study|Lost to Follow-up|11|||
161681975|NCT04451161|583887437|FG005|Overall Study|Lost to Follow-up|14|||
161681976|NCT04451161|583887432|FG000|Overall Study|Withdrawal by Subject|3|||
161681977|NCT04451161|583887433|FG001|Overall Study|Withdrawal by Subject|0|||
161681978|NCT04451161|583887434|FG002|Overall Study|Withdrawal by Subject|0|||
161830600|NCT00545688|584420175|FG001|Adjuvant Treatment Period|Adverse Event|3|||
161681979|NCT04451161|583887435|FG003|Overall Study|Withdrawal by Subject|0|||
161681980|NCT04451161|583887436|FG004|Overall Study|Withdrawal by Subject|2|||
161681981|NCT04451161|583887437|FG005|Overall Study|Withdrawal by Subject|4|||
161681982|NCT03596866|583887441|FG000|Overall Study|Site terminated by Sponsor|64|||
161681983|NCT03596866|583887442|FG001|Overall Study|Site terminated by Sponsor|65|||
161681984|NCT03596866|583887441|FG000|Overall Study|Death|37|||
161681985|NCT03596866|583887442|FG001|Overall Study|Death|24|||
161830601|NCT00545688|584420176|FG002|Adjuvant Treatment Period|Adverse Event|2|||
161830602|NCT00545688|584420177|FG003|Adjuvant Treatment Period|Adverse Event|2|||
161941391|NCT00725985|584836137|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161941392|NCT00725985|584836138|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161830603|NCT00545688|584420174|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
161681986|NCT03596866|583887441|FG000|Overall Study|Withdrawal by Subject|4|||
161681987|NCT03596866|583887442|FG001|Overall Study|Withdrawal by Subject|6|||
161681988|NCT03596866|583887441|FG000|Overall Study|Missing|0|||
161681989|NCT03596866|583887442|FG001|Overall Study|Missing|6|||
161681990|NCT03596866|583887441|FG000|Overall Study|Lost to Follow-up|2|||
161681991|NCT03596866|583887442|FG001|Overall Study|Lost to Follow-up|3|||
161681992|NCT03596866|583887441|FG000|Overall Study|Protocol Violation|1|||
161681993|NCT03596866|583887442|FG001|Overall Study|Protocol Violation|0|||
161681994|NCT03596866|583887441|FG000|Overall Study|Reason Not Specified|14|||
161681995|NCT03596866|583887442|FG001|Overall Study|Reason Not Specified|13|||
161681996|NCT00596947|583887443|FG000|Overall Study|study halted due to low enrollment|5|||
161681997|NCT00596947|583887444|FG001|Overall Study|study halted due to low enrollment|3|||
161681998|NCT00596947|583887443|FG000|Overall Study|Lost to Follow-up|1|||
161681999|NCT00596947|583887444|FG001|Overall Study|Lost to Follow-up|0|||
161682000|NCT03000179|583887445|FG000|Overall Study|Lost to Follow-up|2|||
161682001|NCT01431274|583887451|FG000|Overall Study|Adverse Event|51|||
161682002|NCT01431274|583887452|FG001|Overall Study|Adverse Event|37|||
161682003|NCT01431274|583887453|FG002|Overall Study|Adverse Event|43|||
161682004|NCT01431274|583887454|FG003|Overall Study|Adverse Event|30|||
161682005|NCT01431274|583887455|FG004|Overall Study|Adverse Event|37|||
161682006|NCT01431274|583887451|FG000|Overall Study|Consent withdrawn not due to AE|29|||
161682007|NCT01431274|583887452|FG001|Overall Study|Consent withdrawn not due to AE|20|||
161682008|NCT01431274|583887453|FG002|Overall Study|Consent withdrawn not due to AE|17|||
161682009|NCT01431274|583887454|FG003|Overall Study|Consent withdrawn not due to AE|20|||
161682010|NCT01431274|583887455|FG004|Overall Study|Consent withdrawn not due to AE|11|||
161682011|NCT01431274|583887451|FG000|Overall Study|Non compliant with protocol|5|||
161682012|NCT01431274|583887452|FG001|Overall Study|Non compliant with protocol|8|||
161682013|NCT01431274|583887453|FG002|Overall Study|Non compliant with protocol|4|||
161682014|NCT01431274|583887454|FG003|Overall Study|Non compliant with protocol|4|||
161682015|NCT01431274|583887455|FG004|Overall Study|Non compliant with protocol|4|||
161682016|NCT01431274|583887451|FG000|Overall Study|Lost to Follow-up|6|||
161682017|NCT01431274|583887452|FG001|Overall Study|Lost to Follow-up|7|||
161682018|NCT01431274|583887453|FG002|Overall Study|Lost to Follow-up|1|||
161682019|NCT01431274|583887454|FG003|Overall Study|Lost to Follow-up|4|||
161682020|NCT01431274|583887455|FG004|Overall Study|Lost to Follow-up|0|||
161682021|NCT01431274|583887451|FG000|Overall Study|Other reason not stated above|6|||
161682022|NCT01431274|583887452|FG001|Overall Study|Other reason not stated above|5|||
161682023|NCT01431274|583887453|FG002|Overall Study|Other reason not stated above|7|||
161682024|NCT01431274|583887454|FG003|Overall Study|Other reason not stated above|2|||
161682025|NCT01431274|583887455|FG004|Overall Study|Other reason not stated above|4|||
161682026|NCT00003702|583887456|FG000|Overall Study|Ineligible cell types|2|||
161682027|NCT00003702|583887457|FG001|Overall Study|Ineligible cell types|2|||
161682028|NCT00003702|583887456|FG000|Overall Study|Did not meet criteria for persistence|8|||
161682029|NCT00003702|583887457|FG001|Overall Study|Did not meet criteria for persistence|5|||
161682030|NCT00003702|583887456|FG000|Overall Study|WHO score > 6|2|||
161682031|NCT00003702|583887457|FG001|Overall Study|WHO score > 6|1|||
161682032|NCT00003702|583887456|FG000|Overall Study|Inadequate documentation of disease|1|||
161682033|NCT00003702|583887457|FG001|Overall Study|Inadequate documentation of disease|3|||
161682034|NCT04995055|583887458|FG000|Period 1|COVID-19 Related|1|||
161682035|NCT04995055|583887459|FG001|Period 1|COVID-19 Related|0|||
161682036|NCT04995055|583887458|FG000|Period 1|Withdrawal by Subject|0|||
161682037|NCT04995055|583887459|FG001|Period 1|Withdrawal by Subject|1|||
161682038|NCT04995055|583887458|FG000|Period 1|Subject discontinued due to timing|4|||
161682039|NCT04995055|583887459|FG001|Period 1|Subject discontinued due to timing|4|||
161682040|NCT01358760|583887464|FG000|Overall Study|Adverse Event|3|||
161682041|NCT01358760|583887465|FG001|Overall Study|Adverse Event|4|||
161682042|NCT01358760|583887466|FG002|Overall Study|Adverse Event|3|||
161682043|NCT01358760|583887464|FG000|Overall Study|Lost to Follow-up|1|||
161682044|NCT01358760|583887465|FG001|Overall Study|Lost to Follow-up|1|||
161682045|NCT01358760|583887466|FG002|Overall Study|Lost to Follow-up|3|||
161682046|NCT01358760|583887464|FG000|Overall Study|Withdrawal by Subject|5|||
161682047|NCT01358760|583887465|FG001|Overall Study|Withdrawal by Subject|3|||
161682048|NCT01358760|583887466|FG002|Overall Study|Withdrawal by Subject|2|||
161682049|NCT01358760|583887464|FG000|Overall Study|Physician Decision|1|||
161682050|NCT01358760|583887465|FG001|Overall Study|Physician Decision|0|||
161682051|NCT01358760|583887466|FG002|Overall Study|Physician Decision|1|||
161682052|NCT01358760|583887464|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
161682053|NCT01358760|583887465|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
161682054|NCT01358760|583887466|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
161682055|NCT01506960|583887469|FG000|Overall Study|Did not meet angiographic criteria|47|||
161682056|NCT00397033|583887470|FG000|Overall Study|Adverse Event|7|||
161682057|NCT00397033|583887471|FG001|Overall Study|Adverse Event|10|||
161682058|NCT00397033|583887472|FG002|Overall Study|Adverse Event|4|||
161682059|NCT00397033|583887470|FG000|Overall Study|Lack of Efficacy|22|||
161682060|NCT00397033|583887471|FG001|Overall Study|Lack of Efficacy|12|||
161682061|NCT00397033|583887472|FG002|Overall Study|Lack of Efficacy|9|||
161682062|NCT00397033|583887470|FG000|Overall Study|Lost to Follow-up|3|||
161682063|NCT00397033|583887471|FG001|Overall Study|Lost to Follow-up|3|||
161682064|NCT00397033|583887472|FG002|Overall Study|Lost to Follow-up|3|||
161682065|NCT00397033|583887470|FG000|Overall Study|Withdrawal by Subject|12|||
161682066|NCT00397033|583887471|FG001|Overall Study|Withdrawal by Subject|7|||
161682067|NCT00397033|583887472|FG002|Overall Study|Withdrawal by Subject|5|||
161682068|NCT00397033|583887470|FG000|Overall Study|Other|0|||
161682069|NCT00397033|583887471|FG001|Overall Study|Other|5|||
161682070|NCT00397033|583887472|FG002|Overall Study|Other|2|||
161682071|NCT03519867|583887473|FG000|Overall Study|Adverse Event|1|||
161682072|NCT03519867|583887474|FG001|Overall Study|Adverse Event|1|||
161682073|NCT03519867|583887475|FG002|Overall Study|Adverse Event|0|||
161682074|NCT03519867|583887476|FG003|Overall Study|Adverse Event|0|||
161682075|NCT03519867|583887477|FG004|Overall Study|Adverse Event|0|||
161682076|NCT03519867|583887478|FG005|Overall Study|Adverse Event|0|||
161941393|NCT00725985|584836139|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
161941394|NCT00725985|584836140|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161682077|NCT03519867|583887479|FG006|Overall Study|Adverse Event|0|||
161682078|NCT03519867|583887480|FG007|Overall Study|Adverse Event|0|||
161682079|NCT03519867|583887481|FG008|Overall Study|Adverse Event|0|||
161682080|NCT03519867|583887482|FG009|Overall Study|Adverse Event|0|||
161682081|NCT03519867|583887473|FG000|Overall Study|Protocol Violation|0|||
161682082|NCT03519867|583887474|FG001|Overall Study|Protocol Violation|0|||
161682083|NCT03519867|583887475|FG002|Overall Study|Protocol Violation|0|||
161682084|NCT03519867|583887476|FG003|Overall Study|Protocol Violation|0|||
161682085|NCT03519867|583887477|FG004|Overall Study|Protocol Violation|0|||
161682086|NCT03519867|583887478|FG005|Overall Study|Protocol Violation|1|||
161682087|NCT03519867|583887479|FG006|Overall Study|Protocol Violation|0|||
161682088|NCT03519867|583887480|FG007|Overall Study|Protocol Violation|0|||
161682089|NCT03519867|583887481|FG008|Overall Study|Protocol Violation|0|||
161682090|NCT03519867|583887482|FG009|Overall Study|Protocol Violation|0|||
161682091|NCT03519867|583887473|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682092|NCT03519867|583887474|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682093|NCT03519867|583887475|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682094|NCT03519867|583887476|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682095|NCT03519867|583887477|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682096|NCT03519867|583887478|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682097|NCT03519867|583887479|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
161830604|NCT00545688|584420175|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
161682098|NCT03519867|583887480|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682099|NCT03519867|583887481|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682100|NCT03519867|583887482|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161682101|NCT03519867|583887473|FG000|Overall Study|Admin. of other reversal agent|1|||
162025520|NCT02744040|585150770|FG000|Overall Study|Withdrawal by Subject|3|||
162025521|NCT02744040|585150771|FG001|Overall Study|Withdrawal by Subject|2|||
162025522|NCT02744040|585150772|FG002|Overall Study|Withdrawal by Subject|2|||
162025523|NCT02744040|585150770|FG000|Overall Study|Physician Decision|0|||
162025524|NCT02744040|585150771|FG001|Overall Study|Physician Decision|8|||
162025525|NCT02744040|585150772|FG002|Overall Study|Physician Decision|13|||
162025526|NCT02744040|585150770|FG000|Overall Study|Lost to Follow-up|3|||
162025527|NCT02744040|585150771|FG001|Overall Study|Lost to Follow-up|1|||
162025528|NCT02744040|585150772|FG002|Overall Study|Lost to Follow-up|7|||
162025529|NCT01642615|585150773|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
161830605|NCT00545688|584420176|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
161830606|NCT00545688|584420177|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
161830607|NCT00545688|584420174|FG000|Follow-Up Period|Death|4|||
161830608|NCT00545688|584420175|FG001|Follow-Up Period|Death|2|||
161830609|NCT00545688|584420176|FG002|Follow-Up Period|Death|2|||
161830610|NCT00545688|584420177|FG003|Follow-Up Period|Death|6|||
161830611|NCT00545688|584420174|FG000|Follow-Up Period|Disease Progression|6|||
161830612|NCT00545688|584420175|FG001|Follow-Up Period|Disease Progression|5|||
161830613|NCT00545688|584420176|FG002|Follow-Up Period|Disease Progression|9|||
161830614|NCT00545688|584420177|FG003|Follow-Up Period|Disease Progression|9|||
161830615|NCT00545688|584420174|FG000|Follow-Up Period|Refused Treatment|6|||
161830616|NCT00545688|584420175|FG001|Follow-Up Period|Refused Treatment|2|||
161830617|NCT00545688|584420176|FG002|Follow-Up Period|Refused Treatment|0|||
161830618|NCT00545688|584420177|FG003|Follow-Up Period|Refused Treatment|2|||
161830619|NCT00545688|584420174|FG000|Follow-Up Period|Lost to Follow-up|3|||
161830620|NCT00545688|584420175|FG001|Follow-Up Period|Lost to Follow-up|3|||
161830621|NCT00545688|584420176|FG002|Follow-Up Period|Lost to Follow-up|3|||
161830622|NCT00545688|584420177|FG003|Follow-Up Period|Lost to Follow-up|1|||
161830623|NCT00545688|584420174|FG000|Follow-Up Period|Unspecified Reason|2|||
161830624|NCT00545688|584420175|FG001|Follow-Up Period|Unspecified Reason|5|||
161830625|NCT00545688|584420176|FG002|Follow-Up Period|Unspecified Reason|6|||
161830626|NCT00545688|584420177|FG003|Follow-Up Period|Unspecified Reason|8|||
161830627|NCT00545688|584420174|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
161830628|NCT00545688|584420175|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
161830629|NCT00545688|584420176|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
161830630|NCT00545688|584420177|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
161830631|NCT02339090|584420178|FG000|Overall Study|Adverse Event|1|||
161830632|NCT02339090|584420179|FG001|Overall Study|Adverse Event|0|||
161830633|NCT02339090|584420178|FG000|Overall Study|Lost to Follow-up|0|||
161830634|NCT02339090|584420179|FG001|Overall Study|Lost to Follow-up|1|||
161830635|NCT02339090|584420178|FG000|Overall Study|Non-compliance With Study Drug|0|||
161830636|NCT02339090|584420179|FG001|Overall Study|Non-compliance With Study Drug|1|||
161830637|NCT02339090|584420178|FG000|Overall Study|Withdrawal by Subject|2|||
161830638|NCT02339090|584420179|FG001|Overall Study|Withdrawal by Subject|1|||
161830639|NCT02339090|584420178|FG000|Overall Study|Poor Growth|3|||
161830640|NCT02339090|584420179|FG001|Overall Study|Poor Growth|0|||
161682102|NCT03519867|583887474|FG001|Overall Study|Admin. of other reversal agent|1|||
161830641|NCT02339090|584420178|FG000|Overall Study|Randomized but not treated|0|||
161830642|NCT02339090|584420179|FG001|Overall Study|Randomized but not treated|2|||
161830643|NCT02792218|584420183|FG000|Overall Study|Patient/guardian decision|15|||
161830644|NCT02792218|584420184|FG001|Overall Study|Patient/guardian decision|42|||
161830645|NCT02792218|584420183|FG000|Overall Study|Adverse Event|15|||
161830646|NCT02792218|584420184|FG001|Overall Study|Adverse Event|14|||
161830647|NCT02792218|584420183|FG000|Overall Study|Lost to Follow-up|10|||
161830648|NCT02792218|584420184|FG001|Overall Study|Lost to Follow-up|5|||
161830649|NCT02792218|584420183|FG000|Overall Study|Lack of Efficacy|1|||
161830650|NCT02792218|584420184|FG001|Overall Study|Lack of Efficacy|12|||
161682103|NCT03519867|583887475|FG002|Overall Study|Admin. of other reversal agent|0|||
161682104|NCT03519867|583887476|FG003|Overall Study|Admin. of other reversal agent|0|||
161682105|NCT03519867|583887477|FG004|Overall Study|Admin. of other reversal agent|0|||
161682106|NCT03519867|583887478|FG005|Overall Study|Admin. of other reversal agent|1|||
161682107|NCT03519867|583887479|FG006|Overall Study|Admin. of other reversal agent|0|||
161682108|NCT03519867|583887480|FG007|Overall Study|Admin. of other reversal agent|0|||
161682109|NCT03519867|583887481|FG008|Overall Study|Admin. of other reversal agent|0|||
161682110|NCT03519867|583887482|FG009|Overall Study|Admin. of other reversal agent|0|||
161682111|NCT03519867|583887473|FG000|Overall Study|Reason not provided|1|||
161682112|NCT03519867|583887474|FG001|Overall Study|Reason not provided|1|||
161682113|NCT03519867|583887475|FG002|Overall Study|Reason not provided|1|||
161682114|NCT03519867|583887476|FG003|Overall Study|Reason not provided|1|||
161682115|NCT03519867|583887477|FG004|Overall Study|Reason not provided|0|||
161682116|NCT03519867|583887478|FG005|Overall Study|Reason not provided|1|||
161682117|NCT03519867|583887479|FG006|Overall Study|Reason not provided|0|||
161682118|NCT03519867|583887480|FG007|Overall Study|Reason not provided|1|||
161682119|NCT03519867|583887481|FG008|Overall Study|Reason not provided|1|||
161682120|NCT03519867|583887482|FG009|Overall Study|Reason not provided|0|||
161682121|NCT01846624|583887483|FG000|Overall Study|Died during induction, no midostaurin|1|||
161682122|NCT01202279|583887486|FG000|Overall Study|Adverse Event|8|||
161682123|NCT01202279|583887487|FG001|Overall Study|Adverse Event|6|||
161682124|NCT01202279|583887486|FG000|Overall Study|Withdrawal by Subject|13|||
161682125|NCT01202279|583887487|FG001|Overall Study|Withdrawal by Subject|10|||
161941395|NCT00725985|584836141|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161941396|NCT00725985|584836142|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161682126|NCT01202279|583887486|FG000|Overall Study|Physician Decision|0|||
161682127|NCT01202279|583887487|FG001|Overall Study|Physician Decision|1|||
161682128|NCT01202279|583887486|FG000|Overall Study|Lost to Follow-up|10|||
161682129|NCT01202279|583887487|FG001|Overall Study|Lost to Follow-up|7|||
161682130|NCT01202279|583887486|FG000|Overall Study|Protocol Violation|1|||
161682131|NCT01202279|583887487|FG001|Overall Study|Protocol Violation|1|||
161682132|NCT01202279|583887486|FG000|Overall Study|study compliance|5|||
161682133|NCT01202279|583887487|FG001|Overall Study|study compliance|2|||
161682134|NCT03574753|583887488|FG000|Overall Study|Adverse Event|3|||
161682135|NCT03574753|583887488|FG000|Overall Study|Progression/relapse|19|||
161682136|NCT03574753|583887488|FG000|Overall Study|Death|1|||
161682137|NCT03472924|583887489|FG000|Overall Study|Adverse Event|1|||
161682138|NCT03472924|583887490|FG001|Overall Study|Adverse Event|0|||
161682139|NCT02546765|583887492|FG000|Overall Study|Withdrawal by Subject|0|||
161682140|NCT02546765|583887493|FG001|Overall Study|Withdrawal by Subject|1|||
161682141|NCT02546765|583887494|FG002|Overall Study|Withdrawal by Subject|0|||
161682142|NCT02546765|583887495|FG003|Overall Study|Withdrawal by Subject|0|||
161682143|NCT04425720|583887498|FG000|Overall Study|Withdrawal by Subject|0|||
161682144|NCT04425720|583887499|FG001|Overall Study|Withdrawal by Subject|20|||
161682145|NCT00807742|583887500|FG000|Overall Study|Death|9|||
161682146|NCT00807742|583887501|FG001|Overall Study|Death|2|||
161682147|NCT00807742|583887500|FG000|Overall Study|Withdrawal by Subject|2|||
161682148|NCT00807742|583887501|FG001|Overall Study|Withdrawal by Subject|1|||
161682149|NCT00807742|583887500|FG000|Overall Study|Lost to Follow-up|35|||
161682150|NCT00807742|583887501|FG001|Overall Study|Lost to Follow-up|51|||
161682151|NCT04814823|583887503|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
161682152|NCT02044133|583887507|FG000|Overall Study|Lost to Follow-up|1|||
162025530|NCT01642615|585150774|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
161682153|NCT02044133|583887508|FG001|Overall Study|Lost to Follow-up|1|||
161682154|NCT02044133|583887507|FG000|Overall Study|Death|1|||
161682155|NCT02044133|583887508|FG001|Overall Study|Death|0|||
161830651|NCT02792218|584420183|FG000|Overall Study|Physician Decision|4|||
161830652|NCT02792218|584420184|FG001|Overall Study|Physician Decision|4|||
161830653|NCT02792218|584420183|FG000|Overall Study|Protocol deviation|3|||
161830654|NCT02792218|584420184|FG001|Overall Study|Protocol deviation|2|||
161830655|NCT02792218|584420183|FG000|Overall Study|New therapy for study indication|0|||
161830656|NCT02792218|584420184|FG001|Overall Study|New therapy for study indication|1|||
161830657|NCT02792218|584420183|FG000|Overall Study|Non-compliance with study treatment|0|||
161830658|NCT02792218|584420184|FG001|Overall Study|Non-compliance with study treatment|1|||
161830659|NCT02792218|584420183|FG000|Overall Study|Pregnancy|1|||
161830660|NCT02792218|584420184|FG001|Overall Study|Pregnancy|0|||
161830661|NCT00248170|584420185|FG000|Overall Study|Withdrawal by Subject|71|||
161830662|NCT00248170|584420186|FG001|Overall Study|Withdrawal by Subject|79|||
161830663|NCT00248170|584420185|FG000|Overall Study|Protocol Violation|35|||
161830664|NCT00248170|584420186|FG001|Overall Study|Protocol Violation|30|||
161830665|NCT00248170|584420185|FG000|Overall Study|Lost to Follow-up|28|||
161830666|NCT00248170|584420186|FG001|Overall Study|Lost to Follow-up|35|||
161830667|NCT00248170|584420185|FG000|Overall Study|Disease progression|196|||
161830668|NCT00248170|584420186|FG001|Overall Study|Disease progression|216|||
161830669|NCT00248170|584420185|FG000|Overall Study|Death|28|||
161830670|NCT00248170|584420186|FG001|Overall Study|Death|47|||
161830671|NCT00248170|584420185|FG000|Overall Study|Adverse Event|311|||
161830672|NCT00248170|584420186|FG001|Overall Study|Adverse Event|296|||
161830673|NCT00248170|584420185|FG000|Overall Study|Administrative problems|22|||
161830674|NCT00248170|584420186|FG001|Overall Study|Administrative problems|25|||
161830675|NCT00248170|584420185|FG000|Overall Study|Abnormal test procedure(s) result|49|||
161830676|NCT00248170|584420186|FG001|Overall Study|Abnormal test procedure(s) result|61|||
161830677|NCT00248170|584420185|FG000|Overall Study|Abnormal laboratory values|4|||
161830678|NCT00248170|584420186|FG001|Overall Study|Abnormal laboratory values|0|||
161830679|NCT00248170|584420185|FG000|Overall Study|Protocol deviation|17|||
161830680|NCT00248170|584420186|FG001|Overall Study|Protocol deviation|19|||
161830681|NCT03123783|584420187|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161830682|NCT03123783|584420188|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
161830683|NCT03123783|584420189|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161830684|NCT03123783|584420190|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161830685|NCT03123783|584420191|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161830686|NCT03123783|584420192|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161830687|NCT03123783|584420193|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161830688|NCT03123783|584420187|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
161830689|NCT03123783|584420188|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
161830690|NCT03123783|584420189|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
161830691|NCT03123783|584420190|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
161830692|NCT03123783|584420191|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
161830693|NCT03123783|584420192|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
161830694|NCT03123783|584420193|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
161830695|NCT03123783|584420187|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
161830696|NCT03123783|584420188|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
161830697|NCT03123783|584420189|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
161830698|NCT03123783|584420190|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
161830699|NCT03123783|584420191|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
161830700|NCT03123783|584420192|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
161830701|NCT03123783|584420193|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
161830702|NCT03123783|584420187|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161831594|NCT00384293|584424838|FG002|Post-randomization Period|Protocol Violation|0|||
162025531|NCT01642615|585150775|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
162025532|NCT01642615|585150773|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
162025533|NCT01642615|585150774|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
161830703|NCT03123783|584420188|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161830704|NCT03123783|584420189|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161830705|NCT03123783|584420190|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161830706|NCT03123783|584420191|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
161830707|NCT03123783|584420192|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161830708|NCT03123783|584420193|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161830709|NCT01253317|584420199|FG000|Overall Study|Adverse Event|2|||
161830710|NCT00749411|584420202|FG000|Overall Study|Adverse Event|0|||
161830711|NCT00749411|584420203|FG001|Overall Study|Adverse Event|2|||
161830712|NCT00749411|584420202|FG000|Overall Study|Lack of Efficacy|0|||
161830713|NCT00749411|584420203|FG001|Overall Study|Lack of Efficacy|1|||
161830714|NCT00749411|584420202|FG000|Overall Study|Protocol Violation|1|||
161830715|NCT00749411|584420203|FG001|Overall Study|Protocol Violation|1|||
161830716|NCT00749411|584420202|FG000|Overall Study|Protocol-defined stopping criteria|0|||
161830717|NCT00749411|584420203|FG001|Overall Study|Protocol-defined stopping criteria|1|||
161830718|NCT03183141|584420204|FG000|Overall Study|Withdrawal by Subject|2|||
161830719|NCT03183141|584420205|FG001|Overall Study|Withdrawal by Subject|4|||
161830720|NCT03183141|584420204|FG000|Overall Study|Death|0|||
161830721|NCT03183141|584420205|FG001|Overall Study|Death|8|||
161830722|NCT01507090|584420209|FG000|Overall Study|incomplete dataset|18|||
161830723|NCT02953678|584420210|FG000|Overall Study|Adverse Event|20|||
161682156|NCT02044133|583887507|FG000|Overall Study|Release|3|||
161682157|NCT02044133|583887508|FG001|Overall Study|Release|4|||
161682158|NCT02044133|583887507|FG000|Overall Study|Transfer|1|||
161682159|NCT02044133|583887508|FG001|Overall Study|Transfer|0|||
161682160|NCT02044133|583887507|FG000|Overall Study|refusal of blood sampling|0|||
161682161|NCT02044133|583887508|FG001|Overall Study|refusal of blood sampling|1|||
161682162|NCT04085523|583887509|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161682163|NCT04085523|583887510|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161682164|NCT04085523|583887511|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161682165|NCT04085523|583887512|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161682166|NCT04085523|583887513|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161682167|NCT04085523|583887514|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
161682168|NCT00430482|583887516|FG000|Completed Treatment|Insufficient Treatment|7|||
161682169|NCT00430482|583887517|FG001|Completed Treatment|Insufficient Treatment|11|||
161682170|NCT00583024|583887518|FG000|Overall Study|Lost to Follow-up|4|||
161682171|NCT00449670|583888811|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
161682172|NCT00449670|583888812|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
161682173|NCT00449670|583888811|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
161682174|NCT00449670|583888812|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
161682175|NCT00449670|583888811|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
161682176|NCT00449670|583888812|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
161682177|NCT00449670|583888811|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
161682178|NCT00449670|583888812|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
161682179|NCT00449670|583888811|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
161682180|NCT00449670|583888812|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
161682181|NCT00449670|583888811|FG000|Booster Phase (Study no.109873)|Other|0|||
161682182|NCT00449670|583888812|FG001|Booster Phase (Study no.109873)|Other|2|||
161682183|NCT01502709|583888813|FG000|Overall Study|Lost to Follow-up|4|||
161682184|NCT01502709|583888814|FG001|Overall Study|Lost to Follow-up|0|||
161682185|NCT02966509|583888820|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
161682186|NCT02966509|583888821|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
161682187|NCT02966509|583888820|FG000|Baseline Satisfaction Survey|Death|0|||
161682188|NCT02966509|583888821|FG001|Baseline Satisfaction Survey|Death|1|||
161682189|NCT02966509|583888820|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
161682190|NCT02966509|583888821|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
161682191|NCT02966509|583888820|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
161682192|NCT02966509|583888821|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
161682193|NCT02966509|583888820|FG000|6 Month Satisfaction Decision Survey|Death|22|||
161682194|NCT02966509|583888821|FG001|6 Month Satisfaction Decision Survey|Death|25|||
162235941|NCT01313689|585914929|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
162235942|NCT01313689|585914930|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
162235943|NCT01313689|585914931|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
162235944|NCT01313689|585914932|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
162235945|NCT01313689|585914933|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
162235946|NCT01313689|585914929|FG000|24-Week Randomization 2|Adverse Event|0|||
162235947|NCT01313689|585914930|FG001|24-Week Randomization 2|Adverse Event|0|||
162235948|NCT01313689|585914931|FG002|24-Week Randomization 2|Adverse Event|2|||
162235949|NCT01313689|585914932|FG003|24-Week Randomization 2|Adverse Event|0|||
162235950|NCT01313689|585914933|FG004|24-Week Randomization 2|Adverse Event|8|||
162235951|NCT01313689|585914929|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
162235952|NCT01313689|585914930|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
162235953|NCT01313689|585914931|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
162235954|NCT01313689|585914932|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
162235955|NCT01313689|585914933|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
162235956|NCT01313689|585914929|FG000|24-Week Randomization 2|Physician Decision|0|||
162235957|NCT01313689|585914930|FG001|24-Week Randomization 2|Physician Decision|0|||
162235958|NCT01313689|585914931|FG002|24-Week Randomization 2|Physician Decision|0|||
162235959|NCT01313689|585914932|FG003|24-Week Randomization 2|Physician Decision|0|||
162235960|NCT01313689|585914933|FG004|24-Week Randomization 2|Physician Decision|4|||
162235961|NCT01768637|585914934|FG000|Overall Study|Lost to Follow-up|2|||
162235962|NCT01768637|585914935|FG001|Overall Study|Lost to Follow-up|7|||
162235963|NCT01768637|585914934|FG000|Overall Study|Difficult blood draw|1|||
162235964|NCT01768637|585914935|FG001|Overall Study|Difficult blood draw|0|||
162235965|NCT01054170|585914936|FG000|Overall Study|Protocol Violation|1|||
162235966|NCT01054170|585914937|FG001|Overall Study|Protocol Violation|0|||
162235967|NCT01054170|585914936|FG000|Overall Study|Withdrawal by Subject|3|||
162235968|NCT01054170|585914937|FG001|Overall Study|Withdrawal by Subject|2|||
162235969|NCT01054170|585914936|FG000|Overall Study|Adverse Event|0|||
162235970|NCT01054170|585914937|FG001|Overall Study|Adverse Event|4|||
161682195|NCT02966509|583888820|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
161682196|NCT02966509|583888821|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
162235971|NCT02951767|585914938|FG000|Overall Study|Study Terminated By Sponsor|9|||
161682197|NCT02966509|583888820|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
161682198|NCT02966509|583888821|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
161682199|NCT02966509|583888820|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
161682200|NCT02966509|583888821|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
161682201|NCT02966509|583888820|FG000|6 Month Satisfaction Survey|Death|36|||
161682202|NCT02966509|583888821|FG001|6 Month Satisfaction Survey|Death|33|||
161682203|NCT02966509|583888820|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
161682204|NCT02966509|583888821|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
161682205|NCT02966509|583888820|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
161682206|NCT02966509|583888821|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
161682207|NCT02966509|583888820|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
161682208|NCT02966509|583888821|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
161682209|NCT02966509|583888820|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
161682210|NCT02966509|583888821|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
161682211|NCT02966509|583888820|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
161682212|NCT02966509|583888821|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
161830724|NCT02953678|584420210|FG000|Overall Study|Death|7|||
161682213|NCT02982954|583888822|FG000|Overall Study|Death|55|||
161830725|NCT02953678|584420210|FG000|Overall Study|Physician Decision|23|||
161830726|NCT02953678|584420210|FG000|Overall Study|Progressive Disease of GVHD|7|||
161830727|NCT02953678|584420210|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
161830728|NCT02953678|584420210|FG000|Overall Study|Withdrawal by participant|3|||
161830729|NCT02953678|584420210|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
161830730|NCT02953678|584420210|FG000|Overall Study|Participants were transferred to commercial product.|3|||
161830731|NCT02070757|584421765|FG000|Overall Study|Adverse Event|107|||
161830732|NCT02070757|584421766|FG001|Overall Study|Adverse Event|99|||
161830733|NCT02070757|584421765|FG000|Overall Study|Lost to Follow-up|7|||
161830734|NCT02070757|584421766|FG001|Overall Study|Lost to Follow-up|4|||
161830735|NCT02070757|584421765|FG000|Overall Study|Protocol Violation|0|||
161830736|NCT02070757|584421766|FG001|Overall Study|Protocol Violation|4|||
161830737|NCT02070757|584421765|FG000|Overall Study|Withdrawal by Subject|1|||
161830738|NCT02070757|584421766|FG001|Overall Study|Withdrawal by Subject|3|||
161830739|NCT02070757|584421765|FG000|Overall Study|Investigator Decision|0|||
161830740|NCT02070757|584421766|FG001|Overall Study|Investigator Decision|2|||
161830741|NCT02070757|584421765|FG000|Overall Study|Discharged from Study Hospital|2|||
161830742|NCT02070757|584421766|FG001|Overall Study|Discharged from Study Hospital|2|||
161830743|NCT00126126|584421772|FG000|Overall Study|Lost to Follow-up|0|||
161830744|NCT00126126|584421773|FG001|Overall Study|Lost to Follow-up|2|||
161830745|NCT01570283|584421777|FG000|Cohort 1: Dose Level 1|Death|0|||
161830746|NCT01570283|584421778|FG001|Cohort 1: Dose Level 1|Death|1|||
161830747|NCT01570283|584421779|FG002|Cohort 1: Dose Level 1|Death|0|||
161830748|NCT01570283|584421780|FG003|Cohort 1: Dose Level 1|Death|0|||
161830749|NCT01570283|584421781|FG004|Cohort 1: Dose Level 1|Death|0|||
161830750|NCT01570283|584421782|FG005|Cohort 1: Dose Level 1|Death|0|||
161830751|NCT01570283|584421777|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161830752|NCT01570283|584421778|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
161830753|NCT01570283|584421779|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161830754|NCT01570283|584421780|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161830755|NCT01570283|584421781|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161830756|NCT01570283|584421782|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161830757|NCT01570283|584421777|FG000|Cohort 2: Dose Level 2|Death|0|||
161830758|NCT01570283|584421778|FG001|Cohort 2: Dose Level 2|Death|0|||
161830759|NCT01570283|584421779|FG002|Cohort 2: Dose Level 2|Death|1|||
161830760|NCT01570283|584421780|FG003|Cohort 2: Dose Level 2|Death|0|||
161830761|NCT01570283|584421781|FG004|Cohort 2: Dose Level 2|Death|0|||
161830762|NCT01570283|584421782|FG005|Cohort 2: Dose Level 2|Death|0|||
161830763|NCT01570283|584421777|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161830764|NCT01570283|584421778|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161830765|NCT01570283|584421779|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161830766|NCT01570283|584421780|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
162025534|NCT01642615|585150775|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
162025535|NCT01642615|585150773|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
161682214|NCT02982954|583888823|FG001|Overall Study|Death|29|||
161830767|NCT01570283|584421781|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161830768|NCT01570283|584421782|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161830769|NCT01570283|584421777|FG000|Cohort 3: Dose Level 3|Death|0|||
161830770|NCT01570283|584421778|FG001|Cohort 3: Dose Level 3|Death|0|||
162025536|NCT01642615|585150774|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
161830771|NCT01570283|584421779|FG002|Cohort 3: Dose Level 3|Death|0|||
161830772|NCT01570283|584421780|FG003|Cohort 3: Dose Level 3|Death|0|||
161830773|NCT01570283|584421781|FG004|Cohort 3: Dose Level 3|Death|0|||
161830774|NCT01570283|584421782|FG005|Cohort 3: Dose Level 3|Death|1|||
161830775|NCT01570283|584421777|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161830776|NCT01570283|584421778|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161830777|NCT01570283|584421779|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161830778|NCT01570283|584421780|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161830779|NCT01570283|584421781|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161830780|NCT01570283|584421782|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
161830781|NCT01833533|584421783|FG000|Overall Study|Adverse Event|0|||
161830782|NCT01833533|584421784|FG001|Overall Study|Adverse Event|1|||
161830783|NCT01833533|584421783|FG000|Overall Study|Lost to Follow-up|4|||
161830784|NCT01833533|584421784|FG001|Overall Study|Lost to Follow-up|9|||
161830785|NCT01833533|584421783|FG000|Overall Study|To Enter an Extension Study|0|||
161830786|NCT01833533|584421784|FG001|Overall Study|To Enter an Extension Study|4|||
161830787|NCT01833533|584421783|FG000|Overall Study|Other|2|||
161830788|NCT01833533|584421784|FG001|Overall Study|Other|7|||
161830789|NCT02017860|584421785|FG000|Overall Study|Adverse Event|1|||
161830790|NCT02017860|584421785|FG000|Overall Study|Withdrawal by Subject|1|||
161830791|NCT01048502|584421788|FG000|Overall Study|Lost to Follow-up|2|||
161830792|NCT01048502|584421789|FG001|Overall Study|Lost to Follow-up|0|||
161830793|NCT01048502|584421790|FG002|Overall Study|Lost to Follow-up|0|||
161830794|NCT01048502|584421791|FG003|Overall Study|Lost to Follow-up|0|||
161830795|NCT01048502|584421788|FG000|Overall Study|Adverse Event|1|||
161830796|NCT01048502|584421789|FG001|Overall Study|Adverse Event|0|||
161830797|NCT01048502|584421790|FG002|Overall Study|Adverse Event|0|||
161830798|NCT01048502|584421791|FG003|Overall Study|Adverse Event|0|||
161830799|NCT01048502|584421788|FG000|Overall Study|Withdrawal by Subject|1|||
161830800|NCT01048502|584421789|FG001|Overall Study|Withdrawal by Subject|4|||
161830801|NCT01048502|584421790|FG002|Overall Study|Withdrawal by Subject|5|||
161830802|NCT01048502|584421791|FG003|Overall Study|Withdrawal by Subject|3|||
161830803|NCT01048502|584421788|FG000|Overall Study|Physician Decision|0|||
161830804|NCT01048502|584421789|FG001|Overall Study|Physician Decision|3|||
161830805|NCT01048502|584421790|FG002|Overall Study|Physician Decision|0|||
161830806|NCT01048502|584421791|FG003|Overall Study|Physician Decision|1|||
161830807|NCT01333072|584421793|FG000|Overall Study|Lost to Follow-up|3|||
161830808|NCT01333072|584421794|FG001|Overall Study|Lost to Follow-up|0|||
161830809|NCT01333072|584421793|FG000|Overall Study|Adverse Event|2|||
161830810|NCT01333072|584421794|FG001|Overall Study|Adverse Event|4|||
161830811|NCT01333072|584421793|FG000|Overall Study|Physician Decision|1|||
161830812|NCT01333072|584421794|FG001|Overall Study|Physician Decision|0|||
161830813|NCT02457611|584421795|FG000|Overall Study|Lost to Follow-up|3|||
161830814|NCT00493454|584421796|FG000|Overall Study|Withdrawal by Subject|1|||
161830815|NCT04220775|584421797|FG000|Overall Study|Adverse Event|1|||
161830816|NCT04220775|584421798|FG001|Overall Study|Adverse Event|0|||
161830817|NCT04220775|584421797|FG000|Overall Study|Disease Progression|1|||
161830818|NCT04220775|584421798|FG001|Overall Study|Disease Progression|0|||
161830819|NCT01857206|584421800|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
161830820|NCT01857206|584421801|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
161830821|NCT01857206|584421800|FG000|Overall Study|Lost to Follow-up|9|||
161830822|NCT01857206|584421801|FG001|Overall Study|Lost to Follow-up|6|||
161830823|NCT01857206|584421800|FG000|Overall Study|Unclassified|3|||
161830824|NCT01857206|584421801|FG001|Overall Study|Unclassified|3|||
161830825|NCT01857206|584421800|FG000|Overall Study|Withdrawal by Subject|1|||
161941397|NCT00725985|584836143|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161941398|NCT00725985|584836144|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161941399|NCT00725985|584836145|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161941400|NCT00725985|584836146|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161941401|NCT00725985|584836147|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
161830826|NCT01857206|584421801|FG001|Overall Study|Withdrawal by Subject|0|||
161830827|NCT01483625|584421804|FG000|Overall Study|Adverse Event|1|||
161830828|NCT01483625|584421805|FG001|Overall Study|Adverse Event|1|||
161830829|NCT01483625|584421804|FG000|Overall Study|Refused to continue medication|2|||
161830830|NCT01483625|584421805|FG001|Overall Study|Refused to continue medication|1|||
161830831|NCT01483625|584421804|FG000|Overall Study|Due to other reason|1|||
161830832|NCT01483625|584421805|FG001|Overall Study|Due to other reason|0|||
161830833|NCT00084799|584421806|FG000|Overall Study|Disease Progression|1|||
161830834|NCT00084799|584421807|FG001|Overall Study|Disease Progression|0|||
161830835|NCT01261624|584421808|FG000|Week 0 to Week 12|Disease Progression|1|||
161830836|NCT01261624|584421809|FG001|Week 0 to Week 12|Disease Progression|1|||
161830837|NCT01261624|584421808|FG000|Week 0 to Week 12|Insufficient Response|0|||
161830838|NCT01261624|584421809|FG001|Week 0 to Week 12|Insufficient Response|2|||
161830839|NCT01261624|584421808|FG000|Week 13 to Week 24|Insufficient Response|0|||
161830840|NCT01261624|584421809|FG001|Week 13 to Week 24|Insufficient Response|1|||
161830841|NCT02094261|584421813|FG000|Overall Study|Death|24|||
161830842|NCT02094261|584421813|FG000|Overall Study|Lost to Follow-up|1|||
161830843|NCT02094261|584421813|FG000|Overall Study|Withdrawal by Subject|4|||
161682215|NCT02982954|583888824|FG002|Overall Study|Death|15|||
161682216|NCT02982954|583888825|FG003|Overall Study|Death|20|||
161682217|NCT02982954|583888822|FG000|Overall Study|Lost to Follow-up|2|||
161682218|NCT02982954|583888823|FG001|Overall Study|Lost to Follow-up|1|||
161682219|NCT02982954|583888824|FG002|Overall Study|Lost to Follow-up|0|||
161682220|NCT02982954|583888825|FG003|Overall Study|Lost to Follow-up|0|||
161682221|NCT02982954|583888822|FG000|Overall Study|Participant withdrew consent|7|||
161682222|NCT02982954|583888823|FG001|Overall Study|Participant withdrew consent|5|||
161682223|NCT02982954|583888824|FG002|Overall Study|Participant withdrew consent|1|||
161682224|NCT02982954|583888825|FG003|Overall Study|Participant withdrew consent|1|||
161682225|NCT02982954|583888822|FG000|Overall Study|Other reasons|42|||
161682226|NCT02982954|583888823|FG001|Overall Study|Other reasons|17|||
161682227|NCT02982954|583888824|FG002|Overall Study|Other reasons|12|||
161682228|NCT02982954|583888825|FG003|Overall Study|Other reasons|3|||
161682229|NCT02982954|583888822|FG000|Overall Study|Premature site closure|0|||
161682230|NCT02982954|583888823|FG001|Overall Study|Premature site closure|0|||
161682231|NCT02982954|583888824|FG002|Overall Study|Premature site closure|0|||
161682232|NCT02982954|583888825|FG003|Overall Study|Premature site closure|1|||
161682233|NCT03577730|583888826|FG000|Overall Study|Physician Decision|3|||
161682234|NCT03577730|583888827|FG001|Overall Study|Physician Decision|1|||
161682235|NCT03577730|583888826|FG000|Overall Study|Did not receive allocated intervention|1|||
161682236|NCT03577730|583888827|FG001|Overall Study|Did not receive allocated intervention|0|||
161682237|NCT03810781|583888829|FG000|Overall Study|COVID shut down|2|||
161682238|NCT00253643|583888834|FG000|Overall Study|Withdrawal by Subject|0|||
161682239|NCT00253643|583888835|FG001|Overall Study|Withdrawal by Subject|0|||
161682240|NCT00253643|583888836|FG002|Overall Study|Withdrawal by Subject|1|||
161682241|NCT00253643|583888837|FG003|Overall Study|Withdrawal by Subject|1|||
161682242|NCT00253643|583888834|FG000|Overall Study|Non-Compliance|0|||
161682243|NCT00253643|583888835|FG001|Overall Study|Non-Compliance|0|||
161682244|NCT00253643|583888836|FG002|Overall Study|Non-Compliance|0|||
161682245|NCT00253643|583888837|FG003|Overall Study|Non-Compliance|2|||
161682246|NCT01368536|583888838|FG000|Overall Study|Adverse Event|5|||
161682247|NCT01368536|583888839|FG001|Overall Study|Adverse Event|6|||
161682248|NCT01368536|583888840|FG002|Overall Study|Adverse Event|8|||
161682249|NCT01368536|583888838|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161682250|NCT01368536|583888839|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161682251|NCT01368536|583888840|FG002|Overall Study|Abnormal laboratory value(s)|2|||
161682252|NCT01368536|583888838|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161682253|NCT01368536|583888839|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161682254|NCT01368536|583888840|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161682255|NCT01368536|583888838|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
161682256|NCT01368536|583888839|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161682257|NCT01368536|583888840|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161682258|NCT01368536|583888838|FG000|Overall Study|No longer required study medication|0|||
161682259|NCT01368536|583888839|FG001|Overall Study|No longer required study medication|0|||
161682260|NCT01368536|583888840|FG002|Overall Study|No longer required study medication|1|||
161682261|NCT01368536|583888838|FG000|Overall Study|Withdrawal by Subject|2|||
161682262|NCT01368536|583888839|FG001|Overall Study|Withdrawal by Subject|5|||
161682263|NCT01368536|583888840|FG002|Overall Study|Withdrawal by Subject|4|||
161682264|NCT01368536|583888838|FG000|Overall Study|Lost to Follow-up|3|||
161682265|NCT01368536|583888839|FG001|Overall Study|Lost to Follow-up|3|||
161682266|NCT01368536|583888840|FG002|Overall Study|Lost to Follow-up|5|||
161682267|NCT01368536|583888838|FG000|Overall Study|Administrative problems|34|||
161682268|NCT01368536|583888839|FG001|Overall Study|Administrative problems|39|||
161682269|NCT01368536|583888840|FG002|Overall Study|Administrative problems|35|||
161682270|NCT01368536|583888838|FG000|Overall Study|Protocol deviation|0|||
161682271|NCT01368536|583888839|FG001|Overall Study|Protocol deviation|3|||
161682272|NCT01368536|583888840|FG002|Overall Study|Protocol deviation|1|||
161682273|NCT04770532|583888841|FG000|Overall Study|Withdrawal by Subject|0|||
161682274|NCT04770532|583888842|FG001|Overall Study|Withdrawal by Subject|3|||
161682275|NCT04770532|583888841|FG000|Overall Study|Physician Decision|1|||
161682276|NCT04770532|583888842|FG001|Overall Study|Physician Decision|0|||
161682277|NCT04770532|583888841|FG000|Overall Study|Death|2|||
161682278|NCT04770532|583888842|FG001|Overall Study|Death|2|||
161682279|NCT00454857|583888846|FG000|Overall Study|Withdrawal by Subject|15|||
161682280|NCT00454857|583888846|FG000|Overall Study|Lost to Follow-up|16|||
161682281|NCT00454857|583888846|FG000|Overall Study|Noncompliance|6|||
161682282|NCT00454857|583888846|FG000|Overall Study|Death|5|||
161682283|NCT00454857|583888846|FG000|Overall Study|Other|11|||
161682284|NCT00454857|583888846|FG000|Overall Study|Reason unknown|1|||
161682285|NCT04707157|583888847|FG000|Overall Study|Adverse Event|12|||
161682286|NCT04707157|583888848|FG001|Overall Study|Adverse Event|3|||
161682287|NCT04707157|583888847|FG000|Overall Study|Lost to Follow-up|2|||
161682288|NCT04707157|583888848|FG001|Overall Study|Lost to Follow-up|0|||
161682289|NCT04707157|583888847|FG000|Overall Study|Sponsor's decision|1|||
161682290|NCT04707157|583888848|FG001|Overall Study|Sponsor's decision|0|||
161682291|NCT04707157|583888847|FG000|Overall Study|Physician Decision|8|||
161941402|NCT00725985|584836136|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
161941403|NCT00725985|584836137|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
161941404|NCT00725985|584836138|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
161941405|NCT00725985|584836139|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
161941406|NCT00725985|584836140|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
161941407|NCT00725985|584836141|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
161941408|NCT00725985|584836142|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
161682292|NCT04707157|583888848|FG001|Overall Study|Physician Decision|5|||
161682293|NCT04707157|583888847|FG000|Overall Study|Protocol Deviation|1|||
161682294|NCT04707157|583888848|FG001|Overall Study|Protocol Deviation|0|||
161682295|NCT04707157|583888847|FG000|Overall Study|Withdrawal by Subject|1|||
161682296|NCT04707157|583888848|FG001|Overall Study|Withdrawal by Subject|1|||
161682297|NCT00827606|583888849|FG000|Overall Study|Protocol Violation|4|||
161682298|NCT00827606|583888850|FG001|Overall Study|Protocol Violation|3|||
161682299|NCT00827606|583888849|FG000|Overall Study|Lost to Follow-up|3|||
161682300|NCT00827606|583888850|FG001|Overall Study|Lost to Follow-up|1|||
161682301|NCT00827606|583888849|FG000|Overall Study|Withdrawal by Subject|7|||
161682302|NCT00827606|583888850|FG001|Overall Study|Withdrawal by Subject|6|||
161682303|NCT00827606|583888849|FG000|Overall Study|Pregnancy|0|||
161682304|NCT00827606|583888850|FG001|Overall Study|Pregnancy|1|||
161682305|NCT00827606|583888849|FG000|Overall Study|Other|5|||
161682306|NCT00827606|583888850|FG001|Overall Study|Other|13|||
161682307|NCT00827606|583888849|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
161682308|NCT00827606|583888850|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
161682309|NCT00827606|583888849|FG000|Overall Study|Adverse Event|4|||
161682310|NCT00827606|583888850|FG001|Overall Study|Adverse Event|2|||
161682311|NCT00243386|583888855|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
161682312|NCT00243386|583888856|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
161682313|NCT00243386|583888857|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
161682314|NCT00243386|583888855|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
161682315|NCT00243386|583888856|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
161682316|NCT00243386|583888857|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
161682317|NCT00243386|583888855|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
161682318|NCT00243386|583888856|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
161682319|NCT00243386|583888857|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
161682320|NCT00243386|583888855|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
161682321|NCT00243386|583888856|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
161682322|NCT00243386|583888857|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
161682323|NCT00243386|583888855|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
161682324|NCT00243386|583888856|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
161682325|NCT00243386|583888857|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
161682326|NCT00243386|583888855|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
161682327|NCT00243386|583888856|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
161682328|NCT00243386|583888857|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
161682329|NCT00243386|583888855|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
161682330|NCT00243386|583888856|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
161682331|NCT00243386|583888857|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
161682332|NCT00243386|583888855|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
161682333|NCT00243386|583888856|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
161682334|NCT00243386|583888857|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
161682335|NCT00133991|583888858|FG000|Overall Study|Death|4|||
161682336|NCT03418129|583888862|FG000|Overall Study|Lost to Follow-up|11|||
161682337|NCT03418129|583888863|FG001|Overall Study|Lost to Follow-up|20|||
161682338|NCT03418129|583888864|FG002|Overall Study|Lost to Follow-up|15|||
161682339|NCT03418129|583888862|FG000|Overall Study|Withdrawal by Subject|3|||
161682340|NCT03418129|583888863|FG001|Overall Study|Withdrawal by Subject|6|||
161682341|NCT03418129|583888864|FG002|Overall Study|Withdrawal by Subject|4|||
161941409|NCT00725985|584836143|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
161941410|NCT00725985|584836144|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
161941411|NCT00725985|584836145|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
161941412|NCT00725985|584836146|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
161941413|NCT00725985|584836147|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
161941414|NCT00725985|584836136|FG000|OLMP (Up to 96 Weeks)|Other|0|||
161682342|NCT01378858|583888867|FG000|Overall Study|Withdrawal by Subject|4|||
161682343|NCT01378858|583888868|FG001|Overall Study|Withdrawal by Subject|4|||
161682344|NCT02664272|583888869|FG000|Overall Study|Fluoroscopic images not made available|2|||
161682345|NCT03073980|583888870|FG000|Overall Study|Lost to Follow-up|10|||
161682346|NCT03073980|583888871|FG001|Overall Study|Lost to Follow-up|2|||
161682347|NCT03073980|583888872|FG002|Overall Study|Lost to Follow-up|9|||
161682348|NCT03073980|583888870|FG000|Overall Study|No post-procedure data|0|||
161682349|NCT03073980|583888871|FG001|Overall Study|No post-procedure data|0|||
161682350|NCT03073980|583888872|FG002|Overall Study|No post-procedure data|2|||
161682351|NCT04810689|583888873|FG000|Overall Study|Withdrawal by Subject|0|||
161682352|NCT04810689|583888874|FG001|Overall Study|Withdrawal by Subject|1|||
161682353|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
161682354|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
161682355|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
161682356|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
161682357|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
161682358|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
161682359|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161682360|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161682361|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
161682362|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
161682363|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
161682364|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
161682365|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
161682366|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
161682367|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
161682368|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
161682369|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
161682370|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
161682371|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
161682372|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
161682373|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
161682374|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
161682375|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
161682376|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
161682377|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Death|2|||
161682378|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Death|1|||
161682379|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Death|0|||
161830844|NCT02094261|584421813|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
161830845|NCT02363439|584421814|FG000|Overall Study|Lack of Efficacy|4|||
161830846|NCT02010255|584421819|FG000|Overall Study|Death|0|||
161682380|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Death|0|||
161682381|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
161830847|NCT02010255|584421820|FG001|Overall Study|Death|1|||
161830848|NCT02010255|584421821|FG002|Overall Study|Death|4|||
161682382|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
161682383|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
161682384|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
161682385|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
161682386|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
161682387|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
161682388|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
161682389|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
161682390|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
161682391|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161682392|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161682393|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
161682394|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
161682395|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
161682396|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
161682397|NCT01940471|583888875|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
161682398|NCT01940471|583888876|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
161682399|NCT01940471|583888877|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
161682400|NCT01940471|583888878|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
161682401|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
161682402|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
161682403|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
161830849|NCT02010255|584421822|FG003|Overall Study|Death|4|||
161830850|NCT02010255|584421823|FG004|Overall Study|Death|2|||
161830851|NCT02010255|584421824|FG005|Overall Study|Death|0|||
161830852|NCT02010255|584421825|FG006|Overall Study|Death|1|||
162025537|NCT01642615|585150775|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
162025538|NCT01642615|585150773|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
161682404|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
161682405|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161682406|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161682407|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
161682408|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
161682409|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
161682410|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
161830853|NCT02010255|584421826|FG007|Overall Study|Death|1|||
161830854|NCT02010255|584421827|FG008|Overall Study|Death|1|||
161830855|NCT02010255|584421828|FG009|Overall Study|Death|0|||
161830856|NCT02010255|584421829|FG010|Overall Study|Death|1|||
161830857|NCT02010255|584421830|FG011|Overall Study|Death|1|||
161830858|NCT02010255|584421831|FG012|Overall Study|Death|0|||
161830859|NCT02010255|584421832|FG013|Overall Study|Death|0|||
161830860|NCT02010255|584421819|FG000|Overall Study|Lack of Efficacy|4|||
161830861|NCT02010255|584421820|FG001|Overall Study|Lack of Efficacy|1|||
161830862|NCT02010255|584421821|FG002|Overall Study|Lack of Efficacy|2|||
161830863|NCT02010255|584421822|FG003|Overall Study|Lack of Efficacy|1|||
161830864|NCT02010255|584421823|FG004|Overall Study|Lack of Efficacy|1|||
161830865|NCT02010255|584421824|FG005|Overall Study|Lack of Efficacy|0|||
161830866|NCT02010255|584421825|FG006|Overall Study|Lack of Efficacy|0|||
161830867|NCT02010255|584421826|FG007|Overall Study|Lack of Efficacy|0|||
161830868|NCT02010255|584421827|FG008|Overall Study|Lack of Efficacy|0|||
161830869|NCT02010255|584421828|FG009|Overall Study|Lack of Efficacy|0|||
161830870|NCT02010255|584421829|FG010|Overall Study|Lack of Efficacy|1|||
161830871|NCT02010255|584421830|FG011|Overall Study|Lack of Efficacy|0|||
161830872|NCT02010255|584421831|FG012|Overall Study|Lack of Efficacy|0|||
161830873|NCT02010255|584421832|FG013|Overall Study|Lack of Efficacy|0|||
161830874|NCT02010255|584421819|FG000|Overall Study|Withdrew Consent|1|||
161830875|NCT02010255|584421820|FG001|Overall Study|Withdrew Consent|0|||
161830876|NCT02010255|584421821|FG002|Overall Study|Withdrew Consent|0|||
161830877|NCT02010255|584421822|FG003|Overall Study|Withdrew Consent|1|||
161830878|NCT02010255|584421823|FG004|Overall Study|Withdrew Consent|0|||
161830879|NCT02010255|584421824|FG005|Overall Study|Withdrew Consent|0|||
161830880|NCT02010255|584421825|FG006|Overall Study|Withdrew Consent|0|||
161830881|NCT02010255|584421826|FG007|Overall Study|Withdrew Consent|0|||
161682411|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
161682412|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
161682413|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
161941415|NCT00725985|584836137|FG001|OLMP (Up to 96 Weeks)|Other|0|||
161941416|NCT00725985|584836138|FG002|OLMP (Up to 96 Weeks)|Other|0|||
161941417|NCT00725985|584836139|FG003|OLMP (Up to 96 Weeks)|Other|15|||
161941418|NCT00725985|584836140|FG004|OLMP (Up to 96 Weeks)|Other|20|||
161941419|NCT00725985|584836141|FG005|OLMP (Up to 96 Weeks)|Other|44|||
161941420|NCT00725985|584836142|FG006|OLMP (Up to 96 Weeks)|Other|0|||
161941421|NCT00725985|584836143|FG007|OLMP (Up to 96 Weeks)|Other|0|||
161941422|NCT00725985|584836144|FG008|OLMP (Up to 96 Weeks)|Other|0|||
161941423|NCT00725985|584836145|FG009|OLMP (Up to 96 Weeks)|Other|0|||
161941424|NCT00725985|584836146|FG010|OLMP (Up to 96 Weeks)|Other|0|||
161941425|NCT00725985|584836147|FG011|OLMP (Up to 96 Weeks)|Other|0|||
161941426|NCT00725985|584836136|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161941427|NCT00725985|584836137|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161941428|NCT00725985|584836138|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161941429|NCT00725985|584836139|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161941430|NCT00725985|584836140|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161941431|NCT00725985|584836141|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161941432|NCT00725985|584836142|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161941433|NCT00725985|584836143|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
161941434|NCT00725985|584836144|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161941435|NCT00725985|584836145|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161941436|NCT00725985|584836146|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161941437|NCT00725985|584836147|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
161941438|NCT00725985|584836136|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161941439|NCT00725985|584836137|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161941440|NCT00725985|584836138|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161941441|NCT00725985|584836139|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161941442|NCT00725985|584836140|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161941443|NCT00725985|584836141|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161941444|NCT00725985|584836142|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161941445|NCT00725985|584836143|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161941446|NCT00725985|584836144|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
161941447|NCT00725985|584836145|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161941448|NCT00725985|584836146|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161941449|NCT00725985|584836147|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
161941450|NCT00725985|584836136|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161941451|NCT00725985|584836137|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161941452|NCT00725985|584836138|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161941453|NCT00725985|584836139|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161941454|NCT00725985|584836140|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161941455|NCT00725985|584836141|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161941456|NCT00725985|584836142|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
161941457|NCT00725985|584836143|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
161941458|NCT00725985|584836144|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
161941459|NCT00725985|584836145|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161941460|NCT00725985|584836146|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161682414|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
161682415|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
161682416|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
161682417|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161682418|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161682419|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
161682420|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
161682421|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161682422|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161682423|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
161682424|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
161682425|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161682426|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161682427|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
161682428|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161682429|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
161682430|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
161682431|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
161830882|NCT02010255|584421827|FG008|Overall Study|Withdrew Consent|0|||
161830883|NCT02010255|584421828|FG009|Overall Study|Withdrew Consent|0|||
161830884|NCT02010255|584421829|FG010|Overall Study|Withdrew Consent|0|||
161830885|NCT02010255|584421830|FG011|Overall Study|Withdrew Consent|0|||
161830886|NCT02010255|584421831|FG012|Overall Study|Withdrew Consent|0|||
161830887|NCT02010255|584421832|FG013|Overall Study|Withdrew Consent|0|||
161830888|NCT02010255|584421819|FG000|Overall Study|Adverse Event|1|||
161830889|NCT02010255|584421820|FG001|Overall Study|Adverse Event|0|||
161830890|NCT02010255|584421821|FG002|Overall Study|Adverse Event|0|||
161830891|NCT02010255|584421822|FG003|Overall Study|Adverse Event|0|||
161830892|NCT02010255|584421823|FG004|Overall Study|Adverse Event|0|||
161830893|NCT02010255|584421824|FG005|Overall Study|Adverse Event|0|||
161830894|NCT02010255|584421825|FG006|Overall Study|Adverse Event|0|||
161830895|NCT02010255|584421826|FG007|Overall Study|Adverse Event|0|||
161830896|NCT02010255|584421827|FG008|Overall Study|Adverse Event|0|||
161830897|NCT02010255|584421828|FG009|Overall Study|Adverse Event|0|||
161830898|NCT02010255|584421829|FG010|Overall Study|Adverse Event|0|||
161830899|NCT02010255|584421830|FG011|Overall Study|Adverse Event|0|||
161830900|NCT02010255|584421831|FG012|Overall Study|Adverse Event|0|||
161830901|NCT02010255|584421832|FG013|Overall Study|Adverse Event|0|||
161830902|NCT02010255|584421819|FG000|Overall Study|Lost to Follow-up|0|||
161830903|NCT02010255|584421820|FG001|Overall Study|Lost to Follow-up|0|||
161830904|NCT02010255|584421821|FG002|Overall Study|Lost to Follow-up|1|||
161830905|NCT02010255|584421822|FG003|Overall Study|Lost to Follow-up|0|||
161830906|NCT02010255|584421823|FG004|Overall Study|Lost to Follow-up|1|||
161830907|NCT02010255|584421824|FG005|Overall Study|Lost to Follow-up|0|||
161830908|NCT02010255|584421825|FG006|Overall Study|Lost to Follow-up|0|||
161830909|NCT02010255|584421826|FG007|Overall Study|Lost to Follow-up|0|||
161830910|NCT02010255|584421827|FG008|Overall Study|Lost to Follow-up|0|||
161830911|NCT02010255|584421828|FG009|Overall Study|Lost to Follow-up|0|||
161830912|NCT02010255|584421829|FG010|Overall Study|Lost to Follow-up|0|||
161830913|NCT02010255|584421830|FG011|Overall Study|Lost to Follow-up|0|||
161830914|NCT02010255|584421831|FG012|Overall Study|Lost to Follow-up|0|||
161830915|NCT02010255|584421832|FG013|Overall Study|Lost to Follow-up|0|||
161830916|NCT02010255|584421819|FG000|Overall Study|Randomized but Not Treated|0|||
161830917|NCT02010255|584421820|FG001|Overall Study|Randomized but Not Treated|0|||
161830918|NCT02010255|584421821|FG002|Overall Study|Randomized but Not Treated|0|||
161830919|NCT02010255|584421822|FG003|Overall Study|Randomized but Not Treated|0|||
161830920|NCT02010255|584421823|FG004|Overall Study|Randomized but Not Treated|0|||
161830921|NCT02010255|584421824|FG005|Overall Study|Randomized but Not Treated|0|||
161830922|NCT02010255|584421825|FG006|Overall Study|Randomized but Not Treated|0|||
161830923|NCT02010255|584421826|FG007|Overall Study|Randomized but Not Treated|0|||
161830924|NCT02010255|584421827|FG008|Overall Study|Randomized but Not Treated|0|||
161830925|NCT02010255|584421828|FG009|Overall Study|Randomized but Not Treated|0|||
161830926|NCT02010255|584421829|FG010|Overall Study|Randomized but Not Treated|0|||
161830927|NCT02010255|584421830|FG011|Overall Study|Randomized but Not Treated|0|||
161830928|NCT02010255|584421831|FG012|Overall Study|Randomized but Not Treated|0|||
161830929|NCT02010255|584421832|FG013|Overall Study|Randomized but Not Treated|1|||
161830930|NCT02013531|584421833|FG000|Overall Study|Lost to Follow-up|3|||
161830931|NCT02013531|584421833|FG000|Overall Study|Met Withdrawal Criteria|1|||
161830932|NCT02013531|584421833|FG000|Overall Study|Withdrawal by Subject|1|||
161830933|NCT03554317|584421839|FG000|Overall Study|Withdrawal by Subject|1|||
161830934|NCT03554317|584421839|FG000|Overall Study|PSA Progression|3|||
161830935|NCT03554317|584421839|FG000|Overall Study|Radiographic Progression|4|||
162025539|NCT01642615|585150774|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
162025540|NCT01642615|585150775|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
162025541|NCT01642615|585150773|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
162025542|NCT01642615|585150774|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
162025543|NCT01642615|585150775|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
162025544|NCT01642615|585150773|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
162025545|NCT01642615|585150774|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
162025546|NCT01642615|585150775|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
162025547|NCT01642615|585150773|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
162025548|NCT01642615|585150774|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
162025549|NCT01642615|585150775|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
162025550|NCT01642615|585150773|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
162025551|NCT01642615|585150774|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
162025552|NCT01642615|585150775|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
162025553|NCT01642615|585150773|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
162025554|NCT01642615|585150774|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
162025555|NCT01642615|585150775|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
162025556|NCT00402740|585150778|FG000|Overall Study|Withdrawal by Subject|18|||
162025557|NCT00402740|585150778|FG000|Overall Study|Death|50|||
162025558|NCT00402740|585150778|FG000|Overall Study|Lost to Follow-up|6|||
162025559|NCT00402740|585150778|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
162025560|NCT00402740|585150778|FG000|Overall Study|Subject disposition unknown.|1|||
162025561|NCT01185353|585150779|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
162025562|NCT01185353|585150780|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
162025563|NCT01185353|585150781|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
162025564|NCT01185353|585150782|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
162025565|NCT01185353|585150783|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
162025566|NCT01185353|585150784|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
162025567|NCT01185353|585150785|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
162025568|NCT01185353|585150786|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
162025569|NCT01185353|585150787|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
162025570|NCT01185353|585150788|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
162025571|NCT01185353|585150779|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
162025572|NCT01185353|585150780|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
162025573|NCT01185353|585150781|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
162025574|NCT01185353|585150782|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
162025575|NCT01185353|585150783|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
162025576|NCT01185353|585150784|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
162025577|NCT01185353|585150785|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
162025578|NCT01185353|585150786|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
162025579|NCT01185353|585150787|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
161830936|NCT00537199|584421840|FG000|Overall Study|Study Terminated|1|||
161830937|NCT03139240|584421841|FG000|Overall Study|Lost to Follow-up|0|||
161830938|NCT03139240|584421842|FG001|Overall Study|Lost to Follow-up|1|||
161830939|NCT03139240|584421843|FG002|Overall Study|Lost to Follow-up|1|||
161830940|NCT03139240|584421844|FG003|Overall Study|Lost to Follow-up|0|||
161830941|NCT00860743|584421846|FG000|Overall Study|Withdrawal by Subject|3|||
161830942|NCT00860743|584421847|FG001|Overall Study|Withdrawal by Subject|0|||
161830943|NCT00823199|584421851|FG000|Overall Study|Withdrawal by Subject|2|||
161830944|NCT02776553|584421852|FG000|Overall Study|Lost to Follow-up|1|||
161830945|NCT02776553|584421853|FG001|Overall Study|Lost to Follow-up|0|||
161830946|NCT02776553|584421852|FG000|Overall Study|got liver transplant|1|||
161830947|NCT02776553|584421853|FG001|Overall Study|got liver transplant|2|||
161830948|NCT02776553|584421852|FG000|Overall Study|had other surgery|1|||
161830949|NCT02776553|584421853|FG001|Overall Study|had other surgery|0|||
161830950|NCT02776553|584421852|FG000|Overall Study|Protocol Violation|0|||
161830951|NCT02776553|584421853|FG001|Overall Study|Protocol Violation|1|||
161830952|NCT00941720|584421854|FG000|Overall Study|Withdrawal by Subject|1|||
161830953|NCT00941720|584421854|FG000|Overall Study|Insurance denied participation|11|||
161830954|NCT00941720|584421854|FG000|Overall Study|ineligible|2|||
161830955|NCT00171340|584421855|FG000|Overall Study|Adverse Event|46|||
161830956|NCT00171340|584421856|FG001|Overall Study|Adverse Event|42|||
161830957|NCT00171340|584421855|FG000|Overall Study|Lack of Efficacy|29|||
161830958|NCT00171340|584421856|FG001|Overall Study|Lack of Efficacy|41|||
161830959|NCT00171340|584421855|FG000|Overall Study|Protocol Violation|7|||
161830960|NCT00171340|584421856|FG001|Overall Study|Protocol Violation|8|||
161941461|NCT00725985|584836147|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
161941462|NCT00725985|584836136|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161941463|NCT00725985|584836137|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161941464|NCT00725985|584836138|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161941465|NCT00725985|584836139|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161941466|NCT00725985|584836140|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161941467|NCT00725985|584836141|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161941468|NCT00725985|584836142|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161941469|NCT00725985|584836143|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161941470|NCT00725985|584836144|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
161941471|NCT00725985|584836145|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
161941472|NCT00725985|584836146|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
161941473|NCT00725985|584836147|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
161941474|NCT02546323|584836148|FG000|Overall Study|Withdrawal by Subject|36|||
161941475|NCT02546323|584836149|FG001|Overall Study|Withdrawal by Subject|33|||
161941476|NCT02546323|584836148|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
161941477|NCT02546323|584836149|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
161941478|NCT02546323|584836148|FG000|Overall Study|Adverse Event|17|||
161941479|NCT02546323|584836149|FG001|Overall Study|Adverse Event|11|||
161941480|NCT02546323|584836148|FG000|Overall Study|Patient Specific Reasons|1|||
161941481|NCT02546323|584836149|FG001|Overall Study|Patient Specific Reasons|2|||
161941482|NCT02546323|584836148|FG000|Overall Study|Lost to Follow-up|2|||
161941483|NCT02546323|584836149|FG001|Overall Study|Lost to Follow-up|3|||
161941484|NCT02546323|584836148|FG000|Overall Study|Non-compliance with Study Drug|2|||
161941485|NCT02546323|584836149|FG001|Overall Study|Non-compliance with Study Drug|2|||
161941486|NCT02546323|584836148|FG000|Overall Study|Met Withdrawal Criteria|2|||
161941487|NCT02546323|584836149|FG001|Overall Study|Met Withdrawal Criteria|14|||
161941488|NCT04476784|584836150|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
161941489|NCT04476784|584836151|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
161941490|NCT00863304|584836155|FG000|Overall Study|Adverse Event|10|||
161941491|NCT00863304|584836156|FG001|Overall Study|Adverse Event|4|||
161941492|NCT00863304|584836157|FG002|Overall Study|Adverse Event|14|||
161941493|NCT00863304|584836158|FG003|Overall Study|Adverse Event|16|||
161941494|NCT00863304|584836155|FG000|Overall Study|Lost to Follow-up|1|||
161941495|NCT00863304|584836156|FG001|Overall Study|Lost to Follow-up|5|||
162235972|NCT02951767|585914938|FG000|Overall Study|Withdrawal by Subject|11|||
162235973|NCT02951767|585914938|FG000|Overall Study|Death|96|||
162235974|NCT02951767|585914938|FG000|Overall Study|Lost to Follow-up|2|||
162235975|NCT02951767|585914938|FG000|Overall Study|Physician Decision|1|||
162235976|NCT01337115|585914942|FG000|Overall Study|Protocol Violation|2|||
162235977|NCT01337115|585914943|FG001|Overall Study|Protocol Violation|0|||
162235978|NCT03426267|585914952|FG000|Overall Study|Physician Decision|1|||
162235979|NCT03426267|585914953|FG001|Overall Study|Physician Decision|4|||
162235980|NCT03426267|585914952|FG000|Overall Study|Lost to Follow-up|1|||
162235981|NCT03426267|585914953|FG001|Overall Study|Lost to Follow-up|0|||
161941496|NCT00863304|584836157|FG002|Overall Study|Lost to Follow-up|4|||
162235982|NCT03426267|585914952|FG000|Overall Study|Withdrawal by Subject|4|||
162235983|NCT03426267|585914953|FG001|Overall Study|Withdrawal by Subject|10|||
162235984|NCT03426267|585914952|FG000|Overall Study|Protocol Violation|1|||
161941497|NCT00863304|584836158|FG003|Overall Study|Lost to Follow-up|2|||
161941498|NCT00863304|584836155|FG000|Overall Study|Lack of Efficacy|57|||
161941499|NCT00863304|584836156|FG001|Overall Study|Lack of Efficacy|26|||
161941500|NCT00863304|584836157|FG002|Overall Study|Lack of Efficacy|30|||
161941501|NCT00863304|584836158|FG003|Overall Study|Lack of Efficacy|28|||
161941502|NCT00863304|584836155|FG000|Overall Study|Withdrawal by Subject|19|||
161941503|NCT00863304|584836156|FG001|Overall Study|Withdrawal by Subject|14|||
161941504|NCT00863304|584836157|FG002|Overall Study|Withdrawal by Subject|20|||
161941505|NCT00863304|584836158|FG003|Overall Study|Withdrawal by Subject|18|||
161941506|NCT00863304|584836155|FG000|Overall Study|Other|1|||
161941507|NCT00863304|584836156|FG001|Overall Study|Other|0|||
161941508|NCT00863304|584836157|FG002|Overall Study|Other|0|||
161941509|NCT00863304|584836158|FG003|Overall Study|Other|1|||
161941510|NCT00863304|584836155|FG000|Overall Study|Protocol Violation|2|||
161941511|NCT00863304|584836156|FG001|Overall Study|Protocol Violation|6|||
161941512|NCT00863304|584836157|FG002|Overall Study|Protocol Violation|2|||
161941513|NCT00863304|584836158|FG003|Overall Study|Protocol Violation|0|||
161941514|NCT00863304|584836155|FG000|Overall Study|Randomized, but not Treated|3|||
161941515|NCT00863304|584836156|FG001|Overall Study|Randomized, but not Treated|1|||
161941516|NCT00863304|584836157|FG002|Overall Study|Randomized, but not Treated|4|||
161941517|NCT00863304|584836158|FG003|Overall Study|Randomized, but not Treated|1|||
161941518|NCT00863304|584836155|FG000|Overall Study|Entered extension study|101|||
161941519|NCT00863304|584836156|FG001|Overall Study|Entered extension study|129|||
161941520|NCT00863304|584836157|FG002|Overall Study|Entered extension study|113|||
161941521|NCT00863304|584836158|FG003|Overall Study|Entered extension study|125|||
161941522|NCT00478257|584836159|FG000|Overall Study|Withdrawal by Subject|8|||
161941523|NCT00478257|584836160|FG001|Overall Study|Withdrawal by Subject|3|||
161941524|NCT00806585|584836161|FG000|Overall Study|Study terminated by Sponsor|0|||
161941525|NCT00806585|584836162|FG001|Overall Study|Study terminated by Sponsor|0|||
162025580|NCT01185353|585150788|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
162025581|NCT01185353|585150779|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
162025582|NCT01185353|585150780|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
161941526|NCT00806585|584836163|FG002|Overall Study|Study terminated by Sponsor|1|||
161941527|NCT00806585|584836164|FG003|Overall Study|Study terminated by Sponsor|2|||
161941528|NCT00806585|584836165|FG004|Overall Study|Study terminated by Sponsor|0|||
161941529|NCT00806585|584836161|FG000|Overall Study|Protocol Violation|3|||
161941530|NCT00806585|584836162|FG001|Overall Study|Protocol Violation|1|||
161941531|NCT00806585|584836163|FG002|Overall Study|Protocol Violation|2|||
161941532|NCT00806585|584836164|FG003|Overall Study|Protocol Violation|0|||
161941533|NCT00806585|584836165|FG004|Overall Study|Protocol Violation|0|||
161941534|NCT00806585|584836161|FG000|Overall Study|Physician Decision|0|||
161941535|NCT00806585|584836162|FG001|Overall Study|Physician Decision|2|||
161941536|NCT00806585|584836163|FG002|Overall Study|Physician Decision|3|||
161941537|NCT00806585|584836164|FG003|Overall Study|Physician Decision|0|||
161941538|NCT00806585|584836165|FG004|Overall Study|Physician Decision|1|||
161941539|NCT00806585|584836161|FG000|Overall Study|Lost to Follow-up|2|||
161941540|NCT00806585|584836162|FG001|Overall Study|Lost to Follow-up|1|||
161941541|NCT00806585|584836163|FG002|Overall Study|Lost to Follow-up|2|||
161941542|NCT00806585|584836164|FG003|Overall Study|Lost to Follow-up|2|||
161941543|NCT00806585|584836165|FG004|Overall Study|Lost to Follow-up|5|||
161941544|NCT00806585|584836161|FG000|Overall Study|Lack of Efficacy|1|||
161941545|NCT00806585|584836162|FG001|Overall Study|Lack of Efficacy|0|||
161941546|NCT00806585|584836163|FG002|Overall Study|Lack of Efficacy|0|||
161941547|NCT00806585|584836164|FG003|Overall Study|Lack of Efficacy|0|||
161941548|NCT00806585|584836165|FG004|Overall Study|Lack of Efficacy|0|||
161941549|NCT00806585|584836161|FG000|Overall Study|Adverse Event|1|||
161941550|NCT00806585|584836162|FG001|Overall Study|Adverse Event|5|||
161941551|NCT00806585|584836163|FG002|Overall Study|Adverse Event|3|||
161941552|NCT00806585|584836164|FG003|Overall Study|Adverse Event|4|||
161941553|NCT00806585|584836165|FG004|Overall Study|Adverse Event|2|||
161941554|NCT00806585|584836161|FG000|Overall Study|Withdrawal by Subject|10|||
161941555|NCT00806585|584836162|FG001|Overall Study|Withdrawal by Subject|8|||
161941556|NCT00806585|584836163|FG002|Overall Study|Withdrawal by Subject|9|||
161941557|NCT00806585|584836164|FG003|Overall Study|Withdrawal by Subject|3|||
161941558|NCT00806585|584836165|FG004|Overall Study|Withdrawal by Subject|11|||
161941559|NCT00806585|584836161|FG000|Overall Study|Completion status unknown|15|||
161941560|NCT00806585|584836162|FG001|Overall Study|Completion status unknown|14|||
161941561|NCT00806585|584836163|FG002|Overall Study|Completion status unknown|12|||
161941562|NCT00806585|584836164|FG003|Overall Study|Completion status unknown|4|||
161941563|NCT00806585|584836165|FG004|Overall Study|Completion status unknown|12|||
161941564|NCT01182350|584836167|FG000|Overall Study|Adverse Event|5|||
161941565|NCT01182350|584836168|FG001|Overall Study|Adverse Event|0|||
161941566|NCT01182350|584836169|FG002|Overall Study|Adverse Event|0|||
161941567|NCT01182350|584836170|FG003|Overall Study|Adverse Event|0|||
161941568|NCT01182350|584836171|FG004|Overall Study|Adverse Event|0|||
161941569|NCT01182350|584836167|FG000|Overall Study|Disease Progression|15|||
161941570|NCT01182350|584836168|FG001|Overall Study|Disease Progression|12|||
161941571|NCT01182350|584836169|FG002|Overall Study|Disease Progression|0|||
161941572|NCT01182350|584836170|FG003|Overall Study|Disease Progression|1|||
161941573|NCT01182350|584836171|FG004|Overall Study|Disease Progression|0|||
161941574|NCT01182350|584836167|FG000|Overall Study|Death|0|||
161941575|NCT01182350|584836168|FG001|Overall Study|Death|1|||
161941576|NCT01182350|584836169|FG002|Overall Study|Death|1|||
162025583|NCT01185353|585150781|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
162025584|NCT01185353|585150782|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
162025585|NCT01185353|585150783|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
162025586|NCT01185353|585150784|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
162025587|NCT01185353|585150785|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
162025588|NCT01185353|585150786|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
162025589|NCT01185353|585150787|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
162025590|NCT01185353|585150788|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
162025591|NCT01185353|585150779|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
162025592|NCT01185353|585150780|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
161941577|NCT01182350|584836170|FG003|Overall Study|Death|0|||
161941578|NCT01182350|584836171|FG004|Overall Study|Death|0|||
161941579|NCT01182350|584836167|FG000|Overall Study|Withdrawal by Subject|3|||
161941580|NCT01182350|584836168|FG001|Overall Study|Withdrawal by Subject|1|||
161941581|NCT01182350|584836169|FG002|Overall Study|Withdrawal by Subject|0|||
161941582|NCT01182350|584836170|FG003|Overall Study|Withdrawal by Subject|1|||
161941583|NCT01182350|584836171|FG004|Overall Study|Withdrawal by Subject|0|||
161941584|NCT01182350|584836167|FG000|Overall Study|Alternative Therapy|2|||
161941585|NCT01182350|584836168|FG001|Overall Study|Alternative Therapy|0|||
161941586|NCT01182350|584836169|FG002|Overall Study|Alternative Therapy|1|||
161941587|NCT01182350|584836170|FG003|Overall Study|Alternative Therapy|0|||
162025593|NCT01185353|585150781|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
162025594|NCT01185353|585150782|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
161941588|NCT01182350|584836171|FG004|Overall Study|Alternative Therapy|0|||
161941589|NCT01182350|584836167|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
161941590|NCT01182350|584836168|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
161941591|NCT01182350|584836169|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
161941592|NCT01182350|584836170|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
161941593|NCT01182350|584836171|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
161941594|NCT01182350|584836167|FG000|Overall Study|Unevaluable for Biopsy|0|||
161941595|NCT01182350|584836168|FG001|Overall Study|Unevaluable for Biopsy|0|||
161941596|NCT01182350|584836169|FG002|Overall Study|Unevaluable for Biopsy|0|||
161941597|NCT01182350|584836170|FG003|Overall Study|Unevaluable for Biopsy|0|||
161941598|NCT01182350|584836171|FG004|Overall Study|Unevaluable for Biopsy|3|||
161941599|NCT04023487|584836172|FG000|Overall Study|Lost to Follow-up|5|||
161941600|NCT04023487|584836173|FG001|Overall Study|Lost to Follow-up|4|||
161941601|NCT04023487|584836172|FG000|Overall Study|Pregnancy|1|||
161941602|NCT04023487|584836173|FG001|Overall Study|Pregnancy|2|||
162025595|NCT01185353|585150783|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
162025596|NCT01185353|585150784|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
162025597|NCT01185353|585150785|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
162025598|NCT01185353|585150786|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
162025599|NCT01185353|585150787|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
162025600|NCT01185353|585150788|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
162025601|NCT01185353|585150779|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
162025602|NCT01185353|585150780|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
162025603|NCT01185353|585150781|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
162025604|NCT01185353|585150782|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
162025605|NCT01185353|585150783|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
162025606|NCT01185353|585150784|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
162025607|NCT01185353|585150785|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
162025608|NCT01185353|585150786|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
162025609|NCT01185353|585150787|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
162025610|NCT01185353|585150788|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
161941603|NCT04023487|584836172|FG000|Overall Study|Withdrawal by Subject|4|||
161941604|NCT04023487|584836173|FG001|Overall Study|Withdrawal by Subject|5|||
161941605|NCT04023487|584836172|FG000|Overall Study|Partially completed testing|8|||
161941606|NCT04023487|584836173|FG001|Overall Study|Partially completed testing|4|||
161941607|NCT00605189|584836174|FG000|Overall Study|Adverse Event|1|||
161941608|NCT00605189|584836175|FG001|Overall Study|Adverse Event|0|||
162025611|NCT01185353|585150779|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
161941609|NCT00605189|584836176|FG002|Overall Study|Adverse Event|0|||
161941610|NCT00605189|584836174|FG000|Overall Study|Other|2|||
162025612|NCT01185353|585150780|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
161830961|NCT00171340|584421855|FG000|Overall Study|Withdrawal by Subject|22|||
161830962|NCT00171340|584421856|FG001|Overall Study|Withdrawal by Subject|19|||
161830963|NCT00171340|584421855|FG000|Overall Study|Lost to Follow-up|0|||
161830964|NCT00171340|584421856|FG001|Overall Study|Lost to Follow-up|5|||
161830965|NCT00171340|584421855|FG000|Overall Study|Abnormal Laboratory Results|2|||
161830966|NCT00171340|584421856|FG001|Overall Study|Abnormal Laboratory Results|0|||
161830967|NCT00171340|584421855|FG000|Overall Study|Abnormal Test Procedure Results|6|||
161830968|NCT00171340|584421856|FG001|Overall Study|Abnormal Test Procedure Results|11|||
161830969|NCT00171340|584421855|FG000|Overall Study|No Longer Required Study Drug|1|||
161830970|NCT00171340|584421856|FG001|Overall Study|No Longer Required Study Drug|1|||
161830971|NCT00171340|584421855|FG000|Overall Study|Administrative Problems|5|||
161830972|NCT00171340|584421856|FG001|Overall Study|Administrative Problems|2|||
161830973|NCT00171340|584421855|FG000|Overall Study|Death|6|||
161830974|NCT00171340|584421856|FG001|Overall Study|Death|6|||
161830975|NCT03827018|584421857|FG000|Overall Study|Adverse Event|1|||
161830976|NCT03827018|584421858|FG001|Overall Study|Adverse Event|0|||
161830977|NCT03827018|584421857|FG000|Overall Study|Withdrawal by Subject|2|||
161830978|NCT03827018|584421858|FG001|Overall Study|Withdrawal by Subject|2|||
161830979|NCT03827018|584421857|FG000|Overall Study|Lack of Efficacy|0|||
161830980|NCT03827018|584421858|FG001|Overall Study|Lack of Efficacy|1|||
161830981|NCT01998243|584421861|FG000|Overall Study|Pregnancy|0|||
161830982|NCT01998243|584421862|FG001|Overall Study|Pregnancy|1|||
161830983|NCT01998243|584421861|FG000|Overall Study|Protocol Violation|5|||
161830984|NCT01998243|584421862|FG001|Overall Study|Protocol Violation|2|||
161830985|NCT01998243|584421861|FG000|Overall Study|Withdrawal by Subject|3|||
161830986|NCT01998243|584421862|FG001|Overall Study|Withdrawal by Subject|4|||
161830987|NCT00680186|584421863|FG000|Overall Study|Adverse Event|47|||
161830988|NCT00680186|584421864|FG001|Overall Study|Adverse Event|44|||
161830989|NCT00680186|584421863|FG000|Overall Study|Protocol Violation|31|||
161830990|NCT00680186|584421864|FG001|Overall Study|Protocol Violation|26|||
161941611|NCT00605189|584836175|FG001|Overall Study|Other|2|||
161941612|NCT00605189|584836176|FG002|Overall Study|Other|0|||
161941613|NCT03898180|584836177|FG000|Overall Study|Death|178|||
161941614|NCT03898180|584836178|FG001|Overall Study|Death|173|||
161941615|NCT03898180|584836177|FG000|Overall Study|Physician Decision|1|||
161941616|NCT03898180|584836178|FG001|Overall Study|Physician Decision|0|||
161941617|NCT03898180|584836177|FG000|Overall Study|Sponsor Decision|3|||
161941618|NCT03898180|584836178|FG001|Overall Study|Sponsor Decision|0|||
161941619|NCT03898180|584836177|FG000|Overall Study|Lost to Follow-up|1|||
161941620|NCT03898180|584836178|FG001|Overall Study|Lost to Follow-up|0|||
161941621|NCT03898180|584836177|FG000|Overall Study|Withdrawal by Subject|5|||
161941622|NCT03898180|584836178|FG001|Overall Study|Withdrawal by Subject|4|||
161941623|NCT02507934|584836179|FG000|Overall Study|Lost to Follow-up|2|||
161941624|NCT02507934|584836180|FG001|Overall Study|Lost to Follow-up|0|||
161941625|NCT02507934|584836179|FG000|Overall Study|Withdrawal by Subject|2|||
161941626|NCT02507934|584836180|FG001|Overall Study|Withdrawal by Subject|0|||
161941627|NCT03766399|584836182|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941628|NCT03766399|584836183|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941629|NCT03766399|584836184|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941630|NCT03766399|584836185|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941631|NCT03766399|584836186|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941632|NCT03766399|584836187|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941633|NCT03766399|584836188|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161830991|NCT00680186|584421863|FG000|Overall Study|Lost to Follow-up|11|||
161830992|NCT00680186|584421864|FG001|Overall Study|Lost to Follow-up|6|||
161830993|NCT00680186|584421863|FG000|Overall Study|Withdrawal by Subject|32|||
161830994|NCT00680186|584421864|FG001|Overall Study|Withdrawal by Subject|39|||
161830995|NCT00680186|584421863|FG000|Overall Study|Other|4|||
161830996|NCT00680186|584421864|FG001|Overall Study|Other|1|||
161830997|NCT01351350|584421867|FG000|Overall Study|Disease Progression|5|||
161830998|NCT01351350|584421868|FG001|Overall Study|Disease Progression|13|||
161830999|NCT01351350|584421869|FG002|Overall Study|Disease Progression|6|||
161941634|NCT03766399|584836189|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941635|NCT03766399|584836190|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161831000|NCT01351350|584421870|FG003|Overall Study|Disease Progression|8|||
161831001|NCT01351350|584421871|FG004|Overall Study|Disease Progression|5|||
161831002|NCT01351350|584421867|FG000|Overall Study|Adverse Event|1|||
161831003|NCT01351350|584421868|FG001|Overall Study|Adverse Event|10|||
161831004|NCT01351350|584421869|FG002|Overall Study|Adverse Event|1|||
161831005|NCT01351350|584421870|FG003|Overall Study|Adverse Event|2|||
161831006|NCT01351350|584421871|FG004|Overall Study|Adverse Event|0|||
161831007|NCT01351350|584421867|FG000|Overall Study|Participant Decision|2|||
161831008|NCT01351350|584421868|FG001|Overall Study|Participant Decision|6|||
161831009|NCT01351350|584421869|FG002|Overall Study|Participant Decision|3|||
161941636|NCT03766399|584836191|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941637|NCT03766399|584836192|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941638|NCT03766399|584836193|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941639|NCT03766399|584836194|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941640|NCT03766399|584836195|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
161941641|NCT03766399|584836196|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941642|NCT03766399|584836197|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941643|NCT03766399|584836198|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941644|NCT03766399|584836199|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
161941645|NCT05030766|584836200|FG000|Phase 1 Participants|Lost to Follow-up|12|||
161941646|NCT05030766|584836201|FG001|Phase 1 Participants|Lost to Follow-up|22|||
161941647|NCT05030766|584836202|FG002|Phase 1 Participants|Lost to Follow-up|0|||
161941648|NCT05030766|584836203|FG003|Phase 1 Participants|Lost to Follow-up|0|||
161941649|NCT05030766|584836200|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
161941650|NCT05030766|584836201|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
161941651|NCT05030766|584836202|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
161941652|NCT05030766|584836203|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
161941653|NCT05030766|584836200|FG000|Phase 2 Participants|Lost to Follow-up|0|||
161941654|NCT05030766|584836201|FG001|Phase 2 Participants|Lost to Follow-up|0|||
161941655|NCT05030766|584836202|FG002|Phase 2 Participants|Lost to Follow-up|6|||
161941656|NCT05030766|584836203|FG003|Phase 2 Participants|Lost to Follow-up|2|||
162235985|NCT03426267|585914953|FG001|Overall Study|Protocol Violation|3|||
162235986|NCT03426267|585914952|FG000|Overall Study|Adverse Event|9|||
162235987|NCT03426267|585914953|FG001|Overall Study|Adverse Event|27|||
162235988|NCT03426267|585914952|FG000|Overall Study|Prohibited Treatment Intake|2|||
162235989|NCT03426267|585914953|FG001|Overall Study|Prohibited Treatment Intake|3|||
162235990|NCT03426267|585914952|FG000|Overall Study|Lack of Efficacy|0|||
162235991|NCT03426267|585914953|FG001|Overall Study|Lack of Efficacy|25|||
162235992|NCT03426267|585914952|FG000|Overall Study|other|3|||
162235993|NCT03426267|585914953|FG001|Overall Study|other|0|||
162235994|NCT00609765|585914954|FG000|Overall Study|Study ended prior to 12 months|1|||
162235995|NCT02054520|585914961|FG000|Overall Study|Adverse Event|1|||
162235996|NCT02054520|585914962|FG001|Overall Study|Adverse Event|4|||
162235997|NCT02054520|585914963|FG002|Overall Study|Adverse Event|2|||
162235998|NCT02054520|585914964|FG003|Overall Study|Adverse Event|1|||
162235999|NCT02054520|585914965|FG004|Overall Study|Adverse Event|1|||
162236000|NCT02054520|585914966|FG005|Overall Study|Adverse Event|0|||
162236001|NCT02054520|585914961|FG000|Overall Study|Lack of Efficacy|7|||
162236002|NCT02054520|585914962|FG001|Overall Study|Lack of Efficacy|0|||
162236003|NCT02054520|585914963|FG002|Overall Study|Lack of Efficacy|2|||
162236004|NCT02054520|585914964|FG003|Overall Study|Lack of Efficacy|1|||
162236005|NCT02054520|585914965|FG004|Overall Study|Lack of Efficacy|3|||
162236006|NCT02054520|585914966|FG005|Overall Study|Lack of Efficacy|2|||
162236007|NCT02054520|585914961|FG000|Overall Study|Withdrawal by Subject|1|||
162236008|NCT02054520|585914962|FG001|Overall Study|Withdrawal by Subject|0|||
162236009|NCT02054520|585914963|FG002|Overall Study|Withdrawal by Subject|0|||
162236010|NCT02054520|585914964|FG003|Overall Study|Withdrawal by Subject|2|||
162236011|NCT02054520|585914965|FG004|Overall Study|Withdrawal by Subject|1|||
162236012|NCT02054520|585914966|FG005|Overall Study|Withdrawal by Subject|0|||
162236013|NCT02054520|585914961|FG000|Overall Study|Physician Decision|0|||
162236014|NCT02054520|585914962|FG001|Overall Study|Physician Decision|1|||
162236015|NCT02054520|585914963|FG002|Overall Study|Physician Decision|0|||
162236016|NCT02054520|585914964|FG003|Overall Study|Physician Decision|1|||
162236017|NCT02054520|585914965|FG004|Overall Study|Physician Decision|0|||
162236018|NCT02054520|585914966|FG005|Overall Study|Physician Decision|1|||
162236019|NCT02054520|585914961|FG000|Overall Study|Study terminated by Sponsor|0|||
162236020|NCT02054520|585914962|FG001|Overall Study|Study terminated by Sponsor|0|||
162236021|NCT02054520|585914963|FG002|Overall Study|Study terminated by Sponsor|2|||
162236022|NCT02054520|585914964|FG003|Overall Study|Study terminated by Sponsor|1|||
162236023|NCT02054520|585914965|FG004|Overall Study|Study terminated by Sponsor|0|||
162236024|NCT02054520|585914966|FG005|Overall Study|Study terminated by Sponsor|0|||
162236025|NCT01272804|585914969|FG000|Overall Study|Adverse Event|1|||
162236026|NCT01272804|585914970|FG001|Overall Study|Adverse Event|0|||
162236027|NCT01272804|585914971|FG002|Overall Study|Adverse Event|0|||
162236028|NCT01272804|585914972|FG003|Overall Study|Adverse Event|0|||
162236029|NCT01272804|585914973|FG004|Overall Study|Adverse Event|2|||
162236030|NCT01272804|585914974|FG005|Overall Study|Adverse Event|1|||
162236031|NCT03801915|585914975|FG000|Overall Study|Screen failure|0|||
162236032|NCT03801915|585914976|FG001|Overall Study|Screen failure|0|||
162236033|NCT03801915|585914977|FG002|Overall Study|Screen failure|1|||
162236034|NCT03801915|585914975|FG000|Overall Study|Ineligible|1|||
162236035|NCT03801915|585914976|FG001|Overall Study|Ineligible|0|||
162236036|NCT03801915|585914977|FG002|Overall Study|Ineligible|0|||
162236037|NCT03801915|585914975|FG000|Overall Study|Physician Decision|2|||
162236038|NCT03801915|585914976|FG001|Overall Study|Physician Decision|1|||
162236039|NCT03801915|585914977|FG002|Overall Study|Physician Decision|0|||
162236040|NCT02308020|585914978|FG000|Overall Study|Lost to Follow-up|1|||
162236041|NCT02308020|585914979|FG001|Overall Study|Lost to Follow-up|7|||
161831010|NCT01351350|584421870|FG003|Overall Study|Participant Decision|3|||
161831011|NCT01351350|584421871|FG004|Overall Study|Participant Decision|2|||
161831012|NCT01351350|584421867|FG000|Overall Study|Enrolled but not Treated|0|||
161831013|NCT01351350|584421868|FG001|Overall Study|Enrolled but not Treated|0|||
161831014|NCT01351350|584421869|FG002|Overall Study|Enrolled but not Treated|1|||
161831015|NCT01351350|584421870|FG003|Overall Study|Enrolled but not Treated|0|||
161831016|NCT01351350|584421871|FG004|Overall Study|Enrolled but not Treated|0|||
161831017|NCT04647383|584421872|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
161831018|NCT04647383|584421873|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
161831019|NCT04647383|584421874|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
161831020|NCT04647383|584421875|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
161831021|NCT00479388|584421878|FG000|Overall Study|Adverse Event|90|||
161831022|NCT00479388|584421879|FG001|Overall Study|Adverse Event|45|||
161831023|NCT00479388|584421878|FG000|Overall Study|Lost to Follow-up|0|||
161831024|NCT00479388|584421879|FG001|Overall Study|Lost to Follow-up|2|||
161831025|NCT00479388|584421878|FG000|Overall Study|Protocol Violation|10|||
161831026|NCT00479388|584421879|FG001|Overall Study|Protocol Violation|9|||
161831027|NCT00479388|584421878|FG000|Overall Study|Withdrawal by Subject|32|||
161831028|NCT00479388|584421879|FG001|Overall Study|Withdrawal by Subject|17|||
161831029|NCT00895037|584421889|FG000|Overall Study|Death|0|||
161831030|NCT00895037|584421890|FG001|Overall Study|Death|2|||
161831031|NCT00895037|584421891|FG002|Overall Study|Death|1|||
161831032|NCT01930175|584421893|FG000|Core Study|Lost to Follow-up|0|||
161831033|NCT01930175|584421894|FG001|Core Study|Lost to Follow-up|1|||
161831034|NCT01930175|584421895|FG002|Core Study|Lost to Follow-up|0|||
161831035|NCT01930175|584421893|FG000|Core Study|Adverse Event|0|||
161831036|NCT01930175|584421894|FG001|Core Study|Adverse Event|0|||
161831037|NCT01930175|584421895|FG002|Core Study|Adverse Event|1|||
161831038|NCT02820740|584421896|FG000|Overall Study|Did not have procedure|2|||
161831039|NCT00890552|584421897|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
161831040|NCT00890552|584421897|FG000|On-treatment|Early prog disease/ death|10|||
161831041|NCT03903159|584421898|FG000|Overall Study|Discharged with Staff Approval|2|||
161831042|NCT03903159|584421898|FG000|Overall Study|Discharged at Staff Request|2|||
161831043|NCT03903159|584421898|FG000|Overall Study|Discharged Against Staff Advice|1|||
161831044|NCT01382251|584421901|FG000|Overall Study|Surgeries cancelled or delayed|16|||
161831045|NCT01382251|584421902|FG001|Overall Study|Surgeries cancelled or delayed|16|||
161831046|NCT01382251|584421901|FG000|Overall Study|Lost to Follow-up|4|||
161831047|NCT01382251|584421902|FG001|Overall Study|Lost to Follow-up|4|||
161831048|NCT01382251|584421901|FG000|Overall Study|Contacted after study closed|1|||
161831049|NCT01382251|584421902|FG001|Overall Study|Contacted after study closed|1|||
161831050|NCT00702208|584421903|FG000|Overall Study|Lost to Follow-up|28|||
161831051|NCT00702208|584421903|FG000|Overall Study|Did not self-lavage|1|||
161831052|NCT00702208|584421903|FG000|Overall Study|Unsatisfactory colposcopy|2|||
161831053|NCT00562120|584421904|FG000|First Intervention Period|Adverse Event|1|||
161831054|NCT00562120|584421905|FG001|First Intervention Period|Adverse Event|0|||
161941657|NCT03559530|584836204|FG000|Overall Study|non-location of medical records|44|||
161941658|NCT03559530|584836205|FG001|Overall Study|non-location of medical records|0|||
161941659|NCT03559530|584836204|FG000|Overall Study|culture results not considered for treat|29|||
161941660|NCT03559530|584836205|FG001|Overall Study|culture results not considered for treat|0|||
161941661|NCT03559530|584836204|FG000|Overall Study|duplicate cases|8|||
161941662|NCT03559530|584836205|FG001|Overall Study|duplicate cases|0|||
161941663|NCT03559530|584836204|FG000|Overall Study|other species of Acinetobacte|7|||
161831055|NCT00562120|584421906|FG002|First Intervention Period|Adverse Event|0|||
161831056|NCT00562120|584421907|FG003|First Intervention Period|Adverse Event|0|||
161831057|NCT00562120|584421904|FG000|First Intervention Period|Randomized but not Treated|1|||
161831058|NCT00562120|584421905|FG001|First Intervention Period|Randomized but not Treated|0|||
161831059|NCT00562120|584421906|FG002|First Intervention Period|Randomized but not Treated|0|||
161831060|NCT00562120|584421907|FG003|First Intervention Period|Randomized but not Treated|0|||
161831061|NCT02148445|584421908|FG000|Overall Study|Death|1|||
161831062|NCT02148445|584421909|FG001|Overall Study|Death|3|||
161831063|NCT03450629|584421910|FG000|Overall Study|Adverse Event|15|||
161831064|NCT03450629|584421911|FG001|Overall Study|Adverse Event|14|||
161831065|NCT03450629|584421910|FG000|Overall Study|Physician Decision|2|||
161831066|NCT03450629|584421911|FG001|Overall Study|Physician Decision|2|||
161831067|NCT03450629|584421910|FG000|Overall Study|Lack of Efficacy|2|||
161831068|NCT03450629|584421911|FG001|Overall Study|Lack of Efficacy|0|||
161831069|NCT03450629|584421910|FG000|Overall Study|Lost to Follow-up|4|||
161831070|NCT03450629|584421911|FG001|Overall Study|Lost to Follow-up|2|||
161831071|NCT03450629|584421910|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161831072|NCT03450629|584421911|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
161831073|NCT03450629|584421910|FG000|Overall Study|Non-Compliance With Study Drug|2|||
161831074|NCT03450629|584421911|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161831075|NCT03450629|584421910|FG000|Overall Study|Protocol Violation|11|||
161831076|NCT03450629|584421911|FG001|Overall Study|Protocol Violation|8|||
161831077|NCT03450629|584421910|FG000|Overall Study|Withdrawal by Subject|12|||
161831078|NCT03450629|584421911|FG001|Overall Study|Withdrawal by Subject|6|||
161831079|NCT03366194|584421912|FG000|Overall Study|Lost to Follow-up|2|||
161831080|NCT02093923|584421913|FG000|Overall Study|Lost to Follow-up|0|||
161831081|NCT02093923|584421914|FG001|Overall Study|Lost to Follow-up|0|||
161831082|NCT02093923|584421915|FG002|Overall Study|Lost to Follow-up|0|||
161831083|NCT02093923|584421916|FG003|Overall Study|Lost to Follow-up|1|||
161831084|NCT02093923|584421917|FG004|Overall Study|Lost to Follow-up|0|||
161831085|NCT02093923|584421913|FG000|Overall Study|Screen failure after randomization|0|||
161831086|NCT02093923|584421914|FG001|Overall Study|Screen failure after randomization|0|||
161831087|NCT02093923|584421915|FG002|Overall Study|Screen failure after randomization|0|||
161831088|NCT02093923|584421916|FG003|Overall Study|Screen failure after randomization|1|||
161831089|NCT02093923|584421917|FG004|Overall Study|Screen failure after randomization|0|||
161831090|NCT03438006|584421918|FG000|Overall Study|Adverse Event|1|||
161831091|NCT03438006|584421918|FG000|Overall Study|Lost to Follow-up|67|||
161831092|NCT03438006|584421918|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
161831093|NCT03438006|584421918|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
161831094|NCT02737592|584421919|FG000|Overall Study|Withdrawal by Subject|1|||
161831095|NCT04678817|584422909|FG000|Overall Study|Lost to Follow-up|28|||
161831096|NCT04678817|584422910|FG001|Overall Study|Lost to Follow-up|0|||
161831097|NCT04678817|584422911|FG002|Overall Study|Lost to Follow-up|0|||
161831098|NCT01961687|584422914|FG000|Overall Study|Lost to Follow-up|19|||
161831099|NCT01961687|584422914|FG000|Overall Study|Re-operation|17|||
161831100|NCT01961687|584422914|FG000|Overall Study|Death|7|||
161831101|NCT01961687|584422914|FG000|Overall Study|Withdrawal by Subject|6|||
161831102|NCT01961687|584422914|FG000|Overall Study|Adverse Event|6|||
161831103|NCT01961687|584422914|FG000|Overall Study|Moved to area without study site|2|||
161831104|NCT01961687|584422914|FG000|Overall Study|Sponsor decision|2|||
161831105|NCT01961687|584422914|FG000|Overall Study|Physician Decision|1|||
161831106|NCT01961687|584422914|FG000|Overall Study|Unable to meet follow-up requirements|1|||
161831107|NCT00614926|584422915|FG000|Overall Study|Burden of travel|1|||
161831108|NCT00614926|584422916|FG001|Overall Study|Burden of travel|0|||
161831109|NCT00614926|584422915|FG000|Overall Study|Adverse Event|3|||
161831110|NCT00614926|584422916|FG001|Overall Study|Adverse Event|0|||
161831111|NCT02999984|584422917|FG000|Overall Study|Treatment Failure|1|||
161831112|NCT02310789|584422920|FG000|Overall Study|Adverse Event|1|||
161831113|NCT01197417|584422921|FG000|Overall Study|Physician Decision|3|||
161831114|NCT01197417|584422922|FG001|Overall Study|Physician Decision|2|||
161831115|NCT01197417|584422921|FG000|Overall Study|Withdrawal by Subject|2|||
161831116|NCT01197417|584422922|FG001|Overall Study|Withdrawal by Subject|4|||
161831117|NCT01197417|584422921|FG000|Overall Study|Site miscommunication|0|||
161831118|NCT01197417|584422922|FG001|Overall Study|Site miscommunication|1|||
161831119|NCT01197417|584422921|FG000|Overall Study|Subject transferred to intensive care|0|||
161831120|NCT01197417|584422922|FG001|Overall Study|Subject transferred to intensive care|1|||
161831121|NCT01197417|584422921|FG000|Overall Study|Not consented in time to receive drug|0|||
161831122|NCT01197417|584422922|FG001|Overall Study|Not consented in time to receive drug|1|||
161831123|NCT01197417|584422921|FG000|Overall Study|Hypotension|1|||
161831124|NCT01197417|584422922|FG001|Overall Study|Hypotension|2|||
161831125|NCT01197417|584422921|FG000|Overall Study|Found to be ineligible|2|||
161831126|NCT01197417|584422922|FG001|Overall Study|Found to be ineligible|5|||
161831127|NCT01197417|584422921|FG000|Overall Study|No 25-hour magnesium level|0|||
161831128|NCT01197417|584422922|FG001|Overall Study|No 25-hour magnesium level|2|||
161831129|NCT02813421|584422923|FG000|Overall Study|Withdrawal by Subject|1|||
161831130|NCT02813421|584422924|FG001|Overall Study|Withdrawal by Subject|2|||
161831131|NCT02813421|584422923|FG000|Overall Study|Lost to Follow-up|1|||
161831132|NCT02813421|584422924|FG001|Overall Study|Lost to Follow-up|1|||
161831133|NCT02129647|584422931|FG000|Overall Study|Adverse Event|2|||
161831134|NCT02129647|584422931|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
161831135|NCT02772562|584422932|FG000|Overall Study|Withdrawal by Subject|1|||
161831136|NCT02772562|584422932|FG000|Overall Study|Protocol Violation|1|||
161831137|NCT03756883|584422933|FG000|Overall Study|Adverse Event|2|||
161941664|NCT03559530|584836205|FG001|Overall Study|other species of Acinetobacte|0|||
161941665|NCT03559530|584836204|FG000|Overall Study|contamination / colonization|3|||
161941666|NCT03559530|584836205|FG001|Overall Study|contamination / colonization|0|||
162025613|NCT01185353|585150781|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
162025614|NCT01185353|585150782|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
162025615|NCT01185353|585150783|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
162025616|NCT01185353|585150784|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
162025617|NCT01185353|585150785|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
161941667|NCT01472185|584836206|FG000|Overall Study|Randomized but Not Treated|0|||
161941668|NCT01472185|584836207|FG001|Overall Study|Randomized but Not Treated|1|||
161941669|NCT01472185|584836206|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
161941670|NCT01472185|584836207|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
161941671|NCT01472185|584836206|FG000|Overall Study|Hyperglycemia|5|||
161941672|NCT01472185|584836207|FG001|Overall Study|Hyperglycemia|2|||
161941673|NCT01472185|584836206|FG000|Overall Study|Investigator's Discretion|3|||
161941674|NCT01472185|584836207|FG001|Overall Study|Investigator's Discretion|1|||
161941675|NCT01472185|584836206|FG000|Overall Study|Lost to Follow-up|4|||
161941676|NCT01472185|584836207|FG001|Overall Study|Lost to Follow-up|1|||
161941677|NCT01472185|584836206|FG000|Overall Study|Protocol Violation|5|||
161941678|NCT01472185|584836207|FG001|Overall Study|Protocol Violation|1|||
161941679|NCT01472185|584836206|FG000|Overall Study|Subject Noncompliance|8|||
161941680|NCT01472185|584836207|FG001|Overall Study|Subject Noncompliance|15|||
161941681|NCT01472185|584836206|FG000|Overall Study|Subject Withdrew Consent|6|||
161941682|NCT01472185|584836207|FG001|Overall Study|Subject Withdrew Consent|3|||
161941683|NCT02958865|584836208|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161941684|NCT02958865|584836209|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
161941685|NCT02958865|584836210|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161941686|NCT02958865|584836211|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
161941687|NCT02958865|584836212|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
161941688|NCT02958865|584836213|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
161941689|NCT02958865|584836214|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
161941690|NCT02958865|584836215|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161941691|NCT02958865|584836216|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161941692|NCT02958865|584836217|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161941693|NCT02958865|584836218|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161941694|NCT02958865|584836219|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161941695|NCT02958865|584836220|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
162025618|NCT01185353|585150786|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
162025619|NCT01185353|585150787|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
162025620|NCT01185353|585150788|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
162025621|NCT01185353|585150779|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
162025622|NCT01185353|585150780|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
162025623|NCT01185353|585150781|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
162025624|NCT01185353|585150782|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
162025625|NCT01185353|585150783|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
162025626|NCT01185353|585150784|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
162025627|NCT01185353|585150785|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
162025628|NCT01185353|585150786|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
162025629|NCT01185353|585150787|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
162025630|NCT01185353|585150788|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
162025631|NCT01185353|585150779|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
162025632|NCT01185353|585150780|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
162025633|NCT01185353|585150781|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
161941696|NCT02958865|584836221|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161941697|NCT02958865|584836222|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161941698|NCT02958865|584836223|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
161941699|NCT02958865|584836208|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
161941700|NCT02958865|584836209|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
162025634|NCT01185353|585150782|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
161831138|NCT03756883|584422934|FG001|Overall Study|Adverse Event|2|||
161941701|NCT02958865|584836210|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
162025635|NCT01185353|585150783|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
162025636|NCT01185353|585150784|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
161831139|NCT03756883|584422935|FG002|Overall Study|Adverse Event|2|||
161831140|NCT03756883|584422933|FG000|Overall Study|Lack of Efficacy|0|||
161831141|NCT03756883|584422934|FG001|Overall Study|Lack of Efficacy|1|||
162236042|NCT02308020|585914980|FG002|Overall Study|Lost to Follow-up|0|||
161682432|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
161682433|NCT01940471|583888875|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161682434|NCT01940471|583888876|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161682435|NCT01940471|583888877|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
161682436|NCT01940471|583888878|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161682437|NCT04695392|583888879|FG000|Overall Study|Withdrawn by parent/guardian|0|||
161682438|NCT04695392|583888880|FG001|Overall Study|Withdrawn by parent/guardian|1|||
161682439|NCT04695392|583888879|FG000|Overall Study|Withdrawn by physician|0|||
161682440|NCT04695392|583888880|FG001|Overall Study|Withdrawn by physician|1|||
161682441|NCT00450723|583888881|FG000|Overall Study|Physician Decision|5|||
161682442|NCT01721057|583888884|FG000|Treatment Period|Withdrawal by Subject|11|||
161682443|NCT01721057|583888885|FG001|Treatment Period|Withdrawal by Subject|5|||
161682444|NCT01721057|583888886|FG002|Treatment Period|Withdrawal by Subject|8|||
161682445|NCT01721057|583888887|FG003|Treatment Period|Withdrawal by Subject|0|||
161682446|NCT01721057|583888888|FG004|Treatment Period|Withdrawal by Subject|0|||
161682447|NCT01721057|583888889|FG005|Treatment Period|Withdrawal by Subject|0|||
161682448|NCT01721057|583888890|FG006|Treatment Period|Withdrawal by Subject|0|||
161682449|NCT01721057|583888884|FG000|Treatment Period|Adverse Event|7|||
161682450|NCT01721057|583888885|FG001|Treatment Period|Adverse Event|10|||
161682451|NCT01721057|583888886|FG002|Treatment Period|Adverse Event|12|||
161682452|NCT01721057|583888887|FG003|Treatment Period|Adverse Event|0|||
161682453|NCT01721057|583888888|FG004|Treatment Period|Adverse Event|0|||
161682454|NCT01721057|583888889|FG005|Treatment Period|Adverse Event|0|||
161682455|NCT01721057|583888890|FG006|Treatment Period|Adverse Event|0|||
161682456|NCT01721057|583888884|FG000|Treatment Period|Lack of Efficacy|7|||
161682457|NCT01721057|583888885|FG001|Treatment Period|Lack of Efficacy|3|||
161682458|NCT01721057|583888886|FG002|Treatment Period|Lack of Efficacy|0|||
161682459|NCT01721057|583888887|FG003|Treatment Period|Lack of Efficacy|0|||
161831142|NCT03756883|584422935|FG002|Overall Study|Lack of Efficacy|2|||
161831143|NCT03756883|584422933|FG000|Overall Study|Lost to Follow-up|3|||
161831144|NCT03756883|584422934|FG001|Overall Study|Lost to Follow-up|3|||
161831145|NCT03756883|584422935|FG002|Overall Study|Lost to Follow-up|0|||
161831146|NCT03756883|584422933|FG000|Overall Study|Protocol Violation|2|||
161831147|NCT03756883|584422934|FG001|Overall Study|Protocol Violation|0|||
161831148|NCT03756883|584422935|FG002|Overall Study|Protocol Violation|1|||
161831149|NCT03756883|584422933|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
161831150|NCT03756883|584422934|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
161831151|NCT03756883|584422935|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
161831152|NCT03756883|584422933|FG000|Overall Study|Withdrawal by Subject|4|||
161831153|NCT03756883|584422934|FG001|Overall Study|Withdrawal by Subject|1|||
161831154|NCT03756883|584422935|FG002|Overall Study|Withdrawal by Subject|0|||
161831155|NCT03756883|584422933|FG000|Overall Study|Other Reasons|2|||
161831156|NCT03756883|584422934|FG001|Overall Study|Other Reasons|4|||
161831157|NCT03756883|584422935|FG002|Overall Study|Other Reasons|0|||
161831158|NCT01463982|584422936|FG000|Overall Study|Withdrawal by Subject|0|||
161831159|NCT01463982|584422937|FG001|Overall Study|Withdrawal by Subject|1|||
161831160|NCT01463982|584422938|FG002|Overall Study|Withdrawal by Subject|1|||
161831161|NCT01463982|584422939|FG003|Overall Study|Withdrawal by Subject|0|||
161831162|NCT01463982|584422936|FG000|Overall Study|Treatment delay over 5 week|0|||
161831163|NCT01463982|584422937|FG001|Overall Study|Treatment delay over 5 week|0|||
161831164|NCT01463982|584422938|FG002|Overall Study|Treatment delay over 5 week|1|||
161831165|NCT01463982|584422939|FG003|Overall Study|Treatment delay over 5 week|0|||
161831166|NCT04668274|584422942|FG000|Part 1 Study Period 1|Adverse Event|3|||
161831167|NCT04668274|584422943|FG001|Part 1 Study Period 1|Adverse Event|0|||
161831168|NCT04668274|584422944|FG002|Part 1 Study Period 1|Adverse Event|0|||
161831169|NCT04668274|584422945|FG003|Part 1 Study Period 1|Adverse Event|0|||
161831170|NCT04668274|584422942|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
161831171|NCT04668274|584422943|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
161831172|NCT04668274|584422944|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
161831173|NCT04668274|584422945|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
161831174|NCT04668274|584422942|FG000|Part 1 Study Period 2|Other|0|||
161831175|NCT04668274|584422943|FG001|Part 1 Study Period 2|Other|1|||
161831176|NCT04668274|584422944|FG002|Part 1 Study Period 2|Other|0|||
161831177|NCT04668274|584422945|FG003|Part 1 Study Period 2|Other|0|||
161831178|NCT04668274|584422942|FG000|Part 1 Study Period 3|Adverse Event|0|||
161831179|NCT04668274|584422943|FG001|Part 1 Study Period 3|Adverse Event|0|||
161831180|NCT04668274|584422944|FG002|Part 1 Study Period 3|Adverse Event|1|||
161831181|NCT04668274|584422945|FG003|Part 1 Study Period 3|Adverse Event|0|||
161831182|NCT04668274|584422942|FG000|Part 1 Study Period 3|Other|0|||
161831183|NCT04668274|584422943|FG001|Part 1 Study Period 3|Other|0|||
161941702|NCT02958865|584836211|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
161941703|NCT02958865|584836212|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
161941704|NCT02958865|584836213|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
161941705|NCT02958865|584836214|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
162236043|NCT02308020|585914981|FG003|Overall Study|Lost to Follow-up|0|||
162236044|NCT02308020|585914982|FG004|Overall Study|Lost to Follow-up|1|||
162236045|NCT02308020|585914983|FG005|Overall Study|Lost to Follow-up|2|||
162236046|NCT02308020|585914978|FG000|Overall Study|Sponsor Decision|0|||
162236047|NCT02308020|585914979|FG001|Overall Study|Sponsor Decision|8|||
162236048|NCT02308020|585914980|FG002|Overall Study|Sponsor Decision|0|||
162236049|NCT02308020|585914981|FG003|Overall Study|Sponsor Decision|2|||
162236050|NCT02308020|585914982|FG004|Overall Study|Sponsor Decision|2|||
162236051|NCT02308020|585914983|FG005|Overall Study|Sponsor Decision|1|||
162236052|NCT02308020|585914978|FG000|Overall Study|Withdrawal by Subject|3|||
162236053|NCT02308020|585914979|FG001|Overall Study|Withdrawal by Subject|5|||
162236054|NCT02308020|585914980|FG002|Overall Study|Withdrawal by Subject|3|||
162236055|NCT02308020|585914981|FG003|Overall Study|Withdrawal by Subject|2|||
162236056|NCT02308020|585914982|FG004|Overall Study|Withdrawal by Subject|1|||
162236057|NCT02308020|585914983|FG005|Overall Study|Withdrawal by Subject|2|||
162236058|NCT03265938|585914984|FG000|Overall Study|Withdrawal by Subject|1|||
162236059|NCT03265938|585914984|FG000|Overall Study|Physician Decision|1|||
162236060|NCT03265938|585914984|FG000|Overall Study|friable mass|6|||
162236061|NCT00705523|585914985|FG000|Overall Study|Lost to Follow-up|2|||
162236062|NCT00705523|585914986|FG001|Overall Study|Lost to Follow-up|3|||
162236063|NCT02471833|585914987|FG000|Overall Study|Lost to Follow-up|1|||
162236064|NCT02471833|585914988|FG001|Overall Study|Lost to Follow-up|0|||
162236065|NCT02471833|585914989|FG002|Overall Study|Lost to Follow-up|0|||
162236066|NCT02471833|585914987|FG000|Overall Study|Withdrawal by Subject|2|||
162236067|NCT02471833|585914988|FG001|Overall Study|Withdrawal by Subject|1|||
162236068|NCT02471833|585914989|FG002|Overall Study|Withdrawal by Subject|5|||
162236069|NCT02673515|585914990|FG000|Overall Study|Lack of motivation|2|||
162236070|NCT02673515|585914991|FG001|Overall Study|Lack of motivation|1|||
162236071|NCT01946438|585914992|FG000|Overall Study|Adverse Event|0|||
162236072|NCT01946438|585914993|FG001|Overall Study|Adverse Event|0|||
162236073|NCT01946438|585914994|FG002|Overall Study|Adverse Event|0|||
162236074|NCT01946438|585914995|FG003|Overall Study|Adverse Event|1|||
162236075|NCT01946438|585914992|FG000|Overall Study|Serious Adverse event|1|||
162236076|NCT01946438|585914993|FG001|Overall Study|Serious Adverse event|0|||
162236077|NCT01946438|585914994|FG002|Overall Study|Serious Adverse event|0|||
162236078|NCT01946438|585914995|FG003|Overall Study|Serious Adverse event|0|||
162236079|NCT01946438|585914992|FG000|Overall Study|Protocol Violation|0|||
162236080|NCT01946438|585914993|FG001|Overall Study|Protocol Violation|0|||
162236081|NCT01946438|585914994|FG002|Overall Study|Protocol Violation|1|||
162236082|NCT01946438|585914995|FG003|Overall Study|Protocol Violation|0|||
162236083|NCT01946438|585914992|FG000|Overall Study|Withdrawal by Subject|1|||
162236084|NCT01946438|585914993|FG001|Overall Study|Withdrawal by Subject|0|||
162236085|NCT01946438|585914994|FG002|Overall Study|Withdrawal by Subject|0|||
162236086|NCT01946438|585914995|FG003|Overall Study|Withdrawal by Subject|0|||
162236087|NCT02412371|585914998|FG000|Overall Study|Withdrawal by Subject|0|||
162236088|NCT02412371|585914999|FG001|Overall Study|Withdrawal by Subject|2|||
162236089|NCT02412371|585915000|FG002|Overall Study|Withdrawal by Subject|0|||
162236090|NCT02412371|585915001|FG003|Overall Study|Withdrawal by Subject|1|||
162236091|NCT02412371|585915002|FG004|Overall Study|Withdrawal by Subject|1|||
162236092|NCT02412371|585915003|FG005|Overall Study|Withdrawal by Subject|0|||
162236093|NCT02412371|585914998|FG000|Overall Study|Sponsor Discontinued Study|1|||
162236094|NCT02412371|585914999|FG001|Overall Study|Sponsor Discontinued Study|4|||
162236095|NCT02412371|585915000|FG002|Overall Study|Sponsor Discontinued Study|6|||
161941706|NCT02958865|584836215|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
161941707|NCT02958865|584836216|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
161941708|NCT02958865|584836217|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
161941709|NCT02958865|584836218|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
161941710|NCT02958865|584836219|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
161941711|NCT02958865|584836220|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
161941712|NCT02958865|584836221|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
161941713|NCT02958865|584836222|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
161941714|NCT02958865|584836223|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
161941715|NCT02958865|584836208|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
161941716|NCT02958865|584836209|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
161941717|NCT02958865|584836210|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941718|NCT02958865|584836211|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941719|NCT02958865|584836212|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941720|NCT02958865|584836213|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941721|NCT02958865|584836214|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941722|NCT02958865|584836215|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941723|NCT02958865|584836216|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941724|NCT02958865|584836217|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941725|NCT02958865|584836218|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941726|NCT02958865|584836219|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941727|NCT02958865|584836220|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941728|NCT02958865|584836221|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941729|NCT02958865|584836222|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941730|NCT02958865|584836223|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
161941731|NCT02958865|584836208|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
161941732|NCT02958865|584836209|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161941733|NCT02958865|584836210|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
161941734|NCT02958865|584836211|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
161941735|NCT02958865|584836212|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
161941736|NCT02958865|584836213|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
161941737|NCT02958865|584836214|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
161941738|NCT02958865|584836215|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161941739|NCT02958865|584836216|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161941740|NCT02958865|584836217|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161941741|NCT02958865|584836218|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161941742|NCT02958865|584836219|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161941743|NCT02958865|584836220|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161941744|NCT02958865|584836221|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161941745|NCT02958865|584836222|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161941746|NCT02958865|584836223|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161941747|NCT02958865|584836208|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941748|NCT02958865|584836209|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941749|NCT02958865|584836210|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941750|NCT02958865|584836211|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
161941751|NCT02958865|584836212|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941752|NCT02958865|584836213|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941753|NCT02958865|584836214|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
161941754|NCT02958865|584836215|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941755|NCT02958865|584836216|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941756|NCT02958865|584836217|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941757|NCT02958865|584836218|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941758|NCT02958865|584836219|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941759|NCT02958865|584836220|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941760|NCT02958865|584836221|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941761|NCT02958865|584836222|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941762|NCT02958865|584836223|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
161941763|NCT02958865|584836208|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941764|NCT02958865|584836209|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941765|NCT02958865|584836210|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
161831184|NCT04668274|584422944|FG002|Part 1 Study Period 3|Other|2|||
161831185|NCT04668274|584422945|FG003|Part 1 Study Period 3|Other|0|||
161831186|NCT04668274|584422942|FG000|Part 2 Study Period 4|Other|0|||
161831187|NCT04668274|584422943|FG001|Part 2 Study Period 4|Other|0|||
161831188|NCT04668274|584422944|FG002|Part 2 Study Period 4|Other|0|||
161831189|NCT04668274|584422945|FG003|Part 2 Study Period 4|Other|1|||
161831190|NCT00939627|584422950|FG000|Overall Study|Disease Progression|16|||
161831191|NCT00939627|584422951|FG001|Overall Study|Disease Progression|12|||
161831192|NCT00939627|584422952|FG002|Overall Study|Disease Progression|0|||
161831193|NCT00939627|584422950|FG000|Overall Study|Adverse Event|6|||
161831194|NCT00939627|584422951|FG001|Overall Study|Adverse Event|7|||
161831195|NCT00939627|584422952|FG002|Overall Study|Adverse Event|0|||
161831196|NCT00939627|584422950|FG000|Overall Study|Death|0|||
161831197|NCT00939627|584422951|FG001|Overall Study|Death|2|||
161831198|NCT00939627|584422952|FG002|Overall Study|Death|0|||
161831199|NCT00939627|584422950|FG000|Overall Study|Withdrawal by Subject|2|||
161831200|NCT00939627|584422951|FG001|Overall Study|Withdrawal by Subject|4|||
161831201|NCT00939627|584422952|FG002|Overall Study|Withdrawal by Subject|0|||
161831202|NCT00939627|584422950|FG000|Overall Study|Other complicating disease|1|||
161831203|NCT00939627|584422951|FG001|Overall Study|Other complicating disease|1|||
161831204|NCT00939627|584422952|FG002|Overall Study|Other complicating disease|0|||
161831205|NCT00939627|584422950|FG000|Overall Study|Not compliant|2|||
161831206|NCT00939627|584422951|FG001|Overall Study|Not compliant|0|||
161831207|NCT00939627|584422952|FG002|Overall Study|Not compliant|0|||
161831208|NCT00939627|584422950|FG000|Overall Study|No off-tx reason given|0|||
161831209|NCT00939627|584422951|FG001|Overall Study|No off-tx reason given|2|||
161831210|NCT00939627|584422952|FG002|Overall Study|No off-tx reason given|0|||
161831211|NCT02039063|584422955|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
161831212|NCT02039063|584422956|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
161831213|NCT02039063|584422957|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
161831214|NCT02039063|584422958|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
161831215|NCT02039063|584422955|FG000|Treatment Phase|Progression of disease|0|||
161831216|NCT02039063|584422956|FG001|Treatment Phase|Progression of disease|0|||
161831217|NCT02039063|584422957|FG002|Treatment Phase|Progression of disease|1|||
161831218|NCT02039063|584422958|FG003|Treatment Phase|Progression of disease|1|||
161831219|NCT02039063|584422955|FG000|Extension Phase|Inadequate therapeutic effect|0|||
161831220|NCT02039063|584422956|FG001|Extension Phase|Inadequate therapeutic effect|1|||
161831221|NCT02039063|584422957|FG002|Extension Phase|Inadequate therapeutic effect|2|||
161831222|NCT02039063|584422958|FG003|Extension Phase|Inadequate therapeutic effect|0|||
161831223|NCT02039063|584422955|FG000|Extension Phase|Progression of disease|0|||
161831224|NCT02039063|584422956|FG001|Extension Phase|Progression of disease|0|||
161831225|NCT02039063|584422957|FG002|Extension Phase|Progression of disease|0|||
161831226|NCT02039063|584422958|FG003|Extension Phase|Progression of disease|1|||
161831227|NCT02039063|584422955|FG000|Extension Phase|Adverse Event|0|||
161831228|NCT02039063|584422956|FG001|Extension Phase|Adverse Event|0|||
161831229|NCT02039063|584422957|FG002|Extension Phase|Adverse Event|1|||
161831230|NCT02039063|584422958|FG003|Extension Phase|Adverse Event|0|||
161831231|NCT00467831|584422961|FG000|Overall Study|Death|2|||
161831232|NCT00467831|584422961|FG000|Overall Study|Withdrawal by Subject|1|||
161831233|NCT01832402|584422964|FG000|Overall Study|Lost to Follow-up|2|||
161831234|NCT01832402|584422965|FG001|Overall Study|Lost to Follow-up|0|||
161831235|NCT01832402|584422964|FG000|Overall Study|Withdrawal by Subject|3|||
161831236|NCT01832402|584422965|FG001|Overall Study|Withdrawal by Subject|3|||
161831237|NCT01832402|584422964|FG000|Overall Study|Declining Performance status|2|||
161831238|NCT01832402|584422965|FG001|Overall Study|Declining Performance status|1|||
161831239|NCT01198873|584422966|FG000|Overall Study|Adverse Event|4|||
161831240|NCT01198873|584422967|FG001|Overall Study|Adverse Event|7|||
161831241|NCT01198873|584422966|FG000|Overall Study|Study closure|29|||
161831242|NCT01198873|584422967|FG001|Overall Study|Study closure|23|||
161831243|NCT01198873|584422966|FG000|Overall Study|Other than above|4|||
161831244|NCT01198873|584422967|FG001|Overall Study|Other than above|2|||
161831245|NCT00775528|584422973|FG000|Overall Study|Protocol Violation|1|||
161831246|NCT02492841|584422974|FG000|Overall Study|Lost to Follow-up|34|||
161831247|NCT02492841|584422975|FG001|Overall Study|Lost to Follow-up|31|||
161831248|NCT02492841|584422976|FG002|Overall Study|Lost to Follow-up|35|||
161831249|NCT00613730|584422979|FG000|Overall Study|Disease progression|2|||
161941766|NCT02958865|584836211|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941767|NCT02958865|584836212|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941768|NCT02958865|584836213|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941769|NCT02958865|584836214|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941770|NCT02958865|584836215|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941771|NCT02958865|584836216|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941772|NCT02958865|584836217|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941773|NCT02958865|584836218|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941774|NCT02958865|584836219|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941775|NCT02958865|584836220|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941776|NCT02958865|584836221|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941777|NCT02958865|584836222|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941778|NCT02958865|584836223|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
161941779|NCT02958865|584836208|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
161941780|NCT02958865|584836209|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
161941781|NCT02958865|584836210|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
161941782|NCT02958865|584836211|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941783|NCT02958865|584836212|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941784|NCT02958865|584836213|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941785|NCT02958865|584836214|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941786|NCT02958865|584836215|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941787|NCT02958865|584836216|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941788|NCT02958865|584836217|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941789|NCT02958865|584836218|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941790|NCT02958865|584836219|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941791|NCT02958865|584836220|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941792|NCT02958865|584836221|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941793|NCT02958865|584836222|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941794|NCT02958865|584836223|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161941795|NCT02958865|584836208|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
161941796|NCT02958865|584836209|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
161941797|NCT02958865|584836210|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
161941798|NCT02958865|584836211|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
161941799|NCT02958865|584836212|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
161941800|NCT02958865|584836213|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
161941801|NCT02958865|584836214|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
161941802|NCT02958865|584836215|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
161941803|NCT02958865|584836216|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
161941804|NCT02958865|584836217|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
161941805|NCT02958865|584836218|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
161941806|NCT02958865|584836219|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
161941807|NCT02958865|584836220|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
161941808|NCT02958865|584836221|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
161941809|NCT02958865|584836222|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
161941810|NCT02958865|584836223|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
161941811|NCT02958865|584836208|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941812|NCT02958865|584836209|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941813|NCT02958865|584836210|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941814|NCT02958865|584836211|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941815|NCT02958865|584836212|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
161941816|NCT02958865|584836213|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941817|NCT02958865|584836214|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941818|NCT02958865|584836215|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941819|NCT02958865|584836216|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941820|NCT02958865|584836217|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941821|NCT02958865|584836218|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941822|NCT02958865|584836219|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941823|NCT02958865|584836220|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941824|NCT02958865|584836221|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941825|NCT02958865|584836222|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161941826|NCT02958865|584836223|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162025637|NCT01185353|585150785|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
161941827|NCT02958865|584836208|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161941828|NCT02958865|584836209|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161941829|NCT02958865|584836210|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161941830|NCT02958865|584836211|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161941831|NCT02958865|584836212|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161682460|NCT01721057|583888888|FG004|Treatment Period|Lack of Efficacy|0|||
161682461|NCT01721057|583888889|FG005|Treatment Period|Lack of Efficacy|0|||
161941832|NCT02958865|584836213|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161941833|NCT02958865|584836214|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161941834|NCT02958865|584836215|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
161941835|NCT02958865|584836216|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
161941836|NCT02958865|584836217|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
161941837|NCT02958865|584836218|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
161941838|NCT02958865|584836219|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
161941839|NCT02958865|584836220|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
161941840|NCT02958865|584836221|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
161941841|NCT02958865|584836222|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
161941842|NCT02958865|584836223|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
161941843|NCT02958865|584836208|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161941844|NCT02958865|584836209|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161941845|NCT02958865|584836210|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161941846|NCT02958865|584836211|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161941847|NCT02958865|584836212|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161941848|NCT02958865|584836213|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161941849|NCT02958865|584836214|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161941850|NCT02958865|584836215|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161941851|NCT02958865|584836216|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
161941852|NCT02958865|584836217|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
161941853|NCT02958865|584836218|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161941854|NCT02958865|584836219|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
161941855|NCT02958865|584836220|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161941856|NCT02958865|584836221|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
161941857|NCT02958865|584836222|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
161941858|NCT02958865|584836223|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
161941859|NCT02958865|584836208|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941860|NCT02958865|584836209|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941861|NCT02958865|584836210|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941862|NCT02958865|584836211|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941863|NCT02958865|584836212|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941864|NCT02958865|584836213|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941865|NCT02958865|584836214|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941866|NCT02958865|584836215|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941867|NCT02958865|584836216|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941868|NCT02958865|584836217|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
161941869|NCT02958865|584836218|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941870|NCT02958865|584836219|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941871|NCT02958865|584836220|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941872|NCT02958865|584836221|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941873|NCT02958865|584836222|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
161941874|NCT02958865|584836223|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
161941875|NCT02958865|584836208|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161941876|NCT02958865|584836209|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161941877|NCT02958865|584836210|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161941878|NCT02958865|584836211|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161941879|NCT02958865|584836212|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161941880|NCT02958865|584836213|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161941881|NCT02958865|584836214|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161941882|NCT02958865|584836215|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161941883|NCT02958865|584836216|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161941884|NCT02958865|584836217|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161682462|NCT01721057|583888890|FG006|Treatment Period|Lack of Efficacy|0|||
161941885|NCT02958865|584836218|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
161941886|NCT02958865|584836219|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
161941887|NCT02958865|584836220|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
161941888|NCT02958865|584836221|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
161682463|NCT01721057|583888884|FG000|Treatment Period|Lost to Follow-up|1|||
162236096|NCT02412371|585915001|FG003|Overall Study|Sponsor Discontinued Study|4|||
162236097|NCT02412371|585915002|FG004|Overall Study|Sponsor Discontinued Study|5|||
162236098|NCT02412371|585915003|FG005|Overall Study|Sponsor Discontinued Study|0|||
162236099|NCT02412371|585914998|FG000|Overall Study|Death|4|||
162236100|NCT02412371|585914999|FG001|Overall Study|Death|2|||
162236101|NCT02412371|585915000|FG002|Overall Study|Death|1|||
162236102|NCT02412371|585915001|FG003|Overall Study|Death|3|||
162236103|NCT02412371|585915002|FG004|Overall Study|Death|5|||
162236104|NCT02412371|585915003|FG005|Overall Study|Death|2|||
162236105|NCT02412371|585914998|FG000|Overall Study|Other|2|||
162236106|NCT02412371|585914999|FG001|Overall Study|Other|1|||
162236107|NCT02412371|585915000|FG002|Overall Study|Other|0|||
162236108|NCT02412371|585915001|FG003|Overall Study|Other|0|||
162236109|NCT02412371|585915002|FG004|Overall Study|Other|1|||
162236110|NCT02412371|585915003|FG005|Overall Study|Other|3|||
162236111|NCT02523599|585915004|FG000|Overall Study|Adverse Event|1|||
162236112|NCT02523599|585915005|FG001|Overall Study|Adverse Event|0|||
162236113|NCT02523599|585915004|FG000|Overall Study|Physician Decision|1|||
162236114|NCT02523599|585915005|FG001|Overall Study|Physician Decision|0|||
162236115|NCT02523599|585915004|FG000|Overall Study|Lost to Follow-up|4|||
162236116|NCT02523599|585915005|FG001|Overall Study|Lost to Follow-up|1|||
162236117|NCT02523599|585915004|FG000|Overall Study|Did not return for Day 30 visit|2|||
161831250|NCT00613730|584422979|FG000|Overall Study|Administrative decision|1|||
161831251|NCT04965389|584422988|FG000|Overall Study|Other reasons|1|||
161831252|NCT04965389|584422989|FG001|Overall Study|Other reasons|0|||
162236118|NCT02523599|585915005|FG001|Overall Study|Did not return for Day 30 visit|0|||
162236119|NCT01892540|585915006|FG000|Overall Study|Did not complete PET/MRI|0|||
162236120|NCT01892540|585915007|FG001|Overall Study|Did not complete PET/MRI|0|||
162236121|NCT01892540|585915008|FG002|Overall Study|Did not complete PET/MRI|2|||
162236122|NCT01892540|585915006|FG000|Overall Study|Did not fit in scanner|0|||
162236123|NCT01892540|585915007|FG001|Overall Study|Did not fit in scanner|0|||
162236124|NCT01892540|585915008|FG002|Overall Study|Did not fit in scanner|1|||
162236125|NCT01370590|585915009|FG000|Period 1|Adverse Event|8|||
162236126|NCT01370590|585915010|FG001|Period 1|Adverse Event|4|||
162236127|NCT01370590|585915009|FG000|Period 1|Lost to Follow-up|2|||
162236128|NCT01370590|585915010|FG001|Period 1|Lost to Follow-up|2|||
162236129|NCT01370590|585915009|FG000|Period 1|Protocol Violation|2|||
162236130|NCT01370590|585915010|FG001|Period 1|Protocol Violation|2|||
162236131|NCT01370590|585915009|FG000|Period 1|Withdrawal by Subject|4|||
162236132|NCT01370590|585915010|FG001|Period 1|Withdrawal by Subject|2|||
162236133|NCT01370590|585915009|FG000|Period 1|Could not access randomization system|0|||
162236134|NCT01370590|585915010|FG001|Period 1|Could not access randomization system|1|||
162236135|NCT01370590|585915009|FG000|Crossover Washout Period|Adverse Event|1|||
162236136|NCT01370590|585915010|FG001|Crossover Washout Period|Adverse Event|4|||
162236137|NCT01370590|585915009|FG000|Crossover Washout Period|Lost to Follow-up|2|||
162236138|NCT01370590|585915010|FG001|Crossover Washout Period|Lost to Follow-up|0|||
162236139|NCT01370590|585915009|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
161831253|NCT04965389|584422990|FG002|Overall Study|Other reasons|0|||
161831254|NCT04965389|584422991|FG003|Overall Study|Other reasons|0|||
161831255|NCT04965389|584422988|FG000|Overall Study|Participant withdrew consent|0|||
161831256|NCT04965389|584422989|FG001|Overall Study|Participant withdrew consent|1|||
161831257|NCT04965389|584422990|FG002|Overall Study|Participant withdrew consent|0|||
161831258|NCT04965389|584422991|FG003|Overall Study|Participant withdrew consent|0|||
161831259|NCT04965389|584422988|FG000|Overall Study|Poor/Non-compliance|0|||
161831260|NCT04965389|584422989|FG001|Overall Study|Poor/Non-compliance|1|||
161831261|NCT04965389|584422990|FG002|Overall Study|Poor/Non-compliance|0|||
161831262|NCT04965389|584422991|FG003|Overall Study|Poor/Non-compliance|0|||
161831263|NCT02083926|584422994|FG000|Overall Study|Withdrawal by Subject|1|||
161831264|NCT02083926|584422995|FG001|Overall Study|Withdrawal by Subject|0|||
161831265|NCT01436643|584422996|FG000|2-week Pre-treatment|Abnormal test result|0|||
161831266|NCT01436643|584422997|FG001|2-week Pre-treatment|Abnormal test result|0|||
161831267|NCT01436643|584422998|FG002|2-week Pre-treatment|Abnormal test result|0|||
161831268|NCT01436643|584422999|FG003|2-week Pre-treatment|Abnormal test result|1|||
161831269|NCT01436643|584422996|FG000|2-week Pre-treatment|Adverse Event|0|||
161831270|NCT01436643|584422997|FG001|2-week Pre-treatment|Adverse Event|0|||
161831271|NCT01436643|584422998|FG002|2-week Pre-treatment|Adverse Event|0|||
161831272|NCT01436643|584422999|FG003|2-week Pre-treatment|Adverse Event|5|||
161831273|NCT01436643|584422996|FG000|2-week Pre-treatment|Protocol Violation|0|||
161831274|NCT01436643|584422997|FG001|2-week Pre-treatment|Protocol Violation|0|||
161831275|NCT01436643|584422998|FG002|2-week Pre-treatment|Protocol Violation|0|||
161831276|NCT01436643|584422999|FG003|2-week Pre-treatment|Protocol Violation|4|||
161831277|NCT01436643|584422996|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
161831278|NCT01436643|584422997|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
161941889|NCT02958865|584836222|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
161941890|NCT02958865|584836223|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
161941891|NCT02958865|584836208|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
161941892|NCT02958865|584836209|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
161941893|NCT02958865|584836210|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
161941894|NCT02958865|584836211|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
161941895|NCT02958865|584836212|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
161941896|NCT02958865|584836213|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
161941897|NCT02958865|584836214|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
161941898|NCT02958865|584836215|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
161941899|NCT02958865|584836216|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
161941900|NCT02958865|584836217|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
161941901|NCT02958865|584836218|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
161941902|NCT02958865|584836219|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
161941903|NCT02958865|584836220|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
161941904|NCT02958865|584836221|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
161941905|NCT02958865|584836222|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
161941906|NCT02958865|584836223|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
161941907|NCT02958865|584836208|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941908|NCT02958865|584836209|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941909|NCT02958865|584836210|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941910|NCT02958865|584836211|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941911|NCT02958865|584836212|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941912|NCT02958865|584836213|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941913|NCT02958865|584836214|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941914|NCT02958865|584836215|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941915|NCT02958865|584836216|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941916|NCT02958865|584836217|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941917|NCT02958865|584836218|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941918|NCT02958865|584836219|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941919|NCT02958865|584836220|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941920|NCT02958865|584836221|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
161941921|NCT02958865|584836222|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941922|NCT02958865|584836223|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
161941923|NCT02958865|584836208|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941924|NCT02958865|584836209|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941925|NCT02958865|584836210|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941926|NCT02958865|584836211|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161831279|NCT01436643|584422998|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
161831280|NCT01436643|584422999|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
161831281|NCT01436643|584422996|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
161831282|NCT01436643|584422997|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
161831283|NCT01436643|584422998|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
161831284|NCT01436643|584422999|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
161831285|NCT01436643|584422996|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
161831286|NCT01436643|584422997|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
161831287|NCT01436643|584422998|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
161831288|NCT01436643|584422999|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
161831289|NCT01117987|584423000|FG000|Overall Study|Protocol deviation|0|||
161831290|NCT01117987|584423001|FG001|Overall Study|Protocol deviation|1|||
161831291|NCT01117987|584423000|FG000|Overall Study|Subject no longer requires study drug|1|||
161831292|NCT01117987|584423001|FG001|Overall Study|Subject no longer requires study drug|0|||
161831293|NCT01117987|584423000|FG000|Overall Study|Lost to Follow-up|1|||
161831294|NCT01117987|584423001|FG001|Overall Study|Lost to Follow-up|1|||
161831295|NCT01117987|584423000|FG000|Overall Study|Abnormal test procedure result|2|||
161831296|NCT01117987|584423001|FG001|Overall Study|Abnormal test procedure result|0|||
161831297|NCT01117987|584423000|FG000|Overall Study|Lack of Efficacy|3|||
161831298|NCT01117987|584423001|FG001|Overall Study|Lack of Efficacy|4|||
162025638|NCT01185353|585150786|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
162025639|NCT01185353|585150787|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
162025640|NCT01185353|585150788|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
162025641|NCT01185353|585150779|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
162025642|NCT01185353|585150780|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
162025643|NCT01185353|585150781|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
162025644|NCT01185353|585150782|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
162025645|NCT01185353|585150783|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
162025646|NCT01185353|585150784|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
162025647|NCT01185353|585150785|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
162025648|NCT01185353|585150786|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
162025649|NCT01185353|585150787|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
162025650|NCT01185353|585150788|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
162025651|NCT01185353|585150779|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
162025652|NCT01185353|585150780|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
162025653|NCT01185353|585150781|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
162025654|NCT01185353|585150782|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
162025655|NCT01185353|585150783|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
162025656|NCT01185353|585150784|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
162025657|NCT01185353|585150785|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
162025658|NCT01185353|585150786|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
162025659|NCT01185353|585150787|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
161682464|NCT01721057|583888885|FG001|Treatment Period|Lost to Follow-up|0|||
161831299|NCT01117987|584423000|FG000|Overall Study|Death|5|||
161831300|NCT01117987|584423001|FG001|Overall Study|Death|10|||
161831301|NCT01117987|584423000|FG000|Overall Study|Withdrawal by Subject|5|||
161831302|NCT01117987|584423001|FG001|Overall Study|Withdrawal by Subject|10|||
161831303|NCT01117987|584423000|FG000|Overall Study|Adverse Event|19|||
161831304|NCT01117987|584423001|FG001|Overall Study|Adverse Event|26|||
162025660|NCT01185353|585150788|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
162025661|NCT01185353|585150779|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
162025662|NCT01185353|585150780|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
162025663|NCT01185353|585150781|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
162025664|NCT01185353|585150782|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
162025665|NCT01185353|585150783|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
162025666|NCT01185353|585150784|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
162025667|NCT01185353|585150785|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
162025668|NCT01185353|585150786|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
162025669|NCT01185353|585150787|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
162025670|NCT01185353|585150788|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
162025671|NCT01185353|585150779|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
162025672|NCT01185353|585150780|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
162025673|NCT01185353|585150781|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
162025674|NCT01185353|585150782|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
162025675|NCT01185353|585150783|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
162025676|NCT01185353|585150784|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
162025677|NCT01185353|585150785|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
162025678|NCT01185353|585150786|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
162025679|NCT01185353|585150787|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
162025680|NCT01185353|585150788|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
162025681|NCT01185353|585150779|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
162025682|NCT01185353|585150780|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
162025683|NCT01185353|585150781|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
162025684|NCT01185353|585150782|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
162025685|NCT01185353|585150783|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
162025686|NCT01185353|585150784|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
162025687|NCT01185353|585150785|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
162025688|NCT01185353|585150786|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
162025689|NCT01185353|585150787|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
162025690|NCT01185353|585150788|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
162025691|NCT01185353|585150779|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
162025692|NCT01185353|585150780|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
162025693|NCT01185353|585150781|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
162025694|NCT01185353|585150782|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
162025695|NCT01185353|585150783|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
162025696|NCT01185353|585150784|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
162025697|NCT01185353|585150785|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
162025698|NCT01185353|585150786|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
162025699|NCT01185353|585150787|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
162025700|NCT01185353|585150788|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
162025701|NCT01185353|585150779|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
162025702|NCT01185353|585150780|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
162025703|NCT01185353|585150781|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
162025704|NCT01185353|585150782|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
162025705|NCT01185353|585150783|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
162025706|NCT01185353|585150784|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
162025707|NCT01185353|585150785|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
162025708|NCT01185353|585150786|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
162025709|NCT01185353|585150787|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
162025710|NCT01185353|585150788|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
161682465|NCT01721057|583888886|FG002|Treatment Period|Lost to Follow-up|0|||
162025711|NCT01185353|585150779|FG000|Part C (Weeks 24 Through 76)|Death|0|||
162025712|NCT01185353|585150780|FG001|Part C (Weeks 24 Through 76)|Death|0|||
162025713|NCT01185353|585150781|FG002|Part C (Weeks 24 Through 76)|Death|0|||
161941927|NCT02958865|584836212|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941928|NCT02958865|584836213|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941929|NCT02958865|584836214|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941930|NCT02958865|584836215|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941931|NCT02958865|584836216|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941932|NCT02958865|584836217|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941933|NCT02958865|584836218|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941934|NCT02958865|584836219|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941935|NCT02958865|584836220|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941936|NCT02958865|584836221|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
161941937|NCT02958865|584836222|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941938|NCT02958865|584836223|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
161941939|NCT02958865|584836208|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941940|NCT02958865|584836209|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941941|NCT02958865|584836210|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941942|NCT02958865|584836211|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941943|NCT02958865|584836212|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
162025714|NCT01185353|585150782|FG003|Part C (Weeks 24 Through 76)|Death|0|||
162025715|NCT01185353|585150783|FG004|Part C (Weeks 24 Through 76)|Death|0|||
162025716|NCT01185353|585150784|FG005|Part C (Weeks 24 Through 76)|Death|0|||
162025717|NCT01185353|585150785|FG006|Part C (Weeks 24 Through 76)|Death|0|||
162025718|NCT01185353|585150786|FG007|Part C (Weeks 24 Through 76)|Death|0|||
162025719|NCT01185353|585150787|FG008|Part C (Weeks 24 Through 76)|Death|0|||
161682466|NCT01721057|583888887|FG003|Treatment Period|Lost to Follow-up|0|||
161941944|NCT02958865|584836213|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
162025720|NCT01185353|585150788|FG009|Part C (Weeks 24 Through 76)|Death|1|||
162025721|NCT01185353|585150779|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
161831305|NCT01117987|584423000|FG000|Overall Study|Administrative problems|25|||
161831306|NCT01117987|584423001|FG001|Overall Study|Administrative problems|22|||
161831307|NCT02244424|584423002|FG000|Overall Study|Lost to Follow-up|20|||
161831308|NCT02244424|584423003|FG001|Overall Study|Lost to Follow-up|10|||
161831309|NCT04117945|584423006|FG000|Overall Study|Death|1|||
161831310|NCT04117945|584423007|FG001|Overall Study|Death|0|||
161831311|NCT04117945|584423006|FG000|Overall Study|Withdrawal by Subject|3|||
161831312|NCT04117945|584423007|FG001|Overall Study|Withdrawal by Subject|1|||
161831313|NCT04117945|584423006|FG000|Overall Study|Disease Progression|0|||
161831314|NCT04117945|584423007|FG001|Overall Study|Disease Progression|2|||
161831315|NCT04117945|584423006|FG000|Overall Study|Ineligible|8|||
161831316|NCT04117945|584423007|FG001|Overall Study|Ineligible|7|||
161831317|NCT01181531|584423011|FG000|Overall Study|Other|17|||
161831318|NCT01181531|584423012|FG001|Overall Study|Other|12|||
161831319|NCT01181531|584423011|FG000|Overall Study|Partial consent by subject withdrawn|0|||
161831320|NCT01181531|584423012|FG001|Overall Study|Partial consent by subject withdrawn|1|||
161831321|NCT01181531|584423011|FG000|Overall Study|Physician Decision|3|||
161831322|NCT01181531|584423012|FG001|Overall Study|Physician Decision|1|||
161831323|NCT01181531|584423011|FG000|Overall Study|Noncompliance|2|||
161831324|NCT01181531|584423012|FG001|Overall Study|Noncompliance|2|||
161831325|NCT01181531|584423011|FG000|Overall Study|Ineligibility determined|1|||
161831326|NCT01181531|584423012|FG001|Overall Study|Ineligibility determined|2|||
161831327|NCT01181531|584423011|FG000|Overall Study|Protocol Specified Criteria|15|||
161831328|NCT01181531|584423012|FG001|Overall Study|Protocol Specified Criteria|8|||
161831329|NCT01181531|584423011|FG000|Overall Study|Pregnancy|0|||
161831330|NCT01181531|584423012|FG001|Overall Study|Pregnancy|1|||
161831331|NCT01181531|584423011|FG000|Overall Study|Withdrawal by Subject|8|||
161831332|NCT01181531|584423012|FG001|Overall Study|Withdrawal by Subject|7|||
161831333|NCT01181531|584423011|FG000|Overall Study|Protocol Violation|6|||
161831334|NCT01181531|584423012|FG001|Overall Study|Protocol Violation|6|||
161831335|NCT01181531|584423011|FG000|Overall Study|Death|9|||
161831336|NCT01181531|584423012|FG001|Overall Study|Death|12|||
161831337|NCT01181531|584423011|FG000|Overall Study|Adverse Event|0|||
161831338|NCT01181531|584423012|FG001|Overall Study|Adverse Event|1|||
161831339|NCT00955721|584423013|FG000|Overall Study|Physician Decision|1|||
161831340|NCT00955721|584423014|FG001|Overall Study|Physician Decision|0|||
161831341|NCT00955721|584423013|FG000|Overall Study|Death|1|||
161831342|NCT00955721|584423014|FG001|Overall Study|Death|0|||
161831343|NCT00955721|584423013|FG000|Overall Study|Withdrawal by Subject|1|||
161831344|NCT00955721|584423014|FG001|Overall Study|Withdrawal by Subject|0|||
161831345|NCT04034355|584423019|FG000|Overall Study|Study terminated by Sponsor|10|||
161831346|NCT04034355|584423020|FG001|Overall Study|Study terminated by Sponsor|17|||
161831347|NCT04034355|584423019|FG000|Overall Study|Withdrawal by Subject|12|||
161831348|NCT04034355|584423020|FG001|Overall Study|Withdrawal by Subject|11|||
161831349|NCT04034355|584423019|FG000|Overall Study|Site terminated by Sponsor|4|||
161831350|NCT04034355|584423020|FG001|Overall Study|Site terminated by Sponsor|5|||
161831351|NCT04034355|584423019|FG000|Overall Study|Adverse Event|2|||
161831352|NCT04034355|584423020|FG001|Overall Study|Adverse Event|0|||
161831353|NCT04034355|584423019|FG000|Overall Study|Death|1|||
161831354|NCT04034355|584423020|FG001|Overall Study|Death|1|||
161831355|NCT04034355|584423019|FG000|Overall Study|Not reported|2|||
161831356|NCT04034355|584423020|FG001|Overall Study|Not reported|0|||
161831357|NCT04034355|584423019|FG000|Overall Study|Lost to Follow-up|1|||
161831358|NCT04034355|584423020|FG001|Overall Study|Lost to Follow-up|0|||
161831359|NCT04034355|584423019|FG000|Overall Study|Physician Decision|1|||
161831360|NCT04034355|584423020|FG001|Overall Study|Physician Decision|0|||
161831361|NCT04034355|584423019|FG000|Overall Study|Protocol Violation|0|||
161831362|NCT04034355|584423020|FG001|Overall Study|Protocol Violation|1|||
161831363|NCT04034355|584423019|FG000|Overall Study|Progressive disease|1|||
161831364|NCT04034355|584423020|FG001|Overall Study|Progressive disease|0|||
161831365|NCT02723773|584424722|FG000|Overall Study|Adverse Event|934|||
161831366|NCT02723773|584424723|FG001|Overall Study|Adverse Event|3|||
161831367|NCT02723773|584424724|FG002|Overall Study|Adverse Event|1|||
161831368|NCT02723773|584424725|FG003|Overall Study|Adverse Event|9|||
161831369|NCT02723773|584424722|FG000|Overall Study|Protocol Violation|1|||
161831370|NCT02723773|584424723|FG001|Overall Study|Protocol Violation|0|||
161831371|NCT02723773|584424724|FG002|Overall Study|Protocol Violation|0|||
161831372|NCT02723773|584424725|FG003|Overall Study|Protocol Violation|0|||
161941945|NCT02958865|584836214|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941946|NCT02958865|584836215|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941947|NCT02958865|584836216|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941948|NCT02958865|584836217|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
161941949|NCT02958865|584836218|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941950|NCT02958865|584836219|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941951|NCT02958865|584836220|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941952|NCT02958865|584836221|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941953|NCT02958865|584836222|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941954|NCT02958865|584836223|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
161941955|NCT01309230|584836224|FG000|Overall Study|Withdrawal by Subject|0|||
161941956|NCT01309230|584836225|FG001|Overall Study|Withdrawal by Subject|2|||
161941957|NCT01309230|584836224|FG000|Overall Study|Observation arm closed|0|||
161941958|NCT01309230|584836225|FG001|Overall Study|Observation arm closed|2|||
161941959|NCT02661815|584836226|FG000|Overall Study|Withdrawal by Subject|1|||
161941960|NCT02661815|584836227|FG001|Overall Study|Withdrawal by Subject|0|||
161941961|NCT02661815|584836228|FG002|Overall Study|Withdrawal by Subject|0|||
161941962|NCT02661815|584836229|FG003|Overall Study|Withdrawal by Subject|0|||
161941963|NCT00635050|584836232|FG000|Overall Study|Withdrawal by Subject|1|||
161941964|NCT04380142|584836237|FG000|LD/CD Stabilization Period|Adverse Event|3|||
161941965|NCT04380142|584836238|FG001|LD/CD Stabilization Period|Adverse Event|0|||
161941966|NCT04380142|584836239|FG002|LD/CD Stabilization Period|Adverse Event|0|||
161941967|NCT04380142|584836237|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
161941968|NCT04380142|584836238|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
161941969|NCT04380142|584836239|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
161941970|NCT04380142|584836237|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
161941971|NCT04380142|584836238|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
161941972|NCT04380142|584836239|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
161941973|NCT04380142|584836237|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
161941974|NCT04380142|584836238|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
161941975|NCT04380142|584836239|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
161941976|NCT04380142|584836237|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
161941977|NCT04380142|584836238|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
161941978|NCT04380142|584836239|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
161941979|NCT04380142|584836237|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
161941980|NCT04380142|584836238|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
161941981|NCT04380142|584836239|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
161941982|NCT04380142|584836237|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161682467|NCT01721057|583888888|FG004|Treatment Period|Lost to Follow-up|0|||
161682468|NCT01721057|583888889|FG005|Treatment Period|Lost to Follow-up|0|||
161682469|NCT01721057|583888890|FG006|Treatment Period|Lost to Follow-up|0|||
161941983|NCT04380142|584836238|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161941984|NCT04380142|584836239|FG002|Double-Blind Treatment Period|Adverse Event|14|||
161941985|NCT04380142|584836237|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
161941986|NCT04380142|584836238|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
161941987|NCT04380142|584836239|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
161941988|NCT04380142|584836237|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
161941989|NCT04380142|584836238|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
161941990|NCT04380142|584836239|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
161941991|NCT04380142|584836237|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
161941992|NCT04380142|584836238|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
161941993|NCT04380142|584836239|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
161941994|NCT04380142|584836237|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
161941995|NCT04380142|584836238|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
161941996|NCT04380142|584836239|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
161941997|NCT04380142|584836237|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
161941998|NCT04380142|584836238|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
161941999|NCT04380142|584836239|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
161682470|NCT01721057|583888884|FG000|Treatment Period|Physician Decision|0|||
161682471|NCT01721057|583888885|FG001|Treatment Period|Physician Decision|1|||
161682472|NCT01721057|583888886|FG002|Treatment Period|Physician Decision|3|||
161682473|NCT01721057|583888887|FG003|Treatment Period|Physician Decision|0|||
161682474|NCT01721057|583888888|FG004|Treatment Period|Physician Decision|0|||
161682475|NCT01721057|583888889|FG005|Treatment Period|Physician Decision|0|||
161682476|NCT01721057|583888890|FG006|Treatment Period|Physician Decision|0|||
161682477|NCT01721057|583888884|FG000|Treatment Period|Death|2|||
161682478|NCT01721057|583888885|FG001|Treatment Period|Death|0|||
161682479|NCT01721057|583888886|FG002|Treatment Period|Death|0|||
161682480|NCT01721057|583888887|FG003|Treatment Period|Death|0|||
161682481|NCT01721057|583888888|FG004|Treatment Period|Death|0|||
161682482|NCT01721057|583888889|FG005|Treatment Period|Death|0|||
161682483|NCT01721057|583888890|FG006|Treatment Period|Death|0|||
161682484|NCT01721057|583888884|FG000|Rescue Period|Adverse Event|0|||
161942000|NCT00209131|584836240|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
161942001|NCT00209131|584836241|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
161942002|NCT04875533|584836242|FG000|Overall Study|Adverse Event|6|||
161942003|NCT04875533|584836243|FG001|Overall Study|Adverse Event|4|||
161942004|NCT04875533|584836242|FG000|Overall Study|Protocol Violation|4|||
161942005|NCT04875533|584836243|FG001|Overall Study|Protocol Violation|0|||
161942006|NCT04875533|584836242|FG000|Overall Study|Withdrawal by Subject|8|||
161682485|NCT01721057|583888885|FG001|Rescue Period|Adverse Event|0|||
161682486|NCT01721057|583888886|FG002|Rescue Period|Adverse Event|0|||
161682487|NCT01721057|583888887|FG003|Rescue Period|Adverse Event|1|||
161682488|NCT01721057|583888888|FG004|Rescue Period|Adverse Event|0|||
161682489|NCT01721057|583888889|FG005|Rescue Period|Adverse Event|0|||
161682490|NCT01721057|583888890|FG006|Rescue Period|Adverse Event|0|||
161942007|NCT04875533|584836243|FG001|Overall Study|Withdrawal by Subject|5|||
161682491|NCT01721057|583888884|FG000|Rescue Period|Lack of Efficacy|0|||
161942008|NCT04875533|584836242|FG000|Overall Study|No longer meets eligibility criteria|1|||
161942009|NCT04875533|584836243|FG001|Overall Study|No longer meets eligibility criteria|0|||
161942010|NCT04875533|584836242|FG000|Overall Study|Other|0|||
161942011|NCT04875533|584836243|FG001|Overall Study|Other|2|||
161942012|NCT00539500|584836244|FG000|Overall Study|Disease Progression|1|||
161942013|NCT00539500|584836244|FG000|Overall Study|Lost to Follow-up|2|||
161682492|NCT01721057|583888885|FG001|Rescue Period|Lack of Efficacy|0|||
161682493|NCT01721057|583888886|FG002|Rescue Period|Lack of Efficacy|0|||
161682494|NCT01721057|583888887|FG003|Rescue Period|Lack of Efficacy|2|||
161682495|NCT01721057|583888888|FG004|Rescue Period|Lack of Efficacy|0|||
161682496|NCT01721057|583888889|FG005|Rescue Period|Lack of Efficacy|0|||
161682497|NCT01721057|583888890|FG006|Rescue Period|Lack of Efficacy|0|||
161682498|NCT02047253|583888891|FG000|Overall Study|Lost to Follow-up|8|||
161682499|NCT01987960|583888893|FG000|Period 1|Adverse Event|24|||
161942014|NCT02011542|584836246|FG000|Overall Study|Physician Decision|1|||
161942015|NCT01299961|584836247|FG000|Overall Study|Adverse Event|3|||
161942016|NCT01299961|584836247|FG000|Overall Study|Lack of Efficacy|2|||
161942017|NCT01299961|584836247|FG000|Overall Study|Lost to Follow-up|1|||
161942018|NCT02904096|584836248|FG000|Overall Study|Adverse Event|1|||
161942019|NCT02904096|584836249|FG001|Overall Study|Adverse Event|0|||
162025722|NCT01185353|585150780|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
162025723|NCT01185353|585150781|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
161682500|NCT01987960|583888894|FG001|Period 1|Adverse Event|0|||
161682501|NCT01987960|583888895|FG002|Period 1|Adverse Event|0|||
161942020|NCT02904096|584836248|FG000|Overall Study|Withdrawal by Subject|4|||
161942021|NCT02904096|584836249|FG001|Overall Study|Withdrawal by Subject|3|||
161942022|NCT02904096|584836248|FG000|Overall Study|Lost to Follow-up|10|||
161831373|NCT02723773|584424722|FG000|Overall Study|Withdrawal by Subject|360|||
161831374|NCT02723773|584424723|FG001|Overall Study|Withdrawal by Subject|5|||
161831375|NCT02723773|584424724|FG002|Overall Study|Withdrawal by Subject|6|||
161831376|NCT02723773|584424725|FG003|Overall Study|Withdrawal by Subject|10|||
161831377|NCT02723773|584424722|FG000|Overall Study|Migrated/moved from study area|37|||
161831378|NCT02723773|584424723|FG001|Overall Study|Migrated/moved from study area|0|||
161831379|NCT02723773|584424724|FG002|Overall Study|Migrated/moved from study area|0|||
161831380|NCT02723773|584424725|FG003|Overall Study|Migrated/moved from study area|1|||
161831381|NCT02723773|584424722|FG000|Overall Study|Lost to Follow-up|198|||
161831382|NCT02723773|584424723|FG001|Overall Study|Lost to Follow-up|0|||
161831383|NCT02723773|584424724|FG002|Overall Study|Lost to Follow-up|0|||
161831384|NCT02723773|584424725|FG003|Overall Study|Lost to Follow-up|0|||
161831385|NCT02723773|584424722|FG000|Overall Study|Other|189|||
161831386|NCT02723773|584424723|FG001|Overall Study|Other|1|||
161831387|NCT02723773|584424724|FG002|Overall Study|Other|2|||
161831388|NCT02723773|584424725|FG003|Overall Study|Other|2|||
161831389|NCT05168774|584424726|FG000|Overall Study|Lack of Efficacy|1|||
161831390|NCT05168774|584424727|FG001|Overall Study|Lack of Efficacy|2|||
161831391|NCT05168774|584424726|FG000|Overall Study|Withdrawal by Subject|1|||
161831392|NCT05168774|584424727|FG001|Overall Study|Withdrawal by Subject|2|||
161831393|NCT05168774|584424726|FG000|Overall Study|Adverse Event|2|||
161831394|NCT05168774|584424727|FG001|Overall Study|Adverse Event|0|||
161831395|NCT03064438|584424729|FG000|Overall Study|Lost to Follow-up|1|||
161831396|NCT03064438|584424730|FG001|Overall Study|Lost to Follow-up|0|||
161831397|NCT03064438|584424729|FG000|Overall Study|Withdrawal by Subject|0|||
161831398|NCT03064438|584424730|FG001|Overall Study|Withdrawal by Subject|1|||
161831399|NCT02124902|584424731|FG000|Overall Study|Adverse Event|7|||
161831400|NCT02124902|584424732|FG001|Overall Study|Adverse Event|2|||
161831401|NCT02124902|584424731|FG000|Overall Study|Went to alternative treatment|4|||
161831402|NCT02124902|584424732|FG001|Overall Study|Went to alternative treatment|0|||
161831403|NCT02124902|584424731|FG000|Overall Study|Withdrawal by Subject|2|||
161831404|NCT02124902|584424732|FG001|Overall Study|Withdrawal by Subject|1|||
161831405|NCT02124902|584424731|FG000|Overall Study|Physician Decision|2|||
161831406|NCT02124902|584424732|FG001|Overall Study|Physician Decision|0|||
161831407|NCT02124902|584424731|FG000|Overall Study|Not eligible|1|||
161831408|NCT02124902|584424732|FG001|Overall Study|Not eligible|0|||
161831409|NCT02124902|584424731|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
161831410|NCT02124902|584424732|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
161831411|NCT01937351|584424733|FG000|Overall Study|Withdrawal by Subject|4|||
161831412|NCT01937351|584424734|FG001|Overall Study|Withdrawal by Subject|2|||
162025724|NCT01185353|585150782|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
162025725|NCT01185353|585150783|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
162025726|NCT01185353|585150784|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
162236140|NCT01370590|585915010|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
161831413|NCT01937351|584424733|FG000|Overall Study|Death|1|||
161831414|NCT01937351|584424734|FG001|Overall Study|Death|0|||
161831415|NCT01937351|584424733|FG000|Overall Study|Not treated w device, per protocol fail|4|||
161831416|NCT01937351|584424734|FG001|Overall Study|Not treated w device, per protocol fail|0|||
161831417|NCT01314118|584424735|FG000|Overall Study|Adverse Event|10|||
161831418|NCT01314118|584424735|FG000|Overall Study|Progressive disease|3|||
162236141|NCT01370590|585915009|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
162236142|NCT01370590|585915010|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
162236143|NCT01370590|585915009|FG000|Period 2|Adverse Event|0|||
162236144|NCT01370590|585915010|FG001|Period 2|Adverse Event|1|||
162236145|NCT01370590|585915009|FG000|Period 2|Withdrawal by Subject|1|||
162236146|NCT01370590|585915010|FG001|Period 2|Withdrawal by Subject|1|||
162236147|NCT03110224|585915011|FG000|Overall Study|Death|3|||
162236148|NCT03110224|585915011|FG000|Overall Study|Lost to Follow-up|132|||
162236149|NCT03110224|585915011|FG000|Overall Study|Physician Decision|2|||
162236150|NCT03110224|585915011|FG000|Overall Study|Site Closed by Physician|35|||
162236151|NCT03110224|585915011|FG000|Overall Study|Site Closed by Sponsor|202|||
162236152|NCT03110224|585915011|FG000|Overall Study|Withdrawal by Subject|9|||
162236153|NCT05195489|585916897|FG000|Overall Study|Lost to Follow-up|1|||
162236154|NCT05195489|585916898|FG001|Overall Study|Lost to Follow-up|0|||
162236155|NCT05195489|585916897|FG000|Overall Study|Protocol Violation|0|||
162236156|NCT05195489|585916898|FG001|Overall Study|Protocol Violation|2|||
162236157|NCT05195489|585916897|FG000|Overall Study|Withdrawal by Subject|1|||
162236158|NCT05195489|585916898|FG001|Overall Study|Withdrawal by Subject|1|||
162236159|NCT05195489|585916897|FG000|Overall Study|Removed|0|||
162236160|NCT05195489|585916898|FG001|Overall Study|Removed|1|||
162236161|NCT00409773|585916900|FG000|Overall Study|Adverse Event|3|||
162236162|NCT00409773|585916901|FG001|Overall Study|Adverse Event|4|||
162236163|NCT00409773|585916902|FG002|Overall Study|Adverse Event|4|||
162236164|NCT00409773|585916903|FG003|Overall Study|Adverse Event|2|||
162236165|NCT00409773|585916904|FG004|Overall Study|Adverse Event|6|||
162236166|NCT00409773|585916900|FG000|Overall Study|Lost to Follow-up|6|||
161831419|NCT01314118|584424735|FG000|Overall Study|Death|8|||
161831420|NCT01314118|584424735|FG000|Overall Study|Physician Decision|13|||
161682502|NCT01987960|583888896|FG003|Period 1|Adverse Event|0|||
161682503|NCT01987960|583888893|FG000|Period 1|Lack of Efficacy|4|||
161942023|NCT02904096|584836249|FG001|Overall Study|Lost to Follow-up|17|||
161942024|NCT02904096|584836248|FG000|Overall Study|Non-compliant|3|||
161942025|NCT02904096|584836249|FG001|Overall Study|Non-compliant|1|||
161942026|NCT02904096|584836248|FG000|Overall Study|Sponsor instructed|1|||
161942027|NCT02904096|584836249|FG001|Overall Study|Sponsor instructed|0|||
161942028|NCT00980798|584836250|FG000|Overall Study|Adverse Event|7|||
161942029|NCT00980798|584836251|FG001|Overall Study|Adverse Event|36|||
161942030|NCT00980798|584836250|FG000|Overall Study|Lack of Efficacy|16|||
161942031|NCT00980798|584836251|FG001|Overall Study|Lack of Efficacy|5|||
161942032|NCT00980798|584836250|FG000|Overall Study|Lost to Follow-up|0|||
161942033|NCT00980798|584836251|FG001|Overall Study|Lost to Follow-up|1|||
161942034|NCT00980798|584836250|FG000|Overall Study|Physician Decision|2|||
161942035|NCT00980798|584836251|FG001|Overall Study|Physician Decision|1|||
161942036|NCT00980798|584836250|FG000|Overall Study|Withdrawal by Subject|8|||
161942037|NCT00980798|584836251|FG001|Overall Study|Withdrawal by Subject|11|||
161942038|NCT00980798|584836250|FG000|Overall Study|Other|0|||
161942039|NCT00980798|584836251|FG001|Overall Study|Other|1|||
161942040|NCT00526799|584836252|FG000|Overall Study|Withdrawal by Subject|1|||
161942041|NCT00526799|584836253|FG001|Overall Study|Withdrawal by Subject|0|||
161942042|NCT00526799|584836252|FG000|Overall Study|Intercurrent Complicating Disease|0|||
161942043|NCT00526799|584836253|FG001|Overall Study|Intercurrent Complicating Disease|1|||
161942044|NCT03633058|584836254|FG000|Overall Study|Adverse Event|0|||
161942045|NCT03633058|584836255|FG001|Overall Study|Adverse Event|0|||
161942046|NCT03633058|584836256|FG002|Overall Study|Adverse Event|1|||
161942047|NCT03633058|584836257|FG003|Overall Study|Adverse Event|0|||
161942048|NCT03909971|584836258|FG000|Overall Study|Participant transition to rollover study|26|||
161942049|NCT03909971|584836259|FG001|Overall Study|Participant transition to rollover study|9|||
161942050|NCT03909971|584836258|FG000|Overall Study|Global Deterioration of Health Status|2|||
161942051|NCT03909971|584836259|FG001|Overall Study|Global Deterioration of Health Status|2|||
161942052|NCT03909971|584836258|FG000|Overall Study|Progressive Disease|28|||
161942053|NCT03909971|584836259|FG001|Overall Study|Progressive Disease|21|||
161942054|NCT03909971|584836258|FG000|Overall Study|Death|6|||
161942055|NCT03909971|584836259|FG001|Overall Study|Death|6|||
161942056|NCT03909971|584836258|FG000|Overall Study|Adverse Event|1|||
161942057|NCT03909971|584836259|FG001|Overall Study|Adverse Event|2|||
161942058|NCT03909971|584836258|FG000|Overall Study|Withdrawal by Subject|2|||
161942059|NCT03909971|584836259|FG001|Overall Study|Withdrawal by Subject|1|||
161942060|NCT03909971|584836258|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
161942061|NCT03909971|584836259|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
161942062|NCT03909971|584836258|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
161942063|NCT03909971|584836259|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
161942064|NCT04727151|584836263|FG000|Overall Study|Death|0|||
161942065|NCT04727151|584836264|FG001|Overall Study|Death|0|||
161942066|NCT04727151|584836265|FG002|Overall Study|Death|0|||
161942067|NCT04727151|584836266|FG003|Overall Study|Death|0|||
161942068|NCT04727151|584836267|FG004|Overall Study|Death|3|||
161942069|NCT04727151|584836263|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
161942070|NCT04727151|584836264|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
161942071|NCT04727151|584836265|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
161942072|NCT04727151|584836266|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
161942073|NCT04727151|584836267|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
161942074|NCT01587196|584836268|FG000|Overall Study|Lost to Follow-up|50|||
161942075|NCT01587196|584836268|FG000|Overall Study|Withdrawal by Subject|4|||
161942076|NCT00642759|584836271|FG000|Overall Study|Protocol Violation|1|||
161942077|NCT03537508|584836276|FG000|Overall Study|Adverse Event|2|||
161942078|NCT03537508|584836277|FG001|Overall Study|Adverse Event|1|||
161682504|NCT01987960|583888894|FG001|Period 1|Lack of Efficacy|0|||
161831421|NCT01314118|584424735|FG000|Overall Study|Sponsor Decision|1|||
161682505|NCT01987960|583888895|FG002|Period 1|Lack of Efficacy|0|||
161942079|NCT03537508|584836276|FG000|Overall Study|Protocol Violation|65|||
161942080|NCT03537508|584836277|FG001|Overall Study|Protocol Violation|48|||
161942081|NCT03537508|584836276|FG000|Overall Study|Lost to Follow-up|86|||
161942082|NCT03537508|584836277|FG001|Overall Study|Lost to Follow-up|60|||
161942083|NCT03537508|584836276|FG000|Overall Study|Withdrawal by parent/guardian|263|||
161942084|NCT03537508|584836277|FG001|Overall Study|Withdrawal by parent/guardian|149|||
161942085|NCT03814044|584836281|FG000|Overall Study|Protocol deviation|1|||
161942086|NCT04734210|584838289|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
161942087|NCT04734210|584838290|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
161942088|NCT04734210|584838291|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
161942089|NCT04734210|584838289|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
161942090|NCT04734210|584838290|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
161942091|NCT04734210|584838291|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
161942092|NCT04734210|584838289|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
161942093|NCT04734210|584838290|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
161942094|NCT04734210|584838291|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
161942095|NCT04734210|584838289|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
161942096|NCT04734210|584838290|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
161942097|NCT04734210|584838291|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
161942098|NCT00573768|584838292|FG000|Overall Study|Adverse Event|1|||
161942099|NCT00573768|584838293|FG001|Overall Study|Adverse Event|1|||
161942100|NCT00573768|584838294|FG002|Overall Study|Adverse Event|2|||
161942101|NCT00573768|584838292|FG000|Overall Study|Protocol Violation|1|||
161942102|NCT00573768|584838293|FG001|Overall Study|Protocol Violation|0|||
161942103|NCT00573768|584838294|FG002|Overall Study|Protocol Violation|1|||
161942104|NCT00573768|584838292|FG000|Overall Study|Withdrawal by Subject|0|||
161942105|NCT00573768|584838293|FG001|Overall Study|Withdrawal by Subject|1|||
161942106|NCT00573768|584838294|FG002|Overall Study|Withdrawal by Subject|0|||
161942107|NCT00573768|584838292|FG000|Overall Study|Lost to Follow-up|0|||
161942108|NCT00573768|584838293|FG001|Overall Study|Lost to Follow-up|0|||
161942109|NCT00573768|584838294|FG002|Overall Study|Lost to Follow-up|1|||
161942110|NCT00976456|584838297|FG000|Overall Study|Adverse Event|17|||
161682506|NCT01987960|583888896|FG003|Period 1|Lack of Efficacy|0|||
161942111|NCT00976456|584838298|FG001|Overall Study|Adverse Event|22|||
161682507|NCT01987960|583888893|FG000|Period 1|Non-compliance with IMP|6|||
161682508|NCT01987960|583888894|FG001|Period 1|Non-compliance with IMP|0|||
161942112|NCT00976456|584838297|FG000|Overall Study|Death|7|||
161942113|NCT00976456|584838298|FG001|Overall Study|Death|9|||
161942114|NCT00976456|584838297|FG000|Overall Study|Lack of Efficacy|5|||
161942115|NCT00976456|584838298|FG001|Overall Study|Lack of Efficacy|2|||
161942116|NCT00976456|584838297|FG000|Overall Study|Withdrawal by Subject|3|||
161942117|NCT00976456|584838298|FG001|Overall Study|Withdrawal by Subject|1|||
161942118|NCT00976456|584838297|FG000|Overall Study|screening failure, unknown|11|||
161942119|NCT00976456|584838298|FG001|Overall Study|screening failure, unknown|4|||
161942120|NCT03331354|584838301|FG000|Overall Study|Withdrawal by Subject|1|||
161942121|NCT03331354|584838302|FG001|Overall Study|Withdrawal by Subject|3|||
161942122|NCT03331354|584838301|FG000|Overall Study|Lost to Follow-up|3|||
161942123|NCT03331354|584838302|FG001|Overall Study|Lost to Follow-up|3|||
161942124|NCT03331354|584838301|FG000|Overall Study|Found employment before initiated active intervention|0|||
162236167|NCT00409773|585916901|FG001|Overall Study|Lost to Follow-up|1|||
162236168|NCT00409773|585916902|FG002|Overall Study|Lost to Follow-up|2|||
162236169|NCT00409773|585916903|FG003|Overall Study|Lost to Follow-up|3|||
162236170|NCT00409773|585916904|FG004|Overall Study|Lost to Follow-up|1|||
162236171|NCT00409773|585916900|FG000|Overall Study|Physician Decision|0|||
162236172|NCT00409773|585916901|FG001|Overall Study|Physician Decision|0|||
162236173|NCT00409773|585916902|FG002|Overall Study|Physician Decision|0|||
162236174|NCT00409773|585916903|FG003|Overall Study|Physician Decision|2|||
162236175|NCT00409773|585916904|FG004|Overall Study|Physician Decision|0|||
162236176|NCT00409773|585916900|FG000|Overall Study|Protocol Violation|0|||
162236177|NCT00409773|585916901|FG001|Overall Study|Protocol Violation|2|||
162236178|NCT00409773|585916902|FG002|Overall Study|Protocol Violation|3|||
162236179|NCT00409773|585916903|FG003|Overall Study|Protocol Violation|3|||
162236180|NCT00409773|585916904|FG004|Overall Study|Protocol Violation|1|||
162236181|NCT00409773|585916900|FG000|Overall Study|Withdrawal by Subject|0|||
162236182|NCT00409773|585916901|FG001|Overall Study|Withdrawal by Subject|0|||
162236183|NCT00409773|585916902|FG002|Overall Study|Withdrawal by Subject|0|||
162236184|NCT00409773|585916903|FG003|Overall Study|Withdrawal by Subject|2|||
162236185|NCT00409773|585916904|FG004|Overall Study|Withdrawal by Subject|1|||
162236186|NCT00409773|585916900|FG000|Overall Study|Lack of Eligibility|0|||
162236187|NCT00409773|585916901|FG001|Overall Study|Lack of Eligibility|0|||
162236188|NCT00409773|585916902|FG002|Overall Study|Lack of Eligibility|0|||
162236189|NCT00409773|585916903|FG003|Overall Study|Lack of Eligibility|0|||
162236190|NCT00409773|585916904|FG004|Overall Study|Lack of Eligibility|1|||
162236191|NCT01201343|585916905|FG000|Overall Study|Adverse Event|6|||
162236192|NCT01201343|585916905|FG000|Overall Study|Withdrawal by Subject|5|||
162236193|NCT01201343|585916905|FG000|Overall Study|Lost to Follow-up|2|||
162236194|NCT01201343|585916905|FG000|Overall Study|Lack of Efficacy|2|||
162236195|NCT01201343|585916905|FG000|Overall Study|Participant wrongly included in trial|1|||
162236196|NCT01201343|585916905|FG000|Overall Study|Randomized, not treated|3|||
162236197|NCT01440374|585916906|FG000|Part 1: Open-label Phase|Adverse Event|5|||
162236198|NCT01440374|585916907|FG001|Part 1: Open-label Phase|Adverse Event|0|||
162236199|NCT01440374|585916908|FG002|Part 1: Open-label Phase|Adverse Event|0|||
162236200|NCT01440374|585916909|FG003|Part 1: Open-label Phase|Adverse Event|0|||
162236201|NCT01440374|585916906|FG000|Part 1: Open-label Phase|Physician Decision|1|||
162236202|NCT01440374|585916907|FG001|Part 1: Open-label Phase|Physician Decision|0|||
162236203|NCT01440374|585916908|FG002|Part 1: Open-label Phase|Physician Decision|0|||
162236204|NCT01440374|585916909|FG003|Part 1: Open-label Phase|Physician Decision|0|||
162236205|NCT01440374|585916906|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
162236206|NCT01440374|585916907|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
162236207|NCT01440374|585916908|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
162236208|NCT01440374|585916909|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
162236209|NCT01440374|585916906|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
162236210|NCT01440374|585916907|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
162236211|NCT01440374|585916908|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
162236212|NCT01440374|585916909|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
162236213|NCT01440374|585916906|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
162236214|NCT01440374|585916907|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
162236215|NCT01440374|585916908|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
162236216|NCT01440374|585916909|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
162236217|NCT01440374|585916906|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
162236218|NCT01440374|585916907|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
162236219|NCT01440374|585916908|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
162236220|NCT01440374|585916909|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
162236221|NCT01440374|585916906|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
162236222|NCT01440374|585916907|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
161942125|NCT03331354|584838302|FG001|Overall Study|Found employment before initiated active intervention|4|||
161942126|NCT05889468|584838303|FG000|Overall Study|Lost to Follow-up|9|||
161942127|NCT05889468|584838304|FG001|Overall Study|Lost to Follow-up|2|||
161942128|NCT05889468|584838303|FG000|Overall Study|Withdrawal by Subject|2|||
161942129|NCT05889468|584838304|FG001|Overall Study|Withdrawal by Subject|2|||
161942130|NCT01767987|584838307|FG000|Overall Study|Physician Decision|4|||
161942131|NCT01767987|584838308|FG001|Overall Study|Physician Decision|1|||
161942132|NCT01153516|584838309|FG000|Overall Study|Both subjects refused surgery|2|||
161942133|NCT01153516|584838310|FG001|Overall Study|Both subjects refused surgery|0|||
161942134|NCT01605097|584838319|FG000|Overall Study|Protocol Violation|1|||
161682509|NCT01987960|583888895|FG002|Period 1|Non-compliance with IMP|0|||
161942135|NCT02284893|584838327|FG000|26 Week (Short Term)|Adverse Event|1|||
161942136|NCT02284893|584838328|FG001|26 Week (Short Term)|Adverse Event|9|||
161942137|NCT02284893|584838327|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
161942138|NCT02284893|584838328|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
161682510|NCT01987960|583888896|FG003|Period 1|Non-compliance with IMP|0|||
161942139|NCT02284893|584838327|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
161942140|NCT02284893|584838328|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
161942141|NCT02284893|584838327|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
161942142|NCT02284893|584838328|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
161942143|NCT02284893|584838327|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
161942144|NCT02284893|584838328|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
161942145|NCT02284893|584838327|FG000|26 Week (Short Term)|Other|1|||
161942146|NCT02284893|584838328|FG001|26 Week (Short Term)|Other|1|||
161942147|NCT02284893|584838327|FG000|52 Week (Long Term)|Adverse Event|3|||
161942148|NCT02284893|584838328|FG001|52 Week (Long Term)|Adverse Event|1|||
161942149|NCT02284893|584838327|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
161942150|NCT02284893|584838328|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
161942151|NCT02284893|584838327|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
161942152|NCT02284893|584838328|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
161942153|NCT02284893|584838327|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
161942154|NCT02284893|584838328|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
161942155|NCT02284893|584838327|FG000|52 Week (Long Term)|Non-Compliance|2|||
161942156|NCT02284893|584838328|FG001|52 Week (Long Term)|Non-Compliance|3|||
161942157|NCT03038620|584838331|FG000|Overall Study|Lost to Follow-up|18|||
161942158|NCT03038620|584838332|FG001|Overall Study|Lost to Follow-up|23|||
162025727|NCT01185353|585150785|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
162025728|NCT01185353|585150786|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
162025729|NCT01185353|585150787|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
162025730|NCT01185353|585150788|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
162025731|NCT01185353|585150779|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
162025732|NCT01185353|585150780|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
162025733|NCT01185353|585150781|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
162025734|NCT01185353|585150782|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
162025735|NCT01185353|585150783|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
162025736|NCT01185353|585150784|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
162025737|NCT01185353|585150785|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
162025738|NCT01185353|585150786|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
162025739|NCT01185353|585150787|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
162025740|NCT01185353|585150788|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
162025741|NCT01185353|585150779|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
162025742|NCT01185353|585150780|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
162025743|NCT01185353|585150781|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
162025744|NCT01185353|585150782|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
162025745|NCT01185353|585150783|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
162025746|NCT01185353|585150784|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
162025747|NCT01185353|585150785|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
162025748|NCT01185353|585150786|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
162025749|NCT01185353|585150787|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
162025750|NCT01185353|585150788|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
162025751|NCT01185353|585150779|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
162025752|NCT01185353|585150780|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
162025753|NCT01185353|585150781|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
162025754|NCT01185353|585150782|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
162025755|NCT01185353|585150783|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
162025756|NCT01185353|585150784|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
162025757|NCT01185353|585150785|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
162025758|NCT01185353|585150786|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
162025759|NCT01185353|585150787|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
162025760|NCT01185353|585150788|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
162025761|NCT01185353|585150779|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
162025762|NCT01185353|585150780|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
162025763|NCT01185353|585150781|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
162025764|NCT01185353|585150782|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
162025765|NCT01185353|585150783|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
162025766|NCT01185353|585150784|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
162025767|NCT01185353|585150785|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
162025768|NCT01185353|585150786|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
162025769|NCT01185353|585150787|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
162025770|NCT01185353|585150788|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
162025771|NCT01185353|585150779|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
162025772|NCT01185353|585150780|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
162025773|NCT01185353|585150781|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
162025774|NCT01185353|585150782|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
162025775|NCT01185353|585150783|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
162025776|NCT01185353|585150784|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
162025777|NCT01185353|585150785|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
162025778|NCT01185353|585150786|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
162025779|NCT01185353|585150787|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
162025780|NCT01185353|585150788|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
162025781|NCT00557856|585150789|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
162025782|NCT00557856|585150790|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
162025783|NCT00557856|585150791|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
162025784|NCT00557856|585150792|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
162025785|NCT00557856|585150793|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
162025786|NCT00557856|585150794|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
162025787|NCT00557856|585150795|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
162025788|NCT00557856|585150796|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
162025789|NCT00557856|585150797|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
162025790|NCT00557856|585150789|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
162025791|NCT00557856|585150790|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
162025792|NCT00557856|585150791|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
161831422|NCT01314118|584424735|FG000|Overall Study|Protocol Violation|2|||
161831423|NCT01314118|584424735|FG000|Overall Study|Withdrawal by Subject|26|||
161831424|NCT01314118|584424735|FG000|Overall Study|Other|21|||
162236223|NCT01440374|585916908|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
162236224|NCT01440374|585916909|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
162236225|NCT01440374|585916906|FG000|Part 2; Double-blind Phase|Not treated|0|||
162236226|NCT01440374|585916907|FG001|Part 2; Double-blind Phase|Not treated|0|||
162236227|NCT01440374|585916908|FG002|Part 2; Double-blind Phase|Not treated|1|||
162236228|NCT01440374|585916909|FG003|Part 2; Double-blind Phase|Not treated|0|||
162236229|NCT01440374|585916906|FG000|Part 3: Extension|Withdrawal by Subject|0|||
162236230|NCT01440374|585916907|FG001|Part 3: Extension|Withdrawal by Subject|0|||
162236231|NCT01440374|585916908|FG002|Part 3: Extension|Withdrawal by Subject|0|||
162236232|NCT01440374|585916909|FG003|Part 3: Extension|Withdrawal by Subject|5|||
162236233|NCT01440374|585916906|FG000|Part 3: Extension|Adverse Event|0|||
162236234|NCT01440374|585916907|FG001|Part 3: Extension|Adverse Event|0|||
162236235|NCT01440374|585916908|FG002|Part 3: Extension|Adverse Event|0|||
162236236|NCT01440374|585916909|FG003|Part 3: Extension|Adverse Event|13|||
162236237|NCT01440374|585916906|FG000|Part 3: Extension|Physician Decision|0|||
162236238|NCT01440374|585916907|FG001|Part 3: Extension|Physician Decision|0|||
162236239|NCT01440374|585916908|FG002|Part 3: Extension|Physician Decision|0|||
162236240|NCT01440374|585916909|FG003|Part 3: Extension|Physician Decision|14|||
162236241|NCT04812548|585916911|FG000|Overall Study|Adverse Event|2|||
162236242|NCT04812548|585916912|FG001|Overall Study|Adverse Event|7|||
162236243|NCT04812548|585916911|FG000|Overall Study|HSCT Planned|2|||
162236244|NCT04812548|585916912|FG001|Overall Study|HSCT Planned|3|||
162236245|NCT04812548|585916911|FG000|Overall Study|Progressive Disease|0|||
162236246|NCT04812548|585916912|FG001|Overall Study|Progressive Disease|2|||
162236247|NCT04812548|585916911|FG000|Overall Study|Death|0|||
162236248|NCT04812548|585916912|FG001|Overall Study|Death|1|||
162236249|NCT04812548|585916911|FG000|Overall Study|Post Study Access to Treatment|0|||
162236250|NCT04812548|585916912|FG001|Overall Study|Post Study Access to Treatment|1|||
162236251|NCT04812548|585916911|FG000|Overall Study|Withdrawal by Subject|0|||
162236252|NCT04812548|585916912|FG001|Overall Study|Withdrawal by Subject|1|||
162236253|NCT04812548|585916911|FG000|Overall Study|Physician Decision|1|||
162236254|NCT04812548|585916912|FG001|Overall Study|Physician Decision|0|||
162236255|NCT02141984|585916913|FG000|Overall Study|Lack of Efficacy|2|||
162236256|NCT03057977|585916914|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
162236257|NCT03057977|585916915|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
162236258|NCT03057977|585916914|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
162236259|NCT03057977|585916915|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
162236260|NCT03057977|585916914|FG000|Discontinuation From Treatment|Protocol Violation|6|||
162236261|NCT03057977|585916915|FG001|Discontinuation From Treatment|Protocol Violation|5|||
161682511|NCT01987960|583888893|FG000|Period 1|Protocol Violation|12|||
161682512|NCT01987960|583888894|FG001|Period 1|Protocol Violation|0|||
161682513|NCT01987960|583888895|FG002|Period 1|Protocol Violation|0|||
161682514|NCT01987960|583888896|FG003|Period 1|Protocol Violation|0|||
161682515|NCT01987960|583888893|FG000|Period 1|Withdrawal by Subject|21|||
161682516|NCT01987960|583888894|FG001|Period 1|Withdrawal by Subject|0|||
161682517|NCT01987960|583888895|FG002|Period 1|Withdrawal by Subject|0|||
161682518|NCT01987960|583888896|FG003|Period 1|Withdrawal by Subject|0|||
161682519|NCT01987960|583888893|FG000|Period 1|Lost to Follow-up|40|||
161682520|NCT01987960|583888894|FG001|Period 1|Lost to Follow-up|0|||
161682521|NCT01987960|583888895|FG002|Period 1|Lost to Follow-up|0|||
161682522|NCT01987960|583888896|FG003|Period 1|Lost to Follow-up|0|||
161682523|NCT01987960|583888893|FG000|Period 1|administrative or other reason|75|||
161682524|NCT01987960|583888894|FG001|Period 1|administrative or other reason|0|||
161682525|NCT01987960|583888895|FG002|Period 1|administrative or other reason|0|||
161682526|NCT01987960|583888896|FG003|Period 1|administrative or other reason|0|||
161682527|NCT01987960|583888893|FG000|Period 1|Withdrawal of consent before treatment|4|||
161682528|NCT01987960|583888894|FG001|Period 1|Withdrawal of consent before treatment|0|||
161682529|NCT01987960|583888895|FG002|Period 1|Withdrawal of consent before treatment|0|||
161682530|NCT01987960|583888896|FG003|Period 1|Withdrawal of consent before treatment|0|||
161682531|NCT01987960|583888893|FG000|Period 2|Adverse Event|0|||
161682532|NCT01987960|583888894|FG001|Period 2|Adverse Event|0|||
161682533|NCT01987960|583888895|FG002|Period 2|Adverse Event|1|||
161682534|NCT01987960|583888896|FG003|Period 2|Adverse Event|0|||
162025793|NCT00557856|585150792|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
162025794|NCT00557856|585150793|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
162025795|NCT00557856|585150794|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
162025796|NCT00557856|585150795|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
162025797|NCT00557856|585150796|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
162025798|NCT00557856|585150797|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
162025799|NCT00557856|585150789|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
162025800|NCT00557856|585150790|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
162025801|NCT00557856|585150791|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
162025802|NCT00557856|585150792|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
162025803|NCT00557856|585150793|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
162025804|NCT00557856|585150794|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
162025805|NCT00557856|585150795|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
162025806|NCT00557856|585150796|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
162025807|NCT00557856|585150797|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
162025808|NCT00557856|585150789|FG000|Part 1: Dose Escalation Phase|Other|0|||
162025809|NCT00557856|585150790|FG001|Part 1: Dose Escalation Phase|Other|0|||
162025810|NCT00557856|585150791|FG002|Part 1: Dose Escalation Phase|Other|1|||
162025811|NCT00557856|585150792|FG003|Part 1: Dose Escalation Phase|Other|1|||
162025812|NCT00557856|585150793|FG004|Part 1: Dose Escalation Phase|Other|0|||
162025813|NCT00557856|585150794|FG005|Part 1: Dose Escalation Phase|Other|0|||
162025814|NCT00557856|585150795|FG006|Part 1: Dose Escalation Phase|Other|0|||
162025815|NCT00557856|585150796|FG007|Part 1: Dose Escalation Phase|Other|1|||
162025816|NCT00557856|585150797|FG008|Part 1: Dose Escalation Phase|Other|0|||
161831425|NCT04079712|584424736|FG000|Overall Study|Disease progression before starting treatment|1|||
162025817|NCT00557856|585150789|FG000|Part 1: Dose Escalation Phase|Death|0|||
162025818|NCT00557856|585150790|FG001|Part 1: Dose Escalation Phase|Death|0|||
162025819|NCT00557856|585150791|FG002|Part 1: Dose Escalation Phase|Death|0|||
162025820|NCT00557856|585150792|FG003|Part 1: Dose Escalation Phase|Death|0|||
162025821|NCT00557856|585150793|FG004|Part 1: Dose Escalation Phase|Death|0|||
162025822|NCT00557856|585150794|FG005|Part 1: Dose Escalation Phase|Death|1|||
161831426|NCT01467479|584424742|FG000|Overall Study|No Study Medication|1|||
161831427|NCT01467479|584424743|FG001|Overall Study|No Study Medication|0|||
162236262|NCT03057977|585916914|FG000|Discontinuation From Treatment|Not treated|4|||
162236263|NCT03057977|585916915|FG001|Discontinuation From Treatment|Not treated|0|||
162236264|NCT03057977|585916914|FG000|Discontinuation From Treatment|Adverse Event|343|||
162236265|NCT03057977|585916915|FG001|Discontinuation From Treatment|Adverse Event|337|||
162236266|NCT03057977|585916914|FG000|Discontinuation From Treatment|Reason Unknown|0|||
162236267|NCT03057977|585916915|FG001|Discontinuation From Treatment|Reason Unknown|1|||
162236268|NCT03057977|585916914|FG000|Discontinuation From Treatment|Personal Reasons|1|||
162236269|NCT03057977|585916915|FG001|Discontinuation From Treatment|Personal Reasons|1|||
162236270|NCT03057977|585916914|FG000|Discontinuation From Treatment|Unblinded medication|1|||
162236271|NCT03057977|585916915|FG001|Discontinuation From Treatment|Unblinded medication|0|||
162236272|NCT03057977|585916914|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
162236273|NCT03057977|585916915|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
162236274|NCT03057977|585916914|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
162236275|NCT03057977|585916915|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
162236276|NCT03057977|585916914|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
162236277|NCT03057977|585916915|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
162236278|NCT03057977|585916914|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
162236279|NCT03057977|585916915|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
162236280|NCT03057977|585916914|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
162236281|NCT03057977|585916915|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
162236282|NCT03057977|585916914|FG000|Discontinuation From Treatment|Not attending study visit|3|||
162236283|NCT03057977|585916915|FG001|Discontinuation From Treatment|Not attending study visit|10|||
162236284|NCT03057977|585916914|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
162236285|NCT03057977|585916915|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
162236286|NCT03057977|585916914|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
162236287|NCT03057977|585916915|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
162236288|NCT03057977|585916914|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
162236289|NCT03057977|585916915|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
162236290|NCT03057977|585916914|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
162236291|NCT03057977|585916915|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
162236292|NCT03057977|585916914|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
162236293|NCT03057977|585916915|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
162236294|NCT01350336|585916916|FG000|Overall Study|Lost to Follow-up|31|||
162236295|NCT01350336|585916916|FG000|Overall Study|Withdrawal by Subject|14|||
162236296|NCT01350336|585916916|FG000|Overall Study|Physician Decision|8|||
162236297|NCT01350336|585916916|FG000|Overall Study|Death|4|||
162236298|NCT02079610|585916917|FG000|Overall Study|Withdrawal by Subject|1|||
162236299|NCT02079610|585916918|FG001|Overall Study|Withdrawal by Subject|1|||
162236300|NCT01716117|585916919|FG000|Overall Study|Death|5|||
162236301|NCT01716117|585916920|FG001|Overall Study|Death|2|||
162236302|NCT01716117|585916919|FG000|Overall Study|Withdrawal by Subject|2|||
162236303|NCT01716117|585916920|FG001|Overall Study|Withdrawal by Subject|0|||
162236304|NCT03645057|585916922|FG000|Randomization to Baseline|Lost to Follow-up|1|||
162236305|NCT03645057|585916923|FG001|Randomization to Baseline|Lost to Follow-up|0|||
162236306|NCT03645057|585916924|FG002|Randomization to Baseline|Lost to Follow-up|1|||
162236307|NCT03645057|585916925|FG003|Randomization to Baseline|Lost to Follow-up|0|||
162236308|NCT03645057|585916922|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
162236309|NCT03645057|585916923|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
162236310|NCT03645057|585916924|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
162236311|NCT03645057|585916925|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
162236312|NCT03645057|585916922|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
162236313|NCT03645057|585916923|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
162236314|NCT03645057|585916924|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
162236315|NCT03645057|585916925|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
162236316|NCT03645057|585916922|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
162236317|NCT03645057|585916923|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
162236318|NCT03645057|585916924|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
162236319|NCT03645057|585916925|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
162236320|NCT01171807|585916929|FG000|Overall Study|Treatment failure|2|||
162236321|NCT01171807|585916930|FG001|Overall Study|Treatment failure|4|||
162236322|NCT01171807|585916929|FG000|Overall Study|Non compliance|1|||
162236323|NCT01171807|585916930|FG001|Overall Study|Non compliance|0|||
162236324|NCT01171807|585916929|FG000|Overall Study|Lost to Follow-up|3|||
162236325|NCT01171807|585916930|FG001|Overall Study|Lost to Follow-up|0|||
162236326|NCT01901341|585916931|FG000|Overall Study|Adverse Event|4|||
162236327|NCT01901341|585916932|FG001|Overall Study|Adverse Event|2|||
162236328|NCT01901341|585916931|FG000|Overall Study|Lack of Efficacy|0|||
161682535|NCT01987960|583888893|FG000|Period 2|Withdrawal by Subject|0|||
161682536|NCT01987960|583888894|FG001|Period 2|Withdrawal by Subject|0|||
161682537|NCT01987960|583888895|FG002|Period 2|Withdrawal by Subject|1|||
161682538|NCT01987960|583888896|FG003|Period 2|Withdrawal by Subject|0|||
161682539|NCT01987960|583888893|FG000|Period 2|Administrative or other reason|0|||
161682540|NCT01987960|583888894|FG001|Period 2|Administrative or other reason|5|||
161682541|NCT01987960|583888895|FG002|Period 2|Administrative or other reason|7|||
161682542|NCT01987960|583888896|FG003|Period 2|Administrative or other reason|0|||
161682543|NCT01987960|583888893|FG000|Period 3|Adverse Event|0|||
161682544|NCT01987960|583888894|FG001|Period 3|Adverse Event|0|||
161682545|NCT01987960|583888895|FG002|Period 3|Adverse Event|0|||
161682546|NCT01987960|583888896|FG003|Period 3|Adverse Event|7|||
161682547|NCT01987960|583888893|FG000|Period 3|Non-compliance with IMP|0|||
161682548|NCT01987960|583888894|FG001|Period 3|Non-compliance with IMP|0|||
161682549|NCT01987960|583888895|FG002|Period 3|Non-compliance with IMP|0|||
161682550|NCT01987960|583888896|FG003|Period 3|Non-compliance with IMP|1|||
161682551|NCT01987960|583888893|FG000|Period 3|Protocol Violation|0|||
161682552|NCT01987960|583888894|FG001|Period 3|Protocol Violation|0|||
161682553|NCT01987960|583888895|FG002|Period 3|Protocol Violation|0|||
161682554|NCT01987960|583888896|FG003|Period 3|Protocol Violation|6|||
161682555|NCT01987960|583888893|FG000|Period 3|Withdrawal by Subject|0|||
161682556|NCT01987960|583888894|FG001|Period 3|Withdrawal by Subject|0|||
161682557|NCT01987960|583888895|FG002|Period 3|Withdrawal by Subject|0|||
161682558|NCT01987960|583888896|FG003|Period 3|Withdrawal by Subject|9|||
161682559|NCT01987960|583888893|FG000|Period 3|Lost to Follow-up|0|||
161682560|NCT01987960|583888894|FG001|Period 3|Lost to Follow-up|0|||
161682561|NCT01987960|583888895|FG002|Period 3|Lost to Follow-up|0|||
161682562|NCT01987960|583888896|FG003|Period 3|Lost to Follow-up|5|||
161682563|NCT01987960|583888893|FG000|Period 3|Administrative or other reason|0|||
161682564|NCT01987960|583888894|FG001|Period 3|Administrative or other reason|0|||
161682565|NCT01987960|583888895|FG002|Period 3|Administrative or other reason|0|||
161682566|NCT01987960|583888896|FG003|Period 3|Administrative or other reason|43|||
161682567|NCT00789880|583888898|FG000|Overall Study|Adverse Event|0|||
161682568|NCT00789880|583888899|FG001|Overall Study|Adverse Event|0|||
161682569|NCT00789880|583888900|FG002|Overall Study|Adverse Event|0|||
161682570|NCT00789880|583888901|FG003|Overall Study|Adverse Event|0|||
161682571|NCT00789880|583888902|FG004|Overall Study|Adverse Event|1|||
161682572|NCT00789880|583888903|FG005|Overall Study|Adverse Event|0|||
161682573|NCT00789880|583888898|FG000|Overall Study|Protocol Violation|0|||
161682574|NCT00789880|583888899|FG001|Overall Study|Protocol Violation|1|||
161682575|NCT00789880|583888900|FG002|Overall Study|Protocol Violation|0|||
161682576|NCT00789880|583888901|FG003|Overall Study|Protocol Violation|1|||
161682577|NCT00789880|583888902|FG004|Overall Study|Protocol Violation|0|||
161682578|NCT00789880|583888903|FG005|Overall Study|Protocol Violation|0|||
161682579|NCT00789880|583888898|FG000|Overall Study|Withdrawal by Subject|1|||
161682580|NCT00789880|583888899|FG001|Overall Study|Withdrawal by Subject|0|||
161682581|NCT00789880|583888900|FG002|Overall Study|Withdrawal by Subject|0|||
161682582|NCT00789880|583888901|FG003|Overall Study|Withdrawal by Subject|0|||
161682583|NCT00789880|583888902|FG004|Overall Study|Withdrawal by Subject|2|||
161831428|NCT01467479|584424744|FG002|Overall Study|No Study Medication|2|||
161682584|NCT00789880|583888903|FG005|Overall Study|Withdrawal by Subject|0|||
161682585|NCT01177683|583888904|FG000|Study Treatment|Disease Progressions during treatment|2|||
161682586|NCT01177683|583888905|FG001|Study Treatment|Disease Progressions during treatment|0|||
161831429|NCT01467479|584424742|FG000|Overall Study|Adverse Event|1|||
161682587|NCT01177683|583888906|FG002|Study Treatment|Disease Progressions during treatment|3|||
161682588|NCT01177683|583888904|FG000|Study Treatment|Adverse Event|0|||
161682589|NCT01177683|583888905|FG001|Study Treatment|Adverse Event|1|||
161682590|NCT01177683|583888906|FG002|Study Treatment|Adverse Event|12|||
161831430|NCT01467479|584424743|FG001|Overall Study|Adverse Event|2|||
161682591|NCT01177683|583888904|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
161682592|NCT01177683|583888905|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
161682593|NCT01177683|583888906|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
161682594|NCT01177683|583888904|FG000|Study Treatment|Alternative therapy|0|||
161682595|NCT01177683|583888905|FG001|Study Treatment|Alternative therapy|0|||
161682596|NCT01177683|583888906|FG002|Study Treatment|Alternative therapy|4|||
161682597|NCT01177683|583888904|FG000|Study Treatment|Physician Decision|1|||
161682598|NCT01177683|583888905|FG001|Study Treatment|Physician Decision|0|||
161682599|NCT01177683|583888906|FG002|Study Treatment|Physician Decision|1|||
161682600|NCT01177683|583888904|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
161682601|NCT01177683|583888905|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
161682602|NCT01177683|583888906|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
161682603|NCT01177683|583888904|FG000|Study Treatment|Symptomatic Deterioration|0|||
161682604|NCT01177683|583888905|FG001|Study Treatment|Symptomatic Deterioration|0|||
161682605|NCT01177683|583888906|FG002|Study Treatment|Symptomatic Deterioration|1|||
161682606|NCT01177683|583888904|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
161682607|NCT01177683|583888905|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
161682608|NCT01177683|583888906|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
161682609|NCT01177683|583888904|FG000|Follow up|Patient lost to follow up|0|||
161682610|NCT01177683|583888905|FG001|Follow up|Patient lost to follow up|0|||
161682611|NCT01177683|583888906|FG002|Follow up|Patient lost to follow up|2|||
161682612|NCT01177683|583888904|FG000|Follow up|Death|2|||
161682613|NCT01177683|583888905|FG001|Follow up|Death|1|||
161682614|NCT01177683|583888906|FG002|Follow up|Death|7|||
161682615|NCT01177683|583888904|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
161682616|NCT01177683|583888905|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
161682617|NCT01177683|583888906|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
161682618|NCT06347731|583888907|FG000|Overall Study|Death|1|||
161682619|NCT06347731|583888907|FG000|Overall Study|Protocol Violation|1|||
161682620|NCT06347731|583888907|FG000|Overall Study|Withdrawal by Subject|2|||
161682621|NCT00609986|583888911|FG000|Overall Study|Did not receive transplant or treatment|8|||
161682622|NCT00609986|583888912|FG001|Overall Study|Did not receive transplant or treatment|3|||
161682623|NCT03159091|583888913|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
161682624|NCT03159091|583888914|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
161682625|NCT03159091|583888913|FG000|Overall Study|Patient has taken no dose of study drug|0|||
161682626|NCT03159091|583888914|FG001|Overall Study|Patient has taken no dose of study drug|1|||
161682627|NCT05678257|583888915|FG000|Overall Study|Withdrawal by Subject|2|||
161682628|NCT05678257|583888916|FG001|Overall Study|Withdrawal by Subject|0|||
161682629|NCT05678257|583888917|FG002|Overall Study|Withdrawal by Subject|5|||
161682630|NCT05678257|583888915|FG000|Overall Study|Physician Decision|1|||
161682631|NCT05678257|583888916|FG001|Overall Study|Physician Decision|0|||
161682632|NCT05678257|583888917|FG002|Overall Study|Physician Decision|1|||
161682633|NCT05678257|583888915|FG000|Overall Study|Adverse Event|1|||
161682634|NCT05678257|583888916|FG001|Overall Study|Adverse Event|3|||
161682635|NCT05678257|583888917|FG002|Overall Study|Adverse Event|1|||
161682636|NCT05678257|583888915|FG000|Overall Study|Progressive disease|11|||
161682637|NCT05678257|583888916|FG001|Overall Study|Progressive disease|18|||
161682638|NCT05678257|583888917|FG002|Overall Study|Progressive disease|7|||
161682639|NCT05678257|583888915|FG000|Overall Study|No longer clinically benefitting|2|||
161682640|NCT05678257|583888916|FG001|Overall Study|No longer clinically benefitting|1|||
161682641|NCT05678257|583888917|FG002|Overall Study|No longer clinically benefitting|0|||
161682642|NCT05678257|583888915|FG000|Overall Study|Sponsor decision|5|||
161682643|NCT05678257|583888916|FG001|Overall Study|Sponsor decision|9|||
161682644|NCT05678257|583888917|FG002|Overall Study|Sponsor decision|8|||
161682645|NCT05678257|583888915|FG000|Overall Study|Protocol Violation|0|||
161682646|NCT05678257|583888916|FG001|Overall Study|Protocol Violation|0|||
161682647|NCT05678257|583888917|FG002|Overall Study|Protocol Violation|1|||
161682648|NCT05678257|583888915|FG000|Overall Study|Patient non-compliance|0|||
161831431|NCT01467479|584424744|FG002|Overall Study|Adverse Event|0|||
161682649|NCT05678257|583888916|FG001|Overall Study|Patient non-compliance|0|||
161682650|NCT05678257|583888917|FG002|Overall Study|Patient non-compliance|3|||
161682651|NCT02046096|583888918|FG000|Overall Study|Death|28|||
161682652|NCT02046096|583888919|FG001|Overall Study|Death|45|||
161682653|NCT02046096|583888918|FG000|Overall Study|Lost to Follow-up|9|||
162025823|NCT00557856|585150795|FG006|Part 1: Dose Escalation Phase|Death|0|||
162025824|NCT00557856|585150796|FG007|Part 1: Dose Escalation Phase|Death|0|||
162025825|NCT00557856|585150797|FG008|Part 1: Dose Escalation Phase|Death|0|||
162025826|NCT00557856|585150789|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
162025827|NCT00557856|585150790|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
162025828|NCT00557856|585150791|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
162025829|NCT00557856|585150792|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
162025830|NCT00557856|585150793|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
162025831|NCT00557856|585150794|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
162025832|NCT00557856|585150795|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
162025833|NCT00557856|585150796|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
162025834|NCT00557856|585150797|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
162025835|NCT00557856|585150789|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
162025836|NCT00557856|585150790|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
162025837|NCT00557856|585150791|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
162025838|NCT00557856|585150792|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
162025839|NCT00557856|585150793|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
162025840|NCT00557856|585150794|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
162025841|NCT00557856|585150795|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
162025842|NCT00557856|585150796|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
162025843|NCT00557856|585150797|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
162025844|NCT00557856|585150789|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
162025845|NCT00557856|585150790|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
162025846|NCT00557856|585150791|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
162025847|NCT00557856|585150792|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
162025848|NCT00557856|585150793|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
162025849|NCT00557856|585150794|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
162025850|NCT00557856|585150795|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
162025851|NCT00557856|585150796|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
162025852|NCT00557856|585150797|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
162025853|NCT00557856|585150789|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
162025854|NCT00557856|585150790|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
162025855|NCT00557856|585150791|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
162025856|NCT00557856|585150792|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
162025857|NCT00557856|585150793|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
162025858|NCT00557856|585150794|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
162025859|NCT00557856|585150795|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
162025860|NCT00557856|585150796|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
162025861|NCT00557856|585150797|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
161682654|NCT02046096|583888919|FG001|Overall Study|Lost to Follow-up|20|||
161682655|NCT02046096|583888918|FG000|Overall Study|Withdrawal by Subject|5|||
161682656|NCT02046096|583888919|FG001|Overall Study|Withdrawal by Subject|17|||
161682657|NCT02046096|583888918|FG000|Overall Study|Other endpoint|2|||
161682658|NCT02046096|583888919|FG001|Overall Study|Other endpoint|19|||
161682659|NCT03520959|583888920|FG000|Overall Study|Study terminated by Sponsor|0|||
161682660|NCT03520959|583888921|FG001|Overall Study|Study terminated by Sponsor|1|||
161682661|NCT04969276|583888923|FG000|Overall Study|Protocol Deviation|0|||
161682662|NCT04969276|583888924|FG001|Overall Study|Protocol Deviation|1|||
161682663|NCT04969276|583888925|FG002|Overall Study|Protocol Deviation|0|||
161682664|NCT04969276|583888923|FG000|Overall Study|Withdrawal by Subject|1|||
161682665|NCT04969276|583888924|FG001|Overall Study|Withdrawal by Subject|10|||
161682666|NCT04969276|583888925|FG002|Overall Study|Withdrawal by Subject|0|||
161682667|NCT04969276|583888923|FG000|Overall Study|Lost to Follow-up|0|||
161682668|NCT04969276|583888924|FG001|Overall Study|Lost to Follow-up|1|||
161682669|NCT04969276|583888925|FG002|Overall Study|Lost to Follow-up|0|||
161682670|NCT00943579|583888928|FG000|Overall Study|Adverse Event|4|||
161682671|NCT00943579|583888929|FG001|Overall Study|Adverse Event|3|||
161682672|NCT00943579|583888928|FG000|Overall Study|Lack of Efficacy|2|||
161682673|NCT00943579|583888929|FG001|Overall Study|Lack of Efficacy|2|||
161682674|NCT00418665|583888932|FG000|Treatment Period|Ineligibility determined|1|||
161682675|NCT00418665|583888933|FG001|Treatment Period|Ineligibility determined|1|||
161682676|NCT00418665|583888934|FG002|Treatment Period|Ineligibility determined|0|||
161682677|NCT00418665|583888932|FG000|Treatment Period|Adverse Event|2|||
161682678|NCT00418665|583888933|FG001|Treatment Period|Adverse Event|2|||
161682679|NCT00418665|583888934|FG002|Treatment Period|Adverse Event|0|||
161682680|NCT00418665|583888932|FG000|Treatment Period|Withdrawal by Subject|0|||
161682681|NCT00418665|583888933|FG001|Treatment Period|Withdrawal by Subject|3|||
161682682|NCT00418665|583888934|FG002|Treatment Period|Withdrawal by Subject|1|||
161682683|NCT00418665|583888932|FG000|Treatment Period|Requirement for alternative therapy|1|||
162025862|NCT00557856|585150789|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
162025863|NCT00557856|585150790|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
162025864|NCT00557856|585150791|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
162025865|NCT00557856|585150792|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
162025866|NCT00557856|585150793|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
162025867|NCT00557856|585150794|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
162025868|NCT00557856|585150795|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
162025869|NCT00557856|585150796|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
162025870|NCT00557856|585150797|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
162025871|NCT00557856|585150789|FG000|Part 2: Exploratory Phase|Other|0|||
162025872|NCT00557856|585150790|FG001|Part 2: Exploratory Phase|Other|0|||
162025873|NCT00557856|585150791|FG002|Part 2: Exploratory Phase|Other|0|||
162025874|NCT00557856|585150792|FG003|Part 2: Exploratory Phase|Other|0|||
162025875|NCT00557856|585150793|FG004|Part 2: Exploratory Phase|Other|0|||
162025876|NCT00557856|585150794|FG005|Part 2: Exploratory Phase|Other|0|||
162025877|NCT00557856|585150795|FG006|Part 2: Exploratory Phase|Other|0|||
162025878|NCT00557856|585150796|FG007|Part 2: Exploratory Phase|Other|0|||
162025879|NCT00557856|585150797|FG008|Part 2: Exploratory Phase|Other|1|||
162025880|NCT00557856|585150789|FG000|Part 2: Exploratory Phase|Death|0|||
162025881|NCT00557856|585150790|FG001|Part 2: Exploratory Phase|Death|0|||
162025882|NCT00557856|585150791|FG002|Part 2: Exploratory Phase|Death|0|||
162025883|NCT00557856|585150792|FG003|Part 2: Exploratory Phase|Death|0|||
162025884|NCT00557856|585150793|FG004|Part 2: Exploratory Phase|Death|0|||
162025885|NCT00557856|585150794|FG005|Part 2: Exploratory Phase|Death|0|||
162025886|NCT00557856|585150795|FG006|Part 2: Exploratory Phase|Death|0|||
162025887|NCT00557856|585150796|FG007|Part 2: Exploratory Phase|Death|0|||
162025888|NCT00557856|585150797|FG008|Part 2: Exploratory Phase|Death|2|||
162025889|NCT00557856|585150789|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
162025890|NCT00557856|585150790|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
162025891|NCT00557856|585150791|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
162025892|NCT00557856|585150792|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
162025893|NCT00557856|585150793|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
162025894|NCT00557856|585150794|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
162025895|NCT00557856|585150795|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
162025896|NCT00557856|585150796|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
162025897|NCT00557856|585150797|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
162025898|NCT02509026|585150798|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
162025899|NCT02509026|585150798|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
162025900|NCT02509026|585150798|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
161682684|NCT00418665|583888933|FG001|Treatment Period|Requirement for alternative therapy|0|||
162025901|NCT02509026|585150798|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
161682685|NCT00418665|583888934|FG002|Treatment Period|Requirement for alternative therapy|0|||
162025902|NCT02509026|585150798|FG000|Induction Period (24 Weeks)|Other|2|||
162025903|NCT02509026|585150798|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
161682686|NCT00418665|583888932|FG000|Treatment Period|Physician Decision|1|||
161682687|NCT00418665|583888933|FG001|Treatment Period|Physician Decision|0|||
161682688|NCT00418665|583888934|FG002|Treatment Period|Physician Decision|3|||
161682689|NCT00418665|583888932|FG000|Treatment Extension|Adverse Event|1|||
161682690|NCT00418665|583888933|FG001|Treatment Extension|Adverse Event|0|||
161682691|NCT00418665|583888934|FG002|Treatment Extension|Adverse Event|0|||
161682692|NCT00418665|583888932|FG000|Treatment Extension|Withdrawal by Subject|1|||
161831432|NCT01467479|584424742|FG000|Overall Study|Death|0|||
161682693|NCT00418665|583888933|FG001|Treatment Extension|Withdrawal by Subject|0|||
161831433|NCT01467479|584424743|FG001|Overall Study|Death|0|||
161682694|NCT00418665|583888934|FG002|Treatment Extension|Withdrawal by Subject|0|||
161682695|NCT00418665|583888932|FG000|Treatment Extension|Requirement for alternative therapy|2|||
161682696|NCT00418665|583888933|FG001|Treatment Extension|Requirement for alternative therapy|2|||
161682697|NCT00418665|583888934|FG002|Treatment Extension|Requirement for alternative therapy|0|||
161682698|NCT00418665|583888932|FG000|Treatment Extension|Physician Decision|2|||
161682699|NCT00418665|583888933|FG001|Treatment Extension|Physician Decision|2|||
161682700|NCT00418665|583888934|FG002|Treatment Extension|Physician Decision|1|||
161682701|NCT00418665|583888932|FG000|Treatment Extension|Death|0|||
161682702|NCT00418665|583888933|FG001|Treatment Extension|Death|0|||
161682703|NCT00418665|583888934|FG002|Treatment Extension|Death|1|||
161682704|NCT00687440|583888935|FG000|Overall Study|Adverse Event|3|||
161682705|NCT00687440|583888935|FG000|Overall Study|Lost to Follow-up|3|||
161682706|NCT00687440|583888935|FG000|Overall Study|Lack of Efficacy|2|||
161682707|NCT00687440|583888935|FG000|Overall Study|Death|2|||
161682708|NCT00687440|583888935|FG000|Overall Study|Other|1|||
161682709|NCT00687440|583888935|FG000|Overall Study|Missing|1|||
161682710|NCT01538628|583888945|FG000|Overall Study|Withdrawal by Subject|1|||
161682711|NCT01538628|583888946|FG001|Overall Study|Withdrawal by Subject|1|||
161682712|NCT01538628|583888945|FG000|Overall Study|Lost to Follow-up|0|||
162025904|NCT02509026|585150798|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
162025905|NCT02509026|585150798|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
162025906|NCT02509026|585150798|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
162025907|NCT02509026|585150798|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
162025908|NCT02509026|585150798|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
162025909|NCT02509026|585150798|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
162025910|NCT02509026|585150798|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
162025911|NCT01165216|585150799|FG000|Overall Study|Adverse Event|6|||
162025912|NCT01165216|585150800|FG001|Overall Study|Adverse Event|3|||
161682713|NCT01538628|583888946|FG001|Overall Study|Lost to Follow-up|1|||
161682714|NCT00766038|583890138|FG000|Overall Study|Lost to Follow-up|15|||
161682715|NCT00766038|583890139|FG001|Overall Study|Lost to Follow-up|14|||
161682716|NCT00307151|583890140|FG000|Overall Study|Death|4|||
161682717|NCT00307151|583890141|FG001|Overall Study|Death|3|||
161682718|NCT00307151|583890142|FG002|Overall Study|Death|10|||
161682719|NCT00307151|583890143|FG003|Overall Study|Death|3|||
161682720|NCT00307151|583890140|FG000|Overall Study|Severe debilitation, unable to continue|1|||
161682721|NCT00307151|583890141|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161682722|NCT00307151|583890142|FG002|Overall Study|Severe debilitation, unable to continue|0|||
161682723|NCT00307151|583890143|FG003|Overall Study|Severe debilitation, unable to continue|0|||
161682724|NCT00307151|583890140|FG000|Overall Study|Subject unable to get to clinic|1|||
161682725|NCT00307151|583890141|FG001|Overall Study|Subject unable to get to clinic|0|||
161682726|NCT00307151|583890142|FG002|Overall Study|Subject unable to get to clinic|6|||
161682727|NCT00307151|583890143|FG003|Overall Study|Subject unable to get to clinic|2|||
161682728|NCT00307151|583890140|FG000|Overall Study|Withdrew consent|0|||
161682729|NCT00307151|583890141|FG001|Overall Study|Withdrew consent|1|||
161682730|NCT00307151|583890142|FG002|Overall Study|Withdrew consent|1|||
161682731|NCT00307151|583890143|FG003|Overall Study|Withdrew consent|3|||
161682732|NCT00307151|583890140|FG000|Overall Study|Not willing to adhere to study reqs|2|||
161682733|NCT00307151|583890141|FG001|Overall Study|Not willing to adhere to study reqs|0|||
161682734|NCT00307151|583890142|FG002|Overall Study|Not willing to adhere to study reqs|2|||
161682735|NCT00307151|583890143|FG003|Overall Study|Not willing to adhere to study reqs|2|||
161682736|NCT00307151|583890140|FG000|Overall Study|Clinic unable to contact subject|3|||
161682737|NCT00307151|583890141|FG001|Overall Study|Clinic unable to contact subject|3|||
161682738|NCT00307151|583890142|FG002|Overall Study|Clinic unable to contact subject|1|||
162025913|NCT01165216|585150799|FG000|Overall Study|Withdrawal by Subject|1|||
162025914|NCT01165216|585150800|FG001|Overall Study|Withdrawal by Subject|1|||
162025915|NCT01165216|585150799|FG000|Overall Study|Disease progression|1|||
162025916|NCT01165216|585150800|FG001|Overall Study|Disease progression|3|||
161682739|NCT00307151|583890143|FG003|Overall Study|Clinic unable to contact subject|1|||
161682740|NCT03703882|583890144|FG000|Overall Study|Adverse Event|1|||
161682741|NCT03703882|583890145|FG001|Overall Study|Adverse Event|0|||
161682742|NCT03703882|583890144|FG000|Overall Study|Lost to Follow-up|0|||
162025917|NCT00243841|585150804|FG000|Overall Study|Physician Decision|0|||
162025918|NCT00243841|585150805|FG001|Overall Study|Physician Decision|0|||
162025919|NCT00243841|585150806|FG002|Overall Study|Physician Decision|1|||
161682743|NCT03703882|583890145|FG001|Overall Study|Lost to Follow-up|2|||
161682744|NCT03703882|583890144|FG000|Overall Study|Non-compliance with study drug|0|||
161682745|NCT03703882|583890145|FG001|Overall Study|Non-compliance with study drug|1|||
161682746|NCT03703882|583890144|FG000|Overall Study|Physician Decision|0|||
161682747|NCT03703882|583890145|FG001|Overall Study|Physician Decision|1|||
161682748|NCT03703882|583890144|FG000|Overall Study|Progressive disease|1|||
161682749|NCT03703882|583890145|FG001|Overall Study|Progressive disease|0|||
161682750|NCT03703882|583890144|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161682751|NCT03703882|583890145|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162025920|NCT00243841|585150807|FG003|Overall Study|Physician Decision|0|||
162025921|NCT00243841|585150808|FG004|Overall Study|Physician Decision|0|||
162025922|NCT00243841|585150809|FG005|Overall Study|Physician Decision|2|||
162025923|NCT00363545|585150810|FG000|Overall Study|Serious Adverse Event|0|||
162025924|NCT00363545|585150811|FG001|Overall Study|Serious Adverse Event|1|||
162025925|NCT00363545|585150810|FG000|Overall Study|Withdrawal by Subject|12|||
162025926|NCT00363545|585150811|FG001|Overall Study|Withdrawal by Subject|15|||
162025927|NCT00363545|585150810|FG000|Overall Study|Migrated/moved from study area|3|||
162025928|NCT00363545|585150811|FG001|Overall Study|Migrated/moved from study area|6|||
162025929|NCT00363545|585150810|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
162025930|NCT00363545|585150811|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
162025931|NCT00363545|585150810|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
162025932|NCT00363545|585150811|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
162025933|NCT00363545|585150810|FG000|Overall Study|Others|1|||
162025934|NCT00363545|585150811|FG001|Overall Study|Others|0|||
162025935|NCT05601544|585150812|FG000|Phase 2 Period 1|Adverse Event|0|||
162025936|NCT05601544|585150813|FG001|Phase 2 Period 1|Adverse Event|1|||
162025937|NCT05601544|585150814|FG002|Phase 2 Period 1|Adverse Event|0|||
162025938|NCT05601544|585150815|FG003|Phase 2 Period 1|Adverse Event|0|||
162025939|NCT05601544|585150816|FG004|Phase 2 Period 1|Adverse Event|0|||
162025940|NCT05601544|585150817|FG005|Phase 2 Period 1|Adverse Event|0|||
162025941|NCT01601652|585150819|FG000|Overall Study|Death|1|||
162025942|NCT02537015|585150826|FG000|Overall Study|Adverse Event|3|||
162025943|NCT02537015|585150826|FG000|Overall Study|Withdrawal by Subject|2|||
162025944|NCT02537015|585150826|FG000|Overall Study|Other Miscellaneous Reasons|1|||
162025945|NCT01808092|585150834|FG000|Overall Study|Death|39|||
162025946|NCT01808092|585150835|FG001|Overall Study|Death|29|||
162025947|NCT01808092|585150834|FG000|Overall Study|Lost to Follow-up|3|||
162025948|NCT01808092|585150835|FG001|Overall Study|Lost to Follow-up|7|||
162025949|NCT01808092|585150834|FG000|Overall Study|Withdrawal by Subject|9|||
162025950|NCT01808092|585150835|FG001|Overall Study|Withdrawal by Subject|4|||
162025951|NCT01808092|585150834|FG000|Overall Study|Other Eligibility criteria|3|||
162025952|NCT01808092|585150835|FG001|Overall Study|Other Eligibility criteria|5|||
162025953|NCT02626624|585150838|FG000|Overall Study|Adverse Event|1|||
162025954|NCT02626624|585150838|FG000|Overall Study|Lost to Follow-up|3|||
162025955|NCT02626624|585150838|FG000|Overall Study|Protocol Violation|4|||
162025956|NCT02626624|585150838|FG000|Overall Study|Death|2|||
162025957|NCT01097005|585150842|FG000|Overall Study|Case Report Form not collected|18|||
162025958|NCT01097005|585150842|FG000|Overall Study|Subjects cannot visit the hospital|1|||
162025959|NCT01097005|585150842|FG000|Overall Study|Poor medication compliance|1|||
162025960|NCT01097005|585150842|FG000|Overall Study|No examination data available|244|||
162025961|NCT01097005|585150842|FG000|Overall Study|Deviation from exclusion criteria|37|||
162025962|NCT01097005|585150842|FG000|Overall Study|Adverse Event|14|||
162025963|NCT01097005|585150842|FG000|Overall Study|Discontinuance by complication|50|||
162025964|NCT03425253|585150848|FG000|Overall Study|Adverse Event|2|||
162025965|NCT03425253|585150848|FG000|Overall Study|Lost to Follow-up|3|||
162025966|NCT03425253|585150848|FG000|Overall Study|Withdrew Consent|6|||
162025967|NCT03425253|585150848|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
162025968|NCT04174365|585150853|FG000|Overall Study|Lost to Follow-up|1|||
162025969|NCT04174365|585150854|FG001|Overall Study|Lost to Follow-up|2|||
162025970|NCT04174365|585150853|FG000|Overall Study|Adverse Event|2|||
162025971|NCT04174365|585150854|FG001|Overall Study|Adverse Event|1|||
162025972|NCT04174365|585150853|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
162025973|NCT04174365|585150854|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
162025974|NCT04174365|585150853|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
162025975|NCT04174365|585150854|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
162025976|NCT04174365|585150853|FG000|Overall Study|Protocol Deviation|1|||
162025977|NCT04174365|585150854|FG001|Overall Study|Protocol Deviation|0|||
162025978|NCT04174365|585150853|FG000|Overall Study|Lack of Efficacy|0|||
162025979|NCT04174365|585150854|FG001|Overall Study|Lack of Efficacy|2|||
162025980|NCT04174365|585150853|FG000|Overall Study|Disease Relapse|1|||
162025981|NCT04174365|585150854|FG001|Overall Study|Disease Relapse|0|||
162025982|NCT04174365|585150853|FG000|Overall Study|Reason Not Specified|0|||
162025983|NCT04174365|585150854|FG001|Overall Study|Reason Not Specified|1|||
162025984|NCT04627285|585150855|FG000|Overall Study|Adverse Event|0|||
162025985|NCT04627285|585150856|FG001|Overall Study|Adverse Event|2|||
162025986|NCT04627285|585150855|FG000|Overall Study|Lost to Follow-up|1|||
162025987|NCT04627285|585150856|FG001|Overall Study|Lost to Follow-up|0|||
162025988|NCT04627285|585150855|FG000|Overall Study|Withdrawal by Subject|1|||
162025989|NCT04627285|585150856|FG001|Overall Study|Withdrawal by Subject|1|||
162025990|NCT04627285|585150855|FG000|Overall Study|Sponsor decision|5|||
162025991|NCT04627285|585150856|FG001|Overall Study|Sponsor decision|0|||
162025992|NCT04627285|585150855|FG000|Overall Study|Participant left country; aunt informed the site|0|||
162025993|NCT04627285|585150856|FG001|Overall Study|Participant left country; aunt informed the site|1|||
162025994|NCT03658876|585152859|FG000|Overall Study|Protocol Violation|3|||
162025995|NCT03658876|585152860|FG001|Overall Study|Protocol Violation|2|||
162025996|NCT03658876|585152859|FG000|Overall Study|Withdrawal by Subject|2|||
162025997|NCT03658876|585152860|FG001|Overall Study|Withdrawal by Subject|0|||
162025998|NCT03658876|585152859|FG000|Overall Study|Death|0|||
162025999|NCT03658876|585152860|FG001|Overall Study|Death|1|||
162026000|NCT03658876|585152859|FG000|Overall Study|Intercurrent illness|6|||
162026001|NCT03658876|585152860|FG001|Overall Study|Intercurrent illness|4|||
162026002|NCT03658876|585152859|FG000|Overall Study|Transplantation/other operation|1|||
162026003|NCT03658876|585152860|FG001|Overall Study|Transplantation/other operation|5|||
162026004|NCT01330017|585152861|FG000|Overall Study|Adverse Event|0|||
162026005|NCT01330017|585152862|FG001|Overall Study|Adverse Event|1|||
162026006|NCT01330017|585152863|FG002|Overall Study|Adverse Event|1|||
161682752|NCT03703882|583890144|FG000|Overall Study|Starting another treatment|0|||
161682753|NCT03703882|583890145|FG001|Overall Study|Starting another treatment|1|||
161682754|NCT03703882|583890144|FG000|Overall Study|noncompliance with study procedures|0|||
161682755|NCT03703882|583890145|FG001|Overall Study|noncompliance with study procedures|1|||
161682756|NCT00516048|583890148|FG000|Overall Study|Death|0|||
161682757|NCT00516048|583890149|FG001|Overall Study|Death|0|||
161682758|NCT00516048|583890150|FG002|Overall Study|Death|1|||
161682759|NCT00516048|583890148|FG000|Overall Study|Subject Decision|0|||
161682760|NCT00516048|583890149|FG001|Overall Study|Subject Decision|2|||
161682761|NCT00516048|583890150|FG002|Overall Study|Subject Decision|0|||
161831434|NCT01467479|584424744|FG002|Overall Study|Death|1|||
161682762|NCT02263079|583890151|FG000|Overall Study|Physician Decision|1|||
162026007|NCT01330017|585152864|FG003|Overall Study|Adverse Event|4|||
162026008|NCT01330017|585152865|FG004|Overall Study|Adverse Event|0|||
162026009|NCT01330017|585152861|FG000|Overall Study|Withdrawal by Subject|0|||
162026010|NCT01330017|585152862|FG001|Overall Study|Withdrawal by Subject|0|||
162026011|NCT01330017|585152863|FG002|Overall Study|Withdrawal by Subject|1|||
162026012|NCT01330017|585152864|FG003|Overall Study|Withdrawal by Subject|0|||
162026013|NCT01330017|585152865|FG004|Overall Study|Withdrawal by Subject|1|||
162026014|NCT01330017|585152861|FG000|Overall Study|Lost to Follow-up|0|||
162026015|NCT01330017|585152862|FG001|Overall Study|Lost to Follow-up|0|||
162026016|NCT01330017|585152863|FG002|Overall Study|Lost to Follow-up|1|||
162026017|NCT01330017|585152864|FG003|Overall Study|Lost to Follow-up|0|||
162026018|NCT01330017|585152865|FG004|Overall Study|Lost to Follow-up|0|||
162026019|NCT01330017|585152861|FG000|Overall Study|Protocol Violation|0|||
162026020|NCT01330017|585152862|FG001|Overall Study|Protocol Violation|0|||
162026021|NCT01330017|585152863|FG002|Overall Study|Protocol Violation|0|||
162026022|NCT01330017|585152864|FG003|Overall Study|Protocol Violation|1|||
162026023|NCT01330017|585152865|FG004|Overall Study|Protocol Violation|0|||
162026024|NCT01330017|585152861|FG000|Overall Study|Unknown Reason|5|||
162026025|NCT01330017|585152862|FG001|Overall Study|Unknown Reason|3|||
162026026|NCT01330017|585152863|FG002|Overall Study|Unknown Reason|5|||
162026027|NCT01330017|585152864|FG003|Overall Study|Unknown Reason|7|||
162026028|NCT01330017|585152865|FG004|Overall Study|Unknown Reason|2|||
162026029|NCT03137069|585152868|FG000|Overall Study|Withdrawal by Subject|1|||
162026030|NCT03137069|585152869|FG001|Overall Study|Withdrawal by Subject|2|||
162026031|NCT03137069|585152870|FG002|Overall Study|Withdrawal by Subject|2|||
162026032|NCT03137069|585152871|FG003|Overall Study|Withdrawal by Subject|2|||
162026033|NCT03137069|585152872|FG004|Overall Study|Withdrawal by Subject|0|||
162026034|NCT03137069|585152873|FG005|Overall Study|Withdrawal by Subject|0|||
162026035|NCT03137069|585152868|FG000|Overall Study|Adverse Event|0|||
162026036|NCT03137069|585152869|FG001|Overall Study|Adverse Event|3|||
162026037|NCT03137069|585152870|FG002|Overall Study|Adverse Event|1|||
161682763|NCT02263079|583890152|FG001|Overall Study|Physician Decision|0|||
161682764|NCT02263079|583890153|FG002|Overall Study|Physician Decision|0|||
161682765|NCT02263079|583890151|FG000|Overall Study|Withdrawal by Subject|2|||
161682766|NCT02263079|583890152|FG001|Overall Study|Withdrawal by Subject|8|||
161682767|NCT02263079|583890153|FG002|Overall Study|Withdrawal by Subject|0|||
161682768|NCT00402649|583890154|FG000|Overall Study|Lost to Follow-up|1|||
161682769|NCT00402649|583890154|FG000|Overall Study|Withdrawal by Subject|1|||
161682770|NCT01321710|583890160|FG000|Overall Study|Lost to Follow-up|4|||
161682771|NCT01321710|583890161|FG001|Overall Study|Lost to Follow-up|5|||
161682772|NCT01321710|583890162|FG002|Overall Study|Lost to Follow-up|0|||
161682773|NCT01761292|583890163|FG000|Part 1|Adverse Event|1|||
162026038|NCT03137069|585152871|FG003|Overall Study|Adverse Event|1|||
162026039|NCT03137069|585152872|FG004|Overall Study|Adverse Event|0|||
162026040|NCT03137069|585152873|FG005|Overall Study|Adverse Event|1|||
162026041|NCT03137069|585152868|FG000|Overall Study|Protocol Violation|0|||
162026042|NCT03137069|585152869|FG001|Overall Study|Protocol Violation|1|||
162026043|NCT03137069|585152870|FG002|Overall Study|Protocol Violation|0|||
162026044|NCT03137069|585152871|FG003|Overall Study|Protocol Violation|1|||
162026045|NCT03137069|585152872|FG004|Overall Study|Protocol Violation|1|||
162026046|NCT03137069|585152873|FG005|Overall Study|Protocol Violation|1|||
162026047|NCT03137069|585152868|FG000|Overall Study|Physician Decision|0|||
162026048|NCT03137069|585152869|FG001|Overall Study|Physician Decision|0|||
161682774|NCT01761292|583890163|FG000|Part 1|not receiving treatment in Part 1|1|||
161682775|NCT01761292|583890163|FG000|Extension 1|Withdrawal by Subject|1|||
161682776|NCT00840086|583890164|FG000|Overall Study|Adverse Event|1|||
161682777|NCT00840086|583890164|FG000|Overall Study|Protocol Violation|2|||
161831435|NCT01467479|584424742|FG000|Overall Study|Lost to Follow-up|2|||
162026049|NCT03137069|585152870|FG002|Overall Study|Physician Decision|0|||
161682778|NCT00840086|583890164|FG000|Overall Study|Lost to Follow-up|1|||
161682779|NCT03332498|583890165|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
161682780|NCT03332498|583890166|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
161682781|NCT03332498|583890167|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
161682782|NCT05611671|583890168|FG000|Overall Study|Adverse Event|1|||
161682783|NCT05611671|583890169|FG001|Overall Study|Adverse Event|1|||
161682784|NCT05611671|583890170|FG002|Overall Study|Adverse Event|0|||
161682785|NCT05611671|583890171|FG003|Overall Study|Adverse Event|1|||
161682786|NCT05611671|583890168|FG000|Overall Study|Lack of Efficacy|1|||
161682787|NCT05611671|583890169|FG001|Overall Study|Lack of Efficacy|0|||
161682788|NCT05611671|583890170|FG002|Overall Study|Lack of Efficacy|1|||
161682789|NCT05611671|583890171|FG003|Overall Study|Lack of Efficacy|2|||
161682790|NCT05611671|583890168|FG000|Overall Study|Lost to Follow-up|0|||
161682791|NCT05611671|583890169|FG001|Overall Study|Lost to Follow-up|0|||
161682792|NCT05611671|583890170|FG002|Overall Study|Lost to Follow-up|0|||
161682793|NCT05611671|583890171|FG003|Overall Study|Lost to Follow-up|1|||
161682794|NCT05611671|583890168|FG000|Overall Study|Protocol Violation|0|||
161682795|NCT05611671|583890169|FG001|Overall Study|Protocol Violation|1|||
161682796|NCT05611671|583890170|FG002|Overall Study|Protocol Violation|0|||
161682797|NCT05611671|583890171|FG003|Overall Study|Protocol Violation|0|||
161682798|NCT05611671|583890168|FG000|Overall Study|Withdrawal by Subject|2|||
161682799|NCT05611671|583890169|FG001|Overall Study|Withdrawal by Subject|1|||
161682800|NCT05611671|583890170|FG002|Overall Study|Withdrawal by Subject|2|||
161682801|NCT05611671|583890171|FG003|Overall Study|Withdrawal by Subject|1|||
161682802|NCT03179891|583890172|FG000|First Intervention|Withdrawal by Subject|1|||
161682803|NCT03179891|583890173|FG001|First Intervention|Withdrawal by Subject|1|||
161682804|NCT03179891|583890172|FG000|First Intervention|Unspecified reason|1|||
161682805|NCT03179891|583890173|FG001|First Intervention|Unspecified reason|0|||
161682806|NCT03179891|583890172|FG000|First Intervention|Protocol Violation|0|||
161682807|NCT03179891|583890173|FG001|First Intervention|Protocol Violation|1|||
161682808|NCT00383084|583890180|FG000|Overall Study|Withdrawal by Subject|12|||
161682809|NCT00383084|583890181|FG001|Overall Study|Withdrawal by Subject|10|||
161682810|NCT02113436|583890182|FG000|Period 1: 8 Weeks|Adverse Event|1|||
161682811|NCT02113436|583890183|FG001|Period 1: 8 Weeks|Adverse Event|0|||
161682812|NCT02113436|583890184|FG002|Period 1: 8 Weeks|Adverse Event|0|||
161682813|NCT02113436|583890185|FG003|Period 1: 8 Weeks|Adverse Event|0|||
161682814|NCT02113436|583890182|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
161682815|NCT02113436|583890183|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
161682816|NCT02113436|583890184|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
161682817|NCT02113436|583890185|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
161682818|NCT02113436|583890182|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
161682819|NCT02113436|583890183|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
161682820|NCT02113436|583890184|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
161682821|NCT02113436|583890185|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
161682822|NCT02113436|583890182|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
161682823|NCT02113436|583890183|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
161682824|NCT02113436|583890184|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
161682825|NCT02113436|583890185|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
161682826|NCT02113436|583890182|FG000|Period 2: 16 Weeks|Adverse Event|0|||
161682827|NCT02113436|583890183|FG001|Period 2: 16 Weeks|Adverse Event|0|||
161682828|NCT02113436|583890184|FG002|Period 2: 16 Weeks|Adverse Event|4|||
161682829|NCT02113436|583890185|FG003|Period 2: 16 Weeks|Adverse Event|5|||
161682830|NCT02113436|583890182|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
161682831|NCT02113436|583890183|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
161682832|NCT02113436|583890184|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
161682833|NCT02113436|583890185|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
161682834|NCT02113436|583890182|FG000|Period 2: 16 Weeks|Physician Decision|0|||
161682835|NCT02113436|583890183|FG001|Period 2: 16 Weeks|Physician Decision|0|||
161682836|NCT02113436|583890184|FG002|Period 2: 16 Weeks|Physician Decision|2|||
161682837|NCT02113436|583890185|FG003|Period 2: 16 Weeks|Physician Decision|0|||
161682838|NCT02113436|583890182|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
161682839|NCT02113436|583890183|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
161682840|NCT02113436|583890184|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
161682841|NCT02113436|583890185|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
161682842|NCT01486927|583890186|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
161682843|NCT01486927|583890186|FG000|Overall Study|Physician Decision|1|||
161682844|NCT01486927|583890186|FG000|Overall Study|50 Exposure days not reached|2|||
161831436|NCT01467479|584424743|FG001|Overall Study|Lost to Follow-up|5|||
162026050|NCT03137069|585152871|FG003|Overall Study|Physician Decision|1|||
161682845|NCT01486927|583890186|FG000|Overall Study|Withdrawal by Subject|8|||
161682846|NCT01486927|583890186|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
161682847|NCT02159729|583890187|FG000|Overall Study|Adverse Event|0|||
161682848|NCT02159729|583890188|FG001|Overall Study|Adverse Event|1|||
161682849|NCT02159729|583890187|FG000|Overall Study|Subject's Request|13|||
161682850|NCT02159729|583890188|FG001|Overall Study|Subject's Request|10|||
161682851|NCT02159729|583890187|FG000|Overall Study|Lost to Follow-up|24|||
161682852|NCT02159729|583890188|FG001|Overall Study|Lost to Follow-up|9|||
161682853|NCT02159729|583890187|FG000|Overall Study|Non compliance|2|||
161682854|NCT02159729|583890188|FG001|Overall Study|Non compliance|0|||
161682855|NCT02159729|583890187|FG000|Overall Study|Other Unspecified|3|||
161682856|NCT02159729|583890188|FG001|Overall Study|Other Unspecified|1|||
161682857|NCT02636582|583890189|FG000|Overall Study|Surgical Pathology|1|||
161831437|NCT01467479|584424744|FG002|Overall Study|Lost to Follow-up|3|||
161682858|NCT02636582|583890190|FG001|Overall Study|Surgical Pathology|0|||
161682859|NCT00573430|583890191|FG000|Overall Study|Incorrect enrollment of randomization|0|||
161682860|NCT00573430|583890192|FG001|Overall Study|Incorrect enrollment of randomization|4|||
161682861|NCT00573430|583890193|FG002|Overall Study|Incorrect enrollment of randomization|3|||
161682862|NCT00573430|583890191|FG000|Overall Study|Adverse Event|0|||
161682863|NCT00573430|583890192|FG001|Overall Study|Adverse Event|0|||
161682864|NCT00573430|583890193|FG002|Overall Study|Adverse Event|2|||
161682865|NCT00573430|583890191|FG000|Overall Study|Withdrawal by Subject|1|||
161682866|NCT00573430|583890192|FG001|Overall Study|Withdrawal by Subject|0|||
161682867|NCT00573430|583890193|FG002|Overall Study|Withdrawal by Subject|1|||
161682868|NCT00573430|583890191|FG000|Overall Study|Protocol Violation|0|||
161682869|NCT00573430|583890192|FG001|Overall Study|Protocol Violation|1|||
161682870|NCT00573430|583890193|FG002|Overall Study|Protocol Violation|1|||
161682871|NCT00573430|583890191|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161682872|NCT00573430|583890192|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161682873|NCT00573430|583890193|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
161682874|NCT05895552|583890194|FG000|Overall Study|Adverse Event|2|||
161682875|NCT05895552|583890195|FG001|Overall Study|Adverse Event|2|||
161682876|NCT05895552|583890196|FG002|Overall Study|Adverse Event|1|||
161682877|NCT05895552|583890194|FG000|Overall Study|Lost to Follow-up|0|||
161682878|NCT05895552|583890195|FG001|Overall Study|Lost to Follow-up|1|||
161682879|NCT05895552|583890196|FG002|Overall Study|Lost to Follow-up|0|||
161682880|NCT05895552|583890194|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161682881|NCT05895552|583890195|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161682882|NCT05895552|583890196|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161682883|NCT05895552|583890194|FG000|Overall Study|Protocol Deviation|0|||
161682884|NCT05895552|583890195|FG001|Overall Study|Protocol Deviation|0|||
161682885|NCT05895552|583890196|FG002|Overall Study|Protocol Deviation|2|||
161682886|NCT05895552|583890194|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
161682887|NCT05895552|583890195|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
161682888|NCT05895552|583890196|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
161682889|NCT05895552|583890194|FG000|Overall Study|Withdrawal by Subject|2|||
161682890|NCT05895552|583890195|FG001|Overall Study|Withdrawal by Subject|2|||
161682891|NCT05895552|583890196|FG002|Overall Study|Withdrawal by Subject|4|||
161682892|NCT03810911|583890197|FG000|Overall Study|Death|1|||
161682893|NCT03810911|583890198|FG001|Overall Study|Death|1|||
161682894|NCT03810911|583890197|FG000|Overall Study|Withdrawal by Subject|1|||
161682895|NCT03810911|583890198|FG001|Overall Study|Withdrawal by Subject|1|||
161682896|NCT05374525|583890199|FG000|Overall Study|Adverse Event|5|||
161682897|NCT05374525|583890200|FG001|Overall Study|Adverse Event|6|||
161682898|NCT05374525|583890199|FG000|Overall Study|Lost to Follow-up|3|||
161682899|NCT05374525|583890200|FG001|Overall Study|Lost to Follow-up|3|||
161682900|NCT05374525|583890199|FG000|Overall Study|Physician Decision|2|||
161682901|NCT05374525|583890200|FG001|Overall Study|Physician Decision|2|||
161682902|NCT05374525|583890199|FG000|Overall Study|Withdrawal by Subject|26|||
161682903|NCT05374525|583890200|FG001|Overall Study|Withdrawal by Subject|8|||
161682904|NCT01349101|583890203|FG000|Overall Study|Disease Progression|1|||
161682905|NCT01349101|583890204|FG001|Overall Study|Disease Progression|1|||
161682906|NCT01349101|583890203|FG000|Overall Study|Death|3|||
161682907|NCT01349101|583890204|FG001|Overall Study|Death|8|||
161682908|NCT00829179|583890205|FG000|Overall Study|Withdrawal by Subject|1|||
161682909|NCT00271596|583890208|FG000|Overall Study|Protocol Violation|1|||
161682910|NCT00271596|583890209|FG001|Overall Study|Protocol Violation|0|||
161831438|NCT01467479|584424742|FG000|Overall Study|Withdrawal of Consent|3|||
162026051|NCT03137069|585152872|FG004|Overall Study|Physician Decision|0|||
161682911|NCT00271596|583890208|FG000|Overall Study|Withdrawal by Subject|0|||
161682912|NCT00271596|583890209|FG001|Overall Study|Withdrawal by Subject|1|||
161682913|NCT04232553|583890210|FG000|Overall Study|Adverse Event|3|||
161682914|NCT04232553|583890211|FG001|Overall Study|Adverse Event|2|||
161682915|NCT04232553|583890212|FG002|Overall Study|Adverse Event|1|||
161682916|NCT04232553|583890213|FG003|Overall Study|Adverse Event|2|||
161682917|NCT04232553|583890214|FG004|Overall Study|Adverse Event|1|||
161682918|NCT04232553|583890215|FG005|Overall Study|Adverse Event|1|||
161682919|NCT04232553|583890216|FG006|Overall Study|Adverse Event|0|||
161682920|NCT04232553|583890217|FG007|Overall Study|Adverse Event|0|||
161682921|NCT04232553|583890218|FG008|Overall Study|Adverse Event|0|||
161682922|NCT04232553|583890210|FG000|Overall Study|Death|0|||
161682923|NCT04232553|583890211|FG001|Overall Study|Death|1|||
161682924|NCT04232553|583890212|FG002|Overall Study|Death|0|||
161682925|NCT04232553|583890213|FG003|Overall Study|Death|1|||
161682926|NCT04232553|583890214|FG004|Overall Study|Death|0|||
162026052|NCT03137069|585152873|FG005|Overall Study|Physician Decision|0|||
162026053|NCT03137069|585152868|FG000|Overall Study|Study Terminated by Sponsor|0|||
162026054|NCT03137069|585152869|FG001|Overall Study|Study Terminated by Sponsor|0|||
162026055|NCT03137069|585152870|FG002|Overall Study|Study Terminated by Sponsor|0|||
162026056|NCT03137069|585152871|FG003|Overall Study|Study Terminated by Sponsor|0|||
162026057|NCT03137069|585152872|FG004|Overall Study|Study Terminated by Sponsor|1|||
162026058|NCT03137069|585152873|FG005|Overall Study|Study Terminated by Sponsor|0|||
162026059|NCT03137069|585152868|FG000|Overall Study|Data Entry Error|0|||
162026060|NCT03137069|585152869|FG001|Overall Study|Data Entry Error|0|||
162026061|NCT03137069|585152870|FG002|Overall Study|Data Entry Error|0|||
162026062|NCT03137069|585152871|FG003|Overall Study|Data Entry Error|1|||
162026063|NCT03137069|585152872|FG004|Overall Study|Data Entry Error|0|||
162026064|NCT03137069|585152873|FG005|Overall Study|Data Entry Error|0|||
162026065|NCT01106092|585152875|FG000|Overall Study|Withdrawal by Subject|0|||
162026066|NCT01106092|585152876|FG001|Overall Study|Withdrawal by Subject|0|||
162026067|NCT01106092|585152877|FG002|Overall Study|Withdrawal by Subject|0|||
162026068|NCT01106092|585152878|FG003|Overall Study|Withdrawal by Subject|1|||
162026069|NCT02434471|585152879|FG000|Overall Study|Physician Decision|9|||
162026070|NCT00369629|585152884|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
162026071|NCT00369629|585152885|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
162026072|NCT00369629|585152886|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
162026073|NCT00369629|585152887|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
162026074|NCT00369629|585152884|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
161682927|NCT04232553|583890215|FG005|Overall Study|Death|0|||
161682928|NCT04232553|583890216|FG006|Overall Study|Death|0|||
161682929|NCT04232553|583890217|FG007|Overall Study|Death|0|||
161682930|NCT04232553|583890218|FG008|Overall Study|Death|0|||
161682931|NCT04232553|583890210|FG000|Overall Study|Lack of Efficacy|0|||
161682932|NCT04232553|583890211|FG001|Overall Study|Lack of Efficacy|2|||
161682933|NCT04232553|583890212|FG002|Overall Study|Lack of Efficacy|0|||
161682934|NCT04232553|583890213|FG003|Overall Study|Lack of Efficacy|0|||
161682935|NCT04232553|583890214|FG004|Overall Study|Lack of Efficacy|0|||
161682936|NCT04232553|583890215|FG005|Overall Study|Lack of Efficacy|0|||
161682937|NCT04232553|583890216|FG006|Overall Study|Lack of Efficacy|0|||
161682938|NCT04232553|583890217|FG007|Overall Study|Lack of Efficacy|0|||
161682939|NCT04232553|583890218|FG008|Overall Study|Lack of Efficacy|1|||
161682940|NCT04232553|583890210|FG000|Overall Study|Lost to Follow-up|0|||
161682941|NCT04232553|583890211|FG001|Overall Study|Lost to Follow-up|1|||
161682942|NCT04232553|583890212|FG002|Overall Study|Lost to Follow-up|0|||
161682943|NCT04232553|583890213|FG003|Overall Study|Lost to Follow-up|0|||
161682944|NCT04232553|583890214|FG004|Overall Study|Lost to Follow-up|1|||
161682945|NCT04232553|583890215|FG005|Overall Study|Lost to Follow-up|0|||
161682946|NCT04232553|583890216|FG006|Overall Study|Lost to Follow-up|0|||
161682947|NCT04232553|583890217|FG007|Overall Study|Lost to Follow-up|0|||
161682948|NCT04232553|583890218|FG008|Overall Study|Lost to Follow-up|1|||
161682949|NCT04232553|583890210|FG000|Overall Study|Other - As reported by the investigator|0|||
161682950|NCT04232553|583890211|FG001|Overall Study|Other - As reported by the investigator|1|||
161682951|NCT04232553|583890212|FG002|Overall Study|Other - As reported by the investigator|0|||
161682952|NCT04232553|583890213|FG003|Overall Study|Other - As reported by the investigator|0|||
161682953|NCT04232553|583890214|FG004|Overall Study|Other - As reported by the investigator|0|||
161682954|NCT04232553|583890215|FG005|Overall Study|Other - As reported by the investigator|0|||
161682955|NCT04232553|583890216|FG006|Overall Study|Other - As reported by the investigator|0|||
161682956|NCT04232553|583890217|FG007|Overall Study|Other - As reported by the investigator|0|||
161682957|NCT04232553|583890218|FG008|Overall Study|Other - As reported by the investigator|0|||
161682958|NCT04232553|583890210|FG000|Overall Study|Physician Decision|1|||
161682959|NCT04232553|583890211|FG001|Overall Study|Physician Decision|1|||
161682960|NCT04232553|583890212|FG002|Overall Study|Physician Decision|0|||
161682961|NCT04232553|583890213|FG003|Overall Study|Physician Decision|0|||
161682962|NCT04232553|583890214|FG004|Overall Study|Physician Decision|1|||
162026075|NCT00369629|585152885|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
162026076|NCT00369629|585152886|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
162026077|NCT00369629|585152887|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
162026078|NCT00369629|585152884|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
162026079|NCT00369629|585152885|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
162026080|NCT00369629|585152886|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
162026081|NCT00369629|585152887|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
161682963|NCT04232553|583890215|FG005|Overall Study|Physician Decision|0|||
161682964|NCT04232553|583890216|FG006|Overall Study|Physician Decision|0|||
161682965|NCT04232553|583890217|FG007|Overall Study|Physician Decision|0|||
161682966|NCT04232553|583890218|FG008|Overall Study|Physician Decision|0|||
161831439|NCT01467479|584424743|FG001|Overall Study|Withdrawal of Consent|7|||
162236329|NCT01901341|585916932|FG001|Overall Study|Lack of Efficacy|2|||
161682967|NCT04232553|583890210|FG000|Overall Study|Pregnancy|1|||
161682968|NCT04232553|583890211|FG001|Overall Study|Pregnancy|0|||
161682969|NCT04232553|583890212|FG002|Overall Study|Pregnancy|0|||
161682970|NCT04232553|583890213|FG003|Overall Study|Pregnancy|0|||
161682971|NCT04232553|583890214|FG004|Overall Study|Pregnancy|0|||
161682972|NCT04232553|583890215|FG005|Overall Study|Pregnancy|0|||
161682973|NCT04232553|583890216|FG006|Overall Study|Pregnancy|0|||
162026082|NCT00369629|585152884|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
162026083|NCT00369629|585152885|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
162026084|NCT00369629|585152886|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
162026085|NCT00369629|585152887|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
162026086|NCT00369629|585152884|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
162026087|NCT00369629|585152885|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
162026088|NCT00369629|585152886|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
162236330|NCT01901341|585916931|FG000|Overall Study|Lost to Follow-up|0|||
162236331|NCT01901341|585916932|FG001|Overall Study|Lost to Follow-up|1|||
161682974|NCT04232553|583890217|FG007|Overall Study|Pregnancy|0|||
161682975|NCT04232553|583890218|FG008|Overall Study|Pregnancy|0|||
161682976|NCT04232553|583890210|FG000|Overall Study|Withdrawal by Subject|7|||
161682977|NCT04232553|583890211|FG001|Overall Study|Withdrawal by Subject|5|||
161682978|NCT04232553|583890212|FG002|Overall Study|Withdrawal by Subject|0|||
161682979|NCT04232553|583890213|FG003|Overall Study|Withdrawal by Subject|0|||
161682980|NCT04232553|583890214|FG004|Overall Study|Withdrawal by Subject|2|||
161682981|NCT04232553|583890215|FG005|Overall Study|Withdrawal by Subject|2|||
161682982|NCT04232553|583890216|FG006|Overall Study|Withdrawal by Subject|0|||
162236332|NCT01901341|585916931|FG000|Overall Study|Protocol Violation|2|||
162236333|NCT01901341|585916932|FG001|Overall Study|Protocol Violation|0|||
161682983|NCT04232553|583890217|FG007|Overall Study|Withdrawal by Subject|2|||
161682984|NCT04232553|583890218|FG008|Overall Study|Withdrawal by Subject|0|||
162236334|NCT01901341|585916931|FG000|Overall Study|Study Terminated by Sponsor|13|||
162236335|NCT01901341|585916932|FG001|Overall Study|Study Terminated by Sponsor|15|||
162236336|NCT01901341|585916931|FG000|Overall Study|Withdrawal by Subject|1|||
162236337|NCT01901341|585916932|FG001|Overall Study|Withdrawal by Subject|1|||
162236338|NCT04964388|585916933|FG000|Overall Study|Lost to Follow-up|3|||
162236339|NCT04964388|585916934|FG001|Overall Study|Lost to Follow-up|2|||
162236340|NCT00250679|585916935|FG000|Overall Study|Adverse Event|12|||
162236341|NCT00250679|585916936|FG001|Overall Study|Adverse Event|15|||
162236342|NCT00250679|585916937|FG002|Overall Study|Adverse Event|16|||
162236343|NCT00250679|585916935|FG000|Overall Study|Protocol Violation|2|||
162236344|NCT00250679|585916936|FG001|Overall Study|Protocol Violation|4|||
162236345|NCT00250679|585916937|FG002|Overall Study|Protocol Violation|3|||
162236346|NCT00250679|585916935|FG000|Overall Study|Withdrawal by Subject|15|||
162236347|NCT00250679|585916936|FG001|Overall Study|Withdrawal by Subject|18|||
162236348|NCT00250679|585916937|FG002|Overall Study|Withdrawal by Subject|15|||
162236349|NCT00250679|585916935|FG000|Overall Study|Lost to Follow-up|3|||
162236350|NCT00250679|585916936|FG001|Overall Study|Lost to Follow-up|4|||
162236351|NCT00250679|585916937|FG002|Overall Study|Lost to Follow-up|2|||
162236352|NCT00250679|585916935|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
162236353|NCT00250679|585916936|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
162236354|NCT00250679|585916937|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
162236355|NCT00250679|585916935|FG000|Overall Study|Lack of Efficacy|0|||
162236356|NCT00250679|585916936|FG001|Overall Study|Lack of Efficacy|1|||
162236357|NCT00250679|585916937|FG002|Overall Study|Lack of Efficacy|3|||
162236358|NCT00250679|585916935|FG000|Overall Study|Technical Holter issues|1|||
162236359|NCT00250679|585916936|FG001|Overall Study|Technical Holter issues|0|||
162236360|NCT00250679|585916937|FG002|Overall Study|Technical Holter issues|2|||
162236361|NCT00250679|585916935|FG000|Overall Study|Moved|1|||
162026107|NCT04839562|585152889|FG001|Overall Study|Withdrawal by Subject|1|||
162026108|NCT04839562|585152888|FG000|Overall Study|Physician Decision|0|||
162026109|NCT04839562|585152889|FG001|Overall Study|Physician Decision|1|||
162026110|NCT00877773|585152890|FG000|Overall Study|Disease Progression|44|||
162026111|NCT02907892|585152893|FG000|Overall Study|Lost to Follow-up|27|||
162026112|NCT02907892|585152894|FG001|Overall Study|Lost to Follow-up|40|||
162026113|NCT01347580|585152895|FG000|Overall Study|Withdrawal by Subject|13|||
162026114|NCT01347580|585152896|FG001|Overall Study|Withdrawal by Subject|23|||
162026115|NCT01347580|585152895|FG000|Overall Study|Death|30|||
162026116|NCT01347580|585152896|FG001|Overall Study|Death|19|||
162026117|NCT01347580|585152895|FG000|Overall Study|Protocol Violation|10|||
162026118|NCT01347580|585152896|FG001|Overall Study|Protocol Violation|7|||
162026119|NCT01347580|585152895|FG000|Overall Study|Lost to Follow-up|3|||
162026120|NCT01347580|585152896|FG001|Overall Study|Lost to Follow-up|1|||
162026121|NCT01347580|585152895|FG000|Overall Study|Had other reason|9|||
162026122|NCT01347580|585152896|FG001|Overall Study|Had other reason|6|||
162026123|NCT01964755|585152897|FG000|Overall Study|Death|2|||
162026124|NCT00412373|585152898|FG000|Overall Study|Adverse Event|8|||
162026125|NCT00412373|585152899|FG001|Overall Study|Adverse Event|13|||
162026126|NCT00412373|585152898|FG000|Overall Study|Lack of Efficacy|16|||
162026127|NCT00412373|585152899|FG001|Overall Study|Lack of Efficacy|22|||
162026128|NCT00412373|585152898|FG000|Overall Study|Lost to Follow-up|7|||
162026129|NCT00412373|585152899|FG001|Overall Study|Lost to Follow-up|13|||
162026130|NCT00412373|585152898|FG000|Overall Study|Withdrawal by Subject|8|||
162026131|NCT00412373|585152899|FG001|Overall Study|Withdrawal by Subject|27|||
162026132|NCT00412373|585152898|FG000|Overall Study|Other|2|||
162026133|NCT00412373|585152899|FG001|Overall Study|Other|2|||
162026134|NCT00422513|585152900|FG000|Overall Study|Lack of Efficacy|4|||
162026135|NCT00422513|585152901|FG001|Overall Study|Lack of Efficacy|5|||
162026136|NCT00422513|585152900|FG000|Overall Study|Protocol Violation|23|||
162026137|NCT00422513|585152901|FG001|Overall Study|Protocol Violation|7|||
162026138|NCT00422513|585152900|FG000|Overall Study|Refused Treatment|4|||
162026139|NCT00422513|585152901|FG001|Overall Study|Refused Treatment|2|||
162026140|NCT00422513|585152900|FG000|Overall Study|Withdrawal by Subject|2|||
162026141|NCT00422513|585152901|FG001|Overall Study|Withdrawal by Subject|1|||
162026142|NCT00422513|585152900|FG000|Overall Study|early termination of the study|67|||
162026143|NCT00422513|585152901|FG001|Overall Study|early termination of the study|80|||
162026144|NCT00422513|585152900|FG000|Overall Study|Adverse Event|4|||
162026145|NCT00422513|585152901|FG001|Overall Study|Adverse Event|4|||
162026146|NCT00422513|585152900|FG000|Overall Study|Death|3|||
162026147|NCT00422513|585152901|FG001|Overall Study|Death|7|||
162026148|NCT03135119|585152902|FG000|Overall Study|Lost to Follow-up|2|||
162026149|NCT03135119|585152903|FG001|Overall Study|Lost to Follow-up|0|||
162026150|NCT03135119|585152902|FG000|Overall Study|Physician Decision|1|||
162026151|NCT03135119|585152903|FG001|Overall Study|Physician Decision|1|||
162026152|NCT03135119|585152902|FG000|Overall Study|COVID-19 Shutdown|2|||
162026153|NCT03135119|585152903|FG001|Overall Study|COVID-19 Shutdown|2|||
162026154|NCT01478048|585152904|FG000|Overall Study|Disease Progression|52|||
162026155|NCT01478048|585152905|FG001|Overall Study|Disease Progression|35|||
162026156|NCT01478048|585152904|FG000|Overall Study|study drug toxicity|11|||
162026157|NCT01478048|585152905|FG001|Overall Study|study drug toxicity|14|||
162026158|NCT01478048|585152904|FG000|Overall Study|Adverse Event|2|||
162026159|NCT01478048|585152905|FG001|Overall Study|Adverse Event|11|||
162026160|NCT01478048|585152904|FG000|Overall Study|subject request to discontinue treatment|3|||
162026161|NCT01478048|585152905|FG001|Overall Study|subject request to discontinue treatment|5|||
162026162|NCT01478048|585152904|FG000|Overall Study|Withdrawal by Subject|2|||
162026163|NCT01478048|585152905|FG001|Overall Study|Withdrawal by Subject|5|||
162026164|NCT01478048|585152904|FG000|Overall Study|non-specified|6|||
162026165|NCT01478048|585152905|FG001|Overall Study|non-specified|4|||
162026166|NCT01478048|585152904|FG000|Overall Study|poor/non-compliance|0|||
162026167|NCT01478048|585152905|FG001|Overall Study|poor/non-compliance|1|||
162026168|NCT01478048|585152904|FG000|Overall Study|no longer meets study criteria|1|||
162026169|NCT01478048|585152905|FG001|Overall Study|no longer meets study criteria|0|||
162026170|NCT01369329|585152907|FG000|Overall Study|Withdrawal by Subject|8|||
162026171|NCT01369329|585152908|FG001|Overall Study|Withdrawal by Subject|6|||
162026172|NCT01369329|585152909|FG002|Overall Study|Withdrawal by Subject|10|||
162026173|NCT01369329|585152907|FG000|Overall Study|Lost to Follow-up|2|||
162026174|NCT01369329|585152908|FG001|Overall Study|Lost to Follow-up|2|||
162026175|NCT01369329|585152909|FG002|Overall Study|Lost to Follow-up|2|||
162026176|NCT01369329|585152907|FG000|Overall Study|Other|2|||
162026177|NCT01369329|585152908|FG001|Overall Study|Other|3|||
162026178|NCT01369329|585152909|FG002|Overall Study|Other|2|||
161683073|NCT01843842|583891240|FG001|Overall Study|Do not meet inclusion criteria|1|||
162026179|NCT03032380|585152910|FG000|Overall Study|Adverse Event|0|||
162026180|NCT03032380|585152911|FG001|Overall Study|Adverse Event|1|||
162026181|NCT03032380|585152910|FG000|Overall Study|Lack of Efficacy|1|||
162026182|NCT03032380|585152911|FG001|Overall Study|Lack of Efficacy|0|||
162026183|NCT03032380|585152910|FG000|Overall Study|Withdrawal by Subject|2|||
162026184|NCT03032380|585152911|FG001|Overall Study|Withdrawal by Subject|3|||
162026185|NCT03032380|585152910|FG000|Overall Study|Recovery|0|||
162026186|NCT03032380|585152911|FG001|Overall Study|Recovery|1|||
162026187|NCT03032380|585152910|FG000|Overall Study|Death|39|||
162026188|NCT03032380|585152911|FG001|Overall Study|Death|34|||
162026189|NCT03032380|585152910|FG000|Overall Study|Other - Miscellaneous|0|||
162026190|NCT03032380|585152911|FG001|Overall Study|Other - Miscellaneous|1|||
162026191|NCT02937584|585152912|FG000|Period 1|Adverse Event|1|||
162026192|NCT02937584|585152913|FG001|Period 1|Adverse Event|2|||
162026193|NCT02937584|585152912|FG000|Washout|Adverse Event|0|||
162026194|NCT02937584|585152913|FG001|Washout|Adverse Event|1|||
162026195|NCT01883453|585152914|FG000|Overall Study|No episode of common cold|25|||
162026196|NCT01883453|585152915|FG001|Overall Study|No episode of common cold|23|||
162026197|NCT02238080|585152916|FG000|Overall Study|Death|13|||
162026198|NCT02238080|585152916|FG000|Overall Study|Treatment interrupted|6|||
162026199|NCT02238080|585152916|FG000|Overall Study|Withdrawal by Subject|2|||
162026200|NCT02238080|585152916|FG000|Overall Study|Other|4|||
162026201|NCT01038869|585152917|FG000|Overall Study|Withdrawal by Subject|1|||
162026202|NCT01038869|585152917|FG000|Overall Study|Lost to Follow-up|6|||
162026203|NCT04136444|585152918|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
162026204|NCT04136444|585152919|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
162026205|NCT02238067|585152920|FG000|Overall Study|Not completed survey at Month 6|45|||
162026206|NCT02350764|585152922|FG000|Overall Study|Adverse Event|4|||
162026207|NCT02350764|585152922|FG000|Overall Study|Death|3|||
162026208|NCT02350764|585152922|FG000|Overall Study|Physician Decision|2|||
162026209|NCT02350764|585152922|FG000|Overall Study|Withdrawal by Subject|2|||
162026210|NCT01433289|585152923|FG000|Overall Study|Pregnancy|0|||
162026211|NCT01433289|585152924|FG001|Overall Study|Pregnancy|1|||
162026212|NCT01433289|585152925|FG002|Overall Study|Pregnancy|0|||
162026213|NCT01433289|585152926|FG003|Overall Study|Pregnancy|0|||
162026214|NCT00600119|585152927|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
162026215|NCT00600119|585152928|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
162026216|NCT00600119|585152929|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
162026217|NCT00600119|585152930|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
162026218|NCT00600119|585152931|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
162026219|NCT00600119|585152932|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
162026220|NCT00600119|585152927|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
162026221|NCT00600119|585152928|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
162026222|NCT00600119|585152929|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
162026223|NCT00600119|585152930|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
162026224|NCT00600119|585152931|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
162026225|NCT00600119|585152932|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
162026226|NCT00600119|585152927|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
162026227|NCT00600119|585152928|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
162026228|NCT00600119|585152929|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
162026229|NCT00600119|585152930|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
162026230|NCT00600119|585152931|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
162026231|NCT00600119|585152932|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
162026232|NCT00600119|585152927|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
162026233|NCT00600119|585152928|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
162026234|NCT00600119|585152929|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
162026235|NCT00600119|585152930|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
162026236|NCT00600119|585152931|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
162026237|NCT00600119|585152932|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
162026238|NCT00600119|585152927|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
161831595|NCT00384293|584424836|FG000|Post-randomization Period|Withdrawal by Subject|0|||
161831596|NCT00384293|584424837|FG001|Post-randomization Period|Withdrawal by Subject|8|||
161831597|NCT00384293|584424838|FG002|Post-randomization Period|Withdrawal by Subject|6|||
161831598|NCT00384293|584424836|FG000|Post-randomization Period|Trial Termination|0|||
161831599|NCT00384293|584424837|FG001|Post-randomization Period|Trial Termination|180|||
161831600|NCT00384293|584424838|FG002|Post-randomization Period|Trial Termination|204|||
161831601|NCT00384293|584424836|FG000|Post-randomization Period|Patient Randomized in Error|0|||
161831602|NCT00384293|584424837|FG001|Post-randomization Period|Patient Randomized in Error|0|||
161831603|NCT00384293|584424838|FG002|Post-randomization Period|Patient Randomized in Error|1|||
161831604|NCT03005067|584424839|FG000|Overall Study|Withdrawal by Subject|3|||
161831605|NCT03005067|584424840|FG001|Overall Study|Withdrawal by Subject|2|||
162026239|NCT00600119|585152928|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
162026240|NCT00600119|585152929|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
162026241|NCT00600119|585152930|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
162026242|NCT00600119|585152931|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
162026243|NCT00600119|585152932|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
161683074|NCT02953340|583891241|FG000|Overall Study|Death|0|||
162026244|NCT00600119|585152927|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
162026245|NCT00600119|585152928|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
162026246|NCT00600119|585152929|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
162026247|NCT00600119|585152930|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
162026248|NCT00600119|585152931|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
162026249|NCT00600119|585152932|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
162026250|NCT00600119|585152927|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
162026251|NCT00600119|585152928|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
162026252|NCT00600119|585152929|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
162026253|NCT00600119|585152930|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
162026254|NCT00600119|585152931|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
162026255|NCT00600119|585152932|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
162026256|NCT00600119|585152927|FG000|Double-blind Treatment Period|Other|0|||
162026257|NCT00600119|585152928|FG001|Double-blind Treatment Period|Other|0|||
162026258|NCT00600119|585152929|FG002|Double-blind Treatment Period|Other|0|||
162026259|NCT00600119|585152930|FG003|Double-blind Treatment Period|Other|0|||
162026260|NCT00600119|585152931|FG004|Double-blind Treatment Period|Other|2|||
162026261|NCT00600119|585152932|FG005|Double-blind Treatment Period|Other|1|||
162026262|NCT00600119|585152927|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
162026263|NCT00600119|585152928|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
162026264|NCT00600119|585152929|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
162026265|NCT00600119|585152930|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
162026266|NCT00600119|585152931|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
162026267|NCT00600119|585152932|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
162026268|NCT00600119|585152927|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
162026269|NCT00600119|585152928|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
162026270|NCT00600119|585152929|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
162026271|NCT00600119|585152930|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
162026272|NCT00600119|585152931|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
162026273|NCT00600119|585152932|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
162026274|NCT00600119|585152927|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
162026275|NCT00600119|585152928|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
162026276|NCT00600119|585152929|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
162026277|NCT00600119|585152930|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
162026278|NCT00600119|585152931|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
162026279|NCT00600119|585152932|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
162026280|NCT00600119|585152927|FG000|Double-blind Treatment Period|Physician Decision|2|||
162026281|NCT00600119|585152928|FG001|Double-blind Treatment Period|Physician Decision|0|||
162026282|NCT00600119|585152929|FG002|Double-blind Treatment Period|Physician Decision|0|||
162026283|NCT00600119|585152930|FG003|Double-blind Treatment Period|Physician Decision|0|||
162026284|NCT00600119|585152931|FG004|Double-blind Treatment Period|Physician Decision|0|||
162026285|NCT00600119|585152932|FG005|Double-blind Treatment Period|Physician Decision|0|||
162026286|NCT00600119|585152927|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
162026287|NCT00600119|585152928|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
162026288|NCT00600119|585152929|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
162026289|NCT00600119|585152930|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
162026290|NCT00600119|585152931|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
162026291|NCT00600119|585152932|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
162026292|NCT00600119|585152927|FG000|Double-blind Treatment Period|Adverse Event|1|||
162026293|NCT00600119|585152928|FG001|Double-blind Treatment Period|Adverse Event|1|||
162026294|NCT00600119|585152929|FG002|Double-blind Treatment Period|Adverse Event|0|||
162026295|NCT00600119|585152930|FG003|Double-blind Treatment Period|Adverse Event|1|||
162026296|NCT00600119|585152931|FG004|Double-blind Treatment Period|Adverse Event|2|||
162026297|NCT00600119|585152932|FG005|Double-blind Treatment Period|Adverse Event|10|||
162026298|NCT00600119|585152927|FG000|Follow-up Period|Adverse Event|0|||
162026299|NCT00600119|585152928|FG001|Follow-up Period|Adverse Event|0|||
162026300|NCT00600119|585152929|FG002|Follow-up Period|Adverse Event|0|||
162026301|NCT00600119|585152930|FG003|Follow-up Period|Adverse Event|0|||
162026302|NCT00600119|585152931|FG004|Follow-up Period|Adverse Event|0|||
162026303|NCT00600119|585152932|FG005|Follow-up Period|Adverse Event|1|||
162026304|NCT00600119|585152927|FG000|Follow-up Period|Other|1|||
162026305|NCT00600119|585152928|FG001|Follow-up Period|Other|0|||
162026306|NCT00600119|585152929|FG002|Follow-up Period|Other|0|||
162026307|NCT00600119|585152930|FG003|Follow-up Period|Other|0|||
162026308|NCT00600119|585152931|FG004|Follow-up Period|Other|0|||
162026309|NCT00600119|585152932|FG005|Follow-up Period|Other|0|||
162026310|NCT00561977|585152933|FG000|Overall Study|Withdrawal by Subject|0|||
162026311|NCT00561977|585152934|FG001|Overall Study|Withdrawal by Subject|2|||
162026312|NCT00561977|585152935|FG002|Overall Study|Withdrawal by Subject|1|||
162026313|NCT00561977|585152933|FG000|Overall Study|Pregnancy|0|||
162026314|NCT00561977|585152934|FG001|Overall Study|Pregnancy|1|||
162026315|NCT00561977|585152935|FG002|Overall Study|Pregnancy|1|||
162026316|NCT00783198|585152944|FG000|Overall Study|Adverse Event|15|||
162026317|NCT00783198|585152945|FG001|Overall Study|Adverse Event|19|||
162026318|NCT00783198|585152946|FG002|Overall Study|Adverse Event|3|||
162026319|NCT00783198|585152944|FG000|Overall Study|Lost to Follow-up|11|||
162026320|NCT00783198|585152945|FG001|Overall Study|Lost to Follow-up|1|||
162026321|NCT00783198|585152946|FG002|Overall Study|Lost to Follow-up|7|||
162026322|NCT00783198|585152944|FG000|Overall Study|Withdrawal by Subject|22|||
162026323|NCT00783198|585152945|FG001|Overall Study|Withdrawal by Subject|14|||
162026324|NCT00783198|585152946|FG002|Overall Study|Withdrawal by Subject|20|||
162026325|NCT00783198|585152944|FG000|Overall Study|Noncompliance with protocol|7|||
162026326|NCT00783198|585152945|FG001|Overall Study|Noncompliance with protocol|7|||
162026327|NCT00783198|585152946|FG002|Overall Study|Noncompliance with protocol|10|||
162026328|NCT00783198|585152944|FG000|Overall Study|Did not meet protocol eligibility|0|||
162026329|NCT00783198|585152945|FG001|Overall Study|Did not meet protocol eligibility|1|||
162026330|NCT00783198|585152946|FG002|Overall Study|Did not meet protocol eligibility|0|||
162026331|NCT00783198|585152944|FG000|Overall Study|Administrative|2|||
162026332|NCT00783198|585152945|FG001|Overall Study|Administrative|1|||
162026333|NCT00783198|585152946|FG002|Overall Study|Administrative|2|||
162026334|NCT01546623|585152949|FG000|Overall Study|Adverse Event|2|||
162026335|NCT01546623|585152950|FG001|Overall Study|Adverse Event|3|||
162026336|NCT01546623|585152949|FG000|Overall Study|Major Protocol Deviation|1|||
162026337|NCT01546623|585152950|FG001|Overall Study|Major Protocol Deviation|1|||
162026338|NCT01546623|585152949|FG000|Overall Study|High Prostate specific antigen|2|||
162026339|NCT01546623|585152950|FG001|Overall Study|High Prostate specific antigen|1|||
162026340|NCT01546623|585152949|FG000|Overall Study|Did Not Receive Study Drug|1|||
162026341|NCT01546623|585152950|FG001|Overall Study|Did Not Receive Study Drug|1|||
162026342|NCT00246740|585152951|FG000|Initial Enrollment|Death|1|||
162026343|NCT00246740|585152952|FG001|Initial Enrollment|Death|0|||
162026344|NCT00246740|585152951|FG000|Initial Enrollment|Additional surgery scheduled|0|||
162026345|NCT00246740|585152952|FG001|Initial Enrollment|Additional surgery scheduled|2|||
162026346|NCT00246740|585152951|FG000|Initial Enrollment|Surgery schedule change|4|||
162026347|NCT00246740|585152952|FG001|Initial Enrollment|Surgery schedule change|4|||
162026348|NCT00246740|585152951|FG000|Initial Enrollment|Other|1|||
162026349|NCT00246740|585152952|FG001|Initial Enrollment|Other|2|||
162026350|NCT00101452|585152953|FG000|Overall Study|Adverse Event|2|||
162026351|NCT00101452|585152954|FG001|Overall Study|Adverse Event|0|||
162026352|NCT00101452|585152955|FG002|Overall Study|Adverse Event|1|||
162026353|NCT00101452|585152953|FG000|Overall Study|Lost to Follow-up|13|||
162026354|NCT00101452|585152954|FG001|Overall Study|Lost to Follow-up|8|||
162026355|NCT00101452|585152955|FG002|Overall Study|Lost to Follow-up|14|||
162026356|NCT00101452|585152953|FG000|Overall Study|Withdrawal by Subject|10|||
162026357|NCT00101452|585152954|FG001|Overall Study|Withdrawal by Subject|14|||
162026358|NCT00101452|585152955|FG002|Overall Study|Withdrawal by Subject|9|||
162026359|NCT00101452|585152953|FG000|Overall Study|Baseline Fail|2|||
162026360|NCT00101452|585152954|FG001|Overall Study|Baseline Fail|1|||
162026361|NCT00101452|585152955|FG002|Overall Study|Baseline Fail|2|||
162026362|NCT00101452|585152953|FG000|Overall Study|Physician Decision|0|||
162026363|NCT00101452|585152954|FG001|Overall Study|Physician Decision|3|||
162026364|NCT00101452|585152955|FG002|Overall Study|Physician Decision|2|||
162026365|NCT00101452|585152953|FG000|Overall Study|Protocol Violation|2|||
162026366|NCT00101452|585152954|FG001|Overall Study|Protocol Violation|1|||
162026367|NCT00101452|585152955|FG002|Overall Study|Protocol Violation|3|||
162026368|NCT00101452|585152953|FG000|Overall Study|Other|15|||
162026369|NCT00101452|585152954|FG001|Overall Study|Other|16|||
162026370|NCT00101452|585152955|FG002|Overall Study|Other|12|||
162026371|NCT01510769|585152956|FG000|Overall Study|Adverse Event|7|||
162026372|NCT01510769|585152957|FG001|Overall Study|Adverse Event|6|||
162026373|NCT01510769|585152958|FG002|Overall Study|Adverse Event|4|||
162026374|NCT01510769|585152956|FG000|Overall Study|Gout Flare|0|||
162026375|NCT01510769|585152957|FG001|Overall Study|Gout Flare|3|||
162026376|NCT01510769|585152958|FG002|Overall Study|Gout Flare|1|||
162026377|NCT01510769|585152956|FG000|Overall Study|Protocol Violation|11|||
162026378|NCT01510769|585152957|FG001|Overall Study|Protocol Violation|10|||
161831606|NCT03005067|584424839|FG000|Overall Study|Adverse Event|4|||
162026379|NCT01510769|585152958|FG002|Overall Study|Protocol Violation|9|||
162026380|NCT01510769|585152956|FG000|Overall Study|Lost to Follow-up|5|||
162026381|NCT01510769|585152957|FG001|Overall Study|Lost to Follow-up|1|||
162026382|NCT01510769|585152958|FG002|Overall Study|Lost to Follow-up|5|||
162026383|NCT01510769|585152956|FG000|Overall Study|Withdrawal by Subject|3|||
162026384|NCT01510769|585152957|FG001|Overall Study|Withdrawal by Subject|4|||
162026385|NCT01510769|585152958|FG002|Overall Study|Withdrawal by Subject|3|||
162026386|NCT01510769|585152956|FG000|Overall Study|Death|1|||
162026387|NCT01510769|585152957|FG001|Overall Study|Death|1|||
162026388|NCT01510769|585152958|FG002|Overall Study|Death|0|||
162026389|NCT02674204|585152959|FG000|Overall Study|Adverse Event|1|||
161683075|NCT02953340|583891242|FG001|Overall Study|Death|1|||
161683076|NCT02953340|583891241|FG000|Overall Study|Investigator Decision|3|||
161683077|NCT02953340|583891242|FG001|Overall Study|Investigator Decision|3|||
161683078|NCT02953340|583891241|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
161683079|NCT02953340|583891242|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
161683080|NCT02953340|583891241|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
161683081|NCT02953340|583891242|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
161683082|NCT02953340|583891241|FG000|Overall Study|Withdrawal by Subject|9|||
161683083|NCT02953340|583891242|FG001|Overall Study|Withdrawal by Subject|9|||
161683084|NCT02953340|583891241|FG000|Overall Study|Sponsor decision|0|||
161683085|NCT02953340|583891242|FG001|Overall Study|Sponsor decision|2|||
161683086|NCT02953340|583891241|FG000|Overall Study|Lost to Follow-up|3|||
161683087|NCT02953340|583891242|FG001|Overall Study|Lost to Follow-up|2|||
161683088|NCT02953340|583891241|FG000|Overall Study|Reason not specified|2|||
161683089|NCT02953340|583891242|FG001|Overall Study|Reason not specified|2|||
161683090|NCT01376778|583891243|FG000|Overall Study|Lost to Follow-up|3|||
161683091|NCT01376778|583891244|FG001|Overall Study|Lost to Follow-up|2|||
161683092|NCT00632099|583891245|FG000|Overall Study|Lost to Follow-up|3|||
161683093|NCT00632099|583891246|FG001|Overall Study|Lost to Follow-up|3|||
161683094|NCT03374189|583891252|FG000|Overall Study|Lost to Follow-up|1|||
161683095|NCT03374189|583891253|FG001|Overall Study|Lost to Follow-up|0|||
161683096|NCT01517893|583891254|FG000|Overall Study|Withdrawal by Subject|3|||
161683097|NCT01517893|583891255|FG001|Overall Study|Withdrawal by Subject|0|||
161683098|NCT02018822|583891256|FG000|Overall Study|filling replaced by crown|0|||
161683099|NCT02018822|583891257|FG001|Overall Study|filling replaced by crown|1|||
161942343|NCT02303821|584838371|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
161942344|NCT02303821|584838372|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
161942345|NCT02303821|584838373|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
161942346|NCT02303821|584838374|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
161942347|NCT02303821|584838375|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
161942348|NCT02303821|584838368|FG000|Overall Study|Decision by sponsor|0|||
161942349|NCT02303821|584838369|FG001|Overall Study|Decision by sponsor|0|||
161942350|NCT02303821|584838370|FG002|Overall Study|Decision by sponsor|0|||
161942351|NCT02303821|584838371|FG003|Overall Study|Decision by sponsor|0|||
161942352|NCT02303821|584838372|FG004|Overall Study|Decision by sponsor|0|||
161942353|NCT02303821|584838373|FG005|Overall Study|Decision by sponsor|1|||
161942354|NCT02303821|584838374|FG006|Overall Study|Decision by sponsor|0|||
161942355|NCT02303821|584838375|FG007|Overall Study|Decision by sponsor|0|||
161942356|NCT02303821|584838368|FG000|Overall Study|Protocol-specified criteria|0|||
161942357|NCT02303821|584838369|FG001|Overall Study|Protocol-specified criteria|1|||
161942358|NCT02303821|584838370|FG002|Overall Study|Protocol-specified criteria|0|||
161942359|NCT02303821|584838371|FG003|Overall Study|Protocol-specified criteria|0|||
161942360|NCT02303821|584838372|FG004|Overall Study|Protocol-specified criteria|0|||
161683100|NCT02018822|583891258|FG002|Overall Study|filling replaced by crown|0|||
161683101|NCT02018822|583891256|FG000|Overall Study|Physician Decision|0|||
161683102|NCT02018822|583891257|FG001|Overall Study|Physician Decision|1|||
161683103|NCT02018822|583891258|FG002|Overall Study|Physician Decision|1|||
161683104|NCT02018822|583891256|FG000|Overall Study|Lost to Follow-up|6|||
161683105|NCT02018822|583891257|FG001|Overall Study|Lost to Follow-up|6|||
161683106|NCT02018822|583891258|FG002|Overall Study|Lost to Follow-up|5|||
161683107|NCT03201458|583891259|FG000|Overall Study|No longer eligible|2|||
161683108|NCT03201458|583891260|FG001|Overall Study|No longer eligible|5|||
161683109|NCT03201458|583891259|FG000|Overall Study|Health event before starting|1|||
161683110|NCT03201458|583891260|FG001|Overall Study|Health event before starting|0|||
161683111|NCT03201458|583891259|FG000|Overall Study|Physician Decision|1|||
161683112|NCT03201458|583891260|FG001|Overall Study|Physician Decision|0|||
161683113|NCT01069172|583891269|FG000|Overall Study|Withdrawal by Subject|1|||
161683114|NCT01069172|583891270|FG001|Overall Study|Withdrawal by Subject|0|||
161683115|NCT02184195|583891273|FG000|Overall Study|Patient decision|5|||
161683116|NCT02184195|583891274|FG001|Overall Study|Patient decision|2|||
161683117|NCT02184195|583891273|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162026390|NCT02674204|585152960|FG001|Overall Study|Adverse Event|0|||
162026391|NCT02466659|585152961|FG000|Overall Study|Lost to Follow-up|5|||
162026392|NCT02466659|585152962|FG001|Overall Study|Lost to Follow-up|2|||
162026393|NCT01536392|585152963|FG000|Overall Study|Adverse Event|2|||
162026394|NCT01536392|585152964|FG001|Overall Study|Adverse Event|2|||
162026395|NCT01536392|585152963|FG000|Overall Study|Physician Decision|2|||
162026396|NCT01536392|585152964|FG001|Overall Study|Physician Decision|3|||
162026397|NCT01536392|585152963|FG000|Overall Study|Withdrawal by Subject|3|||
162026398|NCT01536392|585152964|FG001|Overall Study|Withdrawal by Subject|6|||
162026399|NCT01536392|585152963|FG000|Overall Study|Non Compliance|3|||
162026400|NCT01536392|585152964|FG001|Overall Study|Non Compliance|4|||
162026401|NCT01536392|585152963|FG000|Overall Study|Completed therapy early|3|||
162026402|NCT01536392|585152964|FG001|Overall Study|Completed therapy early|0|||
162026403|NCT02874144|585152965|FG000|Overall Study|Lost to Follow-up|3|||
162026404|NCT02874144|585152966|FG001|Overall Study|Lost to Follow-up|5|||
162026405|NCT02756806|585152972|FG000|Overall Study|Study terminated early|5|||
162026406|NCT03158285|585152973|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
162026407|NCT03158285|585152974|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
162026408|NCT03158285|585152975|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
161683118|NCT02184195|583891274|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161683119|NCT02184195|583891273|FG000|Overall Study|Death|67|||
162026409|NCT03158285|585152973|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
162026410|NCT03158285|585152974|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
162026411|NCT03158285|585152975|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
162026412|NCT03158285|585152973|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
162026413|NCT03158285|585152974|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
162026414|NCT03158285|585152975|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
162026415|NCT03158285|585152973|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
162026416|NCT03158285|585152974|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
162026417|NCT03158285|585152975|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
162026418|NCT03158285|585152973|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
162026419|NCT03158285|585152974|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
162026420|NCT03158285|585152975|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
162026421|NCT03158285|585152973|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
162026422|NCT03158285|585152974|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
162026423|NCT03158285|585152975|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
162026424|NCT03158285|585152973|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
162026425|NCT03158285|585152974|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
162026426|NCT03158285|585152975|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
162026427|NCT03158285|585152973|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
162026428|NCT03158285|585152974|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
162026429|NCT03158285|585152975|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
162026430|NCT03158285|585152973|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
162026431|NCT03158285|585152974|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
162026432|NCT03158285|585152975|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
162026433|NCT03158285|585152973|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
162026434|NCT03158285|585152974|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
162026435|NCT03158285|585152975|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
162026436|NCT03158285|585152973|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
162026437|NCT03158285|585152974|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
162026438|NCT03158285|585152975|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
162026439|NCT03158285|585152973|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
162026440|NCT03158285|585152974|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
162026441|NCT03158285|585152975|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
162026442|NCT03158285|585152973|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
162026443|NCT03158285|585152974|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
162026444|NCT03158285|585152975|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
162026445|NCT03158285|585152973|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
162026446|NCT03158285|585152974|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
162026447|NCT03158285|585152975|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
162026448|NCT03158285|585152973|FG000|Active Treatment Period: Week 52-100|Death|1|||
162026449|NCT03158285|585152974|FG001|Active Treatment Period: Week 52-100|Death|0|||
162026450|NCT03158285|585152975|FG002|Active Treatment Period: Week 52-100|Death|0|||
162026451|NCT03158285|585152973|FG000|Active Treatment Period: Week 52-100|Other|4|||
162026452|NCT03158285|585152974|FG001|Active Treatment Period: Week 52-100|Other|1|||
162026453|NCT03158285|585152975|FG002|Active Treatment Period: Week 52-100|Other|0|||
162026454|NCT02228980|585152978|FG000|Overall Study|Adverse Event|14|||
162026455|NCT02228980|585152979|FG001|Overall Study|Adverse Event|0|||
162026456|NCT02228980|585152980|FG002|Overall Study|Adverse Event|0|||
162026457|NCT02228980|585152981|FG003|Overall Study|Adverse Event|0|||
162026458|NCT02228980|585152978|FG000|Overall Study|Protocol Violation|7|||
162026459|NCT02228980|585152979|FG001|Overall Study|Protocol Violation|0|||
162026460|NCT02228980|585152980|FG002|Overall Study|Protocol Violation|0|||
162026461|NCT02228980|585152981|FG003|Overall Study|Protocol Violation|0|||
162026462|NCT02228980|585152978|FG000|Overall Study|Withdrawal by Subject|3|||
161831607|NCT03005067|584424840|FG001|Overall Study|Adverse Event|3|||
161831608|NCT03005067|584424839|FG000|Overall Study|Other (reason not specified)|3|||
161831609|NCT03005067|584424840|FG001|Overall Study|Other (reason not specified)|1|||
161831610|NCT03005067|584424839|FG000|Overall Study|Protocol Violation|0|||
161831611|NCT03005067|584424840|FG001|Overall Study|Protocol Violation|1|||
161831612|NCT00103038|584424846|FG000|Overall Study|Withdrawal by Subject|8|||
161831613|NCT00103038|584424846|FG000|Overall Study|Screen failure|3|||
161831614|NCT00103038|584424846|FG000|Overall Study|Death|1|||
161831615|NCT00103038|584424846|FG000|Overall Study|Physician Decision|1|||
161831616|NCT00355472|584424849|FG000|Overall Study|Physician Decision|1|||
161831617|NCT05445843|584424850|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
161831618|NCT05445843|584424851|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
161831619|NCT05445843|584424850|FG000|Overall Study|Progressive disease|17|||
162026463|NCT02228980|585152979|FG001|Overall Study|Withdrawal by Subject|3|||
162026464|NCT02228980|585152980|FG002|Overall Study|Withdrawal by Subject|2|||
162026465|NCT02228980|585152981|FG003|Overall Study|Withdrawal by Subject|3|||
161831620|NCT05445843|584424851|FG001|Overall Study|Progressive disease|9|||
162026466|NCT00750152|585152982|FG000|Overall Study|Adverse Event|2|||
162026467|NCT00750152|585152983|FG001|Overall Study|Adverse Event|1|||
162026468|NCT00750152|585152982|FG000|Overall Study|Lost to Follow-up|8|||
162026469|NCT00750152|585152983|FG001|Overall Study|Lost to Follow-up|13|||
162026470|NCT00750152|585152982|FG000|Overall Study|Withdrawal by Subject|3|||
162026471|NCT00750152|585152983|FG001|Overall Study|Withdrawal by Subject|3|||
162026472|NCT00750152|585152982|FG000|Overall Study|Physician Decision|1|||
162026473|NCT00750152|585152983|FG001|Overall Study|Physician Decision|1|||
162026474|NCT00750152|585152982|FG000|Overall Study|Non-compliance|0|||
162026475|NCT00750152|585152983|FG001|Overall Study|Non-compliance|1|||
162026476|NCT00750152|585152982|FG000|Overall Study|Termination by sponsor|1|||
162026477|NCT00750152|585152983|FG001|Overall Study|Termination by sponsor|0|||
162026478|NCT00750152|585152982|FG000|Overall Study|Other|7|||
162026479|NCT00750152|585152983|FG001|Overall Study|Other|8|||
162026480|NCT00978757|585152986|FG000|Overall Study|Physician Decision|1|||
162026481|NCT00978757|585152987|FG001|Overall Study|Physician Decision|3|||
162026482|NCT01028300|585152988|FG000|Overall Study|Study Terminated|4|||
162026483|NCT00715910|585152991|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
162026484|NCT00715910|585152992|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
162026485|NCT00715910|585152993|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
162026486|NCT00715910|585152994|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
162026487|NCT00715910|585152995|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
162026488|NCT00715910|585152996|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
162026489|NCT00715910|585152991|FG000|Booster and ESFU Phase|Other|0|||
162026490|NCT00715910|585152992|FG001|Booster and ESFU Phase|Other|0|||
162026491|NCT00715910|585152993|FG002|Booster and ESFU Phase|Other|0|||
162026492|NCT00715910|585152994|FG003|Booster and ESFU Phase|Other|5|||
162026493|NCT00715910|585152995|FG004|Booster and ESFU Phase|Other|1|||
162026494|NCT00715910|585152996|FG005|Booster and ESFU Phase|Other|0|||
162026495|NCT00946153|585152997|FG000|Phase 2|Adverse Event|0|||
162026496|NCT00946153|585152998|FG001|Phase 2|Adverse Event|0|||
162026497|NCT00946153|585152999|FG002|Phase 2|Adverse Event|0|||
162026498|NCT00946153|585153000|FG003|Phase 2|Adverse Event|0|||
162026499|NCT00946153|585153001|FG004|Phase 2|Adverse Event|6|||
162026500|NCT00946153|585152997|FG000|Phase 2|Need more reduction of dose|0|||
162026501|NCT00946153|585152998|FG001|Phase 2|Need more reduction of dose|0|||
162026502|NCT00946153|585152999|FG002|Phase 2|Need more reduction of dose|0|||
162026503|NCT00946153|585153000|FG003|Phase 2|Need more reduction of dose|0|||
162026504|NCT00946153|585153001|FG004|Phase 2|Need more reduction of dose|2|||
162026505|NCT00946153|585152997|FG000|Phase 2|Physician Decision|0|||
162026506|NCT00946153|585152998|FG001|Phase 2|Physician Decision|0|||
162026507|NCT00946153|585152999|FG002|Phase 2|Physician Decision|0|||
162026508|NCT00946153|585153000|FG003|Phase 2|Physician Decision|0|||
162026509|NCT00946153|585153001|FG004|Phase 2|Physician Decision|1|||
162026510|NCT00946153|585152997|FG000|Phase 2|14 days washout for recovery due to AE|0|||
162026511|NCT00946153|585152998|FG001|Phase 2|14 days washout for recovery due to AE|0|||
162026512|NCT00946153|585152999|FG002|Phase 2|14 days washout for recovery due to AE|0|||
162026513|NCT00946153|585153000|FG003|Phase 2|14 days washout for recovery due to AE|0|||
162026514|NCT00946153|585153001|FG004|Phase 2|14 days washout for recovery due to AE|4|||
162026515|NCT01030666|585153002|FG000|Overall Study|Lost to Follow-up|3|||
162026516|NCT01030666|585153003|FG001|Overall Study|Lost to Follow-up|2|||
162026517|NCT01144299|585153004|FG000|Overall Study|Lost to Follow-up|1|||
162026518|NCT01144299|585153005|FG001|Overall Study|Lost to Follow-up|0|||
162026519|NCT01144299|585153004|FG000|Overall Study|Withdrawal by Subject|1|||
162026520|NCT01144299|585153005|FG001|Overall Study|Withdrawal by Subject|0|||
162026521|NCT04002908|585153014|FG000|Overall Study|Death|41|||
162026522|NCT04002908|585153015|FG001|Overall Study|Death|0|||
162026523|NCT04002908|585153016|FG002|Overall Study|Death|0|||
162026524|NCT04002908|585153017|FG003|Overall Study|Death|0|||
162026525|NCT04002908|585153014|FG000|Overall Study|Withdrawal by Subject|112|||
162026526|NCT04002908|585153015|FG001|Overall Study|Withdrawal by Subject|0|||
162026527|NCT04002908|585153016|FG002|Overall Study|Withdrawal by Subject|0|||
162026528|NCT04002908|585153017|FG003|Overall Study|Withdrawal by Subject|0|||
162026529|NCT04002908|585153014|FG000|Overall Study|Lost to Follow-up|72|||
162026530|NCT04002908|585153015|FG001|Overall Study|Lost to Follow-up|0|||
162026531|NCT04002908|585153016|FG002|Overall Study|Lost to Follow-up|0|||
162026532|NCT04002908|585153017|FG003|Overall Study|Lost to Follow-up|0|||
162026533|NCT04002908|585153014|FG000|Overall Study|Infant died, so mother withdrawn|34|||
162026534|NCT04002908|585153015|FG001|Overall Study|Infant died, so mother withdrawn|0|||
162026535|NCT04002908|585153016|FG002|Overall Study|Infant died, so mother withdrawn|0|||
162026536|NCT04002908|585153017|FG003|Overall Study|Infant died, so mother withdrawn|0|||
162026537|NCT04359901|585153022|FG000|Overall Study|Withdrawal by Subject|0|||
162026538|NCT04359901|585153023|FG001|Overall Study|Withdrawal by Subject|1|||
162026539|NCT04359901|585153022|FG000|Overall Study|Death|6|||
162026540|NCT04359901|585153023|FG001|Overall Study|Death|2|||
162026541|NCT03255083|585153024|FG000|Overall Study|Clinical progression|1|||
162026542|NCT03255083|585153025|FG001|Overall Study|Clinical progression|0|||
162026543|NCT03255083|585153026|FG002|Overall Study|Clinical progression|0|||
162026544|NCT03255083|585153027|FG003|Overall Study|Clinical progression|0|||
162026545|NCT03255083|585153024|FG000|Overall Study|Adverse Event|0|||
162026546|NCT03255083|585153025|FG001|Overall Study|Adverse Event|1|||
162026547|NCT03255083|585153026|FG002|Overall Study|Adverse Event|0|||
162026548|NCT03255083|585153027|FG003|Overall Study|Adverse Event|0|||
162026549|NCT03255083|585153024|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
162026550|NCT03255083|585153025|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
162026551|NCT03255083|585153026|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
162026552|NCT03255083|585153027|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
162026553|NCT03255083|585153024|FG000|Overall Study|Withdrawal by Subject|1|||
162026554|NCT03255083|585153025|FG001|Overall Study|Withdrawal by Subject|1|||
162026555|NCT03255083|585153026|FG002|Overall Study|Withdrawal by Subject|1|||
162026556|NCT03255083|585153027|FG003|Overall Study|Withdrawal by Subject|0|||
162026557|NCT05009979|585153028|FG000|Overall Study|Withdrawal by Subject|1|||
162026558|NCT02043899|585154340|FG000|Overall Study|Adverse Event|3|||
162026559|NCT02043899|585154340|FG000|Overall Study|Physician Decision|1|||
162026560|NCT02043899|585154340|FG000|Overall Study|Withdrawal by Subject|2|||
162026561|NCT02043899|585154340|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
162026562|NCT02043899|585154340|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
162026563|NCT02043899|585154340|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
162026564|NCT02043899|585154340|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
162026565|NCT02043899|585154340|FG000|Overall Study|Treatment delayed|1|||
162026566|NCT01771809|585154342|FG000|Overall Study|Adverse Event|4|||
162026567|NCT01771809|585154343|FG001|Overall Study|Adverse Event|12|||
162026568|NCT01771809|585154342|FG000|Overall Study|Protocol Violation|0|||
162026569|NCT01771809|585154343|FG001|Overall Study|Protocol Violation|1|||
162026570|NCT01771809|585154342|FG000|Overall Study|Withdrawal by Subject|34|||
162026571|NCT01771809|585154343|FG001|Overall Study|Withdrawal by Subject|42|||
162026572|NCT01771809|585154342|FG000|Overall Study|Lost to Follow-up|1|||
162026573|NCT01771809|585154343|FG001|Overall Study|Lost to Follow-up|3|||
162026574|NCT01771809|585154342|FG000|Overall Study|Other (Insufficient clinical response)|22|||
162026575|NCT01771809|585154343|FG001|Overall Study|Other (Insufficient clinical response)|20|||
162026576|NCT01771809|585154342|FG000|Overall Study|Death|1|||
162026577|NCT01771809|585154343|FG001|Overall Study|Death|0|||
162026578|NCT01771809|585154342|FG000|Overall Study|Other (other)|9|||
162026579|NCT01771809|585154343|FG001|Overall Study|Other (other)|5|||
162026580|NCT01974765|585154349|FG000|Overall Study|Withdrawal by Subject|1|||
162026581|NCT01974765|585154349|FG000|Overall Study|Death|1|||
162026582|NCT01974765|585154349|FG000|Overall Study|Adverse Event|2|||
162026583|NCT02870933|585154354|FG000|Overall Study|Death|2|||
162026584|NCT02870933|585154355|FG001|Overall Study|Death|1|||
162026585|NCT02870933|585154354|FG000|Overall Study|Withdrawal by Subject|0|||
162026586|NCT02870933|585154355|FG001|Overall Study|Withdrawal by Subject|1|||
162026587|NCT02168387|585154356|FG000|Overall Study|Planned exubation|6|||
162026588|NCT02168387|585154357|FG001|Overall Study|Planned exubation|3|||
162026589|NCT02168387|585154356|FG000|Overall Study|Death|1|||
162026590|NCT02168387|585154357|FG001|Overall Study|Death|0|||
162026591|NCT01659554|585154358|FG000|Overall Study|Study Termination|4|||
162026592|NCT00910624|585154360|FG000|Treatment Phase|Adverse Event|2|||
162026593|NCT00910624|585154361|FG001|Treatment Phase|Adverse Event|6|||
162026594|NCT00910624|585154362|FG002|Treatment Phase|Adverse Event|6|||
162026595|NCT00910624|585154363|FG003|Treatment Phase|Adverse Event|0|||
162026596|NCT00910624|585154360|FG000|Treatment Phase|Treatment Failure|23|||
162026597|NCT00910624|585154361|FG001|Treatment Phase|Treatment Failure|10|||
162026598|NCT00910624|585154362|FG002|Treatment Phase|Treatment Failure|0|||
162026599|NCT00910624|585154363|FG003|Treatment Phase|Treatment Failure|0|||
162026600|NCT00910624|585154360|FG000|Treatment Phase|Lost to Follow-up|0|||
162026601|NCT00910624|585154361|FG001|Treatment Phase|Lost to Follow-up|0|||
162026602|NCT00910624|585154362|FG002|Treatment Phase|Lost to Follow-up|1|||
161683120|NCT02184195|583891274|FG001|Overall Study|Death|44|||
161683121|NCT02184195|583891273|FG000|Overall Study|Lost to Follow-up|1|||
161683122|NCT02184195|583891274|FG001|Overall Study|Lost to Follow-up|5|||
161683123|NCT02184195|583891273|FG000|Overall Study|Other|0|||
161683124|NCT02184195|583891274|FG001|Overall Study|Other|3|||
162026603|NCT00910624|585154363|FG003|Treatment Phase|Lost to Follow-up|0|||
162026604|NCT00910624|585154360|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
162026605|NCT00910624|585154361|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
162026606|NCT00910624|585154362|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
162026607|NCT00910624|585154363|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
162026608|NCT00910624|585154360|FG000|Treatment Phase|Withdrawal by Subject|2|||
162026609|NCT00910624|585154361|FG001|Treatment Phase|Withdrawal by Subject|1|||
162026610|NCT00910624|585154362|FG002|Treatment Phase|Withdrawal by Subject|0|||
161683125|NCT00589420|583891275|FG000|Overall Study|screen failure|1|||
162026611|NCT00910624|585154363|FG003|Treatment Phase|Withdrawal by Subject|0|||
162026612|NCT00910624|585154360|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
162026613|NCT00910624|585154361|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
161683126|NCT00841568|583891276|FG000|Overall Study|Adverse Event|1|||
161831621|NCT05445843|584424850|FG000|Overall Study|Physician Decision|16|||
161831622|NCT05445843|584424851|FG001|Overall Study|Physician Decision|4|||
161831623|NCT05445843|584424850|FG000|Overall Study|Death|6|||
161831624|NCT05445843|584424851|FG001|Overall Study|Death|3|||
161831625|NCT05445843|584424850|FG000|Overall Study|Subject decision|6|||
161831626|NCT05445843|584424851|FG001|Overall Study|Subject decision|2|||
161831627|NCT05445843|584424850|FG000|Overall Study|Adverse Event|2|||
161831628|NCT05445843|584424851|FG001|Overall Study|Adverse Event|0|||
161831629|NCT05307679|584424856|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
161831630|NCT05307679|584424857|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
161831631|NCT02310763|584424860|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
161831632|NCT02310763|584424861|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
161831633|NCT02310763|584424862|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
161831634|NCT02310763|584424860|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
161831635|NCT02310763|584424861|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
161831636|NCT02310763|584424862|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
161831637|NCT02310763|584424860|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
161831638|NCT02310763|584424861|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
161831639|NCT02310763|584424862|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
161831640|NCT02310763|584424860|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
161831641|NCT02310763|584424861|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
161831642|NCT02310763|584424862|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
161831643|NCT02310763|584424860|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
161831644|NCT02310763|584424861|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
161831645|NCT02310763|584424862|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
161831646|NCT01731886|584424864|FG000|Overall Study|Death|1|||
161831647|NCT01731886|584424865|FG001|Overall Study|Death|0|||
161831648|NCT01731886|584424864|FG000|Overall Study|Never started treatment|0|||
161831649|NCT01731886|584424865|FG001|Overall Study|Never started treatment|1|||
161831650|NCT01731886|584424864|FG000|Overall Study|Non-compliant|1|||
161831651|NCT01731886|584424865|FG001|Overall Study|Non-compliant|0|||
161831652|NCT02280187|584424866|FG000|Overall Study|Lost to Follow-up|218|||
161831653|NCT03417830|584424869|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
161831654|NCT03417830|584424870|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
161831655|NCT02563769|584424871|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
161831656|NCT02563769|584424872|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
161831657|NCT02563769|584424873|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
161831658|NCT01192399|584424885|FG000|Overall Study|Lack of Efficacy|2|||
161831659|NCT00724373|584424887|FG000|Overall Study|Adverse Event|41|||
161831660|NCT00724373|584424887|FG000|Overall Study|Lack of Efficacy|82|||
161831661|NCT00724373|584424887|FG000|Overall Study|Lost to Follow-up|7|||
161831662|NCT00724373|584424887|FG000|Overall Study|Non-compliance|2|||
161831663|NCT00724373|584424887|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
161831664|NCT00724373|584424887|FG000|Overall Study|Participant moved away|1|||
161831665|NCT00724373|584424887|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
161831666|NCT00724373|584424887|FG000|Overall Study|Only to have 24 week regimen|1|||
161831667|NCT00724373|584424887|FG000|Overall Study|Viral Relapse|1|||
161831668|NCT00724373|584424887|FG000|Overall Study|Acute HCV infection|1|||
161831669|NCT00724373|584424887|FG000|Overall Study|Drug Relapse|1|||
161831670|NCT00724373|584424887|FG000|Overall Study|Tolerability|23|||
161831671|NCT02377063|584424888|FG000|Overall Study|Non-compliance|5|||
161831672|NCT01524913|584424889|FG000|Overall Study|Lost to Follow-up|4|||
161831673|NCT01524913|584424890|FG001|Overall Study|Lost to Follow-up|0|||
161831674|NCT01524913|584424891|FG002|Overall Study|Lost to Follow-up|0|||
161831675|NCT01221090|584426925|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
161831676|NCT01221090|584426926|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
161831677|NCT01221090|584426927|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
161831678|NCT01221090|584426928|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
161831679|NCT01221090|584426925|FG000|Overall Study|Withdrawal by Subject|0|||
161831680|NCT01221090|584426926|FG001|Overall Study|Withdrawal by Subject|22|||
161831681|NCT01221090|584426927|FG002|Overall Study|Withdrawal by Subject|27|||
161831682|NCT01221090|584426928|FG003|Overall Study|Withdrawal by Subject|2|||
161831683|NCT04507126|584426929|FG000|Overall Study|Withdrawal by Subject|3|||
161831684|NCT04507126|584426929|FG000|Overall Study|Protocol Violation|4|||
161831685|NCT04213209|584426930|FG000|Overall Study|Protocol Violation|1|||
161831686|NCT04213209|584426931|FG001|Overall Study|Protocol Violation|0|||
161831687|NCT04213209|584426932|FG002|Overall Study|Protocol Violation|0|||
161831688|NCT04213209|584426933|FG003|Overall Study|Protocol Violation|0|||
161831689|NCT04213209|584426934|FG004|Overall Study|Protocol Violation|0|||
161831690|NCT04213209|584426935|FG005|Overall Study|Protocol Violation|0|||
161831691|NCT00440466|584426937|FG000|Overall Study|Death|3|||
161831692|NCT00440466|584426938|FG001|Overall Study|Death|2|||
161831693|NCT00440466|584426939|FG002|Overall Study|Death|9|||
161831694|NCT00440466|584426937|FG000|Overall Study|Adverse Event|3|||
161942361|NCT02303821|584838373|FG005|Overall Study|Protocol-specified criteria|1|||
161942362|NCT02303821|584838374|FG006|Overall Study|Protocol-specified criteria|0|||
161942363|NCT02303821|584838375|FG007|Overall Study|Protocol-specified criteria|0|||
161942364|NCT04562090|584838376|FG000|Overall Study|Withdrawal by Subject|3|||
161942365|NCT04562090|584838377|FG001|Overall Study|Withdrawal by Subject|4|||
161942366|NCT04562090|584838376|FG000|Overall Study|Protocol Violation|2|||
161942367|NCT04562090|584838377|FG001|Overall Study|Protocol Violation|0|||
161942368|NCT04562090|584838376|FG000|Overall Study|Lack of Efficacy|0|||
161942369|NCT04562090|584838377|FG001|Overall Study|Lack of Efficacy|1|||
161942370|NCT04562090|584838376|FG000|Overall Study|Adverse Event|1|||
161942371|NCT04562090|584838377|FG001|Overall Study|Adverse Event|4|||
161942372|NCT04562090|584838376|FG000|Overall Study|Miscellaneous|0|||
161942373|NCT04562090|584838377|FG001|Overall Study|Miscellaneous|3|||
161942374|NCT00847730|584838378|FG000|Overall Study|Multiple interruptions in therapy|8|||
161942375|NCT00432965|584838381|FG000|Overall Study|Lost to Follow-up|22|||
161942376|NCT00432965|584838382|FG001|Overall Study|Lost to Follow-up|19|||
161942377|NCT00432965|584838381|FG000|Overall Study|Withdrawal by Subject|13|||
161942378|NCT00432965|584838382|FG001|Overall Study|Withdrawal by Subject|13|||
161942379|NCT00432965|584838381|FG000|Overall Study|Physician Decision|14|||
161942380|NCT00432965|584838382|FG001|Overall Study|Physician Decision|13|||
161942381|NCT00432965|584838381|FG000|Overall Study|Lack of Efficacy|8|||
161942382|NCT00432965|584838382|FG001|Overall Study|Lack of Efficacy|13|||
161942383|NCT00432965|584838381|FG000|Overall Study|Non-compliance|7|||
161942384|NCT00432965|584838382|FG001|Overall Study|Non-compliance|0|||
161942385|NCT00432965|584838381|FG000|Overall Study|Adverse Event|22|||
161942386|NCT00432965|584838382|FG001|Overall Study|Adverse Event|19|||
161942387|NCT00432965|584838381|FG000|Overall Study|Death|3|||
161942388|NCT00432965|584838382|FG001|Overall Study|Death|4|||
161942389|NCT00432965|584838381|FG000|Overall Study|Exclusionary Methods|1|||
161942390|NCT00432965|584838382|FG001|Overall Study|Exclusionary Methods|2|||
161942391|NCT00432965|584838381|FG000|Overall Study|Incomplete Data|4|||
161942392|NCT00432965|584838382|FG001|Overall Study|Incomplete Data|3|||
161942393|NCT01889251|584838383|FG000|Overall Study|Adverse Event|1|||
161942394|NCT01889251|584838384|FG001|Overall Study|Adverse Event|0|||
161942395|NCT01903863|584838385|FG000|Overall Study|Physician Decision|2|||
161942396|NCT01903863|584838386|FG001|Overall Study|Physician Decision|0|||
161942397|NCT01722669|584838394|FG000|Overall Study|Withdrawal by Subject|0|||
161942398|NCT01722669|584838395|FG001|Overall Study|Withdrawal by Subject|0|||
161942399|NCT01722669|584838396|FG002|Overall Study|Withdrawal by Subject|0|||
161831695|NCT00440466|584426938|FG001|Overall Study|Adverse Event|4|||
161831696|NCT00440466|584426939|FG002|Overall Study|Adverse Event|11|||
161831697|NCT00440466|584426937|FG000|Overall Study|Lost to Follow-up|1|||
161831698|NCT00440466|584426938|FG001|Overall Study|Lost to Follow-up|0|||
161831699|NCT00440466|584426939|FG002|Overall Study|Lost to Follow-up|2|||
161831700|NCT00440466|584426937|FG000|Overall Study|Physician Decision|2|||
161831701|NCT00440466|584426938|FG001|Overall Study|Physician Decision|0|||
161831702|NCT00440466|584426939|FG002|Overall Study|Physician Decision|1|||
161831703|NCT00440466|584426937|FG000|Overall Study|Protocol Violation|2|||
161831704|NCT00440466|584426938|FG001|Overall Study|Protocol Violation|0|||
161831705|NCT00440466|584426939|FG002|Overall Study|Protocol Violation|4|||
161942400|NCT01722669|584838397|FG003|Overall Study|Withdrawal by Subject|0|||
161942401|NCT01722669|584838398|FG004|Overall Study|Withdrawal by Subject|0|||
161942402|NCT01722669|584838399|FG005|Overall Study|Withdrawal by Subject|2|||
161942403|NCT01344226|584838400|FG000|Overall Study|Protocol Violation|2|||
161942404|NCT01344226|584838400|FG000|Overall Study|Withdrawal by Subject|3|||
161831706|NCT00440466|584426937|FG000|Overall Study|Withdrawal by Subject|2|||
161831707|NCT00440466|584426938|FG001|Overall Study|Withdrawal by Subject|5|||
161942405|NCT01344226|584838400|FG000|Overall Study|Lack of Efficacy|3|||
161831708|NCT00440466|584426939|FG002|Overall Study|Withdrawal by Subject|9|||
161831709|NCT00440466|584426937|FG000|Overall Study|Began Dialysis|0|||
161942406|NCT02255656|584838407|FG000|Overall Study|Adverse Event|11|||
161683127|NCT00841568|583891276|FG000|Overall Study|Death|1|||
161683128|NCT00841568|583891276|FG000|Overall Study|Withdrawal by Subject|2|||
161683129|NCT00841568|583891276|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
161683130|NCT03002155|583891277|FG000|Overall Study|Lost to Follow-up|1|||
161683131|NCT03002155|583891278|FG001|Overall Study|Lost to Follow-up|2|||
161683132|NCT03002155|583891277|FG000|Overall Study|Withdrawal by Subject|1|||
161683133|NCT03002155|583891278|FG001|Overall Study|Withdrawal by Subject|0|||
161683134|NCT03002155|583891277|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
161831710|NCT00440466|584426938|FG001|Overall Study|Began Dialysis|0|||
161831711|NCT00440466|584426939|FG002|Overall Study|Began Dialysis|1|||
161831712|NCT00440466|584426937|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
161831713|NCT00440466|584426938|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
161831714|NCT00440466|584426939|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
161831715|NCT02065713|584426940|FG000|Overall Study|Adverse Event|0|||
161831716|NCT02065713|584426941|FG001|Overall Study|Adverse Event|1|||
161831717|NCT02065713|584426940|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161831718|NCT02065713|584426941|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161831719|NCT01223235|584426944|FG000|Overall Study|Withdrawal by Subject|1|||
161831720|NCT01014624|584426947|FG000|Overall Study|Adverse Event|0|||
161831721|NCT01014624|584426948|FG001|Overall Study|Adverse Event|1|||
161831722|NCT01014624|584426947|FG000|Overall Study|Protocol Violation|1|||
161831723|NCT01014624|584426948|FG001|Overall Study|Protocol Violation|0|||
161831724|NCT01014624|584426947|FG000|Overall Study|Withdrawal by Subject|1|||
161831725|NCT01014624|584426948|FG001|Overall Study|Withdrawal by Subject|0|||
161831726|NCT00754442|584426951|FG000|Overall Study|Withdrawal by Subject|5|||
161831727|NCT00754442|584426952|FG001|Overall Study|Withdrawal by Subject|3|||
161831728|NCT05560763|584426957|FG000|Overall Study|Withdrawal by Subject|4|||
161831729|NCT00296491|584426960|FG000|Overall Study|Low Pollen Counts|18|||
161831730|NCT00296491|584426961|FG001|Overall Study|Low Pollen Counts|26|||
161831731|NCT00296491|584426962|FG002|Overall Study|Low Pollen Counts|25|||
161831732|NCT00296491|584426963|FG003|Overall Study|Low Pollen Counts|16|||
161831733|NCT00296491|584426960|FG000|Overall Study|Protocol Violation|4|||
161831734|NCT00296491|584426961|FG001|Overall Study|Protocol Violation|6|||
161831735|NCT00296491|584426962|FG002|Overall Study|Protocol Violation|2|||
161831736|NCT00296491|584426963|FG003|Overall Study|Protocol Violation|3|||
161831737|NCT00296491|584426960|FG000|Overall Study|Adverse Event|1|||
161831738|NCT00296491|584426961|FG001|Overall Study|Adverse Event|3|||
161831739|NCT00296491|584426962|FG002|Overall Study|Adverse Event|1|||
161831740|NCT00296491|584426963|FG003|Overall Study|Adverse Event|4|||
161831741|NCT00296491|584426960|FG000|Overall Study|Withdrawn due to Asthma|0|||
161831742|NCT00296491|584426961|FG001|Overall Study|Withdrawn due to Asthma|0|||
161831743|NCT00296491|584426962|FG002|Overall Study|Withdrawn due to Asthma|0|||
161831744|NCT00296491|584426963|FG003|Overall Study|Withdrawn due to Asthma|4|||
161831745|NCT00296491|584426960|FG000|Overall Study|Withdrawal by Subject|7|||
161831746|NCT00296491|584426961|FG001|Overall Study|Withdrawal by Subject|3|||
161831747|NCT00296491|584426962|FG002|Overall Study|Withdrawal by Subject|3|||
161831748|NCT00296491|584426963|FG003|Overall Study|Withdrawal by Subject|2|||
161831749|NCT00296491|584426960|FG000|Overall Study|Non-Compliance|12|||
161831750|NCT00296491|584426961|FG001|Overall Study|Non-Compliance|13|||
161831751|NCT00296491|584426962|FG002|Overall Study|Non-Compliance|10|||
161831752|NCT00296491|584426963|FG003|Overall Study|Non-Compliance|14|||
161831753|NCT00296491|584426960|FG000|Overall Study|Lost to Follow-up|0|||
161831754|NCT00296491|584426961|FG001|Overall Study|Lost to Follow-up|2|||
161831755|NCT00296491|584426962|FG002|Overall Study|Lost to Follow-up|2|||
161831756|NCT00296491|584426963|FG003|Overall Study|Lost to Follow-up|0|||
161831757|NCT01929395|584426965|FG000|Overall Study|Did not complete - non-related toxicity|1|||
161831758|NCT01929395|584426966|FG001|Overall Study|Did not complete - non-related toxicity|0|||
161831759|NCT01929395|584426967|FG002|Overall Study|Did not complete - non-related toxicity|0|||
161831760|NCT01929395|584426965|FG000|Overall Study|Withdrawal by Subject|0|||
161831761|NCT01929395|584426966|FG001|Overall Study|Withdrawal by Subject|1|||
161831762|NCT01929395|584426967|FG002|Overall Study|Withdrawal by Subject|0|||
161831763|NCT01929395|584426965|FG000|Overall Study|Screen Fail|0|||
161831764|NCT01929395|584426966|FG001|Overall Study|Screen Fail|0|||
161831765|NCT01929395|584426967|FG002|Overall Study|Screen Fail|1|||
161831766|NCT00484419|584426969|FG000|Overall Study|Adverse Event|3|||
161831767|NCT00484419|584426970|FG001|Overall Study|Adverse Event|0|||
161831768|NCT00484419|584426971|FG002|Overall Study|Adverse Event|0|||
161831769|NCT00484419|584426969|FG000|Overall Study|Lost to Follow-up|1|||
161831770|NCT00484419|584426970|FG001|Overall Study|Lost to Follow-up|0|||
161831771|NCT00484419|584426971|FG002|Overall Study|Lost to Follow-up|2|||
161831772|NCT00484419|584426969|FG000|Overall Study|Withdrawal by Subject|3|||
161831773|NCT00484419|584426970|FG001|Overall Study|Withdrawal by Subject|1|||
161831774|NCT00484419|584426971|FG002|Overall Study|Withdrawal by Subject|1|||
161831775|NCT00484419|584426969|FG000|Overall Study|subject met discontinuation criteria|2|||
162026614|NCT00910624|585154362|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
161942407|NCT02255656|584838407|FG000|Overall Study|Poor compliance to protocol|3|||
161942408|NCT02255656|584838407|FG000|Overall Study|Lost to Follow-up|30|||
161942409|NCT02255656|584838407|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
161942410|NCT02255656|584838407|FG000|Overall Study|Other|126|||
161942411|NCT03734536|584838408|FG000|Overall Study|Withdrew Consent|1|||
161942412|NCT03734536|584838409|FG001|Overall Study|Withdrew Consent|5|||
161942413|NCT03734536|584838408|FG000|Overall Study|Lost to Follow-up|10|||
161942414|NCT03734536|584838409|FG001|Overall Study|Lost to Follow-up|7|||
161942415|NCT03448393|584838410|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161942416|NCT03448393|584838411|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161942417|NCT03448393|584838412|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
161942418|NCT03448393|584838413|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161942419|NCT03448393|584838414|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161942420|NCT03448393|584838415|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161942421|NCT03448393|584838416|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161942422|NCT03448393|584838417|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
161942423|NCT03448393|584838418|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
161942424|NCT03448393|584838410|FG000|Dose Expansion|Not treated - screen failure|0|||
161942425|NCT03448393|584838411|FG001|Dose Expansion|Not treated - screen failure|0|||
161942426|NCT03448393|584838412|FG002|Dose Expansion|Not treated - screen failure|0|||
161942427|NCT03448393|584838413|FG003|Dose Expansion|Not treated - screen failure|0|||
161942428|NCT03448393|584838414|FG004|Dose Expansion|Not treated - screen failure|0|||
161942429|NCT03448393|584838415|FG005|Dose Expansion|Not treated - screen failure|0|||
161942430|NCT03448393|584838416|FG006|Dose Expansion|Not treated - screen failure|0|||
161942431|NCT03448393|584838417|FG007|Dose Expansion|Not treated - screen failure|0|||
161942432|NCT03448393|584838418|FG008|Dose Expansion|Not treated - screen failure|7|||
161942433|NCT03612570|584838422|FG000|Overall Study|Lost to Follow-up|1|||
161942434|NCT05318287|584838427|FG000|Overall Study|Lost to Follow-up|8|||
161942435|NCT05185453|584838428|FG000|Overall Study|Lost to Follow-up|13|||
161942436|NCT05185453|584838429|FG001|Overall Study|Lost to Follow-up|3|||
161942437|NCT05929326|584838448|FG000|Overall Study|unqualified sample|2|||
161942438|NCT05929326|584838449|FG001|Overall Study|unqualified sample|3|||
161942439|NCT05929326|584838450|FG002|Overall Study|unqualified sample|7|||
161942440|NCT03941093|584838461|FG000|Overall Study|Protocol Violation|0|||
161942441|NCT03941093|584838462|FG001|Overall Study|Protocol Violation|1|||
161942442|NCT03941093|584838461|FG000|Overall Study|Withdrawal by Subject|9|||
161942443|NCT03941093|584838462|FG001|Overall Study|Withdrawal by Subject|6|||
161942444|NCT02495883|584838465|FG000|Overall Study|Excessive head motion|1|||
161942445|NCT02495883|584838466|FG001|Overall Study|Excessive head motion|0|||
161942446|NCT00964678|584838470|FG000|Overall Study|Physician Decision|4|||
161942447|NCT03359395|584838471|FG000|First Intervention A / B|Withdrawal by Subject|1|||
161942448|NCT03359395|584838472|FG001|First Intervention A / B|Withdrawal by Subject|0|||
161942449|NCT03359395|584838471|FG000|First Intervention A / B|Lost to Follow-up|2|||
161942450|NCT03359395|584838472|FG001|First Intervention A / B|Lost to Follow-up|3|||
161942451|NCT03359395|584838471|FG000|Second Intervention B/A|Exclusion criteria|0|||
161942452|NCT03359395|584838472|FG001|Second Intervention B/A|Exclusion criteria|1|||
161942453|NCT03359395|584838471|FG000|Second Intervention B/A|Lost to Follow-up|3|||
161942454|NCT03359395|584838472|FG001|Second Intervention B/A|Lost to Follow-up|2|||
161942455|NCT05484895|584839758|FG000|Overall Study|Lost to Follow-up|63|||
161942456|NCT05484895|584839759|FG001|Overall Study|Lost to Follow-up|64|||
161942457|NCT04795531|584839760|FG000|Overall Study|Withdrawal by Subject|4|||
161942458|NCT04795531|584839761|FG001|Overall Study|Withdrawal by Subject|4|||
161942459|NCT04795531|584839760|FG000|Overall Study|Lost to Follow-up|0|||
161942460|NCT04795531|584839761|FG001|Overall Study|Lost to Follow-up|1|||
161942461|NCT04795531|584839760|FG000|Overall Study|Physician Decision|0|||
161942462|NCT04795531|584839761|FG001|Overall Study|Physician Decision|2|||
161942463|NCT04795531|584839760|FG000|Overall Study|Death|2|||
161942464|NCT04795531|584839761|FG001|Overall Study|Death|1|||
161942465|NCT01323192|584839762|FG000|Overall Study|Adverse Event|6|||
161942466|NCT01323192|584839763|FG001|Overall Study|Adverse Event|1|||
161942467|NCT01323192|584839762|FG000|Overall Study|Withdrawal by Subject|3|||
161942468|NCT01323192|584839763|FG001|Overall Study|Withdrawal by Subject|1|||
161942469|NCT01323192|584839762|FG000|Overall Study|Noncompliance with study medication|0|||
161942470|NCT01323192|584839763|FG001|Overall Study|Noncompliance with study medication|3|||
161942471|NCT01323192|584839762|FG000|Overall Study|Nonmedical reasons|0|||
161942472|NCT01323192|584839763|FG001|Overall Study|Nonmedical reasons|1|||
161942473|NCT03698279|584839764|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161942474|NCT03698279|584839765|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161942475|NCT03698279|584839766|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161942476|NCT03698279|584839767|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161942477|NCT03698279|584839768|FG004|Overall Study|Withdrawal by parent/guardian|0|||
161942478|NCT03698279|584839769|FG005|Overall Study|Withdrawal by parent/guardian|0|||
161831776|NCT00484419|584426970|FG001|Overall Study|subject met discontinuation criteria|2|||
161831777|NCT00484419|584426971|FG002|Overall Study|subject met discontinuation criteria|4|||
161831778|NCT00484419|584426969|FG000|Overall Study|required restricted medication|1|||
161831779|NCT00484419|584426970|FG001|Overall Study|required restricted medication|0|||
161831780|NCT00484419|584426971|FG002|Overall Study|required restricted medication|1|||
161831781|NCT00484419|584426969|FG000|Overall Study|Physician Decision|1|||
161831782|NCT00484419|584426970|FG001|Overall Study|Physician Decision|1|||
161831783|NCT00484419|584426971|FG002|Overall Study|Physician Decision|1|||
161831784|NCT00484419|584426969|FG000|Overall Study|subject unable to receive medication|1|||
161831785|NCT00484419|584426970|FG001|Overall Study|subject unable to receive medication|0|||
161831786|NCT00484419|584426971|FG002|Overall Study|subject unable to receive medication|0|||
161831787|NCT00484419|584426969|FG000|Overall Study|subject relocated|0|||
161831788|NCT00484419|584426970|FG001|Overall Study|subject relocated|1|||
161831789|NCT00484419|584426971|FG002|Overall Study|subject relocated|0|||
161831790|NCT00484419|584426969|FG000|Overall Study|sponsor decision, randomized in error|0|||
161831791|NCT00484419|584426970|FG001|Overall Study|sponsor decision, randomized in error|0|||
161831792|NCT00484419|584426971|FG002|Overall Study|sponsor decision, randomized in error|2|||
161831793|NCT03604341|584426972|FG000|Overall Study|Withdrawal by Subject|1|||
161831794|NCT03604341|584426973|FG001|Overall Study|Withdrawal by Subject|1|||
161831795|NCT03604341|584426972|FG000|Overall Study|Adverse Event|1|||
161831796|NCT03604341|584426973|FG001|Overall Study|Adverse Event|0|||
161831797|NCT03604341|584426972|FG000|Overall Study|Protocol Violation|0|||
161831798|NCT03604341|584426973|FG001|Overall Study|Protocol Violation|1|||
161831799|NCT01829113|584426974|FG000|Overall Study|Disease Progression|37|||
161831800|NCT01829113|584426975|FG001|Overall Study|Disease Progression|48|||
161831801|NCT01829113|584426974|FG000|Overall Study|Adverse Event|14|||
161831802|NCT01829113|584426975|FG001|Overall Study|Adverse Event|10|||
161831803|NCT01829113|584426974|FG000|Overall Study|Withdrawal by Subject|17|||
161831804|NCT01829113|584426975|FG001|Overall Study|Withdrawal by Subject|10|||
161831805|NCT01829113|584426974|FG000|Overall Study|Death|4|||
161831806|NCT01829113|584426975|FG001|Overall Study|Death|6|||
161831807|NCT01829113|584426974|FG000|Overall Study|Sponsor Decision|1|||
161831808|NCT01829113|584426975|FG001|Overall Study|Sponsor Decision|1|||
161831809|NCT01829113|584426974|FG000|Overall Study|No Study Treatment Received|3|||
161831810|NCT01829113|584426975|FG001|Overall Study|No Study Treatment Received|2|||
161831811|NCT01829113|584426974|FG000|Overall Study|Physician Decision|1|||
161831812|NCT01829113|584426975|FG001|Overall Study|Physician Decision|1|||
161831813|NCT01740791|584426976|FG000|Overall Study|Randomized but never treated|5|||
161831814|NCT01740791|584426977|FG001|Overall Study|Randomized but never treated|3|||
161831815|NCT01740791|584426978|FG002|Overall Study|Randomized but never treated|2|||
161942479|NCT03698279|584839764|FG000|Overall Study|Protocol deviation|1|||
161942480|NCT03698279|584839765|FG001|Overall Study|Protocol deviation|0|||
161942481|NCT03698279|584839766|FG002|Overall Study|Protocol deviation|1|||
161831816|NCT01740791|584426979|FG003|Overall Study|Randomized but never treated|2|||
161831817|NCT01740791|584426980|FG004|Overall Study|Randomized but never treated|1|||
161831818|NCT01740791|584426981|FG005|Overall Study|Randomized but never treated|3|||
161942482|NCT03698279|584839767|FG003|Overall Study|Protocol deviation|0|||
161942483|NCT03698279|584839768|FG004|Overall Study|Protocol deviation|0|||
161942484|NCT03698279|584839769|FG005|Overall Study|Protocol deviation|0|||
161942485|NCT03698279|584839764|FG000|Overall Study|Withdrawal by Subject|0|||
161942486|NCT03698279|584839765|FG001|Overall Study|Withdrawal by Subject|0|||
161942487|NCT03698279|584839766|FG002|Overall Study|Withdrawal by Subject|1|||
161942488|NCT03698279|584839767|FG003|Overall Study|Withdrawal by Subject|0|||
161942489|NCT03698279|584839768|FG004|Overall Study|Withdrawal by Subject|0|||
161942490|NCT03698279|584839769|FG005|Overall Study|Withdrawal by Subject|0|||
161942491|NCT03698279|584839764|FG000|Overall Study|Lost to Follow-up|3|||
161942492|NCT03698279|584839765|FG001|Overall Study|Lost to Follow-up|1|||
161942493|NCT03698279|584839766|FG002|Overall Study|Lost to Follow-up|4|||
161942494|NCT03698279|584839767|FG003|Overall Study|Lost to Follow-up|5|||
161942495|NCT03698279|584839768|FG004|Overall Study|Lost to Follow-up|0|||
161942496|NCT03698279|584839769|FG005|Overall Study|Lost to Follow-up|0|||
161942497|NCT03552029|584839770|FG000|Overall Study|Death|3|||
161942498|NCT03552029|584839771|FG001|Overall Study|Death|0|||
161942499|NCT03552029|584839770|FG000|Overall Study|Adverse Event|1|||
161942500|NCT03552029|584839771|FG001|Overall Study|Adverse Event|0|||
161942501|NCT03552029|584839770|FG000|Overall Study|Lack of Efficacy|0|||
161942502|NCT03552029|584839771|FG001|Overall Study|Lack of Efficacy|2|||
161942503|NCT03552029|584839770|FG000|Overall Study|Physician Decision|0|||
161942504|NCT03552029|584839771|FG001|Overall Study|Physician Decision|1|||
161942505|NCT03552029|584839770|FG000|Overall Study|Study terminated by Sponsor|0|||
161942506|NCT03552029|584839771|FG001|Overall Study|Study terminated by Sponsor|1|||
161942507|NCT03552029|584839770|FG000|Overall Study|Other|0|||
161942508|NCT03552029|584839771|FG001|Overall Study|Other|2|||
161942509|NCT03122184|584839772|FG000|Overall Study|Lost to Follow-up|4|||
161942510|NCT03122184|584839773|FG001|Overall Study|Lost to Follow-up|6|||
161942511|NCT03122184|584839772|FG000|Overall Study|Withdrawal by Subject|3|||
161942512|NCT03122184|584839773|FG001|Overall Study|Withdrawal by Subject|0|||
161942513|NCT03122184|584839772|FG000|Overall Study|Terminated due to cognitive problem|1|||
161942514|NCT03122184|584839773|FG001|Overall Study|Terminated due to cognitive problem|0|||
161942515|NCT00633126|584839774|FG000|Overall Study|Did not receive full dose|1|||
161942516|NCT01168596|584839777|FG000|Overall Study|Withdrawal by Subject|3|||
161942517|NCT01168596|584839778|FG001|Overall Study|Withdrawal by Subject|1|||
161942518|NCT01276704|584839779|FG000|Overall Study|Lost to Follow-up|2|||
161942519|NCT01276704|584839780|FG001|Overall Study|Lost to Follow-up|3|||
161942520|NCT01276704|584839779|FG000|Overall Study|Non-compliant|2|||
161942521|NCT01276704|584839780|FG001|Overall Study|Non-compliant|2|||
161942522|NCT01276704|584839779|FG000|Overall Study|Withdrawal by Subject|7|||
161942523|NCT01276704|584839780|FG001|Overall Study|Withdrawal by Subject|1|||
161942524|NCT01276704|584839779|FG000|Overall Study|Physician Decision|3|||
161942525|NCT01276704|584839780|FG001|Overall Study|Physician Decision|5|||
161831819|NCT01740791|584426976|FG000|Overall Study|Lost to Follow-up|2|||
161831820|NCT01740791|584426977|FG001|Overall Study|Lost to Follow-up|0|||
161831821|NCT01740791|584426978|FG002|Overall Study|Lost to Follow-up|2|||
161831822|NCT01740791|584426979|FG003|Overall Study|Lost to Follow-up|3|||
161831823|NCT01740791|584426980|FG004|Overall Study|Lost to Follow-up|2|||
161831824|NCT01740791|584426981|FG005|Overall Study|Lost to Follow-up|3|||
161831825|NCT01740791|584426976|FG000|Overall Study|Withdrew Consent|4|||
161831826|NCT01740791|584426977|FG001|Overall Study|Withdrew Consent|0|||
161831827|NCT01740791|584426978|FG002|Overall Study|Withdrew Consent|1|||
161831828|NCT01740791|584426979|FG003|Overall Study|Withdrew Consent|2|||
161831829|NCT01740791|584426980|FG004|Overall Study|Withdrew Consent|0|||
161831830|NCT01740791|584426981|FG005|Overall Study|Withdrew Consent|3|||
161831831|NCT01740791|584426976|FG000|Overall Study|Investigator's discretion|1|||
161831832|NCT01740791|584426977|FG001|Overall Study|Investigator's discretion|0|||
161831833|NCT01740791|584426978|FG002|Overall Study|Investigator's discretion|1|||
161831834|NCT01740791|584426979|FG003|Overall Study|Investigator's discretion|0|||
161831835|NCT01740791|584426980|FG004|Overall Study|Investigator's discretion|0|||
161831836|NCT01740791|584426981|FG005|Overall Study|Investigator's discretion|1|||
161831837|NCT01740791|584426976|FG000|Overall Study|Adverse Event|0|||
161831838|NCT01740791|584426977|FG001|Overall Study|Adverse Event|0|||
161942526|NCT02297516|584839781|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
161831839|NCT01740791|584426978|FG002|Overall Study|Adverse Event|0|||
161942527|NCT02297516|584839782|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
161942528|NCT02297516|584839781|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
161831840|NCT01740791|584426979|FG003|Overall Study|Adverse Event|0|||
161831841|NCT01740791|584426980|FG004|Overall Study|Adverse Event|0|||
161831842|NCT01740791|584426981|FG005|Overall Study|Adverse Event|1|||
161831843|NCT02674386|584426984|FG000|Overall Study|Lost to Follow-up|0|||
161831844|NCT02674386|584426985|FG001|Overall Study|Lost to Follow-up|1|||
161831845|NCT02674386|584426986|FG002|Overall Study|Lost to Follow-up|1|||
161831846|NCT02674386|584426984|FG000|Overall Study|Withdrawal by Subject|0|||
161831847|NCT02674386|584426985|FG001|Overall Study|Withdrawal by Subject|4|||
161831848|NCT02674386|584426986|FG002|Overall Study|Withdrawal by Subject|0|||
161831849|NCT02674386|584426984|FG000|Overall Study|Other|0|||
161831850|NCT02674386|584426985|FG001|Overall Study|Other|1|||
161831851|NCT02674386|584426986|FG002|Overall Study|Other|0|||
161831852|NCT02674386|584426984|FG000|Overall Study|Enrolled but not evaluated|0|||
161831853|NCT02674386|584426985|FG001|Overall Study|Enrolled but not evaluated|4|||
161831854|NCT02674386|584426986|FG002|Overall Study|Enrolled but not evaluated|0|||
161831855|NCT02462486|584426991|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
161831856|NCT02462486|584426992|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
161831857|NCT02462486|584426993|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
161831858|NCT02462486|584426991|FG000|Overall Study|Adverse Event|53|||
161831859|NCT02462486|584426992|FG001|Overall Study|Adverse Event|48|||
161831860|NCT02462486|584426993|FG002|Overall Study|Adverse Event|21|||
161831861|NCT02462486|584426991|FG000|Overall Study|Lack of Efficacy|6|||
161831862|NCT02462486|584426992|FG001|Overall Study|Lack of Efficacy|12|||
161831863|NCT02462486|584426993|FG002|Overall Study|Lack of Efficacy|3|||
161831864|NCT02462486|584426991|FG000|Overall Study|Lost to Follow-up|3|||
161831865|NCT02462486|584426992|FG001|Overall Study|Lost to Follow-up|4|||
161831866|NCT02462486|584426993|FG002|Overall Study|Lost to Follow-up|2|||
161831867|NCT02462486|584426991|FG000|Overall Study|Withdrawal by Subject|25|||
161831868|NCT02462486|584426992|FG001|Overall Study|Withdrawal by Subject|22|||
161831869|NCT02462486|584426993|FG002|Overall Study|Withdrawal by Subject|19|||
161831870|NCT02462486|584426991|FG000|Overall Study|Protocol Violation|3|||
161831871|NCT02462486|584426992|FG001|Overall Study|Protocol Violation|1|||
161831872|NCT02462486|584426993|FG002|Overall Study|Protocol Violation|1|||
161831873|NCT02462486|584426991|FG000|Overall Study|Reason not Specified|3|||
161831874|NCT02462486|584426992|FG001|Overall Study|Reason not Specified|4|||
161831875|NCT02462486|584426993|FG002|Overall Study|Reason not Specified|3|||
161831876|NCT04706507|584426994|FG000|Overall Study|Death|45|||
161831877|NCT04706507|584426995|FG001|Overall Study|Death|22|||
161831878|NCT04706507|584426994|FG000|Overall Study|Unable to adhere|0|||
161831879|NCT04706507|584426995|FG001|Overall Study|Unable to adhere|2|||
161831880|NCT04706507|584426994|FG000|Overall Study|Lost to Follow-up|13|||
161831881|NCT04706507|584426995|FG001|Overall Study|Lost to Follow-up|12|||
161831882|NCT04706507|584426994|FG000|Overall Study|Withdrawal of consent|1|||
161831883|NCT04706507|584426995|FG001|Overall Study|Withdrawal of consent|1|||
161831884|NCT04706507|584426994|FG000|Overall Study|Patient or LAR refuses further participation|0|||
161831885|NCT04706507|584426995|FG001|Overall Study|Patient or LAR refuses further participation|3|||
161831886|NCT04099641|584427000|FG000|Overall Study|Death|46|||
161831887|NCT04099641|584427001|FG001|Overall Study|Death|12|||
161831888|NCT04099641|584427000|FG000|Overall Study|Lost to Follow-up|1|||
161831889|NCT04099641|584427001|FG001|Overall Study|Lost to Follow-up|0|||
161831890|NCT04099641|584427000|FG000|Overall Study|Withdrawal by Subject|2|||
161831891|NCT04099641|584427001|FG001|Overall Study|Withdrawal by Subject|0|||
161831892|NCT02470091|584427003|FG000|Overall Study|Withdrawal by Subject|1|||
161831893|NCT02470091|584427004|FG001|Overall Study|Withdrawal by Subject|0|||
161831894|NCT02470091|584427003|FG000|Overall Study|Ineligible|0|||
161831895|NCT02470091|584427004|FG001|Overall Study|Ineligible|2|||
161831896|NCT00303667|584427006|FG000|Overall Study|Death|0|||
161831897|NCT00303667|584427007|FG001|Overall Study|Death|4|||
161831898|NCT01029392|584427008|FG000|Overall Study|Withdrawal by Subject|18|||
161831899|NCT01029392|584427009|FG001|Overall Study|Withdrawal by Subject|11|||
161831900|NCT01029392|584427008|FG000|Overall Study|Physician Decision|2|||
161831901|NCT01029392|584427009|FG001|Overall Study|Physician Decision|0|||
161831902|NCT01103479|584427010|FG000|Overall Study|Up to date with CRC screening|1|||
161831903|NCT01103479|584427011|FG001|Overall Study|Up to date with CRC screening|9|||
161831904|NCT01103479|584427012|FG002|Overall Study|Up to date with CRC screening|12|||
161831905|NCT01103479|584427010|FG000|Overall Study|Family history of CRC|1|||
161831906|NCT01103479|584427011|FG001|Overall Study|Family history of CRC|0|||
161831907|NCT01103479|584427012|FG002|Overall Study|Family history of CRC|2|||
161831908|NCT01103479|584427010|FG000|Overall Study|Active cancer|1|||
161831909|NCT01103479|584427011|FG001|Overall Study|Active cancer|0|||
161831910|NCT01103479|584427012|FG002|Overall Study|Active cancer|0|||
161831911|NCT01103479|584427010|FG000|Overall Study|Saw non-study physician|2|||
161831912|NCT01103479|584427011|FG001|Overall Study|Saw non-study physician|0|||
161831913|NCT01103479|584427012|FG002|Overall Study|Saw non-study physician|0|||
161831914|NCT01523587|584427013|FG000|Overall Study|Other than listed|5|||
161831915|NCT01523587|584427014|FG001|Overall Study|Other than listed|5|||
161831916|NCT01523587|584427013|FG000|Overall Study|Worsening of underlying cancer disease|19|||
161831917|NCT01523587|584427014|FG001|Overall Study|Worsening of underlying cancer disease|34|||
161831918|NCT01523587|584427013|FG000|Overall Study|Adverse Event|68|||
161942529|NCT02297516|584839782|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
161942530|NCT02297516|584839781|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
161942531|NCT02297516|584839782|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
161942532|NCT00710593|584839783|FG000|Overall Study|Incarceration|1|||
161942533|NCT00710593|584839784|FG001|Overall Study|Incarceration|0|||
161942534|NCT00710593|584839783|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
161942535|NCT00710593|584839784|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
161942536|NCT00710593|584839783|FG000|Overall Study|Lost to Follow-up|3|||
161942537|NCT00710593|584839784|FG001|Overall Study|Lost to Follow-up|1|||
161942538|NCT00710593|584839783|FG000|Overall Study|Moved out of area|1|||
161942539|NCT00710593|584839784|FG001|Overall Study|Moved out of area|0|||
161942540|NCT00710593|584839783|FG000|Overall Study|Failure to adhere or complete study eval|1|||
161942541|NCT00710593|584839784|FG001|Overall Study|Failure to adhere or complete study eval|1|||
161942542|NCT00710593|584839783|FG000|Overall Study|Protocol Violation|1|||
161942543|NCT00710593|584839784|FG001|Overall Study|Protocol Violation|1|||
161942544|NCT00710593|584839783|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
161942545|NCT00710593|584839784|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
161942546|NCT04490278|584839785|FG000|Overall Study|Lost to Follow-up|6|||
161942547|NCT00183248|584839795|FG000|Overall Study|Lost to Follow-up|0|||
161942548|NCT00183248|584839796|FG001|Overall Study|Lost to Follow-up|1|||
161942549|NCT00183248|584839795|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
161942550|NCT00183248|584839796|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
161942551|NCT03801525|584839797|FG000|Overall Study|Adverse Event|17|||
161942552|NCT03801525|584839798|FG001|Overall Study|Adverse Event|1|||
161942553|NCT03801525|584839799|FG002|Overall Study|Adverse Event|0|||
161942554|NCT03801525|584839797|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
161942555|NCT03801525|584839798|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
161942556|NCT03801525|584839799|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
161942557|NCT03801525|584839797|FG000|Overall Study|Death|29|||
161942558|NCT03801525|584839798|FG001|Overall Study|Death|1|||
161942559|NCT03801525|584839799|FG002|Overall Study|Death|4|||
161942560|NCT03801525|584839797|FG000|Overall Study|Disease Progression|6|||
161942561|NCT03801525|584839798|FG001|Overall Study|Disease Progression|0|||
161831919|NCT01523587|584427014|FG001|Overall Study|Adverse Event|52|||
161831920|NCT01523587|584427013|FG000|Overall Study|Protocol Violation|5|||
161831921|NCT01523587|584427014|FG001|Overall Study|Protocol Violation|3|||
161831922|NCT01523587|584427013|FG000|Overall Study|Lost to Follow-up|2|||
161831923|NCT01523587|584427014|FG001|Overall Study|Lost to Follow-up|2|||
161831924|NCT01523587|584427013|FG000|Overall Study|Withdrawal by Subject|28|||
161831925|NCT01523587|584427014|FG001|Overall Study|Withdrawal by Subject|20|||
161831926|NCT01523587|584427013|FG000|Overall Study|Withdrew due to Progressive disease|265|||
161831927|NCT01523587|584427014|FG001|Overall Study|Withdrew due to Progressive disease|279|||
161831928|NCT01523587|584427013|FG000|Overall Study|Randomised but bot treated|6|||
161831929|NCT01523587|584427014|FG001|Overall Study|Randomised but bot treated|2|||
161831930|NCT01298778|584427015|FG000|Overall Study|Lost to Follow-up|2|||
161831931|NCT01298778|584427016|FG001|Overall Study|Lost to Follow-up|3|||
161831932|NCT01298778|584427015|FG000|Overall Study|Incorrect use of VAS|1|||
161831933|NCT01298778|584427016|FG001|Overall Study|Incorrect use of VAS|0|||
161831934|NCT01298778|584427015|FG000|Overall Study|Withdrawal by Subject|0|||
161831935|NCT01298778|584427016|FG001|Overall Study|Withdrawal by Subject|1|||
161831936|NCT01298778|584427015|FG000|Overall Study|Protocol Violation|0|||
161831937|NCT01298778|584427016|FG001|Overall Study|Protocol Violation|1|||
161831938|NCT01298778|584427015|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
161831939|NCT01298778|584427016|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
161831940|NCT02709486|584427017|FG000|Overall Study|Adverse Event|2|||
161831941|NCT02709486|584427018|FG001|Overall Study|Adverse Event|5|||
161831942|NCT02709486|584427019|FG002|Overall Study|Adverse Event|3|||
161831943|NCT02709486|584427017|FG000|Overall Study|Death|0|||
161831944|NCT02709486|584427018|FG001|Overall Study|Death|0|||
161831945|NCT02709486|584427019|FG002|Overall Study|Death|2|||
161831946|NCT02709486|584427017|FG000|Overall Study|Insufficient clinical response|7|||
161831947|NCT02709486|584427018|FG001|Overall Study|Insufficient clinical response|3|||
161831948|NCT02709486|584427019|FG002|Overall Study|Insufficient clinical response|3|||
161831949|NCT02709486|584427017|FG000|Overall Study|Lost to Follow-up|3|||
161831950|NCT02709486|584427018|FG001|Overall Study|Lost to Follow-up|2|||
161831951|NCT02709486|584427019|FG002|Overall Study|Lost to Follow-up|2|||
161831952|NCT02709486|584427017|FG000|Overall Study|Other|0|||
161831953|NCT02709486|584427018|FG001|Overall Study|Other|2|||
161831954|NCT02709486|584427019|FG002|Overall Study|Other|3|||
161831955|NCT02709486|584427017|FG000|Overall Study|Withdrawal by Subject|32|||
161831956|NCT02709486|584427018|FG001|Overall Study|Withdrawal by Subject|22|||
161831957|NCT02709486|584427019|FG002|Overall Study|Withdrawal by Subject|32|||
161831958|NCT00384176|584427026|FG000|Overall Study|Death|239|||
161831959|NCT00384176|584427027|FG001|Overall Study|Death|247|||
161831960|NCT00384176|584427028|FG002|Overall Study|Death|105|||
161831961|NCT00384176|584427026|FG000|Overall Study|Withdrawal by Subject|52|||
161831962|NCT00384176|584427027|FG001|Overall Study|Withdrawal by Subject|48|||
161831963|NCT00384176|584427028|FG002|Overall Study|Withdrawal by Subject|22|||
161831964|NCT00384176|584427026|FG000|Overall Study|Lost to Follow-up|16|||
161831965|NCT00384176|584427027|FG001|Overall Study|Lost to Follow-up|18|||
161831966|NCT00384176|584427028|FG002|Overall Study|Lost to Follow-up|4|||
161831967|NCT00384176|584427026|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
161831968|NCT00384176|584427027|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
161831969|NCT00384176|584427028|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
161831970|NCT00384176|584427026|FG000|Overall Study|Longer QTC as Visit 1|1|||
161831971|NCT00384176|584427027|FG001|Overall Study|Longer QTC as Visit 1|0|||
161831972|NCT00384176|584427028|FG002|Overall Study|Longer QTC as Visit 1|0|||
161831973|NCT00384176|584427026|FG000|Overall Study|Toxicity of treatment|1|||
161831974|NCT00384176|584427027|FG001|Overall Study|Toxicity of treatment|0|||
161831975|NCT00384176|584427028|FG002|Overall Study|Toxicity of treatment|0|||
161831976|NCT00384176|584427026|FG000|Overall Study|Did not receive study treatment|0|||
161831977|NCT00384176|584427027|FG001|Overall Study|Did not receive study treatment|1|||
161831978|NCT00384176|584427028|FG002|Overall Study|Did not receive study treatment|1|||
161831979|NCT00384176|584427026|FG000|Overall Study|Physician Decision|0|||
161831980|NCT00384176|584427027|FG001|Overall Study|Physician Decision|2|||
161831981|NCT00384176|584427028|FG002|Overall Study|Physician Decision|0|||
161831982|NCT00384176|584427026|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
161831983|NCT00384176|584427027|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
161831984|NCT00384176|584427028|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
161831985|NCT02691741|584427029|FG000|Overall Study|Adverse Event|0|||
161831986|NCT02691741|584427030|FG001|Overall Study|Adverse Event|2|||
161831987|NCT02691741|584427029|FG000|Overall Study|Lost to Follow-up|1|||
161831988|NCT02691741|584427030|FG001|Overall Study|Lost to Follow-up|0|||
161831989|NCT02691741|584427029|FG000|Overall Study|Physician Decision|0|||
161831990|NCT02691741|584427030|FG001|Overall Study|Physician Decision|1|||
161831991|NCT02691741|584427029|FG000|Overall Study|Withdrawal by Subject|0|||
161831992|NCT02691741|584427030|FG001|Overall Study|Withdrawal by Subject|4|||
161831993|NCT03465436|584427031|FG000|Period 1|Protocol Violation|0|||
161831994|NCT03465436|584427032|FG001|Period 1|Protocol Violation|0|||
161831995|NCT03465436|584427033|FG002|Period 1|Protocol Violation|1|||
161831996|NCT03465436|584427034|FG003|Period 1|Protocol Violation|0|||
161831997|NCT03465436|584427031|FG000|Period 2|Protocol Violation|0|||
161831998|NCT03465436|584427032|FG001|Period 2|Protocol Violation|1|||
161831999|NCT03465436|584427033|FG002|Period 2|Protocol Violation|0|||
161832000|NCT03465436|584427034|FG003|Period 2|Protocol Violation|0|||
161832001|NCT03465436|584427031|FG000|Period 3|Protocol Violation|1|||
161832002|NCT03465436|584427032|FG001|Period 3|Protocol Violation|1|||
161832003|NCT03465436|584427033|FG002|Period 3|Protocol Violation|0|||
161832004|NCT03465436|584427034|FG003|Period 3|Protocol Violation|0|||
161832005|NCT03465436|584427031|FG000|Period 4|Protocol Violation|0|||
161832006|NCT03465436|584427032|FG001|Period 4|Protocol Violation|0|||
161832007|NCT03465436|584427033|FG002|Period 4|Protocol Violation|1|||
161832008|NCT03465436|584427034|FG003|Period 4|Protocol Violation|0|||
161832009|NCT01425528|584427035|FG000|Overall Study|Withdrawal by Subject|1|||
161832010|NCT01425528|584427036|FG001|Overall Study|Withdrawal by Subject|1|||
161832011|NCT02697773|584427037|FG000|Overall Study|Adverse Event|2|||
161832012|NCT02697773|584427038|FG001|Overall Study|Adverse Event|1|||
161832013|NCT02697773|584427039|FG002|Overall Study|Adverse Event|2|||
161832014|NCT02697773|584427037|FG000|Overall Study|Death|0|||
161832015|NCT02697773|584427038|FG001|Overall Study|Death|0|||
161832016|NCT02697773|584427039|FG002|Overall Study|Death|2|||
161832017|NCT02697773|584427037|FG000|Overall Study|Lack of Efficacy|4|||
161832018|NCT02697773|584427038|FG001|Overall Study|Lack of Efficacy|6|||
161832019|NCT02697773|584427039|FG002|Overall Study|Lack of Efficacy|6|||
161832020|NCT02697773|584427037|FG000|Overall Study|Lost to Follow-up|5|||
161832021|NCT02697773|584427038|FG001|Overall Study|Lost to Follow-up|5|||
161832022|NCT02697773|584427039|FG002|Overall Study|Lost to Follow-up|7|||
161832023|NCT02697773|584427037|FG000|Overall Study|Other|15|||
161832024|NCT02697773|584427038|FG001|Overall Study|Other|11|||
161942562|NCT03801525|584839799|FG002|Overall Study|Disease Progression|1|||
161942563|NCT03801525|584839797|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
161942564|NCT03801525|584839798|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
161942565|NCT03801525|584839799|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
161942566|NCT03801525|584839797|FG000|Overall Study|Investigator Decision|18|||
161942567|NCT03801525|584839798|FG001|Overall Study|Investigator Decision|1|||
161942568|NCT03801525|584839799|FG002|Overall Study|Investigator Decision|0|||
161942569|NCT03801525|584839797|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
161942570|NCT03801525|584839798|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
161942571|NCT03801525|584839799|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
161942572|NCT03801525|584839797|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
161942573|NCT03801525|584839798|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
161942574|NCT03801525|584839799|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
161942575|NCT03801525|584839797|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
161942576|NCT03801525|584839798|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
161942577|NCT03801525|584839799|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
161942578|NCT03801525|584839797|FG000|Overall Study|Withdrawal of Subject Consent|38|||
161942579|NCT03801525|584839798|FG001|Overall Study|Withdrawal of Subject Consent|2|||
161942580|NCT03801525|584839799|FG002|Overall Study|Withdrawal of Subject Consent|1|||
161942581|NCT03801525|584839797|FG000|Overall Study|Reason not Specified|4|||
161942582|NCT03801525|584839798|FG001|Overall Study|Reason not Specified|0|||
161942583|NCT03801525|584839799|FG002|Overall Study|Reason not Specified|4|||
161942584|NCT03309202|584839800|FG000|Overall Study|Lost to Follow-up|1|||
161942585|NCT03309202|584839801|FG001|Overall Study|Lost to Follow-up|0|||
161942586|NCT03309202|584839802|FG002|Overall Study|Lost to Follow-up|0|||
161942587|NCT03309202|584839803|FG003|Overall Study|Lost to Follow-up|0|||
161942588|NCT01822925|584839804|FG000|Overall Study|Adverse Event|1|||
161942589|NCT01822925|584839805|FG001|Overall Study|Adverse Event|1|||
161942590|NCT01822925|584839806|FG002|Overall Study|Adverse Event|1|||
161942591|NCT01822925|584839807|FG003|Overall Study|Adverse Event|1|||
161942592|NCT01822925|584839804|FG000|Overall Study|Lost to Follow-up|0|||
161942593|NCT01822925|584839805|FG001|Overall Study|Lost to Follow-up|1|||
161942594|NCT01822925|584839806|FG002|Overall Study|Lost to Follow-up|0|||
161942595|NCT01822925|584839807|FG003|Overall Study|Lost to Follow-up|0|||
161942596|NCT01822925|584839804|FG000|Overall Study|Protocol Violation|1|||
161942597|NCT01822925|584839805|FG001|Overall Study|Protocol Violation|0|||
161942598|NCT01822925|584839806|FG002|Overall Study|Protocol Violation|0|||
161942599|NCT01822925|584839807|FG003|Overall Study|Protocol Violation|1|||
161942600|NCT01822925|584839804|FG000|Overall Study|Withdrawal by Subject|2|||
161942601|NCT01822925|584839805|FG001|Overall Study|Withdrawal by Subject|0|||
161942602|NCT01822925|584839806|FG002|Overall Study|Withdrawal by Subject|2|||
161942603|NCT01822925|584839807|FG003|Overall Study|Withdrawal by Subject|2|||
161942604|NCT01822925|584839804|FG000|Overall Study|Taking prohibited medication|2|||
161942605|NCT01822925|584839805|FG001|Overall Study|Taking prohibited medication|0|||
161942606|NCT01822925|584839806|FG002|Overall Study|Taking prohibited medication|0|||
161942607|NCT01822925|584839807|FG003|Overall Study|Taking prohibited medication|1|||
161942608|NCT03243084|584839809|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
161942609|NCT03243084|584839810|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
161942610|NCT03847519|584839816|FG000|Overall Study|Death|5|||
161942611|NCT03847519|584839817|FG001|Overall Study|Death|8|||
161942612|NCT03847519|584839818|FG002|Overall Study|Death|1|||
161942613|NCT03847519|584839816|FG000|Overall Study|Lost to Follow-up|1|||
161942614|NCT03847519|584839817|FG001|Overall Study|Lost to Follow-up|2|||
161942615|NCT03847519|584839818|FG002|Overall Study|Lost to Follow-up|0|||
161942616|NCT03847519|584839816|FG000|Overall Study|Study Terminated by Sponsor|0|||
161942617|NCT03847519|584839817|FG001|Overall Study|Study Terminated by Sponsor|3|||
161942618|NCT03847519|584839818|FG002|Overall Study|Study Terminated by Sponsor|2|||
161942619|NCT01500317|584839821|FG000|Overall Study|Withdrawal by Subject|3|||
161942620|NCT01500317|584839822|FG001|Overall Study|Withdrawal by Subject|2|||
161942621|NCT01500317|584839823|FG002|Overall Study|Withdrawal by Subject|0|||
161942622|NCT00335829|584839824|FG000|Overall Study|Withdrawal by Subject|1|||
161942623|NCT00335829|584839824|FG000|Overall Study|Lost to Follow-up|1|||
161942624|NCT00335829|584839824|FG000|Overall Study|Adverse Event|1|||
161942625|NCT04562116|584839825|FG000|Overall Study|Lost to Follow-up|1|||
161942626|NCT04562116|584839825|FG000|Overall Study|Withdrawal by Subject|3|||
161942627|NCT01559935|584839826|FG000|Car Phase|Toxicity|4|||
161683135|NCT03002155|583891278|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
161683136|NCT00974675|583891281|FG000|Overall Study|Adverse Event|2|||
161683137|NCT00974675|583891282|FG001|Overall Study|Adverse Event|1|||
161683138|NCT00974675|583891283|FG002|Overall Study|Adverse Event|1|||
161683139|NCT00974675|583891284|FG003|Overall Study|Adverse Event|1|||
161683140|NCT00974675|583891281|FG000|Overall Study|Physician Decision|0|||
161683141|NCT00974675|583891282|FG001|Overall Study|Physician Decision|0|||
161683142|NCT00974675|583891283|FG002|Overall Study|Physician Decision|1|||
161683143|NCT00974675|583891284|FG003|Overall Study|Physician Decision|0|||
161683144|NCT00974675|583891281|FG000|Overall Study|Participant on holiday; unable to attend|0|||
161683145|NCT00974675|583891282|FG001|Overall Study|Participant on holiday; unable to attend|0|||
161832025|NCT02697773|584427039|FG002|Overall Study|Other|10|||
161832026|NCT02697773|584427037|FG000|Overall Study|Protocol Violation|1|||
161832027|NCT02697773|584427038|FG001|Overall Study|Protocol Violation|1|||
161832028|NCT02697773|584427039|FG002|Overall Study|Protocol Violation|0|||
161832029|NCT02697773|584427037|FG000|Overall Study|Withdrawal by Subject|10|||
161832030|NCT02697773|584427038|FG001|Overall Study|Withdrawal by Subject|13|||
161832031|NCT02697773|584427039|FG002|Overall Study|Withdrawal by Subject|13|||
161832032|NCT02697773|584427037|FG000|Overall Study|Randomized but not treated|1|||
161832033|NCT02697773|584427038|FG001|Overall Study|Randomized but not treated|1|||
161832034|NCT02697773|584427039|FG002|Overall Study|Randomized but not treated|0|||
161683146|NCT00974675|583891283|FG002|Overall Study|Participant on holiday; unable to attend|0|||
161683147|NCT00974675|583891284|FG003|Overall Study|Participant on holiday; unable to attend|1|||
161683148|NCT03302975|583891288|FG000|Overall Study|Lost to Follow-up|4|||
161683149|NCT01436084|583891289|FG000|Overall Study|Disease Progression|2|||
161683150|NCT01436084|583891289|FG000|Overall Study|Withdrawal by Subject|1|||
161683151|NCT01436084|583891289|FG000|Overall Study|Early Closure of Study|1|||
161683152|NCT05998148|583891290|FG000|Allocation|Did not attend any appointments|1|||
161683153|NCT05998148|583891291|FG001|Allocation|Did not attend any appointments|4|||
161683154|NCT05998148|583891290|FG000|Follow-Up|Lost to Follow-up|1|||
161683155|NCT05998148|583891291|FG001|Follow-Up|Lost to Follow-up|2|||
161683156|NCT05998148|583891290|FG000|Follow-Up|Change in insurance|1|||
161683157|NCT05998148|583891291|FG001|Follow-Up|Change in insurance|1|||
161683158|NCT03834519|583891293|FG000|Overall Study|Lost to Follow-up|2|||
161683159|NCT03834519|583891294|FG001|Overall Study|Lost to Follow-up|1|||
161683160|NCT03834519|583891293|FG000|Overall Study|Withdrawal by Subject|5|||
161683161|NCT03834519|583891294|FG001|Overall Study|Withdrawal by Subject|8|||
161683162|NCT03834519|583891293|FG000|Overall Study|Death|368|||
161683163|NCT03834519|583891294|FG001|Overall Study|Death|174|||
161683164|NCT03834519|583891293|FG000|Overall Study|Physician Decision|5|||
161683165|NCT03834519|583891294|FG001|Overall Study|Physician Decision|1|||
161683166|NCT03834519|583891293|FG000|Overall Study|Sponsor decision|149|||
161683167|NCT03834519|583891294|FG001|Overall Study|Sponsor decision|80|||
161683168|NCT04506086|583891295|FG000|Overall Study|Withdrawal by Subject|2|||
161683169|NCT01129921|583891298|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
161683170|NCT01129921|583891299|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
161683171|NCT01129921|583891298|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
161683172|NCT01129921|583891299|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
161683173|NCT01129921|583891298|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
161683174|NCT01129921|583891299|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
161683175|NCT01129921|583891298|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
161683176|NCT01129921|583891299|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
161683177|NCT01380379|583891300|FG000|Overall Study|Pregnancy|1|||
161683178|NCT05937165|583891303|FG000|Overall Study|Withdrawal by Subject|0|||
161683179|NCT05937165|583891304|FG001|Overall Study|Withdrawal by Subject|1|||
161683180|NCT06608368|583891305|FG000|Overall Study|Family Emergency|0|||
161683181|NCT06608368|583891306|FG001|Overall Study|Family Emergency|1|||
161683182|NCT06608368|583891307|FG002|Overall Study|Family Emergency|0|||
161683183|NCT06608368|583891305|FG000|Overall Study|Scheduling Issues|0|||
161683184|NCT06608368|583891306|FG001|Overall Study|Scheduling Issues|1|||
161683185|NCT06608368|583891307|FG002|Overall Study|Scheduling Issues|0|||
161683186|NCT03977974|583891308|FG000|Period 2|Adverse Event|0|||
161683187|NCT03977974|583891309|FG001|Period 2|Adverse Event|0|||
161683188|NCT03977974|583891310|FG002|Period 2|Adverse Event|0|||
161683189|NCT03977974|583891311|FG003|Period 2|Adverse Event|0|||
161683190|NCT03977974|583891312|FG004|Period 2|Adverse Event|1|||
161683191|NCT03977974|583891313|FG005|Period 2|Adverse Event|0|||
161683192|NCT03977974|583891314|FG006|Period 2|Adverse Event|0|||
161832035|NCT00842530|584427040|FG000|Overall Study|Serious adverse event|0|||
161832036|NCT00842530|584427041|FG001|Overall Study|Serious adverse event|6|||
161832037|NCT00842530|584427040|FG000|Overall Study|Other adverse event|6|||
161832038|NCT00842530|584427041|FG001|Overall Study|Other adverse event|1|||
161832039|NCT00842530|584427040|FG000|Overall Study|Protocol Violation|32|||
161832040|NCT00842530|584427041|FG001|Overall Study|Protocol Violation|14|||
161832041|NCT00842530|584427040|FG000|Overall Study|Lost to Follow-up|6|||
161832042|NCT00842530|584427041|FG001|Overall Study|Lost to Follow-up|8|||
161832043|NCT00842530|584427040|FG000|Overall Study|Withdrawal by Subject|73|||
161832044|NCT00842530|584427041|FG001|Overall Study|Withdrawal by Subject|28|||
161832045|NCT02939950|584427042|FG000|Overall Study|Lost to Follow-up|13|||
161832046|NCT02939950|584427043|FG001|Overall Study|Lost to Follow-up|16|||
161832047|NCT02939950|584427042|FG000|Overall Study|Positive slit lamp findings|0|||
161832048|NCT02939950|584427043|FG001|Overall Study|Positive slit lamp findings|1|||
161832049|NCT02939950|584427042|FG000|Overall Study|Chalazion upper lid|0|||
161832050|NCT02939950|584427043|FG001|Overall Study|Chalazion upper lid|1|||
161832051|NCT02939950|584427042|FG000|Overall Study|Lack of motivation|0|||
161832052|NCT02939950|584427043|FG001|Overall Study|Lack of motivation|2|||
161832053|NCT02939950|584427042|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
161832054|NCT02939950|584427043|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
161832055|NCT02939950|584427042|FG000|Overall Study|Military orders|1|||
161832056|NCT02939950|584427043|FG001|Overall Study|Military orders|0|||
161832057|NCT02939950|584427042|FG000|Overall Study|Participant Relocated|5|||
161832058|NCT02939950|584427043|FG001|Overall Study|Participant Relocated|3|||
161832059|NCT02939950|584427042|FG000|Overall Study|Study related symptoms|8|||
161832060|NCT02939950|584427043|FG001|Overall Study|Study related symptoms|8|||
161832061|NCT02939950|584427042|FG000|Overall Study|Unacceptable lens movement|2|||
161832062|NCT02939950|584427043|FG001|Overall Study|Unacceptable lens movement|0|||
161832063|NCT02939950|584427042|FG000|Overall Study|Protocol Violation|6|||
161832064|NCT02939950|584427043|FG001|Overall Study|Protocol Violation|3|||
161832065|NCT02939950|584427042|FG000|Overall Study|Physician Decision|2|||
161832066|NCT02939950|584427043|FG001|Overall Study|Physician Decision|0|||
161832067|NCT02939950|584427042|FG000|Overall Study|Pregnancy|6|||
161832068|NCT02939950|584427043|FG001|Overall Study|Pregnancy|7|||
161832069|NCT02939950|584427042|FG000|Overall Study|Withdrawal by Subject|12|||
161832070|NCT02939950|584427043|FG001|Overall Study|Withdrawal by Subject|28|||
161683193|NCT03977974|583891315|FG007|Period 2|Adverse Event|0|||
161683194|NCT03977974|583891316|FG008|Period 2|Adverse Event|0|||
161683195|NCT03977974|583891317|FG009|Period 2|Adverse Event|0|||
161683196|NCT03977974|583891318|FG010|Period 2|Adverse Event|0|||
161683197|NCT03977974|583891319|FG011|Period 2|Adverse Event|0|||
161683198|NCT03977974|583891320|FG012|Period 2|Adverse Event|0|||
161683199|NCT03080883|583891321|FG000|Overall Study|Withdrawal by Subject|11|||
161832071|NCT02939950|584427042|FG000|Overall Study|Adverse Event|7|||
161832072|NCT02939950|584427043|FG001|Overall Study|Adverse Event|3|||
161832073|NCT02939950|584427042|FG000|Overall Study|Randomized, not dispensed|1|||
161832074|NCT02939950|584427043|FG001|Overall Study|Randomized, not dispensed|0|||
161832075|NCT02939950|584427042|FG000|Overall Study|Ineligible at Baseline|2|||
161683200|NCT03080883|583891322|FG001|Overall Study|Withdrawal by Subject|15|||
161942628|NCT01559935|584839826|FG000|Car Phase|Death|1|||
161942629|NCT01559935|584839826|FG000|Car Phase|Lack of Efficacy|2|||
161942630|NCT01559935|584839826|FG000|Car Phase|Lost to Follow-up|1|||
161942631|NCT01559935|584839826|FG000|Car Phase|Physician Decision|1|||
161942632|NCT01559935|584839826|FG000|Car Phase|Withdrawal by Subject|2|||
161942633|NCT01559935|584839826|FG000|Car Phase|Per protocol|1|||
161942634|NCT01559935|584839826|FG000|Car Phase|Insurance|1|||
161942635|NCT01559935|584839826|FG000|Car Phase|non-compliance|1|||
161942636|NCT01559935|584839826|FG000|BiRD Phase|Toxicity|1|||
161942637|NCT01559935|584839826|FG000|BiRD Phase|Lack of Efficacy|1|||
161942638|NCT01559935|584839826|FG000|BiRD Phase|Withdrawal by Subject|2|||
161942639|NCT01559935|584839826|FG000|Maintenance Phase|Remains on study|28|||
161942640|NCT01559935|584839826|FG000|Maintenance Phase|Toxicity|1|||
161942641|NCT01559935|584839826|FG000|Maintenance Phase|Lack of Efficacy|18|||
161942642|NCT01559935|584839826|FG000|Maintenance Phase|Withdrawal by Subject|5|||
161942643|NCT01559935|584839826|FG000|Maintenance Phase|Non-compliance|2|||
161942644|NCT03078868|584839830|FG000|Overall Study|Physician Decision|3|||
161942645|NCT00105066|584839831|FG000|Overall Study|Adverse Event|2|||
161942646|NCT00105066|584839832|FG001|Overall Study|Adverse Event|5|||
161942647|NCT01979185|584839844|FG000|Period 2|Other|0|||
161942648|NCT01979185|584839845|FG001|Period 2|Other|1|||
161942649|NCT02231580|584839852|FG000|Overall Study|Adverse Event|5|||
161942650|NCT02231580|584839853|FG001|Overall Study|Adverse Event|0|||
161942651|NCT04079738|584839855|FG000|Study Treatment|Death|1|||
161942652|NCT04079738|584839856|FG001|Study Treatment|Death|0|||
161942653|NCT04079738|584839857|FG002|Study Treatment|Death|0|||
161942654|NCT04079738|584839858|FG003|Study Treatment|Death|0|||
161942655|NCT04079738|584839855|FG000|Study Treatment|Adverse Event|2|||
161942656|NCT04079738|584839856|FG001|Study Treatment|Adverse Event|0|||
161942657|NCT04079738|584839857|FG002|Study Treatment|Adverse Event|0|||
161942658|NCT04079738|584839858|FG003|Study Treatment|Adverse Event|0|||
161942659|NCT04079738|584839855|FG000|Study Treatment|withdrawal before treatment|1|||
161942660|NCT04079738|584839856|FG001|Study Treatment|withdrawal before treatment|0|||
161942661|NCT04079738|584839857|FG002|Study Treatment|withdrawal before treatment|0|||
161942662|NCT04079738|584839858|FG003|Study Treatment|withdrawal before treatment|0|||
161942663|NCT04079738|584839855|FG000|Study Treatment|symptomatic deterioration|2|||
161942664|NCT04079738|584839856|FG001|Study Treatment|symptomatic deterioration|0|||
161942665|NCT04079738|584839857|FG002|Study Treatment|symptomatic deterioration|0|||
161942666|NCT04079738|584839858|FG003|Study Treatment|symptomatic deterioration|0|||
161942667|NCT04079738|584839855|FG000|Study Treatment|Disease Progression|1|||
161942668|NCT04079738|584839856|FG001|Study Treatment|Disease Progression|0|||
161942669|NCT04079738|584839857|FG002|Study Treatment|Disease Progression|0|||
161942670|NCT04079738|584839858|FG003|Study Treatment|Disease Progression|0|||
161942671|NCT04079738|584839855|FG000|Study Treatment|withdrawal after treatment|1|||
161942672|NCT04079738|584839856|FG001|Study Treatment|withdrawal after treatment|0|||
161942673|NCT04079738|584839857|FG002|Study Treatment|withdrawal after treatment|0|||
161942674|NCT04079738|584839858|FG003|Study Treatment|withdrawal after treatment|0|||
161942675|NCT04079738|584839855|FG000|Follow up|Withdrawal by Subject|3|||
161942676|NCT04079738|584839856|FG001|Follow up|Withdrawal by Subject|0|||
161942677|NCT04079738|584839857|FG002|Follow up|Withdrawal by Subject|0|||
161942678|NCT04079738|584839858|FG003|Follow up|Withdrawal by Subject|0|||
161942679|NCT04079738|584839855|FG000|Follow up|Death|5|||
161942680|NCT04079738|584839856|FG001|Follow up|Death|0|||
161942681|NCT04079738|584839857|FG002|Follow up|Death|0|||
161942682|NCT04079738|584839858|FG003|Follow up|Death|0|||
161942683|NCT03620981|584839859|FG000|Overall Study|Adverse Event|14|||
161942684|NCT03620981|584839860|FG001|Overall Study|Adverse Event|38|||
161942685|NCT03620981|584839861|FG002|Overall Study|Adverse Event|25|||
161942686|NCT03620981|584839859|FG000|Overall Study|Lack of Efficacy|2|||
161942687|NCT03620981|584839860|FG001|Overall Study|Lack of Efficacy|1|||
161683201|NCT03080883|583891321|FG000|Overall Study|Adverse Event|22|||
161942688|NCT03620981|584839861|FG002|Overall Study|Lack of Efficacy|1|||
161942689|NCT03620981|584839859|FG000|Overall Study|Physician Decision|7|||
161942690|NCT03620981|584839860|FG001|Overall Study|Physician Decision|4|||
161942691|NCT03620981|584839861|FG002|Overall Study|Physician Decision|4|||
161942692|NCT03620981|584839859|FG000|Overall Study|Protocol Violation|1|||
161942693|NCT03620981|584839860|FG001|Overall Study|Protocol Violation|2|||
161942694|NCT03620981|584839861|FG002|Overall Study|Protocol Violation|1|||
161942695|NCT03620981|584839859|FG000|Overall Study|Withdrawal by Legal Representative|2|||
161942696|NCT03620981|584839860|FG001|Overall Study|Withdrawal by Legal Representative|1|||
161942697|NCT03620981|584839861|FG002|Overall Study|Withdrawal by Legal Representative|1|||
161942698|NCT03620981|584839859|FG000|Overall Study|Withdrawal by Care Giver|2|||
161942699|NCT03620981|584839860|FG001|Overall Study|Withdrawal by Care Giver|0|||
161942700|NCT03620981|584839861|FG002|Overall Study|Withdrawal by Care Giver|1|||
161942701|NCT03620981|584839859|FG000|Overall Study|Non-compliance with Study Drug|1|||
161942702|NCT03620981|584839860|FG001|Overall Study|Non-compliance with Study Drug|1|||
161942703|NCT03620981|584839861|FG002|Overall Study|Non-compliance with Study Drug|0|||
161942704|NCT05552859|584839864|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
161942705|NCT05552859|584839865|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
161942706|NCT01380080|584839866|FG000|Overall Study|Death|36|||
161942707|NCT01380080|584839867|FG001|Overall Study|Death|44|||
161942708|NCT01380080|584839866|FG000|Overall Study|Site is closing|28|||
161942709|NCT01380080|584839867|FG001|Overall Study|Site is closing|31|||
161942710|NCT01380080|584839866|FG000|Overall Study|Not able to get to clinic|7|||
161942711|NCT01380080|584839867|FG001|Overall Study|Not able to get to clinic|1|||
161942712|NCT01380080|584839866|FG000|Overall Study|Not willing to adhere to requirements|6|||
161942713|NCT01380080|584839867|FG001|Overall Study|Not willing to adhere to requirements|2|||
161942714|NCT01380080|584839866|FG000|Overall Study|Withdrawal by Subject|5|||
161942715|NCT01380080|584839867|FG001|Overall Study|Withdrawal by Subject|2|||
161942716|NCT01380080|584839866|FG000|Overall Study|Lost to Follow-up|3|||
161942717|NCT01380080|584839867|FG001|Overall Study|Lost to Follow-up|3|||
161942718|NCT00210132|584839870|FG000|Overall Study|Protocol Violation|1|||
161942719|NCT00210132|584839871|FG001|Overall Study|Protocol Violation|4|||
161942720|NCT02711202|584839872|FG000|Overall Study|Adverse Event|3|||
161942721|NCT02711202|584839873|FG001|Overall Study|Adverse Event|0|||
161942722|NCT02711202|584839872|FG000|Overall Study|graft loss|1|||
161942723|NCT02711202|584839873|FG001|Overall Study|graft loss|0|||
161942724|NCT02402647|584839874|FG000|Overall Study|Lost to Follow-up|13|||
161942725|NCT02402647|584839875|FG001|Overall Study|Lost to Follow-up|7|||
161942726|NCT02402647|584839874|FG000|Overall Study|Protocol Violation|1|||
161942727|NCT02402647|584839875|FG001|Overall Study|Protocol Violation|1|||
161942728|NCT02402647|584839874|FG000|Overall Study|scheduled and timed out|2|||
161942729|NCT02402647|584839875|FG001|Overall Study|scheduled and timed out|1|||
161942730|NCT02402647|584839874|FG000|Overall Study|medical illness|2|||
161942731|NCT02402647|584839875|FG001|Overall Study|medical illness|4|||
161942732|NCT02402647|584839874|FG000|Overall Study|Moved|2|||
161942733|NCT02402647|584839875|FG001|Overall Study|Moved|0|||
161942734|NCT02402647|584839874|FG000|Overall Study|loved one illness|1|||
161942735|NCT02402647|584839875|FG001|Overall Study|loved one illness|0|||
161942736|NCT02402647|584839874|FG000|Overall Study|deceased preexisting condition|2|||
161942737|NCT02402647|584839875|FG001|Overall Study|deceased preexisting condition|0|||
161942738|NCT02402647|584839874|FG000|Overall Study|Other|2|||
161942739|NCT02402647|584839875|FG001|Overall Study|Other|1|||
161942740|NCT05852470|584839877|FG000|Overall Study|Withdrawal by Subject|0|||
161942741|NCT05852470|584839878|FG001|Overall Study|Withdrawal by Subject|1|||
161942742|NCT04144517|584839890|FG000|Overall Study|Physician Decision|0|||
161942743|NCT04144517|584839891|FG001|Overall Study|Physician Decision|1|||
161942744|NCT04144517|584839890|FG000|Overall Study|Other|2|||
161942745|NCT04144517|584839891|FG001|Overall Study|Other|2|||
161942746|NCT04144517|584839890|FG000|Overall Study|Death|6|||
161942747|NCT04144517|584839891|FG001|Overall Study|Death|3|||
161942748|NCT05212168|584839896|FG000|Overall Study|Lost to Follow-up|0|||
161942749|NCT05212168|584839897|FG001|Overall Study|Lost to Follow-up|3|||
161683202|NCT03080883|583891322|FG001|Overall Study|Adverse Event|22|||
161683203|NCT03080883|583891321|FG000|Overall Study|Alternative Therapy|0|||
161683204|NCT03080883|583891322|FG001|Overall Study|Alternative Therapy|3|||
161683205|NCT03080883|583891321|FG000|Overall Study|Other Complicating Disease|9|||
161683206|NCT03080883|583891322|FG001|Overall Study|Other Complicating Disease|5|||
161683207|NCT03080883|583891321|FG000|Overall Study|Death|21|||
161683208|NCT03080883|583891322|FG001|Overall Study|Death|16|||
161683209|NCT03080883|583891321|FG000|Overall Study|Physician Decision|2|||
161683210|NCT03080883|583891322|FG001|Overall Study|Physician Decision|2|||
161832076|NCT02939950|584427043|FG001|Overall Study|Ineligible at Baseline|8|||
161942750|NCT05212168|584839896|FG000|Overall Study|Study terminated by sponsor|30|||
161942751|NCT05212168|584839897|FG001|Overall Study|Study terminated by sponsor|27|||
161942752|NCT05212168|584839896|FG000|Overall Study|Other|4|||
161942753|NCT05212168|584839897|FG001|Overall Study|Other|7|||
161942754|NCT02333799|584841614|FG000|Treatment Period|Withdrawal by Subject|1|||
161942755|NCT02333799|584841614|FG000|Treatment Period|Death|6|||
161942756|NCT02333799|584841614|FG000|6 Month Follow Up Period|Physician Decision|1|||
161942757|NCT02333799|584841614|FG000|6 Month Follow Up Period|Death|1|||
161942758|NCT02333799|584841614|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
161942759|NCT02333799|584841614|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
161942760|NCT05847686|584841615|FG000|Overall Study|Withdrawal by Subject|3|||
161942761|NCT03716830|584841616|FG000|Overall Study|Withdrawal by Subject|2|||
161942762|NCT03716830|584841617|FG001|Overall Study|Withdrawal by Subject|2|||
161942763|NCT03716830|584841618|FG002|Overall Study|Withdrawal by Subject|6|||
161942764|NCT03716830|584841619|FG003|Overall Study|Withdrawal by Subject|5|||
161942765|NCT03716830|584841616|FG000|Overall Study|Adverse Event|1|||
161942766|NCT03716830|584841617|FG001|Overall Study|Adverse Event|2|||
161942767|NCT03716830|584841618|FG002|Overall Study|Adverse Event|0|||
161942768|NCT03716830|584841619|FG003|Overall Study|Adverse Event|1|||
161942769|NCT03716830|584841616|FG000|Overall Study|Lost to Follow-up|1|||
161942770|NCT03716830|584841617|FG001|Overall Study|Lost to Follow-up|1|||
161942771|NCT03716830|584841618|FG002|Overall Study|Lost to Follow-up|0|||
161942772|NCT03716830|584841619|FG003|Overall Study|Lost to Follow-up|0|||
161942773|NCT02552225|584841621|FG000|Overall Study|Withdrawal by Subject|1|||
161942774|NCT02552225|584841622|FG001|Overall Study|Withdrawal by Subject|0|||
161942775|NCT00876447|584841623|FG000|Overall Study|Other miscellaneous reasons|3|||
161942776|NCT00876447|584841624|FG001|Overall Study|Other miscellaneous reasons|8|||
161942777|NCT00876447|584841623|FG000|Overall Study|Site closure|19|||
161942778|NCT00876447|584841624|FG001|Overall Study|Site closure|14|||
161942779|NCT00876447|584841623|FG000|Overall Study|Protocol Violation|9|||
161942780|NCT00876447|584841624|FG001|Overall Study|Protocol Violation|3|||
161942781|NCT00876447|584841623|FG000|Overall Study|Personal reasons|30|||
161942782|NCT00876447|584841624|FG001|Overall Study|Personal reasons|28|||
161942783|NCT00876447|584841623|FG000|Overall Study|Lost to Follow-up|6|||
161942784|NCT00876447|584841624|FG001|Overall Study|Lost to Follow-up|15|||
161942785|NCT00876447|584841623|FG000|Overall Study|Pregnancy|4|||
161942786|NCT00876447|584841624|FG001|Overall Study|Pregnancy|2|||
161942787|NCT00876447|584841623|FG000|Overall Study|Lack of Efficacy|5|||
161942788|NCT00876447|584841624|FG001|Overall Study|Lack of Efficacy|3|||
161942789|NCT00876447|584841623|FG000|Overall Study|Adverse Event|4|||
161942790|NCT00876447|584841624|FG001|Overall Study|Adverse Event|8|||
161942791|NCT00567502|584841625|FG000|Overall Study|Lost to Follow-up|91|||
161942792|NCT00567502|584841626|FG001|Overall Study|Lost to Follow-up|14|||
161942793|NCT00567502|584841627|FG002|Overall Study|Lost to Follow-up|351|||
161942794|NCT00567502|584841628|FG003|Overall Study|Lost to Follow-up|2|||
161942795|NCT00567502|584841625|FG000|Overall Study|Death|65|||
161942796|NCT00567502|584841626|FG001|Overall Study|Death|16|||
161942797|NCT00567502|584841627|FG002|Overall Study|Death|360|||
161942798|NCT00567502|584841628|FG003|Overall Study|Death|5|||
161942799|NCT00567502|584841625|FG000|Overall Study|Other|64|||
161942800|NCT00567502|584841626|FG001|Overall Study|Other|2|||
161942801|NCT00567502|584841627|FG002|Overall Study|Other|134|||
162026615|NCT00910624|585154363|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
161683211|NCT03080883|583891321|FG000|Overall Study|Disease Progression|2|||
161683212|NCT03080883|583891322|FG001|Overall Study|Disease Progression|8|||
161683213|NCT03080883|583891321|FG000|Overall Study|Lost to Follow-up|1|||
161832077|NCT02243293|584427044|FG000|Overall Study|Adverse Event|1|||
161832078|NCT02243293|584427045|FG001|Overall Study|Adverse Event|0|||
161832079|NCT02243293|584427046|FG002|Overall Study|Adverse Event|0|||
161832080|NCT02243293|584427047|FG003|Overall Study|Adverse Event|0|||
161832081|NCT02243293|584427048|FG004|Overall Study|Adverse Event|0|||
161832082|NCT02243293|584427049|FG005|Overall Study|Adverse Event|0|||
161832083|NCT02243293|584427050|FG006|Overall Study|Adverse Event|0|||
161832084|NCT02243293|584427051|FG007|Overall Study|Adverse Event|0|||
161832085|NCT02243293|584427052|FG008|Overall Study|Adverse Event|0|||
161832086|NCT02243293|584427053|FG009|Overall Study|Adverse Event|0|||
161832087|NCT02243293|584427054|FG010|Overall Study|Adverse Event|0|||
161832088|NCT02243293|584427055|FG011|Overall Study|Adverse Event|0|||
161832089|NCT02243293|584427056|FG012|Overall Study|Adverse Event|0|||
161832090|NCT02243293|584427057|FG013|Overall Study|Adverse Event|0|||
161942802|NCT00567502|584841628|FG003|Overall Study|Other|6|||
161942803|NCT00567502|584841625|FG000|Overall Study|Participant request|12|||
161942804|NCT00567502|584841626|FG001|Overall Study|Participant request|1|||
161942805|NCT00567502|584841627|FG002|Overall Study|Participant request|33|||
161942806|NCT00567502|584841628|FG003|Overall Study|Participant request|1|||
161942807|NCT00567502|584841625|FG000|Overall Study|Sponsor request|9|||
161942808|NCT00567502|584841626|FG001|Overall Study|Sponsor request|0|||
161942809|NCT00567502|584841627|FG002|Overall Study|Sponsor request|30|||
161942810|NCT00567502|584841628|FG003|Overall Study|Sponsor request|1|||
162026616|NCT00910624|585154360|FG000|Follow-Up Phase|Adverse Event|0|||
162026617|NCT00910624|585154361|FG001|Follow-Up Phase|Adverse Event|0|||
162026618|NCT00910624|585154362|FG002|Follow-Up Phase|Adverse Event|1|||
162026619|NCT00910624|585154363|FG003|Follow-Up Phase|Adverse Event|0|||
162026620|NCT00910624|585154360|FG000|Follow-Up Phase|Lost to Follow-up|3|||
162026621|NCT00910624|585154361|FG001|Follow-Up Phase|Lost to Follow-up|1|||
162026622|NCT00910624|585154362|FG002|Follow-Up Phase|Lost to Follow-up|2|||
162026623|NCT00910624|585154363|FG003|Follow-Up Phase|Lost to Follow-up|0|||
162026624|NCT00910624|585154360|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
162026625|NCT00910624|585154361|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
162026626|NCT00910624|585154362|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
162026627|NCT00910624|585154363|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
162026628|NCT00910624|585154360|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
161942811|NCT00567502|584841625|FG000|Overall Study|Never Initiated Treatment|0|||
161942812|NCT00567502|584841626|FG001|Overall Study|Never Initiated Treatment|0|||
161942813|NCT00567502|584841627|FG002|Overall Study|Never Initiated Treatment|0|||
161942814|NCT00567502|584841628|FG003|Overall Study|Never Initiated Treatment|72|||
161942815|NCT02835690|584841629|FG000|Overall Study|Death|12|||
161942816|NCT02835690|584841630|FG001|Overall Study|Death|11|||
161942817|NCT02835690|584841631|FG002|Overall Study|Death|13|||
161942818|NCT02835690|584841629|FG000|Overall Study|Transferred to Extension Study|2|||
161942819|NCT02835690|584841630|FG001|Overall Study|Transferred to Extension Study|2|||
161942820|NCT02835690|584841631|FG002|Overall Study|Transferred to Extension Study|1|||
161942821|NCT02835690|584841629|FG000|Overall Study|Did Not Continue on Extension Study|0|||
161942822|NCT02835690|584841630|FG001|Overall Study|Did Not Continue on Extension Study|0|||
161942823|NCT02835690|584841631|FG002|Overall Study|Did Not Continue on Extension Study|1|||
161942824|NCT02835690|584841629|FG000|Overall Study|Not Treated|0|||
162026629|NCT00910624|585154361|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
162026630|NCT00910624|585154362|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
162026631|NCT00910624|585154363|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
161942825|NCT02835690|584841630|FG001|Overall Study|Not Treated|2|||
161942826|NCT02835690|584841631|FG002|Overall Study|Not Treated|0|||
161942827|NCT03728933|584841632|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161942828|NCT03728933|584841633|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161942829|NCT03728933|584841634|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161942830|NCT03728933|584841632|FG000|Overall Study|Withdrawal by Subject|0|||
161942831|NCT03728933|584841633|FG001|Overall Study|Withdrawal by Subject|0|||
161942832|NCT03728933|584841634|FG002|Overall Study|Withdrawal by Subject|1|||
161942833|NCT03728933|584841632|FG000|Overall Study|Lost to Follow-up|0|||
161942834|NCT03728933|584841633|FG001|Overall Study|Lost to Follow-up|1|||
161942835|NCT03728933|584841634|FG002|Overall Study|Lost to Follow-up|0|||
161942836|NCT03728933|584841632|FG000|Overall Study|Adverse Event|1|||
161942837|NCT03728933|584841633|FG001|Overall Study|Adverse Event|0|||
161942838|NCT03728933|584841634|FG002|Overall Study|Adverse Event|0|||
161942839|NCT02538614|584841637|FG000|Overall Study|Progressive Disease|2|||
161942840|NCT00582907|584841638|FG000|1st Course|Withdrawal by Subject|1|||
161942841|NCT00582907|584841639|FG001|1st Course|Withdrawal by Subject|0|||
161942842|NCT00582907|584841640|FG002|1st Course|Withdrawal by Subject|0|||
161942843|NCT00582907|584841641|FG003|1st Course|Withdrawal by Subject|0|||
161942844|NCT00582907|584841638|FG000|1st Course|Lost to Follow-up|0|||
161942845|NCT00582907|584841639|FG001|1st Course|Lost to Follow-up|0|||
161942846|NCT00582907|584841640|FG002|1st Course|Lost to Follow-up|0|||
161942847|NCT00582907|584841641|FG003|1st Course|Lost to Follow-up|1|||
161942848|NCT00582907|584841638|FG000|2nd Course|Lack of Efficacy|1|||
161942849|NCT00582907|584841639|FG001|2nd Course|Lack of Efficacy|0|||
161942850|NCT00582907|584841640|FG002|2nd Course|Lack of Efficacy|0|||
161942851|NCT00582907|584841641|FG003|2nd Course|Lack of Efficacy|0|||
161942852|NCT01441960|584841643|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
161942853|NCT01441960|584841644|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
161942854|NCT01441960|584841643|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
161942855|NCT01441960|584841644|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
161942856|NCT01441960|584841643|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
161942857|NCT01441960|584841644|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
161942858|NCT00189423|584841645|FG000|Overall Study|Death|746|||
161942859|NCT00189423|584841646|FG001|Overall Study|Death|747|||
161942860|NCT00189423|584841645|FG000|Overall Study|Withdrawal by Subject|9|||
161942861|NCT00189423|584841646|FG001|Overall Study|Withdrawal by Subject|9|||
161942862|NCT00189423|584841645|FG000|Overall Study|Lost to Follow-up|10|||
161942863|NCT00189423|584841646|FG001|Overall Study|Lost to Follow-up|10|||
161942864|NCT00415636|584841652|FG000|Overall Study|Symptomatic deterioration|1|||
161942865|NCT00415636|584841653|FG001|Overall Study|Symptomatic deterioration|0|||
161942866|NCT00415636|584841654|FG002|Overall Study|Symptomatic deterioration|1|||
161942867|NCT00415636|584841655|FG003|Overall Study|Symptomatic deterioration|2|||
161942868|NCT00415636|584841656|FG004|Overall Study|Symptomatic deterioration|0|||
161942869|NCT00415636|584841657|FG005|Overall Study|Symptomatic deterioration|1|||
161942870|NCT00415636|584841652|FG000|Overall Study|Adverse Event|0|||
161942871|NCT00415636|584841653|FG001|Overall Study|Adverse Event|0|||
161942872|NCT00415636|584841654|FG002|Overall Study|Adverse Event|0|||
161942873|NCT00415636|584841655|FG003|Overall Study|Adverse Event|1|||
161942874|NCT00415636|584841656|FG004|Overall Study|Adverse Event|1|||
161942875|NCT00415636|584841657|FG005|Overall Study|Adverse Event|0|||
161942876|NCT00415636|584841652|FG000|Overall Study|Withdrawal by Subject|0|||
161942877|NCT00415636|584841653|FG001|Overall Study|Withdrawal by Subject|0|||
161942878|NCT00415636|584841654|FG002|Overall Study|Withdrawal by Subject|0|||
161942879|NCT00415636|584841655|FG003|Overall Study|Withdrawal by Subject|0|||
161942880|NCT00415636|584841656|FG004|Overall Study|Withdrawal by Subject|1|||
161942881|NCT00415636|584841657|FG005|Overall Study|Withdrawal by Subject|0|||
161942882|NCT00415636|584841652|FG000|Overall Study|Disease progression|0|||
161942883|NCT00415636|584841653|FG001|Overall Study|Disease progression|0|||
161942884|NCT00415636|584841654|FG002|Overall Study|Disease progression|0|||
161942885|NCT00415636|584841655|FG003|Overall Study|Disease progression|3|||
161942886|NCT00415636|584841656|FG004|Overall Study|Disease progression|0|||
161942887|NCT00415636|584841657|FG005|Overall Study|Disease progression|1|||
161942888|NCT01263119|584841658|FG000|Period 1|Protocol Violation|2|||
161942889|NCT01263119|584841658|FG000|Period 2|Adverse Event|2|||
161942890|NCT02138825|584841659|FG000|Main Study Treatment|Adverse Event|11|||
161942891|NCT02138825|584841660|FG001|Main Study Treatment|Adverse Event|3|||
161942892|NCT02138825|584841659|FG000|Main Study Treatment|Death|1|||
161942893|NCT02138825|584841660|FG001|Main Study Treatment|Death|2|||
161942894|NCT02138825|584841659|FG000|Main Study Treatment|Protocol Violation|2|||
161942895|NCT02138825|584841660|FG001|Main Study Treatment|Protocol Violation|2|||
161942896|NCT02138825|584841659|FG000|Main Study Treatment|Sponsor decision|12|||
161942897|NCT02138825|584841660|FG001|Main Study Treatment|Sponsor decision|18|||
161942898|NCT02138825|584841659|FG000|Main Study Treatment|Study terminated by sponsor|10|||
161942899|NCT02138825|584841660|FG001|Main Study Treatment|Study terminated by sponsor|9|||
162026632|NCT00910624|585154360|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
162026633|NCT00910624|585154361|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
161942900|NCT02138825|584841659|FG000|Main Study Treatment|Withdrawal by Subject|3|||
161942901|NCT02138825|584841660|FG001|Main Study Treatment|Withdrawal by Subject|1|||
161942902|NCT02138825|584841659|FG000|Main Study Treatment|Medical decision|1|||
161942903|NCT02138825|584841660|FG001|Main Study Treatment|Medical decision|0|||
161942904|NCT02138825|584841659|FG000|Long-term Extension|Study termination by sponsor|32|||
161942905|NCT02138825|584841660|FG001|Long-term Extension|Study termination by sponsor|38|||
161942906|NCT02138825|584841659|FG000|Safety Follow-up|Adverse Event|4|||
161683214|NCT03080883|583891322|FG001|Overall Study|Lost to Follow-up|1|||
161683215|NCT00388973|583892871|FG000|Overall Study|Adverse Event|16|||
161683216|NCT00388973|583892872|FG001|Overall Study|Adverse Event|6|||
161683217|NCT00388973|583892871|FG000|Overall Study|Lack of Efficacy|1|||
161683218|NCT00388973|583892872|FG001|Overall Study|Lack of Efficacy|12|||
161683219|NCT00388973|583892871|FG000|Overall Study|Protocol Violation|3|||
161832091|NCT02243293|584427058|FG014|Overall Study|Adverse Event|0|||
161832092|NCT02243293|584427059|FG015|Overall Study|Adverse Event|1|||
161832093|NCT02243293|584427060|FG016|Overall Study|Adverse Event|0|||
161832094|NCT02243293|584427061|FG017|Overall Study|Adverse Event|0|||
161832095|NCT02243293|584427062|FG018|Overall Study|Adverse Event|0|||
161832096|NCT02243293|584427063|FG019|Overall Study|Adverse Event|0|||
161832097|NCT02243293|584427064|FG020|Overall Study|Adverse Event|1|||
161832098|NCT02243293|584427065|FG021|Overall Study|Adverse Event|0|||
161832099|NCT02243293|584427044|FG000|Overall Study|Withdrawal by Subject|1|||
161832100|NCT02243293|584427045|FG001|Overall Study|Withdrawal by Subject|0|||
161832101|NCT02243293|584427046|FG002|Overall Study|Withdrawal by Subject|0|||
161832102|NCT02243293|584427047|FG003|Overall Study|Withdrawal by Subject|0|||
161832103|NCT02243293|584427048|FG004|Overall Study|Withdrawal by Subject|0|||
161832104|NCT02243293|584427049|FG005|Overall Study|Withdrawal by Subject|0|||
161832105|NCT02243293|584427050|FG006|Overall Study|Withdrawal by Subject|0|||
161832106|NCT02243293|584427051|FG007|Overall Study|Withdrawal by Subject|0|||
161832107|NCT02243293|584427052|FG008|Overall Study|Withdrawal by Subject|0|||
161832108|NCT02243293|584427053|FG009|Overall Study|Withdrawal by Subject|1|||
161832109|NCT02243293|584427054|FG010|Overall Study|Withdrawal by Subject|0|||
161832110|NCT02243293|584427055|FG011|Overall Study|Withdrawal by Subject|1|||
161832111|NCT02243293|584427056|FG012|Overall Study|Withdrawal by Subject|0|||
161832112|NCT02243293|584427057|FG013|Overall Study|Withdrawal by Subject|0|||
161832113|NCT02243293|584427058|FG014|Overall Study|Withdrawal by Subject|0|||
161832114|NCT02243293|584427059|FG015|Overall Study|Withdrawal by Subject|0|||
161832115|NCT02243293|584427060|FG016|Overall Study|Withdrawal by Subject|0|||
161832116|NCT02243293|584427061|FG017|Overall Study|Withdrawal by Subject|0|||
161832117|NCT02243293|584427062|FG018|Overall Study|Withdrawal by Subject|0|||
161832118|NCT02243293|584427063|FG019|Overall Study|Withdrawal by Subject|0|||
161832119|NCT02243293|584427064|FG020|Overall Study|Withdrawal by Subject|0|||
161832120|NCT02243293|584427065|FG021|Overall Study|Withdrawal by Subject|1|||
161832121|NCT02243293|584427044|FG000|Overall Study|Lost to Follow-up|0|||
161832122|NCT02243293|584427045|FG001|Overall Study|Lost to Follow-up|1|||
161832123|NCT02243293|584427046|FG002|Overall Study|Lost to Follow-up|1|||
161832124|NCT02243293|584427047|FG003|Overall Study|Lost to Follow-up|1|||
161832125|NCT02243293|584427048|FG004|Overall Study|Lost to Follow-up|0|||
161832126|NCT02243293|584427049|FG005|Overall Study|Lost to Follow-up|0|||
161832127|NCT02243293|584427050|FG006|Overall Study|Lost to Follow-up|3|||
161832128|NCT02243293|584427051|FG007|Overall Study|Lost to Follow-up|0|||
161832129|NCT02243293|584427052|FG008|Overall Study|Lost to Follow-up|0|||
161832130|NCT02243293|584427053|FG009|Overall Study|Lost to Follow-up|0|||
161832131|NCT02243293|584427054|FG010|Overall Study|Lost to Follow-up|0|||
161832132|NCT02243293|584427055|FG011|Overall Study|Lost to Follow-up|2|||
161832133|NCT02243293|584427056|FG012|Overall Study|Lost to Follow-up|0|||
161832134|NCT02243293|584427057|FG013|Overall Study|Lost to Follow-up|0|||
161832135|NCT02243293|584427058|FG014|Overall Study|Lost to Follow-up|0|||
161832136|NCT02243293|584427059|FG015|Overall Study|Lost to Follow-up|0|||
161832137|NCT02243293|584427060|FG016|Overall Study|Lost to Follow-up|3|||
161832138|NCT02243293|584427061|FG017|Overall Study|Lost to Follow-up|1|||
161832139|NCT02243293|584427062|FG018|Overall Study|Lost to Follow-up|0|||
161832140|NCT02243293|584427063|FG019|Overall Study|Lost to Follow-up|0|||
161832141|NCT02243293|584427064|FG020|Overall Study|Lost to Follow-up|1|||
161832142|NCT02243293|584427065|FG021|Overall Study|Lost to Follow-up|2|||
161832143|NCT02243293|584427044|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
161832144|NCT02243293|584427045|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
161832145|NCT02243293|584427046|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
161832146|NCT02243293|584427047|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
161832147|NCT02243293|584427048|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
161832148|NCT02243293|584427049|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
161832149|NCT02243293|584427050|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
161832150|NCT02243293|584427051|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
161832151|NCT02243293|584427052|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
161832152|NCT02243293|584427053|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
161832153|NCT02243293|584427054|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
161832154|NCT02243293|584427055|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
161832155|NCT02243293|584427056|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
161942907|NCT02138825|584841660|FG001|Safety Follow-up|Adverse Event|3|||
161832156|NCT02243293|584427057|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
161832157|NCT02243293|584427058|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
161683220|NCT00388973|583892872|FG001|Overall Study|Protocol Violation|0|||
161832158|NCT02243293|584427059|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
161832159|NCT02243293|584427060|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
161683221|NCT00388973|583892871|FG000|Overall Study|Withdrawal by Subject|14|||
161683222|NCT00388973|583892872|FG001|Overall Study|Withdrawal by Subject|17|||
161683223|NCT00388973|583892871|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
161683224|NCT00388973|583892872|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
161683225|NCT00388973|583892871|FG000|Overall Study|Did not complete 61 days of treatment|5|||
161683226|NCT00388973|583892872|FG001|Overall Study|Did not complete 61 days of treatment|4|||
161683227|NCT00388973|583892871|FG000|Overall Study|Left region|0|||
161683228|NCT00388973|583892872|FG001|Overall Study|Left region|1|||
161683229|NCT00388973|583892871|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
161683230|NCT00388973|583892872|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
161683231|NCT01999465|583892873|FG000|Overall Study|Lost to Follow-up|0|||
161683232|NCT01999465|583892874|FG001|Overall Study|Lost to Follow-up|2|||
161683233|NCT01999465|583892873|FG000|Overall Study|Protocol Violation|0|||
161683234|NCT01999465|583892874|FG001|Overall Study|Protocol Violation|1|||
161683235|NCT00390546|583892875|FG000|Overall Study|Renal impairment|1|||
161683236|NCT00390546|583892876|FG001|Overall Study|Renal impairment|0|||
161683237|NCT00390546|583892875|FG000|Overall Study|Physician Decision|5|||
161683238|NCT00390546|583892876|FG001|Overall Study|Physician Decision|5|||
161683239|NCT01308008|583892877|FG000|4 Weeks|Illness, disinterest, time|9|||
161683240|NCT01308008|583892878|FG001|4 Weeks|Illness, disinterest, time|2|||
161683241|NCT02325219|583892879|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
161683242|NCT02325219|583892880|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
161683243|NCT02325219|583892881|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
161683244|NCT02325219|583892882|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
161683245|NCT02325219|583892883|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
161683246|NCT02325219|583892879|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
161683247|NCT02325219|583892880|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
161683248|NCT02325219|583892881|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161683249|NCT02325219|583892882|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161683250|NCT02325219|583892883|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161683251|NCT02325219|583892879|FG000|Controlled Period (Week 0 - 16)|Other|0|||
161683252|NCT02325219|583892880|FG001|Controlled Period (Week 0 - 16)|Other|0|||
161683253|NCT02325219|583892881|FG002|Controlled Period (Week 0 - 16)|Other|1|||
161683254|NCT02325219|583892882|FG003|Controlled Period (Week 0 - 16)|Other|0|||
161683255|NCT02325219|583892883|FG004|Controlled Period (Week 0 - 16)|Other|0|||
161683256|NCT02325219|583892879|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161683257|NCT02325219|583892880|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161683258|NCT02325219|583892881|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161683259|NCT02325219|583892882|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161683260|NCT02325219|583892883|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
161683261|NCT02325219|583892879|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
161683262|NCT02325219|583892880|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
161683263|NCT02325219|583892881|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
161683264|NCT02325219|583892882|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
161683265|NCT02325219|583892883|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
161683266|NCT02325219|583892879|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161683267|NCT02325219|583892880|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
161683268|NCT02325219|583892881|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161683269|NCT02325219|583892882|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161683270|NCT02325219|583892883|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161683271|NCT02187172|583892884|FG000|Overall Study|Lost to Follow-up|1|||
161683272|NCT02187172|583892885|FG001|Overall Study|Lost to Follow-up|2|||
161683273|NCT02187172|583892884|FG000|Overall Study|Lack of Efficacy|1|||
161683274|NCT02187172|583892885|FG001|Overall Study|Lack of Efficacy|2|||
161683275|NCT02187172|583892884|FG000|Overall Study|Adverse Event|0|||
161683276|NCT02187172|583892885|FG001|Overall Study|Adverse Event|1|||
161683277|NCT02187172|583892884|FG000|Overall Study|Physician Decision|1|||
161683278|NCT02187172|583892885|FG001|Overall Study|Physician Decision|1|||
161683279|NCT00880399|583892886|FG000|Overall Study|Adverse Event|4|||
161683280|NCT00880399|583892887|FG001|Overall Study|Adverse Event|6|||
161683281|NCT00880399|583892888|FG002|Overall Study|Adverse Event|5|||
161683282|NCT00880399|583892886|FG000|Overall Study|Lack of Efficacy|1|||
161683283|NCT00880399|583892887|FG001|Overall Study|Lack of Efficacy|4|||
161683284|NCT00880399|583892888|FG002|Overall Study|Lack of Efficacy|2|||
161683285|NCT00880399|583892886|FG000|Overall Study|Protocol Violation|4|||
161683286|NCT00880399|583892887|FG001|Overall Study|Protocol Violation|4|||
161683287|NCT00880399|583892888|FG002|Overall Study|Protocol Violation|6|||
161683288|NCT00880399|583892886|FG000|Overall Study|Study closed/terminated|3|||
161683289|NCT00880399|583892887|FG001|Overall Study|Study closed/terminated|7|||
161683290|NCT00880399|583892888|FG002|Overall Study|Study closed/terminated|4|||
161683291|NCT00880399|583892886|FG000|Overall Study|Lost to Follow-up|8|||
161683292|NCT00880399|583892887|FG001|Overall Study|Lost to Follow-up|5|||
161683293|NCT00880399|583892888|FG002|Overall Study|Lost to Follow-up|3|||
161683294|NCT00880399|583892886|FG000|Overall Study|Physician Decision|5|||
161683295|NCT00880399|583892887|FG001|Overall Study|Physician Decision|0|||
161683296|NCT00880399|583892888|FG002|Overall Study|Physician Decision|3|||
161683297|NCT00880399|583892886|FG000|Overall Study|Withdrawal by Subject|6|||
161683298|NCT00880399|583892887|FG001|Overall Study|Withdrawal by Subject|3|||
161683299|NCT00880399|583892888|FG002|Overall Study|Withdrawal by Subject|3|||
161683300|NCT02181816|583892893|FG000|Overall Study|Case Report Forms Uncollected|38|||
161683301|NCT02181816|583892893|FG000|Overall Study|Protocol Deviation|21|||
161683302|NCT00909181|583892894|FG000|Overall Study|Lost to Follow-up|39|||
161683303|NCT00909181|583892895|FG001|Overall Study|Lost to Follow-up|18|||
161942908|NCT02138825|584841659|FG000|Safety Follow-up|Death|11|||
161942909|NCT02138825|584841660|FG001|Safety Follow-up|Death|5|||
161942910|NCT02138825|584841659|FG000|Safety Follow-up|Withdrawal by Subject|5|||
161942911|NCT02138825|584841660|FG001|Safety Follow-up|Withdrawal by Subject|3|||
161942912|NCT02138825|584841659|FG000|Safety Follow-up|clinic worsening|1|||
161942913|NCT02138825|584841660|FG001|Safety Follow-up|clinic worsening|0|||
161942914|NCT02138825|584841659|FG000|Safety Follow-up|withdrawal by PI|1|||
161942915|NCT02138825|584841660|FG001|Safety Follow-up|withdrawal by PI|0|||
161942916|NCT02138825|584841659|FG000|Safety Follow-up|logistical difficulties|0|||
161942917|NCT02138825|584841660|FG001|Safety Follow-up|logistical difficulties|1|||
161942918|NCT02138825|584841659|FG000|Safety Follow-up|progressive disease|0|||
161942919|NCT02138825|584841660|FG001|Safety Follow-up|progressive disease|2|||
161942920|NCT02138825|584841659|FG000|Safety Follow-up|too unwell to attend the visit|0|||
161942921|NCT02138825|584841660|FG001|Safety Follow-up|too unwell to attend the visit|1|||
161942922|NCT02138825|584841659|FG000|Safety Follow-up|treatment unblinded|0|||
161942923|NCT02138825|584841660|FG001|Safety Follow-up|treatment unblinded|1|||
161942924|NCT02138825|584841659|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
161942925|NCT02138825|584841660|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
161942926|NCT01702298|584841666|FG000|Overall Study|Withdrawal by Subject|1|||
161942927|NCT02090764|584841674|FG000|Overall Study|Adverse Event|1|||
161942928|NCT02090764|584841675|FG001|Overall Study|Adverse Event|3|||
161942929|NCT02090764|584841674|FG000|Overall Study|Lack of Efficacy|0|||
161942930|NCT02090764|584841675|FG001|Overall Study|Lack of Efficacy|13|||
161942931|NCT02090764|584841674|FG000|Overall Study|Withdrawal by Subject|2|||
161942932|NCT02090764|584841675|FG001|Overall Study|Withdrawal by Subject|1|||
161942933|NCT02090764|584841674|FG000|Overall Study|Intercurrent illness and other|1|||
161942934|NCT02090764|584841675|FG001|Overall Study|Intercurrent illness and other|1|||
161942935|NCT02090764|584841674|FG000|Overall Study|Lost to Follow-up|2|||
161942936|NCT02090764|584841675|FG001|Overall Study|Lost to Follow-up|2|||
161942937|NCT02300233|584841678|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
161942938|NCT02300233|584841679|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
161942939|NCT02300233|584841680|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
161942940|NCT02300233|584841678|FG000|Overall Study|Withdrawal by Subject|1|||
161942941|NCT02300233|584841679|FG001|Overall Study|Withdrawal by Subject|0|||
161942942|NCT02300233|584841680|FG002|Overall Study|Withdrawal by Subject|3|||
161942943|NCT02300233|584841678|FG000|Overall Study|Investigator Judgement|0|||
161942944|NCT02300233|584841679|FG001|Overall Study|Investigator Judgement|0|||
161942945|NCT02300233|584841680|FG002|Overall Study|Investigator Judgement|1|||
161942946|NCT02300233|584841678|FG000|Overall Study|Reason Not Specified|0|||
161942947|NCT02300233|584841679|FG001|Overall Study|Reason Not Specified|0|||
161942948|NCT02300233|584841680|FG002|Overall Study|Reason Not Specified|5|||
161942949|NCT00833690|584841681|FG000|Overall Study|Withdrawal by Subject|1|||
161942950|NCT00833690|584841682|FG001|Overall Study|Withdrawal by Subject|0|||
161942951|NCT00833690|584841683|FG002|Overall Study|Withdrawal by Subject|0|||
161942952|NCT00833690|584841681|FG000|Overall Study|Discontinued study drug|3|||
161942953|NCT00833690|584841682|FG001|Overall Study|Discontinued study drug|2|||
161942954|NCT00833690|584841683|FG002|Overall Study|Discontinued study drug|0|||
161942955|NCT00744861|584841684|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
161683304|NCT00909181|583892896|FG002|Overall Study|Lost to Follow-up|33|||
161683305|NCT02830880|583892897|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
161683306|NCT02830880|583892897|FG000|Overall Study|Death|1|||
161683307|NCT02830880|583892897|FG000|Overall Study|Physician Decision|1|||
161942956|NCT00744861|584841685|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
161942957|NCT00744861|584841686|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
161942958|NCT00744861|584841687|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
161942959|NCT00744861|584841684|FG000|Feasibility Stage 1|Pregnancy|0|||
161942960|NCT00744861|584841685|FG001|Feasibility Stage 1|Pregnancy|1|||
161942961|NCT00744861|584841686|FG002|Feasibility Stage 1|Pregnancy|0|||
161942962|NCT00744861|584841687|FG003|Feasibility Stage 1|Pregnancy|0|||
161942963|NCT00744861|584841684|FG000|Pivotal Stage 2|Adverse Event|0|||
161942964|NCT00744861|584841685|FG001|Pivotal Stage 2|Adverse Event|0|||
161683308|NCT02349048|583892902|FG000|Overall Study|Withdrawal by Subject|4|||
161683309|NCT02349048|583892903|FG001|Overall Study|Withdrawal by Subject|0|||
161683310|NCT02349048|583892902|FG000|Overall Study|Lost to Follow-up|1|||
161683311|NCT02349048|583892903|FG001|Overall Study|Lost to Follow-up|0|||
161683312|NCT03709654|583892906|FG000|Overall Study|Lost to Follow-up|1|||
161683313|NCT03709654|583892907|FG001|Overall Study|Lost to Follow-up|1|||
161683314|NCT03709654|583892906|FG000|Overall Study|Withdrawal by Subject|1|||
161683315|NCT03709654|583892907|FG001|Overall Study|Withdrawal by Subject|1|||
161683316|NCT03709654|583892906|FG000|Overall Study|Adverse Event|1|||
161683317|NCT03709654|583892907|FG001|Overall Study|Adverse Event|0|||
161683318|NCT01040351|583892908|FG000|Overall Study|poor ovarian response|1|||
161683319|NCT01040351|583892909|FG001|Overall Study|poor ovarian response|2|||
161683320|NCT01648790|583892914|FG000|Treatment 3|Withdrawal by Subject|0|||
161683321|NCT01648790|583892915|FG001|Treatment 3|Withdrawal by Subject|0|||
161683322|NCT01648790|583892916|FG002|Treatment 3|Withdrawal by Subject|0|||
161683323|NCT01648790|583892917|FG003|Treatment 3|Withdrawal by Subject|1|||
161683324|NCT01648790|583892918|FG004|Treatment 3|Withdrawal by Subject|0|||
161683325|NCT02969187|583892919|FG000|Overall Study|Physician Decision|12|||
161683326|NCT02969187|583892920|FG001|Overall Study|Physician Decision|13|||
161683327|NCT03923426|583892924|FG000|Overall Study|Other|19|||
161683328|NCT03923426|583892924|FG000|Overall Study|Lost to Follow-up|16|||
161683329|NCT03923426|583892924|FG000|Overall Study|Death|107|||
161683330|NCT03923426|583892924|FG000|Overall Study|Incomplete response to question|13|||
161683331|NCT01278745|583892929|FG000|Overall Study|Death|2|||
161683332|NCT01278745|583892930|FG001|Overall Study|Death|5|||
161683333|NCT01278745|583892931|FG002|Overall Study|Death|7|||
161683334|NCT01278745|583892932|FG003|Overall Study|Death|0|||
161683335|NCT01278745|583892929|FG000|Overall Study|Physician Decision|1|||
161832160|NCT02243293|584427061|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
161832161|NCT02243293|584427062|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
161832162|NCT02243293|584427063|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
161942965|NCT00744861|584841686|FG002|Pivotal Stage 2|Adverse Event|6|||
161942966|NCT00744861|584841687|FG003|Pivotal Stage 2|Adverse Event|11|||
161942967|NCT00744861|584841684|FG000|Pivotal Stage 2|Death|0|||
161942968|NCT00744861|584841685|FG001|Pivotal Stage 2|Death|0|||
161942969|NCT00744861|584841686|FG002|Pivotal Stage 2|Death|0|||
161942970|NCT00744861|584841687|FG003|Pivotal Stage 2|Death|1|||
161942971|NCT00744861|584841684|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
161832163|NCT02243293|584427064|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
161832164|NCT02243293|584427065|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
161832165|NCT02243293|584427044|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
161832166|NCT02243293|584427045|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
161832167|NCT02243293|584427046|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
161832168|NCT02243293|584427047|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
161832169|NCT02243293|584427048|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
161832170|NCT02243293|584427049|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
161832171|NCT02243293|584427050|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
161832172|NCT02243293|584427051|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
161832173|NCT02243293|584427052|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
161832174|NCT02243293|584427053|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
161832175|NCT02243293|584427054|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
161832176|NCT02243293|584427055|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
161832177|NCT02243293|584427056|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
161832178|NCT02243293|584427057|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
161832179|NCT02243293|584427058|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
161832180|NCT02243293|584427059|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
161832181|NCT02243293|584427060|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
161832182|NCT02243293|584427061|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
161832183|NCT02243293|584427062|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
161832184|NCT02243293|584427063|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
161832185|NCT02243293|584427064|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
161942972|NCT00744861|584841685|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
161942973|NCT00744861|584841686|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
161942974|NCT00744861|584841687|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
161942975|NCT00744861|584841684|FG000|Pivotal Stage 2|Physician Decision|0|||
161942976|NCT00744861|584841685|FG001|Pivotal Stage 2|Physician Decision|0|||
161942977|NCT00744861|584841686|FG002|Pivotal Stage 2|Physician Decision|3|||
161942978|NCT00744861|584841687|FG003|Pivotal Stage 2|Physician Decision|1|||
161942979|NCT00744861|584841684|FG000|Pivotal Stage 2|Protocol Violation|0|||
161942980|NCT00744861|584841685|FG001|Pivotal Stage 2|Protocol Violation|0|||
161942981|NCT00744861|584841686|FG002|Pivotal Stage 2|Protocol Violation|0|||
161942982|NCT00744861|584841687|FG003|Pivotal Stage 2|Protocol Violation|1|||
161942983|NCT00744861|584841684|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
161942984|NCT00744861|584841685|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
161683336|NCT01278745|583892930|FG001|Overall Study|Physician Decision|0|||
161683337|NCT01278745|583892931|FG002|Overall Study|Physician Decision|0|||
161683338|NCT01278745|583892932|FG003|Overall Study|Physician Decision|9|||
161683339|NCT01278745|583892929|FG000|Overall Study|Withdrawal by Subject|1|||
161683340|NCT01278745|583892930|FG001|Overall Study|Withdrawal by Subject|1|||
161683341|NCT01278745|583892931|FG002|Overall Study|Withdrawal by Subject|5|||
161942985|NCT00744861|584841686|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
161942986|NCT00744861|584841687|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
161942987|NCT00744861|584841684|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
162026634|NCT00910624|585154362|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
162026635|NCT00910624|585154363|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
162026636|NCT00910624|585154360|FG000|Follow-Up Phase|Administrative|0|||
162026637|NCT00910624|585154361|FG001|Follow-Up Phase|Administrative|1|||
161942988|NCT00744861|584841685|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
161942989|NCT00744861|584841686|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
161942990|NCT00744861|584841687|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
161942991|NCT04856527|584841688|FG000|Overall Study|Unable to complete experimental task|2|||
161942992|NCT04856527|584841689|FG001|Overall Study|Unable to complete experimental task|0|||
161942993|NCT02115321|584841690|FG000|Overall Study|Death|1|||
161942994|NCT02115321|584841691|FG001|Overall Study|Death|0|||
161942995|NCT04403919|584841694|FG000|Overall Study|Lost to Follow-up|0|||
161942996|NCT04403919|584841695|FG001|Overall Study|Lost to Follow-up|0|||
161942997|NCT04403919|584841696|FG002|Overall Study|Lost to Follow-up|0|||
161942998|NCT04403919|584841697|FG003|Overall Study|Lost to Follow-up|1|||
161942999|NCT03605693|584841698|FG000|Overall Study|Lost to Follow-up|4|||
161943000|NCT03605693|584841699|FG001|Overall Study|Lost to Follow-up|0|||
161943001|NCT03605693|584841698|FG000|Overall Study|Physician Decision|1|||
161943002|NCT03605693|584841699|FG001|Overall Study|Physician Decision|0|||
161943003|NCT04752566|584841700|FG000|Overall Study|Protocol Violation|0|||
161943004|NCT04752566|584841701|FG001|Overall Study|Protocol Violation|1|||
161943005|NCT04752566|584841700|FG000|Overall Study|Death|1|||
161943006|NCT04752566|584841701|FG001|Overall Study|Death|0|||
162026638|NCT00910624|585154362|FG002|Follow-Up Phase|Administrative|1|||
161943007|NCT04752566|584841700|FG000|Overall Study|Adverse Event|1|||
161943008|NCT04752566|584841701|FG001|Overall Study|Adverse Event|0|||
161943009|NCT04752566|584841700|FG000|Overall Study|Withdrawal by Subject|2|||
161943010|NCT04752566|584841701|FG001|Overall Study|Withdrawal by Subject|0|||
161943011|NCT04752566|584841700|FG000|Overall Study|Physician Decision|1|||
161943012|NCT04752566|584841701|FG001|Overall Study|Physician Decision|1|||
161943013|NCT05134649|584841702|FG000|Overall Study|Lost to Follow-up|12|||
161943014|NCT05134649|584841702|FG000|Overall Study|Withdrawal by Subject|14|||
161943015|NCT05134649|584841702|FG000|Overall Study|Pregnancy|1|||
161943016|NCT05134649|584841702|FG000|Overall Study|Other, not specified|3|||
161943017|NCT04392154|584841705|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
161943018|NCT04392154|584841706|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
161943019|NCT04392154|584841707|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
161943020|NCT04392154|584841708|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
161943021|NCT04392154|584841705|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
161943022|NCT04392154|584841706|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
161943023|NCT04392154|584841707|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
161943024|NCT04392154|584841708|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
161943025|NCT04392154|584841705|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
161943026|NCT04392154|584841706|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
161943027|NCT04392154|584841707|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
161943028|NCT04392154|584841708|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
161943029|NCT04392154|584841705|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
161943030|NCT04392154|584841706|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
161943031|NCT04392154|584841707|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
161943032|NCT04392154|584841708|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
161943033|NCT04392154|584841705|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
161943034|NCT04392154|584841706|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
161943035|NCT04392154|584841707|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
161943036|NCT04392154|584841708|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
162026639|NCT00910624|585154363|FG003|Follow-Up Phase|Administrative|0|||
162026640|NCT03699475|585154364|FG000|Overall Study|Death|1|||
162026641|NCT00640224|585154369|FG000|Overall Study|Lost to Follow-up|5|||
161943037|NCT04392154|584841705|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
161943038|NCT04392154|584841706|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
161943039|NCT04392154|584841707|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
161943040|NCT04392154|584841708|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
161943041|NCT04392154|584841705|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
161943042|NCT04392154|584841706|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
161943043|NCT04392154|584841707|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
161943044|NCT04392154|584841708|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
161943045|NCT04392154|584841705|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
161943046|NCT04392154|584841706|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
161943047|NCT04392154|584841707|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
161943048|NCT04392154|584841708|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
161943049|NCT04392154|584841705|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
161943050|NCT04392154|584841706|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
161943051|NCT04392154|584841707|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
161943052|NCT04392154|584841708|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
161943053|NCT04392154|584841705|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
161943054|NCT04392154|584841706|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
161943055|NCT04392154|584841707|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
161943056|NCT04392154|584841708|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
161943057|NCT04392154|584841705|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
161943058|NCT04392154|584841706|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
161943059|NCT04392154|584841707|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
161943060|NCT04392154|584841708|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
161943061|NCT04392154|584841705|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
161943062|NCT04392154|584841706|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
161943063|NCT04392154|584841707|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
161943064|NCT04392154|584841708|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
161943065|NCT04392154|584841705|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
161943066|NCT04392154|584841706|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
161943067|NCT04392154|584841707|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
161943068|NCT04392154|584841708|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
161943069|NCT04392154|584841705|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
161943070|NCT04392154|584841706|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
161943071|NCT04392154|584841707|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
161943072|NCT04392154|584841708|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
161943073|NCT00023595|584841711|FG000|5 Year Follow up|Lost to Follow-up|2|||
161943074|NCT00023595|584841712|FG001|5 Year Follow up|Lost to Follow-up|2|||
161943075|NCT00023595|584841713|FG002|5 Year Follow up|Lost to Follow-up|1|||
161943076|NCT00023595|584841714|FG003|5 Year Follow up|Lost to Follow-up|7|||
161943077|NCT00023595|584841715|FG004|5 Year Follow up|Lost to Follow-up|3|||
161943078|NCT00023595|584841711|FG000|10 Year Follow up|Lost to Follow-up|12|||
161943079|NCT00023595|584841712|FG001|10 Year Follow up|Lost to Follow-up|10|||
161943080|NCT00023595|584841713|FG002|10 Year Follow up|Lost to Follow-up|3|||
161943081|NCT00023595|584841714|FG003|10 Year Follow up|Lost to Follow-up|0|||
161943082|NCT00023595|584841715|FG004|10 Year Follow up|Lost to Follow-up|0|||
161943083|NCT02038647|584841717|FG000|Overall Study|Progressive Disease|50|||
161943084|NCT02038647|584841718|FG001|Overall Study|Progressive Disease|59|||
161943085|NCT02038647|584841717|FG000|Overall Study|Adverse Event|18|||
161943086|NCT02038647|584841718|FG001|Overall Study|Adverse Event|10|||
161943087|NCT02038647|584841717|FG000|Overall Study|Symptomatic Deterioration|7|||
161943088|NCT02038647|584841718|FG001|Overall Study|Symptomatic Deterioration|7|||
161943089|NCT02038647|584841717|FG000|Overall Study|Withdrawal by Subject|5|||
161943090|NCT02038647|584841718|FG001|Overall Study|Withdrawal by Subject|2|||
161943091|NCT02038647|584841717|FG000|Overall Study|Not Reported|0|||
161943092|NCT02038647|584841718|FG001|Overall Study|Not Reported|1|||
161943093|NCT02038647|584841717|FG000|Overall Study|Ongoing at Datacut|9|||
161943094|NCT02038647|584841718|FG001|Overall Study|Ongoing at Datacut|10|||
161943095|NCT02757430|584841719|FG000|Overall Study|Physician Decision|6|||
161943096|NCT02757430|584841719|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
161943097|NCT02757430|584841719|FG000|Overall Study|No informed consent|1|||
161943098|NCT02757430|584841719|FG000|Overall Study|No procedure performed|2|||
161943099|NCT01983111|584841722|FG000|Overall Study|Withdrawal by Subject|8|||
161943100|NCT01983111|584841723|FG001|Overall Study|Withdrawal by Subject|6|||
161943101|NCT01983111|584841722|FG000|Overall Study|Adverse Event|4|||
161943102|NCT01983111|584841723|FG001|Overall Study|Adverse Event|0|||
161943103|NCT01983111|584841722|FG000|Overall Study|Protocol Violation|0|||
161943104|NCT01983111|584841723|FG001|Overall Study|Protocol Violation|1|||
161943105|NCT03502200|584841724|FG000|Overall Study|Adverse Event|1|||
161683342|NCT01278745|583892932|FG003|Overall Study|Withdrawal by Subject|1|||
161683343|NCT01278745|583892929|FG000|Overall Study|Sponsor Decision|1|||
161683344|NCT01278745|583892930|FG001|Overall Study|Sponsor Decision|0|||
161683345|NCT01278745|583892931|FG002|Overall Study|Sponsor Decision|62|||
161683346|NCT01278745|583892932|FG003|Overall Study|Sponsor Decision|6|||
161683347|NCT01278745|583892929|FG000|Overall Study|Ineligible|0|||
161943106|NCT03502200|584841725|FG001|Overall Study|Adverse Event|0|||
161943107|NCT03502200|584841724|FG000|Overall Study|Lost to Follow-up|36|||
161943108|NCT03502200|584841725|FG001|Overall Study|Lost to Follow-up|38|||
161943109|NCT03502200|584841724|FG000|Overall Study|Study Team Decision|1|||
161943110|NCT03502200|584841725|FG001|Overall Study|Study Team Decision|1|||
161943111|NCT03502200|584841724|FG000|Overall Study|Withdrawal by Subject|5|||
161943112|NCT03502200|584841725|FG001|Overall Study|Withdrawal by Subject|7|||
161943113|NCT03502200|584841724|FG000|Overall Study|Death|0|||
161683348|NCT01278745|583892930|FG001|Overall Study|Ineligible|0|||
161943114|NCT03502200|584841725|FG001|Overall Study|Death|2|||
161943115|NCT00855335|584841726|FG000|Overall Study|Lost to Follow-up|0|||
161943116|NCT00855335|584841727|FG001|Overall Study|Lost to Follow-up|0|||
161943117|NCT00855335|584841728|FG002|Overall Study|Lost to Follow-up|3|||
161943118|NCT00855335|584841729|FG003|Overall Study|Lost to Follow-up|1|||
161943119|NCT00855335|584841730|FG004|Overall Study|Lost to Follow-up|0|||
161943120|NCT00855335|584841726|FG000|Overall Study|Withdrawal by Subject|0|||
161832186|NCT02243293|584427065|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
161832187|NCT00402025|584427069|FG000|Overall Study|Adverse Event|0|||
161832188|NCT00402025|584427070|FG001|Overall Study|Adverse Event|0|||
161832189|NCT00402025|584427071|FG002|Overall Study|Adverse Event|2|||
161832190|NCT00402025|584427069|FG000|Overall Study|Death|0|||
161943121|NCT00855335|584841727|FG001|Overall Study|Withdrawal by Subject|0|||
161943122|NCT00855335|584841728|FG002|Overall Study|Withdrawal by Subject|0|||
161943123|NCT00855335|584841729|FG003|Overall Study|Withdrawal by Subject|1|||
161943124|NCT00855335|584841730|FG004|Overall Study|Withdrawal by Subject|0|||
161943125|NCT00855335|584841726|FG000|Overall Study|Adverse Event|2|||
161943126|NCT00855335|584841727|FG001|Overall Study|Adverse Event|0|||
161943127|NCT00855335|584841728|FG002|Overall Study|Adverse Event|0|||
161943128|NCT00855335|584841729|FG003|Overall Study|Adverse Event|0|||
161943129|NCT00855335|584841730|FG004|Overall Study|Adverse Event|0|||
161943130|NCT00855335|584841726|FG000|Overall Study|Physician Decision|1|||
161683349|NCT01278745|583892931|FG002|Overall Study|Ineligible|42|||
161832191|NCT00402025|584427070|FG001|Overall Study|Death|1|||
161832192|NCT00402025|584427071|FG002|Overall Study|Death|5|||
161832193|NCT00402025|584427069|FG000|Overall Study|Disease Progression|1|||
161832194|NCT00402025|584427070|FG001|Overall Study|Disease Progression|1|||
161832195|NCT00402025|584427071|FG002|Overall Study|Disease Progression|2|||
161832196|NCT00402025|584427069|FG000|Overall Study|Physician Decision|1|||
161832197|NCT00402025|584427070|FG001|Overall Study|Physician Decision|1|||
161832198|NCT00402025|584427071|FG002|Overall Study|Physician Decision|0|||
161832199|NCT00402025|584427069|FG000|Overall Study|Participant Decision|0|||
161832200|NCT00402025|584427070|FG001|Overall Study|Participant Decision|0|||
161832201|NCT00402025|584427071|FG002|Overall Study|Participant Decision|1|||
161832202|NCT01172821|584427106|FG000|Overall Study|Adverse Event|5|||
161832203|NCT01172821|584427107|FG001|Overall Study|Adverse Event|2|||
161832204|NCT01172821|584427108|FG002|Overall Study|Adverse Event|2|||
161832205|NCT01172821|584427109|FG003|Overall Study|Adverse Event|7|||
161832206|NCT01172821|584427106|FG000|Overall Study|Protocol Violation|0|||
161832207|NCT01172821|584427107|FG001|Overall Study|Protocol Violation|2|||
161943131|NCT00855335|584841727|FG001|Overall Study|Physician Decision|1|||
161943132|NCT00855335|584841728|FG002|Overall Study|Physician Decision|0|||
161943133|NCT00855335|584841729|FG003|Overall Study|Physician Decision|0|||
161683350|NCT01278745|583892932|FG003|Overall Study|Ineligible|61|||
161683351|NCT01278745|583892929|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
161683352|NCT01278745|583892930|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
161683353|NCT01278745|583892931|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
161683354|NCT01278745|583892932|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
161683355|NCT01923285|583892934|FG000|Overall Study|Withdrawal by Subject|7|||
161683356|NCT01923285|583892935|FG001|Overall Study|Withdrawal by Subject|6|||
161683357|NCT03462576|583892936|FG000|Overall Study|Protocol Violation|5|||
161683358|NCT03462576|583892937|FG001|Overall Study|Protocol Violation|11|||
161683359|NCT03462576|583892938|FG002|Overall Study|Protocol Violation|7|||
161683360|NCT03462576|583892936|FG000|Overall Study|Device Malfunction|0|||
161683361|NCT03462576|583892937|FG001|Overall Study|Device Malfunction|0|||
161683362|NCT03462576|583892938|FG002|Overall Study|Device Malfunction|1|||
161683363|NCT00715026|583892939|FG000|Overall Study|Withdrawal by Subject|5|||
161683364|NCT00715026|583892939|FG000|Overall Study|Lost to Follow-up|3|||
161683365|NCT00715026|583892939|FG000|Overall Study|Protocol Violation|1|||
161683366|NCT00715026|583892939|FG000|Overall Study|Surgery done on non-study consented hip|1|||
161683367|NCT00750737|583892947|FG000|Overall Study|Withdrawal by Subject|3|||
161683368|NCT00750737|583892948|FG001|Overall Study|Withdrawal by Subject|3|||
161683369|NCT00865904|583892951|FG000|Overall Study|Randomized but not Treated|2|||
161683370|NCT00865904|583892952|FG001|Overall Study|Randomized but not Treated|0|||
161683371|NCT00865904|583892953|FG002|Overall Study|Randomized but not Treated|0|||
161683372|NCT00865904|583892954|FG003|Overall Study|Randomized but not Treated|1|||
161683373|NCT00865904|583892955|FG004|Overall Study|Randomized but not Treated|1|||
161683374|NCT01543828|583892956|FG000|Treatment 2|Lost to Follow-up|1|||
161683375|NCT01543828|583892957|FG001|Treatment 2|Lost to Follow-up|0|||
161943134|NCT00855335|584841730|FG004|Overall Study|Physician Decision|0|||
161943135|NCT00855335|584841726|FG000|Overall Study|Other|2|||
161683376|NCT00711425|583892960|FG000|Overall Study|Protocol Violation|1|||
161683377|NCT00711425|583892960|FG000|Overall Study|Death|2|||
161683378|NCT00711425|583892960|FG000|Overall Study|Lost to Follow-up|1|||
161683379|NCT05879107|583892961|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
161832208|NCT01172821|584427108|FG002|Overall Study|Protocol Violation|1|||
161832209|NCT01172821|584427109|FG003|Overall Study|Protocol Violation|2|||
161832210|NCT01172821|584427106|FG000|Overall Study|Lost to Follow-up|4|||
161832211|NCT01172821|584427107|FG001|Overall Study|Lost to Follow-up|1|||
161943136|NCT00855335|584841727|FG001|Overall Study|Other|1|||
161943137|NCT00855335|584841728|FG002|Overall Study|Other|2|||
161943138|NCT00855335|584841729|FG003|Overall Study|Other|5|||
161943139|NCT00855335|584841730|FG004|Overall Study|Other|1|||
161943140|NCT03097289|584841732|FG000|Overall Study|Adverse Event|1|||
161943141|NCT03097289|584841732|FG000|Overall Study|Equipment failure|2|||
161943142|NCT03097289|584841732|FG000|Overall Study|Collected platelet product unusable|3|||
161832212|NCT01172821|584427108|FG002|Overall Study|Lost to Follow-up|2|||
161832213|NCT01172821|584427109|FG003|Overall Study|Lost to Follow-up|2|||
161832214|NCT01172821|584427106|FG000|Overall Study|Withdrawal by Subject|2|||
161832215|NCT01172821|584427107|FG001|Overall Study|Withdrawal by Subject|3|||
161832216|NCT01172821|584427108|FG002|Overall Study|Withdrawal by Subject|3|||
161832217|NCT01172821|584427109|FG003|Overall Study|Withdrawal by Subject|3|||
161832218|NCT01172821|584427106|FG000|Overall Study|Other|3|||
161832219|NCT01172821|584427107|FG001|Overall Study|Other|4|||
161832220|NCT01172821|584427108|FG002|Overall Study|Other|5|||
161832221|NCT01172821|584427109|FG003|Overall Study|Other|3|||
161832222|NCT02985879|584427110|FG000|Overall Study|Adverse Event|7|||
161943143|NCT02526290|584841737|FG000|Overall Study|Adverse Event|3|||
161943144|NCT02526290|584841737|FG000|Overall Study|Withdrawal by Subject|4|||
161943145|NCT02526290|584841737|FG000|Overall Study|Physician Decision|1|||
161943146|NCT00049543|584841738|FG000|Overall Study|still on treatment|2|||
161943147|NCT00049543|584841739|FG001|Overall Study|still on treatment|9|||
161943148|NCT02106832|584841740|FG000|Overall Study|Adverse Event|1|||
161943149|NCT02106832|584841741|FG001|Overall Study|Adverse Event|2|||
161943150|NCT02106832|584841742|FG002|Overall Study|Adverse Event|3|||
161943151|NCT02106832|584841743|FG003|Overall Study|Adverse Event|0|||
161943152|NCT02106832|584841740|FG000|Overall Study|Death|4|||
161943153|NCT02106832|584841741|FG001|Overall Study|Death|4|||
161943154|NCT02106832|584841742|FG002|Overall Study|Death|1|||
161943155|NCT02106832|584841743|FG003|Overall Study|Death|4|||
161943156|NCT02106832|584841740|FG000|Overall Study|Deterioration of general conditions|0|||
161943157|NCT02106832|584841741|FG001|Overall Study|Deterioration of general conditions|0|||
161943158|NCT02106832|584841742|FG002|Overall Study|Deterioration of general conditions|1|||
161943159|NCT02106832|584841743|FG003|Overall Study|Deterioration of general conditions|0|||
161943160|NCT02106832|584841740|FG000|Overall Study|Lost to Follow-up|0|||
161943161|NCT02106832|584841741|FG001|Overall Study|Lost to Follow-up|1|||
161943162|NCT02106832|584841742|FG002|Overall Study|Lost to Follow-up|1|||
161943163|NCT02106832|584841743|FG003|Overall Study|Lost to Follow-up|3|||
161832223|NCT02985879|584427111|FG001|Overall Study|Adverse Event|9|||
161832224|NCT02985879|584427112|FG002|Overall Study|Adverse Event|7|||
161832225|NCT02985879|584427110|FG000|Overall Study|Withdrew consent|6|||
161832226|NCT02985879|584427111|FG001|Overall Study|Withdrew consent|8|||
161832227|NCT02985879|584427112|FG002|Overall Study|Withdrew consent|10|||
161832228|NCT02985879|584427110|FG000|Overall Study|Lost to Follow-up|1|||
161832229|NCT02985879|584427111|FG001|Overall Study|Lost to Follow-up|0|||
161832230|NCT02985879|584427112|FG002|Overall Study|Lost to Follow-up|2|||
161832231|NCT02985879|584427110|FG000|Overall Study|Other, not specified|62|||
161832232|NCT02985879|584427111|FG001|Overall Study|Other, not specified|58|||
161832233|NCT02985879|584427112|FG002|Overall Study|Other, not specified|58|||
161832234|NCT03940703|584428378|FG000|Overall Study|Still under treatment|31|||
161832235|NCT03940703|584428379|FG001|Overall Study|Still under treatment|0|||
161832236|NCT02658487|584428380|FG000|Overall Study|Death|2|||
161943164|NCT02106832|584841740|FG000|Overall Study|Physician Decision|1|||
161943165|NCT02106832|584841741|FG001|Overall Study|Physician Decision|0|||
161943166|NCT02106832|584841742|FG002|Overall Study|Physician Decision|0|||
161943167|NCT02106832|584841743|FG003|Overall Study|Physician Decision|0|||
161943168|NCT02106832|584841740|FG000|Overall Study|Protocol Violation|0|||
161943169|NCT02106832|584841741|FG001|Overall Study|Protocol Violation|0|||
161943170|NCT02106832|584841742|FG002|Overall Study|Protocol Violation|0|||
161943171|NCT02106832|584841743|FG003|Overall Study|Protocol Violation|1|||
161943172|NCT02106832|584841740|FG000|Overall Study|Withdrawal by Subject|17|||
161943173|NCT02106832|584841741|FG001|Overall Study|Withdrawal by Subject|17|||
161943174|NCT02106832|584841742|FG002|Overall Study|Withdrawal by Subject|10|||
162026642|NCT00640224|585154370|FG001|Overall Study|Lost to Follow-up|2|||
161832237|NCT02658487|584428380|FG000|Overall Study|Disease progression|10|||
161832238|NCT02658487|584428380|FG000|Overall Study|Alternative therapy|1|||
161832239|NCT02658487|584428380|FG000|Overall Study|Adverse Event|1|||
161832240|NCT02658487|584428380|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
161832241|NCT02658487|584428380|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
161832242|NCT01885182|584428381|FG000|Overall Study|Adverse Event|11|||
161832243|NCT01885182|584428382|FG001|Overall Study|Adverse Event|13|||
161943175|NCT02106832|584841743|FG003|Overall Study|Withdrawal by Subject|7|||
161943176|NCT02106832|584841740|FG000|Overall Study|Technical problems|0|||
161943177|NCT02106832|584841741|FG001|Overall Study|Technical problems|1|||
161943178|NCT02106832|584841742|FG002|Overall Study|Technical problems|0|||
161943179|NCT02106832|584841743|FG003|Overall Study|Technical problems|0|||
161943180|NCT04716894|584841760|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
161943181|NCT04716894|584841760|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
161943182|NCT01467466|584841763|FG000|Overall Study|Withdrawal by Subject|15|||
161943183|NCT01467466|584841764|FG001|Overall Study|Withdrawal by Subject|18|||
161943184|NCT01467466|584841765|FG002|Overall Study|Withdrawal by Subject|13|||
161943185|NCT01467466|584841766|FG003|Overall Study|Withdrawal by Subject|11|||
161943186|NCT01467466|584841763|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
161943187|NCT01467466|584841764|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
161943188|NCT01467466|584841765|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
161943189|NCT01467466|584841766|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
161943190|NCT01467466|584841763|FG000|Overall Study|Procedure Cancelled|46|||
161943191|NCT01467466|584841764|FG001|Overall Study|Procedure Cancelled|45|||
161943192|NCT01467466|584841765|FG002|Overall Study|Procedure Cancelled|25|||
161943193|NCT01467466|584841766|FG003|Overall Study|Procedure Cancelled|29|||
161943194|NCT01467466|584841763|FG000|Overall Study|No Endpoint Blood Draw|38|||
161943195|NCT01467466|584841764|FG001|Overall Study|No Endpoint Blood Draw|32|||
161943196|NCT01467466|584841765|FG002|Overall Study|No Endpoint Blood Draw|51|||
161943197|NCT01467466|584841766|FG003|Overall Study|No Endpoint Blood Draw|43|||
161943198|NCT00982280|584841769|FG000|Observation Period|Not eligible to be dosed|19|||
161943199|NCT00982280|584841769|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
161943200|NCT00982280|584841769|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
161943201|NCT00982280|584841769|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
161943202|NCT00982280|584841769|FG000|Maintenance Period|Adverse Event|1|||
161943203|NCT06028464|584841771|FG000|Washout|Positive drug test.|1|||
161943204|NCT03557502|584841774|FG000|Protocol 2|Withdrawal by Subject|1|||
161943205|NCT03557502|584841775|FG001|Protocol 2|Withdrawal by Subject|1|||
161943206|NCT03557502|584841774|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
161943207|NCT03557502|584841775|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
161943208|NCT00618787|584841779|FG000|Overall Study|Adverse Event|0|||
161943209|NCT00618787|584841780|FG001|Overall Study|Adverse Event|1|||
161943210|NCT00618787|584841779|FG000|Overall Study|Withdrawal by Subject|2|||
161943211|NCT00618787|584841780|FG001|Overall Study|Withdrawal by Subject|1|||
161943212|NCT00618787|584841779|FG000|Overall Study|Lost to Follow-up|1|||
161943213|NCT00618787|584841780|FG001|Overall Study|Lost to Follow-up|0|||
161943214|NCT01994876|584841781|FG000|Test Period 1|Withdrawal by Subject|0|||
161943215|NCT01994876|584841782|FG001|Test Period 1|Withdrawal by Subject|1|||
161943216|NCT01994876|584841781|FG000|Test Period 1|Adverse Event|0|||
161943217|NCT01994876|584841782|FG001|Test Period 1|Adverse Event|1|||
161943218|NCT01994876|584841781|FG000|Test Period 2|Adverse Event|1|||
161943219|NCT01994876|584841782|FG001|Test Period 2|Adverse Event|0|||
161943220|NCT01994876|584841781|FG000|Test Period 2|Protocol Violation|0|||
161943221|NCT01994876|584841782|FG001|Test Period 2|Protocol Violation|1|||
161943222|NCT05819398|584841783|FG000|Overall Study|Withdrawal by Subject|11|||
161943223|NCT05819398|584841784|FG001|Overall Study|Withdrawal by Subject|7|||
161943224|NCT05819398|584841785|FG002|Overall Study|Withdrawal by Subject|6|||
161943225|NCT05819398|584841786|FG003|Overall Study|Withdrawal by Subject|6|||
161943226|NCT05819398|584841783|FG000|Overall Study|Lost to Follow-up|0|||
161943227|NCT05819398|584841784|FG001|Overall Study|Lost to Follow-up|2|||
161943228|NCT05819398|584841785|FG002|Overall Study|Lost to Follow-up|0|||
161943229|NCT05819398|584841786|FG003|Overall Study|Lost to Follow-up|1|||
161943230|NCT05819398|584841783|FG000|Overall Study|Adverse Event|1|||
161943231|NCT05819398|584841784|FG001|Overall Study|Adverse Event|3|||
161943232|NCT05819398|584841785|FG002|Overall Study|Adverse Event|4|||
161943233|NCT05819398|584841786|FG003|Overall Study|Adverse Event|5|||
161943234|NCT05819398|584841783|FG000|Overall Study|Other than listed|0|||
161943235|NCT05819398|584841784|FG001|Overall Study|Other than listed|2|||
161943236|NCT05819398|584841785|FG002|Overall Study|Other than listed|2|||
161943237|NCT05819398|584841786|FG003|Overall Study|Other than listed|0|||
161943238|NCT05819398|584841783|FG000|Overall Study|Lack of Efficacy|0|||
161943239|NCT05819398|584841784|FG001|Overall Study|Lack of Efficacy|1|||
161943240|NCT05819398|584841785|FG002|Overall Study|Lack of Efficacy|0|||
161943241|NCT05819398|584841786|FG003|Overall Study|Lack of Efficacy|0|||
161943242|NCT05819398|584841783|FG000|Overall Study|Study terminated by sponsor|20|||
161943243|NCT05819398|584841784|FG001|Overall Study|Study terminated by sponsor|18|||
161943244|NCT05819398|584841785|FG002|Overall Study|Study terminated by sponsor|20|||
161943245|NCT05819398|584841786|FG003|Overall Study|Study terminated by sponsor|22|||
161943246|NCT02520154|584841787|FG000|Overall Study|Death|1|||
161943247|NCT02520154|584841787|FG000|Overall Study|Withdrawal by Subject|2|||
161943248|NCT02520154|584841787|FG000|Overall Study|Physician Decision|2|||
162026643|NCT00640224|585154371|FG002|Overall Study|Lost to Follow-up|0|||
162026644|NCT00640224|585154372|FG003|Overall Study|Lost to Follow-up|0|||
161683380|NCT05879107|583892962|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
161832244|NCT01885182|584428381|FG000|Overall Study|Withdrawal by Subject|13|||
161832245|NCT01885182|584428382|FG001|Overall Study|Withdrawal by Subject|6|||
161832246|NCT01885182|584428381|FG000|Overall Study|Lost to Follow-up|2|||
161832247|NCT01885182|584428382|FG001|Overall Study|Lost to Follow-up|2|||
161832248|NCT01885182|584428381|FG000|Overall Study|Lack of Efficacy|8|||
161832249|NCT01885182|584428382|FG001|Overall Study|Lack of Efficacy|1|||
161832250|NCT04146363|584428383|FG000|Induction Period|Adverse Event|1|||
161832251|NCT04146363|584428384|FG001|Induction Period|Adverse Event|2|||
161832252|NCT04146363|584428385|FG002|Induction Period|Adverse Event|0|||
161832253|NCT04146363|584428386|FG003|Induction Period|Adverse Event|0|||
161832254|NCT04146363|584428387|FG004|Induction Period|Adverse Event|0|||
161832255|NCT04146363|584428388|FG005|Induction Period|Adverse Event|0|||
161832256|NCT04146363|584428389|FG006|Induction Period|Adverse Event|0|||
161832257|NCT04146363|584428390|FG007|Induction Period|Adverse Event|0|||
161832258|NCT04146363|584428391|FG008|Induction Period|Adverse Event|0|||
162026645|NCT00640224|585154369|FG000|Overall Study|Withdrawal by Subject|1|||
162026646|NCT00640224|585154370|FG001|Overall Study|Withdrawal by Subject|0|||
162026647|NCT00640224|585154371|FG002|Overall Study|Withdrawal by Subject|0|||
162026648|NCT00640224|585154372|FG003|Overall Study|Withdrawal by Subject|0|||
162026649|NCT00640224|585154369|FG000|Overall Study|Headaches|0|||
162026650|NCT00640224|585154370|FG001|Overall Study|Headaches|1|||
162026651|NCT00640224|585154371|FG002|Overall Study|Headaches|0|||
162026652|NCT00640224|585154372|FG003|Overall Study|Headaches|0|||
162026653|NCT01252667|585154373|FG000|Overall Study|Transplant aborted post-conditioning|0|||
162026654|NCT01252667|585154374|FG001|Overall Study|Transplant aborted post-conditioning|0|||
162026655|NCT01252667|585154375|FG002|Overall Study|Transplant aborted post-conditioning|0|||
162026656|NCT01252667|585154376|FG003|Overall Study|Transplant aborted post-conditioning|0|||
162026657|NCT01252667|585154377|FG004|Overall Study|Transplant aborted post-conditioning|0|||
162026658|NCT01252667|585154378|FG005|Overall Study|Transplant aborted post-conditioning|1|||
162026659|NCT04644315|585154379|FG000|Overall Study|Subject withdrawal of consent|1|||
162026660|NCT00294762|585154380|FG000|Overall Study|Did not receive study treatment|3|||
162026661|NCT00294762|585154381|FG001|Overall Study|Did not receive study treatment|3|||
162026662|NCT00701662|585154382|FG000|Overall Study|Lack of Efficacy|1|||
162026663|NCT04493892|585154383|FG000|Overall Study|Withdrawal by Subject|15|||
162026664|NCT02577887|585154386|FG000|Overall Study|Death|93|||
162026665|NCT02577887|585154386|FG000|Overall Study|Protocol Violation|125|||
162026666|NCT02577887|585154386|FG000|Overall Study|Withdrawal by Subject|80|||
162026667|NCT02267317|585154387|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
162026668|NCT02267317|585154388|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
162026669|NCT02267317|585154389|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
162026670|NCT02267317|585154390|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
162026671|NCT02267317|585154391|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
162026672|NCT02267317|585154392|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
162026673|NCT02267317|585154387|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
162026674|NCT02267317|585154388|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
161943249|NCT06022107|584841788|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
161943250|NCT06022107|584841788|FG000|Overall Study|Dropped out of study for higher level of care|1|||
161943251|NCT06022107|584841788|FG000|Overall Study|Lost to Follow-up|2|||
161943252|NCT04887831|584844071|FG000|Overall Study|Death|26|||
161943253|NCT04887831|584844072|FG001|Overall Study|Death|26|||
161943254|NCT04887831|584844071|FG000|Overall Study|Lost to Follow-up|0|||
161943255|NCT04887831|584844072|FG001|Overall Study|Lost to Follow-up|1|||
161943256|NCT04887831|584844071|FG000|Overall Study|Withdrawal by Subject|2|||
161943257|NCT04887831|584844072|FG001|Overall Study|Withdrawal by Subject|1|||
161943258|NCT04887831|584844071|FG000|Overall Study|Study Terminated by Sponsor|18|||
161943259|NCT04887831|584844072|FG001|Overall Study|Study Terminated by Sponsor|17|||
161943260|NCT04887831|584844071|FG000|Overall Study|Other|1|||
161943261|NCT04887831|584844072|FG001|Overall Study|Other|0|||
161943262|NCT02276040|584844078|FG000|Overall Study|Physician Decision|15|||
161943263|NCT03674281|584844079|FG000|Overall Study|screen failure|2|||
161943264|NCT03674281|584844080|FG001|Overall Study|screen failure|0|||
161943265|NCT03674281|584844081|FG002|Overall Study|screen failure|0|||
161943266|NCT03674281|584844079|FG000|Overall Study|Withdrawal by Subject|1|||
161943267|NCT03674281|584844080|FG001|Overall Study|Withdrawal by Subject|3|||
161943268|NCT03674281|584844081|FG002|Overall Study|Withdrawal by Subject|3|||
161943269|NCT04622592|584844082|FG000|Overall Study|Death|0|||
161943270|NCT04622592|584844083|FG001|Overall Study|Death|0|||
161943271|NCT04622592|584844084|FG002|Overall Study|Death|1|||
161943272|NCT04622592|584844085|FG003|Overall Study|Death|0|||
161943273|NCT04622592|584844086|FG004|Overall Study|Death|0|||
161943274|NCT04622592|584844087|FG005|Overall Study|Death|0|||
161943275|NCT04622592|584844088|FG006|Overall Study|Death|0|||
161943276|NCT04622592|584844089|FG007|Overall Study|Death|1|||
161943277|NCT04622592|584844082|FG000|Overall Study|Lost to Follow-up|0|||
161943278|NCT04622592|584844083|FG001|Overall Study|Lost to Follow-up|0|||
161943279|NCT04622592|584844084|FG002|Overall Study|Lost to Follow-up|0|||
161943280|NCT04622592|584844085|FG003|Overall Study|Lost to Follow-up|3|||
161943281|NCT04622592|584844086|FG004|Overall Study|Lost to Follow-up|1|||
161943282|NCT04622592|584844087|FG005|Overall Study|Lost to Follow-up|0|||
161943283|NCT04622592|584844088|FG006|Overall Study|Lost to Follow-up|2|||
161943284|NCT04622592|584844089|FG007|Overall Study|Lost to Follow-up|2|||
161943285|NCT04622592|584844082|FG000|Overall Study|Physician Decision|0|||
161943286|NCT04622592|584844083|FG001|Overall Study|Physician Decision|0|||
161943287|NCT04622592|584844084|FG002|Overall Study|Physician Decision|0|||
161943288|NCT04622592|584844085|FG003|Overall Study|Physician Decision|0|||
161943289|NCT04622592|584844086|FG004|Overall Study|Physician Decision|1|||
161943290|NCT04622592|584844087|FG005|Overall Study|Physician Decision|0|||
161943291|NCT04622592|584844088|FG006|Overall Study|Physician Decision|0|||
161943292|NCT04622592|584844089|FG007|Overall Study|Physician Decision|0|||
161943293|NCT04622592|584844082|FG000|Overall Study|Withdrawal by Subject|1|||
161943294|NCT04622592|584844083|FG001|Overall Study|Withdrawal by Subject|0|||
161943295|NCT04622592|584844084|FG002|Overall Study|Withdrawal by Subject|2|||
161943296|NCT04622592|584844085|FG003|Overall Study|Withdrawal by Subject|0|||
161943297|NCT04622592|584844086|FG004|Overall Study|Withdrawal by Subject|0|||
161943298|NCT04622592|584844087|FG005|Overall Study|Withdrawal by Subject|0|||
161943299|NCT04622592|584844088|FG006|Overall Study|Withdrawal by Subject|1|||
161943300|NCT04622592|584844089|FG007|Overall Study|Withdrawal by Subject|4|||
161943301|NCT04622592|584844082|FG000|Overall Study|Other than specified above|0|||
161943302|NCT04622592|584844083|FG001|Overall Study|Other than specified above|0|||
161943303|NCT04622592|584844084|FG002|Overall Study|Other than specified above|1|||
161943304|NCT04622592|584844085|FG003|Overall Study|Other than specified above|0|||
161943305|NCT04622592|584844086|FG004|Overall Study|Other than specified above|0|||
161943306|NCT04622592|584844087|FG005|Overall Study|Other than specified above|0|||
161943307|NCT04622592|584844088|FG006|Overall Study|Other than specified above|0|||
161943308|NCT04622592|584844089|FG007|Overall Study|Other than specified above|0|||
161943309|NCT00276419|584844092|FG000|First Intervention|Adverse Event|1|||
161943310|NCT00276419|584844093|FG001|First Intervention|Adverse Event|0|||
161943311|NCT00276419|584844092|FG000|First Intervention|Withdrawal by Subject|0|||
161943312|NCT00276419|584844093|FG001|First Intervention|Withdrawal by Subject|2|||
161943313|NCT00560508|584844096|FG000|12 Week Double-blind Period|Adverse Event|3|||
161943314|NCT00560508|584844097|FG001|12 Week Double-blind Period|Adverse Event|2|||
161943315|NCT00560508|584844096|FG000|12 Week Double-blind Period|Protocol Violation|1|||
161943316|NCT00560508|584844097|FG001|12 Week Double-blind Period|Protocol Violation|0|||
161943317|NCT00560508|584844096|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
161943318|NCT00560508|584844097|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
161943319|NCT00560508|584844096|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
161943320|NCT00560508|584844097|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
161943321|NCT00560508|584844096|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
161943322|NCT00560508|584844097|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
161943323|NCT00560508|584844096|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
161943324|NCT00560508|584844097|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
161943325|NCT00560508|584844096|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
161943326|NCT00560508|584844097|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
161943327|NCT03493958|584844098|FG000|Overall Study|Withdrawal by Subject|6|||
161943328|NCT03493958|584844098|FG000|Overall Study|Lost to Follow-up|7|||
161943329|NCT03493958|584844098|FG000|Overall Study|Did not complete all required study procedures|2|||
161683381|NCT05879107|583892961|FG000|Overall Study|Migrated / moved from the study area|1|||
161943330|NCT02367456|584844099|FG000|Overall Study|Death|8|||
161943331|NCT02367456|584844100|FG001|Overall Study|Death|24|||
161943332|NCT02367456|584844101|FG002|Overall Study|Death|17|||
161943333|NCT02367456|584844099|FG000|Overall Study|Lost to Follow-up|1|||
161943334|NCT02367456|584844100|FG001|Overall Study|Lost to Follow-up|3|||
161943335|NCT02367456|584844101|FG002|Overall Study|Lost to Follow-up|1|||
161943336|NCT02367456|584844099|FG000|Overall Study|Other reason|3|||
161943337|NCT02367456|584844100|FG001|Overall Study|Other reason|3|||
161943338|NCT02367456|584844101|FG002|Overall Study|Other reason|9|||
161943339|NCT02367456|584844099|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
161943340|NCT02367456|584844100|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
161943341|NCT02367456|584844101|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
161943342|NCT01645176|584844106|FG000|Overall Study|Lack of Efficacy|4|||
161943343|NCT01645176|584844106|FG000|Overall Study|did not complete final MRI|1|||
161943344|NCT02569853|584844107|FG000|Overall Study|Adverse Event|2|||
161943345|NCT02569853|584844108|FG001|Overall Study|Adverse Event|0|||
161943346|NCT02569853|584844107|FG000|Overall Study|Withdrawal by Subject|3|||
161943347|NCT02569853|584844108|FG001|Overall Study|Withdrawal by Subject|2|||
161943348|NCT02569853|584844107|FG000|Overall Study|Lost to Follow-up|3|||
161943349|NCT02569853|584844108|FG001|Overall Study|Lost to Follow-up|3|||
161943350|NCT02569853|584844107|FG000|Overall Study|Protocol Violation|1|||
161943351|NCT02569853|584844108|FG001|Overall Study|Protocol Violation|1|||
161943352|NCT02569853|584844107|FG000|Overall Study|Did not experience migraine attack|10|||
161943353|NCT02569853|584844108|FG001|Overall Study|Did not experience migraine attack|7|||
161943354|NCT02569853|584844107|FG000|Overall Study|Physician Decision|1|||
161943355|NCT02569853|584844108|FG001|Overall Study|Physician Decision|1|||
161943356|NCT00402987|584844109|FG000|Overall Study|Lack of Efficacy|0|||
161943357|NCT00402987|584844110|FG001|Overall Study|Lack of Efficacy|0|||
161943358|NCT00402987|584844111|FG002|Overall Study|Lack of Efficacy|1|||
161943359|NCT00402987|584844112|FG003|Overall Study|Lack of Efficacy|0|||
161943360|NCT01668004|584844113|FG000|Overall Study|Adverse Event|7|||
161943361|NCT01668004|584844113|FG000|Overall Study|Withdrawal by Subject|2|||
161943362|NCT01668004|584844113|FG000|Overall Study|Lost to Follow-up|5|||
161943363|NCT01668004|584844113|FG000|Overall Study|Lack of Efficacy|9|||
161943364|NCT01668004|584844113|FG000|Overall Study|Non-compliance with treatment|2|||
161943365|NCT02448381|584844116|FG000|Overall Study|Adverse Event|2|||
161943366|NCT02448381|584844117|FG001|Overall Study|Adverse Event|0|||
161943367|NCT02448381|584844116|FG000|Overall Study|Lost to Follow-up|16|||
161943368|NCT02448381|584844117|FG001|Overall Study|Lost to Follow-up|9|||
161943369|NCT02448381|584844116|FG000|Overall Study|Physician Decision|1|||
161943370|NCT02448381|584844117|FG001|Overall Study|Physician Decision|1|||
161943371|NCT02448381|584844116|FG000|Overall Study|Pregnancy|1|||
161943372|NCT02448381|584844117|FG001|Overall Study|Pregnancy|0|||
161943373|NCT02448381|584844116|FG000|Overall Study|Withdrawal by Subject|13|||
161943374|NCT02448381|584844117|FG001|Overall Study|Withdrawal by Subject|9|||
161943375|NCT02448381|584844116|FG000|Overall Study|Noncompliance with Study Procedures|2|||
161943376|NCT02448381|584844117|FG001|Overall Study|Noncompliance with Study Procedures|0|||
161943377|NCT04617860|584844118|FG000|Overall Study|Adverse Event|0|||
161943378|NCT04617860|584844119|FG001|Overall Study|Adverse Event|2|||
161943379|NCT04617860|584844120|FG002|Overall Study|Adverse Event|2|||
161943380|NCT04617860|584844118|FG000|Overall Study|Withdrawal by Subject|0|||
161943381|NCT04617860|584844119|FG001|Overall Study|Withdrawal by Subject|0|||
161943382|NCT04617860|584844120|FG002|Overall Study|Withdrawal by Subject|2|||
161943383|NCT04617860|584844118|FG000|Overall Study|Physician Decision|0|||
161943384|NCT04617860|584844119|FG001|Overall Study|Physician Decision|1|||
161943385|NCT04617860|584844120|FG002|Overall Study|Physician Decision|0|||
161943386|NCT04617860|584844118|FG000|Overall Study|Sponsor Decision|0|||
161943387|NCT04617860|584844119|FG001|Overall Study|Sponsor Decision|3|||
161943388|NCT04617860|584844120|FG002|Overall Study|Sponsor Decision|1|||
161943389|NCT04617860|584844118|FG000|Overall Study|Termination of Study by Sponsor|8|||
161943390|NCT04617860|584844119|FG001|Overall Study|Termination of Study by Sponsor|4|||
161943391|NCT04617860|584844120|FG002|Overall Study|Termination of Study by Sponsor|13|||
161943392|NCT02735200|584844125|FG000|Overall Study|Lost to Follow-up|0|||
161943393|NCT02735200|584844126|FG001|Overall Study|Lost to Follow-up|5|||
161943394|NCT02735200|584844125|FG000|Overall Study|Withdrawal by Subject|8|||
161943395|NCT02735200|584844126|FG001|Overall Study|Withdrawal by Subject|0|||
161943396|NCT00619866|584844130|FG000|Weeks 1 - 12|Adverse Event|0|||
161943397|NCT00619866|584844131|FG001|Weeks 1 - 12|Adverse Event|1|||
161943398|NCT00619866|584844132|FG002|Weeks 1 - 12|Adverse Event|2|||
161943399|NCT00619866|584844133|FG003|Weeks 1 - 12|Adverse Event|0|||
161943400|NCT00619866|584844134|FG004|Weeks 1 - 12|Adverse Event|0|||
161943401|NCT00619866|584844130|FG000|Weeks 1 - 12|Non-compliance|0|||
161943402|NCT00619866|584844131|FG001|Weeks 1 - 12|Non-compliance|0|||
161943403|NCT00619866|584844132|FG002|Weeks 1 - 12|Non-compliance|1|||
161943404|NCT00619866|584844133|FG003|Weeks 1 - 12|Non-compliance|0|||
161943405|NCT00619866|584844134|FG004|Weeks 1 - 12|Non-compliance|0|||
161943406|NCT00619866|584844130|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
161943407|NCT00619866|584844131|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
161943408|NCT00619866|584844132|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
161943409|NCT00619866|584844133|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
161943410|NCT00619866|584844134|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
161943411|NCT00619866|584844130|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
161943412|NCT00619866|584844131|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
161943413|NCT00619866|584844132|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
161943414|NCT00619866|584844133|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
161943415|NCT00619866|584844134|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
161943416|NCT00619866|584844130|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
161943417|NCT00619866|584844131|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
161943418|NCT00619866|584844132|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
161943419|NCT00619866|584844133|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
161943420|NCT00619866|584844134|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
161943421|NCT00619866|584844130|FG000|Weeks 1 - 12|Sponsor Decision|0|||
161943422|NCT00619866|584844131|FG001|Weeks 1 - 12|Sponsor Decision|1|||
161943423|NCT00619866|584844132|FG002|Weeks 1 - 12|Sponsor Decision|0|||
161943424|NCT00619866|584844133|FG003|Weeks 1 - 12|Sponsor Decision|0|||
161943425|NCT00619866|584844134|FG004|Weeks 1 - 12|Sponsor Decision|0|||
161943426|NCT00619866|584844130|FG000|Weeks 13 - 24|Adverse Event|0|||
161943427|NCT00619866|584844131|FG001|Weeks 13 - 24|Adverse Event|0|||
161943428|NCT00619866|584844132|FG002|Weeks 13 - 24|Adverse Event|2|||
161943429|NCT00619866|584844133|FG003|Weeks 13 - 24|Adverse Event|1|||
161943430|NCT00619866|584844134|FG004|Weeks 13 - 24|Adverse Event|0|||
161943431|NCT00619866|584844130|FG000|Weeks 13 - 24|Protocol Deviation|0|||
161943432|NCT00619866|584844131|FG001|Weeks 13 - 24|Protocol Deviation|0|||
161943433|NCT00619866|584844132|FG002|Weeks 13 - 24|Protocol Deviation|0|||
161943434|NCT00619866|584844133|FG003|Weeks 13 - 24|Protocol Deviation|1|||
161943435|NCT00619866|584844134|FG004|Weeks 13 - 24|Protocol Deviation|0|||
161943436|NCT00619866|584844130|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
161943437|NCT00619866|584844131|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
161943438|NCT00619866|584844132|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
161943439|NCT00619866|584844133|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
161943440|NCT00619866|584844134|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
161943441|NCT00619866|584844130|FG000|Weeks 13 - 24|Non-compliance|0|||
161943442|NCT00619866|584844131|FG001|Weeks 13 - 24|Non-compliance|1|||
161943443|NCT00619866|584844132|FG002|Weeks 13 - 24|Non-compliance|1|||
161943444|NCT00619866|584844133|FG003|Weeks 13 - 24|Non-compliance|0|||
161943445|NCT00619866|584844134|FG004|Weeks 13 - 24|Non-compliance|0|||
161943446|NCT00619866|584844130|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
161943447|NCT00619866|584844131|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
161943448|NCT00619866|584844132|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
161943449|NCT00619866|584844133|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
161943450|NCT00619866|584844134|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
161943451|NCT01656161|584844135|FG000|Overall Study|Death|3|||
161943452|NCT01656161|584844135|FG000|Overall Study|Adverse Event|2|||
161943453|NCT01656161|584844135|FG000|Overall Study|Protocol Violation|1|||
161943454|NCT01656161|584844135|FG000|Overall Study|Withdrawal by Subject|1|||
161943455|NCT03510273|584844140|FG000|Overall Study|Withdrawal by Subject|2|||
161943456|NCT03510273|584844140|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
161943457|NCT03510273|584844140|FG000|Overall Study|Moved away from study area|4|||
161943458|NCT02589938|584844144|FG000|Overall Study|Withdrawal by Subject|11|||
161943459|NCT02589938|584844145|FG001|Overall Study|Withdrawal by Subject|5|||
161943460|NCT02589938|584844146|FG002|Overall Study|Withdrawal by Subject|6|||
161943461|NCT02589938|584844144|FG000|Overall Study|Lost to Follow-up|3|||
161943462|NCT02589938|584844145|FG001|Overall Study|Lost to Follow-up|3|||
161943463|NCT02589938|584844146|FG002|Overall Study|Lost to Follow-up|3|||
161943464|NCT02589938|584844144|FG000|Overall Study|Death|1|||
161943465|NCT02589938|584844145|FG001|Overall Study|Death|0|||
161832259|NCT04146363|584428392|FG009|Induction Period|Adverse Event|0|||
161943466|NCT02589938|584844146|FG002|Overall Study|Death|1|||
161943467|NCT02589938|584844144|FG000|Overall Study|Protocol Violation|6|||
161943468|NCT02589938|584844145|FG001|Overall Study|Protocol Violation|2|||
161943469|NCT02589938|584844146|FG002|Overall Study|Protocol Violation|3|||
161943470|NCT02589938|584844144|FG000|Overall Study|Physician Decision|1|||
161943471|NCT02589938|584844145|FG001|Overall Study|Physician Decision|0|||
161943472|NCT02589938|584844146|FG002|Overall Study|Physician Decision|0|||
161943473|NCT02589938|584844144|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
161943474|NCT02589938|584844145|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
161943475|NCT02589938|584844146|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
161943476|NCT05205616|584844153|FG000|Overall Study|Lost to Follow-up|4|||
161943477|NCT05205616|584844154|FG001|Overall Study|Lost to Follow-up|4|||
161943478|NCT00787150|584844156|FG000|Overall Study|Adverse Event|4|||
161943479|NCT00787150|584844157|FG001|Overall Study|Adverse Event|4|||
161943480|NCT00787150|584844158|FG002|Overall Study|Adverse Event|4|||
162026675|NCT02267317|585154389|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
162026676|NCT02267317|585154390|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
162026677|NCT02267317|585154391|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
162026678|NCT02267317|585154392|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
162026679|NCT03595618|585154395|FG000|Overall Study|Adverse Event|16|||
162026680|NCT03595618|585154396|FG001|Overall Study|Adverse Event|17|||
162026681|NCT03595618|585154397|FG002|Overall Study|Adverse Event|20|||
162026682|NCT03595618|585154398|FG003|Overall Study|Adverse Event|8|||
162026683|NCT03595618|585154395|FG000|Overall Study|Withdrawal by Subject|12|||
162026684|NCT03595618|585154396|FG001|Overall Study|Withdrawal by Subject|14|||
162026685|NCT03595618|585154397|FG002|Overall Study|Withdrawal by Subject|14|||
162026686|NCT03595618|585154398|FG003|Overall Study|Withdrawal by Subject|10|||
162026687|NCT03595618|585154395|FG000|Overall Study|Lost to Follow-up|6|||
162026688|NCT03595618|585154396|FG001|Overall Study|Lost to Follow-up|4|||
162026689|NCT03595618|585154397|FG002|Overall Study|Lost to Follow-up|5|||
162026690|NCT03595618|585154398|FG003|Overall Study|Lost to Follow-up|6|||
162026691|NCT03595618|585154395|FG000|Overall Study|Protocol Violation|2|||
162026692|NCT03595618|585154396|FG001|Overall Study|Protocol Violation|0|||
162026693|NCT03595618|585154397|FG002|Overall Study|Protocol Violation|6|||
162026694|NCT03595618|585154398|FG003|Overall Study|Protocol Violation|2|||
162026695|NCT03595618|585154395|FG000|Overall Study|Physician Decision|0|||
162026696|NCT03595618|585154396|FG001|Overall Study|Physician Decision|0|||
162026697|NCT03595618|585154397|FG002|Overall Study|Physician Decision|1|||
162026698|NCT03595618|585154398|FG003|Overall Study|Physician Decision|2|||
162026699|NCT03595618|585154395|FG000|Overall Study|Miscellaneous|7|||
162026700|NCT03595618|585154396|FG001|Overall Study|Miscellaneous|5|||
162026701|NCT03595618|585154397|FG002|Overall Study|Miscellaneous|10|||
162026702|NCT03595618|585154398|FG003|Overall Study|Miscellaneous|6|||
162026703|NCT02279407|585154401|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
162026704|NCT02279407|585154402|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
162026705|NCT02279407|585154403|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
162026706|NCT02279407|585154404|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
162026707|NCT02279407|585154401|FG000|Overall Study|Withdrawal by Subject|1|||
162026708|NCT02279407|585154402|FG001|Overall Study|Withdrawal by Subject|0|||
162026709|NCT02279407|585154403|FG002|Overall Study|Withdrawal by Subject|1|||
162026710|NCT02279407|585154404|FG003|Overall Study|Withdrawal by Subject|1|||
162026711|NCT02279407|585154401|FG000|Overall Study|Adverse Event|1|||
162026712|NCT02279407|585154402|FG001|Overall Study|Adverse Event|1|||
162026713|NCT02279407|585154403|FG002|Overall Study|Adverse Event|2|||
162026714|NCT02279407|585154404|FG003|Overall Study|Adverse Event|0|||
161943481|NCT00787150|584844156|FG000|Overall Study|Physician Decision|1|||
161943482|NCT00787150|584844157|FG001|Overall Study|Physician Decision|2|||
161943483|NCT00787150|584844158|FG002|Overall Study|Physician Decision|1|||
161943484|NCT00787150|584844156|FG000|Overall Study|Withdrawal by Subject|2|||
161943485|NCT00787150|584844157|FG001|Overall Study|Withdrawal by Subject|1|||
161943486|NCT00787150|584844158|FG002|Overall Study|Withdrawal by Subject|0|||
161943487|NCT00787150|584844156|FG000|Overall Study|Dosing incorrect study durg|2|||
161943488|NCT00787150|584844157|FG001|Overall Study|Dosing incorrect study durg|0|||
161943489|NCT00787150|584844158|FG002|Overall Study|Dosing incorrect study durg|0|||
161943490|NCT01121757|584844169|FG000|First Drug|Death|1|||
161943491|NCT01121757|584844170|FG001|First Drug|Death|0|||
161943492|NCT01121757|584844169|FG000|First Drug|Disease Progression|0|||
161943493|NCT01121757|584844170|FG001|First Drug|Disease Progression|2|||
161943494|NCT01121757|584844169|FG000|Combination|Physician Decision|0|||
161943495|NCT01121757|584844170|FG001|Combination|Physician Decision|1|||
161943496|NCT01121757|584844169|FG000|Combination|Disease Progression|2|||
162026715|NCT00864916|585154405|FG000|Overall Study|Lost to Follow-up|4|||
162026716|NCT00864916|585154406|FG001|Overall Study|Lost to Follow-up|4|||
162026717|NCT00864916|585154405|FG000|Overall Study|Protocol Violation|1|||
162026718|NCT00864916|585154406|FG001|Overall Study|Protocol Violation|0|||
162026719|NCT00864916|585154405|FG000|Overall Study|Withdrawal by Subject|1|||
162026720|NCT00864916|585154406|FG001|Overall Study|Withdrawal by Subject|0|||
162026721|NCT00422084|585154408|FG000|Overall Study|Adverse Event|21|||
162026722|NCT00422084|585154409|FG001|Overall Study|Adverse Event|7|||
162026723|NCT00422084|585154408|FG000|Overall Study|Withdrawal by Subject|12|||
162026724|NCT00422084|585154409|FG001|Overall Study|Withdrawal by Subject|9|||
162026725|NCT00422084|585154408|FG000|Overall Study|Lost to Follow-up|14|||
162026726|NCT00422084|585154409|FG001|Overall Study|Lost to Follow-up|9|||
162026727|NCT00422084|585154408|FG000|Overall Study|Protocol Violation|4|||
162026728|NCT00422084|585154409|FG001|Overall Study|Protocol Violation|1|||
161943497|NCT01121757|584844170|FG001|Combination|Disease Progression|0|||
161943498|NCT06071104|584844187|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
161943499|NCT04116489|584844191|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
162026729|NCT00422084|585154408|FG000|Overall Study|Lack of Efficacy|40|||
162026730|NCT00422084|585154409|FG001|Overall Study|Lack of Efficacy|42|||
162026731|NCT00422084|585154408|FG000|Overall Study|P. vivax infection|3|||
161683382|NCT05879107|583892962|FG001|Overall Study|Migrated / moved from the study area|1|||
162026732|NCT00422084|585154409|FG001|Overall Study|P. vivax infection|6|||
161943500|NCT04116489|584844191|FG000|Overall Study|Withdrawal by Subject|1|||
161943501|NCT03781570|584844192|FG000|Overall Study|Technical Issues (equipment failure)|31|||
161943502|NCT03781570|584844192|FG000|Overall Study|Withdrawal by Subject|7|||
161943503|NCT03781570|584844192|FG000|Overall Study|Physical Constraints|11|||
161943504|NCT03636022|584844196|FG000|Overall Study|Withdrawal by Subject|1|||
161943505|NCT03636022|584844197|FG001|Overall Study|Withdrawal by Subject|3|||
161943506|NCT03330847|584844198|FG000|Overall Study|Patients ongoing study|62|||
161943507|NCT03330847|584844199|FG001|Overall Study|Patients ongoing study|65|||
161943508|NCT03330847|584844200|FG002|Overall Study|Patients ongoing study|15|||
161943509|NCT01346592|584844203|FG000|Overall Study|Lost to Follow-up|62|||
161943510|NCT01346592|584844204|FG001|Overall Study|Lost to Follow-up|29|||
161943511|NCT01346592|584844205|FG002|Overall Study|Lost to Follow-up|29|||
161943512|NCT01346592|584844203|FG000|Overall Study|Protocol Violation|2|||
161943513|NCT01346592|584844204|FG001|Overall Study|Protocol Violation|1|||
161943514|NCT01346592|584844205|FG002|Overall Study|Protocol Violation|0|||
161943515|NCT01346592|584844203|FG000|Overall Study|Death|1|||
161943516|NCT01346592|584844204|FG001|Overall Study|Death|3|||
161943517|NCT01346592|584844205|FG002|Overall Study|Death|4|||
161943518|NCT01346592|584844203|FG000|Overall Study|Adverse Event|0|||
161943519|NCT01346592|584844204|FG001|Overall Study|Adverse Event|1|||
161943520|NCT01346592|584844205|FG002|Overall Study|Adverse Event|0|||
161943521|NCT01346592|584844203|FG000|Overall Study|Withdrawal by Subject|77|||
161943522|NCT01346592|584844204|FG001|Overall Study|Withdrawal by Subject|51|||
161943523|NCT01346592|584844205|FG002|Overall Study|Withdrawal by Subject|38|||
161943524|NCT01346592|584844203|FG000|Overall Study|Inappropriate enrollment|3|||
161943525|NCT01346592|584844204|FG001|Overall Study|Inappropriate enrollment|1|||
161943526|NCT01346592|584844205|FG002|Overall Study|Inappropriate enrollment|1|||
161943527|NCT01346592|584844203|FG000|Overall Study|Administrative reason|1|||
161943528|NCT01346592|584844204|FG001|Overall Study|Administrative reason|0|||
161943529|NCT01346592|584844205|FG002|Overall Study|Administrative reason|0|||
161943530|NCT01346592|584844203|FG000|Overall Study|Unable to Classify|7|||
161943531|NCT01346592|584844204|FG001|Overall Study|Unable to Classify|3|||
161943532|NCT01346592|584844205|FG002|Overall Study|Unable to Classify|6|||
161943533|NCT01107886|584844210|FG000|Overall Study|Lost to Follow-up|15|||
161943534|NCT01107886|584844211|FG001|Overall Study|Lost to Follow-up|13|||
161943535|NCT01107886|584844210|FG000|Overall Study|Withdrawal by Subject|180|||
161943536|NCT01107886|584844211|FG001|Overall Study|Withdrawal by Subject|196|||
161943537|NCT01107886|584844210|FG000|Overall Study|Administrative withdrawal of consent|7|||
161943538|NCT01107886|584844211|FG001|Overall Study|Administrative withdrawal of consent|5|||
161943539|NCT01346176|584844212|FG000|Recruited|Protocol Violation|1|||
161943540|NCT01346176|584844213|FG001|Recruited|Protocol Violation|0|||
161943541|NCT01346176|584844214|FG002|Recruited|Protocol Violation|0|||
161943542|NCT01346176|584844212|FG000|Completed Advance Directive|Death|3|||
161943543|NCT01346176|584844213|FG001|Completed Advance Directive|Death|2|||
161943544|NCT01346176|584844214|FG002|Completed Advance Directive|Death|2|||
161943545|NCT01346176|584844212|FG000|Completed Advance Directive|Became Ineligible|3|||
161943546|NCT01346176|584844213|FG001|Completed Advance Directive|Became Ineligible|0|||
161943547|NCT01346176|584844214|FG002|Completed Advance Directive|Became Ineligible|1|||
161943548|NCT01346176|584844212|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
161943549|NCT01346176|584844213|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
161943550|NCT01346176|584844214|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
161943551|NCT01346176|584844212|FG000|Completed Satisfaction Survey|Death|3|||
161943552|NCT01346176|584844213|FG001|Completed Satisfaction Survey|Death|0|||
161943553|NCT01346176|584844214|FG002|Completed Satisfaction Survey|Death|2|||
161943554|NCT01346176|584844212|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
161943555|NCT01346176|584844213|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
161943556|NCT01346176|584844214|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
161943557|NCT05943990|584844219|FG000|Overall Study|Study Terminated by Sponsor|0|||
161943558|NCT05943990|584844220|FG001|Overall Study|Study Terminated by Sponsor|0|||
161943559|NCT05943990|584844221|FG002|Overall Study|Study Terminated by Sponsor|1|||
161943560|NCT02581930|584844222|FG000|Overall Study|Withdrawal by Subject|1|||
161943561|NCT02581930|584844222|FG000|Overall Study|patient declined further treatment|1|||
161943562|NCT02776735|584844223|FG000|Overall Study|Adverse Event|0|||
162026733|NCT00422084|585154408|FG000|Overall Study|Cyesis|1|||
162026734|NCT00422084|585154409|FG001|Overall Study|Cyesis|0|||
161943563|NCT02776735|584844224|FG001|Overall Study|Adverse Event|0|||
161943564|NCT02776735|584844225|FG002|Overall Study|Adverse Event|0|||
161943565|NCT02776735|584844226|FG003|Overall Study|Adverse Event|1|||
161943566|NCT02776735|584844227|FG004|Overall Study|Adverse Event|0|||
161943567|NCT02776735|584844228|FG005|Overall Study|Adverse Event|1|||
162026735|NCT00422084|585154408|FG000|Overall Study|Withdrawn from study accidentally|1|||
161943568|NCT02776735|584844223|FG000|Overall Study|Lost to Follow-up|0|||
161943569|NCT02776735|584844224|FG001|Overall Study|Lost to Follow-up|0|||
161943570|NCT02776735|584844225|FG002|Overall Study|Lost to Follow-up|0|||
161943571|NCT02776735|584844226|FG003|Overall Study|Lost to Follow-up|1|||
161943572|NCT02776735|584844227|FG004|Overall Study|Lost to Follow-up|0|||
161683383|NCT05879107|583892961|FG000|Overall Study|Lost to Follow-up|8|||
161943573|NCT02776735|584844228|FG005|Overall Study|Lost to Follow-up|0|||
161943574|NCT02776735|584844223|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161943575|NCT02776735|584844224|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161943576|NCT02776735|584844225|FG002|Overall Study|Withdrawal by parent/guardian|2|||
161943577|NCT02776735|584844226|FG003|Overall Study|Withdrawal by parent/guardian|2|||
161943578|NCT02776735|584844227|FG004|Overall Study|Withdrawal by parent/guardian|0|||
161943579|NCT02776735|584844228|FG005|Overall Study|Withdrawal by parent/guardian|0|||
161943580|NCT02776735|584844223|FG000|Overall Study|Withdrawal by Subject|1|||
161943581|NCT02776735|584844224|FG001|Overall Study|Withdrawal by Subject|0|||
161943582|NCT02776735|584844225|FG002|Overall Study|Withdrawal by Subject|0|||
161943583|NCT02776735|584844226|FG003|Overall Study|Withdrawal by Subject|0|||
161943584|NCT02776735|584844227|FG004|Overall Study|Withdrawal by Subject|0|||
161943585|NCT02776735|584844228|FG005|Overall Study|Withdrawal by Subject|1|||
161943586|NCT02776735|584844223|FG000|Overall Study|Other|0|||
161943587|NCT02776735|584844224|FG001|Overall Study|Other|0|||
161943588|NCT02776735|584844225|FG002|Overall Study|Other|3|||
161943589|NCT02776735|584844226|FG003|Overall Study|Other|0|||
161943590|NCT02776735|584844227|FG004|Overall Study|Other|0|||
161943591|NCT02776735|584844228|FG005|Overall Study|Other|0|||
161943592|NCT04696146|584845419|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
161943593|NCT04696146|584845420|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
161943594|NCT04696146|584845419|FG000|Overall Study|Off hours issue with product|1|||
161943595|NCT04696146|584845420|FG001|Overall Study|Off hours issue with product|0|||
161943596|NCT01576783|584845423|FG000|Overall Study|Change in Medical Care|1|||
161943597|NCT01576783|584845424|FG001|Overall Study|Change in Medical Care|0|||
161943598|NCT01576783|584845423|FG000|Overall Study|Lost to Follow-up|14|||
161943599|NCT01576783|584845424|FG001|Overall Study|Lost to Follow-up|16|||
161943600|NCT01576783|584845423|FG000|Overall Study|Withdrawal by Subject|5|||
161943601|NCT01576783|584845424|FG001|Overall Study|Withdrawal by Subject|1|||
161943602|NCT05489328|584845425|FG000|Overall Study|Lost to Follow-up|0|||
161943603|NCT05489328|584845426|FG001|Overall Study|Lost to Follow-up|0|||
161943604|NCT05489328|584845427|FG002|Overall Study|Lost to Follow-up|1|||
161943605|NCT05489328|584845428|FG003|Overall Study|Lost to Follow-up|0|||
161943606|NCT05489328|584845429|FG004|Overall Study|Lost to Follow-up|2|||
161943607|NCT05489328|584845430|FG005|Overall Study|Lost to Follow-up|0|||
161943608|NCT05489328|584845431|FG006|Overall Study|Lost to Follow-up|0|||
161943609|NCT05489328|584845432|FG007|Overall Study|Lost to Follow-up|1|||
161943610|NCT05489328|584845433|FG008|Overall Study|Lost to Follow-up|0|||
161943611|NCT05489328|584845425|FG000|Overall Study|Withdrawal by Subject|0|||
161943612|NCT05489328|584845426|FG001|Overall Study|Withdrawal by Subject|0|||
161943613|NCT05489328|584845427|FG002|Overall Study|Withdrawal by Subject|0|||
161943614|NCT05489328|584845428|FG003|Overall Study|Withdrawal by Subject|0|||
161943615|NCT05489328|584845429|FG004|Overall Study|Withdrawal by Subject|0|||
161943616|NCT05489328|584845430|FG005|Overall Study|Withdrawal by Subject|0|||
161943617|NCT05489328|584845431|FG006|Overall Study|Withdrawal by Subject|1|||
161943618|NCT05489328|584845432|FG007|Overall Study|Withdrawal by Subject|1|||
161943619|NCT05489328|584845433|FG008|Overall Study|Withdrawal by Subject|0|||
161943620|NCT05489328|584845425|FG000|Overall Study|Other|0|||
161943621|NCT05489328|584845426|FG001|Overall Study|Other|0|||
161943622|NCT05489328|584845427|FG002|Overall Study|Other|0|||
161943623|NCT05489328|584845428|FG003|Overall Study|Other|0|||
161943624|NCT05489328|584845429|FG004|Overall Study|Other|0|||
161943625|NCT05489328|584845430|FG005|Overall Study|Other|0|||
161943626|NCT05489328|584845431|FG006|Overall Study|Other|0|||
161943627|NCT05489328|584845432|FG007|Overall Study|Other|1|||
161943628|NCT05489328|584845433|FG008|Overall Study|Other|1|||
161943629|NCT04043286|584845435|FG000|Overall Study|Withdrawal by Subject|2|||
161943630|NCT04043286|584845436|FG001|Overall Study|Withdrawal by Subject|2|||
161943631|NCT01493414|584845441|FG000|Overall Study|Adverse Event|405|||
161943632|NCT01493414|584845441|FG000|Overall Study|Disease progression|204|||
161832260|NCT04146363|584428393|FG010|Induction Period|Adverse Event|0|||
161832261|NCT04146363|584428383|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
161832262|NCT04146363|584428384|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
161832263|NCT04146363|584428385|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
161832264|NCT04146363|584428386|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
161832265|NCT04146363|584428387|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
161832266|NCT04146363|584428388|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
161832267|NCT04146363|584428389|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
161832268|NCT04146363|584428390|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
161832269|NCT04146363|584428391|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
161832270|NCT04146363|584428392|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
161832271|NCT04146363|584428393|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
161832272|NCT04146363|584428383|FG000|Induction Period|Lack of Efficacy|7|||
161832273|NCT04146363|584428384|FG001|Induction Period|Lack of Efficacy|2|||
161832274|NCT04146363|584428385|FG002|Induction Period|Lack of Efficacy|0|||
161832275|NCT04146363|584428386|FG003|Induction Period|Lack of Efficacy|0|||
161832276|NCT04146363|584428387|FG004|Induction Period|Lack of Efficacy|0|||
161832277|NCT04146363|584428388|FG005|Induction Period|Lack of Efficacy|0|||
161832278|NCT04146363|584428389|FG006|Induction Period|Lack of Efficacy|0|||
161832279|NCT04146363|584428390|FG007|Induction Period|Lack of Efficacy|0|||
161832280|NCT04146363|584428391|FG008|Induction Period|Lack of Efficacy|0|||
161832281|NCT04146363|584428392|FG009|Induction Period|Lack of Efficacy|0|||
161832282|NCT04146363|584428393|FG010|Induction Period|Lack of Efficacy|0|||
161832283|NCT04146363|584428383|FG000|Induction Period|Lost to Follow-up|1|||
161832284|NCT04146363|584428384|FG001|Induction Period|Lost to Follow-up|4|||
161832285|NCT04146363|584428385|FG002|Induction Period|Lost to Follow-up|0|||
161832286|NCT04146363|584428386|FG003|Induction Period|Lost to Follow-up|0|||
161832287|NCT04146363|584428387|FG004|Induction Period|Lost to Follow-up|0|||
161832288|NCT04146363|584428388|FG005|Induction Period|Lost to Follow-up|0|||
161832289|NCT04146363|584428389|FG006|Induction Period|Lost to Follow-up|0|||
161832290|NCT04146363|584428390|FG007|Induction Period|Lost to Follow-up|0|||
161832291|NCT04146363|584428391|FG008|Induction Period|Lost to Follow-up|0|||
161943633|NCT01493414|584845441|FG000|Overall Study|Death|101|||
161832292|NCT04146363|584428392|FG009|Induction Period|Lost to Follow-up|0|||
161832293|NCT04146363|584428393|FG010|Induction Period|Lost to Follow-up|0|||
161832294|NCT04146363|584428383|FG000|Induction Period|Positive quantiferon test|0|||
161832295|NCT04146363|584428384|FG001|Induction Period|Positive quantiferon test|1|||
161943634|NCT01493414|584845441|FG000|Overall Study|Physician Decision|93|||
161943635|NCT01493414|584845441|FG000|Overall Study|Withdrawal by Subject|79|||
161943636|NCT01493414|584845441|FG000|Overall Study|Protocol deviation|27|||
161943637|NCT01493414|584845441|FG000|Overall Study|Administrative problems|25|||
161943638|NCT01493414|584845441|FG000|Overall Study|Lost to Follow-up|16|||
161943639|NCT05448950|584845452|FG000|Overall Study|Death|2|||
161943640|NCT05448950|584845452|FG000|Overall Study|Withdrawal by Subject|1|||
161943641|NCT05448950|584845452|FG000|Overall Study|AVG abandoned|4|||
161943642|NCT02706392|584845470|FG000|Overall Study|Death|1|||
161943643|NCT02706392|584845471|FG001|Overall Study|Death|0|||
161943644|NCT02706392|584845472|FG002|Overall Study|Death|2|||
161943645|NCT02706392|584845473|FG003|Overall Study|Death|2|||
161943646|NCT02706392|584845474|FG004|Overall Study|Death|5|||
161943647|NCT02706392|584845475|FG005|Overall Study|Death|2|||
161943648|NCT03773484|584845484|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
161943649|NCT04724837|584845485|FG000|Overall Study|Other|4|||
161943650|NCT04724837|584845486|FG001|Overall Study|Other|16|||
161943651|NCT04724837|584845487|FG002|Overall Study|Other|0|||
161943652|NCT04724837|584845485|FG000|Overall Study|Withdrawal by Subject|2|||
161943653|NCT04724837|584845486|FG001|Overall Study|Withdrawal by Subject|9|||
161943654|NCT04724837|584845487|FG002|Overall Study|Withdrawal by Subject|9|||
161943655|NCT04724837|584845485|FG000|Overall Study|Adverse Event|2|||
161943656|NCT04724837|584845486|FG001|Overall Study|Adverse Event|7|||
161943657|NCT04724837|584845487|FG002|Overall Study|Adverse Event|4|||
161943658|NCT04724837|584845485|FG000|Overall Study|Lost to Follow-up|0|||
161943659|NCT04724837|584845486|FG001|Overall Study|Lost to Follow-up|1|||
161943660|NCT04724837|584845487|FG002|Overall Study|Lost to Follow-up|3|||
161943661|NCT04724837|584845485|FG000|Overall Study|Physician Decision|1|||
161943662|NCT04724837|584845486|FG001|Overall Study|Physician Decision|2|||
161943663|NCT04724837|584845487|FG002|Overall Study|Physician Decision|0|||
161943664|NCT04724837|584845485|FG000|Overall Study|Death|0|||
161943665|NCT04724837|584845486|FG001|Overall Study|Death|0|||
161943666|NCT04724837|584845487|FG002|Overall Study|Death|1|||
161943667|NCT04724837|584845485|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
161943668|NCT04724837|584845486|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
161943669|NCT04724837|584845487|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
161683384|NCT05879107|583892962|FG001|Overall Study|Lost to Follow-up|13|||
161943670|NCT04724837|584845485|FG000|Overall Study|Study Terminated by Sponsor|0|||
161943671|NCT04724837|584845486|FG001|Overall Study|Study Terminated by Sponsor|1|||
161943672|NCT04724837|584845487|FG002|Overall Study|Study Terminated by Sponsor|0|||
161943673|NCT04222673|584845488|FG000|Overall Study|Lost to Follow-up|5|||
161943674|NCT04251533|584845489|FG000|Overall Study|Progressive disease|33|||
161943675|NCT04251533|584845490|FG001|Overall Study|Progressive disease|29|||
161832296|NCT04146363|584428385|FG002|Induction Period|Positive quantiferon test|0|||
161832297|NCT04146363|584428386|FG003|Induction Period|Positive quantiferon test|0|||
161832298|NCT04146363|584428387|FG004|Induction Period|Positive quantiferon test|0|||
161832299|NCT04146363|584428388|FG005|Induction Period|Positive quantiferon test|0|||
161832300|NCT04146363|584428389|FG006|Induction Period|Positive quantiferon test|0|||
161832301|NCT04146363|584428390|FG007|Induction Period|Positive quantiferon test|0|||
161832302|NCT04146363|584428391|FG008|Induction Period|Positive quantiferon test|0|||
161832303|NCT04146363|584428392|FG009|Induction Period|Positive quantiferon test|0|||
161832304|NCT04146363|584428393|FG010|Induction Period|Positive quantiferon test|0|||
161832305|NCT04146363|584428383|FG000|Induction Period|Protocol Deviation|5|||
161832306|NCT04146363|584428384|FG001|Induction Period|Protocol Deviation|6|||
161832307|NCT04146363|584428385|FG002|Induction Period|Protocol Deviation|0|||
161832308|NCT04146363|584428386|FG003|Induction Period|Protocol Deviation|0|||
161832309|NCT04146363|584428387|FG004|Induction Period|Protocol Deviation|0|||
161832310|NCT04146363|584428388|FG005|Induction Period|Protocol Deviation|0|||
161832311|NCT04146363|584428389|FG006|Induction Period|Protocol Deviation|0|||
161943676|NCT04251533|584845491|FG002|Overall Study|Progressive disease|22|||
161943677|NCT04251533|584845489|FG000|Overall Study|Death|5|||
161683385|NCT05879107|583892961|FG000|Overall Study|Death|0|||
161683386|NCT05879107|583892962|FG001|Overall Study|Death|2|||
161683387|NCT05879107|583892961|FG000|Overall Study|Other|0|||
161683388|NCT05879107|583892962|FG001|Overall Study|Other|3|||
161683389|NCT03901079|583892963|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
161683390|NCT00916149|583892964|FG000|Overall Study|Lost to Follow-up|3|||
161683391|NCT00916149|583892965|FG001|Overall Study|Lost to Follow-up|2|||
161683392|NCT00916149|583892966|FG002|Overall Study|Lost to Follow-up|0|||
161683393|NCT00916149|583892964|FG000|Overall Study|Unable to place scalp EEG leads|1|||
161683394|NCT00916149|583892965|FG001|Overall Study|Unable to place scalp EEG leads|0|||
161683395|NCT00916149|583892966|FG002|Overall Study|Unable to place scalp EEG leads|0|||
161683396|NCT00545298|583892967|FG000|Overall Study|Issues with Standard of Care|2|||
161683397|NCT00545298|583892968|FG001|Overall Study|Issues with Standard of Care|0|||
161683398|NCT00545298|583892969|FG002|Overall Study|Issues with Standard of Care|1|||
161683399|NCT00978029|583892970|FG000|Overall Study|Adverse Event|1|||
161683400|NCT00978029|583892971|FG001|Overall Study|Adverse Event|2|||
161683401|NCT00978029|583892972|FG002|Overall Study|Adverse Event|5|||
161683402|NCT00978029|583892970|FG000|Overall Study|Withdrawal by Subject|0|||
161683403|NCT00978029|583892971|FG001|Overall Study|Withdrawal by Subject|0|||
161683404|NCT00978029|583892972|FG002|Overall Study|Withdrawal by Subject|1|||
161683405|NCT00978029|583892970|FG000|Overall Study|Protocol Violation|0|||
161683406|NCT00978029|583892971|FG001|Overall Study|Protocol Violation|1|||
161683407|NCT00978029|583892972|FG002|Overall Study|Protocol Violation|0|||
161683408|NCT01820364|583892973|FG000|Part I: LGX818|Death|1|||
161683409|NCT01820364|583892974|FG001|Part I: LGX818|Death|0|||
161683410|NCT01820364|583892973|FG000|Part I: LGX818|Administrative Problems|3|||
161832312|NCT04146363|584428390|FG007|Induction Period|Protocol Deviation|0|||
161943678|NCT04251533|584845490|FG001|Overall Study|Death|1|||
161943679|NCT04251533|584845491|FG002|Overall Study|Death|3|||
161943680|NCT04251533|584845489|FG000|Overall Study|Physician Decision|3|||
161943681|NCT04251533|584845490|FG001|Overall Study|Physician Decision|2|||
161943682|NCT04251533|584845491|FG002|Overall Study|Physician Decision|4|||
161943683|NCT04251533|584845489|FG000|Overall Study|Participant decision|1|||
161943684|NCT04251533|584845490|FG001|Overall Study|Participant decision|3|||
161943685|NCT04251533|584845491|FG002|Overall Study|Participant decision|1|||
161943686|NCT04251533|584845489|FG000|Overall Study|Adverse Event|2|||
161943687|NCT04251533|584845490|FG001|Overall Study|Adverse Event|1|||
161943688|NCT04251533|584845491|FG002|Overall Study|Adverse Event|1|||
161943689|NCT02420717|584845498|FG000|Overall Study|Did not receive all study medication|2|||
161943690|NCT02420717|584845499|FG001|Overall Study|Did not receive all study medication|0|||
161943691|NCT02420717|584845500|FG002|Overall Study|Did not receive all study medication|0|||
161943692|NCT03138564|584845501|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
161943693|NCT03138564|584845502|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
161943694|NCT03138564|584845501|FG000|Overall Study|Lost to Follow-up|16|||
161943695|NCT03138564|584845502|FG001|Overall Study|Lost to Follow-up|2|||
161943696|NCT03138564|584845501|FG000|Overall Study|Withdrawal by Subject|48|||
161943697|NCT03138564|584845502|FG001|Overall Study|Withdrawal by Subject|4|||
161943698|NCT03138564|584845501|FG000|Overall Study|No longer met eligibility criteria|2|||
161943699|NCT03138564|584845502|FG001|Overall Study|No longer met eligibility criteria|0|||
161943700|NCT03138564|584845501|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
161943701|NCT03138564|584845502|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
161943702|NCT03138564|584845501|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
161943703|NCT03138564|584845502|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
161943704|NCT03138564|584845501|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
161943705|NCT03138564|584845502|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
161943706|NCT03138564|584845501|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
161943707|NCT03138564|584845502|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
161943708|NCT05177354|584845504|FG000|Implant to 30-day Visit|Physician Decision|1|||
161943709|NCT05177354|584845504|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
161943710|NCT05177354|584845504|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
161943711|NCT05177354|584845504|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
161943712|NCT02936323|584845505|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
161943713|NCT02936323|584845506|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
161943714|NCT02936323|584845507|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
161943715|NCT02936323|584845508|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
161943716|NCT02936323|584845509|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
161943717|NCT02936323|584845510|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
161943718|NCT02936323|584845511|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
161943719|NCT02936323|584845512|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
161943720|NCT02936323|584845513|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
161943721|NCT02936323|584845514|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
161943722|NCT02936323|584845505|FG000|Phase 1 Dose Escalation|Death|2|||
161943723|NCT02936323|584845506|FG001|Phase 1 Dose Escalation|Death|1|||
161943724|NCT02936323|584845507|FG002|Phase 1 Dose Escalation|Death|3|||
161943725|NCT02936323|584845508|FG003|Phase 1 Dose Escalation|Death|1|||
161943726|NCT02936323|584845509|FG004|Phase 1 Dose Escalation|Death|2|||
161943727|NCT02936323|584845510|FG005|Phase 1 Dose Escalation|Death|3|||
161943728|NCT02936323|584845511|FG006|Phase 1 Dose Escalation|Death|3|||
161943729|NCT02936323|584845512|FG007|Phase 1 Dose Escalation|Death|0|||
161943730|NCT02936323|584845513|FG008|Phase 1 Dose Escalation|Death|0|||
161943731|NCT02936323|584845514|FG009|Phase 1 Dose Escalation|Death|0|||
161943732|NCT02936323|584845505|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161943733|NCT02936323|584845506|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161943734|NCT02936323|584845507|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161943735|NCT02936323|584845508|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161943736|NCT02936323|584845509|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161943737|NCT02936323|584845510|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
161943738|NCT02936323|584845511|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161943739|NCT02936323|584845512|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161943740|NCT02936323|584845513|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161943741|NCT02936323|584845514|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
161943742|NCT02936323|584845505|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161943743|NCT02936323|584845506|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161943744|NCT02936323|584845507|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161943745|NCT02936323|584845508|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161943746|NCT02936323|584845509|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161943747|NCT02936323|584845510|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161943748|NCT02936323|584845511|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161943749|NCT02936323|584845512|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
161943750|NCT02936323|584845513|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
161943751|NCT02936323|584845514|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
161943752|NCT02936323|584845505|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
161943753|NCT02936323|584845506|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
161943754|NCT02936323|584845507|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
161943755|NCT02936323|584845508|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
161943756|NCT02936323|584845509|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
161943757|NCT02936323|584845510|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
161943758|NCT02936323|584845511|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
161943759|NCT02936323|584845512|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
161943760|NCT02936323|584845513|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
161943761|NCT02936323|584845514|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
161943762|NCT02936323|584845505|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161943763|NCT02936323|584845506|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161943764|NCT02936323|584845507|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161943765|NCT02936323|584845508|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161943766|NCT02936323|584845509|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161943767|NCT02936323|584845510|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161943768|NCT02936323|584845511|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161943769|NCT02936323|584845512|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
161943770|NCT02936323|584845513|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
161943771|NCT02936323|584845514|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
161943772|NCT02936323|584845505|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161943773|NCT02936323|584845506|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161943774|NCT02936323|584845507|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161943775|NCT02936323|584845508|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
162026736|NCT00422084|585154409|FG001|Overall Study|Withdrawn from study accidentally|0|||
161683411|NCT01820364|583892974|FG001|Part I: LGX818|Administrative Problems|0|||
161683412|NCT01820364|583892973|FG000|Part I: LGX818|Adverse Event|6|||
161683413|NCT01820364|583892974|FG001|Part I: LGX818|Adverse Event|0|||
161683414|NCT01820364|583892973|FG000|Part I: LGX818|Disease Progression|4|||
161943776|NCT02936323|584845509|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161943777|NCT02936323|584845510|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161943778|NCT02936323|584845511|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161943779|NCT02936323|584845512|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161683415|NCT01820364|583892974|FG001|Part I: LGX818|Disease Progression|0|||
161683416|NCT01820364|583892973|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
161683417|NCT01820364|583892974|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
161683418|NCT01087775|583892975|FG000|Overall Study|failed inclusion criteria|2|||
161683419|NCT02090413|583892980|FG000|Overall Study|Adverse Event|11|||
161683420|NCT02090413|583892981|FG001|Overall Study|Adverse Event|15|||
161683421|NCT02090413|583892982|FG002|Overall Study|Adverse Event|20|||
161683422|NCT02090413|583892980|FG000|Overall Study|Flushing event|2|||
161683423|NCT02090413|583892981|FG001|Overall Study|Flushing event|0|||
161683424|NCT02090413|583892982|FG002|Overall Study|Flushing event|1|||
161683425|NCT02090413|583892980|FG000|Overall Study|Withdrawal by Subject|2|||
161683426|NCT02090413|583892981|FG001|Overall Study|Withdrawal by Subject|2|||
161683427|NCT02090413|583892982|FG002|Overall Study|Withdrawal by Subject|2|||
161683428|NCT02090413|583892980|FG000|Overall Study|Investigator Decision|1|||
161683429|NCT02090413|583892981|FG001|Overall Study|Investigator Decision|1|||
161683430|NCT02090413|583892982|FG002|Overall Study|Investigator Decision|0|||
161683431|NCT02090413|583892980|FG000|Overall Study|Other|2|||
161683432|NCT02090413|583892981|FG001|Overall Study|Other|1|||
161683433|NCT02090413|583892982|FG002|Overall Study|Other|0|||
161683434|NCT02090413|583892980|FG000|Overall Study|Lost to Follow-up|1|||
161683435|NCT02090413|583892981|FG001|Overall Study|Lost to Follow-up|1|||
161683436|NCT02090413|583892982|FG002|Overall Study|Lost to Follow-up|0|||
161683437|NCT05248295|583892983|FG000|Overall Study|found ineligible|4|||
161683438|NCT05248295|583892984|FG001|Overall Study|found ineligible|1|||
161683439|NCT05248295|583892983|FG000|Overall Study|Withdrawal by Subject|0|||
161683440|NCT05248295|583892984|FG001|Overall Study|Withdrawal by Subject|1|||
161683441|NCT05248295|583892983|FG000|Overall Study|Data loss: audio recording error|1|||
161683442|NCT05248295|583892984|FG001|Overall Study|Data loss: audio recording error|1|||
161683443|NCT04490018|583892985|FG000|Overall Study|Protocol Violation|0|||
161683444|NCT04490018|583892986|FG001|Overall Study|Protocol Violation|2|||
161683445|NCT04490018|583892987|FG002|Overall Study|Protocol Violation|1|||
161683446|NCT04490018|583892985|FG000|Overall Study|Lost to Follow-up|2|||
161683447|NCT04490018|583892986|FG001|Overall Study|Lost to Follow-up|2|||
161683448|NCT04490018|583892987|FG002|Overall Study|Lost to Follow-up|0|||
161683449|NCT04490018|583892985|FG000|Overall Study|Withdrawal by Subject|2|||
161683450|NCT04490018|583892986|FG001|Overall Study|Withdrawal by Subject|1|||
161683451|NCT04490018|583892987|FG002|Overall Study|Withdrawal by Subject|0|||
161683452|NCT04490018|583892985|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161683453|NCT04490018|583892986|FG001|Overall Study|Withdrawal by parent/guardian|3|||
161683454|NCT04490018|583892987|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161683455|NCT02321930|583892988|FG000|Overall Study|Lost to Follow-up|1|||
161683456|NCT01293968|583892989|FG000|Overall Study|non-cooperation|3|||
161683457|NCT01293968|583892990|FG001|Overall Study|non-cooperation|3|||
161683458|NCT01484977|583892991|FG000|Overall Study|Adverse Event|8|||
161683459|NCT01484977|583892991|FG000|Overall Study|Lack of Efficacy|4|||
161683460|NCT01484977|583892991|FG000|Overall Study|Protocol Violation|6|||
161683461|NCT01484977|583892991|FG000|Overall Study|Lost to Follow-up|1|||
161683462|NCT01484977|583892991|FG000|Overall Study|Withdrawal by Subject|4|||
161683463|NCT01484977|583892991|FG000|Overall Study|Subject Protocol Non-compliant|1|||
162026737|NCT00422084|585154408|FG000|Overall Study|Non-compliance|1|||
161683464|NCT01484977|583892991|FG000|Overall Study|Moving Overseas|1|||
161683465|NCT01484977|583892991|FG000|Overall Study|Low White Blood Cell Count|1|||
161683466|NCT01484977|583892991|FG000|Overall Study|Lack of Compliance|1|||
161683467|NCT01133379|583892992|FG000|Overall Study|Withdrawal by Subject|0|||
161683468|NCT01133379|583892993|FG001|Overall Study|Withdrawal by Subject|1|||
161943780|NCT02936323|584845513|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
161943781|NCT02936323|584845514|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
161943782|NCT02936323|584845505|FG000|Phase 2a Dose Expansion|Death|0|||
162026738|NCT00422084|585154409|FG001|Overall Study|Non-compliance|0|||
162026739|NCT00422084|585154408|FG000|Overall Study|Re-location|0|||
162026740|NCT00422084|585154409|FG001|Overall Study|Re-location|1|||
162026741|NCT00422084|585154408|FG000|Overall Study|Not defined|1|||
162026742|NCT00422084|585154409|FG001|Overall Study|Not defined|1|||
162026743|NCT03774823|585154412|FG000|Overall Study|Withdrawal by Subject|1|||
162026744|NCT03774823|585154413|FG001|Overall Study|Withdrawal by Subject|1|||
162026745|NCT03996369|585154420|FG000|Overall Study|Protocol deviation|1|||
162026746|NCT03996369|585154421|FG001|Overall Study|Protocol deviation|1|||
161943783|NCT02936323|584845506|FG001|Phase 2a Dose Expansion|Death|0|||
161943784|NCT02936323|584845507|FG002|Phase 2a Dose Expansion|Death|0|||
162026747|NCT03996369|585154420|FG000|Overall Study|Physician Decision|4|||
162026748|NCT03996369|585154421|FG001|Overall Study|Physician Decision|2|||
161943785|NCT02936323|584845508|FG003|Phase 2a Dose Expansion|Death|0|||
161943786|NCT02936323|584845509|FG004|Phase 2a Dose Expansion|Death|0|||
161943787|NCT02936323|584845510|FG005|Phase 2a Dose Expansion|Death|0|||
161943788|NCT02936323|584845511|FG006|Phase 2a Dose Expansion|Death|0|||
161943789|NCT02936323|584845512|FG007|Phase 2a Dose Expansion|Death|4|||
161943790|NCT02936323|584845513|FG008|Phase 2a Dose Expansion|Death|8|||
161943791|NCT02936323|584845514|FG009|Phase 2a Dose Expansion|Death|10|||
161943792|NCT00643279|584845517|FG000|Overall Study|Death|13|||
161943793|NCT00643279|584845518|FG001|Overall Study|Death|11|||
161943794|NCT00643279|584845517|FG000|Overall Study|Withdrawal by Subject|3|||
161943795|NCT00643279|584845518|FG001|Overall Study|Withdrawal by Subject|0|||
161943796|NCT00643279|584845517|FG000|Overall Study|Lost to Follow-up|0|||
161943797|NCT00643279|584845518|FG001|Overall Study|Lost to Follow-up|1|||
161943798|NCT00643279|584845517|FG000|Overall Study|Physician Decision|0|||
162026749|NCT03996369|585154420|FG000|Overall Study|Participant decision|0|||
162026750|NCT03996369|585154421|FG001|Overall Study|Participant decision|1|||
162026751|NCT03996369|585154420|FG000|Overall Study|Lack of Efficacy|4|||
162026752|NCT03996369|585154421|FG001|Overall Study|Lack of Efficacy|0|||
162026753|NCT03996369|585154420|FG000|Overall Study|Adverse Event|9|||
162026754|NCT03996369|585154421|FG001|Overall Study|Adverse Event|0|||
162026755|NCT03996369|585154420|FG000|Overall Study|Withdrawal by Subject|6|||
162026756|NCT03996369|585154421|FG001|Overall Study|Withdrawal by Subject|8|||
162026757|NCT03996369|585154420|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
162026758|NCT03996369|585154421|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
162026759|NCT03996369|585154420|FG000|Overall Study|Lost to Follow-up|0|||
162026760|NCT03996369|585154421|FG001|Overall Study|Lost to Follow-up|1|||
162026761|NCT01579812|585154422|FG000|Overall Study|Ineligible after treatment start|40|||
162026762|NCT01579812|585154422|FG000|Overall Study|Patient choice|3|||
161943799|NCT00643279|584845518|FG001|Overall Study|Physician Decision|1|||
161943800|NCT06272383|584845519|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
161943801|NCT06272383|584845520|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
161943802|NCT05715827|584845521|FG000|Overall Study|Physician Decision|0|||
161943803|NCT05715827|584845522|FG001|Overall Study|Physician Decision|1|||
162026763|NCT01579812|585154422|FG000|Overall Study|Noncompliance|3|||
162026764|NCT01579812|585154422|FG000|Overall Study|Withdrawal by Subject|6|||
161943804|NCT05715827|584845521|FG000|Overall Study|console communication error|0|||
161943805|NCT05715827|584845522|FG001|Overall Study|console communication error|1|||
161943806|NCT04846868|584845523|FG000|Overall Study|Adverse Event|12|||
161943807|NCT04846868|584845524|FG001|Overall Study|Adverse Event|11|||
161943808|NCT04846868|584845523|FG000|Overall Study|Protocol deviation|6|||
161943809|NCT04846868|584845524|FG001|Overall Study|Protocol deviation|2|||
161943810|NCT04846868|584845523|FG000|Overall Study|Perceived lack of efficacy|3|||
161943811|NCT04846868|584845524|FG001|Overall Study|Perceived lack of efficacy|2|||
161943812|NCT04846868|584845523|FG000|Overall Study|Change of residence|2|||
161832313|NCT04146363|584428391|FG008|Induction Period|Protocol Deviation|0|||
161832314|NCT04146363|584428392|FG009|Induction Period|Protocol Deviation|0|||
161832315|NCT04146363|584428393|FG010|Induction Period|Protocol Deviation|0|||
161832316|NCT04146363|584428383|FG000|Induction Period|Withdrawal by Subject|6|||
161943813|NCT04846868|584845524|FG001|Overall Study|Change of residence|3|||
161943814|NCT04846868|584845523|FG000|Overall Study|Burden of study procedures|1|||
161943815|NCT04846868|584845524|FG001|Overall Study|Burden of study procedures|1|||
161943816|NCT04846868|584845523|FG000|Overall Study|No reason available|2|||
161943817|NCT04846868|584845524|FG001|Overall Study|No reason available|5|||
161943818|NCT04846868|584845523|FG000|Overall Study|Other reason listed|20|||
161943819|NCT04846868|584845524|FG001|Overall Study|Other reason listed|10|||
161943820|NCT04846868|584845523|FG000|Overall Study|Not treated|0|||
161943821|NCT04846868|584845524|FG001|Overall Study|Not treated|1|||
161943822|NCT04398706|584845525|FG000|Overall Study|Adverse Event|0|||
161943823|NCT04398706|584845526|FG001|Overall Study|Adverse Event|0|||
161683469|NCT01133379|583892994|FG002|Overall Study|Withdrawal by Subject|1|||
161683470|NCT01133379|583892992|FG000|Overall Study|Lost to Follow-up|1|||
161943824|NCT04398706|584845527|FG002|Overall Study|Adverse Event|0|||
161683471|NCT01133379|583892993|FG001|Overall Study|Lost to Follow-up|1|||
161943825|NCT04398706|584845528|FG003|Overall Study|Adverse Event|0|||
161943826|NCT04398706|584845529|FG004|Overall Study|Adverse Event|0|||
161943827|NCT04398706|584845530|FG005|Overall Study|Adverse Event|1|||
161943828|NCT04398706|584845531|FG006|Overall Study|Adverse Event|1|||
161943829|NCT04398706|584845532|FG007|Overall Study|Adverse Event|0|||
161943830|NCT04398706|584845525|FG000|Overall Study|Lost to Follow-up|0|||
161943831|NCT04398706|584845526|FG001|Overall Study|Lost to Follow-up|1|||
161943832|NCT04398706|584845527|FG002|Overall Study|Lost to Follow-up|2|||
161943833|NCT04398706|584845528|FG003|Overall Study|Lost to Follow-up|1|||
161943834|NCT04398706|584845529|FG004|Overall Study|Lost to Follow-up|6|||
161943835|NCT04398706|584845530|FG005|Overall Study|Lost to Follow-up|3|||
161943836|NCT04398706|584845531|FG006|Overall Study|Lost to Follow-up|8|||
161943837|NCT04398706|584845532|FG007|Overall Study|Lost to Follow-up|2|||
161943838|NCT04398706|584845525|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161943839|NCT04398706|584845526|FG001|Overall Study|Withdrawal by parent/guardian|2|||
161943840|NCT04398706|584845527|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161943841|NCT04398706|584845528|FG003|Overall Study|Withdrawal by parent/guardian|2|||
161943842|NCT04398706|584845529|FG004|Overall Study|Withdrawal by parent/guardian|19|||
161943843|NCT04398706|584845530|FG005|Overall Study|Withdrawal by parent/guardian|23|||
161943844|NCT04398706|584845531|FG006|Overall Study|Withdrawal by parent/guardian|13|||
161943845|NCT04398706|584845532|FG007|Overall Study|Withdrawal by parent/guardian|11|||
161943846|NCT04398706|584845525|FG000|Overall Study|Protocol deviation|0|||
161943847|NCT04398706|584845526|FG001|Overall Study|Protocol deviation|1|||
161943848|NCT04398706|584845527|FG002|Overall Study|Protocol deviation|0|||
161943849|NCT04398706|584845528|FG003|Overall Study|Protocol deviation|0|||
161943850|NCT04398706|584845529|FG004|Overall Study|Protocol deviation|6|||
161943851|NCT04398706|584845530|FG005|Overall Study|Protocol deviation|4|||
161943852|NCT04398706|584845531|FG006|Overall Study|Protocol deviation|6|||
161943853|NCT04398706|584845532|FG007|Overall Study|Protocol deviation|3|||
161943854|NCT04890509|584845533|FG000|Overall Study|Death|4|||
161943855|NCT04890509|584845534|FG001|Overall Study|Death|4|||
161943856|NCT04116853|584845535|FG000|Overall Study|Adverse Event|1|||
161943857|NCT04116853|584845536|FG001|Overall Study|Adverse Event|3|||
161943858|NCT04116853|584845535|FG000|Overall Study|Lost to Follow-up|2|||
161943859|NCT04116853|584845536|FG001|Overall Study|Lost to Follow-up|0|||
162026765|NCT00653432|585154423|FG000|Overall Study|Adverse Event|4|||
162026766|NCT00653432|585154424|FG001|Overall Study|Adverse Event|1|||
162026767|NCT00653432|585154423|FG000|Overall Study|Withdrawal by Subject|4|||
162026768|NCT00653432|585154424|FG001|Overall Study|Withdrawal by Subject|5|||
162026769|NCT00653432|585154423|FG000|Overall Study|Lost to Follow-up|7|||
161683472|NCT01133379|583892994|FG002|Overall Study|Lost to Follow-up|1|||
161943860|NCT04116853|584845535|FG000|Overall Study|Incarceration|0|||
161943861|NCT04116853|584845536|FG001|Overall Study|Incarceration|1|||
161943862|NCT04116853|584845535|FG000|Overall Study|Pregnancy|1|||
161943863|NCT04116853|584845536|FG001|Overall Study|Pregnancy|1|||
161943864|NCT04116853|584845535|FG000|Overall Study|Began Other Weight Loss program|4|||
161943865|NCT04116853|584845536|FG001|Overall Study|Began Other Weight Loss program|8|||
162026770|NCT00653432|585154424|FG001|Overall Study|Lost to Follow-up|6|||
161943866|NCT04116853|584845535|FG000|Overall Study|Began Anti-Obesity Medication|3|||
161943867|NCT04116853|584845536|FG001|Overall Study|Began Anti-Obesity Medication|3|||
161943868|NCT04116853|584845535|FG000|Overall Study|Protocol Violation|0|||
161943869|NCT04116853|584845536|FG001|Overall Study|Protocol Violation|1|||
161943870|NCT03274466|584845537|FG000|Overall Study|Withdrawal by Subject|7|||
161943871|NCT03274466|584845538|FG001|Overall Study|Withdrawal by Subject|3|||
161943872|NCT03274466|584845537|FG000|Overall Study|Protocol Specified Withdrawal|5|||
161943873|NCT03274466|584845538|FG001|Overall Study|Protocol Specified Withdrawal|11|||
161943874|NCT03274466|584845537|FG000|Overall Study|Lost to Follow-up|5|||
161943875|NCT03274466|584845538|FG001|Overall Study|Lost to Follow-up|7|||
161943876|NCT03274466|584845537|FG000|Overall Study|Subject Non-compliance|0|||
161943877|NCT03274466|584845538|FG001|Overall Study|Subject Non-compliance|1|||
161943878|NCT03274466|584845537|FG000|Overall Study|Adverse Event|3|||
161943879|NCT03274466|584845538|FG001|Overall Study|Adverse Event|3|||
161943880|NCT03274466|584845537|FG000|Overall Study|Physician Decision|0|||
161943881|NCT03274466|584845538|FG001|Overall Study|Physician Decision|1|||
161943882|NCT03274466|584845537|FG000|Overall Study|Protocol Violation|3|||
161943883|NCT03274466|584845538|FG001|Overall Study|Protocol Violation|3|||
161943884|NCT01083602|584847452|FG000|Overall Study|Adverse Event|11|||
161943885|NCT01083602|584847452|FG000|Overall Study|New Cancer Therapy|2|||
161943886|NCT01083602|584847452|FG000|Overall Study|Death|1|||
161943887|NCT01083602|584847452|FG000|Overall Study|Withdrawal by Subject|5|||
161943888|NCT01083602|584847452|FG000|Overall Study|Lack of Efficacy|36|||
161943889|NCT01657370|584847453|FG000|Overall Study|Withdrawal by Subject|0|||
161943890|NCT01657370|584847454|FG001|Overall Study|Withdrawal by Subject|0|||
161943891|NCT01657370|584847455|FG002|Overall Study|Withdrawal by Subject|1|||
161943892|NCT01657370|584847456|FG003|Overall Study|Withdrawal by Subject|0|||
161943893|NCT01657370|584847457|FG004|Overall Study|Withdrawal by Subject|0|||
161943894|NCT01657370|584847458|FG005|Overall Study|Withdrawal by Subject|1|||
161943895|NCT01657370|584847453|FG000|Overall Study|Physician Decision|2|||
161943896|NCT01657370|584847454|FG001|Overall Study|Physician Decision|3|||
161943897|NCT01657370|584847455|FG002|Overall Study|Physician Decision|1|||
161943898|NCT01657370|584847456|FG003|Overall Study|Physician Decision|2|||
161943899|NCT01657370|584847457|FG004|Overall Study|Physician Decision|5|||
161943900|NCT01657370|584847458|FG005|Overall Study|Physician Decision|0|||
161943901|NCT01657370|584847453|FG000|Overall Study|Lack of Qualifying Event|1|||
161943902|NCT01657370|584847454|FG001|Overall Study|Lack of Qualifying Event|0|||
161943903|NCT01657370|584847455|FG002|Overall Study|Lack of Qualifying Event|3|||
161943904|NCT01657370|584847456|FG003|Overall Study|Lack of Qualifying Event|2|||
161943905|NCT01657370|584847457|FG004|Overall Study|Lack of Qualifying Event|1|||
161683473|NCT03996876|583892999|FG000|Overall Study|Incomplete Data|2|||
161943906|NCT01657370|584847458|FG005|Overall Study|Lack of Qualifying Event|2|||
161943907|NCT01657370|584847453|FG000|Overall Study|Adverse Event|0|||
161943908|NCT01657370|584847454|FG001|Overall Study|Adverse Event|0|||
161943909|NCT01657370|584847455|FG002|Overall Study|Adverse Event|0|||
161943910|NCT01657370|584847456|FG003|Overall Study|Adverse Event|0|||
161943911|NCT01657370|584847457|FG004|Overall Study|Adverse Event|1|||
161943912|NCT01657370|584847458|FG005|Overall Study|Adverse Event|0|||
161943913|NCT01657370|584847453|FG000|Overall Study|Protocol Violation|1|||
161943914|NCT01657370|584847454|FG001|Overall Study|Protocol Violation|1|||
161943915|NCT01657370|584847455|FG002|Overall Study|Protocol Violation|1|||
161943916|NCT01657370|584847456|FG003|Overall Study|Protocol Violation|1|||
161943917|NCT01657370|584847457|FG004|Overall Study|Protocol Violation|0|||
161943918|NCT01657370|584847458|FG005|Overall Study|Protocol Violation|0|||
161943919|NCT01657370|584847453|FG000|Overall Study|Lost to Follow-up|2|||
161943920|NCT01657370|584847454|FG001|Overall Study|Lost to Follow-up|0|||
161943921|NCT01657370|584847455|FG002|Overall Study|Lost to Follow-up|1|||
161943922|NCT01657370|584847456|FG003|Overall Study|Lost to Follow-up|0|||
161943923|NCT01657370|584847457|FG004|Overall Study|Lost to Follow-up|0|||
161943924|NCT01657370|584847458|FG005|Overall Study|Lost to Follow-up|1|||
161943925|NCT01819272|584847459|FG000|Overall Study|Adverse Event|1|||
161943926|NCT01819272|584847460|FG001|Overall Study|Adverse Event|0|||
161943927|NCT01819272|584847461|FG002|Overall Study|Adverse Event|0|||
161943928|NCT01819272|584847462|FG003|Overall Study|Adverse Event|2|||
161943929|NCT01819272|584847463|FG004|Overall Study|Adverse Event|0|||
161943930|NCT01819272|584847464|FG005|Overall Study|Adverse Event|0|||
161943931|NCT01819272|584847459|FG000|Overall Study|Lost to Follow-up|3|||
161943932|NCT01819272|584847460|FG001|Overall Study|Lost to Follow-up|0|||
161943933|NCT01819272|584847461|FG002|Overall Study|Lost to Follow-up|1|||
161943934|NCT01819272|584847462|FG003|Overall Study|Lost to Follow-up|0|||
161943935|NCT01819272|584847463|FG004|Overall Study|Lost to Follow-up|0|||
161943936|NCT01819272|584847464|FG005|Overall Study|Lost to Follow-up|3|||
161943937|NCT01819272|584847459|FG000|Overall Study|Protocol Violation|0|||
161943938|NCT01819272|584847460|FG001|Overall Study|Protocol Violation|0|||
161943939|NCT01819272|584847461|FG002|Overall Study|Protocol Violation|0|||
161943940|NCT01819272|584847462|FG003|Overall Study|Protocol Violation|1|||
161943941|NCT01819272|584847463|FG004|Overall Study|Protocol Violation|2|||
161943942|NCT01819272|584847464|FG005|Overall Study|Protocol Violation|3|||
161943943|NCT01819272|584847459|FG000|Overall Study|Physician Decision|0|||
161943944|NCT01819272|584847460|FG001|Overall Study|Physician Decision|1|||
161943945|NCT01819272|584847461|FG002|Overall Study|Physician Decision|0|||
161943946|NCT01819272|584847462|FG003|Overall Study|Physician Decision|0|||
161943947|NCT01819272|584847463|FG004|Overall Study|Physician Decision|0|||
161943948|NCT01819272|584847464|FG005|Overall Study|Physician Decision|0|||
161943949|NCT01819272|584847459|FG000|Overall Study|Withdrawal of Consent|0|||
161943950|NCT01819272|584847460|FG001|Overall Study|Withdrawal of Consent|1|||
161943951|NCT01819272|584847461|FG002|Overall Study|Withdrawal of Consent|2|||
161943952|NCT01819272|584847462|FG003|Overall Study|Withdrawal of Consent|1|||
161943953|NCT01819272|584847463|FG004|Overall Study|Withdrawal of Consent|0|||
161943954|NCT01819272|584847464|FG005|Overall Study|Withdrawal of Consent|1|||
161943955|NCT01819272|584847459|FG000|Overall Study|Loss of Glucose Control|2|||
161943956|NCT01819272|584847460|FG001|Overall Study|Loss of Glucose Control|1|||
161943957|NCT01819272|584847461|FG002|Overall Study|Loss of Glucose Control|0|||
161943958|NCT01819272|584847462|FG003|Overall Study|Loss of Glucose Control|1|||
161943959|NCT01819272|584847463|FG004|Overall Study|Loss of Glucose Control|2|||
161943960|NCT01819272|584847464|FG005|Overall Study|Loss of Glucose Control|0|||
161943961|NCT03021486|584847465|FG000|Overall Study|Withdrawal by Subject|1|||
161943962|NCT03021486|584847466|FG001|Overall Study|Withdrawal by Subject|1|||
161943963|NCT03021486|584847467|FG002|Overall Study|Withdrawal by Subject|3|||
161943964|NCT03021486|584847465|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
161943965|NCT03021486|584847466|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
161943966|NCT03021486|584847467|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
161943967|NCT01732536|584847468|FG000|Overall Study|Withdrawal by Subject|1|||
161943968|NCT01732536|584847469|FG001|Overall Study|Withdrawal by Subject|1|||
161943969|NCT03376516|584847472|FG000|Overall Study|Not treated|1|||
161943970|NCT03376516|584847472|FG000|Overall Study|Consent withdrawn|1|||
161943971|NCT01581684|584847473|FG000|Overall Study|Other reason not defined|0|||
162026771|NCT00653432|585154423|FG000|Overall Study|Use/Need of Con Therapy|2|||
161943972|NCT01581684|584847474|FG001|Overall Study|Other reason not defined|0|||
161943973|NCT01581684|584847475|FG002|Overall Study|Other reason not defined|0|||
161943974|NCT01581684|584847476|FG003|Overall Study|Other reason not defined|0|||
161943975|NCT01581684|584847477|FG004|Overall Study|Other reason not defined|0|||
161943976|NCT01581684|584847478|FG005|Overall Study|Other reason not defined|0|||
161943977|NCT01581684|584847479|FG006|Overall Study|Other reason not defined|0|||
161943978|NCT01581684|584847480|FG007|Overall Study|Other reason not defined|0|||
161943979|NCT01581684|584847481|FG008|Overall Study|Other reason not defined|1|||
161943980|NCT01581684|584847482|FG009|Overall Study|Other reason not defined|0|||
161683474|NCT03996876|583893000|FG001|Overall Study|Incomplete Data|4|||
161943981|NCT02986074|584847483|FG000|First Trial Period|Adverse Event|1|||
161683475|NCT00121108|583893001|FG000|Overall Study|Lost to Follow-up|10|||
161683476|NCT00121108|583893002|FG001|Overall Study|Lost to Follow-up|22|||
161683477|NCT00121108|583893001|FG000|Overall Study|Withdrawal by Subject|106|||
161943982|NCT02986074|584847484|FG001|First Trial Period|Adverse Event|0|||
161943983|NCT02986074|584847485|FG002|First Trial Period|Adverse Event|0|||
161683478|NCT00121108|583893002|FG001|Overall Study|Withdrawal by Subject|195|||
161683479|NCT00121108|583893001|FG000|Overall Study|Death|5|||
161683480|NCT00121108|583893002|FG001|Overall Study|Death|8|||
161683481|NCT00597753|583893009|FG000|Overall Study|Adverse Event|6|||
161683482|NCT00597753|583893010|FG001|Overall Study|Adverse Event|2|||
161683483|NCT00597753|583893009|FG000|Overall Study|Death|55|||
161683484|NCT00597753|583893010|FG001|Overall Study|Death|29|||
161683485|NCT00597753|583893009|FG000|Overall Study|Lack of Efficacy|2|||
161943984|NCT02986074|584847486|FG003|First Trial Period|Adverse Event|0|||
161943985|NCT02986074|584847483|FG000|Follow up Period|system explant|0|||
161832317|NCT04146363|584428384|FG001|Induction Period|Withdrawal by Subject|3|||
161832318|NCT04146363|584428385|FG002|Induction Period|Withdrawal by Subject|0|||
161832319|NCT04146363|584428386|FG003|Induction Period|Withdrawal by Subject|0|||
161832320|NCT04146363|584428387|FG004|Induction Period|Withdrawal by Subject|0|||
161832321|NCT04146363|584428388|FG005|Induction Period|Withdrawal by Subject|0|||
161832322|NCT04146363|584428389|FG006|Induction Period|Withdrawal by Subject|0|||
161832323|NCT04146363|584428390|FG007|Induction Period|Withdrawal by Subject|0|||
161832324|NCT04146363|584428391|FG008|Induction Period|Withdrawal by Subject|0|||
161832325|NCT04146363|584428392|FG009|Induction Period|Withdrawal by Subject|0|||
161832326|NCT04146363|584428393|FG010|Induction Period|Withdrawal by Subject|0|||
161832327|NCT04146363|584428383|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
161832328|NCT04146363|584428384|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
161832329|NCT04146363|584428385|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
161832330|NCT04146363|584428386|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
161832331|NCT04146363|584428387|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
161683486|NCT00597753|583893010|FG001|Overall Study|Lack of Efficacy|0|||
161832332|NCT04146363|584428388|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
162026772|NCT00653432|585154424|FG001|Overall Study|Use/Need of Con Therapy|1|||
162026773|NCT00653432|585154423|FG000|Overall Study|Other - Reason Not Provided|5|||
162026774|NCT00653432|585154424|FG001|Overall Study|Other - Reason Not Provided|3|||
162026775|NCT01782469|585154425|FG000|Overall Study|Lost to Follow-up|1|||
162026776|NCT00357760|585154426|FG000|Overall Study|Disease progression|44|||
162026777|NCT00357760|585154427|FG001|Overall Study|Disease progression|17|||
162026778|NCT00357760|585154426|FG000|Overall Study|Adverse Event|10|||
162026779|NCT00357760|585154427|FG001|Overall Study|Adverse Event|7|||
162026780|NCT00357760|585154426|FG000|Overall Study|Death|0|||
162026781|NCT00357760|585154427|FG001|Overall Study|Death|3|||
162026782|NCT00357760|585154426|FG000|Overall Study|Alternative therapy|1|||
162026783|NCT00357760|585154427|FG001|Overall Study|Alternative therapy|0|||
162026784|NCT00357760|585154426|FG000|Overall Study|Withdrawal by Subject|0|||
162026785|NCT00357760|585154427|FG001|Overall Study|Withdrawal by Subject|2|||
162026786|NCT00357760|585154426|FG000|Overall Study|Never started treatment|2|||
162026787|NCT00357760|585154427|FG001|Overall Study|Never started treatment|1|||
162026788|NCT00357760|585154426|FG000|Overall Study|Ineligible|0|||
162026789|NCT00357760|585154427|FG001|Overall Study|Ineligible|2|||
162026790|NCT00357760|585154426|FG000|Overall Study|Physician Decision|2|||
162026791|NCT00357760|585154427|FG001|Overall Study|Physician Decision|1|||
162026792|NCT00357760|585154426|FG000|Overall Study|Protocol Violation|0|||
162026793|NCT00357760|585154427|FG001|Overall Study|Protocol Violation|1|||
162026794|NCT00357760|585154426|FG000|Overall Study|To receive hospice care|0|||
162026795|NCT00357760|585154427|FG001|Overall Study|To receive hospice care|1|||
162026796|NCT02353143|585154428|FG000|Overall Study|Withdrawal by Subject|1|||
162026797|NCT02353143|585154429|FG001|Overall Study|Withdrawal by Subject|0|||
162026798|NCT02353143|585154430|FG002|Overall Study|Withdrawal by Subject|0|||
161683487|NCT00597753|583893009|FG000|Overall Study|Lost to Follow-up|10|||
161683488|NCT00597753|583893010|FG001|Overall Study|Lost to Follow-up|3|||
161683489|NCT00597753|583893009|FG000|Overall Study|Physician Decision|5|||
161683490|NCT00597753|583893010|FG001|Overall Study|Physician Decision|1|||
161683491|NCT00597753|583893009|FG000|Overall Study|Pregnancy|1|||
161683492|NCT00597753|583893010|FG001|Overall Study|Pregnancy|0|||
161683493|NCT00597753|583893009|FG000|Overall Study|Withdrawal by Subject|35|||
161683494|NCT00597753|583893010|FG001|Overall Study|Withdrawal by Subject|12|||
161683495|NCT00597753|583893009|FG000|Overall Study|Discontinued Dialysis|0|||
161683496|NCT00597753|583893010|FG001|Overall Study|Discontinued Dialysis|1|||
161683497|NCT00597753|583893009|FG000|Overall Study|Never dosed|2|||
161683498|NCT00597753|583893010|FG001|Overall Study|Never dosed|0|||
161683499|NCT00597753|583893009|FG000|Overall Study|Noncompliance|2|||
161683500|NCT00597753|583893010|FG001|Overall Study|Noncompliance|1|||
161683501|NCT00597753|583893009|FG000|Overall Study|Relocation|17|||
161683502|NCT00597753|583893010|FG001|Overall Study|Relocation|6|||
161683503|NCT00597753|583893009|FG000|Overall Study|Renal transplant|10|||
161683504|NCT00597753|583893010|FG001|Overall Study|Renal transplant|3|||
161683505|NCT00597753|583893009|FG000|Overall Study|Site closed by sponsor|19|||
161683506|NCT00597753|583893010|FG001|Overall Study|Site closed by sponsor|7|||
161683507|NCT00597753|583893009|FG000|Overall Study|Site elected to close|2|||
161683508|NCT00597753|583893010|FG001|Overall Study|Site elected to close|4|||
161683509|NCT01652885|583894585|FG000|Overall Study|Adverse Event|1|||
161683510|NCT03723707|583894586|FG000|Overall Study|Death|32|||
161683511|NCT03723707|583894587|FG001|Overall Study|Death|32|||
161683512|NCT03723707|583894586|FG000|Overall Study|Admitted to long term care|12|||
161683513|NCT03723707|583894587|FG001|Overall Study|Admitted to long term care|12|||
161683514|NCT03723707|583894586|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
161683515|NCT03723707|583894587|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
161683516|NCT03723707|583894586|FG000|Overall Study|Lost to Follow-up|40|||
161683517|NCT03723707|583894587|FG001|Overall Study|Lost to Follow-up|22|||
161683518|NCT03723707|583894586|FG000|Overall Study|Discontinued after study closure|24|||
161683519|NCT03723707|583894587|FG001|Overall Study|Discontinued after study closure|12|||
161683520|NCT00075023|583894588|FG000|Pilot Study|Physician Decision|1|||
161683521|NCT00075023|583894589|FG001|Pilot Study|Physician Decision|2|||
161683522|NCT00075023|583894588|FG000|Pilot Study|Withdrawal by Subject|1|||
161683523|NCT00075023|583894589|FG001|Pilot Study|Withdrawal by Subject|0|||
161683524|NCT04342871|583894590|FG000|Overall Study|Death|4|||
161683525|NCT04342871|583894590|FG000|Overall Study|Clinical deterioration/illness progression|2|||
161683526|NCT04342871|583894590|FG000|Overall Study|Did not complete baseline assessments|5|||
161683527|NCT04342871|583894590|FG000|Overall Study|Lost to Follow-up|13|||
161683528|NCT01429584|583894592|FG000|Overall Study|Withdrawal by Subject|1|||
161683529|NCT01429584|583894593|FG001|Overall Study|Withdrawal by Subject|0|||
161683530|NCT01429584|583894592|FG000|Overall Study|Protocol Violation|0|||
161683531|NCT01429584|583894593|FG001|Overall Study|Protocol Violation|1|||
161683532|NCT00750698|583894597|FG000|Overall Study|Withdrawal by Subject|1|||
162026799|NCT02353143|585154431|FG003|Overall Study|Withdrawal by Subject|0|||
161683533|NCT00750698|583894598|FG001|Overall Study|Withdrawal by Subject|0|||
162026800|NCT02353143|585154432|FG004|Overall Study|Withdrawal by Subject|1|||
162026801|NCT02353143|585154433|FG005|Overall Study|Withdrawal by Subject|0|||
162026802|NCT02353143|585154434|FG006|Overall Study|Withdrawal by Subject|0|||
162026803|NCT02353143|585154435|FG007|Overall Study|Withdrawal by Subject|1|||
162026804|NCT02353143|585154436|FG008|Overall Study|Withdrawal by Subject|1|||
162026805|NCT02353143|585154428|FG000|Overall Study|Lack of Efficacy|2|||
162026806|NCT02353143|585154429|FG001|Overall Study|Lack of Efficacy|1|||
162026807|NCT02353143|585154430|FG002|Overall Study|Lack of Efficacy|2|||
162026808|NCT02353143|585154431|FG003|Overall Study|Lack of Efficacy|4|||
162026809|NCT02353143|585154432|FG004|Overall Study|Lack of Efficacy|13|||
162026810|NCT02353143|585154433|FG005|Overall Study|Lack of Efficacy|2|||
162026811|NCT02353143|585154434|FG006|Overall Study|Lack of Efficacy|2|||
162026812|NCT02353143|585154435|FG007|Overall Study|Lack of Efficacy|2|||
162026813|NCT02353143|585154436|FG008|Overall Study|Lack of Efficacy|1|||
162026814|NCT02353143|585154428|FG000|Overall Study|reason not specified|1|||
162026815|NCT02353143|585154429|FG001|Overall Study|reason not specified|2|||
162026816|NCT02353143|585154430|FG002|Overall Study|reason not specified|0|||
162026817|NCT02353143|585154431|FG003|Overall Study|reason not specified|0|||
161683534|NCT00750698|583894597|FG000|Overall Study|Progressive disease|5|||
161683535|NCT00750698|583894598|FG001|Overall Study|Progressive disease|2|||
161683536|NCT01417195|583894599|FG000|Overall Study|Stimulation failure|1|||
161683537|NCT01417195|583894600|FG001|Overall Study|Stimulation failure|0|||
161683538|NCT01417195|583894599|FG000|Overall Study|No embryos for transfer|0|||
161683539|NCT01417195|583894600|FG001|Overall Study|No embryos for transfer|1|||
161683540|NCT01417195|583894599|FG000|Overall Study|No transfer due to risk of OHSS|1|||
161683541|NCT01417195|583894600|FG001|Overall Study|No transfer due to risk of OHSS|0|||
161683542|NCT01417195|583894599|FG000|Overall Study|No transfer due to elevated progesterone|1|||
161683543|NCT01417195|583894600|FG001|Overall Study|No transfer due to elevated progesterone|0|||
161683544|NCT04766021|583894601|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
161683545|NCT04766021|583894601|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
161943986|NCT02986074|584847484|FG001|Follow up Period|system explant|0|||
161943987|NCT02986074|584847485|FG002|Follow up Period|system explant|1|||
161943988|NCT02986074|584847486|FG003|Follow up Period|system explant|2|||
161943989|NCT02986074|584847483|FG000|Follow up Period|Physician Decision|0|||
161943990|NCT02986074|584847484|FG001|Follow up Period|Physician Decision|0|||
161943991|NCT02986074|584847485|FG002|Follow up Period|Physician Decision|0|||
161943992|NCT02986074|584847486|FG003|Follow up Period|Physician Decision|1|||
161943993|NCT03186638|584847489|FG000|Overall Study|Withdrawal by Subject|4|||
161943994|NCT03186638|584847490|FG001|Overall Study|Withdrawal by Subject|4|||
161943995|NCT03186638|584847489|FG000|Overall Study|Withdrawn due to medical problem|3|||
161943996|NCT03186638|584847490|FG001|Overall Study|Withdrawn due to medical problem|2|||
161943997|NCT03186638|584847489|FG000|Overall Study|Lost to Follow-up|1|||
161943998|NCT03186638|584847490|FG001|Overall Study|Lost to Follow-up|0|||
161943999|NCT04099277|584847491|FG000|Overall Study|Physician Decision|1|||
161944000|NCT04099277|584847491|FG000|Overall Study|Withdrawal by Subject|1|||
161944001|NCT01029535|584847494|FG000|Overall Study|Lost to Follow-up|24|||
161944002|NCT01029535|584847494|FG000|Overall Study|Protocol Violation|2|||
161944003|NCT01029535|584847494|FG000|Overall Study|Participant Withdrew Consent|2|||
161944004|NCT01029535|584847494|FG000|Overall Study|Adverse Event|1|||
161944005|NCT01029535|584847494|FG000|Overall Study|Use of Another Treatment|1|||
161944006|NCT01029535|584847494|FG000|Overall Study|Death|1|||
161944007|NCT00524121|584847495|FG000|Overall Study|Disease progression|6|||
161944008|NCT00524121|584847495|FG000|Overall Study|Adverse Event|4|||
161944009|NCT00524121|584847495|FG000|Overall Study|Patient refused|2|||
161944010|NCT00524121|584847495|FG000|Overall Study|Other|1|||
161683546|NCT02257372|583894604|FG000|Overall Study|Adverse Event|3|||
161944011|NCT00524121|584847495|FG000|Overall Study|Death|1|||
162026818|NCT02353143|585154432|FG004|Overall Study|reason not specified|6|||
162026819|NCT02353143|585154433|FG005|Overall Study|reason not specified|1|||
162026820|NCT02353143|585154434|FG006|Overall Study|reason not specified|0|||
161944012|NCT00524121|584847495|FG000|Overall Study|Not treated (became ineligible)|4|||
161944013|NCT00524121|584847495|FG000|Overall Study|Not treated (changed mind)|1|||
161944014|NCT02410772|584847501|FG000|Overall Study|Death|3|||
161944015|NCT02410772|584847502|FG001|Overall Study|Death|4|||
161944016|NCT02410772|584847503|FG002|Overall Study|Death|8|||
161944017|NCT02410772|584847501|FG000|Overall Study|Lost to Follow-up|31|||
161944018|NCT02410772|584847502|FG001|Overall Study|Lost to Follow-up|23|||
161944019|NCT02410772|584847503|FG002|Overall Study|Lost to Follow-up|22|||
161944020|NCT02410772|584847501|FG000|Overall Study|Pregnancy|8|||
161944021|NCT02410772|584847502|FG001|Overall Study|Pregnancy|4|||
161944022|NCT02410772|584847503|FG002|Overall Study|Pregnancy|5|||
161944023|NCT02410772|584847501|FG000|Overall Study|Protocol Violation|8|||
161944024|NCT02410772|584847502|FG001|Overall Study|Protocol Violation|8|||
161944025|NCT02410772|584847503|FG002|Overall Study|Protocol Violation|4|||
161944026|NCT02410772|584847501|FG000|Overall Study|Baseline Drug Resistance|49|||
161944027|NCT02410772|584847502|FG001|Overall Study|Baseline Drug Resistance|40|||
161944028|NCT02410772|584847503|FG002|Overall Study|Baseline Drug Resistance|51|||
161944029|NCT02410772|584847501|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
161944030|NCT02410772|584847502|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
161944031|NCT02410772|584847503|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
161944032|NCT02410772|584847501|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
161944033|NCT02410772|584847502|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
161944034|NCT02410772|584847503|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
161944035|NCT01870869|584847508|FG000|Overall Study|Implanted with nonstudy device|1|||
161944036|NCT01870869|584847509|FG001|Overall Study|Implanted with nonstudy device|3|||
161944037|NCT01870869|584847510|FG002|Overall Study|Implanted with nonstudy device|14|||
161944038|NCT01870869|584847511|FG003|Overall Study|Implanted with nonstudy device|4|||
161944039|NCT01870869|584847508|FG000|Overall Study|Death|0|||
161944040|NCT01870869|584847509|FG001|Overall Study|Death|0|||
161944041|NCT01870869|584847510|FG002|Overall Study|Death|7|||
161944042|NCT01870869|584847511|FG003|Overall Study|Death|1|||
161944043|NCT01870869|584847508|FG000|Overall Study|Subject choice|6|||
161944044|NCT01870869|584847509|FG001|Overall Study|Subject choice|2|||
161944045|NCT01870869|584847510|FG002|Overall Study|Subject choice|22|||
161944046|NCT01870869|584847511|FG003|Overall Study|Subject choice|8|||
161944047|NCT01870869|584847508|FG000|Overall Study|Lost to Follow-up|10|||
161944048|NCT01870869|584847509|FG001|Overall Study|Lost to Follow-up|2|||
161944049|NCT01870869|584847510|FG002|Overall Study|Lost to Follow-up|25|||
161944050|NCT01870869|584847511|FG003|Overall Study|Lost to Follow-up|3|||
161944051|NCT01870869|584847508|FG000|Overall Study|Reason not Specified|1|||
161944052|NCT01870869|584847509|FG001|Overall Study|Reason not Specified|2|||
161944053|NCT01870869|584847510|FG002|Overall Study|Reason not Specified|20|||
161944054|NCT01870869|584847511|FG003|Overall Study|Reason not Specified|4|||
161944055|NCT01870869|584847508|FG000|Overall Study|Not evaluable|10|||
161944056|NCT01870869|584847509|FG001|Overall Study|Not evaluable|5|||
161944057|NCT01870869|584847510|FG002|Overall Study|Not evaluable|42|||
161944058|NCT01870869|584847511|FG003|Overall Study|Not evaluable|10|||
161944059|NCT00904371|584847512|FG000|Overall Study|Adverse Event|2|||
161944060|NCT00904371|584847512|FG000|Overall Study|Lost to Follow-up|4|||
161944061|NCT00904371|584847512|FG000|Overall Study|Discontinued at target blood pressure|2|||
161944062|NCT00904371|584847512|FG000|Overall Study|Continued with Tritace|1|||
161944063|NCT00419744|584847515|FG000|Overall Study|Adverse Event|39|||
161944064|NCT00419744|584847516|FG001|Overall Study|Adverse Event|40|||
161944065|NCT00419744|584847517|FG002|Overall Study|Adverse Event|50|||
161944066|NCT00419744|584847515|FG000|Overall Study|Withdrawal by Subject|45|||
161944067|NCT00419744|584847516|FG001|Overall Study|Withdrawal by Subject|49|||
161944068|NCT00419744|584847517|FG002|Overall Study|Withdrawal by Subject|52|||
161944069|NCT00419744|584847515|FG000|Overall Study|Lost to Follow-up|8|||
161944070|NCT00419744|584847516|FG001|Overall Study|Lost to Follow-up|10|||
161944071|NCT00419744|584847517|FG002|Overall Study|Lost to Follow-up|6|||
161944072|NCT00419744|584847515|FG000|Overall Study|Protocol Violation|4|||
161944073|NCT00419744|584847516|FG001|Overall Study|Protocol Violation|7|||
161944074|NCT00419744|584847517|FG002|Overall Study|Protocol Violation|8|||
161944075|NCT00419744|584847515|FG000|Overall Study|Randomized in error|9|||
161944076|NCT00419744|584847516|FG001|Overall Study|Randomized in error|6|||
161944077|NCT00419744|584847517|FG002|Overall Study|Randomized in error|7|||
161944078|NCT00419744|584847515|FG000|Overall Study|Moving out of state|2|||
161944079|NCT00419744|584847516|FG001|Overall Study|Moving out of state|0|||
161944080|NCT00419744|584847517|FG002|Overall Study|Moving out of state|1|||
161944081|NCT00419744|584847515|FG000|Overall Study|Physician Decision|10|||
161944082|NCT00419744|584847516|FG001|Overall Study|Physician Decision|5|||
162026821|NCT02353143|585154435|FG007|Overall Study|reason not specified|3|||
162026822|NCT02353143|585154436|FG008|Overall Study|reason not specified|1|||
161683547|NCT02257372|583894605|FG001|Overall Study|Adverse Event|7|||
161944083|NCT00419744|584847517|FG002|Overall Study|Physician Decision|6|||
161944084|NCT00419744|584847515|FG000|Overall Study|Spirometry mouthpiece issues|0|||
161944085|NCT00419744|584847516|FG001|Overall Study|Spirometry mouthpiece issues|1|||
161944086|NCT00419744|584847517|FG002|Overall Study|Spirometry mouthpiece issues|2|||
161944087|NCT00419744|584847515|FG000|Overall Study|Incorrect medication kit dispensed|0|||
161944088|NCT00419744|584847516|FG001|Overall Study|Incorrect medication kit dispensed|0|||
161944089|NCT00419744|584847517|FG002|Overall Study|Incorrect medication kit dispensed|1|||
161944090|NCT00583219|584847520|FG000|Phase 2|Withdrawal by Subject|1|||
161944091|NCT00754572|584847521|FG000|Overall Study|Adverse Event|19|||
161944092|NCT00754572|584847521|FG000|Overall Study|Other|39|||
161944093|NCT00754572|584847521|FG000|Overall Study|Protocol Violation|3|||
161944094|NCT00754572|584847521|FG000|Overall Study|Withdrawal by Subject|3|||
161944095|NCT00754572|584847521|FG000|Overall Study|Lack of Efficacy|2|||
162026823|NCT02353143|585154428|FG000|Overall Study|Physician Decision|0|||
161944096|NCT00754572|584847521|FG000|Overall Study|Death|1|||
161683548|NCT02257372|583894604|FG000|Overall Study|Lack of Efficacy|2|||
161683549|NCT02257372|583894605|FG001|Overall Study|Lack of Efficacy|1|||
161683550|NCT02257372|583894604|FG000|Overall Study|Protocol Violation|1|||
161683551|NCT02257372|583894605|FG001|Overall Study|Protocol Violation|1|||
161683552|NCT02257372|583894604|FG000|Overall Study|Lost to Follow-up|0|||
161683553|NCT02257372|583894605|FG001|Overall Study|Lost to Follow-up|1|||
161683554|NCT02257372|583894604|FG000|Overall Study|Withdrew consent|1|||
162026824|NCT02353143|585154429|FG001|Overall Study|Physician Decision|4|||
162026825|NCT02353143|585154430|FG002|Overall Study|Physician Decision|2|||
161683555|NCT02257372|583894605|FG001|Overall Study|Withdrew consent|0|||
161683556|NCT02634151|583894606|FG000|Overall Study|Withdrawal by Subject|1|||
162026826|NCT02353143|585154431|FG003|Overall Study|Physician Decision|3|||
161683557|NCT02634151|583894607|FG001|Overall Study|Withdrawal by Subject|0|||
161944097|NCT00754572|584847521|FG000|Overall Study|Administrative Reason|3|||
161944098|NCT00754572|584847521|FG000|Overall Study|Lost to Follow-up|1|||
161944099|NCT00718315|584847522|FG000|Overall Study|Adverse Event|1|||
161944100|NCT00718315|584847523|FG001|Overall Study|Adverse Event|2|||
161944101|NCT00718315|584847524|FG002|Overall Study|Adverse Event|3|||
161944102|NCT00718315|584847522|FG000|Overall Study|Death|6|||
161944103|NCT00718315|584847523|FG001|Overall Study|Death|6|||
161944104|NCT00718315|584847524|FG002|Overall Study|Death|5|||
161944105|NCT00718315|584847522|FG000|Overall Study|Lost to Follow-up|2|||
161683558|NCT02634151|583894606|FG000|Overall Study|Non-Compliance|0|||
161683559|NCT02634151|583894607|FG001|Overall Study|Non-Compliance|1|||
161944106|NCT00718315|584847523|FG001|Overall Study|Lost to Follow-up|3|||
161944107|NCT00718315|584847524|FG002|Overall Study|Lost to Follow-up|4|||
161944108|NCT00718315|584847522|FG000|Overall Study|Protocol Violation|5|||
161683560|NCT02634151|583894606|FG000|Overall Study|Other|0|||
161944109|NCT00718315|584847523|FG001|Overall Study|Protocol Violation|5|||
161683561|NCT02634151|583894607|FG001|Overall Study|Other|1|||
161944110|NCT00718315|584847524|FG002|Overall Study|Protocol Violation|3|||
161683562|NCT00003535|583894609|FG000|Overall Study|Not evaluable|5|||
161944111|NCT00718315|584847522|FG000|Overall Study|Erlotinib dose decreased|4|||
161944112|NCT00718315|584847523|FG001|Overall Study|Erlotinib dose decreased|3|||
161944113|NCT00718315|584847524|FG002|Overall Study|Erlotinib dose decreased|1|||
161944114|NCT00718315|584847522|FG000|Overall Study|Use of Minocyclin|1|||
161683563|NCT02347098|583894610|FG000|Overall Study|Death|1|||
161944115|NCT00718315|584847523|FG001|Overall Study|Use of Minocyclin|1|||
161944116|NCT00718315|584847524|FG002|Overall Study|Use of Minocyclin|1|||
161683564|NCT02347098|583894611|FG001|Overall Study|Death|0|||
161683565|NCT02347098|583894610|FG000|Overall Study|Withdrawal by Subject|1|||
161683566|NCT02347098|583894611|FG001|Overall Study|Withdrawal by Subject|0|||
161683567|NCT02347098|583894610|FG000|Overall Study|Lost to Follow-up|2|||
161683568|NCT02347098|583894611|FG001|Overall Study|Lost to Follow-up|2|||
161683569|NCT02347098|583894610|FG000|Overall Study|Refuse Follow-up Visit|1|||
161683570|NCT02347098|583894611|FG001|Overall Study|Refuse Follow-up Visit|5|||
161683571|NCT02347098|583894610|FG000|Overall Study|no visit due to illness|2|||
161683572|NCT02347098|583894611|FG001|Overall Study|no visit due to illness|1|||
161683573|NCT00530894|583894612|FG000|Overall Study|Death|84|||
161832333|NCT04146363|584428389|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
161832334|NCT04146363|584428390|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
161683574|NCT00530894|583894613|FG001|Overall Study|Death|89|||
161683575|NCT00530894|583894614|FG002|Overall Study|Death|55|||
161832335|NCT04146363|584428391|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
161683576|NCT00530894|583894615|FG003|Overall Study|Death|89|||
161683577|NCT00530894|583894612|FG000|Overall Study|Lost to Follow-up|1|||
161683578|NCT00530894|583894613|FG001|Overall Study|Lost to Follow-up|3|||
161683579|NCT00530894|583894614|FG002|Overall Study|Lost to Follow-up|0|||
161683580|NCT00530894|583894615|FG003|Overall Study|Lost to Follow-up|0|||
161832336|NCT04146363|584428392|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
161944117|NCT00718315|584847522|FG000|Overall Study|Disease progression|0|||
161683581|NCT00530894|583894612|FG000|Overall Study|Withdrawal by Subject|1|||
161944118|NCT00718315|584847523|FG001|Overall Study|Disease progression|1|||
161944119|NCT00718315|584847524|FG002|Overall Study|Disease progression|1|||
161944120|NCT00718315|584847522|FG000|Overall Study|Other|0|||
161944121|NCT00718315|584847523|FG001|Overall Study|Other|0|||
161944122|NCT00718315|584847524|FG002|Overall Study|Other|1|||
161944123|NCT00718315|584847522|FG000|Overall Study|Use of ATB and Corticoids|0|||
162026827|NCT02353143|585154432|FG004|Overall Study|Physician Decision|4|||
161944124|NCT00718315|584847523|FG001|Overall Study|Use of ATB and Corticoids|1|||
161944125|NCT00718315|584847524|FG002|Overall Study|Use of ATB and Corticoids|2|||
161944126|NCT00673920|584847527|FG000|Baseline up to Week 48|Withdrew consent|1|||
161944127|NCT00673920|584847528|FG001|Baseline up to Week 48|Withdrew consent|0|||
161944128|NCT00673920|584847529|FG002|Baseline up to Week 48|Withdrew consent|2|||
161944129|NCT00673920|584847530|FG003|Baseline up to Week 48|Withdrew consent|0|||
161944130|NCT00673920|584847531|FG004|Baseline up to Week 48|Withdrew consent|0|||
161944131|NCT00673920|584847532|FG005|Baseline up to Week 48|Withdrew consent|0|||
161944132|NCT00673920|584847533|FG006|Baseline up to Week 48|Withdrew consent|0|||
161944133|NCT00673920|584847534|FG007|Baseline up to Week 48|Withdrew consent|0|||
161944134|NCT00673920|584847527|FG000|Baseline up to Week 48|Refused treatment|1|||
161944135|NCT00673920|584847528|FG001|Baseline up to Week 48|Refused treatment|0|||
161944136|NCT00673920|584847529|FG002|Baseline up to Week 48|Refused treatment|0|||
161944137|NCT00673920|584847530|FG003|Baseline up to Week 48|Refused treatment|0|||
161944138|NCT00673920|584847531|FG004|Baseline up to Week 48|Refused treatment|0|||
161944139|NCT00673920|584847532|FG005|Baseline up to Week 48|Refused treatment|0|||
161944140|NCT00673920|584847533|FG006|Baseline up to Week 48|Refused treatment|0|||
161944141|NCT00673920|584847534|FG007|Baseline up to Week 48|Refused treatment|0|||
161944142|NCT00673920|584847527|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
161944143|NCT00673920|584847528|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
161944144|NCT00673920|584847529|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
161944145|NCT00673920|584847530|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
161944146|NCT00673920|584847531|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
161944147|NCT00673920|584847532|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
161944148|NCT00673920|584847533|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
161944149|NCT00673920|584847534|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
161944150|NCT00673920|584847527|FG000|Baseline up to Week 48|Protocol Violation|0|||
162026828|NCT02353143|585154433|FG005|Overall Study|Physician Decision|0|||
161944151|NCT00673920|584847528|FG001|Baseline up to Week 48|Protocol Violation|0|||
161944152|NCT00673920|584847529|FG002|Baseline up to Week 48|Protocol Violation|1|||
161944153|NCT00673920|584847530|FG003|Baseline up to Week 48|Protocol Violation|0|||
161944154|NCT00673920|584847531|FG004|Baseline up to Week 48|Protocol Violation|0|||
161944155|NCT00673920|584847532|FG005|Baseline up to Week 48|Protocol Violation|0|||
161944156|NCT00673920|584847533|FG006|Baseline up to Week 48|Protocol Violation|0|||
161944157|NCT00673920|584847534|FG007|Baseline up to Week 48|Protocol Violation|0|||
162026829|NCT02353143|585154434|FG006|Overall Study|Physician Decision|1|||
161944158|NCT00673920|584847527|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161944159|NCT00673920|584847528|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161944160|NCT00673920|584847529|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
161944161|NCT00673920|584847530|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161944162|NCT00673920|584847531|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161944163|NCT00673920|584847532|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161944164|NCT00673920|584847533|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161944165|NCT00673920|584847534|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
161944166|NCT00673920|584847527|FG000|Baseline up to Week 48|Administrative/Other|0|||
161944167|NCT00673920|584847528|FG001|Baseline up to Week 48|Administrative/Other|1|||
161944168|NCT00673920|584847529|FG002|Baseline up to Week 48|Administrative/Other|2|||
161944169|NCT00673920|584847530|FG003|Baseline up to Week 48|Administrative/Other|0|||
161944170|NCT00673920|584847531|FG004|Baseline up to Week 48|Administrative/Other|0|||
161944171|NCT00673920|584847532|FG005|Baseline up to Week 48|Administrative/Other|0|||
161944172|NCT00673920|584847533|FG006|Baseline up to Week 48|Administrative/Other|0|||
161944173|NCT00673920|584847534|FG007|Baseline up to Week 48|Administrative/Other|0|||
161944174|NCT00673920|584847527|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
161944175|NCT00673920|584847528|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
161944176|NCT00673920|584847529|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
161944177|NCT00673920|584847530|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
161944178|NCT00673920|584847531|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
161944179|NCT00673920|584847532|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
161944180|NCT00673920|584847533|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
161944181|NCT00673920|584847534|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
161944182|NCT00673920|584847527|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
161944183|NCT00673920|584847528|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
161944184|NCT00673920|584847529|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
161944185|NCT00673920|584847530|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
162026830|NCT02353143|585154435|FG007|Overall Study|Physician Decision|2|||
162026831|NCT02353143|585154436|FG008|Overall Study|Physician Decision|0|||
162026832|NCT02353143|585154428|FG000|Overall Study|Adverse Event|0|||
161683582|NCT00530894|583894613|FG001|Overall Study|Withdrawal by Subject|23|||
161683583|NCT00530894|583894614|FG002|Overall Study|Withdrawal by Subject|0|||
161944186|NCT00673920|584847531|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
161944187|NCT00673920|584847532|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
161944188|NCT00673920|584847533|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
161944189|NCT00673920|584847534|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
162026833|NCT02353143|585154429|FG001|Overall Study|Adverse Event|0|||
162026834|NCT02353143|585154430|FG002|Overall Study|Adverse Event|1|||
161944190|NCT00673920|584847527|FG000|Week 24 to Week 48|Failure to return|0|||
161944191|NCT00673920|584847528|FG001|Week 24 to Week 48|Failure to return|0|||
161944192|NCT00673920|584847529|FG002|Week 24 to Week 48|Failure to return|0|||
161944193|NCT00673920|584847530|FG003|Week 24 to Week 48|Failure to return|0|||
161944194|NCT00673920|584847531|FG004|Week 24 to Week 48|Failure to return|0|||
161944195|NCT00673920|584847532|FG005|Week 24 to Week 48|Failure to return|1|||
161683584|NCT00530894|583894615|FG003|Overall Study|Withdrawal by Subject|5|||
161683585|NCT00530894|583894612|FG000|Overall Study|Alive and censored prior to 1 year|2|||
161683586|NCT00530894|583894613|FG001|Overall Study|Alive and censored prior to 1 year|0|||
161683587|NCT00530894|583894614|FG002|Overall Study|Alive and censored prior to 1 year|0|||
161683588|NCT00530894|583894615|FG003|Overall Study|Alive and censored prior to 1 year|0|||
161944196|NCT00673920|584847533|FG006|Week 24 to Week 48|Failure to return|0|||
161944197|NCT00673920|584847534|FG007|Week 24 to Week 48|Failure to return|0|||
161944198|NCT00673920|584847527|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
161944199|NCT00673920|584847528|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
161944200|NCT00673920|584847529|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
161944201|NCT00673920|584847530|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
161944202|NCT00673920|584847531|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
161944203|NCT00673920|584847532|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
161944204|NCT00673920|584847533|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
161944205|NCT00673920|584847534|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
161944206|NCT00673920|584847527|FG000|Week 24 to Week 48|Death|0|||
161944207|NCT00673920|584847528|FG001|Week 24 to Week 48|Death|0|||
161944208|NCT00673920|584847529|FG002|Week 24 to Week 48|Death|0|||
161944209|NCT00673920|584847530|FG003|Week 24 to Week 48|Death|0|||
161944210|NCT00673920|584847531|FG004|Week 24 to Week 48|Death|0|||
161944211|NCT00673920|584847532|FG005|Week 24 to Week 48|Death|1|||
161944212|NCT00673920|584847533|FG006|Week 24 to Week 48|Death|0|||
161944213|NCT00673920|584847534|FG007|Week 24 to Week 48|Death|0|||
161944214|NCT00673920|584847527|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
161944215|NCT00673920|584847528|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
161944216|NCT00673920|584847529|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
161944217|NCT00673920|584847530|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
161944218|NCT00673920|584847531|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
161944219|NCT00673920|584847532|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
161944220|NCT00673920|584847533|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
161944221|NCT00673920|584847534|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
161944222|NCT02493764|584847535|FG000|Overall Study|Adverse Event|2|||
161944223|NCT02493764|584847536|FG001|Overall Study|Adverse Event|2|||
161944224|NCT02493764|584847535|FG000|Overall Study|Death|44|||
161944225|NCT02493764|584847536|FG001|Overall Study|Death|58|||
161944226|NCT02493764|584847535|FG000|Overall Study|Lost to Follow-up|2|||
161944227|NCT02493764|584847536|FG001|Overall Study|Lost to Follow-up|1|||
161944228|NCT02493764|584847535|FG000|Overall Study|Protocol Violation|6|||
161944229|NCT02493764|584847536|FG001|Overall Study|Protocol Violation|7|||
161944230|NCT02493764|584847535|FG000|Overall Study|Physician Decision|1|||
161944231|NCT02493764|584847536|FG001|Overall Study|Physician Decision|1|||
161944232|NCT02493764|584847535|FG000|Overall Study|Participant moved|17|||
161944233|NCT02493764|584847536|FG001|Overall Study|Participant moved|5|||
161944234|NCT02493764|584847535|FG000|Overall Study|Withdrawal parent/guardian|0|||
161944235|NCT02493764|584847536|FG001|Overall Study|Withdrawal parent/guardian|1|||
161944236|NCT02493764|584847535|FG000|Overall Study|Withdrawal by Subject|11|||
161944237|NCT02493764|584847536|FG001|Overall Study|Withdrawal by Subject|7|||
161944238|NCT01463527|584847537|FG000|Overall Study|Protocol Violation|1|||
161944239|NCT01463527|584847538|FG001|Overall Study|Protocol Violation|1|||
161944240|NCT01463527|584847537|FG000|Overall Study|Crying >20% of sedation|5|||
161944241|NCT01463527|584847538|FG001|Overall Study|Crying >20% of sedation|6|||
161944242|NCT04846231|584847539|FG000|Overall Study|Lost to Follow-up|1|||
161944243|NCT04846231|584847540|FG001|Overall Study|Lost to Follow-up|0|||
161944244|NCT04846231|584847541|FG002|Overall Study|Lost to Follow-up|0|||
161944245|NCT04846231|584847542|FG003|Overall Study|Lost to Follow-up|0|||
161944246|NCT04846231|584847543|FG004|Overall Study|Lost to Follow-up|0|||
161944247|NCT04846231|584847544|FG005|Overall Study|Lost to Follow-up|0|||
161944248|NCT04846231|584847545|FG006|Overall Study|Lost to Follow-up|0|||
161944249|NCT04846231|584847546|FG007|Overall Study|Lost to Follow-up|1|||
161944250|NCT04846231|584847539|FG000|Overall Study|Withdrawal by Subject|0|||
161944251|NCT04846231|584847540|FG001|Overall Study|Withdrawal by Subject|1|||
161944252|NCT04846231|584847541|FG002|Overall Study|Withdrawal by Subject|2|||
161944253|NCT04846231|584847542|FG003|Overall Study|Withdrawal by Subject|1|||
161944254|NCT04846231|584847543|FG004|Overall Study|Withdrawal by Subject|0|||
161944255|NCT04846231|584847544|FG005|Overall Study|Withdrawal by Subject|0|||
161944256|NCT04846231|584847545|FG006|Overall Study|Withdrawal by Subject|0|||
161944257|NCT04846231|584847546|FG007|Overall Study|Withdrawal by Subject|0|||
161944258|NCT04846231|584847539|FG000|Overall Study|Protocol Violation|0|||
161944259|NCT04846231|584847540|FG001|Overall Study|Protocol Violation|1|||
161944260|NCT04846231|584847541|FG002|Overall Study|Protocol Violation|0|||
161944261|NCT04846231|584847542|FG003|Overall Study|Protocol Violation|0|||
161944262|NCT04846231|584847543|FG004|Overall Study|Protocol Violation|0|||
161944263|NCT04846231|584847544|FG005|Overall Study|Protocol Violation|0|||
161944264|NCT04846231|584847545|FG006|Overall Study|Protocol Violation|0|||
161944265|NCT04846231|584847546|FG007|Overall Study|Protocol Violation|0|||
161944266|NCT04846231|584847539|FG000|Overall Study|Adverse Event|0|||
161944267|NCT04846231|584847540|FG001|Overall Study|Adverse Event|0|||
161944268|NCT04846231|584847541|FG002|Overall Study|Adverse Event|0|||
161944269|NCT04846231|584847542|FG003|Overall Study|Adverse Event|0|||
161944270|NCT04846231|584847543|FG004|Overall Study|Adverse Event|0|||
161944271|NCT04846231|584847544|FG005|Overall Study|Adverse Event|0|||
161944272|NCT04846231|584847545|FG006|Overall Study|Adverse Event|1|||
161944273|NCT04846231|584847546|FG007|Overall Study|Adverse Event|1|||
161944274|NCT02836249|584847549|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161944275|NCT02836249|584847550|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
161944276|NCT02836249|584847551|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161944277|NCT02836249|584847552|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161944278|NCT02836249|584847549|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
161944279|NCT02836249|584847550|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
161944280|NCT02836249|584847551|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
161944281|NCT02836249|584847552|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
161944282|NCT02836249|584847549|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
161944283|NCT02836249|584847550|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
161944284|NCT02836249|584847551|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
161944285|NCT02836249|584847552|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
161944286|NCT02836249|584847549|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161944287|NCT02836249|584847550|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161944288|NCT02836249|584847551|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161944289|NCT02836249|584847552|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161944290|NCT02836249|584847549|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
161944291|NCT02836249|584847550|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
161944292|NCT02836249|584847551|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
161944293|NCT02836249|584847552|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
161944294|NCT02836249|584847549|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
161944295|NCT02836249|584847550|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
161944296|NCT02836249|584847551|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
161944297|NCT02836249|584847552|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
161944298|NCT02836249|584847549|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
161944299|NCT02836249|584847550|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
161944300|NCT02836249|584847551|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
161944301|NCT02836249|584847552|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
161944302|NCT02836249|584847549|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
161944303|NCT02836249|584847550|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
161944304|NCT02836249|584847551|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
161944305|NCT02836249|584847552|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
161944306|NCT02836249|584847549|FG000|Open-Label TAF Treatment Phase|Death|0|||
161944307|NCT02836249|584847550|FG001|Open-Label TAF Treatment Phase|Death|0|||
161944308|NCT02836249|584847551|FG002|Open-Label TAF Treatment Phase|Death|1|||
161944309|NCT02836249|584847552|FG003|Open-Label TAF Treatment Phase|Death|0|||
161944310|NCT02836249|584847549|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
161944311|NCT02836249|584847550|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
161944312|NCT02836249|584847551|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
161944313|NCT02836249|584847552|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
161944314|NCT02836249|584847549|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
161944315|NCT02836249|584847550|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
161944316|NCT02836249|584847551|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
161944317|NCT02836249|584847552|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
161944318|NCT01646827|584847553|FG000|Overall Study|Lost to Follow-up|0|||
161944319|NCT01646827|584847554|FG001|Overall Study|Lost to Follow-up|3|||
161944320|NCT01646827|584847553|FG000|Overall Study|Physician Decision|1|||
161944321|NCT01646827|584847554|FG001|Overall Study|Physician Decision|2|||
161944322|NCT01646827|584847553|FG000|Overall Study|Withdrawal by Subject|1|||
161944323|NCT01646827|584847554|FG001|Overall Study|Withdrawal by Subject|0|||
161944324|NCT01143402|584847557|FG000|Overall Study|Rapid clinical decline|1|||
161944325|NCT01143402|584847558|FG001|Overall Study|Rapid clinical decline|1|||
161944326|NCT01143402|584847559|FG002|Overall Study|Rapid clinical decline|0|||
161944327|NCT01143402|584847557|FG000|Overall Study|Not Treated|0|||
161944328|NCT01143402|584847558|FG001|Overall Study|Not Treated|0|||
161944329|NCT01143402|584847559|FG002|Overall Study|Not Treated|1|||
161944330|NCT04462471|584847560|FG000|Overall Study|Adverse Event|0|||
161944331|NCT04462471|584847561|FG001|Overall Study|Adverse Event|1|||
161944332|NCT04462471|584847562|FG002|Overall Study|Adverse Event|0|||
161944333|NCT04462471|584847563|FG003|Overall Study|Adverse Event|0|||
161944334|NCT04462471|584847560|FG000|Overall Study|Disease progression|1|||
161944335|NCT04462471|584847561|FG001|Overall Study|Disease progression|0|||
161944336|NCT04462471|584847562|FG002|Overall Study|Disease progression|0|||
161944337|NCT04462471|584847563|FG003|Overall Study|Disease progression|0|||
161944338|NCT00265122|584847566|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
161944339|NCT00265122|584847567|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
161944340|NCT00265122|584847568|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
161944341|NCT00265122|584847569|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
161944342|NCT00265122|584847570|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
161944343|NCT00265122|584847571|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
162026835|NCT02353143|585154431|FG003|Overall Study|Adverse Event|0|||
162026836|NCT02353143|585154432|FG004|Overall Study|Adverse Event|1|||
161944344|NCT00265122|584847566|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
161944345|NCT00265122|584847567|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
161944346|NCT00265122|584847568|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
161944347|NCT00265122|584847569|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
161944348|NCT00265122|584847570|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
161944349|NCT00265122|584847571|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
161944350|NCT00265122|584847566|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
161944351|NCT00265122|584847567|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
161944352|NCT00265122|584847568|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
161944353|NCT00265122|584847569|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
161944354|NCT00265122|584847570|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
161944355|NCT00265122|584847571|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
161944356|NCT00265122|584847566|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
161944357|NCT00265122|584847567|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
161944358|NCT00265122|584847568|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
161944359|NCT00265122|584847569|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
161944360|NCT00265122|584847570|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
161944361|NCT00265122|584847571|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
161944362|NCT00265122|584847566|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
161944363|NCT00265122|584847567|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
161944364|NCT00265122|584847568|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
161944365|NCT00265122|584847569|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
161944366|NCT00265122|584847570|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
161944367|NCT00265122|584847571|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
161944368|NCT00265122|584847566|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
161944369|NCT00265122|584847567|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
161944370|NCT00265122|584847568|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
161944371|NCT00265122|584847569|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
161944372|NCT00265122|584847570|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
161944373|NCT00265122|584847571|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
161944374|NCT01276106|584847572|FG000|Overall Study|Adverse Event|3|||
161944375|NCT01276106|584847573|FG001|Overall Study|Adverse Event|3|||
161944376|NCT01276106|584847574|FG002|Overall Study|Adverse Event|11|||
161944377|NCT01276106|584847575|FG003|Overall Study|Adverse Event|3|||
161944378|NCT01276106|584847572|FG000|Overall Study|Withdrawal by Subject|6|||
161944379|NCT01276106|584847573|FG001|Overall Study|Withdrawal by Subject|3|||
161944380|NCT01276106|584847574|FG002|Overall Study|Withdrawal by Subject|1|||
161944381|NCT01276106|584847575|FG003|Overall Study|Withdrawal by Subject|6|||
161944382|NCT01276106|584847572|FG000|Overall Study|Lack of Efficacy|0|||
161944383|NCT01276106|584847573|FG001|Overall Study|Lack of Efficacy|1|||
161944384|NCT01276106|584847574|FG002|Overall Study|Lack of Efficacy|0|||
161944385|NCT01276106|584847575|FG003|Overall Study|Lack of Efficacy|1|||
161944386|NCT01276106|584847572|FG000|Overall Study|Lost to Follow-up|2|||
161944387|NCT01276106|584847573|FG001|Overall Study|Lost to Follow-up|1|||
161944388|NCT01276106|584847574|FG002|Overall Study|Lost to Follow-up|1|||
161944389|NCT01276106|584847575|FG003|Overall Study|Lost to Follow-up|0|||
161944390|NCT01276106|584847572|FG000|Overall Study|Physician Decision|0|||
161832337|NCT04146363|584428393|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
161832338|NCT04146363|584428383|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832339|NCT04146363|584428384|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832340|NCT04146363|584428385|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832341|NCT04146363|584428386|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832342|NCT04146363|584428387|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832343|NCT04146363|584428388|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832344|NCT04146363|584428389|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832345|NCT04146363|584428390|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
161832346|NCT04146363|584428391|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832347|NCT04146363|584428392|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832348|NCT04146363|584428393|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161832349|NCT04146363|584428383|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832350|NCT04146363|584428384|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832351|NCT04146363|584428385|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832352|NCT04146363|584428386|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832353|NCT04146363|584428387|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161944391|NCT01276106|584847573|FG001|Overall Study|Physician Decision|0|||
161944392|NCT01276106|584847574|FG002|Overall Study|Physician Decision|1|||
161944393|NCT01276106|584847575|FG003|Overall Study|Physician Decision|1|||
161944394|NCT01276106|584847572|FG000|Overall Study|Protocol Violation|1|||
161944395|NCT01276106|584847573|FG001|Overall Study|Protocol Violation|1|||
161944396|NCT01276106|584847574|FG002|Overall Study|Protocol Violation|0|||
161944397|NCT01276106|584847575|FG003|Overall Study|Protocol Violation|2|||
161944398|NCT01276106|584847572|FG000|Overall Study|Insufficient therapeutic effects|0|||
161944399|NCT01276106|584847573|FG001|Overall Study|Insufficient therapeutic effects|0|||
161944400|NCT01276106|584847574|FG002|Overall Study|Insufficient therapeutic effects|2|||
161944401|NCT01276106|584847575|FG003|Overall Study|Insufficient therapeutic effects|0|||
161944402|NCT00862940|584847579|FG000|Overall Study|Adverse Event|15|||
161944403|NCT00862940|584847580|FG001|Overall Study|Adverse Event|12|||
161944404|NCT00862940|584847579|FG000|Overall Study|Lack of Efficacy|1|||
161944405|NCT00862940|584847580|FG001|Overall Study|Lack of Efficacy|3|||
161944406|NCT00862940|584847579|FG000|Overall Study|Protocol Violation|2|||
161944407|NCT00862940|584847580|FG001|Overall Study|Protocol Violation|5|||
161944408|NCT00862940|584847579|FG000|Overall Study|Withdrawal by Subject|4|||
161944409|NCT00862940|584847580|FG001|Overall Study|Withdrawal by Subject|6|||
161944410|NCT00862940|584847579|FG000|Overall Study|Non-compliance|4|||
161944411|NCT00862940|584847580|FG001|Overall Study|Non-compliance|0|||
161944412|NCT00862940|584847579|FG000|Overall Study|Lost to Follow-up|0|||
161944413|NCT00862940|584847580|FG001|Overall Study|Lost to Follow-up|1|||
161944414|NCT00862940|584847579|FG000|Overall Study|Administrative or other reason(s)|4|||
161944415|NCT00862940|584847580|FG001|Overall Study|Administrative or other reason(s)|3|||
161944416|NCT00485173|584847581|FG000|Overall Study|Death|4|||
161944417|NCT00485173|584847582|FG001|Overall Study|Death|3|||
161944418|NCT00485173|584847581|FG000|Overall Study|Lost to Follow-up|32|||
161944419|NCT00485173|584847582|FG001|Overall Study|Lost to Follow-up|61|||
161944420|NCT00879398|584847585|FG000|Overall Study|Visit Stop|399|||
161944421|NCT00879398|584847585|FG000|Overall Study|Lack of Efficacy|64|||
161944422|NCT00879398|584847585|FG000|Overall Study|Adverse Event|41|||
161944423|NCT00879398|584847585|FG000|Overall Study|Other Reasons|171|||
161944424|NCT00829244|584847586|FG000|Overall Study|Adverse Event|1|||
161944425|NCT00829244|584847587|FG001|Overall Study|Adverse Event|3|||
161944426|NCT00829244|584847586|FG000|Overall Study|Protocol Violation|1|||
161944427|NCT00829244|584847587|FG001|Overall Study|Protocol Violation|0|||
161944428|NCT00829244|584847586|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
161944429|NCT00829244|584847587|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
161944430|NCT00829244|584847586|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
161944431|NCT00829244|584847587|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
161944432|NCT00829244|584847586|FG000|Overall Study|No fertilization|2|||
161944433|NCT00829244|584847587|FG001|Overall Study|No fertilization|2|||
161944434|NCT00829244|584847586|FG000|Overall Study|All embryos discarded|0|||
161944435|NCT00829244|584847587|FG001|Overall Study|All embryos discarded|3|||
161944436|NCT00829244|584847586|FG000|Overall Study|No embryo cleavage|0|||
161944437|NCT00829244|584847587|FG001|Overall Study|No embryo cleavage|2|||
161944438|NCT05901636|584847594|FG000|Overall Study|Lost to Follow-up|0|||
161944439|NCT05901636|584847595|FG001|Overall Study|Lost to Follow-up|1|||
161944440|NCT05901636|584847596|FG002|Overall Study|Lost to Follow-up|0|||
161944441|NCT05901636|584847597|FG003|Overall Study|Lost to Follow-up|1|||
161944442|NCT05901636|584847598|FG004|Overall Study|Lost to Follow-up|1|||
161944443|NCT05901636|584847599|FG005|Overall Study|Lost to Follow-up|3|||
161944444|NCT05901636|584847600|FG006|Overall Study|Lost to Follow-up|1|||
161944445|NCT05901636|584847594|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
161944446|NCT05901636|584847595|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
161944447|NCT05901636|584847596|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
161944448|NCT05901636|584847597|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
161944449|NCT05901636|584847598|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
161944450|NCT05901636|584847599|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
161944451|NCT05901636|584847600|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
161944452|NCT05901636|584847594|FG000|Overall Study|Withdrawal by Subject|1|||
161944453|NCT05901636|584847595|FG001|Overall Study|Withdrawal by Subject|1|||
161944454|NCT05901636|584847596|FG002|Overall Study|Withdrawal by Subject|0|||
161944455|NCT05901636|584847597|FG003|Overall Study|Withdrawal by Subject|0|||
161944456|NCT05901636|584847598|FG004|Overall Study|Withdrawal by Subject|1|||
161944457|NCT05901636|584847599|FG005|Overall Study|Withdrawal by Subject|1|||
161944458|NCT05901636|584847600|FG006|Overall Study|Withdrawal by Subject|0|||
161944459|NCT05901636|584847594|FG000|Overall Study|Other|0|||
161944460|NCT05901636|584847595|FG001|Overall Study|Other|0|||
161944461|NCT05901636|584847596|FG002|Overall Study|Other|1|||
161944462|NCT05901636|584847597|FG003|Overall Study|Other|1|||
161944463|NCT05901636|584847598|FG004|Overall Study|Other|0|||
161944464|NCT05901636|584847599|FG005|Overall Study|Other|0|||
161944465|NCT05901636|584847600|FG006|Overall Study|Other|0|||
161944466|NCT04583618|584847608|FG000|Overall Study|Adverse Event|0|||
161944467|NCT04583618|584847609|FG001|Overall Study|Adverse Event|0|||
161944468|NCT04583618|584847610|FG002|Overall Study|Adverse Event|1|||
161944469|NCT04583618|584847611|FG003|Overall Study|Adverse Event|0|||
161944470|NCT04583618|584847612|FG004|Overall Study|Adverse Event|0|||
161944471|NCT04583618|584847608|FG000|Overall Study|Protocol deviation|1|||
161944472|NCT04583618|584847609|FG001|Overall Study|Protocol deviation|1|||
161944473|NCT04583618|584847610|FG002|Overall Study|Protocol deviation|1|||
161944474|NCT04583618|584847611|FG003|Overall Study|Protocol deviation|0|||
161944475|NCT04583618|584847612|FG004|Overall Study|Protocol deviation|0|||
161944476|NCT04583618|584847608|FG000|Overall Study|Withdrawal by Subject|2|||
161944477|NCT04583618|584847609|FG001|Overall Study|Withdrawal by Subject|1|||
161944478|NCT04583618|584847610|FG002|Overall Study|Withdrawal by Subject|3|||
161944479|NCT04583618|584847611|FG003|Overall Study|Withdrawal by Subject|1|||
161944480|NCT04583618|584847612|FG004|Overall Study|Withdrawal by Subject|1|||
161944481|NCT04583618|584847608|FG000|Overall Study|Lost to Follow-up|0|||
161944482|NCT04583618|584847609|FG001|Overall Study|Lost to Follow-up|1|||
161944483|NCT04583618|584847610|FG002|Overall Study|Lost to Follow-up|3|||
161944484|NCT04583618|584847611|FG003|Overall Study|Lost to Follow-up|1|||
161944485|NCT04583618|584847612|FG004|Overall Study|Lost to Follow-up|1|||
161944486|NCT02302222|584847613|FG000|Overall Study|Physician Decision|0|||
161944487|NCT02302222|584847614|FG001|Overall Study|Physician Decision|4|||
161944488|NCT02302222|584847613|FG000|Overall Study|Lost to Follow-up|1|||
161944489|NCT02302222|584847614|FG001|Overall Study|Lost to Follow-up|0|||
161944490|NCT02302222|584847613|FG000|Overall Study|Treatment discontinued before day 5|0|||
161944491|NCT02302222|584847614|FG001|Overall Study|Treatment discontinued before day 5|1|||
161944492|NCT02302222|584847613|FG000|Overall Study|Withdrawn prior to any treatment|0|||
161944493|NCT02302222|584847614|FG001|Overall Study|Withdrawn prior to any treatment|1|||
161944494|NCT00016354|584847615|FG000|Overall Study|Lack of Efficacy|0|||
161944495|NCT00016354|584847616|FG001|Overall Study|Lack of Efficacy|0|||
161944496|NCT00016354|584847617|FG002|Overall Study|Lack of Efficacy|0|||
161944497|NCT00016354|584847618|FG003|Overall Study|Lack of Efficacy|0|||
161944498|NCT00016354|584847619|FG004|Overall Study|Lack of Efficacy|0|||
161944499|NCT00016354|584847620|FG005|Overall Study|Lack of Efficacy|0|||
161944500|NCT00016354|584847621|FG006|Overall Study|Lack of Efficacy|0|||
161944501|NCT00016354|584847622|FG007|Overall Study|Lack of Efficacy|1|||
161944502|NCT03110562|584847623|FG000|Initial Treatment Period|Disease Progression|1|||
161944503|NCT03110562|584847624|FG001|Initial Treatment Period|Disease Progression|1|||
161944504|NCT03110562|584847625|FG002|Initial Treatment Period|Disease Progression|0|||
161944505|NCT03110562|584847626|FG003|Initial Treatment Period|Disease Progression|0|||
161944506|NCT03110562|584847623|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
161944507|NCT03110562|584847624|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
161944508|NCT03110562|584847625|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
161944509|NCT03110562|584847626|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
161944510|NCT03110562|584847623|FG000|Initial Treatment Period|Adverse Event|1|||
161944511|NCT03110562|584847624|FG001|Initial Treatment Period|Adverse Event|0|||
161944512|NCT03110562|584847625|FG002|Initial Treatment Period|Adverse Event|0|||
161944513|NCT03110562|584847626|FG003|Initial Treatment Period|Adverse Event|0|||
161944514|NCT03110562|584847623|FG000|Initial Treatment Period|Death|74|||
161944515|NCT03110562|584847624|FG001|Initial Treatment Period|Death|82|||
161944516|NCT03110562|584847625|FG002|Initial Treatment Period|Death|0|||
161944517|NCT03110562|584847626|FG003|Initial Treatment Period|Death|0|||
161944518|NCT03110562|584847623|FG000|Initial Treatment Period|Lost to Follow-up|13|||
161944519|NCT03110562|584847624|FG001|Initial Treatment Period|Lost to Follow-up|8|||
161944520|NCT03110562|584847625|FG002|Initial Treatment Period|Lost to Follow-up|0|||
161944521|NCT03110562|584847626|FG003|Initial Treatment Period|Lost to Follow-up|0|||
161944522|NCT03110562|584847623|FG000|Initial Treatment Period|Protocol Deviation|1|||
161944523|NCT03110562|584847624|FG001|Initial Treatment Period|Protocol Deviation|0|||
161944524|NCT03110562|584847625|FG002|Initial Treatment Period|Protocol Deviation|0|||
161944525|NCT03110562|584847626|FG003|Initial Treatment Period|Protocol Deviation|0|||
161944526|NCT03110562|584847623|FG000|Initial Treatment Period|Physician Decision|2|||
161944527|NCT03110562|584847624|FG001|Initial Treatment Period|Physician Decision|1|||
161944528|NCT03110562|584847625|FG002|Initial Treatment Period|Physician Decision|0|||
161944529|NCT03110562|584847626|FG003|Initial Treatment Period|Physician Decision|0|||
161944530|NCT03110562|584847623|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
161944531|NCT03110562|584847624|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
161944532|NCT03110562|584847625|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
161944533|NCT03110562|584847626|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
161944534|NCT03110562|584847623|FG000|Initial Treatment Period|Other|5|||
161944535|NCT03110562|584847624|FG001|Initial Treatment Period|Other|4|||
161944536|NCT03110562|584847625|FG002|Initial Treatment Period|Other|0|||
161944537|NCT03110562|584847626|FG003|Initial Treatment Period|Other|0|||
161944538|NCT03110562|584847623|FG000|Initial Treatment Period|Randomized but never treated|0|||
161944539|NCT03110562|584847624|FG001|Initial Treatment Period|Randomized but never treated|3|||
161944540|NCT03110562|584847625|FG002|Initial Treatment Period|Randomized but never treated|0|||
161944541|NCT03110562|584847626|FG003|Initial Treatment Period|Randomized but never treated|0|||
161944542|NCT03110562|584847623|FG000|Crossover Period|Disease Progression|0|||
161944543|NCT03110562|584847624|FG001|Crossover Period|Disease Progression|0|||
161944544|NCT03110562|584847625|FG002|Crossover Period|Disease Progression|1|||
162026837|NCT02353143|585154433|FG005|Overall Study|Adverse Event|1|||
161944545|NCT03110562|584847626|FG003|Crossover Period|Disease Progression|0|||
161944546|NCT03110562|584847623|FG000|Crossover Period|Withdrawal by Subject|0|||
161944547|NCT03110562|584847624|FG001|Crossover Period|Withdrawal by Subject|0|||
161944548|NCT03110562|584847625|FG002|Crossover Period|Withdrawal by Subject|8|||
161944549|NCT03110562|584847626|FG003|Crossover Period|Withdrawal by Subject|6|||
161944550|NCT03110562|584847623|FG000|Crossover Period|Death|0|||
161944551|NCT03110562|584847624|FG001|Crossover Period|Death|0|||
161944552|NCT03110562|584847625|FG002|Crossover Period|Death|37|||
161944553|NCT03110562|584847626|FG003|Crossover Period|Death|3|||
161944554|NCT03110562|584847623|FG000|Crossover Period|Lost to Follow-up|0|||
161944555|NCT03110562|584847624|FG001|Crossover Period|Lost to Follow-up|0|||
161944556|NCT03110562|584847625|FG002|Crossover Period|Lost to Follow-up|0|||
161944557|NCT03110562|584847626|FG003|Crossover Period|Lost to Follow-up|1|||
161944558|NCT03110562|584847623|FG000|Crossover Period|Other|0|||
161944559|NCT03110562|584847624|FG001|Crossover Period|Other|0|||
161944560|NCT03110562|584847625|FG002|Crossover Period|Other|1|||
161944561|NCT03110562|584847626|FG003|Crossover Period|Other|1|||
161944562|NCT03110562|584847623|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
161944563|NCT03110562|584847624|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
161944564|NCT03110562|584847625|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
161944565|NCT03110562|584847626|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
161944566|NCT02769481|584847630|FG000|Overall Study|Protocol Violation|1|||
161944567|NCT02769481|584847631|FG001|Overall Study|Protocol Violation|0|||
161944568|NCT02769481|584847630|FG000|Overall Study|Adverse Event|3|||
161944569|NCT02769481|584847631|FG001|Overall Study|Adverse Event|6|||
161944570|NCT02769481|584847630|FG000|Overall Study|Entry Criteria Not Met|1|||
161944571|NCT02769481|584847631|FG001|Overall Study|Entry Criteria Not Met|2|||
161944572|NCT02769481|584847630|FG000|Overall Study|Withdrawal by Subject|14|||
161944573|NCT02769481|584847631|FG001|Overall Study|Withdrawal by Subject|16|||
161944574|NCT02769481|584847630|FG000|Overall Study|Lost to Follow-up|9|||
161944575|NCT02769481|584847631|FG001|Overall Study|Lost to Follow-up|9|||
161944576|NCT02769481|584847630|FG000|Overall Study|Physician Decision|0|||
161944577|NCT02769481|584847631|FG001|Overall Study|Physician Decision|1|||
161944578|NCT02769481|584847630|FG000|Overall Study|Terminated by Sponsor|1|||
161944579|NCT02769481|584847631|FG001|Overall Study|Terminated by Sponsor|0|||
161944580|NCT02769481|584847630|FG000|Overall Study|Death|0|||
161944581|NCT02769481|584847631|FG001|Overall Study|Death|1|||
161944582|NCT02769481|584847630|FG000|Overall Study|Undefined|4|||
161944583|NCT02769481|584847631|FG001|Overall Study|Undefined|1|||
161944584|NCT02781558|584847632|FG000|Overall Study|Lost to Follow-up|2|||
161944585|NCT02781558|584847633|FG001|Overall Study|Lost to Follow-up|2|||
161944586|NCT02781558|584847632|FG000|Overall Study|Adverse Event|1|||
161944587|NCT02781558|584847633|FG001|Overall Study|Adverse Event|0|||
161944588|NCT01334918|584849521|FG000|Overall Study|Did not receive study drug|6|||
161944589|NCT01334918|584849522|FG001|Overall Study|Did not receive study drug|0|||
161944590|NCT01334918|584849521|FG000|Overall Study|Adverse Event|2|||
161944591|NCT01334918|584849522|FG001|Overall Study|Adverse Event|0|||
161944592|NCT01334918|584849521|FG000|Overall Study|Withdrawal by Subject|0|||
161944593|NCT01334918|584849522|FG001|Overall Study|Withdrawal by Subject|1|||
161944594|NCT02114177|584849523|FG000|Overall Study|Lost to Follow-up|1|||
161944595|NCT02114177|584849524|FG001|Overall Study|Lost to Follow-up|2|||
161944596|NCT02114177|584849523|FG000|Overall Study|Withdrawal by Subject|6|||
161944597|NCT02114177|584849524|FG001|Overall Study|Withdrawal by Subject|1|||
161944598|NCT02114177|584849523|FG000|Overall Study|Other|2|||
161944599|NCT02114177|584849524|FG001|Overall Study|Other|1|||
161944600|NCT01897493|584849526|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
161832354|NCT04146363|584428388|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161944601|NCT02777086|584849531|FG000|Overall Study|Lost to Follow-up|96|||
161944602|NCT02777086|584849532|FG001|Overall Study|Lost to Follow-up|99|||
161944603|NCT01133665|584849533|FG000|Overall Study|Physician Decision|2|||
161944604|NCT00805389|584849534|FG000|Overall Study|Adverse Event|0|||
161944605|NCT00805389|584849535|FG001|Overall Study|Adverse Event|0|||
161944606|NCT00805389|584849536|FG002|Overall Study|Adverse Event|1|||
161683589|NCT02256540|583894616|FG000|Overall Study|Withdrawal by Subject|0|||
161683590|NCT02256540|583894617|FG001|Overall Study|Withdrawal by Subject|1|||
161683591|NCT02256540|583894618|FG002|Overall Study|Withdrawal by Subject|1|||
161683592|NCT02256540|583894616|FG000|Overall Study|Back pain preventing exercise|0|||
161683593|NCT02256540|583894617|FG001|Overall Study|Back pain preventing exercise|0|||
161683594|NCT02256540|583894618|FG002|Overall Study|Back pain preventing exercise|1|||
161683595|NCT01230242|583894619|FG000|Overall Study|Physician Decision|2|||
161683596|NCT01230242|583894619|FG000|Overall Study|Withdrawal by Subject|1|||
161683597|NCT02576444|583894628|FG000|Overall Study|Death|1|||
161683598|NCT02576444|583894629|FG001|Overall Study|Death|1|||
161683599|NCT02576444|583894630|FG002|Overall Study|Death|0|||
161683600|NCT02576444|583894631|FG003|Overall Study|Death|0|||
161683601|NCT02576444|583894628|FG000|Overall Study|Withdrawal by Subject|0|||
161683602|NCT02576444|583894629|FG001|Overall Study|Withdrawal by Subject|0|||
161683603|NCT02576444|583894630|FG002|Overall Study|Withdrawal by Subject|2|||
161683604|NCT02576444|583894631|FG003|Overall Study|Withdrawal by Subject|0|||
161683605|NCT02576444|583894628|FG000|Overall Study|Adverse Event|0|||
161683606|NCT02576444|583894629|FG001|Overall Study|Adverse Event|0|||
161683607|NCT02576444|583894630|FG002|Overall Study|Adverse Event|1|||
161683608|NCT02576444|583894631|FG003|Overall Study|Adverse Event|0|||
161683609|NCT02576444|583894628|FG000|Overall Study|Physician Decision|0|||
161683610|NCT02576444|583894629|FG001|Overall Study|Physician Decision|0|||
161683611|NCT02576444|583894630|FG002|Overall Study|Physician Decision|1|||
161683612|NCT02576444|583894631|FG003|Overall Study|Physician Decision|0|||
161683613|NCT00928889|583894639|FG000|Overall Study|Lost to Follow-up|3|||
161683614|NCT00928889|583894640|FG001|Overall Study|Lost to Follow-up|1|||
161683615|NCT00928889|583894639|FG000|Overall Study|Protocol Violation|0|||
161683616|NCT00928889|583894640|FG001|Overall Study|Protocol Violation|1|||
161683617|NCT00928889|583894639|FG000|Overall Study|Adverse Event|1|||
161683618|NCT00928889|583894640|FG001|Overall Study|Adverse Event|0|||
161683619|NCT00928889|583894639|FG000|Overall Study|Other|1|||
161683620|NCT00928889|583894640|FG001|Overall Study|Other|0|||
161683621|NCT02700412|583894641|FG000|Overall Study|Adverse Event|6|||
161683622|NCT02700412|583894641|FG000|Overall Study|Death|1|||
161683623|NCT02700412|583894641|FG000|Overall Study|Lack of Efficacy|19|||
161683624|NCT02700412|583894641|FG000|Overall Study|Protocol Violation|5|||
161683625|NCT02700412|583894641|FG000|Overall Study|Withdrawal by Subject|2|||
161683626|NCT04416555|583894643|FG000|Overall Study|Withdrawal by Subject|0|||
161683627|NCT04416555|583894644|FG001|Overall Study|Withdrawal by Subject|3|||
161683628|NCT00530270|583894647|FG000|Overall Study|Protocol Violation|1|||
161683629|NCT00530270|583894648|FG001|Overall Study|Protocol Violation|0|||
161683630|NCT01197521|583894657|FG000|Overall Study|Not reported|24|||
161683631|NCT01197521|583894658|FG001|Overall Study|Not reported|25|||
161683632|NCT01197521|583894659|FG002|Overall Study|Not reported|21|||
161683633|NCT01197521|583894657|FG000|Overall Study|Enrolment in long term extension|42|||
161683634|NCT01197521|583894658|FG001|Overall Study|Enrolment in long term extension|36|||
161683635|NCT01197521|583894659|FG002|Overall Study|Enrolment in long term extension|87|||
161683636|NCT01197521|583894657|FG000|Overall Study|Severe non-compliance to protocol|1|||
161683637|NCT01197521|583894658|FG001|Overall Study|Severe non-compliance to protocol|3|||
161683638|NCT01197521|583894659|FG002|Overall Study|Severe non-compliance to protocol|3|||
161683639|NCT01197521|583894657|FG000|Overall Study|Lack of therapeutic response|2|||
161683640|NCT01197521|583894658|FG001|Overall Study|Lack of therapeutic response|3|||
161683641|NCT01197521|583894659|FG002|Overall Study|Lack of therapeutic response|4|||
161683642|NCT01197521|583894657|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
161683643|NCT01197521|583894658|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
161683644|NCT01197521|583894659|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
161683645|NCT01197521|583894657|FG000|Overall Study|Lost to Follow-up|3|||
161683646|NCT01197521|583894658|FG001|Overall Study|Lost to Follow-up|2|||
161683647|NCT01197521|583894659|FG002|Overall Study|Lost to Follow-up|2|||
161683648|NCT01197521|583894657|FG000|Overall Study|Adverse Event|25|||
161683649|NCT01197521|583894658|FG001|Overall Study|Adverse Event|28|||
161683650|NCT01197521|583894659|FG002|Overall Study|Adverse Event|24|||
161683651|NCT01309659|583894660|FG000|Overall Study|Protocol Violation|0|||
161683652|NCT01309659|583894661|FG001|Overall Study|Protocol Violation|1|||
161683653|NCT04607148|583894662|FG000|Overall Study|Withdrawal by Subject|0|||
161683654|NCT04607148|583894663|FG001|Overall Study|Withdrawal by Subject|4|||
161683655|NCT04607148|583894664|FG002|Overall Study|Withdrawal by Subject|2|||
161683656|NCT04607148|583894665|FG003|Overall Study|Withdrawal by Subject|8|||
161683657|NCT04607148|583894662|FG000|Overall Study|Study Terminated by Sponsor|14|||
161683658|NCT04607148|583894663|FG001|Overall Study|Study Terminated by Sponsor|59|||
161683659|NCT04607148|583894664|FG002|Overall Study|Study Terminated by Sponsor|9|||
161683660|NCT04607148|583894665|FG003|Overall Study|Study Terminated by Sponsor|39|||
161683661|NCT04607148|583894662|FG000|Overall Study|Sponsor Decision|0|||
161683662|NCT04607148|583894663|FG001|Overall Study|Sponsor Decision|0|||
161683663|NCT04607148|583894664|FG002|Overall Study|Sponsor Decision|1|||
161683664|NCT04607148|583894665|FG003|Overall Study|Sponsor Decision|0|||
161683665|NCT04607148|583894662|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162026838|NCT02353143|585154434|FG006|Overall Study|Adverse Event|0|||
162026839|NCT02353143|585154435|FG007|Overall Study|Adverse Event|0|||
162026840|NCT02353143|585154436|FG008|Overall Study|Adverse Event|0|||
162026841|NCT02353143|585154428|FG000|Overall Study|patient receiving other treatment for AML|0|||
162026842|NCT02353143|585154429|FG001|Overall Study|patient receiving other treatment for AML|0|||
162026843|NCT02353143|585154430|FG002|Overall Study|patient receiving other treatment for AML|1|||
162026844|NCT02353143|585154431|FG003|Overall Study|patient receiving other treatment for AML|0|||
162026845|NCT02353143|585154432|FG004|Overall Study|patient receiving other treatment for AML|0|||
162026846|NCT02353143|585154433|FG005|Overall Study|patient receiving other treatment for AML|0|||
162026847|NCT02353143|585154434|FG006|Overall Study|patient receiving other treatment for AML|0|||
162026848|NCT02353143|585154435|FG007|Overall Study|patient receiving other treatment for AML|0|||
162026849|NCT02353143|585154436|FG008|Overall Study|patient receiving other treatment for AML|0|||
162026850|NCT02353143|585154428|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
162026851|NCT02353143|585154429|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
161832355|NCT04146363|584428389|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
161832356|NCT04146363|584428390|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
161944607|NCT00805389|584849537|FG003|Overall Study|Adverse Event|2|||
161944608|NCT00805389|584849538|FG004|Overall Study|Adverse Event|0|||
161944609|NCT00805389|584849534|FG000|Overall Study|Lost to Follow-up|4|||
161944610|NCT00805389|584849535|FG001|Overall Study|Lost to Follow-up|3|||
161944611|NCT00805389|584849536|FG002|Overall Study|Lost to Follow-up|6|||
161944612|NCT00805389|584849537|FG003|Overall Study|Lost to Follow-up|10|||
161944613|NCT00805389|584849538|FG004|Overall Study|Lost to Follow-up|9|||
161944614|NCT00805389|584849534|FG000|Overall Study|Protocol Violation|0|||
161944615|NCT00805389|584849535|FG001|Overall Study|Protocol Violation|0|||
161944616|NCT00805389|584849536|FG002|Overall Study|Protocol Violation|1|||
161944617|NCT00805389|584849537|FG003|Overall Study|Protocol Violation|0|||
161944618|NCT00805389|584849538|FG004|Overall Study|Protocol Violation|0|||
161944619|NCT00805389|584849534|FG000|Overall Study|Withdrawal by Subject|3|||
161944620|NCT00805389|584849535|FG001|Overall Study|Withdrawal by Subject|2|||
161944621|NCT00805389|584849536|FG002|Overall Study|Withdrawal by Subject|4|||
161944622|NCT00805389|584849537|FG003|Overall Study|Withdrawal by Subject|5|||
161944623|NCT00805389|584849538|FG004|Overall Study|Withdrawal by Subject|4|||
161944624|NCT01246960|584849539|FG000|Overall Study|Lost to Follow-up|3|||
161944625|NCT01246960|584849540|FG001|Overall Study|Lost to Follow-up|1|||
161944626|NCT01246960|584849539|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
161944627|NCT01246960|584849540|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
161944628|NCT05111145|584849543|FG000|Overall Study|Commercial drug is available for participant|76|||
161944629|NCT05111145|584849543|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
161944630|NCT02336815|584849544|FG000|Overall Study|Disease Progression|45|||
161944631|NCT02336815|584849545|FG001|Overall Study|Disease Progression|70|||
161944632|NCT02336815|584849544|FG000|Overall Study|Adverse Event|18|||
161944633|NCT02336815|584849545|FG001|Overall Study|Adverse Event|39|||
161944634|NCT02336815|584849544|FG000|Overall Study|Physician Decision|11|||
161944635|NCT02336815|584849545|FG001|Overall Study|Physician Decision|4|||
161944636|NCT02336815|584849544|FG000|Overall Study|Withdrawal by Subject|3|||
161944637|NCT02336815|584849545|FG001|Overall Study|Withdrawal by Subject|2|||
161944638|NCT02336815|584849544|FG000|Overall Study|Lost to Follow-up|1|||
161944639|NCT02336815|584849545|FG001|Overall Study|Lost to Follow-up|3|||
161944640|NCT02336815|584849544|FG000|Overall Study|Other|1|||
161944641|NCT02336815|584849545|FG001|Overall Study|Other|5|||
161944642|NCT00370292|584849546|FG000|Overall Study|Disease Progression|4|||
161944643|NCT00370292|584849546|FG000|Overall Study|Adverse Event|7|||
161944644|NCT00370292|584849546|FG000|Overall Study|Physician Decision|2|||
161944645|NCT02239926|584849547|FG000|Overall Study|Withdrawal by Subject|0|||
161944646|NCT02239926|584849548|FG001|Overall Study|Withdrawal by Subject|1|||
161944647|NCT00598650|584849551|FG000|Overall Study|Withdrawal by Subject|3|||
161944648|NCT00598650|584849551|FG000|Overall Study|Adverse Event|18|||
162026852|NCT02353143|585154430|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
162026853|NCT02353143|585154431|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
162026854|NCT02353143|585154432|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
162026855|NCT02353143|585154433|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
162026856|NCT02353143|585154434|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
162026857|NCT02353143|585154435|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
161944649|NCT00598650|584849551|FG000|Overall Study|No treatment for 3 weeks|1|||
161944650|NCT00598650|584849551|FG000|Overall Study|Not eligible|1|||
161944651|NCT00598650|584849551|FG000|Overall Study|Prohibited Concomitant Medication|2|||
161944652|NCT00598650|584849551|FG000|Overall Study|Physician Decision|2|||
161944653|NCT01628913|584849552|FG000|Overall Study|Adverse Event|12|||
161944654|NCT01628913|584849553|FG001|Overall Study|Adverse Event|5|||
161944655|NCT01628913|584849552|FG000|Overall Study|Disease Progression|11|||
161944656|NCT01628913|584849553|FG001|Overall Study|Disease Progression|14|||
161944657|NCT01628913|584849552|FG000|Overall Study|Protocol Violation|1|||
161944658|NCT01628913|584849553|FG001|Overall Study|Protocol Violation|0|||
161944659|NCT01628913|584849552|FG000|Overall Study|Death|1|||
161944660|NCT01628913|584849553|FG001|Overall Study|Death|0|||
161944661|NCT01628913|584849552|FG000|Overall Study|study terminated by Sponsor|4|||
161944662|NCT01628913|584849553|FG001|Overall Study|study terminated by Sponsor|9|||
161944663|NCT01628913|584849552|FG000|Overall Study|Withdrawal by Subject|1|||
161944664|NCT01628913|584849553|FG001|Overall Study|Withdrawal by Subject|0|||
161944665|NCT01628913|584849552|FG000|Overall Study|Physician Decision|1|||
161944666|NCT01628913|584849553|FG001|Overall Study|Physician Decision|3|||
161944667|NCT05201807|584849557|FG000|Overall Study|Adverse Event|1|||
162026858|NCT02353143|585154436|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
161944668|NCT05201807|584849557|FG000|Overall Study|COVID-19 Related|1|||
161944669|NCT01664624|584849560|FG000|Overall Study|Adverse Event|0|||
162026859|NCT04740905|585154437|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
162026860|NCT04740905|585154438|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
162026861|NCT04740905|585154437|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
162026862|NCT04740905|585154438|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
161683666|NCT04607148|583894663|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161683667|NCT04607148|583894664|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161944670|NCT01664624|584849561|FG001|Overall Study|Adverse Event|1|||
161944671|NCT01664624|584849562|FG002|Overall Study|Adverse Event|0|||
161944672|NCT01664624|584849563|FG003|Overall Study|Adverse Event|0|||
161944673|NCT02862574|584849566|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161944674|NCT02862574|584849567|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161944675|NCT02862574|584849568|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161944676|NCT02862574|584849566|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
161944677|NCT02862574|584849567|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
161944678|NCT02862574|584849568|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
161944679|NCT02862574|584849566|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
161944680|NCT02862574|584849567|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
161944681|NCT02862574|584849568|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
161944682|NCT01146613|584849570|FG000|Overall Study|Lost to Follow-up|3|||
161944683|NCT01146613|584849571|FG001|Overall Study|Lost to Follow-up|8|||
161944684|NCT01146613|584849570|FG000|Overall Study|Lack of Efficacy|0|||
161944685|NCT01146613|584849571|FG001|Overall Study|Lack of Efficacy|1|||
161944686|NCT01146613|584849570|FG000|Overall Study|Death|1|||
161944687|NCT01146613|584849571|FG001|Overall Study|Death|0|||
161944688|NCT01146613|584849570|FG000|Overall Study|Physician Decision|1|||
161944689|NCT01146613|584849571|FG001|Overall Study|Physician Decision|0|||
161944690|NCT01146613|584849570|FG000|Overall Study|Withdrawal by Subject|0|||
161944691|NCT01146613|584849571|FG001|Overall Study|Withdrawal by Subject|3|||
161944692|NCT01146613|584849570|FG000|Overall Study|schedule conflict|1|||
161944693|NCT01146613|584849571|FG001|Overall Study|schedule conflict|0|||
161944694|NCT01146613|584849570|FG000|Overall Study|Outpatient detox|1|||
161944695|NCT01146613|584849571|FG001|Overall Study|Outpatient detox|0|||
161944696|NCT02136914|584849572|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
161944697|NCT02136914|584849573|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
161944698|NCT02136914|584849572|FG000|Overall Study|Withdrawal by Subject|3|||
161944699|NCT02136914|584849573|FG001|Overall Study|Withdrawal by Subject|10|||
161944700|NCT02136914|584849572|FG000|Overall Study|Subject Unwilling to Proceed|7|||
161944701|NCT02136914|584849573|FG001|Overall Study|Subject Unwilling to Proceed|2|||
161944702|NCT02136914|584849572|FG000|Overall Study|Lost to Follow-up|1|||
161944703|NCT02136914|584849573|FG001|Overall Study|Lost to Follow-up|1|||
161944704|NCT02136914|584849572|FG000|Overall Study|Did Not Receive Study Drug|2|||
161944705|NCT02136914|584849573|FG001|Overall Study|Did Not Receive Study Drug|0|||
161944706|NCT02136914|584849572|FG000|Overall Study|Lack of Efficacy|1|||
161944707|NCT02136914|584849573|FG001|Overall Study|Lack of Efficacy|0|||
161944708|NCT02136914|584849572|FG000|Overall Study|Death|0|||
161944709|NCT02136914|584849573|FG001|Overall Study|Death|1|||
161944710|NCT00949533|584849576|FG000|Overall Study|Lost to Follow-up|0|||
161944711|NCT00949533|584849577|FG001|Overall Study|Lost to Follow-up|1|||
161944712|NCT01493089|584849580|FG000|Overall Study|Protocol Violation|2|||
161944713|NCT01493089|584849581|FG001|Overall Study|Protocol Violation|2|||
161944714|NCT01493089|584849580|FG000|Overall Study|Withdrawal by Subject|1|||
161944715|NCT01493089|584849581|FG001|Overall Study|Withdrawal by Subject|0|||
161944716|NCT01493089|584849580|FG000|Overall Study|Physician Decision|0|||
161944717|NCT01493089|584849581|FG001|Overall Study|Physician Decision|1|||
161944718|NCT02234362|584849582|FG000|Overall Study|Not eligible after first screening visit|17|||
161944719|NCT02234362|584849582|FG000|Overall Study|Lost to Follow-up|6|||
161944720|NCT02234362|584849582|FG000|Overall Study|Withdrawal by Subject|3|||
161944721|NCT00329030|584849583|FG000|Overall Study|Withdrawal by Subject|1|||
161944722|NCT00329030|584849584|FG001|Overall Study|Withdrawal by Subject|3|||
161944723|NCT00329030|584849583|FG000|Overall Study|Progressive Disease|6|||
161944724|NCT00329030|584849584|FG001|Overall Study|Progressive Disease|2|||
161944725|NCT00329030|584849583|FG000|Overall Study|Ineligible Pathology|1|||
161944726|NCT00329030|584849584|FG001|Overall Study|Ineligible Pathology|1|||
161944727|NCT00560417|584849585|FG000|Overall Study|Adverse Event|3|||
161944728|NCT00560417|584849586|FG001|Overall Study|Adverse Event|2|||
162026863|NCT04740905|585154437|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
162026864|NCT04740905|585154438|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
161944729|NCT00560417|584849585|FG000|Overall Study|Entry Criteria Not Met|1|||
161944730|NCT00560417|584849586|FG001|Overall Study|Entry Criteria Not Met|0|||
161944731|NCT00560417|584849585|FG000|Overall Study|Lost to Follow-up|0|||
161944732|NCT00560417|584849586|FG001|Overall Study|Lost to Follow-up|1|||
161944733|NCT00560417|584849585|FG000|Overall Study|Physician Decision|2|||
161944734|NCT00560417|584849586|FG001|Overall Study|Physician Decision|6|||
161944735|NCT00560417|584849585|FG000|Overall Study|Protocol Violation|6|||
161944736|NCT00560417|584849586|FG001|Overall Study|Protocol Violation|5|||
161944737|NCT00560417|584849585|FG000|Overall Study|Sponsor Decision|2|||
161683668|NCT04607148|583894665|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161683669|NCT04607148|583894662|FG000|Overall Study|Lost to Follow-up|0|||
161683670|NCT04607148|583894663|FG001|Overall Study|Lost to Follow-up|2|||
161683671|NCT04607148|583894664|FG002|Overall Study|Lost to Follow-up|0|||
161683672|NCT04607148|583894665|FG003|Overall Study|Lost to Follow-up|0|||
161683673|NCT04607148|583894662|FG000|Overall Study|Death|0|||
161683674|NCT04607148|583894663|FG001|Overall Study|Death|3|||
161683675|NCT04607148|583894664|FG002|Overall Study|Death|0|||
161683676|NCT04607148|583894665|FG003|Overall Study|Death|1|||
161683677|NCT04607148|583894662|FG000|Overall Study|Adverse Event|0|||
161683678|NCT04607148|583894663|FG001|Overall Study|Adverse Event|1|||
161683679|NCT04607148|583894664|FG002|Overall Study|Adverse Event|0|||
161683680|NCT04607148|583894665|FG003|Overall Study|Adverse Event|0|||
161683681|NCT01793142|583894666|FG000|Overall Study|Randomized not treated|7|||
161683682|NCT03029143|583894667|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
161683683|NCT03029143|583894668|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
161683684|NCT03029143|583894669|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
161944738|NCT00560417|584849586|FG001|Overall Study|Sponsor Decision|0|||
162026865|NCT04740905|585154437|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
162026866|NCT04740905|585154438|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
162026867|NCT04740905|585154437|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
162026868|NCT04740905|585154438|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
162026869|NCT04740905|585154437|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
162026870|NCT04740905|585154438|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
162026871|NCT04740905|585154437|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
162026872|NCT04740905|585154438|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
162026873|NCT04740905|585154437|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
162026874|NCT04740905|585154438|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
162026875|NCT04740905|585154437|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
162026876|NCT04740905|585154438|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
162026877|NCT04740905|585154437|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
162026878|NCT04740905|585154438|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
162026879|NCT04740905|585154437|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
162026880|NCT04740905|585154438|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
162026881|NCT04740905|585154437|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
162026882|NCT04740905|585154438|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
162026883|NCT04740905|585154437|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
162026884|NCT04740905|585154438|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
162026885|NCT04740905|585154437|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
162026886|NCT04740905|585154438|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
162026887|NCT03077087|585154439|FG000|Overall Study|Physician Decision|2|||
162026888|NCT01989468|585154440|FG000|Overall Study|Adverse Event|10|||
162026889|NCT01989468|585154441|FG001|Overall Study|Adverse Event|15|||
162026890|NCT01989468|585154442|FG002|Overall Study|Adverse Event|4|||
162026891|NCT01989468|585154443|FG003|Overall Study|Adverse Event|5|||
161944739|NCT00560417|584849585|FG000|Overall Study|Withdrawal by Subject|3|||
161944740|NCT00560417|584849586|FG001|Overall Study|Withdrawal by Subject|3|||
161944741|NCT02164864|584849587|FG000|Overall Study|Trial disease worsening|7|||
161944742|NCT02164864|584849588|FG001|Overall Study|Trial disease worsening|5|||
161944743|NCT02164864|584849589|FG002|Overall Study|Trial disease worsening|1|||
161944744|NCT02164864|584849587|FG000|Overall Study|Other pre-existing disease worsening|6|||
161944745|NCT02164864|584849588|FG001|Overall Study|Other pre-existing disease worsening|4|||
161944746|NCT02164864|584849589|FG002|Overall Study|Other pre-existing disease worsening|9|||
161944747|NCT02164864|584849587|FG000|Overall Study|Other Adverse Event (AE)|52|||
161944748|NCT02164864|584849588|FG001|Overall Study|Other Adverse Event (AE)|32|||
161944749|NCT02164864|584849589|FG002|Overall Study|Other Adverse Event (AE)|49|||
161944750|NCT02164864|584849587|FG000|Overall Study|Protocol Violation|2|||
161944751|NCT02164864|584849588|FG001|Overall Study|Protocol Violation|4|||
161944752|NCT02164864|584849589|FG002|Overall Study|Protocol Violation|1|||
161944753|NCT02164864|584849587|FG000|Overall Study|Lost to Follow-up|4|||
161944754|NCT02164864|584849588|FG001|Overall Study|Lost to Follow-up|3|||
161944755|NCT02164864|584849589|FG002|Overall Study|Lost to Follow-up|2|||
161944756|NCT02164864|584849587|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
161944757|NCT02164864|584849588|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
161944758|NCT02164864|584849589|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
161944759|NCT02164864|584849587|FG000|Overall Study|Other than stated|3|||
162026892|NCT01989468|585154444|FG004|Overall Study|Adverse Event|4|||
162026893|NCT01989468|585154440|FG000|Overall Study|Lack of Efficacy|11|||
162026894|NCT01989468|585154441|FG001|Overall Study|Lack of Efficacy|11|||
162026895|NCT01989468|585154442|FG002|Overall Study|Lack of Efficacy|7|||
161944760|NCT02164864|584849588|FG001|Overall Study|Other than stated|4|||
161683685|NCT03029143|583894667|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
161944761|NCT02164864|584849589|FG002|Overall Study|Other than stated|14|||
162026896|NCT01989468|585154443|FG003|Overall Study|Lack of Efficacy|4|||
161944762|NCT00261833|584849590|FG000|Overall Study|Death|1|||
161944763|NCT00261833|584849591|FG001|Overall Study|Death|3|||
161944764|NCT00261833|584849590|FG000|Overall Study|Adverse Event|1|||
161944765|NCT00261833|584849591|FG001|Overall Study|Adverse Event|4|||
161944766|NCT00261833|584849590|FG000|Overall Study|Withdrawal by Subject|5|||
161944767|NCT00261833|584849591|FG001|Overall Study|Withdrawal by Subject|7|||
161944768|NCT00261833|584849590|FG000|Overall Study|Protocol Violation|0|||
161944769|NCT00261833|584849591|FG001|Overall Study|Protocol Violation|1|||
161944770|NCT00261833|584849590|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
161944771|NCT00261833|584849591|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
161944772|NCT00261833|584849590|FG000|Overall Study|Lung transplantation|1|||
161944773|NCT00261833|584849591|FG001|Overall Study|Lung transplantation|1|||
161944774|NCT00261833|584849590|FG000|Overall Study|Missing reason|1|||
161944775|NCT00261833|584849591|FG001|Overall Study|Missing reason|0|||
161944776|NCT00261833|584849590|FG000|Overall Study|Not interested in being participant|0|||
161944777|NCT00261833|584849591|FG001|Overall Study|Not interested in being participant|1|||
161944778|NCT02037529|584849595|FG000|Overall Study|Withdrawal by Subject|1|||
161944779|NCT02037529|584849596|FG001|Overall Study|Withdrawal by Subject|3|||
161944780|NCT02037529|584849595|FG000|Overall Study|Adverse Event|0|||
161944781|NCT02037529|584849596|FG001|Overall Study|Adverse Event|1|||
161944782|NCT02131766|584849597|FG000|Overall Study|Withdrawal by Subject|4|||
161944783|NCT02271880|584849599|FG000|Overall Study|Premature discontinuation of study|3|||
161944784|NCT02271880|584849600|FG001|Overall Study|Premature discontinuation of study|4|||
161944785|NCT00474903|584849602|FG000|Overall Study|Protocol Violation|1|||
161944786|NCT00474903|584849603|FG001|Overall Study|Protocol Violation|5|||
161944787|NCT00474903|584849604|FG002|Overall Study|Protocol Violation|2|||
161944788|NCT02006927|584849605|FG000|Overall Study|Adverse Event|2|||
161944789|NCT02006927|584849605|FG000|Overall Study|Withdrawal by Subject|1|||
161944790|NCT02519842|584849608|FG000|Base Study: Cycle 1|Screening Failure|1|||
161944791|NCT02519842|584849609|FG001|Base Study: Cycle 1|Screening Failure|1|||
161944792|NCT02519842|584849610|FG002|Base Study: Cycle 1|Screening Failure|0|||
161944793|NCT02519842|584849608|FG000|Base Study: Cycle 1|Adverse Event|1|||
161944794|NCT02519842|584849609|FG001|Base Study: Cycle 1|Adverse Event|0|||
161944795|NCT02519842|584849610|FG002|Base Study: Cycle 1|Adverse Event|0|||
161944796|NCT02519842|584849608|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
161944797|NCT02519842|584849609|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
161944798|NCT02519842|584849610|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
161944799|NCT02519842|584849608|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
161944800|NCT02519842|584849609|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
161944801|NCT02519842|584849610|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
161944802|NCT02519842|584849608|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
161944803|NCT02519842|584849609|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
161944804|NCT02519842|584849610|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
161944805|NCT02519842|584849608|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
161944806|NCT02519842|584849609|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
161944807|NCT02519842|584849610|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
161944808|NCT02519842|584849608|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
162026897|NCT01989468|585154444|FG004|Overall Study|Lack of Efficacy|2|||
161944809|NCT02519842|584849609|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161944810|NCT02519842|584849610|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
162026898|NCT01989468|585154440|FG000|Overall Study|Lost to Follow-up|5|||
161944811|NCT02519842|584849608|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
161944812|NCT02519842|584849609|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
162026899|NCT01989468|585154441|FG001|Overall Study|Lost to Follow-up|2|||
161683686|NCT03029143|583894668|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
161683687|NCT03029143|583894669|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
161683688|NCT03029143|583894667|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
161683689|NCT03029143|583894668|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
161683690|NCT03029143|583894669|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
161683691|NCT03029143|583894667|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
161683692|NCT03029143|583894668|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
161683693|NCT03029143|583894669|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
161832357|NCT04146363|584428391|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832358|NCT04146363|584428392|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832359|NCT04146363|584428393|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161832360|NCT04146363|584428383|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
161944813|NCT02519842|584849610|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
161944814|NCT02519842|584849608|FG000|Optional Extension: Cycles 2-6|Death|0|||
161944815|NCT02519842|584849609|FG001|Optional Extension: Cycles 2-6|Death|0|||
161944816|NCT02519842|584849610|FG002|Optional Extension: Cycles 2-6|Death|1|||
161944817|NCT02519842|584849608|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
161944818|NCT02519842|584849609|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
161944819|NCT02519842|584849610|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
161944820|NCT02519842|584849608|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
161944821|NCT02519842|584849609|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
161944822|NCT02519842|584849610|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
161944823|NCT02519842|584849608|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
161944824|NCT02519842|584849609|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
161944825|NCT02519842|584849610|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
161944826|NCT02519842|584849608|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
161944827|NCT02519842|584849609|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
161944828|NCT02519842|584849610|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
161944829|NCT02639390|584849612|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
161944830|NCT02639390|584849613|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
161944831|NCT01561976|584849614|FG000|Period 1|Adverse Event|0|||
161944832|NCT01561976|584849615|FG001|Period 1|Adverse Event|0|||
161944833|NCT01561976|584849616|FG002|Period 1|Adverse Event|1|||
161944834|NCT01561976|584849617|FG003|Period 1|Adverse Event|0|||
161944835|NCT01561976|584849618|FG004|Period 1|Adverse Event|0|||
161944836|NCT01561976|584849619|FG005|Period 1|Adverse Event|0|||
161944837|NCT01561976|584849614|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
161944838|NCT01561976|584849615|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
161944839|NCT01561976|584849616|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
161944840|NCT01561976|584849617|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
161944841|NCT01561976|584849618|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
161944842|NCT01561976|584849619|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
161944843|NCT01561976|584849614|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161944844|NCT01561976|584849615|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161944845|NCT01561976|584849616|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161944846|NCT01561976|584849617|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161944847|NCT01561976|584849618|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161944848|NCT01561976|584849619|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161944849|NCT01561976|584849614|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
161944850|NCT01561976|584849615|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
161944851|NCT01561976|584849616|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
161944852|NCT01561976|584849617|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
161944853|NCT01561976|584849618|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
161944854|NCT01561976|584849619|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
161944855|NCT01977222|584849622|FG000|Overall Study|Withdrawal by Subject|1|||
161944856|NCT02980107|584849623|FG000|Overall Study|Withdrawal by Subject|51|||
161944857|NCT02980107|584849624|FG001|Overall Study|Withdrawal by Subject|62|||
161944858|NCT03746015|584849625|FG000|Overall Study|Withdrawal of Consent|1|||
161944859|NCT03746015|584849626|FG001|Overall Study|Withdrawal of Consent|0|||
161944860|NCT03746015|584849627|FG002|Overall Study|Withdrawal of Consent|0|||
161944861|NCT00928668|584849628|FG000|Overall Study|Adverse Event|1|||
161944862|NCT00928668|584849629|FG001|Overall Study|Adverse Event|0|||
161944863|NCT00928668|584849630|FG002|Overall Study|Adverse Event|0|||
161944864|NCT00928668|584849631|FG003|Overall Study|Adverse Event|0|||
161944865|NCT00928668|584849632|FG004|Overall Study|Adverse Event|0|||
161944866|NCT00928668|584849628|FG000|Overall Study|Protocol Violation|0|||
161944867|NCT00928668|584849629|FG001|Overall Study|Protocol Violation|0|||
161944868|NCT00928668|584849630|FG002|Overall Study|Protocol Violation|0|||
161944869|NCT00928668|584849631|FG003|Overall Study|Protocol Violation|0|||
161944870|NCT00928668|584849632|FG004|Overall Study|Protocol Violation|1|||
161944871|NCT00928668|584849628|FG000|Overall Study|Withdrawal by Subject|0|||
161944872|NCT00928668|584849629|FG001|Overall Study|Withdrawal by Subject|1|||
161944873|NCT00928668|584849630|FG002|Overall Study|Withdrawal by Subject|1|||
161944874|NCT00928668|584849631|FG003|Overall Study|Withdrawal by Subject|0|||
161944875|NCT00928668|584849632|FG004|Overall Study|Withdrawal by Subject|0|||
161944876|NCT00928668|584849628|FG000|Overall Study|Other reasons not listed above|0|||
161944877|NCT00928668|584849629|FG001|Overall Study|Other reasons not listed above|0|||
161944878|NCT00928668|584849630|FG002|Overall Study|Other reasons not listed above|0|||
161944879|NCT00928668|584849631|FG003|Overall Study|Other reasons not listed above|1|||
161944880|NCT00928668|584849632|FG004|Overall Study|Other reasons not listed above|0|||
161944881|NCT02303262|584849633|FG000|Overall Study|Withdrawal by Subject|2|||
161944882|NCT02412670|584849634|FG000|Overall Study|Adverse Event|4|||
161944883|NCT02412670|584849635|FG001|Overall Study|Adverse Event|1|||
161944884|NCT02412670|584849634|FG000|Overall Study|Physician Decision|1|||
161944885|NCT02412670|584849635|FG001|Overall Study|Physician Decision|0|||
161944886|NCT02412670|584849634|FG000|Overall Study|Withdrawal by Subject|1|||
161944887|NCT02412670|584849635|FG001|Overall Study|Withdrawal by Subject|0|||
161944888|NCT02412670|584849634|FG000|Overall Study|Ineligible|1|||
161944889|NCT02412670|584849635|FG001|Overall Study|Ineligible|0|||
161944890|NCT02943473|584849636|FG000|Overall Study|enrolled but not dosed|1|||
161944891|NCT02943473|584849636|FG000|Overall Study|screen failure|1|||
161944892|NCT02943473|584849636|FG000|Overall Study|Physician Decision|4|||
161944893|NCT01728246|584849637|FG000|Overall Study|Participant needed rescue medication|1|||
161944894|NCT01728246|584849638|FG001|Overall Study|Participant needed rescue medication|5|||
161944895|NCT01728246|584849637|FG000|Overall Study|Protocol Violation|1|||
161944896|NCT01728246|584849638|FG001|Overall Study|Protocol Violation|0|||
161944897|NCT01728246|584849637|FG000|Overall Study|Withdrawal by Subject|2|||
161944898|NCT01728246|584849638|FG001|Overall Study|Withdrawal by Subject|3|||
161944899|NCT01728246|584849637|FG000|Overall Study|Lost to Follow-up|23|||
161944900|NCT01728246|584849638|FG001|Overall Study|Lost to Follow-up|22|||
161944901|NCT01728246|584849637|FG000|Overall Study|Lack of Efficacy|1|||
161944902|NCT01728246|584849638|FG001|Overall Study|Lack of Efficacy|1|||
161944903|NCT01728246|584849637|FG000|Overall Study|Adverse Event|8|||
161944904|NCT01728246|584849638|FG001|Overall Study|Adverse Event|5|||
161944905|NCT05805150|584849639|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
161944906|NCT05805150|584849640|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
161944907|NCT04138056|584849643|FG000|Primary Study|Lost to Follow-up|3|||
161683694|NCT03029143|583894667|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
161683695|NCT03029143|583894668|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
161683696|NCT03029143|583894669|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
161683697|NCT03029143|583894667|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
161683698|NCT03029143|583894668|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
161683699|NCT03029143|583894669|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
161683700|NCT03029143|583894667|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
161683701|NCT03029143|583894668|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
161683702|NCT03029143|583894669|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
161683703|NCT03029143|583894667|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161683704|NCT03029143|583894668|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161683705|NCT03029143|583894669|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
161683706|NCT03029143|583894667|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
161683707|NCT03029143|583894668|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
161683708|NCT03029143|583894669|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
161683709|NCT03029143|583894667|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161683710|NCT03029143|583894668|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
161683711|NCT03029143|583894669|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
161683712|NCT03029143|583894667|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
161683713|NCT03029143|583894668|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
161683714|NCT03029143|583894669|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
161683715|NCT04744207|583894670|FG000|Treatment|Withdrawal by Subject|2|||
161683716|NCT04744207|583894671|FG001|Treatment|Withdrawal by Subject|0|||
161683717|NCT04744207|583894670|FG000|Treatment|Adverse Event|1|||
161683718|NCT04744207|583894671|FG001|Treatment|Adverse Event|2|||
161683719|NCT00825162|583894678|FG000|Overall Study|Withdrawal by Subject|11|||
161683720|NCT00825162|583894679|FG001|Overall Study|Withdrawal by Subject|13|||
161683721|NCT00825162|583894680|FG002|Overall Study|Withdrawal by Subject|3|||
161683722|NCT00825162|583894678|FG000|Overall Study|Lost to Follow-up|9|||
161683723|NCT00825162|583894679|FG001|Overall Study|Lost to Follow-up|6|||
161683724|NCT00825162|583894680|FG002|Overall Study|Lost to Follow-up|3|||
161683725|NCT00825162|583894678|FG000|Overall Study|Physician Decision|2|||
161683726|NCT00825162|583894679|FG001|Overall Study|Physician Decision|0|||
161683727|NCT00825162|583894680|FG002|Overall Study|Physician Decision|0|||
161683728|NCT00825162|583894678|FG000|Overall Study|Move away from the study area|1|||
161683729|NCT00825162|583894679|FG001|Overall Study|Move away from the study area|0|||
161683730|NCT00825162|583894680|FG002|Overall Study|Move away from the study area|0|||
161683731|NCT00825162|583894678|FG000|Overall Study|Unable to attend the study visit|5|||
161683732|NCT00825162|583894679|FG001|Overall Study|Unable to attend the study visit|2|||
161683733|NCT00825162|583894680|FG002|Overall Study|Unable to attend the study visit|0|||
161683734|NCT00258674|583894685|FG000|Overall Study|Death|32|||
161683735|NCT00258674|583894686|FG001|Overall Study|Death|53|||
161683736|NCT00258674|583894687|FG002|Overall Study|Death|34|||
161683737|NCT02973087|583894688|FG000|Overall Study|Withdrawal by Subject|2|||
161683738|NCT02973087|583894689|FG001|Overall Study|Withdrawal by Subject|1|||
161683739|NCT02973087|583894688|FG000|Overall Study|Adverse Event|1|||
161944908|NCT04138056|584849644|FG001|Primary Study|Lost to Follow-up|4|||
161944909|NCT04138056|584849645|FG002|Primary Study|Lost to Follow-up|1|||
161944910|NCT04138056|584849646|FG003|Primary Study|Lost to Follow-up|1|||
161944911|NCT04138056|584849647|FG004|Primary Study|Lost to Follow-up|4|||
161944912|NCT04138056|584849643|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
161944913|NCT04138056|584849644|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
161944914|NCT04138056|584849645|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
161944915|NCT04138056|584849646|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
161944916|NCT04138056|584849647|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
161944917|NCT04138056|584849643|FG000|Extension Study|Lost to Follow-up|1|||
162026900|NCT01989468|585154442|FG002|Overall Study|Lost to Follow-up|0|||
162026901|NCT01989468|585154443|FG003|Overall Study|Lost to Follow-up|1|||
162026902|NCT01989468|585154444|FG004|Overall Study|Lost to Follow-up|1|||
162026903|NCT01989468|585154440|FG000|Overall Study|Physician Decision|4|||
161683740|NCT02973087|583894689|FG001|Overall Study|Adverse Event|0|||
161683741|NCT02973087|583894688|FG000|Overall Study|other|1|||
161683742|NCT02973087|583894689|FG001|Overall Study|other|1|||
161683743|NCT03710486|583894690|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
161683744|NCT03710486|583894691|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
161683745|NCT03710486|583894690|FG000|Overall Study|Missing|0|||
161683746|NCT03710486|583894691|FG001|Overall Study|Missing|2|||
161683747|NCT01279850|583894696|FG000|Overall Study|Protocol Violation|50|||
161683748|NCT01279850|583894696|FG000|Overall Study|No Drug Administration Information|7|||
161683749|NCT01279850|583894696|FG000|Overall Study|No Visit After Treatment|34|||
162026904|NCT01989468|585154441|FG001|Overall Study|Physician Decision|1|||
161944918|NCT04138056|584849644|FG001|Extension Study|Lost to Follow-up|2|||
161944919|NCT04138056|584849645|FG002|Extension Study|Lost to Follow-up|1|||
161944920|NCT04138056|584849646|FG003|Extension Study|Lost to Follow-up|0|||
161944921|NCT04138056|584849647|FG004|Extension Study|Lost to Follow-up|1|||
161944922|NCT01968980|584849651|FG000|Overall Study|Death|0|||
161944923|NCT01968980|584849652|FG001|Overall Study|Death|1|||
161944924|NCT01968980|584849651|FG000|Overall Study|Adverse Event|1|||
161944925|NCT01968980|584849652|FG001|Overall Study|Adverse Event|3|||
161944926|NCT01968980|584849651|FG000|Overall Study|Does not meet entry criteria|1|||
161944927|NCT01968980|584849652|FG001|Overall Study|Does not meet entry criteria|3|||
161944928|NCT01968980|584849651|FG000|Overall Study|Withdrawal by Subject|13|||
161944929|NCT01968980|584849652|FG001|Overall Study|Withdrawal by Subject|5|||
161944930|NCT01968980|584849651|FG000|Overall Study|Other unspecified|1|||
161944931|NCT01968980|584849652|FG001|Overall Study|Other unspecified|2|||
161944932|NCT01242514|584849653|FG000|Overall Study|e.g., project closure|1042|||
161944933|NCT01242514|584849654|FG001|Overall Study|e.g., project closure|305|||
161944934|NCT01242514|584849655|FG002|Overall Study|e.g., project closure|171|||
161944935|NCT01242514|584849653|FG000|Overall Study|Subject decision|33|||
161944936|NCT01242514|584849654|FG001|Overall Study|Subject decision|8|||
161944937|NCT01242514|584849655|FG002|Overall Study|Subject decision|2|||
161944938|NCT01242514|584849653|FG000|Overall Study|Severe non-compliance to protocol|5|||
161944939|NCT01242514|584849654|FG001|Overall Study|Severe non-compliance to protocol|2|||
161944940|NCT01242514|584849655|FG002|Overall Study|Severe non-compliance to protocol|1|||
161944941|NCT01242514|584849653|FG000|Overall Study|Lack of therapeutic response|99|||
161944942|NCT01242514|584849654|FG001|Overall Study|Lack of therapeutic response|16|||
161944943|NCT01242514|584849655|FG002|Overall Study|Lack of therapeutic response|10|||
161944944|NCT01242514|584849653|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
161944945|NCT01242514|584849654|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
161944946|NCT01242514|584849655|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
161944947|NCT01242514|584849653|FG000|Overall Study|Lost to Follow-up|14|||
161944948|NCT01242514|584849654|FG001|Overall Study|Lost to Follow-up|5|||
161944949|NCT01242514|584849655|FG002|Overall Study|Lost to Follow-up|4|||
161944950|NCT01242514|584849653|FG000|Overall Study|Adverse Event|129|||
161944951|NCT01242514|584849654|FG001|Overall Study|Adverse Event|18|||
161944952|NCT01242514|584849655|FG002|Overall Study|Adverse Event|19|||
161944953|NCT03193801|584849659|FG000|Overall Study|Physician Decision|2|||
161944954|NCT03193801|584849659|FG000|Overall Study|Withdrawal by Subject|1|||
161944955|NCT05239221|584849664|FG000|Overall Study|Adverse Event|0|||
161944956|NCT05239221|584849665|FG001|Overall Study|Adverse Event|0|||
161944957|NCT05239221|584849666|FG002|Overall Study|Adverse Event|0|||
161944958|NCT05239221|584849667|FG003|Overall Study|Adverse Event|0|||
161944959|NCT05239221|584849668|FG004|Overall Study|Adverse Event|0|||
161944960|NCT05239221|584849669|FG005|Overall Study|Adverse Event|0|||
161944961|NCT05239221|584849670|FG006|Overall Study|Adverse Event|1|||
161944962|NCT05239221|584849671|FG007|Overall Study|Adverse Event|0|||
161944963|NCT05239221|584849672|FG008|Overall Study|Adverse Event|0|||
161944964|NCT05239221|584849673|FG009|Overall Study|Adverse Event|0|||
161944965|NCT05239221|584849674|FG010|Overall Study|Adverse Event|1|||
161944966|NCT05239221|584849675|FG011|Overall Study|Adverse Event|1|||
161944967|NCT05239221|584849676|FG012|Overall Study|Adverse Event|0|||
161944968|NCT05239221|584849677|FG013|Overall Study|Adverse Event|0|||
161944969|NCT05239221|584849678|FG014|Overall Study|Adverse Event|0|||
161944970|NCT05239221|584849679|FG015|Overall Study|Adverse Event|0|||
161944971|NCT05239221|584849664|FG000|Overall Study|Withdrawal by Subject|0|||
161944972|NCT05239221|584849665|FG001|Overall Study|Withdrawal by Subject|0|||
161944973|NCT05239221|584849666|FG002|Overall Study|Withdrawal by Subject|0|||
161944974|NCT05239221|584849667|FG003|Overall Study|Withdrawal by Subject|0|||
161944975|NCT05239221|584849668|FG004|Overall Study|Withdrawal by Subject|0|||
161944976|NCT05239221|584849669|FG005|Overall Study|Withdrawal by Subject|0|||
161944977|NCT05239221|584849670|FG006|Overall Study|Withdrawal by Subject|0|||
161944978|NCT05239221|584849671|FG007|Overall Study|Withdrawal by Subject|0|||
161944979|NCT05239221|584849672|FG008|Overall Study|Withdrawal by Subject|0|||
161944980|NCT05239221|584849673|FG009|Overall Study|Withdrawal by Subject|0|||
161944981|NCT05239221|584849674|FG010|Overall Study|Withdrawal by Subject|1|||
161944982|NCT05239221|584849675|FG011|Overall Study|Withdrawal by Subject|0|||
161944983|NCT05239221|584849676|FG012|Overall Study|Withdrawal by Subject|0|||
161944984|NCT05239221|584849677|FG013|Overall Study|Withdrawal by Subject|0|||
161944985|NCT05239221|584849678|FG014|Overall Study|Withdrawal by Subject|0|||
161944986|NCT05239221|584849679|FG015|Overall Study|Withdrawal by Subject|1|||
161944987|NCT00529633|584851157|FG000|Overall Study|Withdrawal by Subject|1|||
161944988|NCT00529633|584851158|FG001|Overall Study|Withdrawal by Subject|1|||
161944989|NCT01359956|584851159|FG000|Overall Study|Death|58|||
161944990|NCT01359956|584851160|FG001|Overall Study|Death|60|||
161944991|NCT01359956|584851161|FG002|Overall Study|Death|66|||
161944992|NCT01359956|584851162|FG003|Overall Study|Death|57|||
161944993|NCT01359956|584851159|FG000|Overall Study|Lost to Follow-up|3|||
161944994|NCT01359956|584851160|FG001|Overall Study|Lost to Follow-up|4|||
161944995|NCT01359956|584851161|FG002|Overall Study|Lost to Follow-up|1|||
161944996|NCT01359956|584851162|FG003|Overall Study|Lost to Follow-up|1|||
161944997|NCT01784029|584851163|FG000|Overall Study|Lost to Follow-up|19|||
161944998|NCT01784029|584851164|FG001|Overall Study|Lost to Follow-up|20|||
161944999|NCT01784029|584851165|FG002|Overall Study|Lost to Follow-up|22|||
161945000|NCT03235050|584851168|FG000|Overall Study|Adverse Event|0|||
161945001|NCT03235050|584851169|FG001|Overall Study|Adverse Event|0|||
161945002|NCT03235050|584851170|FG002|Overall Study|Adverse Event|1|||
161945003|NCT03235050|584851171|FG003|Overall Study|Adverse Event|4|||
161945004|NCT03235050|584851172|FG004|Overall Study|Adverse Event|1|||
161945005|NCT03235050|584851168|FG000|Overall Study|Death|0|||
161945006|NCT03235050|584851169|FG001|Overall Study|Death|0|||
161945007|NCT03235050|584851170|FG002|Overall Study|Death|0|||
161945008|NCT03235050|584851171|FG003|Overall Study|Death|2|||
161945009|NCT03235050|584851172|FG004|Overall Study|Death|1|||
161945010|NCT03235050|584851168|FG000|Overall Study|Lost to Follow-up|1|||
161945011|NCT03235050|584851169|FG001|Overall Study|Lost to Follow-up|2|||
161945012|NCT03235050|584851170|FG002|Overall Study|Lost to Follow-up|1|||
161945013|NCT03235050|584851171|FG003|Overall Study|Lost to Follow-up|2|||
161945014|NCT03235050|584851172|FG004|Overall Study|Lost to Follow-up|0|||
161945015|NCT03235050|584851168|FG000|Overall Study|Withdrawal by Subject|3|||
161945016|NCT03235050|584851169|FG001|Overall Study|Withdrawal by Subject|2|||
161945017|NCT03235050|584851170|FG002|Overall Study|Withdrawal by Subject|2|||
161945018|NCT03235050|584851171|FG003|Overall Study|Withdrawal by Subject|5|||
161945019|NCT03235050|584851172|FG004|Overall Study|Withdrawal by Subject|7|||
161945020|NCT03235050|584851168|FG000|Overall Study|Other reasons|0|||
161945021|NCT03235050|584851169|FG001|Overall Study|Other reasons|1|||
161945022|NCT03235050|584851170|FG002|Overall Study|Other reasons|0|||
161945023|NCT03235050|584851171|FG003|Overall Study|Other reasons|1|||
161945024|NCT03235050|584851172|FG004|Overall Study|Other reasons|2|||
161945025|NCT00069641|584851173|FG000|Overall Study|Death|1|||
161945026|NCT00069641|584851174|FG001|Overall Study|Death|0|||
161945027|NCT00069641|584851175|FG002|Overall Study|Death|1|||
161945028|NCT02704208|584851176|FG000|Overall Study|Lost to Follow-up|42|||
161945029|NCT02704208|584851177|FG001|Overall Study|Lost to Follow-up|37|||
161945030|NCT03545672|584851178|FG000|Overall Study|Uncertain diagnosis|2|||
161945031|NCT03545672|584851179|FG001|Overall Study|Uncertain diagnosis|1|||
161945032|NCT03545672|584851178|FG000|Overall Study|Protocol Violation|2|||
161945033|NCT03545672|584851179|FG001|Overall Study|Protocol Violation|2|||
161945034|NCT02415556|584851180|FG000|Overall Study|Adverse Event|3|||
161945035|NCT02415556|584851181|FG001|Overall Study|Adverse Event|4|||
161945036|NCT02415556|584851182|FG002|Overall Study|Adverse Event|2|||
161945037|NCT02415556|584851183|FG003|Overall Study|Adverse Event|4|||
161945038|NCT02415556|584851180|FG000|Overall Study|Lost to Follow-up|4|||
161945039|NCT02415556|584851181|FG001|Overall Study|Lost to Follow-up|5|||
161945040|NCT02415556|584851182|FG002|Overall Study|Lost to Follow-up|4|||
161945041|NCT02415556|584851183|FG003|Overall Study|Lost to Follow-up|1|||
161945042|NCT02415556|584851180|FG000|Overall Study|Withdrawal by Subject|13|||
161945043|NCT02415556|584851181|FG001|Overall Study|Withdrawal by Subject|4|||
161945044|NCT02415556|584851182|FG002|Overall Study|Withdrawal by Subject|14|||
161945045|NCT02415556|584851183|FG003|Overall Study|Withdrawal by Subject|12|||
161945046|NCT02415556|584851180|FG000|Overall Study|Physician Decision|1|||
161945047|NCT02415556|584851181|FG001|Overall Study|Physician Decision|3|||
161945048|NCT02415556|584851182|FG002|Overall Study|Physician Decision|1|||
161945049|NCT02415556|584851183|FG003|Overall Study|Physician Decision|2|||
161945050|NCT02415556|584851180|FG000|Overall Study|Censored - study completion|4|||
161945051|NCT02415556|584851181|FG001|Overall Study|Censored - study completion|5|||
161945052|NCT02415556|584851182|FG002|Overall Study|Censored - study completion|1|||
161945053|NCT02415556|584851183|FG003|Overall Study|Censored - study completion|0|||
161945054|NCT02415556|584851180|FG000|Overall Study|Family-related issues|0|||
161945055|NCT02415556|584851181|FG001|Overall Study|Family-related issues|0|||
161945056|NCT02415556|584851182|FG002|Overall Study|Family-related issues|0|||
161945057|NCT02415556|584851183|FG003|Overall Study|Family-related issues|1|||
161945058|NCT01209767|584851184|FG000|Overall Study|Withdrawal by Subject|1|||
161945059|NCT01209767|584851184|FG000|Overall Study|Lost to Follow-up|3|||
161945060|NCT00105534|584851185|FG000|Overall Study|Adverse Event|2|||
161945061|NCT00105534|584851186|FG001|Overall Study|Adverse Event|5|||
161945062|NCT00105534|584851185|FG000|Overall Study|Protocol Violation|1|||
161945063|NCT00105534|584851186|FG001|Overall Study|Protocol Violation|4|||
161945064|NCT00105534|584851185|FG000|Overall Study|Withdrawal by Subject|6|||
161945065|NCT00105534|584851186|FG001|Overall Study|Withdrawal by Subject|6|||
161945066|NCT00105534|584851185|FG000|Overall Study|Lost to Follow-up|5|||
161945067|NCT00105534|584851186|FG001|Overall Study|Lost to Follow-up|1|||
161945068|NCT00105534|584851185|FG000|Overall Study|Lack of Efficacy|7|||
161945069|NCT00105534|584851186|FG001|Overall Study|Lack of Efficacy|15|||
161945070|NCT00105534|584851185|FG000|Overall Study|Treatment unmasked|1|||
161683750|NCT01147744|583894697|FG000|Overall Study|Protocol Violation|1|||
161683751|NCT01147744|583894698|FG001|Overall Study|Protocol Violation|0|||
161683752|NCT01147744|583894699|FG002|Overall Study|Protocol Violation|1|||
161683753|NCT01147744|583894700|FG003|Overall Study|Protocol Violation|0|||
161683754|NCT01147744|583894701|FG004|Overall Study|Protocol Violation|1|||
161683755|NCT01147744|583894702|FG005|Overall Study|Protocol Violation|3|||
161683756|NCT01147744|583894703|FG006|Overall Study|Protocol Violation|1|||
161683757|NCT01147744|583894697|FG000|Overall Study|Physician Decision|0|||
161683758|NCT01147744|583894698|FG001|Overall Study|Physician Decision|1|||
161683759|NCT01147744|583894699|FG002|Overall Study|Physician Decision|1|||
161683760|NCT01147744|583894700|FG003|Overall Study|Physician Decision|0|||
161683761|NCT01147744|583894701|FG004|Overall Study|Physician Decision|0|||
161683762|NCT01147744|583894702|FG005|Overall Study|Physician Decision|0|||
161683763|NCT01147744|583894703|FG006|Overall Study|Physician Decision|1|||
161683764|NCT01147744|583894697|FG000|Overall Study|Lack of Efficacy|11|||
161832361|NCT04146363|584428384|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
161832362|NCT04146363|584428385|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
161832363|NCT04146363|584428386|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
161832364|NCT04146363|584428387|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
161832365|NCT04146363|584428388|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
161945071|NCT00105534|584851186|FG001|Overall Study|Treatment unmasked|0|||
161945072|NCT00105534|584851185|FG000|Overall Study|Other Reason|0|||
161945073|NCT00105534|584851186|FG001|Overall Study|Other Reason|2|||
161945074|NCT01621178|584851187|FG000|Overall Study|Adverse Event|5|||
161945075|NCT01621178|584851188|FG001|Overall Study|Adverse Event|2|||
161945076|NCT01621178|584851189|FG002|Overall Study|Adverse Event|8|||
161945077|NCT01621178|584851187|FG000|Overall Study|Death|6|||
161945078|NCT01621178|584851188|FG001|Overall Study|Death|7|||
161945079|NCT01621178|584851189|FG002|Overall Study|Death|2|||
161945080|NCT01621178|584851187|FG000|Overall Study|Lost to Follow-up|1|||
161945081|NCT01621178|584851188|FG001|Overall Study|Lost to Follow-up|2|||
161945082|NCT01621178|584851189|FG002|Overall Study|Lost to Follow-up|1|||
161945083|NCT01621178|584851187|FG000|Overall Study|Withdrawal by Subject|14|||
161945084|NCT01621178|584851188|FG001|Overall Study|Withdrawal by Subject|17|||
161945085|NCT01621178|584851189|FG002|Overall Study|Withdrawal by Subject|18|||
161945086|NCT01621178|584851187|FG000|Overall Study|Physician Decision|5|||
161945087|NCT01621178|584851188|FG001|Overall Study|Physician Decision|2|||
161945088|NCT01621178|584851189|FG002|Overall Study|Physician Decision|7|||
161945089|NCT02465931|584851190|FG000|Overall Study|Lost to Follow-up|9|||
161945090|NCT02465931|584851191|FG001|Overall Study|Lost to Follow-up|11|||
161945091|NCT02465931|584851190|FG000|Overall Study|Protocol Violation|1|||
161945092|NCT02465931|584851191|FG001|Overall Study|Protocol Violation|0|||
161945093|NCT02465931|584851190|FG000|Overall Study|Withdrawal by Subject|1|||
161945094|NCT02465931|584851191|FG001|Overall Study|Withdrawal by Subject|0|||
161945095|NCT03423121|584851193|FG000|Overall Study|Lost to Follow-up|2|||
161945096|NCT03423121|584851194|FG001|Overall Study|Lost to Follow-up|6|||
161945097|NCT03423121|584851193|FG000|Overall Study|Adverse Event|1|||
161945098|NCT03423121|584851194|FG001|Overall Study|Adverse Event|0|||
161945099|NCT04102007|584851199|FG000|Overall Study|Adverse Event|4|||
161945100|NCT04102007|584851199|FG000|Overall Study|Lost to Follow-up|3|||
161945101|NCT04102007|584851199|FG000|Overall Study|Withdrawal by Subject|12|||
161945102|NCT04102007|584851199|FG000|Overall Study|Eligibility Violation|5|||
161945103|NCT04102007|584851199|FG000|Overall Study|Lack of Efficacy|6|||
161945104|NCT04102007|584851199|FG000|Overall Study|Protocol Deviation|5|||
161945105|NCT04102007|584851199|FG000|Overall Study|Protocol Compliance|1|||
161945106|NCT04102007|584851199|FG000|Overall Study|Withdrew Treatment|2|||
161945107|NCT04102007|584851199|FG000|Overall Study|Pregnancy|1|||
161945108|NCT03289143|584851200|FG000|Overall Study|Caregiver Unavailability|1|||
161945109|NCT03289143|584851201|FG001|Overall Study|Caregiver Unavailability|1|||
161945110|NCT03289143|584851202|FG002|Overall Study|Caregiver Unavailability|0|||
161683765|NCT01147744|583894698|FG001|Overall Study|Lack of Efficacy|11|||
161683766|NCT01147744|583894699|FG002|Overall Study|Lack of Efficacy|9|||
161683767|NCT01147744|583894700|FG003|Overall Study|Lack of Efficacy|11|||
161683768|NCT01147744|583894701|FG004|Overall Study|Lack of Efficacy|13|||
161683769|NCT01147744|583894702|FG005|Overall Study|Lack of Efficacy|8|||
161683770|NCT01147744|583894703|FG006|Overall Study|Lack of Efficacy|7|||
161683771|NCT01147744|583894697|FG000|Overall Study|Adverse Event|1|||
161945111|NCT03289143|584851203|FG003|Overall Study|Caregiver Unavailability|0|||
161945112|NCT03289143|584851200|FG000|Overall Study|Research Department Closure|0|||
161945113|NCT03289143|584851201|FG001|Overall Study|Research Department Closure|0|||
161683772|NCT01147744|583894698|FG001|Overall Study|Adverse Event|2|||
161683773|NCT01147744|583894699|FG002|Overall Study|Adverse Event|3|||
161945114|NCT03289143|584851202|FG002|Overall Study|Research Department Closure|1|||
161945115|NCT03289143|584851203|FG003|Overall Study|Research Department Closure|0|||
161945116|NCT03289143|584851200|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
161683774|NCT01147744|583894700|FG003|Overall Study|Adverse Event|0|||
161945117|NCT03289143|584851201|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
161945118|NCT03289143|584851202|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
161683775|NCT01147744|583894701|FG004|Overall Study|Adverse Event|2|||
161683776|NCT01147744|583894702|FG005|Overall Study|Adverse Event|1|||
161683777|NCT01147744|583894703|FG006|Overall Study|Adverse Event|2|||
161683778|NCT01147744|583894697|FG000|Overall Study|Withdrawal by Subject|8|||
161683779|NCT01147744|583894698|FG001|Overall Study|Withdrawal by Subject|4|||
161683780|NCT01147744|583894699|FG002|Overall Study|Withdrawal by Subject|2|||
161683781|NCT01147744|583894700|FG003|Overall Study|Withdrawal by Subject|2|||
161683782|NCT01147744|583894701|FG004|Overall Study|Withdrawal by Subject|2|||
161683783|NCT01147744|583894702|FG005|Overall Study|Withdrawal by Subject|5|||
161683784|NCT01147744|583894703|FG006|Overall Study|Withdrawal by Subject|2|||
161683785|NCT01147744|583894697|FG000|Overall Study|Lost to Follow-up|0|||
161683786|NCT01147744|583894698|FG001|Overall Study|Lost to Follow-up|1|||
161683787|NCT01147744|583894699|FG002|Overall Study|Lost to Follow-up|0|||
161683788|NCT01147744|583894700|FG003|Overall Study|Lost to Follow-up|0|||
161683789|NCT01147744|583894701|FG004|Overall Study|Lost to Follow-up|0|||
161683790|NCT01147744|583894702|FG005|Overall Study|Lost to Follow-up|0|||
161683791|NCT01147744|583894703|FG006|Overall Study|Lost to Follow-up|0|||
161683792|NCT01147744|583894697|FG000|Overall Study|Sponsor decision to amend protocol|7|||
161683793|NCT01147744|583894698|FG001|Overall Study|Sponsor decision to amend protocol|4|||
161683794|NCT01147744|583894699|FG002|Overall Study|Sponsor decision to amend protocol|2|||
161683795|NCT01147744|583894700|FG003|Overall Study|Sponsor decision to amend protocol|5|||
161683796|NCT01147744|583894701|FG004|Overall Study|Sponsor decision to amend protocol|7|||
161683797|NCT01147744|583894702|FG005|Overall Study|Sponsor decision to amend protocol|2|||
161683798|NCT01147744|583894703|FG006|Overall Study|Sponsor decision to amend protocol|6|||
161683799|NCT01147744|583894697|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161683800|NCT01147744|583894698|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161683801|NCT01147744|583894699|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161683802|NCT01147744|583894700|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161683803|NCT01147744|583894701|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161683804|NCT01147744|583894702|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161683805|NCT01147744|583894703|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161683806|NCT01342484|583894712|FG000|Overall Study|Other Reasons|1|||
161683807|NCT01342484|583894713|FG001|Overall Study|Other Reasons|0|||
161683808|NCT01342484|583894714|FG002|Overall Study|Other Reasons|0|||
161683809|NCT01342484|583894712|FG000|Overall Study|Protocol Violation|0|||
161832366|NCT04146363|584428389|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
161832367|NCT04146363|584428390|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
161832368|NCT04146363|584428391|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
161945119|NCT03289143|584851203|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
161945120|NCT03289143|584851200|FG000|Overall Study|Medical Monitor Decision|1|||
161945121|NCT03289143|584851201|FG001|Overall Study|Medical Monitor Decision|0|||
161945122|NCT03289143|584851202|FG002|Overall Study|Medical Monitor Decision|0|||
161945123|NCT03289143|584851203|FG003|Overall Study|Medical Monitor Decision|0|||
161945124|NCT03289143|584851200|FG000|Overall Study|Participant Non-Compliance|0|||
161945125|NCT03289143|584851201|FG001|Overall Study|Participant Non-Compliance|0|||
161945126|NCT03289143|584851202|FG002|Overall Study|Participant Non-Compliance|1|||
161945127|NCT03289143|584851203|FG003|Overall Study|Participant Non-Compliance|0|||
161683810|NCT01342484|583894713|FG001|Overall Study|Protocol Violation|0|||
161683811|NCT01342484|583894714|FG002|Overall Study|Protocol Violation|1|||
161683812|NCT01342484|583894712|FG000|Overall Study|Withdrawal by Subject|1|||
161683813|NCT01342484|583894713|FG001|Overall Study|Withdrawal by Subject|0|||
161683814|NCT01342484|583894714|FG002|Overall Study|Withdrawal by Subject|0|||
161945128|NCT03289143|584851200|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
162026905|NCT01989468|585154442|FG002|Overall Study|Physician Decision|0|||
162026906|NCT01989468|585154443|FG003|Overall Study|Physician Decision|1|||
162026907|NCT01989468|585154444|FG004|Overall Study|Physician Decision|0|||
162026908|NCT01989468|585154440|FG000|Overall Study|Pregnancy|0|||
162026909|NCT01989468|585154441|FG001|Overall Study|Pregnancy|1|||
162026910|NCT01989468|585154442|FG002|Overall Study|Pregnancy|0|||
162026911|NCT01989468|585154443|FG003|Overall Study|Pregnancy|0|||
162026912|NCT01989468|585154444|FG004|Overall Study|Pregnancy|0|||
162026913|NCT01989468|585154440|FG000|Overall Study|Technical Problems|3|||
162026914|NCT01989468|585154441|FG001|Overall Study|Technical Problems|1|||
162026915|NCT01989468|585154442|FG002|Overall Study|Technical Problems|3|||
162026916|NCT01989468|585154443|FG003|Overall Study|Technical Problems|1|||
162026917|NCT01989468|585154444|FG004|Overall Study|Technical Problems|0|||
162026918|NCT01989468|585154440|FG000|Overall Study|Subject Guardian Decision|11|||
162026919|NCT01989468|585154441|FG001|Overall Study|Subject Guardian Decision|6|||
162026920|NCT01989468|585154442|FG002|Overall Study|Subject Guardian Decision|4|||
162026921|NCT01989468|585154443|FG003|Overall Study|Subject Guardian Decision|4|||
161683815|NCT00432042|583894715|FG000|Overall Study|Protocol Violation|2|||
161683816|NCT00432042|583894716|FG001|Overall Study|Protocol Violation|0|||
161683817|NCT00432042|583894717|FG002|Overall Study|Protocol Violation|0|||
161832369|NCT04146363|584428392|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
161945129|NCT03289143|584851201|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
161945130|NCT03289143|584851202|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
161945131|NCT03289143|584851203|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
161945132|NCT03289143|584851200|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
161945133|NCT03289143|584851201|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
161945134|NCT03289143|584851202|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
161945135|NCT03289143|584851203|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
161945136|NCT03289143|584851200|FG000|Overall Study|Caregiver Passed Away|1|||
161945137|NCT03289143|584851201|FG001|Overall Study|Caregiver Passed Away|0|||
161945138|NCT03289143|584851202|FG002|Overall Study|Caregiver Passed Away|0|||
161945139|NCT03289143|584851203|FG003|Overall Study|Caregiver Passed Away|0|||
161945140|NCT03289143|584851200|FG000|Overall Study|Physician Decision|0|||
161945141|NCT03289143|584851201|FG001|Overall Study|Physician Decision|2|||
161945142|NCT03289143|584851202|FG002|Overall Study|Physician Decision|2|||
161945143|NCT03289143|584851203|FG003|Overall Study|Physician Decision|2|||
161945144|NCT03289143|584851200|FG000|Overall Study|Protocol Deviation|2|||
161945145|NCT03289143|584851201|FG001|Overall Study|Protocol Deviation|1|||
161945146|NCT03289143|584851202|FG002|Overall Study|Protocol Deviation|3|||
161945147|NCT03289143|584851203|FG003|Overall Study|Protocol Deviation|1|||
161945148|NCT03289143|584851200|FG000|Overall Study|Study Terminated By Sponsor|101|||
161945149|NCT03289143|584851201|FG001|Overall Study|Study Terminated By Sponsor|75|||
161945150|NCT03289143|584851202|FG002|Overall Study|Study Terminated By Sponsor|100|||
161945151|NCT03289143|584851203|FG003|Overall Study|Study Terminated By Sponsor|69|||
161945152|NCT03289143|584851200|FG000|Overall Study|Withdrawal by Subject|14|||
161945153|NCT03289143|584851201|FG001|Overall Study|Withdrawal by Subject|6|||
161945154|NCT03289143|584851202|FG002|Overall Study|Withdrawal by Subject|14|||
161945155|NCT03289143|584851203|FG003|Overall Study|Withdrawal by Subject|12|||
161945156|NCT03289143|584851200|FG000|Overall Study|Adverse Event|10|||
161945157|NCT03289143|584851201|FG001|Overall Study|Adverse Event|7|||
161945158|NCT03289143|584851202|FG002|Overall Study|Adverse Event|6|||
161945159|NCT03289143|584851203|FG003|Overall Study|Adverse Event|5|||
161945160|NCT03289143|584851200|FG000|Overall Study|Death|2|||
161945161|NCT03289143|584851201|FG001|Overall Study|Death|0|||
161945162|NCT03289143|584851202|FG002|Overall Study|Death|2|||
161945163|NCT03289143|584851203|FG003|Overall Study|Death|1|||
161945164|NCT03289143|584851200|FG000|Overall Study|Lost to Follow-up|2|||
161945165|NCT03289143|584851201|FG001|Overall Study|Lost to Follow-up|1|||
161945166|NCT03289143|584851202|FG002|Overall Study|Lost to Follow-up|1|||
161945167|NCT03289143|584851203|FG003|Overall Study|Lost to Follow-up|0|||
161945168|NCT03289143|584851200|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
161945169|NCT03289143|584851201|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
161945170|NCT03289143|584851202|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
161945171|NCT03289143|584851203|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
161945172|NCT03289143|584851200|FG000|Overall Study|Withdrawal by Caregiver|0|||
162026922|NCT01989468|585154444|FG004|Overall Study|Subject Guardian Decision|1|||
161832370|NCT04146363|584428393|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
161945173|NCT03289143|584851201|FG001|Overall Study|Withdrawal by Caregiver|1|||
161945174|NCT03289143|584851202|FG002|Overall Study|Withdrawal by Caregiver|0|||
161945175|NCT03289143|584851203|FG003|Overall Study|Withdrawal by Caregiver|0|||
161945176|NCT03289143|584851200|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
161683818|NCT00432042|583894715|FG000|Overall Study|Withdrawal by Subject|0|||
162026923|NCT01989468|585154440|FG000|Overall Study|Death|3|||
162026924|NCT01989468|585154441|FG001|Overall Study|Death|0|||
162026925|NCT01989468|585154442|FG002|Overall Study|Death|1|||
162026926|NCT01989468|585154443|FG003|Overall Study|Death|0|||
162026927|NCT01989468|585154444|FG004|Overall Study|Death|0|||
162026928|NCT01224782|585154445|FG000|Overall Study|Lost to Follow-up|177|||
162026929|NCT01224782|585154445|FG000|Overall Study|Withdrawal by Subject|16|||
162026930|NCT01224782|585154445|FG000|Overall Study|Death|14|||
162026931|NCT01224782|585154445|FG000|Overall Study|Improvement|13|||
162026932|NCT01224782|585154445|FG000|Overall Study|Adverse Event|12|||
162026933|NCT01224782|585154445|FG000|Overall Study|Adverse Reaction|11|||
162026934|NCT01224782|585154445|FG000|Overall Study|Noncompliance|10|||
162026935|NCT01224782|585154445|FG000|Overall Study|Other|4|||
162026936|NCT01224782|585154445|FG000|Overall Study|Start of Dialysis|3|||
162026937|NCT01224782|585154445|FG000|Overall Study|Change of Treatment|1|||
162026938|NCT01224782|585154445|FG000|Overall Study|Financial Reasons|1|||
162026939|NCT01224782|585154445|FG000|Overall Study|Deterioration|1|||
162026940|NCT01224782|585154445|FG000|Overall Study|Transplantation|1|||
162026941|NCT01960907|585154446|FG000|Overall Study|Death|4|||
162026942|NCT01960907|585154447|FG001|Overall Study|Death|3|||
162026943|NCT01960907|585154446|FG000|Overall Study|Withdrawal by Subject|32|||
162026944|NCT01960907|585154447|FG001|Overall Study|Withdrawal by Subject|42|||
162026945|NCT01950013|585154449|FG000|Overall Study|Withdrawal by Subject|0|||
162026946|NCT01950013|585154450|FG001|Overall Study|Withdrawal by Subject|2|||
162026947|NCT01950013|585154451|FG002|Overall Study|Withdrawal by Subject|0|||
162026948|NCT01765218|585154452|FG000|Overall Study|Protocol Violation|1|||
162026949|NCT01765218|585154453|FG001|Overall Study|Protocol Violation|2|||
162026950|NCT01590758|585154454|FG000|Overall Study|Withdrawal by Subject|0|||
162026951|NCT01590758|585154455|FG001|Overall Study|Withdrawal by Subject|3|||
162026952|NCT01590758|585154454|FG000|Overall Study|Physician Decision|1|||
162026953|NCT01590758|585154455|FG001|Overall Study|Physician Decision|2|||
162026954|NCT01590758|585154454|FG000|Overall Study|Lost to Follow-up|4|||
162026955|NCT01590758|585154455|FG001|Overall Study|Lost to Follow-up|2|||
162026956|NCT02929498|585154456|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
162026957|NCT02929498|585154457|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
162026958|NCT02929498|585154458|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
162026959|NCT02929498|585154456|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
162026960|NCT02929498|585154457|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
162026961|NCT02929498|585154458|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
162026962|NCT01011309|585154463|FG000|Overall Study|Adverse Event|2|||
162026963|NCT01011309|585154464|FG001|Overall Study|Adverse Event|1|||
162026964|NCT01011309|585154465|FG002|Overall Study|Adverse Event|2|||
162026965|NCT01011309|585154463|FG000|Overall Study|Lack of Efficacy|0|||
162026966|NCT01011309|585154464|FG001|Overall Study|Lack of Efficacy|1|||
162026967|NCT01011309|585154465|FG002|Overall Study|Lack of Efficacy|0|||
162026968|NCT01011309|585154463|FG000|Overall Study|Protocol Violation|0|||
162026969|NCT01011309|585154464|FG001|Overall Study|Protocol Violation|1|||
162026970|NCT01011309|585154465|FG002|Overall Study|Protocol Violation|3|||
162026971|NCT00530504|585154468|FG000|Overall Study|Death|54|||
162026972|NCT00530504|585154468|FG000|Overall Study|Lost to Follow-up|26|||
162026973|NCT00530504|585154468|FG000|Overall Study|Withdrawal by Subject|39|||
162026974|NCT00530504|585154468|FG000|Overall Study|Exited study due to other reasons|33|||
162026975|NCT00006289|585154469|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
162026976|NCT00006289|585154470|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
162026977|NCT00006289|585154469|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
161945177|NCT03289143|584851201|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
161945178|NCT03289143|584851202|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
161945179|NCT03289143|584851203|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
161945180|NCT03289143|584851200|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
161945181|NCT03289143|584851201|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
161945182|NCT03289143|584851202|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
161945183|NCT03289143|584851203|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
161945184|NCT00730756|584851204|FG000|Overall Study|Adverse Event|2|||
161945185|NCT00730756|584851205|FG001|Overall Study|Adverse Event|0|||
161945186|NCT00730756|584851204|FG000|Overall Study|Lack of Efficacy|1|||
161945187|NCT00730756|584851205|FG001|Overall Study|Lack of Efficacy|1|||
161945188|NCT00730756|584851204|FG000|Overall Study|Protocol Deviation|1|||
161945189|NCT00730756|584851205|FG001|Overall Study|Protocol Deviation|2|||
162026978|NCT00006289|585154470|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
162026979|NCT00576420|585156096|FG000|Overall Study|Death|0|||
162026980|NCT00576420|585156097|FG001|Overall Study|Death|0|||
162026981|NCT00576420|585156098|FG002|Overall Study|Death|1|||
162026982|NCT02616146|585156099|FG000|Overall Study|Adverse Event|64|||
162026983|NCT02616146|585156100|FG001|Overall Study|Adverse Event|24|||
162026984|NCT02616146|585156099|FG000|Overall Study|Lost to Follow-up|23|||
162026985|NCT02616146|585156100|FG001|Overall Study|Lost to Follow-up|13|||
162026986|NCT02616146|585156099|FG000|Overall Study|Non-compliance with study protocol|2|||
162026987|NCT02616146|585156100|FG001|Overall Study|Non-compliance with study protocol|0|||
162026988|NCT02616146|585156099|FG000|Overall Study|Non-compliance with study drug|4|||
162026989|NCT02616146|585156100|FG001|Overall Study|Non-compliance with study drug|2|||
161945190|NCT00730756|584851204|FG000|Overall Study|Lost to Follow-up|0|||
161945191|NCT00730756|584851205|FG001|Overall Study|Lost to Follow-up|1|||
161945192|NCT00730756|584851204|FG000|Overall Study|Withdrew Consent|0|||
161945193|NCT00730756|584851205|FG001|Overall Study|Withdrew Consent|1|||
161945194|NCT00948688|584851206|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
161945195|NCT00948688|584851207|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
161945196|NCT00948688|584851206|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
161945197|NCT00948688|584851207|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
161945198|NCT00948688|584851206|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
161945199|NCT00948688|584851207|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
161945200|NCT04388826|584851208|FG000|Overall Study|Lost to Follow-up|3|||
161945201|NCT04388826|584851209|FG001|Overall Study|Lost to Follow-up|2|||
161945202|NCT04388826|584851208|FG000|Overall Study|Adverse Event|1|||
161945203|NCT04388826|584851209|FG001|Overall Study|Adverse Event|0|||
161945204|NCT01840943|584851210|FG000|Overall Study|Withdrawal by Subject|5|||
161945205|NCT01840943|584851211|FG001|Overall Study|Withdrawal by Subject|6|||
161945206|NCT01840943|584851210|FG000|Overall Study|Physician Decision|4|||
161945207|NCT01840943|584851211|FG001|Overall Study|Physician Decision|2|||
161945208|NCT01840943|584851210|FG000|Overall Study|Lost to Follow-up|4|||
161945209|NCT01840943|584851211|FG001|Overall Study|Lost to Follow-up|4|||
161945210|NCT01446874|584851212|FG000|Overall Study|Not eligible|1|||
161945211|NCT01446874|584851213|FG001|Overall Study|Not eligible|0|||
161945212|NCT01446874|584851214|FG002|Overall Study|Not eligible|0|||
161945213|NCT01446874|584851212|FG000|Overall Study|No surgery/No qualifying surgery|1|||
161945214|NCT01446874|584851213|FG001|Overall Study|No surgery/No qualifying surgery|0|||
161945215|NCT01446874|584851214|FG002|Overall Study|No surgery/No qualifying surgery|12|||
161945216|NCT01446874|584851212|FG000|Overall Study|Non-compliance|0|||
161945217|NCT01446874|584851213|FG001|Overall Study|Non-compliance|4|||
161945218|NCT01446874|584851214|FG002|Overall Study|Non-compliance|0|||
161945219|NCT01446874|584851212|FG000|Overall Study|Antibiotics for pre-op infection|0|||
161945220|NCT01446874|584851213|FG001|Overall Study|Antibiotics for pre-op infection|0|||
161945221|NCT01446874|584851214|FG002|Overall Study|Antibiotics for pre-op infection|2|||
161945222|NCT01446874|584851212|FG000|Overall Study|Withdrawal by Subject|0|||
161945223|NCT01446874|584851213|FG001|Overall Study|Withdrawal by Subject|0|||
161945224|NCT01446874|584851214|FG002|Overall Study|Withdrawal by Subject|4|||
161945225|NCT03639610|584851219|FG000|Overall Study|Adverse Event|7|||
161945226|NCT03639610|584851220|FG001|Overall Study|Adverse Event|1|||
161945227|NCT03639610|584851221|FG002|Overall Study|Adverse Event|0|||
161945228|NCT03639610|584851219|FG000|Overall Study|Physician Decision|3|||
161945229|NCT03639610|584851220|FG001|Overall Study|Physician Decision|1|||
161945230|NCT03639610|584851221|FG002|Overall Study|Physician Decision|0|||
161945231|NCT03639610|584851219|FG000|Overall Study|Disease progression|8|||
161945232|NCT03639610|584851220|FG001|Overall Study|Disease progression|5|||
161945233|NCT03639610|584851221|FG002|Overall Study|Disease progression|3|||
161945234|NCT03639610|584851219|FG000|Overall Study|Study terminated by sponsor|2|||
161945235|NCT03639610|584851220|FG001|Overall Study|Study terminated by sponsor|1|||
161945236|NCT03639610|584851221|FG002|Overall Study|Study terminated by sponsor|1|||
161945237|NCT03639610|584851219|FG000|Overall Study|Patient request to stop treatment|1|||
161945238|NCT03639610|584851220|FG001|Overall Study|Patient request to stop treatment|2|||
161945239|NCT03639610|584851221|FG002|Overall Study|Patient request to stop treatment|0|||
161945240|NCT02727322|584851222|FG000|Overall Study|Withdrawal by Subject|1|||
161945241|NCT02727322|584851223|FG001|Overall Study|Withdrawal by Subject|1|||
161945242|NCT02727322|584851222|FG000|Overall Study|Protocol Violation|1|||
161945243|NCT02727322|584851223|FG001|Overall Study|Protocol Violation|0|||
161945244|NCT04573972|584851227|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
161945245|NCT04573972|584851228|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
161945246|NCT01517984|584851229|FG000|Overall Study|Lost to Follow-up|0|||
161945247|NCT01517984|584851230|FG001|Overall Study|Lost to Follow-up|1|||
161945248|NCT01517984|584851231|FG002|Overall Study|Lost to Follow-up|0|||
161945249|NCT01517984|584851232|FG003|Overall Study|Lost to Follow-up|0|||
161945250|NCT01517984|584851229|FG000|Overall Study|Withdrawal by Subject|1|||
161945251|NCT01517984|584851230|FG001|Overall Study|Withdrawal by Subject|8|||
161945252|NCT01517984|584851231|FG002|Overall Study|Withdrawal by Subject|4|||
161945253|NCT01517984|584851232|FG003|Overall Study|Withdrawal by Subject|1|||
161945254|NCT01517984|584851229|FG000|Overall Study|Screen Failure|4|||
161945255|NCT01517984|584851230|FG001|Overall Study|Screen Failure|0|||
161945256|NCT01517984|584851231|FG002|Overall Study|Screen Failure|0|||
161945257|NCT01517984|584851232|FG003|Overall Study|Screen Failure|0|||
161945258|NCT01517984|584851229|FG000|Overall Study|Ineligible for randomization|0|||
161945259|NCT01517984|584851230|FG001|Overall Study|Ineligible for randomization|14|||
161945260|NCT01517984|584851231|FG002|Overall Study|Ineligible for randomization|0|||
161945261|NCT01517984|584851232|FG003|Overall Study|Ineligible for randomization|0|||
161945262|NCT05067335|584851235|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
161945263|NCT05067335|584851236|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
161945264|NCT05067335|584851237|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
161945265|NCT05067335|584851238|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
162026990|NCT02616146|585156099|FG000|Overall Study|Pregnancy|2|||
162026991|NCT02616146|585156100|FG001|Overall Study|Pregnancy|2|||
162026992|NCT02616146|585156099|FG000|Overall Study|Pregnancy wish|3|||
162026993|NCT02616146|585156100|FG001|Overall Study|Pregnancy wish|0|||
162026994|NCT02616146|585156099|FG000|Overall Study|Protocol Violation|6|||
162026995|NCT02616146|585156100|FG001|Overall Study|Protocol Violation|3|||
162026996|NCT02616146|585156099|FG000|Overall Study|Study terminated by sponsor|1372|||
162026997|NCT02616146|585156100|FG001|Overall Study|Study terminated by sponsor|432|||
162026998|NCT02616146|585156099|FG000|Overall Study|Participant moved|4|||
162026999|NCT02616146|585156100|FG001|Overall Study|Participant moved|3|||
162027000|NCT02616146|585156099|FG000|Overall Study|Withdrawal by Subject|30|||
162027001|NCT02616146|585156100|FG001|Overall Study|Withdrawal by Subject|24|||
162027002|NCT02616146|585156099|FG000|Overall Study|Physician Decision|2|||
162027003|NCT02616146|585156100|FG001|Overall Study|Physician Decision|1|||
162027004|NCT01221272|585156101|FG000|Period 1|Adverse Event|2|||
162027005|NCT01221272|585156102|FG001|Period 1|Adverse Event|0|||
162027006|NCT01221272|585156101|FG000|Period 1|Consent Withdrawal|0|||
162027007|NCT01221272|585156102|FG001|Period 1|Consent Withdrawal|1|||
162027008|NCT01221272|585156101|FG000|Period 1|Significant Dosing Noncompliance|0|||
162027009|NCT01221272|585156102|FG001|Period 1|Significant Dosing Noncompliance|1|||
162027010|NCT01221272|585156101|FG000|Period 2|Adverse Event|0|||
162027011|NCT01221272|585156102|FG001|Period 2|Adverse Event|2|||
162027012|NCT01340872|585156103|FG000|Double-blind Phase|Adverse Event|6|||
162027013|NCT01340872|585156104|FG001|Double-blind Phase|Adverse Event|4|||
162027014|NCT01340872|585156105|FG002|Double-blind Phase|Adverse Event|0|||
162027015|NCT01340872|585156106|FG003|Double-blind Phase|Adverse Event|0|||
162027016|NCT01340872|585156103|FG000|Double-blind Phase|Withdrawal by Subject|3|||
162027017|NCT01340872|585156104|FG001|Double-blind Phase|Withdrawal by Subject|5|||
162027018|NCT01340872|585156105|FG002|Double-blind Phase|Withdrawal by Subject|0|||
162027019|NCT01340872|585156106|FG003|Double-blind Phase|Withdrawal by Subject|0|||
161683819|NCT00432042|583894716|FG001|Overall Study|Withdrawal by Subject|0|||
161683820|NCT00432042|583894717|FG002|Overall Study|Withdrawal by Subject|2|||
162027020|NCT01340872|585156103|FG000|Double-blind Phase|Lost to Follow-up|0|||
162027021|NCT01340872|585156104|FG001|Double-blind Phase|Lost to Follow-up|1|||
162027022|NCT01340872|585156105|FG002|Double-blind Phase|Lost to Follow-up|0|||
162027023|NCT01340872|585156106|FG003|Double-blind Phase|Lost to Follow-up|0|||
162027024|NCT01340872|585156103|FG000|Double-blind Phase|Protocol Violation|0|||
162027025|NCT01340872|585156104|FG001|Double-blind Phase|Protocol Violation|1|||
162027026|NCT01340872|585156105|FG002|Double-blind Phase|Protocol Violation|0|||
162027027|NCT01340872|585156106|FG003|Double-blind Phase|Protocol Violation|0|||
162027028|NCT01340872|585156103|FG000|Open-label Phase|Physician Decision|0|||
161832371|NCT04146363|584428383|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161832372|NCT04146363|584428384|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161945266|NCT05067335|584851235|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
161945267|NCT05067335|584851236|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
161945268|NCT05067335|584851237|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
161945269|NCT05067335|584851238|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
161945270|NCT05067335|584851235|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
161945271|NCT05067335|584851236|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
161945272|NCT05067335|584851237|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
161945273|NCT05067335|584851238|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
161945274|NCT05067335|584851235|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
161945275|NCT05067335|584851236|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
161945276|NCT05067335|584851237|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
161945277|NCT05067335|584851238|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
161945278|NCT05067335|584851235|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
161945279|NCT05067335|584851236|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
161945280|NCT05067335|584851237|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
161945281|NCT05067335|584851238|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
161945282|NCT05067335|584851235|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
161945283|NCT05067335|584851236|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
161945284|NCT05067335|584851237|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
161945285|NCT05067335|584851238|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
161945286|NCT05067335|584851235|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
161945287|NCT05067335|584851236|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
161945288|NCT05067335|584851237|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
161945289|NCT05067335|584851238|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
161945290|NCT05067335|584851235|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
161945291|NCT05067335|584851236|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
161945292|NCT05067335|584851237|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
161945293|NCT05067335|584851238|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
161945294|NCT05067335|584851235|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
161683821|NCT00432042|583894715|FG000|Overall Study|Lost to Follow-up|5|||
161683822|NCT00432042|583894716|FG001|Overall Study|Lost to Follow-up|1|||
161683823|NCT00432042|583894717|FG002|Overall Study|Lost to Follow-up|0|||
161683824|NCT01744665|583894719|FG000|Monitoring Phase|Adverse Event|4|||
161683825|NCT01744665|583894719|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
161683826|NCT01744665|583894719|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
161683827|NCT01744665|583894719|FG000|Monitoring Phase|Withdrawal by Subject|5|||
161683828|NCT01744665|583894719|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
161683829|NCT01744665|583894719|FG000|Consolidation Phase|Adverse Event|2|||
161683830|NCT01744665|583894719|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
161832373|NCT04146363|584428385|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161832374|NCT04146363|584428386|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161832375|NCT04146363|584428387|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
161832376|NCT04146363|584428388|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
161832377|NCT04146363|584428389|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
161832378|NCT04146363|584428390|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
161832379|NCT04146363|584428391|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161832380|NCT04146363|584428392|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161832381|NCT04146363|584428393|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161832382|NCT04146363|584428383|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161683831|NCT01744665|583894719|FG000|Consolidation Phase|Withdrawal by Subject|4|||
161832383|NCT04146363|584428384|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161832384|NCT04146363|584428385|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
161832385|NCT04146363|584428386|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161832386|NCT04146363|584428387|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161832387|NCT04146363|584428388|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
161832388|NCT04146363|584428389|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
161832389|NCT04146363|584428390|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
161832390|NCT04146363|584428391|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161832391|NCT04146363|584428392|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161832392|NCT04146363|584428393|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161832393|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832394|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832395|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832396|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832397|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832398|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832399|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832400|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832401|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
161832402|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
161832403|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
161832404|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832405|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832406|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832407|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832408|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832409|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832410|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832411|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161832412|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
161832413|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
161832414|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
161832415|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161832416|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161832417|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161832418|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161832419|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161832420|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161945295|NCT05067335|584851236|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
161945296|NCT05067335|584851237|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
161683832|NCT01744665|583894719|FG000|Consolidation Phase|Administrative problems|9|||
161945297|NCT05067335|584851238|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
161945298|NCT05067335|584851235|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
161945299|NCT05067335|584851236|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
161945300|NCT05067335|584851237|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
161945301|NCT05067335|584851238|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
161945302|NCT02724839|584851239|FG000|Overall Study|Withdrawal by Subject|1|||
161945303|NCT02724839|584851240|FG001|Overall Study|Withdrawal by Subject|1|||
161945304|NCT02724839|584851241|FG002|Overall Study|Withdrawal by Subject|0|||
161945305|NCT02724839|584851239|FG000|Overall Study|Lost to Follow-up|0|||
161945306|NCT02724839|584851240|FG001|Overall Study|Lost to Follow-up|3|||
161945307|NCT02724839|584851241|FG002|Overall Study|Lost to Follow-up|2|||
161945308|NCT02724839|584851239|FG000|Overall Study|Physician Decision|0|||
161945309|NCT02724839|584851240|FG001|Overall Study|Physician Decision|0|||
161945310|NCT02724839|584851241|FG002|Overall Study|Physician Decision|3|||
161945311|NCT03610048|584851242|FG000|Overall Study|Study terminated by sponsor|84|||
161945312|NCT03610048|584851242|FG000|Overall Study|Adverse Event|32|||
161945313|NCT03610048|584851242|FG000|Overall Study|Withdrawal by Subject|31|||
161945314|NCT03610048|584851242|FG000|Overall Study|Lost to Follow-up|8|||
161945315|NCT03610048|584851242|FG000|Overall Study|Other|4|||
161945316|NCT03610048|584851242|FG000|Overall Study|Physician Decision|1|||
161945317|NCT03610048|584851242|FG000|Overall Study|Pregnancy|1|||
161945318|NCT01155050|584851243|FG000|Overall Study|Lost to Follow-up|15|||
161945319|NCT01155050|584851244|FG001|Overall Study|Lost to Follow-up|20|||
161945320|NCT01155050|584851245|FG002|Overall Study|Lost to Follow-up|19|||
161945321|NCT01155050|584851246|FG003|Overall Study|Lost to Follow-up|22|||
161945322|NCT05878067|584851247|FG000|Overall Study|Lost to Follow-up|2|||
161945323|NCT01198587|584851248|FG000|Overall Study|Lost to Follow-up|8|||
161945324|NCT01198587|584851249|FG001|Overall Study|Lost to Follow-up|0|||
161945325|NCT01198587|584851250|FG002|Overall Study|Lost to Follow-up|9|||
161945326|NCT01198587|584851251|FG003|Overall Study|Lost to Follow-up|0|||
161945327|NCT01959529|584851252|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
161945328|NCT01959529|584851253|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
161945329|NCT01959529|584851252|FG000|Overall Study|Lost to Follow-up|4|||
161945330|NCT01959529|584851253|FG001|Overall Study|Lost to Follow-up|1|||
161945331|NCT01959529|584851252|FG000|Overall Study|Other|70|||
161945332|NCT01959529|584851253|FG001|Overall Study|Other|68|||
161945333|NCT01959529|584851252|FG000|Overall Study|Hypoglycaemia|1|||
161945334|NCT01959529|584851253|FG001|Overall Study|Hypoglycaemia|1|||
161945335|NCT01959529|584851252|FG000|Overall Study|Lack of glycaemic control|1|||
161945336|NCT01959529|584851253|FG001|Overall Study|Lack of glycaemic control|1|||
161945337|NCT00399529|584851254|FG000|Overall Study|Off Study Prior to Treatment|2|||
161945338|NCT01164007|584851255|FG000|Overall Study|Adverse Event|5|||
161945339|NCT01164007|584851255|FG000|Overall Study|Progression of Disease|30|||
161945340|NCT01164007|584851255|FG000|Overall Study|Protocol Violation|1|||
161945341|NCT01164007|584851255|FG000|Overall Study|Withdrawal by Subject|1|||
161945342|NCT01164007|584851255|FG000|Overall Study|Medical Decision|3|||
161945343|NCT01908140|584851260|FG000|Overall Study|Other or Progressive Disease|5|||
161945344|NCT01908140|584851261|FG001|Overall Study|Other or Progressive Disease|12|||
161945345|NCT01908140|584851260|FG000|Overall Study|Lack of Efficacy|7|||
161945346|NCT01908140|584851261|FG001|Overall Study|Lack of Efficacy|5|||
161945347|NCT01908140|584851260|FG000|Overall Study|Withdrawal by Subject|23|||
161945348|NCT01908140|584851261|FG001|Overall Study|Withdrawal by Subject|24|||
161945349|NCT01908140|584851260|FG000|Overall Study|Lost to Follow-up|1|||
161945350|NCT01908140|584851261|FG001|Overall Study|Lost to Follow-up|6|||
161945351|NCT01908140|584851260|FG000|Overall Study|Protocol Violation|8|||
161945352|NCT01908140|584851261|FG001|Overall Study|Protocol Violation|9|||
161945353|NCT01908140|584851260|FG000|Overall Study|Adverse Event|22|||
161945354|NCT01908140|584851261|FG001|Overall Study|Adverse Event|23|||
161945355|NCT03218917|584851262|FG000|Overall Study|Adverse Event|3|||
161945356|NCT03218917|584851263|FG001|Overall Study|Adverse Event|3|||
161945357|NCT03218917|584851264|FG002|Overall Study|Adverse Event|2|||
161945358|NCT03218917|584851262|FG000|Overall Study|Subject withdrew consent|2|||
161945359|NCT03218917|584851263|FG001|Overall Study|Subject withdrew consent|4|||
161945360|NCT03218917|584851264|FG002|Overall Study|Subject withdrew consent|10|||
161945361|NCT03218917|584851262|FG000|Overall Study|Physician Decision|0|||
161945362|NCT03218917|584851263|FG001|Overall Study|Physician Decision|1|||
161945363|NCT03218917|584851264|FG002|Overall Study|Physician Decision|1|||
161945364|NCT03218917|584851262|FG000|Overall Study|Lost to Follow-up|1|||
161945365|NCT03218917|584851263|FG001|Overall Study|Lost to Follow-up|0|||
161945366|NCT03218917|584851264|FG002|Overall Study|Lost to Follow-up|0|||
161945367|NCT03218917|584851262|FG000|Overall Study|Reason Missing|0|||
161945368|NCT03218917|584851263|FG001|Overall Study|Reason Missing|2|||
161945369|NCT03218917|584851264|FG002|Overall Study|Reason Missing|0|||
161945370|NCT03218917|584851262|FG000|Overall Study|Death|0|||
161945371|NCT03218917|584851263|FG001|Overall Study|Death|1|||
161945372|NCT03218917|584851264|FG002|Overall Study|Death|0|||
161683833|NCT01744665|583894719|FG000|Re-initiation Phase|Administrative problems|10|||
161683834|NCT01744665|583894719|FG000|Re-initiation Phase|Adverse Event|1|||
161683835|NCT01744665|583894719|FG000|Re-initiation Phase|No longer required treatment|1|||
161683836|NCT01744665|583894719|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
161683837|NCT00492752|583894720|FG000|Double Blind Treatment|Death|13|||
161683838|NCT00492752|583894721|FG001|Double Blind Treatment|Death|0|||
161683839|NCT00492752|583894722|FG002|Double Blind Treatment|Death|2|||
161683840|NCT00492752|583894723|FG003|Double Blind Treatment|Death|0|||
161683841|NCT00492752|583894720|FG000|Double Blind Treatment|Adverse Event|1|||
161683842|NCT00492752|583894721|FG001|Double Blind Treatment|Adverse Event|0|||
161683843|NCT00492752|583894722|FG002|Double Blind Treatment|Adverse Event|0|||
161683844|NCT00492752|583894723|FG003|Double Blind Treatment|Adverse Event|0|||
161683845|NCT00492752|583894720|FG000|Double Blind Treatment|Protocol Violation|0|||
161683846|NCT00492752|583894721|FG001|Double Blind Treatment|Protocol Violation|0|||
161683847|NCT00492752|583894722|FG002|Double Blind Treatment|Protocol Violation|1|||
161683848|NCT00492752|583894723|FG003|Double Blind Treatment|Protocol Violation|0|||
161683849|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
161683850|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
161683851|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
161683852|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
161683853|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
161683854|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
161683855|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
161683856|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
161945373|NCT03218917|584851262|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161945374|NCT03218917|584851263|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161945375|NCT03218917|584851264|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161945376|NCT01076010|584851267|FG000|Overall Study|Death|15|||
161945377|NCT01076010|584851268|FG001|Overall Study|Death|1|||
161945378|NCT01076010|584851269|FG002|Overall Study|Death|0|||
161945379|NCT01076010|584851267|FG000|Overall Study|Adverse Event|7|||
161945380|NCT01076010|584851268|FG001|Overall Study|Adverse Event|2|||
161945381|NCT01076010|584851269|FG002|Overall Study|Adverse Event|0|||
161945382|NCT01076010|584851267|FG000|Overall Study|Progressive disease|90|||
161945383|NCT01076010|584851268|FG001|Overall Study|Progressive disease|30|||
161945384|NCT01076010|584851269|FG002|Overall Study|Progressive disease|1|||
161945385|NCT01076010|584851267|FG000|Overall Study|Lack of Efficacy|4|||
161945386|NCT01076010|584851268|FG001|Overall Study|Lack of Efficacy|0|||
161945387|NCT01076010|584851269|FG002|Overall Study|Lack of Efficacy|0|||
161945388|NCT01076010|584851267|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
161945389|NCT01076010|584851268|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
161945390|NCT01076010|584851269|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
161945391|NCT01076010|584851267|FG000|Overall Study|Significant Surgical Procedure|0|||
161945392|NCT01076010|584851268|FG001|Overall Study|Significant Surgical Procedure|1|||
161945393|NCT01076010|584851269|FG002|Overall Study|Significant Surgical Procedure|0|||
161945394|NCT01076010|584851267|FG000|Overall Study|Protocol Violation|0|||
161945395|NCT01076010|584851268|FG001|Overall Study|Protocol Violation|1|||
161945396|NCT01076010|584851269|FG002|Overall Study|Protocol Violation|0|||
161945397|NCT01076010|584851267|FG000|Overall Study|Noncompliance|1|||
161945398|NCT01076010|584851268|FG001|Overall Study|Noncompliance|1|||
161945399|NCT01076010|584851269|FG002|Overall Study|Noncompliance|0|||
161945400|NCT01076010|584851267|FG000|Overall Study|Withdrawal by Subject|3|||
161945401|NCT01076010|584851268|FG001|Overall Study|Withdrawal by Subject|0|||
161945402|NCT01076010|584851269|FG002|Overall Study|Withdrawal by Subject|1|||
161945403|NCT01076010|584851267|FG000|Overall Study|Other|5|||
161945404|NCT01076010|584851268|FG001|Overall Study|Other|2|||
161945405|NCT01076010|584851269|FG002|Overall Study|Other|0|||
161945406|NCT05200845|584851272|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
161945407|NCT05200845|584851273|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
161945408|NCT05200845|584851274|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
161945409|NCT05200845|584851275|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
161683857|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
161683858|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
161683859|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
161683860|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
161945410|NCT05200845|584851272|FG000|Overall Study|Withdrawal by Subject|0|||
161945411|NCT05200845|584851273|FG001|Overall Study|Withdrawal by Subject|1|||
161945412|NCT05200845|584851274|FG002|Overall Study|Withdrawal by Subject|1|||
161945413|NCT05200845|584851275|FG003|Overall Study|Withdrawal by Subject|0|||
161945414|NCT00431964|584851283|FG000|Overall Study|Adverse Event|1|||
161945415|NCT00431964|584851284|FG001|Overall Study|Adverse Event|0|||
161945416|NCT00431964|584851283|FG000|Overall Study|Lost to Follow-up|1|||
161945417|NCT00431964|584851284|FG001|Overall Study|Lost to Follow-up|2|||
161945418|NCT00431964|584851283|FG000|Overall Study|Physician Decision|2|||
161945419|NCT00431964|584851284|FG001|Overall Study|Physician Decision|2|||
161945420|NCT00431964|584851283|FG000|Overall Study|Withdrawal by Subject|2|||
161945421|NCT00431964|584851284|FG001|Overall Study|Withdrawal by Subject|1|||
161945422|NCT00431964|584851283|FG000|Overall Study|Parental Consent Withdrawn|0|||
161945423|NCT00431964|584851284|FG001|Overall Study|Parental Consent Withdrawn|2|||
161945424|NCT00431964|584851283|FG000|Overall Study|Due to Unstable Health|0|||
161945425|NCT00431964|584851284|FG001|Overall Study|Due to Unstable Health|1|||
161945426|NCT00397540|584851285|FG000|Overall Study|short follow-up duration < 12 months|1|||
161945427|NCT00397540|584851286|FG001|Overall Study|short follow-up duration < 12 months|0|||
161945428|NCT00776230|584851291|FG000|Overall Study|Lost to Follow-up|2|||
161945429|NCT00776230|584851292|FG001|Overall Study|Lost to Follow-up|1|||
161945430|NCT00776230|584851293|FG002|Overall Study|Lost to Follow-up|5|||
161945431|NCT00776230|584851291|FG000|Overall Study|Not vaccinated at Day 0|1|||
161945432|NCT00776230|584851292|FG001|Overall Study|Not vaccinated at Day 0|0|||
161945433|NCT00776230|584851293|FG002|Overall Study|Not vaccinated at Day 0|0|||
161945434|NCT00776230|584851291|FG000|Overall Study|Withdrawal by Subject|0|||
161945435|NCT00776230|584851292|FG001|Overall Study|Withdrawal by Subject|1|||
161945436|NCT00776230|584851293|FG002|Overall Study|Withdrawal by Subject|0|||
161945437|NCT00776230|584851291|FG000|Overall Study|Subject missed Visit 4|0|||
161945438|NCT00776230|584851292|FG001|Overall Study|Subject missed Visit 4|1|||
161945439|NCT00776230|584851293|FG002|Overall Study|Subject missed Visit 4|0|||
161945440|NCT01215851|584851294|FG000|Treatment Period|Adverse Event|1|||
161945441|NCT01215851|584851295|FG001|Treatment Period|Adverse Event|1|||
161945442|NCT01215851|584851296|FG002|Treatment Period|Adverse Event|1|||
161945443|NCT01215851|584851297|FG003|Treatment Period|Adverse Event|3|||
161945444|NCT01215851|584851298|FG004|Treatment Period|Adverse Event|0|||
161945445|NCT01215851|584851299|FG005|Treatment Period|Adverse Event|1|||
161945446|NCT01215851|584851294|FG000|Follow up Period|Lost to Follow-up|0|||
161945447|NCT01215851|584851295|FG001|Follow up Period|Lost to Follow-up|0|||
161945448|NCT01215851|584851296|FG002|Follow up Period|Lost to Follow-up|0|||
161945449|NCT01215851|584851297|FG003|Follow up Period|Lost to Follow-up|0|||
161945450|NCT01215851|584851298|FG004|Follow up Period|Lost to Follow-up|0|||
161945451|NCT01215851|584851299|FG005|Follow up Period|Lost to Follow-up|1|||
161945452|NCT02297412|584851300|FG000|Overall Study|Canceled|1|||
161945453|NCT02297412|584851301|FG001|Overall Study|Canceled|1|||
161945454|NCT03189719|584851302|FG000|Overall Study|Death|325|||
161945455|NCT03189719|584851303|FG001|Overall Study|Death|361|||
161945456|NCT03189719|584851302|FG000|Overall Study|Physician Decision|1|||
161945457|NCT03189719|584851303|FG001|Overall Study|Physician Decision|0|||
161945458|NCT03189719|584851302|FG000|Overall Study|Sponsor Decision|40|||
161945459|NCT03189719|584851303|FG001|Overall Study|Sponsor Decision|12|||
162027029|NCT01340872|585156104|FG001|Open-label Phase|Physician Decision|0|||
162027030|NCT01340872|585156105|FG002|Open-label Phase|Physician Decision|2|||
162027031|NCT01340872|585156106|FG003|Open-label Phase|Physician Decision|1|||
162027032|NCT01340872|585156103|FG000|Open-label Phase|Pregnancy|0|||
162027033|NCT01340872|585156104|FG001|Open-label Phase|Pregnancy|0|||
162027034|NCT01340872|585156105|FG002|Open-label Phase|Pregnancy|1|||
162027035|NCT01340872|585156106|FG003|Open-label Phase|Pregnancy|0|||
162027036|NCT01340872|585156103|FG000|Open-label Phase|Adverse Event|0|||
162027037|NCT01340872|585156104|FG001|Open-label Phase|Adverse Event|0|||
162027038|NCT01340872|585156105|FG002|Open-label Phase|Adverse Event|8|||
162027039|NCT01340872|585156106|FG003|Open-label Phase|Adverse Event|4|||
162027040|NCT01340872|585156103|FG000|Open-label Phase|Withdrawal by Subject|0|||
162027041|NCT01340872|585156104|FG001|Open-label Phase|Withdrawal by Subject|0|||
162027042|NCT01340872|585156105|FG002|Open-label Phase|Withdrawal by Subject|1|||
162027043|NCT01340872|585156106|FG003|Open-label Phase|Withdrawal by Subject|6|||
162027044|NCT01340872|585156103|FG000|Open-label Phase|Worsening of IBD|0|||
162027045|NCT01340872|585156104|FG001|Open-label Phase|Worsening of IBD|0|||
162027046|NCT01340872|585156105|FG002|Open-label Phase|Worsening of IBD|1|||
162027047|NCT01340872|585156106|FG003|Open-label Phase|Worsening of IBD|0|||
162027048|NCT03039621|585156111|FG000|Overall Study|Violation of inclusion criteria|3|||
162027049|NCT03039621|585156112|FG001|Overall Study|Violation of inclusion criteria|2|||
162027050|NCT03039621|585156111|FG000|Overall Study|Non-compliance with protocol requirement|4|||
162027051|NCT03039621|585156112|FG001|Overall Study|Non-compliance with protocol requirement|5|||
162027052|NCT03039621|585156111|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
162027053|NCT03039621|585156112|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
162027054|NCT03039621|585156111|FG000|Overall Study|Violation of non-inclusion criteria|1|||
162027055|NCT03039621|585156112|FG001|Overall Study|Violation of non-inclusion criteria|2|||
162027056|NCT02522624|585156113|FG000|Overall Study|Technical failure|1|||
162027057|NCT02522624|585156114|FG001|Overall Study|Technical failure|0|||
162027058|NCT03254108|585156115|FG000|Overall Study|Adverse Event|0|||
162027059|NCT03254108|585156116|FG001|Overall Study|Adverse Event|2|||
162027060|NCT03254108|585156117|FG002|Overall Study|Adverse Event|0|||
162027061|NCT03254108|585156118|FG003|Overall Study|Adverse Event|1|||
162027062|NCT03254108|585156119|FG004|Overall Study|Adverse Event|1|||
162027063|NCT03254108|585156115|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
162027064|NCT03254108|585156116|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
162027065|NCT03254108|585156117|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
162027066|NCT03254108|585156118|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
162027067|NCT03254108|585156119|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
162027068|NCT00362180|585156120|FG000|Treated Period|Withdrawal by Subject|1|||
162027069|NCT00362180|585156121|FG001|Treated Period|Withdrawal by Subject|0|||
162027070|NCT00362180|585156122|FG002|Treated Period|Withdrawal by Subject|0|||
162027071|NCT00362180|585156123|FG003|Treated Period|Withdrawal by Subject|0|||
162027072|NCT00362180|585156124|FG004|Treated Period|Withdrawal by Subject|0|||
162027073|NCT00362180|585156125|FG005|Treated Period|Withdrawal by Subject|0|||
162027074|NCT00362180|585156126|FG006|Treated Period|Withdrawal by Subject|0|||
162027075|NCT00362180|585156127|FG007|Treated Period|Withdrawal by Subject|0|||
162027076|NCT00362180|585156128|FG008|Treated Period|Withdrawal by Subject|0|||
162027077|NCT00362180|585156120|FG000|Treated Period|Adverse Event|0|||
162027078|NCT00362180|585156121|FG001|Treated Period|Adverse Event|0|||
162027079|NCT00362180|585156122|FG002|Treated Period|Adverse Event|0|||
162027080|NCT00362180|585156123|FG003|Treated Period|Adverse Event|0|||
162027081|NCT00362180|585156124|FG004|Treated Period|Adverse Event|0|||
162027082|NCT00362180|585156125|FG005|Treated Period|Adverse Event|1|||
162027083|NCT00362180|585156126|FG006|Treated Period|Adverse Event|0|||
162027084|NCT00362180|585156127|FG007|Treated Period|Adverse Event|1|||
162027085|NCT00362180|585156128|FG008|Treated Period|Adverse Event|0|||
162027086|NCT02600871|585156131|FG000|Overall Study|Lost to Follow-up|13|||
162027087|NCT02600871|585156132|FG001|Overall Study|Lost to Follow-up|10|||
162027088|NCT01246466|585156136|FG000|Overall Study|Death|1|||
162027089|NCT01246466|585156136|FG000|Overall Study|Withdrawal by Subject|1|||
162027090|NCT01142089|585156137|FG000|Overall Study|Physician Decision|1|||
162027091|NCT01142089|585156138|FG001|Overall Study|Physician Decision|0|||
162027092|NCT01142089|585156137|FG000|Overall Study|Withdrawal by Subject|1|||
162027093|NCT01142089|585156138|FG001|Overall Study|Withdrawal by Subject|2|||
162027094|NCT01142089|585156137|FG000|Overall Study|Use of prohibited medications|0|||
162027095|NCT01142089|585156138|FG001|Overall Study|Use of prohibited medications|1|||
162027096|NCT01142089|585156137|FG000|Overall Study|Noncompliance with study procedures|2|||
162027097|NCT01142089|585156138|FG001|Overall Study|Noncompliance with study procedures|1|||
162027098|NCT01142089|585156137|FG000|Overall Study|Patient required rescue medication|8|||
162027099|NCT01142089|585156138|FG001|Overall Study|Patient required rescue medication|17|||
162027100|NCT00348933|585156141|FG000|Overall Study|Withdrawal by Subject|10|||
162027101|NCT00348933|585156141|FG000|Overall Study|Lost to Follow-up|6|||
162027102|NCT00348933|585156141|FG000|Overall Study|Protocol Violation|2|||
162027103|NCT00348933|585156141|FG000|Overall Study|Adverse Event|7|||
162027104|NCT01489111|585156142|FG000|Overall Study|Withdrawal criterion|1|||
162027105|NCT00003472|585156145|FG000|Overall Study|Not evaluable|3|||
162027106|NCT00874939|585156146|FG000|Overall Study|Study terminated|4|||
162027107|NCT01350544|585156147|FG000|Overall Study|Administrative Withdrawal|0|||
162027108|NCT01350544|585156148|FG001|Overall Study|Administrative Withdrawal|1|||
162027109|NCT01350544|585156147|FG000|Overall Study|Death|1|||
162027110|NCT01350544|585156148|FG001|Overall Study|Death|2|||
162027111|NCT01350544|585156147|FG000|Overall Study|Moved out of LA County|2|||
162027112|NCT01350544|585156148|FG001|Overall Study|Moved out of LA County|2|||
162027113|NCT01350544|585156147|FG000|Overall Study|Medical Issues|1|||
162027114|NCT01350544|585156148|FG001|Overall Study|Medical Issues|1|||
162027115|NCT01350544|585156147|FG000|Overall Study|Withdrawal by Subject|0|||
162027116|NCT01350544|585156148|FG001|Overall Study|Withdrawal by Subject|1|||
162027117|NCT01350544|585156147|FG000|Overall Study|Incarceration|1|||
162027118|NCT01350544|585156148|FG001|Overall Study|Incarceration|0|||
162027119|NCT01350544|585156147|FG000|Overall Study|Lost to Follow-up|18|||
162027120|NCT01350544|585156148|FG001|Overall Study|Lost to Follow-up|15|||
162027121|NCT01444092|585156149|FG000|Overall Study|Adverse Event|8|||
162027122|NCT01444092|585156149|FG000|Overall Study|Protocol Violation|1|||
162027123|NCT01444092|585156149|FG000|Overall Study|Withdrawal by Subject|1|||
162027124|NCT01444092|585156149|FG000|Overall Study|Other Eligibility criteria|7|||
162027125|NCT00603590|585156150|FG000|Overall Study|Did not attend study clinic|39|||
162027126|NCT00603590|585156151|FG001|Overall Study|Did not attend study clinic|30|||
162027127|NCT00603590|585156150|FG000|Overall Study|Refused blood test|5|||
162027128|NCT00603590|585156151|FG001|Overall Study|Refused blood test|1|||
162027129|NCT00603590|585156150|FG000|Overall Study|Patient discontinued study drug|22|||
162027130|NCT00603590|585156151|FG001|Overall Study|Patient discontinued study drug|15|||
162027131|NCT00603590|585156150|FG000|Overall Study|Adverse Event|2|||
162027132|NCT00603590|585156151|FG001|Overall Study|Adverse Event|0|||
162027133|NCT00603590|585156150|FG000|Overall Study|Lost to Follow-up|8|||
161832421|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161832422|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161945460|NCT03189719|584851302|FG000|Overall Study|Withdrawal by Subject|7|||
161945461|NCT03189719|584851303|FG001|Overall Study|Withdrawal by Subject|3|||
161945462|NCT03012880|584851304|FG000|Overall Study|Withdrawal by Subject|1|||
161945463|NCT03012880|584851305|FG001|Overall Study|Withdrawal by Subject|0|||
161945464|NCT03012880|584851304|FG000|Overall Study|Ineligible|1|||
161945465|NCT03012880|584851305|FG001|Overall Study|Ineligible|0|||
161945466|NCT05211596|584851306|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
161945467|NCT05211596|584851306|FG000|Baseline to 6 Months|Death|1|||
161945468|NCT05211596|584851306|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
161945469|NCT05211596|584851306|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
161945470|NCT02293551|584851307|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
161945471|NCT02293551|584851308|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
161945472|NCT02293551|584851309|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
161945473|NCT02293551|584851310|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
161945474|NCT02293551|584851311|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
161945475|NCT02293551|584851312|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
162027134|NCT00603590|585156151|FG001|Overall Study|Lost to Follow-up|4|||
162027135|NCT00603590|585156150|FG000|Overall Study|Cardiovascular event|0|||
162027136|NCT00603590|585156151|FG001|Overall Study|Cardiovascular event|1|||
162027137|NCT03005873|585156155|FG000|Overall Study|Prohibited medication use post radnomization|1|||
162027138|NCT03005873|585156156|FG001|Overall Study|Prohibited medication use post radnomization|1|||
162027139|NCT03005873|585156157|FG002|Overall Study|Prohibited medication use post radnomization|1|||
162027140|NCT03005873|585156155|FG000|Overall Study|Withdrew consent|0|||
162027141|NCT03005873|585156156|FG001|Overall Study|Withdrew consent|1|||
162027142|NCT03005873|585156157|FG002|Overall Study|Withdrew consent|2|||
162027143|NCT03005873|585156155|FG000|Overall Study|Lost to Follow-up|0|||
162027144|NCT03005873|585156156|FG001|Overall Study|Lost to Follow-up|1|||
161945476|NCT02293551|584851307|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
161945477|NCT02293551|584851308|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
161945478|NCT02293551|584851309|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
161945479|NCT02293551|584851310|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
161945480|NCT02293551|584851311|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
161945481|NCT02293551|584851312|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
161945482|NCT02293551|584851307|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
161945483|NCT02293551|584851308|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
161945484|NCT02293551|584851309|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
161945485|NCT02293551|584851310|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
161945486|NCT02293551|584851311|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
161945487|NCT02293551|584851312|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
161945488|NCT04532749|584851313|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
161945489|NCT04532749|584851314|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
161945490|NCT04532749|584851313|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
161945491|NCT04532749|584851314|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
161945492|NCT04532749|584851313|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
161945493|NCT04532749|584851314|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
161945494|NCT04532749|584851313|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
161945495|NCT04532749|584851314|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
161945496|NCT04532749|584851313|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
161945497|NCT04532749|584851314|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
161945498|NCT04532749|584851313|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
161945499|NCT04532749|584851314|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
161945500|NCT04532749|584851313|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
161945501|NCT04532749|584851314|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
161945502|NCT04532749|584851313|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
161945503|NCT04532749|584851314|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
161945504|NCT04532749|584851313|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
161945505|NCT04532749|584851314|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
161945506|NCT04532749|584851313|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
161945507|NCT04532749|584851314|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
161945508|NCT01400412|584851315|FG000|Overall Study|Lost to Follow-up|4|||
161945509|NCT01400412|584851316|FG001|Overall Study|Lost to Follow-up|7|||
161945510|NCT01400412|584851315|FG000|Overall Study|Withdrawal by Subject|3|||
161945511|NCT01400412|584851316|FG001|Overall Study|Withdrawal by Subject|4|||
161945512|NCT01400412|584851315|FG000|Overall Study|Unable to complete|3|||
161945513|NCT01400412|584851316|FG001|Overall Study|Unable to complete|3|||
161945514|NCT01400412|584851315|FG000|Overall Study|Never started study treatment|0|||
161945515|NCT01400412|584851316|FG001|Overall Study|Never started study treatment|3|||
161945516|NCT01649869|584851317|FG000|Overall Study|Family member illness|1|||
161945517|NCT01649869|584851318|FG001|Overall Study|Family member illness|0|||
161945518|NCT01649869|584851317|FG000|Overall Study|Required treatment outside protocol|1|||
161945519|NCT01649869|584851318|FG001|Overall Study|Required treatment outside protocol|0|||
161945520|NCT01649869|584851317|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
161945521|NCT01649869|584851318|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
161945522|NCT02935192|584853088|FG000|Overall Study|Withdrawal by Subject|8|||
161945523|NCT02935192|584853089|FG001|Overall Study|Withdrawal by Subject|4|||
161945524|NCT00492557|584853091|FG000|Overall Study|Subject request|12|||
161945525|NCT00492557|584853092|FG001|Overall Study|Subject request|11|||
161683861|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
161683862|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
161683863|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
161683864|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
161683865|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
161683866|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
161683867|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
161683868|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
161683869|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
161683870|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
161683871|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
161683872|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
161683873|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
161683874|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
161683875|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
161683876|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
161683877|NCT00492752|583894720|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
161683878|NCT00492752|583894721|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
161683879|NCT00492752|583894722|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
161683880|NCT00492752|583894723|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
161683881|NCT04857996|583894724|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
161683882|NCT04857996|583894725|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
161683883|NCT04857996|583894724|FG000|Overall Study|Lost to Follow-up|1|||
161683884|NCT04857996|583894725|FG001|Overall Study|Lost to Follow-up|3|||
161683885|NCT04857996|583894724|FG000|Overall Study|Site Closure|1|||
161683886|NCT04857996|583894725|FG001|Overall Study|Site Closure|0|||
161683887|NCT04857996|583894724|FG000|Overall Study|Withdrawal by Subject|1|||
161683888|NCT04857996|583894725|FG001|Overall Study|Withdrawal by Subject|0|||
161683889|NCT02988661|583894726|FG000|Overall Study|Death|2|||
161683890|NCT02988661|583894727|FG001|Overall Study|Death|18|||
161683891|NCT02988661|583894726|FG000|Overall Study|Lost to Follow-up|0|||
161683892|NCT02988661|583894727|FG001|Overall Study|Lost to Follow-up|33|||
161683893|NCT02988661|583894726|FG000|Overall Study|Withdrawal by Subject|0|||
161683894|NCT02988661|583894727|FG001|Overall Study|Withdrawal by Subject|6|||
161683895|NCT02988661|583894726|FG000|Overall Study|Unable to complete the 18-month survey|1|||
161683896|NCT02988661|583894727|FG001|Overall Study|Unable to complete the 18-month survey|27|||
161683897|NCT04050982|583894728|FG000|Overall Study|Did not meet eligibility criteria|0|||
161683898|NCT04050982|583894729|FG001|Overall Study|Did not meet eligibility criteria|1|||
161683899|NCT04050982|583894730|FG002|Overall Study|Did not meet eligibility criteria|0|||
161683900|NCT04050982|583894728|FG000|Overall Study|Withdrawal by Subject|1|||
161683901|NCT04050982|583894729|FG001|Overall Study|Withdrawal by Subject|0|||
161683902|NCT04050982|583894730|FG002|Overall Study|Withdrawal by Subject|0|||
161683903|NCT04050982|583894728|FG000|Overall Study|Unable to enroll on platform|1|||
161683904|NCT04050982|583894729|FG001|Overall Study|Unable to enroll on platform|0|||
161683905|NCT04050982|583894730|FG002|Overall Study|Unable to enroll on platform|0|||
161683906|NCT04649255|583895877|FG000|Overall Study|Death|9|||
161683907|NCT04649255|583895877|FG000|Overall Study|Withdrawal by Subject|1|||
161683908|NCT02222207|583895881|FG000|Overall Study|Death|1|||
161683909|NCT02222207|583895881|FG000|Overall Study|Other reasons|2|||
161683910|NCT02222207|583895881|FG000|Overall Study|Adverse Event|1|||
161683911|NCT04682405|583895882|FG000|Overall Study|Adverse Event|0|||
161945526|NCT00492557|584853091|FG000|Overall Study|Protocol Violation|7|||
161683912|NCT04682405|583895883|FG001|Overall Study|Adverse Event|1|||
161945527|NCT00492557|584853092|FG001|Overall Study|Protocol Violation|8|||
161683913|NCT00747643|583895884|FG000|Overall Study|Withdrawal by Subject|36|||
161683914|NCT00747643|583895885|FG001|Overall Study|Withdrawal by Subject|27|||
161945528|NCT00492557|584853091|FG000|Overall Study|Other|2|||
161683915|NCT03557281|583895886|FG000|Overall Study|Investigator discretion|0|||
161683916|NCT03557281|583895887|FG001|Overall Study|Investigator discretion|0|||
161683917|NCT03557281|583895888|FG002|Overall Study|Investigator discretion|1|||
161683918|NCT03557281|583895889|FG003|Overall Study|Investigator discretion|0|||
161683919|NCT03557281|583895890|FG004|Overall Study|Investigator discretion|0|||
161945529|NCT00492557|584853092|FG001|Overall Study|Other|2|||
161945530|NCT00492557|584853091|FG000|Overall Study|Death|1|||
161683920|NCT03557281|583895886|FG000|Overall Study|Withdrawal by Subject|0|||
161683921|NCT03557281|583895887|FG001|Overall Study|Withdrawal by Subject|1|||
161683922|NCT03557281|583895888|FG002|Overall Study|Withdrawal by Subject|1|||
161683923|NCT03557281|583895889|FG003|Overall Study|Withdrawal by Subject|1|||
161683924|NCT03557281|583895890|FG004|Overall Study|Withdrawal by Subject|2|||
161683925|NCT03557281|583895886|FG000|Overall Study|Randomized, but did not receive treatment|0|||
161683926|NCT03557281|583895887|FG001|Overall Study|Randomized, but did not receive treatment|0|||
161683927|NCT03557281|583895888|FG002|Overall Study|Randomized, but did not receive treatment|0|||
161683928|NCT03557281|583895889|FG003|Overall Study|Randomized, but did not receive treatment|0|||
161683929|NCT03557281|583895890|FG004|Overall Study|Randomized, but did not receive treatment|1|||
161683930|NCT01199042|583895891|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
161683931|NCT01199042|583895891|FG000|At Home (3 Months)|Lost to Follow-up|1|||
161683932|NCT03357731|583895896|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
161683933|NCT03357731|583895897|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
161683934|NCT03357731|583895898|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
161683935|NCT03357731|583895899|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
161683936|NCT03357731|583895900|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
161683937|NCT03357731|583895901|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
161683938|NCT03357731|583895896|FG000|Overall Study|Acute bradycardia and hypotension|0|||
161683939|NCT03357731|583895897|FG001|Overall Study|Acute bradycardia and hypotension|0|||
161683940|NCT03357731|583895898|FG002|Overall Study|Acute bradycardia and hypotension|0|||
161683941|NCT03357731|583895899|FG003|Overall Study|Acute bradycardia and hypotension|1|||
161945531|NCT00492557|584853092|FG001|Overall Study|Death|1|||
161683942|NCT03357731|583895900|FG004|Overall Study|Acute bradycardia and hypotension|0|||
161683943|NCT03357731|583895901|FG005|Overall Study|Acute bradycardia and hypotension|0|||
161683944|NCT03357731|583895896|FG000|Overall Study|Adverse Event|0|||
161683945|NCT03357731|583895897|FG001|Overall Study|Adverse Event|0|||
161683946|NCT03357731|583895898|FG002|Overall Study|Adverse Event|0|||
161945532|NCT00492557|584853091|FG000|Overall Study|Adverse Event|1|||
161945533|NCT00492557|584853092|FG001|Overall Study|Adverse Event|0|||
161683947|NCT03357731|583895899|FG003|Overall Study|Adverse Event|0|||
161683948|NCT03357731|583895900|FG004|Overall Study|Adverse Event|0|||
161683949|NCT03357731|583895901|FG005|Overall Study|Adverse Event|1|||
161945534|NCT00492557|584853091|FG000|Overall Study|Failed to return|1|||
161945535|NCT00492557|584853092|FG001|Overall Study|Failed to return|0|||
161945536|NCT00492557|584853091|FG000|Overall Study|Lost to Follow-up|0|||
161945537|NCT00492557|584853092|FG001|Overall Study|Lost to Follow-up|1|||
161945538|NCT04778592|584853096|FG000|Overall Study|Adverse Event|1|||
161945539|NCT04778592|584853097|FG001|Overall Study|Adverse Event|2|||
161945540|NCT04778592|584853096|FG000|Overall Study|Withdrawal by Subject|1|||
161945541|NCT04778592|584853097|FG001|Overall Study|Withdrawal by Subject|2|||
161945542|NCT01354223|584853099|FG000|Overall Study|Withdrawal by Subject|3|||
161945543|NCT01354223|584853100|FG001|Overall Study|Withdrawal by Subject|1|||
161945544|NCT05173974|584853104|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
161945545|NCT05173974|584853105|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
161945546|NCT05173974|584853106|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
162027145|NCT03005873|585156157|FG002|Overall Study|Lost to Follow-up|0|||
161683950|NCT03357731|583895896|FG000|Overall Study|Hypotension|0|||
161683951|NCT03357731|583895897|FG001|Overall Study|Hypotension|0|||
161683952|NCT03357731|583895898|FG002|Overall Study|Hypotension|1|||
161832423|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
161832424|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
162027146|NCT03005873|585156155|FG000|Overall Study|Ineligible post randomization|0|||
162027147|NCT03005873|585156156|FG001|Overall Study|Ineligible post randomization|0|||
161683953|NCT03357731|583895899|FG003|Overall Study|Hypotension|1|||
161683954|NCT03357731|583895900|FG004|Overall Study|Hypotension|0|||
161683955|NCT03357731|583895901|FG005|Overall Study|Hypotension|0|||
161683956|NCT03357731|583895896|FG000|Overall Study|Lost to Follow-up|0|||
161683957|NCT03357731|583895897|FG001|Overall Study|Lost to Follow-up|0|||
161683958|NCT03357731|583895898|FG002|Overall Study|Lost to Follow-up|0|||
161683959|NCT03357731|583895899|FG003|Overall Study|Lost to Follow-up|1|||
161683960|NCT03357731|583895900|FG004|Overall Study|Lost to Follow-up|0|||
161683961|NCT03357731|583895901|FG005|Overall Study|Lost to Follow-up|0|||
161683962|NCT01773109|583895902|FG000|Overall Study|Symptomatic Progression|2|||
161683963|NCT01773109|583895902|FG000|Overall Study|Death|1|||
161683964|NCT01239342|583895903|FG000|Overall Study|Adverse Event|1|||
161683965|NCT01239342|583895904|FG001|Overall Study|Adverse Event|0|||
161683966|NCT01239342|583895903|FG000|Overall Study|Withdrawal by Subject|1|||
161683967|NCT01239342|583895904|FG001|Overall Study|Withdrawal by Subject|5|||
161683968|NCT01239342|583895903|FG000|Overall Study|Reason Unknown|1|||
161683969|NCT01239342|583895904|FG001|Overall Study|Reason Unknown|1|||
161683970|NCT01849874|583895907|FG000|Overall Study|Death|89|||
161683971|NCT01849874|583895908|FG001|Overall Study|Death|42|||
161683972|NCT01849874|583895907|FG000|Overall Study|Withdrawal by Subject|17|||
161683973|NCT01849874|583895908|FG001|Overall Study|Withdrawal by Subject|16|||
161683974|NCT01849874|583895907|FG000|Overall Study|Lost to Follow-up|3|||
161683975|NCT01849874|583895908|FG001|Overall Study|Lost to Follow-up|2|||
161683976|NCT01849874|583895907|FG000|Overall Study|Study Termination By Sponsor|93|||
161683977|NCT01849874|583895908|FG001|Overall Study|Study Termination By Sponsor|48|||
161683978|NCT01849874|583895907|FG000|Overall Study|Completed as per protocol amendment 6|3|||
161683979|NCT01849874|583895908|FG001|Overall Study|Completed as per protocol amendment 6|0|||
161683980|NCT01849874|583895907|FG000|Overall Study|Physician Decision|7|||
161683981|NCT01849874|583895908|FG001|Overall Study|Physician Decision|1|||
161683982|NCT01849874|583895907|FG000|Overall Study|Other|16|||
161683983|NCT01849874|583895908|FG001|Overall Study|Other|4|||
161683984|NCT04640272|583895910|FG000|Overall Study|Subject moved out of area|1|||
161683985|NCT02535715|583895914|FG000|Overall Study|Withdrawal by Subject|0|||
161683986|NCT02535715|583895915|FG001|Overall Study|Withdrawal by Subject|0|||
161683987|NCT02535715|583895916|FG002|Overall Study|Withdrawal by Subject|1|||
161683988|NCT04353284|583895917|FG000|Overall Study|Adverse Event|1|||
161683989|NCT04353284|583895918|FG001|Overall Study|Adverse Event|1|||
161683990|NCT04353284|583895917|FG000|Overall Study|Lost to Follow-up|1|||
161683991|NCT04353284|583895918|FG001|Overall Study|Lost to Follow-up|0|||
161832425|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161683992|NCT01438489|583895922|FG000|Overall Study|Lost to Follow-up|4|||
161683993|NCT01438489|583895923|FG001|Overall Study|Lost to Follow-up|2|||
161683994|NCT01438489|583895924|FG002|Overall Study|Lost to Follow-up|2|||
161683995|NCT01438489|583895922|FG000|Overall Study|Withdrawal by Subject|11|||
161683996|NCT01438489|583895923|FG001|Overall Study|Withdrawal by Subject|3|||
161945547|NCT05173974|584853107|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
161945548|NCT05173974|584853104|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
161945549|NCT05173974|584853105|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
161945550|NCT05173974|584853106|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
161945551|NCT05173974|584853107|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
161945552|NCT04047446|584853108|FG000|Overall Study|Physician Decision|1|||
161945553|NCT04047446|584853109|FG001|Overall Study|Physician Decision|0|||
161945554|NCT00329420|584853110|FG000|Re-induction Phase|Lack of Efficacy|0|||
161945555|NCT00329420|584853111|FG001|Re-induction Phase|Lack of Efficacy|1|||
161945556|NCT00329420|584853112|FG002|Re-induction Phase|Lack of Efficacy|0|||
161945557|NCT00329420|584853110|FG000|Re-induction Phase|Withdrawal of Consent|0|||
161945558|NCT00329420|584853111|FG001|Re-induction Phase|Withdrawal of Consent|0|||
161945559|NCT00329420|584853112|FG002|Re-induction Phase|Withdrawal of Consent|1|||
161945560|NCT00329420|584853110|FG000|Re-induction Phase|Did not respond to re-induction|6|||
161945561|NCT00329420|584853111|FG001|Re-induction Phase|Did not respond to re-induction|5|||
161945562|NCT00329420|584853112|FG002|Re-induction Phase|Did not respond to re-induction|7|||
161945563|NCT00329420|584853110|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
161945564|NCT00329420|584853111|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
161945565|NCT00329420|584853112|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
161945566|NCT00329420|584853110|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
161945567|NCT00329420|584853111|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
161945568|NCT00329420|584853112|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
161945569|NCT00329420|584853110|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
161945570|NCT00329420|584853111|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
161945571|NCT00329420|584853112|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
161945572|NCT01135992|584853113|FG000|Overall Study|Adverse Event|1|||
161945573|NCT01135992|584853113|FG000|Overall Study|Lack of Efficacy|1|||
161945574|NCT01135992|584853113|FG000|Overall Study|Protocol Violation|2|||
161945575|NCT01135992|584853113|FG000|Overall Study|Withdrawal criteria|10|||
161945576|NCT01135992|584853113|FG000|Overall Study|Unclassified|7|||
161945577|NCT01977898|584853114|FG000|Overall Study|Non functioning catheter|1|||
161945578|NCT01977898|584853115|FG001|Overall Study|Non functioning catheter|1|||
161945579|NCT03983421|584853116|FG000|Overall Study|Lost to Follow-up|1|||
161945580|NCT03386773|584853117|FG000|Overall Study|Lost to Follow-up|24|||
161945581|NCT03386773|584853118|FG001|Overall Study|Lost to Follow-up|33|||
161945582|NCT03386773|584853117|FG000|Overall Study|Withdrawal by Subject|3|||
161945583|NCT03386773|584853118|FG001|Overall Study|Withdrawal by Subject|2|||
161945584|NCT02660229|584853119|FG000|Overall Study|Adverse Event|2|||
161945585|NCT02660229|584853120|FG001|Overall Study|Adverse Event|0|||
161945586|NCT02660229|584853119|FG000|Overall Study|Withdrawal by Subject|0|||
161945587|NCT02660229|584853120|FG001|Overall Study|Withdrawal by Subject|1|||
161945588|NCT01049373|584853124|FG000|Overall Study|Protocol Violation|9|||
161945589|NCT01049373|584853125|FG001|Overall Study|Protocol Violation|9|||
161945590|NCT01049373|584853124|FG000|Overall Study|Withdrawal by Subject|8|||
161945591|NCT01049373|584853125|FG001|Overall Study|Withdrawal by Subject|5|||
161945592|NCT01049373|584853124|FG000|Overall Study|Adverse Event|3|||
161945593|NCT01049373|584853125|FG001|Overall Study|Adverse Event|3|||
161945594|NCT01049373|584853124|FG000|Overall Study|Lost to Follow-up|9|||
161945595|NCT01049373|584853125|FG001|Overall Study|Lost to Follow-up|4|||
161945596|NCT01049373|584853124|FG000|Overall Study|no evaluable study values|9|||
161945597|NCT01049373|584853125|FG001|Overall Study|no evaluable study values|21|||
161945598|NCT01049373|584853124|FG000|Overall Study|Other|1|||
161945599|NCT01049373|584853125|FG001|Overall Study|Other|1|||
161945600|NCT01049373|584853124|FG000|Overall Study|Non-cooperation|0|||
161945601|NCT01049373|584853125|FG001|Overall Study|Non-cooperation|1|||
161945602|NCT01496287|584853126|FG000|Overall Study|Lost to Follow-up|1|||
161945603|NCT01496287|584853126|FG000|Overall Study|Incomplete anesthesia|5|||
161945604|NCT00557193|584853136|FG000|Induction|Adverse Event|2|||
162027148|NCT03005873|585156157|FG002|Overall Study|Ineligible post randomization|1|||
162027149|NCT04585009|585156158|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
161945605|NCT00557193|584853137|FG001|Induction|Adverse Event|0|||
161683997|NCT01438489|583895924|FG002|Overall Study|Withdrawal by Subject|8|||
161945606|NCT00557193|584853138|FG002|Induction|Adverse Event|0|||
161945607|NCT00557193|584853139|FG003|Induction|Adverse Event|0|||
161945608|NCT00557193|584853140|FG004|Induction|Adverse Event|0|||
161945609|NCT00557193|584853141|FG005|Induction|Adverse Event|0|||
161945610|NCT00557193|584853136|FG000|Induction|Death|6|||
161945611|NCT00557193|584853137|FG001|Induction|Death|0|||
161945612|NCT00557193|584853138|FG002|Induction|Death|0|||
161945613|NCT00557193|584853139|FG003|Induction|Death|0|||
161945614|NCT00557193|584853140|FG004|Induction|Death|0|||
161945615|NCT00557193|584853141|FG005|Induction|Death|0|||
161945616|NCT00557193|584853136|FG000|Induction|Physician Decision|3|||
161945617|NCT00557193|584853137|FG001|Induction|Physician Decision|0|||
161945618|NCT00557193|584853138|FG002|Induction|Physician Decision|0|||
161945619|NCT00557193|584853139|FG003|Induction|Physician Decision|0|||
161945620|NCT00557193|584853140|FG004|Induction|Physician Decision|0|||
161945621|NCT00557193|584853141|FG005|Induction|Physician Decision|0|||
161945622|NCT00557193|584853136|FG000|Induction|Withdrawal by Subject|1|||
161945623|NCT00557193|584853137|FG001|Induction|Withdrawal by Subject|0|||
161945624|NCT00557193|584853138|FG002|Induction|Withdrawal by Subject|0|||
161945625|NCT00557193|584853139|FG003|Induction|Withdrawal by Subject|0|||
161945626|NCT00557193|584853140|FG004|Induction|Withdrawal by Subject|0|||
161945627|NCT00557193|584853141|FG005|Induction|Withdrawal by Subject|0|||
161945628|NCT00557193|584853136|FG000|Induction|Refusal of Further Protocol Therapy|2|||
161945629|NCT00557193|584853137|FG001|Induction|Refusal of Further Protocol Therapy|0|||
161945630|NCT00557193|584853138|FG002|Induction|Refusal of Further Protocol Therapy|0|||
161945631|NCT00557193|584853139|FG003|Induction|Refusal of Further Protocol Therapy|0|||
161945632|NCT00557193|584853140|FG004|Induction|Refusal of Further Protocol Therapy|0|||
161945633|NCT00557193|584853141|FG005|Induction|Refusal of Further Protocol Therapy|0|||
161945634|NCT00557193|584853136|FG000|Induction|Ineligible|8|||
161945635|NCT00557193|584853137|FG001|Induction|Ineligible|0|||
161945636|NCT00557193|584853138|FG002|Induction|Ineligible|0|||
161945637|NCT00557193|584853139|FG003|Induction|Ineligible|0|||
161945638|NCT00557193|584853140|FG004|Induction|Ineligible|0|||
161945639|NCT00557193|584853141|FG005|Induction|Ineligible|0|||
161945640|NCT00557193|584853136|FG000|Induction|Inevaluable for post Induction|2|||
161945641|NCT00557193|584853137|FG001|Induction|Inevaluable for post Induction|0|||
161945642|NCT00557193|584853138|FG002|Induction|Inevaluable for post Induction|0|||
161945643|NCT00557193|584853139|FG003|Induction|Inevaluable for post Induction|0|||
161945644|NCT00557193|584853140|FG004|Induction|Inevaluable for post Induction|0|||
161945645|NCT00557193|584853141|FG005|Induction|Inevaluable for post Induction|0|||
161945646|NCT00557193|584853136|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
161945647|NCT00557193|584853137|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
161945648|NCT00557193|584853138|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
161945649|NCT00557193|584853139|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
161945650|NCT00557193|584853140|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
161945651|NCT00557193|584853141|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
161945652|NCT00557193|584853136|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161945653|NCT00557193|584853137|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
161945654|NCT00557193|584853138|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
161945655|NCT00557193|584853139|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
161945656|NCT00557193|584853140|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161945657|NCT00557193|584853141|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
161945658|NCT00557193|584853136|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
161945659|NCT00557193|584853137|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
161945660|NCT00557193|584853138|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
161945661|NCT00557193|584853139|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
161945662|NCT00557193|584853140|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
161945663|NCT00557193|584853141|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
161945664|NCT00557193|584853136|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
162027150|NCT04585009|585156159|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161683998|NCT01438489|583895922|FG000|Overall Study|Death|0|||
161945665|NCT00557193|584853137|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
161945666|NCT00557193|584853138|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
161945667|NCT00557193|584853139|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
161945668|NCT00557193|584853140|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
161945669|NCT00557193|584853141|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
161945670|NCT00557193|584853136|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
161945671|NCT00557193|584853137|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
161945672|NCT00557193|584853138|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
161683999|NCT01438489|583895923|FG001|Overall Study|Death|0|||
161684000|NCT01438489|583895924|FG002|Overall Study|Death|1|||
161945673|NCT00557193|584853139|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
161945674|NCT00557193|584853140|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
162027151|NCT04585009|585156160|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
162027152|NCT04585009|585156161|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
162027153|NCT04585009|585156162|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
162027154|NCT04585009|585156163|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
162027155|NCT04585009|585156164|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
162027156|NCT04585009|585156165|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
162027157|NCT04585009|585156166|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
162027158|NCT04585009|585156167|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
162027159|NCT04585009|585156168|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
162027160|NCT04585009|585156169|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
162027161|NCT04585009|585156158|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
162027162|NCT04585009|585156159|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
162027163|NCT04585009|585156160|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
162027164|NCT04585009|585156161|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
162027165|NCT04585009|585156162|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
162027166|NCT04585009|585156163|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
162027167|NCT04585009|585156164|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
162027168|NCT04585009|585156165|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
162027169|NCT04585009|585156166|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
162027170|NCT04585009|585156167|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
162027171|NCT04585009|585156168|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
162027172|NCT04585009|585156169|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
162027173|NCT04585009|585156158|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162027174|NCT04585009|585156159|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162027175|NCT04585009|585156160|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162027176|NCT04585009|585156161|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162027177|NCT04585009|585156162|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162027178|NCT04585009|585156163|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162027179|NCT04585009|585156164|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162027180|NCT04585009|585156165|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
162027181|NCT04585009|585156166|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162027182|NCT04585009|585156167|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162027183|NCT04585009|585156168|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162027184|NCT04585009|585156169|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
162027185|NCT04585009|585156158|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
162027186|NCT04585009|585156159|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
162027187|NCT04585009|585156160|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
162027188|NCT04585009|585156161|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
162027189|NCT04585009|585156162|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
162027190|NCT04585009|585156163|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
162027191|NCT04585009|585156164|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
162027192|NCT04585009|585156165|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
162027193|NCT04585009|585156166|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
162027194|NCT04585009|585156167|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
162027195|NCT04585009|585156168|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
162027196|NCT04585009|585156169|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
162027197|NCT04585009|585156158|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
162027198|NCT04585009|585156159|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
162027199|NCT04585009|585156160|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
162027200|NCT04585009|585156161|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
162027201|NCT04585009|585156162|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
162027202|NCT04585009|585156163|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
162027203|NCT04585009|585156164|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
162027204|NCT04585009|585156165|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
162027205|NCT04585009|585156166|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
162027206|NCT04585009|585156167|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
162027207|NCT04585009|585156168|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
162027208|NCT04585009|585156169|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
162027209|NCT04585009|585156158|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
162027210|NCT04585009|585156159|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
162027211|NCT04585009|585156160|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
162027212|NCT04585009|585156161|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
162027213|NCT04585009|585156162|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
162027214|NCT04585009|585156163|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161945675|NCT00557193|584853141|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
161945676|NCT00557193|584853136|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
161945677|NCT00557193|584853137|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
161945678|NCT00557193|584853138|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
161945679|NCT00557193|584853139|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
161832426|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
161832427|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
161832428|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
161945680|NCT00557193|584853140|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
161945681|NCT00557193|584853141|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
161945682|NCT00557193|584853136|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
161945683|NCT00557193|584853137|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
161945684|NCT00557193|584853138|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
161945685|NCT00557193|584853139|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
161945686|NCT00557193|584853140|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
161945687|NCT00557193|584853141|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
161945688|NCT00557193|584853136|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
161945689|NCT00557193|584853137|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
161945690|NCT00557193|584853138|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
161945691|NCT00557193|584853139|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
161945692|NCT00557193|584853140|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
161945693|NCT00557193|584853141|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
161945694|NCT00557193|584853136|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
161945695|NCT00557193|584853137|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
161945696|NCT00557193|584853138|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
161945697|NCT00557193|584853139|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
161945698|NCT00557193|584853140|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
161945699|NCT00557193|584853141|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
161945700|NCT03036852|584853142|FG000|Overall Study|Death|2|||
161945701|NCT03036852|584853142|FG000|Overall Study|Lack of Efficacy|2|||
161945702|NCT03036852|584853142|FG000|Overall Study|Adverse Event|1|||
161945703|NCT03036852|584853142|FG000|Overall Study|Lost to Follow-up|1|||
161945704|NCT00652834|584853143|FG000|Overall Study|Withdrawal by Subject|3|||
161945705|NCT00652834|584853143|FG000|Overall Study|Lost to Follow-up|2|||
161945706|NCT00320606|584853144|FG000|Overall Study|Adverse Event|1|||
161945707|NCT00320606|584853144|FG000|Overall Study|Protocol Violation|1|||
161945708|NCT00320606|584853144|FG000|Overall Study|Withdrawal by Subject|1|||
161945709|NCT03984825|584853147|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
161945710|NCT03984825|584853147|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
161945711|NCT03984825|584853147|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
161945712|NCT00622726|584853148|FG000|March, 2008 to August, 2010|Death|5|||
161945713|NCT00622726|584853149|FG001|March, 2008 to August, 2010|Death|2|||
161945714|NCT00622726|584853148|FG000|August, 2010 to April, 2013|Death|1|||
161945715|NCT00622726|584853149|FG001|August, 2010 to April, 2013|Death|5|||
161945716|NCT01948427|584853152|FG000|Overall Study|Serious Adverse Event|3|||
161945717|NCT01948427|584853153|FG001|Overall Study|Serious Adverse Event|0|||
161945718|NCT01948427|584853154|FG002|Overall Study|Serious Adverse Event|0|||
161945719|NCT01948427|584853155|FG003|Overall Study|Serious Adverse Event|0|||
161945720|NCT01948427|584853156|FG004|Overall Study|Serious Adverse Event|1|||
161945721|NCT01948427|584853152|FG000|Overall Study|Investigator Request|0|||
161945722|NCT01948427|584853153|FG001|Overall Study|Investigator Request|8|||
161945723|NCT01948427|584853154|FG002|Overall Study|Investigator Request|0|||
161945724|NCT01948427|584853155|FG003|Overall Study|Investigator Request|0|||
161945725|NCT01948427|584853156|FG004|Overall Study|Investigator Request|6|||
161945726|NCT01948427|584853152|FG000|Overall Study|Lost to Follow-up|1|||
161945727|NCT01948427|584853153|FG001|Overall Study|Lost to Follow-up|0|||
161945728|NCT01948427|584853154|FG002|Overall Study|Lost to Follow-up|0|||
161945729|NCT01948427|584853155|FG003|Overall Study|Lost to Follow-up|0|||
161945730|NCT01948427|584853156|FG004|Overall Study|Lost to Follow-up|4|||
161945731|NCT01948427|584853152|FG000|Overall Study|Withdrawal by Subject|2|||
161945732|NCT01948427|584853153|FG001|Overall Study|Withdrawal by Subject|0|||
161945733|NCT01948427|584853154|FG002|Overall Study|Withdrawal by Subject|0|||
161945734|NCT01948427|584853155|FG003|Overall Study|Withdrawal by Subject|0|||
162027215|NCT04585009|585156164|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161832429|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
161832430|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
161832431|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
161945735|NCT01948427|584853156|FG004|Overall Study|Withdrawal by Subject|1|||
161945736|NCT01948427|584853152|FG000|Overall Study|Other, Not Specified|1|||
161945737|NCT01948427|584853153|FG001|Overall Study|Other, Not Specified|9|||
161945738|NCT01948427|584853154|FG002|Overall Study|Other, Not Specified|0|||
161945739|NCT01948427|584853155|FG003|Overall Study|Other, Not Specified|0|||
161945740|NCT01948427|584853156|FG004|Overall Study|Other, Not Specified|2|||
161945741|NCT00256126|584853157|FG000|Overall Study|Adverse Event|1|||
161945742|NCT00256126|584853158|FG001|Overall Study|Adverse Event|0|||
161945743|NCT00256126|584853157|FG000|Overall Study|Other|1|||
161945744|NCT00256126|584853158|FG001|Overall Study|Other|2|||
161945745|NCT02434081|584853159|FG000|Overall Study|Death (never started treatment)|2|||
161945746|NCT02434081|584853159|FG000|Overall Study|Death|2|||
161945747|NCT02434081|584853159|FG000|Overall Study|Progression|20|||
161945748|NCT02434081|584853159|FG000|Overall Study|Adverse Event|20|||
161945749|NCT02434081|584853159|FG000|Overall Study|Physician Decision|2|||
161945750|NCT02434081|584853159|FG000|Overall Study|Withdrawal by Subject|1|||
161945751|NCT02434081|584853159|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
161945752|NCT00854360|584853168|FG000|Overall Study|Adverse Event|0|||
161945753|NCT00854360|584853169|FG001|Overall Study|Adverse Event|1|||
161945754|NCT00854360|584853170|FG002|Overall Study|Adverse Event|2|||
161945755|NCT00854360|584853171|FG003|Overall Study|Adverse Event|6|||
161945756|NCT00854360|584853168|FG000|Overall Study|Withdrawal by Subject|0|||
161945757|NCT00854360|584853169|FG001|Overall Study|Withdrawal by Subject|0|||
161945758|NCT00854360|584853170|FG002|Overall Study|Withdrawal by Subject|0|||
161945759|NCT00854360|584853171|FG003|Overall Study|Withdrawal by Subject|1|||
161945760|NCT00854360|584853168|FG000|Overall Study|Pregnancy|0|||
161945761|NCT00854360|584853169|FG001|Overall Study|Pregnancy|1|||
161945762|NCT00854360|584853170|FG002|Overall Study|Pregnancy|0|||
161945763|NCT00854360|584853171|FG003|Overall Study|Pregnancy|0|||
161945764|NCT00854360|584853168|FG000|Overall Study|Lack of Efficacy|2|||
161945765|NCT00854360|584853169|FG001|Overall Study|Lack of Efficacy|1|||
161945766|NCT00854360|584853170|FG002|Overall Study|Lack of Efficacy|0|||
161945767|NCT00854360|584853171|FG003|Overall Study|Lack of Efficacy|0|||
161945768|NCT00854360|584853168|FG000|Overall Study|Other|0|||
161945769|NCT00854360|584853169|FG001|Overall Study|Other|0|||
161945770|NCT00854360|584853170|FG002|Overall Study|Other|0|||
161945771|NCT00854360|584853171|FG003|Overall Study|Other|3|||
161945772|NCT03435380|584853172|FG000|Overall Study|Death|1|||
161945773|NCT03435380|584853173|FG001|Overall Study|Death|2|||
161945774|NCT03435380|584853174|FG002|Overall Study|Death|1|||
161945775|NCT03435380|584853172|FG000|Overall Study|Lost to Follow-up|12|||
161945776|NCT03435380|584853173|FG001|Overall Study|Lost to Follow-up|8|||
161945777|NCT03435380|584853174|FG002|Overall Study|Lost to Follow-up|6|||
161945778|NCT03435380|584853172|FG000|Overall Study|Physician Decision|1|||
161945779|NCT03435380|584853173|FG001|Overall Study|Physician Decision|0|||
161945780|NCT03435380|584853174|FG002|Overall Study|Physician Decision|0|||
161945781|NCT03435380|584853172|FG000|Overall Study|Withdrawal by Subject|0|||
161945782|NCT03435380|584853173|FG001|Overall Study|Withdrawal by Subject|1|||
161945783|NCT03435380|584853174|FG002|Overall Study|Withdrawal by Subject|1|||
161945784|NCT03435380|584853172|FG000|Overall Study|Ineligible|0|||
161945785|NCT03435380|584853173|FG001|Overall Study|Ineligible|1|||
161945786|NCT03435380|584853174|FG002|Overall Study|Ineligible|1|||
161945787|NCT00742625|584853175|FG000|Remission Induction|Progression|6|||
161945788|NCT00742625|584853175|FG000|Remission Induction|Failed induction|8|||
161945789|NCT00742625|584853175|FG000|Remission Induction|Adverse Event|3|||
161945790|NCT00742625|584853175|FG000|Remission Induction|Death|10|||
161945791|NCT00742625|584853175|FG000|Remission Induction|Refusal|5|||
161945792|NCT00742625|584853175|FG000|Remission Induction|Non protocol treatment|17|||
161945793|NCT00742625|584853175|FG000|Remission Induction|Other, not specified|5|||
161945794|NCT00742625|584853175|FG000|Consolidation|Progression|5|||
161945795|NCT00742625|584853175|FG000|Consolidation|Adverse Event|1|||
161945796|NCT00742625|584853175|FG000|Consolidation|Death|1|||
161945797|NCT00742625|584853175|FG000|Consolidation|Refused|1|||
161945798|NCT00742625|584853175|FG000|Consolidation|Non protocol therapy|13|||
161945799|NCT01307449|584853176|FG000|Overall Study|Adverse Event|1|||
161945800|NCT01307449|584853177|FG001|Overall Study|Adverse Event|0|||
161945801|NCT01307449|584853178|FG002|Overall Study|Adverse Event|0|||
161945802|NCT01307449|584853179|FG003|Overall Study|Adverse Event|0|||
161945803|NCT02581891|584853182|FG000|Overall Study|Adverse Event|4|||
161945804|NCT02581891|584853183|FG001|Overall Study|Adverse Event|6|||
161945805|NCT02581891|584853182|FG000|Overall Study|Death|3|||
161945806|NCT02581891|584853183|FG001|Overall Study|Death|4|||
161945807|NCT02581891|584853182|FG000|Overall Study|Lost to Follow-up|1|||
161945808|NCT02581891|584853183|FG001|Overall Study|Lost to Follow-up|2|||
161945809|NCT02581891|584853182|FG000|Overall Study|Physician Decision|0|||
161945810|NCT02581891|584853183|FG001|Overall Study|Physician Decision|1|||
161945811|NCT02581891|584853182|FG000|Overall Study|Withdrawal by Subject|4|||
161945812|NCT02581891|584853183|FG001|Overall Study|Withdrawal by Subject|5|||
161945813|NCT02581891|584853182|FG000|Overall Study|Other Reasons|3|||
161945814|NCT02581891|584853183|FG001|Overall Study|Other Reasons|1|||
161945815|NCT02581891|584853182|FG000|Overall Study|Discontinued during followup|1|||
161945816|NCT02581891|584853183|FG001|Overall Study|Discontinued during followup|0|||
161945817|NCT01612676|584853184|FG000|Overall Study|Adverse Event|2|||
161945818|NCT01612676|584853185|FG001|Overall Study|Adverse Event|3|||
161945819|NCT01612676|584853186|FG002|Overall Study|Adverse Event|1|||
161945820|NCT01612676|584853187|FG003|Overall Study|Adverse Event|3|||
161945821|NCT01612676|584853184|FG000|Overall Study|Protocol Violation|0|||
161945822|NCT01612676|584853185|FG001|Overall Study|Protocol Violation|1|||
161945823|NCT01612676|584853186|FG002|Overall Study|Protocol Violation|0|||
161945824|NCT01612676|584853187|FG003|Overall Study|Protocol Violation|0|||
161945825|NCT00181844|584853194|FG000|Signed Consent|Withdrawal by Subject|5|||
161945826|NCT00181844|584853194|FG000|Signed Consent|Did not meet entrance criteria|7|||
161945827|NCT00181844|584853194|FG000|Exposed to Study Medication|Adverse Event|10|||
161945828|NCT00181844|584853194|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
161945829|NCT00181844|584853194|FG000|Exposed to Study Medication|Non-compliance|2|||
161945830|NCT00181844|584853194|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
161945831|NCT00181844|584853194|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
161945832|NCT01959932|584853197|FG000|Overall Study|Withdrawal by Subject|1|||
161945833|NCT01959932|584853198|FG001|Overall Study|Withdrawal by Subject|0|||
161945834|NCT01959932|584853199|FG002|Overall Study|Withdrawal by Subject|0|||
161945835|NCT00060944|584853202|FG000|Overall Study|Adverse Event|12|||
161945836|NCT00060944|584853203|FG001|Overall Study|Adverse Event|10|||
161945837|NCT00060944|584853202|FG000|Overall Study|Death|2|||
161945838|NCT00060944|584853203|FG001|Overall Study|Death|3|||
161945839|NCT00060944|584853202|FG000|Overall Study|Withdrawal by Subject|18|||
161945840|NCT00060944|584853203|FG001|Overall Study|Withdrawal by Subject|5|||
161945841|NCT00060944|584853202|FG000|Overall Study|Disease Progression|93|||
161945842|NCT00060944|584853203|FG001|Overall Study|Disease Progression|94|||
161945843|NCT00060944|584853202|FG000|Overall Study|Lost to Follow-up|1|||
161945844|NCT00060944|584853203|FG001|Overall Study|Lost to Follow-up|0|||
161945845|NCT00060944|584853202|FG000|Overall Study|Subject Ineligible To Continue|2|||
161945846|NCT00060944|584853203|FG001|Overall Study|Subject Ineligible To Continue|1|||
161945847|NCT00060944|584853202|FG000|Overall Study|Treatment Switch|0|||
161945848|NCT00060944|584853203|FG001|Overall Study|Treatment Switch|13|||
161945849|NCT00060944|584853202|FG000|Overall Study|Other|2|||
161945850|NCT00060944|584853203|FG001|Overall Study|Other|4|||
161945851|NCT00060944|584853202|FG000|Overall Study|randomized but not treated|6|||
161945852|NCT00060944|584853203|FG001|Overall Study|randomized but not treated|4|||
161945853|NCT03961308|584853205|FG000|Overall Study|Withdrawal by Subject|1|||
161945854|NCT03961308|584853206|FG001|Overall Study|Withdrawal by Subject|0|||
161945855|NCT03961308|584853205|FG000|Overall Study|Other|1|||
161945856|NCT03961308|584853206|FG001|Overall Study|Other|0|||
161945857|NCT03961308|584853205|FG000|Overall Study|Lost to Follow-up|0|||
161945858|NCT03961308|584853206|FG001|Overall Study|Lost to Follow-up|1|||
161945859|NCT03961308|584853205|FG000|Overall Study|Adverse Event|0|||
161945860|NCT03961308|584853206|FG001|Overall Study|Adverse Event|1|||
161945861|NCT02081586|584853212|FG000|Overall Study|Lost to Follow-up|0|||
161945862|NCT02081586|584853213|FG001|Overall Study|Lost to Follow-up|1|||
161945863|NCT02081586|584853214|FG002|Overall Study|Lost to Follow-up|0|||
161945864|NCT02081586|584853215|FG003|Overall Study|Lost to Follow-up|1|||
161945865|NCT02081586|584853212|FG000|Overall Study|Head injury not related to study|0|||
161945866|NCT02081586|584853213|FG001|Overall Study|Head injury not related to study|0|||
161945867|NCT02081586|584853214|FG002|Overall Study|Head injury not related to study|1|||
161945868|NCT02081586|584853215|FG003|Overall Study|Head injury not related to study|0|||
161945869|NCT04549454|584853222|FG000|T1 to T2|Lost to Follow-up|22|||
161945870|NCT04549454|584853223|FG001|T1 to T2|Lost to Follow-up|26|||
161945871|NCT04549454|584853222|FG000|T1 to T3|Lost to Follow-up|31|||
161945872|NCT04549454|584853223|FG001|T1 to T3|Lost to Follow-up|36|||
161945873|NCT01355627|584853229|FG000|Overall Study|Request By the Patient to Discontinue|5|||
161945874|NCT01355627|584853230|FG001|Overall Study|Request By the Patient to Discontinue|7|||
161945875|NCT01355627|584853229|FG000|Overall Study|Lost to Follow-up|8|||
161945876|NCT01355627|584853230|FG001|Overall Study|Lost to Follow-up|7|||
161945877|NCT01355627|584853229|FG000|Overall Study|Fatal Adverse Event|19|||
161945878|NCT01355627|584853230|FG001|Overall Study|Fatal Adverse Event|23|||
161945879|NCT01355627|584853229|FG000|Overall Study|Other|1|||
161945880|NCT01355627|584853230|FG001|Overall Study|Other|1|||
161945881|NCT00545779|584853237|FG000|Overall Study|Violation of selection criteria at entry|8|||
161945882|NCT00545779|584853237|FG000|Overall Study|Other protocol violation|1|||
161945883|NCT00545779|584853237|FG000|Overall Study|Did not cooperate|7|||
161945884|NCT00545779|584853237|FG000|Overall Study|Withdrawal by Subject|20|||
161945885|NCT00545779|584853237|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
161945886|NCT00545779|584853237|FG000|Overall Study|Failure to return|3|||
161945887|NCT01405196|584853238|FG000|Overall Study|Study Terminated by Sponsor|0|||
161945888|NCT01405196|584853239|FG001|Overall Study|Study Terminated by Sponsor|0|||
161945889|NCT01405196|584853240|FG002|Overall Study|Study Terminated by Sponsor|9|||
161945890|NCT01405196|584853241|FG003|Overall Study|Study Terminated by Sponsor|0|||
161945891|NCT01405196|584853238|FG000|Overall Study|Other|2|||
161945892|NCT01405196|584853239|FG001|Overall Study|Other|2|||
161945893|NCT01405196|584853240|FG002|Overall Study|Other|5|||
161945894|NCT01405196|584853241|FG003|Overall Study|Other|0|||
161945895|NCT01405196|584853238|FG000|Overall Study|Withdrawal by Subject|4|||
161945896|NCT01405196|584853239|FG001|Overall Study|Withdrawal by Subject|6|||
161945897|NCT01405196|584853240|FG002|Overall Study|Withdrawal by Subject|3|||
161945898|NCT01405196|584853241|FG003|Overall Study|Withdrawal by Subject|6|||
161945899|NCT01405196|584853238|FG000|Overall Study|Adverse Event|2|||
161945900|NCT01405196|584853239|FG001|Overall Study|Adverse Event|2|||
161945901|NCT01405196|584853240|FG002|Overall Study|Adverse Event|0|||
161945902|NCT01405196|584853241|FG003|Overall Study|Adverse Event|2|||
161945903|NCT01405196|584853238|FG000|Overall Study|Death|1|||
161945904|NCT01405196|584853239|FG001|Overall Study|Death|0|||
161945905|NCT01405196|584853240|FG002|Overall Study|Death|3|||
161945906|NCT01405196|584853241|FG003|Overall Study|Death|0|||
161945907|NCT01405196|584853238|FG000|Overall Study|Lost to Follow-up|2|||
161945908|NCT01405196|584853239|FG001|Overall Study|Lost to Follow-up|2|||
161945909|NCT01405196|584853240|FG002|Overall Study|Lost to Follow-up|3|||
161945910|NCT01405196|584853241|FG003|Overall Study|Lost to Follow-up|1|||
161945911|NCT01542788|584853242|FG000|Overall Study|Randomized but Not Treated|2|||
161945912|NCT01542788|584853243|FG001|Overall Study|Randomized but Not Treated|0|||
161945913|NCT01542788|584853242|FG000|Overall Study|Lack of Efficacy|41|||
161945914|NCT01542788|584853243|FG001|Overall Study|Lack of Efficacy|71|||
161945915|NCT01542788|584853242|FG000|Overall Study|Lost to Follow-up|5|||
161945916|NCT01542788|584853243|FG001|Overall Study|Lost to Follow-up|0|||
161945917|NCT01542788|584853242|FG000|Overall Study|Death|3|||
161945918|NCT01542788|584853243|FG001|Overall Study|Death|0|||
161945919|NCT01542788|584853242|FG000|Overall Study|Protocol Violation|2|||
161945920|NCT01542788|584853243|FG001|Overall Study|Protocol Violation|0|||
161945921|NCT01542788|584853242|FG000|Overall Study|Physician Decision|1|||
161945922|NCT01542788|584853243|FG001|Overall Study|Physician Decision|0|||
161945923|NCT01542788|584853242|FG000|Overall Study|Withdrawal by Subject|1|||
161945924|NCT01542788|584853243|FG001|Overall Study|Withdrawal by Subject|0|||
161945925|NCT01126190|584854598|FG000|Double-Blind Phase|Death|0|||
161945926|NCT01126190|584854599|FG001|Double-Blind Phase|Death|1|||
161945927|NCT01126190|584854600|FG002|Double-Blind Phase|Death|0|||
161945928|NCT01126190|584854598|FG000|Double-Blind Phase|Adverse Event|1|||
161945929|NCT01126190|584854599|FG001|Double-Blind Phase|Adverse Event|2|||
161945930|NCT01126190|584854600|FG002|Double-Blind Phase|Adverse Event|0|||
161945931|NCT01126190|584854598|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
161945932|NCT01126190|584854599|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
161945933|NCT01126190|584854600|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161945934|NCT01126190|584854598|FG000|Double-Blind Phase|Request of Investigator|1|||
161945935|NCT01126190|584854599|FG001|Double-Blind Phase|Request of Investigator|0|||
161945936|NCT01126190|584854600|FG002|Double-Blind Phase|Request of Investigator|0|||
161945937|NCT01126190|584854598|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
161945938|NCT01126190|584854599|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
161945939|NCT01126190|584854600|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
161945940|NCT01126190|584854598|FG000|Double-Blind Phase|Non-compliance|1|||
161945941|NCT01126190|584854599|FG001|Double-Blind Phase|Non-compliance|0|||
161945942|NCT01126190|584854600|FG002|Double-Blind Phase|Non-compliance|0|||
161945943|NCT01126190|584854598|FG000|Double-Blind Phase|Lost to Follow-up|1|||
161945944|NCT01126190|584854599|FG001|Double-Blind Phase|Lost to Follow-up|3|||
161945945|NCT01126190|584854600|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161945946|NCT01126190|584854598|FG000|Open-Label Phase|Death|0|||
161945947|NCT01126190|584854599|FG001|Open-Label Phase|Death|0|||
161945948|NCT01126190|584854600|FG002|Open-Label Phase|Death|1|||
161945949|NCT01126190|584854598|FG000|Open-Label Phase|Adverse Event|0|||
161945950|NCT01126190|584854599|FG001|Open-Label Phase|Adverse Event|0|||
161945951|NCT01126190|584854600|FG002|Open-Label Phase|Adverse Event|4|||
161945952|NCT01126190|584854598|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161945953|NCT01126190|584854599|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161945954|NCT01126190|584854600|FG002|Open-Label Phase|Withdrawal by Subject|6|||
161945955|NCT01170663|584854601|FG000|Overall Study|Lost to Follow-up|3|||
161945956|NCT01170663|584854602|FG001|Overall Study|Lost to Follow-up|9|||
161945957|NCT01170663|584854601|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
161945958|NCT01170663|584854602|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
161945959|NCT02746809|584854603|FG000|Enrollment|Inclusion Exclusion not met|9|||
161945960|NCT02746809|584854603|FG000|Enrollment|Withdrawal by Subject|1|||
161945961|NCT02746809|584854603|FG000|Enrollment|Expected Enrollment Met|2|||
161945962|NCT02746809|584854603|FG000|Procedure|Death|1|||
161945963|NCT02746809|584854603|FG000|1-Month|Death|5|||
161945964|NCT02746809|584854603|FG000|6-Month|Death|2|||
161945965|NCT02746809|584854603|FG000|6-Month|Withdrawal by Subject|1|||
161945966|NCT02746809|584854603|FG000|12-Month|Death|3|||
161945967|NCT02746809|584854603|FG000|12-Month|Withdrawal by Subject|2|||
161945968|NCT02746809|584854603|FG000|24-Month|Death|1|||
161945969|NCT02746809|584854603|FG000|24-Month|Withdrawal by Subject|1|||
161945970|NCT02746809|584854603|FG000|36-Month|Death|8|||
162027216|NCT04585009|585156165|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161945971|NCT02746809|584854603|FG000|36-Month|Withdrawal by Subject|1|||
161945972|NCT02746809|584854603|FG000|48-Month|Death|7|||
161945973|NCT02746809|584854603|FG000|48-Month|Withdrawal by Subject|1|||
162027217|NCT04585009|585156166|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
162027218|NCT04585009|585156167|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
162027219|NCT04585009|585156168|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
162027220|NCT04585009|585156169|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
162027221|NCT04618770|585156178|FG000|Overall Study|Censored from Analysis|12|||
162027222|NCT04618770|585156178|FG000|Overall Study|Early Termination|25|||
162027223|NCT01738646|585156179|FG000|Overall Study|Still Receiving Treatment|2|||
162027224|NCT03642132|585156181|FG000|Chemotherapy Period|Adverse Event|1|||
162027225|NCT03642132|585156182|FG001|Chemotherapy Period|Adverse Event|1|||
162027226|NCT03642132|585156183|FG002|Chemotherapy Period|Adverse Event|0|||
162027227|NCT03642132|585156181|FG000|Chemotherapy Period|Physician's decision|4|||
162027228|NCT03642132|585156182|FG001|Chemotherapy Period|Physician's decision|1|||
162027229|NCT03642132|585156183|FG002|Chemotherapy Period|Physician's decision|0|||
162027230|NCT03642132|585156181|FG000|Chemotherapy Period|Progressive disease|0|||
162027231|NCT03642132|585156182|FG001|Chemotherapy Period|Progressive disease|0|||
162027232|NCT03642132|585156183|FG002|Chemotherapy Period|Progressive disease|1|||
162027233|NCT03642132|585156181|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
162027234|NCT03642132|585156182|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
162027235|NCT03642132|585156183|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
162027236|NCT03642132|585156181|FG000|Chemotherapy Period|Other|1|||
162027237|NCT03642132|585156182|FG001|Chemotherapy Period|Other|0|||
162027238|NCT03642132|585156183|FG002|Chemotherapy Period|Other|2|||
162027239|NCT03642132|585156181|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
162027240|NCT03642132|585156182|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
162027241|NCT03642132|585156183|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
162027242|NCT03642132|585156181|FG000|Maintenance Period|Adverse Event|1|||
162027243|NCT03642132|585156182|FG001|Maintenance Period|Adverse Event|2|||
162027244|NCT03642132|585156183|FG002|Maintenance Period|Adverse Event|0|||
162027245|NCT03642132|585156181|FG000|Maintenance Period|Non-compliance with study drug|0|||
162027246|NCT03642132|585156182|FG001|Maintenance Period|Non-compliance with study drug|0|||
162027247|NCT03642132|585156183|FG002|Maintenance Period|Non-compliance with study drug|1|||
162027248|NCT03642132|585156181|FG000|Maintenance Period|Physician's decision|2|||
162027249|NCT03642132|585156182|FG001|Maintenance Period|Physician's decision|2|||
162027250|NCT03642132|585156183|FG002|Maintenance Period|Physician's decision|2|||
162027251|NCT03642132|585156181|FG000|Maintenance Period|Progressive disease|9|||
162027252|NCT03642132|585156182|FG001|Maintenance Period|Progressive disease|3|||
162027253|NCT03642132|585156183|FG002|Maintenance Period|Progressive disease|6|||
162027254|NCT03642132|585156181|FG000|Maintenance Period|Other|0|||
162027255|NCT03642132|585156182|FG001|Maintenance Period|Other|0|||
162027256|NCT03642132|585156183|FG002|Maintenance Period|Other|3|||
162027257|NCT03642132|585156181|FG000|Maintenance Period|Withdrawal by Subject|1|||
162027258|NCT03642132|585156182|FG001|Maintenance Period|Withdrawal by Subject|1|||
162027259|NCT03642132|585156183|FG002|Maintenance Period|Withdrawal by Subject|2|||
162027260|NCT03642132|585156181|FG000|Follow-up Period|Other|0|||
162027261|NCT03642132|585156182|FG001|Follow-up Period|Other|0|||
162027262|NCT03642132|585156183|FG002|Follow-up Period|Other|1|||
162027263|NCT03642132|585156181|FG000|Follow-up Period|Withdrawal by Subject|1|||
162027264|NCT03642132|585156182|FG001|Follow-up Period|Withdrawal by Subject|2|||
162027265|NCT03642132|585156183|FG002|Follow-up Period|Withdrawal by Subject|0|||
162027266|NCT03642132|585156181|FG000|Follow-up Period|Study terminated by sponsor|1|||
162027267|NCT03642132|585156182|FG001|Follow-up Period|Study terminated by sponsor|0|||
162027268|NCT03642132|585156183|FG002|Follow-up Period|Study terminated by sponsor|1|||
162027269|NCT03642132|585156181|FG000|Follow-up Period|Lack of Efficacy|1|||
162027270|NCT03642132|585156182|FG001|Follow-up Period|Lack of Efficacy|0|||
162027271|NCT03642132|585156183|FG002|Follow-up Period|Lack of Efficacy|0|||
162027272|NCT03642132|585156181|FG000|Follow-up Period|Death|1|||
162027273|NCT03642132|585156182|FG001|Follow-up Period|Death|0|||
162027274|NCT03642132|585156183|FG002|Follow-up Period|Death|2|||
162027275|NCT03642132|585156181|FG000|Follow-up Period|Adverse Event|1|||
162027276|NCT03642132|585156182|FG001|Follow-up Period|Adverse Event|0|||
162027277|NCT03642132|585156183|FG002|Follow-up Period|Adverse Event|0|||
162027278|NCT03531632|585156189|FG000|Overall Study|Adverse Event|0|||
162027279|NCT03531632|585156190|FG001|Overall Study|Adverse Event|0|||
161684001|NCT01438489|583895922|FG000|Overall Study|Sponsor decision|4|||
162027280|NCT03531632|585156191|FG002|Overall Study|Adverse Event|1|||
162027281|NCT03531632|585156189|FG000|Overall Study|Death|4|||
162027282|NCT03531632|585156190|FG001|Overall Study|Death|0|||
162027283|NCT03531632|585156191|FG002|Overall Study|Death|14|||
162027284|NCT03531632|585156189|FG000|Overall Study|Study Terminated|1|||
162027285|NCT03531632|585156190|FG001|Overall Study|Study Terminated|3|||
162027286|NCT03531632|585156191|FG002|Overall Study|Study Terminated|11|||
162027287|NCT00470834|585156192|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
162027288|NCT00470834|585156193|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
161684002|NCT01438489|583895923|FG001|Overall Study|Sponsor decision|1|||
162027289|NCT00470834|585156192|FG000|Treatment Period (18 Months)|Adverse Event|7|||
162027290|NCT00470834|585156193|FG001|Treatment Period (18 Months)|Adverse Event|6|||
162027291|NCT00470834|585156192|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
161684003|NCT01438489|583895924|FG002|Overall Study|Sponsor decision|4|||
161684004|NCT01438489|583895922|FG000|Overall Study|Subject choice/Subject moved|2|||
161684005|NCT01438489|583895923|FG001|Overall Study|Subject choice/Subject moved|1|||
161684006|NCT01438489|583895924|FG002|Overall Study|Subject choice/Subject moved|1|||
161684007|NCT01438489|583895922|FG000|Overall Study|Investigator decision|0|||
161684008|NCT01438489|583895923|FG001|Overall Study|Investigator decision|1|||
161684009|NCT01438489|583895924|FG002|Overall Study|Investigator decision|0|||
161684010|NCT01438489|583895922|FG000|Overall Study|AE/SAEs|2|||
161684011|NCT01438489|583895923|FG001|Overall Study|AE/SAEs|1|||
161684012|NCT01438489|583895924|FG002|Overall Study|AE/SAEs|1|||
161684013|NCT01438489|583895922|FG000|Overall Study|Received prohibited medication|1|||
161684014|NCT01438489|583895923|FG001|Overall Study|Received prohibited medication|0|||
161684015|NCT01438489|583895924|FG002|Overall Study|Received prohibited medication|0|||
161684016|NCT01438489|583895922|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
161832432|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
161945974|NCT02746809|584854603|FG000|60-Month|Death|1|||
161945975|NCT02746809|584854603|FG000|60-Month|Lost to Follow-up|2|||
161945976|NCT01128569|584854607|FG000|Washout Period 1|Adverse Event|0|||
161945977|NCT01128569|584854608|FG001|Washout Period 1|Adverse Event|0|||
161945978|NCT01128569|584854609|FG002|Washout Period 1|Adverse Event|1|||
161945979|NCT01128569|584854610|FG003|Washout Period 1|Adverse Event|0|||
161945980|NCT01128569|584854611|FG004|Washout Period 1|Adverse Event|0|||
161945981|NCT01128569|584854612|FG005|Washout Period 1|Adverse Event|0|||
161945982|NCT01128569|584854607|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161945983|NCT01128569|584854608|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161945984|NCT01128569|584854609|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161945985|NCT01128569|584854610|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161945986|NCT01128569|584854611|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161945987|NCT01128569|584854612|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161945988|NCT00894387|584854613|FG000|Overall Study|Adverse Event|44|||
161945989|NCT00894387|584854614|FG001|Overall Study|Adverse Event|45|||
161945990|NCT00894387|584854613|FG000|Overall Study|Abnormal Laboratory values|2|||
161945991|NCT00894387|584854614|FG001|Overall Study|Abnormal Laboratory values|2|||
161945992|NCT00894387|584854613|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161945993|NCT00894387|584854614|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161945994|NCT00894387|584854613|FG000|Overall Study|Lost to Follow-up|3|||
161945995|NCT00894387|584854614|FG001|Overall Study|Lost to Follow-up|5|||
161945996|NCT00894387|584854613|FG000|Overall Study|Administrative problems|2|||
161945997|NCT00894387|584854614|FG001|Overall Study|Administrative problems|2|||
161945998|NCT00894387|584854613|FG000|Overall Study|Death|77|||
161945999|NCT00894387|584854614|FG001|Overall Study|Death|76|||
161946000|NCT00894387|584854613|FG000|Overall Study|Protocol Deviation|4|||
161946001|NCT00894387|584854614|FG001|Overall Study|Protocol Deviation|0|||
161946002|NCT00894387|584854613|FG000|Overall Study|Patient's request|25|||
161946003|NCT00894387|584854614|FG001|Overall Study|Patient's request|30|||
161946004|NCT00894387|584854613|FG000|Overall Study|Other (Missing)|5|||
161946005|NCT00894387|584854614|FG001|Overall Study|Other (Missing)|3|||
161946006|NCT00894387|584854613|FG000|Overall Study|Mis-randomized|13|||
161946007|NCT00894387|584854614|FG001|Overall Study|Mis-randomized|9|||
161946008|NCT00894387|584854613|FG000|Overall Study|GCP non-compliance|0|||
161946009|NCT00894387|584854614|FG001|Overall Study|GCP non-compliance|2|||
161946010|NCT01865487|584854615|FG000|Overall Study|Lost to Follow-up|0|||
161946011|NCT01865487|584854616|FG001|Overall Study|Lost to Follow-up|0|||
161946012|NCT01865487|584854617|FG002|Overall Study|Lost to Follow-up|0|||
161946013|NCT01865487|584854618|FG003|Overall Study|Lost to Follow-up|1|||
161946014|NCT01865487|584854619|FG004|Overall Study|Lost to Follow-up|0|||
161946015|NCT01865487|584854620|FG005|Overall Study|Lost to Follow-up|0|||
161946016|NCT01865487|584854621|FG006|Overall Study|Lost to Follow-up|1|||
161946017|NCT01865487|584854622|FG007|Overall Study|Lost to Follow-up|0|||
161946018|NCT01865487|584854623|FG008|Overall Study|Lost to Follow-up|0|||
161946019|NCT01865487|584854624|FG009|Overall Study|Lost to Follow-up|0|||
161946020|NCT01865487|584854615|FG000|Overall Study|Withdrawal by Subject|0|||
161946021|NCT01865487|584854616|FG001|Overall Study|Withdrawal by Subject|0|||
161946022|NCT01865487|584854617|FG002|Overall Study|Withdrawal by Subject|0|||
161946023|NCT01865487|584854618|FG003|Overall Study|Withdrawal by Subject|0|||
161946024|NCT01865487|584854619|FG004|Overall Study|Withdrawal by Subject|1|||
161946025|NCT01865487|584854620|FG005|Overall Study|Withdrawal by Subject|0|||
161684017|NCT01438489|583895923|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
161684018|NCT01438489|583895924|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
161684019|NCT01438489|583895922|FG000|Overall Study|Inadequate venous access|0|||
161684020|NCT01438489|583895923|FG001|Overall Study|Inadequate venous access|2|||
161684021|NCT01438489|583895924|FG002|Overall Study|Inadequate venous access|0|||
161684022|NCT00766532|583895925|FG000|Overall Study|Protocol Violation|2|||
161946026|NCT01865487|584854621|FG006|Overall Study|Withdrawal by Subject|0|||
161946027|NCT01865487|584854622|FG007|Overall Study|Withdrawal by Subject|0|||
161684023|NCT03719690|583895927|FG000|Overall Study|Withdrawal by Subject|5|||
161946028|NCT01865487|584854623|FG008|Overall Study|Withdrawal by Subject|0|||
161832433|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
162027292|NCT00470834|585156193|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
162027293|NCT00470834|585156192|FG000|Treatment Period (18 Months)|Physician Decision|4|||
162027294|NCT00470834|585156193|FG001|Treatment Period (18 Months)|Physician Decision|4|||
162027295|NCT00470834|585156192|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
162027296|NCT00470834|585156193|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
162027297|NCT00470834|585156192|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
162027298|NCT00470834|585156193|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
162027299|NCT00470834|585156192|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
162027300|NCT00470834|585156193|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
162027301|NCT00470834|585156192|FG000|Treatment Period (18 Months)|Non-compliance|1|||
162027302|NCT00470834|585156193|FG001|Treatment Period (18 Months)|Non-compliance|0|||
162027303|NCT00470834|585156192|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
162027304|NCT00470834|585156193|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
162027305|NCT00470834|585156192|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
162027306|NCT00470834|585156193|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
162027307|NCT00470834|585156192|FG000|Extension Period (24 Months)|Adverse Event|3|||
162027308|NCT00470834|585156193|FG001|Extension Period (24 Months)|Adverse Event|4|||
162027309|NCT00470834|585156192|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
162027310|NCT00470834|585156193|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
162027311|NCT00470834|585156192|FG000|Extension Period (24 Months)|Physician Decision|4|||
162027312|NCT00470834|585156193|FG001|Extension Period (24 Months)|Physician Decision|3|||
162027313|NCT00470834|585156192|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
162027314|NCT00470834|585156193|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
162027315|NCT00470834|585156192|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
162027316|NCT00470834|585156193|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
162027317|NCT00470834|585156192|FG000|Extension Period (24 Months)|Non-compliance|0|||
162027318|NCT00470834|585156193|FG001|Extension Period (24 Months)|Non-compliance|1|||
162027319|NCT00470834|585156192|FG000|Extension Period (24 Months)|Disease Progression|0|||
162027320|NCT00470834|585156193|FG001|Extension Period (24 Months)|Disease Progression|1|||
162027321|NCT01534182|585156194|FG000|Overall Study|Administrative problems|1|||
162027322|NCT01534182|585156195|FG001|Overall Study|Administrative problems|0|||
162027323|NCT01534182|585156194|FG000|Overall Study|Withdrawal by Subject|4|||
162027324|NCT01534182|585156195|FG001|Overall Study|Withdrawal by Subject|7|||
162027325|NCT01534182|585156194|FG000|Overall Study|Adverse Event|7|||
162027326|NCT01534182|585156195|FG001|Overall Study|Adverse Event|3|||
162027327|NCT00065429|585156200|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
162027328|NCT00065429|585156201|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
162027329|NCT00065429|585156202|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
162027330|NCT00065429|585156203|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
162027331|NCT00065429|585156204|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
162027332|NCT00065429|585156205|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
162027333|NCT00065429|585156206|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
162027334|NCT00065429|585156200|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
162027335|NCT00065429|585156201|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
162027336|NCT00065429|585156202|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
162027337|NCT00065429|585156203|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
162027338|NCT00065429|585156204|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
162027339|NCT00065429|585156205|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
162027340|NCT00065429|585156206|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
162027341|NCT00065429|585156200|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
162027342|NCT00065429|585156201|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
162027343|NCT00065429|585156202|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
162027344|NCT00065429|585156203|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
162027345|NCT00065429|585156204|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
162027346|NCT00065429|585156205|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
162027347|NCT00065429|585156206|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
162027348|NCT00065429|585156200|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
162027349|NCT00065429|585156201|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
162027350|NCT00065429|585156202|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
162027351|NCT00065429|585156203|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
162027352|NCT00065429|585156204|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
162027353|NCT00065429|585156205|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
162027354|NCT00065429|585156206|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
162027355|NCT00065429|585156200|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
162027356|NCT00065429|585156201|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
162027357|NCT00065429|585156202|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
162027358|NCT00065429|585156203|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
161832434|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
161946029|NCT01865487|584854624|FG009|Overall Study|Withdrawal by Subject|0|||
161946030|NCT01627691|584854625|FG000|Overall Study|Death|11|||
161946031|NCT01627691|584854625|FG000|Overall Study|Lost to Follow-up|3|||
161946032|NCT01627691|584854625|FG000|Overall Study|Withdrawal by Subject|1|||
161946033|NCT01627691|584854625|FG000|Overall Study|Missed the visit|3|||
161946034|NCT01531998|584854631|FG000|Overall Study|Withdrawal by Subject|3|||
161946035|NCT02927795|584854632|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
161946036|NCT02927795|584854632|FG000|Overall Study|Not Treated|4|||
161946037|NCT01156844|584854634|FG000|Overall Study|Adverse Event|0|||
161946038|NCT01156844|584854635|FG001|Overall Study|Adverse Event|0|||
161946039|NCT01156844|584854636|FG002|Overall Study|Adverse Event|1|||
161946040|NCT01156844|584854637|FG003|Overall Study|Adverse Event|1|||
161946041|NCT01156844|584854634|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161946042|NCT01156844|584854635|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161946043|NCT01156844|584854636|FG002|Overall Study|Abnormal test procedure result(s)|2|||
161946044|NCT01156844|584854637|FG003|Overall Study|Abnormal test procedure result(s)|2|||
161946045|NCT01156844|584854634|FG000|Overall Study|Withdrawal by Subject|0|||
161946046|NCT01156844|584854635|FG001|Overall Study|Withdrawal by Subject|0|||
161946047|NCT01156844|584854636|FG002|Overall Study|Withdrawal by Subject|2|||
161946048|NCT01156844|584854637|FG003|Overall Study|Withdrawal by Subject|2|||
161946049|NCT01156844|584854634|FG000|Overall Study|Lost to Follow-up|0|||
161946050|NCT01156844|584854635|FG001|Overall Study|Lost to Follow-up|0|||
161946051|NCT01156844|584854636|FG002|Overall Study|Lost to Follow-up|1|||
161946052|NCT01156844|584854637|FG003|Overall Study|Lost to Follow-up|0|||
161946053|NCT01156844|584854634|FG000|Overall Study|Administrative problems|0|||
161946054|NCT01156844|584854635|FG001|Overall Study|Administrative problems|1|||
161946055|NCT01156844|584854636|FG002|Overall Study|Administrative problems|0|||
161946056|NCT01156844|584854637|FG003|Overall Study|Administrative problems|1|||
161946057|NCT01156844|584854634|FG000|Overall Study|Protocol deviation|2|||
161946058|NCT01156844|584854635|FG001|Overall Study|Protocol deviation|0|||
161946059|NCT01156844|584854636|FG002|Overall Study|Protocol deviation|0|||
161946060|NCT01156844|584854637|FG003|Overall Study|Protocol deviation|0|||
161946061|NCT04661033|584854639|FG000|Overall Study|Adverse Event|0|||
161946062|NCT04661033|584854640|FG001|Overall Study|Adverse Event|0|||
161946063|NCT04661033|584854641|FG002|Overall Study|Adverse Event|1|||
161946064|NCT04661033|584854642|FG003|Overall Study|Adverse Event|0|||
161946065|NCT04661033|584854639|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
161946066|NCT04661033|584854640|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
161946067|NCT04661033|584854641|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
161946068|NCT04661033|584854642|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
161946069|NCT04661033|584854639|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
161946070|NCT04661033|584854640|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
161946071|NCT04661033|584854641|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
161946072|NCT04661033|584854642|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
161946073|NCT04661033|584854639|FG000|Overall Study|Early discontinuation as per PI|1|||
161946074|NCT04661033|584854640|FG001|Overall Study|Early discontinuation as per PI|0|||
161946075|NCT04661033|584854641|FG002|Overall Study|Early discontinuation as per PI|0|||
161946076|NCT04661033|584854642|FG003|Overall Study|Early discontinuation as per PI|0|||
161946077|NCT03440008|584854643|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
161946078|NCT03440008|584854644|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
161946079|NCT03440008|584854643|FG000|Overall Study|Withdrawal by Subject|1|||
161946080|NCT03440008|584854644|FG001|Overall Study|Withdrawal by Subject|0|||
161946081|NCT01734902|584854653|FG000|Overall Study|Other than listed|0|||
161946082|NCT01734902|584854654|FG001|Overall Study|Other than listed|2|||
161946083|NCT00956293|584854658|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
161946084|NCT00956293|584854659|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
161946085|NCT00956293|584854660|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
161946086|NCT00956293|584854658|FG000|Main Period (Pre-randomization)|Death|0|||
161946087|NCT00956293|584854659|FG001|Main Period (Pre-randomization)|Death|0|||
161946088|NCT00956293|584854660|FG002|Main Period (Pre-randomization)|Death|1|||
161946089|NCT00956293|584854658|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
161946090|NCT00956293|584854659|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
161946091|NCT00956293|584854660|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
161946092|NCT00956293|584854658|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
161946093|NCT00956293|584854659|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
161946094|NCT00956293|584854660|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
161946095|NCT00956293|584854658|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
162027359|NCT00065429|585156204|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
161946096|NCT00956293|584854659|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
161946097|NCT00956293|584854660|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
161946098|NCT00956293|584854658|FG000|Main Period (Pre-randomization)|Graft loss|0|||
161946099|NCT00956293|584854659|FG001|Main Period (Pre-randomization)|Graft loss|0|||
161946100|NCT00956293|584854660|FG002|Main Period (Pre-randomization)|Graft loss|7|||
161946101|NCT00956293|584854658|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
161946102|NCT00956293|584854659|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
161946103|NCT00956293|584854660|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
161946104|NCT00956293|584854658|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
161946105|NCT00956293|584854659|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
161946106|NCT00956293|584854660|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
161946107|NCT00956293|584854658|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
161946108|NCT00956293|584854659|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
161946109|NCT00956293|584854660|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
161946110|NCT00956293|584854658|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
161946111|NCT00956293|584854659|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
161946112|NCT00956293|584854660|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
161946113|NCT00956293|584854658|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
161946114|NCT00956293|584854659|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
161946115|NCT00956293|584854660|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
161946116|NCT00956293|584854658|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
161946117|NCT00956293|584854659|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
161946118|NCT00956293|584854660|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
161946119|NCT00956293|584854658|FG000|Main Period (Randomization)|Adverse Event|0|||
161946120|NCT00956293|584854659|FG001|Main Period (Randomization)|Adverse Event|15|||
161946121|NCT00956293|584854660|FG002|Main Period (Randomization)|Adverse Event|0|||
161946122|NCT00956293|584854658|FG000|Follow-up Period|Follow-up period was terminated.|20|||
161946123|NCT00956293|584854659|FG001|Follow-up Period|Follow-up period was terminated.|32|||
161946124|NCT00956293|584854660|FG002|Follow-up Period|Follow-up period was terminated.|0|||
161946125|NCT02359903|584854661|FG000|Overall Study|Adverse Event|0|||
161946126|NCT02359903|584854662|FG001|Overall Study|Adverse Event|2|||
161946127|NCT03383666|584854663|FG000|Overall Study|Withdrawal by Subject|2|||
161946128|NCT03383666|584854663|FG000|Overall Study|Lost to Follow-up|2|||
161946129|NCT02536664|584854664|FG000|Overall Study|Inadequate completion of documentation|2|||
161946130|NCT02536664|584854665|FG001|Overall Study|Inadequate completion of documentation|4|||
161946131|NCT02536664|584854664|FG000|Overall Study|Progression|13|||
161946132|NCT02536664|584854665|FG001|Overall Study|Progression|18|||
161946133|NCT02536664|584854664|FG000|Overall Study|Death due to lymphoma|2|||
161946134|NCT02536664|584854665|FG001|Overall Study|Death due to lymphoma|1|||
161946135|NCT02536664|584854664|FG000|Overall Study|Death due to other reason|3|||
161946136|NCT02536664|584854665|FG001|Overall Study|Death due to other reason|2|||
161946137|NCT02536664|584854664|FG000|Overall Study|Intolerability|8|||
161946138|NCT02536664|584854665|FG001|Overall Study|Intolerability|6|||
161946139|NCT02536664|584854664|FG000|Overall Study|Withdrawal by Subject|8|||
161946140|NCT02536664|584854665|FG001|Overall Study|Withdrawal by Subject|5|||
161946141|NCT02536664|584854664|FG000|Overall Study|Other|18|||
161946142|NCT02536664|584854665|FG001|Overall Study|Other|24|||
161946143|NCT02536664|584854664|FG000|Overall Study|Missing|53|||
161946144|NCT02536664|584854665|FG001|Overall Study|Missing|20|||
161946145|NCT03507127|584854669|FG000|Overall Study|Withdrawal by Subject|1|||
161946146|NCT03507127|584854670|FG001|Overall Study|Withdrawal by Subject|0|||
161946147|NCT03507127|584854669|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
161946148|NCT03507127|584854670|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
161946149|NCT01240863|584854671|FG000|Open-label Titration Period|Adverse Event|47|||
161946150|NCT01240863|584854672|FG001|Open-label Titration Period|Adverse Event|0|||
161946151|NCT01240863|584854673|FG002|Open-label Titration Period|Adverse Event|0|||
161946152|NCT01240863|584854671|FG000|Open-label Titration Period|Lack of Efficacy|19|||
161946153|NCT01240863|584854672|FG001|Open-label Titration Period|Lack of Efficacy|0|||
161946154|NCT01240863|584854673|FG002|Open-label Titration Period|Lack of Efficacy|0|||
161946155|NCT01240863|584854671|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
161946156|NCT01240863|584854672|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
161946157|NCT01240863|584854673|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
161946158|NCT01240863|584854671|FG000|Open-label Titration Period|Protocol Violation|7|||
161946159|NCT01240863|584854672|FG001|Open-label Titration Period|Protocol Violation|0|||
161946160|NCT01240863|584854673|FG002|Open-label Titration Period|Protocol Violation|0|||
161946161|NCT01240863|584854671|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
161946162|NCT01240863|584854672|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
161946163|NCT01240863|584854673|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
161946164|NCT01240863|584854671|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
161946165|NCT01240863|584854672|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
161946166|NCT01240863|584854673|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
161946167|NCT01240863|584854671|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
161946168|NCT01240863|584854672|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
161946169|NCT01240863|584854673|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
161946170|NCT01240863|584854671|FG000|Open-label Titration Period|Other|7|||
161946171|NCT01240863|584854672|FG001|Open-label Titration Period|Other|0|||
161946172|NCT01240863|584854673|FG002|Open-label Titration Period|Other|0|||
161946173|NCT01240863|584854671|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
161946174|NCT01240863|584854672|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
161946175|NCT01240863|584854673|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
161946176|NCT01240863|584854671|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161946177|NCT01240863|584854672|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
161946178|NCT01240863|584854673|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
161946179|NCT01240863|584854671|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161946180|NCT01240863|584854672|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
161946181|NCT01240863|584854673|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
161946182|NCT01240863|584854671|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
161946183|NCT01240863|584854672|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
161946184|NCT01240863|584854673|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
161946185|NCT01240863|584854671|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
161946186|NCT01240863|584854672|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
161946187|NCT01240863|584854673|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
161946188|NCT01240863|584854671|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
161946189|NCT01240863|584854672|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
161946190|NCT01240863|584854673|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
161946191|NCT01240863|584854671|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
161946192|NCT01240863|584854672|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
161684024|NCT03719690|583895928|FG001|Overall Study|Withdrawal by Subject|10|||
161684025|NCT03719690|583895927|FG000|Overall Study|Death|40|||
161946193|NCT01240863|584854673|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
161946194|NCT01240863|584854671|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
161684026|NCT03719690|583895928|FG001|Overall Study|Death|149|||
161684027|NCT03719690|583895927|FG000|Overall Study|Miscellaneous|12|||
161684028|NCT03719690|583895928|FG001|Overall Study|Miscellaneous|56|||
161684029|NCT03719690|583895927|FG000|Overall Study|Lost to Follow-up|2|||
161946195|NCT01240863|584854672|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
161946196|NCT01240863|584854673|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
161946197|NCT04756531|584854674|FG000|Overall Study|Adverse Event|0|||
161946198|NCT04756531|584854675|FG001|Overall Study|Adverse Event|0|||
161946199|NCT04756531|584854676|FG002|Overall Study|Adverse Event|0|||
161832435|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
161684030|NCT03719690|583895928|FG001|Overall Study|Lost to Follow-up|18|||
161684031|NCT03719690|583895927|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
161946200|NCT04756531|584854677|FG003|Overall Study|Adverse Event|0|||
161946201|NCT04756531|584854678|FG004|Overall Study|Adverse Event|1|||
161946202|NCT04756531|584854679|FG005|Overall Study|Adverse Event|0|||
161946203|NCT04756531|584854680|FG006|Overall Study|Adverse Event|0|||
161832436|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
161832437|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161684032|NCT03719690|583895928|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
161684033|NCT01372384|583895929|FG000|Overall Study|Progression of disease|3|||
161832438|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161946204|NCT04756531|584854681|FG007|Overall Study|Adverse Event|0|||
161946205|NCT04756531|584854682|FG008|Overall Study|Adverse Event|0|||
161946206|NCT04756531|584854683|FG009|Overall Study|Adverse Event|0|||
161946207|NCT04756531|584854684|FG010|Overall Study|Adverse Event|0|||
161946208|NCT04756531|584854685|FG011|Overall Study|Adverse Event|0|||
161946209|NCT04756531|584854686|FG012|Overall Study|Adverse Event|0|||
161946210|NCT04756531|584854687|FG013|Overall Study|Adverse Event|0|||
161946211|NCT04756531|584854688|FG014|Overall Study|Adverse Event|0|||
161946212|NCT04756531|584854689|FG015|Overall Study|Adverse Event|0|||
161832439|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161832440|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161832441|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161832442|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161832443|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161832444|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161832445|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
161946213|NCT04756531|584854690|FG016|Overall Study|Adverse Event|0|||
161946214|NCT04756531|584854691|FG017|Overall Study|Adverse Event|0|||
161946215|NCT04756531|584854674|FG000|Overall Study|Withdrawal by Subject|0|||
161946216|NCT04756531|584854675|FG001|Overall Study|Withdrawal by Subject|0|||
161946217|NCT04756531|584854676|FG002|Overall Study|Withdrawal by Subject|0|||
161684034|NCT03370120|583895930|FG000|Overall Study|Adverse event, non-fatal|24|||
161684035|NCT03370120|583895930|FG000|Overall Study|Withdrawal by Subject|6|||
161684036|NCT03370120|583895930|FG000|Overall Study|Lost to Follow-up|1|||
161684037|NCT03370120|583895930|FG000|Overall Study|Lack of Efficacy|37|||
161684038|NCT03370120|583895930|FG000|Overall Study|Per sponsor's instructions|1|||
161946218|NCT04756531|584854677|FG003|Overall Study|Withdrawal by Subject|0|||
161684039|NCT03370120|583895930|FG000|Overall Study|Study was terminated by parent company UCB|2|||
161946219|NCT04756531|584854678|FG004|Overall Study|Withdrawal by Subject|0|||
161946220|NCT04756531|584854679|FG005|Overall Study|Withdrawal by Subject|0|||
161832446|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
161946221|NCT04756531|584854680|FG006|Overall Study|Withdrawal by Subject|1|||
161946222|NCT04756531|584854681|FG007|Overall Study|Withdrawal by Subject|0|||
161946223|NCT04756531|584854682|FG008|Overall Study|Withdrawal by Subject|0|||
161946224|NCT04756531|584854683|FG009|Overall Study|Withdrawal by Subject|0|||
161946225|NCT04756531|584854684|FG010|Overall Study|Withdrawal by Subject|0|||
161946226|NCT04756531|584854685|FG011|Overall Study|Withdrawal by Subject|0|||
161946227|NCT04756531|584854686|FG012|Overall Study|Withdrawal by Subject|0|||
161946228|NCT04756531|584854687|FG013|Overall Study|Withdrawal by Subject|0|||
161946229|NCT04756531|584854688|FG014|Overall Study|Withdrawal by Subject|0|||
161946230|NCT04756531|584854689|FG015|Overall Study|Withdrawal by Subject|0|||
161946231|NCT04756531|584854690|FG016|Overall Study|Withdrawal by Subject|0|||
161946232|NCT04756531|584854691|FG017|Overall Study|Withdrawal by Subject|0|||
161946233|NCT05643495|584854692|FG000|Overall Study|Adverse Event|0|||
161946234|NCT05643495|584854693|FG001|Overall Study|Adverse Event|1|||
162027360|NCT00065429|585156205|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
162027361|NCT00065429|585156206|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
162027362|NCT00065429|585156200|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
162027363|NCT00065429|585156201|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
162027364|NCT00065429|585156202|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
162027365|NCT00065429|585156203|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
162027366|NCT00065429|585156204|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
162027367|NCT00065429|585156205|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
162027368|NCT00065429|585156206|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
161946235|NCT05643495|584854692|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
161946236|NCT05643495|584854693|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
161946237|NCT02257528|584854694|FG000|Overall Study|Never received study treatment|1|||
161946238|NCT01729039|584854697|FG000|Overall Study|disqualified|2|||
161946239|NCT01729039|584854698|FG001|Overall Study|disqualified|5|||
161946240|NCT01729039|584854697|FG000|Overall Study|Withdrawal by Subject|8|||
161946241|NCT01729039|584854698|FG001|Overall Study|Withdrawal by Subject|7|||
161946242|NCT00698841|584854701|FG000|Overall Study|Withdrawal by Subject|2|||
162027369|NCT00065429|585156200|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
162027370|NCT00065429|585156201|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
162027371|NCT00065429|585156202|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
161946243|NCT00698841|584854701|FG000|Overall Study|Adverse Event|3|||
161946244|NCT00698841|584854701|FG000|Overall Study|Disease progression|7|||
161946245|NCT00698841|584854701|FG000|Overall Study|Failure to meet eligibility criteria|2|||
161946246|NCT00698841|584854701|FG000|Overall Study|Study drug toxicity|2|||
162027372|NCT00065429|585156203|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
161684040|NCT03370120|583895930|FG000|Overall Study|The study was ended by the promoter|3|||
161684041|NCT03370120|583895930|FG000|Overall Study|Discontinuation of drug development|3|||
161684042|NCT03370120|583895930|FG000|Overall Study|End of project|2|||
161946247|NCT00698841|584854701|FG000|Overall Study|Other|2|||
161946248|NCT00789555|584854702|FG000|Overall Study|Protocol Amendment|78|||
161684043|NCT03370120|583895930|FG000|Overall Study|Premature study closure|2|||
161684044|NCT03370120|583895930|FG000|Overall Study|Premature program termination|1|||
161684045|NCT03370120|583895930|FG000|Overall Study|Premature study termination|7|||
161684046|NCT03370120|583895930|FG000|Overall Study|Trial terminated by sponsor|2|||
161684047|NCT03370120|583895930|FG000|Overall Study|Trial discontinued by sponsor|2|||
161684048|NCT03370120|583895930|FG000|Overall Study|Study ended|15|||
161684049|NCT03370120|583895930|FG000|Overall Study|Clinical trial has been cancelled|1|||
161684050|NCT03370120|583895930|FG000|Overall Study|End of study per sponsor decision|2|||
161684051|NCT03370120|583895930|FG000|Overall Study|Promoter's decision|2|||
161684052|NCT03370120|583895930|FG000|Overall Study|The trial has been suspended|3|||
161684053|NCT03370120|583895930|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
161684054|NCT03370120|583895930|FG000|Overall Study|Early termination by order of sponsor|2|||
161684055|NCT03370120|583895930|FG000|Overall Study|Discontinuation of the study|5|||
161684056|NCT03370120|583895930|FG000|Overall Study|End of clinical trial discontinuation|1|||
161684057|NCT03370120|583895930|FG000|Overall Study|Because the clinical trial ended halfway|4|||
161684058|NCT03370120|583895930|FG000|Overall Study|Development discontinued|5|||
161684059|NCT03370120|583895930|FG000|Overall Study|Padsenovil program closed|3|||
161684060|NCT03370120|583895930|FG000|Overall Study|End of project|2|||
161684061|NCT03370120|583895930|FG000|Overall Study|Termination of project|1|||
161684062|NCT03370120|583895930|FG000|Overall Study|The study was interrupted by sponsor|4|||
161684063|NCT03370120|583895930|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
161684064|NCT03370120|583895930|FG000|Overall Study|End of sponsor decision|1|||
161684065|NCT03370120|583895930|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
161684066|NCT03370120|583895930|FG000|Overall Study|Early termination of studies|5|||
161684067|NCT03370120|583895930|FG000|Overall Study|This study is ended early|1|||
161946249|NCT00789555|584854703|FG001|Overall Study|Protocol Amendment|76|||
161946250|NCT00789555|584854704|FG002|Overall Study|Protocol Amendment|80|||
161946251|NCT00789555|584854702|FG000|Overall Study|Adverse Event|17|||
161684068|NCT03370120|583895930|FG000|Overall Study|End of padsevonil program|2|||
161684069|NCT03370120|583895930|FG000|Overall Study|Decision of sponsor|6|||
161684070|NCT03370120|583895930|FG000|Overall Study|Asked by the sponsor|3|||
161832447|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
161832448|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832449|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832450|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832451|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832452|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832453|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832454|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
161946252|NCT00789555|584854703|FG001|Overall Study|Adverse Event|7|||
161946253|NCT00789555|584854704|FG002|Overall Study|Adverse Event|10|||
161946254|NCT00789555|584854702|FG000|Overall Study|Lost to Follow-up|9|||
161946255|NCT00789555|584854703|FG001|Overall Study|Lost to Follow-up|10|||
161684071|NCT03370120|583895930|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
161684072|NCT03370120|583895930|FG000|Overall Study|PI decision poor compliance from participant|1|||
161684073|NCT03370120|583895930|FG000|Overall Study|Promoter ended the study|3|||
161684074|NCT03370120|583895930|FG000|Overall Study|Premature study close by sponsor's decision|4|||
161684075|NCT03370120|583895930|FG000|Overall Study|Study terminated by sponsor|33|||
161684076|NCT03370120|583895930|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
161684077|NCT03370120|583895930|FG000|Overall Study|Sponsor decision to terminate study|63|||
161684078|NCT03370120|583895930|FG000|Overall Study|Program closure|3|||
161684079|NCT03370120|583895930|FG000|Overall Study|Study ended prematurely|1|||
161684080|NCT03370120|583895930|FG000|Overall Study|Study stopped by sponsor|2|||
161684081|NCT03370120|583895930|FG000|Overall Study|Program termination|55|||
161684082|NCT03370120|583895930|FG000|Overall Study|Sponsor decision|62|||
161684083|NCT03370120|583895930|FG000|Overall Study|Sponsor study closure|10|||
161684084|NCT02375724|583895932|FG000|Overall Study|Lack of Efficacy|1|||
161684085|NCT02375724|583895933|FG001|Overall Study|Lack of Efficacy|1|||
161684086|NCT02375724|583895932|FG000|Overall Study|Withdrawal by Subject|1|||
161684087|NCT02375724|583895933|FG001|Overall Study|Withdrawal by Subject|1|||
161684088|NCT02375724|583895932|FG000|Overall Study|Lost to Follow-up|1|||
161832455|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
161946256|NCT00789555|584854704|FG002|Overall Study|Lost to Follow-up|18|||
161684089|NCT02375724|583895933|FG001|Overall Study|Lost to Follow-up|0|||
161684090|NCT02375724|583895932|FG000|Overall Study|Protocol Violation|1|||
161684091|NCT02375724|583895933|FG001|Overall Study|Protocol Violation|0|||
161684092|NCT02375724|583895932|FG000|Overall Study|Adverse Event|2|||
161946257|NCT00789555|584854702|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
161946258|NCT00789555|584854703|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
161946259|NCT00789555|584854704|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
161946260|NCT00789555|584854702|FG000|Overall Study|Treatment failure|11|||
161946261|NCT00789555|584854703|FG001|Overall Study|Treatment failure|8|||
161946262|NCT00789555|584854704|FG002|Overall Study|Treatment failure|12|||
161946263|NCT00789555|584854702|FG000|Overall Study|Protocol Violation|6|||
161946264|NCT00789555|584854703|FG001|Overall Study|Protocol Violation|9|||
161946265|NCT00789555|584854704|FG002|Overall Study|Protocol Violation|13|||
161946266|NCT00404248|584854705|FG000|Overall Study|pts declining status|0|||
161946267|NCT00404248|584854706|FG001|Overall Study|pts declining status|1|||
161946268|NCT00404248|584854707|FG002|Overall Study|pts declining status|0|||
161946269|NCT00404248|584854708|FG003|Overall Study|pts declining status|0|||
161946270|NCT00404248|584854709|FG004|Overall Study|pts declining status|0|||
161946271|NCT00404248|584854710|FG005|Overall Study|pts declining status|0|||
161946272|NCT00404248|584854711|FG006|Overall Study|pts declining status|0|||
161946273|NCT00404248|584854712|FG007|Overall Study|pts declining status|0|||
161946274|NCT00404248|584854713|FG008|Overall Study|pts declining status|0|||
161946275|NCT04646005|584854717|FG000|Overall Study|Adverse Event|1|||
161946276|NCT04646005|584854717|FG000|Overall Study|Progressive Disease|71|||
161946277|NCT04646005|584854717|FG000|Overall Study|Death|20|||
161946278|NCT04646005|584854717|FG000|Overall Study|Withdrawal by Subject|12|||
161946279|NCT04646005|584854717|FG000|Overall Study|Sponsor Request|9|||
161946280|NCT05788991|584854719|FG000|Overall Study|Not treated with study medication|1|||
161946281|NCT05788991|584854720|FG001|Overall Study|Not treated with study medication|3|||
161946282|NCT05788991|584854719|FG000|Overall Study|Withdrawal by Subject|1|||
161946283|NCT05788991|584854720|FG001|Overall Study|Withdrawal by Subject|0|||
161946284|NCT05788991|584854719|FG000|Overall Study|Lack of Efficacy|0|||
161946285|NCT05788991|584854720|FG001|Overall Study|Lack of Efficacy|1|||
161946286|NCT05788991|584854719|FG000|Overall Study|Protocol Violation|1|||
161946287|NCT05788991|584854720|FG001|Overall Study|Protocol Violation|2|||
161946288|NCT04712669|584854721|FG000|Double Blind Phase|Adverse Event|4|||
161946289|NCT04712669|584854722|FG001|Double Blind Phase|Adverse Event|4|||
161946290|NCT04712669|584854723|FG002|Double Blind Phase|Adverse Event|3|||
161946291|NCT04712669|584854724|FG003|Double Blind Phase|Adverse Event|0|||
161946292|NCT04712669|584854725|FG004|Double Blind Phase|Adverse Event|0|||
161946293|NCT04712669|584854726|FG005|Double Blind Phase|Adverse Event|0|||
161946294|NCT04712669|584854727|FG006|Double Blind Phase|Adverse Event|0|||
161946295|NCT04712669|584854728|FG007|Double Blind Phase|Adverse Event|0|||
161946296|NCT04712669|584854721|FG000|Double Blind Phase|Physician Decision|1|||
161946297|NCT04712669|584854722|FG001|Double Blind Phase|Physician Decision|0|||
161946298|NCT04712669|584854723|FG002|Double Blind Phase|Physician Decision|0|||
161946299|NCT04712669|584854724|FG003|Double Blind Phase|Physician Decision|0|||
161946300|NCT04712669|584854725|FG004|Double Blind Phase|Physician Decision|0|||
161946301|NCT04712669|584854726|FG005|Double Blind Phase|Physician Decision|0|||
161946302|NCT04712669|584854727|FG006|Double Blind Phase|Physician Decision|0|||
161946303|NCT04712669|584854728|FG007|Double Blind Phase|Physician Decision|0|||
161946304|NCT04712669|584854721|FG000|Double Blind Phase|Withdrawal by Subject|3|||
161946305|NCT04712669|584854722|FG001|Double Blind Phase|Withdrawal by Subject|6|||
161946306|NCT04712669|584854723|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161946307|NCT04712669|584854724|FG003|Double Blind Phase|Withdrawal by Subject|0|||
161946308|NCT04712669|584854725|FG004|Double Blind Phase|Withdrawal by Subject|0|||
161946309|NCT04712669|584854726|FG005|Double Blind Phase|Withdrawal by Subject|0|||
161946310|NCT04712669|584854727|FG006|Double Blind Phase|Withdrawal by Subject|0|||
161946311|NCT04712669|584854728|FG007|Double Blind Phase|Withdrawal by Subject|0|||
161946312|NCT04712669|584854721|FG000|Double Blind Phase|Termination by Sponsor|0|||
161946313|NCT04712669|584854722|FG001|Double Blind Phase|Termination by Sponsor|0|||
161946314|NCT04712669|584854723|FG002|Double Blind Phase|Termination by Sponsor|1|||
161684093|NCT02375724|583895933|FG001|Overall Study|Adverse Event|4|||
161684094|NCT04712110|583895934|FG000|Overall Study|Lost to Follow-up|0|||
161684095|NCT04712110|583895935|FG001|Overall Study|Lost to Follow-up|1|||
161684096|NCT04712110|583895934|FG000|Overall Study|Withdrawal by Subject|0|||
161684097|NCT04712110|583895935|FG001|Overall Study|Withdrawal by Subject|4|||
161684098|NCT04712110|583895934|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
161684099|NCT04712110|583895935|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
161684100|NCT01356407|583895936|FG000|Overall Study|Lost to Follow-up|2|||
161684101|NCT01356407|583895937|FG001|Overall Study|Lost to Follow-up|0|||
161684102|NCT01356407|583895936|FG000|Overall Study|Patient Withdrew Consent|2|||
161684103|NCT01356407|583895937|FG001|Overall Study|Patient Withdrew Consent|1|||
161684104|NCT01356407|583895936|FG000|Overall Study|Could not afford IMP administration|0|||
161684105|NCT01356407|583895937|FG001|Overall Study|Could not afford IMP administration|1|||
161684106|NCT01356407|583895936|FG000|Overall Study|Not complete Endoscopy|2|||
161684107|NCT01356407|583895937|FG001|Overall Study|Not complete Endoscopy|2|||
161684108|NCT02285777|583895938|FG000|Overall Study|Withdrawal by Subject|1|||
161684109|NCT02285777|583895939|FG001|Overall Study|Withdrawal by Subject|1|||
161684110|NCT02285777|583895938|FG000|Overall Study|Lost to Follow-up|4|||
161684111|NCT02285777|583895939|FG001|Overall Study|Lost to Follow-up|2|||
161684112|NCT03962101|583895940|FG000|Overall Study|Adverse Event|1|||
161684113|NCT03962101|583895940|FG000|Overall Study|Physician Decision|2|||
161684114|NCT03962101|583895940|FG000|Overall Study|Not related to medical events|1|||
161684115|NCT01074190|583895941|FG000|Overall Study|Emergency Cesarean Delivery|1|||
161684116|NCT01074190|583895942|FG001|Overall Study|Emergency Cesarean Delivery|2|||
161684117|NCT01074190|583895943|FG002|Overall Study|Emergency Cesarean Delivery|1|||
161684118|NCT01074190|583895941|FG000|Overall Study|Protocol Violation|2|||
161684119|NCT01074190|583895942|FG001|Overall Study|Protocol Violation|1|||
161684120|NCT01074190|583895943|FG002|Overall Study|Protocol Violation|0|||
161684121|NCT01074190|583895941|FG000|Overall Study|Delivered in under 90 minutes|0|||
161684122|NCT01074190|583895942|FG001|Overall Study|Delivered in under 90 minutes|2|||
161684123|NCT01074190|583895943|FG002|Overall Study|Delivered in under 90 minutes|1|||
161684124|NCT01074190|583895941|FG000|Overall Study|Subject withdrew consent|1|||
161684125|NCT01074190|583895942|FG001|Overall Study|Subject withdrew consent|1|||
161684126|NCT01074190|583895943|FG002|Overall Study|Subject withdrew consent|1|||
161684127|NCT00290342|583895946|FG000|Overall Study|Other|0|||
161684128|NCT00290342|583895947|FG001|Overall Study|Other|1|||
161684129|NCT00290342|583895946|FG000|Overall Study|Withdrawal by Subject|6|||
161684130|NCT00290342|583895947|FG001|Overall Study|Withdrawal by Subject|4|||
161684131|NCT00290342|583895946|FG000|Overall Study|Lost to Follow-up|1|||
161684132|NCT00290342|583895947|FG001|Overall Study|Lost to Follow-up|0|||
161684133|NCT00912028|583895952|FG000|Overall Study|Lost to Follow-up|2|||
161684134|NCT00912028|583895953|FG001|Overall Study|Lost to Follow-up|3|||
161832456|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832457|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
161946315|NCT04712669|584854724|FG003|Double Blind Phase|Termination by Sponsor|0|||
161946316|NCT04712669|584854725|FG004|Double Blind Phase|Termination by Sponsor|0|||
161946317|NCT04712669|584854726|FG005|Double Blind Phase|Termination by Sponsor|0|||
161946318|NCT04712669|584854727|FG006|Double Blind Phase|Termination by Sponsor|0|||
161946319|NCT04712669|584854728|FG007|Double Blind Phase|Termination by Sponsor|0|||
161946320|NCT04712669|584854721|FG000|Open Label Phase|Adverse Event|0|||
161832458|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
161832459|NCT04146363|584428383|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161684135|NCT00912028|583895954|FG002|Overall Study|Lost to Follow-up|0|||
161684136|NCT00912028|583895955|FG003|Overall Study|Lost to Follow-up|1|||
161684137|NCT00912028|583895956|FG004|Overall Study|Lost to Follow-up|3|||
161684138|NCT00912028|583895952|FG000|Overall Study|Withdrawal by Subject|3|||
161684139|NCT00912028|583895953|FG001|Overall Study|Withdrawal by Subject|0|||
161946321|NCT04712669|584854722|FG001|Open Label Phase|Adverse Event|0|||
161946322|NCT04712669|584854723|FG002|Open Label Phase|Adverse Event|0|||
161946323|NCT04712669|584854724|FG003|Open Label Phase|Adverse Event|1|||
161946324|NCT04712669|584854725|FG004|Open Label Phase|Adverse Event|1|||
161946325|NCT04712669|584854726|FG005|Open Label Phase|Adverse Event|3|||
161946326|NCT04712669|584854727|FG006|Open Label Phase|Adverse Event|1|||
161946327|NCT04712669|584854728|FG007|Open Label Phase|Adverse Event|2|||
161946328|NCT04712669|584854721|FG000|Open Label Phase|Death|0|||
161946329|NCT04712669|584854722|FG001|Open Label Phase|Death|0|||
161946330|NCT04712669|584854723|FG002|Open Label Phase|Death|0|||
161946331|NCT04712669|584854724|FG003|Open Label Phase|Death|1|||
161946332|NCT04712669|584854725|FG004|Open Label Phase|Death|0|||
161946333|NCT04712669|584854726|FG005|Open Label Phase|Death|0|||
161946334|NCT04712669|584854727|FG006|Open Label Phase|Death|0|||
161946335|NCT04712669|584854728|FG007|Open Label Phase|Death|0|||
161946336|NCT04712669|584854721|FG000|Open Label Phase|Lack of Efficacy|0|||
161946337|NCT04712669|584854722|FG001|Open Label Phase|Lack of Efficacy|0|||
161946338|NCT04712669|584854723|FG002|Open Label Phase|Lack of Efficacy|0|||
161946339|NCT04712669|584854724|FG003|Open Label Phase|Lack of Efficacy|0|||
161946340|NCT04712669|584854725|FG004|Open Label Phase|Lack of Efficacy|1|||
161946341|NCT04712669|584854726|FG005|Open Label Phase|Lack of Efficacy|0|||
161946342|NCT04712669|584854727|FG006|Open Label Phase|Lack of Efficacy|0|||
161946343|NCT04712669|584854728|FG007|Open Label Phase|Lack of Efficacy|0|||
161946344|NCT04712669|584854721|FG000|Open Label Phase|Lost to Follow-up|0|||
161946345|NCT04712669|584854722|FG001|Open Label Phase|Lost to Follow-up|0|||
161946346|NCT04712669|584854723|FG002|Open Label Phase|Lost to Follow-up|0|||
161946347|NCT04712669|584854724|FG003|Open Label Phase|Lost to Follow-up|0|||
161684140|NCT00912028|583895954|FG002|Overall Study|Withdrawal by Subject|0|||
161684141|NCT00912028|583895955|FG003|Overall Study|Withdrawal by Subject|0|||
161684142|NCT00912028|583895956|FG004|Overall Study|Withdrawal by Subject|0|||
161684143|NCT02285998|583895957|FG000|Overall Study|Adverse Event|9|||
161684144|NCT02285998|583895958|FG001|Overall Study|Adverse Event|8|||
161684145|NCT02285998|583895957|FG000|Overall Study|Physician Decision|1|||
161684146|NCT02285998|583895958|FG001|Overall Study|Physician Decision|2|||
161684147|NCT02285998|583895957|FG000|Overall Study|Lost to Follow-up|176|||
161684148|NCT02285998|583895958|FG001|Overall Study|Lost to Follow-up|172|||
161684149|NCT02285998|583895957|FG000|Overall Study|Withdrawal by Subject|53|||
161684150|NCT02285998|583895958|FG001|Overall Study|Withdrawal by Subject|61|||
161684151|NCT02285998|583895957|FG000|Overall Study|Other Reasons|7|||
161684152|NCT02285998|583895958|FG001|Overall Study|Other Reasons|10|||
161684153|NCT02829138|583895959|FG000|Overall Study|Withdrawal by Subject|1|||
161832460|NCT04146363|584428384|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161832461|NCT04146363|584428385|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161684154|NCT02829138|583895960|FG001|Overall Study|Withdrawal by Subject|0|||
161684155|NCT01394627|583895961|FG000|First Intervention (1 Day)|poor intravenous access|0|||
161832462|NCT04146363|584428386|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161946348|NCT04712669|584854725|FG004|Open Label Phase|Lost to Follow-up|0|||
161946349|NCT04712669|584854726|FG005|Open Label Phase|Lost to Follow-up|0|||
161946350|NCT04712669|584854727|FG006|Open Label Phase|Lost to Follow-up|1|||
161946351|NCT04712669|584854728|FG007|Open Label Phase|Lost to Follow-up|1|||
161946352|NCT04712669|584854721|FG000|Open Label Phase|Physician Decision|0|||
161946353|NCT04712669|584854722|FG001|Open Label Phase|Physician Decision|0|||
161946354|NCT04712669|584854723|FG002|Open Label Phase|Physician Decision|0|||
161946355|NCT04712669|584854724|FG003|Open Label Phase|Physician Decision|1|||
161946356|NCT04712669|584854725|FG004|Open Label Phase|Physician Decision|0|||
161946357|NCT04712669|584854726|FG005|Open Label Phase|Physician Decision|0|||
161946358|NCT04712669|584854727|FG006|Open Label Phase|Physician Decision|0|||
161946359|NCT04712669|584854728|FG007|Open Label Phase|Physician Decision|0|||
161946360|NCT04712669|584854721|FG000|Open Label Phase|Withdrawal by Subject|0|||
161946361|NCT04712669|584854722|FG001|Open Label Phase|Withdrawal by Subject|0|||
161946362|NCT04712669|584854723|FG002|Open Label Phase|Withdrawal by Subject|0|||
161684156|NCT01394627|583895962|FG001|First Intervention (1 Day)|poor intravenous access|1|||
162027373|NCT00065429|585156204|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
162027374|NCT00065429|585156205|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
162027375|NCT00065429|585156206|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
161946363|NCT04712669|584854724|FG003|Open Label Phase|Withdrawal by Subject|1|||
161946364|NCT04712669|584854725|FG004|Open Label Phase|Withdrawal by Subject|5|||
161946365|NCT04712669|584854726|FG005|Open Label Phase|Withdrawal by Subject|5|||
161946366|NCT04712669|584854727|FG006|Open Label Phase|Withdrawal by Subject|0|||
162027376|NCT00977080|585156207|FG000|Overall Study|Adverse Event|2|||
162027377|NCT00977080|585156208|FG001|Overall Study|Adverse Event|7|||
162027378|NCT00977080|585156209|FG002|Overall Study|Adverse Event|7|||
162027379|NCT00977080|585156210|FG003|Overall Study|Adverse Event|7|||
162027380|NCT00977080|585156207|FG000|Overall Study|Withdrawal by Subject|1|||
162027381|NCT00977080|585156208|FG001|Overall Study|Withdrawal by Subject|5|||
162027382|NCT00977080|585156209|FG002|Overall Study|Withdrawal by Subject|1|||
162027383|NCT00977080|585156210|FG003|Overall Study|Withdrawal by Subject|5|||
162027384|NCT00977080|585156207|FG000|Overall Study|Protocol Violation|7|||
162027385|NCT00977080|585156208|FG001|Overall Study|Protocol Violation|3|||
162027386|NCT00977080|585156209|FG002|Overall Study|Protocol Violation|4|||
162027387|NCT00977080|585156210|FG003|Overall Study|Protocol Violation|3|||
162027388|NCT00977080|585156207|FG000|Overall Study|Noncompliance|0|||
161832463|NCT04146363|584428387|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161832464|NCT04146363|584428388|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161832465|NCT04146363|584428389|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161832466|NCT04146363|584428390|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161832467|NCT04146363|584428391|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161832468|NCT04146363|584428392|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
161832469|NCT04146363|584428393|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161946367|NCT04712669|584854728|FG007|Open Label Phase|Withdrawal by Subject|4|||
161946368|NCT04712669|584854721|FG000|Open Label Phase|Termination by Sponsor|0|||
161946369|NCT04712669|584854722|FG001|Open Label Phase|Termination by Sponsor|0|||
161946370|NCT04712669|584854723|FG002|Open Label Phase|Termination by Sponsor|0|||
161946371|NCT04712669|584854724|FG003|Open Label Phase|Termination by Sponsor|11|||
161946372|NCT04712669|584854725|FG004|Open Label Phase|Termination by Sponsor|9|||
161946373|NCT04712669|584854726|FG005|Open Label Phase|Termination by Sponsor|14|||
162027389|NCT00977080|585156208|FG001|Overall Study|Noncompliance|2|||
162027390|NCT00977080|585156209|FG002|Overall Study|Noncompliance|1|||
162027391|NCT00977080|585156210|FG003|Overall Study|Noncompliance|0|||
162027392|NCT00977080|585156207|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
162027393|NCT00977080|585156208|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
161684157|NCT01394627|583895961|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
162027394|NCT00977080|585156209|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
161684158|NCT01394627|583895962|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
162027395|NCT00977080|585156210|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
161684159|NCT04041284|583895965|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
161684160|NCT04041284|583895966|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
161684161|NCT04041284|583895965|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
161684162|NCT04041284|583895966|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
161684163|NCT04041284|583895965|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
161684164|NCT04041284|583895966|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
161684165|NCT04041284|583895965|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
161684166|NCT04041284|583895966|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
161684167|NCT04041284|583895965|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
161684168|NCT04041284|583895966|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
161684169|NCT04041284|583895965|FG000|DB Phase (12 Weeks)|Other than specified|1|||
161684170|NCT04041284|583895966|FG001|DB Phase (12 Weeks)|Other than specified|0|||
161684171|NCT04041284|583895965|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
161684172|NCT04041284|583895966|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
161684173|NCT04041284|583895965|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
161684174|NCT04041284|583895966|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
161684175|NCT04041284|583895965|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
161684176|NCT04041284|583895966|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
161684177|NCT04041284|583895965|FG000|OL Phase (12 Weeks)|Other than specified|6|||
161684178|NCT04041284|583895966|FG001|OL Phase (12 Weeks)|Other than specified|2|||
161684179|NCT02016820|583895972|FG000|Overall Study|Lost to Follow-up|2|||
161684180|NCT02016820|583895973|FG001|Overall Study|Lost to Follow-up|4|||
162027396|NCT00977080|585156207|FG000|Overall Study|Required kidney transplantation|1|||
161684181|NCT00884273|583895974|FG000|Overall Study|Adverse Event|0|||
161684182|NCT00884273|583895975|FG001|Overall Study|Adverse Event|2|||
161684183|NCT00884273|583895974|FG000|Overall Study|Protocol Violation|1|||
161684184|NCT00884273|583895975|FG001|Overall Study|Protocol Violation|3|||
161684185|NCT00884273|583895974|FG000|Overall Study|Practical reasons|1|||
161684186|NCT00884273|583895975|FG001|Overall Study|Practical reasons|0|||
161684187|NCT02437864|583895976|FG000|Overall Study|Protocol Violation|4|||
161684188|NCT02437864|583895977|FG001|Overall Study|Protocol Violation|0|||
161684189|NCT03803059|583895978|FG000|Overall Study|Protocol Violation|2|||
161684190|NCT03803059|583895978|FG000|Overall Study|Lost to Follow-up|1|||
161684191|NCT05419128|583895982|FG000|Overall Study|Withdrawal by Subject|1|||
161684192|NCT05419128|583895983|FG001|Overall Study|Withdrawal by Subject|1|||
161684193|NCT05419128|583895984|FG002|Overall Study|Withdrawal by Subject|0|||
161684194|NCT05419128|583895985|FG003|Overall Study|Withdrawal by Subject|1|||
161684195|NCT05419128|583895986|FG004|Overall Study|Withdrawal by Subject|1|||
161684196|NCT05419128|583895987|FG005|Overall Study|Withdrawal by Subject|0|||
161946374|NCT04712669|584854727|FG006|Open Label Phase|Termination by Sponsor|0|||
161946375|NCT04712669|584854728|FG007|Open Label Phase|Termination by Sponsor|14|||
161946376|NCT04464473|584854729|FG000|Overall Study|New piercing could not be removed for scanning|0|||
161946377|NCT04464473|584854730|FG001|Overall Study|New piercing could not be removed for scanning|0|||
161946378|NCT04464473|584854731|FG002|Overall Study|New piercing could not be removed for scanning|0|||
161946379|NCT04464473|584854732|FG003|Overall Study|New piercing could not be removed for scanning|1|||
161946380|NCT04464473|584854733|FG004|Overall Study|New piercing could not be removed for scanning|0|||
161684197|NCT05419128|583895982|FG000|Overall Study|Lost to Follow-up|0|||
161684198|NCT05419128|583895983|FG001|Overall Study|Lost to Follow-up|0|||
161684199|NCT05419128|583895984|FG002|Overall Study|Lost to Follow-up|1|||
161684200|NCT05419128|583895985|FG003|Overall Study|Lost to Follow-up|0|||
161684201|NCT05419128|583895986|FG004|Overall Study|Lost to Follow-up|0|||
161684202|NCT05419128|583895987|FG005|Overall Study|Lost to Follow-up|1|||
161684203|NCT02581202|583895988|FG000|Overall Study|Lack of Efficacy|2|||
161684204|NCT02581202|583895988|FG000|Overall Study|Withdrawal by Subject|4|||
161684205|NCT02581202|583895988|FG000|Overall Study|Lost to Follow-up|5|||
161832470|NCT00380692|584428400|FG000|Study Period II - Double Blind|Adverse Event|1|||
161832471|NCT00380692|584428401|FG001|Study Period II - Double Blind|Adverse Event|0|||
161946381|NCT04464473|584854734|FG005|Overall Study|New piercing could not be removed for scanning|0|||
161946382|NCT04464473|584854729|FG000|Overall Study|Adverse Event|0|||
161946383|NCT04464473|584854730|FG001|Overall Study|Adverse Event|0|||
161946384|NCT04464473|584854731|FG002|Overall Study|Adverse Event|0|||
161946385|NCT04464473|584854732|FG003|Overall Study|Adverse Event|1|||
161946386|NCT04464473|584854733|FG004|Overall Study|Adverse Event|0|||
161946387|NCT04464473|584854734|FG005|Overall Study|Adverse Event|0|||
161946388|NCT04464473|584854729|FG000|Overall Study|Lost to Follow-up|0|||
161946389|NCT04464473|584854730|FG001|Overall Study|Lost to Follow-up|0|||
161946390|NCT04464473|584854731|FG002|Overall Study|Lost to Follow-up|0|||
161946391|NCT04464473|584854732|FG003|Overall Study|Lost to Follow-up|1|||
161946392|NCT04464473|584854733|FG004|Overall Study|Lost to Follow-up|0|||
161946393|NCT04464473|584854734|FG005|Overall Study|Lost to Follow-up|0|||
161946394|NCT03802396|584854735|FG000|Overall Study|Withdrawal by Subject|2|||
161946395|NCT03802396|584854736|FG001|Overall Study|Withdrawal by Subject|0|||
161946396|NCT03802396|584854735|FG000|Overall Study|Surgery Cancelled|1|||
161946397|NCT03802396|584854736|FG001|Overall Study|Surgery Cancelled|0|||
161946398|NCT04237584|584854742|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
161946399|NCT04237584|584854743|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
161946400|NCT04237584|584854744|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
161946401|NCT04237584|584854745|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
161684206|NCT02581202|583895988|FG000|Overall Study|Pregnancy|3|||
161684207|NCT04218201|583897861|FG000|Overall Study|Death|0|||
161684208|NCT04218201|583897862|FG001|Overall Study|Death|0|||
161684209|NCT04218201|583897863|FG002|Overall Study|Death|2|||
161684210|NCT04218201|583897864|FG003|Overall Study|Death|0|||
161684211|NCT04218201|583897861|FG000|Overall Study|Unable to contact participant|4|||
161946402|NCT04237584|584854742|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
161946403|NCT04237584|584854743|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
161946404|NCT04237584|584854744|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
161946405|NCT04237584|584854745|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
161946406|NCT04237584|584854742|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
161684212|NCT04218201|583897862|FG001|Overall Study|Unable to contact participant|0|||
161684213|NCT04218201|583897863|FG002|Overall Study|Unable to contact participant|3|||
161684214|NCT04218201|583897864|FG003|Overall Study|Unable to contact participant|0|||
161832472|NCT00380692|584428400|FG000|Study Period II - Double Blind|Protocol Violation|2|||
161684215|NCT04218201|583897861|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
161684216|NCT04218201|583897862|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
161684217|NCT04218201|583897863|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
161684218|NCT04218201|583897864|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
161684219|NCT04218201|583897861|FG000|Overall Study|Withdrawal by Subject|2|||
161684220|NCT04218201|583897862|FG001|Overall Study|Withdrawal by Subject|0|||
161684221|NCT04218201|583897863|FG002|Overall Study|Withdrawal by Subject|0|||
161684222|NCT04218201|583897864|FG003|Overall Study|Withdrawal by Subject|0|||
161684223|NCT04218201|583897861|FG000|Overall Study|PCP plans to leave practice|0|||
161946407|NCT04237584|584854743|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
161946408|NCT04237584|584854744|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
161946409|NCT04237584|584854745|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
161946410|NCT04237584|584854742|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
161946411|NCT04237584|584854743|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
161946412|NCT04237584|584854744|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
161946413|NCT04237584|584854745|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
161946414|NCT04237584|584854742|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
161946415|NCT04237584|584854743|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
161946416|NCT04237584|584854744|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
161946417|NCT04237584|584854745|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
161946418|NCT01492426|584856164|FG000|Treatment|Death|0|||
161946419|NCT01492426|584856165|FG001|Treatment|Death|1|||
161946420|NCT01492426|584856164|FG000|Treatment|Other|1|||
161946421|NCT01492426|584856165|FG001|Treatment|Other|0|||
161946422|NCT01492426|584856164|FG000|Treatment|Adverse Event|25|||
161946423|NCT01492426|584856165|FG001|Treatment|Adverse Event|25|||
161946424|NCT01492426|584856164|FG000|Treatment|Lack of Efficacy|38|||
161946425|NCT01492426|584856165|FG001|Treatment|Lack of Efficacy|5|||
161946426|NCT01492426|584856164|FG000|Treatment|Participant withdrew consent|1|||
161946427|NCT01492426|584856165|FG001|Treatment|Participant withdrew consent|2|||
161946428|NCT01492426|584856164|FG000|Treatment|Poor compliance/noncompliance|1|||
161946429|NCT01492426|584856165|FG001|Treatment|Poor compliance/noncompliance|0|||
161946430|NCT01492426|584856164|FG000|Treatment|Subject requested discontinue study drug|7|||
161946431|NCT01492426|584856165|FG001|Treatment|Subject requested discontinue study drug|3|||
161946432|NCT01492426|584856164|FG000|Treatment|Lost to Follow-up|9|||
161946433|NCT01492426|584856165|FG001|Treatment|Lost to Follow-up|4|||
161946434|NCT01492426|584856164|FG000|Treatment|Participant does not meet study criteria|1|||
161946435|NCT01492426|584856165|FG001|Treatment|Participant does not meet study criteria|0|||
161946436|NCT01492426|584856164|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
161946437|NCT01492426|584856165|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
161946438|NCT01492426|584856164|FG000|Follow-Up|Death|1|||
161946439|NCT01492426|584856165|FG001|Follow-Up|Death|0|||
161946440|NCT01492426|584856164|FG000|Follow-Up|Other|4|||
161946441|NCT01492426|584856165|FG001|Follow-Up|Other|2|||
161946442|NCT01492426|584856164|FG000|Follow-Up|Participant Withdrew Consent|6|||
161946443|NCT01492426|584856165|FG001|Follow-Up|Participant Withdrew Consent|1|||
161946444|NCT01492426|584856164|FG000|Follow-Up|Lost to Follow-up|12|||
161946445|NCT01492426|584856165|FG001|Follow-Up|Lost to Follow-up|6|||
161946446|NCT03549338|584856166|FG000|Overall Study|Progressive Disease|1|||
161946447|NCT03549338|584856167|FG001|Overall Study|Progressive Disease|0|||
161946448|NCT03549338|584856168|FG002|Overall Study|Progressive Disease|0|||
161946449|NCT03549338|584856166|FG000|Overall Study|Clinical Progression|0|||
161946450|NCT03549338|584856167|FG001|Overall Study|Clinical Progression|1|||
161946451|NCT03549338|584856168|FG002|Overall Study|Clinical Progression|0|||
161946452|NCT00269113|584856169|FG000|Overall Study|Adverse Event|14|||
161946453|NCT00269113|584856170|FG001|Overall Study|Adverse Event|7|||
161946454|NCT00269113|584856169|FG000|Overall Study|Lack of Efficacy|35|||
161946455|NCT00269113|584856170|FG001|Overall Study|Lack of Efficacy|18|||
161946456|NCT00269113|584856169|FG000|Overall Study|Early Improvement|2|||
161946457|NCT00269113|584856170|FG001|Overall Study|Early Improvement|0|||
161946458|NCT00269113|584856169|FG000|Overall Study|Withdrawal by Subject|0|||
161946459|NCT00269113|584856170|FG001|Overall Study|Withdrawal by Subject|2|||
161946460|NCT00269113|584856169|FG000|Overall Study|Death|6|||
161946461|NCT00269113|584856170|FG001|Overall Study|Death|2|||
161946462|NCT00269113|584856169|FG000|Overall Study|Lost to Follow-up|2|||
161946463|NCT00269113|584856170|FG001|Overall Study|Lost to Follow-up|1|||
161946464|NCT00269113|584856169|FG000|Overall Study|Protocol Violation|15|||
161946465|NCT00269113|584856170|FG001|Overall Study|Protocol Violation|5|||
161946466|NCT00269113|584856169|FG000|Overall Study|Other|0|||
161946467|NCT00269113|584856170|FG001|Overall Study|Other|2|||
161946468|NCT00140140|584856171|FG000|Overall Study|Unacceptable toxicity|1|||
161946469|NCT00140140|584856172|FG001|Overall Study|Unacceptable toxicity|1|||
161946470|NCT00140140|584856173|FG002|Overall Study|Unacceptable toxicity|2|||
161946471|NCT00140140|584856171|FG000|Overall Study|Physician Decision|1|||
161946472|NCT00140140|584856172|FG001|Overall Study|Physician Decision|1|||
161946473|NCT00140140|584856173|FG002|Overall Study|Physician Decision|0|||
161946474|NCT00639457|584856174|FG000|Overall Study|Withdrawal by Subject|2|||
161946475|NCT00639457|584856175|FG001|Overall Study|Withdrawal by Subject|3|||
161946476|NCT02580877|584856176|FG000|Overall Study|Withdrawal by Subject|1|||
161946477|NCT02580877|584856177|FG001|Overall Study|Withdrawal by Subject|3|||
161946478|NCT02580877|584856176|FG000|Overall Study|Adverse Event|0|||
161946479|NCT02580877|584856177|FG001|Overall Study|Adverse Event|1|||
161946480|NCT01466491|584856178|FG000|Overall Study|Protocol Violation|0|||
161946481|NCT01466491|584856179|FG001|Overall Study|Protocol Violation|3|||
161946482|NCT01466491|584856180|FG002|Overall Study|Protocol Violation|2|||
161946483|NCT01466491|584856181|FG003|Overall Study|Protocol Violation|0|||
161946484|NCT01466491|584856178|FG000|Overall Study|Missing Data|0|||
161946485|NCT01466491|584856179|FG001|Overall Study|Missing Data|0|||
161946486|NCT01466491|584856180|FG002|Overall Study|Missing Data|1|||
161946487|NCT01466491|584856181|FG003|Overall Study|Missing Data|0|||
161946488|NCT00892008|584856182|FG000|Overall Study|Death|5|||
161946489|NCT00892008|584856182|FG000|Overall Study|Lack of Efficacy|3|||
162027397|NCT00977080|585156208|FG001|Overall Study|Required kidney transplantation|3|||
162027398|NCT00977080|585156209|FG002|Overall Study|Required kidney transplantation|3|||
162027399|NCT00977080|585156210|FG003|Overall Study|Required kidney transplantation|1|||
162027400|NCT00977080|585156207|FG000|Overall Study|Travel for family reasons|1|||
162027401|NCT00977080|585156208|FG001|Overall Study|Travel for family reasons|0|||
162027402|NCT00977080|585156209|FG002|Overall Study|Travel for family reasons|0|||
162027403|NCT00977080|585156210|FG003|Overall Study|Travel for family reasons|0|||
162027404|NCT01616693|585156213|FG000|Evaluated for Safety|Physician Decision|1|||
162027405|NCT01616693|585156214|FG001|Evaluated for Safety|Physician Decision|0|||
162027406|NCT01616693|585156215|FG002|Evaluated for Safety|Physician Decision|1|||
162027407|NCT01616693|585156216|FG003|Evaluated for Safety|Physician Decision|0|||
162027408|NCT01616693|585156213|FG000|Received Both Vaccines|Adverse Event|2|||
162027409|NCT01616693|585156214|FG001|Received Both Vaccines|Adverse Event|0|||
162027410|NCT01616693|585156215|FG002|Received Both Vaccines|Adverse Event|0|||
162027411|NCT01616693|585156216|FG003|Received Both Vaccines|Adverse Event|0|||
162027412|NCT01616693|585156213|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
162027413|NCT01616693|585156214|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
162027414|NCT01616693|585156215|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
162027415|NCT01616693|585156216|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
162027416|NCT01616693|585156213|FG000|Received Both Vaccines|Lost to Follow-up|4|||
162027417|NCT01616693|585156214|FG001|Received Both Vaccines|Lost to Follow-up|3|||
162027418|NCT01616693|585156215|FG002|Received Both Vaccines|Lost to Follow-up|4|||
162027419|NCT01616693|585156216|FG003|Received Both Vaccines|Lost to Follow-up|4|||
162027420|NCT01616693|585156213|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
162027421|NCT01616693|585156214|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
162027422|NCT01616693|585156215|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
162027423|NCT01616693|585156216|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
162027424|NCT00441116|585156220|FG000|Overall Study|Adverse Event|1|||
162027425|NCT00441116|585156221|FG001|Overall Study|Adverse Event|1|||
162027426|NCT00441116|585156220|FG000|Overall Study|Withdrawal by Subject|1|||
162027427|NCT00441116|585156221|FG001|Overall Study|Withdrawal by Subject|0|||
162027428|NCT00441116|585156220|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
162027429|NCT00441116|585156221|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
162027430|NCT02925338|585156222|FG000|Overall Study|Death|0|||
162027431|NCT02925338|585156223|FG001|Overall Study|Death|2|||
162027432|NCT02925338|585156224|FG002|Overall Study|Death|1|||
162027433|NCT02925338|585156225|FG003|Overall Study|Death|0|||
162027434|NCT02925338|585156226|FG004|Overall Study|Death|0|||
162027435|NCT02925338|585156222|FG000|Overall Study|Lost to Follow-up|30|||
162027436|NCT02925338|585156223|FG001|Overall Study|Lost to Follow-up|10|||
162027437|NCT02925338|585156224|FG002|Overall Study|Lost to Follow-up|1|||
162027438|NCT02925338|585156225|FG003|Overall Study|Lost to Follow-up|16|||
162027439|NCT02925338|585156226|FG004|Overall Study|Lost to Follow-up|3|||
162027440|NCT02925338|585156222|FG000|Overall Study|Withdrawal by Subject|3|||
162027441|NCT02925338|585156223|FG001|Overall Study|Withdrawal by Subject|0|||
162027442|NCT02925338|585156224|FG002|Overall Study|Withdrawal by Subject|3|||
162027443|NCT02925338|585156225|FG003|Overall Study|Withdrawal by Subject|2|||
162027444|NCT02925338|585156226|FG004|Overall Study|Withdrawal by Subject|2|||
162027445|NCT02925338|585156222|FG000|Overall Study|Missing|38|||
162027446|NCT02925338|585156223|FG001|Overall Study|Missing|27|||
162027447|NCT02925338|585156224|FG002|Overall Study|Missing|0|||
162027448|NCT02925338|585156225|FG003|Overall Study|Missing|3|||
162027449|NCT02925338|585156226|FG004|Overall Study|Missing|2|||
162027450|NCT02925338|585156222|FG000|Overall Study|Participant's Decision|11|||
162027451|NCT02925338|585156223|FG001|Overall Study|Participant's Decision|7|||
162027452|NCT02925338|585156224|FG002|Overall Study|Participant's Decision|3|||
162027453|NCT02925338|585156225|FG003|Overall Study|Participant's Decision|8|||
162027454|NCT02925338|585156226|FG004|Overall Study|Participant's Decision|1|||
162027455|NCT02925338|585156222|FG000|Overall Study|Treatment Discontinuation|144|||
162027456|NCT02925338|585156223|FG001|Overall Study|Treatment Discontinuation|65|||
162027457|NCT02925338|585156224|FG002|Overall Study|Treatment Discontinuation|56|||
162027458|NCT02925338|585156225|FG003|Overall Study|Treatment Discontinuation|131|||
162027459|NCT02925338|585156226|FG004|Overall Study|Treatment Discontinuation|22|||
162027460|NCT00636363|585156229|FG000|Overall Study|Conjunctivitis|0|||
162027461|NCT00636363|585156230|FG001|Overall Study|Conjunctivitis|0|||
162027462|NCT00636363|585156231|FG002|Overall Study|Conjunctivitis|1|||
162027463|NCT00636363|585156229|FG000|Overall Study|Adverse Event|0|||
162027464|NCT00636363|585156230|FG001|Overall Study|Adverse Event|0|||
162027465|NCT00636363|585156231|FG002|Overall Study|Adverse Event|1|||
162027466|NCT00636363|585156229|FG000|Overall Study|Positive slit lamp finding|0|||
162027467|NCT00636363|585156230|FG001|Overall Study|Positive slit lamp finding|2|||
162027468|NCT00636363|585156231|FG002|Overall Study|Positive slit lamp finding|1|||
162027469|NCT00636363|585156229|FG000|Overall Study|Study related symptoms/complaints|8|||
162027470|NCT00636363|585156230|FG001|Overall Study|Study related symptoms/complaints|7|||
162027471|NCT00636363|585156231|FG002|Overall Study|Study related symptoms/complaints|4|||
162027472|NCT00636363|585156229|FG000|Overall Study|Met ineligibility criteria|0|||
161946490|NCT00892008|584856182|FG000|Overall Study|Lost to Follow-up|142|||
161946491|NCT00892008|584856182|FG000|Overall Study|Other|378|||
161946492|NCT00892008|584856182|FG000|Overall Study|Adverse Event|37|||
161946493|NCT01123148|584856183|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
161946494|NCT01123148|584856183|FG000|Overall Study|Didn't meet milestone criteria|1|||
161946495|NCT00355030|584856184|FG000|Study Period 1 Treatment|Adverse Event|1|||
161946496|NCT00355030|584856185|FG001|Study Period 1 Treatment|Adverse Event|1|||
161946497|NCT00355030|584856184|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
161946498|NCT00355030|584856185|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
161946499|NCT00355030|584856184|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
161946500|NCT00355030|584856185|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
161946501|NCT00355030|584856184|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
161946502|NCT00355030|584856185|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
161946503|NCT00355030|584856184|FG000|Study Period 1 Treatment|Physician Decision|0|||
161946504|NCT00355030|584856185|FG001|Study Period 1 Treatment|Physician Decision|1|||
161946505|NCT00355030|584856184|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
161946506|NCT00355030|584856185|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
161946507|NCT00355030|584856184|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
161946508|NCT00355030|584856185|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
161946509|NCT00355030|584856184|FG000|Study Period 1 Treatment|Other|2|||
161946510|NCT00355030|584856185|FG001|Study Period 1 Treatment|Other|6|||
161946511|NCT00355030|584856184|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
161946512|NCT00355030|584856185|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
161946513|NCT00355030|584856184|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
161946514|NCT00355030|584856185|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
161946515|NCT01693367|584856186|FG000|Overall Study|Withdrawal by Subject|1|||
161946516|NCT01693367|584856187|FG001|Overall Study|Withdrawal by Subject|1|||
161946517|NCT01693367|584856186|FG000|Overall Study|Physician Decision|0|||
161946518|NCT01693367|584856187|FG001|Overall Study|Physician Decision|1|||
161946519|NCT00690794|584856188|FG000|Overall Study|Adverse Event|12|||
161684224|NCT04218201|583897862|FG001|Overall Study|PCP plans to leave practice|8|||
161684225|NCT04218201|583897863|FG002|Overall Study|PCP plans to leave practice|0|||
161684226|NCT04218201|583897864|FG003|Overall Study|PCP plans to leave practice|5|||
161684227|NCT04218201|583897861|FG000|Overall Study|Reduced panel|0|||
161684228|NCT04218201|583897862|FG001|Overall Study|Reduced panel|0|||
161684229|NCT04218201|583897863|FG002|Overall Study|Reduced panel|0|||
161684230|NCT04218201|583897864|FG003|Overall Study|Reduced panel|1|||
161684231|NCT04218201|583897861|FG000|Overall Study|No longer interested in participating|0|||
161684232|NCT04218201|583897862|FG001|Overall Study|No longer interested in participating|1|||
161684233|NCT04218201|583897863|FG002|Overall Study|No longer interested in participating|0|||
161684234|NCT04218201|583897864|FG003|Overall Study|No longer interested in participating|0|||
161684235|NCT04036708|583897873|FG000|Overall Study|Lost to Follow-up|14|||
161684236|NCT04036708|583897874|FG001|Overall Study|Lost to Follow-up|4|||
161684237|NCT04036708|583897875|FG002|Overall Study|Lost to Follow-up|14|||
161684238|NCT04036708|583897876|FG003|Overall Study|Lost to Follow-up|4|||
161684239|NCT02918864|583897877|FG000|Overall Study|Withdrawal by Subject|1|||
161684240|NCT02918864|583897878|FG001|Overall Study|Withdrawal by Subject|1|||
161684241|NCT02918864|583897877|FG000|Overall Study|Lost to Follow-up|3|||
161684242|NCT02918864|583897878|FG001|Overall Study|Lost to Follow-up|2|||
161684243|NCT02104583|583897881|FG000|Overall Study|New ICD or CRT-D implanted|2|||
161684244|NCT02104583|583897882|FG001|Overall Study|New ICD or CRT-D implanted|0|||
161684245|NCT02104583|583897883|FG002|Overall Study|New ICD or CRT-D implanted|1|||
161684246|NCT02104583|583897884|FG003|Overall Study|New ICD or CRT-D implanted|0|||
161684247|NCT02104583|583897885|FG004|Overall Study|New ICD or CRT-D implanted|0|||
161684248|NCT02104583|583897881|FG000|Overall Study|Death|2|||
161684249|NCT02104583|583897882|FG001|Overall Study|Death|1|||
161684250|NCT02104583|583897883|FG002|Overall Study|Death|3|||
161946520|NCT00690794|584856189|FG001|Overall Study|Adverse Event|10|||
161946521|NCT00690794|584856188|FG000|Overall Study|Lost to Follow-up|1|||
161946522|NCT00690794|584856189|FG001|Overall Study|Lost to Follow-up|4|||
161946523|NCT00690794|584856188|FG000|Overall Study|Withdrawal by Subject|0|||
161946524|NCT00690794|584856189|FG001|Overall Study|Withdrawal by Subject|9|||
161946525|NCT00690794|584856188|FG000|Overall Study|Protocol Violation|6|||
161684251|NCT02104583|583897884|FG003|Overall Study|Death|3|||
161684252|NCT02104583|583897885|FG004|Overall Study|Death|5|||
161684253|NCT02104583|583897881|FG000|Overall Study|Subject required cardiac ablation|6|||
161946526|NCT00690794|584856189|FG001|Overall Study|Protocol Violation|7|||
161946527|NCT00690794|584856188|FG000|Overall Study|Noncompliance|1|||
161946528|NCT00690794|584856189|FG001|Overall Study|Noncompliance|2|||
161946529|NCT00690794|584856188|FG000|Overall Study|Other not specified|1|||
161684254|NCT02104583|583897882|FG001|Overall Study|Subject required cardiac ablation|4|||
161684255|NCT02104583|583897883|FG002|Overall Study|Subject required cardiac ablation|4|||
161946530|NCT00690794|584856189|FG001|Overall Study|Other not specified|3|||
161684256|NCT02104583|583897884|FG003|Overall Study|Subject required cardiac ablation|5|||
161684257|NCT02104583|583897885|FG004|Overall Study|Subject required cardiac ablation|4|||
161946531|NCT00325143|584856190|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
161946532|NCT00325143|584856190|FG000|Overall Study|Migrated/moved from study area|1|||
161946533|NCT00325143|584856190|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
161946534|NCT00325143|584856190|FG000|Overall Study|Withdrawal by Subject|8|||
161946535|NCT02286895|584856191|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
161946536|NCT02286895|584856192|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
161946537|NCT02286895|584856191|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
161946538|NCT02286895|584856192|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
161946539|NCT02286895|584856191|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
161946540|NCT02286895|584856192|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
161946541|NCT00399035|584856194|FG000|Overall Study|Death|289|||
161946542|NCT00399035|584856195|FG001|Overall Study|Death|141|||
161946543|NCT00399035|584856196|FG002|Overall Study|Death|234|||
161946544|NCT00399035|584856194|FG000|Overall Study|Lost to Follow-up|2|||
161946545|NCT00399035|584856195|FG001|Overall Study|Lost to Follow-up|1|||
161946546|NCT00399035|584856196|FG002|Overall Study|Lost to Follow-up|5|||
161946547|NCT00399035|584856194|FG000|Overall Study|Withdrawal by Subject|19|||
161946548|NCT00399035|584856195|FG001|Overall Study|Withdrawal by Subject|15|||
161946549|NCT00399035|584856196|FG002|Overall Study|Withdrawal by Subject|12|||
161946550|NCT00399035|584856194|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
161946551|NCT00399035|584856195|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
162027473|NCT00636363|585156230|FG001|Overall Study|Met ineligibility criteria|0|||
162027474|NCT00636363|585156231|FG002|Overall Study|Met ineligibility criteria|3|||
162027475|NCT00636363|585156229|FG000|Overall Study|Missed > 1 visit|0|||
162027476|NCT00636363|585156230|FG001|Overall Study|Missed > 1 visit|1|||
161684258|NCT02104583|583897881|FG000|Overall Study|Subject required prohibited medication|0|||
161946552|NCT00399035|584856196|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
161946553|NCT00399035|584856194|FG000|Overall Study|Severe non-compliance with protocol|2|||
161946554|NCT00399035|584856195|FG001|Overall Study|Severe non-compliance with protocol|1|||
162027477|NCT00636363|585156231|FG002|Overall Study|Missed > 1 visit|3|||
161946555|NCT00399035|584856196|FG002|Overall Study|Severe non-compliance with protocol|0|||
161946556|NCT02949011|584856199|FG000|Overall Study|Adverse Event|6|||
161946557|NCT02949011|584856200|FG001|Overall Study|Adverse Event|7|||
161946558|NCT02949011|584856201|FG002|Overall Study|Adverse Event|3|||
161946559|NCT02949011|584856199|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
161946560|NCT02949011|584856200|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
161946561|NCT02949011|584856201|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
161946562|NCT02949011|584856199|FG000|Overall Study|Protocol Deviation|5|||
161946563|NCT02949011|584856200|FG001|Overall Study|Protocol Deviation|3|||
161946564|NCT02949011|584856201|FG002|Overall Study|Protocol Deviation|3|||
161946565|NCT02949011|584856199|FG000|Overall Study|Lack of Efficacy|0|||
161946566|NCT02949011|584856200|FG001|Overall Study|Lack of Efficacy|2|||
161946567|NCT02949011|584856201|FG002|Overall Study|Lack of Efficacy|0|||
161946568|NCT02949011|584856199|FG000|Overall Study|Withdrawal by Subject|13|||
161946569|NCT02949011|584856200|FG001|Overall Study|Withdrawal by Subject|13|||
161946570|NCT02949011|584856201|FG002|Overall Study|Withdrawal by Subject|21|||
161946571|NCT02949011|584856199|FG000|Overall Study|Lost to Follow-up|7|||
161946572|NCT02949011|584856200|FG001|Overall Study|Lost to Follow-up|5|||
161946573|NCT02949011|584856201|FG002|Overall Study|Lost to Follow-up|5|||
161946574|NCT02949011|584856199|FG000|Overall Study|Death|0|||
161946575|NCT02949011|584856200|FG001|Overall Study|Death|0|||
161946576|NCT02949011|584856201|FG002|Overall Study|Death|1|||
161946577|NCT02949011|584856199|FG000|Overall Study|Miscellaneous|2|||
161946578|NCT02949011|584856200|FG001|Overall Study|Miscellaneous|4|||
161946579|NCT02949011|584856201|FG002|Overall Study|Miscellaneous|6|||
161946580|NCT00163189|584856202|FG000|Overall Study|Other|6|||
161946581|NCT00163189|584856202|FG000|Overall Study|Lost to Follow-up|1|||
161946582|NCT00163189|584856202|FG000|Overall Study|Protocol Violation|2|||
161946583|NCT00163189|584856202|FG000|Overall Study|Death|3|||
161946584|NCT00163189|584856202|FG000|Overall Study|Adverse Event|6|||
161946585|NCT00163189|584856202|FG000|Overall Study|Lack of Efficacy|7|||
161946586|NCT00163189|584856202|FG000|Overall Study|Study terminated by sponsor|11|||
161946587|NCT00163189|584856202|FG000|Overall Study|Withdrawal by Subject|11|||
161946588|NCT00163189|584856202|FG000|Overall Study|Did not meet continuation criterion|16|||
161946589|NCT00454116|584856203|FG000|Overall Study|Adverse Event|5|||
161946590|NCT00454116|584856204|FG001|Overall Study|Adverse Event|11|||
161946591|NCT00454116|584856205|FG002|Overall Study|Adverse Event|9|||
161946592|NCT00454116|584856203|FG000|Overall Study|Condition under investigation worsened|17|||
161946593|NCT00454116|584856204|FG001|Overall Study|Condition under investigation worsened|13|||
161946594|NCT00454116|584856205|FG002|Overall Study|Condition under investigation worsened|18|||
161946595|NCT00454116|584856203|FG000|Overall Study|Withdrawal by Subject|3|||
161946596|NCT00454116|584856204|FG001|Overall Study|Withdrawal by Subject|3|||
161946597|NCT00454116|584856205|FG002|Overall Study|Withdrawal by Subject|1|||
161946598|NCT00454116|584856203|FG000|Overall Study|Other|2|||
161946599|NCT00454116|584856204|FG001|Overall Study|Other|2|||
161946600|NCT00454116|584856205|FG002|Overall Study|Other|0|||
161946601|NCT02431325|584856208|FG000|Overall Study|Adverse Event|3|||
161946602|NCT02431325|584856209|FG001|Overall Study|Adverse Event|0|||
161946603|NCT02431325|584856208|FG000|Overall Study|Lost to Follow-up|0|||
161946604|NCT02431325|584856209|FG001|Overall Study|Lost to Follow-up|1|||
161946605|NCT02431325|584856208|FG000|Overall Study|Withdrawal by Subject|1|||
161946606|NCT02431325|584856209|FG001|Overall Study|Withdrawal by Subject|2|||
161946607|NCT02431325|584856208|FG000|Overall Study|Declined to take study medication|1|||
161946608|NCT02431325|584856209|FG001|Overall Study|Declined to take study medication|0|||
161946609|NCT02431325|584856208|FG000|Overall Study|Withdrew before starting study medication|1|||
161946610|NCT02431325|584856209|FG001|Overall Study|Withdrew before starting study medication|0|||
161946611|NCT02431325|584856208|FG000|Overall Study|Placebo shortage|2|||
161946612|NCT02431325|584856209|FG001|Overall Study|Placebo shortage|0|||
161946613|NCT03500211|584856210|FG000|Overall Study|Withdrawal by Subject|1|||
161946614|NCT03500211|584856211|FG001|Overall Study|Withdrawal by Subject|1|||
161946615|NCT01917318|584856212|FG000|First Treatment|Withdrawal by Subject|0|||
161946616|NCT01917318|584856213|FG001|First Treatment|Withdrawal by Subject|1|||
161946617|NCT01008618|584856214|FG000|Period 1 (Titration Period)|Physician Decision|2|||
161946618|NCT01008618|584856215|FG001|Period 1 (Titration Period)|Physician Decision|0|||
162027478|NCT00636363|585156229|FG000|Overall Study|Lack of motivation|1|||
161946619|NCT01008618|584856216|FG002|Period 1 (Titration Period)|Physician Decision|0|||
161946620|NCT01008618|584856214|FG000|Period 1 (Titration Period)|Adverse Event|33|||
161946621|NCT01008618|584856215|FG001|Period 1 (Titration Period)|Adverse Event|0|||
161946622|NCT01008618|584856216|FG002|Period 1 (Titration Period)|Adverse Event|0|||
161946623|NCT01008618|584856214|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
161946624|NCT01008618|584856215|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
161946625|NCT01008618|584856216|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
161946626|NCT01008618|584856214|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
161946627|NCT01008618|584856215|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
161946628|NCT01008618|584856216|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
161946629|NCT01008618|584856214|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
161946630|NCT01008618|584856215|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
161946631|NCT01008618|584856216|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
161946632|NCT01008618|584856214|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
161946633|NCT01008618|584856215|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
161946634|NCT01008618|584856216|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
161946635|NCT01008618|584856214|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
161946636|NCT01008618|584856215|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
161946637|NCT01008618|584856216|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
161946638|NCT01008618|584856214|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
161946639|NCT01008618|584856215|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
161946640|NCT01008618|584856216|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
161946641|NCT01008618|584856214|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
161946642|NCT01008618|584856215|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
162027479|NCT00636363|585156230|FG001|Overall Study|Lack of motivation|0|||
162027480|NCT00636363|585156231|FG002|Overall Study|Lack of motivation|1|||
161832473|NCT00380692|584428401|FG001|Study Period II - Double Blind|Protocol Violation|2|||
161946643|NCT01008618|584856216|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
161946644|NCT01008618|584856214|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
161946645|NCT01008618|584856215|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
161946646|NCT01008618|584856216|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
161946647|NCT01008618|584856214|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
161946648|NCT01008618|584856215|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
161946649|NCT01008618|584856216|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
161946650|NCT01008618|584856214|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
161946651|NCT01008618|584856215|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
161946652|NCT01008618|584856216|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
161946653|NCT03338400|584856217|FG000|Overall Study|Lost to Follow-up|1|||
161946654|NCT03338400|584856218|FG001|Overall Study|Lost to Follow-up|2|||
161946655|NCT00487981|584856219|FG000|Overall Study|Hypothyroidism diagnosis|1|||
161946656|NCT01213082|584856225|FG000|Overall Study|Lost to Follow-up|6|||
161946657|NCT01213082|584856226|FG001|Overall Study|Lost to Follow-up|7|||
161946658|NCT01213082|584856227|FG002|Overall Study|Lost to Follow-up|4|||
161946659|NCT01213082|584856225|FG000|Overall Study|Physician Decision|0|||
161946660|NCT01213082|584856226|FG001|Overall Study|Physician Decision|0|||
161946661|NCT01213082|584856227|FG002|Overall Study|Physician Decision|1|||
161946662|NCT00698828|584856233|FG000|Overall Study|Adverse Event|3|||
161946663|NCT00698828|584856234|FG001|Overall Study|Adverse Event|4|||
161946664|NCT00698828|584856235|FG002|Overall Study|Adverse Event|4|||
162027481|NCT00636363|585156229|FG000|Overall Study|Protocol Violation|0|||
162027482|NCT00636363|585156230|FG001|Overall Study|Protocol Violation|3|||
162027483|NCT00636363|585156231|FG002|Overall Study|Protocol Violation|0|||
162027484|NCT00636363|585156229|FG000|Overall Study|Lost to Follow-up|3|||
162027485|NCT00636363|585156230|FG001|Overall Study|Lost to Follow-up|4|||
162027486|NCT00636363|585156231|FG002|Overall Study|Lost to Follow-up|2|||
162027487|NCT00636363|585156229|FG000|Overall Study|Withdrawal by Subject|1|||
161946665|NCT00698828|584856233|FG000|Overall Study|Death|0|||
161946666|NCT00698828|584856234|FG001|Overall Study|Death|0|||
161946667|NCT00698828|584856235|FG002|Overall Study|Death|1|||
161946668|NCT00698828|584856233|FG000|Overall Study|Exacerbation of COPD|1|||
161946669|NCT00698828|584856234|FG001|Overall Study|Exacerbation of COPD|3|||
161946670|NCT00698828|584856235|FG002|Overall Study|Exacerbation of COPD|0|||
161946671|NCT00698828|584856233|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
161946672|NCT00698828|584856234|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
161946673|NCT00698828|584856235|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
161946674|NCT00698828|584856233|FG000|Overall Study|Investigator/Sponsor decision|1|||
161946675|NCT00698828|584856234|FG001|Overall Study|Investigator/Sponsor decision|0|||
161946676|NCT00698828|584856235|FG002|Overall Study|Investigator/Sponsor decision|2|||
161946677|NCT00698828|584856233|FG000|Overall Study|Lost to Follow-up|1|||
161946678|NCT00698828|584856234|FG001|Overall Study|Lost to Follow-up|1|||
161946679|NCT00698828|584856235|FG002|Overall Study|Lost to Follow-up|0|||
161946680|NCT00698828|584856233|FG000|Overall Study|Withdrew consent|0|||
161946681|NCT00698828|584856234|FG001|Overall Study|Withdrew consent|7|||
161946682|NCT00698828|584856235|FG002|Overall Study|Withdrew consent|4|||
161946683|NCT00698828|584856233|FG000|Overall Study|Withdrew consent (not treated)|2|||
161946684|NCT00698828|584856234|FG001|Overall Study|Withdrew consent (not treated)|0|||
161946685|NCT00698828|584856235|FG002|Overall Study|Withdrew consent (not treated)|0|||
161946686|NCT02013609|584856238|FG000|Overall Study|Withdrawal by Subject|9|||
161946687|NCT02013609|584856238|FG000|Overall Study|Lost to Follow-up|3|||
161946688|NCT02013609|584856238|FG000|Overall Study|Adverse Event|3|||
161946689|NCT02013609|584856238|FG000|Overall Study|Met Withdrawal Criteria|3|||
161946690|NCT01816295|584856239|FG000|Double Blind Phase|Adverse Event|11|||
161946691|NCT01816295|584856240|FG001|Double Blind Phase|Adverse Event|8|||
161946692|NCT01816295|584856239|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
161946693|NCT01816295|584856240|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
161946694|NCT01816295|584856239|FG000|Double Blind Phase|Lost to Follow-up|3|||
161946695|NCT01816295|584856240|FG001|Double Blind Phase|Lost to Follow-up|5|||
161946696|NCT01816295|584856239|FG000|Double Blind Phase|Physician Decision|2|||
161946697|NCT01816295|584856240|FG001|Double Blind Phase|Physician Decision|2|||
161946698|NCT01816295|584856239|FG000|Double Blind Phase|Protocol Violation|17|||
161946699|NCT01816295|584856240|FG001|Double Blind Phase|Protocol Violation|11|||
161946700|NCT01816295|584856239|FG000|Double Blind Phase|Sponsor Decision|8|||
161946701|NCT01816295|584856240|FG001|Double Blind Phase|Sponsor Decision|8|||
161946702|NCT01816295|584856239|FG000|Double Blind Phase|Withdrawal by Subject|22|||
161946703|NCT01816295|584856240|FG001|Double Blind Phase|Withdrawal by Subject|20|||
161946704|NCT01816295|584856239|FG000|OLE Phase|Adverse Event|17|||
161946705|NCT01816295|584856240|FG001|OLE Phase|Adverse Event|15|||
161946706|NCT01816295|584856239|FG000|OLE Phase|Death|1|||
161946707|NCT01816295|584856240|FG001|OLE Phase|Death|0|||
161946708|NCT01816295|584856239|FG000|OLE Phase|Entry Criteria Not Met|3|||
161946709|NCT01816295|584856240|FG001|OLE Phase|Entry Criteria Not Met|5|||
161946710|NCT01816295|584856239|FG000|OLE Phase|Lost to Follow-up|5|||
161946711|NCT01816295|584856240|FG001|OLE Phase|Lost to Follow-up|5|||
161946712|NCT01816295|584856239|FG000|OLE Phase|Physician Decision|3|||
161946713|NCT01816295|584856240|FG001|OLE Phase|Physician Decision|1|||
161946714|NCT01816295|584856239|FG000|OLE Phase|Protocol Violation|4|||
161946715|NCT01816295|584856240|FG001|OLE Phase|Protocol Violation|4|||
161946716|NCT01816295|584856239|FG000|OLE Phase|Sponsor Decision|7|||
161946717|NCT01816295|584856240|FG001|OLE Phase|Sponsor Decision|9|||
161946718|NCT01816295|584856239|FG000|OLE Phase|Withdrawal by Subject|10|||
161946719|NCT01816295|584856240|FG001|OLE Phase|Withdrawal by Subject|10|||
161946720|NCT01816295|584856239|FG000|OLE Phase|Lack of Efficacy|3|||
161946721|NCT01816295|584856240|FG001|OLE Phase|Lack of Efficacy|7|||
161946722|NCT01130337|584856242|FG000|Overall Study|Withdrawal by Subject|3|||
161946723|NCT01130337|584856242|FG000|Overall Study|Principal investigator decision|1|||
161946724|NCT01130337|584856242|FG000|Overall Study|Death|1|||
161946725|NCT01130337|584856242|FG000|Overall Study|Disease progression|1|||
161946726|NCT01130337|584856242|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
161946727|NCT01130337|584856242|FG000|Overall Study|Surgical resection (R2)|1|||
161946728|NCT03886493|584856243|FG000|Overall Study|Adverse Event|1|||
161946729|NCT04067011|584856245|FG000|Overall Study|Not Treated|8|||
161946730|NCT04067011|584856246|FG001|Overall Study|Not Treated|7|||
161946731|NCT04067011|584856247|FG002|Overall Study|Not Treated|5|||
161946732|NCT04067011|584856245|FG000|Overall Study|Adverse Event|2|||
161946733|NCT04067011|584856246|FG001|Overall Study|Adverse Event|1|||
161946734|NCT04067011|584856247|FG002|Overall Study|Adverse Event|0|||
161946735|NCT04067011|584856245|FG000|Overall Study|Withdrawal by Subject|6|||
161946736|NCT04067011|584856246|FG001|Overall Study|Withdrawal by Subject|2|||
161946737|NCT04067011|584856247|FG002|Overall Study|Withdrawal by Subject|1|||
161946738|NCT04067011|584856245|FG000|Overall Study|Lost to Follow-up|0|||
161946739|NCT04067011|584856246|FG001|Overall Study|Lost to Follow-up|0|||
161946740|NCT04067011|584856247|FG002|Overall Study|Lost to Follow-up|1|||
161946741|NCT04067011|584856245|FG000|Overall Study|Physician Decision|1|||
161946742|NCT04067011|584856246|FG001|Overall Study|Physician Decision|1|||
161946743|NCT04067011|584856247|FG002|Overall Study|Physician Decision|0|||
161946744|NCT04067011|584856245|FG000|Overall Study|Other Reasons|2|||
161946745|NCT04067011|584856246|FG001|Overall Study|Other Reasons|0|||
161946746|NCT04067011|584856247|FG002|Overall Study|Other Reasons|1|||
161946747|NCT04067011|584856245|FG000|Overall Study|Missing|0|||
161946748|NCT04067011|584856246|FG001|Overall Study|Missing|2|||
161946749|NCT04067011|584856247|FG002|Overall Study|Missing|0|||
161946750|NCT05209386|584856248|FG000|Overall Study|Withdrawal by Subject|8|||
161946751|NCT05209386|584856248|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
161946752|NCT03139448|584856252|FG000|Overall Study|Lack of Efficacy|6|||
161946753|NCT03139448|584856253|FG001|Overall Study|Lack of Efficacy|7|||
161946754|NCT03139448|584856252|FG000|Overall Study|Location of procedure changed|2|||
161946755|NCT03139448|584856253|FG001|Overall Study|Location of procedure changed|8|||
161946756|NCT03139448|584856252|FG000|Overall Study|Withdrawal by Subject|3|||
161946757|NCT03139448|584856253|FG001|Overall Study|Withdrawal by Subject|6|||
161946758|NCT03139448|584856252|FG000|Overall Study|Screen fail|1|||
161946759|NCT03139448|584856253|FG001|Overall Study|Screen fail|3|||
161946760|NCT03139448|584856252|FG000|Overall Study|Physician Decision|0|||
161946761|NCT03139448|584856253|FG001|Overall Study|Physician Decision|2|||
161946762|NCT01038323|584856254|FG000|Overall Study|Withdrawal by Subject|3|||
161684259|NCT02104583|583897882|FG001|Overall Study|Subject required prohibited medication|1|||
161946763|NCT01038323|584856255|FG001|Overall Study|Withdrawal by Subject|2|||
161946764|NCT01038323|584856256|FG002|Overall Study|Withdrawal by Subject|4|||
161946765|NCT04436744|584856259|FG000|Overall Study|Adverse Event|1|||
161946766|NCT04436744|584856260|FG001|Overall Study|Adverse Event|1|||
161946767|NCT04436744|584856259|FG000|Overall Study|Death|1|||
161946768|NCT04436744|584856260|FG001|Overall Study|Death|0|||
161946769|NCT04436744|584856259|FG000|Overall Study|Lost to Follow-up|0|||
161946770|NCT04436744|584856260|FG001|Overall Study|Lost to Follow-up|2|||
161946771|NCT04436744|584856259|FG000|Overall Study|Physician Decision|0|||
161946772|NCT04436744|584856260|FG001|Overall Study|Physician Decision|1|||
161946773|NCT04436744|584856259|FG000|Overall Study|Progressive Disease|0|||
161946774|NCT04436744|584856260|FG001|Overall Study|Progressive Disease|4|||
161946775|NCT04436744|584856259|FG000|Overall Study|Protocol Deviation|1|||
161946776|NCT04436744|584856260|FG001|Overall Study|Protocol Deviation|1|||
161946777|NCT04436744|584856259|FG000|Overall Study|Withdrawal by Subject|1|||
161946778|NCT04436744|584856260|FG001|Overall Study|Withdrawal by Subject|2|||
161946779|NCT01463033|584856261|FG000|Overall Study|Lost to Follow-up|4|||
161946780|NCT01463033|584856262|FG001|Overall Study|Lost to Follow-up|4|||
161946781|NCT01463033|584856261|FG000|Overall Study|Death|3|||
161946782|NCT01463033|584856262|FG001|Overall Study|Death|2|||
161946783|NCT00746811|584856263|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
161946784|NCT00746811|584856264|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
161946785|NCT01538199|584856265|FG000|Overall Study|Lost to Follow-up|1|||
161946786|NCT01538199|584856266|FG001|Overall Study|Lost to Follow-up|2|||
161946787|NCT01538199|584856267|FG002|Overall Study|Lost to Follow-up|1|||
161946788|NCT01538199|584856268|FG003|Overall Study|Lost to Follow-up|0|||
161946789|NCT01538199|584856265|FG000|Overall Study|participant did not have time|1|||
161946790|NCT01538199|584856266|FG001|Overall Study|participant did not have time|0|||
161946791|NCT01538199|584856267|FG002|Overall Study|participant did not have time|0|||
161946792|NCT01538199|584856268|FG003|Overall Study|participant did not have time|2|||
161946793|NCT01538199|584856265|FG000|Overall Study|Lack of Efficacy|0|||
161946794|NCT01538199|584856266|FG001|Overall Study|Lack of Efficacy|1|||
161946795|NCT01538199|584856267|FG002|Overall Study|Lack of Efficacy|0|||
161946796|NCT01538199|584856268|FG003|Overall Study|Lack of Efficacy|0|||
161946797|NCT03358030|584856269|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
161946798|NCT03358030|584856270|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
161946799|NCT03358030|584856271|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
161946800|NCT03358030|584856272|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
161946801|NCT03358030|584856269|FG000|Overall Study|Ineligibility|0|||
161946802|NCT03358030|584856270|FG001|Overall Study|Ineligibility|0|||
161946803|NCT03358030|584856271|FG002|Overall Study|Ineligibility|0|||
161946804|NCT03358030|584856272|FG003|Overall Study|Ineligibility|2|||
161946805|NCT03358030|584856269|FG000|Overall Study|Voluntary Withdrawal|1|||
161946806|NCT03358030|584856270|FG001|Overall Study|Voluntary Withdrawal|1|||
161946807|NCT03358030|584856271|FG002|Overall Study|Voluntary Withdrawal|3|||
161946808|NCT03358030|584856272|FG003|Overall Study|Voluntary Withdrawal|1|||
161946809|NCT03358030|584856269|FG000|Overall Study|Other|0|||
161946810|NCT03358030|584856270|FG001|Overall Study|Other|0|||
161684260|NCT02104583|583897883|FG002|Overall Study|Subject required prohibited medication|1|||
161684261|NCT02104583|583897884|FG003|Overall Study|Subject required prohibited medication|0|||
161684262|NCT02104583|583897885|FG004|Overall Study|Subject required prohibited medication|1|||
161946811|NCT03358030|584856271|FG002|Overall Study|Other|1|||
161946812|NCT03358030|584856272|FG003|Overall Study|Other|0|||
161946813|NCT03342560|584856273|FG000|Overall Study|Lost to Follow-up|2|||
161946814|NCT02604511|584856274|FG000|Overall Study|Adverse Event|3|||
161946815|NCT02604511|584856274|FG000|Overall Study|Disease Progression|4|||
161946816|NCT02604511|584856274|FG000|Overall Study|Withdrawal by Subject|3|||
161946817|NCT02604511|584856274|FG000|Overall Study|Participant ineligible|1|||
161946818|NCT02604511|584856274|FG000|Overall Study|Intercurrent illness|1|||
161946819|NCT03770286|584856275|FG000|Overall Study|Lost to Follow-up|6|||
161684263|NCT02104583|583897881|FG000|Overall Study|Withdrew Consent|3|||
161684264|NCT02104583|583897882|FG001|Overall Study|Withdrew Consent|2|||
161946820|NCT03770286|584856276|FG001|Overall Study|Lost to Follow-up|4|||
161946821|NCT03770286|584856277|FG002|Overall Study|Lost to Follow-up|3|||
161946822|NCT03770286|584856275|FG000|Overall Study|Protocol Violation|1|||
161946823|NCT03770286|584856276|FG001|Overall Study|Protocol Violation|0|||
161946824|NCT03770286|584856277|FG002|Overall Study|Protocol Violation|2|||
161946825|NCT02505425|584856278|FG000|Overall Study|Lost to Follow-up|41|||
161946826|NCT02505425|584856279|FG001|Overall Study|Lost to Follow-up|61|||
161946827|NCT02505425|584856280|FG002|Overall Study|Lost to Follow-up|31|||
161946828|NCT02505425|584856281|FG003|Overall Study|Lost to Follow-up|19|||
161946829|NCT02505425|584856278|FG000|Overall Study|Withdrawal by Subject|39|||
161946830|NCT02505425|584856279|FG001|Overall Study|Withdrawal by Subject|9|||
161946831|NCT02505425|584856280|FG002|Overall Study|Withdrawal by Subject|19|||
161946832|NCT02505425|584856281|FG003|Overall Study|Withdrawal by Subject|7|||
161946833|NCT02505425|584856278|FG000|Overall Study|Death|8|||
161946834|NCT02505425|584856279|FG001|Overall Study|Death|12|||
161946835|NCT02505425|584856280|FG002|Overall Study|Death|0|||
161946836|NCT02505425|584856281|FG003|Overall Study|Death|0|||
161946837|NCT01150357|584856298|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
161946838|NCT01150357|584856299|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
161946839|NCT01150357|584856300|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
161946840|NCT01150357|584856298|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
161946841|NCT01150357|584856299|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
161946842|NCT01150357|584856300|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
161946843|NCT01150357|584856298|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
161832474|NCT00380692|584428400|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
161832475|NCT00380692|584428401|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
161946844|NCT01150357|584856299|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
161946845|NCT01150357|584856300|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
161946846|NCT01150357|584856298|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
161946847|NCT01150357|584856299|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
161946848|NCT01150357|584856300|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
161684265|NCT02104583|583897883|FG002|Overall Study|Withdrew Consent|0|||
161684266|NCT02104583|583897884|FG003|Overall Study|Withdrew Consent|2|||
161946849|NCT01150357|584856298|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
161946850|NCT01150357|584856299|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
161946851|NCT01150357|584856300|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
161946852|NCT01150357|584856298|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
161946853|NCT01150357|584856299|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
161946854|NCT01150357|584856300|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
161946855|NCT01150357|584856298|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
161946856|NCT01150357|584856299|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
161946857|NCT01150357|584856300|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
161946858|NCT02661672|584856301|FG000|Overall Study|Lost to Follow-up|1|||
161946859|NCT02661672|584856301|FG000|Overall Study|Death|4|||
161946860|NCT00652743|584858424|FG000|Months 12-18|Lost to Follow-up|1|||
161946861|NCT00652743|584858425|FG001|Months 12-18|Lost to Follow-up|2|||
161946862|NCT00652743|584858426|FG002|Months 12-18|Lost to Follow-up|7|||
161946863|NCT00652743|584858424|FG000|Months 24-30|Other|5|||
161946864|NCT00652743|584858425|FG001|Months 24-30|Other|1|||
161946865|NCT00652743|584858426|FG002|Months 24-30|Other|11|||
161946866|NCT00652743|584858424|FG000|Months 36-42|Serious Adverse Events|0|||
161946867|NCT00652743|584858425|FG001|Months 36-42|Serious Adverse Events|1|||
161946868|NCT00652743|584858426|FG002|Months 36-42|Serious Adverse Events|1|||
161946869|NCT00652743|584858424|FG000|Months 36-42|Withdrawal by Subject|1|||
161946870|NCT00652743|584858425|FG001|Months 36-42|Withdrawal by Subject|1|||
161946871|NCT00652743|584858426|FG002|Months 36-42|Withdrawal by Subject|0|||
161946872|NCT00652743|584858424|FG000|Months 36-42|Lost to Follow-up|0|||
161946873|NCT00652743|584858425|FG001|Months 36-42|Lost to Follow-up|1|||
161946874|NCT00652743|584858426|FG002|Months 36-42|Lost to Follow-up|0|||
161946875|NCT00652743|584858424|FG000|Months 36-42|Migrated/moved from study area|1|||
161946876|NCT00652743|584858425|FG001|Months 36-42|Migrated/moved from study area|0|||
161946877|NCT00652743|584858426|FG002|Months 36-42|Migrated/moved from study area|0|||
161946878|NCT00652743|584858424|FG000|Months 36-42|Other|4|||
161946879|NCT00652743|584858425|FG001|Months 36-42|Other|2|||
161946880|NCT00652743|584858426|FG002|Months 36-42|Other|8|||
161946881|NCT01248793|584858427|FG000|Overall Study|Lost to Follow-up|0|||
161946882|NCT01248793|584858428|FG001|Overall Study|Lost to Follow-up|1|||
161946883|NCT01248793|584858427|FG000|Overall Study|Adverse Event|1|||
161946884|NCT01248793|584858428|FG001|Overall Study|Adverse Event|1|||
161946885|NCT01248793|584858427|FG000|Overall Study|Protocol Violation|0|||
161946886|NCT01248793|584858428|FG001|Overall Study|Protocol Violation|1|||
161946887|NCT01248793|584858427|FG000|Overall Study|Withdrawal by Subject|3|||
161946888|NCT01248793|584858428|FG001|Overall Study|Withdrawal by Subject|3|||
161946889|NCT00517699|584858429|FG000|Overall Study|Withdrawal by Subject|1|||
161946890|NCT00517699|584858429|FG000|Overall Study|Lack of Efficacy|1|||
161946891|NCT00517699|584858429|FG000|Overall Study|Administrative error|1|||
161946892|NCT00517699|584858429|FG000|Overall Study|Study terminated by Sponsor|2|||
161946893|NCT01114737|584858430|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
161946894|NCT01114737|584858431|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
161946895|NCT01114737|584858430|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
161946896|NCT01114737|584858431|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
161946897|NCT01114737|584858430|FG000|Randomized Treatment Period|Pregnancy|1|||
162027488|NCT00636363|585156230|FG001|Overall Study|Withdrawal by Subject|3|||
161684267|NCT02104583|583897885|FG004|Overall Study|Withdrew Consent|1|||
161946898|NCT01114737|584858431|FG001|Randomized Treatment Period|Pregnancy|0|||
161946899|NCT01114737|584858430|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
161946900|NCT01114737|584858431|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
161946901|NCT01114737|584858430|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
161946902|NCT01114737|584858431|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
161946903|NCT01114737|584858430|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
161946904|NCT01114737|584858431|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
161946905|NCT00387088|584858434|FG000|Overall Study|Adverse Event|143|||
161946906|NCT00387088|584858435|FG001|Overall Study|Adverse Event|156|||
161946907|NCT00387088|584858434|FG000|Overall Study|Protocol Violation|47|||
161946908|NCT00387088|584858435|FG001|Overall Study|Protocol Violation|35|||
161946909|NCT00387088|584858434|FG000|Overall Study|Withdrawal by Subject|20|||
161946910|NCT00387088|584858435|FG001|Overall Study|Withdrawal by Subject|35|||
161946911|NCT00387088|584858434|FG000|Overall Study|Lack of Efficacy|28|||
161946912|NCT00387088|584858435|FG001|Overall Study|Lack of Efficacy|67|||
161946913|NCT00387088|584858434|FG000|Overall Study|Lost to Follow-up|22|||
161946914|NCT00387088|584858435|FG001|Overall Study|Lost to Follow-up|28|||
161946915|NCT00387088|584858434|FG000|Overall Study|Other|58|||
161946916|NCT00387088|584858435|FG001|Overall Study|Other|52|||
161946917|NCT04108273|584858436|FG000|Overall Study|COVID Pandemic|1|||
161946918|NCT04108273|584858437|FG001|Overall Study|COVID Pandemic|0|||
161946919|NCT02441218|584858438|FG000|Overall Study|Death|503|||
161946920|NCT02441218|584858439|FG001|Overall Study|Death|553|||
161946921|NCT02441218|584858438|FG000|Overall Study|Withdrawal by Subject|73|||
161946922|NCT02441218|584858439|FG001|Overall Study|Withdrawal by Subject|58|||
161946923|NCT02441218|584858438|FG000|Overall Study|Lost to Follow-up|2|||
161946924|NCT02441218|584858439|FG001|Overall Study|Lost to Follow-up|1|||
161946925|NCT01541371|584858440|FG000|Overall Study|Withdrawal by Subject|14|||
161946926|NCT01541371|584858440|FG000|Overall Study|Lost to Follow-up|21|||
161946927|NCT01541371|584858440|FG000|Overall Study|Adverse Event|15|||
161946928|NCT01541371|584858440|FG000|Overall Study|Lack of Efficacy|12|||
161946929|NCT01541371|584858440|FG000|Overall Study|Protocol Violation|6|||
161946930|NCT01541371|584858440|FG000|Overall Study|Study medication non-compliance|3|||
161946931|NCT01541371|584858440|FG000|Overall Study|Other|6|||
161946932|NCT04460183|584858444|FG000|Overall Study|Lost to Follow-up|3|||
161946933|NCT04460183|584858445|FG001|Overall Study|Lost to Follow-up|1|||
161946934|NCT04460183|584858444|FG000|Overall Study|Withdrawal by Subject|1|||
161946935|NCT04460183|584858445|FG001|Overall Study|Withdrawal by Subject|0|||
161946936|NCT00856609|584858448|FG000|Overall Study|Adverse Event|1|||
161946937|NCT00856609|584858449|FG001|Overall Study|Adverse Event|0|||
161946938|NCT01788943|584858450|FG000|Overall Study|Withdrawal by Subject|1|||
161946939|NCT01788943|584858451|FG001|Overall Study|Withdrawal by Subject|0|||
161946940|NCT00783432|584858452|FG000|Overall Study|Adverse Event|22|||
161946941|NCT00783432|584858453|FG001|Overall Study|Adverse Event|17|||
161946942|NCT00783432|584858452|FG000|Overall Study|Lack of Efficacy|20|||
161946943|NCT00783432|584858453|FG001|Overall Study|Lack of Efficacy|21|||
161946944|NCT00783432|584858452|FG000|Overall Study|Lost to Follow-up|11|||
161946945|NCT00783432|584858453|FG001|Overall Study|Lost to Follow-up|6|||
161946946|NCT00783432|584858452|FG000|Overall Study|Withdrawal by Subject|23|||
161946947|NCT00783432|584858453|FG001|Overall Study|Withdrawal by Subject|20|||
161946948|NCT00783432|584858452|FG000|Overall Study|subject moved|3|||
161946949|NCT00783432|584858453|FG001|Overall Study|subject moved|5|||
161946950|NCT00783432|584858452|FG000|Overall Study|Protocol Violation|6|||
161946951|NCT00783432|584858453|FG001|Overall Study|Protocol Violation|9|||
161946952|NCT01119287|584858454|FG000|Overall Study|Patient Decision, not related to AE|0|||
162027489|NCT00636363|585156231|FG002|Overall Study|Withdrawal by Subject|2|||
161946953|NCT01119287|584858455|FG001|Overall Study|Patient Decision, not related to AE|0|||
161946954|NCT01119287|584858456|FG002|Overall Study|Patient Decision, not related to AE|2|||
161946955|NCT01119287|584858457|FG003|Overall Study|Patient Decision, not related to AE|2|||
161946956|NCT01119287|584858458|FG004|Overall Study|Patient Decision, not related to AE|1|||
161946957|NCT01119287|584858459|FG005|Overall Study|Patient Decision, not related to AE|0|||
161684268|NCT02104583|583897881|FG000|Overall Study|Investigator's Discretion|1|||
161946958|NCT00186628|584858464|FG000|Overall Study|Death|2|||
161946959|NCT00186628|584858464|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
161946960|NCT01331681|584858467|FG000|Overall Study|Adverse Event|10|||
161946961|NCT01331681|584858468|FG001|Overall Study|Adverse Event|13|||
161946962|NCT01331681|584858469|FG002|Overall Study|Adverse Event|10|||
161946963|NCT01331681|584858467|FG000|Overall Study|Death|6|||
161946964|NCT01331681|584858468|FG001|Overall Study|Death|6|||
161946965|NCT01331681|584858469|FG002|Overall Study|Death|2|||
161684269|NCT02104583|583897882|FG001|Overall Study|Investigator's Discretion|0|||
161946966|NCT01331681|584858467|FG000|Overall Study|Lack of Efficacy|0|||
161946967|NCT01331681|584858468|FG001|Overall Study|Lack of Efficacy|1|||
161946968|NCT01331681|584858469|FG002|Overall Study|Lack of Efficacy|0|||
161946969|NCT01331681|584858467|FG000|Overall Study|Withdrawal by Subject|12|||
161946970|NCT01331681|584858468|FG001|Overall Study|Withdrawal by Subject|8|||
161946971|NCT01331681|584858469|FG002|Overall Study|Withdrawal by Subject|15|||
161946972|NCT01331681|584858467|FG000|Overall Study|Protocol Violation|1|||
161946973|NCT01331681|584858468|FG001|Overall Study|Protocol Violation|1|||
161946974|NCT01331681|584858469|FG002|Overall Study|Protocol Violation|0|||
161946975|NCT01331681|584858467|FG000|Overall Study|Lost to Follow-up|2|||
161946976|NCT01331681|584858468|FG001|Overall Study|Lost to Follow-up|4|||
161946977|NCT01331681|584858469|FG002|Overall Study|Lost to Follow-up|1|||
161946978|NCT01331681|584858467|FG000|Overall Study|Physician Decision|2|||
161946979|NCT01331681|584858468|FG001|Overall Study|Physician Decision|0|||
161946980|NCT01331681|584858469|FG002|Overall Study|Physician Decision|4|||
161946981|NCT01331681|584858467|FG000|Overall Study|Therapeutic procedure required|1|||
161946982|NCT01331681|584858468|FG001|Overall Study|Therapeutic procedure required|0|||
161946983|NCT01331681|584858469|FG002|Overall Study|Therapeutic procedure required|0|||
161946984|NCT01331681|584858467|FG000|Overall Study|Sponsor decision|1|||
161946985|NCT01331681|584858468|FG001|Overall Study|Sponsor decision|1|||
161946986|NCT01331681|584858469|FG002|Overall Study|Sponsor decision|0|||
161946987|NCT01331681|584858467|FG000|Overall Study|Switching to other therapy|0|||
161946988|NCT01331681|584858468|FG001|Overall Study|Switching to other therapy|0|||
161946989|NCT01331681|584858469|FG002|Overall Study|Switching to other therapy|1|||
161946990|NCT01331681|584858467|FG000|Overall Study|Not Received Study Treatment|0|||
161946991|NCT01331681|584858468|FG001|Overall Study|Not Received Study Treatment|0|||
161946992|NCT01331681|584858469|FG002|Overall Study|Not Received Study Treatment|2|||
161946993|NCT01534481|584858470|FG000|Overall Study|Lost to Follow-up|29|||
161946994|NCT01534481|584858471|FG001|Overall Study|Lost to Follow-up|24|||
161946995|NCT01534481|584858470|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
161946996|NCT01534481|584858471|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
162027490|NCT00313781|585156234|FG000|Before Crossover|Death|22|||
161946997|NCT05525910|584858472|FG000|Period 4|Per sponsor due to study timelines|0|||
161946998|NCT05525910|584858473|FG001|Period 4|Per sponsor due to study timelines|0|||
161946999|NCT05525910|584858474|FG002|Period 4|Per sponsor due to study timelines|1|||
161947000|NCT05525910|584858475|FG003|Period 4|Per sponsor due to study timelines|1|||
161947001|NCT05525910|584858476|FG004|Period 4|Per sponsor due to study timelines|1|||
161947002|NCT00107276|584858477|FG000|Overall Study|Progression|46|||
161947003|NCT00107276|584858477|FG000|Overall Study|Adverse Event|6|||
161947004|NCT00107276|584858477|FG000|Overall Study|M.D. decision|2|||
161947005|NCT00107276|584858477|FG000|Overall Study|Patient refusal|1|||
161947006|NCT00107276|584858477|FG000|Overall Study|Death|1|||
161947007|NCT00107276|584858477|FG000|Overall Study|Ineligible|16|||
161947008|NCT03179761|584858478|FG000|Overall Study|Death|2|||
161947009|NCT03179761|584858479|FG001|Overall Study|Death|5|||
161947010|NCT03179761|584858478|FG000|Overall Study|Lost to Follow-up|2|||
161947011|NCT03179761|584858479|FG001|Overall Study|Lost to Follow-up|2|||
161947012|NCT03179761|584858478|FG000|Overall Study|Protocol Violation|1|||
161947013|NCT03179761|584858479|FG001|Overall Study|Protocol Violation|0|||
161947014|NCT03179761|584858478|FG000|Overall Study|Withdrawal by Subject|1|||
161947015|NCT03179761|584858479|FG001|Overall Study|Withdrawal by Subject|4|||
161947016|NCT03179761|584858478|FG000|Overall Study|Investigator Request|0|||
161947017|NCT03179761|584858479|FG001|Overall Study|Investigator Request|2|||
161947018|NCT00565409|584858480|FG000|Period 1 Open Label|Adverse Event|17|||
161947019|NCT00565409|584858481|FG001|Period 1 Open Label|Adverse Event|0|||
161947020|NCT00565409|584858482|FG002|Period 1 Open Label|Adverse Event|0|||
161947021|NCT00565409|584858483|FG003|Period 1 Open Label|Adverse Event|0|||
161947022|NCT00565409|584858480|FG000|Period 1 Open Label|Death|2|||
161947023|NCT00565409|584858481|FG001|Period 1 Open Label|Death|0|||
161947024|NCT00565409|584858482|FG002|Period 1 Open Label|Death|0|||
161947025|NCT00565409|584858483|FG003|Period 1 Open Label|Death|0|||
161947026|NCT00565409|584858480|FG000|Period 1 Open Label|Lost to Follow-up|1|||
161947027|NCT00565409|584858481|FG001|Period 1 Open Label|Lost to Follow-up|0|||
161947028|NCT00565409|584858482|FG002|Period 1 Open Label|Lost to Follow-up|0|||
161947029|NCT00565409|584858483|FG003|Period 1 Open Label|Lost to Follow-up|0|||
161947030|NCT00565409|584858480|FG000|Period 1 Open Label|Other|21|||
161947031|NCT00565409|584858481|FG001|Period 1 Open Label|Other|0|||
161947032|NCT00565409|584858482|FG002|Period 1 Open Label|Other|0|||
161947033|NCT00565409|584858483|FG003|Period 1 Open Label|Other|0|||
161947034|NCT00565409|584858480|FG000|Period 1 Open Label|Protocol Violation|14|||
161947035|NCT00565409|584858481|FG001|Period 1 Open Label|Protocol Violation|0|||
161947036|NCT00565409|584858482|FG002|Period 1 Open Label|Protocol Violation|0|||
161947037|NCT00565409|584858483|FG003|Period 1 Open Label|Protocol Violation|0|||
161947038|NCT00565409|584858480|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
161947039|NCT00565409|584858481|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
161947040|NCT00565409|584858482|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
161947041|NCT00565409|584858483|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
161947042|NCT00565409|584858480|FG000|Period 1 Open Label|no conclusion of participation record|1|||
161947043|NCT00565409|584858481|FG001|Period 1 Open Label|no conclusion of participation record|0|||
161947044|NCT00565409|584858482|FG002|Period 1 Open Label|no conclusion of participation record|0|||
161947045|NCT00565409|584858483|FG003|Period 1 Open Label|no conclusion of participation record|0|||
161947046|NCT00565409|584858480|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
161947047|NCT00565409|584858481|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
161947048|NCT00565409|584858482|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
161947049|NCT00565409|584858483|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
161947050|NCT00565409|584858480|FG000|Period 2 Double-Blind|Adverse Event|0|||
161947051|NCT00565409|584858481|FG001|Period 2 Double-Blind|Adverse Event|7|||
161947052|NCT00565409|584858482|FG002|Period 2 Double-Blind|Adverse Event|4|||
161947053|NCT00565409|584858483|FG003|Period 2 Double-Blind|Adverse Event|5|||
161947054|NCT00565409|584858480|FG000|Period 2 Double-Blind|Death|0|||
161947055|NCT00565409|584858481|FG001|Period 2 Double-Blind|Death|2|||
161947056|NCT00565409|584858482|FG002|Period 2 Double-Blind|Death|0|||
161947057|NCT00565409|584858483|FG003|Period 2 Double-Blind|Death|0|||
161947058|NCT00565409|584858480|FG000|Period 2 Double-Blind|Protocol Violation|0|||
162027491|NCT00313781|585156235|FG001|Before Crossover|Death|8|||
162027492|NCT00313781|585156236|FG002|Before Crossover|Death|0|||
162027493|NCT00313781|585156234|FG000|Before Crossover|Lost to Follow-up|0|||
162027494|NCT00313781|585156235|FG001|Before Crossover|Lost to Follow-up|3|||
162027495|NCT00313781|585156236|FG002|Before Crossover|Lost to Follow-up|0|||
162027496|NCT00313781|585156234|FG000|Before Crossover|Withdrawal by Subject|3|||
162027497|NCT00313781|585156235|FG001|Before Crossover|Withdrawal by Subject|1|||
162027498|NCT00313781|585156236|FG002|Before Crossover|Withdrawal by Subject|0|||
162027499|NCT00313781|585156234|FG000|Before Crossover|Other|45|||
162027500|NCT00313781|585156235|FG001|Before Crossover|Other|30|||
161684270|NCT02104583|583897883|FG002|Overall Study|Investigator's Discretion|0|||
161684271|NCT02104583|583897884|FG003|Overall Study|Investigator's Discretion|0|||
161947059|NCT00565409|584858481|FG001|Period 2 Double-Blind|Protocol Violation|4|||
161947060|NCT00565409|584858482|FG002|Period 2 Double-Blind|Protocol Violation|6|||
161947061|NCT00565409|584858483|FG003|Period 2 Double-Blind|Protocol Violation|2|||
161947062|NCT00565409|584858480|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
161947063|NCT00565409|584858481|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
161947064|NCT00565409|584858482|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
161947065|NCT00565409|584858483|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
161947066|NCT00565409|584858480|FG000|Period 2 Double-Blind|Other|0|||
161947067|NCT00565409|584858481|FG001|Period 2 Double-Blind|Other|4|||
161947068|NCT00565409|584858482|FG002|Period 2 Double-Blind|Other|5|||
161947069|NCT00565409|584858483|FG003|Period 2 Double-Blind|Other|9|||
161947070|NCT00565409|584858480|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
161947071|NCT00565409|584858481|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
161947072|NCT00565409|584858482|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
161947073|NCT00565409|584858483|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
161947074|NCT03498716|584858500|FG000|Overall Study|Withdrawal by Subject|88|||
161947075|NCT03498716|584858501|FG001|Overall Study|Withdrawal by Subject|73|||
161947076|NCT03498716|584858500|FG000|Overall Study|Study Terminated By Sponsor|933|||
161684272|NCT02104583|583897885|FG004|Overall Study|Investigator's Discretion|0|||
161947077|NCT03498716|584858501|FG001|Overall Study|Study Terminated By Sponsor|927|||
161947078|NCT03498716|584858500|FG000|Overall Study|Lost to Follow-up|15|||
161947079|NCT03498716|584858501|FG001|Overall Study|Lost to Follow-up|26|||
161947080|NCT03498716|584858500|FG000|Overall Study|Disease Relapse|0|||
161684273|NCT02104583|583897881|FG000|Overall Study|Protocol Violation|0|||
161684274|NCT02104583|583897882|FG001|Overall Study|Protocol Violation|0|||
162027501|NCT00313781|585156236|FG002|Before Crossover|Other|0|||
162027502|NCT00313781|585156234|FG000|Before Crossover|Crossover|0|||
162027503|NCT00313781|585156235|FG001|Before Crossover|Crossover|37|||
162027504|NCT00313781|585156236|FG002|Before Crossover|Crossover|0|||
162027505|NCT00313781|585156234|FG000|Before Crossover|Randomized, not treated|5|||
162027506|NCT00313781|585156235|FG001|Before Crossover|Randomized, not treated|0|||
162027507|NCT00313781|585156236|FG002|Before Crossover|Randomized, not treated|0|||
162027508|NCT00313781|585156234|FG000|After Crossover|Death|0|||
162027509|NCT00313781|585156235|FG001|After Crossover|Death|0|||
162027510|NCT00313781|585156236|FG002|After Crossover|Death|6|||
162027511|NCT00313781|585156234|FG000|After Crossover|Withdrawal by Subject|0|||
162027512|NCT00313781|585156235|FG001|After Crossover|Withdrawal by Subject|0|||
162027513|NCT00313781|585156236|FG002|After Crossover|Withdrawal by Subject|3|||
162027514|NCT00313781|585156234|FG000|After Crossover|Other|0|||
162027515|NCT00313781|585156235|FG001|After Crossover|Other|0|||
162027516|NCT00313781|585156236|FG002|After Crossover|Other|18|||
162027517|NCT03148691|585156237|FG000|Overall Study|Protocol Violation|1|||
162027518|NCT03148691|585156238|FG001|Overall Study|Protocol Violation|2|||
162027519|NCT03148691|585156239|FG002|Overall Study|Protocol Violation|7|||
162027520|NCT03148691|585156237|FG000|Overall Study|Lost to Follow-up|0|||
162027521|NCT03148691|585156238|FG001|Overall Study|Lost to Follow-up|0|||
162027522|NCT03148691|585156239|FG002|Overall Study|Lost to Follow-up|1|||
162027523|NCT03148691|585156237|FG000|Overall Study|Other|1|||
162027524|NCT03148691|585156238|FG001|Overall Study|Other|0|||
162027525|NCT03148691|585156239|FG002|Overall Study|Other|0|||
162027526|NCT03148691|585156237|FG000|Overall Study|Withdrawal by Subject|1|||
162027527|NCT03148691|585156238|FG001|Overall Study|Withdrawal by Subject|0|||
162027528|NCT03148691|585156239|FG002|Overall Study|Withdrawal by Subject|0|||
162027529|NCT00096356|585156240|FG000|Overall Study|Adverse Event|11|||
162027530|NCT00096356|585156241|FG001|Overall Study|Adverse Event|9|||
162027531|NCT00096356|585156240|FG000|Overall Study|Physician Decision|5|||
162027532|NCT00096356|585156241|FG001|Overall Study|Physician Decision|3|||
162027533|NCT00096356|585156240|FG000|Overall Study|Withdrawal by Subject|17|||
162027534|NCT00096356|585156241|FG001|Overall Study|Withdrawal by Subject|23|||
162027535|NCT00096356|585156240|FG000|Overall Study|Lack of Efficacy|1|||
162027536|NCT00096356|585156241|FG001|Overall Study|Lack of Efficacy|0|||
162027537|NCT00096356|585156240|FG000|Overall Study|multiple reasons|10|||
162027538|NCT00096356|585156241|FG001|Overall Study|multiple reasons|18|||
162027539|NCT01008423|585156242|FG000|Overall Study|Adverse Event|13|||
162027540|NCT01008423|585156243|FG001|Overall Study|Adverse Event|6|||
162027541|NCT01008423|585156242|FG000|Overall Study|Withdrawal by Subject|4|||
162027542|NCT01008423|585156243|FG001|Overall Study|Withdrawal by Subject|7|||
162027543|NCT01008423|585156242|FG000|Overall Study|Lost to Follow-up|0|||
162027544|NCT01008423|585156243|FG001|Overall Study|Lost to Follow-up|2|||
162027545|NCT01008423|585156242|FG000|Overall Study|Low Cortisol|0|||
162027546|NCT01008423|585156243|FG001|Overall Study|Low Cortisol|1|||
162027547|NCT01008423|585156242|FG000|Overall Study|Lack of Efficacy|0|||
162027548|NCT01008423|585156243|FG001|Overall Study|Lack of Efficacy|5|||
162027549|NCT01008423|585156242|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
162027550|NCT01008423|585156243|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
162027551|NCT01008423|585156242|FG000|Overall Study|Personal Conflict|1|||
162027552|NCT01008423|585156243|FG001|Overall Study|Personal Conflict|0|||
162027553|NCT01008423|585156242|FG000|Overall Study|Other|0|||
162027554|NCT01008423|585156243|FG001|Overall Study|Other|1|||
162027555|NCT01181986|585156247|FG000|Phase 1|Lost to Follow-up|0|||
162027556|NCT01181986|585156248|FG001|Phase 1|Lost to Follow-up|1|||
162027557|NCT01181986|585156249|FG002|Phase 1|Lost to Follow-up|1|||
162027558|NCT01181986|585156247|FG000|Phase 1|Adverse Event|0|||
162027559|NCT01181986|585156248|FG001|Phase 1|Adverse Event|0|||
162027560|NCT01181986|585156249|FG002|Phase 1|Adverse Event|1|||
162027561|NCT01181986|585156247|FG000|Phase 1|Protocol Violation|1|||
161684275|NCT02104583|583897883|FG002|Overall Study|Protocol Violation|1|||
161684276|NCT02104583|583897884|FG003|Overall Study|Protocol Violation|0|||
161684277|NCT02104583|583897885|FG004|Overall Study|Protocol Violation|0|||
162027562|NCT01181986|585156248|FG001|Phase 1|Protocol Violation|0|||
162027563|NCT01181986|585156249|FG002|Phase 1|Protocol Violation|0|||
162027564|NCT01181986|585156247|FG000|Phase 2|Adverse Event|0|||
162027565|NCT01181986|585156248|FG001|Phase 2|Adverse Event|3|||
161684278|NCT02104583|583897881|FG000|Overall Study|Adverse Event|3|||
162027566|NCT01181986|585156249|FG002|Phase 2|Adverse Event|0|||
162027567|NCT01181986|585156247|FG000|Phase 2|Medical condition|0|||
162027568|NCT01181986|585156248|FG001|Phase 2|Medical condition|1|||
162027569|NCT01181986|585156249|FG002|Phase 2|Medical condition|0|||
162027570|NCT00831493|585156250|FG000|Overall Study|Intractable nausea and vomiting|1|||
162027571|NCT00835731|585156251|FG000|Overall Study|Withdrawal by Subject|1|||
162027572|NCT00835731|585156252|FG001|Overall Study|Withdrawal by Subject|0|||
162027573|NCT00835731|585156251|FG000|Overall Study|Physician Decision|1|||
162027574|NCT00835731|585156252|FG001|Overall Study|Physician Decision|1|||
162027575|NCT00348881|585156253|FG000|Overall Study|Lost to Follow-up|12|||
162027576|NCT00348881|585156254|FG001|Overall Study|Lost to Follow-up|6|||
162027577|NCT00348881|585156253|FG000|Overall Study|Withdrawal by Subject|3|||
161684279|NCT02104583|583897882|FG001|Overall Study|Adverse Event|3|||
162027578|NCT00348881|585156254|FG001|Overall Study|Withdrawal by Subject|4|||
162027579|NCT00348881|585156253|FG000|Overall Study|Adverse Event|2|||
162027580|NCT00348881|585156254|FG001|Overall Study|Adverse Event|0|||
161684280|NCT02104583|583897883|FG002|Overall Study|Adverse Event|6|||
161684281|NCT02104583|583897884|FG003|Overall Study|Adverse Event|6|||
161684282|NCT02104583|583897885|FG004|Overall Study|Adverse Event|1|||
161684283|NCT02104583|583897881|FG000|Overall Study|Lost to Follow-up|1|||
161684284|NCT02104583|583897882|FG001|Overall Study|Lost to Follow-up|0|||
161684285|NCT02104583|583897883|FG002|Overall Study|Lost to Follow-up|0|||
161684286|NCT02104583|583897884|FG003|Overall Study|Lost to Follow-up|0|||
161684287|NCT02104583|583897885|FG004|Overall Study|Lost to Follow-up|0|||
161684288|NCT02104583|583897881|FG000|Overall Study|Randomized but Never Treated|0|||
161684289|NCT02104583|583897882|FG001|Overall Study|Randomized but Never Treated|0|||
161947081|NCT03498716|584858501|FG001|Overall Study|Disease Relapse|1|||
161947082|NCT03498716|584858500|FG000|Overall Study|Death|58|||
161947083|NCT03498716|584858501|FG001|Overall Study|Death|72|||
161947084|NCT03498716|584858500|FG000|Overall Study|Physician Decision|4|||
161947085|NCT03498716|584858501|FG001|Overall Study|Physician Decision|2|||
161947086|NCT02284191|584858502|FG000|Overall Study|Withdrawal by Subject|1|||
161947087|NCT02284191|584858503|FG001|Overall Study|Withdrawal by Subject|3|||
161947088|NCT02284191|584858502|FG000|Overall Study|Lost to Follow-up|1|||
161947089|NCT02284191|584858503|FG001|Overall Study|Lost to Follow-up|0|||
161947090|NCT04064905|584858506|FG000|Overall Study|Lost to Follow-up|0|||
161947091|NCT04064905|584858507|FG001|Overall Study|Lost to Follow-up|3|||
161947092|NCT04064905|584858508|FG002|Overall Study|Lost to Follow-up|1|||
161947093|NCT04064905|584858509|FG003|Overall Study|Lost to Follow-up|4|||
161947094|NCT04064905|584858510|FG004|Overall Study|Lost to Follow-up|2|||
161947095|NCT02257684|584858511|FG000|Overall Study|Adverse Event|2|||
161947096|NCT02257684|584858511|FG000|Overall Study|Lack of Efficacy|1|||
161947097|NCT02257684|584858511|FG000|Overall Study|Sponsor's Decision|1|||
161947098|NCT01987557|584858512|FG000|Overall Study|Protocol Violation|1|||
161947099|NCT01987557|584858513|FG001|Overall Study|Protocol Violation|0|||
161947100|NCT01987557|584858514|FG002|Overall Study|Protocol Violation|1|||
161947101|NCT01987557|584858512|FG000|Overall Study|Withdrawal by Subject|2|||
162027581|NCT00348881|585156253|FG000|Overall Study|Serious Adverse Event|0|||
162027582|NCT00348881|585156254|FG001|Overall Study|Serious Adverse Event|2|||
161684290|NCT02104583|583897883|FG002|Overall Study|Randomized but Never Treated|0|||
161947102|NCT01987557|584858513|FG001|Overall Study|Withdrawal by Subject|1|||
161947103|NCT01987557|584858514|FG002|Overall Study|Withdrawal by Subject|2|||
161684291|NCT02104583|583897884|FG003|Overall Study|Randomized but Never Treated|1|||
161684292|NCT02104583|583897885|FG004|Overall Study|Randomized but Never Treated|0|||
161947104|NCT01987557|584858512|FG000|Overall Study|Adverse Event|0|||
161947105|NCT01987557|584858513|FG001|Overall Study|Adverse Event|2|||
161947106|NCT01987557|584858514|FG002|Overall Study|Adverse Event|0|||
161947107|NCT00760552|584858515|FG000|Overall Study|Death|2|||
161947108|NCT00760552|584858516|FG001|Overall Study|Death|0|||
161947109|NCT00760552|584858515|FG000|Overall Study|Lost to Follow-up|11|||
161947110|NCT00760552|584858516|FG001|Overall Study|Lost to Follow-up|10|||
161947111|NCT01832727|584858527|FG000|Overall Study|Adverse Event|4|||
161947112|NCT01832727|584858528|FG001|Overall Study|Adverse Event|6|||
161947113|NCT01832727|584858529|FG002|Overall Study|Adverse Event|1|||
161947114|NCT01832727|584858530|FG003|Overall Study|Adverse Event|0|||
161947115|NCT01832727|584858531|FG004|Overall Study|Adverse Event|1|||
161947116|NCT01832727|584858532|FG005|Overall Study|Adverse Event|1|||
161947117|NCT01832727|584858533|FG006|Overall Study|Adverse Event|2|||
161947118|NCT01832727|584858534|FG007|Overall Study|Adverse Event|1|||
161947119|NCT01832727|584858535|FG008|Overall Study|Adverse Event|9|||
161947120|NCT01832727|584858527|FG000|Overall Study|Disease progression|3|||
161947121|NCT01832727|584858528|FG001|Overall Study|Disease progression|0|||
161947122|NCT01832727|584858529|FG002|Overall Study|Disease progression|2|||
161947123|NCT01832727|584858530|FG003|Overall Study|Disease progression|1|||
161947124|NCT01832727|584858531|FG004|Overall Study|Disease progression|3|||
161947125|NCT01832727|584858532|FG005|Overall Study|Disease progression|3|||
161947126|NCT01832727|584858533|FG006|Overall Study|Disease progression|6|||
161947127|NCT01832727|584858534|FG007|Overall Study|Disease progression|2|||
161947128|NCT01832727|584858535|FG008|Overall Study|Disease progression|7|||
161947129|NCT01832727|584858527|FG000|Overall Study|Lost to Follow-up|0|||
161947130|NCT01832727|584858528|FG001|Overall Study|Lost to Follow-up|0|||
161947131|NCT01832727|584858529|FG002|Overall Study|Lost to Follow-up|0|||
161947132|NCT01832727|584858530|FG003|Overall Study|Lost to Follow-up|1|||
161947133|NCT01832727|584858531|FG004|Overall Study|Lost to Follow-up|0|||
161947134|NCT01832727|584858532|FG005|Overall Study|Lost to Follow-up|0|||
161947135|NCT01832727|584858533|FG006|Overall Study|Lost to Follow-up|0|||
161947136|NCT01832727|584858534|FG007|Overall Study|Lost to Follow-up|0|||
161947137|NCT01832727|584858535|FG008|Overall Study|Lost to Follow-up|0|||
161947138|NCT01832727|584858527|FG000|Overall Study|Physician Decision|1|||
161947139|NCT01832727|584858528|FG001|Overall Study|Physician Decision|0|||
161947140|NCT01832727|584858529|FG002|Overall Study|Physician Decision|0|||
161947141|NCT01832727|584858530|FG003|Overall Study|Physician Decision|1|||
161947142|NCT01832727|584858531|FG004|Overall Study|Physician Decision|0|||
161947143|NCT01832727|584858532|FG005|Overall Study|Physician Decision|1|||
161947144|NCT01832727|584858533|FG006|Overall Study|Physician Decision|0|||
161947145|NCT01832727|584858534|FG007|Overall Study|Physician Decision|0|||
161947146|NCT01832727|584858535|FG008|Overall Study|Physician Decision|0|||
161947147|NCT01832727|584858527|FG000|Overall Study|Withdrawal by Subject|1|||
161947148|NCT01832727|584858528|FG001|Overall Study|Withdrawal by Subject|1|||
161947149|NCT01832727|584858529|FG002|Overall Study|Withdrawal by Subject|0|||
161947150|NCT01832727|584858530|FG003|Overall Study|Withdrawal by Subject|1|||
161947151|NCT01832727|584858531|FG004|Overall Study|Withdrawal by Subject|0|||
161947152|NCT01832727|584858532|FG005|Overall Study|Withdrawal by Subject|1|||
161947153|NCT01832727|584858533|FG006|Overall Study|Withdrawal by Subject|0|||
161947154|NCT01832727|584858534|FG007|Overall Study|Withdrawal by Subject|2|||
161947155|NCT01832727|584858535|FG008|Overall Study|Withdrawal by Subject|1|||
161947156|NCT01832727|584858527|FG000|Overall Study|Study terminated by sponsor|0|||
161947157|NCT01832727|584858528|FG001|Overall Study|Study terminated by sponsor|0|||
161947158|NCT01832727|584858529|FG002|Overall Study|Study terminated by sponsor|0|||
161947159|NCT01832727|584858530|FG003|Overall Study|Study terminated by sponsor|0|||
161947160|NCT01832727|584858531|FG004|Overall Study|Study terminated by sponsor|0|||
161947161|NCT01832727|584858532|FG005|Overall Study|Study terminated by sponsor|0|||
161947162|NCT01832727|584858533|FG006|Overall Study|Study terminated by sponsor|0|||
161947163|NCT01832727|584858534|FG007|Overall Study|Study terminated by sponsor|1|||
161947164|NCT01832727|584858535|FG008|Overall Study|Study terminated by sponsor|1|||
161947165|NCT02170064|584858536|FG000|Overall Study|Withdrawal by Subject|5|||
161947166|NCT02170064|584858537|FG001|Overall Study|Withdrawal by Subject|1|||
161947167|NCT02170064|584858538|FG002|Overall Study|Withdrawal by Subject|1|||
161947168|NCT02170064|584858536|FG000|Overall Study|Physician Decision|1|||
161947169|NCT02170064|584858537|FG001|Overall Study|Physician Decision|1|||
161947170|NCT02170064|584858538|FG002|Overall Study|Physician Decision|0|||
161947171|NCT03323164|584858539|FG000|Overall Study|Poor quality imaging/scans|2|||
161947172|NCT03323164|584858540|FG001|Overall Study|Poor quality imaging/scans|2|||
161947173|NCT04211363|584858543|FG000|Overall Study|Adverse Event|5|||
161947174|NCT04211363|584858544|FG001|Overall Study|Adverse Event|2|||
161947175|NCT04211363|584858543|FG000|Overall Study|Physician Decision|0|||
161947176|NCT04211363|584858544|FG001|Overall Study|Physician Decision|1|||
161947177|NCT04211363|584858543|FG000|Overall Study|Protocol Violation|1|||
161947178|NCT04211363|584858544|FG001|Overall Study|Protocol Violation|0|||
161947179|NCT04211363|584858543|FG000|Overall Study|Pregnancy|1|||
161947180|NCT04211363|584858544|FG001|Overall Study|Pregnancy|0|||
161947181|NCT04211363|584858543|FG000|Overall Study|Lost to Follow-up|12|||
161947182|NCT04211363|584858544|FG001|Overall Study|Lost to Follow-up|4|||
161947183|NCT04211363|584858543|FG000|Overall Study|Withdrawal by Subject|11|||
161947184|NCT04211363|584858544|FG001|Overall Study|Withdrawal by Subject|11|||
161947185|NCT04211363|584858543|FG000|Overall Study|Other|1|||
161947186|NCT04211363|584858544|FG001|Overall Study|Other|2|||
161947187|NCT00461708|584858545|FG000|Overall Study|Adverse Event|17|||
161947188|NCT00461708|584858546|FG001|Overall Study|Adverse Event|7|||
161947189|NCT00461708|584858545|FG000|Overall Study|Lack of Efficacy|68|||
161947190|NCT00461708|584858546|FG001|Overall Study|Lack of Efficacy|20|||
161947191|NCT00461708|584858545|FG000|Overall Study|Physician Decision|10|||
161947192|NCT00461708|584858546|FG001|Overall Study|Physician Decision|4|||
161947193|NCT00461708|584858545|FG000|Overall Study|Withdrawal by Subject|8|||
161947194|NCT00461708|584858546|FG001|Overall Study|Withdrawal by Subject|2|||
161947195|NCT00461708|584858545|FG000|Overall Study|Other|4|||
161947196|NCT00461708|584858546|FG001|Overall Study|Other|4|||
161947197|NCT00461708|584858545|FG000|Overall Study|Death|8|||
161947198|NCT00461708|584858546|FG001|Overall Study|Death|1|||
161947199|NCT00501644|584858547|FG000|Overall Study|Adverse Event|4|||
161947200|NCT00501644|584858547|FG000|Overall Study|Withdrawal by Subject|1|||
161947201|NCT02394561|584858548|FG000|CORE Phase|Adverse Event|7|||
161947202|NCT02394561|584858549|FG001|CORE Phase|Adverse Event|9|||
162027583|NCT05092360|585156260|FG000|Overall Study|Withdrawal by Subject|21|||
161947203|NCT02394561|584858548|FG000|CORE Phase|Death|0|||
161947204|NCT02394561|584858549|FG001|CORE Phase|Death|1|||
161947205|NCT02394561|584858548|FG000|CORE Phase|Pregnancy|1|||
161947206|NCT02394561|584858549|FG001|CORE Phase|Pregnancy|0|||
162027584|NCT05092360|585156261|FG001|Overall Study|Withdrawal by Subject|4|||
161684293|NCT00129766|583897886|FG000|Overall Study|Death|3|||
161947207|NCT02394561|584858548|FG000|CORE Phase|Lost to Follow-up|1|||
161947208|NCT02394561|584858549|FG001|CORE Phase|Lost to Follow-up|0|||
161947209|NCT02394561|584858548|FG000|CORE Phase|Physician Decision|1|||
161947210|NCT02394561|584858549|FG001|CORE Phase|Physician Decision|1|||
161947211|NCT02394561|584858548|FG000|CORE Phase|Withdrawal by Subject|2|||
161947212|NCT02394561|584858549|FG001|CORE Phase|Withdrawal by Subject|2|||
161947213|NCT02394561|584858548|FG000|CORE Phase|Lack of Efficacy|1|||
161947214|NCT02394561|584858549|FG001|CORE Phase|Lack of Efficacy|6|||
161947215|NCT02394561|584858548|FG000|Extension Phase|Adverse Event|6|||
161947216|NCT02394561|584858549|FG001|Extension Phase|Adverse Event|1|||
161947217|NCT02394561|584858548|FG000|Extension Phase|Death|0|||
161947218|NCT02394561|584858549|FG001|Extension Phase|Death|1|||
161947219|NCT02394561|584858548|FG000|Extension Phase|Protocol Violation|1|||
161947220|NCT02394561|584858549|FG001|Extension Phase|Protocol Violation|0|||
161947221|NCT02394561|584858548|FG000|Extension Phase|Lost to Follow-up|1|||
161947222|NCT02394561|584858549|FG001|Extension Phase|Lost to Follow-up|0|||
161947223|NCT02394561|584858548|FG000|Extension Phase|Physician Decision|0|||
161947224|NCT02394561|584858549|FG001|Extension Phase|Physician Decision|2|||
161947225|NCT02394561|584858548|FG000|Extension Phase|Withdrawal by Subject|0|||
161947226|NCT02394561|584858549|FG001|Extension Phase|Withdrawal by Subject|5|||
161947227|NCT02394561|584858548|FG000|Extension Phase|Lack of Efficacy|3|||
161947228|NCT02394561|584858549|FG001|Extension Phase|Lack of Efficacy|3|||
161947229|NCT02553629|584858550|FG000|Overall Study|Logistic reasons|3|||
161947230|NCT02553629|584858551|FG001|Overall Study|Logistic reasons|6|||
161947231|NCT03434834|584858552|FG000|Overall Study|unable to swallow OCT probe|16|||
161947232|NCT01823289|584858557|FG000|Overall Study|Lost to Follow-up|5|||
161684294|NCT00129766|583897887|FG001|Overall Study|Death|8|||
161947233|NCT01823289|584858557|FG000|Overall Study|Adverse Event|5|||
161947234|NCT01823289|584858557|FG000|Overall Study|Lack of Efficacy|1|||
161947235|NCT01823289|584858557|FG000|Overall Study|Physician Decision|9|||
161947236|NCT01823289|584858557|FG000|Overall Study|Administered contraindicated medicine|1|||
161947237|NCT01823289|584858557|FG000|Overall Study|Transaminase increased more than 3 times|1|||
161947238|NCT01823289|584858557|FG000|Overall Study|Drug affected efficacy and safety|1|||
161947239|NCT01823289|584858557|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
161947240|NCT01812057|584858558|FG000|Overall Study|Protocol Violation|1|||
161947241|NCT01812057|584858559|FG001|Overall Study|Protocol Violation|0|||
161947242|NCT01812057|584858558|FG000|Overall Study|Physician Decision|1|||
161947243|NCT01812057|584858559|FG001|Overall Study|Physician Decision|0|||
161947244|NCT01736917|584858560|FG000|Overall Study|Adverse Event|1|||
161947245|NCT01736917|584858560|FG000|Overall Study|Protocol Violation|10|||
161947246|NCT01133847|584858567|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
161947247|NCT01133847|584858568|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
161947248|NCT01133847|584858569|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
161947249|NCT01133847|584858567|FG000|Follow-Up Phase|Lost to Follow-up|1|||
161947250|NCT01133847|584858568|FG001|Follow-Up Phase|Lost to Follow-up|3|||
161947251|NCT01133847|584858569|FG002|Follow-Up Phase|Lost to Follow-up|7|||
161947252|NCT01880957|584858570|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
161947253|NCT01880957|584858571|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
161947254|NCT01880957|584858570|FG000|Overall Study|Lost to Follow-up|11|||
161947255|NCT01880957|584858571|FG001|Overall Study|Lost to Follow-up|0|||
161947256|NCT01880957|584858570|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
161947257|NCT01880957|584858571|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
161947258|NCT01378117|584858572|FG000|Overall Study|withdrawal|2|||
161947259|NCT01378117|584858573|FG001|Overall Study|withdrawal|1|||
161947260|NCT01378117|584858574|FG002|Overall Study|withdrawal|2|||
161947261|NCT01378117|584858572|FG000|Overall Study|discharged before med given|2|||
161947262|NCT01378117|584858573|FG001|Overall Study|discharged before med given|0|||
161947263|NCT01378117|584858574|FG002|Overall Study|discharged before med given|1|||
161947264|NCT02961244|584858575|FG000|Overall Study|Protocol Violation|0|||
161947265|NCT02961244|584858576|FG001|Overall Study|Protocol Violation|1|||
161947266|NCT02961244|584858575|FG000|Overall Study|Withdrawal by Subject|1|||
161947267|NCT02961244|584858576|FG001|Overall Study|Withdrawal by Subject|2|||
161947268|NCT02961244|584858575|FG000|Overall Study|Surgery plan change after study approval|0|||
161684295|NCT00129766|583897886|FG000|Overall Study|Withdrawal of consent|31|||
161684296|NCT00129766|583897887|FG001|Overall Study|Withdrawal of consent|30|||
161684297|NCT00129766|583897886|FG000|Overall Study|Lost to Follow-up|26|||
161684298|NCT00129766|583897887|FG001|Overall Study|Lost to Follow-up|21|||
161684299|NCT01230307|583897889|FG000|Overall Study|LVAD Placement|0|||
161947269|NCT02961244|584858576|FG001|Overall Study|Surgery plan change after study approval|2|||
161947270|NCT02961244|584858575|FG000|Overall Study|Lost to Follow-up|0|||
161947271|NCT02961244|584858576|FG001|Overall Study|Lost to Follow-up|2|||
161947272|NCT02961244|584858575|FG000|Overall Study|İnadequate data|0|||
161684300|NCT01230307|583897890|FG001|Overall Study|LVAD Placement|2|||
161947273|NCT02961244|584858576|FG001|Overall Study|İnadequate data|2|||
161947274|NCT01854528|584858577|FG000|Overall Study|Adverse Event|0|||
161947275|NCT01854528|584858578|FG001|Overall Study|Adverse Event|4|||
161947276|NCT01854528|584858577|FG000|Overall Study|Withdrawal by Subject|0|||
161947277|NCT01854528|584858578|FG001|Overall Study|Withdrawal by Subject|2|||
161947278|NCT01854528|584858577|FG000|Overall Study|Virologic Failure|0|||
161947279|NCT01854528|584858578|FG001|Overall Study|Virologic Failure|9|||
161947280|NCT01368614|584858579|FG000|Screening Period|Screen Failure|58|||
161947281|NCT01368614|584858580|FG001|Screening Period|Screen Failure|0|||
161947282|NCT01368614|584858581|FG002|Screening Period|Screen Failure|0|||
161947283|NCT01368614|584858582|FG003|Screening Period|Screen Failure|0|||
161947284|NCT01368614|584858579|FG000|Study Period|Withdrawal by Subject|0|||
161947285|NCT01368614|584858580|FG001|Study Period|Withdrawal by Subject|1|||
161947286|NCT01368614|584858581|FG002|Study Period|Withdrawal by Subject|1|||
161947287|NCT01368614|584858582|FG003|Study Period|Withdrawal by Subject|3|||
161947288|NCT01368614|584858579|FG000|Study Period|Lost to Follow-up|0|||
161947289|NCT01368614|584858580|FG001|Study Period|Lost to Follow-up|0|||
161947290|NCT01368614|584858581|FG002|Study Period|Lost to Follow-up|1|||
161947291|NCT01368614|584858582|FG003|Study Period|Lost to Follow-up|0|||
161947292|NCT00659425|584858591|FG000|Overall Study|Disease progression|1|||
161947293|NCT00659425|584858592|FG001|Overall Study|Disease progression|0|||
161947294|NCT00659425|584858593|FG002|Overall Study|Disease progression|0|||
161947295|NCT00659425|584858594|FG003|Overall Study|Disease progression|1|||
161947296|NCT00659425|584858595|FG004|Overall Study|Disease progression|0|||
161947297|NCT00659425|584858596|FG005|Overall Study|Disease progression|2|||
161947298|NCT00659425|584858597|FG006|Overall Study|Disease progression|4|||
161684301|NCT04773106|583897891|FG000|Overall Study|Withdrawal by Subject|3|||
161947299|NCT00659425|584858598|FG007|Overall Study|Disease progression|3|||
161947300|NCT00659425|584858599|FG008|Overall Study|Disease progression|5|||
162027585|NCT05092360|585156262|FG002|Overall Study|Withdrawal by Subject|9|||
161947301|NCT00659425|584858600|FG009|Overall Study|Disease progression|3|||
161947302|NCT00659425|584858591|FG000|Overall Study|Death|0|||
161947303|NCT00659425|584858592|FG001|Overall Study|Death|0|||
161947304|NCT00659425|584858593|FG002|Overall Study|Death|0|||
162027586|NCT05092360|585156263|FG003|Overall Study|Withdrawal by Subject|26|||
162027587|NCT05092360|585156260|FG000|Overall Study|Death|97|||
162027588|NCT05092360|585156261|FG001|Overall Study|Death|14|||
162027589|NCT05092360|585156262|FG002|Overall Study|Death|31|||
162027590|NCT05092360|585156263|FG003|Overall Study|Death|101|||
162027591|NCT05092360|585156260|FG000|Overall Study|Lost to Follow-up|1|||
162027592|NCT05092360|585156261|FG001|Overall Study|Lost to Follow-up|2|||
162027593|NCT05092360|585156262|FG002|Overall Study|Lost to Follow-up|2|||
162027594|NCT05092360|585156263|FG003|Overall Study|Lost to Follow-up|2|||
162027595|NCT05092360|585156260|FG000|Overall Study|Study terminated by sponsor|65|||
162027596|NCT05092360|585156261|FG001|Overall Study|Study terminated by sponsor|7|||
162027597|NCT05092360|585156262|FG002|Overall Study|Study terminated by sponsor|13|||
162027598|NCT05092360|585156263|FG003|Overall Study|Study terminated by sponsor|61|||
162027599|NCT01675167|585156264|FG000|Open-label Titration Phase|Adverse Event|81|||
162027600|NCT01675167|585156265|FG001|Open-label Titration Phase|Adverse Event|0|||
162027601|NCT01675167|585156266|FG002|Open-label Titration Phase|Adverse Event|0|||
162027602|NCT01675167|585156264|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
162027603|NCT01675167|585156265|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
162027604|NCT01675167|585156266|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
162027605|NCT01675167|585156264|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
162027606|NCT01675167|585156265|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
162027607|NCT01675167|585156266|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
162027608|NCT01675167|585156264|FG000|Open-label Titration Phase|Protocol Violation|43|||
162027609|NCT01675167|585156265|FG001|Open-label Titration Phase|Protocol Violation|0|||
162027610|NCT01675167|585156266|FG002|Open-label Titration Phase|Protocol Violation|0|||
162027611|NCT01675167|585156264|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
162027612|NCT01675167|585156265|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
162027613|NCT01675167|585156266|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
162027614|NCT01675167|585156264|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
162027615|NCT01675167|585156265|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
162027616|NCT01675167|585156266|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
162027617|NCT01675167|585156264|FG000|Open-label Titration Phase|Other|55|||
162027618|NCT01675167|585156265|FG001|Open-label Titration Phase|Other|0|||
162027619|NCT01675167|585156266|FG002|Open-label Titration Phase|Other|0|||
162027620|NCT01675167|585156264|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
162027621|NCT01675167|585156265|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
162027622|NCT01675167|585156266|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
162027623|NCT01675167|585156264|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162027624|NCT01675167|585156265|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
162027625|NCT01675167|585156266|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
162027626|NCT01675167|585156264|FG000|Double-blind Treatment Phase|Adverse Event|0|||
162027627|NCT01675167|585156265|FG001|Double-blind Treatment Phase|Adverse Event|5|||
162027628|NCT01675167|585156266|FG002|Double-blind Treatment Phase|Adverse Event|13|||
162027629|NCT01675167|585156264|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
162027630|NCT01675167|585156265|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
162027631|NCT01675167|585156266|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
162027632|NCT01675167|585156264|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
162027633|NCT01675167|585156265|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
162027634|NCT01675167|585156266|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
162027635|NCT01675167|585156264|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
161947305|NCT00659425|584858594|FG003|Overall Study|Death|1|||
161947306|NCT00659425|584858595|FG004|Overall Study|Death|0|||
161947307|NCT00659425|584858596|FG005|Overall Study|Death|0|||
161947308|NCT00659425|584858597|FG006|Overall Study|Death|1|||
161947309|NCT00659425|584858598|FG007|Overall Study|Death|0|||
161947310|NCT00659425|584858599|FG008|Overall Study|Death|0|||
161947311|NCT00659425|584858600|FG009|Overall Study|Death|0|||
161947312|NCT00659425|584858591|FG000|Overall Study|Adverse Event|0|||
161947313|NCT00659425|584858592|FG001|Overall Study|Adverse Event|0|||
161947314|NCT00659425|584858593|FG002|Overall Study|Adverse Event|0|||
161947315|NCT00659425|584858594|FG003|Overall Study|Adverse Event|0|||
161947316|NCT00659425|584858595|FG004|Overall Study|Adverse Event|0|||
162027636|NCT01675167|585156265|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
161947317|NCT00659425|584858596|FG005|Overall Study|Adverse Event|1|||
161947318|NCT00659425|584858597|FG006|Overall Study|Adverse Event|0|||
162027637|NCT01675167|585156266|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
162027638|NCT01675167|585156264|FG000|Double-blind Treatment Phase|Other|0|||
162027639|NCT01675167|585156265|FG001|Double-blind Treatment Phase|Other|7|||
162027640|NCT01675167|585156266|FG002|Double-blind Treatment Phase|Other|5|||
162027641|NCT04531462|585157240|FG000|Overall Study|Withdrawal by Subject|3|||
162027642|NCT04531462|585157241|FG001|Overall Study|Withdrawal by Subject|1|||
162027643|NCT04531462|585157240|FG000|Overall Study|Adverse Event|3|||
161947319|NCT00659425|584858598|FG007|Overall Study|Adverse Event|3|||
161947320|NCT00659425|584858599|FG008|Overall Study|Adverse Event|1|||
162027644|NCT04531462|585157241|FG001|Overall Study|Adverse Event|3|||
162027645|NCT00504582|585157242|FG000|Overall Study|Lost to Follow-up|1|||
162027646|NCT00504582|585157243|FG001|Overall Study|Lost to Follow-up|0|||
162027647|NCT00504582|585157244|FG002|Overall Study|Lost to Follow-up|0|||
162027648|NCT05338671|585157246|FG000|Overall Study|Lost to Follow-up|2|||
162027649|NCT05338671|585157247|FG001|Overall Study|Lost to Follow-up|2|||
162027650|NCT05338671|585157246|FG000|Overall Study|Root canal completed in a single visit|1|||
162027651|NCT05338671|585157247|FG001|Overall Study|Root canal completed in a single visit|0|||
162027652|NCT03859973|585157248|FG000|Overall Study|Other reason than listed|3|||
162027653|NCT03859973|585157249|FG001|Overall Study|Other reason than listed|2|||
162027654|NCT03859973|585157248|FG000|Overall Study|COVID-19 related, not due to AE|3|||
162027655|NCT03859973|585157249|FG001|Overall Study|COVID-19 related, not due to AE|4|||
162027656|NCT03859973|585157248|FG000|Overall Study|Withdrawal by Subject|8|||
162027657|NCT03859973|585157249|FG001|Overall Study|Withdrawal by Subject|9|||
162027658|NCT03859973|585157248|FG000|Overall Study|Lost to Follow-up|2|||
162027659|NCT03859973|585157249|FG001|Overall Study|Lost to Follow-up|3|||
162027660|NCT03859973|585157248|FG000|Overall Study|Protocol Violation|1|||
162027661|NCT03859973|585157249|FG001|Overall Study|Protocol Violation|3|||
162027662|NCT03859973|585157248|FG000|Overall Study|Adverse Event|3|||
162027663|NCT03859973|585157249|FG001|Overall Study|Adverse Event|5|||
162027664|NCT02855541|585157250|FG000|Overall Study|Change in health status|2|||
162027665|NCT02855541|585157250|FG000|Overall Study|Withdrawal by Subject|2|||
162027666|NCT03085914|585157251|FG000|Overall Study|Death|6|||
162027667|NCT03085914|585157252|FG001|Overall Study|Death|6|||
162027668|NCT03085914|585157253|FG002|Overall Study|Death|4|||
162027669|NCT03085914|585157254|FG003|Overall Study|Death|1|||
162027670|NCT03085914|585157255|FG004|Overall Study|Death|5|||
162027671|NCT03085914|585157256|FG005|Overall Study|Death|2|||
162027672|NCT03085914|585157257|FG006|Overall Study|Death|2|||
162027673|NCT03085914|585157251|FG000|Overall Study|Withdrawal by Subject|1|||
162027674|NCT03085914|585157252|FG001|Overall Study|Withdrawal by Subject|1|||
162027675|NCT03085914|585157253|FG002|Overall Study|Withdrawal by Subject|2|||
162027676|NCT03085914|585157254|FG003|Overall Study|Withdrawal by Subject|2|||
162027677|NCT03085914|585157255|FG004|Overall Study|Withdrawal by Subject|2|||
162027678|NCT03085914|585157256|FG005|Overall Study|Withdrawal by Subject|0|||
162027679|NCT03085914|585157257|FG006|Overall Study|Withdrawal by Subject|1|||
162027680|NCT03085914|585157251|FG000|Overall Study|Lost to Follow-up|0|||
162027681|NCT03085914|585157252|FG001|Overall Study|Lost to Follow-up|0|||
162027682|NCT03085914|585157253|FG002|Overall Study|Lost to Follow-up|1|||
162027683|NCT03085914|585157254|FG003|Overall Study|Lost to Follow-up|0|||
162027684|NCT03085914|585157255|FG004|Overall Study|Lost to Follow-up|0|||
162027685|NCT03085914|585157256|FG005|Overall Study|Lost to Follow-up|1|||
162027686|NCT03085914|585157257|FG006|Overall Study|Lost to Follow-up|1|||
162027687|NCT03085914|585157251|FG000|Overall Study|Reason was not specified,|2|||
162027688|NCT03085914|585157252|FG001|Overall Study|Reason was not specified,|2|||
162027689|NCT03085914|585157253|FG002|Overall Study|Reason was not specified,|2|||
162027690|NCT03085914|585157254|FG003|Overall Study|Reason was not specified,|3|||
162027691|NCT03085914|585157255|FG004|Overall Study|Reason was not specified,|3|||
162027692|NCT03085914|585157256|FG005|Overall Study|Reason was not specified,|3|||
162027693|NCT03085914|585157257|FG006|Overall Study|Reason was not specified,|6|||
162027694|NCT03085914|585157251|FG000|Overall Study|Progressive Disease|0|||
162027695|NCT03085914|585157252|FG001|Overall Study|Progressive Disease|0|||
162027696|NCT03085914|585157253|FG002|Overall Study|Progressive Disease|2|||
162027697|NCT03085914|585157254|FG003|Overall Study|Progressive Disease|2|||
162027698|NCT03085914|585157255|FG004|Overall Study|Progressive Disease|1|||
162027699|NCT03085914|585157256|FG005|Overall Study|Progressive Disease|1|||
162027700|NCT03085914|585157257|FG006|Overall Study|Progressive Disease|1|||
162027701|NCT03085914|585157251|FG000|Overall Study|Study Terminated by the Sponsor|0|||
162027702|NCT03085914|585157252|FG001|Overall Study|Study Terminated by the Sponsor|0|||
162027703|NCT03085914|585157253|FG002|Overall Study|Study Terminated by the Sponsor|0|||
162027704|NCT03085914|585157254|FG003|Overall Study|Study Terminated by the Sponsor|1|||
162027705|NCT03085914|585157255|FG004|Overall Study|Study Terminated by the Sponsor|2|||
162027706|NCT03085914|585157256|FG005|Overall Study|Study Terminated by the Sponsor|1|||
162027707|NCT03085914|585157257|FG006|Overall Study|Study Terminated by the Sponsor|0|||
162027708|NCT01561898|585157261|FG000|Overall Study|Withdrawal by Subject|0|||
162027709|NCT01561898|585157262|FG001|Overall Study|Withdrawal by Subject|8|||
162027710|NCT01561898|585157263|FG002|Overall Study|Withdrawal by Subject|12|||
162027711|NCT01561898|585157264|FG003|Overall Study|Withdrawal by Subject|5|||
162027712|NCT01561898|585157261|FG000|Overall Study|Lack of Efficacy|0|||
162027713|NCT01561898|585157262|FG001|Overall Study|Lack of Efficacy|8|||
162027714|NCT01561898|585157263|FG002|Overall Study|Lack of Efficacy|10|||
162027715|NCT01561898|585157264|FG003|Overall Study|Lack of Efficacy|5|||
162027716|NCT01561898|585157261|FG000|Overall Study|Worsening of complications|0|||
162027717|NCT01561898|585157262|FG001|Overall Study|Worsening of complications|1|||
162027718|NCT01561898|585157263|FG002|Overall Study|Worsening of complications|0|||
162027719|NCT01561898|585157264|FG003|Overall Study|Worsening of complications|0|||
162027720|NCT01561898|585157261|FG000|Overall Study|Lost to Follow-up|0|||
162027721|NCT01561898|585157262|FG001|Overall Study|Lost to Follow-up|0|||
161947321|NCT00659425|584858600|FG009|Overall Study|Adverse Event|4|||
161947322|NCT00659425|584858591|FG000|Overall Study|Investigator Discretion|0|||
161947323|NCT00659425|584858592|FG001|Overall Study|Investigator Discretion|0|||
161947324|NCT00659425|584858593|FG002|Overall Study|Investigator Discretion|0|||
161947325|NCT00659425|584858594|FG003|Overall Study|Investigator Discretion|0|||
161947326|NCT00659425|584858595|FG004|Overall Study|Investigator Discretion|0|||
161947327|NCT00659425|584858596|FG005|Overall Study|Investigator Discretion|1|||
161947328|NCT00659425|584858597|FG006|Overall Study|Investigator Discretion|0|||
161947329|NCT00659425|584858598|FG007|Overall Study|Investigator Discretion|3|||
161947330|NCT00659425|584858599|FG008|Overall Study|Investigator Discretion|0|||
161947331|NCT00659425|584858600|FG009|Overall Study|Investigator Discretion|0|||
161947332|NCT00659425|584858591|FG000|Overall Study|Other|0|||
161947333|NCT00659425|584858592|FG001|Overall Study|Other|1|||
161947334|NCT00659425|584858593|FG002|Overall Study|Other|1|||
161947335|NCT00659425|584858594|FG003|Overall Study|Other|2|||
161947336|NCT00659425|584858595|FG004|Overall Study|Other|4|||
161947337|NCT00659425|584858596|FG005|Overall Study|Other|0|||
161947338|NCT00659425|584858597|FG006|Overall Study|Other|3|||
161947339|NCT00659425|584858598|FG007|Overall Study|Other|2|||
161947340|NCT00659425|584858599|FG008|Overall Study|Other|0|||
161947341|NCT00659425|584858600|FG009|Overall Study|Other|6|||
161947342|NCT00636181|584858604|FG000|Overall Study|Withdrawal by Subject|8|||
161947343|NCT00636181|584858605|FG001|Overall Study|Withdrawal by Subject|6|||
161947344|NCT00636181|584858606|FG002|Overall Study|Withdrawal by Subject|10|||
161947345|NCT02561962|584858608|FG000|Overall Study|Withdrawal by Subject|1|||
161947346|NCT02561962|584858609|FG001|Overall Study|Withdrawal by Subject|0|||
161947347|NCT02561962|584858610|FG002|Overall Study|Withdrawal by Subject|0|||
161947348|NCT02561962|584858611|FG003|Overall Study|Withdrawal by Subject|0|||
161947349|NCT02561962|584858612|FG004|Overall Study|Withdrawal by Subject|1|||
161947350|NCT02561962|584858613|FG005|Overall Study|Withdrawal by Subject|1|||
161947351|NCT02561962|584858614|FG006|Overall Study|Withdrawal by Subject|2|||
161947352|NCT02561962|584858615|FG007|Overall Study|Withdrawal by Subject|1|||
161947353|NCT02561962|584858616|FG008|Overall Study|Withdrawal by Subject|0|||
161947354|NCT02561962|584858608|FG000|Overall Study|Decision by sponsor|0|||
161947355|NCT02561962|584858609|FG001|Overall Study|Decision by sponsor|0|||
161947356|NCT02561962|584858610|FG002|Overall Study|Decision by sponsor|0|||
161947357|NCT02561962|584858611|FG003|Overall Study|Decision by sponsor|0|||
161947358|NCT02561962|584858612|FG004|Overall Study|Decision by sponsor|1|||
161947359|NCT02561962|584858613|FG005|Overall Study|Decision by sponsor|1|||
161947360|NCT02561962|584858614|FG006|Overall Study|Decision by sponsor|0|||
161947361|NCT02561962|584858615|FG007|Overall Study|Decision by sponsor|3|||
161947362|NCT02561962|584858616|FG008|Overall Study|Decision by sponsor|0|||
161947363|NCT02561962|584858608|FG000|Overall Study|Lost to Follow-up|0|||
161947364|NCT02561962|584858609|FG001|Overall Study|Lost to Follow-up|0|||
161947365|NCT02561962|584858610|FG002|Overall Study|Lost to Follow-up|0|||
161947366|NCT02561962|584858611|FG003|Overall Study|Lost to Follow-up|0|||
161947367|NCT02561962|584858612|FG004|Overall Study|Lost to Follow-up|0|||
161947368|NCT02561962|584858613|FG005|Overall Study|Lost to Follow-up|1|||
161947369|NCT02561962|584858614|FG006|Overall Study|Lost to Follow-up|0|||
161947370|NCT02561962|584858615|FG007|Overall Study|Lost to Follow-up|0|||
161947371|NCT02561962|584858616|FG008|Overall Study|Lost to Follow-up|0|||
161947372|NCT03586973|584858617|FG000|Overall Study|Death|15|||
161947373|NCT03586973|584858618|FG001|Overall Study|Death|8|||
161947374|NCT03586973|584858617|FG000|Overall Study|Site Terminated by Sponsor|3|||
161947375|NCT03586973|584858618|FG001|Overall Study|Site Terminated by Sponsor|6|||
161947376|NCT03586973|584858617|FG000|Overall Study|Withdrawal by Subject|1|||
161947377|NCT03586973|584858618|FG001|Overall Study|Withdrawal by Subject|0|||
161947378|NCT03586973|584858617|FG000|Overall Study|Lost to Follow-up|1|||
161947379|NCT03586973|584858618|FG001|Overall Study|Lost to Follow-up|0|||
161947380|NCT02735421|584860209|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
161947381|NCT02735421|584860209|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
161947382|NCT02735421|584860209|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
161947383|NCT02735421|584860209|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
161947384|NCT02735421|584860209|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
161947385|NCT02735421|584860209|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
161947386|NCT02735421|584860209|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
161947387|NCT00322049|584860211|FG000|Overall Study|Moved out of area|0|||
161947388|NCT00322049|584860212|FG001|Overall Study|Moved out of area|0|||
161947389|NCT00322049|584860213|FG002|Overall Study|Moved out of area|0|||
162027722|NCT01561898|585157263|FG002|Overall Study|Lost to Follow-up|1|||
161947390|NCT00322049|584860214|FG003|Overall Study|Moved out of area|1|||
161947391|NCT00322049|584860211|FG000|Overall Study|Infected with Dengue during study|0|||
162027723|NCT01561898|585157264|FG003|Overall Study|Lost to Follow-up|0|||
162027724|NCT01561898|585157261|FG000|Overall Study|Adverse Event|1|||
162027725|NCT01561898|585157262|FG001|Overall Study|Adverse Event|19|||
162027726|NCT01561898|585157263|FG002|Overall Study|Adverse Event|14|||
162027727|NCT01561898|585157264|FG003|Overall Study|Adverse Event|9|||
162027728|NCT01561898|585157261|FG000|Overall Study|Physician Decision|1|||
162027729|NCT01561898|585157262|FG001|Overall Study|Physician Decision|5|||
162027730|NCT01561898|585157263|FG002|Overall Study|Physician Decision|7|||
162027731|NCT01561898|585157264|FG003|Overall Study|Physician Decision|1|||
162027732|NCT03874429|585157265|FG000|Overall Study|Adverse Event|2|||
162027733|NCT03874429|585157266|FG001|Overall Study|Adverse Event|2|||
162027734|NCT03874429|585157265|FG000|Overall Study|Lack of Efficacy|0|||
162027735|NCT03874429|585157266|FG001|Overall Study|Lack of Efficacy|1|||
162027736|NCT03874429|585157265|FG000|Overall Study|Covid-19 pandemic|4|||
162027737|NCT03874429|585157266|FG001|Overall Study|Covid-19 pandemic|2|||
162027738|NCT00331552|585157267|FG000|Period 3: Phase II|Neurological Symptoms|1|||
162027739|NCT00331552|585157268|FG001|Period 3: Phase II|Neurological Symptoms|0|||
162027740|NCT00331552|585157267|FG000|Period 3: Phase II|Severe Nausea|1|||
162027741|NCT00331552|585157268|FG001|Period 3: Phase II|Severe Nausea|0|||
162027742|NCT01445548|585157269|FG000|Overall Study|Adverse Event|1|||
162027743|NCT03560518|585157270|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
162027744|NCT03560518|585157271|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
162027745|NCT03560518|585157272|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
162027746|NCT03560518|585157270|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
162027747|NCT03560518|585157271|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
162027748|NCT03560518|585157272|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
162027749|NCT03560518|585157270|FG000|Double Blind Treatment Period|Protocol Violation|1|||
162027750|NCT03560518|585157271|FG001|Double Blind Treatment Period|Protocol Violation|2|||
162027751|NCT03560518|585157272|FG002|Double Blind Treatment Period|Protocol Violation|0|||
162027752|NCT03560518|585157270|FG000|Double Blind Treatment Period|Pregnancy|0|||
162027753|NCT03560518|585157271|FG001|Double Blind Treatment Period|Pregnancy|2|||
162027754|NCT03560518|585157272|FG002|Double Blind Treatment Period|Pregnancy|0|||
162027755|NCT03560518|585157270|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
162027756|NCT03560518|585157271|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
162027757|NCT03560518|585157272|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
162027758|NCT03560518|585157270|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
162027759|NCT03560518|585157271|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
162027760|NCT03560518|585157272|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
162027761|NCT03560518|585157270|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
162027762|NCT03560518|585157271|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
162027763|NCT03560518|585157272|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
162027764|NCT03560518|585157270|FG000|Double Blind Treatment Period|Adverse Event|0|||
162027765|NCT03560518|585157271|FG001|Double Blind Treatment Period|Adverse Event|3|||
162027766|NCT03560518|585157272|FG002|Double Blind Treatment Period|Adverse Event|1|||
162027767|NCT00159822|585157273|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
162027768|NCT00159822|585157273|FG000|Voriconazole Treatment Period|Adverse Event|9|||
162027769|NCT00159822|585157273|FG000|Voriconazole Treatment Period|Death|4|||
162027770|NCT00159822|585157273|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
162027771|NCT00159822|585157273|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
162027772|NCT00159822|585157273|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
162027773|NCT00159822|585157273|FG000|Post-treatment Follow-up Period|Death|1|||
162027774|NCT00159822|585157273|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
161947392|NCT00322049|584860212|FG001|Overall Study|Infected with Dengue during study|1|||
161947393|NCT00322049|584860213|FG002|Overall Study|Infected with Dengue during study|0|||
162027775|NCT00159822|585157273|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
162027776|NCT01215916|585157275|FG000|Overall Study|Progressive Disease|0|||
162027777|NCT01215916|585157276|FG001|Overall Study|Progressive Disease|2|||
162027778|NCT01215916|585157277|FG002|Overall Study|Progressive Disease|1|||
162027779|NCT01215916|585157278|FG003|Overall Study|Progressive Disease|2|||
162027780|NCT01215916|585157279|FG004|Overall Study|Progressive Disease|5|||
162027781|NCT01215916|585157280|FG005|Overall Study|Progressive Disease|4|||
162027782|NCT01215916|585157281|FG006|Overall Study|Progressive Disease|5|||
162027783|NCT01215916|585157282|FG007|Overall Study|Progressive Disease|3|||
162027784|NCT01215916|585157283|FG008|Overall Study|Progressive Disease|1|||
162027785|NCT01215916|585157275|FG000|Overall Study|Adverse Event|1|||
162027786|NCT01215916|585157276|FG001|Overall Study|Adverse Event|1|||
162027787|NCT01215916|585157277|FG002|Overall Study|Adverse Event|0|||
162027788|NCT01215916|585157278|FG003|Overall Study|Adverse Event|1|||
162027789|NCT01215916|585157279|FG004|Overall Study|Adverse Event|0|||
162027790|NCT01215916|585157280|FG005|Overall Study|Adverse Event|0|||
162027791|NCT01215916|585157281|FG006|Overall Study|Adverse Event|3|||
162027792|NCT01215916|585157282|FG007|Overall Study|Adverse Event|0|||
162027793|NCT01215916|585157283|FG008|Overall Study|Adverse Event|0|||
162027794|NCT01215916|585157275|FG000|Overall Study|Withdrawal by Subject|0|||
162027795|NCT01215916|585157276|FG001|Overall Study|Withdrawal by Subject|1|||
162027796|NCT01215916|585157277|FG002|Overall Study|Withdrawal by Subject|1|||
162027797|NCT01215916|585157278|FG003|Overall Study|Withdrawal by Subject|2|||
162027798|NCT01215916|585157279|FG004|Overall Study|Withdrawal by Subject|0|||
162027799|NCT01215916|585157280|FG005|Overall Study|Withdrawal by Subject|0|||
162027800|NCT01215916|585157281|FG006|Overall Study|Withdrawal by Subject|1|||
162027801|NCT01215916|585157282|FG007|Overall Study|Withdrawal by Subject|0|||
162027802|NCT01215916|585157283|FG008|Overall Study|Withdrawal by Subject|0|||
162027803|NCT01215916|585157275|FG000|Overall Study|Death|0|||
162027804|NCT01215916|585157276|FG001|Overall Study|Death|1|||
161947394|NCT00322049|584860214|FG003|Overall Study|Infected with Dengue during study|0|||
161947395|NCT01978145|584860215|FG000|Treatment Period 1|Adverse Event|1|||
161947396|NCT01978145|584860216|FG001|Treatment Period 1|Adverse Event|9|||
161947397|NCT01978145|584860215|FG000|Treatment Period 1|Physician Decision|1|||
161947398|NCT01978145|584860216|FG001|Treatment Period 1|Physician Decision|0|||
161947399|NCT01978145|584860215|FG000|Treatment Period 1|Withdrawal by Subject|5|||
161947400|NCT01978145|584860216|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161947401|NCT01978145|584860215|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
161947402|NCT01978145|584860216|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
161947403|NCT01978145|584860215|FG000|Washout Period 1|Adverse Event|0|||
161947404|NCT01978145|584860216|FG001|Washout Period 1|Adverse Event|1|||
161947405|NCT01978145|584860215|FG000|Washout Period 1|Withdrawal by Subject|1|||
161947406|NCT01978145|584860216|FG001|Washout Period 1|Withdrawal by Subject|1|||
161947407|NCT01978145|584860215|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
161947408|NCT01978145|584860216|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
161947409|NCT01978145|584860215|FG000|Treatment Period 2|Adverse Event|3|||
161947410|NCT01978145|584860216|FG001|Treatment Period 2|Adverse Event|3|||
161947411|NCT01978145|584860215|FG000|Treatment Period 2|Protocol Violation|0|||
161947412|NCT01978145|584860216|FG001|Treatment Period 2|Protocol Violation|1|||
161947413|NCT01978145|584860215|FG000|Treatment Period 2|Lost to Follow-up|1|||
161947414|NCT01978145|584860216|FG001|Treatment Period 2|Lost to Follow-up|1|||
161947415|NCT01978145|584860215|FG000|Treatment Period 2|Withdrawal by Subject|7|||
161947416|NCT01978145|584860216|FG001|Treatment Period 2|Withdrawal by Subject|4|||
161947417|NCT01978145|584860215|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
161947418|NCT01978145|584860216|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
162027805|NCT01215916|585157277|FG002|Overall Study|Death|0|||
162027806|NCT01215916|585157278|FG003|Overall Study|Death|0|||
162027807|NCT01215916|585157279|FG004|Overall Study|Death|1|||
162027808|NCT01215916|585157280|FG005|Overall Study|Death|0|||
162027809|NCT01215916|585157281|FG006|Overall Study|Death|0|||
162027810|NCT01215916|585157282|FG007|Overall Study|Death|0|||
162027811|NCT01215916|585157283|FG008|Overall Study|Death|1|||
162027812|NCT01215916|585157275|FG000|Overall Study|Physician Decision|0|||
162027813|NCT01215916|585157276|FG001|Overall Study|Physician Decision|0|||
162027814|NCT01215916|585157277|FG002|Overall Study|Physician Decision|1|||
162027815|NCT01215916|585157278|FG003|Overall Study|Physician Decision|1|||
162027816|NCT01215916|585157279|FG004|Overall Study|Physician Decision|0|||
161947419|NCT01250054|584860217|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
161947420|NCT01250054|584860218|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
161947421|NCT01770743|584860219|FG000|Overall Study|Adverse Event|1|||
161947422|NCT01770743|584860220|FG001|Overall Study|Adverse Event|0|||
162027817|NCT01215916|585157280|FG005|Overall Study|Physician Decision|0|||
162027818|NCT01215916|585157281|FG006|Overall Study|Physician Decision|0|||
162027819|NCT01215916|585157282|FG007|Overall Study|Physician Decision|0|||
162027820|NCT01215916|585157283|FG008|Overall Study|Physician Decision|0|||
161947423|NCT01770743|584860221|FG002|Overall Study|Adverse Event|0|||
161947424|NCT01770743|584860222|FG003|Overall Study|Adverse Event|0|||
161947425|NCT01770743|584860223|FG004|Overall Study|Adverse Event|0|||
161947426|NCT01770743|584860219|FG000|Overall Study|Withdrawal by Subject|0|||
161947427|NCT01770743|584860220|FG001|Overall Study|Withdrawal by Subject|0|||
161947428|NCT01770743|584860221|FG002|Overall Study|Withdrawal by Subject|1|||
161947429|NCT01770743|584860222|FG003|Overall Study|Withdrawal by Subject|1|||
161947430|NCT01770743|584860223|FG004|Overall Study|Withdrawal by Subject|1|||
161947431|NCT01770743|584860219|FG000|Overall Study|Lost to Follow-up|0|||
161947432|NCT01770743|584860220|FG001|Overall Study|Lost to Follow-up|2|||
161947433|NCT01770743|584860221|FG002|Overall Study|Lost to Follow-up|0|||
161947434|NCT01770743|584860222|FG003|Overall Study|Lost to Follow-up|0|||
161947435|NCT01770743|584860223|FG004|Overall Study|Lost to Follow-up|1|||
161947436|NCT01770743|584860219|FG000|Overall Study|Sponsor Terminated Subject|1|||
161947437|NCT01770743|584860220|FG001|Overall Study|Sponsor Terminated Subject|0|||
161947438|NCT01770743|584860221|FG002|Overall Study|Sponsor Terminated Subject|0|||
161947439|NCT01770743|584860222|FG003|Overall Study|Sponsor Terminated Subject|1|||
161947440|NCT01770743|584860223|FG004|Overall Study|Sponsor Terminated Subject|0|||
161947441|NCT01770743|584860219|FG000|Overall Study|Moving Out of State|0|||
161947442|NCT01770743|584860220|FG001|Overall Study|Moving Out of State|1|||
161947443|NCT01770743|584860221|FG002|Overall Study|Moving Out of State|0|||
161947444|NCT01770743|584860222|FG003|Overall Study|Moving Out of State|0|||
161947445|NCT01770743|584860223|FG004|Overall Study|Moving Out of State|0|||
161947446|NCT00755807|584860228|FG000|Acute Phase|Adverse Event|16|||
161947447|NCT00755807|584860229|FG001|Acute Phase|Adverse Event|5|||
161947448|NCT00755807|584860228|FG000|Acute Phase|Protocol Violation|1|||
161947449|NCT00755807|584860229|FG001|Acute Phase|Protocol Violation|3|||
161947450|NCT00755807|584860228|FG000|Acute Phase|Withdrawal by Subject|1|||
161947451|NCT00755807|584860229|FG001|Acute Phase|Withdrawal by Subject|2|||
161947452|NCT00755807|584860228|FG000|Acute Phase|Lack of Efficacy|0|||
161947453|NCT00755807|584860229|FG001|Acute Phase|Lack of Efficacy|1|||
161947454|NCT00755807|584860228|FG000|Acute Phase|Physician Decision|0|||
161947455|NCT00755807|584860229|FG001|Acute Phase|Physician Decision|1|||
161947456|NCT00755807|584860228|FG000|Open-label Extension Phase|Adverse Event|7|||
161947457|NCT00755807|584860229|FG001|Open-label Extension Phase|Adverse Event|7|||
161947458|NCT00755807|584860228|FG000|Open-label Extension Phase|Protocol Violation|5|||
161947459|NCT00755807|584860229|FG001|Open-label Extension Phase|Protocol Violation|2|||
161947460|NCT00755807|584860228|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
161947461|NCT00755807|584860229|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
161947462|NCT00755807|584860228|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
161947463|NCT00755807|584860229|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
161947464|NCT00755807|584860228|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
161947465|NCT00755807|584860229|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
161947466|NCT00755807|584860228|FG000|Open-label Extension Phase|Sponsor Decision|0|||
161947467|NCT00755807|584860229|FG001|Open-label Extension Phase|Sponsor Decision|1|||
161947468|NCT00939107|584860230|FG000|Overall Study|Lost to Follow-up|14|||
161947469|NCT00939107|584860231|FG001|Overall Study|Lost to Follow-up|12|||
161947470|NCT01585025|584860238|FG000|Overall Study|Withdrawal by Subject|0|||
161947471|NCT01585025|584860239|FG001|Overall Study|Withdrawal by Subject|3|||
161947472|NCT01585025|584860240|FG002|Overall Study|Withdrawal by Subject|4|||
161947473|NCT00503984|584860241|FG000|Overall Study|Protocol Violation|0|||
161947474|NCT00503984|584860242|FG001|Overall Study|Protocol Violation|1|||
161947475|NCT00503984|584860243|FG002|Overall Study|Protocol Violation|0|||
161947476|NCT00503984|584860244|FG003|Overall Study|Protocol Violation|0|||
161947477|NCT00503984|584860245|FG004|Overall Study|Protocol Violation|0|||
161947478|NCT00503984|584860246|FG005|Overall Study|Protocol Violation|0|||
161947479|NCT00503984|584860241|FG000|Overall Study|Adverse Event|0|||
161947480|NCT00503984|584860242|FG001|Overall Study|Adverse Event|1|||
161947481|NCT00503984|584860243|FG002|Overall Study|Adverse Event|0|||
161947482|NCT00503984|584860244|FG003|Overall Study|Adverse Event|0|||
161947483|NCT00503984|584860245|FG004|Overall Study|Adverse Event|0|||
161947484|NCT00503984|584860246|FG005|Overall Study|Adverse Event|0|||
161947485|NCT00503984|584860241|FG000|Overall Study|Death|0|||
161947486|NCT00503984|584860242|FG001|Overall Study|Death|0|||
161947487|NCT00503984|584860243|FG002|Overall Study|Death|0|||
161947488|NCT00503984|584860244|FG003|Overall Study|Death|0|||
161947489|NCT00503984|584860245|FG004|Overall Study|Death|1|||
161947490|NCT00503984|584860246|FG005|Overall Study|Death|0|||
161947491|NCT02122380|584860249|FG000|First Intervention (30 Days)|Adverse Event|1|||
161947492|NCT02122380|584860250|FG001|First Intervention (30 Days)|Adverse Event|0|||
161947493|NCT02122380|584860249|FG000|First Intervention (30 Days)|Physician Decision|0|||
161947494|NCT02122380|584860250|FG001|First Intervention (30 Days)|Physician Decision|1|||
161947495|NCT02122380|584860249|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
161947496|NCT02122380|584860250|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
161947497|NCT02122380|584860249|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
161947498|NCT02122380|584860250|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
161947499|NCT02122380|584860249|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
161684302|NCT04773106|583897891|FG000|Overall Study|Death|1|||
161947500|NCT02122380|584860250|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
161947501|NCT00427011|584860252|FG000|Overall Study|Adverse Event|10|||
161947502|NCT00427011|584860252|FG000|Overall Study|Withdrawal by Subject|1|||
161947503|NCT00427011|584860252|FG000|Overall Study|Lack of Efficacy|2|||
161947504|NCT00427011|584860252|FG000|Overall Study|Other|12|||
161947505|NCT00952705|584860253|FG000|Overall Study|Lost to Follow-up|24|||
161947506|NCT00952705|584860254|FG001|Overall Study|Lost to Follow-up|8|||
161947507|NCT00952705|584860255|FG002|Overall Study|Lost to Follow-up|9|||
161947508|NCT00952705|584860253|FG000|Overall Study|Withdrawal by Subject|2|||
161947509|NCT00952705|584860254|FG001|Overall Study|Withdrawal by Subject|1|||
161947510|NCT00952705|584860255|FG002|Overall Study|Withdrawal by Subject|1|||
161947511|NCT00952705|584860253|FG000|Overall Study|Death|2|||
161947512|NCT00952705|584860254|FG001|Overall Study|Death|0|||
161947513|NCT00952705|584860255|FG002|Overall Study|Death|0|||
161947514|NCT00952705|584860253|FG000|Overall Study|Incarcerated post dose|5|||
161947515|NCT00952705|584860254|FG001|Overall Study|Incarcerated post dose|0|||
161947516|NCT00952705|584860255|FG002|Overall Study|Incarcerated post dose|0|||
161947517|NCT00952705|584860253|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
161947518|NCT00952705|584860254|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
161947519|NCT00952705|584860255|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
161947520|NCT01192126|584860256|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
161947521|NCT01192126|584860257|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
161947522|NCT01192126|584860256|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
161947523|NCT01192126|584860257|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
161947524|NCT00688467|584860258|FG000|Treatment Period 1|Adverse Event|2|||
161947525|NCT00688467|584860259|FG001|Treatment Period 1|Adverse Event|1|||
161947526|NCT00688467|584860258|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
161947527|NCT00688467|584860259|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
161947528|NCT00688467|584860258|FG000|Treatment Period 2|Protocol Violation|0|||
161947529|NCT00688467|584860259|FG001|Treatment Period 2|Protocol Violation|1|||
161947530|NCT00688467|584860258|FG000|Treatment Period 2|Adverse Event|0|||
161947531|NCT00688467|584860259|FG001|Treatment Period 2|Adverse Event|1|||
162027821|NCT00958438|585157284|FG000|Overall Study|Protocol Violation|3|||
162027822|NCT00958438|585157285|FG001|Overall Study|Protocol Violation|2|||
161947532|NCT02808897|584860260|FG000|Overall Study|Lost to Follow-up|9|||
162027823|NCT00958438|585157286|FG002|Overall Study|Protocol Violation|2|||
161947533|NCT02808897|584860261|FG001|Overall Study|Lost to Follow-up|11|||
161947534|NCT00002766|584860262|FG000|Overall Study|Withdrawal by Subject|0|||
162027824|NCT00958438|585157284|FG000|Overall Study|Withdrawal by Subject|4|||
161947535|NCT00002766|584860263|FG001|Overall Study|Withdrawal by Subject|1|||
161947536|NCT00002766|584860262|FG000|Overall Study|Patient Not Treated|1|||
161947537|NCT00002766|584860263|FG001|Overall Study|Patient Not Treated|2|||
161947538|NCT00002766|584860262|FG000|Overall Study|Adverse Event|1|||
161947539|NCT00002766|584860263|FG001|Overall Study|Adverse Event|1|||
161947540|NCT00002766|584860262|FG000|Overall Study|Protocol Violation|1|||
161947541|NCT00002766|584860263|FG001|Overall Study|Protocol Violation|0|||
161947542|NCT01847092|584860277|FG000|Overall Study|Adverse Event|12|||
161947543|NCT01847092|584860278|FG001|Overall Study|Adverse Event|3|||
161947544|NCT01847092|584860277|FG000|Overall Study|Withdrawal by Subject|5|||
162027825|NCT00958438|585157285|FG001|Overall Study|Withdrawal by Subject|2|||
162027826|NCT00958438|585157286|FG002|Overall Study|Withdrawal by Subject|1|||
162027827|NCT00958438|585157284|FG000|Overall Study|Adverse Event|0|||
162027828|NCT00958438|585157285|FG001|Overall Study|Adverse Event|3|||
162027829|NCT00958438|585157286|FG002|Overall Study|Adverse Event|0|||
162027830|NCT00958438|585157284|FG000|Overall Study|Physician Decision|1|||
162027831|NCT00958438|585157285|FG001|Overall Study|Physician Decision|0|||
161947545|NCT01847092|584860278|FG001|Overall Study|Withdrawal by Subject|5|||
162027832|NCT00958438|585157286|FG002|Overall Study|Physician Decision|1|||
162027833|NCT00958438|585157284|FG000|Overall Study|Other than specified above|2|||
161947546|NCT01847092|584860277|FG000|Overall Study|Protocol Specified|8|||
161947547|NCT01847092|584860278|FG001|Overall Study|Protocol Specified|0|||
162027834|NCT00958438|585157285|FG001|Overall Study|Other than specified above|3|||
162027835|NCT00958438|585157286|FG002|Overall Study|Other than specified above|2|||
162027836|NCT01185301|585157287|FG000|Overall Study|Adverse Event|3|||
162027837|NCT01185301|585157288|FG001|Overall Study|Adverse Event|0|||
162027838|NCT01185301|585157289|FG002|Overall Study|Adverse Event|2|||
162027839|NCT01185301|585157290|FG003|Overall Study|Adverse Event|3|||
162027840|NCT01185301|585157287|FG000|Overall Study|Withdrawal by Subject|7|||
162027841|NCT01185301|585157288|FG001|Overall Study|Withdrawal by Subject|5|||
162027842|NCT01185301|585157289|FG002|Overall Study|Withdrawal by Subject|2|||
162027843|NCT01185301|585157290|FG003|Overall Study|Withdrawal by Subject|3|||
162027844|NCT01185301|585157287|FG000|Overall Study|Lost to Follow-up|2|||
162027845|NCT01185301|585157288|FG001|Overall Study|Lost to Follow-up|0|||
162027846|NCT01185301|585157289|FG002|Overall Study|Lost to Follow-up|0|||
162027847|NCT01185301|585157290|FG003|Overall Study|Lost to Follow-up|1|||
162027848|NCT01185301|585157287|FG000|Overall Study|Other Reason|3|||
162027849|NCT01185301|585157288|FG001|Overall Study|Other Reason|2|||
162027850|NCT01185301|585157289|FG002|Overall Study|Other Reason|2|||
162027851|NCT01185301|585157290|FG003|Overall Study|Other Reason|2|||
162027852|NCT02683746|585157291|FG000|Overall Study|Adverse Event|3|||
162027853|NCT02683746|585157292|FG001|Overall Study|Adverse Event|2|||
162027854|NCT02683746|585157291|FG000|Overall Study|Lost to Follow-up|5|||
162027855|NCT02683746|585157292|FG001|Overall Study|Lost to Follow-up|6|||
162027856|NCT02683746|585157291|FG000|Overall Study|Withdrawal by Subject|6|||
162027857|NCT02683746|585157292|FG001|Overall Study|Withdrawal by Subject|5|||
162027858|NCT02683746|585157291|FG000|Overall Study|Physician Decision|2|||
162027859|NCT02683746|585157292|FG001|Overall Study|Physician Decision|1|||
162027860|NCT04987944|585157293|FG000|Overall Study|Adverse Event|0|||
162027861|NCT04987944|585157294|FG001|Overall Study|Adverse Event|1|||
162027862|NCT04987944|585157293|FG000|Overall Study|Withdrawal by Subject|0|||
162027863|NCT04987944|585157294|FG001|Overall Study|Withdrawal by Subject|1|||
162027864|NCT02946931|585157299|FG000|Overall Study|Did not require collection of CRFs|588|||
162027865|NCT02946931|585157299|FG000|Overall Study|Other than listed|37|||
162027866|NCT02946931|585157299|FG000|Overall Study|Discharge from hospital|118|||
162027867|NCT02946931|585157299|FG000|Overall Study|Adverse Event|81|||
162027868|NCT02946931|585157299|FG000|Overall Study|CRFs not valid|1|||
161947548|NCT01847092|584860277|FG000|Overall Study|Physician Decision|1|||
161947549|NCT01847092|584860278|FG001|Overall Study|Physician Decision|1|||
161832476|NCT00380692|584428400|FG000|Study Period II - Double Blind|Physician Decision|0|||
161832477|NCT00380692|584428401|FG001|Study Period II - Double Blind|Physician Decision|1|||
161832478|NCT00380692|584428400|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
161832479|NCT00380692|584428401|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
161832480|NCT00380692|584428400|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
161832481|NCT00380692|584428401|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
161832482|NCT00380692|584428400|FG000|Study Period III - Open Label|Adverse Event|5|||
161832483|NCT00380692|584428401|FG001|Study Period III - Open Label|Adverse Event|3|||
161832484|NCT00380692|584428400|FG000|Study Period III - Open Label|Protocol Violation|0|||
161832485|NCT00380692|584428401|FG001|Study Period III - Open Label|Protocol Violation|0|||
161832486|NCT00380692|584428400|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
161832487|NCT00380692|584428401|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
161832488|NCT00380692|584428400|FG000|Study Period III - Open Label|Physician Decision|0|||
161947550|NCT01847092|584860277|FG000|Overall Study|Protocol Violation|0|||
161947551|NCT01847092|584860278|FG001|Overall Study|Protocol Violation|2|||
161947552|NCT03604497|584860280|FG000|Overall Study|Protocol Violation|52|||
161947553|NCT00811954|584860281|FG000|Overall Study|Death|10|||
161684303|NCT02819635|583897892|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
161832489|NCT00380692|584428401|FG001|Study Period III - Open Label|Physician Decision|3|||
161832490|NCT00380692|584428400|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
161947554|NCT00811954|584860282|FG001|Overall Study|Death|6|||
161947555|NCT00811954|584860283|FG002|Overall Study|Death|13|||
161947556|NCT00811954|584860281|FG000|Overall Study|Lost to Follow-up|29|||
161947557|NCT00811954|584860282|FG001|Overall Study|Lost to Follow-up|23|||
161947558|NCT00811954|584860283|FG002|Overall Study|Lost to Follow-up|34|||
161947559|NCT00811954|584860281|FG000|Overall Study|Not able to get to clinic|28|||
161947560|NCT00811954|584860282|FG001|Overall Study|Not able to get to clinic|35|||
161947561|NCT00811954|584860283|FG002|Overall Study|Not able to get to clinic|30|||
161832491|NCT00380692|584428401|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
161832492|NCT00380692|584428400|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
161832493|NCT00380692|584428401|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
161832494|NCT00107042|584428402|FG000|Overall Study|Lost to Follow-up|9|||
161832495|NCT00107042|584428403|FG001|Overall Study|Lost to Follow-up|7|||
161947562|NCT00811954|584860281|FG000|Overall Study|Not willing to adhere to requirements|12|||
161947563|NCT00811954|584860282|FG001|Overall Study|Not willing to adhere to requirements|2|||
161947564|NCT00811954|584860283|FG002|Overall Study|Not willing to adhere to requirements|16|||
161947565|NCT00811954|584860281|FG000|Overall Study|Withdraw consent prior study completion|4|||
161947566|NCT00811954|584860282|FG001|Overall Study|Withdraw consent prior study completion|6|||
161947567|NCT00811954|584860283|FG002|Overall Study|Withdraw consent prior study completion|5|||
161832496|NCT00107042|584428402|FG000|Overall Study|Withdrawal by Subject|6|||
161832497|NCT00107042|584428403|FG001|Overall Study|Withdrawal by Subject|1|||
161832498|NCT00107042|584428402|FG000|Overall Study|Moved out of area|5|||
161947568|NCT00811954|584860281|FG000|Overall Study|Site Closure|4|||
161947569|NCT00811954|584860282|FG001|Overall Study|Site Closure|0|||
161947570|NCT00811954|584860283|FG002|Overall Study|Site Closure|1|||
161832499|NCT00107042|584428403|FG001|Overall Study|Moved out of area|3|||
161832500|NCT00107042|584428402|FG000|Overall Study|Pregnancy|1|||
161832501|NCT00107042|584428403|FG001|Overall Study|Pregnancy|1|||
161832502|NCT00107042|584428402|FG000|Overall Study|Inadvertent enrollment|0|||
161832503|NCT00107042|584428403|FG001|Overall Study|Inadvertent enrollment|1|||
161832504|NCT00107042|584428402|FG000|Overall Study|vaccinated outside window|1|||
161947571|NCT00811954|584860281|FG000|Overall Study|Severe Debilitation|2|||
161832505|NCT00107042|584428403|FG001|Overall Study|vaccinated outside window|1|||
161832506|NCT00107042|584428402|FG000|Overall Study|Disallowed medications|0|||
161832507|NCT00107042|584428403|FG001|Overall Study|Disallowed medications|2|||
161832508|NCT00708708|584428404|FG000|Overall Study|Another therapy instead of Enbrel|141|||
161832509|NCT00708708|584428404|FG000|Overall Study|Lost to Follow-up|52|||
161832510|NCT00708708|584428404|FG000|Overall Study|Withdrawal by Subject|51|||
161832511|NCT00708708|584428404|FG000|Overall Study|Intolerance|42|||
161947572|NCT00811954|584860282|FG001|Overall Study|Severe Debilitation|0|||
161947573|NCT00811954|584860283|FG002|Overall Study|Severe Debilitation|1|||
161947574|NCT00811954|584860281|FG000|Overall Study|Complete Protocol: No follow-up|0|||
161947575|NCT00811954|584860282|FG001|Overall Study|Complete Protocol: No follow-up|0|||
161947576|NCT00811954|584860283|FG002|Overall Study|Complete Protocol: No follow-up|1|||
161947577|NCT00945659|584860287|FG000|Overall Study|Lost to Follow-up|7|||
161947578|NCT00945659|584860288|FG001|Overall Study|Lost to Follow-up|20|||
161947579|NCT00945659|584860289|FG002|Overall Study|Lost to Follow-up|17|||
161947580|NCT00658541|584860290|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
161947581|NCT00658541|584860291|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161947582|NCT00658541|584860290|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161947583|NCT00658541|584860291|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161947584|NCT04828707|584860292|FG000|Overall Study|Lost to Follow-up|3|||
161947585|NCT04828707|584860293|FG001|Overall Study|Lost to Follow-up|2|||
161947586|NCT04828707|584860292|FG000|Overall Study|Withdrawal by Subject|2|||
161947587|NCT04828707|584860293|FG001|Overall Study|Withdrawal by Subject|1|||
161947588|NCT01570387|584860295|FG000|Overall Study|Adverse Event|1|||
161947589|NCT01570387|584860296|FG001|Overall Study|Adverse Event|0|||
161947590|NCT01570387|584860297|FG002|Overall Study|Adverse Event|0|||
161947591|NCT01570387|584860298|FG003|Overall Study|Adverse Event|0|||
161947592|NCT01570387|584860295|FG000|Overall Study|Death|0|||
161947593|NCT01570387|584860296|FG001|Overall Study|Death|0|||
161947594|NCT01570387|584860297|FG002|Overall Study|Death|0|||
161947595|NCT01570387|584860298|FG003|Overall Study|Death|1|||
161947596|NCT01570387|584860295|FG000|Overall Study|Withdrawal by Subject|0|||
161947597|NCT01570387|584860296|FG001|Overall Study|Withdrawal by Subject|0|||
161947598|NCT01570387|584860297|FG002|Overall Study|Withdrawal by Subject|0|||
161947599|NCT01570387|584860298|FG003|Overall Study|Withdrawal by Subject|1|||
161947600|NCT01876381|584860299|FG000|Overall Study|Lack of Efficacy|5|||
161947601|NCT01876381|584860299|FG000|Overall Study|Physician Decision|1|||
161947602|NCT01876381|584860299|FG000|Overall Study|Withdrawal by Subject|1|||
161947603|NCT00654732|584860303|FG000|Overall Study|Adverse Event|4|||
161947604|NCT00654732|584860304|FG001|Overall Study|Adverse Event|6|||
161947605|NCT00518180|584860308|FG000|Overall Study|Withdrawal by Subject|29|||
161947606|NCT00518180|584860309|FG001|Overall Study|Withdrawal by Subject|30|||
161947607|NCT00518180|584860310|FG002|Overall Study|Withdrawal by Subject|42|||
161947608|NCT00518180|584860308|FG000|Overall Study|Lost to Follow-up|30|||
161947609|NCT00518180|584860309|FG001|Overall Study|Lost to Follow-up|28|||
161947610|NCT00518180|584860310|FG002|Overall Study|Lost to Follow-up|34|||
161947611|NCT00518180|584860308|FG000|Overall Study|Administrative reason|0|||
161947612|NCT00518180|584860309|FG001|Overall Study|Administrative reason|2|||
161947613|NCT00518180|584860310|FG002|Overall Study|Administrative reason|2|||
162027869|NCT02946931|585157299|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
162027870|NCT00869778|585157303|FG000|Overall Study|Adverse Event|2|||
162027871|NCT00869778|585157304|FG001|Overall Study|Adverse Event|0|||
162027872|NCT00869778|585157305|FG002|Overall Study|Adverse Event|0|||
162027873|NCT00869778|585157303|FG000|Overall Study|Withdrawal by Subject|3|||
162027874|NCT00869778|585157304|FG001|Overall Study|Withdrawal by Subject|4|||
162027875|NCT00869778|585157305|FG002|Overall Study|Withdrawal by Subject|5|||
162027876|NCT00869778|585157303|FG000|Overall Study|Pregnancy|1|||
162027877|NCT00869778|585157304|FG001|Overall Study|Pregnancy|0|||
162027878|NCT00869778|585157305|FG002|Overall Study|Pregnancy|0|||
162027879|NCT00869778|585157303|FG000|Overall Study|Protocol Violation|5|||
162027880|NCT00869778|585157304|FG001|Overall Study|Protocol Violation|3|||
162027881|NCT00869778|585157305|FG002|Overall Study|Protocol Violation|5|||
162027882|NCT00869778|585157303|FG000|Overall Study|Unblinding|1|||
162027883|NCT00869778|585157304|FG001|Overall Study|Unblinding|0|||
162027884|NCT00869778|585157305|FG002|Overall Study|Unblinding|0|||
162027885|NCT03339297|585157306|FG000|Overall Study|Relapse of Hematologic Disease|1|||
162027886|NCT03339297|585157307|FG001|Overall Study|Relapse of Hematologic Disease|0|||
162027887|NCT03339297|585157306|FG000|Overall Study|Death|10|||
162027888|NCT03339297|585157307|FG001|Overall Study|Death|7|||
162027889|NCT03339297|585157306|FG000|Overall Study|Hepatic Candidosis|1|||
162027890|NCT03339297|585157307|FG001|Overall Study|Hepatic Candidosis|0|||
162027891|NCT03339297|585157306|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
162027892|NCT03339297|585157307|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
162027893|NCT03339297|585157306|FG000|Overall Study|Consent Withdrawn by Participant|3|||
162027894|NCT03339297|585157307|FG001|Overall Study|Consent Withdrawn by Participant|3|||
162027895|NCT03339297|585157306|FG000|Overall Study|Disease Relapse|2|||
162027896|NCT03339297|585157307|FG001|Overall Study|Disease Relapse|0|||
162027897|NCT03339297|585157306|FG000|Overall Study|Physician Decision|1|||
162027898|NCT03339297|585157307|FG001|Overall Study|Physician Decision|1|||
162027899|NCT03339297|585157306|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
162027900|NCT03339297|585157307|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
162027901|NCT03339297|585157306|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
161947614|NCT00518180|584860308|FG000|Overall Study|Protocol Violation|5|||
161947615|NCT00518180|584860309|FG001|Overall Study|Protocol Violation|7|||
161947616|NCT00518180|584860310|FG002|Overall Study|Protocol Violation|4|||
162027902|NCT03339297|585157307|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
162027903|NCT03339297|585157306|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
162027904|NCT03339297|585157307|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
162027905|NCT03339297|585157306|FG000|Overall Study|Adverse Event, Non-fatal|1|||
162027906|NCT03339297|585157307|FG001|Overall Study|Adverse Event, Non-fatal|0|||
162027907|NCT03339297|585157306|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
161947617|NCT00518180|584860308|FG000|Overall Study|Unable to classify|0|||
161947618|NCT00518180|584860309|FG001|Overall Study|Unable to classify|2|||
161947619|NCT00518180|584860310|FG002|Overall Study|Unable to classify|0|||
161947620|NCT00518180|584860308|FG000|Overall Study|Adverse Event|1|||
161947621|NCT00518180|584860309|FG001|Overall Study|Adverse Event|0|||
161947622|NCT00518180|584860310|FG002|Overall Study|Adverse Event|0|||
161947623|NCT02951780|584860311|FG000|Period 1|Adverse Event|0|||
161947624|NCT02951780|584860312|FG001|Period 1|Adverse Event|0|||
161947625|NCT02951780|584860313|FG002|Period 1|Adverse Event|0|||
161947626|NCT02951780|584860314|FG003|Period 1|Adverse Event|1|||
161947627|NCT02951780|584860315|FG004|Period 1|Adverse Event|0|||
161947628|NCT02951780|584860316|FG005|Period 1|Adverse Event|0|||
161947629|NCT02951780|584860317|FG006|Period 1|Adverse Event|0|||
161947630|NCT02951780|584860318|FG007|Period 1|Adverse Event|0|||
161947631|NCT02951780|584860319|FG008|Period 1|Adverse Event|0|||
161947632|NCT02951780|584860311|FG000|Period 1|Scheduling Conflicts|0|||
161947633|NCT02951780|584860312|FG001|Period 1|Scheduling Conflicts|0|||
161947634|NCT02951780|584860313|FG002|Period 1|Scheduling Conflicts|0|||
161947635|NCT02951780|584860314|FG003|Period 1|Scheduling Conflicts|0|||
161947636|NCT02951780|584860315|FG004|Period 1|Scheduling Conflicts|0|||
161947637|NCT02951780|584860316|FG005|Period 1|Scheduling Conflicts|0|||
161947638|NCT02951780|584860317|FG006|Period 1|Scheduling Conflicts|0|||
161947639|NCT02951780|584860318|FG007|Period 1|Scheduling Conflicts|1|||
161947640|NCT02951780|584860319|FG008|Period 1|Scheduling Conflicts|0|||
161947641|NCT02951780|584860311|FG000|Period 2|Scheduling Conflicts|0|||
161947642|NCT02951780|584860312|FG001|Period 2|Scheduling Conflicts|0|||
161947643|NCT02951780|584860313|FG002|Period 2|Scheduling Conflicts|0|||
161947644|NCT02951780|584860314|FG003|Period 2|Scheduling Conflicts|0|||
161947645|NCT02951780|584860315|FG004|Period 2|Scheduling Conflicts|0|||
161947646|NCT02951780|584860316|FG005|Period 2|Scheduling Conflicts|0|||
161947647|NCT02951780|584860317|FG006|Period 2|Scheduling Conflicts|0|||
161947648|NCT02951780|584860318|FG007|Period 2|Scheduling Conflicts|1|||
161947649|NCT02951780|584860319|FG008|Period 2|Scheduling Conflicts|0|||
161947650|NCT00508482|584860320|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
161947651|NCT00508482|584860321|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
161947652|NCT00508482|584860322|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
161947653|NCT00508482|584860320|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
161947654|NCT00508482|584860321|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
161947655|NCT00508482|584860322|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
161947656|NCT00508482|584860320|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
161947657|NCT00508482|584860321|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
161947658|NCT00508482|584860322|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
161947659|NCT00546481|584860323|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
161947660|NCT00546481|584860324|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
161947661|NCT00546481|584860325|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
161947662|NCT00546481|584860323|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
161947663|NCT00546481|584860324|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
161947664|NCT00546481|584860325|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
161947665|NCT00546481|584860323|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
161947666|NCT00546481|584860324|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
161947667|NCT00546481|584860325|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
161947668|NCT00546481|584860323|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
161947669|NCT00546481|584860324|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
161947670|NCT00546481|584860325|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
161947671|NCT00546481|584860323|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
161947672|NCT00546481|584860324|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
161947673|NCT00546481|584860325|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
161947674|NCT00546481|584860323|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
161947675|NCT00546481|584860324|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
161947676|NCT00546481|584860325|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
162027908|NCT03339297|585157307|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
162027909|NCT03339297|585157306|FG000|Overall Study|Patient Was Not Eligible|1|||
162027910|NCT03339297|585157307|FG001|Overall Study|Patient Was Not Eligible|0|||
162027911|NCT03726996|585157310|FG000|Overall Study|Parent's decision|2|||
162027912|NCT03726996|585157310|FG000|Overall Study|Study early termination|2|||
162027913|NCT03051620|585157315|FG000|Overall Study|Lost to Follow-up|6|||
162027914|NCT03051620|585157315|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
162027915|NCT00393510|585157316|FG000|Overall Study|Physician Decision|3|||
162027916|NCT00393510|585157317|FG001|Overall Study|Physician Decision|9|||
162027917|NCT02412488|585157318|FG000|Overall Study|Lost to Follow-up|10|||
162027918|NCT02412488|585157318|FG000|Overall Study|Withdrawal by Subject|5|||
162027919|NCT02412488|585157318|FG000|Overall Study|Physician Decision|1|||
162027920|NCT02412488|585157318|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
162027921|NCT02412488|585157318|FG000|Overall Study|Reveal LINQ explant|1|||
162027922|NCT00674154|585157319|FG000|Overall Study|Withdrawal by Subject|3|||
162027923|NCT00674154|585157320|FG001|Overall Study|Withdrawal by Subject|1|||
162027924|NCT00674154|585157319|FG000|Overall Study|Did not want parathyroidectomy|0|||
162027925|NCT00674154|585157320|FG001|Overall Study|Did not want parathyroidectomy|2|||
161684304|NCT02819635|583897893|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
161684305|NCT02819635|583897894|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
161684306|NCT02819635|583897895|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
161684307|NCT02819635|583897896|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
161684308|NCT02819635|583897897|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
161684309|NCT02819635|583897898|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
161684310|NCT02819635|583897899|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161684311|NCT02819635|583897900|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161684312|NCT02819635|583897901|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161684313|NCT02819635|583897902|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161684314|NCT02819635|583897903|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161684315|NCT02819635|583897892|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684316|NCT02819635|583897893|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684317|NCT02819635|583897894|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684318|NCT02819635|583897895|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684319|NCT02819635|583897896|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
161684320|NCT02819635|583897897|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
161684321|NCT02819635|583897898|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
161684322|NCT02819635|583897899|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684323|NCT02819635|583897900|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684324|NCT02819635|583897901|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684325|NCT02819635|583897902|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684326|NCT02819635|583897903|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161684327|NCT02819635|583897892|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684328|NCT02819635|583897893|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684329|NCT02819635|583897894|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684330|NCT02819635|583897895|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684331|NCT02819635|583897896|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684332|NCT02819635|583897897|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
161684333|NCT02819635|583897898|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
161684334|NCT02819635|583897899|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684335|NCT02819635|583897900|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684336|NCT02819635|583897901|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684337|NCT02819635|583897902|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684338|NCT02819635|583897903|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161684339|NCT02819635|583897892|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684340|NCT02819635|583897893|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684341|NCT02819635|583897894|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684342|NCT02819635|583897895|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684343|NCT02819635|583897896|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684344|NCT02819635|583897897|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684345|NCT02819635|583897898|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
161684346|NCT02819635|583897899|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684347|NCT02819635|583897900|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684348|NCT02819635|583897901|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161832512|NCT00708708|584428404|FG000|Overall Study|Another therapy along with Enbrel|15|||
162027926|NCT00816023|585157321|FG000|Overall Study|Lost to Follow-up|1|||
162027927|NCT00816023|585157322|FG001|Overall Study|Lost to Follow-up|1|||
162027928|NCT00816023|585157323|FG002|Overall Study|Lost to Follow-up|0|||
162027929|NCT00816023|585157324|FG003|Overall Study|Lost to Follow-up|0|||
161947677|NCT00546481|584860323|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
161947678|NCT00546481|584860324|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
161947679|NCT00546481|584860325|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
161947680|NCT00546481|584860323|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
161947681|NCT00546481|584860324|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
161947682|NCT00546481|584860325|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
161832513|NCT00708708|584428404|FG000|Overall Study|Other unspecified|11|||
161832514|NCT00708708|584428404|FG000|Overall Study|Good effectiveness|9|||
161832515|NCT00708708|584428404|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
161832516|NCT00708708|584428404|FG000|Overall Study|Administrative reasons|7|||
161832517|NCT00708708|584428404|FG000|Overall Study|Lack of effectiveness|4|||
161832518|NCT00708708|584428404|FG000|Overall Study|Lack of compliance|3|||
161832519|NCT00708708|584428404|FG000|Overall Study|Pregnancy|3|||
161832520|NCT00708708|584428404|FG000|Overall Study|Adverse Event|3|||
161832521|NCT00708708|584428404|FG000|Overall Study|Missing values|392|||
161684349|NCT02819635|583897902|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684350|NCT02819635|583897903|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161684351|NCT02819635|583897892|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
161684352|NCT02819635|583897893|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
161684353|NCT02819635|583897894|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
161684354|NCT02819635|583897895|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
161684355|NCT02819635|583897896|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
161684356|NCT02819635|583897897|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
161684357|NCT02819635|583897898|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
161832522|NCT00140413|584428405|FG000|Overall Study|Lost to Follow-up|1|||
161947683|NCT00546481|584860323|FG000|Maintenance Phase (CERA)|Other Reason|0|||
161947684|NCT00546481|584860324|FG001|Maintenance Phase (CERA)|Other Reason|0|||
161947685|NCT00546481|584860325|FG002|Maintenance Phase (CERA)|Other Reason|1|||
161684358|NCT02819635|583897899|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161684359|NCT02819635|583897900|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161684360|NCT02819635|583897901|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161832523|NCT00140413|584428406|FG001|Overall Study|Lost to Follow-up|0|||
161947686|NCT00244621|584860326|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161947687|NCT00244621|584860327|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161947688|NCT00244621|584860328|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
161947689|NCT00244621|584860326|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
162027930|NCT00816023|585157321|FG000|Overall Study|Withdrawal by Subject|1|||
162027931|NCT00816023|585157322|FG001|Overall Study|Withdrawal by Subject|0|||
162027932|NCT00816023|585157323|FG002|Overall Study|Withdrawal by Subject|0|||
162027933|NCT00816023|585157324|FG003|Overall Study|Withdrawal by Subject|0|||
161832524|NCT00140413|584428405|FG000|Overall Study|Withdrawal by Subject|2|||
161832525|NCT00140413|584428406|FG001|Overall Study|Withdrawal by Subject|0|||
161832526|NCT02459665|584428407|FG000|Overall Study|Withdrawal by Subject|0|||
161832527|NCT02459665|584428408|FG001|Overall Study|Withdrawal by Subject|1|||
161832528|NCT02459665|584428409|FG002|Overall Study|Withdrawal by Subject|1|||
161947690|NCT00244621|584860327|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
161947691|NCT00244621|584860328|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161832529|NCT02459665|584428410|FG003|Overall Study|Withdrawal by Subject|2|||
162027934|NCT00816023|585157321|FG000|Overall Study|Physician Decision|0|||
161832530|NCT00865098|584428414|FG000|Overall Study|Progressive disease|1|||
161832531|NCT01117337|584428431|FG000|Overall Study|Lost to Follow-up|4|||
161832532|NCT01117337|584428432|FG001|Overall Study|Lost to Follow-up|0|||
161832533|NCT05444556|584428433|FG000|Overall Study|Withdrawal by Subject|0|||
161832534|NCT05444556|584428434|FG001|Overall Study|Withdrawal by Subject|0|||
161832535|NCT05444556|584428435|FG002|Overall Study|Withdrawal by Subject|2|||
161832536|NCT05444556|584428436|FG003|Overall Study|Withdrawal by Subject|1|||
162027935|NCT00816023|585157322|FG001|Overall Study|Physician Decision|0|||
162027936|NCT00816023|585157323|FG002|Overall Study|Physician Decision|1|||
161832537|NCT02791893|584428438|FG000|Blinded Phase|Lost to Follow-up|2|||
162027937|NCT00816023|585157324|FG003|Overall Study|Physician Decision|0|||
161832538|NCT02791893|584428439|FG001|Blinded Phase|Lost to Follow-up|2|||
161684361|NCT02819635|583897902|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161684362|NCT02819635|583897903|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161684363|NCT02819635|583897892|FG000|Substudy 2, Part 2|Adverse Event|0|||
161832539|NCT02791893|584428438|FG000|Blinded Phase|Withdrawal by Subject|1|||
161947692|NCT00244621|584860326|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161684364|NCT02819635|583897893|FG001|Substudy 2, Part 2|Adverse Event|0|||
161947693|NCT00244621|584860327|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
161947694|NCT00244621|584860328|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
161947695|NCT00244621|584860326|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
161947696|NCT00244621|584860327|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
161947697|NCT00244621|584860328|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
161947698|NCT00244621|584860326|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
161947699|NCT00244621|584860327|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
161947700|NCT00244621|584860328|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
161947701|NCT00244621|584860326|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
161947702|NCT00244621|584860327|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161947703|NCT00244621|584860328|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
161947704|NCT00244621|584860326|FG000|Open-label Treatment Period|Adverse Event|0|||
161947705|NCT00244621|584860327|FG001|Open-label Treatment Period|Adverse Event|0|||
161947706|NCT00244621|584860328|FG002|Open-label Treatment Period|Adverse Event|1|||
161947707|NCT00244621|584860326|FG000|Open-label Treatment Period|Moved abroad|0|||
161947708|NCT00244621|584860327|FG001|Open-label Treatment Period|Moved abroad|0|||
161947709|NCT00244621|584860328|FG002|Open-label Treatment Period|Moved abroad|1|||
161947710|NCT01193101|584860332|FG000|Overall Study|Adverse Event|0|||
161947711|NCT01193101|584860333|FG001|Overall Study|Adverse Event|1|||
161947712|NCT01193101|584860334|FG002|Overall Study|Adverse Event|1|||
161947713|NCT01193101|584860335|FG003|Overall Study|Adverse Event|3|||
161947714|NCT01193101|584860332|FG000|Overall Study|Lack of Efficacy|3|||
161832540|NCT02791893|584428439|FG001|Blinded Phase|Withdrawal by Subject|2|||
161832541|NCT02791893|584428438|FG000|Open Label Phase|Lost to Follow-up|3|||
161832542|NCT02791893|584428439|FG001|Open Label Phase|Lost to Follow-up|0|||
161832543|NCT02791893|584428438|FG000|Open Label Phase|Withdrawal by Subject|0|||
161832544|NCT02791893|584428439|FG001|Open Label Phase|Withdrawal by Subject|2|||
161832545|NCT04319159|584428445|FG000|Overall Study|Screening failure|13|||
161832546|NCT04319159|584428445|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
161832547|NCT04319159|584428445|FG000|Overall Study|Withdrawal by Subject|1|||
161832548|NCT05575063|584428453|FG000|Overall Study|Withdrawal by Subject|1|||
161832549|NCT00949988|584428458|FG000|Overall Study|Withdrawal by Subject|3|||
161832550|NCT00396331|584428461|FG000|Overall Study|Failed to mobilize - no transplant|8|||
161832551|NCT00396331|584428461|FG000|Overall Study|Did not go on to transplant|5|||
161947715|NCT01193101|584860333|FG001|Overall Study|Lack of Efficacy|1|||
162027938|NCT00816023|585157321|FG000|Overall Study|assessments complete prior to window|1|||
162027939|NCT00816023|585157322|FG001|Overall Study|assessments complete prior to window|1|||
162027940|NCT00816023|585157323|FG002|Overall Study|assessments complete prior to window|2|||
162027941|NCT00816023|585157324|FG003|Overall Study|assessments complete prior to window|1|||
162027942|NCT00816023|585157321|FG000|Overall Study|Randomized Not Treated|6|||
162027943|NCT00816023|585157322|FG001|Overall Study|Randomized Not Treated|4|||
162027944|NCT00816023|585157323|FG002|Overall Study|Randomized Not Treated|6|||
162027945|NCT00816023|585157324|FG003|Overall Study|Randomized Not Treated|11|||
161832552|NCT00396331|584428461|FG000|Overall Study|Lost to Follow-up|3|||
161684365|NCT02819635|583897894|FG002|Substudy 2, Part 2|Adverse Event|0|||
161684366|NCT02819635|583897895|FG003|Substudy 2, Part 2|Adverse Event|0|||
161684367|NCT02819635|583897896|FG004|Substudy 2, Part 2|Adverse Event|0|||
161684368|NCT02819635|583897897|FG005|Substudy 2, Part 2|Adverse Event|4|||
161684369|NCT02819635|583897898|FG006|Substudy 2, Part 2|Adverse Event|0|||
161684370|NCT02819635|583897899|FG007|Substudy 2, Part 2|Adverse Event|0|||
161832553|NCT00396331|584428461|FG000|Overall Study|Death|16|||
161947716|NCT01193101|584860334|FG002|Overall Study|Lack of Efficacy|0|||
161947717|NCT01193101|584860335|FG003|Overall Study|Lack of Efficacy|8|||
161947718|NCT01193101|584860332|FG000|Overall Study|Withdrawal by Subject|2|||
161947719|NCT01193101|584860333|FG001|Overall Study|Withdrawal by Subject|4|||
161947720|NCT01193101|584860334|FG002|Overall Study|Withdrawal by Subject|1|||
161947721|NCT01193101|584860335|FG003|Overall Study|Withdrawal by Subject|1|||
161947722|NCT01193101|584860332|FG000|Overall Study|Administrative problems|0|||
161947723|NCT01193101|584860333|FG001|Overall Study|Administrative problems|0|||
161947724|NCT01193101|584860334|FG002|Overall Study|Administrative problems|1|||
161947725|NCT01193101|584860335|FG003|Overall Study|Administrative problems|0|||
161947726|NCT01193101|584860332|FG000|Overall Study|Abnormal test procedure results|0|||
161947727|NCT01193101|584860333|FG001|Overall Study|Abnormal test procedure results|1|||
161947728|NCT01193101|584860334|FG002|Overall Study|Abnormal test procedure results|0|||
161947729|NCT01193101|584860335|FG003|Overall Study|Abnormal test procedure results|0|||
161947730|NCT02347085|584860336|FG000|Overall Study|Adverse Event|2|||
161947731|NCT02347085|584860336|FG000|Overall Study|Lack of Efficacy|1|||
161947732|NCT02347085|584860336|FG000|Overall Study|Withdrawal by Subject|4|||
161947733|NCT02347085|584860336|FG000|Overall Study|Lost to Follow-up|1|||
161947734|NCT02347085|584860336|FG000|Overall Study|Protocol Criteria|2|||
161947735|NCT01957865|584860338|FG000|Overall Study|Found HIV negative|0|||
161947736|NCT01957865|584860339|FG001|Overall Study|Found HIV negative|0|||
161947737|NCT01957865|584860340|FG002|Overall Study|Found HIV negative|1|||
161947738|NCT01957865|584860338|FG000|Overall Study|Lost to Follow-up|0|||
161947739|NCT01957865|584860339|FG001|Overall Study|Lost to Follow-up|2|||
161947740|NCT01957865|584860340|FG002|Overall Study|Lost to Follow-up|2|||
161947741|NCT01082614|584860341|FG000|Overall Study|Adverse Event|1|||
161947742|NCT01082614|584860342|FG001|Overall Study|Adverse Event|4|||
161947743|NCT01082614|584860341|FG000|Overall Study|Equipment Malfunction|0|||
161947744|NCT01082614|584860342|FG001|Overall Study|Equipment Malfunction|1|||
161947745|NCT01082614|584860341|FG000|Overall Study|Physician Decision|2|||
161947746|NCT01082614|584860342|FG001|Overall Study|Physician Decision|0|||
161947747|NCT00811720|584860343|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
161947748|NCT00811720|584860344|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
161947749|NCT00811720|584860343|FG000|All Treated Patients|Adverse Event|20|||
161947750|NCT00811720|584860344|FG001|All Treated Patients|Adverse Event|62|||
161947751|NCT00811720|584860343|FG000|All Treated Patients|Lack of Efficacy|22|||
161947752|NCT00811720|584860344|FG001|All Treated Patients|Lack of Efficacy|18|||
161947753|NCT00811720|584860343|FG000|All Treated Patients|Non-compliance|0|||
161947754|NCT00811720|584860344|FG001|All Treated Patients|Non-compliance|14|||
161947755|NCT00811720|584860343|FG000|All Treated Patients|Protocol Violation|9|||
161947756|NCT00811720|584860344|FG001|All Treated Patients|Protocol Violation|16|||
161947757|NCT00811720|584860343|FG000|All Treated Patients|Withdrawal by Subject|28|||
161947758|NCT00811720|584860344|FG001|All Treated Patients|Withdrawal by Subject|34|||
161947759|NCT00811720|584860343|FG000|All Treated Patients|Lost to Follow-up|10|||
161947760|NCT00811720|584860344|FG001|All Treated Patients|Lost to Follow-up|16|||
161947761|NCT00811720|584860343|FG000|All Treated Patients|Other Reason|7|||
161947762|NCT00811720|584860344|FG001|All Treated Patients|Other Reason|4|||
161947763|NCT00950651|584860348|FG000|Overall Study|Adverse Event|17|||
161947764|NCT00950651|584860349|FG001|Overall Study|Adverse Event|20|||
161947765|NCT00950651|584860348|FG000|Overall Study|Death|1|||
161947766|NCT00950651|584860349|FG001|Overall Study|Death|0|||
161947767|NCT00950651|584860348|FG000|Overall Study|Lack of Efficacy|2|||
161947768|NCT00950651|584860349|FG001|Overall Study|Lack of Efficacy|2|||
161947769|NCT00950651|584860348|FG000|Overall Study|Protocol Violation|3|||
161947770|NCT00950651|584860349|FG001|Overall Study|Protocol Violation|4|||
161947771|NCT00950651|584860348|FG000|Overall Study|Withdrawal by Subject|8|||
161947772|NCT00950651|584860349|FG001|Overall Study|Withdrawal by Subject|9|||
161947773|NCT03783780|584860354|FG000|Overall Study|Withdrawn prior to completion|1|||
161947774|NCT03768427|584860355|FG000|Overall Study|Death|0|||
161947775|NCT03768427|584860356|FG001|Overall Study|Death|0|||
161947776|NCT03768427|584860357|FG002|Overall Study|Death|1|||
161947777|NCT03768427|584860358|FG003|Overall Study|Death|0|||
161947778|NCT03768427|584860355|FG000|Overall Study|Lost to Follow-up|2|||
161947779|NCT03768427|584860356|FG001|Overall Study|Lost to Follow-up|0|||
161947780|NCT03768427|584860357|FG002|Overall Study|Lost to Follow-up|0|||
161947781|NCT03768427|584860358|FG003|Overall Study|Lost to Follow-up|0|||
161947782|NCT03768427|584860355|FG000|Overall Study|Physician Decision|3|||
161947783|NCT03768427|584860356|FG001|Overall Study|Physician Decision|2|||
161947784|NCT03768427|584860357|FG002|Overall Study|Physician Decision|4|||
161947785|NCT03768427|584860358|FG003|Overall Study|Physician Decision|4|||
161947786|NCT03768427|584860355|FG000|Overall Study|Withdrawal by Subject|7|||
161684371|NCT02819635|583897900|FG008|Substudy 2, Part 2|Adverse Event|0|||
161947787|NCT03768427|584860356|FG001|Overall Study|Withdrawal by Subject|2|||
161947788|NCT03768427|584860357|FG002|Overall Study|Withdrawal by Subject|6|||
161947789|NCT03768427|584860358|FG003|Overall Study|Withdrawal by Subject|7|||
161947790|NCT03710889|584860361|FG000|Overall Study|Adverse Event|2|||
161947791|NCT03710889|584860361|FG000|Overall Study|Protocol Deviation|1|||
161947792|NCT02121509|584860365|FG000|Washout Period (35 Days)|Adverse Event|1|||
161947793|NCT02121509|584860366|FG001|Washout Period (35 Days)|Adverse Event|1|||
161947794|NCT02121509|584860367|FG002|Washout Period (35 Days)|Adverse Event|0|||
161947795|NCT02121509|584860368|FG003|Washout Period (35 Days)|Adverse Event|0|||
161947796|NCT02121509|584860365|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
161947797|NCT02121509|584860366|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
161947798|NCT02121509|584860367|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
161947799|NCT02121509|584860368|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
161947800|NCT02121509|584860365|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
161947801|NCT02121509|584860366|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
161947802|NCT02121509|584860367|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
161947803|NCT02121509|584860368|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
161947804|NCT00867035|584860369|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
161947805|NCT00867035|584860370|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
161947806|NCT00867035|584860369|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
161947807|NCT00867035|584860370|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
161947808|NCT02993263|584860372|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
161947809|NCT00542178|584860373|FG000|Overall Study|did not complete year 4 follow-up|75|||
161947810|NCT00542178|584860374|FG001|Overall Study|did not complete year 4 follow-up|80|||
161947811|NCT00542178|584860375|FG002|Overall Study|did not complete year 4 follow-up|74|||
161947812|NCT00542178|584860376|FG003|Overall Study|did not complete year 4 follow-up|62|||
161947813|NCT00542178|584860377|FG004|Overall Study|did not complete year 4 follow-up|64|||
161947814|NCT00542178|584860378|FG005|Overall Study|did not complete year 4 follow-up|89|||
161947815|NCT00542178|584860379|FG006|Overall Study|did not complete year 4 follow-up|87|||
161947816|NCT00542178|584860380|FG007|Overall Study|did not complete year 4 follow-up|85|||
161947817|NCT00829998|584860381|FG000|Washout|Adverse Event|0|||
161947818|NCT00829998|584860382|FG001|Washout|Adverse Event|1|||
161947819|NCT01173679|584861984|FG000|Overall Study|Death|1|||
161947820|NCT02026011|584861985|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
161947821|NCT02026011|584861986|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
161947822|NCT02026011|584861985|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
161947823|NCT02026011|584861986|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
161947824|NCT02026011|584861985|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
161947825|NCT02026011|584861986|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
161947826|NCT02026011|584861985|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
161947827|NCT02026011|584861986|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
161947828|NCT05010070|584861987|FG000|Overall Study|Lost to Follow-up|1|||
161947829|NCT05010070|584861987|FG000|Overall Study|Withdrawal by Subject|1|||
161947830|NCT00441272|584861988|FG000|Overall Study|Study terminated prior to enrollment|25|||
161947831|NCT00441272|584861989|FG001|Overall Study|Study terminated prior to enrollment|25|||
161947832|NCT02921789|584861990|FG000|Overall Study|Adverse Event|0|||
161947833|NCT02921789|584861991|FG001|Overall Study|Adverse Event|1|||
161947834|NCT02921789|584861990|FG000|Overall Study|Lost to Follow-up|1|||
161947835|NCT02921789|584861991|FG001|Overall Study|Lost to Follow-up|0|||
161947836|NCT02921789|584861990|FG000|Overall Study|Protocol Deviation|2|||
161947837|NCT02921789|584861991|FG001|Overall Study|Protocol Deviation|0|||
161947838|NCT02921789|584861990|FG000|Overall Study|Withdrawal by Subject|2|||
161947839|NCT02921789|584861991|FG001|Overall Study|Withdrawal by Subject|1|||
161947840|NCT02921789|584861990|FG000|Overall Study|Miscellaneous|3|||
161947841|NCT02921789|584861991|FG001|Overall Study|Miscellaneous|2|||
161947842|NCT01944020|584861992|FG000|Overall Study|Withdrawal by Subject|5|||
161947843|NCT01944020|584861993|FG001|Overall Study|Withdrawal by Subject|0|||
161947844|NCT01669902|584861994|FG000|Overall Study|Adverse Event|11|||
161947845|NCT01669902|584861994|FG000|Overall Study|Lack of Efficacy|10|||
161947846|NCT01669902|584861994|FG000|Overall Study|Other|8|||
161947847|NCT02391311|584862001|FG000|Overall Study|Lost to Follow-up|2|||
161947848|NCT02391311|584862002|FG001|Overall Study|Lost to Follow-up|1|||
161947849|NCT02391311|584862001|FG000|Overall Study|deemed ineligible after baseline|1|||
161947850|NCT02391311|584862002|FG001|Overall Study|deemed ineligible after baseline|1|||
161947851|NCT00305448|584862005|FG000|Overall Study|Protocol Violation|0|||
161947852|NCT00305448|584862006|FG001|Overall Study|Protocol Violation|1|||
161947853|NCT00305448|584862007|FG002|Overall Study|Protocol Violation|0|||
161947854|NCT00305448|584862005|FG000|Overall Study|Withdrawal by Subject|2|||
161947855|NCT00305448|584862006|FG001|Overall Study|Withdrawal by Subject|0|||
161832554|NCT00873119|584428468|FG000|Overall Study|Patient request|4|||
161832555|NCT00873119|584428469|FG001|Overall Study|Patient request|2|||
161832556|NCT00873119|584428468|FG000|Overall Study|Adverse Event|8|||
161947856|NCT00305448|584862007|FG002|Overall Study|Withdrawal by Subject|1|||
161947857|NCT00305448|584862005|FG000|Overall Study|Adverse Event|1|||
161947858|NCT00305448|584862006|FG001|Overall Study|Adverse Event|0|||
161947859|NCT00305448|584862007|FG002|Overall Study|Adverse Event|1|||
161947860|NCT00305448|584862005|FG000|Overall Study|Disease Progression|27|||
161947861|NCT00305448|584862006|FG001|Overall Study|Disease Progression|31|||
161947862|NCT00305448|584862007|FG002|Overall Study|Disease Progression|28|||
161947863|NCT00305448|584862005|FG000|Overall Study|Subjective Disease Progression|1|||
161947864|NCT00305448|584862006|FG001|Overall Study|Subjective Disease Progression|2|||
161947865|NCT00305448|584862007|FG002|Overall Study|Subjective Disease Progression|2|||
161947866|NCT00305448|584862005|FG000|Overall Study|Tumor Marker Elevation|0|||
161947867|NCT00305448|584862006|FG001|Overall Study|Tumor Marker Elevation|0|||
161947868|NCT00305448|584862007|FG002|Overall Study|Tumor Marker Elevation|1|||
161947869|NCT01343888|584862008|FG000|Overall Study|Adverse Event|12|||
161947870|NCT01343888|584862009|FG001|Overall Study|Adverse Event|22|||
161947871|NCT01343888|584862010|FG002|Overall Study|Adverse Event|5|||
161947872|NCT01343888|584862008|FG000|Overall Study|Lack of Efficacy|9|||
161947873|NCT01343888|584862009|FG001|Overall Study|Lack of Efficacy|9|||
161947874|NCT01343888|584862010|FG002|Overall Study|Lack of Efficacy|13|||
161947875|NCT01343888|584862008|FG000|Overall Study|Lost to Follow-up|0|||
161947876|NCT01343888|584862009|FG001|Overall Study|Lost to Follow-up|2|||
161947877|NCT01343888|584862010|FG002|Overall Study|Lost to Follow-up|1|||
161947878|NCT01343888|584862008|FG000|Overall Study|Protocol Violation|0|||
161947879|NCT01343888|584862009|FG001|Overall Study|Protocol Violation|2|||
161947880|NCT01343888|584862010|FG002|Overall Study|Protocol Violation|0|||
161947881|NCT01343888|584862008|FG000|Overall Study|Withdrawal by Subject|4|||
161947882|NCT01343888|584862009|FG001|Overall Study|Withdrawal by Subject|4|||
161947883|NCT01343888|584862010|FG002|Overall Study|Withdrawal by Subject|2|||
161947884|NCT01343888|584862008|FG000|Overall Study|other than stated above|0|||
161947885|NCT01343888|584862009|FG001|Overall Study|other than stated above|0|||
161947886|NCT01343888|584862010|FG002|Overall Study|other than stated above|1|||
161947887|NCT02154061|584862012|FG000|Overall Study|Pregnancy|1|||
161947888|NCT02154061|584862013|FG001|Overall Study|Pregnancy|0|||
161947889|NCT02154061|584862012|FG000|Overall Study|enrolled but not vaccinated|1|||
161947890|NCT02154061|584862013|FG001|Overall Study|enrolled but not vaccinated|0|||
161947891|NCT01936831|584862019|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161947892|NCT01936831|584862020|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161947893|NCT01936831|584862021|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161947894|NCT01936831|584862022|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161947895|NCT01936831|584862023|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161947896|NCT01936831|584862024|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
161947897|NCT01936831|584862025|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161947898|NCT01936831|584862026|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161947899|NCT01936831|584862027|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
161947900|NCT02133573|584862028|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
161947901|NCT02133573|584862029|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
161947902|NCT02133573|584862028|FG000|Overall Study|Child Deaths|3|||
161947903|NCT02133573|584862029|FG001|Overall Study|Child Deaths|5|||
161947904|NCT02133573|584862028|FG000|Overall Study|Child Declined Follow Ups|2|||
161947905|NCT02133573|584862029|FG001|Overall Study|Child Declined Follow Ups|1|||
161947906|NCT02133573|584862028|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
161947907|NCT02133573|584862029|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
161947908|NCT03848416|584862041|FG000|Overall Study|Withdrawal by Subject|1|||
161947909|NCT03848416|584862042|FG001|Overall Study|Withdrawal by Subject|0|||
161947910|NCT03848416|584862043|FG002|Overall Study|Withdrawal by Subject|0|||
161947911|NCT03848416|584862041|FG000|Overall Study|Death|0|||
161947912|NCT03848416|584862042|FG001|Overall Study|Death|0|||
161832557|NCT00873119|584428469|FG001|Overall Study|Adverse Event|0|||
161947913|NCT03848416|584862043|FG002|Overall Study|Death|1|||
161947914|NCT02808429|584862044|FG000|Overall Study|Lost to Follow-up|1|||
161947915|NCT02808429|584862045|FG001|Overall Study|Lost to Follow-up|0|||
161947916|NCT02808429|584862046|FG002|Overall Study|Lost to Follow-up|0|||
161947917|NCT02808429|584862044|FG000|Overall Study|Protocol Violation|0|||
161947918|NCT02808429|584862045|FG001|Overall Study|Protocol Violation|1|||
161947919|NCT02808429|584862046|FG002|Overall Study|Protocol Violation|0|||
161947920|NCT02808429|584862044|FG000|Overall Study|Premature study termination by sponsor|2|||
161947921|NCT02808429|584862045|FG001|Overall Study|Premature study termination by sponsor|0|||
161947922|NCT02808429|584862046|FG002|Overall Study|Premature study termination by sponsor|1|||
161947923|NCT02808429|584862044|FG000|Overall Study|Relocation|0|||
161947924|NCT02808429|584862045|FG001|Overall Study|Relocation|0|||
161947925|NCT02808429|584862046|FG002|Overall Study|Relocation|1|||
161947926|NCT01436110|584862047|FG000|Overall Study|Lack of Efficacy|23|||
161832558|NCT00873119|584428468|FG000|Overall Study|Progressive disease|26|||
162027946|NCT02034409|585157325|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
162027947|NCT02034409|585157326|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
162027948|NCT02034409|585157325|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
162027949|NCT02034409|585157326|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
162027950|NCT02034409|585157325|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
162027951|NCT02034409|585157326|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
162027952|NCT02034409|585157325|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
162027953|NCT02034409|585157326|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
162027954|NCT02034409|585157325|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
162027955|NCT02034409|585157326|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
162027956|NCT02034409|585157325|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
162027957|NCT02034409|585157326|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
162027958|NCT01699867|585157327|FG000|Overall Study|Screening Failure|3|||
162027959|NCT02342418|585157328|FG000|Overall Study|Adverse Event|0|||
162027960|NCT02342418|585157329|FG001|Overall Study|Adverse Event|1|||
162027961|NCT04255394|585157330|FG000|Overall Study|Death|35|||
162027962|NCT04255394|585157331|FG001|Overall Study|Death|25|||
162027963|NCT04255394|585157330|FG000|Overall Study|Device removed|2|||
162027964|NCT04255394|585157331|FG001|Overall Study|Device removed|10|||
162027965|NCT04255394|585157330|FG000|Overall Study|Withdrawal by Subject|9|||
162027966|NCT04255394|585157331|FG001|Overall Study|Withdrawal by Subject|8|||
162027967|NCT04255394|585157330|FG000|Overall Study|Screen Failure/Not treated|12|||
162027968|NCT04255394|585157331|FG001|Overall Study|Screen Failure/Not treated|8|||
162027969|NCT04255394|585157330|FG000|Overall Study|Lost to Follow-up|123|||
162027970|NCT04255394|585157331|FG001|Overall Study|Lost to Follow-up|265|||
162027971|NCT04255394|585157330|FG000|Overall Study|Adverse Event|1|||
162027972|NCT04255394|585157331|FG001|Overall Study|Adverse Event|3|||
162027973|NCT01525225|585157340|FG000|Enrollment|No longer met study criteria|1|||
162027974|NCT01525225|585157340|FG000|Enrollment|Other|1|||
162027975|NCT01182844|585157341|FG000|Overall Study|Withdrawal by Subject|0|||
162027976|NCT01182844|585157342|FG001|Overall Study|Withdrawal by Subject|2|||
162027977|NCT01379508|585157343|FG000|Treatment to Week 104|Adverse Event|2|||
162027978|NCT01379508|585157344|FG001|Treatment to Week 104|Adverse Event|0|||
162027979|NCT01379508|585157345|FG002|Treatment to Week 104|Adverse Event|5|||
162027980|NCT01379508|585157346|FG003|Treatment to Week 104|Adverse Event|0|||
162027981|NCT01379508|585157343|FG000|Treatment to Week 104|Abnormal lab value|1|||
162027982|NCT01379508|585157344|FG001|Treatment to Week 104|Abnormal lab value|0|||
162027983|NCT01379508|585157345|FG002|Treatment to Week 104|Abnormal lab value|0|||
162027984|NCT01379508|585157346|FG003|Treatment to Week 104|Abnormal lab value|0|||
162027985|NCT01379508|585157343|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
162027986|NCT01379508|585157344|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
162027987|NCT01379508|585157345|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
162027988|NCT01379508|585157346|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
162027989|NCT01379508|585157343|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
162027990|NCT01379508|585157344|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
162027991|NCT01379508|585157345|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
162027992|NCT01379508|585157346|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
162027993|NCT01379508|585157343|FG000|Treatment to Week 104|Lost to Follow-up|5|||
162027994|NCT01379508|585157344|FG001|Treatment to Week 104|Lost to Follow-up|0|||
162027995|NCT01379508|585157345|FG002|Treatment to Week 104|Lost to Follow-up|3|||
162027996|NCT01379508|585157346|FG003|Treatment to Week 104|Lost to Follow-up|0|||
162027997|NCT01379508|585157343|FG000|Treatment to Week 104|Administrative problems|3|||
162027998|NCT01379508|585157344|FG001|Treatment to Week 104|Administrative problems|1|||
162027999|NCT01379508|585157345|FG002|Treatment to Week 104|Administrative problems|0|||
162028000|NCT01379508|585157346|FG003|Treatment to Week 104|Administrative problems|0|||
162028001|NCT01379508|585157343|FG000|Treatment to Week 104|Protocol Violation|1|||
162028002|NCT01379508|585157344|FG001|Treatment to Week 104|Protocol Violation|1|||
162028003|NCT01379508|585157345|FG002|Treatment to Week 104|Protocol Violation|1|||
162028004|NCT01379508|585157346|FG003|Treatment to Week 104|Protocol Violation|0|||
162028005|NCT01379508|585157343|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
162028006|NCT01379508|585157344|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
162028007|NCT01379508|585157345|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
162028008|NCT01379508|585157346|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
162028009|NCT01379508|585157343|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
162028010|NCT01379508|585157344|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
162028011|NCT01379508|585157345|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
162028012|NCT01379508|585157346|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
162028013|NCT01379508|585157343|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
162028014|NCT01379508|585157344|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
162028015|NCT01379508|585157345|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
162028016|NCT01379508|585157346|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
161947927|NCT01436110|584862048|FG001|Overall Study|Lack of Efficacy|14|||
161947928|NCT01436110|584862049|FG002|Overall Study|Lack of Efficacy|9|||
161947929|NCT01436110|584862047|FG000|Overall Study|Withdrawal by Subject|6|||
161947930|NCT01436110|584862048|FG001|Overall Study|Withdrawal by Subject|8|||
161947931|NCT01436110|584862049|FG002|Overall Study|Withdrawal by Subject|4|||
161947932|NCT01436110|584862047|FG000|Overall Study|Adverse Event|2|||
161947933|NCT01436110|584862048|FG001|Overall Study|Adverse Event|1|||
161947934|NCT01436110|584862049|FG002|Overall Study|Adverse Event|2|||
161947935|NCT01436110|584862047|FG000|Overall Study|Physician Decision|3|||
161947936|NCT01436110|584862048|FG001|Overall Study|Physician Decision|1|||
161947937|NCT01436110|584862049|FG002|Overall Study|Physician Decision|1|||
161947938|NCT01436110|584862047|FG000|Overall Study|Lost to Follow-up|1|||
161947939|NCT01436110|584862048|FG001|Overall Study|Lost to Follow-up|1|||
161947940|NCT01436110|584862049|FG002|Overall Study|Lost to Follow-up|3|||
161947941|NCT01436110|584862047|FG000|Overall Study|Protocol Violation|3|||
161947942|NCT01436110|584862048|FG001|Overall Study|Protocol Violation|1|||
161947943|NCT01436110|584862049|FG002|Overall Study|Protocol Violation|1|||
161947944|NCT01436110|584862047|FG000|Overall Study|Did Not Receive Trial Medication|1|||
161947945|NCT01436110|584862048|FG001|Overall Study|Did Not Receive Trial Medication|0|||
161947946|NCT01436110|584862049|FG002|Overall Study|Did Not Receive Trial Medication|3|||
161947947|NCT00110214|584862051|FG000|Overall Study|Never started treatment|21|||
161947948|NCT00110214|584862052|FG001|Overall Study|Never started treatment|20|||
161947949|NCT00110214|584862051|FG000|Overall Study|Disease progression or death|260|||
161947950|NCT00110214|584862052|FG001|Overall Study|Disease progression or death|151|||
161947951|NCT00110214|584862051|FG000|Overall Study|Adverse Event|115|||
161947952|NCT00110214|584862052|FG001|Overall Study|Adverse Event|192|||
161947953|NCT00110214|584862051|FG000|Overall Study|Refused further treatment|52|||
161947954|NCT00110214|584862052|FG001|Overall Study|Refused further treatment|65|||
161947955|NCT00110214|584862051|FG000|Overall Study|Other (not specified)|61|||
161947956|NCT00110214|584862052|FG001|Overall Study|Other (not specified)|75|||
161947957|NCT01088503|584862053|FG000|Overall Study|Withdrawal by Subject|118|||
161947958|NCT01088503|584862054|FG001|Overall Study|Withdrawal by Subject|327|||
161947959|NCT01088503|584862055|FG002|Overall Study|Withdrawal by Subject|10|||
161947960|NCT01088503|584862053|FG000|Overall Study|Death|64|||
161947961|NCT01088503|584862054|FG001|Overall Study|Death|358|||
161947962|NCT01088503|584862055|FG002|Overall Study|Death|7|||
161947963|NCT01016067|584862056|FG000|Overall Study|Lost to Follow-up|1|||
161947964|NCT01016067|584862057|FG001|Overall Study|Lost to Follow-up|2|||
161947965|NCT01016067|584862056|FG000|Overall Study|Physician Decision|1|||
161947966|NCT01016067|584862057|FG001|Overall Study|Physician Decision|1|||
161947967|NCT01016067|584862056|FG000|Overall Study|Withdrew due to Relocation|0|||
161947968|NCT01016067|584862057|FG001|Overall Study|Withdrew due to Relocation|1|||
161947969|NCT01664247|584862061|FG000|Overall Study|Adverse Event|5|||
161947970|NCT01664247|584862062|FG001|Overall Study|Adverse Event|3|||
161947971|NCT01664247|584862061|FG000|Overall Study|Protocol Violation|3|||
161947972|NCT01664247|584862062|FG001|Overall Study|Protocol Violation|5|||
161947973|NCT01664247|584862061|FG000|Overall Study|Withdrawal Criteria|1|||
161947974|NCT01664247|584862062|FG001|Overall Study|Withdrawal Criteria|4|||
161947975|NCT01664247|584862061|FG000|Overall Study|Unclassified|5|||
161947976|NCT01664247|584862062|FG001|Overall Study|Unclassified|29|||
161947977|NCT01000506|584862063|FG000|Overall Study|Adverse Event|6|||
161947978|NCT01000506|584862064|FG001|Overall Study|Adverse Event|5|||
161947979|NCT01000506|584862065|FG002|Overall Study|Adverse Event|8|||
161947980|NCT01000506|584862066|FG003|Overall Study|Adverse Event|9|||
161947981|NCT01000506|584862063|FG000|Overall Study|Lack of Efficacy|8|||
161947982|NCT01000506|584862064|FG001|Overall Study|Lack of Efficacy|6|||
161947983|NCT01000506|584862065|FG002|Overall Study|Lack of Efficacy|4|||
161947984|NCT01000506|584862066|FG003|Overall Study|Lack of Efficacy|4|||
161947985|NCT01000506|584862063|FG000|Overall Study|Protocol Violation|1|||
161947986|NCT01000506|584862064|FG001|Overall Study|Protocol Violation|1|||
161947987|NCT01000506|584862065|FG002|Overall Study|Protocol Violation|0|||
161947988|NCT01000506|584862066|FG003|Overall Study|Protocol Violation|0|||
161947989|NCT01000506|584862063|FG000|Overall Study|Lost to Follow-up|1|||
161947990|NCT01000506|584862064|FG001|Overall Study|Lost to Follow-up|1|||
161947991|NCT01000506|584862065|FG002|Overall Study|Lost to Follow-up|4|||
161947992|NCT01000506|584862066|FG003|Overall Study|Lost to Follow-up|0|||
161947993|NCT01000506|584862063|FG000|Overall Study|Physician Decision|1|||
161947994|NCT01000506|584862064|FG001|Overall Study|Physician Decision|3|||
161947995|NCT01000506|584862065|FG002|Overall Study|Physician Decision|3|||
161947996|NCT01000506|584862066|FG003|Overall Study|Physician Decision|3|||
161947997|NCT01000506|584862063|FG000|Overall Study|Withdrawal by Subject|11|||
161947998|NCT01000506|584862064|FG001|Overall Study|Withdrawal by Subject|8|||
161947999|NCT01000506|584862065|FG002|Overall Study|Withdrawal by Subject|2|||
161948000|NCT01000506|584862066|FG003|Overall Study|Withdrawal by Subject|7|||
161948001|NCT03064074|584862067|FG000|Overall Study|Physician Decision|0|||
161948002|NCT03064074|584862068|FG001|Overall Study|Physician Decision|0|||
161948003|NCT03064074|584862069|FG002|Overall Study|Physician Decision|0|||
161948004|NCT03064074|584862070|FG003|Overall Study|Physician Decision|1|||
161948005|NCT00269087|584862071|FG000|Overall Study|Adverse Event|20|||
162028017|NCT01379508|585157343|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
162028018|NCT01379508|585157344|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
162028019|NCT01379508|585157345|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
162028020|NCT01379508|585157346|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
162028021|NCT03952039|585157349|FG000|Overall Study|Adverse Event|22|||
162028022|NCT03952039|585157350|FG001|Overall Study|Adverse Event|8|||
162028023|NCT03952039|585157349|FG000|Overall Study|Withdrawal by Participant|17|||
162028024|NCT03952039|585157350|FG001|Overall Study|Withdrawal by Participant|12|||
162028025|NCT03952039|585157349|FG000|Overall Study|Death|13|||
162028026|NCT03952039|585157350|FG001|Overall Study|Death|6|||
162028027|NCT03952039|585157349|FG000|Overall Study|Lack of Efficacy|12|||
162028028|NCT03952039|585157350|FG001|Overall Study|Lack of Efficacy|2|||
162028029|NCT03952039|585157349|FG000|Overall Study|Physician Decision|9|||
162028030|NCT03952039|585157350|FG001|Overall Study|Physician Decision|3|||
162028031|NCT03952039|585157349|FG000|Overall Study|Progressive Disease|6|||
162028032|NCT03952039|585157350|FG001|Overall Study|Progressive Disease|4|||
162028033|NCT03952039|585157349|FG000|Overall Study|Other Reasons|12|||
162028034|NCT03952039|585157350|FG001|Overall Study|Other Reasons|4|||
162028035|NCT02055365|585159255|FG000|Overall Study|Prematurely Withdrawn|1|||
161948006|NCT00269087|584862071|FG000|Overall Study|Withdrawal by Subject|1|||
161948007|NCT00269087|584862071|FG000|Overall Study|Exacerbation of COPD|13|||
161948008|NCT01188967|584862077|FG000|Overall Study|Withdrawal by Subject|1|||
161948009|NCT01188967|584862078|FG001|Overall Study|Withdrawal by Subject|1|||
161948010|NCT01188967|584862077|FG000|Overall Study|Physician Decision|1|||
161948011|NCT01188967|584862078|FG001|Overall Study|Physician Decision|1|||
162028036|NCT03603509|585159259|FG000|Overall Study|Lost to Follow-up|3|||
162028037|NCT03603509|585159260|FG001|Overall Study|Lost to Follow-up|4|||
162028038|NCT02656680|585159263|FG000|Overall Study|Lost to Follow-up|0|||
162028039|NCT02656680|585159264|FG001|Overall Study|Lost to Follow-up|1|||
162028040|NCT02656680|585159265|FG002|Overall Study|Lost to Follow-up|7|||
162028041|NCT01258998|585159266|FG000|Overall Study|Ineligible|1|||
162028042|NCT01143389|585159267|FG000|Overall Study|Lost to Follow-up|26|||
162028043|NCT01143389|585159268|FG001|Overall Study|Lost to Follow-up|25|||
162028044|NCT04966910|585159271|FG000|Baseline|Participant did not complete measure|0|||
162028045|NCT04966910|585159272|FG001|Baseline|Participant did not complete measure|0|||
162028046|NCT04966910|585159273|FG002|Baseline|Participant did not complete measure|1|||
162028047|NCT04966910|585159274|FG003|Baseline|Participant did not complete measure|0|||
162028048|NCT04966910|585159271|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
162028049|NCT04966910|585159272|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
162028050|NCT04966910|585159273|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
162028051|NCT04966910|585159274|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
162028052|NCT04966910|585159271|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
162028053|NCT04966910|585159272|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
162028054|NCT04966910|585159273|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
162028055|NCT04966910|585159274|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
162028056|NCT04966910|585159271|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
162028057|NCT04966910|585159272|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
162028058|NCT04966910|585159273|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
162028059|NCT04966910|585159274|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
162028060|NCT00002931|585159275|FG000|Overall Study|rapidly progressing disease during|2|||
162028061|NCT01264081|585159278|FG000|Participants Screened|Screening failures|30|||
162028062|NCT01264081|585159278|FG000|Started Treatment|Withdrawal by Subject|1|||
162028063|NCT01264081|585159278|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
162028064|NCT02716896|585159279|FG000|Overall Study|Physician Decision|0|||
162028065|NCT02716896|585159280|FG001|Overall Study|Physician Decision|1|||
162028066|NCT01727700|585159281|FG000|Overall Study|Adverse Event|0|||
162028067|NCT01727700|585159282|FG001|Overall Study|Adverse Event|7|||
162028068|NCT01727700|585159283|FG002|Overall Study|Adverse Event|1|||
162028069|NCT01727700|585159281|FG000|Overall Study|Particpant withdrew consent|0|||
162028070|NCT01727700|585159282|FG001|Overall Study|Particpant withdrew consent|3|||
162028071|NCT01727700|585159283|FG002|Overall Study|Particpant withdrew consent|1|||
162028072|NCT01727700|585159281|FG000|Overall Study|Protocol Violation|2|||
162028073|NCT01727700|585159282|FG001|Overall Study|Protocol Violation|0|||
162028074|NCT01727700|585159283|FG002|Overall Study|Protocol Violation|0|||
161948012|NCT01188967|584862077|FG000|Overall Study|Lost to Follow-up|3|||
162028075|NCT01757691|585159285|FG000|Overall Study|Administrative problems|2|||
162028076|NCT01757691|585159286|FG001|Overall Study|Administrative problems|0|||
162028077|NCT02054481|585159290|FG000|Overall Study|Adverse Event|1|||
162028078|NCT02054481|585159291|FG001|Overall Study|Adverse Event|1|||
162028079|NCT02054481|585159292|FG002|Overall Study|Adverse Event|0|||
162028080|NCT02054481|585159293|FG003|Overall Study|Adverse Event|1|||
161948013|NCT01188967|584862078|FG001|Overall Study|Lost to Follow-up|2|||
162028081|NCT02054481|585159290|FG000|Overall Study|Lost to Follow-up|1|||
162028082|NCT02054481|585159291|FG001|Overall Study|Lost to Follow-up|0|||
162028083|NCT02054481|585159292|FG002|Overall Study|Lost to Follow-up|0|||
162028084|NCT02054481|585159293|FG003|Overall Study|Lost to Follow-up|0|||
161948014|NCT01448616|584862079|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
161948015|NCT01448616|584862080|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
161948016|NCT01448616|584862081|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
161948017|NCT01448616|584862082|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
161948018|NCT01448616|584862079|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
161948019|NCT01448616|584862080|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
161948020|NCT01448616|584862081|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
161948021|NCT01448616|584862082|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
161948022|NCT01448616|584862079|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
161948023|NCT01448616|584862080|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
161948024|NCT01448616|584862081|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
161948025|NCT01448616|584862082|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
161948026|NCT01448616|584862079|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
161948027|NCT01448616|584862080|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
161948028|NCT01448616|584862081|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
161948029|NCT01448616|584862082|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
161948030|NCT01448616|584862079|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
161948031|NCT01448616|584862080|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
161948032|NCT01448616|584862081|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
161948033|NCT01448616|584862082|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
161948034|NCT00523978|584862083|FG000|Overall Study|Withdrawal by Subject|3|||
161948035|NCT00523978|584862084|FG001|Overall Study|Withdrawal by Subject|7|||
161948036|NCT00523978|584862083|FG000|Overall Study|Screen Failures|5|||
161948037|NCT00523978|584862084|FG001|Overall Study|Screen Failures|1|||
161948038|NCT00523978|584862083|FG000|Overall Study|Death|1|||
161948039|NCT00523978|584862084|FG001|Overall Study|Death|0|||
161948040|NCT01911260|584862087|FG000|Supplementation Period|transference or evasion of school|7|||
161948041|NCT01911260|584862088|FG001|Supplementation Period|transference or evasion of school|9|||
161948042|NCT01911260|584862089|FG002|Supplementation Period|transference or evasion of school|7|||
161948043|NCT01911260|584862090|FG003|Supplementation Period|transference or evasion of school|6|||
161948044|NCT01911260|584862087|FG000|Supplementation Period|Adverse Event|2|||
161948045|NCT01911260|584862088|FG001|Supplementation Period|Adverse Event|0|||
161948046|NCT01911260|584862089|FG002|Supplementation Period|Adverse Event|1|||
161948047|NCT01911260|584862090|FG003|Supplementation Period|Adverse Event|0|||
161948048|NCT01911260|584862087|FG000|Supplementation Period|refused to receive supplement|1|||
161948049|NCT01911260|584862088|FG001|Supplementation Period|refused to receive supplement|0|||
161948050|NCT01911260|584862089|FG002|Supplementation Period|refused to receive supplement|1|||
161948051|NCT01911260|584862090|FG003|Supplementation Period|refused to receive supplement|0|||
161948052|NCT01911260|584862087|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
161948053|NCT01911260|584862088|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
161948054|NCT01911260|584862089|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
161948055|NCT01911260|584862090|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
161948056|NCT01911260|584862087|FG000|Follow-up Period|transference or evasion of school|13|||
161948057|NCT01911260|584862088|FG001|Follow-up Period|transference or evasion of school|20|||
161948058|NCT01911260|584862089|FG002|Follow-up Period|transference or evasion of school|15|||
161948059|NCT01911260|584862090|FG003|Follow-up Period|transference or evasion of school|12|||
161948060|NCT01696643|584862095|FG000|Overall Study|Adverse Event|15|||
161948061|NCT01696643|584862096|FG001|Overall Study|Adverse Event|7|||
161948062|NCT01696643|584862095|FG000|Overall Study|Death|1|||
161948063|NCT01696643|584862096|FG001|Overall Study|Death|2|||
161948064|NCT01696643|584862095|FG000|Overall Study|Lack of Efficacy|3|||
161948065|NCT01696643|584862096|FG001|Overall Study|Lack of Efficacy|0|||
161948066|NCT01696643|584862095|FG000|Overall Study|Lost to Follow-up|67|||
161948067|NCT01696643|584862096|FG001|Overall Study|Lost to Follow-up|67|||
161948068|NCT01696643|584862095|FG000|Overall Study|Physician Decision|3|||
161948069|NCT01696643|584862096|FG001|Overall Study|Physician Decision|2|||
161948070|NCT01696643|584862095|FG000|Overall Study|Pregnancy|0|||
161948071|NCT01696643|584862096|FG001|Overall Study|Pregnancy|1|||
161948072|NCT01696643|584862095|FG000|Overall Study|Protocol Violation|7|||
161948073|NCT01696643|584862096|FG001|Overall Study|Protocol Violation|7|||
161948074|NCT01696643|584862095|FG000|Overall Study|Study Terminated by Sponsor|286|||
161948075|NCT01696643|584862096|FG001|Overall Study|Study Terminated by Sponsor|294|||
161948076|NCT01696643|584862095|FG000|Overall Study|Withdrawal by Subject|142|||
161948077|NCT01696643|584862096|FG001|Overall Study|Withdrawal by Subject|149|||
161948078|NCT01696643|584862095|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
161948079|NCT01696643|584862096|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
161948080|NCT01696643|584862095|FG000|Overall Study|Site Error|2|||
161948081|NCT01696643|584862096|FG001|Overall Study|Site Error|1|||
161948082|NCT01696643|584862095|FG000|Overall Study|Participant Incarcerated|0|||
161948083|NCT01696643|584862096|FG001|Overall Study|Participant Incarcerated|1|||
161948084|NCT01696643|584862095|FG000|Overall Study|Medical Monitor Decision|0|||
161948085|NCT01696643|584862096|FG001|Overall Study|Medical Monitor Decision|2|||
162028085|NCT02054481|585159290|FG000|Overall Study|Other reason|2|||
162028086|NCT02054481|585159291|FG001|Overall Study|Other reason|1|||
161948086|NCT01696643|584862095|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
161948087|NCT01696643|584862096|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
161948088|NCT02271529|584862100|FG000|Overall Study|Withdrawal by Subject|1|||
161948089|NCT03508050|584862101|FG000|Overall Study|Pleural adhesions|1|||
162028087|NCT02054481|585159292|FG002|Overall Study|Other reason|2|||
162028088|NCT02054481|585159293|FG003|Overall Study|Other reason|0|||
162028089|NCT01909791|585159295|FG000|Overall Study|Death|9|||
162028090|NCT01909791|585159296|FG001|Overall Study|Death|8|||
162028091|NCT01909791|585159297|FG002|Overall Study|Death|4|||
162028092|NCT01909791|585159295|FG000|Overall Study|Withdrawal by Subject|5|||
162028093|NCT01909791|585159296|FG001|Overall Study|Withdrawal by Subject|9|||
162028094|NCT01909791|585159297|FG002|Overall Study|Withdrawal by Subject|13|||
162028095|NCT01909791|585159295|FG000|Overall Study|Lost to Follow-up|5|||
162028096|NCT01909791|585159296|FG001|Overall Study|Lost to Follow-up|11|||
162028097|NCT01909791|585159297|FG002|Overall Study|Lost to Follow-up|10|||
162028098|NCT01909791|585159295|FG000|Overall Study|Missed Visit|2|||
162028099|NCT01909791|585159296|FG001|Overall Study|Missed Visit|0|||
162028100|NCT01909791|585159297|FG002|Overall Study|Missed Visit|1|||
162028101|NCT01328366|585159300|FG000|Overall Study|Death|1|||
162028102|NCT01328366|585159300|FG000|Overall Study|Withdrawal by Subject|2|||
162028103|NCT01328366|585159300|FG000|Overall Study|Lost to Follow-up|7|||
162028104|NCT01713933|585159301|FG000|Overall Study|Lost to Follow-up|2|||
162028105|NCT01713933|585159301|FG000|Overall Study|Withdrawal by Subject|3|||
162028106|NCT01713933|585159301|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
162028107|NCT00528970|585159302|FG000|Overall Study|Adverse Event|6|||
162028108|NCT00528970|585159303|FG001|Overall Study|Adverse Event|8|||
162028109|NCT00528970|585159304|FG002|Overall Study|Adverse Event|5|||
162028110|NCT00528970|585159302|FG000|Overall Study|Lost to Follow-up|0|||
162028111|NCT00528970|585159303|FG001|Overall Study|Lost to Follow-up|0|||
162028112|NCT00528970|585159304|FG002|Overall Study|Lost to Follow-up|1|||
162028113|NCT00528970|585159302|FG000|Overall Study|Other than specified|2|||
162028114|NCT00528970|585159303|FG001|Overall Study|Other than specified|3|||
162028115|NCT00528970|585159304|FG002|Overall Study|Other than specified|3|||
162028116|NCT00528970|585159302|FG000|Overall Study|Protocol Violation|2|||
162028117|NCT00528970|585159303|FG001|Overall Study|Protocol Violation|1|||
162028118|NCT00528970|585159304|FG002|Overall Study|Protocol Violation|4|||
162028119|NCT00528970|585159302|FG000|Overall Study|Lack of Efficacy|0|||
162028120|NCT00528970|585159303|FG001|Overall Study|Lack of Efficacy|0|||
162028121|NCT00528970|585159304|FG002|Overall Study|Lack of Efficacy|1|||
162028122|NCT00528970|585159302|FG000|Overall Study|Withdrawal by Subject|4|||
162028123|NCT00528970|585159303|FG001|Overall Study|Withdrawal by Subject|3|||
162028124|NCT00528970|585159304|FG002|Overall Study|Withdrawal by Subject|5|||
162028125|NCT00528970|585159302|FG000|Overall Study|Randomized but not treated|0|||
162028126|NCT00528970|585159303|FG001|Overall Study|Randomized but not treated|0|||
162028127|NCT00528970|585159304|FG002|Overall Study|Randomized but not treated|1|||
162028128|NCT02882152|585159305|FG000|Overall Study|Lost to Follow-up|1|||
162028129|NCT02882152|585159306|FG001|Overall Study|Lost to Follow-up|0|||
162028130|NCT01673347|585159309|FG000|Overall Study|failure of allograft|7|||
162028131|NCT00895011|585159313|FG000|Overall Study|Withdrawal by Subject|14|||
162028132|NCT00895011|585159314|FG001|Overall Study|Withdrawal by Subject|7|||
162028133|NCT00895011|585159315|FG002|Overall Study|Withdrawal by Subject|2|||
162028134|NCT00895011|585159313|FG000|Overall Study|Lost to Follow-up|5|||
162028135|NCT00895011|585159314|FG001|Overall Study|Lost to Follow-up|4|||
162028136|NCT00895011|585159315|FG002|Overall Study|Lost to Follow-up|1|||
162028137|NCT00895011|585159313|FG000|Overall Study|Protocol Violation|3|||
162028138|NCT00895011|585159314|FG001|Overall Study|Protocol Violation|1|||
162028139|NCT00895011|585159315|FG002|Overall Study|Protocol Violation|3|||
162028140|NCT00895011|585159313|FG000|Overall Study|Adverse Event|1|||
162028141|NCT00895011|585159314|FG001|Overall Study|Adverse Event|2|||
162028142|NCT00895011|585159315|FG002|Overall Study|Adverse Event|2|||
161948090|NCT03508050|584862102|FG001|Overall Study|Pleural adhesions|0|||
161948091|NCT03508050|584862101|FG000|Overall Study|Mucus plug|1|||
161948092|NCT03508050|584862102|FG001|Overall Study|Mucus plug|0|||
162028143|NCT00895011|585159313|FG000|Overall Study|schedule conflict|1|||
162028144|NCT00895011|585159314|FG001|Overall Study|schedule conflict|0|||
162028145|NCT00895011|585159315|FG002|Overall Study|schedule conflict|0|||
162028146|NCT01430754|585159316|FG000|Run-In Phase|Circadian Period Ineligible|24|||
162028147|NCT01430754|585159317|FG001|Run-In Phase|Circadian Period Ineligible|0|||
162028148|NCT01430754|585159316|FG000|Run-In Phase|Protocol Violation|6|||
162028149|NCT01430754|585159317|FG001|Run-In Phase|Protocol Violation|0|||
162028150|NCT01430754|585159316|FG000|Run-In Phase|Adverse Event|2|||
162028151|NCT01430754|585159317|FG001|Run-In Phase|Adverse Event|0|||
162028152|NCT01430754|585159316|FG000|Run-In Phase|Other|2|||
162028153|NCT01430754|585159317|FG001|Run-In Phase|Other|0|||
162028154|NCT01430754|585159316|FG000|Run-In Phase|Withdrawal by Subject|2|||
162028155|NCT01430754|585159317|FG001|Run-In Phase|Withdrawal by Subject|0|||
162028156|NCT01430754|585159316|FG000|Run-In Phase|Lost to Follow-up|1|||
161948093|NCT03508050|584862101|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
161948094|NCT03508050|584862102|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
161948095|NCT03508050|584862101|FG000|Overall Study|Sustained desaturation|0|||
161948096|NCT03508050|584862102|FG001|Overall Study|Sustained desaturation|1|||
161948097|NCT03894891|584862103|FG000|Overall Study|Withdrawal by Subject|1|||
161948098|NCT03894891|584862103|FG000|Overall Study|Completed protocol treatment per protocol|5|||
161948099|NCT04389866|584862107|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
161948100|NCT04389866|584862108|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
161948101|NCT00776789|584862113|FG000|Overall Study|Consent refusal|2|||
161948102|NCT00776789|584862114|FG001|Overall Study|Consent refusal|2|||
161948103|NCT00776789|584862113|FG000|Overall Study|Poor quality video|1|||
161948104|NCT00776789|584862114|FG001|Overall Study|Poor quality video|1|||
161948105|NCT04940130|584862115|FG000|Overall Study|Travel|1|||
161948106|NCT04940130|584862116|FG001|Overall Study|Travel|0|||
161948107|NCT04940130|584862117|FG002|Overall Study|Travel|2|||
161948108|NCT04940130|584862115|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
161948109|NCT04940130|584862116|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
161948110|NCT04940130|584862117|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
161948111|NCT04940130|584862115|FG000|Overall Study|Adverse Event|0|||
161948112|NCT04940130|584862116|FG001|Overall Study|Adverse Event|0|||
161948113|NCT04940130|584862117|FG002|Overall Study|Adverse Event|2|||
161948114|NCT04940130|584862115|FG000|Overall Study|Disease progression/treatment failure|0|||
161948115|NCT04940130|584862116|FG001|Overall Study|Disease progression/treatment failure|0|||
161948116|NCT04940130|584862117|FG002|Overall Study|Disease progression/treatment failure|1|||
161948117|NCT04940130|584862115|FG000|Overall Study|Participant refusal|0|||
161948118|NCT04940130|584862116|FG001|Overall Study|Participant refusal|0|||
161948119|NCT04940130|584862117|FG002|Overall Study|Participant refusal|1|||
161948120|NCT01284959|584862120|FG000|Overall Study|Withdrawal by Subject|1|||
161948121|NCT01284959|584862121|FG001|Overall Study|Withdrawal by Subject|0|||
161948122|NCT01284959|584862122|FG002|Overall Study|Withdrawal by Subject|0|||
161948123|NCT01284959|584862120|FG000|Overall Study|Adverse Event|0|||
161948124|NCT01284959|584862121|FG001|Overall Study|Adverse Event|0|||
161948125|NCT01284959|584862122|FG002|Overall Study|Adverse Event|1|||
161948126|NCT01055613|584862123|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
161948127|NCT01055613|584862124|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161948128|NCT01055613|584862123|FG000|Overall Study|Unacceptable lens fit|1|||
161948129|NCT01055613|584862124|FG001|Overall Study|Unacceptable lens fit|0|||
161948130|NCT01055613|584862123|FG000|Overall Study|Discomfort|2|||
161948131|NCT01055613|584862124|FG001|Overall Study|Discomfort|1|||
161948132|NCT01055613|584862123|FG000|Overall Study|Lost to Follow-up|1|||
161948133|NCT01055613|584862124|FG001|Overall Study|Lost to Follow-up|1|||
161948134|NCT01055613|584862123|FG000|Overall Study|Protocol Violation|1|||
161948135|NCT01055613|584862124|FG001|Overall Study|Protocol Violation|1|||
161948136|NCT01055613|584862123|FG000|Overall Study|Subject Disinterest|1|||
161948137|NCT01055613|584862124|FG001|Overall Study|Subject Disinterest|1|||
161948138|NCT00363311|584862125|FG000|Overall Study|Adverse Event|6|||
161948139|NCT00363311|584862126|FG001|Overall Study|Adverse Event|4|||
161948140|NCT00363311|584862125|FG000|Overall Study|Lost to Follow-up|3|||
161948141|NCT00363311|584862126|FG001|Overall Study|Lost to Follow-up|0|||
161948142|NCT00363311|584862125|FG000|Overall Study|Protocol Violation|1|||
161948143|NCT00363311|584862126|FG001|Overall Study|Protocol Violation|2|||
161948144|NCT00363311|584862125|FG000|Overall Study|Withdrawal by Subject|12|||
161948145|NCT00363311|584862126|FG001|Overall Study|Withdrawal by Subject|6|||
161948146|NCT00363311|584862125|FG000|Overall Study|Physician Decision|1|||
161948147|NCT00363311|584862126|FG001|Overall Study|Physician Decision|1|||
161948148|NCT00363311|584862125|FG000|Overall Study|Sponsor Terminated Study|2|||
161948149|NCT00363311|584862126|FG001|Overall Study|Sponsor Terminated Study|2|||
161948150|NCT00363311|584862125|FG000|Overall Study|Disease Progression|46|||
161948151|NCT00363311|584862126|FG001|Overall Study|Disease Progression|26|||
161948152|NCT00363311|584862125|FG000|Overall Study|Non-Compliance|1|||
161948153|NCT00363311|584862126|FG001|Overall Study|Non-Compliance|1|||
161948154|NCT00363311|584862125|FG000|Overall Study|Participant Refused Biopsy|1|||
161948155|NCT00363311|584862126|FG001|Overall Study|Participant Refused Biopsy|0|||
161948156|NCT00363311|584862125|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
161948157|NCT00363311|584862126|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
161948158|NCT00363311|584862125|FG000|Overall Study|Participant Opted for Treatment|1|||
161948159|NCT00363311|584862126|FG001|Overall Study|Participant Opted for Treatment|0|||
161948160|NCT00363311|584862125|FG000|Overall Study|Participant Moved to Another Country|1|||
161948161|NCT00363311|584862126|FG001|Overall Study|Participant Moved to Another Country|0|||
161948162|NCT00363311|584862125|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
161948163|NCT00363311|584862126|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
161948164|NCT00363311|584862125|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
161948165|NCT00363311|584862126|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
161948166|NCT00363311|584862125|FG000|Overall Study|Participant Moved to Louisiana|0|||
161948167|NCT00363311|584862126|FG001|Overall Study|Participant Moved to Louisiana|1|||
161684372|NCT02819635|583897901|FG009|Substudy 2, Part 2|Adverse Event|0|||
161948168|NCT00401843|584862127|FG000|Overall Study|Achieved Complete Response|1|||
161948169|NCT00401843|584862128|FG001|Overall Study|Achieved Complete Response|5|||
161948170|NCT00401843|584862129|FG002|Overall Study|Achieved Complete Response|11|||
161948171|NCT00401843|584862127|FG000|Overall Study|Adverse Event|7|||
161948172|NCT00401843|584862128|FG001|Overall Study|Adverse Event|26|||
161948173|NCT00401843|584862129|FG002|Overall Study|Adverse Event|27|||
161948174|NCT00401843|584862127|FG000|Overall Study|Death|0|||
161948175|NCT00401843|584862128|FG001|Overall Study|Death|8|||
161948176|NCT00401843|584862129|FG002|Overall Study|Death|10|||
161948177|NCT00401843|584862127|FG000|Overall Study|Disease progression|10|||
161948178|NCT00401843|584862128|FG001|Overall Study|Disease progression|60|||
161948179|NCT00401843|584862129|FG002|Overall Study|Disease progression|49|||
161948180|NCT00401843|584862127|FG000|Overall Study|End of Study|1|||
161948181|NCT00401843|584862128|FG001|Overall Study|End of Study|1|||
161948182|NCT00401843|584862129|FG002|Overall Study|End of Study|2|||
161948183|NCT00401843|584862127|FG000|Overall Study|Lost to Follow-up|0|||
161948184|NCT00401843|584862128|FG001|Overall Study|Lost to Follow-up|0|||
161948185|NCT00401843|584862129|FG002|Overall Study|Lost to Follow-up|2|||
161948186|NCT00401843|584862127|FG000|Overall Study|Other Unspecified|0|||
161948187|NCT00401843|584862128|FG001|Overall Study|Other Unspecified|3|||
161948188|NCT00401843|584862129|FG002|Overall Study|Other Unspecified|5|||
161948189|NCT00401843|584862127|FG000|Overall Study|Physician Decision|0|||
161948190|NCT00401843|584862128|FG001|Overall Study|Physician Decision|16|||
161948191|NCT00401843|584862129|FG002|Overall Study|Physician Decision|10|||
161948192|NCT00401843|584862127|FG000|Overall Study|Protocol Violation|0|||
161948193|NCT00401843|584862128|FG001|Overall Study|Protocol Violation|0|||
161948194|NCT00401843|584862129|FG002|Overall Study|Protocol Violation|1|||
161948195|NCT00401843|584862127|FG000|Overall Study|Withdrawal by Subject|1|||
161948196|NCT00401843|584862128|FG001|Overall Study|Withdrawal by Subject|5|||
161948197|NCT00401843|584862129|FG002|Overall Study|Withdrawal by Subject|5|||
161948198|NCT00401843|584862127|FG000|Overall Study|Withdrawal of consent to study agent|1|||
161948199|NCT00401843|584862128|FG001|Overall Study|Withdrawal of consent to study agent|15|||
161948200|NCT00401843|584862129|FG002|Overall Study|Withdrawal of consent to study agent|17|||
161948201|NCT00401843|584862127|FG000|Overall Study|Randomized but not Treated|0|||
161948202|NCT00401843|584862128|FG001|Overall Study|Randomized but not Treated|2|||
161948203|NCT00401843|584862129|FG002|Overall Study|Randomized but not Treated|3|||
161948204|NCT00401843|584862127|FG000|Overall Study|Received incorrect treatment|0|||
161948205|NCT00401843|584862128|FG001|Overall Study|Received incorrect treatment|3|||
161948206|NCT00401843|584862129|FG002|Overall Study|Received incorrect treatment|0|||
161948207|NCT04881760|584862132|FG000|Overall Study|Adverse Event|0|||
161948208|NCT04881760|584862133|FG001|Overall Study|Adverse Event|1|||
161948209|NCT04881760|584862134|FG002|Overall Study|Adverse Event|1|||
161948210|NCT04881760|584862135|FG003|Overall Study|Adverse Event|0|||
161948211|NCT04881760|584862136|FG004|Overall Study|Adverse Event|1|||
161948212|NCT04881760|584862137|FG005|Overall Study|Adverse Event|1|||
161948213|NCT04881760|584862138|FG006|Overall Study|Adverse Event|2|||
161948214|NCT04881760|584862132|FG000|Overall Study|Death|0|||
161948215|NCT04881760|584862133|FG001|Overall Study|Death|0|||
161948216|NCT04881760|584862134|FG002|Overall Study|Death|0|||
161948217|NCT04881760|584862135|FG003|Overall Study|Death|1|||
161948218|NCT04881760|584862136|FG004|Overall Study|Death|0|||
161948219|NCT04881760|584862137|FG005|Overall Study|Death|0|||
161948220|NCT04881760|584862138|FG006|Overall Study|Death|0|||
161948221|NCT04881760|584862132|FG000|Overall Study|Lost to Follow-up|5|||
161948222|NCT04881760|584862133|FG001|Overall Study|Lost to Follow-up|7|||
161948223|NCT04881760|584862134|FG002|Overall Study|Lost to Follow-up|5|||
161948224|NCT04881760|584862135|FG003|Overall Study|Lost to Follow-up|1|||
161948225|NCT04881760|584862136|FG004|Overall Study|Lost to Follow-up|2|||
161948226|NCT04881760|584862137|FG005|Overall Study|Lost to Follow-up|4|||
161948227|NCT04881760|584862138|FG006|Overall Study|Lost to Follow-up|4|||
161948228|NCT04881760|584862132|FG000|Overall Study|Withdrawal by Subject|13|||
161948229|NCT04881760|584862133|FG001|Overall Study|Withdrawal by Subject|1|||
161948230|NCT04881760|584862134|FG002|Overall Study|Withdrawal by Subject|1|||
161948231|NCT04881760|584862135|FG003|Overall Study|Withdrawal by Subject|4|||
161948232|NCT04881760|584862136|FG004|Overall Study|Withdrawal by Subject|2|||
161948233|NCT04881760|584862137|FG005|Overall Study|Withdrawal by Subject|1|||
161948234|NCT04881760|584862138|FG006|Overall Study|Withdrawal by Subject|2|||
161948235|NCT04881760|584862132|FG000|Overall Study|Randomized but Never Treated|0|||
161948236|NCT04881760|584862133|FG001|Overall Study|Randomized but Never Treated|0|||
161948237|NCT04881760|584862134|FG002|Overall Study|Randomized but Never Treated|0|||
161948238|NCT04881760|584862135|FG003|Overall Study|Randomized but Never Treated|1|||
161948239|NCT04881760|584862136|FG004|Overall Study|Randomized but Never Treated|0|||
161948240|NCT04881760|584862137|FG005|Overall Study|Randomized but Never Treated|0|||
161948241|NCT04881760|584862138|FG006|Overall Study|Randomized but Never Treated|0|||
161948242|NCT04881760|584862132|FG000|Overall Study|Inadvertent Enrollment|2|||
161684373|NCT02819635|583897902|FG010|Substudy 2, Part 2|Adverse Event|0|||
161948243|NCT04881760|584862133|FG001|Overall Study|Inadvertent Enrollment|0|||
162028157|NCT01430754|585159317|FG001|Run-In Phase|Lost to Follow-up|0|||
162028158|NCT02661178|585159324|FG000|Part 1|Protocol Violation|1|||
162028159|NCT02661178|585159325|FG001|Part 1|Protocol Violation|0|||
162028160|NCT02661178|585159326|FG002|Part 1|Protocol Violation|0|||
162028161|NCT02661178|585159327|FG003|Part 1|Protocol Violation|0|||
162028162|NCT02661178|585159328|FG004|Part 1|Protocol Violation|0|||
162028163|NCT02661178|585159329|FG005|Part 1|Protocol Violation|0|||
162028164|NCT02661178|585159330|FG006|Part 1|Protocol Violation|0|||
162028165|NCT02661178|585159331|FG007|Part 1|Protocol Violation|0|||
162028166|NCT02661178|585159332|FG008|Part 1|Protocol Violation|0|||
162028167|NCT02661178|585159333|FG009|Part 1|Protocol Violation|0|||
162028168|NCT02661178|585159334|FG010|Part 1|Protocol Violation|0|||
162028169|NCT02661178|585159335|FG011|Part 1|Protocol Violation|0|||
162028170|NCT02661178|585159336|FG012|Part 1|Protocol Violation|0|||
162028171|NCT02661178|585159337|FG013|Part 1|Protocol Violation|0|||
162028172|NCT02661178|585159338|FG014|Part 1|Protocol Violation|0|||
162028173|NCT02278471|585159339|FG000|Overall Study|Lost to Follow-up|6|||
162028174|NCT02278471|585159340|FG001|Overall Study|Lost to Follow-up|15|||
162028175|NCT02278471|585159339|FG000|Overall Study|Death|2|||
162028176|NCT02278471|585159340|FG001|Overall Study|Death|2|||
162028177|NCT02278471|585159339|FG000|Overall Study|Withdrawal by Subject|0|||
162028178|NCT02278471|585159340|FG001|Overall Study|Withdrawal by Subject|3|||
162028179|NCT04391049|585159341|FG000|Overall Study|Protocol Violation|1|||
162028180|NCT01242813|585159342|FG000|Overall Study|Lost to Follow-up|2|||
162028181|NCT00275821|585159344|FG000|Overall Study|Adverse Event|4|||
162028182|NCT00275821|585159345|FG001|Overall Study|Adverse Event|12|||
162028183|NCT00275821|585159346|FG002|Overall Study|Adverse Event|5|||
162028184|NCT00275821|585159344|FG000|Overall Study|Administrative problems|3|||
162028185|NCT00275821|585159345|FG001|Overall Study|Administrative problems|4|||
162028186|NCT00275821|585159346|FG002|Overall Study|Administrative problems|4|||
162028187|NCT00275821|585159344|FG000|Overall Study|Withdrawal by Subject|0|||
162028188|NCT00275821|585159345|FG001|Overall Study|Withdrawal by Subject|2|||
162028189|NCT00275821|585159346|FG002|Overall Study|Withdrawal by Subject|1|||
162028190|NCT00275821|585159344|FG000|Overall Study|Lost to Follow-up|0|||
162028191|NCT00275821|585159345|FG001|Overall Study|Lost to Follow-up|1|||
162028192|NCT00275821|585159346|FG002|Overall Study|Lost to Follow-up|1|||
162028193|NCT00275821|585159344|FG000|Overall Study|Death|0|||
162028194|NCT00275821|585159345|FG001|Overall Study|Death|2|||
162028195|NCT00275821|585159346|FG002|Overall Study|Death|1|||
162028196|NCT00275821|585159344|FG000|Overall Study|Lack of Efficacy|2|||
162028197|NCT00275821|585159345|FG001|Overall Study|Lack of Efficacy|1|||
162028198|NCT00275821|585159346|FG002|Overall Study|Lack of Efficacy|0|||
162028199|NCT00275821|585159344|FG000|Overall Study|Protocol Violation|5|||
162028200|NCT00275821|585159345|FG001|Overall Study|Protocol Violation|1|||
162028201|NCT00275821|585159346|FG002|Overall Study|Protocol Violation|0|||
162028202|NCT02788279|585159347|FG000|Overall Study|Death|62|||
162028203|NCT02788279|585159348|FG001|Overall Study|Death|136|||
162028204|NCT02788279|585159349|FG002|Overall Study|Death|72|||
162028205|NCT02788279|585159347|FG000|Overall Study|Withdrawal by Subject|10|||
162028206|NCT02788279|585159348|FG001|Overall Study|Withdrawal by Subject|15|||
162028207|NCT02788279|585159349|FG002|Overall Study|Withdrawal by Subject|5|||
162028208|NCT02788279|585159347|FG000|Overall Study|Lost to Follow-up|0|||
162028209|NCT02788279|585159348|FG001|Overall Study|Lost to Follow-up|3|||
162028210|NCT02788279|585159349|FG002|Overall Study|Lost to Follow-up|2|||
162028211|NCT02788279|585159347|FG000|Overall Study|Sponsor decision|18|||
162028212|NCT02788279|585159348|FG001|Overall Study|Sponsor decision|29|||
162028213|NCT02788279|585159349|FG002|Overall Study|Sponsor decision|11|||
162028214|NCT00329849|585159351|FG000|Overall Study|Withdrawal by Subject|6|||
162028215|NCT00329849|585159352|FG001|Overall Study|Withdrawal by Subject|4|||
162028216|NCT01133990|585159357|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
162028217|NCT01133990|585159358|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162028218|NCT01133990|585159359|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162028219|NCT01133990|585159360|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162028220|NCT01133990|585159361|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162028221|NCT01133990|585159362|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162028222|NCT01133990|585159357|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
162028223|NCT01133990|585159358|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
162028224|NCT01133990|585159359|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
162028225|NCT01133990|585159360|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
162028226|NCT01133990|585159361|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
162028227|NCT01133990|585159362|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
162028228|NCT01133990|585159357|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
162028229|NCT01133990|585159358|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
162028230|NCT01133990|585159359|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
162028231|NCT01133990|585159360|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
162028232|NCT01133990|585159361|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
162028233|NCT01133990|585159362|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
162028234|NCT01133990|585159357|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
161832559|NCT00873119|584428469|FG001|Overall Study|Progressive disease|18|||
161832560|NCT00873119|584428468|FG000|Overall Study|Death|2|||
161832561|NCT00873119|584428469|FG001|Overall Study|Death|1|||
161832562|NCT00873119|584428468|FG000|Overall Study|Other|2|||
161832563|NCT00873119|584428469|FG001|Overall Study|Other|5|||
161832564|NCT00873119|584428468|FG000|Overall Study|Not treated|2|||
161832565|NCT00873119|584428469|FG001|Overall Study|Not treated|0|||
161832566|NCT03648879|584428470|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
161832567|NCT00285584|584428471|FG000|Month 3|Lost to Follow-up|3|||
161832568|NCT00285584|584428472|FG001|Month 3|Lost to Follow-up|3|||
161832569|NCT00285584|584428471|FG000|Month 3|Withdrawal by Subject|1|||
161832570|NCT00285584|584428472|FG001|Month 3|Withdrawal by Subject|0|||
161832571|NCT00285584|584428471|FG000|Month 6|Lost to Follow-up|0|||
161832572|NCT00285584|584428472|FG001|Month 6|Lost to Follow-up|1|||
161832573|NCT01884688|584428473|FG000|Overall Study|Screen Failure|2|||
161832574|NCT00536484|584428474|FG000|Overall Study|Adverse Event|21|||
161832575|NCT00536484|584428475|FG001|Overall Study|Adverse Event|34|||
161832576|NCT00536484|584428474|FG000|Overall Study|Withdrawal by Subject|11|||
161832577|NCT00536484|584428475|FG001|Overall Study|Withdrawal by Subject|11|||
161948244|NCT04881760|584862134|FG002|Overall Study|Inadvertent Enrollment|0|||
161948245|NCT04881760|584862135|FG003|Overall Study|Inadvertent Enrollment|0|||
161948246|NCT04881760|584862136|FG004|Overall Study|Inadvertent Enrollment|0|||
161948247|NCT04881760|584862137|FG005|Overall Study|Inadvertent Enrollment|0|||
161948248|NCT04881760|584862138|FG006|Overall Study|Inadvertent Enrollment|0|||
161948249|NCT04881760|584862132|FG000|Overall Study|Site Closure|0|||
161948250|NCT04881760|584862133|FG001|Overall Study|Site Closure|0|||
161948251|NCT04881760|584862134|FG002|Overall Study|Site Closure|0|||
161948252|NCT04881760|584862135|FG003|Overall Study|Site Closure|1|||
161948253|NCT04881760|584862136|FG004|Overall Study|Site Closure|0|||
161948254|NCT04881760|584862137|FG005|Overall Study|Site Closure|0|||
161948255|NCT04881760|584862138|FG006|Overall Study|Site Closure|0|||
161948256|NCT01182298|584862139|FG000|Overall Study|Lack of Efficacy|4|||
161948257|NCT01182298|584862139|FG000|Overall Study|Withdrawal by Subject|2|||
161948258|NCT01595529|584862140|FG000|Overall Study|Adverse Event|2|||
161948259|NCT01595529|584862141|FG001|Overall Study|Adverse Event|0|||
161948260|NCT01595529|584862140|FG000|Overall Study|Subject Non-Compliant|2|||
161948261|NCT01595529|584862141|FG001|Overall Study|Subject Non-Compliant|0|||
161948262|NCT01595529|584862140|FG000|Overall Study|Lost to Follow-up|8|||
161948263|NCT01595529|584862141|FG001|Overall Study|Lost to Follow-up|14|||
161948264|NCT01595529|584862140|FG000|Overall Study|Protocol Violation|1|||
161948265|NCT01595529|584862141|FG001|Overall Study|Protocol Violation|2|||
161948266|NCT01595529|584862140|FG000|Overall Study|Physician Decision|1|||
161948267|NCT01595529|584862141|FG001|Overall Study|Physician Decision|0|||
161948268|NCT01595529|584862140|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
161948269|NCT01595529|584862141|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
161948270|NCT01595529|584862140|FG000|Overall Study|Administrative Decision|1|||
161948271|NCT01595529|584862141|FG001|Overall Study|Administrative Decision|0|||
161948272|NCT01595529|584862140|FG000|Overall Study|Entry Failure/Screening Failure|6|||
161948273|NCT01595529|584862141|FG001|Overall Study|Entry Failure/Screening Failure|1|||
161948274|NCT01508910|584862142|FG000|Treatment|Death|2|||
161948275|NCT01508910|584862143|FG001|Treatment|Death|3|||
161948276|NCT01508910|584862144|FG002|Treatment|Death|2|||
161948277|NCT01508910|584862145|FG003|Treatment|Death|0|||
161948278|NCT01508910|584862142|FG000|Treatment|Lost to Follow-up|0|||
161948279|NCT01508910|584862143|FG001|Treatment|Lost to Follow-up|0|||
161948280|NCT01508910|584862144|FG002|Treatment|Lost to Follow-up|2|||
161948281|NCT01508910|584862145|FG003|Treatment|Lost to Follow-up|1|||
161948282|NCT01508910|584862142|FG000|Treatment|Withdrawal by Subject|0|||
161948283|NCT01508910|584862143|FG001|Treatment|Withdrawal by Subject|1|||
161948284|NCT01508910|584862144|FG002|Treatment|Withdrawal by Subject|6|||
161948285|NCT01508910|584862145|FG003|Treatment|Withdrawal by Subject|1|||
161948286|NCT01508910|584862142|FG000|Treatment|Sponsor Decision|0|||
161948287|NCT01508910|584862143|FG001|Treatment|Sponsor Decision|0|||
161948288|NCT01508910|584862144|FG002|Treatment|Sponsor Decision|0|||
161948289|NCT01508910|584862145|FG003|Treatment|Sponsor Decision|1|||
161948290|NCT04016714|584862146|FG000|Overall Study|Death|1|||
161948291|NCT04016714|584862147|FG001|Overall Study|Death|0|||
161948292|NCT04016714|584862146|FG000|Overall Study|Lost to Follow-up|3|||
161684374|NCT02819635|583897903|FG011|Substudy 2, Part 2|Adverse Event|0|||
161832578|NCT00536484|584428474|FG000|Overall Study|Lost to Follow-up|8|||
161832579|NCT00536484|584428475|FG001|Overall Study|Lost to Follow-up|6|||
161832580|NCT00536484|584428474|FG000|Overall Study|Lack of Efficacy|16|||
161832581|NCT00536484|584428475|FG001|Overall Study|Lack of Efficacy|5|||
161832582|NCT00536484|584428474|FG000|Overall Study|Other|4|||
161832583|NCT00536484|584428475|FG001|Overall Study|Other|0|||
161948293|NCT04016714|584862147|FG001|Overall Study|Lost to Follow-up|1|||
161948294|NCT04016714|584862146|FG000|Overall Study|Physician Decision|3|||
161948295|NCT04016714|584862147|FG001|Overall Study|Physician Decision|3|||
161948296|NCT04016714|584862146|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
161948297|NCT04016714|584862147|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
161832584|NCT00706355|584428476|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
161832585|NCT00706355|584428477|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
162028235|NCT01133990|585159358|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
162028236|NCT01133990|585159359|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
162028237|NCT01133990|585159360|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
162028238|NCT01133990|585159361|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
162028239|NCT01133990|585159362|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
162028240|NCT05277337|585159363|FG000|Overall Study|Lost to Follow-up|2|||
162028241|NCT05277337|585159364|FG001|Overall Study|Lost to Follow-up|0|||
162028242|NCT05277337|585159363|FG000|Overall Study|Withdrawal by Subject|1|||
162028243|NCT05277337|585159364|FG001|Overall Study|Withdrawal by Subject|0|||
162028244|NCT00409175|585159374|FG000|Overall Study|Adverse Event|4|||
162028245|NCT00409175|585159375|FG001|Overall Study|Adverse Event|3|||
162028246|NCT00409175|585159374|FG000|Overall Study|Withdrawal by Subject|1|||
162028247|NCT00409175|585159375|FG001|Overall Study|Withdrawal by Subject|2|||
162028248|NCT00409175|585159374|FG000|Overall Study|Negative genotype|0|||
162028249|NCT00409175|585159375|FG001|Overall Study|Negative genotype|1|||
162028250|NCT00409175|585159374|FG000|Overall Study|Liver transplantation|13|||
162028251|NCT00409175|585159375|FG001|Overall Study|Liver transplantation|13|||
162028252|NCT01328444|585159378|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
162028253|NCT01328444|585159379|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
162028254|NCT01328444|585159380|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
162028255|NCT01328444|585159381|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
162028256|NCT01328444|585159382|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
162028257|NCT01328444|585159383|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
162028258|NCT01328444|585159378|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
162028259|NCT01328444|585159379|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
162028260|NCT01328444|585159380|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
162028261|NCT01328444|585159381|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
162028262|NCT01328444|585159382|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
162028263|NCT01328444|585159383|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
162028264|NCT01328444|585159378|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
162028265|NCT01328444|585159379|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
162028266|NCT01328444|585159380|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
162028267|NCT01328444|585159381|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
162028268|NCT01328444|585159382|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
162028269|NCT01328444|585159383|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
162028270|NCT01328444|585159378|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
162028271|NCT01328444|585159379|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
162028272|NCT01328444|585159380|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
162028273|NCT01328444|585159381|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
162028274|NCT01328444|585159382|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
162028275|NCT01328444|585159383|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
162028276|NCT01328444|585159378|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
162028277|NCT01328444|585159379|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162028278|NCT01328444|585159380|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162028279|NCT01328444|585159381|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
162028280|NCT01328444|585159382|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162028281|NCT01328444|585159383|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
162028282|NCT01328444|585159378|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162028283|NCT01328444|585159379|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
161832586|NCT00706355|584428478|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
161832587|NCT00706355|584428479|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
161832588|NCT00706355|584428476|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
161832589|NCT00706355|584428477|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
162236719|NCT01395888|585917033|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
161832590|NCT00706355|584428478|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
161832591|NCT00706355|584428479|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
161832592|NCT00706355|584428476|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
161832593|NCT00706355|584428477|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
161832594|NCT00706355|584428478|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
161832595|NCT00706355|584428479|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
161832596|NCT00706355|584428476|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
162028284|NCT01328444|585159380|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
162028285|NCT01328444|585159381|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
162028286|NCT01328444|585159382|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
162028287|NCT01328444|585159383|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162028288|NCT01328444|585159378|FG000|Washout Period (14 Days)|Adverse Event|1|||
162028289|NCT01328444|585159379|FG001|Washout Period (14 Days)|Adverse Event|1|||
162028290|NCT01328444|585159380|FG002|Washout Period (14 Days)|Adverse Event|0|||
162028291|NCT01328444|585159381|FG003|Washout Period (14 Days)|Adverse Event|1|||
162028292|NCT01328444|585159382|FG004|Washout Period (14 Days)|Adverse Event|1|||
162028293|NCT01328444|585159383|FG005|Washout Period (14 Days)|Adverse Event|2|||
162028294|NCT01328444|585159378|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
162028295|NCT01328444|585159379|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
162028296|NCT01328444|585159380|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
162028297|NCT01328444|585159381|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
162028298|NCT01328444|585159382|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
162028299|NCT01328444|585159383|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
162028300|NCT01328444|585159378|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
162028301|NCT01328444|585159379|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
162028302|NCT01328444|585159380|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
162028303|NCT01328444|585159381|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
162028304|NCT01328444|585159382|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
162028305|NCT01328444|585159383|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
162028306|NCT01328444|585159378|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
162028307|NCT01328444|585159379|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
162028308|NCT01328444|585159380|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
162028309|NCT01328444|585159381|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
162028310|NCT01328444|585159382|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
162028311|NCT01328444|585159383|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
162028312|NCT01328444|585159378|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
162028313|NCT01328444|585159379|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
162028314|NCT01328444|585159380|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
162028315|NCT01328444|585159381|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
162028316|NCT01328444|585159382|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
162028317|NCT01328444|585159383|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
162028318|NCT01328444|585159378|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
162028319|NCT01328444|585159379|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
162028320|NCT01328444|585159380|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
162028321|NCT01328444|585159381|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
162028322|NCT01328444|585159382|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
162028323|NCT01328444|585159383|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
162028324|NCT01328444|585159378|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
162028325|NCT01328444|585159379|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
162028326|NCT01328444|585159380|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
162028327|NCT01328444|585159381|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
162028328|NCT01328444|585159382|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
162028329|NCT01328444|585159383|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
162028330|NCT01328444|585159378|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
162028331|NCT01328444|585159379|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
162028332|NCT01328444|585159380|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
162028333|NCT01328444|585159381|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
162028334|NCT01328444|585159382|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
162028335|NCT01328444|585159383|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
162028336|NCT01328444|585159378|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162028337|NCT01328444|585159379|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162028338|NCT01328444|585159380|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162028339|NCT01328444|585159381|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162028340|NCT01328444|585159382|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162028341|NCT01328444|585159383|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
162028342|NCT03241368|585159388|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
162028343|NCT03241368|585159388|FG000|Overall Study|Lost to Follow-up|1|||
162028344|NCT03241368|585159388|FG000|Overall Study|Physician Decision|6|||
162028345|NCT03241368|585159388|FG000|Overall Study|Withdrawal by Subject|6|||
162028346|NCT03241368|585159388|FG000|Overall Study|Protocol Violation|1|||
162028347|NCT01119937|585159389|FG000|Overall Study|Adverse Event|11|||
162028348|NCT01119937|585159390|FG001|Overall Study|Adverse Event|5|||
162028349|NCT01119937|585159389|FG000|Overall Study|Protocol deviation|3|||
162028350|NCT01119937|585159390|FG001|Overall Study|Protocol deviation|1|||
162028351|NCT01119937|585159389|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
162028352|NCT01119937|585159390|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162028353|NCT01119937|585159389|FG000|Overall Study|Withdrawal by Subject|2|||
162028354|NCT01119937|585159390|FG001|Overall Study|Withdrawal by Subject|1|||
162028355|NCT03316911|585159391|FG000|Overall Study|Lost to Follow-up|33|||
162028356|NCT03316911|585159392|FG001|Overall Study|Lost to Follow-up|29|||
162028357|NCT01270802|585159393|FG000|Overall Study|Withdrawal by Subject|1|||
162028358|NCT01270802|585159394|FG001|Overall Study|Withdrawal by Subject|0|||
162028359|NCT01270802|585159393|FG000|Overall Study|Adverse Event|1|||
162028360|NCT01270802|585159394|FG001|Overall Study|Adverse Event|0|||
162028361|NCT01270802|585159393|FG000|Overall Study|Lost to Follow-up|0|||
162028362|NCT01270802|585159394|FG001|Overall Study|Lost to Follow-up|1|||
162028363|NCT01566214|585159395|FG000|Overall Study|Lost to Follow-up|3|||
162028364|NCT01566214|585159396|FG001|Overall Study|Lost to Follow-up|0|||
162028365|NCT04620798|585159397|FG000|Overall Study|Lost to Follow-up|126|||
162028366|NCT04620798|585159398|FG001|Overall Study|Lost to Follow-up|138|||
162028367|NCT03222492|585159406|FG000|Overall Study|Withdrawal by Subject|0|||
162028368|NCT03222492|585159407|FG001|Overall Study|Withdrawal by Subject|0|||
162028369|NCT03222492|585159408|FG002|Overall Study|Withdrawal by Subject|1|||
162028370|NCT03222492|585159409|FG003|Overall Study|Withdrawal by Subject|0|||
162028371|NCT03222492|585159406|FG000|Overall Study|COVID-19 related|0|||
162028372|NCT03222492|585159407|FG001|Overall Study|COVID-19 related|0|||
162028373|NCT03222492|585159408|FG002|Overall Study|COVID-19 related|1|||
162028374|NCT03222492|585159409|FG003|Overall Study|COVID-19 related|0|||
162028375|NCT02486627|585159413|FG000|Overall Study|Death|1|||
162028376|NCT02486627|585159414|FG001|Overall Study|Death|0|||
162028377|NCT02486627|585159413|FG000|Overall Study|Other Unspecified|0|||
162028378|NCT02486627|585159414|FG001|Overall Study|Other Unspecified|2|||
162028379|NCT02486627|585159413|FG000|Overall Study|Consent Withdrawn by Participant|4|||
162028380|NCT02486627|585159414|FG001|Overall Study|Consent Withdrawn by Participant|3|||
162028381|NCT02486627|585159413|FG000|Overall Study|Significant Participant Noncompliance|1|||
162028382|NCT02486627|585159414|FG001|Overall Study|Significant Participant Noncompliance|1|||
162028383|NCT02486627|585159413|FG000|Overall Study|Lost to Follow-up|1|||
162028384|NCT02486627|585159414|FG001|Overall Study|Lost to Follow-up|3|||
162028385|NCT02112045|585159417|FG000|Overall Study|Withdrawal by Subject|1|||
162028386|NCT02112045|585159418|FG001|Overall Study|Withdrawal by Subject|0|||
162028387|NCT00627445|585159419|FG000|Overall Study|Adverse Event|3|||
162028388|NCT00627445|585159420|FG001|Overall Study|Adverse Event|3|||
162028389|NCT00627445|585159419|FG000|Overall Study|Lack of Efficacy|0|||
162028390|NCT00627445|585159420|FG001|Overall Study|Lack of Efficacy|1|||
162028391|NCT00627445|585159419|FG000|Overall Study|Other|6|||
162028392|NCT00627445|585159420|FG001|Overall Study|Other|8|||
162028393|NCT03554486|585159421|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
162028394|NCT03554486|585159422|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
162028395|NCT03554486|585159423|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
162028396|NCT03554486|585159421|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
162028397|NCT03554486|585159422|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
162028398|NCT03554486|585159423|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
162028399|NCT03554486|585159421|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
162028400|NCT03554486|585159422|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
162028401|NCT03554486|585159423|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
162028402|NCT00796523|585159424|FG000|Overall Study|Lost to Follow-up|9|||
161684375|NCT02819635|583897892|FG000|Substudy 2, Part 2|Withdrew consent|0|||
162028403|NCT00796523|585159425|FG001|Overall Study|Lost to Follow-up|7|||
162028404|NCT02431260|585159430|FG000|Overall Study|Subject Decision|0|||
162028405|NCT02431260|585159431|FG001|Overall Study|Subject Decision|1|||
162028406|NCT02431260|585159432|FG002|Overall Study|Subject Decision|1|||
162028407|NCT02431260|585159433|FG003|Overall Study|Subject Decision|0|||
162028408|NCT02431260|585159434|FG004|Overall Study|Subject Decision|0|||
162028409|NCT02431260|585159435|FG005|Overall Study|Subject Decision|0|||
162028410|NCT02431260|585159436|FG006|Overall Study|Subject Decision|0|||
162028411|NCT02431260|585159437|FG007|Overall Study|Subject Decision|0|||
162028412|NCT02431260|585159438|FG008|Overall Study|Subject Decision|1|||
162028413|NCT02431260|585159439|FG009|Overall Study|Subject Decision|1|||
161948298|NCT01677988|584862148|FG000|Overall Study|Lack of Efficacy|2|||
161948299|NCT02629861|584862153|FG000|Overall Study|Adverse Event|7|||
161948300|NCT02629861|584862154|FG001|Overall Study|Adverse Event|5|||
161948301|NCT02629861|584862155|FG002|Overall Study|Adverse Event|4|||
161948302|NCT02629861|584862153|FG000|Overall Study|Withdrawal by Subject|5|||
161948303|NCT02629861|584862154|FG001|Overall Study|Withdrawal by Subject|8|||
161948304|NCT02629861|584862155|FG002|Overall Study|Withdrawal by Subject|13|||
161948305|NCT02629861|584862153|FG000|Overall Study|Protocol Violation|2|||
161948306|NCT02629861|584862154|FG001|Overall Study|Protocol Violation|3|||
162028414|NCT02431260|585159440|FG010|Overall Study|Subject Decision|0|||
162028415|NCT02431260|585159441|FG011|Overall Study|Subject Decision|1|||
162028416|NCT02431260|585159442|FG012|Overall Study|Subject Decision|0|||
162028417|NCT02431260|585159443|FG013|Overall Study|Subject Decision|0|||
162028418|NCT02431260|585159430|FG000|Overall Study|Death|4|||
162028419|NCT02431260|585159431|FG001|Overall Study|Death|4|||
162028420|NCT02431260|585159432|FG002|Overall Study|Death|3|||
162028421|NCT02431260|585159433|FG003|Overall Study|Death|4|||
162028422|NCT02431260|585159434|FG004|Overall Study|Death|2|||
162028423|NCT02431260|585159435|FG005|Overall Study|Death|2|||
162028424|NCT02431260|585159436|FG006|Overall Study|Death|3|||
161948307|NCT02629861|584862155|FG002|Overall Study|Protocol Violation|7|||
161948308|NCT02629861|584862153|FG000|Overall Study|Lost to Follow-up|12|||
161948309|NCT02629861|584862154|FG001|Overall Study|Lost to Follow-up|9|||
162028425|NCT02431260|585159437|FG007|Overall Study|Death|1|||
162028426|NCT02431260|585159438|FG008|Overall Study|Death|6|||
161684376|NCT02819635|583897893|FG001|Substudy 2, Part 2|Withdrew consent|0|||
161684377|NCT02819635|583897894|FG002|Substudy 2, Part 2|Withdrew consent|0|||
161684378|NCT02819635|583897895|FG003|Substudy 2, Part 2|Withdrew consent|0|||
161684379|NCT02819635|583897896|FG004|Substudy 2, Part 2|Withdrew consent|0|||
161684380|NCT02819635|583897897|FG005|Substudy 2, Part 2|Withdrew consent|3|||
161684381|NCT02819635|583897898|FG006|Substudy 2, Part 2|Withdrew consent|1|||
161684382|NCT02819635|583897899|FG007|Substudy 2, Part 2|Withdrew consent|0|||
161684383|NCT02819635|583897900|FG008|Substudy 2, Part 2|Withdrew consent|0|||
161684384|NCT02819635|583897901|FG009|Substudy 2, Part 2|Withdrew consent|0|||
161684385|NCT02819635|583897902|FG010|Substudy 2, Part 2|Withdrew consent|0|||
161684386|NCT02819635|583897903|FG011|Substudy 2, Part 2|Withdrew consent|0|||
161684387|NCT02819635|583897892|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
161684388|NCT02819635|583897893|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
161684389|NCT02819635|583897894|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
161684390|NCT02819635|583897895|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
161684391|NCT02819635|583897896|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
161684392|NCT02819635|583897897|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
161684393|NCT02819635|583897898|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
161948310|NCT02629861|584862155|FG002|Overall Study|Lost to Follow-up|4|||
161948311|NCT02629861|584862153|FG000|Overall Study|Other|1|||
161948312|NCT02629861|584862154|FG001|Overall Study|Other|1|||
161948313|NCT02629861|584862155|FG002|Overall Study|Other|0|||
161948314|NCT02629861|584862153|FG000|Overall Study|Pregnancy|2|||
161948315|NCT02629861|584862154|FG001|Overall Study|Pregnancy|1|||
161948316|NCT02629861|584862155|FG002|Overall Study|Pregnancy|0|||
161948317|NCT01822665|584862156|FG000|Overall Study|Adverse Event|3|||
161948318|NCT01822665|584862156|FG000|Overall Study|Other Reason|5|||
161948319|NCT04592341|584864007|FG000|Overall Study|Physician Decision|5|||
161948320|NCT04592341|584864007|FG000|Overall Study|Study Terminated by Sponsor|5|||
161948321|NCT04592341|584864007|FG000|Overall Study|Withdrawal by Subject|53|||
161948322|NCT04592341|584864007|FG000|Overall Study|Lost to Follow-up|3|||
161948323|NCT04592341|584864007|FG000|Overall Study|Death|1|||
161948324|NCT04592341|584864007|FG000|Overall Study|Adverse Event|5|||
161684394|NCT02819635|583897899|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
161684395|NCT02819635|583897900|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
161684396|NCT02819635|583897901|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
161948325|NCT04592341|584864007|FG000|Overall Study|other|4|||
161948326|NCT02896257|584864008|FG000|Providers|Without eligible patients|21|||
161948327|NCT02896257|584864009|FG001|Providers|Without eligible patients|28|||
161948328|NCT02896257|584864008|FG000|Patients|PFT entry criteria not met|43|||
161948329|NCT02896257|584864009|FG001|Patients|PFT entry criteria not met|50|||
161948330|NCT02896257|584864008|FG000|Patients|No capacity to review|8|||
161948331|NCT02896257|584864009|FG001|Patients|No capacity to review|11|||
161948332|NCT02896257|584864008|FG000|Patients|Appointment rescheduled/cancelled|5|||
161948333|NCT02896257|584864009|FG001|Patients|Appointment rescheduled/cancelled|7|||
161948334|NCT02896257|584864008|FG000|Patients|PCP not assigned a clinic|4|||
161948335|NCT02896257|584864009|FG001|Patients|PCP not assigned a clinic|0|||
161948336|NCT02896257|584864008|FG000|Patients|No history of COPD|0|||
161948337|NCT02896257|584864009|FG001|Patients|No history of COPD|1|||
161948338|NCT02896257|584864008|FG000|Patients|Deceased between review and index date|0|||
161948339|NCT02896257|584864009|FG001|Patients|Deceased between review and index date|1|||
161948340|NCT02896257|584864008|FG000|Patients|No ICS Rx upon review|1|||
161948341|NCT02896257|584864009|FG001|Patients|No ICS Rx upon review|1|||
161948342|NCT02896257|584864008|FG000|Patients|Protocol Violation|2|||
161948343|NCT02896257|584864009|FG001|Patients|Protocol Violation|1|||
161948344|NCT02896257|584864008|FG000|Patients|Hospice care|0|||
161948345|NCT02896257|584864009|FG001|Patients|Hospice care|1|||
161684397|NCT02819635|583897902|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
161948346|NCT03423602|584864014|FG000|Overall Study|Death|1|||
161948347|NCT03423602|584864014|FG000|Overall Study|Lost to Follow-up|6|||
161948348|NCT03423602|584864014|FG000|Overall Study|Protocol Violation|1|||
161948349|NCT03423602|584864014|FG000|Overall Study|Withdrawal by Subject|4|||
161948350|NCT02332187|584864015|FG000|Overall Study|Withdrawal by Subject|2|||
161948351|NCT02332187|584864016|FG001|Overall Study|Withdrawal by Subject|2|||
161948352|NCT02332187|584864015|FG000|Overall Study|Adverse Event|0|||
161948353|NCT02332187|584864016|FG001|Overall Study|Adverse Event|1|||
161948354|NCT02903823|584864017|FG000|Overall Study|Physician Decision|5|||
161948355|NCT02903823|584864017|FG000|Overall Study|Could not advance catheter|1|||
161948356|NCT02903823|584864017|FG000|Overall Study|Catheter dislodgement|1|||
161948357|NCT01747915|584864018|FG000|Overall Study|Other|1|||
161948358|NCT01747915|584864019|FG001|Overall Study|Other|1|||
161948359|NCT01747915|584864020|FG002|Overall Study|Other|1|||
161948360|NCT01747915|584864018|FG000|Overall Study|Adverse Event|8|||
161948361|NCT01747915|584864019|FG001|Overall Study|Adverse Event|5|||
161948362|NCT01747915|584864020|FG002|Overall Study|Adverse Event|2|||
161948363|NCT01747915|584864018|FG000|Overall Study|Death|0|||
161684398|NCT02819635|583897903|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
161684399|NCT02819635|583897892|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161684400|NCT02819635|583897893|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161948364|NCT01747915|584864019|FG001|Overall Study|Death|0|||
161948365|NCT01747915|584864020|FG002|Overall Study|Death|1|||
161948366|NCT01747915|584864018|FG000|Overall Study|Lack of Efficacy|0|||
161948367|NCT01747915|584864019|FG001|Overall Study|Lack of Efficacy|1|||
161948368|NCT01747915|584864020|FG002|Overall Study|Lack of Efficacy|0|||
161948369|NCT01747915|584864018|FG000|Overall Study|Lost to Follow-up|1|||
161948370|NCT01747915|584864019|FG001|Overall Study|Lost to Follow-up|0|||
161948371|NCT01747915|584864020|FG002|Overall Study|Lost to Follow-up|0|||
161948372|NCT01747915|584864018|FG000|Overall Study|Withdrawal by Subject|4|||
162028427|NCT02431260|585159439|FG009|Overall Study|Death|6|||
162028428|NCT02431260|585159440|FG010|Overall Study|Death|3|||
162028429|NCT02431260|585159441|FG011|Overall Study|Death|2|||
162028430|NCT02431260|585159442|FG012|Overall Study|Death|5|||
162028431|NCT02431260|585159443|FG013|Overall Study|Death|1|||
162028432|NCT02431260|585159430|FG000|Overall Study|Lost to Follow-up|0|||
162028433|NCT02431260|585159431|FG001|Overall Study|Lost to Follow-up|0|||
162028434|NCT02431260|585159432|FG002|Overall Study|Lost to Follow-up|0|||
162028435|NCT02431260|585159433|FG003|Overall Study|Lost to Follow-up|0|||
162028436|NCT02431260|585159434|FG004|Overall Study|Lost to Follow-up|0|||
162028437|NCT02431260|585159435|FG005|Overall Study|Lost to Follow-up|1|||
162028438|NCT02431260|585159436|FG006|Overall Study|Lost to Follow-up|0|||
162028439|NCT02431260|585159437|FG007|Overall Study|Lost to Follow-up|0|||
162028440|NCT02431260|585159438|FG008|Overall Study|Lost to Follow-up|0|||
162028441|NCT02431260|585159439|FG009|Overall Study|Lost to Follow-up|0|||
162028442|NCT02431260|585159440|FG010|Overall Study|Lost to Follow-up|0|||
162028443|NCT02431260|585159441|FG011|Overall Study|Lost to Follow-up|0|||
162028444|NCT02431260|585159442|FG012|Overall Study|Lost to Follow-up|0|||
162028445|NCT02431260|585159443|FG013|Overall Study|Lost to Follow-up|0|||
161948373|NCT01747915|584864019|FG001|Overall Study|Withdrawal by Subject|4|||
161948374|NCT01747915|584864020|FG002|Overall Study|Withdrawal by Subject|1|||
161948375|NCT01747915|584864018|FG000|Overall Study|Protocol Violation|1|||
161948376|NCT01747915|584864019|FG001|Overall Study|Protocol Violation|0|||
161948377|NCT01747915|584864020|FG002|Overall Study|Protocol Violation|0|||
161948378|NCT01747915|584864018|FG000|Overall Study|Pregnancy|0|||
161948379|NCT01747915|584864019|FG001|Overall Study|Pregnancy|0|||
161948380|NCT01747915|584864020|FG002|Overall Study|Pregnancy|1|||
161948381|NCT03341637|584864021|FG000|Overall Study|Lost to Follow-up|1|||
161948382|NCT03341637|584864022|FG001|Overall Study|Lost to Follow-up|0|||
161948383|NCT03341637|584864021|FG000|Overall Study|Withdrawal by Subject|3|||
161948384|NCT03341637|584864022|FG001|Overall Study|Withdrawal by Subject|3|||
161948385|NCT03341637|584864021|FG000|Overall Study|Reason not Specified|1|||
161948386|NCT03341637|584864022|FG001|Overall Study|Reason not Specified|1|||
161948387|NCT01462929|584864029|FG000|Overall Study|Adverse Event|3|||
161948388|NCT01462929|584864030|FG001|Overall Study|Adverse Event|3|||
162028446|NCT02431260|585159430|FG000|Overall Study|Study Terminated by the Sponsor|0|||
162028447|NCT02431260|585159431|FG001|Overall Study|Study Terminated by the Sponsor|0|||
162028448|NCT02431260|585159432|FG002|Overall Study|Study Terminated by the Sponsor|2|||
162028449|NCT02431260|585159433|FG003|Overall Study|Study Terminated by the Sponsor|1|||
161832597|NCT00706355|584428477|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
161948389|NCT01462929|584864031|FG002|Overall Study|Adverse Event|4|||
161948390|NCT01462929|584864029|FG000|Overall Study|Withdrawal by Subject|2|||
161948391|NCT01462929|584864030|FG001|Overall Study|Withdrawal by Subject|1|||
161948392|NCT01462929|584864031|FG002|Overall Study|Withdrawal by Subject|0|||
161948393|NCT01462929|584864029|FG000|Overall Study|Lack of Efficacy|0|||
161832598|NCT00706355|584428478|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
161948394|NCT01462929|584864030|FG001|Overall Study|Lack of Efficacy|0|||
161832599|NCT00706355|584428479|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
161948395|NCT01462929|584864031|FG002|Overall Study|Lack of Efficacy|1|||
161948396|NCT00887159|584864032|FG000|Overall Study|Disease progression|6|||
161832600|NCT00706355|584428476|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
161832601|NCT00706355|584428477|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
161832602|NCT00706355|584428478|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
161948397|NCT00887159|584864033|FG001|Overall Study|Disease progression|39|||
161948398|NCT00887159|584864034|FG002|Overall Study|Disease progression|33|||
161948399|NCT00887159|584864032|FG000|Overall Study|Adverse Event|3|||
161832603|NCT00706355|584428479|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
161832604|NCT00706355|584428476|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
161832605|NCT00706355|584428477|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
161832606|NCT00706355|584428478|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
161832607|NCT00706355|584428479|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
161684401|NCT02819635|583897894|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161684402|NCT02819635|583897895|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161684403|NCT02819635|583897896|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161684404|NCT02819635|583897897|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161948400|NCT00887159|584864033|FG001|Overall Study|Adverse Event|4|||
161832608|NCT00706355|584428476|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
161832609|NCT00706355|584428477|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
161832610|NCT00706355|584428478|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
161948401|NCT00887159|584864034|FG002|Overall Study|Adverse Event|17|||
161948402|NCT00887159|584864032|FG000|Overall Study|Death|2|||
161948403|NCT00887159|584864033|FG001|Overall Study|Death|2|||
161948404|NCT00887159|584864034|FG002|Overall Study|Death|0|||
161948405|NCT00887159|584864032|FG000|Overall Study|Withdrawal by Subject|4|||
161948406|NCT00887159|584864033|FG001|Overall Study|Withdrawal by Subject|4|||
161948407|NCT00887159|584864034|FG002|Overall Study|Withdrawal by Subject|2|||
161948408|NCT00887159|584864032|FG000|Overall Study|Alternative therapy|2|||
161948409|NCT00887159|584864033|FG001|Overall Study|Alternative therapy|0|||
161948410|NCT00887159|584864034|FG002|Overall Study|Alternative therapy|0|||
161948411|NCT00887159|584864032|FG000|Overall Study|Physician Decision|1|||
161948412|NCT00887159|584864033|FG001|Overall Study|Physician Decision|1|||
161948413|NCT00887159|584864034|FG002|Overall Study|Physician Decision|0|||
161948414|NCT00887159|584864032|FG000|Overall Study|Sympomatic deterioration|1|||
161948415|NCT00887159|584864033|FG001|Overall Study|Sympomatic deterioration|0|||
161948416|NCT00887159|584864034|FG002|Overall Study|Sympomatic deterioration|0|||
161948417|NCT00887159|584864032|FG000|Overall Study|Treatment delayed|1|||
162028450|NCT02431260|585159434|FG004|Overall Study|Study Terminated by the Sponsor|1|||
161948418|NCT00887159|584864033|FG001|Overall Study|Treatment delayed|1|||
161948419|NCT00887159|584864034|FG002|Overall Study|Treatment delayed|0|||
161948420|NCT00887159|584864032|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
161948421|NCT00887159|584864033|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
161948422|NCT00887159|584864034|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
161948423|NCT00887159|584864032|FG000|Overall Study|Received more tx instead of observation|1|||
161832611|NCT00706355|584428479|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
161832612|NCT00706355|584428476|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
161832613|NCT00706355|584428477|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
161832614|NCT00706355|584428478|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
161948424|NCT00887159|584864033|FG001|Overall Study|Received more tx instead of observation|0|||
161832615|NCT00706355|584428479|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
161832616|NCT00706355|584428476|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
161832617|NCT00706355|584428477|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
161832618|NCT00706355|584428478|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
161832619|NCT00706355|584428479|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
161832620|NCT02549573|584428482|FG000|Overall Study|Withdrawal by Subject|0|||
161832621|NCT02549573|584428483|FG001|Overall Study|Withdrawal by Subject|2|||
161832622|NCT02549573|584428482|FG000|Overall Study|Protocol Violation|0|||
161832623|NCT02549573|584428483|FG001|Overall Study|Protocol Violation|1|||
161832624|NCT02610816|584428486|FG000|Phase 1|Withdrawal by Subject|2|||
161832625|NCT02610816|584428487|FG001|Phase 1|Withdrawal by Subject|6|||
161832626|NCT02610816|584428488|FG002|Phase 1|Withdrawal by Subject|0|||
161832627|NCT02610816|584428489|FG003|Phase 1|Withdrawal by Subject|0|||
161832628|NCT02610816|584428486|FG000|Phase 1|Lost to Follow-up|2|||
161832629|NCT02610816|584428487|FG001|Phase 1|Lost to Follow-up|1|||
161832630|NCT02610816|584428488|FG002|Phase 1|Lost to Follow-up|0|||
161832631|NCT02610816|584428489|FG003|Phase 1|Lost to Follow-up|0|||
161832632|NCT02610816|584428486|FG000|Phase 1|Physician Decision|0|||
161832633|NCT02610816|584428487|FG001|Phase 1|Physician Decision|1|||
161832634|NCT02610816|584428488|FG002|Phase 1|Physician Decision|0|||
161832635|NCT02610816|584428489|FG003|Phase 1|Physician Decision|0|||
161832636|NCT02610816|584428486|FG000|Phase 2|Withdrawal by Subject|0|||
161832637|NCT02610816|584428487|FG001|Phase 2|Withdrawal by Subject|0|||
161832638|NCT02610816|584428488|FG002|Phase 2|Withdrawal by Subject|9|||
161832639|NCT02610816|584428489|FG003|Phase 2|Withdrawal by Subject|3|||
161832640|NCT02610816|584428486|FG000|Phase 2|Lost to Follow-up|0|||
161832641|NCT02610816|584428487|FG001|Phase 2|Lost to Follow-up|0|||
161832642|NCT02610816|584428488|FG002|Phase 2|Lost to Follow-up|2|||
161832643|NCT02610816|584428489|FG003|Phase 2|Lost to Follow-up|0|||
161832644|NCT02610816|584428486|FG000|Phase 2|Physician Decision|0|||
161832645|NCT02610816|584428487|FG001|Phase 2|Physician Decision|0|||
161832646|NCT02610816|584428488|FG002|Phase 2|Physician Decision|0|||
161832647|NCT02610816|584428489|FG003|Phase 2|Physician Decision|2|||
161832648|NCT02610816|584428486|FG000|Phase 2|Pregnancy|0|||
161832649|NCT02610816|584428487|FG001|Phase 2|Pregnancy|0|||
161832650|NCT02610816|584428488|FG002|Phase 2|Pregnancy|0|||
161832651|NCT02610816|584428489|FG003|Phase 2|Pregnancy|1|||
161832652|NCT02139124|584428490|FG000|Overall Study|Adverse Event|2|||
161832653|NCT02139124|584428491|FG001|Overall Study|Adverse Event|0|||
161832654|NCT02139124|584428492|FG002|Overall Study|Adverse Event|1|||
161832655|NCT02139124|584428493|FG003|Overall Study|Adverse Event|2|||
161832656|NCT02139124|584428494|FG004|Overall Study|Adverse Event|5|||
161832657|NCT02139124|584428490|FG000|Overall Study|Withdrawal by Subject|2|||
161832658|NCT02139124|584428491|FG001|Overall Study|Withdrawal by Subject|2|||
161832659|NCT02139124|584428492|FG002|Overall Study|Withdrawal by Subject|2|||
161832660|NCT02139124|584428493|FG003|Overall Study|Withdrawal by Subject|2|||
161832661|NCT02139124|584428494|FG004|Overall Study|Withdrawal by Subject|3|||
161948425|NCT00887159|584864034|FG002|Overall Study|Received more tx instead of observation|0|||
161948426|NCT00887159|584864032|FG000|Overall Study|Ineligible|5|||
161948427|NCT00887159|584864033|FG001|Overall Study|Ineligible|1|||
161948428|NCT00887159|584864034|FG002|Overall Study|Ineligible|0|||
161948429|NCT00887159|584864032|FG000|Overall Study|Never started assigned therapy|3|||
161948430|NCT00887159|584864033|FG001|Overall Study|Never started assigned therapy|3|||
161948431|NCT00887159|584864034|FG002|Overall Study|Never started assigned therapy|4|||
161948432|NCT06164691|584864036|FG000|Overall Study|Withdrawal by Subject|2|||
161832662|NCT02139124|584428490|FG000|Overall Study|Protocol Violation|0|||
161948433|NCT06164691|584864037|FG001|Overall Study|Withdrawal by Subject|0|||
161948434|NCT06164691|584864038|FG002|Overall Study|Withdrawal by Subject|0|||
161948435|NCT00812955|584864039|FG000|Overall Study|Adverse Event|7|||
161948436|NCT00812955|584864040|FG001|Overall Study|Adverse Event|6|||
161948437|NCT00812955|584864041|FG002|Overall Study|Adverse Event|3|||
161948438|NCT00812955|584864042|FG003|Overall Study|Adverse Event|4|||
161948439|NCT00812955|584864039|FG000|Overall Study|Lost to Follow-up|2|||
161948440|NCT00812955|584864040|FG001|Overall Study|Lost to Follow-up|1|||
161948441|NCT00812955|584864041|FG002|Overall Study|Lost to Follow-up|1|||
161948442|NCT00812955|584864042|FG003|Overall Study|Lost to Follow-up|2|||
161684405|NCT02819635|583897898|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
161684406|NCT02819635|583897899|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161684407|NCT02819635|583897900|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161948443|NCT00812955|584864039|FG000|Overall Study|Withdrawal by Subject|1|||
161948444|NCT00812955|584864040|FG001|Overall Study|Withdrawal by Subject|0|||
161832663|NCT02139124|584428491|FG001|Overall Study|Protocol Violation|0|||
161832664|NCT02139124|584428492|FG002|Overall Study|Protocol Violation|0|||
161832665|NCT02139124|584428493|FG003|Overall Study|Protocol Violation|1|||
161832666|NCT02139124|584428494|FG004|Overall Study|Protocol Violation|1|||
161832667|NCT02139124|584428490|FG000|Overall Study|non-compliant|1|||
161832668|NCT02139124|584428491|FG001|Overall Study|non-compliant|0|||
161832669|NCT02139124|584428492|FG002|Overall Study|non-compliant|0|||
161832670|NCT02139124|584428493|FG003|Overall Study|non-compliant|2|||
161832671|NCT02139124|584428494|FG004|Overall Study|non-compliant|0|||
161832672|NCT02139124|584428490|FG000|Overall Study|incarceration|0|||
161832673|NCT02139124|584428491|FG001|Overall Study|incarceration|0|||
161832674|NCT02139124|584428492|FG002|Overall Study|incarceration|1|||
161832675|NCT02139124|584428493|FG003|Overall Study|incarceration|0|||
161832676|NCT02139124|584428494|FG004|Overall Study|incarceration|0|||
162028451|NCT02431260|585159435|FG005|Overall Study|Study Terminated by the Sponsor|0|||
162028452|NCT02431260|585159436|FG006|Overall Study|Study Terminated by the Sponsor|1|||
162028453|NCT02431260|585159437|FG007|Overall Study|Study Terminated by the Sponsor|2|||
162028454|NCT02431260|585159438|FG008|Overall Study|Study Terminated by the Sponsor|1|||
162028455|NCT02431260|585159439|FG009|Overall Study|Study Terminated by the Sponsor|1|||
161832677|NCT02139124|584428490|FG000|Overall Study|subject moved|1|||
161832678|NCT02139124|584428491|FG001|Overall Study|subject moved|0|||
161832679|NCT02139124|584428492|FG002|Overall Study|subject moved|0|||
161948445|NCT00812955|584864041|FG002|Overall Study|Withdrawal by Subject|1|||
161948446|NCT00812955|584864042|FG003|Overall Study|Withdrawal by Subject|2|||
161948447|NCT00812955|584864039|FG000|Overall Study|randomized in error|0|||
161948448|NCT00812955|584864040|FG001|Overall Study|randomized in error|0|||
161948449|NCT00812955|584864041|FG002|Overall Study|randomized in error|1|||
161948450|NCT00812955|584864042|FG003|Overall Study|randomized in error|0|||
161948451|NCT03046446|584864043|FG000|Overall Study|Lack of Efficacy|7|||
161948452|NCT03046446|584864043|FG000|Overall Study|Adverse Event|6|||
162028456|NCT02431260|585159440|FG010|Overall Study|Study Terminated by the Sponsor|1|||
162028457|NCT02431260|585159441|FG011|Overall Study|Study Terminated by the Sponsor|0|||
162028458|NCT02431260|585159442|FG012|Overall Study|Study Terminated by the Sponsor|4|||
162028459|NCT02431260|585159443|FG013|Overall Study|Study Terminated by the Sponsor|0|||
162028460|NCT02431260|585159430|FG000|Overall Study|Physician Decision|0|||
161948453|NCT03046446|584864043|FG000|Overall Study|Lost to Follow-up|3|||
161948454|NCT03046446|584864043|FG000|Overall Study|Withdrawal by Subject|14|||
161948455|NCT03046446|584864043|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
161948456|NCT03046446|584864043|FG000|Overall Study|Disease Progression (see caveats)|25|||
162028461|NCT02431260|585159431|FG001|Overall Study|Physician Decision|0|||
161684408|NCT02819635|583897901|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
162028462|NCT02431260|585159432|FG002|Overall Study|Physician Decision|0|||
161948457|NCT03046446|584864043|FG000|Overall Study|Non OA related knee surgery|1|||
161948458|NCT03183063|584864044|FG000|Overall Study|Withdrawal by Subject|2|||
161948459|NCT03183063|584864045|FG001|Overall Study|Withdrawal by Subject|0|||
161948460|NCT03183063|584864046|FG002|Overall Study|Withdrawal by Subject|0|||
161948461|NCT03183063|584864044|FG000|Overall Study|Physician Decision|3|||
161948462|NCT03183063|584864045|FG001|Overall Study|Physician Decision|4|||
161948463|NCT03183063|584864046|FG002|Overall Study|Physician Decision|4|||
161948464|NCT00399568|584864047|FG000|Overall Study|Adverse Event|1|||
161948465|NCT00399568|584864048|FG001|Overall Study|Adverse Event|2|||
161948466|NCT00399568|584864047|FG000|Overall Study|Withdrawal by Subject|7|||
161948467|NCT00399568|584864048|FG001|Overall Study|Withdrawal by Subject|3|||
161948468|NCT00399568|584864047|FG000|Overall Study|Protocol non-compliance|2|||
161948469|NCT00399568|584864048|FG001|Overall Study|Protocol non-compliance|2|||
161948470|NCT00399568|584864047|FG000|Overall Study|Lost to Follow-up|2|||
161948471|NCT00399568|584864048|FG001|Overall Study|Lost to Follow-up|2|||
161684409|NCT02819635|583897902|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161948472|NCT00925002|584864049|FG000|Overall Study|Other|1|||
161948473|NCT00925002|584864050|FG001|Overall Study|Other|4|||
161948474|NCT00925002|584864051|FG002|Overall Study|Other|0|||
161948475|NCT00925002|584864049|FG000|Overall Study|Death|1|||
161948476|NCT00925002|584864050|FG001|Overall Study|Death|1|||
161948477|NCT00925002|584864051|FG002|Overall Study|Death|5|||
161948478|NCT00925002|584864049|FG000|Overall Study|Adverse Event|3|||
161948479|NCT00925002|584864050|FG001|Overall Study|Adverse Event|1|||
161948480|NCT00925002|584864051|FG002|Overall Study|Adverse Event|2|||
161948481|NCT00925002|584864049|FG000|Overall Study|Participant withdrew consent|1|||
161948482|NCT00925002|584864050|FG001|Overall Study|Participant withdrew consent|3|||
161948483|NCT00925002|584864051|FG002|Overall Study|Participant withdrew consent|3|||
161948484|NCT00558636|584864054|FG000|Treatment|Adverse Event|9|||
161948485|NCT00558636|584864055|FG001|Treatment|Adverse Event|2|||
161948486|NCT00558636|584864054|FG000|Treatment|Withdrawal by Subject|2|||
161948487|NCT00558636|584864055|FG001|Treatment|Withdrawal by Subject|0|||
161948488|NCT00558636|584864054|FG000|Treatment|Premature termination of the study|35|||
161948489|NCT00558636|584864055|FG001|Treatment|Premature termination of the study|37|||
161948490|NCT00558636|584864054|FG000|Treatment|Disease progression|1|||
161948491|NCT00558636|584864055|FG001|Treatment|Disease progression|5|||
161948492|NCT00558636|584864054|FG000|Follow-up|Premature termination of the study|12|||
161948493|NCT00558636|584864055|FG001|Follow-up|Premature termination of the study|7|||
161948494|NCT01990742|584864056|FG000|Overall Study|Withdrawal by facility|407|||
161948495|NCT01990742|584864057|FG001|Overall Study|Withdrawal by facility|1083|||
161948496|NCT01990742|584864056|FG000|Overall Study|Facility closed|0|||
161948497|NCT01990742|584864057|FG001|Overall Study|Facility closed|270|||
161948498|NCT03443687|584864058|FG000|Overall Study|Lost to Follow-up|3|||
161948499|NCT03443687|584864059|FG001|Overall Study|Lost to Follow-up|5|||
161948500|NCT03443687|584864058|FG000|Overall Study|Withdrawal by Subject|1|||
161948501|NCT03443687|584864059|FG001|Overall Study|Withdrawal by Subject|0|||
161948502|NCT03443687|584864058|FG000|Overall Study|Discontinued intervention|1|||
161948503|NCT03443687|584864059|FG001|Overall Study|Discontinued intervention|1|||
161948504|NCT00800735|584864060|FG000|Overall Study|Administrative/Other|2|||
161948505|NCT00800735|584864060|FG000|Overall Study|Insufficient Therapeutic Response|2|||
161948506|NCT00800735|584864060|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
161948507|NCT00800735|584864060|FG000|Overall Study|Withdrew Consent|3|||
161948508|NCT02805790|584864061|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
161948509|NCT02805790|584864062|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
161948510|NCT00506142|584864063|FG000|Overall Study|Adverse Event|8|||
161948511|NCT00506142|584864064|FG001|Overall Study|Adverse Event|7|||
161948512|NCT00506142|584864063|FG000|Overall Study|Lack of Efficacy|21|||
161948513|NCT00506142|584864064|FG001|Overall Study|Lack of Efficacy|7|||
161948514|NCT00506142|584864063|FG000|Overall Study|Withdrawal by Subject|4|||
161948515|NCT00506142|584864064|FG001|Overall Study|Withdrawal by Subject|5|||
161948516|NCT00506142|584864063|FG000|Overall Study|Physician Decision|1|||
161948517|NCT00506142|584864064|FG001|Overall Study|Physician Decision|0|||
161948518|NCT00506142|584864063|FG000|Overall Study|New health condition|1|||
161948519|NCT00506142|584864064|FG001|Overall Study|New health condition|0|||
161948520|NCT03273907|584864065|FG000|Overall Study|Death|1|||
161948521|NCT03273907|584864065|FG000|Overall Study|Lost to Follow-up|4|||
161948522|NCT03273907|584864065|FG000|Overall Study|Withdrawal by Subject|2|||
161948523|NCT03273907|584864065|FG000|Overall Study|COVID 19|2|||
161948524|NCT01673646|584864066|FG000|Overall Study|Adverse Event|2|||
161948525|NCT01673646|584864067|FG001|Overall Study|Adverse Event|1|||
161948526|NCT01673646|584864068|FG002|Overall Study|Adverse Event|1|||
161948527|NCT01673646|584864066|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161948528|NCT01673646|584864067|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161948529|NCT01673646|584864068|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161948530|NCT01673646|584864066|FG000|Overall Study|Condition no longer requires study drug|0|||
161948531|NCT01673646|584864067|FG001|Overall Study|Condition no longer requires study drug|1|||
161948532|NCT01673646|584864068|FG002|Overall Study|Condition no longer requires study drug|0|||
161948533|NCT01673646|584864066|FG000|Overall Study|Withdrawal by Subject|0|||
161948534|NCT01673646|584864067|FG001|Overall Study|Withdrawal by Subject|2|||
161948535|NCT01673646|584864068|FG002|Overall Study|Withdrawal by Subject|2|||
161948536|NCT01673646|584864066|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
161948537|NCT01673646|584864067|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
161684410|NCT02819635|583897903|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161948538|NCT01673646|584864068|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
161948539|NCT00382174|584864072|FG000|Overall Study|Lost to Follow-up|1|||
161948540|NCT00382174|584864073|FG001|Overall Study|Lost to Follow-up|4|||
161948541|NCT00382174|584864074|FG002|Overall Study|Lost to Follow-up|5|||
161948542|NCT00382174|584864072|FG000|Overall Study|Adverse Event|1|||
161948543|NCT00382174|584864073|FG001|Overall Study|Adverse Event|4|||
161948544|NCT00382174|584864074|FG002|Overall Study|Adverse Event|5|||
161948545|NCT00382174|584864072|FG000|Overall Study|Withdrawal by Subject|1|||
161948546|NCT00382174|584864073|FG001|Overall Study|Withdrawal by Subject|4|||
161948547|NCT00382174|584864074|FG002|Overall Study|Withdrawal by Subject|5|||
161948548|NCT00382174|584864072|FG000|Overall Study|Non compliance|1|||
161948549|NCT00382174|584864073|FG001|Overall Study|Non compliance|0|||
161948550|NCT00382174|584864074|FG002|Overall Study|Non compliance|1|||
161948551|NCT00382174|584864072|FG000|Overall Study|Physician Decision|0|||
161948552|NCT00382174|584864073|FG001|Overall Study|Physician Decision|2|||
161948553|NCT00382174|584864074|FG002|Overall Study|Physician Decision|2|||
161948554|NCT00382174|584864072|FG000|Overall Study|Failed to meet criteria|0|||
161948555|NCT00382174|584864073|FG001|Overall Study|Failed to meet criteria|1|||
161948556|NCT00382174|584864074|FG002|Overall Study|Failed to meet criteria|1|||
161948557|NCT00382174|584864072|FG000|Overall Study|Wounds merged|0|||
161948558|NCT00382174|584864073|FG001|Overall Study|Wounds merged|2|||
161948559|NCT00382174|584864074|FG002|Overall Study|Wounds merged|2|||
161948560|NCT04577781|584864075|FG000|Overall Study|Adverse Event|2|||
161948561|NCT04577781|584864076|FG001|Overall Study|Adverse Event|2|||
161948562|NCT04577781|584864075|FG000|Overall Study|Physician Decision|1|||
161948563|NCT04577781|584864076|FG001|Overall Study|Physician Decision|0|||
161948564|NCT01464879|584864077|FG000|Overall Study|Physician Decision|1|||
161948565|NCT01464879|584864077|FG000|Overall Study|Non-compliance|1|||
161948566|NCT01657305|584864078|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
161948567|NCT01657305|584864078|FG000|Overall Study|Withdrawal by Subject|4|||
161948568|NCT01657305|584864078|FG000|Overall Study|Adverse Event|1|||
161948569|NCT01657305|584864078|FG000|Overall Study|Lost to Follow-up|1|||
161948570|NCT01657305|584864078|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
161684411|NCT02819635|583897892|FG000|Substudy 2, Part 2|Other, not specified|0|||
161684412|NCT02819635|583897893|FG001|Substudy 2, Part 2|Other, not specified|0|||
161684413|NCT02819635|583897894|FG002|Substudy 2, Part 2|Other, not specified|0|||
161684414|NCT02819635|583897895|FG003|Substudy 2, Part 2|Other, not specified|0|||
161684415|NCT02819635|583897896|FG004|Substudy 2, Part 2|Other, not specified|0|||
161684416|NCT02819635|583897897|FG005|Substudy 2, Part 2|Other, not specified|4|||
161684417|NCT02819635|583897898|FG006|Substudy 2, Part 2|Other, not specified|8|||
161684418|NCT02819635|583897899|FG007|Substudy 2, Part 2|Other, not specified|0|||
161684419|NCT02819635|583897900|FG008|Substudy 2, Part 2|Other, not specified|0|||
161948571|NCT00940602|584864080|FG000|Overall Study|Administrative problems|1|||
161948572|NCT00940602|584864081|FG001|Overall Study|Administrative problems|1|||
161948573|NCT00940602|584864080|FG000|Overall Study|Patient/guardian decision|13|||
161832680|NCT02139124|584428493|FG003|Overall Study|subject moved|0|||
161948574|NCT00940602|584864081|FG001|Overall Study|Patient/guardian decision|28|||
161684420|NCT02819635|583897901|FG009|Substudy 2, Part 2|Other, not specified|0|||
161684421|NCT02819635|583897902|FG010|Substudy 2, Part 2|Other, not specified|0|||
161684422|NCT02819635|583897903|FG011|Substudy 2, Part 2|Other, not specified|0|||
161684423|NCT02819635|583897892|FG000|Substudy 3|Adverse Event|0|||
161684424|NCT02819635|583897893|FG001|Substudy 3|Adverse Event|0|||
161684425|NCT02819635|583897894|FG002|Substudy 3|Adverse Event|0|||
161684426|NCT02819635|583897895|FG003|Substudy 3|Adverse Event|0|||
161948575|NCT00940602|584864080|FG000|Overall Study|Physician Decision|8|||
161948576|NCT00940602|584864081|FG001|Overall Study|Physician Decision|5|||
161948577|NCT00940602|584864080|FG000|Overall Study|Pregnancy|1|||
161948578|NCT00940602|584864081|FG001|Overall Study|Pregnancy|0|||
161948579|NCT00940602|584864080|FG000|Overall Study|Protocol Deviation (untreated)|1|||
161948580|NCT00940602|584864081|FG001|Overall Study|Protocol Deviation (untreated)|0|||
161948581|NCT00940602|584864080|FG000|Overall Study|Disease progression|8|||
161948582|NCT00940602|584864081|FG001|Overall Study|Disease progression|2|||
161948583|NCT00940602|584864080|FG000|Overall Study|Death|38|||
161948584|NCT00940602|584864081|FG001|Overall Study|Death|19|||
161948585|NCT00940602|584864080|FG000|Overall Study|Lost to Follow-up|3|||
161948586|NCT00940602|584864081|FG001|Overall Study|Lost to Follow-up|1|||
161948587|NCT00940602|584864080|FG000|Overall Study|Patient withdrew consent|26|||
161948588|NCT00940602|584864081|FG001|Overall Study|Patient withdrew consent|13|||
161948589|NCT00940602|584864080|FG000|Overall Study|Adverse Event|7|||
161948590|NCT00940602|584864081|FG001|Overall Study|Adverse Event|2|||
161948591|NCT00940602|584864080|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
161684427|NCT02819635|583897896|FG004|Substudy 3|Adverse Event|0|||
161684428|NCT02819635|583897897|FG005|Substudy 3|Adverse Event|0|||
161684429|NCT02819635|583897898|FG006|Substudy 3|Adverse Event|0|||
161948592|NCT00940602|584864081|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
161948593|NCT00575666|584864082|FG000|Overall Study|Withdrawal by Subject|3|||
161684430|NCT02819635|583897899|FG007|Substudy 3|Adverse Event|0|||
161684431|NCT02819635|583897900|FG008|Substudy 3|Adverse Event|32|||
161684432|NCT02819635|583897901|FG009|Substudy 3|Adverse Event|3|||
161948594|NCT00575666|584864083|FG001|Overall Study|Withdrawal by Subject|2|||
161684433|NCT02819635|583897902|FG010|Substudy 3|Adverse Event|12|||
161684434|NCT02819635|583897903|FG011|Substudy 3|Adverse Event|18|||
161684435|NCT02819635|583897892|FG000|Substudy 3|Withdrew consent|0|||
161684436|NCT02819635|583897893|FG001|Substudy 3|Withdrew consent|0|||
161684437|NCT02819635|583897894|FG002|Substudy 3|Withdrew consent|0|||
161684438|NCT02819635|583897895|FG003|Substudy 3|Withdrew consent|0|||
161684439|NCT02819635|583897896|FG004|Substudy 3|Withdrew consent|0|||
161684440|NCT02819635|583897897|FG005|Substudy 3|Withdrew consent|0|||
162028463|NCT02431260|585159433|FG003|Overall Study|Physician Decision|0|||
162028464|NCT02431260|585159434|FG004|Overall Study|Physician Decision|0|||
161684441|NCT02819635|583897898|FG006|Substudy 3|Withdrew consent|0|||
161684442|NCT02819635|583897899|FG007|Substudy 3|Withdrew consent|0|||
161684443|NCT02819635|583897900|FG008|Substudy 3|Withdrew consent|11|||
162028465|NCT02431260|585159435|FG005|Overall Study|Physician Decision|1|||
161684444|NCT02819635|583897901|FG009|Substudy 3|Withdrew consent|1|||
161684445|NCT02819635|583897902|FG010|Substudy 3|Withdrew consent|4|||
162028466|NCT02431260|585159436|FG006|Overall Study|Physician Decision|0|||
161948595|NCT00575666|584864082|FG000|Overall Study|Physician Decision|1|||
161948596|NCT00575666|584864083|FG001|Overall Study|Physician Decision|1|||
161684446|NCT02819635|583897903|FG011|Substudy 3|Withdrew consent|9|||
161948597|NCT01374425|584864084|FG000|Overall Study|Radiographic Disease Progression|86|||
161948598|NCT01374425|584864085|FG001|Overall Study|Radiographic Disease Progression|81|||
161684447|NCT02819635|583897892|FG000|Substudy 3|Lost to Follow-up|0|||
161948599|NCT01374425|584864084|FG000|Overall Study|Clinical Disease Progression|9|||
161948600|NCT01374425|584864085|FG001|Overall Study|Clinical Disease Progression|6|||
161948601|NCT01374425|584864084|FG000|Overall Study|Adverse Event|29|||
162028467|NCT02431260|585159437|FG007|Overall Study|Physician Decision|0|||
161684448|NCT02819635|583897893|FG001|Substudy 3|Lost to Follow-up|0|||
161948602|NCT01374425|584864085|FG001|Overall Study|Adverse Event|18|||
161948603|NCT01374425|584864084|FG000|Overall Study|Death (Progression of Disease)|1|||
162028468|NCT02431260|585159438|FG008|Overall Study|Physician Decision|0|||
162028469|NCT02431260|585159439|FG009|Overall Study|Physician Decision|0|||
162028470|NCT02431260|585159440|FG010|Overall Study|Physician Decision|0|||
162028471|NCT02431260|585159441|FG011|Overall Study|Physician Decision|0|||
162028472|NCT02431260|585159442|FG012|Overall Study|Physician Decision|0|||
161684449|NCT02819635|583897894|FG002|Substudy 3|Lost to Follow-up|0|||
161684450|NCT02819635|583897895|FG003|Substudy 3|Lost to Follow-up|0|||
161684451|NCT02819635|583897896|FG004|Substudy 3|Lost to Follow-up|0|||
161684452|NCT02819635|583897897|FG005|Substudy 3|Lost to Follow-up|0|||
161832681|NCT02139124|584428494|FG004|Overall Study|subject moved|0|||
161684453|NCT02819635|583897898|FG006|Substudy 3|Lost to Follow-up|0|||
161684454|NCT02819635|583897899|FG007|Substudy 3|Lost to Follow-up|0|||
161948604|NCT01374425|584864085|FG001|Overall Study|Death (Progression of Disease)|0|||
161948605|NCT01374425|584864084|FG000|Overall Study|Death (Adverse Event)|2|||
161948606|NCT01374425|584864085|FG001|Overall Study|Death (Adverse Event)|4|||
161832682|NCT02139124|584428490|FG000|Overall Study|Lost to Follow-up|3|||
161832683|NCT02139124|584428491|FG001|Overall Study|Lost to Follow-up|2|||
161832684|NCT02139124|584428492|FG002|Overall Study|Lost to Follow-up|0|||
161832685|NCT02139124|584428493|FG003|Overall Study|Lost to Follow-up|5|||
161832686|NCT02139124|584428494|FG004|Overall Study|Lost to Follow-up|4|||
161832687|NCT00613834|584428495|FG000|Overall Study|Withdrawal by Subject|0|||
161832688|NCT00613834|584428496|FG001|Overall Study|Withdrawal by Subject|3|||
161832689|NCT02756637|584428499|FG000|Overall Study|Not eligible for initial SWOG study|10|||
161832690|NCT02756637|584428500|FG001|Overall Study|Not eligible for initial SWOG study|10|||
161832691|NCT02756637|584428499|FG000|Overall Study|No available NLR value|44|||
161832692|NCT02756637|584428500|FG001|Overall Study|No available NLR value|44|||
161832693|NCT02756637|584428499|FG000|Overall Study|Did not complete curative therapy|33|||
161832694|NCT02756637|584428500|FG001|Overall Study|Did not complete curative therapy|0|||
161832695|NCT03310957|584429589|FG000|Overall Study|Withdrawal by Subject|1|||
161832696|NCT03310957|584429590|FG001|Overall Study|Withdrawal by Subject|1|||
161832697|NCT03310957|584429591|FG002|Overall Study|Withdrawal by Subject|1|||
161832698|NCT03310957|584429592|FG003|Overall Study|Withdrawal by Subject|5|||
161832699|NCT03310957|584429593|FG004|Overall Study|Withdrawal by Subject|0|||
161832700|NCT03310957|584429594|FG005|Overall Study|Withdrawal by Subject|4|||
161832701|NCT03310957|584429595|FG006|Overall Study|Withdrawal by Subject|3|||
161832702|NCT03310957|584429589|FG000|Overall Study|Site Terminated|0|||
161832703|NCT03310957|584429590|FG001|Overall Study|Site Terminated|1|||
161832704|NCT03310957|584429591|FG002|Overall Study|Site Terminated|1|||
161832705|NCT03310957|584429592|FG003|Overall Study|Site Terminated|1|||
161832706|NCT03310957|584429593|FG004|Overall Study|Site Terminated|0|||
161832707|NCT03310957|584429594|FG005|Overall Study|Site Terminated|2|||
161832708|NCT03310957|584429595|FG006|Overall Study|Site Terminated|8|||
161832709|NCT03310957|584429589|FG000|Overall Study|Lost to Follow-up|1|||
161832710|NCT03310957|584429590|FG001|Overall Study|Lost to Follow-up|1|||
161832711|NCT03310957|584429591|FG002|Overall Study|Lost to Follow-up|1|||
161832712|NCT03310957|584429592|FG003|Overall Study|Lost to Follow-up|4|||
161832713|NCT03310957|584429593|FG004|Overall Study|Lost to Follow-up|0|||
161948607|NCT01374425|584864084|FG000|Overall Study|Withdrawal by Subject|6|||
161948608|NCT01374425|584864085|FG001|Overall Study|Withdrawal by Subject|7|||
161948609|NCT01374425|584864084|FG000|Overall Study|Refused Treatment|10|||
161684455|NCT02819635|583897900|FG008|Substudy 3|Lost to Follow-up|1|||
161832714|NCT03310957|584429594|FG005|Overall Study|Lost to Follow-up|4|||
161832715|NCT03310957|584429595|FG006|Overall Study|Lost to Follow-up|2|||
161832716|NCT03310957|584429589|FG000|Overall Study|Death|5|||
161832717|NCT03310957|584429590|FG001|Overall Study|Death|8|||
161832718|NCT03310957|584429591|FG002|Overall Study|Death|18|||
161832719|NCT03310957|584429592|FG003|Overall Study|Death|31|||
161832720|NCT03310957|584429593|FG004|Overall Study|Death|1|||
161832721|NCT03310957|584429594|FG005|Overall Study|Death|29|||
161948610|NCT01374425|584864085|FG001|Overall Study|Refused Treatment|24|||
161948611|NCT01374425|584864084|FG000|Overall Study|Protocol Violation|2|||
161948612|NCT01374425|584864085|FG001|Overall Study|Protocol Violation|3|||
161948613|NCT01374425|584864084|FG000|Overall Study|Sponsor Decision|0|||
161948614|NCT01374425|584864085|FG001|Overall Study|Sponsor Decision|1|||
161948615|NCT01374425|584864084|FG000|Overall Study|Lost to Follow-up|2|||
161948616|NCT01374425|584864085|FG001|Overall Study|Lost to Follow-up|1|||
161948617|NCT01374425|584864084|FG000|Overall Study|Other|41|||
161948618|NCT01374425|584864085|FG001|Overall Study|Other|43|||
161948619|NCT02289469|584864086|FG000|Overall Study|Unable to match a control|6|||
161948620|NCT02289469|584864087|FG001|Overall Study|Unable to match a control|0|||
161948621|NCT02750930|584864095|FG000|Overall Study|Study closed/terminated|8|||
161948622|NCT02761642|584864096|FG000|Overall Study|Did not Receive Study Treatment|3|||
161948623|NCT02761642|584864096|FG000|Overall Study|Adverse Event|13|||
161948624|NCT02761642|584864096|FG000|Overall Study|Withdrawal by Subject|2|||
161948625|NCT02761642|584864096|FG000|Overall Study|Non-compliant|7|||
161948626|NCT02761642|584864096|FG000|Overall Study|Death|3|||
161948627|NCT02761642|584864096|FG000|Overall Study|Lack of Efficacy|20|||
161684456|NCT02819635|583897901|FG009|Substudy 3|Lost to Follow-up|0|||
161684457|NCT02819635|583897902|FG010|Substudy 3|Lost to Follow-up|1|||
161684458|NCT02819635|583897903|FG011|Substudy 3|Lost to Follow-up|1|||
161684459|NCT02819635|583897892|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
161948628|NCT02761642|584864096|FG000|Overall Study|Physician Decision|1|||
162028473|NCT02431260|585159443|FG013|Overall Study|Physician Decision|0|||
161832722|NCT03310957|584429595|FG006|Overall Study|Death|7|||
161832723|NCT03310957|584429589|FG000|Overall Study|Discontinuation per sponsor|0|||
161832724|NCT03310957|584429590|FG001|Overall Study|Discontinuation per sponsor|1|||
161832725|NCT03310957|584429591|FG002|Overall Study|Discontinuation per sponsor|2|||
161832726|NCT03310957|584429592|FG003|Overall Study|Discontinuation per sponsor|4|||
162028474|NCT02431260|585159430|FG000|Overall Study|Other Unspecified|0|||
162028475|NCT02431260|585159431|FG001|Overall Study|Other Unspecified|0|||
162028476|NCT02431260|585159432|FG002|Overall Study|Other Unspecified|0|||
162028477|NCT02431260|585159433|FG003|Overall Study|Other Unspecified|0|||
162028478|NCT02431260|585159434|FG004|Overall Study|Other Unspecified|0|||
162028479|NCT02431260|585159435|FG005|Overall Study|Other Unspecified|0|||
162028480|NCT02431260|585159436|FG006|Overall Study|Other Unspecified|0|||
162028481|NCT02431260|585159437|FG007|Overall Study|Other Unspecified|0|||
162028482|NCT02431260|585159438|FG008|Overall Study|Other Unspecified|0|||
162028483|NCT02431260|585159439|FG009|Overall Study|Other Unspecified|0|||
162028484|NCT02431260|585159440|FG010|Overall Study|Other Unspecified|0|||
162028485|NCT02431260|585159441|FG011|Overall Study|Other Unspecified|1|||
162028486|NCT02431260|585159442|FG012|Overall Study|Other Unspecified|1|||
162028487|NCT02431260|585159443|FG013|Overall Study|Other Unspecified|0|||
161832727|NCT03310957|584429593|FG004|Overall Study|Discontinuation per sponsor|1|||
162028488|NCT00321646|585159444|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
162028489|NCT00321646|585159444|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
161832728|NCT03310957|584429594|FG005|Overall Study|Discontinuation per sponsor|9|||
162028490|NCT00321646|585159444|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
162028491|NCT03288142|585159445|FG000|Overall Study|Lost to Follow-up|22|||
162028492|NCT03288142|585159446|FG001|Overall Study|Lost to Follow-up|15|||
162028493|NCT02270944|585159450|FG000|Overall Study|Lost to Follow-up|9|||
161832729|NCT03310957|584429595|FG006|Overall Study|Discontinuation per sponsor|12|||
161832730|NCT03310957|584429589|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
161832731|NCT03310957|584429590|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
161832732|NCT03310957|584429591|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
161948629|NCT02761642|584864096|FG000|Overall Study|Reason Unspecified|21|||
161832733|NCT03310957|584429592|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
161832734|NCT03310957|584429593|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
161684460|NCT02819635|583897893|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
161684461|NCT02819635|583897894|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
161948630|NCT01644643|584864099|FG000|Overall Study|Death|1|||
161948631|NCT01644643|584864100|FG001|Overall Study|Death|0|||
161948632|NCT01644643|584864101|FG002|Overall Study|Death|3|||
161948633|NCT01644643|584864102|FG003|Overall Study|Death|3|||
161948634|NCT01644643|584864099|FG000|Overall Study|Lost to Follow-up|0|||
161684462|NCT02819635|583897895|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
161684463|NCT02819635|583897896|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
161948635|NCT01644643|584864100|FG001|Overall Study|Lost to Follow-up|0|||
161948636|NCT01644643|584864101|FG002|Overall Study|Lost to Follow-up|0|||
161948637|NCT01644643|584864102|FG003|Overall Study|Lost to Follow-up|4|||
161948638|NCT01644643|584864099|FG000|Overall Study|Withdrawal by Subject|1|||
161832735|NCT03310957|584429594|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
161832736|NCT03310957|584429595|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
161832737|NCT03310957|584429589|FG000|Overall Study|Treatment landscape|0|||
161832738|NCT03310957|584429590|FG001|Overall Study|Treatment landscape|0|||
161832739|NCT03310957|584429591|FG002|Overall Study|Treatment landscape|1|||
161832740|NCT03310957|584429592|FG003|Overall Study|Treatment landscape|1|||
161832741|NCT03310957|584429593|FG004|Overall Study|Treatment landscape|0|||
161832742|NCT03310957|584429594|FG005|Overall Study|Treatment landscape|1|||
161832743|NCT03310957|584429595|FG006|Overall Study|Treatment landscape|0|||
161832744|NCT03310957|584429589|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161832745|NCT03310957|584429590|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161832746|NCT03310957|584429591|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161832747|NCT03310957|584429592|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161832748|NCT03310957|584429593|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
161832749|NCT03310957|584429594|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161832750|NCT03310957|584429595|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161832751|NCT03310957|584429589|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161832752|NCT03310957|584429590|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161948639|NCT01644643|584864100|FG001|Overall Study|Withdrawal by Subject|0|||
161948640|NCT01644643|584864101|FG002|Overall Study|Withdrawal by Subject|2|||
161948641|NCT01644643|584864102|FG003|Overall Study|Withdrawal by Subject|1|||
161684464|NCT02819635|583897897|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
161684465|NCT02819635|583897898|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
161684466|NCT02819635|583897899|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
161684467|NCT02819635|583897900|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
161832753|NCT03310957|584429591|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
161948642|NCT01644643|584864099|FG000|Overall Study|Other Eligibility criteria|0|||
161832754|NCT03310957|584429592|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161948643|NCT01644643|584864100|FG001|Overall Study|Other Eligibility criteria|0|||
161948644|NCT01644643|584864101|FG002|Overall Study|Other Eligibility criteria|0|||
161948645|NCT01644643|584864102|FG003|Overall Study|Other Eligibility criteria|2|||
161684468|NCT02819635|583897901|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
161948646|NCT02850978|584864103|FG000|Overall Study|Uncollectable CRF|27|||
161948647|NCT02850978|584864103|FG000|Overall Study|No visit since the first visit|35|||
161948648|NCT02850978|584864103|FG000|Overall Study|Adverse Event|81|||
161948649|NCT02850978|584864103|FG000|Overall Study|Lack of Efficacy|40|||
161832755|NCT03310957|584429593|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161832756|NCT03310957|584429594|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161948650|NCT02850978|584864103|FG000|Overall Study|Improvement in condition|34|||
161948651|NCT02850978|584864103|FG000|Overall Study|Lost to Follow-up|121|||
161948652|NCT02850978|584864103|FG000|Overall Study|Reason not listed|88|||
161948653|NCT00114127|584864104|FG000|Overall Study|Adverse Event|2|||
161948654|NCT00114127|584864105|FG001|Overall Study|Adverse Event|1|||
161684469|NCT02819635|583897902|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
161684470|NCT02819635|583897903|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
161684471|NCT02819635|583897892|FG000|Substudy 3|Other, not specified|0|||
161684472|NCT02819635|583897893|FG001|Substudy 3|Other, not specified|0|||
161684473|NCT02819635|583897894|FG002|Substudy 3|Other, not specified|0|||
161684474|NCT02819635|583897895|FG003|Substudy 3|Other, not specified|0|||
161684475|NCT02819635|583897896|FG004|Substudy 3|Other, not specified|0|||
161684476|NCT02819635|583897897|FG005|Substudy 3|Other, not specified|0|||
161684477|NCT02819635|583897898|FG006|Substudy 3|Other, not specified|0|||
161684478|NCT02819635|583897899|FG007|Substudy 3|Other, not specified|0|||
161684479|NCT02819635|583897900|FG008|Substudy 3|Other, not specified|202|||
161684480|NCT02819635|583897901|FG009|Substudy 3|Other, not specified|5|||
161832757|NCT03310957|584429595|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161684481|NCT02819635|583897902|FG010|Substudy 3|Other, not specified|89|||
161684482|NCT02819635|583897903|FG011|Substudy 3|Other, not specified|39|||
161684483|NCT01349465|583897905|FG000|Overall Study|Adverse Event|1|||
161948655|NCT00114127|584864104|FG000|Overall Study|Lost to Follow-up|1|||
161948656|NCT00114127|584864105|FG001|Overall Study|Lost to Follow-up|0|||
161948657|NCT00114127|584864104|FG000|Overall Study|Withdrawal by Subject|1|||
161948658|NCT00114127|584864105|FG001|Overall Study|Withdrawal by Subject|3|||
161948659|NCT00421148|584864106|FG000|Overall Study|Lost to Follow-up|0|||
161684484|NCT01349465|583897906|FG001|Overall Study|Adverse Event|0|||
161684485|NCT01349465|583897905|FG000|Overall Study|Death|3|||
161684486|NCT01349465|583897906|FG001|Overall Study|Death|0|||
161832758|NCT03310957|584429589|FG000|Overall Study|Hospice|0|||
161948660|NCT00421148|584864107|FG001|Overall Study|Lost to Follow-up|0|||
161948661|NCT00421148|584864108|FG002|Overall Study|Lost to Follow-up|0|||
161948662|NCT00421148|584864109|FG003|Overall Study|Lost to Follow-up|0|||
161948663|NCT00421148|584864110|FG004|Overall Study|Lost to Follow-up|0|||
161948664|NCT00421148|584864111|FG005|Overall Study|Lost to Follow-up|0|||
161948665|NCT00421148|584864112|FG006|Overall Study|Lost to Follow-up|0|||
161948666|NCT00421148|584864113|FG007|Overall Study|Lost to Follow-up|0|||
161948667|NCT00421148|584864114|FG008|Overall Study|Lost to Follow-up|0|||
161948668|NCT00421148|584864115|FG009|Overall Study|Lost to Follow-up|0|||
161948669|NCT00421148|584864116|FG010|Overall Study|Lost to Follow-up|0|||
161684487|NCT01349465|583897905|FG000|Overall Study|Lost to Follow-up|10|||
161684488|NCT01349465|583897906|FG001|Overall Study|Lost to Follow-up|1|||
161684489|NCT01349465|583897905|FG000|Overall Study|Withdrawal by Subject|4|||
161684490|NCT01349465|583897906|FG001|Overall Study|Withdrawal by Subject|2|||
161684491|NCT01349465|583897905|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
161832759|NCT03310957|584429590|FG001|Overall Study|Hospice|0|||
161684492|NCT01349465|583897906|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
161684493|NCT04329702|583897909|FG000|Overall Study|illness|3|||
161684494|NCT04329702|583897910|FG001|Overall Study|illness|4|||
161684495|NCT04329702|583897911|FG002|Overall Study|illness|0|||
161684496|NCT04329702|583897909|FG000|Overall Study|Lost to Follow-up|0|||
161684497|NCT04329702|583897910|FG001|Overall Study|Lost to Follow-up|0|||
161684498|NCT04329702|583897911|FG002|Overall Study|Lost to Follow-up|2|||
161684499|NCT04329702|583897909|FG000|Overall Study|Death|0|||
161684500|NCT04329702|583897910|FG001|Overall Study|Death|2|||
161684501|NCT04329702|583897911|FG002|Overall Study|Death|0|||
161684502|NCT01476475|583897912|FG000|Overall Study|Adverse Event|6|||
161684503|NCT01476475|583897913|FG001|Overall Study|Adverse Event|0|||
161684504|NCT01476475|583897912|FG000|Overall Study|Poor compliance to protocol|1|||
161684505|NCT01476475|583897913|FG001|Overall Study|Poor compliance to protocol|1|||
161684506|NCT01476475|583897912|FG000|Overall Study|Other reasons|4|||
161684507|NCT01476475|583897913|FG001|Overall Study|Other reasons|2|||
161684508|NCT00751400|583897915|FG000|Overall Study|Lost to Follow-up|10|||
161684509|NCT01918007|583897918|FG000|Overall Study|Baseline oximetry not acceptable|11|||
161684510|NCT01918007|583897919|FG001|Overall Study|Baseline oximetry not acceptable|7|||
161684511|NCT01918007|583897918|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
161684512|NCT01918007|583897919|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
161684513|NCT01918007|583897918|FG000|Overall Study|Lost to Follow-up|4|||
161684514|NCT01918007|583897919|FG001|Overall Study|Lost to Follow-up|7|||
161684515|NCT01471015|583897926|FG000|Overall Study|Death|0|||
161684516|NCT01471015|583897927|FG001|Overall Study|Death|1|||
161684517|NCT01471015|583897928|FG002|Overall Study|Death|1|||
161684518|NCT04206020|583897929|FG000|Overall Study|Adverse Event|1|||
161684519|NCT04206020|583897930|FG001|Overall Study|Adverse Event|4|||
161684520|NCT04206020|583897929|FG000|Overall Study|Protocol Violation|2|||
161684521|NCT04206020|583897930|FG001|Overall Study|Protocol Violation|0|||
161684522|NCT04206020|583897929|FG000|Overall Study|Withdrawal by Subject|2|||
161684523|NCT04206020|583897930|FG001|Overall Study|Withdrawal by Subject|0|||
161684524|NCT04206020|583897929|FG000|Overall Study|Lost to Follow-up|2|||
161684525|NCT04206020|583897930|FG001|Overall Study|Lost to Follow-up|0|||
161684526|NCT04206020|583897929|FG000|Overall Study|Pregnancy|0|||
161684527|NCT04206020|583897930|FG001|Overall Study|Pregnancy|1|||
161684528|NCT04206020|583897929|FG000|Overall Study|Unable to attend visits|1|||
161684529|NCT04206020|583897930|FG001|Overall Study|Unable to attend visits|2|||
161684530|NCT04962022|583897931|FG000|Period 1|Withdrawal by Subject|1|||
161684531|NCT04962022|583897932|FG001|Period 1|Withdrawal by Subject|0|||
161684532|NCT02055820|583897939|FG000|Phase I: Dose-Finding|Death|1|||
161684533|NCT02055820|583897940|FG001|Phase I: Dose-Finding|Death|0|||
161684534|NCT02055820|583897941|FG002|Phase I: Dose-Finding|Death|1|||
161684535|NCT02055820|583897942|FG003|Phase I: Dose-Finding|Death|2|||
161684536|NCT02055820|583897943|FG004|Phase I: Dose-Finding|Death|0|||
161684537|NCT02055820|583897944|FG005|Phase I: Dose-Finding|Death|1|||
161684538|NCT02055820|583897945|FG006|Phase I: Dose-Finding|Death|1|||
161684539|NCT02055820|583897946|FG007|Phase I: Dose-Finding|Death|0|||
161948670|NCT00421148|584864117|FG011|Overall Study|Lost to Follow-up|0|||
161948671|NCT00421148|584864118|FG012|Overall Study|Lost to Follow-up|0|||
161948672|NCT00421148|584864119|FG013|Overall Study|Lost to Follow-up|0|||
161948673|NCT00421148|584864120|FG014|Overall Study|Lost to Follow-up|0|||
161684540|NCT02055820|583897947|FG008|Phase I: Dose-Finding|Death|0|||
161684541|NCT02055820|583897948|FG009|Phase I: Dose-Finding|Death|0|||
161684542|NCT02055820|583897939|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684543|NCT02055820|583897940|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684544|NCT02055820|583897941|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684545|NCT02055820|583897942|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684546|NCT02055820|583897943|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161948674|NCT00421148|584864121|FG015|Overall Study|Lost to Follow-up|0|||
161948675|NCT00421148|584864122|FG016|Overall Study|Lost to Follow-up|0|||
161684547|NCT02055820|583897944|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
161684548|NCT02055820|583897945|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684549|NCT02055820|583897946|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684550|NCT02055820|583897947|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161684551|NCT02055820|583897948|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161948676|NCT00421148|584864123|FG017|Overall Study|Lost to Follow-up|1|||
162028494|NCT02270944|585159451|FG001|Overall Study|Lost to Follow-up|4|||
162028495|NCT02270944|585159450|FG000|Overall Study|Withdrawal by Subject|2|||
162028496|NCT02270944|585159451|FG001|Overall Study|Withdrawal by Subject|1|||
161684552|NCT02055820|583897939|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
162028497|NCT01375075|585159458|FG000|Overall Study|Adverse Event|0|||
161832760|NCT03310957|584429591|FG002|Overall Study|Hospice|0|||
162028498|NCT01375075|585159459|FG001|Overall Study|Adverse Event|0|||
161948677|NCT00421148|584864124|FG018|Overall Study|Lost to Follow-up|0|||
161684553|NCT02055820|583897940|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
161684554|NCT02055820|583897941|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
161948678|NCT00421148|584864125|FG019|Overall Study|Lost to Follow-up|0|||
161948679|NCT00421148|584864106|FG000|Overall Study|Withdrawal by Subject|0|||
161948680|NCT00421148|584864107|FG001|Overall Study|Withdrawal by Subject|0|||
161948681|NCT00421148|584864108|FG002|Overall Study|Withdrawal by Subject|0|||
161948682|NCT00421148|584864109|FG003|Overall Study|Withdrawal by Subject|0|||
161948683|NCT00421148|584864110|FG004|Overall Study|Withdrawal by Subject|0|||
161948684|NCT00421148|584864111|FG005|Overall Study|Withdrawal by Subject|0|||
161948685|NCT00421148|584864112|FG006|Overall Study|Withdrawal by Subject|0|||
161948686|NCT00421148|584864113|FG007|Overall Study|Withdrawal by Subject|0|||
161948687|NCT00421148|584864114|FG008|Overall Study|Withdrawal by Subject|0|||
161948688|NCT00421148|584864115|FG009|Overall Study|Withdrawal by Subject|0|||
161948689|NCT00421148|584864116|FG010|Overall Study|Withdrawal by Subject|0|||
161948690|NCT00421148|584864117|FG011|Overall Study|Withdrawal by Subject|0|||
161948691|NCT00421148|584864118|FG012|Overall Study|Withdrawal by Subject|0|||
161948692|NCT00421148|584864119|FG013|Overall Study|Withdrawal by Subject|0|||
161948693|NCT00421148|584864120|FG014|Overall Study|Withdrawal by Subject|0|||
161948694|NCT00421148|584864121|FG015|Overall Study|Withdrawal by Subject|0|||
161948695|NCT00421148|584864122|FG016|Overall Study|Withdrawal by Subject|0|||
161948696|NCT00421148|584864123|FG017|Overall Study|Withdrawal by Subject|1|||
161948697|NCT00421148|584864124|FG018|Overall Study|Withdrawal by Subject|0|||
161948698|NCT00421148|584864125|FG019|Overall Study|Withdrawal by Subject|0|||
161948699|NCT00421148|584864106|FG000|Overall Study|Protocol Violation|0|||
161948700|NCT00421148|584864107|FG001|Overall Study|Protocol Violation|0|||
161948701|NCT00421148|584864108|FG002|Overall Study|Protocol Violation|0|||
161948702|NCT00421148|584864109|FG003|Overall Study|Protocol Violation|0|||
161948703|NCT00421148|584864110|FG004|Overall Study|Protocol Violation|0|||
161948704|NCT00421148|584864111|FG005|Overall Study|Protocol Violation|1|||
161948705|NCT00421148|584864112|FG006|Overall Study|Protocol Violation|0|||
161948706|NCT00421148|584864113|FG007|Overall Study|Protocol Violation|0|||
161948707|NCT00421148|584864114|FG008|Overall Study|Protocol Violation|0|||
161948708|NCT00421148|584864115|FG009|Overall Study|Protocol Violation|0|||
161948709|NCT00421148|584864116|FG010|Overall Study|Protocol Violation|0|||
161948710|NCT00421148|584864117|FG011|Overall Study|Protocol Violation|0|||
161948711|NCT00421148|584864118|FG012|Overall Study|Protocol Violation|0|||
161948712|NCT00421148|584864119|FG013|Overall Study|Protocol Violation|0|||
161948713|NCT00421148|584864120|FG014|Overall Study|Protocol Violation|0|||
161948714|NCT00421148|584864121|FG015|Overall Study|Protocol Violation|0|||
161948715|NCT00421148|584864122|FG016|Overall Study|Protocol Violation|0|||
161948716|NCT00421148|584864123|FG017|Overall Study|Protocol Violation|0|||
161948717|NCT00421148|584864124|FG018|Overall Study|Protocol Violation|1|||
161948718|NCT00421148|584864125|FG019|Overall Study|Protocol Violation|0|||
161948719|NCT00570713|584864126|FG000|Overall Study|Adverse Event|16|||
161948720|NCT00570713|584864127|FG001|Overall Study|Adverse Event|9|||
161948721|NCT00570713|584864126|FG000|Overall Study|Death|7|||
161948722|NCT00570713|584864127|FG001|Overall Study|Death|7|||
161948723|NCT00570713|584864126|FG000|Overall Study|Lack of Efficacy|40|||
162028499|NCT01375075|585159460|FG002|Overall Study|Adverse Event|3|||
162028500|NCT01375075|585159461|FG003|Overall Study|Adverse Event|1|||
161684555|NCT02055820|583897942|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
161684556|NCT02055820|583897943|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
161684557|NCT02055820|583897944|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
161684558|NCT02055820|583897945|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
161684559|NCT02055820|583897946|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
161684560|NCT02055820|583897947|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
161684561|NCT02055820|583897948|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
161684562|NCT02055820|583897939|FG000|Phase II: Expansion|Death|0|||
161684563|NCT02055820|583897940|FG001|Phase II: Expansion|Death|0|||
161684564|NCT02055820|583897941|FG002|Phase II: Expansion|Death|0|||
161684565|NCT02055820|583897942|FG003|Phase II: Expansion|Death|0|||
161684566|NCT02055820|583897943|FG004|Phase II: Expansion|Death|33|||
161684567|NCT02055820|583897944|FG005|Phase II: Expansion|Death|0|||
161832761|NCT03310957|584429592|FG003|Overall Study|Hospice|0|||
161832762|NCT03310957|584429593|FG004|Overall Study|Hospice|0|||
161832763|NCT03310957|584429594|FG005|Overall Study|Hospice|1|||
161684568|NCT02055820|583897945|FG006|Phase II: Expansion|Death|0|||
161684569|NCT02055820|583897946|FG007|Phase II: Expansion|Death|0|||
161832764|NCT03310957|584429595|FG006|Overall Study|Hospice|0|||
161948724|NCT00570713|584864127|FG001|Overall Study|Lack of Efficacy|49|||
161948725|NCT00570713|584864126|FG000|Overall Study|Physician Decision|2|||
161948726|NCT00570713|584864127|FG001|Overall Study|Physician Decision|2|||
161948727|NCT00570713|584864126|FG000|Overall Study|Withdrawal by Subject|3|||
161948728|NCT00570713|584864127|FG001|Overall Study|Withdrawal by Subject|3|||
161948729|NCT00570713|584864126|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
161684570|NCT02055820|583897947|FG008|Phase II: Expansion|Death|0|||
161684571|NCT02055820|583897948|FG009|Phase II: Expansion|Death|0|||
161684572|NCT02055820|583897939|FG000|Phase II: Expansion|Lost to Follow-up|0|||
161684573|NCT02055820|583897940|FG001|Phase II: Expansion|Lost to Follow-up|0|||
161684574|NCT02055820|583897941|FG002|Phase II: Expansion|Lost to Follow-up|0|||
161684575|NCT02055820|583897942|FG003|Phase II: Expansion|Lost to Follow-up|0|||
161684576|NCT02055820|583897943|FG004|Phase II: Expansion|Lost to Follow-up|4|||
161684577|NCT02055820|583897944|FG005|Phase II: Expansion|Lost to Follow-up|0|||
161684578|NCT02055820|583897945|FG006|Phase II: Expansion|Lost to Follow-up|0|||
161684579|NCT02055820|583897946|FG007|Phase II: Expansion|Lost to Follow-up|0|||
161684580|NCT02055820|583897947|FG008|Phase II: Expansion|Lost to Follow-up|0|||
161684581|NCT02055820|583897948|FG009|Phase II: Expansion|Lost to Follow-up|0|||
161684582|NCT02055820|583897939|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
161684583|NCT02055820|583897940|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
161684584|NCT02055820|583897941|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
161684585|NCT02055820|583897942|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
161948730|NCT00570713|584864127|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
161948731|NCT00469833|584864128|FG000|Overall Study|No IV access|2|||
161948732|NCT03289533|584864129|FG000|Overall Study|Death|12|||
161948733|NCT03289533|584864129|FG000|Overall Study|Terminated from study by sponsor|10|||
161948734|NCT00539240|584864130|FG000|Overall Study|Withdrawal by Subject|0|||
161948735|NCT00539240|584864131|FG001|Overall Study|Withdrawal by Subject|2|||
161948736|NCT00539240|584864132|FG002|Overall Study|Withdrawal by Subject|0|||
161948737|NCT00539240|584864130|FG000|Overall Study|Protocol Violation|1|||
161948738|NCT00539240|584864131|FG001|Overall Study|Protocol Violation|1|||
161684586|NCT02055820|583897943|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
161684587|NCT02055820|583897944|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
161684588|NCT02055820|583897945|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
161684589|NCT02055820|583897946|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
161684590|NCT02055820|583897947|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
161948739|NCT00539240|584864132|FG002|Overall Study|Protocol Violation|4|||
161948740|NCT00539240|584864130|FG000|Overall Study|Lost to Follow-up|2|||
161948741|NCT00539240|584864131|FG001|Overall Study|Lost to Follow-up|3|||
161948742|NCT00539240|584864132|FG002|Overall Study|Lost to Follow-up|1|||
161948743|NCT00539240|584864130|FG000|Overall Study|Adverse Event|3|||
161948744|NCT00539240|584864131|FG001|Overall Study|Adverse Event|1|||
161948745|NCT00539240|584864132|FG002|Overall Study|Adverse Event|10|||
162028501|NCT01375075|585159462|FG004|Overall Study|Adverse Event|0|||
161684591|NCT02055820|583897948|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
161948746|NCT00271544|584864152|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
161948747|NCT00271544|584864152|FG000|Overall Study|Model 4196 lead not attempted|9|||
162028502|NCT01375075|585159463|FG005|Overall Study|Adverse Event|1|||
161684592|NCT03548935|583897949|FG000|Overall Study|Withdrawal by Subject|26|||
161684593|NCT03548935|583897950|FG001|Overall Study|Withdrawal by Subject|17|||
161684594|NCT03548935|583897949|FG000|Overall Study|Lost to Follow-up|39|||
161948748|NCT00271544|584864152|FG000|Overall Study|Implant not attempted|4|||
161948749|NCT00902330|584864153|FG000|Overall Study|Too overwhelmed by treatment|2|||
161948750|NCT00902330|584864154|FG001|Overall Study|Too overwhelmed by treatment|5|||
161948751|NCT00902330|584864153|FG000|Overall Study|Adverse Event|1|||
161948752|NCT00902330|584864154|FG001|Overall Study|Adverse Event|0|||
161948753|NCT00902330|584864153|FG000|Overall Study|No post baseline data|1|||
161948754|NCT00902330|584864154|FG001|Overall Study|No post baseline data|0|||
161948755|NCT00165789|584864155|FG000|Overall Study|Adverse Event|0|||
161948756|NCT00165789|584864156|FG001|Overall Study|Adverse Event|3|||
161684595|NCT03548935|583897950|FG001|Overall Study|Lost to Follow-up|28|||
161684596|NCT03548935|583897949|FG000|Overall Study|Death|1|||
161684597|NCT03548935|583897950|FG001|Overall Study|Death|1|||
161684598|NCT02919436|583897951|FG000|Overall Study|Did not undergo surgery|16|||
161684599|NCT02919436|583897952|FG001|Overall Study|Did not undergo surgery|20|||
161684600|NCT02919436|583897951|FG000|Overall Study|Enrolled before trial registration|44|||
161684601|NCT02919436|583897952|FG001|Overall Study|Enrolled before trial registration|33|||
161684602|NCT00804570|583897953|FG000|Overall Study|Adverse Event|14|||
161684603|NCT00804570|583897954|FG001|Overall Study|Adverse Event|7|||
161684604|NCT00804570|583897953|FG000|Overall Study|Lack of Efficacy|0|||
161948757|NCT00165789|584864157|FG002|Overall Study|Adverse Event|0|||
161684605|NCT00804570|583897954|FG001|Overall Study|Lack of Efficacy|1|||
161684606|NCT00804570|583897953|FG000|Overall Study|Lost to Follow-up|18|||
161684607|NCT00804570|583897954|FG001|Overall Study|Lost to Follow-up|21|||
161948758|NCT00165789|584864158|FG003|Overall Study|Adverse Event|12|||
161684608|NCT00804570|583897953|FG000|Overall Study|Entry criteria not met|5|||
161684609|NCT00804570|583897954|FG001|Overall Study|Entry criteria not met|5|||
161948759|NCT00165789|584864155|FG000|Overall Study|Withdrawal by Subject|0|||
161684610|NCT00804570|583897953|FG000|Overall Study|Protocol Violation|12|||
162028503|NCT01375075|585159458|FG000|Overall Study|Entry Criterion Not Met|1|||
162028504|NCT01375075|585159459|FG001|Overall Study|Entry Criterion Not Met|0|||
162028505|NCT01375075|585159460|FG002|Overall Study|Entry Criterion Not Met|0|||
161684611|NCT00804570|583897954|FG001|Overall Study|Protocol Violation|16|||
161684612|NCT00804570|583897953|FG000|Overall Study|Physician Decision|1|||
161684613|NCT00804570|583897954|FG001|Overall Study|Physician Decision|2|||
161684614|NCT00804570|583897953|FG000|Overall Study|Sponsor decision|1|||
161684615|NCT00804570|583897954|FG001|Overall Study|Sponsor decision|4|||
161684616|NCT00804570|583897953|FG000|Overall Study|Withdrawal by Subject|21|||
161684617|NCT00804570|583897954|FG001|Overall Study|Withdrawal by Subject|38|||
161684618|NCT01056510|583897955|FG000|Overall Study|Dropout Before Start of Treatment|1|||
161684619|NCT01056510|583897956|FG001|Overall Study|Dropout Before Start of Treatment|1|||
161684620|NCT01056510|583897955|FG000|Overall Study|Withdrawal by Subject|4|||
161684621|NCT01056510|583897956|FG001|Overall Study|Withdrawal by Subject|2|||
161684622|NCT01056510|583897955|FG000|Overall Study|Death|29|||
161684623|NCT01056510|583897956|FG001|Overall Study|Death|34|||
161684624|NCT01056510|583897955|FG000|Overall Study|Noncompliance|1|||
161948760|NCT00165789|584864156|FG001|Overall Study|Withdrawal by Subject|1|||
161948761|NCT00165789|584864157|FG002|Overall Study|Withdrawal by Subject|1|||
161948762|NCT00165789|584864158|FG003|Overall Study|Withdrawal by Subject|2|||
161684625|NCT01056510|583897956|FG001|Overall Study|Noncompliance|3|||
161684626|NCT01056510|583897955|FG000|Overall Study|Physician Decision|4|||
161684627|NCT01056510|583897956|FG001|Overall Study|Physician Decision|5|||
161684628|NCT01056510|583897955|FG000|Overall Study|Lost to Follow-up|5|||
161684629|NCT01056510|583897956|FG001|Overall Study|Lost to Follow-up|6|||
161684630|NCT01056510|583897955|FG000|Overall Study|Other|10|||
161684631|NCT01056510|583897956|FG001|Overall Study|Other|12|||
161684632|NCT01056510|583897955|FG000|Overall Study|Missing|0|||
161684633|NCT01056510|583897956|FG001|Overall Study|Missing|1|||
161684634|NCT03451084|583897959|FG000|Overall Study|Withdrawal by Subject|2|||
161684635|NCT03451084|583897960|FG001|Overall Study|Withdrawal by Subject|1|||
161684636|NCT03451084|583897961|FG002|Overall Study|Withdrawal by Subject|2|||
161948763|NCT02031302|584864159|FG000|Overall Study|Death|115|||
161948764|NCT02031302|584864160|FG001|Overall Study|Death|0|||
161948765|NCT02031302|584864159|FG000|Overall Study|Not treated with study valve system|18|||
161684637|NCT03451084|583897962|FG003|Overall Study|Withdrawal by Subject|1|||
161684638|NCT03451084|583897959|FG000|Overall Study|Disease recurrence|0|||
161948766|NCT02031302|584864160|FG001|Overall Study|Not treated with study valve system|0|||
161948767|NCT02031302|584864159|FG000|Overall Study|Missed Follow Up|27|||
161684639|NCT03451084|583897960|FG001|Overall Study|Disease recurrence|2|||
161684640|NCT03451084|583897961|FG002|Overall Study|Disease recurrence|0|||
161684641|NCT03451084|583897962|FG003|Overall Study|Disease recurrence|0|||
161684642|NCT03451084|583897959|FG000|Overall Study|Lack of Efficacy|0|||
161684643|NCT03451084|583897960|FG001|Overall Study|Lack of Efficacy|3|||
162028506|NCT01375075|585159461|FG003|Overall Study|Entry Criterion Not Met|0|||
162028507|NCT01375075|585159462|FG004|Overall Study|Entry Criterion Not Met|0|||
162028508|NCT01375075|585159463|FG005|Overall Study|Entry Criterion Not Met|1|||
161684644|NCT03451084|583897961|FG002|Overall Study|Lack of Efficacy|0|||
161684645|NCT03451084|583897962|FG003|Overall Study|Lack of Efficacy|1|||
161684646|NCT03451084|583897959|FG000|Overall Study|Death|1|||
162028509|NCT01375075|585159458|FG000|Overall Study|Withdrawal by Subject|0|||
162028510|NCT01375075|585159459|FG001|Overall Study|Withdrawal by Subject|1|||
161684647|NCT03451084|583897960|FG001|Overall Study|Death|0|||
161684648|NCT03451084|583897961|FG002|Overall Study|Death|2|||
161684649|NCT03451084|583897962|FG003|Overall Study|Death|0|||
161684650|NCT03451084|583897959|FG000|Overall Study|Physician Decision|0|||
161684651|NCT03451084|583897960|FG001|Overall Study|Physician Decision|0|||
161684652|NCT03451084|583897961|FG002|Overall Study|Physician Decision|2|||
161684653|NCT03451084|583897962|FG003|Overall Study|Physician Decision|2|||
161684654|NCT03451084|583897959|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
161684655|NCT03451084|583897960|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
161684656|NCT03451084|583897961|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
161684657|NCT03451084|583897962|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
161684658|NCT02121262|583897965|FG000|Overall Study|Adverse Event|6|||
161684659|NCT02121262|583897966|FG001|Overall Study|Adverse Event|3|||
161684660|NCT02121262|583897965|FG000|Overall Study|Lack of Efficacy|3|||
161684661|NCT02121262|583897966|FG001|Overall Study|Lack of Efficacy|0|||
161684662|NCT02121262|583897965|FG000|Overall Study|Personal Reasons|19|||
161684663|NCT02121262|583897966|FG001|Overall Study|Personal Reasons|5|||
161948768|NCT02031302|584864160|FG001|Overall Study|Missed Follow Up|0|||
161948769|NCT02031302|584864159|FG000|Overall Study|Lost to Follow-up|4|||
161948770|NCT02031302|584864160|FG001|Overall Study|Lost to Follow-up|0|||
161948771|NCT01847443|584864161|FG000|Study Period 1|Withdrawal by Subject|0|||
161948772|NCT01847443|584864162|FG001|Study Period 1|Withdrawal by Subject|1|||
161948773|NCT01847443|584864163|FG002|Study Period 1|Withdrawal by Subject|0|||
161948774|NCT01847443|584864164|FG003|Study Period 1|Withdrawal by Subject|0|||
161948775|NCT01847443|584864161|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
161684664|NCT02121262|583897965|FG000|Overall Study|Protocol Violation|1|||
161684665|NCT02121262|583897966|FG001|Overall Study|Protocol Violation|1|||
161684666|NCT02121262|583897965|FG000|Overall Study|Participant Dropped-out|0|||
161684667|NCT02121262|583897966|FG001|Overall Study|Participant Dropped-out|1|||
161948776|NCT01847443|584864162|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
161684668|NCT02121262|583897965|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
161684669|NCT02121262|583897966|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
161684670|NCT02121262|583897965|FG000|Overall Study|Consent Withdrawn|1|||
161948777|NCT01847443|584864163|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
161948778|NCT01847443|584864164|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
161948779|NCT01847443|584864161|FG000|Washout Period Before Study Period 2|Other reason|1|||
161948780|NCT01847443|584864162|FG001|Washout Period Before Study Period 2|Other reason|0|||
161948781|NCT01847443|584864163|FG002|Washout Period Before Study Period 2|Other reason|0|||
161948782|NCT01847443|584864164|FG003|Washout Period Before Study Period 2|Other reason|0|||
161948783|NCT01847443|584864161|FG000|Washout Period Before Study Period 3|Other reason|1|||
161948784|NCT01847443|584864162|FG001|Washout Period Before Study Period 3|Other reason|0|||
161948785|NCT01847443|584864163|FG002|Washout Period Before Study Period 3|Other reason|0|||
161948786|NCT01847443|584864164|FG003|Washout Period Before Study Period 3|Other reason|0|||
161948787|NCT01847443|584864161|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
161948788|NCT01847443|584864162|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
161948789|NCT01847443|584864163|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
161948790|NCT01847443|584864164|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
162028511|NCT01375075|585159460|FG002|Overall Study|Withdrawal by Subject|0|||
162028512|NCT01375075|585159461|FG003|Overall Study|Withdrawal by Subject|0|||
161948791|NCT01847443|584864161|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
161948792|NCT01847443|584864162|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
161948793|NCT01847443|584864163|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
162028513|NCT01375075|585159462|FG004|Overall Study|Withdrawal by Subject|0|||
161948794|NCT01847443|584864164|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
161948795|NCT03571971|584864165|FG000|Overall Study|Lost to Follow-up|2|||
161948796|NCT03571971|584864166|FG001|Overall Study|Lost to Follow-up|2|||
161948797|NCT03571971|584864165|FG000|Overall Study|Protocol Violation|2|||
161948798|NCT03571971|584864166|FG001|Overall Study|Protocol Violation|3|||
161948799|NCT03571971|584864165|FG000|Overall Study|Withdrawal by Subject|2|||
161948800|NCT03571971|584864166|FG001|Overall Study|Withdrawal by Subject|0|||
161948801|NCT03571971|584864165|FG000|Overall Study|Incomplete primary outcome data|2|||
161948802|NCT03571971|584864166|FG001|Overall Study|Incomplete primary outcome data|0|||
161948803|NCT03950856|584864172|FG000|Overall Study|Death|1|||
161948804|NCT03950856|584864173|FG001|Overall Study|Death|2|||
161948805|NCT03950856|584864174|FG002|Overall Study|Death|0|||
161948806|NCT03950856|584864175|FG003|Overall Study|Death|0|||
161948807|NCT03950856|584864172|FG000|Overall Study|Lost to Follow-up|5|||
161948808|NCT03950856|584864173|FG001|Overall Study|Lost to Follow-up|6|||
161948809|NCT03950856|584864174|FG002|Overall Study|Lost to Follow-up|8|||
161948810|NCT03950856|584864175|FG003|Overall Study|Lost to Follow-up|2|||
161948811|NCT03950856|584864172|FG000|Overall Study|Protocol Violation|2|||
161948812|NCT03950856|584864173|FG001|Overall Study|Protocol Violation|0|||
161948813|NCT03950856|584864174|FG002|Overall Study|Protocol Violation|0|||
161948814|NCT03950856|584864175|FG003|Overall Study|Protocol Violation|1|||
161948815|NCT03950856|584864172|FG000|Overall Study|Withdrawal by Subject|4|||
161948816|NCT03950856|584864173|FG001|Overall Study|Withdrawal by Subject|1|||
161948817|NCT03950856|584864174|FG002|Overall Study|Withdrawal by Subject|3|||
161948818|NCT03950856|584864175|FG003|Overall Study|Withdrawal by Subject|1|||
161948819|NCT03950856|584864172|FG000|Overall Study|Unable to phone|7|||
161948820|NCT03950856|584864173|FG001|Overall Study|Unable to phone|6|||
161948821|NCT03950856|584864174|FG002|Overall Study|Unable to phone|7|||
161948822|NCT03950856|584864175|FG003|Overall Study|Unable to phone|2|||
161948823|NCT01816984|584864176|FG000|Overall Study|declining health status|1|||
161948824|NCT05899829|584864177|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
161948825|NCT05899829|584864178|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
161832765|NCT03310957|584429589|FG000|Overall Study|Progressive|0|||
161832766|NCT03310957|584429590|FG001|Overall Study|Progressive|0|||
161948826|NCT05899829|584864177|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
161948827|NCT05899829|584864178|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
161948828|NCT05076045|584864183|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
161948829|NCT05076045|584864184|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
161948830|NCT04422431|584864185|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
161948831|NCT04422431|584864185|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
161832767|NCT03310957|584429591|FG002|Overall Study|Progressive|1|||
161948832|NCT04422431|584864185|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
161948833|NCT04422431|584864185|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
161948834|NCT04422431|584864185|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
161948835|NCT04422431|584864185|FG000|Extension Period (48 Weeks)|Other than specified|2|||
161832768|NCT03310957|584429592|FG003|Overall Study|Progressive|0|||
161948836|NCT01174563|584864186|FG000|Overall Study|Progressive Disease|45|||
161832769|NCT03310957|584429593|FG004|Overall Study|Progressive|0|||
161832770|NCT03310957|584429594|FG005|Overall Study|Progressive|0|||
161832771|NCT03310957|584429595|FG006|Overall Study|Progressive|0|||
161832772|NCT01475253|584429600|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
161832773|NCT01475253|584429601|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
161832774|NCT01475253|584429602|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
161832775|NCT01475253|584429603|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
161832776|NCT01475253|584429600|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
161832777|NCT01475253|584429601|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
161832778|NCT01475253|584429602|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
161948837|NCT01174563|584864186|FG000|Overall Study|Death|5|||
161948838|NCT01174563|584864186|FG000|Overall Study|Investigator's Discretion|5|||
161948839|NCT01174563|584864186|FG000|Overall Study|Participant Withdrew Consent|3|||
161948840|NCT01174563|584864186|FG000|Overall Study|Rash Adverse Event|1|||
161948841|NCT01174563|584864186|FG000|Overall Study|Sponsor's decision|1|||
161948842|NCT03402841|584864187|FG000|Overall Study|Withdrawal by Subject|3|||
161948843|NCT03402841|584864187|FG000|Overall Study|Lost to Follow-up|2|||
161948844|NCT03402841|584864187|FG000|Overall Study|Death|146|||
161948845|NCT00444106|584864190|FG000|Overall Study|Lost to Follow-up|2|||
161948846|NCT00444106|584864191|FG001|Overall Study|Lost to Follow-up|1|||
161948847|NCT00444106|584864192|FG002|Overall Study|Lost to Follow-up|0|||
161948848|NCT00444106|584864190|FG000|Overall Study|Abnormal Test Procedure Results|0|||
161948849|NCT00444106|584864191|FG001|Overall Study|Abnormal Test Procedure Results|0|||
161948850|NCT00444106|584864192|FG002|Overall Study|Abnormal Test Procedure Results|1|||
161948851|NCT05270863|584864193|FG000|Visit 2 First Intervention|Randomization error|0|||
161948852|NCT05270863|584864194|FG001|Visit 2 First Intervention|Randomization error|0|||
161948853|NCT05270863|584864195|FG002|Visit 2 First Intervention|Randomization error|0|||
161948854|NCT05270863|584864196|FG003|Visit 2 First Intervention|Randomization error|1|||
161948855|NCT05270863|584864197|FG004|Visit 2 First Intervention|Randomization error|0|||
161948856|NCT05270863|584864198|FG005|Visit 2 First Intervention|Randomization error|0|||
161948857|NCT05270863|584864193|FG000|First Washout|Withdrawal by Subject|0|||
161948858|NCT05270863|584864194|FG001|First Washout|Withdrawal by Subject|0|||
161948859|NCT05270863|584864195|FG002|First Washout|Withdrawal by Subject|0|||
161684671|NCT02121262|583897966|FG001|Overall Study|Consent Withdrawn|0|||
161684672|NCT02716987|583897967|FG000|Overall Study|Ligand synthesis failure|0|||
161684673|NCT02716987|583897968|FG001|Overall Study|Ligand synthesis failure|0|||
161684674|NCT02716987|583897969|FG002|Overall Study|Ligand synthesis failure|1|||
161684675|NCT02716987|583897970|FG003|Overall Study|Ligand synthesis failure|0|||
161684676|NCT02716987|583897971|FG004|Overall Study|Ligand synthesis failure|0|||
161684677|NCT02716987|583897972|FG005|Overall Study|Ligand synthesis failure|0|||
161684678|NCT02716987|583897967|FG000|Overall Study|Withdrawal by Subject|0|||
161684679|NCT02716987|583897968|FG001|Overall Study|Withdrawal by Subject|0|||
161684680|NCT02716987|583897969|FG002|Overall Study|Withdrawal by Subject|0|||
161684681|NCT02716987|583897970|FG003|Overall Study|Withdrawal by Subject|0|||
161684682|NCT02716987|583897971|FG004|Overall Study|Withdrawal by Subject|1|||
161684683|NCT02716987|583897972|FG005|Overall Study|Withdrawal by Subject|1|||
161684684|NCT01553188|583897973|FG000|Overall Study|Patient choice|1|||
161684685|NCT01553188|583897974|FG001|Overall Study|Patient choice|0|||
161684686|NCT01553188|583897975|FG002|Overall Study|Patient choice|0|||
161684687|NCT01553188|583897976|FG003|Overall Study|Patient choice|0|||
161684688|NCT01553188|583897973|FG000|Overall Study|Intercurrent illness and adverse event|0|||
161684689|NCT01553188|583897974|FG001|Overall Study|Intercurrent illness and adverse event|1|||
161684690|NCT01553188|583897975|FG002|Overall Study|Intercurrent illness and adverse event|2|||
161684691|NCT01553188|583897976|FG003|Overall Study|Intercurrent illness and adverse event|0|||
161684692|NCT01617070|583897978|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
161684693|NCT04544475|583897979|FG000|Overall Study|Withdrawal by Subject|1|||
161684694|NCT04544475|583897980|FG001|Overall Study|Withdrawal by Subject|3|||
161684695|NCT03223428|583897981|FG000|Overall Study|No longer taking Xermelo|27|||
161684696|NCT03223428|583897981|FG000|Overall Study|Declined Consent|1|||
161684697|NCT03223428|583897981|FG000|Overall Study|Non-responders|56|||
161948860|NCT05270863|584864196|FG003|First Washout|Withdrawal by Subject|0|||
161948861|NCT05270863|584864197|FG004|First Washout|Withdrawal by Subject|1|||
161684698|NCT03223428|583897981|FG000|Overall Study|Withdrawal by Subject|14|||
161684699|NCT02230384|583897983|FG000|Phase 1|Lost to Follow-up|1|||
161948862|NCT05270863|584864198|FG005|First Washout|Withdrawal by Subject|1|||
161684700|NCT02230384|583897984|FG001|Phase 1|Lost to Follow-up|0|||
161684701|NCT02230384|583897983|FG000|Phase 1|Physician Decision|0|||
161684702|NCT02230384|583897984|FG001|Phase 1|Physician Decision|1|||
161684703|NCT02230384|583897983|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
161684704|NCT02230384|583897984|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
161684705|NCT02230384|583897983|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
161684706|NCT02230384|583897984|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
161948863|NCT05270863|584864193|FG000|First Washout|Lost to Follow-up|0|||
161684707|NCT02230384|583897983|FG000|Phase 2 - Switch|Adverse Event|2|||
161948864|NCT05270863|584864194|FG001|First Washout|Lost to Follow-up|0|||
161948865|NCT05270863|584864195|FG002|First Washout|Lost to Follow-up|0|||
161948866|NCT05270863|584864196|FG003|First Washout|Lost to Follow-up|0|||
161948867|NCT05270863|584864197|FG004|First Washout|Lost to Follow-up|0|||
161948868|NCT05270863|584864198|FG005|First Washout|Lost to Follow-up|1|||
161948869|NCT05270863|584864193|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
161948870|NCT05270863|584864194|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
161948871|NCT05270863|584864195|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
161948872|NCT05270863|584864196|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
161948873|NCT05270863|584864197|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
161948874|NCT05270863|584864198|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
161948875|NCT05270863|584864193|FG000|Second Washout|Withdrawal by Subject|1|||
161948876|NCT05270863|584864194|FG001|Second Washout|Withdrawal by Subject|1|||
161948877|NCT05270863|584864195|FG002|Second Washout|Withdrawal by Subject|0|||
161948878|NCT05270863|584864196|FG003|Second Washout|Withdrawal by Subject|0|||
161948879|NCT05270863|584864197|FG004|Second Washout|Withdrawal by Subject|0|||
161948880|NCT05270863|584864198|FG005|Second Washout|Withdrawal by Subject|0|||
161948881|NCT05270863|584864193|FG000|Second Washout|Lost to Follow-up|0|||
161948882|NCT05270863|584864194|FG001|Second Washout|Lost to Follow-up|0|||
161948883|NCT05270863|584864195|FG002|Second Washout|Lost to Follow-up|0|||
161832779|NCT01475253|584429603|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
161832780|NCT02676284|584429604|FG000|Overall Study|Withdrawal by Subject|1|||
161832781|NCT03919448|584429606|FG000|Overall Study|Withdrawal by Subject|1|||
161832782|NCT03919448|584429607|FG001|Overall Study|Withdrawal by Subject|0|||
161832783|NCT03919448|584429608|FG002|Overall Study|Withdrawal by Subject|0|||
161832784|NCT04776746|584429610|FG000|Overall Study|Study terminated by sponsor|61|||
161832785|NCT04776746|584429610|FG000|Overall Study|Adverse Event|5|||
161832786|NCT04776746|584429610|FG000|Overall Study|Death|4|||
161832787|NCT04776746|584429610|FG000|Overall Study|Lack of Efficacy|3|||
161832788|NCT04776746|584429610|FG000|Overall Study|Noncompliance with study drug|2|||
161832789|NCT04776746|584429610|FG000|Overall Study|Not related to COVID-19|2|||
161832790|NCT01567826|584429619|FG000|Overall Study|Lost to Follow-up|3|||
161832791|NCT01567826|584429620|FG001|Overall Study|Lost to Follow-up|2|||
161832792|NCT03265288|584429623|FG000|Overall Study|Adverse Event|0|||
161832793|NCT03265288|584429624|FG001|Overall Study|Adverse Event|1|||
161832794|NCT03265288|584429623|FG000|Overall Study|Withdrawal by Subject|13|||
161832795|NCT03265288|584429624|FG001|Overall Study|Withdrawal by Subject|5|||
161832796|NCT03265288|584429623|FG000|Overall Study|Drug Withdrawn|3|||
161832797|NCT03265288|584429624|FG001|Overall Study|Drug Withdrawn|3|||
161832798|NCT03265288|584429623|FG000|Overall Study|Any Other Reason|7|||
161948884|NCT05270863|584864196|FG003|Second Washout|Lost to Follow-up|1|||
161948885|NCT05270863|584864197|FG004|Second Washout|Lost to Follow-up|0|||
161948886|NCT05270863|584864198|FG005|Second Washout|Lost to Follow-up|0|||
161832799|NCT03265288|584429624|FG001|Overall Study|Any Other Reason|3|||
161832800|NCT00171301|584429625|FG000|Overall Study|Death|1|||
161832801|NCT00171301|584429626|FG001|Overall Study|Death|2|||
161832802|NCT00171301|584429625|FG000|Overall Study|Adverse Event|1|||
161832803|NCT00171301|584429626|FG001|Overall Study|Adverse Event|2|||
161832804|NCT00171301|584429625|FG000|Overall Study|Lost to Follow-up|6|||
161832805|NCT00171301|584429626|FG001|Overall Study|Lost to Follow-up|2|||
161832806|NCT00171301|584429625|FG000|Overall Study|Protocol Violation|0|||
161948887|NCT03984188|584864199|FG000|Overall Study|Death|2|||
161948888|NCT03984188|584864200|FG001|Overall Study|Death|4|||
161832807|NCT00171301|584429626|FG001|Overall Study|Protocol Violation|2|||
161832808|NCT00171301|584429625|FG000|Overall Study|Withdrawal by Subject|0|||
161832809|NCT00171301|584429626|FG001|Overall Study|Withdrawal by Subject|1|||
161832810|NCT02100319|584429631|FG000|Overall Study|Case Report Forms Uncollected|11|||
161832811|NCT02100319|584429631|FG000|Overall Study|Protocol Deviation|5|||
161948889|NCT03984188|584864199|FG000|Overall Study|Physician Decision|0|||
161832812|NCT04976621|584429632|FG000|Overall Study|Lost to Follow-up|2|||
161832813|NCT04976621|584429633|FG001|Overall Study|Lost to Follow-up|2|||
161832814|NCT04976621|584429632|FG000|Overall Study|Withdrawal by Subject|1|||
161832815|NCT04976621|584429633|FG001|Overall Study|Withdrawal by Subject|1|||
161832816|NCT02589522|584429634|FG000|Overall Study|Physician Decision|1|||
161948890|NCT03984188|584864200|FG001|Overall Study|Physician Decision|2|||
161832817|NCT02589522|584429635|FG001|Overall Study|Physician Decision|2|||
161832818|NCT02589522|584429636|FG002|Overall Study|Physician Decision|0|||
161948891|NCT03984188|584864199|FG000|Overall Study|Lost to Follow-up|3|||
161684708|NCT02230384|583897984|FG001|Phase 2 - Switch|Adverse Event|0|||
161684709|NCT00808236|583897985|FG000|Overall Study|Was not resuscitated|50|||
161832819|NCT02589522|584429634|FG000|Overall Study|Did not start treatment|1|||
161832820|NCT02589522|584429635|FG001|Overall Study|Did not start treatment|0|||
161832821|NCT02589522|584429636|FG002|Overall Study|Did not start treatment|0|||
161684710|NCT00808236|583897986|FG001|Overall Study|Was not resuscitated|56|||
161684711|NCT00808236|583897985|FG000|Overall Study|Pre-defined exclusion|13|||
161832822|NCT01478828|584429637|FG000|Overall Study|Adverse Event|1|||
162028514|NCT01375075|585159463|FG005|Overall Study|Withdrawal by Subject|1|||
162028515|NCT00384111|585159464|FG000|Overall Study|Disease Progression|3|||
162028516|NCT00384111|585159464|FG000|Overall Study|Adverse Event|1|||
162028517|NCT00384111|585159464|FG000|Overall Study|Investigator Decision|3|||
162028518|NCT00384111|585159464|FG000|Overall Study|Study Terminated by the Sponsor|19|||
162028519|NCT04463069|585159465|FG000|Overall Study|Withdrawal by Subject|2|||
162028520|NCT04463069|585159466|FG001|Overall Study|Withdrawal by Subject|10|||
162028521|NCT04463069|585159465|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
162028522|NCT04463069|585159466|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
162028523|NCT00129311|585159474|FG000|Overall Study|Withdrawal by Subject|12|||
162028524|NCT00129311|585159475|FG001|Overall Study|Withdrawal by Subject|19|||
162028525|NCT02446171|585161741|FG000|Overall Study|Withdrawal by Subject|0|||
162028526|NCT02446171|585161742|FG001|Overall Study|Withdrawal by Subject|0|||
162028527|NCT02446171|585161743|FG002|Overall Study|Withdrawal by Subject|2|||
161684712|NCT00808236|583897986|FG001|Overall Study|Pre-defined exclusion|3|||
162028528|NCT02446171|585161744|FG003|Overall Study|Withdrawal by Subject|0|||
162028529|NCT02320903|585161747|FG000|Overall Study|Withdrawal by Subject|0|||
161832823|NCT01557842|584429638|FG000|Overall Study|Lost to Follow-up|0|||
161948892|NCT03984188|584864200|FG001|Overall Study|Lost to Follow-up|2|||
161948893|NCT03984188|584864199|FG000|Overall Study|Withdrawal by Subject|6|||
161948894|NCT03984188|584864200|FG001|Overall Study|Withdrawal by Subject|0|||
161948895|NCT00810277|584866048|FG000|Overall Study|Adverse Event|1|||
161832824|NCT01557842|584429639|FG001|Overall Study|Lost to Follow-up|1|||
161832825|NCT01557842|584429638|FG000|Overall Study|Death|1|||
161832826|NCT01557842|584429639|FG001|Overall Study|Death|0|||
161832827|NCT01557842|584429638|FG000|Overall Study|Lack of Efficacy|0|||
162028530|NCT02320903|585161748|FG001|Overall Study|Withdrawal by Subject|9|||
161832828|NCT01557842|584429639|FG001|Overall Study|Lack of Efficacy|1|||
162028531|NCT02320903|585161749|FG002|Overall Study|Withdrawal by Subject|9|||
162028532|NCT02320903|585161747|FG000|Overall Study|Exited therapy; no longer eligible|8|||
161684713|NCT00808236|583897985|FG000|Overall Study|Lost to Follow-up|1|||
162028533|NCT02320903|585161748|FG001|Overall Study|Exited therapy; no longer eligible|2|||
162028534|NCT02320903|585161749|FG002|Overall Study|Exited therapy; no longer eligible|2|||
161684714|NCT00808236|583897986|FG001|Overall Study|Lost to Follow-up|1|||
161684715|NCT00808236|583897985|FG000|Overall Study|Physician Decision|0|||
162028535|NCT02320903|585161747|FG000|Overall Study|Lost to Follow-up|0|||
161684716|NCT00808236|583897986|FG001|Overall Study|Physician Decision|1|||
161684717|NCT00808236|583897985|FG000|Overall Study|Death|18|||
162028536|NCT02320903|585161748|FG001|Overall Study|Lost to Follow-up|5|||
161948896|NCT00937495|584866049|FG000|Overall Study|Protocol Violation|2|||
161948897|NCT01856322|584866050|FG000|Overall Study|off study due to lack of accrual|0|||
161948898|NCT01856322|584866051|FG001|Overall Study|off study due to lack of accrual|0|||
161948899|NCT01856322|584866052|FG002|Overall Study|off study due to lack of accrual|3|||
161948900|NCT02628444|584866053|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
161684718|NCT00808236|583897986|FG001|Overall Study|Death|30|||
161948901|NCT02628444|584866054|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161948902|NCT02628444|584866055|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161948903|NCT02628444|584866056|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
162028537|NCT02320903|585161749|FG002|Overall Study|Lost to Follow-up|5|||
161684719|NCT00961220|583897987|FG000|Overall Study|Adverse Event|3|||
161684720|NCT00961220|583897987|FG000|Overall Study|Lack of Efficacy|1|||
161684721|NCT00961220|583897987|FG000|Overall Study|No IV access for O6BG|1|||
161684722|NCT00961220|583897987|FG000|Overall Study|O6BG no longer supplied|1|||
161684723|NCT00961220|583897987|FG000|Overall Study|Complete Response prior to 12 courses|1|||
161684724|NCT05376215|583897988|FG000|Overall Study|Withdrawal by Subject|2|||
161684725|NCT05376215|583897989|FG001|Overall Study|Withdrawal by Subject|1|||
161684726|NCT05376215|583897988|FG000|Overall Study|Lost to Follow-up|0|||
161684727|NCT05376215|583897989|FG001|Overall Study|Lost to Follow-up|1|||
161684728|NCT01301950|583897990|FG000|Overall Study|Surgery was cancelled by patient|0|||
161684729|NCT01301950|583897991|FG001|Overall Study|Surgery was cancelled by patient|1|||
161684730|NCT00942175|583897992|FG000|Overall Study|Adverse Event|2|||
161684731|NCT00942175|583897993|FG001|Overall Study|Adverse Event|1|||
161684732|NCT00942175|583897994|FG002|Overall Study|Adverse Event|0|||
161684733|NCT00942175|583897995|FG003|Overall Study|Adverse Event|0|||
161684734|NCT00942175|583897992|FG000|Overall Study|Protocol Violation|0|||
161684735|NCT00942175|583897993|FG001|Overall Study|Protocol Violation|1|||
161684736|NCT00942175|583897994|FG002|Overall Study|Protocol Violation|2|||
161684737|NCT00942175|583897995|FG003|Overall Study|Protocol Violation|0|||
162028538|NCT00773383|585161750|FG000|Overall Study|Adverse Event|4|||
161684738|NCT00942175|583897992|FG000|Overall Study|Pregnancy|0|||
161684739|NCT00942175|583897993|FG001|Overall Study|Pregnancy|0|||
161684740|NCT00942175|583897994|FG002|Overall Study|Pregnancy|0|||
161684741|NCT00942175|583897995|FG003|Overall Study|Pregnancy|1|||
161684742|NCT00942175|583897992|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
161684743|NCT00942175|583897993|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
161948904|NCT02628444|584866057|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161948905|NCT02628444|584866058|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161948906|NCT02628444|584866059|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161948907|NCT02628444|584866060|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161948908|NCT02628444|584866061|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
161948909|NCT02628444|584866053|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161948910|NCT02628444|584866054|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
161948911|NCT02628444|584866055|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
161948912|NCT02628444|584866056|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161948913|NCT02628444|584866057|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161948914|NCT02628444|584866058|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161948915|NCT02628444|584866059|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161948916|NCT02628444|584866060|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161948917|NCT02628444|584866061|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
161832829|NCT01557842|584429638|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
161832830|NCT01557842|584429639|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
161832831|NCT01557842|584429638|FG000|Overall Study|Study Terminated by Sponsor|3|||
161832832|NCT01557842|584429639|FG001|Overall Study|Study Terminated by Sponsor|4|||
161832833|NCT01557842|584429638|FG000|Overall Study|Not Ablated|2|||
161832834|NCT01557842|584429639|FG001|Overall Study|Not Ablated|0|||
161832835|NCT05611996|584429640|FG000|Overall Study|Ineligible|1|||
161684744|NCT00942175|583897994|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
161684745|NCT00942175|583897995|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
161684746|NCT00942175|583897992|FG000|Overall Study|Low Platelet Count|0|||
161684747|NCT00942175|583897993|FG001|Overall Study|Low Platelet Count|2|||
161684748|NCT00942175|583897994|FG002|Overall Study|Low Platelet Count|0|||
161684749|NCT00942175|583897995|FG003|Overall Study|Low Platelet Count|0|||
161684750|NCT01066585|583897996|FG000|Overall Study|Protocol Violation|1|||
161684751|NCT01066585|583897997|FG001|Overall Study|Protocol Violation|0|||
161684752|NCT01066585|583897996|FG000|Overall Study|Withdrawal by Subject|0|||
161684753|NCT01066585|583897997|FG001|Overall Study|Withdrawal by Subject|3|||
161684754|NCT00886600|583897999|FG000|Double-blind Monotherapy|Adverse Event|1|||
161684755|NCT00886600|583898000|FG001|Double-blind Monotherapy|Adverse Event|1|||
161684756|NCT00886600|583898001|FG002|Double-blind Monotherapy|Adverse Event|1|||
161684757|NCT00886600|583898002|FG003|Double-blind Monotherapy|Adverse Event|1|||
161948918|NCT02628444|584866053|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
161948919|NCT02628444|584866054|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
161948920|NCT02628444|584866055|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
161948921|NCT02628444|584866056|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
161948922|NCT02628444|584866057|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
161948923|NCT02628444|584866058|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
161948924|NCT02628444|584866059|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
161948925|NCT02628444|584866060|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
161948926|NCT02628444|584866061|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
162028539|NCT00773383|585161750|FG000|Overall Study|Death|1|||
161948927|NCT02628444|584866053|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
161948928|NCT02628444|584866054|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
161948929|NCT02628444|584866055|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
161948930|NCT02628444|584866056|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
161948931|NCT02628444|584866057|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
161948932|NCT02628444|584866058|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
161832836|NCT05611996|584429640|FG000|Overall Study|Withdrawal by Subject|9|||
161832837|NCT04479475|584429644|FG000|Overall Study|Withdrawal by Subject|7|||
161832838|NCT00619359|584429647|FG000|Overall Study|Adverse Event|32|||
161832839|NCT00619359|584429648|FG001|Overall Study|Adverse Event|36|||
161832840|NCT00619359|584429647|FG000|Overall Study|Lost to Follow-up|12|||
161832841|NCT00619359|584429648|FG001|Overall Study|Lost to Follow-up|16|||
161832842|NCT00619359|584429647|FG000|Overall Study|Physician Decision|0|||
161832843|NCT00619359|584429648|FG001|Overall Study|Physician Decision|7|||
161832844|NCT00619359|584429647|FG000|Overall Study|Protocol Violation|1|||
161832845|NCT00619359|584429648|FG001|Overall Study|Protocol Violation|1|||
161832846|NCT00619359|584429647|FG000|Overall Study|Withdrawal by Subject|19|||
161832847|NCT00619359|584429648|FG001|Overall Study|Withdrawal by Subject|20|||
161832848|NCT00619359|584429647|FG000|Overall Study|Progressive Disease|3|||
161832849|NCT00619359|584429648|FG001|Overall Study|Progressive Disease|1|||
161832850|NCT06972251|584429649|FG000|Overall Study|Withdrawal by Subject|1|||
161832851|NCT06972251|584429650|FG001|Overall Study|Withdrawal by Subject|0|||
161832852|NCT06972251|584429649|FG000|Overall Study|Lost to Follow-up|10|||
161832853|NCT06972251|584429650|FG001|Overall Study|Lost to Follow-up|2|||
161832854|NCT00351351|584429652|FG000|Overall Study|surgical access pbs; device issues|9|||
161832855|NCT00351351|584429653|FG001|Overall Study|surgical access pbs; device issues|4|||
161832856|NCT03891329|584429654|FG000|Overall Study|Death|5|||
161832857|NCT03891329|584429654|FG000|Overall Study|Lost to Follow-up|4|||
161832858|NCT03891329|584429654|FG000|Overall Study|Physician Decision|4|||
161832859|NCT03891329|584429654|FG000|Overall Study|Device explanted|3|||
161832860|NCT03891329|584429654|FG000|Overall Study|No study device implanted|3|||
161832861|NCT03176784|584429655|FG000|Overall Study|Lost to Follow-up|77|||
161832862|NCT03176784|584429656|FG001|Overall Study|Lost to Follow-up|79|||
161832863|NCT03176784|584429657|FG002|Overall Study|Lost to Follow-up|79|||
161832864|NCT03176784|584429658|FG003|Overall Study|Lost to Follow-up|49|||
161832865|NCT03176784|584429655|FG000|Overall Study|Withdrawal by Subject|28|||
161832866|NCT03176784|584429656|FG001|Overall Study|Withdrawal by Subject|34|||
161832867|NCT03176784|584429657|FG002|Overall Study|Withdrawal by Subject|34|||
161832868|NCT03176784|584429658|FG003|Overall Study|Withdrawal by Subject|21|||
161832869|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
161832870|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
161832871|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
161832872|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
161832873|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
161832874|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
161832875|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
161832876|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
161832877|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
161832878|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
161832879|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
162028540|NCT00773383|585161750|FG000|Overall Study|Progression of Disease|23|||
161832880|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
161832881|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161832882|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161832883|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
161832884|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
162028541|NCT00773383|585161750|FG000|Overall Study|Other|2|||
162028542|NCT00773383|585161750|FG000|Overall Study|No study dose received|1|||
162028543|NCT01012219|585161753|FG000|Period 1|Withdrawal by Subject|1|||
162028544|NCT01012219|585161753|FG000|Period 2|Withdrawal by Subject|1|||
162028545|NCT03811093|585161769|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
162028546|NCT03811093|585161770|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
161832885|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
161832886|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
161948933|NCT02628444|584866059|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
161948934|NCT02628444|584866060|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
161948935|NCT02628444|584866061|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
161948936|NCT02628444|584866053|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
161948937|NCT02628444|584866054|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
161948938|NCT02628444|584866055|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
161948939|NCT02628444|584866056|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
161948940|NCT02628444|584866057|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
161948941|NCT02628444|584866058|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
161832887|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
161832888|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
161948942|NCT02628444|584866059|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
161948943|NCT02628444|584866060|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
161948944|NCT02628444|584866061|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
161948945|NCT02628444|584866053|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161948946|NCT02628444|584866054|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161948947|NCT02628444|584866055|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161948948|NCT02628444|584866056|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
161832889|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
161948949|NCT02628444|584866057|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161948950|NCT02628444|584866058|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161948951|NCT02628444|584866059|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161948952|NCT02628444|584866060|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161948953|NCT02628444|584866061|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
161948954|NCT02628444|584866053|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
161684758|NCT00886600|583897999|FG000|Double-blind Monotherapy|Protocol Violation|0|||
161684759|NCT00886600|583898000|FG001|Double-blind Monotherapy|Protocol Violation|0|||
161684760|NCT00886600|583898001|FG002|Double-blind Monotherapy|Protocol Violation|0|||
161684761|NCT00886600|583898002|FG003|Double-blind Monotherapy|Protocol Violation|1|||
161684762|NCT00886600|583897999|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
161684763|NCT00886600|583898000|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
161684764|NCT00886600|583898001|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
161684765|NCT00886600|583898002|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
161684766|NCT00886600|583897999|FG000|Combination Therapy Period|Adverse Event|0|||
161684767|NCT00886600|583898000|FG001|Combination Therapy Period|Adverse Event|0|||
161684768|NCT00886600|583898001|FG002|Combination Therapy Period|Adverse Event|1|||
161684769|NCT00886600|583898002|FG003|Combination Therapy Period|Adverse Event|0|||
161684770|NCT00886600|583897999|FG000|Combination Therapy Period|Protocol Violation|0|||
161684771|NCT00886600|583898000|FG001|Combination Therapy Period|Protocol Violation|0|||
161684772|NCT00886600|583898001|FG002|Combination Therapy Period|Protocol Violation|1|||
161684773|NCT00886600|583898002|FG003|Combination Therapy Period|Protocol Violation|0|||
161684774|NCT00578136|583898008|FG000|Overall Study|Not given intervention|1|||
161684775|NCT00578136|583898009|FG001|Overall Study|Not given intervention|1|||
161684776|NCT01840579|583898012|FG000|Overall Study|Status not recorded|0|||
161684777|NCT01840579|583898013|FG001|Overall Study|Status not recorded|0|||
161684778|NCT01840579|583898014|FG002|Overall Study|Status not recorded|2|||
161684779|NCT01840579|583898015|FG003|Overall Study|Status not recorded|3|||
161684780|NCT01840579|583898016|FG004|Overall Study|Status not recorded|4|||
161684781|NCT01840579|583898017|FG005|Overall Study|Status not recorded|3|||
161684782|NCT01840579|583898018|FG006|Overall Study|Status not recorded|0|||
161684783|NCT01840579|583898019|FG007|Overall Study|Status not recorded|3|||
161684784|NCT01840579|583898020|FG008|Overall Study|Status not recorded|3|||
161684785|NCT01840579|583898021|FG009|Overall Study|Status not recorded|3|||
161684786|NCT01840579|583898012|FG000|Overall Study|Progressive disease|3|||
161684787|NCT01840579|583898013|FG001|Overall Study|Progressive disease|5|||
161684788|NCT01840579|583898014|FG002|Overall Study|Progressive disease|0|||
161684789|NCT01840579|583898015|FG003|Overall Study|Progressive disease|0|||
161948955|NCT02628444|584866054|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
161684790|NCT01840579|583898016|FG004|Overall Study|Progressive disease|0|||
161832890|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
161948956|NCT02628444|584866055|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
161684791|NCT01840579|583898017|FG005|Overall Study|Progressive disease|0|||
161684792|NCT01840579|583898018|FG006|Overall Study|Progressive disease|0|||
161684793|NCT01840579|583898019|FG007|Overall Study|Progressive disease|0|||
161684794|NCT01840579|583898020|FG008|Overall Study|Progressive disease|0|||
161684795|NCT01840579|583898021|FG009|Overall Study|Progressive disease|0|||
161684796|NCT01840579|583898012|FG000|Overall Study|Ongoing in study|0|||
161684797|NCT01840579|583898013|FG001|Overall Study|Ongoing in study|1|||
161684798|NCT01840579|583898014|FG002|Overall Study|Ongoing in study|0|||
161684799|NCT01840579|583898015|FG003|Overall Study|Ongoing in study|0|||
161684800|NCT01840579|583898016|FG004|Overall Study|Ongoing in study|0|||
161684801|NCT01840579|583898017|FG005|Overall Study|Ongoing in study|0|||
161684802|NCT01840579|583898018|FG006|Overall Study|Ongoing in study|0|||
161684803|NCT01840579|583898019|FG007|Overall Study|Ongoing in study|0|||
161684804|NCT01840579|583898020|FG008|Overall Study|Ongoing in study|0|||
161684805|NCT01840579|583898021|FG009|Overall Study|Ongoing in study|0|||
161684806|NCT01840579|583898012|FG000|Overall Study|Death|0|||
161684807|NCT01840579|583898013|FG001|Overall Study|Death|0|||
161684808|NCT01840579|583898014|FG002|Overall Study|Death|0|||
161684809|NCT01840579|583898015|FG003|Overall Study|Death|0|||
161684810|NCT01840579|583898016|FG004|Overall Study|Death|0|||
161684811|NCT01840579|583898017|FG005|Overall Study|Death|1|||
161684812|NCT01840579|583898018|FG006|Overall Study|Death|0|||
161684813|NCT01840579|583898019|FG007|Overall Study|Death|0|||
161684814|NCT01840579|583898020|FG008|Overall Study|Death|0|||
161684815|NCT01840579|583898021|FG009|Overall Study|Death|0|||
161684816|NCT01840579|583898012|FG000|Overall Study|Adverse Event|0|||
161684817|NCT01840579|583898013|FG001|Overall Study|Adverse Event|1|||
161684818|NCT01840579|583898014|FG002|Overall Study|Adverse Event|0|||
161684819|NCT01840579|583898015|FG003|Overall Study|Adverse Event|0|||
161684820|NCT01840579|583898016|FG004|Overall Study|Adverse Event|0|||
161684821|NCT01840579|583898017|FG005|Overall Study|Adverse Event|0|||
161684822|NCT01840579|583898018|FG006|Overall Study|Adverse Event|0|||
161684823|NCT01840579|583898019|FG007|Overall Study|Adverse Event|0|||
161948957|NCT02628444|584866056|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
161948958|NCT02628444|584866057|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
161684824|NCT01840579|583898020|FG008|Overall Study|Adverse Event|0|||
161684825|NCT01840579|583898021|FG009|Overall Study|Adverse Event|0|||
161948959|NCT02628444|584866058|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
161684826|NCT01840579|583898012|FG000|Overall Study|Follow-up ended by Sponsor|0|||
161684827|NCT01840579|583898013|FG001|Overall Study|Follow-up ended by Sponsor|0|||
161832891|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
161832892|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
161832893|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
161832894|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
161832895|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
161832896|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
161832897|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Death|0|||
161832898|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Death|1|||
161832899|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Death|0|||
161832900|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Death|0|||
161832901|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
161832902|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
161832903|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
161832904|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
161832905|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
161832906|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
161832907|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
161832908|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
161832909|NCT02990806|584429659|FG000|Stage 1 (22 Weeks)|Other|1|||
161832910|NCT02990806|584429660|FG001|Stage 1 (22 Weeks)|Other|3|||
161832911|NCT02990806|584429661|FG002|Stage 1 (22 Weeks)|Other|0|||
161832912|NCT02990806|584429662|FG003|Stage 1 (22 Weeks)|Other|0|||
161832913|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
161832914|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
161832915|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
161832916|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
161832917|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Death|1|||
161832918|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Death|0|||
161832919|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Death|0|||
161832920|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Death|0|||
161832921|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
161832922|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
161832923|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
161832924|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
161832925|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
161832926|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
161832927|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
161832928|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
161832929|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
161832930|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
161832931|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
161832932|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
161832933|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
161832934|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
161832935|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
161832936|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
161832937|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161832938|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
161832939|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
161684828|NCT01840579|583898014|FG002|Overall Study|Follow-up ended by Sponsor|0|||
161684829|NCT01840579|583898015|FG003|Overall Study|Follow-up ended by Sponsor|0|||
161684830|NCT01840579|583898016|FG004|Overall Study|Follow-up ended by Sponsor|0|||
161684831|NCT01840579|583898017|FG005|Overall Study|Follow-up ended by Sponsor|0|||
161684832|NCT01840579|583898018|FG006|Overall Study|Follow-up ended by Sponsor|2|||
161684833|NCT01840579|583898019|FG007|Overall Study|Follow-up ended by Sponsor|0|||
161684834|NCT01840579|583898020|FG008|Overall Study|Follow-up ended by Sponsor|0|||
161684835|NCT01840579|583898021|FG009|Overall Study|Follow-up ended by Sponsor|0|||
161684836|NCT01585272|583898028|FG000|Overall Study|Adverse Event|22|||
161684837|NCT01585272|583898028|FG000|Overall Study|Protocol Violation|7|||
161684838|NCT01585272|583898028|FG000|Overall Study|Withdrawal by Subject|10|||
161684839|NCT00645593|583898029|FG000|Overall Study|Later found to be ineligible|1|||
161684840|NCT00645593|583898030|FG001|Overall Study|Later found to be ineligible|0|||
161832940|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
161948960|NCT02628444|584866059|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
161948961|NCT02628444|584866060|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
161948962|NCT02628444|584866061|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
161948963|NCT02628444|584866053|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
161948964|NCT02628444|584866054|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
161948965|NCT02628444|584866055|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
161832941|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
161948966|NCT02628444|584866056|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
161948967|NCT02628444|584866057|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
161832942|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
161684841|NCT04013529|583898033|FG000|Overall Study|Withdrawal by Subject|1|||
161684842|NCT04013529|583898034|FG001|Overall Study|Withdrawal by Subject|1|||
161684843|NCT00609791|583899571|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
161684844|NCT02484911|583899573|FG000|Overall Study|Withdrawal by Subject|2|||
161684845|NCT02484911|583899574|FG001|Overall Study|Withdrawal by Subject|1|||
161684846|NCT02484911|583899573|FG000|Overall Study|Protocol Violation|2|||
161684847|NCT02484911|583899574|FG001|Overall Study|Protocol Violation|1|||
161684848|NCT04129528|583899578|FG000|Overall Study|Adverse Event|1|||
161684849|NCT04129528|583899579|FG001|Overall Study|Adverse Event|0|||
161684850|NCT04129528|583899578|FG000|Overall Study|Physician Decision|1|||
161684851|NCT04129528|583899579|FG001|Overall Study|Physician Decision|1|||
161948968|NCT02628444|584866058|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
161948969|NCT02628444|584866059|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
161684852|NCT04129528|583899578|FG000|Overall Study|Withdrawal by Subject|1|||
161684853|NCT04129528|583899579|FG001|Overall Study|Withdrawal by Subject|1|||
161684854|NCT00490568|583899580|FG000|Overall Study|Adverse Event|116|||
161684855|NCT00490568|583899580|FG000|Overall Study|Lost to Follow-up|13|||
161684856|NCT00490568|583899580|FG000|Overall Study|Protocol Violation|45|||
161948970|NCT02628444|584866060|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
161948971|NCT02628444|584866061|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
161948972|NCT02628444|584866053|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
161684857|NCT00490568|583899580|FG000|Overall Study|Withdrawal by Subject|135|||
161684858|NCT00490568|583899580|FG000|Overall Study|Still in the study at termination|974|||
161684859|NCT00490568|583899580|FG000|Overall Study|Other|1|||
161684860|NCT00490568|583899580|FG000|Overall Study|Exclusion criteria met|1|||
161684861|NCT00490568|583899580|FG000|Overall Study|Caregiver related|20|||
161684862|NCT00490568|583899580|FG000|Overall Study|Abnormal ECG|25|||
162028547|NCT03811093|585161769|FG000|Overall Study|Unable to measure body fat percentage|2|||
161684863|NCT00490568|583899580|FG000|Overall Study|Participant refused follow-up|9|||
161684864|NCT00490568|583899580|FG000|Overall Study|Legal representative withdrew consent|1|||
161684865|NCT00490568|583899580|FG000|Overall Study|Disease progression|4|||
161684866|NCT00490568|583899580|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
161684867|NCT00490568|583899580|FG000|Overall Study|Investigator decision|3|||
161684868|NCT00490568|583899580|FG000|Overall Study|Non-Compliance|7|||
161684869|NCT00490568|583899580|FG000|Overall Study|Efficacy related|3|||
161948973|NCT02628444|584866054|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
161948974|NCT02628444|584866055|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
161684870|NCT00490568|583899580|FG000|Overall Study|Participant died|1|||
161948975|NCT02628444|584866056|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
161948976|NCT02628444|584866057|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
161948977|NCT02628444|584866058|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
161684871|NCT00490568|583899580|FG000|Overall Study|Participant withdrawal due to surgery|1|||
161832943|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
161832944|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
161832945|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
161832946|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
161832947|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
161832948|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
161832949|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
161832950|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
161832951|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
161832952|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
161832953|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
161832954|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
162028548|NCT03811093|585161770|FG001|Overall Study|Unable to measure body fat percentage|0|||
162028549|NCT01009840|585161771|FG000|Overall Study|Lost to Follow-up|1|||
161684872|NCT01081912|583899588|FG000|Conversion/Titration|Adverse Event|47|||
161684873|NCT01081912|583899589|FG001|Conversion/Titration|Adverse Event|0|||
161684874|NCT01081912|583899590|FG002|Conversion/Titration|Adverse Event|0|||
161684875|NCT01081912|583899588|FG000|Conversion/Titration|Lack of Efficacy|17|||
161684876|NCT01081912|583899589|FG001|Conversion/Titration|Lack of Efficacy|0|||
161684877|NCT01081912|583899590|FG002|Conversion/Titration|Lack of Efficacy|0|||
161684878|NCT01081912|583899588|FG000|Conversion/Titration|Lost to Follow-up|5|||
161684879|NCT01081912|583899589|FG001|Conversion/Titration|Lost to Follow-up|0|||
161684880|NCT01081912|583899590|FG002|Conversion/Titration|Lost to Follow-up|0|||
161684881|NCT01081912|583899588|FG000|Conversion/Titration|Physician Decision|2|||
161684882|NCT01081912|583899589|FG001|Conversion/Titration|Physician Decision|0|||
161832955|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
161832956|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
161832957|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Other|3|||
161832958|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Other|0|||
161832959|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Other|4|||
161684883|NCT01081912|583899590|FG002|Conversion/Titration|Physician Decision|0|||
161684884|NCT01081912|583899588|FG000|Conversion/Titration|Protocol Violation|67|||
161684885|NCT01081912|583899589|FG001|Conversion/Titration|Protocol Violation|0|||
161684886|NCT01081912|583899590|FG002|Conversion/Titration|Protocol Violation|0|||
161684887|NCT01081912|583899588|FG000|Conversion/Titration|Withdrawal by Subject|23|||
161832960|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Other|1|||
161832961|NCT02990806|584429659|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
161832962|NCT02990806|584429660|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
161948978|NCT02628444|584866059|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
161948979|NCT02628444|584866060|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
161948980|NCT02628444|584866061|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
161948981|NCT02628444|584866053|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
161948982|NCT02628444|584866054|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
161948983|NCT02628444|584866055|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
161948984|NCT02628444|584866056|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
161948985|NCT02628444|584866057|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
161684888|NCT01081912|583899589|FG001|Conversion/Titration|Withdrawal by Subject|0|||
161684889|NCT01081912|583899590|FG002|Conversion/Titration|Withdrawal by Subject|0|||
161684890|NCT01081912|583899588|FG000|Conversion/Titration|Non-Compliance|47|||
161684891|NCT01081912|583899589|FG001|Conversion/Titration|Non-Compliance|0|||
161684892|NCT01081912|583899590|FG002|Conversion/Titration|Non-Compliance|0|||
161684893|NCT01081912|583899588|FG000|Maintenance Treatment|Adverse Event|0|||
161684894|NCT01081912|583899589|FG001|Maintenance Treatment|Adverse Event|2|||
161684895|NCT01081912|583899590|FG002|Maintenance Treatment|Adverse Event|12|||
161684896|NCT01081912|583899588|FG000|Maintenance Treatment|Lack of Efficacy|0|||
161684897|NCT01081912|583899589|FG001|Maintenance Treatment|Lack of Efficacy|14|||
161684898|NCT01081912|583899590|FG002|Maintenance Treatment|Lack of Efficacy|64|||
161684899|NCT01081912|583899588|FG000|Maintenance Treatment|Lost to Follow-up|0|||
161948986|NCT02628444|584866058|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
161948987|NCT02628444|584866059|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
161948988|NCT02628444|584866060|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
162028550|NCT01009840|585161771|FG000|Overall Study|Adverse Event|4|||
161684900|NCT01081912|583899589|FG001|Maintenance Treatment|Lost to Follow-up|1|||
161684901|NCT01081912|583899590|FG002|Maintenance Treatment|Lost to Follow-up|0|||
161684902|NCT01081912|583899588|FG000|Maintenance Treatment|Physician Decision|0|||
161684903|NCT01081912|583899589|FG001|Maintenance Treatment|Physician Decision|0|||
161684904|NCT01081912|583899590|FG002|Maintenance Treatment|Physician Decision|1|||
161684905|NCT01081912|583899588|FG000|Maintenance Treatment|Protocol Violation|0|||
161684906|NCT01081912|583899589|FG001|Maintenance Treatment|Protocol Violation|1|||
161684907|NCT01081912|583899590|FG002|Maintenance Treatment|Protocol Violation|2|||
161684908|NCT01081912|583899588|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
161684909|NCT01081912|583899589|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
161684910|NCT01081912|583899590|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
161684911|NCT01081912|583899588|FG000|Maintenance Treatment|Non-Compliance|0|||
161684912|NCT01081912|583899589|FG001|Maintenance Treatment|Non-Compliance|4|||
161684913|NCT01081912|583899590|FG002|Maintenance Treatment|Non-Compliance|7|||
161948989|NCT02628444|584866061|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
161684914|NCT01081912|583899588|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
161684915|NCT01081912|583899589|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
161948990|NCT00288015|584866062|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
161948991|NCT00288015|584866062|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
161948992|NCT00288015|584866062|FG000|First Response Assessment|Withdrawal by Subject|1|||
161948993|NCT00288015|584866062|FG000|First Response Assessment|Death|1|||
161948994|NCT00288015|584866062|FG000|First Response Assessment|Physician Decision|2|||
161948995|NCT00288015|584866062|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
161948996|NCT00288015|584866062|FG000|Follow up for Survival x 2 Years|Death|13|||
161948997|NCT00288015|584866062|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
161948998|NCT00288015|584866062|FG000|Follow up for Survival x 2 Years|Other|9|||
161948999|NCT00443703|584866065|FG000|Overall Study|Never Treated|3|||
161949000|NCT00443703|584866066|FG001|Overall Study|Never Treated|1|||
161832963|NCT02990806|584429661|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
161949001|NCT00443703|584866065|FG000|Overall Study|Adverse Event|7|||
161949002|NCT00443703|584866066|FG001|Overall Study|Adverse Event|3|||
161949003|NCT00443703|584866065|FG000|Overall Study|Lack of Efficacy|3|||
161684916|NCT01081912|583899590|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
161684917|NCT01140451|583899591|FG000|Overall Study|Withdrawal by Subject|26|||
161684918|NCT01140451|583899592|FG001|Overall Study|Withdrawal by Subject|33|||
161684919|NCT01140451|583899591|FG000|Overall Study|Adverse Event|2|||
161684920|NCT01140451|583899592|FG001|Overall Study|Adverse Event|6|||
161684921|NCT01140451|583899591|FG000|Overall Study|Physician Decision|5|||
161684922|NCT01140451|583899592|FG001|Overall Study|Physician Decision|3|||
161684923|NCT01140451|583899591|FG000|Overall Study|Lost to Follow-up|2|||
161684924|NCT01140451|583899592|FG001|Overall Study|Lost to Follow-up|0|||
161684925|NCT01140451|583899591|FG000|Overall Study|Participants Planning Pregnancy|3|||
161949004|NCT00443703|584866066|FG001|Overall Study|Lack of Efficacy|1|||
161684926|NCT01140451|583899592|FG001|Overall Study|Participants Planning Pregnancy|0|||
161684927|NCT00441974|583899593|FG000|Overall Study|Adverse Event|6|||
161684928|NCT00441974|583899593|FG000|Overall Study|Consent Withdrawn|35|||
161949005|NCT00443703|584866065|FG000|Overall Study|Lost to Follow-up|0|||
161949006|NCT00443703|584866066|FG001|Overall Study|Lost to Follow-up|4|||
161949007|NCT00443703|584866065|FG000|Overall Study|Physician Decision|4|||
161949008|NCT00443703|584866066|FG001|Overall Study|Physician Decision|2|||
161949009|NCT00443703|584866065|FG000|Overall Study|Protocol Violation|1|||
161684929|NCT00441974|583899593|FG000|Overall Study|Lost to Follow-up|80|||
161684930|NCT00441974|583899593|FG000|Overall Study|Protocol Violation|7|||
161684931|NCT01146873|583899601|FG000|Overall Study|Transfer out|0|||
161684932|NCT01146873|583899602|FG001|Overall Study|Transfer out|6|||
161684933|NCT03200366|583899605|FG000|Patient Navigation Intervention Given|Death|0|||
161949010|NCT00443703|584866066|FG001|Overall Study|Protocol Violation|1|||
161949011|NCT00443703|584866065|FG000|Overall Study|Withdrawal by Subject|9|||
161949012|NCT00443703|584866066|FG001|Overall Study|Withdrawal by Subject|6|||
161949013|NCT00443703|584866065|FG000|Overall Study|Progressive Disease|1|||
161949014|NCT00443703|584866066|FG001|Overall Study|Progressive Disease|0|||
162028551|NCT01009840|585161771|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
162028552|NCT01009840|585161771|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
162028553|NCT01009840|585161771|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
162028554|NCT01104376|585161776|FG000|Overall Study|Withdrawal by Subject|15|||
161832964|NCT02990806|584429662|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
161832965|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
161832966|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
161832967|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
161832968|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
161832969|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
161832970|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
161832971|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
161832972|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
162028555|NCT01104376|585161776|FG000|Overall Study|Consented but excluded after labs|13|||
162028556|NCT00797966|585161777|FG000|Phase A|Lost to Follow-up|0|||
162028557|NCT00797966|585161778|FG001|Phase A|Lost to Follow-up|0|||
162028558|NCT00797966|585161779|FG002|Phase A|Lost to Follow-up|0|||
162028559|NCT00797966|585161780|FG003|Phase A|Lost to Follow-up|0|||
162028560|NCT00797966|585161781|FG004|Phase A|Lost to Follow-up|33|||
162028561|NCT00797966|585161782|FG005|Phase A|Lost to Follow-up|0|||
162028562|NCT00797966|585161777|FG000|Phase A|Adverse Event|0|||
162028563|NCT00797966|585161778|FG001|Phase A|Adverse Event|0|||
162028564|NCT00797966|585161779|FG002|Phase A|Adverse Event|0|||
161684934|NCT03200366|583899606|FG001|Patient Navigation Intervention Given|Death|2|||
161684935|NCT03200366|583899607|FG002|Patient Navigation Intervention Given|Death|0|||
161832973|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
162028565|NCT00797966|585161780|FG003|Phase A|Adverse Event|0|||
162028566|NCT00797966|585161781|FG004|Phase A|Adverse Event|46|||
161832974|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
161832975|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161832976|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161832977|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
161832978|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
161832979|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
161832980|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
161832981|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
161832982|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
161832983|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
161832984|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
161684936|NCT03200366|583899605|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
161684937|NCT03200366|583899606|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
161684938|NCT03200366|583899607|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
161684939|NCT03200366|583899605|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
161684940|NCT03200366|583899606|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
161684941|NCT03200366|583899607|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
161684942|NCT03200366|583899605|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
161684943|NCT03200366|583899606|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
161832985|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
161832986|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
161832987|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
161684944|NCT03200366|583899607|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
161684945|NCT03200366|583899605|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
161684946|NCT03200366|583899606|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
161684947|NCT03200366|583899607|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
161684948|NCT03200366|583899605|FG000|6 Month Post-Baseline Interview|Death|1|||
161684949|NCT03200366|583899606|FG001|6 Month Post-Baseline Interview|Death|1|||
161684950|NCT03200366|583899607|FG002|6 Month Post-Baseline Interview|Death|1|||
161832988|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
161832989|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
161832990|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
161832991|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
161949015|NCT03759600|584866067|FG000|Overall Study|Adverse Event|2|||
161949016|NCT03759600|584866067|FG000|Overall Study|Progressive Disease|15|||
161832992|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
161832993|NCT02990806|584429659|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
161832994|NCT02990806|584429660|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
161832995|NCT02990806|584429661|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
161832996|NCT02990806|584429662|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
161832997|NCT02654587|584429663|FG000|Overall Study|patient alive at end of study|22|||
161832998|NCT02654587|584429664|FG001|Overall Study|patient alive at end of study|8|||
161832999|NCT02654587|584429663|FG000|Overall Study|Withdrawal by Subject|1|||
161833000|NCT02654587|584429664|FG001|Overall Study|Withdrawal by Subject|7|||
161833001|NCT01825837|584429665|FG000|PART I|Withdrawal by Subject|0|||
161833002|NCT01825837|584429666|FG001|PART I|Withdrawal by Subject|0|||
161833003|NCT01825837|584429667|FG002|PART I|Withdrawal by Subject|0|||
161833004|NCT01825837|584429668|FG003|PART I|Withdrawal by Subject|6|||
161833005|NCT01825837|584429665|FG000|PART I|Patient non-compliance|0|||
161949017|NCT03759600|584866067|FG000|Overall Study|Site Terminated by Sponsor|3|||
161949018|NCT00692003|584866069|FG000|Overall Study|Sponsor Decision|5|||
161833006|NCT01825837|584429666|FG001|PART I|Patient non-compliance|0|||
161833007|NCT01825837|584429667|FG002|PART I|Patient non-compliance|0|||
161833008|NCT01825837|584429668|FG003|PART I|Patient non-compliance|1|||
161833009|NCT01825837|584429665|FG000|PART I|Treatment failure|0|||
161833010|NCT01825837|584429666|FG001|PART I|Treatment failure|0|||
161833011|NCT01825837|584429667|FG002|PART I|Treatment failure|0|||
161833012|NCT01825837|584429668|FG003|PART I|Treatment failure|7|||
161833013|NCT01825837|584429665|FG000|PART I|reason unspecified|0|||
161833014|NCT01825837|584429666|FG001|PART I|reason unspecified|0|||
161833015|NCT01825837|584429667|FG002|PART I|reason unspecified|0|||
161833016|NCT01825837|584429668|FG003|PART I|reason unspecified|3|||
161833017|NCT01825837|584429665|FG000|PART II|Withdrawal by Subject|3|||
161833018|NCT01825837|584429666|FG001|PART II|Withdrawal by Subject|3|||
161833019|NCT01825837|584429667|FG002|PART II|Withdrawal by Subject|7|||
161833020|NCT01825837|584429668|FG003|PART II|Withdrawal by Subject|0|||
161833021|NCT01825837|584429665|FG000|PART II|Patient non-compliance|5|||
161833022|NCT01825837|584429666|FG001|PART II|Patient non-compliance|2|||
161833023|NCT01825837|584429667|FG002|PART II|Patient non-compliance|4|||
161833024|NCT01825837|584429668|FG003|PART II|Patient non-compliance|0|||
161833025|NCT01825837|584429665|FG000|PART II|Adverse Event|3|||
161833026|NCT01825837|584429666|FG001|PART II|Adverse Event|3|||
161833027|NCT01825837|584429667|FG002|PART II|Adverse Event|1|||
161833028|NCT01825837|584429668|FG003|PART II|Adverse Event|0|||
161833029|NCT01825837|584429665|FG000|PART II|Treatment failure|6|||
161833030|NCT01825837|584429666|FG001|PART II|Treatment failure|4|||
161833031|NCT01825837|584429667|FG002|PART II|Treatment failure|5|||
161833032|NCT01825837|584429668|FG003|PART II|Treatment failure|0|||
161833033|NCT01825837|584429665|FG000|PART II|reason unspecified|2|||
161833034|NCT01825837|584429666|FG001|PART II|reason unspecified|2|||
161833035|NCT01825837|584429667|FG002|PART II|reason unspecified|2|||
161833036|NCT01825837|584429668|FG003|PART II|reason unspecified|0|||
161833037|NCT00904748|584429671|FG000|Overall Study|Withdrawal by Subject|1|||
161833038|NCT00904748|584429672|FG001|Overall Study|Withdrawal by Subject|1|||
161833039|NCT00904748|584429673|FG002|Overall Study|Withdrawal by Subject|1|||
161833040|NCT00904748|584429674|FG003|Overall Study|Withdrawal by Subject|2|||
161833041|NCT00904748|584429675|FG004|Overall Study|Withdrawal by Subject|0|||
161833042|NCT00904748|584429676|FG005|Overall Study|Withdrawal by Subject|0|||
161833043|NCT00904748|584429671|FG000|Overall Study|Adverse Event|0|||
161833044|NCT00904748|584429672|FG001|Overall Study|Adverse Event|0|||
161833045|NCT00904748|584429673|FG002|Overall Study|Adverse Event|0|||
161833046|NCT00904748|584429674|FG003|Overall Study|Adverse Event|0|||
161833047|NCT00904748|584429675|FG004|Overall Study|Adverse Event|1|||
161833048|NCT00904748|584429676|FG005|Overall Study|Adverse Event|0|||
161833049|NCT01682148|584429677|FG000|Overall Study|Withdrawal by Subject|2|||
161833050|NCT01682148|584429678|FG001|Overall Study|Withdrawal by Subject|0|||
161833051|NCT01682148|584429677|FG000|Overall Study|Lost to Follow-up|1|||
161833052|NCT01682148|584429678|FG001|Overall Study|Lost to Follow-up|2|||
161833053|NCT01682148|584429677|FG000|Overall Study|Protocol Violation|1|||
161833054|NCT01682148|584429678|FG001|Overall Study|Protocol Violation|1|||
161833055|NCT01202877|584429679|FG000|Overall Study|Disease Progression|0|||
161833056|NCT01202877|584429680|FG001|Overall Study|Disease Progression|1|||
161833057|NCT01202877|584429681|FG002|Overall Study|Disease Progression|2|||
161833058|NCT01202877|584429679|FG000|Overall Study|Adverse Event|0|||
161833059|NCT01202877|584429680|FG001|Overall Study|Adverse Event|0|||
161833060|NCT01202877|584429681|FG002|Overall Study|Adverse Event|2|||
161833061|NCT01202877|584429679|FG000|Overall Study|Withdrawal by Subject|0|||
161833062|NCT01202877|584429680|FG001|Overall Study|Withdrawal by Subject|0|||
161833063|NCT01202877|584429681|FG002|Overall Study|Withdrawal by Subject|1|||
161833064|NCT01202877|584429679|FG000|Overall Study|Death|0|||
161833065|NCT01202877|584429680|FG001|Overall Study|Death|0|||
161949019|NCT00692003|584866070|FG001|Overall Study|Sponsor Decision|1|||
161949020|NCT03257358|584866071|FG000|Overall Study|Adverse Event|25|||
161949021|NCT03257358|584866072|FG001|Overall Study|Adverse Event|12|||
161949022|NCT03257358|584866071|FG000|Overall Study|Lack of Efficacy|1|||
161833066|NCT01202877|584429681|FG002|Overall Study|Death|1|||
161833067|NCT04403763|584429682|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
161833068|NCT04403763|584429683|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
161833069|NCT04403763|584429684|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
161833070|NCT04403763|584429685|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
161833071|NCT04403763|584429686|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
161833072|NCT04403763|584429687|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
161833073|NCT04403763|584429688|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
161833074|NCT04403763|584429682|FG000|Stage 1|Early termination due to PK tube failure|0|||
161833075|NCT04403763|584429683|FG001|Stage 1|Early termination due to PK tube failure|0|||
161833076|NCT04403763|584429684|FG002|Stage 1|Early termination due to PK tube failure|1|||
161833077|NCT04403763|584429685|FG003|Stage 1|Early termination due to PK tube failure|0|||
161833078|NCT04403763|584429686|FG004|Stage 1|Early termination due to PK tube failure|0|||
161833079|NCT04403763|584429687|FG005|Stage 1|Early termination due to PK tube failure|0|||
161833080|NCT04403763|584429688|FG006|Stage 1|Early termination due to PK tube failure|0|||
161833081|NCT04403763|584429682|FG000|Stage 2A|Adverse Event|0|||
161833082|NCT04403763|584429683|FG001|Stage 2A|Adverse Event|0|||
161833083|NCT04403763|584429684|FG002|Stage 2A|Adverse Event|0|||
161833084|NCT04403763|584429685|FG003|Stage 2A|Adverse Event|0|||
162028567|NCT00797966|585161782|FG005|Phase A|Adverse Event|0|||
162028568|NCT00797966|585161777|FG000|Phase A|Met withdrawal criteria|0|||
162028569|NCT00797966|585161778|FG001|Phase A|Met withdrawal criteria|0|||
161833085|NCT04403763|584429686|FG004|Stage 2A|Adverse Event|0|||
161684951|NCT03200366|583899605|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
161684952|NCT03200366|583899606|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
161684953|NCT03200366|583899607|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
161684954|NCT03200366|583899605|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
161684955|NCT03200366|583899606|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
161684956|NCT03200366|583899607|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
161684957|NCT03200366|583899605|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
161684958|NCT03200366|583899606|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
162028570|NCT00797966|585161779|FG002|Phase A|Met withdrawal criteria|0|||
162028571|NCT00797966|585161780|FG003|Phase A|Met withdrawal criteria|0|||
162028572|NCT00797966|585161781|FG004|Phase A|Met withdrawal criteria|4|||
162028573|NCT00797966|585161782|FG005|Phase A|Met withdrawal criteria|0|||
162028574|NCT00797966|585161777|FG000|Phase A|Physician Decision|0|||
162028575|NCT00797966|585161778|FG001|Phase A|Physician Decision|0|||
162028576|NCT00797966|585161779|FG002|Phase A|Physician Decision|0|||
162028577|NCT00797966|585161780|FG003|Phase A|Physician Decision|0|||
162028578|NCT00797966|585161781|FG004|Phase A|Physician Decision|13|||
162028579|NCT00797966|585161782|FG005|Phase A|Physician Decision|0|||
162028580|NCT00797966|585161777|FG000|Phase A|Withdrawal by Subject|0|||
162028581|NCT00797966|585161778|FG001|Phase A|Withdrawal by Subject|0|||
162028582|NCT00797966|585161779|FG002|Phase A|Withdrawal by Subject|0|||
162028583|NCT00797966|585161780|FG003|Phase A|Withdrawal by Subject|0|||
162028584|NCT00797966|585161781|FG004|Phase A|Withdrawal by Subject|33|||
162028585|NCT00797966|585161782|FG005|Phase A|Withdrawal by Subject|0|||
162028586|NCT00797966|585161777|FG000|Phase A|Protocol deviation|0|||
162028587|NCT00797966|585161778|FG001|Phase A|Protocol deviation|0|||
162028588|NCT00797966|585161779|FG002|Phase A|Protocol deviation|0|||
162028589|NCT00797966|585161780|FG003|Phase A|Protocol deviation|0|||
162028590|NCT00797966|585161781|FG004|Phase A|Protocol deviation|56|||
162028591|NCT00797966|585161782|FG005|Phase A|Protocol deviation|0|||
162028592|NCT00797966|585161777|FG000|Phase B|Lost to Follow-up|0|||
162028593|NCT00797966|585161778|FG001|Phase B|Lost to Follow-up|1|||
161684959|NCT03200366|583899607|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
161684960|NCT03200366|583899605|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
161684961|NCT03200366|583899606|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
161684962|NCT03200366|583899607|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
161684963|NCT03200366|583899605|FG000|9 Month Post-Baseline Interview|Death|1|||
161684964|NCT03200366|583899606|FG001|9 Month Post-Baseline Interview|Death|1|||
161684965|NCT03200366|583899607|FG002|9 Month Post-Baseline Interview|Death|1|||
161684966|NCT03200366|583899605|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
161684967|NCT03200366|583899606|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
161684968|NCT03200366|583899607|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
161684969|NCT03200366|583899605|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
161684970|NCT03200366|583899606|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
161684971|NCT03200366|583899607|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
161684972|NCT03200366|583899605|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
161684973|NCT03200366|583899606|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
161684974|NCT03200366|583899607|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
161684975|NCT00405067|583899608|FG000|Overall Study|Adverse Event|4|||
161684976|NCT00405067|583899609|FG001|Overall Study|Adverse Event|9|||
161684977|NCT00405067|583899610|FG002|Overall Study|Adverse Event|4|||
161684978|NCT00405067|583899608|FG000|Overall Study|Lost to Follow-up|0|||
161684979|NCT00405067|583899609|FG001|Overall Study|Lost to Follow-up|0|||
161684980|NCT00405067|583899610|FG002|Overall Study|Lost to Follow-up|1|||
161684981|NCT00552175|583899611|FG000|Overall Study|Lack of Efficacy|2|||
161684982|NCT00552175|583899612|FG001|Overall Study|Lack of Efficacy|0|||
162028594|NCT00797966|585161779|FG002|Phase B|Lost to Follow-up|3|||
162028595|NCT00797966|585161780|FG003|Phase B|Lost to Follow-up|0|||
162028596|NCT00797966|585161781|FG004|Phase B|Lost to Follow-up|0|||
161949023|NCT03257358|584866072|FG001|Overall Study|Lack of Efficacy|1|||
161949024|NCT03257358|584866071|FG000|Overall Study|Lost to Follow-up|12|||
161949025|NCT03257358|584866072|FG001|Overall Study|Lost to Follow-up|4|||
161949026|NCT03257358|584866071|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
161949027|NCT03257358|584866072|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
161949028|NCT03257358|584866071|FG000|Overall Study|Physician Decision|2|||
161949029|NCT03257358|584866072|FG001|Overall Study|Physician Decision|2|||
161949030|NCT03257358|584866071|FG000|Overall Study|Protocol Violation|5|||
161949031|NCT03257358|584866072|FG001|Overall Study|Protocol Violation|3|||
161949032|NCT03257358|584866071|FG000|Overall Study|Technical problems|4|||
161949033|NCT03257358|584866072|FG001|Overall Study|Technical problems|1|||
161949034|NCT03257358|584866071|FG000|Overall Study|Withdrawal by Subject|8|||
161949035|NCT03257358|584866072|FG001|Overall Study|Withdrawal by Subject|3|||
161684983|NCT00552175|583899613|FG002|Overall Study|Lack of Efficacy|1|||
161684984|NCT00552175|583899611|FG000|Overall Study|Adverse Event|9|||
161949036|NCT03257358|584866071|FG000|Overall Study|Withdrawal of informed consent|9|||
161949037|NCT03257358|584866072|FG001|Overall Study|Withdrawal of informed consent|5|||
161949038|NCT03257358|584866071|FG000|Overall Study|New therapy for study indication|1|||
161684985|NCT00552175|583899612|FG001|Overall Study|Adverse Event|9|||
161684986|NCT00552175|583899613|FG002|Overall Study|Adverse Event|10|||
161684987|NCT00552175|583899611|FG000|Overall Study|Withdrawal by Subject|2|||
161684988|NCT00552175|583899612|FG001|Overall Study|Withdrawal by Subject|2|||
161684989|NCT00552175|583899613|FG002|Overall Study|Withdrawal by Subject|1|||
161684990|NCT00552175|583899611|FG000|Overall Study|Lost to Follow-up|0|||
161684991|NCT00552175|583899612|FG001|Overall Study|Lost to Follow-up|0|||
161684992|NCT00552175|583899613|FG002|Overall Study|Lost to Follow-up|1|||
161684993|NCT00552175|583899611|FG000|Overall Study|Entry Criteria Not Met|1|||
161684994|NCT00552175|583899612|FG001|Overall Study|Entry Criteria Not Met|1|||
161684995|NCT00552175|583899613|FG002|Overall Study|Entry Criteria Not Met|0|||
161684996|NCT00552175|583899611|FG000|Overall Study|Reason Not Specified|3|||
161684997|NCT00552175|583899612|FG001|Overall Study|Reason Not Specified|1|||
161684998|NCT00552175|583899613|FG002|Overall Study|Reason Not Specified|1|||
161833086|NCT04403763|584429687|FG005|Stage 2A|Adverse Event|0|||
161949039|NCT03257358|584866072|FG001|Overall Study|New therapy for study indication|0|||
161684999|NCT00631020|583899614|FG000|Overall Study|Lost to Follow-up|7|||
161685000|NCT00631020|583899614|FG000|Overall Study|Incarcerated|1|||
161949040|NCT03257358|584866071|FG000|Overall Study|No longer requires treatment|0|||
161685001|NCT02614859|583899615|FG000|Overall Study|Physician Decision|0|||
161685002|NCT02614859|583899616|FG001|Overall Study|Physician Decision|1|||
161685003|NCT04677959|583899618|FG000|Overall Study|Adverse Event|1|||
161685004|NCT04677959|583899619|FG001|Overall Study|Adverse Event|9|||
161685005|NCT04677959|583899618|FG000|Overall Study|Withdrawal by Subject|2|||
161685006|NCT04677959|583899619|FG001|Overall Study|Withdrawal by Subject|15|||
161685007|NCT04677959|583899618|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161685008|NCT04677959|583899619|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161685009|NCT04677959|583899618|FG000|Overall Study|Non-compliance with study drug|0|||
161685010|NCT04677959|583899619|FG001|Overall Study|Non-compliance with study drug|2|||
161685011|NCT04677959|583899618|FG000|Overall Study|Protocol deviation|0|||
161685012|NCT04677959|583899619|FG001|Overall Study|Protocol deviation|11|||
161685013|NCT04677959|583899618|FG000|Overall Study|Lost to Follow-up|9|||
161685014|NCT04677959|583899619|FG001|Overall Study|Lost to Follow-up|13|||
161685015|NCT04677959|583899618|FG000|Overall Study|Other than specified|0|||
161685016|NCT04677959|583899619|FG001|Overall Study|Other than specified|8|||
161685017|NCT01399788|583899626|FG000|First Intervention Period|Adverse Event|1|||
161685018|NCT01399788|583899627|FG001|First Intervention Period|Adverse Event|0|||
161685019|NCT01389752|583899628|FG000|Study Period 1|Sponsor decision|0|||
161685020|NCT01389752|583899629|FG001|Study Period 1|Sponsor decision|2|||
161685021|NCT01389752|583899628|FG000|Study Period 2|Sponsor decision|1|||
161685022|NCT01389752|583899629|FG001|Study Period 2|Sponsor decision|0|||
161685023|NCT01576549|583899630|FG000|Overall Study|Sponsor Decision|2|||
161685024|NCT00053417|583899631|FG000|Overall Study|Adverse Event|1|||
161685025|NCT00053417|583899632|FG001|Overall Study|Adverse Event|0|||
161685026|NCT00053417|583899633|FG002|Overall Study|Adverse Event|1|||
161685027|NCT00053417|583899634|FG003|Overall Study|Adverse Event|5|||
161685028|NCT00053417|583899631|FG000|Overall Study|Non-Compliance|0|||
161685029|NCT00053417|583899632|FG001|Overall Study|Non-Compliance|0|||
161685030|NCT00053417|583899633|FG002|Overall Study|Non-Compliance|0|||
161685031|NCT00053417|583899634|FG003|Overall Study|Non-Compliance|1|||
161685032|NCT00053417|583899631|FG000|Overall Study|Withdrawal by Subject|0|||
161685033|NCT00053417|583899632|FG001|Overall Study|Withdrawal by Subject|1|||
161685034|NCT00053417|583899633|FG002|Overall Study|Withdrawal by Subject|0|||
161685035|NCT00053417|583899634|FG003|Overall Study|Withdrawal by Subject|0|||
161685036|NCT00053417|583899631|FG000|Overall Study|Lost to Follow-up|1|||
161685037|NCT00053417|583899632|FG001|Overall Study|Lost to Follow-up|1|||
161685038|NCT00053417|583899633|FG002|Overall Study|Lost to Follow-up|0|||
161685039|NCT00053417|583899634|FG003|Overall Study|Lost to Follow-up|0|||
161685040|NCT04081363|583899635|FG000|Overall Study|Withdrawal by Subject|1|||
161685041|NCT04081363|583899636|FG001|Overall Study|Withdrawal by Subject|0|||
161685042|NCT02409290|583899637|FG000|Overall Study|Protocol Violation|3|||
161685043|NCT02409290|583899638|FG001|Overall Study|Protocol Violation|6|||
161833087|NCT04403763|584429688|FG006|Stage 2A|Adverse Event|1|||
161833088|NCT00350402|584429689|FG000|Overall Study|Lost to Follow-up|1|||
161833089|NCT00350402|584429690|FG001|Overall Study|Lost to Follow-up|1|||
161833090|NCT01376310|584429691|FG000|Overall Study|Study closed/terminated|1|||
161833091|NCT01376310|584429692|FG001|Overall Study|Study closed/terminated|2|||
161833092|NCT01376310|584429691|FG000|Overall Study|Withdrawal by Subject|8|||
161833093|NCT01376310|584429692|FG001|Overall Study|Withdrawal by Subject|2|||
161833094|NCT01376310|584429691|FG000|Overall Study|Physician Decision|26|||
161833095|NCT01376310|584429692|FG001|Overall Study|Physician Decision|7|||
161833096|NCT01376310|584429691|FG000|Overall Study|Lost to Follow-up|1|||
161833097|NCT01376310|584429692|FG001|Overall Study|Lost to Follow-up|0|||
161833098|NCT01534637|584429695|FG000|Overall Study|Physician Decision|3|||
161833099|NCT01534637|584429695|FG000|Overall Study|Lack of Efficacy|3|||
161833100|NCT01534637|584429695|FG000|Overall Study|Withdrawal by Subject|1|||
161833101|NCT01534637|584429695|FG000|Overall Study|Adverse Event|1|||
161833102|NCT01534637|584429695|FG000|Overall Study|Liver Mets before treatment|1|||
161833103|NCT00834899|584429696|FG000|Overall Study|Withdrawal by Subject|1|||
161833104|NCT00834899|584429697|FG001|Overall Study|Withdrawal by Subject|1|||
161833105|NCT00606502|584429698|FG000|Randomization|Randomized but not treated|3|||
161833106|NCT00606502|584429699|FG001|Randomization|Randomized but not treated|0|||
161833107|NCT00606502|584429698|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
161833108|NCT00606502|584429699|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
161833109|NCT02377921|584429702|FG000|Overall Study|Subject non-compliance|1|||
161833110|NCT02377921|584429703|FG001|Overall Study|Subject non-compliance|1|||
161833111|NCT02443545|584429704|FG000|Overall Study|Adverse Event|1|||
161833112|NCT02443545|584429705|FG001|Overall Study|Adverse Event|1|||
161833113|NCT02443545|584429704|FG000|Overall Study|Lost to Follow-up|0|||
161833114|NCT02443545|584429705|FG001|Overall Study|Lost to Follow-up|2|||
161833115|NCT02443545|584429704|FG000|Overall Study|Physician Decision|3|||
161833116|NCT02443545|584429705|FG001|Overall Study|Physician Decision|0|||
161833117|NCT02443545|584429704|FG000|Overall Study|Protocol Violation|8|||
161833118|NCT02443545|584429705|FG001|Overall Study|Protocol Violation|1|||
161833119|NCT02443545|584429704|FG000|Overall Study|Pregnancy|1|||
161833120|NCT02443545|584429705|FG001|Overall Study|Pregnancy|1|||
161833121|NCT02443545|584429704|FG000|Overall Study|Withdrawal by Subject|6|||
161833122|NCT02443545|584429705|FG001|Overall Study|Withdrawal by Subject|3|||
161833123|NCT02443545|584429704|FG000|Overall Study|Termination of study|20|||
161833124|NCT02443545|584429705|FG001|Overall Study|Termination of study|11|||
161833125|NCT04179019|584429711|FG000|Overall Study|Lost to Follow-up|2|||
161833126|NCT04179019|584429711|FG000|Overall Study|Physician Decision|2|||
161833127|NCT04179019|584429711|FG000|Overall Study|Withdrawal by Subject|5|||
161833128|NCT04179019|584429711|FG000|Overall Study|Adverse Event|4|||
161833129|NCT01560507|584429712|FG000|Overall Study|Lost to Follow-up|3|||
161833130|NCT01560507|584429713|FG001|Overall Study|Lost to Follow-up|1|||
161833131|NCT01560507|584429714|FG002|Overall Study|Lost to Follow-up|2|||
161833132|NCT01560507|584429712|FG000|Overall Study|Withdrawal by Subject|1|||
161833133|NCT01560507|584429713|FG001|Overall Study|Withdrawal by Subject|1|||
161833134|NCT01560507|584429714|FG002|Overall Study|Withdrawal by Subject|0|||
161833135|NCT00440115|584429715|FG000|Overall Study|Death|7|||
161833136|NCT00440115|584429716|FG001|Overall Study|Death|9|||
161833137|NCT00440115|584429717|FG002|Overall Study|Death|5|||
161833138|NCT00440115|584429715|FG000|Overall Study|Incarceration|0|||
161833139|NCT00440115|584429716|FG001|Overall Study|Incarceration|2|||
161833140|NCT00440115|584429717|FG002|Overall Study|Incarceration|1|||
161833141|NCT03078478|584429718|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
161833142|NCT03078478|584429719|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
161833143|NCT03078478|584429718|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
161833144|NCT03078478|584429719|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
161833145|NCT03078478|584429718|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
161949041|NCT03257358|584866072|FG001|Overall Study|No longer requires treatment|1|||
161833146|NCT03078478|584429719|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
161833147|NCT03078478|584429718|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
161833148|NCT03078478|584429719|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
161833149|NCT03078478|584429718|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
161833150|NCT03078478|584429719|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
161949042|NCT02852967|584866073|FG000|Overall Study|Adverse Event|3|||
161949043|NCT02852967|584866074|FG001|Overall Study|Adverse Event|1|||
161833151|NCT03078478|584429718|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
161833152|NCT03078478|584429719|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
161833153|NCT03078478|584429718|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
161833154|NCT03078478|584429719|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
161833155|NCT03078478|584429718|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
161833156|NCT03078478|584429719|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
161685044|NCT02409290|583899639|FG002|Overall Study|Protocol Violation|9|||
161685045|NCT02409290|583899640|FG003|Overall Study|Protocol Violation|4|||
161949044|NCT02852967|584866075|FG002|Overall Study|Adverse Event|0|||
161949045|NCT02852967|584866076|FG003|Overall Study|Adverse Event|1|||
161685046|NCT02409290|583899637|FG000|Overall Study|No positive culture/no baseline sample|3|||
161685047|NCT02409290|583899638|FG001|Overall Study|No positive culture/no baseline sample|9|||
161685048|NCT02409290|583899639|FG002|Overall Study|No positive culture/no baseline sample|6|||
161833157|NCT01688726|584429720|FG000|Overall Study|Adverse Event|1|||
161949046|NCT02852967|584866077|FG004|Overall Study|Adverse Event|0|||
161685049|NCT02409290|583899640|FG003|Overall Study|No positive culture/no baseline sample|5|||
161833158|NCT01688726|584429721|FG001|Overall Study|Adverse Event|0|||
161833159|NCT01688726|584429720|FG000|Overall Study|Relocated abroad|0|||
161833160|NCT01688726|584429721|FG001|Overall Study|Relocated abroad|1|||
161833161|NCT03821272|584431004|FG000|Overall Study|Death|1|||
161833162|NCT03821272|584431005|FG001|Overall Study|Death|0|||
161833163|NCT03821272|584431004|FG000|Overall Study|Physician Decision|1|||
161685050|NCT02409290|583899637|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
161685051|NCT02409290|583899638|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
161949047|NCT02852967|584866073|FG000|Overall Study|Death|1|||
161949048|NCT02852967|584866074|FG001|Overall Study|Death|0|||
161949049|NCT02852967|584866075|FG002|Overall Study|Death|0|||
161949050|NCT02852967|584866076|FG003|Overall Study|Death|0|||
161949051|NCT02852967|584866077|FG004|Overall Study|Death|0|||
161949052|NCT02852967|584866073|FG000|Overall Study|Lost to Follow-up|1|||
161949053|NCT02852967|584866074|FG001|Overall Study|Lost to Follow-up|2|||
161949054|NCT02852967|584866075|FG002|Overall Study|Lost to Follow-up|3|||
161833164|NCT03821272|584431005|FG001|Overall Study|Physician Decision|0|||
161833165|NCT03821272|584431004|FG000|Overall Study|Withdrawal by Subject|1|||
161685052|NCT02409290|583899639|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
161833166|NCT03821272|584431005|FG001|Overall Study|Withdrawal by Subject|0|||
161833167|NCT05904769|584431006|FG000|Overall Study|Physician Decision|0|||
161833168|NCT05904769|584431007|FG001|Overall Study|Physician Decision|6|||
161833169|NCT05626803|584431013|FG000|Overall Study|Lost to Follow-up|0|||
161833170|NCT05626803|584431014|FG001|Overall Study|Lost to Follow-up|1|||
161833171|NCT05626803|584431015|FG002|Overall Study|Lost to Follow-up|0|||
161833172|NCT05626803|584431016|FG003|Overall Study|Lost to Follow-up|0|||
161833173|NCT04974619|584431017|FG000|Overall Study|Lost to Follow-up|0|||
161833174|NCT04974619|584431018|FG001|Overall Study|Lost to Follow-up|0|||
161833175|NCT04974619|584431019|FG002|Overall Study|Lost to Follow-up|1|||
161833176|NCT04974619|584431017|FG000|Overall Study|Withdrawal by Subject|0|||
161949055|NCT02852967|584866076|FG003|Overall Study|Lost to Follow-up|4|||
161949056|NCT02852967|584866077|FG004|Overall Study|Lost to Follow-up|4|||
161949057|NCT02852967|584866073|FG000|Overall Study|Withdrawal by Subject|6|||
161833177|NCT04974619|584431018|FG001|Overall Study|Withdrawal by Subject|0|||
161685053|NCT02409290|583899640|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
161685054|NCT04251910|583899645|FG000|Overall Study|Covid 19 lockdown|0|||
162028597|NCT00797966|585161782|FG005|Phase B|Lost to Follow-up|0|||
161685055|NCT04251910|583899646|FG001|Overall Study|Covid 19 lockdown|5|||
161685056|NCT04251910|583899647|FG002|Overall Study|Covid 19 lockdown|0|||
161685057|NCT04251910|583899648|FG003|Overall Study|Covid 19 lockdown|4|||
162028598|NCT00797966|585161777|FG000|Phase B|Adverse Event|2|||
162028599|NCT00797966|585161778|FG001|Phase B|Adverse Event|1|||
162028600|NCT00797966|585161779|FG002|Phase B|Adverse Event|3|||
162028601|NCT00797966|585161780|FG003|Phase B|Adverse Event|1|||
162028602|NCT00797966|585161781|FG004|Phase B|Adverse Event|0|||
162028603|NCT00797966|585161782|FG005|Phase B|Adverse Event|0|||
161833178|NCT04974619|584431019|FG002|Overall Study|Withdrawal by Subject|1|||
161833179|NCT04974619|584431017|FG000|Overall Study|Protocol Violation|0|||
161833180|NCT04974619|584431018|FG001|Overall Study|Protocol Violation|1|||
161833181|NCT04974619|584431019|FG002|Overall Study|Protocol Violation|0|||
161833182|NCT01688466|584431020|FG000|Overall Study|Withdrawal by Subject|2|||
161833183|NCT01688466|584431021|FG001|Overall Study|Withdrawal by Subject|1|||
161833184|NCT01688466|584431020|FG000|Overall Study|Death|0|||
161833185|NCT01688466|584431021|FG001|Overall Study|Death|1|||
161833186|NCT01688466|584431020|FG000|Overall Study|Adverse Event|0|||
161833187|NCT01688466|584431021|FG001|Overall Study|Adverse Event|4|||
161833188|NCT01688466|584431020|FG000|Overall Study|Not evaluable|0|||
161833189|NCT01688466|584431021|FG001|Overall Study|Not evaluable|1|||
161833190|NCT02516410|584431024|FG000|Overall Study|Adverse Event|0|||
161833191|NCT02516410|584431025|FG001|Overall Study|Adverse Event|1|||
161833192|NCT02516410|584431024|FG000|Overall Study|Withdrawal by Subject|0|||
161833193|NCT02516410|584431025|FG001|Overall Study|Withdrawal by Subject|1|||
161833194|NCT01286558|584431026|FG000|Overall Study|Adverse Event|1|||
161833195|NCT01286558|584431027|FG001|Overall Study|Adverse Event|1|||
161833196|NCT01286558|584431026|FG000|Overall Study|Withdrawal by Subject|0|||
161833197|NCT01286558|584431027|FG001|Overall Study|Withdrawal by Subject|1|||
161833198|NCT01220297|584431028|FG000|Overall Study|Death|2|||
161833199|NCT01220297|584431028|FG000|Overall Study|Lost to Follow-up|1|||
161833200|NCT01787279|584431030|FG000|Overall Study|Lost to Follow-up|2|||
161833201|NCT01787279|584431030|FG000|Overall Study|Lack of Efficacy|1|||
161833202|NCT02148913|584431031|FG000|Overall Study|Death|0|||
161833203|NCT02148913|584431032|FG001|Overall Study|Death|1|||
161833204|NCT02148913|584431033|FG002|Overall Study|Death|0|||
161833205|NCT02148913|584431034|FG003|Overall Study|Death|0|||
161833206|NCT01287039|584431036|FG000|Overall Study|Noncompliance with study procedures|0|||
161833207|NCT01287039|584431037|FG001|Overall Study|Noncompliance with study procedures|1|||
161833208|NCT01287039|584431036|FG000|Overall Study|Change of location/residence|0|||
161833209|NCT01287039|584431037|FG001|Overall Study|Change of location/residence|3|||
161833210|NCT01287039|584431036|FG000|Overall Study|Elective surgery|0|||
161833211|NCT01287039|584431037|FG001|Overall Study|Elective surgery|1|||
161833212|NCT01287039|584431036|FG000|Overall Study|Protocol Violation|2|||
161833213|NCT01287039|584431037|FG001|Overall Study|Protocol Violation|3|||
161833214|NCT01287039|584431036|FG000|Overall Study|Excluded medication taken|1|||
161833215|NCT01287039|584431037|FG001|Overall Study|Excluded medication taken|0|||
161833216|NCT01287039|584431036|FG000|Overall Study|Noncompliance with study medication|0|||
161833217|NCT01287039|584431037|FG001|Overall Study|Noncompliance with study medication|1|||
161833218|NCT01287039|584431036|FG000|Overall Study|Problem with travel|0|||
161833219|NCT01287039|584431037|FG001|Overall Study|Problem with travel|1|||
161833220|NCT01287039|584431036|FG000|Overall Study|Death|1|||
161833221|NCT01287039|584431037|FG001|Overall Study|Death|0|||
161833222|NCT01287039|584431036|FG000|Overall Study|Change of residence|1|||
161833223|NCT01287039|584431037|FG001|Overall Study|Change of residence|0|||
161833224|NCT01287039|584431036|FG000|Overall Study|Adverse Event|7|||
161833225|NCT01287039|584431037|FG001|Overall Study|Adverse Event|4|||
161833226|NCT01287039|584431036|FG000|Overall Study|Withdrawal by Subject|14|||
161833227|NCT01287039|584431037|FG001|Overall Study|Withdrawal by Subject|11|||
161833228|NCT01287039|584431036|FG000|Overall Study|Lost to Follow-up|3|||
161833229|NCT01287039|584431037|FG001|Overall Study|Lost to Follow-up|2|||
161833230|NCT01360866|584431038|FG000|Overall Study|Lost to Follow-up|11|||
161833231|NCT01360866|584431039|FG001|Overall Study|Lost to Follow-up|28|||
161833232|NCT01360866|584431040|FG002|Overall Study|Lost to Follow-up|41|||
161833233|NCT01360866|584431041|FG003|Overall Study|Lost to Follow-up|0|||
161833234|NCT01360866|584431038|FG000|Overall Study|Adverse Event|56|||
161833235|NCT01360866|584431039|FG001|Overall Study|Adverse Event|61|||
161833236|NCT01360866|584431040|FG002|Overall Study|Adverse Event|134|||
161833237|NCT01360866|584431041|FG003|Overall Study|Adverse Event|6|||
161833238|NCT01360866|584431038|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
161833239|NCT01360866|584431039|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
161833240|NCT01360866|584431040|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
161833241|NCT01360866|584431041|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
161833242|NCT01360866|584431038|FG000|Overall Study|Withdrawn by Investigator|9|||
161833243|NCT01360866|584431039|FG001|Overall Study|Withdrawn by Investigator|8|||
161833244|NCT01360866|584431040|FG002|Overall Study|Withdrawn by Investigator|31|||
161833245|NCT01360866|584431041|FG003|Overall Study|Withdrawn by Investigator|2|||
161833246|NCT01360866|584431038|FG000|Overall Study|Withdrawal by participant|79|||
161833247|NCT01360866|584431039|FG001|Overall Study|Withdrawal by participant|89|||
161833248|NCT01360866|584431040|FG002|Overall Study|Withdrawal by participant|168|||
161833249|NCT01360866|584431041|FG003|Overall Study|Withdrawal by participant|8|||
161833250|NCT01360866|584431038|FG000|Overall Study|Protocol Deviation|25|||
161833251|NCT01360866|584431039|FG001|Overall Study|Protocol Deviation|33|||
161833252|NCT01360866|584431040|FG002|Overall Study|Protocol Deviation|61|||
161833253|NCT01360866|584431041|FG003|Overall Study|Protocol Deviation|2|||
161833254|NCT01360866|584431038|FG000|Overall Study|Lack of Efficacy|30|||
161833255|NCT01360866|584431039|FG001|Overall Study|Lack of Efficacy|40|||
161833256|NCT01360866|584431040|FG002|Overall Study|Lack of Efficacy|30|||
161833257|NCT01360866|584431041|FG003|Overall Study|Lack of Efficacy|4|||
161833258|NCT05016622|584431042|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
161833259|NCT05016622|584431042|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
161833260|NCT03575871|584431051|FG000|Overall Study|Adverse Event|5|||
161833261|NCT03575871|584431052|FG001|Overall Study|Adverse Event|5|||
161833262|NCT03575871|584431053|FG002|Overall Study|Adverse Event|8|||
161833263|NCT03575871|584431051|FG000|Overall Study|Death|1|||
161833264|NCT03575871|584431052|FG001|Overall Study|Death|0|||
161833265|NCT03575871|584431053|FG002|Overall Study|Death|0|||
161833266|NCT03575871|584431051|FG000|Overall Study|Lack of Efficacy|5|||
161833267|NCT03575871|584431052|FG001|Overall Study|Lack of Efficacy|4|||
161833268|NCT03575871|584431053|FG002|Overall Study|Lack of Efficacy|7|||
161833269|NCT03575871|584431051|FG000|Overall Study|Lost to Follow-up|1|||
161833270|NCT03575871|584431052|FG001|Overall Study|Lost to Follow-up|1|||
161833271|NCT03575871|584431053|FG002|Overall Study|Lost to Follow-up|1|||
161833272|NCT03575871|584431051|FG000|Overall Study|Protocol Deviation|1|||
161833273|NCT03575871|584431052|FG001|Overall Study|Protocol Deviation|1|||
161833274|NCT03575871|584431053|FG002|Overall Study|Protocol Deviation|1|||
161833275|NCT03575871|584431051|FG000|Overall Study|Withdrawal by Subject|6|||
161833276|NCT03575871|584431052|FG001|Overall Study|Withdrawal by Subject|1|||
161833277|NCT03575871|584431053|FG002|Overall Study|Withdrawal by Subject|9|||
161833278|NCT03575871|584431051|FG000|Overall Study|Other than specified|2|||
161833279|NCT03575871|584431052|FG001|Overall Study|Other than specified|2|||
161833280|NCT03575871|584431053|FG002|Overall Study|Other than specified|0|||
161833281|NCT05506358|584431054|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
161833282|NCT05506358|584431055|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
161833283|NCT05506358|584431056|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
161833284|NCT05506358|584431057|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
161833285|NCT05506358|584431058|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
161685058|NCT04251910|583899649|FG004|Overall Study|Covid 19 lockdown|0|||
161685059|NCT04251910|583899650|FG005|Overall Study|Covid 19 lockdown|0|||
161685060|NCT04251910|583899645|FG000|Overall Study|Assisted living facility was closed|0|||
161685061|NCT04251910|583899646|FG001|Overall Study|Assisted living facility was closed|0|||
162028604|NCT00797966|585161777|FG000|Phase B|Met Withdrawal Criteria|3|||
161685062|NCT04251910|583899647|FG002|Overall Study|Assisted living facility was closed|0|||
162028605|NCT00797966|585161778|FG001|Phase B|Met Withdrawal Criteria|3|||
162028606|NCT00797966|585161779|FG002|Phase B|Met Withdrawal Criteria|6|||
161949058|NCT02852967|584866074|FG001|Overall Study|Withdrawal by Subject|12|||
161949059|NCT02852967|584866075|FG002|Overall Study|Withdrawal by Subject|7|||
161949060|NCT02852967|584866076|FG003|Overall Study|Withdrawal by Subject|10|||
161949061|NCT02852967|584866077|FG004|Overall Study|Withdrawal by Subject|10|||
161949062|NCT02852967|584866073|FG000|Overall Study|SAE|0|||
161949063|NCT02852967|584866074|FG001|Overall Study|SAE|0|||
161949064|NCT02852967|584866075|FG002|Overall Study|SAE|0|||
161949065|NCT02852967|584866076|FG003|Overall Study|SAE|3|||
161949066|NCT02852967|584866077|FG004|Overall Study|SAE|0|||
161949067|NCT02852967|584866073|FG000|Overall Study|Elevated Liver Enzymes|2|||
161949068|NCT02852967|584866074|FG001|Overall Study|Elevated Liver Enzymes|0|||
161949069|NCT02852967|584866075|FG002|Overall Study|Elevated Liver Enzymes|0|||
161949070|NCT02852967|584866076|FG003|Overall Study|Elevated Liver Enzymes|2|||
161949071|NCT02852967|584866077|FG004|Overall Study|Elevated Liver Enzymes|2|||
161949072|NCT02852967|584866073|FG000|Overall Study|Physician Decision|0|||
161949073|NCT02852967|584866074|FG001|Overall Study|Physician Decision|0|||
161949074|NCT02852967|584866075|FG002|Overall Study|Physician Decision|0|||
161949075|NCT02852967|584866076|FG003|Overall Study|Physician Decision|1|||
161949076|NCT02852967|584866077|FG004|Overall Study|Physician Decision|0|||
161949077|NCT02852967|584866073|FG000|Overall Study|Lack of Efficacy|0|||
161949078|NCT02852967|584866074|FG001|Overall Study|Lack of Efficacy|1|||
161949079|NCT02852967|584866075|FG002|Overall Study|Lack of Efficacy|0|||
161949080|NCT02852967|584866076|FG003|Overall Study|Lack of Efficacy|0|||
161949081|NCT02852967|584866077|FG004|Overall Study|Lack of Efficacy|0|||
161949082|NCT02852967|584866073|FG000|Overall Study|Non-compliance|0|||
161949083|NCT02852967|584866074|FG001|Overall Study|Non-compliance|0|||
161949084|NCT02852967|584866075|FG002|Overall Study|Non-compliance|1|||
161949085|NCT02852967|584866076|FG003|Overall Study|Non-compliance|1|||
161949086|NCT02852967|584866077|FG004|Overall Study|Non-compliance|0|||
161949087|NCT02852967|584866073|FG000|Overall Study|Dispensing Drug Violation|0|||
161949088|NCT02852967|584866074|FG001|Overall Study|Dispensing Drug Violation|0|||
161949089|NCT02852967|584866075|FG002|Overall Study|Dispensing Drug Violation|1|||
161949090|NCT02852967|584866076|FG003|Overall Study|Dispensing Drug Violation|0|||
161949091|NCT02852967|584866077|FG004|Overall Study|Dispensing Drug Violation|0|||
161949092|NCT02852967|584866073|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
161949093|NCT02852967|584866074|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
161949094|NCT02852967|584866075|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
161949095|NCT02852967|584866076|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
161949096|NCT02852967|584866077|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
161949097|NCT00339040|584866084|FG000|Stage I|Not able to attend clinic|1|||
161949098|NCT00339040|584866085|FG001|Stage I|Not able to attend clinic|0|||
162028607|NCT00797966|585161780|FG003|Phase B|Met Withdrawal Criteria|1|||
161685063|NCT04251910|583899648|FG003|Overall Study|Assisted living facility was closed|0|||
161949099|NCT00339040|584866084|FG000|Stage I|Protocol Violation|1|||
161949100|NCT00339040|584866085|FG001|Stage I|Protocol Violation|1|||
161949101|NCT00339040|584866084|FG000|Stage II|Lost to Follow-up|3|||
161949102|NCT00339040|584866085|FG001|Stage II|Lost to Follow-up|0|||
161949103|NCT00339040|584866084|FG000|Stage II|Withdrawal by Subject|1|||
161949104|NCT00339040|584866085|FG001|Stage II|Withdrawal by Subject|2|||
161949105|NCT00339040|584866084|FG000|Stage II|Protocol Violation|3|||
161949106|NCT00339040|584866085|FG001|Stage II|Protocol Violation|0|||
161949107|NCT00339040|584866084|FG000|Stage II|Not able to attend clinic|1|||
161949108|NCT00339040|584866085|FG001|Stage II|Not able to attend clinic|0|||
161949109|NCT00339040|584866084|FG000|Stage II|Site closing|2|||
161949110|NCT00339040|584866085|FG001|Stage II|Site closing|0|||
161949111|NCT02071771|584866093|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
161949112|NCT02071771|584866094|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
161949113|NCT02071771|584866093|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
161949114|NCT02071771|584866094|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
161949115|NCT02078752|584866095|FG000|Overall Study|Death|0|||
161949116|NCT02078752|584866096|FG001|Overall Study|Death|3|||
161949117|NCT02078752|584866097|FG002|Overall Study|Death|0|||
161949118|NCT02078752|584866098|FG003|Overall Study|Death|0|||
161685064|NCT04251910|583899649|FG004|Overall Study|Assisted living facility was closed|1|||
161685065|NCT04251910|583899650|FG005|Overall Study|Assisted living facility was closed|0|||
161685066|NCT02830776|583899653|FG000|Overall Study|Lost to Follow-up|1|||
161685067|NCT05289570|583899662|FG000|Overall Study|Physician Decision|1|||
161685068|NCT01765920|583899667|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
161685069|NCT01765920|583899668|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
161685070|NCT01765920|583899667|FG000|Overall Study|Patient code disclosure|0|||
161685071|NCT01765920|583899668|FG001|Overall Study|Patient code disclosure|1|||
161685072|NCT00777101|583899669|FG000|Overall Study|Death|48|||
161685073|NCT00777101|583899670|FG001|Overall Study|Death|43|||
161685074|NCT00777101|583899669|FG000|Overall Study|Withdrawal by Subject|11|||
161685075|NCT00777101|583899670|FG001|Overall Study|Withdrawal by Subject|6|||
161685076|NCT00777101|583899669|FG000|Overall Study|Lost to Follow-up|2|||
161685077|NCT00777101|583899670|FG001|Overall Study|Lost to Follow-up|1|||
161685078|NCT00777101|583899669|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
161685079|NCT00777101|583899670|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161685080|NCT00777101|583899669|FG000|Overall Study|Failed to Return|0|||
161685081|NCT00777101|583899670|FG001|Overall Study|Failed to Return|1|||
161685082|NCT00282334|583899673|FG000|Overall Study|Withdrawal by Subject|8|||
161685083|NCT00282334|583899674|FG001|Overall Study|Withdrawal by Subject|5|||
161685084|NCT00964743|583899683|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
161685085|NCT03317795|583899686|FG000|Overall Study|IUD Expulsion|1|||
161685086|NCT03317795|583899687|FG001|Overall Study|IUD Expulsion|0|||
161685087|NCT03317795|583899686|FG000|Overall Study|Lost to Follow-up|1|||
161685088|NCT03317795|583899687|FG001|Overall Study|Lost to Follow-up|3|||
161685089|NCT03317795|583899686|FG000|Overall Study|Treatment change|0|||
161685090|NCT03317795|583899687|FG001|Overall Study|Treatment change|3|||
161685091|NCT03317795|583899686|FG000|Overall Study|Intolerance of medication|0|||
161685092|NCT03317795|583899687|FG001|Overall Study|Intolerance of medication|1|||
161949119|NCT02078752|584866099|FG004|Overall Study|Death|0|||
161949120|NCT02078752|584866100|FG005|Overall Study|Death|1|||
161949121|NCT02078752|584866101|FG006|Overall Study|Death|0|||
161949122|NCT02078752|584866102|FG007|Overall Study|Death|1|||
161949123|NCT02078752|584866103|FG008|Overall Study|Death|0|||
161949124|NCT02078752|584866104|FG009|Overall Study|Death|4|||
161949125|NCT02078752|584866095|FG000|Overall Study|Lost to Follow-up|1|||
161949126|NCT02078752|584866096|FG001|Overall Study|Lost to Follow-up|0|||
161949127|NCT02078752|584866097|FG002|Overall Study|Lost to Follow-up|0|||
161949128|NCT02078752|584866098|FG003|Overall Study|Lost to Follow-up|1|||
161949129|NCT02078752|584866099|FG004|Overall Study|Lost to Follow-up|0|||
161949130|NCT02078752|584866100|FG005|Overall Study|Lost to Follow-up|0|||
161833286|NCT05506358|584431054|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
161833287|NCT05506358|584431055|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
161833288|NCT05506358|584431056|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
161833289|NCT05506358|584431057|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
161833290|NCT05506358|584431058|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
161833291|NCT05506358|584431054|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
161833292|NCT05506358|584431055|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
161833293|NCT05506358|584431056|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
161833294|NCT05506358|584431057|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
161833295|NCT05506358|584431058|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
161833296|NCT05506358|584431054|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
161833297|NCT05506358|584431055|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
161949131|NCT02078752|584866101|FG006|Overall Study|Lost to Follow-up|0|||
161833298|NCT05506358|584431056|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
161833299|NCT05506358|584431057|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
161833300|NCT05506358|584431058|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
161833301|NCT05506358|584431054|FG000|Overall Study|HbE trait|0|||
161833302|NCT05506358|584431055|FG001|Overall Study|HbE trait|0|||
161833303|NCT05506358|584431056|FG002|Overall Study|HbE trait|0|||
161833304|NCT05506358|584431057|FG003|Overall Study|HbE trait|1|||
161833305|NCT05506358|584431058|FG004|Overall Study|HbE trait|0|||
161833306|NCT01173471|584431064|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161833307|NCT01173471|584431065|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161833308|NCT01173471|584431066|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161833309|NCT01173471|584431067|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
161833310|NCT01173471|584431064|FG000|Overall Study|Condition under investigation worsened|2|||
161833311|NCT01173471|584431065|FG001|Overall Study|Condition under investigation worsened|0|||
161833312|NCT01173471|584431066|FG002|Overall Study|Condition under investigation worsened|0|||
161833313|NCT01173471|584431067|FG003|Overall Study|Condition under investigation worsened|0|||
161833314|NCT01173471|584431064|FG000|Overall Study|Lost to Follow-up|0|||
161833315|NCT01173471|584431065|FG001|Overall Study|Lost to Follow-up|0|||
161833316|NCT01173471|584431066|FG002|Overall Study|Lost to Follow-up|1|||
161833317|NCT01173471|584431067|FG003|Overall Study|Lost to Follow-up|0|||
161833318|NCT01173471|584431064|FG000|Overall Study|Reason given as Other|0|||
161833319|NCT01173471|584431065|FG001|Overall Study|Reason given as Other|0|||
161833320|NCT01173471|584431066|FG002|Overall Study|Reason given as Other|1|||
161833321|NCT01173471|584431067|FG003|Overall Study|Reason given as Other|0|||
161833322|NCT00584844|584431069|FG000|Overall Study|Withdrawal by Subject|59|||
161833323|NCT00584844|584431069|FG000|Overall Study|Screen Failure|20|||
161833324|NCT03028740|584431070|FG000|Overall Study|Did not Receive Study Drug|4|||
161833325|NCT03028740|584431071|FG001|Overall Study|Did not Receive Study Drug|5|||
161833326|NCT03028740|584431070|FG000|Overall Study|Adverse Event|8|||
161833327|NCT03028740|584431071|FG001|Overall Study|Adverse Event|26|||
161833328|NCT03028740|584431070|FG000|Overall Study|Lack of Efficacy|0|||
161833329|NCT03028740|584431071|FG001|Overall Study|Lack of Efficacy|1|||
161833330|NCT03028740|584431070|FG000|Overall Study|Withdrawal by Subject|48|||
161833331|NCT03028740|584431071|FG001|Overall Study|Withdrawal by Subject|101|||
161833332|NCT03028740|584431070|FG000|Overall Study|Lost to Follow-up|30|||
161833333|NCT03028740|584431071|FG001|Overall Study|Lost to Follow-up|54|||
161833334|NCT03028740|584431070|FG000|Overall Study|Physician Decision|4|||
161833335|NCT03028740|584431071|FG001|Overall Study|Physician Decision|11|||
161833336|NCT03028740|584431070|FG000|Overall Study|Protocol Violation|4|||
161833337|NCT03028740|584431071|FG001|Overall Study|Protocol Violation|8|||
161833338|NCT03028740|584431070|FG000|Overall Study|Non-compliance with Study Drug|0|||
161949132|NCT02078752|584866102|FG007|Overall Study|Lost to Follow-up|0|||
161949133|NCT02078752|584866103|FG008|Overall Study|Lost to Follow-up|0|||
161949134|NCT02078752|584866104|FG009|Overall Study|Lost to Follow-up|0|||
161949135|NCT02078752|584866095|FG000|Overall Study|Withdrawal by Subject|1|||
161833339|NCT03028740|584431071|FG001|Overall Study|Non-compliance with Study Drug|2|||
161833340|NCT03028740|584431070|FG000|Overall Study|Study Terminated by Sponsor|467|||
161833341|NCT03028740|584431071|FG001|Overall Study|Study Terminated by Sponsor|917|||
161833342|NCT03028740|584431070|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
161949136|NCT02078752|584866096|FG001|Overall Study|Withdrawal by Subject|1|||
161833343|NCT03028740|584431071|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
161833344|NCT03028740|584431070|FG000|Overall Study|Reason not Specified|1|||
161833345|NCT03028740|584431071|FG001|Overall Study|Reason not Specified|5|||
161833346|NCT05224544|584431074|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
161833347|NCT05224544|584431075|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
161833348|NCT01341587|584431076|FG000|Overall Study|Lost to Follow-up|2|||
161833349|NCT01341587|584431077|FG001|Overall Study|Lost to Follow-up|0|||
161833350|NCT01341587|584431076|FG000|Overall Study|stopped using the meters|2|||
161833351|NCT01341587|584431077|FG001|Overall Study|stopped using the meters|10|||
161833352|NCT00645944|584431080|FG000|Randomized|Withdrawal by Subject|1|||
161833353|NCT00645944|584431081|FG001|Randomized|Withdrawal by Subject|2|||
161833354|NCT00645944|584431080|FG000|Received Medication|Adverse Event|2|||
161833355|NCT00645944|584431081|FG001|Received Medication|Adverse Event|1|||
161833356|NCT00645944|584431080|FG000|Received Medication|Withdrawal by Subject|1|||
161833357|NCT00645944|584431081|FG001|Received Medication|Withdrawal by Subject|1|||
161833358|NCT00645944|584431080|FG000|Received Medication|Lost to Follow-up|1|||
161833359|NCT00645944|584431081|FG001|Received Medication|Lost to Follow-up|0|||
161833360|NCT00645944|584431080|FG000|Received Medication|Protocol Violation|2|||
161833361|NCT00645944|584431081|FG001|Received Medication|Protocol Violation|1|||
161833362|NCT02080832|584431089|FG000|Overall Study|Excluded from analysis by MRI|9|||
161833363|NCT02080832|584431090|FG001|Overall Study|Excluded from analysis by MRI|10|||
161833364|NCT02080832|584431091|FG002|Overall Study|Excluded from analysis by MRI|14|||
161833365|NCT02080832|584431089|FG000|Overall Study|Lost to Follow-up|0|||
161833366|NCT02080832|584431090|FG001|Overall Study|Lost to Follow-up|2|||
161833367|NCT02080832|584431091|FG002|Overall Study|Lost to Follow-up|2|||
161833368|NCT00560937|584431092|FG000|Overall Study|Withdrawal by Subject|0|||
161833369|NCT00560937|584431093|FG001|Overall Study|Withdrawal by Subject|1|||
161833370|NCT00560937|584431092|FG000|Overall Study|Physician Decision|1|||
161833371|NCT00560937|584431093|FG001|Overall Study|Physician Decision|1|||
161833372|NCT03069417|584431094|FG000|Overall Study|Lost to Follow-up|2|||
161833373|NCT03069417|584431095|FG001|Overall Study|Lost to Follow-up|0|||
161833374|NCT03069417|584431094|FG000|Overall Study|Reason Unknown|4|||
161949137|NCT02078752|584866097|FG002|Overall Study|Withdrawal by Subject|1|||
161949138|NCT02078752|584866098|FG003|Overall Study|Withdrawal by Subject|1|||
161949139|NCT02078752|584866099|FG004|Overall Study|Withdrawal by Subject|0|||
161949140|NCT02078752|584866100|FG005|Overall Study|Withdrawal by Subject|3|||
161949141|NCT02078752|584866101|FG006|Overall Study|Withdrawal by Subject|2|||
161949142|NCT02078752|584866102|FG007|Overall Study|Withdrawal by Subject|1|||
161949143|NCT02078752|584866103|FG008|Overall Study|Withdrawal by Subject|0|||
161949144|NCT02078752|584866104|FG009|Overall Study|Withdrawal by Subject|1|||
161949145|NCT02078752|584866095|FG000|Overall Study|Other|0|||
161949146|NCT02078752|584866096|FG001|Overall Study|Other|3|||
161949147|NCT02078752|584866097|FG002|Overall Study|Other|0|||
161949148|NCT02078752|584866098|FG003|Overall Study|Other|0|||
161949149|NCT02078752|584866099|FG004|Overall Study|Other|1|||
161949150|NCT02078752|584866100|FG005|Overall Study|Other|0|||
161833375|NCT03069417|584431095|FG001|Overall Study|Reason Unknown|7|||
161949151|NCT02078752|584866101|FG006|Overall Study|Other|0|||
161833376|NCT01660022|584431097|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
161833377|NCT01660022|584431098|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
161833378|NCT01660022|584431099|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
161833379|NCT01660022|584431100|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
161833380|NCT01660022|584431101|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
161833381|NCT01660022|584431102|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
161833382|NCT01660022|584431097|FG000|First Sequence (7 Days)|Adverse Event|0|||
162028608|NCT00797966|585161781|FG004|Phase B|Met Withdrawal Criteria|0|||
162028609|NCT00797966|585161782|FG005|Phase B|Met Withdrawal Criteria|0|||
162028610|NCT00797966|585161777|FG000|Phase B|Physician Decision|1|||
162028611|NCT00797966|585161778|FG001|Phase B|Physician Decision|0|||
162028612|NCT00797966|585161779|FG002|Phase B|Physician Decision|3|||
162028613|NCT00797966|585161780|FG003|Phase B|Physician Decision|1|||
162028614|NCT00797966|585161781|FG004|Phase B|Physician Decision|0|||
162028615|NCT00797966|585161782|FG005|Phase B|Physician Decision|0|||
162028616|NCT00797966|585161777|FG000|Phase B|Withdrawal by Subject|1|||
161833383|NCT01660022|584431098|FG001|First Sequence (7 Days)|Adverse Event|0|||
161833384|NCT01660022|584431099|FG002|First Sequence (7 Days)|Adverse Event|0|||
161833385|NCT01660022|584431100|FG003|First Sequence (7 Days)|Adverse Event|0|||
161833386|NCT01660022|584431101|FG004|First Sequence (7 Days)|Adverse Event|1|||
161833387|NCT01660022|584431102|FG005|First Sequence (7 Days)|Adverse Event|3|||
161949152|NCT02078752|584866102|FG007|Overall Study|Other|1|||
161949153|NCT02078752|584866103|FG008|Overall Study|Other|0|||
161949154|NCT02078752|584866104|FG009|Overall Study|Other|0|||
161949155|NCT02078752|584866095|FG000|Overall Study|Study terminated by sponsor|0|||
161949156|NCT02078752|584866096|FG001|Overall Study|Study terminated by sponsor|0|||
161949157|NCT02078752|584866097|FG002|Overall Study|Study terminated by sponsor|0|||
161685093|NCT00501007|583899688|FG000|Overall Study|Inclusion criteria not met.|29|||
161685094|NCT00501007|583899689|FG001|Overall Study|Inclusion criteria not met.|25|||
161685095|NCT03917823|583899690|FG000|Overall Study|Lost to Follow-up|1|||
161685096|NCT03917823|583899691|FG001|Overall Study|Lost to Follow-up|1|||
161685097|NCT03917823|583899690|FG000|Overall Study|Withdrawal by Subject|0|||
161685098|NCT03917823|583899691|FG001|Overall Study|Withdrawal by Subject|1|||
161685099|NCT02424253|583899694|FG000|Overall Study|Other, unspecified|1|||
161685100|NCT02424253|583899695|FG001|Overall Study|Other, unspecified|0|||
161685101|NCT02424253|583899694|FG000|Overall Study|Compliance problems|1|||
161685102|NCT02424253|583899695|FG001|Overall Study|Compliance problems|0|||
161685103|NCT02424253|583899694|FG000|Overall Study|Physician Decision|2|||
161685104|NCT02424253|583899695|FG001|Overall Study|Physician Decision|0|||
161685105|NCT02424253|583899694|FG000|Overall Study|Lack of Efficacy|0|||
161685106|NCT02424253|583899695|FG001|Overall Study|Lack of Efficacy|7|||
161685107|NCT02424253|583899694|FG000|Overall Study|Adverse Event|2|||
161685108|NCT02424253|583899695|FG001|Overall Study|Adverse Event|0|||
161685109|NCT02424253|583899694|FG000|Overall Study|Consent withdrawn by subject|4|||
161685110|NCT02424253|583899695|FG001|Overall Study|Consent withdrawn by subject|1|||
161685111|NCT02424253|583899694|FG000|Overall Study|Lost to Follow-up|1|||
161949158|NCT02078752|584866098|FG003|Overall Study|Study terminated by sponsor|0|||
161685112|NCT02424253|583899695|FG001|Overall Study|Lost to Follow-up|1|||
161685113|NCT00473343|583899696|FG000|Overall Study|Adverse Event|9|||
161685114|NCT00473343|583899696|FG000|Overall Study|Lost to Follow-up|8|||
161685115|NCT00473343|583899696|FG000|Overall Study|Treatment failure|27|||
161949159|NCT02078752|584866099|FG004|Overall Study|Study terminated by sponsor|0|||
161949160|NCT02078752|584866100|FG005|Overall Study|Study terminated by sponsor|0|||
161949161|NCT02078752|584866101|FG006|Overall Study|Study terminated by sponsor|0|||
161685116|NCT00473343|583899696|FG000|Overall Study|Withdrew consent|3|||
161833388|NCT01660022|584431097|FG000|First Sequence (7 Days)|Protocol Violation|0|||
161833389|NCT01660022|584431098|FG001|First Sequence (7 Days)|Protocol Violation|0|||
161833390|NCT01660022|584431099|FG002|First Sequence (7 Days)|Protocol Violation|0|||
161833391|NCT01660022|584431100|FG003|First Sequence (7 Days)|Protocol Violation|0|||
161833392|NCT01660022|584431101|FG004|First Sequence (7 Days)|Protocol Violation|0|||
161833393|NCT01660022|584431102|FG005|First Sequence (7 Days)|Protocol Violation|1|||
161833394|NCT03545191|584431105|FG000|Overall Study|Death|1|||
161949162|NCT02078752|584866102|FG007|Overall Study|Study terminated by sponsor|0|||
161949163|NCT02078752|584866103|FG008|Overall Study|Study terminated by sponsor|0|||
161949164|NCT02078752|584866104|FG009|Overall Study|Study terminated by sponsor|5|||
161949165|NCT00592631|584866105|FG000|Overall Study|Lost to Follow-up|0|||
161949166|NCT00592631|584866106|FG001|Overall Study|Lost to Follow-up|2|||
161949167|NCT03389308|584866108|FG000|Overall Study|Withdrawal by Subject|5|||
161685117|NCT00473343|583899696|FG000|Overall Study|Other un-specified reason|3|||
161685118|NCT02290873|583899697|FG000|Overall Study|Withdrawal by Subject|0|||
161685119|NCT02290873|583899698|FG001|Overall Study|Withdrawal by Subject|1|||
161685120|NCT02290873|583899699|FG002|Overall Study|Withdrawal by Subject|1|||
161949168|NCT03389308|584866108|FG000|Overall Study|Lost to Follow-up|3|||
161949169|NCT03389308|584866108|FG000|Overall Study|Adverse Event|2|||
162028617|NCT00797966|585161778|FG001|Phase B|Withdrawal by Subject|4|||
161949170|NCT03389308|584866108|FG000|Overall Study|Sponsor Request|2|||
161949171|NCT00616642|584866110|FG000|Overall Study|Withdrawal by Subject|0|||
161949172|NCT00616642|584866111|FG001|Overall Study|Withdrawal by Subject|1|||
162028618|NCT00797966|585161779|FG002|Phase B|Withdrawal by Subject|3|||
162028619|NCT00797966|585161780|FG003|Phase B|Withdrawal by Subject|3|||
162028620|NCT00797966|585161781|FG004|Phase B|Withdrawal by Subject|0|||
162028621|NCT00797966|585161782|FG005|Phase B|Withdrawal by Subject|0|||
161949173|NCT00570323|584866112|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
161949174|NCT00570323|584866113|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
161949175|NCT00570323|584866112|FG000|Started Treatment After Randomization|Protocol Violation|1|||
161949176|NCT00570323|584866113|FG001|Started Treatment After Randomization|Protocol Violation|0|||
161949177|NCT00570323|584866112|FG000|Started Treatment After Randomization|Physician Decision|1|||
161949178|NCT00570323|584866113|FG001|Started Treatment After Randomization|Physician Decision|0|||
161949179|NCT00570323|584866112|FG000|Complete Study After Start|Lost to Follow-up|0|||
161949180|NCT00570323|584866113|FG001|Complete Study After Start|Lost to Follow-up|1|||
161949181|NCT00570323|584866112|FG000|Complete Study After Start|Withdrawal by Subject|2|||
161949182|NCT00570323|584866113|FG001|Complete Study After Start|Withdrawal by Subject|0|||
161949183|NCT00570323|584866112|FG000|Complete Study After Start|Physician Decision|1|||
161949184|NCT00570323|584866113|FG001|Complete Study After Start|Physician Decision|0|||
161949185|NCT02266147|584866116|FG000|PART 1: Dose Escalation|Physician Decision|0|||
161949186|NCT02266147|584866117|FG001|PART 1: Dose Escalation|Physician Decision|0|||
161949187|NCT02266147|584866118|FG002|PART 1: Dose Escalation|Physician Decision|1|||
161833395|NCT03545191|584431106|FG001|Overall Study|Death|0|||
161833396|NCT03545191|584431107|FG002|Overall Study|Death|0|||
162028622|NCT00797966|585161777|FG000|Phase B|Protocol Deviation|4|||
161949188|NCT02266147|584866119|FG003|PART 1: Dose Escalation|Physician Decision|0|||
161949189|NCT02266147|584866116|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
161949190|NCT02266147|584866117|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
161949191|NCT02266147|584866118|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
161949192|NCT02266147|584866119|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
161949193|NCT02266147|584866116|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
161949194|NCT02266147|584866117|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
161949195|NCT02266147|584866118|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
161949196|NCT02266147|584866119|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
161949197|NCT02266147|584866116|FG000|PART 1: Dose Escalation|Other|1|||
161949198|NCT02266147|584866117|FG001|PART 1: Dose Escalation|Other|1|||
161949199|NCT02266147|584866118|FG002|PART 1: Dose Escalation|Other|0|||
161949200|NCT02266147|584866119|FG003|PART 1: Dose Escalation|Other|0|||
161949201|NCT02266147|584866116|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
161949202|NCT02266147|584866117|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
161949203|NCT02266147|584866118|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
161949204|NCT02266147|584866119|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
161949205|NCT02266147|584866116|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
161949206|NCT02266147|584866117|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
161949207|NCT02266147|584866118|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
161949208|NCT02266147|584866119|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
161949209|NCT00332696|584866128|FG000|Overall Study|Death|24|||
161949210|NCT00332696|584866129|FG001|Overall Study|Death|14|||
161949211|NCT00332696|584866128|FG000|Overall Study|Insufficient therapeutic effect|4|||
161949212|NCT00332696|584866129|FG001|Overall Study|Insufficient therapeutic effect|11|||
161949213|NCT00332696|584866128|FG000|Overall Study|Adverse Event|1|||
161949214|NCT00332696|584866129|FG001|Overall Study|Adverse Event|2|||
161949215|NCT00332696|584866128|FG000|Overall Study|Condition does not justify treatment|0|||
161949216|NCT00332696|584866129|FG001|Overall Study|Condition does not justify treatment|2|||
161949217|NCT00332696|584866128|FG000|Overall Study|Lost to Follow-up|0|||
161949218|NCT00332696|584866129|FG001|Overall Study|Lost to Follow-up|1|||
161949219|NCT00332696|584866128|FG000|Overall Study|Withdrawal by Subject|1|||
161833397|NCT03545191|584431105|FG000|Overall Study|Adverse Event|4|||
161833398|NCT03545191|584431106|FG001|Overall Study|Adverse Event|2|||
161833399|NCT03545191|584431107|FG002|Overall Study|Adverse Event|7|||
161833400|NCT03545191|584431105|FG000|Overall Study|Other reasons|3|||
161833401|NCT03545191|584431106|FG001|Overall Study|Other reasons|11|||
161833402|NCT03545191|584431107|FG002|Overall Study|Other reasons|8|||
161949220|NCT00332696|584866129|FG001|Overall Study|Withdrawal by Subject|0|||
161949221|NCT01567722|584866130|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
161949222|NCT01567722|584866131|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
161949223|NCT01567722|584866132|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
161833403|NCT03545191|584431105|FG000|Overall Study|Withdrawal by Subject|13|||
161949224|NCT01567722|584866130|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
161949225|NCT01567722|584866131|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
161833404|NCT03545191|584431106|FG001|Overall Study|Withdrawal by Subject|10|||
161949226|NCT01567722|584866132|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
161949227|NCT01567722|584866130|FG000|Overall Study|Protocol closure by the OCG|2|||
161949228|NCT01567722|584866131|FG001|Overall Study|Protocol closure by the OCG|0|||
161949229|NCT01567722|584866132|FG002|Overall Study|Protocol closure by the OCG|0|||
161949230|NCT01567722|584866130|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
161949231|NCT01567722|584866131|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
161949232|NCT01567722|584866132|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
161949233|NCT02259114|584866136|FG000|Overall Study|Progressive Disease|14|||
161949234|NCT02259114|584866137|FG001|Overall Study|Progressive Disease|2|||
161949235|NCT02259114|584866138|FG002|Overall Study|Progressive Disease|10|||
161949236|NCT02259114|584866139|FG003|Overall Study|Progressive Disease|2|||
161949237|NCT02259114|584866140|FG004|Overall Study|Progressive Disease|5|||
161949238|NCT02259114|584866136|FG000|Overall Study|Adverse Event|2|||
161949239|NCT02259114|584866137|FG001|Overall Study|Adverse Event|1|||
161949240|NCT02259114|584866138|FG002|Overall Study|Adverse Event|0|||
161949241|NCT02259114|584866139|FG003|Overall Study|Adverse Event|0|||
161949242|NCT02259114|584866140|FG004|Overall Study|Adverse Event|1|||
161949243|NCT02259114|584866136|FG000|Overall Study|Death|3|||
161949244|NCT02259114|584866137|FG001|Overall Study|Death|0|||
161949245|NCT02259114|584866138|FG002|Overall Study|Death|1|||
161949246|NCT02259114|584866139|FG003|Overall Study|Death|0|||
161949247|NCT02259114|584866140|FG004|Overall Study|Death|0|||
161949248|NCT02259114|584866136|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
161949249|NCT02259114|584866137|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
161949250|NCT02259114|584866138|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
161949251|NCT02259114|584866139|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
161949252|NCT02259114|584866140|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
161949253|NCT02259114|584866136|FG000|Overall Study|Withdrawal by Subject|0|||
161949254|NCT02259114|584866137|FG001|Overall Study|Withdrawal by Subject|0|||
161949255|NCT02259114|584866138|FG002|Overall Study|Withdrawal by Subject|1|||
161949256|NCT02259114|584866139|FG003|Overall Study|Withdrawal by Subject|1|||
161949257|NCT02259114|584866140|FG004|Overall Study|Withdrawal by Subject|0|||
161833405|NCT03545191|584431107|FG002|Overall Study|Withdrawal by Subject|12|||
161949258|NCT02259114|584866136|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
161833406|NCT03545191|584431105|FG000|Overall Study|Lost to Follow-up|1|||
161833407|NCT03545191|584431106|FG001|Overall Study|Lost to Follow-up|2|||
161833408|NCT03545191|584431107|FG002|Overall Study|Lost to Follow-up|3|||
161833409|NCT01277718|584431110|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
161833410|NCT01277718|584431111|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
161833411|NCT01277718|584431110|FG000|Period 2 - Second Intervention|Physician Decision|0|||
161833412|NCT01277718|584431111|FG001|Period 2 - Second Intervention|Physician Decision|2|||
161833413|NCT03919162|584431114|FG000|Overall Study|Adverse Event|3|||
161833414|NCT03919162|584431115|FG001|Overall Study|Adverse Event|2|||
161833415|NCT03919162|584431114|FG000|Overall Study|Death|2|||
161833416|NCT03919162|584431115|FG001|Overall Study|Death|0|||
161833417|NCT03919162|584431114|FG000|Overall Study|Lost to Follow-up|1|||
161949259|NCT02259114|584866137|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
161949260|NCT02259114|584866138|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
161833418|NCT03919162|584431115|FG001|Overall Study|Lost to Follow-up|0|||
161833419|NCT03919162|584431114|FG000|Overall Study|Withdrawal by Subject|12|||
161949261|NCT02259114|584866139|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
161949262|NCT02259114|584866140|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
161949263|NCT02259114|584866136|FG000|Overall Study|Not Treated|1|||
161949264|NCT02259114|584866137|FG001|Overall Study|Not Treated|0|||
161949265|NCT02259114|584866138|FG002|Overall Study|Not Treated|0|||
161949266|NCT02259114|584866139|FG003|Overall Study|Not Treated|0|||
161949267|NCT02259114|584866140|FG004|Overall Study|Not Treated|0|||
161949268|NCT03937479|584866141|FG000|Overall Study|Adverse Event|2|||
161949269|NCT03937479|584866142|FG001|Overall Study|Adverse Event|3|||
161949270|NCT03937479|584866143|FG002|Overall Study|Adverse Event|0|||
161949271|NCT03937479|584866144|FG003|Overall Study|Adverse Event|0|||
161949272|NCT03937479|584866145|FG004|Overall Study|Adverse Event|1|||
161949273|NCT03937479|584866141|FG000|Overall Study|Withdrawal by Subject|3|||
161949274|NCT03937479|584866142|FG001|Overall Study|Withdrawal by Subject|5|||
161949275|NCT03937479|584866143|FG002|Overall Study|Withdrawal by Subject|2|||
161949276|NCT03937479|584866144|FG003|Overall Study|Withdrawal by Subject|2|||
161949277|NCT03937479|584866145|FG004|Overall Study|Withdrawal by Subject|1|||
161949278|NCT03937479|584866141|FG000|Overall Study|Protocol Violation|5|||
161949279|NCT03937479|584866142|FG001|Overall Study|Protocol Violation|6|||
161949280|NCT03937479|584866143|FG002|Overall Study|Protocol Violation|4|||
161949281|NCT03937479|584866144|FG003|Overall Study|Protocol Violation|3|||
161949282|NCT03937479|584866145|FG004|Overall Study|Protocol Violation|2|||
161949283|NCT03937479|584866141|FG000|Overall Study|Lost to Follow-up|0|||
161949284|NCT03937479|584866142|FG001|Overall Study|Lost to Follow-up|1|||
161949285|NCT03937479|584866143|FG002|Overall Study|Lost to Follow-up|0|||
161949286|NCT03937479|584866144|FG003|Overall Study|Lost to Follow-up|1|||
161949287|NCT03937479|584866145|FG004|Overall Study|Lost to Follow-up|0|||
161949288|NCT03937479|584866141|FG000|Overall Study|Physician Decision|0|||
161949289|NCT03937479|584866142|FG001|Overall Study|Physician Decision|0|||
161949290|NCT03937479|584866143|FG002|Overall Study|Physician Decision|1|||
161949291|NCT03937479|584866144|FG003|Overall Study|Physician Decision|0|||
161949292|NCT03937479|584866145|FG004|Overall Study|Physician Decision|1|||
161949293|NCT02712788|584866148|FG000|Overall Study|Physician Decision|1|||
161949294|NCT02712788|584866149|FG001|Overall Study|Physician Decision|0|||
161949295|NCT02712788|584866148|FG000|Overall Study|Protocol Violation|1|||
161949296|NCT02712788|584866149|FG001|Overall Study|Protocol Violation|0|||
161949297|NCT03789292|584866151|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
161949298|NCT03789292|584866152|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
161949299|NCT03789292|584866153|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
161949300|NCT03789292|584866151|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
161949301|NCT03789292|584866152|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
161949302|NCT03789292|584866153|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
161949303|NCT03789292|584866151|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
161949304|NCT03789292|584866152|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
161949305|NCT03789292|584866153|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
161949306|NCT03789292|584866151|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
161949307|NCT03789292|584866152|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
161949308|NCT03789292|584866153|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
161949309|NCT03789292|584866151|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
161949310|NCT03789292|584866152|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
161949311|NCT03789292|584866153|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
161949312|NCT03789292|584866151|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
162028623|NCT00797966|585161778|FG001|Phase B|Protocol Deviation|8|||
161833420|NCT03919162|584431115|FG001|Overall Study|Withdrawal by Subject|12|||
161833421|NCT03919162|584431114|FG000|Overall Study|Study terminated by Sponsor|20|||
161833422|NCT03919162|584431115|FG001|Overall Study|Study terminated by Sponsor|24|||
161833423|NCT03919162|584431114|FG000|Overall Study|Screen failure|1|||
161833424|NCT03919162|584431115|FG001|Overall Study|Screen failure|0|||
161833425|NCT03919162|584431114|FG000|Overall Study|Missing|1|||
161833426|NCT03919162|584431115|FG001|Overall Study|Missing|1|||
161833427|NCT02746627|584431117|FG000|Overall Study|Withdrawal by Subject|1|||
161833428|NCT02746627|584431118|FG001|Overall Study|Withdrawal by Subject|1|||
161833429|NCT02746627|584431119|FG002|Overall Study|Withdrawal by Subject|1|||
161833430|NCT00233987|584431124|FG000|Overall Study|Withdrawal by Subject|1|||
161833431|NCT00233987|584431124|FG000|Overall Study|Lack of Efficacy|2|||
161833432|NCT00233987|584431124|FG000|Overall Study|Reason Under Review|1|||
161833433|NCT00233987|584431124|FG000|Overall Study|Other - Not Protocol Specified|5|||
161833434|NCT00233987|584431124|FG000|Overall Study|Eligible but No Treatment Received|2|||
161833435|NCT00233987|584431124|FG000|Overall Study|Ineligible|4|||
161833436|NCT04553913|584431127|FG000|Overall Study|patient's block resolved prior to PACU|1|||
161833437|NCT04553913|584431127|FG000|Overall Study|did not use the device properly|5|||
161833438|NCT01481324|584431129|FG000|Overall Study|Missing Data|0|||
161833439|NCT01481324|584431130|FG001|Overall Study|Missing Data|2|||
161833440|NCT01481324|584431131|FG002|Overall Study|Missing Data|2|||
161833441|NCT00710749|584431133|FG000|First Intervention|Withdrawal by Subject|1|||
161949313|NCT03789292|584866152|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
161949314|NCT03789292|584866153|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
161833442|NCT00710749|584431134|FG001|First Intervention|Withdrawal by Subject|0|||
161833443|NCT05478252|584431135|FG000|Overall Study|Withdrawal by Subject|2|||
161833444|NCT05478252|584431136|FG001|Overall Study|Withdrawal by Subject|3|||
161833445|NCT05478252|584431135|FG000|Overall Study|Lost to Follow-up|4|||
161833446|NCT05478252|584431136|FG001|Overall Study|Lost to Follow-up|2|||
161833447|NCT05478252|584431135|FG000|Overall Study|Physician Decision|1|||
161949315|NCT03789292|584866151|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
161949316|NCT03789292|584866152|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
161833448|NCT05478252|584431136|FG001|Overall Study|Physician Decision|1|||
161833449|NCT05478252|584431135|FG000|Overall Study|Death|1|||
161833450|NCT05478252|584431136|FG001|Overall Study|Death|0|||
161833451|NCT04846881|584431137|FG000|Overall Study|Adverse Event|14|||
161833452|NCT04846881|584431138|FG001|Overall Study|Adverse Event|15|||
161949317|NCT03789292|584866153|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
161833453|NCT04846881|584431137|FG000|Overall Study|Burden of study procedures|7|||
161949318|NCT03789292|584866151|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
161949319|NCT03789292|584866152|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
161949320|NCT03789292|584866153|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
161949321|NCT03789292|584866151|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
161949322|NCT03789292|584866152|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
161949323|NCT03789292|584866153|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
161949324|NCT03789292|584866151|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
161949325|NCT03789292|584866152|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
161949326|NCT03789292|584866153|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
161949327|NCT03789292|584866151|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
161949328|NCT03789292|584866152|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
161949329|NCT03789292|584866153|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
161949330|NCT03789292|584866151|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
161949331|NCT03789292|584866152|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
161949332|NCT03789292|584866153|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
161949333|NCT03789292|584866151|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
161949334|NCT03789292|584866152|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
161949335|NCT03789292|584866153|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
161949336|NCT01904721|584866154|FG000|Overall Study|Other Reasons|0|||
161949337|NCT01904721|584866155|FG001|Overall Study|Other Reasons|0|||
161949338|NCT01904721|584866156|FG002|Overall Study|Other Reasons|1|||
161949339|NCT01904721|584866157|FG003|Overall Study|Other Reasons|1|||
161949340|NCT01904721|584866158|FG004|Overall Study|Other Reasons|2|||
161685121|NCT02290873|583899697|FG000|Overall Study|Nellcor device error|1|||
161685122|NCT02290873|583899698|FG001|Overall Study|Nellcor device error|0|||
161685123|NCT02290873|583899699|FG002|Overall Study|Nellcor device error|0|||
161685124|NCT02290873|583899697|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
161685125|NCT02290873|583899698|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
161685126|NCT02290873|583899699|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
161685127|NCT02290873|583899697|FG000|Overall Study|Protocol Violation|0|||
161685128|NCT02290873|583899698|FG001|Overall Study|Protocol Violation|0|||
161685129|NCT02290873|583899699|FG002|Overall Study|Protocol Violation|1|||
161685130|NCT03715153|583899700|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
161685131|NCT03715153|583899701|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
161685132|NCT03715153|583899700|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
161685133|NCT03715153|583899701|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
161685134|NCT03715153|583899700|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
161685135|NCT03715153|583899701|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
161685136|NCT03715153|583899700|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
161685137|NCT03715153|583899701|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
161685138|NCT03715153|583899700|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
161685139|NCT03715153|583899701|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
161685140|NCT03715153|583899700|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
161685141|NCT03715153|583899701|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
161685142|NCT01519765|583899702|FG000|Overall Study|Adverse Event|0|||
161685143|NCT01519765|583899703|FG001|Overall Study|Adverse Event|1|||
161685144|NCT01519765|583899702|FG000|Overall Study|Lack of Efficacy|2|||
161685145|NCT01519765|583899703|FG001|Overall Study|Lack of Efficacy|0|||
161685146|NCT01519765|583899702|FG000|Overall Study|Protocol Violation|1|||
161685147|NCT01519765|583899703|FG001|Overall Study|Protocol Violation|0|||
161685148|NCT01519765|583899702|FG000|Overall Study|Withdrawal by Subject|0|||
161685149|NCT01519765|583899703|FG001|Overall Study|Withdrawal by Subject|1|||
161685150|NCT04126083|583899704|FG000|Overall Study|Withdrawal by Subject|1|||
161685151|NCT01892163|583899707|FG000|Overall Study|Death|1|||
161685152|NCT01892163|583899708|FG001|Overall Study|Death|1|||
161685153|NCT01892163|583899707|FG000|Overall Study|Lost to Follow-up|1|||
161685154|NCT01892163|583899708|FG001|Overall Study|Lost to Follow-up|0|||
161685155|NCT02577146|583899709|FG000|Overall Study|Lost to Follow-up|8|||
161685156|NCT02577146|583899709|FG000|Overall Study|Physician Decision|3|||
161685157|NCT02577146|583899709|FG000|Overall Study|Screen Failure|17|||
161685158|NCT03116698|583899710|FG000|Overall Study|Adverse Event|1|||
161833454|NCT04846881|584431138|FG001|Overall Study|Burden of study procedures|3|||
161833455|NCT04846881|584431137|FG000|Overall Study|Protocol deviation|6|||
161833456|NCT04846881|584431138|FG001|Overall Study|Protocol deviation|4|||
161833457|NCT04846881|584431137|FG000|Overall Study|Perceived lack of efficacy|5|||
161833458|NCT04846881|584431138|FG001|Overall Study|Perceived lack of efficacy|2|||
161833459|NCT04846881|584431137|FG000|Overall Study|Change of residence|2|||
161833460|NCT04846881|584431138|FG001|Overall Study|Change of residence|0|||
161833461|NCT04846881|584431137|FG000|Overall Study|Technical problems|0|||
161833462|NCT04846881|584431138|FG001|Overall Study|Technical problems|1|||
161685159|NCT03116698|583899711|FG001|Overall Study|Adverse Event|1|||
161685160|NCT03116698|583899712|FG002|Overall Study|Adverse Event|1|||
161685161|NCT03116698|583899713|FG003|Overall Study|Adverse Event|0|||
161685162|NCT03116698|583899710|FG000|Overall Study|Withdrawal by Subject|1|||
161833463|NCT04846881|584431137|FG000|Overall Study|Other than listed|3|||
161833464|NCT04846881|584431138|FG001|Overall Study|Other than listed|10|||
161685163|NCT03116698|583899711|FG001|Overall Study|Withdrawal by Subject|4|||
161685164|NCT03116698|583899712|FG002|Overall Study|Withdrawal by Subject|5|||
161833465|NCT04846881|584431137|FG000|Overall Study|No reason available|1|||
162028624|NCT00797966|585161779|FG002|Phase B|Protocol Deviation|2|||
162028625|NCT00797966|585161780|FG003|Phase B|Protocol Deviation|6|||
162028626|NCT00797966|585161781|FG004|Phase B|Protocol Deviation|0|||
162028627|NCT00797966|585161782|FG005|Phase B|Protocol Deviation|0|||
162028628|NCT00797966|585161777|FG000|Phase B|Lack of Efficacy|0|||
162028629|NCT00797966|585161778|FG001|Phase B|Lack of Efficacy|1|||
162028630|NCT00797966|585161779|FG002|Phase B|Lack of Efficacy|1|||
162028631|NCT00797966|585161780|FG003|Phase B|Lack of Efficacy|4|||
162028632|NCT00797966|585161781|FG004|Phase B|Lack of Efficacy|0|||
162028633|NCT00797966|585161782|FG005|Phase B|Lack of Efficacy|0|||
161685165|NCT03116698|583899713|FG003|Overall Study|Withdrawal by Subject|2|||
161685166|NCT03116698|583899710|FG000|Overall Study|Lost to Follow-up|2|||
162028634|NCT00797966|585161777|FG000|Phase A+|Lost to Follow-up|0|||
162028635|NCT00797966|585161778|FG001|Phase A+|Lost to Follow-up|0|||
162028636|NCT00797966|585161779|FG002|Phase A+|Lost to Follow-up|0|||
162028637|NCT00797966|585161780|FG003|Phase A+|Lost to Follow-up|0|||
162028638|NCT00797966|585161781|FG004|Phase A+|Lost to Follow-up|0|||
162028639|NCT00797966|585161782|FG005|Phase A+|Lost to Follow-up|9|||
162028640|NCT00797966|585161777|FG000|Phase A+|Met withdrawal criteria|0|||
162028641|NCT00797966|585161778|FG001|Phase A+|Met withdrawal criteria|0|||
162028642|NCT00797966|585161779|FG002|Phase A+|Met withdrawal criteria|0|||
162028643|NCT00797966|585161780|FG003|Phase A+|Met withdrawal criteria|0|||
161685167|NCT03116698|583899711|FG001|Overall Study|Lost to Follow-up|0|||
161685168|NCT03116698|583899712|FG002|Overall Study|Lost to Follow-up|0|||
161685169|NCT03116698|583899713|FG003|Overall Study|Lost to Follow-up|0|||
161833466|NCT04846881|584431138|FG001|Overall Study|No reason available|3|||
161685170|NCT03116698|583899710|FG000|Overall Study|Physician Decision|1|||
161685171|NCT03116698|583899711|FG001|Overall Study|Physician Decision|1|||
161685172|NCT03116698|583899712|FG002|Overall Study|Physician Decision|0|||
161685173|NCT03116698|583899713|FG003|Overall Study|Physician Decision|0|||
161685174|NCT03116698|583899710|FG000|Overall Study|Protocol Violation|1|||
161685175|NCT03116698|583899711|FG001|Overall Study|Protocol Violation|0|||
161685176|NCT03116698|583899712|FG002|Overall Study|Protocol Violation|0|||
161685177|NCT03116698|583899713|FG003|Overall Study|Protocol Violation|0|||
161685178|NCT03116698|583899710|FG000|Overall Study|Death|0|||
161685179|NCT03116698|583899711|FG001|Overall Study|Death|0|||
161685180|NCT03116698|583899712|FG002|Overall Study|Death|2|||
161685181|NCT03116698|583899713|FG003|Overall Study|Death|0|||
161685182|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
161685183|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
161685184|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
161685185|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
161685186|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
161685187|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
161685188|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
161685189|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
161685190|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to death|4|||
161685191|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to death|3|||
161685192|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
161685193|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
161685194|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
161685195|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
161685196|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
161685197|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
161685198|NCT02258451|583899714|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
161685199|NCT02258451|583899715|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
161685200|NCT02258451|583899714|FG000|Overall Study|Other reason|1|||
161685201|NCT02258451|583899715|FG001|Overall Study|Other reason|1|||
161685202|NCT02258451|583899714|FG000|Overall Study|Never treated|2|||
161685203|NCT02258451|583899715|FG001|Overall Study|Never treated|3|||
161685204|NCT00517751|583899720|FG000|Overall Study|Death|3|||
161685205|NCT00517751|583899720|FG000|Overall Study|Withdrawal by Subject|37|||
161685206|NCT00517751|583899720|FG000|Overall Study|Lost to Follow-up|4|||
161685207|NCT00517751|583899720|FG000|Overall Study|patient not over due|6|||
161685208|NCT00517751|583899720|FG000|Overall Study|Patient not due for visit|76|||
162028644|NCT00797966|585161781|FG004|Phase A+|Met withdrawal criteria|0|||
161685209|NCT00517751|583899720|FG000|Overall Study|Missing|3|||
161685210|NCT03021499|583899723|FG000|Overall Study|Adverse Event|1|||
161685211|NCT03021499|583899724|FG001|Overall Study|Adverse Event|0|||
161685212|NCT03021499|583899723|FG000|Overall Study|Death|1|||
161685213|NCT03021499|583899724|FG001|Overall Study|Death|5|||
161685214|NCT03021499|583899723|FG000|Overall Study|Lack of Efficacy|0|||
161685215|NCT03021499|583899724|FG001|Overall Study|Lack of Efficacy|1|||
161833467|NCT04846881|584431137|FG000|Overall Study|Patient randomised in error|1|||
161949341|NCT01904721|584866159|FG005|Overall Study|Other Reasons|2|||
161949342|NCT01904721|584866160|FG006|Overall Study|Other Reasons|2|||
161949343|NCT01904721|584866154|FG000|Overall Study|Personal Reasons|0|||
161949344|NCT01904721|584866155|FG001|Overall Study|Personal Reasons|0|||
161949345|NCT01904721|584866156|FG002|Overall Study|Personal Reasons|0|||
161949346|NCT01904721|584866157|FG003|Overall Study|Personal Reasons|0|||
161949347|NCT01904721|584866158|FG004|Overall Study|Personal Reasons|2|||
161949348|NCT01904721|584866159|FG005|Overall Study|Personal Reasons|3|||
161949349|NCT01904721|584866160|FG006|Overall Study|Personal Reasons|3|||
161949350|NCT01904721|584866154|FG000|Overall Study|Lost to Follow-up|0|||
161949351|NCT01904721|584866155|FG001|Overall Study|Lost to Follow-up|0|||
161949352|NCT01904721|584866156|FG002|Overall Study|Lost to Follow-up|0|||
161949353|NCT01904721|584866157|FG003|Overall Study|Lost to Follow-up|0|||
161949354|NCT01904721|584866158|FG004|Overall Study|Lost to Follow-up|1|||
161949355|NCT01904721|584866159|FG005|Overall Study|Lost to Follow-up|3|||
161949356|NCT01904721|584866160|FG006|Overall Study|Lost to Follow-up|1|||
161949357|NCT01904721|584866154|FG000|Overall Study|Lack of Efficacy|0|||
161949358|NCT01904721|584866155|FG001|Overall Study|Lack of Efficacy|0|||
161949359|NCT01904721|584866156|FG002|Overall Study|Lack of Efficacy|0|||
161949360|NCT01904721|584866157|FG003|Overall Study|Lack of Efficacy|0|||
161949361|NCT01904721|584866158|FG004|Overall Study|Lack of Efficacy|0|||
161949362|NCT01904721|584866159|FG005|Overall Study|Lack of Efficacy|0|||
161949363|NCT01904721|584866160|FG006|Overall Study|Lack of Efficacy|1|||
161949364|NCT01904721|584866154|FG000|Overall Study|Adverse Event|0|||
161949365|NCT01904721|584866155|FG001|Overall Study|Adverse Event|0|||
161949366|NCT01904721|584866156|FG002|Overall Study|Adverse Event|0|||
161949367|NCT01904721|584866157|FG003|Overall Study|Adverse Event|0|||
161949368|NCT01904721|584866158|FG004|Overall Study|Adverse Event|3|||
161949369|NCT01904721|584866159|FG005|Overall Study|Adverse Event|1|||
161949370|NCT01904721|584866160|FG006|Overall Study|Adverse Event|0|||
161949371|NCT00532844|584866162|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
161949372|NCT00532844|584866163|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
161949373|NCT00532844|584866162|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
161949374|NCT00532844|584866163|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
161949375|NCT00532844|584866162|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
161949376|NCT00532844|584866163|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
161949377|NCT00532844|584866162|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
161949378|NCT00532844|584866163|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
161949379|NCT00532844|584866162|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
161949380|NCT00532844|584866163|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
161949381|NCT01077063|584866164|FG000|Overall Study|Adverse Event|3|||
161949382|NCT01077063|584866165|FG001|Overall Study|Adverse Event|0|||
161949383|NCT01077063|584866164|FG000|Overall Study|Death|1|||
161949384|NCT01077063|584866165|FG001|Overall Study|Death|1|||
161949385|NCT01077063|584866164|FG000|Overall Study|Withdrawal by Subject|0|||
162028645|NCT00797966|585161782|FG005|Phase A+|Met withdrawal criteria|5|||
162028646|NCT00797966|585161777|FG000|Phase A+|Withdrawal by Subject|0|||
162028647|NCT00797966|585161778|FG001|Phase A+|Withdrawal by Subject|0|||
162028648|NCT00797966|585161779|FG002|Phase A+|Withdrawal by Subject|0|||
161949386|NCT01077063|584866165|FG001|Overall Study|Withdrawal by Subject|2|||
161949387|NCT00553631|584866167|FG000|Overall Study|Withdrawal by Subject|0|||
161949388|NCT00553631|584866168|FG001|Overall Study|Withdrawal by Subject|1|||
161949389|NCT00553631|584866167|FG000|Overall Study|Lost to Follow-up|1|||
161949390|NCT00553631|584866168|FG001|Overall Study|Lost to Follow-up|0|||
161949391|NCT00251693|584866170|FG000|Overall Study|Adverse Event|17|||
161949392|NCT00251693|584866171|FG001|Overall Study|Adverse Event|9|||
161949393|NCT00251693|584866172|FG002|Overall Study|Adverse Event|9|||
161949394|NCT00251693|584866170|FG000|Overall Study|Protocol Violation|2|||
162028649|NCT00797966|585161780|FG003|Phase A+|Withdrawal by Subject|0|||
161949395|NCT00251693|584866171|FG001|Overall Study|Protocol Violation|0|||
162028650|NCT00797966|585161781|FG004|Phase A+|Withdrawal by Subject|0|||
161949396|NCT00251693|584866172|FG002|Overall Study|Protocol Violation|2|||
161949397|NCT00251693|584866170|FG000|Overall Study|Lost to Follow-up|12|||
161949398|NCT00251693|584866171|FG001|Overall Study|Lost to Follow-up|7|||
161949399|NCT00251693|584866172|FG002|Overall Study|Lost to Follow-up|8|||
161949400|NCT00251693|584866170|FG000|Overall Study|Withdrawal by Subject|11|||
161949401|NCT00251693|584866171|FG001|Overall Study|Withdrawal by Subject|17|||
161949402|NCT00251693|584866172|FG002|Overall Study|Withdrawal by Subject|14|||
161949403|NCT00251693|584866170|FG000|Overall Study|Lack of Efficacy|0|||
161949404|NCT00251693|584866171|FG001|Overall Study|Lack of Efficacy|1|||
161949405|NCT00251693|584866172|FG002|Overall Study|Lack of Efficacy|0|||
161949406|NCT00251693|584866170|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
161949407|NCT00251693|584866171|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
161949408|NCT00251693|584866172|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
161949409|NCT00251693|584866170|FG000|Overall Study|Noncompliant|0|||
161949410|NCT00251693|584866171|FG001|Overall Study|Noncompliant|0|||
161833468|NCT04846881|584431138|FG001|Overall Study|Patient randomised in error|0|||
161833469|NCT01000610|584433131|FG000|Overall Study|Adverse Event|1|||
161833470|NCT01000610|584433131|FG000|Overall Study|Lost to Follow-up|4|||
161833471|NCT01000610|584433131|FG000|Overall Study|Treatment failure|1|||
161833472|NCT01010126|584433132|FG000|Overall Study|Withdrawal by Subject|1|||
161833473|NCT01010126|584433133|FG001|Overall Study|Withdrawal by Subject|0|||
162028651|NCT00797966|585161782|FG005|Phase A+|Withdrawal by Subject|6|||
161949411|NCT00251693|584866172|FG002|Overall Study|Noncompliant|2|||
161949412|NCT00251693|584866170|FG000|Overall Study|Possible Barrett's esophagus|3|||
161833474|NCT01010126|584433134|FG002|Overall Study|Withdrawal by Subject|1|||
161949413|NCT00251693|584866171|FG001|Overall Study|Possible Barrett's esophagus|5|||
161685216|NCT03021499|583899723|FG000|Overall Study|Lost to Follow-up|1|||
161685217|NCT03021499|583899724|FG001|Overall Study|Lost to Follow-up|3|||
161685218|NCT03021499|583899723|FG000|Overall Study|Physician Decision|2|||
161685219|NCT03021499|583899724|FG001|Overall Study|Physician Decision|3|||
161685220|NCT03021499|583899723|FG000|Overall Study|Pregnancy|1|||
161685221|NCT03021499|583899724|FG001|Overall Study|Pregnancy|0|||
161833475|NCT01010126|584433135|FG003|Overall Study|Withdrawal by Subject|0|||
161833476|NCT01010126|584433136|FG004|Overall Study|Withdrawal by Subject|3|||
161685222|NCT03021499|583899723|FG000|Overall Study|Withdrawal by Subject|7|||
161685223|NCT03021499|583899724|FG001|Overall Study|Withdrawal by Subject|14|||
161833477|NCT01010126|584433137|FG005|Overall Study|Withdrawal by Subject|0|||
162028652|NCT00797966|585161777|FG000|Phase A+|Adverse Event|0|||
162028653|NCT00797966|585161778|FG001|Phase A+|Adverse Event|0|||
162028654|NCT00797966|585161779|FG002|Phase A+|Adverse Event|0|||
162028655|NCT00797966|585161780|FG003|Phase A+|Adverse Event|0|||
162028656|NCT00797966|585161781|FG004|Phase A+|Adverse Event|0|||
162028657|NCT00797966|585161782|FG005|Phase A+|Adverse Event|4|||
162028658|NCT00797966|585161777|FG000|Phase A+|Protocol deviation|0|||
162028659|NCT00797966|585161778|FG001|Phase A+|Protocol deviation|0|||
162028660|NCT00797966|585161779|FG002|Phase A+|Protocol deviation|0|||
162028661|NCT00797966|585161780|FG003|Phase A+|Protocol deviation|0|||
162028662|NCT00797966|585161781|FG004|Phase A+|Protocol deviation|0|||
162028663|NCT00797966|585161782|FG005|Phase A+|Protocol deviation|4|||
162028664|NCT01002820|585161784|FG000|Overall Study|Adverse Event|1|||
162028665|NCT01002820|585161784|FG000|Overall Study|Withdrawal by Subject|2|||
161685224|NCT03021499|583899723|FG000|Overall Study|Prohibited medication required|1|||
161685225|NCT03021499|583899724|FG001|Overall Study|Prohibited medication required|0|||
161685226|NCT03021499|583899723|FG000|Overall Study|Protocol non-compliance|1|||
161685227|NCT03021499|583899724|FG001|Overall Study|Protocol non-compliance|1|||
161685228|NCT03021499|583899723|FG000|Overall Study|None of the above|0|||
161685229|NCT03021499|583899724|FG001|Overall Study|None of the above|4|||
161685230|NCT03021499|583899723|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
161833478|NCT04495283|584433140|FG000|Overall Study|Physician Decision|0|||
161833479|NCT04495283|584433141|FG001|Overall Study|Physician Decision|0|||
161833480|NCT04495283|584433142|FG002|Overall Study|Physician Decision|1|||
161833481|NCT04495283|584433140|FG000|Overall Study|Withdrawal by Subject|0|||
161949414|NCT00251693|584866172|FG002|Overall Study|Possible Barrett's esophagus|2|||
161949415|NCT00251693|584866170|FG000|Overall Study|Subject request/subject unavailable|1|||
161949416|NCT00251693|584866171|FG001|Overall Study|Subject request/subject unavailable|2|||
161949417|NCT00251693|584866172|FG002|Overall Study|Subject request/subject unavailable|0|||
161949418|NCT00251693|584866170|FG000|Overall Study|Abnormal laboratory findings|0|||
161949419|NCT00251693|584866171|FG001|Overall Study|Abnormal laboratory findings|0|||
161949420|NCT00251693|584866172|FG002|Overall Study|Abnormal laboratory findings|1|||
161949421|NCT03386435|584866176|FG000|Overall Study|Protocol Violation|5|||
161949422|NCT03386435|584866177|FG001|Overall Study|Protocol Violation|7|||
161949423|NCT04540367|584866178|FG000|Overall Study|Withdrawal by Subject|0|||
162028666|NCT01002820|585161784|FG000|Overall Study|Lack of Efficacy|1|||
162028667|NCT02478398|585161785|FG000|Overall Study|Adverse Event|20|||
162028668|NCT02478398|585161786|FG001|Overall Study|Adverse Event|5|||
162028669|NCT02478398|585161785|FG000|Overall Study|Lost to Follow-up|5|||
162028670|NCT02478398|585161786|FG001|Overall Study|Lost to Follow-up|4|||
162028671|NCT02478398|585161785|FG000|Overall Study|Non-Compliance With Study Drug|5|||
161685231|NCT03021499|583899724|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
161685232|NCT00495820|583899725|FG000|Overall Study|Adverse Event|1|||
161949424|NCT04540367|584866179|FG001|Overall Study|Withdrawal by Subject|0|||
161949425|NCT04540367|584866180|FG002|Overall Study|Withdrawal by Subject|0|||
161833482|NCT04495283|584433141|FG001|Overall Study|Withdrawal by Subject|1|||
161949426|NCT04540367|584866181|FG003|Overall Study|Withdrawal by Subject|2|||
162028672|NCT02478398|585161786|FG001|Overall Study|Non-Compliance With Study Drug|1|||
162028673|NCT02478398|585161785|FG000|Overall Study|Protocol Violation|3|||
162028674|NCT02478398|585161786|FG001|Overall Study|Protocol Violation|1|||
161949427|NCT04540367|584866178|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
161949428|NCT04540367|584866179|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
161949429|NCT04540367|584866180|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
161949430|NCT04540367|584866181|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
161949431|NCT04540367|584866178|FG000|Overall Study|Adverse Event|0|||
161949432|NCT04540367|584866179|FG001|Overall Study|Adverse Event|0|||
161949433|NCT04540367|584866180|FG002|Overall Study|Adverse Event|1|||
161949434|NCT04540367|584866181|FG003|Overall Study|Adverse Event|1|||
161949435|NCT00730886|584866183|FG000|Overall Study|Lost to Follow-up|1|||
161949436|NCT00730886|584866184|FG001|Overall Study|Lost to Follow-up|0|||
161949437|NCT00730886|584866183|FG000|Overall Study|Physician Decision|1|||
161949438|NCT00730886|584866184|FG001|Overall Study|Physician Decision|0|||
161949439|NCT01816048|584866185|FG000|Overall Study|Adverse Event|1|||
161949440|NCT01816048|584866185|FG000|Overall Study|Death|1|||
161949441|NCT01816048|584866185|FG000|Overall Study|Withdrawal by Subject|1|||
161949442|NCT01816048|584866185|FG000|Overall Study|Disease Progression|3|||
161949443|NCT04067492|584866186|FG000|Overall Study|Lost to Follow-up|0|||
161949444|NCT04067492|584866187|FG001|Overall Study|Lost to Follow-up|0|||
161949445|NCT04067492|584866188|FG002|Overall Study|Lost to Follow-up|0|||
161949446|NCT04067492|584866189|FG003|Overall Study|Lost to Follow-up|0|||
161949447|NCT04067492|584866190|FG004|Overall Study|Lost to Follow-up|0|||
161949448|NCT04067492|584866191|FG005|Overall Study|Lost to Follow-up|1|||
161949449|NCT04067492|584866186|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
161949450|NCT04067492|584866187|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
161949451|NCT04067492|584866188|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
161949452|NCT04067492|584866189|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
161949453|NCT04067492|584866190|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
161949454|NCT04067492|584866191|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
161949455|NCT04067492|584866186|FG000|Overall Study|COVID-19 epidemiological situation|0|||
161949456|NCT04067492|584866187|FG001|Overall Study|COVID-19 epidemiological situation|0|||
161949457|NCT04067492|584866188|FG002|Overall Study|COVID-19 epidemiological situation|0|||
161949458|NCT04067492|584866189|FG003|Overall Study|COVID-19 epidemiological situation|1|||
161949459|NCT04067492|584866190|FG004|Overall Study|COVID-19 epidemiological situation|0|||
161949460|NCT04067492|584866191|FG005|Overall Study|COVID-19 epidemiological situation|0|||
161949461|NCT03913130|584866194|FG000|Overall Study|Sponsor Decision|1|||
161949462|NCT04046939|584866199|FG000|Primary Assessment Period|Adverse Event|1|||
161949463|NCT04046939|584866200|FG001|Primary Assessment Period|Adverse Event|0|||
161685233|NCT00495820|583899726|FG001|Overall Study|Adverse Event|1|||
161685234|NCT00820950|583899727|FG000|Overall Study|Scheduling Conflict|0|||
161685235|NCT00820950|583899728|FG001|Overall Study|Scheduling Conflict|0|||
161685236|NCT00820950|583899729|FG002|Overall Study|Scheduling Conflict|0|||
161685237|NCT00820950|583899730|FG003|Overall Study|Scheduling Conflict|0|||
161685238|NCT00820950|583899731|FG004|Overall Study|Scheduling Conflict|0|||
161685239|NCT00820950|583899732|FG005|Overall Study|Scheduling Conflict|0|||
161685240|NCT00820950|583899733|FG006|Overall Study|Scheduling Conflict|1|||
161685241|NCT00820950|583899734|FG007|Overall Study|Scheduling Conflict|1|||
161685242|NCT00820950|583899735|FG008|Overall Study|Scheduling Conflict|0|||
161685243|NCT00820950|583899736|FG009|Overall Study|Scheduling Conflict|0|||
161685244|NCT00820950|583899727|FG000|Overall Study|Protocol Violation|1|||
161685245|NCT00820950|583899728|FG001|Overall Study|Protocol Violation|1|||
161685246|NCT00820950|583899729|FG002|Overall Study|Protocol Violation|0|||
161685247|NCT00820950|583899730|FG003|Overall Study|Protocol Violation|0|||
161685248|NCT00820950|583899731|FG004|Overall Study|Protocol Violation|0|||
161949464|NCT04046939|584866201|FG002|Primary Assessment Period|Adverse Event|0|||
161949465|NCT04046939|584866202|FG003|Primary Assessment Period|Adverse Event|0|||
161949466|NCT04046939|584866199|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
161949467|NCT04046939|584866200|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
161949468|NCT04046939|584866201|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
161685249|NCT00820950|583899732|FG005|Overall Study|Protocol Violation|0|||
161685250|NCT00820950|583899733|FG006|Overall Study|Protocol Violation|0|||
161685251|NCT00820950|583899734|FG007|Overall Study|Protocol Violation|0|||
161685252|NCT00820950|583899735|FG008|Overall Study|Protocol Violation|0|||
161685253|NCT00820950|583899736|FG009|Overall Study|Protocol Violation|0|||
161949469|NCT04046939|584866202|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
161949470|NCT04046939|584866199|FG000|Primary Assessment Period|Physician Decision|0|||
161949471|NCT04046939|584866200|FG001|Primary Assessment Period|Physician Decision|0|||
161949472|NCT04046939|584866201|FG002|Primary Assessment Period|Physician Decision|1|||
161949473|NCT04046939|584866202|FG003|Primary Assessment Period|Physician Decision|0|||
161949474|NCT04046939|584866199|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
161949475|NCT04046939|584866200|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
161949476|NCT04046939|584866201|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
161949477|NCT04046939|584866202|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
161949478|NCT04704193|584866203|FG000|Overall Study|Withdrawal by Subject|1|||
161949479|NCT00038948|584866204|FG000|Overall Study|Adverse Event|131|||
161949480|NCT00038948|584866205|FG001|Overall Study|Adverse Event|43|||
161949481|NCT00038948|584866204|FG000|Overall Study|Lost to Follow-up|4|||
161949482|NCT00038948|584866205|FG001|Overall Study|Lost to Follow-up|4|||
161949483|NCT00038948|584866204|FG000|Overall Study|Nonmedical event|5|||
161949484|NCT00038948|584866205|FG001|Overall Study|Nonmedical event|7|||
161949485|NCT00038948|584866204|FG000|Overall Study|Withdrawal by Subject|23|||
161949486|NCT00038948|584866205|FG001|Overall Study|Withdrawal by Subject|10|||
161949487|NCT00038948|584866204|FG000|Overall Study|Protocol Violation|3|||
161949488|NCT00038948|584866205|FG001|Overall Study|Protocol Violation|7|||
161949489|NCT00038948|584866204|FG000|Overall Study|Lack of Efficacy|3|||
161949490|NCT00038948|584866205|FG001|Overall Study|Lack of Efficacy|6|||
161949491|NCT03384875|584866206|FG000|Overall Study|Death|1|||
161949492|NCT03384875|584866207|FG001|Overall Study|Death|1|||
161949493|NCT03384875|584866208|FG002|Overall Study|Death|0|||
161949494|NCT03384875|584866206|FG000|Overall Study|Reason not provided|1|||
161949495|NCT03384875|584866207|FG001|Overall Study|Reason not provided|0|||
161949496|NCT03384875|584866208|FG002|Overall Study|Reason not provided|0|||
161949497|NCT00529243|584867775|FG000|Overall Study|Adverse Event|1|||
161949498|NCT00529243|584867775|FG000|Overall Study|Death|1|||
161949499|NCT00529243|584867775|FG000|Overall Study|Relocated|1|||
161949500|NCT00678288|584867782|FG000|Overall Study|Adverse Event|0|||
161949501|NCT00678288|584867783|FG001|Overall Study|Adverse Event|2|||
161949502|NCT00678288|584867782|FG000|Overall Study|Withdrawal by Subject|1|||
161949503|NCT00678288|584867783|FG001|Overall Study|Withdrawal by Subject|1|||
161949504|NCT00678288|584867782|FG000|Overall Study|Study terminated by the sponsor|2|||
161949505|NCT00678288|584867783|FG001|Overall Study|Study terminated by the sponsor|0|||
161949506|NCT00678288|584867782|FG000|Overall Study|Not compliant with study medication|0|||
161949507|NCT00678288|584867783|FG001|Overall Study|Not compliant with study medication|1|||
161949508|NCT00678288|584867782|FG000|Overall Study|Switch to commercial drug|0|||
161949509|NCT00678288|584867783|FG001|Overall Study|Switch to commercial drug|1|||
161949510|NCT00678288|584867782|FG000|Overall Study|Reason not reported|1|||
161949511|NCT00678288|584867783|FG001|Overall Study|Reason not reported|0|||
161949512|NCT00678288|584867782|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
161949513|NCT00678288|584867783|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
161949514|NCT04472650|584867794|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
161949515|NCT04472650|584867795|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
161949516|NCT03247829|584867798|FG000|Overall Study|Death|3|||
161949517|NCT03247829|584867799|FG001|Overall Study|Death|4|||
161949518|NCT03247829|584867798|FG000|Overall Study|Enter Hospice Care|1|||
161949519|NCT03247829|584867799|FG001|Overall Study|Enter Hospice Care|0|||
161949520|NCT03247829|584867798|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
161949521|NCT03247829|584867799|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
161949522|NCT03247829|584867798|FG000|Overall Study|LVAD Explant|1|||
161949523|NCT03247829|584867799|FG001|Overall Study|LVAD Explant|1|||
161949524|NCT03247829|584867798|FG000|Overall Study|Transplant|1|||
161949525|NCT03247829|584867799|FG001|Overall Study|Transplant|1|||
161949526|NCT01783444|584867800|FG000|Treatment Phase|Adverse Event|9|||
161949527|NCT01783444|584867801|FG001|Treatment Phase|Adverse Event|20|||
161949528|NCT01783444|584867802|FG002|Treatment Phase|Adverse Event|19|||
161949529|NCT01783444|584867800|FG000|Treatment Phase|Disease Progression|76|||
161949530|NCT01783444|584867801|FG001|Treatment Phase|Disease Progression|66|||
161949531|NCT01783444|584867802|FG002|Treatment Phase|Disease Progression|64|||
161949532|NCT01783444|584867800|FG000|Treatment Phase|Death|2|||
161949533|NCT01783444|584867801|FG001|Treatment Phase|Death|2|||
161949534|NCT01783444|584867802|FG002|Treatment Phase|Death|2|||
161949535|NCT01783444|584867800|FG000|Treatment Phase|Protocol Violation|1|||
161949536|NCT01783444|584867801|FG001|Treatment Phase|Protocol Violation|1|||
161949537|NCT01783444|584867802|FG002|Treatment Phase|Protocol Violation|2|||
161949538|NCT01783444|584867800|FG000|Treatment Phase|Withdrawal by Subject|6|||
161949539|NCT01783444|584867801|FG001|Treatment Phase|Withdrawal by Subject|8|||
161949540|NCT01783444|584867802|FG002|Treatment Phase|Withdrawal by Subject|9|||
161949541|NCT01783444|584867800|FG000|Treatment Phase|Administrative problems|2|||
161949542|NCT01783444|584867801|FG001|Treatment Phase|Administrative problems|0|||
161949543|NCT01783444|584867802|FG002|Treatment Phase|Administrative problems|1|||
161949544|NCT01783444|584867800|FG000|Treatment Phase|Physician Decision|8|||
161949545|NCT01783444|584867801|FG001|Treatment Phase|Physician Decision|6|||
161949546|NCT01783444|584867802|FG002|Treatment Phase|Physician Decision|5|||
161949547|NCT01783444|584867800|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
161949548|NCT01783444|584867801|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
161949549|NCT01783444|584867802|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
161949550|NCT01783444|584867800|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
161949551|NCT01783444|584867801|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
161949552|NCT01783444|584867802|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
161949553|NCT01783444|584867800|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
161949554|NCT01783444|584867801|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
161949555|NCT01783444|584867802|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
161949556|NCT01783444|584867800|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
161949557|NCT01783444|584867801|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
161949558|NCT01783444|584867802|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
161949559|NCT01783444|584867800|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
161949560|NCT01783444|584867801|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
161949561|NCT01783444|584867802|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
161949562|NCT01783444|584867800|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
161949563|NCT01783444|584867801|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
161949564|NCT01783444|584867802|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
161949565|NCT00552071|584867804|FG000|Overall Study|Adverse Event|1|||
161949566|NCT00552071|584867805|FG001|Overall Study|Adverse Event|0|||
161949567|NCT00552071|584867804|FG000|Overall Study|Lack of Efficacy|1|||
161949568|NCT00552071|584867805|FG001|Overall Study|Lack of Efficacy|0|||
161949569|NCT00552071|584867804|FG000|Overall Study|Physician Decision|1|||
161949570|NCT00552071|584867805|FG001|Overall Study|Physician Decision|0|||
161949571|NCT00552071|584867804|FG000|Overall Study|Pregnancy|1|||
161949572|NCT00552071|584867805|FG001|Overall Study|Pregnancy|0|||
161949573|NCT00552071|584867804|FG000|Overall Study|Death|0|||
161949574|NCT00552071|584867805|FG001|Overall Study|Death|1|||
161949575|NCT00552071|584867804|FG000|Overall Study|Withdrawal by Subject|0|||
161949576|NCT00552071|584867805|FG001|Overall Study|Withdrawal by Subject|1|||
161949577|NCT00272792|584867806|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
161949578|NCT00272792|584867807|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
161949579|NCT00272792|584867806|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
161949580|NCT00272792|584867807|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
161949581|NCT00272792|584867806|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
161949582|NCT00272792|584867807|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
161949583|NCT00272792|584867806|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
161949584|NCT00272792|584867807|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
161949585|NCT02549989|584867812|FG000|Overall Study|Adverse Event|4|||
161949586|NCT02549989|584867812|FG000|Overall Study|Death|1|||
161949587|NCT02549989|584867812|FG000|Overall Study|Lack of Efficacy|19|||
161949588|NCT02549989|584867812|FG000|Overall Study|Withdrawal by Subject|3|||
161949589|NCT01333722|584867816|FG000|Overall Study|Lack of Efficacy|0|||
161949590|NCT01333722|584867817|FG001|Overall Study|Lack of Efficacy|2|||
161949591|NCT01333722|584867816|FG000|Overall Study|Withdrawal by Subject|0|||
161949592|NCT01333722|584867817|FG001|Overall Study|Withdrawal by Subject|1|||
161949593|NCT00784368|584867818|FG000|Overall Study|Physician Decision|0|||
161949594|NCT00784368|584867819|FG001|Overall Study|Physician Decision|0|||
161949595|NCT00784368|584867820|FG002|Overall Study|Physician Decision|6|||
161949596|NCT00784368|584867818|FG000|Overall Study|Lack of Efficacy|2|||
161949597|NCT00784368|584867819|FG001|Overall Study|Lack of Efficacy|0|||
161949598|NCT00784368|584867820|FG002|Overall Study|Lack of Efficacy|1|||
161949599|NCT00784368|584867818|FG000|Overall Study|Adverse Event|6|||
161949600|NCT00784368|584867819|FG001|Overall Study|Adverse Event|9|||
161949601|NCT00784368|584867820|FG002|Overall Study|Adverse Event|2|||
161949602|NCT00784368|584867818|FG000|Overall Study|Diagnosis of fever|0|||
161949603|NCT00784368|584867819|FG001|Overall Study|Diagnosis of fever|0|||
161949604|NCT00784368|584867820|FG002|Overall Study|Diagnosis of fever|1|||
161949605|NCT00784368|584867818|FG000|Overall Study|Worsening of complications|0|||
161949606|NCT00784368|584867819|FG001|Overall Study|Worsening of complications|0|||
161949607|NCT00784368|584867820|FG002|Overall Study|Worsening of complications|1|||
161949608|NCT00784368|584867818|FG000|Overall Study|Worsening of symptoms|0|||
161949609|NCT00784368|584867819|FG001|Overall Study|Worsening of symptoms|1|||
161949610|NCT00784368|584867820|FG002|Overall Study|Worsening of symptoms|0|||
161949611|NCT00784368|584867818|FG000|Overall Study|Withdrawal of informed consent|0|||
161949612|NCT00784368|584867819|FG001|Overall Study|Withdrawal of informed consent|1|||
161949613|NCT00784368|584867820|FG002|Overall Study|Withdrawal of informed consent|0|||
161949614|NCT02079909|584867821|FG000|Overall Study|Adverse Event|23|||
162028675|NCT02478398|585161785|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
161685254|NCT05885737|583899739|FG000|DB Period|Adverse Event|4|||
161685255|NCT05885737|583899740|FG001|DB Period|Adverse Event|4|||
161685256|NCT05885737|583899739|FG000|DB Period|Lost to Follow-up|0|||
161685257|NCT05885737|583899740|FG001|DB Period|Lost to Follow-up|1|||
161685258|NCT05885737|583899739|FG000|DB Period|Physician Decision|2|||
161685259|NCT05885737|583899740|FG001|DB Period|Physician Decision|0|||
161685260|NCT05885737|583899739|FG000|DB Period|Withdrawal by Subject|12|||
161685261|NCT05885737|583899740|FG001|DB Period|Withdrawal by Subject|6|||
161685262|NCT05885737|583899739|FG000|DB Period|Other: Unspecified|2|||
161949615|NCT02079909|584867822|FG001|Overall Study|Adverse Event|23|||
161949616|NCT02079909|584867823|FG002|Overall Study|Adverse Event|7|||
161949617|NCT02079909|584867821|FG000|Overall Study|Withdrawal by Subject|9|||
161949618|NCT02079909|584867822|FG001|Overall Study|Withdrawal by Subject|17|||
161949619|NCT02079909|584867823|FG002|Overall Study|Withdrawal by Subject|4|||
161685263|NCT05885737|583899740|FG001|DB Period|Other: Unspecified|2|||
161685264|NCT05885737|583899739|FG000|OLE Period|Adverse Event|3|||
161949620|NCT02079909|584867821|FG000|Overall Study|Lost to Follow-up|2|||
161949621|NCT02079909|584867822|FG001|Overall Study|Lost to Follow-up|3|||
161949622|NCT02079909|584867823|FG002|Overall Study|Lost to Follow-up|1|||
161949623|NCT02079909|584867821|FG000|Overall Study|Death|2|||
161949624|NCT02079909|584867822|FG001|Overall Study|Death|2|||
161949625|NCT02079909|584867823|FG002|Overall Study|Death|0|||
161685265|NCT05885737|583899740|FG001|OLE Period|Adverse Event|2|||
161685266|NCT05885737|583899739|FG000|OLE Period|Physician Decision|1|||
161949626|NCT02079909|584867821|FG000|Overall Study|Lack of Efficacy|0|||
161949627|NCT02079909|584867822|FG001|Overall Study|Lack of Efficacy|0|||
161949628|NCT02079909|584867823|FG002|Overall Study|Lack of Efficacy|1|||
161949629|NCT02079909|584867821|FG000|Overall Study|Protocol Violation|0|||
161949630|NCT02079909|584867822|FG001|Overall Study|Protocol Violation|1|||
161949631|NCT02079909|584867823|FG002|Overall Study|Protocol Violation|1|||
161949632|NCT02079909|584867821|FG000|Overall Study|Physician Decision|0|||
161949633|NCT02079909|584867822|FG001|Overall Study|Physician Decision|1|||
161949634|NCT02079909|584867823|FG002|Overall Study|Physician Decision|1|||
161949635|NCT02079909|584867821|FG000|Overall Study|Relocation etc.|2|||
161949636|NCT02079909|584867822|FG001|Overall Study|Relocation etc.|2|||
161949637|NCT02079909|584867823|FG002|Overall Study|Relocation etc.|3|||
161949638|NCT00720356|584867828|FG000|Registration to Study|Determined to have methylated MGMT|67|||
161949639|NCT00720356|584867828|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
161949640|NCT00720356|584867828|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
161949641|NCT00720356|584867828|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
161949642|NCT00720356|584867828|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
161949643|NCT00720356|584867828|FG000|Follow up Until Death|Withdrawal by Subject|1|||
161949644|NCT00720356|584867828|FG000|Follow up Until Death|Alive at last data collection|4|||
161949645|NCT02237001|584867831|FG000|Overall Study|Lost to Follow-up|2|||
161949646|NCT02237001|584867831|FG000|Overall Study|Withdrawal by Subject|1|||
161949647|NCT02237001|584867831|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
161949648|NCT02237001|584867831|FG000|Overall Study|Re-operation|4|||
161949649|NCT02237001|584867831|FG000|Overall Study|Incarceration|1|||
161949650|NCT01047007|584867832|FG000|Overall Study|Adverse Event|0|||
161949651|NCT01047007|584867833|FG001|Overall Study|Adverse Event|2|||
161949652|NCT01047007|584867834|FG002|Overall Study|Adverse Event|1|||
161949653|NCT01047007|584867835|FG003|Overall Study|Adverse Event|0|||
161949654|NCT01047007|584867832|FG000|Overall Study|Progressive Disease|2|||
161949655|NCT01047007|584867833|FG001|Overall Study|Progressive Disease|4|||
161949656|NCT01047007|584867834|FG002|Overall Study|Progressive Disease|1|||
161949657|NCT01047007|584867835|FG003|Overall Study|Progressive Disease|0|||
161949658|NCT00457392|584867838|FG000|Overall Study|Objective Progression or Relapse|229|||
161949659|NCT00457392|584867839|FG001|Overall Study|Objective Progression or Relapse|296|||
161685267|NCT05885737|583899740|FG001|OLE Period|Physician Decision|0|||
161685268|NCT05885737|583899739|FG000|OLE Period|Withdrawal by Subject|5|||
161685269|NCT05885737|583899740|FG001|OLE Period|Withdrawal by Subject|5|||
161685270|NCT05885737|583899739|FG000|OLE Period|Other: Unspecified|2|||
161685271|NCT05885737|583899740|FG001|OLE Period|Other: Unspecified|1|||
161685272|NCT03927105|583901822|FG000|Overall Study|Death|1|||
161685273|NCT03927105|583901822|FG000|Overall Study|In observation for potential re-treatment|2|||
161949660|NCT00457392|584867838|FG000|Overall Study|Death|106|||
161949661|NCT00457392|584867839|FG001|Overall Study|Death|106|||
161949662|NCT00457392|584867838|FG000|Overall Study|Adverse Event|84|||
161949663|NCT00457392|584867839|FG001|Overall Study|Adverse Event|41|||
161949664|NCT00457392|584867838|FG000|Overall Study|Global Deterioration of Health Status|22|||
161949665|NCT00457392|584867839|FG001|Overall Study|Global Deterioration of Health Status|8|||
161949666|NCT00457392|584867838|FG000|Overall Study|Withdrawal by Subject|14|||
161949667|NCT00457392|584867839|FG001|Overall Study|Withdrawal by Subject|8|||
161949668|NCT00457392|584867838|FG000|Overall Study|Lost to Follow-up|6|||
161949669|NCT00457392|584867839|FG001|Overall Study|Lost to Follow-up|7|||
161949670|NCT00457392|584867838|FG000|Overall Study|Protocol Violation|4|||
161949671|NCT00457392|584867839|FG001|Overall Study|Protocol Violation|3|||
161949672|NCT00457392|584867838|FG000|Overall Study|Other|7|||
161949673|NCT00457392|584867839|FG001|Overall Study|Other|4|||
161949674|NCT00457392|584867838|FG000|Overall Study|Study Terminated by Sponsor|1|||
161949675|NCT00457392|584867839|FG001|Overall Study|Study Terminated by Sponsor|4|||
161949676|NCT00457392|584867838|FG000|Overall Study|Randomized, Not Treated|7|||
161949677|NCT00457392|584867839|FG001|Overall Study|Randomized, Not Treated|3|||
161949678|NCT00756275|584867840|FG000|Overall Study|Lost to Follow-up|25|||
161949679|NCT00756275|584867841|FG001|Overall Study|Lost to Follow-up|21|||
161949680|NCT00756275|584867840|FG000|Overall Study|Withdrawal by Subject|4|||
161949681|NCT00756275|584867841|FG001|Overall Study|Withdrawal by Subject|7|||
161949682|NCT00980148|584867842|FG000|Overall Study|Discharged from facility|89|||
161949683|NCT00980148|584867843|FG001|Overall Study|Discharged from facility|96|||
161949684|NCT00980148|584867842|FG000|Overall Study|Received other antichlamydia treatment|20|||
161949685|NCT00980148|584867843|FG001|Overall Study|Received other antichlamydia treatment|14|||
161949686|NCT00980148|584867842|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
161949687|NCT00980148|584867843|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
161949688|NCT00980148|584867842|FG000|Overall Study|Various other reasons|8|||
161685274|NCT03927105|583901822|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
161685275|NCT00789529|583901823|FG000|Overall Study|Withdrawal by Subject|0|||
161685276|NCT00789529|583901824|FG001|Overall Study|Withdrawal by Subject|1|||
161685277|NCT00789529|583901823|FG000|Overall Study|Other Reason|1|||
161685278|NCT00789529|583901824|FG001|Overall Study|Other Reason|0|||
161685279|NCT01870401|583901825|FG000|Overall Study|Death|48|||
161685280|NCT01870401|583901826|FG001|Overall Study|Death|24|||
161685281|NCT01870401|583901825|FG000|Overall Study|Withdrawal by Subject|39|||
161685282|NCT01870401|583901826|FG001|Overall Study|Withdrawal by Subject|26|||
161685283|NCT01870401|583901825|FG000|Overall Study|Lost to Follow-up|19|||
161949689|NCT00980148|584867843|FG001|Overall Study|Various other reasons|9|||
161685284|NCT01870401|583901826|FG001|Overall Study|Lost to Follow-up|14|||
161685285|NCT01870401|583901825|FG000|Overall Study|Other|9|||
161949690|NCT00420381|584867846|FG000|Overall Study|Protocol Violation|1|||
161949691|NCT01244035|584867859|FG000|Part 1: Period 1|Adverse Event|0|||
161949692|NCT01244035|584867860|FG001|Part 1: Period 1|Adverse Event|0|||
161949693|NCT01244035|584867861|FG002|Part 1: Period 1|Adverse Event|0|||
161949694|NCT01244035|584867862|FG003|Part 1: Period 1|Adverse Event|0|||
161685286|NCT01870401|583901826|FG001|Overall Study|Other|7|||
161685287|NCT01870401|583901825|FG000|Overall Study|On-going in the Study|35|||
161685288|NCT01870401|583901826|FG001|Overall Study|On-going in the Study|25|||
161685289|NCT01135498|583901828|FG000|Overall Study|Adverse Event|20|||
161949695|NCT01244035|584867863|FG004|Part 1: Period 1|Adverse Event|0|||
161685290|NCT01135498|583901828|FG000|Overall Study|Progressive disease|38|||
161685291|NCT01135498|583901828|FG000|Overall Study|Investigator judgement|25|||
161685292|NCT01135498|583901828|FG000|Overall Study|Withdrawal by Subject|4|||
161685293|NCT01135498|583901828|FG000|Overall Study|Death|1|||
161685294|NCT01135498|583901828|FG000|Overall Study|Ongoing at time of analysis|2|||
161685295|NCT01192022|583901829|FG000|Overall Study|Withdrawal of Consent|3|||
161685296|NCT01192022|583901830|FG001|Overall Study|Withdrawal of Consent|1|||
161685297|NCT01192022|583901831|FG002|Overall Study|Withdrawal of Consent|0|||
161685298|NCT01192022|583901832|FG003|Overall Study|Withdrawal of Consent|0|||
161685299|NCT01192022|583901833|FG004|Overall Study|Withdrawal of Consent|0|||
161685300|NCT01192022|583901829|FG000|Overall Study|Lost to Follow-up|4|||
161685301|NCT01192022|583901830|FG001|Overall Study|Lost to Follow-up|2|||
161685302|NCT01192022|583901831|FG002|Overall Study|Lost to Follow-up|1|||
161833483|NCT04495283|584433142|FG002|Overall Study|Withdrawal by Subject|1|||
161833484|NCT04495283|584433140|FG000|Overall Study|Other|1|||
161685303|NCT01192022|583901832|FG003|Overall Study|Lost to Follow-up|1|||
161685304|NCT01192022|583901833|FG004|Overall Study|Lost to Follow-up|0|||
161685305|NCT01192022|583901829|FG000|Overall Study|Adverse Event|1|||
161685306|NCT01192022|583901830|FG001|Overall Study|Adverse Event|0|||
161685307|NCT01192022|583901831|FG002|Overall Study|Adverse Event|0|||
161685308|NCT01192022|583901832|FG003|Overall Study|Adverse Event|0|||
161685309|NCT01192022|583901833|FG004|Overall Study|Adverse Event|0|||
161685310|NCT01192022|583901829|FG000|Overall Study|Fatal Adverse Event|4|||
161685311|NCT01192022|583901830|FG001|Overall Study|Fatal Adverse Event|6|||
161685312|NCT01192022|583901831|FG002|Overall Study|Fatal Adverse Event|0|||
161685313|NCT01192022|583901832|FG003|Overall Study|Fatal Adverse Event|0|||
161685314|NCT01192022|583901833|FG004|Overall Study|Fatal Adverse Event|1|||
161949696|NCT01244035|584867864|FG005|Part 1: Period 1|Adverse Event|1|||
161949697|NCT01244035|584867859|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
161949698|NCT01244035|584867860|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
161949699|NCT01244035|584867861|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
161949700|NCT01244035|584867862|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
161949701|NCT01244035|584867863|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
161949702|NCT01244035|584867864|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
161949703|NCT01244035|584867859|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
161949704|NCT01244035|584867860|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
161949705|NCT01244035|584867861|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
161949706|NCT01244035|584867862|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
161949707|NCT01244035|584867863|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
161949708|NCT01244035|584867864|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
161949709|NCT01244035|584867859|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
161949710|NCT01244035|584867860|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
161949711|NCT01244035|584867861|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
161949712|NCT01244035|584867862|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
161949713|NCT01244035|584867863|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
161949714|NCT01244035|584867864|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
161949715|NCT01244035|584867859|FG000|Part 1: Period 3|Adverse Event|0|||
161949716|NCT01244035|584867860|FG001|Part 1: Period 3|Adverse Event|0|||
161949717|NCT01244035|584867861|FG002|Part 1: Period 3|Adverse Event|0|||
161949718|NCT01244035|584867862|FG003|Part 1: Period 3|Adverse Event|0|||
161949719|NCT01244035|584867863|FG004|Part 1: Period 3|Adverse Event|0|||
161949720|NCT01244035|584867864|FG005|Part 1: Period 3|Adverse Event|1|||
161949721|NCT01244035|584867859|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
161949722|NCT01244035|584867860|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
161949723|NCT01244035|584867861|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
161685315|NCT01192022|583901829|FG000|Overall Study|Physician withdrew-patient hardship|1|||
161833485|NCT04495283|584433141|FG001|Overall Study|Other|0|||
161833486|NCT04495283|584433142|FG002|Overall Study|Other|1|||
161833487|NCT03341000|584433156|FG000|Overall Study|Adverse Event|1|||
161833488|NCT04718194|584433157|FG000|Overall Study|Withdrawal by Subject|3|||
161833489|NCT04718194|584433158|FG001|Overall Study|Withdrawal by Subject|0|||
161833490|NCT04718194|584433157|FG000|Overall Study|Lost to Follow-up|3|||
161949724|NCT01244035|584867862|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
161949725|NCT01244035|584867863|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
161949726|NCT01244035|584867864|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
161685316|NCT01192022|583901830|FG001|Overall Study|Physician withdrew-patient hardship|0|||
161685317|NCT01192022|583901831|FG002|Overall Study|Physician withdrew-patient hardship|0|||
161833491|NCT04718194|584433158|FG001|Overall Study|Lost to Follow-up|0|||
161833492|NCT01215513|584433159|FG000|Overall Study|Not completed CS42|9|||
161833493|NCT01215513|584433159|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
161685318|NCT01192022|583901832|FG003|Overall Study|Physician withdrew-patient hardship|0|||
161685319|NCT01192022|583901833|FG004|Overall Study|Physician withdrew-patient hardship|0|||
161685320|NCT01192022|583901829|FG000|Overall Study|Patient too sick from chemotherapy|0|||
161685321|NCT01192022|583901830|FG001|Overall Study|Patient too sick from chemotherapy|1|||
161833494|NCT01215513|584433159|FG000|Overall Study|Adverse event (CS42A)|2|||
161833495|NCT01215513|584433159|FG000|Overall Study|Physician decision (CS42A)|6|||
161833496|NCT01215513|584433159|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
161685322|NCT01192022|583901831|FG002|Overall Study|Patient too sick from chemotherapy|0|||
161685323|NCT01192022|583901832|FG003|Overall Study|Patient too sick from chemotherapy|0|||
161685324|NCT01192022|583901833|FG004|Overall Study|Patient too sick from chemotherapy|0|||
161685325|NCT01192022|583901829|FG000|Overall Study|Patient needed surgery|0|||
161685326|NCT01192022|583901830|FG001|Overall Study|Patient needed surgery|1|||
161685327|NCT01192022|583901831|FG002|Overall Study|Patient needed surgery|0|||
161685328|NCT01192022|583901832|FG003|Overall Study|Patient needed surgery|0|||
161685329|NCT01192022|583901833|FG004|Overall Study|Patient needed surgery|0|||
161685330|NCT01192022|583901829|FG000|Overall Study|Parents did not allow all follow up|0|||
161685331|NCT01192022|583901830|FG001|Overall Study|Parents did not allow all follow up|0|||
161685332|NCT01192022|583901831|FG002|Overall Study|Parents did not allow all follow up|0|||
161685333|NCT01192022|583901832|FG003|Overall Study|Parents did not allow all follow up|1|||
161685334|NCT01192022|583901833|FG004|Overall Study|Parents did not allow all follow up|0|||
161685335|NCT01351389|583901834|FG000|Overall Study|Withdrawal by Subject|7|||
161685336|NCT01351389|583901835|FG001|Overall Study|Withdrawal by Subject|0|||
161685337|NCT01351389|583901834|FG000|Overall Study|did not complete intervention|23|||
161685338|NCT01351389|583901835|FG001|Overall Study|did not complete intervention|15|||
161685339|NCT04839978|583901836|FG000|Overall Study|Lost to Follow-up|135|||
161685340|NCT04839978|583901837|FG001|Overall Study|Lost to Follow-up|147|||
161685341|NCT03551509|583901842|FG000|Overall Study|Lost to Follow-up|0|||
161685342|NCT03551509|583901843|FG001|Overall Study|Lost to Follow-up|1|||
161685343|NCT03551509|583901844|FG002|Overall Study|Lost to Follow-up|0|||
161685344|NCT01902966|583901845|FG000|Overall Study|Death|1|||
161685345|NCT01902966|583901845|FG000|Overall Study|Physician Decision|1|||
161685346|NCT01902966|583901845|FG000|Overall Study|Withdrawal by Subject|1|||
161685347|NCT01549275|583901846|FG000|Overall Study|Lost to Follow-up|1|||
161685348|NCT01549275|583901847|FG001|Overall Study|Lost to Follow-up|0|||
161685349|NCT00122681|583901848|FG000|Overall Study|Adverse Event|20|||
161685350|NCT00122681|583901849|FG001|Overall Study|Adverse Event|16|||
161685351|NCT00122681|583901848|FG000|Overall Study|Lost to Follow-up|1080|||
161685352|NCT00122681|583901849|FG001|Overall Study|Lost to Follow-up|1097|||
161685353|NCT00122681|583901848|FG000|Overall Study|Protocol Violation|7|||
161685354|NCT00122681|583901849|FG001|Overall Study|Protocol Violation|10|||
161685355|NCT00122681|583901848|FG000|Overall Study|Withdrawal by Subject|257|||
161685356|NCT00122681|583901849|FG001|Overall Study|Withdrawal by Subject|251|||
161685357|NCT00122681|583901848|FG000|Overall Study|Personal reasons|150|||
161685358|NCT00122681|583901849|FG001|Overall Study|Personal reasons|147|||
161685359|NCT00783094|583901856|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
161685360|NCT00783094|583901857|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
161685361|NCT00783094|583901858|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
161685362|NCT00783094|583901856|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
161685363|NCT00783094|583901857|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
161685364|NCT00783094|583901858|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
161685365|NCT00783094|583901856|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
161685366|NCT00783094|583901857|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
161685367|NCT00783094|583901858|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
161685368|NCT00783094|583901856|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
161685369|NCT00783094|583901857|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
161685370|NCT00783094|583901858|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
161685371|NCT00783094|583901856|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
161685372|NCT00783094|583901857|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
161833497|NCT01215513|584433159|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
161949727|NCT01244035|584867859|FG000|Part 1: Period 3|Protocol Deviation|0|||
161949728|NCT01244035|584867860|FG001|Part 1: Period 3|Protocol Deviation|1|||
161685373|NCT00783094|583901858|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
161685374|NCT00783094|583901856|FG000|Open-Label Extension Period|Adverse Event|12|||
161949729|NCT01244035|584867861|FG002|Part 1: Period 3|Protocol Deviation|0|||
161949730|NCT01244035|584867862|FG003|Part 1: Period 3|Protocol Deviation|0|||
161685375|NCT00783094|583901857|FG001|Open-Label Extension Period|Adverse Event|7|||
161685376|NCT00783094|583901858|FG002|Open-Label Extension Period|Adverse Event|16|||
161685377|NCT00783094|583901856|FG000|Open-Label Extension Period|Death|0|||
161685378|NCT00783094|583901857|FG001|Open-Label Extension Period|Death|0|||
161685379|NCT00783094|583901858|FG002|Open-Label Extension Period|Death|1|||
161685380|NCT00783094|583901856|FG000|Open-Label Extension Period|Protocol Violation|4|||
161949731|NCT01244035|584867863|FG004|Part 1: Period 3|Protocol Deviation|0|||
161949732|NCT01244035|584867864|FG005|Part 1: Period 3|Protocol Deviation|0|||
161949733|NCT02776683|584867865|FG000|Pre-switch Period|Protocol Violation|1|||
161949734|NCT02776683|584867866|FG001|Pre-switch Period|Protocol Violation|0|||
161949735|NCT02776683|584867865|FG000|Pre-switch Period|Adverse Event|21|||
161949736|NCT02776683|584867866|FG001|Pre-switch Period|Adverse Event|0|||
161949737|NCT02776683|584867865|FG000|Pre-switch Period|Withdrawal by Subject|9|||
161949738|NCT02776683|584867866|FG001|Pre-switch Period|Withdrawal by Subject|0|||
161949739|NCT02776683|584867865|FG000|Pre-switch Period|Physician Decision|7|||
161949740|NCT02776683|584867866|FG001|Pre-switch Period|Physician Decision|0|||
161949741|NCT02776683|584867865|FG000|Pre-switch Period|Progressive disease|39|||
161949742|NCT02776683|584867866|FG001|Pre-switch Period|Progressive disease|0|||
161949743|NCT02776683|584867865|FG000|Pre-switch Period|Other than listed|3|||
161949744|NCT02776683|584867866|FG001|Pre-switch Period|Other than listed|0|||
161949745|NCT02776683|584867865|FG000|Post-switch Period|Adverse Event|0|||
161949746|NCT02776683|584867866|FG001|Post-switch Period|Adverse Event|3|||
161949747|NCT02776683|584867865|FG000|Post-switch Period|Withdrawal by Subject|0|||
161949748|NCT02776683|584867866|FG001|Post-switch Period|Withdrawal by Subject|2|||
161949749|NCT02776683|584867865|FG000|Post-switch Period|Physician Decision|0|||
161949750|NCT02776683|584867866|FG001|Post-switch Period|Physician Decision|3|||
161949751|NCT02776683|584867865|FG000|Post-switch Period|Progressive disease|0|||
161949752|NCT02776683|584867866|FG001|Post-switch Period|Progressive disease|20|||
161949753|NCT02776683|584867865|FG000|Post-switch Period|Other than listed|0|||
161949754|NCT02776683|584867866|FG001|Post-switch Period|Other than listed|15|||
161949755|NCT01023217|584867870|FG000|Overall Study|Withdrawal by Subject|1|||
161949756|NCT01023217|584867871|FG001|Overall Study|Withdrawal by Subject|0|||
161949757|NCT02216526|584867872|FG000|Overall Study|Adverse Event|1|||
161949758|NCT02216526|584867873|FG001|Overall Study|Adverse Event|1|||
161949759|NCT02216526|584867874|FG002|Overall Study|Adverse Event|0|||
161949760|NCT02216526|584867872|FG000|Overall Study|Death|0|||
161949761|NCT02216526|584867873|FG001|Overall Study|Death|1|||
161949762|NCT02216526|584867874|FG002|Overall Study|Death|3|||
161949763|NCT02216526|584867872|FG000|Overall Study|Protocol Violation|2|||
161949764|NCT02216526|584867873|FG001|Overall Study|Protocol Violation|0|||
161949765|NCT02216526|584867874|FG002|Overall Study|Protocol Violation|2|||
161949766|NCT02216526|584867872|FG000|Overall Study|Hospitalization|2|||
161949767|NCT02216526|584867873|FG001|Overall Study|Hospitalization|1|||
161949768|NCT02216526|584867874|FG002|Overall Study|Hospitalization|3|||
161949769|NCT04103450|584867877|FG000|Overall Study|Adverse Event|4|||
161949770|NCT04103450|584867878|FG001|Overall Study|Adverse Event|2|||
161949771|NCT04103450|584867877|FG000|Overall Study|Lack of Efficacy|3|||
161949772|NCT04103450|584867878|FG001|Overall Study|Lack of Efficacy|0|||
161949773|NCT04103450|584867877|FG000|Overall Study|Withdrawal by Subject|5|||
161949774|NCT04103450|584867878|FG001|Overall Study|Withdrawal by Subject|3|||
161949775|NCT04103450|584867877|FG000|Overall Study|Lost to Follow-up|1|||
161949776|NCT04103450|584867878|FG001|Overall Study|Lost to Follow-up|2|||
161949777|NCT04103450|584867877|FG000|Overall Study|Physician Decision|1|||
161949778|NCT04103450|584867878|FG001|Overall Study|Physician Decision|2|||
161949779|NCT04103450|584867877|FG000|Overall Study|Protocol Violation|1|||
161949780|NCT04103450|584867878|FG001|Overall Study|Protocol Violation|0|||
161685381|NCT00783094|583901857|FG001|Open-Label Extension Period|Protocol Violation|5|||
161949781|NCT04103450|584867877|FG000|Overall Study|Other|1|||
161949782|NCT04103450|584867878|FG001|Overall Study|Other|1|||
162028676|NCT02478398|585161786|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
162028677|NCT02478398|585161785|FG000|Overall Study|Withdrawal By Participant|10|||
162028678|NCT02478398|585161786|FG001|Overall Study|Withdrawal By Participant|4|||
162028679|NCT01475071|585161790|FG000|Overall Study|Physician Decision|1|||
162028680|NCT01475071|585161790|FG000|Overall Study|Withdrawal by Subject|6|||
162028681|NCT01475071|585161790|FG000|Overall Study|Lost to Follow-up|1|||
162028682|NCT01205581|585161794|FG000|Overall Study|Withdrawal by Subject|1|||
162028683|NCT01205581|585161795|FG001|Overall Study|Withdrawal by Subject|0|||
161685382|NCT00783094|583901858|FG002|Open-Label Extension Period|Protocol Violation|7|||
161685383|NCT00783094|583901856|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
161685384|NCT00783094|583901857|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
161685385|NCT00783094|583901858|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
161685386|NCT00783094|583901856|FG000|Open-Label Extension Period|Physician Decision|4|||
161685387|NCT00783094|583901857|FG001|Open-Label Extension Period|Physician Decision|2|||
161685388|NCT00783094|583901858|FG002|Open-Label Extension Period|Physician Decision|3|||
161685389|NCT00783094|583901856|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
161685390|NCT00783094|583901857|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
161685391|NCT00783094|583901858|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
161685392|NCT01324232|583901859|FG000|Overall Study|Protocol Violation|0|||
161685393|NCT01324232|583901860|FG001|Overall Study|Protocol Violation|0|||
161949783|NCT00696878|584867879|FG000|Overall Study|Adverse Event|8|||
161949784|NCT00696878|584867879|FG000|Overall Study|Withdrawal by Subject|87|||
161949785|NCT00696878|584867879|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
161949786|NCT00696878|584867879|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
161949787|NCT00696878|584867879|FG000|Overall Study|Trial stopped|32|||
161949788|NCT00696878|584867879|FG000|Overall Study|Other reason (not specified)|55|||
161949789|NCT02230189|584867885|FG000|Overall Study|Withdrawal by Subject|3|||
161949790|NCT02230189|584867886|FG001|Overall Study|Withdrawal by Subject|0|||
161949791|NCT02230189|584867887|FG002|Overall Study|Withdrawal by Subject|1|||
161949792|NCT02230189|584867885|FG000|Overall Study|Lost to Follow-up|1|||
161949793|NCT02230189|584867886|FG001|Overall Study|Lost to Follow-up|0|||
161949794|NCT02230189|584867887|FG002|Overall Study|Lost to Follow-up|0|||
161949795|NCT02230189|584867885|FG000|Overall Study|Physician Decision|1|||
161949796|NCT02230189|584867886|FG001|Overall Study|Physician Decision|0|||
161949797|NCT02230189|584867887|FG002|Overall Study|Physician Decision|0|||
161949798|NCT03824392|584867888|FG000|Overall Study|Adverse Event|1|||
161949799|NCT03824392|584867889|FG001|Overall Study|Adverse Event|0|||
161949800|NCT03824392|584867890|FG002|Overall Study|Adverse Event|0|||
161949801|NCT03824392|584867891|FG003|Overall Study|Adverse Event|0|||
161949802|NCT03824392|584867888|FG000|Overall Study|Investigator Decision|0|||
161949803|NCT03824392|584867889|FG001|Overall Study|Investigator Decision|1|||
161949804|NCT03824392|584867890|FG002|Overall Study|Investigator Decision|0|||
161949805|NCT03824392|584867891|FG003|Overall Study|Investigator Decision|0|||
161949806|NCT03824392|584867888|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
161949807|NCT03824392|584867889|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
161949808|NCT03824392|584867890|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
161949809|NCT03824392|584867891|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
161949810|NCT00967616|584867892|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
161949811|NCT00967616|584867893|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
161949812|NCT00967616|584867892|FG000|Overall Study|Death|0|||
161949813|NCT00967616|584867893|FG001|Overall Study|Death|3|||
161949814|NCT00967616|584867892|FG000|Overall Study|Withdrawal by Subject|8|||
162028684|NCT01205581|585161796|FG002|Overall Study|Withdrawal by Subject|0|||
162028685|NCT01205581|585161797|FG003|Overall Study|Withdrawal by Subject|0|||
162028686|NCT01205581|585161798|FG004|Overall Study|Withdrawal by Subject|0|||
161685394|NCT01324232|583901861|FG002|Overall Study|Protocol Violation|0|||
161685395|NCT01324232|583901862|FG003|Overall Study|Protocol Violation|2|||
161685396|NCT01324232|583901859|FG000|Overall Study|Missing|0|||
161685397|NCT01324232|583901860|FG001|Overall Study|Missing|0|||
161949815|NCT00967616|584867893|FG001|Overall Study|Withdrawal by Subject|4|||
161949816|NCT00967616|584867892|FG000|Overall Study|Progressive Disease|31|||
161685398|NCT01324232|583901861|FG002|Overall Study|Missing|1|||
161949817|NCT00967616|584867893|FG001|Overall Study|Progressive Disease|18|||
161949818|NCT00967616|584867892|FG000|Overall Study|Other|8|||
161949819|NCT00967616|584867893|FG001|Overall Study|Other|8|||
161949820|NCT00967616|584867892|FG000|Overall Study|Protocol Violation|1|||
161949821|NCT00967616|584867893|FG001|Overall Study|Protocol Violation|0|||
161949822|NCT01847755|584867894|FG000|Overall Study|Adverse Event|2|||
161949823|NCT01847755|584867894|FG000|Overall Study|Withdrawal by Subject|2|||
162028687|NCT01205581|585161799|FG005|Overall Study|Withdrawal by Subject|0|||
161685399|NCT01324232|583901862|FG003|Overall Study|Missing|0|||
161685400|NCT01324232|583901859|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
161685401|NCT01324232|583901860|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
161685402|NCT01324232|583901861|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
161949824|NCT01847755|584867894|FG000|Overall Study|Physician Decision|1|||
161949825|NCT03188263|584867904|FG000|Overall Study|Withdrawal by Subject|3|||
162028688|NCT01238588|585161813|FG000|Overall Study|Withdrawal by Subject|1|||
162028689|NCT01238588|585161813|FG000|Overall Study|Physician Decision|2|||
161685403|NCT01324232|583901862|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
161833498|NCT03861481|584433161|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
162028690|NCT05395091|585161816|FG000|Baseline to Month 12|Adverse Event|7|||
162028691|NCT05395091|585161817|FG001|Baseline to Month 12|Adverse Event|2|||
162028692|NCT05395091|585161818|FG002|Baseline to Month 12|Adverse Event|0|||
162028693|NCT05395091|585161816|FG000|Baseline to Month 12|Death|3|||
161833499|NCT03861481|584433162|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
161833500|NCT03861481|584433161|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
161685404|NCT01324232|583901859|FG000|Overall Study|Lack of Efficacy|2|||
161833501|NCT03861481|584433162|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
161949826|NCT03188263|584867905|FG001|Overall Study|Withdrawal by Subject|0|||
161949827|NCT03188263|584867904|FG000|Overall Study|Physician Decision|1|||
161949828|NCT03188263|584867905|FG001|Overall Study|Physician Decision|0|||
161949829|NCT00699413|584867906|FG000|Overall Study|Withdrawal by Subject|0|||
161949830|NCT00699413|584867907|FG001|Overall Study|Withdrawal by Subject|2|||
161949831|NCT00699413|584867906|FG000|Overall Study|Study terminated by sponsor|4|||
161949832|NCT00699413|584867907|FG001|Overall Study|Study terminated by sponsor|2|||
161949833|NCT02779777|584867908|FG000|Overall Study|Disease Progression|1|||
161949834|NCT02779777|584867909|FG001|Overall Study|Disease Progression|0|||
161949835|NCT02779777|584867910|FG002|Overall Study|Disease Progression|0|||
161949836|NCT02779777|584867908|FG000|Overall Study|Adverse Event|3|||
161949837|NCT02779777|584867909|FG001|Overall Study|Adverse Event|1|||
161949838|NCT02779777|584867910|FG002|Overall Study|Adverse Event|0|||
161949839|NCT02779777|584867908|FG000|Overall Study|Physician Decision|9|||
161949840|NCT02779777|584867909|FG001|Overall Study|Physician Decision|0|||
161949841|NCT02779777|584867910|FG002|Overall Study|Physician Decision|1|||
161949842|NCT02779777|584867908|FG000|Overall Study|Withdrawal by Subject|1|||
161949843|NCT02779777|584867909|FG001|Overall Study|Withdrawal by Subject|0|||
161949844|NCT02779777|584867910|FG002|Overall Study|Withdrawal by Subject|0|||
161949845|NCT01030822|584867911|FG000|Overall Study|Moved/migrated from study area|6|||
161949846|NCT01030822|584867912|FG001|Overall Study|Moved/migrated from study area|7|||
161949847|NCT01030822|584867913|FG002|Overall Study|Moved/migrated from study area|3|||
161949848|NCT01030822|584867911|FG000|Overall Study|Withdrawal by Subject|16|||
161949849|NCT01030822|584867912|FG001|Overall Study|Withdrawal by Subject|13|||
161949850|NCT01030822|584867913|FG002|Overall Study|Withdrawal by Subject|16|||
161949851|NCT01030822|584867911|FG000|Overall Study|Lost to Follow-up|9|||
161949852|NCT01030822|584867912|FG001|Overall Study|Lost to Follow-up|4|||
161949853|NCT01030822|584867913|FG002|Overall Study|Lost to Follow-up|7|||
161949854|NCT00120627|584867919|FG000|Overall Study|Withdrawal by Subject|5|||
161949855|NCT00120627|584867920|FG001|Overall Study|Withdrawal by Subject|5|||
161949856|NCT01261975|584867923|FG000|Overall Study|Surgical complication|1|||
161949857|NCT01932788|584867924|FG000|Overall Study|Protocol Violation|18|||
161949858|NCT01932788|584867925|FG001|Overall Study|Protocol Violation|0|||
161949859|NCT01932788|584867924|FG000|Overall Study|Lost to Follow-up|18|||
161949860|NCT01932788|584867925|FG001|Overall Study|Lost to Follow-up|46|||
161949861|NCT01932788|584867924|FG000|Overall Study|Lack of Efficacy|2|||
161949862|NCT01932788|584867925|FG001|Overall Study|Lack of Efficacy|0|||
161949863|NCT01932788|584867924|FG000|Overall Study|Withdrawal by Subject|0|||
161949864|NCT01932788|584867925|FG001|Overall Study|Withdrawal by Subject|5|||
161949865|NCT04290624|584867926|FG000|Overall Study|Adverse Event|1|||
161949866|NCT04290624|584867927|FG001|Overall Study|Adverse Event|0|||
161949867|NCT01171677|584867928|FG000|Overall Study|Withdrawal by Subject|0|||
161949868|NCT01171677|584867929|FG001|Overall Study|Withdrawal by Subject|3|||
161949869|NCT01171677|584867928|FG000|Overall Study|Adverse Event|1|||
161949870|NCT01171677|584867929|FG001|Overall Study|Adverse Event|0|||
161949871|NCT01171677|584867928|FG000|Overall Study|completed <70% IntenSati classes|5|||
161949872|NCT01171677|584867929|FG001|Overall Study|completed <70% IntenSati classes|0|||
161949873|NCT00656370|584867932|FG000|Overall Study|Screen Failures|7|||
161949874|NCT00656370|584867932|FG000|Overall Study|Alternates|3|||
161949875|NCT04021290|584867939|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
161949876|NCT04021290|584867940|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
161949877|NCT04021290|584867941|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
161949878|NCT04021290|584867939|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
161949879|NCT04021290|584867940|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
161949880|NCT04021290|584867941|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
161949881|NCT04021290|584867939|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
161949882|NCT04021290|584867940|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
161949883|NCT04021290|584867941|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
161949884|NCT04021290|584867939|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
161949885|NCT04021290|584867940|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
161949886|NCT04021290|584867941|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
161949887|NCT04021290|584867939|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
161949888|NCT04021290|584867940|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
161949889|NCT04021290|584867941|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
161949890|NCT04021290|584867939|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
161949891|NCT04021290|584867940|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
161949892|NCT04021290|584867941|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
161949893|NCT04021290|584867939|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
161949894|NCT04021290|584867940|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
161949895|NCT04021290|584867941|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
161949896|NCT04021290|584867939|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
161949897|NCT04021290|584867940|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
161949898|NCT04021290|584867941|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
161949899|NCT04021290|584867939|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
161949900|NCT04021290|584867940|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
161949901|NCT04021290|584867941|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
161949902|NCT04021290|584867939|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
161949903|NCT04021290|584867940|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
161949904|NCT04021290|584867941|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
161949905|NCT04021290|584867939|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
161949906|NCT04021290|584867940|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
161949907|NCT04021290|584867941|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
161949908|NCT04021290|584867939|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
161949909|NCT04021290|584867940|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
161949910|NCT04021290|584867941|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
161949911|NCT03391882|584867942|FG000|Study Overall|Adverse Event|3|||
161949912|NCT03391882|584867943|FG001|Study Overall|Adverse Event|6|||
161949913|NCT03391882|584867944|FG002|Study Overall|Adverse Event|1|||
161949914|NCT03391882|584867945|FG003|Study Overall|Adverse Event|1|||
161949915|NCT03391882|584867946|FG004|Study Overall|Adverse Event|3|||
161949916|NCT03391882|584867947|FG005|Study Overall|Adverse Event|1|||
161949917|NCT03391882|584867942|FG000|Study Overall|Lack of Efficacy|13|||
161949918|NCT03391882|584867943|FG001|Study Overall|Lack of Efficacy|9|||
161949919|NCT03391882|584867944|FG002|Study Overall|Lack of Efficacy|0|||
161949920|NCT03391882|584867945|FG003|Study Overall|Lack of Efficacy|0|||
161949921|NCT03391882|584867946|FG004|Study Overall|Lack of Efficacy|0|||
161949922|NCT03391882|584867947|FG005|Study Overall|Lack of Efficacy|0|||
161685405|NCT01324232|583901860|FG001|Overall Study|Lack of Efficacy|1|||
161685406|NCT01324232|583901861|FG002|Overall Study|Lack of Efficacy|2|||
161685407|NCT01324232|583901862|FG003|Overall Study|Lack of Efficacy|2|||
161685408|NCT01324232|583901859|FG000|Overall Study|Participant Refused Medication|0|||
161949923|NCT03391882|584867942|FG000|Study Overall|Withdrawal by Subject|3|||
161949924|NCT03391882|584867943|FG001|Study Overall|Withdrawal by Subject|3|||
161685409|NCT01324232|583901860|FG001|Overall Study|Participant Refused Medication|1|||
161685410|NCT01324232|583901861|FG002|Overall Study|Participant Refused Medication|0|||
161685411|NCT01324232|583901862|FG003|Overall Study|Participant Refused Medication|0|||
161685412|NCT01324232|583901859|FG000|Overall Study|Intercurrent illness|0|||
161685413|NCT01324232|583901860|FG001|Overall Study|Intercurrent illness|0|||
161833502|NCT03861481|584433161|FG000|Overall Study|Relapse|1|||
161833503|NCT03861481|584433162|FG001|Overall Study|Relapse|0|||
161833504|NCT03861481|584433161|FG000|Overall Study|Withdrawal by Subject|0|||
161833505|NCT03861481|584433162|FG001|Overall Study|Withdrawal by Subject|1|||
161833506|NCT03861481|584433161|FG000|Overall Study|Lack of Efficacy|4|||
161833507|NCT03861481|584433162|FG001|Overall Study|Lack of Efficacy|5|||
161833508|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
161833509|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
161833510|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
161833511|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
161833512|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
161833513|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
161833514|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
161685414|NCT01324232|583901861|FG002|Overall Study|Intercurrent illness|0|||
161685415|NCT01324232|583901862|FG003|Overall Study|Intercurrent illness|1|||
161833515|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
161833516|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
161833517|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
161833518|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
161833519|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
161833520|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
161833521|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
161833522|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
161833523|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
161833524|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
161833525|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
161833526|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
161833527|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161833528|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161833529|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161833530|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161833531|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161833532|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
161833533|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
161833534|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
161833535|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
161833536|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
161833537|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
161833538|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
161833539|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
161833540|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
161833541|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
161833542|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
161833543|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
161833544|NCT00773734|584433163|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
161833545|NCT00773734|584433164|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
161833546|NCT00773734|584433165|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
161833547|NCT00773734|584433166|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
161833548|NCT00773734|584433167|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
161833549|NCT00773734|584433168|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
161833550|NCT00773734|584433163|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
161833551|NCT00773734|584433164|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
161833552|NCT00773734|584433165|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
161833553|NCT00773734|584433166|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
161833554|NCT00773734|584433167|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
161833555|NCT00773734|584433168|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
161833556|NCT00773734|584433163|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
161833557|NCT00773734|584433164|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
161833558|NCT00773734|584433165|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
161833559|NCT00773734|584433166|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
161833560|NCT00773734|584433167|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
161833561|NCT00773734|584433168|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
161833562|NCT00773734|584433163|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
161833563|NCT00773734|584433164|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
161833564|NCT00773734|584433165|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
161833565|NCT00773734|584433166|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
161833566|NCT00773734|584433167|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
161833567|NCT00773734|584433168|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
161833568|NCT00773734|584433163|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
161949925|NCT03391882|584867944|FG002|Study Overall|Withdrawal by Subject|2|||
161949926|NCT03391882|584867945|FG003|Study Overall|Withdrawal by Subject|2|||
161949927|NCT03391882|584867946|FG004|Study Overall|Withdrawal by Subject|1|||
161949928|NCT03391882|584867947|FG005|Study Overall|Withdrawal by Subject|3|||
161949929|NCT03391882|584867942|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
161949930|NCT03391882|584867943|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
161949931|NCT03391882|584867944|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
161949932|NCT03391882|584867945|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
161949933|NCT03391882|584867946|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
161949934|NCT03391882|584867947|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
161949935|NCT03391882|584867942|FG000|Study Overall|Protocol Violation|1|||
161949936|NCT03391882|584867943|FG001|Study Overall|Protocol Violation|0|||
161949937|NCT03391882|584867944|FG002|Study Overall|Protocol Violation|0|||
161949938|NCT03391882|584867945|FG003|Study Overall|Protocol Violation|0|||
161949939|NCT03391882|584867946|FG004|Study Overall|Protocol Violation|0|||
161949940|NCT03391882|584867947|FG005|Study Overall|Protocol Violation|0|||
161949941|NCT03391882|584867942|FG000|Part A - Titration Phase|Adverse Event|3|||
161949942|NCT03391882|584867943|FG001|Part A - Titration Phase|Adverse Event|6|||
161949943|NCT03391882|584867944|FG002|Part A - Titration Phase|Adverse Event|0|||
161949944|NCT03391882|584867945|FG003|Part A - Titration Phase|Adverse Event|0|||
161949945|NCT03391882|584867946|FG004|Part A - Titration Phase|Adverse Event|0|||
161949946|NCT03391882|584867947|FG005|Part A - Titration Phase|Adverse Event|0|||
161949947|NCT03391882|584867942|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
161949948|NCT03391882|584867943|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
161949949|NCT03391882|584867944|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
161949950|NCT03391882|584867945|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
161949951|NCT03391882|584867946|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
161949952|NCT03391882|584867947|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
161949953|NCT03391882|584867942|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
161949954|NCT03391882|584867943|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
161949955|NCT03391882|584867944|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
161949956|NCT03391882|584867945|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
161949957|NCT03391882|584867946|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
161949958|NCT03391882|584867947|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
161949959|NCT03391882|584867942|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
161949960|NCT03391882|584867943|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
161949961|NCT03391882|584867944|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
161949962|NCT03391882|584867945|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
161949963|NCT03391882|584867946|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
161949964|NCT03391882|584867947|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
161949965|NCT03391882|584867942|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
161949966|NCT03391882|584867943|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
161949967|NCT03391882|584867944|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
161949968|NCT03391882|584867945|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
161949969|NCT03391882|584867946|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
161949970|NCT03391882|584867947|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
161949971|NCT03391882|584867942|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
161949972|NCT03391882|584867943|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
161949973|NCT03391882|584867944|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
161949974|NCT03391882|584867945|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
161949975|NCT03391882|584867946|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
161949976|NCT03391882|584867947|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
161949977|NCT03391882|584867942|FG000|Part B - Treatment Phase|Adverse Event|0|||
161949978|NCT03391882|584867943|FG001|Part B - Treatment Phase|Adverse Event|0|||
161949979|NCT03391882|584867944|FG002|Part B - Treatment Phase|Adverse Event|1|||
161949980|NCT03391882|584867945|FG003|Part B - Treatment Phase|Adverse Event|1|||
161949981|NCT03391882|584867946|FG004|Part B - Treatment Phase|Adverse Event|3|||
161949982|NCT03391882|584867947|FG005|Part B - Treatment Phase|Adverse Event|1|||
161949983|NCT03391882|584867942|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
161949984|NCT03391882|584867943|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
161949985|NCT03391882|584867944|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
161949986|NCT03391882|584867945|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
161949987|NCT03391882|584867946|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
161949988|NCT03391882|584867947|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
161949989|NCT03092479|584867948|FG000|Overall Study|Lost to Follow-up|3|||
161685416|NCT01324232|583901859|FG000|Overall Study|Adverse Event|2|||
161949990|NCT03092479|584867949|FG001|Overall Study|Lost to Follow-up|2|||
161949991|NCT03092479|584867948|FG000|Overall Study|Withdrawal by Subject|4|||
161949992|NCT03092479|584867949|FG001|Overall Study|Withdrawal by Subject|0|||
161949993|NCT04790279|584870366|FG000|Overall Study|Did not meet medication start criteria|27|||
161949994|NCT04790279|584870367|FG001|Overall Study|Did not meet medication start criteria|15|||
162028694|NCT05395091|585161817|FG001|Baseline to Month 12|Death|1|||
161833569|NCT00773734|584433164|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
161833570|NCT00773734|584433165|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
161833571|NCT00773734|584433166|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
161833572|NCT00773734|584433167|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
161833573|NCT00773734|584433168|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
161833574|NCT00773734|584433163|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
161833575|NCT00773734|584433164|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
161833576|NCT00773734|584433165|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
161833577|NCT00773734|584433166|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
161833578|NCT00773734|584433167|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
161833579|NCT00773734|584433168|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
161833580|NCT00773734|584433163|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
161833581|NCT00773734|584433164|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
161833582|NCT00773734|584433165|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
161833583|NCT00773734|584433166|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
161833584|NCT00773734|584433167|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
161833585|NCT00773734|584433168|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
161833586|NCT00773734|584433163|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
161833587|NCT00773734|584433164|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
161833588|NCT00773734|584433165|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
161833589|NCT00773734|584433166|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
161833590|NCT00773734|584433167|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
161833591|NCT00773734|584433168|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
161833592|NCT00773734|584433163|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
161833593|NCT00773734|584433164|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
161833594|NCT00773734|584433165|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
161833595|NCT00773734|584433166|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
161833596|NCT00773734|584433167|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
161833597|NCT00773734|584433168|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
161833598|NCT00773734|584433163|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
161833599|NCT00773734|584433164|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
161833600|NCT00773734|584433165|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
161833601|NCT00773734|584433166|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
161833602|NCT00773734|584433167|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
161833603|NCT00773734|584433168|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
161833604|NCT00773734|584433163|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
161833605|NCT00773734|584433164|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
162028695|NCT05395091|585161818|FG002|Baseline to Month 12|Death|0|||
161685417|NCT01324232|583901860|FG001|Overall Study|Adverse Event|5|||
161685418|NCT01324232|583901861|FG002|Overall Study|Adverse Event|6|||
161685419|NCT01324232|583901862|FG003|Overall Study|Adverse Event|6|||
161685420|NCT01324232|583901859|FG000|Overall Study|Withdrawal by Subject|0|||
161685421|NCT01324232|583901860|FG001|Overall Study|Withdrawal by Subject|3|||
161685422|NCT01324232|583901861|FG002|Overall Study|Withdrawal by Subject|4|||
161949995|NCT04790279|584870366|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
161949996|NCT04790279|584870367|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
161949997|NCT04790279|584870366|FG000|Overall Study|Protocol Violation|8|||
161949998|NCT04790279|584870367|FG001|Overall Study|Protocol Violation|3|||
161949999|NCT04790279|584870366|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
161950000|NCT04790279|584870367|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
161950001|NCT01713582|584870368|FG000|Overall Study|Disease progression|3|||
161950002|NCT01713582|584870369|FG001|Overall Study|Disease progression|3|||
161950003|NCT01713582|584870370|FG002|Overall Study|Disease progression|3|||
161950004|NCT01713582|584870371|FG003|Overall Study|Disease progression|2|||
161950005|NCT01713582|584870372|FG004|Overall Study|Disease progression|3|||
161950006|NCT01713582|584870373|FG005|Overall Study|Disease progression|3|||
161950007|NCT01713582|584870374|FG006|Overall Study|Disease progression|3|||
161950008|NCT01713582|584870375|FG007|Overall Study|Disease progression|3|||
161950009|NCT01713582|584870376|FG008|Overall Study|Disease progression|3|||
161950010|NCT01713582|584870377|FG009|Overall Study|Disease progression|11|||
161950011|NCT01713582|584870378|FG010|Overall Study|Disease progression|10|||
161950012|NCT01713582|584870379|FG011|Overall Study|Disease progression|5|||
161950013|NCT01713582|584870380|FG012|Overall Study|Disease progression|3|||
161950014|NCT01713582|584870381|FG013|Overall Study|Disease progression|3|||
161950015|NCT01713582|584870382|FG014|Overall Study|Disease progression|6|||
161685423|NCT01324232|583901862|FG003|Overall Study|Withdrawal by Subject|0|||
161685424|NCT01324232|583901859|FG000|Overall Study|Lost to Follow-up|1|||
161685425|NCT01324232|583901860|FG001|Overall Study|Lost to Follow-up|0|||
161685426|NCT01324232|583901861|FG002|Overall Study|Lost to Follow-up|0|||
161685427|NCT01324232|583901862|FG003|Overall Study|Lost to Follow-up|0|||
161685428|NCT02513329|583901863|FG000|Overall Study|Lost to Follow-up|5|||
161685429|NCT02513329|583901864|FG001|Overall Study|Lost to Follow-up|2|||
161685430|NCT05440539|583901865|FG000|Overall Study|Lost to Follow-up|4|||
161685431|NCT05440539|583901866|FG001|Overall Study|Lost to Follow-up|4|||
161685432|NCT05440539|583901865|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
161685433|NCT05440539|583901866|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
161685434|NCT01265615|583901867|FG000|Overall Study|Protocol Violation|2|||
161685435|NCT01265615|583901868|FG001|Overall Study|Protocol Violation|2|||
161685436|NCT01265615|583901869|FG002|Overall Study|Protocol Violation|4|||
161685437|NCT01265615|583901870|FG003|Overall Study|Protocol Violation|3|||
161685438|NCT01732796|583901871|FG000|Overall Study|Adverse Event|16|||
161685439|NCT01732796|583901872|FG001|Overall Study|Adverse Event|16|||
161685440|NCT01732796|583901873|FG002|Overall Study|Adverse Event|4|||
161685441|NCT01732796|583901871|FG000|Overall Study|Lack of Efficacy|21|||
161685442|NCT01732796|583901872|FG001|Overall Study|Lack of Efficacy|18|||
161950016|NCT01713582|584870383|FG015|Overall Study|Disease progression|6|||
161950017|NCT01713582|584870384|FG016|Overall Study|Disease progression|5|||
161950018|NCT01713582|584870385|FG017|Overall Study|Disease progression|2|||
161950019|NCT01713582|584870386|FG018|Overall Study|Disease progression|3|||
161950020|NCT01713582|584870387|FG019|Overall Study|Disease progression|5|||
161950021|NCT01713582|584870388|FG020|Overall Study|Disease progression|15|||
161950022|NCT01713582|584870368|FG000|Overall Study|Death|0|||
161950023|NCT01713582|584870369|FG001|Overall Study|Death|0|||
161950024|NCT01713582|584870370|FG002|Overall Study|Death|0|||
161950025|NCT01713582|584870371|FG003|Overall Study|Death|1|||
161950026|NCT01713582|584870372|FG004|Overall Study|Death|1|||
161950027|NCT01713582|584870373|FG005|Overall Study|Death|3|||
161950028|NCT01713582|584870374|FG006|Overall Study|Death|3|||
161950029|NCT01713582|584870375|FG007|Overall Study|Death|2|||
161950030|NCT01713582|584870376|FG008|Overall Study|Death|3|||
161950031|NCT01713582|584870377|FG009|Overall Study|Death|4|||
161950032|NCT01713582|584870378|FG010|Overall Study|Death|3|||
161950033|NCT01713582|584870379|FG011|Overall Study|Death|0|||
161950034|NCT01713582|584870380|FG012|Overall Study|Death|0|||
161950035|NCT01713582|584870381|FG013|Overall Study|Death|0|||
161950036|NCT01713582|584870382|FG014|Overall Study|Death|0|||
161950037|NCT01713582|584870383|FG015|Overall Study|Death|0|||
161950038|NCT01713582|584870384|FG016|Overall Study|Death|0|||
161685443|NCT01732796|583901873|FG002|Overall Study|Lack of Efficacy|5|||
161685444|NCT01732796|583901871|FG000|Overall Study|Lost to Follow-up|2|||
161950039|NCT01713582|584870385|FG017|Overall Study|Death|0|||
161950040|NCT01713582|584870386|FG018|Overall Study|Death|0|||
161950041|NCT01713582|584870387|FG019|Overall Study|Death|0|||
161950042|NCT01713582|584870388|FG020|Overall Study|Death|0|||
161950043|NCT01713582|584870368|FG000|Overall Study|Adverse event-related|0|||
161950044|NCT01713582|584870369|FG001|Overall Study|Adverse event-related|0|||
161950045|NCT01713582|584870370|FG002|Overall Study|Adverse event-related|0|||
161685445|NCT01732796|583901872|FG001|Overall Study|Lost to Follow-up|0|||
161950046|NCT01713582|584870371|FG003|Overall Study|Adverse event-related|0|||
161950047|NCT01713582|584870372|FG004|Overall Study|Adverse event-related|0|||
161685446|NCT01732796|583901873|FG002|Overall Study|Lost to Follow-up|0|||
161685447|NCT01732796|583901871|FG000|Overall Study|Withdrawal by Subject|6|||
161950048|NCT01713582|584870373|FG005|Overall Study|Adverse event-related|0|||
161950049|NCT01713582|584870374|FG006|Overall Study|Adverse event-related|0|||
161950050|NCT01713582|584870375|FG007|Overall Study|Adverse event-related|0|||
161950051|NCT01713582|584870376|FG008|Overall Study|Adverse event-related|0|||
161950052|NCT01713582|584870377|FG009|Overall Study|Adverse event-related|1|||
161950053|NCT01713582|584870378|FG010|Overall Study|Adverse event-related|1|||
161950054|NCT01713582|584870379|FG011|Overall Study|Adverse event-related|0|||
161950055|NCT01713582|584870380|FG012|Overall Study|Adverse event-related|0|||
161950056|NCT01713582|584870381|FG013|Overall Study|Adverse event-related|0|||
161950057|NCT01713582|584870382|FG014|Overall Study|Adverse event-related|0|||
161833606|NCT00773734|584433165|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
161950058|NCT01713582|584870383|FG015|Overall Study|Adverse event-related|0|||
161950059|NCT01713582|584870384|FG016|Overall Study|Adverse event-related|0|||
161950060|NCT01713582|584870385|FG017|Overall Study|Adverse event-related|0|||
161950061|NCT01713582|584870386|FG018|Overall Study|Adverse event-related|1|||
161950062|NCT01713582|584870387|FG019|Overall Study|Adverse event-related|0|||
161950063|NCT01713582|584870388|FG020|Overall Study|Adverse event-related|0|||
161950064|NCT01713582|584870368|FG000|Overall Study|Adverse event-unrelated|0|||
161950065|NCT01713582|584870369|FG001|Overall Study|Adverse event-unrelated|0|||
161950066|NCT01713582|584870370|FG002|Overall Study|Adverse event-unrelated|0|||
161950067|NCT01713582|584870371|FG003|Overall Study|Adverse event-unrelated|0|||
161950068|NCT01713582|584870372|FG004|Overall Study|Adverse event-unrelated|0|||
161950069|NCT01713582|584870373|FG005|Overall Study|Adverse event-unrelated|1|||
161950070|NCT01713582|584870374|FG006|Overall Study|Adverse event-unrelated|1|||
161950071|NCT01713582|584870375|FG007|Overall Study|Adverse event-unrelated|1|||
161950072|NCT01713582|584870376|FG008|Overall Study|Adverse event-unrelated|0|||
161950073|NCT01713582|584870377|FG009|Overall Study|Adverse event-unrelated|0|||
161950074|NCT01713582|584870378|FG010|Overall Study|Adverse event-unrelated|0|||
161950075|NCT01713582|584870379|FG011|Overall Study|Adverse event-unrelated|0|||
161950076|NCT01713582|584870380|FG012|Overall Study|Adverse event-unrelated|0|||
161950077|NCT01713582|584870381|FG013|Overall Study|Adverse event-unrelated|1|||
161950078|NCT01713582|584870382|FG014|Overall Study|Adverse event-unrelated|1|||
161950079|NCT01713582|584870383|FG015|Overall Study|Adverse event-unrelated|0|||
161950080|NCT01713582|584870384|FG016|Overall Study|Adverse event-unrelated|0|||
161950081|NCT01713582|584870385|FG017|Overall Study|Adverse event-unrelated|0|||
161950082|NCT01713582|584870386|FG018|Overall Study|Adverse event-unrelated|0|||
161950083|NCT01713582|584870387|FG019|Overall Study|Adverse event-unrelated|0|||
161950084|NCT01713582|584870388|FG020|Overall Study|Adverse event-unrelated|0|||
161950085|NCT01713582|584870368|FG000|Overall Study|Withdrawal of consent|0|||
161950086|NCT01713582|584870369|FG001|Overall Study|Withdrawal of consent|0|||
161950087|NCT01713582|584870370|FG002|Overall Study|Withdrawal of consent|1|||
161950088|NCT01713582|584870371|FG003|Overall Study|Withdrawal of consent|0|||
161685448|NCT01732796|583901872|FG001|Overall Study|Withdrawal by Subject|8|||
161685449|NCT01732796|583901873|FG002|Overall Study|Withdrawal by Subject|2|||
161685450|NCT01732796|583901871|FG000|Overall Study|Other reason not defined above|1|||
161685451|NCT01732796|583901872|FG001|Overall Study|Other reason not defined above|0|||
161685452|NCT01732796|583901873|FG002|Overall Study|Other reason not defined above|2|||
161685453|NCT00876187|583901875|FG000|Overall Study|Adverse Event|14|||
161685454|NCT00876187|583901876|FG001|Overall Study|Adverse Event|12|||
161685455|NCT00876187|583901877|FG002|Overall Study|Adverse Event|19|||
161685456|NCT00876187|583901878|FG003|Overall Study|Adverse Event|29|||
161685457|NCT00876187|583901879|FG004|Overall Study|Adverse Event|10|||
161685458|NCT00876187|583901875|FG000|Overall Study|Lack of Efficacy|59|||
161685459|NCT00876187|583901876|FG001|Overall Study|Lack of Efficacy|34|||
161685460|NCT00876187|583901877|FG002|Overall Study|Lack of Efficacy|45|||
161685461|NCT00876187|583901878|FG003|Overall Study|Lack of Efficacy|34|||
161685462|NCT00876187|583901879|FG004|Overall Study|Lack of Efficacy|59|||
161685463|NCT00876187|583901875|FG000|Overall Study|Lost to Follow-up|9|||
161685464|NCT00876187|583901876|FG001|Overall Study|Lost to Follow-up|10|||
161950089|NCT01713582|584870372|FG004|Overall Study|Withdrawal of consent|0|||
161950090|NCT01713582|584870373|FG005|Overall Study|Withdrawal of consent|1|||
161950091|NCT01713582|584870374|FG006|Overall Study|Withdrawal of consent|0|||
161950092|NCT01713582|584870375|FG007|Overall Study|Withdrawal of consent|0|||
161950093|NCT01713582|584870376|FG008|Overall Study|Withdrawal of consent|0|||
161950094|NCT01713582|584870377|FG009|Overall Study|Withdrawal of consent|1|||
161950095|NCT01713582|584870378|FG010|Overall Study|Withdrawal of consent|0|||
161950096|NCT01713582|584870379|FG011|Overall Study|Withdrawal of consent|0|||
161685465|NCT00876187|583901877|FG002|Overall Study|Lost to Follow-up|8|||
161685466|NCT00876187|583901878|FG003|Overall Study|Lost to Follow-up|8|||
161685467|NCT00876187|583901879|FG004|Overall Study|Lost to Follow-up|11|||
161685468|NCT00876187|583901875|FG000|Overall Study|Protocol Violation|6|||
161833607|NCT00773734|584433166|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
161833608|NCT00773734|584433167|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
161685469|NCT00876187|583901876|FG001|Overall Study|Protocol Violation|7|||
161833609|NCT00773734|584433168|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
161833610|NCT00773734|584433163|FG000|Extension: Active Treatment Week 24-52|Other|0|||
161950097|NCT01713582|584870380|FG012|Overall Study|Withdrawal of consent|0|||
161950098|NCT01713582|584870381|FG013|Overall Study|Withdrawal of consent|0|||
161685470|NCT00876187|583901877|FG002|Overall Study|Protocol Violation|7|||
161685471|NCT00876187|583901878|FG003|Overall Study|Protocol Violation|6|||
161685472|NCT00876187|583901879|FG004|Overall Study|Protocol Violation|3|||
161685473|NCT00876187|583901875|FG000|Overall Study|Withdrawal by Subject|16|||
161685474|NCT00876187|583901876|FG001|Overall Study|Withdrawal by Subject|26|||
161685475|NCT00876187|583901877|FG002|Overall Study|Withdrawal by Subject|32|||
161685476|NCT00876187|583901878|FG003|Overall Study|Withdrawal by Subject|38|||
161685477|NCT00876187|583901879|FG004|Overall Study|Withdrawal by Subject|37|||
161685478|NCT00876187|583901875|FG000|Overall Study|Entered extension study|101|||
161685479|NCT00876187|583901876|FG001|Overall Study|Entered extension study|120|||
161685480|NCT00876187|583901877|FG002|Overall Study|Entered extension study|156|||
161685481|NCT00876187|583901878|FG003|Overall Study|Entered extension study|151|||
161685482|NCT00876187|583901879|FG004|Overall Study|Entered extension study|144|||
161685483|NCT00876187|583901875|FG000|Overall Study|Randomized but not treated|3|||
161685484|NCT00876187|583901876|FG001|Overall Study|Randomized but not treated|1|||
161685485|NCT00876187|583901877|FG002|Overall Study|Randomized but not treated|3|||
161685486|NCT00876187|583901878|FG003|Overall Study|Randomized but not treated|2|||
161685487|NCT00876187|583901879|FG004|Overall Study|Randomized but not treated|3|||
161685488|NCT00876187|583901875|FG000|Overall Study|Other|2|||
161685489|NCT00876187|583901876|FG001|Overall Study|Other|5|||
161685490|NCT00876187|583901877|FG002|Overall Study|Other|9|||
161685491|NCT00876187|583901878|FG003|Overall Study|Other|7|||
161685492|NCT00876187|583901879|FG004|Overall Study|Other|4|||
161685493|NCT03287219|583901883|FG000|Overall Study|Protocol Violation|0|||
161685494|NCT03287219|583901884|FG001|Overall Study|Protocol Violation|2|||
161685495|NCT00957008|583901885|FG000|Overall Study|Withdrawal by Subject|13|||
161685496|NCT00957008|583901886|FG001|Overall Study|Withdrawal by Subject|10|||
161685497|NCT00957008|583901887|FG002|Overall Study|Withdrawal by Subject|12|||
161685498|NCT00957008|583901888|FG003|Overall Study|Withdrawal by Subject|16|||
161685499|NCT00957008|583901885|FG000|Overall Study|Lost to Follow-up|3|||
161685500|NCT00957008|583901886|FG001|Overall Study|Lost to Follow-up|1|||
161685501|NCT00957008|583901887|FG002|Overall Study|Lost to Follow-up|3|||
161685502|NCT00957008|583901888|FG003|Overall Study|Lost to Follow-up|4|||
161685503|NCT00957008|583901885|FG000|Overall Study|Physician Decision|1|||
161685504|NCT00957008|583901886|FG001|Overall Study|Physician Decision|0|||
161685505|NCT00957008|583901887|FG002|Overall Study|Physician Decision|1|||
161685506|NCT00957008|583901888|FG003|Overall Study|Physician Decision|1|||
161685507|NCT00957008|583901885|FG000|Overall Study|Relocated; Family conflict|4|||
161685508|NCT00957008|583901886|FG001|Overall Study|Relocated; Family conflict|1|||
161685509|NCT00957008|583901887|FG002|Overall Study|Relocated; Family conflict|1|||
161685510|NCT00957008|583901888|FG003|Overall Study|Relocated; Family conflict|3|||
161685511|NCT03571646|583901896|FG000|Overall Study|Adverse Event|1|||
161685512|NCT03571646|583901897|FG001|Overall Study|Adverse Event|0|||
161685513|NCT03571646|583901896|FG000|Overall Study|Withdrawal by Subject|1|||
161685514|NCT03571646|583901897|FG001|Overall Study|Withdrawal by Subject|1|||
161685515|NCT03972969|583901898|FG000|3-month Follow-up|Death|1|||
161685516|NCT03972969|583901899|FG001|3-month Follow-up|Death|1|||
161685517|NCT03972969|583901900|FG002|3-month Follow-up|Death|0|||
161685518|NCT03972969|583901898|FG000|6-month Follow-up|Death|1|||
161685519|NCT03972969|583901899|FG001|6-month Follow-up|Death|1|||
161685520|NCT03972969|583901900|FG002|6-month Follow-up|Death|1|||
161685521|NCT03972969|583901898|FG000|6-month Follow-up|Lost to Follow-up|2|||
161685522|NCT03972969|583901899|FG001|6-month Follow-up|Lost to Follow-up|2|||
161685523|NCT03972969|583901900|FG002|6-month Follow-up|Lost to Follow-up|2|||
161685524|NCT00732303|583901901|FG000|Overall Study|Study Terminated|2|||
161685525|NCT00283595|583901902|FG000|Overall Study|Withdrawal by Subject|1|||
161685526|NCT00283595|583901903|FG001|Overall Study|Withdrawal by Subject|2|||
161950099|NCT01713582|584870382|FG014|Overall Study|Withdrawal of consent|0|||
161685527|NCT04718974|583901907|FG000|Overall Study|Death|0|||
161685528|NCT04718974|583901908|FG001|Overall Study|Death|2|||
161685529|NCT04718974|583901907|FG000|Overall Study|Lost to Follow-up|10|||
161685530|NCT04718974|583901908|FG001|Overall Study|Lost to Follow-up|20|||
161685531|NCT04718974|583901907|FG000|Overall Study|Transferred out|2|||
161685532|NCT04718974|583901908|FG001|Overall Study|Transferred out|4|||
161685533|NCT00845728|583901909|FG000|Overall Study|Abnormal laboratory value (s)|2|||
161685534|NCT00845728|583901910|FG001|Overall Study|Abnormal laboratory value (s)|2|||
161685535|NCT00845728|583901909|FG000|Overall Study|Patient's inability to use the device|4|||
161950100|NCT01713582|584870383|FG015|Overall Study|Withdrawal of consent|0|||
162028696|NCT05395091|585161816|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
162028697|NCT05395091|585161817|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
162028698|NCT05395091|585161818|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
162028699|NCT05395091|585161816|FG000|Baseline to Month 12|Protocol Violation|2|||
162028700|NCT05395091|585161817|FG001|Baseline to Month 12|Protocol Violation|3|||
162028701|NCT05395091|585161818|FG002|Baseline to Month 12|Protocol Violation|0|||
162028702|NCT05395091|585161816|FG000|Baseline to Month 12|Physician Decision|1|||
162028703|NCT05395091|585161817|FG001|Baseline to Month 12|Physician Decision|0|||
162028704|NCT05395091|585161818|FG002|Baseline to Month 12|Physician Decision|0|||
162028705|NCT05395091|585161816|FG000|Month 12 to Month 18|Death|1|||
162028706|NCT05395091|585161817|FG001|Month 12 to Month 18|Death|0|||
162028707|NCT05395091|585161818|FG002|Month 12 to Month 18|Death|0|||
162028708|NCT05395091|585161816|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
162028709|NCT05395091|585161817|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
162028710|NCT05395091|585161818|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
162028711|NCT05395091|585161816|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
162028712|NCT05395091|585161817|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
162028713|NCT05395091|585161818|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
162028714|NCT05395091|585161816|FG000|Month 12 to Month 18|Other reasons|0|||
162028715|NCT05395091|585161817|FG001|Month 12 to Month 18|Other reasons|0|||
162028716|NCT05395091|585161818|FG002|Month 12 to Month 18|Other reasons|1|||
161685536|NCT00845728|583901910|FG001|Overall Study|Patient's inability to use the device|6|||
161685537|NCT00845728|583901909|FG000|Overall Study|Abnormal test procedure result (s)|7|||
161685538|NCT00845728|583901910|FG001|Overall Study|Abnormal test procedure result (s)|2|||
161685539|NCT00845728|583901909|FG000|Overall Study|Lost to Follow-up|22|||
161685540|NCT00845728|583901910|FG001|Overall Study|Lost to Follow-up|13|||
161685541|NCT00845728|583901909|FG000|Overall Study|Death|24|||
161685542|NCT00845728|583901910|FG001|Overall Study|Death|26|||
161685543|NCT00845728|583901909|FG000|Overall Study|Administrative Problems|34|||
162028717|NCT01915303|585161825|FG000|Core Phase|Adverse Event|7|||
162028718|NCT01915303|585161825|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
162028719|NCT01915303|585161825|FG000|Core Phase|Death|2|||
162028720|NCT01915303|585161825|FG000|Core Phase|Protocol Violation|2|||
162028721|NCT01915303|585161825|FG000|Core Phase|Abnormal lab value|1|||
162028722|NCT01915303|585161825|FG000|Core Phase|Withdrawal by Subject|1|||
162028723|NCT01915303|585161825|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
162028724|NCT01915303|585161825|FG000|Extension Phase|Withdrawal by Subject|4|||
162028725|NCT01915303|585161825|FG000|Extension Phase|Adverse Event|3|||
162028726|NCT01915303|585161825|FG000|Extension Phase|Death|1|||
161685544|NCT00845728|583901910|FG001|Overall Study|Administrative Problems|26|||
161685545|NCT00845728|583901909|FG000|Overall Study|Protocol Violation|36|||
161685546|NCT00845728|583901910|FG001|Overall Study|Protocol Violation|24|||
161685547|NCT00845728|583901909|FG000|Overall Study|Lack of Efficacy|51|||
161685548|NCT00845728|583901910|FG001|Overall Study|Lack of Efficacy|39|||
161685549|NCT00845728|583901909|FG000|Overall Study|Adverse Event|101|||
161685550|NCT00845728|583901910|FG001|Overall Study|Adverse Event|96|||
162236720|NCT01395888|585917034|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
162236721|NCT01395888|585917035|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
162236722|NCT01395888|585917033|FG000|Treatment Period (TP)|Protocol Violation|0|||
162236723|NCT01395888|585917034|FG001|Treatment Period (TP)|Protocol Violation|1|||
162236724|NCT01395888|585917035|FG002|Treatment Period (TP)|Protocol Violation|5|||
162236725|NCT01395888|585917033|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
162236726|NCT01395888|585917034|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
162236727|NCT01395888|585917035|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
162236728|NCT01395888|585917033|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
162236729|NCT01395888|585917034|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
162236730|NCT01395888|585917035|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
162236731|NCT02457559|585917036|FG000|Overall Study|Progressive Disease|1|||
162236732|NCT02457559|585917037|FG001|Overall Study|Progressive Disease|2|||
162236733|NCT02457559|585917038|FG002|Overall Study|Progressive Disease|3|||
162236734|NCT02457559|585917039|FG003|Overall Study|Progressive Disease|0|||
162236735|NCT02457559|585917040|FG004|Overall Study|Progressive Disease|0|||
162236736|NCT02457559|585917041|FG005|Overall Study|Progressive Disease|2|||
162236737|NCT02457559|585917042|FG006|Overall Study|Progressive Disease|1|||
162236738|NCT02457559|585917043|FG007|Overall Study|Progressive Disease|0|||
162236739|NCT02457559|585917044|FG008|Overall Study|Progressive Disease|1|||
162236740|NCT02457559|585917045|FG009|Overall Study|Progressive Disease|1|||
162236741|NCT02457559|585917046|FG010|Overall Study|Progressive Disease|1|||
162236742|NCT02457559|585917036|FG000|Overall Study|Investigator's Discretion|0|||
162236743|NCT02457559|585917037|FG001|Overall Study|Investigator's Discretion|0|||
162236744|NCT02457559|585917038|FG002|Overall Study|Investigator's Discretion|2|||
162236745|NCT02457559|585917039|FG003|Overall Study|Investigator's Discretion|0|||
162236746|NCT02457559|585917040|FG004|Overall Study|Investigator's Discretion|1|||
162236747|NCT02457559|585917041|FG005|Overall Study|Investigator's Discretion|0|||
162236748|NCT02457559|585917042|FG006|Overall Study|Investigator's Discretion|1|||
162236749|NCT02457559|585917043|FG007|Overall Study|Investigator's Discretion|0|||
162236750|NCT02457559|585917044|FG008|Overall Study|Investigator's Discretion|1|||
162236751|NCT02457559|585917045|FG009|Overall Study|Investigator's Discretion|0|||
162236752|NCT02457559|585917046|FG010|Overall Study|Investigator's Discretion|1|||
162236753|NCT02457559|585917036|FG000|Overall Study|Adverse Event|0|||
162236754|NCT02457559|585917037|FG001|Overall Study|Adverse Event|1|||
162236755|NCT02457559|585917038|FG002|Overall Study|Adverse Event|2|||
162236756|NCT02457559|585917039|FG003|Overall Study|Adverse Event|0|||
162236757|NCT02457559|585917040|FG004|Overall Study|Adverse Event|0|||
162236758|NCT02457559|585917041|FG005|Overall Study|Adverse Event|0|||
162236759|NCT02457559|585917042|FG006|Overall Study|Adverse Event|0|||
162236760|NCT02457559|585917043|FG007|Overall Study|Adverse Event|0|||
162236761|NCT02457559|585917044|FG008|Overall Study|Adverse Event|0|||
162236762|NCT02457559|585917045|FG009|Overall Study|Adverse Event|0|||
162236763|NCT02457559|585917046|FG010|Overall Study|Adverse Event|0|||
162236764|NCT02457559|585917036|FG000|Overall Study|Reason not Specified|1|||
162236765|NCT02457559|585917037|FG001|Overall Study|Reason not Specified|0|||
162236766|NCT02457559|585917038|FG002|Overall Study|Reason not Specified|0|||
162236767|NCT02457559|585917039|FG003|Overall Study|Reason not Specified|0|||
162236768|NCT02457559|585917040|FG004|Overall Study|Reason not Specified|0|||
162236769|NCT02457559|585917041|FG005|Overall Study|Reason not Specified|0|||
162236770|NCT02457559|585917042|FG006|Overall Study|Reason not Specified|0|||
162236771|NCT02457559|585917043|FG007|Overall Study|Reason not Specified|0|||
162236772|NCT02457559|585917044|FG008|Overall Study|Reason not Specified|0|||
162236773|NCT02457559|585917045|FG009|Overall Study|Reason not Specified|2|||
162236774|NCT02457559|585917046|FG010|Overall Study|Reason not Specified|0|||
162236775|NCT02457559|585917036|FG000|Overall Study|Death|0|||
162236776|NCT02457559|585917037|FG001|Overall Study|Death|0|||
162236777|NCT02457559|585917038|FG002|Overall Study|Death|0|||
162236778|NCT02457559|585917039|FG003|Overall Study|Death|0|||
162236779|NCT02457559|585917040|FG004|Overall Study|Death|0|||
162236780|NCT02457559|585917041|FG005|Overall Study|Death|0|||
162236781|NCT02457559|585917042|FG006|Overall Study|Death|0|||
162236782|NCT02457559|585917043|FG007|Overall Study|Death|0|||
162236783|NCT02457559|585917044|FG008|Overall Study|Death|1|||
162236784|NCT02457559|585917045|FG009|Overall Study|Death|1|||
162236785|NCT02457559|585917046|FG010|Overall Study|Death|0|||
162236786|NCT05590884|585917047|FG000|Overall Study|Withdrawal by Subject|1|||
162236787|NCT05590884|585917048|FG001|Overall Study|Withdrawal by Subject|0|||
162236788|NCT05590884|585917049|FG002|Overall Study|Withdrawal by Subject|0|||
162236789|NCT04134845|585917059|FG000|Overall Study|withdrawl by PI|12|||
162236790|NCT04134845|585917060|FG001|Overall Study|withdrawl by PI|5|||
162236791|NCT01620255|585919070|FG000|Overall Study|Withdrawal by Subject|4|||
162236792|NCT01620255|585919071|FG001|Overall Study|Withdrawal by Subject|1|||
162236793|NCT01620255|585919072|FG002|Overall Study|Withdrawal by Subject|1|||
162236794|NCT01620255|585919073|FG003|Overall Study|Withdrawal by Subject|2|||
162236795|NCT01620255|585919074|FG004|Overall Study|Withdrawal by Subject|4|||
162236796|NCT01620255|585919070|FG000|Overall Study|Participant underwent fecal transplant|0|||
161685551|NCT00845728|583901909|FG000|Overall Study|Withdrawal by Subject|105|||
161685552|NCT00845728|583901910|FG001|Overall Study|Withdrawal by Subject|108|||
161950101|NCT01713582|584870384|FG016|Overall Study|Withdrawal of consent|0|||
161950102|NCT01713582|584870385|FG017|Overall Study|Withdrawal of consent|0|||
161950103|NCT01713582|584870386|FG018|Overall Study|Withdrawal of consent|1|||
161950104|NCT01713582|584870387|FG019|Overall Study|Withdrawal of consent|0|||
161950105|NCT01713582|584870388|FG020|Overall Study|Withdrawal of consent|0|||
161950106|NCT01713582|584870368|FG000|Overall Study|Lack of Efficacy|0|||
161950107|NCT01713582|584870369|FG001|Overall Study|Lack of Efficacy|0|||
161950108|NCT01713582|584870370|FG002|Overall Study|Lack of Efficacy|0|||
161950109|NCT01713582|584870371|FG003|Overall Study|Lack of Efficacy|0|||
161950110|NCT01713582|584870372|FG004|Overall Study|Lack of Efficacy|0|||
161950111|NCT01713582|584870373|FG005|Overall Study|Lack of Efficacy|0|||
161950112|NCT01713582|584870374|FG006|Overall Study|Lack of Efficacy|0|||
161950113|NCT01713582|584870375|FG007|Overall Study|Lack of Efficacy|0|||
161950114|NCT01713582|584870376|FG008|Overall Study|Lack of Efficacy|0|||
161950115|NCT01713582|584870377|FG009|Overall Study|Lack of Efficacy|1|||
161685553|NCT03259074|583901911|FG000|Overall Study|Adverse Event|9|||
161685554|NCT03259074|583901912|FG001|Overall Study|Adverse Event|12|||
161685555|NCT03259074|583901913|FG002|Overall Study|Adverse Event|8|||
161685556|NCT03259074|583901911|FG000|Overall Study|Death|1|||
161685557|NCT03259074|583901912|FG001|Overall Study|Death|1|||
161685558|NCT03259074|583901913|FG002|Overall Study|Death|3|||
161685559|NCT03259074|583901911|FG000|Overall Study|Lost to Follow-up|2|||
161685560|NCT03259074|583901912|FG001|Overall Study|Lost to Follow-up|4|||
161685561|NCT03259074|583901913|FG002|Overall Study|Lost to Follow-up|3|||
161685562|NCT03259074|583901911|FG000|Overall Study|New Therapy For Study Indication|1|||
161685563|NCT03259074|583901912|FG001|Overall Study|New Therapy For Study Indication|2|||
161685564|NCT03259074|583901913|FG002|Overall Study|New Therapy For Study Indication|2|||
161685565|NCT03259074|583901911|FG000|Overall Study|Physician Decision|4|||
161950116|NCT01713582|584870378|FG010|Overall Study|Lack of Efficacy|2|||
161950117|NCT01713582|584870379|FG011|Overall Study|Lack of Efficacy|0|||
161950118|NCT01713582|584870380|FG012|Overall Study|Lack of Efficacy|0|||
161950119|NCT01713582|584870381|FG013|Overall Study|Lack of Efficacy|0|||
161950120|NCT01713582|584870382|FG014|Overall Study|Lack of Efficacy|0|||
161950121|NCT01713582|584870383|FG015|Overall Study|Lack of Efficacy|0|||
161950122|NCT01713582|584870384|FG016|Overall Study|Lack of Efficacy|0|||
161950123|NCT01713582|584870385|FG017|Overall Study|Lack of Efficacy|0|||
161950124|NCT01713582|584870386|FG018|Overall Study|Lack of Efficacy|0|||
161950125|NCT01713582|584870387|FG019|Overall Study|Lack of Efficacy|0|||
161685566|NCT03259074|583901912|FG001|Overall Study|Physician Decision|12|||
161685567|NCT03259074|583901913|FG002|Overall Study|Physician Decision|10|||
161685568|NCT03259074|583901911|FG000|Overall Study|Pregnancy|1|||
161685569|NCT03259074|583901912|FG001|Overall Study|Pregnancy|1|||
161685570|NCT03259074|583901913|FG002|Overall Study|Pregnancy|0|||
161685571|NCT03259074|583901911|FG000|Overall Study|Progressive Disease|1|||
161685572|NCT03259074|583901912|FG001|Overall Study|Progressive Disease|0|||
161685573|NCT03259074|583901913|FG002|Overall Study|Progressive Disease|0|||
161685574|NCT03259074|583901911|FG000|Overall Study|Protocol Deviation|1|||
161950126|NCT01713582|584870388|FG020|Overall Study|Lack of Efficacy|0|||
161950127|NCT01713582|584870368|FG000|Overall Study|Withdrawal by Subject|0|||
161950128|NCT01713582|584870369|FG001|Overall Study|Withdrawal by Subject|0|||
161950129|NCT01713582|584870370|FG002|Overall Study|Withdrawal by Subject|0|||
161950130|NCT01713582|584870371|FG003|Overall Study|Withdrawal by Subject|0|||
161950131|NCT01713582|584870372|FG004|Overall Study|Withdrawal by Subject|0|||
161950132|NCT01713582|584870373|FG005|Overall Study|Withdrawal by Subject|0|||
161685575|NCT03259074|583901912|FG001|Overall Study|Protocol Deviation|1|||
161685576|NCT03259074|583901913|FG002|Overall Study|Protocol Deviation|3|||
161685577|NCT03259074|583901911|FG000|Overall Study|Subject/Guardian Decision|13|||
161685578|NCT03259074|583901912|FG001|Overall Study|Subject/Guardian Decision|16|||
161685579|NCT03259074|583901913|FG002|Overall Study|Subject/Guardian Decision|14|||
161685580|NCT00705783|583901924|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
161685581|NCT00705783|583901925|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
161685582|NCT00705783|583901926|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
161685583|NCT00705783|583901924|FG000|Conversion Phase|Lost to Follow-up|13|||
161685584|NCT00705783|583901925|FG001|Conversion Phase|Lost to Follow-up|0|||
161685585|NCT00705783|583901926|FG002|Conversion Phase|Lost to Follow-up|0|||
161685586|NCT00705783|583901924|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
161685587|NCT00705783|583901925|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
161685588|NCT00705783|583901926|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
161685589|NCT00705783|583901924|FG000|Conversion Phase|Withdrawn by Investigator|4|||
161685590|NCT00705783|583901925|FG001|Conversion Phase|Withdrawn by Investigator|0|||
161685591|NCT00705783|583901926|FG002|Conversion Phase|Withdrawn by Investigator|0|||
161685592|NCT00705783|583901924|FG000|Conversion Phase|Withdrew Consent|24|||
161685593|NCT00705783|583901925|FG001|Conversion Phase|Withdrew Consent|0|||
161685594|NCT00705783|583901926|FG002|Conversion Phase|Withdrew Consent|0|||
161685595|NCT00705783|583901924|FG000|Conversion Phase|Protocol Deviation|2|||
161685596|NCT00705783|583901925|FG001|Conversion Phase|Protocol Deviation|0|||
161685597|NCT00705783|583901926|FG002|Conversion Phase|Protocol Deviation|0|||
161685598|NCT00705783|583901924|FG000|Conversion Phase|Adverse Event|11|||
161685599|NCT00705783|583901925|FG001|Conversion Phase|Adverse Event|0|||
161685600|NCT00705783|583901926|FG002|Conversion Phase|Adverse Event|0|||
161685601|NCT00705783|583901924|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
161685602|NCT00705783|583901925|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161685603|NCT00705783|583901926|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161685604|NCT00705783|583901924|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
161685605|NCT00705783|583901925|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
161685606|NCT00705783|583901926|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
161685607|NCT00705783|583901924|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
161685608|NCT00705783|583901925|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
161685609|NCT00705783|583901926|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
161685610|NCT00705783|583901924|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
161685611|NCT00705783|583901925|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
161685612|NCT00705783|583901926|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
161685613|NCT00705783|583901924|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
161685614|NCT00705783|583901925|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
161685615|NCT00705783|583901926|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
161685616|NCT00705783|583901924|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
161685617|NCT00705783|583901925|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
161685618|NCT00705783|583901926|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
161685619|NCT00705783|583901924|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
161950133|NCT01713582|584870374|FG006|Overall Study|Withdrawal by Subject|0|||
161950134|NCT01713582|584870375|FG007|Overall Study|Withdrawal by Subject|0|||
161950135|NCT01713582|584870376|FG008|Overall Study|Withdrawal by Subject|0|||
161950136|NCT01713582|584870377|FG009|Overall Study|Withdrawal by Subject|0|||
161950137|NCT01713582|584870378|FG010|Overall Study|Withdrawal by Subject|0|||
161950138|NCT01713582|584870379|FG011|Overall Study|Withdrawal by Subject|0|||
161950139|NCT01713582|584870380|FG012|Overall Study|Withdrawal by Subject|0|||
161950140|NCT01713582|584870381|FG013|Overall Study|Withdrawal by Subject|0|||
161950141|NCT01713582|584870382|FG014|Overall Study|Withdrawal by Subject|0|||
161950142|NCT01713582|584870383|FG015|Overall Study|Withdrawal by Subject|0|||
161950143|NCT01713582|584870384|FG016|Overall Study|Withdrawal by Subject|0|||
161950144|NCT01713582|584870385|FG017|Overall Study|Withdrawal by Subject|1|||
161950145|NCT01713582|584870386|FG018|Overall Study|Withdrawal by Subject|0|||
161685620|NCT00705783|583901925|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
161950146|NCT01713582|584870387|FG019|Overall Study|Withdrawal by Subject|0|||
161950147|NCT01713582|584870388|FG020|Overall Study|Withdrawal by Subject|0|||
161950148|NCT01713582|584870368|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
161950149|NCT01713582|584870369|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
161950150|NCT01713582|584870370|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
161950151|NCT01713582|584870371|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
161950152|NCT01713582|584870372|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
161950153|NCT01713582|584870373|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
161950154|NCT01713582|584870374|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
161685621|NCT00705783|583901926|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
161685622|NCT00705783|583901924|FG000|Oral Stabilization Phase|Adverse Event|14|||
161685623|NCT00705783|583901925|FG001|Oral Stabilization Phase|Adverse Event|0|||
161685624|NCT00705783|583901926|FG002|Oral Stabilization Phase|Adverse Event|0|||
161685625|NCT00705783|583901924|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
161685626|NCT00705783|583901925|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161685627|NCT00705783|583901926|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161685628|NCT00705783|583901924|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
161685629|NCT00705783|583901925|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161685630|NCT00705783|583901926|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161685631|NCT00705783|583901924|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
161685632|NCT00705783|583901925|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
161685633|NCT00705783|583901926|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
161685634|NCT00705783|583901924|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
161685635|NCT00705783|583901925|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
161685636|NCT00705783|583901926|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
161685637|NCT00705783|583901924|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
161685638|NCT00705783|583901925|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
161685639|NCT00705783|583901926|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
161685640|NCT00705783|583901924|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
161685641|NCT00705783|583901925|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
161685642|NCT00705783|583901926|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
161685643|NCT00705783|583901924|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
161685644|NCT00705783|583901925|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
161685645|NCT00705783|583901926|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
161685646|NCT00705783|583901924|FG000|Depot Stabilization Phase|Adverse Event|17|||
161685647|NCT00705783|583901925|FG001|Depot Stabilization Phase|Adverse Event|0|||
161685648|NCT00705783|583901926|FG002|Depot Stabilization Phase|Adverse Event|0|||
161685649|NCT00705783|583901924|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
161685650|NCT00705783|583901925|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161685651|NCT00705783|583901926|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161685652|NCT00705783|583901924|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
161685653|NCT00705783|583901925|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161685654|NCT00705783|583901926|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161950155|NCT01713582|584870375|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
161950156|NCT01713582|584870376|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
161950157|NCT01713582|584870377|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
161950158|NCT01713582|584870378|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
161950159|NCT01713582|584870379|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
161950160|NCT01713582|584870380|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
161950161|NCT01713582|584870381|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
161950162|NCT01713582|584870382|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
161950163|NCT01713582|584870383|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
161950164|NCT01713582|584870384|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
161685655|NCT00705783|583901924|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
161685656|NCT00705783|583901925|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
161685657|NCT00705783|583901926|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
161950165|NCT01713582|584870385|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
161950166|NCT01713582|584870386|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
161950167|NCT01713582|584870387|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
162028727|NCT01915303|585161825|FG000|Extension Phase|Protocol Violation|1|||
162028728|NCT02509117|585161827|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161950168|NCT01713582|584870388|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
161950169|NCT01713582|584870368|FG000|Overall Study|Disease progression and adverse event|0|||
161950170|NCT01713582|584870369|FG001|Overall Study|Disease progression and adverse event|0|||
161950171|NCT01713582|584870370|FG002|Overall Study|Disease progression and adverse event|0|||
161950172|NCT01713582|584870371|FG003|Overall Study|Disease progression and adverse event|0|||
161950173|NCT01713582|584870372|FG004|Overall Study|Disease progression and adverse event|0|||
161950174|NCT01713582|584870373|FG005|Overall Study|Disease progression and adverse event|0|||
161950175|NCT01713582|584870374|FG006|Overall Study|Disease progression and adverse event|0|||
161685658|NCT00705783|583901924|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
161685659|NCT00705783|583901925|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
161950176|NCT01713582|584870375|FG007|Overall Study|Disease progression and adverse event|0|||
161950177|NCT01713582|584870376|FG008|Overall Study|Disease progression and adverse event|0|||
161950178|NCT01713582|584870377|FG009|Overall Study|Disease progression and adverse event|0|||
161950179|NCT01713582|584870378|FG010|Overall Study|Disease progression and adverse event|0|||
161685660|NCT00705783|583901926|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
161685661|NCT00705783|583901924|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
161685662|NCT00705783|583901925|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
161685663|NCT00705783|583901926|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
161685664|NCT00705783|583901924|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
161685665|NCT00705783|583901925|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
161685666|NCT00705783|583901926|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
161685667|NCT00705783|583901924|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
161685668|NCT00705783|583901925|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
161685669|NCT00705783|583901926|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
161685670|NCT00705783|583901924|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
161685671|NCT00705783|583901925|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
161685672|NCT00705783|583901926|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
161685673|NCT00705783|583901924|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
161685674|NCT00705783|583901925|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
161685675|NCT00705783|583901926|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
161685676|NCT00705783|583901924|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
161685677|NCT00705783|583901925|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
161685678|NCT00705783|583901926|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
161685679|NCT00705783|583901924|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
161685680|NCT00705783|583901925|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
161685681|NCT00705783|583901926|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
161685682|NCT02182687|583901927|FG000|Overall Study|Withdrawal by Subject|4|||
161685683|NCT02182687|583901928|FG001|Overall Study|Withdrawal by Subject|0|||
161685684|NCT02182687|583901927|FG000|Overall Study|Adverse Event|1|||
161685685|NCT02182687|583901928|FG001|Overall Study|Adverse Event|0|||
161685686|NCT02182687|583901927|FG000|Overall Study|Lost to Follow-up|0|||
161685687|NCT02182687|583901928|FG001|Overall Study|Lost to Follow-up|1|||
161685688|NCT02025907|583901935|FG000|Overall Study|Lack of Efficacy|1|||
161950180|NCT01713582|584870379|FG011|Overall Study|Disease progression and adverse event|0|||
161950181|NCT01713582|584870380|FG012|Overall Study|Disease progression and adverse event|0|||
161950182|NCT01713582|584870381|FG013|Overall Study|Disease progression and adverse event|0|||
161685689|NCT02025907|583901936|FG001|Overall Study|Lack of Efficacy|0|||
161685690|NCT02025907|583901935|FG000|Overall Study|Withdrawal by Subject|15|||
161833611|NCT00773734|584433164|FG001|Extension: Active Treatment Week 24-52|Other|0|||
161833612|NCT00773734|584433165|FG002|Extension: Active Treatment Week 24-52|Other|1|||
161833613|NCT00773734|584433166|FG003|Extension: Active Treatment Week 24-52|Other|2|||
162028729|NCT02509117|585161828|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
161685691|NCT02025907|583901936|FG001|Overall Study|Withdrawal by Subject|8|||
161685692|NCT02025907|583901935|FG000|Overall Study|Protocol Violation|2|||
161685693|NCT02025907|583901936|FG001|Overall Study|Protocol Violation|0|||
161685694|NCT02025907|583901935|FG000|Overall Study|Physician Decision|2|||
161685695|NCT02025907|583901936|FG001|Overall Study|Physician Decision|0|||
161685696|NCT02025907|583901935|FG000|Overall Study|Lost to Follow-up|2|||
161685697|NCT02025907|583901936|FG001|Overall Study|Lost to Follow-up|2|||
161685698|NCT02025907|583901935|FG000|Overall Study|Adverse Event|3|||
161685699|NCT02025907|583901936|FG001|Overall Study|Adverse Event|1|||
161685700|NCT02025907|583901935|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
161685701|NCT02025907|583901936|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
161685702|NCT02411539|583901937|FG000|Overall Study|Lost to Follow-up|2|||
161685703|NCT02411539|583901938|FG001|Overall Study|Lost to Follow-up|0|||
161685704|NCT02411539|583901937|FG000|Overall Study|Confounding medical condition|0|||
161685705|NCT02411539|583901938|FG001|Overall Study|Confounding medical condition|1|||
161685706|NCT01422915|583901939|FG000|Overall Study|Adverse Event|1|||
161685707|NCT01549002|583901940|FG000|Overall Study|Excessive pain|0|||
161685708|NCT01549002|583901941|FG001|Overall Study|Excessive pain|2|||
161685709|NCT01549002|583901940|FG000|Overall Study|Moderate sedation required|0|||
161685710|NCT01549002|583901941|FG001|Overall Study|Moderate sedation required|2|||
161685711|NCT03631732|583901944|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
161685712|NCT03631732|583901945|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
161685713|NCT03631732|583901944|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
161685714|NCT03631732|583901945|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
161685715|NCT03631732|583901944|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
161685716|NCT03631732|583901945|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
161685717|NCT03631732|583901944|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
161685718|NCT03631732|583901945|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
161685719|NCT03631732|583901944|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
161685720|NCT03631732|583901945|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
161685721|NCT03631732|583901944|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
161685722|NCT03631732|583901945|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
161685723|NCT03631732|583901944|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
161685724|NCT03631732|583901945|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
161685725|NCT03631732|583901944|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
161685726|NCT03631732|583901945|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
161950183|NCT01713582|584870382|FG014|Overall Study|Disease progression and adverse event|0|||
161950184|NCT01713582|584870383|FG015|Overall Study|Disease progression and adverse event|0|||
161950185|NCT01713582|584870384|FG016|Overall Study|Disease progression and adverse event|1|||
161950186|NCT01713582|584870385|FG017|Overall Study|Disease progression and adverse event|0|||
161950187|NCT01713582|584870386|FG018|Overall Study|Disease progression and adverse event|0|||
161685727|NCT03631732|583901944|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
161685728|NCT03631732|583901945|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
161685729|NCT03631732|583901944|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
161685730|NCT03631732|583901945|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
161685731|NCT01439204|583901946|FG000|Overall Study|Withdrawal by Subject|0|||
161685732|NCT01439204|583901947|FG001|Overall Study|Withdrawal by Subject|1|||
161685733|NCT01439204|583901946|FG000|Overall Study|Lost to Follow-up|0|||
161685734|NCT01439204|583901947|FG001|Overall Study|Lost to Follow-up|2|||
161685735|NCT01439204|583901946|FG000|Overall Study|No longer meets study criteria|1|||
161685736|NCT01439204|583901947|FG001|Overall Study|No longer meets study criteria|0|||
161685737|NCT01439204|583901946|FG000|Overall Study|poor/non-compliance|3|||
161685738|NCT01439204|583901947|FG001|Overall Study|poor/non-compliance|0|||
161685739|NCT01251367|583901948|FG000|Overall Study|Protocol Violation|1|||
161685740|NCT01251367|583901948|FG000|Overall Study|Lack of Efficacy|2|||
161685741|NCT01251367|583901948|FG000|Overall Study|Adverse Event|19|||
161685742|NCT01251367|583901948|FG000|Overall Study|Withdrawal by Subject|36|||
161685743|NCT01251367|583901948|FG000|Overall Study|Lost to Follow-up|5|||
161685744|NCT01251367|583901948|FG000|Overall Study|Subject Required Alternative Treatment|7|||
161685745|NCT01251367|583901948|FG000|Overall Study|No Study Drug Available|1|||
161685746|NCT01251367|583901948|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
161685747|NCT01251367|583901948|FG000|Overall Study|End of Study Visit Performed in Error|1|||
161685748|NCT02255409|583901949|FG000|Overall Study|Administrative Reason|3|||
161685749|NCT02255409|583901950|FG001|Overall Study|Administrative Reason|7|||
161685750|NCT02255409|583901949|FG000|Overall Study|Withdrawal by Subject|1|||
161685751|NCT02255409|583901950|FG001|Overall Study|Withdrawal by Subject|5|||
161685752|NCT02255409|583901949|FG000|Overall Study|Lost to Follow-up|10|||
161685753|NCT02255409|583901950|FG001|Overall Study|Lost to Follow-up|19|||
161685754|NCT00135668|583901952|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
161685755|NCT00135668|583901953|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
161685756|NCT00135668|583901954|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
161685757|NCT00135668|583901955|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
161685758|NCT02370615|583901958|FG000|Overall Study|Adverse Event|1|||
162028730|NCT02509117|585161829|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161950188|NCT01713582|584870387|FG019|Overall Study|Disease progression and adverse event|0|||
161950189|NCT01713582|584870388|FG020|Overall Study|Disease progression and adverse event|0|||
161950190|NCT04551898|584870389|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
161950191|NCT04551898|584870390|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
161950192|NCT04551898|584870391|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
161950193|NCT04551898|584870392|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
161950194|NCT04551898|584870389|FG000|Overall Study|Withdrawal by Subject|5|||
161950195|NCT04551898|584870390|FG001|Overall Study|Withdrawal by Subject|1|||
161950196|NCT04551898|584870391|FG002|Overall Study|Withdrawal by Subject|2|||
161950197|NCT04551898|584870392|FG003|Overall Study|Withdrawal by Subject|2|||
161950198|NCT04551898|584870389|FG000|Overall Study|Lost to Follow-up|2|||
161950199|NCT04551898|584870390|FG001|Overall Study|Lost to Follow-up|1|||
161950200|NCT04551898|584870391|FG002|Overall Study|Lost to Follow-up|2|||
161950201|NCT04551898|584870392|FG003|Overall Study|Lost to Follow-up|2|||
161950202|NCT04551898|584870389|FG000|Overall Study|Death|1|||
161950203|NCT04551898|584870390|FG001|Overall Study|Death|0|||
161950204|NCT04551898|584870391|FG002|Overall Study|Death|0|||
161950205|NCT04551898|584870392|FG003|Overall Study|Death|0|||
161950206|NCT04551898|584870389|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
161950207|NCT04551898|584870390|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
161950208|NCT04551898|584870391|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
161950209|NCT04551898|584870392|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
161950210|NCT03427814|584870393|FG000|Overall Study|Withdrawal by Subject|4|||
161950211|NCT03427814|584870394|FG001|Overall Study|Withdrawal by Subject|4|||
161950212|NCT03427814|584870393|FG000|Overall Study|Lost to Follow-up|0|||
161950213|NCT03427814|584870394|FG001|Overall Study|Lost to Follow-up|2|||
161950214|NCT03427814|584870393|FG000|Overall Study|Death|42|||
161950215|NCT03427814|584870394|FG001|Overall Study|Death|31|||
161950216|NCT03427814|584870393|FG000|Overall Study|Sponsor's Decision|1|||
161950217|NCT03427814|584870394|FG001|Overall Study|Sponsor's Decision|0|||
161950218|NCT03427814|584870393|FG000|Overall Study|Investigator's Decision|1|||
161950219|NCT03427814|584870394|FG001|Overall Study|Investigator's Decision|2|||
161950220|NCT03427814|584870393|FG000|Overall Study|Disease progression|1|||
161950221|NCT03427814|584870394|FG001|Overall Study|Disease progression|0|||
161950222|NCT03427814|584870393|FG000|Overall Study|Treatment Completed|0|||
161950223|NCT03427814|584870394|FG001|Overall Study|Treatment Completed|1|||
161950224|NCT03427814|584870393|FG000|Overall Study|Sponsor's Decision to End study|21|||
161950225|NCT03427814|584870394|FG001|Overall Study|Sponsor's Decision to End study|25|||
161950226|NCT03427814|584870393|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
161950227|NCT03427814|584870394|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
161950228|NCT03846427|584870395|FG000|Overall Study|Death|13|||
161950229|NCT03846427|584870395|FG000|Overall Study|Withdrawal by Subject|3|||
161950230|NCT03846427|584870395|FG000|Overall Study|Physician Decision|1|||
161950231|NCT01334554|584870396|FG000|Overall Study|Adverse Event|4|||
161950232|NCT01334554|584870397|FG001|Overall Study|Adverse Event|2|||
161950233|NCT02393859|584870399|FG000|Overall Study|Decision by Sponsor|2|||
161950234|NCT02393859|584870400|FG001|Overall Study|Decision by Sponsor|4|||
161950235|NCT02393859|584870399|FG000|Overall Study|Withdrawal by Subject|11|||
161950236|NCT02393859|584870400|FG001|Overall Study|Withdrawal by Subject|6|||
161950237|NCT02393859|584870399|FG000|Overall Study|Death|27|||
161950238|NCT02393859|584870400|FG001|Overall Study|Death|10|||
161950239|NCT02393859|584870399|FG000|Overall Study|Lost to Follow-up|1|||
161950240|NCT02393859|584870400|FG001|Overall Study|Lost to Follow-up|1|||
161950241|NCT00954447|584870401|FG000|Overall Study|Adverse Event|33|||
161950242|NCT00954447|584870402|FG001|Overall Study|Adverse Event|25|||
161950243|NCT00954447|584870401|FG000|Overall Study|Lack of Efficacy|17|||
161950244|NCT00954447|584870402|FG001|Overall Study|Lack of Efficacy|3|||
161950245|NCT00954447|584870401|FG000|Overall Study|Protocol Violation|5|||
161950246|NCT00954447|584870402|FG001|Overall Study|Protocol Violation|7|||
161685759|NCT02370615|583901959|FG001|Overall Study|Adverse Event|0|||
161950247|NCT00954447|584870401|FG000|Overall Study|Lost to Follow-up|8|||
161950248|NCT00954447|584870402|FG001|Overall Study|Lost to Follow-up|14|||
161950249|NCT00954447|584870401|FG000|Overall Study|Withdrawal by Subject|26|||
161950250|NCT00954447|584870402|FG001|Overall Study|Withdrawal by Subject|21|||
161950251|NCT00954447|584870401|FG000|Overall Study|Other|21|||
161950252|NCT00954447|584870402|FG001|Overall Study|Other|18|||
161950253|NCT01979614|584870403|FG000|Overall Study|Adverse Event|1|||
161950254|NCT01979614|584870404|FG001|Overall Study|Adverse Event|1|||
161950255|NCT00488514|584870405|FG000|Overall Study|Adverse Event|41|||
161950256|NCT00488514|584870405|FG000|Overall Study|Lost to Follow-up|44|||
161833614|NCT00773734|584433167|FG004|Extension: Active Treatment Week 24-52|Other|0|||
161833615|NCT00773734|584433168|FG005|Extension: Active Treatment Week 24-52|Other|1|||
161833616|NCT00773734|584433163|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161833617|NCT00773734|584433164|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161833618|NCT00773734|584433165|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161833619|NCT00773734|584433166|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
161833620|NCT00773734|584433167|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161833621|NCT00773734|584433168|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161685760|NCT00078325|583901960|FG000|Overall Study|Adverse Event|15|||
161685761|NCT00078325|583901961|FG001|Overall Study|Adverse Event|10|||
161833622|NCT00773734|584433163|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
161950257|NCT00488514|584870405|FG000|Overall Study|Protocol Violation|32|||
161685762|NCT00078325|583901962|FG002|Overall Study|Adverse Event|5|||
161950258|NCT00488514|584870405|FG000|Overall Study|Withdrawal by Subject|106|||
161950259|NCT00488514|584870405|FG000|Overall Study|Lack of Efficacy|28|||
161950260|NCT00488514|584870405|FG000|Overall Study|Did not meet criteria for treatment|30|||
161950261|NCT00488514|584870405|FG000|Overall Study|Postive drug screen|1|||
161950262|NCT00488514|584870405|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
161950263|NCT00488514|584870405|FG000|Overall Study|Investigator decision|1|||
161950264|NCT00488514|584870405|FG000|Overall Study|Participant had too few migraines|5|||
161950265|NCT00488514|584870405|FG000|Overall Study|Increase in number of migraines|2|||
161950266|NCT00488514|584870405|FG000|Overall Study|Increased use of concomitant medication|1|||
161950267|NCT00305877|584870406|FG000|Overall Study|Lack of Efficacy|6|||
161950268|NCT00305877|584870407|FG001|Overall Study|Lack of Efficacy|9|||
161950269|NCT00305877|584870406|FG000|Overall Study|Adverse Event|9|||
161833623|NCT00773734|584433164|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
161833624|NCT00773734|584433165|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
161833625|NCT00773734|584433166|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
161833626|NCT00773734|584433167|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
161833627|NCT00773734|584433168|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
161833628|NCT00773734|584433163|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
161833629|NCT00773734|584433164|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
161833630|NCT00773734|584433165|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
161833631|NCT00773734|584433166|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
161833632|NCT00773734|584433167|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
161833633|NCT00773734|584433168|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
161833634|NCT00773734|584433163|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
161833635|NCT00773734|584433164|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
161833636|NCT00773734|584433165|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
161833637|NCT00773734|584433166|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
161833638|NCT00773734|584433167|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
161833639|NCT00773734|584433168|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
161833640|NCT00856830|584433172|FG000|Irinotecan & Bendamustine|Death|0|||
162028731|NCT02509117|585161830|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161685763|NCT00078325|583901960|FG000|Overall Study|Protocol Violation|2|||
161950270|NCT00305877|584870407|FG001|Overall Study|Adverse Event|14|||
161950271|NCT00305877|584870406|FG000|Overall Study|Death|0|||
161950272|NCT00305877|584870407|FG001|Overall Study|Death|1|||
161950273|NCT00305877|584870406|FG000|Overall Study|Withdrawal by Subject|4|||
161950274|NCT00305877|584870407|FG001|Overall Study|Withdrawal by Subject|2|||
161950275|NCT00305877|584870406|FG000|Overall Study|Physician Decision|1|||
161685764|NCT00078325|583901961|FG001|Overall Study|Protocol Violation|2|||
161950276|NCT00305877|584870407|FG001|Overall Study|Physician Decision|1|||
161685765|NCT00078325|583901962|FG002|Overall Study|Protocol Violation|0|||
161950277|NCT00305877|584870406|FG000|Overall Study|Never start treatment|2|||
162028732|NCT02509117|585161831|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
161685766|NCT00078325|583901960|FG000|Overall Study|Withdrawal by Subject|1|||
161833641|NCT00856830|584433173|FG001|Irinotecan & Bendamustine|Death|0|||
161833642|NCT00856830|584433174|FG002|Irinotecan & Bendamustine|Death|0|||
161833643|NCT00856830|584433175|FG003|Irinotecan & Bendamustine|Death|2|||
161833644|NCT00856830|584433172|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
161833645|NCT00856830|584433173|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
161950278|NCT00305877|584870407|FG001|Overall Study|Never start treatment|5|||
161950279|NCT00305877|584870406|FG000|Overall Study|Ineligible|2|||
161950280|NCT00305877|584870407|FG001|Overall Study|Ineligible|1|||
161950281|NCT00305877|584870406|FG000|Overall Study|Transportation issue with daily RT|0|||
161950282|NCT00305877|584870407|FG001|Overall Study|Transportation issue with daily RT|1|||
161950283|NCT01535287|584870408|FG000|Overall Study|drug not prepared in time|5|||
161950284|NCT01535287|584870409|FG001|Overall Study|drug not prepared in time|6|||
161950285|NCT00628446|584870412|FG000|Overall Study|Lost to Follow-up|3|||
161950286|NCT00628446|584870412|FG000|Overall Study|Withdrawal by Subject|1|||
161950287|NCT00628446|584870412|FG000|Overall Study|Protocol Violation|3|||
161950288|NCT04971967|584870413|FG000|Overall Study|Lost to Follow-up|6|||
161950289|NCT04971967|584870414|FG001|Overall Study|Lost to Follow-up|7|||
161950290|NCT00682929|584870417|FG000|Overall Study|Adverse Event|4|||
161950291|NCT00682929|584870418|FG001|Overall Study|Adverse Event|1|||
161950292|NCT00682929|584870419|FG002|Overall Study|Adverse Event|1|||
161950293|NCT00682929|584870417|FG000|Overall Study|Withdrawal by Subject|1|||
161950294|NCT00682929|584870418|FG001|Overall Study|Withdrawal by Subject|2|||
161950295|NCT00682929|584870419|FG002|Overall Study|Withdrawal by Subject|1|||
161950296|NCT00682929|584870417|FG000|Overall Study|dosing compliance < 80%|0|||
161950297|NCT00682929|584870418|FG001|Overall Study|dosing compliance < 80%|2|||
161950298|NCT00682929|584870419|FG002|Overall Study|dosing compliance < 80%|0|||
161950299|NCT00682929|584870417|FG000|Overall Study|lag in DEA renewal|1|||
161950300|NCT00682929|584870418|FG001|Overall Study|lag in DEA renewal|0|||
161950301|NCT00682929|584870419|FG002|Overall Study|lag in DEA renewal|0|||
161950302|NCT00938912|584870420|FG000|Overall Study|Withdrawal by Subject|28|||
161950303|NCT00938912|584870420|FG000|Overall Study|Lost to Follow-up|4|||
161950304|NCT00938912|584870420|FG000|Overall Study|Lack of Efficacy|43|||
161950305|NCT00938912|584870420|FG000|Overall Study|Adverse event, non-fatal|24|||
161950306|NCT00938912|584870420|FG000|Overall Study|Adverse event, fatal|1|||
161950307|NCT00938912|584870420|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
161950308|NCT00938912|584870420|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
161950309|NCT00938912|584870420|FG000|Overall Study|Participant needed prohibit medication|1|||
161950310|NCT00938912|584870420|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
161950311|NCT00938912|584870420|FG000|Overall Study|Did not meet Eligibility criteria|1|||
161950312|NCT00938912|584870420|FG000|Overall Study|Participant relocated not related to AE|1|||
161950313|NCT00938912|584870420|FG000|Overall Study|Participant moved to another city|1|||
161950314|NCT00938912|584870420|FG000|Overall Study|Participant experienced break through seizures|1|||
161950315|NCT00938912|584870420|FG000|Overall Study|No longer wished to participate in the study|1|||
161950316|NCT00938912|584870420|FG000|Overall Study|Protocol Deviation|2|||
161950317|NCT00803738|584870426|FG000|Overall Study|Adverse Event|3|||
161950318|NCT00803738|584870427|FG001|Overall Study|Adverse Event|5|||
161950319|NCT00803738|584870426|FG000|Overall Study|Lost to Follow-up|4|||
161950320|NCT00803738|584870427|FG001|Overall Study|Lost to Follow-up|4|||
161950321|NCT00803738|584870426|FG000|Overall Study|Protocol Violation|18|||
161950322|NCT00803738|584870427|FG001|Overall Study|Protocol Violation|10|||
161950323|NCT00803738|584870426|FG000|Overall Study|Withdrawal by Subject|1|||
161950324|NCT00803738|584870427|FG001|Overall Study|Withdrawal by Subject|4|||
161950325|NCT00803738|584870426|FG000|Overall Study|Lack of Efficacy|10|||
161950326|NCT00803738|584870427|FG001|Overall Study|Lack of Efficacy|16|||
161950327|NCT00803738|584870426|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
161950328|NCT00803738|584870427|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
161950329|NCT00803738|584870426|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
161950330|NCT00803738|584870427|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
161950331|NCT02964273|584870428|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
161950332|NCT02964273|584870429|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
161950333|NCT02964273|584870430|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
161950334|NCT02964273|584870431|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
161950335|NCT02964273|584870428|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
161950336|NCT02964273|584870429|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
161950337|NCT02964273|584870430|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
161950338|NCT02964273|584870431|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
161950339|NCT02964273|584870428|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
161950340|NCT02964273|584870429|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
161950341|NCT02964273|584870430|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
161950342|NCT02964273|584870431|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
161950343|NCT02964273|584870428|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
161950344|NCT02964273|584870429|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
161950345|NCT02964273|584870430|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
161950346|NCT02964273|584870431|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
161950347|NCT02964273|584870428|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
161950348|NCT02964273|584870429|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
161950349|NCT02964273|584870430|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
161950350|NCT02964273|584870431|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
161950351|NCT02964273|584870428|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
161950352|NCT02964273|584870429|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
161950353|NCT02964273|584870430|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
161950354|NCT02964273|584870431|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
161950355|NCT03012334|584870432|FG000|Period 1|Withdrawal by Subject|0|||
161950356|NCT03012334|584870433|FG001|Period 1|Withdrawal by Subject|0|||
161950357|NCT03012334|584870434|FG002|Period 1|Withdrawal by Subject|0|||
161950358|NCT03012334|584870435|FG003|Period 1|Withdrawal by Subject|0|||
161950359|NCT03012334|584870436|FG004|Period 1|Withdrawal by Subject|0|||
161950360|NCT03012334|584870437|FG005|Period 1|Withdrawal by Subject|0|||
161950361|NCT03012334|584870438|FG006|Period 1|Withdrawal by Subject|0|||
161950362|NCT03012334|584870439|FG007|Period 1|Withdrawal by Subject|0|||
161950363|NCT03012334|584870440|FG008|Period 1|Withdrawal by Subject|0|||
161950364|NCT03012334|584870441|FG009|Period 1|Withdrawal by Subject|1|||
161950365|NCT03012334|584870432|FG000|Period 2|Withdrawal by Subject|0|||
161950366|NCT03012334|584870433|FG001|Period 2|Withdrawal by Subject|1|||
161950367|NCT03012334|584870434|FG002|Period 2|Withdrawal by Subject|0|||
161950368|NCT03012334|584870435|FG003|Period 2|Withdrawal by Subject|0|||
161950369|NCT03012334|584870436|FG004|Period 2|Withdrawal by Subject|0|||
161950370|NCT03012334|584870437|FG005|Period 2|Withdrawal by Subject|0|||
161950371|NCT03012334|584870438|FG006|Period 2|Withdrawal by Subject|0|||
161950372|NCT03012334|584870439|FG007|Period 2|Withdrawal by Subject|0|||
161950373|NCT03012334|584870440|FG008|Period 2|Withdrawal by Subject|0|||
161833646|NCT00856830|584433174|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
161833647|NCT00856830|584433175|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
161833648|NCT03768726|584433176|FG000|Treatment Phase|Adverse Event|2|||
161833649|NCT03768726|584433177|FG001|Treatment Phase|Adverse Event|2|||
161833650|NCT03768726|584433176|FG000|Treatment Phase|Lost to Follow-up|1|||
161833651|NCT03768726|584433177|FG001|Treatment Phase|Lost to Follow-up|0|||
161833652|NCT03768726|584433176|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
161833653|NCT03768726|584433177|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
161833654|NCT03768726|584433176|FG000|Treatment Phase|Withdrawal by Subject|3|||
161833655|NCT03768726|584433177|FG001|Treatment Phase|Withdrawal by Subject|1|||
161833656|NCT03768726|584433176|FG000|Follow-Up|Adverse Event|2|||
161833657|NCT03768726|584433177|FG001|Follow-Up|Adverse Event|2|||
161833658|NCT03768726|584433176|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
161833659|NCT03768726|584433177|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
161833660|NCT03768726|584433176|FG000|Follow-Up|Withdrawal by Subject|2|||
161833661|NCT03768726|584433177|FG001|Follow-Up|Withdrawal by Subject|0|||
161833662|NCT03768726|584433176|FG000|Follow-Up|Other|1|||
161833663|NCT03768726|584433177|FG001|Follow-Up|Other|0|||
161833664|NCT01744093|584433179|FG000|Overall Study|Withdrawal by Subject|6|||
161833665|NCT01744093|584433180|FG001|Overall Study|Withdrawal by Subject|1|||
161833666|NCT02006628|584433181|FG000|Overall Study|Adverse Event|1|||
161950374|NCT03012334|584870441|FG009|Period 2|Withdrawal by Subject|0|||
161950375|NCT03012334|584870432|FG000|Period 2|Protocol Violation|0|||
161950376|NCT03012334|584870433|FG001|Period 2|Protocol Violation|0|||
161685767|NCT00078325|583901961|FG001|Overall Study|Withdrawal by Subject|5|||
161685768|NCT00078325|583901962|FG002|Overall Study|Withdrawal by Subject|3|||
161685769|NCT00078325|583901960|FG000|Overall Study|Lost to Follow-up|0|||
161685770|NCT00078325|583901961|FG001|Overall Study|Lost to Follow-up|1|||
161685771|NCT00078325|583901962|FG002|Overall Study|Lost to Follow-up|1|||
161685772|NCT00078325|583901960|FG000|Overall Study|Physician Decision|2|||
161685773|NCT00078325|583901961|FG001|Overall Study|Physician Decision|0|||
161685774|NCT00078325|583901962|FG002|Overall Study|Physician Decision|1|||
161685775|NCT00078325|583901960|FG000|Overall Study|Miscellaneous|1|||
161950377|NCT03012334|584870434|FG002|Period 2|Protocol Violation|1|||
161950378|NCT03012334|584870435|FG003|Period 2|Protocol Violation|0|||
161685776|NCT00078325|583901961|FG001|Overall Study|Miscellaneous|1|||
161950379|NCT03012334|584870436|FG004|Period 2|Protocol Violation|0|||
161685777|NCT00078325|583901962|FG002|Overall Study|Miscellaneous|1|||
161833667|NCT02006628|584433182|FG001|Overall Study|Adverse Event|1|||
161833668|NCT02006628|584433181|FG000|Overall Study|Withdrawal by Subject|2|||
161833669|NCT02006628|584433182|FG001|Overall Study|Withdrawal by Subject|1|||
161833670|NCT03578237|584433185|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
161950380|NCT03012334|584870437|FG005|Period 2|Protocol Violation|0|||
161950381|NCT03012334|584870438|FG006|Period 2|Protocol Violation|0|||
161685778|NCT01473563|583901963|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
161685779|NCT03610724|583901964|FG000|Overall Study|Death|17|||
161685780|NCT03610724|583901964|FG000|Overall Study|Lost to Follow-up|1|||
161685781|NCT03610724|583901964|FG000|Overall Study|Physician Decision|1|||
161685782|NCT03610724|583901964|FG000|Overall Study|Died prior to infusion|1|||
161685783|NCT02943564|583901965|FG000|Overall Study|Miscellaneous Reasons|0|||
161685784|NCT02943564|583901966|FG001|Overall Study|Miscellaneous Reasons|0|||
161685785|NCT02943564|583901967|FG002|Overall Study|Miscellaneous Reasons|3|||
161685786|NCT02943564|583901965|FG000|Overall Study|Site terminated by sponsor|0|||
161685787|NCT02943564|583901966|FG001|Overall Study|Site terminated by sponsor|1|||
161685788|NCT02943564|583901967|FG002|Overall Study|Site terminated by sponsor|0|||
161685789|NCT02943564|583901965|FG000|Overall Study|Non-compliance with study drug|0|||
161685790|NCT02943564|583901966|FG001|Overall Study|Non-compliance with study drug|1|||
161685791|NCT02943564|583901967|FG002|Overall Study|Non-compliance with study drug|0|||
161685792|NCT02943564|583901965|FG000|Overall Study|Pregnancy|0|||
161685793|NCT02943564|583901966|FG001|Overall Study|Pregnancy|1|||
161685794|NCT02943564|583901967|FG002|Overall Study|Pregnancy|1|||
161685795|NCT02943564|583901965|FG000|Overall Study|Protocol Violation|2|||
161685796|NCT02943564|583901966|FG001|Overall Study|Protocol Violation|2|||
161685797|NCT02943564|583901967|FG002|Overall Study|Protocol Violation|2|||
161685798|NCT02943564|583901965|FG000|Overall Study|Lost to Follow-up|1|||
161685799|NCT02943564|583901966|FG001|Overall Study|Lost to Follow-up|0|||
161685800|NCT02943564|583901967|FG002|Overall Study|Lost to Follow-up|0|||
161685801|NCT02943564|583901965|FG000|Overall Study|Withdrawal by Subject|6|||
161685802|NCT02943564|583901966|FG001|Overall Study|Withdrawal by Subject|5|||
161685803|NCT02943564|583901967|FG002|Overall Study|Withdrawal by Subject|2|||
161685804|NCT02943564|583901965|FG000|Overall Study|Adverse Event|1|||
161685805|NCT02943564|583901966|FG001|Overall Study|Adverse Event|2|||
161685806|NCT02943564|583901967|FG002|Overall Study|Adverse Event|1|||
161685807|NCT02943564|583901965|FG000|Overall Study|Lack of Efficacy|0|||
161685808|NCT02943564|583901966|FG001|Overall Study|Lack of Efficacy|1|||
161685809|NCT02943564|583901967|FG002|Overall Study|Lack of Efficacy|0|||
161685810|NCT00932360|583901968|FG000|Washout (One Week)|Withdrawal by Subject|0|||
161685811|NCT00932360|583901969|FG001|Washout (One Week)|Withdrawal by Subject|0|||
161685812|NCT00932360|583901970|FG002|Washout (One Week)|Withdrawal by Subject|0|||
161685813|NCT00932360|583901971|FG003|Washout (One Week)|Withdrawal by Subject|0|||
161685814|NCT00932360|583901972|FG004|Washout (One Week)|Withdrawal by Subject|2|||
161685815|NCT00932360|583901973|FG005|Washout (One Week)|Withdrawal by Subject|0|||
161685816|NCT04143009|583901974|FG000|Pilot Trial|Lost to Follow-up|0|||
161685817|NCT04143009|583901975|FG001|Pilot Trial|Lost to Follow-up|1|||
161685818|NCT04143009|583901976|FG002|Pilot Trial|Lost to Follow-up|1|||
161685819|NCT00781911|583901981|FG000|Overall Study|Adverse Event|4|||
161685820|NCT00781911|583901982|FG001|Overall Study|Adverse Event|4|||
161685821|NCT00781911|583901981|FG000|Overall Study|Withdrawal by Subject|1|||
161685822|NCT00781911|583901982|FG001|Overall Study|Withdrawal by Subject|2|||
161685823|NCT00781911|583901981|FG000|Overall Study|Physician Decision|0|||
161685824|NCT00781911|583901982|FG001|Overall Study|Physician Decision|2|||
161685825|NCT00781911|583901981|FG000|Overall Study|Sponsor Decision|1|||
161685826|NCT00781911|583901982|FG001|Overall Study|Sponsor Decision|0|||
161685827|NCT01357655|583901983|FG000|Overall Study|Administrative Reason by Sponsor|45|||
161685828|NCT01357655|583901984|FG001|Overall Study|Administrative Reason by Sponsor|0|||
161685829|NCT01357655|583901983|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
161685830|NCT01357655|583901984|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
161685831|NCT01357655|583901983|FG000|Overall Study|Disease Progression|1|||
161685832|NCT01357655|583901984|FG001|Overall Study|Disease Progression|0|||
161685833|NCT01357655|583901983|FG000|Overall Study|Lost to Follow-up|2|||
161685834|NCT01357655|583901984|FG001|Overall Study|Lost to Follow-up|0|||
161685835|NCT01357655|583901983|FG000|Overall Study|Maximum Clinical Benefit|2|||
161685836|NCT01357655|583901984|FG001|Overall Study|Maximum Clinical Benefit|0|||
161685837|NCT01357655|583901983|FG000|Overall Study|Reason Unspecified|1|||
161685838|NCT01357655|583901984|FG001|Overall Study|Reason Unspecified|0|||
161685839|NCT01357655|583901983|FG000|Overall Study|Study Drug Toxicity|11|||
161685840|NCT01357655|583901984|FG001|Overall Study|Study Drug Toxicity|0|||
161685841|NCT01357655|583901983|FG000|Overall Study|Subject Withdrew Consent|1|||
161685842|NCT01357655|583901984|FG001|Overall Study|Subject Withdrew Consent|0|||
161685843|NCT01624662|583901988|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
161950382|NCT03012334|584870439|FG007|Period 2|Protocol Violation|1|||
161950383|NCT03012334|584870440|FG008|Period 2|Protocol Violation|0|||
161950384|NCT03012334|584870441|FG009|Period 2|Protocol Violation|0|||
161950385|NCT03012334|584870432|FG000|Period 4|Non-Compliance|0|||
161950386|NCT03012334|584870433|FG001|Period 4|Non-Compliance|0|||
161950387|NCT03012334|584870434|FG002|Period 4|Non-Compliance|0|||
161950388|NCT03012334|584870435|FG003|Period 4|Non-Compliance|0|||
161950389|NCT03012334|584870436|FG004|Period 4|Non-Compliance|0|||
161950390|NCT03012334|584870437|FG005|Period 4|Non-Compliance|0|||
161950391|NCT03012334|584870438|FG006|Period 4|Non-Compliance|1|||
161950392|NCT03012334|584870439|FG007|Period 4|Non-Compliance|0|||
161950393|NCT03012334|584870440|FG008|Period 4|Non-Compliance|0|||
161950394|NCT03012334|584870441|FG009|Period 4|Non-Compliance|0|||
161950395|NCT03012334|584870432|FG000|Period 4|Adverse Event|0|||
161950396|NCT03012334|584870433|FG001|Period 4|Adverse Event|0|||
161950397|NCT03012334|584870434|FG002|Period 4|Adverse Event|0|||
161950398|NCT03012334|584870435|FG003|Period 4|Adverse Event|0|||
161950399|NCT03012334|584870436|FG004|Period 4|Adverse Event|0|||
161950400|NCT03012334|584870437|FG005|Period 4|Adverse Event|0|||
161950401|NCT03012334|584870438|FG006|Period 4|Adverse Event|0|||
161950402|NCT03012334|584870439|FG007|Period 4|Adverse Event|0|||
161950403|NCT03012334|584870440|FG008|Period 4|Adverse Event|1|||
161950404|NCT03012334|584870441|FG009|Period 4|Adverse Event|0|||
161950405|NCT01823107|584870442|FG000|Overall Study|Withdrawal by Subject|1|||
161950406|NCT01073293|584870443|FG000|Overall Study|Lost to Follow-up|0|||
161950407|NCT01073293|584870444|FG001|Overall Study|Lost to Follow-up|1|||
161950408|NCT01073293|584870443|FG000|Overall Study|Withdrawal by Subject|5|||
161950409|NCT01073293|584870444|FG001|Overall Study|Withdrawal by Subject|10|||
161950410|NCT00328172|584870447|FG000|Overall Study|Adverse Event|3|||
161950411|NCT00328172|584870448|FG001|Overall Study|Adverse Event|2|||
161950412|NCT00328172|584870449|FG002|Overall Study|Adverse Event|1|||
161950413|NCT00328172|584870450|FG003|Overall Study|Adverse Event|2|||
161833671|NCT03578237|584433186|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
161833672|NCT02370914|584433192|FG000|Overall Study|Protocol Violation|2|||
161833673|NCT00252174|584433193|FG000|Overall Study|Withdrawal by Subject|0|||
161833674|NCT00252174|584433194|FG001|Overall Study|Withdrawal by Subject|1|||
161833675|NCT00252174|584433195|FG002|Overall Study|Withdrawal by Subject|0|||
161833676|NCT01138826|584433196|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
161833677|NCT01138826|584433197|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
161833678|NCT01138826|584433198|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
161833679|NCT01138826|584433199|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
161833680|NCT01138826|584433200|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
161833681|NCT01138826|584433201|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
161833682|NCT02566993|584433202|FG000|Overall Study|Randomized but not treated|5|||
161833683|NCT02566993|584433203|FG001|Overall Study|Randomized but not treated|16|||
161833684|NCT02566993|584433202|FG000|Overall Study|Progressive disease|213|||
161833685|NCT02566993|584433203|FG001|Overall Study|Progressive disease|152|||
161833686|NCT02566993|584433202|FG000|Overall Study|Withdrawal by Subject|12|||
161833687|NCT02566993|584433203|FG001|Overall Study|Withdrawal by Subject|28|||
161833688|NCT02566993|584433202|FG000|Overall Study|Death|17|||
161833689|NCT02566993|584433203|FG001|Overall Study|Death|23|||
161833690|NCT02566993|584433202|FG000|Overall Study|Physician Decision|10|||
161833691|NCT02566993|584433203|FG001|Overall Study|Physician Decision|17|||
161833692|NCT02566993|584433202|FG000|Overall Study|Study drug-related adverse event|20|||
161833693|NCT02566993|584433203|FG001|Overall Study|Study drug-related adverse event|41|||
161833694|NCT02566993|584433202|FG000|Overall Study|Non study drug-related adverse event|9|||
161833695|NCT02566993|584433203|FG001|Overall Study|Non study drug-related adverse event|9|||
161833696|NCT02566993|584433202|FG000|Overall Study|Symptomatic deterioration|9|||
161833697|NCT02566993|584433203|FG001|Overall Study|Symptomatic deterioration|16|||
161685844|NCT01624662|583901989|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
161685845|NCT01624662|583901990|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
161685846|NCT01624662|583901991|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
161833698|NCT02566993|584433202|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
161833699|NCT02566993|584433203|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
161685847|NCT01624662|583901988|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
161833700|NCT02566993|584433202|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
161833701|NCT02566993|584433203|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
161950414|NCT00328172|584870451|FG004|Overall Study|Adverse Event|1|||
161950415|NCT00328172|584870447|FG000|Overall Study|Protocol Violation|0|||
161950416|NCT00328172|584870448|FG001|Overall Study|Protocol Violation|1|||
161950417|NCT00328172|584870449|FG002|Overall Study|Protocol Violation|1|||
161685848|NCT01624662|583901989|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
161685849|NCT01624662|583901990|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
161685850|NCT01624662|583901991|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
161833702|NCT02566993|584433202|FG000|Overall Study|Screening failure|2|||
161950418|NCT00328172|584870450|FG003|Overall Study|Protocol Violation|0|||
161950419|NCT00328172|584870451|FG004|Overall Study|Protocol Violation|0|||
161950420|NCT00328172|584870447|FG000|Overall Study|Lost to Follow-up|1|||
161685851|NCT01624662|583901988|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161685852|NCT01624662|583901989|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
161950421|NCT00328172|584870448|FG001|Overall Study|Lost to Follow-up|1|||
161950422|NCT00328172|584870449|FG002|Overall Study|Lost to Follow-up|2|||
161950423|NCT00328172|584870450|FG003|Overall Study|Lost to Follow-up|1|||
161950424|NCT00328172|584870451|FG004|Overall Study|Lost to Follow-up|1|||
161950425|NCT00328172|584870447|FG000|Overall Study|Withdrawal by Subject|1|||
161950426|NCT00328172|584870448|FG001|Overall Study|Withdrawal by Subject|1|||
161950427|NCT00328172|584870449|FG002|Overall Study|Withdrawal by Subject|1|||
161685853|NCT01624662|583901990|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161833703|NCT02566993|584433203|FG001|Overall Study|Screening failure|0|||
161833704|NCT02566993|584433202|FG000|Overall Study|Lost to Follow-up|0|||
161833705|NCT02566993|584433203|FG001|Overall Study|Lost to Follow-up|1|||
161833706|NCT02566993|584433202|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
161833707|NCT02566993|584433203|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
161833708|NCT05206448|584433204|FG000|Overall Study|Lost to Follow-up|2|||
161833709|NCT05206448|584433205|FG001|Overall Study|Lost to Follow-up|2|||
161833710|NCT05206448|584433204|FG000|Overall Study|Withdrawal by Subject|2|||
161833711|NCT05206448|584433205|FG001|Overall Study|Withdrawal by Subject|0|||
161833712|NCT05206448|584433204|FG000|Overall Study|found ineligible after randomization|1|||
161833713|NCT05206448|584433205|FG001|Overall Study|found ineligible after randomization|1|||
161833714|NCT05206448|584433204|FG000|Overall Study|unable to complete study due to personal constraints|1|||
161833715|NCT05206448|584433205|FG001|Overall Study|unable to complete study due to personal constraints|0|||
161833716|NCT05206448|584433204|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
161833717|NCT05206448|584433205|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
161833718|NCT04572243|584433208|FG000|Core Study: 14 Weeks|Adverse Event|1|||
161833719|NCT04572243|584433209|FG001|Core Study: 14 Weeks|Adverse Event|2|||
161833720|NCT04572243|584433210|FG002|Core Study: 14 Weeks|Adverse Event|0|||
161833721|NCT04572243|584433211|FG003|Core Study: 14 Weeks|Adverse Event|0|||
161833722|NCT04572243|584433208|FG000|Core Study: 14 Weeks|Subject choice|0|||
161833723|NCT04572243|584433209|FG001|Core Study: 14 Weeks|Subject choice|2|||
161833724|NCT04572243|584433210|FG002|Core Study: 14 Weeks|Subject choice|0|||
161833725|NCT04572243|584433211|FG003|Core Study: 14 Weeks|Subject choice|0|||
161833726|NCT04572243|584433208|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
161833727|NCT04572243|584433209|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
161833728|NCT04572243|584433210|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
161833729|NCT04572243|584433211|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
161833730|NCT04572243|584433208|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
161833731|NCT04572243|584433209|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
161833732|NCT04572243|584433210|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
161685854|NCT01624662|583901991|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161685855|NCT01624662|583901988|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
161833733|NCT04572243|584433211|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
161950428|NCT00328172|584870450|FG003|Overall Study|Withdrawal by Subject|6|||
161950429|NCT00328172|584870451|FG004|Overall Study|Withdrawal by Subject|0|||
161950430|NCT00328172|584870447|FG000|Overall Study|Lack of Efficacy|14|||
161950431|NCT00328172|584870448|FG001|Overall Study|Lack of Efficacy|9|||
161950432|NCT00328172|584870449|FG002|Overall Study|Lack of Efficacy|4|||
161950433|NCT00328172|584870450|FG003|Overall Study|Lack of Efficacy|4|||
161950434|NCT00328172|584870451|FG004|Overall Study|Lack of Efficacy|3|||
161950435|NCT00328172|584870447|FG000|Overall Study|Other reason (not specified)|3|||
161950436|NCT00328172|584870448|FG001|Overall Study|Other reason (not specified)|0|||
161950437|NCT00328172|584870449|FG002|Overall Study|Other reason (not specified)|1|||
161950438|NCT00328172|584870450|FG003|Overall Study|Other reason (not specified)|0|||
161950439|NCT00328172|584870451|FG004|Overall Study|Other reason (not specified)|0|||
161950440|NCT00077974|584870452|FG000|Overall Study|Adverse Event|22|||
161950441|NCT00077974|584870452|FG000|Overall Study|Protocol Violation|1|||
161950442|NCT00077974|584870452|FG000|Overall Study|Withdrawal by Subject|3|||
161950443|NCT00077974|584870452|FG000|Overall Study|Lack of Efficacy|76|||
161950444|NCT00077974|584870452|FG000|Overall Study|Decision of Sponsor|2|||
161950445|NCT02897115|584870455|FG000|Overall Study|Early termination of study by sponsor|11|||
161950446|NCT02897115|584870456|FG001|Overall Study|Early termination of study by sponsor|8|||
161950447|NCT04512001|584870459|FG000|Week 0 to Week 24|Adverse Event|14|||
161950448|NCT04512001|584870460|FG001|Week 0 to Week 24|Adverse Event|10|||
161950449|NCT04512001|584870461|FG002|Week 0 to Week 24|Adverse Event|0|||
161950450|NCT04512001|584870462|FG003|Week 0 to Week 24|Adverse Event|0|||
161950451|NCT04512001|584870463|FG004|Week 0 to Week 24|Adverse Event|0|||
161685856|NCT01624662|583901989|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
161685857|NCT01624662|583901990|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
161685858|NCT01624662|583901991|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
161685859|NCT01624662|583901988|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
161685860|NCT01624662|583901989|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
161685861|NCT01624662|583901990|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
161685862|NCT01624662|583901991|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
161685863|NCT01624662|583901988|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161685864|NCT01624662|583901989|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
161950452|NCT04512001|584870459|FG000|Week 0 to Week 24|Death|0|||
161950453|NCT04512001|584870460|FG001|Week 0 to Week 24|Death|2|||
161950454|NCT04512001|584870461|FG002|Week 0 to Week 24|Death|0|||
161950455|NCT04512001|584870462|FG003|Week 0 to Week 24|Death|0|||
161950456|NCT04512001|584870463|FG004|Week 0 to Week 24|Death|0|||
161950457|NCT04512001|584870459|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
161950458|NCT04512001|584870460|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
161950459|NCT04512001|584870461|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
161950460|NCT04512001|584870462|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
161950461|NCT04512001|584870463|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
161833734|NCT01661881|584433212|FG000|Overall Study|Disease Progression|1|||
161950462|NCT04512001|584870459|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
161950463|NCT04512001|584870460|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
161950464|NCT04512001|584870461|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
161950465|NCT04512001|584870462|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
161950466|NCT04512001|584870463|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
161950467|NCT04512001|584870459|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
161950468|NCT04512001|584870460|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
161950469|NCT04512001|584870461|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
161950470|NCT04512001|584870462|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
161685865|NCT01624662|583901990|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161685866|NCT01624662|583901991|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161685867|NCT01624662|583901988|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
161685868|NCT01624662|583901989|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
161685869|NCT01624662|583901990|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
161685870|NCT01624662|583901991|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
161685871|NCT00361270|583901992|FG000|Overall Study|Death|0|||
161685872|NCT00361270|583901993|FG001|Overall Study|Death|0|||
161685873|NCT00361270|583901994|FG002|Overall Study|Death|0|||
161685874|NCT00361270|583901995|FG003|Overall Study|Death|2|||
161950471|NCT04512001|584870463|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
161950472|NCT04512001|584870459|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
161950473|NCT04512001|584870460|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
161950474|NCT04512001|584870461|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
161685875|NCT00361270|583901992|FG000|Overall Study|Lost to Follow-up|4|||
161685876|NCT00361270|583901993|FG001|Overall Study|Lost to Follow-up|1|||
161950475|NCT04512001|584870462|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
161950476|NCT04512001|584870463|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
161950477|NCT04512001|584870459|FG000|Week 24 to Week 63|Adverse Event|0|||
161950478|NCT04512001|584870460|FG001|Week 24 to Week 63|Adverse Event|0|||
161950479|NCT04512001|584870461|FG002|Week 24 to Week 63|Adverse Event|13|||
161950480|NCT04512001|584870462|FG003|Week 24 to Week 63|Adverse Event|8|||
161950481|NCT04512001|584870463|FG004|Week 24 to Week 63|Adverse Event|6|||
161950482|NCT04512001|584870459|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
161950483|NCT04512001|584870460|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
161950484|NCT04512001|584870461|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
161950485|NCT04512001|584870462|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
161950486|NCT04512001|584870463|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
161950487|NCT04512001|584870459|FG000|Week 24 to Week 63|Death|0|||
161950488|NCT04512001|584870460|FG001|Week 24 to Week 63|Death|0|||
161950489|NCT04512001|584870461|FG002|Week 24 to Week 63|Death|0|||
161950490|NCT04512001|584870462|FG003|Week 24 to Week 63|Death|1|||
161950491|NCT04512001|584870463|FG004|Week 24 to Week 63|Death|1|||
161950492|NCT04512001|584870459|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
161950493|NCT04512001|584870460|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
161950494|NCT04512001|584870461|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
161950495|NCT04512001|584870462|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
161950496|NCT04512001|584870463|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
161950497|NCT04512001|584870459|FG000|Week 24 to Week 63|Miscellaneous|0|||
161950498|NCT04512001|584870460|FG001|Week 24 to Week 63|Miscellaneous|0|||
161950499|NCT04512001|584870461|FG002|Week 24 to Week 63|Miscellaneous|3|||
161950500|NCT04512001|584870462|FG003|Week 24 to Week 63|Miscellaneous|2|||
161950501|NCT04512001|584870463|FG004|Week 24 to Week 63|Miscellaneous|1|||
161950502|NCT04232943|584870464|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
161950503|NCT04232943|584870465|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
161950504|NCT04232943|584870466|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
161950505|NCT04232943|584870464|FG000|Overall Study|Withdrawal by Subject|1|||
161950506|NCT04232943|584870465|FG001|Overall Study|Withdrawal by Subject|1|||
161950507|NCT04232943|584870466|FG002|Overall Study|Withdrawal by Subject|0|||
161950508|NCT03896477|584870472|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
161950509|NCT03896477|584870473|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
161950510|NCT03896477|584870474|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
161950511|NCT03896477|584870472|FG000|Overall Study|Parent Requested Withdrawal|8|||
161950512|NCT03896477|584870473|FG001|Overall Study|Parent Requested Withdrawal|12|||
161950513|NCT03896477|584870474|FG002|Overall Study|Parent Requested Withdrawal|9|||
161950514|NCT03896477|584870472|FG000|Overall Study|Adverse Event|0|||
161950515|NCT03896477|584870473|FG001|Overall Study|Adverse Event|0|||
161950516|NCT03896477|584870474|FG002|Overall Study|Adverse Event|1|||
161950517|NCT03896477|584870472|FG000|Overall Study|Death|1|||
161950518|NCT03896477|584870473|FG001|Overall Study|Death|0|||
161950519|NCT03896477|584870474|FG002|Overall Study|Death|0|||
161950520|NCT03896477|584870472|FG000|Overall Study|Other|5|||
161950521|NCT03896477|584870473|FG001|Overall Study|Other|6|||
161950522|NCT03896477|584870474|FG002|Overall Study|Other|7|||
161950523|NCT03896477|584870472|FG000|Overall Study|Lost to Follow-up|2|||
161950524|NCT03896477|584870473|FG001|Overall Study|Lost to Follow-up|1|||
161950525|NCT03896477|584870474|FG002|Overall Study|Lost to Follow-up|1|||
161950526|NCT01106157|584870478|FG000|Overall Study|Withdrawal by Subject|1|||
161950527|NCT01106157|584870479|FG001|Overall Study|Withdrawal by Subject|0|||
161950528|NCT02298868|584870483|FG000|Overall Study|Adverse Event|1|||
161950529|NCT02298868|584870483|FG000|Overall Study|Death|1|||
161950530|NCT02298868|584870483|FG000|Overall Study|Patient underwent transplant|1|||
161950531|NCT01063348|584870484|FG000|Overall Study|Lost to Follow-up|3|||
161950532|NCT01063348|584870485|FG001|Overall Study|Lost to Follow-up|10|||
161950533|NCT04068922|584870486|FG000|Overall Study|Lost to Follow-up|5|||
161950534|NCT04068922|584870486|FG000|Overall Study|Withdrawal by Subject|7|||
161950535|NCT04068922|584870486|FG000|Overall Study|Adverse Event|1|||
161950536|NCT00907621|584870488|FG000|Overall Study|Lost to Follow-up|6|||
161950537|NCT00907621|584870489|FG001|Overall Study|Lost to Follow-up|3|||
161950538|NCT00907621|584870488|FG000|Overall Study|intercurrent febrile illness|1|||
161950539|NCT00907621|584870489|FG001|Overall Study|intercurrent febrile illness|1|||
161950540|NCT00959907|584870490|FG000|Overall Study|Protocol Violation|0|||
161950541|NCT00959907|584870491|FG001|Overall Study|Protocol Violation|1|||
161950542|NCT00959907|584870490|FG000|Overall Study|Adverse Event|1|||
161950543|NCT00959907|584870491|FG001|Overall Study|Adverse Event|0|||
161950544|NCT00959907|584870490|FG000|Overall Study|Withdrawal by Subject|2|||
161950545|NCT00959907|584870491|FG001|Overall Study|Withdrawal by Subject|0|||
161950546|NCT00716274|584870497|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
161950547|NCT00716274|584870498|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
161950548|NCT00716274|584870499|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
161950549|NCT00716274|584870500|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
161950550|NCT00716274|584870501|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
161950551|NCT00716274|584870502|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
161685877|NCT00361270|583901994|FG002|Overall Study|Lost to Follow-up|0|||
161685878|NCT00361270|583901995|FG003|Overall Study|Lost to Follow-up|0|||
161685879|NCT00361270|583901992|FG000|Overall Study|Physician Decision|0|||
161685880|NCT00361270|583901993|FG001|Overall Study|Physician Decision|0|||
161685881|NCT00361270|583901994|FG002|Overall Study|Physician Decision|1|||
161685882|NCT00361270|583901995|FG003|Overall Study|Physician Decision|0|||
161685883|NCT00361270|583901992|FG000|Overall Study|Protocol Violation|9|||
161685884|NCT00361270|583901993|FG001|Overall Study|Protocol Violation|4|||
161685885|NCT00361270|583901994|FG002|Overall Study|Protocol Violation|5|||
161685886|NCT00361270|583901995|FG003|Overall Study|Protocol Violation|4|||
161685887|NCT00361270|583901992|FG000|Overall Study|Withdrawal by Subject|6|||
161685888|NCT00361270|583901993|FG001|Overall Study|Withdrawal by Subject|6|||
161685889|NCT00361270|583901994|FG002|Overall Study|Withdrawal by Subject|3|||
161950552|NCT00716274|584870497|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
161950553|NCT00716274|584870498|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
161950554|NCT00716274|584870499|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
161950555|NCT00716274|584870500|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
161950556|NCT00716274|584870501|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
161950557|NCT00716274|584870502|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
161950558|NCT00716274|584870497|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
161950559|NCT00716274|584870498|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
161950560|NCT00716274|584870499|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
161950561|NCT00716274|584870500|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
161950562|NCT00716274|584870501|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
161950563|NCT00716274|584870502|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
161950564|NCT00716274|584870497|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
161950565|NCT00716274|584870498|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
161950566|NCT00716274|584870499|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
161950567|NCT00716274|584870500|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
161950568|NCT00716274|584870501|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
161950569|NCT00716274|584870502|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
161950570|NCT00716274|584870497|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
161950571|NCT00716274|584870498|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
161950572|NCT00716274|584870499|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
161950573|NCT00716274|584870500|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
161950574|NCT00716274|584870501|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
161950575|NCT00716274|584870502|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
161950576|NCT00716274|584870497|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
161950577|NCT00716274|584870498|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
161950578|NCT00716274|584870499|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
161950579|NCT00716274|584870500|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
161950580|NCT00716274|584870501|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
161950581|NCT00716274|584870502|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
161833735|NCT01790113|584433213|FG000|Overall Study|Adverse Event|2|||
161833736|NCT01790113|584433214|FG001|Overall Study|Adverse Event|7|||
161833737|NCT01790113|584433213|FG000|Overall Study|Study ended due to FDA clearance|1|||
161833738|NCT01790113|584433214|FG001|Overall Study|Study ended due to FDA clearance|68|||
161833739|NCT03451006|584433215|FG000|Overall Study|Withdrawal by Subject|2|||
161833740|NCT03451006|584433216|FG001|Overall Study|Withdrawal by Subject|2|||
161833741|NCT00775606|584433217|FG000|Overall Study|Study sponsor terminated funding|3|||
161833742|NCT00775606|584433218|FG001|Overall Study|Study sponsor terminated funding|0|||
161833743|NCT02278718|584433219|FG000|Overall Study|Adverse Event|1|||
161833744|NCT02278718|584433220|FG001|Overall Study|Adverse Event|0|||
161833745|NCT02278718|584433219|FG000|Overall Study|Lost to Follow-up|2|||
161833746|NCT02278718|584433220|FG001|Overall Study|Lost to Follow-up|4|||
161833747|NCT02278718|584433219|FG000|Overall Study|Withdrawal by Subject|1|||
161833748|NCT02278718|584433220|FG001|Overall Study|Withdrawal by Subject|4|||
161833749|NCT02278718|584433219|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
161833750|NCT02278718|584433220|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
161833751|NCT02278718|584433219|FG000|Overall Study|Missing|0|||
161833752|NCT02278718|584433220|FG001|Overall Study|Missing|1|||
161833753|NCT04440449|584433221|FG000|Overall Study|Lost to Follow-up|2|||
161833754|NCT04440449|584433222|FG001|Overall Study|Lost to Follow-up|0|||
161833755|NCT02547766|584433223|FG000|Overall Study|Withdrawal by Subject|1|||
161833756|NCT03212794|584433224|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
161833757|NCT03212794|584433225|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
161833758|NCT03212794|584433224|FG000|Overall Study|Lost to Follow-up|5|||
161833759|NCT03212794|584433225|FG001|Overall Study|Lost to Follow-up|6|||
161833760|NCT03212794|584433224|FG000|Overall Study|Incarcerated; unable to participate|2|||
161833761|NCT03212794|584433225|FG001|Overall Study|Incarcerated; unable to participate|0|||
161833762|NCT03212794|584433224|FG000|Overall Study|Withdrawal by Subject|1|||
161833763|NCT03212794|584433225|FG001|Overall Study|Withdrawal by Subject|0|||
161833764|NCT03212794|584433224|FG000|Overall Study|Death|0|||
161833765|NCT03212794|584433225|FG001|Overall Study|Death|1|||
161833766|NCT03212794|584433224|FG000|Overall Study|Found to be ineligible after allocation|0|||
161833767|NCT03212794|584433225|FG001|Overall Study|Found to be ineligible after allocation|1|||
161833768|NCT03212794|584433224|FG000|Overall Study|Relocated out of area|2|||
161833769|NCT03212794|584433225|FG001|Overall Study|Relocated out of area|0|||
161833770|NCT00897949|584433228|FG000|Overall Study|Adverse Event|1|||
161833771|NCT00897949|584433229|FG001|Overall Study|Adverse Event|1|||
161833772|NCT00897949|584433230|FG002|Overall Study|Adverse Event|0|||
161833773|NCT00897949|584433228|FG000|Overall Study|Lost to Follow-up|0|||
161833774|NCT00897949|584433229|FG001|Overall Study|Lost to Follow-up|2|||
161833775|NCT00897949|584433230|FG002|Overall Study|Lost to Follow-up|1|||
161833776|NCT00897949|584433228|FG000|Overall Study|Protocol Violation|6|||
161833777|NCT00897949|584433229|FG001|Overall Study|Protocol Violation|3|||
161833778|NCT00897949|584433230|FG002|Overall Study|Protocol Violation|1|||
161833779|NCT00897949|584433228|FG000|Overall Study|Withdrawal by Subject|1|||
161833780|NCT00897949|584433229|FG001|Overall Study|Withdrawal by Subject|2|||
161833781|NCT00897949|584433230|FG002|Overall Study|Withdrawal by Subject|0|||
161833782|NCT00897949|584433228|FG000|Overall Study|Patient Uncoorperative|0|||
161833783|NCT00897949|584433229|FG001|Overall Study|Patient Uncoorperative|2|||
161833784|NCT00897949|584433230|FG002|Overall Study|Patient Uncoorperative|1|||
161833785|NCT00897949|584433228|FG000|Overall Study|Lost to Follow-up|30|||
161833786|NCT00897949|584433229|FG001|Overall Study|Lost to Follow-up|23|||
161833787|NCT00897949|584433230|FG002|Overall Study|Lost to Follow-up|17|||
161833788|NCT00897949|584433228|FG000|Overall Study|Withdrawal by Subject|24|||
161833789|NCT00897949|584433229|FG001|Overall Study|Withdrawal by Subject|31|||
161833790|NCT00897949|584433230|FG002|Overall Study|Withdrawal by Subject|17|||
161833791|NCT00897949|584433228|FG000|Overall Study|Abnormal Prestudy Labs|2|||
161833792|NCT00897949|584433229|FG001|Overall Study|Abnormal Prestudy Labs|3|||
161833793|NCT00897949|584433230|FG002|Overall Study|Abnormal Prestudy Labs|4|||
161833794|NCT00897949|584433228|FG000|Overall Study|Abnormal Baseline ECG|2|||
161833795|NCT00897949|584433229|FG001|Overall Study|Abnormal Baseline ECG|2|||
161833796|NCT00897949|584433230|FG002|Overall Study|Abnormal Baseline ECG|4|||
161833797|NCT00897949|584433228|FG000|Overall Study|Need for Concom. Med.|0|||
161833798|NCT00897949|584433229|FG001|Overall Study|Need for Concom. Med.|1|||
161833799|NCT00897949|584433230|FG002|Overall Study|Need for Concom. Med.|1|||
161833800|NCT00897949|584433228|FG000|Overall Study|Lack of Migraine Attack|29|||
161833801|NCT00897949|584433229|FG001|Overall Study|Lack of Migraine Attack|30|||
161833802|NCT00897949|584433230|FG002|Overall Study|Lack of Migraine Attack|19|||
161833803|NCT00897949|584433228|FG000|Overall Study|Did not take study drug|9|||
161833804|NCT00897949|584433229|FG001|Overall Study|Did not take study drug|3|||
161685890|NCT00361270|583901995|FG003|Overall Study|Withdrawal by Subject|7|||
161685891|NCT00361270|583901992|FG000|Overall Study|Afraid of Hypnosis|1|||
161685892|NCT00361270|583901993|FG001|Overall Study|Afraid of Hypnosis|2|||
161685893|NCT00361270|583901994|FG002|Overall Study|Afraid of Hypnosis|0|||
161685894|NCT00361270|583901995|FG003|Overall Study|Afraid of Hypnosis|0|||
161685895|NCT00361270|583901992|FG000|Overall Study|Problems with Transportation|4|||
161685896|NCT00361270|583901993|FG001|Overall Study|Problems with Transportation|0|||
161685897|NCT00361270|583901994|FG002|Overall Study|Problems with Transportation|0|||
161685898|NCT00361270|583901995|FG003|Overall Study|Problems with Transportation|0|||
161685899|NCT00361270|583901992|FG000|Overall Study|Adverse Event|0|||
161685900|NCT00361270|583901993|FG001|Overall Study|Adverse Event|1|||
161685901|NCT00361270|583901994|FG002|Overall Study|Adverse Event|1|||
161685902|NCT00361270|583901995|FG003|Overall Study|Adverse Event|0|||
161685903|NCT01423851|583901999|FG000|Whole Study|Disease progression|2|||
161685904|NCT01423851|583902000|FG001|Whole Study|Disease progression|1|||
161685905|NCT01423851|583902001|FG002|Whole Study|Disease progression|1|||
161685906|NCT01423851|583902002|FG003|Whole Study|Disease progression|4|||
161685907|NCT01423851|583902003|FG004|Whole Study|Disease progression|1|||
161685908|NCT01423851|583902004|FG005|Whole Study|Disease progression|3|||
161685909|NCT01423851|583902005|FG006|Whole Study|Disease progression|1|||
161685910|NCT01423851|583902006|FG007|Whole Study|Disease progression|4|||
161685911|NCT01423851|583902007|FG008|Whole Study|Disease progression|0|||
161685912|NCT01423851|583902008|FG009|Whole Study|Disease progression|2|||
161685913|NCT01423851|583902009|FG010|Whole Study|Disease progression|10|||
161685914|NCT01423851|583901999|FG000|Whole Study|Physician Decision|0|||
161685915|NCT01423851|583902000|FG001|Whole Study|Physician Decision|1|||
161685916|NCT01423851|583902001|FG002|Whole Study|Physician Decision|2|||
161685917|NCT01423851|583902002|FG003|Whole Study|Physician Decision|0|||
161685918|NCT01423851|583902003|FG004|Whole Study|Physician Decision|2|||
161685919|NCT01423851|583902004|FG005|Whole Study|Physician Decision|0|||
161685920|NCT01423851|583902005|FG006|Whole Study|Physician Decision|2|||
161685921|NCT01423851|583902006|FG007|Whole Study|Physician Decision|1|||
161685922|NCT01423851|583902007|FG008|Whole Study|Physician Decision|3|||
161685923|NCT01423851|583902008|FG009|Whole Study|Physician Decision|4|||
161685924|NCT01423851|583902009|FG010|Whole Study|Physician Decision|12|||
161685925|NCT01423851|583901999|FG000|Whole Study|Withdrawal by Subject|1|||
161685926|NCT01423851|583902000|FG001|Whole Study|Withdrawal by Subject|1|||
161685927|NCT01423851|583902001|FG002|Whole Study|Withdrawal by Subject|0|||
161685928|NCT01423851|583902002|FG003|Whole Study|Withdrawal by Subject|0|||
161685929|NCT01423851|583902003|FG004|Whole Study|Withdrawal by Subject|0|||
161685930|NCT01423851|583902004|FG005|Whole Study|Withdrawal by Subject|0|||
161685931|NCT01423851|583902005|FG006|Whole Study|Withdrawal by Subject|0|||
161685932|NCT01423851|583902006|FG007|Whole Study|Withdrawal by Subject|0|||
161685933|NCT01423851|583902007|FG008|Whole Study|Withdrawal by Subject|2|||
161685934|NCT01423851|583902008|FG009|Whole Study|Withdrawal by Subject|0|||
161685935|NCT01423851|583902009|FG010|Whole Study|Withdrawal by Subject|4|||
161685936|NCT01423851|583901999|FG000|Whole Study|Adverse Event|0|||
161685937|NCT01423851|583902000|FG001|Whole Study|Adverse Event|0|||
161685938|NCT01423851|583902001|FG002|Whole Study|Adverse Event|0|||
161685939|NCT01423851|583902002|FG003|Whole Study|Adverse Event|2|||
161833805|NCT00897949|584433230|FG002|Overall Study|Did not take study drug|4|||
161833806|NCT01763918|584433231|FG000|Overall Study|Withdrawal by Subject|2|||
161950582|NCT00716274|584870497|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
161685940|NCT01423851|583902003|FG004|Whole Study|Adverse Event|0|||
161685941|NCT01423851|583902004|FG005|Whole Study|Adverse Event|0|||
161685942|NCT01423851|583902005|FG006|Whole Study|Adverse Event|0|||
161685943|NCT01423851|583902006|FG007|Whole Study|Adverse Event|3|||
161685944|NCT01423851|583902007|FG008|Whole Study|Adverse Event|3|||
161685945|NCT01423851|583902008|FG009|Whole Study|Adverse Event|2|||
161685946|NCT01423851|583902009|FG010|Whole Study|Adverse Event|3|||
161685947|NCT00874120|583903267|FG000|First Intervention|Adverse Event|0|||
161833807|NCT01763918|584433232|FG001|Overall Study|Withdrawal by Subject|1|||
161950583|NCT00716274|584870498|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
161950584|NCT00716274|584870499|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
161950585|NCT00716274|584870500|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
161950586|NCT00716274|584870501|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
161950587|NCT00716274|584870502|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
161950588|NCT00716274|584870497|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
161950589|NCT00716274|584870498|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
161950590|NCT00716274|584870499|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
161950591|NCT00716274|584870500|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
161950592|NCT00716274|584870501|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
161950593|NCT00716274|584870502|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
161950594|NCT00716274|584870497|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
161950595|NCT00716274|584870498|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
161950596|NCT00716274|584870499|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
161950597|NCT00716274|584870500|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
161950598|NCT00716274|584870501|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
161950599|NCT00716274|584870502|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
161950600|NCT00716274|584870497|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
161950601|NCT00716274|584870498|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
161950602|NCT00716274|584870499|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
161950603|NCT00716274|584870500|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
161950604|NCT00716274|584870501|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
161950605|NCT00716274|584870502|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
161950606|NCT01342094|584870503|FG000|Overall Study|Adverse Event|5|||
161950607|NCT01342094|584870504|FG001|Overall Study|Adverse Event|0|||
161950608|NCT01342094|584870503|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161950609|NCT01342094|584870504|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161950610|NCT01342094|584870503|FG000|Overall Study|Withdrawal by Subject|0|||
161950611|NCT01342094|584870504|FG001|Overall Study|Withdrawal by Subject|2|||
161950612|NCT02806414|584870507|FG000|Overall Study|Lost to Follow-up|2|||
161950613|NCT05653700|584870519|FG000|Overall Study|Non Responders|9|||
161950614|NCT05653700|584870520|FG001|Overall Study|Non Responders|0|||
161685948|NCT00874120|583903268|FG001|First Intervention|Adverse Event|1|||
161950615|NCT00543985|584870525|FG000|Overall Study|Withdrawal by Subject|4|||
161950616|NCT01634152|584870526|FG000|Overall Study|Adverse Event|2|||
161950617|NCT01634152|584870527|FG001|Overall Study|Adverse Event|0|||
161950618|NCT01634152|584870528|FG002|Overall Study|Adverse Event|2|||
161833808|NCT01763918|584433233|FG002|Overall Study|Withdrawal by Subject|1|||
161685949|NCT00874120|583903267|FG000|First Intervention|Withdrawal by Subject|2|||
161833809|NCT01763918|584433234|FG003|Overall Study|Withdrawal by Subject|2|||
161950619|NCT01634152|584870526|FG000|Overall Study|Consent withdrawn not due to AE|1|||
161685950|NCT00874120|583903268|FG001|First Intervention|Withdrawal by Subject|0|||
161685951|NCT00874120|583903267|FG000|First Intervention|Lost to Follow-up|0|||
161685952|NCT00874120|583903268|FG001|First Intervention|Lost to Follow-up|1|||
161685953|NCT00874120|583903267|FG000|First Intervention|Protocol Violation|3|||
161685954|NCT00874120|583903268|FG001|First Intervention|Protocol Violation|0|||
161685955|NCT00874120|583903267|FG000|First Intervention|positive drug test|1|||
161685956|NCT00874120|583903268|FG001|First Intervention|positive drug test|0|||
161685957|NCT00874120|583903267|FG000|Second Intervention|Withdrawal by Subject|1|||
161685958|NCT00874120|583903268|FG001|Second Intervention|Withdrawal by Subject|0|||
161685959|NCT00874120|583903267|FG000|Second Intervention|Protocol Violation|1|||
161685960|NCT00874120|583903268|FG001|Second Intervention|Protocol Violation|0|||
161685961|NCT00105443|583903274|FG000|Double-Blind Treatment|Adverse Event|1|||
161950620|NCT01634152|584870527|FG001|Overall Study|Consent withdrawn not due to AE|0|||
161950621|NCT01634152|584870528|FG002|Overall Study|Consent withdrawn not due to AE|1|||
161950622|NCT01634152|584870526|FG000|Overall Study|Not treated|0|||
161950623|NCT01634152|584870527|FG001|Overall Study|Not treated|1|||
161950624|NCT01634152|584870528|FG002|Overall Study|Not treated|0|||
161950625|NCT01634152|584870526|FG000|Overall Study|Other reason not defined above|1|||
161950626|NCT01634152|584870527|FG001|Overall Study|Other reason not defined above|0|||
161950627|NCT01634152|584870528|FG002|Overall Study|Other reason not defined above|1|||
161950628|NCT01900665|584870534|FG000|Placebo Controlled Period|Death|9|||
161950629|NCT01900665|584870535|FG001|Placebo Controlled Period|Death|16|||
161950630|NCT01900665|584870534|FG000|Placebo Controlled Period|Adverse Event|48|||
161950631|NCT01900665|584870535|FG001|Placebo Controlled Period|Adverse Event|39|||
161950632|NCT01900665|584870534|FG000|Placebo Controlled Period|Protocol Violation|1|||
161950633|NCT01900665|584870535|FG001|Placebo Controlled Period|Protocol Violation|7|||
161950634|NCT01900665|584870534|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
161950635|NCT01900665|584870535|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
161950636|NCT01900665|584870534|FG000|Placebo Controlled Period|Physician Decision|11|||
161950637|NCT01900665|584870535|FG001|Placebo Controlled Period|Physician Decision|7|||
161950638|NCT01900665|584870534|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
161950639|NCT01900665|584870535|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
161950640|NCT01900665|584870534|FG000|Placebo Controlled Period|Caregiver Decision|33|||
161950641|NCT01900665|584870535|FG001|Placebo Controlled Period|Caregiver Decision|41|||
161950642|NCT01900665|584870534|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
161950643|NCT01900665|584870535|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
161950644|NCT01900665|584870534|FG000|Open Label Period|Adverse Event|16|||
161950645|NCT01900665|584870535|FG001|Open Label Period|Adverse Event|20|||
161950646|NCT01900665|584870534|FG000|Open Label Period|Death|5|||
161950647|NCT01900665|584870535|FG001|Open Label Period|Death|6|||
161950648|NCT01900665|584870534|FG000|Open Label Period|Lost to Follow-up|1|||
161950649|NCT01900665|584870535|FG001|Open Label Period|Lost to Follow-up|1|||
161950650|NCT01900665|584870534|FG000|Open Label Period|Parent/Caregiver Decision|33|||
161950651|NCT01900665|584870535|FG001|Open Label Period|Parent/Caregiver Decision|34|||
161950652|NCT01900665|584870534|FG000|Open Label Period|Physician Decision|4|||
161950653|NCT01900665|584870535|FG001|Open Label Period|Physician Decision|4|||
161950654|NCT01900665|584870534|FG000|Open Label Period|Protocol Violation|0|||
161950655|NCT01900665|584870535|FG001|Open Label Period|Protocol Violation|1|||
161950656|NCT01900665|584870534|FG000|Open Label Period|Sponsor Decision|802|||
161950657|NCT01900665|584870535|FG001|Open Label Period|Sponsor Decision|765|||
161950658|NCT01900665|584870534|FG000|Open Label Period|Withdrawal by Subject|20|||
161950659|NCT01900665|584870535|FG001|Open Label Period|Withdrawal by Subject|28|||
161950660|NCT02317627|584870538|FG000|Overall Study|Withdrawal by Subject|0|||
161950661|NCT02317627|584870539|FG001|Overall Study|Withdrawal by Subject|1|||
161950662|NCT02317627|584870540|FG002|Overall Study|Withdrawal by Subject|1|||
161950663|NCT02317627|584870538|FG000|Overall Study|Lost to Follow-up|2|||
161950664|NCT02317627|584870539|FG001|Overall Study|Lost to Follow-up|0|||
161950665|NCT02317627|584870540|FG002|Overall Study|Lost to Follow-up|0|||
161950666|NCT02317627|584870538|FG000|Overall Study|Stopped by Investigator|0|||
161950667|NCT02317627|584870539|FG001|Overall Study|Stopped by Investigator|1|||
161950668|NCT02317627|584870540|FG002|Overall Study|Stopped by Investigator|0|||
161950669|NCT02317627|584870538|FG000|Overall Study|Adverse Event|0|||
161950670|NCT02317627|584870539|FG001|Overall Study|Adverse Event|2|||
161950671|NCT02317627|584870540|FG002|Overall Study|Adverse Event|3|||
161950672|NCT02317627|584870538|FG000|Overall Study|Non-compliance with study drug|0|||
161950673|NCT02317627|584870539|FG001|Overall Study|Non-compliance with study drug|1|||
161950674|NCT02317627|584870540|FG002|Overall Study|Non-compliance with study drug|0|||
161950675|NCT04749914|584870541|FG000|Period 1|Adverse Event|1|||
161950676|NCT04749914|584870542|FG001|Period 1|Adverse Event|0|||
161950677|NCT04749914|584870543|FG002|Period 1|Adverse Event|0|||
161950678|NCT04749914|584870544|FG003|Period 1|Adverse Event|0|||
161950679|NCT04749914|584870541|FG000|Period 1|Withdrawal by Subject|1|||
161950680|NCT04749914|584870542|FG001|Period 1|Withdrawal by Subject|0|||
161950681|NCT04749914|584870543|FG002|Period 1|Withdrawal by Subject|1|||
161950682|NCT04749914|584870544|FG003|Period 1|Withdrawal by Subject|0|||
161950683|NCT00279214|584870545|FG000|Overall Study|Physician Decision|3|||
161950684|NCT00279214|584870546|FG001|Overall Study|Physician Decision|2|||
161950685|NCT00403130|584870547|FG000|2 Years From Start of Treatment|Not Eligible|3|||
161950686|NCT00403130|584870547|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
161950687|NCT00403130|584870547|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
161950688|NCT00403130|584870547|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
161950689|NCT01280968|584870548|FG000|Overall Study|Lost to Follow-up|8|||
161950690|NCT01280968|584870549|FG001|Overall Study|Lost to Follow-up|2|||
161950691|NCT01280968|584870548|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
161950692|NCT01280968|584870549|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
161950693|NCT01280968|584870548|FG000|Overall Study|Commuting Problems|2|||
161950694|NCT01280968|584870549|FG001|Overall Study|Commuting Problems|0|||
161950695|NCT01280968|584870548|FG000|Overall Study|Anxiety|2|||
161950696|NCT01280968|584870549|FG001|Overall Study|Anxiety|0|||
161950697|NCT01280968|584870548|FG000|Overall Study|Adverse Event|1|||
161950698|NCT01280968|584870549|FG001|Overall Study|Adverse Event|0|||
161950699|NCT01280968|584870548|FG000|Overall Study|Scheduling Conflicts|1|||
161950700|NCT01280968|584870549|FG001|Overall Study|Scheduling Conflicts|1|||
161950701|NCT01280968|584870548|FG000|Overall Study|Pre-existing Neurological Condition|1|||
161950702|NCT01280968|584870549|FG001|Overall Study|Pre-existing Neurological Condition|0|||
161950703|NCT01280968|584870548|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
161950704|NCT01280968|584870549|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
161950705|NCT00806260|584870550|FG000|Period 1 (1 Day)|Adverse Event|0|||
161685962|NCT00105443|583903275|FG001|Double-Blind Treatment|Adverse Event|0|||
161685963|NCT00105443|583903276|FG002|Double-Blind Treatment|Adverse Event|0|||
161833810|NCT01763918|584433231|FG000|Overall Study|Sponsor Decision|4|||
161950706|NCT00806260|584870551|FG001|Period 1 (1 Day)|Adverse Event|0|||
161950707|NCT00806260|584870552|FG002|Period 1 (1 Day)|Adverse Event|0|||
161833811|NCT01763918|584433232|FG001|Overall Study|Sponsor Decision|0|||
161950708|NCT00806260|584870553|FG003|Period 1 (1 Day)|Adverse Event|0|||
161950709|NCT00806260|584870554|FG004|Period 1 (1 Day)|Adverse Event|3|||
161950710|NCT00806260|584870555|FG005|Period 1 (1 Day)|Adverse Event|0|||
161833812|NCT01763918|584433233|FG002|Overall Study|Sponsor Decision|9|||
161833813|NCT01763918|584433234|FG003|Overall Study|Sponsor Decision|0|||
161833814|NCT01553747|584433235|FG000|Overall Study|Protocol Violation|0|||
161833815|NCT01553747|584433236|FG001|Overall Study|Protocol Violation|2|||
161833816|NCT01553747|584433237|FG002|Overall Study|Protocol Violation|0|||
161833817|NCT01553747|584433235|FG000|Overall Study|Voluntarily withdrew|70|||
161833818|NCT01553747|584433236|FG001|Overall Study|Voluntarily withdrew|66|||
161833819|NCT01553747|584433237|FG002|Overall Study|Voluntarily withdrew|74|||
161833820|NCT01553747|584433235|FG000|Overall Study|Adverse event or SAE|32|||
161833821|NCT01553747|584433236|FG001|Overall Study|Adverse event or SAE|28|||
161833822|NCT01553747|584433237|FG002|Overall Study|Adverse event or SAE|19|||
161833823|NCT01553747|584433235|FG000|Overall Study|Physician decision: other|10|||
161833824|NCT01553747|584433236|FG001|Overall Study|Physician decision: other|8|||
161833825|NCT01553747|584433237|FG002|Overall Study|Physician decision: other|7|||
161833826|NCT01553747|584433235|FG000|Overall Study|Lost to Follow-up|11|||
161833827|NCT01553747|584433236|FG001|Overall Study|Lost to Follow-up|5|||
161833828|NCT01553747|584433237|FG002|Overall Study|Lost to Follow-up|6|||
161833829|NCT01553747|584433235|FG000|Overall Study|Sponsor decision, specify|7|||
161833830|NCT01553747|584433236|FG001|Overall Study|Sponsor decision, specify|5|||
161833831|NCT01553747|584433237|FG002|Overall Study|Sponsor decision, specify|0|||
161833832|NCT01553747|584433235|FG000|Overall Study|Physician decision: lack of efficacy|1|||
161833833|NCT01553747|584433236|FG001|Overall Study|Physician decision: lack of efficacy|5|||
161833834|NCT01553747|584433237|FG002|Overall Study|Physician decision: lack of efficacy|3|||
161833835|NCT00102687|584433238|FG000|Initial Period|Withdrawal by Subject|6|||
161833836|NCT00102687|584433239|FG001|Initial Period|Withdrawal by Subject|3|||
161833837|NCT00102687|584433240|FG002|Initial Period|Withdrawal by Subject|5|||
161833838|NCT00102687|584433241|FG003|Initial Period|Withdrawal by Subject|0|||
161833839|NCT00102687|584433242|FG004|Initial Period|Withdrawal by Subject|0|||
161833840|NCT00102687|584433238|FG000|Initial Period|Adverse Event|4|||
161833841|NCT00102687|584433239|FG001|Initial Period|Adverse Event|7|||
161833842|NCT00102687|584433240|FG002|Initial Period|Adverse Event|9|||
161833843|NCT00102687|584433241|FG003|Initial Period|Adverse Event|0|||
161833844|NCT00102687|584433242|FG004|Initial Period|Adverse Event|0|||
161833845|NCT00102687|584433238|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
161833846|NCT00102687|584433239|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
161833847|NCT00102687|584433240|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
161833848|NCT00102687|584433241|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
161833849|NCT00102687|584433242|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
161833850|NCT00102687|584433238|FG000|Initial Period|Protocol Violation|0|||
161833851|NCT00102687|584433239|FG001|Initial Period|Protocol Violation|0|||
161833852|NCT00102687|584433240|FG002|Initial Period|Protocol Violation|2|||
161833853|NCT00102687|584433241|FG003|Initial Period|Protocol Violation|0|||
161833854|NCT00102687|584433242|FG004|Initial Period|Protocol Violation|0|||
161833855|NCT00102687|584433238|FG000|Initial Period|Physician Decision|2|||
161833856|NCT00102687|584433239|FG001|Initial Period|Physician Decision|9|||
161950711|NCT00806260|584870550|FG000|Period 2|Adverse Event|0|||
161833857|NCT00102687|584433240|FG002|Initial Period|Physician Decision|6|||
161833858|NCT00102687|584433241|FG003|Initial Period|Physician Decision|0|||
161833859|NCT00102687|584433242|FG004|Initial Period|Physician Decision|0|||
161950712|NCT00806260|584870551|FG001|Period 2|Adverse Event|0|||
161833860|NCT00102687|584433238|FG000|Initial Period|Sponsor's decision|0|||
161833861|NCT00102687|584433239|FG001|Initial Period|Sponsor's decision|1|||
161833862|NCT00102687|584433240|FG002|Initial Period|Sponsor's decision|1|||
161833863|NCT00102687|584433241|FG003|Initial Period|Sponsor's decision|0|||
161833864|NCT00102687|584433242|FG004|Initial Period|Sponsor's decision|0|||
161950713|NCT00806260|584870552|FG002|Period 2|Adverse Event|0|||
161950714|NCT00806260|584870553|FG003|Period 2|Adverse Event|1|||
161950715|NCT00806260|584870554|FG004|Period 2|Adverse Event|0|||
161950716|NCT00806260|584870555|FG005|Period 2|Adverse Event|0|||
161950717|NCT00806260|584870550|FG000|Period 2|Protocol Violation|1|||
161950718|NCT00806260|584870551|FG001|Period 2|Protocol Violation|0|||
161950719|NCT00806260|584870552|FG002|Period 2|Protocol Violation|1|||
161950720|NCT00806260|584870553|FG003|Period 2|Protocol Violation|0|||
161950721|NCT00806260|584870554|FG004|Period 2|Protocol Violation|0|||
161950722|NCT00806260|584870555|FG005|Period 2|Protocol Violation|0|||
161950723|NCT00806260|584870550|FG000|Period 2|Need to take concomitant medication|1|||
161950724|NCT00806260|584870551|FG001|Period 2|Need to take concomitant medication|0|||
161950725|NCT00806260|584870552|FG002|Period 2|Need to take concomitant medication|0|||
161950726|NCT00806260|584870553|FG003|Period 2|Need to take concomitant medication|0|||
161950727|NCT00806260|584870554|FG004|Period 2|Need to take concomitant medication|0|||
161950728|NCT00806260|584870555|FG005|Period 2|Need to take concomitant medication|0|||
161950729|NCT00806260|584870550|FG000|Period 2|sponsor request|0|||
161950730|NCT00806260|584870551|FG001|Period 2|sponsor request|0|||
161950731|NCT00806260|584870552|FG002|Period 2|sponsor request|1|||
161950732|NCT00806260|584870553|FG003|Period 2|sponsor request|1|||
161950733|NCT00806260|584870554|FG004|Period 2|sponsor request|0|||
161950734|NCT00806260|584870555|FG005|Period 2|sponsor request|0|||
161950735|NCT00806260|584870550|FG000|Period 3|Protocol Violation|0|||
161950736|NCT00806260|584870551|FG001|Period 3|Protocol Violation|1|||
161950737|NCT00806260|584870552|FG002|Period 3|Protocol Violation|1|||
161950738|NCT00806260|584870553|FG003|Period 3|Protocol Violation|0|||
161950739|NCT00806260|584870554|FG004|Period 3|Protocol Violation|0|||
161950740|NCT00806260|584870555|FG005|Period 3|Protocol Violation|0|||
161950741|NCT00806260|584870550|FG000|Period 3|Pregnancy|1|||
161950742|NCT00806260|584870551|FG001|Period 3|Pregnancy|0|||
161950743|NCT00806260|584870552|FG002|Period 3|Pregnancy|0|||
161950744|NCT00806260|584870553|FG003|Period 3|Pregnancy|0|||
161950745|NCT00806260|584870554|FG004|Period 3|Pregnancy|0|||
161950746|NCT00806260|584870555|FG005|Period 3|Pregnancy|0|||
161950747|NCT00953706|584870559|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
161950748|NCT00953706|584870560|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
161950749|NCT00953706|584870561|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
161950750|NCT00953706|584870562|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
161950751|NCT00953706|584870559|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
161950752|NCT00953706|584870560|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
161950753|NCT00953706|584870561|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
161950754|NCT00953706|584870562|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
161950755|NCT00953706|584870559|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
161950756|NCT00953706|584870560|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
161950757|NCT00953706|584870561|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
161950758|NCT00953706|584870562|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
161950759|NCT00953706|584870559|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
161950760|NCT00953706|584870560|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
161950761|NCT00953706|584870561|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
161950762|NCT00953706|584870562|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
161950763|NCT00953706|584870559|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
161950764|NCT00953706|584870560|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
161950765|NCT00953706|584870561|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
161950766|NCT00953706|584870562|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
161950767|NCT00953706|584870559|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
161950768|NCT00953706|584870560|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
161950769|NCT00953706|584870561|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
161950770|NCT00953706|584870562|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
161950771|NCT00953706|584870559|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
161950772|NCT00953706|584870560|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
161950773|NCT00953706|584870561|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
161950774|NCT00953706|584870562|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
161950775|NCT00953706|584870559|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
161950776|NCT00953706|584870560|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
161950777|NCT00953706|584870561|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
161950778|NCT00953706|584870562|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
161950779|NCT00953706|584870559|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
161950780|NCT00953706|584870560|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
161950781|NCT00953706|584870561|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
161950782|NCT00953706|584870562|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
161950783|NCT00953706|584870559|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
161950784|NCT00953706|584870560|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
161950785|NCT00953706|584870561|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
161950786|NCT00953706|584870562|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
161950787|NCT00953706|584870559|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
161950788|NCT00953706|584870560|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
161833865|NCT00102687|584433238|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
161950789|NCT00953706|584870561|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
161950790|NCT00953706|584870562|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
161950791|NCT02670473|584870563|FG000|Overall Study|Withdrawal by Subject|1|||
161950792|NCT01404234|584870564|FG000|Overall Study|Withdrawal by Subject|2|||
161950793|NCT01214837|584870565|FG000|Overall Study|Death|0|||
161950794|NCT01214837|584870566|FG001|Overall Study|Death|0|||
161950795|NCT01214837|584870567|FG002|Overall Study|Death|1|||
161950796|NCT01214837|584870565|FG000|Overall Study|Adverse Event|1|||
161950797|NCT01214837|584870566|FG001|Overall Study|Adverse Event|2|||
161950798|NCT01214837|584870567|FG002|Overall Study|Adverse Event|1|||
161950799|NCT01214837|584870565|FG000|Overall Study|Withdrawal by Subject|27|||
161950800|NCT01214837|584870566|FG001|Overall Study|Withdrawal by Subject|36|||
161950801|NCT01214837|584870567|FG002|Overall Study|Withdrawal by Subject|28|||
161950802|NCT01214837|584870565|FG000|Overall Study|Lost to Follow-up|20|||
161950803|NCT01214837|584870566|FG001|Overall Study|Lost to Follow-up|15|||
161950804|NCT01214837|584870567|FG002|Overall Study|Lost to Follow-up|21|||
161950805|NCT01214837|584870565|FG000|Overall Study|Inappropriate Enrolment|0|||
161950806|NCT01214837|584870566|FG001|Overall Study|Inappropriate Enrolment|1|||
161950807|NCT01214837|584870567|FG002|Overall Study|Inappropriate Enrolment|2|||
161950808|NCT01214837|584870565|FG000|Overall Study|Administrative Reason|2|||
161950809|NCT01214837|584870566|FG001|Overall Study|Administrative Reason|6|||
161950810|NCT01214837|584870567|FG002|Overall Study|Administrative Reason|4|||
161950811|NCT01214837|584870565|FG000|Overall Study|Protocol Violation|3|||
161950812|NCT01214837|584870566|FG001|Overall Study|Protocol Violation|1|||
161950813|NCT01214837|584870567|FG002|Overall Study|Protocol Violation|5|||
161950814|NCT01214837|584870565|FG000|Overall Study|Unable to Classify|1|||
161950815|NCT01214837|584870566|FG001|Overall Study|Unable to Classify|3|||
161950816|NCT01214837|584870567|FG002|Overall Study|Unable to Classify|0|||
161950817|NCT05414175|584870568|FG000|Overall Study|Withdrawal by Subject|1|||
161950818|NCT05414175|584870568|FG000|Overall Study|Other Reasons|1|||
161950819|NCT00027560|584870571|FG000|Overall Study|Withdrawal by Subject|1|||
161950820|NCT03559270|584870575|FG000|Overall Study|Adverse Event|6|||
161950821|NCT03559270|584870576|FG001|Overall Study|Adverse Event|5|||
161950822|NCT03559270|584870577|FG002|Overall Study|Adverse Event|3|||
161950823|NCT03559270|584870578|FG003|Overall Study|Adverse Event|0|||
161950824|NCT03559270|584870575|FG000|Overall Study|Lack of Efficacy|34|||
161950825|NCT03559270|584870576|FG001|Overall Study|Lack of Efficacy|52|||
161950826|NCT03559270|584870577|FG002|Overall Study|Lack of Efficacy|37|||
161950827|NCT03559270|584870578|FG003|Overall Study|Lack of Efficacy|2|||
161950828|NCT03559270|584870575|FG000|Overall Study|Death|0|||
161685964|NCT00105443|583903277|FG003|Double-Blind Treatment|Adverse Event|0|||
161685965|NCT00105443|583903274|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
161685966|NCT00105443|583903275|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
161950829|NCT03559270|584870576|FG001|Overall Study|Death|2|||
161685967|NCT00105443|583903276|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
161950830|NCT03559270|584870577|FG002|Overall Study|Death|0|||
161950831|NCT03559270|584870578|FG003|Overall Study|Death|0|||
161950832|NCT03559270|584870575|FG000|Overall Study|Lost to Follow-up|16|||
161950833|NCT03559270|584870576|FG001|Overall Study|Lost to Follow-up|4|||
161950834|NCT03559270|584870577|FG002|Overall Study|Lost to Follow-up|12|||
161950835|NCT03559270|584870578|FG003|Overall Study|Lost to Follow-up|3|||
161950836|NCT03559270|584870575|FG000|Overall Study|Sponsor Decision|38|||
161950837|NCT03559270|584870576|FG001|Overall Study|Sponsor Decision|31|||
161950838|NCT03559270|584870577|FG002|Overall Study|Sponsor Decision|35|||
161950839|NCT03559270|584870578|FG003|Overall Study|Sponsor Decision|18|||
161950840|NCT03559270|584870575|FG000|Overall Study|Withdrawal by Subject|19|||
161950841|NCT03559270|584870576|FG001|Overall Study|Withdrawal by Subject|21|||
161950842|NCT03559270|584870577|FG002|Overall Study|Withdrawal by Subject|18|||
161950843|NCT03559270|584870578|FG003|Overall Study|Withdrawal by Subject|7|||
161950844|NCT03559270|584870575|FG000|Overall Study|Physician Decision|3|||
161950845|NCT03559270|584870576|FG001|Overall Study|Physician Decision|2|||
161950846|NCT03559270|584870577|FG002|Overall Study|Physician Decision|1|||
161950847|NCT03559270|584870578|FG003|Overall Study|Physician Decision|0|||
161685968|NCT00105443|583903277|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
161685969|NCT00105443|583903274|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
161685970|NCT00105443|583903275|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
161685971|NCT00105443|583903276|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
161685972|NCT00105443|583903277|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
161685973|NCT00105443|583903274|FG000|Double-Blind Treatment|Physician Decision|1|||
161685974|NCT00105443|583903275|FG001|Double-Blind Treatment|Physician Decision|0|||
161685975|NCT00105443|583903276|FG002|Double-Blind Treatment|Physician Decision|2|||
161833866|NCT00102687|584433239|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
161950848|NCT03559270|584870575|FG000|Overall Study|Pregnancy|0|||
161950849|NCT03559270|584870576|FG001|Overall Study|Pregnancy|1|||
161950850|NCT03559270|584870577|FG002|Overall Study|Pregnancy|0|||
161950851|NCT03559270|584870578|FG003|Overall Study|Pregnancy|0|||
161950852|NCT03559270|584870575|FG000|Overall Study|Protocol Violation|1|||
161950853|NCT03559270|584870576|FG001|Overall Study|Protocol Violation|0|||
161950854|NCT03559270|584870577|FG002|Overall Study|Protocol Violation|2|||
161685976|NCT00105443|583903277|FG003|Double-Blind Treatment|Physician Decision|0|||
161685977|NCT00105443|583903274|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
161685978|NCT00105443|583903275|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
161685979|NCT00105443|583903276|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
161685980|NCT00105443|583903277|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
161685981|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
161685982|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
161685983|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
161685984|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
161685985|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
161685986|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
161685987|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
161685988|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
161685989|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
161685990|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
161685991|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
161685992|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
161685993|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
161685994|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
161685995|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
161685996|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
161685997|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
161685998|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
161685999|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
161686000|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
161686001|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
161686002|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
161686003|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
161686004|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
161686005|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
161686006|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
161686007|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
161950855|NCT03559270|584870578|FG003|Overall Study|Protocol Violation|0|||
161950856|NCT04776161|584872008|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
161950857|NCT04776161|584872009|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
161950858|NCT04776161|584872010|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
161950859|NCT04776161|584872008|FG000|Overall Study|Withdrawal by Subject|1|||
161950860|NCT04776161|584872009|FG001|Overall Study|Withdrawal by Subject|0|||
161950861|NCT04776161|584872010|FG002|Overall Study|Withdrawal by Subject|1|||
161950862|NCT04776161|584872008|FG000|Overall Study|Adverse Event|0|||
161950863|NCT04776161|584872009|FG001|Overall Study|Adverse Event|1|||
161950864|NCT04776161|584872010|FG002|Overall Study|Adverse Event|1|||
161950865|NCT00342628|584872011|FG000|Overall Study|Withdrawal by Subject|19|||
161950866|NCT00342628|584872012|FG001|Overall Study|Withdrawal by Subject|19|||
161950867|NCT00342628|584872013|FG002|Overall Study|Withdrawal by Subject|18|||
161950868|NCT00342628|584872011|FG000|Overall Study|Death|1|||
161950869|NCT00342628|584872012|FG001|Overall Study|Death|1|||
161950870|NCT00342628|584872013|FG002|Overall Study|Death|0|||
161950871|NCT00342628|584872011|FG000|Overall Study|moved residence|0|||
161950872|NCT00342628|584872012|FG001|Overall Study|moved residence|1|||
161950873|NCT00342628|584872013|FG002|Overall Study|moved residence|1|||
161950874|NCT00456755|584872018|FG000|Overall Study|Lost to Follow-up|2|||
161950875|NCT00456755|584872019|FG001|Overall Study|Lost to Follow-up|1|||
161833867|NCT00102687|584433240|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
161950876|NCT01475721|584872022|FG000|Overall Study|Death|3|||
161833868|NCT00102687|584433241|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
161686008|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
161950877|NCT01475721|584872023|FG001|Overall Study|Death|6|||
161950878|NCT01475721|584872022|FG000|Overall Study|Withdrawal by Subject|8|||
161686009|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
161686010|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
161686011|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
161686012|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
161686013|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
161950879|NCT01475721|584872023|FG001|Overall Study|Withdrawal by Subject|8|||
161950880|NCT01048242|584872024|FG000|Overall Study|See study flow chart|4|||
161950881|NCT01048242|584872025|FG001|Overall Study|See study flow chart|2|||
161950882|NCT01772550|584872028|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
161950883|NCT01772550|584872029|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
161950884|NCT01772550|584872030|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
161950885|NCT01772550|584872028|FG000|Overall Study|Adverse Event|0|||
161950886|NCT01772550|584872029|FG001|Overall Study|Adverse Event|0|||
161950887|NCT01772550|584872030|FG002|Overall Study|Adverse Event|1|||
161833869|NCT00102687|584433242|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
161833870|NCT00102687|584433238|FG000|Initial Period|Death|1|||
161950888|NCT00559104|584872031|FG000|Overall Study|Lack of Efficacy|9|||
161950889|NCT00559104|584872032|FG001|Overall Study|Lack of Efficacy|0|||
161950890|NCT01815424|584872033|FG000|Week 0 to 16|Adverse Event|1|||
161950891|NCT01815424|584872034|FG001|Week 0 to 16|Adverse Event|3|||
161950892|NCT01815424|584872035|FG002|Week 0 to 16|Adverse Event|3|||
161950893|NCT01815424|584872036|FG003|Week 0 to 16|Adverse Event|0|||
161950894|NCT01815424|584872037|FG004|Week 0 to 16|Adverse Event|0|||
161950895|NCT01815424|584872033|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
161950896|NCT01815424|584872034|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
161950897|NCT01815424|584872035|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
161950898|NCT01815424|584872036|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
161950899|NCT01815424|584872037|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
161950900|NCT01815424|584872033|FG000|Week 0 to 16|Lost to Follow-up|0|||
161950901|NCT01815424|584872034|FG001|Week 0 to 16|Lost to Follow-up|1|||
161950902|NCT01815424|584872035|FG002|Week 0 to 16|Lost to Follow-up|0|||
161950903|NCT01815424|584872036|FG003|Week 0 to 16|Lost to Follow-up|0|||
161950904|NCT01815424|584872037|FG004|Week 0 to 16|Lost to Follow-up|0|||
161950905|NCT01815424|584872033|FG000|Week 0 to 16|Withdrawal by Subject|0|||
161950906|NCT01815424|584872034|FG001|Week 0 to 16|Withdrawal by Subject|0|||
161950907|NCT01815424|584872035|FG002|Week 0 to 16|Withdrawal by Subject|1|||
161950908|NCT01815424|584872036|FG003|Week 0 to 16|Withdrawal by Subject|0|||
161950909|NCT01815424|584872037|FG004|Week 0 to 16|Withdrawal by Subject|0|||
161950910|NCT01815424|584872033|FG000|Week 0 to 16|Other|1|||
161950911|NCT01815424|584872034|FG001|Week 0 to 16|Other|0|||
161950912|NCT01815424|584872035|FG002|Week 0 to 16|Other|3|||
161950913|NCT01815424|584872036|FG003|Week 0 to 16|Other|0|||
161950914|NCT01815424|584872037|FG004|Week 0 to 16|Other|0|||
161950915|NCT01815424|584872033|FG000|Week 0 to 16|Protocol Violation|1|||
161950916|NCT01815424|584872034|FG001|Week 0 to 16|Protocol Violation|0|||
161950917|NCT01815424|584872035|FG002|Week 0 to 16|Protocol Violation|0|||
161950918|NCT01815424|584872036|FG003|Week 0 to 16|Protocol Violation|0|||
161950919|NCT01815424|584872037|FG004|Week 0 to 16|Protocol Violation|0|||
161950920|NCT01815424|584872033|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
161950921|NCT01815424|584872034|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
161950922|NCT01815424|584872035|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
161950923|NCT01815424|584872036|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
161950924|NCT01815424|584872037|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
161950925|NCT01815424|584872033|FG000|Week 16 to 52|Other|0|||
161950926|NCT01815424|584872034|FG001|Week 16 to 52|Other|1|||
161950927|NCT01815424|584872035|FG002|Week 16 to 52|Other|0|||
161950928|NCT01815424|584872036|FG003|Week 16 to 52|Other|0|||
161950929|NCT01815424|584872037|FG004|Week 16 to 52|Other|0|||
161950930|NCT01815424|584872033|FG000|Week 16 to 52|Adverse Event|0|||
161950931|NCT01815424|584872034|FG001|Week 16 to 52|Adverse Event|0|||
161950932|NCT01815424|584872035|FG002|Week 16 to 52|Adverse Event|0|||
161950933|NCT01815424|584872036|FG003|Week 16 to 52|Adverse Event|0|||
161950934|NCT01815424|584872037|FG004|Week 16 to 52|Adverse Event|1|||
161950935|NCT01815424|584872033|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
161950936|NCT01815424|584872034|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
161950937|NCT01815424|584872035|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
161950938|NCT01815424|584872036|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
161950939|NCT01815424|584872037|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
161950940|NCT01815424|584872033|FG000|Week 16 to 52|Lost to Follow-up|0|||
161950941|NCT01815424|584872034|FG001|Week 16 to 52|Lost to Follow-up|2|||
161950942|NCT01815424|584872035|FG002|Week 16 to 52|Lost to Follow-up|0|||
161950943|NCT01815424|584872036|FG003|Week 16 to 52|Lost to Follow-up|2|||
161950944|NCT01815424|584872037|FG004|Week 16 to 52|Lost to Follow-up|1|||
161950945|NCT01815424|584872033|FG000|Week 16 to 52|Withdrawal by Subject|1|||
161950946|NCT01815424|584872034|FG001|Week 16 to 52|Withdrawal by Subject|2|||
161950947|NCT01815424|584872035|FG002|Week 16 to 52|Withdrawal by Subject|0|||
161950948|NCT01815424|584872036|FG003|Week 16 to 52|Withdrawal by Subject|0|||
161950949|NCT01815424|584872037|FG004|Week 16 to 52|Withdrawal by Subject|0|||
161950950|NCT01309204|584872038|FG000|Overall Study|Adverse Event|48|||
161950951|NCT01309204|584872039|FG001|Overall Study|Adverse Event|58|||
161950952|NCT01309204|584872038|FG000|Overall Study|Lost to Follow-up|2|||
161950953|NCT01309204|584872039|FG001|Overall Study|Lost to Follow-up|2|||
161950954|NCT01309204|584872038|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
161950955|NCT01309204|584872039|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
161950956|NCT01309204|584872038|FG000|Overall Study|Inadequate control of IOP|4|||
161950957|NCT01309204|584872039|FG001|Overall Study|Inadequate control of IOP|4|||
161950958|NCT01309204|584872038|FG000|Overall Study|Other|4|||
161950959|NCT01309204|584872039|FG001|Overall Study|Other|1|||
161950960|NCT04723355|584872040|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
161950961|NCT04723355|584872040|FG000|Overall Study|Errors in the informed consent form|2|||
161950962|NCT03374358|584872042|FG000|Overall Study|Withdrawal by Subject|0|||
161950963|NCT03374358|584872043|FG001|Overall Study|Withdrawal by Subject|2|||
161950964|NCT01127633|584872044|FG000|Overall Study|Adverse Event|74|||
161950965|NCT01127633|584872045|FG001|Overall Study|Adverse Event|73|||
161950966|NCT01127633|584872044|FG000|Overall Study|Death|40|||
161950967|NCT01127633|584872045|FG001|Overall Study|Death|43|||
161950968|NCT01127633|584872044|FG000|Overall Study|Lost to Follow-up|4|||
161950969|NCT01127633|584872045|FG001|Overall Study|Lost to Follow-up|0|||
161950970|NCT01127633|584872044|FG000|Overall Study|Parent/Caregiver Decision|246|||
161950971|NCT01127633|584872045|FG001|Overall Study|Parent/Caregiver Decision|228|||
161950972|NCT01127633|584872044|FG000|Overall Study|Physician Decision|60|||
161950973|NCT01127633|584872045|FG001|Overall Study|Physician Decision|45|||
161950974|NCT01127633|584872044|FG000|Overall Study|Withdrawal by Subject|57|||
161950975|NCT01127633|584872045|FG001|Overall Study|Withdrawal by Subject|72|||
161950976|NCT01127633|584872044|FG000|Overall Study|Sponsor Decision|163|||
161950977|NCT01127633|584872045|FG001|Overall Study|Sponsor Decision|195|||
161950978|NCT01127633|584872044|FG000|Overall Study|Protocol Violation|8|||
161950979|NCT01127633|584872045|FG001|Overall Study|Protocol Violation|16|||
161950980|NCT01127633|584872044|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
161950981|NCT01127633|584872045|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
161950982|NCT01127633|584872044|FG000|Overall Study|Not treated|1|||
161950983|NCT01127633|584872045|FG001|Overall Study|Not treated|0|||
161950984|NCT03432494|584872056|FG000|Overall Study|Death|1|||
161950985|NCT03432494|584872056|FG000|Overall Study|Noncompliance|1|||
161950986|NCT00775268|584872057|FG000|Baseline|Drug not synthesize dose|1|||
161950987|NCT00775268|584872058|FG001|Baseline|Drug not synthesize dose|0|||
161950988|NCT00775268|584872057|FG000|Baseline|Not treated-ineligible per CT|0|||
161950989|NCT00775268|584872058|FG001|Baseline|Not treated-ineligible per CT|1|||
161950990|NCT00775268|584872057|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
161950991|NCT00775268|584872058|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
161950992|NCT00775268|584872057|FG000|After Completion|Participant missed scan appointment|1|||
161950993|NCT00775268|584872058|FG001|After Completion|Participant missed scan appointment|0|||
161950994|NCT01833494|584872060|FG000|Overall Study|Adverse Event|24|||
161950995|NCT01833494|584872060|FG000|Overall Study|Physician Decision|6|||
161950996|NCT01833494|584872060|FG000|Overall Study|Withdrawal by Subject|6|||
161950997|NCT01833494|584872060|FG000|Overall Study|Decrease in serum phosphorus|4|||
161950998|NCT01833494|584872060|FG000|Overall Study|Decrease in serum calcium|4|||
161950999|NCT01833494|584872060|FG000|Overall Study|Increase in serum ferritin|1|||
161951000|NCT03745768|584872061|FG000|Overall Study|discontinued study|2|||
161951001|NCT03745768|584872062|FG001|Overall Study|discontinued study|0|||
161951002|NCT00443118|584872063|FG000|Overall Study|unknown primary outcome|3|||
161951003|NCT00443118|584872064|FG001|Overall Study|unknown primary outcome|1|||
161951004|NCT00443118|584872065|FG002|Overall Study|unknown primary outcome|0|||
161951005|NCT00443118|584872063|FG000|Overall Study|Withdrawal by Subject|1|||
161951006|NCT00443118|584872064|FG001|Overall Study|Withdrawal by Subject|0|||
161951007|NCT00443118|584872065|FG002|Overall Study|Withdrawal by Subject|0|||
161951008|NCT00506779|584872066|FG000|Overall Study|Withdrawal by Subject|1|||
161951009|NCT00506779|584872067|FG001|Overall Study|Withdrawal by Subject|0|||
161951010|NCT00506779|584872068|FG002|Overall Study|Withdrawal by Subject|1|||
161951011|NCT00506779|584872069|FG003|Overall Study|Withdrawal by Subject|0|||
161951012|NCT00506779|584872066|FG000|Overall Study|Adverse Event|0|||
161951013|NCT00506779|584872067|FG001|Overall Study|Adverse Event|1|||
161951014|NCT00506779|584872068|FG002|Overall Study|Adverse Event|1|||
161951015|NCT00506779|584872069|FG003|Overall Study|Adverse Event|1|||
161951016|NCT04263766|584872070|FG000|Overall Study|Withdrawal by Subject|6|||
161951017|NCT04263766|584872071|FG001|Overall Study|Withdrawal by Subject|4|||
161951018|NCT04263766|584872070|FG000|Overall Study|Lack of Efficacy|1|||
161951019|NCT04263766|584872071|FG001|Overall Study|Lack of Efficacy|3|||
161951020|NCT02639247|584872072|FG000|Overall Study|Lost to Follow-up|2|||
161951021|NCT02639247|584872073|FG001|Overall Study|Lost to Follow-up|1|||
161951022|NCT02639247|584872072|FG000|Overall Study|Death|2|||
161951023|NCT02639247|584872073|FG001|Overall Study|Death|0|||
161951024|NCT02639247|584872072|FG000|Overall Study|Withdrew Consent|0|||
161951025|NCT02639247|584872073|FG001|Overall Study|Withdrew Consent|1|||
161951026|NCT02639247|584872072|FG000|Overall Study|Protocol Violation|1|||
161951027|NCT02639247|584872073|FG001|Overall Study|Protocol Violation|0|||
161951028|NCT01891396|584872074|FG000|Overall Study|Withdrawal by Subject|4|||
161951029|NCT01891396|584872075|FG001|Overall Study|Withdrawal by Subject|4|||
161951030|NCT01891396|584872076|FG002|Overall Study|Withdrawal by Subject|3|||
161951031|NCT01891396|584872074|FG000|Overall Study|Lost to Follow-up|0|||
161951032|NCT01891396|584872075|FG001|Overall Study|Lost to Follow-up|1|||
161951033|NCT01891396|584872076|FG002|Overall Study|Lost to Follow-up|0|||
161951034|NCT00573391|584872077|FG000|Overall Study|study stopped|2|||
161951035|NCT00573391|584872078|FG001|Overall Study|study stopped|2|||
161951036|NCT00573391|584872077|FG000|Overall Study|Death|1|||
161951037|NCT00573391|584872078|FG001|Overall Study|Death|0|||
161951038|NCT02168101|584872079|FG000|Overall Study|Death|2|||
161951039|NCT02168101|584872080|FG001|Overall Study|Death|2|||
161951040|NCT02168101|584872081|FG002|Overall Study|Death|1|||
161951041|NCT00400517|584872082|FG000|Overall Study|Withdrawal by Subject|1|||
161951042|NCT00400517|584872082|FG000|Overall Study|Physician Decision|1|||
161951043|NCT01194245|584872083|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
161951044|NCT01194245|584872084|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
161951045|NCT01194245|584872085|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
161951046|NCT01194245|584872086|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
161951047|NCT01194245|584872087|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
161951048|NCT01194245|584872083|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
161951049|NCT01194245|584872084|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
161833871|NCT00102687|584433239|FG001|Initial Period|Death|1|||
161833872|NCT00102687|584433240|FG002|Initial Period|Death|1|||
161833873|NCT00102687|584433241|FG003|Initial Period|Death|0|||
161833874|NCT00102687|584433242|FG004|Initial Period|Death|0|||
161833875|NCT00102687|584433238|FG000|Maintenance Period|Withdrawal by Subject|4|||
161833876|NCT00102687|584433239|FG001|Maintenance Period|Withdrawal by Subject|0|||
161833877|NCT00102687|584433240|FG002|Maintenance Period|Withdrawal by Subject|2|||
161833878|NCT00102687|584433241|FG003|Maintenance Period|Withdrawal by Subject|3|||
161833879|NCT00102687|584433242|FG004|Maintenance Period|Withdrawal by Subject|1|||
161833880|NCT00102687|584433238|FG000|Maintenance Period|Adverse Event|1|||
161833881|NCT00102687|584433239|FG001|Maintenance Period|Adverse Event|0|||
161833882|NCT00102687|584433240|FG002|Maintenance Period|Adverse Event|0|||
161951050|NCT01194245|584872085|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
161951051|NCT01194245|584872086|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
161951052|NCT01194245|584872087|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
161951053|NCT01194245|584872083|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
161951054|NCT01194245|584872084|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
161951055|NCT01194245|584872085|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
161951056|NCT01194245|584872086|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
161951057|NCT01194245|584872087|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
161951058|NCT01194245|584872083|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
161951059|NCT01194245|584872084|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
161951060|NCT01194245|584872085|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
161951061|NCT01194245|584872086|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
161833883|NCT00102687|584433241|FG003|Maintenance Period|Adverse Event|1|||
161833884|NCT00102687|584433242|FG004|Maintenance Period|Adverse Event|3|||
161951062|NCT01194245|584872087|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
161951063|NCT01194245|584872083|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161951064|NCT01194245|584872084|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161951065|NCT01194245|584872085|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161951066|NCT01194245|584872086|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161951067|NCT01194245|584872087|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
161951068|NCT01194245|584872083|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161951069|NCT01194245|584872084|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161951070|NCT01194245|584872085|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
161951071|NCT01194245|584872086|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
161951072|NCT01194245|584872087|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
161951073|NCT01118780|584872088|FG000|Overall Study|Adverse Event|15|||
161951074|NCT01118780|584872089|FG001|Overall Study|Adverse Event|15|||
161951075|NCT01118780|584872088|FG000|Overall Study|Death|1|||
161951076|NCT01118780|584872089|FG001|Overall Study|Death|0|||
161951077|NCT01118780|584872088|FG000|Overall Study|Lack of Efficacy|2|||
161951078|NCT01118780|584872089|FG001|Overall Study|Lack of Efficacy|6|||
161833885|NCT00102687|584433238|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
161833886|NCT00102687|584433239|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
161951079|NCT01118780|584872088|FG000|Overall Study|Physician Decision|2|||
161951080|NCT01118780|584872089|FG001|Overall Study|Physician Decision|0|||
161951081|NCT01118780|584872088|FG000|Overall Study|Protocol Violation|3|||
161833887|NCT00102687|584433240|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
161833888|NCT00102687|584433241|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
161833889|NCT00102687|584433242|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
161833890|NCT00102687|584433238|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
161833891|NCT00102687|584433239|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
161833892|NCT00102687|584433240|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
161833893|NCT00102687|584433241|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
161833894|NCT00102687|584433242|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
161833895|NCT00102687|584433238|FG000|Maintenance Period|Death|0|||
161833896|NCT00102687|584433239|FG001|Maintenance Period|Death|0|||
161833897|NCT00102687|584433240|FG002|Maintenance Period|Death|0|||
161833898|NCT00102687|584433241|FG003|Maintenance Period|Death|1|||
161833899|NCT00102687|584433242|FG004|Maintenance Period|Death|1|||
161833900|NCT00102687|584433238|FG000|Maintenance Period|Physician Decision|1|||
161951082|NCT01118780|584872089|FG001|Overall Study|Protocol Violation|6|||
161951083|NCT01118780|584872088|FG000|Overall Study|Withdrawal by Subject|13|||
161951084|NCT01118780|584872089|FG001|Overall Study|Withdrawal by Subject|8|||
161833901|NCT00102687|584433239|FG001|Maintenance Period|Physician Decision|2|||
161833902|NCT00102687|584433240|FG002|Maintenance Period|Physician Decision|3|||
161833903|NCT00102687|584433241|FG003|Maintenance Period|Physician Decision|0|||
161833904|NCT00102687|584433242|FG004|Maintenance Period|Physician Decision|4|||
161833905|NCT03253744|584433248|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
161833906|NCT03253744|584433249|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
161833907|NCT03253744|584433250|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
161833908|NCT03253744|584433251|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
161833909|NCT06279871|584433252|FG000|Overall Study|Death|0|||
161833910|NCT06279871|584433253|FG001|Overall Study|Death|0|||
161833911|NCT06279871|584433254|FG002|Overall Study|Death|0|||
161833912|NCT06279871|584433255|FG003|Overall Study|Death|0|||
161833913|NCT06279871|584433256|FG004|Overall Study|Death|0|||
161833914|NCT06279871|584433257|FG005|Overall Study|Death|1|||
161833915|NCT06279871|584433258|FG006|Overall Study|Death|0|||
161833916|NCT06279871|584433252|FG000|Overall Study|Other than Specified|1|||
161833917|NCT06279871|584433253|FG001|Overall Study|Other than Specified|0|||
161833918|NCT06279871|584433254|FG002|Overall Study|Other than Specified|4|||
161833919|NCT06279871|584433255|FG003|Overall Study|Other than Specified|0|||
161833920|NCT06279871|584433256|FG004|Overall Study|Other than Specified|0|||
161833921|NCT06279871|584433257|FG005|Overall Study|Other than Specified|0|||
161833922|NCT06279871|584433258|FG006|Overall Study|Other than Specified|0|||
161833923|NCT06279871|584433252|FG000|Overall Study|Withdrawal by Subject|4|||
161833924|NCT06279871|584433253|FG001|Overall Study|Withdrawal by Subject|8|||
161833925|NCT06279871|584433254|FG002|Overall Study|Withdrawal by Subject|4|||
161833926|NCT06279871|584433255|FG003|Overall Study|Withdrawal by Subject|2|||
161833927|NCT06279871|584433256|FG004|Overall Study|Withdrawal by Subject|0|||
161833928|NCT06279871|584433257|FG005|Overall Study|Withdrawal by Subject|0|||
161833929|NCT06279871|584433258|FG006|Overall Study|Withdrawal by Subject|0|||
161833930|NCT06279871|584433252|FG000|Overall Study|Lost to Follow-up|11|||
161833931|NCT06279871|584433253|FG001|Overall Study|Lost to Follow-up|10|||
161833932|NCT06279871|584433254|FG002|Overall Study|Lost to Follow-up|8|||
161833933|NCT06279871|584433255|FG003|Overall Study|Lost to Follow-up|0|||
161833934|NCT06279871|584433256|FG004|Overall Study|Lost to Follow-up|0|||
161833935|NCT06279871|584433257|FG005|Overall Study|Lost to Follow-up|0|||
161833936|NCT06279871|584433258|FG006|Overall Study|Lost to Follow-up|0|||
161833937|NCT06279871|584433252|FG000|Overall Study|Adverse Event|0|||
161833938|NCT06279871|584433253|FG001|Overall Study|Adverse Event|1|||
161951085|NCT05518461|584872090|FG000|Overall Study|Lost to Follow-up|25|||
161951086|NCT03962855|584872091|FG000|Overall Study|Death|0|||
161951087|NCT03962855|584872092|FG001|Overall Study|Death|1|||
161951088|NCT03962855|584872091|FG000|Overall Study|Lost to Follow-up|0|||
161951089|NCT03962855|584872092|FG001|Overall Study|Lost to Follow-up|1|||
161951090|NCT03962855|584872091|FG000|Overall Study|Adverse Event|0|||
161951091|NCT03962855|584872092|FG001|Overall Study|Adverse Event|1|||
161951092|NCT03962855|584872091|FG000|Overall Study|Physician Decision|0|||
161951093|NCT03962855|584872092|FG001|Overall Study|Physician Decision|2|||
161951094|NCT02457247|584872093|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
161951095|NCT02457247|584872094|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
161951096|NCT02457247|584872095|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
161951097|NCT02457247|584872096|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
161951098|NCT02457247|584872093|FG000|Period 1|Significant Protocol Deviation|1|||
161951099|NCT02457247|584872094|FG001|Period 1|Significant Protocol Deviation|1|||
161951100|NCT02457247|584872095|FG002|Period 1|Significant Protocol Deviation|0|||
161951101|NCT02457247|584872096|FG003|Period 1|Significant Protocol Deviation|0|||
161951102|NCT02457247|584872093|FG000|Period 1|Voluntary Withdrawal|1|||
161951103|NCT02457247|584872094|FG001|Period 1|Voluntary Withdrawal|0|||
161833939|NCT06279871|584433254|FG002|Overall Study|Adverse Event|0|||
161833940|NCT06279871|584433255|FG003|Overall Study|Adverse Event|0|||
161833941|NCT06279871|584433256|FG004|Overall Study|Adverse Event|0|||
161951104|NCT02457247|584872095|FG002|Period 1|Voluntary Withdrawal|0|||
161951105|NCT02457247|584872096|FG003|Period 1|Voluntary Withdrawal|0|||
161833942|NCT06279871|584433257|FG005|Overall Study|Adverse Event|0|||
161833943|NCT06279871|584433258|FG006|Overall Study|Adverse Event|0|||
161833944|NCT03847194|584433261|FG000|Overall Study|Lost to Follow-up|2|||
161833945|NCT03847194|584433262|FG001|Overall Study|Lost to Follow-up|5|||
161833946|NCT03847194|584433261|FG000|Overall Study|Withdrawal by Subject|1|||
161951106|NCT02457247|584872093|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
161833947|NCT03847194|584433262|FG001|Overall Study|Withdrawal by Subject|2|||
161833948|NCT03847194|584433261|FG000|Overall Study|Death|0|||
161833949|NCT03847194|584433262|FG001|Overall Study|Death|1|||
161833950|NCT01144403|584433266|FG000|Overall Study|Lost to Follow-up|3|||
161951107|NCT02457247|584872094|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
161951108|NCT02457247|584872095|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
161951109|NCT02457247|584872096|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
161951110|NCT02457247|584872093|FG000|Period 2|Significant Protocol Deviation|1|||
161951111|NCT02457247|584872094|FG001|Period 2|Significant Protocol Deviation|0|||
161951112|NCT02457247|584872095|FG002|Period 2|Significant Protocol Deviation|0|||
161951113|NCT02457247|584872096|FG003|Period 2|Significant Protocol Deviation|0|||
161951114|NCT02457247|584872093|FG000|Period 2|Lost to Follow-up|0|||
161951115|NCT02457247|584872094|FG001|Period 2|Lost to Follow-up|1|||
161951116|NCT02457247|584872095|FG002|Period 2|Lost to Follow-up|0|||
161951117|NCT02457247|584872096|FG003|Period 2|Lost to Follow-up|0|||
161951118|NCT02457247|584872093|FG000|Period 2|Voluntary Withdrawal|1|||
161951119|NCT02457247|584872094|FG001|Period 2|Voluntary Withdrawal|1|||
161951120|NCT02457247|584872095|FG002|Period 2|Voluntary Withdrawal|0|||
161951121|NCT02457247|584872096|FG003|Period 2|Voluntary Withdrawal|0|||
161951122|NCT03326063|584872097|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
161951123|NCT03326063|584872098|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
161951124|NCT00739310|584872099|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
161951125|NCT00739310|584872099|FG000|Overall Study|Withdrawal by Subject|1|||
161951126|NCT00739310|584872099|FG000|Overall Study|Lost to Follow-up|2|||
161951127|NCT02954887|584872100|FG000|Overall Study|Withdrawal by Subject|3|||
161951128|NCT02954887|584872100|FG000|Overall Study|Lack of Efficacy|3|||
161951129|NCT02954887|584872100|FG000|Overall Study|Other|1|||
161951130|NCT01882465|584872102|FG000|Period 1|Lens Discomfort|0|||
161951131|NCT01882465|584872103|FG001|Period 1|Lens Discomfort|0|||
161951132|NCT01882465|584872104|FG002|Period 1|Lens Discomfort|0|||
161951133|NCT01882465|584872105|FG003|Period 1|Lens Discomfort|1|||
161951134|NCT01882465|584872106|FG004|Period 1|Lens Discomfort|0|||
161951135|NCT01882465|584872107|FG005|Period 1|Lens Discomfort|0|||
161951136|NCT01882465|584872108|FG006|Period 1|Lens Discomfort|0|||
161951137|NCT01882465|584872102|FG000|Period 1|Withdrawal by Subject|0|||
161951138|NCT01882465|584872103|FG001|Period 1|Withdrawal by Subject|0|||
161951139|NCT01882465|584872104|FG002|Period 1|Withdrawal by Subject|0|||
161686014|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
161686015|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
161686016|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
161686017|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
161686018|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
161686019|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
161686020|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
161686021|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
161686022|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
161686023|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
161686024|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
161686025|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
161686026|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
161686027|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
161686028|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
161686029|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
161686030|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
161686031|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
161686032|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
161686033|NCT00105443|583903274|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
161686034|NCT00105443|583903275|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
161686035|NCT00105443|583903276|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
161686036|NCT00105443|583903277|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
161686037|NCT01623271|583903280|FG000|Overall Study|Withdrawal by Subject|2|||
161686038|NCT02037295|583903283|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
161686039|NCT02037295|583903284|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
161686040|NCT02037295|583903285|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
161686041|NCT02037295|583903286|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
161951140|NCT01882465|584872105|FG003|Period 1|Withdrawal by Subject|0|||
161951141|NCT01882465|584872106|FG004|Period 1|Withdrawal by Subject|0|||
161951142|NCT01882465|584872107|FG005|Period 1|Withdrawal by Subject|0|||
161951143|NCT01882465|584872108|FG006|Period 1|Withdrawal by Subject|1|||
161951144|NCT01882465|584872102|FG000|Period 2|Protocol Violation|0|||
161951145|NCT01882465|584872103|FG001|Period 2|Protocol Violation|0|||
161951146|NCT01882465|584872104|FG002|Period 2|Protocol Violation|0|||
161951147|NCT01882465|584872105|FG003|Period 2|Protocol Violation|0|||
161951148|NCT01882465|584872106|FG004|Period 2|Protocol Violation|1|||
161951149|NCT01882465|584872107|FG005|Period 2|Protocol Violation|0|||
161951150|NCT01882465|584872108|FG006|Period 2|Protocol Violation|0|||
161686042|NCT03776175|583903287|FG000|Treatment Period (42 Days)|Adverse Event|0|||
161686043|NCT03776175|583903288|FG001|Treatment Period (42 Days)|Adverse Event|1|||
161686044|NCT03776175|583903289|FG002|Treatment Period (42 Days)|Adverse Event|1|||
161686045|NCT03776175|583903290|FG003|Treatment Period (42 Days)|Adverse Event|0|||
161686046|NCT03776175|583903287|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
161686047|NCT03776175|583903288|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
161686048|NCT03776175|583903289|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
161686049|NCT03776175|583903290|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
161686050|NCT03776175|583903287|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
161686051|NCT03776175|583903288|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
161686052|NCT03776175|583903289|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
161686053|NCT03776175|583903290|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
161686054|NCT03776175|583903287|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
161951151|NCT01824290|584872111|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
161951152|NCT01824290|584872112|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
161951153|NCT01824290|584872113|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
161951154|NCT01824290|584872114|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
161951155|NCT01824290|584872111|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
161951156|NCT01824290|584872112|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
161951157|NCT01824290|584872113|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
161951158|NCT01824290|584872114|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
161951159|NCT01824290|584872111|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
161951160|NCT01824290|584872112|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
161951161|NCT01824290|584872113|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
161951162|NCT01824290|584872114|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
161951163|NCT01824290|584872111|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
161951164|NCT01824290|584872112|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
161951165|NCT01824290|584872113|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
161951166|NCT01824290|584872114|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
161951167|NCT01824290|584872111|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
161951168|NCT01824290|584872112|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
161951169|NCT01824290|584872113|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
161951170|NCT01824290|584872114|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
161951171|NCT01824290|584872111|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
161951172|NCT01824290|584872112|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
161951173|NCT01824290|584872113|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
161951174|NCT01824290|584872114|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
161951175|NCT00800982|584872115|FG000|Overall Study|Lost to Follow-up|1|||
161951176|NCT00800982|584872116|FG001|Overall Study|Lost to Follow-up|2|||
161951177|NCT00800982|584872115|FG000|Overall Study|Withdrawal by Subject|0|||
161951178|NCT00800982|584872116|FG001|Overall Study|Withdrawal by Subject|1|||
161951179|NCT00800982|584872115|FG000|Overall Study|Patient moved out of state|1|||
161951180|NCT00800982|584872116|FG001|Overall Study|Patient moved out of state|0|||
161951181|NCT01490918|584872117|FG000|Overall Study|Lost to Follow-up|2|||
161951182|NCT01490918|584872118|FG001|Overall Study|Lost to Follow-up|1|||
161951183|NCT01490918|584872119|FG002|Overall Study|Lost to Follow-up|0|||
161951184|NCT01490918|584872117|FG000|Overall Study|Withdrawal by Subject|7|||
161951185|NCT01490918|584872118|FG001|Overall Study|Withdrawal by Subject|8|||
161951186|NCT01490918|584872119|FG002|Overall Study|Withdrawal by Subject|3|||
161951187|NCT01490918|584872117|FG000|Overall Study|Adverse Event|0|||
161951188|NCT01490918|584872118|FG001|Overall Study|Adverse Event|0|||
161951189|NCT01490918|584872119|FG002|Overall Study|Adverse Event|1|||
161951190|NCT01490918|584872117|FG000|Overall Study|other cause|4|||
161951191|NCT01490918|584872118|FG001|Overall Study|other cause|5|||
161951192|NCT01490918|584872119|FG002|Overall Study|other cause|8|||
161951193|NCT00003631|584872133|FG000|Overall Study|Patient not treated|1|||
161951194|NCT00003631|584872134|FG001|Overall Study|Patient not treated|0|||
161951195|NCT00003631|584872135|FG002|Overall Study|Patient not treated|1|||
161951196|NCT00003631|584872133|FG000|Overall Study|Protocol Violation|1|||
161951197|NCT00003631|584872134|FG001|Overall Study|Protocol Violation|0|||
161951198|NCT00003631|584872135|FG002|Overall Study|Protocol Violation|0|||
161951199|NCT00003631|584872133|FG000|Overall Study|Adverse Event|1|||
161951200|NCT00003631|584872134|FG001|Overall Study|Adverse Event|1|||
161951201|NCT00003631|584872135|FG002|Overall Study|Adverse Event|5|||
161951202|NCT00003631|584872133|FG000|Overall Study|Death|0|||
161951203|NCT00003631|584872134|FG001|Overall Study|Death|0|||
161951204|NCT00003631|584872135|FG002|Overall Study|Death|1|||
161951205|NCT00003631|584872133|FG000|Overall Study|Evaluable for toxicity only|0|||
161951206|NCT00003631|584872134|FG001|Overall Study|Evaluable for toxicity only|0|||
161951207|NCT00003631|584872135|FG002|Overall Study|Evaluable for toxicity only|2|||
161951208|NCT02765399|584872136|FG000|Overall Study|Nausea|1|||
161951209|NCT02765399|584872137|FG001|Overall Study|Nausea|0|||
161951210|NCT03958331|584872138|FG000|Overall Study|Withdrawal by Subject|3|||
161951211|NCT03958331|584872139|FG001|Overall Study|Withdrawal by Subject|1|||
161951212|NCT03958331|584872140|FG002|Overall Study|Withdrawal by Subject|5|||
161951213|NCT03958331|584872138|FG000|Overall Study|Weaned from medicine|2|||
161951214|NCT03958331|584872139|FG001|Overall Study|Weaned from medicine|0|||
161951215|NCT03958331|584872140|FG002|Overall Study|Weaned from medicine|0|||
161951216|NCT03958331|584872138|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
161951217|NCT03958331|584872139|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
161951218|NCT03958331|584872140|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
161951219|NCT01991483|584872141|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
161951220|NCT01991483|584872142|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
161951221|NCT01991483|584872143|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
161833951|NCT01144403|584433266|FG000|Overall Study|Death|1|||
161833952|NCT01144403|584433266|FG000|Overall Study|Adverse Event|1|||
161833953|NCT02339740|584433270|FG000|Overall Study|Death|1|||
161833954|NCT02339740|584433271|FG001|Overall Study|Death|0|||
161833955|NCT02339740|584433270|FG000|Overall Study|Physician Decision|0|||
161833956|NCT02339740|584433271|FG001|Overall Study|Physician Decision|2|||
161951222|NCT01991483|584872144|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
161951223|NCT01991483|584872141|FG000|Dose Level 600 mg|Physician Decision|0|||
161951224|NCT01991483|584872142|FG001|Dose Level 600 mg|Physician Decision|0|||
161951225|NCT01991483|584872143|FG002|Dose Level 600 mg|Physician Decision|1|||
161951226|NCT01991483|584872144|FG003|Dose Level 600 mg|Physician Decision|0|||
161951227|NCT01991483|584872141|FG000|Dose Level 1000 mg|Protocol Violation|0|||
161951228|NCT01991483|584872142|FG001|Dose Level 1000 mg|Protocol Violation|0|||
161951229|NCT01991483|584872143|FG002|Dose Level 1000 mg|Protocol Violation|0|||
161951230|NCT01991483|584872144|FG003|Dose Level 1000 mg|Protocol Violation|1|||
161951231|NCT02030821|584872145|FG000|Overall Study|Physician Decision|2|||
161951232|NCT02030821|584872146|FG001|Overall Study|Physician Decision|2|||
161951233|NCT02030821|584872147|FG002|Overall Study|Physician Decision|5|||
161951234|NCT02030821|584872148|FG003|Overall Study|Physician Decision|2|||
161951235|NCT03192137|584872149|FG000|Overall Study|Adverse Event|10|||
161951236|NCT03192137|584872150|FG001|Overall Study|Adverse Event|11|||
161951237|NCT03192137|584872149|FG000|Overall Study|Physician Decision|1|||
161951238|NCT03192137|584872150|FG001|Overall Study|Physician Decision|0|||
161951239|NCT03192137|584872149|FG000|Overall Study|Lack of Efficacy|20|||
161951240|NCT03192137|584872150|FG001|Overall Study|Lack of Efficacy|37|||
161951241|NCT03192137|584872149|FG000|Overall Study|Withdrawal by Subject|3|||
161951242|NCT03192137|584872150|FG001|Overall Study|Withdrawal by Subject|3|||
161951243|NCT03192137|584872149|FG000|Overall Study|Protocol Violation|4|||
161951244|NCT03192137|584872150|FG001|Overall Study|Protocol Violation|3|||
161951245|NCT03192137|584872149|FG000|Overall Study|Surgery Cancelled|4|||
161951246|NCT03192137|584872150|FG001|Overall Study|Surgery Cancelled|1|||
161951247|NCT03192137|584872149|FG000|Overall Study|Other - Various Administrative Reasons|8|||
161951248|NCT03192137|584872150|FG001|Overall Study|Other - Various Administrative Reasons|3|||
161951249|NCT01897532|584872154|FG000|Discontinuation From Treatment|Not Treated|7|||
161951250|NCT01897532|584872155|FG001|Discontinuation From Treatment|Not Treated|5|||
161951251|NCT01897532|584872154|FG000|Discontinuation From Treatment|Other reason than specified|196|||
161951252|NCT01897532|584872155|FG001|Discontinuation From Treatment|Other reason than specified|176|||
161951253|NCT01897532|584872154|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
161951254|NCT01897532|584872155|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
161951255|NCT01897532|584872154|FG000|Discontinuation From Treatment|Non compliance|24|||
161951256|NCT01897532|584872155|FG001|Discontinuation From Treatment|Non compliance|15|||
161951257|NCT01897532|584872154|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
161951258|NCT01897532|584872155|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
161951259|NCT01897532|584872154|FG000|Discontinuation From Trial|Not Treated|7|||
161951260|NCT01897532|584872155|FG001|Discontinuation From Trial|Not Treated|5|||
161951261|NCT01897532|584872154|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
161951262|NCT01897532|584872155|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
161951263|NCT01074931|584872160|FG000|Overall Study|Economic reasons|1|||
161951264|NCT01074931|584872160|FG000|Overall Study|Death|5|||
162028733|NCT02509117|585161832|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
162028734|NCT02509117|585161833|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
162028735|NCT02509117|585161834|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
162028736|NCT02509117|585161835|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
162028737|NCT02509117|585161836|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
162028738|NCT02509117|585161827|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
162028739|NCT02509117|585161828|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
162028740|NCT02509117|585161829|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
162028741|NCT02509117|585161830|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
162028742|NCT02509117|585161831|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
162028743|NCT02509117|585161832|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
162028744|NCT02509117|585161833|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
162028745|NCT02509117|585161834|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
162028746|NCT02509117|585161835|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
162028747|NCT02509117|585161836|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
161951265|NCT04567524|584873568|FG000|Overall Study|Adverse Event|1|||
161951266|NCT04567524|584873569|FG001|Overall Study|Adverse Event|1|||
161951267|NCT04567524|584873570|FG002|Overall Study|Adverse Event|0|||
161951268|NCT04567524|584873571|FG003|Overall Study|Adverse Event|0|||
161951269|NCT04567524|584873568|FG000|Overall Study|Withdrawal by Subject|2|||
161951270|NCT04567524|584873569|FG001|Overall Study|Withdrawal by Subject|0|||
161951271|NCT04567524|584873570|FG002|Overall Study|Withdrawal by Subject|0|||
161951272|NCT04567524|584873571|FG003|Overall Study|Withdrawal by Subject|1|||
161951273|NCT02848092|584873572|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
161951274|NCT02848092|584873573|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
161951275|NCT02848092|584873572|FG000|1-month Post-training Follow-up|Adverse Event|2|||
161951276|NCT02848092|584873573|FG001|1-month Post-training Follow-up|Adverse Event|1|||
161951277|NCT02848092|584873572|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
161951278|NCT02848092|584873573|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
161951279|NCT02848092|584873572|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
161951280|NCT02848092|584873573|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
161951281|NCT02848092|584873572|FG000|1-month Post-training Follow-up|fatigue|0|||
161951282|NCT02848092|584873573|FG001|1-month Post-training Follow-up|fatigue|1|||
161951283|NCT02848092|584873572|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
161951284|NCT02848092|584873573|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
161951285|NCT02848092|584873572|FG000|6-month Post-training Follow-up|Adverse Event|1|||
161951286|NCT02848092|584873573|FG001|6-month Post-training Follow-up|Adverse Event|1|||
161951287|NCT02848092|584873572|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
161951288|NCT02848092|584873573|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
161951289|NCT02848092|584873572|FG000|6-month Post-training Follow-up|frustrated with task|1|||
161951290|NCT02848092|584873573|FG001|6-month Post-training Follow-up|frustrated with task|0|||
161951291|NCT02848092|584873572|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
161951292|NCT02848092|584873573|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
161951293|NCT02848092|584873572|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
161951294|NCT02848092|584873573|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
161951295|NCT01147393|584873577|FG000|Dose Level 1|Dose limiting Toxicity|2|||
161951296|NCT01147393|584873577|FG000|Dose Level -1|Dose Limited Toxicity|1|||
161951297|NCT01428219|584873586|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
161951298|NCT00825994|584873589|FG000|Overall Study|Withdrawal by Subject|2|||
161951299|NCT00825994|584873589|FG000|Overall Study|Lost to Follow-up|1|||
161951300|NCT00825994|584873589|FG000|Overall Study|Protocol Violation|1|||
161951301|NCT00825994|584873589|FG000|Overall Study|Placebo Responder at V2|1|||
161951302|NCT01694433|584873595|FG000|Overall Study|Adverse Event|7|||
161951303|NCT01694433|584873596|FG001|Overall Study|Adverse Event|0|||
161951304|NCT01694433|584873595|FG000|Overall Study|Physician Decision|1|||
161951305|NCT01694433|584873596|FG001|Overall Study|Physician Decision|0|||
161951306|NCT01694433|584873595|FG000|Overall Study|Withdrawal by Subject|3|||
161951307|NCT01694433|584873596|FG001|Overall Study|Withdrawal by Subject|4|||
161951308|NCT00374595|584873597|FG000|Overall Study|Death|23|||
161951309|NCT00374595|584873597|FG000|Overall Study|Withdrawal by Subject|39|||
161951310|NCT00374595|584873597|FG000|Overall Study|Lost to Follow-up|3|||
161951311|NCT00374595|584873597|FG000|Overall Study|too much time commitment|1|||
161951312|NCT00374595|584873597|FG000|Overall Study|transfer care to other clinical site|1|||
161951313|NCT00374595|584873597|FG000|Overall Study|relocation|3|||
162236797|NCT01620255|585919071|FG001|Overall Study|Participant underwent fecal transplant|0|||
161951314|NCT01881009|584873603|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
161951315|NCT01881009|584873604|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
161951316|NCT04011735|584873605|FG000|Overall Study|Withdrawal by Subject|1|||
161951317|NCT04011735|584873606|FG001|Overall Study|Withdrawal by Subject|0|||
161951318|NCT04011735|584873607|FG002|Overall Study|Withdrawal by Subject|1|||
161951319|NCT04011735|584873605|FG000|Overall Study|Met exclusion criteria after study entry|0|||
161951320|NCT04011735|584873606|FG001|Overall Study|Met exclusion criteria after study entry|1|||
161951321|NCT04011735|584873607|FG002|Overall Study|Met exclusion criteria after study entry|0|||
162028748|NCT02509117|585161827|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
162028749|NCT02509117|585161828|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
162236798|NCT01620255|585919072|FG002|Overall Study|Participant underwent fecal transplant|1|||
162236799|NCT01620255|585919073|FG003|Overall Study|Participant underwent fecal transplant|0|||
162236800|NCT01620255|585919074|FG004|Overall Study|Participant underwent fecal transplant|0|||
162236801|NCT01620255|585919070|FG000|Overall Study|Non-compliance|0|||
162236802|NCT01620255|585919071|FG001|Overall Study|Non-compliance|1|||
162236803|NCT01620255|585919072|FG002|Overall Study|Non-compliance|0|||
162236804|NCT01620255|585919073|FG003|Overall Study|Non-compliance|0|||
162236805|NCT01620255|585919074|FG004|Overall Study|Non-compliance|0|||
162236806|NCT01620255|585919070|FG000|Overall Study|Adverse Event|0|||
162236807|NCT01620255|585919071|FG001|Overall Study|Adverse Event|4|||
162236808|NCT01620255|585919072|FG002|Overall Study|Adverse Event|0|||
162236809|NCT01620255|585919073|FG003|Overall Study|Adverse Event|1|||
162236810|NCT01620255|585919074|FG004|Overall Study|Adverse Event|1|||
162236811|NCT01620255|585919070|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
162236812|NCT01620255|585919071|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
162236813|NCT01620255|585919072|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
162236814|NCT01620255|585919073|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
162236815|NCT01620255|585919074|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
162236816|NCT01873495|585919081|FG000|Overall Study|Withdrawal by Subject|1|||
162236817|NCT01873495|585919081|FG000|Overall Study|Physician Decision|3|||
162236818|NCT01873495|585919081|FG000|Overall Study|Adverse Event|1|||
162236819|NCT01873495|585919081|FG000|Overall Study|Removed for Transplantation|1|||
162236820|NCT01873495|585919081|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
162236821|NCT04335812|585919082|FG000|Overall Study|Withdrawal by Subject|1|||
162236822|NCT04335812|585919083|FG001|Overall Study|Withdrawal by Subject|3|||
162236823|NCT04335812|585919082|FG000|Overall Study|Lost to Follow-up|12|||
162236824|NCT04335812|585919083|FG001|Overall Study|Lost to Follow-up|12|||
162236825|NCT04335812|585919082|FG000|Overall Study|Did not engage in the intervention|22|||
162236826|NCT04335812|585919083|FG001|Overall Study|Did not engage in the intervention|18|||
162236827|NCT03864146|585919087|FG000|Overall Study|Lost to Follow-up|14|||
162236828|NCT03864146|585919088|FG001|Overall Study|Lost to Follow-up|23|||
161951322|NCT02831855|584873610|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
161951323|NCT02831855|584873611|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
161951324|NCT02831855|584873612|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
161951325|NCT02831855|584873610|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
162236829|NCT03864146|585919087|FG000|Overall Study|Withdrawal by Subject|3|||
162236830|NCT03864146|585919088|FG001|Overall Study|Withdrawal by Subject|2|||
162236831|NCT00799513|585919089|FG000|Overall Study|Physician Decision|1|||
161951326|NCT02831855|584873611|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
161951327|NCT02831855|584873612|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
161951328|NCT02831855|584873610|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
161951329|NCT02831855|584873611|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
161951330|NCT02831855|584873612|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
161951331|NCT02831855|584873610|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
161951332|NCT02831855|584873611|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
161951333|NCT02831855|584873612|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
161951334|NCT02831855|584873610|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
161951335|NCT02831855|584873611|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
161951336|NCT02831855|584873612|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
161951337|NCT02831855|584873610|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
161951338|NCT02831855|584873611|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
161951339|NCT02831855|584873612|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
161951340|NCT02831855|584873610|FG000|Open Label Phase (24 Weeks)|Other|4|||
161951341|NCT02831855|584873611|FG001|Open Label Phase (24 Weeks)|Other|0|||
161951342|NCT02831855|584873612|FG002|Open Label Phase (24 Weeks)|Other|0|||
161951343|NCT02831855|584873610|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
161951344|NCT02831855|584873611|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
161951345|NCT02831855|584873612|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
161951346|NCT02831855|584873610|FG000|Double Blind Phase (24 Weeks)|Death|0|||
161951347|NCT02831855|584873611|FG001|Double Blind Phase (24 Weeks)|Death|0|||
161951348|NCT02831855|584873612|FG002|Double Blind Phase (24 Weeks)|Death|2|||
161951349|NCT02831855|584873610|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
161951350|NCT02831855|584873611|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
161951351|NCT02831855|584873612|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
161951352|NCT02831855|584873610|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
161951353|NCT02831855|584873611|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
161951354|NCT02831855|584873612|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
161951355|NCT02831855|584873610|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
161951356|NCT02831855|584873611|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
161951357|NCT02831855|584873612|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
161951358|NCT02831855|584873610|FG000|Double Blind Phase (24 Weeks)|Other|0|||
161951359|NCT02831855|584873611|FG001|Double Blind Phase (24 Weeks)|Other|2|||
161951360|NCT02831855|584873612|FG002|Double Blind Phase (24 Weeks)|Other|5|||
161951361|NCT02831855|584873610|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
161951362|NCT02831855|584873611|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
161951363|NCT02831855|584873612|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
161951364|NCT02831855|584873610|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
161951365|NCT02831855|584873611|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
161951366|NCT02831855|584873612|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
161951367|NCT02831855|584873610|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
161951368|NCT02831855|584873611|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
161951369|NCT02831855|584873612|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
161951370|NCT02750514|584873614|FG000|Track 1|Disease progression|20|||
161951371|NCT02750514|584873615|FG001|Track 1|Disease progression|1|||
161951372|NCT02750514|584873616|FG002|Track 1|Disease progression|0|||
161951373|NCT02750514|584873617|FG003|Track 1|Disease progression|1|||
161951374|NCT02750514|584873618|FG004|Track 1|Disease progression|0|||
161951375|NCT02750514|584873614|FG000|Track 1|Adverse event unrelated to study drug|1|||
161951376|NCT02750514|584873615|FG001|Track 1|Adverse event unrelated to study drug|0|||
161951377|NCT02750514|584873616|FG002|Track 1|Adverse event unrelated to study drug|0|||
161951378|NCT02750514|584873617|FG003|Track 1|Adverse event unrelated to study drug|0|||
161951379|NCT02750514|584873618|FG004|Track 1|Adverse event unrelated to study drug|0|||
161951380|NCT02750514|584873614|FG000|Track 1|Study drug toxicity|4|||
161951381|NCT02750514|584873615|FG001|Track 1|Study drug toxicity|1|||
161951382|NCT02750514|584873616|FG002|Track 1|Study drug toxicity|0|||
161951383|NCT02750514|584873617|FG003|Track 1|Study drug toxicity|1|||
161951384|NCT02750514|584873618|FG004|Track 1|Study drug toxicity|0|||
161951385|NCT02750514|584873614|FG000|Track 1|Participant request to discontinue|1|||
161951386|NCT02750514|584873615|FG001|Track 1|Participant request to discontinue|0|||
161951387|NCT02750514|584873616|FG002|Track 1|Participant request to discontinue|0|||
161951388|NCT02750514|584873617|FG003|Track 1|Participant request to discontinue|0|||
161951389|NCT02750514|584873618|FG004|Track 1|Participant request to discontinue|0|||
161686055|NCT03776175|583903288|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
161686056|NCT03776175|583903289|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
161686057|NCT03776175|583903290|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
161686058|NCT03776175|583903287|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
161951390|NCT02750514|584873614|FG000|Track 1|Other reasons|1|||
161951391|NCT02750514|584873615|FG001|Track 1|Other reasons|0|||
161951392|NCT02750514|584873616|FG002|Track 1|Other reasons|0|||
161951393|NCT02750514|584873617|FG003|Track 1|Other reasons|0|||
161951394|NCT02750514|584873618|FG004|Track 1|Other reasons|0|||
161951395|NCT02750514|584873614|FG000|Track 2|Disease progression|4|||
161951396|NCT02750514|584873615|FG001|Track 2|Disease progression|5|||
161951397|NCT02750514|584873616|FG002|Track 2|Disease progression|2|||
161951398|NCT02750514|584873617|FG003|Track 2|Disease progression|5|||
161951399|NCT02750514|584873618|FG004|Track 2|Disease progression|0|||
161951400|NCT02750514|584873614|FG000|Track 2|Adverse event unrelated to study drug|1|||
161951401|NCT02750514|584873615|FG001|Track 2|Adverse event unrelated to study drug|0|||
161951402|NCT02750514|584873616|FG002|Track 2|Adverse event unrelated to study drug|0|||
161951403|NCT02750514|584873617|FG003|Track 2|Adverse event unrelated to study drug|0|||
161951404|NCT02750514|584873618|FG004|Track 2|Adverse event unrelated to study drug|0|||
161951405|NCT02750514|584873614|FG000|Track 2|Study drug toxicity|1|||
161951406|NCT02750514|584873615|FG001|Track 2|Study drug toxicity|2|||
161951407|NCT02750514|584873616|FG002|Track 2|Study drug toxicity|0|||
161951408|NCT02750514|584873617|FG003|Track 2|Study drug toxicity|2|||
161951409|NCT02750514|584873618|FG004|Track 2|Study drug toxicity|0|||
161951410|NCT02750514|584873614|FG000|Track 2|Participant withdrew consent|0|||
161951411|NCT02750514|584873615|FG001|Track 2|Participant withdrew consent|1|||
161951412|NCT02750514|584873616|FG002|Track 2|Participant withdrew consent|0|||
161951413|NCT02750514|584873617|FG003|Track 2|Participant withdrew consent|0|||
161951414|NCT02750514|584873618|FG004|Track 2|Participant withdrew consent|0|||
161951415|NCT02750514|584873614|FG000|Track 3|Disease progression|0|||
161951416|NCT02750514|584873615|FG001|Track 3|Disease progression|24|||
161951417|NCT02750514|584873616|FG002|Track 3|Disease progression|13|||
161951418|NCT02750514|584873617|FG003|Track 3|Disease progression|14|||
161951419|NCT02750514|584873618|FG004|Track 3|Disease progression|0|||
161951420|NCT02750514|584873614|FG000|Track 3|Adverse event unrelated to study drug|0|||
161951421|NCT02750514|584873615|FG001|Track 3|Adverse event unrelated to study drug|1|||
161951422|NCT02750514|584873616|FG002|Track 3|Adverse event unrelated to study drug|1|||
161951423|NCT02750514|584873617|FG003|Track 3|Adverse event unrelated to study drug|1|||
161951424|NCT02750514|584873618|FG004|Track 3|Adverse event unrelated to study drug|0|||
161951425|NCT02750514|584873614|FG000|Track 3|Study drug toxicity|0|||
161951426|NCT02750514|584873615|FG001|Track 3|Study drug toxicity|3|||
161951427|NCT02750514|584873616|FG002|Track 3|Study drug toxicity|0|||
161951428|NCT02750514|584873617|FG003|Track 3|Study drug toxicity|1|||
161951429|NCT02750514|584873618|FG004|Track 3|Study drug toxicity|0|||
161951430|NCT02750514|584873614|FG000|Track 3|Participant request to discontinue|0|||
161951431|NCT02750514|584873615|FG001|Track 3|Participant request to discontinue|2|||
161951432|NCT02750514|584873616|FG002|Track 3|Participant request to discontinue|0|||
161951433|NCT02750514|584873617|FG003|Track 3|Participant request to discontinue|0|||
161951434|NCT02750514|584873618|FG004|Track 3|Participant request to discontinue|0|||
161951435|NCT02750514|584873614|FG000|Track 3|Participant withdrew consent|0|||
161951436|NCT02750514|584873615|FG001|Track 3|Participant withdrew consent|3|||
161951437|NCT02750514|584873616|FG002|Track 3|Participant withdrew consent|1|||
161951438|NCT02750514|584873617|FG003|Track 3|Participant withdrew consent|0|||
161951439|NCT02750514|584873618|FG004|Track 3|Participant withdrew consent|0|||
161951440|NCT02750514|584873614|FG000|Track 3|Other reasons|0|||
161951441|NCT02750514|584873615|FG001|Track 3|Other reasons|3|||
161951442|NCT02750514|584873616|FG002|Track 3|Other reasons|0|||
161951443|NCT02750514|584873617|FG003|Track 3|Other reasons|0|||
161951444|NCT02750514|584873618|FG004|Track 3|Other reasons|0|||
161951445|NCT02750514|584873614|FG000|Track 4|Study drug toxicity|0|||
161951446|NCT02750514|584873615|FG001|Track 4|Study drug toxicity|6|||
161686059|NCT03776175|583903288|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
161686060|NCT03776175|583903289|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
161686061|NCT03776175|583903290|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
161686062|NCT03776175|583903287|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
161686063|NCT03776175|583903288|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
161686064|NCT03776175|583903289|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
161686065|NCT03776175|583903290|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
161686066|NCT02770547|583903294|FG000|Overall Study|Patient non-compliant|1|||
161686067|NCT02770547|583903295|FG001|Overall Study|Patient non-compliant|0|||
161686068|NCT02770547|583903294|FG000|Overall Study|Adverse Event|0|||
161686069|NCT02770547|583903295|FG001|Overall Study|Adverse Event|1|||
161686070|NCT00661531|583903296|FG000|Overall Study|Withdrawal by Subject|3|||
161686071|NCT03134599|583903298|FG000|Week 1|Lost to Follow-up|0|||
161686072|NCT03134599|583903299|FG001|Week 1|Lost to Follow-up|0|||
161686073|NCT03134599|583903300|FG002|Week 1|Lost to Follow-up|0|||
161686074|NCT03134599|583903301|FG003|Week 1|Lost to Follow-up|0|||
161951447|NCT02750514|584873616|FG002|Track 4|Study drug toxicity|0|||
161951448|NCT02750514|584873617|FG003|Track 4|Study drug toxicity|5|||
161951449|NCT02750514|584873618|FG004|Track 4|Study drug toxicity|0|||
161951450|NCT02750514|584873614|FG000|Track 4|Participant request to discontinue|0|||
161951451|NCT02750514|584873615|FG001|Track 4|Participant request to discontinue|1|||
161951452|NCT02750514|584873616|FG002|Track 4|Participant request to discontinue|0|||
161951453|NCT02750514|584873617|FG003|Track 4|Participant request to discontinue|1|||
161951454|NCT02750514|584873618|FG004|Track 4|Participant request to discontinue|0|||
161951455|NCT02750514|584873614|FG000|Track 4|Participant withdrew consent|0|||
161951456|NCT02750514|584873615|FG001|Track 4|Participant withdrew consent|1|||
161951457|NCT02750514|584873616|FG002|Track 4|Participant withdrew consent|0|||
161951458|NCT02750514|584873617|FG003|Track 4|Participant withdrew consent|0|||
161951459|NCT02750514|584873618|FG004|Track 4|Participant withdrew consent|0|||
161951460|NCT02750514|584873614|FG000|Track 4|Other reasons|0|||
161951461|NCT02750514|584873615|FG001|Track 4|Other reasons|5|||
161951462|NCT02750514|584873616|FG002|Track 4|Other reasons|0|||
161951463|NCT02750514|584873617|FG003|Track 4|Other reasons|3|||
161951464|NCT02750514|584873618|FG004|Track 4|Other reasons|0|||
161951465|NCT02750514|584873614|FG000|Track 4|Disease progression|0|||
161951466|NCT02750514|584873615|FG001|Track 4|Disease progression|33|||
161951467|NCT02750514|584873616|FG002|Track 4|Disease progression|0|||
161951468|NCT02750514|584873617|FG003|Track 4|Disease progression|32|||
161951469|NCT02750514|584873618|FG004|Track 4|Disease progression|0|||
161951470|NCT02750514|584873614|FG000|Track 4|Adverse event unrelated to study drug|0|||
161951471|NCT02750514|584873615|FG001|Track 4|Adverse event unrelated to study drug|5|||
161951472|NCT02750514|584873616|FG002|Track 4|Adverse event unrelated to study drug|0|||
161951473|NCT02750514|584873617|FG003|Track 4|Adverse event unrelated to study drug|0|||
161951474|NCT02750514|584873618|FG004|Track 4|Adverse event unrelated to study drug|0|||
161951475|NCT02750514|584873614|FG000|Track 4|Death|0|||
161951476|NCT02750514|584873615|FG001|Track 4|Death|0|||
161951477|NCT02750514|584873616|FG002|Track 4|Death|0|||
161951478|NCT02750514|584873617|FG003|Track 4|Death|1|||
161951479|NCT02750514|584873618|FG004|Track 4|Death|0|||
161951480|NCT02750514|584873614|FG000|Track 5|Disease progression|0|||
161951481|NCT02750514|584873615|FG001|Track 5|Disease progression|0|||
161951482|NCT02750514|584873616|FG002|Track 5|Disease progression|0|||
161951483|NCT02750514|584873617|FG003|Track 5|Disease progression|0|||
161951484|NCT02750514|584873618|FG004|Track 5|Disease progression|34|||
161951485|NCT02750514|584873614|FG000|Track 5|Adverse event unrelated to study drug|0|||
161951486|NCT02750514|584873615|FG001|Track 5|Adverse event unrelated to study drug|0|||
161951487|NCT02750514|584873616|FG002|Track 5|Adverse event unrelated to study drug|0|||
161951488|NCT02750514|584873617|FG003|Track 5|Adverse event unrelated to study drug|0|||
161951489|NCT02750514|584873618|FG004|Track 5|Adverse event unrelated to study drug|2|||
161951490|NCT02750514|584873614|FG000|Track 5|Study drug toxicity|0|||
161951491|NCT02750514|584873615|FG001|Track 5|Study drug toxicity|0|||
161951492|NCT02750514|584873616|FG002|Track 5|Study drug toxicity|0|||
162028750|NCT02509117|585161829|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
162028751|NCT02509117|585161830|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
162028752|NCT02509117|585161831|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
161951493|NCT02750514|584873617|FG003|Track 5|Study drug toxicity|0|||
162028753|NCT02509117|585161832|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
162028754|NCT02509117|585161833|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
162028755|NCT02509117|585161834|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
161686075|NCT03134599|583903302|FG004|Week 1|Lost to Follow-up|1|||
161686076|NCT03134599|583903303|FG005|Week 1|Lost to Follow-up|0|||
161951494|NCT02750514|584873618|FG004|Track 5|Study drug toxicity|2|||
161951495|NCT02750514|584873614|FG000|Track 5|Participant request to discontinue|0|||
161951496|NCT02750514|584873615|FG001|Track 5|Participant request to discontinue|0|||
161951497|NCT02750514|584873616|FG002|Track 5|Participant request to discontinue|0|||
161951498|NCT02750514|584873617|FG003|Track 5|Participant request to discontinue|0|||
161686077|NCT03134599|583903298|FG000|Week 2|Lost to Follow-up|1|||
161686078|NCT03134599|583903299|FG001|Week 2|Lost to Follow-up|0|||
161686079|NCT03134599|583903300|FG002|Week 2|Lost to Follow-up|0|||
161686080|NCT03134599|583903301|FG003|Week 2|Lost to Follow-up|1|||
161686081|NCT03134599|583903302|FG004|Week 2|Lost to Follow-up|1|||
161686082|NCT03134599|583903303|FG005|Week 2|Lost to Follow-up|0|||
161686083|NCT03134599|583903298|FG000|Week 3|Lost to Follow-up|0|||
161686084|NCT03134599|583903299|FG001|Week 3|Lost to Follow-up|0|||
161686085|NCT03134599|583903300|FG002|Week 3|Lost to Follow-up|0|||
161686086|NCT03134599|583903301|FG003|Week 3|Lost to Follow-up|1|||
161686087|NCT03134599|583903302|FG004|Week 3|Lost to Follow-up|0|||
161686088|NCT03134599|583903303|FG005|Week 3|Lost to Follow-up|1|||
161686089|NCT00393887|583903304|FG000|Overall Study|Physician Decision|5|||
161686090|NCT00393887|583903305|FG001|Overall Study|Physician Decision|0|||
161686091|NCT00393887|583903304|FG000|Overall Study|Lost to Follow-up|11|||
161686092|NCT00393887|583903305|FG001|Overall Study|Lost to Follow-up|9|||
161686093|NCT02004262|583903308|FG000|Overall Study|Death|67|||
161686094|NCT02004262|583903309|FG001|Overall Study|Death|64|||
161686095|NCT02004262|583903310|FG002|Overall Study|Death|66|||
161686096|NCT02004262|583903311|FG003|Overall Study|Death|28|||
161686097|NCT02004262|583903312|FG004|Overall Study|Death|29|||
161686098|NCT02004262|583903313|FG005|Overall Study|Death|22|||
161686099|NCT02004262|583903308|FG000|Overall Study|Withdrawal by Subject|1|||
161686100|NCT02004262|583903309|FG001|Overall Study|Withdrawal by Subject|0|||
161686101|NCT02004262|583903310|FG002|Overall Study|Withdrawal by Subject|4|||
161686102|NCT02004262|583903311|FG003|Overall Study|Withdrawal by Subject|0|||
161686103|NCT02004262|583903312|FG004|Overall Study|Withdrawal by Subject|1|||
161686104|NCT02004262|583903313|FG005|Overall Study|Withdrawal by Subject|3|||
161686105|NCT02004262|583903308|FG000|Overall Study|Lost to Follow-up|1|||
161686106|NCT02004262|583903309|FG001|Overall Study|Lost to Follow-up|1|||
161686107|NCT02004262|583903310|FG002|Overall Study|Lost to Follow-up|0|||
161686108|NCT02004262|583903311|FG003|Overall Study|Lost to Follow-up|0|||
161686109|NCT02004262|583903312|FG004|Overall Study|Lost to Follow-up|0|||
161686110|NCT02004262|583903313|FG005|Overall Study|Lost to Follow-up|0|||
161686111|NCT02004262|583903308|FG000|Overall Study|Study Terminated by Sponsor|4|||
161686112|NCT02004262|583903309|FG001|Overall Study|Study Terminated by Sponsor|3|||
161686113|NCT02004262|583903310|FG002|Overall Study|Study Terminated by Sponsor|2|||
161686114|NCT02004262|583903311|FG003|Overall Study|Study Terminated by Sponsor|1|||
161686115|NCT02004262|583903312|FG004|Overall Study|Study Terminated by Sponsor|1|||
161686116|NCT02004262|583903313|FG005|Overall Study|Study Terminated by Sponsor|5|||
161686117|NCT03703102|583903314|FG000|Overall Study|Adverse Event|4|||
161686118|NCT03703102|583903315|FG001|Overall Study|Adverse Event|3|||
161686119|NCT03703102|583903316|FG002|Overall Study|Adverse Event|7|||
161686120|NCT03703102|583903317|FG003|Overall Study|Adverse Event|3|||
161686121|NCT03703102|583903318|FG004|Overall Study|Adverse Event|13|||
161686122|NCT03703102|583903314|FG000|Overall Study|Lack of Efficacy|4|||
161686123|NCT03703102|583903315|FG001|Overall Study|Lack of Efficacy|0|||
161686124|NCT03703102|583903316|FG002|Overall Study|Lack of Efficacy|1|||
161686125|NCT03703102|583903317|FG003|Overall Study|Lack of Efficacy|4|||
161686126|NCT03703102|583903318|FG004|Overall Study|Lack of Efficacy|1|||
161686127|NCT03703102|583903314|FG000|Overall Study|Lost to Follow-up|0|||
161686128|NCT03703102|583903315|FG001|Overall Study|Lost to Follow-up|0|||
161686129|NCT03703102|583903316|FG002|Overall Study|Lost to Follow-up|1|||
161686130|NCT03703102|583903317|FG003|Overall Study|Lost to Follow-up|2|||
161686131|NCT03703102|583903318|FG004|Overall Study|Lost to Follow-up|2|||
161833957|NCT02339740|584433270|FG000|Overall Study|Withdrawal by Subject|5|||
161833958|NCT02339740|584433271|FG001|Overall Study|Withdrawal by Subject|1|||
161833959|NCT02339740|584433270|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
161833960|NCT02339740|584433271|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
161833961|NCT01807117|584433273|FG000|Overall Study|Physician Decision|2|||
161833962|NCT01807117|584433273|FG000|Overall Study|Disease diagnosis not a study disease|1|||
161833963|NCT02777918|584433274|FG000|Overall Study|Medical reasons|1|||
161833964|NCT02777918|584433275|FG001|Overall Study|Medical reasons|2|||
161833965|NCT02777918|584433274|FG000|Overall Study|Too busy / stressed|1|||
161833966|NCT02777918|584433275|FG001|Overall Study|Too busy / stressed|1|||
161833967|NCT02777918|584433274|FG000|Overall Study|Withdrawal by Subject|1|||
161833968|NCT02777918|584433275|FG001|Overall Study|Withdrawal by Subject|1|||
161833969|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
161833970|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
161833971|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
162236832|NCT00799513|585919089|FG000|Overall Study|Adverse Event|1|||
161686132|NCT03703102|583903314|FG000|Overall Study|Physician Decision|2|||
161686133|NCT03703102|583903315|FG001|Overall Study|Physician Decision|2|||
161686134|NCT03703102|583903316|FG002|Overall Study|Physician Decision|2|||
161686135|NCT03703102|583903317|FG003|Overall Study|Physician Decision|2|||
161686136|NCT03703102|583903318|FG004|Overall Study|Physician Decision|4|||
161686137|NCT03703102|583903314|FG000|Overall Study|Withdrawal by Subject|7|||
161686138|NCT03703102|583903315|FG001|Overall Study|Withdrawal by Subject|5|||
161686139|NCT03703102|583903316|FG002|Overall Study|Withdrawal by Subject|5|||
161686140|NCT03703102|583903317|FG003|Overall Study|Withdrawal by Subject|5|||
161951499|NCT02750514|584873618|FG004|Track 5|Participant request to discontinue|3|||
161951500|NCT02750514|584873614|FG000|Track 5|Other reasons|0|||
161951501|NCT02750514|584873615|FG001|Track 5|Other reasons|0|||
161951502|NCT02750514|584873616|FG002|Track 5|Other reasons|0|||
161951503|NCT02750514|584873617|FG003|Track 5|Other reasons|0|||
161951504|NCT02750514|584873618|FG004|Track 5|Other reasons|2|||
161951505|NCT00889707|584873620|FG000|Overall Study|Adverse Event|1|||
161951506|NCT00889707|584873621|FG001|Overall Study|Adverse Event|0|||
161951507|NCT00889707|584873620|FG000|Overall Study|Withdrawal by Subject|4|||
161951508|NCT00889707|584873621|FG001|Overall Study|Withdrawal by Subject|3|||
161951509|NCT00889707|584873620|FG000|Overall Study|Lost to Follow-up|0|||
161951510|NCT00889707|584873621|FG001|Overall Study|Lost to Follow-up|2|||
161951511|NCT00889707|584873620|FG000|Overall Study|Lack of Efficacy|2|||
161951512|NCT00889707|584873621|FG001|Overall Study|Lack of Efficacy|5|||
161951513|NCT02756403|584873623|FG000|Overall Study|Unable to swallow medication|0|||
161951514|NCT02756403|584873624|FG001|Overall Study|Unable to swallow medication|1|||
161951515|NCT02756403|584873625|FG002|Overall Study|Unable to swallow medication|1|||
161951516|NCT02756403|584873626|FG003|Overall Study|Unable to swallow medication|1|||
161951517|NCT02756403|584873623|FG000|Overall Study|Did not complete Procedure|0|||
161951518|NCT02756403|584873624|FG001|Overall Study|Did not complete Procedure|1|||
161951519|NCT02756403|584873625|FG002|Overall Study|Did not complete Procedure|0|||
161951520|NCT02756403|584873626|FG003|Overall Study|Did not complete Procedure|0|||
161951521|NCT02756403|584873623|FG000|Overall Study|Changed Mind About Procedure|0|||
161951522|NCT02756403|584873624|FG001|Overall Study|Changed Mind About Procedure|0|||
161951523|NCT02756403|584873625|FG002|Overall Study|Changed Mind About Procedure|1|||
161951524|NCT02756403|584873626|FG003|Overall Study|Changed Mind About Procedure|0|||
161951525|NCT02756403|584873623|FG000|Overall Study|Protocol Violation|0|||
161951526|NCT02756403|584873624|FG001|Overall Study|Protocol Violation|1|||
161951527|NCT02756403|584873625|FG002|Overall Study|Protocol Violation|0|||
161951528|NCT02756403|584873626|FG003|Overall Study|Protocol Violation|1|||
161951529|NCT00527618|584873627|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
161951530|NCT00527618|584873628|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
161951531|NCT00527618|584873627|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
161951532|NCT00527618|584873628|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
161951533|NCT00527618|584873627|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
161951534|NCT00527618|584873628|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
161951535|NCT00527618|584873627|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
161951536|NCT00527618|584873628|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
161951537|NCT00527618|584873627|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
161951538|NCT00527618|584873628|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
161951539|NCT00527618|584873627|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
161951540|NCT00527618|584873628|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
161951541|NCT02240121|584873633|FG000|Overall Study|Protocol Violation|1|||
161951542|NCT02240121|584873634|FG001|Overall Study|Protocol Violation|2|||
161951543|NCT02240121|584873633|FG000|Overall Study|Physician Decision|0|||
161951544|NCT02240121|584873634|FG001|Overall Study|Physician Decision|1|||
161951545|NCT02240121|584873633|FG000|Overall Study|Change in protocol interpretation|1|||
161951546|NCT02240121|584873634|FG001|Overall Study|Change in protocol interpretation|0|||
161951547|NCT02240121|584873633|FG000|Overall Study|Lack of Efficacy|2|||
161951548|NCT02240121|584873634|FG001|Overall Study|Lack of Efficacy|3|||
161951549|NCT02240121|584873633|FG000|Overall Study|Site closed|1|||
161951550|NCT02240121|584873634|FG001|Overall Study|Site closed|1|||
161951551|NCT02240121|584873633|FG000|Overall Study|Pregnancy|1|||
161951552|NCT02240121|584873634|FG001|Overall Study|Pregnancy|0|||
161951553|NCT02240121|584873633|FG000|Overall Study|Adverse Event|2|||
161951554|NCT02240121|584873634|FG001|Overall Study|Adverse Event|4|||
161951555|NCT02240121|584873633|FG000|Overall Study|Withdrawal by Subject|6|||
161951556|NCT02240121|584873634|FG001|Overall Study|Withdrawal by Subject|2|||
161951557|NCT02240121|584873633|FG000|Overall Study|Lost to Follow-up|3|||
161951558|NCT02240121|584873634|FG001|Overall Study|Lost to Follow-up|4|||
161951559|NCT02240121|584873633|FG000|Overall Study|Other than specified|1|||
161951560|NCT02240121|584873634|FG001|Overall Study|Other than specified|3|||
161951561|NCT01151020|584873635|FG000|Overall Study|Death|25|||
161951562|NCT01151020|584873635|FG000|Overall Study|Conversion to open repair|1|||
161951563|NCT01151020|584873635|FG000|Overall Study|Lost to Follow-up|4|||
161951564|NCT01151020|584873635|FG000|Overall Study|Withdrawal by Subject|22|||
161951565|NCT01151020|584873635|FG000|Overall Study|Patients did not receive the device|2|||
161951566|NCT00648037|584873636|FG000|Overall Study|Not Treated|1|||
161951567|NCT00648037|584873636|FG000|Overall Study|Withdrawal by Subject|1|||
161686141|NCT03703102|583903318|FG004|Overall Study|Withdrawal by Subject|9|||
161686142|NCT03703102|583903314|FG000|Overall Study|Ineligibility|0|||
161686143|NCT03703102|583903315|FG001|Overall Study|Ineligibility|0|||
161686144|NCT03703102|583903316|FG002|Overall Study|Ineligibility|1|||
161686145|NCT03703102|583903317|FG003|Overall Study|Ineligibility|0|||
161686146|NCT03703102|583903318|FG004|Overall Study|Ineligibility|0|||
161686147|NCT03703102|583903314|FG000|Overall Study|Protocol Deviation|4|||
161686148|NCT03703102|583903315|FG001|Overall Study|Protocol Deviation|4|||
161686149|NCT03703102|583903316|FG002|Overall Study|Protocol Deviation|3|||
161686150|NCT03703102|583903317|FG003|Overall Study|Protocol Deviation|0|||
161951568|NCT00648037|584873636|FG000|Overall Study|Adverse Event|11|||
161951569|NCT00648037|584873636|FG000|Overall Study|Relapse|2|||
161951570|NCT00648037|584873636|FG000|Overall Study|Other|1|||
161951571|NCT01635998|584873637|FG000|Overall Study|Death|1|||
161951572|NCT01635998|584873638|FG001|Overall Study|Death|1|||
161951573|NCT01635998|584873637|FG000|Overall Study|Lost to Follow-up|2|||
161951574|NCT01635998|584873638|FG001|Overall Study|Lost to Follow-up|1|||
161951575|NCT01635998|584873637|FG000|Overall Study|Withdrawal by Subject|1|||
161951576|NCT01635998|584873638|FG001|Overall Study|Withdrawal by Subject|5|||
161951577|NCT00846846|584873639|FG000|Overall Study|Death|56|||
161951578|NCT00846846|584873639|FG000|Overall Study|Withdrawal by Subject|19|||
161951579|NCT04419467|584873640|FG000|Overall Study|Not treated with IP|0|||
161951580|NCT04419467|584873641|FG001|Overall Study|Not treated with IP|0|||
161951581|NCT04419467|584873642|FG002|Overall Study|Not treated with IP|2|||
161951582|NCT04419467|584873640|FG000|Overall Study|Adverse Event|0|||
161951583|NCT04419467|584873641|FG001|Overall Study|Adverse Event|2|||
161951584|NCT04419467|584873642|FG002|Overall Study|Adverse Event|0|||
161951585|NCT04419467|584873640|FG000|Overall Study|Death|1|||
161951586|NCT04419467|584873641|FG001|Overall Study|Death|0|||
161951587|NCT04419467|584873642|FG002|Overall Study|Death|0|||
161951588|NCT04419467|584873640|FG000|Overall Study|Lost to Follow-up|0|||
161951589|NCT04419467|584873641|FG001|Overall Study|Lost to Follow-up|1|||
161951590|NCT04419467|584873642|FG002|Overall Study|Lost to Follow-up|2|||
161951591|NCT04419467|584873640|FG000|Overall Study|Withdrawal by Subject|0|||
161951592|NCT04419467|584873641|FG001|Overall Study|Withdrawal by Subject|0|||
161951593|NCT04419467|584873642|FG002|Overall Study|Withdrawal by Subject|4|||
161951594|NCT04419467|584873640|FG000|Overall Study|Pandemic related|0|||
161951595|NCT04419467|584873641|FG001|Overall Study|Pandemic related|0|||
161951596|NCT04419467|584873642|FG002|Overall Study|Pandemic related|1|||
161951597|NCT04419467|584873640|FG000|Overall Study|Reason not known|1|||
161951598|NCT04419467|584873641|FG001|Overall Study|Reason not known|0|||
161951599|NCT04419467|584873642|FG002|Overall Study|Reason not known|0|||
161951600|NCT02967679|584873645|FG000|Overall Study|Adverse Event|1|||
161951601|NCT00600067|584873648|FG000|Overall Study|Adverse Event|0|||
161951602|NCT00600067|584873649|FG001|Overall Study|Adverse Event|1|||
161951603|NCT00600067|584873648|FG000|Overall Study|Lost to Follow-up|2|||
161951604|NCT00600067|584873649|FG001|Overall Study|Lost to Follow-up|3|||
161951605|NCT00600067|584873648|FG000|Overall Study|protocol non-compliance|0|||
161951606|NCT00600067|584873649|FG001|Overall Study|protocol non-compliance|3|||
161951607|NCT00600067|584873648|FG000|Overall Study|Lack of Efficacy|1|||
161951608|NCT00600067|584873649|FG001|Overall Study|Lack of Efficacy|0|||
161951609|NCT00881894|584873651|FG000|Overall Study|Consent withdrawn|0|||
161951610|NCT00881894|584873652|FG001|Overall Study|Consent withdrawn|1|||
161951611|NCT00881894|584873651|FG000|Overall Study|Other reasons for premature termination|1|||
161951612|NCT00881894|584873652|FG001|Overall Study|Other reasons for premature termination|2|||
161951613|NCT04571060|584873655|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
161686151|NCT03703102|583903318|FG004|Overall Study|Protocol Deviation|0|||
161951614|NCT04571060|584873656|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
161951615|NCT04571060|584873655|FG000|Overall Study|Never treated migraine|47|||
161951616|NCT04571060|584873656|FG001|Overall Study|Never treated migraine|36|||
161951617|NCT04571060|584873655|FG000|Overall Study|Protocol Violation|4|||
161951618|NCT04571060|584873656|FG001|Overall Study|Protocol Violation|2|||
161951619|NCT04571060|584873655|FG000|Overall Study|Withdrawal by Subject|6|||
161686152|NCT03703102|583903314|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161686153|NCT03703102|583903315|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161686154|NCT03703102|583903316|FG002|Overall Study|Non-Compliance with Study Drug|2|||
161686155|NCT03703102|583903317|FG003|Overall Study|Non-Compliance with Study Drug|1|||
161686156|NCT03703102|583903318|FG004|Overall Study|Non-Compliance with Study Drug|4|||
161951620|NCT04571060|584873656|FG001|Overall Study|Withdrawal by Subject|2|||
161951621|NCT04571060|584873655|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
161951622|NCT04571060|584873656|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
161951623|NCT01253369|584873657|FG000|Overall Study|Adverse Event|4|||
162028756|NCT02509117|585161835|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
162028757|NCT02509117|585161836|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
161686157|NCT02311153|583903319|FG000|Overall Study|Lost to Follow-up|5|||
161951624|NCT01253369|584873657|FG000|Overall Study|Withdrawal by Subject|2|||
161951625|NCT01253369|584873657|FG000|Overall Study|Death|1|||
161951626|NCT01253369|584873657|FG000|Overall Study|Progressive disease|23|||
161833972|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
161833973|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
161833974|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
161833975|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
161833976|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
161833977|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
161833978|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
161833979|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
161833980|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
161833981|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
161833982|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
161833983|NCT02510014|584433278|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
161833984|NCT02510014|584433279|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
161833985|NCT02510014|584433278|FG000|Treatment Period|Adverse Event|11|||
161951627|NCT01253369|584873657|FG000|Overall Study|Not Evaluable|3|||
161951628|NCT01220401|584873663|FG000|Overall Study|Withdrawal by Subject|2|||
161833986|NCT02510014|584433279|FG001|Treatment Period|Adverse Event|4|||
161833987|NCT02510014|584433278|FG000|Treatment Period|Withdrawal symptoms|3|||
161833988|NCT02510014|584433279|FG001|Treatment Period|Withdrawal symptoms|0|||
161833989|NCT02510014|584433278|FG000|Treatment Period|Lost to Follow-up|80|||
161833990|NCT02510014|584433279|FG001|Treatment Period|Lost to Follow-up|19|||
161951629|NCT01220401|584873663|FG000|Overall Study|Protocol Violation|1|||
161833991|NCT02510014|584433278|FG000|Treatment Period|Physician Decision|5|||
161833992|NCT02510014|584433279|FG001|Treatment Period|Physician Decision|0|||
161833993|NCT02510014|584433278|FG000|Treatment Period|Withdrawal by Subject|67|||
161833994|NCT02510014|584433279|FG001|Treatment Period|Withdrawal by Subject|24|||
161833995|NCT02510014|584433278|FG000|Treatment Period|Withdrawn by the investigator|7|||
161833996|NCT02510014|584433279|FG001|Treatment Period|Withdrawn by the investigator|1|||
161833997|NCT02510014|584433278|FG000|Treatment Period|Protocol Violation|4|||
161833998|NCT02510014|584433279|FG001|Treatment Period|Protocol Violation|4|||
161833999|NCT02510014|584433278|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
161834000|NCT02510014|584433279|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
161834001|NCT01949116|584433281|FG000|Overall Study|Death|2|||
161834002|NCT01949116|584433282|FG001|Overall Study|Death|0|||
161834003|NCT01949116|584433281|FG000|Overall Study|Lost to Follow-up|1|||
161834004|NCT01949116|584433282|FG001|Overall Study|Lost to Follow-up|3|||
161834005|NCT01949116|584433281|FG000|Overall Study|Withdrawal by Subject|5|||
161834006|NCT01949116|584433282|FG001|Overall Study|Withdrawal by Subject|3|||
161834007|NCT05486065|584433284|FG000|Overall Study|Withdrawal by Subject|1|||
161834008|NCT05486065|584433285|FG001|Overall Study|Withdrawal by Subject|5|||
161834009|NCT05486065|584433286|FG002|Overall Study|Withdrawal by Subject|4|||
161834010|NCT05486065|584433287|FG003|Overall Study|Withdrawal by Subject|3|||
161834011|NCT05486065|584433284|FG000|Overall Study|Lost to Follow-up|4|||
161834012|NCT05486065|584433285|FG001|Overall Study|Lost to Follow-up|2|||
161834013|NCT05486065|584433286|FG002|Overall Study|Lost to Follow-up|2|||
161834014|NCT05486065|584433287|FG003|Overall Study|Lost to Follow-up|2|||
161951630|NCT01853462|584873664|FG000|Overall Study|Withdrawal by Subject|1|||
161951631|NCT01853462|584873665|FG001|Overall Study|Withdrawal by Subject|1|||
161951632|NCT03943290|584873667|FG000|Overall Study|Sponsor Terminated Study|6|||
161951633|NCT03943290|584873668|FG001|Overall Study|Sponsor Terminated Study|1|||
161951634|NCT03943290|584873669|FG002|Overall Study|Sponsor Terminated Study|11|||
161951635|NCT03943290|584873670|FG003|Overall Study|Sponsor Terminated Study|6|||
161951636|NCT03943290|584873671|FG004|Overall Study|Sponsor Terminated Study|7|||
161951637|NCT03943290|584873672|FG005|Overall Study|Sponsor Terminated Study|6|||
161951638|NCT03943290|584873673|FG006|Overall Study|Sponsor Terminated Study|6|||
161951639|NCT03943290|584873674|FG007|Overall Study|Sponsor Terminated Study|7|||
161951640|NCT03943290|584873675|FG008|Overall Study|Sponsor Terminated Study|8|||
161951641|NCT03943290|584873667|FG000|Overall Study|Lost to Follow-up|1|||
161951642|NCT03943290|584873668|FG001|Overall Study|Lost to Follow-up|0|||
161951643|NCT03943290|584873669|FG002|Overall Study|Lost to Follow-up|1|||
161951644|NCT03943290|584873670|FG003|Overall Study|Lost to Follow-up|0|||
161951645|NCT03943290|584873671|FG004|Overall Study|Lost to Follow-up|0|||
161951646|NCT03943290|584873672|FG005|Overall Study|Lost to Follow-up|0|||
161951647|NCT03943290|584873673|FG006|Overall Study|Lost to Follow-up|0|||
161951648|NCT03943290|584873674|FG007|Overall Study|Lost to Follow-up|1|||
161951649|NCT03943290|584873675|FG008|Overall Study|Lost to Follow-up|0|||
161951650|NCT03943290|584873667|FG000|Overall Study|Withdrawal by Subject|0|||
161951651|NCT03943290|584873668|FG001|Overall Study|Withdrawal by Subject|0|||
161951652|NCT03943290|584873669|FG002|Overall Study|Withdrawal by Subject|1|||
161951653|NCT03943290|584873670|FG003|Overall Study|Withdrawal by Subject|0|||
161951654|NCT03943290|584873671|FG004|Overall Study|Withdrawal by Subject|0|||
161951655|NCT03943290|584873672|FG005|Overall Study|Withdrawal by Subject|0|||
161951656|NCT03943290|584873673|FG006|Overall Study|Withdrawal by Subject|0|||
161951657|NCT03943290|584873674|FG007|Overall Study|Withdrawal by Subject|0|||
161951658|NCT03943290|584873675|FG008|Overall Study|Withdrawal by Subject|0|||
161951659|NCT02103062|584873676|FG000|Overall Study|Adverse Event|1|||
161951660|NCT02103062|584873677|FG001|Overall Study|Adverse Event|2|||
162028758|NCT00832624|585161837|FG000|Overall Study|Study Terminated|10|||
161834015|NCT05486065|584433284|FG000|Overall Study|Physician Decision|0|||
161951661|NCT02103062|584873676|FG000|Overall Study|Progressive Disease|17|||
162028759|NCT00548184|585161840|FG000|Overall Study|Adverse Event|3|||
161686158|NCT02311153|583903320|FG001|Overall Study|Lost to Follow-up|7|||
161686159|NCT01967628|583903321|FG000|Overall Study|Withdrawal by Subject|2|||
161951662|NCT02103062|584873677|FG001|Overall Study|Progressive Disease|20|||
161951663|NCT02103062|584873676|FG000|Overall Study|Death|0|||
161951664|NCT02103062|584873677|FG001|Overall Study|Death|1|||
161951665|NCT01985022|584873681|FG000|Overall Study|Lost to Follow-up|0|||
161951666|NCT01985022|584873682|FG001|Overall Study|Lost to Follow-up|1|||
161951667|NCT01985022|584873681|FG000|Overall Study|Protocol Violation|0|||
161951668|NCT01985022|584873682|FG001|Overall Study|Protocol Violation|1|||
161951669|NCT01985022|584873681|FG000|Overall Study|Withdrawal by Subject|4|||
161951670|NCT01985022|584873682|FG001|Overall Study|Withdrawal by Subject|1|||
161951671|NCT01152437|584873683|FG000|Overall Study|Other Adverse Event|8|||
161951672|NCT01152437|584873684|FG001|Overall Study|Other Adverse Event|1|||
161951673|NCT01152437|584873685|FG002|Overall Study|Other Adverse Event|7|||
161951674|NCT01152437|584873683|FG000|Overall Study|Not treated|0|||
161951675|NCT01152437|584873684|FG001|Overall Study|Not treated|1|||
161951676|NCT01152437|584873685|FG002|Overall Study|Not treated|2|||
161951677|NCT01152437|584873683|FG000|Overall Study|Progressive disease|27|||
161951678|NCT01152437|584873684|FG001|Overall Study|Progressive disease|13|||
161951679|NCT01152437|584873685|FG002|Overall Study|Progressive disease|32|||
161951680|NCT01152437|584873683|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
161951681|NCT01152437|584873684|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
161951682|NCT01152437|584873685|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
161951683|NCT02015039|584873686|FG000|Overall Study|Not eligible|0|||
161951684|NCT02015039|584873687|FG001|Overall Study|Not eligible|1|||
161951685|NCT03132467|584873688|FG000|Overall Study|Adverse Event|2|||
161951686|NCT03132467|584873688|FG000|Overall Study|Withdrawal by Subject|2|||
161951687|NCT01088906|584873689|FG000|Overall Study|Inclusion error|1|||
161951688|NCT01088906|584873689|FG000|Overall Study|Did not receive study treatment|3|||
161951689|NCT01088906|584873689|FG000|Overall Study|Missing data|1|||
161951690|NCT00457626|584873692|FG000|Overall Study|Adverse Event|3|||
161951691|NCT00457626|584873692|FG000|Overall Study|Administrative Problems|2|||
161951692|NCT00457626|584873692|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
161951693|NCT01365455|584873693|FG000|Induction Period|Adverse Event|5|||
161951694|NCT01365455|584873694|FG001|Induction Period|Adverse Event|3|||
161951695|NCT01365455|584873695|FG002|Induction Period|Adverse Event|4|||
161951696|NCT01365455|584873696|FG003|Induction Period|Adverse Event|0|||
161951697|NCT01365455|584873697|FG004|Induction Period|Adverse Event|0|||
161951698|NCT01365455|584873693|FG000|Induction Period|Lack of Efficacy|1|||
161951699|NCT01365455|584873694|FG001|Induction Period|Lack of Efficacy|1|||
161951700|NCT01365455|584873695|FG002|Induction Period|Lack of Efficacy|0|||
161951701|NCT01365455|584873696|FG003|Induction Period|Lack of Efficacy|0|||
161951702|NCT01365455|584873697|FG004|Induction Period|Lack of Efficacy|0|||
161951703|NCT01365455|584873693|FG000|Induction Period|Pregnancy|0|||
161951704|NCT01365455|584873694|FG001|Induction Period|Pregnancy|1|||
161951705|NCT01365455|584873695|FG002|Induction Period|Pregnancy|0|||
161951706|NCT01365455|584873696|FG003|Induction Period|Pregnancy|0|||
161951707|NCT01365455|584873697|FG004|Induction Period|Pregnancy|0|||
161951708|NCT01365455|584873693|FG000|Induction Period|Protocol deviation|0|||
161951709|NCT01365455|584873694|FG001|Induction Period|Protocol deviation|1|||
161951710|NCT01365455|584873695|FG002|Induction Period|Protocol deviation|1|||
161951711|NCT01365455|584873696|FG003|Induction Period|Protocol deviation|0|||
161951712|NCT01365455|584873697|FG004|Induction Period|Protocol deviation|0|||
162028760|NCT00548184|585161840|FG000|Overall Study|took other drug|1|||
161951713|NCT01365455|584873693|FG000|Induction Period|Subject/guardian decision|9|||
161951714|NCT01365455|584873694|FG001|Induction Period|Subject/guardian decision|1|||
161951715|NCT01365455|584873695|FG002|Induction Period|Subject/guardian decision|8|||
161951716|NCT01365455|584873696|FG003|Induction Period|Subject/guardian decision|0|||
161951717|NCT01365455|584873697|FG004|Induction Period|Subject/guardian decision|0|||
161951718|NCT01365455|584873693|FG000|Induction Period|Lost to Follow-up|0|||
161834016|NCT05486065|584433285|FG001|Overall Study|Physician Decision|1|||
161834017|NCT05486065|584433286|FG002|Overall Study|Physician Decision|1|||
162028761|NCT00548184|585161840|FG000|Overall Study|Found Her2 negative|1|||
161686160|NCT01967628|583903322|FG001|Overall Study|Withdrawal by Subject|0|||
161834018|NCT05486065|584433287|FG003|Overall Study|Physician Decision|0|||
161686161|NCT01967628|583903321|FG000|Overall Study|Unable to complete bronchoscopy|4|||
161686162|NCT01967628|583903322|FG001|Overall Study|Unable to complete bronchoscopy|6|||
161686163|NCT01967628|583903321|FG000|Overall Study|Lost to Follow-up|1|||
161686164|NCT01967628|583903322|FG001|Overall Study|Lost to Follow-up|0|||
161686165|NCT01967628|583903321|FG000|Overall Study|Low protein concentration in sample|20|||
161686166|NCT01967628|583903322|FG001|Overall Study|Low protein concentration in sample|25|||
161686167|NCT00838331|583903323|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
161686168|NCT01379274|583903324|FG000|Overall Study|funding withdrawn|1|||
161951719|NCT01365455|584873694|FG001|Induction Period|Lost to Follow-up|0|||
161951720|NCT01365455|584873695|FG002|Induction Period|Lost to Follow-up|3|||
161951721|NCT01365455|584873696|FG003|Induction Period|Lost to Follow-up|0|||
161951722|NCT01365455|584873697|FG004|Induction Period|Lost to Follow-up|0|||
161951723|NCT01365455|584873693|FG000|Maintenance Period|Adverse Event|12|||
162028762|NCT00280748|585161847|FG000|Overall Study|Decline in performance|3|||
162028763|NCT00280748|585161847|FG000|Overall Study|Extra-cranial disease progression|1|||
162028764|NCT01433250|585161848|FG000|Overall Study|Protocol Violation|0|||
161951724|NCT01365455|584873694|FG001|Maintenance Period|Adverse Event|5|||
161951725|NCT01365455|584873695|FG002|Maintenance Period|Adverse Event|1|||
161951726|NCT01365455|584873696|FG003|Maintenance Period|Adverse Event|2|||
161951727|NCT01365455|584873697|FG004|Maintenance Period|Adverse Event|4|||
161951728|NCT01365455|584873693|FG000|Maintenance Period|Lack of Efficacy|10|||
161951729|NCT01365455|584873694|FG001|Maintenance Period|Lack of Efficacy|2|||
161951730|NCT01365455|584873695|FG002|Maintenance Period|Lack of Efficacy|0|||
161951731|NCT01365455|584873696|FG003|Maintenance Period|Lack of Efficacy|2|||
161951732|NCT01365455|584873697|FG004|Maintenance Period|Lack of Efficacy|2|||
161951733|NCT01365455|584873693|FG000|Maintenance Period|Lost to Follow-up|2|||
161951734|NCT01365455|584873694|FG001|Maintenance Period|Lost to Follow-up|4|||
161951735|NCT01365455|584873695|FG002|Maintenance Period|Lost to Follow-up|0|||
161951736|NCT01365455|584873696|FG003|Maintenance Period|Lost to Follow-up|0|||
161951737|NCT01365455|584873697|FG004|Maintenance Period|Lost to Follow-up|3|||
162028765|NCT01433250|585161849|FG001|Overall Study|Protocol Violation|1|||
162028766|NCT01433250|585161848|FG000|Overall Study|Withdrawal by Subject|3|||
162028767|NCT01433250|585161849|FG001|Overall Study|Withdrawal by Subject|2|||
162028768|NCT01227824|585161854|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
161951738|NCT01365455|584873693|FG000|Maintenance Period|Non-compliance with study treatment|0|||
161951739|NCT01365455|584873694|FG001|Maintenance Period|Non-compliance with study treatment|0|||
161951740|NCT01365455|584873695|FG002|Maintenance Period|Non-compliance with study treatment|0|||
161951741|NCT01365455|584873696|FG003|Maintenance Period|Non-compliance with study treatment|1|||
161951742|NCT01365455|584873697|FG004|Maintenance Period|Non-compliance with study treatment|0|||
161951743|NCT01365455|584873693|FG000|Maintenance Period|Physician Decision|0|||
161951744|NCT01365455|584873694|FG001|Maintenance Period|Physician Decision|1|||
161951745|NCT01365455|584873695|FG002|Maintenance Period|Physician Decision|0|||
161951746|NCT01365455|584873696|FG003|Maintenance Period|Physician Decision|0|||
161951747|NCT01365455|584873697|FG004|Maintenance Period|Physician Decision|1|||
161951748|NCT01365455|584873693|FG000|Maintenance Period|Pregnancy|0|||
161951749|NCT01365455|584873694|FG001|Maintenance Period|Pregnancy|4|||
161951750|NCT01365455|584873695|FG002|Maintenance Period|Pregnancy|0|||
161951751|NCT01365455|584873696|FG003|Maintenance Period|Pregnancy|0|||
161951752|NCT01365455|584873697|FG004|Maintenance Period|Pregnancy|2|||
161951753|NCT01365455|584873693|FG000|Maintenance Period|Protocol deviation|1|||
161951754|NCT01365455|584873694|FG001|Maintenance Period|Protocol deviation|1|||
161951755|NCT01365455|584873695|FG002|Maintenance Period|Protocol deviation|0|||
161951756|NCT01365455|584873696|FG003|Maintenance Period|Protocol deviation|0|||
161951757|NCT01365455|584873697|FG004|Maintenance Period|Protocol deviation|0|||
161951758|NCT01365455|584873693|FG000|Maintenance Period|Subject/guardian decision|4|||
161951759|NCT01365455|584873694|FG001|Maintenance Period|Subject/guardian decision|6|||
161951760|NCT01365455|584873695|FG002|Maintenance Period|Subject/guardian decision|2|||
161951761|NCT01365455|584873696|FG003|Maintenance Period|Subject/guardian decision|4|||
161951762|NCT01365455|584873697|FG004|Maintenance Period|Subject/guardian decision|1|||
161951763|NCT03965403|584873698|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
161951764|NCT02364037|584874684|FG000|Overall Study|Withdrawal by Subject|7|||
161951765|NCT02364037|584874685|FG001|Overall Study|Withdrawal by Subject|4|||
161951766|NCT02364037|584874684|FG000|Overall Study|Lost to Follow-up|37|||
161951767|NCT02364037|584874685|FG001|Overall Study|Lost to Follow-up|49|||
161951768|NCT01453036|584874686|FG000|Overall Study|Lost to Follow-up|26|||
162028769|NCT01227824|585161855|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
161951769|NCT01453036|584874687|FG001|Overall Study|Lost to Follow-up|115|||
161951770|NCT01453036|584874688|FG002|Overall Study|Lost to Follow-up|31|||
161951771|NCT04072835|584874689|FG000|Overall Study|Overall trial ended|603|||
161951772|NCT04072835|584874689|FG000|Overall Study|Ablation|97|||
161951773|NCT04072835|584874689|FG000|Overall Study|Withdrawal of consent|66|||
161834019|NCT05486065|584433284|FG000|Overall Study|Failure to meet randomization criteria|0|||
161834020|NCT05486065|584433285|FG001|Overall Study|Failure to meet randomization criteria|0|||
161834021|NCT05486065|584433286|FG002|Overall Study|Failure to meet randomization criteria|0|||
161834022|NCT05486065|584433287|FG003|Overall Study|Failure to meet randomization criteria|1|||
161834023|NCT02858726|584433292|FG000|Overall Study|Adverse Event|4|||
161834024|NCT02858726|584433293|FG001|Overall Study|Adverse Event|4|||
161834025|NCT02858726|584433294|FG002|Overall Study|Adverse Event|9|||
161834026|NCT02858726|584433295|FG003|Overall Study|Adverse Event|1|||
161834027|NCT02858726|584433292|FG000|Overall Study|Physician Decision|0|||
161834028|NCT02858726|584433293|FG001|Overall Study|Physician Decision|0|||
161834029|NCT02858726|584433294|FG002|Overall Study|Physician Decision|1|||
161834030|NCT02858726|584433295|FG003|Overall Study|Physician Decision|0|||
161834031|NCT02858726|584433292|FG000|Overall Study|Protocol Violation|0|||
161834032|NCT02858726|584433293|FG001|Overall Study|Protocol Violation|0|||
161834033|NCT02858726|584433294|FG002|Overall Study|Protocol Violation|0|||
161834034|NCT02858726|584433295|FG003|Overall Study|Protocol Violation|1|||
161834035|NCT02858726|584433292|FG000|Overall Study|Study Terminated by Sponsor|0|||
161834036|NCT02858726|584433293|FG001|Overall Study|Study Terminated by Sponsor|0|||
161834037|NCT02858726|584433294|FG002|Overall Study|Study Terminated by Sponsor|0|||
161834038|NCT02858726|584433295|FG003|Overall Study|Study Terminated by Sponsor|1|||
161834039|NCT02858726|584433292|FG000|Overall Study|Withdrawal by Subject|1|||
161834040|NCT02858726|584433293|FG001|Overall Study|Withdrawal by Subject|2|||
161834041|NCT02858726|584433294|FG002|Overall Study|Withdrawal by Subject|1|||
161834042|NCT02858726|584433295|FG003|Overall Study|Withdrawal by Subject|0|||
161834043|NCT02858726|584433292|FG000|Overall Study|Noncompliance|0|||
161834044|NCT02858726|584433293|FG001|Overall Study|Noncompliance|1|||
161834045|NCT02858726|584433294|FG002|Overall Study|Noncompliance|0|||
161834046|NCT02858726|584433295|FG003|Overall Study|Noncompliance|0|||
161834047|NCT04560998|584433296|FG000|Overall Study|Withdrawal by Subject|18|||
161834048|NCT04560998|584433297|FG001|Overall Study|Withdrawal by Subject|12|||
161834049|NCT04560998|584433296|FG000|Overall Study|Lost to Follow-up|8|||
161834050|NCT04560998|584433297|FG001|Overall Study|Lost to Follow-up|5|||
161834051|NCT04560998|584433296|FG000|Overall Study|Physician Decision|4|||
161834052|NCT04560998|584433297|FG001|Overall Study|Physician Decision|0|||
161951774|NCT04072835|584874689|FG000|Overall Study|Physician Decision|50|||
161951775|NCT04072835|584874689|FG000|Overall Study|Lost to Follow-up|39|||
161834053|NCT00493246|584435543|FG000|Overall Study|Withdrawal by Subject|0|||
161834054|NCT00493246|584435544|FG001|Overall Study|Withdrawal by Subject|0|||
161834055|NCT00493246|584435545|FG002|Overall Study|Withdrawal by Subject|0|||
161834056|NCT00493246|584435546|FG003|Overall Study|Withdrawal by Subject|0|||
161834057|NCT00493246|584435547|FG004|Overall Study|Withdrawal by Subject|1|||
162236833|NCT05062759|585919092|FG000|Overall Study|Death|0|||
162236834|NCT05062759|585919093|FG001|Overall Study|Death|1|||
162236835|NCT05062759|585919092|FG000|Overall Study|Lost to Follow-up|1|||
162236836|NCT05062759|585919093|FG001|Overall Study|Lost to Follow-up|0|||
162236837|NCT04981366|585919094|FG000|Overall Study|Withdrawal by Subject|5|||
162236838|NCT04981366|585919095|FG001|Overall Study|Withdrawal by Subject|4|||
162236839|NCT04981366|585919096|FG002|Overall Study|Withdrawal by Subject|8|||
162236840|NCT04981366|585919094|FG000|Overall Study|Health issues unrelated to the trial|1|||
162236841|NCT04981366|585919095|FG001|Overall Study|Health issues unrelated to the trial|2|||
162236842|NCT04981366|585919096|FG002|Overall Study|Health issues unrelated to the trial|0|||
162236843|NCT04371198|585919097|FG000|Overall Study|inadequate sample|4|||
162236844|NCT01112306|585919098|FG000|Overall Study|Death|175|||
162236845|NCT01112306|585919098|FG000|Overall Study|Lost to Follow-up|9|||
162236846|NCT01112306|585919098|FG000|Overall Study|Withdrawal by Subject|31|||
162236847|NCT01112306|585919098|FG000|Overall Study|Other|70|||
162236848|NCT03214094|585919099|FG000|Overall Study|Case Report Forms Uncollected|14|||
162236849|NCT03214094|585919099|FG000|Overall Study|Protocol Deviation|46|||
162236850|NCT05559099|585919117|FG000|Overall Study|Death|5|||
162236851|NCT05559099|585919118|FG001|Overall Study|Death|4|||
162236852|NCT05559099|585919117|FG000|Overall Study|Lost to Follow-up|0|||
162236853|NCT05559099|585919118|FG001|Overall Study|Lost to Follow-up|2|||
162236854|NCT05559099|585919117|FG000|Overall Study|Adverse Event|1|||
162236855|NCT05559099|585919118|FG001|Overall Study|Adverse Event|1|||
162236856|NCT04018092|585919119|FG000|Overall Study|Withdrawal by Subject|1|||
162236857|NCT04018092|585919120|FG001|Overall Study|Withdrawal by Subject|1|||
162236858|NCT04018092|585919119|FG000|Overall Study|Withdrawal by Subject|1|||
162236859|NCT04018092|585919120|FG001|Overall Study|Withdrawal by Subject|1|||
162236860|NCT04218084|585919121|FG000|Overall Study|Adverse Event|7|||
161951776|NCT04072835|584874689|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
161951777|NCT04072835|584874689|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
161951778|NCT04072835|584874689|FG000|Overall Study|Adverse Event|25|||
161951779|NCT04072835|584874689|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
161951780|NCT04072835|584874689|FG000|Overall Study|Death|11|||
161951781|NCT04072835|584874689|FG000|Overall Study|Participant felt the drug did not work|8|||
161951782|NCT04072835|584874689|FG000|Overall Study|Participant tolerability|5|||
161951783|NCT04072835|584874689|FG000|Overall Study|Missing|5|||
161951784|NCT04072835|584874689|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
161951785|NCT04072835|584874689|FG000|Overall Study|Pregnancy|3|||
161951786|NCT01336712|584874690|FG000|Overall Study|Death|2|||
161951787|NCT01336712|584874690|FG000|Overall Study|Lack of Efficacy|1|||
161951788|NCT00841776|584874691|FG000|Overall Study|Lack of Efficacy|0|||
161951789|NCT00841776|584874692|FG001|Overall Study|Lack of Efficacy|1|||
161951790|NCT00841776|584874691|FG000|Overall Study|Lost to Follow-up|2|||
161951791|NCT00841776|584874692|FG001|Overall Study|Lost to Follow-up|1|||
161951792|NCT00841776|584874691|FG000|Overall Study|Withdrawal by Subject|0|||
161951793|NCT00841776|584874692|FG001|Overall Study|Withdrawal by Subject|1|||
161951794|NCT00856323|584874693|FG000|Overall Study|Withdrawal by Subject|2|||
161951795|NCT01639469|584874694|FG000|Overall Study|Death|4|||
161951796|NCT01639469|584874695|FG001|Overall Study|Death|2|||
161951797|NCT01639469|584874694|FG000|Overall Study|Lost to Follow-up|1|||
161951798|NCT01639469|584874695|FG001|Overall Study|Lost to Follow-up|1|||
161951799|NCT01119443|584874698|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
162028770|NCT01227824|585161856|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
162028771|NCT01227824|585161854|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
161686169|NCT01265797|583903331|FG000|Run-in Month|Withdrawal by Subject|0|||
161686170|NCT01265797|583903332|FG001|Run-in Month|Withdrawal by Subject|4|||
161686171|NCT01265797|583903331|FG000|Run-in Month|1st seizure during run-in month|0|||
161686172|NCT01265797|583903332|FG001|Run-in Month|1st seizure during run-in month|1|||
161686173|NCT01265797|583903331|FG000|Blinded Month|Lack of Efficacy|5|||
161686174|NCT01265797|583903332|FG001|Blinded Month|Lack of Efficacy|0|||
161686175|NCT01265797|583903331|FG000|Blinded Month|Lost to Follow-up|1|||
161686176|NCT01265797|583903332|FG001|Blinded Month|Lost to Follow-up|0|||
161686177|NCT01265797|583903331|FG000|Blinded Month|Protocol Violation|2|||
162028772|NCT01227824|585161855|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
161686178|NCT01265797|583903332|FG001|Blinded Month|Protocol Violation|1|||
161951800|NCT01119443|584874699|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
161951801|NCT02329743|584874700|FG000|Overall Study|Adverse Event|1|||
161951802|NCT02329743|584874701|FG001|Overall Study|Adverse Event|1|||
161951803|NCT02329743|584874702|FG002|Overall Study|Adverse Event|3|||
161951804|NCT02329743|584874700|FG000|Overall Study|Lost to Follow-up|1|||
161951805|NCT02329743|584874701|FG001|Overall Study|Lost to Follow-up|0|||
161951806|NCT02329743|584874702|FG002|Overall Study|Lost to Follow-up|1|||
161951807|NCT02329743|584874700|FG000|Overall Study|Withdrawal by Subject|4|||
161951808|NCT02329743|584874701|FG001|Overall Study|Withdrawal by Subject|4|||
161951809|NCT02329743|584874702|FG002|Overall Study|Withdrawal by Subject|1|||
161951810|NCT02329743|584874700|FG000|Overall Study|Other|0|||
161951811|NCT02329743|584874701|FG001|Overall Study|Other|2|||
161951812|NCT02329743|584874702|FG002|Overall Study|Other|3|||
161951813|NCT00355368|584874707|FG000|Overall Study|Protocol Violation|8|||
161951814|NCT00355368|584874708|FG001|Overall Study|Protocol Violation|7|||
161951815|NCT00355368|584874707|FG000|Overall Study|cardiac arrest prior to intubation|2|||
161951816|NCT00355368|584874708|FG001|Overall Study|cardiac arrest prior to intubation|2|||
161951817|NCT01665911|584874714|FG000|Overall Study|Protocol Violation|4|||
161951818|NCT01665911|584874714|FG000|Overall Study|Withdrawal by Subject|1|||
161951819|NCT01665911|584874714|FG000|Overall Study|Adverse Event|1|||
161951820|NCT00347932|584874715|FG000|Overall Study|Adverse Event|4|||
161951821|NCT00347932|584874716|FG001|Overall Study|Adverse Event|5|||
161951822|NCT00347932|584874715|FG000|Overall Study|Lack of Efficacy|3|||
161951823|NCT00347932|584874716|FG001|Overall Study|Lack of Efficacy|14|||
161951824|NCT00347932|584874715|FG000|Overall Study|Lost to Follow-up|10|||
161951825|NCT00347932|584874716|FG001|Overall Study|Lost to Follow-up|9|||
161951826|NCT00347932|584874715|FG000|Overall Study|Withdrawal by Subject|10|||
161951827|NCT00347932|584874716|FG001|Overall Study|Withdrawal by Subject|16|||
161951828|NCT00347932|584874715|FG000|Overall Study|Did not meet inclusion criteria|4|||
161951829|NCT00347932|584874716|FG001|Overall Study|Did not meet inclusion criteria|8|||
161951830|NCT01484496|584874717|FG000|Period 1|Protocol Violation|3|||
161951831|NCT01484496|584874718|FG001|Period 1|Protocol Violation|4|||
161951832|NCT01484496|584874719|FG002|Period 1|Protocol Violation|0|||
161951833|NCT01484496|584874720|FG003|Period 1|Protocol Violation|0|||
161951834|NCT01484496|584874717|FG000|Period 1|Physician Decision|5|||
161951835|NCT01484496|584874718|FG001|Period 1|Physician Decision|1|||
161951836|NCT01484496|584874719|FG002|Period 1|Physician Decision|0|||
161951837|NCT01484496|584874720|FG003|Period 1|Physician Decision|0|||
161951838|NCT01484496|584874717|FG000|Period 1|Lack of Efficacy|10|||
161951839|NCT01484496|584874718|FG001|Period 1|Lack of Efficacy|15|||
161951840|NCT01484496|584874719|FG002|Period 1|Lack of Efficacy|0|||
161951841|NCT01484496|584874720|FG003|Period 1|Lack of Efficacy|0|||
161951842|NCT01484496|584874717|FG000|Period 1|Adverse Event|25|||
161951843|NCT01484496|584874718|FG001|Period 1|Adverse Event|40|||
161951844|NCT01484496|584874719|FG002|Period 1|Adverse Event|0|||
161951845|NCT01484496|584874720|FG003|Period 1|Adverse Event|0|||
161951846|NCT01484496|584874717|FG000|Period 1|Withdrawal by Subject|15|||
162028773|NCT01227824|585161856|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
162028774|NCT01227824|585161854|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
162028775|NCT01227824|585161855|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
162028776|NCT01227824|585161856|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
162028777|NCT01227824|585161854|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
162028778|NCT01227824|585161855|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
162028779|NCT01227824|585161856|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
162028780|NCT01227824|585161854|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
162028781|NCT01227824|585161855|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
162028782|NCT01227824|585161856|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
162028783|NCT01227824|585161854|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
162028784|NCT01227824|585161855|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
162028785|NCT01227824|585161856|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
162028786|NCT01227824|585161854|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
162028787|NCT01227824|585161855|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
162028788|NCT01227824|585161856|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
162028789|NCT01227824|585161854|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
162028790|NCT01227824|585161855|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
162028791|NCT01227824|585161856|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
162028792|NCT01227824|585161854|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
162028793|NCT01227824|585161855|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
161951847|NCT01484496|584874718|FG001|Period 1|Withdrawal by Subject|12|||
161951848|NCT01484496|584874719|FG002|Period 1|Withdrawal by Subject|0|||
161951849|NCT01484496|584874720|FG003|Period 1|Withdrawal by Subject|0|||
161951850|NCT01484496|584874717|FG000|Period 1|Lost to Follow-up|2|||
161951851|NCT01484496|584874718|FG001|Period 1|Lost to Follow-up|6|||
161951852|NCT01484496|584874719|FG002|Period 1|Lost to Follow-up|0|||
161951853|NCT01484496|584874720|FG003|Period 1|Lost to Follow-up|0|||
161951854|NCT01484496|584874717|FG000|Period 1|Positive Pregnancy|1|||
161951855|NCT01484496|584874718|FG001|Period 1|Positive Pregnancy|6|||
161951856|NCT01484496|584874719|FG002|Period 1|Positive Pregnancy|0|||
161951857|NCT01484496|584874720|FG003|Period 1|Positive Pregnancy|0|||
161951858|NCT01484496|584874717|FG000|Period 1|Treatment Failure|3|||
161951859|NCT01484496|584874718|FG001|Period 1|Treatment Failure|6|||
161951860|NCT01484496|584874719|FG002|Period 1|Treatment Failure|0|||
161951861|NCT01484496|584874720|FG003|Period 1|Treatment Failure|0|||
161951862|NCT01484496|584874717|FG000|Period 1|Lack of Compliance|2|||
161951863|NCT01484496|584874718|FG001|Period 1|Lack of Compliance|1|||
161951864|NCT01484496|584874719|FG002|Period 1|Lack of Compliance|0|||
161951865|NCT01484496|584874720|FG003|Period 1|Lack of Compliance|0|||
161951866|NCT01484496|584874717|FG000|Period 1|Unable to Visit Site|0|||
161951867|NCT01484496|584874718|FG001|Period 1|Unable to Visit Site|2|||
161951868|NCT01484496|584874719|FG002|Period 1|Unable to Visit Site|0|||
161951869|NCT01484496|584874720|FG003|Period 1|Unable to Visit Site|0|||
161951870|NCT01484496|584874717|FG000|Period 2|Lack of Efficacy|0|||
161951871|NCT01484496|584874718|FG001|Period 2|Lack of Efficacy|0|||
161951872|NCT01484496|584874719|FG002|Period 2|Lack of Efficacy|1|||
161951873|NCT01484496|584874720|FG003|Period 2|Lack of Efficacy|3|||
161951874|NCT01484496|584874717|FG000|Period 2|Adverse Event|0|||
161951875|NCT01484496|584874718|FG001|Period 2|Adverse Event|0|||
161951876|NCT01484496|584874719|FG002|Period 2|Adverse Event|5|||
161951877|NCT01484496|584874720|FG003|Period 2|Adverse Event|13|||
161951878|NCT01484496|584874717|FG000|Period 2|Other|0|||
161951879|NCT01484496|584874718|FG001|Period 2|Other|0|||
161951880|NCT01484496|584874719|FG002|Period 2|Other|9|||
161951881|NCT01484496|584874720|FG003|Period 2|Other|6|||
162028794|NCT01227824|585161856|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
162028795|NCT01227824|585161854|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
162028796|NCT01227824|585161855|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
162028797|NCT01227824|585161856|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
162028798|NCT01227824|585161854|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
161951882|NCT01645735|584874721|FG000|Overall Study|Physician Decision|2|||
161951883|NCT01645735|584874722|FG001|Overall Study|Physician Decision|0|||
161951884|NCT01645735|584874721|FG000|Overall Study|Withdrawal by Subject|1|||
161951885|NCT01645735|584874722|FG001|Overall Study|Withdrawal by Subject|0|||
161951886|NCT01645735|584874721|FG000|Overall Study|Protocol Violation|1|||
161951887|NCT01645735|584874722|FG001|Overall Study|Protocol Violation|0|||
161951888|NCT01645735|584874721|FG000|Overall Study|Adverse Event|0|||
161951889|NCT01645735|584874722|FG001|Overall Study|Adverse Event|1|||
161951890|NCT01492088|584874727|FG000|Overall Study|Withdrawal by Patient|0|||
161951891|NCT01492088|584874728|FG001|Overall Study|Withdrawal by Patient|2|||
161951892|NCT01492088|584874729|FG002|Overall Study|Withdrawal by Patient|0|||
161951893|NCT01492088|584874727|FG000|Overall Study|Death|1|||
161951894|NCT01492088|584874728|FG001|Overall Study|Death|6|||
161951895|NCT01492088|584874729|FG002|Overall Study|Death|2|||
161951896|NCT01492088|584874727|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
161951897|NCT01492088|584874728|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
161951898|NCT01492088|584874729|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
161951899|NCT01492088|584874727|FG000|Overall Study|Alive at Last Follow-up|0|||
161951900|NCT01492088|584874728|FG001|Overall Study|Alive at Last Follow-up|6|||
161951901|NCT01492088|584874729|FG002|Overall Study|Alive at Last Follow-up|11|||
161951902|NCT00590967|584874730|FG000|Overall Study|Withdrawal by Subject|1|||
161951903|NCT00590967|584874731|FG001|Overall Study|Withdrawal by Subject|1|||
161951904|NCT00590967|584874730|FG000|Overall Study|Ineligible|1|||
161951905|NCT00590967|584874731|FG001|Overall Study|Ineligible|0|||
161951906|NCT00590967|584874730|FG000|Overall Study|Poor performance status|0|||
161951907|NCT00590967|584874731|FG001|Overall Study|Poor performance status|1|||
161951908|NCT00590967|584874730|FG000|Overall Study|Non-compliant|0|||
161951909|NCT00590967|584874731|FG001|Overall Study|Non-compliant|2|||
161951910|NCT00590967|584874730|FG000|Overall Study|Did not sign consent form|0|||
161951911|NCT00590967|584874731|FG001|Overall Study|Did not sign consent form|1|||
161951912|NCT00590967|584874730|FG000|Overall Study|Did not receive chemo per protocol|1|||
161951913|NCT00590967|584874731|FG001|Overall Study|Did not receive chemo per protocol|0|||
161951914|NCT03637491|584874732|FG000|Overall Study|Death|9|||
161951915|NCT03637491|584874733|FG001|Overall Study|Death|9|||
161951916|NCT03637491|584874734|FG002|Overall Study|Death|5|||
161951917|NCT03637491|584874735|FG003|Overall Study|Death|3|||
161951918|NCT03637491|584874732|FG000|Overall Study|Lost to Follow-up|0|||
161951919|NCT03637491|584874733|FG001|Overall Study|Lost to Follow-up|1|||
161951920|NCT03637491|584874734|FG002|Overall Study|Lost to Follow-up|0|||
161951921|NCT03637491|584874735|FG003|Overall Study|Lost to Follow-up|1|||
161951922|NCT03637491|584874732|FG000|Overall Study|Study Terminated By Sponsor|0|||
161951923|NCT03637491|584874733|FG001|Overall Study|Study Terminated By Sponsor|2|||
161951924|NCT03637491|584874734|FG002|Overall Study|Study Terminated By Sponsor|1|||
161951925|NCT03637491|584874735|FG003|Overall Study|Study Terminated By Sponsor|0|||
161951926|NCT03637491|584874732|FG000|Overall Study|Withdrawal by Subject|1|||
161951927|NCT03637491|584874733|FG001|Overall Study|Withdrawal by Subject|0|||
161951928|NCT03637491|584874734|FG002|Overall Study|Withdrawal by Subject|1|||
161951929|NCT03637491|584874735|FG003|Overall Study|Withdrawal by Subject|2|||
161951930|NCT04179305|584874739|FG000|Overall Study|Death|1|||
161951931|NCT04179305|584874740|FG001|Overall Study|Death|1|||
161951932|NCT04179305|584874741|FG002|Overall Study|Death|0|||
161951933|NCT04179305|584874742|FG003|Overall Study|Death|0|||
161951934|NCT04179305|584874739|FG000|Overall Study|Lost to Follow-up|1|||
161951935|NCT04179305|584874740|FG001|Overall Study|Lost to Follow-up|1|||
161951936|NCT04179305|584874741|FG002|Overall Study|Lost to Follow-up|0|||
161951937|NCT04179305|584874742|FG003|Overall Study|Lost to Follow-up|0|||
161951938|NCT04179305|584874739|FG000|Overall Study|Withdrawal by Subject|0|||
161951939|NCT04179305|584874740|FG001|Overall Study|Withdrawal by Subject|1|||
161951940|NCT04179305|584874741|FG002|Overall Study|Withdrawal by Subject|0|||
161951941|NCT04179305|584874742|FG003|Overall Study|Withdrawal by Subject|0|||
161951942|NCT04179305|584874739|FG000|Overall Study|Did not have scan|1|||
161951943|NCT04179305|584874740|FG001|Overall Study|Did not have scan|0|||
161951944|NCT04179305|584874741|FG002|Overall Study|Did not have scan|0|||
161951945|NCT04179305|584874742|FG003|Overall Study|Did not have scan|0|||
161951946|NCT04179305|584874739|FG000|Overall Study|In hospice care|3|||
161951947|NCT04179305|584874740|FG001|Overall Study|In hospice care|0|||
161951948|NCT04179305|584874741|FG002|Overall Study|In hospice care|0|||
161951949|NCT04179305|584874742|FG003|Overall Study|In hospice care|0|||
161951950|NCT01737762|584874745|FG000|Overall Study|Adverse Event|2|||
161951951|NCT01737762|584874746|FG001|Overall Study|Adverse Event|2|||
161951952|NCT01737762|584874745|FG000|Overall Study|Lost to Follow-up|1|||
161951953|NCT01737762|584874746|FG001|Overall Study|Lost to Follow-up|0|||
161951954|NCT01737762|584874745|FG000|Overall Study|Withdrawal by Subject|2|||
161951955|NCT01737762|584874746|FG001|Overall Study|Withdrawal by Subject|2|||
161951956|NCT01737762|584874745|FG000|Overall Study|Progressive disease|1|||
161951957|NCT01737762|584874746|FG001|Overall Study|Progressive disease|2|||
161951958|NCT01737762|584874745|FG000|Overall Study|Physician Decision|1|||
161951959|NCT01737762|584874746|FG001|Overall Study|Physician Decision|1|||
161951960|NCT01737762|584874745|FG000|Overall Study|Moved from area|2|||
161951961|NCT01737762|584874746|FG001|Overall Study|Moved from area|1|||
161834058|NCT00493246|584435548|FG005|Overall Study|Withdrawal by Subject|0|||
161951962|NCT01737762|584874745|FG000|Overall Study|Trial termination|11|||
161951963|NCT01737762|584874746|FG001|Overall Study|Trial termination|9|||
161951964|NCT00326599|584874747|FG000|Overall Study|Withdrawal by Subject|1|||
161951965|NCT00326599|584874748|FG001|Overall Study|Withdrawal by Subject|0|||
161951966|NCT00326599|584874749|FG002|Overall Study|Withdrawal by Subject|5|||
161951967|NCT00326599|584874750|FG003|Overall Study|Withdrawal by Subject|2|||
161951968|NCT00326599|584874747|FG000|Overall Study|Adverse Event|1|||
161951969|NCT00326599|584874748|FG001|Overall Study|Adverse Event|0|||
161951970|NCT00326599|584874749|FG002|Overall Study|Adverse Event|32|||
161951971|NCT00326599|584874750|FG003|Overall Study|Adverse Event|3|||
161951972|NCT00326599|584874747|FG000|Overall Study|Disease Progression|3|||
161951973|NCT00326599|584874748|FG001|Overall Study|Disease Progression|1|||
161951974|NCT00326599|584874749|FG002|Overall Study|Disease Progression|13|||
161951975|NCT00326599|584874750|FG003|Overall Study|Disease Progression|11|||
161951976|NCT00326599|584874747|FG000|Overall Study|Alternate Treatment|1|||
161951977|NCT00326599|584874748|FG001|Overall Study|Alternate Treatment|0|||
161951978|NCT00326599|584874749|FG002|Overall Study|Alternate Treatment|0|||
161951979|NCT00326599|584874750|FG003|Overall Study|Alternate Treatment|0|||
161951980|NCT00326599|584874747|FG000|Overall Study|Death|0|||
161951981|NCT00326599|584874748|FG001|Overall Study|Death|0|||
161951982|NCT00326599|584874749|FG002|Overall Study|Death|1|||
161951983|NCT00326599|584874750|FG003|Overall Study|Death|2|||
161951984|NCT00326599|584874747|FG000|Overall Study|Other Unspecified Reason|0|||
161951985|NCT00326599|584874748|FG001|Overall Study|Other Unspecified Reason|0|||
161951986|NCT00326599|584874749|FG002|Overall Study|Other Unspecified Reason|2|||
161951987|NCT00326599|584874750|FG003|Overall Study|Other Unspecified Reason|1|||
161951988|NCT00625586|584874751|FG000|Overall Study|Adverse Event|1|||
161951989|NCT00625586|584874751|FG000|Overall Study|Progressive disease|1|||
161951990|NCT01070979|584874755|FG000|Overall Study|Adverse Event|2|||
161951991|NCT01070979|584874756|FG001|Overall Study|Adverse Event|3|||
161951992|NCT01070979|584874757|FG002|Overall Study|Adverse Event|3|||
161951993|NCT01070979|584874755|FG000|Overall Study|Lost to Follow-up|2|||
161951994|NCT01070979|584874756|FG001|Overall Study|Lost to Follow-up|1|||
161951995|NCT01070979|584874757|FG002|Overall Study|Lost to Follow-up|1|||
161951996|NCT01070979|584874755|FG000|Overall Study|Protocol Violation|0|||
161951997|NCT01070979|584874756|FG001|Overall Study|Protocol Violation|2|||
161951998|NCT01070979|584874757|FG002|Overall Study|Protocol Violation|6|||
161951999|NCT01070979|584874755|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
161952000|NCT01070979|584874756|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
161952001|NCT01070979|584874757|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
161952002|NCT01070979|584874755|FG000|Overall Study|Withdrawal by Subject|3|||
161952003|NCT01070979|584874756|FG001|Overall Study|Withdrawal by Subject|1|||
161952004|NCT01070979|584874757|FG002|Overall Study|Withdrawal by Subject|1|||
161952005|NCT01070979|584874755|FG000|Overall Study|No study drug taken|0|||
161952006|NCT01070979|584874756|FG001|Overall Study|No study drug taken|1|||
161952007|NCT01070979|584874757|FG002|Overall Study|No study drug taken|0|||
161952008|NCT04819113|584874758|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161952009|NCT04819113|584874758|FG000|Overall Study|Lost to Follow-up|1|||
161952010|NCT04819113|584874758|FG000|Overall Study|Withdrawn before vaccination|2|||
161952011|NCT00437268|584874759|FG000|Overall Study|Adverse Event|1|||
161952012|NCT00437268|584874760|FG001|Overall Study|Adverse Event|1|||
161952013|NCT00437268|584874759|FG000|Overall Study|Withdrawal by Subject|2|||
161952014|NCT00437268|584874760|FG001|Overall Study|Withdrawal by Subject|2|||
161952015|NCT00437268|584874759|FG000|Overall Study|Progressive disease|9|||
161952016|NCT00437268|584874760|FG001|Overall Study|Progressive disease|9|||
161952017|NCT00437268|584874759|FG000|Overall Study|Physician Decision|1|||
161952018|NCT00437268|584874760|FG001|Overall Study|Physician Decision|0|||
161952019|NCT00437268|584874759|FG000|Overall Study|Death|0|||
162236861|NCT04218084|585919122|FG001|Overall Study|Adverse Event|2|||
162236862|NCT04218084|585919121|FG000|Overall Study|Withdrawal of Consent|4|||
162236863|NCT04218084|585919122|FG001|Overall Study|Withdrawal of Consent|5|||
162236864|NCT04218084|585919121|FG000|Overall Study|Physician Decision|1|||
162236865|NCT04218084|585919122|FG001|Overall Study|Physician Decision|1|||
162236866|NCT04218084|585919121|FG000|Overall Study|Lost to Follow-up|1|||
162236867|NCT04218084|585919122|FG001|Overall Study|Lost to Follow-up|1|||
162236868|NCT04218084|585919121|FG000|Overall Study|Non-compliance with study drug|1|||
162236869|NCT04218084|585919122|FG001|Overall Study|Non-compliance with study drug|1|||
162236870|NCT04218084|585919121|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
162236871|NCT04218084|585919122|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
162236872|NCT04218084|585919121|FG000|Overall Study|Other|0|||
161952020|NCT00437268|584874760|FG001|Overall Study|Death|1|||
161952021|NCT04417257|584874765|FG000|Pilot Phase 2|Adverse Event|2|||
161952022|NCT04417257|584874766|FG001|Pilot Phase 2|Adverse Event|0|||
161952023|NCT04417257|584874765|FG000|Pilot Phase 2|Death|14|||
161952024|NCT04417257|584874766|FG001|Pilot Phase 2|Death|11|||
161952025|NCT04417257|584874765|FG000|Pilot Phase 2|Lost to Follow-up|3|||
162236873|NCT04218084|585919122|FG001|Overall Study|Other|1|||
161834059|NCT00493246|584435549|FG006|Overall Study|Withdrawal by Subject|0|||
161834060|NCT00493246|584435550|FG007|Overall Study|Withdrawal by Subject|0|||
161834061|NCT00493246|584435543|FG000|Overall Study|No access to draw blood|0|||
161952026|NCT04417257|584874766|FG001|Pilot Phase 2|Lost to Follow-up|5|||
161952027|NCT04417257|584874765|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
161952028|NCT04417257|584874766|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
161952029|NCT04417257|584874765|FG000|Pilot Phase 2|Hepatic impairment|1|||
161952030|NCT04417257|584874766|FG001|Pilot Phase 2|Hepatic impairment|0|||
161952031|NCT04417257|584874765|FG000|Pilot Phase 2|Unblinding|1|||
161952032|NCT04417257|584874766|FG001|Pilot Phase 2|Unblinding|0|||
161952033|NCT04417257|584874765|FG000|Pilot Phase 2|All other|0|||
161952034|NCT04417257|584874766|FG001|Pilot Phase 2|All other|2|||
161952035|NCT04417257|584874765|FG000|Phase 3 Extension|Death|3|||
161952036|NCT04417257|584874766|FG001|Phase 3 Extension|Death|1|||
161952037|NCT04417257|584874765|FG000|Phase 3 Extension|Lost to Follow-up|4|||
161952038|NCT04417257|584874766|FG001|Phase 3 Extension|Lost to Follow-up|2|||
161952039|NCT04417257|584874765|FG000|Phase 3 Extension|Patient withdrawal|2|||
161952040|NCT04417257|584874766|FG001|Phase 3 Extension|Patient withdrawal|2|||
161952041|NCT04417257|584874765|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
161952042|NCT04417257|584874766|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
161952043|NCT00786422|584874767|FG000|Rivaroxaban Treatment|Death|2|||
161952044|NCT00786422|584874767|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
161952045|NCT00786422|584874767|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
161952046|NCT00786422|584874767|FG000|Rivaroxaban Treatment|Physician Decision|1|||
161952047|NCT00786422|584874767|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
161952048|NCT00786422|584874767|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
161952049|NCT00786422|584874767|FG000|Rivaroxaban Treatment|Adverse Event|2|||
161952050|NCT00786422|584874767|FG000|Follow-up Period|Death|1|||
161952051|NCT00786422|584874767|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
161952052|NCT03484429|584874768|FG000|Overall Study|Withdrawal by Subject|1|||
161952053|NCT03484429|584874769|FG001|Overall Study|Withdrawal by Subject|0|||
161952054|NCT03484429|584874768|FG000|Overall Study|Adverse Event|2|||
161952055|NCT03484429|584874769|FG001|Overall Study|Adverse Event|0|||
161952056|NCT04466384|584874770|FG000|First Phase|Protocol Violation|1|||
161952057|NCT04466384|584874771|FG001|First Phase|Protocol Violation|0|||
161952058|NCT04466384|584874770|FG000|First Phase|Missing data|1|||
161952059|NCT04466384|584874771|FG001|First Phase|Missing data|0|||
161952060|NCT04466384|584874770|FG000|Cross Over Phase|Physician Decision|1|||
161952061|NCT04466384|584874771|FG001|Cross Over Phase|Physician Decision|0|||
161952062|NCT04466384|584874770|FG000|Cross Over Phase|Withdrawal by Subject|0|||
161834062|NCT00493246|584435544|FG001|Overall Study|No access to draw blood|0|||
161834063|NCT00493246|584435545|FG002|Overall Study|No access to draw blood|0|||
161952063|NCT04466384|584874771|FG001|Cross Over Phase|Withdrawal by Subject|1|||
161952064|NCT01085214|584874774|FG000|Overall Study|Alternate treatment required|1|||
161952065|NCT04267926|584876541|FG000|Overall Study|abnormal labs. No longer eligible|0|||
161952066|NCT04267926|584876542|FG001|Overall Study|abnormal labs. No longer eligible|0|||
161952067|NCT04267926|584876543|FG002|Overall Study|abnormal labs. No longer eligible|1|||
161952068|NCT04267926|584876541|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
161952069|NCT04267926|584876542|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
161952070|NCT04267926|584876543|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
161952071|NCT00972023|584876546|FG000|Overall Study|Withdrawal by Subject|1|||
161952072|NCT00532129|584876547|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
161952073|NCT00532129|584876547|FG000|Treatment Period|Physician Decision|15|||
161952074|NCT00532129|584876547|FG000|Treatment Period|Disease progression|3|||
161952075|NCT00532129|584876547|FG000|Treatment Period|Protocol Violation|1|||
161952076|NCT00532129|584876547|FG000|Treatment Period|Other|5|||
161952077|NCT00532129|584876547|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
161952078|NCT00532129|584876547|FG000|Follow-up Period|Disease progression|57|||
161952079|NCT00532129|584876547|FG000|Follow-up Period|Lost to Follow-up|1|||
161952080|NCT00532129|584876547|FG000|Follow-up Period|Other|6|||
161952081|NCT03052608|584876548|FG000|Treatment Phase|Adverse Event|10|||
161952082|NCT03052608|584876549|FG001|Treatment Phase|Adverse Event|12|||
161952083|NCT03052608|584876548|FG000|Treatment Phase|Death|6|||
161952084|NCT03052608|584876549|FG001|Treatment Phase|Death|4|||
161952085|NCT03052608|584876548|FG000|Treatment Phase|Withdrawal by Subject|4|||
161952086|NCT03052608|584876549|FG001|Treatment Phase|Withdrawal by Subject|12|||
161952087|NCT03052608|584876548|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
161952088|NCT03052608|584876549|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
161952089|NCT03052608|584876548|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
161952090|NCT03052608|584876549|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
161952091|NCT03052608|584876548|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
161952092|NCT03052608|584876549|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
161952093|NCT03052608|584876548|FG000|Treatment Phase|Ongoing|103|||
161952094|NCT03052608|584876549|FG001|Treatment Phase|Ongoing|31|||
161952095|NCT03052608|584876548|FG000|Long-Term Follow-up Phase|Death|23|||
161952096|NCT03052608|584876549|FG001|Long-Term Follow-up Phase|Death|28|||
161952097|NCT03052608|584876548|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
161952098|NCT03052608|584876549|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
161952099|NCT03052608|584876548|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
161952100|NCT03052608|584876549|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
162028799|NCT01227824|585161855|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
161952101|NCT03052608|584876548|FG000|Long-Term Follow-up Phase|Ongoing|122|||
161952102|NCT03052608|584876549|FG001|Long-Term Follow-up Phase|Ongoing|99|||
161952103|NCT00551031|584876550|FG000|Overall Study|Adverse Event|0|||
161952104|NCT00551031|584876551|FG001|Overall Study|Adverse Event|1|||
161952105|NCT00551031|584876552|FG002|Overall Study|Adverse Event|0|||
161952106|NCT00551031|584876553|FG003|Overall Study|Adverse Event|0|||
161952107|NCT00551031|584876554|FG004|Overall Study|Adverse Event|0|||
161952108|NCT00551031|584876550|FG000|Overall Study|Protocol Violation|1|||
161952109|NCT00551031|584876551|FG001|Overall Study|Protocol Violation|1|||
161952110|NCT00551031|584876552|FG002|Overall Study|Protocol Violation|0|||
161952111|NCT00551031|584876553|FG003|Overall Study|Protocol Violation|0|||
161952112|NCT00551031|584876554|FG004|Overall Study|Protocol Violation|0|||
161952113|NCT00551031|584876550|FG000|Overall Study|Lost to Follow-up|0|||
161952114|NCT00551031|584876551|FG001|Overall Study|Lost to Follow-up|1|||
161952115|NCT00551031|584876552|FG002|Overall Study|Lost to Follow-up|0|||
161952116|NCT00551031|584876553|FG003|Overall Study|Lost to Follow-up|1|||
161952117|NCT00551031|584876554|FG004|Overall Study|Lost to Follow-up|1|||
161952118|NCT00551031|584876550|FG000|Overall Study|Withdrawal by Subject|0|||
161952119|NCT00551031|584876551|FG001|Overall Study|Withdrawal by Subject|4|||
161952120|NCT00551031|584876552|FG002|Overall Study|Withdrawal by Subject|1|||
161952121|NCT00551031|584876553|FG003|Overall Study|Withdrawal by Subject|2|||
161952122|NCT00551031|584876554|FG004|Overall Study|Withdrawal by Subject|0|||
161952123|NCT00551031|584876550|FG000|Overall Study|Serious Adverse Event|0|||
161952124|NCT00551031|584876551|FG001|Overall Study|Serious Adverse Event|2|||
161952125|NCT00551031|584876552|FG002|Overall Study|Serious Adverse Event|1|||
161952126|NCT00551031|584876553|FG003|Overall Study|Serious Adverse Event|0|||
161952127|NCT00551031|584876554|FG004|Overall Study|Serious Adverse Event|0|||
161952128|NCT00551031|584876550|FG000|Overall Study|Did not receive vaccine|1|||
161952129|NCT00551031|584876551|FG001|Overall Study|Did not receive vaccine|2|||
161952130|NCT00551031|584876552|FG002|Overall Study|Did not receive vaccine|0|||
161952131|NCT00551031|584876553|FG003|Overall Study|Did not receive vaccine|0|||
161952132|NCT00551031|584876554|FG004|Overall Study|Did not receive vaccine|0|||
161952133|NCT05554146|584876555|FG000|Overall Study|Adverse Event|0|||
161952134|NCT05554146|584876556|FG001|Overall Study|Adverse Event|1|||
161952135|NCT05554146|584876557|FG002|Overall Study|Adverse Event|0|||
161952136|NCT05554146|584876558|FG003|Overall Study|Adverse Event|0|||
161952137|NCT05554146|584876555|FG000|Overall Study|Protocol Violation|0|||
161952138|NCT05554146|584876556|FG001|Overall Study|Protocol Violation|1|||
161952139|NCT05554146|584876557|FG002|Overall Study|Protocol Violation|0|||
161952140|NCT05554146|584876558|FG003|Overall Study|Protocol Violation|0|||
161952141|NCT05554146|584876555|FG000|Overall Study|No longer interested in participating|0|||
161952142|NCT05554146|584876556|FG001|Overall Study|No longer interested in participating|0|||
161952143|NCT05554146|584876557|FG002|Overall Study|No longer interested in participating|1|||
161686179|NCT01265797|583903331|FG000|Blinded Month|Adverse Event|2|||
161686180|NCT01265797|583903332|FG001|Blinded Month|Adverse Event|0|||
161952144|NCT05554146|584876558|FG003|Overall Study|No longer interested in participating|0|||
161952145|NCT05554146|584876555|FG000|Overall Study|Lost to Follow-up|1|||
161952146|NCT05554146|584876556|FG001|Overall Study|Lost to Follow-up|0|||
161952147|NCT05554146|584876557|FG002|Overall Study|Lost to Follow-up|0|||
161952148|NCT05554146|584876558|FG003|Overall Study|Lost to Follow-up|0|||
161952149|NCT03073525|584876561|FG000|Overall Study|Withdrawal by Subject|0|||
162236874|NCT04218084|585919121|FG000|Overall Study|Ongoing at data cut-off date|62|||
162236875|NCT04218084|585919122|FG001|Overall Study|Ongoing at data cut-off date|58|||
162236876|NCT06469242|585919123|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
162236877|NCT06469242|585919124|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
162236878|NCT06469242|585919123|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
162236879|NCT06469242|585919124|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
162236880|NCT05041101|585919125|FG000|Overall Study|Adverse Event|1|||
162236881|NCT05041101|585919126|FG001|Overall Study|Adverse Event|0|||
162236882|NCT05041101|585919127|FG002|Overall Study|Adverse Event|0|||
162236883|NCT05041101|585919125|FG000|Overall Study|Diease Progression|5|||
162236884|NCT05041101|585919126|FG001|Overall Study|Diease Progression|0|||
162236885|NCT05041101|585919127|FG002|Overall Study|Diease Progression|0|||
162236886|NCT01205152|585919128|FG000|Overall Study|Death|1|||
162236887|NCT02783768|585919129|FG000|Overall Study|Lost to Follow-up|1|||
162236888|NCT02783768|585919130|FG001|Overall Study|Lost to Follow-up|0|||
162236889|NCT02208999|585919131|FG000|Overall Study|Lost to Follow-up|1|||
162236890|NCT00319839|585919132|FG000|Overall Study|Adverse Event|5|||
162236891|NCT00319839|585919132|FG000|Overall Study|Withdrawal by Subject|1|||
162236892|NCT00986674|585919133|FG000|Overall Study|Lack of Efficacy|28|||
162236893|NCT00986674|585919134|FG001|Overall Study|Lack of Efficacy|25|||
162236894|NCT00986674|585919135|FG002|Overall Study|Lack of Efficacy|23|||
162236895|NCT00986674|585919133|FG000|Overall Study|Adverse Event|4|||
162236896|NCT00986674|585919134|FG001|Overall Study|Adverse Event|8|||
162236897|NCT00986674|585919135|FG002|Overall Study|Adverse Event|9|||
162236898|NCT00986674|585919133|FG000|Overall Study|Death|5|||
162236899|NCT00986674|585919134|FG001|Overall Study|Death|0|||
162236900|NCT00986674|585919135|FG002|Overall Study|Death|4|||
162236901|NCT00986674|585919133|FG000|Overall Study|Withdrawal by Subject|6|||
162236902|NCT00986674|585919134|FG001|Overall Study|Withdrawal by Subject|2|||
162236903|NCT00986674|585919135|FG002|Overall Study|Withdrawal by Subject|1|||
162236904|NCT00986674|585919133|FG000|Overall Study|alternative therapy|0|||
162236905|NCT00986674|585919134|FG001|Overall Study|alternative therapy|0|||
162236906|NCT00986674|585919135|FG002|Overall Study|alternative therapy|1|||
162236907|NCT00986674|585919133|FG000|Overall Study|not start protocol therapy|4|||
162236908|NCT00986674|585919134|FG001|Overall Study|not start protocol therapy|3|||
162236909|NCT00986674|585919135|FG002|Overall Study|not start protocol therapy|1|||
162236910|NCT00986674|585919133|FG000|Overall Study|unknown/not specify|0|||
162236911|NCT00986674|585919134|FG001|Overall Study|unknown/not specify|7|||
162236912|NCT00986674|585919135|FG002|Overall Study|unknown/not specify|9|||
162236913|NCT01853137|585919136|FG000|Overall Study|Lost to Follow-up|4|||
162236914|NCT01853137|585919137|FG001|Overall Study|Lost to Follow-up|1|||
162236915|NCT00842985|585919138|FG000|Screening|Did not meet entrance requirements|27|||
162236916|NCT00842985|585919138|FG000|First Intervention|Withdrawal by Subject|3|||
162236917|NCT00842985|585919138|FG000|First Intervention|Protocol Violation|3|||
162236918|NCT00842985|585919138|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
162236919|NCT00842985|585919138|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
162236920|NCT01037244|585919139|FG000|Overall Study|Adverse Event|3|||
162236921|NCT01037244|585919140|FG001|Overall Study|Adverse Event|2|||
162236922|NCT01037244|585919141|FG002|Overall Study|Adverse Event|6|||
162236923|NCT01037244|585919142|FG003|Overall Study|Adverse Event|3|||
162236924|NCT01037244|585919139|FG000|Overall Study|Lack of Efficacy|1|||
162236925|NCT01037244|585919140|FG001|Overall Study|Lack of Efficacy|1|||
162236926|NCT01037244|585919141|FG002|Overall Study|Lack of Efficacy|0|||
161952150|NCT03073525|584876562|FG001|Overall Study|Withdrawal by Subject|0|||
161952151|NCT03073525|584876563|FG002|Overall Study|Withdrawal by Subject|3|||
161952152|NCT01976299|584876564|FG000|Overall Study|Withdrawal by Subject|3|||
161952153|NCT01976299|584876565|FG001|Overall Study|Withdrawal by Subject|1|||
161952154|NCT01976299|584876564|FG000|Overall Study|Death|4|||
161952155|NCT01976299|584876565|FG001|Overall Study|Death|2|||
161952156|NCT01976299|584876564|FG000|Overall Study|Lost to Follow-up|7|||
161952157|NCT01976299|584876565|FG001|Overall Study|Lost to Follow-up|1|||
161952158|NCT01976299|584876564|FG000|Overall Study|See clarification above in comments|9|||
161952159|NCT01976299|584876565|FG001|Overall Study|See clarification above in comments|2|||
161952160|NCT00564733|584876567|FG000|Overall Study|Withdrawal by Subject|4|||
161952161|NCT00564733|584876567|FG000|Overall Study|Ineligible|5|||
161952162|NCT03198767|584876572|FG000|Overall Study|Protocol Violation|0|||
161952163|NCT03198767|584876573|FG001|Overall Study|Protocol Violation|0|||
162028800|NCT01227824|585161856|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
162028801|NCT01227824|585161854|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
161834064|NCT00493246|584435546|FG003|Overall Study|No access to draw blood|0|||
161952164|NCT03198767|584876574|FG002|Overall Study|Protocol Violation|0|||
161952165|NCT03198767|584876575|FG003|Overall Study|Protocol Violation|6|||
161952166|NCT03198767|584876576|FG004|Overall Study|Protocol Violation|0|||
161952167|NCT03198767|584876577|FG005|Overall Study|Protocol Violation|0|||
161952168|NCT03198767|584876578|FG006|Overall Study|Protocol Violation|0|||
161952169|NCT03462758|584876579|FG000|Overall Study|Chose no or other method of contraception|20|||
161952170|NCT03462758|584876580|FG001|Overall Study|Chose no or other method of contraception|23|||
161952171|NCT03462758|584876579|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
161952172|NCT03462758|584876580|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
161952173|NCT03462758|584876579|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
161952174|NCT03462758|584876580|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
161952175|NCT03462758|584876579|FG000|Overall Study|Medical contraindication|2|||
161952176|NCT03462758|584876580|FG001|Overall Study|Medical contraindication|2|||
161952177|NCT03462758|584876579|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
161952178|NCT03462758|584876580|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
161952179|NCT02820844|584876581|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
161952180|NCT02820844|584876582|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
161952181|NCT02820844|584876583|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
161952182|NCT02820844|584876584|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
161952183|NCT02820844|584876585|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
161952184|NCT02820844|584876586|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
161952185|NCT02820844|584876581|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
161952186|NCT02820844|584876582|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
161952187|NCT02820844|584876583|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
161952188|NCT02820844|584876584|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
161952189|NCT02820844|584876585|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
161952190|NCT02820844|584876586|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
161952191|NCT02820844|584876581|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
161952192|NCT02820844|584876582|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
161952193|NCT02820844|584876583|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
161952194|NCT02820844|584876584|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
161952195|NCT02820844|584876585|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
161952196|NCT02820844|584876586|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
161952197|NCT02820844|584876581|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
161952198|NCT02820844|584876582|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
161952199|NCT02820844|584876583|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
161952200|NCT02820844|584876584|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
162236927|NCT01037244|585919142|FG003|Overall Study|Lack of Efficacy|1|||
162236928|NCT01037244|585919139|FG000|Overall Study|Lost to Follow-up|3|||
162236929|NCT01037244|585919140|FG001|Overall Study|Lost to Follow-up|3|||
162236930|NCT01037244|585919141|FG002|Overall Study|Lost to Follow-up|4|||
162236931|NCT01037244|585919142|FG003|Overall Study|Lost to Follow-up|4|||
162236932|NCT01037244|585919139|FG000|Overall Study|Withdrawal by Subject|1|||
162236933|NCT01037244|585919140|FG001|Overall Study|Withdrawal by Subject|5|||
162236934|NCT01037244|585919141|FG002|Overall Study|Withdrawal by Subject|3|||
162236935|NCT01037244|585919142|FG003|Overall Study|Withdrawal by Subject|5|||
162236936|NCT01037244|585919139|FG000|Overall Study|Partner Withdrew Consent|2|||
162236937|NCT01037244|585919140|FG001|Overall Study|Partner Withdrew Consent|1|||
162236938|NCT01037244|585919141|FG002|Overall Study|Partner Withdrew Consent|0|||
162236939|NCT01037244|585919142|FG003|Overall Study|Partner Withdrew Consent|0|||
162236940|NCT01037244|585919139|FG000|Overall Study|Various|3|||
162236941|NCT01037244|585919140|FG001|Overall Study|Various|2|||
162236942|NCT01037244|585919141|FG002|Overall Study|Various|1|||
162236943|NCT01037244|585919142|FG003|Overall Study|Various|1|||
162236944|NCT00690820|585919143|FG000|Period 1|Withdrawal by Subject|0|||
162236945|NCT00690820|585919144|FG001|Period 1|Withdrawal by Subject|1|||
162236946|NCT00848926|585919145|FG000|Treatment Period|Progressive disease|45|||
162236947|NCT00848926|585919145|FG000|Treatment Period|Adverse Event|20|||
162236948|NCT00848926|585919145|FG000|Treatment Period|Physician Decision|12|||
162236949|NCT00848926|585919145|FG000|Treatment Period|Withdrawal by Subject|7|||
162236950|NCT00848926|585919145|FG000|Follow-up Period|Lost to Follow-up|7|||
162236951|NCT00848926|585919145|FG000|Follow-up Period|Withdrawal by Subject|3|||
162236952|NCT00848926|585919145|FG000|Follow-up Period|Other|2|||
162236953|NCT04025580|585919146|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
162236954|NCT04025580|585919147|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
162236955|NCT04025580|585919148|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
162236956|NCT00966277|585919149|FG000|Overall Study|Withdrawal by Subject|3|||
162236957|NCT00966277|585919150|FG001|Overall Study|Withdrawal by Subject|0|||
162236958|NCT00966277|585919149|FG000|Overall Study|Ineligible|1|||
162236959|NCT00966277|585919150|FG001|Overall Study|Ineligible|3|||
162236960|NCT00966277|585919149|FG000|Overall Study|Treatment Plan Changed|0|||
162236961|NCT00966277|585919150|FG001|Overall Study|Treatment Plan Changed|1|||
162236962|NCT01249274|585919151|FG000|Overall Study|Lost to Follow-up|3|||
162236963|NCT01249274|585919152|FG001|Overall Study|Lost to Follow-up|4|||
162236964|NCT01249274|585919151|FG000|Overall Study|Received inpatient substance treatment|1|||
162236965|NCT01249274|585919152|FG001|Overall Study|Received inpatient substance treatment|2|||
161952201|NCT02820844|584876585|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
161952202|NCT02820844|584876586|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
161952203|NCT02820844|584876581|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
161952204|NCT02820844|584876582|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
161952205|NCT02820844|584876583|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
161952206|NCT02820844|584876584|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
161952207|NCT02820844|584876585|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
161952208|NCT02820844|584876586|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
161952209|NCT02820844|584876581|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
161952210|NCT02820844|584876582|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
161952211|NCT02820844|584876583|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
161952212|NCT02820844|584876584|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
161952213|NCT02820844|584876585|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
161952214|NCT02820844|584876586|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
161952215|NCT02820844|584876581|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
161952216|NCT02820844|584876582|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
161952217|NCT02820844|584876583|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
161952218|NCT02820844|584876584|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
161952219|NCT02820844|584876585|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
161952220|NCT02820844|584876586|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
161952221|NCT02820844|584876581|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161952222|NCT02820844|584876582|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161952223|NCT02820844|584876583|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
161952224|NCT02820844|584876584|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
161952225|NCT02820844|584876585|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161952226|NCT02820844|584876586|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161952227|NCT02820844|584876581|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
161952228|NCT02820844|584876582|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
161952229|NCT02820844|584876583|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
161952230|NCT02820844|584876584|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
161952231|NCT02820844|584876585|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
161952232|NCT02820844|584876586|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
161952233|NCT02820844|584876581|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161952234|NCT02820844|584876582|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161952235|NCT02820844|584876583|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161952236|NCT02820844|584876584|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161952237|NCT02820844|584876585|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
161952238|NCT02820844|584876586|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
161952239|NCT00413660|584876588|FG000|Up To Week 12|Adverse Event|1|||
161952240|NCT00413660|584876589|FG001|Up To Week 12|Adverse Event|3|||
161952241|NCT00413660|584876590|FG002|Up To Week 12|Adverse Event|1|||
161952242|NCT00413660|584876591|FG003|Up To Week 12|Adverse Event|4|||
161952243|NCT00413660|584876592|FG004|Up To Week 12|Adverse Event|6|||
161952244|NCT00413660|584876593|FG005|Up To Week 12|Adverse Event|4|||
161952245|NCT00413660|584876594|FG006|Up To Week 12|Adverse Event|1|||
161952246|NCT00413660|584876595|FG007|Up To Week 12|Adverse Event|0|||
161952247|NCT00413660|584876596|FG008|Up To Week 12|Adverse Event|0|||
161952248|NCT00413660|584876597|FG009|Up To Week 12|Adverse Event|0|||
161952249|NCT00413660|584876598|FG010|Up To Week 12|Adverse Event|0|||
161952250|NCT00413660|584876588|FG000|Up To Week 12|Lack of Efficacy|2|||
161952251|NCT00413660|584876589|FG001|Up To Week 12|Lack of Efficacy|0|||
161952252|NCT00413660|584876590|FG002|Up To Week 12|Lack of Efficacy|0|||
161952253|NCT00413660|584876591|FG003|Up To Week 12|Lack of Efficacy|0|||
161952254|NCT00413660|584876592|FG004|Up To Week 12|Lack of Efficacy|0|||
161952255|NCT00413660|584876593|FG005|Up To Week 12|Lack of Efficacy|0|||
161952256|NCT00413660|584876594|FG006|Up To Week 12|Lack of Efficacy|5|||
161952257|NCT00413660|584876595|FG007|Up To Week 12|Lack of Efficacy|0|||
161952258|NCT00413660|584876596|FG008|Up To Week 12|Lack of Efficacy|0|||
161952259|NCT00413660|584876597|FG009|Up To Week 12|Lack of Efficacy|0|||
161952260|NCT00413660|584876598|FG010|Up To Week 12|Lack of Efficacy|0|||
161686181|NCT01265797|583903331|FG000|Blinded Month|Diary data incomplete|0|||
161686182|NCT01265797|583903332|FG001|Blinded Month|Diary data incomplete|1|||
161686183|NCT01265797|583903331|FG000|Open Label Month|Lost to Follow-up|0|||
161686184|NCT01265797|583903332|FG001|Open Label Month|Lost to Follow-up|1|||
161686185|NCT00939783|583903334|FG000|Overall Study|Death|6|||
161686186|NCT00939783|583903334|FG000|Overall Study|Adverse Event|39|||
161686187|NCT00939783|583903334|FG000|Overall Study|Study Terminated by Sponsor|498|||
161686188|NCT00939783|583903334|FG000|Overall Study|Withdrawal by Subject|78|||
161686189|NCT00939783|583903334|FG000|Overall Study|Other|16|||
161686190|NCT00939783|583903334|FG000|Overall Study|Lost to Follow-up|8|||
161686191|NCT00939783|583903334|FG000|Overall Study|Protocol Violation|3|||
161686192|NCT00939783|583903334|FG000|Overall Study|Enrolled but not treated|1|||
161686193|NCT02250274|583903342|FG000|Overall Study|Insufficient blood draw amount|7|||
161686194|NCT02250274|583903343|FG001|Overall Study|Insufficient blood draw amount|6|||
161686195|NCT00583362|583903344|FG000|Overall Study|Adverse Event|44|||
161686196|NCT00583362|583903344|FG000|Overall Study|Lack of Efficacy|22|||
161686197|NCT00583362|583903344|FG000|Overall Study|Lost to Follow-up|4|||
161686198|NCT00583362|583903344|FG000|Overall Study|Non-compliance with study drug|28|||
161686199|NCT00583362|583903344|FG000|Overall Study|Pregnancy|7|||
161686200|NCT00583362|583903344|FG000|Overall Study|Miscommunication of visit window|5|||
161686201|NCT00583362|583903344|FG000|Overall Study|Current site closed|7|||
161686202|NCT00583362|583903344|FG000|Overall Study|Subject not dosed in LBSL99|1|||
161686203|NCT00583362|583903344|FG000|Overall Study|Subject moved out of the country/state|2|||
161686204|NCT00583362|583903344|FG000|Overall Study|Missed visits due to staff changes|1|||
161686205|NCT00583362|583903344|FG000|Overall Study|Misunderstanding of protocol|1|||
161686206|NCT00583362|583903344|FG000|Overall Study|Behavioral problems and non-compliance|1|||
161952261|NCT00413660|584876588|FG000|Up To Week 12|Lost to Follow-up|0|||
161952262|NCT00413660|584876589|FG001|Up To Week 12|Lost to Follow-up|1|||
161952263|NCT00413660|584876590|FG002|Up To Week 12|Lost to Follow-up|0|||
161952264|NCT00413660|584876591|FG003|Up To Week 12|Lost to Follow-up|0|||
161952265|NCT00413660|584876592|FG004|Up To Week 12|Lost to Follow-up|1|||
161952266|NCT00413660|584876593|FG005|Up To Week 12|Lost to Follow-up|0|||
161952267|NCT00413660|584876594|FG006|Up To Week 12|Lost to Follow-up|0|||
161952268|NCT00413660|584876595|FG007|Up To Week 12|Lost to Follow-up|0|||
161952269|NCT00413660|584876596|FG008|Up To Week 12|Lost to Follow-up|0|||
161952270|NCT00413660|584876597|FG009|Up To Week 12|Lost to Follow-up|0|||
161952271|NCT00413660|584876598|FG010|Up To Week 12|Lost to Follow-up|0|||
161952272|NCT00413660|584876588|FG000|Up To Week 12|Withdrawal by Subject|0|||
161952273|NCT00413660|584876589|FG001|Up To Week 12|Withdrawal by Subject|2|||
161952274|NCT00413660|584876590|FG002|Up To Week 12|Withdrawal by Subject|0|||
161952275|NCT00413660|584876591|FG003|Up To Week 12|Withdrawal by Subject|2|||
161952276|NCT00413660|584876592|FG004|Up To Week 12|Withdrawal by Subject|0|||
161952277|NCT00413660|584876593|FG005|Up To Week 12|Withdrawal by Subject|2|||
161952278|NCT00413660|584876594|FG006|Up To Week 12|Withdrawal by Subject|2|||
161952279|NCT00413660|584876595|FG007|Up To Week 12|Withdrawal by Subject|0|||
161952280|NCT00413660|584876596|FG008|Up To Week 12|Withdrawal by Subject|0|||
161952281|NCT00413660|584876597|FG009|Up To Week 12|Withdrawal by Subject|0|||
161952282|NCT00413660|584876598|FG010|Up To Week 12|Withdrawal by Subject|0|||
161952283|NCT00413660|584876588|FG000|Up To Week 12|Randomized, Not Treated|1|||
161952284|NCT00413660|584876589|FG001|Up To Week 12|Randomized, Not Treated|0|||
161952285|NCT00413660|584876590|FG002|Up To Week 12|Randomized, Not Treated|0|||
161952286|NCT00413660|584876591|FG003|Up To Week 12|Randomized, Not Treated|1|||
161952287|NCT00413660|584876592|FG004|Up To Week 12|Randomized, Not Treated|0|||
161952288|NCT00413660|584876593|FG005|Up To Week 12|Randomized, Not Treated|0|||
161952289|NCT00413660|584876594|FG006|Up To Week 12|Randomized, Not Treated|0|||
161952290|NCT00413660|584876595|FG007|Up To Week 12|Randomized, Not Treated|0|||
161952291|NCT00413660|584876596|FG008|Up To Week 12|Randomized, Not Treated|0|||
161952292|NCT00413660|584876597|FG009|Up To Week 12|Randomized, Not Treated|0|||
161952293|NCT00413660|584876598|FG010|Up To Week 12|Randomized, Not Treated|0|||
162236966|NCT01498653|585919153|FG000|Overall Study|Adverse Event|2|||
162236967|NCT01498653|585919154|FG001|Overall Study|Adverse Event|2|||
162236968|NCT01498653|585919153|FG000|Overall Study|Lack of Efficacy|12|||
162236969|NCT01498653|585919154|FG001|Overall Study|Lack of Efficacy|26|||
162236970|NCT01498653|585919153|FG000|Overall Study|Protocol Violation|0|||
162236971|NCT01498653|585919154|FG001|Overall Study|Protocol Violation|4|||
162236972|NCT01498653|585919153|FG000|Overall Study|Lost to Follow-up|1|||
162236973|NCT01498653|585919154|FG001|Overall Study|Lost to Follow-up|0|||
162236974|NCT01498653|585919153|FG000|Overall Study|Physician Decision|2|||
162236975|NCT01498653|585919154|FG001|Overall Study|Physician Decision|0|||
162236976|NCT01498653|585919153|FG000|Overall Study|Withdrawal by Subject|2|||
162236977|NCT01498653|585919154|FG001|Overall Study|Withdrawal by Subject|3|||
162236978|NCT02070588|585919160|FG000|Overall Study|Withdrawal by Subject|29|||
162236979|NCT02070588|585919161|FG001|Overall Study|Withdrawal by Subject|1|||
162236980|NCT02070588|585919162|FG002|Overall Study|Withdrawal by Subject|0|||
162236981|NCT02070588|585919160|FG000|Overall Study|Writhdrawal due to early termination|9|||
162236982|NCT02070588|585919161|FG001|Overall Study|Writhdrawal due to early termination|0|||
162236983|NCT02070588|585919162|FG002|Overall Study|Writhdrawal due to early termination|0|||
162236984|NCT02070588|585919160|FG000|Overall Study|Adverse Event|1|||
162236985|NCT02070588|585919161|FG001|Overall Study|Adverse Event|0|||
162236986|NCT02070588|585919162|FG002|Overall Study|Adverse Event|0|||
162236987|NCT03421431|585919163|FG000|Overall Study|Adverse Event|2|||
162236988|NCT03421431|585919164|FG001|Overall Study|Adverse Event|1|||
162236989|NCT03421431|585919165|FG002|Overall Study|Adverse Event|12|||
162236990|NCT03421431|585919163|FG000|Overall Study|Lost to Follow-up|1|||
162236991|NCT03421431|585919164|FG001|Overall Study|Lost to Follow-up|1|||
162236992|NCT03421431|585919165|FG002|Overall Study|Lost to Follow-up|1|||
162236993|NCT03421431|585919163|FG000|Overall Study|Withdrawal by Subject|3|||
162236994|NCT03421431|585919164|FG001|Overall Study|Withdrawal by Subject|2|||
162236995|NCT03421431|585919165|FG002|Overall Study|Withdrawal by Subject|1|||
161952294|NCT00413660|584876588|FG000|Up To Week 12|Other|3|||
161952295|NCT00413660|584876589|FG001|Up To Week 12|Other|1|||
161952296|NCT00413660|584876590|FG002|Up To Week 12|Other|6|||
161952297|NCT00413660|584876591|FG003|Up To Week 12|Other|1|||
161952298|NCT00413660|584876592|FG004|Up To Week 12|Other|2|||
161952299|NCT00413660|584876593|FG005|Up To Week 12|Other|4|||
161952300|NCT00413660|584876594|FG006|Up To Week 12|Other|3|||
161952301|NCT00413660|584876595|FG007|Up To Week 12|Other|0|||
161952302|NCT00413660|584876596|FG008|Up To Week 12|Other|0|||
161952303|NCT00413660|584876597|FG009|Up To Week 12|Other|0|||
161952304|NCT00413660|584876598|FG010|Up To Week 12|Other|0|||
161952305|NCT00413660|584876588|FG000|Post Week 12|Adverse Event|2|||
161952306|NCT00413660|584876589|FG001|Post Week 12|Adverse Event|0|||
161952307|NCT00413660|584876590|FG002|Post Week 12|Adverse Event|2|||
161952308|NCT00413660|584876591|FG003|Post Week 12|Adverse Event|1|||
161952309|NCT00413660|584876592|FG004|Post Week 12|Adverse Event|4|||
161952310|NCT00413660|584876593|FG005|Post Week 12|Adverse Event|2|||
161952311|NCT00413660|584876594|FG006|Post Week 12|Adverse Event|2|||
161952312|NCT00413660|584876595|FG007|Post Week 12|Adverse Event|0|||
161952313|NCT00413660|584876596|FG008|Post Week 12|Adverse Event|0|||
161952314|NCT00413660|584876597|FG009|Post Week 12|Adverse Event|0|||
161686207|NCT00583362|583903344|FG000|Overall Study|Sponsor request due to missed doses|1|||
161686208|NCT00583362|583903344|FG000|Overall Study|Physician Decision|19|||
161834065|NCT00493246|584435547|FG004|Overall Study|No access to draw blood|0|||
161834066|NCT00493246|584435548|FG005|Overall Study|No access to draw blood|1|||
161686209|NCT00583362|583903344|FG000|Overall Study|Protocol Violation|2|||
161686210|NCT00583362|583903344|FG000|Overall Study|Withdrawal by Subject|57|||
161834067|NCT00493246|584435549|FG006|Overall Study|No access to draw blood|0|||
161952315|NCT00413660|584876598|FG010|Post Week 12|Adverse Event|0|||
161952316|NCT00413660|584876588|FG000|Post Week 12|Lack of Efficacy|0|||
161952317|NCT00413660|584876589|FG001|Post Week 12|Lack of Efficacy|0|||
161952318|NCT00413660|584876590|FG002|Post Week 12|Lack of Efficacy|1|||
161952319|NCT00413660|584876591|FG003|Post Week 12|Lack of Efficacy|0|||
161952320|NCT00413660|584876592|FG004|Post Week 12|Lack of Efficacy|0|||
161952321|NCT00413660|584876593|FG005|Post Week 12|Lack of Efficacy|0|||
161952322|NCT00413660|584876594|FG006|Post Week 12|Lack of Efficacy|0|||
161952323|NCT00413660|584876595|FG007|Post Week 12|Lack of Efficacy|0|||
161686211|NCT00506883|583903360|FG000|Overall Study|Lost to Follow-up|1|||
161686212|NCT00506883|583903361|FG001|Overall Study|Lost to Follow-up|1|||
161686213|NCT00506883|583903362|FG002|Overall Study|Lost to Follow-up|1|||
161686214|NCT00506883|583903360|FG000|Overall Study|Withdrawal by Subject|1|||
161686215|NCT00506883|583903361|FG001|Overall Study|Withdrawal by Subject|0|||
161686216|NCT00506883|583903362|FG002|Overall Study|Withdrawal by Subject|1|||
161686217|NCT00506883|583903360|FG000|Overall Study|Lack of Efficacy|0|||
161686218|NCT00506883|583903361|FG001|Overall Study|Lack of Efficacy|1|||
161834068|NCT00493246|584435550|FG007|Overall Study|No access to draw blood|0|||
161834069|NCT00493246|584435543|FG000|Overall Study|Lost to Follow-up|0|||
161834070|NCT00493246|584435544|FG001|Overall Study|Lost to Follow-up|0|||
161952324|NCT00413660|584876596|FG008|Post Week 12|Lack of Efficacy|0|||
161952325|NCT00413660|584876597|FG009|Post Week 12|Lack of Efficacy|1|||
161834071|NCT00493246|584435545|FG002|Overall Study|Lost to Follow-up|0|||
161952326|NCT00413660|584876598|FG010|Post Week 12|Lack of Efficacy|0|||
161686219|NCT00506883|583903362|FG002|Overall Study|Lack of Efficacy|1|||
161686220|NCT00506883|583903360|FG000|Overall Study|Other|5|||
161686221|NCT00506883|583903361|FG001|Overall Study|Other|1|||
162028802|NCT01227824|585161855|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
162028803|NCT01227824|585161856|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
161686222|NCT00506883|583903362|FG002|Overall Study|Other|1|||
161686223|NCT00455013|583903364|FG000|Short Term Period|Adverse Event|2|||
161686224|NCT00455013|583903365|FG001|Short Term Period|Adverse Event|5|||
161686225|NCT00455013|583903366|FG002|Short Term Period|Adverse Event|0|||
161686226|NCT00455013|583903364|FG000|Short Term Period|Withdrawal by Subject|0|||
161686227|NCT00455013|583903365|FG001|Short Term Period|Withdrawal by Subject|0|||
161686228|NCT00455013|583903366|FG002|Short Term Period|Withdrawal by Subject|1|||
161686229|NCT00455013|583903364|FG000|Short Term Period|Lack of Efficacy|4|||
161686230|NCT00455013|583903365|FG001|Short Term Period|Lack of Efficacy|0|||
161686231|NCT00455013|583903366|FG002|Short Term Period|Lack of Efficacy|0|||
161686232|NCT00455013|583903364|FG000|Short Term Period|Other|0|||
161686233|NCT00455013|583903365|FG001|Short Term Period|Other|0|||
161686234|NCT00455013|583903366|FG002|Short Term Period|Other|1|||
161686235|NCT00455013|583903364|FG000|Long Term Extension (LTE)|Adverse Event|0|||
161686236|NCT00455013|583903365|FG001|Long Term Extension (LTE)|Adverse Event|1|||
161686237|NCT00455013|583903366|FG002|Long Term Extension (LTE)|Adverse Event|1|||
161686238|NCT00455013|583903364|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
161686239|NCT00455013|583903365|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
161686240|NCT00455013|583903366|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
161686241|NCT00455013|583903364|FG000|Long Term Extension (LTE)|Death|1|||
161686242|NCT00455013|583903365|FG001|Long Term Extension (LTE)|Death|1|||
161686243|NCT00455013|583903366|FG002|Long Term Extension (LTE)|Death|0|||
161686244|NCT00455013|583903364|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
161686245|NCT00455013|583903365|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
161686246|NCT00455013|583903366|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
161686247|NCT00455013|583903364|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
161686248|NCT00455013|583903365|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
161686249|NCT00455013|583903366|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
161686250|NCT00455013|583903364|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
161686251|NCT00455013|583903365|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
161686252|NCT00455013|583903366|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
161686253|NCT00455013|583903364|FG000|Long Term Extension (LTE)|non-specified|0|||
161686254|NCT00455013|583903365|FG001|Long Term Extension (LTE)|non-specified|0|||
161686255|NCT00455013|583903366|FG002|Long Term Extension (LTE)|non-specified|1|||
161686256|NCT00786565|583903370|FG000|Enrollment Prior to Surgery|Site Closed|3|||
161686257|NCT00786565|583903370|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
161686258|NCT00786565|583903370|FG000|Post Surgery|Abnormal macular pucker|1|||
161686259|NCT00786565|583903370|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
161686260|NCT05513625|583903373|FG000|Overall Study|Withdrawal by Subject|1|||
161686261|NCT00754793|583903375|FG000|Overall Study|voluntary withdrawn from study|0|||
161686262|NCT00754793|583903376|FG001|Overall Study|voluntary withdrawn from study|1|||
161686263|NCT02536313|583903378|FG000|Overall Study|Lack of Efficacy|0|||
161686264|NCT02536313|583903379|FG001|Overall Study|Lack of Efficacy|1|||
161686265|NCT00917150|583903380|FG000|Overall Study|Adverse Event|12|||
161686266|NCT00917150|583903381|FG001|Overall Study|Adverse Event|7|||
161686267|NCT00917150|583903382|FG002|Overall Study|Adverse Event|12|||
161686268|NCT00917150|583903383|FG003|Overall Study|Adverse Event|11|||
161686269|NCT00917150|583903380|FG000|Overall Study|Death|1|||
161686270|NCT00917150|583903381|FG001|Overall Study|Death|4|||
161686271|NCT00917150|583903382|FG002|Overall Study|Death|3|||
161686272|NCT00917150|583903383|FG003|Overall Study|Death|2|||
161686273|NCT00917150|583903380|FG000|Overall Study|Lost to Follow-up|1|||
161686274|NCT00917150|583903381|FG001|Overall Study|Lost to Follow-up|0|||
161686275|NCT00917150|583903382|FG002|Overall Study|Lost to Follow-up|4|||
161686276|NCT00917150|583903383|FG003|Overall Study|Lost to Follow-up|2|||
161686277|NCT00917150|583903380|FG000|Overall Study|Physician Decision|0|||
161686278|NCT00917150|583903381|FG001|Overall Study|Physician Decision|2|||
161686279|NCT00917150|583903382|FG002|Overall Study|Physician Decision|0|||
161686280|NCT00917150|583903383|FG003|Overall Study|Physician Decision|1|||
161686281|NCT00917150|583903380|FG000|Overall Study|Protocol Violation|5|||
161686282|NCT00917150|583903381|FG001|Overall Study|Protocol Violation|5|||
161686283|NCT00917150|583903382|FG002|Overall Study|Protocol Violation|3|||
161686284|NCT00917150|583903383|FG003|Overall Study|Protocol Violation|5|||
161686285|NCT00917150|583903380|FG000|Overall Study|Withdrawal by Subject|15|||
161834072|NCT00493246|584435546|FG003|Overall Study|Lost to Follow-up|0|||
161952327|NCT00413660|584876588|FG000|Post Week 12|Lost to Follow-up|0|||
161686286|NCT00917150|583903381|FG001|Overall Study|Withdrawal by Subject|16|||
161686287|NCT00917150|583903382|FG002|Overall Study|Withdrawal by Subject|18|||
161686288|NCT00917150|583903383|FG003|Overall Study|Withdrawal by Subject|11|||
161834073|NCT00493246|584435547|FG004|Overall Study|Lost to Follow-up|0|||
161834074|NCT00493246|584435548|FG005|Overall Study|Lost to Follow-up|0|||
161834075|NCT00493246|584435549|FG006|Overall Study|Lost to Follow-up|1|||
161834076|NCT00493246|584435550|FG007|Overall Study|Lost to Follow-up|0|||
161834077|NCT00595335|584435551|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
161834078|NCT00595335|584435552|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
161834079|NCT00595335|584435551|FG000|Baseline to Six Months|Disease Progression|1|||
161834080|NCT00595335|584435552|FG001|Baseline to Six Months|Disease Progression|1|||
161834081|NCT00595335|584435551|FG000|Baseline to Six Months|Adverse Event|1|||
161834082|NCT00595335|584435552|FG001|Baseline to Six Months|Adverse Event|0|||
161834083|NCT00595335|584435551|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
161834084|NCT00595335|584435552|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
161834085|NCT00595335|584435551|FG000|Six Months to Twelve Months|Disease Progression|1|||
161834086|NCT00595335|584435552|FG001|Six Months to Twelve Months|Disease Progression|0|||
161834087|NCT01013649|584435555|FG000|First Step|Withdrawal by Subject|36|||
161834088|NCT01013649|584435556|FG001|First Step|Withdrawal by Subject|19|||
161834089|NCT01013649|584435557|FG002|First Step|Withdrawal by Subject|0|||
161834090|NCT01013649|584435558|FG003|First Step|Withdrawal by Subject|0|||
161834091|NCT01013649|584435555|FG000|First Step|Progression|58|||
161952328|NCT00413660|584876589|FG001|Post Week 12|Lost to Follow-up|1|||
161952329|NCT00413660|584876590|FG002|Post Week 12|Lost to Follow-up|1|||
161952330|NCT00413660|584876591|FG003|Post Week 12|Lost to Follow-up|0|||
161952331|NCT00413660|584876592|FG004|Post Week 12|Lost to Follow-up|0|||
161952332|NCT00413660|584876593|FG005|Post Week 12|Lost to Follow-up|0|||
161952333|NCT00413660|584876594|FG006|Post Week 12|Lost to Follow-up|0|||
161952334|NCT00413660|584876595|FG007|Post Week 12|Lost to Follow-up|0|||
161952335|NCT00413660|584876596|FG008|Post Week 12|Lost to Follow-up|0|||
161952336|NCT00413660|584876597|FG009|Post Week 12|Lost to Follow-up|0|||
161952337|NCT00413660|584876598|FG010|Post Week 12|Lost to Follow-up|0|||
161952338|NCT00413660|584876588|FG000|Post Week 12|Withdrawal by Subject|0|||
161952339|NCT00413660|584876589|FG001|Post Week 12|Withdrawal by Subject|1|||
161952340|NCT00413660|584876590|FG002|Post Week 12|Withdrawal by Subject|1|||
161952341|NCT00413660|584876591|FG003|Post Week 12|Withdrawal by Subject|0|||
161952342|NCT00413660|584876592|FG004|Post Week 12|Withdrawal by Subject|1|||
161952343|NCT00413660|584876593|FG005|Post Week 12|Withdrawal by Subject|0|||
161952344|NCT00413660|584876594|FG006|Post Week 12|Withdrawal by Subject|0|||
161952345|NCT00413660|584876595|FG007|Post Week 12|Withdrawal by Subject|0|||
161952346|NCT00413660|584876596|FG008|Post Week 12|Withdrawal by Subject|0|||
161952347|NCT00413660|584876597|FG009|Post Week 12|Withdrawal by Subject|0|||
161952348|NCT00413660|584876598|FG010|Post Week 12|Withdrawal by Subject|1|||
161952349|NCT00413660|584876588|FG000|Post Week 12|Other|1|||
161952350|NCT00413660|584876589|FG001|Post Week 12|Other|2|||
161952351|NCT00413660|584876590|FG002|Post Week 12|Other|3|||
161952352|NCT00413660|584876591|FG003|Post Week 12|Other|0|||
161952353|NCT00413660|584876592|FG004|Post Week 12|Other|1|||
161952354|NCT00413660|584876593|FG005|Post Week 12|Other|1|||
161952355|NCT00413660|584876594|FG006|Post Week 12|Other|1|||
161952356|NCT00413660|584876595|FG007|Post Week 12|Other|0|||
161952357|NCT00413660|584876596|FG008|Post Week 12|Other|0|||
161952358|NCT00413660|584876597|FG009|Post Week 12|Other|0|||
161952359|NCT00413660|584876598|FG010|Post Week 12|Other|0|||
161952360|NCT01791517|584876599|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
161952361|NCT01791517|584876600|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
161952362|NCT01791517|584876601|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
161952363|NCT01791517|584876602|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
161952364|NCT01791517|584876603|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
161952365|NCT01791517|584876604|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
161952366|NCT01791517|584876605|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
161952367|NCT01791517|584876606|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
161952368|NCT01791517|584876607|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
161952369|NCT01791517|584876608|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
161952370|NCT01791517|584876609|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
161952371|NCT01791517|584876610|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
161952372|NCT01791517|584876599|FG000|Phase I: Period 1|Adverse Event|0|||
161952373|NCT01791517|584876600|FG001|Phase I: Period 1|Adverse Event|0|||
161952374|NCT01791517|584876601|FG002|Phase I: Period 1|Adverse Event|1|||
161952375|NCT01791517|584876602|FG003|Phase I: Period 1|Adverse Event|1|||
161952376|NCT01791517|584876603|FG004|Phase I: Period 1|Adverse Event|0|||
162236996|NCT03421431|585919163|FG000|Overall Study|Protocol Violation|0|||
161952377|NCT01791517|584876604|FG005|Phase I: Period 1|Adverse Event|0|||
161952378|NCT01791517|584876605|FG006|Phase I: Period 1|Adverse Event|0|||
161952379|NCT01791517|584876606|FG007|Phase I: Period 1|Adverse Event|0|||
161952380|NCT01791517|584876607|FG008|Phase I: Period 1|Adverse Event|0|||
161952381|NCT01791517|584876608|FG009|Phase I: Period 1|Adverse Event|0|||
161952382|NCT01791517|584876609|FG010|Phase I: Period 1|Adverse Event|0|||
161952383|NCT01791517|584876610|FG011|Phase I: Period 1|Adverse Event|0|||
161952384|NCT01791517|584876599|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
161952385|NCT01791517|584876600|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161952386|NCT01791517|584876601|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161952387|NCT01791517|584876602|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
162236997|NCT03421431|585919164|FG001|Overall Study|Protocol Violation|1|||
162236998|NCT03421431|585919165|FG002|Overall Study|Protocol Violation|0|||
162236999|NCT03421431|585919163|FG000|Overall Study|Participant met Stopping Rules|0|||
162237000|NCT03421431|585919164|FG001|Overall Study|Participant met Stopping Rules|1|||
162237001|NCT03421431|585919165|FG002|Overall Study|Participant met Stopping Rules|0|||
162237002|NCT00141726|585919166|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
162237003|NCT02216357|585919170|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
162237004|NCT02216357|585919171|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
162237005|NCT00235326|585919177|FG000|Overall Study|Lost to Follow-up|746|||
162237006|NCT00235326|585919178|FG001|Overall Study|Lost to Follow-up|1400|||
162237007|NCT01790126|585919181|FG000|Overall Study|PSA Progression|12|||
162237008|NCT01790126|585919182|FG001|Overall Study|PSA Progression|16|||
162237009|NCT01790126|585919183|FG002|Overall Study|PSA Progression|16|||
162237010|NCT01790126|585919181|FG000|Overall Study|Other|5|||
162237011|NCT01790126|585919182|FG001|Overall Study|Other|4|||
162237012|NCT01790126|585919183|FG002|Overall Study|Other|8|||
162237013|NCT01790126|585919181|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
161952388|NCT01791517|584876603|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161952389|NCT01791517|584876604|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161952390|NCT01791517|584876605|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161952391|NCT01791517|584876606|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161952392|NCT01791517|584876607|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161952393|NCT01791517|584876608|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161952394|NCT01791517|584876609|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161952395|NCT01791517|584876610|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161952396|NCT01791517|584876599|FG000|Phase I: Period 1|Protocol Violation|0|||
161952397|NCT01791517|584876600|FG001|Phase I: Period 1|Protocol Violation|1|||
161952398|NCT01791517|584876601|FG002|Phase I: Period 1|Protocol Violation|0|||
161952399|NCT01791517|584876602|FG003|Phase I: Period 1|Protocol Violation|0|||
161952400|NCT01791517|584876603|FG004|Phase I: Period 1|Protocol Violation|0|||
161952401|NCT01791517|584876604|FG005|Phase I: Period 1|Protocol Violation|0|||
161952402|NCT01791517|584876605|FG006|Phase I: Period 1|Protocol Violation|0|||
161952403|NCT01791517|584876606|FG007|Phase I: Period 1|Protocol Violation|0|||
161952404|NCT01791517|584876607|FG008|Phase I: Period 1|Protocol Violation|0|||
161952405|NCT01791517|584876608|FG009|Phase I: Period 1|Protocol Violation|0|||
161952406|NCT01791517|584876609|FG010|Phase I: Period 1|Protocol Violation|0|||
161952407|NCT01791517|584876610|FG011|Phase I: Period 1|Protocol Violation|0|||
161952408|NCT01791517|584876599|FG000|Phase I: Period 1|Lost to Follow-up|0|||
161834092|NCT01013649|584435556|FG001|First Step|Progression|23|||
161952409|NCT01791517|584876600|FG001|Phase I: Period 1|Lost to Follow-up|0|||
162028804|NCT01227824|585161854|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
161952410|NCT01791517|584876601|FG002|Phase I: Period 1|Lost to Follow-up|0|||
161952411|NCT01791517|584876602|FG003|Phase I: Period 1|Lost to Follow-up|1|||
161952412|NCT01791517|584876603|FG004|Phase I: Period 1|Lost to Follow-up|0|||
161952413|NCT01791517|584876604|FG005|Phase I: Period 1|Lost to Follow-up|0|||
161952414|NCT01791517|584876605|FG006|Phase I: Period 1|Lost to Follow-up|1|||
161952415|NCT01791517|584876606|FG007|Phase I: Period 1|Lost to Follow-up|0|||
161952416|NCT01791517|584876607|FG008|Phase I: Period 1|Lost to Follow-up|1|||
161952417|NCT01791517|584876608|FG009|Phase I: Period 1|Lost to Follow-up|1|||
161952418|NCT01791517|584876609|FG010|Phase I: Period 1|Lost to Follow-up|0|||
161952419|NCT01791517|584876610|FG011|Phase I: Period 1|Lost to Follow-up|0|||
161952420|NCT01791517|584876599|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
161952421|NCT01791517|584876600|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
161952422|NCT01791517|584876601|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
161952423|NCT01791517|584876602|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
161952424|NCT01791517|584876603|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
161952425|NCT01791517|584876604|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
161952426|NCT01791517|584876605|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
161952427|NCT01791517|584876606|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
161952428|NCT01791517|584876607|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
161952429|NCT01791517|584876608|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
161952430|NCT01791517|584876609|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
161952431|NCT01791517|584876610|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
161952432|NCT01791517|584876599|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
161952433|NCT01791517|584876600|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161952434|NCT01791517|584876601|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161952435|NCT01791517|584876602|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161952436|NCT01791517|584876603|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161952437|NCT01791517|584876604|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161952438|NCT01791517|584876605|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161952439|NCT01791517|584876606|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161952440|NCT01791517|584876607|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161952441|NCT01791517|584876608|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161952442|NCT01791517|584876609|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161952443|NCT01791517|584876610|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
161952444|NCT01791517|584876599|FG000|Phase I: Period 2|Protocol Violation|0|||
161952445|NCT01791517|584876600|FG001|Phase I: Period 2|Protocol Violation|0|||
161952446|NCT01791517|584876601|FG002|Phase I: Period 2|Protocol Violation|0|||
161952447|NCT01791517|584876602|FG003|Phase I: Period 2|Protocol Violation|1|||
161952448|NCT01791517|584876603|FG004|Phase I: Period 2|Protocol Violation|0|||
161952449|NCT01791517|584876604|FG005|Phase I: Period 2|Protocol Violation|0|||
161952450|NCT01791517|584876605|FG006|Phase I: Period 2|Protocol Violation|0|||
161952451|NCT01791517|584876606|FG007|Phase I: Period 2|Protocol Violation|0|||
161952452|NCT01791517|584876607|FG008|Phase I: Period 2|Protocol Violation|0|||
161952453|NCT01791517|584876608|FG009|Phase I: Period 2|Protocol Violation|0|||
161952454|NCT01791517|584876609|FG010|Phase I: Period 2|Protocol Violation|0|||
161952455|NCT01791517|584876610|FG011|Phase I: Period 2|Protocol Violation|0|||
161952456|NCT01791517|584876599|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
161952457|NCT01791517|584876600|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
161952458|NCT01791517|584876601|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
161952459|NCT01791517|584876602|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
161952460|NCT01791517|584876603|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
161952461|NCT01791517|584876604|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
161952462|NCT01791517|584876605|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
161952463|NCT01791517|584876606|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
161952464|NCT01791517|584876607|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
161952465|NCT01791517|584876608|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
161952466|NCT01791517|584876609|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
161952467|NCT01791517|584876610|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
161952468|NCT01791517|584876599|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
162237014|NCT01790126|585919182|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
162237015|NCT01790126|585919183|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
162237016|NCT01790126|585919181|FG000|Overall Study|Withdrawal by Physician|1|||
162237017|NCT01790126|585919182|FG001|Overall Study|Withdrawal by Physician|1|||
162237018|NCT01790126|585919183|FG002|Overall Study|Withdrawal by Physician|2|||
162237019|NCT01790126|585919181|FG000|Overall Study|Withdrawal by Subject|3|||
162237020|NCT01790126|585919182|FG001|Overall Study|Withdrawal by Subject|1|||
162237021|NCT01790126|585919183|FG002|Overall Study|Withdrawal by Subject|2|||
162237022|NCT01790126|585919181|FG000|Overall Study|Lost to Follow-up|1|||
162237023|NCT01790126|585919182|FG001|Overall Study|Lost to Follow-up|0|||
162237024|NCT01790126|585919183|FG002|Overall Study|Lost to Follow-up|1|||
162237025|NCT01790126|585919181|FG000|Overall Study|Adverse Event|0|||
162237026|NCT01790126|585919182|FG001|Overall Study|Adverse Event|2|||
162237027|NCT01790126|585919183|FG002|Overall Study|Adverse Event|0|||
162237028|NCT01790126|585919181|FG000|Overall Study|Death|2|||
162237029|NCT01790126|585919182|FG001|Overall Study|Death|0|||
162237030|NCT01790126|585919183|FG002|Overall Study|Death|0|||
162237031|NCT01790126|585919181|FG000|Overall Study|Radiographic Progression|3|||
162237032|NCT01790126|585919182|FG001|Overall Study|Radiographic Progression|1|||
162237033|NCT01790126|585919183|FG002|Overall Study|Radiographic Progression|0|||
162237034|NCT00455325|585919184|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
162237035|NCT00455325|585919185|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
162237036|NCT00455325|585919186|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
162237037|NCT00455325|585919187|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
162237038|NCT00455325|585919184|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
162237039|NCT00455325|585919185|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
162237040|NCT00455325|585919186|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
162237041|NCT00455325|585919187|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
162237042|NCT00455325|585919184|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
162237043|NCT00455325|585919185|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
162237044|NCT00455325|585919186|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
162237045|NCT00455325|585919187|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
162237046|NCT00455325|585919184|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
162237047|NCT00455325|585919185|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
162237048|NCT00455325|585919186|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
162237049|NCT00455325|585919187|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
162237050|NCT00455325|585919184|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
162237051|NCT00455325|585919185|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
162237052|NCT00455325|585919186|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
162237053|NCT00455325|585919187|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
162237054|NCT00455325|585919184|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
162237055|NCT00455325|585919185|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
162237056|NCT00455325|585919186|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
162237057|NCT00455325|585919187|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
162237058|NCT00455325|585919184|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
162237059|NCT00455325|585919185|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
162237060|NCT00455325|585919186|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
162237061|NCT00455325|585919187|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
162237062|NCT02435966|585919188|FG000|Overall Study|Withdrawal by Subject|0|||
162237063|NCT02435966|585919189|FG001|Overall Study|Withdrawal by Subject|1|||
162237064|NCT02435966|585919190|FG002|Overall Study|Withdrawal by Subject|0|||
162237065|NCT00928746|585919192|FG000|Overall Study|Adverse Event|2|||
162237066|NCT00928746|585919192|FG000|Overall Study|Protocol Violation|1|||
162237067|NCT00928746|585919192|FG000|Overall Study|Withdrawal by Subject|1|||
162237068|NCT00928746|585919192|FG000|Overall Study|Other|2|||
162237069|NCT02745392|585919197|FG000|Overall Study|Lost to Follow-up|0|||
162237070|NCT02745392|585919198|FG001|Overall Study|Lost to Follow-up|1|||
162237071|NCT02745392|585919199|FG002|Overall Study|Lost to Follow-up|0|||
162237072|NCT02745392|585919200|FG003|Overall Study|Lost to Follow-up|0|||
162237073|NCT02004353|585919205|FG000|Overall Study|Voluntary participation|1334|||
162237074|NCT01691768|585919206|FG000|Overall Study|Death|0|||
162237075|NCT01691768|585919207|FG001|Overall Study|Death|2|||
162237076|NCT01691768|585919206|FG000|Overall Study|Lost to Follow-up|4|||
162237077|NCT01691768|585919207|FG001|Overall Study|Lost to Follow-up|3|||
162237078|NCT01691768|585919206|FG000|Overall Study|Withdrawal by Subject|10|||
162237079|NCT01691768|585919207|FG001|Overall Study|Withdrawal by Subject|9|||
162237080|NCT01691768|585919206|FG000|Overall Study|Relocated|0|||
161834093|NCT01013649|584435557|FG002|First Step|Progression|0|||
161834094|NCT01013649|584435558|FG003|First Step|Progression|0|||
161834095|NCT01013649|584435555|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
161834096|NCT01013649|584435556|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
161834097|NCT01013649|584435557|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
161952469|NCT01791517|584876600|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161952470|NCT01791517|584876601|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161952471|NCT01791517|584876602|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161952472|NCT01791517|584876603|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161952473|NCT01791517|584876604|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161952474|NCT01791517|584876605|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161952475|NCT01791517|584876606|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161952476|NCT01791517|584876607|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161952477|NCT01791517|584876608|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161952478|NCT01791517|584876609|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
161952479|NCT01791517|584876610|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
161952480|NCT01791517|584876599|FG000|Phase I: Period 2|Lens Discomfort|0|||
161952481|NCT01791517|584876600|FG001|Phase I: Period 2|Lens Discomfort|0|||
161686289|NCT00917150|583903380|FG000|Overall Study|Other than specified|3|||
161686290|NCT00917150|583903381|FG001|Overall Study|Other than specified|3|||
161952482|NCT01791517|584876601|FG002|Phase I: Period 2|Lens Discomfort|0|||
161952483|NCT01791517|584876602|FG003|Phase I: Period 2|Lens Discomfort|0|||
161952484|NCT01791517|584876603|FG004|Phase I: Period 2|Lens Discomfort|0|||
161952485|NCT01791517|584876604|FG005|Phase I: Period 2|Lens Discomfort|1|||
161952486|NCT01791517|584876605|FG006|Phase I: Period 2|Lens Discomfort|0|||
161834098|NCT01013649|584435558|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
162237081|NCT01691768|585919207|FG001|Overall Study|Relocated|1|||
162237082|NCT01691768|585919206|FG000|Overall Study|Investigator decision|1|||
162237083|NCT01691768|585919207|FG001|Overall Study|Investigator decision|1|||
162237084|NCT02481947|585919218|FG000|Overall Study|Withdrawal by Subject|24|||
162237085|NCT02481947|585919219|FG001|Overall Study|Withdrawal by Subject|10|||
162237086|NCT02481947|585919218|FG000|Overall Study|Lost to Follow-up|11|||
162237087|NCT02481947|585919219|FG001|Overall Study|Lost to Follow-up|5|||
162237088|NCT02481947|585919218|FG000|Overall Study|Adverse Event|6|||
162237089|NCT02481947|585919219|FG001|Overall Study|Adverse Event|11|||
162237090|NCT02481947|585919218|FG000|Overall Study|Physician Decision|4|||
162237091|NCT02481947|585919219|FG001|Overall Study|Physician Decision|5|||
162237092|NCT02481947|585919218|FG000|Overall Study|Protocol Violation|1|||
162237093|NCT02481947|585919219|FG001|Overall Study|Protocol Violation|5|||
162237094|NCT01007448|585919220|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
162237095|NCT01007448|585919221|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
162237096|NCT01007448|585919220|FG000|Overall Study|Staph Skin Infection Flare|1|||
162237097|NCT01007448|585919221|FG001|Overall Study|Staph Skin Infection Flare|0|||
162237098|NCT01007448|585919220|FG000|Overall Study|Participant Leaving the Country|1|||
162237099|NCT01007448|585919221|FG001|Overall Study|Participant Leaving the Country|0|||
162237100|NCT01007448|585919220|FG000|Overall Study|Participant Given Prohibited Medication|1|||
162237101|NCT01007448|585919221|FG001|Overall Study|Participant Given Prohibited Medication|0|||
162237102|NCT01007448|585919220|FG000|Overall Study|Progressive Disease|1|||
162237103|NCT01007448|585919221|FG001|Overall Study|Progressive Disease|2|||
162237104|NCT01007448|585919220|FG000|Overall Study|Lack of Efficacy|2|||
162237105|NCT01007448|585919221|FG001|Overall Study|Lack of Efficacy|0|||
162237106|NCT01007448|585919220|FG000|Overall Study|Withdrawal by Subject|2|||
162237107|NCT01007448|585919221|FG001|Overall Study|Withdrawal by Subject|3|||
162237108|NCT01007448|585919220|FG000|Overall Study|Adverse Event|1|||
162237109|NCT01007448|585919221|FG001|Overall Study|Adverse Event|4|||
162237110|NCT02751320|585919222|FG000|Overall Study|Adverse Event|2|||
162237111|NCT02751320|585919222|FG000|Overall Study|Withdrawal by Subject|1|||
162237112|NCT03426605|585919223|FG000|Overall Study|AML relapse or progression|2|||
162237113|NCT03426605|585919224|FG001|Overall Study|AML relapse or progression|1|||
162237114|NCT03426605|585919225|FG002|Overall Study|AML relapse or progression|2|||
162237115|NCT03426605|585919226|FG003|Overall Study|AML relapse or progression|2|||
162237116|NCT03426605|585919223|FG000|Overall Study|Treatment failure|3|||
162237117|NCT03426605|585919224|FG001|Overall Study|Treatment failure|2|||
162237118|NCT03426605|585919225|FG002|Overall Study|Treatment failure|0|||
162237119|NCT03426605|585919226|FG003|Overall Study|Treatment failure|0|||
162237120|NCT03426605|585919223|FG000|Overall Study|Adverse Event|1|||
162237121|NCT03426605|585919224|FG001|Overall Study|Adverse Event|0|||
162237122|NCT03426605|585919225|FG002|Overall Study|Adverse Event|1|||
162237123|NCT03426605|585919226|FG003|Overall Study|Adverse Event|1|||
162237124|NCT03426605|585919223|FG000|Overall Study|Withdrawal by Subject|0|||
162237125|NCT03426605|585919224|FG001|Overall Study|Withdrawal by Subject|0|||
162237126|NCT03426605|585919225|FG002|Overall Study|Withdrawal by Subject|1|||
162237127|NCT03426605|585919226|FG003|Overall Study|Withdrawal by Subject|1|||
162237128|NCT01920854|585919229|FG000|Overall Study|Withdrawal by Subject|1|||
162237129|NCT01920854|585919230|FG001|Overall Study|Withdrawal by Subject|0|||
162237130|NCT01920854|585919231|FG002|Overall Study|Withdrawal by Subject|0|||
162237131|NCT01920854|585919232|FG003|Overall Study|Withdrawal by Subject|0|||
162237132|NCT01920854|585919233|FG004|Overall Study|Withdrawal by Subject|1|||
162237133|NCT01920854|585919234|FG005|Overall Study|Withdrawal by Subject|0|||
162237134|NCT01920854|585919235|FG006|Overall Study|Withdrawal by Subject|1|||
162237135|NCT01886378|585919236|FG000|Overall Study|Adverse Event|1|||
162237136|NCT01886378|585919236|FG000|Overall Study|Withdrawal by Subject|4|||
162237137|NCT03333837|585919246|FG000|Overall Study|Adverse Event|2|||
162237138|NCT03333837|585919247|FG001|Overall Study|Adverse Event|1|||
162237139|NCT03333837|585919248|FG002|Overall Study|Adverse Event|1|||
162237140|NCT03333837|585919249|FG003|Overall Study|Adverse Event|1|||
162237141|NCT03333837|585919250|FG004|Overall Study|Adverse Event|0|||
162237142|NCT03333837|585919246|FG000|Overall Study|Caregiver withdrew|0|||
162237143|NCT03333837|585919247|FG001|Overall Study|Caregiver withdrew|2|||
162237144|NCT03333837|585919248|FG002|Overall Study|Caregiver withdrew|1|||
162237145|NCT03333837|585919249|FG003|Overall Study|Caregiver withdrew|0|||
162237146|NCT03333837|585919250|FG004|Overall Study|Caregiver withdrew|0|||
162237147|NCT03333837|585919246|FG000|Overall Study|Withdrawal by Subject|0|||
162237148|NCT03333837|585919247|FG001|Overall Study|Withdrawal by Subject|0|||
162237149|NCT03333837|585919248|FG002|Overall Study|Withdrawal by Subject|1|||
162237150|NCT03333837|585919249|FG003|Overall Study|Withdrawal by Subject|1|||
162237151|NCT03333837|585919250|FG004|Overall Study|Withdrawal by Subject|3|||
162237152|NCT03333837|585919246|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
162237153|NCT03333837|585919247|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
162237154|NCT03333837|585919248|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
162237399|NCT00490724|585921087|FG001|Period II|Treatment Discontinuation|1|||
161686291|NCT00917150|583903382|FG002|Overall Study|Other than specified|2|||
161686292|NCT00917150|583903383|FG003|Overall Study|Other than specified|2|||
161686293|NCT03891264|583903385|FG000|Overall Study|Adverse Event|1|||
161686294|NCT03891264|583903385|FG000|Overall Study|Withdrawal by Subject|2|||
161686295|NCT03891264|583903385|FG000|Overall Study|Physician Decision|2|||
161686296|NCT01924182|583903386|FG000|Overall Study|Withdrawal by Subject|1|||
161686297|NCT01924182|583903387|FG001|Overall Study|Withdrawal by Subject|0|||
161686298|NCT00993265|583903389|FG000|Overall Study|Adverse Event|1|||
161686299|NCT00993265|583903390|FG001|Overall Study|Adverse Event|0|||
161686300|NCT00993265|583903389|FG000|Overall Study|Changed dose of concomitant drug|2|||
161686301|NCT00993265|583903390|FG001|Overall Study|Changed dose of concomitant drug|0|||
161686302|NCT00993265|583903389|FG000|Overall Study|Non-compliant with study medication|1|||
161686303|NCT00993265|583903390|FG001|Overall Study|Non-compliant with study medication|0|||
161686304|NCT00219284|583903391|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
161686305|NCT00219284|583903392|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
161686306|NCT00219284|583903391|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
161686307|NCT00219284|583903392|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
161686308|NCT00219284|583903391|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
161686309|NCT00219284|583903392|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
161686310|NCT00219284|583903391|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
161686311|NCT00219284|583903392|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
161686312|NCT00219284|583903391|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
161686313|NCT00219284|583903392|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
161686314|NCT00219284|583903391|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
161686315|NCT00219284|583903392|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
161686316|NCT00219284|583903391|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
161686317|NCT00219284|583903392|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
161686318|NCT00219284|583903391|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
161686319|NCT00219284|583903392|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
161686320|NCT00219284|583903391|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
161686321|NCT00219284|583903392|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
161834099|NCT01013649|584435555|FG000|First Step|Death|3|||
161834100|NCT01013649|584435556|FG001|First Step|Death|4|||
161686322|NCT05003622|583903393|FG000|Overall Study|Progressive disease|2|||
161686323|NCT05003622|583903393|FG000|Overall Study|Withdrawal by Subject|1|||
161686324|NCT01692275|583903394|FG000|Overall Study|Lost to Follow-up|57|||
161686325|NCT01692275|583903395|FG001|Overall Study|Lost to Follow-up|48|||
161834101|NCT01013649|584435557|FG002|First Step|Death|0|||
161834102|NCT01013649|584435558|FG003|First Step|Death|0|||
161834103|NCT01013649|584435555|FG000|First Step|Adverse Event|9|||
161834104|NCT01013649|584435556|FG001|First Step|Adverse Event|5|||
161686326|NCT01692275|583903394|FG000|Overall Study|Withdrawal by Subject|9|||
161686327|NCT01692275|583903395|FG001|Overall Study|Withdrawal by Subject|11|||
161686328|NCT05264740|583903403|FG000|Baseline|Withdrawal by Subject|0|||
161686329|NCT05264740|583903404|FG001|Baseline|Withdrawal by Subject|1|||
161686330|NCT05264740|583903403|FG000|Follow Up 1|Lost to Follow-up|1|||
161686331|NCT05264740|583903404|FG001|Follow Up 1|Lost to Follow-up|1|||
161686332|NCT05264740|583903403|FG000|Follow Up 1|Withdrawal by Subject|0|||
161686333|NCT05264740|583903404|FG001|Follow Up 1|Withdrawal by Subject|1|||
161686334|NCT05264740|583903403|FG000|Follow Up 2|Lost to Follow-up|1|||
161686335|NCT05264740|583903404|FG001|Follow Up 2|Lost to Follow-up|4|||
161686336|NCT05264740|583903403|FG000|Follow Up 3|Lost to Follow-up|7|||
161686337|NCT05264740|583903404|FG001|Follow Up 3|Lost to Follow-up|4|||
161686338|NCT02356562|583904802|FG000|Overall Study|Withdrawal by Subject|0|||
161686339|NCT02356562|583904803|FG001|Overall Study|Withdrawal by Subject|1|||
161686340|NCT02356562|583904802|FG000|Overall Study|Re-entered treatment in a previous study|1|||
161686341|NCT02356562|583904803|FG001|Overall Study|Re-entered treatment in a previous study|0|||
161686342|NCT02356562|583904802|FG000|Overall Study|site closure|1|||
161686343|NCT02356562|583904803|FG001|Overall Study|site closure|0|||
161686344|NCT00412750|583904804|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161686345|NCT00412750|583904805|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161686346|NCT00412750|583904806|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161686347|NCT00412750|583904804|FG000|Overall Study|Administrative problems|21|||
161686348|NCT00412750|583904805|FG001|Overall Study|Administrative problems|17|||
161686349|NCT00412750|583904806|FG002|Overall Study|Administrative problems|14|||
161686350|NCT00412750|583904804|FG000|Overall Study|Adverse Event|8|||
161686351|NCT00412750|583904805|FG001|Overall Study|Adverse Event|3|||
161686352|NCT00412750|583904806|FG002|Overall Study|Adverse Event|3|||
161686353|NCT00412750|583904804|FG000|Overall Study|Lost to Follow-up|1|||
161686354|NCT00412750|583904805|FG001|Overall Study|Lost to Follow-up|0|||
161686355|NCT00412750|583904806|FG002|Overall Study|Lost to Follow-up|1|||
161686356|NCT00412750|583904804|FG000|Overall Study|Withdrawal by Subject|0|||
161686357|NCT00412750|583904805|FG001|Overall Study|Withdrawal by Subject|1|||
161686358|NCT00412750|583904806|FG002|Overall Study|Withdrawal by Subject|2|||
161686359|NCT00412750|583904804|FG000|Overall Study|Lack of Efficacy|0|||
161686360|NCT00412750|583904805|FG001|Overall Study|Lack of Efficacy|0|||
161686361|NCT00412750|583904806|FG002|Overall Study|Lack of Efficacy|3|||
161686362|NCT01611974|583904813|FG000|Overall Study|Death|10|||
161686363|NCT01611974|583904814|FG001|Overall Study|Death|12|||
161686364|NCT01611974|583904815|FG002|Overall Study|Death|10|||
161686365|NCT01611974|583904813|FG000|Overall Study|Lost to Follow-up|0|||
161686366|NCT01611974|583904814|FG001|Overall Study|Lost to Follow-up|1|||
161686367|NCT01611974|583904815|FG002|Overall Study|Lost to Follow-up|0|||
161686368|NCT01611974|583904813|FG000|Overall Study|Physician Decision|5|||
161686369|NCT01611974|583904814|FG001|Overall Study|Physician Decision|1|||
161686370|NCT01611974|583904815|FG002|Overall Study|Physician Decision|2|||
161686371|NCT01611974|583904813|FG000|Overall Study|Withdrawal by Subject|0|||
161686372|NCT01611974|583904814|FG001|Overall Study|Withdrawal by Subject|1|||
161686373|NCT01611974|583904815|FG002|Overall Study|Withdrawal by Subject|4|||
161686374|NCT00522431|583904816|FG000|Overall Study|Adverse Event|5|||
161686375|NCT00522431|583904816|FG000|Overall Study|Protocol Violation|2|||
161686376|NCT00522431|583904816|FG000|Overall Study|Withdrawal by Subject|2|||
161686377|NCT00522431|583904816|FG000|Overall Study|Subject non-compliance|1|||
161686378|NCT00522431|583904816|FG000|Overall Study|Other/unknown|1|||
161686379|NCT00132132|583904817|FG000|Overall Study|Lost to Follow-up|7|||
161686380|NCT00132132|583904818|FG001|Overall Study|Lost to Follow-up|2|||
161686381|NCT03808077|583904819|FG000|Overall Study|Physician Decision|2|||
161686382|NCT03808077|583904820|FG001|Overall Study|Physician Decision|3|||
161686383|NCT03808077|583904819|FG000|Overall Study|Withdrawal by Subject|1|||
161686384|NCT03808077|583904820|FG001|Overall Study|Withdrawal by Subject|0|||
161686385|NCT03808077|583904819|FG000|Overall Study|Equipment Issues|2|||
161952487|NCT01791517|584876606|FG007|Phase I: Period 2|Lens Discomfort|0|||
161952488|NCT01791517|584876607|FG008|Phase I: Period 2|Lens Discomfort|0|||
161686386|NCT03808077|583904820|FG001|Overall Study|Equipment Issues|1|||
161686387|NCT00930761|583904825|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
161686388|NCT00930761|583904826|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
161686389|NCT00930761|583904825|FG000|Overall Study|less than 3 music therapy sessions|0|||
161686390|NCT00930761|583904826|FG001|Overall Study|less than 3 music therapy sessions|3|||
161686391|NCT00811135|583904827|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
161686392|NCT00811135|583904827|FG000|Overall Study|Death|3|||
161686393|NCT00811135|583904827|FG000|Overall Study|Protocol Violation|2|||
161686394|NCT00811135|583904827|FG000|Overall Study|Violation of Selection Criteria|1|||
161686395|NCT00811135|583904827|FG000|Overall Study|Refused Treatment|1|||
161686396|NCT00811135|583904827|FG000|Overall Study|Withdrawal by Subject|3|||
161686397|NCT00811135|583904827|FG000|Overall Study|Administrative/Other Unspecified|11|||
161686398|NCT00811135|583904827|FG000|Overall Study|Ongoing|59|||
161686399|NCT01118351|583904828|FG000|Overall Study|Adverse Event|3|||
161686400|NCT01118351|583904828|FG000|Overall Study|Withdrawal by Subject|1|||
161952489|NCT01791517|584876608|FG009|Phase I: Period 2|Lens Discomfort|0|||
161686401|NCT02192827|583904830|FG000|Overall Study|Lost to Follow-up|25|||
161686402|NCT02192827|583904831|FG001|Overall Study|Lost to Follow-up|27|||
161952490|NCT01791517|584876609|FG010|Phase I: Period 2|Lens Discomfort|0|||
161952491|NCT01791517|584876610|FG011|Phase I: Period 2|Lens Discomfort|0|||
161952492|NCT01791517|584876599|FG000|Phase I: Period 2|Lost to Follow-up|0|||
161952493|NCT01791517|584876600|FG001|Phase I: Period 2|Lost to Follow-up|3|||
161952494|NCT01791517|584876601|FG002|Phase I: Period 2|Lost to Follow-up|2|||
161952495|NCT01791517|584876602|FG003|Phase I: Period 2|Lost to Follow-up|0|||
161952496|NCT01791517|584876603|FG004|Phase I: Period 2|Lost to Follow-up|0|||
161952497|NCT01791517|584876604|FG005|Phase I: Period 2|Lost to Follow-up|0|||
161952498|NCT01791517|584876605|FG006|Phase I: Period 2|Lost to Follow-up|0|||
161952499|NCT01791517|584876606|FG007|Phase I: Period 2|Lost to Follow-up|0|||
161952500|NCT01791517|584876607|FG008|Phase I: Period 2|Lost to Follow-up|0|||
161952501|NCT01791517|584876608|FG009|Phase I: Period 2|Lost to Follow-up|0|||
161952502|NCT01791517|584876609|FG010|Phase I: Period 2|Lost to Follow-up|0|||
161952503|NCT01791517|584876610|FG011|Phase I: Period 2|Lost to Follow-up|0|||
161952504|NCT01791517|584876599|FG000|Phase I: Period 3|Lens Discomfort|0|||
162028805|NCT01227824|585161855|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
162028806|NCT01227824|585161856|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
162237155|NCT03333837|585919249|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
162237156|NCT03333837|585919250|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
162237157|NCT02232243|585919254|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
162237158|NCT02232243|585919255|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
162237159|NCT02232243|585919256|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
162237160|NCT00704405|585919257|FG000|Overall Study (NC Population)|Adverse Event|1|||
162237161|NCT00704405|585919258|FG001|Overall Study (NC Population)|Adverse Event|0|||
162237162|NCT00704405|585919259|FG002|Overall Study (NC Population)|Adverse Event|0|||
162237163|NCT00704405|585919260|FG003|Overall Study (NC Population)|Adverse Event|0|||
162237164|NCT00704405|585919261|FG004|Overall Study (NC Population)|Adverse Event|0|||
162237165|NCT00704405|585919257|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
162237166|NCT00704405|585919258|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
162237167|NCT00704405|585919259|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
162237168|NCT00704405|585919260|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
162237169|NCT00704405|585919261|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
162237170|NCT00704405|585919257|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
162237171|NCT00704405|585919258|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
162237172|NCT00704405|585919259|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
162237173|NCT00704405|585919260|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
162237174|NCT00704405|585919261|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
162237175|NCT00704405|585919257|FG000|Overall Study (NC Population)|Other|0|||
162237176|NCT00704405|585919258|FG001|Overall Study (NC Population)|Other|0|||
162237177|NCT00704405|585919259|FG002|Overall Study (NC Population)|Other|0|||
162237178|NCT00704405|585919260|FG003|Overall Study (NC Population)|Other|0|||
162237179|NCT00704405|585919261|FG004|Overall Study (NC Population)|Other|1|||
162237180|NCT00704405|585919257|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
162237181|NCT00704405|585919258|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
162237182|NCT00704405|585919259|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
162237183|NCT00704405|585919260|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
162237184|NCT00704405|585919261|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
162237185|NCT00704405|585919257|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
162237186|NCT00704405|585919258|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
162237187|NCT00704405|585919259|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
162237188|NCT00704405|585919260|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
162237189|NCT00704405|585919261|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
162237190|NCT02374671|585919262|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
162237191|NCT02374671|585919263|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
162237192|NCT02374671|585919264|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
162237193|NCT02374671|585919262|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
162237194|NCT02374671|585919263|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
162237195|NCT02374671|585919264|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
162237196|NCT02374671|585919262|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
162237197|NCT02374671|585919263|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
162237198|NCT02374671|585919264|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
162237199|NCT02374671|585919262|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
162237200|NCT02374671|585919263|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
162237201|NCT02374671|585919264|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
162237202|NCT02374671|585919262|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
162237203|NCT02374671|585919263|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
162237204|NCT02374671|585919264|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
161834105|NCT01013649|584435557|FG002|First Step|Adverse Event|0|||
161834106|NCT01013649|584435558|FG003|First Step|Adverse Event|0|||
161834107|NCT01013649|584435555|FG000|First Step|Other|4|||
161834108|NCT01013649|584435556|FG001|First Step|Other|6|||
161834109|NCT01013649|584435557|FG002|First Step|Other|0|||
161834110|NCT01013649|584435558|FG003|First Step|Other|0|||
161834111|NCT01647958|584435559|FG000|Initial Study|Lost to Follow-up|2|||
161834112|NCT01647958|584435560|FG001|Initial Study|Lost to Follow-up|3|||
161834113|NCT01647958|584435559|FG000|Continuation Phase|treatment received during Overall Study|39|||
161834114|NCT01647958|584435560|FG001|Continuation Phase|treatment received during Overall Study|0|||
161834115|NCT01647958|584435559|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
161834116|NCT01647958|584435560|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
161834117|NCT01131299|584435561|FG000|Overall Study|Withdrawal by Subject|4|||
161834118|NCT01131299|584435562|FG001|Overall Study|Withdrawal by Subject|7|||
161834119|NCT01207440|584435570|FG000|Overall Study|Adverse Event|46|||
161834120|NCT01207440|584435571|FG001|Overall Study|Adverse Event|11|||
161834121|NCT01207440|584435572|FG002|Overall Study|Adverse Event|7|||
161834122|NCT01207440|584435573|FG003|Overall Study|Adverse Event|2|||
161834123|NCT01207440|584435574|FG004|Overall Study|Adverse Event|6|||
161834124|NCT01207440|584435575|FG005|Overall Study|Adverse Event|6|||
161834125|NCT01207440|584435576|FG006|Overall Study|Adverse Event|2|||
161834126|NCT01207440|584435570|FG000|Overall Study|Death|6|||
161834127|NCT01207440|584435571|FG001|Overall Study|Death|3|||
161834128|NCT01207440|584435572|FG002|Overall Study|Death|2|||
161834129|NCT01207440|584435573|FG003|Overall Study|Death|2|||
161834130|NCT01207440|584435574|FG004|Overall Study|Death|7|||
161834131|NCT01207440|584435575|FG005|Overall Study|Death|5|||
161834132|NCT01207440|584435576|FG006|Overall Study|Death|1|||
161834133|NCT01207440|584435570|FG000|Overall Study|Lack of Efficacy|13|||
161834134|NCT01207440|584435571|FG001|Overall Study|Lack of Efficacy|2|||
161834135|NCT01207440|584435572|FG002|Overall Study|Lack of Efficacy|5|||
161834136|NCT01207440|584435573|FG003|Overall Study|Lack of Efficacy|1|||
161834137|NCT01207440|584435574|FG004|Overall Study|Lack of Efficacy|2|||
161834138|NCT01207440|584435575|FG005|Overall Study|Lack of Efficacy|3|||
161952505|NCT01791517|584876600|FG001|Phase I: Period 3|Lens Discomfort|0|||
161952506|NCT01791517|584876601|FG002|Phase I: Period 3|Lens Discomfort|0|||
161952507|NCT01791517|584876602|FG003|Phase I: Period 3|Lens Discomfort|0|||
161952508|NCT01791517|584876603|FG004|Phase I: Period 3|Lens Discomfort|0|||
161686403|NCT02192827|583904830|FG000|Overall Study|Given additional steroids with admission|13|||
161834139|NCT01207440|584435576|FG006|Overall Study|Lack of Efficacy|0|||
161952509|NCT01791517|584876604|FG005|Phase I: Period 3|Lens Discomfort|0|||
161686404|NCT02192827|583904831|FG001|Overall Study|Given additional steroids with admission|11|||
161834140|NCT01207440|584435570|FG000|Overall Study|Lost to Follow-up|0|||
161834141|NCT01207440|584435571|FG001|Overall Study|Lost to Follow-up|0|||
161834142|NCT01207440|584435572|FG002|Overall Study|Lost to Follow-up|2|||
161834143|NCT01207440|584435573|FG003|Overall Study|Lost to Follow-up|1|||
161834144|NCT01207440|584435574|FG004|Overall Study|Lost to Follow-up|0|||
161834145|NCT01207440|584435575|FG005|Overall Study|Lost to Follow-up|0|||
161834146|NCT01207440|584435576|FG006|Overall Study|Lost to Follow-up|0|||
161952510|NCT01791517|584876605|FG006|Phase I: Period 3|Lens Discomfort|0|||
161834147|NCT01207440|584435570|FG000|Overall Study|Non-compliance with Study Drug|3|||
161834148|NCT01207440|584435571|FG001|Overall Study|Non-compliance with Study Drug|0|||
161952511|NCT01791517|584876606|FG007|Phase I: Period 3|Lens Discomfort|0|||
161834149|NCT01207440|584435572|FG002|Overall Study|Non-compliance with Study Drug|1|||
161952512|NCT01791517|584876607|FG008|Phase I: Period 3|Lens Discomfort|0|||
161952513|NCT01791517|584876608|FG009|Phase I: Period 3|Lens Discomfort|0|||
161952514|NCT01791517|584876609|FG010|Phase I: Period 3|Lens Discomfort|0|||
161952515|NCT01791517|584876610|FG011|Phase I: Period 3|Lens Discomfort|1|||
161952516|NCT01791517|584876599|FG000|Phase I: Period 3|Lost to Follow-up|0|||
161952517|NCT01791517|584876600|FG001|Phase I: Period 3|Lost to Follow-up|1|||
161952518|NCT01791517|584876601|FG002|Phase I: Period 3|Lost to Follow-up|0|||
161952519|NCT01791517|584876602|FG003|Phase I: Period 3|Lost to Follow-up|0|||
161952520|NCT01791517|584876603|FG004|Phase I: Period 3|Lost to Follow-up|1|||
161952521|NCT01791517|584876604|FG005|Phase I: Period 3|Lost to Follow-up|0|||
161952522|NCT01791517|584876605|FG006|Phase I: Period 3|Lost to Follow-up|0|||
161952523|NCT01791517|584876606|FG007|Phase I: Period 3|Lost to Follow-up|0|||
161952524|NCT01791517|584876607|FG008|Phase I: Period 3|Lost to Follow-up|0|||
161952525|NCT01791517|584876608|FG009|Phase I: Period 3|Lost to Follow-up|0|||
161952526|NCT01791517|584876609|FG010|Phase I: Period 3|Lost to Follow-up|0|||
161952527|NCT01791517|584876610|FG011|Phase I: Period 3|Lost to Follow-up|0|||
161952528|NCT01791517|584876599|FG000|Phase I: Period 3|Adverse Event|0|||
161952529|NCT01791517|584876600|FG001|Phase I: Period 3|Adverse Event|0|||
161952530|NCT01791517|584876601|FG002|Phase I: Period 3|Adverse Event|0|||
161952531|NCT01791517|584876602|FG003|Phase I: Period 3|Adverse Event|1|||
161952532|NCT01791517|584876603|FG004|Phase I: Period 3|Adverse Event|0|||
161952533|NCT01791517|584876604|FG005|Phase I: Period 3|Adverse Event|0|||
161952534|NCT01791517|584876605|FG006|Phase I: Period 3|Adverse Event|0|||
161952535|NCT01791517|584876606|FG007|Phase I: Period 3|Adverse Event|0|||
161952536|NCT01791517|584876607|FG008|Phase I: Period 3|Adverse Event|0|||
161952537|NCT01791517|584876608|FG009|Phase I: Period 3|Adverse Event|0|||
161952538|NCT01791517|584876609|FG010|Phase I: Period 3|Adverse Event|0|||
161952539|NCT01791517|584876610|FG011|Phase I: Period 3|Adverse Event|0|||
161952540|NCT01791517|584876599|FG000|Phase II|Lost to Follow-up|1|||
161952541|NCT01791517|584876600|FG001|Phase II|Lost to Follow-up|0|||
161952542|NCT01791517|584876601|FG002|Phase II|Lost to Follow-up|1|||
161952543|NCT01791517|584876602|FG003|Phase II|Lost to Follow-up|0|||
161952544|NCT01791517|584876603|FG004|Phase II|Lost to Follow-up|1|||
161952545|NCT01791517|584876604|FG005|Phase II|Lost to Follow-up|2|||
161952546|NCT01791517|584876605|FG006|Phase II|Lost to Follow-up|0|||
161952547|NCT01791517|584876606|FG007|Phase II|Lost to Follow-up|1|||
161952548|NCT01791517|584876607|FG008|Phase II|Lost to Follow-up|1|||
161952549|NCT01791517|584876608|FG009|Phase II|Lost to Follow-up|1|||
161952550|NCT01791517|584876609|FG010|Phase II|Lost to Follow-up|0|||
161952551|NCT01791517|584876610|FG011|Phase II|Lost to Follow-up|0|||
161952552|NCT01791517|584876599|FG000|Phase II|Withdrawal by Subject|1|||
161952553|NCT01791517|584876600|FG001|Phase II|Withdrawal by Subject|0|||
161952554|NCT01791517|584876601|FG002|Phase II|Withdrawal by Subject|0|||
161952555|NCT01791517|584876602|FG003|Phase II|Withdrawal by Subject|0|||
161952556|NCT01791517|584876603|FG004|Phase II|Withdrawal by Subject|0|||
161952557|NCT01791517|584876604|FG005|Phase II|Withdrawal by Subject|2|||
161952558|NCT01791517|584876605|FG006|Phase II|Withdrawal by Subject|0|||
161952559|NCT01791517|584876606|FG007|Phase II|Withdrawal by Subject|1|||
161952560|NCT01791517|584876607|FG008|Phase II|Withdrawal by Subject|0|||
161952561|NCT01791517|584876608|FG009|Phase II|Withdrawal by Subject|0|||
161952562|NCT01791517|584876609|FG010|Phase II|Withdrawal by Subject|1|||
161952563|NCT01791517|584876610|FG011|Phase II|Withdrawal by Subject|0|||
161952564|NCT01791517|584876599|FG000|Phase II|Lack of Efficacy|0|||
161952565|NCT01791517|584876600|FG001|Phase II|Lack of Efficacy|0|||
161952566|NCT01791517|584876601|FG002|Phase II|Lack of Efficacy|0|||
161952567|NCT01791517|584876602|FG003|Phase II|Lack of Efficacy|0|||
161952568|NCT01791517|584876603|FG004|Phase II|Lack of Efficacy|1|||
161952569|NCT01791517|584876604|FG005|Phase II|Lack of Efficacy|0|||
161952570|NCT01791517|584876605|FG006|Phase II|Lack of Efficacy|0|||
161952571|NCT01791517|584876606|FG007|Phase II|Lack of Efficacy|0|||
161952572|NCT01791517|584876607|FG008|Phase II|Lack of Efficacy|0|||
161952573|NCT01791517|584876608|FG009|Phase II|Lack of Efficacy|0|||
161952574|NCT01791517|584876609|FG010|Phase II|Lack of Efficacy|0|||
161952575|NCT01791517|584876610|FG011|Phase II|Lack of Efficacy|0|||
161952576|NCT01791517|584876599|FG000|Phase II|Adverse Event|0|||
161952577|NCT01791517|584876600|FG001|Phase II|Adverse Event|0|||
161952578|NCT01791517|584876601|FG002|Phase II|Adverse Event|0|||
161952579|NCT01791517|584876602|FG003|Phase II|Adverse Event|0|||
161952580|NCT01791517|584876603|FG004|Phase II|Adverse Event|0|||
161952581|NCT01791517|584876604|FG005|Phase II|Adverse Event|0|||
161952582|NCT01791517|584876605|FG006|Phase II|Adverse Event|2|||
161952583|NCT01791517|584876606|FG007|Phase II|Adverse Event|1|||
161952584|NCT01791517|584876607|FG008|Phase II|Adverse Event|0|||
161952585|NCT01791517|584876608|FG009|Phase II|Adverse Event|1|||
161952586|NCT01791517|584876609|FG010|Phase II|Adverse Event|0|||
161952587|NCT01791517|584876610|FG011|Phase II|Adverse Event|0|||
161952588|NCT01791517|584876599|FG000|Phase II|Lens Handling Difficulties|0|||
161952589|NCT01791517|584876600|FG001|Phase II|Lens Handling Difficulties|0|||
161952590|NCT01791517|584876601|FG002|Phase II|Lens Handling Difficulties|0|||
161952591|NCT01791517|584876602|FG003|Phase II|Lens Handling Difficulties|0|||
161952592|NCT01791517|584876603|FG004|Phase II|Lens Handling Difficulties|0|||
161952593|NCT01791517|584876604|FG005|Phase II|Lens Handling Difficulties|0|||
161952594|NCT01791517|584876605|FG006|Phase II|Lens Handling Difficulties|0|||
161952595|NCT01791517|584876606|FG007|Phase II|Lens Handling Difficulties|0|||
161952596|NCT01791517|584876607|FG008|Phase II|Lens Handling Difficulties|1|||
161952597|NCT01791517|584876608|FG009|Phase II|Lens Handling Difficulties|0|||
161952598|NCT01791517|584876609|FG010|Phase II|Lens Handling Difficulties|0|||
161952599|NCT01791517|584876610|FG011|Phase II|Lens Handling Difficulties|0|||
161952600|NCT01791517|584876599|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
161952601|NCT01791517|584876600|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
161952602|NCT01791517|584876601|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
161686405|NCT03699007|583904834|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
161686406|NCT03699007|583904835|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
161686407|NCT03699007|583904834|FG000|6-month Follow Up|Lost to Follow-up|2|||
161686408|NCT03699007|583904835|FG001|6-month Follow Up|Lost to Follow-up|3|||
161686409|NCT01970995|583904836|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
161686410|NCT01970995|583904837|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
161686411|NCT01970995|583904838|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
161686412|NCT01970995|583904836|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
161686413|NCT01970995|583904837|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
161952603|NCT01791517|584876602|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
161952604|NCT01791517|584876603|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
161952605|NCT01791517|584876604|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
161952606|NCT01791517|584876605|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
161952607|NCT01791517|584876606|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
161952608|NCT01791517|584876607|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
161952609|NCT01791517|584876608|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
161952610|NCT01791517|584876609|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
161952611|NCT01791517|584876610|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
161952612|NCT01791517|584876599|FG000|Phase II|Pre-Existing Ocular Issue|0|||
161952613|NCT01791517|584876600|FG001|Phase II|Pre-Existing Ocular Issue|0|||
161952614|NCT01791517|584876601|FG002|Phase II|Pre-Existing Ocular Issue|0|||
161952615|NCT01791517|584876602|FG003|Phase II|Pre-Existing Ocular Issue|0|||
161952616|NCT01791517|584876603|FG004|Phase II|Pre-Existing Ocular Issue|0|||
161952617|NCT01791517|584876604|FG005|Phase II|Pre-Existing Ocular Issue|0|||
161952618|NCT01791517|584876605|FG006|Phase II|Pre-Existing Ocular Issue|0|||
161952619|NCT01791517|584876606|FG007|Phase II|Pre-Existing Ocular Issue|0|||
161952620|NCT01791517|584876607|FG008|Phase II|Pre-Existing Ocular Issue|0|||
161952621|NCT01791517|584876608|FG009|Phase II|Pre-Existing Ocular Issue|0|||
161952622|NCT01791517|584876609|FG010|Phase II|Pre-Existing Ocular Issue|0|||
161952623|NCT01791517|584876610|FG011|Phase II|Pre-Existing Ocular Issue|1|||
161952624|NCT00589797|584876611|FG000|Overall Study|Death|1|||
161952625|NCT00589797|584876612|FG001|Overall Study|Death|0|||
161952626|NCT00589797|584876611|FG000|Overall Study|Lost to Follow-up|12|||
161952627|NCT00589797|584876612|FG001|Overall Study|Lost to Follow-up|9|||
161952628|NCT00589797|584876611|FG000|Overall Study|Physician Decision|8|||
161952629|NCT00589797|584876612|FG001|Overall Study|Physician Decision|3|||
161952630|NCT00589797|584876611|FG000|Overall Study|Withdrawal by Subject|6|||
161952631|NCT00589797|584876612|FG001|Overall Study|Withdrawal by Subject|5|||
161952632|NCT00589797|584876611|FG000|Overall Study|Non-Randomized Training Subjects|46|||
162237205|NCT03169101|585919268|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
162237206|NCT03169101|585919269|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
162237207|NCT03169101|585919270|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
162237208|NCT03169101|585919271|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
162237209|NCT02641496|585919272|FG000|Overall Study|Lost to Follow-up|13|||
162237210|NCT02641496|585919273|FG001|Overall Study|Lost to Follow-up|12|||
162237211|NCT02641496|585919272|FG000|Overall Study|Withdrawal by Subject|1|||
162237212|NCT02641496|585919273|FG001|Overall Study|Withdrawal by Subject|0|||
162237213|NCT01912456|585921036|FG000|Period 1|Physician Decision|0|||
162237214|NCT01912456|585921037|FG001|Period 1|Physician Decision|0|||
162237215|NCT01912456|585921038|FG002|Period 1|Physician Decision|1|||
162237216|NCT01912456|585921039|FG003|Period 1|Physician Decision|0|||
162237217|NCT01912456|585921036|FG000|Period 1|non-compliance|1|||
162237218|NCT01912456|585921037|FG001|Period 1|non-compliance|0|||
162237219|NCT01912456|585921038|FG002|Period 1|non-compliance|0|||
162237220|NCT01912456|585921039|FG003|Period 1|non-compliance|1|||
162237221|NCT01912456|585921036|FG000|Period 1|Adverse Event|1|||
162237222|NCT01912456|585921037|FG001|Period 1|Adverse Event|0|||
162237223|NCT01912456|585921038|FG002|Period 1|Adverse Event|0|||
162237224|NCT01912456|585921039|FG003|Period 1|Adverse Event|1|||
162237225|NCT01912456|585921036|FG000|Period 1|Withdrawal by Subject|0|||
162237226|NCT01912456|585921037|FG001|Period 1|Withdrawal by Subject|1|||
162237227|NCT01912456|585921038|FG002|Period 1|Withdrawal by Subject|1|||
162237228|NCT01912456|585921039|FG003|Period 1|Withdrawal by Subject|1|||
162237229|NCT01912456|585921036|FG000|Period 2|Lack of Efficacy|0|||
162237230|NCT01912456|585921037|FG001|Period 2|Lack of Efficacy|2|||
162237231|NCT01912456|585921038|FG002|Period 2|Lack of Efficacy|0|||
162237232|NCT01912456|585921039|FG003|Period 2|Lack of Efficacy|0|||
162237233|NCT01912456|585921036|FG000|Period 2|Adverse Event|0|||
162237234|NCT01912456|585921037|FG001|Period 2|Adverse Event|0|||
161686414|NCT01970995|583904838|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
161686415|NCT01709435|583904839|FG000|Overall Study|Adverse Event|1|||
161686416|NCT01709435|583904840|FG001|Overall Study|Adverse Event|1|||
161686417|NCT01709435|583904841|FG002|Overall Study|Adverse Event|1|||
161686418|NCT01709435|583904842|FG003|Overall Study|Adverse Event|0|||
161686419|NCT01709435|583904843|FG004|Overall Study|Adverse Event|0|||
161686420|NCT01709435|583904844|FG005|Overall Study|Adverse Event|1|||
161686421|NCT01709435|583904839|FG000|Overall Study|Lack of Efficacy|5|||
161686422|NCT01709435|583904840|FG001|Overall Study|Lack of Efficacy|7|||
161686423|NCT01709435|583904841|FG002|Overall Study|Lack of Efficacy|2|||
161686424|NCT01709435|583904842|FG003|Overall Study|Lack of Efficacy|2|||
161686425|NCT01709435|583904843|FG004|Overall Study|Lack of Efficacy|6|||
161686426|NCT01709435|583904844|FG005|Overall Study|Lack of Efficacy|3|||
161686427|NCT01709435|583904839|FG000|Overall Study|Physician Decision|0|||
161686428|NCT01709435|583904840|FG001|Overall Study|Physician Decision|1|||
161686429|NCT01709435|583904841|FG002|Overall Study|Physician Decision|0|||
161686430|NCT01709435|583904842|FG003|Overall Study|Physician Decision|1|||
161686431|NCT01709435|583904843|FG004|Overall Study|Physician Decision|2|||
161686432|NCT01709435|583904844|FG005|Overall Study|Physician Decision|0|||
161686433|NCT01709435|583904839|FG000|Overall Study|Withdrawal by Subject|0|||
161686434|NCT01709435|583904840|FG001|Overall Study|Withdrawal by Subject|0|||
161686435|NCT01709435|583904841|FG002|Overall Study|Withdrawal by Subject|3|||
161686436|NCT01709435|583904842|FG003|Overall Study|Withdrawal by Subject|0|||
161686437|NCT01709435|583904843|FG004|Overall Study|Withdrawal by Subject|2|||
161686438|NCT01709435|583904844|FG005|Overall Study|Withdrawal by Subject|2|||
161686439|NCT01263639|583904845|FG000|Overall Study|Lost to Follow-up|66|||
161686440|NCT01263639|583904846|FG001|Overall Study|Lost to Follow-up|70|||
161686441|NCT01263639|583904845|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
161952633|NCT00589797|584876612|FG001|Overall Study|Non-Randomized Training Subjects|6|||
161952634|NCT02141672|584876614|FG000|Overall Study|Adverse Event|0|||
161952635|NCT02141672|584876615|FG001|Overall Study|Adverse Event|1|||
161952636|NCT02141672|584876616|FG002|Overall Study|Adverse Event|0|||
161952637|NCT02141672|584876614|FG000|Overall Study|Death|10|||
161952638|NCT02141672|584876615|FG001|Overall Study|Death|2|||
161952639|NCT02141672|584876616|FG002|Overall Study|Death|1|||
161952640|NCT02141672|584876614|FG000|Overall Study|Lack of Efficacy|0|||
161952641|NCT02141672|584876615|FG001|Overall Study|Lack of Efficacy|0|||
161952642|NCT02141672|584876616|FG002|Overall Study|Lack of Efficacy|2|||
161686442|NCT01263639|583904846|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
161686443|NCT01780662|583904847|FG000|Overall Study|Adverse Event|1|||
161686444|NCT01780662|583904848|FG001|Overall Study|Adverse Event|0|||
161952643|NCT02141672|584876614|FG000|Overall Study|Lost to Follow-up|1|||
161952644|NCT02141672|584876615|FG001|Overall Study|Lost to Follow-up|1|||
161686445|NCT01780662|583904849|FG002|Overall Study|Adverse Event|2|||
161686446|NCT01780662|583904847|FG000|Overall Study|Physician Decision|0|||
161686447|NCT01780662|583904848|FG001|Overall Study|Physician Decision|5|||
161686448|NCT01780662|583904849|FG002|Overall Study|Physician Decision|7|||
161686449|NCT01780662|583904847|FG000|Overall Study|Protocol Violation|0|||
161686450|NCT01780662|583904848|FG001|Overall Study|Protocol Violation|1|||
161686451|NCT01780662|583904849|FG002|Overall Study|Protocol Violation|0|||
161686452|NCT01780662|583904847|FG000|Overall Study|Ineligible|0|||
161952645|NCT02141672|584876616|FG002|Overall Study|Lost to Follow-up|3|||
161952646|NCT02141672|584876614|FG000|Overall Study|Physician Decision|1|||
161952647|NCT02141672|584876615|FG001|Overall Study|Physician Decision|2|||
161952648|NCT02141672|584876616|FG002|Overall Study|Physician Decision|5|||
161952649|NCT02141672|584876614|FG000|Overall Study|Protocol Violation|0|||
161952650|NCT02141672|584876615|FG001|Overall Study|Protocol Violation|0|||
161952651|NCT02141672|584876616|FG002|Overall Study|Protocol Violation|1|||
161952652|NCT02141672|584876614|FG000|Overall Study|Withdrawal by Subject|3|||
161952653|NCT02141672|584876615|FG001|Overall Study|Withdrawal by Subject|2|||
161952654|NCT02141672|584876616|FG002|Overall Study|Withdrawal by Subject|5|||
161952655|NCT02141672|584876614|FG000|Overall Study|refused to follow-up|1|||
161952656|NCT02141672|584876615|FG001|Overall Study|refused to follow-up|0|||
161952657|NCT02141672|584876616|FG002|Overall Study|refused to follow-up|1|||
161952658|NCT02688192|584876617|FG000|Overall Study|Lost to Follow-up|11|||
161952659|NCT02688192|584876618|FG001|Overall Study|Lost to Follow-up|5|||
161952660|NCT02688192|584876617|FG000|Overall Study|Physician Decision|1|||
161952661|NCT02688192|584876618|FG001|Overall Study|Physician Decision|0|||
161952662|NCT02010593|584876619|FG000|Overall Study|Lost to Follow-up|1|||
161952663|NCT02010593|584876620|FG001|Overall Study|Lost to Follow-up|0|||
161952664|NCT02010593|584876619|FG000|Overall Study|Physician Decision|1|||
161952665|NCT02010593|584876620|FG001|Overall Study|Physician Decision|0|||
162028807|NCT01227824|585161854|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
162028808|NCT01227824|585161855|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
162028809|NCT01227824|585161856|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
161952666|NCT02010593|584876619|FG000|Overall Study|Unable to adhere to visit schedule|0|||
161952667|NCT02010593|584876620|FG001|Overall Study|Unable to adhere to visit schedule|2|||
161952668|NCT01773967|584876621|FG000|Overall Study|Lost to Follow-up|15|||
161952669|NCT01773967|584876622|FG001|Overall Study|Lost to Follow-up|13|||
161952670|NCT00579553|584876630|FG000|Overall Study|Lost to Follow-up|16|||
161952671|NCT00579553|584876631|FG001|Overall Study|Lost to Follow-up|13|||
161952672|NCT04860869|584876636|FG000|Overall Study|Withdrawal by Subject|1|||
162237235|NCT01912456|585921038|FG002|Period 2|Adverse Event|0|||
162237236|NCT01912456|585921039|FG003|Period 2|Adverse Event|1|||
162237237|NCT01340196|585921040|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
162237238|NCT00171704|585921046|FG000|Overall Study|Adverse Event|24|||
162237239|NCT00171704|585921047|FG001|Overall Study|Adverse Event|33|||
162237240|NCT00171704|585921046|FG000|Overall Study|Disease Progression|14|||
162237241|NCT00171704|585921047|FG001|Overall Study|Disease Progression|9|||
162237242|NCT00171704|585921046|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
162237243|NCT00171704|585921047|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
162237244|NCT00171704|585921046|FG000|Overall Study|Administrative Problems|2|||
162237245|NCT00171704|585921047|FG001|Overall Study|Administrative Problems|1|||
162237246|NCT00171704|585921046|FG000|Overall Study|Death|2|||
162237247|NCT00171704|585921047|FG001|Overall Study|Death|2|||
162237248|NCT00171704|585921046|FG000|Overall Study|Withdrawal by Subject|1|||
162237249|NCT00171704|585921047|FG001|Overall Study|Withdrawal by Subject|3|||
162237250|NCT00171704|585921046|FG000|Overall Study|Protocol Violation|0|||
162237251|NCT00171704|585921047|FG001|Overall Study|Protocol Violation|1|||
162237252|NCT00320541|585921051|FG000|Overall Study|Adverse Event|21|||
162237253|NCT00320541|585921052|FG001|Overall Study|Adverse Event|19|||
162237254|NCT00320541|585921051|FG000|Overall Study|Protocol Violation|0|||
162237255|NCT00320541|585921052|FG001|Overall Study|Protocol Violation|1|||
162237256|NCT00320541|585921051|FG000|Overall Study|Withdrawal by Subject|12|||
162237257|NCT00320541|585921052|FG001|Overall Study|Withdrawal by Subject|16|||
162237258|NCT00320541|585921051|FG000|Overall Study|Physician Decision|9|||
162237259|NCT00320541|585921052|FG001|Overall Study|Physician Decision|13|||
162237260|NCT00320541|585921051|FG000|Overall Study|Other|3|||
162237261|NCT00320541|585921052|FG001|Overall Study|Other|4|||
162237262|NCT00320541|585921051|FG000|Overall Study|Sponsor Decision|2|||
162237263|NCT00320541|585921052|FG001|Overall Study|Sponsor Decision|1|||
162237264|NCT00320541|585921051|FG000|Overall Study|Death due to Study Disease|1|||
162237265|NCT00320541|585921052|FG001|Overall Study|Death due to Study Disease|3|||
162237266|NCT00320541|585921051|FG000|Overall Study|Death due to Adverse Event(s)|1|||
162237267|NCT00320541|585921052|FG001|Overall Study|Death due to Adverse Event(s)|0|||
161686453|NCT01780662|583904848|FG001|Overall Study|Ineligible|0|||
162237268|NCT00320541|585921051|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
162237269|NCT00320541|585921052|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
162237270|NCT00655486|585921055|FG000|Overall Study|Adverse Event|10|||
162237271|NCT00655486|585921055|FG000|Overall Study|Lack of Efficacy|8|||
162237272|NCT00655486|585921055|FG000|Overall Study|Withdrawal by Subject|4|||
162237273|NCT00655486|585921055|FG000|Overall Study|Protocol Violation|1|||
162237274|NCT00655486|585921055|FG000|Overall Study|Unsatisfactory compliance|2|||
161952673|NCT04860869|584876637|FG001|Overall Study|Withdrawal by Subject|0|||
161952674|NCT02651116|584876638|FG000|Overall Study|Adverse Event|0|||
161952675|NCT02651116|584876639|FG001|Overall Study|Adverse Event|1|||
161952676|NCT02651116|584876638|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
161952677|NCT02651116|584876639|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
161952678|NCT01775553|584876640|FG000|Overall Study|Adverse Event|1|||
161952679|NCT01775553|584876640|FG000|Overall Study|Disease Progression|12|||
161952680|NCT02803203|584876648|FG000|Overall Study|Adverse Event|4|||
161952681|NCT02803203|584876648|FG000|Overall Study|Death|4|||
161952682|NCT02803203|584876648|FG000|Overall Study|Progressive disease|29|||
161952683|NCT02803203|584876648|FG000|Overall Study|Withdrawal by Subject|8|||
161952684|NCT02803203|584876648|FG000|Overall Study|Complete resection of target disease|2|||
161952685|NCT02803203|584876648|FG000|Overall Study|Switched to commercial Osi|1|||
161952686|NCT02803203|584876648|FG000|Overall Study|Participant moved away|1|||
161952687|NCT01881789|584876649|FG000|Overall Study|Withdrawal by Subject|0|||
161952688|NCT01881789|584876650|FG001|Overall Study|Withdrawal by Subject|2|||
161952689|NCT01881789|584876651|FG002|Overall Study|Withdrawal by Subject|1|||
161952690|NCT01881789|584876652|FG003|Overall Study|Withdrawal by Subject|0|||
161952691|NCT01881789|584876653|FG004|Overall Study|Withdrawal by Subject|1|||
161952692|NCT01881789|584876654|FG005|Overall Study|Withdrawal by Subject|1|||
161952693|NCT01881789|584876649|FG000|Overall Study|Study Terminated by Sponsor|0|||
161952694|NCT01881789|584876650|FG001|Overall Study|Study Terminated by Sponsor|0|||
161952695|NCT01881789|584876651|FG002|Overall Study|Study Terminated by Sponsor|0|||
161952696|NCT01881789|584876652|FG003|Overall Study|Study Terminated by Sponsor|0|||
161952697|NCT01881789|584876653|FG004|Overall Study|Study Terminated by Sponsor|0|||
161952698|NCT01881789|584876654|FG005|Overall Study|Study Terminated by Sponsor|1|||
161952699|NCT01881789|584876649|FG000|Overall Study|Other|3|||
161952700|NCT01881789|584876650|FG001|Overall Study|Other|5|||
161952701|NCT01881789|584876651|FG002|Overall Study|Other|2|||
161952702|NCT01881789|584876652|FG003|Overall Study|Other|3|||
161952703|NCT01881789|584876653|FG004|Overall Study|Other|1|||
161952704|NCT01881789|584876654|FG005|Overall Study|Other|1|||
161952705|NCT01887717|584876655|FG000|Overall Study|Withdrawal by Subject|1|||
161952706|NCT01887717|584876656|FG001|Overall Study|Withdrawal by Subject|7|||
161952707|NCT01887717|584876655|FG000|Overall Study|Physician Decision|0|||
161952708|NCT01887717|584876656|FG001|Overall Study|Physician Decision|2|||
161952709|NCT01887717|584876655|FG000|Overall Study|Administrative reasons|5|||
161952710|NCT01887717|584876656|FG001|Overall Study|Administrative reasons|2|||
161952711|NCT00920556|584876659|FG000|Overall Study|Adverse Event|16|||
161952712|NCT00920556|584876659|FG000|Overall Study|Physician Decision|7|||
161952713|NCT00920556|584876659|FG000|Overall Study|Withdrawal by Subject|1|||
161952714|NCT01299389|584876660|FG000|Double-blind|Adverse Event|45|||
161952715|NCT01299389|584876661|FG001|Double-blind|Adverse Event|27|||
161952716|NCT01299389|584876662|FG002|Double-blind|Adverse Event|0|||
161952717|NCT01299389|584876663|FG003|Double-blind|Adverse Event|0|||
161952718|NCT01299389|584876660|FG000|Double-blind|Lack of Efficacy|45|||
161952719|NCT01299389|584876661|FG001|Double-blind|Lack of Efficacy|21|||
161952720|NCT01299389|584876662|FG002|Double-blind|Lack of Efficacy|0|||
161952721|NCT01299389|584876663|FG003|Double-blind|Lack of Efficacy|0|||
161952722|NCT01299389|584876660|FG000|Double-blind|Lost to Follow-up|2|||
161952723|NCT01299389|584876661|FG001|Double-blind|Lost to Follow-up|1|||
161952724|NCT01299389|584876662|FG002|Double-blind|Lost to Follow-up|0|||
161952725|NCT01299389|584876663|FG003|Double-blind|Lost to Follow-up|0|||
161952726|NCT01299389|584876660|FG000|Double-blind|Withdrawal by Subject|16|||
161952727|NCT01299389|584876661|FG001|Double-blind|Withdrawal by Subject|13|||
161952728|NCT01299389|584876662|FG002|Double-blind|Withdrawal by Subject|0|||
161952729|NCT01299389|584876663|FG003|Double-blind|Withdrawal by Subject|0|||
161952730|NCT01299389|584876660|FG000|Double-blind|Other|1|||
161952731|NCT01299389|584876661|FG001|Double-blind|Other|1|||
161952732|NCT01299389|584876662|FG002|Double-blind|Other|0|||
161952733|NCT01299389|584876663|FG003|Double-blind|Other|0|||
162028810|NCT01227824|585161854|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
162028811|NCT01227824|585161855|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
162028812|NCT01227824|585161856|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
161952734|NCT01299389|584876660|FG000|Double-blind|"fail to meet study population criteria"|0|||
161952735|NCT01299389|584876661|FG001|Double-blind|"fail to meet study population criteria"|1|||
161952736|NCT01299389|584876662|FG002|Double-blind|"fail to meet study population criteria"|0|||
161952737|NCT01299389|584876663|FG003|Double-blind|"fail to meet study population criteria"|0|||
161952738|NCT01299389|584876660|FG000|Post-observational|Other|0|||
161952739|NCT01299389|584876661|FG001|Post-observational|Other|0|||
161952740|NCT01299389|584876662|FG002|Post-observational|Other|12|||
161952741|NCT01299389|584876663|FG003|Post-observational|Other|6|||
161952742|NCT02834819|584876664|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
161952743|NCT02834819|584876665|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
161952744|NCT02185534|584876666|FG000|First Period|Withdrawal by Subject|0|||
161686454|NCT01780662|583904849|FG002|Overall Study|Ineligible|1|||
161686455|NCT03975920|583904850|FG000|Overall Study|Lost to Follow-up|1|||
161686456|NCT03975920|583904851|FG001|Overall Study|Lost to Follow-up|2|||
161686457|NCT03975920|583904850|FG000|Overall Study|Protocol Violation|1|||
161686458|NCT03975920|583904851|FG001|Overall Study|Protocol Violation|1|||
161686459|NCT03975920|583904850|FG000|Overall Study|Did not complete survey|2|||
161686460|NCT03975920|583904851|FG001|Overall Study|Did not complete survey|1|||
161686461|NCT03882970|583904852|FG000|Overall Study|Adverse Event|5|||
161686462|NCT03882970|583904853|FG001|Overall Study|Adverse Event|7|||
161952745|NCT02185534|584876667|FG001|First Period|Withdrawal by Subject|0|||
161952746|NCT02185534|584876668|FG002|First Period|Withdrawal by Subject|0|||
161952747|NCT02185534|584876669|FG003|First Period|Withdrawal by Subject|1|||
161952748|NCT02185534|584876670|FG004|First Period|Withdrawal by Subject|0|||
161952749|NCT02185534|584876671|FG005|First Period|Withdrawal by Subject|0|||
161952750|NCT02185534|584876666|FG000|First Washout Period|Withdrawal by Subject|1|||
161952751|NCT02185534|584876667|FG001|First Washout Period|Withdrawal by Subject|0|||
161952752|NCT02185534|584876668|FG002|First Washout Period|Withdrawal by Subject|0|||
161952753|NCT02185534|584876669|FG003|First Washout Period|Withdrawal by Subject|0|||
161952754|NCT02185534|584876670|FG004|First Washout Period|Withdrawal by Subject|1|||
161686463|NCT03882970|583904854|FG002|Overall Study|Adverse Event|3|||
161686464|NCT03882970|583904855|FG003|Overall Study|Adverse Event|1|||
161686465|NCT03882970|583904852|FG000|Overall Study|Death|1|||
161686466|NCT03882970|583904853|FG001|Overall Study|Death|2|||
161686467|NCT03882970|583904854|FG002|Overall Study|Death|1|||
161952755|NCT02185534|584876671|FG005|First Washout Period|Withdrawal by Subject|0|||
161952756|NCT02185534|584876666|FG000|First Washout Period|Protocol Violation|0|||
161952757|NCT02185534|584876667|FG001|First Washout Period|Protocol Violation|0|||
161952758|NCT02185534|584876668|FG002|First Washout Period|Protocol Violation|0|||
161834150|NCT01207440|584435573|FG003|Overall Study|Non-compliance with Study Drug|0|||
161834151|NCT01207440|584435574|FG004|Overall Study|Non-compliance with Study Drug|0|||
161834152|NCT01207440|584435575|FG005|Overall Study|Non-compliance with Study Drug|0|||
161834153|NCT01207440|584435576|FG006|Overall Study|Non-compliance with Study Drug|0|||
161834154|NCT01207440|584435570|FG000|Overall Study|Physician Decision|6|||
161834155|NCT01207440|584435571|FG001|Overall Study|Physician Decision|5|||
161834156|NCT01207440|584435572|FG002|Overall Study|Physician Decision|5|||
161834157|NCT01207440|584435573|FG003|Overall Study|Physician Decision|0|||
161834158|NCT01207440|584435574|FG004|Overall Study|Physician Decision|1|||
161834159|NCT01207440|584435575|FG005|Overall Study|Physician Decision|0|||
161834160|NCT01207440|584435576|FG006|Overall Study|Physician Decision|0|||
161834161|NCT01207440|584435570|FG000|Overall Study|Progressive Disease|19|||
161834162|NCT01207440|584435571|FG001|Overall Study|Progressive Disease|10|||
161834163|NCT01207440|584435572|FG002|Overall Study|Progressive Disease|19|||
161834164|NCT01207440|584435573|FG003|Overall Study|Progressive Disease|7|||
161834165|NCT01207440|584435574|FG004|Overall Study|Progressive Disease|23|||
161834166|NCT01207440|584435575|FG005|Overall Study|Progressive Disease|27|||
161834167|NCT01207440|584435576|FG006|Overall Study|Progressive Disease|0|||
161834168|NCT01207440|584435570|FG000|Overall Study|Protocol Violation|2|||
161834169|NCT01207440|584435571|FG001|Overall Study|Protocol Violation|0|||
161834170|NCT01207440|584435572|FG002|Overall Study|Protocol Violation|0|||
161834171|NCT01207440|584435573|FG003|Overall Study|Protocol Violation|0|||
161834172|NCT01207440|584435574|FG004|Overall Study|Protocol Violation|0|||
161834173|NCT01207440|584435575|FG005|Overall Study|Protocol Violation|0|||
161834174|NCT01207440|584435576|FG006|Overall Study|Protocol Violation|0|||
161834175|NCT01207440|584435570|FG000|Overall Study|Site Terminated by Sponsor|69|||
161834176|NCT01207440|584435571|FG001|Overall Study|Site Terminated by Sponsor|19|||
161834177|NCT01207440|584435572|FG002|Overall Study|Site Terminated by Sponsor|12|||
161834178|NCT01207440|584435573|FG003|Overall Study|Site Terminated by Sponsor|2|||
161834179|NCT01207440|584435574|FG004|Overall Study|Site Terminated by Sponsor|3|||
161834180|NCT01207440|584435575|FG005|Overall Study|Site Terminated by Sponsor|0|||
161834181|NCT01207440|584435576|FG006|Overall Study|Site Terminated by Sponsor|2|||
161834182|NCT01207440|584435570|FG000|Overall Study|Withdrawal by Subject|29|||
161834183|NCT01207440|584435571|FG001|Overall Study|Withdrawal by Subject|4|||
161834184|NCT01207440|584435572|FG002|Overall Study|Withdrawal by Subject|5|||
161834185|NCT01207440|584435573|FG003|Overall Study|Withdrawal by Subject|3|||
161834186|NCT01207440|584435574|FG004|Overall Study|Withdrawal by Subject|2|||
161834187|NCT01207440|584435575|FG005|Overall Study|Withdrawal by Subject|2|||
161834188|NCT01207440|584435576|FG006|Overall Study|Withdrawal by Subject|0|||
161834189|NCT01207440|584435570|FG000|Overall Study|Reason Not Specified|10|||
161834190|NCT01207440|584435571|FG001|Overall Study|Reason Not Specified|10|||
161834191|NCT01207440|584435572|FG002|Overall Study|Reason Not Specified|7|||
161834192|NCT01207440|584435573|FG003|Overall Study|Reason Not Specified|0|||
161834193|NCT01207440|584435574|FG004|Overall Study|Reason Not Specified|4|||
161834194|NCT01207440|584435575|FG005|Overall Study|Reason Not Specified|3|||
161834195|NCT01207440|584435576|FG006|Overall Study|Reason Not Specified|0|||
161834196|NCT01592721|584435577|FG000|Long-term Follow-up|Death|1|||
161834197|NCT00821873|584435584|FG000|Overall Study|Lost to Follow-up|4|||
161834198|NCT02698865|584435589|FG000|Overall Study|Other|11|||
161834199|NCT02698865|584435590|FG001|Overall Study|Other|11|||
161834200|NCT02698865|584435589|FG000|Overall Study|Withdrawal by Subject|20|||
161834201|NCT02698865|584435590|FG001|Overall Study|Withdrawal by Subject|16|||
161834202|NCT02698865|584435589|FG000|Overall Study|Physician Decision|0|||
161834203|NCT02698865|584435590|FG001|Overall Study|Physician Decision|4|||
161834204|NCT02698865|584435589|FG000|Overall Study|Lost to Follow-up|4|||
161952759|NCT02185534|584876669|FG003|First Washout Period|Protocol Violation|0|||
161952760|NCT02185534|584876670|FG004|First Washout Period|Protocol Violation|0|||
161952761|NCT02185534|584876671|FG005|First Washout Period|Protocol Violation|1|||
161952762|NCT02737501|584876689|FG000|Randomized Phase|Died|41|||
161834205|NCT02698865|584435590|FG001|Overall Study|Lost to Follow-up|2|||
161834206|NCT01386684|584435594|FG000|Overall Study|Lost to Follow-up|51|||
161834207|NCT01386684|584435594|FG000|Overall Study|Other|51|||
161834208|NCT01386684|584435594|FG000|Overall Study|Death|47|||
161834209|NCT01386684|584435594|FG000|Overall Study|Withdrawal of Consent|44|||
161834210|NCT01386684|584435594|FG000|Overall Study|Alternative Therapy Required|37|||
161834211|NCT01386684|584435594|FG000|Overall Study|Disease Progression|28|||
161834212|NCT01386684|584435594|FG000|Overall Study|Adverse Event|20|||
161834213|NCT01386684|584435594|FG000|Overall Study|Noncompliance|8|||
161834214|NCT01386684|584435594|FG000|Overall Study|Protocol Violation|4|||
161834215|NCT01386684|584435594|FG000|Overall Study|Missing|3|||
161834216|NCT02694549|584435600|FG000|Overall Study|screen failures|2|||
161952763|NCT02737501|584876690|FG001|Randomized Phase|Died|29|||
161952764|NCT02737501|584876691|FG002|Randomized Phase|Died|0|||
161834217|NCT01996332|584435601|FG000|Overall Study|Adverse Event|117|||
161834218|NCT01996332|584435601|FG000|Overall Study|Lack of Efficacy|1245|||
161952765|NCT02737501|584876689|FG000|Randomized Phase|Withdrawal by Subject|16|||
161952766|NCT02737501|584876690|FG001|Randomized Phase|Withdrawal by Subject|6|||
161834219|NCT01996332|584435601|FG000|Overall Study|Death|264|||
161834220|NCT01996332|584435601|FG000|Overall Study|Protocol Violation|9|||
161686468|NCT03882970|583904855|FG003|Overall Study|Death|1|||
161686469|NCT03882970|583904852|FG000|Overall Study|Lost to Follow-up|8|||
161686470|NCT03882970|583904853|FG001|Overall Study|Lost to Follow-up|9|||
161686471|NCT03882970|583904854|FG002|Overall Study|Lost to Follow-up|5|||
161686472|NCT03882970|583904855|FG003|Overall Study|Lost to Follow-up|5|||
161686473|NCT03882970|583904852|FG000|Overall Study|Physician Decision|0|||
161686474|NCT03882970|583904853|FG001|Overall Study|Physician Decision|2|||
161686475|NCT03882970|583904854|FG002|Overall Study|Physician Decision|2|||
161686476|NCT03882970|583904855|FG003|Overall Study|Physician Decision|2|||
161686477|NCT03882970|583904852|FG000|Overall Study|Protocol Violation|2|||
161686478|NCT03882970|583904853|FG001|Overall Study|Protocol Violation|0|||
161686479|NCT03882970|583904854|FG002|Overall Study|Protocol Violation|0|||
161686480|NCT03882970|583904855|FG003|Overall Study|Protocol Violation|0|||
161686481|NCT03882970|583904852|FG000|Overall Study|Withdrawal by Subject|8|||
161686482|NCT03882970|583904853|FG001|Overall Study|Withdrawal by Subject|17|||
161686483|NCT03882970|583904854|FG002|Overall Study|Withdrawal by Subject|7|||
161686484|NCT03882970|583904855|FG003|Overall Study|Withdrawal by Subject|22|||
161686485|NCT03882970|583904852|FG000|Overall Study|Personal Reason|2|||
161686486|NCT03882970|583904853|FG001|Overall Study|Personal Reason|3|||
161686487|NCT03882970|583904854|FG002|Overall Study|Personal Reason|1|||
161686488|NCT03882970|583904855|FG003|Overall Study|Personal Reason|3|||
161686489|NCT02863809|583904856|FG000|Overall Study|Adverse Event|8|||
161686490|NCT02863809|583904857|FG001|Overall Study|Adverse Event|8|||
161686491|NCT02863809|583904856|FG000|Overall Study|Withdrawal by Subject|0|||
161686492|NCT02863809|583904857|FG001|Overall Study|Withdrawal by Subject|1|||
161686493|NCT02863809|583904856|FG000|Overall Study|Lost to Follow-up|1|||
161686494|NCT02863809|583904857|FG001|Overall Study|Lost to Follow-up|1|||
161686495|NCT02863809|583904856|FG000|Overall Study|Death|1|||
161686496|NCT02863809|583904857|FG001|Overall Study|Death|0|||
161686497|NCT01081249|583904860|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
161686498|NCT01081249|583904861|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
161686499|NCT02813694|583904862|FG000|Overall Study|Physician Decision|0|||
161686500|NCT02813694|583904863|FG001|Overall Study|Physician Decision|1|||
161686501|NCT02813694|583904862|FG000|Overall Study|Withdrawal by Subject|10|||
161686502|NCT02813694|583904863|FG001|Overall Study|Withdrawal by Subject|9|||
161686503|NCT02813694|583904862|FG000|Overall Study|Lost to Follow-up|1|||
161686504|NCT02813694|583904863|FG001|Overall Study|Lost to Follow-up|1|||
161686505|NCT02813694|583904862|FG000|Overall Study|Death|3|||
161686506|NCT02813694|583904863|FG001|Overall Study|Death|3|||
161686507|NCT02813694|583904862|FG000|Overall Study|Randomized- did not receive study drug|2|||
161686508|NCT02813694|583904863|FG001|Overall Study|Randomized- did not receive study drug|0|||
161686509|NCT02813694|583904862|FG000|Overall Study|Patient hospitalized|1|||
161686510|NCT02813694|583904863|FG001|Overall Study|Patient hospitalized|0|||
161686511|NCT02980224|583904865|FG000|Overall Study|Adverse Event|4|||
161686512|NCT02980224|583904866|FG001|Overall Study|Adverse Event|1|||
161686513|NCT02980224|583904865|FG000|Overall Study|Withdrawal by Subject|0|||
161686514|NCT02980224|583904866|FG001|Overall Study|Withdrawal by Subject|2|||
161686515|NCT00606320|583904869|FG000|Overall Study|Adverse Event|3|||
161686516|NCT00606320|583904869|FG000|Overall Study|Lack of Efficacy|5|||
161686517|NCT00606320|583904869|FG000|Overall Study|Physician Decision|7|||
161686518|NCT00606320|583904869|FG000|Overall Study|Protocol Violation|8|||
161686519|NCT00606320|583904869|FG000|Overall Study|Withdrawal by Subject|10|||
161686520|NCT00606320|583904869|FG000|Overall Study|Progression to depressive phase|4|||
161686521|NCT04839380|583904870|FG000|Overall Study|Withdrawal by Subject|2|||
161686522|NCT04839380|583904870|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
161686523|NCT00879645|583904871|FG000|Overall Study|Adverse Event|1|||
161686524|NCT00879645|583904872|FG001|Overall Study|Adverse Event|0|||
161686525|NCT00879645|583904873|FG002|Overall Study|Adverse Event|0|||
161686526|NCT00879645|583904874|FG003|Overall Study|Adverse Event|0|||
161686527|NCT00749996|583904875|FG000|Overall Study|Lost to Follow-up|7|||
161686528|NCT00749996|583904876|FG001|Overall Study|Lost to Follow-up|4|||
161686529|NCT00749996|583904875|FG000|Overall Study|Withdrawal by Subject|5|||
161686530|NCT00749996|583904876|FG001|Overall Study|Withdrawal by Subject|4|||
161686531|NCT00749996|583904875|FG000|Overall Study|Protocol Violation|2|||
161686532|NCT00749996|583904876|FG001|Overall Study|Protocol Violation|3|||
161686533|NCT00749996|583904875|FG000|Overall Study|Physician Decision|2|||
161686534|NCT00749996|583904876|FG001|Overall Study|Physician Decision|0|||
161686535|NCT00749996|583904875|FG000|Overall Study|Pregnancy|0|||
161686536|NCT00749996|583904876|FG001|Overall Study|Pregnancy|2|||
161686537|NCT00749996|583904875|FG000|Overall Study|Adverse Event|1|||
161686538|NCT00749996|583904876|FG001|Overall Study|Adverse Event|0|||
161686539|NCT00749996|583904875|FG000|Overall Study|Death|1|||
161686540|NCT00749996|583904876|FG001|Overall Study|Death|0|||
161686541|NCT00996944|583904877|FG000|Double-blind Treatment Period|Adverse Event|2|||
161686542|NCT00996944|583904878|FG001|Double-blind Treatment Period|Adverse Event|1|||
161686543|NCT00996944|583904877|FG000|Double-blind Treatment Period|Protocol Violation|1|||
161686544|NCT00996944|583904878|FG001|Double-blind Treatment Period|Protocol Violation|0|||
161686545|NCT00996944|583904877|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
161686546|NCT00996944|583904878|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
161686547|NCT00996944|583904877|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161686548|NCT00996944|583904878|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
161686549|NCT00996944|583904877|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
161686550|NCT00996944|583904878|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
161686551|NCT03775421|583904881|FG000|Overall Study|Lost to Follow-up|2|||
161686552|NCT03775421|583904881|FG000|Overall Study|Withdrawal by Subject|10|||
161686553|NCT03775421|583904881|FG000|Overall Study|Physician Decision|3|||
161686554|NCT03775421|583904881|FG000|Overall Study|Death|1|||
161686555|NCT03775421|583904881|FG000|Overall Study|Study Terminated by Sponsor|94|||
161686556|NCT01227044|583904884|FG000|Overall Study|Lost to Follow-up|5|||
161686557|NCT01227044|583904885|FG001|Overall Study|Lost to Follow-up|7|||
161686558|NCT01227044|583904884|FG000|Overall Study|Discontinued Intervention|1|||
161686559|NCT01227044|583904885|FG001|Overall Study|Discontinued Intervention|2|||
161686560|NCT04247061|583904886|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
161686561|NCT04247061|583904886|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
161686562|NCT04247061|583904886|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
161686563|NCT01378104|583904889|FG000|Overall Study|Adverse Event|8|||
161686564|NCT01378104|583904890|FG001|Overall Study|Adverse Event|8|||
161686565|NCT01378104|583904889|FG000|Overall Study|Lack of Efficacy|7|||
161686566|NCT01378104|583904890|FG001|Overall Study|Lack of Efficacy|5|||
161686567|NCT01378104|583904889|FG000|Overall Study|Withdrawal by Subject|12|||
161686568|NCT01378104|583904890|FG001|Overall Study|Withdrawal by Subject|13|||
161686569|NCT02287623|583904891|FG000|Overall Study|Protocol Violation|0|||
161952767|NCT02737501|584876691|FG002|Randomized Phase|Withdrawal by Subject|0|||
161952768|NCT02737501|584876689|FG000|Randomized Phase|Lost to Follow-up|0|||
161952769|NCT02737501|584876690|FG001|Randomized Phase|Lost to Follow-up|1|||
161952770|NCT02737501|584876691|FG002|Randomized Phase|Lost to Follow-up|0|||
161952771|NCT02737501|584876689|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
161686570|NCT02287623|583904892|FG001|Overall Study|Protocol Violation|1|||
161686571|NCT02700997|583904893|FG000|Overall Study|Did not undergo CT imaging|1|||
161686572|NCT02700997|583904893|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
161952772|NCT02737501|584876690|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
161952773|NCT02737501|584876691|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
161952774|NCT02737501|584876689|FG000|Randomized Phase|Reason not Specified|1|||
161952775|NCT02737501|584876690|FG001|Randomized Phase|Reason not Specified|1|||
161686573|NCT00205855|583904896|FG000|Overall Study|Only received temporary implants|16|||
161686574|NCT00205855|583904896|FG000|Overall Study|Withdrawal by Subject|5|||
161686575|NCT01445951|583904897|FG000|Overall Study|Adverse Event|16|||
161686576|NCT01445951|583904898|FG001|Overall Study|Adverse Event|9|||
161686577|NCT01445951|583904899|FG002|Overall Study|Adverse Event|0|||
161686578|NCT01445951|583904897|FG000|Overall Study|Protocol Violation|2|||
161686579|NCT01445951|583904898|FG001|Overall Study|Protocol Violation|2|||
161686580|NCT01445951|583904899|FG002|Overall Study|Protocol Violation|2|||
161686581|NCT01445951|583904897|FG000|Overall Study|Withdrawal by Subject|21|||
161952776|NCT02737501|584876691|FG002|Randomized Phase|Reason not Specified|0|||
161952777|NCT02737501|584876689|FG000|Randomized Phase|Never Treated|1|||
161686582|NCT01445951|583904898|FG001|Overall Study|Withdrawal by Subject|16|||
161686583|NCT01445951|583904899|FG002|Overall Study|Withdrawal by Subject|8|||
161686584|NCT01445951|583904897|FG000|Overall Study|Physician Decision|3|||
161686585|NCT01445951|583904898|FG001|Overall Study|Physician Decision|1|||
161686586|NCT01445951|583904899|FG002|Overall Study|Physician Decision|0|||
161686587|NCT01445951|583904897|FG000|Overall Study|Lost to Follow-up|1|||
161686588|NCT01445951|583904898|FG001|Overall Study|Lost to Follow-up|2|||
161686589|NCT01445951|583904899|FG002|Overall Study|Lost to Follow-up|4|||
161686590|NCT01445951|583904897|FG000|Overall Study|Pregnancy|0|||
161686591|NCT01445951|583904898|FG001|Overall Study|Pregnancy|1|||
161686592|NCT01445951|583904899|FG002|Overall Study|Pregnancy|4|||
161686593|NCT01445951|583904897|FG000|Overall Study|Death|0|||
161686594|NCT01445951|583904898|FG001|Overall Study|Death|0|||
161686595|NCT01445951|583904899|FG002|Overall Study|Death|1|||
161686596|NCT01445951|583904897|FG000|Overall Study|Non-compliance with study drug|1|||
161686597|NCT01445951|583904898|FG001|Overall Study|Non-compliance with study drug|2|||
161686598|NCT01445951|583904899|FG002|Overall Study|Non-compliance with study drug|0|||
161686599|NCT01445951|583904897|FG000|Overall Study|Non-compliance with protocol|0|||
161686600|NCT01445951|583904898|FG001|Overall Study|Non-compliance with protocol|1|||
161686601|NCT01445951|583904899|FG002|Overall Study|Non-compliance with protocol|0|||
161686602|NCT01445951|583904897|FG000|Overall Study|Sponsor decision - subject travel|0|||
161686603|NCT01445951|583904898|FG001|Overall Study|Sponsor decision - subject travel|1|||
161686604|NCT01445951|583904899|FG002|Overall Study|Sponsor decision - subject travel|0|||
161686605|NCT01445951|583904897|FG000|Overall Study|Cough|0|||
161686606|NCT01445951|583904898|FG001|Overall Study|Cough|1|||
161686607|NCT01445951|583904899|FG002|Overall Study|Cough|0|||
161686608|NCT02739620|583904902|FG000|Overall Study|Lost to Follow-up|3|||
161686609|NCT02739620|583904903|FG001|Overall Study|Lost to Follow-up|1|||
161686610|NCT02739620|583904902|FG000|Overall Study|Adverse Event|0|||
161686611|NCT02739620|583904903|FG001|Overall Study|Adverse Event|1|||
161686612|NCT02039375|583904910|FG000|Overall Study|Lost to Follow-up|2|||
161686613|NCT03765138|583904911|FG000|Overall Study|Lost to Follow-up|1|||
161686614|NCT03099187|583904920|FG000|Double-blind Treatment|Adverse Event|19|||
161686615|NCT03099187|583904921|FG001|Double-blind Treatment|Adverse Event|1|||
161686616|NCT03099187|583904922|FG002|Double-blind Treatment|Adverse Event|0|||
161686617|NCT03099187|583904923|FG003|Double-blind Treatment|Adverse Event|0|||
161686618|NCT03099187|583904920|FG000|Double-blind Treatment|Death|1|||
161686619|NCT03099187|583904921|FG001|Double-blind Treatment|Death|3|||
161686620|NCT03099187|583904922|FG002|Double-blind Treatment|Death|0|||
161686621|NCT03099187|583904923|FG003|Double-blind Treatment|Death|0|||
161686622|NCT03099187|583904920|FG000|Double-blind Treatment|Lack of Efficacy|1|||
161686623|NCT03099187|583904921|FG001|Double-blind Treatment|Lack of Efficacy|0|||
161686624|NCT03099187|583904922|FG002|Double-blind Treatment|Lack of Efficacy|0|||
161686625|NCT03099187|583904923|FG003|Double-blind Treatment|Lack of Efficacy|0|||
161686626|NCT03099187|583904920|FG000|Double-blind Treatment|Physician Decision|2|||
161686627|NCT03099187|583904921|FG001|Double-blind Treatment|Physician Decision|1|||
161686628|NCT03099187|583904922|FG002|Double-blind Treatment|Physician Decision|0|||
161686629|NCT03099187|583904923|FG003|Double-blind Treatment|Physician Decision|0|||
161686630|NCT03099187|583904920|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
161686631|NCT03099187|583904921|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
161686632|NCT03099187|583904922|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
161686633|NCT03099187|583904923|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
161686634|NCT03099187|583904920|FG000|Double-blind Treatment|Lung transplantation|0|||
161686635|NCT03099187|583904921|FG001|Double-blind Treatment|Lung transplantation|1|||
161686636|NCT03099187|583904922|FG002|Double-blind Treatment|Lung transplantation|0|||
161686637|NCT03099187|583904923|FG003|Double-blind Treatment|Lung transplantation|0|||
161686638|NCT03099187|583904920|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
161686639|NCT03099187|583904921|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
161686640|NCT03099187|583904922|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
161686641|NCT03099187|583904923|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
161952778|NCT02737501|584876690|FG001|Randomized Phase|Never Treated|1|||
161952779|NCT02737501|584876691|FG002|Randomized Phase|Never Treated|0|||
161686642|NCT03099187|583904920|FG000|Double-blind Treatment|Disease progression|0|||
161686643|NCT03099187|583904921|FG001|Double-blind Treatment|Disease progression|1|||
161686644|NCT03099187|583904922|FG002|Double-blind Treatment|Disease progression|0|||
161686645|NCT03099187|583904923|FG003|Double-blind Treatment|Disease progression|0|||
161686646|NCT03099187|583904920|FG000|Double-blind Treatment|Randomization error|0|||
161686647|NCT03099187|583904921|FG001|Double-blind Treatment|Randomization error|2|||
161686648|NCT03099187|583904922|FG002|Double-blind Treatment|Randomization error|0|||
161686649|NCT03099187|583904923|FG003|Double-blind Treatment|Randomization error|0|||
161686650|NCT03099187|583904920|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
161686651|NCT03099187|583904921|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
161686652|NCT03099187|583904922|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
161686653|NCT03099187|583904923|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
161686654|NCT03099187|583904920|FG000|12-month Safety Follow-up|Adverse Event|0|||
161686655|NCT03099187|583904921|FG001|12-month Safety Follow-up|Adverse Event|0|||
161686656|NCT03099187|583904922|FG002|12-month Safety Follow-up|Adverse Event|5|||
161686657|NCT03099187|583904923|FG003|12-month Safety Follow-up|Adverse Event|12|||
161686658|NCT03099187|583904920|FG000|12-month Safety Follow-up|Death|0|||
161686659|NCT03099187|583904921|FG001|12-month Safety Follow-up|Death|0|||
161686660|NCT03099187|583904922|FG002|12-month Safety Follow-up|Death|7|||
161686661|NCT03099187|583904923|FG003|12-month Safety Follow-up|Death|9|||
161686662|NCT03099187|583904920|FG000|12-month Safety Follow-up|Lung transplantation|0|||
161686663|NCT03099187|583904921|FG001|12-month Safety Follow-up|Lung transplantation|0|||
161686664|NCT03099187|583904922|FG002|12-month Safety Follow-up|Lung transplantation|2|||
161686665|NCT03099187|583904923|FG003|12-month Safety Follow-up|Lung transplantation|1|||
161686666|NCT03099187|583904920|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
161686667|NCT03099187|583904921|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
161686668|NCT03099187|583904922|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
161686669|NCT03099187|583904923|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
161686670|NCT03099187|583904920|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
161686671|NCT03099187|583904921|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
161686672|NCT03099187|583904922|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
161686673|NCT03099187|583904923|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
161686674|NCT03099187|583904920|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
161686675|NCT03099187|583904921|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
161686676|NCT03099187|583904922|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
161686677|NCT03099187|583904923|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
161686678|NCT03099187|583904920|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
161686679|NCT03099187|583904921|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
161686680|NCT03099187|583904922|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
161686681|NCT03099187|583904923|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
161686682|NCT03885089|583904924|FG000|Overall Study|No informed consent for publication of study results|2|||
161686683|NCT01210690|583904927|FG000|Overall Study|Adverse Event|7|||
161686684|NCT01210690|583904927|FG000|Overall Study|Lack of Efficacy|12|||
161686685|NCT01210690|583904927|FG000|Overall Study|Lost to Follow-up|3|||
161686686|NCT01210690|583904927|FG000|Overall Study|Disease Remission|1|||
161834221|NCT01996332|584435601|FG000|Overall Study|Withdrawal by Subject|71|||
161834222|NCT01996332|584435601|FG000|Overall Study|Other|20|||
161952780|NCT02737501|584876689|FG000|Crossover Phase|Died|0|||
161952781|NCT02737501|584876690|FG001|Crossover Phase|Died|0|||
162237275|NCT00655486|585921055|FG000|Overall Study|Other: Pregnancy|1|||
162237276|NCT00655486|585921055|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
162237277|NCT00655486|585921055|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
162237278|NCT00310037|585921056|FG000|Overall Study|Adverse Event|7|||
162237279|NCT00310037|585921057|FG001|Overall Study|Adverse Event|14|||
162237280|NCT00310037|585921056|FG000|Overall Study|Withdrawal by Subject|4|||
162237281|NCT00310037|585921057|FG001|Overall Study|Withdrawal by Subject|3|||
162237282|NCT00310037|585921056|FG000|Overall Study|Progression|6|||
162237283|NCT00310037|585921057|FG001|Overall Study|Progression|0|||
162237284|NCT00310037|585921056|FG000|Overall Study|Non-protocol treatment|1|||
162237285|NCT00310037|585921057|FG001|Overall Study|Non-protocol treatment|0|||
162237286|NCT00440999|585921058|FG000|Overall Study|Adverse Event|0|||
162237287|NCT00440999|585921059|FG001|Overall Study|Adverse Event|2|||
162237288|NCT00440999|585921058|FG000|Overall Study|Lack of Efficacy|6|||
162237289|NCT00440999|585921059|FG001|Overall Study|Lack of Efficacy|7|||
162237290|NCT00440999|585921058|FG000|Overall Study|Lost to Follow-up|19|||
162237291|NCT00440999|585921059|FG001|Overall Study|Lost to Follow-up|12|||
162237292|NCT00440999|585921058|FG000|Overall Study|Protocol Violation|1|||
162237293|NCT00440999|585921059|FG001|Overall Study|Protocol Violation|0|||
162237294|NCT00440999|585921058|FG000|Overall Study|Withdrawal by Subject|2|||
162237295|NCT00440999|585921059|FG001|Overall Study|Withdrawal by Subject|5|||
162237296|NCT00440999|585921058|FG000|Overall Study|Subjets missed the visit|1|||
162237297|NCT00440999|585921059|FG001|Overall Study|Subjets missed the visit|0|||
162237298|NCT00440999|585921058|FG000|Overall Study|Mixed infection at entry|1|||
162237299|NCT00440999|585921059|FG001|Overall Study|Mixed infection at entry|0|||
162237300|NCT00440999|585921058|FG000|Overall Study|P. falciparum malaria|5|||
162237301|NCT00440999|585921059|FG001|Overall Study|P. falciparum malaria|14|||
162237302|NCT00440999|585921058|FG000|Overall Study|Subj left hosp without inform staff|0|||
162237303|NCT00440999|585921059|FG001|Overall Study|Subj left hosp without inform staff|1|||
162237304|NCT01122862|585921060|FG000|Period 1|Protocol Violation|0|||
162237305|NCT01122862|585921061|FG001|Period 1|Protocol Violation|1|||
162237306|NCT01122862|585921062|FG002|Period 1|Protocol Violation|0|||
162237307|NCT01122862|585921060|FG000|Period 2|Adverse Event|0|||
162237308|NCT01122862|585921061|FG001|Period 2|Adverse Event|0|||
162237309|NCT01122862|585921062|FG002|Period 2|Adverse Event|1|||
162237310|NCT01477333|585921065|FG000|Overall Study|Adverse Event|1|||
162237311|NCT01477333|585921065|FG000|Overall Study|Withdrawal by Subject|1|||
162237312|NCT01477333|585921065|FG000|Overall Study|Clinical Deterioration|1|||
162237313|NCT01178671|585921066|FG000|Overall Study|Adverse Event|4|||
161686687|NCT01210690|583904927|FG000|Overall Study|Withdrawal by Subject|1|||
161686688|NCT01210690|583904927|FG000|Overall Study|Patient refused to swallow|1|||
161686689|NCT01210690|583904927|FG000|Overall Study|Patient could not take glucose|1|||
161686690|NCT00470054|583904928|FG000|Overall Study|Ineligible|1|||
161686691|NCT01439555|583904929|FG000|Overall Study|Protocol Violation|1|||
161686692|NCT04869345|583904930|FG000|Overall Study|Lost to Follow-up|8|||
161686693|NCT04869345|583904931|FG001|Overall Study|Lost to Follow-up|3|||
161686694|NCT04194528|583904939|FG000|Overall Study|Adverse Event|1|||
161686695|NCT00528021|583904940|FG000|Overall Study|Lack of Efficacy|17|||
161686696|NCT00528021|583904941|FG001|Overall Study|Lack of Efficacy|13|||
161686697|NCT00528021|583904942|FG002|Overall Study|Lack of Efficacy|7|||
161686698|NCT00528021|583904943|FG003|Overall Study|Lack of Efficacy|9|||
161686699|NCT03921424|583904950|FG000|Overall Study|Lost to Follow-up|0|||
161686700|NCT03921424|583904951|FG001|Overall Study|Lost to Follow-up|1|||
161686701|NCT03921424|583904950|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161686702|NCT03921424|583904951|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
161686703|NCT01246583|583904960|FG000|Overall Study|Lost to Follow-up|0|||
161686704|NCT01246583|583904961|FG001|Overall Study|Lost to Follow-up|0|||
161686705|NCT01246583|583904962|FG002|Overall Study|Lost to Follow-up|0|||
161686706|NCT01246583|583904963|FG003|Overall Study|Lost to Follow-up|1|||
161686707|NCT01246583|583904960|FG000|Overall Study|Protocol Violation|0|||
161686708|NCT01246583|583904961|FG001|Overall Study|Protocol Violation|0|||
161686709|NCT01246583|583904962|FG002|Overall Study|Protocol Violation|1|||
161686710|NCT01246583|583904963|FG003|Overall Study|Protocol Violation|0|||
161686711|NCT01246583|583904960|FG000|Overall Study|Withdrawal by Subject|1|||
161686712|NCT01246583|583904961|FG001|Overall Study|Withdrawal by Subject|0|||
161686713|NCT01246583|583904962|FG002|Overall Study|Withdrawal by Subject|0|||
161834223|NCT01996332|584435601|FG000|Overall Study|Clinical Deterioration|28|||
161834224|NCT01996332|584435601|FG000|Overall Study|Physician Decision|17|||
161834225|NCT01996332|584435601|FG000|Overall Study|Lost to Follow-up|34|||
161834226|NCT02113189|584435602|FG000|Overall Study|Lost to follow up|2|||
161834227|NCT02113189|584435603|FG001|Overall Study|Lost to follow up|1|||
161834228|NCT02113189|584435604|FG002|Overall Study|Lost to follow up|3|||
161834229|NCT00099268|584435607|FG000|Overall Study|Withdrawal by Subject|46|||
161834230|NCT00099268|584435608|FG001|Overall Study|Withdrawal by Subject|28|||
161834231|NCT00099268|584435607|FG000|Overall Study|Adverse Event|19|||
161834232|NCT00099268|584435608|FG001|Overall Study|Adverse Event|19|||
161834233|NCT00099268|584435607|FG000|Overall Study|Protocol Violation|9|||
161834234|NCT00099268|584435608|FG001|Overall Study|Protocol Violation|8|||
161834235|NCT00099268|584435607|FG000|Overall Study|Lost to Follow-up|6|||
161834236|NCT00099268|584435608|FG001|Overall Study|Lost to Follow-up|4|||
161834237|NCT00099268|584435607|FG000|Overall Study|Lack of Efficacy|5|||
161834238|NCT00099268|584435608|FG001|Overall Study|Lack of Efficacy|18|||
161834239|NCT00099268|584435607|FG000|Overall Study|Administrative problems|4|||
161834240|NCT00099268|584435608|FG001|Overall Study|Administrative problems|4|||
161834241|NCT00099268|584435607|FG000|Overall Study|Death|3|||
161834242|NCT00099268|584435608|FG001|Overall Study|Death|1|||
161834243|NCT03702049|584435609|FG000|Overall Study|Lost to Follow-up|4|||
161834244|NCT03702049|584435609|FG000|Overall Study|Physician Decision|1|||
161834245|NCT02954159|584435610|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
161834246|NCT02954159|584435611|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
161834247|NCT02954159|584435610|FG000|Overall Study|Withdrawal by Subject|0|||
161834248|NCT02954159|584435611|FG001|Overall Study|Withdrawal by Subject|1|||
161834249|NCT03438396|584435612|FG000|Overall Study|Reason Not Specified|9|||
161834250|NCT03438396|584435612|FG000|Overall Study|Withdrawal by Subject|5|||
161834251|NCT03438396|584435612|FG000|Overall Study|Lost to Follow-up|2|||
161834252|NCT03438396|584435612|FG000|Overall Study|Death|85|||
161834253|NCT03438396|584435612|FG000|Overall Study|Not treated|1|||
161834254|NCT00262041|584435613|FG000|Overall Study|Withdrawal by Subject|0|||
161834255|NCT00262041|584435614|FG001|Overall Study|Withdrawal by Subject|3|||
161834256|NCT00262041|584435615|FG002|Overall Study|Withdrawal by Subject|1|||
161834257|NCT00262041|584435613|FG000|Overall Study|Lost to Follow-up|1|||
161834258|NCT00262041|584435614|FG001|Overall Study|Lost to Follow-up|1|||
161834259|NCT00262041|584435615|FG002|Overall Study|Lost to Follow-up|5|||
161834260|NCT00262041|584435613|FG000|Overall Study|Unable to classify|1|||
161834261|NCT00262041|584435614|FG001|Overall Study|Unable to classify|0|||
161834262|NCT00262041|584435615|FG002|Overall Study|Unable to classify|0|||
161834263|NCT04132336|584435616|FG000|Overall Study|Investigator Decision|0|||
161834264|NCT04132336|584435617|FG001|Overall Study|Investigator Decision|1|||
161834265|NCT04132336|584435618|FG002|Overall Study|Investigator Decision|0|||
161834266|NCT04132336|584435619|FG003|Overall Study|Investigator Decision|0|||
161834267|NCT04132336|584435620|FG004|Overall Study|Investigator Decision|0|||
161834268|NCT04132336|584435621|FG005|Overall Study|Investigator Decision|0|||
161834269|NCT04132336|584435622|FG006|Overall Study|Investigator Decision|0|||
161834270|NCT02488330|584435623|FG000|Overall Study|Adverse Event|1|||
161834271|NCT02488330|584435623|FG000|Overall Study|Physician Decision|2|||
161834272|NCT02488330|584435623|FG000|Overall Study|Death|2|||
161834273|NCT02488330|584435623|FG000|Overall Study|Disease Progression|3|||
161834274|NCT02488330|584435623|FG000|Overall Study|Study Termination by Sponsor|4|||
161834275|NCT02384941|584435626|FG000|Overall Study|Adverse Event|11|||
161834276|NCT02384941|584435627|FG001|Overall Study|Adverse Event|13|||
161834277|NCT02384941|584435628|FG002|Overall Study|Adverse Event|17|||
161834278|NCT02384941|584435626|FG000|Overall Study|Lost to Follow-up|3|||
161834279|NCT02384941|584435627|FG001|Overall Study|Lost to Follow-up|2|||
161834280|NCT02384941|584435628|FG002|Overall Study|Lost to Follow-up|1|||
161834281|NCT02384941|584435626|FG000|Overall Study|Non-Compliance With Study Drug|2|||
161834282|NCT02384941|584435627|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161834283|NCT02384941|584435628|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161834284|NCT02384941|584435626|FG000|Overall Study|Physician Decision|1|||
161834285|NCT02384941|584435627|FG001|Overall Study|Physician Decision|1|||
161834286|NCT02384941|584435628|FG002|Overall Study|Physician Decision|0|||
161834287|NCT02384941|584435626|FG000|Overall Study|Protocol Violation|3|||
161834288|NCT02384941|584435627|FG001|Overall Study|Protocol Violation|0|||
161834289|NCT02384941|584435628|FG002|Overall Study|Protocol Violation|0|||
161834290|NCT02384941|584435626|FG000|Overall Study|Withdrawal by Subject|26|||
161834291|NCT02384941|584435627|FG001|Overall Study|Withdrawal by Subject|19|||
161834292|NCT02384941|584435628|FG002|Overall Study|Withdrawal by Subject|20|||
161834293|NCT02384941|584435626|FG000|Overall Study|Pregnancy|0|||
161834294|NCT02384941|584435627|FG001|Overall Study|Pregnancy|0|||
161834295|NCT02384941|584435628|FG002|Overall Study|Pregnancy|1|||
161834296|NCT02384941|584435626|FG000|Overall Study|Other than specified above|4|||
161834297|NCT02384941|584435627|FG001|Overall Study|Other than specified above|0|||
161952782|NCT02737501|584876691|FG002|Crossover Phase|Died|22|||
161952783|NCT02737501|584876689|FG000|Crossover Phase|Withdrew Consent|0|||
161952784|NCT02737501|584876690|FG001|Crossover Phase|Withdrew Consent|0|||
161952785|NCT02737501|584876691|FG002|Crossover Phase|Withdrew Consent|9|||
161686714|NCT01246583|583904963|FG003|Overall Study|Withdrawal by Subject|0|||
161686715|NCT02595450|583904966|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
161686716|NCT02595450|583904966|FG000|Overall Study|Enrolled, but not treated|8|||
161686717|NCT00102960|583904972|FG000|Overall Study|Death|23|||
161686718|NCT00102960|583904973|FG001|Overall Study|Death|11|||
161686719|NCT00102960|583904974|FG002|Overall Study|Death|11|||
161686720|NCT00102960|583904972|FG000|Overall Study|Lost to Follow-up|6|||
161686721|NCT00102960|583904973|FG001|Overall Study|Lost to Follow-up|12|||
161686722|NCT00102960|583904974|FG002|Overall Study|Lost to Follow-up|16|||
161834298|NCT02384941|584435628|FG002|Overall Study|Other than specified above|1|||
161834299|NCT02493777|584435629|FG000|Overall Study|Lost to Follow-up|0|||
161834300|NCT02493777|584435630|FG001|Overall Study|Lost to Follow-up|1|||
161834301|NCT00468728|584435631|FG000|Treatment|criteria for mITT population|4|||
161834302|NCT00468728|584435632|FG001|Treatment|criteria for mITT population|11|||
161834303|NCT00468728|584435631|FG000|Follow-up|mITT failure|34|||
161834304|NCT00468728|584435632|FG001|Follow-up|mITT failure|31|||
161834305|NCT01705236|584435633|FG000|Overall Study|Lost to Follow-up|1|||
161834306|NCT01705236|584435633|FG000|Overall Study|Administrative problems|2|||
161834307|NCT01705236|584435633|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
161834308|NCT01705236|584435633|FG000|Overall Study|Protocol Violation|3|||
161834309|NCT01705236|584435633|FG000|Overall Study|Abnormal test procedure result(s)|4|||
161834310|NCT01705236|584435633|FG000|Overall Study|Abnormal laboratory value(s)|4|||
161834311|NCT01705236|584435633|FG000|Overall Study|Withdrawal by Subject|5|||
161834312|NCT01705236|584435633|FG000|Overall Study|Adverse Event|5|||
161834313|NCT06005597|584435634|FG000|Overall Study|Lost to Follow-up|1|||
161834314|NCT06005597|584435635|FG001|Overall Study|Lost to Follow-up|2|||
161834315|NCT06005597|584435636|FG002|Overall Study|Lost to Follow-up|1|||
161834316|NCT06005597|584435637|FG003|Overall Study|Lost to Follow-up|2|||
161834317|NCT06005597|584435634|FG000|Overall Study|Death|1|||
161834318|NCT06005597|584435635|FG001|Overall Study|Death|1|||
161834319|NCT06005597|584435636|FG002|Overall Study|Death|1|||
161834320|NCT06005597|584435637|FG003|Overall Study|Death|0|||
161834321|NCT02224573|584435638|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
161834322|NCT02224573|584435639|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
161834323|NCT02224573|584435638|FG000|Treatment Phase|Started on Other IMP|1|||
161834324|NCT02224573|584435639|FG001|Treatment Phase|Started on Other IMP|0|||
161834325|NCT02224573|584435638|FG000|Treatment Phase|Participant Discontinued IMP|0|||
161834326|NCT02224573|584435639|FG001|Treatment Phase|Participant Discontinued IMP|1|||
161834327|NCT02224573|584435638|FG000|Treatment Phase|Lack of Efficacy|15|||
161834328|NCT02224573|584435639|FG001|Treatment Phase|Lack of Efficacy|8|||
161834329|NCT02224573|584435638|FG000|Treatment Phase|Began Commercial Product|1|||
161834330|NCT02224573|584435639|FG001|Treatment Phase|Began Commercial Product|0|||
161834331|NCT02224573|584435638|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
161834332|NCT02224573|584435639|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
161834333|NCT02224573|584435638|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
161834334|NCT02224573|584435639|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
161834335|NCT02224573|584435638|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
161834336|NCT02224573|584435639|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
161834337|NCT02224573|584435638|FG000|Treatment Phase|Continued Compassionate Use|1|||
161834338|NCT02224573|584435639|FG001|Treatment Phase|Continued Compassionate Use|0|||
161834339|NCT02224573|584435638|FG000|Treatment Phase|Lack of Efficiency|2|||
161834340|NCT02224573|584435639|FG001|Treatment Phase|Lack of Efficiency|1|||
161834341|NCT02224573|584435638|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
161834342|NCT02224573|584435639|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
161834343|NCT02224573|584435638|FG000|Treatment Phase|Participant Moved|2|||
161834344|NCT02224573|584435639|FG001|Treatment Phase|Participant Moved|0|||
161834345|NCT02224573|584435638|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
161834346|NCT02224573|584435639|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
161834347|NCT02224573|584435638|FG000|Treatment Phase|Refused Medication|1|||
161834348|NCT02224573|584435639|FG001|Treatment Phase|Refused Medication|1|||
161834349|NCT02224573|584435638|FG000|Treatment Phase|Adverse Event|26|||
161834350|NCT02224573|584435639|FG001|Treatment Phase|Adverse Event|38|||
161834351|NCT02224573|584435638|FG000|Treatment Phase|Placed in Group Home|0|||
161834352|NCT02224573|584435639|FG001|Treatment Phase|Placed in Group Home|1|||
161834353|NCT02224573|584435638|FG000|Treatment Phase|Pursued Other Trials|1|||
161834354|NCT02224573|584435639|FG001|Treatment Phase|Pursued Other Trials|0|||
161834355|NCT02224573|584435638|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
161834356|NCT02224573|584435639|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
161834357|NCT02224573|584435638|FG000|Treatment Phase|Lost to Follow-up|2|||
161834358|NCT02224573|584435639|FG001|Treatment Phase|Lost to Follow-up|1|||
161834359|NCT02224573|584435638|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
161834360|NCT02224573|584435639|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
161834361|NCT02224573|584435638|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
161834362|NCT02224573|584435639|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
161952786|NCT02737501|584876689|FG000|Crossover Phase|Physician Decision|0|||
161952787|NCT02737501|584876690|FG001|Crossover Phase|Physician Decision|0|||
161952788|NCT02737501|584876691|FG002|Crossover Phase|Physician Decision|1|||
161686723|NCT00102960|583904972|FG000|Overall Study|Withdrawal by Subject|1|||
161686724|NCT00102960|583904973|FG001|Overall Study|Withdrawal by Subject|0|||
161686725|NCT00102960|583904974|FG002|Overall Study|Withdrawal by Subject|1|||
161686726|NCT03040999|583907062|FG000|Overall Study|Lost to Follow-up|2|||
161686727|NCT03040999|583907063|FG001|Overall Study|Lost to Follow-up|2|||
161686728|NCT03040999|583907062|FG000|Overall Study|Withdrawal by Subject|12|||
162028813|NCT02576145|585161857|FG000|Overall Study|Adverse Event|1|||
161686729|NCT03040999|583907063|FG001|Overall Study|Withdrawal by Subject|13|||
161952789|NCT02737501|584876689|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
161952790|NCT02737501|584876690|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
161952791|NCT02737501|584876691|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
161952792|NCT02012218|584876692|FG000|Overall Study|Withdrawal by Subject|1|||
161952793|NCT02012218|584876693|FG001|Overall Study|Withdrawal by Subject|0|||
161952794|NCT02012218|584876694|FG002|Overall Study|Withdrawal by Subject|1|||
161952795|NCT02012218|584876695|FG003|Overall Study|Withdrawal by Subject|1|||
161952796|NCT02012218|584876696|FG004|Overall Study|Withdrawal by Subject|1|||
161952797|NCT02012218|584876692|FG000|Overall Study|Adverse Event|1|||
161952798|NCT02012218|584876693|FG001|Overall Study|Adverse Event|0|||
161952799|NCT02012218|584876694|FG002|Overall Study|Adverse Event|0|||
161952800|NCT02012218|584876695|FG003|Overall Study|Adverse Event|1|||
162028814|NCT02576145|585161858|FG001|Overall Study|Adverse Event|0|||
162028815|NCT02576145|585161857|FG000|Overall Study|Withdrawal by Subject|1|||
162028816|NCT02576145|585161858|FG001|Overall Study|Withdrawal by Subject|0|||
161686730|NCT03040999|583907062|FG000|Overall Study|Death|155|||
161686731|NCT03040999|583907063|FG001|Overall Study|Death|171|||
161686732|NCT03040999|583907062|FG000|Overall Study|Physician Decision|0|||
161686733|NCT03040999|583907063|FG001|Overall Study|Physician Decision|3|||
161686734|NCT01395394|583907064|FG000|Baseline Study Visit|Protocol Violation|1|||
161686735|NCT01395394|583907065|FG001|Baseline Study Visit|Protocol Violation|0|||
161686736|NCT01395394|583907066|FG002|Baseline Study Visit|Protocol Violation|0|||
161686737|NCT05121480|583907067|FG000|Overall Study|Lack of Efficacy|2|||
161686738|NCT05121480|583907068|FG001|Overall Study|Lack of Efficacy|2|||
161686739|NCT05121480|583907069|FG002|Overall Study|Lack of Efficacy|1|||
161686740|NCT05121480|583907070|FG003|Overall Study|Lack of Efficacy|4|||
161686741|NCT05121480|583907071|FG004|Overall Study|Lack of Efficacy|0|||
161686742|NCT05121480|583907072|FG005|Overall Study|Lack of Efficacy|1|||
161686743|NCT05121480|583907073|FG006|Overall Study|Lack of Efficacy|0|||
161686744|NCT05121480|583907074|FG007|Overall Study|Lack of Efficacy|2|||
161686745|NCT05121480|583907067|FG000|Overall Study|Treatment Failure|0|||
161686746|NCT05121480|583907068|FG001|Overall Study|Treatment Failure|2|||
161686747|NCT05121480|583907069|FG002|Overall Study|Treatment Failure|0|||
161686748|NCT05121480|583907070|FG003|Overall Study|Treatment Failure|1|||
161686749|NCT05121480|583907071|FG004|Overall Study|Treatment Failure|0|||
161686750|NCT05121480|583907072|FG005|Overall Study|Treatment Failure|0|||
161686751|NCT05121480|583907073|FG006|Overall Study|Treatment Failure|0|||
161686752|NCT05121480|583907074|FG007|Overall Study|Treatment Failure|0|||
161686753|NCT05121480|583907067|FG000|Overall Study|Adverse Event|0|||
161686754|NCT05121480|583907068|FG001|Overall Study|Adverse Event|1|||
161686755|NCT05121480|583907069|FG002|Overall Study|Adverse Event|0|||
161686756|NCT05121480|583907070|FG003|Overall Study|Adverse Event|5|||
161686757|NCT05121480|583907071|FG004|Overall Study|Adverse Event|3|||
161952801|NCT02012218|584876696|FG004|Overall Study|Adverse Event|0|||
161686758|NCT05121480|583907072|FG005|Overall Study|Adverse Event|2|||
161686759|NCT05121480|583907073|FG006|Overall Study|Adverse Event|0|||
161952802|NCT02012218|584876692|FG000|Overall Study|Lost to Follow-up|0|||
161952803|NCT02012218|584876693|FG001|Overall Study|Lost to Follow-up|1|||
162028817|NCT02576145|585161857|FG000|Overall Study|Acute rejection|1|||
162028818|NCT02576145|585161858|FG001|Overall Study|Acute rejection|0|||
162028819|NCT02576145|585161857|FG000|Overall Study|Tetanus Titers Decreased|0|||
161686760|NCT05121480|583907074|FG007|Overall Study|Adverse Event|4|||
161686761|NCT05121480|583907067|FG000|Overall Study|Withdrawal by Subject|4|||
161686762|NCT05121480|583907068|FG001|Overall Study|Withdrawal by Subject|9|||
161686763|NCT05121480|583907069|FG002|Overall Study|Withdrawal by Subject|1|||
161686764|NCT05121480|583907070|FG003|Overall Study|Withdrawal by Subject|8|||
161686765|NCT05121480|583907071|FG004|Overall Study|Withdrawal by Subject|0|||
161686766|NCT05121480|583907072|FG005|Overall Study|Withdrawal by Subject|9|||
161686767|NCT05121480|583907073|FG006|Overall Study|Withdrawal by Subject|0|||
161834363|NCT02224573|584435638|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
161834364|NCT02224573|584435639|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
161834365|NCT02224573|584435638|FG000|Taper Phase|Adverse Event|1|||
161834366|NCT02224573|584435639|FG001|Taper Phase|Adverse Event|1|||
161834367|NCT02546362|584435640|FG000|4-week Treatment Period|Lost to Follow-up|1|||
161834368|NCT02546362|584435640|FG000|4-week Treatment Period|Change in medication|2|||
161834369|NCT02546362|584435640|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
161834370|NCT02546362|584435640|FG000|12-week Treatment Period|Lost to Follow-up|2|||
161834371|NCT02546362|584435640|FG000|12-week Treatment Period|Change in medication|1|||
161834372|NCT02025010|584435641|FG000|Overall Study|Symptomatic or radiographic progression|36|||
161834373|NCT02025010|584435641|FG000|Overall Study|Adverse Event|6|||
161834374|NCT02025010|584435641|FG000|Overall Study|Physician Decision|7|||
161834375|NCT02025010|584435641|FG000|Overall Study|Withdrawal by Subject|3|||
161834376|NCT02025010|584435641|FG000|Overall Study|Intercurrent illness|3|||
161834377|NCT02025010|584435641|FG000|Overall Study|Patients still on treatment|3|||
161834378|NCT02025010|584435641|FG000|Overall Study|Never initiate the treatment|2|||
161834379|NCT01134627|584435646|FG000|Overall Study|Adverse Event|47|||
161834380|NCT01134627|584435647|FG001|Overall Study|Adverse Event|31|||
161834381|NCT01134627|584435646|FG000|Overall Study|Lost to Follow-up|1|||
161834382|NCT01134627|584435647|FG001|Overall Study|Lost to Follow-up|2|||
161834383|NCT01134627|584435646|FG000|Overall Study|Protocol Violation|3|||
161834384|NCT01134627|584435647|FG001|Overall Study|Protocol Violation|5|||
161834385|NCT01134627|584435646|FG000|Overall Study|Lack of Efficacy|2|||
161834386|NCT01134627|584435647|FG001|Overall Study|Lack of Efficacy|12|||
161834387|NCT01134627|584435646|FG000|Overall Study|Withdrawal by Subject|4|||
161834388|NCT01134627|584435647|FG001|Overall Study|Withdrawal by Subject|3|||
161834389|NCT01134627|584435646|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
161834390|NCT01134627|584435647|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
161834391|NCT01134627|584435646|FG000|Overall Study|Other|11|||
161834392|NCT01134627|584435647|FG001|Overall Study|Other|14|||
161834393|NCT01010750|584435648|FG000|Second Intervention|Adverse Event|0|||
161834394|NCT01010750|584435649|FG001|Second Intervention|Adverse Event|1|||
161834395|NCT01010750|584435650|FG002|Second Intervention|Adverse Event|0|||
161834396|NCT01010750|584435651|FG003|Second Intervention|Adverse Event|0|||
161834397|NCT01010750|584435652|FG004|Second Intervention|Adverse Event|0|||
161834398|NCT01010750|584435653|FG005|Second Intervention|Adverse Event|0|||
161834399|NCT01056640|584435654|FG000|Overall Study|Withdrawal by Subject|11|||
161834400|NCT01056640|584435655|FG001|Overall Study|Withdrawal by Subject|8|||
161834401|NCT01056640|584435654|FG000|Overall Study|Death|15|||
161834402|NCT01056640|584435655|FG001|Overall Study|Death|4|||
161834403|NCT01803269|584435656|FG000|Overall Study|Withdrawal by Subject|3|||
161834404|NCT01803269|584435657|FG001|Overall Study|Withdrawal by Subject|0|||
161834405|NCT01803269|584435658|FG002|Overall Study|Withdrawal by Subject|0|||
161834406|NCT00466726|584435661|FG000|Overall Study|Not evaluable for response|14|||
161834407|NCT02696031|584435662|FG000|Up to Week 24|Adverse Event|2|||
161834408|NCT02696031|584435663|FG001|Up to Week 24|Adverse Event|4|||
162028820|NCT02576145|585161858|FG001|Overall Study|Tetanus Titers Decreased|1|||
161834409|NCT02696031|584435664|FG002|Up to Week 24|Adverse Event|2|||
161834410|NCT02696031|584435665|FG003|Up to Week 24|Adverse Event|0|||
161834411|NCT02696031|584435666|FG004|Up to Week 24|Adverse Event|0|||
161834412|NCT02696031|584435667|FG005|Up to Week 24|Adverse Event|0|||
162028821|NCT00821509|585161859|FG000|Overall Study|Withdrawal by Subject|12|||
161834413|NCT02696031|584435662|FG000|Up to Week 24|Lack of Efficacy|2|||
161834414|NCT02696031|584435663|FG001|Up to Week 24|Lack of Efficacy|1|||
161686768|NCT05121480|583907074|FG007|Overall Study|Withdrawal by Subject|4|||
161686769|NCT05121480|583907067|FG000|Overall Study|Non-compliance with the protocol|0|||
161686770|NCT05121480|583907068|FG001|Overall Study|Non-compliance with the protocol|0|||
161686771|NCT05121480|583907069|FG002|Overall Study|Non-compliance with the protocol|0|||
161686772|NCT05121480|583907070|FG003|Overall Study|Non-compliance with the protocol|0|||
161686773|NCT05121480|583907071|FG004|Overall Study|Non-compliance with the protocol|1|||
161686774|NCT05121480|583907072|FG005|Overall Study|Non-compliance with the protocol|6|||
161686775|NCT05121480|583907073|FG006|Overall Study|Non-compliance with the protocol|0|||
161686776|NCT05121480|583907074|FG007|Overall Study|Non-compliance with the protocol|1|||
161686777|NCT05121480|583907067|FG000|Overall Study|Lost to Follow-up|0|||
161686778|NCT05121480|583907068|FG001|Overall Study|Lost to Follow-up|4|||
161686779|NCT05121480|583907069|FG002|Overall Study|Lost to Follow-up|1|||
161686780|NCT05121480|583907070|FG003|Overall Study|Lost to Follow-up|3|||
161686781|NCT05121480|583907071|FG004|Overall Study|Lost to Follow-up|1|||
161686782|NCT05121480|583907072|FG005|Overall Study|Lost to Follow-up|1|||
161686783|NCT05121480|583907073|FG006|Overall Study|Lost to Follow-up|1|||
161686784|NCT05121480|583907074|FG007|Overall Study|Lost to Follow-up|4|||
161686785|NCT05121480|583907067|FG000|Overall Study|Physician Decision|0|||
161686786|NCT05121480|583907068|FG001|Overall Study|Physician Decision|0|||
161686787|NCT05121480|583907069|FG002|Overall Study|Physician Decision|0|||
161686788|NCT05121480|583907070|FG003|Overall Study|Physician Decision|0|||
161686789|NCT05121480|583907071|FG004|Overall Study|Physician Decision|0|||
161686790|NCT05121480|583907072|FG005|Overall Study|Physician Decision|1|||
161686791|NCT05121480|583907073|FG006|Overall Study|Physician Decision|0|||
161686792|NCT05121480|583907074|FG007|Overall Study|Physician Decision|1|||
161686793|NCT05121480|583907067|FG000|Overall Study|Other Reason|0|||
161686794|NCT05121480|583907068|FG001|Overall Study|Other Reason|0|||
161686795|NCT05121480|583907069|FG002|Overall Study|Other Reason|0|||
161686796|NCT05121480|583907070|FG003|Overall Study|Other Reason|0|||
161834415|NCT02696031|584435664|FG002|Up to Week 24|Lack of Efficacy|2|||
161834416|NCT02696031|584435665|FG003|Up to Week 24|Lack of Efficacy|0|||
161686797|NCT05121480|583907071|FG004|Overall Study|Other Reason|0|||
161686798|NCT05121480|583907072|FG005|Overall Study|Other Reason|1|||
161834417|NCT02696031|584435666|FG004|Up to Week 24|Lack of Efficacy|0|||
161952804|NCT02012218|584876694|FG002|Overall Study|Lost to Follow-up|1|||
161952805|NCT02012218|584876695|FG003|Overall Study|Lost to Follow-up|0|||
161834418|NCT02696031|584435667|FG005|Up to Week 24|Lack of Efficacy|0|||
161686799|NCT05121480|583907073|FG006|Overall Study|Other Reason|1|||
161686800|NCT05121480|583907074|FG007|Overall Study|Other Reason|1|||
161834419|NCT02696031|584435662|FG000|Up to Week 24|Lost to Follow-up|0|||
161834420|NCT02696031|584435663|FG001|Up to Week 24|Lost to Follow-up|1|||
161834421|NCT02696031|584435664|FG002|Up to Week 24|Lost to Follow-up|1|||
161834422|NCT02696031|584435665|FG003|Up to Week 24|Lost to Follow-up|0|||
161834423|NCT02696031|584435666|FG004|Up to Week 24|Lost to Follow-up|0|||
161834424|NCT02696031|584435667|FG005|Up to Week 24|Lost to Follow-up|0|||
161834425|NCT02696031|584435662|FG000|Up to Week 24|Physician Decision|1|||
161834426|NCT02696031|584435663|FG001|Up to Week 24|Physician Decision|0|||
161834427|NCT02696031|584435664|FG002|Up to Week 24|Physician Decision|1|||
161834428|NCT02696031|584435665|FG003|Up to Week 24|Physician Decision|0|||
161834429|NCT02696031|584435666|FG004|Up to Week 24|Physician Decision|0|||
161834430|NCT02696031|584435667|FG005|Up to Week 24|Physician Decision|0|||
161834431|NCT02696031|584435662|FG000|Up to Week 24|Protocol Violation|1|||
161834432|NCT02696031|584435663|FG001|Up to Week 24|Protocol Violation|0|||
161834433|NCT02696031|584435664|FG002|Up to Week 24|Protocol Violation|0|||
161834434|NCT02696031|584435665|FG003|Up to Week 24|Protocol Violation|0|||
161834435|NCT02696031|584435666|FG004|Up to Week 24|Protocol Violation|0|||
161834436|NCT02696031|584435667|FG005|Up to Week 24|Protocol Violation|0|||
161834437|NCT02696031|584435662|FG000|Up to Week 24|Withdrawal by Subject|4|||
161834438|NCT02696031|584435663|FG001|Up to Week 24|Withdrawal by Subject|1|||
161834439|NCT02696031|584435664|FG002|Up to Week 24|Withdrawal by Subject|5|||
161834440|NCT02696031|584435665|FG003|Up to Week 24|Withdrawal by Subject|0|||
161834441|NCT02696031|584435666|FG004|Up to Week 24|Withdrawal by Subject|0|||
161834442|NCT02696031|584435667|FG005|Up to Week 24|Withdrawal by Subject|0|||
161834443|NCT02696031|584435662|FG000|Up to Week 52|Adverse Event|4|||
161834444|NCT02696031|584435663|FG001|Up to Week 52|Adverse Event|5|||
161834445|NCT02696031|584435664|FG002|Up to Week 52|Adverse Event|3|||
161834446|NCT02696031|584435665|FG003|Up to Week 52|Adverse Event|0|||
161834447|NCT02696031|584435666|FG004|Up to Week 52|Adverse Event|0|||
161834448|NCT02696031|584435667|FG005|Up to Week 52|Adverse Event|0|||
161834449|NCT02696031|584435662|FG000|Up to Week 52|Lack of Efficacy|10|||
161834450|NCT02696031|584435663|FG001|Up to Week 52|Lack of Efficacy|7|||
161834451|NCT02696031|584435664|FG002|Up to Week 52|Lack of Efficacy|11|||
161834452|NCT02696031|584435665|FG003|Up to Week 52|Lack of Efficacy|0|||
161834453|NCT02696031|584435666|FG004|Up to Week 52|Lack of Efficacy|0|||
161834454|NCT02696031|584435667|FG005|Up to Week 52|Lack of Efficacy|0|||
161834455|NCT02696031|584435662|FG000|Up to Week 52|Lost to Follow-up|1|||
161834456|NCT02696031|584435663|FG001|Up to Week 52|Lost to Follow-up|1|||
161834457|NCT02696031|584435664|FG002|Up to Week 52|Lost to Follow-up|1|||
161834458|NCT02696031|584435665|FG003|Up to Week 52|Lost to Follow-up|0|||
161834459|NCT02696031|584435666|FG004|Up to Week 52|Lost to Follow-up|0|||
161834460|NCT02696031|584435667|FG005|Up to Week 52|Lost to Follow-up|0|||
161834461|NCT02696031|584435662|FG000|Up to Week 52|Physician Decision|1|||
161834462|NCT02696031|584435663|FG001|Up to Week 52|Physician Decision|1|||
161834463|NCT02696031|584435664|FG002|Up to Week 52|Physician Decision|2|||
161834464|NCT02696031|584435665|FG003|Up to Week 52|Physician Decision|0|||
161834465|NCT02696031|584435666|FG004|Up to Week 52|Physician Decision|0|||
161834466|NCT02696031|584435667|FG005|Up to Week 52|Physician Decision|0|||
161834467|NCT02696031|584435662|FG000|Up to Week 52|Pregnancy|0|||
161834468|NCT02696031|584435663|FG001|Up to Week 52|Pregnancy|2|||
161834469|NCT02696031|584435664|FG002|Up to Week 52|Pregnancy|0|||
161834470|NCT02696031|584435665|FG003|Up to Week 52|Pregnancy|0|||
161834471|NCT02696031|584435666|FG004|Up to Week 52|Pregnancy|0|||
161834472|NCT02696031|584435667|FG005|Up to Week 52|Pregnancy|0|||
161834473|NCT02696031|584435662|FG000|Up to Week 52|Protocol Violation|1|||
161834474|NCT02696031|584435663|FG001|Up to Week 52|Protocol Violation|0|||
161952806|NCT02012218|584876696|FG004|Overall Study|Lost to Follow-up|0|||
161952807|NCT02012218|584876692|FG000|Overall Study|Protocol Specified|1|||
161834475|NCT02696031|584435664|FG002|Up to Week 52|Protocol Violation|0|||
161834476|NCT02696031|584435665|FG003|Up to Week 52|Protocol Violation|0|||
161834477|NCT02696031|584435666|FG004|Up to Week 52|Protocol Violation|0|||
161834478|NCT02696031|584435667|FG005|Up to Week 52|Protocol Violation|0|||
161834479|NCT02696031|584435662|FG000|Up to Week 52|Withdrawal by Subject|12|||
161952808|NCT02012218|584876693|FG001|Overall Study|Protocol Specified|0|||
161952809|NCT02012218|584876694|FG002|Overall Study|Protocol Specified|0|||
161834480|NCT02696031|584435663|FG001|Up to Week 52|Withdrawal by Subject|3|||
161834481|NCT02696031|584435664|FG002|Up to Week 52|Withdrawal by Subject|9|||
161834482|NCT02696031|584435665|FG003|Up to Week 52|Withdrawal by Subject|0|||
161834483|NCT02696031|584435666|FG004|Up to Week 52|Withdrawal by Subject|0|||
161952810|NCT02012218|584876695|FG003|Overall Study|Protocol Specified|0|||
161952811|NCT02012218|584876696|FG004|Overall Study|Protocol Specified|0|||
161834484|NCT02696031|584435667|FG005|Up to Week 52|Withdrawal by Subject|0|||
161834485|NCT02696031|584435662|FG000|Up to Week 104|Pregnancy|0|||
161834486|NCT02696031|584435663|FG001|Up to Week 104|Pregnancy|2|||
161834487|NCT02696031|584435664|FG002|Up to Week 104|Pregnancy|1|||
161834488|NCT02696031|584435665|FG003|Up to Week 104|Pregnancy|0|||
161834489|NCT02696031|584435666|FG004|Up to Week 104|Pregnancy|0|||
161952812|NCT02012218|584876692|FG000|Overall Study|Protocol Deviation|1|||
161834490|NCT02696031|584435667|FG005|Up to Week 104|Pregnancy|0|||
161834491|NCT02696031|584435662|FG000|Up to Week 104|Withdrawal by Subject|15|||
161834492|NCT02696031|584435663|FG001|Up to Week 104|Withdrawal by Subject|10|||
161834493|NCT02696031|584435664|FG002|Up to Week 104|Withdrawal by Subject|16|||
161834494|NCT02696031|584435665|FG003|Up to Week 104|Withdrawal by Subject|0|||
161834495|NCT02696031|584435666|FG004|Up to Week 104|Withdrawal by Subject|0|||
161834496|NCT02696031|584435667|FG005|Up to Week 104|Withdrawal by Subject|0|||
161834497|NCT02696031|584435662|FG000|Up to Week 104|Protocol Violation|1|||
161834498|NCT02696031|584435663|FG001|Up to Week 104|Protocol Violation|0|||
161834499|NCT02696031|584435664|FG002|Up to Week 104|Protocol Violation|0|||
161834500|NCT02696031|584435665|FG003|Up to Week 104|Protocol Violation|0|||
161834501|NCT02696031|584435666|FG004|Up to Week 104|Protocol Violation|0|||
161834502|NCT02696031|584435667|FG005|Up to Week 104|Protocol Violation|0|||
161834503|NCT02696031|584435662|FG000|Up to Week 104|Physician Decision|1|||
161834504|NCT02696031|584435663|FG001|Up to Week 104|Physician Decision|2|||
161834505|NCT02696031|584435664|FG002|Up to Week 104|Physician Decision|3|||
161834506|NCT02696031|584435665|FG003|Up to Week 104|Physician Decision|0|||
161834507|NCT02696031|584435666|FG004|Up to Week 104|Physician Decision|0|||
161834508|NCT02696031|584435667|FG005|Up to Week 104|Physician Decision|0|||
161834509|NCT02696031|584435662|FG000|Up to Week 104|Lost to Follow-up|2|||
161834510|NCT02696031|584435663|FG001|Up to Week 104|Lost to Follow-up|3|||
161834511|NCT02696031|584435664|FG002|Up to Week 104|Lost to Follow-up|1|||
161834512|NCT02696031|584435665|FG003|Up to Week 104|Lost to Follow-up|0|||
161834513|NCT02696031|584435666|FG004|Up to Week 104|Lost to Follow-up|0|||
161834514|NCT02696031|584435667|FG005|Up to Week 104|Lost to Follow-up|0|||
161834515|NCT02696031|584435662|FG000|Up to Week 104|Lack of Efficacy|13|||
161834516|NCT02696031|584435663|FG001|Up to Week 104|Lack of Efficacy|12|||
161834517|NCT02696031|584435664|FG002|Up to Week 104|Lack of Efficacy|11|||
161834518|NCT02696031|584435665|FG003|Up to Week 104|Lack of Efficacy|0|||
161834519|NCT02696031|584435666|FG004|Up to Week 104|Lack of Efficacy|0|||
161834520|NCT02696031|584435667|FG005|Up to Week 104|Lack of Efficacy|0|||
161834521|NCT02696031|584435662|FG000|Up to Week 104|Adverse Event|7|||
161834522|NCT02696031|584435663|FG001|Up to Week 104|Adverse Event|11|||
161834523|NCT02696031|584435664|FG002|Up to Week 104|Adverse Event|5|||
161834524|NCT02696031|584435665|FG003|Up to Week 104|Adverse Event|0|||
161834525|NCT02696031|584435666|FG004|Up to Week 104|Adverse Event|0|||
161834526|NCT02696031|584435667|FG005|Up to Week 104|Adverse Event|0|||
161834527|NCT02696031|584435662|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161834528|NCT02696031|584435663|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
161834529|NCT02696031|584435664|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161834530|NCT02696031|584435665|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161834531|NCT02696031|584435666|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161834532|NCT02696031|584435667|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161834533|NCT02696031|584435662|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
161834534|NCT02696031|584435663|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
161834535|NCT02696031|584435664|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
161834536|NCT02696031|584435665|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
161834537|NCT02696031|584435666|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
161834538|NCT02696031|584435667|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
161834539|NCT02696031|584435662|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
161834540|NCT02696031|584435663|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
161834541|NCT02696031|584435664|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
161834542|NCT02696031|584435665|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
161834543|NCT02696031|584435666|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
161834544|NCT02696031|584435667|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
161834545|NCT02696031|584435662|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161834546|NCT02696031|584435663|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161834547|NCT02696031|584435664|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161834548|NCT02696031|584435665|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
161834549|NCT02696031|584435666|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161834550|NCT02696031|584435667|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161834551|NCT02696031|584435662|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161834552|NCT02696031|584435663|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161834553|NCT02696031|584435664|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161834554|NCT02696031|584435665|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161834555|NCT02696031|584435666|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
161834556|NCT02696031|584435667|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161834557|NCT02696031|584435662|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
161834558|NCT02696031|584435663|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
161834559|NCT02696031|584435664|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
161834560|NCT02696031|584435665|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
161686801|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
161686802|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
161686803|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
161686804|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
161686805|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
161686806|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
161686807|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
161686808|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
161686809|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
161686810|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
161686811|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
161686812|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
161686813|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
161686814|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
161686815|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
161686816|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
161686817|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
161686818|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
161686819|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
161686820|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
161686821|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
161686822|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
161686823|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
161686824|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
161686825|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
161686826|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
161686827|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
161686828|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
161686829|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
161686830|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
161686831|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
161686832|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
161686833|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
161686834|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
161686835|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
161686836|NCT02831673|583907081|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
161686837|NCT02831673|583907082|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
161686838|NCT02831673|583907083|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
161686839|NCT02831673|583907084|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
161686840|NCT02831673|583907085|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
161686841|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161686842|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161686843|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
161686844|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
161686845|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161686846|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161686847|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161686848|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
161686849|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
162028822|NCT00821509|585161860|FG001|Overall Study|Withdrawal by Subject|11|||
162028823|NCT00821509|585161861|FG002|Overall Study|Withdrawal by Subject|34|||
161686850|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161686851|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161686852|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161686853|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161686854|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
161686855|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161686856|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
161686857|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
161686858|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
161686859|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
161686860|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
161686861|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161686862|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161686863|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
161686864|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
161686865|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161686866|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161686867|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161686868|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
161686869|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
161686870|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161686871|NCT02831673|583907081|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161686872|NCT02831673|583907082|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161686873|NCT02831673|583907083|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
161686874|NCT02831673|583907084|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
161686875|NCT02831673|583907085|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161686876|NCT02831673|583907081|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
161686877|NCT02831673|583907082|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
161686878|NCT02831673|583907083|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
162028824|NCT01551420|585161862|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
162028825|NCT01551420|585161863|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
162028826|NCT01551420|585161862|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
162028827|NCT01551420|585161863|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
162028828|NCT01551420|585161862|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
162028829|NCT01551420|585161863|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
162028830|NCT01551420|585161862|FG000|Screened for Part B Eligibility|Declined participation|8|||
162028831|NCT01551420|585161863|FG001|Screened for Part B Eligibility|Declined participation|1|||
162028832|NCT01551420|585161862|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
162028833|NCT01551420|585161863|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
162028834|NCT01551420|585161862|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
162028835|NCT01551420|585161863|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
162028836|NCT01551420|585161862|FG000|Home Use (Part B)|Withdrawal by staff|0|||
162028837|NCT01551420|585161863|FG001|Home Use (Part B)|Withdrawal by staff|1|||
162028838|NCT03612856|585161864|FG000|Pre-dose Period|Physician Decision|0|||
162028839|NCT03612856|585161865|FG001|Pre-dose Period|Physician Decision|1|||
162028840|NCT03612856|585161866|FG002|Pre-dose Period|Physician Decision|1|||
162028841|NCT03612856|585161864|FG000|Pre-dose Period|Withdrawal by Subject|0|||
162028842|NCT03612856|585161865|FG001|Pre-dose Period|Withdrawal by Subject|1|||
162028843|NCT03612856|585161866|FG002|Pre-dose Period|Withdrawal by Subject|0|||
162028844|NCT01576159|585161867|FG000|Overall Study|Withdrawal by Subject|0|||
161686879|NCT02831673|583907084|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
161952813|NCT02012218|584876693|FG001|Overall Study|Protocol Deviation|0|||
161952814|NCT02012218|584876694|FG002|Overall Study|Protocol Deviation|0|||
161952815|NCT02012218|584876695|FG003|Overall Study|Protocol Deviation|0|||
161952816|NCT02012218|584876696|FG004|Overall Study|Protocol Deviation|0|||
161952817|NCT03761056|584876701|FG000|Overall Study|Death|8|||
161952818|NCT03761056|584876701|FG000|Overall Study|Enrolled but never treated|2|||
161952819|NCT03761056|584876701|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
161952820|NCT03761056|584876701|FG000|Overall Study|Investigator decision|1|||
161686880|NCT02831673|583907085|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
161686881|NCT02831673|583907081|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161686882|NCT02831673|583907082|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161686883|NCT02831673|583907083|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161686884|NCT02831673|583907084|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161686885|NCT02831673|583907085|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
161686886|NCT02831673|583907081|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161686887|NCT02831673|583907082|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161686888|NCT02831673|583907083|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161686889|NCT02831673|583907084|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161686890|NCT02831673|583907085|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
161686891|NCT02831673|583907081|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161686892|NCT02831673|583907082|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161686893|NCT02831673|583907083|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161686894|NCT02831673|583907084|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161686895|NCT02831673|583907085|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
161686896|NCT02831673|583907081|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161686897|NCT02831673|583907082|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161686898|NCT02831673|583907083|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161686899|NCT02831673|583907084|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161686900|NCT02831673|583907085|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
161686901|NCT00150592|583907086|FG000|Overall Study|Adverse Event|4|||
161834561|NCT02696031|584435666|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
161834562|NCT02696031|584435667|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
161834563|NCT02696031|584435662|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
161834564|NCT02696031|584435663|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
161834565|NCT02696031|584435664|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
161834566|NCT02696031|584435665|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
161834567|NCT02696031|584435666|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
161834568|NCT02696031|584435667|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
161834569|NCT00597116|584435668|FG000|Overall Study|Adverse Event|2|||
161834570|NCT00597116|584435669|FG001|Overall Study|Adverse Event|1|||
161834571|NCT00597116|584435668|FG000|Overall Study|Withdrawal by Subject|0|||
162028845|NCT01576159|585161868|FG001|Overall Study|Withdrawal by Subject|1|||
161834572|NCT00597116|584435669|FG001|Overall Study|Withdrawal by Subject|2|||
161834573|NCT00597116|584435668|FG000|Overall Study|Physician Decision|0|||
161834574|NCT00597116|584435669|FG001|Overall Study|Physician Decision|1|||
161834575|NCT00597116|584435668|FG000|Overall Study|Death|0|||
161834576|NCT00597116|584435669|FG001|Overall Study|Death|1|||
161834577|NCT00597116|584435668|FG000|Overall Study|Lost to Follow-up|1|||
161834578|NCT00597116|584435669|FG001|Overall Study|Lost to Follow-up|0|||
161834579|NCT00597116|584435668|FG000|Overall Study|Progressive disease|11|||
161834580|NCT00597116|584435669|FG001|Overall Study|Progressive disease|6|||
161834581|NCT00063882|584435672|FG000|Overall Study|Protocol Violation|3|||
161834582|NCT00063882|584435673|FG001|Overall Study|Protocol Violation|3|||
161834583|NCT00063882|584435672|FG000|Overall Study|Withdrawal by Subject|2|||
161834584|NCT00063882|584435673|FG001|Overall Study|Withdrawal by Subject|1|||
161952821|NCT00996658|584876702|FG000|Overall Study|Adverse Event|2|||
161952822|NCT00996658|584876703|FG001|Overall Study|Adverse Event|5|||
161952823|NCT00996658|584876702|FG000|Overall Study|Protocol Violation|0|||
161952824|NCT00996658|584876703|FG001|Overall Study|Protocol Violation|1|||
161952825|NCT00996658|584876702|FG000|Overall Study|Lost to Follow-up|2|||
161952826|NCT00996658|584876703|FG001|Overall Study|Lost to Follow-up|5|||
161834585|NCT02903238|584435674|FG000|Overall Study|Lost to Follow-up|4|||
161834586|NCT01855048|584435694|FG000|Overall Study|Withdrawal by Subject|0|||
161952827|NCT00996658|584876702|FG000|Overall Study|Non-compliance issues|3|||
161834587|NCT01855048|584435695|FG001|Overall Study|Withdrawal by Subject|1|||
161834588|NCT01855048|584435696|FG002|Overall Study|Withdrawal by Subject|0|||
161834589|NCT01855048|584435697|FG003|Overall Study|Withdrawal by Subject|0|||
161834590|NCT01855048|584435698|FG004|Overall Study|Withdrawal by Subject|1|||
161686902|NCT00150592|583907087|FG001|Overall Study|Adverse Event|1|||
161686903|NCT00150592|583907086|FG000|Overall Study|Protocol Violation|1|||
161686904|NCT00150592|583907087|FG001|Overall Study|Protocol Violation|0|||
161686905|NCT00150592|583907086|FG000|Overall Study|Withdrawal by Subject|1|||
161686906|NCT00150592|583907087|FG001|Overall Study|Withdrawal by Subject|2|||
161686907|NCT00150592|583907086|FG000|Overall Study|Non-compliance|1|||
161686908|NCT00150592|583907087|FG001|Overall Study|Non-compliance|0|||
161686909|NCT01823679|583907088|FG000|Overall Study|Death|1|||
161686910|NCT01157078|583907089|FG000|Overall Study|Withdrawal by Subject|12|||
161686911|NCT01157078|583907090|FG001|Overall Study|Withdrawal by Subject|14|||
161686912|NCT01157078|583907089|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161686913|NCT01157078|583907090|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161686914|NCT01157078|583907089|FG000|Overall Study|Adverse Event|6|||
161686915|NCT01157078|583907090|FG001|Overall Study|Adverse Event|6|||
161686916|NCT01157078|583907089|FG000|Overall Study|Severe non-compliance to protocol|2|||
161686917|NCT01157078|583907090|FG001|Overall Study|Severe non-compliance to protocol|4|||
161686918|NCT01157078|583907089|FG000|Overall Study|Condition under investigation worsened|0|||
161686919|NCT01157078|583907090|FG001|Overall Study|Condition under investigation worsened|1|||
161686920|NCT01157078|583907089|FG000|Overall Study|Lack of Efficacy|2|||
161686921|NCT01157078|583907090|FG001|Overall Study|Lack of Efficacy|0|||
161686922|NCT01157078|583907089|FG000|Overall Study|Study-specific withdrawal criteria|2|||
161686923|NCT01157078|583907090|FG001|Overall Study|Study-specific withdrawal criteria|2|||
161686924|NCT01157078|583907089|FG000|Overall Study|Lost to Follow-up|7|||
161686925|NCT01157078|583907090|FG001|Overall Study|Lost to Follow-up|5|||
161686926|NCT01157078|583907089|FG000|Overall Study|Other|2|||
161686927|NCT01157078|583907090|FG001|Overall Study|Other|4|||
161686928|NCT02495844|583907092|FG000|Overall Study|Lack of Efficacy|1|||
161686929|NCT02495844|583907093|FG001|Overall Study|Lack of Efficacy|2|||
161686930|NCT02495844|583907092|FG000|Overall Study|AE, non-fatal|0|||
161686931|NCT02495844|583907093|FG001|Overall Study|AE, non-fatal|1|||
161686932|NCT02495844|583907092|FG000|Overall Study|Hepatitis Positivity|0|||
161686933|NCT02495844|583907093|FG001|Overall Study|Hepatitis Positivity|1|||
161686934|NCT02145741|583907095|FG000|Overall Study|Progressive disease|3|||
161686935|NCT02145741|583907096|FG001|Overall Study|Progressive disease|6|||
161686936|NCT02145741|583907097|FG002|Overall Study|Progressive disease|6|||
161686937|NCT02145741|583907095|FG000|Overall Study|quality issue with the administered drug|3|||
161686938|NCT02145741|583907096|FG001|Overall Study|quality issue with the administered drug|0|||
161686939|NCT02145741|583907097|FG002|Overall Study|quality issue with the administered drug|0|||
161686940|NCT01594853|583907098|FG000|Overall Study|Withdrawal by Subject|1|||
161686941|NCT01594853|583907099|FG001|Overall Study|Withdrawal by Subject|1|||
161686942|NCT01594853|583907098|FG000|Overall Study|Lost to Follow-up|1|||
161686943|NCT01594853|583907099|FG001|Overall Study|Lost to Follow-up|1|||
161686944|NCT01594853|583907098|FG000|Overall Study|noncompliance with exercise|0|||
161686945|NCT01594853|583907099|FG001|Overall Study|noncompliance with exercise|1|||
161686946|NCT00769002|583907100|FG000|Overall Study|Study was not completed, no data|9|||
161686947|NCT00769002|583907101|FG001|Overall Study|Study was not completed, no data|9|||
161686948|NCT00847912|583907107|FG000|Overall Study|Protocol Violation|6|||
161686949|NCT00847912|583907108|FG001|Overall Study|Protocol Violation|7|||
161686950|NCT00847912|583907107|FG000|Overall Study|Withdrawal by Subject|3|||
161686951|NCT00847912|583907108|FG001|Overall Study|Withdrawal by Subject|6|||
161686952|NCT01496885|583907109|FG000|Overall Study|Lost to Follow-up|13|||
161686953|NCT01496885|583907109|FG000|Overall Study|Withdrawal by Subject|7|||
161686954|NCT01496885|583907109|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
161686955|NCT01496885|583907109|FG000|Overall Study|Death|1|||
161686956|NCT03273166|583907110|FG000|Overall Study|Withdrawn prior to Completion|31|||
161686957|NCT01294670|583907111|FG000|Overall Study|Not treated|1|||
161686958|NCT01294670|583907112|FG001|Overall Study|Not treated|0|||
161686959|NCT01294670|583907113|FG002|Overall Study|Not treated|0|||
161686960|NCT01294670|583907114|FG003|Overall Study|Not treated|0|||
161686961|NCT01294670|583907115|FG004|Overall Study|Not treated|0|||
161686962|NCT02412787|583907116|FG000|Overall Study|Withdrawal by Subject|9|||
161686963|NCT02412787|583907116|FG000|Overall Study|Participation Terminated by Investigator|1|||
161686964|NCT02412787|583907116|FG000|Overall Study|Site Terminated by Sponsor|21|||
161686965|NCT02412787|583907116|FG000|Overall Study|Technical Problems|1|||
161686966|NCT02412787|583907116|FG000|Overall Study|Reason Not Specified|1|||
161686967|NCT03246958|583907117|FG000|Overall Study|Withdrawal by Subject|0|||
161686968|NCT03246958|583907118|FG001|Overall Study|Withdrawal by Subject|1|||
161686969|NCT03246958|583907119|FG002|Overall Study|Withdrawal by Subject|0|||
161686970|NCT03246958|583907120|FG003|Overall Study|Withdrawal by Subject|0|||
161686971|NCT03246958|583907121|FG004|Overall Study|Withdrawal by Subject|0|||
161686972|NCT03246958|583907122|FG005|Overall Study|Withdrawal by Subject|1|||
161686973|NCT03246958|583907123|FG006|Overall Study|Withdrawal by Subject|0|||
161686974|NCT03246958|583907117|FG000|Overall Study|Progression|13|||
161686975|NCT03246958|583907118|FG001|Overall Study|Progression|9|||
161686976|NCT03246958|583907119|FG002|Overall Study|Progression|3|||
161686977|NCT03246958|583907120|FG003|Overall Study|Progression|2|||
161686978|NCT03246958|583907121|FG004|Overall Study|Progression|1|||
161952828|NCT00996658|584876703|FG001|Overall Study|Non-compliance issues|3|||
161686979|NCT03246958|583907122|FG005|Overall Study|Progression|2|||
161686980|NCT03246958|583907123|FG006|Overall Study|Progression|1|||
161686981|NCT03246958|583907117|FG000|Overall Study|Adverse Event|2|||
161686982|NCT03246958|583907118|FG001|Overall Study|Adverse Event|2|||
161686983|NCT03246958|583907119|FG002|Overall Study|Adverse Event|0|||
161952829|NCT00996658|584876702|FG000|Overall Study|Other|9|||
161952830|NCT00996658|584876703|FG001|Overall Study|Other|7|||
161686984|NCT03246958|583907120|FG003|Overall Study|Adverse Event|1|||
161834591|NCT01855048|584435699|FG005|Overall Study|Withdrawal by Subject|0|||
161834592|NCT02972502|584435704|FG000|Overall Study|Lost to Follow-up|3|||
161834593|NCT02972502|584435705|FG001|Overall Study|Lost to Follow-up|1|||
161834594|NCT02972502|584435704|FG000|Overall Study|Withdrawal by Subject|1|||
161834595|NCT02972502|584435705|FG001|Overall Study|Withdrawal by Subject|1|||
161834596|NCT03832738|584435706|FG000|Overall Study|Withdrawal by Subject|6|||
161834597|NCT03832738|584435707|FG001|Overall Study|Withdrawal by Subject|7|||
161834598|NCT03832738|584435708|FG002|Overall Study|Withdrawal by Subject|16|||
161834599|NCT03832738|584435706|FG000|Overall Study|Physician Decision|0|||
161834600|NCT03832738|584435707|FG001|Overall Study|Physician Decision|1|||
161834601|NCT03832738|584435708|FG002|Overall Study|Physician Decision|2|||
161834602|NCT03832738|584435706|FG000|Overall Study|Adverse Event|2|||
161834603|NCT03832738|584435707|FG001|Overall Study|Adverse Event|3|||
161834604|NCT03832738|584435708|FG002|Overall Study|Adverse Event|1|||
161834605|NCT03832738|584435706|FG000|Overall Study|Pregnancy|0|||
161834606|NCT03832738|584435707|FG001|Overall Study|Pregnancy|1|||
161834607|NCT03832738|584435708|FG002|Overall Study|Pregnancy|0|||
161834608|NCT03852459|584435709|FG000|Overall Study|Adverse Event|2|||
161834609|NCT03852459|584435710|FG001|Overall Study|Adverse Event|2|||
161834610|NCT03852459|584435709|FG000|Overall Study|Withdrawal by Subject|1|||
161834611|NCT03852459|584435710|FG001|Overall Study|Withdrawal by Subject|1|||
161834612|NCT00049842|584435711|FG000|Treatment Phase|Adverse Event|47|||
161834613|NCT00049842|584435712|FG001|Treatment Phase|Adverse Event|12|||
161834614|NCT00049842|584435711|FG000|Treatment Phase|Withdrawal by Subject|35|||
161834615|NCT00049842|584435712|FG001|Treatment Phase|Withdrawal by Subject|46|||
161834616|NCT00049842|584435711|FG000|Treatment Phase|Non-compliance with protocol|7|||
161834617|NCT00049842|584435712|FG001|Treatment Phase|Non-compliance with protocol|8|||
161834618|NCT00049842|584435711|FG000|Treatment Phase|Lost to Follow-up|4|||
161834619|NCT00049842|584435712|FG001|Treatment Phase|Lost to Follow-up|8|||
161834620|NCT00049842|584435711|FG000|Treatment Phase|Administrative|0|||
161834621|NCT00049842|584435712|FG001|Treatment Phase|Administrative|3|||
161834622|NCT00049842|584435711|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
161834623|NCT00049842|584435712|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
161834624|NCT00049842|584435711|FG000|Follow-up Phase|Adverse Event|6|||
161834625|NCT00049842|584435712|FG001|Follow-up Phase|Adverse Event|1|||
161834626|NCT00049842|584435711|FG000|Follow-up Phase|Other|1|||
161952831|NCT04749745|584876704|FG000|Overall Study|Withdrawal by Subject|1|||
161834627|NCT00049842|584435712|FG001|Follow-up Phase|Other|4|||
161952832|NCT04749745|584876705|FG001|Overall Study|Withdrawal by Subject|0|||
161952833|NCT01234480|584878144|FG000|Overall Study|Pregnancy|88|||
161952834|NCT01234480|584878144|FG000|Overall Study|>36/Normal History|50|||
161952835|NCT01234480|584878144|FG000|Overall Study|Age|3|||
161952836|NCT01234480|584878144|FG000|Overall Study|HPV Vaccine History|28|||
161952837|NCT01234480|584878144|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
161686985|NCT03246958|583907121|FG004|Overall Study|Adverse Event|1|||
161686986|NCT03246958|583907122|FG005|Overall Study|Adverse Event|0|||
161686987|NCT03246958|583907123|FG006|Overall Study|Adverse Event|2|||
161686988|NCT03246958|583907117|FG000|Overall Study|Death|0|||
161686989|NCT03246958|583907118|FG001|Overall Study|Death|1|||
161686990|NCT03246958|583907119|FG002|Overall Study|Death|0|||
161686991|NCT03246958|583907120|FG003|Overall Study|Death|0|||
161686992|NCT03246958|583907121|FG004|Overall Study|Death|0|||
161686993|NCT03246958|583907122|FG005|Overall Study|Death|0|||
161686994|NCT03246958|583907123|FG006|Overall Study|Death|0|||
161686995|NCT03246958|583907117|FG000|Overall Study|Physician Decision|0|||
161686996|NCT03246958|583907118|FG001|Overall Study|Physician Decision|0|||
161686997|NCT03246958|583907119|FG002|Overall Study|Physician Decision|0|||
161686998|NCT03246958|583907120|FG003|Overall Study|Physician Decision|1|||
161686999|NCT03246958|583907121|FG004|Overall Study|Physician Decision|0|||
161687000|NCT03246958|583907122|FG005|Overall Study|Physician Decision|0|||
161687001|NCT03246958|583907123|FG006|Overall Study|Physician Decision|0|||
161687002|NCT03246958|583907117|FG000|Overall Study|Never start treatment|1|||
161687003|NCT03246958|583907118|FG001|Overall Study|Never start treatment|0|||
161687004|NCT03246958|583907119|FG002|Overall Study|Never start treatment|0|||
161834628|NCT01813071|584435713|FG000|Overall Study|Protocol Violation|0|||
161834629|NCT01813071|584435714|FG001|Overall Study|Protocol Violation|0|||
161834630|NCT01813071|584435715|FG002|Overall Study|Protocol Violation|0|||
161952838|NCT01234480|584878144|FG000|Overall Study|Hysterectomy|2|||
161687005|NCT03246958|583907120|FG003|Overall Study|Never start treatment|0|||
161687006|NCT03246958|583907121|FG004|Overall Study|Never start treatment|0|||
161834631|NCT01813071|584435716|FG003|Overall Study|Protocol Violation|0|||
161687007|NCT03246958|583907122|FG005|Overall Study|Never start treatment|0|||
161834632|NCT01813071|584435717|FG004|Overall Study|Protocol Violation|1|||
161834633|NCT01813071|584435718|FG005|Overall Study|Protocol Violation|4|||
161834634|NCT01813071|584435719|FG006|Overall Study|Protocol Violation|2|||
161834635|NCT01813071|584435720|FG007|Overall Study|Protocol Violation|4|||
161834636|NCT01813071|584435721|FG008|Overall Study|Protocol Violation|2|||
161834637|NCT01813071|584435713|FG000|Overall Study|Withdrawal by Subject|0|||
161834638|NCT01813071|584435714|FG001|Overall Study|Withdrawal by Subject|0|||
161834639|NCT01813071|584435715|FG002|Overall Study|Withdrawal by Subject|0|||
161834640|NCT01813071|584435716|FG003|Overall Study|Withdrawal by Subject|0|||
161834641|NCT01813071|584435717|FG004|Overall Study|Withdrawal by Subject|0|||
161834642|NCT01813071|584435718|FG005|Overall Study|Withdrawal by Subject|1|||
161834643|NCT01813071|584435719|FG006|Overall Study|Withdrawal by Subject|0|||
161834644|NCT01813071|584435720|FG007|Overall Study|Withdrawal by Subject|0|||
161834645|NCT01813071|584435721|FG008|Overall Study|Withdrawal by Subject|0|||
161834646|NCT01813071|584435713|FG000|Overall Study|Adverse Event|0|||
161834647|NCT01813071|584435714|FG001|Overall Study|Adverse Event|0|||
161834648|NCT01813071|584435715|FG002|Overall Study|Adverse Event|0|||
161834649|NCT01813071|584435716|FG003|Overall Study|Adverse Event|0|||
161834650|NCT01813071|584435717|FG004|Overall Study|Adverse Event|0|||
161687008|NCT03246958|583907123|FG006|Overall Study|Never start treatment|0|||
161834651|NCT01813071|584435718|FG005|Overall Study|Adverse Event|1|||
161834652|NCT01813071|584435719|FG006|Overall Study|Adverse Event|0|||
161834653|NCT01813071|584435720|FG007|Overall Study|Adverse Event|0|||
161834654|NCT01813071|584435721|FG008|Overall Study|Adverse Event|0|||
161687009|NCT03246958|583907117|FG000|Overall Study|Over enrollment|0|||
161687010|NCT03246958|583907118|FG001|Overall Study|Over enrollment|2|||
161687011|NCT03246958|583907119|FG002|Overall Study|Over enrollment|0|||
162028846|NCT01576159|585161869|FG002|Overall Study|Withdrawal by Subject|0|||
162237314|NCT01178671|585921067|FG001|Overall Study|Adverse Event|6|||
162237315|NCT01178671|585921066|FG000|Overall Study|Protocol Violation|1|||
162237316|NCT01178671|585921067|FG001|Overall Study|Protocol Violation|1|||
162237317|NCT01178671|585921066|FG000|Overall Study|Lack of Efficacy|0|||
162237318|NCT01178671|585921067|FG001|Overall Study|Lack of Efficacy|1|||
162237319|NCT01178671|585921066|FG000|Overall Study|Lost to Follow-up|3|||
162237320|NCT01178671|585921067|FG001|Overall Study|Lost to Follow-up|1|||
162237321|NCT01178671|585921066|FG000|Overall Study|Physician Decision|4|||
162237322|NCT01178671|585921067|FG001|Overall Study|Physician Decision|6|||
162237323|NCT04620811|585921068|FG000|Overall Study|Withdrawal by Subject|18|||
162237324|NCT04620811|585921069|FG001|Overall Study|Withdrawal by Subject|15|||
162237325|NCT04620811|585921068|FG000|Overall Study|Adverse Event|6|||
162237326|NCT04620811|585921069|FG001|Overall Study|Adverse Event|11|||
162237327|NCT04620811|585921068|FG000|Overall Study|Lost to Follow-up|4|||
162237328|NCT04620811|585921069|FG001|Overall Study|Lost to Follow-up|8|||
162237329|NCT04620811|585921068|FG000|Overall Study|Physician Decision|1|||
162237330|NCT04620811|585921069|FG001|Overall Study|Physician Decision|4|||
162237331|NCT04620811|585921068|FG000|Overall Study|Sponsor Decision|0|||
162237332|NCT04620811|585921069|FG001|Overall Study|Sponsor Decision|1|||
162237333|NCT04620811|585921068|FG000|Overall Study|Elevation of ALT or AST|1|||
162237334|NCT04620811|585921069|FG001|Overall Study|Elevation of ALT or AST|0|||
162237335|NCT04620811|585921068|FG000|Overall Study|Other|3|||
162237336|NCT04620811|585921069|FG001|Overall Study|Other|5|||
162237337|NCT01078675|585921070|FG000|Overall Study|Withdrawal by Subject|7|||
162237338|NCT01078675|585921071|FG001|Overall Study|Withdrawal by Subject|3|||
162237339|NCT01078675|585921070|FG000|Overall Study|Protocol Violation|56|||
162237340|NCT01078675|585921071|FG001|Overall Study|Protocol Violation|0|||
162237341|NCT01078675|585921070|FG000|Overall Study|Provided in CRF for specific reasons|2|||
162237342|NCT01078675|585921071|FG001|Overall Study|Provided in CRF for specific reasons|3|||
162237343|NCT01078675|585921070|FG000|Overall Study|Adverse Event|3|||
162237344|NCT01078675|585921071|FG001|Overall Study|Adverse Event|0|||
162237345|NCT02513303|585921072|FG000|Overall Study|Withdrawal by Subject|9|||
162237346|NCT02513303|585921073|FG001|Overall Study|Withdrawal by Subject|7|||
162237347|NCT02513303|585921074|FG002|Overall Study|Withdrawal by Subject|2|||
162237348|NCT02513303|585921072|FG000|Overall Study|Lost to Follow-up|2|||
162237349|NCT02513303|585921073|FG001|Overall Study|Lost to Follow-up|4|||
162237350|NCT02513303|585921074|FG002|Overall Study|Lost to Follow-up|0|||
162237351|NCT02513303|585921072|FG000|Overall Study|Adverse Event|0|||
162237352|NCT02513303|585921073|FG001|Overall Study|Adverse Event|1|||
162237353|NCT02513303|585921074|FG002|Overall Study|Adverse Event|0|||
162237354|NCT02513303|585921072|FG000|Overall Study|Physician Decision|1|||
162237355|NCT02513303|585921073|FG001|Overall Study|Physician Decision|1|||
162237356|NCT02513303|585921074|FG002|Overall Study|Physician Decision|0|||
162237357|NCT02513303|585921072|FG000|Overall Study|Death|8|||
162237358|NCT02513303|585921073|FG001|Overall Study|Death|4|||
162237359|NCT02513303|585921074|FG002|Overall Study|Death|2|||
162237360|NCT00679627|585921075|FG000|Overall Study|Death|41|||
162237361|NCT00679627|585921076|FG001|Overall Study|Death|29|||
162237362|NCT00679627|585921075|FG000|Overall Study|Adverse Event|43|||
162237363|NCT00679627|585921076|FG001|Overall Study|Adverse Event|53|||
162237364|NCT00679627|585921075|FG000|Overall Study|Withdrawal by Subject|168|||
162237365|NCT00679627|585921076|FG001|Overall Study|Withdrawal by Subject|172|||
161687012|NCT03246958|583907120|FG003|Overall Study|Over enrollment|0|||
161952839|NCT01234480|584878144|FG000|Overall Study|Hysterectomy post enrollment|1|||
161952840|NCT01234480|584878144|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
161952841|NCT01234480|584878144|FG000|Overall Study|Informed Consent Form Violation|30|||
161952842|NCT01234480|584878144|FG000|Overall Study|Incorrect Visit|3|||
161834655|NCT01813071|584435713|FG000|Overall Study|Physician Decision|0|||
161834656|NCT01813071|584435714|FG001|Overall Study|Physician Decision|0|||
161834657|NCT01813071|584435715|FG002|Overall Study|Physician Decision|0|||
161834658|NCT01813071|584435716|FG003|Overall Study|Physician Decision|0|||
161834659|NCT01813071|584435717|FG004|Overall Study|Physician Decision|0|||
161834660|NCT01813071|584435718|FG005|Overall Study|Physician Decision|0|||
161834661|NCT01813071|584435719|FG006|Overall Study|Physician Decision|1|||
161834662|NCT01813071|584435720|FG007|Overall Study|Physician Decision|0|||
161834663|NCT01813071|584435721|FG008|Overall Study|Physician Decision|0|||
161834664|NCT01813071|584435713|FG000|Overall Study|Met inc/exc criteria|0|||
161834665|NCT01813071|584435714|FG001|Overall Study|Met inc/exc criteria|0|||
161834666|NCT01813071|584435715|FG002|Overall Study|Met inc/exc criteria|0|||
161834667|NCT01813071|584435716|FG003|Overall Study|Met inc/exc criteria|0|||
161834668|NCT01813071|584435717|FG004|Overall Study|Met inc/exc criteria|0|||
161834669|NCT01813071|584435718|FG005|Overall Study|Met inc/exc criteria|1|||
161834670|NCT01813071|584435719|FG006|Overall Study|Met inc/exc criteria|0|||
161834671|NCT01813071|584435720|FG007|Overall Study|Met inc/exc criteria|1|||
161834672|NCT01813071|584435721|FG008|Overall Study|Met inc/exc criteria|1|||
161834673|NCT00307931|584435722|FG000|Overall Study|Adverse Event|1|||
161834674|NCT02442271|584435729|FG000|Overall Study|Adverse Event|1|||
161834675|NCT02442271|584435729|FG000|Overall Study|Withdrew Consent|1|||
161834676|NCT02442271|584435729|FG000|Overall Study|Lost to Follow-up|1|||
161834677|NCT02442271|584435729|FG000|Overall Study|Other|1|||
161834678|NCT00831623|584435733|FG000|Overall Study|Withdrawal by Subject|9|||
161834679|NCT00831623|584435733|FG000|Overall Study|Lost to Follow-up|1|||
161834680|NCT00831623|584435733|FG000|Overall Study|Not 2 years post-treatment|12|||
161834681|NCT01138111|584435735|FG000|Overall Study|Withdrawal by Subject|5|||
161834682|NCT01138111|584435735|FG000|Overall Study|Adverse Event|1|||
161834683|NCT01138111|584435735|FG000|Overall Study|Death|1|||
161834684|NCT01138111|584435735|FG000|Overall Study|Lost to Follow-up|2|||
161834685|NCT01118117|584435736|FG000|Overall Study|Death|8|||
161834686|NCT01118117|584435737|FG001|Overall Study|Death|0|||
161834687|NCT01118117|584435736|FG000|Overall Study|Lost to Follow-up|6|||
161834688|NCT01118117|584435737|FG001|Overall Study|Lost to Follow-up|0|||
161834689|NCT01118117|584435736|FG000|Overall Study|Missed 12 Month Visit|7|||
161834690|NCT01118117|584435737|FG001|Overall Study|Missed 12 Month Visit|0|||
161834691|NCT02149121|584435738|FG000|Main Study Period|Lack of Efficacy|2|||
161834692|NCT02149121|584435739|FG001|Main Study Period|Lack of Efficacy|2|||
161834693|NCT02149121|584435740|FG002|Main Study Period|Lack of Efficacy|1|||
161834694|NCT02149121|584435741|FG003|Main Study Period|Lack of Efficacy|0|||
161834695|NCT02149121|584435742|FG004|Main Study Period|Lack of Efficacy|0|||
161834696|NCT02149121|584435743|FG005|Main Study Period|Lack of Efficacy|0|||
161834697|NCT02149121|584435744|FG006|Main Study Period|Lack of Efficacy|0|||
161834698|NCT02149121|584435738|FG000|Main Study Period|Withdrawal by Subject|9|||
161834699|NCT02149121|584435739|FG001|Main Study Period|Withdrawal by Subject|5|||
161834700|NCT02149121|584435740|FG002|Main Study Period|Withdrawal by Subject|1|||
161834701|NCT02149121|584435741|FG003|Main Study Period|Withdrawal by Subject|0|||
161834702|NCT02149121|584435742|FG004|Main Study Period|Withdrawal by Subject|0|||
161834703|NCT02149121|584435743|FG005|Main Study Period|Withdrawal by Subject|0|||
161834704|NCT02149121|584435744|FG006|Main Study Period|Withdrawal by Subject|0|||
161834705|NCT02149121|584435738|FG000|Main Study Period|Adverse Event|2|||
161834706|NCT02149121|584435739|FG001|Main Study Period|Adverse Event|5|||
161834707|NCT02149121|584435740|FG002|Main Study Period|Adverse Event|1|||
161834708|NCT02149121|584435741|FG003|Main Study Period|Adverse Event|0|||
161834709|NCT02149121|584435742|FG004|Main Study Period|Adverse Event|0|||
161834710|NCT02149121|584435743|FG005|Main Study Period|Adverse Event|0|||
161834711|NCT02149121|584435744|FG006|Main Study Period|Adverse Event|0|||
161834712|NCT02149121|584435738|FG000|Main Study Period|Protocol Violation|2|||
161834713|NCT02149121|584435739|FG001|Main Study Period|Protocol Violation|0|||
161834714|NCT02149121|584435740|FG002|Main Study Period|Protocol Violation|0|||
161834715|NCT02149121|584435741|FG003|Main Study Period|Protocol Violation|0|||
161834716|NCT02149121|584435742|FG004|Main Study Period|Protocol Violation|0|||
161834717|NCT02149121|584435743|FG005|Main Study Period|Protocol Violation|0|||
161834718|NCT02149121|584435744|FG006|Main Study Period|Protocol Violation|0|||
161834719|NCT02149121|584435738|FG000|Main Study Period|Lost to Follow-up|2|||
161834720|NCT02149121|584435739|FG001|Main Study Period|Lost to Follow-up|1|||
161834721|NCT02149121|584435740|FG002|Main Study Period|Lost to Follow-up|0|||
161834722|NCT02149121|584435741|FG003|Main Study Period|Lost to Follow-up|0|||
161834723|NCT02149121|584435742|FG004|Main Study Period|Lost to Follow-up|0|||
161834724|NCT02149121|584435743|FG005|Main Study Period|Lost to Follow-up|0|||
161834725|NCT02149121|584435744|FG006|Main Study Period|Lost to Follow-up|0|||
161834726|NCT02149121|584435738|FG000|Main Study Period|Death|1|||
161834727|NCT02149121|584435739|FG001|Main Study Period|Death|0|||
161834728|NCT02149121|584435740|FG002|Main Study Period|Death|0|||
161834729|NCT02149121|584435741|FG003|Main Study Period|Death|0|||
161834730|NCT02149121|584435742|FG004|Main Study Period|Death|0|||
161834731|NCT02149121|584435743|FG005|Main Study Period|Death|0|||
161834732|NCT02149121|584435744|FG006|Main Study Period|Death|0|||
161834733|NCT02149121|584435738|FG000|Main Study Period|Physician Decision|1|||
161687013|NCT03246958|583907121|FG004|Overall Study|Over enrollment|0|||
161687014|NCT03246958|583907122|FG005|Overall Study|Over enrollment|0|||
161687015|NCT03246958|583907123|FG006|Overall Study|Over enrollment|0|||
161687016|NCT01650636|583907126|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
161687017|NCT01650636|583907127|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
161687018|NCT01650636|583907126|FG000|Washout up to 5 Months|Physician Decision|2|||
161687019|NCT01650636|583907127|FG001|Washout up to 5 Months|Physician Decision|2|||
161687020|NCT01650636|583907126|FG000|Washout up to 5 Months|Death|1|||
161687021|NCT01650636|583907127|FG001|Washout up to 5 Months|Death|0|||
161687022|NCT01650636|583907126|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
161687023|NCT01650636|583907127|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
161687024|NCT01650636|583907126|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
161687025|NCT01650636|583907127|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
161687026|NCT01650636|583907126|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
161687027|NCT01650636|583907127|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
161687028|NCT01560780|583907128|FG000|Overall Study|Death|2|||
161687029|NCT01560780|583907129|FG001|Overall Study|Death|1|||
161687030|NCT01560780|583907128|FG000|Overall Study|Patient Preference|11|||
161687031|NCT01560780|583907129|FG001|Overall Study|Patient Preference|11|||
161687032|NCT01500278|583907130|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
161687033|NCT01500278|583907131|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
161687034|NCT01500278|583907130|FG000|Week 0 - Week 12|Protocol Violation|10|||
161687035|NCT01500278|583907131|FG001|Week 0 - Week 12|Protocol Violation|16|||
161687036|NCT01500278|583907130|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
161687037|NCT01500278|583907131|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
161687038|NCT01500278|583907130|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
161687039|NCT01500278|583907131|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
161687040|NCT01500278|583907130|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
161687041|NCT01500278|583907131|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
161687042|NCT01500278|583907130|FG000|Week 0 - Week 12|Patient decision|1|||
161687043|NCT01500278|583907131|FG001|Week 0 - Week 12|Patient decision|0|||
161687044|NCT01500278|583907130|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
161687045|NCT01500278|583907131|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
161687046|NCT01500278|583907130|FG000|Week 0 - Week 12|Investigator decision|1|||
161687047|NCT01500278|583907131|FG001|Week 0 - Week 12|Investigator decision|0|||
161952843|NCT01234480|584878144|FG000|Overall Study|No Florida Lab License|20|||
161687048|NCT01500278|583907130|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
161687049|NCT01500278|583907131|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
161687050|NCT01500278|583907130|FG000|Week 0 - Week 12|Sponsor decision|1|||
161687051|NCT01500278|583907131|FG001|Week 0 - Week 12|Sponsor decision|0|||
161687052|NCT01500278|583907130|FG000|Week 0 - Week 12|Personal reason|0|||
161687053|NCT01500278|583907131|FG001|Week 0 - Week 12|Personal reason|1|||
161687054|NCT01500278|583907130|FG000|Week 0 - Week 12|Other serious disease|0|||
161687055|NCT01500278|583907131|FG001|Week 0 - Week 12|Other serious disease|1|||
161687056|NCT01500278|583907130|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
161687057|NCT01500278|583907131|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
161834734|NCT02149121|584435739|FG001|Main Study Period|Physician Decision|0|||
161834735|NCT02149121|584435740|FG002|Main Study Period|Physician Decision|0|||
161834736|NCT02149121|584435741|FG003|Main Study Period|Physician Decision|0|||
161834737|NCT02149121|584435742|FG004|Main Study Period|Physician Decision|0|||
161834738|NCT02149121|584435743|FG005|Main Study Period|Physician Decision|0|||
161834739|NCT02149121|584435744|FG006|Main Study Period|Physician Decision|0|||
161834740|NCT02149121|584435738|FG000|Main Study Period|Developed any malignancy|0|||
161834741|NCT02149121|584435739|FG001|Main Study Period|Developed any malignancy|1|||
161834742|NCT02149121|584435740|FG002|Main Study Period|Developed any malignancy|1|||
161834743|NCT02149121|584435741|FG003|Main Study Period|Developed any malignancy|0|||
161834744|NCT02149121|584435742|FG004|Main Study Period|Developed any malignancy|0|||
161834745|NCT02149121|584435743|FG005|Main Study Period|Developed any malignancy|0|||
161834746|NCT02149121|584435744|FG006|Main Study Period|Developed any malignancy|0|||
161834747|NCT02149121|584435738|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
161834748|NCT02149121|584435739|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
161834749|NCT02149121|584435740|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
161834750|NCT02149121|584435741|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
161834751|NCT02149121|584435742|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
161834752|NCT02149121|584435743|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
161834753|NCT02149121|584435744|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
161834754|NCT02149121|584435738|FG000|Main Study Period|Disease progression|0|||
161834755|NCT02149121|584435739|FG001|Main Study Period|Disease progression|1|||
161834756|NCT02149121|584435740|FG002|Main Study Period|Disease progression|0|||
161834757|NCT02149121|584435741|FG003|Main Study Period|Disease progression|0|||
161834758|NCT02149121|584435742|FG004|Main Study Period|Disease progression|0|||
161834759|NCT02149121|584435743|FG005|Main Study Period|Disease progression|0|||
161834760|NCT02149121|584435744|FG006|Main Study Period|Disease progression|0|||
161687058|NCT01500278|583907130|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
161687059|NCT01500278|583907131|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
161687060|NCT01500278|583907130|FG000|Week 13 - Week 104|Protocol Violation|6|||
161687061|NCT01500278|583907131|FG001|Week 13 - Week 104|Protocol Violation|6|||
161687062|NCT01500278|583907130|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
161687063|NCT01500278|583907131|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
161687064|NCT01500278|583907130|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
161687065|NCT01500278|583907131|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
161687066|NCT01500278|583907130|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
161687067|NCT01500278|583907131|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
161834761|NCT02149121|584435738|FG000|Extension Study Period|Withdrawal by Subject|0|||
161834762|NCT02149121|584435739|FG001|Extension Study Period|Withdrawal by Subject|0|||
161834763|NCT02149121|584435740|FG002|Extension Study Period|Withdrawal by Subject|0|||
161834764|NCT02149121|584435741|FG003|Extension Study Period|Withdrawal by Subject|1|||
161834765|NCT02149121|584435742|FG004|Extension Study Period|Withdrawal by Subject|0|||
161834766|NCT02149121|584435743|FG005|Extension Study Period|Withdrawal by Subject|2|||
161834767|NCT02149121|584435744|FG006|Extension Study Period|Withdrawal by Subject|0|||
161834768|NCT01408563|584437146|FG000|Overall Study|Ineligible after consent/ registration|2|||
161834769|NCT02119286|584437151|FG000|Overall Study|Adverse Event|9|||
161834770|NCT02119286|584437152|FG001|Overall Study|Adverse Event|7|||
161834771|NCT02119286|584437153|FG002|Overall Study|Adverse Event|2|||
161834772|NCT02119286|584437151|FG000|Overall Study|Lack of Efficacy|11|||
161834773|NCT02119286|584437152|FG001|Overall Study|Lack of Efficacy|3|||
161834774|NCT02119286|584437153|FG002|Overall Study|Lack of Efficacy|4|||
161834775|NCT02119286|584437151|FG000|Overall Study|Lost to Follow-up|2|||
161834776|NCT02119286|584437152|FG001|Overall Study|Lost to Follow-up|0|||
161834777|NCT02119286|584437153|FG002|Overall Study|Lost to Follow-up|1|||
161834778|NCT02119286|584437151|FG000|Overall Study|Withdrawal by Subject|4|||
161834779|NCT02119286|584437152|FG001|Overall Study|Withdrawal by Subject|1|||
161834780|NCT02119286|584437153|FG002|Overall Study|Withdrawal by Subject|0|||
161834781|NCT04109313|584437154|FG000|Overall Study|Pregnancy|1|||
161952844|NCT01234480|584878144|FG000|Overall Study|Out of Window|42|||
161952845|NCT01234480|584878144|FG000|Overall Study|Sample Processing/Storage|92|||
161952846|NCT01234480|584878144|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
161952847|NCT01234480|584878144|FG000|Overall Study|Site/Subject non-compliance|44|||
161952848|NCT01234480|584878144|FG000|Overall Study|Missing Sample|9|||
161952849|NCT03370419|584878145|FG000|Overall Study|Lost to Follow-up|16|||
161952850|NCT02595879|584878151|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
161952851|NCT02595879|584878152|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
161834782|NCT04109313|584437154|FG000|Overall Study|Adverse Event|11|||
161834783|NCT04109313|584437154|FG000|Overall Study|Lack of Efficacy|11|||
161834784|NCT04109313|584437154|FG000|Overall Study|Lost to Follow-up|1|||
162028847|NCT01576159|585161870|FG003|Overall Study|Withdrawal by Subject|0|||
161952852|NCT03145064|584878153|FG000|Overall Study|Death|24|||
161952853|NCT03145064|584878153|FG000|Overall Study|Lost to Follow-up|3|||
162028848|NCT01576159|585161867|FG000|Overall Study|Physician Decision|0|||
161687068|NCT01500278|583907130|FG000|Week 13 - Week 104|Non/bad compliance|7|||
161834785|NCT04109313|584437154|FG000|Overall Study|Physician Decision|2|||
161834786|NCT04109313|584437154|FG000|Overall Study|Subject Decision|13|||
161834787|NCT04109313|584437154|FG000|Overall Study|Covid-19 situation|2|||
161834788|NCT01272921|584437155|FG000|Overall Study|Protocol Violation|2|||
161834789|NCT01272921|584437156|FG001|Overall Study|Protocol Violation|1|||
161834790|NCT01132664|584437157|FG000|Phase lb|Adverse Event|0|||
161834791|NCT01132664|584437158|FG001|Phase lb|Adverse Event|1|||
161834792|NCT01132664|584437159|FG002|Phase lb|Adverse Event|0|||
161834793|NCT01132664|584437160|FG003|Phase lb|Adverse Event|0|||
161834794|NCT01132664|584437161|FG004|Phase lb|Adverse Event|0|||
161834795|NCT01132664|584437157|FG000|Phase lb|Withdrawal by Subject|1|||
161834796|NCT01132664|584437158|FG001|Phase lb|Withdrawal by Subject|2|||
161834797|NCT01132664|584437159|FG002|Phase lb|Withdrawal by Subject|0|||
161834798|NCT01132664|584437160|FG003|Phase lb|Withdrawal by Subject|0|||
161834799|NCT01132664|584437161|FG004|Phase lb|Withdrawal by Subject|0|||
161834800|NCT01132664|584437157|FG000|Phase lb|Disease Progression|4|||
161834801|NCT01132664|584437158|FG001|Phase lb|Disease Progression|9|||
161834802|NCT01132664|584437159|FG002|Phase lb|Disease Progression|0|||
161834803|NCT01132664|584437160|FG003|Phase lb|Disease Progression|0|||
161834804|NCT01132664|584437161|FG004|Phase lb|Disease Progression|0|||
161834805|NCT01132664|584437157|FG000|Phase ll|Death|0|||
161834806|NCT01132664|584437158|FG001|Phase ll|Death|0|||
161834807|NCT01132664|584437159|FG002|Phase ll|Death|2|||
161834808|NCT01132664|584437160|FG003|Phase ll|Death|0|||
161952854|NCT03145064|584878153|FG000|Overall Study|Withdrawal by Subject|6|||
161952855|NCT03145064|584878153|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
161952856|NCT03145064|584878153|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
161952857|NCT00661830|584878154|FG000|Overall Study|Death|37|||
161952858|NCT00661830|584878155|FG001|Overall Study|Death|33|||
161952859|NCT00661830|584878154|FG000|Overall Study|Lost to Follow-up|1|||
161952860|NCT00661830|584878155|FG001|Overall Study|Lost to Follow-up|3|||
161952861|NCT00661830|584878154|FG000|Overall Study|Withdrawal by Subject|1|||
161834809|NCT01132664|584437161|FG004|Phase ll|Death|0|||
161834810|NCT01132664|584437157|FG000|Phase ll|Adverse Event|0|||
161834811|NCT01132664|584437158|FG001|Phase ll|Adverse Event|0|||
161834812|NCT01132664|584437159|FG002|Phase ll|Adverse Event|10|||
161834813|NCT01132664|584437160|FG003|Phase ll|Adverse Event|0|||
161834814|NCT01132664|584437161|FG004|Phase ll|Adverse Event|0|||
161834815|NCT01132664|584437157|FG000|Phase ll|Withdrawal by Subject|0|||
161834816|NCT01132664|584437158|FG001|Phase ll|Withdrawal by Subject|0|||
161834817|NCT01132664|584437159|FG002|Phase ll|Withdrawal by Subject|3|||
161834818|NCT01132664|584437160|FG003|Phase ll|Withdrawal by Subject|0|||
161834819|NCT01132664|584437161|FG004|Phase ll|Withdrawal by Subject|0|||
161834820|NCT01132664|584437157|FG000|Phase ll|Disease progression|0|||
161834821|NCT01132664|584437158|FG001|Phase ll|Disease progression|0|||
161834822|NCT01132664|584437159|FG002|Phase ll|Disease progression|35|||
161834823|NCT01132664|584437160|FG003|Phase ll|Disease progression|0|||
161834824|NCT01132664|584437161|FG004|Phase ll|Disease progression|0|||
161834825|NCT01132664|584437157|FG000|BM Cohort|Disease progression|0|||
161834826|NCT01132664|584437158|FG001|BM Cohort|Disease progression|0|||
161834827|NCT01132664|584437159|FG002|BM Cohort|Disease progression|0|||
161834828|NCT01132664|584437160|FG003|BM Cohort|Disease progression|3|||
161834829|NCT01132664|584437161|FG004|BM Cohort|Disease progression|4|||
161834830|NCT01132664|584437157|FG000|BM Cohort|Adverse Event|0|||
161834831|NCT01132664|584437158|FG001|BM Cohort|Adverse Event|0|||
161834832|NCT01132664|584437159|FG002|BM Cohort|Adverse Event|0|||
161834833|NCT01132664|584437160|FG003|BM Cohort|Adverse Event|0|||
161834834|NCT01132664|584437161|FG004|BM Cohort|Adverse Event|1|||
161834835|NCT01132664|584437157|FG000|BM Cohort|Withdrawal by Subject|0|||
161834836|NCT01132664|584437158|FG001|BM Cohort|Withdrawal by Subject|0|||
161952862|NCT00661830|584878155|FG001|Overall Study|Withdrawal by Subject|1|||
161952863|NCT00661830|584878154|FG000|Overall Study|Other reason|1|||
162028849|NCT01576159|585161868|FG001|Overall Study|Physician Decision|0|||
162028850|NCT01576159|585161869|FG002|Overall Study|Physician Decision|1|||
162028851|NCT01576159|585161870|FG003|Overall Study|Physician Decision|0|||
161834837|NCT01132664|584437159|FG002|BM Cohort|Withdrawal by Subject|0|||
161834838|NCT01132664|584437160|FG003|BM Cohort|Withdrawal by Subject|0|||
161687069|NCT01500278|583907131|FG001|Week 13 - Week 104|Non/bad compliance|5|||
161834839|NCT01132664|584437161|FG004|BM Cohort|Withdrawal by Subject|1|||
161834840|NCT04271735|584437163|FG000|Overall Study|Physician Decision|2|||
161834841|NCT04271735|584437164|FG001|Overall Study|Physician Decision|0|||
161834842|NCT04268316|584437165|FG000|Overall Study|Withdrawal by Subject|2|||
162028852|NCT01576159|585161867|FG000|Overall Study|Lost to Follow-up|0|||
161952864|NCT00661830|584878155|FG001|Overall Study|Other reason|5|||
162028853|NCT01576159|585161868|FG001|Overall Study|Lost to Follow-up|0|||
161834843|NCT04268316|584437166|FG001|Overall Study|Withdrawal by Subject|1|||
161834844|NCT04268316|584437167|FG002|Overall Study|Withdrawal by Subject|0|||
161834845|NCT02040779|584437169|FG000|Overall Study|Adverse Event|1|||
161834846|NCT02040779|584437170|FG001|Overall Study|Adverse Event|0|||
161834847|NCT02040779|584437171|FG002|Overall Study|Adverse Event|0|||
161834848|NCT02040779|584437169|FG000|Overall Study|Withdrawal by Subject|4|||
161834849|NCT02040779|584437170|FG001|Overall Study|Withdrawal by Subject|1|||
161834850|NCT02040779|584437171|FG002|Overall Study|Withdrawal by Subject|3|||
161834851|NCT02040779|584437169|FG000|Overall Study|Non-compliance|0|||
161834852|NCT02040779|584437170|FG001|Overall Study|Non-compliance|1|||
161834853|NCT02040779|584437171|FG002|Overall Study|Non-compliance|0|||
161834854|NCT02040779|584437169|FG000|Overall Study|Protocol Violation|2|||
161834855|NCT02040779|584437170|FG001|Overall Study|Protocol Violation|1|||
161834856|NCT02040779|584437171|FG002|Overall Study|Protocol Violation|0|||
161834857|NCT02040779|584437169|FG000|Overall Study|Lost to Follow-up|1|||
161834858|NCT02040779|584437170|FG001|Overall Study|Lost to Follow-up|2|||
161834859|NCT02040779|584437171|FG002|Overall Study|Lost to Follow-up|1|||
161834860|NCT02040779|584437169|FG000|Overall Study|Lack of Efficacy|4|||
161834861|NCT02040779|584437170|FG001|Overall Study|Lack of Efficacy|2|||
161834862|NCT02040779|584437171|FG002|Overall Study|Lack of Efficacy|0|||
161834863|NCT02132637|584437172|FG000|Study Period 1|Withdrawal by Subject|0|||
161834864|NCT02132637|584437173|FG001|Study Period 1|Withdrawal by Subject|4|||
161834865|NCT02132637|584437172|FG000|Study Period 1|Physician Decision|1|||
161834866|NCT02132637|584437173|FG001|Study Period 1|Physician Decision|0|||
161834867|NCT02132637|584437172|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
161834868|NCT02132637|584437173|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
161834869|NCT02132637|584437172|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
161834870|NCT02132637|584437173|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
161834871|NCT00922272|584437176|FG000|Open-label Phase|Adverse Event|5|||
161834872|NCT00922272|584437177|FG001|Open-label Phase|Adverse Event|0|||
161834873|NCT00922272|584437176|FG000|Open-label Phase|Protocol Violation|1|||
161834874|NCT00922272|584437177|FG001|Open-label Phase|Protocol Violation|0|||
161834875|NCT00922272|584437176|FG000|Open-label Phase|Withdrawal by Subject|11|||
161834876|NCT00922272|584437177|FG001|Open-label Phase|Withdrawal by Subject|0|||
161834877|NCT00922272|584437176|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
161834878|NCT00922272|584437177|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
161834879|NCT00922272|584437176|FG000|Open-label Phase|Withdrawal criteria met|5|||
161834880|NCT00922272|584437177|FG001|Open-label Phase|Withdrawal criteria met|0|||
161834881|NCT00922272|584437176|FG000|Double-blind Phase|Adverse Event|1|||
161834882|NCT00922272|584437177|FG001|Double-blind Phase|Adverse Event|1|||
161834883|NCT00922272|584437176|FG000|Double-blind Phase|Withdrawal by Subject|1|||
161834884|NCT00922272|584437177|FG001|Double-blind Phase|Withdrawal by Subject|1|||
161834885|NCT00922272|584437176|FG000|Double-blind Phase|Lost to Follow-up|2|||
161834886|NCT00922272|584437177|FG001|Double-blind Phase|Lost to Follow-up|1|||
161834887|NCT00922272|584437176|FG000|Double-blind Phase|Withdrawal criteria met|1|||
161834888|NCT00922272|584437177|FG001|Double-blind Phase|Withdrawal criteria met|1|||
161834889|NCT00922272|584437176|FG000|Double-blind Phase|Noncompliance|1|||
161834890|NCT00922272|584437177|FG001|Double-blind Phase|Noncompliance|1|||
161834891|NCT00922272|584437176|FG000|Double-blind Phase|Positive urine drug screen|1|||
161834892|NCT00922272|584437177|FG001|Double-blind Phase|Positive urine drug screen|1|||
161834893|NCT03197558|584437178|FG000|Overall Study|Tubes not placed|1|||
161834894|NCT02581163|584437180|FG000|Overall Study|Failure to return|15|||
161834895|NCT02581163|584437180|FG000|Overall Study|Insufficient virological response|3|||
161952865|NCT01396187|584878156|FG000|Overall Study|Adverse Event|0|||
161952866|NCT01396187|584878157|FG001|Overall Study|Adverse Event|1|||
161952867|NCT01396187|584878158|FG002|Overall Study|Adverse Event|0|||
161952868|NCT01396187|584878159|FG003|Overall Study|Adverse Event|0|||
161952869|NCT01396187|584878160|FG004|Overall Study|Adverse Event|0|||
161952870|NCT01396187|584878156|FG000|Overall Study|Withdrawal by Subject|0|||
161952871|NCT01396187|584878157|FG001|Overall Study|Withdrawal by Subject|1|||
161952872|NCT01396187|584878158|FG002|Overall Study|Withdrawal by Subject|1|||
161952873|NCT01396187|584878159|FG003|Overall Study|Withdrawal by Subject|0|||
161952874|NCT01396187|584878160|FG004|Overall Study|Withdrawal by Subject|0|||
161952875|NCT01396187|584878156|FG000|Overall Study|Other|1|||
161952876|NCT01396187|584878157|FG001|Overall Study|Other|1|||
161952877|NCT01396187|584878158|FG002|Overall Study|Other|0|||
161834896|NCT02581163|584437180|FG000|Overall Study|Withdrew consent|1|||
161834897|NCT02581163|584437180|FG000|Overall Study|Death|1|||
161834898|NCT02581163|584437180|FG000|Overall Study|Other, not specified|9|||
161834899|NCT00977431|584437188|FG000|Overall Study|Other than listed|1|||
161834900|NCT00977431|584437189|FG001|Overall Study|Other than listed|0|||
162028854|NCT01576159|585161869|FG002|Overall Study|Lost to Follow-up|0|||
161834901|NCT00977431|584437190|FG002|Overall Study|Other than listed|0|||
161834902|NCT00977431|584437191|FG003|Overall Study|Other than listed|0|||
161834903|NCT00977431|584437192|FG004|Overall Study|Other than listed|2|||
161834904|NCT00977431|584437188|FG000|Overall Study|Protocol Violation|0|||
161952878|NCT01396187|584878159|FG003|Overall Study|Other|0|||
161952879|NCT01396187|584878160|FG004|Overall Study|Other|1|||
161952880|NCT01898286|584878161|FG000|Overall Study|Withdrawal by Subject|1|||
161834905|NCT00977431|584437189|FG001|Overall Study|Protocol Violation|0|||
161834906|NCT00977431|584437190|FG002|Overall Study|Protocol Violation|1|||
161687070|NCT01500278|583907130|FG000|Week 13 - Week 104|Recurrent infections|1|||
161687071|NCT01500278|583907131|FG001|Week 13 - Week 104|Recurrent infections|0|||
161687072|NCT01500278|583907130|FG000|Week 13 - Week 104|False positive test|1|||
161687073|NCT01500278|583907131|FG001|Week 13 - Week 104|False positive test|2|||
161687074|NCT01500278|583907130|FG000|Week 13 - Week 104|Sponsor request|4|||
161687075|NCT01500278|583907131|FG001|Week 13 - Week 104|Sponsor request|0|||
161687076|NCT01500278|583907130|FG000|Week 13 - Week 104|Withdrawn in error|1|||
161687077|NCT01500278|583907131|FG001|Week 13 - Week 104|Withdrawn in error|0|||
161687078|NCT01500278|583907130|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
161687079|NCT01500278|583907131|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
161687080|NCT01500278|583907130|FG000|Week 13 - Week 104|Protocol deviation|1|||
161687081|NCT01500278|583907131|FG001|Week 13 - Week 104|Protocol deviation|0|||
161687082|NCT01500278|583907130|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
161687083|NCT01500278|583907131|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
161687084|NCT01500278|583907130|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
161687085|NCT01500278|583907131|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
161687086|NCT01500278|583907130|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
161687087|NCT01500278|583907131|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
161687088|NCT01500278|583907130|FG000|Week 13 - Week 104|Relocation|0|||
161687089|NCT01500278|583907131|FG001|Week 13 - Week 104|Relocation|1|||
161687090|NCT01500278|583907130|FG000|Week 13 - Week 104|Sponsor decision|0|||
161687091|NCT01500278|583907131|FG001|Week 13 - Week 104|Sponsor decision|2|||
161687092|NCT01500278|583907130|FG000|Week 13 - Week 104|Medical monitor decision|0|||
161687093|NCT01500278|583907131|FG001|Week 13 - Week 104|Medical monitor decision|2|||
161687094|NCT01500278|583907130|FG000|Week 13 - Week 104|Personal reason|0|||
161687095|NCT01500278|583907131|FG001|Week 13 - Week 104|Personal reason|1|||
161687096|NCT01500278|583907130|FG000|Week 13 - Week 104|Not completed|0|||
161687097|NCT01500278|583907131|FG001|Week 13 - Week 104|Not completed|1|||
161687098|NCT01500278|583907130|FG000|Week 13 - Week 104|Death|2|||
161687099|NCT01500278|583907131|FG001|Week 13 - Week 104|Death|4|||
161687100|NCT01500278|583907130|FG000|Week 13 - Week 104|Adverse Event|54|||
161687101|NCT01500278|583907131|FG001|Week 13 - Week 104|Adverse Event|54|||
161687102|NCT00414453|583907132|FG000|Overall Study|Abnormal lab work|16|||
161687103|NCT01157364|583907133|FG000|Overall Study|Other Reasons|1|||
161687104|NCT01157364|583907134|FG001|Overall Study|Other Reasons|1|||
161687105|NCT01157364|583907135|FG002|Overall Study|Other Reasons|2|||
161687106|NCT01157364|583907136|FG003|Overall Study|Other Reasons|1|||
161687107|NCT01157364|583907137|FG004|Overall Study|Other Reasons|0|||
161687108|NCT01157364|583907138|FG005|Overall Study|Other Reasons|0|||
161687109|NCT01157364|583907133|FG000|Overall Study|Personal Reasons|0|||
161687110|NCT01157364|583907134|FG001|Overall Study|Personal Reasons|2|||
161687111|NCT01157364|583907135|FG002|Overall Study|Personal Reasons|0|||
161687112|NCT01157364|583907136|FG003|Overall Study|Personal Reasons|0|||
161687113|NCT01157364|583907137|FG004|Overall Study|Personal Reasons|1|||
161687114|NCT01157364|583907138|FG005|Overall Study|Personal Reasons|1|||
161952881|NCT01898286|584878161|FG000|Overall Study|Protocol Violation|1|||
161952882|NCT01898286|584878161|FG000|Overall Study|Lost to Follow-up|1|||
161687115|NCT01157364|583907133|FG000|Overall Study|Lost to Follow-up|1|||
161687116|NCT01157364|583907134|FG001|Overall Study|Lost to Follow-up|0|||
161687117|NCT01157364|583907135|FG002|Overall Study|Lost to Follow-up|1|||
161687118|NCT01157364|583907136|FG003|Overall Study|Lost to Follow-up|0|||
161687119|NCT01157364|583907137|FG004|Overall Study|Lost to Follow-up|0|||
161952883|NCT01650831|584878162|FG000|Overall Study|Screen failure|1|||
161687120|NCT01157364|583907138|FG005|Overall Study|Lost to Follow-up|0|||
161952884|NCT01897727|584878165|FG000|Overall Study|Exclusion: central sleep apnea|0|||
161952885|NCT01897727|584878166|FG001|Overall Study|Exclusion: central sleep apnea|1|||
161952886|NCT04245449|584878167|FG000|Overall Study|COVID shutdown|7|||
161687121|NCT01157364|583907133|FG000|Overall Study|Lack of Efficacy|0|||
161687122|NCT01157364|583907134|FG001|Overall Study|Lack of Efficacy|0|||
161687123|NCT01157364|583907135|FG002|Overall Study|Lack of Efficacy|0|||
161834907|NCT00977431|584437191|FG003|Overall Study|Protocol Violation|0|||
161834908|NCT00977431|584437192|FG004|Overall Study|Protocol Violation|0|||
161834909|NCT00977431|584437188|FG000|Overall Study|Adverse Event|3|||
161834910|NCT00977431|584437189|FG001|Overall Study|Adverse Event|0|||
161834911|NCT00977431|584437190|FG002|Overall Study|Adverse Event|4|||
161834912|NCT00977431|584437191|FG003|Overall Study|Adverse Event|0|||
161834913|NCT00977431|584437192|FG004|Overall Study|Adverse Event|6|||
161834914|NCT00977431|584437188|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
161834915|NCT00977431|584437189|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
161834916|NCT00977431|584437190|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
161834917|NCT00977431|584437191|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
161834918|NCT00977431|584437192|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
161834919|NCT00977431|584437188|FG000|Overall Study|Progressive disease|2|||
161834920|NCT00977431|584437189|FG001|Overall Study|Progressive disease|6|||
161834921|NCT00977431|584437190|FG002|Overall Study|Progressive disease|1|||
161834922|NCT00977431|584437191|FG003|Overall Study|Progressive disease|3|||
161834923|NCT00977431|584437192|FG004|Overall Study|Progressive disease|5|||
161834924|NCT03739138|584437199|FG000|Overall Study|Death|0|||
161834925|NCT03739138|584437200|FG001|Overall Study|Death|7|||
161834926|NCT03739138|584437201|FG002|Overall Study|Death|4|||
161834927|NCT03739138|584437202|FG003|Overall Study|Death|13|||
161834928|NCT03739138|584437203|FG004|Overall Study|Death|0|||
161834929|NCT03739138|584437199|FG000|Overall Study|Lost to Follow-up|0|||
161834930|NCT03739138|584437200|FG001|Overall Study|Lost to Follow-up|0|||
161834931|NCT03739138|584437201|FG002|Overall Study|Lost to Follow-up|1|||
161834932|NCT03739138|584437202|FG003|Overall Study|Lost to Follow-up|0|||
161834933|NCT03739138|584437203|FG004|Overall Study|Lost to Follow-up|0|||
161834934|NCT03739138|584437199|FG000|Overall Study|Study Terminated By Sponsor|0|||
161834935|NCT03739138|584437200|FG001|Overall Study|Study Terminated By Sponsor|0|||
161834936|NCT03739138|584437201|FG002|Overall Study|Study Terminated By Sponsor|0|||
161834937|NCT03739138|584437202|FG003|Overall Study|Study Terminated By Sponsor|4|||
161834938|NCT03739138|584437203|FG004|Overall Study|Study Terminated By Sponsor|0|||
161834939|NCT03739138|584437199|FG000|Overall Study|Withdrawal by Subject|0|||
161834940|NCT03739138|584437200|FG001|Overall Study|Withdrawal by Subject|0|||
161834941|NCT03739138|584437201|FG002|Overall Study|Withdrawal by Subject|0|||
161834942|NCT03739138|584437202|FG003|Overall Study|Withdrawal by Subject|1|||
161834943|NCT03739138|584437203|FG004|Overall Study|Withdrawal by Subject|0|||
161834944|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
161834945|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
161834946|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
161834947|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
161834948|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
161834949|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
161834950|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
161834951|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
161834952|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
161834953|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
161834954|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Subject decision|1|||
161834955|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Subject decision|1|||
161834956|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
161834957|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
161834958|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
161834959|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
161834960|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
161834961|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
161952887|NCT01273038|584878168|FG000|Second Intervention (14 Days)|Adverse Event|0|||
161952888|NCT01273038|584878169|FG001|Second Intervention (14 Days)|Adverse Event|1|||
161834962|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
161834963|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
161834964|NCT00518882|584437204|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
161834965|NCT00518882|584437205|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
161834966|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
161834967|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
161834968|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
161834969|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
161834970|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
161952889|NCT01273038|584878168|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
161834971|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
161834972|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
161834973|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
161834974|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
161834975|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
161834976|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
161834977|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
161834978|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
161834979|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
161834980|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
161834981|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
161834982|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
161834983|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
161834984|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
161834985|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
161834986|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
161834987|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
161834988|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
161834989|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
161834990|NCT00518882|584437204|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
161834991|NCT00518882|584437205|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
161834992|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
161834993|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
161834994|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
161834995|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
161834996|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
161834997|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
161834998|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
161834999|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
161835000|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
161835001|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
161835002|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
161835003|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
161835004|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
161835005|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
161835006|NCT04740931|584437206|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
161835007|NCT04740931|584437207|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
161835008|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
161835009|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
161835010|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
161835011|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
161835012|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
161835013|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
161835014|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
161835015|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
161835016|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
161835017|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
161835018|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
161835019|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
161835020|NCT04740931|584437206|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
161835021|NCT04740931|584437207|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
161835022|NCT02096588|584437209|FG000|Overall Study|Lack of Efficacy|2|||
161835023|NCT02096588|584437210|FG001|Overall Study|Lack of Efficacy|0|||
161835024|NCT02096588|584437209|FG000|Overall Study|Withdrawal by Subject|0|||
161835025|NCT02096588|584437210|FG001|Overall Study|Withdrawal by Subject|1|||
161835026|NCT01258101|584437211|FG000|Overall Study|Adverse Event|5|||
161835027|NCT01258101|584437212|FG001|Overall Study|Adverse Event|6|||
161835028|NCT01258101|584437213|FG002|Overall Study|Adverse Event|0|||
161835029|NCT01258101|584437214|FG003|Overall Study|Adverse Event|0|||
161687124|NCT01157364|583907136|FG003|Overall Study|Lack of Efficacy|1|||
161687125|NCT01157364|583907137|FG004|Overall Study|Lack of Efficacy|0|||
161687126|NCT01157364|583907138|FG005|Overall Study|Lack of Efficacy|0|||
161687127|NCT01157364|583907133|FG000|Overall Study|Adverse Event|0|||
161687128|NCT01157364|583907134|FG001|Overall Study|Adverse Event|1|||
161835030|NCT01258101|584437211|FG000|Overall Study|Extra exclusion criterion amended|2|||
161835031|NCT01258101|584437212|FG001|Overall Study|Extra exclusion criterion amended|1|||
161835032|NCT01258101|584437213|FG002|Overall Study|Extra exclusion criterion amended|1|||
161835033|NCT01258101|584437214|FG003|Overall Study|Extra exclusion criterion amended|1|||
161835034|NCT01258101|584437211|FG000|Overall Study|Informed consent has been withdrawn|2|||
161835035|NCT01258101|584437212|FG001|Overall Study|Informed consent has been withdrawn|2|||
161835036|NCT01258101|584437213|FG002|Overall Study|Informed consent has been withdrawn|1|||
161835037|NCT01258101|584437214|FG003|Overall Study|Informed consent has been withdrawn|1|||
161835038|NCT01258101|584437211|FG000|Overall Study|Patient is not able to attend visits|8|||
161835039|NCT01258101|584437212|FG001|Overall Study|Patient is not able to attend visits|9|||
161835040|NCT01258101|584437213|FG002|Overall Study|Patient is not able to attend visits|7|||
161835041|NCT01258101|584437214|FG003|Overall Study|Patient is not able to attend visits|6|||
161835042|NCT01258101|584437211|FG000|Overall Study|Patient´s compliance|4|||
161835043|NCT01258101|584437212|FG001|Overall Study|Patient´s compliance|3|||
161835044|NCT01258101|584437213|FG002|Overall Study|Patient´s compliance|1|||
161835045|NCT01258101|584437214|FG003|Overall Study|Patient´s compliance|2|||
161835046|NCT01258101|584437211|FG000|Overall Study|Lost to Follow-up|5|||
161835047|NCT01258101|584437212|FG001|Overall Study|Lost to Follow-up|5|||
161835048|NCT01258101|584437213|FG002|Overall Study|Lost to Follow-up|0|||
161835049|NCT01258101|584437214|FG003|Overall Study|Lost to Follow-up|6|||
161835050|NCT01258101|584437211|FG000|Overall Study|PCR positive at week 24|0|||
161835051|NCT01258101|584437212|FG001|Overall Study|PCR positive at week 24|0|||
161835052|NCT01258101|584437213|FG002|Overall Study|PCR positive at week 24|0|||
161835053|NCT01258101|584437214|FG003|Overall Study|PCR positive at week 24|1|||
161835054|NCT01258101|584437211|FG000|Overall Study|Other reason|7|||
161835055|NCT01258101|584437212|FG001|Overall Study|Other reason|8|||
161835056|NCT01258101|584437213|FG002|Overall Study|Other reason|1|||
161835057|NCT01258101|584437214|FG003|Overall Study|Other reason|8|||
161835058|NCT01020799|584437220|FG000|Overall Study|Adverse Event|4|||
161835059|NCT01020799|584437221|FG001|Overall Study|Adverse Event|3|||
161835060|NCT01020799|584437222|FG002|Overall Study|Adverse Event|2|||
161835061|NCT01020799|584437220|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
161835062|NCT01020799|584437221|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
161835063|NCT01020799|584437222|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
161835064|NCT01020799|584437220|FG000|Overall Study|Protocol Violation|3|||
161835065|NCT01020799|584437221|FG001|Overall Study|Protocol Violation|2|||
161835066|NCT01020799|584437222|FG002|Overall Study|Protocol Violation|0|||
161835067|NCT01020799|584437220|FG000|Overall Study|Withdrawal by Subject|2|||
161835068|NCT01020799|584437221|FG001|Overall Study|Withdrawal by Subject|2|||
161835069|NCT01020799|584437222|FG002|Overall Study|Withdrawal by Subject|3|||
161835070|NCT01020799|584437220|FG000|Overall Study|Lost to Follow-up|6|||
161835071|NCT01020799|584437221|FG001|Overall Study|Lost to Follow-up|4|||
161835072|NCT01020799|584437222|FG002|Overall Study|Lost to Follow-up|2|||
161835073|NCT02556307|584437225|FG000|Overall Study|Premature treatment interruption|11|||
161835074|NCT02556307|584437225|FG000|Overall Study|Lost to Follow-up|36|||
161835075|NCT02556307|584437225|FG000|Overall Study|Change to triple therapy|4|||
161835076|NCT02556307|584437225|FG000|Overall Study|Enrolled but not treated|2|||
161835077|NCT03438227|584437226|FG000|Overall Study|Withdrawal by Subject|10|||
161835078|NCT03438227|584437227|FG001|Overall Study|Withdrawal by Subject|5|||
161835079|NCT00706992|584437228|FG000|Overall Study|Study termination|5|||
161835080|NCT00706992|584437229|FG001|Overall Study|Study termination|5|||
161835081|NCT00706992|584437230|FG002|Overall Study|Study termination|6|||
161835082|NCT00706992|584437231|FG003|Overall Study|Study termination|2|||
161835083|NCT00706992|584437232|FG004|Overall Study|Study termination|3|||
161835084|NCT00706992|584437233|FG005|Overall Study|Study termination|2|||
161835085|NCT00706992|584437234|FG006|Overall Study|Study termination|3|||
161835086|NCT00706992|584437228|FG000|Overall Study|Disease progression before treatment|0|||
161835087|NCT00706992|584437229|FG001|Overall Study|Disease progression before treatment|0|||
161835088|NCT00706992|584437230|FG002|Overall Study|Disease progression before treatment|0|||
161835089|NCT00706992|584437231|FG003|Overall Study|Disease progression before treatment|0|||
161835090|NCT00706992|584437232|FG004|Overall Study|Disease progression before treatment|1|||
161835091|NCT00706992|584437233|FG005|Overall Study|Disease progression before treatment|0|||
161835092|NCT00706992|584437234|FG006|Overall Study|Disease progression before treatment|0|||
161835093|NCT01244061|584437237|FG000|Overall Study|Death|1|||
162028855|NCT01576159|585161870|FG003|Overall Study|Lost to Follow-up|1|||
161687129|NCT01157364|583907135|FG002|Overall Study|Adverse Event|1|||
161687130|NCT01157364|583907136|FG003|Overall Study|Adverse Event|0|||
161687131|NCT01157364|583907137|FG004|Overall Study|Adverse Event|1|||
161687132|NCT01157364|583907138|FG005|Overall Study|Adverse Event|0|||
161687133|NCT00183274|583907141|FG000|Phase 1: Open-Label|Adverse Event|31|||
161687134|NCT00183274|583907142|FG001|Phase 1: Open-Label|Adverse Event|0|||
161687135|NCT00183274|583907143|FG002|Phase 1: Open-Label|Adverse Event|0|||
161687136|NCT00183274|583907144|FG003|Phase 1: Open-Label|Adverse Event|0|||
161687137|NCT00183274|583907145|FG004|Phase 1: Open-Label|Adverse Event|0|||
161687138|NCT00183274|583907146|FG005|Phase 1: Open-Label|Adverse Event|0|||
161687139|NCT00183274|583907141|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
161687140|NCT00183274|583907142|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
161687141|NCT00183274|583907143|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
161687142|NCT00183274|583907144|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
161687143|NCT00183274|583907145|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
161687144|NCT00183274|583907146|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
161687145|NCT00183274|583907141|FG000|Phase 1: Open-Label|Protocol Violation|11|||
161687146|NCT00183274|583907142|FG001|Phase 1: Open-Label|Protocol Violation|0|||
161687147|NCT00183274|583907143|FG002|Phase 1: Open-Label|Protocol Violation|0|||
161687148|NCT00183274|583907144|FG003|Phase 1: Open-Label|Protocol Violation|0|||
161687149|NCT00183274|583907145|FG004|Phase 1: Open-Label|Protocol Violation|0|||
161687150|NCT00183274|583907146|FG005|Phase 1: Open-Label|Protocol Violation|0|||
161687151|NCT00183274|583907141|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
161687152|NCT00183274|583907142|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
161687153|NCT00183274|583907143|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
161687154|NCT00183274|583907144|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
161687155|NCT00183274|583907145|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
161835094|NCT01244061|584437238|FG001|Overall Study|Death|0|||
161835095|NCT01244061|584437237|FG000|Overall Study|Did not meet entrance criteria|1|||
161835096|NCT01244061|584437238|FG001|Overall Study|Did not meet entrance criteria|0|||
161687156|NCT00183274|583907146|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
161687157|NCT00183274|583907141|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
161687158|NCT00183274|583907142|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
161687159|NCT00183274|583907143|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
161687160|NCT00183274|583907144|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
161687161|NCT00183274|583907145|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
161687162|NCT00183274|583907146|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
161687163|NCT00183274|583907141|FG000|Phase 1: Open-Label|Other|9|||
161687164|NCT00183274|583907142|FG001|Phase 1: Open-Label|Other|0|||
161687165|NCT00183274|583907143|FG002|Phase 1: Open-Label|Other|0|||
161687166|NCT00183274|583907144|FG003|Phase 1: Open-Label|Other|0|||
161835097|NCT01244061|584437237|FG000|Overall Study|Lack of Efficacy|1|||
161835098|NCT01244061|584437238|FG001|Overall Study|Lack of Efficacy|3|||
161835099|NCT01244061|584437237|FG000|Overall Study|Lost to Follow-up|34|||
161835100|NCT01244061|584437238|FG001|Overall Study|Lost to Follow-up|30|||
161835101|NCT01244061|584437237|FG000|Overall Study|Withdrawal by Subject|29|||
161835102|NCT01244061|584437238|FG001|Overall Study|Withdrawal by Subject|46|||
161835103|NCT01244061|584437237|FG000|Overall Study|Other|8|||
161835104|NCT01244061|584437238|FG001|Overall Study|Other|19|||
161835105|NCT01244061|584437237|FG000|Overall Study|Protocol Violation|1|||
161835106|NCT01244061|584437238|FG001|Overall Study|Protocol Violation|1|||
161835107|NCT01244061|584437237|FG000|Overall Study|Adverse Event|5|||
161835108|NCT01244061|584437238|FG001|Overall Study|Adverse Event|2|||
161835109|NCT01244061|584437237|FG000|Overall Study|Randomized but not treated|2|||
161835110|NCT01244061|584437238|FG001|Overall Study|Randomized but not treated|2|||
161687167|NCT00183274|583907145|FG004|Phase 1: Open-Label|Other|0|||
161687168|NCT00183274|583907146|FG005|Phase 1: Open-Label|Other|0|||
161687169|NCT00183274|583907141|FG000|Phase 2: Double-Blind|Relapsed|0|||
161687170|NCT00183274|583907142|FG001|Phase 2: Double-Blind|Relapsed|8|||
161687171|NCT00183274|583907143|FG002|Phase 2: Double-Blind|Relapsed|29|||
161687172|NCT00183274|583907144|FG003|Phase 2: Double-Blind|Relapsed|0|||
161687173|NCT00183274|583907145|FG004|Phase 2: Double-Blind|Relapsed|0|||
161687174|NCT00183274|583907146|FG005|Phase 2: Double-Blind|Relapsed|0|||
161687175|NCT00183274|583907141|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
161687176|NCT00183274|583907142|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
161687177|NCT00183274|583907143|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
161835111|NCT03166124|584437239|FG000|Treatment Period 1|Adverse Event|0|||
161835112|NCT03166124|584437240|FG001|Treatment Period 1|Adverse Event|0|||
161835113|NCT03166124|584437241|FG002|Treatment Period 1|Adverse Event|1|||
161835114|NCT03166124|584437242|FG003|Treatment Period 1|Adverse Event|0|||
161835115|NCT03166124|584437239|FG000|Wash-out Period|Withdrawal by Subject|0|||
161687178|NCT00183274|583907144|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
161835116|NCT03166124|584437240|FG001|Wash-out Period|Withdrawal by Subject|1|||
161835117|NCT03166124|584437241|FG002|Wash-out Period|Withdrawal by Subject|0|||
161835118|NCT03166124|584437242|FG003|Wash-out Period|Withdrawal by Subject|1|||
161835119|NCT03166124|584437239|FG000|Wash-out Period|Adverse Event|0|||
161835120|NCT03166124|584437240|FG001|Wash-out Period|Adverse Event|1|||
161687179|NCT00183274|583907145|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
161952890|NCT01273038|584878169|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
161952891|NCT02477527|584878170|FG000|Overall Study|Lost to Follow-up|2|||
161952892|NCT02477527|584878170|FG000|Overall Study|Withdrawal by Subject|1|||
161952893|NCT02477527|584878170|FG000|Overall Study|Screen Failure|3|||
161952894|NCT03692403|584878171|FG000|Overall Study|Withdrawal by Subject|1|||
161952895|NCT03692403|584878172|FG001|Overall Study|Withdrawal by Subject|0|||
161952896|NCT03692403|584878173|FG002|Overall Study|Withdrawal by Subject|1|||
161952897|NCT03692403|584878174|FG003|Overall Study|Withdrawal by Subject|0|||
161687180|NCT00183274|583907146|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
161687181|NCT00183274|583907141|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
161687182|NCT00183274|583907142|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
161952898|NCT03692403|584878171|FG000|Overall Study|Adverse Event|0|||
161952899|NCT03692403|584878172|FG001|Overall Study|Adverse Event|0|||
162237366|NCT00679627|585921075|FG000|Overall Study|Lost to Follow-up|22|||
162237367|NCT00679627|585921076|FG001|Overall Study|Lost to Follow-up|26|||
162237368|NCT00679627|585921075|FG000|Overall Study|Early Study Closure|425|||
162237369|NCT00679627|585921076|FG001|Overall Study|Early Study Closure|405|||
162237370|NCT03513588|585921078|FG000|Overall Study|Lost to Follow-up|0|||
162237371|NCT03513588|585921079|FG001|Overall Study|Lost to Follow-up|1|||
162237372|NCT03513588|585921080|FG002|Overall Study|Lost to Follow-up|1|||
162237373|NCT03513588|585921078|FG000|Overall Study|Study dosing paused by sponsor|1|||
162237374|NCT03513588|585921079|FG001|Overall Study|Study dosing paused by sponsor|1|||
162237375|NCT03513588|585921080|FG002|Overall Study|Study dosing paused by sponsor|0|||
162237376|NCT03513588|585921078|FG000|Overall Study|Death|0|||
162237377|NCT03513588|585921079|FG001|Overall Study|Death|0|||
162237378|NCT03513588|585921080|FG002|Overall Study|Death|1|||
162237379|NCT01275131|585921081|FG000|Period 1|Withdrawal by Subject|1|||
162237380|NCT01275131|585921082|FG001|Period 1|Withdrawal by Subject|0|||
162237381|NCT01275131|585921083|FG002|Period 1|Withdrawal by Subject|3|||
162237382|NCT01275131|585921084|FG003|Period 1|Withdrawal by Subject|2|||
162237383|NCT01275131|585921081|FG000|Period 1|Physician Decision|1|||
162237384|NCT01275131|585921082|FG001|Period 1|Physician Decision|0|||
162237385|NCT01275131|585921083|FG002|Period 1|Physician Decision|0|||
162237386|NCT01275131|585921084|FG003|Period 1|Physician Decision|0|||
162237387|NCT01275131|585921081|FG000|Period 2 (Crossover)|Adverse Event|0|||
162237388|NCT01275131|585921082|FG001|Period 2 (Crossover)|Adverse Event|1|||
162237389|NCT01275131|585921083|FG002|Period 2 (Crossover)|Adverse Event|0|||
162237390|NCT01275131|585921084|FG003|Period 2 (Crossover)|Adverse Event|0|||
162237391|NCT01275131|585921081|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
162237392|NCT01275131|585921082|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
162237393|NCT01275131|585921083|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
162237394|NCT01275131|585921084|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
162237395|NCT00490724|585921086|FG000|Period I|Physician Decision|0|||
162237396|NCT00490724|585921087|FG001|Period I|Physician Decision|0|||
162237397|NCT00490724|585921088|FG002|Period I|Physician Decision|1|||
162237398|NCT00490724|585921086|FG000|Period II|Treatment Discontinuation|3|||
161687183|NCT00183274|583907143|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
161687184|NCT00183274|583907144|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
161687185|NCT00183274|583907145|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
161952900|NCT03692403|584878173|FG002|Overall Study|Adverse Event|0|||
161952901|NCT03692403|584878174|FG003|Overall Study|Adverse Event|1|||
161952902|NCT03692403|584878171|FG000|Overall Study|Pregnancy|0|||
161952903|NCT03692403|584878172|FG001|Overall Study|Pregnancy|1|||
161952904|NCT03692403|584878173|FG002|Overall Study|Pregnancy|0|||
161687186|NCT00183274|583907146|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
161687187|NCT00183274|583907141|FG000|Phase 3: Double-Blind|Relapsed|0|||
161687188|NCT00183274|583907142|FG001|Phase 3: Double-Blind|Relapsed|0|||
161687189|NCT00183274|583907143|FG002|Phase 3: Double-Blind|Relapsed|0|||
161687190|NCT00183274|583907144|FG003|Phase 3: Double-Blind|Relapsed|1|||
161687191|NCT00183274|583907145|FG004|Phase 3: Double-Blind|Relapsed|11|||
161687192|NCT00183274|583907146|FG005|Phase 3: Double-Blind|Relapsed|2|||
161687193|NCT00586495|583907151|FG000|Treatment Period|Adverse Event|11|||
161687194|NCT00586495|583907151|FG000|Treatment Period|Death|1|||
161687195|NCT00586495|583907151|FG000|Treatment Period|Protocol Violation|1|||
161687196|NCT00586495|583907151|FG000|Treatment Period|Withdrawal by Subject|1|||
161687197|NCT00586495|583907151|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
161687198|NCT00586495|583907151|FG000|Treatment Period|Switch to commercial drug|10|||
161687199|NCT00586495|583907151|FG000|Follow-up|Death|40|||
161687200|NCT00586495|583907151|FG000|Follow-up|Lost to Follow-up|1|||
161835121|NCT03166124|584437241|FG002|Wash-out Period|Adverse Event|1|||
161687201|NCT00586495|583907151|FG000|Follow-up|Withdrawal by Subject|4|||
161687202|NCT00586495|583907151|FG000|Follow-up|Protocol driven decision point|37|||
161687203|NCT00586495|583907151|FG000|Follow-up|Switch to commercial drug|10|||
161687204|NCT01046877|583907154|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
161835122|NCT03166124|584437242|FG003|Wash-out Period|Adverse Event|0|||
161835123|NCT00788593|584437243|FG000|Placebo Run-in Phase|Adverse Event|2|||
161835124|NCT00788593|584437244|FG001|Placebo Run-in Phase|Adverse Event|0|||
161835125|NCT00788593|584437245|FG002|Placebo Run-in Phase|Adverse Event|0|||
161835126|NCT00788593|584437243|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
161835127|NCT00788593|584437244|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
161835128|NCT00788593|584437245|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
161835129|NCT00788593|584437243|FG000|Placebo Run-in Phase|Protocol Violation|2|||
161835130|NCT00788593|584437244|FG001|Placebo Run-in Phase|Protocol Violation|0|||
161835131|NCT00788593|584437245|FG002|Placebo Run-in Phase|Protocol Violation|0|||
161835132|NCT00788593|584437243|FG000|First Intervention Period|Adverse Event|0|||
161835133|NCT00788593|584437244|FG001|First Intervention Period|Adverse Event|1|||
161952905|NCT03692403|584878174|FG003|Overall Study|Pregnancy|0|||
161952906|NCT03692403|584878171|FG000|Overall Study|Other|0|||
161952907|NCT03692403|584878172|FG001|Overall Study|Other|0|||
161952908|NCT03692403|584878173|FG002|Overall Study|Other|1|||
161687205|NCT01046877|583907154|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
161687206|NCT04770389|583907160|FG000|Overall Study|Adverse Event|1|||
161687207|NCT04770389|583907161|FG001|Overall Study|Adverse Event|2|||
161687208|NCT04770389|583907162|FG002|Overall Study|Adverse Event|0|||
161835134|NCT00788593|584437245|FG002|First Intervention Period|Adverse Event|0|||
161952909|NCT03692403|584878174|FG003|Overall Study|Other|0|||
161687209|NCT04770389|583907163|FG003|Overall Study|Adverse Event|1|||
161687210|NCT04770389|583907160|FG000|Overall Study|Withdrawal by Subject|0|||
161952910|NCT02479880|584878175|FG000|Overall Study|Study Terminated by Sponsor|13|||
161952911|NCT02479880|584878176|FG001|Overall Study|Study Terminated by Sponsor|12|||
161835135|NCT00788593|584437243|FG000|Second Intervention Period|Lost to Follow-up|0|||
161835136|NCT00788593|584437244|FG001|Second Intervention Period|Lost to Follow-up|1|||
161835137|NCT00788593|584437245|FG002|Second Intervention Period|Lost to Follow-up|0|||
161835138|NCT00788593|584437243|FG000|Second Intervention Period|Other|0|||
161835139|NCT00788593|584437244|FG001|Second Intervention Period|Other|0|||
161835140|NCT00788593|584437245|FG002|Second Intervention Period|Other|1|||
161835141|NCT01392326|584437246|FG000|Overall Study|Death|2|||
161835142|NCT01392326|584437247|FG001|Overall Study|Death|0|||
161835143|NCT01392326|584437248|FG002|Overall Study|Death|0|||
161835144|NCT01392326|584437246|FG000|Overall Study|Withdrawal by Subject|12|||
161952912|NCT02479880|584878175|FG000|Overall Study|Pregnancy|0|||
161835145|NCT01392326|584437247|FG001|Overall Study|Withdrawal by Subject|11|||
161952913|NCT02479880|584878176|FG001|Overall Study|Pregnancy|1|||
161952914|NCT02840253|584878177|FG000|Overall Study|Unsuccessful block|4|||
161952915|NCT00856635|584878178|FG000|Overall Study|Lost to Follow-up|2|||
161835146|NCT01392326|584437248|FG002|Overall Study|Withdrawal by Subject|15|||
161952916|NCT00856635|584878179|FG001|Overall Study|Lost to Follow-up|5|||
161835147|NCT01392326|584437246|FG000|Overall Study|Protocol Violation|2|||
161835148|NCT01392326|584437247|FG001|Overall Study|Protocol Violation|0|||
161952917|NCT00856635|584878178|FG000|Overall Study|Pregnancy|1|||
161952918|NCT00856635|584878179|FG001|Overall Study|Pregnancy|0|||
161952919|NCT00856635|584878178|FG000|Overall Study|Withdrawal by Subject|3|||
161952920|NCT00856635|584878179|FG001|Overall Study|Withdrawal by Subject|1|||
161952921|NCT00856635|584878178|FG000|Overall Study|Serious Adverse Event|1|||
161687211|NCT04770389|583907161|FG001|Overall Study|Withdrawal by Subject|2|||
161687212|NCT04770389|583907162|FG002|Overall Study|Withdrawal by Subject|1|||
161687213|NCT04770389|583907163|FG003|Overall Study|Withdrawal by Subject|0|||
161687214|NCT04770389|583907160|FG000|Overall Study|Failed attempt to draw blood|1|||
161687215|NCT04770389|583907161|FG001|Overall Study|Failed attempt to draw blood|0|||
161687216|NCT04770389|583907162|FG002|Overall Study|Failed attempt to draw blood|0|||
161687217|NCT04770389|583907163|FG003|Overall Study|Failed attempt to draw blood|0|||
161687218|NCT04770389|583907160|FG000|Overall Study|Left the country|0|||
161687219|NCT04770389|583907161|FG001|Overall Study|Left the country|0|||
161835149|NCT01392326|584437248|FG002|Overall Study|Protocol Violation|0|||
161687220|NCT04770389|583907162|FG002|Overall Study|Left the country|1|||
161687221|NCT04770389|583907163|FG003|Overall Study|Left the country|2|||
161835150|NCT01392326|584437246|FG000|Overall Study|Pregnancy|0|||
161687222|NCT04770389|583907160|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
161835151|NCT01392326|584437247|FG001|Overall Study|Pregnancy|0|||
161835152|NCT01392326|584437248|FG002|Overall Study|Pregnancy|1|||
161687223|NCT04770389|583907161|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
161687224|NCT04770389|583907162|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
161687225|NCT04770389|583907163|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
161687226|NCT04770389|583907160|FG000|Overall Study|Lost to Follow-up|0|||
161687227|NCT04770389|583907161|FG001|Overall Study|Lost to Follow-up|0|||
161687228|NCT04770389|583907162|FG002|Overall Study|Lost to Follow-up|0|||
161687229|NCT04770389|583907163|FG003|Overall Study|Lost to Follow-up|1|||
161687230|NCT04770389|583907160|FG000|Overall Study|Moved away from study site|0|||
161687231|NCT04770389|583907161|FG001|Overall Study|Moved away from study site|1|||
161687232|NCT04770389|583907162|FG002|Overall Study|Moved away from study site|0|||
161687233|NCT04770389|583907163|FG003|Overall Study|Moved away from study site|0|||
161687234|NCT00794157|583907164|FG000|Overall Study|Adverse Event|4|||
161687235|NCT00794157|583907165|FG001|Overall Study|Adverse Event|1|||
161687236|NCT00794157|583907166|FG002|Overall Study|Adverse Event|8|||
161687237|NCT00794157|583907164|FG000|Overall Study|Subject withdrew consent|2|||
161835153|NCT01392326|584437246|FG000|Overall Study|Physician Decision|7|||
161835154|NCT01392326|584437247|FG001|Overall Study|Physician Decision|5|||
161835155|NCT01392326|584437248|FG002|Overall Study|Physician Decision|2|||
161835156|NCT01392326|584437246|FG000|Overall Study|Lost to Follow-up|1|||
161835157|NCT01392326|584437247|FG001|Overall Study|Lost to Follow-up|3|||
161952922|NCT00856635|584878179|FG001|Overall Study|Serious Adverse Event|0|||
161952923|NCT00856635|584878178|FG000|Overall Study|Other|1|||
161952924|NCT00856635|584878179|FG001|Overall Study|Other|0|||
161687238|NCT00794157|583907165|FG001|Overall Study|Subject withdrew consent|0|||
161687239|NCT00794157|583907166|FG002|Overall Study|Subject withdrew consent|3|||
161687240|NCT00794157|583907164|FG000|Overall Study|Lost to Follow-up|2|||
161687241|NCT00794157|583907165|FG001|Overall Study|Lost to Follow-up|0|||
161687242|NCT00794157|583907166|FG002|Overall Study|Lost to Follow-up|1|||
161687243|NCT00794157|583907164|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161687244|NCT00794157|583907165|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161687245|NCT00794157|583907166|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161687246|NCT00794157|583907164|FG000|Overall Study|Administrative problems|1|||
161687247|NCT00794157|583907165|FG001|Overall Study|Administrative problems|7|||
161687248|NCT00794157|583907166|FG002|Overall Study|Administrative problems|4|||
161687249|NCT00794157|583907164|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161952925|NCT00856635|584878178|FG000|Overall Study|Discontinued at Randomization|2|||
161952926|NCT00856635|584878179|FG001|Overall Study|Discontinued at Randomization|2|||
161952927|NCT01349673|584878180|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
161952928|NCT01349673|584878180|FG000|Overall Study|No Longer Qualified For Study|1|||
161952929|NCT01349673|584878180|FG000|Overall Study|Site Closure|10|||
161952930|NCT01349673|584878180|FG000|Overall Study|Withdrawal by Subject|21|||
161952931|NCT01349673|584878180|FG000|Overall Study|Lost to Follow-up|6|||
161952932|NCT01349673|584878180|FG000|Overall Study|Adverse Event|17|||
161952933|NCT01349673|584878180|FG000|Overall Study|Study Terminated By Sponsor|50|||
161687250|NCT00794157|583907165|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161687251|NCT00794157|583907166|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161687252|NCT00794157|583907164|FG000|Overall Study|Protocol deviation|0|||
161687253|NCT00794157|583907165|FG001|Overall Study|Protocol deviation|1|||
161952934|NCT01349673|584878180|FG000|Overall Study|Lack of Efficacy|8|||
161952935|NCT00075764|584878181|FG000|Overall Study|Adverse Event|5|||
161952936|NCT00075764|584878182|FG001|Overall Study|Adverse Event|12|||
161952937|NCT00075764|584878181|FG000|Overall Study|Death|4|||
161952938|NCT00075764|584878182|FG001|Overall Study|Death|8|||
161952939|NCT00075764|584878181|FG000|Overall Study|Withdrawal by Subject|28|||
161952940|NCT00075764|584878182|FG001|Overall Study|Withdrawal by Subject|18|||
161952941|NCT00075764|584878181|FG000|Overall Study|Progression|269|||
161952942|NCT00075764|584878182|FG001|Overall Study|Progression|274|||
161952943|NCT00075764|584878181|FG000|Overall Study|Still on treatment|8|||
161952944|NCT00075764|584878182|FG001|Overall Study|Still on treatment|15|||
161952945|NCT00075764|584878181|FG000|Overall Study|Delinquent|4|||
161687254|NCT00794157|583907166|FG002|Overall Study|Protocol deviation|1|||
161952946|NCT00075764|584878182|FG001|Overall Study|Delinquent|2|||
161687255|NCT04486950|583907174|FG000|Overall Study|Lost to Follow-up|0|||
161687256|NCT04486950|583907175|FG001|Overall Study|Lost to Follow-up|0|||
161952947|NCT00075764|584878181|FG000|Overall Study|Not protocol specified|27|||
161952948|NCT00075764|584878182|FG001|Overall Study|Not protocol specified|19|||
161952949|NCT00075764|584878181|FG000|Overall Study|Under review|0|||
161952950|NCT00075764|584878182|FG001|Overall Study|Under review|1|||
161835158|NCT01392326|584437248|FG002|Overall Study|Lost to Follow-up|4|||
161835159|NCT01392326|584437246|FG000|Overall Study|Lack of Efficacy|14|||
161835160|NCT01392326|584437247|FG001|Overall Study|Lack of Efficacy|10|||
161835161|NCT01392326|584437248|FG002|Overall Study|Lack of Efficacy|15|||
161835162|NCT01392326|584437246|FG000|Overall Study|Adverse Event|9|||
162028856|NCT01576159|585161867|FG000|Overall Study|Protocol Violation|1|||
162028857|NCT01576159|585161868|FG001|Overall Study|Protocol Violation|0|||
162028858|NCT01576159|585161869|FG002|Overall Study|Protocol Violation|0|||
162028859|NCT01576159|585161870|FG003|Overall Study|Protocol Violation|0|||
162028860|NCT00311584|585161872|FG000|Overall Study|Death|1|||
162028861|NCT00311584|585161873|FG001|Overall Study|Death|0|||
162028862|NCT00311584|585161872|FG000|Overall Study|Lack of Efficacy|12|||
162028863|NCT00311584|585161873|FG001|Overall Study|Lack of Efficacy|15|||
162028864|NCT00311584|585161872|FG000|Overall Study|Physician Decision|4|||
162028865|NCT00311584|585161873|FG001|Overall Study|Physician Decision|5|||
162028866|NCT00311584|585161872|FG000|Overall Study|Withdrawal by Subject|1|||
162028867|NCT00311584|585161873|FG001|Overall Study|Withdrawal by Subject|1|||
162028868|NCT00311584|585161872|FG000|Overall Study|ineligible|2|||
162028869|NCT00311584|585161873|FG001|Overall Study|ineligible|2|||
162028870|NCT03073733|585161874|FG000|Overall Study|Lost to Follow-up|1|||
162028871|NCT03073733|585161875|FG001|Overall Study|Lost to Follow-up|0|||
162028872|NCT03073733|585161876|FG002|Overall Study|Lost to Follow-up|0|||
162028873|NCT03073733|585161874|FG000|Overall Study|Physician Decision|0|||
162028874|NCT03073733|585161875|FG001|Overall Study|Physician Decision|1|||
162028875|NCT03073733|585161876|FG002|Overall Study|Physician Decision|0|||
162028876|NCT03073733|585161874|FG000|Overall Study|Withdrawal by Subject|0|||
162028877|NCT03073733|585161875|FG001|Overall Study|Withdrawal by Subject|0|||
162028878|NCT03073733|585161876|FG002|Overall Study|Withdrawal by Subject|1|||
162028879|NCT01454778|585161877|FG000|Overall Study|Lost to Follow-up|2|||
162028880|NCT01454778|585161877|FG000|Overall Study|Death|1|||
162028881|NCT01227629|585161878|FG000|Overall Study|Adverse Event|2|||
162028882|NCT01227629|585161879|FG001|Overall Study|Adverse Event|2|||
162028883|NCT01227629|585161880|FG002|Overall Study|Adverse Event|1|||
162028884|NCT01227629|585161881|FG003|Overall Study|Adverse Event|6|||
162028885|NCT01227629|585161882|FG004|Overall Study|Adverse Event|1|||
162028886|NCT01227629|585161883|FG005|Overall Study|Adverse Event|1|||
162028887|NCT01227629|585161884|FG006|Overall Study|Adverse Event|6|||
162028888|NCT01227629|585161885|FG007|Overall Study|Adverse Event|6|||
162028889|NCT01227629|585161886|FG008|Overall Study|Adverse Event|4|||
162028890|NCT01227629|585161887|FG009|Overall Study|Adverse Event|0|||
162028891|NCT01227629|585161878|FG000|Overall Study|Protocol Violation|0|||
162028892|NCT01227629|585161879|FG001|Overall Study|Protocol Violation|0|||
162028893|NCT01227629|585161880|FG002|Overall Study|Protocol Violation|0|||
162028894|NCT01227629|585161881|FG003|Overall Study|Protocol Violation|1|||
162028895|NCT01227629|585161882|FG004|Overall Study|Protocol Violation|0|||
162028896|NCT01227629|585161883|FG005|Overall Study|Protocol Violation|0|||
162028897|NCT01227629|585161884|FG006|Overall Study|Protocol Violation|0|||
162028898|NCT01227629|585161885|FG007|Overall Study|Protocol Violation|0|||
162028899|NCT01227629|585161886|FG008|Overall Study|Protocol Violation|0|||
162028900|NCT01227629|585161887|FG009|Overall Study|Protocol Violation|0|||
162028901|NCT01227629|585161878|FG000|Overall Study|Lost to Follow-up|0|||
162028902|NCT01227629|585161879|FG001|Overall Study|Lost to Follow-up|0|||
162028903|NCT01227629|585161880|FG002|Overall Study|Lost to Follow-up|0|||
162028904|NCT01227629|585161881|FG003|Overall Study|Lost to Follow-up|0|||
162028905|NCT01227629|585161882|FG004|Overall Study|Lost to Follow-up|1|||
162028906|NCT01227629|585161883|FG005|Overall Study|Lost to Follow-up|0|||
162028907|NCT01227629|585161884|FG006|Overall Study|Lost to Follow-up|0|||
161687257|NCT04486950|583907176|FG002|Overall Study|Lost to Follow-up|0|||
161687258|NCT04486950|583907177|FG003|Overall Study|Lost to Follow-up|0|||
161687259|NCT04486950|583907178|FG004|Overall Study|Lost to Follow-up|0|||
161687260|NCT04486950|583907179|FG005|Overall Study|Lost to Follow-up|1|||
161687261|NCT04486950|583907180|FG006|Overall Study|Lost to Follow-up|0|||
161687262|NCT02821715|583907181|FG000|Overall Study|Protocol Violation|1|||
161687263|NCT02821715|583907182|FG001|Overall Study|Protocol Violation|0|||
161687264|NCT02821715|583907183|FG002|Overall Study|Protocol Violation|0|||
161687265|NCT02821715|583907184|FG003|Overall Study|Protocol Violation|0|||
161687266|NCT02821715|583907185|FG004|Overall Study|Protocol Violation|0|||
161687267|NCT02821715|583907186|FG005|Overall Study|Protocol Violation|0|||
161687268|NCT00640328|583907187|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161687269|NCT00640328|583907188|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
161687270|NCT00640328|583907189|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161687271|NCT00640328|583907190|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161687272|NCT00640328|583907191|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161687273|NCT00640328|583907192|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161687274|NCT00640328|583907187|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161687275|NCT00640328|583907188|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161687276|NCT00640328|583907189|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161687277|NCT00640328|583907190|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161687278|NCT00640328|583907191|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
161687279|NCT00640328|583907192|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161687280|NCT00640328|583907187|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161687281|NCT00640328|583907188|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161687282|NCT00640328|583907189|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
161687283|NCT00640328|583907190|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161835163|NCT01392326|584437247|FG001|Overall Study|Adverse Event|6|||
161835164|NCT01392326|584437248|FG002|Overall Study|Adverse Event|11|||
162028908|NCT01227629|585161885|FG007|Overall Study|Lost to Follow-up|0|||
161835165|NCT03487848|584437251|FG000|Overall Study|Lost to Follow-up|1|||
161835166|NCT00123955|584437252|FG000|Overall Study|Adverse Event|1|||
161835167|NCT00123955|584437253|FG001|Overall Study|Adverse Event|0|||
161835168|NCT00123955|584437252|FG000|Overall Study|Withdrawal by Subject|4|||
161835169|NCT00123955|584437253|FG001|Overall Study|Withdrawal by Subject|3|||
161835170|NCT00123955|584437252|FG000|Overall Study|Death|0|||
161835171|NCT00123955|584437253|FG001|Overall Study|Death|1|||
161835172|NCT00094094|584437256|FG000|Overall Study|Death|2|||
161835173|NCT00094094|584437256|FG000|Overall Study|Lack of Efficacy|23|||
161835174|NCT00094094|584437256|FG000|Overall Study|Adverse Event|7|||
161835175|NCT04459715|584437259|FG000|Overall Study|Adverse Event|3|||
161835176|NCT04459715|584437260|FG001|Overall Study|Adverse Event|3|||
161952951|NCT02817594|584878186|FG000|Overall Study|Withdrawal by Subject|1|||
161835177|NCT04459715|584437259|FG000|Overall Study|Death|111|||
161952952|NCT02817594|584878186|FG000|Overall Study|Other|1|||
161835178|NCT04459715|584437260|FG001|Overall Study|Death|93|||
161835179|NCT04459715|584437259|FG000|Overall Study|Lost to Follow-up|10|||
161952953|NCT02817594|584878186|FG000|Overall Study|Did Not Receive Treatment|1|||
161952954|NCT01135459|584878187|FG000|Overall Study|Adverse Event|8|||
162028909|NCT01227629|585161886|FG008|Overall Study|Lost to Follow-up|0|||
162028910|NCT01227629|585161887|FG009|Overall Study|Lost to Follow-up|0|||
162028911|NCT01227629|585161878|FG000|Overall Study|Withdrawal by Subject|0|||
162028912|NCT01227629|585161879|FG001|Overall Study|Withdrawal by Subject|0|||
162028913|NCT01227629|585161880|FG002|Overall Study|Withdrawal by Subject|0|||
162028914|NCT01227629|585161881|FG003|Overall Study|Withdrawal by Subject|0|||
162028915|NCT01227629|585161882|FG004|Overall Study|Withdrawal by Subject|0|||
162028916|NCT01227629|585161883|FG005|Overall Study|Withdrawal by Subject|0|||
162028917|NCT01227629|585161884|FG006|Overall Study|Withdrawal by Subject|2|||
162028918|NCT01227629|585161885|FG007|Overall Study|Withdrawal by Subject|0|||
162028919|NCT01227629|585161886|FG008|Overall Study|Withdrawal by Subject|0|||
162028920|NCT01227629|585161887|FG009|Overall Study|Withdrawal by Subject|1|||
162028921|NCT01227629|585161878|FG000|Overall Study|Other|0|||
162028922|NCT01227629|585161879|FG001|Overall Study|Other|0|||
162028923|NCT01227629|585161880|FG002|Overall Study|Other|0|||
162028924|NCT01227629|585161881|FG003|Overall Study|Other|1|||
162028925|NCT01227629|585161882|FG004|Overall Study|Other|0|||
162028926|NCT01227629|585161883|FG005|Overall Study|Other|0|||
162028927|NCT01227629|585161884|FG006|Overall Study|Other|0|||
162028928|NCT01227629|585161885|FG007|Overall Study|Other|0|||
162028929|NCT01227629|585161886|FG008|Overall Study|Other|2|||
162028930|NCT01227629|585161887|FG009|Overall Study|Other|1|||
162028931|NCT02276027|585163529|FG000|Overall Study|Death|1|||
162028932|NCT02276027|585163530|FG001|Overall Study|Death|0|||
162028933|NCT02276027|585163531|FG002|Overall Study|Death|0|||
162028934|NCT02276027|585163532|FG003|Overall Study|Death|2|||
162028935|NCT02276027|585163529|FG000|Overall Study|Physician Decision|0|||
162028936|NCT02276027|585163530|FG001|Overall Study|Physician Decision|0|||
162028937|NCT02276027|585163531|FG002|Overall Study|Physician Decision|0|||
162028938|NCT02276027|585163532|FG003|Overall Study|Physician Decision|1|||
162028939|NCT02276027|585163529|FG000|Overall Study|Progressive disease|1|||
162028940|NCT02276027|585163530|FG001|Overall Study|Progressive disease|13|||
162028941|NCT02276027|585163531|FG002|Overall Study|Progressive disease|12|||
162028942|NCT02276027|585163532|FG003|Overall Study|Progressive disease|14|||
162028943|NCT02276027|585163529|FG000|Overall Study|Subject/guardian decision|0|||
162028944|NCT02276027|585163530|FG001|Overall Study|Subject/guardian decision|1|||
162028945|NCT02276027|585163531|FG002|Overall Study|Subject/guardian decision|0|||
162028946|NCT02276027|585163532|FG003|Overall Study|Subject/guardian decision|3|||
162028947|NCT02276027|585163529|FG000|Overall Study|Adverse Event|0|||
161835180|NCT04459715|584437260|FG001|Overall Study|Lost to Follow-up|9|||
161952955|NCT01135459|584878188|FG001|Overall Study|Adverse Event|10|||
161952956|NCT01135459|584878187|FG000|Overall Study|Lack of Efficacy|3|||
161952957|NCT01135459|584878188|FG001|Overall Study|Lack of Efficacy|1|||
161687284|NCT00640328|583907191|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161687285|NCT00640328|583907192|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161687286|NCT00640328|583907187|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
161687287|NCT00640328|583907188|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
161687288|NCT00640328|583907189|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
161687289|NCT00640328|583907190|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
161835181|NCT04459715|584437259|FG000|Overall Study|Other Reasons|4|||
161835182|NCT04459715|584437260|FG001|Overall Study|Other Reasons|5|||
161835183|NCT04459715|584437259|FG000|Overall Study|PROTOCOL DEVIATION|0|||
161835184|NCT04459715|584437260|FG001|Overall Study|PROTOCOL DEVIATION|1|||
162028948|NCT02276027|585163530|FG001|Overall Study|Adverse Event|2|||
161952958|NCT01135459|584878187|FG000|Overall Study|Withdrawal by Subject|2|||
161952959|NCT01135459|584878188|FG001|Overall Study|Withdrawal by Subject|3|||
161952960|NCT01135459|584878187|FG000|Overall Study|Protocol Violation|5|||
161952961|NCT01135459|584878188|FG001|Overall Study|Protocol Violation|3|||
161952962|NCT01135459|584878187|FG000|Overall Study|Lost to Follow-up|2|||
161952963|NCT01135459|584878188|FG001|Overall Study|Lost to Follow-up|1|||
162028949|NCT02276027|585163531|FG002|Overall Study|Adverse Event|8|||
161687290|NCT00640328|583907191|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
161687291|NCT00640328|583907192|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
161687292|NCT02374099|583907193|FG000|Overall Study|Adverse Event|1|||
161952964|NCT01135459|584878187|FG000|Overall Study|Non-compliance to study procedures|0|||
162028950|NCT02276027|585163532|FG003|Overall Study|Adverse Event|2|||
161687293|NCT02374099|583907194|FG001|Overall Study|Adverse Event|0|||
161687294|NCT02374099|583907193|FG000|Overall Study|Progressive Disease|35|||
161687295|NCT02374099|583907194|FG001|Overall Study|Progressive Disease|40|||
161687296|NCT02374099|583907193|FG000|Overall Study|Withdrawal by Subject|5|||
161687297|NCT02374099|583907194|FG001|Overall Study|Withdrawal by Subject|1|||
161687298|NCT02374099|583907193|FG000|Overall Study|Miscellaneous|2|||
161687299|NCT02374099|583907194|FG001|Overall Study|Miscellaneous|3|||
161835185|NCT04459715|584437259|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
161952965|NCT01135459|584878188|FG001|Overall Study|Non-compliance to study procedures|1|||
161952966|NCT01135459|584878187|FG000|Overall Study|Other than specified|1|||
161952967|NCT01135459|584878188|FG001|Overall Study|Other than specified|1|||
161952968|NCT01803880|584878189|FG000|Overall Study|Adverse Event|1|||
161952969|NCT01803880|584878190|FG001|Overall Study|Adverse Event|0|||
161687300|NCT02374099|583907193|FG000|Overall Study|Randomized, but not treated|2|||
161952970|NCT01803880|584878191|FG002|Overall Study|Adverse Event|0|||
161952971|NCT01803880|584878189|FG000|Overall Study|Withdrawal by Subject|1|||
161952972|NCT01803880|584878190|FG001|Overall Study|Withdrawal by Subject|1|||
162028951|NCT01095094|585163534|FG000|Overall Study|Withdrawal by Subject|1|||
162028952|NCT01095094|585163534|FG000|Overall Study|Death|1|||
162028953|NCT01095094|585163534|FG000|Overall Study|Physician Decision|1|||
162028954|NCT00464490|585163535|FG000|Overall Study|Physician Decision|11|||
162028955|NCT00464490|585163536|FG001|Overall Study|Physician Decision|11|||
162028956|NCT03188042|585163539|FG000|Overall Study|Withdrawal by Subject|1|||
161952973|NCT01803880|584878191|FG002|Overall Study|Withdrawal by Subject|4|||
161952974|NCT01803880|584878189|FG000|Overall Study|Physician Decision|0|||
161952975|NCT01803880|584878190|FG001|Overall Study|Physician Decision|0|||
161952976|NCT01803880|584878191|FG002|Overall Study|Physician Decision|1|||
161687301|NCT02374099|583907194|FG001|Overall Study|Randomized, but not treated|1|||
161687302|NCT02374099|583907193|FG000|Overall Study|Study Terminated by Sponsor|3|||
161687303|NCT02374099|583907194|FG001|Overall Study|Study Terminated by Sponsor|4|||
161687304|NCT01033825|583907195|FG000|Overall Study|Withdrawal by Subject|2|||
161952977|NCT01803880|584878189|FG000|Overall Study|Unable to return for follow-up visits|0|||
161687305|NCT01033825|583907196|FG001|Overall Study|Withdrawal by Subject|3|||
161835186|NCT04459715|584437260|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
161835187|NCT04459715|584437259|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
161835188|NCT04459715|584437260|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
161835189|NCT04459715|584437259|FG000|Overall Study|Withdrawal by Subject|22|||
161835190|NCT04459715|584437260|FG001|Overall Study|Withdrawal by Subject|22|||
161835191|NCT02177136|584438874|FG000|DB Phase|Withdrawal by Subject|2|||
161835192|NCT02177136|584438875|FG001|DB Phase|Withdrawal by Subject|0|||
161952978|NCT01803880|584878190|FG001|Overall Study|Unable to return for follow-up visits|1|||
161952979|NCT01803880|584878191|FG002|Overall Study|Unable to return for follow-up visits|2|||
161952980|NCT01803880|584878189|FG000|Overall Study|Lost to Follow-up|1|||
161952981|NCT01803880|584878190|FG001|Overall Study|Lost to Follow-up|2|||
161952982|NCT01803880|584878191|FG002|Overall Study|Lost to Follow-up|3|||
161952983|NCT01803880|584878189|FG000|Overall Study|Protocol Violation|1|||
161952984|NCT01803880|584878190|FG001|Overall Study|Protocol Violation|0|||
161952985|NCT01803880|584878191|FG002|Overall Study|Protocol Violation|0|||
161952986|NCT01803880|584878189|FG000|Overall Study|Early study termination|0|||
161952987|NCT01803880|584878190|FG001|Overall Study|Early study termination|6|||
161952988|NCT01803880|584878191|FG002|Overall Study|Early study termination|5|||
162028957|NCT03188042|585163540|FG001|Overall Study|Withdrawal by Subject|1|||
162028958|NCT03739242|585163548|FG000|Overall Study|Withdrawal by Subject|1|||
161952989|NCT01803880|584878189|FG000|Overall Study|Incomplete data entry by sites|2|||
161952990|NCT01803880|584878190|FG001|Overall Study|Incomplete data entry by sites|0|||
161952991|NCT01803880|584878191|FG002|Overall Study|Incomplete data entry by sites|0|||
161952992|NCT04245709|584878197|FG000|Overall Study|Adverse Event|13|||
161952993|NCT04245709|584878197|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
161952994|NCT02041299|584878202|FG000|Overall Study|Adverse Event|9|||
161952995|NCT02041299|584878203|FG001|Overall Study|Adverse Event|3|||
161952996|NCT02041299|584878202|FG000|Overall Study|Lost to Follow-up|4|||
161952997|NCT02041299|584878203|FG001|Overall Study|Lost to Follow-up|1|||
161952998|NCT02041299|584878202|FG000|Overall Study|Physician Decision|1|||
161952999|NCT02041299|584878203|FG001|Overall Study|Physician Decision|1|||
161953000|NCT02041299|584878202|FG000|Overall Study|Withdrawal by Subject|13|||
161953001|NCT02041299|584878203|FG001|Overall Study|Withdrawal by Subject|7|||
161953002|NCT02041299|584878202|FG000|Overall Study|Protocol Violation|11|||
161953003|NCT02041299|584878203|FG001|Overall Study|Protocol Violation|4|||
161953004|NCT02041299|584878202|FG000|Overall Study|Termination of the study|7|||
161687306|NCT01033825|583907197|FG002|Overall Study|Withdrawal by Subject|2|||
161687307|NCT01033825|583907198|FG003|Overall Study|Withdrawal by Subject|1|||
161687308|NCT01033825|583907199|FG004|Overall Study|Withdrawal by Subject|1|||
161687309|NCT01033825|583907200|FG005|Overall Study|Withdrawal by Subject|0|||
161687310|NCT01033825|583907201|FG006|Overall Study|Withdrawal by Subject|0|||
161687311|NCT01033825|583907195|FG000|Overall Study|Adverse Event|0|||
161687312|NCT01033825|583907196|FG001|Overall Study|Adverse Event|0|||
161687313|NCT01033825|583907197|FG002|Overall Study|Adverse Event|0|||
161953005|NCT02041299|584878203|FG001|Overall Study|Termination of the study|3|||
161953006|NCT02041299|584878202|FG000|Overall Study|Required bone marrow transplant|0|||
161687314|NCT01033825|583907198|FG003|Overall Study|Adverse Event|1|||
161687315|NCT01033825|583907199|FG004|Overall Study|Adverse Event|0|||
161953007|NCT02041299|584878203|FG001|Overall Study|Required bone marrow transplant|1|||
161687316|NCT01033825|583907200|FG005|Overall Study|Adverse Event|0|||
161953008|NCT02041299|584878202|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
161687317|NCT01033825|583907201|FG006|Overall Study|Adverse Event|0|||
161953009|NCT02041299|584878203|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
161953010|NCT02389465|584878204|FG000|Overall Study|Lost to Follow-up|1|||
161953011|NCT02389465|584878205|FG001|Overall Study|Lost to Follow-up|3|||
161953012|NCT02389465|584878206|FG002|Overall Study|Lost to Follow-up|3|||
161953013|NCT02389465|584878207|FG003|Overall Study|Lost to Follow-up|0|||
161953014|NCT02389465|584878204|FG000|Overall Study|Physician Decision|0|||
161953015|NCT02389465|584878205|FG001|Overall Study|Physician Decision|0|||
161953016|NCT02389465|584878206|FG002|Overall Study|Physician Decision|0|||
161953017|NCT02389465|584878207|FG003|Overall Study|Physician Decision|1|||
161953018|NCT02389465|584878204|FG000|Overall Study|Withdrawal by Subject|0|||
161953019|NCT02389465|584878205|FG001|Overall Study|Withdrawal by Subject|1|||
161953020|NCT02389465|584878206|FG002|Overall Study|Withdrawal by Subject|2|||
161953021|NCT02389465|584878207|FG003|Overall Study|Withdrawal by Subject|2|||
162028959|NCT03739242|585163549|FG001|Overall Study|Withdrawal by Subject|1|||
161953022|NCT01925768|584878208|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
162028960|NCT03739242|585163548|FG000|Overall Study|Protocol Violation|0|||
161953023|NCT01925768|584878209|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161953024|NCT01925768|584878208|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
161953025|NCT01925768|584878209|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
161953026|NCT01925768|584878208|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
161835193|NCT02177136|584438876|FG002|DB Phase|Withdrawal by Subject|0|||
162028961|NCT03739242|585163549|FG001|Overall Study|Protocol Violation|1|||
161835194|NCT02177136|584438877|FG003|DB Phase|Withdrawal by Subject|0|||
161835195|NCT02177136|584438874|FG000|DB Phase|Discontinued Due to Pruritus|1|||
161835196|NCT02177136|584438875|FG001|DB Phase|Discontinued Due to Pruritus|3|||
161835197|NCT02177136|584438876|FG002|DB Phase|Discontinued Due to Pruritus|0|||
161835198|NCT02177136|584438877|FG003|DB Phase|Discontinued Due to Pruritus|0|||
161835199|NCT02177136|584438874|FG000|DB Phase|Adverse Event|3|||
161835200|NCT02177136|584438875|FG001|DB Phase|Adverse Event|2|||
161835201|NCT02177136|584438876|FG002|DB Phase|Adverse Event|3|||
161835202|NCT02177136|584438877|FG003|DB Phase|Adverse Event|0|||
161835203|NCT02177136|584438874|FG000|DB Phase|Protocol Violation|0|||
161835204|NCT02177136|584438875|FG001|DB Phase|Protocol Violation|0|||
161835205|NCT02177136|584438876|FG002|DB Phase|Protocol Violation|1|||
161835206|NCT02177136|584438877|FG003|DB Phase|Protocol Violation|0|||
161835207|NCT02177136|584438874|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
161835208|NCT02177136|584438875|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
161835209|NCT02177136|584438876|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
161835210|NCT02177136|584438877|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
161953027|NCT01925768|584878209|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
161687318|NCT01033825|583907195|FG000|Overall Study|Protocol Violation|1|||
161835211|NCT02177136|584438874|FG000|LTSE Phase|Withdrawal by Subject|0|||
161835212|NCT02177136|584438875|FG001|LTSE Phase|Withdrawal by Subject|0|||
161835213|NCT02177136|584438876|FG002|LTSE Phase|Withdrawal by Subject|0|||
161835214|NCT02177136|584438877|FG003|LTSE Phase|Withdrawal by Subject|6|||
161835215|NCT02177136|584438874|FG000|LTSE Phase|Adverse Event|0|||
161835216|NCT02177136|584438875|FG001|LTSE Phase|Adverse Event|0|||
161835217|NCT02177136|584438876|FG002|LTSE Phase|Adverse Event|0|||
161835218|NCT02177136|584438877|FG003|LTSE Phase|Adverse Event|10|||
161953028|NCT01925768|584878208|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
161835219|NCT02177136|584438874|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
161835220|NCT02177136|584438875|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
161953029|NCT01925768|584878209|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
161835221|NCT02177136|584438876|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
161835222|NCT02177136|584438877|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
161953030|NCT01925768|584878208|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
161953031|NCT01925768|584878209|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
161953032|NCT01925768|584878208|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
161953033|NCT01925768|584878209|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
161953034|NCT01925768|584878208|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
161953035|NCT01925768|584878209|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
161953036|NCT01925768|584878208|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
161687319|NCT01033825|583907196|FG001|Overall Study|Protocol Violation|0|||
161687320|NCT01033825|583907197|FG002|Overall Study|Protocol Violation|0|||
161953037|NCT01925768|584878209|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
161687321|NCT01033825|583907198|FG003|Overall Study|Protocol Violation|0|||
161835223|NCT02177136|584438874|FG000|LTSE Phase|Physician Decision|0|||
161835224|NCT02177136|584438875|FG001|LTSE Phase|Physician Decision|0|||
161835225|NCT02177136|584438876|FG002|LTSE Phase|Physician Decision|0|||
161835226|NCT02177136|584438877|FG003|LTSE Phase|Physician Decision|2|||
161835227|NCT02177136|584438874|FG000|LTSE Phase|Lost to Follow-up|0|||
161835228|NCT02177136|584438875|FG001|LTSE Phase|Lost to Follow-up|0|||
161835229|NCT02177136|584438876|FG002|LTSE Phase|Lost to Follow-up|0|||
161835230|NCT02177136|584438877|FG003|LTSE Phase|Lost to Follow-up|1|||
161835231|NCT02177136|584438874|FG000|LTSE Phase|Participant Moved|0|||
161835232|NCT02177136|584438875|FG001|LTSE Phase|Participant Moved|0|||
161835233|NCT02177136|584438876|FG002|LTSE Phase|Participant Moved|0|||
161835234|NCT02177136|584438877|FG003|LTSE Phase|Participant Moved|1|||
161835235|NCT02054130|584438878|FG000|Overall Study|Withdrawal by Subject|4|||
161835236|NCT02054130|584438879|FG001|Overall Study|Withdrawal by Subject|4|||
161835237|NCT02054130|584438880|FG002|Overall Study|Withdrawal by Subject|7|||
161835238|NCT02054130|584438881|FG003|Overall Study|Withdrawal by Subject|10|||
161835239|NCT02054130|584438878|FG000|Overall Study|Death|0|||
161835240|NCT02054130|584438879|FG001|Overall Study|Death|1|||
161835241|NCT02054130|584438880|FG002|Overall Study|Death|0|||
161835242|NCT02054130|584438881|FG003|Overall Study|Death|0|||
161835243|NCT02054130|584438878|FG000|Overall Study|Lost to Follow-up|0|||
161835244|NCT02054130|584438879|FG001|Overall Study|Lost to Follow-up|0|||
161835245|NCT02054130|584438880|FG002|Overall Study|Lost to Follow-up|1|||
161835246|NCT02054130|584438881|FG003|Overall Study|Lost to Follow-up|2|||
161835247|NCT02054130|584438878|FG000|Overall Study|Missed dose|4|||
161835248|NCT02054130|584438879|FG001|Overall Study|Missed dose|6|||
161835249|NCT02054130|584438880|FG002|Overall Study|Missed dose|7|||
161835250|NCT02054130|584438881|FG003|Overall Study|Missed dose|10|||
161835251|NCT01304693|584438896|FG000|Overall Study|Adverse Event|0|||
161835252|NCT01304693|584438897|FG001|Overall Study|Adverse Event|0|||
161835253|NCT01304693|584438898|FG002|Overall Study|Adverse Event|0|||
161835254|NCT01304693|584438899|FG003|Overall Study|Adverse Event|0|||
161953038|NCT01925768|584878208|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
161953039|NCT01925768|584878209|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
161953040|NCT01925768|584878208|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
161953041|NCT01925768|584878209|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
161835255|NCT01304693|584438900|FG004|Overall Study|Adverse Event|1|||
161835256|NCT01304693|584438896|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
161835257|NCT01304693|584438897|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
161835258|NCT01304693|584438898|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
161835259|NCT01304693|584438899|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
161835260|NCT01304693|584438900|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
161835261|NCT00931268|584438901|FG000|Overall Study|Lost to Follow-up|6|||
161687322|NCT01033825|583907199|FG004|Overall Study|Protocol Violation|0|||
161835262|NCT02072148|584438902|FG000|Overall Study|withdrew prior to surgery|23|||
161835263|NCT02072148|584438903|FG001|Overall Study|withdrew prior to surgery|0|||
161835264|NCT02072148|584438904|FG002|Overall Study|withdrew prior to surgery|0|||
161835265|NCT02072148|584438902|FG000|Overall Study|Death|0|||
161835266|NCT02072148|584438903|FG001|Overall Study|Death|0|||
161835267|NCT02072148|584438904|FG002|Overall Study|Death|1|||
161835268|NCT02072148|584438902|FG000|Overall Study|Withdrawal by Subject|0|||
161835269|NCT02072148|584438903|FG001|Overall Study|Withdrawal by Subject|13|||
161835270|NCT02072148|584438904|FG002|Overall Study|Withdrawal by Subject|12|||
161835271|NCT03656874|584438905|FG000|Overall Study|Lost to Follow-up|3|||
161835272|NCT03656874|584438906|FG001|Overall Study|Lost to Follow-up|17|||
161835273|NCT01206816|584438907|FG000|Overall Study|Protocol Violation|0|||
161835274|NCT01206816|584438908|FG001|Overall Study|Protocol Violation|0|||
161953042|NCT01925768|584878208|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
161953043|NCT01925768|584878209|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
161953044|NCT04339413|584878210|FG000|Overall Study|Reason Not Specified|2|||
161953045|NCT04339413|584878211|FG001|Overall Study|Reason Not Specified|7|||
161953046|NCT04339413|584878210|FG000|Overall Study|Study Terminated by Sponsor|30|||
161953047|NCT04339413|584878211|FG001|Overall Study|Study Terminated by Sponsor|33|||
161953048|NCT04339413|584878210|FG000|Overall Study|Progressive Disease|9|||
161953049|NCT04339413|584878211|FG001|Overall Study|Progressive Disease|6|||
161953050|NCT04339413|584878210|FG000|Overall Study|Withdrawal by Subject|9|||
161953051|NCT04339413|584878211|FG001|Overall Study|Withdrawal by Subject|10|||
161953052|NCT04339413|584878210|FG000|Overall Study|Physician Decision|3|||
161953053|NCT04339413|584878211|FG001|Overall Study|Physician Decision|1|||
161953054|NCT04339413|584878210|FG000|Overall Study|Death|2|||
161953055|NCT04339413|584878211|FG001|Overall Study|Death|0|||
161953056|NCT04339413|584878210|FG000|Overall Study|Adverse Event|3|||
161953057|NCT04339413|584878211|FG001|Overall Study|Adverse Event|0|||
161953058|NCT00087698|584878216|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
161953059|NCT00087698|584878216|FG000|Overall Study|Death from Other Causes|3|||
161953060|NCT00087698|584878216|FG000|Overall Study|Adverse Event|4|||
161953061|NCT00087698|584878216|FG000|Overall Study|Withdrawal by Subject|4|||
161953062|NCT00087698|584878216|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
161953063|NCT00087698|584878216|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
161953064|NCT00087698|584878216|FG000|Overall Study|Clinical Relapse|1|||
161953065|NCT00087698|584878216|FG000|Overall Study|Death from Study Disease|2|||
161953066|NCT00087698|584878216|FG000|Overall Study|Death from Study Drug Toxicity|2|||
161953067|NCT00087698|584878216|FG000|Overall Study|Protocol Violation|1|||
161953068|NCT03542266|584878217|FG000|Treatment Phase|Withdrawal by Subject|1|||
161953069|NCT03542266|584878217|FG000|Treatment Phase|Adverse Event|1|||
161953070|NCT03542266|584878217|FG000|Treatment Phase|PD|1|||
161953071|NCT04721158|584878227|FG000|Overall Study|Lost to Follow-up|4|||
161953072|NCT04721158|584878227|FG000|Overall Study|Device did not connect|1|||
161953073|NCT00657267|584878228|FG000|Overall Study|Progressive disease|45|||
161953074|NCT00657267|584878228|FG000|Overall Study|Adverse Event|9|||
161953075|NCT00142792|584878231|FG000|Overall Study|Death|0|||
161835275|NCT01206816|584438909|FG002|Overall Study|Protocol Violation|1|||
161835276|NCT01206816|584438910|FG003|Overall Study|Protocol Violation|0|||
161953076|NCT00142792|584878232|FG001|Overall Study|Death|0|||
161953077|NCT00142792|584878233|FG002|Overall Study|Death|1|||
161835277|NCT01206816|584438911|FG004|Overall Study|Protocol Violation|0|||
161835278|NCT01206816|584438912|FG005|Overall Study|Protocol Violation|0|||
161953078|NCT00142792|584878231|FG000|Overall Study|Withdrawal by Subject|3|||
161953079|NCT00142792|584878232|FG001|Overall Study|Withdrawal by Subject|2|||
161953080|NCT00142792|584878233|FG002|Overall Study|Withdrawal by Subject|3|||
161687323|NCT01033825|583907200|FG005|Overall Study|Protocol Violation|0|||
161687324|NCT01033825|583907201|FG006|Overall Study|Protocol Violation|0|||
161687325|NCT01033825|583907195|FG000|Overall Study|Other|0|||
161687326|NCT01033825|583907196|FG001|Overall Study|Other|0|||
161687327|NCT01033825|583907197|FG002|Overall Study|Other|0|||
161687328|NCT01033825|583907198|FG003|Overall Study|Other|0|||
161687329|NCT01033825|583907199|FG004|Overall Study|Other|1|||
161687330|NCT01033825|583907200|FG005|Overall Study|Other|0|||
161687331|NCT01033825|583907201|FG006|Overall Study|Other|0|||
161687332|NCT04294719|583907202|FG000|Overall Study|Withdrawal by Subject|1|||
161687333|NCT01714687|583907203|FG000|Overall Study|Withdrawal by Subject|1|||
161687334|NCT01714687|583907204|FG001|Overall Study|Withdrawal by Subject|0|||
161687335|NCT01714687|583907203|FG000|Overall Study|Lost to Follow-up|2|||
161687336|NCT01714687|583907204|FG001|Overall Study|Lost to Follow-up|4|||
161687337|NCT00788372|583907205|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
161687338|NCT00788372|583907205|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
161687339|NCT00788372|583907205|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
161687340|NCT00788372|583907205|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
161687341|NCT00788372|583907205|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
161687342|NCT00788372|583907205|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
161687343|NCT00788372|583907205|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
161687344|NCT01464307|583907210|FG000|Main Period|Death|0|||
161687345|NCT01464307|583907211|FG001|Main Period|Death|1|||
161687346|NCT01464307|583907210|FG000|Main Period|Adverse Event|6|||
161687347|NCT01464307|583907211|FG001|Main Period|Adverse Event|1|||
161687348|NCT01464307|583907210|FG000|Main Period|Lack of Efficacy|2|||
161687349|NCT01464307|583907211|FG001|Main Period|Lack of Efficacy|0|||
161687350|NCT01464307|583907210|FG000|Main Period|Withdrawal by Subject|5|||
161687351|NCT01464307|583907211|FG001|Main Period|Withdrawal by Subject|2|||
161687352|NCT01464307|583907210|FG000|Main Period|Predefined discontinuation criteria|2|||
161687353|NCT01464307|583907211|FG001|Main Period|Predefined discontinuation criteria|1|||
161835279|NCT01206816|584438913|FG006|Overall Study|Protocol Violation|0|||
161835280|NCT01206816|584438907|FG000|Overall Study|Withdrawal by Subject|0|||
161953081|NCT00142792|584878231|FG000|Overall Study|Lost to Follow-up|8|||
161687354|NCT01464307|583907210|FG000|Open-Label Extension Period|Adverse Event|15|||
161687355|NCT01464307|583907211|FG001|Open-Label Extension Period|Adverse Event|0|||
161687356|NCT01464307|583907210|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
161687357|NCT01464307|583907211|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
161687358|NCT01464307|583907210|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
161687359|NCT01464307|583907211|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
161953082|NCT00142792|584878232|FG001|Overall Study|Lost to Follow-up|11|||
161835281|NCT01206816|584438908|FG001|Overall Study|Withdrawal by Subject|0|||
161835282|NCT01206816|584438909|FG002|Overall Study|Withdrawal by Subject|1|||
161953083|NCT00142792|584878233|FG002|Overall Study|Lost to Follow-up|7|||
161835283|NCT01206816|584438910|FG003|Overall Study|Withdrawal by Subject|0|||
161835284|NCT01206816|584438911|FG004|Overall Study|Withdrawal by Subject|0|||
161835285|NCT01206816|584438912|FG005|Overall Study|Withdrawal by Subject|0|||
161835286|NCT01206816|584438913|FG006|Overall Study|Withdrawal by Subject|0|||
161835287|NCT01206816|584438907|FG000|Overall Study|Progressive disease|3|||
161835288|NCT01206816|584438908|FG001|Overall Study|Progressive disease|3|||
161687360|NCT01464307|583907210|FG000|Open-Label Extension Period|Death|1|||
161835289|NCT01206816|584438909|FG002|Overall Study|Progressive disease|13|||
161835290|NCT01206816|584438910|FG003|Overall Study|Progressive disease|3|||
161687361|NCT01464307|583907211|FG001|Open-Label Extension Period|Death|0|||
161687362|NCT01464307|583907210|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
161687363|NCT01464307|583907211|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
161687364|NCT01464307|583907210|FG000|Open-Label Extension Period|Non-compliance|9|||
161687365|NCT01464307|583907211|FG001|Open-Label Extension Period|Non-compliance|0|||
161687366|NCT01464307|583907210|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
161687367|NCT01464307|583907211|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
161687368|NCT00159861|583907214|FG000|Core Study - 16 Weeks|Death|3|||
161687369|NCT00159861|583907215|FG001|Core Study - 16 Weeks|Death|0|||
161835291|NCT01206816|584438911|FG004|Overall Study|Progressive disease|3|||
161835292|NCT01206816|584438912|FG005|Overall Study|Progressive disease|16|||
161835293|NCT01206816|584438913|FG006|Overall Study|Progressive disease|3|||
161953084|NCT00142792|584878231|FG000|Overall Study|No category|1|||
161953085|NCT00142792|584878232|FG001|Overall Study|No category|2|||
161953086|NCT00142792|584878233|FG002|Overall Study|No category|1|||
161953087|NCT02382991|584878239|FG000|Overall Study|Adverse Event|1|||
161953088|NCT02382991|584878240|FG001|Overall Study|Adverse Event|2|||
161953089|NCT02382991|584878239|FG000|Overall Study|Lost to Follow-up|1|||
161953090|NCT02382991|584878240|FG001|Overall Study|Lost to Follow-up|0|||
161953091|NCT02382991|584878239|FG000|Overall Study|Withdrawal by Subject|0|||
161953092|NCT02382991|584878240|FG001|Overall Study|Withdrawal by Subject|1|||
161835294|NCT01206816|584438907|FG000|Overall Study|Other AE|0|||
162028962|NCT01122394|585163550|FG000|Overall Study|Withdrawal by Subject|1|||
162028963|NCT01122394|585163551|FG001|Overall Study|Withdrawal by Subject|1|||
162028964|NCT01122394|585163550|FG000|Overall Study|Lost to Follow-up|2|||
161687370|NCT00159861|583907214|FG000|Core Study - 16 Weeks|Adverse Event|12|||
161687371|NCT00159861|583907215|FG001|Core Study - 16 Weeks|Adverse Event|6|||
161687372|NCT00159861|583907214|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
161687373|NCT00159861|583907215|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
161687374|NCT00159861|583907214|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
162028965|NCT01122394|585163551|FG001|Overall Study|Lost to Follow-up|2|||
161835295|NCT01206816|584438908|FG001|Overall Study|Other AE|0|||
161835296|NCT01206816|584438909|FG002|Overall Study|Other AE|4|||
161687375|NCT00159861|583907215|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
161687376|NCT00159861|583907214|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
161687377|NCT00159861|583907215|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
161687378|NCT00159861|583907214|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
161687379|NCT00159861|583907215|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
161687380|NCT00159861|583907214|FG000|Extension Study - up to 3 Years|Death|24|||
161687381|NCT00159861|583907215|FG001|Extension Study - up to 3 Years|Death|28|||
161687382|NCT00159861|583907214|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
161687383|NCT00159861|583907215|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
161687384|NCT00159861|583907214|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
161687385|NCT00159861|583907215|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
161687386|NCT00159861|583907214|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
161687387|NCT00159861|583907215|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
161687388|NCT00159861|583907214|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
161687389|NCT00159861|583907215|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
161687390|NCT03349099|583907216|FG000|Overall Study|Physician Decision|3|||
161687391|NCT03349099|583907217|FG001|Overall Study|Physician Decision|4|||
161687392|NCT03349099|583907216|FG000|Overall Study|Stone migrated from the kidney|1|||
161687393|NCT03349099|583907217|FG001|Overall Study|Stone migrated from the kidney|0|||
161687394|NCT00278993|583907218|FG000|Overall Study|Adverse Event|24|||
161687395|NCT00278993|583907218|FG000|Overall Study|Withdrawal by Subject|5|||
161687396|NCT00278993|583907218|FG000|Overall Study|Progressive Disease|65|||
161687397|NCT00278993|583907218|FG000|Overall Study|Physician Decision|9|||
161687398|NCT00278993|583907218|FG000|Overall Study|Not Otherwise Specified|4|||
161687399|NCT00894556|583907220|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
161687400|NCT00894556|583907221|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
161687401|NCT00894556|583907222|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
161687402|NCT00894556|583907223|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
161953093|NCT00444925|584878242|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
161953094|NCT00444925|584878243|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
161953095|NCT00444925|584878244|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
161953096|NCT00444925|584878242|FG000|Double-blind Treatment Period|Death|2|||
161687403|NCT00894556|583907220|FG000|Treatment Phase|Lost to Follow-up|2|||
161687404|NCT00894556|583907221|FG001|Treatment Phase|Lost to Follow-up|3|||
161687405|NCT00894556|583907222|FG002|Treatment Phase|Lost to Follow-up|1|||
161687406|NCT00894556|583907223|FG003|Treatment Phase|Lost to Follow-up|0|||
161687407|NCT00894556|583907220|FG000|Treatment Phase|Lack of Qualifying Event|2|||
161953097|NCT00444925|584878243|FG001|Double-blind Treatment Period|Death|0|||
161953098|NCT00444925|584878244|FG002|Double-blind Treatment Period|Death|0|||
161953099|NCT00444925|584878242|FG000|Double-blind Treatment Period|Adverse Event|6|||
161687408|NCT00894556|583907221|FG001|Treatment Phase|Lack of Qualifying Event|1|||
161953100|NCT00444925|584878243|FG001|Double-blind Treatment Period|Adverse Event|28|||
161687409|NCT00894556|583907222|FG002|Treatment Phase|Lack of Qualifying Event|0|||
161687410|NCT00894556|583907223|FG003|Treatment Phase|Lack of Qualifying Event|0|||
161687411|NCT05054114|583907230|FG000|Overall Study|Protocol Violation|13|||
161687412|NCT05054114|583907231|FG001|Overall Study|Protocol Violation|1|||
161953101|NCT00444925|584878244|FG002|Double-blind Treatment Period|Adverse Event|44|||
161953102|NCT00444925|584878242|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
162028966|NCT01122394|585163550|FG000|Overall Study|Adverse Event|0|||
161687413|NCT05054114|583907230|FG000|Overall Study|Pregnancy|0|||
161687414|NCT05054114|583907231|FG001|Overall Study|Pregnancy|1|||
161687415|NCT01806779|583907232|FG000|Overall Study|Physician Decision|2|||
161687416|NCT01806779|583907233|FG001|Overall Study|Physician Decision|0|||
161687417|NCT01806779|583907234|FG002|Overall Study|Physician Decision|1|||
161687418|NCT01806779|583907232|FG000|Overall Study|Lack of Efficacy|1|||
161953103|NCT00444925|584878243|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
161953104|NCT00444925|584878244|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
161953105|NCT00444925|584878242|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
161953106|NCT00444925|584878243|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
161953107|NCT00444925|584878244|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
161953108|NCT00444925|584878242|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
161953109|NCT00444925|584878243|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
161953110|NCT00444925|584878244|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
161953111|NCT00444925|584878242|FG000|Double-blind Treatment Period|Other|7|||
161953112|NCT00444925|584878243|FG001|Double-blind Treatment Period|Other|7|||
161953113|NCT00444925|584878244|FG002|Double-blind Treatment Period|Other|12|||
161953114|NCT00833027|584878245|FG000|Overall Study|Adverse Event|33|||
161953115|NCT00833027|584878245|FG000|Overall Study|Death|1|||
161953116|NCT00833027|584878245|FG000|Overall Study|Lack of Efficacy|12|||
161953117|NCT00833027|584878245|FG000|Overall Study|Lost to Follow-up|24|||
161953118|NCT00833027|584878245|FG000|Overall Study|Protocol Violation|115|||
161953119|NCT00833027|584878245|FG000|Overall Study|Withdrawal by Subject|16|||
161953120|NCT00833027|584878245|FG000|Overall Study|Missing|10|||
161953121|NCT03069716|584878249|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
161687419|NCT01806779|583907233|FG001|Overall Study|Lack of Efficacy|1|||
161687420|NCT01806779|583907234|FG002|Overall Study|Lack of Efficacy|0|||
161953122|NCT03069716|584878250|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
161953123|NCT03069716|584878251|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
161953124|NCT03069716|584878249|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
161687421|NCT01806779|583907232|FG000|Overall Study|Lost to Follow-up|19|||
161953125|NCT03069716|584878250|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
161953126|NCT03069716|584878251|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
161953127|NCT03069716|584878249|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
161953128|NCT03069716|584878250|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
161953129|NCT03069716|584878251|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
161953130|NCT03069716|584878249|FG000|Randomized Treatment|Withdrawal by Subject|0|||
161953131|NCT03069716|584878250|FG001|Randomized Treatment|Withdrawal by Subject|2|||
161953132|NCT03069716|584878251|FG002|Randomized Treatment|Withdrawal by Subject|0|||
161953133|NCT00714948|584878252|FG000|Overall Study|Adverse Event|2|||
161953134|NCT01673126|584878253|FG000|Overall Study|change of diagnosis|4|||
161953135|NCT01673126|584878254|FG001|Overall Study|change of diagnosis|3|||
161953136|NCT00237042|584878257|FG000|Treatment|Became ineligible post-randomization|0|||
161953137|NCT00237042|584878258|FG001|Treatment|Became ineligible post-randomization|1|||
161953138|NCT00237042|584878259|FG002|Treatment|Became ineligible post-randomization|16|||
161953139|NCT00237042|584878257|FG000|Treatment|Moved out of state|1|||
161953140|NCT00237042|584878258|FG001|Treatment|Moved out of state|1|||
161953141|NCT00237042|584878259|FG002|Treatment|Moved out of state|1|||
161953142|NCT00237042|584878257|FG000|Treatment|Completed no treatment|5|||
161953143|NCT00237042|584878258|FG001|Treatment|Completed no treatment|5|||
161953144|NCT00237042|584878259|FG002|Treatment|Completed no treatment|21|||
161953145|NCT00237042|584878257|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
161953146|NCT00237042|584878258|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
161953147|NCT00237042|584878259|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
161835297|NCT01206816|584438910|FG003|Overall Study|Other AE|0|||
161835298|NCT01206816|584438911|FG004|Overall Study|Other AE|0|||
161835299|NCT01206816|584438912|FG005|Overall Study|Other AE|3|||
161835300|NCT01206816|584438913|FG006|Overall Study|Other AE|2|||
161953148|NCT00237042|584878257|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
161687422|NCT01806779|583907233|FG001|Overall Study|Lost to Follow-up|20|||
161687423|NCT01806779|583907234|FG002|Overall Study|Lost to Follow-up|0|||
161687424|NCT01806779|583907232|FG000|Overall Study|Withdrawal by Subject|20|||
161687425|NCT01806779|583907233|FG001|Overall Study|Withdrawal by Subject|23|||
161687426|NCT01806779|583907234|FG002|Overall Study|Withdrawal by Subject|22|||
161687427|NCT00805480|583907235|FG000|Overall Study|Withdrawal by Subject|13|||
161687428|NCT00805480|583907236|FG001|Overall Study|Withdrawal by Subject|5|||
161835301|NCT01206816|584438907|FG000|Overall Study|other than stated above|0|||
161835302|NCT01206816|584438908|FG001|Overall Study|other than stated above|0|||
161835303|NCT01206816|584438909|FG002|Overall Study|other than stated above|1|||
161835304|NCT01206816|584438910|FG003|Overall Study|other than stated above|0|||
161835305|NCT01206816|584438911|FG004|Overall Study|other than stated above|0|||
161835306|NCT01206816|584438912|FG005|Overall Study|other than stated above|0|||
161835307|NCT01206816|584438913|FG006|Overall Study|other than stated above|1|||
161835308|NCT02528123|584438915|FG000|Overall Study|Lost to Follow-up|1|||
161835309|NCT01939496|584438916|FG000|Overall Study|Adverse Event|2|||
161835310|NCT01939496|584438917|FG001|Overall Study|Adverse Event|0|||
161835311|NCT01939496|584438918|FG002|Overall Study|Adverse Event|0|||
161835312|NCT01939496|584438916|FG000|Overall Study|Lost to Follow-up|1|||
161835313|NCT01939496|584438917|FG001|Overall Study|Lost to Follow-up|1|||
161835314|NCT01939496|584438918|FG002|Overall Study|Lost to Follow-up|0|||
161835315|NCT01939496|584438916|FG000|Overall Study|Physician Decision|1|||
161835316|NCT01939496|584438917|FG001|Overall Study|Physician Decision|0|||
161835317|NCT01939496|584438918|FG002|Overall Study|Physician Decision|0|||
161835318|NCT01939496|584438916|FG000|Overall Study|Protocol Violation|3|||
161835319|NCT01939496|584438917|FG001|Overall Study|Protocol Violation|0|||
161835320|NCT01939496|584438918|FG002|Overall Study|Protocol Violation|0|||
161835321|NCT01939496|584438916|FG000|Overall Study|Withdrawal by Subject|0|||
161835322|NCT01939496|584438917|FG001|Overall Study|Withdrawal by Subject|1|||
161835323|NCT01939496|584438918|FG002|Overall Study|Withdrawal by Subject|1|||
161835324|NCT01939496|584438916|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
161835325|NCT01939496|584438917|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
161835326|NCT01939496|584438918|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
161835327|NCT01939496|584438916|FG000|Overall Study|Other|2|||
161835328|NCT01939496|584438917|FG001|Overall Study|Other|0|||
161835329|NCT01939496|584438918|FG002|Overall Study|Other|1|||
161835330|NCT00506129|584438921|FG000|Overall Study|Disease Progression/Relapse|15|||
161835331|NCT00506129|584438921|FG000|Overall Study|Death|7|||
161835332|NCT01642914|584438922|FG000|Overall Study|Adverse Event|11|||
161835333|NCT01642914|584438923|FG001|Overall Study|Adverse Event|7|||
161835334|NCT01642914|584438924|FG002|Overall Study|Adverse Event|15|||
161835335|NCT01642914|584438922|FG000|Overall Study|Lack of Efficacy|9|||
161835336|NCT01642914|584438923|FG001|Overall Study|Lack of Efficacy|4|||
161835337|NCT01642914|584438924|FG002|Overall Study|Lack of Efficacy|2|||
161835338|NCT01642914|584438922|FG000|Overall Study|Protocol Violation|15|||
161687429|NCT00805480|583907237|FG002|Overall Study|Withdrawal by Subject|11|||
161687430|NCT00805480|583907238|FG003|Overall Study|Withdrawal by Subject|5|||
161687431|NCT00805480|583907235|FG000|Overall Study|Lost to Follow-up|1|||
161687432|NCT00805480|583907236|FG001|Overall Study|Lost to Follow-up|2|||
161835339|NCT01642914|584438923|FG001|Overall Study|Protocol Violation|13|||
161835340|NCT01642914|584438924|FG002|Overall Study|Protocol Violation|6|||
161835341|NCT01642914|584438922|FG000|Overall Study|Withdrawal by Subject|5|||
162028967|NCT01122394|585163551|FG001|Overall Study|Adverse Event|1|||
161687433|NCT00805480|583907237|FG002|Overall Study|Lost to Follow-up|0|||
161687434|NCT00805480|583907238|FG003|Overall Study|Lost to Follow-up|0|||
161687435|NCT00805480|583907235|FG000|Overall Study|Adverse Event|0|||
161687436|NCT00805480|583907236|FG001|Overall Study|Adverse Event|0|||
161835342|NCT01642914|584438923|FG001|Overall Study|Withdrawal by Subject|5|||
161835343|NCT01642914|584438924|FG002|Overall Study|Withdrawal by Subject|10|||
161835344|NCT01642914|584438922|FG000|Overall Study|Lost to Follow-up|5|||
161835345|NCT01642914|584438923|FG001|Overall Study|Lost to Follow-up|3|||
161835346|NCT01642914|584438924|FG002|Overall Study|Lost to Follow-up|7|||
161835347|NCT01642914|584438922|FG000|Overall Study|Other Reason|1|||
161835348|NCT01642914|584438923|FG001|Overall Study|Other Reason|0|||
161835349|NCT01642914|584438924|FG002|Overall Study|Other Reason|0|||
161687437|NCT00805480|583907237|FG002|Overall Study|Adverse Event|1|||
161687438|NCT00805480|583907238|FG003|Overall Study|Adverse Event|0|||
161687439|NCT03077685|583907239|FG000|Overall Study|Lost to Follow-up|0|||
161687440|NCT03077685|583907240|FG001|Overall Study|Lost to Follow-up|0|||
161687441|NCT03077685|583907241|FG002|Overall Study|Lost to Follow-up|0|||
161687442|NCT03077685|583907242|FG003|Overall Study|Lost to Follow-up|0|||
161687443|NCT03077685|583907243|FG004|Overall Study|Lost to Follow-up|1|||
161687444|NCT03077685|583907239|FG000|Overall Study|Death|0|||
161687445|NCT03077685|583907240|FG001|Overall Study|Death|0|||
161687446|NCT03077685|583907241|FG002|Overall Study|Death|1|||
161687447|NCT03077685|583907242|FG003|Overall Study|Death|1|||
161687448|NCT03077685|583907243|FG004|Overall Study|Death|3|||
161687449|NCT03077685|583907239|FG000|Overall Study|Withdrawal by Subject|0|||
161687450|NCT03077685|583907240|FG001|Overall Study|Withdrawal by Subject|0|||
161687451|NCT03077685|583907241|FG002|Overall Study|Withdrawal by Subject|0|||
161687452|NCT03077685|583907242|FG003|Overall Study|Withdrawal by Subject|2|||
161687453|NCT03077685|583907243|FG004|Overall Study|Withdrawal by Subject|1|||
161687454|NCT03077685|583907239|FG000|Overall Study|Physician Decision|0|||
161687455|NCT03077685|583907240|FG001|Overall Study|Physician Decision|0|||
161687456|NCT03077685|583907241|FG002|Overall Study|Physician Decision|1|||
161687457|NCT03077685|583907242|FG003|Overall Study|Physician Decision|0|||
161687458|NCT03077685|583907243|FG004|Overall Study|Physician Decision|3|||
161687459|NCT03077685|583907239|FG000|Overall Study|Disease Progression|1|||
161687460|NCT03077685|583907240|FG001|Overall Study|Disease Progression|0|||
161687461|NCT03077685|583907241|FG002|Overall Study|Disease Progression|0|||
161687462|NCT03077685|583907242|FG003|Overall Study|Disease Progression|2|||
161687463|NCT03077685|583907243|FG004|Overall Study|Disease Progression|1|||
161687464|NCT03077685|583907239|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
161687465|NCT03077685|583907240|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
161687466|NCT03077685|583907241|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
161687467|NCT03077685|583907242|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
161687468|NCT03077685|583907243|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
161687469|NCT03077685|583907239|FG000|Overall Study|Subject entered hospice care|0|||
161687470|NCT03077685|583907240|FG001|Overall Study|Subject entered hospice care|0|||
161835350|NCT02923674|584438925|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
161835351|NCT02923674|584438926|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
161835352|NCT02923674|584438927|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
161835353|NCT02923674|584438925|FG000|Overall Study|Lost to Follow-up|7|||
161835354|NCT02923674|584438926|FG001|Overall Study|Lost to Follow-up|12|||
161835355|NCT02923674|584438927|FG002|Overall Study|Lost to Follow-up|7|||
161835356|NCT02923674|584438925|FG000|Overall Study|Problem with intervention|2|||
161835357|NCT02923674|584438926|FG001|Overall Study|Problem with intervention|2|||
161687471|NCT03077685|583907241|FG002|Overall Study|Subject entered hospice care|0|||
161835358|NCT02923674|584438927|FG002|Overall Study|Problem with intervention|1|||
162028968|NCT02446743|585163552|FG000|Overall Study|Withdrawal by Subject|1|||
161835359|NCT02923674|584438925|FG000|Overall Study|Adverse Event|3|||
161687472|NCT03077685|583907242|FG003|Overall Study|Subject entered hospice care|0|||
161687473|NCT03077685|583907243|FG004|Overall Study|Subject entered hospice care|1|||
161687474|NCT02116777|583907244|FG000|Overall Study|Adverse Event|0|||
161687475|NCT02116777|583907245|FG001|Overall Study|Adverse Event|0|||
161953149|NCT00237042|584878258|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
161953150|NCT00237042|584878259|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
161953151|NCT01913327|584878266|FG000|Overall Study|Withdrawal by Subject|0|||
161953152|NCT01913327|584878267|FG001|Overall Study|Withdrawal by Subject|1|||
161953153|NCT02454530|584878268|FG000|Overall Study|Other|8|||
161953154|NCT02454530|584878269|FG001|Overall Study|Other|13|||
161953155|NCT02454530|584878268|FG000|Overall Study|Missing information|56|||
161953156|NCT02454530|584878269|FG001|Overall Study|Missing information|69|||
161687476|NCT02116777|583907246|FG002|Overall Study|Adverse Event|0|||
161687477|NCT02116777|583907247|FG003|Overall Study|Adverse Event|0|||
161687478|NCT02116777|583907248|FG004|Overall Study|Adverse Event|2|||
161687479|NCT02116777|583907249|FG005|Overall Study|Adverse Event|2|||
161687480|NCT02116777|583907250|FG006|Overall Study|Adverse Event|0|||
161687481|NCT02116777|583907244|FG000|Overall Study|Death|0|||
161687482|NCT02116777|583907245|FG001|Overall Study|Death|0|||
161687483|NCT02116777|583907246|FG002|Overall Study|Death|0|||
161687484|NCT02116777|583907247|FG003|Overall Study|Death|1|||
161687485|NCT02116777|583907248|FG004|Overall Study|Death|0|||
161687486|NCT02116777|583907249|FG005|Overall Study|Death|0|||
161687487|NCT02116777|583907250|FG006|Overall Study|Death|0|||
161687488|NCT02116777|583907244|FG000|Overall Study|Lack of Efficacy|3|||
161687489|NCT02116777|583907245|FG001|Overall Study|Lack of Efficacy|3|||
161687490|NCT02116777|583907246|FG002|Overall Study|Lack of Efficacy|3|||
161687491|NCT02116777|583907247|FG003|Overall Study|Lack of Efficacy|8|||
161687492|NCT02116777|583907248|FG004|Overall Study|Lack of Efficacy|4|||
161687493|NCT02116777|583907249|FG005|Overall Study|Lack of Efficacy|1|||
161687494|NCT02116777|583907250|FG006|Overall Study|Lack of Efficacy|9|||
161687495|NCT02116777|583907244|FG000|Overall Study|Physician Decision|0|||
161687496|NCT02116777|583907245|FG001|Overall Study|Physician Decision|0|||
161687497|NCT02116777|583907246|FG002|Overall Study|Physician Decision|0|||
161687498|NCT02116777|583907247|FG003|Overall Study|Physician Decision|2|||
161687499|NCT02116777|583907248|FG004|Overall Study|Physician Decision|0|||
161687500|NCT02116777|583907249|FG005|Overall Study|Physician Decision|0|||
161687501|NCT02116777|583907250|FG006|Overall Study|Physician Decision|0|||
161687502|NCT02116777|583907244|FG000|Overall Study|Protocol Violation|0|||
161687503|NCT02116777|583907245|FG001|Overall Study|Protocol Violation|0|||
161835360|NCT02923674|584438926|FG001|Overall Study|Adverse Event|1|||
161835361|NCT02923674|584438927|FG002|Overall Study|Adverse Event|1|||
161953157|NCT02454530|584878268|FG000|Overall Study|Death|2|||
161953158|NCT02454530|584878269|FG001|Overall Study|Death|41|||
161953159|NCT02454530|584878268|FG000|Overall Study|Lost to Follow-up|4|||
161687504|NCT02116777|583907246|FG002|Overall Study|Protocol Violation|0|||
161687505|NCT02116777|583907247|FG003|Overall Study|Protocol Violation|1|||
161687506|NCT02116777|583907248|FG004|Overall Study|Protocol Violation|0|||
161687507|NCT02116777|583907249|FG005|Overall Study|Protocol Violation|0|||
161687508|NCT02116777|583907250|FG006|Overall Study|Protocol Violation|0|||
161687509|NCT02116777|583907244|FG000|Overall Study|Withdrawal by Subject|0|||
161953160|NCT02454530|584878269|FG001|Overall Study|Lost to Follow-up|4|||
161687510|NCT02116777|583907245|FG001|Overall Study|Withdrawal by Subject|0|||
161687511|NCT02116777|583907246|FG002|Overall Study|Withdrawal by Subject|0|||
161835362|NCT02923674|584438925|FG000|Overall Study|Withdrawal by Subject|2|||
161835363|NCT02923674|584438926|FG001|Overall Study|Withdrawal by Subject|2|||
161687512|NCT02116777|583907247|FG003|Overall Study|Withdrawal by Subject|1|||
161687513|NCT02116777|583907248|FG004|Overall Study|Withdrawal by Subject|0|||
161687514|NCT02116777|583907249|FG005|Overall Study|Withdrawal by Subject|0|||
161687515|NCT02116777|583907250|FG006|Overall Study|Withdrawal by Subject|0|||
161687516|NCT00733954|583907251|FG000|Overall Study|Lost to Follow-up|5|||
161687517|NCT00733954|583907252|FG001|Overall Study|Lost to Follow-up|2|||
161687518|NCT00733954|583907251|FG000|Overall Study|Protocol Violation|1|||
161687519|NCT00733954|583907252|FG001|Overall Study|Protocol Violation|0|||
161687520|NCT00733954|583907251|FG000|Overall Study|Withdrawal by Subject|2|||
161835364|NCT02923674|584438927|FG002|Overall Study|Withdrawal by Subject|2|||
161835365|NCT02712333|584438931|FG000|First Period|Withdrawal by Subject|3|||
161835366|NCT02712333|584438932|FG001|First Period|Withdrawal by Subject|2|||
161953161|NCT00326001|584878270|FG000|Overall Study|Adverse Event|4|||
161687521|NCT00733954|583907252|FG001|Overall Study|Withdrawal by Subject|0|||
161687522|NCT02663453|583907253|FG000|Overall Study|Death|4|||
161687523|NCT02663453|583907254|FG001|Overall Study|Death|4|||
161687524|NCT02663453|583907253|FG000|Overall Study|Withdrawal by Subject|1|||
161953162|NCT00326001|584878271|FG001|Overall Study|Adverse Event|5|||
161687525|NCT02663453|583907254|FG001|Overall Study|Withdrawal by Subject|0|||
161835367|NCT03463993|584438933|FG000|Overall Study|Lost to Follow-up|7|||
161835368|NCT03463993|584438934|FG001|Overall Study|Lost to Follow-up|8|||
161835369|NCT03463993|584438933|FG000|Overall Study|Withdrawal by Subject|2|||
161835370|NCT03463993|584438934|FG001|Overall Study|Withdrawal by Subject|0|||
161835371|NCT03463993|584438933|FG000|Overall Study|Protocol Violation|4|||
161835372|NCT03463993|584438934|FG001|Overall Study|Protocol Violation|1|||
161835373|NCT03463993|584438933|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
161835374|NCT03463993|584438934|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
161835375|NCT03463993|584438933|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
161835376|NCT03463993|584438934|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
161835377|NCT01231373|584438939|FG000|Overall Study|Withdrew consent prior to randomization|2|||
161835378|NCT01231373|584438940|FG001|Overall Study|Withdrew consent prior to randomization|1|||
161835379|NCT01231373|584438941|FG002|Overall Study|Withdrew consent prior to randomization|0|||
161835380|NCT01231373|584438942|FG003|Overall Study|Withdrew consent prior to randomization|0|||
161835381|NCT01231373|584438939|FG000|Overall Study|Lost to Follow-up|0|||
161835382|NCT01231373|584438940|FG001|Overall Study|Lost to Follow-up|0|||
161835383|NCT01231373|584438941|FG002|Overall Study|Lost to Follow-up|0|||
161835384|NCT01231373|584438942|FG003|Overall Study|Lost to Follow-up|1|||
161835385|NCT01231373|584438939|FG000|Overall Study|Withdrew Consent|1|||
161835386|NCT01231373|584438940|FG001|Overall Study|Withdrew Consent|0|||
161835387|NCT01231373|584438941|FG002|Overall Study|Withdrew Consent|0|||
161835388|NCT01231373|584438942|FG003|Overall Study|Withdrew Consent|0|||
161835389|NCT01621191|584438947|FG000|Overall Study|Adverse Event|9|||
161835390|NCT01621191|584438947|FG000|Overall Study|Withdrawal by Subject|8|||
161835391|NCT01621191|584438947|FG000|Overall Study|Lack of Efficacy|6|||
161835392|NCT01621191|584438947|FG000|Overall Study|Lost to Follow-up|1|||
161835393|NCT01621191|584438947|FG000|Overall Study|Site Removed From Study|1|||
161835394|NCT04355663|584438949|FG000|Overall Study|Physician Decision|2|||
161835395|NCT04355663|584438950|FG001|Overall Study|Physician Decision|7|||
161835396|NCT04355663|584438951|FG002|Overall Study|Physician Decision|0|||
161835397|NCT04355663|584438949|FG000|Overall Study|Adverse Event|0|||
161835398|NCT04355663|584438950|FG001|Overall Study|Adverse Event|0|||
161835399|NCT04355663|584438951|FG002|Overall Study|Adverse Event|1|||
161835400|NCT04355663|584438949|FG000|Overall Study|Withdrawal by Subject|0|||
161835401|NCT04355663|584438950|FG001|Overall Study|Withdrawal by Subject|8|||
161953163|NCT00326001|584878270|FG000|Overall Study|Physician Decision|3|||
161953164|NCT00326001|584878271|FG001|Overall Study|Physician Decision|3|||
161953165|NCT02151786|584878272|FG000|Overall Study|Unavailability of Case Report Form|26|||
161687526|NCT03770260|583908428|FG000|Overall Study|Disease progression|0|||
161687527|NCT03770260|583908429|FG001|Overall Study|Disease progression|1|||
161687528|NCT03770260|583908430|FG002|Overall Study|Disease progression|0|||
161687529|NCT03770260|583908431|FG003|Overall Study|Disease progression|0|||
161687530|NCT01964352|583908433|FG000|Overall Study|Adverse Event|13|||
161687531|NCT01964352|583908434|FG001|Overall Study|Adverse Event|3|||
161835402|NCT04355663|584438951|FG002|Overall Study|Withdrawal by Subject|3|||
161835403|NCT02787408|584438957|FG000|Overall Study|Death|16|||
161835404|NCT02787408|584438957|FG000|Overall Study|Withdrawal by Subject|1|||
161687532|NCT01964352|583908435|FG002|Overall Study|Adverse Event|4|||
161687533|NCT01964352|583908436|FG003|Overall Study|Adverse Event|3|||
161687534|NCT01964352|583908433|FG000|Overall Study|Lack of Efficacy|6|||
161953166|NCT02151786|584878272|FG000|Overall Study|Outside the Contract Period|1|||
161953167|NCT02151786|584878272|FG000|Overall Study|Randomized, not Treated|1|||
161687535|NCT01964352|583908434|FG001|Overall Study|Lack of Efficacy|0|||
161687536|NCT01964352|583908435|FG002|Overall Study|Lack of Efficacy|0|||
161687537|NCT01964352|583908436|FG003|Overall Study|Lack of Efficacy|0|||
161687538|NCT01964352|583908433|FG000|Overall Study|Protocol Violation|2|||
161687539|NCT01964352|583908434|FG001|Overall Study|Protocol Violation|4|||
161687540|NCT01964352|583908435|FG002|Overall Study|Protocol Violation|0|||
161687541|NCT01964352|583908436|FG003|Overall Study|Protocol Violation|2|||
161687542|NCT01964352|583908433|FG000|Overall Study|Lost to Follow-up|1|||
161687543|NCT01964352|583908434|FG001|Overall Study|Lost to Follow-up|0|||
161687544|NCT01964352|583908435|FG002|Overall Study|Lost to Follow-up|0|||
161687545|NCT01964352|583908436|FG003|Overall Study|Lost to Follow-up|1|||
161687546|NCT01964352|583908433|FG000|Overall Study|Withdrawal by Subject|4|||
161687547|NCT01964352|583908434|FG001|Overall Study|Withdrawal by Subject|2|||
161687548|NCT01964352|583908435|FG002|Overall Study|Withdrawal by Subject|1|||
161687549|NCT01964352|583908436|FG003|Overall Study|Withdrawal by Subject|0|||
161687550|NCT01964352|583908433|FG000|Overall Study|Other than stated above|0|||
161687551|NCT01964352|583908434|FG001|Overall Study|Other than stated above|2|||
161687552|NCT01964352|583908435|FG002|Overall Study|Other than stated above|1|||
161687553|NCT01964352|583908436|FG003|Overall Study|Other than stated above|2|||
161687554|NCT00477165|583908439|FG000|Overall Study|Adverse Event|7|||
161687555|NCT00477165|583908440|FG001|Overall Study|Adverse Event|2|||
161687556|NCT02135692|583908444|FG000|Overall Study|Adverse Event|3|||
161687557|NCT02135692|583908444|FG000|Overall Study|Lack of Efficacy|2|||
161687558|NCT02135692|583908444|FG000|Overall Study|Protocol Violation|2|||
161687559|NCT02135692|583908444|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
161687560|NCT02135692|583908444|FG000|Overall Study|Product commercially available|159|||
161687561|NCT02135692|583908444|FG000|Overall Study|Study closed/terminated|153|||
161687562|NCT02135692|583908444|FG000|Overall Study|Lost to Follow-up|4|||
161687563|NCT02135692|583908444|FG000|Overall Study|Withdrawal by Subject|15|||
161687564|NCT01097746|583908446|FG000|Overall Study|Adverse Event|4|||
161687565|NCT01097746|583908446|FG000|Overall Study|taken off study before any treatment given|1|||
161835405|NCT02787408|584438957|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
161835406|NCT05444543|584438960|FG000|Overall Study|Withdrawal by Subject|1|||
161835407|NCT05444543|584438961|FG001|Overall Study|Withdrawal by Subject|0|||
161687566|NCT01514682|583908447|FG000|Overall Study|Withdrawal by Subject|2|||
161687567|NCT01514682|583908448|FG001|Overall Study|Withdrawal by Subject|3|||
161687568|NCT01514682|583908447|FG000|Overall Study|Physician Decision|4|||
161687569|NCT01514682|583908448|FG001|Overall Study|Physician Decision|3|||
161687570|NCT00647556|583908449|FG000|Overall Study|Adverse Event|0|||
161687571|NCT00647556|583908450|FG001|Overall Study|Adverse Event|1|||
161687572|NCT00647556|583908449|FG000|Overall Study|Lost to Follow-up|1|||
161687573|NCT00647556|583908450|FG001|Overall Study|Lost to Follow-up|0|||
161687574|NCT00647556|583908449|FG000|Overall Study|Protocol Violation|0|||
161687575|NCT00647556|583908450|FG001|Overall Study|Protocol Violation|1|||
161687576|NCT00647556|583908449|FG000|Overall Study|Withdrawal by Subject|1|||
161687577|NCT00647556|583908450|FG001|Overall Study|Withdrawal by Subject|0|||
161687578|NCT00647556|583908449|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
161687579|NCT00647556|583908450|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
161687580|NCT00623480|583908451|FG000|Overall Study|Lost to Follow-up|0|||
161687581|NCT00623480|583908452|FG001|Overall Study|Lost to Follow-up|1|||
161687582|NCT00623480|583908451|FG000|Overall Study|Withdrawal by Subject|2|||
161687583|NCT00623480|583908452|FG001|Overall Study|Withdrawal by Subject|4|||
161687584|NCT00623480|583908451|FG000|Overall Study|Lack of Efficacy|1|||
161687585|NCT00623480|583908452|FG001|Overall Study|Lack of Efficacy|0|||
161687586|NCT00623480|583908451|FG000|Overall Study|Non-compliant with study medication|4|||
161687587|NCT00623480|583908452|FG001|Overall Study|Non-compliant with study medication|0|||
161687588|NCT00623480|583908451|FG000|Overall Study|Protocol Violation|0|||
161687589|NCT00623480|583908452|FG001|Overall Study|Protocol Violation|1|||
161687590|NCT00623480|583908451|FG000|Overall Study|Site closed by sponsor|0|||
161687591|NCT00623480|583908452|FG001|Overall Study|Site closed by sponsor|1|||
161687592|NCT00960661|583908453|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
161687593|NCT00960661|583908454|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
161687594|NCT00960661|583908455|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
161687595|NCT00960661|583908453|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
161687596|NCT00960661|583908454|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
161687597|NCT00960661|583908455|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
161687598|NCT00960661|583908453|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
161687599|NCT00960661|583908454|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
161687600|NCT00960661|583908455|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
161687601|NCT00960661|583908453|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
161835408|NCT05444543|584438960|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
161835409|NCT05444543|584438961|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
161835410|NCT05444543|584438960|FG000|Overall Study|Adverse Event|0|||
161835411|NCT05444543|584438961|FG001|Overall Study|Adverse Event|1|||
161835412|NCT05444543|584438960|FG000|Overall Study|Family relocating at a distance from study site|0|||
161835413|NCT05444543|584438961|FG001|Overall Study|Family relocating at a distance from study site|1|||
161687602|NCT00960661|583908454|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
161687603|NCT00960661|583908455|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
161687604|NCT00960661|583908453|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
161835414|NCT02408120|584438964|FG000|Overall Study|Withdrawal by Subject|0|||
161835415|NCT02408120|584438965|FG001|Overall Study|Withdrawal by Subject|1|||
162028969|NCT02446743|585163553|FG001|Overall Study|Withdrawal by Subject|1|||
161687605|NCT00960661|583908454|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
162028970|NCT02446743|585163552|FG000|Overall Study|Lost to Follow-up|1|||
162028971|NCT02446743|585163553|FG001|Overall Study|Lost to Follow-up|0|||
162028972|NCT02446743|585163552|FG000|Overall Study|Adverse Event|1|||
162028973|NCT02446743|585163553|FG001|Overall Study|Adverse Event|1|||
162028974|NCT02446743|585163552|FG000|Overall Study|Other|2|||
162028975|NCT02446743|585163553|FG001|Overall Study|Other|3|||
162028976|NCT00039871|585163554|FG000|Overall Study|Adverse Event|165|||
162028977|NCT00039871|585163554|FG000|Overall Study|Lost to Follow-up|18|||
162028978|NCT00039871|585163554|FG000|Overall Study|Protocol Violation|24|||
162028979|NCT00039871|585163554|FG000|Overall Study|Withdrawal by Subject|97|||
162028980|NCT00039871|585163554|FG000|Overall Study|Did not meet eligibility criteria|11|||
162028981|NCT00039871|585163554|FG000|Overall Study|Administrative|1|||
162028982|NCT00039871|585163554|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
162028983|NCT00039871|585163554|FG000|Overall Study|Never entered follow-up|7|||
162028984|NCT03086967|585163555|FG000|Overall Study|Screen Failure|2|||
162028985|NCT03086967|585163556|FG001|Overall Study|Screen Failure|2|||
162028986|NCT03361176|585163557|FG000|Overall Study|Lost to Follow-up|1|||
162028987|NCT03361176|585163558|FG001|Overall Study|Lost to Follow-up|2|||
162028988|NCT03361176|585163557|FG000|Overall Study|Adverse Event|0|||
162028989|NCT03361176|585163558|FG001|Overall Study|Adverse Event|2|||
162028990|NCT03361176|585163557|FG000|Overall Study|Withdrawal by Subject|0|||
162028991|NCT03361176|585163558|FG001|Overall Study|Withdrawal by Subject|1|||
162028992|NCT01752036|585163562|FG000|Overall Study|Death|2|||
162028993|NCT02230527|585163563|FG000|Overall Study|Withdrawal by Subject|1|||
162028994|NCT02230527|585163564|FG001|Overall Study|Withdrawal by Subject|1|||
162028995|NCT02230527|585163563|FG000|Overall Study|Death|1|||
162028996|NCT02230527|585163564|FG001|Overall Study|Death|0|||
162028997|NCT02230527|585163563|FG000|Overall Study|Lost to Follow-up|2|||
162028998|NCT02230527|585163564|FG001|Overall Study|Lost to Follow-up|1|||
162028999|NCT02230527|585163563|FG000|Overall Study|Other|1|||
162029000|NCT02230527|585163564|FG001|Overall Study|Other|0|||
162029001|NCT01011478|585163565|FG000|Overall Study|No follow up data|12|||
162029002|NCT01011478|585163566|FG001|Overall Study|No follow up data|7|||
161835416|NCT02408120|584438964|FG000|Overall Study|Treatment Refusal|1|||
161835417|NCT02408120|584438965|FG001|Overall Study|Treatment Refusal|0|||
161835418|NCT02408120|584438964|FG000|Overall Study|Received Steroids|1|||
162029003|NCT01437995|585163570|FG000|Overall Study|Lost to Follow-up|11|||
161835419|NCT02408120|584438965|FG001|Overall Study|Received Steroids|1|||
162029004|NCT01437995|585163571|FG001|Overall Study|Lost to Follow-up|18|||
162029005|NCT01437995|585163572|FG002|Overall Study|Lost to Follow-up|20|||
162029006|NCT04456673|585163573|FG000|Overall Study|Adverse Event|7|||
162029007|NCT04456673|585163574|FG001|Overall Study|Adverse Event|14|||
162029008|NCT04456673|585163573|FG000|Overall Study|Poor compliance to protocol|1|||
162029009|NCT04456673|585163574|FG001|Overall Study|Poor compliance to protocol|0|||
162029010|NCT04456673|585163573|FG000|Overall Study|Withdrawal by Subject|31|||
162029011|NCT04456673|585163574|FG001|Overall Study|Withdrawal by Subject|23|||
162029012|NCT04456673|585163573|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
162029013|NCT04456673|585163574|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
162029014|NCT02160002|585163575|FG000|Overall Study|Withdrawal by Subject|2|||
162029015|NCT02160002|585163576|FG001|Overall Study|Withdrawal by Subject|1|||
162029016|NCT04395001|585163578|FG000|Overall Study|Lost to Follow-up|8|||
162029017|NCT04395001|585163579|FG001|Overall Study|Lost to Follow-up|9|||
162029018|NCT04395001|585163580|FG002|Overall Study|Lost to Follow-up|5|||
162029019|NCT04395001|585163578|FG000|Overall Study|Withdrawal by Subject|3|||
162029020|NCT04395001|585163579|FG001|Overall Study|Withdrawal by Subject|1|||
162029021|NCT04395001|585163580|FG002|Overall Study|Withdrawal by Subject|3|||
162029022|NCT04395001|585163578|FG000|Overall Study|missed appointment|7|||
162029023|NCT04395001|585163579|FG001|Overall Study|missed appointment|4|||
162029024|NCT04395001|585163580|FG002|Overall Study|missed appointment|1|||
162029025|NCT04418661|585163581|FG000|Overall Study|Adverse Event|0|||
162029026|NCT04418661|585163582|FG001|Overall Study|Adverse Event|1|||
162029027|NCT04418661|585163583|FG002|Overall Study|Adverse Event|5|||
162029028|NCT04418661|585163584|FG003|Overall Study|Adverse Event|3|||
162029029|NCT04418661|585163585|FG004|Overall Study|Adverse Event|0|||
162029030|NCT04418661|585163586|FG005|Overall Study|Adverse Event|2|||
162029031|NCT04418661|585163581|FG000|Overall Study|Progressive disease|4|||
162029032|NCT04418661|585163582|FG001|Overall Study|Progressive disease|11|||
162029033|NCT04418661|585163583|FG002|Overall Study|Progressive disease|6|||
162029034|NCT04418661|585163584|FG003|Overall Study|Progressive disease|11|||
162029035|NCT04418661|585163585|FG004|Overall Study|Progressive disease|1|||
162029036|NCT04418661|585163586|FG005|Overall Study|Progressive disease|12|||
162029037|NCT04418661|585163581|FG000|Overall Study|Withdrawal by Subject|0|||
162029038|NCT04418661|585163582|FG001|Overall Study|Withdrawal by Subject|1|||
162029039|NCT04418661|585163583|FG002|Overall Study|Withdrawal by Subject|0|||
162029040|NCT04418661|585163584|FG003|Overall Study|Withdrawal by Subject|1|||
162029041|NCT04418661|585163585|FG004|Overall Study|Withdrawal by Subject|0|||
162029042|NCT04418661|585163586|FG005|Overall Study|Withdrawal by Subject|0|||
162029043|NCT04418661|585163581|FG000|Overall Study|Other|0|||
162029044|NCT04418661|585163582|FG001|Overall Study|Other|0|||
162029045|NCT04418661|585163583|FG002|Overall Study|Other|1|||
162029046|NCT04418661|585163584|FG003|Overall Study|Other|3|||
162029047|NCT04418661|585163585|FG004|Overall Study|Other|0|||
162029048|NCT04418661|585163586|FG005|Overall Study|Other|1|||
162029049|NCT03337490|585163587|FG000|Overall Study|Withdrawal by Subject|1|||
162029050|NCT03337490|585163588|FG001|Overall Study|Withdrawal by Subject|0|||
162029051|NCT03337490|585163589|FG002|Overall Study|Withdrawal by Subject|0|||
162029052|NCT03337490|585163587|FG000|Overall Study|Lack of Efficacy|10|||
162029053|NCT03337490|585163588|FG001|Overall Study|Lack of Efficacy|12|||
161835420|NCT02408120|584438964|FG000|Overall Study|Discharged same day|1|||
162029054|NCT03337490|585163589|FG002|Overall Study|Lack of Efficacy|35|||
162029055|NCT03337490|585163587|FG000|Overall Study|Physician Decision|0|||
162029056|NCT03337490|585163588|FG001|Overall Study|Physician Decision|1|||
162029057|NCT03337490|585163589|FG002|Overall Study|Physician Decision|0|||
162029058|NCT03337490|585163587|FG000|Overall Study|Lost to Follow-up|0|||
162029059|NCT03337490|585163588|FG001|Overall Study|Lost to Follow-up|1|||
162029060|NCT03337490|585163589|FG002|Overall Study|Lost to Follow-up|0|||
162029061|NCT01689532|585163590|FG000|Overall Study|Adverse Event|9|||
162029062|NCT01689532|585163591|FG001|Overall Study|Adverse Event|5|||
162029063|NCT01689532|585163590|FG000|Overall Study|Lack of Efficacy|2|||
162029064|NCT01689532|585163591|FG001|Overall Study|Lack of Efficacy|2|||
162029065|NCT01689532|585163590|FG000|Overall Study|Withdrawal by Subject|1|||
162029066|NCT01689532|585163591|FG001|Overall Study|Withdrawal by Subject|2|||
162029067|NCT01689532|585163590|FG000|Overall Study|Physician Decision|2|||
162029068|NCT01689532|585163591|FG001|Overall Study|Physician Decision|0|||
162029069|NCT01363349|585163592|FG000|Overall Study|Adverse Event|6|||
162029070|NCT01363349|585163593|FG001|Overall Study|Adverse Event|7|||
162029071|NCT01363349|585163592|FG000|Overall Study|Lack of Efficacy|3|||
162029072|NCT01363349|585163593|FG001|Overall Study|Lack of Efficacy|10|||
162029073|NCT01363349|585163592|FG000|Overall Study|Non compliance/Protocol deviations|2|||
162029074|NCT01363349|585163593|FG001|Overall Study|Non compliance/Protocol deviations|2|||
162029075|NCT01363349|585163592|FG000|Overall Study|Withdrawal by Subject|14|||
162029076|NCT01363349|585163593|FG001|Overall Study|Withdrawal by Subject|6|||
162029077|NCT01363349|585163592|FG000|Overall Study|Lost to Follow-up|5|||
162029078|NCT01363349|585163593|FG001|Overall Study|Lost to Follow-up|6|||
162029079|NCT01363349|585163592|FG000|Overall Study|Not reported|36|||
162029080|NCT01363349|585163593|FG001|Overall Study|Not reported|37|||
162029081|NCT01363349|585163592|FG000|Overall Study|missing|1|||
162029082|NCT01363349|585163593|FG001|Overall Study|missing|2|||
162029083|NCT00917644|585163595|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
162029084|NCT00917644|585163596|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
162029085|NCT00917644|585163595|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
162029086|NCT00917644|585163596|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
162029087|NCT00917644|585163595|FG000|Period 2: Second Intervention|family emergency|1|||
162029088|NCT00917644|585163596|FG001|Period 2: Second Intervention|family emergency|0|||
162029089|NCT02108262|585163606|FG000|Overall Study|Non-compliance|0|||
162029090|NCT02108262|585163607|FG001|Overall Study|Non-compliance|2|||
162029091|NCT02108262|585163608|FG002|Overall Study|Non-compliance|1|||
162029092|NCT02108262|585163609|FG003|Overall Study|Non-compliance|1|||
162029093|NCT02108262|585163606|FG000|Overall Study|Randomized by error/screen failure|0|||
161687606|NCT00960661|583908455|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
162029094|NCT02108262|585163607|FG001|Overall Study|Randomized by error/screen failure|0|||
162029095|NCT02108262|585163608|FG002|Overall Study|Randomized by error/screen failure|1|||
162029096|NCT02108262|585163609|FG003|Overall Study|Randomized by error/screen failure|0|||
161687607|NCT00960661|583908453|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
162029097|NCT02108262|585163606|FG000|Overall Study|Distance to center|0|||
162029098|NCT02108262|585163607|FG001|Overall Study|Distance to center|1|||
162029099|NCT02108262|585163608|FG002|Overall Study|Distance to center|1|||
162029100|NCT02108262|585163609|FG003|Overall Study|Distance to center|0|||
162029101|NCT02108262|585163606|FG000|Overall Study|Adverse Event|0|||
162029102|NCT02108262|585163607|FG001|Overall Study|Adverse Event|11|||
162029103|NCT02108262|585163608|FG002|Overall Study|Adverse Event|6|||
162029104|NCT02108262|585163609|FG003|Overall Study|Adverse Event|12|||
162029105|NCT02108262|585163606|FG000|Overall Study|Death|0|||
162029106|NCT02108262|585163607|FG001|Overall Study|Death|2|||
162029107|NCT02108262|585163608|FG002|Overall Study|Death|2|||
162029108|NCT02108262|585163609|FG003|Overall Study|Death|1|||
162029109|NCT02108262|585163606|FG000|Overall Study|Lost to Follow-up|0|||
162029110|NCT02108262|585163607|FG001|Overall Study|Lost to Follow-up|0|||
162029111|NCT02108262|585163608|FG002|Overall Study|Lost to Follow-up|1|||
162029112|NCT02108262|585163609|FG003|Overall Study|Lost to Follow-up|0|||
162029113|NCT02108262|585163606|FG000|Overall Study|Physician Decision|0|||
162029114|NCT02108262|585163607|FG001|Overall Study|Physician Decision|0|||
162029115|NCT02108262|585163608|FG002|Overall Study|Physician Decision|2|||
162029116|NCT02108262|585163609|FG003|Overall Study|Physician Decision|0|||
162029117|NCT02108262|585163606|FG000|Overall Study|Withdrawal by Subject|0|||
162029118|NCT02108262|585163607|FG001|Overall Study|Withdrawal by Subject|7|||
162029119|NCT02108262|585163608|FG002|Overall Study|Withdrawal by Subject|3|||
162029120|NCT02108262|585163609|FG003|Overall Study|Withdrawal by Subject|4|||
162029121|NCT02108262|585163606|FG000|Overall Study|Due to key hepatic values|0|||
162029122|NCT02108262|585163607|FG001|Overall Study|Due to key hepatic values|1|||
162029123|NCT02108262|585163608|FG002|Overall Study|Due to key hepatic values|0|||
162029124|NCT02108262|585163609|FG003|Overall Study|Due to key hepatic values|0|||
162029125|NCT02108262|585163606|FG000|Overall Study|Unable to contact patient|0|||
162029126|NCT02108262|585163607|FG001|Overall Study|Unable to contact patient|3|||
162029127|NCT02108262|585163608|FG002|Overall Study|Unable to contact patient|1|||
162029128|NCT02108262|585163609|FG003|Overall Study|Unable to contact patient|2|||
162029129|NCT02108262|585163606|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
162029130|NCT02108262|585163607|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
162029131|NCT02108262|585163608|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
162029132|NCT02108262|585163609|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
162029133|NCT02108262|585163606|FG000|Overall Study|Patient did not want another infusion|0|||
162029134|NCT02108262|585163607|FG001|Overall Study|Patient did not want another infusion|3|||
162029135|NCT02108262|585163608|FG002|Overall Study|Patient did not want another infusion|3|||
162029136|NCT02108262|585163609|FG003|Overall Study|Patient did not want another infusion|2|||
162029137|NCT02108262|585163606|FG000|Overall Study|Vacation|0|||
162029138|NCT02108262|585163607|FG001|Overall Study|Vacation|1|||
162029139|NCT02108262|585163608|FG002|Overall Study|Vacation|0|||
161835421|NCT02408120|584438965|FG001|Overall Study|Discharged same day|1|||
161835422|NCT02408120|584438964|FG000|Overall Study|Did not receive insulin|1|||
162029140|NCT02108262|585163609|FG003|Overall Study|Vacation|0|||
162029141|NCT02108262|585163606|FG000|Overall Study|Patient decision|0|||
162029142|NCT02108262|585163607|FG001|Overall Study|Patient decision|7|||
162029143|NCT02108262|585163608|FG002|Overall Study|Patient decision|9|||
162029144|NCT02108262|585163609|FG003|Overall Study|Patient decision|14|||
162029145|NCT02108262|585163606|FG000|Overall Study|Missed IV due to pharmacy error|0|||
162029146|NCT02108262|585163607|FG001|Overall Study|Missed IV due to pharmacy error|0|||
161953168|NCT02151786|584878272|FG000|Overall Study|Unavailability of Information|8|||
161953169|NCT02112656|584878273|FG000|Overall Study|Death|78|||
161835423|NCT02408120|584438965|FG001|Overall Study|Did not receive insulin|2|||
161953170|NCT02112656|584878274|FG001|Overall Study|Death|82|||
161953171|NCT02112656|584878273|FG000|Overall Study|Withdrawal by Subject|9|||
161953172|NCT02112656|584878274|FG001|Overall Study|Withdrawal by Subject|11|||
161953173|NCT02112656|584878273|FG000|Overall Study|Lost to Follow-up|2|||
161953174|NCT02112656|584878274|FG001|Overall Study|Lost to Follow-up|4|||
161953175|NCT02112656|584878273|FG000|Overall Study|Noncompliance|1|||
161953176|NCT02112656|584878274|FG001|Overall Study|Noncompliance|2|||
161953177|NCT02197572|584879732|FG000|Overall Study|Progressive Disease|28|||
161953178|NCT02197572|584879732|FG000|Overall Study|Withdrawal by Subject|9|||
161953179|NCT02197572|584879732|FG000|Overall Study|Adverse Event|3|||
161953180|NCT02197572|584879732|FG000|Overall Study|Reason Not Specified|4|||
161953181|NCT02383862|584879733|FG000|3 Month Follow up|Lost to Follow-up|23|||
161953182|NCT02383862|584879734|FG001|3 Month Follow up|Lost to Follow-up|21|||
161953183|NCT03801928|584879735|FG000|Overall Study|Adverse Event|1|||
161953184|NCT03801928|584879736|FG001|Overall Study|Adverse Event|0|||
161953185|NCT03801928|584879737|FG002|Overall Study|Adverse Event|1|||
161953186|NCT03801928|584879738|FG003|Overall Study|Adverse Event|2|||
162029147|NCT02108262|585163608|FG002|Overall Study|Missed IV due to pharmacy error|1|||
162029148|NCT02108262|585163609|FG003|Overall Study|Missed IV due to pharmacy error|0|||
162029149|NCT00770146|585163612|FG000|Treatment Period|Withdrawal by Subject|6|||
162029150|NCT00770146|585163613|FG001|Treatment Period|Withdrawal by Subject|13|||
162029151|NCT00770146|585163612|FG000|Treatment Period|Adverse Event|2|||
162029152|NCT00770146|585163613|FG001|Treatment Period|Adverse Event|26|||
162029153|NCT00770146|585163612|FG000|Treatment Period|Other|1|||
162029154|NCT00770146|585163613|FG001|Treatment Period|Other|5|||
162029155|NCT00770146|585163612|FG000|Treatment Period|Protocol non-compliance|0|||
162029156|NCT00770146|585163613|FG001|Treatment Period|Protocol non-compliance|1|||
162029157|NCT00770146|585163612|FG000|Follow-up Period|Withdrawal by Subject|7|||
162029158|NCT00770146|585163613|FG001|Follow-up Period|Withdrawal by Subject|13|||
162029159|NCT00770146|585163612|FG000|Follow-up Period|Adverse Event|0|||
162029160|NCT00770146|585163613|FG001|Follow-up Period|Adverse Event|2|||
161687608|NCT00960661|583908454|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
162029161|NCT00770146|585163612|FG000|Follow-up Period|Other|4|||
162029162|NCT00770146|585163613|FG001|Follow-up Period|Other|5|||
162029163|NCT01525901|585163615|FG000|Period 2: 12 Weeks|Adverse Event|0|||
162029164|NCT01525901|585163616|FG001|Period 2: 12 Weeks|Adverse Event|1|||
162029165|NCT01525901|585163617|FG002|Period 2: 12 Weeks|Adverse Event|0|||
162029166|NCT01525901|585163618|FG003|Period 2: 12 Weeks|Adverse Event|0|||
162029167|NCT04449029|585163619|FG000|Overall Study|Adverse Event|0|||
162029168|NCT04449029|585163620|FG001|Overall Study|Adverse Event|1|||
162029169|NCT04449029|585163621|FG002|Overall Study|Adverse Event|1|||
162029170|NCT04449029|585163622|FG003|Overall Study|Adverse Event|0|||
162029171|NCT04449029|585163623|FG004|Overall Study|Adverse Event|1|||
162029172|NCT04449029|585163624|FG005|Overall Study|Adverse Event|0|||
162029173|NCT04449029|585163625|FG006|Overall Study|Adverse Event|1|||
162029174|NCT04449029|585163626|FG007|Overall Study|Adverse Event|0|||
162029175|NCT04449029|585163619|FG000|Overall Study|Lost to Follow-up|0|||
162029176|NCT04449029|585163620|FG001|Overall Study|Lost to Follow-up|1|||
162029177|NCT04449029|585163621|FG002|Overall Study|Lost to Follow-up|0|||
162029178|NCT04449029|585163622|FG003|Overall Study|Lost to Follow-up|0|||
162029179|NCT04449029|585163623|FG004|Overall Study|Lost to Follow-up|0|||
162029180|NCT04449029|585163624|FG005|Overall Study|Lost to Follow-up|0|||
162029181|NCT04449029|585163625|FG006|Overall Study|Lost to Follow-up|0|||
162029182|NCT04449029|585163626|FG007|Overall Study|Lost to Follow-up|0|||
162029183|NCT04449029|585163619|FG000|Overall Study|Protocol Violation|0|||
162029184|NCT04449029|585163620|FG001|Overall Study|Protocol Violation|1|||
162029185|NCT04449029|585163621|FG002|Overall Study|Protocol Violation|0|||
162029186|NCT04449029|585163622|FG003|Overall Study|Protocol Violation|0|||
162029187|NCT04449029|585163623|FG004|Overall Study|Protocol Violation|0|||
161687609|NCT00960661|583908455|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
161687610|NCT00960661|583908453|FG000|Interventional Phase|Adverse Event|0|||
161687611|NCT00960661|583908454|FG001|Interventional Phase|Adverse Event|17|||
161687612|NCT00960661|583908455|FG002|Interventional Phase|Adverse Event|8|||
161687613|NCT00960661|583908453|FG000|Interventional Phase|Death|0|||
161687614|NCT00960661|583908454|FG001|Interventional Phase|Death|1|||
161687615|NCT00960661|583908455|FG002|Interventional Phase|Death|0|||
161687616|NCT00960661|583908453|FG000|Interventional Phase|Lost to Follow-up|0|||
161687617|NCT00960661|583908454|FG001|Interventional Phase|Lost to Follow-up|0|||
161687618|NCT00960661|583908455|FG002|Interventional Phase|Lost to Follow-up|2|||
161835424|NCT00958126|584438966|FG000|Overall Study|Serious Adverse Event|0|||
161687619|NCT00960661|583908453|FG000|Interventional Phase|entry criteria not met|0|||
161835425|NCT00958126|584438967|FG001|Overall Study|Serious Adverse Event|2|||
161835426|NCT00958126|584438968|FG002|Overall Study|Serious Adverse Event|0|||
161835427|NCT00958126|584438969|FG003|Overall Study|Serious Adverse Event|0|||
162029188|NCT04449029|585163624|FG005|Overall Study|Protocol Violation|0|||
162029189|NCT04449029|585163625|FG006|Overall Study|Protocol Violation|0|||
162029190|NCT04449029|585163626|FG007|Overall Study|Protocol Violation|0|||
162029191|NCT04449029|585163619|FG000|Overall Study|Physician Decision|0|||
162029192|NCT04449029|585163620|FG001|Overall Study|Physician Decision|0|||
162029193|NCT04449029|585163621|FG002|Overall Study|Physician Decision|0|||
162029194|NCT04449029|585163622|FG003|Overall Study|Physician Decision|0|||
162029195|NCT04449029|585163623|FG004|Overall Study|Physician Decision|0|||
162029196|NCT04449029|585163624|FG005|Overall Study|Physician Decision|1|||
162029197|NCT04449029|585163625|FG006|Overall Study|Physician Decision|0|||
162029198|NCT04449029|585163626|FG007|Overall Study|Physician Decision|0|||
162029199|NCT04449029|585163619|FG000|Overall Study|Withdrawal by Subject|3|||
161953187|NCT03801928|584879739|FG004|Overall Study|Adverse Event|0|||
161953188|NCT03801928|584879740|FG005|Overall Study|Adverse Event|2|||
161953189|NCT03801928|584879735|FG000|Overall Study|Lack of Efficacy|0|||
161953190|NCT03801928|584879736|FG001|Overall Study|Lack of Efficacy|0|||
161953191|NCT03801928|584879737|FG002|Overall Study|Lack of Efficacy|1|||
161953192|NCT03801928|584879738|FG003|Overall Study|Lack of Efficacy|0|||
161953193|NCT03801928|584879739|FG004|Overall Study|Lack of Efficacy|0|||
161953194|NCT03801928|584879740|FG005|Overall Study|Lack of Efficacy|0|||
161953195|NCT03801928|584879735|FG000|Overall Study|Lost to Follow-up|5|||
161953196|NCT03801928|584879736|FG001|Overall Study|Lost to Follow-up|1|||
161953197|NCT03801928|584879737|FG002|Overall Study|Lost to Follow-up|1|||
161953198|NCT03801928|584879738|FG003|Overall Study|Lost to Follow-up|4|||
161953199|NCT03801928|584879739|FG004|Overall Study|Lost to Follow-up|4|||
161953200|NCT03801928|584879740|FG005|Overall Study|Lost to Follow-up|2|||
161953201|NCT03801928|584879735|FG000|Overall Study|Withdrawal by Subject|0|||
161953202|NCT03801928|584879736|FG001|Overall Study|Withdrawal by Subject|0|||
161953203|NCT03801928|584879737|FG002|Overall Study|Withdrawal by Subject|2|||
161953204|NCT03801928|584879738|FG003|Overall Study|Withdrawal by Subject|1|||
161953205|NCT03801928|584879739|FG004|Overall Study|Withdrawal by Subject|0|||
161953206|NCT03801928|584879740|FG005|Overall Study|Withdrawal by Subject|0|||
161953207|NCT03801928|584879735|FG000|Overall Study|Other|0|||
161953208|NCT03801928|584879736|FG001|Overall Study|Other|2|||
161953209|NCT03801928|584879737|FG002|Overall Study|Other|0|||
161953210|NCT03801928|584879738|FG003|Overall Study|Other|1|||
161953211|NCT03801928|584879739|FG004|Overall Study|Other|0|||
161953212|NCT03801928|584879740|FG005|Overall Study|Other|1|||
161953213|NCT02763059|584879741|FG000|Overall Study|Lost to Follow-up|4|||
161953214|NCT02763059|584879742|FG001|Overall Study|Lost to Follow-up|1|||
161953215|NCT02763059|584879743|FG002|Overall Study|Lost to Follow-up|6|||
161953216|NCT02763059|584879741|FG000|Overall Study|Withdrawal by Subject|1|||
161953217|NCT02763059|584879742|FG001|Overall Study|Withdrawal by Subject|0|||
161953218|NCT02763059|584879743|FG002|Overall Study|Withdrawal by Subject|3|||
161953219|NCT03688919|584879744|FG000|Overall Study|Lost to Follow-up|2|||
161953220|NCT03688919|584879745|FG001|Overall Study|Lost to Follow-up|1|||
161953221|NCT03688919|584879744|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
161953222|NCT03688919|584879745|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
161953223|NCT01724216|584879750|FG000|Overall Study|Scan was not completed|1|||
161953224|NCT00175916|584879751|FG000|Overall Study|Death|19|||
161953225|NCT00175916|584879751|FG000|Overall Study|Adverse Event|81|||
161953226|NCT00175916|584879751|FG000|Overall Study|Lack of Efficacy|354|||
161687620|NCT00960661|583908454|FG001|Interventional Phase|entry criteria not met|3|||
161687621|NCT00960661|583908455|FG002|Interventional Phase|entry criteria not met|0|||
161687622|NCT00960661|583908453|FG000|Interventional Phase|Protocol Violation|0|||
161687623|NCT00960661|583908454|FG001|Interventional Phase|Protocol Violation|7|||
161687624|NCT00960661|583908455|FG002|Interventional Phase|Protocol Violation|2|||
161687625|NCT00960661|583908453|FG000|Interventional Phase|Withdrawal by Subject|0|||
161687626|NCT00960661|583908454|FG001|Interventional Phase|Withdrawal by Subject|18|||
161687627|NCT00960661|583908455|FG002|Interventional Phase|Withdrawal by Subject|29|||
161687628|NCT00960661|583908453|FG000|Interventional Phase|Physician Decision|0|||
161687629|NCT00960661|583908454|FG001|Interventional Phase|Physician Decision|3|||
161687630|NCT00960661|583908455|FG002|Interventional Phase|Physician Decision|5|||
161687631|NCT00960661|583908453|FG000|Interventional Phase|sponsor decision|0|||
161687632|NCT00960661|583908454|FG001|Interventional Phase|sponsor decision|1|||
161687633|NCT00960661|583908455|FG002|Interventional Phase|sponsor decision|0|||
161687634|NCT00960661|583908453|FG000|Interventional Phase|Lack of Efficacy|0|||
161687635|NCT00960661|583908454|FG001|Interventional Phase|Lack of Efficacy|2|||
161687636|NCT00960661|583908455|FG002|Interventional Phase|Lack of Efficacy|0|||
161687637|NCT02699892|583908456|FG000|Overall Study|Other|36|||
161687638|NCT00711100|583908457|FG000|Overall Study|Lack of Efficacy|5|||
161953227|NCT00175916|584879751|FG000|Overall Study|Lost to Follow-up|17|||
161953228|NCT00175916|584879751|FG000|Overall Study|Subject Choice|98|||
161953229|NCT00175916|584879751|FG000|Overall Study|Lack of compliance|8|||
161953230|NCT00175916|584879751|FG000|Overall Study|Patient cannot record seizures|1|||
161953231|NCT00175916|584879751|FG000|Overall Study|Sponsor decision|17|||
161953232|NCT00175916|584879751|FG000|Overall Study|Vigabatrin intake|1|||
161953233|NCT00175916|584879751|FG000|Overall Study|Suicidal behaviour|1|||
161953234|NCT00175916|584879751|FG000|Overall Study|Withdrawal by Subject|1|||
161953235|NCT00175916|584879751|FG000|Overall Study|Seizure - free|4|||
161953236|NCT00175916|584879751|FG000|Overall Study|Administrative reason|1|||
161953237|NCT00175916|584879751|FG000|Overall Study|Pregnancy|1|||
161953238|NCT00175916|584879751|FG000|Overall Study|Patient's request|2|||
161953239|NCT00175916|584879751|FG000|Overall Study|Treating physiciant's choice|1|||
161953240|NCT00175916|584879751|FG000|Overall Study|Moved overseas|1|||
161953241|NCT00175916|584879751|FG000|Overall Study|Loss of job and economic burden|1|||
161953242|NCT00175916|584879751|FG000|Overall Study|Site was closed|9|||
161953243|NCT00175916|584879751|FG000|Overall Study|Patient went to prison|1|||
161953244|NCT04423939|584879752|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
161953245|NCT04423939|584879753|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
161953246|NCT04423939|584879752|FG000|Overall Study|Death|3|||
161687639|NCT00711100|583908457|FG000|Overall Study|Withdrawal by Subject|8|||
161687640|NCT02083380|583908458|FG000|Overall Study|Lack of Efficacy|68|||
161687641|NCT02083380|583908459|FG001|Overall Study|Lack of Efficacy|79|||
161835428|NCT00958126|584438970|FG004|Overall Study|Serious Adverse Event|0|||
161835429|NCT00958126|584438971|FG005|Overall Study|Serious Adverse Event|0|||
161953247|NCT04423939|584879753|FG001|Overall Study|Death|0|||
161953248|NCT04423939|584879752|FG000|Overall Study|Withdrawal by Subject|3|||
161953249|NCT04423939|584879753|FG001|Overall Study|Withdrawal by Subject|0|||
162029200|NCT04449029|585163620|FG001|Overall Study|Withdrawal by Subject|0|||
162029201|NCT04449029|585163621|FG002|Overall Study|Withdrawal by Subject|1|||
162029202|NCT04449029|585163622|FG003|Overall Study|Withdrawal by Subject|1|||
162029203|NCT04449029|585163623|FG004|Overall Study|Withdrawal by Subject|5|||
162029204|NCT04449029|585163624|FG005|Overall Study|Withdrawal by Subject|1|||
162029205|NCT04449029|585163625|FG006|Overall Study|Withdrawal by Subject|4|||
162029206|NCT04449029|585163626|FG007|Overall Study|Withdrawal by Subject|0|||
162029207|NCT01073462|585163628|FG000|Overall Study|Death|14|||
162029208|NCT01073462|585163628|FG000|Overall Study|Kidney transplant|10|||
162029209|NCT01073462|585163628|FG000|Overall Study|Low parathyroid hormone levels|8|||
162029210|NCT01073462|585163628|FG000|Overall Study|Serious adverse event|2|||
162029211|NCT01073462|585163628|FG000|Overall Study|Lost to Follow-up|7|||
161687642|NCT02083380|583908460|FG002|Overall Study|Lack of Efficacy|64|||
161687643|NCT02083380|583908458|FG000|Overall Study|Withdrawal by Subject|9|||
161687644|NCT02083380|583908459|FG001|Overall Study|Withdrawal by Subject|3|||
161687645|NCT02083380|583908460|FG002|Overall Study|Withdrawal by Subject|7|||
161687646|NCT02083380|583908458|FG000|Overall Study|Physician Decision|1|||
161687647|NCT02083380|583908459|FG001|Overall Study|Physician Decision|6|||
161687648|NCT02083380|583908460|FG002|Overall Study|Physician Decision|3|||
161687649|NCT02083380|583908458|FG000|Overall Study|Adverse Event|0|||
161687650|NCT02083380|583908459|FG001|Overall Study|Adverse Event|0|||
161687651|NCT02083380|583908460|FG002|Overall Study|Adverse Event|1|||
161687652|NCT02083380|583908458|FG000|Overall Study|Lost to Follow-up|5|||
161687653|NCT02083380|583908459|FG001|Overall Study|Lost to Follow-up|3|||
161687654|NCT02083380|583908460|FG002|Overall Study|Lost to Follow-up|3|||
161687655|NCT02083380|583908458|FG000|Overall Study|Other|8|||
161687656|NCT02083380|583908459|FG001|Overall Study|Other|4|||
161687657|NCT02083380|583908460|FG002|Overall Study|Other|6|||
161687658|NCT00001379|583908461|FG000|Initial Treatment|Disease progression|21|||
161687659|NCT00001379|583908462|FG001|Initial Treatment|Disease progression|3|||
161687660|NCT00001379|583908463|FG002|Initial Treatment|Disease progression|0|||
161687661|NCT00001379|583908464|FG003|Initial Treatment|Disease progression|0|||
161687662|NCT00001379|583908461|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
161687663|NCT00001379|583908462|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
161687664|NCT00001379|583908463|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
161687665|NCT00001379|583908464|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
161687666|NCT00001379|583908461|FG000|Initial Treatment|Received alternative treatment|2|||
161687667|NCT00001379|583908462|FG001|Initial Treatment|Received alternative treatment|1|||
161687668|NCT00001379|583908463|FG002|Initial Treatment|Received alternative treatment|0|||
161687669|NCT00001379|583908464|FG003|Initial Treatment|Received alternative treatment|0|||
161687670|NCT00001379|583908461|FG000|Initial Treatment|Refused further treatment|2|||
161687671|NCT00001379|583908462|FG001|Initial Treatment|Refused further treatment|0|||
161687672|NCT00001379|583908463|FG002|Initial Treatment|Refused further treatment|0|||
161687673|NCT00001379|583908464|FG003|Initial Treatment|Refused further treatment|0|||
161687674|NCT00001379|583908461|FG000|Initial Treatment|Did not receive protocol treatment|0|||
161687675|NCT00001379|583908462|FG001|Initial Treatment|Did not receive protocol treatment|0|||
161687676|NCT00001379|583908463|FG002|Initial Treatment|Did not receive protocol treatment|5|||
161687677|NCT00001379|583908464|FG003|Initial Treatment|Did not receive protocol treatment|0|||
161687678|NCT00001379|583908461|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
161687679|NCT00001379|583908462|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
161687680|NCT00001379|583908463|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
161687681|NCT00001379|583908464|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
161687682|NCT00001379|583908461|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
161687683|NCT00001379|583908462|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
161687684|NCT00001379|583908463|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
161687685|NCT00001379|583908464|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
161687686|NCT00001379|583908461|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
161953250|NCT04423939|584879752|FG000|Overall Study|Caregiver to patient who died|0|||
161953251|NCT04423939|584879753|FG001|Overall Study|Caregiver to patient who died|3|||
162029212|NCT00247611|585163631|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
162029213|NCT00247611|585163632|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
162029214|NCT00247611|585163631|FG000|Baselined|Completed baseline only|9|||
162029215|NCT00247611|585163632|FG001|Baselined|Completed baseline only|8|||
161687687|NCT00001379|583908462|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
161835430|NCT00958126|584438972|FG006|Overall Study|Serious Adverse Event|1|||
161835431|NCT00958126|584438973|FG007|Overall Study|Serious Adverse Event|0|||
161835432|NCT00958126|584438966|FG000|Overall Study|Withdrawal by Subject|0|||
161835433|NCT00958126|584438967|FG001|Overall Study|Withdrawal by Subject|2|||
161835434|NCT00958126|584438968|FG002|Overall Study|Withdrawal by Subject|0|||
161835435|NCT00958126|584438969|FG003|Overall Study|Withdrawal by Subject|0|||
161835436|NCT00958126|584438970|FG004|Overall Study|Withdrawal by Subject|0|||
161835437|NCT00958126|584438971|FG005|Overall Study|Withdrawal by Subject|0|||
161835438|NCT00958126|584438972|FG006|Overall Study|Withdrawal by Subject|0|||
161835439|NCT00958126|584438973|FG007|Overall Study|Withdrawal by Subject|0|||
161835440|NCT00958126|584438966|FG000|Overall Study|Moved away from study area|0|||
161835441|NCT00958126|584438967|FG001|Overall Study|Moved away from study area|0|||
161835442|NCT00958126|584438968|FG002|Overall Study|Moved away from study area|1|||
161835443|NCT00958126|584438969|FG003|Overall Study|Moved away from study area|1|||
161835444|NCT00958126|584438970|FG004|Overall Study|Moved away from study area|0|||
161687688|NCT00001379|583908463|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
161835445|NCT00958126|584438971|FG005|Overall Study|Moved away from study area|0|||
161835446|NCT00958126|584438972|FG006|Overall Study|Moved away from study area|0|||
161953252|NCT04423939|584879752|FG000|Overall Study|Caregiver to patient who withdrew|0|||
161953253|NCT04423939|584879753|FG001|Overall Study|Caregiver to patient who withdrew|3|||
161953254|NCT01456130|584879755|FG000|Overall Study|Adverse Event|4|||
161953255|NCT01456130|584879755|FG000|Overall Study|Voluntary Withdrawal|1|||
161953256|NCT01456130|584879755|FG000|Overall Study|Lack of Efficacy|4|||
161953257|NCT01456130|584879755|FG000|Overall Study|Other|1|||
161953258|NCT03369665|584879760|FG000|Overall Study|Adverse Event|3|||
161953259|NCT03369665|584879760|FG000|Overall Study|Lost to Follow-up|7|||
161953260|NCT03369665|584879760|FG000|Overall Study|Withdrawal by Subject|15|||
161953261|NCT03369665|584879760|FG000|Overall Study|Progression Disease|2|||
161953262|NCT03369665|584879760|FG000|Overall Study|Not classified|3|||
161953263|NCT03230318|584879764|FG000|Overall Study|Radiographic disease progression|72|||
161953264|NCT03230318|584879765|FG001|Overall Study|Radiographic disease progression|19|||
161953265|NCT03230318|584879764|FG000|Overall Study|Clinical progression|17|||
161953266|NCT03230318|584879765|FG001|Overall Study|Clinical progression|7|||
161953267|NCT03230318|584879764|FG000|Overall Study|Adverse Event|5|||
161953268|NCT03230318|584879765|FG001|Overall Study|Adverse Event|3|||
161953269|NCT03230318|584879764|FG000|Overall Study|Physician Decision|2|||
161953270|NCT03230318|584879765|FG001|Overall Study|Physician Decision|3|||
161953271|NCT03230318|584879764|FG000|Overall Study|Death|3|||
161835447|NCT00958126|584438973|FG007|Overall Study|Moved away from study area|0|||
161835448|NCT00958126|584438966|FG000|Overall Study|Lost to Follow-up|1|||
161835449|NCT00958126|584438967|FG001|Overall Study|Lost to Follow-up|5|||
161835450|NCT00958126|584438968|FG002|Overall Study|Lost to Follow-up|9|||
161835451|NCT00958126|584438969|FG003|Overall Study|Lost to Follow-up|8|||
161953272|NCT03230318|584879765|FG001|Overall Study|Death|2|||
161953273|NCT03230318|584879764|FG000|Overall Study|Lost to Follow-up|1|||
161953274|NCT03230318|584879765|FG001|Overall Study|Lost to Follow-up|0|||
161953275|NCT03230318|584879764|FG000|Overall Study|Withdrawal by Subject|1|||
161953276|NCT03230318|584879765|FG001|Overall Study|Withdrawal by Subject|3|||
161953277|NCT03230318|584879764|FG000|Overall Study|Other|3|||
161953278|NCT03230318|584879765|FG001|Overall Study|Other|7|||
162029216|NCT01509053|585163633|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
162029217|NCT01509053|585163633|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
162029218|NCT01509053|585163633|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
162029219|NCT01509053|585163633|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
162029220|NCT01509053|585163633|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
162029221|NCT01509053|585163633|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
162029222|NCT00392379|585163638|FG000|Overall Study|Withdrawal by Subject|17|||
162029223|NCT00392379|585163639|FG001|Overall Study|Withdrawal by Subject|28|||
162029224|NCT00392379|585163638|FG000|Overall Study|Lost to Follow-up|4|||
162029225|NCT00392379|585163639|FG001|Overall Study|Lost to Follow-up|9|||
162029226|NCT00392379|585163638|FG000|Overall Study|Adverse Event|1|||
162029227|NCT00392379|585163639|FG001|Overall Study|Adverse Event|1|||
162029228|NCT01700387|585163640|FG000|Overall Study|Withdrawal by Subject|1|||
162029229|NCT01700387|585163641|FG001|Overall Study|Withdrawal by Subject|2|||
162029230|NCT01700387|585163640|FG000|Overall Study|Adverse Event|1|||
162029231|NCT01700387|585163641|FG001|Overall Study|Adverse Event|1|||
162029232|NCT01700387|585163640|FG000|Overall Study|Lost to Follow-up|2|||
162029233|NCT01700387|585163641|FG001|Overall Study|Lost to Follow-up|1|||
162029234|NCT02730793|585163649|FG000|Overall Study|Physician Decision|0|||
162029235|NCT02730793|585163650|FG001|Overall Study|Physician Decision|1|||
162029236|NCT02730793|585163649|FG000|Overall Study|Withdrawal by Subject|0|||
162029237|NCT02730793|585163650|FG001|Overall Study|Withdrawal by Subject|1|||
162029238|NCT02365233|585163651|FG000|Overall Study|IRB withheld the data|1|||
162029239|NCT02365233|585163652|FG001|Overall Study|IRB withheld the data|2|||
162029240|NCT02365233|585163653|FG002|Overall Study|IRB withheld the data|2|||
162029241|NCT00934843|585163654|FG000|Overall Study|Protocol Violation|0|||
162029242|NCT00934843|585163655|FG001|Overall Study|Protocol Violation|1|||
162029243|NCT00160667|585163656|FG000|Overall Study|Adverse Event|3|||
162029244|NCT00160667|585163657|FG001|Overall Study|Adverse Event|1|||
162029245|NCT00160667|585163658|FG002|Overall Study|Adverse Event|4|||
162029246|NCT00160667|585163656|FG000|Overall Study|Withdrawal by Subject|2|||
162029247|NCT00160667|585163657|FG001|Overall Study|Withdrawal by Subject|0|||
162029248|NCT00160667|585163658|FG002|Overall Study|Withdrawal by Subject|1|||
162029249|NCT00160667|585163656|FG000|Overall Study|Lack of Efficacy|0|||
162029250|NCT00160667|585163657|FG001|Overall Study|Lack of Efficacy|1|||
162029251|NCT00160667|585163658|FG002|Overall Study|Lack of Efficacy|0|||
162029252|NCT00160667|585163656|FG000|Overall Study|Protocol Violation|0|||
162029253|NCT00160667|585163657|FG001|Overall Study|Protocol Violation|1|||
162029254|NCT00160667|585163658|FG002|Overall Study|Protocol Violation|0|||
162029255|NCT00160667|585163656|FG000|Overall Study|Patient decision|0|||
162029256|NCT00160667|585163657|FG001|Overall Study|Patient decision|0|||
162029257|NCT00160667|585163658|FG002|Overall Study|Patient decision|1|||
162029258|NCT00995566|585163666|FG000|Overall Study|Adverse Event|2|||
162029259|NCT00995566|585163666|FG000|Overall Study|Early study termination|52|||
162029260|NCT00336583|585165403|FG000|Overall Study|Lost to Follow-up|1|||
162029261|NCT00336583|585165403|FG000|Overall Study|Death|1|||
162029262|NCT03224598|585165406|FG000|Overall Study|Lost to Follow-up|0|||
162029263|NCT03224598|585165407|FG001|Overall Study|Lost to Follow-up|2|||
162029264|NCT03224598|585165408|FG002|Overall Study|Lost to Follow-up|0|||
162029265|NCT03224598|585165406|FG000|Overall Study|Other|0|||
162029266|NCT03224598|585165407|FG001|Overall Study|Other|1|||
162029267|NCT03224598|585165408|FG002|Overall Study|Other|0|||
162029268|NCT03328182|585165411|FG000|Overall Study|Withdrawal by Subject|1|||
162029269|NCT03328182|585165411|FG000|Overall Study|Protocol Violation|2|||
162029270|NCT03328182|585165411|FG000|Overall Study|No Product Evaluated|1|||
162029271|NCT00003830|585165412|FG000|Overall Study|No follow up data|3|||
162029272|NCT00003830|585165413|FG001|Overall Study|No follow up data|0|||
162029273|NCT00003830|585165412|FG000|Overall Study|Sentinel node positive patients|829|||
162029274|NCT00003830|585165413|FG001|Overall Study|Sentinel node positive patients|793|||
162029275|NCT00883688|585165414|FG000|Overall Study|Ineligible|2|||
162029276|NCT05347147|585165415|FG000|Overall Study|Lost to Follow-up|0|||
162029277|NCT05347147|585165416|FG001|Overall Study|Lost to Follow-up|1|||
162029278|NCT05347147|585165415|FG000|Overall Study|Sponsor request|3|||
162029279|NCT05347147|585165416|FG001|Overall Study|Sponsor request|3|||
162029280|NCT05347147|585165415|FG000|Overall Study|Study termination|2|||
162029281|NCT05347147|585165416|FG001|Overall Study|Study termination|1|||
162029282|NCT00137839|585165420|FG000|Overall Study|Adverse Event|7|||
162029283|NCT00137839|585165420|FG000|Overall Study|Physician Decision|7|||
162029284|NCT00137839|585165420|FG000|Overall Study|Death|8|||
162029285|NCT00137839|585165420|FG000|Overall Study|Disease Progression|60|||
162029286|NCT00137839|585165420|FG000|Overall Study|Not Start Treatment|1|||
162029287|NCT00137839|585165420|FG000|Overall Study|Prolonged Treatment Delay|1|||
162029288|NCT03860935|585165425|FG000|Overall Study|Withdrawal of Consent|15|||
162029289|NCT03860935|585165426|FG001|Overall Study|Withdrawal of Consent|6|||
162029290|NCT03860935|585165425|FG000|Overall Study|Death|75|||
162029291|NCT03860935|585165426|FG001|Overall Study|Death|51|||
162029292|NCT04461600|585165430|FG000|Overall Study|Death|6|||
162029293|NCT04461600|585165431|FG001|Overall Study|Death|5|||
161953279|NCT01722994|584879766|FG000|Overall Study|Missing data|25|||
161953280|NCT01722994|584879767|FG001|Overall Study|Missing data|17|||
162029294|NCT04461600|585165430|FG000|Overall Study|Withdrawal by Subject|0|||
162029295|NCT04461600|585165431|FG001|Overall Study|Withdrawal by Subject|1|||
162029296|NCT00704522|585165432|FG000|Overall Study|Lack of Efficacy|65|||
162029297|NCT00704522|585165433|FG001|Overall Study|Lack of Efficacy|17|||
162029298|NCT00704522|585165432|FG000|Overall Study|Failure to appear again at hospital|56|||
162029299|NCT00704522|585165433|FG001|Overall Study|Failure to appear again at hospital|10|||
162029300|NCT00704522|585165432|FG000|Overall Study|Withdrawal by Subject|17|||
162029301|NCT00704522|585165433|FG001|Overall Study|Withdrawal by Subject|8|||
162029302|NCT00704522|585165432|FG000|Overall Study|Adverse Event|9|||
162029303|NCT00704522|585165433|FG001|Overall Study|Adverse Event|1|||
162029304|NCT00704522|585165432|FG000|Overall Study|Undefined causes|9|||
162029305|NCT00704522|585165433|FG001|Overall Study|Undefined causes|7|||
162029306|NCT00704522|585165432|FG000|Overall Study|No information on therapy end|27|||
162029307|NCT00704522|585165433|FG001|Overall Study|No information on therapy end|2|||
162029308|NCT04896229|585165434|FG000|Overall Study|Lost to Follow-up|113|||
162029309|NCT04896229|585165435|FG001|Overall Study|Lost to Follow-up|113|||
162029310|NCT00635024|585165436|FG000|Overall Study|Adverse Event|1|||
162029311|NCT01958489|585165437|FG000|Period 2|Adverse Event|0|||
162029312|NCT01958489|585165438|FG001|Period 2|Adverse Event|1|||
162029313|NCT00992589|585165439|FG000|Open-Label Phase|Adverse Event|4|||
162029314|NCT00992589|585165440|FG001|Open-Label Phase|Adverse Event|0|||
162029315|NCT00992589|585165441|FG002|Open-Label Phase|Adverse Event|0|||
162029316|NCT00992589|585165442|FG003|Open-Label Phase|Adverse Event|0|||
162029317|NCT00992589|585165439|FG000|Open-Label Phase|Withdrawal by Subject|20|||
162029318|NCT00992589|585165440|FG001|Open-Label Phase|Withdrawal by Subject|0|||
162029319|NCT00992589|585165441|FG002|Open-Label Phase|Withdrawal by Subject|0|||
162029320|NCT00992589|585165442|FG003|Open-Label Phase|Withdrawal by Subject|0|||
162029321|NCT00992589|585165439|FG000|Open-Label Phase|Lost to Follow-up|1|||
162029322|NCT00992589|585165440|FG001|Open-Label Phase|Lost to Follow-up|0|||
162029323|NCT00992589|585165441|FG002|Open-Label Phase|Lost to Follow-up|0|||
162029324|NCT00992589|585165442|FG003|Open-Label Phase|Lost to Follow-up|0|||
162029325|NCT00992589|585165439|FG000|Open-Label Phase|Protocol Violation|3|||
162029326|NCT00992589|585165440|FG001|Open-Label Phase|Protocol Violation|0|||
162029327|NCT00992589|585165441|FG002|Open-Label Phase|Protocol Violation|0|||
162029328|NCT00992589|585165442|FG003|Open-Label Phase|Protocol Violation|0|||
161953281|NCT01206140|584879771|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
161953282|NCT01206140|584879772|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
161953283|NCT00709319|584879773|FG000|Overall Study|Death|4|||
161953284|NCT00709319|584879773|FG000|Overall Study|Withdrawal by Subject|2|||
161953285|NCT00090779|584879774|FG000|Step 1|Withdrawal by Subject|4|||
161953286|NCT00090779|584879775|FG001|Step 1|Withdrawal by Subject|2|||
161953287|NCT00090779|584879774|FG000|Step 1|Lost to Follow-up|3|||
161953288|NCT00090779|584879775|FG001|Step 1|Lost to Follow-up|2|||
161953289|NCT00090779|584879774|FG000|Step 1|Death|0|||
161953290|NCT00090779|584879775|FG001|Step 1|Death|2|||
161953291|NCT00090779|584879774|FG000|Step 1|Physician Decision|1|||
162029329|NCT00992589|585165439|FG000|Open-Label Phase|Physician Decision|4|||
162029330|NCT00992589|585165440|FG001|Open-Label Phase|Physician Decision|0|||
162029331|NCT00992589|585165441|FG002|Open-Label Phase|Physician Decision|0|||
161953292|NCT00090779|584879775|FG001|Step 1|Physician Decision|0|||
162029332|NCT00992589|585165442|FG003|Open-Label Phase|Physician Decision|0|||
162029333|NCT00992589|585165439|FG000|Open-Label Phase|Other|45|||
162029334|NCT00992589|585165440|FG001|Open-Label Phase|Other|0|||
162029335|NCT00992589|585165441|FG002|Open-Label Phase|Other|0|||
162029336|NCT00992589|585165442|FG003|Open-Label Phase|Other|0|||
161953293|NCT00090779|584879774|FG000|Step 1|Pregnancy|1|||
161953294|NCT00090779|584879775|FG001|Step 1|Pregnancy|0|||
161953295|NCT00090779|584879774|FG000|Step 1|Non-compliance to study requirements|0|||
161953296|NCT00090779|584879775|FG001|Step 1|Non-compliance to study requirements|1|||
161835452|NCT00958126|584438970|FG004|Overall Study|Lost to Follow-up|0|||
161835453|NCT00958126|584438971|FG005|Overall Study|Lost to Follow-up|0|||
161835454|NCT00958126|584438972|FG006|Overall Study|Lost to Follow-up|0|||
161835455|NCT00958126|584438973|FG007|Overall Study|Lost to Follow-up|0|||
161835456|NCT00958126|584438966|FG000|Overall Study|Sponsor/Investigator decision|0|||
161835457|NCT00958126|584438967|FG001|Overall Study|Sponsor/Investigator decision|0|||
161835458|NCT00958126|584438968|FG002|Overall Study|Sponsor/Investigator decision|0|||
161835459|NCT00958126|584438969|FG003|Overall Study|Sponsor/Investigator decision|1|||
161835460|NCT00958126|584438970|FG004|Overall Study|Sponsor/Investigator decision|0|||
161835461|NCT00958126|584438971|FG005|Overall Study|Sponsor/Investigator decision|0|||
161835462|NCT00958126|584438972|FG006|Overall Study|Sponsor/Investigator decision|0|||
161835463|NCT00958126|584438973|FG007|Overall Study|Sponsor/Investigator decision|0|||
161835464|NCT00958126|584438966|FG000|Overall Study|Other Reason|0|||
161835465|NCT00958126|584438967|FG001|Overall Study|Other Reason|0|||
161835466|NCT00958126|584438968|FG002|Overall Study|Other Reason|0|||
161835467|NCT00958126|584438969|FG003|Overall Study|Other Reason|1|||
161835468|NCT00958126|584438970|FG004|Overall Study|Other Reason|0|||
161835469|NCT00958126|584438971|FG005|Overall Study|Other Reason|1|||
161835470|NCT00958126|584438972|FG006|Overall Study|Other Reason|0|||
161835471|NCT00958126|584438973|FG007|Overall Study|Other Reason|0|||
161835472|NCT00720226|584438974|FG000|Overall Study|Withdrawal by Subject|7|||
161835473|NCT00720226|584438975|FG001|Overall Study|Withdrawal by Subject|4|||
161835474|NCT00733369|584438976|FG000|Overall Study|Lost to Follow-up|2|||
161835475|NCT00733369|584438977|FG001|Overall Study|Lost to Follow-up|1|||
161835476|NCT00733369|584438976|FG000|Overall Study|Adverse Event|4|||
161835477|NCT00733369|584438977|FG001|Overall Study|Adverse Event|4|||
161835478|NCT00733369|584438976|FG000|Overall Study|Protocol Violation|4|||
161835479|NCT00733369|584438977|FG001|Overall Study|Protocol Violation|4|||
161835480|NCT03401073|584438980|FG000|Overall Study|Lost to Follow-up|1|||
161835481|NCT03401073|584438981|FG001|Overall Study|Lost to Follow-up|2|||
161835482|NCT01470612|584438982|FG000|Overall Study|Adverse Event|20|||
161835483|NCT01470612|584438983|FG001|Overall Study|Adverse Event|80|||
161835484|NCT01470612|584438982|FG000|Overall Study|Death|0|||
161835485|NCT01470612|584438983|FG001|Overall Study|Death|1|||
161835486|NCT01470612|584438982|FG000|Overall Study|Lack of Efficacy|20|||
161835487|NCT01470612|584438983|FG001|Overall Study|Lack of Efficacy|326|||
161835488|NCT01470612|584438982|FG000|Overall Study|Lost to Follow-up|2|||
161835489|NCT01470612|584438983|FG001|Overall Study|Lost to Follow-up|5|||
161835490|NCT01470612|584438982|FG000|Overall Study|Did not meet entrance criteria|0|||
161835491|NCT01470612|584438983|FG001|Overall Study|Did not meet entrance criteria|1|||
161835492|NCT01470612|584438982|FG000|Overall Study|Pregnancy|2|||
161835493|NCT01470612|584438983|FG001|Overall Study|Pregnancy|10|||
161835494|NCT01470612|584438982|FG000|Overall Study|Protocol Violation|2|||
161835495|NCT01470612|584438983|FG001|Overall Study|Protocol Violation|7|||
161835496|NCT01470612|584438982|FG000|Overall Study|Withdrawal by Subject|24|||
161835497|NCT01470612|584438983|FG001|Overall Study|Withdrawal by Subject|79|||
161835498|NCT01470612|584438982|FG000|Overall Study|Other|14|||
161835499|NCT01470612|584438983|FG001|Overall Study|Other|156|||
161953297|NCT00090779|584879774|FG000|Step 1|Subject relocated|2|||
161953298|NCT00090779|584879775|FG001|Step 1|Subject relocated|8|||
161953299|NCT00090779|584879774|FG000|Step 2|Off study per study closure|6|||
161953300|NCT00090779|584879775|FG001|Step 2|Off study per study closure|16|||
161687689|NCT00001379|583908464|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
161835500|NCT02039414|584438984|FG000|Overall Study|Delivered|1|||
161835501|NCT02039414|584438985|FG001|Overall Study|Delivered|1|||
161953301|NCT00090779|584879774|FG000|Step 2|Subject relocated|0|||
161953302|NCT00090779|584879775|FG001|Step 2|Subject relocated|1|||
161953303|NCT00090779|584879774|FG000|Step 2|Non-compliance to study requirements|0|||
161953304|NCT00090779|584879775|FG001|Step 2|Non-compliance to study requirements|1|||
161953305|NCT00090779|584879774|FG000|Step 3|Initiation of ART and off extended study|3|||
161953306|NCT00090779|584879775|FG001|Step 3|Initiation of ART and off extended study|2|||
161953307|NCT00090779|584879774|FG000|Step 3|Off extended study due to study closure|4|||
161953308|NCT00090779|584879775|FG001|Step 3|Off extended study due to study closure|3|||
161953309|NCT01672879|584879778|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
161953310|NCT01672879|584879779|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
161953311|NCT01672879|584879780|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
161953312|NCT01672879|584879778|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
161953313|NCT01672879|584879779|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
161953314|NCT01672879|584879780|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
161953315|NCT01672879|584879778|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
161953316|NCT01672879|584879779|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
161953317|NCT01672879|584879780|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
161953318|NCT01672879|584879778|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
161953319|NCT01672879|584879779|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
161953320|NCT01672879|584879780|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
161953321|NCT01672879|584879778|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
161953322|NCT01672879|584879779|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
161953323|NCT01672879|584879780|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
161953324|NCT01672879|584879778|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
161953325|NCT01672879|584879779|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
161953326|NCT01672879|584879780|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
161953327|NCT01672879|584879778|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
161953328|NCT01672879|584879779|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
161953329|NCT01672879|584879780|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
161953330|NCT01672879|584879778|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
161953331|NCT01672879|584879779|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
161953332|NCT01672879|584879780|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
161953333|NCT01672879|584879778|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
161953334|NCT01672879|584879779|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
161953335|NCT01672879|584879780|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
161953336|NCT01672879|584879778|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
161953337|NCT01672879|584879779|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
161953338|NCT01672879|584879780|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
161953339|NCT01672879|584879778|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
161953340|NCT01672879|584879779|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
161953341|NCT01672879|584879780|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
161953342|NCT01672879|584879778|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
161953343|NCT01672879|584879779|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
161953344|NCT01672879|584879780|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
161953345|NCT01672879|584879778|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
162029337|NCT00992589|585165439|FG000|Double-Blind Phase|Adverse Event|0|||
161953346|NCT01672879|584879779|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
162029338|NCT00992589|585165440|FG001|Double-Blind Phase|Adverse Event|6|||
162029339|NCT00992589|585165441|FG002|Double-Blind Phase|Adverse Event|2|||
162029340|NCT00992589|585165442|FG003|Double-Blind Phase|Adverse Event|3|||
162029341|NCT00992589|585165439|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
162029342|NCT00992589|585165440|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
162029343|NCT00992589|585165441|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
162029344|NCT00992589|585165442|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
162029345|NCT00992589|585165439|FG000|Double-Blind Phase|Lost to Follow-up|0|||
162029346|NCT00992589|585165440|FG001|Double-Blind Phase|Lost to Follow-up|0|||
162029347|NCT00992589|585165441|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162029348|NCT00992589|585165442|FG003|Double-Blind Phase|Lost to Follow-up|2|||
162029349|NCT00992589|585165439|FG000|Double-Blind Phase|Other|0|||
162029350|NCT00992589|585165440|FG001|Double-Blind Phase|Other|1|||
162029351|NCT00992589|585165441|FG002|Double-Blind Phase|Other|6|||
161953347|NCT01672879|584879780|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
161953348|NCT04158375|584879787|FG000|Overall Study|Withdrawal by Subject|0|||
161953349|NCT04158375|584879788|FG001|Overall Study|Withdrawal by Subject|3|||
161953350|NCT04158375|584879789|FG002|Overall Study|Withdrawal by Subject|0|||
161953351|NCT04847843|584879790|FG000|Overall Study|Scheduling Conflicts|6|||
161953352|NCT04847843|584879791|FG001|Overall Study|Scheduling Conflicts|9|||
161953353|NCT04847843|584879790|FG000|Overall Study|Withdrawal by Subject|1|||
161953354|NCT04847843|584879791|FG001|Overall Study|Withdrawal by Subject|0|||
161953355|NCT04847843|584879790|FG000|Overall Study|Lost to Follow-up|1|||
161953356|NCT04847843|584879791|FG001|Overall Study|Lost to Follow-up|1|||
161953357|NCT04847843|584879790|FG000|Overall Study|Pregnancy|0|||
161953358|NCT04847843|584879791|FG001|Overall Study|Pregnancy|2|||
161953359|NCT04847843|584879790|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
161953360|NCT04847843|584879791|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
161953361|NCT02734004|584879792|FG000|Overall Study|Death|36|||
161953362|NCT02734004|584879793|FG001|Overall Study|Death|24|||
161953363|NCT02734004|584879794|FG002|Overall Study|Death|26|||
161953364|NCT02734004|584879795|FG003|Overall Study|Death|35|||
161953365|NCT02734004|584879796|FG004|Overall Study|Death|13|||
162029352|NCT00992589|585165442|FG003|Double-Blind Phase|Other|3|||
162029353|NCT00045942|585165443|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
162029354|NCT00045942|585165444|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
162029355|NCT00045942|585165445|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
161953366|NCT02734004|584879797|FG005|Overall Study|Death|17|||
161953367|NCT02734004|584879798|FG006|Overall Study|Death|20|||
161953368|NCT02734004|584879792|FG000|Overall Study|Lost to Follow-up|1|||
161953369|NCT02734004|584879793|FG001|Overall Study|Lost to Follow-up|1|||
161953370|NCT02734004|584879794|FG002|Overall Study|Lost to Follow-up|0|||
161953371|NCT02734004|584879795|FG003|Overall Study|Lost to Follow-up|0|||
161953372|NCT02734004|584879796|FG004|Overall Study|Lost to Follow-up|1|||
161953373|NCT02734004|584879797|FG005|Overall Study|Lost to Follow-up|0|||
161953374|NCT02734004|584879798|FG006|Overall Study|Lost to Follow-up|0|||
161953375|NCT02734004|584879792|FG000|Overall Study|Withdrawal by Subject|3|||
161953376|NCT02734004|584879793|FG001|Overall Study|Withdrawal by Subject|1|||
161953377|NCT02734004|584879794|FG002|Overall Study|Withdrawal by Subject|1|||
161953378|NCT02734004|584879795|FG003|Overall Study|Withdrawal by Subject|1|||
161953379|NCT02734004|584879796|FG004|Overall Study|Withdrawal by Subject|3|||
161953380|NCT02734004|584879797|FG005|Overall Study|Withdrawal by Subject|0|||
161953381|NCT02734004|584879798|FG006|Overall Study|Withdrawal by Subject|2|||
161953382|NCT02734004|584879792|FG000|Overall Study|Other|0|||
161953383|NCT02734004|584879793|FG001|Overall Study|Other|8|||
161953384|NCT02734004|584879794|FG002|Overall Study|Other|7|||
161953385|NCT02734004|584879795|FG003|Overall Study|Other|4|||
161953386|NCT02734004|584879796|FG004|Overall Study|Other|34|||
161953387|NCT02734004|584879797|FG005|Overall Study|Other|14|||
161953388|NCT02734004|584879798|FG006|Overall Study|Other|10|||
161953389|NCT05615220|584879799|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
161953390|NCT05615220|584879800|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
161953391|NCT05615220|584879801|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
161953392|NCT05615220|584879799|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
161953393|NCT05615220|584879800|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
161953394|NCT05615220|584879801|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
161953395|NCT05615220|584879799|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
161953396|NCT05615220|584879800|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
161953397|NCT05615220|584879801|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
161953398|NCT05615220|584879799|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
161953399|NCT05615220|584879800|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
161953400|NCT05615220|584879801|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
161953401|NCT05615220|584879799|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
161953402|NCT05615220|584879800|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
161953403|NCT05615220|584879801|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
161953404|NCT05615220|584879799|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
161953405|NCT05615220|584879800|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
161953406|NCT05615220|584879801|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
161953407|NCT05615220|584879799|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
161953408|NCT05615220|584879800|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
161953409|NCT05615220|584879801|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
161953410|NCT05615220|584879799|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
161953411|NCT05615220|584879800|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
161953412|NCT05615220|584879801|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
161953413|NCT05615220|584879799|FG000|Open label stabilization Part (12 weeks)|Other|6|||
161953414|NCT05615220|584879800|FG001|Open label stabilization Part (12 weeks)|Other|0|||
161953415|NCT05615220|584879801|FG002|Open label stabilization Part (12 weeks)|Other|0|||
161953416|NCT05615220|584879799|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
161953417|NCT05615220|584879800|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
161953418|NCT05615220|584879801|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
161953419|NCT05615220|584879799|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
161953420|NCT05615220|584879800|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
161953421|NCT05615220|584879801|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
161953422|NCT05615220|584879799|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
161953423|NCT05615220|584879800|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
161953424|NCT05615220|584879801|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
161953425|NCT05615220|584879799|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
161953426|NCT05615220|584879800|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
161953427|NCT05615220|584879801|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
161953428|NCT05615220|584879799|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
162029356|NCT00045942|585165446|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
162029357|NCT00045942|585165447|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
161835502|NCT02039414|584438984|FG000|Overall Study|Lost to Follow-up|2|||
161953429|NCT05615220|584879800|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
161953430|NCT05615220|584879801|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
161953431|NCT05615220|584879799|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
161953432|NCT05615220|584879800|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
161953433|NCT05615220|584879801|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
161953434|NCT01459666|584879802|FG000|Overall Study|PI left institution|5|||
161953435|NCT01459666|584879803|FG001|Overall Study|PI left institution|4|||
161953436|NCT01061385|584879804|FG000|Overall Study|Lost to Follow-up|1|||
161953437|NCT01061385|584879805|FG001|Overall Study|Lost to Follow-up|0|||
161953438|NCT01061385|584879804|FG000|Overall Study|subject decision not related to AE|0|||
161953439|NCT01061385|584879805|FG001|Overall Study|subject decision not related to AE|1|||
161953440|NCT00533429|584879807|FG000|Overall Study|Adverse Event|3|||
161953441|NCT00533429|584879808|FG001|Overall Study|Adverse Event|1|||
161953442|NCT00533429|584879807|FG000|Overall Study|Death|1|||
161953443|NCT00533429|584879808|FG001|Overall Study|Death|0|||
161953444|NCT00533429|584879807|FG000|Overall Study|Withdrawal by Subject|2|||
161953445|NCT00533429|584879808|FG001|Overall Study|Withdrawal by Subject|0|||
161953446|NCT00533429|584879807|FG000|Overall Study|Progressive Disease|12|||
161953447|NCT00533429|584879808|FG001|Overall Study|Progressive Disease|13|||
161953448|NCT00533429|584879807|FG000|Overall Study|Symptomatic deterioration|1|||
161953449|NCT00533429|584879808|FG001|Overall Study|Symptomatic deterioration|2|||
161953450|NCT02655887|584879809|FG000|Overall Study|Lost to Follow-up|3|||
161953451|NCT02655887|584879809|FG000|Overall Study|Death|4|||
161953452|NCT02655887|584879809|FG000|Overall Study|Withdrawal by Subject|3|||
161687690|NCT00001379|583908461|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
161687691|NCT00001379|583908462|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
161687692|NCT00001379|583908463|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
162029358|NCT00045942|585165448|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
162029359|NCT00045942|585165449|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
162029360|NCT00045942|585165450|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
162029361|NCT00045942|585165451|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
162029362|NCT00045942|585165443|FG000|PKC412A2104 (Core)|Adverse Event|5|||
162029363|NCT00045942|585165444|FG001|PKC412A2104 (Core)|Adverse Event|0|||
162029364|NCT00045942|585165445|FG002|PKC412A2104 (Core)|Adverse Event|0|||
162029365|NCT00045942|585165446|FG003|PKC412A2104 (Core)|Adverse Event|0|||
162029366|NCT00045942|585165447|FG004|PKC412A2104 (Core)|Adverse Event|0|||
162029367|NCT00045942|585165448|FG005|PKC412A2104 (Core)|Adverse Event|0|||
162029368|NCT00045942|585165449|FG006|PKC412A2104 (Core)|Adverse Event|0|||
162029369|NCT00045942|585165450|FG007|PKC412A2104 (Core)|Adverse Event|0|||
162029370|NCT00045942|585165451|FG008|PKC412A2104 (Core)|Adverse Event|0|||
162029371|NCT00045942|585165443|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
162029372|NCT00045942|585165444|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
162029373|NCT00045942|585165445|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
162029374|NCT00045942|585165446|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
162029375|NCT00045942|585165447|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
162029376|NCT00045942|585165448|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
162029377|NCT00045942|585165449|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
162029378|NCT00045942|585165450|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
162029379|NCT00045942|585165451|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
162029380|NCT00045942|585165443|FG000|PKC412A2104 (Core)|Death|1|||
162029381|NCT00045942|585165444|FG001|PKC412A2104 (Core)|Death|0|||
162029382|NCT00045942|585165445|FG002|PKC412A2104 (Core)|Death|0|||
162029383|NCT00045942|585165446|FG003|PKC412A2104 (Core)|Death|0|||
161687693|NCT00001379|583908464|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
161687694|NCT00001379|583908461|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
162029384|NCT00045942|585165447|FG004|PKC412A2104 (Core)|Death|0|||
162029385|NCT00045942|585165448|FG005|PKC412A2104 (Core)|Death|0|||
162029386|NCT00045942|585165449|FG006|PKC412A2104 (Core)|Death|0|||
162029387|NCT00045942|585165450|FG007|PKC412A2104 (Core)|Death|0|||
162029388|NCT00045942|585165451|FG008|PKC412A2104 (Core)|Death|0|||
162029389|NCT00045942|585165443|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
162029390|NCT00045942|585165444|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
162029391|NCT00045942|585165445|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
162029392|NCT00045942|585165446|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
161687695|NCT00001379|583908462|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
161687696|NCT00001379|583908463|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
161687697|NCT00001379|583908464|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
161687698|NCT01577186|583908467|FG000|Overall Study|Adverse Event|23|||
161687699|NCT01577186|583908467|FG000|Overall Study|Death|1|||
161687700|NCT01577186|583908467|FG000|Overall Study|Lost to Follow-up|28|||
161687701|NCT01577186|583908467|FG000|Overall Study|Withdrawal by Subject|35|||
161687702|NCT01577186|583908467|FG000|Overall Study|Insufficient Response|18|||
161687703|NCT01577186|583908467|FG000|Overall Study|Ineligible to Continue|15|||
161687704|NCT01577186|583908467|FG000|Overall Study|Non-Compliant|8|||
161687705|NCT01577186|583908467|FG000|Overall Study|Other|2|||
161687706|NCT01032915|583908468|FG000|Overall Study|Adverse Event|2|||
161687707|NCT01032915|583908469|FG001|Overall Study|Adverse Event|2|||
161953453|NCT02655887|584879809|FG000|Overall Study|Missed 12-month follow-up visit|4|||
161953454|NCT01964378|584879811|FG000|Overall Study|Disc. due to death before first dosing|0|||
161953455|NCT01964378|584879812|FG001|Overall Study|Disc. due to death before first dosing|1|||
161953456|NCT01964378|584879811|FG000|Overall Study|Disc. due to AE before first dosing|1|||
161953457|NCT01964378|584879812|FG001|Overall Study|Disc. due to AE before first dosing|0|||
161953458|NCT01964378|584879811|FG000|Overall Study|Death|3|||
161953459|NCT01964378|584879812|FG001|Overall Study|Death|2|||
161953460|NCT01964378|584879811|FG000|Overall Study|Adverse Event|12|||
161953461|NCT01964378|584879812|FG001|Overall Study|Adverse Event|5|||
161953462|NCT01964378|584879811|FG000|Overall Study|Lack of Efficacy|0|||
161953463|NCT01964378|584879812|FG001|Overall Study|Lack of Efficacy|1|||
161953464|NCT01964378|584879811|FG000|Overall Study|Protocol Violation|0|||
161953465|NCT01964378|584879812|FG001|Overall Study|Protocol Violation|1|||
161953466|NCT01964378|584879811|FG000|Overall Study|Lost to Follow-up|0|||
161953467|NCT01964378|584879812|FG001|Overall Study|Lost to Follow-up|1|||
161953468|NCT01964378|584879811|FG000|Overall Study|Withdrawal by Subject|7|||
161953469|NCT01964378|584879812|FG001|Overall Study|Withdrawal by Subject|5|||
161953470|NCT01964378|584879811|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
161953471|NCT01964378|584879812|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
161953472|NCT01964378|584879811|FG000|Overall Study|Other|1|||
161953473|NCT01964378|584879812|FG001|Overall Study|Other|2|||
161953474|NCT04872569|584879816|FG000|Overall Study|Withdrawal by Subject|2|||
161953475|NCT04951622|584879817|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
161953476|NCT04951622|584879818|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
161953477|NCT04951622|584879819|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
161953478|NCT04951622|584879820|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
161953479|NCT04951622|584879821|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
161953480|NCT04951622|584879817|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
161953481|NCT04951622|584879818|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
161953482|NCT04951622|584879819|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
161953483|NCT04951622|584879820|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
161953484|NCT04951622|584879821|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
161953485|NCT04951622|584879817|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
161953486|NCT04951622|584879818|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
161953487|NCT04951622|584879819|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
161953488|NCT04951622|584879820|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
161953489|NCT04951622|584879821|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
161953490|NCT04951622|584879817|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
161953491|NCT04951622|584879818|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
161953492|NCT04951622|584879819|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
161953493|NCT04951622|584879820|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
161953494|NCT04951622|584879821|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
161953495|NCT04951622|584879817|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
161953496|NCT04951622|584879818|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
161953497|NCT04951622|584879819|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
161953498|NCT04951622|584879820|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
161953499|NCT04951622|584879821|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
161953500|NCT04951622|584879817|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
161953501|NCT04951622|584879818|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
161953502|NCT04951622|584879819|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
161953503|NCT04951622|584879820|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
161953504|NCT04951622|584879821|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
161953505|NCT04951622|584879817|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
161953506|NCT04951622|584879818|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
161953507|NCT04951622|584879819|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
161953508|NCT04951622|584879820|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
161953509|NCT04951622|584879821|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
161953510|NCT04951622|584879817|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
161687708|NCT01032915|583908470|FG002|Overall Study|Adverse Event|1|||
161687709|NCT01032915|583908471|FG003|Overall Study|Adverse Event|1|||
161687710|NCT01032915|583908468|FG000|Overall Study|Abnormal test procedure result|0|||
161687711|NCT01032915|583908469|FG001|Overall Study|Abnormal test procedure result|0|||
161953511|NCT04951622|584879818|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
161953512|NCT04951622|584879819|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
161953513|NCT04951622|584879820|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
161953514|NCT04951622|584879821|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
161953515|NCT04951622|584879817|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
161953516|NCT04951622|584879818|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
161953517|NCT04951622|584879819|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
161953518|NCT04951622|584879820|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
161953519|NCT04951622|584879821|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
161953520|NCT04951622|584879817|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
161953521|NCT04951622|584879818|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
161953522|NCT04951622|584879819|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
161953523|NCT04951622|584879820|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
161953524|NCT04951622|584879821|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
161953525|NCT04951622|584879817|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
161953526|NCT04951622|584879818|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
161953527|NCT04951622|584879819|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
161953528|NCT04951622|584879820|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
161953529|NCT04951622|584879821|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
161953530|NCT04951622|584879817|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
161953531|NCT04951622|584879818|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
161953532|NCT04951622|584879819|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
161953533|NCT04951622|584879820|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
161953534|NCT04951622|584879821|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
161953535|NCT04951622|584879817|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
161953536|NCT04951622|584879818|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
161953537|NCT04951622|584879819|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
161953538|NCT04951622|584879820|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
161953539|NCT04951622|584879821|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
161953540|NCT04951622|584879817|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
161953541|NCT04951622|584879818|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
161953542|NCT04951622|584879819|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
161953543|NCT04951622|584879820|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
161953544|NCT04951622|584879821|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
161953545|NCT04951622|584879817|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
161953546|NCT04951622|584879818|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
161953547|NCT04951622|584879819|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
161953548|NCT04951622|584879820|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
161953549|NCT04951622|584879821|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
161953550|NCT04951622|584879817|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
161953551|NCT04951622|584879818|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
161953552|NCT04951622|584879819|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
161953553|NCT04951622|584879820|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
161953554|NCT04951622|584879821|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
161953555|NCT04951622|584879817|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
161953556|NCT04951622|584879818|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
161953557|NCT04951622|584879819|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
161953558|NCT04951622|584879820|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
161953559|NCT04951622|584879821|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
161953560|NCT04951622|584879817|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
161953561|NCT04951622|584879818|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
161953562|NCT04951622|584879819|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
161953563|NCT04951622|584879820|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
161953564|NCT04951622|584879821|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
161953565|NCT04951622|584879817|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
161953566|NCT04951622|584879818|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
161953567|NCT04951622|584879819|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
161953568|NCT04951622|584879820|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
161953569|NCT04951622|584879821|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
162029393|NCT00045942|585165447|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
162029394|NCT00045942|585165448|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
161835503|NCT02039414|584438985|FG001|Overall Study|Lost to Follow-up|0|||
162029395|NCT00045942|585165449|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
162029396|NCT00045942|585165450|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
162029397|NCT00045942|585165451|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
162029398|NCT00045942|585165443|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
162029399|NCT00045942|585165444|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
162029400|NCT00045942|585165445|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
162029401|NCT00045942|585165446|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
162029402|NCT00045942|585165447|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
162029403|NCT00045942|585165448|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
162029404|NCT00045942|585165449|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
162029405|NCT00045942|585165450|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
162029406|NCT00045942|585165451|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
162029407|NCT00045942|585165443|FG000|PKC412A2104E1|Lack of Efficacy|0|||
162029408|NCT00045942|585165444|FG001|PKC412A2104E1|Lack of Efficacy|11|||
162029409|NCT00045942|585165445|FG002|PKC412A2104E1|Lack of Efficacy|11|||
162029410|NCT00045942|585165446|FG003|PKC412A2104E1|Lack of Efficacy|23|||
162029411|NCT00045942|585165447|FG004|PKC412A2104E1|Lack of Efficacy|17|||
162029412|NCT00045942|585165448|FG005|PKC412A2104E1|Lack of Efficacy|0|||
162029413|NCT00045942|585165449|FG006|PKC412A2104E1|Lack of Efficacy|0|||
162029414|NCT00045942|585165450|FG007|PKC412A2104E1|Lack of Efficacy|0|||
162029415|NCT00045942|585165451|FG008|PKC412A2104E1|Lack of Efficacy|0|||
162029416|NCT00045942|585165443|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
162029417|NCT00045942|585165444|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
162029418|NCT00045942|585165445|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
162029419|NCT00045942|585165446|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
162029420|NCT00045942|585165447|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
162029421|NCT00045942|585165448|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
162029422|NCT00045942|585165449|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
162029423|NCT00045942|585165450|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
162029424|NCT00045942|585165451|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
162029425|NCT00045942|585165443|FG000|PKC412A2104E1|Adverse Event|0|||
162029426|NCT00045942|585165444|FG001|PKC412A2104E1|Adverse Event|1|||
162029427|NCT00045942|585165445|FG002|PKC412A2104E1|Adverse Event|1|||
162029428|NCT00045942|585165446|FG003|PKC412A2104E1|Adverse Event|3|||
162029429|NCT00045942|585165447|FG004|PKC412A2104E1|Adverse Event|6|||
162029430|NCT00045942|585165448|FG005|PKC412A2104E1|Adverse Event|0|||
162029431|NCT00045942|585165449|FG006|PKC412A2104E1|Adverse Event|0|||
162029432|NCT00045942|585165450|FG007|PKC412A2104E1|Adverse Event|0|||
162029433|NCT00045942|585165451|FG008|PKC412A2104E1|Adverse Event|0|||
162029434|NCT00045942|585165443|FG000|PKC412A2104E1|Death|0|||
162029435|NCT00045942|585165444|FG001|PKC412A2104E1|Death|4|||
162029436|NCT00045942|585165445|FG002|PKC412A2104E1|Death|1|||
162029437|NCT00045942|585165446|FG003|PKC412A2104E1|Death|1|||
162029438|NCT00045942|585165447|FG004|PKC412A2104E1|Death|1|||
162029439|NCT00045942|585165448|FG005|PKC412A2104E1|Death|0|||
162029440|NCT00045942|585165449|FG006|PKC412A2104E1|Death|0|||
162029441|NCT00045942|585165450|FG007|PKC412A2104E1|Death|0|||
161687712|NCT01032915|583908470|FG002|Overall Study|Abnormal test procedure result|1|||
161687713|NCT01032915|583908471|FG003|Overall Study|Abnormal test procedure result|0|||
161687714|NCT01032915|583908468|FG000|Overall Study|Withdrawal by Subject|0|||
161687715|NCT01032915|583908469|FG001|Overall Study|Withdrawal by Subject|3|||
161687716|NCT01032915|583908470|FG002|Overall Study|Withdrawal by Subject|1|||
161687717|NCT01032915|583908471|FG003|Overall Study|Withdrawal by Subject|1|||
161687718|NCT01032915|583908468|FG000|Overall Study|Administrative reasons|5|||
161687719|NCT01032915|583908469|FG001|Overall Study|Administrative reasons|6|||
162029442|NCT00045942|585165451|FG008|PKC412A2104E1|Death|0|||
162029443|NCT00045942|585165443|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
162029444|NCT00045942|585165444|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
162029445|NCT00045942|585165445|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
162029446|NCT00045942|585165446|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
162029447|NCT00045942|585165447|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
162029448|NCT00045942|585165448|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
162029449|NCT00045942|585165449|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
162029450|NCT00045942|585165450|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
162029451|NCT00045942|585165451|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
162029452|NCT00045942|585165443|FG000|PKC412A2104E2|Lost to Follow-up|0|||
162029453|NCT00045942|585165444|FG001|PKC412A2104E2|Lost to Follow-up|0|||
162029454|NCT00045942|585165445|FG002|PKC412A2104E2|Lost to Follow-up|0|||
162029455|NCT00045942|585165446|FG003|PKC412A2104E2|Lost to Follow-up|0|||
162029456|NCT00045942|585165447|FG004|PKC412A2104E2|Lost to Follow-up|0|||
162029457|NCT00045942|585165448|FG005|PKC412A2104E2|Lost to Follow-up|0|||
162029458|NCT00045942|585165449|FG006|PKC412A2104E2|Lost to Follow-up|0|||
162029459|NCT00045942|585165450|FG007|PKC412A2104E2|Lost to Follow-up|3|||
162029460|NCT00045942|585165451|FG008|PKC412A2104E2|Lost to Follow-up|0|||
162029461|NCT00045942|585165443|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
162029462|NCT00045942|585165444|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
162029463|NCT00045942|585165445|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
162029464|NCT00045942|585165446|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
162029465|NCT00045942|585165447|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
162029466|NCT00045942|585165448|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
162029467|NCT00045942|585165449|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
162029468|NCT00045942|585165450|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
162029469|NCT00045942|585165451|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
162029470|NCT00045942|585165443|FG000|PKC412A2104E2|Lack of Efficacy|0|||
162029471|NCT00045942|585165444|FG001|PKC412A2104E2|Lack of Efficacy|0|||
162029472|NCT00045942|585165445|FG002|PKC412A2104E2|Lack of Efficacy|0|||
162029473|NCT00045942|585165446|FG003|PKC412A2104E2|Lack of Efficacy|0|||
162029474|NCT00045942|585165447|FG004|PKC412A2104E2|Lack of Efficacy|0|||
162029475|NCT00045942|585165448|FG005|PKC412A2104E2|Lack of Efficacy|3|||
162029476|NCT00045942|585165449|FG006|PKC412A2104E2|Lack of Efficacy|2|||
162029477|NCT00045942|585165450|FG007|PKC412A2104E2|Lack of Efficacy|2|||
162029478|NCT00045942|585165451|FG008|PKC412A2104E2|Lack of Efficacy|6|||
162029479|NCT00045942|585165443|FG000|PKC412A2104E2|Adverse Event|0|||
162029480|NCT00045942|585165444|FG001|PKC412A2104E2|Adverse Event|0|||
162029481|NCT00045942|585165445|FG002|PKC412A2104E2|Adverse Event|0|||
162029482|NCT00045942|585165446|FG003|PKC412A2104E2|Adverse Event|0|||
162029483|NCT00045942|585165447|FG004|PKC412A2104E2|Adverse Event|0|||
162029484|NCT00045942|585165448|FG005|PKC412A2104E2|Adverse Event|4|||
162029485|NCT00045942|585165449|FG006|PKC412A2104E2|Adverse Event|3|||
162029486|NCT00045942|585165450|FG007|PKC412A2104E2|Adverse Event|1|||
162029487|NCT00045942|585165451|FG008|PKC412A2104E2|Adverse Event|0|||
162029488|NCT00045942|585165443|FG000|PKC412A2104E2|Death|0|||
162029489|NCT00045942|585165444|FG001|PKC412A2104E2|Death|0|||
162029490|NCT00045942|585165445|FG002|PKC412A2104E2|Death|0|||
162029491|NCT00045942|585165446|FG003|PKC412A2104E2|Death|0|||
162029492|NCT00045942|585165447|FG004|PKC412A2104E2|Death|0|||
162029493|NCT00045942|585165448|FG005|PKC412A2104E2|Death|1|||
162029494|NCT00045942|585165449|FG006|PKC412A2104E2|Death|2|||
162029495|NCT00045942|585165450|FG007|PKC412A2104E2|Death|0|||
162029496|NCT00045942|585165451|FG008|PKC412A2104E2|Death|0|||
162029497|NCT05508074|585165452|FG000|Overall Study|Death|2|||
162029498|NCT05508074|585165453|FG001|Overall Study|Death|5|||
162029499|NCT05508074|585165452|FG000|Overall Study|Withdrawal by Subject|1|||
162029500|NCT05508074|585165453|FG001|Overall Study|Withdrawal by Subject|2|||
162029501|NCT05508074|585165452|FG000|Overall Study|Adverse Event|0|||
162029502|NCT05508074|585165453|FG001|Overall Study|Adverse Event|1|||
161835504|NCT02039414|584438984|FG000|Overall Study|Protocol Violation|3|||
161835505|NCT02039414|584438985|FG001|Overall Study|Protocol Violation|1|||
161835506|NCT03977701|584438986|FG000|Overall Study|COVID-19 pandemic|0|||
161835507|NCT03977701|584438987|FG001|Overall Study|COVID-19 pandemic|0|||
161835508|NCT03977701|584438988|FG002|Overall Study|COVID-19 pandemic|0|||
161835509|NCT03977701|584438989|FG003|Overall Study|COVID-19 pandemic|0|||
161835510|NCT03977701|584438990|FG004|Overall Study|COVID-19 pandemic|0|||
161835511|NCT03977701|584438991|FG005|Overall Study|COVID-19 pandemic|1|||
161835512|NCT03977701|584438992|FG006|Overall Study|COVID-19 pandemic|0|||
161835513|NCT03977701|584438993|FG007|Overall Study|COVID-19 pandemic|1|||
161835514|NCT03977701|584438994|FG008|Overall Study|COVID-19 pandemic|0|||
161835515|NCT03977701|584438995|FG009|Overall Study|COVID-19 pandemic|0|||
161835516|NCT00430950|584438997|FG000|Overall Study|Adverse Event|7|||
161835517|NCT00430950|584438998|FG001|Overall Study|Adverse Event|6|||
161835518|NCT00430950|584438997|FG000|Overall Study|Withdrawal by Subject|1|||
161835519|NCT00430950|584438998|FG001|Overall Study|Withdrawal by Subject|0|||
161835520|NCT00430950|584438997|FG000|Overall Study|concomitant medication,etc.|5|||
161835521|NCT00430950|584438998|FG001|Overall Study|concomitant medication,etc.|7|||
161835522|NCT02429934|584438999|FG000|Overall Study|Withdrawal by Subject|0|||
161835523|NCT02429934|584439000|FG001|Overall Study|Withdrawal by Subject|2|||
161835524|NCT02429934|584438999|FG000|Overall Study|Adverse Event|2|||
161835525|NCT02429934|584439000|FG001|Overall Study|Adverse Event|0|||
161835526|NCT02429934|584438999|FG000|Overall Study|Lost to Follow-up|1|||
161835527|NCT02429934|584439000|FG001|Overall Study|Lost to Follow-up|1|||
161835528|NCT02429934|584438999|FG000|Overall Study|Physician Decision|1|||
161835529|NCT02429934|584439000|FG001|Overall Study|Physician Decision|0|||
161835530|NCT00869024|584439001|FG000|Overall Study|Death|2|||
161835531|NCT00869024|584439002|FG001|Overall Study|Death|3|||
161953570|NCT04951622|584879817|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
161953571|NCT04951622|584879818|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
161953572|NCT04951622|584879819|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
161953573|NCT04951622|584879820|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
161953574|NCT04951622|584879821|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
161953575|NCT02891226|584879826|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
161953576|NCT02891226|584879827|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
161953577|NCT02891226|584879828|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
161953578|NCT02891226|584879829|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953579|NCT02891226|584879830|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953580|NCT02891226|584879831|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953581|NCT02891226|584879832|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953582|NCT02891226|584879833|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953583|NCT02891226|584879834|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953584|NCT02891226|584879835|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953585|NCT02891226|584879836|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953586|NCT02891226|584879837|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953587|NCT02891226|584879838|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953588|NCT02891226|584879839|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953589|NCT02891226|584879840|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953590|NCT02891226|584879841|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
161953591|NCT02891226|584879826|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
161953592|NCT02891226|584879827|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
161953593|NCT02891226|584879828|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161953594|NCT02891226|584879829|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161953595|NCT02891226|584879830|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161953596|NCT02891226|584879831|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161953597|NCT02891226|584879832|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161953598|NCT02891226|584879833|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161835532|NCT00869024|584439001|FG000|Overall Study|Lost to Follow-up|0|||
161835533|NCT00869024|584439002|FG001|Overall Study|Lost to Follow-up|1|||
161835534|NCT00869024|584439001|FG000|Overall Study|Protocol Violation|0|||
161835535|NCT00869024|584439002|FG001|Overall Study|Protocol Violation|1|||
161835536|NCT00293202|584439003|FG000|Overall Study|Withdrawal by Subject|1|||
161835537|NCT00293202|584439004|FG001|Overall Study|Withdrawal by Subject|2|||
161835538|NCT00293202|584439003|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
161835539|NCT00293202|584439004|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
162029503|NCT05508074|585165452|FG000|Overall Study|Physician Decision|0|||
162029504|NCT05508074|585165453|FG001|Overall Study|Physician Decision|1|||
162029505|NCT05508074|585165452|FG000|Overall Study|wrongly randomized|0|||
162029506|NCT05508074|585165453|FG001|Overall Study|wrongly randomized|1|||
162029507|NCT05508074|585165452|FG000|Overall Study|non-compliance|0|||
162029508|NCT05508074|585165453|FG001|Overall Study|non-compliance|1|||
162029509|NCT02142387|585165454|FG000|Overall Study|<19 years old|49|||
162029510|NCT02142387|585165455|FG001|Overall Study|<19 years old|326|||
162029511|NCT02142387|585165454|FG000|Overall Study|non-cardiac etiology|504|||
162029512|NCT02142387|585165455|FG001|Overall Study|non-cardiac etiology|3431|||
162029513|NCT02142387|585165454|FG000|Overall Study|CPR not performed|74|||
162029514|NCT02142387|585165455|FG001|Overall Study|CPR not performed|473|||
162029515|NCT02142387|585165454|FG000|Overall Study|witnessed by paramedic|139|||
162029516|NCT02142387|585165455|FG001|Overall Study|witnessed by paramedic|917|||
162029517|NCT02142387|585165454|FG000|Overall Study|incomplete data|1|||
162029518|NCT02142387|585165455|FG001|Overall Study|incomplete data|9|||
162029519|NCT02142387|585165454|FG000|Overall Study|occurred not at home|298|||
162029520|NCT02142387|585165455|FG001|Overall Study|occurred not at home|2474|||
162029521|NCT01101308|585165456|FG000|Period 1|Adverse Event|2|||
162029522|NCT01101308|585165457|FG001|Period 1|Adverse Event|1|||
162029523|NCT01101308|585165456|FG000|Period 1|Positive for cotinine|1|||
162029524|NCT01101308|585165457|FG001|Period 1|Positive for cotinine|0|||
162029525|NCT02984943|585165458|FG000|Overall Study|Withdrawal by Subject|3|||
162029526|NCT02984943|585165458|FG000|Overall Study|Physician Decision|1|||
162029527|NCT02282345|585165461|FG000|Overall Study|Progression|0|||
162029528|NCT02282345|585165462|FG001|Overall Study|Progression|1|||
162029529|NCT02296138|585165463|FG000|Overall Study|Adverse Event|348|||
162029530|NCT02296138|585165464|FG001|Overall Study|Adverse Event|259|||
162029531|NCT02296138|585165463|FG000|Overall Study|Lack of Efficacy|59|||
162029532|NCT02296138|585165464|FG001|Overall Study|Lack of Efficacy|37|||
162029533|NCT02296138|585165463|FG000|Overall Study|Protocol Violation|35|||
162029534|NCT02296138|585165464|FG001|Overall Study|Protocol Violation|36|||
162029535|NCT02296138|585165463|FG000|Overall Study|Lost to Follow-up|9|||
162029536|NCT02296138|585165464|FG001|Overall Study|Lost to Follow-up|12|||
162029537|NCT02296138|585165463|FG000|Overall Study|Withdrawal by Subject|184|||
162029538|NCT02296138|585165464|FG001|Overall Study|Withdrawal by Subject|131|||
162029539|NCT02296138|585165463|FG000|Overall Study|Not Treated|1|||
162029540|NCT02296138|585165464|FG001|Overall Study|Not Treated|1|||
162029541|NCT02296138|585165463|FG000|Overall Study|Patients with data irregularities|10|||
162029542|NCT02296138|585165464|FG001|Overall Study|Patients with data irregularities|11|||
162029543|NCT02296138|585165463|FG000|Overall Study|Other than specified|15|||
162029544|NCT02296138|585165464|FG001|Overall Study|Other than specified|13|||
162029545|NCT00711516|585165465|FG000|Overall Study|Adverse Event|1|||
162029546|NCT00711516|585165466|FG001|Overall Study|Adverse Event|1|||
162029547|NCT00711516|585165465|FG000|Overall Study|Withdrawal by Subject|0|||
162029548|NCT00711516|585165466|FG001|Overall Study|Withdrawal by Subject|1|||
162029549|NCT00711516|585165465|FG000|Overall Study|Protocol Violation|0|||
162029550|NCT00711516|585165466|FG001|Overall Study|Protocol Violation|1|||
161835540|NCT00293202|584439003|FG000|Overall Study|on-hold due to fistula maturation time|1|||
161835541|NCT00293202|584439004|FG001|Overall Study|on-hold due to fistula maturation time|0|||
161835542|NCT01564459|584439005|FG000|Run-In|Adverse Event|7|||
161835543|NCT01564459|584439006|FG001|Run-In|Adverse Event|0|||
161835544|NCT01564459|584439007|FG002|Run-In|Adverse Event|0|||
161835545|NCT01564459|584439005|FG000|Run-In|Lost to Follow-up|1|||
161835546|NCT01564459|584439006|FG001|Run-In|Lost to Follow-up|0|||
161835547|NCT01564459|584439007|FG002|Run-In|Lost to Follow-up|0|||
161953599|NCT02891226|584879834|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161953600|NCT02891226|584879835|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161953601|NCT02891226|584879836|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161953602|NCT02891226|584879837|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161953603|NCT02891226|584879838|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161953604|NCT02891226|584879839|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161953605|NCT02891226|584879840|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161953606|NCT02891226|584879841|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
161835548|NCT01564459|584439005|FG000|Run-In|Non-compliance with study drug|2|||
161835549|NCT01564459|584439006|FG001|Run-In|Non-compliance with study drug|0|||
161953607|NCT02891226|584879826|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161687720|NCT01032915|583908470|FG002|Overall Study|Administrative reasons|4|||
161835550|NCT01564459|584439007|FG002|Run-In|Non-compliance with study drug|0|||
161953608|NCT02891226|584879827|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161953609|NCT02891226|584879828|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161953610|NCT02891226|584879829|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
161953611|NCT02891226|584879830|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161953612|NCT02891226|584879831|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161953613|NCT02891226|584879832|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161953614|NCT02891226|584879833|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161835551|NCT01564459|584439005|FG000|Run-In|Protocol Violation|1|||
161953615|NCT02891226|584879834|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161953616|NCT02891226|584879835|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161953617|NCT02891226|584879836|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161835552|NCT01564459|584439006|FG001|Run-In|Protocol Violation|0|||
161953618|NCT02891226|584879837|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161687721|NCT01032915|583908471|FG003|Overall Study|Administrative reasons|4|||
161687722|NCT01032915|583908468|FG000|Overall Study|Protocol Violation|1|||
161687723|NCT01032915|583908469|FG001|Overall Study|Protocol Violation|0|||
161687724|NCT01032915|583908470|FG002|Overall Study|Protocol Violation|0|||
161687725|NCT01032915|583908471|FG003|Overall Study|Protocol Violation|1|||
161687726|NCT02797808|583908473|FG000|Overall Study|Withdrawal by Subject|1|||
161687727|NCT02797808|583908474|FG001|Overall Study|Withdrawal by Subject|1|||
161687728|NCT02797808|583908473|FG000|Overall Study|Physician Decision|6|||
161687729|NCT02797808|583908474|FG001|Overall Study|Physician Decision|2|||
161687730|NCT00535132|583908477|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
161687731|NCT00535132|583908478|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
161687732|NCT00535132|583908477|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
161687733|NCT00535132|583908478|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
161687734|NCT00264875|583908479|FG000|Overall Study|Adverse Event|6|||
161687735|NCT00264875|583908479|FG000|Overall Study|Lost to Follow-up|6|||
161687736|NCT00264875|583908479|FG000|Overall Study|Protocol Violation|11|||
161687737|NCT00264875|583908479|FG000|Overall Study|Withdrawal by Subject|7|||
161687738|NCT00143312|583908492|FG000|Overall Study|Death|11|||
161687739|NCT00143312|583908492|FG000|Overall Study|Adverse Event|2|||
161687740|NCT00143312|583908492|FG000|Overall Study|Lost to Follow-up|1|||
161687741|NCT00143312|583908492|FG000|Overall Study|Other|1|||
161687742|NCT00143312|583908492|FG000|Overall Study|Withdrawal by Subject|1|||
161687743|NCT01029366|583908493|FG000|Overall Study|Withdrawal by Subject|1|||
161687744|NCT01029366|583908494|FG001|Overall Study|Withdrawal by Subject|0|||
161687745|NCT01029366|583908493|FG000|Overall Study|Death|1|||
161687746|NCT01029366|583908494|FG001|Overall Study|Death|1|||
161687747|NCT01029366|583908493|FG000|Overall Study|disease progression|2|||
161687748|NCT01029366|583908494|FG001|Overall Study|disease progression|0|||
161687749|NCT01029366|583908493|FG000|Overall Study|manufacturing failure|0|||
161687750|NCT01029366|583908494|FG001|Overall Study|manufacturing failure|1|||
161687751|NCT01834274|583908495|FG000|Overall Study|Study Termination|41|||
161687752|NCT01834274|583908496|FG001|Overall Study|Study Termination|38|||
161687753|NCT01834274|583908495|FG000|Overall Study|Withdrawal by Subject|1|||
161687754|NCT01834274|583908496|FG001|Overall Study|Withdrawal by Subject|1|||
161687755|NCT01834274|583908495|FG000|Overall Study|Lost to Follow-up|3|||
161687756|NCT01834274|583908496|FG001|Overall Study|Lost to Follow-up|1|||
161687757|NCT01834274|583908495|FG000|Overall Study|Other|2|||
161687758|NCT01834274|583908496|FG001|Overall Study|Other|1|||
161687759|NCT01827670|583908497|FG000|Overall Study|Withdrawal of Consent|3|||
161687760|NCT01827670|583908498|FG001|Overall Study|Withdrawal of Consent|2|||
161687761|NCT01827670|583908497|FG000|Overall Study|Lost to Follow-up|0|||
161687762|NCT01827670|583908498|FG001|Overall Study|Lost to Follow-up|1|||
161687763|NCT02941627|583908499|FG000|Overall Study|Death|1|||
161687764|NCT02941627|583908499|FG000|Overall Study|Surgical failure|1|||
161687765|NCT02941627|583908499|FG000|Overall Study|cholesteatoma prevented implantation|1|||
161687766|NCT00563186|583908502|FG000|Overall Study|LOS<48 hours|97|||
161687767|NCT00563186|583908503|FG001|Overall Study|LOS<48 hours|74|||
161687768|NCT00563186|583908502|FG000|Overall Study|Incomplete data|1|||
161835553|NCT01564459|584439007|FG002|Run-In|Protocol Violation|0|||
161835554|NCT01564459|584439005|FG000|Run-In|Withdrawal by Subject|1|||
161835555|NCT01564459|584439006|FG001|Run-In|Withdrawal by Subject|0|||
161835556|NCT01564459|584439007|FG002|Run-In|Withdrawal by Subject|0|||
161835557|NCT01564459|584439005|FG000|Double-blind Treatment|Adverse Event|0|||
161835558|NCT01564459|584439006|FG001|Double-blind Treatment|Adverse Event|0|||
161835559|NCT01564459|584439007|FG002|Double-blind Treatment|Adverse Event|1|||
161687769|NCT00563186|583908503|FG001|Overall Study|Incomplete data|1|||
161687770|NCT00446511|583908504|FG000|Overall Study|Adverse Event|7|||
161687771|NCT00446511|583908505|FG001|Overall Study|Adverse Event|2|||
161687772|NCT00446511|583908506|FG002|Overall Study|Adverse Event|3|||
161835560|NCT00653991|584439013|FG000|3 Month Follow-up|Participant would not respond|150|||
161835561|NCT00653991|584439014|FG001|3 Month Follow-up|Participant would not respond|157|||
161687773|NCT00446511|583908507|FG003|Overall Study|Adverse Event|1|||
161687774|NCT00446511|583908504|FG000|Overall Study|Protocol Violation|0|||
161687775|NCT00446511|583908505|FG001|Overall Study|Protocol Violation|0|||
161687776|NCT00446511|583908506|FG002|Overall Study|Protocol Violation|0|||
161835562|NCT00653991|584439013|FG000|6 Month Follow-up|Participant would not respond|133|||
161687777|NCT00446511|583908507|FG003|Overall Study|Protocol Violation|1|||
161687778|NCT00446511|583908504|FG000|Overall Study|Withdrawal by Subject|0|||
161835563|NCT00653991|584439014|FG001|6 Month Follow-up|Participant would not respond|141|||
161835564|NCT00518622|584439019|FG000|Overall Study|Lost to Follow-up|0|||
161835565|NCT00518622|584439020|FG001|Overall Study|Lost to Follow-up|0|||
161953619|NCT02891226|584879838|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161687779|NCT00446511|583908505|FG001|Overall Study|Withdrawal by Subject|0|||
161687780|NCT00446511|583908506|FG002|Overall Study|Withdrawal by Subject|0|||
161687781|NCT00446511|583908507|FG003|Overall Study|Withdrawal by Subject|3|||
161687782|NCT00446511|583908504|FG000|Overall Study|Administrative Problems|3|||
161687783|NCT00446511|583908505|FG001|Overall Study|Administrative Problems|0|||
161687784|NCT00446511|583908506|FG002|Overall Study|Administrative Problems|4|||
161687785|NCT00446511|583908507|FG003|Overall Study|Administrative Problems|1|||
161687786|NCT01136655|583908508|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
161687787|NCT01136655|583908508|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
161687788|NCT01136655|583908508|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
161687789|NCT01136655|583908508|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
161687790|NCT01265550|583908509|FG000|Pre Randomization|Withdrawal by Subject|0|||
161687791|NCT01265550|583908510|FG001|Pre Randomization|Withdrawal by Subject|0|||
161687792|NCT01265550|583908511|FG002|Pre Randomization|Withdrawal by Subject|0|||
161687793|NCT01265550|583908512|FG003|Pre Randomization|Withdrawal by Subject|70|||
161687794|NCT01265550|583908509|FG000|Pre Randomization|Technical Exclusions|0|||
161687795|NCT01265550|583908510|FG001|Pre Randomization|Technical Exclusions|0|||
161687796|NCT01265550|583908511|FG002|Pre Randomization|Technical Exclusions|0|||
161687797|NCT01265550|583908512|FG003|Pre Randomization|Technical Exclusions|54|||
161687798|NCT01265550|583908509|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
161687799|NCT01265550|583908510|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
161687800|NCT01265550|583908511|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
161687801|NCT01265550|583908512|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
161687802|NCT01265550|583908509|FG000|Pre Randomization|Non-GERD organic disorders|0|||
161687803|NCT01265550|583908510|FG001|Pre Randomization|Non-GERD organic disorders|0|||
161687804|NCT01265550|583908511|FG002|Pre Randomization|Non-GERD organic disorders|0|||
161687805|NCT01265550|583908512|FG003|Pre Randomization|Non-GERD organic disorders|23|||
161687806|NCT01265550|583908509|FG000|Pre Randomization|Functional heartburn|0|||
161687807|NCT01265550|583908510|FG001|Pre Randomization|Functional heartburn|0|||
161687808|NCT01265550|583908511|FG002|Pre Randomization|Functional heartburn|0|||
161687809|NCT01265550|583908512|FG003|Pre Randomization|Functional heartburn|99|||
161687810|NCT01073267|583908513|FG000|Overall Study|Disease Progression|3|||
161687811|NCT01970501|583908514|FG000|Overall Study|Discontinuation of study by sponsor|16|||
161687812|NCT01970501|583908515|FG001|Overall Study|Discontinuation of study by sponsor|14|||
161687813|NCT01970501|583908514|FG000|Overall Study|Withdrawal by Subject|6|||
161687814|NCT01970501|583908515|FG001|Overall Study|Withdrawal by Subject|7|||
161687815|NCT01970501|583908514|FG000|Overall Study|Adverse Event|2|||
161687816|NCT01970501|583908515|FG001|Overall Study|Adverse Event|4|||
161835566|NCT00518622|584439021|FG002|Overall Study|Lost to Follow-up|1|||
161835567|NCT00518622|584439022|FG003|Overall Study|Lost to Follow-up|0|||
161835568|NCT00518622|584439023|FG004|Overall Study|Lost to Follow-up|0|||
161835569|NCT00518622|584439024|FG005|Overall Study|Lost to Follow-up|0|||
161835570|NCT00518622|584439025|FG006|Overall Study|Lost to Follow-up|0|||
161835571|NCT00518622|584439026|FG007|Overall Study|Lost to Follow-up|0|||
161835572|NCT00518622|584439019|FG000|Overall Study|Study medication taken incorrectly|0|||
161835573|NCT00518622|584439020|FG001|Overall Study|Study medication taken incorrectly|1|||
161835574|NCT00518622|584439021|FG002|Overall Study|Study medication taken incorrectly|0|||
161835575|NCT00518622|584439022|FG003|Overall Study|Study medication taken incorrectly|0|||
161687817|NCT01970501|583908514|FG000|Overall Study|Death|1|||
161687818|NCT01970501|583908515|FG001|Overall Study|Death|3|||
161687819|NCT01970501|583908514|FG000|Overall Study|Physician Decision|2|||
161687820|NCT01970501|583908515|FG001|Overall Study|Physician Decision|0|||
161687821|NCT00708123|583908516|FG000|Period 1|Protocol Violation|0|||
161687822|NCT00708123|583908517|FG001|Period 1|Protocol Violation|1|||
161687823|NCT00708123|583908518|FG002|Period 1|Protocol Violation|0|||
161687824|NCT00708123|583908519|FG003|Period 1|Protocol Violation|1|||
161835576|NCT00518622|584439023|FG004|Overall Study|Study medication taken incorrectly|0|||
161835577|NCT00518622|584439024|FG005|Overall Study|Study medication taken incorrectly|0|||
161835578|NCT00518622|584439025|FG006|Overall Study|Study medication taken incorrectly|0|||
161835579|NCT00518622|584439026|FG007|Overall Study|Study medication taken incorrectly|0|||
161835580|NCT03499119|584439027|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
161835581|NCT03499119|584439028|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
161835582|NCT03499119|584439029|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
161835583|NCT03499119|584439030|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
161835584|NCT03499119|584439027|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
161835585|NCT03499119|584439028|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
162029551|NCT04575597|585165467|FG000|Overall Study|Death|0|||
162029552|NCT04575597|585165468|FG001|Overall Study|Death|0|||
162029553|NCT04575597|585165469|FG002|Overall Study|Death|0|||
162029554|NCT04575597|585165470|FG003|Overall Study|Death|1|||
161835586|NCT03499119|584439029|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
162029555|NCT04575597|585165471|FG004|Overall Study|Death|3|||
161687825|NCT00708123|583908520|FG004|Period 1|Protocol Violation|0|||
161687826|NCT00708123|583908516|FG000|Period 1|Adverse Event|0|||
161687827|NCT00708123|583908517|FG001|Period 1|Adverse Event|0|||
161687828|NCT00708123|583908518|FG002|Period 1|Adverse Event|1|||
161687829|NCT00708123|583908519|FG003|Period 1|Adverse Event|0|||
161953620|NCT02891226|584879839|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161687830|NCT00708123|583908520|FG004|Period 1|Adverse Event|0|||
161687831|NCT00708123|583908516|FG000|Period 2|Protocol Violation|0|||
161687832|NCT00708123|583908517|FG001|Period 2|Protocol Violation|0|||
161687833|NCT00708123|583908518|FG002|Period 2|Protocol Violation|0|||
161687834|NCT00708123|583908519|FG003|Period 2|Protocol Violation|1|||
161687835|NCT00708123|583908520|FG004|Period 2|Protocol Violation|0|||
161687836|NCT00708123|583908516|FG000|Period 2|Other Reason|1|||
161835587|NCT03499119|584439030|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
161687837|NCT00708123|583908517|FG001|Period 2|Other Reason|0|||
161687838|NCT00708123|583908518|FG002|Period 2|Other Reason|0|||
161953621|NCT02891226|584879840|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161687839|NCT00708123|583908519|FG003|Period 2|Other Reason|0|||
161687840|NCT00708123|583908520|FG004|Period 2|Other Reason|0|||
161687841|NCT00708123|583908516|FG000|Period 3|Lost to Follow-up|0|||
161687842|NCT00708123|583908517|FG001|Period 3|Lost to Follow-up|0|||
161687843|NCT00708123|583908518|FG002|Period 3|Lost to Follow-up|1|||
161687844|NCT00708123|583908519|FG003|Period 3|Lost to Follow-up|1|||
161687845|NCT00708123|583908520|FG004|Period 3|Lost to Follow-up|0|||
161687846|NCT00708123|583908516|FG000|Period 4|Protocol Violation|0|||
161687847|NCT00708123|583908517|FG001|Period 4|Protocol Violation|1|||
161953622|NCT02891226|584879841|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
161953623|NCT02891226|584879826|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161687848|NCT00708123|583908518|FG002|Period 4|Protocol Violation|0|||
161687849|NCT00708123|583908519|FG003|Period 4|Protocol Violation|0|||
161687850|NCT00708123|583908520|FG004|Period 4|Protocol Violation|0|||
161687851|NCT02970292|583908521|FG000|Overall Study|Physician Decision|1|||
161687852|NCT02970292|583908522|FG001|Overall Study|Physician Decision|1|||
161687853|NCT02970292|583908521|FG000|Overall Study|Withdrawal by Subject|11|||
161687854|NCT02970292|583908522|FG001|Overall Study|Withdrawal by Subject|5|||
161687855|NCT02970292|583908521|FG000|Overall Study|Noncompliance with study drug|2|||
161687856|NCT02970292|583908522|FG001|Overall Study|Noncompliance with study drug|2|||
161687857|NCT02970292|583908521|FG000|Overall Study|Adverse Event|5|||
161687858|NCT02970292|583908522|FG001|Overall Study|Adverse Event|0|||
161687859|NCT02970292|583908521|FG000|Overall Study|Lack of Efficacy|1|||
161687860|NCT02970292|583908522|FG001|Overall Study|Lack of Efficacy|0|||
161835588|NCT03499119|584439027|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
161835589|NCT03499119|584439028|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
161835590|NCT03499119|584439029|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
161835591|NCT03499119|584439030|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
161835592|NCT03499119|584439027|FG000|Optional Extension Phase|Lost to Follow-up|0|||
161835593|NCT03499119|584439028|FG001|Optional Extension Phase|Lost to Follow-up|0|||
161835594|NCT03499119|584439029|FG002|Optional Extension Phase|Lost to Follow-up|0|||
161835595|NCT03499119|584439030|FG003|Optional Extension Phase|Lost to Follow-up|1|||
161835596|NCT03499119|584439027|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
161835597|NCT03499119|584439028|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
161835598|NCT03499119|584439029|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
161835599|NCT03499119|584439030|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
161835600|NCT03499119|584439027|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
161835601|NCT03499119|584439028|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
161835602|NCT03499119|584439029|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
161835603|NCT03499119|584439030|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
161835604|NCT01558297|584439031|FG000|Overall Study|Withdrawal by Subject|2|||
161835605|NCT01558297|584439032|FG001|Overall Study|Withdrawal by Subject|2|||
161835606|NCT01558297|584439033|FG002|Overall Study|Withdrawal by Subject|1|||
161835607|NCT02655016|584439036|FG000|Overall Study|Disease progression|6|||
161835608|NCT02655016|584439037|FG001|Overall Study|Disease progression|4|||
161835609|NCT02655016|584439036|FG000|Overall Study|Site closed|0|||
161835610|NCT02655016|584439037|FG001|Overall Study|Site closed|1|||
161835611|NCT02655016|584439036|FG000|Overall Study|Death|30|||
161835612|NCT02655016|584439037|FG001|Overall Study|Death|48|||
161835613|NCT02655016|584439036|FG000|Overall Study|Lost to Follow-up|1|||
161835614|NCT02655016|584439037|FG001|Overall Study|Lost to Follow-up|1|||
161835615|NCT02655016|584439036|FG000|Overall Study|Withdrawal by Subject|18|||
161835616|NCT02655016|584439037|FG001|Overall Study|Withdrawal by Subject|36|||
161835617|NCT02427984|584439040|FG000|Overall Study|Lost to Follow-up|13|||
161835618|NCT02427984|584439041|FG001|Overall Study|Lost to Follow-up|5|||
161835619|NCT02427984|584439042|FG002|Overall Study|Lost to Follow-up|18|||
161835620|NCT03959527|584440748|FG000|Overall Study|Withdrawal by Subject|8|||
161835621|NCT03959527|584440749|FG001|Overall Study|Withdrawal by Subject|3|||
161835622|NCT03959527|584440748|FG000|Overall Study|Lost to Follow-up|31|||
161835623|NCT03959527|584440749|FG001|Overall Study|Lost to Follow-up|15|||
161835624|NCT03959527|584440748|FG000|Overall Study|Did not meet eligibility criteria|1|||
161835625|NCT03959527|584440749|FG001|Overall Study|Did not meet eligibility criteria|1|||
161835626|NCT03959527|584440748|FG000|Overall Study|Protocol Violation|10|||
161835627|NCT03959527|584440749|FG001|Overall Study|Protocol Violation|5|||
161835628|NCT06029959|584440750|FG000|Overall Study|Physician Decision|6|||
161835629|NCT02960893|584440755|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
161835630|NCT02960893|584440756|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
161835631|NCT02960893|584440757|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
161835632|NCT02960893|584440758|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
161835633|NCT02960893|584440755|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
161835634|NCT02960893|584440756|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
161835635|NCT02960893|584440757|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
161835636|NCT02960893|584440758|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
161835637|NCT02960893|584440755|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
161835638|NCT02960893|584440756|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
161835639|NCT02960893|584440757|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
161835640|NCT02960893|584440758|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
161835641|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
161835642|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
161835643|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
161687861|NCT02970292|583908521|FG000|Overall Study|Lost to Follow-up|1|||
161835644|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
161835645|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
161953624|NCT02891226|584879827|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161953625|NCT02891226|584879828|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
161953626|NCT02891226|584879829|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161687862|NCT02970292|583908522|FG001|Overall Study|Lost to Follow-up|0|||
161687863|NCT02970292|583908521|FG000|Overall Study|Protocol Violation|2|||
161835646|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
161687864|NCT02970292|583908522|FG001|Overall Study|Protocol Violation|0|||
161687865|NCT02970292|583908521|FG000|Overall Study|Other|1|||
161835647|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
161835648|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
161835649|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
161835650|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
161835651|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
161835652|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
161835653|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
161835654|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
161835655|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
161835656|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
161835657|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
161953627|NCT02891226|584879830|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161687866|NCT02970292|583908522|FG001|Overall Study|Other|0|||
161687867|NCT00814892|583908523|FG000|Overall Study|Disease Progression|1|||
161687868|NCT00814892|583908523|FG000|Overall Study|Study Termination|1|||
161687869|NCT00845650|583908524|FG000|Overall Study|Withdrawal by Subject|0|||
161687870|NCT00845650|583908525|FG001|Overall Study|Withdrawal by Subject|0|||
161687871|NCT00845650|583908526|FG002|Overall Study|Withdrawal by Subject|0|||
161687872|NCT00845650|583908527|FG003|Overall Study|Withdrawal by Subject|0|||
161687873|NCT00845650|583908528|FG004|Overall Study|Withdrawal by Subject|2|||
161687874|NCT00845650|583908529|FG005|Overall Study|Withdrawal by Subject|0|||
161687875|NCT00845650|583908524|FG000|Overall Study|Lost to Follow-up|0|||
161687876|NCT00845650|583908525|FG001|Overall Study|Lost to Follow-up|0|||
161687877|NCT00845650|583908526|FG002|Overall Study|Lost to Follow-up|3|||
161687878|NCT00845650|583908527|FG003|Overall Study|Lost to Follow-up|1|||
161687879|NCT00845650|583908528|FG004|Overall Study|Lost to Follow-up|0|||
161687880|NCT00845650|583908529|FG005|Overall Study|Lost to Follow-up|1|||
161687881|NCT00845650|583908524|FG000|Overall Study|Sponsor hold on dosing|0|||
161687882|NCT00845650|583908525|FG001|Overall Study|Sponsor hold on dosing|0|||
161687883|NCT00845650|583908526|FG002|Overall Study|Sponsor hold on dosing|0|||
161687884|NCT00845650|583908527|FG003|Overall Study|Sponsor hold on dosing|0|||
161687885|NCT00845650|583908528|FG004|Overall Study|Sponsor hold on dosing|1|||
161687886|NCT00845650|583908529|FG005|Overall Study|Sponsor hold on dosing|1|||
161687887|NCT00845650|583908524|FG000|Overall Study|Unable to access IV line|1|||
161687888|NCT00845650|583908525|FG001|Overall Study|Unable to access IV line|0|||
161687889|NCT00845650|583908526|FG002|Overall Study|Unable to access IV line|0|||
161687890|NCT00845650|583908527|FG003|Overall Study|Unable to access IV line|0|||
161687891|NCT00845650|583908528|FG004|Overall Study|Unable to access IV line|0|||
161687892|NCT00845650|583908529|FG005|Overall Study|Unable to access IV line|0|||
161687893|NCT00531752|583908531|FG000|First Double-blind Intervention Period|Adverse Event|2|||
161687894|NCT00531752|583908532|FG001|First Double-blind Intervention Period|Adverse Event|0|||
161687895|NCT00531752|583908533|FG002|First Double-blind Intervention Period|Adverse Event|1|||
161687896|NCT00531752|583908534|FG003|First Double-blind Intervention Period|Adverse Event|1|||
161687897|NCT00531752|583908531|FG000|First Double-blind Intervention Period|Other|1|||
161687898|NCT00531752|583908532|FG001|First Double-blind Intervention Period|Other|4|||
161687899|NCT00531752|583908533|FG002|First Double-blind Intervention Period|Other|4|||
161687900|NCT00531752|583908534|FG003|First Double-blind Intervention Period|Other|0|||
161687901|NCT00531752|583908531|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
161687902|NCT00531752|583908532|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
161687903|NCT00531752|583908533|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
161687904|NCT00531752|583908534|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
161687905|NCT00531752|583908531|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
161687906|NCT00531752|583908532|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
161835658|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
161835659|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
161835660|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
161835661|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
161835662|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
162029556|NCT04575597|585165472|FG005|Overall Study|Death|14|||
161687907|NCT00531752|583908533|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
161687908|NCT00531752|583908534|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
161687909|NCT00531752|583908531|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
161835663|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
161835664|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
161835665|NCT02960893|584440755|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
161835666|NCT02960893|584440756|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
162029557|NCT04575597|585165467|FG000|Overall Study|Lost to Follow-up|2|||
161687910|NCT00531752|583908532|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
161835667|NCT02960893|584440757|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
161835668|NCT02960893|584440758|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
161835669|NCT02631876|584440761|FG000|Overall Study|Death|96|||
161835670|NCT02631876|584440762|FG001|Overall Study|Death|50|||
161835671|NCT02631876|584440761|FG000|Overall Study|Investigator's discretion|1|||
161835672|NCT02631876|584440762|FG001|Overall Study|Investigator's discretion|0|||
161835673|NCT02631876|584440761|FG000|Overall Study|Lost to Follow-up|2|||
161835674|NCT02631876|584440762|FG001|Overall Study|Lost to Follow-up|0|||
161835675|NCT02631876|584440761|FG000|Overall Study|Withdrawal by Subject|16|||
161835676|NCT02631876|584440762|FG001|Overall Study|Withdrawal by Subject|9|||
161835677|NCT02631876|584440761|FG000|Overall Study|Other than specified|4|||
161835678|NCT02631876|584440762|FG001|Overall Study|Other than specified|4|||
161835679|NCT04285567|584440763|FG000|Overall Study|Death|3|||
161687911|NCT00531752|583908533|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
161687912|NCT00531752|583908534|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
161835680|NCT04285567|584440764|FG001|Overall Study|Death|3|||
162029558|NCT04575597|585165468|FG001|Overall Study|Lost to Follow-up|1|||
161835681|NCT04285567|584440763|FG000|Overall Study|Lost to Follow-up|1|||
161835682|NCT04285567|584440764|FG001|Overall Study|Lost to Follow-up|1|||
161835683|NCT04285567|584440763|FG000|Overall Study|Reason Not Specified|1|||
161835684|NCT04285567|584440764|FG001|Overall Study|Reason Not Specified|1|||
161835685|NCT04285567|584440763|FG000|Overall Study|Physician Decision|2|||
161835686|NCT04285567|584440764|FG001|Overall Study|Physician Decision|1|||
161687913|NCT00531752|583908531|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
161687914|NCT00531752|583908532|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
161687915|NCT00531752|583908533|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
161687916|NCT00531752|583908534|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
161687917|NCT00531752|583908531|FG000|Second Double-blind Intervention Period|Other|1|||
161687918|NCT00531752|583908532|FG001|Second Double-blind Intervention Period|Other|1|||
161687919|NCT00531752|583908533|FG002|Second Double-blind Intervention Period|Other|0|||
161687920|NCT00531752|583908534|FG003|Second Double-blind Intervention Period|Other|0|||
161687921|NCT00531752|583908531|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
161687922|NCT00531752|583908532|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
161687923|NCT00531752|583908533|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
161687924|NCT00531752|583908534|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
161835687|NCT04285567|584440763|FG000|Overall Study|Withdrawal by Subject|2|||
161835688|NCT04285567|584440764|FG001|Overall Study|Withdrawal by Subject|6|||
161835689|NCT04285567|584440763|FG000|Overall Study|Adverse Event|1|||
161835690|NCT04285567|584440764|FG001|Overall Study|Adverse Event|0|||
161835691|NCT04285567|584440763|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
161835692|NCT04285567|584440764|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
161835693|NCT00493779|584440765|FG000|Overall Study|Logistical issue at site|1|||
161835694|NCT02091141|584440767|FG000|Overall Study|Death|280|||
161835695|NCT02091141|584440768|FG001|Overall Study|Death|118|||
161835696|NCT02091141|584440769|FG002|Overall Study|Death|46|||
161835697|NCT02091141|584440770|FG003|Overall Study|Death|13|||
161835698|NCT02091141|584440771|FG004|Overall Study|Death|31|||
161835699|NCT02091141|584440772|FG005|Overall Study|Death|16|||
161835700|NCT02091141|584440773|FG006|Overall Study|Death|12|||
161835701|NCT02091141|584440767|FG000|Overall Study|Withdrawal by Subject|21|||
161835702|NCT02091141|584440768|FG001|Overall Study|Withdrawal by Subject|13|||
161835703|NCT02091141|584440769|FG002|Overall Study|Withdrawal by Subject|3|||
161835704|NCT02091141|584440770|FG003|Overall Study|Withdrawal by Subject|2|||
161835705|NCT02091141|584440771|FG004|Overall Study|Withdrawal by Subject|2|||
161953628|NCT02891226|584879831|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161953629|NCT02891226|584879832|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161835706|NCT02091141|584440772|FG005|Overall Study|Withdrawal by Subject|3|||
161835707|NCT02091141|584440773|FG006|Overall Study|Withdrawal by Subject|0|||
161953630|NCT02891226|584879833|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161835708|NCT02091141|584440767|FG000|Overall Study|Lost to Follow-up|21|||
161835709|NCT02091141|584440768|FG001|Overall Study|Lost to Follow-up|5|||
161835710|NCT02091141|584440769|FG002|Overall Study|Lost to Follow-up|1|||
161835711|NCT02091141|584440770|FG003|Overall Study|Lost to Follow-up|0|||
161835712|NCT02091141|584440771|FG004|Overall Study|Lost to Follow-up|1|||
161835713|NCT02091141|584440772|FG005|Overall Study|Lost to Follow-up|2|||
161835714|NCT02091141|584440773|FG006|Overall Study|Lost to Follow-up|0|||
161835715|NCT02091141|584440767|FG000|Overall Study|Reason Not Specified|6|||
161835716|NCT02091141|584440768|FG001|Overall Study|Reason Not Specified|5|||
161835717|NCT02091141|584440769|FG002|Overall Study|Reason Not Specified|2|||
161835718|NCT02091141|584440770|FG003|Overall Study|Reason Not Specified|0|||
161835719|NCT02091141|584440771|FG004|Overall Study|Reason Not Specified|0|||
161835720|NCT02091141|584440772|FG005|Overall Study|Reason Not Specified|0|||
161835721|NCT02091141|584440773|FG006|Overall Study|Reason Not Specified|1|||
161835722|NCT02091141|584440767|FG000|Overall Study|Study Ended by Sponsor|1|||
161953631|NCT02891226|584879834|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161953632|NCT02891226|584879835|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161953633|NCT02891226|584879836|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161953634|NCT02891226|584879837|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161953635|NCT02891226|584879838|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161835723|NCT02091141|584440768|FG001|Overall Study|Study Ended by Sponsor|9|||
161835724|NCT02091141|584440769|FG002|Overall Study|Study Ended by Sponsor|0|||
161953636|NCT02891226|584879839|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161953637|NCT02891226|584879840|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161953638|NCT02891226|584879841|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
161953639|NCT02891226|584879826|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953640|NCT02891226|584879827|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953641|NCT02891226|584879828|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953642|NCT02891226|584879829|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
161953643|NCT02891226|584879830|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953644|NCT02891226|584879831|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953645|NCT02891226|584879832|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953646|NCT02891226|584879833|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953647|NCT02891226|584879834|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953648|NCT02891226|584879835|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953649|NCT02891226|584879836|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953650|NCT02891226|584879837|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953651|NCT02891226|584879838|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953652|NCT02891226|584879839|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953653|NCT02891226|584879840|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953654|NCT02891226|584879841|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
161953655|NCT02891226|584879826|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953656|NCT02891226|584879827|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953657|NCT02891226|584879828|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953658|NCT02891226|584879829|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
161953659|NCT02891226|584879830|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953660|NCT02891226|584879831|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953661|NCT02891226|584879832|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953662|NCT02891226|584879833|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953663|NCT02891226|584879834|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953664|NCT02891226|584879835|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953665|NCT02891226|584879836|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953666|NCT02891226|584879837|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953667|NCT02891226|584879838|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953668|NCT02891226|584879839|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953669|NCT02891226|584879840|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953670|NCT02891226|584879841|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
161953671|NCT02891226|584879826|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161953672|NCT02891226|584879827|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161953673|NCT02891226|584879828|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161953674|NCT02891226|584879829|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161953675|NCT02891226|584879830|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161953676|NCT02891226|584879831|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161953677|NCT02891226|584879832|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
161953678|NCT02891226|584879833|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
161953679|NCT02891226|584879834|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
161953680|NCT02891226|584879835|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
161953681|NCT02891226|584879836|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161953682|NCT02891226|584879837|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161953683|NCT02891226|584879838|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161953684|NCT02891226|584879839|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161953685|NCT02891226|584879840|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161953686|NCT02891226|584879841|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
161953687|NCT02891226|584879826|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953688|NCT02891226|584879827|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953689|NCT02891226|584879828|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953690|NCT02891226|584879829|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953691|NCT02891226|584879830|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953692|NCT02891226|584879831|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
161953693|NCT02891226|584879832|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953694|NCT02891226|584879833|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953695|NCT02891226|584879834|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953696|NCT02891226|584879835|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
161953697|NCT02891226|584879836|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953698|NCT02891226|584879837|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953699|NCT02891226|584879838|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953700|NCT02891226|584879839|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953701|NCT02891226|584879840|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953702|NCT02891226|584879841|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
161953703|NCT02891226|584879826|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161953704|NCT02891226|584879827|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161953705|NCT02891226|584879828|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161953706|NCT02891226|584879829|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161953707|NCT02891226|584879830|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161953708|NCT02891226|584879831|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161953709|NCT02891226|584879832|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
161953710|NCT02891226|584879833|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
161953711|NCT02891226|584879834|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
161953712|NCT02891226|584879835|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
161953713|NCT02891226|584879836|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161953714|NCT02891226|584879837|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161953715|NCT02891226|584879838|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161953716|NCT02891226|584879839|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161953717|NCT02891226|584879840|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161953718|NCT02891226|584879841|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
161953719|NCT02891226|584879826|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953720|NCT02891226|584879827|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953721|NCT02891226|584879828|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953722|NCT02891226|584879829|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953723|NCT02891226|584879830|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
161953724|NCT02891226|584879831|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953725|NCT02891226|584879832|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953726|NCT02891226|584879833|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953727|NCT02891226|584879834|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953728|NCT02891226|584879835|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953729|NCT02891226|584879836|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953730|NCT02891226|584879837|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953731|NCT02891226|584879838|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953732|NCT02891226|584879839|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953733|NCT02891226|584879840|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
161953734|NCT02891226|584879841|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
162029559|NCT04575597|585165469|FG002|Overall Study|Lost to Follow-up|1|||
162029560|NCT04575597|585165470|FG003|Overall Study|Lost to Follow-up|2|||
161953735|NCT02891226|584879826|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953736|NCT02891226|584879827|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953737|NCT02891226|584879828|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953738|NCT02891226|584879829|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953739|NCT02891226|584879830|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953740|NCT02891226|584879831|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953741|NCT02891226|584879832|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
161953742|NCT02891226|584879833|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953743|NCT02891226|584879834|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953744|NCT02891226|584879835|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953745|NCT02891226|584879836|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953746|NCT02891226|584879837|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953747|NCT02891226|584879838|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953748|NCT02891226|584879839|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953749|NCT02891226|584879840|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953750|NCT02891226|584879841|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
161953751|NCT02891226|584879826|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953752|NCT02891226|584879827|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953753|NCT02891226|584879828|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953754|NCT02891226|584879829|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953755|NCT02891226|584879830|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953756|NCT02891226|584879831|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953757|NCT02891226|584879832|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953758|NCT02891226|584879833|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
161953759|NCT02891226|584879834|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
161953760|NCT02891226|584879835|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
161953761|NCT02891226|584879836|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953762|NCT02891226|584879837|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953763|NCT02891226|584879838|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953764|NCT02891226|584879839|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953765|NCT02891226|584879840|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953766|NCT02891226|584879841|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
161953767|NCT02891226|584879826|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953768|NCT02891226|584879827|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953769|NCT02891226|584879828|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953770|NCT02891226|584879829|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953771|NCT02891226|584879830|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953772|NCT02891226|584879831|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953773|NCT02891226|584879832|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953774|NCT02891226|584879833|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
161953775|NCT02891226|584879834|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953776|NCT02891226|584879835|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953777|NCT02891226|584879836|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953778|NCT02891226|584879837|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953779|NCT02891226|584879838|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953780|NCT02891226|584879839|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953781|NCT02891226|584879840|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953782|NCT02891226|584879841|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
161953783|NCT02891226|584879826|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953784|NCT02891226|584879827|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953785|NCT02891226|584879828|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161835725|NCT02091141|584440770|FG003|Overall Study|Study Ended by Sponsor|0|||
161835726|NCT02091141|584440771|FG004|Overall Study|Study Ended by Sponsor|0|||
161835727|NCT02091141|584440772|FG005|Overall Study|Study Ended by Sponsor|0|||
161953786|NCT02891226|584879829|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953787|NCT02891226|584879830|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953788|NCT02891226|584879831|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953789|NCT02891226|584879832|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953790|NCT02891226|584879833|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953791|NCT02891226|584879834|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
161953792|NCT02891226|584879835|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953793|NCT02891226|584879836|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953794|NCT02891226|584879837|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953795|NCT02891226|584879838|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953796|NCT02891226|584879839|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953797|NCT02891226|584879840|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953798|NCT02891226|584879841|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161953799|NCT02891226|584879826|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953800|NCT02891226|584879827|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953801|NCT02891226|584879828|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953802|NCT02891226|584879829|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953803|NCT02891226|584879830|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953804|NCT02891226|584879831|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953805|NCT02891226|584879832|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953806|NCT02891226|584879833|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953807|NCT02891226|584879834|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953808|NCT02891226|584879835|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
161953809|NCT02891226|584879836|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953810|NCT02891226|584879837|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953811|NCT02891226|584879838|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953812|NCT02891226|584879839|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953813|NCT02891226|584879840|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953814|NCT02891226|584879841|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
161953815|NCT02891226|584879826|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953816|NCT02891226|584879827|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953817|NCT02891226|584879828|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953818|NCT02891226|584879829|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161835728|NCT02091141|584440773|FG006|Overall Study|Study Ended by Sponsor|0|||
161835729|NCT02091141|584440767|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
161953819|NCT02891226|584879830|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953820|NCT02891226|584879831|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953821|NCT02891226|584879832|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953822|NCT02891226|584879833|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953823|NCT02891226|584879834|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953824|NCT02891226|584879835|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
161953825|NCT02891226|584879836|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953826|NCT02891226|584879837|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953827|NCT02891226|584879838|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953828|NCT02891226|584879839|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953829|NCT02891226|584879840|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953830|NCT02891226|584879841|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
161953831|NCT02891226|584879826|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953832|NCT02891226|584879827|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953833|NCT02891226|584879828|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953834|NCT02891226|584879829|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953835|NCT02891226|584879830|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953836|NCT02891226|584879831|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953837|NCT02891226|584879832|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953838|NCT02891226|584879833|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953839|NCT02891226|584879834|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953840|NCT02891226|584879835|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953841|NCT02891226|584879836|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
161953842|NCT02891226|584879837|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953843|NCT02891226|584879838|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953844|NCT02891226|584879839|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953845|NCT02891226|584879840|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953846|NCT02891226|584879841|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161953847|NCT02891226|584879826|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953848|NCT02891226|584879827|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953849|NCT02891226|584879828|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
162029561|NCT04575597|585165471|FG004|Overall Study|Lost to Follow-up|10|||
162029562|NCT04575597|585165472|FG005|Overall Study|Lost to Follow-up|8|||
162029563|NCT04575597|585165467|FG000|Overall Study|Withdrawal by Subject|2|||
162029564|NCT04575597|585165468|FG001|Overall Study|Withdrawal by Subject|2|||
162029565|NCT04575597|585165469|FG002|Overall Study|Withdrawal by Subject|4|||
161953850|NCT02891226|584879829|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953851|NCT02891226|584879830|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953852|NCT02891226|584879831|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953853|NCT02891226|584879832|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953854|NCT02891226|584879833|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953855|NCT02891226|584879834|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953856|NCT02891226|584879835|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953857|NCT02891226|584879836|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
161953858|NCT02891226|584879837|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953859|NCT02891226|584879838|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953860|NCT02891226|584879839|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953861|NCT02891226|584879840|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953862|NCT02891226|584879841|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
161953863|NCT02891226|584879826|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953864|NCT02891226|584879827|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953865|NCT02891226|584879828|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953866|NCT02891226|584879829|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953867|NCT02891226|584879830|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953868|NCT02891226|584879831|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953869|NCT02891226|584879832|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953870|NCT02891226|584879833|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953871|NCT02891226|584879834|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953872|NCT02891226|584879835|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953873|NCT02891226|584879836|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
161953874|NCT02891226|584879837|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953875|NCT02891226|584879838|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953876|NCT02891226|584879839|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953877|NCT02891226|584879840|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953878|NCT02891226|584879841|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
161953879|NCT02891226|584879826|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953880|NCT02891226|584879827|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953881|NCT02891226|584879828|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953882|NCT02891226|584879829|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953883|NCT02891226|584879830|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953884|NCT02891226|584879831|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953885|NCT02891226|584879832|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953886|NCT02891226|584879833|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953887|NCT02891226|584879834|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953888|NCT02891226|584879835|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953889|NCT02891226|584879836|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
161953890|NCT02891226|584879837|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953891|NCT02891226|584879838|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953892|NCT02891226|584879839|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953893|NCT02891226|584879840|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953894|NCT02891226|584879841|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
161953895|NCT02891226|584879826|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953896|NCT02891226|584879827|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953897|NCT02891226|584879828|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953898|NCT02891226|584879829|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953899|NCT02891226|584879830|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953900|NCT02891226|584879831|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953901|NCT02891226|584879832|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953902|NCT02891226|584879833|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953903|NCT02891226|584879834|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953904|NCT02891226|584879835|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161687925|NCT00531752|583908531|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
161687926|NCT00531752|583908532|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
161953905|NCT02891226|584879836|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
161953906|NCT02891226|584879837|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953907|NCT02891226|584879838|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953908|NCT02891226|584879839|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953909|NCT02891226|584879840|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161953910|NCT02891226|584879841|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
161687927|NCT00531752|583908533|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
161835730|NCT02091141|584440768|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
161835731|NCT02091141|584440769|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
161835732|NCT02091141|584440770|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
161835733|NCT02091141|584440771|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
161953911|NCT02891226|584879826|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953912|NCT02891226|584879827|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953913|NCT02891226|584879828|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953914|NCT02891226|584879829|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953915|NCT02891226|584879830|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953916|NCT02891226|584879831|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953917|NCT02891226|584879832|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953918|NCT02891226|584879833|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953919|NCT02891226|584879834|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953920|NCT02891226|584879835|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953921|NCT02891226|584879836|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
161953922|NCT02891226|584879837|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953923|NCT02891226|584879838|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953924|NCT02891226|584879839|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953925|NCT02891226|584879840|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953926|NCT02891226|584879841|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
161953927|NCT02891226|584879826|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953928|NCT02891226|584879827|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953929|NCT02891226|584879828|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953930|NCT02891226|584879829|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953931|NCT02891226|584879830|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953932|NCT02891226|584879831|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953933|NCT02891226|584879832|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953934|NCT02891226|584879833|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161835734|NCT02091141|584440772|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
161835735|NCT02091141|584440773|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
161835736|NCT02246439|584440774|FG000|Overall Study|Adverse Event|3|||
161835737|NCT02246439|584440775|FG001|Overall Study|Adverse Event|0|||
161835738|NCT02246439|584440774|FG000|Overall Study|Lost to Follow-up|7|||
161835739|NCT02246439|584440775|FG001|Overall Study|Lost to Follow-up|5|||
161835740|NCT02246439|584440774|FG000|Overall Study|Protocol Violation|0|||
161835741|NCT02246439|584440775|FG001|Overall Study|Protocol Violation|2|||
161835742|NCT02246439|584440774|FG000|Overall Study|Physician Decision|0|||
161835743|NCT02246439|584440775|FG001|Overall Study|Physician Decision|1|||
161835744|NCT02246439|584440774|FG000|Overall Study|Unkonwn|1|||
161835745|NCT02246439|584440775|FG001|Overall Study|Unkonwn|3|||
161835746|NCT02246439|584440774|FG000|Overall Study|Withdrawal by Subject|1|||
161835747|NCT02246439|584440775|FG001|Overall Study|Withdrawal by Subject|0|||
161953935|NCT02891226|584879834|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953936|NCT02891226|584879835|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953937|NCT02891226|584879836|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
161835748|NCT03439852|584440778|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
161835749|NCT03439852|584440779|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
161835750|NCT03439852|584440778|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
161835751|NCT03439852|584440779|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
161835752|NCT03439852|584440778|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
161835753|NCT03439852|584440779|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
161835754|NCT04551911|584440780|FG000|Overall Study|Lost to Follow-up|2|||
161835755|NCT04551911|584440781|FG001|Overall Study|Lost to Follow-up|1|||
161835756|NCT04551911|584440780|FG000|Overall Study|Withdrawal by Subject|10|||
161835757|NCT04551911|584440781|FG001|Overall Study|Withdrawal by Subject|10|||
161835758|NCT04551911|584440780|FG000|Overall Study|Did not receive the study drug|3|||
161835759|NCT04551911|584440781|FG001|Overall Study|Did not receive the study drug|4|||
161835760|NCT00866658|584440792|FG000|Overall Study|Adverse Event|5|||
161835761|NCT00866658|584440793|FG001|Overall Study|Adverse Event|14|||
161835762|NCT00866658|584440792|FG000|Overall Study|Lack of Efficacy|2|||
161953938|NCT02891226|584879837|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953939|NCT02891226|584879838|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161835763|NCT00866658|584440793|FG001|Overall Study|Lack of Efficacy|1|||
162029566|NCT04575597|585165470|FG003|Overall Study|Withdrawal by Subject|2|||
161835764|NCT00866658|584440792|FG000|Overall Study|Withdrawal by Subject|1|||
161835765|NCT00866658|584440793|FG001|Overall Study|Withdrawal by Subject|0|||
161835766|NCT00866658|584440792|FG000|Overall Study|Protocol Violation|1|||
161835767|NCT00866658|584440793|FG001|Overall Study|Protocol Violation|1|||
161953940|NCT02891226|584879839|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953941|NCT02891226|584879840|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953942|NCT02891226|584879841|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
161953943|NCT02891226|584879826|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
162029567|NCT04575597|585165471|FG004|Overall Study|Withdrawal by Subject|25|||
161687928|NCT00531752|583908534|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
161687929|NCT01883635|583908535|FG000|Overall Study|Withdrawal by Subject|4|||
161687930|NCT01883635|583908536|FG001|Overall Study|Withdrawal by Subject|0|||
161687931|NCT00761514|583908537|FG000|Overall Study|Adverse Event|1|||
161687932|NCT00761514|583908537|FG000|Overall Study|Withdrawal by Subject|2|||
161687933|NCT00761514|583908537|FG000|Overall Study|Lost to Follow-up|1|||
161687934|NCT00761514|583908537|FG000|Overall Study|Health insurance didn't cover study drug|1|||
161687935|NCT00761514|583908537|FG000|Overall Study|Problem complying with study visit|1|||
161687936|NCT00761514|583908537|FG000|Overall Study|Unable to pay for medications|1|||
161687937|NCT01979536|583908540|FG000|Overall Study|Physician Decision|2|||
161687938|NCT01979536|583908541|FG001|Overall Study|Physician Decision|3|||
161687939|NCT01979536|583908540|FG000|Overall Study|Withdrawal by Subject|0|||
161687940|NCT01979536|583908541|FG001|Overall Study|Withdrawal by Subject|1|||
161687941|NCT01979536|583908540|FG000|Overall Study|Refusal|0|||
161687942|NCT01979536|583908541|FG001|Overall Study|Refusal|1|||
161687943|NCT01979536|583908540|FG000|Overall Study|Relapse|0|||
161687944|NCT01979536|583908541|FG001|Overall Study|Relapse|1|||
161687945|NCT01979536|583908540|FG000|Overall Study|Study terminated by Sponsor|0|||
161687946|NCT01979536|583908541|FG001|Overall Study|Study terminated by Sponsor|1|||
161687947|NCT01979536|583908540|FG000|Overall Study|Did not start treatment|0|||
161687948|NCT01979536|583908541|FG001|Overall Study|Did not start treatment|1|||
161687949|NCT04294901|583908543|FG000|Overall Study|Death|86|||
161687950|NCT04294901|583908544|FG001|Overall Study|Death|110|||
161687951|NCT04294901|583908543|FG000|Overall Study|Provider did not have historical control patients|581|||
161687952|NCT04294901|583908544|FG001|Overall Study|Provider did not have historical control patients|0|||
161687953|NCT04294901|583908543|FG000|Overall Study|Provider did not have intervention patients|0|||
161687954|NCT04294901|583908544|FG001|Overall Study|Provider did not have intervention patients|98|||
161687955|NCT01934556|583908547|FG000|Overall Study|Withdrawal by Subject|0|||
161687956|NCT01934556|583908548|FG001|Overall Study|Withdrawal by Subject|1|||
161687957|NCT01934556|583908549|FG002|Overall Study|Withdrawal by Subject|1|||
161687958|NCT01934556|583908547|FG000|Overall Study|Lost to Follow-up|4|||
161687959|NCT01934556|583908548|FG001|Overall Study|Lost to Follow-up|10|||
161687960|NCT01934556|583908549|FG002|Overall Study|Lost to Follow-up|7|||
161687961|NCT01934556|583908547|FG000|Overall Study|Death|1|||
161687962|NCT01934556|583908548|FG001|Overall Study|Death|5|||
161687963|NCT01934556|583908549|FG002|Overall Study|Death|2|||
161687964|NCT01908101|583909770|FG000|Overall Study|Physician Decision|1|||
161687965|NCT01908101|583909770|FG000|Overall Study|Withdrawal by Subject|1|||
161687966|NCT01908101|583909770|FG000|Overall Study|Incorrect Diagnosis|2|||
161687967|NCT01908101|583909770|FG000|Overall Study|Incorrect Starting Dose|1|||
161687968|NCT01908101|583909770|FG000|Overall Study|Did not complete the first cycle|4|||
161687969|NCT01394939|583909771|FG000|Overall Study|Adverse Event|1|||
161687970|NCT01394939|583909772|FG001|Overall Study|Adverse Event|3|||
161687971|NCT01394939|583909773|FG002|Overall Study|Adverse Event|0|||
161687972|NCT01394939|583909774|FG003|Overall Study|Adverse Event|2|||
161687973|NCT01394939|583909771|FG000|Overall Study|Death|0|||
161687974|NCT01394939|583909772|FG001|Overall Study|Death|2|||
161687975|NCT01394939|583909773|FG002|Overall Study|Death|0|||
161687976|NCT01394939|583909774|FG003|Overall Study|Death|0|||
161687977|NCT01394939|583909771|FG000|Overall Study|Physician Decision|0|||
161687978|NCT01394939|583909772|FG001|Overall Study|Physician Decision|1|||
161687979|NCT01394939|583909773|FG002|Overall Study|Physician Decision|0|||
161687980|NCT01394939|583909774|FG003|Overall Study|Physician Decision|0|||
161687981|NCT01394939|583909771|FG000|Overall Study|Withdrawal by Subject|0|||
161687982|NCT01394939|583909772|FG001|Overall Study|Withdrawal by Subject|2|||
161687983|NCT01394939|583909773|FG002|Overall Study|Withdrawal by Subject|0|||
161687984|NCT01394939|583909774|FG003|Overall Study|Withdrawal by Subject|2|||
161687985|NCT01394939|583909771|FG000|Overall Study|Others|0|||
161687986|NCT01394939|583909772|FG001|Overall Study|Others|2|||
161687987|NCT01394939|583909773|FG002|Overall Study|Others|0|||
161687988|NCT01394939|583909774|FG003|Overall Study|Others|3|||
161687989|NCT03657043|583909777|FG000|Overall Study|Withdrawal by Subject|1|||
161687990|NCT03657043|583909778|FG001|Overall Study|Withdrawal by Subject|1|||
161687991|NCT03657043|583909779|FG002|Overall Study|Withdrawal by Subject|0|||
161687992|NCT03657043|583909780|FG003|Overall Study|Withdrawal by Subject|0|||
161687993|NCT03657043|583909781|FG004|Overall Study|Withdrawal by Subject|4|||
161687994|NCT03657043|583909777|FG000|Overall Study|Study closure by Sponsor|0|||
161687995|NCT03657043|583909778|FG001|Overall Study|Study closure by Sponsor|2|||
161687996|NCT03657043|583909779|FG002|Overall Study|Study closure by Sponsor|0|||
161687997|NCT03657043|583909780|FG003|Overall Study|Study closure by Sponsor|0|||
161687998|NCT03657043|583909781|FG004|Overall Study|Study closure by Sponsor|17|||
162029568|NCT04575597|585165472|FG005|Overall Study|Withdrawal by Subject|28|||
161687999|NCT03657043|583909777|FG000|Overall Study|Lost to Follow-up|0|||
161688000|NCT03657043|583909778|FG001|Overall Study|Lost to Follow-up|0|||
161688001|NCT03657043|583909779|FG002|Overall Study|Lost to Follow-up|0|||
161688002|NCT03657043|583909780|FG003|Overall Study|Lost to Follow-up|0|||
161688003|NCT03657043|583909781|FG004|Overall Study|Lost to Follow-up|4|||
161688004|NCT03657043|583909777|FG000|Overall Study|Death|6|||
161953944|NCT02891226|584879827|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953945|NCT02891226|584879828|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953946|NCT02891226|584879829|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953947|NCT02891226|584879830|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953948|NCT02891226|584879831|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953949|NCT02891226|584879832|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953950|NCT02891226|584879833|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953951|NCT02891226|584879834|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953952|NCT02891226|584879835|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953953|NCT02891226|584879836|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
161953954|NCT02891226|584879837|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953955|NCT02891226|584879838|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953956|NCT02891226|584879839|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953957|NCT02891226|584879840|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953958|NCT02891226|584879841|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
161953959|NCT02891226|584879826|FG000|Follow-up Period|Withdrawal by Subject|0|||
161953960|NCT02891226|584879827|FG001|Follow-up Period|Withdrawal by Subject|0|||
161953961|NCT02891226|584879828|FG002|Follow-up Period|Withdrawal by Subject|0|||
161953962|NCT02891226|584879829|FG003|Follow-up Period|Withdrawal by Subject|0|||
161953963|NCT02891226|584879830|FG004|Follow-up Period|Withdrawal by Subject|0|||
161953964|NCT02891226|584879831|FG005|Follow-up Period|Withdrawal by Subject|0|||
161953965|NCT02891226|584879832|FG006|Follow-up Period|Withdrawal by Subject|0|||
161953966|NCT02891226|584879833|FG007|Follow-up Period|Withdrawal by Subject|0|||
161953967|NCT02891226|584879834|FG008|Follow-up Period|Withdrawal by Subject|0|||
161953968|NCT02891226|584879835|FG009|Follow-up Period|Withdrawal by Subject|0|||
161953969|NCT02891226|584879836|FG010|Follow-up Period|Withdrawal by Subject|0|||
161953970|NCT02891226|584879837|FG011|Follow-up Period|Withdrawal by Subject|1|||
161953971|NCT02891226|584879838|FG012|Follow-up Period|Withdrawal by Subject|0|||
161953972|NCT02891226|584879839|FG013|Follow-up Period|Withdrawal by Subject|0|||
161953973|NCT02891226|584879840|FG014|Follow-up Period|Withdrawal by Subject|1|||
161953974|NCT02891226|584879841|FG015|Follow-up Period|Withdrawal by Subject|1|||
161953975|NCT01445847|584879844|FG000|Overall Study|Protocol Violation|13|||
161953976|NCT01445847|584879845|FG001|Overall Study|Protocol Violation|14|||
161953977|NCT01445847|584879844|FG000|Overall Study|Missed Data|1|||
161953978|NCT01445847|584879845|FG001|Overall Study|Missed Data|0|||
161953979|NCT04570384|584879846|FG000|Overall Study|Adverse Event|2|||
161953980|NCT04570384|584879847|FG001|Overall Study|Adverse Event|1|||
161953981|NCT04570384|584879846|FG000|Overall Study|Death|2|||
161953982|NCT04570384|584879847|FG001|Overall Study|Death|5|||
161953983|NCT04570384|584879846|FG000|Overall Study|Lost to Follow-up|1|||
161953984|NCT04570384|584879847|FG001|Overall Study|Lost to Follow-up|0|||
161953985|NCT04570384|584879846|FG000|Overall Study|Other|1|||
161953986|NCT04570384|584879847|FG001|Overall Study|Other|0|||
161953987|NCT04570384|584879846|FG000|Overall Study|Protocol Violation|0|||
161953988|NCT04570384|584879847|FG001|Overall Study|Protocol Violation|1|||
161953989|NCT04570384|584879846|FG000|Overall Study|Sponsor Decision|1|||
161953990|NCT04570384|584879847|FG001|Overall Study|Sponsor Decision|0|||
161953991|NCT04570384|584879846|FG000|Overall Study|Withdrawal by Subject|4|||
161953992|NCT04570384|584879847|FG001|Overall Study|Withdrawal by Subject|2|||
161953993|NCT03654274|584879850|FG000|Overall Study|Adverse Event|19|||
161953994|NCT03654274|584879851|FG001|Overall Study|Adverse Event|23|||
161953995|NCT03654274|584879852|FG002|Overall Study|Adverse Event|24|||
161953996|NCT03654274|584879850|FG000|Overall Study|Protocol Deviation|0|||
161953997|NCT03654274|584879851|FG001|Overall Study|Protocol Deviation|2|||
161953998|NCT03654274|584879852|FG002|Overall Study|Protocol Deviation|0|||
161953999|NCT03654274|584879850|FG000|Overall Study|Lost to Follow-up|8|||
161954000|NCT03654274|584879851|FG001|Overall Study|Lost to Follow-up|6|||
161688005|NCT03657043|583909778|FG001|Overall Study|Death|5|||
161954001|NCT03654274|584879852|FG002|Overall Study|Lost to Follow-up|5|||
161954002|NCT03654274|584879850|FG000|Overall Study|Withdrawal by Subject|46|||
161954003|NCT03654274|584879851|FG001|Overall Study|Withdrawal by Subject|25|||
161954004|NCT03654274|584879852|FG002|Overall Study|Withdrawal by Subject|33|||
161954005|NCT03654274|584879850|FG000|Overall Study|Lack of Efficacy|4|||
161954006|NCT03654274|584879851|FG001|Overall Study|Lack of Efficacy|5|||
161954007|NCT03654274|584879852|FG002|Overall Study|Lack of Efficacy|7|||
161954008|NCT03654274|584879850|FG000|Overall Study|Pregnancy|2|||
161954009|NCT03654274|584879851|FG001|Overall Study|Pregnancy|2|||
161954010|NCT03654274|584879852|FG002|Overall Study|Pregnancy|1|||
161954011|NCT03654274|584879850|FG000|Overall Study|Other|27|||
161954012|NCT03654274|584879851|FG001|Overall Study|Other|29|||
161688006|NCT03657043|583909779|FG002|Overall Study|Death|0|||
161688007|NCT03657043|583909780|FG003|Overall Study|Death|0|||
161688008|NCT03657043|583909781|FG004|Overall Study|Death|53|||
161688009|NCT03657043|583909777|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
161688010|NCT03657043|583909778|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
161688011|NCT03657043|583909779|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
161688012|NCT03657043|583909780|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
161688013|NCT03657043|583909781|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
161688014|NCT03657043|583909777|FG000|Overall Study|Adverse Event|0|||
161688015|NCT03657043|583909778|FG001|Overall Study|Adverse Event|0|||
161688016|NCT03657043|583909779|FG002|Overall Study|Adverse Event|0|||
161688017|NCT03657043|583909780|FG003|Overall Study|Adverse Event|0|||
161688018|NCT03657043|583909781|FG004|Overall Study|Adverse Event|2|||
161688019|NCT03657043|583909777|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
161688020|NCT03657043|583909778|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
161688021|NCT03657043|583909779|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
161688022|NCT03657043|583909780|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
161688023|NCT03657043|583909781|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
161688024|NCT03657043|583909777|FG000|Overall Study|Withdrawal - declined follow-up|0|||
161688025|NCT03657043|583909778|FG001|Overall Study|Withdrawal - declined follow-up|0|||
161688026|NCT03657043|583909779|FG002|Overall Study|Withdrawal - declined follow-up|0|||
161688027|NCT03657043|583909780|FG003|Overall Study|Withdrawal - declined follow-up|0|||
161688028|NCT03657043|583909781|FG004|Overall Study|Withdrawal - declined follow-up|1|||
161688029|NCT01995071|583909782|FG000|Overall Study|Adverse Event|0|||
161688030|NCT01995071|583909783|FG001|Overall Study|Adverse Event|0|||
161688031|NCT01995071|583909784|FG002|Overall Study|Adverse Event|0|||
161688032|NCT01995071|583909785|FG003|Overall Study|Adverse Event|0|||
161688033|NCT01995071|583909786|FG004|Overall Study|Adverse Event|0|||
161688034|NCT01995071|583909787|FG005|Overall Study|Adverse Event|0|||
161688035|NCT01995071|583909788|FG006|Overall Study|Adverse Event|1|||
161688036|NCT01995071|583909789|FG007|Overall Study|Adverse Event|0|||
161688037|NCT01995071|583909790|FG008|Overall Study|Adverse Event|0|||
161688038|NCT01995071|583909791|FG009|Overall Study|Adverse Event|0|||
161688039|NCT01995071|583909792|FG010|Overall Study|Adverse Event|0|||
161688040|NCT01995071|583909793|FG011|Overall Study|Adverse Event|0|||
161688041|NCT01995071|583909782|FG000|Overall Study|Moved|0|||
161688042|NCT01995071|583909783|FG001|Overall Study|Moved|0|||
161688043|NCT01995071|583909784|FG002|Overall Study|Moved|1|||
161688044|NCT01995071|583909785|FG003|Overall Study|Moved|0|||
161688045|NCT01995071|583909786|FG004|Overall Study|Moved|1|||
161688046|NCT01995071|583909787|FG005|Overall Study|Moved|0|||
161688047|NCT01995071|583909788|FG006|Overall Study|Moved|0|||
161688048|NCT01995071|583909789|FG007|Overall Study|Moved|0|||
161688049|NCT01995071|583909790|FG008|Overall Study|Moved|0|||
161688050|NCT01995071|583909791|FG009|Overall Study|Moved|0|||
161688051|NCT01995071|583909792|FG010|Overall Study|Moved|1|||
161688052|NCT01995071|583909793|FG011|Overall Study|Moved|0|||
161954013|NCT03654274|584879852|FG002|Overall Study|Other|32|||
161688053|NCT01995071|583909782|FG000|Overall Study|Lost to Follow-up|1|||
161688054|NCT01995071|583909783|FG001|Overall Study|Lost to Follow-up|0|||
161688055|NCT01995071|583909784|FG002|Overall Study|Lost to Follow-up|0|||
161688056|NCT01995071|583909785|FG003|Overall Study|Lost to Follow-up|0|||
161688057|NCT01995071|583909786|FG004|Overall Study|Lost to Follow-up|0|||
161688058|NCT01995071|583909787|FG005|Overall Study|Lost to Follow-up|0|||
161688059|NCT01995071|583909788|FG006|Overall Study|Lost to Follow-up|0|||
161688060|NCT01995071|583909789|FG007|Overall Study|Lost to Follow-up|1|||
161688061|NCT01995071|583909790|FG008|Overall Study|Lost to Follow-up|1|||
161688062|NCT01995071|583909791|FG009|Overall Study|Lost to Follow-up|0|||
161688063|NCT01995071|583909792|FG010|Overall Study|Lost to Follow-up|0|||
161688064|NCT01995071|583909793|FG011|Overall Study|Lost to Follow-up|0|||
161688065|NCT01995071|583909782|FG000|Overall Study|Incarcerated|0|||
161954014|NCT03654274|584879850|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
161688066|NCT01995071|583909783|FG001|Overall Study|Incarcerated|0|||
161688067|NCT01995071|583909784|FG002|Overall Study|Incarcerated|0|||
161688068|NCT01995071|583909785|FG003|Overall Study|Incarcerated|0|||
161954015|NCT03654274|584879851|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
162029569|NCT04575597|585165467|FG000|Overall Study|Not Recorded|0|||
161688069|NCT01995071|583909786|FG004|Overall Study|Incarcerated|0|||
161688070|NCT01995071|583909787|FG005|Overall Study|Incarcerated|0|||
161688071|NCT01995071|583909788|FG006|Overall Study|Incarcerated|0|||
161688072|NCT01995071|583909789|FG007|Overall Study|Incarcerated|1|||
161688073|NCT01995071|583909790|FG008|Overall Study|Incarcerated|0|||
161954016|NCT03654274|584879852|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
161954017|NCT01265992|584879855|FG000|Overall Study|Lost to Follow-up|1|||
161954018|NCT01265992|584879855|FG000|Overall Study|Withdrawal by Subject|1|||
161954019|NCT01265992|584879855|FG000|Overall Study|Adverse Event|1|||
161954020|NCT01265992|584879855|FG000|Overall Study|Administrative reasons|2|||
161954021|NCT01265992|584879855|FG000|Overall Study|Stopped treatment|3|||
161954022|NCT01265992|584879855|FG000|Overall Study|Did not receive treatment|1|||
161954023|NCT01102491|584879856|FG000|Overall Study|Protocol Violation|11|||
161954024|NCT01102491|584879857|FG001|Overall Study|Protocol Violation|12|||
161954025|NCT03265145|584879858|FG000|Overall Study|Protocol Violation|2|||
161954026|NCT03265145|584879859|FG001|Overall Study|Protocol Violation|0|||
161954027|NCT03265145|584879858|FG000|Overall Study|Adverse Event|1|||
161954028|NCT03265145|584879859|FG001|Overall Study|Adverse Event|0|||
161954029|NCT03265145|584879858|FG000|Overall Study|Withdrawal by Subject|23|||
161954030|NCT03265145|584879859|FG001|Overall Study|Withdrawal by Subject|19|||
161954031|NCT03265145|584879858|FG000|Overall Study|Death|12|||
161954032|NCT03265145|584879859|FG001|Overall Study|Death|12|||
161954033|NCT03265145|584879858|FG000|Overall Study|Lost to Follow-up|13|||
161954034|NCT03265145|584879859|FG001|Overall Study|Lost to Follow-up|9|||
161954035|NCT03265145|584879858|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
161954036|NCT03265145|584879859|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
161954037|NCT03265145|584879858|FG000|Overall Study|Switched back to previous medication|1|||
161954038|NCT03265145|584879859|FG001|Overall Study|Switched back to previous medication|0|||
161954039|NCT03265145|584879858|FG000|Overall Study|Did not want to take medication|1|||
161954040|NCT03265145|584879859|FG001|Overall Study|Did not want to take medication|0|||
161954041|NCT03265145|584879858|FG000|Overall Study|Subject could not afford medication|0|||
161954042|NCT03265145|584879859|FG001|Overall Study|Subject could not afford medication|1|||
161954043|NCT03265145|584879858|FG000|Overall Study|Site closed|2|||
161954044|NCT03265145|584879859|FG001|Overall Study|Site closed|3|||
161954045|NCT03265145|584879858|FG000|Overall Study|Incorrectly randomized|16|||
161954046|NCT03265145|584879859|FG001|Overall Study|Incorrectly randomized|6|||
161954047|NCT03265145|584879858|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
161954048|NCT03265145|584879859|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
161954049|NCT03265145|584879858|FG000|Overall Study|Physician Decision|0|||
161954050|NCT03265145|584879859|FG001|Overall Study|Physician Decision|3|||
161954051|NCT03265145|584879858|FG000|Overall Study|Subject transferred to another facility|0|||
161954052|NCT03265145|584879859|FG001|Overall Study|Subject transferred to another facility|1|||
161954053|NCT02137070|584879860|FG000|Overall Study|Adverse Event|12|||
161954054|NCT02137070|584879861|FG001|Overall Study|Adverse Event|3|||
161954055|NCT02137070|584879860|FG000|Overall Study|Death|2|||
161954056|NCT02137070|584879861|FG001|Overall Study|Death|0|||
161954057|NCT02137070|584879860|FG000|Overall Study|Lost to Follow-up|24|||
161954058|NCT02137070|584879861|FG001|Overall Study|Lost to Follow-up|9|||
161954059|NCT02137070|584879860|FG000|Overall Study|Physician Decision|0|||
161954060|NCT02137070|584879861|FG001|Overall Study|Physician Decision|1|||
161954061|NCT02137070|584879860|FG000|Overall Study|Protocol Violation|18|||
161954062|NCT02137070|584879861|FG001|Overall Study|Protocol Violation|4|||
161954063|NCT02137070|584879860|FG000|Overall Study|Withdrawal by Subject|18|||
161688074|NCT01995071|583909791|FG009|Overall Study|Incarcerated|0|||
161954064|NCT02137070|584879861|FG001|Overall Study|Withdrawal by Subject|1|||
161954065|NCT05223673|584879862|FG000|Overall Study|Protocol Violation|1|||
161954066|NCT05223673|584879862|FG000|Overall Study|Study termination|6|||
161954067|NCT03941483|584879863|FG000|Overall Study|Miscellaneous|2|||
161954068|NCT03941483|584879864|FG001|Overall Study|Miscellaneous|3|||
161954069|NCT03941483|584879865|FG002|Overall Study|Miscellaneous|0|||
161954070|NCT03941483|584879863|FG000|Overall Study|Study Terminated by Sponsor|1|||
161954071|NCT03941483|584879864|FG001|Overall Study|Study Terminated by Sponsor|0|||
161688075|NCT01995071|583909792|FG010|Overall Study|Incarcerated|0|||
161688076|NCT01995071|583909793|FG011|Overall Study|Incarcerated|0|||
161688077|NCT01659320|583909798|FG000|Overall Study|Withdrawal by Subject|2|||
161688078|NCT01659320|583909798|FG000|Overall Study|Physician Decision|1|||
161954072|NCT03941483|584879865|FG002|Overall Study|Study Terminated by Sponsor|0|||
161954073|NCT03941483|584879863|FG000|Overall Study|Withdrawal by Subject|1|||
161954074|NCT03941483|584879864|FG001|Overall Study|Withdrawal by Subject|4|||
161954075|NCT03941483|584879865|FG002|Overall Study|Withdrawal by Subject|1|||
161954076|NCT03941483|584879863|FG000|Overall Study|Lost to Follow-up|2|||
161688079|NCT00590590|583909799|FG000|Overall Study|Lack of Efficacy|1|||
161688080|NCT00590590|583909800|FG001|Overall Study|Lack of Efficacy|2|||
161688081|NCT00590590|583909801|FG002|Overall Study|Lack of Efficacy|0|||
161688082|NCT00590590|583909799|FG000|Overall Study|Adverse Event|1|||
161688083|NCT00590590|583909800|FG001|Overall Study|Adverse Event|0|||
161688084|NCT00590590|583909801|FG002|Overall Study|Adverse Event|0|||
161688085|NCT00590590|583909799|FG000|Overall Study|Protocol Violation|0|||
161688086|NCT00590590|583909800|FG001|Overall Study|Protocol Violation|0|||
161688087|NCT00590590|583909801|FG002|Overall Study|Protocol Violation|2|||
161688088|NCT00590590|583909799|FG000|Overall Study|Lost to Follow-up|4|||
161688089|NCT00590590|583909800|FG001|Overall Study|Lost to Follow-up|1|||
161688090|NCT00590590|583909801|FG002|Overall Study|Lost to Follow-up|2|||
161688091|NCT00590590|583909799|FG000|Overall Study|Withdrawal by Subject|0|||
161688092|NCT00590590|583909800|FG001|Overall Study|Withdrawal by Subject|1|||
161688093|NCT00590590|583909801|FG002|Overall Study|Withdrawal by Subject|1|||
161688094|NCT00590590|583909799|FG000|Overall Study|Did not complete due to study closure|1|||
161688095|NCT00590590|583909800|FG001|Overall Study|Did not complete due to study closure|1|||
161688096|NCT00590590|583909801|FG002|Overall Study|Did not complete due to study closure|1|||
161688097|NCT00590590|583909799|FG000|Overall Study|Did not complete study|0|||
161688098|NCT00590590|583909800|FG001|Overall Study|Did not complete study|1|||
161688099|NCT00590590|583909801|FG002|Overall Study|Did not complete study|0|||
161688100|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
161688101|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
161688102|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
161688103|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
161688104|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
161688105|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
161688106|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
161688107|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
161688108|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
161688109|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
161688110|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
161688111|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
161688112|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
161688113|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
161688114|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
161688115|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
161688116|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
161688117|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
161688118|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
161688119|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
161688120|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
161688121|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
161688122|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
161688123|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
161688124|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
161954077|NCT03941483|584879864|FG001|Overall Study|Lost to Follow-up|1|||
161954078|NCT03941483|584879865|FG002|Overall Study|Lost to Follow-up|8|||
161954079|NCT03941483|584879863|FG000|Overall Study|Death|3|||
161954080|NCT03941483|584879864|FG001|Overall Study|Death|2|||
161954081|NCT03941483|584879865|FG002|Overall Study|Death|6|||
162029570|NCT04575597|585165468|FG001|Overall Study|Not Recorded|0|||
161688125|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
161688126|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
161688127|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
161688128|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
161688129|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
161688130|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
161688131|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
161688132|NCT03605680|583909803|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
161688133|NCT03605680|583909804|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
161688134|NCT03605680|583909805|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
161688135|NCT03605680|583909806|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
161688136|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
161954082|NCT02685826|584879870|FG000|Overall Study|Adverse Event|2|||
161954083|NCT02685826|584879871|FG001|Overall Study|Adverse Event|0|||
161954084|NCT02685826|584879872|FG002|Overall Study|Adverse Event|1|||
161954085|NCT02685826|584879870|FG000|Overall Study|Progressive Disease|2|||
161954086|NCT02685826|584879871|FG001|Overall Study|Progressive Disease|1|||
161954087|NCT02685826|584879872|FG002|Overall Study|Progressive Disease|0|||
161954088|NCT02685826|584879870|FG000|Overall Study|Withdrawal by Subject|2|||
161954089|NCT02685826|584879871|FG001|Overall Study|Withdrawal by Subject|0|||
161954090|NCT02685826|584879872|FG002|Overall Study|Withdrawal by Subject|0|||
161954091|NCT02685826|584879870|FG000|Overall Study|Full Clinical Hold by FDA|19|||
161954092|NCT02685826|584879871|FG001|Overall Study|Full Clinical Hold by FDA|9|||
161954093|NCT02685826|584879872|FG002|Overall Study|Full Clinical Hold by FDA|20|||
161954094|NCT03154476|584879873|FG000|Overall Study|Lost to Follow-up|4|||
161954095|NCT03154476|584879874|FG001|Overall Study|Lost to Follow-up|4|||
161954096|NCT01444430|584879876|FG000|Overall Study|Withdrawal by Subject|53|||
161954097|NCT01444430|584879877|FG001|Overall Study|Withdrawal by Subject|72|||
161954098|NCT01444430|584879876|FG000|Overall Study|Death|6|||
161954099|NCT01444430|584879877|FG001|Overall Study|Death|8|||
161954100|NCT01444430|584879876|FG000|Overall Study|Lost to Follow-up|2|||
161954101|NCT01444430|584879877|FG001|Overall Study|Lost to Follow-up|0|||
161954102|NCT01444430|584879876|FG000|Overall Study|CRF termination module not completed.|0|||
161954103|NCT01444430|584879877|FG001|Overall Study|CRF termination module not completed.|1|||
161954104|NCT03640325|584881338|FG000|Overall Study|Withdrawal by Subject|4|||
161954105|NCT03640325|584881339|FG001|Overall Study|Withdrawal by Subject|1|||
161954106|NCT03640325|584881340|FG002|Overall Study|Withdrawal by Subject|0|||
161954107|NCT03640325|584881338|FG000|Overall Study|Lost to Follow-up|4|||
161954108|NCT03640325|584881339|FG001|Overall Study|Lost to Follow-up|5|||
161954109|NCT03640325|584881340|FG002|Overall Study|Lost to Follow-up|21|||
161954110|NCT03640325|584881338|FG000|Overall Study|Death|5|||
161954111|NCT03640325|584881339|FG001|Overall Study|Death|5|||
161954112|NCT03640325|584881340|FG002|Overall Study|Death|0|||
161954113|NCT01566149|584881343|FG000|Overall Study|Adverse Event|0|||
161954114|NCT01566149|584881344|FG001|Overall Study|Adverse Event|1|||
161954115|NCT01566149|584881343|FG000|Overall Study|Non-compliance with study medication|2|||
161954116|NCT01566149|584881344|FG001|Overall Study|Non-compliance with study medication|0|||
161954117|NCT01566149|584881343|FG000|Overall Study|Protocol Violation|0|||
161954118|NCT01566149|584881344|FG001|Overall Study|Protocol Violation|1|||
161954119|NCT01566149|584881343|FG000|Overall Study|Withdrawal by Subject|1|||
161954120|NCT01566149|584881344|FG001|Overall Study|Withdrawal by Subject|0|||
161954121|NCT03687957|584881349|FG000|Overall Study|Withdrawal by Subject|0|||
161954122|NCT03687957|584881350|FG001|Overall Study|Withdrawal by Subject|0|||
161954123|NCT03687957|584881351|FG002|Overall Study|Withdrawal by Subject|0|||
161954124|NCT03687957|584881352|FG003|Overall Study|Withdrawal by Subject|2|||
161954125|NCT03687957|584881353|FG004|Overall Study|Withdrawal by Subject|0|||
161954126|NCT03687957|584881354|FG005|Overall Study|Withdrawal by Subject|0|||
161954127|NCT03687957|584881355|FG006|Overall Study|Withdrawal by Subject|3|||
161954128|NCT03687957|584881356|FG007|Overall Study|Withdrawal by Subject|1|||
161954129|NCT03687957|584881357|FG008|Overall Study|Withdrawal by Subject|1|||
161954130|NCT03687957|584881358|FG009|Overall Study|Withdrawal by Subject|0|||
161954131|NCT03687957|584881349|FG000|Overall Study|Disease progression|0|||
161954132|NCT03687957|584881350|FG001|Overall Study|Disease progression|1|||
161954133|NCT03687957|584881351|FG002|Overall Study|Disease progression|1|||
161954134|NCT03687957|584881352|FG003|Overall Study|Disease progression|2|||
161954135|NCT03687957|584881353|FG004|Overall Study|Disease progression|2|||
161954136|NCT03687957|584881354|FG005|Overall Study|Disease progression|0|||
161954137|NCT03687957|584881355|FG006|Overall Study|Disease progression|2|||
161954138|NCT03687957|584881356|FG007|Overall Study|Disease progression|1|||
161954139|NCT03687957|584881357|FG008|Overall Study|Disease progression|0|||
161954140|NCT03687957|584881358|FG009|Overall Study|Disease progression|0|||
161954141|NCT03687957|584881349|FG000|Overall Study|Physician Decision|0|||
161954142|NCT03687957|584881350|FG001|Overall Study|Physician Decision|0|||
161954143|NCT03687957|584881351|FG002|Overall Study|Physician Decision|0|||
161954144|NCT03687957|584881352|FG003|Overall Study|Physician Decision|2|||
162029571|NCT04575597|585165469|FG002|Overall Study|Not Recorded|0|||
161954145|NCT03687957|584881353|FG004|Overall Study|Physician Decision|1|||
161954146|NCT03687957|584881354|FG005|Overall Study|Physician Decision|0|||
161954147|NCT03687957|584881355|FG006|Overall Study|Physician Decision|1|||
161954148|NCT03687957|584881356|FG007|Overall Study|Physician Decision|0|||
161954149|NCT03687957|584881357|FG008|Overall Study|Physician Decision|0|||
161954150|NCT03687957|584881358|FG009|Overall Study|Physician Decision|0|||
161954151|NCT03687957|584881349|FG000|Overall Study|New malignancy|0|||
161954152|NCT03687957|584881350|FG001|Overall Study|New malignancy|0|||
161954153|NCT03687957|584881351|FG002|Overall Study|New malignancy|0|||
161954154|NCT03687957|584881352|FG003|Overall Study|New malignancy|0|||
161954155|NCT03687957|584881353|FG004|Overall Study|New malignancy|1|||
161954156|NCT03687957|584881354|FG005|Overall Study|New malignancy|0|||
161954157|NCT03687957|584881355|FG006|Overall Study|New malignancy|0|||
161835768|NCT00866658|584440792|FG000|Overall Study|Familial and Personal Reasons|4|||
161954158|NCT03687957|584881356|FG007|Overall Study|New malignancy|0|||
161954159|NCT03687957|584881357|FG008|Overall Study|New malignancy|0|||
161954160|NCT03687957|584881358|FG009|Overall Study|New malignancy|0|||
161954161|NCT03687957|584881349|FG000|Overall Study|Adverse Event|0|||
161954162|NCT03687957|584881350|FG001|Overall Study|Adverse Event|0|||
161954163|NCT03687957|584881351|FG002|Overall Study|Adverse Event|0|||
161954164|NCT03687957|584881352|FG003|Overall Study|Adverse Event|0|||
161954165|NCT03687957|584881353|FG004|Overall Study|Adverse Event|0|||
161954166|NCT03687957|584881354|FG005|Overall Study|Adverse Event|2|||
161954167|NCT03687957|584881355|FG006|Overall Study|Adverse Event|0|||
161954168|NCT03687957|584881356|FG007|Overall Study|Adverse Event|3|||
161954169|NCT03687957|584881357|FG008|Overall Study|Adverse Event|0|||
161954170|NCT03687957|584881358|FG009|Overall Study|Adverse Event|0|||
161954171|NCT03687957|584881349|FG000|Overall Study|Patient went on hospice|0|||
161954172|NCT03687957|584881350|FG001|Overall Study|Patient went on hospice|0|||
161954173|NCT03687957|584881351|FG002|Overall Study|Patient went on hospice|0|||
161954174|NCT03687957|584881352|FG003|Overall Study|Patient went on hospice|0|||
161954175|NCT03687957|584881353|FG004|Overall Study|Patient went on hospice|0|||
161954176|NCT03687957|584881354|FG005|Overall Study|Patient went on hospice|0|||
161954177|NCT03687957|584881355|FG006|Overall Study|Patient went on hospice|1|||
161954178|NCT03687957|584881356|FG007|Overall Study|Patient went on hospice|0|||
161954179|NCT03687957|584881357|FG008|Overall Study|Patient went on hospice|0|||
161954180|NCT03687957|584881358|FG009|Overall Study|Patient went on hospice|0|||
161954181|NCT03687957|584881349|FG000|Overall Study|Death|0|||
161954182|NCT03687957|584881350|FG001|Overall Study|Death|0|||
161954183|NCT03687957|584881351|FG002|Overall Study|Death|0|||
161835769|NCT00866658|584440793|FG001|Overall Study|Familial and Personal Reasons|5|||
161835770|NCT00430495|584440795|FG000|Overall Study|Adverse Event|2|||
161954184|NCT03687957|584881352|FG003|Overall Study|Death|0|||
162029572|NCT04575597|585165470|FG003|Overall Study|Not Recorded|0|||
161954185|NCT03687957|584881353|FG004|Overall Study|Death|0|||
161954186|NCT03687957|584881354|FG005|Overall Study|Death|0|||
161954187|NCT03687957|584881355|FG006|Overall Study|Death|0|||
161954188|NCT03687957|584881356|FG007|Overall Study|Death|1|||
161954189|NCT03687957|584881357|FG008|Overall Study|Death|0|||
162029573|NCT04575597|585165471|FG004|Overall Study|Not Recorded|0|||
161954190|NCT03687957|584881358|FG009|Overall Study|Death|0|||
161954191|NCT03718325|584881359|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
161954192|NCT03718325|584881360|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
161835771|NCT00430495|584440796|FG001|Overall Study|Adverse Event|3|||
161835772|NCT00430495|584440797|FG002|Overall Study|Adverse Event|2|||
161835773|NCT00430495|584440798|FG003|Overall Study|Adverse Event|0|||
161835774|NCT00430495|584440795|FG000|Overall Study|Death|0|||
161835775|NCT00430495|584440796|FG001|Overall Study|Death|0|||
161835776|NCT00430495|584440797|FG002|Overall Study|Death|1|||
161835777|NCT00430495|584440798|FG003|Overall Study|Death|0|||
161835778|NCT00430495|584440795|FG000|Overall Study|Lost to Follow-up|0|||
161835779|NCT00430495|584440796|FG001|Overall Study|Lost to Follow-up|1|||
161835780|NCT00430495|584440797|FG002|Overall Study|Lost to Follow-up|4|||
161835781|NCT00430495|584440798|FG003|Overall Study|Lost to Follow-up|0|||
161835782|NCT00430495|584440795|FG000|Overall Study|Protocol Violation|1|||
161835783|NCT00430495|584440796|FG001|Overall Study|Protocol Violation|0|||
161835784|NCT00430495|584440797|FG002|Overall Study|Protocol Violation|1|||
161835785|NCT00430495|584440798|FG003|Overall Study|Protocol Violation|0|||
161835786|NCT00430495|584440795|FG000|Overall Study|Disease Progression|1|||
161835787|NCT00430495|584440796|FG001|Overall Study|Disease Progression|1|||
161835788|NCT00430495|584440797|FG002|Overall Study|Disease Progression|0|||
161835789|NCT00430495|584440798|FG003|Overall Study|Disease Progression|0|||
161835790|NCT00430495|584440795|FG000|Overall Study|Other|8|||
161835791|NCT00430495|584440796|FG001|Overall Study|Other|2|||
161835792|NCT00430495|584440797|FG002|Overall Study|Other|5|||
161835793|NCT00430495|584440798|FG003|Overall Study|Other|4|||
161835794|NCT00430495|584440795|FG000|Overall Study|Randomized but not Treated|2|||
161835795|NCT00430495|584440796|FG001|Overall Study|Randomized but not Treated|0|||
161835796|NCT00430495|584440797|FG002|Overall Study|Randomized but not Treated|0|||
161835797|NCT00430495|584440798|FG003|Overall Study|Randomized but not Treated|0|||
161835798|NCT00158756|584440799|FG000|Overall Study|Withdrawal by Subject|5|||
161835799|NCT00158756|584440800|FG001|Overall Study|Withdrawal by Subject|0|||
161835800|NCT00158756|584440801|FG002|Overall Study|Withdrawal by Subject|6|||
161835801|NCT00158756|584440802|FG003|Overall Study|Withdrawal by Subject|1|||
161835802|NCT00158756|584440803|FG004|Overall Study|Withdrawal by Subject|3|||
161835803|NCT00158756|584440799|FG000|Overall Study|Adverse Event|0|||
161954193|NCT03718325|584881361|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
161954194|NCT03718325|584881359|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
161954195|NCT03718325|584881360|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
161954196|NCT03718325|584881361|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
161954197|NCT01147965|584881367|FG000|Overall Study|Progressive Disease|3|||
161954198|NCT01147965|584881368|FG001|Overall Study|Progressive Disease|3|||
161954199|NCT01147965|584881369|FG002|Overall Study|Progressive Disease|5|||
161954200|NCT01147965|584881370|FG003|Overall Study|Progressive Disease|9|||
161954201|NCT01147965|584881371|FG004|Overall Study|Progressive Disease|5|||
161954202|NCT01147965|584881372|FG005|Overall Study|Progressive Disease|5|||
161954203|NCT01147965|584881367|FG000|Overall Study|Death|0|||
161954204|NCT01147965|584881368|FG001|Overall Study|Death|0|||
161954205|NCT01147965|584881369|FG002|Overall Study|Death|1|||
161954206|NCT01147965|584881370|FG003|Overall Study|Death|1|||
161954207|NCT01147965|584881371|FG004|Overall Study|Death|0|||
161954208|NCT01147965|584881372|FG005|Overall Study|Death|2|||
161954209|NCT01147965|584881367|FG000|Overall Study|Withdrawal by Subject|0|||
161954210|NCT01147965|584881368|FG001|Overall Study|Withdrawal by Subject|0|||
161954211|NCT01147965|584881369|FG002|Overall Study|Withdrawal by Subject|1|||
161954212|NCT01147965|584881370|FG003|Overall Study|Withdrawal by Subject|1|||
161954213|NCT01147965|584881371|FG004|Overall Study|Withdrawal by Subject|0|||
161954214|NCT01147965|584881372|FG005|Overall Study|Withdrawal by Subject|0|||
161954215|NCT01147965|584881367|FG000|Overall Study|Administration Of Alternative Therapy|0|||
161954216|NCT01147965|584881368|FG001|Overall Study|Administration Of Alternative Therapy|0|||
161954217|NCT01147965|584881369|FG002|Overall Study|Administration Of Alternative Therapy|0|||
161954218|NCT01147965|584881370|FG003|Overall Study|Administration Of Alternative Therapy|0|||
161954219|NCT01147965|584881371|FG004|Overall Study|Administration Of Alternative Therapy|0|||
161954220|NCT01147965|584881372|FG005|Overall Study|Administration Of Alternative Therapy|1|||
161954221|NCT01147965|584881367|FG000|Overall Study|Other|0|||
161954222|NCT01147965|584881368|FG001|Overall Study|Other|0|||
161954223|NCT01147965|584881369|FG002|Overall Study|Other|0|||
161954224|NCT01147965|584881370|FG003|Overall Study|Other|3|||
161954225|NCT01147965|584881371|FG004|Overall Study|Other|1|||
161954226|NCT01147965|584881372|FG005|Overall Study|Other|0|||
161954227|NCT00620373|584881373|FG000|Overall Study|Unverified cancer status|33|||
161954228|NCT01465386|584881378|FG000|Overall Study|Lack of Efficacy|3|||
161954229|NCT01465386|584881378|FG000|Overall Study|Adverse Event|1|||
161954230|NCT01279044|584881379|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
161954231|NCT01279044|584881380|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
161954232|NCT01279044|584881381|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
161954233|NCT01279044|584881379|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
161954234|NCT01279044|584881380|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
161954235|NCT01279044|584881381|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
161954236|NCT01279044|584881379|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
161954237|NCT01279044|584881380|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
161954238|NCT01279044|584881381|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
161954239|NCT01408277|584881384|FG000|Overall Study|Adverse Event|3|||
161954240|NCT01408277|584881385|FG001|Overall Study|Adverse Event|4|||
161954241|NCT01408277|584881384|FG000|Overall Study|Lost to Follow-up|1|||
161954242|NCT01408277|584881385|FG001|Overall Study|Lost to Follow-up|0|||
161954243|NCT01408277|584881384|FG000|Overall Study|Withdrawal by Subject|2|||
161954244|NCT01408277|584881385|FG001|Overall Study|Withdrawal by Subject|0|||
161954245|NCT01408277|584881384|FG000|Overall Study|Protocol Violation|2|||
161954246|NCT01408277|584881385|FG001|Overall Study|Protocol Violation|0|||
161954247|NCT02630693|584881392|FG000|Overall Study|No receive treatment|0|||
161954248|NCT02630693|584881393|FG001|Overall Study|No receive treatment|1|||
161954249|NCT01057693|584881395|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
161954250|NCT01057693|584881396|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
161954251|NCT01057693|584881397|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
161954252|NCT01057693|584881395|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
161954253|NCT01057693|584881396|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
161954254|NCT01057693|584881397|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
161954255|NCT01057693|584881395|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
161954256|NCT01057693|584881396|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
161954257|NCT01057693|584881397|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
161954258|NCT01057693|584881395|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
161954259|NCT01057693|584881396|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
161954260|NCT01057693|584881397|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
161954261|NCT01057693|584881395|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
161954262|NCT01057693|584881396|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
161835804|NCT00158756|584440800|FG001|Overall Study|Adverse Event|0|||
161835805|NCT00158756|584440801|FG002|Overall Study|Adverse Event|1|||
161835806|NCT00158756|584440802|FG003|Overall Study|Adverse Event|0|||
161835807|NCT00158756|584440803|FG004|Overall Study|Adverse Event|0|||
161954263|NCT01057693|584881397|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
161954264|NCT01057693|584881395|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
161954265|NCT01057693|584881396|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
161954266|NCT01057693|584881397|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
161954267|NCT01057693|584881395|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
161954268|NCT01057693|584881396|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
161954269|NCT01057693|584881397|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
161954270|NCT01057693|584881395|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
161688137|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
161688138|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
161688139|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
161688140|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
161688141|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
161688142|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
161835808|NCT00158756|584440799|FG000|Overall Study|Serious adverse event|0|||
162029574|NCT04575597|585165472|FG005|Overall Study|Not Recorded|2|||
161835809|NCT00158756|584440800|FG001|Overall Study|Serious adverse event|0|||
161688143|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
161688144|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161688145|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161688146|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161688147|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
161688148|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
161688149|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
161688150|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
161688151|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
161688152|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
161688153|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
161688154|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
161688155|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
161688156|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
161688157|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
161688158|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
161954271|NCT01057693|584881396|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
161954272|NCT01057693|584881397|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
161954273|NCT01057693|584881395|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
161954274|NCT01057693|584881396|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
161954275|NCT01057693|584881397|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
161954276|NCT01057693|584881395|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
161954277|NCT01057693|584881396|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
161954278|NCT01057693|584881397|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
161954279|NCT01057693|584881395|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
161954280|NCT01057693|584881396|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
161954281|NCT01057693|584881397|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
161954282|NCT01057693|584881395|FG000|Between Single-Blind and Double-Blind|Other|6|||
161954283|NCT01057693|584881396|FG001|Between Single-Blind and Double-Blind|Other|0|||
161954284|NCT01057693|584881397|FG002|Between Single-Blind and Double-Blind|Other|0|||
161954285|NCT01057693|584881395|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
161954286|NCT01057693|584881396|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
161954287|NCT01057693|584881397|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
161954288|NCT01057693|584881395|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
161954289|NCT01057693|584881396|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
161954290|NCT01057693|584881397|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
161954291|NCT01057693|584881395|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
161954292|NCT01057693|584881396|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
161954293|NCT01057693|584881397|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
161954294|NCT01057693|584881395|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
161954295|NCT01057693|584881396|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
161954296|NCT01057693|584881397|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
161954297|NCT01057693|584881395|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
161954298|NCT01057693|584881396|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
161954299|NCT01057693|584881397|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
161954300|NCT01057693|584881395|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
161954301|NCT01057693|584881396|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
161688159|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
161954302|NCT01057693|584881397|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
161954303|NCT01057693|584881395|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
161954304|NCT01057693|584881396|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
161954305|NCT01057693|584881397|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
161954306|NCT02959463|584881398|FG000|Overall Study|Adverse Event|1|||
161954307|NCT02959463|584881399|FG001|Overall Study|Adverse Event|1|||
161954308|NCT02959463|584881398|FG000|Overall Study|Death|1|||
161954309|NCT02959463|584881399|FG001|Overall Study|Death|0|||
161954310|NCT02959463|584881398|FG000|Overall Study|Withdrawal by Subject|1|||
161954311|NCT02959463|584881399|FG001|Overall Study|Withdrawal by Subject|0|||
161954312|NCT02413996|584881400|FG000|Overall Study|not comfortable with the intervention|9|||
161954313|NCT02413996|584881401|FG001|Overall Study|not comfortable with the intervention|2|||
161954314|NCT03951766|584881404|FG000|Treatment Phase|Lost to Follow-up|1|||
161954315|NCT03951766|584881404|FG000|Follow-up Phase|Lost to Follow-up|10|||
161954316|NCT00041470|584881405|FG000|Overall Study|Loss of Funding|38|||
161954317|NCT02379052|584881422|FG000|Overall Study|Protocol Violation|0|||
161954318|NCT02379052|584881423|FG001|Overall Study|Protocol Violation|1|||
161954319|NCT02379052|584881422|FG000|Overall Study|Adverse Event|0|||
161688160|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
161688161|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
161688162|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
161688163|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
161688164|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
161954320|NCT02379052|584881423|FG001|Overall Study|Adverse Event|1|||
161954321|NCT02379052|584881422|FG000|Overall Study|Physician Decision|1|||
161954322|NCT02379052|584881423|FG001|Overall Study|Physician Decision|1|||
161954323|NCT02379052|584881422|FG000|Overall Study|Withdrawal by Subject|2|||
161954324|NCT02379052|584881423|FG001|Overall Study|Withdrawal by Subject|0|||
161954325|NCT02379052|584881422|FG000|Overall Study|Lost to Follow-up|2|||
161954326|NCT02379052|584881423|FG001|Overall Study|Lost to Follow-up|1|||
161954327|NCT02379052|584881422|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
161954328|NCT02379052|584881423|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
161954329|NCT02379052|584881422|FG000|Overall Study|Subject was Incarcerated|0|||
161954330|NCT02379052|584881423|FG001|Overall Study|Subject was Incarcerated|1|||
161954331|NCT00127855|584881425|FG000|Primary Vaccination Course|Adverse Event|0|||
161954332|NCT00127855|584881426|FG001|Primary Vaccination Course|Adverse Event|0|||
161954333|NCT00127855|584881427|FG002|Primary Vaccination Course|Adverse Event|1|||
161954334|NCT00127855|584881428|FG003|Primary Vaccination Course|Adverse Event|0|||
161954335|NCT00127855|584881429|FG004|Primary Vaccination Course|Adverse Event|0|||
161954336|NCT00127855|584881425|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
161954337|NCT00127855|584881426|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
161954338|NCT00127855|584881427|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
161954339|NCT00127855|584881428|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
161954340|NCT00127855|584881429|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
161954341|NCT00127855|584881425|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
161954342|NCT00127855|584881426|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
161954343|NCT00127855|584881427|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
161954344|NCT00127855|584881428|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
161954345|NCT00127855|584881429|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
161954346|NCT00127855|584881425|FG000|Primary Vaccination Course|Other|0|||
161954347|NCT00127855|584881426|FG001|Primary Vaccination Course|Other|0|||
161954348|NCT00127855|584881427|FG002|Primary Vaccination Course|Other|0|||
161954349|NCT00127855|584881428|FG003|Primary Vaccination Course|Other|0|||
161954350|NCT00127855|584881429|FG004|Primary Vaccination Course|Other|1|||
161954351|NCT02343302|584881430|FG000|Overall Study|Physician Decision|1|||
161954352|NCT02343302|584881431|FG001|Overall Study|Physician Decision|1|||
161954353|NCT01282866|584881434|FG000|Overall Study|Adverse Event|1|||
161954354|NCT04834726|584881435|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
162029575|NCT04575597|585165467|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162029576|NCT04575597|585165468|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161688165|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
161688166|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
161688167|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
161688168|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
161688169|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
161688170|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
161688171|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
161688172|NCT03605680|583909803|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
161688173|NCT03605680|583909804|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
161688174|NCT03605680|583909805|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
161688175|NCT03605680|583909806|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
161688176|NCT03865706|583909809|FG000|Overall Study|Death|0|||
161688177|NCT03865706|583909810|FG001|Overall Study|Death|3|||
161688178|NCT03865706|583909811|FG002|Overall Study|Death|1|||
161954355|NCT04834726|584881436|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
161954356|NCT04834726|584881437|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
161954357|NCT04834726|584881438|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
161954358|NCT04834726|584881439|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
161954359|NCT04834726|584881440|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
161954360|NCT04834726|584881441|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
161688179|NCT02095535|583909812|FG000|Recruitment|Protocol Violation|2|||
161954361|NCT04834726|584881442|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
161954362|NCT04834726|584881443|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
161954363|NCT02948582|584881450|FG000|Washout Period 1|Adverse Event|0|||
161954364|NCT02948582|584881451|FG001|Washout Period 1|Adverse Event|2|||
161954365|NCT02948582|584881452|FG002|Washout Period 1|Adverse Event|0|||
161954366|NCT02948582|584881453|FG003|Washout Period 1|Adverse Event|0|||
161954367|NCT02948582|584881454|FG004|Washout Period 1|Adverse Event|0|||
161954368|NCT02948582|584881455|FG005|Washout Period 1|Adverse Event|0|||
161954369|NCT02948582|584881450|FG000|Washout Period 1|Protocol Violation|0|||
161954370|NCT02948582|584881451|FG001|Washout Period 1|Protocol Violation|0|||
161954371|NCT02948582|584881452|FG002|Washout Period 1|Protocol Violation|0|||
161954372|NCT02948582|584881453|FG003|Washout Period 1|Protocol Violation|0|||
161954373|NCT02948582|584881454|FG004|Washout Period 1|Protocol Violation|0|||
161954374|NCT02948582|584881455|FG005|Washout Period 1|Protocol Violation|1|||
161954375|NCT02948582|584881450|FG000|Washout Period 2|Adverse Event|0|||
161954376|NCT02948582|584881451|FG001|Washout Period 2|Adverse Event|1|||
161954377|NCT02948582|584881452|FG002|Washout Period 2|Adverse Event|0|||
161954378|NCT02948582|584881453|FG003|Washout Period 2|Adverse Event|0|||
161954379|NCT02948582|584881454|FG004|Washout Period 2|Adverse Event|0|||
161954380|NCT02948582|584881455|FG005|Washout Period 2|Adverse Event|0|||
161954381|NCT02948582|584881450|FG000|Washout Period 2|personal reasons|0|||
161954382|NCT02948582|584881451|FG001|Washout Period 2|personal reasons|0|||
161954383|NCT02948582|584881452|FG002|Washout Period 2|personal reasons|0|||
161954384|NCT02948582|584881453|FG003|Washout Period 2|personal reasons|1|||
161954385|NCT02948582|584881454|FG004|Washout Period 2|personal reasons|0|||
161954386|NCT02948582|584881455|FG005|Washout Period 2|personal reasons|0|||
161954387|NCT02948582|584881450|FG000|Washout Period 4|Adverse Event|1|||
161954388|NCT02948582|584881451|FG001|Washout Period 4|Adverse Event|0|||
161954389|NCT02948582|584881452|FG002|Washout Period 4|Adverse Event|1|||
161954390|NCT02948582|584881453|FG003|Washout Period 4|Adverse Event|0|||
161954391|NCT02948582|584881454|FG004|Washout Period 4|Adverse Event|0|||
161954392|NCT02948582|584881455|FG005|Washout Period 4|Adverse Event|0|||
161954393|NCT03810014|584881461|FG000|Overall Study|Pregnancy|2|||
161954394|NCT03810014|584881462|FG001|Overall Study|Pregnancy|2|||
161954395|NCT03810014|584881463|FG002|Overall Study|Pregnancy|0|||
161954396|NCT03810014|584881464|FG003|Overall Study|Pregnancy|2|||
161954397|NCT03606486|584881465|FG000|Overall Study|Unable to collect sample|5|||
161954398|NCT00442416|584881473|FG000|Overall Study|Adverse Event|4|||
161954399|NCT00442416|584881474|FG001|Overall Study|Adverse Event|1|||
161954400|NCT00442416|584881473|FG000|Overall Study|Death|1|||
161954401|NCT00442416|584881474|FG001|Overall Study|Death|0|||
161954402|NCT00442416|584881473|FG000|Overall Study|Lack of Efficacy|2|||
161954403|NCT00442416|584881474|FG001|Overall Study|Lack of Efficacy|0|||
161954404|NCT00442416|584881473|FG000|Overall Study|Protocol Violation|2|||
161954405|NCT00442416|584881474|FG001|Overall Study|Protocol Violation|3|||
161954406|NCT00442416|584881473|FG000|Overall Study|Withdrew consent|1|||
161954407|NCT00442416|584881474|FG001|Overall Study|Withdrew consent|2|||
161954408|NCT00442416|584881473|FG000|Overall Study|Administrative/Other|27|||
161954409|NCT00442416|584881474|FG001|Overall Study|Administrative/Other|33|||
161954410|NCT03328832|584881479|FG000|Overall Study|Lost to Follow-up|0|||
161954411|NCT03328832|584881480|FG001|Overall Study|Lost to Follow-up|1|||
161954412|NCT00886769|584881481|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
161954413|NCT00886769|584881482|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
161954414|NCT03517436|584881484|FG000|Overall Study|Death|3|||
161954415|NCT03517436|584881484|FG000|Overall Study|Withdrawal by Subject|4|||
161954416|NCT03517436|584881484|FG000|Overall Study|Did not receive study valve.|1|||
161954417|NCT04271540|584881485|FG000|Overall Study|Lost to Follow-up|1|||
161954418|NCT04271540|584881485|FG000|Overall Study|Screen Fail|5|||
161954419|NCT04587869|584881488|FG000|Overall Study|Death|1|||
161954420|NCT04587869|584881489|FG001|Overall Study|Death|0|||
161954421|NCT04587869|584881488|FG000|Overall Study|Lost to Follow-up|27|||
161954422|NCT04587869|584881489|FG001|Overall Study|Lost to Follow-up|34|||
161954423|NCT04587869|584881488|FG000|Overall Study|Grant Termination|13|||
161954424|NCT04587869|584881489|FG001|Overall Study|Grant Termination|25|||
161954425|NCT04587869|584881488|FG000|Overall Study|too busy|2|||
161954426|NCT04587869|584881489|FG001|Overall Study|too busy|0|||
161954427|NCT04587869|584881488|FG000|Overall Study|Withdrawal by Subject|2|||
161954428|NCT04587869|584881489|FG001|Overall Study|Withdrawal by Subject|2|||
161835810|NCT00158756|584440801|FG002|Overall Study|Serious adverse event|1|||
161835811|NCT00158756|584440802|FG003|Overall Study|Serious adverse event|0|||
161835812|NCT00158756|584440803|FG004|Overall Study|Serious adverse event|0|||
161835813|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
161835814|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
161835815|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
161835816|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
161835817|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
161835818|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
161835819|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
161835820|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
161835821|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
161835822|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
161835823|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
161835824|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
161688180|NCT02646982|583909813|FG000|Overall Study|Adverse Event|1|||
161688181|NCT02646982|583909814|FG001|Overall Study|Adverse Event|1|||
161688182|NCT02646982|583909813|FG000|Overall Study|Withdrawal by Subject|2|||
161688183|NCT02646982|583909814|FG001|Overall Study|Withdrawal by Subject|1|||
161688184|NCT01877187|583909815|FG000|Overall Study|Death|2|||
161688185|NCT01877187|583909815|FG000|Overall Study|Withdrawal by Subject|4|||
161688186|NCT01877187|583909815|FG000|Overall Study|Lost to Follow-up|3|||
161688187|NCT01877187|583909815|FG000|Overall Study|Declining clinical status|11|||
161688188|NCT01877187|583909815|FG000|Overall Study|Liver transplant|2|||
161688189|NCT04677712|583909817|FG000|Overall Study|Lost to Follow-up|0|||
161688190|NCT04677712|583909818|FG001|Overall Study|Lost to Follow-up|1|||
161688191|NCT04677712|583909819|FG002|Overall Study|Lost to Follow-up|0|||
161688192|NCT04677712|583909820|FG003|Overall Study|Lost to Follow-up|0|||
161688193|NCT04677712|583909821|FG004|Overall Study|Lost to Follow-up|0|||
161688194|NCT04677712|583909822|FG005|Overall Study|Lost to Follow-up|0|||
161688195|NCT02915523|583909826|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
161688196|NCT02915523|583909827|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
161688197|NCT02915523|583909828|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
161688198|NCT02915523|583909829|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
161688199|NCT02915523|583909826|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
161688200|NCT02915523|583909827|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
161688201|NCT02915523|583909828|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
161688202|NCT02915523|583909829|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
161688203|NCT02915523|583909826|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
161688204|NCT02915523|583909827|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
161688205|NCT02915523|583909828|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
161688206|NCT02915523|583909829|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
161688207|NCT02915523|583909826|FG000|Expansion Phase (Phase 2)|Death|0|||
161688208|NCT02915523|583909827|FG001|Expansion Phase (Phase 2)|Death|0|||
161688209|NCT02915523|583909828|FG002|Expansion Phase (Phase 2)|Death|26|||
161688210|NCT02915523|583909829|FG003|Expansion Phase (Phase 2)|Death|53|||
161688211|NCT02915523|583909826|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
161835825|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
161835826|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
161835827|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
161835828|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
161835829|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
161688212|NCT02915523|583909827|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
161688213|NCT02915523|583909828|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
161835830|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
161688214|NCT02915523|583909829|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
161688215|NCT02915523|583909826|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
161688216|NCT02915523|583909827|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
161688217|NCT02915523|583909828|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
161688218|NCT02915523|583909829|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
161688219|NCT02915523|583909826|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
161688220|NCT02915523|583909827|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
161688221|NCT02915523|583909828|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
161688222|NCT02915523|583909829|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
161688223|NCT00708500|583909832|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
161954429|NCT04587869|584881488|FG000|Overall Study|Other|1|||
161954430|NCT04587869|584881489|FG001|Overall Study|Other|0|||
161688224|NCT00708500|583909833|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
161688225|NCT00708500|583909834|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
161688226|NCT00708500|583909832|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
161688227|NCT00708500|583909833|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
161688228|NCT00708500|583909834|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
161688229|NCT00708500|583909832|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
161688230|NCT00708500|583909833|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
161688231|NCT00708500|583909834|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
161688232|NCT00708500|583909832|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
161688233|NCT00708500|583909833|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
161688234|NCT00708500|583909834|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
161688235|NCT00708500|583909832|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
161688236|NCT00708500|583909833|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
161688237|NCT00708500|583909834|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
161688238|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
161688239|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
161688240|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
161688241|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
161688242|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
161688243|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
161954431|NCT00943761|584881490|FG000|Overall Study|Lost to Follow-up|2|||
161954432|NCT00943761|584881491|FG001|Overall Study|Lost to Follow-up|0|||
161954433|NCT00943761|584881490|FG000|Overall Study|Withdrawal by Subject|2|||
161688244|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
161688245|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
161688246|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
161688247|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
161688248|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
161688249|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
161688250|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
161688251|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
161688252|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
161688253|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
161954434|NCT00943761|584881491|FG001|Overall Study|Withdrawal by Subject|1|||
161954435|NCT03382912|584881492|FG000|Overall Study|Physician Decision|0|||
161954436|NCT03382912|584881493|FG001|Overall Study|Physician Decision|1|||
161954437|NCT03382912|584881492|FG000|Overall Study|Sponsor Decision|6|||
161954438|NCT03382912|584881493|FG001|Overall Study|Sponsor Decision|6|||
161954439|NCT03382912|584881492|FG000|Overall Study|Withdrawal by Subject|0|||
161954440|NCT03382912|584881493|FG001|Overall Study|Withdrawal by Subject|5|||
161954441|NCT01402869|584881494|FG000|Overall Study|Required Tooth Extraction|0|||
161954442|NCT01402869|584881495|FG001|Overall Study|Required Tooth Extraction|0|||
161954443|NCT01402869|584881496|FG002|Overall Study|Required Tooth Extraction|1|||
161954444|NCT00707993|584881497|FG000|Overall Study|Adverse Event|16|||
161954445|NCT00707993|584881498|FG001|Overall Study|Adverse Event|20|||
161688254|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
161688255|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
161688256|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
161688257|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
161688258|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
161688259|NCT00708500|583909832|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
161688260|NCT00708500|583909833|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
161688261|NCT00708500|583909834|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
161688262|NCT00708500|583909832|FG000|FOLLOWUP|Adverse Event|0|||
161688263|NCT00708500|583909833|FG001|FOLLOWUP|Adverse Event|1|||
161688264|NCT00708500|583909834|FG002|FOLLOWUP|Adverse Event|0|||
161688265|NCT00708500|583909832|FG000|FOLLOWUP|Lost to Follow-up|1|||
161688266|NCT00708500|583909833|FG001|FOLLOWUP|Lost to Follow-up|6|||
161688267|NCT00708500|583909834|FG002|FOLLOWUP|Lost to Follow-up|4|||
161688268|NCT00708500|583909832|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
161688269|NCT00708500|583909833|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
161688270|NCT00708500|583909834|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
161954446|NCT00707993|584881497|FG000|Overall Study|Protocol Violation|4|||
161954447|NCT00707993|584881498|FG001|Overall Study|Protocol Violation|7|||
161954448|NCT00707993|584881497|FG000|Overall Study|Lost to Follow-up|0|||
161954449|NCT00707993|584881498|FG001|Overall Study|Lost to Follow-up|4|||
161954450|NCT00707993|584881497|FG000|Overall Study|Withdrawal by Subject|12|||
161954451|NCT00707993|584881498|FG001|Overall Study|Withdrawal by Subject|16|||
161954452|NCT00707993|584881497|FG000|Overall Study|Hyperglycemic Rescue|55|||
161954453|NCT00707993|584881498|FG001|Overall Study|Hyperglycemic Rescue|47|||
161954454|NCT00707993|584881497|FG000|Overall Study|Other|2|||
161954455|NCT00707993|584881498|FG001|Overall Study|Other|0|||
161954456|NCT00436436|584881501|FG000|Overall Study|Progression|4|||
161954457|NCT00436436|584881501|FG000|Overall Study|Adverse Event|2|||
161954458|NCT00436436|584881501|FG000|Overall Study|Death|6|||
161954459|NCT01837680|584881502|FG000|Overall Study|Lost to Follow-up|2|||
161954460|NCT01837680|584881503|FG001|Overall Study|Lost to Follow-up|2|||
161954461|NCT01837680|584881502|FG000|Overall Study|lack of insurance|0|||
161688271|NCT00708500|583909832|FG000|FOLLOWUP|Subject withdrew consent|31|||
161688272|NCT00708500|583909833|FG001|FOLLOWUP|Subject withdrew consent|4|||
161688273|NCT00708500|583909834|FG002|FOLLOWUP|Subject withdrew consent|5|||
161688274|NCT00708500|583909832|FG000|FOLLOWUP|Non-compliance with protocol|5|||
161688275|NCT00708500|583909833|FG001|FOLLOWUP|Non-compliance with protocol|0|||
161688276|NCT00708500|583909834|FG002|FOLLOWUP|Non-compliance with protocol|1|||
161835831|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
161688277|NCT00382993|583909844|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
161954462|NCT01837680|584881503|FG001|Overall Study|lack of insurance|2|||
161954463|NCT01837680|584881502|FG000|Overall Study|allergic reaction|6|||
161954464|NCT01837680|584881503|FG001|Overall Study|allergic reaction|0|||
161954465|NCT01837680|584881502|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
161954466|NCT01837680|584881503|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
161954467|NCT01142388|584883147|FG000|Overall Study|Lack of Efficacy|21|||
161954468|NCT01142388|584883148|FG001|Overall Study|Lack of Efficacy|31|||
161954469|NCT01142388|584883147|FG000|Overall Study|Adverse Event|9|||
161954470|NCT01142388|584883148|FG001|Overall Study|Adverse Event|5|||
161954471|NCT01142388|584883147|FG000|Overall Study|Death|3|||
161954472|NCT01142388|584883148|FG001|Overall Study|Death|2|||
161954473|NCT01142388|584883147|FG000|Overall Study|Withdrawal by Subject|5|||
161954474|NCT01142388|584883148|FG001|Overall Study|Withdrawal by Subject|3|||
161954475|NCT01142388|584883147|FG000|Overall Study|Alternative therapy|1|||
161954476|NCT01142388|584883148|FG001|Overall Study|Alternative therapy|0|||
161688278|NCT00382993|583909845|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
161688279|NCT00382993|583909844|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
161688280|NCT00382993|583909845|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
161688281|NCT00382993|583909844|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
161688282|NCT00382993|583909845|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
161835832|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
161835833|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
161835834|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
161835835|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
161835836|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
161835837|NCT01421342|584440804|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
161835838|NCT01421342|584440805|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
161835839|NCT01421342|584440806|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
161835840|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
161835841|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
161835842|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
161835843|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
161835844|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
161835845|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
161835846|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
161835847|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
161835848|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
161835849|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
161835850|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
161835851|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
161835852|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
161835853|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
161835854|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
161835855|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
161835856|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
161835857|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
161835858|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
161835859|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
161835860|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
161835861|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
161835862|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
161835863|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
161835864|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
161835865|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
161835866|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
161835867|NCT01421342|584440804|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
161835868|NCT01421342|584440805|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
161835869|NCT01421342|584440806|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
161835870|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
161835871|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
161835872|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
161835873|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
161835874|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
161835875|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
161835876|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
161835877|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
161835878|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
161835879|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
161835880|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
161835881|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
161835882|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
161835883|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
161835884|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
161835885|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
161835886|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
161835887|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
161835888|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
161835889|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
161954477|NCT01142388|584883147|FG000|Overall Study|Other complications|0|||
161954478|NCT01142388|584883148|FG001|Overall Study|Other complications|2|||
161954479|NCT01142388|584883147|FG000|Overall Study|Other|1|||
161954480|NCT01142388|584883148|FG001|Overall Study|Other|1|||
161954481|NCT01142388|584883147|FG000|Overall Study|Never started therapy|7|||
161954482|NCT01142388|584883148|FG001|Overall Study|Never started therapy|3|||
161954483|NCT05265728|584883154|FG000|Overall Study|Adverse Event|1|||
161954484|NCT05265728|584883154|FG000|Overall Study|Study Terminated by Sponsor|5|||
161954485|NCT05265728|584883154|FG000|Overall Study|Withdrawal by Subject|2|||
161954486|NCT03493451|584883155|FG000|Overall Study|Death|11|||
161954487|NCT03493451|584883156|FG001|Overall Study|Death|26|||
161954488|NCT03493451|584883157|FG002|Overall Study|Death|3|||
161954489|NCT03493451|584883155|FG000|Overall Study|Lost to Follow-up|1|||
161954490|NCT03493451|584883156|FG001|Overall Study|Lost to Follow-up|4|||
161954491|NCT03493451|584883157|FG002|Overall Study|Lost to Follow-up|1|||
161954492|NCT03493451|584883155|FG000|Overall Study|Withdrawal by Subject|1|||
161954493|NCT03493451|584883156|FG001|Overall Study|Withdrawal by Subject|1|||
161954494|NCT03493451|584883157|FG002|Overall Study|Withdrawal by Subject|2|||
161954495|NCT03493451|584883155|FG000|Overall Study|Progressive Disease|1|||
161954496|NCT03493451|584883156|FG001|Overall Study|Progressive Disease|0|||
161954497|NCT03493451|584883157|FG002|Overall Study|Progressive Disease|0|||
161954498|NCT03493451|584883155|FG000|Overall Study|Transferred to long term extension study|8|||
161954499|NCT03493451|584883156|FG001|Overall Study|Transferred to long term extension study|13|||
161954500|NCT03493451|584883157|FG002|Overall Study|Transferred to long term extension study|5|||
161954501|NCT00617084|584883158|FG000|Overall Study|Withdrawal by Subject|5|||
161954502|NCT00617084|584883159|FG001|Overall Study|Withdrawal by Subject|7|||
161954503|NCT00617084|584883158|FG000|Overall Study|Missed 12 Months visit|16|||
161954504|NCT00617084|584883159|FG001|Overall Study|Missed 12 Months visit|19|||
161954505|NCT01693250|584883160|FG000|Overall Study|Lost to Follow-up|2|||
161954506|NCT01693250|584883161|FG001|Overall Study|Lost to Follow-up|2|||
161954507|NCT02257242|584883162|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
161954508|NCT02257242|584883163|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161954509|NCT02257242|584883164|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161954510|NCT02257242|584883165|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161954511|NCT02257242|584883166|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161954512|NCT02257242|584883167|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161954513|NCT02257242|584883168|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161954514|NCT02257242|584883169|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161954515|NCT02257242|584883170|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
161954516|NCT00600106|584883171|FG000|Overall Study|Withdrawal by Subject|1|||
161954517|NCT00600106|584883172|FG001|Overall Study|Withdrawal by Subject|1|||
161954518|NCT02213926|584883175|FG000|Overall Study|Death|59|||
161954519|NCT02213926|584883175|FG000|Overall Study|Withdrawal by Subject|10|||
161954520|NCT02213926|584883175|FG000|Overall Study|study terminated by sponsor|51|||
161954521|NCT02213926|584883175|FG000|Overall Study|Lost to Follow-up|3|||
161954522|NCT02213926|584883175|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
161954523|NCT03783962|584883180|FG000|Overall Study|Lost to Follow-up|3|||
161954524|NCT03783962|584883181|FG001|Overall Study|Lost to Follow-up|6|||
161954525|NCT03783962|584883180|FG000|Overall Study|Protocol Violation|0|||
161954526|NCT03783962|584883181|FG001|Overall Study|Protocol Violation|1|||
161954527|NCT03458325|584883182|FG000|Overall Study|Withdrawal by Subject|1|||
161954528|NCT02370368|584883183|FG000|Overall Study|Adverse Event|1|||
161954529|NCT02370368|584883184|FG001|Overall Study|Adverse Event|2|||
161954530|NCT02370368|584883183|FG000|Overall Study|Withdrawal by Subject|5|||
161954531|NCT02370368|584883184|FG001|Overall Study|Withdrawal by Subject|4|||
161954532|NCT01169337|584883185|FG000|Overall Study|Lack of Efficacy|5|||
161688283|NCT00382993|583909844|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
161835890|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
161835891|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
161835892|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
161954533|NCT01169337|584883186|FG001|Overall Study|Lack of Efficacy|7|||
161954534|NCT01169337|584883187|FG002|Overall Study|Lack of Efficacy|0|||
161954535|NCT01169337|584883185|FG000|Overall Study|Adverse Event|12|||
161954536|NCT01169337|584883186|FG001|Overall Study|Adverse Event|18|||
161954537|NCT01169337|584883187|FG002|Overall Study|Adverse Event|0|||
161954538|NCT01169337|584883185|FG000|Overall Study|Death|2|||
161954539|NCT01169337|584883186|FG001|Overall Study|Death|0|||
161954540|NCT01169337|584883187|FG002|Overall Study|Death|0|||
161954541|NCT01169337|584883185|FG000|Overall Study|Withdrawal by Subject|11|||
161954542|NCT01169337|584883186|FG001|Overall Study|Withdrawal by Subject|11|||
161954543|NCT01169337|584883187|FG002|Overall Study|Withdrawal by Subject|6|||
161954544|NCT01169337|584883185|FG000|Overall Study|Noncompliance|2|||
161954545|NCT01169337|584883186|FG001|Overall Study|Noncompliance|0|||
161954546|NCT01169337|584883187|FG002|Overall Study|Noncompliance|0|||
161954547|NCT01169337|584883185|FG000|Overall Study|Other complicating disease|1|||
161954548|NCT01169337|584883186|FG001|Overall Study|Other complicating disease|1|||
161954549|NCT01169337|584883187|FG002|Overall Study|Other complicating disease|0|||
161954550|NCT01169337|584883185|FG000|Overall Study|Physician Decision|1|||
161954551|NCT01169337|584883186|FG001|Overall Study|Physician Decision|5|||
161954552|NCT01169337|584883187|FG002|Overall Study|Physician Decision|0|||
161954553|NCT01169337|584883185|FG000|Overall Study|Alternative therapy|0|||
161954554|NCT01169337|584883186|FG001|Overall Study|Alternative therapy|2|||
161954555|NCT01169337|584883187|FG002|Overall Study|Alternative therapy|0|||
161954556|NCT01169337|584883185|FG000|Overall Study|Changed hospital|0|||
161954557|NCT01169337|584883186|FG001|Overall Study|Changed hospital|1|||
161954558|NCT01169337|584883187|FG002|Overall Study|Changed hospital|0|||
161954559|NCT01169337|584883185|FG000|Overall Study|Never started treatment|0|||
161954560|NCT01169337|584883186|FG001|Overall Study|Never started treatment|2|||
161954561|NCT01169337|584883187|FG002|Overall Study|Never started treatment|0|||
161954562|NCT01169337|584883185|FG000|Overall Study|Reason not reported|1|||
161954563|NCT01169337|584883186|FG001|Overall Study|Reason not reported|0|||
161954564|NCT01169337|584883187|FG002|Overall Study|Reason not reported|0|||
161954565|NCT01169337|584883185|FG000|Overall Study|Continuing lenalidomide|9|||
161954566|NCT01169337|584883186|FG001|Overall Study|Continuing lenalidomide|43|||
161954567|NCT01169337|584883187|FG002|Overall Study|Continuing lenalidomide|0|||
161954568|NCT01485796|584883189|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
161954569|NCT01485796|584883189|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
161954570|NCT01485796|584883189|FG000|Period 2: Epoch 2|Adverse Event|3|||
161954571|NCT01485796|584883189|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
161954572|NCT01485796|584883189|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
161954573|NCT01485796|584883189|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
161954574|NCT01485796|584883189|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
161954575|NCT01485796|584883189|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
161954576|NCT01766037|584883190|FG000|Overall Study|Adverse Event|1|||
161954577|NCT01766037|584883191|FG001|Overall Study|Adverse Event|0|||
161954578|NCT01766037|584883190|FG000|Overall Study|Lack of Efficacy|1|||
161954579|NCT01766037|584883191|FG001|Overall Study|Lack of Efficacy|0|||
161954580|NCT01766037|584883190|FG000|Overall Study|Lost to Follow-up|0|||
161954581|NCT01766037|584883191|FG001|Overall Study|Lost to Follow-up|10|||
161954582|NCT01766037|584883190|FG000|Overall Study|Physician Decision|0|||
161954583|NCT01766037|584883191|FG001|Overall Study|Physician Decision|1|||
161954584|NCT01766037|584883190|FG000|Overall Study|Withdrawal by Subject|18|||
161954585|NCT01766037|584883191|FG001|Overall Study|Withdrawal by Subject|16|||
161954586|NCT01766037|584883190|FG000|Overall Study|Moved from area|5|||
161954587|NCT01766037|584883191|FG001|Overall Study|Moved from area|0|||
161954588|NCT01766037|584883190|FG000|Overall Study|medical - unrelated|1|||
161954589|NCT01766037|584883191|FG001|Overall Study|medical - unrelated|2|||
161954590|NCT01766037|584883190|FG000|Overall Study|nausea / discomfort|3|||
161954591|NCT01766037|584883191|FG001|Overall Study|nausea / discomfort|0|||
161954592|NCT01643408|584883193|FG000|Overall Study|Adverse Event|12|||
161954593|NCT01643408|584883193|FG000|Overall Study|Other|2|||
161954594|NCT01194219|584883194|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
161954595|NCT01194219|584883195|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
161954596|NCT01194219|584883196|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161688284|NCT00382993|583909845|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
161688285|NCT00382993|583909844|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
161688286|NCT00382993|583909845|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
161688287|NCT00382993|583909844|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
161688288|NCT00382993|583909845|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
161688289|NCT00382993|583909844|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
161835893|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
161954597|NCT01194219|584883197|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161954598|NCT01194219|584883198|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161954599|NCT01194219|584883199|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161954600|NCT01194219|584883200|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161954601|NCT01194219|584883201|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161954602|NCT01194219|584883202|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161954603|NCT01194219|584883203|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
161954604|NCT01194219|584883194|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
161954605|NCT01194219|584883195|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
161954606|NCT01194219|584883196|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161954607|NCT01194219|584883197|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161954608|NCT01194219|584883198|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161954609|NCT01194219|584883199|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161954610|NCT01194219|584883200|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161954611|NCT01194219|584883201|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161954612|NCT01194219|584883202|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161954613|NCT01194219|584883203|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
161954614|NCT01194219|584883194|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
161954615|NCT01194219|584883195|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161954616|NCT01194219|584883196|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161954617|NCT01194219|584883197|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161954618|NCT01194219|584883198|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161954619|NCT01194219|584883199|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161954620|NCT01194219|584883200|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161954621|NCT01194219|584883201|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161954622|NCT01194219|584883202|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161954623|NCT01194219|584883203|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
161954624|NCT01194219|584883194|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
161954625|NCT01194219|584883195|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
161954626|NCT01194219|584883196|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161954627|NCT01194219|584883197|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161954628|NCT01194219|584883198|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161954629|NCT01194219|584883199|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161954630|NCT01194219|584883200|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161954631|NCT01194219|584883201|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161954632|NCT01194219|584883202|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161954633|NCT01194219|584883203|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161954634|NCT01194219|584883194|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161954635|NCT01194219|584883195|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
161954636|NCT01194219|584883196|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161954637|NCT01194219|584883197|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161954638|NCT01194219|584883198|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161954639|NCT01194219|584883199|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161954640|NCT01194219|584883200|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161954641|NCT01194219|584883201|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161954642|NCT01194219|584883202|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161954643|NCT01194219|584883203|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
161954644|NCT01194219|584883194|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
161954645|NCT01194219|584883195|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
161954646|NCT01194219|584883196|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161954647|NCT01194219|584883197|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161954648|NCT01194219|584883198|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161954649|NCT01194219|584883199|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161954650|NCT01194219|584883200|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161954651|NCT01194219|584883201|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161954652|NCT01194219|584883202|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161954653|NCT01194219|584883203|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
161954654|NCT01194219|584883194|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
161954655|NCT01194219|584883195|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
161954656|NCT01194219|584883196|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161954657|NCT01194219|584883197|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161954658|NCT01194219|584883198|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161954659|NCT01194219|584883199|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161954660|NCT01194219|584883200|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161954661|NCT01194219|584883201|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161954662|NCT01194219|584883202|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161954663|NCT01194219|584883203|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
161954664|NCT01194219|584883194|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
161954665|NCT01194219|584883195|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
161954666|NCT01194219|584883196|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161954667|NCT01194219|584883197|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161954668|NCT01194219|584883198|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161954669|NCT01194219|584883199|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161954670|NCT01194219|584883200|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161954671|NCT01194219|584883201|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161954672|NCT01194219|584883202|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161954673|NCT01194219|584883203|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
161954674|NCT01194219|584883194|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
161954675|NCT01194219|584883195|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
161954676|NCT01194219|584883196|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
161954677|NCT01194219|584883197|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
161954678|NCT01194219|584883198|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
161954679|NCT01194219|584883199|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
161954680|NCT01194219|584883200|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
161954681|NCT01194219|584883201|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
161954682|NCT01194219|584883202|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
161954683|NCT01194219|584883203|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
161954684|NCT01194219|584883194|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161954685|NCT01194219|584883195|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161954686|NCT01194219|584883196|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
161954687|NCT01194219|584883197|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
161954688|NCT01194219|584883198|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161954689|NCT01194219|584883199|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161954690|NCT01194219|584883200|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161954691|NCT01194219|584883201|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161954692|NCT01194219|584883202|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161954693|NCT01194219|584883203|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161954694|NCT01194219|584883194|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161954695|NCT01194219|584883195|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161954696|NCT01194219|584883196|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
161954697|NCT01194219|584883197|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
161954698|NCT01194219|584883198|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161954699|NCT01194219|584883199|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161954700|NCT01194219|584883200|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161954701|NCT01194219|584883201|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161954702|NCT01194219|584883202|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161954703|NCT01194219|584883203|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
161954704|NCT01194219|584883194|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161954705|NCT01194219|584883195|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161954706|NCT01194219|584883196|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
161954707|NCT01194219|584883197|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
161954708|NCT01194219|584883198|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161954709|NCT01194219|584883199|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161954710|NCT01194219|584883200|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161954711|NCT01194219|584883201|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161954712|NCT01194219|584883202|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161954713|NCT01194219|584883203|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
161954714|NCT01194219|584883194|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161954715|NCT01194219|584883195|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161954716|NCT01194219|584883196|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
161954717|NCT01194219|584883197|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161954718|NCT01194219|584883198|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161954719|NCT01194219|584883199|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161688290|NCT00382993|583909845|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
161688291|NCT00382993|583909844|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
161688292|NCT00382993|583909845|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
161688293|NCT00382993|583909844|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
161688294|NCT00382993|583909845|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
161954720|NCT01194219|584883200|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161954721|NCT01194219|584883201|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161954722|NCT01194219|584883202|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
161954723|NCT01194219|584883203|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
162029577|NCT04575597|585165469|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161954724|NCT01194219|584883194|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161835894|NCT01421342|584440804|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
161835895|NCT01421342|584440805|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
161835896|NCT01421342|584440806|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
161835897|NCT04505293|584440807|FG000|Overall Study|Lost to Follow-up|2|||
161835898|NCT04505293|584440807|FG000|Overall Study|Withdrawal by Subject|6|||
161835899|NCT04505293|584440807|FG000|Overall Study|CT scan unreadable|277|||
161835900|NCT04295135|584440808|FG000|Overall Study|Withdrawal by Subject|2|||
161835901|NCT04295135|584440809|FG001|Overall Study|Withdrawal by Subject|1|||
161835902|NCT04295135|584440808|FG000|Overall Study|Subject left organization|8|||
161835903|NCT04295135|584440809|FG001|Overall Study|Subject left organization|4|||
161835904|NCT01300052|584440812|FG000|Overall Study|Adverse Event|3|||
161835905|NCT01300052|584440813|FG001|Overall Study|Adverse Event|0|||
161835906|NCT01300052|584440812|FG000|Overall Study|Withdrawal by Subject|2|||
161835907|NCT01300052|584440813|FG001|Overall Study|Withdrawal by Subject|2|||
161835908|NCT01300052|584440812|FG000|Overall Study|Protocol Violation|1|||
161835909|NCT01300052|584440813|FG001|Overall Study|Protocol Violation|1|||
161835910|NCT01550744|584440814|FG000|Open-Label|Lost to Follow-up|7|||
161835911|NCT01550744|584440815|FG001|Open-Label|Lost to Follow-up|0|||
161835912|NCT01550744|584440816|FG002|Open-Label|Lost to Follow-up|0|||
161835913|NCT01550744|584440814|FG000|Open-Label|Withdrawal by Subject|13|||
161835914|NCT01550744|584440815|FG001|Open-Label|Withdrawal by Subject|0|||
161835915|NCT01550744|584440816|FG002|Open-Label|Withdrawal by Subject|0|||
161835916|NCT01550744|584440814|FG000|Open-Label|Adverse Event|11|||
161835917|NCT01550744|584440815|FG001|Open-Label|Adverse Event|0|||
161835918|NCT01550744|584440816|FG002|Open-Label|Adverse Event|0|||
161835919|NCT01550744|584440814|FG000|Open-Label|Lack of Efficacy|4|||
161835920|NCT01550744|584440815|FG001|Open-Label|Lack of Efficacy|0|||
161835921|NCT01550744|584440816|FG002|Open-Label|Lack of Efficacy|0|||
161835922|NCT01550744|584440814|FG000|Open-Label|Protocol Violation|4|||
161835923|NCT01550744|584440815|FG001|Open-Label|Protocol Violation|0|||
161954725|NCT01194219|584883195|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161954726|NCT01194219|584883196|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161954727|NCT01194219|584883197|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
161954728|NCT01194219|584883198|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161954729|NCT01194219|584883199|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161954730|NCT01194219|584883200|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161954731|NCT01194219|584883201|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161954732|NCT01194219|584883202|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161954733|NCT01194219|584883203|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
161954734|NCT01194219|584883194|FG000|Maintenance Phase Weeks16-32|Other|0|||
161954735|NCT01194219|584883195|FG001|Maintenance Phase Weeks16-32|Other|0|||
161954736|NCT01194219|584883196|FG002|Maintenance Phase Weeks16-32|Other|2|||
161954737|NCT01194219|584883197|FG003|Maintenance Phase Weeks16-32|Other|1|||
161954738|NCT01194219|584883198|FG004|Maintenance Phase Weeks16-32|Other|0|||
161954739|NCT01194219|584883199|FG005|Maintenance Phase Weeks16-32|Other|0|||
161954740|NCT01194219|584883200|FG006|Maintenance Phase Weeks16-32|Other|0|||
161954741|NCT01194219|584883201|FG007|Maintenance Phase Weeks16-32|Other|0|||
161954742|NCT01194219|584883202|FG008|Maintenance Phase Weeks16-32|Other|0|||
161954743|NCT01194219|584883203|FG009|Maintenance Phase Weeks16-32|Other|0|||
161954744|NCT01194219|584883194|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161954745|NCT01194219|584883195|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161954746|NCT01194219|584883196|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161954747|NCT01194219|584883197|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161954748|NCT01194219|584883198|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161954749|NCT01194219|584883199|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
161954750|NCT01194219|584883200|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
161954751|NCT01194219|584883201|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
161954752|NCT01194219|584883202|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161954753|NCT01194219|584883203|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
161954754|NCT01194219|584883194|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
161954755|NCT01194219|584883195|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
161954756|NCT01194219|584883196|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
162029578|NCT04575597|585165470|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162029579|NCT04575597|585165471|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
162029580|NCT04575597|585165472|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
161835924|NCT01550744|584440816|FG002|Open-Label|Protocol Violation|0|||
161954757|NCT01194219|584883197|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
161954758|NCT01194219|584883198|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
161954759|NCT01194219|584883199|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
161954760|NCT01194219|584883200|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
161954761|NCT01194219|584883201|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
161954762|NCT01194219|584883202|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
161954763|NCT01194219|584883203|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
161954764|NCT01194219|584883194|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161954765|NCT01194219|584883195|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161954766|NCT01194219|584883196|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161954767|NCT01194219|584883197|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161954768|NCT01194219|584883198|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
161954769|NCT01194219|584883199|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161954770|NCT01194219|584883200|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
161954771|NCT01194219|584883201|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161954772|NCT01194219|584883202|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161954773|NCT01194219|584883203|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
161954774|NCT01194219|584883194|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161954775|NCT01194219|584883195|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161954776|NCT01194219|584883196|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161954777|NCT01194219|584883197|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161954778|NCT01194219|584883198|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
161954779|NCT01194219|584883199|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161954780|NCT01194219|584883200|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
161954781|NCT01194219|584883201|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
161954782|NCT01194219|584883202|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161954783|NCT01194219|584883203|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
161954784|NCT01194219|584883194|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161954785|NCT01194219|584883195|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161954786|NCT01194219|584883196|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161954787|NCT01194219|584883197|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161954788|NCT01194219|584883198|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
161835925|NCT01550744|584440814|FG000|Open-Label|Not all 3 study drug injections received|2|||
161835926|NCT01550744|584440815|FG001|Open-Label|Not all 3 study drug injections received|0|||
161835927|NCT01550744|584440816|FG002|Open-Label|Not all 3 study drug injections received|0|||
161835928|NCT01550744|584440814|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
161835929|NCT01550744|584440815|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
161954789|NCT01194219|584883199|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
161954790|NCT01194219|584883200|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
161954791|NCT01194219|584883201|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161954792|NCT01194219|584883202|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161954793|NCT01194219|584883203|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
161954794|NCT01194219|584883194|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161954795|NCT01194219|584883195|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161954796|NCT01194219|584883196|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161954797|NCT01194219|584883197|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161954798|NCT01194219|584883198|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161954799|NCT01194219|584883199|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161954800|NCT01194219|584883200|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161954801|NCT01194219|584883201|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
161954802|NCT01194219|584883202|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161954803|NCT01194219|584883203|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
161954804|NCT01194219|584883194|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161954805|NCT01194219|584883195|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161954806|NCT01194219|584883196|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161954807|NCT01194219|584883197|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161954808|NCT01194219|584883198|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161954809|NCT01194219|584883199|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161954810|NCT01194219|584883200|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
161954811|NCT01194219|584883201|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161954812|NCT01194219|584883202|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161954813|NCT01194219|584883203|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161954814|NCT01194219|584883194|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161954815|NCT01194219|584883195|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161954816|NCT01194219|584883196|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161954817|NCT01194219|584883197|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161954818|NCT01194219|584883198|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161688295|NCT00382993|583909844|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
161688296|NCT00382993|583909845|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
161688297|NCT00794677|583909846|FG000|First Intervention|Withdrawal by Subject|2|||
161688298|NCT00794677|583909847|FG001|First Intervention|Withdrawal by Subject|0|||
161688299|NCT01965262|583909860|FG000|Second Intervention (7 Days)|Discontinued|0|||
161688300|NCT01965262|583909861|FG001|Second Intervention (7 Days)|Discontinued|1|||
161688301|NCT01965262|583909860|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
161688302|NCT01965262|583909861|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
161688303|NCT01965262|583909860|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
161688304|NCT01965262|583909861|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
161688305|NCT00607386|583909862|FG000|Overall Study|Physician Decision|1|||
161688306|NCT00440947|583909863|FG000|36-Week Induction Phase|Adverse Event|16|||
161688307|NCT00440947|583909864|FG001|36-Week Induction Phase|Adverse Event|0|||
161688308|NCT00440947|583909865|FG002|36-Week Induction Phase|Adverse Event|0|||
161688309|NCT00440947|583909866|FG003|36-Week Induction Phase|Adverse Event|0|||
161688310|NCT00440947|583909867|FG004|36-Week Induction Phase|Adverse Event|0|||
161688311|NCT00440947|583909863|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
161688312|NCT00440947|583909864|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
161688313|NCT00440947|583909865|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
161688314|NCT00440947|583909866|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
161688315|NCT00440947|583909867|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
161688316|NCT00440947|583909863|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
161688317|NCT00440947|583909864|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
161688318|NCT00440947|583909865|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
161688319|NCT00440947|583909866|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
161688320|NCT00440947|583909867|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
161688321|NCT00440947|583909863|FG000|36-Week Induction Phase|Non-compliance|10|||
161688322|NCT00440947|583909864|FG001|36-Week Induction Phase|Non-compliance|0|||
161688323|NCT00440947|583909865|FG002|36-Week Induction Phase|Non-compliance|0|||
161688324|NCT00440947|583909866|FG003|36-Week Induction Phase|Non-compliance|0|||
161688325|NCT00440947|583909867|FG004|36-Week Induction Phase|Non-compliance|0|||
161688326|NCT00440947|583909863|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
161688327|NCT00440947|583909864|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
161688328|NCT00440947|583909865|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
161688329|NCT00440947|583909866|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
161688330|NCT00440947|583909867|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
161688331|NCT00440947|583909863|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
161688332|NCT00440947|583909864|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
161688333|NCT00440947|583909865|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
161688334|NCT00440947|583909866|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
161688335|NCT00440947|583909867|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
161688336|NCT00440947|583909863|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
161835930|NCT01550744|584440816|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
161835931|NCT01550744|584440814|FG000|Open-Label|Other|1|||
161954819|NCT01194219|584883199|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161688337|NCT00440947|583909864|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
161688338|NCT00440947|583909865|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
161688339|NCT00440947|583909866|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
161688340|NCT00440947|583909867|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
161688341|NCT00440947|583909863|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
161688342|NCT00440947|583909864|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
161835932|NCT01550744|584440815|FG001|Open-Label|Other|0|||
161954820|NCT01194219|584883200|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161954821|NCT01194219|584883201|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
161954822|NCT01194219|584883202|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
161954823|NCT01194219|584883203|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
161954824|NCT01194219|584883194|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161954825|NCT01194219|584883195|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161954826|NCT01194219|584883196|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161954827|NCT01194219|584883197|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161954828|NCT01194219|584883198|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161954829|NCT01194219|584883199|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161954830|NCT01194219|584883200|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161954831|NCT01194219|584883201|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
161954832|NCT01194219|584883202|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
161954833|NCT01194219|584883203|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
161954834|NCT01194219|584883194|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161954835|NCT01194219|584883195|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161954836|NCT01194219|584883196|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161954837|NCT01194219|584883197|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161954838|NCT01194219|584883198|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161954839|NCT01194219|584883199|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161954840|NCT01194219|584883200|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161954841|NCT01194219|584883201|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
161954842|NCT01194219|584883202|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
161954843|NCT01194219|584883203|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
161954844|NCT01194219|584883194|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161954845|NCT01194219|584883195|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161954846|NCT01194219|584883196|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161954847|NCT01194219|584883197|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161954848|NCT01194219|584883198|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161954849|NCT01194219|584883199|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161954850|NCT01194219|584883200|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161954851|NCT01194219|584883201|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
161954852|NCT01194219|584883202|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
161954853|NCT01194219|584883203|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
161954854|NCT01194219|584883194|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
161954855|NCT01194219|584883195|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
161954856|NCT01194219|584883196|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
161954857|NCT01194219|584883197|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
161954858|NCT01194219|584883198|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
161954859|NCT01194219|584883199|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
161954860|NCT01194219|584883200|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
161954861|NCT01194219|584883201|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
161954862|NCT01194219|584883202|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
161954863|NCT01194219|584883203|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
161954864|NCT01194219|584883194|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161954865|NCT01194219|584883195|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161954866|NCT01194219|584883196|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161954867|NCT01194219|584883197|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161954868|NCT01194219|584883198|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161954869|NCT01194219|584883199|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161954870|NCT01194219|584883200|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161954871|NCT01194219|584883201|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
161954872|NCT01194219|584883202|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
161954873|NCT01194219|584883203|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
161954874|NCT01194219|584883194|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161954875|NCT01194219|584883195|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161954876|NCT01194219|584883196|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161954877|NCT01194219|584883197|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161954878|NCT01194219|584883198|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161954879|NCT01194219|584883199|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161954880|NCT01194219|584883200|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161954881|NCT01194219|584883201|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161954882|NCT01194219|584883202|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
161954883|NCT01194219|584883203|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161954884|NCT01194219|584883194|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161954885|NCT01194219|584883195|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161954886|NCT01194219|584883196|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161954887|NCT01194219|584883197|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161954888|NCT01194219|584883198|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161954889|NCT01194219|584883199|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161954890|NCT01194219|584883200|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161954891|NCT01194219|584883201|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161954892|NCT01194219|584883202|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
161954893|NCT01194219|584883203|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
161954894|NCT05226598|584883204|FG000|Overall Study|Death|186|||
161954895|NCT05226598|584883205|FG001|Overall Study|Death|191|||
161954896|NCT05226598|584883204|FG000|Overall Study|Withdrawal by Subject|6|||
161954897|NCT05226598|584883205|FG001|Overall Study|Withdrawal by Subject|6|||
161954898|NCT05226598|584883204|FG000|Overall Study|Ongoing|174|||
161954899|NCT05226598|584883205|FG001|Overall Study|Ongoing|176|||
161954900|NCT02236572|584883206|FG000|Overall Study|Withdrawal by Subject|1|||
161954901|NCT02236572|584883206|FG000|Overall Study|Protocol Violation|1|||
161954902|NCT02236572|584883206|FG000|Overall Study|Lost to Follow-up|1|||
161954903|NCT03726658|584883207|FG000|Overall Study|Lost to Follow-up|0|||
161954904|NCT03726658|584883208|FG001|Overall Study|Lost to Follow-up|0|||
161954905|NCT03726658|584883209|FG002|Overall Study|Lost to Follow-up|2|||
161954906|NCT03726658|584883210|FG003|Overall Study|Lost to Follow-up|0|||
161954907|NCT03726658|584883211|FG004|Overall Study|Lost to Follow-up|0|||
161954908|NCT03726658|584883212|FG005|Overall Study|Lost to Follow-up|1|||
161954909|NCT03726658|584883213|FG006|Overall Study|Lost to Follow-up|1|||
161954910|NCT03726658|584883207|FG000|Overall Study|Withdrawal by Subject|1|||
161954911|NCT03726658|584883208|FG001|Overall Study|Withdrawal by Subject|0|||
161954912|NCT03726658|584883209|FG002|Overall Study|Withdrawal by Subject|0|||
161954913|NCT03726658|584883210|FG003|Overall Study|Withdrawal by Subject|0|||
161954914|NCT03726658|584883211|FG004|Overall Study|Withdrawal by Subject|6|||
161954915|NCT03726658|584883212|FG005|Overall Study|Withdrawal by Subject|4|||
161954916|NCT03726658|584883213|FG006|Overall Study|Withdrawal by Subject|2|||
161954917|NCT03726658|584883207|FG000|Overall Study|Pregnancy|0|||
161954918|NCT03726658|584883208|FG001|Overall Study|Pregnancy|0|||
161954919|NCT03726658|584883209|FG002|Overall Study|Pregnancy|0|||
161954920|NCT03726658|584883210|FG003|Overall Study|Pregnancy|0|||
161954921|NCT03726658|584883211|FG004|Overall Study|Pregnancy|0|||
161954922|NCT03726658|584883212|FG005|Overall Study|Pregnancy|0|||
161954923|NCT03726658|584883213|FG006|Overall Study|Pregnancy|1|||
161954924|NCT03726658|584883207|FG000|Overall Study|Not Reported|0|||
161954925|NCT03726658|584883208|FG001|Overall Study|Not Reported|0|||
161954926|NCT03726658|584883209|FG002|Overall Study|Not Reported|0|||
161954927|NCT03726658|584883210|FG003|Overall Study|Not Reported|0|||
161954928|NCT03726658|584883211|FG004|Overall Study|Not Reported|0|||
161954929|NCT03726658|584883212|FG005|Overall Study|Not Reported|0|||
161954930|NCT03726658|584883213|FG006|Overall Study|Not Reported|1|||
161954931|NCT05710640|584883214|FG000|Overall Study|Physician Decision|0|||
161954932|NCT05710640|584883215|FG001|Overall Study|Physician Decision|1|||
161954933|NCT05710640|584883214|FG000|Overall Study|Withdrawal by Subject|1|||
161954934|NCT05710640|584883215|FG001|Overall Study|Withdrawal by Subject|0|||
161954935|NCT05710640|584883214|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
161954936|NCT05710640|584883215|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
161954937|NCT04188509|584883216|FG000|Overall Study|Adverse Event|2|||
162029581|NCT02095132|585165477|FG000|Overall Study|Adverse Event|0|||
161954938|NCT04188509|584883216|FG000|Overall Study|Lost to Follow-up|1|||
161954939|NCT04188509|584883216|FG000|Overall Study|Withdrawal of Consent|1|||
161954940|NCT04188509|584883216|FG000|Overall Study|Discretion of Investigator|1|||
161954941|NCT04188509|584883216|FG000|Overall Study|Noncompliance|3|||
161954942|NCT04188509|584883216|FG000|Overall Study|Sponsor Decision|127|||
161954943|NCT04188509|584883216|FG000|Overall Study|Other|2|||
161954944|NCT03465722|584883217|FG000|Overall Study|Withdrawal by Subject|21|||
161954945|NCT03465722|584883218|FG001|Overall Study|Withdrawal by Subject|14|||
161954946|NCT03465722|584883217|FG000|Overall Study|Death|89|||
161954947|NCT03465722|584883218|FG001|Overall Study|Death|87|||
161954948|NCT03465722|584883217|FG000|Overall Study|Lost to Follow-up|5|||
161954949|NCT03465722|584883218|FG001|Overall Study|Lost to Follow-up|3|||
161954950|NCT03465722|584883217|FG000|Overall Study|Administrative/Other|33|||
161954951|NCT03465722|584883218|FG001|Overall Study|Administrative/Other|32|||
161954952|NCT03465722|584883217|FG000|Overall Study|Not treated|1|||
161954953|NCT03465722|584883218|FG001|Overall Study|Not treated|2|||
161954954|NCT03465722|584883217|FG000|Overall Study|Sponsor decision|91|||
161954955|NCT03465722|584883218|FG001|Overall Study|Sponsor decision|98|||
161954956|NCT00049322|584883223|FG000|Overall Study|disease burden|0|||
161954957|NCT00049322|584883224|FG001|Overall Study|disease burden|3|||
161954958|NCT00049322|584883223|FG000|Overall Study|Adverse Event|1|||
161954959|NCT00049322|584883224|FG001|Overall Study|Adverse Event|0|||
161954960|NCT00049322|584883223|FG000|Overall Study|refused angio|0|||
161954961|NCT00049322|584883224|FG001|Overall Study|refused angio|3|||
161954962|NCT00703963|584883225|FG000|Overall Study|Withdrawal by Subject|7|||
161954963|NCT00703963|584883226|FG001|Overall Study|Withdrawal by Subject|13|||
161954964|NCT00703963|584883225|FG000|Overall Study|Physician Decision|0|||
161954965|NCT00703963|584883226|FG001|Overall Study|Physician Decision|1|||
161954966|NCT03994211|584883227|FG000|Core Phase|Adverse Event|0|||
161954967|NCT03994211|584883228|FG001|Core Phase|Adverse Event|1|||
161954968|NCT03994211|584883229|FG002|Core Phase|Adverse Event|0|||
161954969|NCT03994211|584883227|FG000|Extension Phase|Adverse Event|0|||
161954970|NCT03994211|584883228|FG001|Extension Phase|Adverse Event|0|||
161954971|NCT03994211|584883229|FG002|Extension Phase|Adverse Event|1|||
161954972|NCT03994211|584883227|FG000|Extension Phase|Physician Decision|0|||
161954973|NCT03994211|584883228|FG001|Extension Phase|Physician Decision|0|||
161688343|NCT00440947|583909865|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
161954974|NCT03994211|584883229|FG002|Extension Phase|Physician Decision|1|||
161954975|NCT03994211|584883227|FG000|Extension Phase|Progressive Disease|0|||
161954976|NCT03994211|584883228|FG001|Extension Phase|Progressive Disease|0|||
161954977|NCT03994211|584883229|FG002|Extension Phase|Progressive Disease|20|||
161954978|NCT03994211|584883227|FG000|Extension Phase|Withdrawal by Subject|0|||
161954979|NCT03994211|584883228|FG001|Extension Phase|Withdrawal by Subject|0|||
161954980|NCT03994211|584883229|FG002|Extension Phase|Withdrawal by Subject|2|||
161954981|NCT00955474|584883239|FG000|Overall Study|Physician Decision|7|||
161954982|NCT00955474|584883240|FG001|Overall Study|Physician Decision|5|||
161954983|NCT02148263|584883242|FG000|Overall Study|Withdrawal by Subject|3|||
161954984|NCT02148263|584883243|FG001|Overall Study|Withdrawal by Subject|2|||
161954985|NCT00503425|584883244|FG000|Overall Study|Participant files lost|6|||
161954986|NCT00503425|584883244|FG000|Overall Study|Adverse Event|5|||
161954987|NCT00503425|584883244|FG000|Overall Study|Lack of Efficacy|25|||
161954988|NCT00503425|584883244|FG000|Overall Study|Withdrawal by Subject|8|||
161954989|NCT00503425|584883244|FG000|Overall Study|Lost to Follow-up|3|||
161954990|NCT00503425|584883244|FG000|Overall Study|Death|3|||
161954991|NCT00503425|584883244|FG000|Overall Study|Missing Data/Unknown|4|||
161954992|NCT03900728|584883245|FG000|Overall Study|No text responses|0|||
162029582|NCT02095132|585165478|FG001|Overall Study|Adverse Event|0|||
161688344|NCT00440947|583909866|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
161954993|NCT03900728|584883246|FG001|Overall Study|No text responses|0|||
161954994|NCT03900728|584883247|FG002|Overall Study|No text responses|4|||
161954995|NCT00003869|584883248|FG000|Overall Study|Adverse Event|14|||
161954996|NCT00003869|584883249|FG001|Overall Study|Adverse Event|3|||
161954997|NCT00003869|584883248|FG000|Overall Study|Withdrawal by Subject|21|||
161954998|NCT00003869|584883249|FG001|Overall Study|Withdrawal by Subject|3|||
161954999|NCT00003869|584883248|FG000|Overall Study|Death|1|||
161955000|NCT00003869|584883249|FG001|Overall Study|Death|2|||
161955001|NCT00003869|584883248|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
161955002|NCT00003869|584883249|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
161955003|NCT01272037|584883258|FG000|Overall Study|Death|25|||
161955004|NCT01272037|584883259|FG001|Overall Study|Death|28|||
161955005|NCT01272037|584883258|FG000|Overall Study|Adverse Event|12|||
161955006|NCT01272037|584883259|FG001|Overall Study|Adverse Event|7|||
161955007|NCT01272037|584883258|FG000|Overall Study|Withdrawal by Subject|175|||
161955008|NCT01272037|584883259|FG001|Overall Study|Withdrawal by Subject|93|||
161955009|NCT01272037|584883258|FG000|Overall Study|Disease progression|70|||
161955010|NCT01272037|584883259|FG001|Overall Study|Disease progression|111|||
161955011|NCT01272037|584883258|FG000|Overall Study|Other reason|42|||
161955012|NCT01272037|584883259|FG001|Overall Study|Other reason|41|||
161955013|NCT01272037|584883258|FG000|Overall Study|Delinquent data|24|||
161955014|NCT01272037|584883259|FG001|Overall Study|Delinquent data|19|||
161955015|NCT01272037|584883258|FG000|Overall Study|Reason under review|33|||
161955016|NCT01272037|584883259|FG001|Overall Study|Reason under review|29|||
161955017|NCT01272037|584883258|FG000|Overall Study|On treatment|626|||
161955018|NCT01272037|584883259|FG001|Overall Study|On treatment|632|||
161955019|NCT01393899|584883260|FG000|Overall Study|Study terminated by sponsor|1|||
161955020|NCT01393899|584883261|FG001|Overall Study|Study terminated by sponsor|0|||
161955021|NCT01393899|584883262|FG002|Overall Study|Study terminated by sponsor|1|||
161955022|NCT01393899|584883260|FG000|Overall Study|Other|1|||
161955023|NCT01393899|584883261|FG001|Overall Study|Other|0|||
161955024|NCT01393899|584883262|FG002|Overall Study|Other|0|||
161955025|NCT01393899|584883260|FG000|Overall Study|Withdrawal by Subject|2|||
161688345|NCT00440947|583909867|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
161688346|NCT00440947|583909863|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
161688347|NCT00440947|583909864|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
161688348|NCT00440947|583909865|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
161688349|NCT00440947|583909866|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
161688350|NCT00440947|583909867|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
161688351|NCT00440947|583909863|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
161688352|NCT00440947|583909864|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
161688353|NCT00440947|583909865|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
161688354|NCT00440947|583909866|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
161688355|NCT00440947|583909867|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
161955026|NCT01393899|584883261|FG001|Overall Study|Withdrawal by Subject|2|||
161955027|NCT01393899|584883262|FG002|Overall Study|Withdrawal by Subject|1|||
161955028|NCT01393899|584883260|FG000|Overall Study|Lost to Follow-up|0|||
161955029|NCT01393899|584883261|FG001|Overall Study|Lost to Follow-up|0|||
161955030|NCT01393899|584883262|FG002|Overall Study|Lost to Follow-up|1|||
161955031|NCT01393899|584883260|FG000|Overall Study|Does not meet entrance criteria|1|||
161955032|NCT01393899|584883261|FG001|Overall Study|Does not meet entrance criteria|0|||
161955033|NCT01393899|584883262|FG002|Overall Study|Does not meet entrance criteria|1|||
161955034|NCT01393899|584883260|FG000|Overall Study|Lack of Efficacy|26|||
161955035|NCT01393899|584883261|FG001|Overall Study|Lack of Efficacy|21|||
161955036|NCT01393899|584883262|FG002|Overall Study|Lack of Efficacy|16|||
161955037|NCT01393899|584883260|FG000|Overall Study|Adverse Event|1|||
161955038|NCT01393899|584883261|FG001|Overall Study|Adverse Event|5|||
161955039|NCT01393899|584883262|FG002|Overall Study|Adverse Event|3|||
161955040|NCT02503085|584883263|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
161955041|NCT02503085|584883264|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
161955042|NCT02503085|584883265|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
161955043|NCT02503085|584883266|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
161955044|NCT01162473|584883270|FG000|Overall Study|Adverse Event|2|||
161955045|NCT01162473|584883271|FG001|Overall Study|Adverse Event|1|||
161955046|NCT01162473|584883270|FG000|Overall Study|Withdrawal by Subject|0|||
161688356|NCT00440947|583909863|FG000|36-Week Induction Phase|Incarceration|3|||
161688357|NCT00440947|583909864|FG001|36-Week Induction Phase|Incarceration|0|||
161688358|NCT00440947|583909865|FG002|36-Week Induction Phase|Incarceration|0|||
161955047|NCT01162473|584883271|FG001|Overall Study|Withdrawal by Subject|4|||
161955048|NCT01144416|584883272|FG000|Intervention Period|Adverse Event|5|||
161955049|NCT01144416|584883273|FG001|Intervention Period|Adverse Event|6|||
161955050|NCT01144416|584883272|FG000|Intervention Period|Insufficient ovarian response|11|||
161955051|NCT01144416|584883273|FG001|Intervention Period|Insufficient ovarian response|17|||
161955052|NCT01144416|584883272|FG000|Intervention Period|Risk of OHSS|0|||
161955053|NCT01144416|584883273|FG001|Intervention Period|Risk of OHSS|1|||
161955054|NCT01144416|584883272|FG000|Intervention Period|Too high ovarian response|4|||
161955055|NCT01144416|584883273|FG001|Intervention Period|Too high ovarian response|2|||
161835933|NCT01550744|584440816|FG002|Open-Label|Other|0|||
162029583|NCT02095132|585165479|FG002|Overall Study|Adverse Event|0|||
162029584|NCT02095132|585165480|FG003|Overall Study|Adverse Event|0|||
161955056|NCT01144416|584883272|FG000|Intervention Period|No/too few/bad oocytes|7|||
161955057|NCT01144416|584883273|FG001|Intervention Period|No/too few/bad oocytes|5|||
161688359|NCT00440947|583909866|FG003|36-Week Induction Phase|Incarceration|0|||
161955058|NCT01144416|584883272|FG000|Intervention Period|No or abnormal fertilization|25|||
161955059|NCT01144416|584883273|FG001|Intervention Period|No or abnormal fertilization|10|||
161955060|NCT01144416|584883272|FG000|Intervention Period|No/too few/bad quality embryos|3|||
161955061|NCT01144416|584883273|FG001|Intervention Period|No/too few/bad quality embryos|3|||
161955062|NCT01144416|584883272|FG000|Intervention Period|Other|7|||
161955063|NCT01144416|584883273|FG001|Intervention Period|Other|5|||
161955064|NCT02534883|584883275|FG000|Overall Study|Early Termination|8|||
161955065|NCT02534883|584883276|FG001|Overall Study|Early Termination|3|||
161955066|NCT00049257|584883277|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
161955067|NCT00049257|584883277|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
161955068|NCT00049257|584883277|FG000|Carboplatin, Paclitaxel|Death|2|||
161955069|NCT00049257|584883277|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
161955070|NCT00132301|584883278|FG000|Overall Study|Death|7|||
161955071|NCT00132301|584883279|FG001|Overall Study|Death|6|||
161955072|NCT00132301|584883278|FG000|Overall Study|Withdrawal by Subject|5|||
161835934|NCT01550744|584440814|FG000|Double-Blind|Lost to Follow-up|0|||
161955073|NCT00132301|584883279|FG001|Overall Study|Withdrawal by Subject|2|||
161955074|NCT00132301|584883278|FG000|Overall Study|Physician Decision|1|||
161955075|NCT00132301|584883279|FG001|Overall Study|Physician Decision|1|||
161955076|NCT00132301|584883278|FG000|Overall Study|Lost to Follow-up|5|||
161955077|NCT00132301|584883279|FG001|Overall Study|Lost to Follow-up|3|||
161955078|NCT00132301|584883278|FG000|Overall Study|Other|1|||
161955079|NCT00132301|584883279|FG001|Overall Study|Other|1|||
161955080|NCT00132301|584883278|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
161955081|NCT00132301|584883279|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
161955082|NCT01890265|584883282|FG000|Overall Study|Other (Unspecified reason)|0|||
161955083|NCT01890265|584883283|FG001|Overall Study|Other (Unspecified reason)|1|||
161955084|NCT01890265|584883284|FG002|Overall Study|Other (Unspecified reason)|0|||
161955085|NCT01890265|584883285|FG003|Overall Study|Other (Unspecified reason)|0|||
161955086|NCT01890265|584883286|FG004|Overall Study|Other (Unspecified reason)|0|||
161955087|NCT01890265|584883287|FG005|Overall Study|Other (Unspecified reason)|0|||
161955088|NCT01890265|584883282|FG000|Overall Study|Progressive disease|6|||
161955089|NCT01890265|584883283|FG001|Overall Study|Progressive disease|6|||
161955090|NCT01890265|584883284|FG002|Overall Study|Progressive disease|0|||
161955091|NCT01890265|584883285|FG003|Overall Study|Progressive disease|0|||
161955092|NCT01890265|584883286|FG004|Overall Study|Progressive disease|0|||
161955093|NCT01890265|584883287|FG005|Overall Study|Progressive disease|0|||
161955094|NCT01890265|584883282|FG000|Overall Study|Adverse Event|2|||
161955095|NCT01890265|584883283|FG001|Overall Study|Adverse Event|1|||
161955096|NCT01890265|584883284|FG002|Overall Study|Adverse Event|0|||
161955097|NCT01890265|584883285|FG003|Overall Study|Adverse Event|0|||
161955098|NCT01890265|584883286|FG004|Overall Study|Adverse Event|0|||
161955099|NCT01890265|584883287|FG005|Overall Study|Adverse Event|0|||
161955100|NCT01890265|584883282|FG000|Overall Study|Death|2|||
161955101|NCT01890265|584883283|FG001|Overall Study|Death|3|||
161955102|NCT01890265|584883284|FG002|Overall Study|Death|1|||
161955103|NCT01890265|584883285|FG003|Overall Study|Death|0|||
161955104|NCT01890265|584883286|FG004|Overall Study|Death|0|||
161955105|NCT01890265|584883287|FG005|Overall Study|Death|0|||
161955106|NCT01890265|584883282|FG000|Overall Study|Withdrawal by Subject|0|||
161955107|NCT01890265|584883283|FG001|Overall Study|Withdrawal by Subject|2|||
161955108|NCT01890265|584883284|FG002|Overall Study|Withdrawal by Subject|3|||
161955109|NCT01890265|584883285|FG003|Overall Study|Withdrawal by Subject|0|||
161955110|NCT01890265|584883286|FG004|Overall Study|Withdrawal by Subject|2|||
161955111|NCT01890265|584883287|FG005|Overall Study|Withdrawal by Subject|0|||
161955112|NCT03670355|584883292|FG000|Overall Study|Adverse Event|1|||
161955113|NCT03670355|584883293|FG001|Overall Study|Adverse Event|0|||
161955114|NCT03670355|584883292|FG000|Overall Study|Unable to comply with study procedures|0|||
161955115|NCT03670355|584883293|FG001|Overall Study|Unable to comply with study procedures|1|||
161955116|NCT03670355|584883292|FG000|Overall Study|Participant refused|0|||
161955117|NCT03670355|584883293|FG001|Overall Study|Participant refused|1|||
161955118|NCT02268383|584883296|FG000|Overall Study|Death|12|||
161955119|NCT02268383|584883296|FG000|Overall Study|Lost to Follow-up|2|||
161955120|NCT02268383|584883296|FG000|Overall Study|Withdrawal by Subject|9|||
161955121|NCT02268383|584883296|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
161955122|NCT02268383|584883296|FG000|Overall Study|Protocol deviation|3|||
161955123|NCT02268383|584883296|FG000|Overall Study|Sponsor decision|22|||
161955124|NCT02268383|584883296|FG000|Overall Study|Not reported|12|||
161955125|NCT02708680|584883299|FG000|Overall Study|Withdrawal by Subject|4|||
161955126|NCT02708680|584883300|FG001|Overall Study|Withdrawal by Subject|12|||
161955127|NCT02708680|584883301|FG002|Overall Study|Withdrawal by Subject|12|||
161955128|NCT02708680|584883299|FG000|Overall Study|Death|4|||
161955129|NCT02708680|584883300|FG001|Overall Study|Death|19|||
161955130|NCT02708680|584883301|FG002|Overall Study|Death|21|||
161955131|NCT02708680|584883299|FG000|Overall Study|Lost to Follow-up|0|||
161955132|NCT02708680|584883300|FG001|Overall Study|Lost to Follow-up|3|||
161955133|NCT02708680|584883301|FG002|Overall Study|Lost to Follow-up|3|||
161955134|NCT02708680|584883299|FG000|Overall Study|Study Terminated By Sponsor|0|||
161955135|NCT02708680|584883300|FG001|Overall Study|Study Terminated By Sponsor|5|||
161955136|NCT02708680|584883301|FG002|Overall Study|Study Terminated By Sponsor|4|||
161955137|NCT02708680|584883299|FG000|Overall Study|Other than Specified|0|||
161955138|NCT02708680|584883300|FG001|Overall Study|Other than Specified|0|||
161955139|NCT02708680|584883301|FG002|Overall Study|Other than Specified|1|||
161955140|NCT02708680|584883299|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
161955141|NCT02708680|584883300|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
161955142|NCT02708680|584883301|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
161955143|NCT01342926|584883302|FG000|Overall Study|Adverse Event|5|||
161955144|NCT01342926|584883303|FG001|Overall Study|Adverse Event|8|||
161955145|NCT01342926|584883304|FG002|Overall Study|Adverse Event|10|||
161955146|NCT01342926|584883305|FG003|Overall Study|Adverse Event|7|||
161955147|NCT01342926|584883302|FG000|Overall Study|Lost to Follow-up|0|||
161955148|NCT01342926|584883303|FG001|Overall Study|Lost to Follow-up|1|||
161955149|NCT01342926|584883304|FG002|Overall Study|Lost to Follow-up|1|||
161835935|NCT01550744|584440815|FG001|Double-Blind|Lost to Follow-up|6|||
161955150|NCT01342926|584883305|FG003|Overall Study|Lost to Follow-up|0|||
161955151|NCT01342926|584883302|FG000|Overall Study|Investigator Discretion|2|||
161955152|NCT01342926|584883303|FG001|Overall Study|Investigator Discretion|2|||
161955153|NCT01342926|584883304|FG002|Overall Study|Investigator Discretion|0|||
161955154|NCT01342926|584883305|FG003|Overall Study|Investigator Discretion|0|||
161955155|NCT01342926|584883302|FG000|Overall Study|Withdrawal by Subject|2|||
161955156|NCT01342926|584883303|FG001|Overall Study|Withdrawal by Subject|4|||
161955157|NCT01342926|584883304|FG002|Overall Study|Withdrawal by Subject|3|||
161955158|NCT01342926|584883305|FG003|Overall Study|Withdrawal by Subject|5|||
162029585|NCT02095132|585165481|FG004|Overall Study|Adverse Event|1|||
161955159|NCT04162470|584883306|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
161955160|NCT03929913|584883311|FG000|Overall Study|Death|4|||
161955161|NCT03929913|584883311|FG000|Overall Study|Lost to Follow-up|1|||
161955162|NCT03929913|584883311|FG000|Overall Study|Failed Procedure|2|||
161955163|NCT03919929|584883314|FG000|Overall Study|Withdrawal by Subject|0|||
161955164|NCT03919929|584883315|FG001|Overall Study|Withdrawal by Subject|4|||
161955165|NCT03919929|584883314|FG000|Overall Study|Screen Failure|0|||
161955166|NCT03919929|584883315|FG001|Overall Study|Screen Failure|5|||
161955167|NCT00642707|584883316|FG000|Overall Study|Adverse Event|0|||
161955168|NCT00642707|584883317|FG001|Overall Study|Adverse Event|0|||
161955169|NCT00642707|584883318|FG002|Overall Study|Adverse Event|0|||
161955170|NCT00642707|584883319|FG003|Overall Study|Adverse Event|2|||
161955171|NCT00642707|584883316|FG000|Overall Study|Withdrawal by Subject|1|||
161955172|NCT00642707|584883317|FG001|Overall Study|Withdrawal by Subject|0|||
161955173|NCT00642707|584883318|FG002|Overall Study|Withdrawal by Subject|0|||
161955174|NCT00642707|584883319|FG003|Overall Study|Withdrawal by Subject|0|||
161955175|NCT02573948|584883325|FG000|Longitudinal Cohort|Death|9|||
161955176|NCT02573948|584883325|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
161955177|NCT02573948|584883325|FG000|Longitudinal Cohort|Incarcerated|25|||
161955178|NCT03960684|584883326|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
161955179|NCT03533660|584883327|FG000|Overall Study|Withdrawal by Subject|2|||
161955180|NCT03533660|584883328|FG001|Overall Study|Withdrawal by Subject|2|||
161955181|NCT03533660|584883327|FG000|Overall Study|Death|2|||
161955182|NCT03533660|584883328|FG001|Overall Study|Death|4|||
161955183|NCT03533660|584883327|FG000|Overall Study|Adverse Event|0|||
161955184|NCT03533660|584883328|FG001|Overall Study|Adverse Event|2|||
161955185|NCT05823974|584885175|FG000|Overall Study|Lost to Follow-up|0|||
161955186|NCT05823974|584885176|FG001|Overall Study|Lost to Follow-up|3|||
161955187|NCT05823974|584885177|FG002|Overall Study|Lost to Follow-up|1|||
161955188|NCT05823974|584885178|FG003|Overall Study|Lost to Follow-up|0|||
161955189|NCT05823974|584885179|FG004|Overall Study|Lost to Follow-up|1|||
161955190|NCT05823974|584885180|FG005|Overall Study|Lost to Follow-up|0|||
161955191|NCT05823974|584885181|FG006|Overall Study|Lost to Follow-up|1|||
161955192|NCT05823974|584885182|FG007|Overall Study|Lost to Follow-up|0|||
161955193|NCT05823974|584885183|FG008|Overall Study|Lost to Follow-up|0|||
161955194|NCT05823974|584885184|FG009|Overall Study|Lost to Follow-up|1|||
161955195|NCT05823974|584885185|FG010|Overall Study|Lost to Follow-up|1|||
161955196|NCT05823974|584885186|FG011|Overall Study|Lost to Follow-up|0|||
161955197|NCT05823974|584885187|FG012|Overall Study|Lost to Follow-up|1|||
161955198|NCT05823974|584885188|FG013|Overall Study|Lost to Follow-up|2|||
161955199|NCT05823974|584885189|FG014|Overall Study|Lost to Follow-up|1|||
161955200|NCT05823974|584885190|FG015|Overall Study|Lost to Follow-up|1|||
161955201|NCT05823974|584885191|FG016|Overall Study|Lost to Follow-up|1|||
161955202|NCT05823974|584885192|FG017|Overall Study|Lost to Follow-up|0|||
161955203|NCT05823974|584885193|FG018|Overall Study|Lost to Follow-up|0|||
161955204|NCT05823974|584885194|FG019|Overall Study|Lost to Follow-up|2|||
161955205|NCT05823974|584885195|FG020|Overall Study|Lost to Follow-up|0|||
161955206|NCT05823974|584885175|FG000|Overall Study|Physician Decision|0|||
161955207|NCT05823974|584885176|FG001|Overall Study|Physician Decision|0|||
161955208|NCT05823974|584885177|FG002|Overall Study|Physician Decision|0|||
161955209|NCT05823974|584885178|FG003|Overall Study|Physician Decision|0|||
161955210|NCT05823974|584885179|FG004|Overall Study|Physician Decision|0|||
161955211|NCT05823974|584885180|FG005|Overall Study|Physician Decision|0|||
161955212|NCT05823974|584885181|FG006|Overall Study|Physician Decision|0|||
161955213|NCT05823974|584885182|FG007|Overall Study|Physician Decision|0|||
161955214|NCT05823974|584885183|FG008|Overall Study|Physician Decision|0|||
161955215|NCT05823974|584885184|FG009|Overall Study|Physician Decision|0|||
161955216|NCT05823974|584885185|FG010|Overall Study|Physician Decision|0|||
161955217|NCT05823974|584885186|FG011|Overall Study|Physician Decision|0|||
161955218|NCT05823974|584885187|FG012|Overall Study|Physician Decision|0|||
161955219|NCT05823974|584885188|FG013|Overall Study|Physician Decision|0|||
161955220|NCT05823974|584885189|FG014|Overall Study|Physician Decision|0|||
161955221|NCT05823974|584885190|FG015|Overall Study|Physician Decision|1|||
161955222|NCT05823974|584885191|FG016|Overall Study|Physician Decision|0|||
161955223|NCT05823974|584885192|FG017|Overall Study|Physician Decision|1|||
161955224|NCT05823974|584885193|FG018|Overall Study|Physician Decision|1|||
161955225|NCT05823974|584885194|FG019|Overall Study|Physician Decision|0|||
161955226|NCT05823974|584885195|FG020|Overall Study|Physician Decision|0|||
161955227|NCT05823974|584885175|FG000|Overall Study|Withdrawal by Subject|1|||
161955228|NCT05823974|584885176|FG001|Overall Study|Withdrawal by Subject|1|||
161955229|NCT05823974|584885177|FG002|Overall Study|Withdrawal by Subject|2|||
161955230|NCT05823974|584885178|FG003|Overall Study|Withdrawal by Subject|0|||
161955231|NCT05823974|584885179|FG004|Overall Study|Withdrawal by Subject|2|||
161955232|NCT05823974|584885180|FG005|Overall Study|Withdrawal by Subject|3|||
161955233|NCT05823974|584885181|FG006|Overall Study|Withdrawal by Subject|1|||
161955234|NCT05823974|584885182|FG007|Overall Study|Withdrawal by Subject|1|||
161955235|NCT05823974|584885183|FG008|Overall Study|Withdrawal by Subject|2|||
161955236|NCT05823974|584885184|FG009|Overall Study|Withdrawal by Subject|1|||
161955237|NCT05823974|584885185|FG010|Overall Study|Withdrawal by Subject|1|||
161955238|NCT05823974|584885186|FG011|Overall Study|Withdrawal by Subject|0|||
161955239|NCT05823974|584885187|FG012|Overall Study|Withdrawal by Subject|0|||
161955240|NCT05823974|584885188|FG013|Overall Study|Withdrawal by Subject|1|||
161955241|NCT05823974|584885189|FG014|Overall Study|Withdrawal by Subject|1|||
161955242|NCT05823974|584885190|FG015|Overall Study|Withdrawal by Subject|3|||
161955243|NCT05823974|584885191|FG016|Overall Study|Withdrawal by Subject|0|||
161955244|NCT05823974|584885192|FG017|Overall Study|Withdrawal by Subject|2|||
161955245|NCT05823974|584885193|FG018|Overall Study|Withdrawal by Subject|2|||
161955246|NCT05823974|584885194|FG019|Overall Study|Withdrawal by Subject|0|||
161955247|NCT05823974|584885195|FG020|Overall Study|Withdrawal by Subject|1|||
161955248|NCT05823974|584885175|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955249|NCT05823974|584885176|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955250|NCT05823974|584885177|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161955251|NCT05823974|584885178|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955252|NCT05823974|584885179|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955253|NCT05823974|584885180|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955254|NCT05823974|584885181|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161835936|NCT01550744|584440816|FG002|Double-Blind|Lost to Follow-up|12|||
161835937|NCT01550744|584440814|FG000|Double-Blind|Withdrawal by Subject|0|||
161835938|NCT01550744|584440815|FG001|Double-Blind|Withdrawal by Subject|2|||
161955255|NCT05823974|584885182|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955256|NCT05823974|584885183|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955257|NCT05823974|584885184|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955258|NCT05823974|584885185|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162029586|NCT02095132|585165482|FG005|Overall Study|Adverse Event|0|||
162029587|NCT02095132|585165483|FG006|Overall Study|Adverse Event|1|||
162029588|NCT02095132|585165484|FG007|Overall Study|Adverse Event|0|||
162029589|NCT02095132|585165485|FG008|Overall Study|Adverse Event|0|||
161688360|NCT00440947|583909867|FG004|36-Week Induction Phase|Incarceration|0|||
161688361|NCT00440947|583909863|FG000|36-Week Induction Phase|Pregnancy|1|||
161955259|NCT05823974|584885186|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955260|NCT05823974|584885187|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955261|NCT05823974|584885188|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955262|NCT05823974|584885189|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161955263|NCT05823974|584885190|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955264|NCT05823974|584885191|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955265|NCT05823974|584885192|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955266|NCT05823974|584885193|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955267|NCT05823974|584885194|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955268|NCT05823974|584885195|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161955269|NCT05823974|584885175|FG000|Overall Study|Other|0|||
161955270|NCT05823974|584885176|FG001|Overall Study|Other|1|||
161688362|NCT00440947|583909864|FG001|36-Week Induction Phase|Pregnancy|0|||
161688363|NCT00440947|583909865|FG002|36-Week Induction Phase|Pregnancy|0|||
161688364|NCT00440947|583909866|FG003|36-Week Induction Phase|Pregnancy|0|||
161688365|NCT00440947|583909867|FG004|36-Week Induction Phase|Pregnancy|0|||
161688366|NCT00440947|583909863|FG000|48-Week Randomization Phase|Adverse Event|0|||
161688367|NCT00440947|583909864|FG001|48-Week Randomization Phase|Adverse Event|2|||
161955271|NCT05823974|584885177|FG002|Overall Study|Other|1|||
161955272|NCT05823974|584885178|FG003|Overall Study|Other|1|||
161955273|NCT05823974|584885179|FG004|Overall Study|Other|0|||
161688368|NCT00440947|583909865|FG002|48-Week Randomization Phase|Adverse Event|5|||
161688369|NCT00440947|583909866|FG003|48-Week Randomization Phase|Adverse Event|0|||
161688370|NCT00440947|583909867|FG004|48-Week Randomization Phase|Adverse Event|0|||
161688371|NCT00440947|583909863|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
161688372|NCT00440947|583909864|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
161688373|NCT00440947|583909865|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
161688374|NCT00440947|583909866|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
161688375|NCT00440947|583909867|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
161688376|NCT00440947|583909863|FG000|48-Week Randomization Phase|Non-compliance|0|||
161688377|NCT00440947|583909864|FG001|48-Week Randomization Phase|Non-compliance|3|||
161688378|NCT00440947|583909865|FG002|48-Week Randomization Phase|Non-compliance|4|||
161688379|NCT00440947|583909866|FG003|48-Week Randomization Phase|Non-compliance|0|||
161688380|NCT00440947|583909867|FG004|48-Week Randomization Phase|Non-compliance|0|||
161688381|NCT00440947|583909863|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
161688382|NCT00440947|583909864|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
161688383|NCT00440947|583909865|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
161955274|NCT05823974|584885180|FG005|Overall Study|Other|1|||
161955275|NCT05823974|584885181|FG006|Overall Study|Other|1|||
161955276|NCT05823974|584885182|FG007|Overall Study|Other|1|||
161955277|NCT05823974|584885183|FG008|Overall Study|Other|1|||
161955278|NCT05823974|584885184|FG009|Overall Study|Other|0|||
161688384|NCT00440947|583909866|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
161688385|NCT00440947|583909867|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
161688386|NCT00440947|583909863|FG000|48-Week Randomization Phase|Protocol Violation|0|||
161688387|NCT00440947|583909864|FG001|48-Week Randomization Phase|Protocol Violation|0|||
161955279|NCT05823974|584885185|FG010|Overall Study|Other|0|||
161955280|NCT05823974|584885186|FG011|Overall Study|Other|0|||
161835939|NCT01550744|584440816|FG002|Double-Blind|Withdrawal by Subject|15|||
161835940|NCT01550744|584440814|FG000|Double-Blind|Adverse Event|0|||
161835941|NCT01550744|584440815|FG001|Double-Blind|Adverse Event|4|||
161835942|NCT01550744|584440816|FG002|Double-Blind|Adverse Event|15|||
161835943|NCT01550744|584440814|FG000|Double-Blind|Death|0|||
161955281|NCT05823974|584885187|FG012|Overall Study|Other|2|||
161955282|NCT05823974|584885188|FG013|Overall Study|Other|1|||
161955283|NCT05823974|584885189|FG014|Overall Study|Other|0|||
161955284|NCT05823974|584885190|FG015|Overall Study|Other|1|||
161955285|NCT05823974|584885191|FG016|Overall Study|Other|0|||
161955286|NCT05823974|584885192|FG017|Overall Study|Other|0|||
161955287|NCT05823974|584885193|FG018|Overall Study|Other|0|||
161955288|NCT05823974|584885194|FG019|Overall Study|Other|0|||
161955289|NCT05823974|584885195|FG020|Overall Study|Other|0|||
161955290|NCT00316706|584885196|FG000|Overall Study|Lost to Follow-up|38|||
161955291|NCT00316706|584885197|FG001|Overall Study|Lost to Follow-up|48|||
161835944|NCT01550744|584440815|FG001|Double-Blind|Death|1|||
161835945|NCT01550744|584440816|FG002|Double-Blind|Death|0|||
161955292|NCT01133756|584885200|FG000|Overall Study|Adverse Event|1|||
161955293|NCT01133756|584885201|FG001|Overall Study|Adverse Event|2|||
161955294|NCT01133756|584885202|FG002|Overall Study|Adverse Event|1|||
161835946|NCT01550744|584440814|FG000|Double-Blind|Lack of Efficacy|0|||
161835947|NCT01550744|584440815|FG001|Double-Blind|Lack of Efficacy|2|||
161955295|NCT01133756|584885200|FG000|Overall Study|Investigator Decision|1|||
161955296|NCT01133756|584885201|FG001|Overall Study|Investigator Decision|0|||
161955297|NCT01133756|584885202|FG002|Overall Study|Investigator Decision|0|||
161955298|NCT01133756|584885200|FG000|Overall Study|Withdrawal by Subject|0|||
161955299|NCT01133756|584885201|FG001|Overall Study|Withdrawal by Subject|1|||
161955300|NCT01133756|584885202|FG002|Overall Study|Withdrawal by Subject|0|||
161955301|NCT01133756|584885200|FG000|Overall Study|Progression of Disease|0|||
161955302|NCT01133756|584885201|FG001|Overall Study|Progression of Disease|0|||
161955303|NCT01133756|584885202|FG002|Overall Study|Progression of Disease|1|||
161955304|NCT03941873|584885203|FG000|Overall Study|Death|0|||
161955305|NCT03941873|584885204|FG001|Overall Study|Death|12|||
161955306|NCT03941873|584885205|FG002|Overall Study|Death|2|||
161955307|NCT03941873|584885206|FG003|Overall Study|Death|53|||
161955308|NCT03941873|584885203|FG000|Overall Study|Withdrawal by Subject|1|||
161955309|NCT03941873|584885204|FG001|Overall Study|Withdrawal by Subject|1|||
161955310|NCT03941873|584885205|FG002|Overall Study|Withdrawal by Subject|0|||
161955311|NCT03941873|584885206|FG003|Overall Study|Withdrawal by Subject|5|||
161955312|NCT03941873|584885203|FG000|Overall Study|Lost to Follow-up|1|||
161955313|NCT03941873|584885204|FG001|Overall Study|Lost to Follow-up|2|||
161955314|NCT03941873|584885205|FG002|Overall Study|Lost to Follow-up|0|||
161955315|NCT03941873|584885206|FG003|Overall Study|Lost to Follow-up|0|||
161955316|NCT03941873|584885203|FG000|Overall Study|Sponsor Decision|0|||
161955317|NCT03941873|584885204|FG001|Overall Study|Sponsor Decision|6|||
161955318|NCT03941873|584885205|FG002|Overall Study|Sponsor Decision|0|||
161688388|NCT00440947|583909865|FG002|48-Week Randomization Phase|Protocol Violation|1|||
161688389|NCT00440947|583909866|FG003|48-Week Randomization Phase|Protocol Violation|0|||
161688390|NCT00440947|583909867|FG004|48-Week Randomization Phase|Protocol Violation|0|||
161688391|NCT00440947|583909863|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
161835948|NCT01550744|584440816|FG002|Double-Blind|Lack of Efficacy|8|||
161835949|NCT01550744|584440814|FG000|Double-Blind|Protocol Violation|0|||
161835950|NCT01550744|584440815|FG001|Double-Blind|Protocol Violation|0|||
161835951|NCT01550744|584440816|FG002|Double-Blind|Protocol Violation|4|||
161835952|NCT01550744|584440814|FG000|Double-Blind|Pregnancy|0|||
161835953|NCT01550744|584440815|FG001|Double-Blind|Pregnancy|0|||
161835954|NCT01550744|584440816|FG002|Double-Blind|Pregnancy|3|||
161835955|NCT01550744|584440814|FG000|Double-Blind|Other|0|||
161835956|NCT01550744|584440815|FG001|Double-Blind|Other|2|||
161835957|NCT01550744|584440816|FG002|Double-Blind|Other|10|||
161835958|NCT01782482|584440817|FG000|Overall Study|Adverse Event|2|||
161835959|NCT01782482|584440818|FG001|Overall Study|Adverse Event|1|||
161835960|NCT01782482|584440817|FG000|Overall Study|Lost to Follow-up|2|||
161835961|NCT01782482|584440818|FG001|Overall Study|Lost to Follow-up|3|||
162029590|NCT02095132|585165477|FG000|Overall Study|Death|0|||
162029591|NCT02095132|585165478|FG001|Overall Study|Death|0|||
162029592|NCT02095132|585165479|FG002|Overall Study|Death|0|||
162029593|NCT02095132|585165480|FG003|Overall Study|Death|0|||
162029594|NCT02095132|585165481|FG004|Overall Study|Death|0|||
162029595|NCT02095132|585165482|FG005|Overall Study|Death|0|||
162029596|NCT02095132|585165483|FG006|Overall Study|Death|1|||
162029597|NCT02095132|585165484|FG007|Overall Study|Death|0|||
162029598|NCT02095132|585165485|FG008|Overall Study|Death|0|||
162029599|NCT02095132|585165477|FG000|Overall Study|Lack of Efficacy|3|||
162029600|NCT02095132|585165478|FG001|Overall Study|Lack of Efficacy|5|||
162029601|NCT02095132|585165479|FG002|Overall Study|Lack of Efficacy|2|||
162029602|NCT02095132|585165480|FG003|Overall Study|Lack of Efficacy|8|||
162029603|NCT02095132|585165481|FG004|Overall Study|Lack of Efficacy|3|||
162029604|NCT02095132|585165482|FG005|Overall Study|Lack of Efficacy|6|||
162029605|NCT02095132|585165483|FG006|Overall Study|Lack of Efficacy|10|||
162029606|NCT02095132|585165484|FG007|Overall Study|Lack of Efficacy|9|||
162029607|NCT02095132|585165485|FG008|Overall Study|Lack of Efficacy|8|||
162029608|NCT02095132|585165477|FG000|Overall Study|Physician Decision|1|||
162029609|NCT02095132|585165478|FG001|Overall Study|Physician Decision|0|||
162029610|NCT02095132|585165479|FG002|Overall Study|Physician Decision|0|||
162029611|NCT02095132|585165480|FG003|Overall Study|Physician Decision|0|||
161688392|NCT00440947|583909864|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
161688393|NCT00440947|583909865|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
161688394|NCT00440947|583909866|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
161688395|NCT00440947|583909867|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
161688396|NCT00440947|583909863|FG000|48-Week Randomization Phase|Pregnancy|0|||
161688397|NCT00440947|583909864|FG001|48-Week Randomization Phase|Pregnancy|0|||
161688398|NCT00440947|583909865|FG002|48-Week Randomization Phase|Pregnancy|1|||
161688399|NCT00440947|583909866|FG003|48-Week Randomization Phase|Pregnancy|0|||
161688400|NCT00440947|583909867|FG004|48-Week Randomization Phase|Pregnancy|0|||
161688401|NCT00440947|583909863|FG000|48-Week Randomization Phase|Incarceration|0|||
162029612|NCT02095132|585165481|FG004|Overall Study|Physician Decision|0|||
162029613|NCT02095132|585165482|FG005|Overall Study|Physician Decision|0|||
162029614|NCT02095132|585165483|FG006|Overall Study|Physician Decision|1|||
162029615|NCT02095132|585165484|FG007|Overall Study|Physician Decision|0|||
162029616|NCT02095132|585165485|FG008|Overall Study|Physician Decision|2|||
162029617|NCT02095132|585165477|FG000|Overall Study|Withdrawal by Subject|0|||
162029618|NCT02095132|585165478|FG001|Overall Study|Withdrawal by Subject|0|||
162029619|NCT02095132|585165479|FG002|Overall Study|Withdrawal by Subject|2|||
162029620|NCT02095132|585165480|FG003|Overall Study|Withdrawal by Subject|2|||
162029621|NCT02095132|585165481|FG004|Overall Study|Withdrawal by Subject|3|||
162029622|NCT02095132|585165482|FG005|Overall Study|Withdrawal by Subject|0|||
162029623|NCT02095132|585165483|FG006|Overall Study|Withdrawal by Subject|5|||
162029624|NCT02095132|585165484|FG007|Overall Study|Withdrawal by Subject|0|||
162029625|NCT02095132|585165485|FG008|Overall Study|Withdrawal by Subject|0|||
162029626|NCT04905498|585165488|FG000|Overall Study|Lost to Follow-up|0|||
162029627|NCT04905498|585165489|FG001|Overall Study|Lost to Follow-up|2|||
162029628|NCT04905498|585165488|FG000|Overall Study|COVID lockdown|1|||
162029629|NCT04905498|585165489|FG001|Overall Study|COVID lockdown|0|||
162029630|NCT01029405|585165490|FG000|Overall Study|Withdrawal by Subject|0|||
162029631|NCT01029405|585165491|FG001|Overall Study|Withdrawal by Subject|1|||
162029632|NCT01029405|585165492|FG002|Overall Study|Withdrawal by Subject|2|||
162029633|NCT01029405|585165493|FG003|Overall Study|Withdrawal by Subject|0|||
162029634|NCT01029405|585165490|FG000|Overall Study|Protocol Violation|0|||
162029635|NCT01029405|585165491|FG001|Overall Study|Protocol Violation|0|||
162029636|NCT01029405|585165492|FG002|Overall Study|Protocol Violation|0|||
162029637|NCT01029405|585165493|FG003|Overall Study|Protocol Violation|1|||
162029638|NCT01029405|585165490|FG000|Overall Study|Adverse Event|0|||
162029639|NCT01029405|585165491|FG001|Overall Study|Adverse Event|0|||
162029640|NCT01029405|585165492|FG002|Overall Study|Adverse Event|1|||
162029641|NCT01029405|585165493|FG003|Overall Study|Adverse Event|1|||
162029642|NCT01029405|585165490|FG000|Overall Study|Lost to Follow-up|2|||
162029643|NCT01029405|585165491|FG001|Overall Study|Lost to Follow-up|1|||
162029644|NCT01029405|585165492|FG002|Overall Study|Lost to Follow-up|1|||
161688402|NCT00440947|583909864|FG001|48-Week Randomization Phase|Incarceration|3|||
161688403|NCT00440947|583909865|FG002|48-Week Randomization Phase|Incarceration|0|||
161688404|NCT00440947|583909866|FG003|48-Week Randomization Phase|Incarceration|0|||
161688405|NCT00440947|583909867|FG004|48-Week Randomization Phase|Incarceration|0|||
161688406|NCT00440947|583909863|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
161688407|NCT00440947|583909864|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
161688408|NCT00440947|583909865|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
161688409|NCT00440947|583909866|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
161688410|NCT00440947|583909867|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
161688411|NCT00440947|583909863|FG000|48-Week Randomization Phase|Physician Decision|0|||
161688412|NCT00440947|583909864|FG001|48-Week Randomization Phase|Physician Decision|2|||
161688413|NCT00440947|583909865|FG002|48-Week Randomization Phase|Physician Decision|0|||
161688414|NCT00440947|583909866|FG003|48-Week Randomization Phase|Physician Decision|0|||
161688415|NCT00440947|583909867|FG004|48-Week Randomization Phase|Physician Decision|0|||
161688416|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
161688417|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
161688418|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
161688419|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
161688420|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
161688421|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
161688422|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
161688423|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
161688424|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
161688425|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
161688426|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
161688427|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
161688428|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
161688429|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
161688430|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
161688431|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
161688432|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
161688433|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
161688434|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
161688435|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
161688436|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
162029645|NCT01029405|585165493|FG003|Overall Study|Lost to Follow-up|2|||
162029646|NCT01029405|585165490|FG000|Overall Study|Other|0|||
162029647|NCT01029405|585165491|FG001|Overall Study|Other|1|||
162029648|NCT01029405|585165492|FG002|Overall Study|Other|0|||
161688437|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
161688438|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
161688439|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
161688440|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
161688441|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
162029649|NCT01029405|585165493|FG003|Overall Study|Other|1|||
162029650|NCT02692651|585165494|FG000|Study Treatment|Death|7|||
162029651|NCT02692651|585165495|FG001|Study Treatment|Death|3|||
162029652|NCT02692651|585165494|FG000|Study Treatment|comfort care|1|||
162029653|NCT02692651|585165495|FG001|Study Treatment|comfort care|1|||
161688442|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
161688443|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
161688444|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
161688445|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
161688446|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
161688447|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
161688448|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
161688449|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
161688450|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
161688451|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
161688452|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
161688453|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
161688454|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
161688455|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
161688456|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
161688457|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
161688458|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
161688459|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
161688460|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
161688461|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
161688462|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
161688463|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
161688464|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
161688465|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
161688466|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
161688467|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
161688468|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
161688469|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
161688470|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
161688471|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Other|0|||
161688472|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Other|0|||
161688473|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Other|0|||
161688474|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Other|1|||
161835962|NCT01782482|584440817|FG000|Overall Study|Physician Decision|1|||
161835963|NCT01782482|584440818|FG001|Overall Study|Physician Decision|0|||
161835964|NCT01782482|584440817|FG000|Overall Study|Protocol Violation|1|||
161835965|NCT01782482|584440818|FG001|Overall Study|Protocol Violation|0|||
161835966|NCT01782482|584440817|FG000|Overall Study|Withdrawal by Subject|2|||
161835967|NCT01782482|584440818|FG001|Overall Study|Withdrawal by Subject|3|||
161835968|NCT01782482|584440817|FG000|Overall Study|Randomized in Error|2|||
161835969|NCT01782482|584440818|FG001|Overall Study|Randomized in Error|2|||
161835970|NCT01782482|584440817|FG000|Overall Study|Habitually wearing toric lens OS|0|||
161835971|NCT01782482|584440818|FG001|Overall Study|Habitually wearing toric lens OS|1|||
161835972|NCT00767520|584440819|FG000|Overall Study|Participants still on treatment|11|||
161835973|NCT00767520|584440820|FG001|Overall Study|Participants still on treatment|15|||
161835974|NCT00767520|584440819|FG000|Overall Study|Randomized in error and Never treated|0|||
161835975|NCT00767520|584440820|FG001|Overall Study|Randomized in error and Never treated|2|||
161835976|NCT00757848|584440821|FG000|Overall Study|Voluntary discontinuation|1|||
161955319|NCT03941873|584885206|FG003|Overall Study|Sponsor Decision|15|||
161955320|NCT03276728|584885209|FG000|Overall Study|Lost to Follow-up|0|||
161955321|NCT03276728|584885210|FG001|Overall Study|Lost to Follow-up|0|||
161955322|NCT03276728|584885211|FG002|Overall Study|Lost to Follow-up|2|||
161955323|NCT03276728|584885212|FG003|Overall Study|Lost to Follow-up|2|||
161955324|NCT03276728|584885213|FG004|Overall Study|Lost to Follow-up|0|||
161955325|NCT03276728|584885214|FG005|Overall Study|Lost to Follow-up|0|||
161955326|NCT03276728|584885215|FG006|Overall Study|Lost to Follow-up|0|||
161955327|NCT03276728|584885216|FG007|Overall Study|Lost to Follow-up|0|||
161955328|NCT03276728|584885209|FG000|Overall Study|Withdrawal by Subject|0|||
161955329|NCT03276728|584885210|FG001|Overall Study|Withdrawal by Subject|0|||
161955330|NCT03276728|584885211|FG002|Overall Study|Withdrawal by Subject|0|||
161955331|NCT03276728|584885212|FG003|Overall Study|Withdrawal by Subject|3|||
161955332|NCT03276728|584885213|FG004|Overall Study|Withdrawal by Subject|0|||
161955333|NCT03276728|584885214|FG005|Overall Study|Withdrawal by Subject|0|||
161955334|NCT03276728|584885215|FG006|Overall Study|Withdrawal by Subject|0|||
161955335|NCT03276728|584885216|FG007|Overall Study|Withdrawal by Subject|0|||
161955336|NCT03276728|584885209|FG000|Overall Study|Decision by sponsor|0|||
161955337|NCT03276728|584885210|FG001|Overall Study|Decision by sponsor|0|||
161955338|NCT03276728|584885211|FG002|Overall Study|Decision by sponsor|0|||
161955339|NCT03276728|584885212|FG003|Overall Study|Decision by sponsor|0|||
161955340|NCT03276728|584885213|FG004|Overall Study|Decision by sponsor|1|||
161955341|NCT03276728|584885214|FG005|Overall Study|Decision by sponsor|0|||
161955342|NCT03276728|584885215|FG006|Overall Study|Decision by sponsor|2|||
161835977|NCT00757848|584440822|FG001|Overall Study|Voluntary discontinuation|0|||
161835978|NCT00757848|584440821|FG000|Overall Study|Adverse Event|1|||
161688475|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Other|0|||
161688476|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
161955343|NCT03276728|584885216|FG007|Overall Study|Decision by sponsor|1|||
161955344|NCT02222688|584885217|FG000|Overall Study|Withdrawal by Subject|0|||
161955345|NCT02222688|584885218|FG001|Overall Study|Withdrawal by Subject|0|||
161688477|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
161955346|NCT02222688|584885219|FG002|Overall Study|Withdrawal by Subject|0|||
161955347|NCT02222688|584885220|FG003|Overall Study|Withdrawal by Subject|2|||
161955348|NCT02222688|584885221|FG004|Overall Study|Withdrawal by Subject|1|||
161955349|NCT02222688|584885222|FG005|Overall Study|Withdrawal by Subject|0|||
161955350|NCT02222688|584885223|FG006|Overall Study|Withdrawal by Subject|1|||
161955351|NCT02222688|584885217|FG000|Overall Study|Disease progression|1|||
161955352|NCT02222688|584885218|FG001|Overall Study|Disease progression|0|||
161955353|NCT02222688|584885219|FG002|Overall Study|Disease progression|0|||
161955354|NCT02222688|584885220|FG003|Overall Study|Disease progression|0|||
161955355|NCT02222688|584885221|FG004|Overall Study|Disease progression|0|||
161955356|NCT02222688|584885222|FG005|Overall Study|Disease progression|0|||
161955357|NCT02222688|584885223|FG006|Overall Study|Disease progression|0|||
161955358|NCT01188551|584885227|FG000|Overall Study|Pharmacy issues|1|||
161955359|NCT01188551|584885228|FG001|Overall Study|Pharmacy issues|0|||
161955360|NCT01188551|584885229|FG002|Overall Study|Pharmacy issues|0|||
161955361|NCT01188551|584885230|FG003|Overall Study|Pharmacy issues|0|||
161955362|NCT01306643|584885233|FG000|Overall Study|Adverse Event|5|||
161955363|NCT01306643|584885233|FG000|Overall Study|Disease Progression|7|||
161955364|NCT01306643|584885233|FG000|Overall Study|Other: Change in Eligibility Status|1|||
161955365|NCT01582009|584885237|FG000|Overall Study|Withdrawal by Subject|1|||
161955366|NCT01582009|584885237|FG000|Overall Study|Physician Decision|1|||
161955367|NCT00310375|584885238|FG000|Primary Reporting Phase|Adverse Event|28|||
161955368|NCT00310375|584885239|FG001|Primary Reporting Phase|Adverse Event|22|||
161955369|NCT00310375|584885240|FG002|Primary Reporting Phase|Adverse Event|0|||
161955370|NCT00310375|584885238|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
161955371|NCT00310375|584885239|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
161955372|NCT00310375|584885240|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
161955373|NCT00310375|584885238|FG000|Primary Reporting Phase|Pregnancy|2|||
161955374|NCT00310375|584885239|FG001|Primary Reporting Phase|Pregnancy|2|||
161955375|NCT00310375|584885240|FG002|Primary Reporting Phase|Pregnancy|0|||
161955376|NCT00310375|584885238|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
161955377|NCT00310375|584885239|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
161955378|NCT00310375|584885240|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
161955379|NCT00310375|584885238|FG000|Primary Reporting Phase|Protocol Violation|8|||
161955380|NCT00310375|584885239|FG001|Primary Reporting Phase|Protocol Violation|5|||
161955381|NCT00310375|584885240|FG002|Primary Reporting Phase|Protocol Violation|0|||
161955382|NCT00310375|584885238|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
161955383|NCT00310375|584885239|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
161955384|NCT00310375|584885240|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
161955385|NCT00310375|584885238|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
161955386|NCT00310375|584885239|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
161955387|NCT00310375|584885240|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
161955388|NCT00310375|584885238|FG000|Primary Reporting Phase|Physician Decision|5|||
161955389|NCT00310375|584885239|FG001|Primary Reporting Phase|Physician Decision|3|||
161955390|NCT00310375|584885240|FG002|Primary Reporting Phase|Physician Decision|0|||
161955391|NCT00310375|584885238|FG000|Primary Reporting Phase|Request of the sponsor|2|||
161955392|NCT00310375|584885239|FG001|Primary Reporting Phase|Request of the sponsor|2|||
161955393|NCT00310375|584885240|FG002|Primary Reporting Phase|Request of the sponsor|0|||
161955394|NCT00310375|584885238|FG000|Primary Reporting Phase|Failed to return|1|||
161955395|NCT00310375|584885239|FG001|Primary Reporting Phase|Failed to return|3|||
161955396|NCT00310375|584885240|FG002|Primary Reporting Phase|Failed to return|0|||
161955397|NCT00310375|584885238|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
161955398|NCT00310375|584885239|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
161955399|NCT00310375|584885240|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
161955400|NCT00310375|584885238|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
161955401|NCT00310375|584885239|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
161955402|NCT00310375|584885240|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
161955403|NCT00310375|584885238|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
161955404|NCT00310375|584885239|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
161955405|NCT00310375|584885240|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
161955406|NCT00310375|584885238|FG000|Primary Reporting Phase|Site closure|3|||
161955407|NCT00310375|584885239|FG001|Primary Reporting Phase|Site closure|0|||
162029654|NCT02692651|585165494|FG000|Study Treatment|Protocol violation per treating team preference|8|||
162029655|NCT02692651|585165495|FG001|Study Treatment|Protocol violation per treating team preference|6|||
162029656|NCT02692651|585165494|FG000|Post Study Treatment Follow-up|Death|4|||
162029657|NCT02692651|585165495|FG001|Post Study Treatment Follow-up|Death|4|||
162029658|NCT03490981|585165496|FG000|Overall Study|Lost to Follow-up|1|||
162029659|NCT03490981|585165497|FG001|Overall Study|Lost to Follow-up|2|||
162029660|NCT02480712|585165504|FG000|Overall Study|Enrolled but Never Treated|1|||
162029661|NCT02480712|585165504|FG000|Overall Study|Lost to Follow-up|5|||
162029662|NCT02480712|585165504|FG000|Overall Study|Withdrew Consent|3|||
162029663|NCT02480712|585165504|FG000|Overall Study|Death|1|||
162029664|NCT02480712|585165504|FG000|Overall Study|Lack of Efficacy|1|||
162029665|NCT01860846|585165505|FG000|Overall Study|Lost to Follow-up|33|||
162029666|NCT00466687|585165506|FG000|Overall Study|Adverse Event|1|||
162029667|NCT00466687|585165506|FG000|Overall Study|Other complicating illness|3|||
162029668|NCT00466687|585165506|FG000|Overall Study|Withdrawal by Subject|1|||
162029669|NCT00466687|585165506|FG000|Overall Study|Disease progression|29|||
162029670|NCT02586506|585165507|FG000|Overall Study|Protocol Violation|6|||
162029671|NCT02586506|585165507|FG000|Overall Study|Lost to Follow-up|1|||
162029672|NCT02586506|585165507|FG000|Overall Study|Other Reason|2|||
162029673|NCT05027971|585165517|FG000|Overall Study|Physician Decision|7|||
162029674|NCT05027971|585165518|FG001|Overall Study|Physician Decision|3|||
162029675|NCT05027971|585165517|FG000|Overall Study|Lost to Follow-up|1|||
162029676|NCT05027971|585165518|FG001|Overall Study|Lost to Follow-up|1|||
162029677|NCT05027971|585165517|FG000|Overall Study|Withdrawal by Subject|0|||
162029678|NCT05027971|585165518|FG001|Overall Study|Withdrawal by Subject|2|||
162029679|NCT05027971|585165517|FG000|Overall Study|Non-study fiber used.|0|||
161688478|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
161688479|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
161688480|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
161688481|NCT00440947|583909863|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
161688482|NCT00440947|583909864|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
161688483|NCT00440947|583909865|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
161688484|NCT00440947|583909866|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
161688485|NCT00440947|583909867|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
161688486|NCT03681119|583909874|FG000|Overall Study|No specific reason|4|||
161688487|NCT03681119|583909875|FG001|Overall Study|No specific reason|0|||
161688488|NCT03681119|583909874|FG000|Overall Study|Sickness|2|||
161688489|NCT03681119|583909875|FG001|Overall Study|Sickness|0|||
161688490|NCT00513500|583909884|FG000|Overall Study|Lost to Follow-up|35|||
162029680|NCT05027971|585165518|FG001|Overall Study|Non-study fiber used.|1|||
162029681|NCT05027971|585165517|FG000|Overall Study|Protocol Violation|0|||
162029682|NCT05027971|585165518|FG001|Overall Study|Protocol Violation|2|||
162029683|NCT02025556|585165519|FG000|Overall Study|Adverse Event|0|||
162029684|NCT02025556|585165520|FG001|Overall Study|Adverse Event|4|||
162029685|NCT02025556|585165521|FG002|Overall Study|Adverse Event|2|||
162029686|NCT02025556|585165519|FG000|Overall Study|Lack of Efficacy|2|||
162029687|NCT02025556|585165520|FG001|Overall Study|Lack of Efficacy|1|||
162029688|NCT02025556|585165521|FG002|Overall Study|Lack of Efficacy|0|||
162029689|NCT02025556|585165519|FG000|Overall Study|Protocol Violation|2|||
161688491|NCT00513500|583909885|FG001|Overall Study|Lost to Follow-up|39|||
161688492|NCT00513500|583909884|FG000|Overall Study|Death|2|||
161688493|NCT00513500|583909885|FG001|Overall Study|Death|1|||
161688494|NCT00513500|583909884|FG000|Overall Study|Hospitalized|4|||
161688495|NCT00513500|583909885|FG001|Overall Study|Hospitalized|14|||
161688496|NCT00517829|583909886|FG000|Overall Study|Adverse Event|22|||
161688497|NCT00517829|583909887|FG001|Overall Study|Adverse Event|34|||
161688498|NCT00517829|583909886|FG000|Overall Study|Disease Progression|39|||
161688499|NCT00517829|583909887|FG001|Overall Study|Disease Progression|32|||
161835979|NCT00757848|584440822|FG001|Overall Study|Adverse Event|2|||
161835980|NCT00757848|584440821|FG000|Overall Study|Incorrect enrolment|1|||
161835981|NCT00757848|584440822|FG001|Overall Study|Incorrect enrolment|0|||
162029690|NCT02025556|585165520|FG001|Overall Study|Protocol Violation|1|||
162029691|NCT02025556|585165521|FG002|Overall Study|Protocol Violation|0|||
161688500|NCT00517829|583909886|FG000|Overall Study|Patient Request|6|||
161688501|NCT00517829|583909887|FG001|Overall Study|Patient Request|5|||
161688502|NCT00517829|583909886|FG000|Overall Study|Investigator Request|5|||
161688503|NCT00517829|583909887|FG001|Overall Study|Investigator Request|3|||
161688504|NCT00517829|583909886|FG000|Overall Study|Other|3|||
161688505|NCT00517829|583909887|FG001|Overall Study|Other|1|||
162029692|NCT02025556|585165519|FG000|Overall Study|Withdrawal by Subject|0|||
162029693|NCT02025556|585165520|FG001|Overall Study|Withdrawal by Subject|3|||
162029694|NCT02025556|585165521|FG002|Overall Study|Withdrawal by Subject|6|||
162029695|NCT02025556|585165519|FG000|Overall Study|Lost to Follow-up|2|||
162029696|NCT02025556|585165520|FG001|Overall Study|Lost to Follow-up|4|||
162029697|NCT02025556|585165521|FG002|Overall Study|Lost to Follow-up|0|||
162029698|NCT02025556|585165519|FG000|Overall Study|Reason not reported|0|||
162029699|NCT02025556|585165520|FG001|Overall Study|Reason not reported|0|||
162029700|NCT02025556|585165521|FG002|Overall Study|Reason not reported|1|||
162029701|NCT00796991|585165523|FG000|Overall Study|Adverse Event|0|||
162029702|NCT00796991|585165524|FG001|Overall Study|Adverse Event|0|||
162029703|NCT00796991|585165525|FG002|Overall Study|Adverse Event|1|||
162029704|NCT00796991|585165523|FG000|Overall Study|Death|2|||
162029705|NCT00796991|585165524|FG001|Overall Study|Death|0|||
162029706|NCT00796991|585165525|FG002|Overall Study|Death|0|||
162029707|NCT00796991|585165523|FG000|Overall Study|Disease Progression|10|||
162029708|NCT00796991|585165524|FG001|Overall Study|Disease Progression|9|||
162029709|NCT00796991|585165525|FG002|Overall Study|Disease Progression|7|||
162029710|NCT00796991|585165523|FG000|Overall Study|Study Drug Toxicity|3|||
162029711|NCT00796991|585165524|FG001|Overall Study|Study Drug Toxicity|3|||
162029712|NCT00796991|585165525|FG002|Overall Study|Study Drug Toxicity|5|||
162029713|NCT00796991|585165523|FG000|Overall Study|Withdrawal by Subject|0|||
162029714|NCT00796991|585165524|FG001|Overall Study|Withdrawal by Subject|0|||
162029715|NCT00796991|585165525|FG002|Overall Study|Withdrawal by Subject|1|||
162029716|NCT00171834|585165528|FG000|Overall Study|Adverse Event|2|||
162029717|NCT00171834|585165529|FG001|Overall Study|Adverse Event|1|||
162029718|NCT00171834|585165530|FG002|Overall Study|Adverse Event|3|||
162029719|NCT00171834|585165531|FG003|Overall Study|Adverse Event|2|||
162029720|NCT00171834|585165532|FG004|Overall Study|Adverse Event|2|||
162029721|NCT00171834|585165533|FG005|Overall Study|Adverse Event|15|||
162029722|NCT00171834|585165534|FG006|Overall Study|Adverse Event|1|||
162029723|NCT00171834|585165528|FG000|Overall Study|Withdrawal by Subject|0|||
162029724|NCT00171834|585165529|FG001|Overall Study|Withdrawal by Subject|2|||
162029725|NCT00171834|585165530|FG002|Overall Study|Withdrawal by Subject|0|||
162029726|NCT00171834|585165531|FG003|Overall Study|Withdrawal by Subject|1|||
162029727|NCT00171834|585165532|FG004|Overall Study|Withdrawal by Subject|1|||
162029728|NCT00171834|585165533|FG005|Overall Study|Withdrawal by Subject|1|||
162029729|NCT00171834|585165534|FG006|Overall Study|Withdrawal by Subject|0|||
162029730|NCT00171834|585165528|FG000|Overall Study|Death from study indication|0|||
162029731|NCT00171834|585165529|FG001|Overall Study|Death from study indication|1|||
162029732|NCT00171834|585165530|FG002|Overall Study|Death from study indication|0|||
162029733|NCT00171834|585165531|FG003|Overall Study|Death from study indication|0|||
162029734|NCT00171834|585165532|FG004|Overall Study|Death from study indication|1|||
162029735|NCT00171834|585165533|FG005|Overall Study|Death from study indication|0|||
162029736|NCT00171834|585165534|FG006|Overall Study|Death from study indication|0|||
162029737|NCT00171834|585165528|FG000|Overall Study|Disease Progression|4|||
162029738|NCT00171834|585165529|FG001|Overall Study|Disease Progression|8|||
162029739|NCT00171834|585165530|FG002|Overall Study|Disease Progression|8|||
162029740|NCT00171834|585165531|FG003|Overall Study|Disease Progression|9|||
162029741|NCT00171834|585165532|FG004|Overall Study|Disease Progression|2|||
162029742|NCT00171834|585165533|FG005|Overall Study|Disease Progression|18|||
162029743|NCT00171834|585165534|FG006|Overall Study|Disease Progression|3|||
162029744|NCT00171834|585165528|FG000|Overall Study|Treatment Duration Completed|0|||
162029745|NCT00171834|585165529|FG001|Overall Study|Treatment Duration Completed|0|||
162029746|NCT00171834|585165530|FG002|Overall Study|Treatment Duration Completed|1|||
162029747|NCT00171834|585165531|FG003|Overall Study|Treatment Duration Completed|0|||
162029748|NCT00171834|585165532|FG004|Overall Study|Treatment Duration Completed|2|||
162029749|NCT00171834|585165533|FG005|Overall Study|Treatment Duration Completed|1|||
162029750|NCT00171834|585165534|FG006|Overall Study|Treatment Duration Completed|0|||
162029751|NCT00834080|585165535|FG000|Overall Study|Adverse Event|7|||
162029752|NCT00834080|585165535|FG000|Overall Study|Lost to Follow-up|7|||
162029753|NCT00834080|585165535|FG000|Overall Study|Withdrawal by Subject|5|||
162029754|NCT00834080|585165535|FG000|Overall Study|Other - Pregnancy|1|||
162029755|NCT00834080|585165535|FG000|Overall Study|Other - False positive tests of the UDS|1|||
162029756|NCT00834080|585165535|FG000|Overall Study|Physician Decision|1|||
162029757|NCT00834080|585165535|FG000|Overall Study|Subject Relocated|1|||
162029758|NCT04345367|585165537|FG000|Overall Study|Other|3|||
162029759|NCT04345367|585165538|FG001|Overall Study|Other|4|||
162029760|NCT04345367|585165537|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
162029761|NCT04345367|585165538|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
162029762|NCT04345367|585165537|FG000|Overall Study|Withdrawal by Subject|11|||
161688506|NCT00606086|583909889|FG000|Overall Study|Adverse Event|1|||
161688507|NCT00606086|583909890|FG001|Overall Study|Adverse Event|1|||
162029763|NCT04345367|585165538|FG001|Overall Study|Withdrawal by Subject|11|||
162029764|NCT04345367|585165537|FG000|Overall Study|Protocol Violation|4|||
162029765|NCT04345367|585165538|FG001|Overall Study|Protocol Violation|3|||
162029766|NCT04345367|585165537|FG000|Overall Study|Lost to Follow-up|2|||
162029767|NCT04345367|585165538|FG001|Overall Study|Lost to Follow-up|4|||
162029768|NCT04345367|585165537|FG000|Overall Study|Lack of Efficacy|2|||
162029769|NCT04345367|585165538|FG001|Overall Study|Lack of Efficacy|0|||
162029770|NCT04345367|585165537|FG000|Overall Study|Death|2|||
162029771|NCT04345367|585165538|FG001|Overall Study|Death|0|||
162029772|NCT04345367|585165537|FG000|Overall Study|Adverse Event|10|||
162029773|NCT04345367|585165538|FG001|Overall Study|Adverse Event|9|||
162029774|NCT00439738|585165541|FG000|Overall Study|Withdrawal by Subject|16|||
162029775|NCT00439738|585165542|FG001|Overall Study|Withdrawal by Subject|13|||
162029776|NCT00439738|585165541|FG000|Overall Study|Adverse Event|6|||
162029777|NCT00439738|585165542|FG001|Overall Study|Adverse Event|4|||
161688508|NCT00606086|583909889|FG000|Overall Study|Lost to Follow-up|4|||
161688509|NCT00606086|583909890|FG001|Overall Study|Lost to Follow-up|8|||
161688510|NCT00606086|583909889|FG000|Overall Study|Protocol Violation|1|||
161688511|NCT00606086|583909890|FG001|Overall Study|Protocol Violation|0|||
161688512|NCT00606086|583909889|FG000|Overall Study|Withdrawal by Subject|5|||
161688513|NCT00606086|583909890|FG001|Overall Study|Withdrawal by Subject|3|||
161688514|NCT00606086|583909889|FG000|Overall Study|Non-compliance|0|||
161688515|NCT00606086|583909890|FG001|Overall Study|Non-compliance|1|||
161688516|NCT00606086|583909889|FG000|Overall Study|Randomized, not treated|1|||
161955408|NCT00310375|584885240|FG002|Primary Reporting Phase|Site closure|0|||
161955409|NCT00310375|584885238|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
161955410|NCT00310375|584885239|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
161955411|NCT00310375|584885240|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
161955412|NCT00310375|584885238|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
161955413|NCT00310375|584885239|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
161955414|NCT00310375|584885240|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
161955415|NCT00310375|584885238|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
161955416|NCT00310375|584885239|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
161955417|NCT00310375|584885240|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
161955418|NCT00310375|584885238|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
161955419|NCT00310375|584885239|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
161955420|NCT00310375|584885240|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
161955421|NCT04024436|584885241|FG000|Overall Study|Death|10|||
161955422|NCT04024436|584885242|FG001|Overall Study|Death|14|||
161955423|NCT04024436|584885243|FG002|Overall Study|Death|2|||
161955424|NCT04024436|584885244|FG003|Overall Study|Death|7|||
161955425|NCT04024436|584885241|FG000|Overall Study|Loss to follow up|1|||
161955426|NCT04024436|584885242|FG001|Overall Study|Loss to follow up|0|||
161955427|NCT04024436|584885243|FG002|Overall Study|Loss to follow up|0|||
161955428|NCT04024436|584885244|FG003|Overall Study|Loss to follow up|1|||
161955429|NCT04024436|584885241|FG000|Overall Study|Withdrawal of consent|2|||
161955430|NCT04024436|584885242|FG001|Overall Study|Withdrawal of consent|0|||
161955431|NCT04024436|584885243|FG002|Overall Study|Withdrawal of consent|0|||
161955432|NCT04024436|584885244|FG003|Overall Study|Withdrawal of consent|1|||
161955433|NCT04024436|584885241|FG000|Overall Study|Study termination by sponsor|4|||
161955434|NCT04024436|584885242|FG001|Overall Study|Study termination by sponsor|6|||
161955435|NCT04024436|584885243|FG002|Overall Study|Study termination by sponsor|2|||
161955436|NCT04024436|584885244|FG003|Overall Study|Study termination by sponsor|11|||
161955437|NCT04024436|584885241|FG000|Overall Study|Reason Not Specified|0|||
161955438|NCT04024436|584885242|FG001|Overall Study|Reason Not Specified|1|||
161955439|NCT04024436|584885243|FG002|Overall Study|Reason Not Specified|0|||
161955440|NCT04024436|584885244|FG003|Overall Study|Reason Not Specified|2|||
161955441|NCT01134614|584885245|FG000|Overall Study|Still on treatment as of March 2013|21|||
161955442|NCT01134614|584885246|FG001|Overall Study|Still on treatment as of March 2013|13|||
161955443|NCT01134614|584885245|FG000|Overall Study|Progressive disease|60|||
161955444|NCT01134614|584885246|FG001|Overall Study|Progressive disease|54|||
161955445|NCT01134614|584885245|FG000|Overall Study|Adverse Event|26|||
161955446|NCT01134614|584885246|FG001|Overall Study|Adverse Event|39|||
161955447|NCT01134614|584885245|FG000|Overall Study|Death|5|||
161955448|NCT01134614|584885246|FG001|Overall Study|Death|8|||
161955449|NCT01134614|584885245|FG000|Overall Study|Withdrawal by Subject|3|||
161955450|NCT01134614|584885246|FG001|Overall Study|Withdrawal by Subject|2|||
161955451|NCT01134614|584885245|FG000|Overall Study|Alternative therapy|2|||
161955452|NCT01134614|584885246|FG001|Overall Study|Alternative therapy|0|||
161955453|NCT01134614|584885245|FG000|Overall Study|Complicating disease|2|||
161955454|NCT01134614|584885246|FG001|Overall Study|Complicating disease|1|||
161955455|NCT01134614|584885245|FG000|Overall Study|Physician's decision|0|||
161955456|NCT01134614|584885246|FG001|Overall Study|Physician's decision|1|||
161955457|NCT01134614|584885245|FG000|Overall Study|Never started treatment|4|||
161955458|NCT01134614|584885246|FG001|Overall Study|Never started treatment|1|||
161955459|NCT01134614|584885245|FG000|Overall Study|Pt received tx not allowed on study|0|||
161955460|NCT01134614|584885246|FG001|Overall Study|Pt received tx not allowed on study|1|||
161955461|NCT01134614|584885245|FG000|Overall Study|Symptomatic deterioration|0|||
161955462|NCT01134614|584885246|FG001|Overall Study|Symptomatic deterioration|1|||
161955463|NCT01134614|584885245|FG000|Overall Study|Patient in hospice care|0|||
161955464|NCT01134614|584885246|FG001|Overall Study|Patient in hospice care|1|||
161955465|NCT02553928|584885247|FG000|Overall Study|Adverse Event|2|||
161955466|NCT02553928|584885248|FG001|Overall Study|Adverse Event|1|||
161955467|NCT02553928|584885247|FG000|Overall Study|Lost to Follow-up|0|||
161955468|NCT02553928|584885248|FG001|Overall Study|Lost to Follow-up|1|||
161955469|NCT02553928|584885247|FG000|Overall Study|Administrative reason(s)|0|||
161955470|NCT02553928|584885248|FG001|Overall Study|Administrative reason(s)|1|||
162029778|NCT00439738|585165541|FG000|Overall Study|Lost to Follow-up|5|||
162029779|NCT00439738|585165542|FG001|Overall Study|Lost to Follow-up|6|||
162029780|NCT00439738|585165541|FG000|Overall Study|Protocol Violation|6|||
162029781|NCT00439738|585165542|FG001|Overall Study|Protocol Violation|3|||
162029782|NCT00439738|585165541|FG000|Overall Study|Lack of Efficacy|2|||
162029783|NCT00439738|585165542|FG001|Overall Study|Lack of Efficacy|2|||
162029784|NCT00439738|585165541|FG000|Overall Study|Abnormal Lab Values|1|||
162029785|NCT00439738|585165542|FG001|Overall Study|Abnormal Lab Values|0|||
162029786|NCT00781885|585165545|FG000|Overall Study|Physician Decision|1|||
162029787|NCT03836001|585165546|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
162029788|NCT03836001|585165547|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
162029789|NCT03836001|585165548|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
162029790|NCT03836001|585165546|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
162029791|NCT03836001|585165547|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
162029792|NCT03836001|585165548|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
162029793|NCT03836001|585165546|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
162029794|NCT03836001|585165547|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
162029795|NCT03836001|585165548|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
162029796|NCT03836001|585165546|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
162029797|NCT03836001|585165547|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
162029798|NCT03836001|585165548|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
162029799|NCT01755026|585165549|FG000|Overall Study|Adverse Event|1|||
162029800|NCT01755026|585165550|FG001|Overall Study|Adverse Event|0|||
162029801|NCT01755026|585165549|FG000|Overall Study|Withdrawal by Subject|1|||
162029802|NCT01755026|585165550|FG001|Overall Study|Withdrawal by Subject|1|||
162029803|NCT01284491|585165551|FG000|Overall Study|Study termination|13|||
162029804|NCT01978938|585165552|FG000|Overall Study|Lost to Follow-up|12|||
162029805|NCT01978938|585165553|FG001|Overall Study|Lost to Follow-up|6|||
162029806|NCT01978938|585165552|FG000|Overall Study|Withdrawal by Subject|8|||
162029807|NCT01978938|585165553|FG001|Overall Study|Withdrawal by Subject|4|||
162029808|NCT01978938|585165552|FG000|Overall Study|Adverse Event, non-fatal|2|||
162029809|NCT01978938|585165553|FG001|Overall Study|Adverse Event, non-fatal|1|||
162029810|NCT01978938|585165552|FG000|Overall Study|Participant noncompliance|1|||
162029811|NCT01978938|585165553|FG001|Overall Study|Participant noncompliance|1|||
162029812|NCT01978938|585165552|FG000|Overall Study|Did not meet inclusion criteria|0|||
162029813|NCT01978938|585165553|FG001|Overall Study|Did not meet inclusion criteria|1|||
162029814|NCT01978938|585165552|FG000|Overall Study|Previously scheduled procedure|0|||
162029815|NCT01978938|585165553|FG001|Overall Study|Previously scheduled procedure|1|||
162029816|NCT02694757|585165554|FG000|Overall Study|Lack of Efficacy|3|||
162029817|NCT02650921|585165555|FG000|Overall Study|Withdrawal by Subject|4|||
162029818|NCT02650921|585165555|FG000|Overall Study|Lost to Follow-up|2|||
162029819|NCT02650921|585165555|FG000|Overall Study|Adverse Event|1|||
162029820|NCT02650921|585165555|FG000|Overall Study|Due to Medical Condition|1|||
162029821|NCT01087788|585165556|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
162029822|NCT01087788|585165557|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
162029823|NCT01087788|585165558|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
162029824|NCT01087788|585165556|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
162029825|NCT01087788|585165557|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
162029826|NCT01087788|585165558|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
162029827|NCT01087788|585165556|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
162029828|NCT01087788|585165557|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
161955471|NCT05507567|584885249|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
161955472|NCT05507567|584885250|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
161955473|NCT05507567|584885251|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
161955474|NCT05507567|584885249|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
161955475|NCT05507567|584885250|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
161955476|NCT05507567|584885251|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
161955477|NCT05507567|584885249|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
161955478|NCT05507567|584885250|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
161955479|NCT05507567|584885251|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
161955480|NCT05507567|584885249|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
161955481|NCT05507567|584885250|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
161955482|NCT05507567|584885251|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
161955483|NCT04830215|584885252|FG000|Overall Study|Adverse Event|6|||
162029829|NCT01087788|585165558|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
162029830|NCT01087788|585165556|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
162029831|NCT01087788|585165557|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
162029832|NCT01087788|585165558|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
162029833|NCT01087788|585165556|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
162029834|NCT01087788|585165557|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
162029835|NCT01087788|585165558|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
161688517|NCT00606086|583909890|FG001|Overall Study|Randomized, not treated|2|||
161688518|NCT01929408|583909891|FG000|Overall Study|received HCT as initial treatment|8|||
161688519|NCT00652366|583909902|FG000|Overall Study|Adverse Event|8|||
161688520|NCT00652366|583909903|FG001|Overall Study|Adverse Event|4|||
161688521|NCT00652366|583909904|FG002|Overall Study|Adverse Event|7|||
161688522|NCT00652366|583909905|FG003|Overall Study|Adverse Event|17|||
161688523|NCT00652366|583909906|FG004|Overall Study|Adverse Event|13|||
161688524|NCT00652366|583909902|FG000|Overall Study|Death|5|||
161688525|NCT00652366|583909903|FG001|Overall Study|Death|4|||
161955484|NCT04830215|584885252|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
161955485|NCT04830215|584885252|FG000|Overall Study|Withdrawal by Subject|3|||
161955486|NCT04830215|584885252|FG000|Overall Study|Protocol Deviation|1|||
161955487|NCT00770562|584885254|FG000|Overall Study|Did not take treatment|1|||
161688526|NCT00652366|583909904|FG002|Overall Study|Death|1|||
161688527|NCT00652366|583909905|FG003|Overall Study|Death|8|||
161688528|NCT00652366|583909906|FG004|Overall Study|Death|5|||
161955488|NCT00770562|584885255|FG001|Overall Study|Did not take treatment|1|||
161688529|NCT00652366|583909902|FG000|Overall Study|Lack of Efficacy|84|||
161688530|NCT00652366|583909903|FG001|Overall Study|Lack of Efficacy|58|||
161955489|NCT05338710|584885259|FG000|Overall Study|Withdrawal by Subject|3|||
161955490|NCT01081951|584885260|FG000|Overall Study|Death|54|||
161955491|NCT01081951|584885261|FG001|Overall Study|Death|47|||
161955492|NCT01081951|584885260|FG000|Overall Study|Withdrawal by Subject|2|||
161955493|NCT01081951|584885261|FG001|Overall Study|Withdrawal by Subject|6|||
161955494|NCT01081951|584885260|FG000|Overall Study|Allocated treatment but did not take it|0|||
161955495|NCT01081951|584885261|FG001|Overall Study|Allocated treatment but did not take it|1|||
161955496|NCT01081951|584885260|FG000|Overall Study|Lost to Follow-up|0|||
161955497|NCT01081951|584885261|FG001|Overall Study|Lost to Follow-up|1|||
161955498|NCT00292045|584885264|FG000|Core Study (Through Week 13)|Adverse Event|1|||
161955499|NCT00292045|584885264|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
161955500|NCT00606411|584885265|FG000|Overall Study|Adverse Event|1|||
161955501|NCT00606411|584885266|FG001|Overall Study|Adverse Event|2|||
161955502|NCT00606411|584885265|FG000|Overall Study|Lack of Adherence|1|||
161955503|NCT00606411|584885266|FG001|Overall Study|Lack of Adherence|1|||
161955504|NCT00606411|584885265|FG000|Overall Study|Lack of Efficacy|1|||
161955505|NCT00606411|584885266|FG001|Overall Study|Lack of Efficacy|1|||
161955506|NCT00606411|584885265|FG000|Overall Study|Withdrawal by Subject|2|||
161955507|NCT00606411|584885266|FG001|Overall Study|Withdrawal by Subject|0|||
161955508|NCT00606411|584885265|FG000|Overall Study|Lost to Follow-up|1|||
161955509|NCT00606411|584885266|FG001|Overall Study|Lost to Follow-up|2|||
161955510|NCT00606411|584885265|FG000|Overall Study|Move out of state|0|||
161955511|NCT00606411|584885266|FG001|Overall Study|Move out of state|1|||
161955512|NCT04503551|584885267|FG000|Overall Study|Withdrawal by Subject|5|||
161955513|NCT04503551|584885268|FG001|Overall Study|Withdrawal by Subject|3|||
161955514|NCT04503551|584885267|FG000|Overall Study|Physician Decision|1|||
161955515|NCT04503551|584885268|FG001|Overall Study|Physician Decision|0|||
161955516|NCT04503551|584885267|FG000|Overall Study|Death|0|||
161955517|NCT04503551|584885268|FG001|Overall Study|Death|1|||
161955518|NCT04503551|584885267|FG000|Overall Study|Lost to Follow-up|1|||
161955519|NCT04503551|584885268|FG001|Overall Study|Lost to Follow-up|2|||
161955520|NCT04503551|584885267|FG000|Overall Study|Ongoing at Week 52|99|||
161955521|NCT04503551|584885268|FG001|Overall Study|Ongoing at Week 52|62|||
161955522|NCT00412958|584885269|FG000|Overall Study|Withdrawal by Subject|3|||
161955523|NCT00412958|584885270|FG001|Overall Study|Withdrawal by Subject|0|||
161955524|NCT00412958|584885271|FG002|Overall Study|Withdrawal by Subject|0|||
161955525|NCT00412958|584885272|FG003|Overall Study|Withdrawal by Subject|1|||
161955526|NCT00412958|584885269|FG000|Overall Study|Adverse Event|0|||
161955527|NCT00412958|584885270|FG001|Overall Study|Adverse Event|1|||
161955528|NCT00412958|584885271|FG002|Overall Study|Adverse Event|0|||
161955529|NCT00412958|584885272|FG003|Overall Study|Adverse Event|0|||
161955530|NCT00412958|584885269|FG000|Overall Study|Lost to Follow-up|0|||
161955531|NCT00412958|584885270|FG001|Overall Study|Lost to Follow-up|1|||
161955532|NCT00412958|584885271|FG002|Overall Study|Lost to Follow-up|0|||
161955533|NCT00412958|584885272|FG003|Overall Study|Lost to Follow-up|0|||
161955534|NCT00412958|584885269|FG000|Overall Study|Death|0|||
161955535|NCT00412958|584885270|FG001|Overall Study|Death|1|||
161955536|NCT00412958|584885271|FG002|Overall Study|Death|0|||
161955537|NCT00412958|584885272|FG003|Overall Study|Death|0|||
161955538|NCT00412958|584885269|FG000|Overall Study|Transport issue|0|||
161955539|NCT00412958|584885270|FG001|Overall Study|Transport issue|1|||
161955540|NCT00412958|584885271|FG002|Overall Study|Transport issue|0|||
161955541|NCT00412958|584885272|FG003|Overall Study|Transport issue|0|||
161955542|NCT01318135|584885273|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
161955543|NCT01318135|584885274|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161955544|NCT01318135|584885275|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161955545|NCT01318135|584885276|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
162029836|NCT01087788|585165556|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
162029837|NCT01087788|585165557|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
162029838|NCT01087788|585165558|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
162029839|NCT01087788|585165556|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
162029840|NCT01087788|585165557|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
162029841|NCT01087788|585165558|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
162029842|NCT01087788|585165556|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
162029843|NCT01087788|585165557|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
162029844|NCT01087788|585165558|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
162029845|NCT01087788|585165556|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
162029846|NCT01087788|585165557|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
162029847|NCT01087788|585165558|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
162029848|NCT01087788|585165556|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
162029849|NCT01087788|585165557|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
162029850|NCT01087788|585165558|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
162029851|NCT01087788|585165556|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
162029852|NCT01087788|585165557|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
162029853|NCT01087788|585165558|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
162029854|NCT01087788|585165556|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
162029855|NCT01087788|585165557|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
162029856|NCT01087788|585165558|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
162029857|NCT01087788|585165556|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
162029858|NCT01087788|585165557|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
162029859|NCT01087788|585165558|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
162029860|NCT01087788|585165556|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
162029861|NCT01087788|585165557|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
162029862|NCT01087788|585165558|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
162029863|NCT01087788|585165556|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
162029864|NCT01087788|585165557|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
162029865|NCT01087788|585165558|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
162029866|NCT01087788|585165556|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
162029867|NCT01087788|585165557|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
162029868|NCT01087788|585165558|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
162029869|NCT01087788|585165556|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
162029870|NCT01087788|585165557|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
162029871|NCT01087788|585165558|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
162029872|NCT01087788|585165556|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
162029873|NCT01087788|585165557|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
162029874|NCT01087788|585165558|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
162029875|NCT01087788|585165556|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
162029876|NCT01087788|585165557|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
162029877|NCT01087788|585165558|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
162029878|NCT01087788|585165556|FG000|24-weeks Dose-blind Period|Patient moved|0|||
162029879|NCT01087788|585165557|FG001|24-weeks Dose-blind Period|Patient moved|0|||
161688531|NCT00652366|583909904|FG002|Overall Study|Lack of Efficacy|53|||
161688532|NCT00652366|583909905|FG003|Overall Study|Lack of Efficacy|133|||
161688533|NCT00652366|583909906|FG004|Overall Study|Lack of Efficacy|13|||
161688534|NCT00652366|583909902|FG000|Overall Study|Violation of Selection Criteria|0|||
161688535|NCT00652366|583909903|FG001|Overall Study|Violation of Selection Criteria|0|||
161688536|NCT00652366|583909904|FG002|Overall Study|Violation of Selection Criteria|1|||
161688537|NCT00652366|583909905|FG003|Overall Study|Violation of Selection Criteria|0|||
161688538|NCT00652366|583909906|FG004|Overall Study|Violation of Selection Criteria|0|||
161688539|NCT00652366|583909902|FG000|Overall Study|Protocol Violation|1|||
161688540|NCT00652366|583909903|FG001|Overall Study|Protocol Violation|0|||
161688541|NCT00652366|583909904|FG002|Overall Study|Protocol Violation|0|||
161688542|NCT00652366|583909905|FG003|Overall Study|Protocol Violation|0|||
161688543|NCT00652366|583909906|FG004|Overall Study|Protocol Violation|0|||
161688544|NCT00652366|583909902|FG000|Overall Study|Refused treatment|3|||
161688545|NCT00652366|583909903|FG001|Overall Study|Refused treatment|7|||
161688546|NCT00652366|583909904|FG002|Overall Study|Refused treatment|6|||
161688547|NCT00652366|583909905|FG003|Overall Study|Refused treatment|17|||
161688548|NCT00652366|583909906|FG004|Overall Study|Refused treatment|5|||
161688549|NCT00652366|583909902|FG000|Overall Study|Other|5|||
161688550|NCT00652366|583909903|FG001|Overall Study|Other|2|||
161688551|NCT00652366|583909904|FG002|Overall Study|Other|3|||
161688552|NCT00652366|583909905|FG003|Overall Study|Other|4|||
161688553|NCT00652366|583909906|FG004|Overall Study|Other|0|||
161688554|NCT03873714|583909907|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
161688555|NCT00677014|583909908|FG000|Overall Study|Lost to Follow-up|20|||
161835982|NCT01901874|584440834|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
162029880|NCT01087788|585165558|FG002|24-weeks Dose-blind Period|Patient moved|1|||
162029881|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
161835983|NCT01901874|584440834|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
162029882|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
162029883|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
162029884|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
162029885|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
162029886|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
162029887|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
162029888|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
162029889|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
162029890|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
162029891|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
162029892|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
162029893|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
162029894|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
162029895|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
162029896|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
162029897|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
162029898|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
162029899|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
162029900|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
162029901|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
162029902|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
162029903|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
162029904|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
162029905|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
162029906|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
162029907|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
162029908|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
162029909|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
162029910|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
162029911|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
162029912|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
162029913|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
162029914|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
162029915|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
162029916|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
162029917|NCT01087788|585165556|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
162029918|NCT01087788|585165557|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
162029919|NCT01087788|585165558|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
162029920|NCT00783302|585165559|FG000|Overall Study|Lost to Follow-up|17|||
161688556|NCT00677014|583909909|FG001|Overall Study|Lost to Follow-up|12|||
161688557|NCT00677014|583909910|FG002|Overall Study|Lost to Follow-up|24|||
161688558|NCT00677014|583909908|FG000|Overall Study|Death|6|||
161688559|NCT00677014|583909909|FG001|Overall Study|Death|15|||
161688560|NCT00677014|583909910|FG002|Overall Study|Death|7|||
161688561|NCT00677014|583909908|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
161688562|NCT00677014|583909909|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
161688563|NCT00677014|583909910|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
161688564|NCT01326546|583909913|FG000|Overall Study|Lost to Follow-up|8|||
161688565|NCT01326546|583909914|FG001|Overall Study|Lost to Follow-up|7|||
161688566|NCT01326546|583909913|FG000|Overall Study|Protocol Violation|3|||
161688567|NCT01326546|583909914|FG001|Overall Study|Protocol Violation|4|||
161688568|NCT01326546|583909913|FG000|Overall Study|Pregnancy|0|||
161688569|NCT01326546|583909914|FG001|Overall Study|Pregnancy|1|||
161835984|NCT01901874|584440834|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
161835985|NCT01901874|584440834|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
162029921|NCT00783302|585165559|FG000|Overall Study|Technical Problems|11|||
162029922|NCT00783302|585165559|FG000|Overall Study|Protocol Violation|3|||
161688570|NCT01326546|583909913|FG000|Overall Study|Adverse Event|1|||
161688571|NCT01326546|583909914|FG001|Overall Study|Adverse Event|0|||
161835986|NCT01901874|584440834|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
161835987|NCT01901874|584440834|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
161835988|NCT03078582|584440835|FG000|Overall Study|Adverse Event|0|||
162029923|NCT00783302|585165559|FG000|Overall Study|Physician Decision|1|||
162029924|NCT00783302|585165559|FG000|Overall Study|Withdrawal by Subject|3|||
162029925|NCT01806662|585165560|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
162029926|NCT01806662|585165561|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
161688572|NCT01326546|583909913|FG000|Overall Study|Withdrawal by Subject|5|||
161688573|NCT01326546|583909914|FG001|Overall Study|Withdrawal by Subject|1|||
161835989|NCT03078582|584440836|FG001|Overall Study|Adverse Event|8|||
161835990|NCT01491035|584440850|FG000|Overall Study|Lost to Follow-up|0|||
161835991|NCT01491035|584440851|FG001|Overall Study|Lost to Follow-up|0|||
162029927|NCT01806662|585165560|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
162029928|NCT01806662|585165561|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
162029929|NCT01806662|585165560|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
162029930|NCT01806662|585165561|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
162029931|NCT01806662|585165560|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
162029932|NCT01806662|585165561|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
162029933|NCT00043550|585165562|FG000|Overall Study|Withdrawal by Subject|22|||
162029934|NCT00043550|585165563|FG001|Overall Study|Withdrawal by Subject|12|||
162029935|NCT00043550|585165564|FG002|Overall Study|Withdrawal by Subject|20|||
162029936|NCT01917656|585165565|FG000|Overall Study|Adverse Event|11|||
162029937|NCT01917656|585165566|FG001|Overall Study|Adverse Event|0|||
162029938|NCT01917656|585165565|FG000|Overall Study|Withdrawal criteria|8|||
162029939|NCT01917656|585165566|FG001|Overall Study|Withdrawal criteria|14|||
162029940|NCT01917656|585165565|FG000|Overall Study|Unclassified|0|||
162029941|NCT01917656|585165566|FG001|Overall Study|Unclassified|3|||
162029942|NCT01917656|585165565|FG000|Overall Study|Withdrawal by Subject|4|||
162029943|NCT01917656|585165566|FG001|Overall Study|Withdrawal by Subject|3|||
162029944|NCT01917656|585165565|FG000|Overall Study|Lost to Follow-up|3|||
162029945|NCT01917656|585165566|FG001|Overall Study|Lost to Follow-up|4|||
162029946|NCT02285062|585165567|FG000|Pre-Treatment Period|Protocol Violation|0|||
162029947|NCT02285062|585165568|FG001|Pre-Treatment Period|Protocol Violation|2|||
162029948|NCT02285062|585165567|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
162029949|NCT02285062|585165568|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
162029950|NCT00545129|585165569|FG000|Overall Study|Lack of Efficacy|2|||
162029951|NCT00545129|585165570|FG001|Overall Study|Lack of Efficacy|5|||
162029952|NCT00545129|585165569|FG000|Overall Study|Death|2|||
162029953|NCT00545129|585165570|FG001|Overall Study|Death|1|||
162029954|NCT00545129|585165569|FG000|Overall Study|Adverse Event|1|||
162029955|NCT00545129|585165570|FG001|Overall Study|Adverse Event|1|||
162029956|NCT00545129|585165569|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
162029957|NCT00545129|585165570|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
162029958|NCT00545129|585165569|FG000|Overall Study|Other|3|||
162029959|NCT00545129|585165570|FG001|Overall Study|Other|3|||
162029960|NCT03678870|585165571|FG000|Overall Study|prescribed non- protocol medications|10|||
162029961|NCT03678870|585165572|FG001|Overall Study|prescribed non- protocol medications|6|||
162029962|NCT03678870|585165571|FG000|Overall Study|Lost to Follow-up|3|||
162029963|NCT03678870|585165572|FG001|Overall Study|Lost to Follow-up|2|||
162029964|NCT03104816|585165574|FG000|Overall Study|Lack of Efficacy|0|||
162029965|NCT03104816|585165575|FG001|Overall Study|Lack of Efficacy|2|||
162029966|NCT03104816|585165576|FG002|Overall Study|Lack of Efficacy|0|||
162029967|NCT03104816|585165574|FG000|Overall Study|Protocol Violation|2|||
162029968|NCT03104816|585165575|FG001|Overall Study|Protocol Violation|0|||
162029969|NCT03104816|585165576|FG002|Overall Study|Protocol Violation|2|||
162029970|NCT01426789|585165577|FG000|Part 1|Protocol deviation|0|||
162029971|NCT01426789|585165578|FG001|Part 1|Protocol deviation|1|||
162029972|NCT01426789|585165579|FG002|Part 1|Protocol deviation|0|||
162029973|NCT01426789|585165580|FG003|Part 1|Protocol deviation|0|||
162029974|NCT01426789|585165581|FG004|Part 1|Protocol deviation|0|||
162029975|NCT01426789|585165582|FG005|Part 1|Protocol deviation|0|||
162029976|NCT01426789|585165577|FG000|Part 1|Lost to Follow-up|1|||
162029977|NCT01426789|585165578|FG001|Part 1|Lost to Follow-up|2|||
162029978|NCT01426789|585165579|FG002|Part 1|Lost to Follow-up|0|||
162029979|NCT01426789|585165580|FG003|Part 1|Lost to Follow-up|0|||
162029980|NCT01426789|585165581|FG004|Part 1|Lost to Follow-up|0|||
162029981|NCT01426789|585165582|FG005|Part 1|Lost to Follow-up|0|||
162029982|NCT01426789|585165577|FG000|Part 1|Lack of Efficacy|2|||
162029983|NCT01426789|585165578|FG001|Part 1|Lack of Efficacy|1|||
162029984|NCT01426789|585165579|FG002|Part 1|Lack of Efficacy|0|||
162029985|NCT01426789|585165580|FG003|Part 1|Lack of Efficacy|0|||
162029986|NCT01426789|585165581|FG004|Part 1|Lack of Efficacy|0|||
162029987|NCT01426789|585165582|FG005|Part 1|Lack of Efficacy|0|||
162029988|NCT01426789|585165577|FG000|Part 1|Adverse Event|3|||
162029989|NCT01426789|585165578|FG001|Part 1|Adverse Event|0|||
162029990|NCT01426789|585165579|FG002|Part 1|Adverse Event|0|||
161835992|NCT01491035|584440852|FG002|Overall Study|Lost to Follow-up|0|||
162029991|NCT01426789|585165580|FG003|Part 1|Adverse Event|0|||
162029992|NCT01426789|585165581|FG004|Part 1|Adverse Event|0|||
162029993|NCT01426789|585165582|FG005|Part 1|Adverse Event|0|||
162029994|NCT01426789|585165577|FG000|Part 2|Protocol deviation|0|||
162029995|NCT01426789|585165578|FG001|Part 2|Protocol deviation|0|||
162029996|NCT01426789|585165579|FG002|Part 2|Protocol deviation|1|||
162029997|NCT01426789|585165580|FG003|Part 2|Protocol deviation|0|||
162029998|NCT01426789|585165581|FG004|Part 2|Protocol deviation|0|||
161835993|NCT01491035|584440853|FG003|Overall Study|Lost to Follow-up|0|||
162029999|NCT01426789|585165582|FG005|Part 2|Protocol deviation|0|||
162030000|NCT01426789|585165577|FG000|Part 2|Death|0|||
162030001|NCT01426789|585165578|FG001|Part 2|Death|0|||
162030002|NCT01426789|585165579|FG002|Part 2|Death|1|||
162030003|NCT01426789|585165580|FG003|Part 2|Death|0|||
162030004|NCT01426789|585165581|FG004|Part 2|Death|1|||
162030005|NCT01426789|585165582|FG005|Part 2|Death|0|||
162030006|NCT01426789|585165577|FG000|Part 2|Administrative problems|0|||
162030007|NCT01426789|585165578|FG001|Part 2|Administrative problems|0|||
162030008|NCT01426789|585165579|FG002|Part 2|Administrative problems|2|||
162030009|NCT01426789|585165580|FG003|Part 2|Administrative problems|0|||
162030010|NCT01426789|585165581|FG004|Part 2|Administrative problems|1|||
162030011|NCT01426789|585165582|FG005|Part 2|Administrative problems|0|||
162030012|NCT01426789|585165577|FG000|Part 2|Lost to Follow-up|0|||
162030013|NCT01426789|585165578|FG001|Part 2|Lost to Follow-up|0|||
162030014|NCT01426789|585165579|FG002|Part 2|Lost to Follow-up|4|||
162030015|NCT01426789|585165580|FG003|Part 2|Lost to Follow-up|0|||
162030016|NCT01426789|585165581|FG004|Part 2|Lost to Follow-up|1|||
162030017|NCT01426789|585165582|FG005|Part 2|Lost to Follow-up|0|||
162030018|NCT01426789|585165577|FG000|Part 2|Withdrawal by Subject|0|||
162030019|NCT01426789|585165578|FG001|Part 2|Withdrawal by Subject|0|||
162030020|NCT01426789|585165579|FG002|Part 2|Withdrawal by Subject|0|||
162030021|NCT01426789|585165580|FG003|Part 2|Withdrawal by Subject|1|||
162030022|NCT01426789|585165581|FG004|Part 2|Withdrawal by Subject|2|||
162030023|NCT01426789|585165582|FG005|Part 2|Withdrawal by Subject|0|||
162030024|NCT01426789|585165577|FG000|Part 2|Lack of Efficacy|0|||
162030025|NCT01426789|585165578|FG001|Part 2|Lack of Efficacy|0|||
162030026|NCT01426789|585165579|FG002|Part 2|Lack of Efficacy|5|||
162030027|NCT01426789|585165580|FG003|Part 2|Lack of Efficacy|0|||
162030028|NCT01426789|585165581|FG004|Part 2|Lack of Efficacy|2|||
162030029|NCT01426789|585165582|FG005|Part 2|Lack of Efficacy|0|||
162030030|NCT01426789|585165577|FG000|Part 2|Adverse Event|0|||
162030031|NCT01426789|585165578|FG001|Part 2|Adverse Event|0|||
162030032|NCT01426789|585165579|FG002|Part 2|Adverse Event|2|||
162030033|NCT01426789|585165580|FG003|Part 2|Adverse Event|0|||
162030034|NCT01426789|585165581|FG004|Part 2|Adverse Event|1|||
162030035|NCT01426789|585165582|FG005|Part 2|Adverse Event|0|||
162030036|NCT01895361|585167331|FG000|Overall Study|Adverse Event|1|||
162030037|NCT01895361|585167332|FG001|Overall Study|Adverse Event|1|||
162030038|NCT01895361|585167333|FG002|Overall Study|Adverse Event|3|||
162030039|NCT01895361|585167331|FG000|Overall Study|Death|2|||
162030040|NCT01895361|585167332|FG001|Overall Study|Death|1|||
162030041|NCT01895361|585167333|FG002|Overall Study|Death|2|||
162030042|NCT01895361|585167331|FG000|Overall Study|Lost to Follow-up|4|||
162030043|NCT01895361|585167332|FG001|Overall Study|Lost to Follow-up|4|||
162030044|NCT01895361|585167333|FG002|Overall Study|Lost to Follow-up|6|||
162030045|NCT01895361|585167331|FG000|Overall Study|Non-compliance with study|1|||
162030046|NCT01895361|585167332|FG001|Overall Study|Non-compliance with study|3|||
162030047|NCT01895361|585167333|FG002|Overall Study|Non-compliance with study|1|||
162030048|NCT01895361|585167331|FG000|Overall Study|Physician Decision|2|||
162030049|NCT01895361|585167332|FG001|Overall Study|Physician Decision|2|||
162030050|NCT01895361|585167333|FG002|Overall Study|Physician Decision|2|||
162030051|NCT01895361|585167331|FG000|Overall Study|Withdrawal by Subject|7|||
161688574|NCT03152019|583909915|FG000|Overall Study|Adverse Event|0|||
161688575|NCT03152019|583909916|FG001|Overall Study|Adverse Event|1|||
161688576|NCT00081159|583909920|FG000|Overall Study|Withdrawal by Subject|0|||
161688577|NCT00081159|583909921|FG001|Overall Study|Withdrawal by Subject|3|||
161688578|NCT00081159|583909920|FG000|Overall Study|Myelosuppression prior to treatment|0|||
161688579|NCT00081159|583909921|FG001|Overall Study|Myelosuppression prior to treatment|1|||
161688580|NCT00081159|583909920|FG000|Overall Study|Lost to Follow-up|2|||
161688581|NCT00081159|583909921|FG001|Overall Study|Lost to Follow-up|1|||
162030052|NCT01895361|585167332|FG001|Overall Study|Withdrawal by Subject|6|||
162030053|NCT01895361|585167333|FG002|Overall Study|Withdrawal by Subject|6|||
162030054|NCT01895361|585167331|FG000|Overall Study|Lack of Efficacy|0|||
162030055|NCT01895361|585167332|FG001|Overall Study|Lack of Efficacy|1|||
161688582|NCT00923130|583909924|FG000|Overall Study|Stopped treatment due to progression|17|||
161688583|NCT00923130|583909924|FG000|Overall Study|Death|1|||
161688584|NCT00923130|583909924|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
161688585|NCT00923130|583909924|FG000|Overall Study|Switched to alternative treatment|2|||
161688586|NCT00923130|583909924|FG000|Overall Study|Refused further treatment|2|||
161688587|NCT03693625|583909925|FG000|Overall Study|Adverse Event|2|||
161688588|NCT03693625|583909926|FG001|Overall Study|Adverse Event|0|||
161688589|NCT03693625|583909925|FG000|Overall Study|Study Terminated By Sponsor|20|||
162030056|NCT01895361|585167333|FG002|Overall Study|Lack of Efficacy|0|||
162030057|NCT01895361|585167331|FG000|Overall Study|Reasons different from categories above|7|||
162030058|NCT01895361|585167332|FG001|Overall Study|Reasons different from categories above|3|||
162030059|NCT01895361|585167333|FG002|Overall Study|Reasons different from categories above|4|||
162030060|NCT02677324|585167334|FG000|Overall Study|Disease Progression|6|||
162030061|NCT02677324|585167334|FG000|Overall Study|Inability to Swallow pills|1|||
161688590|NCT03693625|583909926|FG001|Overall Study|Study Terminated By Sponsor|7|||
161688591|NCT03693625|583909925|FG000|Overall Study|Withdrawal by Subject|1|||
162030062|NCT02677324|585167334|FG000|Overall Study|Non-compliance|1|||
162030063|NCT02677324|585167334|FG000|Overall Study|Lack of Efficacy|1|||
162030064|NCT02677324|585167334|FG000|Overall Study|Medical insurance coverage|1|||
162030065|NCT02677324|585167334|FG000|Overall Study|Adverse Event|1|||
162030066|NCT02677324|585167334|FG000|Overall Study|IgM Myeloma diagnosis|1|||
162030067|NCT01268579|585167335|FG000|Overall Study|Adverse Event|1|||
162030068|NCT01268579|585167335|FG000|Overall Study|Withdrawal by Subject|2|||
162030069|NCT03312751|585167336|FG000|Overall Study|Death|7|||
162030070|NCT03312751|585167337|FG001|Overall Study|Death|9|||
162030071|NCT03312751|585167336|FG000|Overall Study|Study discontinuation due to other reason|0|||
162030072|NCT03312751|585167337|FG001|Overall Study|Study discontinuation due to other reason|1|||
161688592|NCT03693625|583909926|FG001|Overall Study|Withdrawal by Subject|1|||
161688593|NCT01187953|583909927|FG000|Overall Study|Death|11|||
161688594|NCT01187953|583909928|FG001|Overall Study|Death|13|||
161688595|NCT01187953|583909927|FG000|Overall Study|Adverse Event|1|||
161688596|NCT01187953|583909928|FG001|Overall Study|Adverse Event|2|||
161688597|NCT01187953|583909927|FG000|Overall Study|Lost to Follow-up|0|||
161688598|NCT01187953|583909928|FG001|Overall Study|Lost to Follow-up|3|||
161688599|NCT01187953|583909927|FG000|Overall Study|Withdrawal by Subject|3|||
161688600|NCT01187953|583909928|FG001|Overall Study|Withdrawal by Subject|3|||
161688601|NCT02457637|583909931|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
161688602|NCT01035905|583909932|FG000|Overall Study|Lack of Efficacy|1|||
162030073|NCT05463198|585167338|FG000|Overall Study|Withdrawal by Subject|19|||
162030074|NCT05463198|585167338|FG000|Overall Study|Procedure Notes Missing|18|||
162030075|NCT00046891|585167346|FG000|Overall Study|Cancels|5|||
161688603|NCT01035905|583909933|FG001|Overall Study|Lack of Efficacy|1|||
161688604|NCT05038020|583909934|FG000|Overall Study|Early Termination|3|||
161688605|NCT05038020|583909935|FG001|Overall Study|Early Termination|0|||
161688606|NCT03416153|583909937|FG000|Overall Study|Physician Decision|1|||
161688607|NCT03416153|583909938|FG001|Overall Study|Physician Decision|1|||
161688608|NCT03416153|583909937|FG000|Overall Study|Withdrawal by Subject|1|||
161688609|NCT03416153|583909938|FG001|Overall Study|Withdrawal by Subject|0|||
161688610|NCT03468855|583911665|FG000|Overall Study|Adverse Event|2|||
161688611|NCT03468855|583911665|FG000|Overall Study|Lost to Follow-up|5|||
161688612|NCT03468855|583911665|FG000|Overall Study|Withdrawal by Subject|3|||
161688613|NCT03468855|583911665|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
161688614|NCT02068547|583911666|FG000|Overall Study|Lost to Follow-up|3|||
161688615|NCT02068547|583911667|FG001|Overall Study|Lost to Follow-up|3|||
161688616|NCT02068547|583911666|FG000|Overall Study|Physician Decision|1|||
161688617|NCT02068547|583911667|FG001|Overall Study|Physician Decision|0|||
161688618|NCT00880893|583911668|FG000|Overall Study|Protocol Violation|13|||
161688619|NCT00880893|583911669|FG001|Overall Study|Protocol Violation|1|||
161688620|NCT00880893|583911668|FG000|Overall Study|Withdrawal by Subject|15|||
161688621|NCT00880893|583911669|FG001|Overall Study|Withdrawal by Subject|11|||
161688622|NCT00880893|583911668|FG000|Overall Study|Lost to Follow-up|76|||
161688623|NCT00880893|583911669|FG001|Overall Study|Lost to Follow-up|33|||
161688624|NCT00880893|583911668|FG000|Overall Study|Serious adverse event|3|||
161688625|NCT00880893|583911669|FG001|Overall Study|Serious adverse event|0|||
161688626|NCT01736579|583911673|FG000|Overall Study|Termination of Study by Sponsor|2|||
161688627|NCT01736579|583911674|FG001|Overall Study|Termination of Study by Sponsor|2|||
161688628|NCT01979523|583911676|FG000|Overall Study|Withdrawal by Subject|1|||
161688629|NCT01979523|583911677|FG001|Overall Study|Withdrawal by Subject|0|||
161688630|NCT00772954|583911688|FG000|Overall Study|Adverse Event|0|||
161688631|NCT00772954|583911689|FG001|Overall Study|Adverse Event|0|||
161688632|NCT00772954|583911690|FG002|Overall Study|Adverse Event|1|||
161688633|NCT01661140|583911691|FG000|Open-Label Period|Adverse Event|44|||
161688634|NCT01661140|583911692|FG001|Open-Label Period|Adverse Event|0|||
161688635|NCT01661140|583911693|FG002|Open-Label Period|Adverse Event|0|||
161688636|NCT01661140|583911691|FG000|Open-Label Period|Protocol Violation|3|||
161688637|NCT01661140|583911692|FG001|Open-Label Period|Protocol Violation|0|||
161688638|NCT01661140|583911693|FG002|Open-Label Period|Protocol Violation|0|||
161688639|NCT01661140|583911691|FG000|Open-Label Period|Withdrawal by Subject|5|||
161688640|NCT01661140|583911692|FG001|Open-Label Period|Withdrawal by Subject|0|||
161688641|NCT01661140|583911693|FG002|Open-Label Period|Withdrawal by Subject|0|||
161688642|NCT01661140|583911691|FG000|Open-Label Period|Investigator Decision|3|||
161835994|NCT01491035|584440854|FG004|Overall Study|Lost to Follow-up|1|||
162030076|NCT00046891|585167347|FG001|Overall Study|Cancels|9|||
161688643|NCT01661140|583911692|FG001|Open-Label Period|Investigator Decision|0|||
162030077|NCT00046891|585167346|FG000|Overall Study|Ineligible|1|||
161688644|NCT01661140|583911693|FG002|Open-Label Period|Investigator Decision|0|||
161688645|NCT01661140|583911691|FG000|Open-Label Period|Death|1|||
161688646|NCT01661140|583911692|FG001|Open-Label Period|Death|0|||
161688647|NCT01661140|583911693|FG002|Open-Label Period|Death|0|||
162030078|NCT00046891|585167347|FG001|Overall Study|Ineligible|1|||
161688648|NCT01661140|583911691|FG000|Open-Label Period|Administrative/Other|1|||
161688649|NCT01661140|583911692|FG001|Open-Label Period|Administrative/Other|0|||
161688650|NCT01661140|583911693|FG002|Open-Label Period|Administrative/Other|0|||
161688651|NCT01661140|583911691|FG000|Open-Label Period|Sponsor termination|16|||
161688652|NCT01661140|583911692|FG001|Open-Label Period|Sponsor termination|0|||
161688653|NCT01661140|583911693|FG002|Open-Label Period|Sponsor termination|0|||
161835995|NCT01491035|584440855|FG005|Overall Study|Lost to Follow-up|0|||
162030079|NCT00046891|585167346|FG000|Overall Study|Withdrawal by Subject|18|||
162030080|NCT00046891|585167347|FG001|Overall Study|Withdrawal by Subject|15|||
162030081|NCT00046891|585167346|FG000|Overall Study|Adverse Event|5|||
162030082|NCT00046891|585167347|FG001|Overall Study|Adverse Event|5|||
162030083|NCT00420641|585167350|FG000|Overall Study|Adverse Event|3|||
162030084|NCT00420641|585167351|FG001|Overall Study|Adverse Event|25|||
162030085|NCT00420641|585167352|FG002|Overall Study|Adverse Event|10|||
162030086|NCT00420641|585167350|FG000|Overall Study|Lost to Follow-up|2|||
162030087|NCT00420641|585167351|FG001|Overall Study|Lost to Follow-up|4|||
162030088|NCT00420641|585167352|FG002|Overall Study|Lost to Follow-up|2|||
162030089|NCT00420641|585167350|FG000|Overall Study|Protocol Violation|8|||
162030090|NCT00420641|585167351|FG001|Overall Study|Protocol Violation|8|||
162030091|NCT00420641|585167352|FG002|Overall Study|Protocol Violation|7|||
162030092|NCT00420641|585167350|FG000|Overall Study|Withdrawal by Subject|15|||
162030093|NCT00420641|585167351|FG001|Overall Study|Withdrawal by Subject|21|||
162030094|NCT00420641|585167352|FG002|Overall Study|Withdrawal by Subject|14|||
162030095|NCT00420641|585167350|FG000|Overall Study|Lack of Efficacy|6|||
162030096|NCT00420641|585167351|FG001|Overall Study|Lack of Efficacy|5|||
162030097|NCT00420641|585167352|FG002|Overall Study|Lack of Efficacy|4|||
162030098|NCT00420641|585167350|FG000|Overall Study|Non-compliance|7|||
162030099|NCT00420641|585167351|FG001|Overall Study|Non-compliance|5|||
162030100|NCT00420641|585167352|FG002|Overall Study|Non-compliance|4|||
162030101|NCT00420641|585167350|FG000|Overall Study|Other|4|||
162030102|NCT00420641|585167351|FG001|Overall Study|Other|4|||
162030103|NCT00420641|585167352|FG002|Overall Study|Other|3|||
162030104|NCT02815280|585167366|FG000|Double-Blind Phase|Adverse Event|1|||
162030105|NCT02815280|585167367|FG001|Double-Blind Phase|Adverse Event|1|||
162030106|NCT02815280|585167366|FG000|Double-Blind Phase|Lost to Follow-up|10|||
162030107|NCT02815280|585167367|FG001|Double-Blind Phase|Lost to Follow-up|9|||
162030108|NCT02815280|585167366|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
162030109|NCT02815280|585167367|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
162030110|NCT02815280|585167366|FG000|Double-Blind Phase|Protocol Violation|2|||
162030111|NCT02815280|585167367|FG001|Double-Blind Phase|Protocol Violation|2|||
162030112|NCT02815280|585167366|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
162030113|NCT02815280|585167367|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
162030114|NCT02815280|585167366|FG000|Open-Label Phase|Adverse Event|2|||
162030115|NCT02815280|585167367|FG001|Open-Label Phase|Adverse Event|3|||
162030116|NCT02815280|585167366|FG000|Open-Label Phase|Lost to Follow-up|18|||
162030117|NCT02815280|585167367|FG001|Open-Label Phase|Lost to Follow-up|9|||
162030118|NCT02815280|585167366|FG000|Open-Label Phase|Withdrawal by Subject|33|||
162030119|NCT02815280|585167367|FG001|Open-Label Phase|Withdrawal by Subject|18|||
162030120|NCT02815280|585167366|FG000|Open-Label Phase|Protocol Violation|3|||
162030121|NCT02815280|585167367|FG001|Open-Label Phase|Protocol Violation|0|||
162030122|NCT02815280|585167366|FG000|Open-Label Phase|Administrative|26|||
162030123|NCT02815280|585167367|FG001|Open-Label Phase|Administrative|12|||
162030124|NCT02815280|585167366|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
162030125|NCT02815280|585167367|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
162030126|NCT01944839|585167381|FG000|Overall Study|Physician Decision|2|||
162030127|NCT01944839|585167382|FG001|Overall Study|Physician Decision|2|||
162030128|NCT01944839|585167381|FG000|Overall Study|Protocol Violation|0|||
162030129|NCT01944839|585167382|FG001|Overall Study|Protocol Violation|1|||
162030130|NCT01944839|585167381|FG000|Overall Study|Adverse Event|10|||
162030131|NCT01944839|585167382|FG001|Overall Study|Adverse Event|5|||
162030132|NCT01944839|585167381|FG000|Overall Study|Withdrawal by Subject|9|||
162030133|NCT01944839|585167382|FG001|Overall Study|Withdrawal by Subject|17|||
162030134|NCT01944839|585167381|FG000|Overall Study|Lost to Follow-up|1|||
162030135|NCT01944839|585167382|FG001|Overall Study|Lost to Follow-up|0|||
162030136|NCT01944839|585167381|FG000|Overall Study|Subject non-compliance|0|||
162030137|NCT01944839|585167382|FG001|Overall Study|Subject non-compliance|3|||
162030138|NCT00609362|585167383|FG000|Overall Study|Withdrawal by Subject|2|||
162030139|NCT00609362|585167384|FG001|Overall Study|Withdrawal by Subject|1|||
162030140|NCT00609362|585167383|FG000|Overall Study|Adverse Event|1|||
162030141|NCT00609362|585167384|FG001|Overall Study|Adverse Event|0|||
162030142|NCT05093790|585167385|FG000|Overall Study|Failure to meet continuation criteria|0|||
161835996|NCT01491035|584440856|FG006|Overall Study|Lost to Follow-up|0|||
162030143|NCT05093790|585167386|FG001|Overall Study|Failure to meet continuation criteria|0|||
161835997|NCT01491035|584440857|FG007|Overall Study|Lost to Follow-up|0|||
161835998|NCT02025751|584440858|FG000|Overall Study|Lost to Follow-up|1|||
161835999|NCT02025751|584440859|FG001|Overall Study|Lost to Follow-up|0|||
162030144|NCT05093790|585167387|FG002|Overall Study|Failure to meet continuation criteria|1|||
162030145|NCT05093790|585167388|FG003|Overall Study|Failure to meet continuation criteria|0|||
162030146|NCT05093790|585167385|FG000|Overall Study|Adverse Event|1|||
162030147|NCT05093790|585167386|FG001|Overall Study|Adverse Event|0|||
162030148|NCT05093790|585167387|FG002|Overall Study|Adverse Event|0|||
162030149|NCT05093790|585167388|FG003|Overall Study|Adverse Event|0|||
161836000|NCT02025751|584440858|FG000|Overall Study|Adverse Event|0|||
161955546|NCT01318135|584885277|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161955547|NCT01318135|584885278|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161955548|NCT01318135|584885279|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161955549|NCT01318135|584885280|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161955550|NCT01318135|584885273|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
161955551|NCT01318135|584885274|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161955552|NCT01318135|584885275|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161955553|NCT01318135|584885276|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161955554|NCT01318135|584885277|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161955555|NCT01318135|584885278|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161955556|NCT01318135|584885279|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161955557|NCT01318135|584885280|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
161955558|NCT01318135|584885273|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
161955559|NCT01318135|584885274|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
161955560|NCT01318135|584885275|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
161955561|NCT01318135|584885276|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
161955562|NCT01318135|584885277|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
161955563|NCT01318135|584885278|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
161955564|NCT01318135|584885279|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
161955565|NCT01318135|584885280|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
161955566|NCT01318135|584885273|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
161955567|NCT01318135|584885274|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
161955568|NCT01318135|584885275|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
161955569|NCT01318135|584885276|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
161955570|NCT01318135|584885277|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
161955571|NCT01318135|584885278|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
161955572|NCT01318135|584885279|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
161955573|NCT01318135|584885280|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
161955574|NCT01318135|584885273|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161955575|NCT01318135|584885274|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161955576|NCT01318135|584885275|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161955577|NCT01318135|584885276|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161955578|NCT01318135|584885277|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161955579|NCT01318135|584885278|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161955580|NCT01318135|584885279|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161955581|NCT01318135|584885280|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161955582|NCT01318135|584885273|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
161955583|NCT01318135|584885274|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
161955584|NCT01318135|584885275|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
161955585|NCT01318135|584885276|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
161955586|NCT01318135|584885277|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
161955587|NCT01318135|584885278|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
161955588|NCT01318135|584885279|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
161955589|NCT01318135|584885280|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
161955590|NCT01318135|584885273|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161955591|NCT01318135|584885274|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161955592|NCT01318135|584885275|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161955593|NCT01318135|584885276|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161955594|NCT01318135|584885277|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161955595|NCT01318135|584885278|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161955596|NCT01318135|584885279|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
161955597|NCT01318135|584885280|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
161955598|NCT01541865|584885285|FG000|Overall Study|Lost to Follow-up|11|||
161955599|NCT01541865|584885285|FG000|Overall Study|Withdrawal by Subject|9|||
161955600|NCT01541865|584885285|FG000|Overall Study|Adverse Event|1|||
161955601|NCT01541865|584885285|FG000|Overall Study|Protocol Violation|1|||
161955602|NCT01140867|584885288|FG000|Overall Study|Adverse Event|22|||
161955603|NCT01140867|584885288|FG000|Overall Study|Lack of Efficacy|3|||
161955604|NCT01140867|584885288|FG000|Overall Study|Lost to Follow-up|2|||
161955605|NCT01140867|584885288|FG000|Overall Study|Withdrawal by Subject|1|||
161955606|NCT01140867|584885288|FG000|Overall Study|Protocol Violation|1|||
161955607|NCT01140867|584885288|FG000|Overall Study|Uncooperative patient|2|||
161955608|NCT01140867|584885288|FG000|Overall Study|Medication Noncompliance|2|||
161955609|NCT00881530|584885289|FG000|Overall Study|Adverse Event|5|||
161955610|NCT00881530|584885290|FG001|Overall Study|Adverse Event|1|||
162030150|NCT02582684|585167389|FG000|Overall Study|Unable to contact subject/parent|4|||
162030151|NCT02582684|585167389|FG000|Overall Study|Subject not able to get to clinic|10|||
162030152|NCT02582684|585167389|FG000|Overall Study|Subject withdrew consent|1|||
162030153|NCT02582684|585167389|FG000|Overall Study|Found to be ineligible after enrollment|2|||
162030154|NCT01587898|585167390|FG000|Overall Study|Adverse Event|1|||
162030155|NCT01587898|585167391|FG001|Overall Study|Adverse Event|1|||
162030156|NCT01587898|585167392|FG002|Overall Study|Adverse Event|0|||
162030157|NCT01587898|585167393|FG003|Overall Study|Adverse Event|0|||
162030158|NCT01587898|585167390|FG000|Overall Study|Protocol Violation|0|||
162030159|NCT01587898|585167391|FG001|Overall Study|Protocol Violation|2|||
162030160|NCT01587898|585167392|FG002|Overall Study|Protocol Violation|1|||
162030161|NCT01587898|585167393|FG003|Overall Study|Protocol Violation|1|||
162030162|NCT01587898|585167390|FG000|Overall Study|Lost to Follow-up|0|||
162030163|NCT01587898|585167391|FG001|Overall Study|Lost to Follow-up|0|||
162030164|NCT01587898|585167392|FG002|Overall Study|Lost to Follow-up|0|||
162030165|NCT01587898|585167393|FG003|Overall Study|Lost to Follow-up|1|||
162030166|NCT01587898|585167390|FG000|Overall Study|Withdrawal by Subject|2|||
162030167|NCT01587898|585167391|FG001|Overall Study|Withdrawal by Subject|1|||
162030168|NCT01587898|585167392|FG002|Overall Study|Withdrawal by Subject|0|||
162030169|NCT01587898|585167393|FG003|Overall Study|Withdrawal by Subject|0|||
162030170|NCT01587898|585167390|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
162030171|NCT01587898|585167391|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
162030172|NCT01587898|585167392|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
162030173|NCT01587898|585167393|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
162030174|NCT02437110|585167396|FG000|Screening|Lost to Follow-up|3|||
162030175|NCT02437110|585167396|FG000|Screening|Physician Decision|1|||
162030176|NCT02437110|585167396|FG000|ART|Adverse Event|3|||
162030177|NCT02437110|585167396|FG000|ART|Protocol Violation|3|||
162030178|NCT02437110|585167396|FG000|ART|Withdrawal by Subject|4|||
162030179|NCT02437110|585167396|FG000|ART|Lost to follow-up prior to start of intervention|1|||
162030180|NCT02437110|585167396|FG000|ART|Physician decision prior to start of intervention|2|||
162030181|NCT02437110|585167396|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
162030182|NCT02437110|585167396|FG000|Post-ART|Lost to Follow-up|3|||
162030183|NCT02437110|585167396|FG000|Post-ART|Protocol Violation|4|||
162030184|NCT02437110|585167396|FG000|Post-ART|Withdrawal by Subject|3|||
162030185|NCT03735238|585167397|FG000|Overall Study|Did not want to participate in research|3|||
162030186|NCT03735238|585167397|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
162030187|NCT01261780|585167398|FG000|Overall Study|Withdrawal by Subject|1|||
162030188|NCT01261780|585167399|FG001|Overall Study|Withdrawal by Subject|0|||
162030189|NCT01261780|585167398|FG000|Overall Study|Event not related to subject|1|||
162030190|NCT01261780|585167399|FG001|Overall Study|Event not related to subject|2|||
162030191|NCT01239732|585167400|FG000|Overall Study|Termination of study per protocol|667|||
162030192|NCT01239732|585167400|FG000|Overall Study|Death|226|||
162030193|NCT01239732|585167400|FG000|Overall Study|Withdrawal by Subject|87|||
162030194|NCT01239732|585167400|FG000|Overall Study|Adverse Event|6|||
162030195|NCT01239732|585167400|FG000|Overall Study|Protocol Violation|3|||
162030196|NCT01239732|585167400|FG000|Overall Study|Participant non compliance|5|||
162030197|NCT01239732|585167400|FG000|Overall Study|Study termination by sponsor|2|||
162030198|NCT01239732|585167400|FG000|Overall Study|Investigator's decision|4|||
162030199|NCT01239732|585167400|FG000|Overall Study|Treatment failure|2|||
162030200|NCT01239732|585167400|FG000|Overall Study|Other|19|||
162030201|NCT02395302|585167401|FG000|Overall Study|Screen Failure|3|||
162030202|NCT02395302|585167401|FG000|Overall Study|Run In Failure|7|||
162030203|NCT02395302|585167401|FG000|Overall Study|Withdrawal by Subject|2|||
162030204|NCT02395302|585167401|FG000|Overall Study|Physician Decision|2|||
162030205|NCT02015221|585167407|FG000|Overall Study|Withdrawal by Subject|8|||
162030206|NCT02015221|585167408|FG001|Overall Study|Withdrawal by Subject|6|||
162030207|NCT02015221|585167407|FG000|Overall Study|Lost to Follow-up|1|||
162030208|NCT02015221|585167408|FG001|Overall Study|Lost to Follow-up|0|||
162030209|NCT01306929|585167409|FG000|Overall Study|Withdrawal by Subject|23|||
162030210|NCT01306929|585167409|FG000|Overall Study|Adverse Event|21|||
162030211|NCT01306929|585167409|FG000|Overall Study|Physician Decision|13|||
162030212|NCT01306929|585167409|FG000|Overall Study|Death|8|||
162030213|NCT01306929|585167409|FG000|Overall Study|Withdrawal by parent/guardian|5|||
162030214|NCT01306929|585167409|FG000|Overall Study|Protocol Violation|3|||
162030215|NCT01306929|585167409|FG000|Overall Study|Non-compliance with study drug|2|||
162030216|NCT01306929|585167409|FG000|Overall Study|Lost to Follow-up|2|||
162030217|NCT01306929|585167409|FG000|Overall Study|Various|17|||
162030218|NCT01870076|585167410|FG000|Overall Study|Withdrawal by Subject|1|||
162030219|NCT01870076|585167411|FG001|Overall Study|Withdrawal by Subject|0|||
162030220|NCT01870076|585167412|FG002|Overall Study|Withdrawal by Subject|1|||
162030221|NCT01870076|585167413|FG003|Overall Study|Withdrawal by Subject|0|||
162030222|NCT03041129|585167414|FG000|Overall Study|Withdrawal by Subject|2|||
162030223|NCT03041129|585167415|FG001|Overall Study|Withdrawal by Subject|0|||
162030224|NCT03041129|585167416|FG002|Overall Study|Withdrawal by Subject|0|||
162030225|NCT03041129|585167417|FG003|Overall Study|Withdrawal by Subject|0|||
161836001|NCT02025751|584440859|FG001|Overall Study|Adverse Event|1|||
161955611|NCT00881530|584885291|FG002|Overall Study|Adverse Event|1|||
161955612|NCT00881530|584885292|FG003|Overall Study|Adverse Event|4|||
161836002|NCT02025751|584440858|FG000|Overall Study|Physician Decision|0|||
161955613|NCT00881530|584885293|FG004|Overall Study|Adverse Event|10|||
161955614|NCT00881530|584885294|FG005|Overall Study|Adverse Event|2|||
161955615|NCT00881530|584885289|FG000|Overall Study|Lack of Efficacy|1|||
161955616|NCT00881530|584885290|FG001|Overall Study|Lack of Efficacy|0|||
161955617|NCT00881530|584885291|FG002|Overall Study|Lack of Efficacy|0|||
161955618|NCT00881530|584885292|FG003|Overall Study|Lack of Efficacy|0|||
161955619|NCT00881530|584885293|FG004|Overall Study|Lack of Efficacy|1|||
161955620|NCT00881530|584885294|FG005|Overall Study|Lack of Efficacy|1|||
161955621|NCT00881530|584885289|FG000|Overall Study|Not compliant with the protocol|0|||
161955622|NCT00881530|584885290|FG001|Overall Study|Not compliant with the protocol|0|||
161955623|NCT00881530|584885291|FG002|Overall Study|Not compliant with the protocol|0|||
161955624|NCT00881530|584885292|FG003|Overall Study|Not compliant with the protocol|0|||
161955625|NCT00881530|584885293|FG004|Overall Study|Not compliant with the protocol|2|||
161955626|NCT00881530|584885294|FG005|Overall Study|Not compliant with the protocol|0|||
161955627|NCT00881530|584885289|FG000|Overall Study|Lost to Follow-up|0|||
161955628|NCT00881530|584885290|FG001|Overall Study|Lost to Follow-up|1|||
161955629|NCT00881530|584885291|FG002|Overall Study|Lost to Follow-up|1|||
161955630|NCT00881530|584885292|FG003|Overall Study|Lost to Follow-up|3|||
161955631|NCT00881530|584885293|FG004|Overall Study|Lost to Follow-up|1|||
161955632|NCT00881530|584885294|FG005|Overall Study|Lost to Follow-up|0|||
161955633|NCT00881530|584885289|FG000|Overall Study|Refused to continue medication|7|||
161955634|NCT00881530|584885290|FG001|Overall Study|Refused to continue medication|2|||
161955635|NCT00881530|584885291|FG002|Overall Study|Refused to continue medication|1|||
161955636|NCT00881530|584885292|FG003|Overall Study|Refused to continue medication|2|||
161955637|NCT00881530|584885293|FG004|Overall Study|Refused to continue medication|0|||
161955638|NCT00881530|584885294|FG005|Overall Study|Refused to continue medication|0|||
161955639|NCT00881530|584885289|FG000|Overall Study|Other reason not defined above|1|||
161955640|NCT00881530|584885290|FG001|Overall Study|Other reason not defined above|1|||
161955641|NCT00881530|584885291|FG002|Overall Study|Other reason not defined above|2|||
161955642|NCT00881530|584885292|FG003|Overall Study|Other reason not defined above|0|||
161955643|NCT00881530|584885293|FG004|Overall Study|Other reason not defined above|0|||
161955644|NCT00881530|584885294|FG005|Overall Study|Other reason not defined above|2|||
161955645|NCT00763256|584885296|FG000|Overall Study|Didn't return for appointments|7|||
161955646|NCT00763256|584885297|FG001|Overall Study|Didn't return for appointments|10|||
161955647|NCT03364231|584885298|FG000|Overall Study|Adverse Event|1|||
161955648|NCT03364231|584885299|FG001|Overall Study|Adverse Event|4|||
161955649|NCT03364231|584885298|FG000|Overall Study|Death|1|||
161955650|NCT03364231|584885299|FG001|Overall Study|Death|0|||
161955651|NCT03364231|584885298|FG000|Overall Study|Investigator Decision|2|||
161955652|NCT03364231|584885299|FG001|Overall Study|Investigator Decision|2|||
161955653|NCT03364231|584885298|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
161955654|NCT03364231|584885299|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
161955655|NCT03364231|584885298|FG000|Overall Study|Withdrawal of Subject Consent|1|||
161955656|NCT03364231|584885299|FG001|Overall Study|Withdrawal of Subject Consent|0|||
161955657|NCT03364231|584885298|FG000|Overall Study|Reason Not Specified|1|||
161955658|NCT03364231|584885299|FG001|Overall Study|Reason Not Specified|0|||
161955659|NCT03364231|584885298|FG000|Overall Study|Disease Progression|0|||
161955660|NCT03364231|584885299|FG001|Overall Study|Disease Progression|6|||
161955661|NCT00124072|584885302|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
161955662|NCT00124072|584885303|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
161955663|NCT00124072|584885304|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
161955664|NCT00124072|584885305|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
161955665|NCT00124072|584885302|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
161955666|NCT00124072|584885303|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
161955667|NCT00124072|584885304|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
161955668|NCT00124072|584885305|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
161955669|NCT00124072|584885302|FG000|Overall Study|Death|499|||
161955670|NCT00124072|584885303|FG001|Overall Study|Death|484|||
161955671|NCT00124072|584885304|FG002|Overall Study|Death|471|||
161955672|NCT00124072|584885305|FG003|Overall Study|Death|480|||
161955673|NCT00414076|584885306|FG000|Overall Study|Progression|1|||
161955674|NCT00414076|584885307|FG001|Overall Study|Progression|2|||
161955675|NCT00414076|584885306|FG000|Overall Study|Withdrawal by Subject|1|||
161955676|NCT00414076|584885307|FG001|Overall Study|Withdrawal by Subject|3|||
161955677|NCT00414076|584885306|FG000|Overall Study|Adverse Event|1|||
161955678|NCT00414076|584885307|FG001|Overall Study|Adverse Event|0|||
161955679|NCT02720523|584885311|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
161955680|NCT02720523|584885312|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
161955681|NCT02720523|584885313|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
161955682|NCT02720523|584885314|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
161955683|NCT02720523|584885315|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
161955684|NCT02720523|584885316|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
161955685|NCT02720523|584885317|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
161955686|NCT02720523|584885311|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
161688654|NCT01661140|583911691|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
161688655|NCT01661140|583911692|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
161955687|NCT02720523|584885312|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161955688|NCT02720523|584885313|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161955689|NCT02720523|584885314|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161955690|NCT02720523|584885315|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161955691|NCT02720523|584885316|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161955692|NCT02720523|584885317|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161955693|NCT02720523|584885311|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
161955694|NCT02720523|584885312|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
161955695|NCT02720523|584885313|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
161955696|NCT02720523|584885314|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
161955697|NCT02720523|584885315|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
161955698|NCT02720523|584885316|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
161955699|NCT02720523|584885317|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
161955700|NCT02720523|584885311|FG000|Period 1: Placebo-controlled Period|Other|0|||
161955701|NCT02720523|584885312|FG001|Period 1: Placebo-controlled Period|Other|0|||
161955702|NCT02720523|584885313|FG002|Period 1: Placebo-controlled Period|Other|1|||
161955703|NCT02720523|584885314|FG003|Period 1: Placebo-controlled Period|Other|1|||
161955704|NCT02720523|584885315|FG004|Period 1: Placebo-controlled Period|Other|0|||
161955705|NCT02720523|584885316|FG005|Period 1: Placebo-controlled Period|Other|0|||
161955706|NCT02720523|584885317|FG006|Period 1: Placebo-controlled Period|Other|0|||
161955707|NCT02720523|584885311|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
161955708|NCT02720523|584885312|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
161955709|NCT02720523|584885313|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
161955710|NCT02720523|584885314|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
161955711|NCT02720523|584885315|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
161955712|NCT02720523|584885316|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
161955713|NCT02720523|584885317|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
161955714|NCT02720523|584885311|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
161955715|NCT02720523|584885312|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
161955716|NCT02720523|584885313|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
161955717|NCT02720523|584885314|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
161955718|NCT02720523|584885315|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
161955719|NCT02720523|584885316|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
161955720|NCT02720523|584885317|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
161955721|NCT02720523|584885311|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
161955722|NCT02720523|584885312|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
161955723|NCT02720523|584885313|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
161955724|NCT02720523|584885314|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
161955725|NCT02720523|584885315|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
161955726|NCT02720523|584885316|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
161955727|NCT02720523|584885317|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
161955728|NCT02720523|584885311|FG000|Period 2: Long-term Extension Period|Other|0|||
161955729|NCT02720523|584885312|FG001|Period 2: Long-term Extension Period|Other|0|||
161955730|NCT02720523|584885313|FG002|Period 2: Long-term Extension Period|Other|0|||
161955731|NCT02720523|584885314|FG003|Period 2: Long-term Extension Period|Other|0|||
161955732|NCT02720523|584885315|FG004|Period 2: Long-term Extension Period|Other|2|||
161955733|NCT02720523|584885316|FG005|Period 2: Long-term Extension Period|Other|0|||
161955734|NCT02720523|584885317|FG006|Period 2: Long-term Extension Period|Other|3|||
161955735|NCT03146663|584885318|FG000|Overall Study|Did not receive study treatment|1|||
161955736|NCT03146663|584885319|FG001|Overall Study|Did not receive study treatment|1|||
161955737|NCT05526521|584885320|FG000|Overall Study|Withdrawal by Subject|0|||
161955738|NCT05526521|584885321|FG001|Overall Study|Withdrawal by Subject|1|||
161955739|NCT05526521|584885322|FG002|Overall Study|Withdrawal by Subject|0|||
161955740|NCT05526521|584885323|FG003|Overall Study|Withdrawal by Subject|0|||
161955741|NCT01544348|584885324|FG000|Overall Study|Lost to Follow-up|1|||
161955742|NCT01544348|584885325|FG001|Overall Study|Lost to Follow-up|0|||
161955743|NCT01544348|584885326|FG002|Overall Study|Lost to Follow-up|0|||
161955744|NCT01544348|584885327|FG003|Overall Study|Lost to Follow-up|0|||
161955745|NCT01544348|584885328|FG004|Overall Study|Lost to Follow-up|0|||
161955746|NCT01544348|584885329|FG005|Overall Study|Lost to Follow-up|0|||
161836003|NCT02025751|584440859|FG001|Overall Study|Physician Decision|1|||
162030226|NCT00483756|585167422|FG000|Overall Study|Death|2|||
162030227|NCT00483756|585167423|FG001|Overall Study|Death|0|||
162030228|NCT00483756|585167424|FG002|Overall Study|Death|1|||
162030229|NCT00483756|585167422|FG000|Overall Study|Adverse Event|19|||
162030230|NCT00483756|585167423|FG001|Overall Study|Adverse Event|38|||
162030231|NCT00483756|585167424|FG002|Overall Study|Adverse Event|40|||
162030232|NCT00483756|585167422|FG000|Overall Study|Lack of Efficacy|1|||
162030233|NCT00483756|585167423|FG001|Overall Study|Lack of Efficacy|0|||
162030234|NCT00483756|585167424|FG002|Overall Study|Lack of Efficacy|0|||
162030235|NCT00483756|585167422|FG000|Overall Study|Lost to Follow-up|3|||
162030236|NCT00483756|585167423|FG001|Overall Study|Lost to Follow-up|1|||
162030237|NCT00483756|585167424|FG002|Overall Study|Lost to Follow-up|0|||
162030238|NCT00483756|585167422|FG000|Overall Study|Withdrawal by Subject|5|||
162030239|NCT00483756|585167423|FG001|Overall Study|Withdrawal by Subject|3|||
162030240|NCT00483756|585167424|FG002|Overall Study|Withdrawal by Subject|4|||
162030241|NCT00483756|585167422|FG000|Overall Study|Other|2|||
162030242|NCT00483756|585167423|FG001|Overall Study|Other|4|||
162030243|NCT00483756|585167424|FG002|Overall Study|Other|3|||
162030244|NCT00483756|585167422|FG000|Overall Study|Randomized, Not Treated|1|||
162030245|NCT00483756|585167423|FG001|Overall Study|Randomized, Not Treated|4|||
162030246|NCT00483756|585167424|FG002|Overall Study|Randomized, Not Treated|4|||
162030247|NCT00436501|585167425|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
162030248|NCT00436501|585167426|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
162030249|NCT00436501|585167425|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
162030250|NCT00436501|585167426|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
162030251|NCT01829243|585167437|FG000|First Intervention|Screen Failure|4|||
162030252|NCT01829243|585167438|FG001|First Intervention|Screen Failure|2|||
162030253|NCT00608569|585167443|FG000|Overall Study|Death|4|||
162030254|NCT00608569|585167444|FG001|Overall Study|Death|3|||
162030255|NCT00608569|585167443|FG000|Overall Study|Lost to Follow-up|4|||
162030256|NCT00608569|585167444|FG001|Overall Study|Lost to Follow-up|5|||
162030257|NCT00608569|585167443|FG000|Overall Study|Withdrawal by Subject|1|||
162030258|NCT00608569|585167444|FG001|Overall Study|Withdrawal by Subject|0|||
162030259|NCT00608569|585167443|FG000|Overall Study|Adverse Event|1|||
162030260|NCT00608569|585167444|FG001|Overall Study|Adverse Event|0|||
162030261|NCT00608569|585167443|FG000|Overall Study|Unable to adhere with study requirements|0|||
162030262|NCT00608569|585167444|FG001|Overall Study|Unable to adhere with study requirements|1|||
162030263|NCT02282293|585167445|FG000|Overall Study|Lost to Follow-up|2|||
162030264|NCT02282293|585167446|FG001|Overall Study|Lost to Follow-up|2|||
162030265|NCT02282293|585167445|FG000|Overall Study|Unable to comply with study procedures|1|||
162030266|NCT02282293|585167446|FG001|Overall Study|Unable to comply with study procedures|0|||
162030267|NCT02282293|585167445|FG000|Overall Study|Moved out of study area|0|||
162030268|NCT02282293|585167446|FG001|Overall Study|Moved out of study area|1|||
162030269|NCT03011892|585167447|FG000|Double Blind (DB) Period|Adverse Event|0|||
162030270|NCT03011892|585167448|FG001|Double Blind (DB) Period|Adverse Event|1|||
162030271|NCT03011892|585167449|FG002|Double Blind (DB) Period|Adverse Event|1|||
162030272|NCT03011892|585167450|FG003|Double Blind (DB) Period|Adverse Event|0|||
162030273|NCT03011892|585167451|FG004|Double Blind (DB) Period|Adverse Event|0|||
162030274|NCT03011892|585167452|FG005|Double Blind (DB) Period|Adverse Event|0|||
162030275|NCT03011892|585167453|FG006|Double Blind (DB) Period|Adverse Event|0|||
162030276|NCT03011892|585167454|FG007|Double Blind (DB) Period|Adverse Event|0|||
162030277|NCT03011892|585167455|FG008|Double Blind (DB) Period|Adverse Event|0|||
162030278|NCT03011892|585167456|FG009|Double Blind (DB) Period|Adverse Event|0|||
162030279|NCT03011892|585167457|FG010|Double Blind (DB) Period|Adverse Event|0|||
162030280|NCT03011892|585167458|FG011|Double Blind (DB) Period|Adverse Event|0|||
162030281|NCT03011892|585167447|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
162030282|NCT03011892|585167448|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
162030283|NCT03011892|585167449|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
162030284|NCT03011892|585167450|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
162030285|NCT03011892|585167451|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
162030286|NCT03011892|585167452|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
162030287|NCT03011892|585167453|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
162030288|NCT03011892|585167454|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
162030289|NCT03011892|585167455|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
161836004|NCT02025751|584440858|FG000|Overall Study|Withdrawal by Subject|0|||
162030290|NCT03011892|585167456|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
162030291|NCT03011892|585167457|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
162030292|NCT03011892|585167458|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
162030293|NCT03011892|585167447|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
162030294|NCT03011892|585167448|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
162030295|NCT03011892|585167449|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
162030296|NCT03011892|585167450|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
162030297|NCT03011892|585167451|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
161836005|NCT02025751|584440859|FG001|Overall Study|Withdrawal by Subject|1|||
161836006|NCT02687360|584440862|FG000|Overall Study|Withdrawal by Subject|3|||
162030298|NCT03011892|585167452|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
162030299|NCT03011892|585167453|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
162030300|NCT03011892|585167454|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
162030301|NCT03011892|585167455|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
162030302|NCT03011892|585167456|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
162030303|NCT03011892|585167457|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
162030304|NCT03011892|585167458|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
162030305|NCT03011892|585167447|FG000|Double Blind (DB) Period|Other|1|||
162030306|NCT03011892|585167448|FG001|Double Blind (DB) Period|Other|1|||
162030307|NCT03011892|585167449|FG002|Double Blind (DB) Period|Other|1|||
162030308|NCT03011892|585167450|FG003|Double Blind (DB) Period|Other|0|||
162030309|NCT03011892|585167451|FG004|Double Blind (DB) Period|Other|1|||
162030310|NCT03011892|585167452|FG005|Double Blind (DB) Period|Other|0|||
162030311|NCT03011892|585167453|FG006|Double Blind (DB) Period|Other|0|||
162030312|NCT03011892|585167454|FG007|Double Blind (DB) Period|Other|0|||
162030313|NCT03011892|585167455|FG008|Double Blind (DB) Period|Other|0|||
162030314|NCT03011892|585167456|FG009|Double Blind (DB) Period|Other|0|||
162030315|NCT03011892|585167457|FG010|Double Blind (DB) Period|Other|0|||
162030316|NCT03011892|585167458|FG011|Double Blind (DB) Period|Other|0|||
162030317|NCT03011892|585167447|FG000|Double Blind (DB) Period|Physician Decision|1|||
162030318|NCT03011892|585167448|FG001|Double Blind (DB) Period|Physician Decision|0|||
162030319|NCT03011892|585167449|FG002|Double Blind (DB) Period|Physician Decision|1|||
162030320|NCT03011892|585167450|FG003|Double Blind (DB) Period|Physician Decision|0|||
162030321|NCT03011892|585167451|FG004|Double Blind (DB) Period|Physician Decision|0|||
162030322|NCT03011892|585167452|FG005|Double Blind (DB) Period|Physician Decision|0|||
162030323|NCT03011892|585167453|FG006|Double Blind (DB) Period|Physician Decision|0|||
162030324|NCT03011892|585167454|FG007|Double Blind (DB) Period|Physician Decision|0|||
162030325|NCT03011892|585167455|FG008|Double Blind (DB) Period|Physician Decision|0|||
162030326|NCT03011892|585167456|FG009|Double Blind (DB) Period|Physician Decision|0|||
162030327|NCT03011892|585167457|FG010|Double Blind (DB) Period|Physician Decision|0|||
162030328|NCT03011892|585167458|FG011|Double Blind (DB) Period|Physician Decision|0|||
162030329|NCT03011892|585167447|FG000|Double Blind (DB) Period|Pregnancy|0|||
162030330|NCT03011892|585167448|FG001|Double Blind (DB) Period|Pregnancy|0|||
162030331|NCT03011892|585167449|FG002|Double Blind (DB) Period|Pregnancy|0|||
162030332|NCT03011892|585167450|FG003|Double Blind (DB) Period|Pregnancy|0|||
162030333|NCT03011892|585167451|FG004|Double Blind (DB) Period|Pregnancy|1|||
162030334|NCT03011892|585167452|FG005|Double Blind (DB) Period|Pregnancy|0|||
162030335|NCT03011892|585167453|FG006|Double Blind (DB) Period|Pregnancy|0|||
162030336|NCT03011892|585167454|FG007|Double Blind (DB) Period|Pregnancy|0|||
162030337|NCT03011892|585167455|FG008|Double Blind (DB) Period|Pregnancy|0|||
162030338|NCT03011892|585167456|FG009|Double Blind (DB) Period|Pregnancy|0|||
162030339|NCT03011892|585167457|FG010|Double Blind (DB) Period|Pregnancy|0|||
162030340|NCT03011892|585167458|FG011|Double Blind (DB) Period|Pregnancy|0|||
162030341|NCT03011892|585167447|FG000|Double Blind (DB) Period|Protocol Violation|1|||
162030342|NCT03011892|585167448|FG001|Double Blind (DB) Period|Protocol Violation|0|||
162030343|NCT03011892|585167449|FG002|Double Blind (DB) Period|Protocol Violation|0|||
162030344|NCT03011892|585167450|FG003|Double Blind (DB) Period|Protocol Violation|0|||
162030345|NCT03011892|585167451|FG004|Double Blind (DB) Period|Protocol Violation|0|||
162030346|NCT03011892|585167452|FG005|Double Blind (DB) Period|Protocol Violation|0|||
162030347|NCT03011892|585167453|FG006|Double Blind (DB) Period|Protocol Violation|0|||
162030348|NCT03011892|585167454|FG007|Double Blind (DB) Period|Protocol Violation|0|||
162030349|NCT03011892|585167455|FG008|Double Blind (DB) Period|Protocol Violation|0|||
162030350|NCT03011892|585167456|FG009|Double Blind (DB) Period|Protocol Violation|0|||
162030351|NCT03011892|585167457|FG010|Double Blind (DB) Period|Protocol Violation|0|||
162030352|NCT03011892|585167458|FG011|Double Blind (DB) Period|Protocol Violation|0|||
162030353|NCT03011892|585167447|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
162030354|NCT03011892|585167448|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
162030355|NCT03011892|585167449|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
162030356|NCT03011892|585167450|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
162030357|NCT03011892|585167451|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
162030358|NCT03011892|585167452|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
162030359|NCT03011892|585167453|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
162030360|NCT03011892|585167454|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
162030361|NCT03011892|585167455|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
162030362|NCT03011892|585167456|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
162030363|NCT03011892|585167457|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
162030364|NCT03011892|585167458|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
162030365|NCT03011892|585167447|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
162030366|NCT03011892|585167448|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
162030367|NCT03011892|585167449|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
162030368|NCT03011892|585167450|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
162030369|NCT03011892|585167451|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
162030370|NCT03011892|585167452|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
162030371|NCT03011892|585167453|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
162030372|NCT03011892|585167454|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
162030373|NCT03011892|585167455|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
162030374|NCT03011892|585167456|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
162030375|NCT03011892|585167457|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
162030376|NCT03011892|585167458|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
162030377|NCT03011892|585167447|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
162030378|NCT03011892|585167448|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
162030379|NCT03011892|585167449|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
162030380|NCT03011892|585167450|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
162030381|NCT03011892|585167451|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
162030382|NCT03011892|585167452|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
162030383|NCT03011892|585167453|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
162030384|NCT03011892|585167454|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
162030385|NCT03011892|585167455|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
162030386|NCT03011892|585167456|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
162030387|NCT03011892|585167457|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
162030388|NCT03011892|585167458|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
162030389|NCT03011892|585167447|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
162030390|NCT03011892|585167448|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
162030391|NCT03011892|585167449|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
162030392|NCT03011892|585167450|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
162030393|NCT03011892|585167451|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
162030394|NCT03011892|585167452|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
162030395|NCT03011892|585167453|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
162030396|NCT03011892|585167454|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
162030397|NCT03011892|585167455|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
162030398|NCT03011892|585167456|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
162030399|NCT03011892|585167457|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
162030400|NCT03011892|585167458|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
162030401|NCT03011892|585167447|FG000|Open Label (OL) Period|Reason not specified|0|||
162030402|NCT03011892|585167448|FG001|Open Label (OL) Period|Reason not specified|0|||
162030403|NCT03011892|585167449|FG002|Open Label (OL) Period|Reason not specified|0|||
162030404|NCT03011892|585167450|FG003|Open Label (OL) Period|Reason not specified|0|||
162030405|NCT03011892|585167451|FG004|Open Label (OL) Period|Reason not specified|0|||
162030406|NCT03011892|585167452|FG005|Open Label (OL) Period|Reason not specified|0|||
162030407|NCT03011892|585167453|FG006|Open Label (OL) Period|Reason not specified|0|||
162030408|NCT03011892|585167454|FG007|Open Label (OL) Period|Reason not specified|1|||
162030409|NCT03011892|585167455|FG008|Open Label (OL) Period|Reason not specified|0|||
162030410|NCT03011892|585167456|FG009|Open Label (OL) Period|Reason not specified|0|||
162030411|NCT03011892|585167457|FG010|Open Label (OL) Period|Reason not specified|0|||
162030412|NCT03011892|585167458|FG011|Open Label (OL) Period|Reason not specified|0|||
162030413|NCT02312687|585167474|FG000|Overall Study|Other, Not Specified|1|||
162030414|NCT00906971|585167477|FG000|Overall Study|Withdrawal by Subject|8|||
162030415|NCT00906971|585167478|FG001|Overall Study|Withdrawal by Subject|2|||
162030416|NCT00906971|585167477|FG000|Overall Study|Lost to Follow-up|0|||
162030417|NCT00906971|585167478|FG001|Overall Study|Lost to Follow-up|1|||
162030418|NCT00169442|585167481|FG000|Overall Study|Withdrawal by Subject|0|||
162030419|NCT00169442|585167482|FG001|Overall Study|Withdrawal by Subject|0|||
162030420|NCT00169442|585167483|FG002|Overall Study|Withdrawal by Subject|1|||
162030421|NCT00169442|585167484|FG003|Overall Study|Withdrawal by Subject|0|||
162030422|NCT00169442|585167485|FG004|Overall Study|Withdrawal by Subject|0|||
162030423|NCT00169442|585167486|FG005|Overall Study|Withdrawal by Subject|0|||
162030424|NCT00169442|585167481|FG000|Overall Study|Migrated/moved from study area|0|||
162030425|NCT00169442|585167482|FG001|Overall Study|Migrated/moved from study area|0|||
162030426|NCT00169442|585167483|FG002|Overall Study|Migrated/moved from study area|0|||
162030427|NCT00169442|585167484|FG003|Overall Study|Migrated/moved from study area|0|||
162030428|NCT00169442|585167485|FG004|Overall Study|Migrated/moved from study area|0|||
162030429|NCT00169442|585167486|FG005|Overall Study|Migrated/moved from study area|2|||
162030430|NCT00169442|585167481|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
162030431|NCT00169442|585167482|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
162030432|NCT00169442|585167483|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
162030433|NCT00169442|585167484|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
162030434|NCT00169442|585167485|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
162030435|NCT00169442|585167486|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
162030436|NCT00169442|585167481|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
162030437|NCT00169442|585167482|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
162030438|NCT00169442|585167483|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
162030439|NCT00169442|585167484|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
162030440|NCT00169442|585167485|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
162030441|NCT00169442|585167486|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
162030442|NCT01007253|585167491|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
162030443|NCT01007253|585167492|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
162030444|NCT01007253|585167493|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
162030445|NCT01007253|585167494|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
162030446|NCT01159431|585167497|FG000|Overall Study|Adverse Event|1|||
162030447|NCT01159431|585167498|FG001|Overall Study|Adverse Event|2|||
162030448|NCT01159431|585167497|FG000|Overall Study|non-compliance|1|||
162030449|NCT01159431|585167498|FG001|Overall Study|non-compliance|1|||
162030450|NCT01159431|585167497|FG000|Overall Study|Lack of Efficacy|0|||
162030451|NCT01159431|585167498|FG001|Overall Study|Lack of Efficacy|3|||
162030452|NCT00884377|585169412|FG000|Overall Study|Withdrawal by Subject|1|||
162030453|NCT00884377|585169413|FG001|Overall Study|Withdrawal by Subject|0|||
162030454|NCT00884377|585169412|FG000|Overall Study|Could not confirm diagnosis|1|||
162030455|NCT00884377|585169413|FG001|Overall Study|Could not confirm diagnosis|0|||
162030456|NCT00884377|585169412|FG000|Overall Study|Physician Decision|0|||
162030457|NCT00884377|585169413|FG001|Overall Study|Physician Decision|1|||
162030458|NCT00282464|585169416|FG000|Overall Study|Adverse Event|26|||
162030459|NCT00282464|585169417|FG001|Overall Study|Adverse Event|20|||
162030460|NCT00282464|585169416|FG000|Overall Study|Lack of Efficacy|8|||
162030461|NCT00282464|585169417|FG001|Overall Study|Lack of Efficacy|8|||
162030462|NCT00282464|585169416|FG000|Overall Study|Lost to Follow-up|10|||
162030463|NCT00282464|585169417|FG001|Overall Study|Lost to Follow-up|10|||
162030464|NCT00282464|585169416|FG000|Overall Study|Withdrawal by Subject|24|||
162030465|NCT00282464|585169417|FG001|Overall Study|Withdrawal by Subject|10|||
162030466|NCT00282464|585169416|FG000|Overall Study|laboratory abnormality|1|||
162030467|NCT00282464|585169417|FG001|Overall Study|laboratory abnormality|2|||
162030468|NCT00282464|585169416|FG000|Overall Study|Protocol Violation|0|||
162030469|NCT00282464|585169417|FG001|Overall Study|Protocol Violation|7|||
162030470|NCT00282464|585169416|FG000|Overall Study|Patient moved|1|||
162030471|NCT00282464|585169417|FG001|Overall Study|Patient moved|0|||
162030472|NCT00282464|585169416|FG000|Overall Study|patient non-compliant|3|||
162030473|NCT00282464|585169417|FG001|Overall Study|patient non-compliant|0|||
162030474|NCT00282464|585169416|FG000|Overall Study|patient no show|0|||
162030475|NCT00282464|585169417|FG001|Overall Study|patient no show|1|||
162030476|NCT00282464|585169416|FG000|Overall Study|patient incarcerated|0|||
162030477|NCT00282464|585169417|FG001|Overall Study|patient incarcerated|1|||
162030478|NCT00282464|585169416|FG000|Overall Study|family crisis|0|||
162030479|NCT00282464|585169417|FG001|Overall Study|family crisis|1|||
162030480|NCT00282464|585169416|FG000|Overall Study|dispensed wrong kit|0|||
162030481|NCT00282464|585169417|FG001|Overall Study|dispensed wrong kit|1|||
162030482|NCT00282464|585169416|FG000|Overall Study|dropped due to missed visits|0|||
162030483|NCT00282464|585169417|FG001|Overall Study|dropped due to missed visits|1|||
162030484|NCT00475423|585169418|FG000|Overall Study|Protocol Violation|5|||
162030485|NCT00475423|585169418|FG000|Overall Study|Adverse Event|4|||
162030486|NCT00475423|585169418|FG000|Overall Study|Withdrawal by Subject|6|||
162030487|NCT00475423|585169418|FG000|Overall Study|Lack of Efficacy|8|||
162030488|NCT00475423|585169418|FG000|Overall Study|Death|1|||
162030489|NCT00475423|585169418|FG000|Overall Study|Reason not specified|1|||
162030490|NCT00475423|585169418|FG000|Overall Study|Lost to Follow-up|7|||
162030491|NCT01214174|585169419|FG000|Overall Study|Withdrawal by Subject|0|||
162030492|NCT01214174|585169420|FG001|Overall Study|Withdrawal by Subject|0|||
162030493|NCT01214174|585169421|FG002|Overall Study|Withdrawal by Subject|1|||
162030494|NCT02239120|585169422|FG000|Overall Study|Death|56|||
162030495|NCT02239120|585169423|FG001|Overall Study|Death|58|||
162030496|NCT02239120|585169422|FG000|Overall Study|Lost to Follow-up|19|||
162030497|NCT02239120|585169423|FG001|Overall Study|Lost to Follow-up|14|||
162030498|NCT00548405|585169424|FG000|Overall Study|Adverse Event|6|||
162030499|NCT00548405|585169425|FG001|Overall Study|Adverse Event|2|||
162030500|NCT00548405|585169426|FG002|Overall Study|Adverse Event|0|||
162030501|NCT00548405|585169424|FG000|Overall Study|Lack of Efficacy|6|||
162030502|NCT00548405|585169425|FG001|Overall Study|Lack of Efficacy|0|||
162030503|NCT00548405|585169426|FG002|Overall Study|Lack of Efficacy|0|||
162030504|NCT00548405|585169424|FG000|Overall Study|Physician Decision|3|||
162030505|NCT00548405|585169425|FG001|Overall Study|Physician Decision|4|||
162030506|NCT00548405|585169426|FG002|Overall Study|Physician Decision|1|||
162030507|NCT00548405|585169424|FG000|Overall Study|Pregnancy|1|||
161836007|NCT02687360|584440863|FG001|Overall Study|Withdrawal by Subject|0|||
161836008|NCT02181296|584440865|FG000|Overall Study|Lost to Follow-up|7|||
161836009|NCT02181296|584440866|FG001|Overall Study|Lost to Follow-up|6|||
161836010|NCT01568866|584440867|FG000|Overall Study|Disease Progression|208|||
161836011|NCT01568866|584440868|FG001|Overall Study|Disease Progression|183|||
162030508|NCT00548405|585169425|FG001|Overall Study|Pregnancy|0|||
161836012|NCT01568866|584440867|FG000|Overall Study|Adverse Event|94|||
162030509|NCT00548405|585169426|FG002|Overall Study|Pregnancy|0|||
162030510|NCT00548405|585169424|FG000|Overall Study|Protocol Violation|1|||
162030511|NCT00548405|585169425|FG001|Overall Study|Protocol Violation|0|||
162030512|NCT00548405|585169426|FG002|Overall Study|Protocol Violation|0|||
161836013|NCT01568866|584440868|FG001|Overall Study|Adverse Event|96|||
161836014|NCT01568866|584440867|FG000|Overall Study|Patient Request|55|||
161836015|NCT01568866|584440868|FG001|Overall Study|Patient Request|71|||
161836016|NCT01568866|584440867|FG000|Overall Study|Physician Decision|40|||
161955747|NCT01544348|584885330|FG006|Overall Study|Lost to Follow-up|1|||
161836017|NCT01568866|584440868|FG001|Overall Study|Physician Decision|32|||
161955748|NCT01544348|584885331|FG007|Overall Study|Lost to Follow-up|0|||
161955749|NCT01544348|584885324|FG000|Overall Study|Withdrawal by Subject|1|||
161955750|NCT01544348|584885325|FG001|Overall Study|Withdrawal by Subject|0|||
161955751|NCT01544348|584885326|FG002|Overall Study|Withdrawal by Subject|0|||
161955752|NCT01544348|584885327|FG003|Overall Study|Withdrawal by Subject|0|||
161955753|NCT01544348|584885328|FG004|Overall Study|Withdrawal by Subject|1|||
161955754|NCT01544348|584885329|FG005|Overall Study|Withdrawal by Subject|2|||
161955755|NCT01544348|584885330|FG006|Overall Study|Withdrawal by Subject|1|||
161955756|NCT01544348|584885331|FG007|Overall Study|Withdrawal by Subject|0|||
161955757|NCT01544348|584885324|FG000|Overall Study|Physician Decision|0|||
161955758|NCT01544348|584885325|FG001|Overall Study|Physician Decision|0|||
161955759|NCT01544348|584885326|FG002|Overall Study|Physician Decision|0|||
161955760|NCT01544348|584885327|FG003|Overall Study|Physician Decision|0|||
161955761|NCT01544348|584885328|FG004|Overall Study|Physician Decision|0|||
161955762|NCT01544348|584885329|FG005|Overall Study|Physician Decision|1|||
161955763|NCT01544348|584885330|FG006|Overall Study|Physician Decision|0|||
161955764|NCT01544348|584885331|FG007|Overall Study|Physician Decision|0|||
161955765|NCT03008070|584885335|FG000|Overall Study|Adverse Event|3|||
161955766|NCT03008070|584885336|FG001|Overall Study|Adverse Event|3|||
161955767|NCT03008070|584885337|FG002|Overall Study|Adverse Event|3|||
161955768|NCT03008070|584885335|FG000|Overall Study|Lost to Follow-up|1|||
161955769|NCT03008070|584885336|FG001|Overall Study|Lost to Follow-up|1|||
161955770|NCT03008070|584885337|FG002|Overall Study|Lost to Follow-up|0|||
161955771|NCT03008070|584885335|FG000|Overall Study|Non compliance|0|||
161955772|NCT03008070|584885336|FG001|Overall Study|Non compliance|1|||
161955773|NCT03008070|584885337|FG002|Overall Study|Non compliance|1|||
161955774|NCT03008070|584885335|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
161955775|NCT03008070|584885336|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
161955776|NCT03008070|584885337|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
161955777|NCT03008070|584885335|FG000|Overall Study|Withdrawal by Subject|2|||
161955778|NCT03008070|584885336|FG001|Overall Study|Withdrawal by Subject|0|||
161955779|NCT03008070|584885337|FG002|Overall Study|Withdrawal by Subject|1|||
161955780|NCT03008070|584885335|FG000|Overall Study|Use of prohibited drug|0|||
161955781|NCT03008070|584885336|FG001|Overall Study|Use of prohibited drug|0|||
161955782|NCT03008070|584885337|FG002|Overall Study|Use of prohibited drug|2|||
161955783|NCT05005273|584885338|FG000|Overall Study|Study Terminated|1|||
161955784|NCT05005273|584885339|FG001|Overall Study|Study Terminated|0|||
161955785|NCT04409834|584885340|FG000|Overall Study|Death|55|||
161955786|NCT04409834|584885341|FG001|Overall Study|Death|62|||
161955787|NCT01671956|584885343|FG000|Overall Study|Disease progression|0|||
161955788|NCT01671956|584885344|FG001|Overall Study|Disease progression|1|||
161955789|NCT01671956|584885343|FG000|Overall Study|Withdrawal by Subject|1|||
161955790|NCT01671956|584885344|FG001|Overall Study|Withdrawal by Subject|1|||
161955791|NCT01671956|584885343|FG000|Overall Study|Adverse Event|1|||
161955792|NCT01671956|584885344|FG001|Overall Study|Adverse Event|0|||
161955793|NCT04266912|584885348|FG000|Overall Study|Withdrawal by Subject|1|||
161955794|NCT04266912|584885349|FG001|Overall Study|Withdrawal by Subject|0|||
161955795|NCT04266912|584885350|FG002|Overall Study|Withdrawal by Subject|0|||
161955796|NCT04266912|584885351|FG003|Overall Study|Withdrawal by Subject|0|||
161955797|NCT04266912|584885348|FG000|Overall Study|Progression|6|||
161955798|NCT04266912|584885349|FG001|Overall Study|Progression|6|||
161955799|NCT04266912|584885350|FG002|Overall Study|Progression|0|||
161955800|NCT04266912|584885351|FG003|Overall Study|Progression|10|||
161955801|NCT03816176|584885358|FG000|Overall Study|Miscellaneous|5|||
161955802|NCT03816176|584885358|FG000|Overall Study|Lack of Efficacy|4|||
161955803|NCT03816176|584885358|FG000|Overall Study|Adverse Event|3|||
161955804|NCT02744612|584887332|FG000|Overall Study|Withdrawal by Subject|0|||
161955805|NCT02744612|584887333|FG001|Overall Study|Withdrawal by Subject|2|||
161955806|NCT03419897|584887334|FG000|Overall Study|Death|180|||
161955807|NCT03419897|584887334|FG000|Overall Study|Lost to Follow-up|1|||
161955808|NCT03419897|584887334|FG000|Overall Study|Withdrawal by Subject|6|||
161955809|NCT03419897|584887334|FG000|Overall Study|Sponsor Decision|61|||
161955810|NCT03419897|584887334|FG000|Overall Study|Physician Decision|1|||
161955811|NCT05730725|584887337|FG000|Overall Study|Withdrawal by Subject|3|||
161955812|NCT05730725|584887338|FG001|Overall Study|Withdrawal by Subject|0|||
161955813|NCT05730725|584887339|FG002|Overall Study|Withdrawal by Subject|0|||
161955814|NCT05730725|584887340|FG003|Overall Study|Withdrawal by Subject|1|||
161955815|NCT05730725|584887337|FG000|Overall Study|Not Reported|1|||
161955816|NCT05730725|584887338|FG001|Overall Study|Not Reported|1|||
161955817|NCT05730725|584887339|FG002|Overall Study|Not Reported|1|||
161955818|NCT05730725|584887340|FG003|Overall Study|Not Reported|1|||
161836018|NCT01568866|584440867|FG000|Overall Study|Withdrawal by Subject|19|||
161955819|NCT02574078|584887355|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161955820|NCT02574078|584887356|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161955821|NCT02574078|584887357|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161955822|NCT02574078|584887358|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161955823|NCT02574078|584887359|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161955824|NCT02574078|584887360|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161955825|NCT02574078|584887361|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
161955826|NCT02574078|584887362|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161955827|NCT02574078|584887363|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161955828|NCT02574078|584887364|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161955829|NCT02574078|584887365|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161955830|NCT02574078|584887366|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161955831|NCT02574078|584887367|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161955832|NCT02574078|584887355|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
161955833|NCT02574078|584887356|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
161955834|NCT02574078|584887357|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
161955835|NCT02574078|584887358|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
161955836|NCT02574078|584887359|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
161955837|NCT02574078|584887360|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
161955838|NCT02574078|584887361|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
161955839|NCT02574078|584887362|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
161955840|NCT02574078|584887363|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
161955841|NCT02574078|584887364|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
161955842|NCT02574078|584887365|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
161955843|NCT02574078|584887366|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
161955844|NCT02574078|584887367|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
161955845|NCT02574078|584887355|FG000|Pre-Treatment Period|Other reasons|0|||
161955846|NCT02574078|584887356|FG001|Pre-Treatment Period|Other reasons|0|||
161955847|NCT02574078|584887357|FG002|Pre-Treatment Period|Other reasons|0|||
161955848|NCT02574078|584887358|FG003|Pre-Treatment Period|Other reasons|0|||
161955849|NCT02574078|584887359|FG004|Pre-Treatment Period|Other reasons|0|||
161955850|NCT02574078|584887360|FG005|Pre-Treatment Period|Other reasons|0|||
161955851|NCT02574078|584887361|FG006|Pre-Treatment Period|Other reasons|2|||
161955852|NCT02574078|584887362|FG007|Pre-Treatment Period|Other reasons|0|||
161955853|NCT02574078|584887363|FG008|Pre-Treatment Period|Other reasons|0|||
161955854|NCT02574078|584887364|FG009|Pre-Treatment Period|Other reasons|0|||
161955855|NCT02574078|584887365|FG010|Pre-Treatment Period|Other reasons|2|||
161955856|NCT02574078|584887366|FG011|Pre-Treatment Period|Other reasons|0|||
161955857|NCT02574078|584887367|FG012|Pre-Treatment Period|Other reasons|0|||
161955858|NCT02574078|584887355|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
161955859|NCT02574078|584887356|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
161955860|NCT02574078|584887357|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
161955861|NCT02574078|584887358|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
161955862|NCT02574078|584887359|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
161955863|NCT02574078|584887360|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
161955864|NCT02574078|584887361|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
161955865|NCT02574078|584887362|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
161955866|NCT02574078|584887363|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
161955867|NCT02574078|584887364|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
161955868|NCT02574078|584887365|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
161955869|NCT02574078|584887366|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
161955870|NCT02574078|584887367|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
161955871|NCT02574078|584887355|FG000|Treatment Period|Disease progression|6|||
161955872|NCT02574078|584887356|FG001|Treatment Period|Disease progression|4|||
161955873|NCT02574078|584887357|FG002|Treatment Period|Disease progression|7|||
161955874|NCT02574078|584887358|FG003|Treatment Period|Disease progression|18|||
161955875|NCT02574078|584887359|FG004|Treatment Period|Disease progression|16|||
161955876|NCT02574078|584887360|FG005|Treatment Period|Disease progression|26|||
161955877|NCT02574078|584887361|FG006|Treatment Period|Disease progression|5|||
161955878|NCT02574078|584887362|FG007|Treatment Period|Disease progression|9|||
161955879|NCT02574078|584887363|FG008|Treatment Period|Disease progression|8|||
161955880|NCT02574078|584887364|FG009|Treatment Period|Disease progression|5|||
161955881|NCT02574078|584887365|FG010|Treatment Period|Disease progression|20|||
161955882|NCT02574078|584887366|FG011|Treatment Period|Disease progression|29|||
161955883|NCT02574078|584887367|FG012|Treatment Period|Disease progression|2|||
161955884|NCT02574078|584887355|FG000|Treatment Period|Study drug toxicity|1|||
161955885|NCT02574078|584887356|FG001|Treatment Period|Study drug toxicity|1|||
162030513|NCT00548405|585169424|FG000|Overall Study|Withdrawal by Subject|36|||
162030514|NCT00548405|585169425|FG001|Overall Study|Withdrawal by Subject|12|||
162030515|NCT00548405|585169426|FG002|Overall Study|Withdrawal by Subject|5|||
162030516|NCT00548405|585169424|FG000|Overall Study|Lost to Follow-up|1|||
162030517|NCT00548405|585169425|FG001|Overall Study|Lost to Follow-up|1|||
162030518|NCT00548405|585169426|FG002|Overall Study|Lost to Follow-up|2|||
162030519|NCT00548405|585169424|FG000|Overall Study|Death|0|||
162030520|NCT00548405|585169425|FG001|Overall Study|Death|1|||
162030521|NCT00548405|585169426|FG002|Overall Study|Death|1|||
162030522|NCT00548405|585169424|FG000|Overall Study|Sponsor decision|1|||
162030523|NCT00548405|585169425|FG001|Overall Study|Sponsor decision|0|||
162030524|NCT00548405|585169426|FG002|Overall Study|Sponsor decision|0|||
162030525|NCT00548405|585169424|FG000|Overall Study|Randomized but not treated|1|||
162030526|NCT00548405|585169425|FG001|Overall Study|Randomized but not treated|0|||
162030527|NCT00548405|585169426|FG002|Overall Study|Randomized but not treated|0|||
162030528|NCT01624870|585169427|FG000|Overall Study|Death|19|||
162030529|NCT01624870|585169427|FG000|Overall Study|Withdrawal by Subject|1|||
162030530|NCT01624870|585169427|FG000|Overall Study|CoreValve not implanted|6|||
162030531|NCT01624870|585169427|FG000|Overall Study|Lost to follow up|1|||
162030532|NCT01878149|585169428|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
162030533|NCT01878149|585169429|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
162030534|NCT04672252|585169432|FG000|Overall Study|Protocol Violation|1|||
162030535|NCT04672252|585169433|FG001|Overall Study|Protocol Violation|0|||
162030536|NCT06390839|585169438|FG000|Overall Study|Ineligible|2|||
162030537|NCT06390839|585169438|FG000|Overall Study|Never start protocol therapy|3|||
162030538|NCT06390839|585169438|FG000|Overall Study|Adverse Event|1|||
162030539|NCT06390839|585169438|FG000|Overall Study|Alternative therapy|2|||
162030540|NCT06390839|585169438|FG000|Overall Study|Death|3|||
162030541|NCT06390839|585169438|FG000|Overall Study|Disease progression|28|||
162030542|NCT06390839|585169438|FG000|Overall Study|Withdrawal by Subject|2|||
162030543|NCT06390839|585169438|FG000|Overall Study|Complicating disease|1|||
162030544|NCT06390839|585169438|FG000|Overall Study|Noncompliance|1|||
162030545|NCT00502203|585169443|FG000|Overall Study|Inevaluable|1|||
162030546|NCT02720094|585169444|FG000|Overall Study|Ongoing|2210|||
162030547|NCT02720094|585169445|FG001|Overall Study|Ongoing|2203|||
162030548|NCT02720094|585169444|FG000|Overall Study|Scheduled exit visit/end of study|2|||
162030549|NCT02720094|585169445|FG001|Overall Study|Scheduled exit visit/end of study|1|||
162030550|NCT02720094|585169444|FG000|Overall Study|Death|4|||
162030551|NCT02720094|585169445|FG001|Overall Study|Death|7|||
162030552|NCT02720094|585169444|FG000|Overall Study|Withdrawal by Subject|55|||
162030553|NCT02720094|585169445|FG001|Overall Study|Withdrawal by Subject|56|||
162030554|NCT02720094|585169444|FG000|Overall Study|Lost to Follow-up|2|||
162030555|NCT02720094|585169445|FG001|Overall Study|Lost to Follow-up|7|||
162030556|NCT02720094|585169444|FG000|Overall Study|Physician Decision|1|||
162030557|NCT02720094|585169445|FG001|Overall Study|Physician Decision|3|||
162030558|NCT02720094|585169444|FG000|Overall Study|Inappropriate enrollment|1|||
162030559|NCT02720094|585169445|FG001|Overall Study|Inappropriate enrollment|3|||
162030560|NCT02720094|585169444|FG000|Overall Study|Relocation|1|||
162030561|NCT02720094|585169445|FG001|Overall Study|Relocation|1|||
162030562|NCT01431638|585169448|FG000|Overall Study|Adverse Event|1|||
162030563|NCT01431638|585169449|FG001|Overall Study|Adverse Event|3|||
162030564|NCT01431638|585169450|FG002|Overall Study|Adverse Event|1|||
162030565|NCT01431638|585169448|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162030566|NCT01431638|585169449|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
162030567|NCT01431638|585169450|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
162030568|NCT01431638|585169448|FG000|Overall Study|Participants condition no longer requires study drug|0|||
162030569|NCT01431638|585169449|FG001|Overall Study|Participants condition no longer requires study drug|1|||
162030570|NCT01431638|585169450|FG002|Overall Study|Participants condition no longer requires study drug|0|||
162030571|NCT01431638|585169448|FG000|Overall Study|Participant withdrew consent|14|||
162030572|NCT01431638|585169449|FG001|Overall Study|Participant withdrew consent|5|||
161688656|NCT01661140|583911693|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
161688657|NCT01661140|583911691|FG000|Open-Label Period|Lost to Follow-up|2|||
161688658|NCT01661140|583911692|FG001|Open-Label Period|Lost to Follow-up|0|||
161688659|NCT01661140|583911693|FG002|Open-Label Period|Lost to Follow-up|0|||
161688660|NCT01661140|583911691|FG000|Double-Blind Period|Refused Treatment|0|||
161688661|NCT01661140|583911692|FG001|Double-Blind Period|Refused Treatment|0|||
162030573|NCT01431638|585169450|FG002|Overall Study|Participant withdrew consent|8|||
162030574|NCT01431638|585169448|FG000|Overall Study|Lost to Follow-up|7|||
162030575|NCT01431638|585169449|FG001|Overall Study|Lost to Follow-up|9|||
161836019|NCT01568866|584440868|FG001|Overall Study|Withdrawal by Subject|11|||
162030576|NCT01431638|585169450|FG002|Overall Study|Lost to Follow-up|7|||
162030577|NCT01431638|585169448|FG000|Overall Study|Administrative problems|1|||
162030578|NCT01431638|585169449|FG001|Overall Study|Administrative problems|4|||
162030579|NCT01431638|585169450|FG002|Overall Study|Administrative problems|6|||
162030580|NCT01431638|585169448|FG000|Overall Study|Death|1|||
162030581|NCT01431638|585169449|FG001|Overall Study|Death|0|||
162030582|NCT01431638|585169450|FG002|Overall Study|Death|0|||
162030583|NCT01431638|585169448|FG000|Overall Study|Protocol deviation|1|||
162030584|NCT01431638|585169449|FG001|Overall Study|Protocol deviation|1|||
162030585|NCT01431638|585169450|FG002|Overall Study|Protocol deviation|4|||
162030586|NCT01431638|585169448|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
162030587|NCT01431638|585169449|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
162030588|NCT01431638|585169450|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
162030589|NCT01381562|585169451|FG000|Overall Study|Adverse Event|0|||
162030590|NCT01381562|585169452|FG001|Overall Study|Adverse Event|1|||
162030591|NCT01381562|585169453|FG002|Overall Study|Adverse Event|0|||
162030592|NCT02660138|585169455|FG000|Overall Study|Adverse Event|0|||
162030593|NCT02660138|585169456|FG001|Overall Study|Adverse Event|3|||
162030594|NCT02660138|585169457|FG002|Overall Study|Adverse Event|2|||
162030595|NCT02660138|585169455|FG000|Overall Study|Lack of Efficacy|1|||
162030596|NCT02660138|585169456|FG001|Overall Study|Lack of Efficacy|2|||
162030597|NCT02660138|585169457|FG002|Overall Study|Lack of Efficacy|1|||
162030598|NCT02660138|585169455|FG000|Overall Study|Withdrawal by Subject|7|||
162030599|NCT02660138|585169456|FG001|Overall Study|Withdrawal by Subject|6|||
162030600|NCT02660138|585169457|FG002|Overall Study|Withdrawal by Subject|6|||
162030601|NCT02660138|585169455|FG000|Overall Study|Lost to Follow-up|4|||
162030602|NCT02660138|585169456|FG001|Overall Study|Lost to Follow-up|4|||
162030603|NCT02660138|585169457|FG002|Overall Study|Lost to Follow-up|1|||
162030604|NCT02660138|585169455|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
162030605|NCT02660138|585169456|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
162030606|NCT02660138|585169457|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
162030607|NCT02660138|585169455|FG000|Overall Study|Other|1|||
162030608|NCT02660138|585169456|FG001|Overall Study|Other|1|||
162030609|NCT02660138|585169457|FG002|Overall Study|Other|0|||
162030610|NCT02660138|585169455|FG000|Overall Study|Not treated|0|||
162030611|NCT02660138|585169456|FG001|Overall Study|Not treated|1|||
162030612|NCT02660138|585169457|FG002|Overall Study|Not treated|0|||
162030613|NCT00308581|585169461|FG000|Induction Phase|Adverse Event|0|||
162030614|NCT00308581|585169462|FG001|Induction Phase|Adverse Event|0|||
162030615|NCT00308581|585169463|FG002|Induction Phase|Adverse Event|37|||
162030616|NCT00308581|585169461|FG000|Induction Phase|Lack of Efficacy|0|||
162030617|NCT00308581|585169462|FG001|Induction Phase|Lack of Efficacy|0|||
162030618|NCT00308581|585169463|FG002|Induction Phase|Lack of Efficacy|121|||
162030619|NCT00308581|585169461|FG000|Induction Phase|Withdrawal by Subject|0|||
162030620|NCT00308581|585169462|FG001|Induction Phase|Withdrawal by Subject|0|||
162030621|NCT00308581|585169463|FG002|Induction Phase|Withdrawal by Subject|5|||
162030622|NCT00308581|585169461|FG000|Induction Phase|Unknown reason|0|||
162030623|NCT00308581|585169462|FG001|Induction Phase|Unknown reason|0|||
162030624|NCT00308581|585169463|FG002|Induction Phase|Unknown reason|3|||
162030625|NCT00308581|585169461|FG000|Randomized Maintenance Phase|Adverse Event|10|||
162030626|NCT00308581|585169462|FG001|Randomized Maintenance Phase|Adverse Event|17|||
162030627|NCT00308581|585169463|FG002|Randomized Maintenance Phase|Adverse Event|0|||
162030628|NCT00308581|585169461|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
162030629|NCT00308581|585169462|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
162030630|NCT00308581|585169463|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
162030631|NCT00308581|585169461|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
162030632|NCT00308581|585169462|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
162030633|NCT00308581|585169463|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
162030634|NCT00308581|585169461|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
162030635|NCT00308581|585169462|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
162030636|NCT00308581|585169463|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
162030637|NCT00308581|585169461|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
162030638|NCT00308581|585169462|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
162030639|NCT00308581|585169463|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
162030640|NCT00308581|585169461|FG000|Randomized Maintenance Phase|Unknown reason|3|||
162030641|NCT00308581|585169462|FG001|Randomized Maintenance Phase|Unknown reason|0|||
162030642|NCT00308581|585169463|FG002|Randomized Maintenance Phase|Unknown reason|0|||
162030643|NCT00899353|585169464|FG000|Overall Study|Adverse Event|2|||
162030644|NCT00899353|585169464|FG000|Overall Study|Lost to Follow-up|1|||
162030645|NCT00899353|585169464|FG000|Overall Study|Withdrawal by Subject|2|||
162030646|NCT00095147|585169475|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
162030647|NCT00095147|585169476|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
162030648|NCT00095147|585169477|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
161688662|NCT01661140|583911693|FG002|Double-Blind Period|Refused Treatment|1|||
161688663|NCT01661140|583911691|FG000|Double-Blind Period|Adverse Event|0|||
162030649|NCT00095147|585169478|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
162030650|NCT00095147|585169479|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
162030651|NCT00095147|585169475|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
162030652|NCT00095147|585169476|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
162030653|NCT00095147|585169477|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
162030654|NCT00095147|585169478|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
162030655|NCT00095147|585169479|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
162030656|NCT00095147|585169475|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
162030657|NCT00095147|585169476|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
162030658|NCT00095147|585169477|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
162030659|NCT00095147|585169478|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
162030660|NCT00095147|585169479|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
162030661|NCT00095147|585169475|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
162030662|NCT00095147|585169476|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
162030663|NCT00095147|585169477|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
162030664|NCT00095147|585169478|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
162030665|NCT00095147|585169479|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
162030666|NCT00095147|585169475|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
162030667|NCT00095147|585169476|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
162030668|NCT00095147|585169477|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
162030669|NCT00095147|585169478|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
162030670|NCT00095147|585169479|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
162030671|NCT00095147|585169475|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
162030672|NCT00095147|585169476|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
162030673|NCT00095147|585169477|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
162030674|NCT00095147|585169478|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
162030675|NCT00095147|585169479|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
162030676|NCT00095147|585169475|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
162030677|NCT00095147|585169476|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
162030678|NCT00095147|585169477|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
162030679|NCT00095147|585169478|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
162030680|NCT00095147|585169479|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
162030681|NCT00095147|585169475|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
162030682|NCT00095147|585169476|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
162030683|NCT00095147|585169477|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
162030684|NCT00095147|585169478|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
162030685|NCT00095147|585169479|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
162030686|NCT00095147|585169475|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
162030687|NCT00095147|585169476|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
162030688|NCT00095147|585169477|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
162030689|NCT00095147|585169478|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
162030690|NCT00095147|585169479|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
162030691|NCT00095147|585169475|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
162030692|NCT00095147|585169476|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
162030693|NCT00095147|585169477|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
162030694|NCT00095147|585169478|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
162030695|NCT00095147|585169479|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
162030696|NCT00095147|585169475|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
162030697|NCT00095147|585169476|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
162030698|NCT00095147|585169477|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
162030699|NCT00095147|585169478|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
162030700|NCT00095147|585169479|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
162030701|NCT00095147|585169475|FG000|Long-term Extension Period|Death|0|||
162030702|NCT00095147|585169476|FG001|Long-term Extension Period|Death|0|||
162030703|NCT00095147|585169477|FG002|Long-term Extension Period|Death|0|||
162030704|NCT00095147|585169478|FG003|Long-term Extension Period|Death|0|||
162030705|NCT00095147|585169479|FG004|Long-term Extension Period|Death|3|||
162030706|NCT00095147|585169475|FG000|Long-term Extension Period|Adverse Event|0|||
162030707|NCT00095147|585169476|FG001|Long-term Extension Period|Adverse Event|0|||
162030708|NCT00095147|585169477|FG002|Long-term Extension Period|Adverse Event|0|||
162030709|NCT00095147|585169478|FG003|Long-term Extension Period|Adverse Event|0|||
162030710|NCT00095147|585169479|FG004|Long-term Extension Period|Adverse Event|11|||
162030711|NCT00095147|585169475|FG000|Long-term Extension Period|Lack of Efficacy|0|||
162030712|NCT00095147|585169476|FG001|Long-term Extension Period|Lack of Efficacy|0|||
162030713|NCT00095147|585169477|FG002|Long-term Extension Period|Lack of Efficacy|0|||
162030714|NCT00095147|585169478|FG003|Long-term Extension Period|Lack of Efficacy|0|||
162030715|NCT00095147|585169479|FG004|Long-term Extension Period|Lack of Efficacy|9|||
162030716|NCT00095147|585169475|FG000|Long-term Extension Period|Lost to Follow-up|0|||
162030717|NCT00095147|585169476|FG001|Long-term Extension Period|Lost to Follow-up|0|||
162030718|NCT00095147|585169477|FG002|Long-term Extension Period|Lost to Follow-up|0|||
162030719|NCT00095147|585169478|FG003|Long-term Extension Period|Lost to Follow-up|0|||
162030720|NCT00095147|585169479|FG004|Long-term Extension Period|Lost to Follow-up|6|||
162030721|NCT00095147|585169475|FG000|Long-term Extension Period|Withdrawal of consent|0|||
162030722|NCT00095147|585169476|FG001|Long-term Extension Period|Withdrawal of consent|0|||
162030723|NCT00095147|585169477|FG002|Long-term Extension Period|Withdrawal of consent|0|||
161955886|NCT02574078|584887357|FG002|Treatment Period|Study drug toxicity|0|||
161955887|NCT02574078|584887358|FG003|Treatment Period|Study drug toxicity|5|||
161955888|NCT02574078|584887359|FG004|Treatment Period|Study drug toxicity|3|||
161955889|NCT02574078|584887360|FG005|Treatment Period|Study drug toxicity|1|||
161955890|NCT02574078|584887361|FG006|Treatment Period|Study drug toxicity|2|||
161955891|NCT02574078|584887362|FG007|Treatment Period|Study drug toxicity|0|||
161955892|NCT02574078|584887363|FG008|Treatment Period|Study drug toxicity|2|||
161955893|NCT02574078|584887364|FG009|Treatment Period|Study drug toxicity|1|||
161955894|NCT02574078|584887365|FG010|Treatment Period|Study drug toxicity|16|||
161955895|NCT02574078|584887366|FG011|Treatment Period|Study drug toxicity|2|||
161955896|NCT02574078|584887367|FG012|Treatment Period|Study drug toxicity|4|||
161955897|NCT02574078|584887355|FG000|Treatment Period|Death|2|||
161955898|NCT02574078|584887356|FG001|Treatment Period|Death|0|||
161955899|NCT02574078|584887357|FG002|Treatment Period|Death|0|||
161955900|NCT02574078|584887358|FG003|Treatment Period|Death|0|||
161955901|NCT02574078|584887359|FG004|Treatment Period|Death|1|||
161955902|NCT02574078|584887360|FG005|Treatment Period|Death|1|||
161955903|NCT02574078|584887361|FG006|Treatment Period|Death|1|||
161955904|NCT02574078|584887362|FG007|Treatment Period|Death|1|||
161955905|NCT02574078|584887363|FG008|Treatment Period|Death|7|||
161955906|NCT02574078|584887364|FG009|Treatment Period|Death|1|||
161955907|NCT02574078|584887365|FG010|Treatment Period|Death|0|||
161955908|NCT02574078|584887366|FG011|Treatment Period|Death|2|||
161955909|NCT02574078|584887367|FG012|Treatment Period|Death|1|||
161955910|NCT02574078|584887355|FG000|Treatment Period|Adverse event unrelated to drug|0|||
161955911|NCT02574078|584887356|FG001|Treatment Period|Adverse event unrelated to drug|0|||
161955912|NCT02574078|584887357|FG002|Treatment Period|Adverse event unrelated to drug|1|||
161955913|NCT02574078|584887358|FG003|Treatment Period|Adverse event unrelated to drug|0|||
161955914|NCT02574078|584887359|FG004|Treatment Period|Adverse event unrelated to drug|2|||
161955915|NCT02574078|584887360|FG005|Treatment Period|Adverse event unrelated to drug|3|||
161955916|NCT02574078|584887361|FG006|Treatment Period|Adverse event unrelated to drug|0|||
161955917|NCT02574078|584887362|FG007|Treatment Period|Adverse event unrelated to drug|0|||
161955918|NCT02574078|584887363|FG008|Treatment Period|Adverse event unrelated to drug|1|||
161955919|NCT02574078|584887364|FG009|Treatment Period|Adverse event unrelated to drug|2|||
161955920|NCT02574078|584887365|FG010|Treatment Period|Adverse event unrelated to drug|4|||
161955921|NCT02574078|584887366|FG011|Treatment Period|Adverse event unrelated to drug|1|||
161955922|NCT02574078|584887367|FG012|Treatment Period|Adverse event unrelated to drug|0|||
161955923|NCT02574078|584887355|FG000|Treatment Period|Administrative reason by Sponsor|0|||
161955924|NCT02574078|584887356|FG001|Treatment Period|Administrative reason by Sponsor|1|||
161955925|NCT02574078|584887357|FG002|Treatment Period|Administrative reason by Sponsor|0|||
161955926|NCT02574078|584887358|FG003|Treatment Period|Administrative reason by Sponsor|0|||
161955927|NCT02574078|584887359|FG004|Treatment Period|Administrative reason by Sponsor|0|||
161955928|NCT02574078|584887360|FG005|Treatment Period|Administrative reason by Sponsor|0|||
161955929|NCT02574078|584887361|FG006|Treatment Period|Administrative reason by Sponsor|1|||
161955930|NCT02574078|584887362|FG007|Treatment Period|Administrative reason by Sponsor|0|||
161955931|NCT02574078|584887363|FG008|Treatment Period|Administrative reason by Sponsor|0|||
161955932|NCT02574078|584887364|FG009|Treatment Period|Administrative reason by Sponsor|0|||
161955933|NCT02574078|584887365|FG010|Treatment Period|Administrative reason by Sponsor|0|||
161955934|NCT02574078|584887366|FG011|Treatment Period|Administrative reason by Sponsor|0|||
161955935|NCT02574078|584887367|FG012|Treatment Period|Administrative reason by Sponsor|3|||
161955936|NCT02574078|584887355|FG000|Treatment Period|Other reasons|1|||
161955937|NCT02574078|584887356|FG001|Treatment Period|Other reasons|0|||
161955938|NCT02574078|584887357|FG002|Treatment Period|Other reasons|1|||
161955939|NCT02574078|584887358|FG003|Treatment Period|Other reasons|3|||
161955940|NCT02574078|584887359|FG004|Treatment Period|Other reasons|3|||
161955941|NCT02574078|584887360|FG005|Treatment Period|Other reasons|1|||
161955942|NCT02574078|584887361|FG006|Treatment Period|Other reasons|2|||
161955943|NCT02574078|584887362|FG007|Treatment Period|Other reasons|1|||
161955944|NCT02574078|584887363|FG008|Treatment Period|Other reasons|3|||
161955945|NCT02574078|584887364|FG009|Treatment Period|Other reasons|1|||
161955946|NCT02574078|584887365|FG010|Treatment Period|Other reasons|1|||
161955947|NCT02574078|584887366|FG011|Treatment Period|Other reasons|3|||
161955948|NCT02574078|584887367|FG012|Treatment Period|Other reasons|1|||
161955949|NCT02574078|584887355|FG000|Treatment Period|Participant request to stop drug|0|||
161955950|NCT02574078|584887356|FG001|Treatment Period|Participant request to stop drug|0|||
161955951|NCT02574078|584887357|FG002|Treatment Period|Participant request to stop drug|0|||
161955952|NCT02574078|584887358|FG003|Treatment Period|Participant request to stop drug|2|||
161955953|NCT02574078|584887359|FG004|Treatment Period|Participant request to stop drug|4|||
161955954|NCT02574078|584887360|FG005|Treatment Period|Participant request to stop drug|0|||
161955955|NCT02574078|584887361|FG006|Treatment Period|Participant request to stop drug|1|||
161955956|NCT02574078|584887362|FG007|Treatment Period|Participant request to stop drug|0|||
161955957|NCT02574078|584887363|FG008|Treatment Period|Participant request to stop drug|3|||
161955958|NCT02574078|584887364|FG009|Treatment Period|Participant request to stop drug|2|||
162030724|NCT00095147|585169478|FG003|Long-term Extension Period|Withdrawal of consent|0|||
162030725|NCT00095147|585169479|FG004|Long-term Extension Period|Withdrawal of consent|12|||
162030726|NCT00095147|585169475|FG000|Long-term Extension Period|Pregnancy|0|||
162030727|NCT00095147|585169476|FG001|Long-term Extension Period|Pregnancy|0|||
162030728|NCT00095147|585169477|FG002|Long-term Extension Period|Pregnancy|0|||
162030729|NCT00095147|585169478|FG003|Long-term Extension Period|Pregnancy|0|||
162030730|NCT00095147|585169479|FG004|Long-term Extension Period|Pregnancy|1|||
162030731|NCT00095147|585169475|FG000|Long-term Extension Period|No longer meets study criteria|0|||
162030732|NCT00095147|585169476|FG001|Long-term Extension Period|No longer meets study criteria|0|||
162030733|NCT00095147|585169477|FG002|Long-term Extension Period|No longer meets study criteria|0|||
162030734|NCT00095147|585169478|FG003|Long-term Extension Period|No longer meets study criteria|0|||
162030735|NCT00095147|585169479|FG004|Long-term Extension Period|No longer meets study criteria|1|||
162030736|NCT00095147|585169475|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
162030737|NCT00095147|585169476|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
162030738|NCT00095147|585169477|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
162030739|NCT00095147|585169478|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
162030740|NCT00095147|585169479|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
162030741|NCT00095147|585169475|FG000|Long-term Extension Period|Leaving country|0|||
162030742|NCT00095147|585169476|FG001|Long-term Extension Period|Leaving country|0|||
162030743|NCT00095147|585169477|FG002|Long-term Extension Period|Leaving country|0|||
162030744|NCT00095147|585169478|FG003|Long-term Extension Period|Leaving country|0|||
162030745|NCT00095147|585169479|FG004|Long-term Extension Period|Leaving country|1|||
162030746|NCT04604132|585169480|FG000|Overall Study|Adverse Event|2|||
162030747|NCT04604132|585169481|FG001|Overall Study|Adverse Event|0|||
162030748|NCT04604132|585169482|FG002|Overall Study|Adverse Event|0|||
162030749|NCT04604132|585169483|FG003|Overall Study|Adverse Event|1|||
162030750|NCT04604132|585169484|FG004|Overall Study|Adverse Event|2|||
162030751|NCT04604132|585169480|FG000|Overall Study|Study terminated by sponsor|0|||
162030752|NCT04604132|585169481|FG001|Overall Study|Study terminated by sponsor|0|||
161836020|NCT01568866|584440867|FG000|Overall Study|Death|10|||
161836021|NCT01568866|584440868|FG001|Overall Study|Death|18|||
161836022|NCT01568866|584440867|FG000|Overall Study|Protocol Non-compliance|2|||
161688664|NCT01661140|583911692|FG001|Double-Blind Period|Adverse Event|16|||
161688665|NCT01661140|583911693|FG002|Double-Blind Period|Adverse Event|18|||
161688666|NCT01661140|583911691|FG000|Double-Blind Period|Protocol Violation|0|||
161688667|NCT01661140|583911692|FG001|Double-Blind Period|Protocol Violation|2|||
161688668|NCT01661140|583911693|FG002|Double-Blind Period|Protocol Violation|3|||
161688669|NCT01661140|583911691|FG000|Double-Blind Period|Withdrawal by Subject|0|||
161688670|NCT01661140|583911692|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161688671|NCT01661140|583911693|FG002|Double-Blind Period|Withdrawal by Subject|3|||
161688672|NCT01661140|583911691|FG000|Double-Blind Period|Investigator's Decision|0|||
161688673|NCT01661140|583911692|FG001|Double-Blind Period|Investigator's Decision|1|||
161688674|NCT01661140|583911693|FG002|Double-Blind Period|Investigator's Decision|2|||
161688675|NCT01661140|583911691|FG000|Double-Blind Period|Sponsor Termination|0|||
161688676|NCT01661140|583911692|FG001|Double-Blind Period|Sponsor Termination|14|||
161688677|NCT01661140|583911693|FG002|Double-Blind Period|Sponsor Termination|17|||
161836023|NCT01568866|584440868|FG001|Overall Study|Protocol Non-compliance|4|||
161836024|NCT01568866|584440867|FG000|Overall Study|Lost to Follow-up|1|||
161836025|NCT01568866|584440868|FG001|Overall Study|Lost to Follow-up|0|||
161836026|NCT01568866|584440867|FG000|Overall Study|Randomized but Not Dosed|9|||
161955959|NCT02574078|584887365|FG010|Treatment Period|Participant request to stop drug|2|||
161955960|NCT02574078|584887366|FG011|Treatment Period|Participant request to stop drug|4|||
161955961|NCT02574078|584887367|FG012|Treatment Period|Participant request to stop drug|1|||
161955962|NCT02574078|584887355|FG000|Treatment Period|Participant withdrew consent|0|||
161955963|NCT02574078|584887356|FG001|Treatment Period|Participant withdrew consent|0|||
161955964|NCT02574078|584887357|FG002|Treatment Period|Participant withdrew consent|0|||
161955965|NCT02574078|584887358|FG003|Treatment Period|Participant withdrew consent|0|||
161955966|NCT02574078|584887359|FG004|Treatment Period|Participant withdrew consent|1|||
161955967|NCT02574078|584887360|FG005|Treatment Period|Participant withdrew consent|1|||
161955968|NCT02574078|584887361|FG006|Treatment Period|Participant withdrew consent|0|||
161955969|NCT02574078|584887362|FG007|Treatment Period|Participant withdrew consent|1|||
161955970|NCT02574078|584887363|FG008|Treatment Period|Participant withdrew consent|0|||
161955971|NCT02574078|584887364|FG009|Treatment Period|Participant withdrew consent|2|||
161955972|NCT02574078|584887365|FG010|Treatment Period|Participant withdrew consent|1|||
161955973|NCT02574078|584887366|FG011|Treatment Period|Participant withdrew consent|4|||
161955974|NCT02574078|584887367|FG012|Treatment Period|Participant withdrew consent|1|||
161955975|NCT02574078|584887355|FG000|Treatment Period|Participant no longer meets criteria|0|||
161955976|NCT02574078|584887356|FG001|Treatment Period|Participant no longer meets criteria|0|||
161955977|NCT02574078|584887357|FG002|Treatment Period|Participant no longer meets criteria|0|||
161955978|NCT02574078|584887358|FG003|Treatment Period|Participant no longer meets criteria|0|||
161955979|NCT02574078|584887359|FG004|Treatment Period|Participant no longer meets criteria|1|||
161955980|NCT02574078|584887360|FG005|Treatment Period|Participant no longer meets criteria|0|||
161836027|NCT01568866|584440868|FG001|Overall Study|Randomized but Not Dosed|1|||
161836028|NCT01698775|584440869|FG000|Phase A|Adverse Event|2|||
161836029|NCT01698775|584440870|FG001|Phase A|Adverse Event|1|||
161836030|NCT01698775|584440869|FG000|Phase A|Death|1|||
161836031|NCT01698775|584440870|FG001|Phase A|Death|1|||
161836032|NCT01698775|584440869|FG000|Phase A|Lack of Efficacy|1|||
161836033|NCT01698775|584440870|FG001|Phase A|Lack of Efficacy|0|||
161836034|NCT01698775|584440869|FG000|Phase A|Lost to Follow-up|1|||
161836035|NCT01698775|584440870|FG001|Phase A|Lost to Follow-up|2|||
161836036|NCT01698775|584440869|FG000|Phase A|Protocol Violation|1|||
161688678|NCT01661140|583911691|FG000|Double-Blind Period|Administrative/Other|0|||
161955981|NCT02574078|584887361|FG006|Treatment Period|Participant no longer meets criteria|0|||
161955982|NCT02574078|584887362|FG007|Treatment Period|Participant no longer meets criteria|0|||
161955983|NCT02574078|584887363|FG008|Treatment Period|Participant no longer meets criteria|0|||
161955984|NCT02574078|584887364|FG009|Treatment Period|Participant no longer meets criteria|1|||
161688679|NCT01661140|583911692|FG001|Double-Blind Period|Administrative/Other|7|||
161836037|NCT01698775|584440870|FG001|Phase A|Protocol Violation|0|||
161955985|NCT02574078|584887365|FG010|Treatment Period|Participant no longer meets criteria|1|||
161955986|NCT02574078|584887366|FG011|Treatment Period|Participant no longer meets criteria|1|||
161955987|NCT02574078|584887367|FG012|Treatment Period|Participant no longer meets criteria|0|||
161955988|NCT02574078|584887355|FG000|Treatment Period|Lost to Follow-up|0|||
161955989|NCT02574078|584887356|FG001|Treatment Period|Lost to Follow-up|0|||
161955990|NCT02574078|584887357|FG002|Treatment Period|Lost to Follow-up|0|||
161955991|NCT02574078|584887358|FG003|Treatment Period|Lost to Follow-up|0|||
161955992|NCT02574078|584887359|FG004|Treatment Period|Lost to Follow-up|0|||
161955993|NCT02574078|584887360|FG005|Treatment Period|Lost to Follow-up|0|||
161955994|NCT02574078|584887361|FG006|Treatment Period|Lost to Follow-up|0|||
162030753|NCT04604132|585169482|FG002|Overall Study|Study terminated by sponsor|0|||
161688680|NCT01661140|583911693|FG002|Double-Blind Period|Administrative/Other|6|||
161836038|NCT01698775|584440869|FG000|Phase A|Withdrawal by Subject|3|||
161836039|NCT01698775|584440870|FG001|Phase A|Withdrawal by Subject|4|||
161836040|NCT01698775|584440869|FG000|Phase A|Kidney [transplant]|0|||
161836041|NCT01698775|584440870|FG001|Phase A|Kidney [transplant]|1|||
161836042|NCT01698775|584440869|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
161688681|NCT02239939|583911694|FG000|Overall Study|Adverse Event|1|||
161688682|NCT02239939|583911695|FG001|Overall Study|Adverse Event|0|||
161688683|NCT02239939|583911694|FG000|Overall Study|Withdrawal by Subject|1|||
161688684|NCT02239939|583911695|FG001|Overall Study|Withdrawal by Subject|1|||
161688685|NCT02239939|583911694|FG000|Overall Study|Lost to Follow-up|0|||
161836043|NCT01698775|584440870|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
161836044|NCT01698775|584440869|FG000|Phase B|Adverse Event|6|||
161836045|NCT01698775|584440870|FG001|Phase B|Adverse Event|3|||
161836046|NCT01698775|584440869|FG000|Phase B|Death|0|||
161688686|NCT02239939|583911695|FG001|Overall Study|Lost to Follow-up|1|||
161836047|NCT01698775|584440870|FG001|Phase B|Death|1|||
161836048|NCT01698775|584440869|FG000|Phase B|Lack of Efficacy|0|||
161836049|NCT01698775|584440870|FG001|Phase B|Lack of Efficacy|1|||
161836050|NCT01698775|584440869|FG000|Phase B|Lost to Follow-up|0|||
161836051|NCT01698775|584440870|FG001|Phase B|Lost to Follow-up|1|||
161836052|NCT01698775|584440869|FG000|Phase B|Physician Decision|1|||
161836053|NCT01698775|584440870|FG001|Phase B|Physician Decision|1|||
162030754|NCT04604132|585169483|FG003|Overall Study|Study terminated by sponsor|0|||
161836054|NCT01698775|584440869|FG000|Phase B|Protocol Violation|1|||
161688687|NCT05594173|583911699|FG000|Overall Study|Adverse Event|1|||
161688688|NCT05594173|583911699|FG000|Overall Study|COVID-19 Pandemic|2|||
161688689|NCT00763139|583911700|FG000|Overall Study|Adverse Event|4|||
161688690|NCT00763139|583911701|FG001|Overall Study|Adverse Event|2|||
161955995|NCT02574078|584887362|FG007|Treatment Period|Lost to Follow-up|0|||
161955996|NCT02574078|584887363|FG008|Treatment Period|Lost to Follow-up|0|||
161836055|NCT01698775|584440870|FG001|Phase B|Protocol Violation|1|||
161688691|NCT00763139|583911700|FG000|Overall Study|Withdrawal by Subject|0|||
161688692|NCT00763139|583911701|FG001|Overall Study|Withdrawal by Subject|1|||
161688693|NCT00763139|583911700|FG000|Overall Study|med change not allowed by protocol|1|||
161688694|NCT00763139|583911701|FG001|Overall Study|med change not allowed by protocol|0|||
161688695|NCT05634577|583911702|FG000|Overall Study|Lost to Follow-up|1|||
161688696|NCT05634577|583911702|FG000|Overall Study|Withdrawal by Subject|1|||
161688697|NCT03468309|583911703|FG000|Overall Study|Lost to Follow-up|4|||
161688698|NCT03468309|583911703|FG000|Overall Study|Withdrawal by Subject|2|||
161688699|NCT02631200|583911706|FG000|First Period|Death|1|||
161688700|NCT02631200|583911707|FG001|First Period|Death|2|||
161688701|NCT02631200|583911706|FG000|First Period|Patient ill-health|2|||
161688702|NCT02631200|583911707|FG001|First Period|Patient ill-health|4|||
161688703|NCT02631200|583911706|FG000|First Period|Withdrawal by Subject|4|||
161688704|NCT02631200|583911707|FG001|First Period|Withdrawal by Subject|1|||
161688705|NCT02631200|583911706|FG000|Deferred Period|Death|0|||
161688706|NCT02631200|583911707|FG001|Deferred Period|Death|1|||
161688707|NCT02631200|583911706|FG000|Deferred Period|Received kidney transplant|0|||
161688708|NCT02631200|583911707|FG001|Deferred Period|Received kidney transplant|1|||
161688709|NCT02631200|583911706|FG000|Deferred Period|Withdrawal by Subject|0|||
161688710|NCT02631200|583911707|FG001|Deferred Period|Withdrawal by Subject|2|||
161688711|NCT02631200|583911706|FG000|Deferred Period|Lost to Follow-up|0|||
161688712|NCT02631200|583911707|FG001|Deferred Period|Lost to Follow-up|1|||
161836056|NCT01698775|584440869|FG000|Phase B|Withdrawal by Subject|6|||
161955997|NCT02574078|584887364|FG009|Treatment Period|Lost to Follow-up|1|||
161955998|NCT02574078|584887365|FG010|Treatment Period|Lost to Follow-up|0|||
161955999|NCT02574078|584887366|FG011|Treatment Period|Lost to Follow-up|1|||
161956000|NCT02574078|584887367|FG012|Treatment Period|Lost to Follow-up|0|||
161956001|NCT02574078|584887355|FG000|Treatment Period|Maximum clinical benefit|0|||
161956002|NCT02574078|584887356|FG001|Treatment Period|Maximum clinical benefit|0|||
161688713|NCT03363321|583911712|FG000|Overall Study|Withdrawal by Subject|0|||
161688714|NCT03363321|583911713|FG001|Overall Study|Withdrawal by Subject|1|||
161956003|NCT02574078|584887357|FG002|Treatment Period|Maximum clinical benefit|0|||
161688715|NCT03363321|583911714|FG002|Overall Study|Withdrawal by Subject|0|||
161688716|NCT03363321|583911715|FG003|Overall Study|Withdrawal by Subject|1|||
161688717|NCT03363321|583911716|FG004|Overall Study|Withdrawal by Subject|0|||
161688718|NCT00915681|583911717|FG000|Overall Study|Screening failures|46|||
161956004|NCT02574078|584887358|FG003|Treatment Period|Maximum clinical benefit|0|||
161956005|NCT02574078|584887359|FG004|Treatment Period|Maximum clinical benefit|0|||
161956006|NCT02574078|584887360|FG005|Treatment Period|Maximum clinical benefit|0|||
161956007|NCT02574078|584887361|FG006|Treatment Period|Maximum clinical benefit|0|||
161956008|NCT02574078|584887362|FG007|Treatment Period|Maximum clinical benefit|0|||
161836057|NCT01698775|584440870|FG001|Phase B|Withdrawal by Subject|2|||
161956009|NCT02574078|584887363|FG008|Treatment Period|Maximum clinical benefit|0|||
161956010|NCT02574078|584887364|FG009|Treatment Period|Maximum clinical benefit|1|||
161956011|NCT02574078|584887365|FG010|Treatment Period|Maximum clinical benefit|0|||
161956012|NCT02574078|584887366|FG011|Treatment Period|Maximum clinical benefit|0|||
161836058|NCT03864042|584440871|FG000|DDI Phase|Adverse Event|2|||
161836059|NCT03864042|584440872|FG001|DDI Phase|Adverse Event|0|||
161836060|NCT03864042|584440873|FG002|DDI Phase|Adverse Event|0|||
161836061|NCT03864042|584440871|FG000|DDI Phase|Physician Decision|1|||
161836062|NCT03864042|584440872|FG001|DDI Phase|Physician Decision|0|||
161836063|NCT03864042|584440873|FG002|DDI Phase|Physician Decision|0|||
161836064|NCT03864042|584440871|FG000|DDI Phase|Progressive Disease|1|||
161836065|NCT03864042|584440872|FG001|DDI Phase|Progressive Disease|0|||
161836066|NCT03864042|584440873|FG002|DDI Phase|Progressive Disease|0|||
161836067|NCT03864042|584440871|FG000|Post-DDI Phase|Adverse Event|5|||
161836068|NCT03864042|584440872|FG001|Post-DDI Phase|Adverse Event|3|||
161836069|NCT03864042|584440873|FG002|Post-DDI Phase|Adverse Event|2|||
161836070|NCT03864042|584440871|FG000|Post-DDI Phase|Progressive Disease|11|||
161836071|NCT03864042|584440872|FG001|Post-DDI Phase|Progressive Disease|6|||
161836072|NCT03864042|584440873|FG002|Post-DDI Phase|Progressive Disease|13|||
161836073|NCT03864042|584440871|FG000|Post-DDI Phase|Discretion of investigator|1|||
161836074|NCT03864042|584440872|FG001|Post-DDI Phase|Discretion of investigator|1|||
161836075|NCT03864042|584440873|FG002|Post-DDI Phase|Discretion of investigator|0|||
161836076|NCT03864042|584440871|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
161836077|NCT03864042|584440872|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
161836078|NCT03864042|584440873|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
161836079|NCT03864042|584440871|FG000|Post-DDI Phase|Withdrawal of consent|1|||
161836080|NCT03864042|584440872|FG001|Post-DDI Phase|Withdrawal of consent|2|||
161836081|NCT03864042|584440873|FG002|Post-DDI Phase|Withdrawal of consent|0|||
161836082|NCT00766831|584440876|FG000|Overall Study|Withdrawal by Subject|4|||
161836083|NCT00766831|584440876|FG000|Overall Study|Lost to Follow-up|3|||
161836084|NCT00766831|584440876|FG000|Overall Study|Adverse Event|20|||
161836085|NCT00766831|584440876|FG000|Overall Study|Protocol Violation|15|||
161836086|NCT00766831|584440876|FG000|Overall Study|Physician Decision|5|||
161836087|NCT00766831|584440876|FG000|Overall Study|Withdrawal of consent|26|||
161836088|NCT00766831|584440876|FG000|Overall Study|Non cooperation by participants|14|||
161836089|NCT00766831|584440876|FG000|Overall Study|Other|28|||
161836090|NCT00515034|584440879|FG000|Overall Study|Adverse Event|2|||
161836091|NCT00515034|584440880|FG001|Overall Study|Adverse Event|0|||
161836092|NCT00515034|584440881|FG002|Overall Study|Adverse Event|1|||
161836093|NCT00515034|584440882|FG003|Overall Study|Adverse Event|0|||
161956013|NCT02574078|584887367|FG012|Treatment Period|Maximum clinical benefit|0|||
161956014|NCT05935878|584887374|FG000|Overall Study|Death|1|||
161956015|NCT05935878|584887375|FG001|Overall Study|Death|2|||
161956016|NCT05935878|584887374|FG000|Overall Study|Withdrawal by Subject|5|||
161956017|NCT05935878|584887375|FG001|Overall Study|Withdrawal by Subject|5|||
161956018|NCT05935878|584887374|FG000|Overall Study|Revision of implant|1|||
161956019|NCT05935878|584887375|FG001|Overall Study|Revision of implant|1|||
161956020|NCT05935878|584887374|FG000|Overall Study|Mobile bearing dislocation|0|||
161956021|NCT05935878|584887375|FG001|Overall Study|Mobile bearing dislocation|1|||
161956022|NCT02297815|584887391|FG000|Overall Study|Lost to Follow-up|236|||
161956023|NCT02297815|584887392|FG001|Overall Study|Lost to Follow-up|140|||
161836094|NCT00515034|584440879|FG000|Overall Study|Death|4|||
161956024|NCT00662831|584887393|FG000|Overall Study|Death|4|||
161956025|NCT00662831|584887394|FG001|Overall Study|Death|1|||
161956026|NCT00662831|584887393|FG000|Overall Study|Lack of Efficacy|6|||
161956027|NCT00662831|584887394|FG001|Overall Study|Lack of Efficacy|6|||
161956028|NCT00662831|584887393|FG000|Overall Study|Lost to Follow-up|1|||
161688719|NCT03221751|583911722|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
161688720|NCT03221751|583911723|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
161688721|NCT02590588|583911726|FG000|Overall Study|Adverse Event|1|||
161688722|NCT01780831|583911734|FG000|Overall Study|Withdrawal by Subject|0|||
161688723|NCT01780831|583911735|FG001|Overall Study|Withdrawal by Subject|0|||
161688724|NCT01780831|583911736|FG002|Overall Study|Withdrawal by Subject|4|||
161688725|NCT01780831|583911737|FG003|Overall Study|Withdrawal by Subject|0|||
161956029|NCT00662831|584887394|FG001|Overall Study|Lost to Follow-up|0|||
161956030|NCT00662831|584887393|FG000|Overall Study|Withdrawal by Subject|2|||
161688726|NCT01780831|583911734|FG000|Overall Study|Lost to Follow-up|0|||
161688727|NCT01780831|583911735|FG001|Overall Study|Lost to Follow-up|0|||
161688728|NCT01780831|583911736|FG002|Overall Study|Lost to Follow-up|0|||
161688729|NCT01780831|583911737|FG003|Overall Study|Lost to Follow-up|1|||
161688730|NCT01784861|583911738|FG000|Overall Study|Adverse Event|0|||
161956031|NCT00662831|584887394|FG001|Overall Study|Withdrawal by Subject|1|||
161688731|NCT01784861|583911739|FG001|Overall Study|Adverse Event|0|||
161956032|NCT00662831|584887393|FG000|Overall Study|Other|62|||
161956033|NCT00662831|584887394|FG001|Overall Study|Other|31|||
161956034|NCT00662831|584887393|FG000|Overall Study|Protocol Violation|8|||
161688732|NCT01784861|583911740|FG002|Overall Study|Adverse Event|1|||
161956035|NCT00662831|584887394|FG001|Overall Study|Protocol Violation|4|||
161956036|NCT00662831|584887393|FG000|Overall Study|Adverse Event|23|||
161956037|NCT00662831|584887394|FG001|Overall Study|Adverse Event|16|||
161956038|NCT01734785|584887396|FG000|Open-Label Period|Adverse Event|0|||
161956039|NCT01734785|584887397|FG001|Open-Label Period|Adverse Event|0|||
161956040|NCT01734785|584887398|FG002|Open-Label Period|Adverse Event|0|||
161956041|NCT01734785|584887399|FG003|Open-Label Period|Adverse Event|9|||
161956042|NCT01734785|584887396|FG000|Open-Label Period|Lack of Efficacy|0|||
161956043|NCT01734785|584887397|FG001|Open-Label Period|Lack of Efficacy|0|||
161836095|NCT00515034|584440880|FG001|Overall Study|Death|2|||
161836096|NCT00515034|584440881|FG002|Overall Study|Death|1|||
161836097|NCT00515034|584440882|FG003|Overall Study|Death|3|||
161836098|NCT00515034|584440879|FG000|Overall Study|Withdrawal by Subject|1|||
161688733|NCT01784861|583911741|FG003|Overall Study|Adverse Event|2|||
161688734|NCT01784861|583911742|FG004|Overall Study|Adverse Event|1|||
161688735|NCT01784861|583911743|FG005|Overall Study|Adverse Event|0|||
161836099|NCT00515034|584440880|FG001|Overall Study|Withdrawal by Subject|0|||
161956044|NCT01734785|584887398|FG002|Open-Label Period|Lack of Efficacy|0|||
161956045|NCT01734785|584887399|FG003|Open-Label Period|Lack of Efficacy|1|||
161956046|NCT01734785|584887396|FG000|Open-Label Period|Protocol Violation|0|||
161956047|NCT01734785|584887397|FG001|Open-Label Period|Protocol Violation|0|||
161956048|NCT01734785|584887398|FG002|Open-Label Period|Protocol Violation|0|||
161956049|NCT01734785|584887399|FG003|Open-Label Period|Protocol Violation|13|||
161836100|NCT00515034|584440881|FG002|Overall Study|Withdrawal by Subject|3|||
161836101|NCT00515034|584440882|FG003|Overall Study|Withdrawal by Subject|0|||
161836102|NCT00515034|584440879|FG000|Overall Study|Physician Decision|0|||
161956050|NCT01734785|584887396|FG000|Open-Label Period|Lost to Follow-up|0|||
161956051|NCT01734785|584887397|FG001|Open-Label Period|Lost to Follow-up|0|||
161956052|NCT01734785|584887398|FG002|Open-Label Period|Lost to Follow-up|0|||
161956053|NCT01734785|584887399|FG003|Open-Label Period|Lost to Follow-up|14|||
161956054|NCT01734785|584887396|FG000|Open-Label Period|Withdrawal by Subject|0|||
161956055|NCT01734785|584887397|FG001|Open-Label Period|Withdrawal by Subject|0|||
161956056|NCT01734785|584887398|FG002|Open-Label Period|Withdrawal by Subject|0|||
161956057|NCT01734785|584887399|FG003|Open-Label Period|Withdrawal by Subject|12|||
161956058|NCT01734785|584887396|FG000|Open-Label Period|Other Reasons|0|||
161836103|NCT00515034|584440880|FG001|Overall Study|Physician Decision|0|||
161836104|NCT00515034|584440881|FG002|Overall Study|Physician Decision|1|||
161836105|NCT00515034|584440882|FG003|Overall Study|Physician Decision|1|||
161836106|NCT00515034|584440879|FG000|Overall Study|Other|1|||
161836107|NCT00515034|584440880|FG001|Overall Study|Other|0|||
161836108|NCT00515034|584440881|FG002|Overall Study|Other|2|||
161836109|NCT00515034|584440882|FG003|Overall Study|Other|1|||
161836110|NCT02340221|584440885|FG000|Overall Study|Death|100|||
161688736|NCT01784861|583911738|FG000|Overall Study|Withdrawal by Subject|0|||
161836111|NCT02340221|584440886|FG001|Overall Study|Death|197|||
161836112|NCT02340221|584440885|FG000|Overall Study|Withdrawal by Participant|24|||
161836113|NCT02340221|584440886|FG001|Overall Study|Withdrawal by Participant|37|||
161836114|NCT02340221|584440885|FG000|Overall Study|Lost to Follow-up|4|||
161688737|NCT01784861|583911739|FG001|Overall Study|Withdrawal by Subject|0|||
161688738|NCT01784861|583911740|FG002|Overall Study|Withdrawal by Subject|0|||
161688739|NCT01784861|583911741|FG003|Overall Study|Withdrawal by Subject|1|||
161688740|NCT01784861|583911742|FG004|Overall Study|Withdrawal by Subject|0|||
161688741|NCT01784861|583911743|FG005|Overall Study|Withdrawal by Subject|0|||
161688742|NCT01784861|583911738|FG000|Overall Study|Physician Decision|0|||
161688743|NCT01784861|583911739|FG001|Overall Study|Physician Decision|0|||
161688744|NCT01784861|583911740|FG002|Overall Study|Physician Decision|0|||
161688745|NCT01784861|583911741|FG003|Overall Study|Physician Decision|2|||
161688746|NCT01784861|583911742|FG004|Overall Study|Physician Decision|0|||
161688747|NCT01784861|583911743|FG005|Overall Study|Physician Decision|1|||
161688748|NCT00906087|583911756|FG000|Initial Washout|Withdrawal by Subject|1|||
161688749|NCT00906087|583911756|FG000|Initial Washout|Physician Decision|1|||
161688750|NCT03016325|583911762|FG000|Treatment Period|Participant withdrew consent|0|||
161688751|NCT03016325|583911763|FG001|Treatment Period|Participant withdrew consent|1|||
161688752|NCT03016325|583911764|FG002|Treatment Period|Participant withdrew consent|0|||
161836115|NCT02340221|584440886|FG001|Overall Study|Lost to Follow-up|15|||
161956059|NCT01734785|584887397|FG001|Open-Label Period|Other Reasons|0|||
161688753|NCT03016325|583911765|FG003|Treatment Period|Participant withdrew consent|0|||
161688754|NCT03016325|583911766|FG004|Treatment Period|Participant withdrew consent|0|||
161688755|NCT03016325|583911767|FG005|Treatment Period|Participant withdrew consent|0|||
161688756|NCT03016325|583911768|FG006|Treatment Period|Participant withdrew consent|0|||
161688757|NCT03016325|583911769|FG007|Treatment Period|Participant withdrew consent|0|||
161688758|NCT03016325|583911762|FG000|Treatment Period|Death|0|||
161688759|NCT03016325|583911763|FG001|Treatment Period|Death|0|||
161688760|NCT03016325|583911764|FG002|Treatment Period|Death|0|||
161688761|NCT03016325|583911765|FG003|Treatment Period|Death|0|||
161688762|NCT03016325|583911766|FG004|Treatment Period|Death|2|||
161688763|NCT03016325|583911767|FG005|Treatment Period|Death|0|||
161688764|NCT03016325|583911768|FG006|Treatment Period|Death|0|||
161688765|NCT03016325|583911769|FG007|Treatment Period|Death|0|||
161688766|NCT03016325|583911762|FG000|Treatment Period|Participant refuses assessments|0|||
161688767|NCT03016325|583911763|FG001|Treatment Period|Participant refuses assessments|0|||
161688768|NCT03016325|583911764|FG002|Treatment Period|Participant refuses assessments|1|||
161688769|NCT03016325|583911765|FG003|Treatment Period|Participant refuses assessments|0|||
161688770|NCT03016325|583911766|FG004|Treatment Period|Participant refuses assessments|0|||
161688771|NCT03016325|583911767|FG005|Treatment Period|Participant refuses assessments|0|||
161688772|NCT03016325|583911768|FG006|Treatment Period|Participant refuses assessments|0|||
161688773|NCT03016325|583911769|FG007|Treatment Period|Participant refuses assessments|0|||
161688774|NCT03016325|583911762|FG000|32-Day Follow-Up Period|Death|2|||
161688775|NCT03016325|583911763|FG001|32-Day Follow-Up Period|Death|0|||
161688776|NCT03016325|583911764|FG002|32-Day Follow-Up Period|Death|5|||
161688777|NCT03016325|583911765|FG003|32-Day Follow-Up Period|Death|6|||
161688778|NCT03016325|583911766|FG004|32-Day Follow-Up Period|Death|3|||
161688779|NCT03016325|583911767|FG005|32-Day Follow-Up Period|Death|0|||
161688780|NCT03016325|583911768|FG006|32-Day Follow-Up Period|Death|0|||
161688781|NCT03016325|583911769|FG007|32-Day Follow-Up Period|Death|0|||
161688782|NCT03016325|583911762|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
161688783|NCT03016325|583911763|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
161688784|NCT03016325|583911764|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
161688785|NCT03016325|583911765|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
161688786|NCT03016325|583911766|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
161688787|NCT03016325|583911767|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
161688788|NCT03016325|583911768|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
161688789|NCT03016325|583911769|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
161688790|NCT03016325|583911762|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
161688791|NCT03016325|583911763|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
161836116|NCT02340221|584440885|FG000|Overall Study|Reason Not Specified|85|||
161836117|NCT02340221|584440886|FG001|Overall Study|Reason Not Specified|165|||
161836118|NCT02340221|584440885|FG000|Overall Study|Study Terminated by Sponsor|1|||
161836119|NCT02340221|584440886|FG001|Overall Study|Study Terminated by Sponsor|3|||
161836120|NCT00952276|584440887|FG000|Overall Study|Withdrawal by Subject|1|||
161836121|NCT00952276|584440888|FG001|Overall Study|Withdrawal by Subject|0|||
161836122|NCT00952276|584440889|FG002|Overall Study|Withdrawal by Subject|0|||
161836123|NCT00952276|584440890|FG003|Overall Study|Withdrawal by Subject|1|||
161836124|NCT00952276|584440891|FG004|Overall Study|Withdrawal by Subject|0|||
161836125|NCT04189445|584442878|FG000|Overall Study|Withdrawal of consent|8|||
161836126|NCT04189445|584442879|FG001|Overall Study|Withdrawal of consent|1|||
161956060|NCT01734785|584887398|FG002|Open-Label Period|Other Reasons|0|||
161836127|NCT04189445|584442880|FG002|Overall Study|Withdrawal of consent|0|||
161836128|NCT04189445|584442878|FG000|Overall Study|Study Terminated by Sponsor|25|||
161836129|NCT04189445|584442879|FG001|Overall Study|Study Terminated by Sponsor|3|||
161956061|NCT01734785|584887399|FG003|Open-Label Period|Other Reasons|224|||
161956062|NCT01734785|584887396|FG000|Double-Blind Period|Adverse Event|0|||
161688792|NCT03016325|583911764|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
161688793|NCT03016325|583911765|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
161688794|NCT03016325|583911766|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
161688795|NCT03016325|583911767|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
161688796|NCT03016325|583911768|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
161688797|NCT03016325|583911769|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
161688798|NCT03016325|583911762|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
161688799|NCT03016325|583911763|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
161688800|NCT03016325|583911764|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
161688801|NCT03016325|583911765|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
161688802|NCT03016325|583911766|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
161688803|NCT03016325|583911767|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
161688804|NCT03016325|583911768|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
161688805|NCT03016325|583911769|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
161688806|NCT03016325|583911762|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
161688807|NCT03016325|583911763|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
161688808|NCT03016325|583911764|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
161688809|NCT03016325|583911765|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
161688810|NCT03016325|583911766|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
161956063|NCT01734785|584887397|FG001|Double-Blind Period|Adverse Event|3|||
161956064|NCT01734785|584887398|FG002|Double-Blind Period|Adverse Event|2|||
161688811|NCT03016325|583911767|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
161688812|NCT03016325|583911768|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
161688813|NCT03016325|583911769|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
161688814|NCT03016325|583911762|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688815|NCT03016325|583911763|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688816|NCT03016325|583911764|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
161688817|NCT03016325|583911765|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688818|NCT03016325|583911766|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688819|NCT03016325|583911767|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688820|NCT03016325|583911768|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688821|NCT03016325|583911769|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161688822|NCT03016325|583911762|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688823|NCT03016325|583911763|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
161688824|NCT03016325|583911764|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688825|NCT03016325|583911765|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688826|NCT03016325|583911766|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688827|NCT03016325|583911767|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688828|NCT03016325|583911768|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688829|NCT03016325|583911769|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161688830|NCT03016325|583911762|FG000|182-Day Follow-Up Period|Death|3|||
161688831|NCT03016325|583911763|FG001|182-Day Follow-Up Period|Death|3|||
161688832|NCT03016325|583911764|FG002|182-Day Follow-Up Period|Death|11|||
161688833|NCT03016325|583911765|FG003|182-Day Follow-Up Period|Death|12|||
161688834|NCT03016325|583911766|FG004|182-Day Follow-Up Period|Death|9|||
161688835|NCT03016325|583911767|FG005|182-Day Follow-Up Period|Death|0|||
161688836|NCT03016325|583911768|FG006|182-Day Follow-Up Period|Death|0|||
161688837|NCT03016325|583911769|FG007|182-Day Follow-Up Period|Death|1|||
161688838|NCT03016325|583911762|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
161688839|NCT03016325|583911763|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688840|NCT03016325|583911764|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688841|NCT03016325|583911765|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688842|NCT03016325|583911766|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688843|NCT03016325|583911767|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688844|NCT03016325|583911768|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688845|NCT03016325|583911769|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161688846|NCT03016325|583911762|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
161688847|NCT03016325|583911763|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
161688848|NCT03016325|583911764|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
161688849|NCT03016325|583911765|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
161688850|NCT03016325|583911766|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
161688851|NCT03016325|583911767|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
161688852|NCT03016325|583911768|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
161688853|NCT03016325|583911769|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
161688854|NCT03016325|583911762|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161836130|NCT04189445|584442880|FG002|Overall Study|Study Terminated by Sponsor|0|||
161956065|NCT01734785|584887399|FG003|Double-Blind Period|Adverse Event|0|||
161956066|NCT01734785|584887396|FG000|Double-Blind Period|Lack of Efficacy|0|||
161688855|NCT03016325|583911763|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161688856|NCT03016325|583911764|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161688857|NCT03016325|583911765|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161688858|NCT03016325|583911766|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
161836131|NCT04189445|584442878|FG000|Overall Study|Death|54|||
161836132|NCT04189445|584442879|FG001|Overall Study|Death|24|||
161836133|NCT04189445|584442880|FG002|Overall Study|Death|0|||
161836134|NCT00003138|584442881|FG000|Step 1|Reasons off treatment not documented|60|||
161836135|NCT00003138|584442882|FG001|Step 1|Reasons off treatment not documented|57|||
161836136|NCT00003138|584442881|FG000|Step 1|Never started treatment|1|||
161836137|NCT00003138|584442882|FG001|Step 1|Never started treatment|0|||
161836138|NCT00003138|584442881|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
161836139|NCT00003138|584442882|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
161836140|NCT00003138|584442881|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
161836141|NCT00003138|584442882|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
161836142|NCT00003138|584442881|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
161836143|NCT00003138|584442882|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
161836144|NCT00003138|584442881|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
161836145|NCT00003138|584442882|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
161836146|NCT02522403|584442883|FG000|Overall Study|Lost to Follow-up|2|||
161836147|NCT02522403|584442884|FG001|Overall Study|Lost to Follow-up|2|||
161836148|NCT02522403|584442883|FG000|Overall Study|Withdrawal by Subject|2|||
161836149|NCT02522403|584442884|FG001|Overall Study|Withdrawal by Subject|4|||
161836150|NCT05142566|584442885|FG000|Overall Study|Protocol Violation|1|||
161836151|NCT04556552|584442886|FG000|Overall Study|Lost to Follow-up|1|||
161836152|NCT04556552|584442887|FG001|Overall Study|Lost to Follow-up|0|||
161836153|NCT04556552|584442886|FG000|Overall Study|Claustrophobia|0|||
161836154|NCT04556552|584442887|FG001|Overall Study|Claustrophobia|1|||
161836155|NCT04556552|584442886|FG000|Overall Study|Inability to continue|0|||
161956067|NCT01734785|584887397|FG001|Double-Blind Period|Lack of Efficacy|1|||
161956068|NCT01734785|584887398|FG002|Double-Blind Period|Lack of Efficacy|0|||
161956069|NCT01734785|584887399|FG003|Double-Blind Period|Lack of Efficacy|0|||
161956070|NCT01734785|584887396|FG000|Double-Blind Period|Protocol Violation|0|||
161956071|NCT01734785|584887397|FG001|Double-Blind Period|Protocol Violation|1|||
161956072|NCT01734785|584887398|FG002|Double-Blind Period|Protocol Violation|1|||
161956073|NCT01734785|584887399|FG003|Double-Blind Period|Protocol Violation|0|||
161956074|NCT01734785|584887396|FG000|Double-Blind Period|Lost to Follow-up|2|||
161956075|NCT01734785|584887397|FG001|Double-Blind Period|Lost to Follow-up|4|||
161836156|NCT04556552|584442887|FG001|Overall Study|Inability to continue|1|||
161836157|NCT01553279|584442888|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
161836158|NCT01553279|584442889|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
161836159|NCT01553279|584442888|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
161956076|NCT01734785|584887398|FG002|Double-Blind Period|Lost to Follow-up|2|||
161956077|NCT01734785|584887399|FG003|Double-Blind Period|Lost to Follow-up|0|||
161956078|NCT01734785|584887396|FG000|Double-Blind Period|Withdrawal by Subject|2|||
161956079|NCT01734785|584887397|FG001|Double-Blind Period|Withdrawal by Subject|0|||
161956080|NCT01734785|584887398|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161956081|NCT01734785|584887399|FG003|Double-Blind Period|Withdrawal by Subject|0|||
161688859|NCT03016325|583911767|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161688860|NCT03016325|583911768|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161956082|NCT01734785|584887396|FG000|Double-Blind Period|Not treated|1|||
161956083|NCT01734785|584887397|FG001|Double-Blind Period|Not treated|0|||
161836160|NCT01553279|584442889|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
161836161|NCT01553279|584442888|FG000|Interim Period|Withdrawal by Subject|2|||
161836162|NCT01553279|584442889|FG001|Interim Period|Withdrawal by Subject|2|||
161836163|NCT01553279|584442888|FG000|Interim Period|Lost to Follow-up|1|||
161956084|NCT01734785|584887398|FG002|Double-Blind Period|Not treated|0|||
161836164|NCT01553279|584442889|FG001|Interim Period|Lost to Follow-up|0|||
161956085|NCT01734785|584887399|FG003|Double-Blind Period|Not treated|0|||
161836165|NCT01553279|584442888|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
161836166|NCT01553279|584442889|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
161836167|NCT01553279|584442888|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
161836168|NCT01553279|584442889|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
161836169|NCT00605865|584442890|FG000|Overall Study|Protocol Violation|115|||
161836170|NCT02856880|584442896|FG000|Overall Study|Withdrawal of consent|1|||
161836171|NCT00094458|584442897|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
161836172|NCT00094458|584442898|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
161836173|NCT00094458|584442899|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
161836174|NCT00094458|584442900|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
161836175|NCT00094458|584442901|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
161836176|NCT00094458|584442902|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
161836177|NCT00094458|584442897|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
161836178|NCT00094458|584442898|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
161836179|NCT00094458|584442899|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
161836180|NCT00094458|584442900|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
161836181|NCT00094458|584442901|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
161836182|NCT00094458|584442902|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
161836183|NCT00094458|584442897|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
161836184|NCT00094458|584442898|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
161836185|NCT00094458|584442899|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
161836186|NCT00094458|584442900|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
161836187|NCT00094458|584442901|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
161836188|NCT00094458|584442902|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
161836189|NCT00094458|584442897|FG000|Main Study: Through Week 30|Adverse Event|38|||
161836190|NCT00094458|584442898|FG001|Main Study: Through Week 30|Adverse Event|20|||
161836191|NCT00094458|584442899|FG002|Main Study: Through Week 30|Adverse Event|28|||
161836192|NCT00094458|584442900|FG003|Main Study: Through Week 30|Adverse Event|0|||
161836193|NCT00094458|584442901|FG004|Main Study: Through Week 30|Adverse Event|0|||
161836194|NCT00094458|584442902|FG005|Main Study: Through Week 30|Adverse Event|0|||
161836195|NCT00094458|584442897|FG000|Main Study: Through Week 30|Death|1|||
161836196|NCT00094458|584442898|FG001|Main Study: Through Week 30|Death|0|||
161836197|NCT00094458|584442899|FG002|Main Study: Through Week 30|Death|0|||
161836198|NCT00094458|584442900|FG003|Main Study: Through Week 30|Death|0|||
161836199|NCT00094458|584442901|FG004|Main Study: Through Week 30|Death|0|||
161956086|NCT02397915|584887400|FG000|Period 1|Protocol Violation|0|||
161956087|NCT02397915|584887401|FG001|Period 1|Protocol Violation|1|||
161956088|NCT02397915|584887402|FG002|Period 1|Protocol Violation|0|||
161956089|NCT02397915|584887403|FG003|Period 1|Protocol Violation|0|||
161688861|NCT03016325|583911769|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161688862|NCT03016325|583911762|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688863|NCT03016325|583911763|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688864|NCT03016325|583911764|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688865|NCT03016325|583911765|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688866|NCT03016325|583911766|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
161688867|NCT03016325|583911767|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688868|NCT03016325|583911768|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688869|NCT03016325|583911769|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
161688870|NCT03016325|583911762|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688871|NCT03016325|583911763|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688872|NCT03016325|583911764|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688873|NCT03016325|583911765|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
161688874|NCT03016325|583911766|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688875|NCT03016325|583911767|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688876|NCT03016325|583911768|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688877|NCT03016325|583911769|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161688878|NCT03016325|583911762|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688879|NCT03016325|583911763|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
161688880|NCT03016325|583911764|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688881|NCT03016325|583911765|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688882|NCT03016325|583911766|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688883|NCT03016325|583911767|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688884|NCT03016325|583911768|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688885|NCT03016325|583911769|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161688886|NCT03016325|583911762|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161688887|NCT03016325|583911763|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161688888|NCT03016325|583911764|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161688889|NCT03016325|583911765|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161688890|NCT03016325|583911766|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161688891|NCT03016325|583911767|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
161688892|NCT03016325|583911768|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
161688893|NCT03016325|583911769|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
161688894|NCT01152021|583911771|FG000|Overall Study|Adverse Event|4|||
161688895|NCT01152021|583911772|FG001|Overall Study|Adverse Event|4|||
161688896|NCT01152021|583911771|FG000|Overall Study|Study drug had expired|1|||
161688897|NCT01152021|583911772|FG001|Overall Study|Study drug had expired|0|||
161688898|NCT01152021|583911771|FG000|Overall Study|Physician Decision|1|||
161688899|NCT01152021|583911772|FG001|Overall Study|Physician Decision|1|||
161688900|NCT01152021|583911771|FG000|Overall Study|No access to study drug in Pharmacy|0|||
161688901|NCT01152021|583911772|FG001|Overall Study|No access to study drug in Pharmacy|1|||
161688902|NCT02595723|583911773|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
161688903|NCT02595723|583911774|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
161688904|NCT02595723|583911775|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
161688905|NCT02595723|583911773|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
161688906|NCT02595723|583911774|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
161688907|NCT02595723|583911775|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
161688908|NCT04288154|583911776|FG000|Overall Study|Withdrawal by Subject|9|||
161688909|NCT04288154|583911777|FG001|Overall Study|Withdrawal by Subject|9|||
161688910|NCT01902290|583911783|FG000|Overall Study|Withdrawal by Subject|19|||
161688911|NCT01902290|583911784|FG001|Overall Study|Withdrawal by Subject|27|||
161688912|NCT01902290|583911783|FG000|Overall Study|Lost to Follow-up|2|||
161688913|NCT01902290|583911784|FG001|Overall Study|Lost to Follow-up|2|||
161688914|NCT01902290|583911783|FG000|Overall Study|Death|1|||
161688915|NCT01902290|583911784|FG001|Overall Study|Death|0|||
161688916|NCT01902290|583911783|FG000|Overall Study|Sponsor Decision|26|||
161688917|NCT01902290|583911784|FG001|Overall Study|Sponsor Decision|24|||
161688918|NCT00769184|583911785|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
161688919|NCT00769184|583911786|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
161688920|NCT00769184|583911785|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
161688921|NCT00769184|583911786|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
161688922|NCT00769184|583911785|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
161688923|NCT00769184|583911786|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
161688924|NCT00385255|583911787|FG000|Overall Study|Serious Adverse Event|1|||
161688925|NCT00385255|583911788|FG001|Overall Study|Serious Adverse Event|2|||
161688926|NCT00385255|583911787|FG000|Overall Study|Protocol Violation|0|||
161688927|NCT00385255|583911788|FG001|Overall Study|Protocol Violation|4|||
161688928|NCT00385255|583911787|FG000|Overall Study|Withdrawal by Subject|0|||
161688929|NCT00385255|583911788|FG001|Overall Study|Withdrawal by Subject|8|||
161688930|NCT00385255|583911787|FG000|Overall Study|Migrated/moved from study area|0|||
161956090|NCT02397915|584887400|FG000|Period 1|Physician Decision|1|||
161956091|NCT02397915|584887401|FG001|Period 1|Physician Decision|0|||
161956092|NCT02397915|584887402|FG002|Period 1|Physician Decision|0|||
161956093|NCT02397915|584887403|FG003|Period 1|Physician Decision|0|||
161956094|NCT00368745|584887404|FG000|Double-blind Treatment Period|Adverse Event|6|||
161688931|NCT00385255|583911788|FG001|Overall Study|Migrated/moved from study area|1|||
161688932|NCT00385255|583911787|FG000|Overall Study|Lost to Follow-up|20|||
161688933|NCT00385255|583911788|FG001|Overall Study|Lost to Follow-up|58|||
161688934|NCT00835237|583911793|FG000|Overall Study|Lost to Follow-up|4|||
161688935|NCT00835237|583911794|FG001|Overall Study|Lost to Follow-up|0|||
161688936|NCT00835237|583911793|FG000|Overall Study|Withdrawal by Subject|2|||
161688937|NCT00835237|583911794|FG001|Overall Study|Withdrawal by Subject|0|||
161688938|NCT01015768|583911799|FG000|Overall Study|Some subject data unuseable|4|||
161688939|NCT01015768|583911800|FG001|Overall Study|Some subject data unuseable|4|||
161688940|NCT01627860|583911801|FG000|Overall Study|Adverse Event|9|||
161688941|NCT01627860|583911802|FG001|Overall Study|Adverse Event|4|||
161688942|NCT01627860|583911801|FG000|Overall Study|Withdrawal by Subject|2|||
161688943|NCT01627860|583911802|FG001|Overall Study|Withdrawal by Subject|1|||
161688944|NCT01627860|583911801|FG000|Overall Study|Seizure frequency doubled|0|||
161688945|NCT01627860|583911802|FG001|Overall Study|Seizure frequency doubled|1|||
161688946|NCT01627860|583911801|FG000|Overall Study|Protocol Violation|1|||
161688947|NCT01627860|583911802|FG001|Overall Study|Protocol Violation|0|||
161688948|NCT01225731|583911803|FG000|Part 1|Did not meet eligibility criteria|1|||
161688949|NCT01225731|583911804|FG001|Part 1|Did not meet eligibility criteria|0|||
161688950|NCT01225731|583911805|FG002|Part 1|Did not meet eligibility criteria|0|||
161688951|NCT01225731|583911806|FG003|Part 1|Did not meet eligibility criteria|0|||
161688952|NCT01225731|583911807|FG004|Part 1|Did not meet eligibility criteria|1|||
161688953|NCT01225731|583911808|FG005|Part 1|Did not meet eligibility criteria|0|||
161688954|NCT01225731|583911809|FG006|Part 1|Did not meet eligibility criteria|0|||
161688955|NCT01225731|583911810|FG007|Part 1|Did not meet eligibility criteria|0|||
161688956|NCT01225731|583911811|FG008|Part 1|Did not meet eligibility criteria|0|||
161688957|NCT01225731|583911812|FG009|Part 1|Did not meet eligibility criteria|0|||
161688958|NCT01225731|583911813|FG010|Part 1|Did not meet eligibility criteria|0|||
161688959|NCT01225731|583911814|FG011|Part 1|Did not meet eligibility criteria|0|||
161688960|NCT01225731|583911815|FG012|Part 1|Did not meet eligibility criteria|0|||
161688961|NCT01225731|583911803|FG000|Part 1|Adverse Event|1|||
161688962|NCT01225731|583911804|FG001|Part 1|Adverse Event|2|||
161688963|NCT01225731|583911805|FG002|Part 1|Adverse Event|1|||
161688964|NCT01225731|583911806|FG003|Part 1|Adverse Event|1|||
161688965|NCT01225731|583911807|FG004|Part 1|Adverse Event|1|||
161688966|NCT01225731|583911808|FG005|Part 1|Adverse Event|0|||
161688967|NCT01225731|583911809|FG006|Part 1|Adverse Event|0|||
161688968|NCT01225731|583911810|FG007|Part 1|Adverse Event|0|||
161688969|NCT01225731|583911811|FG008|Part 1|Adverse Event|0|||
161688970|NCT01225731|583911812|FG009|Part 1|Adverse Event|0|||
161688971|NCT01225731|583911813|FG010|Part 1|Adverse Event|0|||
161688972|NCT01225731|583911814|FG011|Part 1|Adverse Event|0|||
161688973|NCT01225731|583911815|FG012|Part 1|Adverse Event|0|||
161688974|NCT01225731|583911803|FG000|Part 1|Withdrawal by Subject|0|||
161688975|NCT01225731|583911804|FG001|Part 1|Withdrawal by Subject|3|||
161688976|NCT01225731|583911805|FG002|Part 1|Withdrawal by Subject|0|||
161688977|NCT01225731|583911806|FG003|Part 1|Withdrawal by Subject|0|||
161688978|NCT01225731|583911807|FG004|Part 1|Withdrawal by Subject|4|||
161688979|NCT01225731|583911808|FG005|Part 1|Withdrawal by Subject|0|||
161688980|NCT01225731|583911809|FG006|Part 1|Withdrawal by Subject|0|||
161688981|NCT01225731|583911810|FG007|Part 1|Withdrawal by Subject|0|||
161688982|NCT01225731|583911811|FG008|Part 1|Withdrawal by Subject|0|||
161688983|NCT01225731|583911812|FG009|Part 1|Withdrawal by Subject|0|||
161688984|NCT01225731|583911813|FG010|Part 1|Withdrawal by Subject|0|||
161688985|NCT01225731|583911814|FG011|Part 1|Withdrawal by Subject|0|||
161688986|NCT01225731|583911815|FG012|Part 1|Withdrawal by Subject|0|||
161688987|NCT01225731|583911803|FG000|Part 1|Protocol Violation|0|||
161688988|NCT01225731|583911804|FG001|Part 1|Protocol Violation|0|||
161688989|NCT01225731|583911805|FG002|Part 1|Protocol Violation|0|||
161688990|NCT01225731|583911806|FG003|Part 1|Protocol Violation|1|||
161688991|NCT01225731|583911807|FG004|Part 1|Protocol Violation|0|||
161688992|NCT01225731|583911808|FG005|Part 1|Protocol Violation|0|||
161688993|NCT01225731|583911809|FG006|Part 1|Protocol Violation|0|||
161688994|NCT01225731|583911810|FG007|Part 1|Protocol Violation|0|||
161688995|NCT01225731|583911811|FG008|Part 1|Protocol Violation|0|||
161688996|NCT01225731|583911812|FG009|Part 1|Protocol Violation|0|||
161688997|NCT01225731|583911813|FG010|Part 1|Protocol Violation|0|||
161688998|NCT01225731|583911814|FG011|Part 1|Protocol Violation|0|||
161688999|NCT01225731|583911815|FG012|Part 1|Protocol Violation|0|||
161689000|NCT01225731|583911803|FG000|Part 2|Protocol Violation|0|||
161689001|NCT01225731|583911804|FG001|Part 2|Protocol Violation|0|||
161689002|NCT01225731|583911805|FG002|Part 2|Protocol Violation|0|||
161689003|NCT01225731|583911806|FG003|Part 2|Protocol Violation|0|||
161689004|NCT01225731|583911807|FG004|Part 2|Protocol Violation|0|||
161689005|NCT01225731|583911808|FG005|Part 2|Protocol Violation|1|||
161689006|NCT01225731|583911809|FG006|Part 2|Protocol Violation|0|||
161689007|NCT01225731|583911810|FG007|Part 2|Protocol Violation|0|||
161689008|NCT01225731|583911811|FG008|Part 2|Protocol Violation|1|||
161689009|NCT01225731|583911812|FG009|Part 2|Protocol Violation|0|||
161689010|NCT01225731|583911813|FG010|Part 2|Protocol Violation|0|||
161689011|NCT01225731|583911814|FG011|Part 2|Protocol Violation|0|||
161689012|NCT01225731|583911815|FG012|Part 2|Protocol Violation|0|||
161689013|NCT01225731|583911803|FG000|Part 2|Adverse Event|0|||
161956095|NCT00368745|584887405|FG001|Double-blind Treatment Period|Adverse Event|6|||
161956096|NCT00368745|584887404|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
161956097|NCT00368745|584887405|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
161956098|NCT00368745|584887404|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
161956099|NCT00368745|584887405|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161956100|NCT00368745|584887404|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
161956101|NCT00368745|584887405|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
161956102|NCT00368745|584887404|FG000|Double-blind Treatment Period|Other|7|||
161956103|NCT00368745|584887405|FG001|Double-blind Treatment Period|Other|6|||
161956104|NCT00293813|584887409|FG000|Overall Study|Physician Decision|0|||
161956105|NCT00293813|584887410|FG001|Overall Study|Physician Decision|1|||
161956106|NCT00293813|584887411|FG002|Overall Study|Physician Decision|0|||
161956107|NCT00293813|584887409|FG000|Overall Study|Adverse Event|3|||
161689014|NCT01225731|583911804|FG001|Part 2|Adverse Event|0|||
161689015|NCT01225731|583911805|FG002|Part 2|Adverse Event|0|||
161689016|NCT01225731|583911806|FG003|Part 2|Adverse Event|0|||
161956108|NCT00293813|584887410|FG001|Overall Study|Adverse Event|1|||
161956109|NCT00293813|584887411|FG002|Overall Study|Adverse Event|1|||
161956110|NCT00293813|584887409|FG000|Overall Study|Withdrawal by Subject|7|||
161956111|NCT00293813|584887410|FG001|Overall Study|Withdrawal by Subject|4|||
161689017|NCT01225731|583911807|FG004|Part 2|Adverse Event|0|||
161689018|NCT01225731|583911808|FG005|Part 2|Adverse Event|0|||
161689019|NCT01225731|583911809|FG006|Part 2|Adverse Event|4|||
161689020|NCT01225731|583911810|FG007|Part 2|Adverse Event|4|||
161689021|NCT01225731|583911811|FG008|Part 2|Adverse Event|2|||
161689022|NCT01225731|583911812|FG009|Part 2|Adverse Event|0|||
161689023|NCT01225731|583911813|FG010|Part 2|Adverse Event|0|||
161689024|NCT01225731|583911814|FG011|Part 2|Adverse Event|0|||
161689025|NCT01225731|583911815|FG012|Part 2|Adverse Event|0|||
161689026|NCT01225731|583911803|FG000|Part 2|Lack of Efficacy|0|||
161689027|NCT01225731|583911804|FG001|Part 2|Lack of Efficacy|0|||
161689028|NCT01225731|583911805|FG002|Part 2|Lack of Efficacy|0|||
161689029|NCT01225731|583911806|FG003|Part 2|Lack of Efficacy|0|||
161689030|NCT01225731|583911807|FG004|Part 2|Lack of Efficacy|0|||
161689031|NCT01225731|583911808|FG005|Part 2|Lack of Efficacy|1|||
161689032|NCT01225731|583911809|FG006|Part 2|Lack of Efficacy|0|||
161689033|NCT01225731|583911810|FG007|Part 2|Lack of Efficacy|12|||
161689034|NCT01225731|583911811|FG008|Part 2|Lack of Efficacy|3|||
161689035|NCT01225731|583911812|FG009|Part 2|Lack of Efficacy|0|||
161689036|NCT01225731|583911813|FG010|Part 2|Lack of Efficacy|0|||
161689037|NCT01225731|583911814|FG011|Part 2|Lack of Efficacy|0|||
161689038|NCT01225731|583911815|FG012|Part 2|Lack of Efficacy|0|||
161689039|NCT01225731|583911803|FG000|Part 2|Pregnancy|0|||
161689040|NCT01225731|583911804|FG001|Part 2|Pregnancy|0|||
161689041|NCT01225731|583911805|FG002|Part 2|Pregnancy|0|||
161689042|NCT01225731|583911806|FG003|Part 2|Pregnancy|0|||
161689043|NCT01225731|583911807|FG004|Part 2|Pregnancy|0|||
161689044|NCT01225731|583911808|FG005|Part 2|Pregnancy|0|||
161689045|NCT01225731|583911809|FG006|Part 2|Pregnancy|1|||
161689046|NCT01225731|583911810|FG007|Part 2|Pregnancy|0|||
161689047|NCT01225731|583911811|FG008|Part 2|Pregnancy|1|||
161689048|NCT01225731|583911812|FG009|Part 2|Pregnancy|0|||
161689049|NCT01225731|583911813|FG010|Part 2|Pregnancy|0|||
161689050|NCT01225731|583911814|FG011|Part 2|Pregnancy|0|||
161689051|NCT01225731|583911815|FG012|Part 2|Pregnancy|0|||
161689052|NCT01225731|583911803|FG000|Part 2|Lost to Follow-up|0|||
161689053|NCT01225731|583911804|FG001|Part 2|Lost to Follow-up|0|||
161689054|NCT01225731|583911805|FG002|Part 2|Lost to Follow-up|0|||
161689055|NCT01225731|583911806|FG003|Part 2|Lost to Follow-up|0|||
161689056|NCT01225731|583911807|FG004|Part 2|Lost to Follow-up|0|||
161689057|NCT01225731|583911808|FG005|Part 2|Lost to Follow-up|0|||
161689058|NCT01225731|583911809|FG006|Part 2|Lost to Follow-up|0|||
161689059|NCT01225731|583911810|FG007|Part 2|Lost to Follow-up|3|||
161689060|NCT01225731|583911811|FG008|Part 2|Lost to Follow-up|1|||
161689061|NCT01225731|583911812|FG009|Part 2|Lost to Follow-up|0|||
161689062|NCT01225731|583911813|FG010|Part 2|Lost to Follow-up|0|||
161689063|NCT01225731|583911814|FG011|Part 2|Lost to Follow-up|0|||
161689064|NCT01225731|583911815|FG012|Part 2|Lost to Follow-up|0|||
161689065|NCT01225731|583911803|FG000|Part 2|Physician Decision|0|||
161956112|NCT00293813|584887411|FG002|Overall Study|Withdrawal by Subject|4|||
161689066|NCT01225731|583911804|FG001|Part 2|Physician Decision|0|||
161689067|NCT01225731|583911805|FG002|Part 2|Physician Decision|0|||
161689068|NCT01225731|583911806|FG003|Part 2|Physician Decision|0|||
161689069|NCT01225731|583911807|FG004|Part 2|Physician Decision|0|||
161689070|NCT01225731|583911808|FG005|Part 2|Physician Decision|0|||
161689071|NCT01225731|583911809|FG006|Part 2|Physician Decision|0|||
161689072|NCT01225731|583911810|FG007|Part 2|Physician Decision|2|||
161689073|NCT01225731|583911811|FG008|Part 2|Physician Decision|2|||
161689074|NCT01225731|583911812|FG009|Part 2|Physician Decision|0|||
161689075|NCT01225731|583911813|FG010|Part 2|Physician Decision|0|||
161689076|NCT01225731|583911814|FG011|Part 2|Physician Decision|0|||
161689077|NCT01225731|583911815|FG012|Part 2|Physician Decision|0|||
161689078|NCT01225731|583911803|FG000|Part 2|Withdrawal by Subject|0|||
161689079|NCT01225731|583911804|FG001|Part 2|Withdrawal by Subject|0|||
161956113|NCT00293813|584887409|FG000|Overall Study|Lost to Follow-up|3|||
161689080|NCT01225731|583911805|FG002|Part 2|Withdrawal by Subject|0|||
161689081|NCT01225731|583911806|FG003|Part 2|Withdrawal by Subject|0|||
161689082|NCT01225731|583911807|FG004|Part 2|Withdrawal by Subject|0|||
161689083|NCT01225731|583911808|FG005|Part 2|Withdrawal by Subject|1|||
161956114|NCT00293813|584887410|FG001|Overall Study|Lost to Follow-up|2|||
161689084|NCT01225731|583911809|FG006|Part 2|Withdrawal by Subject|3|||
161689085|NCT01225731|583911810|FG007|Part 2|Withdrawal by Subject|4|||
161689086|NCT01225731|583911811|FG008|Part 2|Withdrawal by Subject|1|||
161689087|NCT01225731|583911812|FG009|Part 2|Withdrawal by Subject|0|||
161689088|NCT01225731|583911813|FG010|Part 2|Withdrawal by Subject|0|||
161689089|NCT01225731|583911814|FG011|Part 2|Withdrawal by Subject|0|||
161689090|NCT01225731|583911815|FG012|Part 2|Withdrawal by Subject|0|||
161689091|NCT01225731|583911803|FG000|Part 3|Adverse Event|0|||
161689092|NCT01225731|583911804|FG001|Part 3|Adverse Event|0|||
161689093|NCT01225731|583911805|FG002|Part 3|Adverse Event|0|||
161836200|NCT00094458|584442902|FG005|Main Study: Through Week 30|Death|0|||
161956115|NCT00293813|584887411|FG002|Overall Study|Lost to Follow-up|3|||
161956116|NCT00293813|584887409|FG000|Overall Study|Noncompliance|0|||
161956117|NCT00293813|584887410|FG001|Overall Study|Noncompliance|1|||
161956118|NCT00293813|584887411|FG002|Overall Study|Noncompliance|0|||
161956119|NCT00540592|584887415|FG000|Overall Study|Adverse Event|0|||
161956120|NCT00540592|584887416|FG001|Overall Study|Adverse Event|1|||
161956121|NCT00540592|584887417|FG002|Overall Study|Adverse Event|0|||
161956122|NCT00540592|584887418|FG003|Overall Study|Adverse Event|0|||
161956123|NCT00540592|584887419|FG004|Overall Study|Adverse Event|1|||
161956124|NCT00540592|584887420|FG005|Overall Study|Adverse Event|0|||
161956125|NCT00540592|584887421|FG006|Overall Study|Adverse Event|0|||
161956126|NCT00540592|584887422|FG007|Overall Study|Adverse Event|1|||
161836201|NCT00094458|584442897|FG000|Main Study: Through Week 30|Other|19|||
161836202|NCT00094458|584442898|FG001|Main Study: Through Week 30|Other|16|||
161836203|NCT00094458|584442899|FG002|Main Study: Through Week 30|Other|9|||
161956127|NCT00540592|584887423|FG008|Overall Study|Adverse Event|1|||
161956128|NCT00540592|584887424|FG009|Overall Study|Adverse Event|2|||
161956129|NCT00540592|584887415|FG000|Overall Study|Lost to Follow-up|2|||
161956130|NCT00540592|584887416|FG001|Overall Study|Lost to Follow-up|0|||
161956131|NCT00540592|584887417|FG002|Overall Study|Lost to Follow-up|0|||
161836204|NCT00094458|584442900|FG003|Main Study: Through Week 30|Other|0|||
161689094|NCT01225731|583911806|FG003|Part 3|Adverse Event|0|||
161689095|NCT01225731|583911807|FG004|Part 3|Adverse Event|0|||
161689096|NCT01225731|583911808|FG005|Part 3|Adverse Event|0|||
161689097|NCT01225731|583911809|FG006|Part 3|Adverse Event|0|||
161689098|NCT01225731|583911810|FG007|Part 3|Adverse Event|0|||
161689099|NCT01225731|583911811|FG008|Part 3|Adverse Event|0|||
161689100|NCT01225731|583911812|FG009|Part 3|Adverse Event|0|||
161689101|NCT01225731|583911813|FG010|Part 3|Adverse Event|1|||
161689102|NCT01225731|583911814|FG011|Part 3|Adverse Event|1|||
161689103|NCT01225731|583911815|FG012|Part 3|Adverse Event|0|||
161689104|NCT01225731|583911803|FG000|Part 3|Lost to Follow-up|0|||
161689105|NCT01225731|583911804|FG001|Part 3|Lost to Follow-up|0|||
161689106|NCT01225731|583911805|FG002|Part 3|Lost to Follow-up|0|||
161689107|NCT01225731|583911806|FG003|Part 3|Lost to Follow-up|0|||
161689108|NCT01225731|583911807|FG004|Part 3|Lost to Follow-up|0|||
161689109|NCT01225731|583911808|FG005|Part 3|Lost to Follow-up|0|||
161689110|NCT01225731|583911809|FG006|Part 3|Lost to Follow-up|0|||
161689111|NCT01225731|583911810|FG007|Part 3|Lost to Follow-up|0|||
161689112|NCT01225731|583911811|FG008|Part 3|Lost to Follow-up|0|||
161689113|NCT01225731|583911812|FG009|Part 3|Lost to Follow-up|0|||
161689114|NCT01225731|583911813|FG010|Part 3|Lost to Follow-up|1|||
161689115|NCT01225731|583911814|FG011|Part 3|Lost to Follow-up|2|||
161689116|NCT01225731|583911815|FG012|Part 3|Lost to Follow-up|1|||
161689117|NCT01225731|583911803|FG000|Part 3|Physician Decision|0|||
161689118|NCT01225731|583911804|FG001|Part 3|Physician Decision|0|||
161689119|NCT01225731|583911805|FG002|Part 3|Physician Decision|0|||
161689120|NCT01225731|583911806|FG003|Part 3|Physician Decision|0|||
161689121|NCT01225731|583911807|FG004|Part 3|Physician Decision|0|||
161689122|NCT01225731|583911808|FG005|Part 3|Physician Decision|0|||
161689123|NCT01225731|583911809|FG006|Part 3|Physician Decision|0|||
161689124|NCT01225731|583911810|FG007|Part 3|Physician Decision|0|||
161689125|NCT01225731|583911811|FG008|Part 3|Physician Decision|0|||
161689126|NCT01225731|583911812|FG009|Part 3|Physician Decision|0|||
161689127|NCT01225731|583911813|FG010|Part 3|Physician Decision|0|||
161689128|NCT01225731|583911814|FG011|Part 3|Physician Decision|1|||
161689129|NCT01225731|583911815|FG012|Part 3|Physician Decision|2|||
161689130|NCT01225731|583911803|FG000|Part 3|Withdrawal by Subject|0|||
161689131|NCT01225731|583911804|FG001|Part 3|Withdrawal by Subject|0|||
161689132|NCT01225731|583911805|FG002|Part 3|Withdrawal by Subject|0|||
161689133|NCT01225731|583911806|FG003|Part 3|Withdrawal by Subject|0|||
161689134|NCT01225731|583911807|FG004|Part 3|Withdrawal by Subject|0|||
161689135|NCT01225731|583911808|FG005|Part 3|Withdrawal by Subject|0|||
161689136|NCT01225731|583911809|FG006|Part 3|Withdrawal by Subject|0|||
161689137|NCT01225731|583911810|FG007|Part 3|Withdrawal by Subject|0|||
161689138|NCT01225731|583911811|FG008|Part 3|Withdrawal by Subject|0|||
161689139|NCT01225731|583911812|FG009|Part 3|Withdrawal by Subject|0|||
161689140|NCT01225731|583911813|FG010|Part 3|Withdrawal by Subject|4|||
161689141|NCT01225731|583911814|FG011|Part 3|Withdrawal by Subject|6|||
161689142|NCT01225731|583911815|FG012|Part 3|Withdrawal by Subject|4|||
161689143|NCT00577642|583911816|FG000|Overall Study|Clinical Disease Progression|1|||
161689144|NCT00542269|583911822|FG000|Overall Study|Adverse Event|10|||
161689145|NCT00542269|583911823|FG001|Overall Study|Adverse Event|4|||
161689146|NCT00542269|583911824|FG002|Overall Study|Adverse Event|5|||
161689147|NCT00542269|583911822|FG000|Overall Study|Protocol Violation|1|||
161689148|NCT00542269|583911823|FG001|Overall Study|Protocol Violation|1|||
161689149|NCT00542269|583911824|FG002|Overall Study|Protocol Violation|0|||
161689150|NCT00542269|583911822|FG000|Overall Study|Withdrawal by Subject|1|||
161689151|NCT00542269|583911823|FG001|Overall Study|Withdrawal by Subject|0|||
161689152|NCT00542269|583911824|FG002|Overall Study|Withdrawal by Subject|0|||
161689153|NCT00542269|583911822|FG000|Overall Study|Administrative problems|1|||
161836205|NCT00094458|584442901|FG004|Main Study: Through Week 30|Other|0|||
161836206|NCT00094458|584442902|FG005|Main Study: Through Week 30|Other|0|||
161836207|NCT00094458|584442897|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
161689154|NCT00542269|583911823|FG001|Overall Study|Administrative problems|1|||
161689155|NCT00542269|583911824|FG002|Overall Study|Administrative problems|1|||
161689156|NCT02069899|583911825|FG000|Overall Study|Adverse Event|6|||
161689157|NCT02069899|583911826|FG001|Overall Study|Adverse Event|0|||
161689158|NCT02069899|583911827|FG002|Overall Study|Adverse Event|1|||
161689159|NCT02069899|583911825|FG000|Overall Study|Withdrawal by Participant|2|||
161689160|NCT02069899|583911826|FG001|Overall Study|Withdrawal by Participant|0|||
161689161|NCT02069899|583911827|FG002|Overall Study|Withdrawal by Participant|0|||
161689162|NCT02069899|583911825|FG000|Overall Study|Lost to Follow-up|1|||
161689163|NCT02069899|583911826|FG001|Overall Study|Lost to Follow-up|0|||
161689164|NCT02069899|583911827|FG002|Overall Study|Lost to Follow-up|1|||
161689165|NCT02069899|583911825|FG000|Overall Study|Other|4|||
161689166|NCT02069899|583911826|FG001|Overall Study|Other|0|||
161689167|NCT02069899|583911827|FG002|Overall Study|Other|0|||
161689168|NCT02069899|583911825|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
161689169|NCT02069899|583911826|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
161689170|NCT02069899|583911827|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
161689171|NCT02069899|583911825|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
161689172|NCT02069899|583911826|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
161689173|NCT02069899|583911827|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
161689174|NCT00490451|583911828|FG000|Overall Study|Adverse Event|3|||
161689175|NCT00490451|583911829|FG001|Overall Study|Adverse Event|3|||
161689176|NCT00490451|583911828|FG000|Overall Study|Death|3|||
161689177|NCT00490451|583911829|FG001|Overall Study|Death|1|||
161689178|NCT00490451|583911828|FG000|Overall Study|Withdrawal by Subject|2|||
161689179|NCT00490451|583911829|FG001|Overall Study|Withdrawal by Subject|0|||
161689180|NCT00490451|583911828|FG000|Overall Study|Investigator Decision|1|||
161689181|NCT00490451|583911829|FG001|Overall Study|Investigator Decision|0|||
161689182|NCT00490451|583911828|FG000|Overall Study|Protocol Violation|1|||
161689183|NCT00490451|583911829|FG001|Overall Study|Protocol Violation|0|||
161689184|NCT00490451|583911828|FG000|Overall Study|Progressive Disease|53|||
161689185|NCT00490451|583911829|FG001|Overall Study|Progressive Disease|34|||
161689186|NCT01181011|583911830|FG000|Overall Study|Adverse Event|2|||
161689187|NCT01181011|583911830|FG000|Overall Study|Lost to Follow-up|1|||
161689188|NCT00401375|583911833|FG000|Overall Study|Protocol Violation|2|||
161689189|NCT00401375|583911834|FG001|Overall Study|Protocol Violation|2|||
161689190|NCT00401375|583911835|FG002|Overall Study|Protocol Violation|1|||
161689191|NCT00401375|583911833|FG000|Overall Study|Adverse Event|6|||
161689192|NCT00401375|583911834|FG001|Overall Study|Adverse Event|11|||
161689193|NCT00401375|583911835|FG002|Overall Study|Adverse Event|10|||
161689194|NCT00401375|583911833|FG000|Overall Study|Withdrawal by Subject|9|||
161689195|NCT00401375|583911834|FG001|Overall Study|Withdrawal by Subject|7|||
161689196|NCT00401375|583911835|FG002|Overall Study|Withdrawal by Subject|7|||
161689197|NCT00401375|583911833|FG000|Overall Study|Lost to Follow-up|0|||
161689198|NCT00401375|583911834|FG001|Overall Study|Lost to Follow-up|1|||
161689199|NCT00401375|583911835|FG002|Overall Study|Lost to Follow-up|1|||
161689200|NCT00401375|583911833|FG000|Overall Study|Other than specified|2|||
161689201|NCT00401375|583911834|FG001|Overall Study|Other than specified|1|||
161689202|NCT00401375|583911835|FG002|Overall Study|Other than specified|3|||
161689203|NCT00401375|583911833|FG000|Overall Study|Randomized but not treated|3|||
161689204|NCT00401375|583911834|FG001|Overall Study|Randomized but not treated|3|||
161689205|NCT00401375|583911835|FG002|Overall Study|Randomized but not treated|3|||
161689206|NCT00950664|583911836|FG000|First Intervention|Lost to Follow-up|1|||
161689207|NCT00950664|583911837|FG001|First Intervention|Lost to Follow-up|3|||
161689208|NCT00950664|583911836|FG000|First Intervention|Withdrawal by Subject|2|||
161689209|NCT00950664|583911837|FG001|First Intervention|Withdrawal by Subject|2|||
161689210|NCT04703075|583911838|FG000|Overall Study|Adverse Event|11|||
161689211|NCT04703075|583911839|FG001|Overall Study|Adverse Event|7|||
161689212|NCT04703075|583911838|FG000|Overall Study|Lost to Follow-up|6|||
161689213|NCT04703075|583911839|FG001|Overall Study|Lost to Follow-up|12|||
161689214|NCT04703075|583911838|FG000|Overall Study|Physician Decision|3|||
161689215|NCT04703075|583911839|FG001|Overall Study|Physician Decision|0|||
161689216|NCT04703075|583911838|FG000|Overall Study|Moved|0|||
161689217|NCT04703075|583911839|FG001|Overall Study|Moved|2|||
161836208|NCT00094458|584442898|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
161956132|NCT00540592|584887418|FG003|Overall Study|Lost to Follow-up|0|||
161956133|NCT00540592|584887419|FG004|Overall Study|Lost to Follow-up|0|||
161956134|NCT00540592|584887420|FG005|Overall Study|Lost to Follow-up|0|||
161956135|NCT00540592|584887421|FG006|Overall Study|Lost to Follow-up|0|||
161689218|NCT04703075|583911838|FG000|Overall Study|Index INH Resistant|0|||
161689219|NCT04703075|583911839|FG001|Overall Study|Index INH Resistant|1|||
161689220|NCT04703075|583911838|FG000|Overall Study|Lack of Efficacy|6|||
161689221|NCT04703075|583911839|FG001|Overall Study|Lack of Efficacy|18|||
161689222|NCT01273883|583911841|FG000|First Intervention|Adverse Event|2|||
161689223|NCT01273883|583911842|FG001|First Intervention|Adverse Event|1|||
161689224|NCT01273883|583911841|FG000|Second Intervention|Lost to Follow-up|1|||
161689225|NCT01273883|583911842|FG001|Second Intervention|Lost to Follow-up|1|||
161956136|NCT00540592|584887422|FG007|Overall Study|Lost to Follow-up|0|||
161689226|NCT01273883|583911841|FG000|Second Intervention|Lack of Efficacy|1|||
161689227|NCT01273883|583911842|FG001|Second Intervention|Lack of Efficacy|0|||
161689228|NCT01553136|583911844|FG000|Overall Study|Adverse Event|3|||
161689229|NCT01553136|583911845|FG001|Overall Study|Adverse Event|2|||
161689230|NCT01553136|583911844|FG000|Overall Study|Withdrawal by Subject|2|||
161689231|NCT01553136|583911845|FG001|Overall Study|Withdrawal by Subject|3|||
161689232|NCT01553136|583911844|FG000|Overall Study|Lost to Follow-up|4|||
161689233|NCT01553136|583911845|FG001|Overall Study|Lost to Follow-up|10|||
161689234|NCT01553136|583911844|FG000|Overall Study|Physician Decision|2|||
161689235|NCT01553136|583911845|FG001|Overall Study|Physician Decision|3|||
161689236|NCT01553136|583911844|FG000|Overall Study|Scheduling Difficulties|5|||
161689237|NCT01553136|583911845|FG001|Overall Study|Scheduling Difficulties|4|||
161689238|NCT01783678|583913431|FG000|Overall Study|Randomized but Not Treated|0|||
161689239|NCT01783678|583913432|FG001|Overall Study|Randomized but Not Treated|0|||
161689240|NCT01783678|583913433|FG002|Overall Study|Randomized but Not Treated|0|||
161689241|NCT01783678|583913434|FG003|Overall Study|Randomized but Not Treated|1|||
161689242|NCT01783678|583913435|FG004|Overall Study|Randomized but Not Treated|0|||
161689243|NCT01783678|583913436|FG005|Overall Study|Randomized but Not Treated|0|||
161689244|NCT01783678|583913431|FG000|Overall Study|Lack of Efficacy|1|||
161689245|NCT01783678|583913432|FG001|Overall Study|Lack of Efficacy|13|||
161689246|NCT01783678|583913433|FG002|Overall Study|Lack of Efficacy|1|||
161689247|NCT01783678|583913434|FG003|Overall Study|Lack of Efficacy|3|||
161689248|NCT01783678|583913435|FG004|Overall Study|Lack of Efficacy|6|||
161689249|NCT01783678|583913436|FG005|Overall Study|Lack of Efficacy|5|||
161689250|NCT01783678|583913431|FG000|Overall Study|Lost to Follow-up|0|||
161689251|NCT01783678|583913432|FG001|Overall Study|Lost to Follow-up|4|||
161689252|NCT01783678|583913433|FG002|Overall Study|Lost to Follow-up|0|||
161689253|NCT01783678|583913434|FG003|Overall Study|Lost to Follow-up|2|||
161689254|NCT01783678|583913435|FG004|Overall Study|Lost to Follow-up|1|||
161689255|NCT01783678|583913436|FG005|Overall Study|Lost to Follow-up|0|||
161689256|NCT01783678|583913431|FG000|Overall Study|Withdrew Consent|1|||
161689257|NCT01783678|583913432|FG001|Overall Study|Withdrew Consent|1|||
161689258|NCT01783678|583913433|FG002|Overall Study|Withdrew Consent|0|||
161689259|NCT01783678|583913434|FG003|Overall Study|Withdrew Consent|2|||
161689260|NCT01783678|583913435|FG004|Overall Study|Withdrew Consent|0|||
161689261|NCT01783678|583913436|FG005|Overall Study|Withdrew Consent|0|||
161689262|NCT02404103|583913437|FG000|Overall Study|Adverse Event|1|||
161689263|NCT02404103|583913438|FG001|Overall Study|Adverse Event|0|||
161689264|NCT02404103|583913437|FG000|Overall Study|Lost to Follow-up|3|||
161689265|NCT02404103|583913438|FG001|Overall Study|Lost to Follow-up|3|||
161689266|NCT01408147|583913439|FG000|Overall Study|Withdrawal by Subject|0|||
161689267|NCT01408147|583913440|FG001|Overall Study|Withdrawal by Subject|1|||
161689268|NCT01042600|583913441|FG000|Overall Study|Ineligible|1|||
161689269|NCT01042600|583913442|FG001|Overall Study|Ineligible|0|||
161689270|NCT00621504|583913443|FG000|Overall Study|Adverse Event|1|||
161689271|NCT00621504|583913444|FG001|Overall Study|Adverse Event|3|||
161689272|NCT00621504|583913443|FG000|Overall Study|At the request of sponsor/investigator|1|||
161689273|NCT00621504|583913444|FG001|Overall Study|At the request of sponsor/investigator|0|||
161689274|NCT00621504|583913443|FG000|Overall Study|Withdrew consent|9|||
161689275|NCT00621504|583913444|FG001|Overall Study|Withdrew consent|6|||
161689276|NCT00621504|583913443|FG000|Overall Study|Lost to Follow-up|8|||
161689277|NCT00621504|583913444|FG001|Overall Study|Lost to Follow-up|10|||
161689278|NCT00621504|583913443|FG000|Overall Study|Other|1|||
161689279|NCT00621504|583913444|FG001|Overall Study|Other|0|||
161689280|NCT00621504|583913443|FG000|Overall Study|Death|6|||
161689281|NCT00621504|583913444|FG001|Overall Study|Death|6|||
161689282|NCT03311711|583913449|FG000|Overall Study|Death|1|||
161956137|NCT00540592|584887423|FG008|Overall Study|Lost to Follow-up|0|||
161956138|NCT00540592|584887424|FG009|Overall Study|Lost to Follow-up|0|||
161956139|NCT00540592|584887415|FG000|Overall Study|Withdrawal by Subject|0|||
161956140|NCT00540592|584887416|FG001|Overall Study|Withdrawal by Subject|0|||
161689283|NCT03311711|583913450|FG001|Overall Study|Death|0|||
161689284|NCT03311711|583913451|FG002|Overall Study|Death|0|||
161689285|NCT03311711|583913452|FG003|Overall Study|Death|0|||
161689286|NCT03311711|583913453|FG004|Overall Study|Death|0|||
161689287|NCT03311711|583913454|FG005|Overall Study|Death|0|||
161689288|NCT03311711|583913455|FG006|Overall Study|Death|1|||
161689289|NCT03311711|583913456|FG007|Overall Study|Death|0|||
161689290|NCT03311711|583913457|FG008|Overall Study|Death|1|||
161689291|NCT03311711|583913458|FG009|Overall Study|Death|0|||
161689292|NCT03311711|583913449|FG000|Overall Study|Death of dyad partner|0|||
161689293|NCT03311711|583913450|FG001|Overall Study|Death of dyad partner|1|||
161689294|NCT03311711|583913451|FG002|Overall Study|Death of dyad partner|0|||
161689295|NCT03311711|583913452|FG003|Overall Study|Death of dyad partner|0|||
161689296|NCT03311711|583913453|FG004|Overall Study|Death of dyad partner|0|||
161689297|NCT03311711|583913454|FG005|Overall Study|Death of dyad partner|0|||
161689298|NCT03311711|583913455|FG006|Overall Study|Death of dyad partner|0|||
161689299|NCT03311711|583913456|FG007|Overall Study|Death of dyad partner|1|||
161689300|NCT03311711|583913457|FG008|Overall Study|Death of dyad partner|0|||
161956141|NCT00540592|584887417|FG002|Overall Study|Withdrawal by Subject|1|||
161956142|NCT00540592|584887418|FG003|Overall Study|Withdrawal by Subject|1|||
161956143|NCT00540592|584887419|FG004|Overall Study|Withdrawal by Subject|0|||
161956144|NCT00540592|584887420|FG005|Overall Study|Withdrawal by Subject|0|||
161956145|NCT00540592|584887421|FG006|Overall Study|Withdrawal by Subject|0|||
161956146|NCT00540592|584887422|FG007|Overall Study|Withdrawal by Subject|0|||
161956147|NCT00540592|584887423|FG008|Overall Study|Withdrawal by Subject|0|||
161956148|NCT00540592|584887424|FG009|Overall Study|Withdrawal by Subject|0|||
161689301|NCT03311711|583913458|FG009|Overall Study|Death of dyad partner|1|||
161689302|NCT03311711|583913449|FG000|Overall Study|Lost to Follow-up|2|||
161689303|NCT03311711|583913450|FG001|Overall Study|Lost to Follow-up|2|||
161689304|NCT03311711|583913451|FG002|Overall Study|Lost to Follow-up|0|||
161689305|NCT03311711|583913452|FG003|Overall Study|Lost to Follow-up|0|||
161689306|NCT03311711|583913453|FG004|Overall Study|Lost to Follow-up|0|||
161689307|NCT03311711|583913454|FG005|Overall Study|Lost to Follow-up|0|||
161689308|NCT03311711|583913455|FG006|Overall Study|Lost to Follow-up|1|||
161689309|NCT03311711|583913456|FG007|Overall Study|Lost to Follow-up|1|||
161689310|NCT03311711|583913457|FG008|Overall Study|Lost to Follow-up|0|||
161689311|NCT03311711|583913458|FG009|Overall Study|Lost to Follow-up|0|||
161689312|NCT03311711|583913449|FG000|Overall Study|Withdrawal by Subject|1|||
161689313|NCT03311711|583913450|FG001|Overall Study|Withdrawal by Subject|1|||
161689314|NCT03311711|583913451|FG002|Overall Study|Withdrawal by Subject|0|||
161689315|NCT03311711|583913452|FG003|Overall Study|Withdrawal by Subject|0|||
161689316|NCT03311711|583913453|FG004|Overall Study|Withdrawal by Subject|0|||
161689317|NCT03311711|583913454|FG005|Overall Study|Withdrawal by Subject|0|||
161689318|NCT03311711|583913455|FG006|Overall Study|Withdrawal by Subject|3|||
161689319|NCT03311711|583913456|FG007|Overall Study|Withdrawal by Subject|3|||
161689320|NCT03311711|583913457|FG008|Overall Study|Withdrawal by Subject|0|||
161689321|NCT03311711|583913458|FG009|Overall Study|Withdrawal by Subject|0|||
161689322|NCT02229552|583913459|FG000|Baseline|Withdrawal by Subject|6|||
161689323|NCT02229552|583913459|FG000|1-year Follow up|Withdrawal by Subject|7|||
161689324|NCT02229552|583913459|FG000|1-year Follow up|Lost to Follow-up|18|||
161689325|NCT02229552|583913459|FG000|2-Year Follow up|Withdrawal by Subject|9|||
161689326|NCT02229552|583913459|FG000|2-Year Follow up|Lost to Follow-up|17|||
161689327|NCT00706134|583913460|FG000|Overall Study|Adverse Event|8|||
161689328|NCT00706134|583913461|FG001|Overall Study|Adverse Event|7|||
161689329|NCT00706134|583913462|FG002|Overall Study|Adverse Event|2|||
161689330|NCT00706134|583913463|FG003|Overall Study|Adverse Event|3|||
161689331|NCT00706134|583913460|FG000|Overall Study|Lost to Follow-up|0|||
161689332|NCT00706134|583913461|FG001|Overall Study|Lost to Follow-up|1|||
161689333|NCT00706134|583913462|FG002|Overall Study|Lost to Follow-up|0|||
161689334|NCT00706134|583913463|FG003|Overall Study|Lost to Follow-up|0|||
161689335|NCT00706134|583913460|FG000|Overall Study|Protocol Violation|0|||
161689336|NCT00706134|583913461|FG001|Overall Study|Protocol Violation|6|||
161689337|NCT00706134|583913462|FG002|Overall Study|Protocol Violation|0|||
161689338|NCT00706134|583913463|FG003|Overall Study|Protocol Violation|3|||
161689339|NCT00706134|583913460|FG000|Overall Study|Withdrawal by Subject|1|||
161689340|NCT00706134|583913461|FG001|Overall Study|Withdrawal by Subject|2|||
161689341|NCT00706134|583913462|FG002|Overall Study|Withdrawal by Subject|1|||
161689342|NCT00706134|583913463|FG003|Overall Study|Withdrawal by Subject|0|||
161689343|NCT00706134|583913460|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
161689344|NCT00706134|583913461|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161956149|NCT04908683|584887425|FG000|Overall Study|Failure to meet continuation criteria|34|||
161956150|NCT04908683|584887426|FG001|Overall Study|Failure to meet continuation criteria|22|||
161956151|NCT04908683|584887425|FG000|Overall Study|Initiated prohibited medication|3|||
161956152|NCT04908683|584887426|FG001|Overall Study|Initiated prohibited medication|0|||
161956153|NCT04908683|584887425|FG000|Overall Study|Randomized by mistake|1|||
161956154|NCT04908683|584887426|FG001|Overall Study|Randomized by mistake|0|||
161689345|NCT00706134|583913462|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
161689346|NCT00706134|583913463|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
161689347|NCT00706134|583913460|FG000|Overall Study|Did not meet study criteria|2|||
161689348|NCT00706134|583913461|FG001|Overall Study|Did not meet study criteria|0|||
161689349|NCT00706134|583913462|FG002|Overall Study|Did not meet study criteria|0|||
161689350|NCT00706134|583913463|FG003|Overall Study|Did not meet study criteria|0|||
161689351|NCT00631371|583913471|FG000|Overall Study|Lost to Follow-up|24|||
161689352|NCT00631371|583913472|FG001|Overall Study|Lost to Follow-up|19|||
161689353|NCT00631371|583913471|FG000|Overall Study|Other reason|5|||
161689354|NCT00631371|583913472|FG001|Overall Study|Other reason|12|||
161689355|NCT00631371|583913471|FG000|Overall Study|subject request|38|||
161689356|NCT00631371|583913472|FG001|Overall Study|subject request|45|||
161689357|NCT00631371|583913471|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
161956155|NCT04908683|584887425|FG000|Overall Study|Lost to Follow-up|679|||
161956156|NCT04908683|584887426|FG001|Overall Study|Lost to Follow-up|341|||
161689358|NCT00631371|583913472|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
161689359|NCT00631371|583913471|FG000|Overall Study|Death|263|||
161689360|NCT00631371|583913472|FG001|Overall Study|Death|239|||
161689361|NCT03354663|583913473|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
161956157|NCT04908683|584887425|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
161956158|NCT04908683|584887426|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
161836209|NCT00094458|584442899|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
161836210|NCT00094458|584442900|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
161956159|NCT04908683|584887425|FG000|Overall Study|Physician Decision|44|||
161956160|NCT04908683|584887426|FG001|Overall Study|Physician Decision|35|||
161689362|NCT03354663|583913473|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
161689363|NCT03354663|583913473|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
161689364|NCT03354663|583913473|FG000|Completed 30-day Visit|Missed Visit|1|||
161689365|NCT01391000|583913476|FG000|Overall Study|Lost to Follow-up|2|||
161689366|NCT01391000|583913477|FG001|Overall Study|Lost to Follow-up|0|||
161689367|NCT03860961|583913481|FG000|Overall Study|Withdrawal by Subject|6|||
161689368|NCT03860961|583913482|FG001|Overall Study|Withdrawal by Subject|11|||
161689369|NCT03860961|583913481|FG000|Overall Study|Death|10|||
161689370|NCT03860961|583913482|FG001|Overall Study|Death|6|||
161689371|NCT03860961|583913481|FG000|Overall Study|Incomplete two-year data|4|||
161689372|NCT03860961|583913482|FG001|Overall Study|Incomplete two-year data|0|||
161689373|NCT00493870|583913483|FG000|Overall Study|Lost to Follow-up|12|||
161689374|NCT00493870|583913484|FG001|Overall Study|Lost to Follow-up|15|||
161689375|NCT00272038|583913485|FG000|Overall Study|withdrew before they received 2 cycles|7|||
161689376|NCT03189446|583913486|FG000|Overall Study|Adverse Event|2|||
161689377|NCT03189446|583913486|FG000|Overall Study|Withdrawal by Subject|2|||
161689378|NCT03189446|583913486|FG000|Overall Study|Physician Decision|1|||
161689379|NCT00883337|583913487|FG000|Core Treatment Period|Adverse Event|9|||
161689380|NCT00883337|583913488|FG001|Core Treatment Period|Adverse Event|12|||
161689381|NCT00883337|583913489|FG002|Core Treatment Period|Adverse Event|22|||
161689382|NCT00883337|583913487|FG000|Core Treatment Period|Lack of Efficacy|7|||
161689383|NCT00883337|583913488|FG001|Core Treatment Period|Lack of Efficacy|4|||
161689384|NCT00883337|583913489|FG002|Core Treatment Period|Lack of Efficacy|2|||
161689385|NCT00883337|583913487|FG000|Core Treatment Period|Lost to Follow-up|1|||
161689386|NCT00883337|583913488|FG001|Core Treatment Period|Lost to Follow-up|1|||
161689387|NCT00883337|583913489|FG002|Core Treatment Period|Lost to Follow-up|0|||
161689388|NCT00883337|583913487|FG000|Core Treatment Period|Withdrawal by Subject|2|||
161689389|NCT00883337|583913488|FG001|Core Treatment Period|Withdrawal by Subject|2|||
161689390|NCT00883337|583913489|FG002|Core Treatment Period|Withdrawal by Subject|6|||
161689391|NCT00883337|583913487|FG000|Core Treatment Period|Wish to be pregnant|1|||
161689392|NCT00883337|583913488|FG001|Core Treatment Period|Wish to be pregnant|2|||
161689393|NCT00883337|583913489|FG002|Core Treatment Period|Wish to be pregnant|1|||
161689394|NCT00883337|583913487|FG000|Core Treatment Period|Poor compliance to protocol|0|||
161689395|NCT00883337|583913488|FG001|Core Treatment Period|Poor compliance to protocol|0|||
161689396|NCT00883337|583913489|FG002|Core Treatment Period|Poor compliance to protocol|1|||
161689397|NCT00883337|583913487|FG000|Core Treatment Period|Other than above|0|||
161689398|NCT00883337|583913488|FG001|Core Treatment Period|Other than above|1|||
161689399|NCT00883337|583913489|FG002|Core Treatment Period|Other than above|1|||
161689400|NCT00883337|583913487|FG000|Extension Treatment Period|Adverse Event|8|||
161689401|NCT00883337|583913488|FG001|Extension Treatment Period|Adverse Event|5|||
161689402|NCT00883337|583913489|FG002|Extension Treatment Period|Adverse Event|5|||
161689403|NCT00883337|583913487|FG000|Extension Treatment Period|Lack of Efficacy|8|||
161689404|NCT00883337|583913488|FG001|Extension Treatment Period|Lack of Efficacy|8|||
161689405|NCT00883337|583913489|FG002|Extension Treatment Period|Lack of Efficacy|8|||
161689406|NCT00883337|583913487|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
161689407|NCT00883337|583913488|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
161689408|NCT00883337|583913489|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
161689409|NCT00883337|583913487|FG000|Extension Treatment Period|Lost to Follow-up|1|||
161689410|NCT00883337|583913488|FG001|Extension Treatment Period|Lost to Follow-up|0|||
161956161|NCT04908683|584887425|FG000|Overall Study|Technical problems|12|||
161956162|NCT04908683|584887426|FG001|Overall Study|Technical problems|9|||
161689411|NCT00883337|583913489|FG002|Extension Treatment Period|Lost to Follow-up|0|||
161689412|NCT00883337|583913487|FG000|Extension Treatment Period|Other than above|10|||
161689413|NCT00883337|583913488|FG001|Extension Treatment Period|Other than above|9|||
161689414|NCT00883337|583913489|FG002|Extension Treatment Period|Other than above|5|||
161956163|NCT04908683|584887425|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
161956164|NCT04908683|584887426|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
161689415|NCT00713700|583913491|FG000|Overall Study|Lost to Follow-up|3|||
161689416|NCT00713700|583913491|FG000|Overall Study|Withdrawal by Subject|1|||
161689417|NCT00781456|583913492|FG000|Overall Study|Adverse Event|3|||
161689418|NCT00781456|583913493|FG001|Overall Study|Adverse Event|3|||
161689419|NCT00781456|583913492|FG000|Overall Study|Withdrawal by Subject|3|||
161836211|NCT00094458|584442901|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
161689420|NCT00781456|583913493|FG001|Overall Study|Withdrawal by Subject|5|||
161689421|NCT00781456|583913492|FG000|Overall Study|Protocol Violation|4|||
161689422|NCT00781456|583913493|FG001|Overall Study|Protocol Violation|1|||
161689423|NCT00781456|583913492|FG000|Overall Study|Noncompliance With Protocol|1|||
161689424|NCT00781456|583913493|FG001|Overall Study|Noncompliance With Protocol|1|||
161689425|NCT00781456|583913492|FG000|Overall Study|Lost to Follow-up|10|||
161956165|NCT04908683|584887425|FG000|Overall Study|Protocol Violation|2|||
161689426|NCT00781456|583913493|FG001|Overall Study|Lost to Follow-up|5|||
161689427|NCT00781456|583913492|FG000|Overall Study|Other Reason, Unknown|0|||
161689428|NCT00781456|583913493|FG001|Overall Study|Other Reason, Unknown|1|||
161689429|NCT03548558|583913495|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
161689430|NCT03548558|583913496|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
161689431|NCT03548558|583913497|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
161689432|NCT03548558|583913498|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
161689433|NCT03548558|583913499|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
161689434|NCT03548558|583913500|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
161689435|NCT03548558|583913501|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
161689436|NCT03548558|583913495|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
161689437|NCT03548558|583913496|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
161689438|NCT03548558|583913497|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
161689439|NCT03548558|583913498|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
161689440|NCT03548558|583913499|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
161689441|NCT03548558|583913500|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
161689442|NCT03548558|583913501|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
161689443|NCT03548558|583913495|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
161689444|NCT03548558|583913496|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
161689445|NCT03548558|583913497|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
161689446|NCT03548558|583913498|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
161689447|NCT03548558|583913499|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
161689448|NCT03548558|583913500|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
161689449|NCT03548558|583913501|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
161689450|NCT03548558|583913495|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
161689451|NCT03548558|583913496|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
161689452|NCT03548558|583913497|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
161689453|NCT03548558|583913498|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
161689454|NCT03548558|583913499|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
161689455|NCT03548558|583913500|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
161689456|NCT03548558|583913501|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
161689457|NCT03548558|583913495|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
161689458|NCT03548558|583913496|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
161689459|NCT03548558|583913497|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
161689460|NCT03548558|583913498|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
161836212|NCT00094458|584442902|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
161836213|NCT00094458|584442897|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
161836214|NCT00094458|584442898|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
161689461|NCT03548558|583913499|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
161689462|NCT03548558|583913500|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
161689463|NCT03548558|583913501|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
161689464|NCT03548558|583913495|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
161689465|NCT03548558|583913496|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
161689466|NCT03548558|583913497|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
161689467|NCT03548558|583913498|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
161689468|NCT03548558|583913499|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
161689469|NCT03548558|583913500|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
161689470|NCT03548558|583913501|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
161689471|NCT02669017|583913504|FG000|Overall Study|Death|1|||
161689472|NCT02669017|583913505|FG001|Overall Study|Death|2|||
161689473|NCT02669017|583913506|FG002|Overall Study|Death|2|||
161689474|NCT02669017|583913507|FG003|Overall Study|Death|3|||
161689475|NCT02669017|583913508|FG004|Overall Study|Death|8|||
161689476|NCT02669017|583913509|FG005|Overall Study|Death|18|||
161689477|NCT02669017|583913510|FG006|Overall Study|Death|10|||
161689478|NCT02669017|583913511|FG007|Overall Study|Death|47|||
161689479|NCT02669017|583913512|FG008|Overall Study|Death|20|||
161689480|NCT02669017|583913504|FG000|Overall Study|Withdrawal by Subject|0|||
161689481|NCT02669017|583913505|FG001|Overall Study|Withdrawal by Subject|0|||
161689482|NCT02669017|583913506|FG002|Overall Study|Withdrawal by Subject|0|||
161836215|NCT00094458|584442899|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
161956166|NCT04908683|584887426|FG001|Overall Study|Protocol Violation|0|||
161689483|NCT02669017|583913507|FG003|Overall Study|Withdrawal by Subject|1|||
161689484|NCT02669017|583913508|FG004|Overall Study|Withdrawal by Subject|2|||
161689485|NCT02669017|583913509|FG005|Overall Study|Withdrawal by Subject|0|||
161956167|NCT04908683|584887425|FG000|Overall Study|Withdrawal by Subject|1188|||
161689486|NCT02669017|583913510|FG006|Overall Study|Withdrawal by Subject|0|||
161956168|NCT04908683|584887426|FG001|Overall Study|Withdrawal by Subject|570|||
161956169|NCT04908683|584887425|FG000|Overall Study|Site Closure by Sponsor|6|||
161836216|NCT00094458|584442900|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
161836217|NCT00094458|584442901|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
161836218|NCT00094458|584442902|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
161689487|NCT02669017|583913511|FG007|Overall Study|Withdrawal by Subject|2|||
161689488|NCT02669017|583913512|FG008|Overall Study|Withdrawal by Subject|2|||
161689489|NCT02669017|583913504|FG000|Overall Study|Lost to Follow-up|0|||
161689490|NCT02669017|583913505|FG001|Overall Study|Lost to Follow-up|0|||
161689491|NCT02669017|583913506|FG002|Overall Study|Lost to Follow-up|0|||
161689492|NCT02669017|583913507|FG003|Overall Study|Lost to Follow-up|0|||
161689493|NCT02669017|583913508|FG004|Overall Study|Lost to Follow-up|0|||
161689494|NCT02669017|583913509|FG005|Overall Study|Lost to Follow-up|0|||
161689495|NCT02669017|583913510|FG006|Overall Study|Lost to Follow-up|0|||
161689496|NCT02669017|583913511|FG007|Overall Study|Lost to Follow-up|0|||
161689497|NCT02669017|583913512|FG008|Overall Study|Lost to Follow-up|1|||
161689498|NCT02669017|583913504|FG000|Overall Study|Miscellaneous|0|||
161689499|NCT02669017|583913505|FG001|Overall Study|Miscellaneous|0|||
161689500|NCT02669017|583913506|FG002|Overall Study|Miscellaneous|0|||
161689501|NCT02669017|583913507|FG003|Overall Study|Miscellaneous|0|||
161689502|NCT02669017|583913508|FG004|Overall Study|Miscellaneous|2|||
161689503|NCT02669017|583913509|FG005|Overall Study|Miscellaneous|1|||
161689504|NCT02669017|583913510|FG006|Overall Study|Miscellaneous|1|||
161689505|NCT02669017|583913511|FG007|Overall Study|Miscellaneous|13|||
161689506|NCT02669017|583913512|FG008|Overall Study|Miscellaneous|2|||
161689507|NCT04091087|583913513|FG000|Overall Study|Not treated|1|||
161689508|NCT04091087|583913514|FG001|Overall Study|Not treated|0|||
161689509|NCT04091087|583913513|FG000|Overall Study|Adverse Event|4|||
161689510|NCT04091087|583913514|FG001|Overall Study|Adverse Event|4|||
161689511|NCT04091087|583913513|FG000|Overall Study|Protocol Violation|0|||
161689512|NCT04091087|583913514|FG001|Overall Study|Protocol Violation|1|||
161689513|NCT04091087|583913513|FG000|Overall Study|Withdrawal by Subject|5|||
161689514|NCT04091087|583913514|FG001|Overall Study|Withdrawal by Subject|2|||
161689515|NCT04152161|583913515|FG000|Overall Study|Death|0|||
161689516|NCT04152161|583913516|FG001|Overall Study|Death|1|||
161689517|NCT04152161|583913515|FG000|Overall Study|Physician Decision|0|||
161689518|NCT04152161|583913516|FG001|Overall Study|Physician Decision|1|||
161689519|NCT04152161|583913515|FG000|Overall Study|Lost to Follow-up|9|||
161689520|NCT04152161|583913516|FG001|Overall Study|Lost to Follow-up|3|||
161689521|NCT04152161|583913515|FG000|Overall Study|Protocol Violation|1|||
161689522|NCT04152161|583913516|FG001|Overall Study|Protocol Violation|0|||
161689523|NCT04152161|583913515|FG000|Overall Study|Withdrawal by Subject|29|||
161689524|NCT04152161|583913516|FG001|Overall Study|Withdrawal by Subject|28|||
161689525|NCT04152161|583913515|FG000|Overall Study|Sponsor termination of study|750|||
161689526|NCT04152161|583913516|FG001|Overall Study|Sponsor termination of study|755|||
161689527|NCT04152161|583913515|FG000|Overall Study|Other|20|||
161689528|NCT04152161|583913516|FG001|Overall Study|Other|18|||
161689529|NCT02559687|583913517|FG000|Overall Study|Death|112|||
161689530|NCT02559687|583913517|FG000|Overall Study|Sponsor Decision|5|||
161689531|NCT02559687|583913517|FG000|Overall Study|Withdrawal by Subject|4|||
161689532|NCT01098071|583913526|FG000|Overall Study|Surgery (adenoidectomy)|2|||
161689533|NCT01098071|583913526|FG000|Overall Study|Lost to Follow-up|13|||
161689534|NCT02599961|583913530|FG000|Overall Study|Withdrawal by Subject|1|||
161689535|NCT02599961|583913530|FG000|Overall Study|Subject Non-Compliance|2|||
161689536|NCT02599961|583913530|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
161689537|NCT02599961|583913530|FG000|Overall Study|Other, Not Specified|3|||
161689538|NCT00618410|583913531|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
161689539|NCT00618410|583913532|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
161689540|NCT00464334|583913533|FG000|Overall Study|Adverse Event|0|||
161689541|NCT00464334|583913534|FG001|Overall Study|Adverse Event|0|||
161689542|NCT00464334|583913535|FG002|Overall Study|Adverse Event|0|||
161689543|NCT00464334|583913536|FG003|Overall Study|Adverse Event|1|||
161689544|NCT00464334|583913537|FG004|Overall Study|Adverse Event|1|||
161689545|NCT00464334|583913538|FG005|Overall Study|Adverse Event|1|||
161689546|NCT00464334|583913539|FG006|Overall Study|Adverse Event|0|||
161689547|NCT00464334|583913540|FG007|Overall Study|Adverse Event|0|||
161689548|NCT00464334|583913541|FG008|Overall Study|Adverse Event|2|||
161689549|NCT00464334|583913542|FG009|Overall Study|Adverse Event|1|||
161956170|NCT04908683|584887426|FG001|Overall Study|Site Closure by Sponsor|3|||
161956171|NCT04908683|584887425|FG000|Overall Study|Adverse Event|21|||
161689550|NCT00464334|583913543|FG010|Overall Study|Adverse Event|2|||
161689551|NCT00464334|583913533|FG000|Overall Study|Lack of Efficacy|0|||
161689552|NCT00464334|583913534|FG001|Overall Study|Lack of Efficacy|1|||
161689553|NCT00464334|583913535|FG002|Overall Study|Lack of Efficacy|0|||
161689554|NCT00464334|583913536|FG003|Overall Study|Lack of Efficacy|0|||
161689555|NCT00464334|583913537|FG004|Overall Study|Lack of Efficacy|0|||
161689556|NCT00464334|583913538|FG005|Overall Study|Lack of Efficacy|0|||
161689557|NCT00464334|583913539|FG006|Overall Study|Lack of Efficacy|0|||
161689558|NCT00464334|583913540|FG007|Overall Study|Lack of Efficacy|0|||
161689559|NCT00464334|583913541|FG008|Overall Study|Lack of Efficacy|0|||
161689560|NCT00464334|583913542|FG009|Overall Study|Lack of Efficacy|0|||
161689561|NCT00464334|583913543|FG010|Overall Study|Lack of Efficacy|0|||
161689562|NCT00464334|583913533|FG000|Overall Study|Lost to Follow-up|0|||
161956172|NCT04908683|584887426|FG001|Overall Study|Adverse Event|11|||
161689563|NCT00464334|583913534|FG001|Overall Study|Lost to Follow-up|0|||
161689564|NCT00464334|583913535|FG002|Overall Study|Lost to Follow-up|1|||
161689565|NCT00464334|583913536|FG003|Overall Study|Lost to Follow-up|0|||
161689566|NCT00464334|583913537|FG004|Overall Study|Lost to Follow-up|1|||
161689567|NCT00464334|583913538|FG005|Overall Study|Lost to Follow-up|0|||
161689568|NCT00464334|583913539|FG006|Overall Study|Lost to Follow-up|1|||
161689569|NCT00464334|583913540|FG007|Overall Study|Lost to Follow-up|0|||
161689570|NCT00464334|583913541|FG008|Overall Study|Lost to Follow-up|0|||
161689571|NCT00464334|583913542|FG009|Overall Study|Lost to Follow-up|0|||
161689572|NCT00464334|583913543|FG010|Overall Study|Lost to Follow-up|2|||
161689573|NCT00464334|583913533|FG000|Overall Study|Progressive Disease|0|||
161689574|NCT00464334|583913534|FG001|Overall Study|Progressive Disease|0|||
161689575|NCT00464334|583913535|FG002|Overall Study|Progressive Disease|0|||
161689576|NCT00464334|583913536|FG003|Overall Study|Progressive Disease|0|||
161689577|NCT00464334|583913537|FG004|Overall Study|Progressive Disease|0|||
161689578|NCT00464334|583913538|FG005|Overall Study|Progressive Disease|1|||
161689579|NCT00464334|583913539|FG006|Overall Study|Progressive Disease|0|||
161689580|NCT00464334|583913540|FG007|Overall Study|Progressive Disease|0|||
161689581|NCT00464334|583913541|FG008|Overall Study|Progressive Disease|1|||
161689582|NCT00464334|583913542|FG009|Overall Study|Progressive Disease|0|||
161689583|NCT00464334|583913543|FG010|Overall Study|Progressive Disease|0|||
161689584|NCT00464334|583913533|FG000|Overall Study|Study Terminated by Sponsor|0|||
161689585|NCT00464334|583913534|FG001|Overall Study|Study Terminated by Sponsor|0|||
161689586|NCT00464334|583913535|FG002|Overall Study|Study Terminated by Sponsor|0|||
161689587|NCT00464334|583913536|FG003|Overall Study|Study Terminated by Sponsor|1|||
161689588|NCT00464334|583913537|FG004|Overall Study|Study Terminated by Sponsor|0|||
161689589|NCT00464334|583913538|FG005|Overall Study|Study Terminated by Sponsor|0|||
161689590|NCT00464334|583913539|FG006|Overall Study|Study Terminated by Sponsor|0|||
161689591|NCT00464334|583913540|FG007|Overall Study|Study Terminated by Sponsor|0|||
161689592|NCT00464334|583913541|FG008|Overall Study|Study Terminated by Sponsor|0|||
161689593|NCT00464334|583913542|FG009|Overall Study|Study Terminated by Sponsor|0|||
161689594|NCT00464334|583913543|FG010|Overall Study|Study Terminated by Sponsor|0|||
161689595|NCT00464334|583913533|FG000|Overall Study|Withdrawal by Subject|1|||
161689596|NCT00464334|583913534|FG001|Overall Study|Withdrawal by Subject|7|||
161689597|NCT00464334|583913535|FG002|Overall Study|Withdrawal by Subject|4|||
161689598|NCT00464334|583913536|FG003|Overall Study|Withdrawal by Subject|2|||
161689599|NCT00464334|583913537|FG004|Overall Study|Withdrawal by Subject|2|||
161689600|NCT00464334|583913538|FG005|Overall Study|Withdrawal by Subject|2|||
161689601|NCT00464334|583913539|FG006|Overall Study|Withdrawal by Subject|2|||
161689602|NCT00464334|583913540|FG007|Overall Study|Withdrawal by Subject|1|||
161689603|NCT00464334|583913541|FG008|Overall Study|Withdrawal by Subject|3|||
161689604|NCT00464334|583913542|FG009|Overall Study|Withdrawal by Subject|0|||
161689605|NCT00464334|583913543|FG010|Overall Study|Withdrawal by Subject|0|||
161689606|NCT01857869|583913544|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
161689607|NCT01857869|583913545|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
161689608|NCT01857869|583913546|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
161689609|NCT01857869|583913547|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
161689610|NCT01857869|583913548|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
161689611|NCT01857869|583913549|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
161689612|NCT01857869|583913550|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
161689613|NCT01857869|583913551|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
161689614|NCT01857869|583913552|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
161689615|NCT01857869|583913553|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
161689616|NCT01857869|583913544|FG000|Primary/Challenge Phase|Pregnancy|1|||
161689617|NCT01857869|583913545|FG001|Primary/Challenge Phase|Pregnancy|0|||
161689618|NCT01857869|583913546|FG002|Primary/Challenge Phase|Pregnancy|0|||
161689619|NCT01857869|583913547|FG003|Primary/Challenge Phase|Pregnancy|0|||
161689620|NCT01857869|583913548|FG004|Primary/Challenge Phase|Pregnancy|0|||
161689621|NCT01857869|583913549|FG005|Primary/Challenge Phase|Pregnancy|0|||
161689622|NCT01857869|583913550|FG006|Primary/Challenge Phase|Pregnancy|0|||
161689623|NCT01857869|583913551|FG007|Primary/Challenge Phase|Pregnancy|0|||
161689624|NCT01857869|583913552|FG008|Primary/Challenge Phase|Pregnancy|0|||
161689625|NCT01857869|583913553|FG009|Primary/Challenge Phase|Pregnancy|0|||
161689626|NCT01857869|583913544|FG000|Primary/Challenge Phase|Protocol Violation|1|||
161689627|NCT01857869|583913545|FG001|Primary/Challenge Phase|Protocol Violation|0|||
161689628|NCT01857869|583913546|FG002|Primary/Challenge Phase|Protocol Violation|0|||
161689629|NCT01857869|583913547|FG003|Primary/Challenge Phase|Protocol Violation|0|||
161689630|NCT01857869|583913548|FG004|Primary/Challenge Phase|Protocol Violation|0|||
161689631|NCT01857869|583913549|FG005|Primary/Challenge Phase|Protocol Violation|0|||
161689632|NCT01857869|583913550|FG006|Primary/Challenge Phase|Protocol Violation|0|||
161689633|NCT01857869|583913551|FG007|Primary/Challenge Phase|Protocol Violation|0|||
161689634|NCT01857869|583913552|FG008|Primary/Challenge Phase|Protocol Violation|0|||
161689635|NCT01857869|583913553|FG009|Primary/Challenge Phase|Protocol Violation|0|||
161689636|NCT01857869|583913544|FG000|Primary/Challenge Phase|Other|1|||
161689637|NCT01857869|583913545|FG001|Primary/Challenge Phase|Other|1|||
161689638|NCT01857869|583913546|FG002|Primary/Challenge Phase|Other|0|||
161689639|NCT01857869|583913547|FG003|Primary/Challenge Phase|Other|0|||
161689640|NCT01857869|583913548|FG004|Primary/Challenge Phase|Other|0|||
161836219|NCT00094458|584442897|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
161836220|NCT00094458|584442898|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
161836221|NCT00094458|584442899|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
161836222|NCT00094458|584442900|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
161836223|NCT00094458|584442901|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
161836224|NCT00094458|584442902|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
161836225|NCT00094458|584442897|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
161836226|NCT00094458|584442898|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
161689641|NCT01857869|583913549|FG005|Primary/Challenge Phase|Other|0|||
161689642|NCT01857869|583913550|FG006|Primary/Challenge Phase|Other|0|||
161689643|NCT01857869|583913551|FG007|Primary/Challenge Phase|Other|0|||
161689644|NCT01857869|583913552|FG008|Primary/Challenge Phase|Other|0|||
161689645|NCT01857869|583913553|FG009|Primary/Challenge Phase|Other|0|||
161689646|NCT01857869|583913544|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689647|NCT01857869|583913545|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689648|NCT01857869|583913546|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689649|NCT01857869|583913547|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
161689650|NCT01857869|583913548|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689651|NCT01857869|583913549|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689652|NCT01857869|583913550|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689653|NCT01857869|583913551|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689654|NCT01857869|583913552|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689655|NCT01857869|583913553|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161689656|NCT01857869|583913544|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689657|NCT01857869|583913545|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689658|NCT01857869|583913546|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689659|NCT01857869|583913547|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
161689660|NCT01857869|583913548|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689661|NCT01857869|583913549|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689662|NCT01857869|583913550|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689663|NCT01857869|583913551|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689664|NCT01857869|583913552|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689665|NCT01857869|583913553|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161689666|NCT02898259|583913565|FG000|Overall Study|Adverse Event|0|||
161689667|NCT02898259|583913566|FG001|Overall Study|Adverse Event|0|||
161689668|NCT02898259|583913567|FG002|Overall Study|Adverse Event|1|||
161689669|NCT02898259|583913568|FG003|Overall Study|Adverse Event|0|||
161689670|NCT02898259|583913569|FG004|Overall Study|Adverse Event|0|||
161689671|NCT02898259|583913565|FG000|Overall Study|Lack of Efficacy|1|||
161689672|NCT02898259|583913566|FG001|Overall Study|Lack of Efficacy|1|||
161689673|NCT02898259|583913567|FG002|Overall Study|Lack of Efficacy|3|||
161689674|NCT02898259|583913568|FG003|Overall Study|Lack of Efficacy|0|||
161689675|NCT02898259|583913569|FG004|Overall Study|Lack of Efficacy|0|||
161689676|NCT02898259|583913565|FG000|Overall Study|Lost to Follow-up|0|||
161689677|NCT02898259|583913566|FG001|Overall Study|Lost to Follow-up|0|||
161689678|NCT02898259|583913567|FG002|Overall Study|Lost to Follow-up|1|||
161689679|NCT02898259|583913568|FG003|Overall Study|Lost to Follow-up|0|||
161689680|NCT02898259|583913569|FG004|Overall Study|Lost to Follow-up|0|||
161689681|NCT02898259|583913565|FG000|Overall Study|Transformation before study began|0|||
161689682|NCT02898259|583913566|FG001|Overall Study|Transformation before study began|0|||
161689683|NCT02898259|583913567|FG002|Overall Study|Transformation before study began|0|||
161689684|NCT02898259|583913568|FG003|Overall Study|Transformation before study began|1|||
161689685|NCT02898259|583913569|FG004|Overall Study|Transformation before study began|0|||
161689686|NCT02728830|583913583|FG000|Overall Study|Exclusionary Surgery|9|||
161689687|NCT02728830|583913583|FG000|Overall Study|Exclusionary Pathology|6|||
161689688|NCT02728830|583913583|FG000|Overall Study|Physician Decision|3|||
161689689|NCT02728830|583913583|FG000|Overall Study|Withdrawal by Subject|2|||
161689690|NCT02728830|583913583|FG000|Overall Study|Lost to Follow-up|1|||
161689691|NCT02728830|583913583|FG000|Overall Study|Exclusionary Lab Values|1|||
161689692|NCT02728830|583913583|FG000|Overall Study|Contraindicated Illness|1|||
161689693|NCT02728830|583913583|FG000|Overall Study|Language Barrier|1|||
161689694|NCT01087905|583913584|FG000|Overall Study|Lost to Follow-up|24|||
161689695|NCT01087905|583913585|FG001|Overall Study|Lost to Follow-up|28|||
161689696|NCT01087905|583913586|FG002|Overall Study|Lost to Follow-up|18|||
161689697|NCT01087905|583913587|FG003|Overall Study|Lost to Follow-up|31|||
161689698|NCT01087905|583913588|FG004|Overall Study|Lost to Follow-up|27|||
161689699|NCT01087905|583913589|FG005|Overall Study|Lost to Follow-up|25|||
161689700|NCT01087905|583913590|FG006|Overall Study|Lost to Follow-up|20|||
161689701|NCT01087905|583913591|FG007|Overall Study|Lost to Follow-up|24|||
161689702|NCT01087905|583913584|FG000|Overall Study|Withdrawal by Subject|5|||
161689703|NCT01087905|583913585|FG001|Overall Study|Withdrawal by Subject|4|||
161689704|NCT01087905|583913586|FG002|Overall Study|Withdrawal by Subject|4|||
161689705|NCT01087905|583913587|FG003|Overall Study|Withdrawal by Subject|5|||
161689706|NCT01087905|583913588|FG004|Overall Study|Withdrawal by Subject|4|||
161689707|NCT01087905|583913589|FG005|Overall Study|Withdrawal by Subject|3|||
161689708|NCT01087905|583913590|FG006|Overall Study|Withdrawal by Subject|3|||
161689709|NCT01087905|583913591|FG007|Overall Study|Withdrawal by Subject|5|||
161689710|NCT00790907|583913592|FG000|Overall Study|Adverse Event|9|||
161956173|NCT04908683|584887425|FG000|Overall Study|Death|101|||
161956174|NCT04908683|584887426|FG001|Overall Study|Death|61|||
161956175|NCT04908683|584887425|FG000|Overall Study|Sponsor's decision|14398|||
161956176|NCT04908683|584887426|FG001|Overall Study|Sponsor's decision|7205|||
161956177|NCT04908683|584887425|FG000|Overall Study|Other|92|||
161689711|NCT00790907|583913593|FG001|Overall Study|Adverse Event|7|||
161689712|NCT00790907|583913594|FG002|Overall Study|Adverse Event|6|||
161689713|NCT00790907|583913592|FG000|Overall Study|Physician Decision|304|||
161689714|NCT00790907|583913593|FG001|Overall Study|Physician Decision|271|||
161689715|NCT00790907|583913594|FG002|Overall Study|Physician Decision|255|||
161689716|NCT00790907|583913592|FG000|Overall Study|Withdrawal by Subject|1|||
161689717|NCT00790907|583913593|FG001|Overall Study|Withdrawal by Subject|7|||
161689718|NCT00790907|583913594|FG002|Overall Study|Withdrawal by Subject|5|||
161689719|NCT00790907|583913592|FG000|Overall Study|Bleeding Event|11|||
161689720|NCT00790907|583913593|FG001|Overall Study|Bleeding Event|16|||
161689721|NCT00790907|583913594|FG002|Overall Study|Bleeding Event|21|||
161689722|NCT00790907|583913592|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
161689723|NCT00790907|583913593|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
161689724|NCT00790907|583913594|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
161689725|NCT00790907|583913592|FG000|Overall Study|Qualifying Condition Not Present|29|||
161689726|NCT00790907|583913593|FG001|Overall Study|Qualifying Condition Not Present|14|||
161689727|NCT00790907|583913594|FG002|Overall Study|Qualifying Condition Not Present|16|||
161689728|NCT00790907|583913592|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
161689729|NCT00790907|583913593|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
161689730|NCT00790907|583913594|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
161689731|NCT00790907|583913592|FG000|Overall Study|Did Not Receive Study Drug|10|||
161689732|NCT00790907|583913593|FG001|Overall Study|Did Not Receive Study Drug|0|||
161689733|NCT00790907|583913594|FG002|Overall Study|Did Not Receive Study Drug|0|||
161689734|NCT00774345|583913595|FG000|Pre-treatment|Other reasons|2|||
161689735|NCT00774345|583913596|FG001|Pre-treatment|Other reasons|0|||
161689736|NCT00774345|583913595|FG000|Treatment|Adverse Event|61|||
161689737|NCT00774345|583913596|FG001|Treatment|Adverse Event|15|||
161689738|NCT00774345|583913595|FG000|Treatment|Progressive Disease without histologic transformation|51|||
161689739|NCT00774345|583913596|FG001|Treatment|Progressive Disease without histologic transformation|111|||
161689740|NCT00774345|583913595|FG000|Treatment|Progressive Disease with histologic transformation|4|||
161689741|NCT00774345|583913596|FG001|Treatment|Progressive Disease with histologic transformation|2|||
161689742|NCT00774345|583913595|FG000|Treatment|Withdrawal by Subject|5|||
161689743|NCT00774345|583913596|FG001|Treatment|Withdrawal by Subject|2|||
161689744|NCT00774345|583913595|FG000|Treatment|Lost to Follow-up|1|||
161689745|NCT00774345|583913596|FG001|Treatment|Lost to Follow-up|1|||
161689746|NCT00774345|583913595|FG000|Treatment|Death|4|||
161689747|NCT00774345|583913596|FG001|Treatment|Death|0|||
161689748|NCT00774345|583913595|FG000|Treatment|Other Reasons|32|||
161689749|NCT00774345|583913596|FG001|Treatment|Other Reasons|26|||
161689750|NCT03436862|583913597|FG000|Overall Study|Adverse Event|4|||
161689751|NCT03436862|583913597|FG000|Overall Study|Progressive Disease|2|||
161689752|NCT00391222|583913598|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
161689753|NCT00391222|583913599|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
161689754|NCT00391222|583913600|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
161689755|NCT00391222|583913601|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
161689756|NCT00391222|583913598|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
161689757|NCT00391222|583913599|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
161689758|NCT00391222|583913600|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
161689759|NCT00391222|583913601|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
161689760|NCT00391222|583913598|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
161689761|NCT00391222|583913599|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
161689762|NCT00391222|583913600|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
161689763|NCT00391222|583913601|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
161689764|NCT00391222|583913598|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
161689765|NCT00391222|583913599|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
161689766|NCT00391222|583913600|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
161689767|NCT00391222|583913601|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
161689768|NCT00391222|583913598|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
161689769|NCT00391222|583913599|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
161689770|NCT00391222|583913600|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
161689771|NCT00391222|583913601|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
161689772|NCT00391222|583913598|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
161689773|NCT00391222|583913599|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
161956178|NCT04908683|584887426|FG001|Overall Study|Other|50|||
161689774|NCT00391222|583913600|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
161689775|NCT00391222|583913601|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
161689776|NCT00391222|583913598|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
161689777|NCT00391222|583913599|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
161689778|NCT00391222|583913600|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
161956179|NCT04908683|584887425|FG000|Overall Study|Randomized not vaccinated|108|||
161689779|NCT00391222|583913601|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
161956180|NCT04908683|584887426|FG001|Overall Study|Randomized not vaccinated|52|||
161956181|NCT00910910|584887427|FG000|Overall Study|Adverse Event|63|||
161956182|NCT00910910|584887428|FG001|Overall Study|Adverse Event|35|||
161956183|NCT00910910|584887427|FG000|Overall Study|PD without histologic change|27|||
161956184|NCT00910910|584887428|FG001|Overall Study|PD without histologic change|23|||
161956185|NCT00910910|584887427|FG000|Overall Study|PD with histologic change|0|||
161956186|NCT00910910|584887428|FG001|Overall Study|PD with histologic change|2|||
161956187|NCT00910910|584887427|FG000|Overall Study|Withdrawal by Subject|7|||
161956188|NCT00910910|584887428|FG001|Overall Study|Withdrawal by Subject|5|||
161956189|NCT00910910|584887427|FG000|Overall Study|Lost to Follow-up|2|||
161956190|NCT00910910|584887428|FG001|Overall Study|Lost to Follow-up|2|||
161956191|NCT00910910|584887427|FG000|Overall Study|Death|9|||
161956192|NCT00910910|584887428|FG001|Overall Study|Death|3|||
161956193|NCT00910910|584887427|FG000|Overall Study|Protocol Violation|2|||
161956194|NCT00910910|584887428|FG001|Overall Study|Protocol Violation|2|||
161956195|NCT00910910|584887427|FG000|Overall Study|Completed 13 cycles of treatment|0|||
161956196|NCT00910910|584887428|FG001|Overall Study|Completed 13 cycles of treatment|118|||
161956197|NCT00910910|584887427|FG000|Overall Study|Other|114|||
161689780|NCT00391222|583913598|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
161689781|NCT00391222|583913599|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
161956198|NCT00910910|584887428|FG001|Overall Study|Other|32|||
161956199|NCT00910910|584887427|FG000|Overall Study|Untreated before cycle 1|1|||
161956200|NCT00910910|584887428|FG001|Overall Study|Untreated before cycle 1|2|||
161956201|NCT01973231|584887429|FG000|Overall Study|Protocol Violation|1|||
161689782|NCT00391222|583913600|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
162030755|NCT04604132|585169484|FG004|Overall Study|Study terminated by sponsor|1|||
162030756|NCT04604132|585169480|FG000|Overall Study|Progressive disease: Clinical progression|0|||
162030757|NCT04604132|585169481|FG001|Overall Study|Progressive disease: Clinical progression|0|||
161956202|NCT01973231|584887430|FG001|Overall Study|Protocol Violation|1|||
161956203|NCT01973231|584887429|FG000|Overall Study|Lost to Follow-up|1|||
161956204|NCT01973231|584887430|FG001|Overall Study|Lost to Follow-up|1|||
161956205|NCT01973231|584887429|FG000|Overall Study|unclassified|2|||
161956206|NCT01973231|584887430|FG001|Overall Study|unclassified|1|||
161689783|NCT00391222|583913601|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
161836227|NCT00094458|584442899|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
161956207|NCT01973231|584887429|FG000|Overall Study|Withdrawal by Subject|7|||
161956208|NCT01973231|584887430|FG001|Overall Study|Withdrawal by Subject|9|||
161956209|NCT05384834|584887438|FG000|Overall Study|Lost to Follow-up|43|||
161956210|NCT05384834|584887438|FG000|Overall Study|Withdrawal by Subject|5|||
161956211|NCT01871545|584887439|FG000|Overall Study|Death|2|||
161956212|NCT01871545|584887440|FG001|Overall Study|Death|0|||
161956213|NCT01871545|584887439|FG000|Overall Study|Lack of Efficacy|11|||
161956214|NCT01871545|584887440|FG001|Overall Study|Lack of Efficacy|2|||
161956215|NCT01871545|584887439|FG000|Overall Study|Physician Decision|4|||
161956216|NCT01871545|584887440|FG001|Overall Study|Physician Decision|0|||
161956217|NCT01871545|584887439|FG000|Overall Study|Withdrawal by Subject|0|||
161956218|NCT01871545|584887440|FG001|Overall Study|Withdrawal by Subject|1|||
161956219|NCT02569476|584887441|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
161956220|NCT02569476|584887441|FG000|Overall Study|Death|33|||
161956221|NCT02569476|584887441|FG000|Overall Study|Withdrawal by Subject|9|||
161956222|NCT02569476|584887441|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
161956223|NCT02569476|584887441|FG000|Overall Study|Palliative care|1|||
161956224|NCT02569476|584887441|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
161956225|NCT02569476|584887441|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
161956226|NCT01152788|584887442|FG000|Overall Study|Withdrawal by Subject|0|||
161956227|NCT01152788|584887443|FG001|Overall Study|Withdrawal by Subject|3|||
161956228|NCT01152788|584887442|FG000|Overall Study|No treatment|0|||
161956229|NCT01152788|584887443|FG001|Overall Study|No treatment|1|||
161956230|NCT00778336|584887444|FG000|Index Procedure-Discharge|Death|6|||
161689784|NCT00391222|583913598|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
161689785|NCT00391222|583913599|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
161689786|NCT00391222|583913600|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
161689787|NCT00391222|583913601|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
161689788|NCT00391222|583913598|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
161836228|NCT00094458|584442900|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
161836229|NCT00094458|584442901|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
161836230|NCT00094458|584442902|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
161836231|NCT00094458|584442897|FG000|OLE: Open-Label Extension|Adverse Event|0|||
161836232|NCT00094458|584442898|FG001|OLE: Open-Label Extension|Adverse Event|0|||
161836233|NCT00094458|584442899|FG002|OLE: Open-Label Extension|Adverse Event|0|||
161836234|NCT00094458|584442900|FG003|OLE: Open-Label Extension|Adverse Event|0|||
161836235|NCT00094458|584442901|FG004|OLE: Open-Label Extension|Adverse Event|3|||
161836236|NCT00094458|584442902|FG005|OLE: Open-Label Extension|Adverse Event|4|||
161836237|NCT00094458|584442897|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
161836238|NCT00094458|584442898|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
161836239|NCT00094458|584442899|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
161836240|NCT00094458|584442900|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
161836241|NCT00094458|584442901|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
161836242|NCT00094458|584442902|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
161836243|NCT00094458|584442897|FG000|OLE: Open-Label Extension|Patient decision|0|||
161836244|NCT00094458|584442898|FG001|OLE: Open-Label Extension|Patient decision|0|||
161836245|NCT00094458|584442899|FG002|OLE: Open-Label Extension|Patient decision|0|||
161836246|NCT00094458|584442900|FG003|OLE: Open-Label Extension|Patient decision|0|||
161836247|NCT00094458|584442901|FG004|OLE: Open-Label Extension|Patient decision|1|||
161836248|NCT00094458|584442902|FG005|OLE: Open-Label Extension|Patient decision|0|||
161836249|NCT03247517|584442903|FG000|Overall Study|Adverse Event|0|||
161836250|NCT03247517|584442904|FG001|Overall Study|Adverse Event|4|||
161836251|NCT03247517|584442905|FG002|Overall Study|Adverse Event|2|||
161836252|NCT03247517|584442903|FG000|Overall Study|Lost to Follow-up|2|||
161836253|NCT03247517|584442904|FG001|Overall Study|Lost to Follow-up|6|||
161836254|NCT03247517|584442905|FG002|Overall Study|Lost to Follow-up|4|||
161836255|NCT03247517|584442903|FG000|Overall Study|Consent withdrawn by caregiver|1|||
161836256|NCT03247517|584442904|FG001|Overall Study|Consent withdrawn by caregiver|4|||
161956231|NCT00778336|584887445|FG001|Index Procedure-Discharge|Death|3|||
161956232|NCT00778336|584887446|FG002|Index Procedure-Discharge|Death|2|||
161956233|NCT00778336|584887447|FG003|Index Procedure-Discharge|Death|0|||
161956234|NCT00778336|584887444|FG000|3 Month Follow Up|Lost to Follow-up|15|||
161956235|NCT00778336|584887445|FG001|3 Month Follow Up|Lost to Follow-up|20|||
161956236|NCT00778336|584887446|FG002|3 Month Follow Up|Lost to Follow-up|3|||
161689789|NCT00391222|583913599|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
161689790|NCT00391222|583913600|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
161689791|NCT00391222|583913601|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
161689792|NCT00391222|583913598|FG000|Period III (Double-Blind Treatment)|Other|6|||
161689793|NCT00391222|583913599|FG001|Period III (Double-Blind Treatment)|Other|1|||
161689794|NCT00391222|583913600|FG002|Period III (Double-Blind Treatment)|Other|6|||
161689795|NCT00391222|583913601|FG003|Period III (Double-Blind Treatment)|Other|0|||
161689796|NCT01119248|583913602|FG000|Overall Study|Physician Decision|5|||
161689797|NCT00550680|583913603|FG000|Overall Study|Administrative Reasons|1|||
161689798|NCT00550680|583913603|FG000|Overall Study|Adverse Event|5|||
161689799|NCT00550680|583913603|FG000|Overall Study|Death|3|||
161836257|NCT03247517|584442905|FG002|Overall Study|Consent withdrawn by caregiver|7|||
161836258|NCT03247517|584442903|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
161836259|NCT03247517|584442904|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
161956237|NCT00778336|584887447|FG003|3 Month Follow Up|Lost to Follow-up|0|||
161956238|NCT00778336|584887444|FG000|3 Month Follow Up|Death|8|||
161836260|NCT03247517|584442905|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
161836261|NCT03247517|584442903|FG000|Overall Study|Protocol Violation|0|||
161956239|NCT00778336|584887445|FG001|3 Month Follow Up|Death|3|||
161689800|NCT00550680|583913603|FG000|Overall Study|Early Improvement|1|||
161836262|NCT03247517|584442904|FG001|Overall Study|Protocol Violation|2|||
161836263|NCT03247517|584442905|FG002|Overall Study|Protocol Violation|0|||
161836264|NCT03247517|584442903|FG000|Overall Study|Multiple reasons|3|||
161836265|NCT03247517|584442904|FG001|Overall Study|Multiple reasons|1|||
161836266|NCT03247517|584442905|FG002|Overall Study|Multiple reasons|0|||
161836267|NCT03310411|584442906|FG000|Period 1|Adverse Event|0|||
161836268|NCT03310411|584442907|FG001|Period 1|Adverse Event|0|||
161956240|NCT00778336|584887446|FG002|3 Month Follow Up|Death|2|||
161689801|NCT00550680|583913603|FG000|Overall Study|Lost to Follow-up|3|||
161689802|NCT00550680|583913603|FG000|Overall Study|Lack of Efficacy|1|||
161836269|NCT03310411|584442908|FG002|Period 1|Adverse Event|0|||
161836270|NCT03310411|584442909|FG003|Period 1|Adverse Event|1|||
161689803|NCT00550680|583913603|FG000|Overall Study|Other|10|||
161689804|NCT00550680|583913603|FG000|Overall Study|Protocol Violation|7|||
161689805|NCT00550680|583913603|FG000|Overall Study|Refused Treatment|19|||
161689806|NCT00550680|583913603|FG000|Overall Study|Screen Failure|6|||
161689807|NCT01967550|583913604|FG000|Overall Study|Withdrawal by Subject|1|||
161689808|NCT01967550|583913605|FG001|Overall Study|Withdrawal by Subject|0|||
161689809|NCT01967550|583913604|FG000|Overall Study|Adverse Event|2|||
161689810|NCT01967550|583913605|FG001|Overall Study|Adverse Event|0|||
161689811|NCT01967550|583913604|FG000|Overall Study|Protocol Violation|2|||
161689812|NCT01967550|583913605|FG001|Overall Study|Protocol Violation|1|||
161689813|NCT01967550|583913604|FG000|Overall Study|Non Compliance|0|||
161689814|NCT01967550|583913605|FG001|Overall Study|Non Compliance|1|||
161689815|NCT00333359|583913610|FG000|Overall Study|Adverse Event|29|||
161689816|NCT00333359|583913611|FG001|Overall Study|Adverse Event|35|||
161689817|NCT00333359|583913610|FG000|Overall Study|Withdrawal by Subject|19|||
161689818|NCT00333359|583913611|FG001|Overall Study|Withdrawal by Subject|37|||
161689819|NCT00333359|583913610|FG000|Overall Study|Physician Decision|2|||
161689820|NCT00333359|583913611|FG001|Overall Study|Physician Decision|2|||
161689821|NCT00333359|583913610|FG000|Overall Study|Protocol Non-compliance|2|||
161689822|NCT00333359|583913611|FG001|Overall Study|Protocol Non-compliance|8|||
161689823|NCT00333359|583913610|FG000|Overall Study|Lost to Follow-up|15|||
161689824|NCT00333359|583913611|FG001|Overall Study|Lost to Follow-up|25|||
161689825|NCT00333359|583913610|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
161689826|NCT00333359|583913611|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
161689827|NCT00333359|583913610|FG000|Overall Study|Treatment Failure|3|||
161689828|NCT00333359|583913611|FG001|Overall Study|Treatment Failure|8|||
161689829|NCT00333359|583913610|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
161689830|NCT00333359|583913611|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
161689831|NCT02867995|583913616|FG000|Overall Study|Withdrawal by Subject|0|||
161689832|NCT02867995|583913617|FG001|Overall Study|Withdrawal by Subject|1|||
161689833|NCT02867995|583913616|FG000|Overall Study|Lost to Follow-up|0|||
161689834|NCT02867995|583913617|FG001|Overall Study|Lost to Follow-up|2|||
161689835|NCT01534533|583913618|FG000|Overall Study|Lost to Follow-up|3|||
161689836|NCT01534533|583913619|FG001|Overall Study|Lost to Follow-up|0|||
161689837|NCT01534533|583913620|FG002|Overall Study|Lost to Follow-up|4|||
161689838|NCT01534533|583913621|FG003|Overall Study|Lost to Follow-up|3|||
161689839|NCT01534533|583913618|FG000|Overall Study|Withdrawal by Subject|5|||
161689840|NCT01534533|583913619|FG001|Overall Study|Withdrawal by Subject|3|||
161689841|NCT01534533|583913620|FG002|Overall Study|Withdrawal by Subject|4|||
161689842|NCT01534533|583913621|FG003|Overall Study|Withdrawal by Subject|1|||
161689843|NCT03315871|583913622|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
161689844|NCT03315871|583913623|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
161689845|NCT03315871|583913624|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
161689846|NCT03315871|583913622|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
161689847|NCT03315871|583913623|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
161689848|NCT03315871|583913624|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
161689849|NCT03315871|583913622|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
161689850|NCT03315871|583913623|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
161689851|NCT03315871|583913624|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
161689852|NCT03315871|583913622|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
161689853|NCT03315871|583913623|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
161689854|NCT03315871|583913624|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
161689855|NCT03315871|583913622|FG000|PROSTVAC + CV301|Progressive disease|0|||
161689856|NCT03315871|583913623|FG001|PROSTVAC + CV301|Progressive disease|0|||
161689857|NCT03315871|583913624|FG002|PROSTVAC + CV301|Progressive disease|1|||
161689858|NCT03315871|583913622|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
161689859|NCT03315871|583913623|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
161689860|NCT03315871|583913624|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
161689861|NCT04099251|583915684|FG000|Pre-Treatment|Other reasons|1|||
161689862|NCT04099251|583915685|FG001|Pre-Treatment|Other reasons|0|||
161689863|NCT04099251|583915684|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
161689864|NCT04099251|583915685|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
161689865|NCT04099251|583915684|FG000|Blinded Treatment Phase|Other reasons|16|||
161689866|NCT04099251|583915685|FG001|Blinded Treatment Phase|Other reasons|7|||
161689867|NCT04099251|583915684|FG000|Blinded Treatment Phase|Disease recurrence|26|||
161689868|NCT04099251|583915685|FG001|Blinded Treatment Phase|Disease recurrence|41|||
161836271|NCT00619112|584442910|FG000|Overall Study|Adverse Event|1|||
162030758|NCT04604132|585169482|FG002|Overall Study|Progressive disease: Clinical progression|1|||
161689869|NCT04099251|583915684|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
161836272|NCT00619112|584442911|FG001|Overall Study|Adverse Event|2|||
162030759|NCT04604132|585169483|FG003|Overall Study|Progressive disease: Clinical progression|0|||
161836273|NCT00729248|584442912|FG000|Overall Study|Physician Decision|2|||
161836274|NCT03573505|584442913|FG000|Overall Study|Adverse Event|1|||
161689870|NCT04099251|583915685|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
161689871|NCT04099251|583915684|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
161689872|NCT04099251|583915685|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
161689873|NCT04099251|583915684|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
161689874|NCT04099251|583915685|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
161689875|NCT04099251|583915684|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
161689876|NCT04099251|583915685|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
161689877|NCT04099251|583915684|FG000|Blinded Treatment Phase|Death|6|||
161689878|NCT04099251|583915685|FG001|Blinded Treatment Phase|Death|2|||
161689879|NCT04099251|583915684|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
161689880|NCT04099251|583915685|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
161689881|NCT04099251|583915684|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
161689882|NCT04099251|583915685|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
161689883|NCT04099251|583915684|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
161689884|NCT04099251|583915685|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
161689885|NCT04099251|583915684|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
161689886|NCT04099251|583915685|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
161689887|NCT04099251|583915684|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
161689888|NCT04099251|583915685|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
161689889|NCT04099251|583915684|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
161689890|NCT04099251|583915685|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
161689891|NCT04099251|583915684|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
161689892|NCT04099251|583915685|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
161689893|NCT04099251|583915684|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
161689894|NCT04099251|583915685|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
161689895|NCT04099251|583915684|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
161689896|NCT04099251|583915685|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
161689897|NCT04311502|583915686|FG000|Overall Study|Death|1|||
161689898|NCT04311502|583915687|FG001|Overall Study|Death|1|||
161689899|NCT04311502|583915688|FG002|Overall Study|Death|1|||
161689900|NCT04311502|583915686|FG000|Overall Study|Lost to Follow-up|2|||
161689901|NCT04311502|583915687|FG001|Overall Study|Lost to Follow-up|3|||
161689902|NCT04311502|583915688|FG002|Overall Study|Lost to Follow-up|0|||
161689903|NCT04311502|583915686|FG000|Overall Study|Participant is in prison|1|||
161689904|NCT04311502|583915687|FG001|Overall Study|Participant is in prison|0|||
161689905|NCT04311502|583915688|FG002|Overall Study|Participant is in prison|0|||
161689906|NCT04311502|583915686|FG000|Overall Study|Participant moved out of country|1|||
161689907|NCT04311502|583915687|FG001|Overall Study|Participant moved out of country|0|||
161689908|NCT04311502|583915688|FG002|Overall Study|Participant moved out of country|0|||
161689909|NCT04311502|583915686|FG000|Overall Study|Withdrawal by Subject|2|||
161689910|NCT04311502|583915687|FG001|Overall Study|Withdrawal by Subject|0|||
161689911|NCT04311502|583915688|FG002|Overall Study|Withdrawal by Subject|0|||
161689912|NCT04311502|583915686|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
161689913|NCT04311502|583915687|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
161689914|NCT04311502|583915688|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
161689915|NCT05032157|583915695|FG000|Overall Study|Adverse Event|12|||
161689916|NCT05032157|583915696|FG001|Overall Study|Adverse Event|7|||
161689917|NCT05032157|583915695|FG000|Overall Study|Pregnancy|0|||
161689918|NCT05032157|583915696|FG001|Overall Study|Pregnancy|2|||
161689919|NCT05032157|583915695|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161689920|NCT05032157|583915696|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
161689921|NCT05032157|583915695|FG000|Overall Study|Protocol Deviation|8|||
161689922|NCT05032157|583915696|FG001|Overall Study|Protocol Deviation|4|||
162030760|NCT04604132|585169484|FG004|Overall Study|Progressive disease: Clinical progression|0|||
162030761|NCT04604132|585169480|FG000|Overall Study|Progressive disease: Radiological progression|8|||
161689923|NCT05032157|583915695|FG000|Overall Study|Lost to Follow-up|1|||
161689924|NCT05032157|583915696|FG001|Overall Study|Lost to Follow-up|3|||
161689925|NCT05032157|583915695|FG000|Overall Study|Physician Decision|7|||
161689926|NCT05032157|583915696|FG001|Overall Study|Physician Decision|2|||
161689927|NCT05032157|583915695|FG000|Overall Study|Patient Decision|38|||
161689928|NCT05032157|583915696|FG001|Overall Study|Patient Decision|19|||
161689929|NCT03451773|583915697|FG000|Overall Study|Death on study|1|||
161689930|NCT03451773|583915698|FG001|Overall Study|Death on study|5|||
161689931|NCT03451773|583915697|FG000|Overall Study|Death during follow-up period|0|||
161689932|NCT03451773|583915698|FG001|Overall Study|Death during follow-up period|1|||
161689933|NCT02627495|583915699|FG000|Overall Study|Withdrawal by Subject|4|||
161689934|NCT02543528|583915700|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
161689935|NCT02543528|583915701|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
161689936|NCT02543528|583915702|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
161689937|NCT02543528|583915703|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
161689938|NCT02543528|583915704|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
161956241|NCT00778336|584887447|FG003|3 Month Follow Up|Death|0|||
161956242|NCT04585269|584887448|FG000|Intervention|Withdrawal by Subject|9|||
161956243|NCT04585269|584887449|FG001|Intervention|Withdrawal by Subject|0|||
161956244|NCT04585269|584887448|FG000|Intervention|Unable to schedule|15|||
161956245|NCT04585269|584887449|FG001|Intervention|Unable to schedule|0|||
161956246|NCT04585269|584887448|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
161956247|NCT04585269|584887449|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
161956248|NCT04585269|584887448|FG000|FU Time 2 (3 months)|Death|2|||
162030762|NCT04604132|585169481|FG001|Overall Study|Progressive disease: Radiological progression|7|||
162030763|NCT04604132|585169482|FG002|Overall Study|Progressive disease: Radiological progression|10|||
162030764|NCT04604132|585169483|FG003|Overall Study|Progressive disease: Radiological progression|4|||
162030765|NCT04604132|585169484|FG004|Overall Study|Progressive disease: Radiological progression|3|||
161689939|NCT02543528|583915700|FG000|Adaptation Period|Lens Handling Difficultes|0|||
161689940|NCT02543528|583915701|FG001|Adaptation Period|Lens Handling Difficultes|0|||
161689941|NCT02543528|583915702|FG002|Adaptation Period|Lens Handling Difficultes|0|||
161689942|NCT02543528|583915703|FG003|Adaptation Period|Lens Handling Difficultes|0|||
161689943|NCT02543528|583915704|FG004|Adaptation Period|Lens Handling Difficultes|8|||
161689944|NCT02543528|583915700|FG000|Adaptation Period|Lost to Follow-up|0|||
161689945|NCT02543528|583915701|FG001|Adaptation Period|Lost to Follow-up|0|||
161689946|NCT02543528|583915702|FG002|Adaptation Period|Lost to Follow-up|0|||
161689947|NCT02543528|583915703|FG003|Adaptation Period|Lost to Follow-up|0|||
161689948|NCT02543528|583915704|FG004|Adaptation Period|Lost to Follow-up|14|||
161689949|NCT02543528|583915700|FG000|Adaptation Period|Adverse Event|0|||
161689950|NCT02543528|583915701|FG001|Adaptation Period|Adverse Event|0|||
161689951|NCT02543528|583915702|FG002|Adaptation Period|Adverse Event|0|||
161689952|NCT02543528|583915703|FG003|Adaptation Period|Adverse Event|0|||
161689953|NCT02543528|583915704|FG004|Adaptation Period|Adverse Event|2|||
161689954|NCT02543528|583915700|FG000|Extended Wear Period|Adverse Event|17|||
161689955|NCT02543528|583915701|FG001|Extended Wear Period|Adverse Event|11|||
161689956|NCT02543528|583915702|FG002|Extended Wear Period|Adverse Event|16|||
161689957|NCT02543528|583915703|FG003|Extended Wear Period|Adverse Event|3|||
161689958|NCT02543528|583915704|FG004|Extended Wear Period|Adverse Event|0|||
161689959|NCT02543528|583915700|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
161689960|NCT02543528|583915701|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
161689961|NCT02543528|583915702|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
161689962|NCT02543528|583915703|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
161689963|NCT02543528|583915704|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
161689964|NCT02543528|583915700|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
161689965|NCT02543528|583915701|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
161689966|NCT02543528|583915702|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
161689967|NCT02543528|583915703|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
161689968|NCT02543528|583915704|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
161689969|NCT02543528|583915700|FG000|Extended Wear Period|Lost to Follow-up|0|||
161689970|NCT02543528|583915701|FG001|Extended Wear Period|Lost to Follow-up|1|||
161689971|NCT02543528|583915702|FG002|Extended Wear Period|Lost to Follow-up|2|||
161689972|NCT02543528|583915703|FG003|Extended Wear Period|Lost to Follow-up|1|||
161689973|NCT02543528|583915704|FG004|Extended Wear Period|Lost to Follow-up|0|||
161689974|NCT02543528|583915700|FG000|Extended Wear Period|Withdrawal by Subject|10|||
161689975|NCT02543528|583915701|FG001|Extended Wear Period|Withdrawal by Subject|9|||
161689976|NCT02543528|583915702|FG002|Extended Wear Period|Withdrawal by Subject|4|||
161689977|NCT02543528|583915703|FG003|Extended Wear Period|Withdrawal by Subject|5|||
161689978|NCT02543528|583915704|FG004|Extended Wear Period|Withdrawal by Subject|0|||
161689979|NCT01339559|583915705|FG000|Overall Study|Adverse Event|92|||
161689980|NCT01339559|583915705|FG000|Overall Study|Death|5|||
161689981|NCT01339559|583915705|FG000|Overall Study|Lack of Efficacy|164|||
161689982|NCT01339559|583915705|FG000|Overall Study|Lost to Follow-up|22|||
161689983|NCT01339559|583915705|FG000|Overall Study|Subject choice|89|||
161689984|NCT01339559|583915705|FG000|Overall Study|Protocol Violation|15|||
161689985|NCT01339559|583915705|FG000|Overall Study|Study closure at site|1|||
161689986|NCT01339559|583915705|FG000|Overall Study|Incarcerated|2|||
161689987|NCT01339559|583915705|FG000|Overall Study|Epilepsy surgery|1|||
161689988|NCT01339559|583915705|FG000|Overall Study|Pregnancy planned|2|||
161689989|NCT01339559|583915705|FG000|Overall Study|Left the country|1|||
161689990|NCT01339559|583915705|FG000|Overall Study|Investigator decision|2|||
161689991|NCT01339559|583915705|FG000|Overall Study|Patient didn't wish to continue|1|||
161689992|NCT01339559|583915705|FG000|Overall Study|PI decision|1|||
161689993|NCT00971945|583915706|FG000|Overall Study|Progressive Disease|3|||
161689994|NCT00971945|583915706|FG000|Overall Study|Change in treatment policy|1|||
161689995|NCT00971945|583915706|FG000|Overall Study|Other reasons|2|||
161689996|NCT00746252|583915710|FG000|Overall Study|weight gain >7.5 %|1|||
161689997|NCT00746252|583915711|FG001|Overall Study|weight gain >7.5 %|2|||
161689998|NCT01049035|583915712|FG000|Overall Study|Serious adverse event|0|||
161689999|NCT01049035|583915713|FG001|Overall Study|Serious adverse event|1|||
161690000|NCT01049035|583915714|FG002|Overall Study|Serious adverse event|1|||
161690001|NCT01049035|583915715|FG003|Overall Study|Serious adverse event|2|||
161690002|NCT01049035|583915716|FG004|Overall Study|Serious adverse event|0|||
161690003|NCT01049035|583915717|FG005|Overall Study|Serious adverse event|0|||
161690004|NCT01049035|583915718|FG006|Overall Study|Serious adverse event|0|||
161690005|NCT01049035|583915712|FG000|Overall Study|Other adverse event (AE)|0|||
161690006|NCT01049035|583915713|FG001|Overall Study|Other adverse event (AE)|0|||
161690007|NCT01049035|583915714|FG002|Overall Study|Other adverse event (AE)|0|||
161690008|NCT01049035|583915715|FG003|Overall Study|Other adverse event (AE)|1|||
161690009|NCT01049035|583915716|FG004|Overall Study|Other adverse event (AE)|0|||
161690010|NCT01049035|583915717|FG005|Overall Study|Other adverse event (AE)|0|||
161690011|NCT01049035|583915718|FG006|Overall Study|Other adverse event (AE)|0|||
161690012|NCT01049035|583915712|FG000|Overall Study|Non-compliance with the protocol|12|||
161690013|NCT01049035|583915713|FG001|Overall Study|Non-compliance with the protocol|6|||
161690014|NCT01049035|583915714|FG002|Overall Study|Non-compliance with the protocol|14|||
161690015|NCT01049035|583915715|FG003|Overall Study|Non-compliance with the protocol|5|||
161690016|NCT01049035|583915716|FG004|Overall Study|Non-compliance with the protocol|3|||
161690017|NCT01049035|583915717|FG005|Overall Study|Non-compliance with the protocol|4|||
161690018|NCT01049035|583915718|FG006|Overall Study|Non-compliance with the protocol|10|||
161690019|NCT01049035|583915712|FG000|Overall Study|Lost to Follow-up|5|||
161690020|NCT01049035|583915713|FG001|Overall Study|Lost to Follow-up|4|||
161690021|NCT01049035|583915714|FG002|Overall Study|Lost to Follow-up|4|||
161690022|NCT01049035|583915715|FG003|Overall Study|Lost to Follow-up|1|||
161690023|NCT01049035|583915716|FG004|Overall Study|Lost to Follow-up|0|||
161690024|NCT01049035|583915717|FG005|Overall Study|Lost to Follow-up|3|||
161690025|NCT01049035|583915718|FG006|Overall Study|Lost to Follow-up|3|||
161690026|NCT01049035|583915712|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
161690027|NCT01049035|583915713|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
161690028|NCT01049035|583915714|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
161690029|NCT01049035|583915715|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
161690030|NCT01049035|583915716|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
161690031|NCT01049035|583915717|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
161690032|NCT01049035|583915718|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
161690033|NCT01137773|583915719|FG000|Overall Study|Death|3|||
161690034|NCT01137773|583915720|FG001|Overall Study|Death|3|||
161690035|NCT01137773|583915719|FG000|Overall Study|Lost to Follow-up|6|||
161690036|NCT01137773|583915720|FG001|Overall Study|Lost to Follow-up|0|||
161690037|NCT03548051|583915722|FG000|Overall Study|Death|1|||
161690038|NCT03548051|583915723|FG001|Overall Study|Death|1|||
161690039|NCT03548051|583915722|FG000|Overall Study|Withdrawal by Subject|1|||
161690040|NCT03548051|583915723|FG001|Overall Study|Withdrawal by Subject|0|||
161690041|NCT00082888|583915724|FG000|Overall Study|Ineligible|1|||
161690042|NCT00082888|583915725|FG001|Overall Study|Ineligible|0|||
161690043|NCT00082888|583915726|FG002|Overall Study|Ineligible|0|||
161690044|NCT00817531|583915728|FG000|Overall Study|Adverse Event|1|||
161690045|NCT00817531|583915728|FG000|Overall Study|Lack of Efficacy|1|||
161690046|NCT00812214|583915729|FG000|Overall Study|Lost to Follow-up|3|||
161690047|NCT00812214|583915730|FG001|Overall Study|Lost to Follow-up|1|||
161690048|NCT03325673|583915733|FG000|Overall Study|Adverse Event|4|||
161690049|NCT03325673|583915734|FG001|Overall Study|Adverse Event|0|||
161690050|NCT02684981|583915735|FG000|Overall Study|Permanently discontinued the treatment|157|||
161690051|NCT02684981|583915736|FG001|Overall Study|Permanently discontinued the treatment|161|||
161690052|NCT02684981|583915737|FG002|Overall Study|Permanently discontinued the treatment|110|||
161690053|NCT02684981|583915735|FG000|Overall Study|Other|83|||
161690054|NCT02684981|583915736|FG001|Overall Study|Other|49|||
161690055|NCT02684981|583915737|FG002|Overall Study|Other|17|||
161690056|NCT00820898|583915740|FG000|Overall Study|Inelgible - wrong primary site|1|||
161690057|NCT00452699|583915743|FG000|Overall Study|Adverse Event|10|||
161690058|NCT00452699|583915744|FG001|Overall Study|Adverse Event|3|||
161690059|NCT00452699|583915743|FG000|Overall Study|Lack of Efficacy|6|||
161690060|NCT00452699|583915744|FG001|Overall Study|Lack of Efficacy|4|||
161690061|NCT00452699|583915743|FG000|Overall Study|Lost to Follow-up|6|||
161690062|NCT00452699|583915744|FG001|Overall Study|Lost to Follow-up|9|||
161690063|NCT00452699|583915743|FG000|Overall Study|Protocol Violation|21|||
161690064|NCT00452699|583915744|FG001|Overall Study|Protocol Violation|25|||
161690065|NCT00452699|583915743|FG000|Overall Study|Withdrawal by Subject|26|||
161690066|NCT00452699|583915744|FG001|Overall Study|Withdrawal by Subject|25|||
161690067|NCT00452699|583915743|FG000|Overall Study|Other|12|||
161690068|NCT00452699|583915744|FG001|Overall Study|Other|7|||
161690069|NCT01709149|583915752|FG000|Open-label Lead-in Phase|Adverse Event|109|||
161690070|NCT01709149|583915753|FG001|Open-label Lead-in Phase|Adverse Event|0|||
161690071|NCT01709149|583915754|FG002|Open-label Lead-in Phase|Adverse Event|0|||
161690072|NCT01709149|583915752|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
161690073|NCT01709149|583915753|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
161690074|NCT01709149|583915754|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
161690075|NCT01709149|583915752|FG000|Open-label Lead-in Phase|Death|1|||
161690076|NCT01709149|583915753|FG001|Open-label Lead-in Phase|Death|0|||
161690077|NCT01709149|583915754|FG002|Open-label Lead-in Phase|Death|0|||
161690078|NCT01709149|583915752|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
161690079|NCT01709149|583915753|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
161690080|NCT01709149|583915754|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
161690081|NCT01709149|583915752|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
161690082|NCT01709149|583915753|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
161690083|NCT01709149|583915754|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
161690084|NCT01709149|583915752|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161690085|NCT01709149|583915753|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
161690086|NCT01709149|583915754|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
161690087|NCT01709149|583915752|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
161690088|NCT01709149|583915753|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
161690089|NCT01709149|583915754|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
161690090|NCT01709149|583915752|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
161690091|NCT01709149|583915753|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
161690092|NCT01709149|583915754|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
161690093|NCT01709149|583915752|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
161690094|NCT01709149|583915753|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
161690095|NCT01709149|583915754|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
161690096|NCT01709149|583915752|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161690097|NCT01709149|583915753|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
161690098|NCT01709149|583915754|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161690099|NCT03509350|583915755|FG000|Overall Study|Withdrawal by Subject|0|||
161690100|NCT03509350|583915756|FG001|Overall Study|Withdrawal by Subject|2|||
161690101|NCT00763815|583915757|FG000|Overall Study|Adverse Event|14|||
161690102|NCT00763815|583915758|FG001|Overall Study|Adverse Event|29|||
161690103|NCT00763815|583915757|FG000|Overall Study|Lack of Efficacy|10|||
161690104|NCT00763815|583915758|FG001|Overall Study|Lack of Efficacy|11|||
161690105|NCT00763815|583915757|FG000|Overall Study|Poor Compliance to Protocol|6|||
161690106|NCT00763815|583915758|FG001|Overall Study|Poor Compliance to Protocol|6|||
161690107|NCT00763815|583915757|FG000|Overall Study|Lost to Follow-up|2|||
161690108|NCT00763815|583915758|FG001|Overall Study|Lost to Follow-up|4|||
161690109|NCT00763815|583915757|FG000|Overall Study|Early Termination|1|||
161690110|NCT00763815|583915758|FG001|Overall Study|Early Termination|0|||
161690111|NCT00763815|583915757|FG000|Overall Study|Familial and Personal Reasons|9|||
161690112|NCT00763815|583915758|FG001|Overall Study|Familial and Personal Reasons|16|||
161690113|NCT00763815|583915757|FG000|Overall Study|Physician Decision|1|||
161690114|NCT00763815|583915758|FG001|Overall Study|Physician Decision|0|||
161690115|NCT00763815|583915757|FG000|Overall Study|Withdrawal by Subject|7|||
161690116|NCT00763815|583915758|FG001|Overall Study|Withdrawal by Subject|12|||
161690117|NCT00763815|583915757|FG000|Overall Study|Protocol Violation|2|||
161690118|NCT00763815|583915758|FG001|Overall Study|Protocol Violation|5|||
161690119|NCT00763815|583915757|FG000|Overall Study|Sponsor's Decision|0|||
161690120|NCT00763815|583915758|FG001|Overall Study|Sponsor's Decision|1|||
161690121|NCT04951037|583915759|FG000|Overall Study|Lost to Follow-up|16|||
161690122|NCT04951037|583915759|FG000|Overall Study|Withdrawal by Subject|5|||
161690123|NCT04951037|583915759|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
161690124|NCT05630937|583915760|FG000|Overall Study|Study terminated by sponsor|1|||
161690125|NCT05630937|583915761|FG001|Overall Study|Study terminated by sponsor|1|||
161690126|NCT05630937|583915762|FG002|Overall Study|Study terminated by sponsor|8|||
161690127|NCT05630937|583915763|FG003|Overall Study|Study terminated by sponsor|0|||
161690128|NCT05630937|583915760|FG000|Overall Study|Lost to Follow-up|0|||
161690129|NCT05630937|583915761|FG001|Overall Study|Lost to Follow-up|0|||
161690130|NCT05630937|583915762|FG002|Overall Study|Lost to Follow-up|1|||
161690131|NCT05630937|583915763|FG003|Overall Study|Lost to Follow-up|0|||
161690132|NCT05630937|583915760|FG000|Overall Study|Enrolled but not treated|0|||
161690133|NCT05630937|583915761|FG001|Overall Study|Enrolled but not treated|0|||
161690134|NCT05630937|583915762|FG002|Overall Study|Enrolled but not treated|0|||
161690135|NCT05630937|583915763|FG003|Overall Study|Enrolled but not treated|1|||
161690136|NCT03245450|583915764|FG000|Overall Study|Radiological disease progression|3|||
161690137|NCT03245450|583915765|FG001|Overall Study|Radiological disease progression|3|||
161690138|NCT03245450|583915766|FG002|Overall Study|Radiological disease progression|2|||
161690139|NCT03245450|583915767|FG003|Overall Study|Radiological disease progression|2|||
161690140|NCT03245450|583915768|FG004|Overall Study|Radiological disease progression|7|||
161690141|NCT03245450|583915769|FG005|Overall Study|Radiological disease progression|6|||
161690142|NCT03245450|583915770|FG006|Overall Study|Radiological disease progression|6|||
161690143|NCT03245450|583915764|FG000|Overall Study|Clinical disease progression|0|||
161836275|NCT03573505|584442914|FG001|Overall Study|Adverse Event|1|||
161836276|NCT03573505|584442913|FG000|Overall Study|Consent withdrawn|0|||
161836277|NCT03573505|584442914|FG001|Overall Study|Consent withdrawn|1|||
161956249|NCT04585269|584887449|FG001|FU Time 2 (3 months)|Death|2|||
161956250|NCT04585269|584887448|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
161956251|NCT04585269|584887449|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
161690144|NCT03245450|583915765|FG001|Overall Study|Clinical disease progression|0|||
161690145|NCT03245450|583915766|FG002|Overall Study|Clinical disease progression|1|||
161690146|NCT03245450|583915767|FG003|Overall Study|Clinical disease progression|0|||
161690147|NCT03245450|583915768|FG004|Overall Study|Clinical disease progression|0|||
161690148|NCT03245450|583915769|FG005|Overall Study|Clinical disease progression|2|||
161690149|NCT03245450|583915770|FG006|Overall Study|Clinical disease progression|0|||
161690150|NCT03245450|583915764|FG000|Overall Study|Other|0|||
161690151|NCT03245450|583915765|FG001|Overall Study|Other|0|||
161690152|NCT03245450|583915766|FG002|Overall Study|Other|0|||
161690153|NCT03245450|583915767|FG003|Overall Study|Other|1|||
161690154|NCT03245450|583915768|FG004|Overall Study|Other|1|||
161836278|NCT03573505|584442913|FG000|Overall Study|Disease progression|0|||
161836279|NCT03573505|584442914|FG001|Overall Study|Disease progression|1|||
161836280|NCT03573505|584442913|FG000|Overall Study|Site Terminated by Sponsor|1|||
161690155|NCT03245450|583915769|FG005|Overall Study|Other|1|||
161690156|NCT03245450|583915770|FG006|Overall Study|Other|1|||
161690157|NCT03245450|583915764|FG000|Overall Study|Withdrawal by Subject|0|||
161690158|NCT03245450|583915765|FG001|Overall Study|Withdrawal by Subject|1|||
161690159|NCT03245450|583915766|FG002|Overall Study|Withdrawal by Subject|0|||
161690160|NCT03245450|583915767|FG003|Overall Study|Withdrawal by Subject|0|||
161690161|NCT03245450|583915768|FG004|Overall Study|Withdrawal by Subject|0|||
161690162|NCT03245450|583915769|FG005|Overall Study|Withdrawal by Subject|0|||
161690163|NCT03245450|583915770|FG006|Overall Study|Withdrawal by Subject|0|||
161690164|NCT03245450|583915764|FG000|Overall Study|Adverse Event|0|||
161690165|NCT03245450|583915765|FG001|Overall Study|Adverse Event|0|||
161690166|NCT03245450|583915766|FG002|Overall Study|Adverse Event|0|||
161690167|NCT03245450|583915767|FG003|Overall Study|Adverse Event|0|||
161690168|NCT03245450|583915768|FG004|Overall Study|Adverse Event|1|||
161690169|NCT03245450|583915769|FG005|Overall Study|Adverse Event|0|||
161690170|NCT03245450|583915770|FG006|Overall Study|Adverse Event|2|||
161690171|NCT02429414|583915771|FG000|Overall Study|Physician Decision|0|||
161690172|NCT02429414|583915772|FG001|Overall Study|Physician Decision|1|||
161690173|NCT01604265|583915777|FG000|Overall Study|Adverse Event|1|||
161690174|NCT01604265|583915778|FG001|Overall Study|Adverse Event|0|||
161690175|NCT01604265|583915777|FG000|Overall Study|Withdrawal by Subject|1|||
161690176|NCT01604265|583915778|FG001|Overall Study|Withdrawal by Subject|0|||
161690177|NCT01903837|583915779|FG000|Part A|Withdrawal by Subject|4|||
161690178|NCT01903837|583915780|FG001|Part A|Withdrawal by Subject|9|||
161690179|NCT01903837|583915781|FG002|Part A|Withdrawal by Subject|8|||
161690180|NCT01903837|583915782|FG003|Part A|Withdrawal by Subject|5|||
161690181|NCT01903837|583915779|FG000|Part A|Adverse Event|3|||
161690182|NCT01903837|583915780|FG001|Part A|Adverse Event|6|||
161690183|NCT01903837|583915781|FG002|Part A|Adverse Event|9|||
161690184|NCT01903837|583915782|FG003|Part A|Adverse Event|6|||
161690185|NCT01903837|583915779|FG000|Part A|Lost to Follow-up|9|||
161690186|NCT01903837|583915780|FG001|Part A|Lost to Follow-up|7|||
161690187|NCT01903837|583915781|FG002|Part A|Lost to Follow-up|7|||
161690188|NCT01903837|583915782|FG003|Part A|Lost to Follow-up|2|||
161690189|NCT01903837|583915779|FG000|Part A|Non-compliance with study drug|1|||
161690190|NCT01903837|583915780|FG001|Part A|Non-compliance with study drug|4|||
161690191|NCT01903837|583915781|FG002|Part A|Non-compliance with study drug|4|||
161690192|NCT01903837|583915782|FG003|Part A|Non-compliance with study drug|0|||
161690193|NCT01903837|583915779|FG000|Part A|Physician Decision|1|||
161690194|NCT01903837|583915780|FG001|Part A|Physician Decision|1|||
161690195|NCT01903837|583915781|FG002|Part A|Physician Decision|0|||
161690196|NCT01903837|583915782|FG003|Part A|Physician Decision|0|||
161690197|NCT01903837|583915779|FG000|Part A|Protocol Violation|1|||
161690198|NCT01903837|583915780|FG001|Part A|Protocol Violation|1|||
161690199|NCT01903837|583915781|FG002|Part A|Protocol Violation|0|||
161690200|NCT01903837|583915782|FG003|Part A|Protocol Violation|0|||
161690201|NCT01903837|583915779|FG000|Part B|Lost to Follow-up|0|||
161690202|NCT01903837|583915780|FG001|Part B|Lost to Follow-up|3|||
161690203|NCT01903837|583915781|FG002|Part B|Lost to Follow-up|3|||
161690204|NCT01903837|583915782|FG003|Part B|Lost to Follow-up|4|||
161690205|NCT01903837|583915779|FG000|Part B|Withdrawal by Subject|1|||
161690206|NCT01903837|583915780|FG001|Part B|Withdrawal by Subject|2|||
161690207|NCT01903837|583915781|FG002|Part B|Withdrawal by Subject|0|||
161690208|NCT01903837|583915782|FG003|Part B|Withdrawal by Subject|3|||
161690209|NCT01903837|583915779|FG000|Part B|Adverse Event|3|||
161690210|NCT01903837|583915780|FG001|Part B|Adverse Event|0|||
161690211|NCT01903837|583915781|FG002|Part B|Adverse Event|2|||
161690212|NCT01903837|583915782|FG003|Part B|Adverse Event|0|||
161690213|NCT01903837|583915779|FG000|Part B|Non-compliance with study drug|2|||
161690214|NCT01903837|583915780|FG001|Part B|Non-compliance with study drug|0|||
161690215|NCT01903837|583915781|FG002|Part B|Non-compliance with study drug|0|||
161690216|NCT01903837|583915782|FG003|Part B|Non-compliance with study drug|1|||
161690217|NCT01903837|583915779|FG000|Part B|Incarceration|2|||
161836281|NCT03573505|584442914|FG001|Overall Study|Site Terminated by Sponsor|1|||
161836282|NCT03573505|584442913|FG000|Overall Study|Study terminated by sponsor|50|||
161836283|NCT03573505|584442914|FG001|Overall Study|Study terminated by sponsor|45|||
161690218|NCT01903837|583915780|FG001|Part B|Incarceration|0|||
161690219|NCT01903837|583915781|FG002|Part B|Incarceration|0|||
161690220|NCT01903837|583915782|FG003|Part B|Incarceration|1|||
161836284|NCT03573505|584442913|FG000|Overall Study|Reason not specified|0|||
161690221|NCT01903837|583915779|FG000|Part B|Physician Decision|1|||
161690222|NCT01903837|583915780|FG001|Part B|Physician Decision|0|||
161690223|NCT01903837|583915781|FG002|Part B|Physician Decision|0|||
161690224|NCT01903837|583915782|FG003|Part B|Physician Decision|2|||
161836285|NCT03573505|584442914|FG001|Overall Study|Reason not specified|1|||
161690225|NCT01903837|583915779|FG000|Part B|Lack of Efficacy|0|||
161690226|NCT01903837|583915780|FG001|Part B|Lack of Efficacy|1|||
161690227|NCT01903837|583915781|FG002|Part B|Lack of Efficacy|0|||
161690228|NCT01903837|583915782|FG003|Part B|Lack of Efficacy|0|||
161690229|NCT02706873|583915783|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
161690230|NCT02706873|583915784|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
161690231|NCT02706873|583915785|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
161690232|NCT02706873|583915786|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
161690233|NCT02706873|583915783|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
161690234|NCT02706873|583915784|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
161690235|NCT02706873|583915785|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
161690236|NCT02706873|583915786|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
161690237|NCT02706873|583915783|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
161690238|NCT02706873|583915784|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
161690239|NCT02706873|583915785|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
161690240|NCT02706873|583915786|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
161690241|NCT02706873|583915783|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
161690242|NCT02706873|583915784|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
161690243|NCT02706873|583915785|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
161690244|NCT02706873|583915786|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
161690245|NCT02706873|583915783|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
161690246|NCT02706873|583915784|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
161690247|NCT02706873|583915785|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
161690248|NCT02706873|583915786|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
161690249|NCT02706873|583915783|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
161690250|NCT02706873|583915784|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
161690251|NCT02706873|583915785|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
161690252|NCT02706873|583915786|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
161690253|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
161690254|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
161690255|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
161690256|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
161690257|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
161690258|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
161690259|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
161690260|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
161690261|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
161690262|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
161690263|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
161690264|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
161690265|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
161690266|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
161690267|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
161690268|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
161690269|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
161690270|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
161690271|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
161690272|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
161690273|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
161690274|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
161690275|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
161690276|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
161690277|NCT02706873|583915783|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
161690278|NCT02706873|583915784|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
161690279|NCT02706873|583915785|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
161690280|NCT02706873|583915786|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
161690281|NCT05098041|583915788|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
161690282|NCT00705939|583915789|FG000|Overall Study|Protocol Violation|0|||
161690283|NCT00705939|583915790|FG001|Overall Study|Protocol Violation|0|||
161690284|NCT00705939|583915791|FG002|Overall Study|Protocol Violation|1|||
161690285|NCT00705939|583915789|FG000|Overall Study|Withdrawal by Subject|0|||
161690286|NCT00705939|583915790|FG001|Overall Study|Withdrawal by Subject|1|||
161690287|NCT00705939|583915791|FG002|Overall Study|Withdrawal by Subject|3|||
161690288|NCT00705939|583915789|FG000|Overall Study|Physician Decision|0|||
161690289|NCT00705939|583915790|FG001|Overall Study|Physician Decision|1|||
161690290|NCT00705939|583915791|FG002|Overall Study|Physician Decision|0|||
161690291|NCT00797732|583915796|FG000|Overall Study|Withdrawal by Subject|3|||
161690292|NCT00797732|583915797|FG001|Overall Study|Withdrawal by Subject|3|||
161690293|NCT00797732|583915798|FG002|Overall Study|Withdrawal by Subject|0|||
161690294|NCT00797732|583915796|FG000|Overall Study|Lost to Follow-up|1|||
161690295|NCT00797732|583915797|FG001|Overall Study|Lost to Follow-up|0|||
161690296|NCT00797732|583915798|FG002|Overall Study|Lost to Follow-up|0|||
161956252|NCT04585269|584887448|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
161690297|NCT00797732|583915796|FG000|Overall Study|Death|1|||
161690298|NCT00797732|583915797|FG001|Overall Study|Death|0|||
161690299|NCT00797732|583915798|FG002|Overall Study|Death|0|||
161690300|NCT00797732|583915796|FG000|Overall Study|Not meet inclusion criteria|0|||
161690301|NCT00797732|583915797|FG001|Overall Study|Not meet inclusion criteria|0|||
161690302|NCT00797732|583915798|FG002|Overall Study|Not meet inclusion criteria|7|||
161690303|NCT00797732|583915796|FG000|Overall Study|Excluded due to time constraints|0|||
161690304|NCT00797732|583915797|FG001|Overall Study|Excluded due to time constraints|0|||
161690305|NCT00797732|583915798|FG002|Overall Study|Excluded due to time constraints|24|||
161690306|NCT00797732|583915796|FG000|Overall Study|Refused to Participate|0|||
161690307|NCT00797732|583915797|FG001|Overall Study|Refused to Participate|0|||
161690308|NCT00797732|583915798|FG002|Overall Study|Refused to Participate|123|||
161690309|NCT03948178|583915799|FG000|Overall Study|Protocol Violation|1|||
161690310|NCT03948178|583915799|FG000|Overall Study|Lost to Follow-up|2|||
161690311|NCT03948178|583915799|FG000|Overall Study|Withdrawal by Subject|2|||
161690312|NCT03948178|583915799|FG000|Overall Study|Reason not known|2|||
161690313|NCT03948178|583915799|FG000|Overall Study|Personal reason|14|||
161690314|NCT03948178|583915799|FG000|Overall Study|Disease progression|30|||
161690315|NCT03948178|583915799|FG000|Overall Study|Adverse Event|12|||
161690316|NCT03948178|583915799|FG000|Overall Study|Sponsor terminated study|164|||
161690317|NCT01297270|583915800|FG000|Overall Study|Adverse Event|19|||
161690318|NCT01297270|583915801|FG001|Overall Study|Adverse Event|32|||
161690319|NCT01297270|583915802|FG002|Overall Study|Adverse Event|5|||
161690320|NCT01297270|583915800|FG000|Overall Study|Lack of Efficacy|15|||
161690321|NCT01297270|583915801|FG001|Overall Study|Lack of Efficacy|17|||
161690322|NCT01297270|583915802|FG002|Overall Study|Lack of Efficacy|15|||
161690323|NCT01297270|583915800|FG000|Overall Study|Lost to Follow-up|1|||
161690324|NCT01297270|583915801|FG001|Overall Study|Lost to Follow-up|2|||
161690325|NCT01297270|583915802|FG002|Overall Study|Lost to Follow-up|1|||
161690326|NCT01297270|583915800|FG000|Overall Study|Protocol Violation|0|||
161690327|NCT01297270|583915801|FG001|Overall Study|Protocol Violation|2|||
161690328|NCT01297270|583915802|FG002|Overall Study|Protocol Violation|0|||
161690329|NCT01297270|583915800|FG000|Overall Study|Withdrawal by Subject|7|||
161690330|NCT01297270|583915801|FG001|Overall Study|Withdrawal by Subject|15|||
161690331|NCT01297270|583915802|FG002|Overall Study|Withdrawal by Subject|7|||
161690332|NCT01297270|583915800|FG000|Overall Study|Other reason not defined above|3|||
161690333|NCT01297270|583915801|FG001|Overall Study|Other reason not defined above|3|||
161690334|NCT01297270|583915802|FG002|Overall Study|Other reason not defined above|1|||
161690335|NCT01297270|583915800|FG000|Overall Study|Not treated|0|||
161690336|NCT01297270|583915801|FG001|Overall Study|Not treated|1|||
161690337|NCT01297270|583915802|FG002|Overall Study|Not treated|0|||
161690338|NCT02432235|583915805|FG000|Overall Study|Death|1|||
161690339|NCT02432235|583915806|FG001|Overall Study|Death|1|||
161690340|NCT02432235|583915807|FG002|Overall Study|Death|2|||
161690341|NCT02432235|583915808|FG003|Overall Study|Death|2|||
161690342|NCT02432235|583915809|FG004|Overall Study|Death|1|||
161690343|NCT02432235|583915810|FG005|Overall Study|Death|3|||
161690344|NCT02432235|583915811|FG006|Overall Study|Death|11|||
161690345|NCT02432235|583915812|FG007|Overall Study|Death|15|||
161690346|NCT02432235|583915813|FG008|Overall Study|Death|15|||
161690347|NCT02432235|583915814|FG009|Overall Study|Death|3|||
161690348|NCT02432235|583915815|FG010|Overall Study|Death|1|||
161690349|NCT02432235|583915816|FG011|Overall Study|Death|0|||
161690350|NCT02432235|583915805|FG000|Overall Study|Withdrawal by Subject|0|||
161690351|NCT02432235|583915806|FG001|Overall Study|Withdrawal by Subject|1|||
161690352|NCT02432235|583915807|FG002|Overall Study|Withdrawal by Subject|0|||
161690353|NCT02432235|583915808|FG003|Overall Study|Withdrawal by Subject|0|||
161690354|NCT02432235|583915809|FG004|Overall Study|Withdrawal by Subject|0|||
161690355|NCT02432235|583915810|FG005|Overall Study|Withdrawal by Subject|2|||
161690356|NCT02432235|583915811|FG006|Overall Study|Withdrawal by Subject|5|||
161690357|NCT02432235|583915812|FG007|Overall Study|Withdrawal by Subject|3|||
161690358|NCT02432235|583915813|FG008|Overall Study|Withdrawal by Subject|1|||
161690359|NCT02432235|583915814|FG009|Overall Study|Withdrawal by Subject|0|||
161690360|NCT02432235|583915815|FG010|Overall Study|Withdrawal by Subject|0|||
161690361|NCT02432235|583915816|FG011|Overall Study|Withdrawal by Subject|0|||
161690362|NCT02432235|583915805|FG000|Overall Study|Lost to Follow-up|0|||
161956253|NCT04585269|584887449|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
161956254|NCT04585269|584887448|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
161956255|NCT04585269|584887449|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
161956256|NCT04585269|584887448|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
161690363|NCT02432235|583915806|FG001|Overall Study|Lost to Follow-up|0|||
161956257|NCT04585269|584887449|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
161690364|NCT02432235|583915807|FG002|Overall Study|Lost to Follow-up|0|||
161956258|NCT04585269|584887448|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
161690365|NCT02432235|583915808|FG003|Overall Study|Lost to Follow-up|0|||
161690366|NCT02432235|583915809|FG004|Overall Study|Lost to Follow-up|0|||
161690367|NCT02432235|583915810|FG005|Overall Study|Lost to Follow-up|1|||
161690368|NCT02432235|583915811|FG006|Overall Study|Lost to Follow-up|0|||
161690369|NCT02432235|583915812|FG007|Overall Study|Lost to Follow-up|0|||
161690370|NCT02432235|583915813|FG008|Overall Study|Lost to Follow-up|1|||
161690371|NCT02432235|583915814|FG009|Overall Study|Lost to Follow-up|0|||
161690372|NCT02432235|583915815|FG010|Overall Study|Lost to Follow-up|0|||
161690373|NCT02432235|583915816|FG011|Overall Study|Lost to Follow-up|0|||
161690374|NCT02432235|583915805|FG000|Overall Study|Miscellaneous|0|||
162030766|NCT04604132|585169480|FG000|Overall Study|Death|3|||
161690375|NCT02432235|583915806|FG001|Overall Study|Miscellaneous|0|||
161690376|NCT02432235|583915807|FG002|Overall Study|Miscellaneous|0|||
161690377|NCT02432235|583915808|FG003|Overall Study|Miscellaneous|0|||
161956259|NCT04585269|584887449|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
161956260|NCT03666988|584887452|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
161690378|NCT02432235|583915809|FG004|Overall Study|Miscellaneous|1|||
161690379|NCT02432235|583915810|FG005|Overall Study|Miscellaneous|6|||
161690380|NCT02432235|583915811|FG006|Overall Study|Miscellaneous|2|||
161690381|NCT02432235|583915812|FG007|Overall Study|Miscellaneous|2|||
161690382|NCT02432235|583915813|FG008|Overall Study|Miscellaneous|4|||
161690383|NCT02432235|583915814|FG009|Overall Study|Miscellaneous|0|||
161690384|NCT02432235|583915815|FG010|Overall Study|Miscellaneous|0|||
161690385|NCT02432235|583915816|FG011|Overall Study|Miscellaneous|1|||
161690386|NCT00401752|583915817|FG000|Overall Study|Adverse Event|2|||
161690387|NCT00401752|583915818|FG001|Overall Study|Adverse Event|5|||
161690388|NCT00401752|583915817|FG000|Overall Study|Withdrawal by Subject|2|||
161690389|NCT00401752|583915818|FG001|Overall Study|Withdrawal by Subject|6|||
161690390|NCT00401752|583915817|FG000|Overall Study|Lost to Follow-up|1|||
161690391|NCT00401752|583915818|FG001|Overall Study|Lost to Follow-up|4|||
161690392|NCT00401752|583915817|FG000|Overall Study|Development of any exclusion criteria|4|||
161690393|NCT00401752|583915818|FG001|Overall Study|Development of any exclusion criteria|2|||
161690394|NCT00401752|583915817|FG000|Overall Study|Physician Decision|1|||
161690395|NCT00401752|583915818|FG001|Overall Study|Physician Decision|1|||
161690396|NCT01895322|583915819|FG000|Overall Study|Adverse Event|1|||
161690397|NCT01895322|583915819|FG000|Overall Study|Withdrawal by Subject|2|||
161690398|NCT01895322|583915819|FG000|Overall Study|Protocol Violation|10|||
161690399|NCT01347554|583915820|FG000|Overall Study|Lack of Efficacy|7|||
161690400|NCT01347554|583915821|FG001|Overall Study|Lack of Efficacy|11|||
161690401|NCT02873936|583915822|FG000|Overall Study|Withdrew Consent|4|||
161690402|NCT02873936|583915823|FG001|Overall Study|Withdrew Consent|11|||
161690403|NCT02873936|583915824|FG002|Overall Study|Withdrew Consent|20|||
161690404|NCT02873936|583915822|FG000|Overall Study|Investigator's Discretion|3|||
161690405|NCT02873936|583915823|FG001|Overall Study|Investigator's Discretion|5|||
161690406|NCT02873936|583915824|FG002|Overall Study|Investigator's Discretion|4|||
161690407|NCT02873936|583915822|FG000|Overall Study|Adverse Event|3|||
161690408|NCT02873936|583915823|FG001|Overall Study|Adverse Event|5|||
161690409|NCT02873936|583915824|FG002|Overall Study|Adverse Event|3|||
161690410|NCT02873936|583915822|FG000|Overall Study|Protocol Violation|0|||
161690411|NCT02873936|583915823|FG001|Overall Study|Protocol Violation|1|||
161690412|NCT02873936|583915824|FG002|Overall Study|Protocol Violation|3|||
161690413|NCT02873936|583915822|FG000|Overall Study|Lost to Follow-up|1|||
161690414|NCT02873936|583915823|FG001|Overall Study|Lost to Follow-up|1|||
161690415|NCT02873936|583915824|FG002|Overall Study|Lost to Follow-up|1|||
161690416|NCT02873936|583915822|FG000|Overall Study|Non-compliance With Study Drug|1|||
161690417|NCT02873936|583915823|FG001|Overall Study|Non-compliance With Study Drug|0|||
161690418|NCT02873936|583915824|FG002|Overall Study|Non-compliance With Study Drug|1|||
161690419|NCT02873936|583915822|FG000|Overall Study|Randomized but not Dosed|1|||
161690420|NCT02873936|583915823|FG001|Overall Study|Randomized but not Dosed|0|||
161690421|NCT02873936|583915824|FG002|Overall Study|Randomized but not Dosed|0|||
161690422|NCT01505634|583915825|FG000|Overall Study|Withdrawal by Subject|2|||
161690423|NCT01505634|583915826|FG001|Overall Study|Withdrawal by Subject|5|||
161690424|NCT01505634|583915827|FG002|Overall Study|Withdrawal by Subject|1|||
161690425|NCT01505634|583915825|FG000|Overall Study|Physician Decision|1|||
161690426|NCT01505634|583915826|FG001|Overall Study|Physician Decision|1|||
161690427|NCT01505634|583915827|FG002|Overall Study|Physician Decision|0|||
161690428|NCT01505634|583915825|FG000|Overall Study|Adverse Event|1|||
161690429|NCT01505634|583915826|FG001|Overall Study|Adverse Event|0|||
161690430|NCT01505634|583915827|FG002|Overall Study|Adverse Event|0|||
161690431|NCT01505634|583915825|FG000|Overall Study|Insufficient supply of drug at site|1|||
161956261|NCT03666988|584887453|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
161956262|NCT03666988|584887454|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
161956263|NCT03666988|584887455|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
161956264|NCT03666988|584887456|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
161956265|NCT03666988|584887457|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
161690432|NCT01505634|583915826|FG001|Overall Study|Insufficient supply of drug at site|0|||
161690433|NCT01505634|583915827|FG002|Overall Study|Insufficient supply of drug at site|0|||
161690434|NCT01505634|583915825|FG000|Overall Study|Protocol Violation|2|||
161690435|NCT01505634|583915826|FG001|Overall Study|Protocol Violation|0|||
161690436|NCT01505634|583915827|FG002|Overall Study|Protocol Violation|0|||
161690437|NCT01505634|583915825|FG000|Overall Study|Lost to Follow-up|1|||
161690438|NCT01505634|583915826|FG001|Overall Study|Lost to Follow-up|4|||
161956266|NCT03666988|584887452|FG000|Part 1 (Up to 28 Months)|Other|0|||
161690439|NCT01505634|583915827|FG002|Overall Study|Lost to Follow-up|4|||
161690440|NCT01505634|583915825|FG000|Overall Study|Death|1|||
161690441|NCT01505634|583915826|FG001|Overall Study|Death|0|||
161836286|NCT03573505|584442913|FG000|Overall Study|Death|0|||
161690442|NCT01505634|583915827|FG002|Overall Study|Death|0|||
161956267|NCT03666988|584887453|FG001|Part 1 (Up to 28 Months)|Other|1|||
161690443|NCT01505634|583915825|FG000|Overall Study|In a conflict zone|0|||
161690444|NCT01505634|583915826|FG001|Overall Study|In a conflict zone|0|||
161690445|NCT01505634|583915827|FG002|Overall Study|In a conflict zone|1|||
161690446|NCT02054897|583915828|FG000|Overall Study|Withdrawal by Subject|2|||
161690447|NCT02054897|583915829|FG001|Overall Study|Withdrawal by Subject|0|||
161690448|NCT02054897|583915830|FG002|Overall Study|Withdrawal by Subject|2|||
161690449|NCT02054897|583915828|FG000|Overall Study|Missing follow-up information|3|||
161690450|NCT02054897|583915829|FG001|Overall Study|Missing follow-up information|5|||
161690451|NCT02054897|583915830|FG002|Overall Study|Missing follow-up information|3|||
161690452|NCT02054897|583915828|FG000|Overall Study|Lost to Follow-up|4|||
161690453|NCT02054897|583915829|FG001|Overall Study|Lost to Follow-up|2|||
161690454|NCT02054897|583915830|FG002|Overall Study|Lost to Follow-up|7|||
161690455|NCT02054897|583915828|FG000|Overall Study|Randomized but not exposed|1|||
161690456|NCT02054897|583915829|FG001|Overall Study|Randomized but not exposed|0|||
161690457|NCT02054897|583915830|FG002|Overall Study|Randomized but not exposed|0|||
161690458|NCT00960843|583915831|FG000|Overall Study|Lost to Follow-up|2|||
161836287|NCT03573505|584442914|FG001|Overall Study|Death|4|||
161836288|NCT00515541|584442915|FG000|Overall Study|Physician Decision|0|||
161836289|NCT00515541|584442916|FG001|Overall Study|Physician Decision|2|||
161836290|NCT00515541|584442917|FG002|Overall Study|Physician Decision|0|||
161836291|NCT00515541|584442918|FG003|Overall Study|Physician Decision|1|||
161836292|NCT00515541|584442915|FG000|Overall Study|No show for appointments|0|||
161836293|NCT00515541|584442916|FG001|Overall Study|No show for appointments|1|||
161836294|NCT00515541|584442917|FG002|Overall Study|No show for appointments|0|||
161836295|NCT00515541|584442918|FG003|Overall Study|No show for appointments|2|||
161836296|NCT00515541|584442915|FG000|Overall Study|Withdrawal by Subject|0|||
161836297|NCT00515541|584442916|FG001|Overall Study|Withdrawal by Subject|2|||
161836298|NCT00515541|584442917|FG002|Overall Study|Withdrawal by Subject|0|||
161836299|NCT00515541|584442918|FG003|Overall Study|Withdrawal by Subject|2|||
161836300|NCT02145026|584442920|FG000|Overall Study|Adverse Event|2|||
161836301|NCT02145026|584442920|FG000|Overall Study|Death|4|||
161836302|NCT02145026|584442920|FG000|Overall Study|Withdrawal by Subject|2|||
161836303|NCT02145026|584442920|FG000|Overall Study|Physician Decision|4|||
161836304|NCT03052322|584442921|FG000|Overall Study|Other un-specified|1|||
161836305|NCT03052322|584442922|FG001|Overall Study|Other un-specified|2|||
161836306|NCT03052322|584442921|FG000|Overall Study|Withdrawal by Subject|10|||
161836307|NCT03052322|584442922|FG001|Overall Study|Withdrawal by Subject|9|||
161836308|NCT03052322|584442921|FG000|Overall Study|Death|0|||
161836309|NCT03052322|584442922|FG001|Overall Study|Death|2|||
161836310|NCT03052322|584442921|FG000|Overall Study|Lack of Efficacy|1|||
161836311|NCT03052322|584442922|FG001|Overall Study|Lack of Efficacy|2|||
161836312|NCT03052322|584442921|FG000|Overall Study|Protocol Violation|1|||
161836313|NCT03052322|584442922|FG001|Overall Study|Protocol Violation|0|||
161836314|NCT03052322|584442921|FG000|Overall Study|Lost to Follow-up|2|||
161836315|NCT03052322|584442922|FG001|Overall Study|Lost to Follow-up|4|||
161836316|NCT03052322|584442921|FG000|Overall Study|Adverse Event|6|||
161836317|NCT03052322|584442922|FG001|Overall Study|Adverse Event|13|||
161836318|NCT05065983|584442923|FG000|Overall Study|Lost to Follow-up|2|||
161836319|NCT00003875|584442926|FG000|Overall Study|Screen Failed|1|||
161836320|NCT01546649|584442927|FG000|Overall Study|Adverse Event|4|||
161836321|NCT01546649|584442928|FG001|Overall Study|Adverse Event|5|||
161836322|NCT01546649|584442927|FG000|Overall Study|Protocol Violation|1|||
161836323|NCT01546649|584442928|FG001|Overall Study|Protocol Violation|0|||
161836324|NCT01546649|584442927|FG000|Overall Study|Lack of Efficacy|1|||
161836325|NCT01546649|584442928|FG001|Overall Study|Lack of Efficacy|0|||
161836326|NCT01546649|584442927|FG000|Overall Study|Recurrence|1|||
161836327|NCT01546649|584442928|FG001|Overall Study|Recurrence|1|||
161836328|NCT01546649|584442927|FG000|Overall Study|Discovery of secondary cancer|0|||
161836329|NCT01546649|584442928|FG001|Overall Study|Discovery of secondary cancer|1|||
161836330|NCT01546649|584442927|FG000|Overall Study|Withdrawal by Subject|1|||
162030767|NCT04604132|585169481|FG001|Overall Study|Death|1|||
162030768|NCT04604132|585169482|FG002|Overall Study|Death|2|||
161836331|NCT01546649|584442928|FG001|Overall Study|Withdrawal by Subject|2|||
161836332|NCT00706381|584442931|FG000|Overall Study|Lost to Follow-up|0|||
161836333|NCT00706381|584442932|FG001|Overall Study|Lost to Follow-up|1|||
161690459|NCT00960843|583915832|FG001|Overall Study|Lost to Follow-up|0|||
161690460|NCT00960843|583915831|FG000|Overall Study|Protocol Violation|0|||
161690461|NCT00960843|583915832|FG001|Overall Study|Protocol Violation|4|||
161690462|NCT00960843|583915831|FG000|Overall Study|Repeated needle dislodgment|0|||
161690463|NCT00960843|583915832|FG001|Overall Study|Repeated needle dislodgment|1|||
161690464|NCT00254501|583915833|FG000|Overall Study|Lost to Follow-up|1|||
161836334|NCT00706381|584442933|FG002|Overall Study|Lost to Follow-up|1|||
161836335|NCT00706381|584442934|FG003|Overall Study|Lost to Follow-up|0|||
161836336|NCT05420012|584442935|FG000|Overall Study|Lost to Follow-up|0|||
161836337|NCT05420012|584442936|FG001|Overall Study|Lost to Follow-up|1|||
161836338|NCT00038649|584442940|FG000|Overall Study|Adverse Event|9|||
161836339|NCT03395639|584442941|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
161836340|NCT03395639|584442942|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
161836341|NCT03395639|584442943|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
161690465|NCT00254501|583915834|FG001|Overall Study|Lost to Follow-up|1|||
161690466|NCT00879697|583915836|FG000|Overall Study|Physician Decision|2|||
161690467|NCT00879697|583915837|FG001|Overall Study|Physician Decision|2|||
161690468|NCT01836783|583915840|FG000|Overall Study|Withdrawal by Subject|0|||
161690469|NCT01836783|583915841|FG001|Overall Study|Withdrawal by Subject|2|||
161690470|NCT01100437|583915847|FG000|Titration/Stabilization|Adverse Event|0|||
161690471|NCT01100437|583915848|FG001|Titration/Stabilization|Adverse Event|0|||
161690472|NCT01100437|583915849|FG002|Titration/Stabilization|Adverse Event|4|||
161690473|NCT01100437|583915847|FG000|Titration/Stabilization|Non-compliance|0|||
161690474|NCT01100437|583915848|FG001|Titration/Stabilization|Non-compliance|0|||
161690475|NCT01100437|583915849|FG002|Titration/Stabilization|Non-compliance|1|||
161690476|NCT01100437|583915847|FG000|Titration/Stabilization|Sponsor canceled study|0|||
161690477|NCT01100437|583915848|FG001|Titration/Stabilization|Sponsor canceled study|0|||
161690478|NCT01100437|583915849|FG002|Titration/Stabilization|Sponsor canceled study|1|||
161690479|NCT01100437|583915847|FG000|Maintenance|Withdrawal by Subject|0|||
161690480|NCT01100437|583915848|FG001|Maintenance|Withdrawal by Subject|0|||
161690481|NCT01100437|583915849|FG002|Maintenance|Withdrawal by Subject|1|||
161690482|NCT01100437|583915847|FG000|Maintenance|Sponsor termination of study|0|||
161690483|NCT01100437|583915848|FG001|Maintenance|Sponsor termination of study|0|||
161690484|NCT01100437|583915849|FG002|Maintenance|Sponsor termination of study|1|||
161690485|NCT01014689|583915852|FG000|Overall Study|Lack of Efficacy|0|||
161690486|NCT01014689|583915853|FG001|Overall Study|Lack of Efficacy|1|||
161690487|NCT01014689|583915852|FG000|Overall Study|Adverse Event|3|||
161690488|NCT01014689|583915853|FG001|Overall Study|Adverse Event|0|||
161690489|NCT01014689|583915852|FG000|Overall Study|Withdrawal by Subject|5|||
161690490|NCT01014689|583915853|FG001|Overall Study|Withdrawal by Subject|4|||
161690491|NCT01014689|583915852|FG000|Overall Study|Protocol Violation|1|||
161690492|NCT01014689|583915853|FG001|Overall Study|Protocol Violation|1|||
161690493|NCT01014689|583915852|FG000|Overall Study|Lost to Follow-up|3|||
161690494|NCT01014689|583915853|FG001|Overall Study|Lost to Follow-up|7|||
161690495|NCT01014689|583915852|FG000|Overall Study|Pregnancy|1|||
161690496|NCT01014689|583915853|FG001|Overall Study|Pregnancy|0|||
161690497|NCT04418076|583915855|FG000|Overall Study|Death|1|||
161690498|NCT04418076|583915856|FG001|Overall Study|Death|0|||
161690499|NCT04418076|583915857|FG002|Overall Study|Death|0|||
161690500|NCT04418076|583915858|FG003|Overall Study|Death|0|||
161690501|NCT04418076|583915855|FG000|Overall Study|Lost to Follow-up|2|||
161690502|NCT04418076|583915856|FG001|Overall Study|Lost to Follow-up|5|||
161690503|NCT04418076|583915857|FG002|Overall Study|Lost to Follow-up|1|||
161690504|NCT04418076|583915858|FG003|Overall Study|Lost to Follow-up|2|||
161690505|NCT04418076|583915855|FG000|Overall Study|Withdrawal by Subject|1|||
161690506|NCT04418076|583915856|FG001|Overall Study|Withdrawal by Subject|0|||
161690507|NCT04418076|583915857|FG002|Overall Study|Withdrawal by Subject|1|||
161690508|NCT04418076|583915858|FG003|Overall Study|Withdrawal by Subject|1|||
161690509|NCT04418076|583915855|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
161690510|NCT04418076|583915856|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
161690511|NCT04418076|583915857|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
161690512|NCT04418076|583915858|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
161690513|NCT01452152|583915861|FG000|Overall Study|Study termination by sponsor|5|||
161690514|NCT01452152|583915862|FG001|Overall Study|Study termination by sponsor|0|||
161690515|NCT01452152|583915863|FG002|Overall Study|Study termination by sponsor|4|||
161690516|NCT00328627|583918742|FG000|Overall Study|Hyperglycemic Rescue|41|||
161690517|NCT00328627|583918743|FG001|Overall Study|Hyperglycemic Rescue|18|||
161690518|NCT00328627|583918744|FG002|Overall Study|Hyperglycemic Rescue|16|||
161690519|NCT00328627|583918745|FG003|Overall Study|Hyperglycemic Rescue|13|||
161690520|NCT00328627|583918746|FG004|Overall Study|Hyperglycemic Rescue|6|||
161690521|NCT00328627|583918747|FG005|Overall Study|Hyperglycemic Rescue|5|||
161690522|NCT00328627|583918748|FG006|Overall Study|Hyperglycemic Rescue|19|||
161690523|NCT00328627|583918749|FG007|Overall Study|Hyperglycemic Rescue|6|||
161690524|NCT00328627|583918750|FG008|Overall Study|Hyperglycemic Rescue|6|||
161690525|NCT00328627|583918751|FG009|Overall Study|Hyperglycemic Rescue|11|||
161956268|NCT03666988|584887454|FG002|Part 1 (Up to 28 Months)|Other|1|||
161690526|NCT00328627|583918752|FG010|Overall Study|Hyperglycemic Rescue|3|||
161690527|NCT00328627|583918753|FG011|Overall Study|Hyperglycemic Rescue|2|||
161690528|NCT00328627|583918742|FG000|Overall Study|Adverse Event|3|||
161690529|NCT00328627|583918743|FG001|Overall Study|Adverse Event|1|||
161690530|NCT00328627|583918744|FG002|Overall Study|Adverse Event|2|||
161690531|NCT00328627|583918745|FG003|Overall Study|Adverse Event|3|||
161690532|NCT00328627|583918746|FG004|Overall Study|Adverse Event|1|||
161956269|NCT03666988|584887455|FG003|Part 1 (Up to 28 Months)|Other|0|||
161956270|NCT03666988|584887456|FG004|Part 1 (Up to 28 Months)|Other|0|||
161690533|NCT00328627|583918747|FG005|Overall Study|Adverse Event|2|||
161690534|NCT00328627|583918748|FG006|Overall Study|Adverse Event|1|||
161690535|NCT00328627|583918749|FG007|Overall Study|Adverse Event|2|||
161690536|NCT00328627|583918750|FG008|Overall Study|Adverse Event|0|||
161690537|NCT00328627|583918751|FG009|Overall Study|Adverse Event|7|||
161956271|NCT03666988|584887457|FG005|Part 1 (Up to 28 Months)|Other|0|||
161690538|NCT00328627|583918752|FG010|Overall Study|Adverse Event|5|||
161690539|NCT00328627|583918753|FG011|Overall Study|Adverse Event|4|||
161690540|NCT00328627|583918742|FG000|Overall Study|Protocol Violation|2|||
161690541|NCT00328627|583918743|FG001|Overall Study|Protocol Violation|2|||
161690542|NCT00328627|583918744|FG002|Overall Study|Protocol Violation|2|||
161690543|NCT00328627|583918745|FG003|Overall Study|Protocol Violation|8|||
161690544|NCT00328627|583918746|FG004|Overall Study|Protocol Violation|5|||
161690545|NCT00328627|583918747|FG005|Overall Study|Protocol Violation|5|||
161690546|NCT00328627|583918748|FG006|Overall Study|Protocol Violation|6|||
161690547|NCT00328627|583918749|FG007|Overall Study|Protocol Violation|2|||
161690548|NCT00328627|583918750|FG008|Overall Study|Protocol Violation|1|||
161690549|NCT00328627|583918751|FG009|Overall Study|Protocol Violation|4|||
161690550|NCT00328627|583918752|FG010|Overall Study|Protocol Violation|6|||
161690551|NCT00328627|583918753|FG011|Overall Study|Protocol Violation|2|||
161690552|NCT00328627|583918742|FG000|Overall Study|Lost to Follow-up|4|||
161690553|NCT00328627|583918743|FG001|Overall Study|Lost to Follow-up|2|||
161690554|NCT00328627|583918744|FG002|Overall Study|Lost to Follow-up|2|||
161690555|NCT00328627|583918745|FG003|Overall Study|Lost to Follow-up|4|||
161690556|NCT00328627|583918746|FG004|Overall Study|Lost to Follow-up|0|||
161690557|NCT00328627|583918747|FG005|Overall Study|Lost to Follow-up|2|||
161690558|NCT00328627|583918748|FG006|Overall Study|Lost to Follow-up|3|||
161690559|NCT00328627|583918749|FG007|Overall Study|Lost to Follow-up|0|||
161690560|NCT00328627|583918750|FG008|Overall Study|Lost to Follow-up|3|||
161690561|NCT00328627|583918751|FG009|Overall Study|Lost to Follow-up|2|||
161690562|NCT00328627|583918752|FG010|Overall Study|Lost to Follow-up|0|||
161690563|NCT00328627|583918753|FG011|Overall Study|Lost to Follow-up|1|||
161690564|NCT00328627|583918742|FG000|Overall Study|Withdrawal by Subject|5|||
161690565|NCT00328627|583918743|FG001|Overall Study|Withdrawal by Subject|4|||
161690566|NCT00328627|583918744|FG002|Overall Study|Withdrawal by Subject|5|||
161690567|NCT00328627|583918745|FG003|Overall Study|Withdrawal by Subject|6|||
161690568|NCT00328627|583918746|FG004|Overall Study|Withdrawal by Subject|2|||
161690569|NCT00328627|583918747|FG005|Overall Study|Withdrawal by Subject|5|||
161690570|NCT00328627|583918748|FG006|Overall Study|Withdrawal by Subject|4|||
161690571|NCT00328627|583918749|FG007|Overall Study|Withdrawal by Subject|4|||
161690572|NCT00328627|583918750|FG008|Overall Study|Withdrawal by Subject|4|||
161690573|NCT00328627|583918751|FG009|Overall Study|Withdrawal by Subject|5|||
161690574|NCT00328627|583918752|FG010|Overall Study|Withdrawal by Subject|2|||
161690575|NCT00328627|583918753|FG011|Overall Study|Withdrawal by Subject|7|||
161690576|NCT00328627|583918742|FG000|Overall Study|Pregnancy|0|||
161690577|NCT00328627|583918743|FG001|Overall Study|Pregnancy|1|||
161690578|NCT00328627|583918744|FG002|Overall Study|Pregnancy|0|||
161690579|NCT00328627|583918745|FG003|Overall Study|Pregnancy|0|||
161690580|NCT00328627|583918746|FG004|Overall Study|Pregnancy|0|||
161690581|NCT00328627|583918747|FG005|Overall Study|Pregnancy|0|||
161690582|NCT00328627|583918748|FG006|Overall Study|Pregnancy|0|||
161690583|NCT00328627|583918749|FG007|Overall Study|Pregnancy|0|||
161690584|NCT00328627|583918750|FG008|Overall Study|Pregnancy|0|||
161690585|NCT00328627|583918751|FG009|Overall Study|Pregnancy|0|||
161690586|NCT00328627|583918752|FG010|Overall Study|Pregnancy|0|||
161690587|NCT00328627|583918753|FG011|Overall Study|Pregnancy|0|||
161690588|NCT00328627|583918742|FG000|Overall Study|Physician Decision|4|||
161690589|NCT00328627|583918743|FG001|Overall Study|Physician Decision|3|||
161690590|NCT00328627|583918744|FG002|Overall Study|Physician Decision|1|||
161690591|NCT00328627|583918745|FG003|Overall Study|Physician Decision|2|||
161690592|NCT00328627|583918746|FG004|Overall Study|Physician Decision|1|||
161690593|NCT00328627|583918747|FG005|Overall Study|Physician Decision|1|||
161690594|NCT00328627|583918748|FG006|Overall Study|Physician Decision|1|||
161690595|NCT00328627|583918749|FG007|Overall Study|Physician Decision|0|||
161690596|NCT00328627|583918750|FG008|Overall Study|Physician Decision|3|||
161690597|NCT00328627|583918751|FG009|Overall Study|Physician Decision|2|||
161690598|NCT00328627|583918752|FG010|Overall Study|Physician Decision|1|||
161690599|NCT00328627|583918753|FG011|Overall Study|Physician Decision|0|||
161690600|NCT00328627|583918742|FG000|Overall Study|Other|0|||
161690601|NCT00328627|583918743|FG001|Overall Study|Other|0|||
161690602|NCT00328627|583918744|FG002|Overall Study|Other|0|||
161690603|NCT00328627|583918745|FG003|Overall Study|Other|1|||
161690604|NCT00328627|583918746|FG004|Overall Study|Other|0|||
161690605|NCT00328627|583918747|FG005|Overall Study|Other|0|||
161690606|NCT00328627|583918748|FG006|Overall Study|Other|1|||
161690607|NCT00328627|583918749|FG007|Overall Study|Other|0|||
161690608|NCT00328627|583918750|FG008|Overall Study|Other|0|||
161690609|NCT00328627|583918751|FG009|Overall Study|Other|1|||
161690610|NCT00328627|583918752|FG010|Overall Study|Other|1|||
161690611|NCT00328627|583918753|FG011|Overall Study|Other|0|||
161690612|NCT02049944|583918754|FG000|Overall Study|Protocol Violation|2|||
161690613|NCT03691974|583918757|FG000|Overall Study|Physician Decision|1|||
161956272|NCT03666988|584887452|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
161690614|NCT03691974|583918758|FG001|Overall Study|Physician Decision|0|||
161690615|NCT03691974|583918757|FG000|Overall Study|Adverse Event|1|||
161690616|NCT03691974|583918758|FG001|Overall Study|Adverse Event|0|||
161690617|NCT03691974|583918757|FG000|Overall Study|Withdrawal by Subject|11|||
161690618|NCT03691974|583918758|FG001|Overall Study|Withdrawal by Subject|9|||
161956273|NCT03666988|584887453|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
161956274|NCT03666988|584887454|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
161956275|NCT03666988|584887455|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
161956276|NCT03666988|584887456|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
161956277|NCT03666988|584887457|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
161956278|NCT03666988|584887452|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
161956279|NCT03666988|584887453|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
161956280|NCT03666988|584887454|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
161690619|NCT03691974|583918757|FG000|Overall Study|Protocol Violation|1|||
161690620|NCT03691974|583918758|FG001|Overall Study|Protocol Violation|0|||
161690621|NCT03691974|583918757|FG000|Overall Study|Lost to Follow-up|8|||
161690622|NCT03691974|583918758|FG001|Overall Study|Lost to Follow-up|7|||
161690623|NCT00513409|583918759|FG000|Overall Study|Adverse Event|0|||
161690624|NCT00513409|583918760|FG001|Overall Study|Adverse Event|1|||
161690625|NCT00513409|583918759|FG000|Overall Study|Withdrawal by Subject|0|||
161690626|NCT00513409|583918760|FG001|Overall Study|Withdrawal by Subject|2|||
161690627|NCT00513409|583918759|FG000|Overall Study|Lost to Follow-up|0|||
161690628|NCT00513409|583918760|FG001|Overall Study|Lost to Follow-up|1|||
161690629|NCT00513409|583918759|FG000|Overall Study|Physician Decision|1|||
161690630|NCT00513409|583918760|FG001|Overall Study|Physician Decision|0|||
161690631|NCT00513409|583918759|FG000|Overall Study|Visit 3 not done|1|||
161690632|NCT00513409|583918760|FG001|Overall Study|Visit 3 not done|2|||
161690633|NCT00691483|583918761|FG000|Overall Study|Adverse Event|14|||
161690634|NCT00691483|583918762|FG001|Overall Study|Adverse Event|6|||
161690635|NCT00691483|583918761|FG000|Overall Study|Lost to Follow-up|17|||
161690636|NCT00691483|583918762|FG001|Overall Study|Lost to Follow-up|10|||
161690637|NCT00691483|583918761|FG000|Overall Study|Withdrawal by Subject|24|||
161690638|NCT00691483|583918762|FG001|Overall Study|Withdrawal by Subject|7|||
161690639|NCT00691483|583918761|FG000|Overall Study|Other known cause|6|||
161690640|NCT00691483|583918762|FG001|Overall Study|Other known cause|1|||
161690641|NCT00691483|583918761|FG000|Overall Study|Randomized by not treated|7|||
161690642|NCT00691483|583918762|FG001|Overall Study|Randomized by not treated|1|||
161690643|NCT04623242|583918763|FG000|Overall Study|Withdrawal by Subject|7|||
161690644|NCT04623242|583918764|FG001|Overall Study|Withdrawal by Subject|12|||
161690645|NCT04623242|583918765|FG002|Overall Study|Withdrawal by Subject|5|||
161690646|NCT04623242|583918766|FG003|Overall Study|Withdrawal by Subject|7|||
161690647|NCT04623242|583918767|FG004|Overall Study|Withdrawal by Subject|0|||
161690648|NCT04623242|583918763|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
161690649|NCT04623242|583918764|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
161690650|NCT04623242|583918765|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
161690651|NCT04623242|583918766|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
161690652|NCT04623242|583918767|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
161690653|NCT04623242|583918763|FG000|Overall Study|Subject unblinded to mutation status|0|||
161690654|NCT04623242|583918764|FG001|Overall Study|Subject unblinded to mutation status|0|||
161690655|NCT04623242|583918765|FG002|Overall Study|Subject unblinded to mutation status|0|||
161690656|NCT04623242|583918766|FG003|Overall Study|Subject unblinded to mutation status|13|||
161690657|NCT04623242|583918767|FG004|Overall Study|Subject unblinded to mutation status|0|||
161690658|NCT02921971|583918770|FG000|Overall Study|Adverse Event|1|||
161690659|NCT02921971|583918771|FG001|Overall Study|Adverse Event|2|||
161690660|NCT02921971|583918770|FG000|Overall Study|Lack of Efficacy|3|||
161690661|NCT02921971|583918771|FG001|Overall Study|Lack of Efficacy|1|||
161690662|NCT02921971|583918770|FG000|Overall Study|Other than specified above|2|||
161690663|NCT02921971|583918771|FG001|Overall Study|Other than specified above|1|||
161690664|NCT02105454|583918772|FG000|Overall Study|Withdrawal by Subject|1|||
161690665|NCT00326898|583918773|FG000|Overall Study|Disease progression|52|||
161690666|NCT00326898|583918774|FG001|Overall Study|Disease progression|54|||
161690667|NCT00326898|583918775|FG002|Overall Study|Disease progression|102|||
161690668|NCT00326898|583918773|FG000|Overall Study|Adverse Event|124|||
161690669|NCT00326898|583918774|FG001|Overall Study|Adverse Event|128|||
161690670|NCT00326898|583918775|FG002|Overall Study|Adverse Event|33|||
161690671|NCT00326898|583918773|FG000|Overall Study|Death|2|||
161690672|NCT00326898|583918774|FG001|Overall Study|Death|0|||
161690673|NCT00326898|583918775|FG002|Overall Study|Death|0|||
161690674|NCT00326898|583918773|FG000|Overall Study|Withdrawal by Subject|134|||
161690675|NCT00326898|583918774|FG001|Overall Study|Withdrawal by Subject|128|||
161690676|NCT00326898|583918775|FG002|Overall Study|Withdrawal by Subject|32|||
161690677|NCT00326898|583918773|FG000|Overall Study|Alternative therapy|1|||
161690678|NCT00326898|583918774|FG001|Overall Study|Alternative therapy|0|||
161690679|NCT00326898|583918775|FG002|Overall Study|Alternative therapy|0|||
161690680|NCT00326898|583918773|FG000|Overall Study|Other complicating disease|5|||
161690681|NCT00326898|583918774|FG001|Overall Study|Other complicating disease|5|||
161956281|NCT03666988|584887455|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
161690682|NCT00326898|583918775|FG002|Overall Study|Other complicating disease|4|||
162030769|NCT04604132|585169483|FG003|Overall Study|Death|1|||
161690683|NCT00326898|583918773|FG000|Overall Study|Other/Missing/Unknown|33|||
161690684|NCT00326898|583918774|FG001|Overall Study|Other/Missing/Unknown|28|||
161690685|NCT00326898|583918775|FG002|Overall Study|Other/Missing/Unknown|32|||
161690686|NCT03847987|583918776|FG000|Overall Study|Lost to Follow-up|1|||
161690687|NCT03847987|583918777|FG001|Overall Study|Lost to Follow-up|0|||
161690688|NCT03847987|583918776|FG000|Overall Study|Adverse Event|2|||
161690689|NCT03847987|583918777|FG001|Overall Study|Adverse Event|0|||
161690690|NCT02721355|583918780|FG000|Overall Study|Lost to Follow-up|6|||
161690691|NCT02721355|583918781|FG001|Overall Study|Lost to Follow-up|1|||
161690692|NCT00356278|583918782|FG000|Overall Study|Withdrawal by Subject|25|||
161690693|NCT00356278|583918783|FG001|Overall Study|Withdrawal by Subject|15|||
161690694|NCT00356278|583918784|FG002|Overall Study|Withdrawal by Subject|19|||
161690695|NCT00687362|583918791|FG000|Overall Study|Protocol Violation|2|||
161690696|NCT00687362|583918791|FG000|Overall Study|Withdrawal by Subject|1|||
161690697|NCT01268293|583918796|FG000|Overall Study|Disease progression|7|||
161690698|NCT01268293|583918796|FG000|Overall Study|Adverse Event|1|||
161690699|NCT01268293|583918796|FG000|Overall Study|Subject choice|1|||
161690700|NCT02597855|583918797|FG000|Overall Study|Lost to Follow-up|2|||
161690701|NCT02597855|583918798|FG001|Overall Study|Lost to Follow-up|1|||
161690702|NCT01777152|583918800|FG000|Overall Study|Withdrawal by Subject|22|||
161690703|NCT01777152|583918801|FG001|Overall Study|Withdrawal by Subject|16|||
161690704|NCT01777152|583918800|FG000|Overall Study|Lost to Follow-up|3|||
161690705|NCT01777152|583918801|FG001|Overall Study|Lost to Follow-up|5|||
161690706|NCT01777152|583918800|FG000|Overall Study|Death|68|||
161690707|NCT01777152|583918801|FG001|Overall Study|Death|89|||
161956282|NCT03666988|584887456|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
161956283|NCT03666988|584887457|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
161956284|NCT03666988|584887452|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
161690708|NCT01777152|583918800|FG000|Overall Study|Not eligible, no study drug received|1|||
161690709|NCT01777152|583918801|FG001|Overall Study|Not eligible, no study drug received|0|||
161690710|NCT01777152|583918800|FG000|Overall Study|Change of diagnosis|1|||
161690711|NCT01777152|583918801|FG001|Overall Study|Change of diagnosis|0|||
161690712|NCT05882318|583918804|FG000|Overall Study|Withdrawal by Subject|1|||
161690713|NCT05882318|583918805|FG001|Overall Study|Withdrawal by Subject|0|||
161690714|NCT05882318|583918804|FG000|Overall Study|Protocol Violation|0|||
161690715|NCT05882318|583918805|FG001|Overall Study|Protocol Violation|1|||
161690716|NCT03042468|583918806|FG000|Overall Study|Death|0|||
161690717|NCT03042468|583918807|FG001|Overall Study|Death|1|||
161690718|NCT03042468|583918808|FG002|Overall Study|Death|1|||
161690719|NCT03042468|583918809|FG003|Overall Study|Death|0|||
161690720|NCT03042468|583918810|FG004|Overall Study|Death|0|||
161690721|NCT03042468|583918811|FG005|Overall Study|Death|0|||
161690722|NCT03042468|583918806|FG000|Overall Study|Withdrawal by Subject|0|||
161690723|NCT03042468|583918807|FG001|Overall Study|Withdrawal by Subject|0|||
161690724|NCT03042468|583918808|FG002|Overall Study|Withdrawal by Subject|0|||
161690725|NCT03042468|583918809|FG003|Overall Study|Withdrawal by Subject|0|||
161690726|NCT03042468|583918810|FG004|Overall Study|Withdrawal by Subject|0|||
161690727|NCT03042468|583918811|FG005|Overall Study|Withdrawal by Subject|1|||
161690728|NCT03042468|583918806|FG000|Overall Study|Lost to Follow-up|0|||
161690729|NCT03042468|583918807|FG001|Overall Study|Lost to Follow-up|0|||
161690730|NCT03042468|583918808|FG002|Overall Study|Lost to Follow-up|0|||
161690731|NCT03042468|583918809|FG003|Overall Study|Lost to Follow-up|0|||
161690732|NCT03042468|583918810|FG004|Overall Study|Lost to Follow-up|1|||
161690733|NCT03042468|583918811|FG005|Overall Study|Lost to Follow-up|1|||
161690734|NCT01485627|583918812|FG000|Overall Study|Patient withdrew|6|||
161690735|NCT01485627|583918813|FG001|Overall Study|Patient withdrew|5|||
161690736|NCT01485627|583918812|FG000|Overall Study|Patient died|3|||
161690737|NCT01485627|583918813|FG001|Overall Study|Patient died|1|||
161690738|NCT01485627|583918812|FG000|Overall Study|Patient lost to followup|0|||
161956285|NCT03666988|584887453|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
161690739|NCT01485627|583918813|FG001|Overall Study|Patient lost to followup|1|||
161690740|NCT01485627|583918812|FG000|Overall Study|Caregiver withdrew|3|||
161690741|NCT01485627|583918813|FG001|Overall Study|Caregiver withdrew|3|||
161956286|NCT03666988|584887454|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
161956287|NCT03666988|584887455|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
161956288|NCT03666988|584887456|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
161956289|NCT03666988|584887457|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
161690742|NCT01485627|583918812|FG000|Overall Study|Caregiver lost to follow up|11|||
161690743|NCT01485627|583918813|FG001|Overall Study|Caregiver lost to follow up|12|||
161690744|NCT01485627|583918812|FG000|Overall Study|Caregiver died|1|||
161690745|NCT01485627|583918813|FG001|Overall Study|Caregiver died|0|||
161690746|NCT01485627|583918812|FG000|Overall Study|caregiver was not bereaved|42|||
161690747|NCT01485627|583918813|FG001|Overall Study|caregiver was not bereaved|35|||
161690748|NCT00267748|583918815|FG000|Non-randomized Period|Progressive disease|10|||
161690749|NCT00267748|583918816|FG001|Non-randomized Period|Progressive disease|0|||
161690750|NCT00267748|583918817|FG002|Non-randomized Period|Progressive disease|0|||
161690751|NCT00267748|583918815|FG000|Non-randomized Period|Adverse Event|8|||
161690752|NCT00267748|583918816|FG001|Non-randomized Period|Adverse Event|0|||
161690753|NCT00267748|583918817|FG002|Non-randomized Period|Adverse Event|0|||
161690754|NCT00267748|583918815|FG000|Non-randomized Period|Death|1|||
161690755|NCT00267748|583918816|FG001|Non-randomized Period|Death|0|||
161690756|NCT00267748|583918817|FG002|Non-randomized Period|Death|0|||
161690757|NCT00267748|583918815|FG000|Non-randomized Period|Participant not willing to participate|1|||
161690758|NCT00267748|583918816|FG001|Non-randomized Period|Participant not willing to participate|0|||
161690759|NCT00267748|583918817|FG002|Non-randomized Period|Participant not willing to participate|0|||
161690760|NCT00267748|583918815|FG000|Non-randomized Period|Other|3|||
161690761|NCT00267748|583918816|FG001|Non-randomized Period|Other|0|||
161690762|NCT00267748|583918817|FG002|Non-randomized Period|Other|0|||
161690763|NCT00267748|583918815|FG000|Randomized Period|Death|0|||
161690764|NCT00267748|583918816|FG001|Randomized Period|Death|2|||
161690765|NCT00267748|583918817|FG002|Randomized Period|Death|3|||
161690766|NCT00267748|583918815|FG000|Randomized Period|Adverse Event|0|||
161690767|NCT00267748|583918816|FG001|Randomized Period|Adverse Event|23|||
161690768|NCT00267748|583918817|FG002|Randomized Period|Adverse Event|25|||
161690769|NCT00267748|583918815|FG000|Randomized Period|Global deterioration of health status|0|||
161690770|NCT00267748|583918816|FG001|Randomized Period|Global deterioration of health status|6|||
161690771|NCT00267748|583918817|FG002|Randomized Period|Global deterioration of health status|7|||
161690772|NCT00267748|583918815|FG000|Randomized Period|Lost to Follow-up|0|||
161690773|NCT00267748|583918816|FG001|Randomized Period|Lost to Follow-up|1|||
161690774|NCT00267748|583918817|FG002|Randomized Period|Lost to Follow-up|0|||
161690775|NCT00267748|583918815|FG000|Randomized Period|Objective progression or relapse|0|||
161690776|NCT00267748|583918816|FG001|Randomized Period|Objective progression or relapse|77|||
161690777|NCT00267748|583918817|FG002|Randomized Period|Objective progression or relapse|86|||
161690778|NCT00267748|583918815|FG000|Randomized Period|Withdrawal by Subject|0|||
161690779|NCT00267748|583918816|FG001|Randomized Period|Withdrawal by Subject|9|||
161690780|NCT00267748|583918817|FG002|Randomized Period|Withdrawal by Subject|2|||
161690781|NCT00267748|583918815|FG000|Randomized Period|Other|0|||
161690782|NCT00267748|583918816|FG001|Randomized Period|Other|9|||
161690783|NCT00267748|583918817|FG002|Randomized Period|Other|6|||
161690784|NCT00267748|583918815|FG000|Randomized Period|randomized but not treated|0|||
161690785|NCT00267748|583918816|FG001|Randomized Period|randomized but not treated|0|||
161690786|NCT00267748|583918817|FG002|Randomized Period|randomized but not treated|3|||
161690787|NCT01665807|583918823|FG000|Overall Study|Withdrawal by Subject|2|||
161690788|NCT01665807|583918824|FG001|Overall Study|Withdrawal by Subject|0|||
161690789|NCT01665807|583918825|FG002|Overall Study|Withdrawal by Subject|1|||
161690790|NCT03603496|583918826|FG000|Overall Study|Death|19|||
161690791|NCT03603496|583918827|FG001|Overall Study|Death|24|||
161690792|NCT03603496|583918826|FG000|Overall Study|Lost to Follow-up|141|||
161956290|NCT02517398|584887458|FG000|Overall Study|Death|2|||
161956291|NCT02517398|584887459|FG001|Overall Study|Death|3|||
161956292|NCT02517398|584887460|FG002|Overall Study|Death|4|||
161956293|NCT02517398|584887461|FG003|Overall Study|Death|2|||
161956294|NCT02517398|584887462|FG004|Overall Study|Death|3|||
161956295|NCT02517398|584887463|FG005|Overall Study|Death|8|||
161956296|NCT02517398|584887464|FG006|Overall Study|Death|3|||
161956297|NCT02517398|584887465|FG007|Overall Study|Death|2|||
162030770|NCT04604132|585169484|FG004|Overall Study|Death|0|||
161690793|NCT03603496|583918827|FG001|Overall Study|Lost to Follow-up|141|||
161690794|NCT03603496|583918826|FG000|Overall Study|Withdrawal by Subject|26|||
161690795|NCT03603496|583918827|FG001|Overall Study|Withdrawal by Subject|20|||
161690796|NCT00004259|583918830|FG000|Overall Study|Protocol Violation|1|||
161690797|NCT00004259|583918831|FG001|Overall Study|Protocol Violation|2|||
161690798|NCT00004259|583918832|FG002|Overall Study|Protocol Violation|0|||
161690799|NCT00004259|583918833|FG003|Overall Study|Protocol Violation|0|||
162030771|NCT00952380|585169485|FG000|Overall Study|Other|0|||
161690800|NCT00004259|583918830|FG000|Overall Study|Withdrawal by Subject|0|||
161690801|NCT00004259|583918831|FG001|Overall Study|Withdrawal by Subject|2|||
161690802|NCT00004259|583918832|FG002|Overall Study|Withdrawal by Subject|0|||
161690803|NCT00004259|583918833|FG003|Overall Study|Withdrawal by Subject|0|||
161690804|NCT03594227|583918834|FG000|Overall Study|Adverse Event|2|||
161690805|NCT03594227|583918835|FG001|Overall Study|Adverse Event|1|||
161690806|NCT03594227|583918836|FG002|Overall Study|Adverse Event|0|||
161690807|NCT03594227|583918837|FG003|Overall Study|Adverse Event|2|||
161690808|NCT03594227|583918834|FG000|Overall Study|Lost to Follow-up|1|||
161690809|NCT03594227|583918835|FG001|Overall Study|Lost to Follow-up|1|||
161690810|NCT03594227|583918836|FG002|Overall Study|Lost to Follow-up|1|||
161690811|NCT03594227|583918837|FG003|Overall Study|Lost to Follow-up|0|||
161690812|NCT03594227|583918834|FG000|Overall Study|Withdrawal by Subject|1|||
161690813|NCT03594227|583918835|FG001|Overall Study|Withdrawal by Subject|1|||
161690814|NCT03594227|583918836|FG002|Overall Study|Withdrawal by Subject|1|||
161690815|NCT03594227|583918837|FG003|Overall Study|Withdrawal by Subject|1|||
161690816|NCT03594227|583918834|FG000|Overall Study|Pregnancy|0|||
161690817|NCT03594227|583918835|FG001|Overall Study|Pregnancy|1|||
161690818|NCT03594227|583918836|FG002|Overall Study|Pregnancy|0|||
161956298|NCT02517398|584887466|FG008|Overall Study|Death|6|||
161690819|NCT03594227|583918837|FG003|Overall Study|Pregnancy|0|||
161956299|NCT02517398|584887467|FG009|Overall Study|Death|24|||
162030772|NCT00952380|585169486|FG001|Overall Study|Other|0|||
161690820|NCT03594227|583918834|FG000|Overall Study|Sponsor Decision|0|||
161690821|NCT03594227|583918835|FG001|Overall Study|Sponsor Decision|0|||
161690822|NCT03594227|583918836|FG002|Overall Study|Sponsor Decision|0|||
161690823|NCT03594227|583918837|FG003|Overall Study|Sponsor Decision|1|||
161690824|NCT03594227|583918834|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
161690825|NCT03594227|583918835|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
161690826|NCT03594227|583918836|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
161690827|NCT03594227|583918837|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
161690828|NCT01618214|583918843|FG000|Overall Study|Adverse Event|3|||
161690829|NCT01618214|583918844|FG001|Overall Study|Adverse Event|1|||
161690830|NCT01618214|583918843|FG000|Overall Study|Lack of Efficacy|1|||
161690831|NCT01618214|583918844|FG001|Overall Study|Lack of Efficacy|1|||
161690832|NCT01618214|583918843|FG000|Overall Study|Protocol Violation|1|||
161690833|NCT01618214|583918844|FG001|Overall Study|Protocol Violation|4|||
161690834|NCT01618214|583918843|FG000|Overall Study|Withdrawal Criteria|1|||
161690835|NCT01618214|583918844|FG001|Overall Study|Withdrawal Criteria|2|||
161690836|NCT01618214|583918843|FG000|Overall Study|Unclassified|4|||
161690837|NCT01618214|583918844|FG001|Overall Study|Unclassified|5|||
161690838|NCT02937818|583918845|FG000|Overall Study|Participants decision|2|||
161690839|NCT02937818|583918846|FG001|Overall Study|Participants decision|1|||
161690840|NCT02937818|583918847|FG002|Overall Study|Participants decision|1|||
161690841|NCT02937818|583918848|FG003|Overall Study|Participants decision|1|||
161690842|NCT02937818|583918845|FG000|Overall Study|Adverse Event|2|||
161690843|NCT02937818|583918846|FG001|Overall Study|Adverse Event|4|||
161690844|NCT02937818|583918847|FG002|Overall Study|Adverse Event|1|||
161690845|NCT02937818|583918848|FG003|Overall Study|Adverse Event|1|||
161690846|NCT02937818|583918845|FG000|Overall Study|Disease progression|17|||
161690847|NCT02937818|583918846|FG001|Overall Study|Disease progression|15|||
161690848|NCT02937818|583918847|FG002|Overall Study|Disease progression|7|||
161690849|NCT02937818|583918848|FG003|Overall Study|Disease progression|19|||
161690850|NCT02937818|583918845|FG000|Overall Study|Condition under investigation worsened|0|||
161690851|NCT02937818|583918846|FG001|Overall Study|Condition under investigation worsened|0|||
161690852|NCT02937818|583918847|FG002|Overall Study|Condition under investigation worsened|1|||
161690853|NCT02937818|583918848|FG003|Overall Study|Condition under investigation worsened|0|||
161690854|NCT01400451|583918866|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
161690855|NCT01400451|583918867|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
161690856|NCT01400451|583918868|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
161690857|NCT01400451|583918866|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
161690858|NCT01400451|583918867|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
161690859|NCT01400451|583918868|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
161690860|NCT01400451|583918866|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
161690861|NCT01400451|583918867|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
161690862|NCT01400451|583918868|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
161690863|NCT01400451|583918866|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
161690864|NCT01400451|583918867|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
161690865|NCT01400451|583918868|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
161690866|NCT01400451|583918866|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
161690867|NCT01400451|583918867|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
161690868|NCT01400451|583918868|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
161690869|NCT01508702|583918874|FG000|Overall Study|Adverse Event|7|||
161690870|NCT01508702|583918875|FG001|Overall Study|Adverse Event|3|||
161690871|NCT01508702|583918874|FG000|Overall Study|Gout flare|2|||
161690872|NCT01508702|583918875|FG001|Overall Study|Gout flare|0|||
161690873|NCT01508702|583918874|FG000|Overall Study|Protocol Violation|2|||
161690874|NCT01508702|583918875|FG001|Overall Study|Protocol Violation|1|||
161690875|NCT01508702|583918874|FG000|Overall Study|Lost to Follow-up|1|||
161690876|NCT01508702|583918875|FG001|Overall Study|Lost to Follow-up|2|||
161690877|NCT01508702|583918874|FG000|Overall Study|Withdrawal by Subject|11|||
161690878|NCT01508702|583918875|FG001|Overall Study|Withdrawal by Subject|7|||
161690879|NCT04472429|583918876|FG000|Randomized Period|Ongoing|90|||
161690880|NCT04472429|583918877|FG001|Randomized Period|Ongoing|40|||
161690881|NCT04472429|583918878|FG002|Randomized Period|Ongoing|0|||
161690882|NCT04472429|583918876|FG000|Randomized Period|Death|52|||
161690883|NCT04472429|583918877|FG001|Randomized Period|Death|37|||
161956300|NCT02517398|584887468|FG010|Overall Study|Death|53|||
161956301|NCT02517398|584887469|FG011|Overall Study|Death|25|||
161690884|NCT04472429|583918878|FG002|Randomized Period|Death|0|||
161956302|NCT02517398|584887470|FG012|Overall Study|Death|73|||
161690885|NCT04472429|583918876|FG000|Randomized Period|Lost to Follow-up|4|||
161690886|NCT04472429|583918877|FG001|Randomized Period|Lost to Follow-up|0|||
161690887|NCT04472429|583918878|FG002|Randomized Period|Lost to Follow-up|0|||
161690888|NCT04472429|583918876|FG000|Randomized Period|Physician Decision|1|||
161690889|NCT04472429|583918877|FG001|Randomized Period|Physician Decision|2|||
161690890|NCT04472429|583918878|FG002|Randomized Period|Physician Decision|0|||
161690891|NCT04472429|583918876|FG000|Randomized Period|Withdrawal by Subject|6|||
161956303|NCT02517398|584887471|FG013|Overall Study|Death|29|||
161690892|NCT04472429|583918877|FG001|Randomized Period|Withdrawal by Subject|5|||
161690893|NCT04472429|583918878|FG002|Randomized Period|Withdrawal by Subject|0|||
161690894|NCT04472429|583918876|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
161690895|NCT04472429|583918877|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
161690896|NCT04472429|583918878|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
161690897|NCT04472429|583918876|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
161690898|NCT04472429|583918877|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
161690899|NCT04472429|583918878|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
161690900|NCT04472429|583918876|FG000|Open-label Monotherapy Period|Ongoing|0|||
161690901|NCT04472429|583918877|FG001|Open-label Monotherapy Period|Ongoing|0|||
161690902|NCT04472429|583918878|FG002|Open-label Monotherapy Period|Ongoing|32|||
161690903|NCT04472429|583918876|FG000|Open-label Monotherapy Period|Death|0|||
161690904|NCT04472429|583918877|FG001|Open-label Monotherapy Period|Death|0|||
161690905|NCT04472429|583918878|FG002|Open-label Monotherapy Period|Death|35|||
161690906|NCT04472429|583918876|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
161690907|NCT04472429|583918877|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
161690908|NCT04472429|583918878|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
161690909|NCT01180660|583918879|FG000|Overall Study|Changed to open surgery|1|||
161690910|NCT01180660|583918880|FG001|Overall Study|Changed to open surgery|0|||
161690911|NCT00250835|583918881|FG000|Overall Study|Withdrawal by Subject|1|||
161690912|NCT03461757|583918882|FG000|Overall Study|Adverse Event|1|||
161690913|NCT03461757|583918883|FG001|Overall Study|Adverse Event|0|||
161690914|NCT03461757|583918882|FG000|Overall Study|Lost to Follow-up|13|||
161690915|NCT03461757|583918883|FG001|Overall Study|Lost to Follow-up|7|||
161690916|NCT03461757|583918882|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
161690917|NCT03461757|583918883|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
161690918|NCT03461757|583918882|FG000|Overall Study|Non-compliance with study treatment|0|||
161690919|NCT03461757|583918883|FG001|Overall Study|Non-compliance with study treatment|1|||
161690920|NCT03461757|583918882|FG000|Overall Study|Pregnancy|2|||
161690921|NCT03461757|583918883|FG001|Overall Study|Pregnancy|0|||
161690922|NCT03461757|583918882|FG000|Overall Study|Protocol Violation|1|||
161690923|NCT03461757|583918883|FG001|Overall Study|Protocol Violation|1|||
161690924|NCT03461757|583918882|FG000|Overall Study|Withdrawal by Subject|7|||
161690925|NCT03461757|583918883|FG001|Overall Study|Withdrawal by Subject|7|||
161690926|NCT03461757|583918882|FG000|Overall Study|Other Reasons|1|||
161690927|NCT03461757|583918883|FG001|Overall Study|Other Reasons|4|||
161690928|NCT03861559|583918884|FG000|Overall Study|Adverse Event|0|||
161690929|NCT03861559|583918885|FG001|Overall Study|Adverse Event|2|||
161690930|NCT03861559|583918884|FG000|Overall Study|Treatment failure|0|||
161690931|NCT03861559|583918885|FG001|Overall Study|Treatment failure|2|||
161690932|NCT03861559|583918884|FG000|Overall Study|Noncompliance|1|||
161690933|NCT03861559|583918885|FG001|Overall Study|Noncompliance|1|||
161690934|NCT03861559|583918884|FG000|Overall Study|Did not meet eligibility requirements|1|||
161690935|NCT03861559|583918885|FG001|Overall Study|Did not meet eligibility requirements|0|||
161690936|NCT02500121|583918888|FG000|Overall Study|Lost to Follow-up|0|||
161690937|NCT02500121|583918889|FG001|Overall Study|Lost to Follow-up|1|||
161690938|NCT02500121|583918888|FG000|Overall Study|Withdrawal by Subject|1|||
161690939|NCT02500121|583918889|FG001|Overall Study|Withdrawal by Subject|1|||
161690940|NCT02500121|583918888|FG000|Overall Study|Death|26|||
161690941|NCT02500121|583918889|FG001|Overall Study|Death|24|||
161690942|NCT04942925|583918891|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
161690943|NCT04942925|583918892|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
161690944|NCT04942925|583918891|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
161690945|NCT04942925|583918892|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
161690946|NCT02124564|583918893|FG000|Treatment Period|Adverse Event|2|||
161690947|NCT02124564|583918893|FG000|Treatment Period|Lack of Efficacy|3|||
161690948|NCT02124564|583918893|FG000|Treatment Period|Withdrawal by Subject|2|||
161690949|NCT04489888|583918894|FG000|Overall Study|Death|75|||
161690950|NCT04489888|583918894|FG000|Overall Study|Sponsor Decision|26|||
161690951|NCT03829657|583918902|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
161690952|NCT03829657|583918903|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
161690953|NCT03829657|583918904|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
161690954|NCT03829657|583918905|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
161690955|NCT03829657|583918906|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
161956304|NCT02517398|584887472|FG014|Overall Study|Death|26|||
161690956|NCT03829657|583918902|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
161690957|NCT03829657|583918903|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161690958|NCT03829657|583918904|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161690959|NCT03829657|583918905|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161956305|NCT02517398|584887473|FG015|Overall Study|Death|23|||
161956306|NCT02517398|584887474|FG016|Overall Study|Death|26|||
161690960|NCT03829657|583918906|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161690961|NCT03829657|583918902|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
161690962|NCT03829657|583918903|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
161690963|NCT03829657|583918904|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
161690964|NCT03829657|583918905|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
161690965|NCT03829657|583918906|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
161690966|NCT03829657|583918902|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
161690967|NCT03829657|583918903|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
161690968|NCT03829657|583918904|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
161690969|NCT03829657|583918905|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161690970|NCT03829657|583918906|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161690971|NCT03829657|583918902|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
161690972|NCT03829657|583918903|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
161690973|NCT03829657|583918904|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
161690974|NCT03829657|583918905|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
161690975|NCT03829657|583918906|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
161690976|NCT03829657|583918902|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
161690977|NCT03829657|583918903|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
161690978|NCT03829657|583918904|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
161690979|NCT03829657|583918905|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
161690980|NCT03829657|583918906|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
161690981|NCT03829657|583918902|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
161690982|NCT03829657|583918903|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
161690983|NCT03829657|583918904|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
161690984|NCT03829657|583918905|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
161690985|NCT03829657|583918906|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
161690986|NCT03829657|583918902|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
161690987|NCT03829657|583918903|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
161690988|NCT03829657|583918904|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
161690989|NCT03829657|583918905|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
161690990|NCT03829657|583918906|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
161690991|NCT03829657|583918902|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
161690992|NCT03829657|583918903|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
161690993|NCT03829657|583918904|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
161690994|NCT03829657|583918905|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
161690995|NCT03829657|583918906|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
161690996|NCT03829657|583918902|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
161690997|NCT03829657|583918903|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
161690998|NCT03829657|583918904|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
161690999|NCT03829657|583918905|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
161691000|NCT03829657|583918906|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
161691001|NCT00562588|583918908|FG000|Overall Study|Adverse Event|40|||
161691002|NCT00562588|583918909|FG001|Overall Study|Adverse Event|58|||
161691003|NCT00562588|583918908|FG000|Overall Study|Protocol Violation|30|||
161691004|NCT00562588|583918909|FG001|Overall Study|Protocol Violation|26|||
161691005|NCT00562588|583918908|FG000|Overall Study|Lost to Follow-up|12|||
161691006|NCT00562588|583918909|FG001|Overall Study|Lost to Follow-up|4|||
161691007|NCT00562588|583918908|FG000|Overall Study|Withdrawal by Subject|10|||
161691008|NCT00562588|583918909|FG001|Overall Study|Withdrawal by Subject|9|||
161691009|NCT00562588|583918908|FG000|Overall Study|Other|0|||
161691010|NCT00562588|583918909|FG001|Overall Study|Other|2|||
161691011|NCT03368170|583920512|FG000|Overall Study|Adverse Event|2|||
161691012|NCT03368170|583920513|FG001|Overall Study|Adverse Event|1|||
161691013|NCT03257267|583920519|FG000|Overall Study|Adverse Event|17|||
161691014|NCT03257267|583920520|FG001|Overall Study|Adverse Event|7|||
161691015|NCT03257267|583920519|FG000|Overall Study|Death|96|||
161691016|NCT03257267|583920520|FG001|Overall Study|Death|98|||
161691017|NCT03257267|583920519|FG000|Overall Study|Lost to Follow-up|2|||
161691018|NCT03257267|583920520|FG001|Overall Study|Lost to Follow-up|2|||
161691019|NCT03257267|583920519|FG000|Overall Study|Non-compliance with Study Drug|0|||
161691020|NCT03257267|583920520|FG001|Overall Study|Non-compliance with Study Drug|2|||
161691021|NCT03257267|583920519|FG000|Overall Study|Participant Decision|35|||
161691022|NCT03257267|583920520|FG001|Overall Study|Participant Decision|43|||
161691023|NCT03257267|583920519|FG000|Overall Study|Sponsor Decision|1|||
161956307|NCT02517398|584887475|FG017|Overall Study|Death|25|||
161691024|NCT03257267|583920520|FG001|Overall Study|Sponsor Decision|0|||
161691025|NCT03257267|583920519|FG000|Overall Study|Physician Decision|1|||
161956308|NCT02517398|584887476|FG018|Overall Study|Death|22|||
161956309|NCT02517398|584887477|FG019|Overall Study|Death|7|||
161956310|NCT02517398|584887478|FG020|Overall Study|Death|26|||
161956311|NCT02517398|584887479|FG021|Overall Study|Death|30|||
161691026|NCT03257267|583920520|FG001|Overall Study|Physician Decision|3|||
161691027|NCT03257267|583920519|FG000|Overall Study|Disease Progression|109|||
161691028|NCT03257267|583920520|FG001|Overall Study|Disease Progression|121|||
161691029|NCT03257267|583920519|FG000|Overall Study|Withdrawal by Subject|8|||
161691030|NCT03257267|583920520|FG001|Overall Study|Withdrawal by Subject|26|||
161691031|NCT03257267|583920519|FG000|Overall Study|Other|0|||
161691032|NCT03257267|583920520|FG001|Overall Study|Other|2|||
161691033|NCT03445000|583920521|FG000|Overall Study|Disease progression|8|||
161691034|NCT03445000|583920521|FG000|Overall Study|Adverse Event|3|||
161691035|NCT03445000|583920521|FG000|Overall Study|Death|2|||
161691036|NCT03445000|583920521|FG000|Overall Study|Physician Decision|1|||
161691037|NCT01982292|583920522|FG000|Overall Study|Adverse Event|2|||
161691038|NCT01982292|583920523|FG001|Overall Study|Adverse Event|0|||
161691039|NCT01982292|583920522|FG000|Overall Study|Death|1|||
161691040|NCT01982292|583920523|FG001|Overall Study|Death|0|||
161691041|NCT01982292|583920522|FG000|Overall Study|Lost to Follow-up|2|||
161691042|NCT01982292|583920523|FG001|Overall Study|Lost to Follow-up|0|||
161691043|NCT01982292|583920522|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
161691044|NCT01982292|583920523|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
161691045|NCT01982292|583920522|FG000|Overall Study|Protocol Deviation|1|||
161691046|NCT01982292|583920523|FG001|Overall Study|Protocol Deviation|0|||
161691047|NCT01982292|583920522|FG000|Overall Study|Patient/Guardian Decision|3|||
161691048|NCT01982292|583920523|FG001|Overall Study|Patient/Guardian Decision|1|||
161691049|NCT01982292|583920522|FG000|Overall Study|Technical Problems|2|||
161691050|NCT01982292|583920523|FG001|Overall Study|Technical Problems|0|||
161691051|NCT03409744|583920524|FG000|Overall Study|Death|2|||
161691052|NCT03409744|583920524|FG000|Overall Study|Physician Decision|5|||
161691053|NCT03409744|583920524|FG000|Overall Study|Pregnancy|1|||
161691054|NCT03409744|583920524|FG000|Overall Study|Lost to Follow-up|1|||
161691055|NCT03409744|583920524|FG000|Overall Study|Protocol Violation|1|||
161691056|NCT04872101|583920525|FG000|Overall Study|Withdrawal by Subject|10|||
161691057|NCT04872101|583920526|FG001|Overall Study|Withdrawal by Subject|16|||
161691058|NCT04872101|583920525|FG000|Overall Study|Lack of Efficacy|6|||
161691059|NCT04872101|583920526|FG001|Overall Study|Lack of Efficacy|14|||
161691060|NCT04872101|583920525|FG000|Overall Study|Adverse Event|1|||
161691061|NCT04872101|583920526|FG001|Overall Study|Adverse Event|6|||
161691062|NCT04872101|583920525|FG000|Overall Study|Lost to Follow-up|2|||
161691063|NCT04872101|583920526|FG001|Overall Study|Lost to Follow-up|1|||
161691064|NCT04872101|583920525|FG000|Overall Study|Pregnancy|2|||
161691065|NCT04872101|583920526|FG001|Overall Study|Pregnancy|0|||
161691066|NCT04872101|583920525|FG000|Overall Study|Prohibited Medication|1|||
161691067|NCT04872101|583920526|FG001|Overall Study|Prohibited Medication|0|||
161691068|NCT04872101|583920525|FG000|Overall Study|Not dosed|1|||
161691069|NCT04872101|583920526|FG001|Overall Study|Not dosed|0|||
161691070|NCT05804877|583920527|FG000|Overall Study|Lost to Follow-up|1|||
161691071|NCT05804877|583920528|FG001|Overall Study|Lost to Follow-up|3|||
161691072|NCT05804877|583920527|FG000|Overall Study|Withdrawal by Subject|1|||
161691073|NCT05804877|583920528|FG001|Overall Study|Withdrawal by Subject|0|||
161691074|NCT05804877|583920527|FG000|Overall Study|Withdrawal by Subject|1|||
161691075|NCT05804877|583920528|FG001|Overall Study|Withdrawal by Subject|0|||
161691076|NCT00879229|583920529|FG000|Overall Study|Study terminated by Sponsor|13|||
161691077|NCT00879229|583920530|FG001|Overall Study|Study terminated by Sponsor|12|||
161691078|NCT00879229|583920529|FG000|Overall Study|Death|4|||
161691079|NCT00879229|583920530|FG001|Overall Study|Death|2|||
161691080|NCT00879229|583920529|FG000|Overall Study|Adverse Event|2|||
161691081|NCT00879229|583920530|FG001|Overall Study|Adverse Event|0|||
161691082|NCT00879229|583920529|FG000|Overall Study|Withdrawal by Subject|1|||
161691083|NCT00879229|583920530|FG001|Overall Study|Withdrawal by Subject|0|||
161691084|NCT00879229|583920529|FG000|Overall Study|Clinical status did not improve|1|||
161691085|NCT00879229|583920530|FG001|Overall Study|Clinical status did not improve|0|||
161956312|NCT02517398|584887480|FG022|Overall Study|Death|20|||
161956313|NCT02517398|584887458|FG000|Overall Study|Other|0|||
161691086|NCT00879229|583920529|FG000|Overall Study|Other|1|||
161691087|NCT00879229|583920530|FG001|Overall Study|Other|0|||
161691088|NCT00264004|583920531|FG000|Overall Study|Adverse Event|2|||
161691089|NCT00264004|583920532|FG001|Overall Study|Adverse Event|3|||
161691090|NCT00264004|583920533|FG002|Overall Study|Adverse Event|6|||
161691091|NCT00264004|583920534|FG003|Overall Study|Adverse Event|4|||
161691092|NCT00264004|583920531|FG000|Overall Study|Withdrawal by Subject|0|||
161691093|NCT00264004|583920532|FG001|Overall Study|Withdrawal by Subject|1|||
161691094|NCT00264004|583920533|FG002|Overall Study|Withdrawal by Subject|2|||
161956314|NCT02517398|584887459|FG001|Overall Study|Other|0|||
161691095|NCT00264004|583920534|FG003|Overall Study|Withdrawal by Subject|2|||
161691096|NCT00264004|583920531|FG000|Overall Study|Other|2|||
161691097|NCT00264004|583920532|FG001|Overall Study|Other|2|||
161691098|NCT00264004|583920533|FG002|Overall Study|Other|0|||
161691099|NCT00264004|583920534|FG003|Overall Study|Other|3|||
161956315|NCT02517398|584887460|FG002|Overall Study|Other|0|||
161691100|NCT00264004|583920531|FG000|Overall Study|Development study specific disc. crit.|1|||
161956316|NCT02517398|584887461|FG003|Overall Study|Other|1|||
161691101|NCT00264004|583920532|FG001|Overall Study|Development study specific disc. crit.|0|||
161691102|NCT00264004|583920533|FG002|Overall Study|Development study specific disc. crit.|1|||
161691103|NCT00264004|583920534|FG003|Overall Study|Development study specific disc. crit.|0|||
161691104|NCT00264004|583920531|FG000|Overall Study|Cond. under inv. worsened|9|||
161691105|NCT00264004|583920532|FG001|Overall Study|Cond. under inv. worsened|5|||
161691106|NCT00264004|583920533|FG002|Overall Study|Cond. under inv. worsened|3|||
161691107|NCT00264004|583920534|FG003|Overall Study|Cond. under inv. worsened|4|||
161691108|NCT00264004|583920531|FG000|Overall Study|Not treated|3|||
161691109|NCT00264004|583920532|FG001|Overall Study|Not treated|0|||
161691110|NCT00264004|583920533|FG002|Overall Study|Not treated|2|||
161691111|NCT00264004|583920534|FG003|Overall Study|Not treated|2|||
161691112|NCT02475681|583920535|FG000|Overall Study|Death|16|||
161691113|NCT02475681|583920536|FG001|Overall Study|Death|6|||
161691114|NCT02475681|583920537|FG002|Overall Study|Death|9|||
161691115|NCT02475681|583920535|FG000|Overall Study|Physician Decision|0|||
161691116|NCT02475681|583920536|FG001|Overall Study|Physician Decision|3|||
161691117|NCT02475681|583920537|FG002|Overall Study|Physician Decision|1|||
161691118|NCT02475681|583920535|FG000|Overall Study|Withdrawal by Subject|12|||
161691119|NCT02475681|583920536|FG001|Overall Study|Withdrawal by Subject|6|||
161691120|NCT02475681|583920537|FG002|Overall Study|Withdrawal by Subject|9|||
161691121|NCT02475681|583920535|FG000|Overall Study|Lost to Follow-up|2|||
161691122|NCT02475681|583920536|FG001|Overall Study|Lost to Follow-up|1|||
161691123|NCT02475681|583920537|FG002|Overall Study|Lost to Follow-up|3|||
161691124|NCT02475681|583920535|FG000|Overall Study|Ongoing in Study|0|||
161691125|NCT02475681|583920536|FG001|Overall Study|Ongoing in Study|163|||
161691126|NCT02475681|583920537|FG002|Overall Study|Ongoing in Study|157|||
161691127|NCT02475681|583920535|FG000|Overall Study|Reasons other than above listed|2|||
161691128|NCT02475681|583920536|FG001|Overall Study|Reasons other than above listed|0|||
161691129|NCT02475681|583920537|FG002|Overall Study|Reasons other than above listed|0|||
161691130|NCT00527605|583920544|FG000|Overall Study|Adverse Event|3|||
161691131|NCT00527605|583920545|FG001|Overall Study|Adverse Event|0|||
161691132|NCT00527605|583920544|FG000|Overall Study|Withdrawal by Subject|3|||
161691133|NCT00527605|583920545|FG001|Overall Study|Withdrawal by Subject|7|||
161691134|NCT00527605|583920544|FG000|Overall Study|Lost to Follow-up|6|||
161691135|NCT00527605|583920545|FG001|Overall Study|Lost to Follow-up|2|||
161691136|NCT00527605|583920544|FG000|Overall Study|Protocol Violation|1|||
161691137|NCT00527605|583920545|FG001|Overall Study|Protocol Violation|2|||
161691138|NCT01363986|583920549|FG000|Overall Study|Disease progression|1|||
161691139|NCT01637142|583920550|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
161691140|NCT02605642|583920551|FG000|Overall Study|Other|11|||
161691141|NCT02605642|583920552|FG001|Overall Study|Other|1|||
161691142|NCT02605642|583920551|FG000|Overall Study|Participant non-compliance|2|||
161691143|NCT02605642|583920552|FG001|Overall Study|Participant non-compliance|4|||
161691144|NCT02605642|583920551|FG000|Overall Study|Physician Decision|10|||
161691145|NCT02605642|583920552|FG001|Overall Study|Physician Decision|0|||
161691146|NCT02605642|583920551|FG000|Overall Study|Lost to Follow-up|12|||
161691147|NCT02605642|583920552|FG001|Overall Study|Lost to Follow-up|1|||
161691148|NCT02605642|583920551|FG000|Overall Study|Adverse Event|14|||
161691149|NCT02605642|583920552|FG001|Overall Study|Adverse Event|2|||
161691150|NCT02605642|583920551|FG000|Overall Study|Withdrawal by Subject|23|||
161691151|NCT02605642|583920552|FG001|Overall Study|Withdrawal by Subject|2|||
161691152|NCT02605642|583920551|FG000|Overall Study|Lack of response|24|||
161691153|NCT02605642|583920552|FG001|Overall Study|Lack of response|11|||
161691154|NCT02111564|583920555|FG000|Overall Study|Death|109|||
161691155|NCT02111564|583920556|FG001|Overall Study|Death|120|||
161691156|NCT02111564|583920555|FG000|Overall Study|Lost to Follow-up|2|||
161691157|NCT02111564|583920556|FG001|Overall Study|Lost to Follow-up|3|||
161691158|NCT02111564|583920555|FG000|Overall Study|Withdrawal by Subject|20|||
161691159|NCT02111564|583920556|FG001|Overall Study|Withdrawal by Subject|20|||
161691160|NCT03704194|583920565|FG000|Overall Study|Withdrawal by Subject|0|||
161691161|NCT03704194|583920566|FG001|Overall Study|Withdrawal by Subject|1|||
161691162|NCT00925015|583920567|FG000|Overall Study|Adverse Event|1|||
161691163|NCT00925015|583920568|FG001|Overall Study|Adverse Event|2|||
161691164|NCT00925015|583920569|FG002|Overall Study|Adverse Event|1|||
161691165|NCT00925015|583920567|FG000|Overall Study|Physician Decision|0|||
161691166|NCT00925015|583920568|FG001|Overall Study|Physician Decision|1|||
161691167|NCT00925015|583920569|FG002|Overall Study|Physician Decision|0|||
161836342|NCT03395639|584442941|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
161836343|NCT03395639|584442942|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
161691168|NCT00925015|583920567|FG000|Overall Study|Progressive Disease|7|||
161691169|NCT00925015|583920568|FG001|Overall Study|Progressive Disease|3|||
161691170|NCT00925015|583920569|FG002|Overall Study|Progressive Disease|4|||
161836344|NCT03395639|584442943|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
161956317|NCT02517398|584887462|FG004|Overall Study|Other|0|||
161691171|NCT00925015|583920567|FG000|Overall Study|Withdrawal by Subject|0|||
161691172|NCT00925015|583920568|FG001|Overall Study|Withdrawal by Subject|0|||
161956318|NCT02517398|584887463|FG005|Overall Study|Other|0|||
161691173|NCT00925015|583920569|FG002|Overall Study|Withdrawal by Subject|1|||
161956319|NCT02517398|584887464|FG006|Overall Study|Other|0|||
161956320|NCT02517398|584887465|FG007|Overall Study|Other|0|||
161956321|NCT02517398|584887466|FG008|Overall Study|Other|0|||
161956322|NCT02517398|584887467|FG009|Overall Study|Other|1|||
161956323|NCT02517398|584887468|FG010|Overall Study|Other|0|||
161956324|NCT02517398|584887469|FG011|Overall Study|Other|0|||
161956325|NCT02517398|584887470|FG012|Overall Study|Other|0|||
161691174|NCT00179309|583920576|FG000|Treatment|Toxicity|2|||
161956326|NCT02517398|584887471|FG013|Overall Study|Other|1|||
161956327|NCT02517398|584887472|FG014|Overall Study|Other|0|||
161956328|NCT02517398|584887473|FG015|Overall Study|Other|1|||
161691175|NCT00179309|583920577|FG001|Treatment|Toxicity|3|||
161691176|NCT00179309|583920576|FG000|Treatment|Withdrawal by Subject|1|||
161691177|NCT00179309|583920577|FG001|Treatment|Withdrawal by Subject|2|||
161691178|NCT00179309|583920576|FG000|Treatment|Allergy|1|||
161691179|NCT00179309|583920577|FG001|Treatment|Allergy|0|||
161691180|NCT04986202|583920578|FG000|Overall Study|Death|10|||
161691181|NCT04986202|583920579|FG001|Overall Study|Death|3|||
161691182|NCT04986202|583920580|FG002|Overall Study|Death|10|||
161691183|NCT04986202|583920578|FG000|Overall Study|Physician Decision|3|||
161691184|NCT04986202|583920579|FG001|Overall Study|Physician Decision|1|||
161691185|NCT04986202|583920580|FG002|Overall Study|Physician Decision|2|||
161691186|NCT04986202|583920578|FG000|Overall Study|Withdrawal by Subject|4|||
161691187|NCT04986202|583920579|FG001|Overall Study|Withdrawal by Subject|2|||
161691188|NCT04986202|583920580|FG002|Overall Study|Withdrawal by Subject|4|||
161691189|NCT05131204|583920581|FG000|Overall Study|Sponsor request|2|||
161691190|NCT05131204|583920582|FG001|Overall Study|Sponsor request|1|||
161691191|NCT02469090|583920584|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
161691192|NCT02469090|583920585|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
161691193|NCT02469090|583920586|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
161691194|NCT02469090|583920584|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
161691195|NCT02469090|583920585|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
161691196|NCT02469090|583920586|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
161691197|NCT02469090|583920584|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
161691198|NCT02469090|583920585|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
161691199|NCT02469090|583920586|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
161691200|NCT02469090|583920584|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
161691201|NCT02469090|583920585|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
161691202|NCT02469090|583920586|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
161691203|NCT02469090|583920584|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
161691204|NCT02469090|583920585|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
161691205|NCT02469090|583920586|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
161691206|NCT02469090|583920584|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
161691207|NCT02469090|583920585|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
161691208|NCT02469090|583920586|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
161691209|NCT02469090|583920584|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
161691210|NCT02469090|583920585|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
161691211|NCT02469090|583920586|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
161691212|NCT02469090|583920584|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
161691213|NCT02469090|583920585|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
161691214|NCT02469090|583920586|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
161691215|NCT03446885|583920587|FG000|Overall Study|Lost to Follow-up|1|||
161691216|NCT03446885|583920588|FG001|Overall Study|Lost to Follow-up|0|||
161691217|NCT03446885|583920587|FG000|Overall Study|Did not complete entire visit|1|||
161691218|NCT03446885|583920588|FG001|Overall Study|Did not complete entire visit|0|||
161691219|NCT03823391|583920592|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
161691220|NCT03823391|583920593|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
161691221|NCT03823391|583920592|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
161691222|NCT03823391|583920593|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
161691223|NCT05030311|583920595|FG000|Overall Study|Technical problems|0|||
161691224|NCT05030311|583920596|FG001|Overall Study|Technical problems|1|||
161691225|NCT05030311|583920595|FG000|Overall Study|Withdrawal by Subject|31|||
161691226|NCT05030311|583920596|FG001|Overall Study|Withdrawal by Subject|17|||
161691227|NCT05030311|583920595|FG000|Overall Study|Adverse Event|13|||
161691228|NCT05030311|583920596|FG001|Overall Study|Adverse Event|5|||
161691229|NCT05030311|583920595|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161691230|NCT05030311|583920596|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161691231|NCT05030311|583920595|FG000|Overall Study|Physician Decision|5|||
161691232|NCT05030311|583920596|FG001|Overall Study|Physician Decision|2|||
161691233|NCT05030311|583920595|FG000|Overall Study|Lost to Follow-up|5|||
161691234|NCT05030311|583920596|FG001|Overall Study|Lost to Follow-up|1|||
161691235|NCT05030311|583920595|FG000|Overall Study|Protocol Violation|4|||
161691236|NCT05030311|583920596|FG001|Overall Study|Protocol Violation|4|||
161691237|NCT01425203|583920597|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
161691238|NCT01425203|583920598|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
161691239|NCT01425203|583920599|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
161691240|NCT01425203|583920597|FG000|Treatment Phase|Failure at futility timepoint|8|||
161691241|NCT01425203|583920598|FG001|Treatment Phase|Failure at futility timepoint|27|||
161691242|NCT01425203|583920599|FG002|Treatment Phase|Failure at futility timepoint|0|||
161691243|NCT01425203|583920597|FG000|Treatment Phase|Other virologic failure criteria|5|||
161691244|NCT01425203|583920598|FG001|Treatment Phase|Other virologic failure criteria|3|||
161691245|NCT01425203|583920599|FG002|Treatment Phase|Other virologic failure criteria|0|||
161691246|NCT01425203|583920597|FG000|Treatment Phase|Unidentified reasons|11|||
161691247|NCT01425203|583920598|FG001|Treatment Phase|Unidentified reasons|5|||
161691248|NCT01425203|583920599|FG002|Treatment Phase|Unidentified reasons|0|||
161691249|NCT01425203|583920597|FG000|Treatment Phase|Did not receive treatment|0|||
161691250|NCT01425203|583920598|FG001|Treatment Phase|Did not receive treatment|1|||
161691251|NCT01425203|583920599|FG002|Treatment Phase|Did not receive treatment|0|||
161691252|NCT01425203|583920597|FG000|Crossover Phase|Failure at futility timepoint|0|||
161691253|NCT01425203|583920598|FG001|Crossover Phase|Failure at futility timepoint|0|||
161691254|NCT01425203|583920599|FG002|Crossover Phase|Failure at futility timepoint|3|||
161691255|NCT01425203|583920597|FG000|Crossover Phase|Other virologic failure criteria|0|||
161691256|NCT01425203|583920598|FG001|Crossover Phase|Other virologic failure criteria|0|||
161691257|NCT01425203|583920599|FG002|Crossover Phase|Other virologic failure criteria|3|||
161691258|NCT00290433|583920602|FG000|Overall Study|Disease Progression|13|||
161691259|NCT00290433|583920602|FG000|Overall Study|Adverse Event|14|||
161691260|NCT00290433|583920602|FG000|Overall Study|Withdrawal by Subject|1|||
161691261|NCT00290433|583920602|FG000|Overall Study|Non-Compliance|1|||
161691262|NCT00290433|583920602|FG000|Overall Study|Congestive Heart Failure|1|||
161691263|NCT00290433|583920602|FG000|Overall Study|Transplant in CR|5|||
161691264|NCT00290433|583920602|FG000|Overall Study|Unrelated Infection/Death|1|||
161691265|NCT02264990|583920607|FG000|Overall Study|Death|255|||
161691266|NCT02264990|583920608|FG001|Overall Study|Death|250|||
161691267|NCT02264990|583920607|FG000|Overall Study|Withdrawal by Subject|4|||
161691268|NCT02264990|583920608|FG001|Overall Study|Withdrawal by Subject|5|||
161691269|NCT02264990|583920607|FG000|Overall Study|Lost to Follow-up|1|||
161691270|NCT02264990|583920608|FG001|Overall Study|Lost to Follow-up|3|||
161691271|NCT02264990|583920607|FG000|Overall Study|Other|0|||
161691272|NCT02264990|583920608|FG001|Overall Study|Other|1|||
161691273|NCT03031301|583920609|FG000|Overall Study|Protocol Violation|4|||
161691274|NCT03031301|583920610|FG001|Overall Study|Protocol Violation|8|||
161691275|NCT03031301|583920609|FG000|Overall Study|Withdrawal by Subject|7|||
161691276|NCT03031301|583920610|FG001|Overall Study|Withdrawal by Subject|4|||
161691277|NCT03031301|583920609|FG000|Overall Study|Lost to Follow-up|4|||
161691278|NCT03031301|583920610|FG001|Overall Study|Lost to Follow-up|12|||
161691279|NCT03031301|583920609|FG000|Overall Study|Noncompliance|1|||
161691280|NCT03031301|583920610|FG001|Overall Study|Noncompliance|3|||
161691281|NCT03031301|583920609|FG000|Overall Study|Technical issue|1|||
161691282|NCT03031301|583920610|FG001|Overall Study|Technical issue|1|||
161691283|NCT03031301|583920609|FG000|Overall Study|Adverse Event|1|||
161691284|NCT03031301|583920610|FG001|Overall Study|Adverse Event|0|||
161691285|NCT02275338|583920612|FG000|Overall Study|Adverse Event|15|||
161691286|NCT02275338|583920612|FG000|Overall Study|Lack of Efficacy|3|||
161691287|NCT02275338|583920612|FG000|Overall Study|Withdrawal by Subject|4|||
161691288|NCT02275338|583920612|FG000|Overall Study|Disease progression (death)|1|||
161691289|NCT02275338|583920612|FG000|Overall Study|Ineligible to start Phase 2|4|||
161691290|NCT02275338|583920612|FG000|Overall Study|Reason not specified|5|||
161691291|NCT02275338|583920612|FG000|Overall Study|Does not meet entry criteria|1|||
161691292|NCT01100944|583920613|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
161691293|NCT01100944|583920614|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
161691294|NCT01100944|583920615|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
161691295|NCT01100944|583920613|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
161691296|NCT01100944|583920614|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
161691297|NCT01100944|583920615|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
161691298|NCT01100944|583920613|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
161691299|NCT01100944|583920614|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
161691300|NCT01100944|583920615|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
161691301|NCT01100944|583920613|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
161691302|NCT01100944|583920614|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
161691303|NCT01100944|583920615|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
161691304|NCT00109707|583920617|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
161691305|NCT00109707|583920618|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
161691306|NCT00109707|583920619|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
161691307|NCT00109707|583920617|FG000|Overall Study|Abnormal laboratory values|1|||
161691308|NCT00109707|583920618|FG001|Overall Study|Abnormal laboratory values|0|||
161691309|NCT00109707|583920619|FG002|Overall Study|Abnormal laboratory values|0|||
161956329|NCT02517398|584887474|FG016|Overall Study|Other|1|||
161956330|NCT02517398|584887475|FG017|Overall Study|Other|0|||
161956331|NCT02517398|584887476|FG018|Overall Study|Other|0|||
161691310|NCT00109707|583920617|FG000|Overall Study|Administrative problems|2|||
161691311|NCT00109707|583920618|FG001|Overall Study|Administrative problems|0|||
161691312|NCT00109707|583920619|FG002|Overall Study|Administrative problems|1|||
161691313|NCT00109707|583920617|FG000|Overall Study|Adverse Event|10|||
161691314|NCT00109707|583920618|FG001|Overall Study|Adverse Event|2|||
161691315|NCT00109707|583920619|FG002|Overall Study|Adverse Event|3|||
161691316|NCT00109707|583920617|FG000|Overall Study|Death|4|||
161691317|NCT00109707|583920618|FG001|Overall Study|Death|0|||
161691318|NCT00109707|583920619|FG002|Overall Study|Death|0|||
161691319|NCT00109707|583920617|FG000|Overall Study|Disease progression|12|||
161691320|NCT00109707|583920618|FG001|Overall Study|Disease progression|4|||
161691321|NCT00109707|583920619|FG002|Overall Study|Disease progression|3|||
161691322|NCT00109707|583920617|FG000|Overall Study|Lost to Follow-up|3|||
161691323|NCT00109707|583920618|FG001|Overall Study|Lost to Follow-up|0|||
161691324|NCT00109707|583920619|FG002|Overall Study|Lost to Follow-up|0|||
161691325|NCT00109707|583920617|FG000|Overall Study|Protocol Violation|1|||
161691326|NCT00109707|583920618|FG001|Overall Study|Protocol Violation|0|||
161691327|NCT00109707|583920619|FG002|Overall Study|Protocol Violation|0|||
161691328|NCT00109707|583920617|FG000|Overall Study|Patient withdrew consent|6|||
161691329|NCT00109707|583920618|FG001|Overall Study|Patient withdrew consent|1|||
161691330|NCT00109707|583920619|FG002|Overall Study|Patient withdrew consent|0|||
161691331|NCT00623428|583920628|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
161691332|NCT00623428|583920629|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
161691333|NCT00623428|583920628|FG000|Treatment Period|Death|0|||
161691334|NCT00623428|583920629|FG001|Treatment Period|Death|1|||
161691335|NCT00623428|583920628|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
161691336|NCT00623428|583920629|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
161691337|NCT00623428|583920628|FG000|Treatment Period|Insufficient therapeutic response|0|||
161691338|NCT00623428|583920629|FG001|Treatment Period|Insufficient therapeutic response|2|||
161691339|NCT00623428|583920628|FG000|Treatment Period|Other|0|||
161691340|NCT00623428|583920629|FG001|Treatment Period|Other|1|||
161691341|NCT00623428|583920628|FG000|Treatment Period|Withdrawal by Subject|0|||
161691342|NCT00623428|583920629|FG001|Treatment Period|Withdrawal by Subject|1|||
161691343|NCT00623428|583920628|FG000|Follow-up Period|Relapse post-treatment|11|||
161691344|NCT00623428|583920629|FG001|Follow-up Period|Relapse post-treatment|3|||
161691345|NCT00623428|583920628|FG000|Follow-up Period|Failure to return|10|||
161691346|NCT00623428|583920629|FG001|Follow-up Period|Failure to return|2|||
161691347|NCT00623428|583920628|FG000|Follow-up Period|Patient withdrew consent|5|||
161691348|NCT00623428|583920629|FG001|Follow-up Period|Patient withdrew consent|4|||
161691349|NCT00623428|583920628|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
161691350|NCT00623428|583920629|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
161691351|NCT00623428|583920628|FG000|Follow-up Period|Did not cooperate|0|||
161691352|NCT00623428|583920629|FG001|Follow-up Period|Did not cooperate|3|||
161691353|NCT00623428|583920628|FG000|Follow-up Period|Reason not specified|1|||
161691354|NCT00623428|583920629|FG001|Follow-up Period|Reason not specified|1|||
161691355|NCT00623428|583920628|FG000|Follow-up Period|Death|0|||
161691356|NCT00623428|583920629|FG001|Follow-up Period|Death|1|||
161691357|NCT01692301|583920630|FG000|Overall Study|Adverse Event|15|||
161691358|NCT01692301|583920631|FG001|Overall Study|Adverse Event|12|||
161691359|NCT01692301|583920630|FG000|Overall Study|Death|1|||
161691360|NCT01692301|583920631|FG001|Overall Study|Death|2|||
161691361|NCT01692301|583920630|FG000|Overall Study|Lack of Efficacy|0|||
161691362|NCT01692301|583920631|FG001|Overall Study|Lack of Efficacy|5|||
161691363|NCT01692301|583920630|FG000|Overall Study|Non-compliance with study treatment|1|||
161691364|NCT01692301|583920631|FG001|Overall Study|Non-compliance with study treatment|2|||
161691365|NCT01692301|583920630|FG000|Overall Study|Protocol deviation|9|||
161691366|NCT01692301|583920631|FG001|Overall Study|Protocol deviation|2|||
161691367|NCT01692301|583920630|FG000|Overall Study|Patient/guardian decision|16|||
161691368|NCT01692301|583920631|FG001|Overall Study|Patient/guardian decision|15|||
161691369|NCT01692301|583920630|FG000|Overall Study|Technical problems|0|||
161691370|NCT01692301|583920631|FG001|Overall Study|Technical problems|1|||
161691371|NCT01692301|583920630|FG000|Overall Study|Physician Decision|2|||
161691372|NCT01692301|583920631|FG001|Overall Study|Physician Decision|2|||
161691373|NCT01692301|583920630|FG000|Overall Study|Lost to Follow-up|1|||
161691374|NCT01692301|583920631|FG001|Overall Study|Lost to Follow-up|1|||
161691375|NCT01142726|583920632|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
161691376|NCT01142726|583920633|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
161691377|NCT01142726|583920634|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
161691378|NCT01142726|583920632|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
161691379|NCT01142726|583920633|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
161691380|NCT01142726|583920634|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
161691381|NCT01142726|583920632|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
161691382|NCT01142726|583920633|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
161691383|NCT01142726|583920634|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
161691384|NCT01142726|583920632|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
161691385|NCT01142726|583920633|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
161691386|NCT01142726|583920634|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
161691387|NCT01142726|583920632|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
161691388|NCT01142726|583920633|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
161691389|NCT01142726|583920634|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
161691390|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
161691391|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
161956332|NCT02517398|584887477|FG019|Overall Study|Other|1|||
161956333|NCT02517398|584887478|FG020|Overall Study|Other|0|||
161956334|NCT02517398|584887479|FG021|Overall Study|Other|0|||
161691392|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
161691393|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
161691394|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
161691395|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
161691396|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
161691397|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
161691398|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
161691399|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
161691400|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
161691401|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
161691402|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
161691403|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
161691404|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
161691405|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
161691406|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
161691407|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
161691408|NCT01142726|583920632|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
161691409|NCT01142726|583920633|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
161691410|NCT01142726|583920634|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
161691411|NCT01142726|583920632|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
161691412|NCT01142726|583920633|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
161691413|NCT01142726|583920634|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
161691414|NCT01142726|583920632|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
161691415|NCT01142726|583920633|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
161691416|NCT01142726|583920634|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
161691417|NCT01142726|583920632|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
161691418|NCT01142726|583920633|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
161691419|NCT01142726|583920634|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
161691420|NCT01142726|583920632|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
161691421|NCT01142726|583920633|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
161691422|NCT01142726|583920634|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
161691423|NCT02228590|583920635|FG000|Overall Study|Withdrawal by Subject|1|||
161691424|NCT02111993|583920636|FG000|Overall Study|Physician Decision|5|||
161691425|NCT02111993|583920637|FG001|Overall Study|Physician Decision|4|||
161691426|NCT00574275|583920638|FG000|Overall Study|Randomized but not treated|2|||
161691427|NCT00574275|583920639|FG001|Overall Study|Randomized but not treated|3|||
161691428|NCT00574275|583920638|FG000|Overall Study|Adverse Event|32|||
161691429|NCT00574275|583920639|FG001|Overall Study|Adverse Event|76|||
161691430|NCT00574275|583920638|FG000|Overall Study|Disease progression|160|||
161691431|NCT00574275|583920639|FG001|Overall Study|Disease progression|146|||
161691432|NCT00574275|583920638|FG000|Overall Study|Lost to Follow-up|2|||
161691433|NCT00574275|583920639|FG001|Overall Study|Lost to Follow-up|1|||
161691434|NCT00574275|583920638|FG000|Overall Study|Study stopped based on DMC decision|62|||
161691435|NCT00574275|583920639|FG001|Overall Study|Study stopped based on DMC decision|23|||
161691436|NCT00574275|583920638|FG000|Overall Study|Withdrawal by Subject|15|||
161691437|NCT00574275|583920639|FG001|Overall Study|Withdrawal by Subject|17|||
161691438|NCT00574275|583920638|FG000|Overall Study|Error calculating tumor measurement|1|||
161691439|NCT00574275|583920639|FG001|Overall Study|Error calculating tumor measurement|0|||
161691440|NCT00574275|583920638|FG000|Overall Study|Physician Decision|1|||
161691441|NCT00574275|583920639|FG001|Overall Study|Physician Decision|1|||
161691442|NCT00574275|583920638|FG000|Overall Study|Protocol Violation|0|||
161691443|NCT00574275|583920639|FG001|Overall Study|Protocol Violation|1|||
161691444|NCT00574275|583920638|FG000|Overall Study|Patient and Investigator decision|0|||
161691445|NCT00574275|583920639|FG001|Overall Study|Patient and Investigator decision|1|||
161691446|NCT00574275|583920638|FG000|Overall Study|Insurance change|0|||
161691447|NCT00574275|583920639|FG001|Overall Study|Insurance change|1|||
161691448|NCT00574275|583920638|FG000|Overall Study|Operation for curative intent|0|||
161691449|NCT00574275|583920639|FG001|Overall Study|Operation for curative intent|1|||
161691450|NCT00889265|583920642|FG000|Overall Study|Adverse Event|1|||
161691451|NCT00889265|583920642|FG000|Overall Study|Lost to Follow-up|5|||
161691452|NCT00889265|583920642|FG000|Overall Study|Protocol Violation|1|||
161691453|NCT03028870|583920643|FG000|Overall Study|Adverse Event|7|||
161691454|NCT03028870|583920644|FG001|Overall Study|Adverse Event|4|||
161691455|NCT03028870|583920645|FG002|Overall Study|Adverse Event|3|||
161691456|NCT03028870|583920646|FG003|Overall Study|Adverse Event|3|||
161691457|NCT03028870|583920643|FG000|Overall Study|Withdrawal by Subject|1|||
161691458|NCT03028870|583920644|FG001|Overall Study|Withdrawal by Subject|1|||
161956335|NCT02517398|584887480|FG022|Overall Study|Other|0|||
161956336|NCT02517398|584887458|FG000|Overall Study|Lost to Follow-up|0|||
161691459|NCT03028870|583920645|FG002|Overall Study|Withdrawal by Subject|1|||
161691460|NCT03028870|583920646|FG003|Overall Study|Withdrawal by Subject|2|||
161691461|NCT03028870|583920643|FG000|Overall Study|Lost to Follow-up|1|||
161691462|NCT03028870|583920644|FG001|Overall Study|Lost to Follow-up|0|||
161691463|NCT03028870|583920645|FG002|Overall Study|Lost to Follow-up|0|||
161691464|NCT03028870|583920646|FG003|Overall Study|Lost to Follow-up|0|||
161691465|NCT03028870|583920643|FG000|Overall Study|Lack of Efficacy|3|||
161691466|NCT03028870|583920644|FG001|Overall Study|Lack of Efficacy|0|||
161691467|NCT03028870|583920645|FG002|Overall Study|Lack of Efficacy|0|||
161691468|NCT03028870|583920646|FG003|Overall Study|Lack of Efficacy|0|||
161691469|NCT03028870|583920643|FG000|Overall Study|Administrative|5|||
161691470|NCT03028870|583920644|FG001|Overall Study|Administrative|5|||
161691471|NCT03028870|583920645|FG002|Overall Study|Administrative|12|||
161691472|NCT03028870|583920646|FG003|Overall Study|Administrative|4|||
161691473|NCT01967537|583920649|FG000|Overall Study|Withdrawal by Subject|52|||
161691474|NCT01967537|583920649|FG000|Overall Study|Refuse treatment|2|||
161691475|NCT01967537|583920649|FG000|Overall Study|Lost to Follow-up|6|||
161691476|NCT00317109|583920652|FG000|Overall Study|Withdrawal by Subject|2|||
161691477|NCT00317109|583920653|FG001|Overall Study|Withdrawal by Subject|0|||
161691478|NCT00317109|583920652|FG000|Overall Study|Migated/moved from study area|1|||
161691479|NCT00317109|583920653|FG001|Overall Study|Migated/moved from study area|0|||
161956337|NCT02517398|584887459|FG001|Overall Study|Lost to Follow-up|0|||
161691480|NCT02425826|583920655|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
161691481|NCT02425826|583920656|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
161691482|NCT02425826|583920657|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
161691483|NCT02425826|583920655|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
161691484|NCT02425826|583920656|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
161691485|NCT02425826|583920657|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
161691486|NCT02425826|583920655|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
161691487|NCT02425826|583920656|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
161956338|NCT02517398|584887460|FG002|Overall Study|Lost to Follow-up|0|||
161956339|NCT02517398|584887461|FG003|Overall Study|Lost to Follow-up|0|||
161691488|NCT02425826|583920657|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
161691489|NCT02425826|583920655|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
161691490|NCT02425826|583920656|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
161691491|NCT02425826|583920657|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
161691492|NCT02425826|583920655|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
161691493|NCT02425826|583920656|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
161691494|NCT02425826|583920657|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
161691495|NCT02425826|583920655|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
161691496|NCT02425826|583920656|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
161691497|NCT02425826|583920657|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
161691498|NCT02425826|583920655|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
161691499|NCT02425826|583920656|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
161691500|NCT02425826|583920657|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
161691501|NCT02425826|583920655|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
161691502|NCT02425826|583920656|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
161691503|NCT02425826|583920657|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
161691504|NCT02425826|583920655|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
161691505|NCT02425826|583920656|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
161691506|NCT02425826|583920657|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
161691507|NCT02425826|583920655|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
161691508|NCT02425826|583920656|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
161691509|NCT02425826|583920657|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
161691510|NCT01344876|583920658|FG000|Overall Study|Adverse Event|0|||
161691511|NCT01344876|583920659|FG001|Overall Study|Adverse Event|0|||
161691512|NCT01344876|583920660|FG002|Overall Study|Adverse Event|0|||
161691513|NCT01344876|583920661|FG003|Overall Study|Adverse Event|0|||
161691514|NCT01344876|583920662|FG004|Overall Study|Adverse Event|1|||
161691515|NCT01344876|583920658|FG000|Overall Study|Withdrawal by Subject|0|||
161691516|NCT01344876|583920659|FG001|Overall Study|Withdrawal by Subject|0|||
161691517|NCT01344876|583920660|FG002|Overall Study|Withdrawal by Subject|1|||
161691518|NCT01344876|583920661|FG003|Overall Study|Withdrawal by Subject|0|||
161691519|NCT01344876|583920662|FG004|Overall Study|Withdrawal by Subject|0|||
161691520|NCT01344876|583920658|FG000|Overall Study|Definite progression of primary disease|1|||
161691521|NCT01344876|583920659|FG001|Overall Study|Definite progression of primary disease|0|||
161691522|NCT01344876|583920660|FG002|Overall Study|Definite progression of primary disease|0|||
161691523|NCT01344876|583920661|FG003|Overall Study|Definite progression of primary disease|3|||
161691524|NCT01344876|583920662|FG004|Overall Study|Definite progression of primary disease|0|||
161691525|NCT05107765|583920663|FG000|Overall Study|Lost to Follow-up|4|||
161691526|NCT05107765|583920664|FG001|Overall Study|Lost to Follow-up|1|||
161691527|NCT05107765|583920663|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
161691528|NCT05107765|583920664|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
161691529|NCT05107765|583920663|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
161691530|NCT05107765|583920664|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
161691531|NCT03047980|583922294|FG000|Overall Study|Adverse Event|1|||
161691532|NCT02164981|583922295|FG000|Started|Withdrawal by Subject|2|||
161691533|NCT02164981|583922296|FG001|Started|Withdrawal by Subject|1|||
161691534|NCT02164981|583922297|FG002|Started|Withdrawal by Subject|0|||
161691535|NCT02164981|583922295|FG000|Started|Protocol Violation|2|||
161691536|NCT02164981|583922296|FG001|Started|Protocol Violation|0|||
161691537|NCT02164981|583922297|FG002|Started|Protocol Violation|0|||
161691538|NCT02164981|583922295|FG000|Started|Adverse Event|1|||
161691539|NCT02164981|583922296|FG001|Started|Adverse Event|2|||
161691540|NCT02164981|583922297|FG002|Started|Adverse Event|0|||
161691541|NCT02164981|583922295|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
161691542|NCT02164981|583922296|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
161691543|NCT02164981|583922297|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
161691544|NCT02164981|583922295|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
161691545|NCT02164981|583922296|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
161691546|NCT02164981|583922297|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
161691547|NCT02164981|583922295|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
161691548|NCT02164981|583922296|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
161691549|NCT02164981|583922297|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
161691550|NCT01761266|583922298|FG000|Overall Study|Death|415|||
161691551|NCT01761266|583922299|FG001|Overall Study|Death|402|||
161956340|NCT02517398|584887462|FG004|Overall Study|Lost to Follow-up|0|||
161691552|NCT01761266|583922298|FG000|Overall Study|Lost to Follow-up|8|||
161691553|NCT01761266|583922299|FG001|Overall Study|Lost to Follow-up|12|||
161691554|NCT01761266|583922298|FG000|Overall Study|Withdrawal by Subject|14|||
161691555|NCT01761266|583922299|FG001|Overall Study|Withdrawal by Subject|10|||
161691556|NCT01761266|583922298|FG000|Overall Study|Sponsor Decision|41|||
161691557|NCT01761266|583922299|FG001|Overall Study|Sponsor Decision|52|||
161691558|NCT01662440|583922300|FG000|Overall Study|Adverse Event|1|||
161691559|NCT01662440|583922301|FG001|Overall Study|Adverse Event|0|||
161691560|NCT01662440|583922302|FG002|Overall Study|Adverse Event|0|||
161691561|NCT01662440|583922303|FG003|Overall Study|Adverse Event|1|||
161691562|NCT01662440|583922300|FG000|Overall Study|Death|0|||
161691563|NCT01662440|583922301|FG001|Overall Study|Death|1|||
161691564|NCT01662440|583922302|FG002|Overall Study|Death|0|||
161691565|NCT01662440|583922303|FG003|Overall Study|Death|0|||
161691566|NCT01662440|583922300|FG000|Overall Study|Lost to Follow-up|2|||
161691567|NCT01662440|583922301|FG001|Overall Study|Lost to Follow-up|2|||
161691568|NCT01662440|583922302|FG002|Overall Study|Lost to Follow-up|4|||
161691569|NCT01662440|583922303|FG003|Overall Study|Lost to Follow-up|1|||
161691570|NCT01662440|583922300|FG000|Overall Study|Subject moved to another country.|0|||
161691571|NCT01662440|583922301|FG001|Overall Study|Subject moved to another country.|1|||
161691572|NCT01662440|583922302|FG002|Overall Study|Subject moved to another country.|0|||
161691573|NCT01662440|583922303|FG003|Overall Study|Subject moved to another country.|0|||
161691574|NCT01662440|583922300|FG000|Overall Study|Protocol Violation|1|||
161691575|NCT01662440|583922301|FG001|Overall Study|Protocol Violation|0|||
161691576|NCT01662440|583922302|FG002|Overall Study|Protocol Violation|0|||
161691577|NCT01662440|583922303|FG003|Overall Study|Protocol Violation|0|||
161691578|NCT01662440|583922300|FG000|Overall Study|Withdrawal by Subject|5|||
161691579|NCT01662440|583922301|FG001|Overall Study|Withdrawal by Subject|2|||
161691580|NCT01662440|583922302|FG002|Overall Study|Withdrawal by Subject|2|||
161691581|NCT01662440|583922303|FG003|Overall Study|Withdrawal by Subject|2|||
161691582|NCT00112905|583922304|FG000|Overall Study|Adverse Event|4|||
161691583|NCT00112905|583922304|FG000|Overall Study|Death|1|||
161691584|NCT00112905|583922304|FG000|Overall Study|Ineligibility|5|||
161691585|NCT00112905|583922304|FG000|Overall Study|Alternative treatment|1|||
161691586|NCT00112905|583922304|FG000|Overall Study|performance status was deteiorating|1|||
161691587|NCT01765673|583922305|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
161691588|NCT02600507|583922306|FG000|Overall Study|Adverse Event|3|||
161691589|NCT02600507|583922307|FG001|Overall Study|Adverse Event|15|||
161691590|NCT02600507|583922308|FG002|Overall Study|Adverse Event|5|||
161691591|NCT02600507|583922306|FG000|Overall Study|Lack of Efficacy|3|||
161691592|NCT02600507|583922307|FG001|Overall Study|Lack of Efficacy|8|||
161691593|NCT02600507|583922308|FG002|Overall Study|Lack of Efficacy|5|||
161691594|NCT02600507|583922306|FG000|Overall Study|Lost to Follow-up|3|||
161691595|NCT02600507|583922307|FG001|Overall Study|Lost to Follow-up|5|||
161691596|NCT02600507|583922308|FG002|Overall Study|Lost to Follow-up|2|||
161691597|NCT02600507|583922306|FG000|Overall Study|Protocol Violation|12|||
161691598|NCT02600507|583922307|FG001|Overall Study|Protocol Violation|4|||
161691599|NCT02600507|583922308|FG002|Overall Study|Protocol Violation|4|||
161691600|NCT02600507|583922306|FG000|Overall Study|Physician Decision|1|||
161691601|NCT02600507|583922307|FG001|Overall Study|Physician Decision|0|||
161691602|NCT02600507|583922308|FG002|Overall Study|Physician Decision|1|||
161691603|NCT02600507|583922306|FG000|Overall Study|Withdrawal by Subject|7|||
161691604|NCT02600507|583922307|FG001|Overall Study|Withdrawal by Subject|11|||
161691605|NCT02600507|583922308|FG002|Overall Study|Withdrawal by Subject|7|||
161691606|NCT02600507|583922306|FG000|Overall Study|Other|0|||
161691607|NCT02600507|583922307|FG001|Overall Study|Other|1|||
161691608|NCT02600507|583922308|FG002|Overall Study|Other|1|||
161691609|NCT05048719|583922313|FG000|Overall Study|Withdrawal by Subject|2|||
161691610|NCT05048719|583922314|FG001|Overall Study|Withdrawal by Subject|1|||
161691611|NCT05048719|583922315|FG002|Overall Study|Withdrawal by Subject|3|||
161691612|NCT05048719|583922316|FG003|Overall Study|Withdrawal by Subject|1|||
161691613|NCT05048719|583922317|FG004|Overall Study|Withdrawal by Subject|0|||
161691614|NCT05048719|583922318|FG005|Overall Study|Withdrawal by Subject|2|||
161691615|NCT05048719|583922319|FG006|Overall Study|Withdrawal by Subject|1|||
161691616|NCT05048719|583922320|FG007|Overall Study|Withdrawal by Subject|1|||
161691617|NCT05048719|583922321|FG008|Overall Study|Withdrawal by Subject|0|||
161691618|NCT05048719|583922313|FG000|Overall Study|Death|1|||
161691619|NCT05048719|583922314|FG001|Overall Study|Death|0|||
161691620|NCT05048719|583922315|FG002|Overall Study|Death|0|||
161691621|NCT05048719|583922316|FG003|Overall Study|Death|0|||
161691622|NCT05048719|583922317|FG004|Overall Study|Death|0|||
161691623|NCT05048719|583922318|FG005|Overall Study|Death|0|||
161691624|NCT05048719|583922319|FG006|Overall Study|Death|0|||
161691625|NCT05048719|583922320|FG007|Overall Study|Death|0|||
161691626|NCT05048719|583922321|FG008|Overall Study|Death|0|||
161691627|NCT05048719|583922313|FG000|Overall Study|Adverse Event|0|||
161691628|NCT05048719|583922314|FG001|Overall Study|Adverse Event|1|||
161691629|NCT05048719|583922315|FG002|Overall Study|Adverse Event|2|||
161691630|NCT05048719|583922316|FG003|Overall Study|Adverse Event|0|||
161691631|NCT05048719|583922317|FG004|Overall Study|Adverse Event|1|||
161691632|NCT05048719|583922318|FG005|Overall Study|Adverse Event|0|||
161691633|NCT05048719|583922319|FG006|Overall Study|Adverse Event|0|||
161691634|NCT05048719|583922320|FG007|Overall Study|Adverse Event|0|||
161691635|NCT05048719|583922321|FG008|Overall Study|Adverse Event|0|||
161691636|NCT05048719|583922313|FG000|Overall Study|Lost to Follow-up|0|||
161691637|NCT05048719|583922314|FG001|Overall Study|Lost to Follow-up|0|||
161691638|NCT05048719|583922315|FG002|Overall Study|Lost to Follow-up|1|||
161691639|NCT05048719|583922316|FG003|Overall Study|Lost to Follow-up|3|||
161691640|NCT05048719|583922317|FG004|Overall Study|Lost to Follow-up|1|||
161691641|NCT05048719|583922318|FG005|Overall Study|Lost to Follow-up|1|||
161691642|NCT05048719|583922319|FG006|Overall Study|Lost to Follow-up|1|||
161691643|NCT05048719|583922320|FG007|Overall Study|Lost to Follow-up|1|||
161691644|NCT05048719|583922321|FG008|Overall Study|Lost to Follow-up|0|||
161691645|NCT05048719|583922313|FG000|Overall Study|Physician Decision|0|||
161691646|NCT05048719|583922314|FG001|Overall Study|Physician Decision|0|||
161691647|NCT05048719|583922315|FG002|Overall Study|Physician Decision|0|||
161691648|NCT05048719|583922316|FG003|Overall Study|Physician Decision|0|||
161691649|NCT05048719|583922317|FG004|Overall Study|Physician Decision|0|||
161691650|NCT05048719|583922318|FG005|Overall Study|Physician Decision|0|||
161691651|NCT05048719|583922319|FG006|Overall Study|Physician Decision|0|||
161691652|NCT05048719|583922320|FG007|Overall Study|Physician Decision|1|||
161691653|NCT05048719|583922321|FG008|Overall Study|Physician Decision|1|||
161691654|NCT05048719|583922313|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
161691655|NCT05048719|583922314|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691656|NCT05048719|583922315|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691657|NCT05048719|583922316|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691658|NCT05048719|583922317|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691659|NCT05048719|583922318|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691660|NCT05048719|583922319|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691661|NCT05048719|583922320|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691662|NCT05048719|583922321|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161691663|NCT05048719|583922313|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691664|NCT05048719|583922314|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
161691665|NCT05048719|583922315|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691666|NCT05048719|583922316|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691667|NCT05048719|583922317|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691668|NCT05048719|583922318|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691669|NCT05048719|583922319|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691670|NCT05048719|583922320|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691671|NCT05048719|583922321|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161691672|NCT05048719|583922313|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691673|NCT05048719|583922314|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
161691674|NCT05048719|583922315|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691675|NCT05048719|583922316|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691676|NCT05048719|583922317|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691677|NCT05048719|583922318|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691678|NCT05048719|583922319|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161836345|NCT03395639|584442941|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
161691679|NCT05048719|583922320|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691680|NCT05048719|583922321|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161691681|NCT05048719|583922313|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161836346|NCT03395639|584442942|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
161956341|NCT02517398|584887463|FG005|Overall Study|Lost to Follow-up|0|||
161691682|NCT05048719|583922314|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691683|NCT05048719|583922315|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691684|NCT05048719|583922316|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
161691685|NCT05048719|583922317|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691686|NCT05048719|583922318|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691687|NCT05048719|583922319|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691688|NCT05048719|583922320|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691689|NCT05048719|583922321|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161691690|NCT05048719|583922313|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691691|NCT05048719|583922314|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691692|NCT05048719|583922315|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691693|NCT05048719|583922316|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691694|NCT05048719|583922317|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691695|NCT05048719|583922318|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
161691696|NCT05048719|583922319|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691697|NCT05048719|583922320|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691698|NCT05048719|583922321|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161691699|NCT04541004|583922322|FG000|Overall Study|Adverse Event|2|||
161691700|NCT00605085|583922323|FG000|Overall Study|Withdrawal by Subject|8|||
161691701|NCT00605085|583922324|FG001|Overall Study|Withdrawal by Subject|5|||
161691702|NCT00605085|583922323|FG000|Overall Study|Adverse Event|9|||
161691703|NCT00605085|583922324|FG001|Overall Study|Adverse Event|5|||
161691704|NCT00605085|583922323|FG000|Overall Study|Pregnancy|2|||
161691705|NCT00605085|583922324|FG001|Overall Study|Pregnancy|0|||
161691706|NCT00605085|583922323|FG000|Overall Study|Protocol Violation|3|||
161691707|NCT00605085|583922324|FG001|Overall Study|Protocol Violation|2|||
161691708|NCT00605085|583922323|FG000|Overall Study|Lost to Follow-up|10|||
161691709|NCT00605085|583922324|FG001|Overall Study|Lost to Follow-up|5|||
161691710|NCT00605085|583922323|FG000|Overall Study|administrative reasons|18|||
161691711|NCT00605085|583922324|FG001|Overall Study|administrative reasons|8|||
161691712|NCT01262365|583922328|FG000|Overall Study|Lack of Efficacy|35|||
161691713|NCT01262365|583922329|FG001|Overall Study|Lack of Efficacy|30|||
161691714|NCT01262365|583922330|FG002|Overall Study|Lack of Efficacy|47|||
161691715|NCT01262365|583922328|FG000|Overall Study|Protocol Violation|3|||
161691716|NCT01262365|583922329|FG001|Overall Study|Protocol Violation|1|||
161691717|NCT01262365|583922330|FG002|Overall Study|Protocol Violation|1|||
161691718|NCT01262365|583922328|FG000|Overall Study|Lost to Follow-up|3|||
161691719|NCT01262365|583922329|FG001|Overall Study|Lost to Follow-up|7|||
161691720|NCT01262365|583922330|FG002|Overall Study|Lost to Follow-up|6|||
161691721|NCT01262365|583922328|FG000|Overall Study|Withdrawal by Subject|17|||
161691722|NCT01262365|583922329|FG001|Overall Study|Withdrawal by Subject|22|||
161691723|NCT01262365|583922330|FG002|Overall Study|Withdrawal by Subject|22|||
161691724|NCT01262365|583922328|FG000|Overall Study|Death|1|||
161691725|NCT01262365|583922329|FG001|Overall Study|Death|2|||
161691726|NCT01262365|583922330|FG002|Overall Study|Death|1|||
161691727|NCT01262365|583922328|FG000|Overall Study|Adverse Event|26|||
161691728|NCT01262365|583922329|FG001|Overall Study|Adverse Event|16|||
161691729|NCT01262365|583922330|FG002|Overall Study|Adverse Event|11|||
161691730|NCT01262365|583922328|FG000|Overall Study|sponsor decision|1|||
161691731|NCT01262365|583922329|FG001|Overall Study|sponsor decision|1|||
161691732|NCT01262365|583922330|FG002|Overall Study|sponsor decision|0|||
161691733|NCT01262365|583922328|FG000|Overall Study|Randomization error|1|||
161691734|NCT01262365|583922329|FG001|Overall Study|Randomization error|0|||
161691735|NCT01262365|583922330|FG002|Overall Study|Randomization error|2|||
161691736|NCT01262365|583922328|FG000|Overall Study|Non-compliance|1|||
161691737|NCT01262365|583922329|FG001|Overall Study|Non-compliance|0|||
161691738|NCT01262365|583922330|FG002|Overall Study|Non-compliance|2|||
161691739|NCT01262365|583922328|FG000|Overall Study|Suspected pregnancy|1|||
161691740|NCT01262365|583922329|FG001|Overall Study|Suspected pregnancy|0|||
161691741|NCT01262365|583922330|FG002|Overall Study|Suspected pregnancy|0|||
161691742|NCT01262365|583922328|FG000|Overall Study|Patient pregnant|1|||
161691743|NCT01262365|583922329|FG001|Overall Study|Patient pregnant|0|||
161691744|NCT01262365|583922330|FG002|Overall Study|Patient pregnant|1|||
161691745|NCT01262365|583922328|FG000|Overall Study|Toxicity related to study drug|0|||
161691746|NCT01262365|583922329|FG001|Overall Study|Toxicity related to study drug|1|||
161691747|NCT01262365|583922330|FG002|Overall Study|Toxicity related to study drug|0|||
161691748|NCT01262365|583922328|FG000|Overall Study|Cannot tolerate the protocol|0|||
161691749|NCT01262365|583922329|FG001|Overall Study|Cannot tolerate the protocol|1|||
161691750|NCT01262365|583922330|FG002|Overall Study|Cannot tolerate the protocol|0|||
161691751|NCT01262365|583922328|FG000|Overall Study|Patient unavailable|0|||
161691752|NCT01262365|583922329|FG001|Overall Study|Patient unavailable|0|||
161691753|NCT01262365|583922330|FG002|Overall Study|Patient unavailable|1|||
161691754|NCT01592760|583922334|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
161691755|NCT01592760|583922335|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
161691756|NCT01592760|583922336|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
161691757|NCT04312009|583922337|FG000|Overall Study|Withdrawal by Subject|2|||
161691758|NCT04312009|583922338|FG001|Overall Study|Withdrawal by Subject|1|||
161691759|NCT02354703|583922341|FG000|Overall Study|Withdrawal by Subject|1|||
161691760|NCT02354703|583922342|FG001|Overall Study|Withdrawal by Subject|1|||
161691761|NCT02354703|583922343|FG002|Overall Study|Withdrawal by Subject|1|||
161691762|NCT02354703|583922344|FG003|Overall Study|Withdrawal by Subject|1|||
161691763|NCT02354703|583922341|FG000|Overall Study|Lost to Follow-up|2|||
161691764|NCT02354703|583922342|FG001|Overall Study|Lost to Follow-up|7|||
161691765|NCT02354703|583922343|FG002|Overall Study|Lost to Follow-up|9|||
161691766|NCT02354703|583922344|FG003|Overall Study|Lost to Follow-up|2|||
161691767|NCT02354703|583922341|FG000|Overall Study|Adverse Event|0|||
161691768|NCT02354703|583922342|FG001|Overall Study|Adverse Event|0|||
161691769|NCT02354703|583922343|FG002|Overall Study|Adverse Event|1|||
161691770|NCT02354703|583922344|FG003|Overall Study|Adverse Event|0|||
161691771|NCT00699348|583922345|FG000|Overall Study|Death|6|||
161691772|NCT00699348|583922345|FG000|Overall Study|Adverse Event|15|||
161691773|NCT00699348|583922345|FG000|Overall Study|Withdrawal by Subject|11|||
161691774|NCT00699348|583922345|FG000|Overall Study|Protocol Violation|10|||
161691775|NCT00699348|583922345|FG000|Overall Study|Lack of Efficacy|8|||
161691776|NCT00699348|583922345|FG000|Overall Study|Failure to return|1|||
161691777|NCT00699348|583922345|FG000|Overall Study|Blood transfusion|24|||
161691778|NCT00699348|583922345|FG000|Overall Study|Renal transplantation|10|||
161691779|NCT00699348|583922345|FG000|Overall Study|Other|5|||
161691780|NCT00122135|583922346|FG000|Overall Study|Withdrawal by Subject|3|||
161691781|NCT00122135|583922347|FG001|Overall Study|Withdrawal by Subject|0|||
161691782|NCT04681170|583922348|FG000|Stratified Enrolment & run-in|Death|1|||
161691783|NCT04681170|583922349|FG001|Stratified Enrolment & run-in|Death|0|||
161691784|NCT04681170|583922348|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
161691785|NCT04681170|583922349|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
161691786|NCT04681170|583922348|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
161691787|NCT04681170|583922349|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
161691788|NCT04681170|583922348|FG000|Open Label Efficacy Phase|Adverse Event|0|||
161691789|NCT04681170|583922349|FG001|Open Label Efficacy Phase|Adverse Event|2|||
161691790|NCT04681170|583922348|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
161691791|NCT04681170|583922349|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
161691792|NCT04681170|583922348|FG000|Open Label Safety Phase|AEs and none compliance|0|||
161691793|NCT04681170|583922349|FG001|Open Label Safety Phase|AEs and none compliance|1|||
161691794|NCT02468648|583922354|FG000|Overall Study|Death|1|||
161691795|NCT00488982|583922355|FG000|Course 1|Physician Decision|0|||
161691796|NCT00488982|583922356|FG001|Course 1|Physician Decision|2|||
161691797|NCT00488982|583922357|FG002|Course 1|Physician Decision|4|||
161691798|NCT00488982|583922355|FG000|Course 1|Withdrawal by Subject|0|||
161691799|NCT00488982|583922356|FG001|Course 1|Withdrawal by Subject|8|||
161691800|NCT00488982|583922357|FG002|Course 1|Withdrawal by Subject|2|||
161691801|NCT00488982|583922355|FG000|Course 1|nonprotocol therapy|0|||
161691802|NCT00488982|583922356|FG001|Course 1|nonprotocol therapy|2|||
161691803|NCT00488982|583922357|FG002|Course 1|nonprotocol therapy|2|||
161691804|NCT00488982|583922355|FG000|Course 1|Adverse Event|0|||
161691805|NCT00488982|583922356|FG001|Course 1|Adverse Event|0|||
161691806|NCT00488982|583922357|FG002|Course 1|Adverse Event|6|||
161691807|NCT01368835|583922358|FG000|Overall Study|Inclusion criteria/photography quality|22|||
161691808|NCT01368835|583922358|FG000|Overall Study|Lost to Follow-up|11|||
161691809|NCT01678144|583922359|FG000|Stage 1: MAR Classic|Adverse Event|1|||
161691810|NCT02754726|583922360|FG000|Overall Study|Progressive Disease by RECIST|13|||
161691811|NCT02754726|583922360|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
161691812|NCT02754726|583922360|FG000|Overall Study|Clinical Disease Progression|5|||
161691813|NCT02754726|583922360|FG000|Overall Study|Adverse Event|3|||
161691814|NCT02754726|583922360|FG000|Overall Study|Withdrawal by Subject|1|||
161691815|NCT02754726|583922360|FG000|Overall Study|Tolerability|1|||
161691816|NCT03806127|583922369|FG000|Overall Study|Withdrawal by Subject|4|||
161691817|NCT03806127|583922370|FG001|Overall Study|Withdrawal by Subject|5|||
161691818|NCT03806127|583922369|FG000|Overall Study|Protocol Violation|3|||
161691819|NCT03806127|583922370|FG001|Overall Study|Protocol Violation|1|||
161691820|NCT03806127|583922369|FG000|Overall Study|Adverse Event|3|||
161691821|NCT03806127|583922370|FG001|Overall Study|Adverse Event|0|||
161691822|NCT03806127|583922369|FG000|Overall Study|Unable to Complete Procedures|0|||
161691823|NCT03806127|583922370|FG001|Overall Study|Unable to Complete Procedures|1|||
161691824|NCT03806127|583922369|FG000|Overall Study|Pregnancy|0|||
161691825|NCT03806127|583922370|FG001|Overall Study|Pregnancy|1|||
161691826|NCT03806127|583922369|FG000|Overall Study|Lost to Follow-up|5|||
161691827|NCT03806127|583922370|FG001|Overall Study|Lost to Follow-up|1|||
161691828|NCT03806127|583922369|FG000|Overall Study|Physician Decision|1|||
161691829|NCT03806127|583922370|FG001|Overall Study|Physician Decision|1|||
161956342|NCT02517398|584887464|FG006|Overall Study|Lost to Follow-up|0|||
161956343|NCT02517398|584887465|FG007|Overall Study|Lost to Follow-up|0|||
161956344|NCT02517398|584887466|FG008|Overall Study|Lost to Follow-up|0|||
161691830|NCT03806127|583922369|FG000|Overall Study|Could Not Come Due to Covid|1|||
161691831|NCT03806127|583922370|FG001|Overall Study|Could Not Come Due to Covid|0|||
161691832|NCT03806127|583922369|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
161691833|NCT03806127|583922370|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
161691834|NCT03806127|583922369|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
161691835|NCT03806127|583922370|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
161691836|NCT03806127|583922369|FG000|Overall Study|Covid 19 Restrictions|2|||
161691837|NCT03806127|583922370|FG001|Overall Study|Covid 19 Restrictions|0|||
161691838|NCT03806127|583922369|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
161691839|NCT03806127|583922370|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
161691840|NCT03806127|583922369|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
161691841|NCT03806127|583922370|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
161691842|NCT01289015|583922376|FG000|Overall Study|Protocol Violation|12|||
161691843|NCT01289015|583922377|FG001|Overall Study|Protocol Violation|9|||
161691844|NCT01289015|583922376|FG000|Overall Study|Adverse Event|3|||
161691845|NCT01289015|583922377|FG001|Overall Study|Adverse Event|0|||
161691846|NCT01289015|583922376|FG000|Overall Study|Lost to Follow-up|33|||
161691847|NCT01289015|583922377|FG001|Overall Study|Lost to Follow-up|17|||
161691848|NCT01289015|583922376|FG000|Overall Study|Withdrawal by Subject|17|||
161691849|NCT01289015|583922377|FG001|Overall Study|Withdrawal by Subject|8|||
161691850|NCT01289015|583922376|FG000|Overall Study|Disease progression|1|||
161691851|NCT01289015|583922377|FG001|Overall Study|Disease progression|0|||
161691852|NCT01289015|583922376|FG000|Overall Study|Negative baseline culture and others|33|||
161691853|NCT01289015|583922377|FG001|Overall Study|Negative baseline culture and others|20|||
161691854|NCT05980299|583922382|FG000|Overall Study|Death|28|||
161691855|NCT05980299|583922383|FG001|Overall Study|Death|0|||
161691856|NCT05980299|583922382|FG000|Overall Study|Discharged from Nursing Home|9|||
161691857|NCT05980299|583922383|FG001|Overall Study|Discharged from Nursing Home|0|||
161691858|NCT05980299|583922382|FG000|Overall Study|Lost to Follow-up|0|||
161691859|NCT05980299|583922383|FG001|Overall Study|Lost to Follow-up|10|||
161691860|NCT01294800|583922391|FG000|Overall Study|Adverse Event|7|||
161691861|NCT01294800|583922392|FG001|Overall Study|Adverse Event|6|||
161691862|NCT01294800|583922393|FG002|Overall Study|Adverse Event|12|||
161691863|NCT01294800|583922394|FG003|Overall Study|Adverse Event|5|||
161691864|NCT01294800|583922391|FG000|Overall Study|Subject Withdrew Consent|2|||
161691865|NCT01294800|583922392|FG001|Overall Study|Subject Withdrew Consent|2|||
161691866|NCT01294800|583922393|FG002|Overall Study|Subject Withdrew Consent|2|||
161691867|NCT01294800|583922394|FG003|Overall Study|Subject Withdrew Consent|11|||
161691868|NCT01294800|583922391|FG000|Overall Study|Lost to Follow-up|0|||
161691869|NCT01294800|583922392|FG001|Overall Study|Lost to Follow-up|0|||
161691870|NCT01294800|583922393|FG002|Overall Study|Lost to Follow-up|1|||
161691871|NCT01294800|583922394|FG003|Overall Study|Lost to Follow-up|0|||
161691872|NCT01294800|583922391|FG000|Overall Study|Non-compliance With Protocol|0|||
161691873|NCT01294800|583922392|FG001|Overall Study|Non-compliance With Protocol|1|||
161691874|NCT01294800|583922393|FG002|Overall Study|Non-compliance With Protocol|1|||
161691875|NCT01294800|583922394|FG003|Overall Study|Non-compliance With Protocol|0|||
161691876|NCT01294800|583922391|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
161691877|NCT01294800|583922392|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
161691878|NCT01294800|583922393|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
161691879|NCT01294800|583922394|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
161691880|NCT01662895|583922395|FG000|Overall Study|Lost to Follow-up|0|||
161691881|NCT01662895|583922396|FG001|Overall Study|Lost to Follow-up|1|||
161691882|NCT05048342|583922397|FG000|Overall Study|Adverse Event|1|||
161691883|NCT05048342|583922397|FG000|Overall Study|Subject decision|2|||
161691884|NCT00493038|583922398|FG000|Treatment|Adverse Event|8|||
161691885|NCT00493038|583922399|FG001|Treatment|Adverse Event|4|||
161691886|NCT00493038|583922398|FG000|Treatment|Lost to Follow-up|5|||
161691887|NCT00493038|583922399|FG001|Treatment|Lost to Follow-up|3|||
161691888|NCT00493038|583922398|FG000|Treatment|Withdrawal by Subject|11|||
161691889|NCT00493038|583922399|FG001|Treatment|Withdrawal by Subject|12|||
161691890|NCT00493038|583922398|FG000|Treatment|Other|0|||
161691891|NCT00493038|583922399|FG001|Treatment|Other|1|||
161691892|NCT00493038|583922398|FG000|Follow-up|Lost to Follow-up|1|||
161691893|NCT00493038|583922399|FG001|Follow-up|Lost to Follow-up|0|||
161691894|NCT01441063|583922400|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
161691895|NCT01441063|583922400|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
161691896|NCT03345472|583922402|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
161691897|NCT03345472|583922402|FG000|Implant to 3 Months|Physician Decision|1|||
161691898|NCT03345472|583922402|FG000|Implant to 3 Months|Adverse Event|1|||
161691899|NCT03345472|583922402|FG000|3 Months to 12 Months|Physician Decision|3|||
161691900|NCT03345472|583922402|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
161956345|NCT02517398|584887467|FG009|Overall Study|Lost to Follow-up|1|||
161956346|NCT02517398|584887468|FG010|Overall Study|Lost to Follow-up|0|||
161956347|NCT02517398|584887469|FG011|Overall Study|Lost to Follow-up|2|||
161956348|NCT02517398|584887470|FG012|Overall Study|Lost to Follow-up|2|||
161956349|NCT02517398|584887471|FG013|Overall Study|Lost to Follow-up|0|||
161956350|NCT02517398|584887472|FG014|Overall Study|Lost to Follow-up|1|||
161956351|NCT02517398|584887473|FG015|Overall Study|Lost to Follow-up|1|||
161691901|NCT03345472|583922402|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
161956352|NCT02517398|584887474|FG016|Overall Study|Lost to Follow-up|0|||
161956353|NCT02517398|584887475|FG017|Overall Study|Lost to Follow-up|3|||
161956354|NCT02517398|584887476|FG018|Overall Study|Lost to Follow-up|1|||
161956355|NCT02517398|584887477|FG019|Overall Study|Lost to Follow-up|0|||
161956356|NCT02517398|584887478|FG020|Overall Study|Lost to Follow-up|1|||
161956357|NCT02517398|584887479|FG021|Overall Study|Lost to Follow-up|0|||
161691902|NCT03345472|583922402|FG000|3 Months to 12 Months|Adverse Event|1|||
161691903|NCT03345472|583922402|FG000|3 Months to 12 Months|Death|1|||
161691904|NCT02296242|583922428|FG000|Overall Study|Death|1|||
161691905|NCT02296242|583922429|FG001|Overall Study|Death|1|||
161691906|NCT02296242|583922430|FG002|Overall Study|Death|1|||
161691907|NCT02296242|583922431|FG003|Overall Study|Death|1|||
161691908|NCT02296242|583922432|FG004|Overall Study|Death|1|||
161691909|NCT02296242|583922428|FG000|Overall Study|Withdrawal by Subject|0|||
161691910|NCT02296242|583922429|FG001|Overall Study|Withdrawal by Subject|0|||
161691911|NCT02296242|583922430|FG002|Overall Study|Withdrawal by Subject|1|||
161691912|NCT02296242|583922431|FG003|Overall Study|Withdrawal by Subject|1|||
161691913|NCT02296242|583922432|FG004|Overall Study|Withdrawal by Subject|3|||
161691914|NCT02296242|583922428|FG000|Overall Study|Disease Progression|1|||
161691915|NCT02296242|583922429|FG001|Overall Study|Disease Progression|3|||
161691916|NCT02296242|583922430|FG002|Overall Study|Disease Progression|2|||
161691917|NCT02296242|583922431|FG003|Overall Study|Disease Progression|8|||
161691918|NCT02296242|583922432|FG004|Overall Study|Disease Progression|11|||
161691919|NCT02296242|583922428|FG000|Overall Study|Unacceptable Toxicity|0|||
161691920|NCT02296242|583922429|FG001|Overall Study|Unacceptable Toxicity|0|||
161691921|NCT02296242|583922430|FG002|Overall Study|Unacceptable Toxicity|0|||
161691922|NCT02296242|583922431|FG003|Overall Study|Unacceptable Toxicity|0|||
161691923|NCT02296242|583922432|FG004|Overall Study|Unacceptable Toxicity|1|||
161691924|NCT02296242|583922428|FG000|Overall Study|Patient Condition Changed|0|||
161691925|NCT02296242|583922429|FG001|Overall Study|Patient Condition Changed|0|||
161691926|NCT02296242|583922430|FG002|Overall Study|Patient Condition Changed|2|||
161691927|NCT02296242|583922431|FG003|Overall Study|Patient Condition Changed|0|||
161691928|NCT02296242|583922432|FG004|Overall Study|Patient Condition Changed|1|||
161691929|NCT02296242|583922428|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
161691930|NCT02296242|583922429|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
161691931|NCT02296242|583922430|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
161691932|NCT02296242|583922431|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
161691933|NCT02296242|583922432|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
161691934|NCT02296242|583922428|FG000|Overall Study|Lost to Follow-up|1|||
161691935|NCT02296242|583922429|FG001|Overall Study|Lost to Follow-up|0|||
161691936|NCT02296242|583922430|FG002|Overall Study|Lost to Follow-up|0|||
161691937|NCT02296242|583922431|FG003|Overall Study|Lost to Follow-up|0|||
161691938|NCT02296242|583922432|FG004|Overall Study|Lost to Follow-up|0|||
161691939|NCT02296242|583922428|FG000|Overall Study|Need for Hydroxyurea|2|||
161691940|NCT02296242|583922429|FG001|Overall Study|Need for Hydroxyurea|0|||
161691941|NCT02296242|583922430|FG002|Overall Study|Need for Hydroxyurea|0|||
161691942|NCT02296242|583922431|FG003|Overall Study|Need for Hydroxyurea|0|||
161691943|NCT02296242|583922432|FG004|Overall Study|Need for Hydroxyurea|0|||
161691944|NCT02296242|583922428|FG000|Overall Study|Screened for Other Protocol|0|||
161691945|NCT02296242|583922429|FG001|Overall Study|Screened for Other Protocol|1|||
161691946|NCT02296242|583922430|FG002|Overall Study|Screened for Other Protocol|0|||
161691947|NCT02296242|583922431|FG003|Overall Study|Screened for Other Protocol|0|||
161691948|NCT02296242|583922432|FG004|Overall Study|Screened for Other Protocol|0|||
161691949|NCT02296242|583922428|FG000|Overall Study|Physician Decision|0|||
161691950|NCT02296242|583922429|FG001|Overall Study|Physician Decision|1|||
161691951|NCT02296242|583922430|FG002|Overall Study|Physician Decision|0|||
161691952|NCT02296242|583922431|FG003|Overall Study|Physician Decision|1|||
161691953|NCT02296242|583922432|FG004|Overall Study|Physician Decision|0|||
161691954|NCT02296242|583922428|FG000|Overall Study|Alternative Treatment|0|||
161691955|NCT02296242|583922429|FG001|Overall Study|Alternative Treatment|0|||
161691956|NCT02296242|583922430|FG002|Overall Study|Alternative Treatment|0|||
161691957|NCT02296242|583922431|FG003|Overall Study|Alternative Treatment|1|||
161691958|NCT02296242|583922432|FG004|Overall Study|Alternative Treatment|0|||
161691959|NCT02296242|583922428|FG000|Overall Study|Adverse Event|0|||
161691960|NCT02296242|583922429|FG001|Overall Study|Adverse Event|0|||
161956358|NCT02517398|584887480|FG022|Overall Study|Lost to Follow-up|2|||
161691961|NCT02296242|583922430|FG002|Overall Study|Adverse Event|0|||
161691962|NCT02296242|583922431|FG003|Overall Study|Adverse Event|1|||
161691963|NCT02296242|583922432|FG004|Overall Study|Adverse Event|0|||
161691964|NCT02296242|583922428|FG000|Overall Study|Lack of Efficacy|0|||
161691965|NCT02296242|583922429|FG001|Overall Study|Lack of Efficacy|0|||
161691966|NCT02296242|583922430|FG002|Overall Study|Lack of Efficacy|0|||
161691967|NCT02296242|583922431|FG003|Overall Study|Lack of Efficacy|0|||
161691968|NCT02296242|583922432|FG004|Overall Study|Lack of Efficacy|3|||
161691969|NCT01639833|583922433|FG000|Overall Study|Death|4|||
161691970|NCT01639833|583922434|FG001|Overall Study|Death|2|||
161691971|NCT01639833|583922433|FG000|Overall Study|Withdrawal by Subject|2|||
161691972|NCT01639833|583922434|FG001|Overall Study|Withdrawal by Subject|2|||
161691973|NCT00070941|583922435|FG000|Overall Study|Adverse Event|10|||
161691974|NCT00070941|583922436|FG001|Overall Study|Adverse Event|8|||
161691975|NCT00070941|583922437|FG002|Overall Study|Adverse Event|4|||
161691976|NCT01888640|583922438|FG000|Overall Study|Lost to Follow-up|1|||
161691977|NCT01888640|583922439|FG001|Overall Study|Lost to Follow-up|2|||
161691978|NCT01888640|583922440|FG002|Overall Study|Lost to Follow-up|0|||
161691979|NCT01888640|583922438|FG000|Overall Study|Withdrawal by Subject|15|||
161691980|NCT01888640|583922439|FG001|Overall Study|Withdrawal by Subject|11|||
161691981|NCT01888640|583922440|FG002|Overall Study|Withdrawal by Subject|4|||
161691982|NCT01888640|583922438|FG000|Overall Study|Minimum dose not met|10|||
161691983|NCT01888640|583922439|FG001|Overall Study|Minimum dose not met|16|||
161691984|NCT01888640|583922440|FG002|Overall Study|Minimum dose not met|0|||
161691985|NCT01888640|583922438|FG000|Overall Study|Given wrong unit (placebo)|1|||
161691986|NCT01888640|583922439|FG001|Overall Study|Given wrong unit (placebo)|0|||
161691987|NCT01888640|583922440|FG002|Overall Study|Given wrong unit (placebo)|0|||
161691988|NCT01888640|583922438|FG000|Overall Study|Excluded for prior TENS|0|||
161691989|NCT01888640|583922439|FG001|Overall Study|Excluded for prior TENS|1|||
161691990|NCT01888640|583922440|FG002|Overall Study|Excluded for prior TENS|0|||
161691991|NCT01888640|583922438|FG000|Overall Study|Researcher Termination of Participant|0|||
161691992|NCT01888640|583922439|FG001|Overall Study|Researcher Termination of Participant|1|||
161691993|NCT01888640|583922440|FG002|Overall Study|Researcher Termination of Participant|1|||
161691994|NCT02199080|583922441|FG000|Overall Study|Protocol Violation|12|||
161691995|NCT01277549|583922442|FG000|Overall Study|Failed to meet eligibility criteria|13|||
161691996|NCT01277549|583922443|FG001|Overall Study|Failed to meet eligibility criteria|9|||
161691997|NCT01277549|583922442|FG000|Overall Study|Withdrawal by Subject|1|||
161691998|NCT01277549|583922443|FG001|Overall Study|Withdrawal by Subject|3|||
161691999|NCT01277549|583922442|FG000|Overall Study|Protocol Violation|10|||
161692000|NCT01277549|583922443|FG001|Overall Study|Protocol Violation|1|||
161692001|NCT01277549|583922442|FG000|Overall Study|Physician Decision|2|||
161692002|NCT01277549|583922443|FG001|Overall Study|Physician Decision|1|||
161692003|NCT01568593|583922444|FG000|Overall Study|Lack of Efficacy|4|||
161692004|NCT01568593|583922445|FG001|Overall Study|Lack of Efficacy|1|||
161692005|NCT01568593|583922444|FG000|Overall Study|Adverse Event|3|||
161692006|NCT01568593|583922445|FG001|Overall Study|Adverse Event|2|||
161692007|NCT02109484|583922446|FG000|Overall Study|Lost to Follow-up|0|||
161692008|NCT02109484|583922447|FG001|Overall Study|Lost to Follow-up|0|||
161692009|NCT02109484|583922448|FG002|Overall Study|Lost to Follow-up|0|||
161692010|NCT02109484|583922449|FG003|Overall Study|Lost to Follow-up|1|||
161692011|NCT02109484|583922450|FG004|Overall Study|Lost to Follow-up|1|||
161692012|NCT02109484|583922451|FG005|Overall Study|Lost to Follow-up|0|||
161692013|NCT02109484|583922452|FG006|Overall Study|Lost to Follow-up|1|||
161692014|NCT02109484|583922453|FG007|Overall Study|Lost to Follow-up|0|||
161692015|NCT02109484|583922446|FG000|Overall Study|Withdrawal by Subject|0|||
161692016|NCT02109484|583922447|FG001|Overall Study|Withdrawal by Subject|0|||
161692017|NCT02109484|583922448|FG002|Overall Study|Withdrawal by Subject|0|||
161692018|NCT02109484|583922449|FG003|Overall Study|Withdrawal by Subject|0|||
161692019|NCT02109484|583922450|FG004|Overall Study|Withdrawal by Subject|1|||
161692020|NCT02109484|583922451|FG005|Overall Study|Withdrawal by Subject|1|||
161692021|NCT02109484|583922452|FG006|Overall Study|Withdrawal by Subject|1|||
161692022|NCT02109484|583922453|FG007|Overall Study|Withdrawal by Subject|0|||
161692023|NCT02109484|583922446|FG000|Overall Study|Physician Decision|0|||
161692024|NCT02109484|583922447|FG001|Overall Study|Physician Decision|0|||
161692025|NCT02109484|583922448|FG002|Overall Study|Physician Decision|0|||
161692026|NCT02109484|583922449|FG003|Overall Study|Physician Decision|0|||
161692027|NCT02109484|583922450|FG004|Overall Study|Physician Decision|2|||
161692028|NCT02109484|583922451|FG005|Overall Study|Physician Decision|0|||
161692029|NCT02109484|583922452|FG006|Overall Study|Physician Decision|0|||
161692030|NCT02109484|583922453|FG007|Overall Study|Physician Decision|0|||
161692031|NCT02109484|583922446|FG000|Overall Study|Death|0|||
161692032|NCT02109484|583922447|FG001|Overall Study|Death|0|||
161692033|NCT02109484|583922448|FG002|Overall Study|Death|0|||
161692034|NCT02109484|583922449|FG003|Overall Study|Death|0|||
161692035|NCT02109484|583922450|FG004|Overall Study|Death|0|||
161692036|NCT02109484|583922451|FG005|Overall Study|Death|0|||
161692037|NCT02109484|583922452|FG006|Overall Study|Death|0|||
161692038|NCT02109484|583922453|FG007|Overall Study|Death|2|||
161692039|NCT02109484|583922446|FG000|Overall Study|Moved away from study area|0|||
161692040|NCT02109484|583922447|FG001|Overall Study|Moved away from study area|0|||
161692041|NCT02109484|583922448|FG002|Overall Study|Moved away from study area|0|||
161692042|NCT02109484|583922449|FG003|Overall Study|Moved away from study area|0|||
161692043|NCT02109484|583922450|FG004|Overall Study|Moved away from study area|0|||
161692044|NCT02109484|583922451|FG005|Overall Study|Moved away from study area|0|||
161692045|NCT02109484|583922452|FG006|Overall Study|Moved away from study area|1|||
161692046|NCT02109484|583922453|FG007|Overall Study|Moved away from study area|1|||
161692047|NCT01097863|583922454|FG000|Overall Study|Discomfort|1|||
161692048|NCT01097863|583922455|FG001|Overall Study|Discomfort|0|||
161692049|NCT01097863|583922456|FG002|Overall Study|Discomfort|1|||
161692050|NCT01097863|583922454|FG000|Overall Study|Did not return for final visit|0|||
161692051|NCT01097863|583922455|FG001|Overall Study|Did not return for final visit|0|||
161692052|NCT01097863|583922456|FG002|Overall Study|Did not return for final visit|1|||
161692053|NCT00419380|583922457|FG000|Overall Study|Lack of Efficacy|1|||
161692054|NCT00419380|583922458|FG001|Overall Study|Lack of Efficacy|7|||
161692055|NCT00419380|583922457|FG000|Overall Study|Physician Decision|0|||
161692056|NCT00419380|583922458|FG001|Overall Study|Physician Decision|1|||
161692057|NCT00419380|583922457|FG000|Overall Study|Lost to Follow-up|0|||
161692058|NCT00419380|583922458|FG001|Overall Study|Lost to Follow-up|1|||
161692059|NCT00419380|583922457|FG000|Overall Study|Withdrawal by Subject|0|||
161692060|NCT00419380|583922458|FG001|Overall Study|Withdrawal by Subject|1|||
161692061|NCT00796315|583922459|FG000|Overall Study|Protocol Violation|0|||
161692062|NCT00796315|583922460|FG001|Overall Study|Protocol Violation|1|||
161692063|NCT00796315|583922461|FG002|Overall Study|Protocol Violation|0|||
161692064|NCT03099707|583922462|FG000|Overall Study|Withdrawal by Subject|0|||
161692065|NCT03099707|583922463|FG001|Overall Study|Withdrawal by Subject|3|||
161692066|NCT03099707|583922462|FG000|Overall Study|Lost to Follow-up|0|||
161692067|NCT03099707|583922463|FG001|Overall Study|Lost to Follow-up|1|||
161692068|NCT01294579|583922469|FG000|Overall Study|Disease progression|12|||
161692069|NCT01294579|583922469|FG000|Overall Study|Adverse Event|11|||
161692070|NCT01294579|583922469|FG000|Overall Study|Study closed/terminated|3|||
161692071|NCT01294579|583922469|FG000|Overall Study|Lost to Follow-up|1|||
161692072|NCT01294579|583922469|FG000|Overall Study|Physician Decision|3|||
161692073|NCT01294579|583922469|FG000|Overall Study|Withdrawal by Subject|5|||
161692074|NCT02788747|583922470|FG000|Overall Study|Adverse Event|1|||
161692075|NCT02788747|583922471|FG001|Overall Study|Adverse Event|0|||
161692076|NCT02788747|583922472|FG002|Overall Study|Adverse Event|0|||
161692077|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
161692078|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
161692079|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
161692080|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
161692081|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
161692082|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
161692083|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
161692084|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
161692085|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
161692086|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
161692087|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
161692088|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
161692089|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
161692090|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
161692091|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
161692092|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
161692093|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
161692094|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
161692095|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
161692096|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
161692097|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
161692098|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
161692099|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
161692100|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
161692101|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
161692102|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
161692103|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
161692104|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
161692105|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
161692106|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
161692107|NCT00784654|583922473|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
161692108|NCT00784654|583922474|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
161692109|NCT00784654|583922475|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
161692110|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
161692111|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
161692112|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
161692113|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
161692114|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
161692115|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
161692116|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161956359|NCT02517398|584887458|FG000|Overall Study|Withdrew Consent|0|||
161956360|NCT02517398|584887459|FG001|Overall Study|Withdrew Consent|0|||
161692117|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
161692118|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
161692119|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
161692120|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
161956361|NCT02517398|584887460|FG002|Overall Study|Withdrew Consent|0|||
161956362|NCT02517398|584887461|FG003|Overall Study|Withdrew Consent|0|||
161692121|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
161692122|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Adverse Event|0|||
161692123|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Adverse Event|1|||
161956363|NCT02517398|584887462|FG004|Overall Study|Withdrew Consent|0|||
161956364|NCT02517398|584887463|FG005|Overall Study|Withdrew Consent|0|||
161692124|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Adverse Event|1|||
161692125|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
161692126|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
161692127|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
161692128|NCT00784654|583922473|FG000|Randomized Withdrawal Period|Family reasons|0|||
161692129|NCT00784654|583922474|FG001|Randomized Withdrawal Period|Family reasons|0|||
161692130|NCT00784654|583922475|FG002|Randomized Withdrawal Period|Family reasons|1|||
161692131|NCT00562354|583922476|FG000|Overall Study|Physician Decision|0|||
161692132|NCT00562354|583922477|FG001|Overall Study|Physician Decision|1|||
161692133|NCT00562354|583922476|FG000|Overall Study|Lost to Follow-up|0|||
161692134|NCT00562354|583922477|FG001|Overall Study|Lost to Follow-up|1|||
161692135|NCT03074474|583922483|FG000|Overall Study|Lost to Follow-up|10|||
161692136|NCT03074474|583922483|FG000|Overall Study|Withdrawal by Subject|10|||
161692137|NCT03074474|583922483|FG000|Overall Study|Death|4|||
161692138|NCT03074474|583922483|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
161692139|NCT01430455|583922494|FG000|Overall Study|Withdrawal by Subject|1|||
161692140|NCT01430455|583922494|FG000|Overall Study|Switched to follow-up phase|1|||
161692141|NCT05061719|583922498|FG000|Overall Study|Adverse Event|60|||
161692142|NCT05061719|583922498|FG000|Overall Study|Death|1|||
161692143|NCT05061719|583922498|FG000|Overall Study|Lack of Efficacy|7|||
161692144|NCT05061719|583922498|FG000|Overall Study|Lost to Follow-up|5|||
161692145|NCT05061719|583922498|FG000|Overall Study|Pregnancy|1|||
161692146|NCT05061719|583922498|FG000|Overall Study|Protocol Violation|8|||
161692147|NCT05061719|583922498|FG000|Overall Study|Withdrawal by Subject|41|||
161692148|NCT05061719|583922498|FG000|Overall Study|Site Closure|2|||
161692149|NCT00494091|583924267|FG000|Overall Study|Death|5|||
161692150|NCT00494091|583924268|FG001|Overall Study|Death|54|||
161692151|NCT00494091|583924267|FG000|Overall Study|Lost to Follow-up|0|||
161692152|NCT00494091|583924268|FG001|Overall Study|Lost to Follow-up|4|||
161692153|NCT00494091|583924267|FG000|Overall Study|Other|1|||
161692154|NCT00494091|583924268|FG001|Overall Study|Other|11|||
161692155|NCT00494091|583924267|FG000|Overall Study|Withdrawal by Subject|0|||
161692156|NCT00494091|583924268|FG001|Overall Study|Withdrawal by Subject|7|||
161692157|NCT01652287|583924269|FG000|Overall Study|Withdrawal by Subject|2|||
161692158|NCT01652287|583924270|FG001|Overall Study|Withdrawal by Subject|0|||
161692159|NCT00984204|583924282|FG000|Overall Study|Death|1|||
161692160|NCT00984204|583924282|FG000|Overall Study|Lost to Follow-up|4|||
161692161|NCT00984204|583924282|FG000|Overall Study|Lack of Efficacy|10|||
161692162|NCT04478708|583924286|FG000|Overall Study|Lost to Follow-up|0|||
161692163|NCT04478708|583924287|FG001|Overall Study|Lost to Follow-up|0|||
161692164|NCT04478708|583924288|FG002|Overall Study|Lost to Follow-up|0|||
161692165|NCT04478708|583924289|FG003|Overall Study|Lost to Follow-up|0|||
161692166|NCT04478708|583924290|FG004|Overall Study|Lost to Follow-up|0|||
161692167|NCT04478708|583924291|FG005|Overall Study|Lost to Follow-up|0|||
161692168|NCT04478708|583924292|FG006|Overall Study|Lost to Follow-up|0|||
161692169|NCT04478708|583924293|FG007|Overall Study|Lost to Follow-up|0|||
161692170|NCT04478708|583924294|FG008|Overall Study|Lost to Follow-up|1|||
161692171|NCT04478708|583924295|FG009|Overall Study|Lost to Follow-up|1|||
161692172|NCT04478708|583924296|FG010|Overall Study|Lost to Follow-up|1|||
161692173|NCT04478708|583924297|FG011|Overall Study|Lost to Follow-up|2|||
161956365|NCT02517398|584887464|FG006|Overall Study|Withdrew Consent|1|||
161956366|NCT02517398|584887465|FG007|Overall Study|Withdrew Consent|0|||
161956367|NCT02517398|584887466|FG008|Overall Study|Withdrew Consent|0|||
161956368|NCT02517398|584887467|FG009|Overall Study|Withdrew Consent|2|||
161956369|NCT02517398|584887468|FG010|Overall Study|Withdrew Consent|7|||
161692174|NCT04478708|583924298|FG012|Overall Study|Lost to Follow-up|1|||
161692175|NCT04478708|583924299|FG013|Overall Study|Lost to Follow-up|0|||
161692176|NCT04478708|583924300|FG014|Overall Study|Lost to Follow-up|0|||
161692177|NCT04478708|583924301|FG015|Overall Study|Lost to Follow-up|0|||
161692178|NCT04478708|583924302|FG016|Overall Study|Lost to Follow-up|0|||
161692179|NCT04478708|583924286|FG000|Overall Study|Withdrawal of consent from study|0|||
161692180|NCT04478708|583924287|FG001|Overall Study|Withdrawal of consent from study|1|||
161692181|NCT04478708|583924288|FG002|Overall Study|Withdrawal of consent from study|2|||
161692182|NCT04478708|583924289|FG003|Overall Study|Withdrawal of consent from study|0|||
161692183|NCT04478708|583924290|FG004|Overall Study|Withdrawal of consent from study|1|||
161692184|NCT04478708|583924291|FG005|Overall Study|Withdrawal of consent from study|1|||
161692185|NCT04478708|583924292|FG006|Overall Study|Withdrawal of consent from study|1|||
161956370|NCT02517398|584887469|FG011|Overall Study|Withdrew Consent|1|||
161956371|NCT02517398|584887470|FG012|Overall Study|Withdrew Consent|5|||
161692186|NCT04478708|583924293|FG007|Overall Study|Withdrawal of consent from study|0|||
161692187|NCT04478708|583924294|FG008|Overall Study|Withdrawal of consent from study|0|||
161692188|NCT04478708|583924295|FG009|Overall Study|Withdrawal of consent from study|0|||
161692189|NCT04478708|583924296|FG010|Overall Study|Withdrawal of consent from study|4|||
161692190|NCT04478708|583924297|FG011|Overall Study|Withdrawal of consent from study|3|||
161692191|NCT04478708|583924298|FG012|Overall Study|Withdrawal of consent from study|0|||
161692192|NCT04478708|583924299|FG013|Overall Study|Withdrawal of consent from study|0|||
161692193|NCT04478708|583924300|FG014|Overall Study|Withdrawal of consent from study|1|||
161692194|NCT04478708|583924301|FG015|Overall Study|Withdrawal of consent from study|0|||
161692195|NCT04478708|583924302|FG016|Overall Study|Withdrawal of consent from study|4|||
161692196|NCT01869114|583924303|FG000|Overall Study|Death|19|||
161692197|NCT01869114|583924304|FG001|Overall Study|Death|18|||
161692198|NCT01869114|583924305|FG002|Overall Study|Death|8|||
161692199|NCT01869114|583924303|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
161692200|NCT01869114|583924304|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
161692201|NCT01869114|583924305|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
161692202|NCT01869114|583924303|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
161692203|NCT01869114|583924304|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
161692204|NCT01869114|583924305|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
161692205|NCT01869114|583924303|FG000|Overall Study|Withdrawal by Subject|0|||
161692206|NCT01869114|583924304|FG001|Overall Study|Withdrawal by Subject|3|||
161692207|NCT01869114|583924305|FG002|Overall Study|Withdrawal by Subject|0|||
161692208|NCT01869114|583924303|FG000|Overall Study|Disease Progression|0|||
161692209|NCT01869114|583924304|FG001|Overall Study|Disease Progression|1|||
161692210|NCT01869114|583924305|FG002|Overall Study|Disease Progression|0|||
161692211|NCT00559507|583924306|FG000|Overall Study|Not treated, patient ineligible|3|||
161692212|NCT01407926|583924307|FG000|Overall Study|Lost to Follow-up|55|||
161692213|NCT02118792|583924308|FG000|Overall Study|Withdrawal by Subject|6|||
161692214|NCT02118792|583924309|FG001|Overall Study|Withdrawal by Subject|3|||
161692215|NCT02118792|583924308|FG000|Overall Study|Lost to Follow-up|4|||
161692216|NCT02118792|583924309|FG001|Overall Study|Lost to Follow-up|4|||
161692217|NCT02118792|583924308|FG000|Overall Study|Adverse Event|5|||
161692218|NCT02118792|583924309|FG001|Overall Study|Adverse Event|4|||
161956372|NCT02517398|584887471|FG013|Overall Study|Withdrew Consent|4|||
161956373|NCT02517398|584887472|FG014|Overall Study|Withdrew Consent|2|||
161956374|NCT02517398|584887473|FG015|Overall Study|Withdrew Consent|5|||
161692219|NCT02118792|583924308|FG000|Overall Study|Withdrawal by parent/guardian|14|||
161692220|NCT02118792|583924309|FG001|Overall Study|Withdrawal by parent/guardian|20|||
161692221|NCT02118792|583924308|FG000|Overall Study|Other|1|||
161692222|NCT02118792|583924309|FG001|Overall Study|Other|6|||
161692223|NCT02118792|583924308|FG000|Overall Study|Randomised but not treated|1|||
161692224|NCT02118792|583924309|FG001|Overall Study|Randomised but not treated|0|||
161692225|NCT01885000|583924310|FG000|Overall Study|Adverse Event|1|||
161692226|NCT01885000|583924311|FG001|Overall Study|Adverse Event|0|||
161692227|NCT01885000|583924310|FG000|Overall Study|Withdrawal by Subject|1|||
161836347|NCT03395639|584442943|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
161836348|NCT03395639|584442941|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
161836349|NCT03395639|584442942|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
161836350|NCT03395639|584442943|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
161836351|NCT03395639|584442941|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
161836352|NCT03395639|584442942|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
161956375|NCT02517398|584887474|FG016|Overall Study|Withdrew Consent|4|||
161956376|NCT02517398|584887475|FG017|Overall Study|Withdrew Consent|2|||
161836353|NCT03395639|584442943|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
161836354|NCT00942331|584442944|FG000|Overall Study|Did not start treatment|15|||
161956377|NCT02517398|584887476|FG018|Overall Study|Withdrew Consent|3|||
161956378|NCT02517398|584887477|FG019|Overall Study|Withdrew Consent|2|||
161956379|NCT02517398|584887478|FG020|Overall Study|Withdrew Consent|9|||
161956380|NCT02517398|584887479|FG021|Overall Study|Withdrew Consent|3|||
161956381|NCT02517398|584887480|FG022|Overall Study|Withdrew Consent|1|||
161956382|NCT05588440|584887487|FG000|Overall Study|Sponsor Decision|2|||
161956383|NCT05588440|584887488|FG001|Overall Study|Sponsor Decision|0|||
161956384|NCT05588440|584887489|FG002|Overall Study|Sponsor Decision|1|||
161956385|NCT05588440|584887487|FG000|Overall Study|Death|1|||
161956386|NCT05588440|584887488|FG001|Overall Study|Death|1|||
161956387|NCT05588440|584887489|FG002|Overall Study|Death|1|||
161956388|NCT05588440|584887487|FG000|Overall Study|Screen Fail|0|||
161956389|NCT05588440|584887488|FG001|Overall Study|Screen Fail|1|||
161956390|NCT05588440|584887489|FG002|Overall Study|Screen Fail|1|||
161956391|NCT05588440|584887487|FG000|Overall Study|Withdrawal by Subject|0|||
161956392|NCT05588440|584887488|FG001|Overall Study|Withdrawal by Subject|0|||
161692228|NCT01885000|583924311|FG001|Overall Study|Withdrawal by Subject|1|||
161692229|NCT01885000|583924310|FG000|Overall Study|Protocol Violation|0|||
161692230|NCT01885000|583924311|FG001|Overall Study|Protocol Violation|1|||
161692231|NCT02792842|583924315|FG000|Overall Study|Adverse Event|4|||
161692232|NCT02792842|583924316|FG001|Overall Study|Adverse Event|2|||
161692233|NCT02792842|583924317|FG002|Overall Study|Adverse Event|3|||
161692234|NCT02792842|583924315|FG000|Overall Study|Withdrawal by Subject|0|||
161956393|NCT05588440|584887489|FG002|Overall Study|Withdrawal by Subject|1|||
161956394|NCT03581292|584887490|FG000|Overall Study|Physician Decision|9|||
161956395|NCT03581292|584887491|FG001|Overall Study|Physician Decision|5|||
161956396|NCT03581292|584887490|FG000|Overall Study|Withdrawal by Subject|3|||
161956397|NCT03581292|584887491|FG001|Overall Study|Withdrawal by Subject|0|||
161956398|NCT03581292|584887490|FG000|Overall Study|Withdrawal before Therapy Start|1|||
161956399|NCT03581292|584887491|FG001|Overall Study|Withdrawal before Therapy Start|0|||
161692235|NCT02792842|583924316|FG001|Overall Study|Withdrawal by Subject|1|||
161692236|NCT02792842|583924317|FG002|Overall Study|Withdrawal by Subject|2|||
161956400|NCT05200572|584887492|FG000|Overall Study|Withdrawal by Subject|14|||
161956401|NCT02524145|584887496|FG000|Overall Study|Withdrawal by Subject|2|||
161692237|NCT02792842|583924315|FG000|Overall Study|Lost to Follow-up|0|||
161692238|NCT02792842|583924316|FG001|Overall Study|Lost to Follow-up|0|||
161692239|NCT02792842|583924317|FG002|Overall Study|Lost to Follow-up|1|||
161692240|NCT02792842|583924315|FG000|Overall Study|Schedule delay|0|||
161692241|NCT02792842|583924316|FG001|Overall Study|Schedule delay|1|||
161692242|NCT02792842|583924317|FG002|Overall Study|Schedule delay|1|||
161692243|NCT05617911|583924325|FG000|Overall Study|Withdrawal by Subject|1|||
161692244|NCT05617911|583924326|FG001|Overall Study|Withdrawal by Subject|0|||
161692245|NCT03557359|583924327|FG000|Dose 1: 240 mg|Adverse Event|1|||
161692246|NCT03557359|583924328|FG001|Dose 1: 240 mg|Adverse Event|0|||
161692247|NCT03975647|583924329|FG000|Overall Study|Death|71|||
161692248|NCT03975647|583924330|FG001|Overall Study|Death|63|||
161692249|NCT03975647|583924329|FG000|Overall Study|Lost to Follow-up|2|||
161692250|NCT03975647|583924330|FG001|Overall Study|Lost to Follow-up|2|||
161692251|NCT03975647|583924329|FG000|Overall Study|Subject withdrawal of consent|7|||
161692252|NCT03975647|583924330|FG001|Overall Study|Subject withdrawal of consent|11|||
161692253|NCT04868903|583924331|FG000|Overall Study|Adverse Event|0|||
161692254|NCT04868903|583924332|FG001|Overall Study|Adverse Event|0|||
161692255|NCT04868903|583924333|FG002|Overall Study|Adverse Event|0|||
161692256|NCT04868903|583924334|FG003|Overall Study|Adverse Event|1|||
161692257|NCT04868903|583924331|FG000|Overall Study|Withdrawal by Subject|29|||
161692258|NCT04868903|583924332|FG001|Overall Study|Withdrawal by Subject|44|||
161692259|NCT04868903|583924333|FG002|Overall Study|Withdrawal by Subject|17|||
161692260|NCT04868903|583924334|FG003|Overall Study|Withdrawal by Subject|12|||
161692261|NCT04868903|583924331|FG000|Overall Study|Hyperparathyroidism|3|||
161692262|NCT04868903|583924332|FG001|Overall Study|Hyperparathyroidism|5|||
161692263|NCT04868903|583924333|FG002|Overall Study|Hyperparathyroidism|2|||
161692264|NCT04868903|583924334|FG003|Overall Study|Hyperparathyroidism|3|||
161836355|NCT00942331|584442945|FG001|Overall Study|Did not start treatment|22|||
161836356|NCT00995085|584442950|FG000|Overall Study|Withdrawal by Subject|5|||
161836357|NCT00700817|584442954|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
161836358|NCT00700817|584442955|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
161836359|NCT00700817|584442956|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
161836360|NCT00700817|584442957|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
161836361|NCT00700817|584442958|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
161836362|NCT00700817|584442954|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
161836363|NCT00700817|584442955|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
161836364|NCT00700817|584442956|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
161836365|NCT00700817|584442957|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
161836366|NCT00700817|584442958|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
161836367|NCT00700817|584442954|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
161836368|NCT00700817|584442955|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
161836369|NCT00700817|584442956|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
161836370|NCT00700817|584442957|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
161836371|NCT00700817|584442958|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
161836372|NCT00700817|584442954|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
161836373|NCT00700817|584442955|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
161836374|NCT00700817|584442956|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
161836375|NCT00700817|584442957|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
161836376|NCT00700817|584442958|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
161836377|NCT00700817|584442954|FG000|Week 0-26 (Main Period)|Unclassified|14|||
161836378|NCT00700817|584442955|FG001|Week 0-26 (Main Period)|Unclassified|4|||
161836379|NCT00700817|584442956|FG002|Week 0-26 (Main Period)|Unclassified|8|||
161836380|NCT00700817|584442957|FG003|Week 0-26 (Main Period)|Unclassified|0|||
161836381|NCT00700817|584442958|FG004|Week 0-26 (Main Period)|Unclassified|0|||
161836382|NCT00700817|584442954|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
161836383|NCT00700817|584442955|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
161836384|NCT00700817|584442956|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
161836385|NCT00700817|584442957|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
161836386|NCT00700817|584442958|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
161836387|NCT00700817|584442954|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
161836388|NCT00700817|584442955|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
161692265|NCT03735667|583924335|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
161692266|NCT03735667|583924336|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
161692267|NCT03735667|583924337|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
161692268|NCT03735667|583924335|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
161692269|NCT03735667|583924336|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
161836389|NCT00700817|584442956|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
161836390|NCT00700817|584442957|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
161836391|NCT00700817|584442958|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
161956402|NCT02524145|584887497|FG001|Overall Study|Withdrawal by Subject|2|||
161956403|NCT02524145|584887498|FG002|Overall Study|Withdrawal by Subject|3|||
161692270|NCT03735667|583924337|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
161836392|NCT00700817|584442954|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
161692271|NCT03735667|583924335|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
161692272|NCT03735667|583924336|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
161692273|NCT03735667|583924337|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
161692274|NCT03735667|583924335|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
161692275|NCT03735667|583924336|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
161692276|NCT03735667|583924337|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
161692277|NCT03735667|583924335|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
161692278|NCT03735667|583924336|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
161692279|NCT03735667|583924337|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
161692280|NCT03735667|583924335|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
161692281|NCT03735667|583924336|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
161692282|NCT03735667|583924337|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
161692283|NCT03735667|583924335|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
161692284|NCT03735667|583924336|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
161692285|NCT03735667|583924337|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
161692286|NCT03735667|583924335|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
161692287|NCT03735667|583924336|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
161692288|NCT03735667|583924337|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
161692289|NCT03735667|583924335|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
161692290|NCT03735667|583924336|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
161692291|NCT03735667|583924337|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
161692292|NCT03735667|583924335|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
161692293|NCT03735667|583924336|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
161692294|NCT03735667|583924337|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
161692295|NCT03735667|583924335|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
161692296|NCT03735667|583924336|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
161692297|NCT03735667|583924337|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
161692298|NCT03735667|583924335|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
161692299|NCT03735667|583924336|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
161692300|NCT03735667|583924337|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
161692301|NCT03092726|583924338|FG000|Overall Study|Adverse Event|3|||
161692302|NCT03092726|583924339|FG001|Overall Study|Adverse Event|10|||
161692303|NCT03092726|583924338|FG000|Overall Study|Lack of Efficacy|0|||
161692304|NCT03092726|583924339|FG001|Overall Study|Lack of Efficacy|1|||
161692305|NCT03092726|583924338|FG000|Overall Study|Lost to Follow-up|1|||
161692306|NCT03092726|583924339|FG001|Overall Study|Lost to Follow-up|0|||
161692307|NCT03092726|583924338|FG000|Overall Study|Withdrawal by Subject|5|||
161692308|NCT03092726|583924339|FG001|Overall Study|Withdrawal by Subject|3|||
161692309|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
161692310|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
161692311|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
161692312|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
161692313|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
161692314|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
161692315|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
161692316|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
161692317|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
161692318|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
161692319|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
161692320|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
161692321|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
161692322|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
161692323|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
161692324|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
161956404|NCT07214935|584887501|FG000|Overall Study|Adverse Event|1|||
161956405|NCT07214935|584887502|FG001|Overall Study|Adverse Event|1|||
161956406|NCT07214935|584887503|FG002|Overall Study|Adverse Event|1|||
161956407|NCT07214935|584887504|FG003|Overall Study|Adverse Event|0|||
161956408|NCT07214935|584887501|FG000|Overall Study|Lost to Follow-up|0|||
161956409|NCT07214935|584887502|FG001|Overall Study|Lost to Follow-up|1|||
161956410|NCT07214935|584887503|FG002|Overall Study|Lost to Follow-up|0|||
161956411|NCT07214935|584887504|FG003|Overall Study|Lost to Follow-up|0|||
161956412|NCT07214935|584887501|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
161956413|NCT07214935|584887502|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
161956414|NCT07214935|584887503|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
161956415|NCT07214935|584887504|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
161956416|NCT07214935|584887501|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
161956417|NCT07214935|584887502|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
161956418|NCT07214935|584887503|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
161956419|NCT07214935|584887504|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
161956420|NCT00283803|584889663|FG000|Overall Study|Physician Decision|9|||
161956421|NCT00283803|584889663|FG000|Overall Study|Withdrawal by Subject|4|||
161956422|NCT01127607|584889664|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
161956423|NCT01127607|584889665|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
161956424|NCT01127607|584889664|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
161956425|NCT01127607|584889665|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
161692325|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
161692326|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
161692327|NCT04418765|583924345|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
161692328|NCT04418765|583924346|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
161692329|NCT04418765|583924347|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
161692330|NCT04418765|583924345|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
161692331|NCT04418765|583924346|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
161692332|NCT04418765|583924347|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
161692333|NCT04418765|583924345|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
161692334|NCT04418765|583924346|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
161692335|NCT04418765|583924347|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
161692336|NCT04418765|583924345|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
161692337|NCT04418765|583924346|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
161692338|NCT04418765|583924347|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
161692339|NCT04418765|583924345|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
161692340|NCT04418765|583924346|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
161692341|NCT04418765|583924347|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
161692342|NCT04418765|583924345|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
161692343|NCT04418765|583924346|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
161692344|NCT04418765|583924347|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
161692345|NCT04418765|583924345|FG000|Extension Period (48 Weeks)|Other than specified|0|||
161692346|NCT04418765|583924346|FG001|Extension Period (48 Weeks)|Other than specified|5|||
161692347|NCT04418765|583924347|FG002|Extension Period (48 Weeks)|Other than specified|2|||
161692348|NCT01926782|583924351|FG000|Overall Study|Participant moved|2|||
161692349|NCT01926782|583924352|FG001|Overall Study|Participant moved|0|||
161692350|NCT01926782|583924353|FG002|Overall Study|Participant moved|1|||
161692351|NCT01926782|583924354|FG003|Overall Study|Participant moved|1|||
161692352|NCT01926782|583924355|FG004|Overall Study|Participant moved|0|||
161692353|NCT01926782|583924356|FG005|Overall Study|Participant moved|3|||
161692354|NCT01926782|583924351|FG000|Overall Study|Physician Decision|0|||
161692355|NCT01926782|583924352|FG001|Overall Study|Physician Decision|2|||
161692356|NCT01926782|583924353|FG002|Overall Study|Physician Decision|1|||
161692357|NCT01926782|583924354|FG003|Overall Study|Physician Decision|1|||
161692358|NCT01926782|583924355|FG004|Overall Study|Physician Decision|0|||
161692359|NCT01926782|583924356|FG005|Overall Study|Physician Decision|0|||
161692360|NCT01926782|583924351|FG000|Overall Study|Other than specified|2|||
161692361|NCT01926782|583924352|FG001|Overall Study|Other than specified|3|||
161692362|NCT01926782|583924353|FG002|Overall Study|Other than specified|5|||
161692363|NCT01926782|583924354|FG003|Overall Study|Other than specified|12|||
161692364|NCT01926782|583924355|FG004|Overall Study|Other than specified|4|||
161692365|NCT01926782|583924356|FG005|Overall Study|Other than specified|11|||
161692366|NCT01926782|583924351|FG000|Overall Study|Adverse Event|13|||
161692367|NCT01926782|583924352|FG001|Overall Study|Adverse Event|4|||
161692368|NCT01926782|583924353|FG002|Overall Study|Adverse Event|17|||
161692369|NCT01926782|583924354|FG003|Overall Study|Adverse Event|4|||
161692370|NCT01926782|583924355|FG004|Overall Study|Adverse Event|3|||
161692371|NCT01926782|583924356|FG005|Overall Study|Adverse Event|14|||
161692372|NCT01926782|583924351|FG000|Overall Study|Poor compliance to protocol|5|||
161692373|NCT01926782|583924352|FG001|Overall Study|Poor compliance to protocol|3|||
161692374|NCT01926782|583924353|FG002|Overall Study|Poor compliance to protocol|8|||
161692375|NCT01926782|583924354|FG003|Overall Study|Poor compliance to protocol|0|||
161692376|NCT01926782|583924355|FG004|Overall Study|Poor compliance to protocol|1|||
161692377|NCT01926782|583924356|FG005|Overall Study|Poor compliance to protocol|6|||
161836393|NCT00700817|584442955|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
161692378|NCT01926782|583924351|FG000|Overall Study|Randomized and not treated|0|||
161692379|NCT01926782|583924352|FG001|Overall Study|Randomized and not treated|0|||
161692380|NCT01926782|583924353|FG002|Overall Study|Randomized and not treated|0|||
161692381|NCT01926782|583924354|FG003|Overall Study|Randomized and not treated|1|||
161692382|NCT01926782|583924355|FG004|Overall Study|Randomized and not treated|0|||
161692383|NCT01926782|583924356|FG005|Overall Study|Randomized and not treated|0|||
161692384|NCT01926782|583924351|FG000|Overall Study|Withdrawal by Subject|6|||
161692385|NCT01926782|583924352|FG001|Overall Study|Withdrawal by Subject|1|||
161692386|NCT01926782|583924353|FG002|Overall Study|Withdrawal by Subject|8|||
161692387|NCT01926782|583924354|FG003|Overall Study|Withdrawal by Subject|1|||
161692388|NCT01926782|583924355|FG004|Overall Study|Withdrawal by Subject|0|||
161692389|NCT01926782|583924356|FG005|Overall Study|Withdrawal by Subject|5|||
161692390|NCT01926782|583924351|FG000|Overall Study|Related to study drug administration|0|||
161692391|NCT01926782|583924352|FG001|Overall Study|Related to study drug administration|0|||
161692392|NCT01926782|583924353|FG002|Overall Study|Related to study drug administration|0|||
161692393|NCT01926782|583924354|FG003|Overall Study|Related to study drug administration|0|||
161692394|NCT01926782|583924355|FG004|Overall Study|Related to study drug administration|0|||
161692395|NCT01926782|583924356|FG005|Overall Study|Related to study drug administration|2|||
161692396|NCT04607733|583924359|FG000|Overall Study|Lost to Follow-up|1|||
161692397|NCT04607733|583924360|FG001|Overall Study|Lost to Follow-up|0|||
161692398|NCT04607733|583924361|FG002|Overall Study|Lost to Follow-up|0|||
161692399|NCT04607733|583924362|FG003|Overall Study|Lost to Follow-up|1|||
161692400|NCT04607733|583924363|FG004|Overall Study|Lost to Follow-up|1|||
161692401|NCT04607733|583924364|FG005|Overall Study|Lost to Follow-up|0|||
161692402|NCT04607733|583924359|FG000|Overall Study|Withdrawal by Subject|0|||
161692403|NCT04607733|583924360|FG001|Overall Study|Withdrawal by Subject|0|||
161692404|NCT04607733|583924361|FG002|Overall Study|Withdrawal by Subject|0|||
161692405|NCT04607733|583924362|FG003|Overall Study|Withdrawal by Subject|0|||
161692406|NCT04607733|583924363|FG004|Overall Study|Withdrawal by Subject|1|||
161692407|NCT04607733|583924364|FG005|Overall Study|Withdrawal by Subject|0|||
161692408|NCT03504397|583924370|FG000|Overall Study|Progressive Disease|151|||
161692409|NCT03504397|583924371|FG001|Overall Study|Progressive Disease|199|||
161692410|NCT03504397|583924370|FG000|Overall Study|Withdrawal by Subject|29|||
161692411|NCT03504397|583924371|FG001|Overall Study|Withdrawal by Subject|17|||
161692412|NCT03504397|583924370|FG000|Overall Study|Lost to Follow-up|1|||
161692413|NCT03504397|583924371|FG001|Overall Study|Lost to Follow-up|0|||
161692414|NCT03504397|583924370|FG000|Overall Study|Death|14|||
161692415|NCT03504397|583924371|FG001|Overall Study|Death|16|||
161692416|NCT03504397|583924370|FG000|Overall Study|Adverse Event|40|||
161692417|NCT03504397|583924371|FG001|Overall Study|Adverse Event|14|||
161692418|NCT03504397|583924370|FG000|Overall Study|miscellaneous|17|||
161692419|NCT03504397|583924371|FG001|Overall Study|miscellaneous|15|||
161692420|NCT03504397|583924370|FG000|Overall Study|Protocol deviation|1|||
161692421|NCT03504397|583924371|FG001|Overall Study|Protocol deviation|0|||
161692422|NCT03504397|583924370|FG000|Overall Study|Participants who did not take the study drug|4|||
161692423|NCT03504397|583924371|FG001|Overall Study|Participants who did not take the study drug|4|||
161692424|NCT02443883|583924372|FG000|Overall Study|Adverse Event|0|||
161692425|NCT02443883|583924373|FG001|Overall Study|Adverse Event|1|||
161692426|NCT02443883|583924374|FG002|Overall Study|Adverse Event|0|||
161692427|NCT02443883|583924375|FG003|Overall Study|Adverse Event|0|||
161692428|NCT02443883|583924372|FG000|Overall Study|Lost to Follow-up|3|||
161692429|NCT02443883|583924373|FG001|Overall Study|Lost to Follow-up|2|||
161692430|NCT02443883|583924374|FG002|Overall Study|Lost to Follow-up|1|||
161692431|NCT02443883|583924375|FG003|Overall Study|Lost to Follow-up|0|||
161692432|NCT02443883|583924372|FG000|Overall Study|Physician Decision|1|||
161692433|NCT02443883|583924373|FG001|Overall Study|Physician Decision|1|||
161692434|NCT02443883|583924374|FG002|Overall Study|Physician Decision|0|||
161692435|NCT02443883|583924375|FG003|Overall Study|Physician Decision|3|||
161692436|NCT02443883|583924372|FG000|Overall Study|Withdrawal by Subject|1|||
161692437|NCT02443883|583924373|FG001|Overall Study|Withdrawal by Subject|0|||
161692438|NCT02443883|583924374|FG002|Overall Study|Withdrawal by Subject|0|||
161692439|NCT02443883|583924375|FG003|Overall Study|Withdrawal by Subject|2|||
161692440|NCT02443883|583924372|FG000|Overall Study|Randomized, but never treated|1|||
161692441|NCT02443883|583924373|FG001|Overall Study|Randomized, but never treated|0|||
161692442|NCT02443883|583924374|FG002|Overall Study|Randomized, but never treated|0|||
161692443|NCT02443883|583924375|FG003|Overall Study|Randomized, but never treated|0|||
161692444|NCT00999908|583924376|FG000|Treatment Period 1|Subject withdrew consent|2|||
161692445|NCT00999908|583924377|FG001|Treatment Period 1|Subject withdrew consent|0|||
161836394|NCT00700817|584442956|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
161836395|NCT00700817|584442957|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
161836396|NCT00700817|584442958|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
161692446|NCT00999908|583924378|FG002|Treatment Period 1|Subject withdrew consent|0|||
161692447|NCT00999908|583924376|FG000|Treatment Period 2|Protocol Violation|1|||
161692448|NCT00999908|583924377|FG001|Treatment Period 2|Protocol Violation|0|||
161692449|NCT00999908|583924378|FG002|Treatment Period 2|Protocol Violation|0|||
161692450|NCT03167073|583924379|FG000|Overall Study|Stillbirth|1|||
161692451|NCT03167073|583924380|FG001|Overall Study|Stillbirth|0|||
161692452|NCT01079182|583924383|FG000|Overall Study|Lost to Follow-up|1634|||
161692453|NCT01079182|583924383|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
161692454|NCT01079182|583924383|FG000|Overall Study|Lack of Efficacy|514|||
161692455|NCT01079182|583924383|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
161692456|NCT01079182|583924383|FG000|Overall Study|Reasons not Evaluated|271|||
161692457|NCT01026831|583924384|FG000|Overall Study|Adverse Event|4|||
161956426|NCT02220855|584889666|FG000|Overall Study|Adverse Event|8|||
161956427|NCT02220855|584889666|FG000|Overall Study|Disease Progression|5|||
161956428|NCT02220855|584889666|FG000|Overall Study|Withdrawal by Subject|1|||
161956429|NCT01945216|584889669|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
161956430|NCT01945216|584889669|FG000|Overall Study|Protocol Violation|42|||
161956431|NCT01945216|584889669|FG000|Overall Study|CRF not assured by investigators|5|||
161956432|NCT02982772|584889671|FG000|Intervention|Lost to Follow-up|19|||
161956433|NCT02982772|584889672|FG001|Intervention|Lost to Follow-up|13|||
161956434|NCT02982772|584889671|FG000|1M Follow-Up|Lost to Follow-up|21|||
161692458|NCT01026831|583924385|FG001|Overall Study|Adverse Event|3|||
161692459|NCT01026831|583924384|FG000|Overall Study|Lost to Follow-up|2|||
161692460|NCT01026831|583924385|FG001|Overall Study|Lost to Follow-up|0|||
161692461|NCT01026831|583924384|FG000|Overall Study|Physician Decision|1|||
161692462|NCT01026831|583924385|FG001|Overall Study|Physician Decision|1|||
161692463|NCT01026831|583924384|FG000|Overall Study|Protocol Violation|0|||
161692464|NCT01026831|583924385|FG001|Overall Study|Protocol Violation|2|||
161692465|NCT01026831|583924384|FG000|Overall Study|Withdrawal by Subject|7|||
161692466|NCT01026831|583924385|FG001|Overall Study|Withdrawal by Subject|5|||
161692467|NCT04417894|583924386|FG000|Overall Study|Lost to Follow-up|3|||
161692468|NCT04417894|583924387|FG001|Overall Study|Lost to Follow-up|0|||
161692469|NCT04417894|583924386|FG000|Overall Study|Withdrawal by Subject|7|||
161692470|NCT04417894|583924387|FG001|Overall Study|Withdrawal by Subject|6|||
161692471|NCT04417894|583924386|FG000|Overall Study|Lack of Efficacy|3|||
161692472|NCT04417894|583924387|FG001|Overall Study|Lack of Efficacy|1|||
161692473|NCT00262873|583924388|FG000|Overall Study|Adverse Event|3|||
161692474|NCT00262873|583924388|FG000|Overall Study|Withdrawal by Subject|5|||
161692475|NCT00844753|583924389|FG000|Overall Study|Lack of Efficacy|1|||
161692476|NCT00844753|583924390|FG001|Overall Study|Lack of Efficacy|0|||
161692477|NCT00844753|583924391|FG002|Overall Study|Lack of Efficacy|2|||
161692478|NCT00844753|583924392|FG003|Overall Study|Lack of Efficacy|2|||
161692479|NCT00844753|583924389|FG000|Overall Study|Adverse Event|3|||
161692480|NCT00844753|583924390|FG001|Overall Study|Adverse Event|2|||
161692481|NCT00844753|583924391|FG002|Overall Study|Adverse Event|5|||
161692482|NCT00844753|583924392|FG003|Overall Study|Adverse Event|5|||
161692483|NCT00844753|583924389|FG000|Overall Study|Lost to Follow-up|1|||
161692484|NCT00844753|583924390|FG001|Overall Study|Lost to Follow-up|1|||
161692485|NCT00844753|583924391|FG002|Overall Study|Lost to Follow-up|0|||
161692486|NCT00844753|583924392|FG003|Overall Study|Lost to Follow-up|1|||
161692487|NCT00844753|583924389|FG000|Overall Study|could not swallow medication|2|||
161692488|NCT00844753|583924390|FG001|Overall Study|could not swallow medication|0|||
161692489|NCT00844753|583924391|FG002|Overall Study|could not swallow medication|0|||
161692490|NCT00844753|583924392|FG003|Overall Study|could not swallow medication|0|||
161692491|NCT00844753|583924389|FG000|Overall Study|Withdrawal by Subject|1|||
161692492|NCT00844753|583924390|FG001|Overall Study|Withdrawal by Subject|0|||
161692493|NCT00844753|583924391|FG002|Overall Study|Withdrawal by Subject|0|||
161692494|NCT00844753|583924392|FG003|Overall Study|Withdrawal by Subject|3|||
161692495|NCT00903175|583924394|FG000|Period 1 - First Line|Adverse Event|36|||
161692496|NCT00903175|583924395|FG001|Period 1 - First Line|Adverse Event|50|||
161692497|NCT00903175|583924394|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
161692498|NCT00903175|583924395|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
161692499|NCT00903175|583924394|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
161692500|NCT00903175|583924395|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
161692501|NCT00903175|583924394|FG000|Period 1 - First Line|Protocol Violation|3|||
161692502|NCT00903175|583924395|FG001|Period 1 - First Line|Protocol Violation|3|||
161692503|NCT00903175|583924394|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
161692504|NCT00903175|583924395|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
161692505|NCT00903175|583924394|FG000|Period 1 - First Line|Administrative problems|12|||
161692506|NCT00903175|583924395|FG001|Period 1 - First Line|Administrative problems|13|||
161692507|NCT00903175|583924394|FG000|Period 1 - First Line|Death|17|||
161692508|NCT00903175|583924395|FG001|Period 1 - First Line|Death|10|||
161692509|NCT00903175|583924394|FG000|Period 2 - Second Line|Missing|1|||
161692510|NCT00903175|583924395|FG001|Period 2 - Second Line|Missing|0|||
161692511|NCT00903175|583924394|FG000|Period 2 - Second Line|Adverse Event|16|||
161692512|NCT00903175|583924395|FG001|Period 2 - Second Line|Adverse Event|20|||
161692513|NCT00903175|583924394|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
161692514|NCT00903175|583924395|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
161692515|NCT00903175|583924394|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
161692516|NCT00903175|583924395|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
161692517|NCT00903175|583924394|FG000|Period 2 - Second Line|Administrative problems|19|||
161692518|NCT00903175|583924395|FG001|Period 2 - Second Line|Administrative problems|9|||
161692519|NCT00903175|583924394|FG000|Period 2 - Second Line|Death|5|||
161692520|NCT00903175|583924395|FG001|Period 2 - Second Line|Death|2|||
161692521|NCT00371865|583924400|FG000|Overall Study|Lack of Efficacy|0|||
161692522|NCT00371865|583924401|FG001|Overall Study|Lack of Efficacy|2|||
161692523|NCT00371865|583924400|FG000|Overall Study|Protocol Violation|3|||
161692524|NCT00371865|583924401|FG001|Overall Study|Protocol Violation|2|||
161692525|NCT00371865|583924400|FG000|Overall Study|Withdrawal by Subject|12|||
161692526|NCT00371865|583924401|FG001|Overall Study|Withdrawal by Subject|10|||
161692527|NCT05073458|583924405|FG000|24-week Double-blind Period|Adverse Event|1|||
161692528|NCT05073458|583924406|FG001|24-week Double-blind Period|Adverse Event|0|||
161692529|NCT05073458|583924405|FG000|24-week Double-blind Period|Physician Decision|1|||
161692530|NCT05073458|583924406|FG001|24-week Double-blind Period|Physician Decision|0|||
161692531|NCT05073458|583924405|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
161692532|NCT05073458|583924406|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
161692533|NCT05073458|583924405|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
161692534|NCT05073458|583924406|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
161692535|NCT05073458|583924405|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
161692536|NCT05073458|583924406|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
161692537|NCT05073458|583924405|FG000|24-week Open-label Period|Adverse Event|1|||
161692538|NCT05073458|583924406|FG001|24-week Open-label Period|Adverse Event|2|||
161692539|NCT01627899|583924414|FG000|Overall Study|Study terminated early by sponsor.|5|||
161692540|NCT01425008|583924415|FG000|Dose Escalation Phase|Progressive Disease|2|||
161692541|NCT01425008|583924416|FG001|Dose Escalation Phase|Progressive Disease|3|||
161692542|NCT01425008|583924417|FG002|Dose Escalation Phase|Progressive Disease|2|||
161692543|NCT01425008|583924418|FG003|Dose Escalation Phase|Progressive Disease|3|||
161692544|NCT01425008|583924419|FG004|Dose Escalation Phase|Progressive Disease|5|||
161692545|NCT01425008|583924420|FG005|Dose Escalation Phase|Progressive Disease|4|||
161692546|NCT01425008|583924421|FG006|Dose Escalation Phase|Progressive Disease|0|||
161692547|NCT01425008|583924422|FG007|Dose Escalation Phase|Progressive Disease|2|||
161692548|NCT01425008|583924423|FG008|Dose Escalation Phase|Progressive Disease|6|||
161692549|NCT01425008|583924424|FG009|Dose Escalation Phase|Progressive Disease|2|||
161692550|NCT01425008|583924425|FG010|Dose Escalation Phase|Progressive Disease|0|||
161692551|NCT01425008|583924426|FG011|Dose Escalation Phase|Progressive Disease|0|||
161692552|NCT01425008|583924427|FG012|Dose Escalation Phase|Progressive Disease|0|||
161692553|NCT01425008|583924428|FG013|Dose Escalation Phase|Progressive Disease|0|||
161692554|NCT01425008|583924429|FG014|Dose Escalation Phase|Progressive Disease|0|||
161692555|NCT01425008|583924430|FG015|Dose Escalation Phase|Progressive Disease|0|||
161692556|NCT01425008|583924431|FG016|Dose Escalation Phase|Progressive Disease|0|||
161692557|NCT01425008|583924432|FG017|Dose Escalation Phase|Progressive Disease|0|||
161692558|NCT01425008|583924433|FG018|Dose Escalation Phase|Progressive Disease|0|||
161692559|NCT01425008|583924415|FG000|Dose Escalation Phase|Adverse Event|2|||
161692560|NCT01425008|583924416|FG001|Dose Escalation Phase|Adverse Event|0|||
161692561|NCT01425008|583924417|FG002|Dose Escalation Phase|Adverse Event|0|||
161692562|NCT01425008|583924418|FG003|Dose Escalation Phase|Adverse Event|0|||
161692563|NCT01425008|583924419|FG004|Dose Escalation Phase|Adverse Event|0|||
161692564|NCT01425008|583924420|FG005|Dose Escalation Phase|Adverse Event|2|||
161692565|NCT01425008|583924421|FG006|Dose Escalation Phase|Adverse Event|0|||
161692566|NCT01425008|583924422|FG007|Dose Escalation Phase|Adverse Event|0|||
161692567|NCT01425008|583924423|FG008|Dose Escalation Phase|Adverse Event|2|||
161692568|NCT01425008|583924424|FG009|Dose Escalation Phase|Adverse Event|0|||
161692569|NCT01425008|583924425|FG010|Dose Escalation Phase|Adverse Event|0|||
161692570|NCT01425008|583924426|FG011|Dose Escalation Phase|Adverse Event|0|||
161692571|NCT01425008|583924427|FG012|Dose Escalation Phase|Adverse Event|0|||
161692572|NCT01425008|583924428|FG013|Dose Escalation Phase|Adverse Event|0|||
161692573|NCT01425008|583924429|FG014|Dose Escalation Phase|Adverse Event|0|||
161692574|NCT01425008|583924430|FG015|Dose Escalation Phase|Adverse Event|0|||
161692575|NCT01425008|583924431|FG016|Dose Escalation Phase|Adverse Event|0|||
161692576|NCT01425008|583924432|FG017|Dose Escalation Phase|Adverse Event|0|||
161692577|NCT01425008|583924433|FG018|Dose Escalation Phase|Adverse Event|0|||
161692578|NCT01425008|583924415|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692579|NCT01425008|583924416|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692580|NCT01425008|583924417|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692581|NCT01425008|583924418|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692582|NCT01425008|583924419|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
161692583|NCT01425008|583924420|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692584|NCT01425008|583924421|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
161692585|NCT01425008|583924422|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
161692586|NCT01425008|583924423|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
161692587|NCT01425008|583924424|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692588|NCT01425008|583924425|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692589|NCT01425008|583924426|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692590|NCT01425008|583924427|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692591|NCT01425008|583924428|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692592|NCT01425008|583924429|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692593|NCT01425008|583924430|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692594|NCT01425008|583924431|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692595|NCT01425008|583924432|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692596|NCT01425008|583924433|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161692597|NCT01425008|583924415|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
161692598|NCT01425008|583924416|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
161692599|NCT01425008|583924417|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
161692600|NCT01425008|583924418|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161692601|NCT01425008|583924419|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
161692602|NCT01425008|583924420|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
161692603|NCT01425008|583924421|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
161692604|NCT01425008|583924422|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
161956435|NCT02982772|584889672|FG001|1M Follow-Up|Lost to Follow-up|18|||
161956436|NCT02982772|584889671|FG000|3M Follow-Up|Lost to Follow-up|17|||
161956437|NCT02982772|584889672|FG001|3M Follow-Up|Lost to Follow-up|11|||
161956438|NCT02982772|584889671|FG000|6M Follow-Up|Lost to Follow-up|11|||
161956439|NCT02982772|584889672|FG001|6M Follow-Up|Lost to Follow-up|9|||
161956440|NCT02982772|584889671|FG000|12M Follow-Up|Lost to Follow-up|11|||
161956441|NCT02982772|584889672|FG001|12M Follow-Up|Lost to Follow-up|5|||
161956442|NCT01905943|584889673|FG000|Overall Study|Withdrawal of consent|90|||
161956443|NCT01905943|584889673|FG000|Overall Study|Lost to Follow-up|16|||
161692605|NCT01425008|583924423|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
161692606|NCT01425008|583924424|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
161692607|NCT01425008|583924425|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
161692608|NCT01425008|583924426|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
161692609|NCT01425008|583924427|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
161692610|NCT01425008|583924428|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
161692611|NCT01425008|583924429|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
161692612|NCT01425008|583924430|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
161692613|NCT01425008|583924431|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
161692614|NCT01425008|583924432|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
161692615|NCT01425008|583924433|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
161692616|NCT01425008|583924415|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692617|NCT01425008|583924416|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692618|NCT01425008|583924417|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
161692619|NCT01425008|583924418|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692620|NCT01425008|583924419|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692621|NCT01425008|583924420|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692622|NCT01425008|583924421|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692623|NCT01425008|583924422|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692624|NCT01425008|583924423|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
161692625|NCT01425008|583924424|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
161692626|NCT01425008|583924425|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692627|NCT01425008|583924426|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692628|NCT01425008|583924427|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692629|NCT01425008|583924428|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692630|NCT01425008|583924429|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692631|NCT01425008|583924430|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692632|NCT01425008|583924431|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692633|NCT01425008|583924432|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692634|NCT01425008|583924433|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
161692635|NCT01425008|583924415|FG000|Dose Escalation Phase|Other|0|||
161692636|NCT01425008|583924416|FG001|Dose Escalation Phase|Other|0|||
161692637|NCT01425008|583924417|FG002|Dose Escalation Phase|Other|0|||
161692638|NCT01425008|583924418|FG003|Dose Escalation Phase|Other|0|||
161692639|NCT01425008|583924419|FG004|Dose Escalation Phase|Other|0|||
161692640|NCT01425008|583924420|FG005|Dose Escalation Phase|Other|0|||
161692641|NCT01425008|583924421|FG006|Dose Escalation Phase|Other|0|||
161692642|NCT01425008|583924422|FG007|Dose Escalation Phase|Other|0|||
161692643|NCT01425008|583924423|FG008|Dose Escalation Phase|Other|1|||
161692644|NCT01425008|583924424|FG009|Dose Escalation Phase|Other|0|||
161692645|NCT01425008|583924425|FG010|Dose Escalation Phase|Other|0|||
161692646|NCT01425008|583924426|FG011|Dose Escalation Phase|Other|0|||
161692647|NCT01425008|583924427|FG012|Dose Escalation Phase|Other|0|||
161692648|NCT01425008|583924428|FG013|Dose Escalation Phase|Other|0|||
161692649|NCT01425008|583924429|FG014|Dose Escalation Phase|Other|0|||
161692650|NCT01425008|583924430|FG015|Dose Escalation Phase|Other|0|||
161692651|NCT01425008|583924431|FG016|Dose Escalation Phase|Other|0|||
161692652|NCT01425008|583924432|FG017|Dose Escalation Phase|Other|0|||
161692653|NCT01425008|583924433|FG018|Dose Escalation Phase|Other|0|||
161692654|NCT01425008|583924415|FG000|Dose Expansion Phase|Progressive Disease|0|||
161956444|NCT01905943|584889673|FG000|Overall Study|Investigator discretion|7|||
161956445|NCT01905943|584889673|FG000|Overall Study|Death|186|||
161956446|NCT01905943|584889673|FG000|Overall Study|Adverse Event|3|||
161956447|NCT01905943|584889673|FG000|Overall Study|Other|12|||
161956448|NCT02974140|584889674|FG000|Overall Study|Adverse Event|2|||
161956449|NCT02974140|584889674|FG000|Overall Study|Lost to Follow-up|1|||
161692655|NCT01425008|583924416|FG001|Dose Expansion Phase|Progressive Disease|0|||
161956450|NCT02974140|584889674|FG000|Overall Study|Study Terminated by Sponsor|36|||
161692656|NCT01425008|583924417|FG002|Dose Expansion Phase|Progressive Disease|0|||
161692657|NCT01425008|583924418|FG003|Dose Expansion Phase|Progressive Disease|0|||
161692658|NCT01425008|583924419|FG004|Dose Expansion Phase|Progressive Disease|0|||
161692659|NCT01425008|583924420|FG005|Dose Expansion Phase|Progressive Disease|0|||
161692660|NCT01425008|583924421|FG006|Dose Expansion Phase|Progressive Disease|0|||
161692661|NCT01425008|583924422|FG007|Dose Expansion Phase|Progressive Disease|0|||
161956451|NCT01238991|584889677|FG000|Overall Study|Adverse Event|1|||
161692662|NCT01425008|583924423|FG008|Dose Expansion Phase|Progressive Disease|0|||
161956452|NCT01238991|584889678|FG001|Overall Study|Adverse Event|0|||
161956453|NCT01238991|584889679|FG002|Overall Study|Adverse Event|3|||
161692663|NCT01425008|583924424|FG009|Dose Expansion Phase|Progressive Disease|0|||
161692664|NCT01425008|583924425|FG010|Dose Expansion Phase|Progressive Disease|10|||
161692665|NCT01425008|583924426|FG011|Dose Expansion Phase|Progressive Disease|4|||
161692666|NCT01425008|583924427|FG012|Dose Expansion Phase|Progressive Disease|12|||
161692667|NCT01425008|583924428|FG013|Dose Expansion Phase|Progressive Disease|1|||
161692668|NCT01425008|583924429|FG014|Dose Expansion Phase|Progressive Disease|5|||
161692669|NCT01425008|583924430|FG015|Dose Expansion Phase|Progressive Disease|8|||
161692670|NCT01425008|583924431|FG016|Dose Expansion Phase|Progressive Disease|9|||
161692671|NCT01425008|583924432|FG017|Dose Expansion Phase|Progressive Disease|2|||
161692672|NCT01425008|583924433|FG018|Dose Expansion Phase|Progressive Disease|10|||
161692673|NCT01425008|583924415|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
161692674|NCT01425008|583924416|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
161692675|NCT01425008|583924417|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
161692676|NCT01425008|583924418|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
161692677|NCT01425008|583924419|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
161692678|NCT01425008|583924420|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
161692679|NCT01425008|583924421|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
161692680|NCT01425008|583924422|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
161692681|NCT01425008|583924423|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
161692682|NCT01425008|583924424|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
161692683|NCT01425008|583924425|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
161692684|NCT01425008|583924426|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
161692685|NCT01425008|583924427|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
161692686|NCT01425008|583924428|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
161692687|NCT01425008|583924429|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
161692688|NCT01425008|583924430|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
161692689|NCT01425008|583924431|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
161692690|NCT01425008|583924432|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
161692691|NCT01425008|583924433|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
161692692|NCT01425008|583924415|FG000|Dose Expansion Phase|Other|0|||
161692693|NCT01425008|583924416|FG001|Dose Expansion Phase|Other|0|||
161692694|NCT01425008|583924417|FG002|Dose Expansion Phase|Other|0|||
161692695|NCT01425008|583924418|FG003|Dose Expansion Phase|Other|0|||
161692696|NCT01425008|583924419|FG004|Dose Expansion Phase|Other|0|||
161692697|NCT01425008|583924420|FG005|Dose Expansion Phase|Other|0|||
161692698|NCT01425008|583924421|FG006|Dose Expansion Phase|Other|0|||
161692699|NCT01425008|583924422|FG007|Dose Expansion Phase|Other|0|||
161692700|NCT01425008|583924423|FG008|Dose Expansion Phase|Other|0|||
161692701|NCT01425008|583924424|FG009|Dose Expansion Phase|Other|0|||
161692702|NCT01425008|583924425|FG010|Dose Expansion Phase|Other|0|||
161692703|NCT01425008|583924426|FG011|Dose Expansion Phase|Other|0|||
161692704|NCT01425008|583924427|FG012|Dose Expansion Phase|Other|1|||
161692705|NCT01425008|583924428|FG013|Dose Expansion Phase|Other|0|||
161692706|NCT01425008|583924429|FG014|Dose Expansion Phase|Other|0|||
161692707|NCT01425008|583924430|FG015|Dose Expansion Phase|Other|0|||
161692708|NCT01425008|583924431|FG016|Dose Expansion Phase|Other|2|||
161692709|NCT01425008|583924432|FG017|Dose Expansion Phase|Other|0|||
161692710|NCT01425008|583924433|FG018|Dose Expansion Phase|Other|4|||
161692711|NCT01425008|583924415|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692712|NCT01425008|583924416|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692713|NCT01425008|583924417|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692714|NCT01425008|583924418|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692715|NCT01425008|583924419|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692716|NCT01425008|583924420|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692717|NCT01425008|583924421|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692718|NCT01425008|583924422|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692719|NCT01425008|583924423|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692720|NCT01425008|583924424|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692721|NCT01425008|583924425|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
161692722|NCT01425008|583924426|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
161956454|NCT01238991|584889680|FG003|Overall Study|Adverse Event|1|||
161956455|NCT01238991|584889681|FG004|Overall Study|Adverse Event|1|||
161956456|NCT01238991|584889682|FG005|Overall Study|Adverse Event|0|||
161692723|NCT01425008|583924427|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
161956457|NCT01238991|584889683|FG006|Overall Study|Adverse Event|1|||
161956458|NCT01238991|584889684|FG007|Overall Study|Adverse Event|1|||
161956459|NCT01238991|584889685|FG008|Overall Study|Adverse Event|0|||
161692724|NCT01425008|583924428|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692725|NCT01425008|583924429|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
161692726|NCT01425008|583924430|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
161692727|NCT01425008|583924431|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
161692728|NCT01425008|583924432|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
161956460|NCT01238991|584889686|FG009|Overall Study|Adverse Event|0|||
161956461|NCT01238991|584889677|FG000|Overall Study|Death|0|||
161956462|NCT01238991|584889678|FG001|Overall Study|Death|0|||
161956463|NCT01238991|584889679|FG002|Overall Study|Death|0|||
161956464|NCT01238991|584889680|FG003|Overall Study|Death|1|||
161956465|NCT01238991|584889681|FG004|Overall Study|Death|0|||
161956466|NCT01238991|584889682|FG005|Overall Study|Death|0|||
161956467|NCT01238991|584889683|FG006|Overall Study|Death|0|||
161956468|NCT01238991|584889684|FG007|Overall Study|Death|0|||
161956469|NCT01238991|584889685|FG008|Overall Study|Death|0|||
161956470|NCT01238991|584889686|FG009|Overall Study|Death|0|||
161956471|NCT01238991|584889677|FG000|Overall Study|Lack of Efficacy|0|||
161956472|NCT01238991|584889678|FG001|Overall Study|Lack of Efficacy|0|||
161956473|NCT01238991|584889679|FG002|Overall Study|Lack of Efficacy|1|||
161956474|NCT01238991|584889680|FG003|Overall Study|Lack of Efficacy|0|||
161956475|NCT01238991|584889681|FG004|Overall Study|Lack of Efficacy|0|||
161956476|NCT01238991|584889682|FG005|Overall Study|Lack of Efficacy|0|||
161956477|NCT01238991|584889683|FG006|Overall Study|Lack of Efficacy|0|||
161956478|NCT01238991|584889684|FG007|Overall Study|Lack of Efficacy|0|||
161956479|NCT01238991|584889685|FG008|Overall Study|Lack of Efficacy|1|||
161956480|NCT01238991|584889686|FG009|Overall Study|Lack of Efficacy|0|||
161956481|NCT01238991|584889677|FG000|Overall Study|Withdrawal by Subject|0|||
161956482|NCT01238991|584889678|FG001|Overall Study|Withdrawal by Subject|0|||
161956483|NCT01238991|584889679|FG002|Overall Study|Withdrawal by Subject|1|||
161956484|NCT01238991|584889680|FG003|Overall Study|Withdrawal by Subject|0|||
161956485|NCT01238991|584889681|FG004|Overall Study|Withdrawal by Subject|0|||
161956486|NCT01238991|584889682|FG005|Overall Study|Withdrawal by Subject|0|||
161836397|NCT00700817|584442954|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
161836398|NCT00700817|584442955|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
162030773|NCT00952380|585169487|FG002|Overall Study|Other|0|||
161692729|NCT01425008|583924433|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
161692730|NCT01425008|583924415|FG000|Dose Expansion Phase|Adverse Event|0|||
161692731|NCT01425008|583924416|FG001|Dose Expansion Phase|Adverse Event|0|||
161692732|NCT01425008|583924417|FG002|Dose Expansion Phase|Adverse Event|0|||
161692733|NCT01425008|583924418|FG003|Dose Expansion Phase|Adverse Event|0|||
161692734|NCT01425008|583924419|FG004|Dose Expansion Phase|Adverse Event|0|||
161692735|NCT01425008|583924420|FG005|Dose Expansion Phase|Adverse Event|0|||
161692736|NCT01425008|583924421|FG006|Dose Expansion Phase|Adverse Event|0|||
161692737|NCT01425008|583924422|FG007|Dose Expansion Phase|Adverse Event|0|||
161692738|NCT01425008|583924423|FG008|Dose Expansion Phase|Adverse Event|0|||
161692739|NCT01425008|583924424|FG009|Dose Expansion Phase|Adverse Event|0|||
161692740|NCT01425008|583924425|FG010|Dose Expansion Phase|Adverse Event|2|||
161692741|NCT01425008|583924426|FG011|Dose Expansion Phase|Adverse Event|3|||
161692742|NCT01425008|583924427|FG012|Dose Expansion Phase|Adverse Event|3|||
161692743|NCT01425008|583924428|FG013|Dose Expansion Phase|Adverse Event|0|||
161692744|NCT01425008|583924429|FG014|Dose Expansion Phase|Adverse Event|1|||
161692745|NCT01425008|583924430|FG015|Dose Expansion Phase|Adverse Event|1|||
161692746|NCT01425008|583924431|FG016|Dose Expansion Phase|Adverse Event|5|||
161692747|NCT01425008|583924432|FG017|Dose Expansion Phase|Adverse Event|0|||
161692748|NCT01425008|583924433|FG018|Dose Expansion Phase|Adverse Event|3|||
161692749|NCT01425008|583924415|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
161692750|NCT01425008|583924416|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
161692751|NCT01425008|583924417|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
161692752|NCT01425008|583924418|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
161692753|NCT01425008|583924419|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
161692754|NCT01425008|583924420|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
161692755|NCT01425008|583924421|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
161692756|NCT01425008|583924422|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
161692757|NCT01425008|583924423|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
161692758|NCT01425008|583924424|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
161692759|NCT01425008|583924425|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
161692760|NCT01425008|583924426|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
161692761|NCT01425008|583924427|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
161692762|NCT01425008|583924428|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
161692763|NCT01425008|583924429|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
161692764|NCT01425008|583924430|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
161692765|NCT01425008|583924431|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
161692766|NCT01425008|583924432|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
161956487|NCT01238991|584889683|FG006|Overall Study|Withdrawal by Subject|0|||
161956488|NCT01238991|584889684|FG007|Overall Study|Withdrawal by Subject|0|||
161956489|NCT01238991|584889685|FG008|Overall Study|Withdrawal by Subject|0|||
161956490|NCT01238991|584889686|FG009|Overall Study|Withdrawal by Subject|0|||
161956491|NCT01238991|584889677|FG000|Overall Study|Study Terminated by Sponsor|0|||
161692767|NCT01425008|583924433|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
161692768|NCT01425008|583924415|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692769|NCT01425008|583924416|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692770|NCT01425008|583924417|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161956492|NCT01238991|584889678|FG001|Overall Study|Study Terminated by Sponsor|0|||
161692771|NCT01425008|583924418|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692772|NCT01425008|583924419|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692773|NCT01425008|583924420|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692774|NCT01425008|583924421|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692775|NCT01425008|583924422|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692776|NCT01425008|583924423|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692777|NCT01425008|583924424|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692778|NCT01425008|583924425|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692779|NCT01425008|583924426|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692780|NCT01425008|583924427|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692781|NCT01425008|583924428|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692782|NCT01425008|583924429|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692783|NCT01425008|583924430|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692784|NCT01425008|583924431|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692785|NCT01425008|583924432|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161692786|NCT01425008|583924433|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
161692787|NCT04818593|583924434|FG000|Overall Study|Low Oocyte Yield|8|||
161692788|NCT04818593|583924435|FG001|Overall Study|Low Oocyte Yield|8|||
161692789|NCT04818593|583924434|FG000|Overall Study|Not ICSI Insemination|7|||
161692790|NCT04818593|583924435|FG001|Overall Study|Not ICSI Insemination|7|||
161692791|NCT04818593|583924434|FG000|Overall Study|Poor Sperm Quality|2|||
161692792|NCT04818593|583924435|FG001|Overall Study|Poor Sperm Quality|2|||
161692793|NCT04818593|583924434|FG000|Overall Study|Withdrawal by Subject|2|||
161692794|NCT04818593|583924435|FG001|Overall Study|Withdrawal by Subject|2|||
161692795|NCT04818593|583924434|FG000|Overall Study|Conversion to IUI due to low response|1|||
161692796|NCT04818593|583924435|FG001|Overall Study|Conversion to IUI due to low response|1|||
161692797|NCT04179175|583926168|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
161692798|NCT04179175|583926169|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
161692799|NCT04179175|583926170|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
161692800|NCT04179175|583926171|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
161692801|NCT04179175|583926172|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
161692802|NCT04179175|583926173|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
161692803|NCT04179175|583926168|FG000|Overall Study|Adverse Event|5|||
161692804|NCT04179175|583926169|FG001|Overall Study|Adverse Event|3|||
161692805|NCT04179175|583926170|FG002|Overall Study|Adverse Event|3|||
161692806|NCT04179175|583926171|FG003|Overall Study|Adverse Event|4|||
161692807|NCT04179175|583926172|FG004|Overall Study|Adverse Event|6|||
161692808|NCT04179175|583926173|FG005|Overall Study|Adverse Event|6|||
161692809|NCT04179175|583926168|FG000|Overall Study|Lack of Efficacy|5|||
161692810|NCT04179175|583926169|FG001|Overall Study|Lack of Efficacy|1|||
161692811|NCT04179175|583926170|FG002|Overall Study|Lack of Efficacy|3|||
161692812|NCT04179175|583926171|FG003|Overall Study|Lack of Efficacy|2|||
161692813|NCT04179175|583926172|FG004|Overall Study|Lack of Efficacy|18|||
161692814|NCT04179175|583926173|FG005|Overall Study|Lack of Efficacy|7|||
161692815|NCT04179175|583926168|FG000|Overall Study|Lost to Follow-up|5|||
161692816|NCT04179175|583926169|FG001|Overall Study|Lost to Follow-up|3|||
161692817|NCT04179175|583926170|FG002|Overall Study|Lost to Follow-up|2|||
161692818|NCT04179175|583926171|FG003|Overall Study|Lost to Follow-up|2|||
161692819|NCT04179175|583926172|FG004|Overall Study|Lost to Follow-up|4|||
161692820|NCT04179175|583926173|FG005|Overall Study|Lost to Follow-up|5|||
161692821|NCT04179175|583926168|FG000|Overall Study|Physician Decision|2|||
161692822|NCT04179175|583926169|FG001|Overall Study|Physician Decision|0|||
161692823|NCT04179175|583926170|FG002|Overall Study|Physician Decision|2|||
161692824|NCT04179175|583926171|FG003|Overall Study|Physician Decision|3|||
161692825|NCT04179175|583926172|FG004|Overall Study|Physician Decision|1|||
161692826|NCT04179175|583926173|FG005|Overall Study|Physician Decision|1|||
161692827|NCT04179175|583926168|FG000|Overall Study|Pregnancy|3|||
161692828|NCT04179175|583926169|FG001|Overall Study|Pregnancy|0|||
161692829|NCT04179175|583926170|FG002|Overall Study|Pregnancy|3|||
161692830|NCT04179175|583926171|FG003|Overall Study|Pregnancy|0|||
161692831|NCT04179175|583926172|FG004|Overall Study|Pregnancy|1|||
161692832|NCT04179175|583926173|FG005|Overall Study|Pregnancy|2|||
161692833|NCT04179175|583926168|FG000|Overall Study|Withdrawal by Subject|22|||
161692834|NCT04179175|583926169|FG001|Overall Study|Withdrawal by Subject|10|||
161692835|NCT04179175|583926170|FG002|Overall Study|Withdrawal by Subject|12|||
161692836|NCT04179175|583926171|FG003|Overall Study|Withdrawal by Subject|8|||
161692837|NCT04179175|583926172|FG004|Overall Study|Withdrawal by Subject|23|||
161692838|NCT04179175|583926173|FG005|Overall Study|Withdrawal by Subject|31|||
161692839|NCT04179175|583926168|FG000|Overall Study|Technical problems|0|||
161692840|NCT04179175|583926169|FG001|Overall Study|Technical problems|0|||
161692841|NCT04179175|583926170|FG002|Overall Study|Technical problems|1|||
161692842|NCT04179175|583926171|FG003|Overall Study|Technical problems|1|||
161692843|NCT04179175|583926172|FG004|Overall Study|Technical problems|0|||
161692844|NCT04179175|583926173|FG005|Overall Study|Technical problems|0|||
161692845|NCT03215030|583926178|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
161692846|NCT03215030|583926179|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
161692847|NCT03215030|583926180|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692848|NCT03215030|583926181|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
161692849|NCT03215030|583926182|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692850|NCT03215030|583926183|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692851|NCT03215030|583926184|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692852|NCT03215030|583926185|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692853|NCT03215030|583926186|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692854|NCT03215030|583926187|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692855|NCT03215030|583926188|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692856|NCT03215030|583926189|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
161692857|NCT03215030|583926178|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161692858|NCT03215030|583926179|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692859|NCT03215030|583926180|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692860|NCT03215030|583926181|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161692861|NCT03215030|583926182|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692862|NCT03215030|583926183|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692863|NCT03215030|583926184|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692864|NCT03215030|583926185|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692865|NCT03215030|583926186|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692866|NCT03215030|583926187|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692867|NCT03215030|583926188|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692868|NCT03215030|583926189|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161692869|NCT03215030|583926178|FG000|Part 1: Dose Escalation|Death|15|||
161692870|NCT03215030|583926179|FG001|Part 1: Dose Escalation|Death|6|||
161692871|NCT03215030|583926180|FG002|Part 1: Dose Escalation|Death|6|||
161692872|NCT03215030|583926181|FG003|Part 1: Dose Escalation|Death|8|||
161692873|NCT03215030|583926182|FG004|Part 1: Dose Escalation|Death|0|||
161692874|NCT03215030|583926183|FG005|Part 1: Dose Escalation|Death|0|||
161692875|NCT03215030|583926184|FG006|Part 1: Dose Escalation|Death|0|||
161692876|NCT03215030|583926185|FG007|Part 1: Dose Escalation|Death|0|||
161692877|NCT03215030|583926186|FG008|Part 1: Dose Escalation|Death|0|||
161692878|NCT03215030|583926187|FG009|Part 1: Dose Escalation|Death|0|||
161692879|NCT03215030|583926188|FG010|Part 1: Dose Escalation|Death|0|||
161692880|NCT03215030|583926189|FG011|Part 1: Dose Escalation|Death|0|||
161692881|NCT03215030|583926178|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
161692882|NCT03215030|583926179|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
161692883|NCT03215030|583926180|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
161692884|NCT03215030|583926181|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
161692885|NCT03215030|583926182|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
161692886|NCT03215030|583926183|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
161692887|NCT03215030|583926184|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
161692888|NCT03215030|583926185|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
161692889|NCT03215030|583926186|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
161692890|NCT03215030|583926187|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
161692891|NCT03215030|583926188|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
161692892|NCT03215030|583926189|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
161692893|NCT03215030|583926178|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692894|NCT03215030|583926179|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161956493|NCT01238991|584889679|FG002|Overall Study|Study Terminated by Sponsor|0|||
161956494|NCT01238991|584889680|FG003|Overall Study|Study Terminated by Sponsor|0|||
161956495|NCT01238991|584889681|FG004|Overall Study|Study Terminated by Sponsor|1|||
161956496|NCT01238991|584889682|FG005|Overall Study|Study Terminated by Sponsor|0|||
161956497|NCT01238991|584889683|FG006|Overall Study|Study Terminated by Sponsor|7|||
161692895|NCT03215030|583926180|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692896|NCT03215030|583926181|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692897|NCT03215030|583926182|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692898|NCT03215030|583926183|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692899|NCT03215030|583926184|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692900|NCT03215030|583926185|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
161956498|NCT01238991|584889684|FG007|Overall Study|Study Terminated by Sponsor|4|||
161956499|NCT01238991|584889685|FG008|Overall Study|Study Terminated by Sponsor|2|||
161692901|NCT03215030|583926186|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692902|NCT03215030|583926187|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692903|NCT03215030|583926188|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692904|NCT03215030|583926189|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161692905|NCT03215030|583926178|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692906|NCT03215030|583926179|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692907|NCT03215030|583926180|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692908|NCT03215030|583926181|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692909|NCT03215030|583926182|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
161692910|NCT03215030|583926183|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
161692911|NCT03215030|583926184|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
161692912|NCT03215030|583926185|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
161692913|NCT03215030|583926186|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692914|NCT03215030|583926187|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692915|NCT03215030|583926188|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692916|NCT03215030|583926189|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161692917|NCT03215030|583926178|FG000|Part 2: Dose Expansion|Death|0|||
161692918|NCT03215030|583926179|FG001|Part 2: Dose Expansion|Death|0|||
161692919|NCT03215030|583926180|FG002|Part 2: Dose Expansion|Death|0|||
161692920|NCT03215030|583926181|FG003|Part 2: Dose Expansion|Death|0|||
161692921|NCT03215030|583926182|FG004|Part 2: Dose Expansion|Death|3|||
161692922|NCT03215030|583926183|FG005|Part 2: Dose Expansion|Death|1|||
161692923|NCT03215030|583926184|FG006|Part 2: Dose Expansion|Death|5|||
161692924|NCT03215030|583926185|FG007|Part 2: Dose Expansion|Death|4|||
161692925|NCT03215030|583926186|FG008|Part 2: Dose Expansion|Death|0|||
161692926|NCT03215030|583926187|FG009|Part 2: Dose Expansion|Death|0|||
161692927|NCT03215030|583926188|FG010|Part 2: Dose Expansion|Death|0|||
161692928|NCT03215030|583926189|FG011|Part 2: Dose Expansion|Death|0|||
161692929|NCT03215030|583926178|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
161692930|NCT03215030|583926179|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
161692931|NCT03215030|583926180|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
161692932|NCT03215030|583926181|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
161692933|NCT03215030|583926182|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
161692934|NCT03215030|583926183|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
161692935|NCT03215030|583926184|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
161692936|NCT03215030|583926185|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
161692937|NCT03215030|583926186|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
161692938|NCT03215030|583926187|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
161692939|NCT03215030|583926188|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
161692940|NCT03215030|583926189|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
161692941|NCT03215030|583926178|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
161692942|NCT03215030|583926179|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
161692943|NCT03215030|583926180|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
161692944|NCT03215030|583926181|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
161692945|NCT03215030|583926182|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
161692946|NCT03215030|583926183|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
161692947|NCT03215030|583926184|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
161692948|NCT03215030|583926185|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
161692949|NCT03215030|583926186|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
161692950|NCT03215030|583926187|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
161692951|NCT03215030|583926188|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
161692952|NCT03215030|583926189|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
161692953|NCT03215030|583926178|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692954|NCT03215030|583926179|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692955|NCT03215030|583926180|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692956|NCT03215030|583926181|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692957|NCT03215030|583926182|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692958|NCT03215030|583926183|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692959|NCT03215030|583926184|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692960|NCT03215030|583926185|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161956500|NCT01238991|584889686|FG009|Overall Study|Study Terminated by Sponsor|2|||
161956501|NCT01238991|584889677|FG000|Overall Study|Caregiver's request|0|||
161956502|NCT01238991|584889678|FG001|Overall Study|Caregiver's request|0|||
161956503|NCT01238991|584889679|FG002|Overall Study|Caregiver's request|0|||
161956504|NCT01238991|584889680|FG003|Overall Study|Caregiver's request|0|||
161692961|NCT03215030|583926186|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
161692962|NCT03215030|583926187|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
161692963|NCT03215030|583926188|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692964|NCT03215030|583926189|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161692965|NCT03215030|583926178|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692966|NCT03215030|583926179|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
161956505|NCT01238991|584889681|FG004|Overall Study|Caregiver's request|0|||
161692967|NCT03215030|583926180|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692968|NCT03215030|583926181|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692969|NCT03215030|583926182|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692970|NCT03215030|583926183|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692971|NCT03215030|583926184|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692972|NCT03215030|583926185|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692973|NCT03215030|583926186|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
161692974|NCT03215030|583926187|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
161692975|NCT03215030|583926188|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692976|NCT03215030|583926189|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
161692977|NCT03215030|583926178|FG000|Part 3: Dose Extension|Death|0|||
161692978|NCT03215030|583926179|FG001|Part 3: Dose Extension|Death|0|||
161692979|NCT03215030|583926180|FG002|Part 3: Dose Extension|Death|0|||
161692980|NCT03215030|583926181|FG003|Part 3: Dose Extension|Death|0|||
161692981|NCT03215030|583926182|FG004|Part 3: Dose Extension|Death|0|||
161692982|NCT03215030|583926183|FG005|Part 3: Dose Extension|Death|0|||
161692983|NCT03215030|583926184|FG006|Part 3: Dose Extension|Death|0|||
161956506|NCT01238991|584889682|FG005|Overall Study|Caregiver's request|0|||
161692984|NCT03215030|583926185|FG007|Part 3: Dose Extension|Death|0|||
161692985|NCT03215030|583926186|FG008|Part 3: Dose Extension|Death|19|||
161692986|NCT03215030|583926187|FG009|Part 3: Dose Extension|Death|20|||
161692987|NCT03215030|583926188|FG010|Part 3: Dose Extension|Death|0|||
161692988|NCT03215030|583926189|FG011|Part 3: Dose Extension|Death|0|||
161956507|NCT01238991|584889683|FG006|Overall Study|Caregiver's request|0|||
161956508|NCT01238991|584889684|FG007|Overall Study|Caregiver's request|0|||
161956509|NCT01238991|584889685|FG008|Overall Study|Caregiver's request|1|||
161692989|NCT03215030|583926178|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
161692990|NCT03215030|583926179|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
161692991|NCT03215030|583926180|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
161692992|NCT03215030|583926181|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
161692993|NCT03215030|583926182|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
161692994|NCT03215030|583926183|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
161692995|NCT03215030|583926184|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
161692996|NCT03215030|583926185|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
161692997|NCT03215030|583926186|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
161692998|NCT03215030|583926187|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
161692999|NCT03215030|583926188|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
161693000|NCT03215030|583926189|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
161693001|NCT03215030|583926178|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693002|NCT03215030|583926179|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693003|NCT03215030|583926180|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693004|NCT03215030|583926181|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693005|NCT03215030|583926182|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693006|NCT03215030|583926183|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693007|NCT03215030|583926184|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693008|NCT03215030|583926185|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693009|NCT03215030|583926186|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693010|NCT03215030|583926187|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161693011|NCT03215030|583926188|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
161693012|NCT03215030|583926189|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
161693013|NCT01745146|583926192|FG000|Overall Study|Withdrawal by Subject|1|||
161693014|NCT01745146|583926193|FG001|Overall Study|Withdrawal by Subject|3|||
161693015|NCT01745146|583926192|FG000|Overall Study|Lost to Follow-up|2|||
161693016|NCT01745146|583926193|FG001|Overall Study|Lost to Follow-up|0|||
161693017|NCT04316585|583926194|FG000|Overall Study|Adverse Event|2|||
161693018|NCT04316585|583926195|FG001|Overall Study|Adverse Event|1|||
161693019|NCT04316585|583926194|FG000|Overall Study|Lost to Follow-up|1|||
161693020|NCT04316585|583926195|FG001|Overall Study|Lost to Follow-up|0|||
161693021|NCT04316585|583926194|FG000|Overall Study|Withdrawal by Subject|2|||
161693022|NCT04316585|583926195|FG001|Overall Study|Withdrawal by Subject|3|||
161693023|NCT04316585|583926194|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
161693024|NCT04316585|583926195|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
161693025|NCT04316585|583926194|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
161693026|NCT04316585|583926195|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
161693027|NCT00130832|583926196|FG000|Overall Study|Adverse Event|1|||
161693028|NCT00130832|583926197|FG001|Overall Study|Adverse Event|1|||
161693029|NCT00130832|583926196|FG000|Overall Study|Lost to Follow-up|1|||
161693030|NCT00130832|583926197|FG001|Overall Study|Lost to Follow-up|2|||
161693031|NCT00130832|583926196|FG000|Overall Study|Protocol Violation|6|||
161693032|NCT00130832|583926197|FG001|Overall Study|Protocol Violation|8|||
161693033|NCT00130832|583926196|FG000|Overall Study|Withdrawal by Subject|6|||
161693034|NCT00130832|583926197|FG001|Overall Study|Withdrawal by Subject|1|||
161693035|NCT00130832|583926196|FG000|Overall Study|Moved|2|||
161693036|NCT00130832|583926197|FG001|Overall Study|Moved|2|||
161693037|NCT00130832|583926196|FG000|Overall Study|Other|0|||
161693038|NCT00130832|583926197|FG001|Overall Study|Other|3|||
161693039|NCT03269344|583926198|FG000|Overall Study|Protocol Violation|4|||
161693040|NCT03269344|583926199|FG001|Overall Study|Protocol Violation|3|||
161693041|NCT02770326|583926200|FG000|Overall Study|Death|3|||
161693042|NCT02770326|583926200|FG000|Overall Study|Lost to Follow-up|1|||
161693043|NCT04232696|583926204|FG000|Overall Study|Implant attempted but not completed|5|||
161693044|NCT04232696|583926205|FG001|Overall Study|Implant attempted but not completed|2|||
161693045|NCT04232696|583926204|FG000|Overall Study|Not satisfied with therapy outcome|0|||
161693046|NCT04232696|583926205|FG001|Overall Study|Not satisfied with therapy outcome|8|||
161693047|NCT04232696|583926204|FG000|Overall Study|Adverse Event|0|||
161693048|NCT04232696|583926205|FG001|Overall Study|Adverse Event|3|||
161693049|NCT04232696|583926204|FG000|Overall Study|Withdrawal by Subject|0|||
161693050|NCT04232696|583926205|FG001|Overall Study|Withdrawal by Subject|3|||
161693051|NCT04232696|583926204|FG000|Overall Study|Missed Visit|0|||
161693052|NCT04232696|583926205|FG001|Overall Study|Missed Visit|2|||
161693053|NCT04232696|583926204|FG000|Overall Study|Other reason|0|||
161693054|NCT04232696|583926205|FG001|Overall Study|Other reason|1|||
161693055|NCT03118297|583926206|FG000|Overall Study|Lost to Follow-up|0|||
161693056|NCT03118297|583926207|FG001|Overall Study|Lost to Follow-up|2|||
161693057|NCT02363686|583926210|FG000|Overall Study|Withdrawal by Subject|22|||
161693058|NCT02363686|583926210|FG000|Overall Study|incomplete FEES examinations|13|||
161693059|NCT05289830|583926213|FG000|Overall Study|Lost to Follow-up|1|||
161693060|NCT05289830|583926214|FG001|Overall Study|Lost to Follow-up|1|||
161693061|NCT05289830|583926213|FG000|Overall Study|Physician Decision|0|||
161693062|NCT05289830|583926214|FG001|Overall Study|Physician Decision|1|||
161693063|NCT01046825|583926215|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
161693064|NCT01046825|583926216|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
161693065|NCT01046825|583926217|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
161693066|NCT01046825|583926218|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
161693067|NCT01046825|583926219|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
161693068|NCT01046825|583926215|FG000|Overall Study|Physician Decision|0|||
161693069|NCT01046825|583926216|FG001|Overall Study|Physician Decision|1|||
161693070|NCT01046825|583926217|FG002|Overall Study|Physician Decision|2|||
161693071|NCT01046825|583926218|FG003|Overall Study|Physician Decision|0|||
161693072|NCT01046825|583926219|FG004|Overall Study|Physician Decision|0|||
161693073|NCT01046825|583926215|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
161693074|NCT01046825|583926216|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
161693075|NCT01046825|583926217|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
161693076|NCT01046825|583926218|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
161693077|NCT01046825|583926219|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
161693078|NCT01046825|583926215|FG000|Overall Study|Found to be ineligible|0|||
161693079|NCT01046825|583926216|FG001|Overall Study|Found to be ineligible|1|||
161693080|NCT01046825|583926217|FG002|Overall Study|Found to be ineligible|0|||
161693081|NCT01046825|583926218|FG003|Overall Study|Found to be ineligible|0|||
161693082|NCT01046825|583926219|FG004|Overall Study|Found to be ineligible|0|||
161693083|NCT01046825|583926215|FG000|Overall Study|Death|0|||
161693084|NCT01046825|583926216|FG001|Overall Study|Death|0|||
161693085|NCT01046825|583926217|FG002|Overall Study|Death|0|||
161693086|NCT01046825|583926218|FG003|Overall Study|Death|1|||
161693087|NCT01046825|583926219|FG004|Overall Study|Death|0|||
161693088|NCT01046825|583926215|FG000|Overall Study|Did not submit biology samples|0|||
161693089|NCT01046825|583926216|FG001|Overall Study|Did not submit biology samples|0|||
161693090|NCT01046825|583926217|FG002|Overall Study|Did not submit biology samples|0|||
161693091|NCT01046825|583926218|FG003|Overall Study|Did not submit biology samples|0|||
161693092|NCT01046825|583926219|FG004|Overall Study|Did not submit biology samples|13|||
161693093|NCT02872311|583926220|FG000|Overall Study|Death|2|||
161693094|NCT02872311|583926221|FG001|Overall Study|Death|0|||
161693095|NCT02872311|583926222|FG002|Overall Study|Death|0|||
161693096|NCT02872311|583926223|FG003|Overall Study|Death|0|||
161693097|NCT02872311|583926224|FG004|Overall Study|Death|0|||
161693098|NCT02872311|583926220|FG000|Overall Study|Lost to Follow-up|2|||
161693099|NCT02872311|583926221|FG001|Overall Study|Lost to Follow-up|0|||
161693100|NCT02872311|583926222|FG002|Overall Study|Lost to Follow-up|0|||
161693101|NCT02872311|583926223|FG003|Overall Study|Lost to Follow-up|0|||
161693102|NCT02872311|583926224|FG004|Overall Study|Lost to Follow-up|0|||
161693103|NCT02872311|583926220|FG000|Overall Study|Protocol Violation|0|||
161693104|NCT02872311|583926221|FG001|Overall Study|Protocol Violation|2|||
161693105|NCT02872311|583926222|FG002|Overall Study|Protocol Violation|1|||
161693106|NCT02872311|583926223|FG003|Overall Study|Protocol Violation|0|||
161693107|NCT02872311|583926224|FG004|Overall Study|Protocol Violation|0|||
161693108|NCT01121393|583926228|FG000|Overall Study|Progressive disease|201|||
161693109|NCT01121393|583926229|FG001|Overall Study|Progressive disease|20|||
161693110|NCT01121393|583926228|FG000|Overall Study|Other Adverse events|24|||
161693111|NCT01121393|583926229|FG001|Overall Study|Other Adverse events|45|||
161693112|NCT01121393|583926228|FG000|Overall Study|Non-compliant with protocol|0|||
161693113|NCT01121393|583926229|FG001|Overall Study|Non-compliant with protocol|3|||
161693114|NCT01121393|583926228|FG000|Overall Study|Lost to Follow-up|1|||
161693115|NCT01121393|583926229|FG001|Overall Study|Lost to Follow-up|0|||
161693116|NCT01121393|583926228|FG000|Overall Study|Refused cont. medication|7|||
161693117|NCT01121393|583926229|FG001|Overall Study|Refused cont. medication|7|||
161693118|NCT01121393|583926228|FG000|Overall Study|Not treated|3|||
161693119|NCT01121393|583926229|FG001|Overall Study|Not treated|9|||
161836399|NCT00700817|584442956|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
161836400|NCT00700817|584442957|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
161836401|NCT00700817|584442958|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
161836402|NCT00700817|584442954|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
161836403|NCT00700817|584442955|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
161836404|NCT00700817|584442956|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
161836405|NCT00700817|584442957|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
161836406|NCT00700817|584442958|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
161836407|NCT00700817|584442954|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
161693120|NCT01121393|583926228|FG000|Overall Study|Other than listed|6|||
161693121|NCT01121393|583926229|FG001|Overall Study|Other than listed|0|||
161693122|NCT00577993|583926235|FG000|Overall Study|Adverse Event|1|||
161693123|NCT00577993|583926236|FG001|Overall Study|Adverse Event|0|||
161693124|NCT00577993|583926237|FG002|Overall Study|Adverse Event|0|||
161693125|NCT00577993|583926235|FG000|Overall Study|Death|0|||
161693126|NCT00577993|583926236|FG001|Overall Study|Death|1|||
161693127|NCT00577993|583926237|FG002|Overall Study|Death|1|||
161693128|NCT00577993|583926235|FG000|Overall Study|Lack of Efficacy|0|||
161693129|NCT00577993|583926236|FG001|Overall Study|Lack of Efficacy|1|||
161693130|NCT00577993|583926237|FG002|Overall Study|Lack of Efficacy|0|||
161693131|NCT00577993|583926235|FG000|Overall Study|Protocol Violation|2|||
161693132|NCT00577993|583926236|FG001|Overall Study|Protocol Violation|3|||
161693133|NCT00577993|583926237|FG002|Overall Study|Protocol Violation|0|||
161693134|NCT00577993|583926235|FG000|Overall Study|Withdrawal by Subject|1|||
161693135|NCT00577993|583926236|FG001|Overall Study|Withdrawal by Subject|0|||
161693136|NCT00577993|583926237|FG002|Overall Study|Withdrawal by Subject|2|||
161693137|NCT00577993|583926235|FG000|Overall Study|Conversion|2|||
161693138|NCT00577993|583926236|FG001|Overall Study|Conversion|5|||
161693139|NCT00577993|583926237|FG002|Overall Study|Conversion|0|||
161693140|NCT00577993|583926235|FG000|Overall Study|Uninsured|1|||
161693141|NCT00577993|583926236|FG001|Overall Study|Uninsured|0|||
161693142|NCT00577993|583926237|FG002|Overall Study|Uninsured|0|||
161693143|NCT02217566|583926238|FG000|Overall Study|Lost to Follow-up|2|||
161693144|NCT02217566|583926238|FG000|Overall Study|Death|3|||
161693145|NCT02217566|583926238|FG000|Overall Study|Early study termination|6|||
161693146|NCT02064387|583926243|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693147|NCT02064387|583926244|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693148|NCT02064387|583926245|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693149|NCT02064387|583926246|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693150|NCT02064387|583926247|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693151|NCT02064387|583926248|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693152|NCT02064387|583926249|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693153|NCT02064387|583926250|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
161693154|NCT02064387|583926251|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693155|NCT02064387|583926252|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
161693156|NCT02064387|583926253|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693157|NCT02064387|583926254|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161693158|NCT02064387|583926243|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693159|NCT02064387|583926244|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693160|NCT02064387|583926245|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693161|NCT02064387|583926246|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693162|NCT02064387|583926247|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693163|NCT02064387|583926248|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693164|NCT02064387|583926249|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693165|NCT02064387|583926250|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
161693166|NCT02064387|583926251|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693167|NCT02064387|583926252|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693168|NCT02064387|583926253|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693169|NCT02064387|583926254|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161693170|NCT02064387|583926243|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693171|NCT02064387|583926244|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693172|NCT02064387|583926245|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693173|NCT02064387|583926246|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693174|NCT02064387|583926247|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693175|NCT02064387|583926248|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693176|NCT02064387|583926249|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693177|NCT02064387|583926250|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693178|NCT02064387|583926251|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
161693179|NCT02064387|583926252|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693180|NCT02064387|583926253|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693181|NCT02064387|583926254|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161693182|NCT02064387|583926243|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
161693183|NCT02064387|583926244|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
161693184|NCT02064387|583926245|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
161693185|NCT02064387|583926246|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
161693186|NCT02064387|583926247|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
161693187|NCT02064387|583926248|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
161693188|NCT02064387|583926249|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
161693189|NCT02064387|583926250|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
161693190|NCT02064387|583926251|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
161693191|NCT02064387|583926252|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
161693192|NCT02064387|583926253|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
161693193|NCT02064387|583926254|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
161693194|NCT02064387|583926243|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693195|NCT02064387|583926244|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693196|NCT02064387|583926245|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693197|NCT02064387|583926246|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693198|NCT02064387|583926247|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693199|NCT02064387|583926248|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693200|NCT02064387|583926249|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693201|NCT02064387|583926250|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693202|NCT02064387|583926251|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693203|NCT02064387|583926252|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693204|NCT02064387|583926253|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
161693205|NCT02064387|583926254|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161693206|NCT02436876|583926258|FG000|Overall Study|Lost to Follow-up|0|||
161693207|NCT02436876|583926259|FG001|Overall Study|Lost to Follow-up|1|||
161693208|NCT02436876|583926260|FG002|Overall Study|Lost to Follow-up|1|||
161693209|NCT02436876|583926261|FG003|Overall Study|Lost to Follow-up|1|||
161693210|NCT02436876|583926258|FG000|Overall Study|Withdrawal by Subject|1|||
161693211|NCT02436876|583926259|FG001|Overall Study|Withdrawal by Subject|0|||
161693212|NCT02436876|583926260|FG002|Overall Study|Withdrawal by Subject|0|||
161693213|NCT02436876|583926261|FG003|Overall Study|Withdrawal by Subject|1|||
161693214|NCT02436876|583926258|FG000|Overall Study|Physician Decision|0|||
161693215|NCT02436876|583926259|FG001|Overall Study|Physician Decision|2|||
161693216|NCT02436876|583926260|FG002|Overall Study|Physician Decision|1|||
161693217|NCT02436876|583926261|FG003|Overall Study|Physician Decision|0|||
161693218|NCT02436876|583926258|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
161693219|NCT02436876|583926259|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
161693220|NCT02436876|583926260|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
161693221|NCT02436876|583926261|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
161693222|NCT00075504|583926262|FG000|Overall Study|Withdrawal by Subject|9|||
161693223|NCT00075504|583926263|FG001|Overall Study|Withdrawal by Subject|7|||
161693224|NCT01290692|583926264|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
161693225|NCT02780648|583926265|FG000|Overall Study|Disease Progression|1|||
161693226|NCT02780648|583926266|FG001|Overall Study|Disease Progression|0|||
161693227|NCT03127384|583926278|FG000|Overall Study|Lost to Follow-up|4|||
161693228|NCT03127384|583926278|FG000|Overall Study|Subject request|2|||
161693229|NCT00689871|583926279|FG000|Overall Study|Lost to Follow-up|123|||
161693230|NCT00689871|583926280|FG001|Overall Study|Lost to Follow-up|13|||
161693231|NCT00689871|583926281|FG002|Overall Study|Lost to Follow-up|37|||
161693232|NCT00689871|583926282|FG003|Overall Study|Lost to Follow-up|1|||
161693233|NCT00689871|583926279|FG000|Overall Study|Explanted of All Study Devices|36|||
161693234|NCT00689871|583926280|FG001|Overall Study|Explanted of All Study Devices|25|||
161693235|NCT00689871|583926281|FG002|Overall Study|Explanted of All Study Devices|29|||
161693236|NCT00689871|583926282|FG003|Overall Study|Explanted of All Study Devices|3|||
161693237|NCT00689871|583926279|FG000|Overall Study|Withdrawal by Subject|13|||
161693238|NCT00689871|583926280|FG001|Overall Study|Withdrawal by Subject|3|||
161693239|NCT00689871|583926281|FG002|Overall Study|Withdrawal by Subject|4|||
161693240|NCT00689871|583926282|FG003|Overall Study|Withdrawal by Subject|1|||
161693241|NCT00689871|583926279|FG000|Overall Study|Death|1|||
161693242|NCT00689871|583926280|FG001|Overall Study|Death|10|||
161693243|NCT00689871|583926281|FG002|Overall Study|Death|2|||
161693244|NCT00689871|583926282|FG003|Overall Study|Death|2|||
161693245|NCT00689871|583926279|FG000|Overall Study|Physician Decision|2|||
161693246|NCT00689871|583926280|FG001|Overall Study|Physician Decision|1|||
161693247|NCT00689871|583926281|FG002|Overall Study|Physician Decision|1|||
161693248|NCT00689871|583926282|FG003|Overall Study|Physician Decision|0|||
161693249|NCT02703311|583926283|FG000|Overall Study|Death|5|||
161693250|NCT02703311|583926283|FG000|Overall Study|Withdrawal by Subject|3|||
161693251|NCT00343889|583926291|FG000|Overall Study|Lost to Follow-up|2|||
161693252|NCT00343889|583926292|FG001|Overall Study|Lost to Follow-up|0|||
161693253|NCT00343889|583926291|FG000|Overall Study|Withdrawal by Subject|0|||
161693254|NCT00343889|583926292|FG001|Overall Study|Withdrawal by Subject|1|||
161693255|NCT00343889|583926291|FG000|Overall Study|Protocol Violation|1|||
161693256|NCT00343889|583926292|FG001|Overall Study|Protocol Violation|0|||
161693257|NCT00088374|583926295|FG000|Overall Study|patient did not receive any 17AAG|1|||
161693258|NCT00088374|583926295|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
161693259|NCT01110200|583926296|FG000|Overall Study|Adverse Event|28|||
161693260|NCT01110200|583926297|FG001|Overall Study|Adverse Event|28|||
161693261|NCT01110200|583926296|FG000|Overall Study|Withdrawal by Subject|25|||
161693262|NCT01110200|583926297|FG001|Overall Study|Withdrawal by Subject|32|||
161693263|NCT01110200|583926296|FG000|Overall Study|Lack of Efficacy|16|||
161693264|NCT01110200|583926297|FG001|Overall Study|Lack of Efficacy|25|||
161693265|NCT01110200|583926296|FG000|Overall Study|Protocol Violation|14|||
161693266|NCT01110200|583926297|FG001|Overall Study|Protocol Violation|12|||
161693267|NCT01110200|583926296|FG000|Overall Study|Physician Decision|13|||
161693268|NCT01110200|583926297|FG001|Overall Study|Physician Decision|17|||
161693269|NCT01110200|583926296|FG000|Overall Study|Lost to Follow-up|10|||
161693270|NCT01110200|583926297|FG001|Overall Study|Lost to Follow-up|7|||
161693271|NCT05913232|583926301|FG000|Overall Study|Adverse Event|0|||
161693272|NCT05913232|583926302|FG001|Overall Study|Adverse Event|2|||
161693273|NCT05913232|583926303|FG002|Overall Study|Adverse Event|1|||
161693274|NCT05913232|583926304|FG003|Overall Study|Adverse Event|1|||
161693275|NCT05103332|583926307|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693276|NCT05103332|583926308|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
161693277|NCT05103332|583926309|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
161693278|NCT05103332|583926310|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693279|NCT05103332|583926311|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693280|NCT05103332|583926312|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
161693281|NCT05103332|583926313|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693282|NCT05103332|583926314|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693283|NCT05103332|583926315|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693284|NCT05103332|583926316|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693285|NCT05103332|583926317|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693286|NCT05103332|583926318|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693287|NCT05103332|583926319|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693288|NCT05103332|583926320|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693289|NCT05103332|583926321|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693290|NCT05103332|583926322|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693291|NCT05103332|583926323|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693292|NCT05103332|583926324|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693293|NCT05103332|583926307|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693294|NCT05103332|583926308|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
161693295|NCT05103332|583926309|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693296|NCT05103332|583926310|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
161693297|NCT05103332|583926311|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693298|NCT05103332|583926312|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693299|NCT05103332|583926313|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
161836408|NCT00700817|584442955|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
161836409|NCT00700817|584442956|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
161836410|NCT00700817|584442957|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
161836411|NCT00700817|584442958|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
161836412|NCT00700817|584442954|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
161836413|NCT00700817|584442955|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
161693300|NCT05103332|583926314|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693301|NCT05103332|583926315|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693302|NCT05103332|583926316|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693303|NCT05103332|583926317|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693304|NCT05103332|583926318|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693305|NCT05103332|583926319|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693306|NCT05103332|583926320|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693307|NCT05103332|583926321|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693308|NCT05103332|583926322|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693309|NCT05103332|583926323|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693310|NCT05103332|583926324|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
161693311|NCT05103332|583926307|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
161693312|NCT05103332|583926308|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
161693313|NCT05103332|583926309|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
161693314|NCT05103332|583926310|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
161693315|NCT05103332|583926311|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
161693316|NCT05103332|583926312|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
161693317|NCT05103332|583926313|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693318|NCT05103332|583926314|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693319|NCT05103332|583926315|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693320|NCT05103332|583926316|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693321|NCT05103332|583926317|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693322|NCT05103332|583926318|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693323|NCT05103332|583926319|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693324|NCT05103332|583926320|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693325|NCT05103332|583926321|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693326|NCT05103332|583926322|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693327|NCT05103332|583926323|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693328|NCT05103332|583926324|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693329|NCT05103332|583926307|FG000|DB Period (6 Months=168 Days)|Other|0|||
161693330|NCT05103332|583926308|FG001|DB Period (6 Months=168 Days)|Other|0|||
161693331|NCT05103332|583926309|FG002|DB Period (6 Months=168 Days)|Other|0|||
161693332|NCT05103332|583926310|FG003|DB Period (6 Months=168 Days)|Other|1|||
161693333|NCT05103332|583926311|FG004|DB Period (6 Months=168 Days)|Other|0|||
161693334|NCT05103332|583926312|FG005|DB Period (6 Months=168 Days)|Other|0|||
161693335|NCT05103332|583926313|FG006|DB Period (6 Months=168 Days)|Other|0|||
161693336|NCT05103332|583926314|FG007|DB Period (6 Months=168 Days)|Other|0|||
161693337|NCT05103332|583926315|FG008|DB Period (6 Months=168 Days)|Other|0|||
161693338|NCT05103332|583926316|FG009|DB Period (6 Months=168 Days)|Other|0|||
161693339|NCT05103332|583926317|FG010|DB Period (6 Months=168 Days)|Other|0|||
161693340|NCT05103332|583926318|FG011|DB Period (6 Months=168 Days)|Other|0|||
161693341|NCT05103332|583926319|FG012|DB Period (6 Months=168 Days)|Other|0|||
161693342|NCT05103332|583926320|FG013|DB Period (6 Months=168 Days)|Other|0|||
161693343|NCT05103332|583926321|FG014|DB Period (6 Months=168 Days)|Other|0|||
161693344|NCT05103332|583926322|FG015|DB Period (6 Months=168 Days)|Other|0|||
161693345|NCT05103332|583926323|FG016|DB Period (6 Months=168 Days)|Other|0|||
161693346|NCT05103332|583926324|FG017|DB Period (6 Months=168 Days)|Other|0|||
161693347|NCT05103332|583926307|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693348|NCT05103332|583926308|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693349|NCT05103332|583926309|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693350|NCT05103332|583926310|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693351|NCT05103332|583926311|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693352|NCT05103332|583926312|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693353|NCT05103332|583926313|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693354|NCT05103332|583926314|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693355|NCT05103332|583926315|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693356|NCT05103332|583926316|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693357|NCT05103332|583926317|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
161693358|NCT05103332|583926318|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693359|NCT05103332|583926319|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693360|NCT05103332|583926320|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693361|NCT05103332|583926321|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693362|NCT05103332|583926322|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693363|NCT05103332|583926323|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693364|NCT05103332|583926324|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161693365|NCT05103332|583926307|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693366|NCT05103332|583926308|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161836414|NCT00700817|584442956|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
161956510|NCT01238991|584889686|FG009|Overall Study|Caregiver's request|0|||
161956511|NCT01238991|584889677|FG000|Overall Study|Admission to a nursing home|1|||
161956512|NCT01238991|584889678|FG001|Overall Study|Admission to a nursing home|0|||
161956513|NCT01238991|584889679|FG002|Overall Study|Admission to a nursing home|1|||
161693367|NCT05103332|583926309|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693368|NCT05103332|583926310|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161956514|NCT01238991|584889680|FG003|Overall Study|Admission to a nursing home|0|||
161956515|NCT01238991|584889681|FG004|Overall Study|Admission to a nursing home|0|||
161693369|NCT05103332|583926311|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693370|NCT05103332|583926312|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693371|NCT05103332|583926313|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693372|NCT05103332|583926314|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693373|NCT05103332|583926315|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
161693374|NCT05103332|583926316|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693375|NCT05103332|583926317|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693376|NCT05103332|583926318|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693377|NCT05103332|583926319|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693378|NCT05103332|583926320|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693379|NCT05103332|583926321|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693380|NCT05103332|583926322|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693381|NCT05103332|583926323|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693382|NCT05103332|583926324|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161693383|NCT05103332|583926307|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693384|NCT05103332|583926308|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693385|NCT05103332|583926309|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693386|NCT05103332|583926310|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693387|NCT05103332|583926311|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693388|NCT05103332|583926312|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693389|NCT05103332|583926313|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693390|NCT05103332|583926314|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693391|NCT05103332|583926315|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693392|NCT05103332|583926316|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693393|NCT05103332|583926317|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693394|NCT05103332|583926318|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
161693395|NCT05103332|583926319|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693396|NCT05103332|583926320|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693397|NCT05103332|583926321|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693398|NCT05103332|583926322|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693399|NCT05103332|583926323|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693400|NCT05103332|583926324|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161693401|NCT05103332|583926307|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693402|NCT05103332|583926308|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693403|NCT05103332|583926309|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693404|NCT05103332|583926310|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693405|NCT05103332|583926311|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693406|NCT05103332|583926312|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693407|NCT05103332|583926313|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
161693408|NCT05103332|583926314|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
161693409|NCT05103332|583926315|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693410|NCT05103332|583926316|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
161693411|NCT05103332|583926317|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
161693412|NCT05103332|583926318|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
161693413|NCT05103332|583926319|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693414|NCT05103332|583926320|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693415|NCT05103332|583926321|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693416|NCT05103332|583926322|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693417|NCT05103332|583926323|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693418|NCT05103332|583926324|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161693419|NCT05103332|583926307|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693420|NCT05103332|583926308|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693421|NCT05103332|583926309|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693422|NCT05103332|583926310|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693423|NCT05103332|583926311|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693424|NCT05103332|583926312|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693425|NCT05103332|583926313|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693426|NCT05103332|583926314|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693427|NCT05103332|583926315|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693428|NCT05103332|583926316|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693429|NCT05103332|583926317|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693430|NCT05103332|583926318|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161693431|NCT05103332|583926319|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
161693432|NCT05103332|583926320|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
161693433|NCT05103332|583926321|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
161693434|NCT05103332|583926322|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
161693435|NCT05103332|583926323|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
162030774|NCT00952380|585169488|FG003|Overall Study|Other|0|||
161693436|NCT05103332|583926324|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
161693437|NCT05103332|583926307|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693438|NCT05103332|583926308|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693439|NCT05103332|583926309|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693440|NCT05103332|583926310|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693441|NCT05103332|583926311|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693442|NCT05103332|583926312|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693443|NCT05103332|583926313|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693444|NCT05103332|583926314|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693445|NCT05103332|583926315|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693446|NCT05103332|583926316|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693447|NCT05103332|583926317|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693448|NCT05103332|583926318|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693449|NCT05103332|583926319|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693450|NCT05103332|583926320|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693451|NCT05103332|583926321|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693452|NCT05103332|583926322|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693453|NCT05103332|583926323|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161693454|NCT05103332|583926324|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
161693455|NCT05103332|583926307|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693456|NCT05103332|583926308|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693457|NCT05103332|583926309|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693458|NCT05103332|583926310|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693459|NCT05103332|583926311|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693460|NCT05103332|583926312|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693461|NCT05103332|583926313|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693462|NCT05103332|583926314|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693463|NCT05103332|583926315|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693464|NCT05103332|583926316|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693465|NCT05103332|583926317|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693466|NCT05103332|583926318|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161693467|NCT05103332|583926319|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
161956516|NCT01238991|584889682|FG005|Overall Study|Admission to a nursing home|0|||
161956517|NCT01238991|584889683|FG006|Overall Study|Admission to a nursing home|0|||
161956518|NCT01238991|584889684|FG007|Overall Study|Admission to a nursing home|0|||
161956519|NCT01238991|584889685|FG008|Overall Study|Admission to a nursing home|0|||
161956520|NCT01238991|584889686|FG009|Overall Study|Admission to a nursing home|0|||
161956521|NCT02522429|584889687|FG000|Overall Study|Lost to Follow-up|8|||
161956522|NCT02522429|584889687|FG000|Overall Study|Adverse Event|2|||
161956523|NCT02522429|584889687|FG000|Overall Study|Death|1|||
161956524|NCT02522429|584889687|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
161956525|NCT00294671|584889688|FG000|Overall Study|Lack of Efficacy|11|||
161956526|NCT00294671|584889689|FG001|Overall Study|Lack of Efficacy|23|||
161956527|NCT00294671|584889688|FG000|Overall Study|Liver transplant|7|||
161956528|NCT00294671|584889689|FG001|Overall Study|Liver transplant|9|||
161956529|NCT00294671|584889688|FG000|Overall Study|Drug related adverse event (AE)|4|||
161956530|NCT00294671|584889689|FG001|Overall Study|Drug related adverse event (AE)|2|||
161956531|NCT00294671|584889688|FG000|Overall Study|Non-drug related AE|3|||
161956532|NCT00294671|584889689|FG001|Overall Study|Non-drug related AE|2|||
161956533|NCT00294671|584889688|FG000|Overall Study|Lost to Follow-up|1|||
161956534|NCT00294671|584889689|FG001|Overall Study|Lost to Follow-up|3|||
161956535|NCT00294671|584889688|FG000|Overall Study|Non-compliance|1|||
161956536|NCT00294671|584889689|FG001|Overall Study|Non-compliance|0|||
161693468|NCT05103332|583926320|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
161693469|NCT05103332|583926321|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
161693470|NCT05103332|583926322|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
161693471|NCT05103332|583926323|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
161693472|NCT05103332|583926324|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
161693473|NCT05103332|583926307|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693474|NCT05103332|583926308|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693475|NCT05103332|583926309|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693476|NCT05103332|583926310|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693477|NCT05103332|583926311|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693478|NCT05103332|583926312|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693479|NCT05103332|583926313|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693480|NCT05103332|583926314|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693481|NCT05103332|583926315|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693482|NCT05103332|583926316|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693483|NCT05103332|583926317|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693484|NCT05103332|583926318|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693485|NCT05103332|583926319|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693486|NCT05103332|583926320|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693487|NCT05103332|583926321|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
161693488|NCT05103332|583926322|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
161693489|NCT05103332|583926323|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161693490|NCT05103332|583926324|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
161693491|NCT05103332|583926307|FG000|SFU Period (6 Months=168 Days)|Death|0|||
161693492|NCT05103332|583926308|FG001|SFU Period (6 Months=168 Days)|Death|0|||
161693493|NCT05103332|583926309|FG002|SFU Period (6 Months=168 Days)|Death|0|||
161693494|NCT05103332|583926310|FG003|SFU Period (6 Months=168 Days)|Death|0|||
161693495|NCT05103332|583926311|FG004|SFU Period (6 Months=168 Days)|Death|0|||
161693496|NCT05103332|583926312|FG005|SFU Period (6 Months=168 Days)|Death|0|||
161693497|NCT05103332|583926313|FG006|SFU Period (6 Months=168 Days)|Death|0|||
161693498|NCT05103332|583926314|FG007|SFU Period (6 Months=168 Days)|Death|0|||
161693499|NCT05103332|583926315|FG008|SFU Period (6 Months=168 Days)|Death|0|||
161693500|NCT05103332|583926316|FG009|SFU Period (6 Months=168 Days)|Death|0|||
161693501|NCT05103332|583926317|FG010|SFU Period (6 Months=168 Days)|Death|0|||
161693502|NCT05103332|583926318|FG011|SFU Period (6 Months=168 Days)|Death|0|||
161693503|NCT05103332|583926319|FG012|SFU Period (6 Months=168 Days)|Death|0|||
161693504|NCT05103332|583926320|FG013|SFU Period (6 Months=168 Days)|Death|0|||
161693505|NCT05103332|583926321|FG014|SFU Period (6 Months=168 Days)|Death|1|||
161693506|NCT05103332|583926322|FG015|SFU Period (6 Months=168 Days)|Death|0|||
161693507|NCT05103332|583926323|FG016|SFU Period (6 Months=168 Days)|Death|0|||
161693508|NCT05103332|583926324|FG017|SFU Period (6 Months=168 Days)|Death|1|||
161693509|NCT04428476|583926325|FG000|Overall Study|Withdrawal by Subject|1|||
161693510|NCT04428476|583926325|FG000|Overall Study|Still on treatment|12|||
161693511|NCT02043548|583926327|FG000|Overall Study|Lack of Efficacy|1|||
161693512|NCT02043548|583926328|FG001|Overall Study|Lack of Efficacy|0|||
161693513|NCT02043548|583926327|FG000|Overall Study|Adverse Event|0|||
161693514|NCT02043548|583926328|FG001|Overall Study|Adverse Event|1|||
161693515|NCT02289950|583926330|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
161693516|NCT02289950|583926331|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
161693517|NCT02289950|583926330|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
161693518|NCT02289950|583926331|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
161693519|NCT02289950|583926330|FG000|Overall Study|Lost to Follow-up|1|||
161693520|NCT02289950|583926331|FG001|Overall Study|Lost to Follow-up|0|||
161693521|NCT02289950|583926330|FG000|Overall Study|Physician Decision|9|||
161693522|NCT02289950|583926331|FG001|Overall Study|Physician Decision|3|||
161693523|NCT02289950|583926330|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
161693524|NCT02289950|583926331|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
161693525|NCT02289950|583926330|FG000|Overall Study|Withdrawal by Subject|1|||
161693526|NCT02289950|583926331|FG001|Overall Study|Withdrawal by Subject|3|||
161693527|NCT02289950|583926330|FG000|Overall Study|Test article held for greater than 28 days|0|||
161693528|NCT02289950|583926331|FG001|Overall Study|Test article held for greater than 28 days|1|||
161693529|NCT02289950|583926330|FG000|Overall Study|Adverse Event|11|||
161693530|NCT02289950|583926331|FG001|Overall Study|Adverse Event|3|||
161693531|NCT02289950|583926330|FG000|Overall Study|Death|1|||
161693532|NCT02289950|583926331|FG001|Overall Study|Death|1|||
161693533|NCT02289950|583926330|FG000|Overall Study|Other|5|||
161693534|NCT02289950|583926331|FG001|Overall Study|Other|2|||
161693535|NCT02289950|583926330|FG000|Overall Study|Not Treated|2|||
161693536|NCT02289950|583926331|FG001|Overall Study|Not Treated|1|||
161693537|NCT00264238|583926332|FG000|Overall Study|Protocol Violation|1|||
161693538|NCT03359759|583926333|FG000|Overall Study|Death|3|||
161693539|NCT03359759|583926333|FG000|Overall Study|Lost to Follow-up|2|||
161693540|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
161693541|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
161693542|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
161693543|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
161693544|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
161693545|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
161693546|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
161693547|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
161693548|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
161693549|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
161956537|NCT00294671|584889688|FG000|Overall Study|Death|0|||
161956538|NCT00294671|584889689|FG001|Overall Study|Death|1|||
161956539|NCT03107052|584889694|FG000|Overall Study|Adverse Event|6|||
161956540|NCT03107052|584889695|FG001|Overall Study|Adverse Event|1|||
161956541|NCT03107052|584889696|FG002|Overall Study|Adverse Event|2|||
161956542|NCT03107052|584889694|FG000|Overall Study|Withdrawal by Subject|9|||
161956543|NCT03107052|584889695|FG001|Overall Study|Withdrawal by Subject|5|||
161693550|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
161693551|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
161693552|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
161956544|NCT03107052|584889696|FG002|Overall Study|Withdrawal by Subject|8|||
161693553|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
161956545|NCT03107052|584889694|FG000|Overall Study|Protocol Violation|6|||
161956546|NCT03107052|584889695|FG001|Overall Study|Protocol Violation|0|||
161693554|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
161693555|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
161693556|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
161693557|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
161693558|NCT02600494|583926334|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
161693559|NCT02600494|583926335|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
161693560|NCT02600494|583926336|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
161693561|NCT02600494|583926334|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
161693562|NCT02600494|583926335|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
161693563|NCT02600494|583926336|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
161693564|NCT02600494|583926334|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
161693565|NCT02600494|583926335|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
161693566|NCT02600494|583926336|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
161693567|NCT02600494|583926334|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
161693568|NCT02600494|583926335|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
161693569|NCT02600494|583926336|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
161693570|NCT02600494|583926334|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
161693571|NCT02600494|583926335|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
161693572|NCT02600494|583926336|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
161693573|NCT02600494|583926334|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
161836415|NCT00700817|584442957|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
161836416|NCT00700817|584442958|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
161836417|NCT00700817|584442954|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
161836418|NCT00700817|584442955|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
161693574|NCT02600494|583926335|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
161693575|NCT02600494|583926336|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
161693576|NCT02600494|583926334|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
161693577|NCT02600494|583926335|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
161693578|NCT02600494|583926336|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
161836419|NCT00700817|584442956|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
161836420|NCT00700817|584442957|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
161836421|NCT00700817|584442958|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
161836422|NCT00700817|584442954|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
161836423|NCT00700817|584442955|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
161836424|NCT00700817|584442956|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
161836425|NCT00700817|584442957|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
161836426|NCT00700817|584442958|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
161836427|NCT00700817|584442954|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
161836428|NCT00700817|584442955|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
161836429|NCT00700817|584442956|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
161836430|NCT00700817|584442957|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
161836431|NCT00700817|584442958|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
161836432|NCT01194973|584442959|FG000|Screening Period|Screen Failure|3|||
161836433|NCT01194973|584442959|FG000|26 Week Treatment Period|Adverse Event|1|||
161836434|NCT01194973|584442959|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
161836435|NCT01194973|584442959|FG000|26 Week Treatment Period|Pregnancy|1|||
161836436|NCT01338987|584442962|FG000|Overall Study|enrolled on new protocol|0|||
161836437|NCT01338987|584442963|FG001|Overall Study|enrolled on new protocol|0|||
161836438|NCT01338987|584442964|FG002|Overall Study|enrolled on new protocol|1|||
161836439|NCT01338987|584442965|FG003|Overall Study|enrolled on new protocol|0|||
161836440|NCT01338987|584442966|FG004|Overall Study|enrolled on new protocol|0|||
161836441|NCT01338987|584442962|FG000|Overall Study|Disease progression on study|2|||
161836442|NCT01338987|584442963|FG001|Overall Study|Disease progression on study|1|||
161836443|NCT01338987|584442964|FG002|Overall Study|Disease progression on study|1|||
161836444|NCT01338987|584442965|FG003|Overall Study|Disease progression on study|0|||
161836445|NCT01338987|584442966|FG004|Overall Study|Disease progression on study|0|||
161836446|NCT00058214|584442967|FG000|Overall Study|Adverse Event|1|||
161836447|NCT03856593|584442970|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
161836448|NCT03856593|584442971|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
161836449|NCT03407118|584442972|FG000|Period 2|Withdrawal by Subject|1|||
161836450|NCT03407118|584442973|FG001|Period 2|Withdrawal by Subject|0|||
161836451|NCT01347866|584442990|FG000|Overall Study|Death|0|||
161836452|NCT01347866|584442991|FG001|Overall Study|Death|0|||
161836453|NCT01347866|584442992|FG002|Overall Study|Death|0|||
161836454|NCT01347866|584442993|FG003|Overall Study|Death|1|||
161836455|NCT01347866|584442994|FG004|Overall Study|Death|2|||
161836456|NCT01347866|584442995|FG005|Overall Study|Death|2|||
161836457|NCT01347866|584442996|FG006|Overall Study|Death|1|||
161836458|NCT01347866|584442997|FG007|Overall Study|Death|0|||
161836459|NCT01347866|584442998|FG008|Overall Study|Death|4|||
161693579|NCT00661271|583927896|FG000|Overall Study|Lost to Follow-up|28|||
161693580|NCT00661271|583927897|FG001|Overall Study|Lost to Follow-up|25|||
161693581|NCT00953758|583927898|FG000|Overall Study|Death|2|||
161693582|NCT00953758|583927899|FG001|Overall Study|Death|0|||
161693583|NCT00953758|583927900|FG002|Overall Study|Death|1|||
161693584|NCT00953758|583927901|FG003|Overall Study|Death|1|||
161693585|NCT00953758|583927902|FG004|Overall Study|Death|1|||
161693586|NCT00953758|583927903|FG005|Overall Study|Death|1|||
161693587|NCT00953758|583927904|FG006|Overall Study|Death|1|||
161693588|NCT00953758|583927905|FG007|Overall Study|Death|3|||
161693589|NCT00953758|583927906|FG008|Overall Study|Death|1|||
161693590|NCT00953758|583927907|FG009|Overall Study|Death|0|||
161693591|NCT00953758|583927898|FG000|Overall Study|Participant refused further follow-up|0|||
161693592|NCT00953758|583927899|FG001|Overall Study|Participant refused further follow-up|0|||
161693593|NCT00953758|583927900|FG002|Overall Study|Participant refused further follow-up|1|||
161693594|NCT00953758|583927901|FG003|Overall Study|Participant refused further follow-up|0|||
161693595|NCT00953758|583927902|FG004|Overall Study|Participant refused further follow-up|3|||
161693596|NCT00953758|583927903|FG005|Overall Study|Participant refused further follow-up|0|||
161693597|NCT00953758|583927904|FG006|Overall Study|Participant refused further follow-up|0|||
161693598|NCT00953758|583927905|FG007|Overall Study|Participant refused further follow-up|0|||
161693599|NCT00953758|583927906|FG008|Overall Study|Participant refused further follow-up|1|||
161693600|NCT00953758|583927907|FG009|Overall Study|Participant refused further follow-up|0|||
161693601|NCT00953758|583927898|FG000|Overall Study|Lost to Follow-up|0|||
161693602|NCT00953758|583927899|FG001|Overall Study|Lost to Follow-up|0|||
161693603|NCT00953758|583927900|FG002|Overall Study|Lost to Follow-up|0|||
161693604|NCT00953758|583927901|FG003|Overall Study|Lost to Follow-up|1|||
161693605|NCT00953758|583927902|FG004|Overall Study|Lost to Follow-up|0|||
161693606|NCT00953758|583927903|FG005|Overall Study|Lost to Follow-up|0|||
161693607|NCT00953758|583927904|FG006|Overall Study|Lost to Follow-up|0|||
161693608|NCT00953758|583927905|FG007|Overall Study|Lost to Follow-up|1|||
161693609|NCT00953758|583927906|FG008|Overall Study|Lost to Follow-up|0|||
161693610|NCT00953758|583927907|FG009|Overall Study|Lost to Follow-up|1|||
161693611|NCT00953758|583927898|FG000|Overall Study|Physician Decision|0|||
161693612|NCT00953758|583927899|FG001|Overall Study|Physician Decision|0|||
161693613|NCT00953758|583927900|FG002|Overall Study|Physician Decision|0|||
161693614|NCT00953758|583927901|FG003|Overall Study|Physician Decision|0|||
161693615|NCT00953758|583927902|FG004|Overall Study|Physician Decision|1|||
161693616|NCT00953758|583927903|FG005|Overall Study|Physician Decision|0|||
161693617|NCT00953758|583927904|FG006|Overall Study|Physician Decision|0|||
161693618|NCT00953758|583927905|FG007|Overall Study|Physician Decision|0|||
161693619|NCT00953758|583927906|FG008|Overall Study|Physician Decision|0|||
161693620|NCT00953758|583927907|FG009|Overall Study|Physician Decision|0|||
161693621|NCT00953758|583927898|FG000|Overall Study|Disease progression|0|||
161693622|NCT00953758|583927899|FG001|Overall Study|Disease progression|0|||
161693623|NCT00953758|583927900|FG002|Overall Study|Disease progression|0|||
161693624|NCT00953758|583927901|FG003|Overall Study|Disease progression|0|||
161693625|NCT00953758|583927902|FG004|Overall Study|Disease progression|1|||
161693626|NCT00953758|583927903|FG005|Overall Study|Disease progression|0|||
161693627|NCT00953758|583927904|FG006|Overall Study|Disease progression|0|||
161693628|NCT00953758|583927905|FG007|Overall Study|Disease progression|0|||
161693629|NCT00953758|583927906|FG008|Overall Study|Disease progression|0|||
161693630|NCT00953758|583927907|FG009|Overall Study|Disease progression|0|||
161693631|NCT00953758|583927898|FG000|Overall Study|Participant went for transplant|0|||
161693632|NCT00953758|583927899|FG001|Overall Study|Participant went for transplant|0|||
161693633|NCT00953758|583927900|FG002|Overall Study|Participant went for transplant|0|||
161693634|NCT00953758|583927901|FG003|Overall Study|Participant went for transplant|0|||
161693635|NCT00953758|583927902|FG004|Overall Study|Participant went for transplant|0|||
161693636|NCT00953758|583927903|FG005|Overall Study|Participant went for transplant|0|||
161693637|NCT00953758|583927904|FG006|Overall Study|Participant went for transplant|0|||
161693638|NCT00953758|583927905|FG007|Overall Study|Participant went for transplant|0|||
161693639|NCT00953758|583927906|FG008|Overall Study|Participant went for transplant|1|||
161693640|NCT00953758|583927907|FG009|Overall Study|Participant went for transplant|0|||
161693641|NCT00293579|583927909|FG000|Overall Study|Withdrawal by Subject|1|||
161693642|NCT01276236|583927910|FG000|Overall Study|Lack of Efficacy|2|||
161836460|NCT01347866|584442999|FG009|Overall Study|Death|1|||
161693643|NCT01276236|583927910|FG000|Overall Study|Withdrawal by Subject|4|||
161693644|NCT02799069|583927911|FG000|Overall Study|Adverse Event|0|||
161693645|NCT02799069|583927912|FG001|Overall Study|Adverse Event|2|||
161693646|NCT02799069|583927913|FG002|Overall Study|Adverse Event|2|||
161693647|NCT02799069|583927911|FG000|Overall Study|Lack of Efficacy|2|||
161693648|NCT02799069|583927912|FG001|Overall Study|Lack of Efficacy|0|||
161693649|NCT02799069|583927913|FG002|Overall Study|Lack of Efficacy|0|||
161693650|NCT02799069|583927911|FG000|Overall Study|Lost to Follow-up|1|||
161693651|NCT02799069|583927912|FG001|Overall Study|Lost to Follow-up|1|||
161693652|NCT02799069|583927913|FG002|Overall Study|Lost to Follow-up|0|||
161693653|NCT02799069|583927911|FG000|Overall Study|Withdrawal by Subject|4|||
161693654|NCT02799069|583927912|FG001|Overall Study|Withdrawal by Subject|4|||
161693655|NCT02799069|583927913|FG002|Overall Study|Withdrawal by Subject|3|||
161693656|NCT02799069|583927911|FG000|Overall Study|Protocol Violation|1|||
161693657|NCT02799069|583927912|FG001|Overall Study|Protocol Violation|0|||
161693658|NCT02799069|583927913|FG002|Overall Study|Protocol Violation|2|||
161693659|NCT03215771|583927914|FG000|Overall Study|Withdrawal by Subject|2|||
161693660|NCT03215771|583927914|FG000|Overall Study|Physician Decision|1|||
161693661|NCT00137111|583927923|FG000|Total Therapy|Death|35|||
161693662|NCT00137111|583927924|FG001|Total Therapy|Death|0|||
161693663|NCT00137111|583927925|FG002|Total Therapy|Death|0|||
161693664|NCT00137111|583927926|FG003|Total Therapy|Death|0|||
161693665|NCT00137111|583927923|FG000|Total Therapy|Non Compliance|5|||
161693666|NCT00137111|583927924|FG001|Total Therapy|Non Compliance|0|||
161693667|NCT00137111|583927925|FG002|Total Therapy|Non Compliance|0|||
161693668|NCT00137111|583927926|FG003|Total Therapy|Non Compliance|0|||
161693669|NCT00852995|583927927|FG000|Overall Study|Adverse Event|1|||
161693670|NCT00852995|583927928|FG001|Overall Study|Adverse Event|0|||
161693671|NCT00852995|583927929|FG002|Overall Study|Adverse Event|4|||
161693672|NCT00852995|583927930|FG003|Overall Study|Adverse Event|0|||
161693673|NCT00852995|583927931|FG004|Overall Study|Adverse Event|0|||
161693674|NCT00852995|583927927|FG000|Overall Study|Lost to Follow-up|0|||
161693675|NCT00852995|583927928|FG001|Overall Study|Lost to Follow-up|1|||
161693676|NCT00852995|583927929|FG002|Overall Study|Lost to Follow-up|1|||
161693677|NCT00852995|583927930|FG003|Overall Study|Lost to Follow-up|0|||
161693678|NCT00852995|583927931|FG004|Overall Study|Lost to Follow-up|0|||
161693679|NCT00852995|583927927|FG000|Overall Study|Withdrawal by Subject|4|||
161693680|NCT00852995|583927928|FG001|Overall Study|Withdrawal by Subject|0|||
161693681|NCT00852995|583927929|FG002|Overall Study|Withdrawal by Subject|0|||
161693682|NCT00852995|583927930|FG003|Overall Study|Withdrawal by Subject|1|||
161693683|NCT00852995|583927931|FG004|Overall Study|Withdrawal by Subject|2|||
161693684|NCT00852995|583927927|FG000|Overall Study|Non-Compliance|0|||
161693685|NCT00852995|583927928|FG001|Overall Study|Non-Compliance|0|||
161693686|NCT00852995|583927929|FG002|Overall Study|Non-Compliance|0|||
161693687|NCT00852995|583927930|FG003|Overall Study|Non-Compliance|2|||
161693688|NCT00852995|583927931|FG004|Overall Study|Non-Compliance|0|||
161693689|NCT00852995|583927927|FG000|Overall Study|Progressive Disease|1|||
161693690|NCT00852995|583927928|FG001|Overall Study|Progressive Disease|0|||
161693691|NCT00852995|583927929|FG002|Overall Study|Progressive Disease|0|||
161693692|NCT00852995|583927930|FG003|Overall Study|Progressive Disease|2|||
161693693|NCT00852995|583927931|FG004|Overall Study|Progressive Disease|1|||
161693694|NCT00852995|583927927|FG000|Overall Study|Physician Decision|1|||
161693695|NCT00852995|583927928|FG001|Overall Study|Physician Decision|0|||
161693696|NCT00852995|583927929|FG002|Overall Study|Physician Decision|0|||
161693697|NCT00852995|583927930|FG003|Overall Study|Physician Decision|0|||
161693698|NCT00852995|583927931|FG004|Overall Study|Physician Decision|0|||
161693699|NCT00852995|583927927|FG000|Overall Study|Protocol Violation|0|||
161693700|NCT00852995|583927928|FG001|Overall Study|Protocol Violation|0|||
161693701|NCT00852995|583927929|FG002|Overall Study|Protocol Violation|0|||
161693702|NCT00852995|583927930|FG003|Overall Study|Protocol Violation|0|||
161693703|NCT00852995|583927931|FG004|Overall Study|Protocol Violation|1|||
161693704|NCT00852995|583927927|FG000|Overall Study|Moved Out of Area|1|||
161693705|NCT00852995|583927928|FG001|Overall Study|Moved Out of Area|0|||
161693706|NCT00852995|583927929|FG002|Overall Study|Moved Out of Area|0|||
161693707|NCT00852995|583927930|FG003|Overall Study|Moved Out of Area|0|||
161693708|NCT00852995|583927931|FG004|Overall Study|Moved Out of Area|0|||
161693709|NCT00626093|583927934|FG000|Overall Study|Lost to Follow-up|5|||
161693710|NCT00626093|583927934|FG000|Overall Study|Death|1|||
161693711|NCT00626093|583927934|FG000|Overall Study|Physician Decision|4|||
161693712|NCT00626093|583927934|FG000|Overall Study|Withdrawal by Subject|6|||
161693713|NCT00626093|583927934|FG000|Overall Study|Protocol Violation|1|||
161693714|NCT00626093|583927934|FG000|Overall Study|One of the required devices not implante|6|||
161693715|NCT00511355|583927935|FG000|Overall Study|Adverse Event|4|||
161693716|NCT00511355|583927936|FG001|Overall Study|Adverse Event|4|||
161693717|NCT00511355|583927935|FG000|Overall Study|Pregnancy Wish|1|||
161693718|NCT00511355|583927936|FG001|Overall Study|Pregnancy Wish|0|||
161956547|NCT03107052|584889696|FG002|Overall Study|Protocol Violation|3|||
161693719|NCT00511355|583927935|FG000|Overall Study|Lost to Follow-up|2|||
161693720|NCT00511355|583927936|FG001|Overall Study|Lost to Follow-up|1|||
161693721|NCT00511355|583927935|FG000|Overall Study|Other Reason|0|||
161693722|NCT00511355|583927936|FG001|Overall Study|Other Reason|1|||
161693723|NCT00511355|583927935|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
161693724|NCT00511355|583927936|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
161693725|NCT00511355|583927935|FG000|Overall Study|Withdrawal of informed consent|0|||
161693726|NCT00511355|583927936|FG001|Overall Study|Withdrawal of informed consent|1|||
161693727|NCT00511355|583927935|FG000|Overall Study|Other reason pre-treatment|0|||
161693728|NCT00511355|583927936|FG001|Overall Study|Other reason pre-treatment|1|||
161693729|NCT01632566|583927938|FG000|Overall Study|Withdrawal by Subject|0|||
161693730|NCT01632566|583927939|FG001|Overall Study|Withdrawal by Subject|1|||
161693731|NCT01632566|583927940|FG002|Overall Study|Withdrawal by Subject|0|||
161693732|NCT01632566|583927941|FG003|Overall Study|Withdrawal by Subject|0|||
161693733|NCT01632566|583927942|FG004|Overall Study|Withdrawal by Subject|0|||
161693734|NCT01632566|583927938|FG000|Overall Study|Sponsor Decision|0|||
161956548|NCT03107052|584889694|FG000|Overall Study|Lost to Follow-up|4|||
161693735|NCT01632566|583927939|FG001|Overall Study|Sponsor Decision|2|||
161693736|NCT01632566|583927940|FG002|Overall Study|Sponsor Decision|9|||
161693737|NCT01632566|583927941|FG003|Overall Study|Sponsor Decision|2|||
161693738|NCT01632566|583927942|FG004|Overall Study|Sponsor Decision|2|||
161693739|NCT00454805|583927943|FG000|Overall Study|Withdrawal by Subject|9|||
161693740|NCT00454805|583927944|FG001|Overall Study|Withdrawal by Subject|2|||
161693741|NCT00454805|583927943|FG000|Overall Study|Death|0|||
161693742|NCT00454805|583927944|FG001|Overall Study|Death|2|||
161693743|NCT00454805|583927943|FG000|Overall Study|Disease progression|16|||
161693744|NCT00454805|583927944|FG001|Overall Study|Disease progression|19|||
161693745|NCT00454805|583927943|FG000|Overall Study|In order to begin radiotherapy|1|||
161693746|NCT00454805|583927944|FG001|Overall Study|In order to begin radiotherapy|0|||
161693747|NCT00217087|583927945|FG000|Overall Study|decided to have esophagectomy|1|||
161693748|NCT00217087|583927946|FG001|Overall Study|decided to have esophagectomy|2|||
161693749|NCT00217087|583927945|FG000|Overall Study|completed less than 12 months return|10|||
161693750|NCT00217087|583927946|FG001|Overall Study|completed less than 12 months return|18|||
161956549|NCT03107052|584889695|FG001|Overall Study|Lost to Follow-up|0|||
161956550|NCT03107052|584889696|FG002|Overall Study|Lost to Follow-up|1|||
161956551|NCT03107052|584889694|FG000|Overall Study|Lack of Efficacy|23|||
161956552|NCT03107052|584889695|FG001|Overall Study|Lack of Efficacy|7|||
161956553|NCT03107052|584889696|FG002|Overall Study|Lack of Efficacy|4|||
161956554|NCT03107052|584889694|FG000|Overall Study|Other than specified|4|||
161956555|NCT03107052|584889695|FG001|Overall Study|Other than specified|2|||
161956556|NCT03107052|584889696|FG002|Overall Study|Other than specified|0|||
161956557|NCT03107052|584889694|FG000|Overall Study|Study terminated due to futility|67|||
161956558|NCT03107052|584889695|FG001|Overall Study|Study terminated due to futility|31|||
161956559|NCT03107052|584889696|FG002|Overall Study|Study terminated due to futility|23|||
161956560|NCT00958360|584889697|FG000|Overall Study|Withdrawal by Subject|3|||
161956561|NCT00958360|584889698|FG001|Overall Study|Withdrawal by Subject|1|||
161956562|NCT00958360|584889697|FG000|Overall Study|Death|6|||
161956563|NCT00958360|584889698|FG001|Overall Study|Death|7|||
161956564|NCT00958360|584889697|FG000|Overall Study|Physician Decision|2|||
161956565|NCT00958360|584889698|FG001|Overall Study|Physician Decision|1|||
161956566|NCT00958360|584889697|FG000|Overall Study|Lost to Follow-up|0|||
161956567|NCT00958360|584889698|FG001|Overall Study|Lost to Follow-up|1|||
161693751|NCT03892746|583927949|FG000|Overall Study|Withdrawal by Subject|2|||
161693752|NCT03892746|583927950|FG001|Overall Study|Withdrawal by Subject|1|||
161956568|NCT03015363|584889699|FG000|Overall Study|Physician Decision|14|||
161956569|NCT03015363|584889699|FG000|Overall Study|Withdrawal by Subject|3|||
161956570|NCT02263326|584889700|FG000|Overall Study|Lost to Follow-up|1|||
161693753|NCT03892746|583927949|FG000|Overall Study|Lost to Follow-up|2|||
161693754|NCT03892746|583927950|FG001|Overall Study|Lost to Follow-up|0|||
161693755|NCT03977467|583927951|FG000|Overall Study|Disease Progression|1|||
161693756|NCT03977467|583927952|FG001|Overall Study|Disease Progression|1|||
161693757|NCT03977467|583927953|FG002|Overall Study|Disease Progression|30|||
161693758|NCT03977467|583927954|FG003|Overall Study|Disease Progression|0|||
161693759|NCT03977467|583927951|FG000|Overall Study|Adverse Event|0|||
161693760|NCT03977467|583927952|FG001|Overall Study|Adverse Event|1|||
161693761|NCT03977467|583927953|FG002|Overall Study|Adverse Event|0|||
161693762|NCT03977467|583927954|FG003|Overall Study|Adverse Event|0|||
161693763|NCT03977467|583927951|FG000|Overall Study|Death|0|||
161693764|NCT03977467|583927952|FG001|Overall Study|Death|0|||
161693765|NCT03977467|583927953|FG002|Overall Study|Death|3|||
161693766|NCT03977467|583927954|FG003|Overall Study|Death|0|||
161693767|NCT03977467|583927951|FG000|Overall Study|Lack of Efficacy|0|||
161693768|NCT03977467|583927952|FG001|Overall Study|Lack of Efficacy|0|||
161693769|NCT03977467|583927953|FG002|Overall Study|Lack of Efficacy|1|||
161693770|NCT03977467|583927954|FG003|Overall Study|Lack of Efficacy|0|||
161693771|NCT03977467|583927951|FG000|Overall Study|Withdrawal by Subject|2|||
161693772|NCT03977467|583927952|FG001|Overall Study|Withdrawal by Subject|1|||
161693773|NCT03977467|583927953|FG002|Overall Study|Withdrawal by Subject|4|||
161693774|NCT03977467|583927954|FG003|Overall Study|Withdrawal by Subject|0|||
161693775|NCT03977467|583927951|FG000|Overall Study|Study Terminated|1|||
161693776|NCT03977467|583927952|FG001|Overall Study|Study Terminated|0|||
161693777|NCT03977467|583927953|FG002|Overall Study|Study Terminated|0|||
161693778|NCT03977467|583927954|FG003|Overall Study|Study Terminated|1|||
161693779|NCT01328951|583927955|FG000|Overall Study|Disease Progression|17|||
161693780|NCT01328951|583927956|FG001|Overall Study|Disease Progression|14|||
161693781|NCT01328951|583927955|FG000|Overall Study|Adverse Event|2|||
161693782|NCT01328951|583927956|FG001|Overall Study|Adverse Event|0|||
161693783|NCT01328951|583927955|FG000|Overall Study|Death|243|||
161693784|NCT01328951|583927956|FG001|Overall Study|Death|258|||
161693785|NCT01328951|583927955|FG000|Overall Study|Lost to Follow-up|6|||
161693786|NCT01328951|583927956|FG001|Overall Study|Lost to Follow-up|7|||
161693787|NCT01328951|583927955|FG000|Overall Study|Withdrawal by Subject|6|||
161693788|NCT01328951|583927956|FG001|Overall Study|Withdrawal by Subject|6|||
161693789|NCT01328951|583927955|FG000|Overall Study|Study Closed by the Sponsor|36|||
161693790|NCT01328951|583927956|FG001|Overall Study|Study Closed by the Sponsor|31|||
161693791|NCT01328951|583927955|FG000|Overall Study|Other|11|||
161693792|NCT01328951|583927956|FG001|Overall Study|Other|6|||
161693793|NCT04042103|583927962|FG000|Overall Study|Lost to Follow-up|1|||
161693794|NCT04042103|583927962|FG000|Overall Study|Withdrawal by Subject|1|||
161693795|NCT04209855|583927963|FG000|Overall Study|Death|161|||
161693796|NCT04209855|583927964|FG001|Overall Study|Death|177|||
161693797|NCT04209855|583927963|FG000|Overall Study|PI Discretion|1|||
161693798|NCT04209855|583927964|FG001|Overall Study|PI Discretion|1|||
161693799|NCT04209855|583927963|FG000|Overall Study|Lost to Follow-up|5|||
161693800|NCT04209855|583927964|FG001|Overall Study|Lost to Follow-up|2|||
161693801|NCT04209855|583927963|FG000|Overall Study|Withdrew consent|10|||
161693802|NCT04209855|583927964|FG001|Overall Study|Withdrew consent|24|||
161693803|NCT04209855|583927963|FG000|Overall Study|Sponsor decision|44|||
161693804|NCT04209855|583927964|FG001|Overall Study|Sponsor decision|18|||
161693805|NCT04209855|583927963|FG000|Overall Study|Other than specified|6|||
161693806|NCT04209855|583927964|FG001|Overall Study|Other than specified|4|||
161693807|NCT04518462|583927965|FG000|Overall Study|Withdrawal by Subject|0|||
161693808|NCT04518462|583927966|FG001|Overall Study|Withdrawal by Subject|0|||
161693809|NCT04518462|583927967|FG002|Overall Study|Withdrawal by Subject|1|||
161693810|NCT04518462|583927965|FG000|Overall Study|Physician Decision|1|||
161693811|NCT04518462|583927966|FG001|Overall Study|Physician Decision|1|||
161693812|NCT04518462|583927967|FG002|Overall Study|Physician Decision|0|||
161693813|NCT01003210|583927968|FG000|Overall Study|Lost to Follow-up|1|||
161693814|NCT01003210|583927969|FG001|Overall Study|Lost to Follow-up|3|||
161693815|NCT00271817|583927970|FG000|Part 1|Adverse Event|68|||
161693816|NCT00271817|583927971|FG001|Part 1|Adverse Event|25|||
161693817|NCT00271817|583927972|FG002|Part 1|Adverse Event|156|||
161693818|NCT00271817|583927970|FG000|Part 1|Lost to Follow-up|6|||
161693819|NCT00271817|583927971|FG001|Part 1|Lost to Follow-up|8|||
161693820|NCT00271817|583927972|FG002|Part 1|Lost to Follow-up|24|||
161693821|NCT00271817|583927970|FG000|Part 1|Protocol Violation|5|||
161693822|NCT00271817|583927971|FG001|Part 1|Protocol Violation|4|||
161693823|NCT00271817|583927972|FG002|Part 1|Protocol Violation|7|||
161693824|NCT00271817|583927970|FG000|Part 1|Patient Moved|3|||
161693825|NCT00271817|583927971|FG001|Part 1|Patient Moved|1|||
161693826|NCT00271817|583927972|FG002|Part 1|Patient Moved|5|||
161693827|NCT00271817|583927970|FG000|Part 1|Withdrawal by Subject|23|||
161693828|NCT00271817|583927971|FG001|Part 1|Withdrawal by Subject|17|||
161693829|NCT00271817|583927972|FG002|Part 1|Withdrawal by Subject|45|||
161693830|NCT00271817|583927970|FG000|Part 1|LDL < 50 mg/dL|1|||
161693831|NCT00271817|583927971|FG001|Part 1|LDL < 50 mg/dL|4|||
161693832|NCT00271817|583927972|FG002|Part 1|LDL < 50 mg/dL|48|||
161693833|NCT00271817|583927970|FG000|Part 2|Adverse Event|0|||
161693834|NCT00271817|583927971|FG001|Part 2|Adverse Event|17|||
161693835|NCT00271817|583927972|FG002|Part 2|Adverse Event|33|||
161693836|NCT00271817|583927970|FG000|Part 2|Lack of Efficacy|0|||
161693837|NCT00271817|583927971|FG001|Part 2|Lack of Efficacy|1|||
161693838|NCT00271817|583927972|FG002|Part 2|Lack of Efficacy|6|||
161693839|NCT00271817|583927970|FG000|Part 2|Lost to Follow-up|0|||
161693840|NCT00271817|583927971|FG001|Part 2|Lost to Follow-up|6|||
161693841|NCT00271817|583927972|FG002|Part 2|Lost to Follow-up|18|||
161693842|NCT00271817|583927970|FG000|Part 2|Protocol Violation|0|||
161693843|NCT00271817|583927971|FG001|Part 2|Protocol Violation|3|||
161693844|NCT00271817|583927972|FG002|Part 2|Protocol Violation|5|||
161693845|NCT00271817|583927970|FG000|Part 2|Patient Moved|0|||
161693846|NCT00271817|583927971|FG001|Part 2|Patient Moved|0|||
161693847|NCT00271817|583927972|FG002|Part 2|Patient Moved|5|||
161836461|NCT01347866|584443000|FG010|Overall Study|Death|3|||
161836462|NCT01347866|584443001|FG011|Overall Study|Death|1|||
161836463|NCT01347866|584443002|FG012|Overall Study|Death|2|||
161836464|NCT01347866|584443003|FG013|Overall Study|Death|0|||
161836465|NCT01347866|584443004|FG014|Overall Study|Death|0|||
161693848|NCT00271817|583927970|FG000|Part 2|Withdrawal by Subject|0|||
161693849|NCT00271817|583927971|FG001|Part 2|Withdrawal by Subject|2|||
161693850|NCT00271817|583927972|FG002|Part 2|Withdrawal by Subject|13|||
161693851|NCT00271817|583927970|FG000|Part 2|LDL < 50 mg/dL|0|||
161836466|NCT01347866|584443005|FG015|Overall Study|Death|1|||
161836467|NCT01347866|584443006|FG016|Overall Study|Death|0|||
161836468|NCT01347866|584442990|FG000|Overall Study|Lost to Follow-up|0|||
161836469|NCT01347866|584442991|FG001|Overall Study|Lost to Follow-up|0|||
161836470|NCT01347866|584442992|FG002|Overall Study|Lost to Follow-up|0|||
161836471|NCT01347866|584442993|FG003|Overall Study|Lost to Follow-up|0|||
161836472|NCT01347866|584442994|FG004|Overall Study|Lost to Follow-up|0|||
161836473|NCT01347866|584442995|FG005|Overall Study|Lost to Follow-up|0|||
161836474|NCT01347866|584442996|FG006|Overall Study|Lost to Follow-up|0|||
161836475|NCT01347866|584442997|FG007|Overall Study|Lost to Follow-up|1|||
161836476|NCT01347866|584442998|FG008|Overall Study|Lost to Follow-up|1|||
161836477|NCT01347866|584442999|FG009|Overall Study|Lost to Follow-up|0|||
161836478|NCT01347866|584443000|FG010|Overall Study|Lost to Follow-up|0|||
161836479|NCT01347866|584443001|FG011|Overall Study|Lost to Follow-up|0|||
161836480|NCT01347866|584443002|FG012|Overall Study|Lost to Follow-up|0|||
161836481|NCT01347866|584443003|FG013|Overall Study|Lost to Follow-up|0|||
161836482|NCT01347866|584443004|FG014|Overall Study|Lost to Follow-up|0|||
161836483|NCT01347866|584443005|FG015|Overall Study|Lost to Follow-up|0|||
161836484|NCT01347866|584443006|FG016|Overall Study|Lost to Follow-up|0|||
161836485|NCT01347866|584442990|FG000|Overall Study|Other|3|||
161836486|NCT01347866|584442991|FG001|Overall Study|Other|1|||
161836487|NCT01347866|584442992|FG002|Overall Study|Other|1|||
161836488|NCT01347866|584442993|FG003|Overall Study|Other|4|||
161836489|NCT01347866|584442994|FG004|Overall Study|Other|5|||
161836490|NCT01347866|584442995|FG005|Overall Study|Other|0|||
161836491|NCT01347866|584442996|FG006|Overall Study|Other|5|||
161836492|NCT01347866|584442997|FG007|Overall Study|Other|3|||
161693852|NCT00271817|583927971|FG001|Part 2|LDL < 50 mg/dL|3|||
161693853|NCT00271817|583927972|FG002|Part 2|LDL < 50 mg/dL|4|||
161693854|NCT01471782|583927976|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
161693855|NCT01471782|583927977|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
161836493|NCT01347866|584442998|FG008|Overall Study|Other|22|||
161836494|NCT01347866|584442999|FG009|Overall Study|Other|5|||
161836495|NCT01347866|584443000|FG010|Overall Study|Other|0|||
161836496|NCT01347866|584443001|FG011|Overall Study|Other|3|||
161956571|NCT02263326|584889701|FG001|Overall Study|Lost to Follow-up|1|||
161693856|NCT01471782|583927978|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
161693857|NCT01471782|583927979|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
161693858|NCT01471782|583927980|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
161836497|NCT01347866|584443002|FG012|Overall Study|Other|4|||
161836498|NCT01347866|584443003|FG013|Overall Study|Other|4|||
161836499|NCT01347866|584443004|FG014|Overall Study|Other|2|||
161693859|NCT01471782|583927981|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
161693860|NCT01471782|583927976|FG000|Overall Study|Lack of Efficacy|1|||
161836500|NCT01347866|584443005|FG015|Overall Study|Other|3|||
161836501|NCT01347866|584443006|FG016|Overall Study|Other|0|||
161836502|NCT01347866|584442990|FG000|Overall Study|Subject refused further follow-up|2|||
161836503|NCT01347866|584442991|FG001|Overall Study|Subject refused further follow-up|0|||
161693861|NCT01471782|583927977|FG001|Overall Study|Lack of Efficacy|2|||
161693862|NCT01471782|583927978|FG002|Overall Study|Lack of Efficacy|1|||
161693863|NCT01471782|583927979|FG003|Overall Study|Lack of Efficacy|1|||
161693864|NCT01471782|583927980|FG004|Overall Study|Lack of Efficacy|5|||
161693865|NCT01471782|583927981|FG005|Overall Study|Lack of Efficacy|18|||
161693866|NCT01471782|583927976|FG000|Overall Study|Adverse Event|1|||
161693867|NCT01471782|583927977|FG001|Overall Study|Adverse Event|1|||
161693868|NCT01471782|583927978|FG002|Overall Study|Adverse Event|2|||
161693869|NCT01471782|583927979|FG003|Overall Study|Adverse Event|2|||
161693870|NCT01471782|583927980|FG004|Overall Study|Adverse Event|3|||
161693871|NCT01471782|583927981|FG005|Overall Study|Adverse Event|1|||
161693872|NCT01471782|583927976|FG000|Overall Study|Other|0|||
161693873|NCT01471782|583927977|FG001|Overall Study|Other|0|||
161693874|NCT01471782|583927978|FG002|Overall Study|Other|1|||
161693875|NCT01471782|583927979|FG003|Overall Study|Other|1|||
161693876|NCT01471782|583927980|FG004|Overall Study|Other|6|||
161693877|NCT01471782|583927981|FG005|Overall Study|Other|5|||
161693878|NCT01471782|583927976|FG000|Overall Study|Change of Chemotherapy|1|||
161693879|NCT01471782|583927977|FG001|Overall Study|Change of Chemotherapy|1|||
161693880|NCT01471782|583927978|FG002|Overall Study|Change of Chemotherapy|0|||
161693881|NCT01471782|583927979|FG003|Overall Study|Change of Chemotherapy|0|||
161693882|NCT01471782|583927980|FG004|Overall Study|Change of Chemotherapy|1|||
161693883|NCT01471782|583927981|FG005|Overall Study|Change of Chemotherapy|4|||
161693884|NCT01471782|583927976|FG000|Overall Study|Disease Relapse|0|||
161693885|NCT01471782|583927977|FG001|Overall Study|Disease Relapse|0|||
161693886|NCT01471782|583927978|FG002|Overall Study|Disease Relapse|0|||
161693887|NCT01471782|583927979|FG003|Overall Study|Disease Relapse|1|||
161693888|NCT01471782|583927980|FG004|Overall Study|Disease Relapse|2|||
161693889|NCT01471782|583927981|FG005|Overall Study|Disease Relapse|1|||
161693890|NCT01471782|583927976|FG000|Overall Study|Physician Decision|0|||
161693891|NCT01471782|583927977|FG001|Overall Study|Physician Decision|0|||
161693892|NCT01471782|583927978|FG002|Overall Study|Physician Decision|0|||
161693893|NCT01471782|583927979|FG003|Overall Study|Physician Decision|0|||
161693894|NCT01471782|583927980|FG004|Overall Study|Physician Decision|3|||
161693895|NCT01471782|583927981|FG005|Overall Study|Physician Decision|8|||
161693896|NCT01471782|583927976|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161693897|NCT01471782|583927977|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161693898|NCT01471782|583927978|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161693899|NCT01471782|583927979|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161693900|NCT01471782|583927980|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
161693901|NCT01471782|583927981|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161693902|NCT01471782|583927976|FG000|Overall Study|Death|0|||
161693903|NCT01471782|583927977|FG001|Overall Study|Death|0|||
161693904|NCT01471782|583927978|FG002|Overall Study|Death|0|||
161693905|NCT01471782|583927979|FG003|Overall Study|Death|0|||
161693906|NCT01471782|583927980|FG004|Overall Study|Death|0|||
161693907|NCT01471782|583927981|FG005|Overall Study|Death|1|||
161693908|NCT00936208|583927982|FG000|Overall Study|Protocol Violation|37|||
161693909|NCT00936208|583927983|FG001|Overall Study|Protocol Violation|22|||
161693910|NCT04428424|583927984|FG000|Overall Study|Does not meet entrance criteria|132|||
161693911|NCT04428424|583927984|FG000|Overall Study|Lost to Follow-up|115|||
161693912|NCT01411085|583927985|FG000|Overall Study|Physician Decision|1|||
161693913|NCT01411085|583927985|FG000|Overall Study|Protocol Violation|1|||
161693914|NCT01411085|583927985|FG000|Overall Study|Adverse Event|1|||
161693915|NCT01564862|583927986|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
161693916|NCT01564862|583927987|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
161693917|NCT01564862|583927988|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
161693918|NCT01564862|583927986|FG000|Overall Study|Major Protocol Deviation|3|||
161693919|NCT01564862|583927987|FG001|Overall Study|Major Protocol Deviation|3|||
161693920|NCT01564862|583927988|FG002|Overall Study|Major Protocol Deviation|4|||
161693921|NCT01564862|583927986|FG000|Overall Study|Lost to Follow-up|10|||
161693922|NCT01564862|583927987|FG001|Overall Study|Lost to Follow-up|8|||
161693923|NCT01564862|583927988|FG002|Overall Study|Lost to Follow-up|6|||
161693924|NCT01564862|583927986|FG000|Overall Study|Voluntary Withdrawal|9|||
161956572|NCT00500357|584889702|FG000|Overall Study|Death|1|||
161956573|NCT01061723|584889703|FG000|Overall Study|Adverse Event|0|||
161956574|NCT01061723|584889704|FG001|Overall Study|Adverse Event|2|||
161956575|NCT01061723|584889705|FG002|Overall Study|Adverse Event|5|||
161693925|NCT01564862|583927987|FG001|Overall Study|Voluntary Withdrawal|6|||
161693926|NCT01564862|583927988|FG002|Overall Study|Voluntary Withdrawal|8|||
161956576|NCT01061723|584889706|FG003|Overall Study|Adverse Event|5|||
161693927|NCT01564862|583927986|FG000|Overall Study|Lack of Efficacy|1|||
161693928|NCT01564862|583927987|FG001|Overall Study|Lack of Efficacy|5|||
161693929|NCT01564862|583927988|FG002|Overall Study|Lack of Efficacy|6|||
161693930|NCT01564862|583927986|FG000|Overall Study|Other reason(s)|1|||
161693931|NCT01564862|583927987|FG001|Overall Study|Other reason(s)|0|||
161693932|NCT01564862|583927988|FG002|Overall Study|Other reason(s)|0|||
161693933|NCT03809611|583927989|FG000|Overall Study|Withdrawal by Subject|1|||
161693934|NCT03809611|583927990|FG001|Overall Study|Withdrawal by Subject|1|||
161956577|NCT01061723|584889707|FG004|Overall Study|Adverse Event|2|||
161693935|NCT02193074|583927993|FG000|Overall Study|Withdrawal by Subject|1|||
161693936|NCT02193074|583927994|FG001|Overall Study|Withdrawal by Subject|2|||
161693937|NCT02193074|583927993|FG000|Overall Study|Adverse Event|16|||
161693938|NCT02193074|583927994|FG001|Overall Study|Adverse Event|13|||
161693939|NCT03124563|583927996|FG000|Overall Study|Lost to Follow-up|1|||
161693940|NCT03124563|583927997|FG001|Overall Study|Lost to Follow-up|1|||
161693941|NCT03124563|583927996|FG000|Overall Study|Withdrawal by Subject|1|||
161693942|NCT03124563|583927997|FG001|Overall Study|Withdrawal by Subject|1|||
161693943|NCT04745689|583927998|FG000|Overall Study|Death|9|||
161693944|NCT04745689|583927999|FG001|Overall Study|Death|6|||
161693945|NCT04745689|583927998|FG000|Overall Study|Lost to Follow-up|1|||
161693946|NCT04745689|583927999|FG001|Overall Study|Lost to Follow-up|0|||
161693947|NCT04745689|583927998|FG000|Overall Study|Withdrawal by Subject|2|||
161693948|NCT04745689|583927999|FG001|Overall Study|Withdrawal by Subject|0|||
161693949|NCT04745689|583927998|FG000|Overall Study|Study terminated by sponsor|10|||
161693950|NCT04745689|583927999|FG001|Overall Study|Study terminated by sponsor|3|||
161693951|NCT02396589|583928002|FG000|Intervention|Lost to Follow-up|1|||
161693952|NCT02396589|583928003|FG001|Intervention|Lost to Follow-up|0|||
161693953|NCT02396589|583928002|FG000|6 Month Follow-up|change in health status|0|||
161693954|NCT02396589|583928003|FG001|6 Month Follow-up|change in health status|1|||
161693955|NCT02396589|583928002|FG000|9 Month Follow-up|Death|0|||
161693956|NCT02396589|583928003|FG001|9 Month Follow-up|Death|1|||
161693957|NCT02396589|583928002|FG000|12 Month Follow up|Lost to Follow-up|0|||
161693958|NCT02396589|583928003|FG001|12 Month Follow up|Lost to Follow-up|2|||
161693959|NCT04381650|583928004|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693960|NCT04381650|583928005|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693961|NCT04381650|583928006|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693962|NCT04381650|583928007|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
161693963|NCT04381650|583928008|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693964|NCT04381650|583928009|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693965|NCT04381650|583928010|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693966|NCT04381650|583928011|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693967|NCT04381650|583928012|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693968|NCT04381650|583928013|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693969|NCT04381650|583928014|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161693970|NCT04381650|583928004|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693971|NCT04381650|583928005|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693972|NCT04381650|583928006|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693973|NCT04381650|583928007|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
161693974|NCT04381650|583928008|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693975|NCT04381650|583928009|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693976|NCT04381650|583928010|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693977|NCT04381650|583928011|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693978|NCT04381650|583928012|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693979|NCT04381650|583928013|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693980|NCT04381650|583928014|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161693981|NCT04381650|583928004|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
161693982|NCT04381650|583928005|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
161693983|NCT04381650|583928006|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
161693984|NCT04381650|583928007|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
161693985|NCT04381650|583928008|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693986|NCT04381650|583928009|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693987|NCT04381650|583928010|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693988|NCT04381650|583928011|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161956578|NCT01061723|584889708|FG005|Overall Study|Adverse Event|6|||
161956579|NCT01061723|584889703|FG000|Overall Study|Lack of Efficacy|2|||
161956580|NCT01061723|584889704|FG001|Overall Study|Lack of Efficacy|3|||
161693989|NCT04381650|583928012|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693990|NCT04381650|583928013|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693991|NCT04381650|583928014|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161693992|NCT04381650|583928004|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161693993|NCT04381650|583928005|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161693994|NCT04381650|583928006|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
161956581|NCT01061723|584889705|FG002|Overall Study|Lack of Efficacy|4|||
161693995|NCT04381650|583928007|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
161956582|NCT01061723|584889706|FG003|Overall Study|Lack of Efficacy|2|||
161693996|NCT04381650|583928008|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161693997|NCT04381650|583928009|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161693998|NCT04381650|583928010|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161693999|NCT04381650|583928011|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161694000|NCT04381650|583928012|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161694001|NCT04381650|583928013|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161956583|NCT01061723|584889707|FG004|Overall Study|Lack of Efficacy|1|||
161694002|NCT04381650|583928014|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161694003|NCT04381650|583928004|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694004|NCT04381650|583928005|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
161694005|NCT04381650|583928006|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
161694006|NCT04381650|583928007|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
161694007|NCT04381650|583928008|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694008|NCT04381650|583928009|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694009|NCT04381650|583928010|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694010|NCT04381650|583928011|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694011|NCT04381650|583928012|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694012|NCT04381650|583928013|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694013|NCT04381650|583928014|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161694014|NCT04381650|583928004|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694015|NCT04381650|583928005|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161956584|NCT01061723|584889708|FG005|Overall Study|Lack of Efficacy|1|||
161956585|NCT01061723|584889703|FG000|Overall Study|Randomized but not treated|0|||
161956586|NCT01061723|584889704|FG001|Overall Study|Randomized but not treated|0|||
161956587|NCT01061723|584889705|FG002|Overall Study|Randomized but not treated|0|||
161956588|NCT01061723|584889706|FG003|Overall Study|Randomized but not treated|0|||
161956589|NCT01061723|584889707|FG004|Overall Study|Randomized but not treated|0|||
161956590|NCT01061723|584889708|FG005|Overall Study|Randomized but not treated|1|||
161956591|NCT01061723|584889703|FG000|Overall Study|Other than specified above|2|||
161956592|NCT01061723|584889704|FG001|Overall Study|Other than specified above|1|||
161956593|NCT01061723|584889705|FG002|Overall Study|Other than specified above|1|||
161956594|NCT01061723|584889706|FG003|Overall Study|Other than specified above|1|||
161956595|NCT01061723|584889707|FG004|Overall Study|Other than specified above|0|||
161956596|NCT01061723|584889708|FG005|Overall Study|Other than specified above|1|||
161956597|NCT03292874|584889709|FG000|Overall Study|Due to pandemic|5|||
161956598|NCT01961297|584889712|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
161956599|NCT01961297|584889713|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
161694016|NCT04381650|583928006|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694017|NCT04381650|583928007|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694018|NCT04381650|583928008|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
161694019|NCT04381650|583928009|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
161694020|NCT04381650|583928010|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694021|NCT04381650|583928011|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694022|NCT04381650|583928012|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694023|NCT04381650|583928013|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
161694024|NCT04381650|583928014|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161694025|NCT04381650|583928004|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694026|NCT04381650|583928005|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694027|NCT04381650|583928006|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694028|NCT04381650|583928007|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694029|NCT04381650|583928008|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694030|NCT04381650|583928009|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694031|NCT04381650|583928010|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694032|NCT04381650|583928011|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161694033|NCT04381650|583928012|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161694034|NCT04381650|583928013|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161694035|NCT04381650|583928014|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161694036|NCT04381650|583928004|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161694037|NCT04381650|583928005|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161694038|NCT04381650|583928006|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161694039|NCT04381650|583928007|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161956600|NCT02482298|584889714|FG000|Overall Study|Withdrawal by Subject|2|||
161956601|NCT02482298|584889715|FG001|Overall Study|Withdrawal by Subject|1|||
161956602|NCT02482298|584889716|FG002|Overall Study|Withdrawal by Subject|2|||
161956603|NCT02482298|584889714|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
161956604|NCT02482298|584889715|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
161956605|NCT02482298|584889716|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
161956606|NCT02482298|584889714|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
161694040|NCT04381650|583928008|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
161694041|NCT04381650|583928009|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
161694042|NCT04381650|583928010|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161694043|NCT04381650|583928011|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
161956607|NCT02482298|584889715|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
161956608|NCT02482298|584889716|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
161956609|NCT02482298|584889714|FG000|Overall Study|Lost to Follow-up|0|||
161694044|NCT04381650|583928012|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
161694045|NCT04381650|583928013|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
161694046|NCT04381650|583928014|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
161694047|NCT04381650|583928004|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
161694048|NCT04381650|583928005|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
161694049|NCT04381650|583928006|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
161694050|NCT04381650|583928007|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
161694051|NCT04381650|583928008|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
161694052|NCT04381650|583928009|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
161694053|NCT04381650|583928010|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
161694054|NCT04381650|583928011|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
161694055|NCT04381650|583928012|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
161694056|NCT04381650|583928013|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
161694057|NCT04381650|583928014|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
161694058|NCT04381650|583928004|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694059|NCT04381650|583928005|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694060|NCT04381650|583928006|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694061|NCT04381650|583928007|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694062|NCT04381650|583928008|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694063|NCT04381650|583928009|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694064|NCT04381650|583928010|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694065|NCT04381650|583928011|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
161694066|NCT04381650|583928012|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694067|NCT04381650|583928013|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694068|NCT04381650|583928014|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161694069|NCT05593016|583929770|FG000|Overall Study|Death|1|||
161694070|NCT05593016|583929771|FG001|Overall Study|Death|1|||
161694071|NCT05593016|583929772|FG002|Overall Study|Death|1|||
161694072|NCT05593016|583929773|FG003|Overall Study|Death|0|||
161694073|NCT05593016|583929774|FG004|Overall Study|Death|0|||
161694074|NCT05593016|583929770|FG000|Overall Study|Lost to Follow-up|1|||
161694075|NCT05593016|583929771|FG001|Overall Study|Lost to Follow-up|1|||
161694076|NCT05593016|583929772|FG002|Overall Study|Lost to Follow-up|1|||
161694077|NCT05593016|583929773|FG003|Overall Study|Lost to Follow-up|2|||
161694078|NCT05593016|583929774|FG004|Overall Study|Lost to Follow-up|0|||
161694079|NCT05416138|583929775|FG000|Overall Study|Withdrawal by Subject|2|||
161694080|NCT05416138|583929776|FG001|Overall Study|Withdrawal by Subject|1|||
161694081|NCT04705051|583929777|FG000|Overall Study|Enrolled but not treated|1|||
161694082|NCT04705051|583929777|FG000|Overall Study|Study terminated by sponsor|23|||
161694083|NCT03686397|583929778|FG000|Overall Study|Lack of Efficacy|3|||
161694084|NCT03686397|583929779|FG001|Overall Study|Lack of Efficacy|5|||
161694085|NCT03686397|583929778|FG000|Overall Study|Adverse Event|0|||
161694086|NCT03686397|583929779|FG001|Overall Study|Adverse Event|1|||
161694087|NCT03686397|583929778|FG000|Overall Study|Protocol Violation|0|||
161694088|NCT03686397|583929779|FG001|Overall Study|Protocol Violation|1|||
161694089|NCT03686397|583929778|FG000|Overall Study|Withdrawal by Subject|0|||
161694090|NCT03686397|583929779|FG001|Overall Study|Withdrawal by Subject|1|||
161694091|NCT03686397|583929778|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
161694092|NCT03686397|583929779|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
161694093|NCT03160560|583929780|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
161694094|NCT03160560|583929781|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161694095|NCT03160560|583929782|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161694096|NCT03160560|583929783|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
161694097|NCT03160560|583929780|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
161694098|NCT03160560|583929781|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161694099|NCT03160560|583929782|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161694100|NCT03160560|583929783|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161694101|NCT02814565|583929791|FG000|Overall Study|Lack of Efficacy|0|||
161694102|NCT02814565|583929792|FG001|Overall Study|Lack of Efficacy|1|||
161694103|NCT02814565|583929791|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
161694104|NCT02814565|583929792|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
161694105|NCT05587296|583929795|FG000|Overall Study|Adverse Event|15|||
161694106|NCT05587296|583929796|FG001|Overall Study|Adverse Event|7|||
161694107|NCT05587296|583929795|FG000|Overall Study|Lack of Efficacy|2|||
161694108|NCT05587296|583929796|FG001|Overall Study|Lack of Efficacy|0|||
161694109|NCT05587296|583929795|FG000|Overall Study|Lost to Follow-up|1|||
161694110|NCT05587296|583929796|FG001|Overall Study|Lost to Follow-up|0|||
161694111|NCT05587296|583929795|FG000|Overall Study|Withdrawal by Subject|14|||
161694112|NCT05587296|583929796|FG001|Overall Study|Withdrawal by Subject|4|||
161694113|NCT05587296|583929795|FG000|Overall Study|miscellaneous|3|||
161694114|NCT05587296|583929796|FG001|Overall Study|miscellaneous|6|||
161694115|NCT05587296|583929795|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
161694116|NCT05587296|583929796|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
161694117|NCT02847624|583929799|FG000|Overall Study|Lost to Follow-up|28|||
161694118|NCT02847624|583929799|FG000|Overall Study|Protocol Violation|98|||
161694119|NCT02847624|583929799|FG000|Overall Study|Case report failures|4|||
161694120|NCT04735653|583929800|FG000|Overall Study|Lost to Follow-up|17|||
161694121|NCT04735653|583929801|FG001|Overall Study|Lost to Follow-up|7|||
161694122|NCT04735653|583929800|FG000|Overall Study|Withdrawal by Subject|8|||
161694123|NCT04735653|583929801|FG001|Overall Study|Withdrawal by Subject|2|||
161694124|NCT04735653|583929800|FG000|Overall Study|Death|0|||
161956610|NCT02482298|584889715|FG001|Overall Study|Lost to Follow-up|1|||
161956611|NCT02482298|584889716|FG002|Overall Study|Lost to Follow-up|0|||
161956612|NCT03592771|584889721|FG000|Overall Study|Adverse Event|2|||
161956613|NCT03592771|584889722|FG001|Overall Study|Adverse Event|0|||
161956614|NCT03592771|584889723|FG002|Overall Study|Adverse Event|1|||
161956615|NCT03592771|584889721|FG000|Overall Study|Death|0|||
161956616|NCT03592771|584889722|FG001|Overall Study|Death|1|||
161694125|NCT04735653|583929801|FG001|Overall Study|Death|2|||
161694126|NCT04735653|583929800|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
161694127|NCT04735653|583929801|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
161956617|NCT03592771|584889723|FG002|Overall Study|Death|1|||
161694128|NCT00608985|583929816|FG000|Overall Study|Adverse Event|2|||
161694129|NCT00608985|583929817|FG001|Overall Study|Adverse Event|7|||
161694130|NCT00608985|583929818|FG002|Overall Study|Adverse Event|4|||
161694131|NCT00608985|583929819|FG003|Overall Study|Adverse Event|6|||
161694132|NCT00608985|583929816|FG000|Overall Study|Administrative/Other|7|||
161694133|NCT00608985|583929817|FG001|Overall Study|Administrative/Other|4|||
161694134|NCT00608985|583929818|FG002|Overall Study|Administrative/Other|1|||
161694135|NCT00608985|583929819|FG003|Overall Study|Administrative/Other|2|||
161694136|NCT00608985|583929816|FG000|Overall Study|Withdrawal of Consent|5|||
161694137|NCT00608985|583929817|FG001|Overall Study|Withdrawal of Consent|1|||
161694138|NCT00608985|583929818|FG002|Overall Study|Withdrawal of Consent|1|||
161694139|NCT00608985|583929819|FG003|Overall Study|Withdrawal of Consent|1|||
161694140|NCT00608985|583929816|FG000|Overall Study|Lost to Follow-up|2|||
161694141|NCT00608985|583929817|FG001|Overall Study|Lost to Follow-up|1|||
161694142|NCT00608985|583929818|FG002|Overall Study|Lost to Follow-up|0|||
161694143|NCT00608985|583929819|FG003|Overall Study|Lost to Follow-up|0|||
161956618|NCT03592771|584889721|FG000|Overall Study|Lost to Follow-up|5|||
161956619|NCT03592771|584889722|FG001|Overall Study|Lost to Follow-up|11|||
161956620|NCT03592771|584889723|FG002|Overall Study|Lost to Follow-up|15|||
161956621|NCT03592771|584889721|FG000|Overall Study|Withdrawal by Subject|0|||
161956622|NCT03592771|584889722|FG001|Overall Study|Withdrawal by Subject|2|||
161956623|NCT03592771|584889723|FG002|Overall Study|Withdrawal by Subject|0|||
161956624|NCT01642901|584889724|FG000|12-month Follow-up|Withdrawal by Subject|1|||
162030775|NCT00952380|585169489|FG004|Overall Study|Other|1|||
162030776|NCT00952380|585169485|FG000|Overall Study|Withdrawal by Subject|0|||
162030777|NCT00952380|585169486|FG001|Overall Study|Withdrawal by Subject|0|||
162030778|NCT00952380|585169487|FG002|Overall Study|Withdrawal by Subject|1|||
162030779|NCT00952380|585169488|FG003|Overall Study|Withdrawal by Subject|0|||
161694144|NCT03870555|583929820|FG000|Period 3 (2 Days)|Adverse Event|1|||
161694145|NCT03870555|583929821|FG001|Period 3 (2 Days)|Adverse Event|0|||
161694146|NCT03870555|583929822|FG002|Period 3 (2 Days)|Adverse Event|0|||
161694147|NCT03847610|583929823|FG000|Overall Study|Withdrawal by Subject|1|||
161694148|NCT02004873|583929824|FG000|Overall Study|Implant unsuccessful|6|||
161694149|NCT02004873|583929824|FG000|Overall Study|Awaiting 6-month visit|390|||
161956625|NCT01642901|584889725|FG001|12-month Follow-up|Withdrawal by Subject|0|||
162030780|NCT00952380|585169489|FG004|Overall Study|Withdrawal by Subject|2|||
161694150|NCT02004873|583929824|FG000|Overall Study|Missed 6-month visit|4|||
161694151|NCT02004873|583929824|FG000|Overall Study|Death|23|||
161694152|NCT02004873|583929824|FG000|Overall Study|Withdrawal by Subject|1|||
161694153|NCT00044512|583929826|FG000|Follow Up|Lost to Follow-up|2|||
161694154|NCT03440814|583929831|FG000|Overall Study|Adverse Event|2|||
161694155|NCT03440814|583929832|FG001|Overall Study|Adverse Event|1|||
161694156|NCT03440814|583929831|FG000|Overall Study|Lost to Follow-up|2|||
161694157|NCT03440814|583929832|FG001|Overall Study|Lost to Follow-up|0|||
161694158|NCT03440814|583929831|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
161694159|NCT03440814|583929832|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
161694160|NCT01437397|583929833|FG000|Overall Study|Lost to Follow-up|9|||
161694161|NCT01437397|583929834|FG001|Overall Study|Lost to Follow-up|4|||
161694162|NCT01437397|583929835|FG002|Overall Study|Lost to Follow-up|2|||
161694163|NCT01437397|583929836|FG003|Overall Study|Lost to Follow-up|4|||
161694164|NCT01437397|583929837|FG004|Overall Study|Lost to Follow-up|5|||
161694165|NCT01437397|583929833|FG000|Overall Study|Withdrawal by Subject|11|||
161694166|NCT01437397|583929834|FG001|Overall Study|Withdrawal by Subject|12|||
161694167|NCT01437397|583929835|FG002|Overall Study|Withdrawal by Subject|24|||
161694168|NCT01437397|583929836|FG003|Overall Study|Withdrawal by Subject|11|||
161694169|NCT01437397|583929837|FG004|Overall Study|Withdrawal by Subject|22|||
161694170|NCT01437397|583929833|FG000|Overall Study|Protocol Violation|10|||
161694171|NCT01437397|583929834|FG001|Overall Study|Protocol Violation|12|||
161694172|NCT01437397|583929835|FG002|Overall Study|Protocol Violation|13|||
161694173|NCT01437397|583929836|FG003|Overall Study|Protocol Violation|21|||
161694174|NCT01437397|583929837|FG004|Overall Study|Protocol Violation|19|||
161694175|NCT01437397|583929833|FG000|Overall Study|Lack of Efficacy|5|||
161694176|NCT01437397|583929834|FG001|Overall Study|Lack of Efficacy|4|||
161694177|NCT01437397|583929835|FG002|Overall Study|Lack of Efficacy|8|||
161694178|NCT01437397|583929836|FG003|Overall Study|Lack of Efficacy|10|||
161694179|NCT01437397|583929837|FG004|Overall Study|Lack of Efficacy|20|||
161694180|NCT01437397|583929833|FG000|Overall Study|Adverse Event|21|||
161694181|NCT01437397|583929834|FG001|Overall Study|Adverse Event|22|||
161694182|NCT01437397|583929835|FG002|Overall Study|Adverse Event|16|||
161694183|NCT01437397|583929836|FG003|Overall Study|Adverse Event|14|||
161694184|NCT01437397|583929837|FG004|Overall Study|Adverse Event|21|||
161694185|NCT01437397|583929833|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
161694186|NCT01437397|583929834|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
161694187|NCT01437397|583929835|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
161694188|NCT01437397|583929836|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
161694189|NCT01437397|583929837|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
161694190|NCT00866307|583929839|FG000|Induction|Adverse Event|5|||
161694191|NCT00866307|583929840|FG001|Induction|Adverse Event|0|||
161694192|NCT00866307|583929841|FG002|Induction|Adverse Event|0|||
161694193|NCT00866307|583929839|FG000|Induction|Death|2|||
161694194|NCT00866307|583929840|FG001|Induction|Death|0|||
161694195|NCT00866307|583929841|FG002|Induction|Death|0|||
161694196|NCT00866307|583929839|FG000|Induction|Physician Decision|5|||
161694197|NCT00866307|583929840|FG001|Induction|Physician Decision|0|||
161694198|NCT00866307|583929841|FG002|Induction|Physician Decision|0|||
161694199|NCT00866307|583929839|FG000|Induction|Progressive Disease|1|||
161694200|NCT00866307|583929840|FG001|Induction|Progressive Disease|0|||
161694201|NCT00866307|583929841|FG002|Induction|Progressive Disease|0|||
161694202|NCT00866307|583929839|FG000|Induction|Identification of Patients with Day 29 M|3|||
161694203|NCT00866307|583929840|FG001|Induction|Identification of Patients with Day 29 M|0|||
161694204|NCT00866307|583929841|FG002|Induction|Identification of Patients with Day 29 M|0|||
161694205|NCT00866307|583929839|FG000|Induction|Inadequate cytognetic samples th|1|||
161694206|NCT00866307|583929840|FG001|Induction|Inadequate cytognetic samples th|0|||
161694207|NCT00866307|583929841|FG002|Induction|Inadequate cytognetic samples th|0|||
161956626|NCT05069597|584889726|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161956627|NCT05069597|584889727|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
161956628|NCT03650413|584889728|FG000|Overall Study|Adverse Event|1|||
161956629|NCT03650413|584889728|FG000|Overall Study|Lack of Efficacy|17|||
161956630|NCT03650413|584889728|FG000|Overall Study|Other|9|||
161694208|NCT00866307|583929839|FG000|Induction|Improper post-induction consent|2|||
161694209|NCT00866307|583929840|FG001|Induction|Improper post-induction consent|0|||
161694210|NCT00866307|583929841|FG002|Induction|Improper post-induction consent|0|||
161956631|NCT03650413|584889728|FG000|Overall Study|Physician Decision|2|||
161956632|NCT03650413|584889728|FG000|Overall Study|Study Terminated By Sponsor|16|||
161956633|NCT03650413|584889728|FG000|Overall Study|Withdrawal by Subject|16|||
161694211|NCT00866307|583929839|FG000|Induction|Study was closed at the time|1|||
161694212|NCT00866307|583929840|FG001|Induction|Study was closed at the time|0|||
161694213|NCT00866307|583929841|FG002|Induction|Study was closed at the time|0|||
161694214|NCT00866307|583929839|FG000|Consolidation/Maintenance|Adverse Event|0|||
161694215|NCT00866307|583929840|FG001|Consolidation/Maintenance|Adverse Event|0|||
161694216|NCT00866307|583929841|FG002|Consolidation/Maintenance|Adverse Event|8|||
161694217|NCT00866307|583929839|FG000|Consolidation/Maintenance|Death|0|||
161694218|NCT00866307|583929840|FG001|Consolidation/Maintenance|Death|0|||
161694219|NCT00866307|583929841|FG002|Consolidation/Maintenance|Death|1|||
161694220|NCT00866307|583929839|FG000|Consolidation/Maintenance|Physician Decision|0|||
161694221|NCT00866307|583929840|FG001|Consolidation/Maintenance|Physician Decision|3|||
161694222|NCT00866307|583929841|FG002|Consolidation/Maintenance|Physician Decision|2|||
161694223|NCT00866307|583929839|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
161694224|NCT00866307|583929840|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
161694225|NCT00866307|583929841|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
161694226|NCT00866307|583929839|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
161694227|NCT00866307|583929840|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
161694228|NCT00866307|583929841|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
161694229|NCT00866307|583929839|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
161694230|NCT00866307|583929840|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
161694231|NCT00866307|583929841|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
161694232|NCT00866307|583929839|FG000|Consolidation/Maintenance|Therapy error|0|||
161694233|NCT00866307|583929840|FG001|Consolidation/Maintenance|Therapy error|1|||
161694234|NCT00866307|583929841|FG002|Consolidation/Maintenance|Therapy error|0|||
161694235|NCT00866307|583929839|FG000|Consolidation/Maintenance|Non-compliance|0|||
161694236|NCT00866307|583929840|FG001|Consolidation/Maintenance|Non-compliance|0|||
161694237|NCT00866307|583929841|FG002|Consolidation/Maintenance|Non-compliance|1|||
161694238|NCT00866307|583929839|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
161694239|NCT00866307|583929840|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
161694240|NCT00866307|583929841|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
161694241|NCT02573155|583929844|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
161694242|NCT02573155|583929845|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
161694243|NCT02573155|583929844|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
161694244|NCT02573155|583929845|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
161694245|NCT02573155|583929844|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
161694246|NCT02573155|583929845|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
161694247|NCT02573155|583929844|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
161694248|NCT02573155|583929845|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
161694249|NCT02573155|583929844|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
161694250|NCT02573155|583929845|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
161694251|NCT02573155|583929844|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
161694252|NCT02573155|583929845|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
161694253|NCT02573155|583929844|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
161694254|NCT02573155|583929845|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
161694255|NCT02573155|583929844|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
161694256|NCT02573155|583929845|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
161694257|NCT01681433|583929846|FG000|Overall Study|Lack of Efficacy|23|||
161694258|NCT01681433|583929847|FG001|Overall Study|Lack of Efficacy|23|||
161694259|NCT01681433|583929846|FG000|Overall Study|Withdrawal by Subject|5|||
161694260|NCT01681433|583929847|FG001|Overall Study|Withdrawal by Subject|5|||
161694261|NCT01681433|583929846|FG000|Overall Study|Protocol Violation|2|||
161694262|NCT01681433|583929847|FG001|Overall Study|Protocol Violation|0|||
161694263|NCT01681433|583929846|FG000|Overall Study|Adverse Event|2|||
161694264|NCT01681433|583929847|FG001|Overall Study|Adverse Event|4|||
161694265|NCT01681433|583929846|FG000|Overall Study|Lost to Follow-up|0|||
161694266|NCT01681433|583929847|FG001|Overall Study|Lost to Follow-up|1|||
161694267|NCT00903929|583929848|FG000|Overall Study|Withdrawal by Subject|0|||
161694268|NCT00903929|583929849|FG001|Overall Study|Withdrawal by Subject|0|||
161694269|NCT00903929|583929850|FG002|Overall Study|Withdrawal by Subject|1|||
161694270|NCT00903929|583929851|FG003|Overall Study|Withdrawal by Subject|2|||
161694271|NCT00903929|583929848|FG000|Overall Study|Adverse Event|0|||
161694272|NCT00903929|583929849|FG001|Overall Study|Adverse Event|0|||
161836504|NCT01347866|584442992|FG002|Overall Study|Subject refused further follow-up|0|||
161836505|NCT01347866|584442993|FG003|Overall Study|Subject refused further follow-up|2|||
161836506|NCT01347866|584442994|FG004|Overall Study|Subject refused further follow-up|0|||
161836507|NCT01347866|584442995|FG005|Overall Study|Subject refused further follow-up|1|||
161836508|NCT01347866|584442996|FG006|Overall Study|Subject refused further follow-up|0|||
161836509|NCT01347866|584442997|FG007|Overall Study|Subject refused further follow-up|0|||
161836510|NCT01347866|584442998|FG008|Overall Study|Subject refused further follow-up|4|||
161836511|NCT01347866|584442999|FG009|Overall Study|Subject refused further follow-up|1|||
161836512|NCT01347866|584443000|FG010|Overall Study|Subject refused further follow-up|0|||
161836513|NCT01347866|584443001|FG011|Overall Study|Subject refused further follow-up|0|||
161956634|NCT03332173|584889731|FG000|Overall Study|Death|7|||
161694273|NCT00903929|583929850|FG002|Overall Study|Adverse Event|0|||
161694274|NCT00903929|583929851|FG003|Overall Study|Adverse Event|1|||
161694275|NCT02508194|583929855|FG000|Overall Study|Death|5|||
161694276|NCT02508194|583929856|FG001|Overall Study|Death|3|||
161836514|NCT01347866|584443002|FG012|Overall Study|Subject refused further follow-up|1|||
161694277|NCT02508194|583929855|FG000|Overall Study|Lost to Follow-up|25|||
161694278|NCT02508194|583929856|FG001|Overall Study|Lost to Follow-up|18|||
161694279|NCT02508194|583929855|FG000|Overall Study|Withdrawal by Subject|20|||
161694280|NCT02508194|583929856|FG001|Overall Study|Withdrawal by Subject|18|||
161694281|NCT02508194|583929855|FG000|Overall Study|Error in Randomization|1|||
161694282|NCT02508194|583929856|FG001|Overall Study|Error in Randomization|3|||
161694283|NCT02508194|583929855|FG000|Overall Study|Principal Investigator Decision|1|||
161694284|NCT02508194|583929856|FG001|Overall Study|Principal Investigator Decision|2|||
161694285|NCT03208231|583929859|FG000|Overall Study|Death|1|||
161694286|NCT03208231|583929860|FG001|Overall Study|Death|2|||
161694287|NCT03208231|583929859|FG000|Overall Study|Moved and unable to get to clinic|1|||
161694288|NCT03208231|583929860|FG001|Overall Study|Moved and unable to get to clinic|0|||
161694289|NCT03208231|583929859|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
161694290|NCT03208231|583929860|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
161694291|NCT03205995|583929861|FG000|Overall Study|Adverse Event|1|||
161694292|NCT03205995|583929861|FG000|Overall Study|Death|1|||
161694293|NCT03205995|583929861|FG000|Overall Study|Physician Decision|2|||
161694294|NCT03205995|583929861|FG000|Overall Study|Protocol Violation|2|||
161694295|NCT04947800|583929864|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
161694296|NCT04947800|583929865|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
161956635|NCT03332173|584889731|FG000|Overall Study|Withdrawal by Subject|6|||
161956636|NCT03332173|584889731|FG000|Overall Study|Lost to Follow-up|2|||
161956637|NCT03332173|584889731|FG000|Overall Study|Transferred to long-term extension study|29|||
161956638|NCT00131352|584889732|FG000|Initial Treatment Period|Adverse Event|1|||
161694297|NCT04947800|583929866|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
161694298|NCT02158091|583929867|FG000|Overall Study|DLT|2|||
161694299|NCT02158091|583929868|FG001|Overall Study|DLT|1|||
161694300|NCT02158091|583929869|FG002|Overall Study|DLT|0|||
161694301|NCT01318109|583929870|FG000|Overall Study|Adverse Event|0|||
161694302|NCT01318109|583929871|FG001|Overall Study|Adverse Event|2|||
161694303|NCT01318109|583929872|FG002|Overall Study|Adverse Event|0|||
161694304|NCT01318109|583929870|FG000|Overall Study|Withdrawal by Subject|1|||
161694305|NCT01318109|583929871|FG001|Overall Study|Withdrawal by Subject|0|||
161694306|NCT01318109|583929872|FG002|Overall Study|Withdrawal by Subject|0|||
161694307|NCT01318109|583929870|FG000|Overall Study|Schedule Conflict|0|||
161694308|NCT01318109|583929871|FG001|Overall Study|Schedule Conflict|1|||
161694309|NCT01318109|583929872|FG002|Overall Study|Schedule Conflict|0|||
161694310|NCT01358864|583929887|FG000|Overall Study|Adverse Event|0|||
161694311|NCT01358864|583929888|FG001|Overall Study|Adverse Event|6|||
161694312|NCT01358864|583929889|FG002|Overall Study|Adverse Event|9|||
161694313|NCT01358864|583929890|FG003|Overall Study|Adverse Event|0|||
161694314|NCT01358864|583929891|FG004|Overall Study|Adverse Event|4|||
161694315|NCT01358864|583929892|FG005|Overall Study|Adverse Event|8|||
161694316|NCT01358864|583929893|FG006|Overall Study|Adverse Event|12|||
161694317|NCT01358864|583929894|FG007|Overall Study|Adverse Event|7|||
161694318|NCT01358864|583929887|FG000|Overall Study|Lack of Efficacy|26|||
161694319|NCT01358864|583929888|FG001|Overall Study|Lack of Efficacy|3|||
161694320|NCT01358864|583929889|FG002|Overall Study|Lack of Efficacy|4|||
161694321|NCT01358864|583929890|FG003|Overall Study|Lack of Efficacy|19|||
161694322|NCT01358864|583929891|FG004|Overall Study|Lack of Efficacy|7|||
161694323|NCT01358864|583929892|FG005|Overall Study|Lack of Efficacy|4|||
161694324|NCT01358864|583929893|FG006|Overall Study|Lack of Efficacy|49|||
161694325|NCT01358864|583929894|FG007|Overall Study|Lack of Efficacy|44|||
161694326|NCT01358864|583929887|FG000|Overall Study|Lost to Follow-up|0|||
161694327|NCT01358864|583929888|FG001|Overall Study|Lost to Follow-up|0|||
161694328|NCT01358864|583929889|FG002|Overall Study|Lost to Follow-up|1|||
161694329|NCT01358864|583929890|FG003|Overall Study|Lost to Follow-up|0|||
161694330|NCT01358864|583929891|FG004|Overall Study|Lost to Follow-up|0|||
161694331|NCT01358864|583929892|FG005|Overall Study|Lost to Follow-up|0|||
161694332|NCT01358864|583929893|FG006|Overall Study|Lost to Follow-up|0|||
161836515|NCT01347866|584443003|FG013|Overall Study|Subject refused further follow-up|3|||
161836516|NCT01347866|584443004|FG014|Overall Study|Subject refused further follow-up|1|||
161836517|NCT01347866|584443005|FG015|Overall Study|Subject refused further follow-up|0|||
161836518|NCT01347866|584443006|FG016|Overall Study|Subject refused further follow-up|2|||
161836519|NCT02939014|584443007|FG000|Overall Study|Lost to Follow-up|1|||
161694333|NCT01358864|583929894|FG007|Overall Study|Lost to Follow-up|1|||
161694334|NCT01358864|583929887|FG000|Overall Study|Withdrawal by Subject|3|||
161694335|NCT01358864|583929888|FG001|Overall Study|Withdrawal by Subject|4|||
161694336|NCT01358864|583929889|FG002|Overall Study|Withdrawal by Subject|2|||
161694337|NCT01358864|583929890|FG003|Overall Study|Withdrawal by Subject|0|||
161694338|NCT01358864|583929891|FG004|Overall Study|Withdrawal by Subject|0|||
161694339|NCT01358864|583929892|FG005|Overall Study|Withdrawal by Subject|1|||
161694340|NCT01358864|583929893|FG006|Overall Study|Withdrawal by Subject|1|||
161694341|NCT01358864|583929894|FG007|Overall Study|Withdrawal by Subject|3|||
161694342|NCT01358864|583929887|FG000|Overall Study|Other reason not defined above|2|||
161694343|NCT01358864|583929888|FG001|Overall Study|Other reason not defined above|0|||
161694344|NCT01358864|583929889|FG002|Overall Study|Other reason not defined above|0|||
161694345|NCT01358864|583929890|FG003|Overall Study|Other reason not defined above|0|||
161694346|NCT01358864|583929891|FG004|Overall Study|Other reason not defined above|0|||
161694347|NCT01358864|583929892|FG005|Overall Study|Other reason not defined above|0|||
161694348|NCT01358864|583929893|FG006|Overall Study|Other reason not defined above|2|||
161694349|NCT01358864|583929894|FG007|Overall Study|Other reason not defined above|0|||
161694350|NCT01358864|583929887|FG000|Overall Study|Not treated|0|||
161694351|NCT01358864|583929888|FG001|Overall Study|Not treated|0|||
161694352|NCT01358864|583929889|FG002|Overall Study|Not treated|0|||
161694353|NCT01358864|583929890|FG003|Overall Study|Not treated|0|||
161694354|NCT01358864|583929891|FG004|Overall Study|Not treated|0|||
161694355|NCT01358864|583929892|FG005|Overall Study|Not treated|0|||
161694356|NCT01358864|583929893|FG006|Overall Study|Not treated|1|||
161694357|NCT01358864|583929894|FG007|Overall Study|Not treated|0|||
161694358|NCT00861744|583929900|FG000|Overall Study|Adverse Event|0|||
161694359|NCT00861744|583929901|FG001|Overall Study|Adverse Event|0|||
161694360|NCT00861744|583929902|FG002|Overall Study|Adverse Event|0|||
161694361|NCT00861744|583929903|FG003|Overall Study|Adverse Event|1|||
161694362|NCT00861744|583929900|FG000|Overall Study|Lost to Follow-up|7|||
161694363|NCT00861744|583929901|FG001|Overall Study|Lost to Follow-up|19|||
161694364|NCT00861744|583929902|FG002|Overall Study|Lost to Follow-up|17|||
161694365|NCT00861744|583929903|FG003|Overall Study|Lost to Follow-up|12|||
161694366|NCT00861744|583929900|FG000|Overall Study|Withdrawal by Subject|10|||
161694367|NCT00861744|583929901|FG001|Overall Study|Withdrawal by Subject|6|||
161694368|NCT00861744|583929902|FG002|Overall Study|Withdrawal by Subject|6|||
161694369|NCT00861744|583929903|FG003|Overall Study|Withdrawal by Subject|19|||
161694370|NCT00861744|583929900|FG000|Overall Study|Protocol Violation|0|||
161694371|NCT00861744|583929901|FG001|Overall Study|Protocol Violation|1|||
161694372|NCT00861744|583929902|FG002|Overall Study|Protocol Violation|0|||
161694373|NCT00861744|583929903|FG003|Overall Study|Protocol Violation|0|||
161694374|NCT00861744|583929900|FG000|Overall Study|Migration from study area|0|||
161694375|NCT00861744|583929901|FG001|Overall Study|Migration from study area|3|||
161694376|NCT00861744|583929902|FG002|Overall Study|Migration from study area|1|||
161694377|NCT00861744|583929903|FG003|Overall Study|Migration from study area|0|||
161694378|NCT00861744|583929900|FG000|Overall Study|Blood draws|0|||
161694379|NCT00861744|583929901|FG001|Overall Study|Blood draws|0|||
161694380|NCT00861744|583929902|FG002|Overall Study|Blood draws|0|||
161694381|NCT00861744|583929903|FG003|Overall Study|Blood draws|1|||
161694382|NCT05568888|583929904|FG000|Overall Study|Physician Decision|1|||
161694383|NCT05568888|583929905|FG001|Overall Study|Physician Decision|0|||
161694384|NCT05568888|583929904|FG000|Overall Study|Protocol Deviation|2|||
161694385|NCT05568888|583929905|FG001|Overall Study|Protocol Deviation|1|||
161694386|NCT05568888|583929904|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
161694387|NCT05568888|583929905|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
161694388|NCT05568888|583929904|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
161694389|NCT05568888|583929905|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
161694390|NCT05568888|583929904|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
161694391|NCT05568888|583929905|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
161694392|NCT05036083|583929913|FG000|Overall Study|Physician Decision|1|||
161694393|NCT05036083|583929913|FG000|Overall Study|Withdrawal by Subject|1|||
161694394|NCT05036083|583929913|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
161694395|NCT05036083|583929913|FG000|Overall Study|IV not sustainable|1|||
161694396|NCT02028455|583929916|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161694397|NCT02028455|583929917|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161694398|NCT02028455|583929918|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161694399|NCT02028455|583929919|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161836520|NCT02939014|584443008|FG001|Overall Study|Lost to Follow-up|0|||
161836521|NCT02939014|584443007|FG000|Overall Study|Death|4|||
161694400|NCT02028455|583929920|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161694401|NCT02028455|583929921|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161694402|NCT02028455|583929922|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
161694403|NCT02028455|583929923|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
161694404|NCT02028455|583929916|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
161694405|NCT02028455|583929917|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
161694406|NCT02028455|583929918|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
161694407|NCT02028455|583929919|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
161694408|NCT02028455|583929920|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
161694409|NCT02028455|583929921|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
161694410|NCT02028455|583929922|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
161694411|NCT02028455|583929923|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
161694412|NCT02028455|583929916|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161694413|NCT02028455|583929917|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161694414|NCT02028455|583929918|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161694415|NCT02028455|583929919|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161694416|NCT02028455|583929920|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161694417|NCT02028455|583929921|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
161694418|NCT02028455|583929922|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161694419|NCT02028455|583929923|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
161694420|NCT02028455|583929916|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
161694421|NCT02028455|583929917|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
161694422|NCT02028455|583929918|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
161694423|NCT02028455|583929919|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
161694424|NCT02028455|583929920|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
161694425|NCT02028455|583929921|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
161694426|NCT02028455|583929922|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
161694427|NCT02028455|583929923|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
161694428|NCT07099521|583929924|FG000|Overall Study|Incompeleted stimulus program|1|||
161694429|NCT07099521|583929925|FG001|Overall Study|Incompeleted stimulus program|0|||
161694430|NCT07099521|583929924|FG000|Overall Study|Non-social anxiety symtpoms|0|||
161694431|NCT07099521|583929925|FG001|Overall Study|Non-social anxiety symtpoms|1|||
161694432|NCT07099521|583929924|FG000|Overall Study|Extreme values|2|||
161694433|NCT07099521|583929925|FG001|Overall Study|Extreme values|4|||
161694434|NCT00482014|583932317|FG000|Overall Study|Withdrawal by Subject|1|||
161694435|NCT00482014|583932318|FG001|Overall Study|Withdrawal by Subject|2|||
161694436|NCT00482014|583932319|FG002|Overall Study|Withdrawal by Subject|3|||
161694437|NCT00482014|583932320|FG003|Overall Study|Withdrawal by Subject|4|||
161694438|NCT00482014|583932317|FG000|Overall Study|Adverse Event|3|||
161694439|NCT00482014|583932318|FG001|Overall Study|Adverse Event|0|||
161694440|NCT00482014|583932319|FG002|Overall Study|Adverse Event|2|||
161694441|NCT00482014|583932320|FG003|Overall Study|Adverse Event|8|||
161694442|NCT00482014|583932317|FG000|Overall Study|Death|1|||
161694443|NCT00482014|583932318|FG001|Overall Study|Death|2|||
161694444|NCT00482014|583932319|FG002|Overall Study|Death|1|||
161694445|NCT00482014|583932320|FG003|Overall Study|Death|4|||
161694446|NCT00482014|583932317|FG000|Overall Study|Lack of Efficacy|1|||
161694447|NCT00482014|583932318|FG001|Overall Study|Lack of Efficacy|0|||
161694448|NCT00482014|583932319|FG002|Overall Study|Lack of Efficacy|4|||
161694449|NCT00482014|583932320|FG003|Overall Study|Lack of Efficacy|6|||
161694450|NCT00482014|583932317|FG000|Overall Study|Sponsor Decision|1|||
161694451|NCT00482014|583932318|FG001|Overall Study|Sponsor Decision|2|||
161694452|NCT00482014|583932319|FG002|Overall Study|Sponsor Decision|1|||
161694453|NCT00482014|583932320|FG003|Overall Study|Sponsor Decision|1|||
161956639|NCT00131352|584889733|FG001|Initial Treatment Period|Adverse Event|3|||
161956640|NCT00131352|584889732|FG000|Initial Treatment Period|Non-compliant|1|||
161694454|NCT00542997|583932323|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
161694455|NCT00542997|583932323|FG000|Wash in / Wash Out Period|Adverse Event|3|||
161694456|NCT00542997|583932323|FG000|Efficacy Period|Adverse Event|3|||
161694457|NCT01284114|583932326|FG000|Overall Study|viral infection|1|||
161694458|NCT01284114|583932326|FG000|Overall Study|From the results of ALLTITUDE study|1|||
161694459|NCT01284114|583932326|FG000|Overall Study|Symptomatic hypotension|1|||
161694460|NCT01284114|583932326|FG000|Overall Study|dizziness|1|||
161956641|NCT00131352|584889733|FG001|Initial Treatment Period|Non-compliant|2|||
161694461|NCT00598975|583932327|FG000|Overall Study|Adverse Event|1|||
161694462|NCT00598975|583932328|FG001|Overall Study|Adverse Event|1|||
161694463|NCT00598975|583932327|FG000|Overall Study|Brain metastases|1|||
161694464|NCT00598975|583932328|FG001|Overall Study|Brain metastases|0|||
161694465|NCT00598975|583932327|FG000|Overall Study|Withdrawal by Subject|1|||
161694466|NCT00598975|583932328|FG001|Overall Study|Withdrawal by Subject|1|||
161694467|NCT00598975|583932327|FG000|Overall Study|Withdrawal of consent|0|||
161694468|NCT00598975|583932328|FG001|Overall Study|Withdrawal of consent|1|||
161694469|NCT00598975|583932327|FG000|Overall Study|Disease progression|8|||
161694470|NCT00598975|583932328|FG001|Overall Study|Disease progression|3|||
161694471|NCT00598975|583932327|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
161694472|NCT00598975|583932328|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
161694473|NCT04137887|583932329|FG000|Overall Study|Death|102|||
161694474|NCT04137887|583932330|FG001|Overall Study|Death|92|||
161694475|NCT04137887|583932329|FG000|Overall Study|Withdrawal by Subject|2|||
161694476|NCT04137887|583932330|FG001|Overall Study|Withdrawal by Subject|3|||
161694477|NCT04137887|583932329|FG000|Overall Study|Randomized but not treated|0|||
161694478|NCT04137887|583932330|FG001|Overall Study|Randomized but not treated|1|||
161694479|NCT01790503|583932331|FG000|Overall Study|Adverse Event|1|||
161694480|NCT01790503|583932332|FG001|Overall Study|Adverse Event|0|||
161694481|NCT01790503|583932333|FG002|Overall Study|Adverse Event|0|||
161694482|NCT01790503|583932334|FG003|Overall Study|Adverse Event|0|||
161694483|NCT01790503|583932335|FG004|Overall Study|Adverse Event|0|||
161694484|NCT01790503|583932336|FG005|Overall Study|Adverse Event|2|||
161694485|NCT01790503|583932337|FG006|Overall Study|Adverse Event|0|||
161694486|NCT01790503|583932338|FG007|Overall Study|Adverse Event|0|||
161694487|NCT01790503|583932339|FG008|Overall Study|Adverse Event|2|||
161694488|NCT01790503|583932340|FG009|Overall Study|Adverse Event|4|||
161694489|NCT01790503|583932341|FG010|Overall Study|Adverse Event|7|||
161694490|NCT01790503|583932331|FG000|Overall Study|Withdrawal by Subject|0|||
161694491|NCT01790503|583932332|FG001|Overall Study|Withdrawal by Subject|0|||
161694492|NCT01790503|583932333|FG002|Overall Study|Withdrawal by Subject|1|||
161694493|NCT01790503|583932334|FG003|Overall Study|Withdrawal by Subject|1|||
161694494|NCT01790503|583932335|FG004|Overall Study|Withdrawal by Subject|1|||
161694495|NCT01790503|583932336|FG005|Overall Study|Withdrawal by Subject|2|||
161694496|NCT01790503|583932337|FG006|Overall Study|Withdrawal by Subject|1|||
161694497|NCT01790503|583932338|FG007|Overall Study|Withdrawal by Subject|0|||
161694498|NCT01790503|583932339|FG008|Overall Study|Withdrawal by Subject|0|||
161694499|NCT01790503|583932340|FG009|Overall Study|Withdrawal by Subject|0|||
161694500|NCT01790503|583932341|FG010|Overall Study|Withdrawal by Subject|1|||
161694501|NCT01790503|583932331|FG000|Overall Study|Disease progression|2|||
161694502|NCT01790503|583932332|FG001|Overall Study|Disease progression|1|||
161694503|NCT01790503|583932333|FG002|Overall Study|Disease progression|0|||
161694504|NCT01790503|583932334|FG003|Overall Study|Disease progression|1|||
161694505|NCT01790503|583932335|FG004|Overall Study|Disease progression|2|||
161694506|NCT01790503|583932336|FG005|Overall Study|Disease progression|1|||
161694507|NCT01790503|583932337|FG006|Overall Study|Disease progression|0|||
161694508|NCT01790503|583932338|FG007|Overall Study|Disease progression|1|||
161694509|NCT01790503|583932339|FG008|Overall Study|Disease progression|0|||
161694510|NCT01790503|583932340|FG009|Overall Study|Disease progression|17|||
161694511|NCT01790503|583932341|FG010|Overall Study|Disease progression|7|||
161694512|NCT01790503|583932331|FG000|Overall Study|Protocol Violation|0|||
161694513|NCT01790503|583932332|FG001|Overall Study|Protocol Violation|0|||
161694514|NCT01790503|583932333|FG002|Overall Study|Protocol Violation|0|||
161694515|NCT01790503|583932334|FG003|Overall Study|Protocol Violation|0|||
161694516|NCT01790503|583932335|FG004|Overall Study|Protocol Violation|0|||
161694517|NCT01790503|583932336|FG005|Overall Study|Protocol Violation|0|||
161694518|NCT01790503|583932337|FG006|Overall Study|Protocol Violation|0|||
161694519|NCT01790503|583932338|FG007|Overall Study|Protocol Violation|0|||
161694520|NCT01790503|583932339|FG008|Overall Study|Protocol Violation|0|||
161694521|NCT01790503|583932340|FG009|Overall Study|Protocol Violation|1|||
161694522|NCT01790503|583932341|FG010|Overall Study|Protocol Violation|0|||
161694523|NCT01790503|583932331|FG000|Overall Study|Physician Decision|0|||
161694524|NCT01790503|583932332|FG001|Overall Study|Physician Decision|0|||
161694525|NCT01790503|583932333|FG002|Overall Study|Physician Decision|0|||
161694526|NCT01790503|583932334|FG003|Overall Study|Physician Decision|0|||
161694527|NCT01790503|583932335|FG004|Overall Study|Physician Decision|0|||
161694528|NCT01790503|583932336|FG005|Overall Study|Physician Decision|0|||
161694529|NCT01790503|583932337|FG006|Overall Study|Physician Decision|0|||
161694530|NCT01790503|583932338|FG007|Overall Study|Physician Decision|0|||
161694531|NCT01790503|583932339|FG008|Overall Study|Physician Decision|0|||
161836522|NCT02939014|584443008|FG001|Overall Study|Death|3|||
161836523|NCT02143583|584443011|FG000|Overall Study|Withdrawal by Subject|1|||
161836524|NCT02143583|584443012|FG001|Overall Study|Withdrawal by Subject|0|||
161694532|NCT01790503|583932340|FG009|Overall Study|Physician Decision|1|||
161694533|NCT01790503|583932341|FG010|Overall Study|Physician Decision|1|||
161694534|NCT01790503|583932331|FG000|Overall Study|Death|0|||
161694535|NCT01790503|583932332|FG001|Overall Study|Death|0|||
161694536|NCT01790503|583932333|FG002|Overall Study|Death|0|||
161694537|NCT01790503|583932334|FG003|Overall Study|Death|0|||
161694538|NCT01790503|583932335|FG004|Overall Study|Death|0|||
161694539|NCT01790503|583932336|FG005|Overall Study|Death|0|||
161694540|NCT01790503|583932337|FG006|Overall Study|Death|0|||
161694541|NCT01790503|583932338|FG007|Overall Study|Death|0|||
161694542|NCT01790503|583932339|FG008|Overall Study|Death|0|||
161694543|NCT01790503|583932340|FG009|Overall Study|Death|1|||
161694544|NCT01790503|583932341|FG010|Overall Study|Death|0|||
161694545|NCT01790503|583932331|FG000|Overall Study|Non Compliance|0|||
161694546|NCT01790503|583932332|FG001|Overall Study|Non Compliance|0|||
161694547|NCT01790503|583932333|FG002|Overall Study|Non Compliance|0|||
161694548|NCT01790503|583932334|FG003|Overall Study|Non Compliance|0|||
161694549|NCT01790503|583932335|FG004|Overall Study|Non Compliance|1|||
161694550|NCT01790503|583932336|FG005|Overall Study|Non Compliance|0|||
161694551|NCT01790503|583932337|FG006|Overall Study|Non Compliance|0|||
161694552|NCT01790503|583932338|FG007|Overall Study|Non Compliance|0|||
161694553|NCT01790503|583932339|FG008|Overall Study|Non Compliance|0|||
161694554|NCT01790503|583932340|FG009|Overall Study|Non Compliance|0|||
161694555|NCT01790503|583932341|FG010|Overall Study|Non Compliance|0|||
161694556|NCT01790503|583932331|FG000|Overall Study|Other|0|||
161694557|NCT01790503|583932332|FG001|Overall Study|Other|0|||
161694558|NCT01790503|583932333|FG002|Overall Study|Other|0|||
161694559|NCT01790503|583932334|FG003|Overall Study|Other|0|||
161694560|NCT01790503|583932335|FG004|Overall Study|Other|1|||
161694561|NCT01790503|583932336|FG005|Overall Study|Other|0|||
161694562|NCT01790503|583932337|FG006|Overall Study|Other|0|||
161694563|NCT01790503|583932338|FG007|Overall Study|Other|0|||
161694564|NCT01790503|583932339|FG008|Overall Study|Other|1|||
161694565|NCT01790503|583932340|FG009|Overall Study|Other|2|||
161694566|NCT01790503|583932341|FG010|Overall Study|Other|0|||
161694567|NCT04183335|583932342|FG000|Overall Study|Adverse Event|1|||
161694568|NCT04183335|583932343|FG001|Overall Study|Adverse Event|0|||
161694569|NCT04183335|583932342|FG000|Overall Study|Withdrawal by Subject|12|||
161694570|NCT04183335|583932343|FG001|Overall Study|Withdrawal by Subject|3|||
161694571|NCT00049673|583932344|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
161694572|NCT00049673|583932345|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
161694573|NCT01535729|583932346|FG000|Overall Study|Withdrawal by Subject|2|||
161694574|NCT01535729|583932346|FG000|Overall Study|Disease progression|230|||
161694575|NCT01535729|583932346|FG000|Overall Study|Discontinued treatment|25|||
161694576|NCT01535729|583932346|FG000|Overall Study|Lost to Follow-up|8|||
161694577|NCT01535729|583932346|FG000|Overall Study|Death|52|||
161694578|NCT01535729|583932346|FG000|Overall Study|Other|19|||
161694579|NCT01535729|583932346|FG000|Overall Study|Did not sign informed consent|1|||
161694580|NCT01535729|583932346|FG000|Overall Study|No previous chemotherapy|33|||
161694581|NCT01535729|583932346|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
161694582|NCT01535729|583932346|FG000|Overall Study|Protocol Violation|11|||
161694583|NCT01535729|583932346|FG000|Overall Study|Screening failure|1|||
161694584|NCT01535729|583932346|FG000|Overall Study|Not treated|9|||
161694585|NCT01535729|583932346|FG000|Overall Study|No participant record available|5|||
161694586|NCT03733392|583932349|FG000|Overall Study|Withdrawal by Subject|11|||
161694587|NCT03733392|583932350|FG001|Overall Study|Withdrawal by Subject|1|||
161694588|NCT03733392|583932349|FG000|Overall Study|Death|1|||
161694589|NCT03733392|583932350|FG001|Overall Study|Death|0|||
161694590|NCT03733392|583932349|FG000|Overall Study|Lost to Follow-up|5|||
161694591|NCT03733392|583932350|FG001|Overall Study|Lost to Follow-up|0|||
161694592|NCT03733392|583932349|FG000|Overall Study|Protocol Violation|0|||
161694593|NCT03733392|583932350|FG001|Overall Study|Protocol Violation|1|||
161694594|NCT03733392|583932349|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
161694595|NCT03733392|583932350|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
161694596|NCT03733392|583932349|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
161694597|NCT03733392|583932350|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
161694598|NCT03733392|583932349|FG000|Overall Study|Patient Non-Compliance|2|||
161694599|NCT03733392|583932350|FG001|Overall Study|Patient Non-Compliance|1|||
161694600|NCT03733392|583932349|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
161694601|NCT03733392|583932350|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
161694602|NCT03733392|583932349|FG000|Overall Study|Withdrawal prior to procedure|5|||
161694603|NCT03733392|583932350|FG001|Overall Study|Withdrawal prior to procedure|2|||
161694604|NCT02740478|583932351|FG000|Overall Study|Withdrawal by Subject|1|||
161694605|NCT01934140|583932358|FG000|Persistence Phase (Year 6-10)|Other|24|||
161694606|NCT01934140|583932359|FG001|Persistence Phase (Year 6-10)|Other|6|||
161694607|NCT01934140|583932358|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
161836525|NCT02143583|584443013|FG002|Overall Study|Withdrawal by Subject|1|||
161694608|NCT01934140|583932359|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
161694609|NCT01934140|583932358|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
161694610|NCT01934140|583932359|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
161694611|NCT01934140|583932358|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
161694612|NCT01934140|583932359|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
161694613|NCT01934140|583932358|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
161694614|NCT01934140|583932359|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
161694615|NCT01934140|583932358|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
161694616|NCT01934140|583932359|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
161694617|NCT01934140|583932358|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
161694618|NCT01934140|583932359|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
161694619|NCT01934140|583932358|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
161694620|NCT01934140|583932359|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
161694621|NCT01461044|583932363|FG000|Overall Study|Death|58|||
161694622|NCT01461044|583932364|FG001|Overall Study|Death|35|||
161694623|NCT01461044|583932363|FG000|Overall Study|Lost to Follow-up|12|||
161694624|NCT01461044|583932364|FG001|Overall Study|Lost to Follow-up|5|||
161694625|NCT00618748|583932365|FG000|Overall Study|Adverse Event|4|||
161694626|NCT00618748|583932366|FG001|Overall Study|Adverse Event|3|||
161694627|NCT00618748|583932367|FG002|Overall Study|Adverse Event|8|||
161694628|NCT00618748|583932365|FG000|Overall Study|Physician Decision|3|||
161694629|NCT00618748|583932366|FG001|Overall Study|Physician Decision|1|||
161694630|NCT00618748|583932367|FG002|Overall Study|Physician Decision|1|||
161694631|NCT00618748|583932365|FG000|Overall Study|Withdrawal by Subject|4|||
161694632|NCT00618748|583932366|FG001|Overall Study|Withdrawal by Subject|1|||
161694633|NCT00618748|583932367|FG002|Overall Study|Withdrawal by Subject|5|||
161694634|NCT00200850|583932368|FG000|Overall Study|relocation|1|||
161694635|NCT00200850|583932369|FG001|Overall Study|relocation|0|||
161694636|NCT00200850|583932370|FG002|Overall Study|relocation|1|||
161694637|NCT00200850|583932368|FG000|Overall Study|too busy|1|||
161694638|NCT00200850|583932369|FG001|Overall Study|too busy|0|||
161694639|NCT00200850|583932370|FG002|Overall Study|too busy|0|||
161694640|NCT00200850|583932368|FG000|Overall Study|Pregnancy|0|||
161694641|NCT00200850|583932369|FG001|Overall Study|Pregnancy|0|||
161694642|NCT00200850|583932370|FG002|Overall Study|Pregnancy|1|||
161694643|NCT00200850|583932368|FG000|Overall Study|Poor adherence|0|||
161694644|NCT00200850|583932369|FG001|Overall Study|Poor adherence|0|||
161694645|NCT00200850|583932370|FG002|Overall Study|Poor adherence|1|||
161694646|NCT00200850|583932368|FG000|Overall Study|optic neuritis|0|||
161694647|NCT00200850|583932369|FG001|Overall Study|optic neuritis|0|||
161694648|NCT00200850|583932370|FG002|Overall Study|optic neuritis|1|||
161694649|NCT00200850|583932368|FG000|Overall Study|Adverse Event|1|||
161694650|NCT00200850|583932369|FG001|Overall Study|Adverse Event|1|||
161694651|NCT00200850|583932370|FG002|Overall Study|Adverse Event|2|||
161694652|NCT02889796|583932373|FG000|Overall Study|Withdrew Consent|18|||
161694653|NCT02889796|583932374|FG001|Overall Study|Withdrew Consent|29|||
161694654|NCT02889796|583932375|FG002|Overall Study|Withdrew Consent|20|||
161694655|NCT02889796|583932376|FG003|Overall Study|Withdrew Consent|1|||
161694656|NCT02889796|583932377|FG004|Overall Study|Withdrew Consent|2|||
161694657|NCT02889796|583932378|FG005|Overall Study|Withdrew Consent|35|||
161694658|NCT02889796|583932373|FG000|Overall Study|Investigator's Discretion|10|||
161694659|NCT02889796|583932374|FG001|Overall Study|Investigator's Discretion|9|||
161694660|NCT02889796|583932375|FG002|Overall Study|Investigator's Discretion|10|||
161694661|NCT02889796|583932376|FG003|Overall Study|Investigator's Discretion|3|||
161694662|NCT02889796|583932377|FG004|Overall Study|Investigator's Discretion|0|||
161694663|NCT02889796|583932378|FG005|Overall Study|Investigator's Discretion|15|||
161694664|NCT02889796|583932373|FG000|Overall Study|Adverse Event|17|||
161694665|NCT02889796|583932374|FG001|Overall Study|Adverse Event|8|||
161694666|NCT02889796|583932375|FG002|Overall Study|Adverse Event|8|||
161694667|NCT02889796|583932376|FG003|Overall Study|Adverse Event|4|||
161694668|NCT02889796|583932377|FG004|Overall Study|Adverse Event|1|||
161694669|NCT02889796|583932378|FG005|Overall Study|Adverse Event|7|||
161694670|NCT02889796|583932373|FG000|Overall Study|Lost to Follow-up|5|||
161694671|NCT02889796|583932374|FG001|Overall Study|Lost to Follow-up|7|||
161694672|NCT02889796|583932375|FG002|Overall Study|Lost to Follow-up|2|||
161694673|NCT02889796|583932376|FG003|Overall Study|Lost to Follow-up|0|||
161694674|NCT02889796|583932377|FG004|Overall Study|Lost to Follow-up|2|||
161694675|NCT02889796|583932378|FG005|Overall Study|Lost to Follow-up|6|||
161694676|NCT02889796|583932373|FG000|Overall Study|Protocol Violation|0|||
161694677|NCT02889796|583932374|FG001|Overall Study|Protocol Violation|1|||
161836526|NCT02143583|584443011|FG000|Overall Study|husband illness|0|||
161956642|NCT00131352|584889732|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
161956643|NCT00131352|584889733|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
161956644|NCT00131352|584889732|FG000|Initial Treatment Period|Lack of Efficacy|6|||
161694678|NCT02889796|583932375|FG002|Overall Study|Protocol Violation|3|||
161694679|NCT02889796|583932376|FG003|Overall Study|Protocol Violation|0|||
161694680|NCT02889796|583932377|FG004|Overall Study|Protocol Violation|0|||
161694681|NCT02889796|583932378|FG005|Overall Study|Protocol Violation|4|||
161694682|NCT02889796|583932373|FG000|Overall Study|Non-compliance With Study Drug|0|||
161694683|NCT02889796|583932374|FG001|Overall Study|Non-compliance With Study Drug|2|||
161694684|NCT02889796|583932375|FG002|Overall Study|Non-compliance With Study Drug|0|||
161694685|NCT02889796|583932376|FG003|Overall Study|Non-compliance With Study Drug|0|||
161694686|NCT02889796|583932377|FG004|Overall Study|Non-compliance With Study Drug|1|||
161694687|NCT02889796|583932378|FG005|Overall Study|Non-compliance With Study Drug|2|||
161694688|NCT02889796|583932373|FG000|Overall Study|Death|1|||
161694689|NCT02889796|583932374|FG001|Overall Study|Death|1|||
161694690|NCT02889796|583932375|FG002|Overall Study|Death|0|||
161694691|NCT02889796|583932376|FG003|Overall Study|Death|1|||
161694692|NCT02889796|583932377|FG004|Overall Study|Death|0|||
161694693|NCT02889796|583932378|FG005|Overall Study|Death|1|||
161694694|NCT02889796|583932373|FG000|Overall Study|Pregnancy|0|||
161694695|NCT02889796|583932374|FG001|Overall Study|Pregnancy|1|||
161694696|NCT02889796|583932375|FG002|Overall Study|Pregnancy|1|||
161694697|NCT02889796|583932376|FG003|Overall Study|Pregnancy|0|||
161694698|NCT02889796|583932377|FG004|Overall Study|Pregnancy|0|||
161694699|NCT02889796|583932378|FG005|Overall Study|Pregnancy|0|||
161694700|NCT02889796|583932373|FG000|Overall Study|Randomized but not Dosed|2|||
161694701|NCT02889796|583932374|FG001|Overall Study|Randomized but not Dosed|0|||
161694702|NCT02889796|583932375|FG002|Overall Study|Randomized but not Dosed|0|||
161694703|NCT02889796|583932376|FG003|Overall Study|Randomized but not Dosed|0|||
161694704|NCT02889796|583932377|FG004|Overall Study|Randomized but not Dosed|0|||
161694705|NCT02889796|583932378|FG005|Overall Study|Randomized but not Dosed|2|||
161694706|NCT04294459|583932379|FG000|Overall Study|Adverse Event|0|||
161694707|NCT04294459|583932380|FG001|Overall Study|Adverse Event|1|||
161694708|NCT02787863|583932381|FG000|Overall Study|Death|1|||
161694709|NCT02787863|583932382|FG001|Overall Study|Death|0|||
161694710|NCT02787863|583932383|FG002|Overall Study|Death|1|||
161694711|NCT02787863|583932384|FG003|Overall Study|Death|0|||
161694712|NCT02787863|583932385|FG004|Overall Study|Death|0|||
161694713|NCT02787863|583932386|FG005|Overall Study|Death|0|||
161694714|NCT02787863|583932387|FG006|Overall Study|Death|0|||
161694715|NCT02787863|583932388|FG007|Overall Study|Death|0|||
161694716|NCT02787863|583932381|FG000|Overall Study|Withdrawal by Subject|0|||
161694717|NCT02787863|583932382|FG001|Overall Study|Withdrawal by Subject|1|||
161694718|NCT02787863|583932383|FG002|Overall Study|Withdrawal by Subject|1|||
161694719|NCT02787863|583932384|FG003|Overall Study|Withdrawal by Subject|0|||
161694720|NCT02787863|583932385|FG004|Overall Study|Withdrawal by Subject|0|||
161694721|NCT02787863|583932386|FG005|Overall Study|Withdrawal by Subject|0|||
161694722|NCT02787863|583932387|FG006|Overall Study|Withdrawal by Subject|0|||
161694723|NCT02787863|583932388|FG007|Overall Study|Withdrawal by Subject|0|||
161694724|NCT01414257|583932389|FG000|Overall Study|No Visit After First Day of Treatment|12|||
161694725|NCT01414257|583932389|FG000|Overall Study|Protocol Violation|10|||
161694726|NCT02421887|583932390|FG000|Overall Study|Lost to Follow-up|5|||
161694727|NCT02421887|583932391|FG001|Overall Study|Lost to Follow-up|0|||
161694728|NCT02421887|583932390|FG000|Overall Study|Withdrawal by Subject|8|||
161694729|NCT02421887|583932391|FG001|Overall Study|Withdrawal by Subject|5|||
161694730|NCT02421887|583932390|FG000|Overall Study|Physician Decision|2|||
161694731|NCT02421887|583932391|FG001|Overall Study|Physician Decision|4|||
161694732|NCT02421887|583932390|FG000|Overall Study|Adverse Event|2|||
161694733|NCT02421887|583932391|FG001|Overall Study|Adverse Event|0|||
161694734|NCT02479802|583932392|FG000|Overall Study|Lost to Follow-up|1|||
161694735|NCT02479802|583932392|FG000|Overall Study|Adverse Event|1|||
161694736|NCT01882907|583932393|FG000|Overall Study|Adverse Event|3|||
161694737|NCT01882907|583932394|FG001|Overall Study|Adverse Event|1|||
161694738|NCT01882907|583932393|FG000|Overall Study|Lack of Efficacy|0|||
161694739|NCT01882907|583932394|FG001|Overall Study|Lack of Efficacy|3|||
161694740|NCT01882907|583932393|FG000|Overall Study|Lost to Follow-up|1|||
161694741|NCT01882907|583932394|FG001|Overall Study|Lost to Follow-up|4|||
161694742|NCT01882907|583932393|FG000|Overall Study|Protocol Violation|10|||
161694743|NCT01882907|583932394|FG001|Overall Study|Protocol Violation|14|||
161694744|NCT01882907|583932393|FG000|Overall Study|Withdrawal by Subject|0|||
161694745|NCT01882907|583932394|FG001|Overall Study|Withdrawal by Subject|6|||
161694746|NCT01978093|583932395|FG000|Overall Study|Death|1|||
161694747|NCT01978093|583932396|FG001|Overall Study|Death|0|||
161694748|NCT01978093|583932395|FG000|Overall Study|Adverse Event|0|||
161694749|NCT01978093|583932396|FG001|Overall Study|Adverse Event|5|||
161694750|NCT01978093|583932395|FG000|Overall Study|Protocol Violation|8|||
161694751|NCT01978093|583932396|FG001|Overall Study|Protocol Violation|2|||
161694752|NCT01978093|583932395|FG000|Overall Study|Withdrawal by Subject|29|||
161694753|NCT01978093|583932396|FG001|Overall Study|Withdrawal by Subject|25|||
161694754|NCT01978093|583932395|FG000|Overall Study|Lost to Follow-up|11|||
161694755|NCT01978093|583932396|FG001|Overall Study|Lost to Follow-up|15|||
161694756|NCT01978093|583932395|FG000|Overall Study|Migrated/moved from study area|11|||
161694757|NCT01978093|583932396|FG001|Overall Study|Migrated/moved from study area|13|||
161836527|NCT02143583|584443012|FG001|Overall Study|husband illness|0|||
161694758|NCT01978093|583932395|FG000|Overall Study|Loss of kaiser coverage|4|||
161694759|NCT01978093|583932396|FG001|Overall Study|Loss of kaiser coverage|10|||
161694760|NCT01978093|583932395|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
161694761|NCT01978093|583932396|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
161694762|NCT01978093|583932395|FG000|Overall Study|Mother lost custody of child|0|||
161694763|NCT01978093|583932396|FG001|Overall Study|Mother lost custody of child|1|||
161836528|NCT02143583|584443013|FG002|Overall Study|husband illness|1|||
161836529|NCT02333487|584443014|FG000|Overall Study|Adverse Event|0|||
161694764|NCT01978093|583932395|FG000|Overall Study|Child was in care of grandmother|0|||
161694765|NCT01978093|583932396|FG001|Overall Study|Child was in care of grandmother|1|||
161694766|NCT01978093|583932395|FG000|Overall Study|N/A for vaccine administration|0|||
161694767|NCT01978093|583932396|FG001|Overall Study|N/A for vaccine administration|1|||
161694768|NCT03124784|583932401|FG000|Overall Study|Adverse Event|1|||
161836530|NCT02333487|584443015|FG001|Overall Study|Adverse Event|2|||
161694769|NCT03124784|583932401|FG000|Overall Study|Computer/Equip Malfunction|1|||
161694770|NCT05702515|583932402|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
161694771|NCT02162732|583932403|FG000|Overall Study|Biopsy not performed.|18|||
161694772|NCT01784965|583932404|FG000|Overall Study|Withdrawal by Subject|6|||
161694773|NCT01784965|583932405|FG001|Overall Study|Withdrawal by Subject|3|||
161694774|NCT01784965|583932404|FG000|Overall Study|Adverse Event|0|||
161694775|NCT01784965|583932405|FG001|Overall Study|Adverse Event|8|||
161694776|NCT03757988|583932406|FG000|Overall Study|Withdrawal by Subject|1|||
161694777|NCT02450487|583932407|FG000|Overall Study|Lost to Follow-up|3|||
161694778|NCT04269395|583932408|FG000|Overall Study|Lost to Follow-up|1|||
161694779|NCT04269395|583932409|FG001|Overall Study|Lost to Follow-up|0|||
161694780|NCT04269395|583932408|FG000|Overall Study|Study terminated by Sponsor|13|||
161694781|NCT04269395|583932409|FG001|Overall Study|Study terminated by Sponsor|10|||
161694782|NCT04161495|583932410|FG000|Overall Study|Withdrawal by Subject|3|||
161694783|NCT04161495|583932411|FG001|Overall Study|Withdrawal by Subject|0|||
161694784|NCT04161495|583932410|FG000|Overall Study|Protocol Violation|1|||
161694785|NCT04161495|583932411|FG001|Overall Study|Protocol Violation|0|||
161694786|NCT04161495|583932410|FG000|Overall Study|Prohibited concomitant medication|3|||
161694787|NCT04161495|583932411|FG001|Overall Study|Prohibited concomitant medication|0|||
161694788|NCT04161495|583932410|FG000|Overall Study|Adverse Event|1|||
161694789|NCT04161495|583932411|FG001|Overall Study|Adverse Event|0|||
161694790|NCT04161495|583932410|FG000|Overall Study|Other - Unspecified|1|||
161694791|NCT04161495|583932411|FG001|Overall Study|Other - Unspecified|0|||
161694792|NCT04161495|583932410|FG000|Overall Study|Death|0|||
161694793|NCT04161495|583932411|FG001|Overall Study|Death|1|||
161694794|NCT00252057|583932414|FG000|Overall Study|Withdrawal by Subject|2|||
161694795|NCT00252057|583932415|FG001|Overall Study|Withdrawal by Subject|5|||
161694796|NCT00252057|583932414|FG000|Overall Study|Death|1|||
161694797|NCT00252057|583932415|FG001|Overall Study|Death|2|||
161694798|NCT00252057|583932414|FG000|Overall Study|Participant previously enrolled|0|||
161694799|NCT00252057|583932415|FG001|Overall Study|Participant previously enrolled|1|||
161694800|NCT02926209|583932416|FG000|Study Cohort|Poor Bowel Preparation|1|||
161694801|NCT02926209|583932417|FG001|Study Cohort|Poor Bowel Preparation|0|||
161694802|NCT01340209|583932418|FG000|Overall Study|Adverse Event|1|||
161694803|NCT01340209|583932419|FG001|Overall Study|Adverse Event|1|||
161694804|NCT01340209|583932420|FG002|Overall Study|Adverse Event|2|||
161694805|NCT01340209|583932418|FG000|Overall Study|Protocol Violation|1|||
161694806|NCT01340209|583932419|FG001|Overall Study|Protocol Violation|2|||
161694807|NCT01340209|583932420|FG002|Overall Study|Protocol Violation|1|||
161694808|NCT01340209|583932418|FG000|Overall Study|Withdrawal by Subject|0|||
161694809|NCT01340209|583932419|FG001|Overall Study|Withdrawal by Subject|0|||
161694810|NCT01340209|583932420|FG002|Overall Study|Withdrawal by Subject|1|||
161694811|NCT01340209|583932418|FG000|Overall Study|Other reason not defined above|3|||
161694812|NCT01340209|583932419|FG001|Overall Study|Other reason not defined above|5|||
161694813|NCT01340209|583932420|FG002|Overall Study|Other reason not defined above|4|||
161694814|NCT00429858|583932421|FG000|Overall Study|Withdrawal by Subject|1|||
161694815|NCT00429858|583932421|FG000|Overall Study|Study Termination|1|||
161694816|NCT01587079|583932422|FG000|Overall Study|Protocol-specified criteria|9|||
161694817|NCT01587079|583932422|FG000|Overall Study|Protocol Violation|5|||
161694818|NCT01587079|583932422|FG000|Overall Study|Lost to Follow-up|2|||
161694819|NCT01587079|583932422|FG000|Overall Study|Physician Decision|2|||
161694820|NCT01587079|583932422|FG000|Overall Study|Withdrawal by Subject|7|||
161694821|NCT01587079|583932422|FG000|Overall Study|Adverse Event|14|||
161694822|NCT01764633|583932423|FG000|Overall Study|Withdrawal by Subject|105|||
161694823|NCT01764633|583932424|FG001|Overall Study|Withdrawal by Subject|88|||
161694824|NCT01764633|583932423|FG000|Overall Study|Lost to Follow-up|13|||
161694825|NCT01764633|583932424|FG001|Overall Study|Lost to Follow-up|5|||
161694826|NCT02268058|583932425|FG000|Overall Study|Protocol Violation|1|||
161694827|NCT02268058|583932426|FG001|Overall Study|Protocol Violation|0|||
161694828|NCT02268058|583932427|FG002|Overall Study|Protocol Violation|0|||
161694829|NCT02268058|583932428|FG003|Overall Study|Protocol Violation|0|||
161694830|NCT04142983|583932433|FG000|Overall Study|Lost to Follow-up|73|||
161694831|NCT04142983|583932433|FG000|Overall Study|Withdrawal by Subject|10|||
161694832|NCT04142983|583932433|FG000|Overall Study|Physician Decision|1|||
161694833|NCT04142983|583932433|FG000|Overall Study|Adverse Event|1|||
161694834|NCT04142983|583932433|FG000|Overall Study|No longer eligible|4|||
161694835|NCT04142983|583932433|FG000|Overall Study|Screen Failure|10|||
161694836|NCT04781816|583932434|FG000|Overall Study|Adverse Event|0|||
161694837|NCT04781816|583932435|FG001|Overall Study|Adverse Event|1|||
161694838|NCT04781816|583932434|FG000|Overall Study|Withdrawal by Subject|1|||
161694839|NCT04781816|583932435|FG001|Overall Study|Withdrawal by Subject|1|||
161694840|NCT04781816|583932434|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
161694841|NCT04781816|583932435|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
161694842|NCT01789970|583932436|FG000|Open-label Titration Period|Adverse Event|68|||
161694843|NCT01789970|583932437|FG001|Open-label Titration Period|Adverse Event|0|||
161694844|NCT01789970|583932438|FG002|Open-label Titration Period|Adverse Event|0|||
161694845|NCT01789970|583932436|FG000|Open-label Titration Period|Lack of Efficacy|31|||
161694846|NCT01789970|583932437|FG001|Open-label Titration Period|Lack of Efficacy|0|||
161694847|NCT01789970|583932438|FG002|Open-label Titration Period|Lack of Efficacy|0|||
161694848|NCT01789970|583932436|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
161694849|NCT01789970|583932437|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
161694850|NCT01789970|583932438|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
161694851|NCT01789970|583932436|FG000|Open-label Titration Period|Protocol Violation|18|||
161694852|NCT01789970|583932437|FG001|Open-label Titration Period|Protocol Violation|0|||
161694853|NCT01789970|583932438|FG002|Open-label Titration Period|Protocol Violation|0|||
161694854|NCT01789970|583932436|FG000|Open-label Titration Period|Lost to Follow-up|5|||
161694855|NCT01789970|583932437|FG001|Open-label Titration Period|Lost to Follow-up|0|||
161694856|NCT01789970|583932438|FG002|Open-label Titration Period|Lost to Follow-up|0|||
161694857|NCT01789970|583932436|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
161694858|NCT01789970|583932437|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
161694859|NCT01789970|583932438|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
161694860|NCT01789970|583932436|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
161694861|NCT01789970|583932437|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
161694862|NCT01789970|583932438|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
161694863|NCT01789970|583932436|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
161694864|NCT01789970|583932437|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
161694865|NCT01789970|583932438|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
161694866|NCT01789970|583932436|FG000|Open-label Titration Period|Pregnancy|2|||
161694867|NCT01789970|583932437|FG001|Open-label Titration Period|Pregnancy|0|||
161694868|NCT01789970|583932438|FG002|Open-label Titration Period|Pregnancy|0|||
161694869|NCT01789970|583932436|FG000|Open-label Titration Period|Other|76|||
161694870|NCT01789970|583932437|FG001|Open-label Titration Period|Other|0|||
161694871|NCT01789970|583932438|FG002|Open-label Titration Period|Other|0|||
161694872|NCT01789970|583932436|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
161694873|NCT01789970|583932437|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
161694874|NCT01789970|583932438|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
161694875|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
161694876|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
161694877|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
161694878|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161694879|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
161694880|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
161694881|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161694882|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
161694883|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
161694884|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
161694885|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
161694886|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
161694887|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
161694888|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
161694889|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
161694890|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
161694891|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
161694892|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
161694893|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161694894|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
161694895|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
161694896|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
161694897|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
161694898|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
161694899|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
161694900|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
161694901|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
161694902|NCT01789970|583932436|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
161694903|NCT01789970|583932437|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
161694904|NCT01789970|583932438|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
161694905|NCT04372927|583932443|FG000|Overall Study|Death|1|||
161694906|NCT01847885|583932447|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
161694907|NCT01847885|583932448|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
161694908|NCT01847885|583932449|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
161694909|NCT01847885|583932447|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
161956645|NCT00131352|584889733|FG001|Initial Treatment Period|Lack of Efficacy|4|||
161694910|NCT01847885|583932448|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
161694911|NCT01847885|583932449|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
161694912|NCT01847885|583932447|FG000|Initial Enrollment (Consented)|Screen failure|39|||
161694913|NCT01847885|583932448|FG001|Initial Enrollment (Consented)|Screen failure|0|||
161694914|NCT01847885|583932449|FG002|Initial Enrollment (Consented)|Screen failure|0|||
161694915|NCT01847885|583932447|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
161694916|NCT01847885|583932448|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
161694917|NCT01847885|583932449|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
161694918|NCT01847885|583932447|FG000|Randomization|Protocol Violation|0|||
161694919|NCT01847885|583932448|FG001|Randomization|Protocol Violation|1|||
161694920|NCT01847885|583932449|FG002|Randomization|Protocol Violation|0|||
161694921|NCT01847885|583932447|FG000|Randomization|Withdrawal by Subject|0|||
161694922|NCT01847885|583932448|FG001|Randomization|Withdrawal by Subject|0|||
161694923|NCT01847885|583932449|FG002|Randomization|Withdrawal by Subject|2|||
161694924|NCT01847885|583932447|FG000|Randomization|Screen Failure|0|||
161694925|NCT01847885|583932448|FG001|Randomization|Screen Failure|3|||
161694926|NCT01847885|583932449|FG002|Randomization|Screen Failure|0|||
161694927|NCT03033745|583932452|FG000|Overall Study|Protocol Violation|0|||
161694928|NCT03033745|583932453|FG001|Overall Study|Protocol Violation|0|||
161694929|NCT03033745|583932454|FG002|Overall Study|Protocol Violation|1|||
161694930|NCT03033745|583932452|FG000|Overall Study|Adverse Event|1|||
161694931|NCT03033745|583932453|FG001|Overall Study|Adverse Event|0|||
161694932|NCT03033745|583932454|FG002|Overall Study|Adverse Event|1|||
161694933|NCT03033745|583932452|FG000|Overall Study|Withdrawal by Subject|0|||
161694934|NCT03033745|583932453|FG001|Overall Study|Withdrawal by Subject|1|||
161694935|NCT03033745|583932454|FG002|Overall Study|Withdrawal by Subject|0|||
161694936|NCT01999582|583932456|FG000|Overall Study|Withdrawal by Subject|0|||
161694937|NCT01999582|583932457|FG001|Overall Study|Withdrawal by Subject|0|||
161694938|NCT01999582|583932458|FG002|Overall Study|Withdrawal by Subject|0|||
161694939|NCT01999582|583932459|FG003|Overall Study|Withdrawal by Subject|1|||
161694940|NCT01999582|583932460|FG004|Overall Study|Withdrawal by Subject|0|||
161694941|NCT01999582|583932461|FG005|Overall Study|Withdrawal by Subject|0|||
161694942|NCT01999582|583932456|FG000|Overall Study|Adverse Event|0|||
161694943|NCT01999582|583932457|FG001|Overall Study|Adverse Event|0|||
161694944|NCT01999582|583932458|FG002|Overall Study|Adverse Event|3|||
161694945|NCT01999582|583932459|FG003|Overall Study|Adverse Event|0|||
161694946|NCT01999582|583932460|FG004|Overall Study|Adverse Event|1|||
161694947|NCT01999582|583932461|FG005|Overall Study|Adverse Event|0|||
161694948|NCT01999582|583932456|FG000|Overall Study|Other Reasons|1|||
161694949|NCT01999582|583932457|FG001|Overall Study|Other Reasons|0|||
161694950|NCT01999582|583932458|FG002|Overall Study|Other Reasons|3|||
161694951|NCT01999582|583932459|FG003|Overall Study|Other Reasons|1|||
161694952|NCT01999582|583932460|FG004|Overall Study|Other Reasons|1|||
161694953|NCT01999582|583932461|FG005|Overall Study|Other Reasons|2|||
161694954|NCT01999582|583932456|FG000|Overall Study|Protocol Violation|1|||
161694955|NCT01999582|583932457|FG001|Overall Study|Protocol Violation|0|||
161694956|NCT01999582|583932458|FG002|Overall Study|Protocol Violation|0|||
161694957|NCT01999582|583932459|FG003|Overall Study|Protocol Violation|0|||
161694958|NCT01999582|583932460|FG004|Overall Study|Protocol Violation|0|||
161694959|NCT01999582|583932461|FG005|Overall Study|Protocol Violation|1|||
161694960|NCT01999582|583932456|FG000|Overall Study|Lack of Efficacy|1|||
161694961|NCT01999582|583932457|FG001|Overall Study|Lack of Efficacy|3|||
161694962|NCT01999582|583932458|FG002|Overall Study|Lack of Efficacy|0|||
161694963|NCT01999582|583932459|FG003|Overall Study|Lack of Efficacy|1|||
161694964|NCT01999582|583932460|FG004|Overall Study|Lack of Efficacy|0|||
161694965|NCT01999582|583932461|FG005|Overall Study|Lack of Efficacy|0|||
161694966|NCT03728309|583932466|FG000|Overall Study|Randomized but not Treated|0|||
161694967|NCT03728309|583932467|FG001|Overall Study|Randomized but not Treated|1|||
161694968|NCT03728309|583932466|FG000|Overall Study|Adverse Event|0|||
161836531|NCT02333487|584443016|FG002|Overall Study|Adverse Event|0|||
161836532|NCT03303625|584444929|FG000|Overall Study|Withdrawal by Subject|2|||
161836533|NCT03303625|584444930|FG001|Overall Study|Withdrawal by Subject|0|||
161836534|NCT03303625|584444931|FG002|Overall Study|Withdrawal by Subject|0|||
161836535|NCT03303625|584444932|FG003|Overall Study|Withdrawal by Subject|0|||
161836536|NCT02858492|584444935|FG000|Overall Study|Withdrawal by Subject|0|||
161836537|NCT02858492|584444936|FG001|Overall Study|Withdrawal by Subject|1|||
161836538|NCT02858492|584444937|FG002|Overall Study|Withdrawal by Subject|0|||
161694969|NCT03728309|583932467|FG001|Overall Study|Adverse Event|1|||
161694970|NCT03728309|583932466|FG000|Overall Study|Withdrawal by Subject|2|||
161694971|NCT03728309|583932467|FG001|Overall Study|Withdrawal by Subject|8|||
161694972|NCT03728309|583932466|FG000|Overall Study|Lost to Follow-up|9|||
161694973|NCT03728309|583932467|FG001|Overall Study|Lost to Follow-up|10|||
161694974|NCT03728309|583932466|FG000|Overall Study|Protocol Deviation|0|||
161694975|NCT03728309|583932467|FG001|Overall Study|Protocol Deviation|1|||
161694976|NCT03728309|583932466|FG000|Overall Study|Due to COVID|1|||
161694977|NCT03728309|583932467|FG001|Overall Study|Due to COVID|3|||
161836539|NCT02858492|584444938|FG003|Overall Study|Withdrawal by Subject|1|||
161694978|NCT00927095|583932470|FG000|Overall Study|Adverse Event|3|||
161694979|NCT00927095|583932471|FG001|Overall Study|Adverse Event|1|||
161694980|NCT00927095|583932472|FG002|Overall Study|Adverse Event|0|||
161694981|NCT00927095|583932470|FG000|Overall Study|Withdrawal by Subject|2|||
161694982|NCT00927095|583932471|FG001|Overall Study|Withdrawal by Subject|1|||
161694983|NCT00927095|583932472|FG002|Overall Study|Withdrawal by Subject|1|||
161694984|NCT00927095|583932470|FG000|Overall Study|Physician Decision|1|||
161694985|NCT00927095|583932471|FG001|Overall Study|Physician Decision|2|||
161694986|NCT00927095|583932472|FG002|Overall Study|Physician Decision|1|||
161694987|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
161694988|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
161694989|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
161694990|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
161694991|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161694992|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161694993|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
161694994|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161694995|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
161694996|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161694997|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161694998|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161694999|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
161695000|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
161695001|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
161695002|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
161695003|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
161695004|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
161695005|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
161695006|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
161695007|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
161695008|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
161695009|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
161695010|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
161695011|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
161695012|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161695013|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161695014|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161695015|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161695016|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161695017|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161695018|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
161695019|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161695020|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161695021|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161695022|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161695023|NCT03403205|583932479|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
161695024|NCT03403205|583932480|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
161695025|NCT03403205|583932481|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
161695026|NCT03403205|583932482|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
161695027|NCT03403205|583932483|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
161695028|NCT03403205|583932484|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
161695029|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
161695030|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
161695031|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
161695032|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
161695033|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
161695034|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
161695035|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
161695036|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
161695037|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
161695038|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
161695039|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
162030781|NCT00952380|585169485|FG000|Overall Study|Adverse Event|0|||
162030782|NCT00952380|585169486|FG001|Overall Study|Adverse Event|1|||
162030783|NCT00952380|585169487|FG002|Overall Study|Adverse Event|0|||
162030784|NCT00952380|585169488|FG003|Overall Study|Adverse Event|0|||
162030785|NCT00952380|585169489|FG004|Overall Study|Adverse Event|3|||
162030786|NCT00952380|585169485|FG000|Overall Study|Physician Decision|0|||
162030787|NCT00952380|585169486|FG001|Overall Study|Physician Decision|0|||
161956646|NCT00131352|584889732|FG000|Initial Treatment Period|Other|0|||
161956647|NCT00131352|584889733|FG001|Initial Treatment Period|Other|2|||
161956648|NCT00131352|584889732|FG000|Repeat Treatment Period|Adverse Event|1|||
161956649|NCT00131352|584889733|FG001|Repeat Treatment Period|Adverse Event|0|||
161956650|NCT00131352|584889732|FG000|Repeat Treatment Period|Other|1|||
161695040|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
161695041|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Death|1|||
161695042|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Death|0|||
161695043|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Death|0|||
161695044|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Death|0|||
161695045|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Death|0|||
161695046|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Death|0|||
161695047|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
161695048|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161695049|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161695050|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161695051|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161695052|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161695053|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
161695054|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
161695055|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
161695056|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
161695057|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
161695058|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
161695059|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
161695060|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161695061|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161695062|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161695063|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161695064|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161695065|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
161695066|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
161695067|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
161695068|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
161695069|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
161695070|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
161695071|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
161695072|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
161695073|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
161695074|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
161695075|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
161695076|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
161695077|NCT03403205|583932479|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
161695078|NCT03403205|583932480|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
161695079|NCT03403205|583932481|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
161695080|NCT03403205|583932482|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
161836540|NCT02858492|584444935|FG000|Overall Study|Adverse Event|0|||
161956651|NCT00131352|584889733|FG001|Repeat Treatment Period|Other|0|||
161956652|NCT00383331|584889734|FG000|Overall Study|Protocol Violation|0|||
161956653|NCT00383331|584889735|FG001|Overall Study|Protocol Violation|1|||
161956654|NCT00211172|584889737|FG000|Overall Study|Died or lost health plan eligibility|39|||
161956655|NCT00211172|584889738|FG001|Overall Study|Died or lost health plan eligibility|32|||
161956656|NCT00372619|584889741|FG000|Overall Study|Ineligible|0|||
161956657|NCT00372619|584889742|FG001|Overall Study|Ineligible|0|||
161956658|NCT00372619|584889743|FG002|Overall Study|Ineligible|0|||
161956659|NCT00372619|584889744|FG003|Overall Study|Ineligible|0|||
161956660|NCT00372619|584889745|FG004|Overall Study|Ineligible|0|||
161956661|NCT00372619|584889746|FG005|Overall Study|Ineligible|2|||
161956662|NCT00372619|584889747|FG006|Overall Study|Ineligible|0|||
162030788|NCT00952380|585169487|FG002|Overall Study|Physician Decision|1|||
162030789|NCT00952380|585169488|FG003|Overall Study|Physician Decision|2|||
161695081|NCT03403205|583932483|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
161695082|NCT03403205|583932484|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
161695083|NCT00706030|583932485|FG000|Overall Study|Disease Progression|4|||
161695084|NCT00706030|583932486|FG001|Overall Study|Disease Progression|6|||
161695085|NCT00706030|583932487|FG002|Overall Study|Disease Progression|46|||
161695086|NCT00706030|583932488|FG003|Overall Study|Disease Progression|12|||
161695087|NCT00706030|583932485|FG000|Overall Study|Adverse Event|1|||
161695088|NCT00706030|583932486|FG001|Overall Study|Adverse Event|0|||
161695089|NCT00706030|583932487|FG002|Overall Study|Adverse Event|4|||
161695090|NCT00706030|583932488|FG003|Overall Study|Adverse Event|2|||
161695091|NCT00706030|583932485|FG000|Overall Study|Withdrawal by Subject|1|||
161695092|NCT00706030|583932486|FG001|Overall Study|Withdrawal by Subject|0|||
161695093|NCT00706030|583932487|FG002|Overall Study|Withdrawal by Subject|2|||
161695094|NCT00706030|583932488|FG003|Overall Study|Withdrawal by Subject|0|||
161695095|NCT00706030|583932485|FG000|Overall Study|Physician Decision|0|||
161695096|NCT00706030|583932486|FG001|Overall Study|Physician Decision|0|||
161695097|NCT00706030|583932487|FG002|Overall Study|Physician Decision|2|||
161695098|NCT00706030|583932488|FG003|Overall Study|Physician Decision|0|||
161695099|NCT00706030|583932485|FG000|Overall Study|Not recorded|0|||
161695100|NCT00706030|583932486|FG001|Overall Study|Not recorded|0|||
161695101|NCT00706030|583932487|FG002|Overall Study|Not recorded|2|||
161695102|NCT00706030|583932488|FG003|Overall Study|Not recorded|0|||
161695103|NCT00706030|583932485|FG000|Overall Study|Protocol Violation|0|||
161695104|NCT00706030|583932486|FG001|Overall Study|Protocol Violation|0|||
161695105|NCT00706030|583932487|FG002|Overall Study|Protocol Violation|1|||
161695106|NCT00706030|583932488|FG003|Overall Study|Protocol Violation|1|||
161695107|NCT00706030|583932485|FG000|Overall Study|Failed to return|0|||
161695108|NCT00706030|583932486|FG001|Overall Study|Failed to return|0|||
161695109|NCT00706030|583932487|FG002|Overall Study|Failed to return|1|||
161695110|NCT00706030|583932488|FG003|Overall Study|Failed to return|0|||
161695111|NCT00706030|583932485|FG000|Overall Study|Symptomatic Deterioration|0|||
161695112|NCT00706030|583932486|FG001|Overall Study|Symptomatic Deterioration|0|||
161695113|NCT00706030|583932487|FG002|Overall Study|Symptomatic Deterioration|1|||
161695114|NCT00706030|583932488|FG003|Overall Study|Symptomatic Deterioration|0|||
161695115|NCT00706030|583932485|FG000|Overall Study|No treatment received|0|||
161695116|NCT00706030|583932486|FG001|Overall Study|No treatment received|0|||
161695117|NCT00706030|583932487|FG002|Overall Study|No treatment received|0|||
161695118|NCT00706030|583932488|FG003|Overall Study|No treatment received|1|||
161695119|NCT00706030|583932485|FG000|Overall Study|Death|0|||
161695120|NCT00706030|583932486|FG001|Overall Study|Death|0|||
161695121|NCT00706030|583932487|FG002|Overall Study|Death|1|||
161695122|NCT00706030|583932488|FG003|Overall Study|Death|0|||
161695123|NCT05779072|583932489|FG000|Overall Study|Lost to Follow-up|0|||
161695124|NCT05779072|583932490|FG001|Overall Study|Lost to Follow-up|1|||
161695125|NCT05779072|583932489|FG000|Overall Study|Withdrawal by Subject|1|||
161695126|NCT05779072|583932490|FG001|Overall Study|Withdrawal by Subject|5|||
161695127|NCT01445769|583932491|FG000|Overall Study|Consent Withdrawn|2|||
161695128|NCT01445769|583932491|FG000|Overall Study|Disease Progression|1|||
161695129|NCT01445769|583932491|FG000|Overall Study|Lost to Follow-up|5|||
161695130|NCT05130463|583932494|FG000|Overall Study|Unspecified reasons|2|||
161695131|NCT05130463|583932494|FG000|Overall Study|off-label indication dose|435|||
161695132|NCT03652662|583932498|FG000|Overall Study|Withdrawal by Subject|2|||
161695133|NCT03652662|583932499|FG001|Overall Study|Withdrawal by Subject|1|||
161695134|NCT03652662|583932498|FG000|Overall Study|Lost to Follow-up|1|||
161695135|NCT03652662|583932499|FG001|Overall Study|Lost to Follow-up|0|||
161695136|NCT00487539|583932500|FG000|Overall Study|Adverse Event|3|||
161695137|NCT00487539|583932501|FG001|Overall Study|Adverse Event|2|||
161695138|NCT00487539|583932502|FG002|Overall Study|Adverse Event|1|||
161695139|NCT00487539|583932503|FG003|Overall Study|Adverse Event|1|||
161695140|NCT00487539|583932500|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161695141|NCT00487539|583932501|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161695142|NCT00487539|583932502|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161695143|NCT00487539|583932503|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
161695144|NCT00487539|583932500|FG000|Overall Study|Other|3|||
161695145|NCT00487539|583932501|FG001|Overall Study|Other|1|||
161695146|NCT00487539|583932502|FG002|Overall Study|Other|2|||
161695147|NCT00487539|583932503|FG003|Overall Study|Other|2|||
161695148|NCT02695628|583932504|FG000|Overall Study|Withdrawal by Subject|1|||
161695149|NCT02751502|583932505|FG000|Overall Study|Lack of funding|4|||
161695150|NCT02678390|583932506|FG000|AE (1 Day)|Withdrawal by Subject|0|||
161695151|NCT02678390|583932507|FG001|AE (1 Day)|Withdrawal by Subject|1|||
161695152|NCT03499028|583932508|FG000|Overall Study|Lost to Follow-up|12|||
161695153|NCT03499028|583932509|FG001|Overall Study|Lost to Follow-up|9|||
161695154|NCT03499028|583932508|FG000|Overall Study|Withdrawal by Subject|5|||
161695155|NCT03499028|583932509|FG001|Overall Study|Withdrawal by Subject|8|||
161695156|NCT03499028|583932508|FG000|Overall Study|Unplanned SNF discharge|5|||
161695157|NCT03499028|583932509|FG001|Overall Study|Unplanned SNF discharge|8|||
161695158|NCT02925156|583932510|FG000|Overall Study|Lost to Follow-up|27|||
161695159|NCT02925156|583932511|FG001|Overall Study|Lost to Follow-up|53|||
161695160|NCT02925156|583932512|FG002|Overall Study|Lost to Follow-up|51|||
161695161|NCT02925156|583932513|FG003|Overall Study|Lost to Follow-up|59|||
161695162|NCT02925156|583932514|FG004|Overall Study|Lost to Follow-up|89|||
161695163|NCT02925156|583932515|FG005|Overall Study|Lost to Follow-up|107|||
161695164|NCT02925156|583932516|FG006|Overall Study|Lost to Follow-up|34|||
161695165|NCT02925156|583932517|FG007|Overall Study|Lost to Follow-up|36|||
161695166|NCT02925156|583932518|FG008|Overall Study|Lost to Follow-up|73|||
161695167|NCT02925156|583932519|FG009|Overall Study|Lost to Follow-up|34|||
161695168|NCT01844895|583932520|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
161695169|NCT01844895|583932520|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
161695170|NCT01844895|583932520|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
161695171|NCT01844895|583932520|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
161695172|NCT01844895|583932520|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
161695173|NCT01844895|583932520|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
161695174|NCT01844895|583932520|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
161695175|NCT04982250|583932521|FG000|Overall Study|Lost to Follow-up|0|||
161695176|NCT04982250|583932522|FG001|Overall Study|Lost to Follow-up|26|||
161695177|NCT04982250|583932523|FG002|Overall Study|Lost to Follow-up|0|||
161695178|NCT04982250|583932524|FG003|Overall Study|Lost to Follow-up|0|||
161695179|NCT04982250|583932525|FG004|Overall Study|Lost to Follow-up|72|||
161695180|NCT04982250|583932526|FG005|Overall Study|Lost to Follow-up|69|||
161695181|NCT04982250|583932521|FG000|Overall Study|Not Eligible to Enroll|0|||
161695182|NCT04982250|583932522|FG001|Overall Study|Not Eligible to Enroll|0|||
161695183|NCT04982250|583932523|FG002|Overall Study|Not Eligible to Enroll|0|||
161695184|NCT04982250|583932524|FG003|Overall Study|Not Eligible to Enroll|0|||
161695185|NCT04982250|583932525|FG004|Overall Study|Not Eligible to Enroll|10|||
161695186|NCT04982250|583932526|FG005|Overall Study|Not Eligible to Enroll|7|||
161695187|NCT01844986|583932529|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
161695188|NCT01844986|583932530|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
161695189|NCT01844986|583932529|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
161695190|NCT01844986|583932530|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
161695191|NCT01844986|583932529|FG000|Overall Study (Global Cohort)|Death|55|||
161695192|NCT01844986|583932530|FG001|Overall Study (Global Cohort)|Death|26|||
161695193|NCT01844986|583932529|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
161695194|NCT01844986|583932530|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
161695195|NCT01844986|583932529|FG000|Overall Study (China Cohort)|Death|10|||
161695196|NCT01844986|583932530|FG001|Overall Study (China Cohort)|Death|6|||
161695197|NCT02392429|583933642|FG000|Screening|Screen failure|15|||
161695198|NCT02392429|583933642|FG000|Enrolled Participants|Ineligible due to disease|3|||
161695199|NCT02392429|583933642|FG000|Enrolled Participants|Withdrawal by Subject|4|||
161695200|NCT02392429|583933642|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
161695201|NCT02392429|583933642|FG000|Evaluable|Death|5|||
161695202|NCT02392429|583933642|FG000|Evaluable|Withdrawal by Subject|1|||
161695203|NCT02392429|583933642|FG000|Evaluable|Adverse Event|1|||
161695204|NCT02392429|583933642|FG000|Evaluable|remission bone marrow biopsy|3|||
161695205|NCT01178138|583933645|FG000|Overall Study|Lost to Follow-up|8|||
161695206|NCT01178138|583933645|FG000|Overall Study|Withdrawal by Subject|7|||
161695207|NCT01178138|583933645|FG000|Overall Study|Physician Decision|8|||
161695208|NCT00403260|583933646|FG000|Overall Study|Adverse Event|5|||
161695209|NCT00403260|583933647|FG001|Overall Study|Adverse Event|4|||
161695210|NCT00403260|583933646|FG000|Overall Study|Withdrawal by Subject|5|||
161695211|NCT00403260|583933647|FG001|Overall Study|Withdrawal by Subject|6|||
161695212|NCT00403260|583933646|FG000|Overall Study|Lost to Follow-up|49|||
161695213|NCT00403260|583933647|FG001|Overall Study|Lost to Follow-up|25|||
161695214|NCT00403260|583933646|FG000|Overall Study|Re-appearance of P. falciparum|34|||
161695215|NCT00403260|583933647|FG001|Overall Study|Re-appearance of P. falciparum|25|||
161695216|NCT00403260|583933646|FG000|Overall Study|P. vivax infection|26|||
161695217|NCT00403260|583933647|FG001|Overall Study|P. vivax infection|4|||
161695218|NCT00403260|583933646|FG000|Overall Study|Mixed infection with P. vivax|2|||
161695219|NCT00403260|583933647|FG001|Overall Study|Mixed infection with P. vivax|0|||
161695220|NCT00403260|583933646|FG000|Overall Study|Mixed infection with P. falciparum|1|||
161695221|NCT00403260|583933647|FG001|Overall Study|Mixed infection with P. falciparum|0|||
161695222|NCT00403260|583933646|FG000|Overall Study|P. vivax infection at screening|1|||
161695223|NCT00403260|583933647|FG001|Overall Study|P. vivax infection at screening|0|||
161695224|NCT00403260|583933646|FG000|Overall Study|P. ovale infection|1|||
161695225|NCT00403260|583933647|FG001|Overall Study|P. ovale infection|0|||
161695226|NCT00403260|583933646|FG000|Overall Study|Gametocyte re-appearance|1|||
161695227|NCT00403260|583933647|FG001|Overall Study|Gametocyte re-appearance|1|||
161695228|NCT00403260|583933646|FG000|Overall Study|Withdrawn from study accidentally|0|||
161695229|NCT00403260|583933647|FG001|Overall Study|Withdrawn from study accidentally|1|||
161695230|NCT01241708|583933648|FG000|Overall Study|Withdrawal by Subject|6|||
161695231|NCT01241708|583933648|FG000|Overall Study|Screen Failure|6|||
161695232|NCT01241708|583933648|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
161695233|NCT01241708|583933648|FG000|Overall Study|Lost to Follow-up|5|||
161695234|NCT02322710|583933656|FG000|Overall Study|No efficacy assessment post-baseline|0|||
161695235|NCT02322710|583933657|FG001|Overall Study|No efficacy assessment post-baseline|1|||
161695236|NCT02322710|583933656|FG000|Overall Study|Protocol Violation|20|||
161695237|NCT02322710|583933657|FG001|Overall Study|Protocol Violation|25|||
162030790|NCT00952380|585169489|FG004|Overall Study|Physician Decision|0|||
162030791|NCT00952380|585169485|FG000|Overall Study|Non-compliant to protocol|0|||
161695238|NCT04161131|583933658|FG000|Overall Study|Ineligible|2|||
161695239|NCT04161131|583933658|FG000|Overall Study|Lost to Follow-up|4|||
161695240|NCT05064059|583933659|FG000|Overall Study|Death|199|||
161695241|NCT05064059|583933660|FG001|Overall Study|Death|196|||
161695242|NCT05064059|583933659|FG000|Overall Study|Physician Decision|4|||
162030792|NCT00952380|585169486|FG001|Overall Study|Non-compliant to protocol|0|||
161695243|NCT05064059|583933660|FG001|Overall Study|Physician Decision|2|||
161695244|NCT05064059|583933659|FG000|Overall Study|Sponsor Decision|14|||
161695245|NCT05064059|583933660|FG001|Overall Study|Sponsor Decision|11|||
161695246|NCT05064059|583933659|FG000|Overall Study|Withdrawal by Subject|4|||
161695247|NCT05064059|583933660|FG001|Overall Study|Withdrawal by Subject|11|||
161695248|NCT02615990|583933661|FG000|Overall Study|study terminated|1|||
161695249|NCT02615990|583933662|FG001|Overall Study|study terminated|1|||
161695250|NCT00808444|583933665|FG000|Overall Study|Withdrawal by Subject|1|||
161695251|NCT00808444|583933666|FG001|Overall Study|Withdrawal by Subject|0|||
161695252|NCT00808444|583933665|FG000|Overall Study|Lost to Follow-up|0|||
161695253|NCT00808444|583933666|FG001|Overall Study|Lost to Follow-up|1|||
161695254|NCT04401267|583933667|FG000|Overall Study|Death|0|||
161695255|NCT04401267|583933668|FG001|Overall Study|Death|1|||
161695256|NCT04401267|583933667|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
161695257|NCT04401267|583933668|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
161695258|NCT04401267|583933667|FG000|Overall Study|Found to be Ineligible|1|||
161695259|NCT04401267|583933668|FG001|Overall Study|Found to be Ineligible|0|||
161695260|NCT01449708|583933678|FG000|Overall Study|Protocol Violation|0|||
161695261|NCT01449708|583933679|FG001|Overall Study|Protocol Violation|1|||
161695262|NCT01449708|583933678|FG000|Overall Study|surgical complication|1|||
161695263|NCT01449708|583933679|FG001|Overall Study|surgical complication|2|||
161695264|NCT01449708|583933678|FG000|Overall Study|respiratory failure|1|||
161695265|NCT01449708|583933679|FG001|Overall Study|respiratory failure|0|||
161695266|NCT01239160|583933685|FG000|Overall Study|Lost to Follow-up|3|||
161695267|NCT01239160|583933686|FG001|Overall Study|Lost to Follow-up|5|||
161695268|NCT01239160|583933687|FG002|Overall Study|Lost to Follow-up|0|||
161695269|NCT01239160|583933685|FG000|Overall Study|Withdrawal by Subject|17|||
161695270|NCT01239160|583933686|FG001|Overall Study|Withdrawal by Subject|6|||
161695271|NCT01239160|583933687|FG002|Overall Study|Withdrawal by Subject|2|||
161695272|NCT01239160|583933685|FG000|Overall Study|Physician Decision|5|||
161695273|NCT01239160|583933686|FG001|Overall Study|Physician Decision|7|||
161695274|NCT01239160|583933687|FG002|Overall Study|Physician Decision|2|||
161695275|NCT01239160|583933685|FG000|Overall Study|Early Termination Due to Study Closure|0|||
161695276|NCT01239160|583933686|FG001|Overall Study|Early Termination Due to Study Closure|1|||
161695277|NCT01239160|583933687|FG002|Overall Study|Early Termination Due to Study Closure|6|||
161695278|NCT00643994|583933688|FG000|Overall Study|Death|24|||
161695279|NCT00643994|583933688|FG000|Overall Study|Lost to Follow-up|72|||
161695280|NCT04016311|583933692|FG000|Overall Study|Withdrawal by Subject|1|||
161695281|NCT04016311|583933693|FG001|Overall Study|Withdrawal by Subject|0|||
161695282|NCT02706730|583933697|FG000|Overall Study|Adverse Event|3|||
161695283|NCT02706730|583933697|FG000|Overall Study|Lack of Efficacy|5|||
161695284|NCT02706730|583933697|FG000|Overall Study|Withdrawal by Subject|11|||
161695285|NCT02706730|583933697|FG000|Overall Study|Study Terminated by Sponsor|11|||
161695286|NCT02706730|583933697|FG000|Overall Study|Subject chose not to receive injection|3|||
161695287|NCT02499029|583933698|FG000|Overall Study|Lost to Follow-up|2|||
161695288|NCT02499029|583933699|FG001|Overall Study|Lost to Follow-up|2|||
161695289|NCT02499029|583933698|FG000|Overall Study|Physician Decision|2|||
161695290|NCT02499029|583933699|FG001|Overall Study|Physician Decision|1|||
161695291|NCT02499029|583933698|FG000|Overall Study|Death|1|||
161695292|NCT02499029|583933699|FG001|Overall Study|Death|0|||
161695293|NCT00094055|583933700|FG000|Overall Study|Adverse Event|11|||
161695294|NCT00094055|583933700|FG000|Overall Study|Death|4|||
161695295|NCT00094055|583933700|FG000|Overall Study|Lack of Efficacy|17|||
161695296|NCT00094055|583933700|FG000|Overall Study|Lost to Follow-up|2|||
161695297|NCT00094055|583933700|FG000|Overall Study|progressive disease|2|||
161695298|NCT00094055|583933700|FG000|Overall Study|clinical progression|1|||
161695299|NCT00094055|583933700|FG000|Overall Study|roll-over to another study|14|||
161695300|NCT00094055|583933700|FG000|Overall Study|Withdrawal by Subject|9|||
161695301|NCT00756938|583933701|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
161695302|NCT00756938|583933702|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
161695303|NCT00756938|583933703|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
161695304|NCT00756938|583933704|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
161695305|NCT00756938|583933701|FG000|12-week Base Study|Protocol Violation|0|||
161695306|NCT00756938|583933702|FG001|12-week Base Study|Protocol Violation|0|||
161695307|NCT00756938|583933703|FG002|12-week Base Study|Protocol Violation|1|||
161695308|NCT00756938|583933704|FG003|12-week Base Study|Protocol Violation|0|||
161695309|NCT00756938|583933701|FG000|12-week Base Study|Lost to Follow-up|1|||
161956663|NCT00372619|584889741|FG000|Overall Study|Inevaluable|0|||
161695310|NCT00756938|583933702|FG001|12-week Base Study|Lost to Follow-up|0|||
161695311|NCT00756938|583933703|FG002|12-week Base Study|Lost to Follow-up|0|||
161695312|NCT00756938|583933704|FG003|12-week Base Study|Lost to Follow-up|0|||
161695313|NCT00756938|583933701|FG000|Optional Extension|Lack of Efficacy|0|||
161695314|NCT00756938|583933702|FG001|Optional Extension|Lack of Efficacy|0|||
161695315|NCT00756938|583933703|FG002|Optional Extension|Lack of Efficacy|0|||
161695316|NCT00756938|583933704|FG003|Optional Extension|Lack of Efficacy|1|||
161695317|NCT00756938|583933701|FG000|Optional Extension|End of Study|0|||
161695318|NCT00756938|583933702|FG001|Optional Extension|End of Study|0|||
161956664|NCT00372619|584889742|FG001|Overall Study|Inevaluable|0|||
161695319|NCT00756938|583933703|FG002|Optional Extension|End of Study|0|||
161695320|NCT00756938|583933704|FG003|Optional Extension|End of Study|11|||
161695321|NCT00756938|583933701|FG000|Optional Extension|Protocol-specific criteria met|0|||
161695322|NCT00756938|583933702|FG001|Optional Extension|Protocol-specific criteria met|0|||
161695323|NCT00756938|583933703|FG002|Optional Extension|Protocol-specific criteria met|0|||
161695324|NCT00756938|583933704|FG003|Optional Extension|Protocol-specific criteria met|9|||
161695325|NCT00756938|583933701|FG000|Optional Extension|Physician Decision|0|||
161695326|NCT00756938|583933702|FG001|Optional Extension|Physician Decision|0|||
161695327|NCT00756938|583933703|FG002|Optional Extension|Physician Decision|0|||
161695328|NCT00756938|583933704|FG003|Optional Extension|Physician Decision|3|||
161695329|NCT00756938|583933701|FG000|Optional Extension|Lost to Follow-up|0|||
161695330|NCT00756938|583933702|FG001|Optional Extension|Lost to Follow-up|0|||
161695331|NCT00756938|583933703|FG002|Optional Extension|Lost to Follow-up|0|||
161695332|NCT00756938|583933704|FG003|Optional Extension|Lost to Follow-up|1|||
161695333|NCT00756938|583933701|FG000|Optional Extension|Protocol Violation|0|||
161695334|NCT00756938|583933702|FG001|Optional Extension|Protocol Violation|0|||
161695335|NCT00756938|583933703|FG002|Optional Extension|Protocol Violation|0|||
161695336|NCT00756938|583933704|FG003|Optional Extension|Protocol Violation|1|||
161695337|NCT00756938|583933701|FG000|Optional Extension|Withdrawal by Subject|0|||
161695338|NCT00756938|583933702|FG001|Optional Extension|Withdrawal by Subject|0|||
161695339|NCT00756938|583933703|FG002|Optional Extension|Withdrawal by Subject|0|||
161695340|NCT00756938|583933704|FG003|Optional Extension|Withdrawal by Subject|10|||
161695341|NCT00756938|583933701|FG000|Optional Extension|Adverse Event|0|||
161695342|NCT00756938|583933702|FG001|Optional Extension|Adverse Event|0|||
161695343|NCT00756938|583933703|FG002|Optional Extension|Adverse Event|0|||
161695344|NCT00756938|583933704|FG003|Optional Extension|Adverse Event|1|||
161695345|NCT04823949|583933705|FG000|Overall Study|Withdrawal by Subject|0|||
161695346|NCT04823949|583933706|FG001|Overall Study|Withdrawal by Subject|4|||
161695347|NCT04823949|583933705|FG000|Overall Study|Physician Decision|0|||
161695348|NCT04823949|583933706|FG001|Overall Study|Physician Decision|1|||
161695349|NCT00441545|583933707|FG000|First Intervention|Adverse Event|6|||
161695350|NCT00441545|583933708|FG001|First Intervention|Adverse Event|5|||
161695351|NCT00441545|583933707|FG000|First Intervention|Protocol Violation|2|||
161695352|NCT00441545|583933708|FG001|First Intervention|Protocol Violation|2|||
161695353|NCT00441545|583933707|FG000|First Intervention|Withdrawal by Subject|3|||
161695354|NCT00441545|583933708|FG001|First Intervention|Withdrawal by Subject|3|||
161695355|NCT00441545|583933707|FG000|First Intervention|Kidney transplant|1|||
161695356|NCT00441545|583933708|FG001|First Intervention|Kidney transplant|1|||
161695357|NCT00441545|583933707|FG000|First Intervention|Lack of Efficacy|2|||
161695358|NCT00441545|583933708|FG001|First Intervention|Lack of Efficacy|0|||
161695359|NCT00441545|583933707|FG000|First Intervention|Subject exceeded safety criteria|0|||
161695360|NCT00441545|583933708|FG001|First Intervention|Subject exceeded safety criteria|1|||
161695361|NCT00441545|583933707|FG000|First Intervention|Subject met an exclusionary criteria|1|||
161695362|NCT00441545|583933708|FG001|First Intervention|Subject met an exclusionary criteria|0|||
161695363|NCT00441545|583933707|FG000|First Intervention|Extended hospitalization|1|||
161695364|NCT00441545|583933708|FG001|First Intervention|Extended hospitalization|0|||
161695365|NCT00441545|583933707|FG000|First Intervention|Site error|1|||
161695366|NCT00441545|583933708|FG001|First Intervention|Site error|0|||
161695367|NCT00441545|583933707|FG000|First Intervention|Sponsor's request|1|||
161695368|NCT00441545|583933708|FG001|First Intervention|Sponsor's request|0|||
161695369|NCT00441545|583933707|FG000|Second Intervention|Adverse Event|5|||
161695370|NCT00441545|583933708|FG001|Second Intervention|Adverse Event|2|||
161695371|NCT00441545|583933707|FG000|Second Intervention|Protocol Violation|4|||
161695372|NCT00441545|583933708|FG001|Second Intervention|Protocol Violation|1|||
161695373|NCT00441545|583933707|FG000|Second Intervention|Withdrawal by Subject|1|||
161695374|NCT00441545|583933708|FG001|Second Intervention|Withdrawal by Subject|1|||
161695375|NCT00441545|583933707|FG000|Second Intervention|Kidney Transplant|1|||
161695376|NCT00441545|583933708|FG001|Second Intervention|Kidney Transplant|1|||
161695377|NCT00441545|583933707|FG000|Second Intervention|Lack of Efficacy|0|||
161695378|NCT00441545|583933708|FG001|Second Intervention|Lack of Efficacy|1|||
161695379|NCT00441545|583933707|FG000|Second Intervention|Subject exceeded safety criteria|1|||
161695380|NCT00441545|583933708|FG001|Second Intervention|Subject exceeded safety criteria|0|||
161695381|NCT00441545|583933707|FG000|Second Intervention|Subject moved|0|||
161695382|NCT00441545|583933708|FG001|Second Intervention|Subject moved|1|||
161695383|NCT00411554|583933711|FG000|Overall Study|Adverse Event|2|||
161695384|NCT00411554|583933712|FG001|Overall Study|Adverse Event|4|||
161695385|NCT00411554|583933711|FG000|Overall Study|Lack of Efficacy|2|||
161695386|NCT00411554|583933712|FG001|Overall Study|Lack of Efficacy|5|||
161695387|NCT00411554|583933711|FG000|Overall Study|Withdrawal by Subject|3|||
161695388|NCT00411554|583933712|FG001|Overall Study|Withdrawal by Subject|0|||
161695389|NCT00411554|583933711|FG000|Overall Study|Patient Moved|1|||
161695390|NCT00411554|583933712|FG001|Overall Study|Patient Moved|0|||
161695391|NCT00939692|583933715|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
161695392|NCT00939692|583933716|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
161695393|NCT00939692|583933715|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
161695394|NCT00939692|583933716|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
161695395|NCT00143455|583933717|FG000|Cohort 1|Adverse Event|8|||
161695396|NCT00143455|583933718|FG001|Cohort 1|Adverse Event|4|||
161695397|NCT00143455|583933719|FG002|Cohort 1|Adverse Event|0|||
161695398|NCT00143455|583933720|FG003|Cohort 1|Adverse Event|0|||
161695399|NCT00143455|583933717|FG000|Cohort 1|Death|5|||
161695400|NCT00143455|583933718|FG001|Cohort 1|Death|2|||
161695401|NCT00143455|583933719|FG002|Cohort 1|Death|0|||
161695402|NCT00143455|583933720|FG003|Cohort 1|Death|0|||
161695403|NCT00143455|583933717|FG000|Cohort 1|Progressive Disease|0|||
161695404|NCT00143455|583933718|FG001|Cohort 1|Progressive Disease|6|||
161695405|NCT00143455|583933719|FG002|Cohort 1|Progressive Disease|0|||
161695406|NCT00143455|583933720|FG003|Cohort 1|Progressive Disease|0|||
161695407|NCT00143455|583933717|FG000|Cohort 1|Withdrawal by Subject|1|||
161695408|NCT00143455|583933718|FG001|Cohort 1|Withdrawal by Subject|4|||
161695409|NCT00143455|583933719|FG002|Cohort 1|Withdrawal by Subject|0|||
161695410|NCT00143455|583933720|FG003|Cohort 1|Withdrawal by Subject|0|||
161695411|NCT00143455|583933717|FG000|Cohort 1|Randomized But Not Treated|0|||
161695412|NCT00143455|583933718|FG001|Cohort 1|Randomized But Not Treated|1|||
161695413|NCT00143455|583933719|FG002|Cohort 1|Randomized But Not Treated|0|||
161695414|NCT00143455|583933720|FG003|Cohort 1|Randomized But Not Treated|0|||
161695415|NCT00143455|583933717|FG000|Cohort 2|Adverse Event|0|||
161695416|NCT00143455|583933718|FG001|Cohort 2|Adverse Event|0|||
161695417|NCT00143455|583933719|FG002|Cohort 2|Adverse Event|42|||
161695418|NCT00143455|583933720|FG003|Cohort 2|Adverse Event|30|||
161695419|NCT00143455|583933717|FG000|Cohort 2|No Longer Required Study Treatment|0|||
161695420|NCT00143455|583933718|FG001|Cohort 2|No Longer Required Study Treatment|0|||
161695421|NCT00143455|583933719|FG002|Cohort 2|No Longer Required Study Treatment|1|||
161695422|NCT00143455|583933720|FG003|Cohort 2|No Longer Required Study Treatment|0|||
161695423|NCT00143455|583933717|FG000|Cohort 2|Protocol Violation|0|||
161695424|NCT00143455|583933718|FG001|Cohort 2|Protocol Violation|0|||
161695425|NCT00143455|583933719|FG002|Cohort 2|Protocol Violation|1|||
161695426|NCT00143455|583933720|FG003|Cohort 2|Protocol Violation|1|||
161695427|NCT00143455|583933717|FG000|Cohort 2|Lost to Follow-up|0|||
161695428|NCT00143455|583933718|FG001|Cohort 2|Lost to Follow-up|0|||
161695429|NCT00143455|583933719|FG002|Cohort 2|Lost to Follow-up|1|||
161695430|NCT00143455|583933720|FG003|Cohort 2|Lost to Follow-up|4|||
161695431|NCT00143455|583933717|FG000|Cohort 2|Death|0|||
161695432|NCT00143455|583933718|FG001|Cohort 2|Death|0|||
161695433|NCT00143455|583933719|FG002|Cohort 2|Death|20|||
161695434|NCT00143455|583933720|FG003|Cohort 2|Death|12|||
161695435|NCT00143455|583933717|FG000|Cohort 2|Progressive Disease|0|||
161695436|NCT00143455|583933718|FG001|Cohort 2|Progressive Disease|0|||
161695437|NCT00143455|583933719|FG002|Cohort 2|Progressive Disease|20|||
161695438|NCT00143455|583933720|FG003|Cohort 2|Progressive Disease|27|||
161695439|NCT00143455|583933717|FG000|Cohort 2|Withdrawal by Subject|0|||
161695440|NCT00143455|583933718|FG001|Cohort 2|Withdrawal by Subject|0|||
161695441|NCT00143455|583933719|FG002|Cohort 2|Withdrawal by Subject|13|||
161695442|NCT00143455|583933720|FG003|Cohort 2|Withdrawal by Subject|12|||
161695443|NCT00143455|583933717|FG000|Cohort 2|Other|0|||
161836541|NCT02858492|584444936|FG001|Overall Study|Adverse Event|0|||
161695444|NCT00143455|583933718|FG001|Cohort 2|Other|0|||
161695445|NCT00143455|583933719|FG002|Cohort 2|Other|7|||
161695446|NCT00143455|583933720|FG003|Cohort 2|Other|6|||
161695447|NCT00143455|583933717|FG000|Cohort 2|Randomized But Not Treated|0|||
161695448|NCT00143455|583933718|FG001|Cohort 2|Randomized But Not Treated|0|||
161695449|NCT00143455|583933719|FG002|Cohort 2|Randomized But Not Treated|1|||
161695450|NCT00143455|583933720|FG003|Cohort 2|Randomized But Not Treated|1|||
161695451|NCT00720109|583933735|FG000|Induction Period|Did not meet eligibility criteria|3|||
161695452|NCT00720109|583933736|FG001|Induction Period|Did not meet eligibility criteria|0|||
161695453|NCT00720109|583933737|FG002|Induction Period|Did not meet eligibility criteria|0|||
161695454|NCT00720109|583933735|FG000|Induction Period|Bone Marrow Transplant|2|||
161695455|NCT00720109|583933736|FG001|Induction Period|Bone Marrow Transplant|0|||
161695456|NCT00720109|583933737|FG002|Induction Period|Bone Marrow Transplant|0|||
161695457|NCT00720109|583933735|FG000|Induction Period|Physician Decision|1|||
161695458|NCT00720109|583933736|FG001|Induction Period|Physician Decision|0|||
161695459|NCT00720109|583933737|FG002|Induction Period|Physician Decision|0|||
161695460|NCT00720109|583933735|FG000|Risk Stratification Period|Adverse Event|0|||
161836542|NCT02858492|584444937|FG002|Overall Study|Adverse Event|0|||
161836543|NCT02858492|584444938|FG003|Overall Study|Adverse Event|3|||
161695461|NCT00720109|583933736|FG001|Risk Stratification Period|Adverse Event|1|||
161695462|NCT00720109|583933737|FG002|Risk Stratification Period|Adverse Event|0|||
161695463|NCT00720109|583933735|FG000|Risk Stratification Period|Physician Decision|0|||
161695464|NCT00720109|583933736|FG001|Risk Stratification Period|Physician Decision|2|||
161695465|NCT00720109|583933737|FG002|Risk Stratification Period|Physician Decision|1|||
161695466|NCT00720109|583933735|FG000|Risk Stratification Period|Bone marrow transplant|0|||
161695467|NCT00720109|583933736|FG001|Risk Stratification Period|Bone marrow transplant|9|||
161695468|NCT00720109|583933737|FG002|Risk Stratification Period|Bone marrow transplant|7|||
161695469|NCT00720109|583933735|FG000|Risk Stratification Period|Disease progression or relapse|0|||
161836544|NCT02858492|584444935|FG000|Overall Study|Lack of Efficacy|0|||
161695470|NCT00720109|583933736|FG001|Risk Stratification Period|Disease progression or relapse|2|||
161695471|NCT00720109|583933737|FG002|Risk Stratification Period|Disease progression or relapse|0|||
161695472|NCT00720109|583933735|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
161695473|NCT00720109|583933736|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
161695474|NCT00720109|583933737|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
161695475|NCT02665286|583933738|FG000|Overall Study|Lost to Follow-up|3|||
161695476|NCT02665286|583933739|FG001|Overall Study|Lost to Follow-up|2|||
161695477|NCT02665286|583933740|FG002|Overall Study|Lost to Follow-up|1|||
161695478|NCT04153188|583933754|FG000|Overall Study|Lost to Follow-up|1|||
161695479|NCT04153188|583933755|FG001|Overall Study|Lost to Follow-up|1|||
161695480|NCT04153188|583933754|FG000|Overall Study|Withdrawal by Subject|2|||
161695481|NCT04153188|583933755|FG001|Overall Study|Withdrawal by Subject|0|||
161695482|NCT04153188|583933754|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
161695483|NCT04153188|583933755|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
161695484|NCT01489527|583933756|FG000|Overall Study|Pregnancy|9|||
161695485|NCT01489527|583933757|FG001|Overall Study|Pregnancy|14|||
161695486|NCT01489527|583933756|FG000|Overall Study|Participant moved|6|||
161695487|NCT01489527|583933757|FG001|Overall Study|Participant moved|7|||
161695488|NCT01489527|583933756|FG000|Overall Study|Withdrawal by Subject|0|||
161695489|NCT01489527|583933757|FG001|Overall Study|Withdrawal by Subject|4|||
161695490|NCT01489527|583933756|FG000|Overall Study|Lost to Follow-up|5|||
161695491|NCT01489527|583933757|FG001|Overall Study|Lost to Follow-up|1|||
161695492|NCT01489527|583933756|FG000|Overall Study|Procedures|1|||
161695493|NCT01489527|583933757|FG001|Overall Study|Procedures|0|||
161695494|NCT01489527|583933756|FG000|Overall Study|Not compliant|1|||
161695495|NCT01489527|583933757|FG001|Overall Study|Not compliant|0|||
161695496|NCT04899232|583933758|FG000|Screening Period|Physician Decision|1|||
161695497|NCT04899232|583933759|FG001|Screening Period|Physician Decision|0|||
161695498|NCT04899232|583933760|FG002|Screening Period|Physician Decision|0|||
161695499|NCT04899232|583933758|FG000|Screening Period|Withdrawal by Subject|1|||
161695500|NCT04899232|583933759|FG001|Screening Period|Withdrawal by Subject|0|||
161695501|NCT04899232|583933760|FG002|Screening Period|Withdrawal by Subject|0|||
161695502|NCT04899232|583933758|FG000|Screening Period|Participant discharged before receiving intervention|3|||
161695503|NCT04899232|583933759|FG001|Screening Period|Participant discharged before receiving intervention|0|||
161695504|NCT04899232|583933760|FG002|Screening Period|Participant discharged before receiving intervention|0|||
161695505|NCT00700271|583933761|FG000|Overall Study|Adverse Event|4|||
161695506|NCT00700271|583933762|FG001|Overall Study|Adverse Event|6|||
161695507|NCT00700271|583933761|FG000|Overall Study|Protocol Violation|1|||
161695508|NCT00700271|583933762|FG001|Overall Study|Protocol Violation|0|||
161695509|NCT00700271|583933761|FG000|Overall Study|Administrative Reasons|1|||
161695510|NCT00700271|583933762|FG001|Overall Study|Administrative Reasons|0|||
161695511|NCT00700271|583933761|FG000|Overall Study|Withdrawal by Subject|6|||
161695512|NCT00700271|583933762|FG001|Overall Study|Withdrawal by Subject|4|||
161695513|NCT00700271|583933761|FG000|Overall Study|Lost to Follow-up|2|||
161695514|NCT00700271|583933762|FG001|Overall Study|Lost to Follow-up|2|||
161695515|NCT02926950|583933763|FG000|Overall Study|Adverse Event|4|||
161695516|NCT02926950|583933764|FG001|Overall Study|Adverse Event|6|||
161695517|NCT02926950|583933763|FG000|Overall Study|At the participant's own request|21|||
161695518|NCT02926950|583933764|FG001|Overall Study|At the participant's own request|25|||
161695519|NCT02926950|583933763|FG000|Overall Study|Reason not Specified|17|||
161695520|NCT02926950|583933764|FG001|Overall Study|Reason not Specified|9|||
161695521|NCT02926950|583933763|FG000|Overall Study|Lost to Follow-up|7|||
161695522|NCT02926950|583933764|FG001|Overall Study|Lost to Follow-up|8|||
161695523|NCT02553460|583933765|FG000|Overall Study|Death|3|||
161695524|NCT02553460|583933765|FG000|Overall Study|Withdrawal by Subject|1|||
161695525|NCT02553460|583933765|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
161695526|NCT02553460|583933765|FG000|Overall Study|Relapse or Transplant|14|||
161695527|NCT02553460|583933765|FG000|Overall Study|No response to treatment|2|||
161695528|NCT02553460|583933765|FG000|Overall Study|CAR T cells|2|||
161695529|NCT03505021|583933766|FG000|Overall Study|Protocol Violation|1|||
161695530|NCT03505021|583933767|FG001|Overall Study|Protocol Violation|0|||
161695531|NCT03505021|583933766|FG000|Overall Study|Death|9|||
161695532|NCT03505021|583933767|FG001|Overall Study|Death|8|||
161695533|NCT03505021|583933766|FG000|Overall Study|Consent withdrawn by subject|6|||
161695534|NCT03505021|583933767|FG001|Overall Study|Consent withdrawn by subject|1|||
161695535|NCT03505021|583933766|FG000|Overall Study|Lost to Follow-up|5|||
161695536|NCT03505021|583933767|FG001|Overall Study|Lost to Follow-up|3|||
161695537|NCT03505021|583933766|FG000|Overall Study|Adverse Event|26|||
161695538|NCT03505021|583933767|FG001|Overall Study|Adverse Event|9|||
161695539|NCT03505021|583933766|FG000|Overall Study|Disease progression|33|||
161695540|NCT03505021|583933767|FG001|Overall Study|Disease progression|17|||
161695541|NCT03505021|583933766|FG000|Overall Study|Other|11|||
161695542|NCT03505021|583933767|FG001|Overall Study|Other|5|||
161695543|NCT03505021|583933766|FG000|Overall Study|Personal reason|21|||
161695544|NCT03505021|583933767|FG001|Overall Study|Personal reason|12|||
161695545|NCT03087955|583935853|FG000|Overall Study|Death|4|||
161695546|NCT03087955|583935854|FG001|Overall Study|Death|0|||
161695547|NCT03087955|583935853|FG000|Overall Study|Lack of Efficacy|2|||
161695548|NCT03087955|583935854|FG001|Overall Study|Lack of Efficacy|0|||
161695549|NCT03087955|583935853|FG000|Overall Study|Lost to Follow-up|1|||
161695550|NCT03087955|583935854|FG001|Overall Study|Lost to Follow-up|0|||
161695551|NCT03266016|583935861|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
161695552|NCT03266016|583935862|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
161695553|NCT03266016|583935863|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
161695554|NCT03266016|583935864|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
161695555|NCT03266016|583935861|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
161695556|NCT03266016|583935862|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
161695557|NCT03266016|583935863|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
161695558|NCT03266016|583935864|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
161695559|NCT05280756|583935865|FG000|Overall Study|Lost to Follow-up|1|||
161695560|NCT05280756|583935866|FG001|Overall Study|Lost to Follow-up|1|||
161695561|NCT00768898|583935867|FG000|Overall Study|Unrelated injury|1|||
161695562|NCT00768898|583935867|FG000|Overall Study|Headache|1|||
161695563|NCT01777763|583935880|FG000|Overall Study|Adverse Event|2|||
161695564|NCT01777763|583935881|FG001|Overall Study|Adverse Event|32|||
161695565|NCT01777763|583935880|FG000|Overall Study|Protocol Violation|1|||
161695566|NCT01777763|583935881|FG001|Overall Study|Protocol Violation|7|||
161695567|NCT01777763|583935880|FG000|Overall Study|Withdrawal by Subject|0|||
161695568|NCT01777763|583935881|FG001|Overall Study|Withdrawal by Subject|2|||
161695569|NCT01777763|583935880|FG000|Overall Study|Treatment Failure|1|||
161695570|NCT01777763|583935881|FG001|Overall Study|Treatment Failure|6|||
161695571|NCT02968810|583935885|FG000|Overall Study|Lost to Follow-up|1|||
161695572|NCT02968810|583935886|FG001|Overall Study|Lost to Follow-up|0|||
161695573|NCT02968810|583935885|FG000|Overall Study|Physician Decision|1|||
161695574|NCT02968810|583935886|FG001|Overall Study|Physician Decision|0|||
161695575|NCT02968810|583935885|FG000|Overall Study|Withdrawal by Subject|1|||
161695576|NCT02968810|583935886|FG001|Overall Study|Withdrawal by Subject|3|||
161695577|NCT02968810|583935885|FG000|Overall Study|Disease Progression|0|||
161695578|NCT02968810|583935886|FG001|Overall Study|Disease Progression|1|||
161695579|NCT02787850|583935888|FG000|Overall Study|Withdrawal by Subject|0|||
161695580|NCT02787850|583935889|FG001|Overall Study|Withdrawal by Subject|1|||
161695581|NCT03718143|583935890|FG000|Overall Study|Death|1|||
161695582|NCT03718143|583935891|FG001|Overall Study|Death|0|||
161695583|NCT03718143|583935892|FG002|Overall Study|Death|0|||
161695584|NCT03718143|583935890|FG000|Overall Study|Progression of Disease|1|||
161695585|NCT03718143|583935891|FG001|Overall Study|Progression of Disease|0|||
161695586|NCT03718143|583935892|FG002|Overall Study|Progression of Disease|0|||
161695587|NCT03718143|583935890|FG000|Overall Study|Withdrawal of Informed Consent|1|||
161695588|NCT03718143|583935891|FG001|Overall Study|Withdrawal of Informed Consent|2|||
161695589|NCT03718143|583935892|FG002|Overall Study|Withdrawal of Informed Consent|1|||
161695590|NCT03905863|583935893|FG000|Overall Study|Adverse Event|2|||
161695591|NCT03905863|583935894|FG001|Overall Study|Adverse Event|4|||
161956665|NCT00372619|584889743|FG002|Overall Study|Inevaluable|0|||
161695592|NCT03905863|583935893|FG000|Overall Study|Withdrawal by Subject|2|||
161695593|NCT03905863|583935894|FG001|Overall Study|Withdrawal by Subject|2|||
161695594|NCT03905863|583935893|FG000|Overall Study|Physician Decision|0|||
161695595|NCT03905863|583935894|FG001|Overall Study|Physician Decision|3|||
161695596|NCT03905863|583935893|FG000|Overall Study|Lost to Follow-up|1|||
161695597|NCT03905863|583935894|FG001|Overall Study|Lost to Follow-up|0|||
161695598|NCT03905863|583935893|FG000|Overall Study|Protocol Violation|0|||
161695599|NCT03905863|583935894|FG001|Overall Study|Protocol Violation|2|||
161695600|NCT03905863|583935893|FG000|Overall Study|Death|0|||
161695601|NCT03905863|583935894|FG001|Overall Study|Death|1|||
161695602|NCT02944448|583935898|FG000|Overall Study|Adverse Event|37|||
161695603|NCT02944448|583935899|FG001|Overall Study|Adverse Event|6|||
161695604|NCT02944448|583935898|FG000|Overall Study|Lack of Efficacy|8|||
161695605|NCT02944448|583935899|FG001|Overall Study|Lack of Efficacy|5|||
161695606|NCT02944448|583935898|FG000|Overall Study|Lost to Follow-up|3|||
161695607|NCT02944448|583935899|FG001|Overall Study|Lost to Follow-up|1|||
161695608|NCT02944448|583935898|FG000|Overall Study|Protocol Violation|25|||
161695609|NCT02944448|583935899|FG001|Overall Study|Protocol Violation|7|||
161695610|NCT02944448|583935898|FG000|Overall Study|Withdrawal by Subject|14|||
161695611|NCT02944448|583935899|FG001|Overall Study|Withdrawal by Subject|4|||
161695612|NCT02944448|583935898|FG000|Overall Study|Sponsor did not supply drug in time|0|||
161695613|NCT02944448|583935899|FG001|Overall Study|Sponsor did not supply drug in time|1|||
161956666|NCT00372619|584889744|FG003|Overall Study|Inevaluable|0|||
161956667|NCT00372619|584889745|FG004|Overall Study|Inevaluable|0|||
161695614|NCT02944448|583935898|FG000|Overall Study|Noncompliant with dosing|1|||
161695615|NCT02944448|583935899|FG001|Overall Study|Noncompliant with dosing|0|||
161695616|NCT02944448|583935898|FG000|Overall Study|Abnormal laboratory values|1|||
161695617|NCT02944448|583935899|FG001|Overall Study|Abnormal laboratory values|0|||
161695618|NCT01191697|583935902|FG000|Overall Study|Death|1|||
161695619|NCT01191697|583935902|FG000|Overall Study|Physician Decision|2|||
161695620|NCT01191697|583935902|FG000|Overall Study|Pursue chemoradiation|2|||
161956668|NCT00372619|584889746|FG005|Overall Study|Inevaluable|1|||
161956669|NCT00372619|584889747|FG006|Overall Study|Inevaluable|0|||
161956670|NCT01071954|584889748|FG000|Overall Study|Noncompliance|4|||
161956671|NCT01071954|584889748|FG000|Overall Study|Adverse Event|1|||
161956672|NCT01071954|584889748|FG000|Overall Study|Withdrawal by Subject|11|||
161956673|NCT01071954|584889748|FG000|Overall Study|Requirement for Alternative Therapy|5|||
161956674|NCT01071954|584889748|FG000|Overall Study|Administrative Decision|5|||
161956675|NCT01071954|584889748|FG000|Overall Study|Protocol Specified Criteria|1|||
161956676|NCT01434654|584889749|FG000|Overall Study|Withdrawal by Subject|1|||
161956677|NCT01434654|584889750|FG001|Overall Study|Withdrawal by Subject|0|||
161956678|NCT01434654|584889749|FG000|Overall Study|Lost to Follow-up|1|||
161956679|NCT01434654|584889750|FG001|Overall Study|Lost to Follow-up|0|||
161836545|NCT02858492|584444936|FG001|Overall Study|Lack of Efficacy|0|||
161836546|NCT02858492|584444937|FG002|Overall Study|Lack of Efficacy|0|||
161956680|NCT03782064|584889751|FG000|Overall Study|Lack of Efficacy|2|||
161956681|NCT03782064|584889751|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
161695621|NCT01191697|583935902|FG000|Overall Study|Break from chemotherapy|2|||
161695622|NCT01191697|583935902|FG000|Overall Study|Withdrawal by Subject|1|||
161695623|NCT01191697|583935902|FG000|Overall Study|Surveillance|1|||
161695624|NCT01191697|583935902|FG000|Overall Study|Adverse Event|2|||
161695625|NCT01191697|583935902|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
161695626|NCT01191697|583935902|FG000|Overall Study|Not completed but analyzed|25|||
161695627|NCT01396005|583935903|FG000|Overall Study|Withdrawal by Subject|0|||
161695628|NCT01396005|583935904|FG001|Overall Study|Withdrawal by Subject|1|||
161695629|NCT01396005|583935903|FG000|Overall Study|Non-compliance with protocol|0|||
161695630|NCT01396005|583935904|FG001|Overall Study|Non-compliance with protocol|1|||
161695631|NCT02397473|583935907|FG000|Treatment Phase|Adverse Event|1|||
161695632|NCT02397473|583935908|FG001|Treatment Phase|Adverse Event|2|||
161695633|NCT02397473|583935907|FG000|Treatment Phase|Lack of Efficacy|8|||
161695634|NCT02397473|583935908|FG001|Treatment Phase|Lack of Efficacy|1|||
161695635|NCT02397473|583935907|FG000|Treatment Phase|Lost to Follow-up|1|||
161695636|NCT02397473|583935908|FG001|Treatment Phase|Lost to Follow-up|0|||
161695637|NCT02397473|583935907|FG000|Treatment Phase|Withdrawal by Subject|2|||
161695638|NCT02397473|583935908|FG001|Treatment Phase|Withdrawal by Subject|1|||
161695639|NCT02397473|583935907|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
161695640|NCT02397473|583935908|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
161695641|NCT02397473|583935907|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
161695642|NCT02397473|583935908|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
161695643|NCT02397473|583935907|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
161695644|NCT02397473|583935908|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
161695645|NCT02397473|583935907|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
161695646|NCT02397473|583935908|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
161695647|NCT02397473|583935907|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
161695648|NCT02397473|583935908|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
161695649|NCT01467492|583935909|FG000|Overall Study|Withdrawal by Subject|6|||
161695650|NCT01467492|583935910|FG001|Overall Study|Withdrawal by Subject|4|||
161695651|NCT01467492|583935909|FG000|Overall Study|Study Terminated by Sponsor|6|||
161695652|NCT01467492|583935910|FG001|Overall Study|Study Terminated by Sponsor|4|||
161695653|NCT01467492|583935909|FG000|Overall Study|Adverse Event|4|||
161695654|NCT01467492|583935910|FG001|Overall Study|Adverse Event|3|||
161695655|NCT01467492|583935909|FG000|Overall Study|Lost to Follow-up|3|||
161695656|NCT01467492|583935910|FG001|Overall Study|Lost to Follow-up|2|||
161695657|NCT01467492|583935909|FG000|Overall Study|Undefined|2|||
161695658|NCT01467492|583935910|FG001|Overall Study|Undefined|0|||
161695659|NCT01467492|583935909|FG000|Overall Study|Enrolled But Not Treated|1|||
161695660|NCT01467492|583935910|FG001|Overall Study|Enrolled But Not Treated|0|||
161695661|NCT00491179|583935911|FG000|Overall Study|Adverse Event|5|||
161695662|NCT00491179|583935912|FG001|Overall Study|Adverse Event|1|||
161695663|NCT00491179|583935911|FG000|Overall Study|Withdrawal by Subject|2|||
161695664|NCT00491179|583935912|FG001|Overall Study|Withdrawal by Subject|1|||
161695665|NCT02009878|583935914|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
161695666|NCT02009878|583935915|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
161695667|NCT02009878|583935916|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
161695668|NCT01790048|583935917|FG000|Overall Study|Incorrect Age|9|||
161695669|NCT01790048|583935918|FG001|Overall Study|Incorrect Age|14|||
161695670|NCT01790048|583935917|FG000|Overall Study|data entry error|0|||
161695671|NCT01790048|583935918|FG001|Overall Study|data entry error|1|||
161695672|NCT01790048|583935917|FG000|Overall Study|Other|0|||
161695673|NCT01790048|583935918|FG001|Overall Study|Other|2|||
161695674|NCT01790048|583935917|FG000|Overall Study|SAM at Enrollment|2|||
161695675|NCT01790048|583935918|FG001|Overall Study|SAM at Enrollment|0|||
161695676|NCT01790048|583935917|FG000|Overall Study|Measurement error|1|||
161695677|NCT01790048|583935918|FG001|Overall Study|Measurement error|0|||
161695678|NCT01491178|583935919|FG000|Overall Study|Adverse Event|1016|||
161695679|NCT01491178|583935919|FG000|Overall Study|Improvement of NVAF|210|||
161695680|NCT01491178|583935919|FG000|Overall Study|To conduct invasive treatment|59|||
161695681|NCT01491178|583935919|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
161695682|NCT01491178|583935919|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
161695683|NCT01491178|583935919|FG000|Overall Study|To take a contraindication|20|||
161695684|NCT01491178|583935919|FG000|Overall Study|Other than specified above|657|||
161695685|NCT01604512|583935922|FG000|Overall Study|Withdrawal by Subject|3|||
161695686|NCT01604512|583935922|FG000|Overall Study|Not treated|4|||
161695687|NCT01415752|583935925|FG000|Induction (Step 1)|Ineligible|4|||
161695688|NCT01415752|583935926|FG001|Induction (Step 1)|Ineligible|3|||
161695689|NCT01415752|583935927|FG002|Induction (Step 1)|Ineligible|4|||
161695690|NCT01415752|583935928|FG003|Induction (Step 1)|Ineligible|4|||
161695691|NCT01415752|583935925|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
161695692|NCT01415752|583935926|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
161695693|NCT01415752|583935927|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
161695694|NCT01415752|583935928|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
161695695|NCT01415752|583935925|FG000|Maintenance (Step 2)|Adverse Event|3|||
161695696|NCT01415752|583935926|FG001|Maintenance (Step 2)|Adverse Event|4|||
161695697|NCT01415752|583935927|FG002|Maintenance (Step 2)|Adverse Event|9|||
161695698|NCT01415752|583935928|FG003|Maintenance (Step 2)|Adverse Event|6|||
161695699|NCT01415752|583935925|FG000|Maintenance (Step 2)|Death|1|||
161695700|NCT01415752|583935926|FG001|Maintenance (Step 2)|Death|1|||
161695701|NCT01415752|583935927|FG002|Maintenance (Step 2)|Death|2|||
161695702|NCT01415752|583935928|FG003|Maintenance (Step 2)|Death|0|||
161695703|NCT01415752|583935925|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
161695704|NCT01415752|583935926|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
161695705|NCT01415752|583935927|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
161695706|NCT01415752|583935928|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
161695707|NCT01415752|583935925|FG000|Maintenance (Step 2)|Alternative therapy|0|||
161695708|NCT01415752|583935926|FG001|Maintenance (Step 2)|Alternative therapy|1|||
161695709|NCT01415752|583935927|FG002|Maintenance (Step 2)|Alternative therapy|0|||
161695710|NCT01415752|583935928|FG003|Maintenance (Step 2)|Alternative therapy|0|||
161695711|NCT01415752|583935925|FG000|Maintenance (Step 2)|Other reasons|3|||
161695712|NCT01415752|583935926|FG001|Maintenance (Step 2)|Other reasons|6|||
161695713|NCT01415752|583935927|FG002|Maintenance (Step 2)|Other reasons|4|||
161695714|NCT01415752|583935928|FG003|Maintenance (Step 2)|Other reasons|6|||
161695715|NCT01415752|583935925|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
161695716|NCT01415752|583935926|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
161695717|NCT01415752|583935927|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
161695718|NCT01415752|583935928|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
161695719|NCT01415752|583935925|FG000|Maintenance (Step 2)|ineligible|1|||
161695720|NCT01415752|583935926|FG001|Maintenance (Step 2)|ineligible|1|||
161695721|NCT01415752|583935927|FG002|Maintenance (Step 2)|ineligible|1|||
161695722|NCT01415752|583935928|FG003|Maintenance (Step 2)|ineligible|0|||
161695723|NCT01415752|583935925|FG000|Maintenance (Step 2)|Missing|4|||
161695724|NCT01415752|583935926|FG001|Maintenance (Step 2)|Missing|1|||
161695725|NCT01415752|583935927|FG002|Maintenance (Step 2)|Missing|4|||
161695726|NCT01415752|583935928|FG003|Maintenance (Step 2)|Missing|3|||
161695727|NCT03083886|583935929|FG000|Overall Study|Withdrawal by Subject|51|||
161695728|NCT03083886|583935930|FG001|Overall Study|Withdrawal by Subject|73|||
161695729|NCT03083886|583935931|FG002|Overall Study|Withdrawal by Subject|104|||
161695730|NCT03083886|583935929|FG000|Overall Study|Missing Baseline data|43|||
161695731|NCT03083886|583935930|FG001|Overall Study|Missing Baseline data|42|||
161695732|NCT03083886|583935931|FG002|Overall Study|Missing Baseline data|31|||
161695733|NCT03083886|583935929|FG000|Overall Study|Investigator terminated|1|||
161695734|NCT03083886|583935930|FG001|Overall Study|Investigator terminated|6|||
161695735|NCT03083886|583935931|FG002|Overall Study|Investigator terminated|3|||
161695736|NCT01391507|583935932|FG000|Overall Study|Death|0|||
161695737|NCT01391507|583935933|FG001|Overall Study|Death|0|||
161695738|NCT01391507|583935934|FG002|Overall Study|Death|0|||
161695739|NCT01391507|583935935|FG003|Overall Study|Death|1|||
161695740|NCT01391507|583935932|FG000|Overall Study|Adverse Event|1|||
161695741|NCT01391507|583935933|FG001|Overall Study|Adverse Event|1|||
161695742|NCT01391507|583935934|FG002|Overall Study|Adverse Event|2|||
161695743|NCT01391507|583935935|FG003|Overall Study|Adverse Event|2|||
161695744|NCT01391507|583935932|FG000|Overall Study|Withdrawal by Subject|1|||
161695745|NCT01391507|583935933|FG001|Overall Study|Withdrawal by Subject|2|||
161695746|NCT01391507|583935934|FG002|Overall Study|Withdrawal by Subject|1|||
161695747|NCT01391507|583935935|FG003|Overall Study|Withdrawal by Subject|1|||
161695748|NCT01391507|583935932|FG000|Overall Study|Lack of Efficacy|0|||
161695749|NCT01391507|583935933|FG001|Overall Study|Lack of Efficacy|0|||
161695750|NCT01391507|583935934|FG002|Overall Study|Lack of Efficacy|0|||
161695751|NCT01391507|583935935|FG003|Overall Study|Lack of Efficacy|1|||
161695752|NCT01391507|583935932|FG000|Overall Study|Protocol Violation|2|||
161695753|NCT01391507|583935933|FG001|Overall Study|Protocol Violation|1|||
161695754|NCT01391507|583935934|FG002|Overall Study|Protocol Violation|1|||
161695755|NCT01391507|583935935|FG003|Overall Study|Protocol Violation|2|||
161695756|NCT01453855|583935936|FG000|Overall Study|Adverse Event|3|||
161695757|NCT01453855|583935937|FG001|Overall Study|Adverse Event|4|||
161695758|NCT01453855|583935936|FG000|Overall Study|Lost to Follow-up|2|||
161695759|NCT01453855|583935937|FG001|Overall Study|Lost to Follow-up|1|||
161695760|NCT01453855|583935936|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
161836547|NCT02858492|584444938|FG003|Overall Study|Lack of Efficacy|1|||
161695761|NCT01453855|583935937|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
161695762|NCT01453855|583935936|FG000|Overall Study|Noncompliance|1|||
161695763|NCT01453855|583935937|FG001|Overall Study|Noncompliance|0|||
161695764|NCT01453855|583935936|FG000|Overall Study|Inadequate Control of IOP|1|||
161695765|NCT01453855|583935937|FG001|Overall Study|Inadequate Control of IOP|5|||
161695766|NCT01453855|583935936|FG000|Overall Study|Other|0|||
161695767|NCT01453855|583935937|FG001|Overall Study|Other|1|||
161695768|NCT03529773|583935940|FG000|Overall Study|Adverse Event|0|||
161695769|NCT03529773|583935941|FG001|Overall Study|Adverse Event|0|||
161695770|NCT03529773|583935942|FG002|Overall Study|Adverse Event|0|||
161695771|NCT03529773|583935943|FG003|Overall Study|Adverse Event|0|||
161695772|NCT03529773|583935944|FG004|Overall Study|Adverse Event|0|||
161695773|NCT03529773|583935945|FG005|Overall Study|Adverse Event|0|||
161695774|NCT03529773|583935946|FG006|Overall Study|Adverse Event|0|||
161695775|NCT03529773|583935947|FG007|Overall Study|Adverse Event|0|||
161695776|NCT03529773|583935948|FG008|Overall Study|Adverse Event|0|||
161695777|NCT03529773|583935949|FG009|Overall Study|Adverse Event|0|||
161695778|NCT03529773|583935950|FG010|Overall Study|Adverse Event|0|||
161695779|NCT03529773|583935951|FG011|Overall Study|Adverse Event|0|||
161695780|NCT03529773|583935952|FG012|Overall Study|Adverse Event|0|||
161695781|NCT03529773|583935953|FG013|Overall Study|Adverse Event|0|||
161695782|NCT03529773|583935954|FG014|Overall Study|Adverse Event|0|||
161695783|NCT03529773|583935955|FG015|Overall Study|Adverse Event|0|||
161695784|NCT03529773|583935956|FG016|Overall Study|Adverse Event|0|||
161695785|NCT03529773|583935957|FG017|Overall Study|Adverse Event|0|||
161695786|NCT03529773|583935958|FG018|Overall Study|Adverse Event|0|||
161695787|NCT03529773|583935959|FG019|Overall Study|Adverse Event|0|||
161695788|NCT03529773|583935960|FG020|Overall Study|Adverse Event|0|||
161695789|NCT03529773|583935961|FG021|Overall Study|Adverse Event|0|||
161695790|NCT03529773|583935962|FG022|Overall Study|Adverse Event|0|||
161695791|NCT03529773|583935963|FG023|Overall Study|Adverse Event|0|||
161695792|NCT03529773|583935964|FG024|Overall Study|Adverse Event|0|||
161695793|NCT03529773|583935965|FG025|Overall Study|Adverse Event|0|||
161695794|NCT03529773|583935966|FG026|Overall Study|Adverse Event|0|||
161695795|NCT03529773|583935967|FG027|Overall Study|Adverse Event|0|||
161695796|NCT03529773|583935968|FG028|Overall Study|Adverse Event|0|||
161695797|NCT03529773|583935969|FG029|Overall Study|Adverse Event|0|||
161695798|NCT03529773|583935970|FG030|Overall Study|Adverse Event|1|||
161695799|NCT03529773|583935971|FG031|Overall Study|Adverse Event|0|||
161695800|NCT03529773|583935972|FG032|Overall Study|Adverse Event|0|||
161695801|NCT03529773|583935973|FG033|Overall Study|Adverse Event|0|||
161695802|NCT03529773|583935974|FG034|Overall Study|Adverse Event|0|||
161695803|NCT03529773|583935975|FG035|Overall Study|Adverse Event|1|||
161695804|NCT03529773|583935976|FG036|Overall Study|Adverse Event|0|||
161695805|NCT03529773|583935977|FG037|Overall Study|Adverse Event|0|||
161695806|NCT03529773|583935978|FG038|Overall Study|Adverse Event|1|||
161695807|NCT03529773|583935979|FG039|Overall Study|Adverse Event|1|||
161695808|NCT03529773|583935940|FG000|Overall Study|Death|0|||
161695809|NCT03529773|583935941|FG001|Overall Study|Death|0|||
161695810|NCT03529773|583935942|FG002|Overall Study|Death|0|||
161695811|NCT03529773|583935943|FG003|Overall Study|Death|0|||
161695812|NCT03529773|583935944|FG004|Overall Study|Death|0|||
161695813|NCT03529773|583935945|FG005|Overall Study|Death|0|||
161695814|NCT03529773|583935946|FG006|Overall Study|Death|0|||
161695815|NCT03529773|583935947|FG007|Overall Study|Death|0|||
161695816|NCT03529773|583935948|FG008|Overall Study|Death|0|||
161695817|NCT03529773|583935949|FG009|Overall Study|Death|0|||
161695818|NCT03529773|583935950|FG010|Overall Study|Death|0|||
161695819|NCT03529773|583935951|FG011|Overall Study|Death|0|||
161695820|NCT03529773|583935952|FG012|Overall Study|Death|1|||
161695821|NCT03529773|583935953|FG013|Overall Study|Death|0|||
161695822|NCT03529773|583935954|FG014|Overall Study|Death|0|||
161695823|NCT03529773|583935955|FG015|Overall Study|Death|0|||
161695824|NCT03529773|583935956|FG016|Overall Study|Death|0|||
161695825|NCT03529773|583935957|FG017|Overall Study|Death|0|||
161695826|NCT03529773|583935958|FG018|Overall Study|Death|0|||
161695827|NCT03529773|583935959|FG019|Overall Study|Death|1|||
161695828|NCT03529773|583935960|FG020|Overall Study|Death|0|||
161695829|NCT03529773|583935961|FG021|Overall Study|Death|0|||
161695830|NCT03529773|583935962|FG022|Overall Study|Death|1|||
161695831|NCT03529773|583935963|FG023|Overall Study|Death|0|||
161695832|NCT03529773|583935964|FG024|Overall Study|Death|0|||
161695833|NCT03529773|583935965|FG025|Overall Study|Death|0|||
161695834|NCT03529773|583935966|FG026|Overall Study|Death|0|||
161695835|NCT03529773|583935967|FG027|Overall Study|Death|0|||
161695836|NCT03529773|583935968|FG028|Overall Study|Death|0|||
161695837|NCT03529773|583935969|FG029|Overall Study|Death|0|||
161836548|NCT02858492|584444935|FG000|Overall Study|Protocol defined stopping criteria|0|||
161836549|NCT02858492|584444936|FG001|Overall Study|Protocol defined stopping criteria|0|||
161836550|NCT02858492|584444937|FG002|Overall Study|Protocol defined stopping criteria|0|||
161695838|NCT03529773|583935970|FG030|Overall Study|Death|0|||
161695839|NCT03529773|583935971|FG031|Overall Study|Death|0|||
161695840|NCT03529773|583935972|FG032|Overall Study|Death|0|||
161695841|NCT03529773|583935973|FG033|Overall Study|Death|1|||
161695842|NCT03529773|583935974|FG034|Overall Study|Death|1|||
161695843|NCT03529773|583935975|FG035|Overall Study|Death|0|||
161695844|NCT03529773|583935976|FG036|Overall Study|Death|1|||
161695845|NCT03529773|583935977|FG037|Overall Study|Death|0|||
161695846|NCT03529773|583935978|FG038|Overall Study|Death|0|||
161695847|NCT03529773|583935979|FG039|Overall Study|Death|0|||
161695848|NCT03529773|583935940|FG000|Overall Study|Lost to Follow-up|0|||
161695849|NCT03529773|583935941|FG001|Overall Study|Lost to Follow-up|0|||
161695850|NCT03529773|583935942|FG002|Overall Study|Lost to Follow-up|1|||
161695851|NCT03529773|583935943|FG003|Overall Study|Lost to Follow-up|0|||
161695852|NCT03529773|583935944|FG004|Overall Study|Lost to Follow-up|1|||
161695853|NCT03529773|583935945|FG005|Overall Study|Lost to Follow-up|1|||
161695854|NCT03529773|583935946|FG006|Overall Study|Lost to Follow-up|0|||
161695855|NCT03529773|583935947|FG007|Overall Study|Lost to Follow-up|0|||
161695856|NCT03529773|583935948|FG008|Overall Study|Lost to Follow-up|0|||
161695857|NCT03529773|583935949|FG009|Overall Study|Lost to Follow-up|0|||
161695858|NCT03529773|583935950|FG010|Overall Study|Lost to Follow-up|0|||
161836551|NCT02858492|584444938|FG003|Overall Study|Protocol defined stopping criteria|1|||
161836552|NCT02944383|584444939|FG000|Overall Study|Lost to Follow-up|0|||
161836553|NCT02944383|584444940|FG001|Overall Study|Lost to Follow-up|0|||
161836554|NCT02944383|584444941|FG002|Overall Study|Lost to Follow-up|1|||
161836555|NCT02944383|584444939|FG000|Overall Study|Withdrawal by Subject|1|||
161695859|NCT03529773|583935951|FG011|Overall Study|Lost to Follow-up|0|||
161695860|NCT03529773|583935952|FG012|Overall Study|Lost to Follow-up|0|||
161695861|NCT03529773|583935953|FG013|Overall Study|Lost to Follow-up|1|||
161695862|NCT03529773|583935954|FG014|Overall Study|Lost to Follow-up|4|||
161695863|NCT03529773|583935955|FG015|Overall Study|Lost to Follow-up|1|||
161695864|NCT03529773|583935956|FG016|Overall Study|Lost to Follow-up|1|||
161695865|NCT03529773|583935957|FG017|Overall Study|Lost to Follow-up|0|||
161695866|NCT03529773|583935958|FG018|Overall Study|Lost to Follow-up|1|||
161695867|NCT03529773|583935959|FG019|Overall Study|Lost to Follow-up|1|||
161695868|NCT03529773|583935960|FG020|Overall Study|Lost to Follow-up|2|||
161695869|NCT03529773|583935961|FG021|Overall Study|Lost to Follow-up|4|||
161695870|NCT03529773|583935962|FG022|Overall Study|Lost to Follow-up|3|||
161695871|NCT03529773|583935963|FG023|Overall Study|Lost to Follow-up|4|||
161695872|NCT03529773|583935964|FG024|Overall Study|Lost to Follow-up|3|||
161695873|NCT03529773|583935965|FG025|Overall Study|Lost to Follow-up|5|||
161695874|NCT03529773|583935966|FG026|Overall Study|Lost to Follow-up|5|||
161695875|NCT03529773|583935967|FG027|Overall Study|Lost to Follow-up|0|||
161695876|NCT03529773|583935968|FG028|Overall Study|Lost to Follow-up|0|||
161695877|NCT03529773|583935969|FG029|Overall Study|Lost to Follow-up|0|||
161695878|NCT03529773|583935970|FG030|Overall Study|Lost to Follow-up|1|||
161695879|NCT03529773|583935971|FG031|Overall Study|Lost to Follow-up|0|||
161695880|NCT03529773|583935972|FG032|Overall Study|Lost to Follow-up|0|||
161695881|NCT03529773|583935973|FG033|Overall Study|Lost to Follow-up|1|||
161695882|NCT03529773|583935974|FG034|Overall Study|Lost to Follow-up|1|||
161695883|NCT03529773|583935975|FG035|Overall Study|Lost to Follow-up|0|||
161695884|NCT03529773|583935976|FG036|Overall Study|Lost to Follow-up|0|||
161695885|NCT03529773|583935977|FG037|Overall Study|Lost to Follow-up|3|||
161695886|NCT03529773|583935978|FG038|Overall Study|Lost to Follow-up|1|||
161695887|NCT03529773|583935979|FG039|Overall Study|Lost to Follow-up|1|||
161695888|NCT03529773|583935940|FG000|Overall Study|No longer meets eligibility criteria|0|||
161695889|NCT03529773|583935941|FG001|Overall Study|No longer meets eligibility criteria|0|||
161695890|NCT03529773|583935942|FG002|Overall Study|No longer meets eligibility criteria|0|||
161695891|NCT03529773|583935943|FG003|Overall Study|No longer meets eligibility criteria|0|||
161695892|NCT03529773|583935944|FG004|Overall Study|No longer meets eligibility criteria|0|||
161695893|NCT03529773|583935945|FG005|Overall Study|No longer meets eligibility criteria|0|||
161695894|NCT03529773|583935946|FG006|Overall Study|No longer meets eligibility criteria|0|||
161695895|NCT03529773|583935947|FG007|Overall Study|No longer meets eligibility criteria|0|||
161695896|NCT03529773|583935948|FG008|Overall Study|No longer meets eligibility criteria|0|||
161695897|NCT03529773|583935949|FG009|Overall Study|No longer meets eligibility criteria|0|||
161695898|NCT03529773|583935950|FG010|Overall Study|No longer meets eligibility criteria|0|||
161695899|NCT03529773|583935951|FG011|Overall Study|No longer meets eligibility criteria|0|||
161695900|NCT03529773|583935952|FG012|Overall Study|No longer meets eligibility criteria|0|||
161695901|NCT03529773|583935953|FG013|Overall Study|No longer meets eligibility criteria|0|||
161695902|NCT03529773|583935954|FG014|Overall Study|No longer meets eligibility criteria|0|||
161695903|NCT03529773|583935955|FG015|Overall Study|No longer meets eligibility criteria|0|||
161695904|NCT03529773|583935956|FG016|Overall Study|No longer meets eligibility criteria|0|||
161695905|NCT03529773|583935957|FG017|Overall Study|No longer meets eligibility criteria|0|||
161695906|NCT03529773|583935958|FG018|Overall Study|No longer meets eligibility criteria|0|||
161695907|NCT03529773|583935959|FG019|Overall Study|No longer meets eligibility criteria|0|||
161695908|NCT03529773|583935960|FG020|Overall Study|No longer meets eligibility criteria|0|||
161695909|NCT03529773|583935961|FG021|Overall Study|No longer meets eligibility criteria|0|||
161695910|NCT03529773|583935962|FG022|Overall Study|No longer meets eligibility criteria|1|||
161836556|NCT02944383|584444940|FG001|Overall Study|Withdrawal by Subject|0|||
161956682|NCT00363142|584889752|FG000|Overall Study|Adverse Event|2|||
161695911|NCT03529773|583935963|FG023|Overall Study|No longer meets eligibility criteria|0|||
161695912|NCT03529773|583935964|FG024|Overall Study|No longer meets eligibility criteria|0|||
161695913|NCT03529773|583935965|FG025|Overall Study|No longer meets eligibility criteria|0|||
161695914|NCT03529773|583935966|FG026|Overall Study|No longer meets eligibility criteria|0|||
161695915|NCT03529773|583935967|FG027|Overall Study|No longer meets eligibility criteria|0|||
161695916|NCT03529773|583935968|FG028|Overall Study|No longer meets eligibility criteria|0|||
161695917|NCT03529773|583935969|FG029|Overall Study|No longer meets eligibility criteria|0|||
161695918|NCT03529773|583935970|FG030|Overall Study|No longer meets eligibility criteria|0|||
161695919|NCT03529773|583935971|FG031|Overall Study|No longer meets eligibility criteria|0|||
161836557|NCT02944383|584444941|FG002|Overall Study|Withdrawal by Subject|0|||
161695920|NCT03529773|583935972|FG032|Overall Study|No longer meets eligibility criteria|0|||
161956683|NCT00363142|584889753|FG001|Overall Study|Adverse Event|0|||
161956684|NCT00363142|584889752|FG000|Overall Study|Lack of Efficacy|0|||
161956685|NCT00363142|584889753|FG001|Overall Study|Lack of Efficacy|1|||
161956686|NCT00363142|584889752|FG000|Overall Study|Lost to Follow-up|1|||
161695921|NCT03529773|583935973|FG033|Overall Study|No longer meets eligibility criteria|0|||
161695922|NCT03529773|583935974|FG034|Overall Study|No longer meets eligibility criteria|0|||
161695923|NCT03529773|583935975|FG035|Overall Study|No longer meets eligibility criteria|0|||
161695924|NCT03529773|583935976|FG036|Overall Study|No longer meets eligibility criteria|0|||
161695925|NCT03529773|583935977|FG037|Overall Study|No longer meets eligibility criteria|0|||
161695926|NCT03529773|583935978|FG038|Overall Study|No longer meets eligibility criteria|1|||
161695927|NCT03529773|583935979|FG039|Overall Study|No longer meets eligibility criteria|0|||
161695928|NCT03529773|583935940|FG000|Overall Study|Other|0|||
161695929|NCT03529773|583935941|FG001|Overall Study|Other|0|||
161695930|NCT03529773|583935942|FG002|Overall Study|Other|0|||
161695931|NCT03529773|583935943|FG003|Overall Study|Other|0|||
161695932|NCT03529773|583935944|FG004|Overall Study|Other|0|||
161695933|NCT03529773|583935945|FG005|Overall Study|Other|0|||
161695934|NCT03529773|583935946|FG006|Overall Study|Other|0|||
161695935|NCT03529773|583935947|FG007|Overall Study|Other|0|||
161695936|NCT03529773|583935948|FG008|Overall Study|Other|0|||
161695937|NCT03529773|583935949|FG009|Overall Study|Other|0|||
161695938|NCT03529773|583935950|FG010|Overall Study|Other|0|||
161695939|NCT03529773|583935951|FG011|Overall Study|Other|0|||
161695940|NCT03529773|583935952|FG012|Overall Study|Other|1|||
161695941|NCT03529773|583935953|FG013|Overall Study|Other|0|||
161695942|NCT03529773|583935954|FG014|Overall Study|Other|2|||
161695943|NCT03529773|583935955|FG015|Overall Study|Other|0|||
161695944|NCT03529773|583935956|FG016|Overall Study|Other|0|||
161695945|NCT03529773|583935957|FG017|Overall Study|Other|3|||
161695946|NCT03529773|583935958|FG018|Overall Study|Other|0|||
161695947|NCT03529773|583935959|FG019|Overall Study|Other|0|||
161695948|NCT03529773|583935960|FG020|Overall Study|Other|1|||
161695949|NCT03529773|583935961|FG021|Overall Study|Other|0|||
161695950|NCT03529773|583935962|FG022|Overall Study|Other|1|||
161695951|NCT03529773|583935963|FG023|Overall Study|Other|0|||
161695952|NCT03529773|583935964|FG024|Overall Study|Other|3|||
161695953|NCT03529773|583935965|FG025|Overall Study|Other|2|||
161695954|NCT03529773|583935966|FG026|Overall Study|Other|2|||
161695955|NCT03529773|583935967|FG027|Overall Study|Other|0|||
161695956|NCT03529773|583935968|FG028|Overall Study|Other|0|||
161695957|NCT03529773|583935969|FG029|Overall Study|Other|0|||
161695958|NCT03529773|583935970|FG030|Overall Study|Other|0|||
161695959|NCT03529773|583935971|FG031|Overall Study|Other|0|||
161695960|NCT03529773|583935972|FG032|Overall Study|Other|0|||
161695961|NCT03529773|583935973|FG033|Overall Study|Other|0|||
161695962|NCT03529773|583935974|FG034|Overall Study|Other|1|||
161695963|NCT03529773|583935975|FG035|Overall Study|Other|1|||
161695964|NCT03529773|583935976|FG036|Overall Study|Other|0|||
161695965|NCT03529773|583935977|FG037|Overall Study|Other|0|||
161695966|NCT03529773|583935978|FG038|Overall Study|Other|0|||
161695967|NCT03529773|583935979|FG039|Overall Study|Other|0|||
161695968|NCT03529773|583935940|FG000|Overall Study|Physician Decision|0|||
161695969|NCT03529773|583935941|FG001|Overall Study|Physician Decision|0|||
161695970|NCT03529773|583935942|FG002|Overall Study|Physician Decision|0|||
161695971|NCT03529773|583935943|FG003|Overall Study|Physician Decision|0|||
161695972|NCT03529773|583935944|FG004|Overall Study|Physician Decision|0|||
161695973|NCT03529773|583935945|FG005|Overall Study|Physician Decision|0|||
161695974|NCT03529773|583935946|FG006|Overall Study|Physician Decision|0|||
161695975|NCT03529773|583935947|FG007|Overall Study|Physician Decision|0|||
161695976|NCT03529773|583935948|FG008|Overall Study|Physician Decision|0|||
161695977|NCT03529773|583935949|FG009|Overall Study|Physician Decision|0|||
161956687|NCT00363142|584889753|FG001|Overall Study|Lost to Follow-up|0|||
161695978|NCT03529773|583935950|FG010|Overall Study|Physician Decision|0|||
161695979|NCT03529773|583935951|FG011|Overall Study|Physician Decision|0|||
161695980|NCT03529773|583935952|FG012|Overall Study|Physician Decision|0|||
161695981|NCT03529773|583935953|FG013|Overall Study|Physician Decision|0|||
161695982|NCT03529773|583935954|FG014|Overall Study|Physician Decision|0|||
161695983|NCT03529773|583935955|FG015|Overall Study|Physician Decision|0|||
161695984|NCT03529773|583935956|FG016|Overall Study|Physician Decision|0|||
161695985|NCT03529773|583935957|FG017|Overall Study|Physician Decision|0|||
161695986|NCT03529773|583935958|FG018|Overall Study|Physician Decision|0|||
161695987|NCT03529773|583935959|FG019|Overall Study|Physician Decision|1|||
161695988|NCT03529773|583935960|FG020|Overall Study|Physician Decision|1|||
161695989|NCT03529773|583935961|FG021|Overall Study|Physician Decision|0|||
161695990|NCT03529773|583935962|FG022|Overall Study|Physician Decision|0|||
161695991|NCT03529773|583935963|FG023|Overall Study|Physician Decision|0|||
161695992|NCT03529773|583935964|FG024|Overall Study|Physician Decision|0|||
161695993|NCT03529773|583935965|FG025|Overall Study|Physician Decision|0|||
161695994|NCT03529773|583935966|FG026|Overall Study|Physician Decision|0|||
161695995|NCT03529773|583935967|FG027|Overall Study|Physician Decision|0|||
161695996|NCT03529773|583935968|FG028|Overall Study|Physician Decision|0|||
161695997|NCT03529773|583935969|FG029|Overall Study|Physician Decision|0|||
161695998|NCT03529773|583935970|FG030|Overall Study|Physician Decision|0|||
161695999|NCT03529773|583935971|FG031|Overall Study|Physician Decision|0|||
161696000|NCT03529773|583935972|FG032|Overall Study|Physician Decision|0|||
161696001|NCT03529773|583935973|FG033|Overall Study|Physician Decision|0|||
161696002|NCT03529773|583935974|FG034|Overall Study|Physician Decision|0|||
161696003|NCT03529773|583935975|FG035|Overall Study|Physician Decision|0|||
161696004|NCT03529773|583935976|FG036|Overall Study|Physician Decision|0|||
161696005|NCT03529773|583935977|FG037|Overall Study|Physician Decision|0|||
161696006|NCT03529773|583935978|FG038|Overall Study|Physician Decision|0|||
161696007|NCT03529773|583935979|FG039|Overall Study|Physician Decision|0|||
161696008|NCT03529773|583935940|FG000|Overall Study|Protocol Violation|0|||
161696009|NCT03529773|583935941|FG001|Overall Study|Protocol Violation|0|||
161696010|NCT03529773|583935942|FG002|Overall Study|Protocol Violation|0|||
161696011|NCT03529773|583935943|FG003|Overall Study|Protocol Violation|0|||
161696012|NCT03529773|583935944|FG004|Overall Study|Protocol Violation|0|||
161696013|NCT03529773|583935945|FG005|Overall Study|Protocol Violation|0|||
161696014|NCT03529773|583935946|FG006|Overall Study|Protocol Violation|0|||
161696015|NCT03529773|583935947|FG007|Overall Study|Protocol Violation|0|||
161696016|NCT03529773|583935948|FG008|Overall Study|Protocol Violation|0|||
161696017|NCT03529773|583935949|FG009|Overall Study|Protocol Violation|0|||
161696018|NCT03529773|583935950|FG010|Overall Study|Protocol Violation|0|||
161696019|NCT03529773|583935951|FG011|Overall Study|Protocol Violation|0|||
161696020|NCT03529773|583935952|FG012|Overall Study|Protocol Violation|0|||
161696021|NCT03529773|583935953|FG013|Overall Study|Protocol Violation|0|||
161696022|NCT03529773|583935954|FG014|Overall Study|Protocol Violation|0|||
161696023|NCT03529773|583935955|FG015|Overall Study|Protocol Violation|0|||
161836558|NCT01995266|584444942|FG000|Overall Study|Death|1|||
161836559|NCT01995266|584444942|FG000|Overall Study|Lack of Efficacy|6|||
161836560|NCT01995266|584444942|FG000|Overall Study|Adverse Event|2|||
161836561|NCT02588950|584444945|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
161836562|NCT02588950|584444946|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
161836563|NCT02588950|584444947|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
161956688|NCT00363142|584889752|FG000|Overall Study|Non-compliance|1|||
161956689|NCT00363142|584889753|FG001|Overall Study|Non-compliance|1|||
161696024|NCT03529773|583935956|FG016|Overall Study|Protocol Violation|0|||
161696025|NCT03529773|583935957|FG017|Overall Study|Protocol Violation|0|||
161696026|NCT03529773|583935958|FG018|Overall Study|Protocol Violation|0|||
161696027|NCT03529773|583935959|FG019|Overall Study|Protocol Violation|0|||
161696028|NCT03529773|583935960|FG020|Overall Study|Protocol Violation|0|||
161696029|NCT03529773|583935961|FG021|Overall Study|Protocol Violation|0|||
161696030|NCT03529773|583935962|FG022|Overall Study|Protocol Violation|0|||
161696031|NCT03529773|583935963|FG023|Overall Study|Protocol Violation|0|||
161696032|NCT03529773|583935964|FG024|Overall Study|Protocol Violation|0|||
161696033|NCT03529773|583935965|FG025|Overall Study|Protocol Violation|0|||
161696034|NCT03529773|583935966|FG026|Overall Study|Protocol Violation|0|||
161696035|NCT03529773|583935967|FG027|Overall Study|Protocol Violation|0|||
161696036|NCT03529773|583935968|FG028|Overall Study|Protocol Violation|0|||
161696037|NCT03529773|583935969|FG029|Overall Study|Protocol Violation|0|||
161696038|NCT03529773|583935970|FG030|Overall Study|Protocol Violation|1|||
161696039|NCT03529773|583935971|FG031|Overall Study|Protocol Violation|0|||
161696040|NCT03529773|583935972|FG032|Overall Study|Protocol Violation|0|||
161696041|NCT03529773|583935973|FG033|Overall Study|Protocol Violation|0|||
161696042|NCT03529773|583935974|FG034|Overall Study|Protocol Violation|0|||
161696043|NCT03529773|583935975|FG035|Overall Study|Protocol Violation|0|||
161696044|NCT03529773|583935976|FG036|Overall Study|Protocol Violation|0|||
161696045|NCT03529773|583935977|FG037|Overall Study|Protocol Violation|0|||
161696046|NCT03529773|583935978|FG038|Overall Study|Protocol Violation|0|||
161696047|NCT03529773|583935979|FG039|Overall Study|Protocol Violation|0|||
161696048|NCT03529773|583935940|FG000|Overall Study|Withdrawal by Subject|0|||
161696049|NCT03529773|583935941|FG001|Overall Study|Withdrawal by Subject|0|||
161696050|NCT03529773|583935942|FG002|Overall Study|Withdrawal by Subject|0|||
161696051|NCT03529773|583935943|FG003|Overall Study|Withdrawal by Subject|0|||
161696052|NCT03529773|583935944|FG004|Overall Study|Withdrawal by Subject|0|||
161696053|NCT03529773|583935945|FG005|Overall Study|Withdrawal by Subject|0|||
161696054|NCT03529773|583935946|FG006|Overall Study|Withdrawal by Subject|0|||
161696055|NCT03529773|583935947|FG007|Overall Study|Withdrawal by Subject|1|||
161696056|NCT03529773|583935948|FG008|Overall Study|Withdrawal by Subject|0|||
161696057|NCT03529773|583935949|FG009|Overall Study|Withdrawal by Subject|1|||
161696058|NCT03529773|583935950|FG010|Overall Study|Withdrawal by Subject|1|||
161696059|NCT03529773|583935951|FG011|Overall Study|Withdrawal by Subject|0|||
161696060|NCT03529773|583935952|FG012|Overall Study|Withdrawal by Subject|0|||
161696061|NCT03529773|583935953|FG013|Overall Study|Withdrawal by Subject|0|||
161696062|NCT03529773|583935954|FG014|Overall Study|Withdrawal by Subject|0|||
161696063|NCT03529773|583935955|FG015|Overall Study|Withdrawal by Subject|3|||
161696064|NCT03529773|583935956|FG016|Overall Study|Withdrawal by Subject|0|||
161696065|NCT03529773|583935957|FG017|Overall Study|Withdrawal by Subject|2|||
161696066|NCT03529773|583935958|FG018|Overall Study|Withdrawal by Subject|3|||
161696067|NCT03529773|583935959|FG019|Overall Study|Withdrawal by Subject|1|||
161696068|NCT03529773|583935960|FG020|Overall Study|Withdrawal by Subject|3|||
161696069|NCT03529773|583935961|FG021|Overall Study|Withdrawal by Subject|1|||
161696070|NCT03529773|583935962|FG022|Overall Study|Withdrawal by Subject|1|||
161696071|NCT03529773|583935963|FG023|Overall Study|Withdrawal by Subject|2|||
161696072|NCT03529773|583935964|FG024|Overall Study|Withdrawal by Subject|2|||
161696073|NCT03529773|583935965|FG025|Overall Study|Withdrawal by Subject|4|||
161696074|NCT03529773|583935966|FG026|Overall Study|Withdrawal by Subject|2|||
161696075|NCT03529773|583935967|FG027|Overall Study|Withdrawal by Subject|1|||
161696076|NCT03529773|583935968|FG028|Overall Study|Withdrawal by Subject|1|||
161696077|NCT03529773|583935969|FG029|Overall Study|Withdrawal by Subject|0|||
161696078|NCT03529773|583935970|FG030|Overall Study|Withdrawal by Subject|0|||
161696079|NCT03529773|583935971|FG031|Overall Study|Withdrawal by Subject|0|||
161696080|NCT03529773|583935972|FG032|Overall Study|Withdrawal by Subject|0|||
161696081|NCT03529773|583935973|FG033|Overall Study|Withdrawal by Subject|0|||
161696082|NCT03529773|583935974|FG034|Overall Study|Withdrawal by Subject|1|||
161696083|NCT03529773|583935975|FG035|Overall Study|Withdrawal by Subject|2|||
161696084|NCT03529773|583935976|FG036|Overall Study|Withdrawal by Subject|0|||
161696085|NCT03529773|583935977|FG037|Overall Study|Withdrawal by Subject|2|||
161696086|NCT03529773|583935978|FG038|Overall Study|Withdrawal by Subject|1|||
161696087|NCT03529773|583935979|FG039|Overall Study|Withdrawal by Subject|1|||
161696088|NCT03529773|583935940|FG000|Overall Study|Screen Failure|0|||
161696089|NCT03529773|583935941|FG001|Overall Study|Screen Failure|0|||
161696090|NCT03529773|583935942|FG002|Overall Study|Screen Failure|0|||
161696091|NCT03529773|583935943|FG003|Overall Study|Screen Failure|0|||
161696092|NCT03529773|583935944|FG004|Overall Study|Screen Failure|0|||
161696093|NCT03529773|583935945|FG005|Overall Study|Screen Failure|0|||
161696094|NCT03529773|583935946|FG006|Overall Study|Screen Failure|0|||
161696095|NCT03529773|583935947|FG007|Overall Study|Screen Failure|0|||
161696096|NCT03529773|583935948|FG008|Overall Study|Screen Failure|0|||
161696097|NCT03529773|583935949|FG009|Overall Study|Screen Failure|0|||
161696098|NCT03529773|583935950|FG010|Overall Study|Screen Failure|0|||
161696099|NCT03529773|583935951|FG011|Overall Study|Screen Failure|0|||
161696100|NCT03529773|583935952|FG012|Overall Study|Screen Failure|0|||
161696101|NCT03529773|583935953|FG013|Overall Study|Screen Failure|0|||
161696102|NCT03529773|583935954|FG014|Overall Study|Screen Failure|0|||
161696103|NCT03529773|583935955|FG015|Overall Study|Screen Failure|0|||
161696104|NCT03529773|583935956|FG016|Overall Study|Screen Failure|0|||
161696105|NCT03529773|583935957|FG017|Overall Study|Screen Failure|0|||
161696106|NCT03529773|583935958|FG018|Overall Study|Screen Failure|0|||
161696107|NCT03529773|583935959|FG019|Overall Study|Screen Failure|0|||
161696108|NCT03529773|583935960|FG020|Overall Study|Screen Failure|0|||
161696109|NCT03529773|583935961|FG021|Overall Study|Screen Failure|0|||
161696110|NCT03529773|583935962|FG022|Overall Study|Screen Failure|0|||
161696111|NCT03529773|583935963|FG023|Overall Study|Screen Failure|0|||
161696112|NCT03529773|583935964|FG024|Overall Study|Screen Failure|0|||
161696113|NCT03529773|583935965|FG025|Overall Study|Screen Failure|0|||
161696114|NCT03529773|583935966|FG026|Overall Study|Screen Failure|0|||
161696115|NCT03529773|583935967|FG027|Overall Study|Screen Failure|0|||
161696116|NCT03529773|583935968|FG028|Overall Study|Screen Failure|0|||
161696117|NCT03529773|583935969|FG029|Overall Study|Screen Failure|0|||
161696118|NCT03529773|583935970|FG030|Overall Study|Screen Failure|0|||
161696119|NCT03529773|583935971|FG031|Overall Study|Screen Failure|0|||
161696120|NCT03529773|583935972|FG032|Overall Study|Screen Failure|0|||
161696121|NCT03529773|583935973|FG033|Overall Study|Screen Failure|0|||
161696122|NCT03529773|583935974|FG034|Overall Study|Screen Failure|0|||
161696123|NCT03529773|583935975|FG035|Overall Study|Screen Failure|0|||
161696124|NCT03529773|583935976|FG036|Overall Study|Screen Failure|1|||
161696125|NCT03529773|583935977|FG037|Overall Study|Screen Failure|1|||
161696126|NCT03529773|583935978|FG038|Overall Study|Screen Failure|0|||
161696127|NCT03529773|583935979|FG039|Overall Study|Screen Failure|1|||
161696128|NCT03529773|583935940|FG000|Overall Study|Randomized but not vaccinated|0|||
161696129|NCT03529773|583935941|FG001|Overall Study|Randomized but not vaccinated|0|||
161696130|NCT03529773|583935942|FG002|Overall Study|Randomized but not vaccinated|0|||
161696131|NCT03529773|583935943|FG003|Overall Study|Randomized but not vaccinated|0|||
161696132|NCT03529773|583935944|FG004|Overall Study|Randomized but not vaccinated|0|||
161696133|NCT03529773|583935945|FG005|Overall Study|Randomized but not vaccinated|0|||
161696134|NCT03529773|583935946|FG006|Overall Study|Randomized but not vaccinated|0|||
161696135|NCT03529773|583935947|FG007|Overall Study|Randomized but not vaccinated|0|||
161696136|NCT03529773|583935948|FG008|Overall Study|Randomized but not vaccinated|0|||
161696137|NCT03529773|583935949|FG009|Overall Study|Randomized but not vaccinated|0|||
161696138|NCT03529773|583935950|FG010|Overall Study|Randomized but not vaccinated|0|||
161696139|NCT03529773|583935951|FG011|Overall Study|Randomized but not vaccinated|0|||
161696140|NCT03529773|583935952|FG012|Overall Study|Randomized but not vaccinated|0|||
161696141|NCT03529773|583935953|FG013|Overall Study|Randomized but not vaccinated|0|||
161696142|NCT03529773|583935954|FG014|Overall Study|Randomized but not vaccinated|0|||
161696143|NCT03529773|583935955|FG015|Overall Study|Randomized but not vaccinated|0|||
161696144|NCT03529773|583935956|FG016|Overall Study|Randomized but not vaccinated|0|||
161696145|NCT03529773|583935957|FG017|Overall Study|Randomized but not vaccinated|1|||
161696146|NCT03529773|583935958|FG018|Overall Study|Randomized but not vaccinated|0|||
161696147|NCT03529773|583935959|FG019|Overall Study|Randomized but not vaccinated|0|||
161696148|NCT03529773|583935960|FG020|Overall Study|Randomized but not vaccinated|0|||
161696149|NCT03529773|583935961|FG021|Overall Study|Randomized but not vaccinated|0|||
161696150|NCT03529773|583935962|FG022|Overall Study|Randomized but not vaccinated|0|||
161696151|NCT03529773|583935963|FG023|Overall Study|Randomized but not vaccinated|0|||
161696152|NCT03529773|583935964|FG024|Overall Study|Randomized but not vaccinated|0|||
161696153|NCT03529773|583935965|FG025|Overall Study|Randomized but not vaccinated|0|||
161696154|NCT03529773|583935966|FG026|Overall Study|Randomized but not vaccinated|0|||
161696155|NCT03529773|583935967|FG027|Overall Study|Randomized but not vaccinated|1|||
161696156|NCT03529773|583935968|FG028|Overall Study|Randomized but not vaccinated|0|||
161696157|NCT03529773|583935969|FG029|Overall Study|Randomized but not vaccinated|0|||
161696158|NCT03529773|583935970|FG030|Overall Study|Randomized but not vaccinated|0|||
161696159|NCT03529773|583935971|FG031|Overall Study|Randomized but not vaccinated|0|||
161696160|NCT03529773|583935972|FG032|Overall Study|Randomized but not vaccinated|0|||
161696161|NCT03529773|583935973|FG033|Overall Study|Randomized but not vaccinated|0|||
161696162|NCT03529773|583935974|FG034|Overall Study|Randomized but not vaccinated|0|||
161696163|NCT03529773|583935975|FG035|Overall Study|Randomized but not vaccinated|0|||
161696164|NCT03529773|583935976|FG036|Overall Study|Randomized but not vaccinated|0|||
161696165|NCT03529773|583935977|FG037|Overall Study|Randomized but not vaccinated|0|||
161696166|NCT03529773|583935978|FG038|Overall Study|Randomized but not vaccinated|0|||
161696167|NCT03529773|583935979|FG039|Overall Study|Randomized but not vaccinated|0|||
161696168|NCT01496066|583935981|FG000|Overall Study|Lost to Follow-up|8|||
161696169|NCT01496066|583935982|FG001|Overall Study|Lost to Follow-up|5|||
161696170|NCT01496066|583935981|FG000|Overall Study|Explant|3|||
161696171|NCT01496066|583935982|FG001|Overall Study|Explant|0|||
161696172|NCT01496066|583935981|FG000|Overall Study|Death|1|||
161696173|NCT01496066|583935982|FG001|Overall Study|Death|4|||
161696174|NCT00253630|583935983|FG000|Overall Study|ineligible|2|||
161696175|NCT03237065|583935984|FG000|Overall Study|Adverse Event|0|||
161696176|NCT03237065|583935985|FG001|Overall Study|Adverse Event|2|||
161696177|NCT03237065|583935984|FG000|Overall Study|Protocol Violation|0|||
161696178|NCT03237065|583935985|FG001|Overall Study|Protocol Violation|1|||
161696179|NCT03237065|583935984|FG000|Overall Study|Withdrawal by Subject|3|||
161696180|NCT03237065|583935985|FG001|Overall Study|Withdrawal by Subject|0|||
161696181|NCT03237065|583935984|FG000|Overall Study|Lost to Follow-up|1|||
161696182|NCT03237065|583935985|FG001|Overall Study|Lost to Follow-up|0|||
161836564|NCT02588950|584444948|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
161696183|NCT03237065|583935984|FG000|Overall Study|Unable to obtain venous access|0|||
161696184|NCT03237065|583935985|FG001|Overall Study|Unable to obtain venous access|1|||
161836565|NCT02588950|584444945|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
161836566|NCT02588950|584444946|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
161696185|NCT00209339|583935986|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
161696186|NCT00209339|583935986|FG000|At 12 Months Follow-up|Death|1|||
161696187|NCT00209339|583935986|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
161696188|NCT00209339|583935986|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
161696189|NCT00209339|583935986|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
161696190|NCT00209339|583935986|FG000|At 24 Months Follow-up|Death|1|||
161696191|NCT00209339|583935986|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
161696192|NCT00209339|583935986|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
161696193|NCT00209339|583935986|FG000|At 4 Years Follow-up|Death|1|||
161696194|NCT00209339|583935986|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
161696195|NCT00209339|583935986|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
161696196|NCT00209339|583935986|FG000|At 5 Years Follow-up|Death|1|||
161696197|NCT02062658|583935988|FG000|Overall Study|Withdrawal by Subject|1|||
161696198|NCT02062658|583935988|FG000|Overall Study|Lack of Efficacy|1|||
161696199|NCT02475655|583935989|FG000|Overall Study|Lost to Follow-up|0|||
161696200|NCT02475655|583935990|FG001|Overall Study|Lost to Follow-up|1|||
161696201|NCT00257010|583935993|FG000|Overall Study|Lack of Efficacy|11|||
161696202|NCT00257010|583935993|FG000|Overall Study|Lost to Follow-up|53|||
161696203|NCT00257010|583935993|FG000|Overall Study|Withdrawal by Subject|34|||
161696204|NCT00257010|583935993|FG000|Overall Study|Adverse Event|10|||
161696205|NCT00257010|583935993|FG000|Overall Study|various|11|||
161696206|NCT00257010|583935993|FG000|Overall Study|no headache reported|9|||
161696207|NCT02574637|583935994|FG000|Double-blind Period|Adverse Event|1|||
161696208|NCT02574637|583935995|FG001|Double-blind Period|Adverse Event|0|||
161696209|NCT02574637|583935996|FG002|Double-blind Period|Adverse Event|0|||
161696210|NCT02574637|583935997|FG003|Double-blind Period|Adverse Event|0|||
161696211|NCT02574637|583935998|FG004|Double-blind Period|Adverse Event|0|||
161696212|NCT02574637|583935999|FG005|Double-blind Period|Adverse Event|0|||
161696213|NCT02574637|583936000|FG006|Double-blind Period|Adverse Event|0|||
161696214|NCT02574637|583936001|FG007|Double-blind Period|Adverse Event|0|||
161696215|NCT02574637|583936002|FG008|Double-blind Period|Adverse Event|0|||
161696216|NCT02574637|583936003|FG009|Double-blind Period|Adverse Event|0|||
161696217|NCT02574637|583935994|FG000|Double-blind Period|Lack of Efficacy|0|||
161696218|NCT02574637|583935995|FG001|Double-blind Period|Lack of Efficacy|0|||
161696219|NCT02574637|583935996|FG002|Double-blind Period|Lack of Efficacy|2|||
161696220|NCT02574637|583935997|FG003|Double-blind Period|Lack of Efficacy|0|||
161696221|NCT02574637|583935998|FG004|Double-blind Period|Lack of Efficacy|0|||
161696222|NCT02574637|583935999|FG005|Double-blind Period|Lack of Efficacy|0|||
161696223|NCT02574637|583936000|FG006|Double-blind Period|Lack of Efficacy|0|||
161696224|NCT02574637|583936001|FG007|Double-blind Period|Lack of Efficacy|0|||
161696225|NCT02574637|583936002|FG008|Double-blind Period|Lack of Efficacy|0|||
161696226|NCT02574637|583936003|FG009|Double-blind Period|Lack of Efficacy|0|||
161696227|NCT02574637|583935994|FG000|Double-blind Period|Protocol Deviation|1|||
161696228|NCT02574637|583935995|FG001|Double-blind Period|Protocol Deviation|0|||
161696229|NCT02574637|583935996|FG002|Double-blind Period|Protocol Deviation|0|||
161696230|NCT02574637|583935997|FG003|Double-blind Period|Protocol Deviation|0|||
161696231|NCT02574637|583935998|FG004|Double-blind Period|Protocol Deviation|0|||
161696232|NCT02574637|583935999|FG005|Double-blind Period|Protocol Deviation|0|||
161696233|NCT02574637|583936000|FG006|Double-blind Period|Protocol Deviation|0|||
161696234|NCT02574637|583936001|FG007|Double-blind Period|Protocol Deviation|0|||
161696235|NCT02574637|583936002|FG008|Double-blind Period|Protocol Deviation|0|||
161696236|NCT02574637|583936003|FG009|Double-blind Period|Protocol Deviation|0|||
161696237|NCT02574637|583935994|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
161696238|NCT02574637|583935995|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
161696239|NCT02574637|583935996|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
161696240|NCT02574637|583935997|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
161696241|NCT02574637|583935998|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
161956690|NCT00363142|584889752|FG000|Overall Study|Withdrawal by Subject|3|||
161956691|NCT00363142|584889753|FG001|Overall Study|Withdrawal by Subject|1|||
161696242|NCT02574637|583935999|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
161696243|NCT02574637|583936000|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
161696244|NCT02574637|583936001|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
161696245|NCT02574637|583936002|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
161696246|NCT02574637|583936003|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
161696247|NCT02574637|583935994|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
161696248|NCT02574637|583935995|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
161956692|NCT01340664|584889756|FG000|Overall Study|Adverse Event|0|||
161696249|NCT02574637|583935996|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
161696250|NCT02574637|583935997|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
161956693|NCT01340664|584889757|FG001|Overall Study|Adverse Event|1|||
161956694|NCT01340664|584889758|FG002|Overall Study|Adverse Event|7|||
161956695|NCT01340664|584889756|FG000|Overall Study|Lost to Follow-up|2|||
161956696|NCT01340664|584889757|FG001|Overall Study|Lost to Follow-up|0|||
161956697|NCT01340664|584889758|FG002|Overall Study|Lost to Follow-up|2|||
161956698|NCT01340664|584889756|FG000|Overall Study|Withdrawal by Subject|2|||
161956699|NCT01340664|584889757|FG001|Overall Study|Withdrawal by Subject|4|||
161956700|NCT01340664|584889758|FG002|Overall Study|Withdrawal by Subject|0|||
161956701|NCT01340664|584889756|FG000|Overall Study|Glycemic withdrawal criteria|2|||
161956702|NCT01340664|584889757|FG001|Overall Study|Glycemic withdrawal criteria|0|||
161956703|NCT01340664|584889758|FG002|Overall Study|Glycemic withdrawal criteria|0|||
161956704|NCT01340664|584889756|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
161956705|NCT01340664|584889757|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
161956706|NCT01340664|584889758|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
161956707|NCT01340664|584889756|FG000|Overall Study|Other|1|||
161956708|NCT01340664|584889757|FG001|Overall Study|Other|2|||
161696251|NCT02574637|583935998|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
161696252|NCT02574637|583935999|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
161696253|NCT02574637|583936000|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
161696254|NCT02574637|583936001|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
161696255|NCT02574637|583936002|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
161696256|NCT02574637|583936003|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
161696257|NCT02574637|583935994|FG000|Double-blind Period|Reason Not Specified|0|||
161696258|NCT02574637|583935995|FG001|Double-blind Period|Reason Not Specified|0|||
161696259|NCT02574637|583935996|FG002|Double-blind Period|Reason Not Specified|0|||
161696260|NCT02574637|583935997|FG003|Double-blind Period|Reason Not Specified|1|||
161696261|NCT02574637|583935998|FG004|Double-blind Period|Reason Not Specified|0|||
161696262|NCT02574637|583935999|FG005|Double-blind Period|Reason Not Specified|0|||
161696263|NCT02574637|583936000|FG006|Double-blind Period|Reason Not Specified|0|||
161696264|NCT02574637|583936001|FG007|Double-blind Period|Reason Not Specified|0|||
161696265|NCT02574637|583936002|FG008|Double-blind Period|Reason Not Specified|0|||
161696266|NCT02574637|583936003|FG009|Double-blind Period|Reason Not Specified|0|||
161696267|NCT02574637|583935994|FG000|Open-label (OL) Period|Adverse Event|0|||
161696268|NCT02574637|583935995|FG001|Open-label (OL) Period|Adverse Event|0|||
161696269|NCT02574637|583935996|FG002|Open-label (OL) Period|Adverse Event|0|||
161696270|NCT02574637|583935997|FG003|Open-label (OL) Period|Adverse Event|0|||
161696271|NCT02574637|583935998|FG004|Open-label (OL) Period|Adverse Event|0|||
161696272|NCT02574637|583935999|FG005|Open-label (OL) Period|Adverse Event|0|||
161696273|NCT02574637|583936000|FG006|Open-label (OL) Period|Adverse Event|0|||
161696274|NCT02574637|583936001|FG007|Open-label (OL) Period|Adverse Event|0|||
161696275|NCT02574637|583936002|FG008|Open-label (OL) Period|Adverse Event|1|||
161696276|NCT02574637|583936003|FG009|Open-label (OL) Period|Adverse Event|0|||
161696277|NCT02574637|583935994|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
161696278|NCT02574637|583935995|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
161696279|NCT02574637|583935996|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
161696280|NCT02574637|583935997|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
161696281|NCT02574637|583935998|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
161696282|NCT02574637|583935999|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
161696283|NCT02574637|583936000|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
161696284|NCT02574637|583936001|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
161696285|NCT02574637|583936002|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
161696286|NCT02574637|583936003|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
161696287|NCT02574637|583935994|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161696288|NCT02574637|583935995|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161696289|NCT02574637|583935996|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161696290|NCT02574637|583935997|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161696291|NCT02574637|583935998|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161696292|NCT02574637|583935999|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
161696293|NCT02574637|583936000|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
161696294|NCT02574637|583936001|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
161956709|NCT01340664|584889758|FG002|Overall Study|Other|2|||
161956710|NCT01823198|584889759|FG000|Overall Study|Physician Decision|0|||
161956711|NCT01823198|584889760|FG001|Overall Study|Physician Decision|1|||
161956712|NCT01823198|584889761|FG002|Overall Study|Physician Decision|0|||
161956713|NCT01823198|584889762|FG003|Overall Study|Physician Decision|0|||
161956714|NCT01823198|584889763|FG004|Overall Study|Physician Decision|0|||
161696295|NCT02574637|583936002|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
161696296|NCT02574637|583936003|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161696297|NCT00662792|583936004|FG000|Period 1|Personal Reasons|0|||
161696298|NCT00662792|583936005|FG001|Period 1|Personal Reasons|0|||
161696299|NCT00662792|583936006|FG002|Period 1|Personal Reasons|1|||
161696300|NCT00662792|583936007|FG003|Period 1|Personal Reasons|0|||
161696301|NCT00662792|583936004|FG000|Period 1|Refused continuing medication|0|||
161956715|NCT01823198|584889764|FG005|Overall Study|Physician Decision|3|||
161696302|NCT00662792|583936005|FG001|Period 1|Refused continuing medication|1|||
161696303|NCT00662792|583936006|FG002|Period 1|Refused continuing medication|1|||
161696304|NCT00662792|583936007|FG003|Period 1|Refused continuing medication|0|||
161696305|NCT00662792|583936004|FG000|Period 1|Lost to Follow-up|1|||
161696306|NCT00662792|583936005|FG001|Period 1|Lost to Follow-up|0|||
161696307|NCT00662792|583936006|FG002|Period 1|Lost to Follow-up|0|||
161696308|NCT00662792|583936007|FG003|Period 1|Lost to Follow-up|0|||
161696309|NCT00662792|583936004|FG000|Period 1|Other adverse event (AE)|0|||
161696310|NCT00662792|583936005|FG001|Period 1|Other adverse event (AE)|2|||
161696311|NCT00662792|583936006|FG002|Period 1|Other adverse event (AE)|0|||
161696312|NCT00662792|583936007|FG003|Period 1|Other adverse event (AE)|0|||
161696313|NCT00662792|583936004|FG000|Period 1|Worsening of disease under study (AE)|1|||
161696314|NCT00662792|583936005|FG001|Period 1|Worsening of disease under study (AE)|3|||
161696315|NCT00662792|583936006|FG002|Period 1|Worsening of disease under study (AE)|2|||
161696316|NCT00662792|583936007|FG003|Period 1|Worsening of disease under study (AE)|0|||
161696317|NCT00662792|583936004|FG000|Period 1|Not treated|0|||
161696318|NCT00662792|583936005|FG001|Period 1|Not treated|1|||
161696319|NCT00662792|583936006|FG002|Period 1|Not treated|0|||
161696320|NCT00662792|583936007|FG003|Period 1|Not treated|0|||
161696321|NCT00662792|583936004|FG000|Period 2|Worsening of disease under study|1|||
161696322|NCT00662792|583936005|FG001|Period 2|Worsening of disease under study|0|||
161696323|NCT00662792|583936006|FG002|Period 2|Worsening of disease under study|0|||
161696324|NCT00662792|583936007|FG003|Period 2|Worsening of disease under study|3|||
161696325|NCT00662792|583936004|FG000|Period 3|Refused continuing medication|1|||
161696326|NCT00662792|583936005|FG001|Period 3|Refused continuing medication|0|||
161696327|NCT00662792|583936006|FG002|Period 3|Refused continuing medication|1|||
161696328|NCT00662792|583936007|FG003|Period 3|Refused continuing medication|0|||
161696329|NCT00662792|583936004|FG000|Period 3|Other adverse event (AE)|0|||
161696330|NCT00662792|583936005|FG001|Period 3|Other adverse event (AE)|0|||
161696331|NCT00662792|583936006|FG002|Period 3|Other adverse event (AE)|1|||
161696332|NCT00662792|583936007|FG003|Period 3|Other adverse event (AE)|1|||
161696333|NCT00662792|583936004|FG000|Period 4|Refused continuing medication|0|||
161696334|NCT00662792|583936005|FG001|Period 4|Refused continuing medication|1|||
161696335|NCT00662792|583936006|FG002|Period 4|Refused continuing medication|0|||
161696336|NCT00662792|583936007|FG003|Period 4|Refused continuing medication|0|||
161696337|NCT00662792|583936004|FG000|Period 4|Other adverse event (AE)|1|||
161696338|NCT00662792|583936005|FG001|Period 4|Other adverse event (AE)|0|||
161696339|NCT00662792|583936006|FG002|Period 4|Other adverse event (AE)|0|||
161696340|NCT00662792|583936007|FG003|Period 4|Other adverse event (AE)|0|||
161696341|NCT00662792|583936004|FG000|Period 4|Worsening of disease under study (AE)|0|||
161696342|NCT00662792|583936005|FG001|Period 4|Worsening of disease under study (AE)|0|||
161696343|NCT00662792|583936006|FG002|Period 4|Worsening of disease under study (AE)|0|||
161696344|NCT00662792|583936007|FG003|Period 4|Worsening of disease under study (AE)|1|||
161696345|NCT04029519|583936008|FG000|Overall Study|Protocol Violation|1|||
161696346|NCT04029519|583936008|FG000|Overall Study|Withdrawal by Subject|3|||
161696347|NCT04029519|583936008|FG000|Overall Study|Lost to Follow-up|1|||
161696348|NCT02347176|583936015|FG000|Overall Study|Lost to Follow-up|2|||
161696349|NCT02347176|583936016|FG001|Overall Study|Lost to Follow-up|3|||
161696350|NCT02347176|583936017|FG002|Overall Study|Lost to Follow-up|1|||
161696351|NCT02347176|583936018|FG003|Overall Study|Lost to Follow-up|1|||
161696352|NCT02347176|583936015|FG000|Overall Study|Withdrawal by Subject|9|||
161696353|NCT02347176|583936016|FG001|Overall Study|Withdrawal by Subject|5|||
161696354|NCT02347176|583936017|FG002|Overall Study|Withdrawal by Subject|5|||
161696355|NCT02347176|583936018|FG003|Overall Study|Withdrawal by Subject|3|||
161696356|NCT02347176|583936015|FG000|Overall Study|Other|1|||
161696357|NCT02347176|583936016|FG001|Overall Study|Other|2|||
161696358|NCT02347176|583936017|FG002|Overall Study|Other|2|||
161696359|NCT02347176|583936018|FG003|Overall Study|Other|0|||
161696360|NCT00699907|583936027|FG000|Overall Study|Withdrawal by Subject|2|||
161696361|NCT00699907|583936028|FG001|Overall Study|Withdrawal by Subject|1|||
161696362|NCT00699907|583936029|FG002|Overall Study|Withdrawal by Subject|0|||
161696363|NCT00699907|583936027|FG000|Overall Study|No usable sample|0|||
161696364|NCT00699907|583936028|FG001|Overall Study|No usable sample|9|||
161836567|NCT02588950|584444947|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
161696365|NCT00699907|583936029|FG002|Overall Study|No usable sample|8|||
161696366|NCT01081795|583936030|FG000|Overall Study|Adverse Event|18|||
161696367|NCT01081795|583936031|FG001|Overall Study|Adverse Event|23|||
161696368|NCT01081795|583936032|FG002|Overall Study|Adverse Event|6|||
161696369|NCT01081795|583936030|FG000|Overall Study|Lack of Efficacy|7|||
161696370|NCT01081795|583936031|FG001|Overall Study|Lack of Efficacy|5|||
161696371|NCT01081795|583936032|FG002|Overall Study|Lack of Efficacy|19|||
161696372|NCT01081795|583936030|FG000|Overall Study|Subject's schedule|1|||
161696373|NCT01081795|583936031|FG001|Overall Study|Subject's schedule|1|||
161696374|NCT01081795|583936032|FG002|Overall Study|Subject's schedule|2|||
161696375|NCT01081795|583936030|FG000|Overall Study|Revocation of informed consent|2|||
161696376|NCT01081795|583936031|FG001|Overall Study|Revocation of informed consent|0|||
161696377|NCT01081795|583936032|FG002|Overall Study|Revocation of informed consent|0|||
161956716|NCT01823198|584889765|FG006|Overall Study|Physician Decision|3|||
161696378|NCT01081795|583936030|FG000|Overall Study|Ineligible for participation|1|||
161696379|NCT01081795|583936031|FG001|Overall Study|Ineligible for participation|0|||
161696380|NCT01081795|583936032|FG002|Overall Study|Ineligible for participation|0|||
161696381|NCT01081795|583936030|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
161696382|NCT01081795|583936031|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
161696383|NCT01081795|583936032|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
161696384|NCT01081795|583936030|FG000|Overall Study|Using drug with restricted days of use|2|||
161696385|NCT01081795|583936031|FG001|Overall Study|Using drug with restricted days of use|3|||
161696386|NCT01081795|583936032|FG002|Overall Study|Using drug with restricted days of use|2|||
161696387|NCT01081795|583936030|FG000|Overall Study|Other|1|||
161696388|NCT01081795|583936031|FG001|Overall Study|Other|2|||
161696389|NCT01081795|583936032|FG002|Overall Study|Other|0|||
161696390|NCT02462473|583936033|FG000|Overall Study|Death|1|||
161696391|NCT02462473|583936033|FG000|Overall Study|Other|3|||
161696392|NCT01536860|583936035|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
161696393|NCT01536860|583936036|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
161696394|NCT01536860|583936037|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
161696395|NCT01164722|583936038|FG000|Overall Study|Adverse Event|0|||
161696396|NCT01164722|583936039|FG001|Overall Study|Adverse Event|1|||
161696397|NCT01164722|583936038|FG000|Overall Study|Withdrawal by Subject|3|||
161696398|NCT01164722|583936039|FG001|Overall Study|Withdrawal by Subject|4|||
161696399|NCT01164722|583936038|FG000|Overall Study|Lost to Follow-up|3|||
161696400|NCT01164722|583936039|FG001|Overall Study|Lost to Follow-up|6|||
161696401|NCT01164722|583936038|FG000|Overall Study|met protocol criteria for non-treatment|11|||
161696402|NCT01164722|583936039|FG001|Overall Study|met protocol criteria for non-treatment|1|||
161696403|NCT01164722|583936038|FG000|Overall Study|enrolled on other study, concomitant med|1|||
161696404|NCT01164722|583936039|FG001|Overall Study|enrolled on other study, concomitant med|3|||
161696405|NCT03889639|583936041|FG000|Overall Study|Withdrawal by Subject|0|||
161696406|NCT03889639|583936042|FG001|Overall Study|Withdrawal by Subject|0|||
161696407|NCT03889639|583936043|FG002|Overall Study|Withdrawal by Subject|0|||
161696408|NCT03889639|583936044|FG003|Overall Study|Withdrawal by Subject|0|||
161696409|NCT03889639|583936045|FG004|Overall Study|Withdrawal by Subject|0|||
161696410|NCT03889639|583936046|FG005|Overall Study|Withdrawal by Subject|0|||
161696411|NCT03889639|583936047|FG006|Overall Study|Withdrawal by Subject|0|||
161696412|NCT03889639|583936048|FG007|Overall Study|Withdrawal by Subject|1|||
161696413|NCT01707693|583936049|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
161696414|NCT01707693|583936050|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
161696415|NCT01707693|583936049|FG000|Overall Study Allocation|Protocol Violation|4|||
161696416|NCT01707693|583936050|FG001|Overall Study Allocation|Protocol Violation|3|||
161696417|NCT01707693|583936049|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
161696418|NCT01707693|583936050|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
161696419|NCT01707693|583936049|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
161696420|NCT01707693|583936050|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
161696421|NCT02556255|583936052|FG000|Overall Study|Lost to Follow-up|4|||
161696422|NCT00993031|583936053|FG000|Overall Study|Death|0|||
161696423|NCT00993031|583936054|FG001|Overall Study|Death|1|||
161696424|NCT00993031|583936053|FG000|Overall Study|Physician Decision|0|||
161696425|NCT00993031|583936054|FG001|Overall Study|Physician Decision|2|||
161696426|NCT00993031|583936053|FG000|Overall Study|Withdrawal by Subject|3|||
161696427|NCT00993031|583936054|FG001|Overall Study|Withdrawal by Subject|3|||
161696428|NCT00993031|583936053|FG000|Overall Study|Lost to Follow-up|19|||
161696429|NCT00993031|583936054|FG001|Overall Study|Lost to Follow-up|13|||
161696430|NCT03115151|583936055|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
161696431|NCT03115151|583936056|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
161696432|NCT03115151|583936055|FG000|Overall Study|Epidural catheter removal|1|||
161696433|NCT03115151|583936056|FG001|Overall Study|Epidural catheter removal|0|||
161696434|NCT03115151|583936055|FG000|Overall Study|Withdrawal by Subject|0|||
161696435|NCT03115151|583936056|FG001|Overall Study|Withdrawal by Subject|1|||
161696436|NCT03115151|583936055|FG000|Overall Study|Intervention not received according to the protocol.|1|||
161696437|NCT03115151|583936056|FG001|Overall Study|Intervention not received according to the protocol.|1|||
161696438|NCT03115151|583936055|FG000|Overall Study|Physician Decision|1|||
161696439|NCT03115151|583936056|FG001|Overall Study|Physician Decision|0|||
161696440|NCT03115151|583936055|FG000|Overall Study|Randomization not applied|1|||
161696441|NCT03115151|583936056|FG001|Overall Study|Randomization not applied|1|||
161696442|NCT01834729|583936062|FG000|Overall Study|Did not return bowel diaries|0|||
161696443|NCT01834729|583936063|FG001|Overall Study|Did not return bowel diaries|0|||
161696444|NCT01834729|583936064|FG002|Overall Study|Did not return bowel diaries|3|||
161696445|NCT01834729|583936065|FG003|Overall Study|Did not return bowel diaries|0|||
161696446|NCT01834729|583936062|FG000|Overall Study|Withdrawal by Subject|1|||
161696447|NCT01834729|583936063|FG001|Overall Study|Withdrawal by Subject|1|||
161696448|NCT01834729|583936064|FG002|Overall Study|Withdrawal by Subject|0|||
161696449|NCT01834729|583936065|FG003|Overall Study|Withdrawal by Subject|0|||
161696450|NCT01834729|583936062|FG000|Overall Study|Adverse Event|0|||
161696451|NCT01834729|583936063|FG001|Overall Study|Adverse Event|0|||
161696452|NCT01834729|583936064|FG002|Overall Study|Adverse Event|0|||
161696453|NCT01834729|583936065|FG003|Overall Study|Adverse Event|2|||
161696454|NCT01543087|583936066|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
161696455|NCT01543087|583936067|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
161696456|NCT01543087|583936068|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
161696457|NCT01543087|583936069|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
161696458|NCT01543087|583936070|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
161696459|NCT01543087|583936071|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
161696460|NCT01543087|583936066|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
161696461|NCT01543087|583936067|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
161696462|NCT01543087|583936068|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
161696463|NCT01543087|583936069|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
161696464|NCT01543087|583936070|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
161696465|NCT01543087|583936071|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
161696466|NCT01543087|583936066|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
161696467|NCT01543087|583936067|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
161696468|NCT01543087|583936068|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
161696469|NCT01543087|583936069|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
161696470|NCT01543087|583936070|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
161696471|NCT01543087|583936071|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
161696472|NCT01543087|583936066|FG000|Stage 1 (48 Months)|Other than specified|5|||
161696473|NCT01543087|583936067|FG001|Stage 1 (48 Months)|Other than specified|0|||
161696474|NCT01543087|583936068|FG002|Stage 1 (48 Months)|Other than specified|9|||
161696475|NCT01543087|583936069|FG003|Stage 1 (48 Months)|Other than specified|0|||
161696476|NCT01543087|583936070|FG004|Stage 1 (48 Months)|Other than specified|0|||
161696477|NCT01543087|583936071|FG005|Stage 1 (48 Months)|Other than specified|0|||
161696478|NCT01543087|583936066|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
161696479|NCT01543087|583936067|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
161696480|NCT01543087|583936068|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
161696481|NCT01543087|583936069|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
161696482|NCT01543087|583936070|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
161696483|NCT01543087|583936071|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
161696484|NCT01543087|583936066|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
161696485|NCT01543087|583936067|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
161696486|NCT01543087|583936068|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
161696487|NCT01543087|583936069|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
161696488|NCT01543087|583936070|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
161696489|NCT01543087|583936071|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
161696490|NCT01543087|583936066|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
161696491|NCT01543087|583936067|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
161696492|NCT01543087|583936068|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
161696493|NCT01543087|583936069|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
161696494|NCT01543087|583936070|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
161696495|NCT01543087|583936071|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
161696496|NCT02682901|583936072|FG000|Overall Study|Adverse Event|10|||
161696497|NCT02682901|583936073|FG001|Overall Study|Adverse Event|3|||
161696498|NCT02682901|583936072|FG000|Overall Study|Lack of Efficacy|0|||
161696499|NCT02682901|583936073|FG001|Overall Study|Lack of Efficacy|1|||
161696500|NCT03713944|583936074|FG000|Study Treatment|Patient non-compliance|1|||
161696501|NCT03713944|583936074|FG000|Study Treatment|Alternative Cancer Therapy|3|||
161696502|NCT03713944|583936074|FG000|Study Treatment|Disease Progression|18|||
161696503|NCT03713944|583936074|FG000|Study Treatment|AE/Side Effects/Complications|2|||
161696504|NCT03713944|583936074|FG000|Study Treatment|Death|2|||
161696505|NCT03713944|583936074|FG000|Study Treatment|Withdrawal by Subject|1|||
161696506|NCT03713944|583936074|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
161696507|NCT03713944|583936074|FG000|Study Treatment|Symptomatic Deterioration|2|||
161696508|NCT03713944|583936074|FG000|Follow up|Withdrawal by Subject|2|||
161696509|NCT03713944|583936074|FG000|Follow up|Death|11|||
161696510|NCT03713944|583936074|FG000|Follow up|Study Terminated|3|||
161696511|NCT04484285|583937808|FG000|Overall Study|Unable to operate stimulator|3|||
161956717|NCT01926444|584889766|FG000|Overall Study|Colonoscopy not performed|0|||
161696512|NCT04484285|583937809|FG001|Overall Study|Unable to operate stimulator|0|||
161696513|NCT01072344|583937810|FG000|Overall Study|Relasped-reached end point|7|||
161696514|NCT01072344|583937811|FG001|Overall Study|Relasped-reached end point|12|||
161696515|NCT01072344|583937810|FG000|Overall Study|Protocol Violation|1|||
161696516|NCT01072344|583937811|FG001|Overall Study|Protocol Violation|2|||
161696517|NCT01072344|583937810|FG000|Overall Study|Lost to Follow-up|3|||
161696518|NCT01072344|583937811|FG001|Overall Study|Lost to Follow-up|4|||
161696519|NCT00804687|583937812|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
161836568|NCT02588950|584444948|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
161696520|NCT00804687|583937813|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
161696521|NCT00804687|583937814|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
161696522|NCT00804687|583937815|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
161696523|NCT00804687|583937816|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
161696524|NCT00804687|583937817|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
161696525|NCT00804687|583937812|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
161696526|NCT00804687|583937813|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
161696527|NCT00804687|583937814|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
161696528|NCT00804687|583937815|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
161696529|NCT00804687|583937816|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
161696530|NCT00804687|583937817|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
161696531|NCT00804687|583937812|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
161696532|NCT00804687|583937813|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
161696533|NCT00804687|583937814|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
161696534|NCT00804687|583937815|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
161696535|NCT00804687|583937816|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
161696536|NCT00804687|583937817|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
161696537|NCT00804687|583937812|FG000|Period 5: Treatment Period|Positive drug test|1|||
161696538|NCT00804687|583937813|FG001|Period 5: Treatment Period|Positive drug test|0|||
161696539|NCT00804687|583937814|FG002|Period 5: Treatment Period|Positive drug test|0|||
161696540|NCT00804687|583937815|FG003|Period 5: Treatment Period|Positive drug test|0|||
161696541|NCT00804687|583937816|FG004|Period 5: Treatment Period|Positive drug test|0|||
161696542|NCT00804687|583937817|FG005|Period 5: Treatment Period|Positive drug test|0|||
161696543|NCT00716976|583937820|FG000|Overall Study|Adverse Event|2|||
161696544|NCT00716976|583937821|FG001|Overall Study|Adverse Event|0|||
161696545|NCT00716976|583937820|FG000|Overall Study|Death|1|||
161696546|NCT00716976|583937821|FG001|Overall Study|Death|0|||
161696547|NCT00716976|583937820|FG000|Overall Study|Physician Decision|2|||
161696548|NCT00716976|583937821|FG001|Overall Study|Physician Decision|2|||
161696549|NCT00716976|583937820|FG000|Overall Study|Withdrawal by Subject|5|||
161696550|NCT00716976|583937821|FG001|Overall Study|Withdrawal by Subject|1|||
161696551|NCT00716976|583937820|FG000|Overall Study|Premature discontinuation cisplatin|5|||
161696552|NCT00716976|583937821|FG001|Overall Study|Premature discontinuation cisplatin|4|||
161696553|NCT00716976|583937820|FG000|Overall Study|Radiation during protocol|1|||
161696554|NCT00716976|583937821|FG001|Overall Study|Radiation during protocol|0|||
161696555|NCT00716976|583937820|FG000|Overall Study|Ineligibles|4|||
161696556|NCT00716976|583937821|FG001|Overall Study|Ineligibles|2|||
161696557|NCT00805740|583937823|FG000|Overall Study|Death|7|||
161696558|NCT00805740|583937824|FG001|Overall Study|Death|4|||
161696559|NCT00805740|583937823|FG000|Overall Study|Withdrawal by Subject|1|||
161696560|NCT00805740|583937824|FG001|Overall Study|Withdrawal by Subject|0|||
161696561|NCT00805740|583937823|FG000|Overall Study|Lost to Follow-up|1|||
161696562|NCT00805740|583937824|FG001|Overall Study|Lost to Follow-up|0|||
161696563|NCT00805740|583937823|FG000|Overall Study|Randomized, but not treated|2|||
161696564|NCT00805740|583937824|FG001|Overall Study|Randomized, but not treated|0|||
161696565|NCT05227690|583937832|FG000|Overall Study|Adverse Event|5|||
161696566|NCT05227690|583937833|FG001|Overall Study|Adverse Event|6|||
161696567|NCT05227690|583937834|FG002|Overall Study|Adverse Event|10|||
161696568|NCT05227690|583937832|FG000|Overall Study|Lack of Efficacy|2|||
161696569|NCT05227690|583937833|FG001|Overall Study|Lack of Efficacy|4|||
161696570|NCT05227690|583937834|FG002|Overall Study|Lack of Efficacy|1|||
161956718|NCT01926444|584889767|FG001|Overall Study|Colonoscopy not performed|0|||
161956719|NCT01926444|584889768|FG002|Overall Study|Colonoscopy not performed|4|||
161956720|NCT01926444|584889769|FG003|Overall Study|Colonoscopy not performed|2|||
161956721|NCT02243371|584889779|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
161956722|NCT02243371|584889780|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
161956723|NCT02243371|584889779|FG000|Overall Study|Death (unrelated)|2|||
161956724|NCT02243371|584889780|FG001|Overall Study|Death (unrelated)|4|||
161956725|NCT02243371|584889779|FG000|Overall Study|Adverse Event (unrelated)|0|||
161696571|NCT05227690|583937832|FG000|Overall Study|Physician Decision|6|||
161696572|NCT05227690|583937833|FG001|Overall Study|Physician Decision|0|||
161696573|NCT05227690|583937834|FG002|Overall Study|Physician Decision|4|||
161696574|NCT05227690|583937832|FG000|Overall Study|Withdrawal of consent|28|||
161696575|NCT05227690|583937833|FG001|Overall Study|Withdrawal of consent|27|||
161696576|NCT05227690|583937834|FG002|Overall Study|Withdrawal of consent|21|||
161696577|NCT05227690|583937832|FG000|Overall Study|Other, not specified|2|||
161696578|NCT05227690|583937833|FG001|Overall Study|Other, not specified|2|||
161696579|NCT05227690|583937834|FG002|Overall Study|Other, not specified|1|||
161696580|NCT00975156|583937835|FG000|Overall Study|Protocol Violation|0|||
161956726|NCT02243371|584889780|FG001|Overall Study|Adverse Event (unrelated)|1|||
161696581|NCT00975156|583937836|FG001|Overall Study|Protocol Violation|1|||
161696582|NCT01534676|583937842|FG000|Overall Study|Study closed due to poor enrollment|2|||
161696583|NCT01534676|583937843|FG001|Overall Study|Study closed due to poor enrollment|1|||
161696584|NCT02634580|583937844|FG000|Double-blind Treatment Period|Subject Request|1|||
161696585|NCT02634580|583937845|FG001|Double-blind Treatment Period|Subject Request|0|||
161696586|NCT02634580|583937846|FG002|Double-blind Treatment Period|Subject Request|1|||
161696587|NCT02634580|583937847|FG003|Double-blind Treatment Period|Subject Request|1|||
161696588|NCT02634580|583937844|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
161696589|NCT02634580|583937845|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
161696590|NCT02634580|583937846|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
161696591|NCT02634580|583937847|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
161696592|NCT02908880|583937849|FG000|Overall Study|Lost to Follow-up|4|||
161696593|NCT02908880|583937849|FG000|Overall Study|Explantation of the device|1|||
161696594|NCT02908880|583937849|FG000|Overall Study|Withdrawal by Subject|17|||
161696595|NCT02908880|583937849|FG000|Overall Study|Death|5|||
161696596|NCT00424827|583937854|FG000|Overall Study|Adverse Event|1|||
161696597|NCT05689047|583937857|FG000|Overall Study|Lost to Follow-up|0|||
161696598|NCT05689047|583937858|FG001|Overall Study|Lost to Follow-up|1|||
161696599|NCT05689047|583937857|FG000|Overall Study|Protocol Deviation|1|||
161696600|NCT05689047|583937858|FG001|Overall Study|Protocol Deviation|0|||
161696601|NCT03132636|583937859|FG000|Overall Study|Adverse Event|1|||
161696602|NCT03132636|583937860|FG001|Overall Study|Adverse Event|2|||
161696603|NCT03132636|583937859|FG000|Overall Study|Death|4|||
161696604|NCT03132636|583937860|FG001|Overall Study|Death|7|||
161696605|NCT03132636|583937859|FG000|Overall Study|Lost to Follow-up|3|||
161696606|NCT03132636|583937860|FG001|Overall Study|Lost to Follow-up|2|||
161696607|NCT03132636|583937859|FG000|Overall Study|Non compliance with protocol by participant|1|||
161696608|NCT03132636|583937860|FG001|Overall Study|Non compliance with protocol by participant|1|||
161696609|NCT03132636|583937859|FG000|Overall Study|Subject decision|1|||
161696610|NCT03132636|583937860|FG001|Overall Study|Subject decision|9|||
161696611|NCT03132636|583937859|FG000|Overall Study|Sponsor decision|0|||
161696612|NCT03132636|583937860|FG001|Overall Study|Sponsor decision|1|||
161696613|NCT03132636|583937859|FG000|Overall Study|Physician Decision|1|||
161696614|NCT03132636|583937860|FG001|Overall Study|Physician Decision|0|||
161696615|NCT03132636|583937859|FG000|Overall Study|Progressive disease|33|||
161696616|NCT03132636|583937860|FG001|Overall Study|Progressive disease|36|||
161696617|NCT03132636|583937859|FG000|Overall Study|Withdrawal of consent|2|||
161696618|NCT03132636|583937860|FG001|Overall Study|Withdrawal of consent|5|||
161696619|NCT03132636|583937859|FG000|Overall Study|Did not re-consent|1|||
161696620|NCT03132636|583937860|FG001|Overall Study|Did not re-consent|0|||
161696621|NCT03132636|583937859|FG000|Overall Study|Lost insurance coverage|1|||
161696622|NCT03132636|583937860|FG001|Overall Study|Lost insurance coverage|0|||
161696623|NCT03132636|583937859|FG000|Overall Study|Related to radiological outcomes|0|||
161696624|NCT03132636|583937860|FG001|Overall Study|Related to radiological outcomes|1|||
161696625|NCT03132636|583937859|FG000|Overall Study|Unable to come to site for continued visits|0|||
161696626|NCT03132636|583937860|FG001|Overall Study|Unable to come to site for continued visits|1|||
161696627|NCT03286842|583937861|FG000|Overall Study|Patients rolled over to another study|80|||
161696628|NCT01285908|583937867|FG000|Baseline Measurement|unable to insert catheter|1|||
161696629|NCT01285908|583937868|FG001|Baseline Measurement|unable to insert catheter|0|||
161696630|NCT01285908|583937869|FG002|Baseline Measurement|unable to insert catheter|0|||
161696631|NCT01285908|583937867|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
161696632|NCT01285908|583937868|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
161696633|NCT01285908|583937869|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
161696634|NCT01285908|583937867|FG000|Baseline Measurement|unable to tolerate procedure|1|||
161696635|NCT01285908|583937868|FG001|Baseline Measurement|unable to tolerate procedure|0|||
161696636|NCT01285908|583937869|FG002|Baseline Measurement|unable to tolerate procedure|0|||
161696637|NCT01562548|583937870|FG000|Overall Study|Lost to Follow-up|0|||
161836569|NCT00652028|584444951|FG000|Overall Study|Adverse Event|1|||
161956727|NCT02243371|584889779|FG000|Overall Study|Lack of Clinical Benefit|0|||
161956728|NCT02243371|584889780|FG001|Overall Study|Lack of Clinical Benefit|1|||
161956729|NCT02243371|584889779|FG000|Overall Study|Withdrawal by Subject|0|||
161956730|NCT02243371|584889780|FG001|Overall Study|Withdrawal by Subject|2|||
161956731|NCT00271856|584889783|FG000|Overall Study|Withdrawal by Subject|1|||
161956732|NCT00271856|584889784|FG001|Overall Study|Withdrawal by Subject|7|||
161956733|NCT00271856|584889783|FG000|Overall Study|Lost to Follow-up|10|||
161956734|NCT00271856|584889784|FG001|Overall Study|Lost to Follow-up|11|||
161956735|NCT04599803|584889785|FG000|Overall Study|Withdrawal by Subject|5|||
161956736|NCT04599803|584889785|FG000|Overall Study|Lost to Follow-up|26|||
161956737|NCT02544750|584889786|FG000|Overall Study|Physician Decision|3|||
161696638|NCT01562548|583937871|FG001|Overall Study|Lost to Follow-up|0|||
161956738|NCT02544750|584889787|FG001|Overall Study|Physician Decision|1|||
161956739|NCT02544750|584889786|FG000|Overall Study|Other reasons|69|||
161956740|NCT02544750|584889787|FG001|Overall Study|Other reasons|39|||
161956741|NCT02544750|584889786|FG000|Overall Study|Met withdrawal criteria|2|||
161696639|NCT01562548|583937872|FG002|Overall Study|Lost to Follow-up|1|||
161696640|NCT01562548|583937873|FG003|Overall Study|Lost to Follow-up|0|||
161696641|NCT03655756|583937874|FG000|Overall Study|Death|1|||
161696642|NCT02161211|583937877|FG000|Overall Study|Lost to Follow-up|21|||
161696643|NCT02161211|583937878|FG001|Overall Study|Lost to Follow-up|27|||
161696644|NCT02161211|583937879|FG002|Overall Study|Lost to Follow-up|21|||
161836570|NCT00652028|584444952|FG001|Overall Study|Adverse Event|0|||
161696645|NCT02161211|583937877|FG000|Overall Study|Dropped|12|||
161696646|NCT02161211|583937878|FG001|Overall Study|Dropped|5|||
161696647|NCT02161211|583937879|FG002|Overall Study|Dropped|9|||
161696648|NCT01703858|583937880|FG000|Overall Study|Withdrawal by Subject|0|||
161696649|NCT01703858|583937881|FG001|Overall Study|Withdrawal by Subject|1|||
161696650|NCT01703858|583937882|FG002|Overall Study|Withdrawal by Subject|0|||
161696651|NCT03403192|583937883|FG000|Overall Study|Lost to Follow-up|1|||
161696652|NCT03403192|583937884|FG001|Overall Study|Lost to Follow-up|2|||
161696653|NCT03403192|583937885|FG002|Overall Study|Lost to Follow-up|0|||
161696654|NCT03403192|583937886|FG003|Overall Study|Lost to Follow-up|0|||
161696655|NCT03403192|583937883|FG000|Overall Study|Unable to respond|0|||
161696656|NCT03403192|583937884|FG001|Overall Study|Unable to respond|1|||
161696657|NCT03403192|583937885|FG002|Overall Study|Unable to respond|0|||
161696658|NCT03403192|583937886|FG003|Overall Study|Unable to respond|0|||
161696659|NCT03403192|583937883|FG000|Overall Study|Incomplete|3|||
161696660|NCT03403192|583937884|FG001|Overall Study|Incomplete|1|||
161696661|NCT03403192|583937885|FG002|Overall Study|Incomplete|3|||
161696662|NCT03403192|583937886|FG003|Overall Study|Incomplete|6|||
161696663|NCT04673786|583937889|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
161696664|NCT04673786|583937890|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
161696665|NCT04673786|583937891|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
161696666|NCT04673786|583937889|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
161696667|NCT04673786|583937890|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
161696668|NCT04673786|583937891|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
161696669|NCT04673786|583937889|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
161696670|NCT04673786|583937890|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
161696671|NCT04673786|583937891|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
161696672|NCT04673786|583937889|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
161696673|NCT04673786|583937890|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
161696674|NCT04673786|583937891|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
161696675|NCT04673786|583937889|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
161696676|NCT04673786|583937890|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
161696677|NCT04673786|583937891|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
161696678|NCT04673786|583937889|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
161696679|NCT04673786|583937890|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
161696680|NCT04673786|583937891|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
161696681|NCT01325428|583937892|FG000|Part A|Progressive disease according to RECIST|9|||
161696682|NCT01325428|583937892|FG000|Part A|Clinical signs, symptoms of progression|2|||
161696683|NCT01325428|583937892|FG000|Part A|Other adverse event|1|||
161696684|NCT01325428|583937892|FG000|Part A|Refused continue taking trial medication|2|||
161696685|NCT01325428|583937892|FG000|Part A|Other reason not defined above|2|||
161696686|NCT01325428|583937892|FG000|Part B|Refused continue taking trial medication|2|||
161696687|NCT01325428|583937892|FG000|Part B|Other reason not defined above|1|||
161696688|NCT04849780|583937893|FG000|Period 1|Covid-19 Related|1|||
161696689|NCT04849780|583937894|FG001|Period 1|Covid-19 Related|0|||
161696690|NCT04849780|583937893|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
161696691|NCT04849780|583937894|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
161696692|NCT04849780|583937893|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
161696693|NCT04849780|583937894|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
161696694|NCT00725075|583937895|FG000|Overall Study|Use of Excluded Medication|0|||
161696695|NCT00725075|583937896|FG001|Overall Study|Use of Excluded Medication|1|||
161696696|NCT00725075|583937897|FG002|Overall Study|Use of Excluded Medication|0|||
161696697|NCT00725075|583937895|FG000|Overall Study|Protocol Violation|0|||
161696698|NCT00725075|583937896|FG001|Overall Study|Protocol Violation|0|||
161696699|NCT00725075|583937897|FG002|Overall Study|Protocol Violation|1|||
161696700|NCT00725075|583937895|FG000|Overall Study|Lost to Follow-up|1|||
161696701|NCT00725075|583937896|FG001|Overall Study|Lost to Follow-up|0|||
161696702|NCT00725075|583937897|FG002|Overall Study|Lost to Follow-up|0|||
161696703|NCT00725075|583937895|FG000|Overall Study|Withdrawal by Subject|4|||
161696704|NCT00725075|583937896|FG001|Overall Study|Withdrawal by Subject|5|||
161696705|NCT00725075|583937897|FG002|Overall Study|Withdrawal by Subject|4|||
161696706|NCT00725075|583937895|FG000|Overall Study|Adverse Event|2|||
161696707|NCT00725075|583937896|FG001|Overall Study|Adverse Event|1|||
161696708|NCT00725075|583937897|FG002|Overall Study|Adverse Event|1|||
161696709|NCT00725075|583937895|FG000|Overall Study|Worsening of Disease|2|||
161696710|NCT00725075|583937896|FG001|Overall Study|Worsening of Disease|1|||
161696711|NCT00725075|583937897|FG002|Overall Study|Worsening of Disease|2|||
161696712|NCT00725075|583937895|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
161696713|NCT00725075|583937896|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
161696714|NCT00725075|583937897|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
161696715|NCT00725075|583937895|FG000|Overall Study|Other|1|||
161696716|NCT00725075|583937896|FG001|Overall Study|Other|0|||
161696717|NCT00725075|583937897|FG002|Overall Study|Other|0|||
161696718|NCT01298492|583937898|FG000|Overall Study|Death|2|||
161696719|NCT01298492|583937898|FG000|Overall Study|Insufficient Clinical Response|22|||
161696720|NCT01298492|583937898|FG000|Overall Study|Lost to Follow-up|12|||
161696721|NCT01298492|583937898|FG000|Overall Study|Withdrawal by Subject|47|||
161696722|NCT01298492|583937898|FG000|Overall Study|Other (Unspecified)|7|||
161696723|NCT01298492|583937898|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
161696724|NCT01298492|583937898|FG000|Overall Study|Protocol Violation|2|||
161696725|NCT01298492|583937898|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
161696726|NCT01298492|583937898|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
161696727|NCT02340663|583937899|FG000|Overall Study|Lost to Follow-up|1|||
161696728|NCT02340663|583937900|FG001|Overall Study|Lost to Follow-up|0|||
161696729|NCT02340663|583937899|FG000|Overall Study|Protocol Violation|1|||
161696730|NCT02340663|583937900|FG001|Overall Study|Protocol Violation|0|||
161696731|NCT02340663|583937899|FG000|Overall Study|Withdrawal by Subject|3|||
161696732|NCT02340663|583937900|FG001|Overall Study|Withdrawal by Subject|1|||
161696733|NCT02902120|583937902|FG000|Overall Study|Lack of Efficacy|1|||
161696734|NCT01353703|583937903|FG000|Overall Study|Migrated/moved from study area|1|||
161696735|NCT01353703|583937904|FG001|Overall Study|Migrated/moved from study area|0|||
161696736|NCT03298022|583937905|FG000|Overall Study|Lack of Efficacy|4|||
161696737|NCT03298022|583937905|FG000|Overall Study|Withdrawal by Subject|7|||
161696738|NCT03298022|583937905|FG000|Overall Study|Adverse Event|1|||
161696739|NCT03298022|583937905|FG000|Overall Study|disease relapse|1|||
161696740|NCT03694925|583937906|FG000|Overall Study|Inadequate laboratory testing|0|||
161696741|NCT03694925|583937907|FG001|Overall Study|Inadequate laboratory testing|3|||
161696742|NCT03694925|583937908|FG002|Overall Study|Inadequate laboratory testing|0|||
161696743|NCT01422239|583937909|FG000|Overall Study|Lost to Follow-up|4|||
161696744|NCT01422239|583937910|FG001|Overall Study|Lost to Follow-up|3|||
161696745|NCT03033875|583937914|FG000|Overall Study|Withdrawal by Subject|5|||
161696746|NCT03033875|583937915|FG001|Overall Study|Withdrawal by Subject|9|||
161696747|NCT03033875|583937916|FG002|Overall Study|Withdrawal by Subject|4|||
161696748|NCT03033875|583937914|FG000|Overall Study|Other|14|||
161696749|NCT03033875|583937915|FG001|Overall Study|Other|15|||
161696750|NCT03033875|583937916|FG002|Overall Study|Other|8|||
161696751|NCT03595553|583937920|FG000|Overall Study|Withdrawal by Subject|20|||
161696752|NCT03595553|583937921|FG001|Overall Study|Withdrawal by Subject|8|||
161696753|NCT03595553|583937920|FG000|Overall Study|Physician Decision|3|||
161696754|NCT03595553|583937921|FG001|Overall Study|Physician Decision|2|||
161696755|NCT03595553|583937920|FG000|Overall Study|Adverse Event|2|||
161696756|NCT03595553|583937921|FG001|Overall Study|Adverse Event|5|||
161696757|NCT03595553|583937920|FG000|Overall Study|Death|24|||
161696758|NCT03595553|583937921|FG001|Overall Study|Death|22|||
161696759|NCT03595553|583937920|FG000|Overall Study|Lost to Follow-up|6|||
161696760|NCT03595553|583937921|FG001|Overall Study|Lost to Follow-up|7|||
161696761|NCT03595553|583937920|FG000|Overall Study|Other as indicated in CSR|3|||
161696762|NCT03595553|583937921|FG001|Overall Study|Other as indicated in CSR|3|||
161696763|NCT03595553|583937920|FG000|Overall Study|Sponsor Decision|0|||
161696764|NCT03595553|583937921|FG001|Overall Study|Sponsor Decision|1|||
161696765|NCT03467958|583937922|FG000|Overall Study|Adverse Event|20|||
161696766|NCT03467958|583937923|FG001|Overall Study|Adverse Event|32|||
161696767|NCT03467958|583937924|FG002|Overall Study|Adverse Event|5|||
161696768|NCT03467958|583937925|FG003|Overall Study|Adverse Event|3|||
161696769|NCT03467958|583937926|FG004|Overall Study|Adverse Event|3|||
161696770|NCT03467958|583937927|FG005|Overall Study|Adverse Event|3|||
161696771|NCT03467958|583937928|FG006|Overall Study|Adverse Event|6|||
161696772|NCT03467958|583937929|FG007|Overall Study|Adverse Event|5|||
161696773|NCT03467958|583937930|FG008|Overall Study|Adverse Event|0|||
161696774|NCT03467958|583937922|FG000|Overall Study|Lack of Efficacy|59|||
161696775|NCT03467958|583937923|FG001|Overall Study|Lack of Efficacy|120|||
161696776|NCT03467958|583937924|FG002|Overall Study|Lack of Efficacy|6|||
161696777|NCT03467958|583937925|FG003|Overall Study|Lack of Efficacy|9|||
161696778|NCT03467958|583937926|FG004|Overall Study|Lack of Efficacy|8|||
161696779|NCT03467958|583937927|FG005|Overall Study|Lack of Efficacy|9|||
161696780|NCT03467958|583937928|FG006|Overall Study|Lack of Efficacy|11|||
161696781|NCT03467958|583937929|FG007|Overall Study|Lack of Efficacy|9|||
161696782|NCT03467958|583937930|FG008|Overall Study|Lack of Efficacy|3|||
161696783|NCT03467958|583937922|FG000|Overall Study|Lost to Follow-up|1|||
161696784|NCT03467958|583937923|FG001|Overall Study|Lost to Follow-up|2|||
161836571|NCT00652028|584444953|FG002|Overall Study|Adverse Event|0|||
161956742|NCT02544750|584889787|FG001|Overall Study|Met withdrawal criteria|2|||
161696785|NCT03467958|583937924|FG002|Overall Study|Lost to Follow-up|1|||
161696786|NCT03467958|583937925|FG003|Overall Study|Lost to Follow-up|0|||
161696787|NCT03467958|583937926|FG004|Overall Study|Lost to Follow-up|4|||
161696788|NCT03467958|583937927|FG005|Overall Study|Lost to Follow-up|0|||
161696789|NCT03467958|583937928|FG006|Overall Study|Lost to Follow-up|0|||
161696790|NCT03467958|583937929|FG007|Overall Study|Lost to Follow-up|0|||
161696791|NCT03467958|583937930|FG008|Overall Study|Lost to Follow-up|0|||
161696792|NCT03467958|583937922|FG000|Overall Study|Other reasons|8|||
161696793|NCT03467958|583937923|FG001|Overall Study|Other reasons|14|||
161696794|NCT03467958|583937924|FG002|Overall Study|Other reasons|2|||
161696795|NCT03467958|583937925|FG003|Overall Study|Other reasons|1|||
161696796|NCT03467958|583937926|FG004|Overall Study|Other reasons|4|||
161696797|NCT03467958|583937927|FG005|Overall Study|Other reasons|0|||
161696798|NCT03467958|583937928|FG006|Overall Study|Other reasons|1|||
161696799|NCT03467958|583937929|FG007|Overall Study|Other reasons|0|||
161696800|NCT03467958|583937930|FG008|Overall Study|Other reasons|1|||
161696801|NCT03467958|583937922|FG000|Overall Study|Pregnancy|1|||
161696802|NCT03467958|583937923|FG001|Overall Study|Pregnancy|0|||
161696803|NCT03467958|583937924|FG002|Overall Study|Pregnancy|0|||
161696804|NCT03467958|583937925|FG003|Overall Study|Pregnancy|0|||
161696805|NCT03467958|583937926|FG004|Overall Study|Pregnancy|0|||
161696806|NCT03467958|583937927|FG005|Overall Study|Pregnancy|1|||
161696807|NCT03467958|583937928|FG006|Overall Study|Pregnancy|0|||
161696808|NCT03467958|583937929|FG007|Overall Study|Pregnancy|0|||
161696809|NCT03467958|583937930|FG008|Overall Study|Pregnancy|0|||
161696810|NCT03467958|583937922|FG000|Overall Study|Study terminated by sponsor|65|||
161696811|NCT03467958|583937923|FG001|Overall Study|Study terminated by sponsor|117|||
161696812|NCT03467958|583937924|FG002|Overall Study|Study terminated by sponsor|45|||
161696813|NCT03467958|583937925|FG003|Overall Study|Study terminated by sponsor|64|||
161696814|NCT03467958|583937926|FG004|Overall Study|Study terminated by sponsor|66|||
161696815|NCT03467958|583937927|FG005|Overall Study|Study terminated by sponsor|17|||
161696816|NCT03467958|583937928|FG006|Overall Study|Study terminated by sponsor|11|||
161696817|NCT03467958|583937929|FG007|Overall Study|Study terminated by sponsor|5|||
161696818|NCT03467958|583937930|FG008|Overall Study|Study terminated by sponsor|5|||
161696819|NCT03467958|583937922|FG000|Overall Study|Withdrawal by Subject|25|||
161696820|NCT03467958|583937923|FG001|Overall Study|Withdrawal by Subject|44|||
161696821|NCT03467958|583937924|FG002|Overall Study|Withdrawal by Subject|7|||
161696822|NCT03467958|583937925|FG003|Overall Study|Withdrawal by Subject|8|||
161696823|NCT03467958|583937926|FG004|Overall Study|Withdrawal by Subject|6|||
161696824|NCT03467958|583937927|FG005|Overall Study|Withdrawal by Subject|8|||
161696825|NCT03467958|583937928|FG006|Overall Study|Withdrawal by Subject|4|||
161696826|NCT03467958|583937929|FG007|Overall Study|Withdrawal by Subject|1|||
161696827|NCT03467958|583937930|FG008|Overall Study|Withdrawal by Subject|4|||
161696828|NCT02286947|583937931|FG000|Overall Study|Withdrawal by Subject|2|||
161696829|NCT00730639|583937932|FG000|Overall Study|Adverse Event|3|||
161696830|NCT00730639|583937933|FG001|Overall Study|Adverse Event|0|||
161696831|NCT00730639|583937934|FG002|Overall Study|Adverse Event|9|||
161696832|NCT00730639|583937935|FG003|Overall Study|Adverse Event|8|||
161696833|NCT00730639|583937936|FG004|Overall Study|Adverse Event|23|||
161696834|NCT00730639|583937932|FG000|Overall Study|Complete Response|0|||
161696835|NCT00730639|583937933|FG001|Overall Study|Complete Response|0|||
161696836|NCT00730639|583937934|FG002|Overall Study|Complete Response|2|||
161696837|NCT00730639|583937935|FG003|Overall Study|Complete Response|2|||
161696838|NCT00730639|583937936|FG004|Overall Study|Complete Response|1|||
161696839|NCT00730639|583937932|FG000|Overall Study|Completed Maximum Cycles|0|||
161696840|NCT00730639|583937933|FG001|Overall Study|Completed Maximum Cycles|0|||
161696841|NCT00730639|583937934|FG002|Overall Study|Completed Maximum Cycles|11|||
161696842|NCT00730639|583937935|FG003|Overall Study|Completed Maximum Cycles|3|||
161696843|NCT00730639|583937936|FG004|Overall Study|Completed Maximum Cycles|6|||
161696844|NCT00730639|583937932|FG000|Overall Study|Death|0|||
161696845|NCT00730639|583937933|FG001|Overall Study|Death|0|||
161696846|NCT00730639|583937934|FG002|Overall Study|Death|0|||
161696847|NCT00730639|583937935|FG003|Overall Study|Death|0|||
161696848|NCT00730639|583937936|FG004|Overall Study|Death|2|||
161696849|NCT00730639|583937932|FG000|Overall Study|Disease Progression|12|||
161696850|NCT00730639|583937933|FG001|Overall Study|Disease Progression|13|||
161696851|NCT00730639|583937934|FG002|Overall Study|Disease Progression|48|||
161696852|NCT00730639|583937935|FG003|Overall Study|Disease Progression|32|||
161696853|NCT00730639|583937936|FG004|Overall Study|Disease Progression|88|||
161696854|NCT00730639|583937932|FG000|Overall Study|non-specified|0|||
161696855|NCT00730639|583937933|FG001|Overall Study|non-specified|0|||
161696856|NCT00730639|583937934|FG002|Overall Study|non-specified|4|||
161836572|NCT00652028|584444954|FG003|Overall Study|Adverse Event|0|||
161836573|NCT00652028|584444951|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
161836574|NCT00652028|584444952|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
161836575|NCT00652028|584444953|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
161836576|NCT00652028|584444954|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
161836577|NCT00652028|584444951|FG000|Overall Study|Physician Decision|0|||
161836578|NCT00652028|584444952|FG001|Overall Study|Physician Decision|0|||
161836579|NCT00652028|584444953|FG002|Overall Study|Physician Decision|1|||
161836580|NCT00652028|584444954|FG003|Overall Study|Physician Decision|0|||
161836581|NCT02072824|584444955|FG000|Overall Study|Insufficient clinical response|1|||
161836582|NCT02072824|584444956|FG001|Overall Study|Insufficient clinical response|0|||
161696857|NCT00730639|583937935|FG003|Overall Study|non-specified|2|||
161696858|NCT00730639|583937936|FG004|Overall Study|non-specified|3|||
161696859|NCT00730639|583937932|FG000|Overall Study|Protocol Violation|0|||
161696860|NCT00730639|583937933|FG001|Overall Study|Protocol Violation|0|||
161836583|NCT02072824|584444957|FG002|Overall Study|Insufficient clinical response|1|||
161696861|NCT00730639|583937934|FG002|Overall Study|Protocol Violation|1|||
161696862|NCT00730639|583937935|FG003|Overall Study|Protocol Violation|0|||
161696863|NCT00730639|583937936|FG004|Overall Study|Protocol Violation|0|||
161696864|NCT00730639|583937932|FG000|Overall Study|Withdrawal by Subject|0|||
161696865|NCT00730639|583937933|FG001|Overall Study|Withdrawal by Subject|0|||
161696866|NCT00730639|583937934|FG002|Overall Study|Withdrawal by Subject|6|||
161696867|NCT00730639|583937935|FG003|Overall Study|Withdrawal by Subject|3|||
161696868|NCT00730639|583937936|FG004|Overall Study|Withdrawal by Subject|4|||
161696869|NCT00730639|583937932|FG000|Overall Study|Treatment on-going|2|||
161696870|NCT00730639|583937933|FG001|Overall Study|Treatment on-going|5|||
161696871|NCT00730639|583937934|FG002|Overall Study|Treatment on-going|5|||
161696872|NCT00730639|583937935|FG003|Overall Study|Treatment on-going|4|||
161696873|NCT00730639|583937936|FG004|Overall Study|Treatment on-going|4|||
161836584|NCT02072824|584444955|FG000|Overall Study|No longer willing to participate|1|||
161696874|NCT00516737|583937942|FG000|Overall Study|Lost to Follow-up|2|||
161696875|NCT00516737|583937943|FG001|Overall Study|Lost to Follow-up|0|||
161696876|NCT00516737|583937942|FG000|Overall Study|Physician Decision|0|||
161696877|NCT00516737|583937943|FG001|Overall Study|Physician Decision|1|||
161696878|NCT00516737|583937942|FG000|Overall Study|Withdrawal by Subject|0|||
161696879|NCT00516737|583937943|FG001|Overall Study|Withdrawal by Subject|1|||
161696880|NCT00516737|583937942|FG000|Overall Study|Lack of Qualifying Event|9|||
161696881|NCT00516737|583937943|FG001|Overall Study|Lack of Qualifying Event|6|||
161696882|NCT00848354|583937944|FG000|Phase 1|Adverse Event|5|||
161696883|NCT00848354|583937945|FG001|Phase 1|Adverse Event|4|||
161696884|NCT00848354|583937944|FG000|Phase 1|Discontinuation of study by sponsor|2|||
161696885|NCT00848354|583937945|FG001|Phase 1|Discontinuation of study by sponsor|1|||
161696886|NCT00848354|583937944|FG000|Phase 1|Failed to return|0|||
161696887|NCT00848354|583937945|FG001|Phase 1|Failed to return|1|||
161696888|NCT00848354|583937944|FG000|Phase 1|Lost to Follow-up|1|||
161696889|NCT00848354|583937945|FG001|Phase 1|Lost to Follow-up|1|||
161696890|NCT00848354|583937944|FG000|Phase 1|Unspecified Reason|1|||
161696891|NCT00848354|583937945|FG001|Phase 1|Unspecified Reason|1|||
161696892|NCT00848354|583937944|FG000|Phase 1|Protocol Violation|1|||
161696893|NCT00848354|583937945|FG001|Phase 1|Protocol Violation|1|||
161696894|NCT00848354|583937944|FG000|Phase 1|Withdrawal by Subject|2|||
161696895|NCT00848354|583937945|FG001|Phase 1|Withdrawal by Subject|4|||
161696896|NCT00848354|583937944|FG000|Phase 1|Lack of Efficacy|0|||
161696897|NCT00848354|583937945|FG001|Phase 1|Lack of Efficacy|1|||
161696898|NCT00848354|583937944|FG000|Phase 2 Year 1|Adverse Event|7|||
161696899|NCT00848354|583937945|FG001|Phase 2 Year 1|Adverse Event|2|||
161696900|NCT00848354|583937944|FG000|Phase 2 Year 1|Death|1|||
161696901|NCT00848354|583937945|FG001|Phase 2 Year 1|Death|0|||
161696902|NCT00848354|583937944|FG000|Phase 2 Year 1|Failed to Return|1|||
161696903|NCT00848354|583937945|FG001|Phase 2 Year 1|Failed to Return|1|||
161696904|NCT00848354|583937944|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
161696905|NCT00848354|583937945|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
161696906|NCT00848354|583937944|FG000|Phase 2 Year 1|Unspecified Reason|3|||
161696907|NCT00848354|583937945|FG001|Phase 2 Year 1|Unspecified Reason|0|||
161696908|NCT00848354|583937944|FG000|Phase 2 Year 1|Protocol Violation|4|||
161696909|NCT00848354|583937945|FG001|Phase 2 Year 1|Protocol Violation|1|||
161696910|NCT00848354|583937944|FG000|Phase 2 Year 1|Subject Request|1|||
161696911|NCT00848354|583937945|FG001|Phase 2 Year 1|Subject Request|2|||
161696912|NCT00848354|583937944|FG000|Phase 2 Year 2|Adverse Event|12|||
161696913|NCT00848354|583937945|FG001|Phase 2 Year 2|Adverse Event|2|||
161696914|NCT00848354|583937944|FG000|Phase 2 Year 2|Death|2|||
161696915|NCT00848354|583937945|FG001|Phase 2 Year 2|Death|0|||
161696916|NCT00848354|583937944|FG000|Phase 2 Year 2|Failed to return|3|||
161696917|NCT00848354|583937945|FG001|Phase 2 Year 2|Failed to return|0|||
161696918|NCT00848354|583937944|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
161696919|NCT00848354|583937945|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
161696920|NCT00848354|583937944|FG000|Phase 2 Year 2|Unspecified Reason|1|||
161696921|NCT00848354|583937945|FG001|Phase 2 Year 2|Unspecified Reason|0|||
161696922|NCT00848354|583937944|FG000|Phase 2 Year 2|Protocol Violation|1|||
161696923|NCT00848354|583937945|FG001|Phase 2 Year 2|Protocol Violation|1|||
161696924|NCT00848354|583937944|FG000|Phase 2 Year 2|Subject Request|1|||
161696925|NCT00848354|583937945|FG001|Phase 2 Year 2|Subject Request|1|||
161696926|NCT00848354|583937944|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
161696927|NCT00848354|583937945|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
161696928|NCT00512798|583937946|FG000|Overall Study|Death|0|||
161696929|NCT00512798|583937947|FG001|Overall Study|Death|3|||
161696930|NCT00512798|583937946|FG000|Overall Study|Adverse Event|2|||
161696931|NCT00512798|583937947|FG001|Overall Study|Adverse Event|4|||
161696932|NCT00512798|583937946|FG000|Overall Study|Progression of disease|14|||
161696933|NCT00512798|583937947|FG001|Overall Study|Progression of disease|20|||
161696934|NCT00512798|583937946|FG000|Overall Study|Withdrawal by Subject|3|||
161696935|NCT00512798|583937947|FG001|Overall Study|Withdrawal by Subject|0|||
161696936|NCT00915343|583937948|FG000|Part B - Open Label Period|Treatment switch|0|||
161696937|NCT00915343|583937949|FG001|Part B - Open Label Period|Treatment switch|0|||
161696938|NCT00915343|583937950|FG002|Part B - Open Label Period|Treatment switch|1|||
161956743|NCT02544750|584889786|FG000|Overall Study|Transition To Commercial Product|1|||
161956744|NCT02544750|584889787|FG001|Overall Study|Transition To Commercial Product|0|||
161696939|NCT00915343|583937948|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
161696940|NCT00915343|583937949|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
161696941|NCT00915343|583937950|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
161696942|NCT03551743|583937951|FG000|Overall Study|Adverse Event|1|||
161696943|NCT03551743|583937952|FG001|Overall Study|Adverse Event|0|||
161696944|NCT03551743|583937953|FG002|Overall Study|Adverse Event|0|||
161696945|NCT03551743|583937954|FG003|Overall Study|Adverse Event|0|||
161696946|NCT03551743|583937951|FG000|Overall Study|Withdrawal by Subject|1|||
161696947|NCT03551743|583937952|FG001|Overall Study|Withdrawal by Subject|0|||
161696948|NCT03551743|583937953|FG002|Overall Study|Withdrawal by Subject|0|||
161696949|NCT03551743|583937954|FG003|Overall Study|Withdrawal by Subject|0|||
161696950|NCT02317562|583937955|FG000|Overall Study|Physician Decision|1|||
161696951|NCT02317562|583937955|FG000|Overall Study|early termination of the study|8|||
161696952|NCT02317562|583937955|FG000|Overall Study|Lack of Efficacy|4|||
161696953|NCT02317562|583937955|FG000|Overall Study|Withdrawal by Subject|1|||
161696954|NCT00911989|583937956|FG000|Overall Study|Adverse Event|1|||
161696955|NCT03434977|583937957|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
161696956|NCT03434977|583937958|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
161696957|NCT01314716|583937959|FG000|Double-Blind Phase|Randomized but not treated|1|||
161696958|NCT01314716|583937960|FG001|Double-Blind Phase|Randomized but not treated|1|||
161696959|NCT01314716|583937959|FG000|Double-Blind Phase|Adverse Event|10|||
161696960|NCT01314716|583937960|FG001|Double-Blind Phase|Adverse Event|4|||
161696961|NCT01314716|583937959|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
161696962|NCT01314716|583937960|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
161696963|NCT01314716|583937959|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161696964|NCT01314716|583937960|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161696965|NCT01314716|583937959|FG000|Double-Blind Phase|Sponsor request|1|||
161696966|NCT01314716|583937960|FG001|Double-Blind Phase|Sponsor request|2|||
161696967|NCT01314716|583937959|FG000|Double-Blind Phase|Physician Decision|0|||
161696968|NCT01314716|583937960|FG001|Double-Blind Phase|Physician Decision|1|||
161696969|NCT01314716|583937959|FG000|Open-Label Phase|Adverse Event|4|||
161696970|NCT01314716|583937960|FG001|Open-Label Phase|Adverse Event|6|||
161696971|NCT01314716|583937959|FG000|Open-Label Phase|Withdrawal by Subject|1|||
161696972|NCT01314716|583937960|FG001|Open-Label Phase|Withdrawal by Subject|2|||
161696973|NCT01314716|583937959|FG000|Open-Label Phase|Physician Decision|5|||
161696974|NCT01314716|583937960|FG001|Open-Label Phase|Physician Decision|4|||
161696975|NCT01928381|583937963|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
161696976|NCT01928381|583937964|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161696977|NCT01928381|583937965|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161696978|NCT01928381|583937966|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161696979|NCT01928381|583937967|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161696980|NCT01928381|583937968|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161696981|NCT01928381|583937969|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161696982|NCT01928381|583937963|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
161696983|NCT01928381|583937964|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
161696984|NCT01928381|583937965|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
161696985|NCT01928381|583937966|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
161696986|NCT01928381|583937967|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
161696987|NCT01928381|583937968|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
161696988|NCT01928381|583937969|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
161696989|NCT01928381|583937963|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
161696990|NCT01928381|583937964|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
161696991|NCT01928381|583937965|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
161696992|NCT01928381|583937966|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
161696993|NCT01928381|583937967|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
161696994|NCT01928381|583937968|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
161696995|NCT01928381|583937969|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
161696996|NCT01928381|583937963|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
161696997|NCT01928381|583937964|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
161696998|NCT01928381|583937965|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
161696999|NCT01928381|583937966|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
161697000|NCT01928381|583937967|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
161697001|NCT01928381|583937968|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
161697002|NCT01928381|583937969|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
161697003|NCT01928381|583937963|FG000|Part 1 - Pain Training|Protocol Violation|1|||
161697004|NCT01928381|583937964|FG001|Part 1 - Pain Training|Protocol Violation|0|||
161697005|NCT01928381|583937965|FG002|Part 1 - Pain Training|Protocol Violation|0|||
161697006|NCT01928381|583937966|FG003|Part 1 - Pain Training|Protocol Violation|0|||
161697007|NCT01928381|583937967|FG004|Part 1 - Pain Training|Protocol Violation|0|||
161697008|NCT01928381|583937968|FG005|Part 1 - Pain Training|Protocol Violation|0|||
161697009|NCT01928381|583937969|FG006|Part 1 - Pain Training|Protocol Violation|0|||
161697010|NCT01928381|583937963|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
161697011|NCT01928381|583937964|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161697012|NCT01928381|583937965|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161697013|NCT01928381|583937966|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161697014|NCT01928381|583937967|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161697015|NCT01928381|583937968|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161697016|NCT01928381|583937969|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161697017|NCT01928381|583937963|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
161697018|NCT01928381|583937964|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161836585|NCT02072824|584444956|FG001|Overall Study|No longer willing to participate|0|||
161697019|NCT01928381|583937965|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161697020|NCT01928381|583937966|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161956745|NCT02544750|584889786|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
161956746|NCT02544750|584889787|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
161956747|NCT02544750|584889786|FG000|Overall Study|Adverse Event|8|||
161697021|NCT01928381|583937967|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161697022|NCT01928381|583937968|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161697023|NCT01928381|583937969|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161697024|NCT01928381|583937963|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
161697025|NCT01928381|583937964|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161697026|NCT01928381|583937965|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161697027|NCT01928381|583937966|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161697028|NCT01928381|583937967|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161697029|NCT01928381|583937968|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161697030|NCT01928381|583937969|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161697031|NCT01928381|583937963|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
161697032|NCT01928381|583937964|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161697033|NCT01928381|583937965|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161697034|NCT01928381|583937966|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161697035|NCT01928381|583937967|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161697036|NCT01928381|583937968|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161697037|NCT01928381|583937969|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161697038|NCT01928381|583937963|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
161697039|NCT01928381|583937964|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
161697040|NCT01928381|583937965|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
161697041|NCT01928381|583937966|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
161697042|NCT01928381|583937967|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
161697043|NCT01928381|583937968|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
161697044|NCT01928381|583937969|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
161697045|NCT01928381|583937963|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161697046|NCT01928381|583937964|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161697047|NCT01928381|583937965|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
161697048|NCT01928381|583937966|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161697049|NCT01928381|583937967|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161697050|NCT01928381|583937968|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161697051|NCT01928381|583937969|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161697052|NCT01928381|583937963|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
161697053|NCT01928381|583937964|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
161697054|NCT01928381|583937965|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
161697055|NCT01928381|583937966|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
161697056|NCT01928381|583937967|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
161697057|NCT01928381|583937968|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
161697058|NCT01928381|583937969|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
161697059|NCT01928381|583937963|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
161697060|NCT01928381|583937964|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
161697061|NCT01928381|583937965|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
161697062|NCT01928381|583937966|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
161697063|NCT01928381|583937967|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
161697064|NCT01928381|583937968|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
161697065|NCT01928381|583937969|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
161697066|NCT01928381|583937963|FG000|Washout First Intervention|Protocol Violation|0|||
161697067|NCT01928381|583937964|FG001|Washout First Intervention|Protocol Violation|0|||
161697068|NCT01928381|583937965|FG002|Washout First Intervention|Protocol Violation|0|||
161697069|NCT01928381|583937966|FG003|Washout First Intervention|Protocol Violation|0|||
161697070|NCT01928381|583937967|FG004|Washout First Intervention|Protocol Violation|1|||
161697071|NCT01928381|583937968|FG005|Washout First Intervention|Protocol Violation|0|||
161697072|NCT01928381|583937969|FG006|Washout First Intervention|Protocol Violation|0|||
161697073|NCT01928381|583937963|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
161697074|NCT01928381|583937964|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
161697075|NCT01928381|583937965|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
161697076|NCT01928381|583937966|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
161836586|NCT02072824|584444957|FG002|Overall Study|No longer willing to participate|1|||
161836587|NCT02072824|584444955|FG000|Overall Study|Medication error|0|||
161836588|NCT02072824|584444956|FG001|Overall Study|Medication error|1|||
161836589|NCT02072824|584444957|FG002|Overall Study|Medication error|0|||
161836590|NCT02072824|584444955|FG000|Overall Study|Adverse Event|0|||
161836591|NCT02072824|584444956|FG001|Overall Study|Adverse Event|0|||
161836592|NCT02072824|584444957|FG002|Overall Study|Adverse Event|1|||
161836593|NCT01859130|584444958|FG000|Overall Study|Death|4|||
161836594|NCT01859130|584444958|FG000|Overall Study|Lost to Follow-up|16|||
161836595|NCT01859130|584444958|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
161836596|NCT01859130|584444958|FG000|Overall Study|Physician Decision|6|||
161836597|NCT01859130|584444958|FG000|Overall Study|Withdrawal by Subject|17|||
161697077|NCT01928381|583937967|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
161697078|NCT01928381|583937968|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
161697079|NCT01928381|583937969|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
161697080|NCT01928381|583937963|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
161697081|NCT01928381|583937964|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
161697082|NCT01928381|583937965|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
161697083|NCT01928381|583937966|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
161697084|NCT01928381|583937967|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
161697085|NCT01928381|583937968|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
161697086|NCT01928381|583937969|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
161697087|NCT02406781|583937970|FG000|Overall Study|Protocol Violation|2|||
161697088|NCT02406781|583937971|FG001|Overall Study|Protocol Violation|2|||
161697089|NCT02406781|583937972|FG002|Overall Study|Protocol Violation|2|||
161697090|NCT02406781|583937973|FG003|Overall Study|Protocol Violation|2|||
161697091|NCT02406781|583937974|FG004|Overall Study|Protocol Violation|1|||
161697092|NCT02406781|583937975|FG005|Overall Study|Protocol Violation|5|||
161697093|NCT02406781|583937976|FG006|Overall Study|Protocol Violation|3|||
161697094|NCT06272370|583940068|FG000|Overall Study|Lost to Follow-up|0|||
161697095|NCT06272370|583940069|FG001|Overall Study|Lost to Follow-up|3|||
161697096|NCT06272370|583940070|FG002|Overall Study|Lost to Follow-up|1|||
161697097|NCT06272370|583940071|FG003|Overall Study|Lost to Follow-up|1|||
161697098|NCT02527707|583940073|FG000|Overall Study|Adverse Event|1|||
161697099|NCT02527707|583940073|FG000|Overall Study|Adverse Event|1|||
161697100|NCT00930059|583940074|FG000|Overall Study|Death|1|||
161697101|NCT00930059|583940075|FG001|Overall Study|Death|0|||
161697102|NCT00930059|583940074|FG000|Overall Study|Did not meet entrance criteria|1|||
161697103|NCT00930059|583940075|FG001|Overall Study|Did not meet entrance criteria|1|||
161697104|NCT00930059|583940074|FG000|Overall Study|Withdrawal by Subject|3|||
161697105|NCT00930059|583940075|FG001|Overall Study|Withdrawal by Subject|4|||
161697106|NCT00930059|583940074|FG000|Overall Study|Other|1|||
161697107|NCT00930059|583940075|FG001|Overall Study|Other|0|||
161697108|NCT00930059|583940074|FG000|Overall Study|1 site terminated by sponsor|1|||
161697109|NCT00930059|583940075|FG001|Overall Study|1 site terminated by sponsor|1|||
161697110|NCT00930059|583940074|FG000|Overall Study|Adverse Event|1|||
161697111|NCT00930059|583940075|FG001|Overall Study|Adverse Event|6|||
161697112|NCT01299766|583940076|FG000|Overall Study|Death|5|||
161697113|NCT01299766|583940077|FG001|Overall Study|Death|4|||
161697114|NCT01299766|583940076|FG000|Overall Study|Withdrawal by Subject|29|||
161697115|NCT01299766|583940077|FG001|Overall Study|Withdrawal by Subject|19|||
161697116|NCT04002310|583940078|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
161697117|NCT04002310|583940079|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
161697118|NCT04002310|583940080|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
161697119|NCT04002310|583940081|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
161697120|NCT04002310|583940082|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
161697121|NCT00352534|583940083|FG000|Initial Staging|Ineligible|8|||
161697122|NCT00352534|583940084|FG001|Initial Staging|Ineligible|9|||
161697123|NCT00352534|583940085|FG002|Initial Staging|Ineligible|0|||
161697124|NCT00352534|583940086|FG003|Initial Staging|Ineligible|0|||
161697125|NCT00352534|583940087|FG004|Initial Staging|Ineligible|0|||
161697126|NCT00352534|583940088|FG005|Initial Staging|Ineligible|0|||
161697127|NCT00352534|583940089|FG006|Initial Staging|Ineligible|0|||
161697128|NCT00352534|583940083|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
161697129|NCT00352534|583940084|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
161697130|NCT00352534|583940085|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
161697131|NCT00352534|583940086|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
161697132|NCT00352534|583940087|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
161697133|NCT00352534|583940088|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
161697134|NCT00352534|583940089|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
161697135|NCT00352534|583940083|FG000|Final Risk Group Assignment|Physician Decision|0|||
161697136|NCT00352534|583940084|FG001|Final Risk Group Assignment|Physician Decision|0|||
161697137|NCT00352534|583940085|FG002|Final Risk Group Assignment|Physician Decision|0|||
161697138|NCT00352534|583940086|FG003|Final Risk Group Assignment|Physician Decision|0|||
161697139|NCT00352534|583940087|FG004|Final Risk Group Assignment|Physician Decision|0|||
161956748|NCT02544750|584889787|FG001|Overall Study|Adverse Event|10|||
161956749|NCT02544750|584889786|FG000|Overall Study|Withdrawal by Subject|10|||
161956750|NCT02544750|584889787|FG001|Overall Study|Withdrawal by Subject|4|||
161697140|NCT00352534|583940088|FG005|Final Risk Group Assignment|Physician Decision|8|||
161697141|NCT00352534|583940089|FG006|Final Risk Group Assignment|Physician Decision|0|||
161697142|NCT00352534|583940083|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
161697143|NCT00352534|583940084|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
161697144|NCT00352534|583940085|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
161956751|NCT02544750|584889786|FG000|Overall Study|Lost to Follow-up|1|||
161697145|NCT00352534|583940086|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
161697146|NCT00352534|583940087|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
161956752|NCT02544750|584889787|FG001|Overall Study|Lost to Follow-up|0|||
161956753|NCT03307785|584889790|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
161956754|NCT03307785|584889791|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161956755|NCT03307785|584889792|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161956756|NCT03307785|584889793|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161956757|NCT03307785|584889794|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161956758|NCT03307785|584889795|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161956759|NCT03307785|584889796|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161697147|NCT00352534|583940088|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
161697148|NCT00352534|583940089|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
161697149|NCT00352534|583940083|FG000|Final Risk Group Assignment|Ineligible|0|||
161697150|NCT00352534|583940084|FG001|Final Risk Group Assignment|Ineligible|0|||
161697151|NCT00352534|583940085|FG002|Final Risk Group Assignment|Ineligible|3|||
161697152|NCT00352534|583940086|FG003|Final Risk Group Assignment|Ineligible|1|||
161697153|NCT00352534|583940087|FG004|Final Risk Group Assignment|Ineligible|0|||
161697154|NCT00352534|583940088|FG005|Final Risk Group Assignment|Ineligible|13|||
161697155|NCT00352534|583940089|FG006|Final Risk Group Assignment|Ineligible|0|||
161697156|NCT00352534|583940083|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161697157|NCT00352534|583940084|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161697158|NCT00352534|583940085|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161697159|NCT00352534|583940086|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161697160|NCT00352534|583940087|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161697161|NCT00352534|583940088|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161697162|NCT00352534|583940089|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
161697163|NCT00352534|583940083|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161697164|NCT00352534|583940084|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161697165|NCT00352534|583940085|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161697166|NCT00352534|583940086|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161697167|NCT00352534|583940087|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161697168|NCT00352534|583940088|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161697169|NCT00352534|583940089|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
161697170|NCT00352534|583940083|FG000|Final Risk Group Assignment|Death|0|||
161697171|NCT00352534|583940084|FG001|Final Risk Group Assignment|Death|0|||
161697172|NCT00352534|583940085|FG002|Final Risk Group Assignment|Death|0|||
161697173|NCT00352534|583940086|FG003|Final Risk Group Assignment|Death|0|||
161697174|NCT00352534|583940087|FG004|Final Risk Group Assignment|Death|0|||
161697175|NCT00352534|583940088|FG005|Final Risk Group Assignment|Death|2|||
161697176|NCT00352534|583940089|FG006|Final Risk Group Assignment|Death|0|||
161697177|NCT02090855|583940090|FG000|Overall Study|no evaluable Standard of Truth results|2|||
161697178|NCT00544869|583940094|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
161697179|NCT00544869|583940095|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
161697180|NCT00544869|583940096|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
161697181|NCT00544869|583940094|FG000|Overall Study|Adverse Event|6|||
161697182|NCT00544869|583940095|FG001|Overall Study|Adverse Event|1|||
161697183|NCT00544869|583940096|FG002|Overall Study|Adverse Event|0|||
161697184|NCT00544869|583940094|FG000|Overall Study|Lack of Efficacy|1|||
161697185|NCT00544869|583940095|FG001|Overall Study|Lack of Efficacy|1|||
161697186|NCT00544869|583940096|FG002|Overall Study|Lack of Efficacy|0|||
161697187|NCT00544869|583940094|FG000|Overall Study|Physician Decision|2|||
161697188|NCT00544869|583940095|FG001|Overall Study|Physician Decision|0|||
161697189|NCT00544869|583940096|FG002|Overall Study|Physician Decision|0|||
161697190|NCT00619502|583940097|FG000|Overall Study|Lost to Follow-up|8|||
161697191|NCT00619502|583940098|FG001|Overall Study|Lost to Follow-up|10|||
161956760|NCT03307785|584889797|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161697192|NCT01354028|583940099|FG000|Overall Study|Physician Decision|0|||
161697193|NCT01354028|583940100|FG001|Overall Study|Physician Decision|2|||
161697194|NCT01354028|583940099|FG000|Overall Study|Discharged before study start|2|||
161697195|NCT01354028|583940100|FG001|Overall Study|Discharged before study start|2|||
161697196|NCT01354028|583940099|FG000|Overall Study|No quiet alert state|0|||
161697197|NCT01354028|583940100|FG001|Overall Study|No quiet alert state|1|||
161697198|NCT03968419|583940103|FG000|Treatment Period|Adverse Event|0|||
161697199|NCT03968419|583940104|FG001|Treatment Period|Adverse Event|0|||
161697200|NCT03968419|583940105|FG002|Treatment Period|Adverse Event|1|||
161697201|NCT03968419|583940103|FG000|Safety Follow-up Period|Death|3|||
161956761|NCT03307785|584889798|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161697202|NCT03968419|583940104|FG001|Safety Follow-up Period|Death|2|||
161697203|NCT03968419|583940105|FG002|Safety Follow-up Period|Death|1|||
161697204|NCT03968419|583940103|FG000|Safety Follow-up Period|Subject Decision|2|||
161697205|NCT03968419|583940104|FG001|Safety Follow-up Period|Subject Decision|1|||
161697206|NCT03968419|583940105|FG002|Safety Follow-up Period|Subject Decision|0|||
161697207|NCT00935883|583940106|FG000|Treatment Period|Physician Decision|1|||
161697208|NCT00935883|583940107|FG001|Treatment Period|Physician Decision|0|||
161697209|NCT00935883|583940106|FG000|Treatment Period|Withdrawal by Subject|0|||
161697210|NCT00935883|583940107|FG001|Treatment Period|Withdrawal by Subject|2|||
161697211|NCT01641939|583940110|FG000|Overall Study|Death|90|||
161697212|NCT01641939|583940111|FG001|Overall Study|Death|187|||
161697213|NCT01641939|583940112|FG002|Overall Study|Death|61|||
161697214|NCT01641939|583940110|FG000|Overall Study|Lost to Follow-up|3|||
161697215|NCT01641939|583940111|FG001|Overall Study|Lost to Follow-up|2|||
161697216|NCT01641939|583940112|FG002|Overall Study|Lost to Follow-up|1|||
161697217|NCT01641939|583940110|FG000|Overall Study|Withdrawal by Subject|14|||
161697218|NCT01641939|583940111|FG001|Overall Study|Withdrawal by Subject|11|||
161697219|NCT01641939|583940112|FG002|Overall Study|Withdrawal by Subject|5|||
161697220|NCT01641939|583940110|FG000|Overall Study|Study Terminated by Sponsor|10|||
161697221|NCT01641939|583940111|FG001|Overall Study|Study Terminated by Sponsor|28|||
161697222|NCT01641939|583940112|FG002|Overall Study|Study Terminated by Sponsor|3|||
161697223|NCT02894840|583940113|FG000|Overall Study|Lost to Follow-up|1|||
161697224|NCT02894840|583940114|FG001|Overall Study|Lost to Follow-up|0|||
161697225|NCT02894840|583940115|FG002|Overall Study|Lost to Follow-up|3|||
161697226|NCT02894840|583940116|FG003|Overall Study|Lost to Follow-up|0|||
161697227|NCT05499559|583940121|FG000|Overall Study|Lost to Follow-up|467|||
161697228|NCT02971202|583940128|FG000|Overall Study|Pregnancy|1|||
161697229|NCT02971202|583940129|FG001|Overall Study|Pregnancy|0|||
161697230|NCT02971202|583940130|FG002|Overall Study|Pregnancy|0|||
161697231|NCT02971202|583940128|FG000|Overall Study|screen fail after consent|1|||
161697232|NCT02971202|583940129|FG001|Overall Study|screen fail after consent|0|||
161697233|NCT02971202|583940130|FG002|Overall Study|screen fail after consent|1|||
161697234|NCT04033367|583940131|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
161697235|NCT04033367|583940132|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
161697236|NCT04033367|583940131|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
161697237|NCT04033367|583940132|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
161697238|NCT04033367|583940131|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
161697239|NCT04033367|583940132|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
161697240|NCT04033367|583940131|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
161697241|NCT04033367|583940132|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
161697242|NCT02723201|583940133|FG000|Second Intervention Period|Protocol Violation|1|||
161697243|NCT02723201|583940134|FG001|Second Intervention Period|Protocol Violation|0|||
161697244|NCT02723201|583940135|FG002|Second Intervention Period|Protocol Violation|0|||
161697245|NCT02723201|583940133|FG000|Second Intervention Period|Adverse Event|1|||
161697246|NCT02723201|583940134|FG001|Second Intervention Period|Adverse Event|0|||
161697247|NCT02723201|583940135|FG002|Second Intervention Period|Adverse Event|0|||
161697248|NCT03472560|583940136|FG000|Overall Study|Subject transfer to continuation protocol|0|||
161697249|NCT03472560|583940137|FG001|Overall Study|Subject transfer to continuation protocol|1|||
161697250|NCT03472560|583940136|FG000|Overall Study|Withdrawal by Subject|4|||
161697251|NCT03472560|583940137|FG001|Overall Study|Withdrawal by Subject|0|||
161697252|NCT03472560|583940136|FG000|Overall Study|Progressive disease|24|||
161697253|NCT03472560|583940137|FG001|Overall Study|Progressive disease|8|||
161697254|NCT03472560|583940136|FG000|Overall Study|Physician Decision|1|||
161697255|NCT03472560|583940137|FG001|Overall Study|Physician Decision|0|||
161697256|NCT03472560|583940136|FG000|Overall Study|Death|7|||
161697257|NCT03472560|583940137|FG001|Overall Study|Death|4|||
161697258|NCT03472560|583940136|FG000|Overall Study|Adverse Event|5|||
161697259|NCT03472560|583940137|FG001|Overall Study|Adverse Event|3|||
161697260|NCT03472560|583940136|FG000|Overall Study|Global deterioration of health status|0|||
161697261|NCT03472560|583940137|FG001|Overall Study|Global deterioration of health status|4|||
161697262|NCT01946178|583940138|FG000|Overall Study|Pregnancy|1|||
161836598|NCT01859130|584444958|FG000|Overall Study|Adverse Event|11|||
161836599|NCT00127036|584444962|FG000|Overall Study|Insufficient Data for Analysis|6|||
161836600|NCT00127036|584444963|FG001|Overall Study|Insufficient Data for Analysis|11|||
161836601|NCT00127036|584444962|FG000|Overall Study|Screen Failure|2|||
161836602|NCT00127036|584444963|FG001|Overall Study|Screen Failure|0|||
161836603|NCT03921151|584444966|FG000|Overall Study|Withdrawal by Subject|11|||
161836604|NCT03921151|584444967|FG001|Overall Study|Withdrawal by Subject|16|||
161836605|NCT03001219|584444975|FG000|Proof of Concept|Study Termination by Sponsor|0|||
161697263|NCT01946178|583940138|FG000|Overall Study|Lost to Follow-up|1|||
161836606|NCT03001219|584444976|FG001|Proof of Concept|Study Termination by Sponsor|1|||
161697264|NCT05425563|583940143|FG000|Overall Study|Withdrawal by Subject|17|||
161697265|NCT01001702|583940144|FG000|Overall Study|Lost to Follow-up|7|||
161697266|NCT01001702|583940144|FG000|Overall Study|Adverse Event|7|||
161697267|NCT01001702|583940144|FG000|Overall Study|Sponsor Discontinued Study|4|||
161697268|NCT01001702|583940144|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
161697269|NCT01001702|583940144|FG000|Overall Study|Investigator withdrew Subject|10|||
161697270|NCT01001702|583940144|FG000|Overall Study|Withdrawal by Subject|19|||
161697271|NCT01001702|583940144|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
161697272|NCT00584233|583940147|FG000|Overall Study|Withdrawal by Subject|5|||
161697273|NCT00584233|583940147|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
161697274|NCT02494596|583940148|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161956762|NCT03307785|584889799|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161956763|NCT03307785|584889800|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161956764|NCT03307785|584889801|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161956765|NCT03307785|584889802|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
161956766|NCT03307785|584889790|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
161956767|NCT03307785|584889791|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
161956768|NCT03307785|584889792|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161956769|NCT03307785|584889793|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161956770|NCT03307785|584889794|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161956771|NCT03307785|584889795|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161836607|NCT03001219|584444975|FG000|Proof of Concept|Withdrawal by Subject|0|||
161836608|NCT03001219|584444976|FG001|Proof of Concept|Withdrawal by Subject|4|||
161836609|NCT03001219|584444975|FG000|Proof of Concept|Protocol Deviation|0|||
161836610|NCT03001219|584444976|FG001|Proof of Concept|Protocol Deviation|1|||
161836611|NCT03001219|584444975|FG000|Proof of Concept|Adverse Event|1|||
161836612|NCT03001219|584444976|FG001|Proof of Concept|Adverse Event|1|||
161697275|NCT02494596|583940149|FG001|Overall Study|Insufficient Therapeutic Response|3|||
161697276|NCT02494596|583940150|FG002|Overall Study|Insufficient Therapeutic Response|1|||
161697277|NCT02494596|583940148|FG000|Overall Study|Adverse Event|0|||
161697278|NCT02494596|583940149|FG001|Overall Study|Adverse Event|1|||
161697279|NCT02494596|583940150|FG002|Overall Study|Adverse Event|0|||
161697280|NCT02494596|583940148|FG000|Overall Study|Refused Treatment|0|||
161697281|NCT02494596|583940149|FG001|Overall Study|Refused Treatment|1|||
161697282|NCT02494596|583940150|FG002|Overall Study|Refused Treatment|0|||
161697283|NCT02222714|583940151|FG000|Overall Study|Death|0|||
161697284|NCT02222714|583940152|FG001|Overall Study|Death|2|||
161697285|NCT02222714|583940153|FG002|Overall Study|Death|3|||
161697286|NCT02222714|583940154|FG003|Overall Study|Death|4|||
161697287|NCT02222714|583940155|FG004|Overall Study|Death|6|||
161697288|NCT02222714|583940151|FG000|Overall Study|Withdrawal by Subject|0|||
161697289|NCT02222714|583940152|FG001|Overall Study|Withdrawal by Subject|0|||
161697290|NCT02222714|583940153|FG002|Overall Study|Withdrawal by Subject|1|||
161697291|NCT02222714|583940154|FG003|Overall Study|Withdrawal by Subject|0|||
161697292|NCT02222714|583940155|FG004|Overall Study|Withdrawal by Subject|1|||
161697293|NCT00159432|583940156|FG000|Overall Study|Adverse Event|1|||
161697294|NCT00159432|583940156|FG000|Overall Study|Death|1|||
161697295|NCT00159432|583940156|FG000|Overall Study|Lack of Efficacy|8|||
161697296|NCT04537208|583940157|FG000|Overall Study|Adverse Event|0|||
161697297|NCT04537208|583940158|FG001|Overall Study|Adverse Event|0|||
161697298|NCT04537208|583940159|FG002|Overall Study|Adverse Event|0|||
161697299|NCT04537208|583940160|FG003|Overall Study|Adverse Event|0|||
161697300|NCT04537208|583940161|FG004|Overall Study|Adverse Event|0|||
161697301|NCT04537208|583940162|FG005|Overall Study|Adverse Event|0|||
161697302|NCT04537208|583940163|FG006|Overall Study|Adverse Event|0|||
161697303|NCT04537208|583940164|FG007|Overall Study|Adverse Event|0|||
161697304|NCT04537208|583940165|FG008|Overall Study|Adverse Event|1|||
161697305|NCT04537208|583940166|FG009|Overall Study|Adverse Event|0|||
161697306|NCT04537208|583940167|FG010|Overall Study|Adverse Event|0|||
161697307|NCT04537208|583940157|FG000|Overall Study|Protocol deviation|0|||
161697308|NCT04537208|583940158|FG001|Overall Study|Protocol deviation|0|||
161697309|NCT04537208|583940159|FG002|Overall Study|Protocol deviation|2|||
161697310|NCT04537208|583940160|FG003|Overall Study|Protocol deviation|0|||
161697311|NCT04537208|583940161|FG004|Overall Study|Protocol deviation|0|||
161697312|NCT04537208|583940162|FG005|Overall Study|Protocol deviation|2|||
161697313|NCT04537208|583940163|FG006|Overall Study|Protocol deviation|4|||
161697314|NCT04537208|583940164|FG007|Overall Study|Protocol deviation|0|||
161697315|NCT04537208|583940165|FG008|Overall Study|Protocol deviation|1|||
161697316|NCT04537208|583940166|FG009|Overall Study|Protocol deviation|0|||
161697317|NCT04537208|583940167|FG010|Overall Study|Protocol deviation|2|||
161697318|NCT04537208|583940157|FG000|Overall Study|Withdrawal by Subject|4|||
161697319|NCT04537208|583940158|FG001|Overall Study|Withdrawal by Subject|2|||
161697320|NCT04537208|583940159|FG002|Overall Study|Withdrawal by Subject|1|||
161697321|NCT04537208|583940160|FG003|Overall Study|Withdrawal by Subject|3|||
161697322|NCT04537208|583940161|FG004|Overall Study|Withdrawal by Subject|5|||
161697323|NCT04537208|583940162|FG005|Overall Study|Withdrawal by Subject|1|||
161697324|NCT04537208|583940163|FG006|Overall Study|Withdrawal by Subject|6|||
161697325|NCT04537208|583940164|FG007|Overall Study|Withdrawal by Subject|1|||
161697326|NCT04537208|583940165|FG008|Overall Study|Withdrawal by Subject|7|||
161697327|NCT04537208|583940166|FG009|Overall Study|Withdrawal by Subject|2|||
161697328|NCT04537208|583940167|FG010|Overall Study|Withdrawal by Subject|4|||
161697329|NCT04537208|583940157|FG000|Overall Study|Lost to Follow-up|4|||
161697330|NCT04537208|583940158|FG001|Overall Study|Lost to Follow-up|1|||
161697331|NCT04537208|583940159|FG002|Overall Study|Lost to Follow-up|3|||
161697332|NCT04537208|583940160|FG003|Overall Study|Lost to Follow-up|4|||
161697333|NCT04537208|583940161|FG004|Overall Study|Lost to Follow-up|3|||
161697334|NCT04537208|583940162|FG005|Overall Study|Lost to Follow-up|2|||
161697335|NCT04537208|583940163|FG006|Overall Study|Lost to Follow-up|3|||
161697336|NCT04537208|583940164|FG007|Overall Study|Lost to Follow-up|2|||
161697337|NCT04537208|583940165|FG008|Overall Study|Lost to Follow-up|7|||
161697338|NCT04537208|583940166|FG009|Overall Study|Lost to Follow-up|2|||
161697339|NCT04537208|583940167|FG010|Overall Study|Lost to Follow-up|2|||
161697340|NCT03178487|583940168|FG000|Period 1|Adverse Event|1|||
161697341|NCT03178487|583940169|FG001|Period 1|Adverse Event|2|||
161697342|NCT03178487|583940168|FG000|Period 1|Withdrawal by Subject|2|||
161697343|NCT03178487|583940169|FG001|Period 1|Withdrawal by Subject|1|||
161697344|NCT03178487|583940168|FG000|Period 1|Lost to Follow-up|1|||
161697345|NCT03178487|583940169|FG001|Period 1|Lost to Follow-up|0|||
161697346|NCT03178487|583940168|FG000|Period 1|Other|0|||
161697347|NCT03178487|583940169|FG001|Period 1|Other|1|||
161697348|NCT03178487|583940168|FG000|Period 2|Adverse Event|4|||
161697349|NCT03178487|583940169|FG001|Period 2|Adverse Event|4|||
161697350|NCT03178487|583940168|FG000|Period 2|Withdrawal by Subject|6|||
161697351|NCT03178487|583940169|FG001|Period 2|Withdrawal by Subject|6|||
161697352|NCT03178487|583940168|FG000|Period 2|Lost to Follow-up|2|||
161697353|NCT03178487|583940169|FG001|Period 2|Lost to Follow-up|2|||
161697354|NCT03178487|583940168|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
161697355|NCT03178487|583940169|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
161697356|NCT03178487|583940168|FG000|Period 2|Other|8|||
161697357|NCT03178487|583940169|FG001|Period 2|Other|7|||
161697358|NCT00704964|583940173|FG000|Overall Study|Not completed on time|328|||
161697359|NCT02161562|583940174|FG000|Overall Study|Withdrawal by Subject|5|||
161697360|NCT02161562|583940175|FG001|Overall Study|Withdrawal by Subject|8|||
161697361|NCT02161562|583940174|FG000|Overall Study|Protocol Violation|9|||
161697362|NCT02161562|583940175|FG001|Overall Study|Protocol Violation|4|||
161697363|NCT02161562|583940174|FG000|Overall Study|Pregnancy|1|||
161697364|NCT02161562|583940175|FG001|Overall Study|Pregnancy|2|||
161697365|NCT02161562|583940174|FG000|Overall Study|Lost to Follow-up|3|||
161697366|NCT02161562|583940175|FG001|Overall Study|Lost to Follow-up|1|||
161697367|NCT02161562|583940174|FG000|Overall Study|Lack of Efficacy|4|||
161697368|NCT02161562|583940175|FG001|Overall Study|Lack of Efficacy|1|||
161697369|NCT02161562|583940174|FG000|Overall Study|Adverse Event|1|||
161697370|NCT02161562|583940175|FG001|Overall Study|Adverse Event|1|||
161697371|NCT02161562|583940174|FG000|Overall Study|Participant moved back to home country|1|||
161697372|NCT02161562|583940175|FG001|Overall Study|Participant moved back to home country|0|||
161697373|NCT02161562|583940174|FG000|Overall Study|Withdrew due to being out of the country|1|||
161697374|NCT02161562|583940175|FG001|Overall Study|Withdrew due to being out of the country|0|||
161697375|NCT02161562|583940174|FG000|Overall Study|Participant moved out of province|1|||
161697376|NCT02161562|583940175|FG001|Overall Study|Participant moved out of province|0|||
161697377|NCT00197054|583940182|FG000|Overall Study|Withdrawal by Subject|9|||
161697378|NCT00197054|583940183|FG001|Overall Study|Withdrawal by Subject|3|||
161697379|NCT00197054|583940184|FG002|Overall Study|Withdrawal by Subject|3|||
161697380|NCT00197054|583940182|FG000|Overall Study|Moved from area|7|||
161697381|NCT00197054|583940183|FG001|Overall Study|Moved from area|14|||
161697382|NCT00197054|583940184|FG002|Overall Study|Moved from area|9|||
161697383|NCT00197054|583940182|FG000|Overall Study|Lost to Follow-up|1|||
161697384|NCT00197054|583940183|FG001|Overall Study|Lost to Follow-up|4|||
161697385|NCT00197054|583940184|FG002|Overall Study|Lost to Follow-up|0|||
161697386|NCT01163786|583940185|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
161697387|NCT01163786|583940185|FG000|Treatment With Bortezomib|Adverse Event|2|||
161697388|NCT01163786|583940185|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
161697389|NCT02167945|583940190|FG000|Overall Study|Adverse Event|16|||
161697390|NCT02167945|583940190|FG000|Overall Study|Withdrew Consent|42|||
161697391|NCT02167945|583940190|FG000|Overall Study|Lost to Follow-up|122|||
161697392|NCT02167945|583940190|FG000|Overall Study|COVID-19 logistical restrictions|6|||
161697393|NCT02167945|583940190|FG000|Overall Study|Other, not specified|63|||
161697394|NCT00132730|583940191|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
161697395|NCT00132730|583940192|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
161697396|NCT00132730|583940193|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
161697397|NCT00132730|583940194|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
161697398|NCT00132730|583940195|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
161697399|NCT00132730|583940196|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
161697400|NCT00132730|583940191|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
161697401|NCT00132730|583940192|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
161697402|NCT00132730|583940193|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
161697403|NCT00132730|583940194|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
161697404|NCT00132730|583940195|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
161697405|NCT00132730|583940196|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
161697406|NCT00132730|583940191|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
161697407|NCT00132730|583940192|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
161697408|NCT00132730|583940193|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
161697409|NCT00132730|583940194|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
161697410|NCT00132730|583940195|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
161697411|NCT00132730|583940196|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
161697412|NCT00132730|583940191|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
161697413|NCT00132730|583940192|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
161697414|NCT00132730|583940193|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
161697415|NCT00132730|583940194|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
161697416|NCT00132730|583940195|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
161697417|NCT00132730|583940196|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
161697418|NCT00132730|583940191|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
161697419|NCT00132730|583940192|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
161697420|NCT00132730|583940193|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
161697421|NCT00132730|583940194|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
161697422|NCT00132730|583940195|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
161697423|NCT00132730|583940196|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
161956772|NCT03307785|584889796|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161697424|NCT00132730|583940191|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161956773|NCT03307785|584889797|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161956774|NCT03307785|584889798|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161956775|NCT03307785|584889799|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161956776|NCT03307785|584889800|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161956777|NCT03307785|584889801|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161956778|NCT03307785|584889802|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161956779|NCT03307785|584889790|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
161956780|NCT03307785|584889791|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
161956781|NCT03307785|584889792|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
161956782|NCT03307785|584889793|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
161956783|NCT03307785|584889794|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
161956784|NCT03307785|584889795|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
161956785|NCT03307785|584889796|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
162030793|NCT00952380|585169487|FG002|Overall Study|Non-compliant to protocol|0|||
161956786|NCT03307785|584889797|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
161956787|NCT03307785|584889798|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
161956788|NCT03307785|584889799|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
161956789|NCT03307785|584889800|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
161956790|NCT03307785|584889801|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
161956791|NCT03307785|584889802|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
161956792|NCT03307785|584889790|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
161956793|NCT03307785|584889791|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
161956794|NCT03307785|584889792|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161956795|NCT03307785|584889793|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161956796|NCT03307785|584889794|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161956797|NCT03307785|584889795|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161956798|NCT03307785|584889796|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161956799|NCT03307785|584889797|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161956800|NCT03307785|584889798|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161956801|NCT03307785|584889799|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161956802|NCT03307785|584889800|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161956803|NCT03307785|584889801|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161697425|NCT00132730|583940192|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161697426|NCT00132730|583940193|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161697427|NCT00132730|583940194|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
161697428|NCT00132730|583940195|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161697429|NCT00132730|583940196|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161956804|NCT03307785|584889802|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
161956805|NCT03307785|584889790|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161697430|NCT00132730|583940191|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
161697431|NCT00132730|583940192|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
161697432|NCT00132730|583940193|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
161697433|NCT00132730|583940194|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
161697434|NCT00132730|583940195|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
161697435|NCT00132730|583940196|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
161697436|NCT00132730|583940191|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
161697437|NCT00132730|583940192|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
161697438|NCT00132730|583940193|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
161697439|NCT00132730|583940194|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
161697440|NCT00132730|583940195|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
161697441|NCT00132730|583940196|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
161697442|NCT00132730|583940191|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161697443|NCT00132730|583940192|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161697444|NCT00132730|583940193|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161697445|NCT00132730|583940194|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161697446|NCT00132730|583940195|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
161697447|NCT00132730|583940196|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161697448|NCT00132730|583940191|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161697449|NCT00132730|583940192|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161697450|NCT00132730|583940193|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161697451|NCT00132730|583940194|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161697452|NCT00132730|583940195|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
161836613|NCT03001219|584444975|FG000|Proof of Concept|Physician Decision|1|||
161836614|NCT03001219|584444976|FG001|Proof of Concept|Physician Decision|0|||
161836615|NCT03001219|584444975|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
161836616|NCT03001219|584444976|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
161836617|NCT03001219|584444975|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
161836618|NCT03001219|584444976|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
162030794|NCT00952380|585169488|FG003|Overall Study|Non-compliant to protocol|1|||
162030795|NCT00952380|585169489|FG004|Overall Study|Non-compliant to protocol|0|||
162030796|NCT03400956|585169490|FG000|Treatment Period 1|Adverse Event|0|||
161697453|NCT00132730|583940196|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161697454|NCT00132730|583940191|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161697455|NCT00132730|583940192|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161697456|NCT00132730|583940193|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161697457|NCT00132730|583940194|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161697458|NCT00132730|583940195|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
161956806|NCT03307785|584889791|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161956807|NCT03307785|584889792|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
161956808|NCT03307785|584889793|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161956809|NCT03307785|584889794|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161697459|NCT00132730|583940196|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161697460|NCT00132730|583940191|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
161697461|NCT00132730|583940192|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
161697462|NCT00132730|583940193|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
161697463|NCT00132730|583940194|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
161697464|NCT00132730|583940195|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
161697465|NCT00132730|583940196|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
161697466|NCT03021642|583940199|FG000|Washout Period (21 Days)|Adverse Event|1|||
161697467|NCT03021642|583940200|FG001|Washout Period (21 Days)|Adverse Event|1|||
161697468|NCT01192347|583940201|FG000|Overall Study|Death|3|||
161697469|NCT01192347|583940201|FG000|Overall Study|Lost to Follow-up|3|||
161697470|NCT01192347|583940201|FG000|Overall Study|Withdrawal by Subject|1|||
161697471|NCT01192347|583940201|FG000|Overall Study|Adverse Event|1|||
161697472|NCT01192347|583940201|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
161697473|NCT01192347|583940201|FG000|Overall Study|Patient seen in different hospital|1|||
161697474|NCT01192347|583940201|FG000|Overall Study|Patient not visiting hospital regularly|1|||
161697475|NCT01192347|583940201|FG000|Overall Study|Patient did not show up for visits|1|||
161697476|NCT02623335|583940202|FG000|Overall Study|Death|8|||
161697477|NCT02623335|583940203|FG001|Overall Study|Death|7|||
161697478|NCT02623335|583940202|FG000|Overall Study|Lost to Follow-up|15|||
161697479|NCT02623335|583940203|FG001|Overall Study|Lost to Follow-up|23|||
161697480|NCT02623335|583940202|FG000|Overall Study|Withdrawal by Subject|2|||
161697481|NCT02623335|583940203|FG001|Overall Study|Withdrawal by Subject|5|||
161697482|NCT02623335|583940202|FG000|Overall Study|Protocol Violation|2|||
161697483|NCT02623335|583940203|FG001|Overall Study|Protocol Violation|1|||
161697484|NCT00090545|583940204|FG000|Overall Study|Disease progression on study|21|||
161697485|NCT00090545|583940205|FG001|Overall Study|Disease progression on study|17|||
161697486|NCT00090545|583940204|FG000|Overall Study|Refused further treatment|1|||
161697487|NCT00090545|583940205|FG001|Overall Study|Refused further treatment|4|||
161697488|NCT00090545|583940204|FG000|Overall Study|Death|0|||
161697489|NCT00090545|583940205|FG001|Overall Study|Death|1|||
161697490|NCT00090545|583940204|FG000|Overall Study|Adverse Event|0|||
161697491|NCT00090545|583940205|FG001|Overall Study|Adverse Event|2|||
161697492|NCT02474082|583940206|FG000|Overall Study|Adverse Event|2|||
161697493|NCT02474082|583940207|FG001|Overall Study|Adverse Event|32|||
161697494|NCT02474082|583940206|FG000|Overall Study|Withdrawal of informed consent|1|||
161697495|NCT02474082|583940207|FG001|Overall Study|Withdrawal of informed consent|11|||
161697496|NCT02474082|583940206|FG000|Overall Study|Lost to Follow-up|2|||
161697497|NCT02474082|583940207|FG001|Overall Study|Lost to Follow-up|2|||
161697498|NCT02474082|583940206|FG000|Overall Study|Dose tapering not achieved|0|||
161697499|NCT02474082|583940207|FG001|Overall Study|Dose tapering not achieved|4|||
161697500|NCT02474082|583940206|FG000|Overall Study|Participant/guardian decision|1|||
161697501|NCT02474082|583940207|FG001|Overall Study|Participant/guardian decision|2|||
161697502|NCT02474082|583940206|FG000|Overall Study|Non-compliance with study treatment|0|||
161956810|NCT03307785|584889795|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161956811|NCT03307785|584889796|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161697503|NCT02474082|583940207|FG001|Overall Study|Non-compliance with study treatment|2|||
161697504|NCT02474082|583940206|FG000|Overall Study|Protocol deviation|0|||
161697505|NCT02474082|583940207|FG001|Overall Study|Protocol deviation|1|||
161956812|NCT03307785|584889797|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161956813|NCT03307785|584889798|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161956814|NCT03307785|584889799|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161697506|NCT04317274|583940210|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
161697507|NCT04317274|583940211|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
161697508|NCT04317274|583940212|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
161697509|NCT04317274|583940213|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
161697510|NCT00430508|583940214|FG000|Overall Study|Adverse Event|2|||
161697511|NCT00430508|583940215|FG001|Overall Study|Adverse Event|3|||
161697512|NCT00430508|583940216|FG002|Overall Study|Adverse Event|5|||
161956815|NCT03307785|584889800|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161956816|NCT03307785|584889801|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161956817|NCT03307785|584889802|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
161956818|NCT03307785|584889790|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
161956819|NCT03307785|584889791|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
161956820|NCT03307785|584889792|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
161956821|NCT03307785|584889793|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
161956822|NCT03307785|584889794|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
161956823|NCT03307785|584889795|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
161956824|NCT03307785|584889796|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
161956825|NCT03307785|584889797|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
161956826|NCT03307785|584889798|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
161956827|NCT03307785|584889799|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
161956828|NCT03307785|584889800|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
161956829|NCT03307785|584889801|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
161956830|NCT03307785|584889802|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
161956831|NCT03307785|584889790|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161956832|NCT03307785|584889791|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161956833|NCT03307785|584889792|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
161956834|NCT03307785|584889793|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161956835|NCT03307785|584889794|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161956836|NCT03307785|584889795|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161956837|NCT03307785|584889796|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161956838|NCT03307785|584889797|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161956839|NCT03307785|584889798|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161956840|NCT03307785|584889799|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161956841|NCT03307785|584889800|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161956842|NCT03307785|584889801|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161956843|NCT03307785|584889802|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
161956844|NCT03307785|584889790|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161956845|NCT03307785|584889791|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161956846|NCT03307785|584889792|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
161956847|NCT03307785|584889793|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161697513|NCT00430508|583940217|FG003|Overall Study|Adverse Event|3|||
161956848|NCT03307785|584889794|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161956849|NCT03307785|584889795|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161956850|NCT03307785|584889796|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161956851|NCT03307785|584889797|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161956852|NCT03307785|584889798|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161697514|NCT00430508|583940214|FG000|Overall Study|Withdrawal by Subject|0|||
161697515|NCT00430508|583940215|FG001|Overall Study|Withdrawal by Subject|1|||
161697516|NCT00430508|583940216|FG002|Overall Study|Withdrawal by Subject|1|||
161697517|NCT00430508|583940217|FG003|Overall Study|Withdrawal by Subject|1|||
161697518|NCT00430508|583940214|FG000|Overall Study|responder at visit 4|0|||
161697519|NCT00430508|583940215|FG001|Overall Study|responder at visit 4|0|||
161697520|NCT00430508|583940216|FG002|Overall Study|responder at visit 4|2|||
161697521|NCT00430508|583940217|FG003|Overall Study|responder at visit 4|0|||
161697522|NCT00430508|583940214|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
161697523|NCT00430508|583940215|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
161697524|NCT00430508|583940216|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
161697525|NCT00430508|583940217|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
161697526|NCT00430508|583940214|FG000|Overall Study|Other|1|||
161697527|NCT00430508|583940215|FG001|Overall Study|Other|1|||
161697528|NCT00430508|583940216|FG002|Overall Study|Other|3|||
161697529|NCT00430508|583940217|FG003|Overall Study|Other|0|||
161697530|NCT02971670|583940224|FG000|Overall Study|Withdrawal by Subject|4|||
161697531|NCT02971670|583940225|FG001|Overall Study|Withdrawal by Subject|1|||
161697532|NCT02971670|583940226|FG002|Overall Study|Withdrawal by Subject|1|||
161697533|NCT02971670|583940227|FG003|Overall Study|Withdrawal by Subject|2|||
161697534|NCT00288080|583940228|FG000|Overall Study|Withdrawal by Subject|1|||
161697535|NCT00288080|583940229|FG001|Overall Study|Withdrawal by Subject|3|||
161697536|NCT00288080|583940228|FG000|Overall Study|Protocol Violation|25|||
161697537|NCT00288080|583940229|FG001|Overall Study|Protocol Violation|20|||
161697538|NCT00379795|583940230|FG000|Overall Study|Death|31|||
161697539|NCT00379795|583940231|FG001|Overall Study|Death|8|||
161697540|NCT00379795|583940232|FG002|Overall Study|Death|6|||
161697541|NCT00379795|583940233|FG003|Overall Study|Death|4|||
161697542|NCT00379795|583940234|FG004|Overall Study|Death|7|||
161697543|NCT00379795|583940230|FG000|Overall Study|Adverse Event|17|||
161697544|NCT00379795|583940231|FG001|Overall Study|Adverse Event|3|||
161697545|NCT00379795|583940232|FG002|Overall Study|Adverse Event|3|||
161697546|NCT00379795|583940233|FG003|Overall Study|Adverse Event|1|||
161697547|NCT00379795|583940234|FG004|Overall Study|Adverse Event|4|||
161697548|NCT00379795|583940230|FG000|Overall Study|Lost to Follow-up|8|||
161697549|NCT00379795|583940231|FG001|Overall Study|Lost to Follow-up|1|||
161697550|NCT00379795|583940232|FG002|Overall Study|Lost to Follow-up|2|||
161697551|NCT00379795|583940233|FG003|Overall Study|Lost to Follow-up|1|||
161697552|NCT00379795|583940234|FG004|Overall Study|Lost to Follow-up|4|||
161697553|NCT00379795|583940230|FG000|Overall Study|Physician Decision|25|||
161697554|NCT00379795|583940231|FG001|Overall Study|Physician Decision|0|||
161697555|NCT00379795|583940232|FG002|Overall Study|Physician Decision|2|||
161697556|NCT00379795|583940233|FG003|Overall Study|Physician Decision|2|||
161697557|NCT00379795|583940234|FG004|Overall Study|Physician Decision|2|||
161697558|NCT00379795|583940230|FG000|Overall Study|Withdrawal by Subject|94|||
161697559|NCT00379795|583940231|FG001|Overall Study|Withdrawal by Subject|11|||
161697560|NCT00379795|583940232|FG002|Overall Study|Withdrawal by Subject|19|||
161697561|NCT00379795|583940233|FG003|Overall Study|Withdrawal by Subject|7|||
161697562|NCT00379795|583940234|FG004|Overall Study|Withdrawal by Subject|14|||
161697563|NCT00379795|583940230|FG000|Overall Study|Subject non-compliance|7|||
161697564|NCT00379795|583940231|FG001|Overall Study|Subject non-compliance|2|||
161697565|NCT00379795|583940232|FG002|Overall Study|Subject non-compliance|0|||
161697566|NCT00379795|583940233|FG003|Overall Study|Subject non-compliance|0|||
161697567|NCT00379795|583940234|FG004|Overall Study|Subject non-compliance|1|||
161836619|NCT03001219|584444975|FG000|Extension Period Analysis|Physician Decision|0|||
161836620|NCT03001219|584444976|FG001|Extension Period Analysis|Physician Decision|1|||
161836621|NCT03001219|584444975|FG000|Extension Period Analysis|Adverse Event|1|||
161697568|NCT00379795|583940230|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
161697569|NCT00379795|583940231|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
161697570|NCT00379795|583940232|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
161697571|NCT00379795|583940233|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
161697572|NCT00379795|583940234|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
161836622|NCT03001219|584444976|FG001|Extension Period Analysis|Adverse Event|1|||
161836623|NCT03001219|584444975|FG000|Extension Period Analysis|Protocol Deviation|0|||
161956853|NCT03307785|584889799|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161956854|NCT03307785|584889800|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161697573|NCT00379795|583940230|FG000|Overall Study|Subjects condition mandated intervention|34|||
161697574|NCT00379795|583940231|FG001|Overall Study|Subjects condition mandated intervention|9|||
161697575|NCT00379795|583940232|FG002|Overall Study|Subjects condition mandated intervention|7|||
161697576|NCT00379795|583940233|FG003|Overall Study|Subjects condition mandated intervention|5|||
161697577|NCT00379795|583940234|FG004|Overall Study|Subjects condition mandated intervention|7|||
161697578|NCT00379795|583940230|FG000|Overall Study|Sponsor's decision|257|||
161697579|NCT00379795|583940231|FG001|Overall Study|Sponsor's decision|17|||
161697580|NCT00379795|583940232|FG002|Overall Study|Sponsor's decision|54|||
161697581|NCT00379795|583940233|FG003|Overall Study|Sponsor's decision|47|||
161697582|NCT00379795|583940234|FG004|Overall Study|Sponsor's decision|10|||
161697583|NCT01687712|583940235|FG000|Cycle 1|Not Biochemically Pregnant|386|||
161697584|NCT01687712|583940236|FG001|Cycle 1|Not Biochemically Pregnant|348|||
161697585|NCT01687712|583940235|FG000|Cycle 1|Early Pregnancy Loss|43|||
161697586|NCT01687712|583940236|FG001|Cycle 1|Early Pregnancy Loss|60|||
161697587|NCT01687712|583940235|FG000|Cycle 1|Ectopic Pregnancy|5|||
161697588|NCT01687712|583940236|FG001|Cycle 1|Ectopic Pregnancy|5|||
161697589|NCT01687712|583940235|FG000|Cycle 1|Heterotropic Pregnancy|1|||
161697590|NCT01687712|583940236|FG001|Cycle 1|Heterotropic Pregnancy|0|||
161697591|NCT01687712|583940235|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
161697592|NCT01687712|583940236|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
161697593|NCT01687712|583940235|FG000|Cycle 1|Abortion|3|||
161697594|NCT01687712|583940236|FG001|Cycle 1|Abortion|0|||
161697595|NCT01687712|583940235|FG000|Cycle 1|Intrauterine Fetal Death|0|||
161697596|NCT01687712|583940236|FG001|Cycle 1|Intrauterine Fetal Death|1|||
161697597|NCT01687712|583940235|FG000|Cycle 1|Lost to Follow-up|1|||
161697598|NCT01687712|583940236|FG001|Cycle 1|Lost to Follow-up|1|||
161697599|NCT01687712|583940235|FG000|Cycle 2|Not Biochemically Pregnant|74|||
161697600|NCT01687712|583940236|FG001|Cycle 2|Not Biochemically Pregnant|77|||
161697601|NCT01687712|583940235|FG000|Cycle 2|Early Pregnancy Loss|18|||
161697602|NCT01687712|583940236|FG001|Cycle 2|Early Pregnancy Loss|16|||
161697603|NCT01687712|583940235|FG000|Cycle 2|Ectopic Pregnancy|0|||
161697604|NCT01687712|583940236|FG001|Cycle 2|Ectopic Pregnancy|1|||
161697605|NCT01687712|583940235|FG000|Cycle 2|Still Birth|1|||
161697606|NCT01687712|583940236|FG001|Cycle 2|Still Birth|0|||
161697607|NCT01687712|583940235|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
161697608|NCT01687712|583940236|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
161697609|NCT01687712|583940235|FG000|Cycle 3|Not Biochemically Pregnant|21|||
161697610|NCT01687712|583940236|FG001|Cycle 3|Not Biochemically Pregnant|22|||
161697611|NCT01687712|583940235|FG000|Cycle 3|Early Pregnancy Loss|1|||
161697612|NCT01687712|583940236|FG001|Cycle 3|Early Pregnancy Loss|2|||
161697613|NCT01687712|583940235|FG000|Cycle 3|Ectopic Pregnancy|1|||
161697614|NCT01687712|583940236|FG001|Cycle 3|Ectopic Pregnancy|0|||
161697615|NCT01687712|583940235|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
161697616|NCT01687712|583940236|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
161697617|NCT03064841|583940237|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
161697618|NCT03064841|583940237|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
161697619|NCT03064841|583940237|FG000|Overall Study|Screen failure|2|||
161697620|NCT01145066|583940238|FG000|Overall Study|To resume NSAIDs|2|||
161697621|NCT01145066|583940239|FG001|Overall Study|To resume NSAIDs|2|||
161697622|NCT01145066|583940240|FG002|Overall Study|To resume NSAIDs|1|||
161697623|NCT01145066|583940238|FG000|Overall Study|Non-related surgery|0|||
161697624|NCT01145066|583940239|FG001|Overall Study|Non-related surgery|0|||
161697625|NCT01145066|583940240|FG002|Overall Study|Non-related surgery|1|||
161697626|NCT01145066|583940238|FG000|Overall Study|Withdrawal by Subject|0|||
161697627|NCT01145066|583940239|FG001|Overall Study|Withdrawal by Subject|0|||
161697628|NCT01145066|583940240|FG002|Overall Study|Withdrawal by Subject|2|||
161697629|NCT01145066|583940238|FG000|Overall Study|To start new med|1|||
161697630|NCT01145066|583940239|FG001|Overall Study|To start new med|0|||
161697631|NCT01145066|583940240|FG002|Overall Study|To start new med|0|||
161697632|NCT01145066|583940238|FG000|Overall Study|problems swallowing capsule|1|||
161697633|NCT01145066|583940239|FG001|Overall Study|problems swallowing capsule|0|||
161697634|NCT01145066|583940240|FG002|Overall Study|problems swallowing capsule|0|||
161697635|NCT01145066|583940238|FG000|Overall Study|Abdominal discomfort|0|||
161697636|NCT01145066|583940239|FG001|Overall Study|Abdominal discomfort|1|||
161697637|NCT01145066|583940240|FG002|Overall Study|Abdominal discomfort|0|||
161697638|NCT01145066|583940238|FG000|Overall Study|Low platelet count|0|||
161697639|NCT01145066|583940239|FG001|Overall Study|Low platelet count|1|||
161697640|NCT01145066|583940240|FG002|Overall Study|Low platelet count|0|||
161697641|NCT03920670|583940241|FG000|Overall Study|Protocol Violation|2|||
161697642|NCT03920670|583940242|FG001|Overall Study|Protocol Violation|2|||
161697643|NCT03920670|583940241|FG000|Overall Study|Adverse Event|1|||
161697644|NCT03920670|583940242|FG001|Overall Study|Adverse Event|0|||
161697645|NCT01250379|583940249|FG000|Overall Study|Death|141|||
161697646|NCT01250379|583940250|FG001|Overall Study|Death|148|||
161697647|NCT01250379|583940249|FG000|Overall Study|Withdrawal by Subject|32|||
161697648|NCT01250379|583940250|FG001|Overall Study|Withdrawal by Subject|20|||
161697649|NCT01250379|583940249|FG000|Overall Study|Physician Decision|11|||
161697650|NCT01250379|583940250|FG001|Overall Study|Physician Decision|3|||
161697651|NCT01250379|583940249|FG000|Overall Study|Protocol Violation|2|||
161697652|NCT01250379|583940250|FG001|Overall Study|Protocol Violation|8|||
161697653|NCT01250379|583940249|FG000|Overall Study|Lost to Follow-up|9|||
161956855|NCT03307785|584889801|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161956856|NCT03307785|584889802|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
161697654|NCT01250379|583940250|FG001|Overall Study|Lost to Follow-up|6|||
161697655|NCT01250379|583940249|FG000|Overall Study|Adverse Event|5|||
161697656|NCT01250379|583940250|FG001|Overall Study|Adverse Event|4|||
161697657|NCT01250379|583940249|FG000|Overall Study|Other|0|||
161697658|NCT01250379|583940250|FG001|Overall Study|Other|4|||
161697659|NCT01250379|583940249|FG000|Overall Study|Participant noncompliance|2|||
161697660|NCT01250379|583940250|FG001|Overall Study|Participant noncompliance|0|||
161697661|NCT01984268|583940251|FG000|Overall Study|Study Terminated|15|||
161697662|NCT01227902|583941877|FG000|Overall Study|Adverse Event|12|||
161697663|NCT01227902|583941878|FG001|Overall Study|Adverse Event|8|||
161697664|NCT01227902|583941879|FG002|Overall Study|Adverse Event|11|||
161697665|NCT01227902|583941880|FG003|Overall Study|Adverse Event|4|||
161697666|NCT01227902|583941877|FG000|Overall Study|Lack of Efficacy|1|||
161697667|NCT01227902|583941878|FG001|Overall Study|Lack of Efficacy|2|||
161697668|NCT01227902|583941879|FG002|Overall Study|Lack of Efficacy|2|||
161697669|NCT01227902|583941880|FG003|Overall Study|Lack of Efficacy|1|||
161697670|NCT01227902|583941877|FG000|Overall Study|Protocol Violation|1|||
161697671|NCT01227902|583941878|FG001|Overall Study|Protocol Violation|0|||
161697672|NCT01227902|583941879|FG002|Overall Study|Protocol Violation|0|||
161697673|NCT01227902|583941880|FG003|Overall Study|Protocol Violation|0|||
161697674|NCT01227902|583941877|FG000|Overall Study|Lost to Follow-up|0|||
161697675|NCT01227902|583941878|FG001|Overall Study|Lost to Follow-up|0|||
161697676|NCT01227902|583941879|FG002|Overall Study|Lost to Follow-up|1|||
161697677|NCT01227902|583941880|FG003|Overall Study|Lost to Follow-up|2|||
161697678|NCT01227902|583941877|FG000|Overall Study|Physician Decision|0|||
161697679|NCT01227902|583941878|FG001|Overall Study|Physician Decision|1|||
161697680|NCT01227902|583941879|FG002|Overall Study|Physician Decision|1|||
161697681|NCT01227902|583941880|FG003|Overall Study|Physician Decision|0|||
161697682|NCT01227902|583941877|FG000|Overall Study|Withdrawal by Subject|4|||
161697683|NCT01227902|583941878|FG001|Overall Study|Withdrawal by Subject|2|||
161697684|NCT01227902|583941879|FG002|Overall Study|Withdrawal by Subject|4|||
161697685|NCT01227902|583941880|FG003|Overall Study|Withdrawal by Subject|3|||
161697686|NCT02363478|583941885|FG000|Overall Study|Lost to Follow-up|4|||
161697687|NCT02363478|583941885|FG000|Overall Study|Adverse Event|4|||
161697688|NCT01916980|583941889|FG000|Overall Study|Adverse Event|4|||
161697689|NCT01916980|583941890|FG001|Overall Study|Adverse Event|2|||
161697690|NCT01916980|583941889|FG000|Overall Study|Lack of Efficacy|2|||
161697691|NCT01916980|583941890|FG001|Overall Study|Lack of Efficacy|2|||
161697692|NCT01916980|583941889|FG000|Overall Study|Withdrawal by Subject|1|||
161697693|NCT01916980|583941890|FG001|Overall Study|Withdrawal by Subject|0|||
161697694|NCT00546364|583941891|FG000|Overall Study|Disease progression|5|||
161697695|NCT00546364|583941892|FG001|Overall Study|Disease progression|11|||
161697696|NCT00546364|583941893|FG002|Overall Study|Disease progression|8|||
161697697|NCT00546364|583941891|FG000|Overall Study|Completed and off treatment|1|||
161697698|NCT00546364|583941892|FG001|Overall Study|Completed and off treatment|0|||
161697699|NCT00546364|583941893|FG002|Overall Study|Completed and off treatment|2|||
161697700|NCT00546364|583941891|FG000|Overall Study|Administrative reason by sponsor|1|||
161697701|NCT00546364|583941892|FG001|Overall Study|Administrative reason by sponsor|0|||
161697702|NCT00546364|583941893|FG002|Overall Study|Administrative reason by sponsor|0|||
161697703|NCT00546364|583941891|FG000|Overall Study|Poor compliance/noncompliance|0|||
161697704|NCT00546364|583941892|FG001|Overall Study|Poor compliance/noncompliance|0|||
161697705|NCT00546364|583941893|FG002|Overall Study|Poor compliance/noncompliance|1|||
161697706|NCT00546364|583941891|FG000|Overall Study|No longer meets study criteria|1|||
161697707|NCT00546364|583941892|FG001|Overall Study|No longer meets study criteria|1|||
161697708|NCT00546364|583941893|FG002|Overall Study|No longer meets study criteria|0|||
161697709|NCT00546364|583941891|FG000|Overall Study|Withdrawal by Subject|5|||
161697710|NCT00546364|583941892|FG001|Overall Study|Withdrawal by Subject|6|||
161697711|NCT00546364|583941893|FG002|Overall Study|Withdrawal by Subject|3|||
161697712|NCT00546364|583941891|FG000|Overall Study|Prior taxotere|1|||
161836624|NCT03001219|584444976|FG001|Extension Period Analysis|Protocol Deviation|1|||
161697713|NCT00546364|583941892|FG001|Overall Study|Prior taxotere|0|||
161697714|NCT00546364|583941893|FG002|Overall Study|Prior taxotere|0|||
161697715|NCT00546364|583941891|FG000|Overall Study|Mixed response|1|||
161836625|NCT03001219|584444975|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
161697716|NCT00546364|583941892|FG001|Overall Study|Mixed response|0|||
161697717|NCT00546364|583941893|FG002|Overall Study|Mixed response|0|||
161697718|NCT00546364|583941891|FG000|Overall Study|Palliative treatment|1|||
161697719|NCT00546364|583941892|FG001|Overall Study|Palliative treatment|0|||
161697720|NCT00546364|583941893|FG002|Overall Study|Palliative treatment|1|||
161697721|NCT00546364|583941891|FG000|Overall Study|Target lesions resected|1|||
161697722|NCT00546364|583941892|FG001|Overall Study|Target lesions resected|0|||
161697723|NCT00546364|583941893|FG002|Overall Study|Target lesions resected|0|||
161697724|NCT00546364|583941891|FG000|Overall Study|Physician Decision|0|||
161697725|NCT00546364|583941892|FG001|Overall Study|Physician Decision|0|||
161697726|NCT00546364|583941893|FG002|Overall Study|Physician Decision|1|||
161697727|NCT00546364|583941891|FG000|Overall Study|Sponsor decision|0|||
161697728|NCT00546364|583941892|FG001|Overall Study|Sponsor decision|0|||
161697729|NCT00546364|583941893|FG002|Overall Study|Sponsor decision|1|||
161697730|NCT03064763|583941894|FG000|Overall Study|Lost to Follow-up|1|||
161697731|NCT03064763|583941894|FG000|Overall Study|Death|8|||
161697732|NCT02415712|583941895|FG000|Overall Study|Protocol Violation|16|||
161697733|NCT01537211|583941897|FG000|Overall Study|Lost to Follow-up|0|||
161697734|NCT01537211|583941898|FG001|Overall Study|Lost to Follow-up|1|||
161697735|NCT02624492|583941916|FG000|Overall Study|Adverse Event|2|||
161697736|NCT02624492|583941917|FG001|Overall Study|Adverse Event|2|||
161697737|NCT02624492|583941918|FG002|Overall Study|Adverse Event|2|||
161697738|NCT02624492|583941916|FG000|Overall Study|Progressive disease|0|||
161697739|NCT02624492|583941917|FG001|Overall Study|Progressive disease|2|||
161697740|NCT02624492|583941918|FG002|Overall Study|Progressive disease|3|||
161697741|NCT00343512|583941919|FG000|Overall Study|Withdrawal by Subject|2|||
161697742|NCT00323557|583941920|FG000|Overall Study|Physician Decision|1|||
161697743|NCT00323557|583941921|FG001|Overall Study|Physician Decision|0|||
161697744|NCT00684515|583941922|FG000|Overall Study|Adverse Event|3|||
161697745|NCT00684515|583941923|FG001|Overall Study|Adverse Event|3|||
161697746|NCT00684515|583941924|FG002|Overall Study|Adverse Event|1|||
161697747|NCT00684515|583941922|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
161697748|NCT00684515|583941923|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
161697749|NCT00684515|583941924|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
161697750|NCT00763321|583941925|FG000|Open-label Period|Adverse Event|24|||
161836626|NCT03001219|584444976|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
161836627|NCT01797835|584444977|FG000|Overall Study|Lost to Follow-up|31|||
161836628|NCT01797835|584444978|FG001|Overall Study|Lost to Follow-up|27|||
161697751|NCT00763321|583941926|FG001|Open-label Period|Adverse Event|0|||
161697752|NCT00763321|583941927|FG002|Open-label Period|Adverse Event|0|||
161697753|NCT00763321|583941925|FG000|Open-label Period|Lost to Follow-up|14|||
161697754|NCT00763321|583941926|FG001|Open-label Period|Lost to Follow-up|0|||
161697755|NCT00763321|583941927|FG002|Open-label Period|Lost to Follow-up|0|||
161697756|NCT00763321|583941925|FG000|Open-label Period|Withdrawal by Subject|7|||
161697757|NCT00763321|583941926|FG001|Open-label Period|Withdrawal by Subject|0|||
161836629|NCT01403064|584444979|FG000|Overall Study|Death|0|||
161836630|NCT01403064|584444980|FG001|Overall Study|Death|0|||
161956857|NCT03307785|584889790|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161956858|NCT03307785|584889791|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161956859|NCT03307785|584889792|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
161956860|NCT03307785|584889793|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161956861|NCT03307785|584889794|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161956862|NCT03307785|584889795|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161956863|NCT03307785|584889796|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161956864|NCT03307785|584889797|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161956865|NCT03307785|584889798|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161956866|NCT03307785|584889799|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161956867|NCT03307785|584889800|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161697758|NCT00763321|583941927|FG002|Open-label Period|Withdrawal by Subject|0|||
161697759|NCT00763321|583941925|FG000|Open-label Period|Subject noncompliant|7|||
161697760|NCT00763321|583941926|FG001|Open-label Period|Subject noncompliant|0|||
161697761|NCT00763321|583941927|FG002|Open-label Period|Subject noncompliant|0|||
161697762|NCT00763321|583941925|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
161697763|NCT00763321|583941926|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
161697764|NCT00763321|583941927|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
161697765|NCT00763321|583941925|FG000|Open-label Period|Lack of Efficacy|2|||
161697766|NCT00763321|583941926|FG001|Open-label Period|Lack of Efficacy|0|||
161697767|NCT00763321|583941927|FG002|Open-label Period|Lack of Efficacy|0|||
161697768|NCT00763321|583941925|FG000|Open-label Period|Other|4|||
161697769|NCT00763321|583941926|FG001|Open-label Period|Other|0|||
161697770|NCT00763321|583941927|FG002|Open-label Period|Other|0|||
161697771|NCT00763321|583941925|FG000|Double-blind Period|Lack of Efficacy|0|||
161697772|NCT00763321|583941926|FG001|Double-blind Period|Lack of Efficacy|9|||
161697773|NCT00763321|583941927|FG002|Double-blind Period|Lack of Efficacy|17|||
161697774|NCT00763321|583941925|FG000|Double-blind Period|Adverse Event|0|||
161697775|NCT00763321|583941926|FG001|Double-blind Period|Adverse Event|4|||
161697776|NCT00763321|583941927|FG002|Double-blind Period|Adverse Event|4|||
161697777|NCT00763321|583941925|FG000|Double-blind Period|Lost to Follow-up|0|||
161697778|NCT00763321|583941926|FG001|Double-blind Period|Lost to Follow-up|4|||
161697779|NCT00763321|583941927|FG002|Double-blind Period|Lost to Follow-up|2|||
161697780|NCT00763321|583941925|FG000|Double-blind Period|Withdrawal by Subject|0|||
161697781|NCT00763321|583941926|FG001|Double-blind Period|Withdrawal by Subject|2|||
161697782|NCT00763321|583941927|FG002|Double-blind Period|Withdrawal by Subject|3|||
161697783|NCT00763321|583941925|FG000|Double-blind Period|Other|0|||
161697784|NCT00763321|583941926|FG001|Double-blind Period|Other|2|||
161836631|NCT01403064|584444981|FG002|Overall Study|Death|1|||
161697785|NCT00763321|583941927|FG002|Double-blind Period|Other|3|||
161697786|NCT02793232|583941928|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697787|NCT02793232|583941929|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697788|NCT02793232|583941930|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697789|NCT02793232|583941931|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697790|NCT02793232|583941932|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
161697791|NCT02793232|583941933|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697792|NCT02793232|583941934|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
161697793|NCT02793232|583941935|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697794|NCT02793232|583941936|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161697795|NCT02387580|583941939|FG000|Overall Study|Withdrawal by Subject|0|||
161697796|NCT02387580|583941940|FG001|Overall Study|Withdrawal by Subject|0|||
161697797|NCT02387580|583941941|FG002|Overall Study|Withdrawal by Subject|0|||
161697798|NCT02387580|583941942|FG003|Overall Study|Withdrawal by Subject|1|||
161697799|NCT02387580|583941943|FG004|Overall Study|Withdrawal by Subject|0|||
161697800|NCT02387580|583941944|FG005|Overall Study|Withdrawal by Subject|0|||
161697801|NCT00087646|583941945|FG000|Overall Study|Adverse Event|37|||
161697802|NCT00087646|583941946|FG001|Overall Study|Adverse Event|6|||
161697803|NCT00087646|583941947|FG002|Overall Study|Adverse Event|18|||
161697804|NCT00087646|583941948|FG003|Overall Study|Adverse Event|20|||
161697805|NCT00087646|583941945|FG000|Overall Study|Death|0|||
161836632|NCT01403064|584444982|FG003|Overall Study|Death|1|||
161836633|NCT01403064|584444979|FG000|Overall Study|Withdrawal by Subject|0|||
161836634|NCT01403064|584444980|FG001|Overall Study|Withdrawal by Subject|0|||
161836635|NCT01403064|584444981|FG002|Overall Study|Withdrawal by Subject|1|||
161836636|NCT01403064|584444982|FG003|Overall Study|Withdrawal by Subject|1|||
161836637|NCT01403064|584444979|FG000|Overall Study|Other|1|||
161836638|NCT01403064|584444980|FG001|Overall Study|Other|0|||
161836639|NCT01403064|584444981|FG002|Overall Study|Other|2|||
161836640|NCT01403064|584444982|FG003|Overall Study|Other|1|||
161836641|NCT00973765|584444983|FG000|Overall Study|Lost to Follow-up|8|||
161836642|NCT00973765|584444984|FG001|Overall Study|Lost to Follow-up|14|||
161836643|NCT02669940|584444985|FG000|Overall Study|Failure to return|0|||
161836644|NCT02669940|584444986|FG001|Overall Study|Failure to return|3|||
161836645|NCT02669940|584444985|FG000|Overall Study|Insufficient follow-up data|1|||
161836646|NCT02669940|584444986|FG001|Overall Study|Insufficient follow-up data|0|||
161836647|NCT01892657|584444987|FG000|Overall Study|Withdrawal by Subject|6|||
161836648|NCT01892657|584444987|FG000|Overall Study|Protocol Violation|12|||
161836649|NCT00986180|584444988|FG000|Overall Study|Adverse Event|21|||
161836650|NCT00986180|584444989|FG001|Overall Study|Adverse Event|23|||
161836651|NCT00986180|584444988|FG000|Overall Study|Lack of Efficacy|4|||
161836652|NCT00986180|584444989|FG001|Overall Study|Lack of Efficacy|3|||
161836653|NCT00986180|584444988|FG000|Overall Study|Lost to Follow-up|5|||
161836654|NCT00986180|584444989|FG001|Overall Study|Lost to Follow-up|7|||
161836655|NCT00986180|584444988|FG000|Overall Study|Physician Decision|1|||
161836656|NCT00986180|584444989|FG001|Overall Study|Physician Decision|3|||
161836657|NCT00986180|584444988|FG000|Overall Study|Protocol Violation|2|||
161836658|NCT00986180|584444989|FG001|Overall Study|Protocol Violation|0|||
161836659|NCT00986180|584444988|FG000|Overall Study|Withdrawal by Subject|1|||
161836660|NCT00986180|584444989|FG001|Overall Study|Withdrawal by Subject|9|||
161836661|NCT00986180|584444988|FG000|Overall Study|Miscellanies|10|||
161836662|NCT00986180|584444989|FG001|Overall Study|Miscellanies|11|||
161836663|NCT01070771|584444992|FG000|Overall Study|Adverse Event|2|||
161836664|NCT01070771|584444992|FG000|Overall Study|Protocol Violation|1|||
161836665|NCT03835325|584444993|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
161836666|NCT03835325|584444993|FG000|Overall Study|Selection failure|1|||
161836667|NCT01370213|584444996|FG000|Overall Study|Early Death|1|||
161836668|NCT01370213|584444997|FG001|Overall Study|Early Death|0|||
161836669|NCT01370213|584444998|FG002|Overall Study|Early Death|0|||
161697806|NCT00087646|583941946|FG001|Overall Study|Death|1|||
161697807|NCT00087646|583941947|FG002|Overall Study|Death|0|||
161697808|NCT00087646|583941948|FG003|Overall Study|Death|0|||
161697809|NCT00087646|583941945|FG000|Overall Study|Withdrawal by Subject|6|||
161697810|NCT00087646|583941946|FG001|Overall Study|Withdrawal by Subject|1|||
161697811|NCT00087646|583941947|FG002|Overall Study|Withdrawal by Subject|2|||
161697812|NCT00087646|583941948|FG003|Overall Study|Withdrawal by Subject|2|||
161836670|NCT01370213|584444996|FG000|Overall Study|Not evaluable|0|||
161836671|NCT01370213|584444997|FG001|Overall Study|Not evaluable|2|||
161836672|NCT01370213|584444998|FG002|Overall Study|Not evaluable|0|||
161836673|NCT00567476|584445004|FG000|Overall Study|Adverse Event|2|||
161836674|NCT00567476|584445005|FG001|Overall Study|Adverse Event|0|||
161836675|NCT00567476|584445004|FG000|Overall Study|Pregnancy|1|||
161836676|NCT00567476|584445005|FG001|Overall Study|Pregnancy|0|||
161836677|NCT00567476|584445004|FG000|Overall Study|Protocol Violation|4|||
161836678|NCT00567476|584445005|FG001|Overall Study|Protocol Violation|1|||
161836679|NCT00567476|584445004|FG000|Overall Study|Lost to Follow-up|0|||
161836680|NCT00567476|584445005|FG001|Overall Study|Lost to Follow-up|1|||
161836681|NCT00567476|584445004|FG000|Overall Study|Administrative issues|1|||
161697813|NCT00087646|583941945|FG000|Overall Study|Insufficient therapeutic response|64|||
161697814|NCT00087646|583941946|FG001|Overall Study|Insufficient therapeutic response|24|||
161697815|NCT00087646|583941947|FG002|Overall Study|Insufficient therapeutic response|38|||
161697816|NCT00087646|583941948|FG003|Overall Study|Insufficient therapeutic response|51|||
161697817|NCT00087646|583941945|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
161697818|NCT00087646|583941946|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
161697819|NCT00087646|583941947|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
161697820|NCT00087646|583941948|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
161697821|NCT00087646|583941945|FG000|Overall Study|Failure to Return|5|||
161697822|NCT00087646|583941946|FG001|Overall Study|Failure to Return|2|||
161697823|NCT00087646|583941947|FG002|Overall Study|Failure to Return|2|||
161697824|NCT00087646|583941948|FG003|Overall Study|Failure to Return|3|||
161697825|NCT00087646|583941945|FG000|Overall Study|Administrative/Other|6|||
161697826|NCT00087646|583941946|FG001|Overall Study|Administrative/Other|1|||
161697827|NCT00087646|583941947|FG002|Overall Study|Administrative/Other|1|||
161697828|NCT00087646|583941948|FG003|Overall Study|Administrative/Other|2|||
161697829|NCT00087646|583941945|FG000|Overall Study|Other Protocol Violation|3|||
161697830|NCT00087646|583941946|FG001|Overall Study|Other Protocol Violation|1|||
161697831|NCT00087646|583941947|FG002|Overall Study|Other Protocol Violation|0|||
161697832|NCT00087646|583941948|FG003|Overall Study|Other Protocol Violation|0|||
161697833|NCT00087646|583941945|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
161697834|NCT00087646|583941946|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
161697835|NCT00087646|583941947|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
161697836|NCT00087646|583941948|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
161697837|NCT02301403|583941962|FG000|Overall Study|Withdrawal by Subject|28|||
161697838|NCT02301403|583941963|FG001|Overall Study|Withdrawal by Subject|41|||
161697839|NCT01060059|583941964|FG000|Overall Study|Adverse Event|1|||
161697840|NCT01060059|583941965|FG001|Overall Study|Adverse Event|1|||
161697841|NCT01060059|583941964|FG000|Overall Study|Death|2|||
161697842|NCT01060059|583941965|FG001|Overall Study|Death|3|||
161697843|NCT01060059|583941964|FG000|Overall Study|Lost to Follow-up|18|||
161697844|NCT01060059|583941965|FG001|Overall Study|Lost to Follow-up|34|||
161697845|NCT01060059|583941964|FG000|Overall Study|entry criteria not met|4|||
161697846|NCT01060059|583941965|FG001|Overall Study|entry criteria not met|3|||
161697847|NCT01060059|583941964|FG000|Overall Study|Withdrawal by Subject|35|||
161697848|NCT01060059|583941965|FG001|Overall Study|Withdrawal by Subject|23|||
161697849|NCT01060059|583941964|FG000|Overall Study|lack of glycemic control|2|||
161697850|NCT01060059|583941965|FG001|Overall Study|lack of glycemic control|1|||
161697851|NCT01060059|583941964|FG000|Overall Study|lack of compliance|5|||
161697852|NCT01060059|583941965|FG001|Overall Study|lack of compliance|2|||
161697853|NCT02302963|583941968|FG000|Overall Study|Withdrawal by Subject|2|||
161697854|NCT02302963|583941969|FG001|Overall Study|Withdrawal by Subject|1|||
161697855|NCT02302963|583941968|FG000|Overall Study|Steroid injection|0|||
161697856|NCT02302963|583941969|FG001|Overall Study|Steroid injection|1|||
161697857|NCT02302963|583941968|FG000|Overall Study|Physician Decision|1|||
161697858|NCT02302963|583941969|FG001|Overall Study|Physician Decision|0|||
161697859|NCT01816243|583941970|FG000|Overall Study|Adverse Event|6|||
161697860|NCT01816243|583941970|FG000|Overall Study|Lost to Follow-up|1|||
161697861|NCT01816243|583941970|FG000|Overall Study|Lack of Efficacy|1|||
161697862|NCT01816243|583941970|FG000|Overall Study|Not eligible for the study|1|||
161697863|NCT01816243|583941970|FG000|Overall Study|Amputation|3|||
161697864|NCT01920711|583941971|FG000|Overall Study|Death|347|||
161697865|NCT01920711|583941972|FG001|Overall Study|Death|356|||
161697866|NCT01920711|583941971|FG000|Overall Study|Lost to Follow-up|13|||
161697867|NCT01920711|583941972|FG001|Overall Study|Lost to Follow-up|14|||
161697868|NCT01920711|583941971|FG000|Overall Study|Withdrawal by Subject|4|||
161697869|NCT01920711|583941972|FG001|Overall Study|Withdrawal by Subject|3|||
161697870|NCT03891901|583941973|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
161697871|NCT03891901|583941974|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697872|NCT03891901|583941975|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697873|NCT03891901|583941976|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697874|NCT03891901|583941977|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697875|NCT03891901|583941978|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697876|NCT03891901|583941979|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697877|NCT03891901|583941980|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697878|NCT03891901|583941981|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161697879|NCT03891901|583941973|FG000|Overall Study|Adverse Event|2|||
161697880|NCT03891901|583941974|FG001|Overall Study|Adverse Event|2|||
161697881|NCT03891901|583941975|FG002|Overall Study|Adverse Event|0|||
161697882|NCT03891901|583941976|FG003|Overall Study|Adverse Event|0|||
161697883|NCT03891901|583941977|FG004|Overall Study|Adverse Event|0|||
161956868|NCT03307785|584889801|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161697884|NCT03891901|583941978|FG005|Overall Study|Adverse Event|0|||
161697885|NCT03891901|583941979|FG006|Overall Study|Adverse Event|0|||
161697886|NCT03891901|583941980|FG007|Overall Study|Adverse Event|0|||
161697887|NCT03891901|583941981|FG008|Overall Study|Adverse Event|0|||
161956869|NCT03307785|584889802|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
161956870|NCT03307785|584889790|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161956871|NCT03307785|584889791|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161956872|NCT03307785|584889792|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161956873|NCT03307785|584889793|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
161956874|NCT03307785|584889794|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
161697888|NCT03891901|583941973|FG000|Overall Study|Poor venous access|1|||
161697889|NCT03891901|583941974|FG001|Overall Study|Poor venous access|0|||
161697890|NCT03891901|583941975|FG002|Overall Study|Poor venous access|0|||
161697891|NCT03891901|583941976|FG003|Overall Study|Poor venous access|0|||
161697892|NCT03891901|583941977|FG004|Overall Study|Poor venous access|0|||
161697893|NCT03891901|583941978|FG005|Overall Study|Poor venous access|0|||
161697894|NCT03891901|583941979|FG006|Overall Study|Poor venous access|0|||
161697895|NCT03891901|583941980|FG007|Overall Study|Poor venous access|0|||
161697896|NCT03891901|583941981|FG008|Overall Study|Poor venous access|0|||
161697897|NCT03891901|583941973|FG000|Overall Study|Withdrawal by Subject|0|||
161697898|NCT03891901|583941974|FG001|Overall Study|Withdrawal by Subject|2|||
161697899|NCT03891901|583941975|FG002|Overall Study|Withdrawal by Subject|0|||
161697900|NCT03891901|583941976|FG003|Overall Study|Withdrawal by Subject|0|||
161697901|NCT03891901|583941977|FG004|Overall Study|Withdrawal by Subject|0|||
161697902|NCT03891901|583941978|FG005|Overall Study|Withdrawal by Subject|0|||
161697903|NCT03891901|583941979|FG006|Overall Study|Withdrawal by Subject|0|||
161697904|NCT03891901|583941980|FG007|Overall Study|Withdrawal by Subject|0|||
161697905|NCT03891901|583941981|FG008|Overall Study|Withdrawal by Subject|0|||
161697906|NCT00573794|583941982|FG000|Overall Study|Adverse Event|81|||
161697907|NCT00573794|583941982|FG000|Overall Study|Withdrew Consent|90|||
161697908|NCT00573794|583941982|FG000|Overall Study|Lost to Follow-up|13|||
161697909|NCT00573794|583941982|FG000|Overall Study|Protocol Violation|6|||
161697910|NCT00573794|583941982|FG000|Overall Study|Lack of Efficacy|94|||
161697911|NCT00573794|583941982|FG000|Overall Study|Other|46|||
161697912|NCT04556617|583941993|FG000|Overall Study|progressive disease|0|||
161697913|NCT04556617|583941994|FG001|Overall Study|progressive disease|2|||
161836682|NCT00567476|584445005|FG001|Overall Study|Administrative issues|0|||
161836683|NCT00567476|584445004|FG000|Overall Study|Medical Decision|0|||
161836684|NCT00567476|584445005|FG001|Overall Study|Medical Decision|1|||
161836685|NCT00567476|584445004|FG000|Overall Study|Non-adherence to protocol|0|||
161836686|NCT00567476|584445005|FG001|Overall Study|Non-adherence to protocol|1|||
161836687|NCT02595008|584445006|FG000|Overall Study|Enrolled In Error|1|||
161836688|NCT02595008|584445007|FG001|Overall Study|Enrolled In Error|0|||
161836689|NCT02999477|584445008|FG000|Overall Study|found ineligible after first dose|0|||
161836690|NCT02999477|584445009|FG001|Overall Study|found ineligible after first dose|1|||
161836691|NCT02999477|584445008|FG000|Overall Study|Withdrawal by Subject|1|||
161836692|NCT02999477|584445009|FG001|Overall Study|Withdrawal by Subject|1|||
161836693|NCT01846273|584445012|FG000|Overall Study|Adverse Event|9|||
161836694|NCT01846273|584445013|FG001|Overall Study|Adverse Event|7|||
161836695|NCT01846273|584445014|FG002|Overall Study|Adverse Event|0|||
161836696|NCT01846273|584445012|FG000|Overall Study|Subject withdrew consent|5|||
161836697|NCT01846273|584445013|FG001|Overall Study|Subject withdrew consent|8|||
161836698|NCT01846273|584445014|FG002|Overall Study|Subject withdrew consent|0|||
161836699|NCT01846273|584445012|FG000|Overall Study|Lost to Follow-up|2|||
161836700|NCT01846273|584445013|FG001|Overall Study|Lost to Follow-up|1|||
161836701|NCT01846273|584445014|FG002|Overall Study|Lost to Follow-up|0|||
161836702|NCT01846273|584445012|FG000|Overall Study|Administrative problems|1|||
161836703|NCT01846273|584445013|FG001|Overall Study|Administrative problems|0|||
161836704|NCT01846273|584445014|FG002|Overall Study|Administrative problems|0|||
161836705|NCT01846273|584445012|FG000|Overall Study|Death|2|||
161836706|NCT01846273|584445013|FG001|Overall Study|Death|1|||
161836707|NCT01846273|584445014|FG002|Overall Study|Death|0|||
161956875|NCT03307785|584889795|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
162030797|NCT03400956|585169491|FG001|Treatment Period 1|Adverse Event|1|||
161697914|NCT04556617|583941995|FG002|Overall Study|progressive disease|2|||
161697915|NCT04556617|583941996|FG003|Overall Study|progressive disease|1|||
161697916|NCT04556617|583941997|FG004|Overall Study|progressive disease|1|||
161697917|NCT04556617|583941993|FG000|Overall Study|Physician Decision|0|||
161836708|NCT01846273|584445012|FG000|Overall Study|Disease Progression|0|||
161836709|NCT01846273|584445013|FG001|Overall Study|Disease Progression|4|||
161836710|NCT01846273|584445014|FG002|Overall Study|Disease Progression|0|||
161836711|NCT01846273|584445012|FG000|Overall Study|Protocol Deviation|2|||
161836712|NCT01846273|584445013|FG001|Overall Study|Protocol Deviation|3|||
161836713|NCT01846273|584445014|FG002|Overall Study|Protocol Deviation|0|||
161836714|NCT01846273|584445012|FG000|Overall Study|Physician Decision|1|||
161836715|NCT01846273|584445013|FG001|Overall Study|Physician Decision|2|||
162030798|NCT03400956|585169492|FG002|Treatment Period 1|Adverse Event|0|||
161697918|NCT04556617|583941994|FG001|Overall Study|Physician Decision|0|||
161697919|NCT04556617|583941995|FG002|Overall Study|Physician Decision|2|||
161697920|NCT04556617|583941996|FG003|Overall Study|Physician Decision|0|||
161697921|NCT04556617|583941997|FG004|Overall Study|Physician Decision|0|||
161697922|NCT04556617|583941993|FG000|Overall Study|Adverse Event|0|||
161697923|NCT04556617|583941994|FG001|Overall Study|Adverse Event|0|||
161697924|NCT04556617|583941995|FG002|Overall Study|Adverse Event|2|||
161697925|NCT04556617|583941996|FG003|Overall Study|Adverse Event|3|||
161697926|NCT04556617|583941997|FG004|Overall Study|Adverse Event|0|||
161697927|NCT04556617|583941993|FG000|Overall Study|Withdrawal by Subject|0|||
161697928|NCT04556617|583941994|FG001|Overall Study|Withdrawal by Subject|2|||
161697929|NCT04556617|583941995|FG002|Overall Study|Withdrawal by Subject|1|||
161697930|NCT04556617|583941996|FG003|Overall Study|Withdrawal by Subject|1|||
161697931|NCT04556617|583941997|FG004|Overall Study|Withdrawal by Subject|0|||
161697932|NCT04556617|583941993|FG000|Overall Study|PSA increase|0|||
161697933|NCT04556617|583941994|FG001|Overall Study|PSA increase|1|||
161697934|NCT04556617|583941995|FG002|Overall Study|PSA increase|0|||
161697935|NCT04556617|583941996|FG003|Overall Study|PSA increase|0|||
161697936|NCT04556617|583941997|FG004|Overall Study|PSA increase|0|||
161697937|NCT04556617|583941993|FG000|Overall Study|Sponsor study termination|1|||
161697938|NCT04556617|583941994|FG001|Overall Study|Sponsor study termination|0|||
161697939|NCT04556617|583941995|FG002|Overall Study|Sponsor study termination|0|||
161697940|NCT04556617|583941996|FG003|Overall Study|Sponsor study termination|0|||
161697941|NCT04556617|583941997|FG004|Overall Study|Sponsor study termination|0|||
161697942|NCT04949841|583941998|FG000|Overall Study|Adverse Event|7|||
161697943|NCT04949841|583941998|FG000|Overall Study|Death|1|||
161697944|NCT04949841|583941998|FG000|Overall Study|Withdrawal by Subject|52|||
161697945|NCT04949841|583941998|FG000|Overall Study|Pregnancy|4|||
161697946|NCT04949841|583941998|FG000|Overall Study|Lost to Follow-up|9|||
161697947|NCT04949841|583941998|FG000|Overall Study|Lack of Efficacy|55|||
161697948|NCT04949841|583941998|FG000|Overall Study|Various reasons|9|||
161697949|NCT04820309|583941999|FG000|Overall Study|Adverse Event|96|||
161697950|NCT04820309|583941999|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
161697951|NCT04820309|583941999|FG000|Overall Study|Consent Withdrawn|93|||
161697952|NCT04820309|583941999|FG000|Overall Study|failure to adhere to protocol|32|||
161697953|NCT04820309|583941999|FG000|Overall Study|alcohol or drug use|6|||
161697954|NCT04820309|583941999|FG000|Overall Study|Lost to Follow-up|46|||
161697955|NCT04820309|583941999|FG000|Overall Study|Death|2|||
161697956|NCT04820309|583941999|FG000|Overall Study|Pregnancy|1|||
161697957|NCT04820309|583941999|FG000|Overall Study|Other reasons|12|||
161697958|NCT04202679|583942006|FG000|Overall Study|Adverse Event|2|||
161697959|NCT04202679|583942007|FG001|Overall Study|Adverse Event|0|||
161697960|NCT04202679|583942006|FG000|Overall Study|Poor compliance to protocol|1|||
161697961|NCT04202679|583942007|FG001|Overall Study|Poor compliance to protocol|0|||
161697962|NCT04202679|583942006|FG000|Overall Study|Withdrawal by Subject|23|||
161697963|NCT04202679|583942007|FG001|Overall Study|Withdrawal by Subject|6|||
161697964|NCT05902364|583942008|FG000|Overall Study|Adverse Event|1|||
161697965|NCT05902364|583942009|FG001|Overall Study|Adverse Event|0|||
161697966|NCT02270242|583942010|FG000|Overall Study|Withdrawal by Subject|18|||
161697967|NCT02270242|583942011|FG001|Overall Study|Withdrawal by Subject|25|||
161697968|NCT02270242|583942010|FG000|Overall Study|Lost to Follow-up|41|||
161697969|NCT02270242|583942011|FG001|Overall Study|Lost to Follow-up|27|||
161697970|NCT02270242|583942010|FG000|Overall Study|Physician Decision|0|||
161697971|NCT02270242|583942011|FG001|Overall Study|Physician Decision|1|||
161697972|NCT03864653|583942012|FG000|Overall Study|Withdrawal by Subject|1|||
161697973|NCT02531646|583942013|FG000|Overall Study|equip. image processing issue|5|||
161697974|NCT02531646|583942014|FG001|Overall Study|equip. image processing issue|1|||
161697975|NCT02531646|583942015|FG002|Overall Study|equip. image processing issue|0|||
161697976|NCT00429585|583942016|FG000|Overall Study|Death|1|||
161697977|NCT00429585|583942017|FG001|Overall Study|Death|0|||
161697978|NCT00429585|583942016|FG000|Overall Study|Lost to Follow-up|27|||
161697979|NCT00429585|583942017|FG001|Overall Study|Lost to Follow-up|20|||
161697980|NCT00429585|583942016|FG000|Overall Study|Physician Decision|2|||
161697981|NCT00429585|583942017|FG001|Overall Study|Physician Decision|0|||
161697982|NCT01582308|583942018|FG000|Period 1|Withdrawal by Subject|0|||
161697983|NCT01582308|583942019|FG001|Period 1|Withdrawal by Subject|0|||
161697984|NCT01582308|583942020|FG002|Period 1|Withdrawal by Subject|0|||
161697985|NCT01582308|583942021|FG003|Period 1|Withdrawal by Subject|0|||
161697986|NCT01582308|583942022|FG004|Period 1|Withdrawal by Subject|0|||
161697987|NCT01582308|583942023|FG005|Period 1|Withdrawal by Subject|0|||
161697988|NCT01582308|583942024|FG006|Period 1|Withdrawal by Subject|1|||
161697989|NCT01582308|583942025|FG007|Period 1|Withdrawal by Subject|0|||
161697990|NCT01582308|583942026|FG008|Period 1|Withdrawal by Subject|0|||
161697991|NCT01582308|583942027|FG009|Period 1|Withdrawal by Subject|0|||
161697992|NCT01582308|583942018|FG000|10-day Washout Following Period 1|Physician Decision|0|||
161697993|NCT01582308|583942019|FG001|10-day Washout Following Period 1|Physician Decision|0|||
161697994|NCT01582308|583942020|FG002|10-day Washout Following Period 1|Physician Decision|0|||
161697995|NCT01582308|583942021|FG003|10-day Washout Following Period 1|Physician Decision|0|||
161697996|NCT01582308|583942022|FG004|10-day Washout Following Period 1|Physician Decision|1|||
161697997|NCT01582308|583942023|FG005|10-day Washout Following Period 1|Physician Decision|0|||
161697998|NCT01582308|583942024|FG006|10-day Washout Following Period 1|Physician Decision|0|||
161697999|NCT01582308|583942025|FG007|10-day Washout Following Period 1|Physician Decision|0|||
161698000|NCT01582308|583942026|FG008|10-day Washout Following Period 1|Physician Decision|0|||
161698001|NCT01582308|583942027|FG009|10-day Washout Following Period 1|Physician Decision|0|||
161698002|NCT01582308|583942018|FG000|Period 4|Physician Decision|1|||
161698003|NCT01582308|583942019|FG001|Period 4|Physician Decision|0|||
161698004|NCT01582308|583942020|FG002|Period 4|Physician Decision|0|||
161698005|NCT01582308|583942021|FG003|Period 4|Physician Decision|0|||
161698006|NCT01582308|583942022|FG004|Period 4|Physician Decision|0|||
161698007|NCT01582308|583942023|FG005|Period 4|Physician Decision|1|||
161698008|NCT01582308|583942024|FG006|Period 4|Physician Decision|0|||
161698009|NCT01582308|583942025|FG007|Period 4|Physician Decision|0|||
161698010|NCT01582308|583942026|FG008|Period 4|Physician Decision|0|||
161698011|NCT01582308|583942027|FG009|Period 4|Physician Decision|1|||
161698012|NCT00772668|583942030|FG000|Overall Study|Physician Decision|3|||
161698013|NCT01182428|583942031|FG000|Overall Study|Physician Decision|1|||
161698014|NCT01182428|583942032|FG001|Overall Study|Physician Decision|0|||
161698015|NCT01182428|583942031|FG000|Overall Study|Lost to Follow-up|9|||
161698016|NCT01182428|583942032|FG001|Overall Study|Lost to Follow-up|1|||
161698017|NCT01182428|583942031|FG000|Overall Study|Withdrawal by Subject|1|||
161698018|NCT01182428|583942032|FG001|Overall Study|Withdrawal by Subject|0|||
161698019|NCT03631706|583942034|FG000|Overall Study|Randomized, not treated|1|||
161698020|NCT03631706|583942035|FG001|Overall Study|Randomized, not treated|0|||
161698021|NCT00684957|583942039|FG000|Overall Study|Withdrawal by Subject|1|||
161698022|NCT00684957|583942040|FG001|Overall Study|Withdrawal by Subject|1|||
161698023|NCT00684957|583942039|FG000|Overall Study|Lost to Follow-up|1|||
161698024|NCT00684957|583942040|FG001|Overall Study|Lost to Follow-up|0|||
161698025|NCT04341948|583942041|FG000|Overall Study|Adverse Event|0|||
161698026|NCT04341948|583942042|FG001|Overall Study|Adverse Event|1|||
161698027|NCT04341948|583942041|FG000|Overall Study|Lost to Follow-up|6|||
161698028|NCT04341948|583942042|FG001|Overall Study|Lost to Follow-up|1|||
161698029|NCT04341948|583942041|FG000|Overall Study|Physician Decision|1|||
161698030|NCT04341948|583942042|FG001|Overall Study|Physician Decision|2|||
161698031|NCT04341948|583942041|FG000|Overall Study|Withdrawal by Participant|6|||
161956876|NCT03307785|584889796|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161698032|NCT04341948|583942042|FG001|Overall Study|Withdrawal by Participant|3|||
161698033|NCT04341948|583942041|FG000|Overall Study|Lack of compliance by Participant|1|||
161698034|NCT04341948|583942042|FG001|Overall Study|Lack of compliance by Participant|0|||
161698035|NCT03406897|583942043|FG000|Overall Study|Lost to Follow-up|1|||
161698036|NCT03406897|583942044|FG001|Overall Study|Lost to Follow-up|2|||
161698037|NCT03406897|583942043|FG000|Overall Study|Withdrawal by Subject|4|||
161698038|NCT03406897|583942044|FG001|Overall Study|Withdrawal by Subject|4|||
161698039|NCT03406897|583942043|FG000|Overall Study|Physician Decision|0|||
161698040|NCT03406897|583942044|FG001|Overall Study|Physician Decision|1|||
161698041|NCT02554929|583944094|FG000|Overall Study|Lost to Follow-up|4|||
161698042|NCT02554929|583944095|FG001|Overall Study|Lost to Follow-up|4|||
161698043|NCT02554929|583944094|FG000|Overall Study|Withdrawal by Subject|2|||
161698044|NCT02554929|583944095|FG001|Overall Study|Withdrawal by Subject|8|||
161698045|NCT00388947|583944097|FG000|Overall Study|Protocol Violation|47|||
161698046|NCT04187092|583944098|FG000|Overall Study|Lost to Follow-up|1|||
161698047|NCT04187092|583944099|FG001|Overall Study|Lost to Follow-up|1|||
161698048|NCT04187092|583944098|FG000|Overall Study|Withdrawal by Subject|1|||
161698049|NCT04187092|583944099|FG001|Overall Study|Withdrawal by Subject|1|||
161698050|NCT04187092|583944098|FG000|Overall Study|Adverse Event|0|||
161698051|NCT04187092|583944099|FG001|Overall Study|Adverse Event|1|||
161698052|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
161698053|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
161698054|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
161698055|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
161698056|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
161956877|NCT03307785|584889797|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161698057|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
161698058|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
161698059|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
161698060|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
161698061|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
161698062|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
161698063|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
161698064|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
161698065|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
161698066|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
161698067|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
161698068|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
161698069|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
161698070|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
161698071|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
161698072|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
161698073|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
161698074|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
161698075|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
161956878|NCT03307785|584889798|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161956879|NCT03307785|584889799|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161956880|NCT03307785|584889800|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161956881|NCT03307785|584889801|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161956882|NCT03307785|584889802|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
161956883|NCT03307785|584889790|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
161698076|NCT04660643|583944100|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
161698077|NCT04660643|583944101|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
161698078|NCT04660643|583944102|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
161698079|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
161698080|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
161698081|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
161698082|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
161698083|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
161698084|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
161698085|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
161698086|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
161698087|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
161698088|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
161698089|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
161698090|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
161698091|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
161698092|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
161698093|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
161698094|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
161836716|NCT01846273|584445014|FG002|Overall Study|Physician Decision|0|||
161836717|NCT00891839|584445015|FG000|Overall Study|Adverse Event|2|||
161836718|NCT00891839|584445015|FG000|Overall Study|Withdrawal by Subject|2|||
161836719|NCT00891839|584445015|FG000|Overall Study|Disease progression|3|||
161836720|NCT00851643|584445016|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
161836721|NCT00851643|584445017|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161836722|NCT00851643|584445018|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161836723|NCT00851643|584445019|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161836724|NCT00851643|584445020|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161836725|NCT00851643|584445021|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161836726|NCT00851643|584445016|FG000|Base Study (Up to 12 Months)|Other|0|||
161836727|NCT00851643|584445017|FG001|Base Study (Up to 12 Months)|Other|0|||
161836728|NCT00851643|584445018|FG002|Base Study (Up to 12 Months)|Other|0|||
161836729|NCT00851643|584445019|FG003|Base Study (Up to 12 Months)|Other|0|||
161836730|NCT00851643|584445020|FG004|Base Study (Up to 12 Months)|Other|0|||
161836731|NCT00851643|584445021|FG005|Base Study (Up to 12 Months)|Other|1|||
161836732|NCT00851643|584445016|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
161836733|NCT00851643|584445017|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
161836734|NCT00851643|584445018|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
161836735|NCT00851643|584445019|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
161956884|NCT03307785|584889791|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
161956885|NCT03307785|584889792|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
161698095|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
161698096|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
161698097|NCT04660643|583944100|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
161698098|NCT04660643|583944101|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
161698099|NCT04660643|583944102|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
161698100|NCT05162066|583944106|FG000|Overall Study|Adverse Event|1|||
161698101|NCT05162066|583944107|FG001|Overall Study|Adverse Event|0|||
161698102|NCT05162066|583944108|FG002|Overall Study|Adverse Event|0|||
161698103|NCT05162066|583944106|FG000|Overall Study|Perceived lack of efficacy|1|||
161698104|NCT05162066|583944107|FG001|Overall Study|Perceived lack of efficacy|0|||
161698105|NCT05162066|583944108|FG002|Overall Study|Perceived lack of efficacy|0|||
161698106|NCT01220414|583944109|FG000|Overall Study|Withdrawal by Subject|1|||
161698107|NCT01220414|583944110|FG001|Overall Study|Withdrawal by Subject|0|||
161698108|NCT01220414|583944111|FG002|Overall Study|Withdrawal by Subject|0|||
161698109|NCT01220414|583944112|FG003|Overall Study|Withdrawal by Subject|1|||
161698110|NCT00669617|583944115|FG000|Period 1|Withdrawal by Subject|0|||
161698111|NCT00669617|583944116|FG001|Period 1|Withdrawal by Subject|0|||
161698112|NCT00669617|583944117|FG002|Period 1|Withdrawal by Subject|1|||
161698113|NCT00669617|583944118|FG003|Period 1|Withdrawal by Subject|0|||
161698114|NCT00669617|583944119|FG004|Period 1|Withdrawal by Subject|0|||
161698115|NCT00669617|583944115|FG000|Period 1|Protocol Deviation|0|||
161698116|NCT00669617|583944116|FG001|Period 1|Protocol Deviation|0|||
161698117|NCT00669617|583944117|FG002|Period 1|Protocol Deviation|0|||
161698118|NCT00669617|583944118|FG003|Period 1|Protocol Deviation|0|||
161698119|NCT00669617|583944119|FG004|Period 1|Protocol Deviation|1|||
161698120|NCT00669617|583944115|FG000|Period 3|Lost to Follow-up|1|||
161698121|NCT00669617|583944116|FG001|Period 3|Lost to Follow-up|0|||
161698122|NCT00669617|583944117|FG002|Period 3|Lost to Follow-up|0|||
161698123|NCT00669617|583944118|FG003|Period 3|Lost to Follow-up|0|||
161698124|NCT00669617|583944119|FG004|Period 3|Lost to Follow-up|0|||
161698125|NCT00623831|583944120|FG000|Overall Study|Withdrawal by Subject|1|||
161698126|NCT00623831|583944121|FG001|Overall Study|Withdrawal by Subject|0|||
161698127|NCT00623831|583944120|FG000|Overall Study|Progressive Disease|0|||
161698128|NCT00623831|583944121|FG001|Overall Study|Progressive Disease|1|||
161698129|NCT01276821|583944122|FG000|Overall Study|Protocol Violation|0|||
161698130|NCT01276821|583944123|FG001|Overall Study|Protocol Violation|1|||
161698131|NCT01748071|583944124|FG000|Overall Study|Adverse Event|2|||
161698132|NCT01748071|583944125|FG001|Overall Study|Adverse Event|2|||
161698133|NCT01748071|583944126|FG002|Overall Study|Adverse Event|0|||
161698134|NCT03068325|583944127|FG000|Overall Study|Lost to Follow-up|5|||
161698135|NCT00066690|583944130|FG000|Overall Study|Adverse Event|145|||
161698136|NCT00066690|583944131|FG001|Overall Study|Adverse Event|58|||
161698137|NCT00066690|583944132|FG002|Overall Study|Adverse Event|126|||
161698138|NCT00066690|583944130|FG000|Overall Study|Death|3|||
161698139|NCT00066690|583944131|FG001|Overall Study|Death|0|||
161698140|NCT00066690|583944132|FG002|Overall Study|Death|2|||
161698141|NCT00066690|583944130|FG000|Overall Study|Lack of Efficacy|114|||
161698142|NCT00066690|583944131|FG001|Overall Study|Lack of Efficacy|110|||
161698143|NCT00066690|583944132|FG002|Overall Study|Lack of Efficacy|76|||
161698144|NCT00066690|583944130|FG000|Overall Study|Lost to Follow-up|40|||
161698145|NCT00066690|583944131|FG001|Overall Study|Lost to Follow-up|21|||
161698146|NCT00066690|583944132|FG002|Overall Study|Lost to Follow-up|29|||
161698147|NCT00066690|583944130|FG000|Overall Study|Withdrawal by Subject|50|||
161698148|NCT00066690|583944131|FG001|Overall Study|Withdrawal by Subject|55|||
161698149|NCT00066690|583944132|FG002|Overall Study|Withdrawal by Subject|49|||
161698150|NCT00066690|583944130|FG000|Overall Study|Treatment Ongoing|246|||
161698151|NCT00066690|583944131|FG001|Overall Study|Treatment Ongoing|278|||
161698152|NCT00066690|583944132|FG002|Overall Study|Treatment Ongoing|282|||
161698153|NCT00223496|583944133|FG000|Overall Study|screen failure|9|||
161698154|NCT00223496|583944133|FG000|Overall Study|Lost to Follow-up|4|||
161698155|NCT00223496|583944133|FG000|Overall Study|Lack of Efficacy|6|||
161698156|NCT00223496|583944133|FG000|Overall Study|Withdrawal by Subject|1|||
161698157|NCT00223496|583944133|FG000|Overall Study|Physician Decision|2|||
161698158|NCT02939131|583944136|FG000|Overall Study|Unable to get to clinic|6|||
161698159|NCT02939131|583944137|FG001|Overall Study|Unable to get to clinic|4|||
161698160|NCT02939131|583944136|FG000|Overall Study|Lost to Follow-up|2|||
161698161|NCT02939131|583944137|FG001|Overall Study|Lost to Follow-up|4|||
161698162|NCT02939131|583944136|FG000|Overall Study|severe debilitation|1|||
161698163|NCT02939131|583944137|FG001|Overall Study|severe debilitation|0|||
161698164|NCT02939131|583944136|FG000|Overall Study|Other|0|||
161698165|NCT02939131|583944137|FG001|Overall Study|Other|1|||
161698166|NCT02939131|583944136|FG000|Overall Study|not willing to adhere to protocol|2|||
161698167|NCT02939131|583944137|FG001|Overall Study|not willing to adhere to protocol|0|||
161698168|NCT03569202|583944141|FG000|Part 3|Physician Decision|1|||
161698169|NCT03569202|583944142|FG001|Part 3|Physician Decision|0|||
161698170|NCT03569202|583944141|FG000|Part 3|Other|1|||
161698171|NCT03569202|583944142|FG001|Part 3|Other|1|||
161698172|NCT00420511|583944143|FG000|Overall Study|Adverse Event|1|||
161698173|NCT00420511|583944144|FG001|Overall Study|Adverse Event|1|||
161698174|NCT00420511|583944143|FG000|Overall Study|Lost to Follow-up|1|||
161698175|NCT00420511|583944144|FG001|Overall Study|Lost to Follow-up|0|||
161836736|NCT00851643|584445020|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
161836737|NCT00851643|584445021|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
161836738|NCT00851643|584445016|FG000|Extension Study (Up to 36 Months)|Moved|0|||
161836739|NCT00851643|584445017|FG001|Extension Study (Up to 36 Months)|Moved|2|||
161836740|NCT00851643|584445018|FG002|Extension Study (Up to 36 Months)|Moved|1|||
161836741|NCT00851643|584445019|FG003|Extension Study (Up to 36 Months)|Moved|1|||
161836742|NCT00851643|584445020|FG004|Extension Study (Up to 36 Months)|Moved|0|||
161836743|NCT00851643|584445021|FG005|Extension Study (Up to 36 Months)|Moved|1|||
161836744|NCT00359788|584445022|FG000|Overall Study|Adverse Event|11|||
161836745|NCT00359788|584445023|FG001|Overall Study|Adverse Event|10|||
161836746|NCT00359788|584445022|FG000|Overall Study|Lack of Efficacy|1|||
161836747|NCT00359788|584445023|FG001|Overall Study|Lack of Efficacy|2|||
161836748|NCT00359788|584445022|FG000|Overall Study|Lost to Follow-up|3|||
161836749|NCT00359788|584445023|FG001|Overall Study|Lost to Follow-up|2|||
161836750|NCT00359788|584445022|FG000|Overall Study|Withdrawal by Subject|4|||
161836751|NCT00359788|584445023|FG001|Overall Study|Withdrawal by Subject|1|||
161836752|NCT00359788|584445022|FG000|Overall Study|Protocol Violation|4|||
161836753|NCT00359788|584445023|FG001|Overall Study|Protocol Violation|2|||
161836754|NCT01641133|584445024|FG000|Overall Study|Protocol Violation|0|||
161836755|NCT01641133|584445025|FG001|Overall Study|Protocol Violation|1|||
161836756|NCT01641133|584445026|FG002|Overall Study|Protocol Violation|1|||
161836757|NCT01641133|584445024|FG000|Overall Study|Migrated/moved from study area|5|||
161836758|NCT01641133|584445025|FG001|Overall Study|Migrated/moved from study area|3|||
161836759|NCT01641133|584445026|FG002|Overall Study|Migrated/moved from study area|1|||
161836760|NCT01641133|584445024|FG000|Overall Study|Adverse Event|0|||
161836761|NCT01641133|584445025|FG001|Overall Study|Adverse Event|0|||
161836762|NCT01641133|584445026|FG002|Overall Study|Adverse Event|1|||
161836763|NCT01641133|584445024|FG000|Overall Study|Withdrawal by Subject|5|||
161836764|NCT01641133|584445025|FG001|Overall Study|Withdrawal by Subject|3|||
161836765|NCT01641133|584445026|FG002|Overall Study|Withdrawal by Subject|3|||
161836766|NCT01641133|584445024|FG000|Overall Study|Lost to Follow-up|0|||
161698176|NCT02450578|583944145|FG000|Overall Study|ECG abnormality so not treated|1|||
161836767|NCT01641133|584445025|FG001|Overall Study|Lost to Follow-up|2|||
161836768|NCT01641133|584445026|FG002|Overall Study|Lost to Follow-up|2|||
161836769|NCT02220725|584445027|FG000|Overall Study|Lost to Follow-up|0|||
161836770|NCT02220725|584445028|FG001|Overall Study|Lost to Follow-up|0|||
161836771|NCT02220725|584445029|FG002|Overall Study|Lost to Follow-up|0|||
161836772|NCT02220725|584445030|FG003|Overall Study|Lost to Follow-up|1|||
161698177|NCT02450578|583944146|FG001|Overall Study|ECG abnormality so not treated|0|||
161698178|NCT02450578|583944147|FG002|Overall Study|ECG abnormality so not treated|0|||
161698179|NCT02450578|583944148|FG003|Overall Study|ECG abnormality so not treated|0|||
161698180|NCT04428411|583944151|FG000|Overall Study|Lost to Follow-up|114|||
161698181|NCT00634569|583944152|FG000|Overall Study|Withdrawal by Subject|0|||
161698182|NCT00634569|583944153|FG001|Overall Study|Withdrawal by Subject|4|||
161698183|NCT00634569|583944152|FG000|Overall Study|Physician Decision|0|||
161698184|NCT00634569|583944153|FG001|Overall Study|Physician Decision|1|||
161698185|NCT02918019|583944154|FG000|Overall Study|Death|0|||
161698186|NCT02918019|583944155|FG001|Overall Study|Death|0|||
161698187|NCT02918019|583944156|FG002|Overall Study|Death|1|||
161698188|NCT02918019|583944157|FG003|Overall Study|Death|0|||
161698189|NCT02918019|583944154|FG000|Overall Study|Lost to Follow-up|1|||
161698190|NCT02918019|583944155|FG001|Overall Study|Lost to Follow-up|1|||
161698191|NCT02918019|583944156|FG002|Overall Study|Lost to Follow-up|0|||
161698192|NCT02918019|583944157|FG003|Overall Study|Lost to Follow-up|1|||
161698193|NCT02918019|583944154|FG000|Overall Study|Principal investigator request|0|||
161698194|NCT02918019|583944155|FG001|Overall Study|Principal investigator request|0|||
161698195|NCT02918019|583944156|FG002|Overall Study|Principal investigator request|0|||
161698196|NCT02918019|583944157|FG003|Overall Study|Principal investigator request|1|||
161698197|NCT02918019|583944154|FG000|Overall Study|Physician Decision|1|||
161698198|NCT02918019|583944155|FG001|Overall Study|Physician Decision|3|||
161698199|NCT02918019|583944156|FG002|Overall Study|Physician Decision|2|||
161698200|NCT02918019|583944157|FG003|Overall Study|Physician Decision|0|||
161698201|NCT02918019|583944154|FG000|Overall Study|Protocol deviation|1|||
161698202|NCT02918019|583944155|FG001|Overall Study|Protocol deviation|1|||
161698203|NCT02918019|583944156|FG002|Overall Study|Protocol deviation|0|||
161698204|NCT02918019|583944157|FG003|Overall Study|Protocol deviation|2|||
161698205|NCT02918019|583944154|FG000|Overall Study|Withdrawal by Subject|3|||
161698206|NCT02918019|583944155|FG001|Overall Study|Withdrawal by Subject|4|||
161698207|NCT02918019|583944156|FG002|Overall Study|Withdrawal by Subject|6|||
161698208|NCT02918019|583944157|FG003|Overall Study|Withdrawal by Subject|4|||
161698209|NCT02918019|583944154|FG000|Overall Study|Adverse Event|0|||
161698210|NCT02918019|583944155|FG001|Overall Study|Adverse Event|1|||
161698211|NCT02918019|583944156|FG002|Overall Study|Adverse Event|0|||
161698212|NCT02918019|583944157|FG003|Overall Study|Adverse Event|1|||
161698213|NCT01212185|583944159|FG000|Overall Study|Protocol Violation|2|||
161698214|NCT01212185|583944160|FG001|Overall Study|Protocol Violation|1|||
161698215|NCT01699087|583944161|FG000|Overall Study|Lost to Follow-up|7|||
161698216|NCT01699087|583944161|FG000|Overall Study|Screen failure (prior to treatment)|15|||
161698217|NCT01699087|583944161|FG000|Overall Study|Unable to make future visits|2|||
161698218|NCT03370770|583944162|FG000|Overall Study|Patient was followed in another hospital center|1|||
161698219|NCT03370770|583944162|FG000|Overall Study|Progressive Disease|98|||
161698220|NCT03370770|583944162|FG000|Overall Study|Adverse Event|2|||
161698221|NCT03370770|583944162|FG000|Overall Study|Death|5|||
161698222|NCT00094757|583944166|FG000|Overall Study|Adverse Event|11|||
161698223|NCT00094757|583944167|FG001|Overall Study|Adverse Event|9|||
161698224|NCT00094757|583944168|FG002|Overall Study|Adverse Event|6|||
161698225|NCT00094757|583944166|FG000|Overall Study|Lack of Efficacy|11|||
161698226|NCT00094757|583944167|FG001|Overall Study|Lack of Efficacy|15|||
161698227|NCT00094757|583944168|FG002|Overall Study|Lack of Efficacy|8|||
161698228|NCT00094757|583944166|FG000|Overall Study|Lost to Follow-up|3|||
161698229|NCT00094757|583944167|FG001|Overall Study|Lost to Follow-up|5|||
161698230|NCT00094757|583944168|FG002|Overall Study|Lost to Follow-up|6|||
161698231|NCT00094757|583944166|FG000|Overall Study|Patient Moved|2|||
161698232|NCT00094757|583944167|FG001|Overall Study|Patient Moved|1|||
161698233|NCT00094757|583944168|FG002|Overall Study|Patient Moved|1|||
161698234|NCT00094757|583944166|FG000|Overall Study|Protocol Violation|8|||
161698235|NCT00094757|583944167|FG001|Overall Study|Protocol Violation|5|||
161698236|NCT00094757|583944168|FG002|Overall Study|Protocol Violation|3|||
161698237|NCT00094757|583944166|FG000|Overall Study|Withdrawal by Subject|14|||
161698238|NCT00094757|583944167|FG001|Overall Study|Withdrawal by Subject|21|||
161698239|NCT00094757|583944168|FG002|Overall Study|Withdrawal by Subject|5|||
161698240|NCT00094757|583944166|FG000|Overall Study|Other|3|||
161698241|NCT00094757|583944167|FG001|Overall Study|Other|3|||
161698242|NCT00094757|583944168|FG002|Overall Study|Other|1|||
161698243|NCT00094757|583944166|FG000|Overall Study|Protocol specified discontinuation|1|||
161698244|NCT00094757|583944167|FG001|Overall Study|Protocol specified discontinuation|3|||
162030799|NCT03400956|585169490|FG000|Treatment Period 1|Lost to Follow-up|0|||
161698245|NCT00094757|583944168|FG002|Overall Study|Protocol specified discontinuation|0|||
161698246|NCT01463098|583944170|FG000|Part A (11 Days)|Participant Choice|2|||
161698247|NCT01463098|583944171|FG001|Part A (11 Days)|Participant Choice|0|||
161698248|NCT01463098|583944172|FG002|Part A (11 Days)|Participant Choice|0|||
161698249|NCT01463098|583944173|FG003|Part A (11 Days)|Participant Choice|0|||
161698250|NCT01463098|583944174|FG004|Part A (11 Days)|Participant Choice|0|||
161698251|NCT01463098|583944175|FG005|Part A (11 Days)|Participant Choice|0|||
161698252|NCT01463098|583944176|FG006|Part A (11 Days)|Participant Choice|0|||
161698253|NCT01463098|583944177|FG007|Part A (11 Days)|Participant Choice|0|||
161956886|NCT03307785|584889793|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
161956887|NCT03307785|584889794|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
161956888|NCT03307785|584889795|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
161956889|NCT03307785|584889796|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
161956890|NCT03307785|584889797|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
161698254|NCT01463098|583944178|FG008|Part A (11 Days)|Participant Choice|1|||
161698255|NCT01463098|583944179|FG009|Part A (11 Days)|Participant Choice|0|||
161698256|NCT01463098|583944180|FG010|Part A (11 Days)|Participant Choice|0|||
161698257|NCT01463098|583944181|FG011|Part A (11 Days)|Participant Choice|0|||
161698258|NCT01463098|583944182|FG012|Part A (11 Days)|Participant Choice|0|||
161698259|NCT01463098|583944183|FG013|Part A (11 Days)|Participant Choice|0|||
161698260|NCT01463098|583944170|FG000|Part A (11 Days)|Lost to Follow-up|0|||
161698261|NCT01463098|583944171|FG001|Part A (11 Days)|Lost to Follow-up|0|||
161698262|NCT01463098|583944172|FG002|Part A (11 Days)|Lost to Follow-up|0|||
161698263|NCT01463098|583944173|FG003|Part A (11 Days)|Lost to Follow-up|0|||
161698264|NCT01463098|583944174|FG004|Part A (11 Days)|Lost to Follow-up|1|||
161698265|NCT01463098|583944175|FG005|Part A (11 Days)|Lost to Follow-up|0|||
161698266|NCT01463098|583944176|FG006|Part A (11 Days)|Lost to Follow-up|0|||
161698267|NCT01463098|583944177|FG007|Part A (11 Days)|Lost to Follow-up|0|||
161698268|NCT01463098|583944178|FG008|Part A (11 Days)|Lost to Follow-up|0|||
161698269|NCT01463098|583944179|FG009|Part A (11 Days)|Lost to Follow-up|0|||
161698270|NCT01463098|583944180|FG010|Part A (11 Days)|Lost to Follow-up|0|||
161698271|NCT01463098|583944181|FG011|Part A (11 Days)|Lost to Follow-up|0|||
161698272|NCT01463098|583944182|FG012|Part A (11 Days)|Lost to Follow-up|0|||
161698273|NCT01463098|583944183|FG013|Part A (11 Days)|Lost to Follow-up|0|||
161698274|NCT01463098|583944170|FG000|Part B (11 Days)|Participant Choice|0|||
161698275|NCT01463098|583944171|FG001|Part B (11 Days)|Participant Choice|0|||
161698276|NCT01463098|583944172|FG002|Part B (11 Days)|Participant Choice|0|||
161698277|NCT01463098|583944173|FG003|Part B (11 Days)|Participant Choice|0|||
161698278|NCT01463098|583944174|FG004|Part B (11 Days)|Participant Choice|0|||
161698279|NCT01463098|583944175|FG005|Part B (11 Days)|Participant Choice|0|||
161698280|NCT01463098|583944176|FG006|Part B (11 Days)|Participant Choice|0|||
161698281|NCT01463098|583944177|FG007|Part B (11 Days)|Participant Choice|0|||
161698282|NCT01463098|583944178|FG008|Part B (11 Days)|Participant Choice|0|||
161698283|NCT01463098|583944179|FG009|Part B (11 Days)|Participant Choice|0|||
161698284|NCT01463098|583944180|FG010|Part B (11 Days)|Participant Choice|0|||
161698285|NCT01463098|583944181|FG011|Part B (11 Days)|Participant Choice|1|||
161698286|NCT01463098|583944182|FG012|Part B (11 Days)|Participant Choice|0|||
161698287|NCT01463098|583944183|FG013|Part B (11 Days)|Participant Choice|0|||
161698288|NCT00395967|583944184|FG000|Treatment Period|Failed Mobilization|1|||
161698289|NCT00395967|583944184|FG000|Follow-up Period|Death|1|||
161698290|NCT00395967|583944184|FG000|Follow-up Period|Lost to Follow-up|1|||
161698291|NCT01262976|583944185|FG000|Up to Month 2|Serious Adverse Event|0|||
161698292|NCT01262976|583944186|FG001|Up to Month 2|Serious Adverse Event|0|||
161698293|NCT01262976|583944187|FG002|Up to Month 2|Serious Adverse Event|1|||
161698294|NCT01262976|583944188|FG003|Up to Month 2|Serious Adverse Event|0|||
161698295|NCT01262976|583944189|FG004|Up to Month 2|Serious Adverse Event|0|||
161698296|NCT01262976|583944190|FG005|Up to Month 2|Serious Adverse Event|0|||
161698297|NCT01262976|583944185|FG000|Up to Month 2|Withdrawal by Subject|1|||
161698298|NCT01262976|583944186|FG001|Up to Month 2|Withdrawal by Subject|0|||
161698299|NCT01262976|583944187|FG002|Up to Month 2|Withdrawal by Subject|0|||
161698300|NCT01262976|583944188|FG003|Up to Month 2|Withdrawal by Subject|0|||
161698301|NCT01262976|583944189|FG004|Up to Month 2|Withdrawal by Subject|0|||
161698302|NCT01262976|583944190|FG005|Up to Month 2|Withdrawal by Subject|0|||
161698303|NCT01262976|583944185|FG000|Up to Month 2|Migrated/moved from study area|0|||
161698304|NCT01262976|583944186|FG001|Up to Month 2|Migrated/moved from study area|1|||
161698305|NCT01262976|583944187|FG002|Up to Month 2|Migrated/moved from study area|0|||
161698306|NCT01262976|583944188|FG003|Up to Month 2|Migrated/moved from study area|0|||
161698307|NCT01262976|583944189|FG004|Up to Month 2|Migrated/moved from study area|1|||
161698308|NCT01262976|583944190|FG005|Up to Month 2|Migrated/moved from study area|1|||
161698309|NCT01262976|583944185|FG000|Up to Month 2|Lost to Follow-up|1|||
161698310|NCT01262976|583944186|FG001|Up to Month 2|Lost to Follow-up|0|||
161698311|NCT01262976|583944187|FG002|Up to Month 2|Lost to Follow-up|0|||
161698312|NCT01262976|583944188|FG003|Up to Month 2|Lost to Follow-up|1|||
161698313|NCT01262976|583944189|FG004|Up to Month 2|Lost to Follow-up|1|||
161698314|NCT01262976|583944190|FG005|Up to Month 2|Lost to Follow-up|1|||
161698315|NCT01262976|583944185|FG000|Up to Month 2|Other|1|||
161698316|NCT01262976|583944186|FG001|Up to Month 2|Other|0|||
161698317|NCT01262976|583944187|FG002|Up to Month 2|Other|0|||
161698318|NCT01262976|583944188|FG003|Up to Month 2|Other|1|||
161698319|NCT01262976|583944189|FG004|Up to Month 2|Other|0|||
161698320|NCT01262976|583944190|FG005|Up to Month 2|Other|2|||
161956891|NCT03307785|584889798|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
161956892|NCT03307785|584889799|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
161698321|NCT01262976|583944185|FG000|Up to Month 7|Serious Adverse Event|0|||
161698322|NCT01262976|583944186|FG001|Up to Month 7|Serious Adverse Event|0|||
161698323|NCT01262976|583944187|FG002|Up to Month 7|Serious Adverse Event|2|||
161698324|NCT01262976|583944188|FG003|Up to Month 7|Serious Adverse Event|0|||
161698325|NCT01262976|583944189|FG004|Up to Month 7|Serious Adverse Event|0|||
161698326|NCT01262976|583944190|FG005|Up to Month 7|Serious Adverse Event|0|||
161698327|NCT01262976|583944185|FG000|Up to Month 7|Withdrawal by Subject|1|||
161698328|NCT01262976|583944186|FG001|Up to Month 7|Withdrawal by Subject|0|||
161698329|NCT01262976|583944187|FG002|Up to Month 7|Withdrawal by Subject|0|||
161698330|NCT01262976|583944188|FG003|Up to Month 7|Withdrawal by Subject|0|||
161698331|NCT01262976|583944189|FG004|Up to Month 7|Withdrawal by Subject|0|||
161698332|NCT01262976|583944190|FG005|Up to Month 7|Withdrawal by Subject|0|||
161698333|NCT01262976|583944185|FG000|Up to Month 7|Migrated/moved from study area|0|||
161698334|NCT01262976|583944186|FG001|Up to Month 7|Migrated/moved from study area|0|||
161698335|NCT01262976|583944187|FG002|Up to Month 7|Migrated/moved from study area|1|||
161698336|NCT01262976|583944188|FG003|Up to Month 7|Migrated/moved from study area|3|||
161698337|NCT01262976|583944189|FG004|Up to Month 7|Migrated/moved from study area|1|||
161698338|NCT01262976|583944190|FG005|Up to Month 7|Migrated/moved from study area|1|||
161698339|NCT01262976|583944185|FG000|Up to Month 7|Lost to Follow-up|1|||
161698340|NCT01262976|583944186|FG001|Up to Month 7|Lost to Follow-up|0|||
161698341|NCT01262976|583944187|FG002|Up to Month 7|Lost to Follow-up|1|||
161698342|NCT01262976|583944188|FG003|Up to Month 7|Lost to Follow-up|3|||
161698343|NCT01262976|583944189|FG004|Up to Month 7|Lost to Follow-up|1|||
161698344|NCT01262976|583944190|FG005|Up to Month 7|Lost to Follow-up|3|||
161698345|NCT01262976|583944185|FG000|Up to Month 7|Other|3|||
161698346|NCT01262976|583944186|FG001|Up to Month 7|Other|0|||
161698347|NCT01262976|583944187|FG002|Up to Month 7|Other|2|||
161698348|NCT01262976|583944188|FG003|Up to Month 7|Other|0|||
161698349|NCT01262976|583944189|FG004|Up to Month 7|Other|0|||
161698350|NCT01262976|583944190|FG005|Up to Month 7|Other|0|||
161698351|NCT01262976|583944185|FG000|Up to Year 1|Serious Adverse Event|0|||
161698352|NCT01262976|583944186|FG001|Up to Year 1|Serious Adverse Event|0|||
161698353|NCT01262976|583944187|FG002|Up to Year 1|Serious Adverse Event|2|||
161698354|NCT01262976|583944188|FG003|Up to Year 1|Serious Adverse Event|0|||
161698355|NCT01262976|583944189|FG004|Up to Year 1|Serious Adverse Event|0|||
161698356|NCT01262976|583944190|FG005|Up to Year 1|Serious Adverse Event|0|||
161698357|NCT01262976|583944185|FG000|Up to Year 1|Withdrawal by Subject|1|||
161698358|NCT01262976|583944186|FG001|Up to Year 1|Withdrawal by Subject|0|||
161698359|NCT01262976|583944187|FG002|Up to Year 1|Withdrawal by Subject|0|||
161698360|NCT01262976|583944188|FG003|Up to Year 1|Withdrawal by Subject|0|||
161698361|NCT01262976|583944189|FG004|Up to Year 1|Withdrawal by Subject|0|||
161698362|NCT01262976|583944190|FG005|Up to Year 1|Withdrawal by Subject|0|||
161698363|NCT01262976|583944185|FG000|Up to Year 1|Migrated/moved from study area|1|||
161698364|NCT01262976|583944186|FG001|Up to Year 1|Migrated/moved from study area|0|||
161698365|NCT01262976|583944187|FG002|Up to Year 1|Migrated/moved from study area|0|||
161698366|NCT01262976|583944188|FG003|Up to Year 1|Migrated/moved from study area|3|||
161698367|NCT01262976|583944189|FG004|Up to Year 1|Migrated/moved from study area|3|||
161698368|NCT01262976|583944190|FG005|Up to Year 1|Migrated/moved from study area|2|||
161698369|NCT01262976|583944185|FG000|Up to Year 1|Lost to Follow-up|4|||
161698370|NCT01262976|583944186|FG001|Up to Year 1|Lost to Follow-up|0|||
161698371|NCT01262976|583944187|FG002|Up to Year 1|Lost to Follow-up|0|||
161698372|NCT01262976|583944188|FG003|Up to Year 1|Lost to Follow-up|1|||
161698373|NCT01262976|583944189|FG004|Up to Year 1|Lost to Follow-up|6|||
161698374|NCT01262976|583944190|FG005|Up to Year 1|Lost to Follow-up|5|||
161698375|NCT01262976|583944185|FG000|Up to Year 1|Other|3|||
161698376|NCT01262976|583944186|FG001|Up to Year 1|Other|1|||
161698377|NCT01262976|583944187|FG002|Up to Year 1|Other|0|||
161698378|NCT01262976|583944188|FG003|Up to Year 1|Other|0|||
161698379|NCT01262976|583944189|FG004|Up to Year 1|Other|2|||
161698380|NCT01262976|583944190|FG005|Up to Year 1|Other|1|||
161698381|NCT01262976|583944185|FG000|Up to Year 1|Subjects with unknown completion status|0|||
161698382|NCT01262976|583944186|FG001|Up to Year 1|Subjects with unknown completion status|0|||
161698383|NCT01262976|583944187|FG002|Up to Year 1|Subjects with unknown completion status|1|||
161698384|NCT01262976|583944188|FG003|Up to Year 1|Subjects with unknown completion status|0|||
161698385|NCT01262976|583944189|FG004|Up to Year 1|Subjects with unknown completion status|0|||
161698386|NCT01262976|583944190|FG005|Up to Year 1|Subjects with unknown completion status|1|||
161698387|NCT01262976|583944185|FG000|Up to Year 2|Serious Adverse Event|0|||
161698388|NCT01262976|583944186|FG001|Up to Year 2|Serious Adverse Event|0|||
161698389|NCT01262976|583944187|FG002|Up to Year 2|Serious Adverse Event|2|||
161698390|NCT01262976|583944188|FG003|Up to Year 2|Serious Adverse Event|0|||
161698391|NCT01262976|583944189|FG004|Up to Year 2|Serious Adverse Event|0|||
161698392|NCT01262976|583944190|FG005|Up to Year 2|Serious Adverse Event|0|||
161698393|NCT01262976|583944185|FG000|Up to Year 2|Withdrawal by Subject|1|||
161698394|NCT01262976|583944186|FG001|Up to Year 2|Withdrawal by Subject|0|||
161698395|NCT01262976|583944187|FG002|Up to Year 2|Withdrawal by Subject|0|||
161698396|NCT01262976|583944188|FG003|Up to Year 2|Withdrawal by Subject|0|||
161698397|NCT01262976|583944189|FG004|Up to Year 2|Withdrawal by Subject|0|||
161698398|NCT01262976|583944190|FG005|Up to Year 2|Withdrawal by Subject|0|||
161698399|NCT01262976|583944185|FG000|Up to Year 2|Migrated/moved from study area|0|||
161698400|NCT01262976|583944186|FG001|Up to Year 2|Migrated/moved from study area|0|||
161698401|NCT01262976|583944187|FG002|Up to Year 2|Migrated/moved from study area|0|||
161698402|NCT01262976|583944188|FG003|Up to Year 2|Migrated/moved from study area|2|||
161698403|NCT01262976|583944189|FG004|Up to Year 2|Migrated/moved from study area|1|||
161698404|NCT01262976|583944190|FG005|Up to Year 2|Migrated/moved from study area|2|||
161698405|NCT01262976|583944185|FG000|Up to Year 2|Lost to Follow-up|1|||
161698406|NCT01262976|583944186|FG001|Up to Year 2|Lost to Follow-up|1|||
161698407|NCT01262976|583944187|FG002|Up to Year 2|Lost to Follow-up|2|||
161698408|NCT01262976|583944188|FG003|Up to Year 2|Lost to Follow-up|2|||
161698409|NCT01262976|583944189|FG004|Up to Year 2|Lost to Follow-up|3|||
161698410|NCT01262976|583944190|FG005|Up to Year 2|Lost to Follow-up|3|||
161698411|NCT01262976|583944185|FG000|Up to Year 2|Subjects with unknown completion status|0|||
161698412|NCT01262976|583944186|FG001|Up to Year 2|Subjects with unknown completion status|0|||
161698413|NCT01262976|583944187|FG002|Up to Year 2|Subjects with unknown completion status|1|||
161698414|NCT01262976|583944188|FG003|Up to Year 2|Subjects with unknown completion status|0|||
161698415|NCT01262976|583944189|FG004|Up to Year 2|Subjects with unknown completion status|0|||
161698416|NCT01262976|583944190|FG005|Up to Year 2|Subjects with unknown completion status|0|||
161698417|NCT01262976|583944185|FG000|Up to Year 2|Other|3|||
161698418|NCT01262976|583944186|FG001|Up to Year 2|Other|0|||
161698419|NCT01262976|583944187|FG002|Up to Year 2|Other|0|||
161698420|NCT01262976|583944188|FG003|Up to Year 2|Other|0|||
161698421|NCT01262976|583944189|FG004|Up to Year 2|Other|0|||
161698422|NCT01262976|583944190|FG005|Up to Year 2|Other|0|||
161698423|NCT01262976|583944185|FG000|Up to Year 3|Serious Adverse Event|0|||
161698424|NCT01262976|583944186|FG001|Up to Year 3|Serious Adverse Event|0|||
161698425|NCT01262976|583944187|FG002|Up to Year 3|Serious Adverse Event|2|||
161698426|NCT01262976|583944188|FG003|Up to Year 3|Serious Adverse Event|0|||
161698427|NCT01262976|583944189|FG004|Up to Year 3|Serious Adverse Event|0|||
161698428|NCT01262976|583944190|FG005|Up to Year 3|Serious Adverse Event|0|||
161698429|NCT01262976|583944185|FG000|Up to Year 3|Withdrawal by Subject|1|||
161698430|NCT01262976|583944186|FG001|Up to Year 3|Withdrawal by Subject|0|||
161698431|NCT01262976|583944187|FG002|Up to Year 3|Withdrawal by Subject|0|||
161698432|NCT01262976|583944188|FG003|Up to Year 3|Withdrawal by Subject|0|||
161698433|NCT01262976|583944189|FG004|Up to Year 3|Withdrawal by Subject|0|||
161698434|NCT01262976|583944190|FG005|Up to Year 3|Withdrawal by Subject|0|||
161698435|NCT01262976|583944185|FG000|Up to Year 3|Migrated/moved from study area|0|||
161698436|NCT01262976|583944186|FG001|Up to Year 3|Migrated/moved from study area|0|||
161698437|NCT01262976|583944187|FG002|Up to Year 3|Migrated/moved from study area|0|||
161698438|NCT01262976|583944188|FG003|Up to Year 3|Migrated/moved from study area|2|||
161956893|NCT03307785|584889800|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
161956894|NCT03307785|584889801|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
161956895|NCT03307785|584889802|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
161956896|NCT03307785|584889790|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161956897|NCT03307785|584889791|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161956898|NCT03307785|584889792|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161956899|NCT03307785|584889793|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
161698439|NCT01262976|583944189|FG004|Up to Year 3|Migrated/moved from study area|1|||
161698440|NCT01262976|583944190|FG005|Up to Year 3|Migrated/moved from study area|1|||
161698441|NCT01262976|583944185|FG000|Up to Year 3|Lost to Follow-up|2|||
161698442|NCT01262976|583944186|FG001|Up to Year 3|Lost to Follow-up|2|||
161698443|NCT01262976|583944187|FG002|Up to Year 3|Lost to Follow-up|4|||
161698444|NCT01262976|583944188|FG003|Up to Year 3|Lost to Follow-up|3|||
161698445|NCT01262976|583944189|FG004|Up to Year 3|Lost to Follow-up|1|||
161698446|NCT01262976|583944190|FG005|Up to Year 3|Lost to Follow-up|3|||
161698447|NCT01262976|583944185|FG000|Up to Year 3|Subjects with unknown completion status|0|||
161698448|NCT01262976|583944186|FG001|Up to Year 3|Subjects with unknown completion status|0|||
161698449|NCT01262976|583944187|FG002|Up to Year 3|Subjects with unknown completion status|1|||
161698450|NCT01262976|583944188|FG003|Up to Year 3|Subjects with unknown completion status|0|||
161698451|NCT01262976|583944189|FG004|Up to Year 3|Subjects with unknown completion status|0|||
161698452|NCT01262976|583944190|FG005|Up to Year 3|Subjects with unknown completion status|0|||
161698453|NCT01262976|583944185|FG000|Up to Year 3|Other|3|||
161698454|NCT01262976|583944186|FG001|Up to Year 3|Other|0|||
161698455|NCT01262976|583944187|FG002|Up to Year 3|Other|0|||
161698456|NCT01262976|583944188|FG003|Up to Year 3|Other|0|||
161698457|NCT01262976|583944189|FG004|Up to Year 3|Other|0|||
161698458|NCT01262976|583944190|FG005|Up to Year 3|Other|0|||
161698459|NCT01528787|583944191|FG000|Overall Study|Withdrawal by Subject|0|||
161698460|NCT01528787|583944192|FG001|Overall Study|Withdrawal by Subject|0|||
161956900|NCT03307785|584889794|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161698461|NCT01528787|583944193|FG002|Overall Study|Withdrawal by Subject|0|||
161698462|NCT01528787|583944194|FG003|Overall Study|Withdrawal by Subject|1|||
161698463|NCT01528787|583944191|FG000|Overall Study|Family Emergency|0|||
161698464|NCT01528787|583944192|FG001|Overall Study|Family Emergency|0|||
161698465|NCT01528787|583944193|FG002|Overall Study|Family Emergency|1|||
161698466|NCT01528787|583944194|FG003|Overall Study|Family Emergency|0|||
161698467|NCT03433781|583944202|FG000|Overall Study|Progression of Disease|1|||
161698468|NCT03433781|583944203|FG001|Overall Study|Progression of Disease|0|||
161698469|NCT03433781|583944204|FG002|Overall Study|Progression of Disease|0|||
161698470|NCT03433781|583944202|FG000|Overall Study|Physician Decision|0|||
161698471|NCT03433781|583944203|FG001|Overall Study|Physician Decision|1|||
161698472|NCT03433781|583944204|FG002|Overall Study|Physician Decision|0|||
161698473|NCT02400255|583944205|FG000|Overall Study|Relapse|4|||
161698474|NCT02400255|583944206|FG001|Overall Study|Relapse|1|||
161698475|NCT02400255|583944207|FG002|Overall Study|Relapse|1|||
161698476|NCT02400255|583944208|FG003|Overall Study|Relapse|2|||
161698477|NCT02400255|583944205|FG000|Overall Study|Adverse Event|6|||
161698478|NCT02400255|583944206|FG001|Overall Study|Adverse Event|3|||
161698479|NCT02400255|583944207|FG002|Overall Study|Adverse Event|0|||
161698480|NCT02400255|583944208|FG003|Overall Study|Adverse Event|0|||
161698481|NCT02400255|583944205|FG000|Overall Study|Physician Decision|6|||
161698482|NCT02400255|583944206|FG001|Overall Study|Physician Decision|0|||
161698483|NCT02400255|583944207|FG002|Overall Study|Physician Decision|0|||
161698484|NCT02400255|583944208|FG003|Overall Study|Physician Decision|0|||
161698485|NCT02400255|583944205|FG000|Overall Study|Loss of insurance|1|||
161698486|NCT02400255|583944206|FG001|Overall Study|Loss of insurance|0|||
161698487|NCT02400255|583944207|FG002|Overall Study|Loss of insurance|0|||
161698488|NCT02400255|583944208|FG003|Overall Study|Loss of insurance|0|||
161698489|NCT02568046|583944209|FG000|Overall Study|Adverse Event|0|||
161698490|NCT02568046|583944210|FG001|Overall Study|Adverse Event|1|||
161698491|NCT02568046|583944209|FG000|Overall Study|Death|2|||
161698492|NCT02568046|583944210|FG001|Overall Study|Death|0|||
161698493|NCT02568046|583944209|FG000|Overall Study|Progressive Disease|1|||
161698494|NCT02568046|583944210|FG001|Overall Study|Progressive Disease|0|||
161698495|NCT02568046|583944209|FG000|Overall Study|Withdrawal by Subject|2|||
161698496|NCT02568046|583944210|FG001|Overall Study|Withdrawal by Subject|1|||
161836773|NCT02220725|584445027|FG000|Overall Study|Withdrawal by Subject|0|||
161836774|NCT02220725|584445028|FG001|Overall Study|Withdrawal by Subject|0|||
161836775|NCT02220725|584445029|FG002|Overall Study|Withdrawal by Subject|0|||
161956901|NCT03307785|584889795|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161956902|NCT03307785|584889796|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161956903|NCT03307785|584889797|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161956904|NCT03307785|584889798|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161956905|NCT03307785|584889799|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161956906|NCT03307785|584889800|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161956907|NCT03307785|584889801|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161956908|NCT03307785|584889802|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
161956909|NCT03307785|584889790|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161956910|NCT03307785|584889791|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161956911|NCT03307785|584889792|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161956912|NCT03307785|584889793|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161956913|NCT03307785|584889794|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
161956914|NCT03307785|584889795|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161956915|NCT03307785|584889796|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161956916|NCT03307785|584889797|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161956917|NCT03307785|584889798|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161956918|NCT03307785|584889799|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161956919|NCT03307785|584889800|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161956920|NCT03307785|584889801|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161956921|NCT03307785|584889802|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
161956922|NCT03307785|584889790|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161956923|NCT03307785|584889791|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161956924|NCT03307785|584889792|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161956925|NCT03307785|584889793|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161698497|NCT02568046|583944209|FG000|Overall Study|Other Events|0|||
161698498|NCT02568046|583944210|FG001|Overall Study|Other Events|1|||
161698499|NCT02809833|583944211|FG000|Overall Study|Death|3|||
161836776|NCT02220725|584445030|FG003|Overall Study|Withdrawal by Subject|1|||
161836777|NCT03351231|584445031|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
161836778|NCT03351231|584445031|FG000|Combination Therapy Period|Disease progression|2|||
161698500|NCT02809833|583944211|FG000|Overall Study|Intolerance|54|||
161698501|NCT02809833|583944211|FG000|Overall Study|Lack of Efficacy|89|||
161698502|NCT02809833|583944211|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
161698503|NCT02809833|583944211|FG000|Overall Study|Noncompliance|1|||
161698504|NCT02809833|583944211|FG000|Overall Study|Withdrawal by Subject|34|||
161698505|NCT02809833|583944211|FG000|Overall Study|Lost to Follow-up|35|||
161698506|NCT02809833|583944211|FG000|Overall Study|Adverse Event (AE)|24|||
161698507|NCT02809833|583944211|FG000|Overall Study|Other|5|||
161698508|NCT02809833|583944211|FG000|Overall Study|Missing Information|52|||
161698509|NCT00408694|583944212|FG000|Overall Study|Ineligible|1|||
161698510|NCT00408694|583944212|FG000|Overall Study|No protocol treatment|1|||
161698511|NCT00523991|583944215|FG000|Overall Study|Adverse Event|6|||
161698512|NCT00523991|583944216|FG001|Overall Study|Adverse Event|5|||
161698513|NCT00523991|583944215|FG000|Overall Study|Protocol Violation|1|||
161698514|NCT00523991|583944216|FG001|Overall Study|Protocol Violation|4|||
161698515|NCT00523991|583944215|FG000|Overall Study|Lost to Follow-up|4|||
161698516|NCT00523991|583944216|FG001|Overall Study|Lost to Follow-up|1|||
161698517|NCT00523991|583944215|FG000|Overall Study|Withdrawal by Subject|7|||
161698518|NCT00523991|583944216|FG001|Overall Study|Withdrawal by Subject|17|||
161698519|NCT00523991|583944215|FG000|Overall Study|Other reason (not specified)|3|||
161698520|NCT00523991|583944216|FG001|Overall Study|Other reason (not specified)|0|||
161698521|NCT00193063|583944217|FG000|Overall Study|Lack of Efficacy|3|||
161698522|NCT00193063|583944217|FG000|Overall Study|Adverse Event|1|||
161698523|NCT03261531|583944219|FG000|Overall Study|Withdrawal by Subject|4|||
161698524|NCT00744874|583944221|FG000|Overall Study|Lost to Follow-up|1|||
161698525|NCT00744874|583944221|FG000|Overall Study|Withdrawal by Subject|1|||
161698526|NCT00744874|583944221|FG000|Overall Study|Study Device not available at procedure|1|||
161698527|NCT00744874|583944221|FG000|Overall Study|Unable to accomodate schedule|1|||
161698528|NCT01127165|583944224|FG000|Overall Study|Adverse Event|2|||
161956926|NCT03307785|584889794|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161956927|NCT03307785|584889795|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
161956928|NCT03307785|584889796|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161956929|NCT03307785|584889797|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161956930|NCT03307785|584889798|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161956931|NCT03307785|584889799|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161698529|NCT01127165|583944225|FG001|Overall Study|Adverse Event|2|||
161698530|NCT01127165|583944224|FG000|Overall Study|Lack of Efficacy|10|||
161698531|NCT01127165|583944225|FG001|Overall Study|Lack of Efficacy|8|||
161698532|NCT01127165|583944224|FG000|Overall Study|Lost to Follow-up|3|||
161698533|NCT01127165|583944225|FG001|Overall Study|Lost to Follow-up|5|||
161698534|NCT01127165|583944224|FG000|Overall Study|Withdrawal by Subject|1|||
161698535|NCT01127165|583944225|FG001|Overall Study|Withdrawal by Subject|3|||
161698536|NCT01127165|583944224|FG000|Overall Study|Protocol Violation|0|||
161698537|NCT01127165|583944225|FG001|Overall Study|Protocol Violation|1|||
161698538|NCT02435849|583944226|FG000|Overall Study|Death|23|||
161698539|NCT02435849|583944227|FG001|Overall Study|Death|0|||
161698540|NCT02435849|583944226|FG000|Overall Study|Lack of Efficacy|10|||
161698541|NCT02435849|583944227|FG001|Overall Study|Lack of Efficacy|0|||
161698542|NCT02435849|583944226|FG000|Overall Study|New therapy for study indication|8|||
161698543|NCT02435849|583944227|FG001|Overall Study|New therapy for study indication|0|||
161698544|NCT02435849|583944226|FG000|Overall Study|Subject/guardian decision|5|||
161698545|NCT02435849|583944227|FG001|Overall Study|Subject/guardian decision|1|||
161698546|NCT02435849|583944226|FG000|Overall Study|Lost to Follow-up|1|||
161698547|NCT02435849|583944227|FG001|Overall Study|Lost to Follow-up|0|||
161698548|NCT02435849|583944226|FG000|Overall Study|Physician Decision|1|||
161698549|NCT02435849|583944227|FG001|Overall Study|Physician Decision|0|||
161698550|NCT03175549|583944228|FG000|Overall Study|Lost to Follow-up|2|||
161698551|NCT03175549|583944229|FG001|Overall Study|Lost to Follow-up|2|||
161698552|NCT03175549|583944228|FG000|Overall Study|Medication non-compliance|2|||
161698553|NCT03175549|583944229|FG001|Overall Study|Medication non-compliance|2|||
161698554|NCT02486757|583944230|FG000|Overall Study|Lost to Follow-up|1|||
161698555|NCT01064167|583944231|FG000|Overall Study|Protocol Violation|14|||
161698556|NCT01064167|583944232|FG001|Overall Study|Protocol Violation|15|||
161698557|NCT03984305|583944234|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
161698558|NCT03984305|583944235|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
161836779|NCT03351231|584445031|FG000|Combination Therapy Period|Study drug toxicity|1|||
161836780|NCT03351231|584445031|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
161836781|NCT03351231|584445031|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
161956932|NCT03307785|584889800|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
162030800|NCT03400956|585169491|FG001|Treatment Period 1|Lost to Follow-up|0|||
161698559|NCT03984305|583944234|FG000|Overall Study|Withdrawal by Subject|3|||
161698560|NCT03984305|583944235|FG001|Overall Study|Withdrawal by Subject|3|||
161836782|NCT03351231|584445031|FG000|Safety Follow-Up Period|Other reason|2|||
161698561|NCT03984305|583944234|FG000|Overall Study|Lost to Follow-up|1|||
161698562|NCT03984305|583944235|FG001|Overall Study|Lost to Follow-up|0|||
161698563|NCT02883244|583944236|FG000|Overall Study|Lost to Follow-up|0|||
161698564|NCT02883244|583944237|FG001|Overall Study|Lost to Follow-up|1|||
161698565|NCT03979274|583944245|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161698566|NCT03979274|583944246|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161698567|NCT01614093|583944249|FG000|Overall Study|Withdrawal by Subject|1|||
161698568|NCT00603915|583944250|FG000|Overall Study|Physician Decision|1|||
161698569|NCT01724528|583944256|FG000|Overall Study|Death|3|||
161698570|NCT01724528|583944257|FG001|Overall Study|Death|0|||
161698571|NCT01724528|583944256|FG000|Overall Study|Withdrawal by Subject|0|||
161698572|NCT01724528|583944257|FG001|Overall Study|Withdrawal by Subject|2|||
161698573|NCT01724528|583944256|FG000|Overall Study|Protocol Violation|0|||
161698574|NCT01724528|583944257|FG001|Overall Study|Protocol Violation|1|||
161698575|NCT01724528|583944256|FG000|Overall Study|Patient refused to attend last visit|1|||
161698576|NCT01724528|583944257|FG001|Overall Study|Patient refused to attend last visit|0|||
161698577|NCT02183519|583944261|FG000|Overall Study|computer error|3|||
161956933|NCT03307785|584889801|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161698578|NCT02183519|583944262|FG001|Overall Study|computer error|0|||
161698579|NCT02183519|583944261|FG000|Overall Study|Did not respond to cough inducter|0|||
161698580|NCT02183519|583944262|FG001|Overall Study|Did not respond to cough inducter|3|||
161698581|NCT05574062|583944265|FG000|Pre Run-In|Screening failure|3|||
161698582|NCT05574062|583944266|FG001|Pre Run-In|Screening failure|0|||
161698583|NCT05574062|583944267|FG002|Pre Run-In|Screening failure|0|||
161698584|NCT05574062|583944268|FG003|Pre Run-In|Screening failure|0|||
161698585|NCT05574062|583944269|FG004|Pre Run-In|Screening failure|0|||
161698586|NCT05574062|583944265|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
161698587|NCT05574062|583944266|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
161698588|NCT05574062|583944267|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
161698589|NCT05574062|583944268|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
161698590|NCT05574062|583944269|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
161698591|NCT05574062|583944265|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
161698592|NCT05574062|583944266|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
161698593|NCT05574062|583944267|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
161698594|NCT05574062|583944268|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
161698595|NCT05574062|583944269|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
161698596|NCT05574062|583944265|FG000|Continuation Phase Period 1|Physician Decision|1|||
161698597|NCT05574062|583944266|FG001|Continuation Phase Period 1|Physician Decision|0|||
161698598|NCT05574062|583944267|FG002|Continuation Phase Period 1|Physician Decision|0|||
161698599|NCT05574062|583944268|FG003|Continuation Phase Period 1|Physician Decision|0|||
161698600|NCT05574062|583944269|FG004|Continuation Phase Period 1|Physician Decision|0|||
161698601|NCT05574062|583944265|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
161698602|NCT05574062|583944266|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
161698603|NCT05574062|583944267|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
161698604|NCT05574062|583944268|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
161698605|NCT05574062|583944269|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
161698606|NCT05574062|583944265|FG000|Continuation Phase Period 1|Adverse Event|1|||
161698607|NCT05574062|583944266|FG001|Continuation Phase Period 1|Adverse Event|0|||
161698608|NCT05574062|583944267|FG002|Continuation Phase Period 1|Adverse Event|0|||
161698609|NCT05574062|583944268|FG003|Continuation Phase Period 1|Adverse Event|0|||
161698610|NCT05574062|583944269|FG004|Continuation Phase Period 1|Adverse Event|0|||
161698611|NCT05574062|583944265|FG000|Continuation Phase Period 1|Death|1|||
161698612|NCT05574062|583944266|FG001|Continuation Phase Period 1|Death|0|||
161698613|NCT05574062|583944267|FG002|Continuation Phase Period 1|Death|0|||
161698614|NCT05574062|583944268|FG003|Continuation Phase Period 1|Death|0|||
161698615|NCT05574062|583944269|FG004|Continuation Phase Period 1|Death|0|||
161698616|NCT05574062|583944265|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
161698617|NCT05574062|583944266|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
161698618|NCT05574062|583944267|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
161956934|NCT03307785|584889802|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161956935|NCT03307785|584889790|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161956936|NCT03307785|584889791|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161956937|NCT03307785|584889792|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161956938|NCT03307785|584889793|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161956939|NCT03307785|584889794|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161956940|NCT03307785|584889795|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
161956941|NCT03307785|584889796|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161698619|NCT05574062|583944268|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
161698620|NCT05574062|583944269|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
161698621|NCT00700180|583945748|FG000|Overall Study|Death|99|||
161698622|NCT00700180|583945749|FG001|Overall Study|Death|114|||
161698623|NCT00700180|583945748|FG000|Overall Study|Alive on treatment|5|||
161698624|NCT00700180|583945749|FG001|Overall Study|Alive on treatment|3|||
161698625|NCT00700180|583945748|FG000|Overall Study|Alive in follow-up|46|||
161956942|NCT03307785|584889797|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161698626|NCT00700180|583945749|FG001|Overall Study|Alive in follow-up|27|||
161698627|NCT00700180|583945748|FG000|Overall Study|Lost to Follow-up|4|||
161698628|NCT00700180|583945749|FG001|Overall Study|Lost to Follow-up|5|||
161698629|NCT03588741|583945750|FG000|Overall Study|Withdrawal by Subject|1|||
161698630|NCT01445535|583945751|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
161698631|NCT01445535|583945752|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
161956943|NCT03307785|584889798|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161956944|NCT03307785|584889799|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161956945|NCT03307785|584889800|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161956946|NCT03307785|584889801|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161956947|NCT03307785|584889802|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
161956948|NCT03307785|584889790|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161956949|NCT03307785|584889791|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161956950|NCT03307785|584889792|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161956951|NCT03307785|584889793|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161956952|NCT03307785|584889794|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161956953|NCT03307785|584889795|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
161956954|NCT03307785|584889796|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161956955|NCT03307785|584889797|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161956956|NCT03307785|584889798|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161956957|NCT03307785|584889799|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161956958|NCT03307785|584889800|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161956959|NCT03307785|584889801|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161956960|NCT03307785|584889802|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
161698632|NCT01445535|583945753|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
161698633|NCT01445535|583945754|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
161698634|NCT01445535|583945751|FG000|Overall Study|Disease progression|1|||
161698635|NCT01445535|583945752|FG001|Overall Study|Disease progression|0|||
161698636|NCT01445535|583945753|FG002|Overall Study|Disease progression|1|||
161698637|NCT01445535|583945754|FG003|Overall Study|Disease progression|0|||
161698638|NCT01445535|583945751|FG000|Overall Study|PI discretion|0|||
161698639|NCT01445535|583945752|FG001|Overall Study|PI discretion|0|||
161698640|NCT01445535|583945753|FG002|Overall Study|PI discretion|0|||
161698641|NCT01445535|583945754|FG003|Overall Study|PI discretion|1|||
161698642|NCT01668654|583945759|FG000|Overall Study|Study Closed/Terminated|3|||
161698643|NCT01668654|583945759|FG000|Overall Study|Withdrawal by Subject|1|||
161698644|NCT00454779|583945760|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
161698645|NCT00454779|583945761|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
161698646|NCT00454779|583945760|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
161698647|NCT00454779|583945761|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
161698648|NCT00454779|583945760|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
161698649|NCT00454779|583945761|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
161698650|NCT00454779|583945760|FG000|First-line Treatment Phase|Protocol Violation|0|||
161698651|NCT00454779|583945761|FG001|First-line Treatment Phase|Protocol Violation|1|||
161698652|NCT00454779|583945760|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
161698653|NCT00454779|583945761|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
161698654|NCT00454779|583945760|FG000|First-line Treatment Phase|Ongoing|1|||
161698655|NCT00454779|583945761|FG001|First-line Treatment Phase|Ongoing|0|||
161698656|NCT00454779|583945760|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
161698657|NCT00454779|583945761|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
161698658|NCT00454779|583945760|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
161698659|NCT00454779|583945761|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
161698660|NCT00454779|583945760|FG000|Second-line Treatment Phase|Ongoing|0|||
161698661|NCT00454779|583945761|FG001|Second-line Treatment Phase|Ongoing|1|||
161956961|NCT03307785|584889790|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161956962|NCT03307785|584889791|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161956963|NCT03307785|584889792|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161956964|NCT03307785|584889793|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161956965|NCT03307785|584889794|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161956966|NCT03307785|584889795|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
161956967|NCT03307785|584889796|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161956968|NCT03307785|584889797|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161698662|NCT01337973|583945763|FG000|Overall Study|Lost to Follow-up|2|||
161698663|NCT01337973|583945764|FG001|Overall Study|Lost to Follow-up|4|||
161698664|NCT01337973|583945765|FG002|Overall Study|Lost to Follow-up|3|||
161698665|NCT01337973|583945763|FG000|Overall Study|Death|1|||
161698666|NCT01337973|583945764|FG001|Overall Study|Death|2|||
161698667|NCT01337973|583945765|FG002|Overall Study|Death|1|||
161698668|NCT01337973|583945763|FG000|Overall Study|Withdrawal by Subject|10|||
161698669|NCT01337973|583945764|FG001|Overall Study|Withdrawal by Subject|8|||
161698670|NCT01337973|583945765|FG002|Overall Study|Withdrawal by Subject|4|||
161698671|NCT01337973|583945763|FG000|Overall Study|missing data on primary outcome|3|||
161698672|NCT01337973|583945764|FG001|Overall Study|missing data on primary outcome|1|||
161698673|NCT01337973|583945765|FG002|Overall Study|missing data on primary outcome|3|||
161956969|NCT03307785|584889798|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161956970|NCT03307785|584889799|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161956971|NCT03307785|584889800|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161956972|NCT03307785|584889801|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161956973|NCT03307785|584889802|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
161956974|NCT03307785|584889790|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161956975|NCT03307785|584889791|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161956976|NCT03307785|584889792|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161956977|NCT03307785|584889793|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161956978|NCT03307785|584889794|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161956979|NCT03307785|584889795|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
161956980|NCT03307785|584889796|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161956981|NCT03307785|584889797|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161956982|NCT03307785|584889798|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161956983|NCT03307785|584889799|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161698674|NCT03634800|583945766|FG000|Overall Study|Adverse Event|1|||
161698675|NCT03634800|583945766|FG000|Overall Study|Disease Progression|4|||
161698676|NCT03634800|583945766|FG000|Overall Study|Withdrawal by Subject|1|||
161698677|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
161698678|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
161698679|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
161698680|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
161698681|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
161698682|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
161698683|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
161698684|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
161698685|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
161698686|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
161698687|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
161698688|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
161698689|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
161698690|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
161698691|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
161698692|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
161698693|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
161698694|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
161698695|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
161698696|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
161698697|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
161698698|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
161698699|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
161698700|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
161698701|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Death|2|||
161698702|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Death|1|||
161698703|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Death|2|||
161698704|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Graft loss|0|||
161698705|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Graft loss|2|||
161698706|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Graft loss|0|||
161698707|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
161698708|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
161698709|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
161698710|NCT01114529|583945767|FG000|Completed Study Medication at Month 24|Missing|2|||
161698711|NCT01114529|583945768|FG001|Completed Study Medication at Month 24|Missing|0|||
161698712|NCT01114529|583945769|FG002|Completed Study Medication at Month 24|Missing|0|||
161698713|NCT01114529|583945767|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
161698714|NCT01114529|583945768|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
161698715|NCT01114529|583945769|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
161698716|NCT01114529|583945767|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
161698717|NCT01114529|583945768|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
161956984|NCT03307785|584889800|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161956985|NCT03307785|584889801|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161698718|NCT01114529|583945769|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
161698719|NCT01114529|583945767|FG000|Completed Study Phase at Month 24|Death|8|||
161698720|NCT01114529|583945768|FG001|Completed Study Phase at Month 24|Death|5|||
161698721|NCT01114529|583945769|FG002|Completed Study Phase at Month 24|Death|4|||
161698722|NCT01114529|583945767|FG000|Completed Study Phase at Month 24|Other|2|||
161698723|NCT01114529|583945768|FG001|Completed Study Phase at Month 24|Other|0|||
161698724|NCT01114529|583945769|FG002|Completed Study Phase at Month 24|Other|0|||
161698725|NCT01114529|583945767|FG000|Completed Study Phase at Month 24|Missing|2|||
161698726|NCT01114529|583945768|FG001|Completed Study Phase at Month 24|Missing|0|||
161698727|NCT01114529|583945769|FG002|Completed Study Phase at Month 24|Missing|0|||
161698728|NCT03555266|583945770|FG000|Overall Study|Protocol Violation|6|||
161698729|NCT03555266|583945771|FG001|Overall Study|Protocol Violation|4|||
161698730|NCT00797823|583945772|FG000|First Period (Initial Randomization)|Physician Decision|1|||
161698731|NCT00797823|583945773|FG001|First Period (Initial Randomization)|Physician Decision|0|||
161698732|NCT00797823|583945774|FG002|First Period (Initial Randomization)|Physician Decision|0|||
161698733|NCT01700192|583945775|FG000|Overall Study|Adverse Event|73|||
161698734|NCT01700192|583945776|FG001|Overall Study|Adverse Event|18|||
161698735|NCT01700192|583945775|FG000|Overall Study|Lack of Efficacy|1|||
161698736|NCT01700192|583945776|FG001|Overall Study|Lack of Efficacy|0|||
161698737|NCT01700192|583945775|FG000|Overall Study|Lost to Follow-up|42|||
161698738|NCT01700192|583945776|FG001|Overall Study|Lost to Follow-up|29|||
161698739|NCT01700192|583945775|FG000|Overall Study|Noncompliance with study drug|0|||
161698740|NCT01700192|583945776|FG001|Overall Study|Noncompliance with study drug|5|||
161698741|NCT01700192|583945775|FG000|Overall Study|Physician Decision|2|||
161698742|NCT01700192|583945776|FG001|Overall Study|Physician Decision|3|||
161698743|NCT01700192|583945775|FG000|Overall Study|Pregnancy|1|||
161698744|NCT01700192|583945776|FG001|Overall Study|Pregnancy|4|||
161698745|NCT01700192|583945775|FG000|Overall Study|Progressive disease|1|||
161698746|NCT01700192|583945776|FG001|Overall Study|Progressive disease|0|||
161698747|NCT01700192|583945775|FG000|Overall Study|Protocol Violation|3|||
161698748|NCT01700192|583945776|FG001|Overall Study|Protocol Violation|4|||
161698749|NCT01700192|583945775|FG000|Overall Study|Technical problems|0|||
161698750|NCT01700192|583945776|FG001|Overall Study|Technical problems|1|||
161698751|NCT01700192|583945775|FG000|Overall Study|Withdrawal by Subject|56|||
161698752|NCT01700192|583945776|FG001|Overall Study|Withdrawal by Subject|64|||
161698753|NCT01700192|583945775|FG000|Overall Study|Never received study drug|1|||
161698754|NCT01700192|583945776|FG001|Overall Study|Never received study drug|0|||
161698755|NCT01017952|583945781|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
161698756|NCT01017952|583945782|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161698757|NCT01017952|583945783|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161698758|NCT01017952|583945784|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161698759|NCT01017952|583945785|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161698760|NCT01017952|583945781|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
161698761|NCT01017952|583945782|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
161698762|NCT01017952|583945783|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
161698763|NCT01017952|583945784|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
161698764|NCT01017952|583945785|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
161698765|NCT01017952|583945781|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
161698766|NCT01017952|583945782|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
161698767|NCT01017952|583945783|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
161698768|NCT01017952|583945784|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
161698769|NCT01017952|583945785|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
161698770|NCT01017952|583945781|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
161698771|NCT01017952|583945782|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161836783|NCT00103402|584445034|FG000|Overall Study|Adverse Event|3|||
161836784|NCT00103402|584445035|FG001|Overall Study|Adverse Event|4|||
161836785|NCT00103402|584445034|FG000|Overall Study|Lost to Follow-up|8|||
161836786|NCT00103402|584445035|FG001|Overall Study|Lost to Follow-up|7|||
161836787|NCT00103402|584445034|FG000|Overall Study|Dissatisfied/No longer interested|6|||
161956986|NCT03307785|584889802|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
161836788|NCT00103402|584445035|FG001|Overall Study|Dissatisfied/No longer interested|6|||
161698772|NCT01017952|583945783|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161698773|NCT01017952|583945784|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161698774|NCT01017952|583945785|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161698775|NCT01017952|583945781|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
161698776|NCT01017952|583945782|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
161698777|NCT01017952|583945783|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
161698778|NCT01017952|583945784|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
161836789|NCT00103402|584445034|FG000|Overall Study|Personal constraints/Other|5|||
161698779|NCT01017952|583945785|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
161698780|NCT01017952|583945781|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
161836790|NCT00103402|584445035|FG001|Overall Study|Personal constraints/Other|0|||
161956987|NCT03307785|584889790|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
161956988|NCT03307785|584889791|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
161956989|NCT03307785|584889792|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
161956990|NCT03307785|584889793|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
161956991|NCT03307785|584889794|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
161956992|NCT03307785|584889795|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
161956993|NCT03307785|584889796|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
161956994|NCT03307785|584889797|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
161956995|NCT03307785|584889798|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
161956996|NCT03307785|584889799|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
161956997|NCT03307785|584889800|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
161956998|NCT03307785|584889801|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
161956999|NCT03307785|584889802|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
161957000|NCT03307785|584889790|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161957001|NCT03307785|584889791|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161957002|NCT03307785|584889792|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161957003|NCT03307785|584889793|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161957004|NCT03307785|584889794|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161957005|NCT03307785|584889795|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161836791|NCT01673698|584445036|FG000|Overall Study|Lost to Follow-up|51|||
161836792|NCT01673698|584445037|FG001|Overall Study|Lost to Follow-up|13|||
161957006|NCT03307785|584889796|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
161957007|NCT03307785|584889797|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161957008|NCT03307785|584889798|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161698781|NCT01017952|583945782|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161698782|NCT01017952|583945783|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161698783|NCT01017952|583945784|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161698784|NCT01017952|583945785|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161698785|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
161698786|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
161698787|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
161698788|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
161698789|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
161698790|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161698791|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
161698792|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
161698793|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
161698794|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
161698795|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
161698796|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
161698797|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
161698798|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
161698799|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
161698800|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
161698801|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
161698802|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
161698803|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
161698804|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
161698805|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161698806|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
161698807|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
161698808|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
161698809|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
161698810|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161698811|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
161698812|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
161698813|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161698814|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161698815|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161698816|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
161698817|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
161698818|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
161836793|NCT01297322|584445038|FG000|Overall Study|Lost to Follow-up|1|||
161957009|NCT03307785|584889799|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161957010|NCT03307785|584889800|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161957011|NCT03307785|584889801|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161957012|NCT03307785|584889802|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
161957013|NCT03307785|584889790|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161957014|NCT03307785|584889791|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161957015|NCT03307785|584889792|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161957016|NCT03307785|584889793|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161957017|NCT03307785|584889794|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161957018|NCT03307785|584889795|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161957019|NCT03307785|584889796|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161957020|NCT03307785|584889797|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
161957021|NCT03307785|584889798|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161957022|NCT03307785|584889799|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161957023|NCT03307785|584889800|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161957024|NCT03307785|584889801|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161957025|NCT03307785|584889802|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
161957026|NCT03307785|584889790|FG000|PACT Phase: Up to 19 Months|Death|0|||
161957027|NCT03307785|584889791|FG001|PACT Phase: Up to 19 Months|Death|0|||
161957028|NCT03307785|584889792|FG002|PACT Phase: Up to 19 Months|Death|0|||
161957029|NCT03307785|584889793|FG003|PACT Phase: Up to 19 Months|Death|0|||
161957030|NCT03307785|584889794|FG004|PACT Phase: Up to 19 Months|Death|0|||
161957031|NCT03307785|584889795|FG005|PACT Phase: Up to 19 Months|Death|0|||
161957032|NCT03307785|584889796|FG006|PACT Phase: Up to 19 Months|Death|0|||
161957033|NCT03307785|584889797|FG007|PACT Phase: Up to 19 Months|Death|0|||
161957034|NCT03307785|584889798|FG008|PACT Phase: Up to 19 Months|Death|0|||
161957035|NCT03307785|584889799|FG009|PACT Phase: Up to 19 Months|Death|0|||
161957036|NCT03307785|584889800|FG010|PACT Phase: Up to 19 Months|Death|0|||
161957037|NCT03307785|584889801|FG011|PACT Phase: Up to 19 Months|Death|0|||
161957038|NCT03307785|584889802|FG012|PACT Phase: Up to 19 Months|Death|1|||
161957039|NCT01154452|584889807|FG000|Phase Ib|Not Treated|1|||
161957040|NCT01154452|584889808|FG001|Phase Ib|Not Treated|0|||
161836794|NCT01297322|584445039|FG001|Overall Study|Lost to Follow-up|0|||
161957041|NCT01154452|584889809|FG002|Phase Ib|Not Treated|0|||
161957042|NCT01154452|584889810|FG003|Phase Ib|Not Treated|0|||
161957043|NCT01154452|584889807|FG000|Phase Ib|Adverse Event|2|||
161957044|NCT01154452|584889808|FG001|Phase Ib|Adverse Event|1|||
161957045|NCT01154452|584889809|FG002|Phase Ib|Adverse Event|0|||
161957046|NCT01154452|584889810|FG003|Phase Ib|Adverse Event|0|||
161957047|NCT01154452|584889807|FG000|Phase II|Withdrawal by Subject|0|||
161957048|NCT01154452|584889808|FG001|Phase II|Withdrawal by Subject|0|||
161957049|NCT01154452|584889809|FG002|Phase II|Withdrawal by Subject|1|||
161957050|NCT01154452|584889810|FG003|Phase II|Withdrawal by Subject|2|||
161957051|NCT01154452|584889807|FG000|Phase II|Adverse Event|0|||
161957052|NCT01154452|584889808|FG001|Phase II|Adverse Event|0|||
161957053|NCT01154452|584889809|FG002|Phase II|Adverse Event|4|||
161957054|NCT01154452|584889810|FG003|Phase II|Adverse Event|4|||
161957055|NCT01392573|584889811|FG000|Overall Study|Adverse Event|1|||
161957056|NCT01392573|584889812|FG001|Overall Study|Adverse Event|3|||
161957057|NCT01392573|584889811|FG000|Overall Study|Lack of Efficacy|1|||
161957058|NCT01392573|584889812|FG001|Overall Study|Lack of Efficacy|2|||
161957059|NCT01392573|584889811|FG000|Overall Study|Protocol Violation|0|||
161957060|NCT01392573|584889812|FG001|Overall Study|Protocol Violation|2|||
161957061|NCT01392573|584889811|FG000|Overall Study|Withdrawal Criteria|13|||
161957062|NCT01392573|584889812|FG001|Overall Study|Withdrawal Criteria|15|||
161957063|NCT01392573|584889811|FG000|Overall Study|Site closure|8|||
161698819|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
161698820|NCT01017952|583945781|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
161698821|NCT01017952|583945782|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
161698822|NCT01017952|583945783|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
161698823|NCT01017952|583945784|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
161698824|NCT01017952|583945785|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
161698825|NCT00352105|583945787|FG000|Overall Study|Death|5|||
161698826|NCT00352105|583945787|FG000|Overall Study|Withdrawal by Subject|5|||
161698827|NCT00352105|583945787|FG000|Overall Study|Lack of Efficacy|9|||
161698828|NCT00352105|583945787|FG000|Overall Study|Adverse Event|19|||
161698829|NCT00352105|583945787|FG000|Overall Study|Protocol Violation|2|||
161698830|NCT02979431|583945790|FG000|Overall Study|Parent/guardian withdrew consent|2|||
161698831|NCT02979431|583945791|FG001|Overall Study|Parent/guardian withdrew consent|1|||
161698832|NCT02979431|583945792|FG002|Overall Study|Parent/guardian withdrew consent|1|||
161698833|NCT02979431|583945793|FG003|Overall Study|Parent/guardian withdrew consent|1|||
161698834|NCT02979431|583945790|FG000|Overall Study|Randomized but received no study drug|1|||
161698835|NCT02979431|583945791|FG001|Overall Study|Randomized but received no study drug|1|||
161698836|NCT02979431|583945792|FG002|Overall Study|Randomized but received no study drug|0|||
161698837|NCT02979431|583945793|FG003|Overall Study|Randomized but received no study drug|0|||
161698838|NCT02979431|583945790|FG000|Overall Study|Adverse Event|0|||
161698839|NCT02979431|583945791|FG001|Overall Study|Adverse Event|0|||
161698840|NCT02979431|583945792|FG002|Overall Study|Adverse Event|1|||
161698841|NCT02979431|583945793|FG003|Overall Study|Adverse Event|0|||
161698842|NCT02979431|583945790|FG000|Overall Study|Subject left country after Day14|1|||
161698843|NCT02979431|583945791|FG001|Overall Study|Subject left country after Day14|0|||
161698844|NCT02979431|583945792|FG002|Overall Study|Subject left country after Day14|0|||
161698845|NCT02979431|583945793|FG003|Overall Study|Subject left country after Day14|0|||
161698846|NCT01656434|583945794|FG000|Overall Study|Adverse Event|199|||
161698847|NCT01656434|583945795|FG001|Overall Study|Adverse Event|63|||
161698848|NCT01656434|583945794|FG000|Overall Study|Enrollment terminated at trial site|2|||
161698849|NCT01656434|583945795|FG001|Overall Study|Enrollment terminated at trial site|0|||
161698850|NCT01656434|583945794|FG000|Overall Study|Lost to Follow-up|309|||
161836795|NCT01297322|584445038|FG000|Overall Study|Withdrawal by Subject|0|||
161836796|NCT01297322|584445039|FG001|Overall Study|Withdrawal by Subject|1|||
161698851|NCT01656434|583945795|FG001|Overall Study|Lost to Follow-up|76|||
161698852|NCT01656434|583945794|FG000|Overall Study|Site discontinued study participation|24|||
161698853|NCT01656434|583945795|FG001|Overall Study|Site discontinued study participation|9|||
161698854|NCT01656434|583945794|FG000|Overall Study|Screen failure|2|||
161698855|NCT01656434|583945795|FG001|Overall Study|Screen failure|0|||
161698856|NCT01656434|583945794|FG000|Overall Study|Protocol Violation|7|||
161698857|NCT01656434|583945795|FG001|Overall Study|Protocol Violation|0|||
161698858|NCT01656434|583945794|FG000|Overall Study|Pregnancy wish|18|||
161698859|NCT01656434|583945795|FG001|Overall Study|Pregnancy wish|6|||
161698860|NCT01656434|583945794|FG000|Overall Study|Pregnancy|45|||
161698861|NCT01656434|583945795|FG001|Overall Study|Pregnancy|10|||
161698862|NCT01656434|583945794|FG000|Overall Study|Physician Decision|7|||
161698863|NCT01656434|583945795|FG001|Overall Study|Physician Decision|2|||
161698864|NCT01656434|583945794|FG000|Overall Study|Non-compliance with study drug|48|||
161698865|NCT01656434|583945795|FG001|Overall Study|Non-compliance with study drug|9|||
161698866|NCT01656434|583945794|FG000|Overall Study|Study terminated by sponsor|1501|||
161698867|NCT01656434|583945795|FG001|Overall Study|Study terminated by sponsor|348|||
161698868|NCT01656434|583945794|FG000|Overall Study|Participant discontinued; drug related|13|||
161698869|NCT01656434|583945795|FG001|Overall Study|Participant discontinued; drug related|4|||
161698870|NCT01656434|583945794|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
161698871|NCT01656434|583945795|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
161698872|NCT01656434|583945794|FG000|Overall Study|Non-compliance with protocol|39|||
161698873|NCT01656434|583945795|FG001|Overall Study|Non-compliance with protocol|15|||
161698874|NCT01656434|583945794|FG000|Overall Study|Participant moved|40|||
161698875|NCT01656434|583945795|FG001|Overall Study|Participant moved|12|||
161698876|NCT01656434|583945794|FG000|Overall Study|Participant withdrew consent|28|||
161698877|NCT01656434|583945795|FG001|Overall Study|Participant withdrew consent|9|||
161698878|NCT01656434|583945794|FG000|Overall Study|Withdrawal by Subject|64|||
161698879|NCT01656434|583945795|FG001|Overall Study|Withdrawal by Subject|7|||
161957064|NCT01392573|584889812|FG001|Overall Study|Site closure|7|||
161957065|NCT01392573|584889811|FG000|Overall Study|Unclassified|9|||
161957066|NCT01392573|584889812|FG001|Overall Study|Unclassified|6|||
161698880|NCT01235962|583945796|FG000|Overall Study|Withdrawal by Subject|20|||
161698881|NCT01235962|583945797|FG001|Overall Study|Withdrawal by Subject|19|||
161698882|NCT01235962|583945798|FG002|Overall Study|Withdrawal by Subject|62|||
161698883|NCT01235962|583945799|FG003|Overall Study|Withdrawal by Subject|49|||
161698884|NCT01235962|583945796|FG000|Overall Study|Lost to Follow-up|21|||
161698885|NCT01235962|583945797|FG001|Overall Study|Lost to Follow-up|16|||
161698886|NCT01235962|583945798|FG002|Overall Study|Lost to Follow-up|47|||
161698887|NCT01235962|583945799|FG003|Overall Study|Lost to Follow-up|32|||
161698888|NCT01235962|583945796|FG000|Overall Study|Physician Decision|5|||
161698889|NCT01235962|583945797|FG001|Overall Study|Physician Decision|0|||
161698890|NCT01235962|583945798|FG002|Overall Study|Physician Decision|9|||
161698891|NCT01235962|583945799|FG003|Overall Study|Physician Decision|5|||
161698892|NCT01580397|583945800|FG000|Overall Study|Lack of Efficacy|14|||
161698893|NCT02435914|583945801|FG000|Overall Study|Ocular Adverse Event|1|||
161698894|NCT02435914|583945802|FG001|Overall Study|Ocular Adverse Event|0|||
161698895|NCT02435914|583945803|FG002|Overall Study|Ocular Adverse Event|0|||
161698896|NCT02435914|583945804|FG003|Overall Study|Ocular Adverse Event|0|||
161698897|NCT02435914|583945801|FG000|Overall Study|Withdrawal by Subject|0|||
161698898|NCT02435914|583945802|FG001|Overall Study|Withdrawal by Subject|1|||
161698899|NCT02435914|583945803|FG002|Overall Study|Withdrawal by Subject|0|||
161698900|NCT02435914|583945804|FG003|Overall Study|Withdrawal by Subject|0|||
161698901|NCT02435914|583945801|FG000|Overall Study|Other Miscellaneous Reason|0|||
161698902|NCT02435914|583945802|FG001|Overall Study|Other Miscellaneous Reason|0|||
161698903|NCT02435914|583945803|FG002|Overall Study|Other Miscellaneous Reason|1|||
161698904|NCT02435914|583945804|FG003|Overall Study|Other Miscellaneous Reason|0|||
161698905|NCT01727258|583945805|FG000|Overall Study|Adverse Event|0|||
161836797|NCT01297322|584445038|FG000|Overall Study|Protocol Violation|0|||
161836798|NCT01297322|584445039|FG001|Overall Study|Protocol Violation|3|||
161957067|NCT00325130|584889852|FG000|Overall Study|Lost to Follow-up|6|||
161957068|NCT00325130|584889853|FG001|Overall Study|Lost to Follow-up|14|||
161957069|NCT00325130|584889852|FG000|Overall Study|Withdrawal by Subject|12|||
161957070|NCT00325130|584889853|FG001|Overall Study|Withdrawal by Subject|14|||
161698906|NCT01727258|583945806|FG001|Overall Study|Adverse Event|2|||
161698907|NCT01727258|583945807|FG002|Overall Study|Adverse Event|0|||
161698908|NCT01727258|583945805|FG000|Overall Study|Noncompliance with Study Drug|0|||
161698909|NCT01727258|583945806|FG001|Overall Study|Noncompliance with Study Drug|0|||
161698910|NCT01727258|583945807|FG002|Overall Study|Noncompliance with Study Drug|1|||
161698911|NCT01727258|583945805|FG000|Overall Study|Withdrawal by Subject|1|||
161698912|NCT01727258|583945806|FG001|Overall Study|Withdrawal by Subject|1|||
161698913|NCT01727258|583945807|FG002|Overall Study|Withdrawal by Subject|0|||
161698914|NCT01727258|583945805|FG000|Overall Study|Lost to Follow-up|1|||
161698915|NCT01727258|583945806|FG001|Overall Study|Lost to Follow-up|0|||
161698916|NCT01727258|583945807|FG002|Overall Study|Lost to Follow-up|0|||
161836799|NCT01111019|584445040|FG000|Overall Study|Withdrew Prematurely|2|||
161957071|NCT00325130|584889852|FG000|Overall Study|Protocol Deviation|0|||
161698917|NCT01405053|583945813|FG000|Overall Study|Adverse Event|3|||
161698918|NCT01405053|583945814|FG001|Overall Study|Adverse Event|0|||
161698919|NCT01405053|583945813|FG000|Overall Study|Lost to Follow-up|0|||
161698920|NCT01405053|583945814|FG001|Overall Study|Lost to Follow-up|1|||
161698921|NCT01405053|583945813|FG000|Overall Study|Participant choice|2|||
161698922|NCT01405053|583945814|FG001|Overall Study|Participant choice|1|||
161698923|NCT01405053|583945813|FG000|Overall Study|Inadequate therapeutic effect|2|||
161698924|NCT01405053|583945814|FG001|Overall Study|Inadequate therapeutic effect|1|||
161698925|NCT01405053|583945813|FG000|Overall Study|Withdrawal by Subject|3|||
161698926|NCT01405053|583945814|FG001|Overall Study|Withdrawal by Subject|4|||
161698927|NCT01405053|583945813|FG000|Overall Study|Other|0|||
161698928|NCT01405053|583945814|FG001|Overall Study|Other|1|||
161698929|NCT00130286|583945817|FG000|Overall Study|Withdrawal by Subject|0|||
161698930|NCT00130286|583945818|FG001|Overall Study|Withdrawal by Subject|1|||
161698931|NCT00130286|583945819|FG002|Overall Study|Withdrawal by Subject|2|||
161698932|NCT00130286|583945820|FG003|Overall Study|Withdrawal by Subject|2|||
161698933|NCT00130286|583945817|FG000|Overall Study|Adverse Event|0|||
161698934|NCT00130286|583945818|FG001|Overall Study|Adverse Event|0|||
161698935|NCT00130286|583945819|FG002|Overall Study|Adverse Event|2|||
161698936|NCT00130286|583945820|FG003|Overall Study|Adverse Event|0|||
161698937|NCT00130286|583945817|FG000|Overall Study|Missing lab specimens|0|||
161698938|NCT00130286|583945818|FG001|Overall Study|Missing lab specimens|2|||
161698939|NCT00130286|583945819|FG002|Overall Study|Missing lab specimens|0|||
161698940|NCT00130286|583945820|FG003|Overall Study|Missing lab specimens|0|||
161698941|NCT01818726|583945826|FG000|Overall Study|Administrative reasons|5|||
161698942|NCT01818726|583945827|FG001|Overall Study|Administrative reasons|1|||
161698943|NCT01818726|583945826|FG000|Overall Study|Withdrawal by Subject|0|||
161698944|NCT01818726|583945827|FG001|Overall Study|Withdrawal by Subject|1|||
161698945|NCT01818726|583945826|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
161698946|NCT01818726|583945827|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
161698947|NCT00357500|583945828|FG000|Overall Study|Adverse Event|3|||
161698948|NCT00357500|583945828|FG000|Overall Study|Withdrawal by Subject|5|||
161698949|NCT00357500|583945828|FG000|Overall Study|Progressive Disease|65|||
161698950|NCT00357500|583945828|FG000|Overall Study|Not Started Protocol Therapy|4|||
161698951|NCT00993928|583945829|FG000|Overall Study|Withdrawal by Subject|4|||
161698952|NCT00993928|583945830|FG001|Overall Study|Withdrawal by Subject|7|||
161698953|NCT00993928|583945829|FG000|Overall Study|ineligible|1|||
161698954|NCT00993928|583945830|FG001|Overall Study|ineligible|0|||
161698955|NCT02319044|583945832|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
161698956|NCT02319044|583945833|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
161698957|NCT02319044|583945834|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
161698958|NCT02319044|583945832|FG000|Overall Study|Withdrawal by Subject|3|||
161698959|NCT02319044|583945833|FG001|Overall Study|Withdrawal by Subject|3|||
161698960|NCT02319044|583945834|FG002|Overall Study|Withdrawal by Subject|6|||
161698961|NCT02319044|583945832|FG000|Overall Study|Condition under investigation worsened|100|||
161698962|NCT02319044|583945833|FG001|Overall Study|Condition under investigation worsened|50|||
161698963|NCT02319044|583945834|FG002|Overall Study|Condition under investigation worsened|46|||
161698964|NCT02319044|583945832|FG000|Overall Study|Adverse Event|17|||
161698965|NCT02319044|583945833|FG001|Overall Study|Adverse Event|2|||
161698966|NCT02319044|583945834|FG002|Overall Study|Adverse Event|8|||
161698967|NCT02319044|583945832|FG000|Overall Study|Study specific discontinuation criteria|2|||
161698968|NCT02319044|583945833|FG001|Overall Study|Study specific discontinuation criteria|2|||
161698969|NCT02319044|583945834|FG002|Overall Study|Study specific discontinuation criteria|1|||
161698970|NCT02319044|583945832|FG000|Overall Study|Not treated|0|||
161698971|NCT02319044|583945833|FG001|Overall Study|Not treated|2|||
161698972|NCT02319044|583945834|FG002|Overall Study|Not treated|2|||
161698973|NCT02154087|583945842|FG000|Overall Study|Study Termination|1|||
161698974|NCT03687502|583945846|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
161698975|NCT03687502|583945846|FG000|Overall Study|Lumason not available|1|||
161698976|NCT00486278|583945848|FG000|Overall Study|Adverse Event|5|||
161698977|NCT00486278|583945848|FG000|Overall Study|Withdrawal by Subject|2|||
161836800|NCT01111019|584445040|FG000|Overall Study|Other|1|||
161836801|NCT01583218|584445041|FG000|Overall Study|Withdrawal by Subject|43|||
161698978|NCT00486278|583945848|FG000|Overall Study|Physician Decision|2|||
161698979|NCT05702736|583945855|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
161698980|NCT05702736|583945856|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
161698981|NCT05702736|583945855|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
161698982|NCT05702736|583945856|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
161698983|NCT03110900|583945871|FG000|Overall Study|Sponsor withdrew|1|||
161698984|NCT03110900|583945872|FG001|Overall Study|Sponsor withdrew|1|||
161698985|NCT02321436|583945873|FG000|Overall Study|Withdrawal by Subject|1|||
161698986|NCT02321436|583945874|FG001|Overall Study|Withdrawal by Subject|0|||
161698987|NCT02321436|583945873|FG000|Overall Study|Lost to Follow-up|0|||
161698988|NCT02321436|583945874|FG001|Overall Study|Lost to Follow-up|1|||
161836802|NCT01583218|584445042|FG001|Overall Study|Withdrawal by Subject|29|||
161698989|NCT00644787|583945875|FG000|Period 1: Titration Phase|Adverse Event|11|||
161698990|NCT00644787|583945876|FG001|Period 1: Titration Phase|Adverse Event|0|||
161698991|NCT00644787|583945877|FG002|Period 1: Titration Phase|Adverse Event|0|||
161698992|NCT00644787|583945875|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
161698993|NCT00644787|583945876|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
161698994|NCT00644787|583945877|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
161698995|NCT00644787|583945875|FG000|Period 1: Titration Phase|Physician Decision|1|||
161698996|NCT00644787|583945876|FG001|Period 1: Titration Phase|Physician Decision|0|||
161698997|NCT00644787|583945877|FG002|Period 1: Titration Phase|Physician Decision|0|||
161698998|NCT00644787|583945875|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
161698999|NCT00644787|583945876|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
161699000|NCT00644787|583945877|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
161699001|NCT00644787|583945875|FG000|Period 1: Titration Phase|Worsening of complications|1|||
161699002|NCT00644787|583945876|FG001|Period 1: Titration Phase|Worsening of complications|0|||
161699003|NCT00644787|583945877|FG002|Period 1: Titration Phase|Worsening of complications|0|||
161699004|NCT00644787|583945875|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
161699005|NCT00644787|583945876|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
161699006|NCT00644787|583945877|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
161699007|NCT00644787|583945875|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
161699008|NCT00644787|583945876|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
161699009|NCT00644787|583945877|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
161699010|NCT00644787|583945875|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
161699011|NCT00644787|583945876|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
161699012|NCT00644787|583945877|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
162030801|NCT03400956|585169492|FG002|Treatment Period 1|Lost to Follow-up|1|||
161699013|NCT00644787|583945875|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
161699014|NCT00644787|583945876|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
161699015|NCT00644787|583945877|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
161699016|NCT00644787|583945875|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
161699017|NCT00644787|583945876|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
161699018|NCT00644787|583945877|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
161699019|NCT00644787|583945875|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
161699020|NCT00644787|583945876|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
161699021|NCT00644787|583945877|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
161699022|NCT00644787|583945875|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
161699023|NCT00644787|583945876|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
161699024|NCT00644787|583945877|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
161699025|NCT03355300|583945878|FG000|Overall Study|Physician Decision|0|||
161699026|NCT03355300|583945879|FG001|Overall Study|Physician Decision|1|||
161699027|NCT03355300|583945878|FG000|Overall Study|Lack of Efficacy|2|||
161699028|NCT03355300|583945879|FG001|Overall Study|Lack of Efficacy|1|||
161699029|NCT03355300|583945878|FG000|Overall Study|Other reason|1|||
161699030|NCT03355300|583945879|FG001|Overall Study|Other reason|0|||
161699031|NCT00546052|583945880|FG000|Overall Study|Adverse Event|47|||
161699032|NCT00546052|583945880|FG000|Overall Study|Lost to Follow-up|144|||
161699033|NCT00546052|583945880|FG000|Overall Study|Protocol Violation|9|||
161699034|NCT00546052|583945880|FG000|Overall Study|Withdrawal by Subject|20|||
161699035|NCT00546052|583945880|FG000|Overall Study|Non Compliance|7|||
161699036|NCT03048422|583945883|FG000|Overall Study|Death|1|||
161699037|NCT03048422|583945884|FG001|Overall Study|Death|0|||
161699038|NCT03048422|583945885|FG002|Overall Study|Death|0|||
161699039|NCT03048422|583945883|FG000|Overall Study|Lost to Follow-up|5|||
161699040|NCT03048422|583945884|FG001|Overall Study|Lost to Follow-up|0|||
161699041|NCT03048422|583945885|FG002|Overall Study|Lost to Follow-up|1|||
161699042|NCT03048422|583945883|FG000|Overall Study|Withdrawal by Subject|5|||
161699043|NCT03048422|583945884|FG001|Overall Study|Withdrawal by Subject|7|||
161699044|NCT03048422|583945885|FG002|Overall Study|Withdrawal by Subject|4|||
161699045|NCT03048422|583945883|FG000|Overall Study|Moved|3|||
161699046|NCT03048422|583945884|FG001|Overall Study|Moved|2|||
161699047|NCT03048422|583945885|FG002|Overall Study|Moved|2|||
161699048|NCT03048422|583945883|FG000|Overall Study|Noncompliant with Study Requirements|2|||
161699049|NCT03048422|583945884|FG001|Overall Study|Noncompliant with Study Requirements|1|||
161699050|NCT03048422|583945885|FG002|Overall Study|Noncompliant with Study Requirements|2|||
161699051|NCT03048422|583945883|FG000|Overall Study|Not Able to Get to Clinic|1|||
161699052|NCT03048422|583945884|FG001|Overall Study|Not Able to Get to Clinic|0|||
161699053|NCT03048422|583945885|FG002|Overall Study|Not Able to Get to Clinic|0|||
161699054|NCT02482129|583945889|FG000|Overall Study|Adverse Event-prior to treatment|0|||
161699055|NCT02482129|583945890|FG001|Overall Study|Adverse Event-prior to treatment|1|||
161699056|NCT02482129|583945889|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
161699057|NCT02482129|583945890|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
161699058|NCT02482129|583945889|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
161699059|NCT02482129|583945890|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
161699060|NCT02482129|583945889|FG000|Overall Study|Criteria not met-prior to treatment|1|||
161699061|NCT02482129|583945890|FG001|Overall Study|Criteria not met-prior to treatment|0|||
161699062|NCT02482129|583945889|FG000|Overall Study|Adverse Event|1|||
161699063|NCT02482129|583945890|FG001|Overall Study|Adverse Event|0|||
161699064|NCT02482129|583945889|FG000|Overall Study|Withdrawal by Subject|2|||
161699065|NCT02482129|583945890|FG001|Overall Study|Withdrawal by Subject|0|||
161699066|NCT02482129|583945889|FG000|Overall Study|Criteria not met|1|||
161699067|NCT02482129|583945890|FG001|Overall Study|Criteria not met|0|||
161699068|NCT01031446|583945892|FG000|Overall Study|Disease Progression|38|||
161699069|NCT01031446|583945892|FG000|Overall Study|Adverse Event|9|||
161699070|NCT01031446|583945892|FG000|Overall Study|Physician Decision|4|||
161699071|NCT01031446|583945892|FG000|Overall Study|Withdrawal by Subject|3|||
161699072|NCT01031446|583945892|FG000|Overall Study|Still on treatment|1|||
161699073|NCT01877083|583945895|FG000|Treatment Phase|Disease Progression|10|||
161699074|NCT01877083|583945895|FG000|Treatment Phase|Clinical Progression|1|||
161699075|NCT01877083|583945895|FG000|Treatment Phase|Adverse Event|6|||
161699076|NCT01877083|583945895|FG000|Treatment Phase|Withdrawal by Subject|2|||
161699077|NCT01877083|583945895|FG000|Treatment Phase|Lost to Follow-up|1|||
161699078|NCT01877083|583945895|FG000|Extension Phase|Disease Progression|3|||
161699079|NCT01877083|583945895|FG000|Extension Phase|Adverse Event|2|||
161699080|NCT03344003|583945902|FG000|Overall Study|Switched to alternative treatment|1|||
161699081|NCT03344003|583945903|FG001|Overall Study|Switched to alternative treatment|0|||
161699082|NCT03344003|583945902|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
161699083|NCT03344003|583945903|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
161699084|NCT01602341|583946936|FG000|Overall Study|Adverse Event|0|||
161699085|NCT01602341|583946937|FG001|Overall Study|Adverse Event|1|||
161699086|NCT02324270|583946939|FG000|Overall Study|Withdrawal by Subject|0|||
161699087|NCT02324270|583946940|FG001|Overall Study|Withdrawal by Subject|1|||
161699088|NCT02324270|583946941|FG002|Overall Study|Withdrawal by Subject|0|||
161699089|NCT02324270|583946939|FG000|Overall Study|Lost to Follow-up|4|||
161699090|NCT02324270|583946940|FG001|Overall Study|Lost to Follow-up|3|||
161699091|NCT02324270|583946941|FG002|Overall Study|Lost to Follow-up|4|||
161699092|NCT02324270|583946939|FG000|Overall Study|Protocol Violation|0|||
161699093|NCT02324270|583946940|FG001|Overall Study|Protocol Violation|1|||
161699094|NCT02324270|583946941|FG002|Overall Study|Protocol Violation|1|||
161699095|NCT02324270|583946939|FG000|Overall Study|Non Compliance with Study Drug|1|||
161699096|NCT02324270|583946940|FG001|Overall Study|Non Compliance with Study Drug|2|||
161699097|NCT02324270|583946941|FG002|Overall Study|Non Compliance with Study Drug|0|||
161699098|NCT03521791|583946942|FG000|Overall Study|Protocol Violation|7|||
161699099|NCT03521791|583946943|FG001|Overall Study|Protocol Violation|17|||
161699100|NCT00680836|583946944|FG000|Overall Study|Withdrawal by Subject|3|||
161699101|NCT00680836|583946945|FG001|Overall Study|Withdrawal by Subject|0|||
161699102|NCT00680836|583946944|FG000|Overall Study|Lost to Follow-up|3|||
161699103|NCT00680836|583946945|FG001|Overall Study|Lost to Follow-up|1|||
161699104|NCT00680836|583946944|FG000|Overall Study|Physician Decision|2|||
161699105|NCT00680836|583946945|FG001|Overall Study|Physician Decision|1|||
161699106|NCT03786432|583946946|FG000|Overall Study|Screen Failure after consent|1|||
161699107|NCT03786432|583946946|FG000|Overall Study|Lost to Follow-up|4|||
161699108|NCT03786432|583946946|FG000|Overall Study|did not complete 12 month CT scan|1|||
161699109|NCT03038308|583946947|FG000|Overall Study|Surgical resection|1|||
161699110|NCT03038308|583946947|FG000|Overall Study|Withdrawal by Subject|2|||
161699111|NCT03038308|583946947|FG000|Overall Study|Lost to Follow-up|1|||
161699112|NCT01475734|583946951|FG000|Overall Study|Withdrawal by Subject|1|||
161699113|NCT01475734|583946952|FG001|Overall Study|Withdrawal by Subject|0|||
161699114|NCT01475734|583946951|FG000|Overall Study|Protocol Violation|1|||
161699115|NCT01475734|583946952|FG001|Overall Study|Protocol Violation|0|||
161699116|NCT01475734|583946951|FG000|Overall Study|Physician Decision|0|||
161699117|NCT01475734|583946952|FG001|Overall Study|Physician Decision|1|||
161699118|NCT00771472|583946953|FG000|Overall Study|Physician Decision|2|||
161699119|NCT00771472|583946954|FG001|Overall Study|Physician Decision|3|||
161699120|NCT00771472|583946953|FG000|Overall Study|Progressive Disease|3|||
161699121|NCT00771472|583946954|FG001|Overall Study|Progressive Disease|1|||
161699122|NCT00771472|583946953|FG000|Overall Study|Protocol Violation|1|||
161699123|NCT00771472|583946954|FG001|Overall Study|Protocol Violation|0|||
161699124|NCT00880750|583946960|FG000|First Intervention|Adverse Event|1|||
161699125|NCT00880750|583946961|FG001|First Intervention|Adverse Event|0|||
161699126|NCT00880750|583946960|FG000|First Intervention|Unable to collect urine|4|||
161699127|NCT00880750|583946961|FG001|First Intervention|Unable to collect urine|0|||
161699128|NCT00880750|583946960|FG000|First Intervention|Non-compliance with meals|0|||
161699129|NCT00880750|583946961|FG001|First Intervention|Non-compliance with meals|1|||
161699130|NCT00880750|583946960|FG000|First Intervention|Withdrawal by Subject|2|||
161699131|NCT00880750|583946961|FG001|First Intervention|Withdrawal by Subject|0|||
161699132|NCT00880750|583946960|FG000|First Intervention|Lost to Follow-up|2|||
161699133|NCT00880750|583946961|FG001|First Intervention|Lost to Follow-up|0|||
161699134|NCT00880750|583946960|FG000|Second Intervention|Withdrawal by Subject|2|||
161699135|NCT00880750|583946961|FG001|Second Intervention|Withdrawal by Subject|2|||
161699136|NCT00880750|583946960|FG000|Second Intervention|Protocol Violation|1|||
161699137|NCT00880750|583946961|FG001|Second Intervention|Protocol Violation|0|||
161699138|NCT00880750|583946960|FG000|Second Intervention|Unable to collect urine|1|||
161699139|NCT00880750|583946961|FG001|Second Intervention|Unable to collect urine|0|||
161699140|NCT00667576|583946962|FG000|Overall Study|Withdrawal by Subject|1|||
161836803|NCT01583218|584445041|FG000|Overall Study|Death|206|||
161836804|NCT01583218|584445042|FG001|Overall Study|Death|211|||
161836805|NCT01583218|584445041|FG000|Overall Study|Lost to Follow-up|11|||
161699141|NCT00667576|583946963|FG001|Overall Study|Withdrawal by Subject|0|||
161699142|NCT00667576|583946964|FG002|Overall Study|Withdrawal by Subject|1|||
161836806|NCT01583218|584445042|FG001|Overall Study|Lost to Follow-up|17|||
161699143|NCT00667576|583946965|FG003|Overall Study|Withdrawal by Subject|1|||
161699144|NCT00667576|583946966|FG004|Overall Study|Withdrawal by Subject|1|||
161699145|NCT00667576|583946962|FG000|Overall Study|Adverse Event|1|||
161699146|NCT00667576|583946963|FG001|Overall Study|Adverse Event|1|||
161699147|NCT00667576|583946964|FG002|Overall Study|Adverse Event|0|||
161699148|NCT00667576|583946965|FG003|Overall Study|Adverse Event|0|||
161699149|NCT00667576|583946966|FG004|Overall Study|Adverse Event|0|||
161699150|NCT00667576|583946962|FG000|Overall Study|Lost to Follow-up|0|||
161699151|NCT00667576|583946963|FG001|Overall Study|Lost to Follow-up|0|||
161699152|NCT00667576|583946964|FG002|Overall Study|Lost to Follow-up|1|||
161699153|NCT00667576|583946965|FG003|Overall Study|Lost to Follow-up|0|||
161699154|NCT00667576|583946966|FG004|Overall Study|Lost to Follow-up|0|||
161699155|NCT00667576|583946962|FG000|Overall Study|Protocol Violation|0|||
161699156|NCT00667576|583946963|FG001|Overall Study|Protocol Violation|0|||
161957072|NCT00325130|584889853|FG001|Overall Study|Protocol Deviation|1|||
161957073|NCT00325130|584889852|FG000|Overall Study|Moved|0|||
161957074|NCT00325130|584889853|FG001|Overall Study|Moved|1|||
161699157|NCT00667576|583946964|FG002|Overall Study|Protocol Violation|0|||
161699158|NCT00667576|583946965|FG003|Overall Study|Protocol Violation|1|||
161699159|NCT00667576|583946966|FG004|Overall Study|Protocol Violation|0|||
161699160|NCT00667576|583946962|FG000|Overall Study|Physician Decision|0|||
161699161|NCT00667576|583946963|FG001|Overall Study|Physician Decision|0|||
161699162|NCT00667576|583946964|FG002|Overall Study|Physician Decision|0|||
161699163|NCT00667576|583946965|FG003|Overall Study|Physician Decision|1|||
161699164|NCT00667576|583946966|FG004|Overall Study|Physician Decision|0|||
161699165|NCT00667576|583946962|FG000|Overall Study|Missed Visit|0|||
161699166|NCT00667576|583946963|FG001|Overall Study|Missed Visit|0|||
161699167|NCT00667576|583946964|FG002|Overall Study|Missed Visit|0|||
161699168|NCT00667576|583946965|FG003|Overall Study|Missed Visit|1|||
161699169|NCT00667576|583946966|FG004|Overall Study|Missed Visit|0|||
161699170|NCT03988907|583946967|FG000|Overall Study|Unable to complete visit|0|||
161699171|NCT03988907|583946968|FG001|Overall Study|Unable to complete visit|1|||
161699172|NCT03523351|583946971|FG000|Overall Study|Death|13|||
161699173|NCT03523351|583946972|FG001|Overall Study|Death|11|||
161699174|NCT03523351|583946971|FG000|Overall Study|Lost to Follow-up|2|||
161699175|NCT03523351|583946972|FG001|Overall Study|Lost to Follow-up|3|||
161699176|NCT03523351|583946971|FG000|Overall Study|Withdrawal by Subject|4|||
161699177|NCT03523351|583946972|FG001|Overall Study|Withdrawal by Subject|0|||
161699178|NCT03523351|583946971|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
161699179|NCT03523351|583946972|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
161699180|NCT03609619|583946977|FG000|Overall Study|Adverse Event|1|||
161699181|NCT03609619|583946978|FG001|Overall Study|Adverse Event|0|||
161699182|NCT03609619|583946977|FG000|Overall Study|Lack of Efficacy|1|||
161699183|NCT03609619|583946978|FG001|Overall Study|Lack of Efficacy|2|||
161699184|NCT03609619|583946977|FG000|Overall Study|Protocol Violation|5|||
161699185|NCT03609619|583946978|FG001|Overall Study|Protocol Violation|0|||
161699186|NCT03609619|583946977|FG000|Overall Study|Withdrawal by Subject|2|||
161699187|NCT03609619|583946978|FG001|Overall Study|Withdrawal by Subject|3|||
161699188|NCT03609619|583946977|FG000|Overall Study|Lost to Follow-up|1|||
161699189|NCT03609619|583946978|FG001|Overall Study|Lost to Follow-up|1|||
161699190|NCT00568555|583946979|FG000|Overall Study|Withdrawal by Subject|1|||
161699191|NCT00568555|583946980|FG001|Overall Study|Withdrawal by Subject|1|||
161699192|NCT01231555|583946981|FG000|Overall Study|Study terminated|8|||
161699193|NCT01231555|583946982|FG001|Overall Study|Study terminated|5|||
161699194|NCT01231555|583946983|FG002|Overall Study|Study terminated|8|||
161699195|NCT01231555|583946981|FG000|Overall Study|Withdrawal by Subject|0|||
161699196|NCT01231555|583946982|FG001|Overall Study|Withdrawal by Subject|2|||
161699197|NCT01231555|583946983|FG002|Overall Study|Withdrawal by Subject|0|||
161699198|NCT00688909|583946984|FG000|Overall Study|Adverse Event|28|||
161699199|NCT00688909|583946984|FG000|Overall Study|Patient withdrew consent|2|||
161699200|NCT00688909|583946984|FG000|Overall Study|Administrative problems|1|||
161699201|NCT00688909|583946984|FG000|Overall Study|Protocol Violation|2|||
161699202|NCT02817087|583946988|FG000|Overall Study|Withdrawal by Subject|2|||
161699203|NCT02817087|583946989|FG001|Overall Study|Withdrawal by Subject|0|||
161699204|NCT06098729|583946992|FG000|Overall Study|Withdrawal by Subject|1|||
161699205|NCT01890421|583946993|FG000|Overall Study|Adverse Event|1|||
161699206|NCT01890421|583946993|FG000|Overall Study|Other reason|10|||
161699207|NCT04871711|583946994|FG000|Overall Study|Withdrawal by Subject|11|||
161957075|NCT00325130|584889852|FG000|Overall Study|Patient Discontinued for Other|1|||
161957076|NCT00325130|584889853|FG001|Overall Study|Patient Discontinued for Other|0|||
161699208|NCT04871711|583946995|FG001|Overall Study|Withdrawal by Subject|5|||
161699209|NCT04871711|583946994|FG000|Overall Study|Lack of Efficacy|5|||
161699210|NCT04871711|583946995|FG001|Overall Study|Lack of Efficacy|7|||
161699211|NCT04871711|583946994|FG000|Overall Study|Adverse Event|2|||
161699212|NCT04871711|583946995|FG001|Overall Study|Adverse Event|6|||
161699213|NCT04871711|583946994|FG000|Overall Study|Various reasons|2|||
161699214|NCT04871711|583946995|FG001|Overall Study|Various reasons|1|||
161957077|NCT05959447|584891067|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
161699215|NCT04871711|583946994|FG000|Overall Study|Lost to Follow-up|0|||
161699216|NCT04871711|583946995|FG001|Overall Study|Lost to Follow-up|2|||
161699217|NCT01665144|583946996|FG000|Core Part|Withdrawal by Subject|96|||
161699218|NCT01665144|583946997|FG001|Core Part|Withdrawal by Subject|77|||
161699219|NCT01665144|583946998|FG002|Core Part|Withdrawal by Subject|0|||
161699220|NCT01665144|583946996|FG000|Core Part|Adverse Event|45|||
161699221|NCT01665144|583946997|FG001|Core Part|Adverse Event|18|||
161699222|NCT01665144|583946998|FG002|Core Part|Adverse Event|0|||
161699223|NCT01665144|583946996|FG000|Core Part|Lack of Efficacy|16|||
161699224|NCT01665144|583946997|FG001|Core Part|Lack of Efficacy|11|||
161699225|NCT01665144|583946998|FG002|Core Part|Lack of Efficacy|0|||
161699226|NCT01665144|583946996|FG000|Core Part|Lost to Follow-up|9|||
161699227|NCT01665144|583946997|FG001|Core Part|Lost to Follow-up|8|||
161699228|NCT01665144|583946998|FG002|Core Part|Lost to Follow-up|0|||
161699229|NCT01665144|583946996|FG000|Core Part|Physician Decision|13|||
161699230|NCT01665144|583946997|FG001|Core Part|Physician Decision|1|||
161699231|NCT01665144|583946998|FG002|Core Part|Physician Decision|0|||
161699232|NCT01665144|583946996|FG000|Core Part|Progressive disease|8|||
161699233|NCT01665144|583946997|FG001|Core Part|Progressive disease|4|||
161699234|NCT01665144|583946998|FG002|Core Part|Progressive disease|0|||
161699235|NCT01665144|583946996|FG000|Core Part|Non-compliance with study treatment|5|||
161699236|NCT01665144|583946997|FG001|Core Part|Non-compliance with study treatment|0|||
161699237|NCT01665144|583946998|FG002|Core Part|Non-compliance with study treatment|0|||
161699238|NCT01665144|583946996|FG000|Core Part|Death|3|||
161699239|NCT01665144|583946997|FG001|Core Part|Death|1|||
161699240|NCT01665144|583946998|FG002|Core Part|Death|0|||
161699241|NCT01665144|583946996|FG000|Core Part|Protocol deviation|3|||
161699242|NCT01665144|583946997|FG001|Core Part|Protocol deviation|1|||
161699243|NCT01665144|583946998|FG002|Core Part|Protocol deviation|0|||
161699244|NCT01665144|583946996|FG000|Core Part|New therapy for study indication|2|||
161699245|NCT01665144|583946997|FG001|Core Part|New therapy for study indication|1|||
161699246|NCT01665144|583946998|FG002|Core Part|New therapy for study indication|0|||
161699247|NCT01665144|583946996|FG000|Core Part|Technical problems|2|||
161699248|NCT01665144|583946997|FG001|Core Part|Technical problems|0|||
161699249|NCT01665144|583946998|FG002|Core Part|Technical problems|0|||
161699250|NCT01665144|583946996|FG000|Extension Part|Patient/guardian decision|180|||
161699251|NCT01665144|583946997|FG001|Extension Part|Patient/guardian decision|0|||
161699252|NCT01665144|583946998|FG002|Extension Part|Patient/guardian decision|98|||
161699253|NCT01665144|583946996|FG000|Extension Part|Adverse Event|104|||
161699254|NCT01665144|583946997|FG001|Extension Part|Adverse Event|0|||
161699255|NCT01665144|583946998|FG002|Extension Part|Adverse Event|59|||
161699256|NCT01665144|583946996|FG000|Extension Part|Study closed early|42|||
161699257|NCT01665144|583946997|FG001|Extension Part|Study closed early|0|||
161699258|NCT01665144|583946998|FG002|Extension Part|Study closed early|19|||
161699259|NCT01665144|583946996|FG000|Extension Part|Progressive disease|36|||
161699260|NCT01665144|583946997|FG001|Extension Part|Progressive disease|0|||
161699261|NCT01665144|583946998|FG002|Extension Part|Progressive disease|14|||
161699262|NCT01665144|583946996|FG000|Extension Part|Lack of Efficacy|37|||
161699263|NCT01665144|583946997|FG001|Extension Part|Lack of Efficacy|0|||
161699264|NCT01665144|583946998|FG002|Extension Part|Lack of Efficacy|12|||
161699265|NCT01665144|583946996|FG000|Extension Part|Physician Decision|29|||
161699266|NCT01665144|583946997|FG001|Extension Part|Physician Decision|0|||
161699267|NCT01665144|583946998|FG002|Extension Part|Physician Decision|13|||
161699268|NCT01665144|583946996|FG000|Extension Part|Technical problems|20|||
161699269|NCT01665144|583946997|FG001|Extension Part|Technical problems|0|||
161699270|NCT01665144|583946998|FG002|Extension Part|Technical problems|8|||
161699271|NCT01665144|583946996|FG000|Extension Part|Death|20|||
161699272|NCT01665144|583946997|FG001|Extension Part|Death|0|||
161699273|NCT01665144|583946998|FG002|Extension Part|Death|4|||
161699274|NCT01665144|583946996|FG000|Extension Part|Missing|12|||
161699275|NCT01665144|583946997|FG001|Extension Part|Missing|0|||
161699276|NCT01665144|583946998|FG002|Extension Part|Missing|6|||
161699277|NCT01665144|583946996|FG000|Extension Part|Lost to Follow-up|9|||
161699278|NCT01665144|583946997|FG001|Extension Part|Lost to Follow-up|0|||
161699279|NCT01665144|583946998|FG002|Extension Part|Lost to Follow-up|5|||
161699280|NCT01665144|583946996|FG000|Extension Part|New therapy for study indication|3|||
161699281|NCT01665144|583946997|FG001|Extension Part|New therapy for study indication|0|||
161699282|NCT01665144|583946998|FG002|Extension Part|New therapy for study indication|2|||
161699283|NCT01665144|583946996|FG000|Extension Part|Protocol deviation|3|||
161699284|NCT01665144|583946997|FG001|Extension Part|Protocol deviation|0|||
161699285|NCT01665144|583946998|FG002|Extension Part|Protocol deviation|0|||
161699286|NCT01972074|583947006|FG000|Overall Study|Adverse Event|4|||
161836807|NCT01583218|584445041|FG000|Overall Study|Adverse event or serious adverse event|3|||
161836808|NCT01583218|584445042|FG001|Overall Study|Adverse event or serious adverse event|3|||
161699287|NCT01972074|583947007|FG001|Overall Study|Adverse Event|1|||
161699288|NCT01972074|583947008|FG002|Overall Study|Adverse Event|0|||
161836809|NCT01583218|584445041|FG000|Overall Study|Patient /Family decision|3|||
161836810|NCT01583218|584445042|FG001|Overall Study|Patient /Family decision|0|||
161699289|NCT01972074|583947006|FG000|Overall Study|Lack of Efficacy|1|||
161699290|NCT01972074|583947007|FG001|Overall Study|Lack of Efficacy|1|||
161699291|NCT01972074|583947008|FG002|Overall Study|Lack of Efficacy|0|||
161699292|NCT01972074|583947006|FG000|Overall Study|Lost to Follow-up|0|||
161699293|NCT01972074|583947007|FG001|Overall Study|Lost to Follow-up|1|||
161699294|NCT01972074|583947008|FG002|Overall Study|Lost to Follow-up|1|||
161699295|NCT01972074|583947006|FG000|Overall Study|Withdrawal by Subject|1|||
161699296|NCT01972074|583947007|FG001|Overall Study|Withdrawal by Subject|1|||
161699297|NCT01972074|583947008|FG002|Overall Study|Withdrawal by Subject|1|||
161699298|NCT01972074|583947006|FG000|Overall Study|Scanner Unavailable|0|||
161699299|NCT01972074|583947007|FG001|Overall Study|Scanner Unavailable|0|||
161699300|NCT01972074|583947008|FG002|Overall Study|Scanner Unavailable|1|||
161699301|NCT02026063|583947011|FG000|Overall Study|Physician Decision|0|||
161699302|NCT02026063|583947012|FG001|Overall Study|Physician Decision|10|||
161699303|NCT02026063|583947011|FG000|Overall Study|Noncompliance with Study Drug|1|||
161699304|NCT02026063|583947012|FG001|Overall Study|Noncompliance with Study Drug|1|||
161699305|NCT02026063|583947011|FG000|Overall Study|Withdrawal of Consent|1|||
161699306|NCT02026063|583947012|FG001|Overall Study|Withdrawal of Consent|6|||
161699307|NCT02026063|583947011|FG000|Overall Study|Adverse Event|5|||
161699308|NCT02026063|583947012|FG001|Overall Study|Adverse Event|20|||
161699309|NCT02026063|583947011|FG000|Overall Study|Lack of Efficacy|0|||
161699310|NCT02026063|583947012|FG001|Overall Study|Lack of Efficacy|4|||
161699311|NCT02026063|583947011|FG000|Overall Study|Lost to Follow-up|0|||
161699312|NCT02026063|583947012|FG001|Overall Study|Lost to Follow-up|1|||
161699313|NCT02026063|583947011|FG000|Overall Study|Reason not Specified|2|||
161699314|NCT02026063|583947012|FG001|Overall Study|Reason not Specified|7|||
161699315|NCT01777581|583947013|FG000|Overall Study|Lost to Follow-up|1|||
161699316|NCT01777581|583947014|FG001|Overall Study|Lost to Follow-up|1|||
161699317|NCT01777581|583947013|FG000|Overall Study|Adverse Event|2|||
161699318|NCT01777581|583947014|FG001|Overall Study|Adverse Event|0|||
161699319|NCT01777581|583947013|FG000|Overall Study|Lack of Efficacy|0|||
161699320|NCT01777581|583947014|FG001|Overall Study|Lack of Efficacy|1|||
161699321|NCT02887521|583947017|FG000|Overall Study|Withdrawal by Subject|0|||
161699322|NCT02887521|583947018|FG001|Overall Study|Withdrawal by Subject|3|||
161699323|NCT00695565|583947019|FG000|Overall Study|Lost to Follow-up|4|||
161699324|NCT00695565|583947020|FG001|Overall Study|Lost to Follow-up|4|||
161699325|NCT00695565|583947019|FG000|Overall Study|Adverse Event|3|||
161699326|NCT00695565|583947020|FG001|Overall Study|Adverse Event|1|||
161699327|NCT00695565|583947019|FG000|Overall Study|Protocol Violation|3|||
161699328|NCT00695565|583947020|FG001|Overall Study|Protocol Violation|1|||
161699329|NCT00695565|583947019|FG000|Overall Study|Withdrawal by Subject|1|||
161699330|NCT00695565|583947020|FG001|Overall Study|Withdrawal by Subject|1|||
161699331|NCT00695565|583947019|FG000|Overall Study|Lack of Efficacy|1|||
161699332|NCT00695565|583947020|FG001|Overall Study|Lack of Efficacy|1|||
161699333|NCT00695565|583947019|FG000|Overall Study|Subject did not follow instructions|1|||
161699334|NCT00695565|583947020|FG001|Overall Study|Subject did not follow instructions|1|||
161699335|NCT02937350|583947021|FG000|Overall Study|Withdrawal by Subject|0|||
161699336|NCT02937350|583947022|FG001|Overall Study|Withdrawal by Subject|1|||
161699337|NCT02937350|583947023|FG002|Overall Study|Withdrawal by Subject|0|||
161699338|NCT01462266|583947024|FG000|Overall Study|Adverse Event|7|||
161699339|NCT01462266|583947025|FG001|Overall Study|Adverse Event|6|||
161699340|NCT01462266|583947024|FG000|Overall Study|Death|2|||
161699341|NCT01462266|583947025|FG001|Overall Study|Death|1|||
161699342|NCT01462266|583947024|FG000|Overall Study|Lack of Efficacy|0|||
161699343|NCT01462266|583947025|FG001|Overall Study|Lack of Efficacy|2|||
161699344|NCT01462266|583947024|FG000|Overall Study|Lost to Follow-up|4|||
161699345|NCT01462266|583947025|FG001|Overall Study|Lost to Follow-up|3|||
161699346|NCT01462266|583947024|FG000|Overall Study|Non-compliance with study drug|3|||
161699347|NCT01462266|583947025|FG001|Overall Study|Non-compliance with study drug|0|||
161699348|NCT01462266|583947024|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
161699349|NCT01462266|583947025|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
161699350|NCT01462266|583947024|FG000|Overall Study|Physician Decision|2|||
161699351|NCT01462266|583947025|FG001|Overall Study|Physician Decision|5|||
161699352|NCT01462266|583947024|FG000|Overall Study|Protocol Violation|1|||
161699353|NCT01462266|583947025|FG001|Overall Study|Protocol Violation|3|||
161699354|NCT01462266|583947024|FG000|Overall Study|Withdrawal by Subject|7|||
161836811|NCT01583218|584445041|FG000|Overall Study|Cannot contact patient directly|1|||
161836812|NCT01583218|584445042|FG001|Overall Study|Cannot contact patient directly|2|||
161836813|NCT01583218|584445041|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
161836814|NCT01583218|584445042|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
161836815|NCT01583218|584445041|FG000|Overall Study|Patient did not wish to attend visits|0|||
161836816|NCT01583218|584445042|FG001|Overall Study|Patient did not wish to attend visits|1|||
161836817|NCT01583218|584445041|FG000|Overall Study|Patient randomized but not dosed|17|||
161836818|NCT01583218|584445042|FG001|Overall Study|Patient randomized but not dosed|16|||
161699355|NCT01462266|583947025|FG001|Overall Study|Withdrawal by Subject|2|||
161699356|NCT01462266|583947024|FG000|Overall Study|Screen failure|1|||
161699357|NCT01462266|583947025|FG001|Overall Study|Screen failure|1|||
161699358|NCT01106846|583947026|FG000|Overall Study|Change in surgical procedure|0|||
161699359|NCT01106846|583947027|FG001|Overall Study|Change in surgical procedure|1|||
161699360|NCT04811716|583947029|FG000|Overall Study|Withdrawal by Subject|2|||
161699361|NCT04811716|583947030|FG001|Overall Study|Withdrawal by Subject|0|||
161699362|NCT02320487|583947031|FG000|Overall Study|Reason not Specified|1|||
161699363|NCT02320487|583947031|FG000|Overall Study|Physician Decision|5|||
161699364|NCT02320487|583947031|FG000|Overall Study|Withdrawal by Subject|1|||
161957078|NCT05959447|584891068|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
161957079|NCT05959447|584891067|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
161957080|NCT05959447|584891068|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
161957081|NCT05959447|584891067|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
161957082|NCT05959447|584891068|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
161957083|NCT05959447|584891067|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
161957084|NCT05959447|584891068|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
161957085|NCT01893411|584891073|FG000|Overall Study|Protocol Violation|1|||
161957086|NCT01893411|584891074|FG001|Overall Study|Protocol Violation|0|||
161957087|NCT01893411|584891075|FG002|Overall Study|Protocol Violation|0|||
161957088|NCT01893411|584891073|FG000|Overall Study|Physician Decision|1|||
161957089|NCT01893411|584891074|FG001|Overall Study|Physician Decision|1|||
161957090|NCT01893411|584891075|FG002|Overall Study|Physician Decision|2|||
161957091|NCT01893411|584891073|FG000|Overall Study|Lack of Efficacy|2|||
161957092|NCT01893411|584891074|FG001|Overall Study|Lack of Efficacy|1|||
161957093|NCT01893411|584891075|FG002|Overall Study|Lack of Efficacy|0|||
161957094|NCT01893411|584891073|FG000|Overall Study|Other|3|||
161957095|NCT01893411|584891074|FG001|Overall Study|Other|1|||
161957096|NCT01893411|584891075|FG002|Overall Study|Other|3|||
161957097|NCT01893411|584891073|FG000|Overall Study|Adverse Event|1|||
161957098|NCT01893411|584891074|FG001|Overall Study|Adverse Event|0|||
161957099|NCT01893411|584891075|FG002|Overall Study|Adverse Event|0|||
161957100|NCT01893411|584891073|FG000|Overall Study|Withdrawal by Subject|7|||
161957101|NCT01893411|584891074|FG001|Overall Study|Withdrawal by Subject|4|||
161957102|NCT01893411|584891075|FG002|Overall Study|Withdrawal by Subject|3|||
161957103|NCT01893411|584891073|FG000|Overall Study|Lost to Follow-up|2|||
161957104|NCT01893411|584891074|FG001|Overall Study|Lost to Follow-up|0|||
161957105|NCT01893411|584891075|FG002|Overall Study|Lost to Follow-up|1|||
161957106|NCT00566982|584891076|FG000|Overall Study|Adverse Event|6|||
161957107|NCT00566982|584891077|FG001|Overall Study|Adverse Event|48|||
161957108|NCT00566982|584891076|FG000|Overall Study|Withdrawal by Subject|1|||
161957109|NCT00566982|584891077|FG001|Overall Study|Withdrawal by Subject|14|||
161957110|NCT00566982|584891076|FG000|Overall Study|Protocol Violation|1|||
161957111|NCT00566982|584891077|FG001|Overall Study|Protocol Violation|4|||
161957112|NCT00566982|584891076|FG000|Overall Study|Lost to Follow-up|0|||
161699365|NCT02320487|583947031|FG000|Overall Study|Death|3|||
161699366|NCT02320487|583947031|FG000|Overall Study|Adverse Event|11|||
161699367|NCT05900115|583948461|FG000|Overall Study|Lost to Follow-up|129|||
161699368|NCT05900115|583948462|FG001|Overall Study|Lost to Follow-up|98|||
161699369|NCT02152345|583948463|FG000|Overall Study|Case Cancellations|2|||
161699370|NCT02152345|583948464|FG001|Overall Study|Case Cancellations|4|||
161699371|NCT02152345|583948463|FG000|Overall Study|Withdrawal by Subject|2|||
161699372|NCT02152345|583948464|FG001|Overall Study|Withdrawal by Subject|1|||
161699373|NCT00483327|583948468|FG000|Overall Study|Adverse Event|1|||
161699374|NCT00483327|583948468|FG000|Overall Study|Withdrawal by Subject|3|||
161699375|NCT00483327|583948468|FG000|Overall Study|Lost to Follow-up|4|||
161699376|NCT00483327|583948468|FG000|Overall Study|Patient Non Compliance|2|||
161699377|NCT01390389|583948469|FG000|Overall Study|Withdrawal by Subject|2|||
161699378|NCT01390389|583948470|FG001|Overall Study|Withdrawal by Subject|0|||
161699379|NCT01390389|583948469|FG000|Overall Study|Screen Fail|2|||
161699380|NCT01390389|583948470|FG001|Overall Study|Screen Fail|1|||
161699381|NCT03593915|583948471|FG000|Overall Study|Adverse Event|0|||
161699382|NCT03593915|583948472|FG001|Overall Study|Adverse Event|0|||
161699383|NCT03593915|583948473|FG002|Overall Study|Adverse Event|0|||
161699384|NCT03593915|583948474|FG003|Overall Study|Adverse Event|1|||
161699385|NCT03593915|583948475|FG004|Overall Study|Adverse Event|0|||
161699386|NCT03593915|583948476|FG005|Overall Study|Adverse Event|0|||
161699387|NCT03593915|583948471|FG000|Overall Study|Physician Decision|0|||
161699388|NCT03593915|583948472|FG001|Overall Study|Physician Decision|0|||
161699389|NCT03593915|583948473|FG002|Overall Study|Physician Decision|0|||
161699390|NCT03593915|583948474|FG003|Overall Study|Physician Decision|0|||
161699391|NCT03593915|583948475|FG004|Overall Study|Physician Decision|0|||
161699392|NCT03593915|583948476|FG005|Overall Study|Physician Decision|1|||
161699393|NCT01583179|583948477|FG000|Overall Study|Screen failure|1|||
161699394|NCT01583179|583948478|FG001|Overall Study|Screen failure|2|||
161699395|NCT01246206|583948479|FG000|Overall Study|Patient did not receive study regiments.|1|||
161957113|NCT00566982|584891077|FG001|Overall Study|Lost to Follow-up|1|||
161957114|NCT00566982|584891076|FG000|Overall Study|Other-family problems & doctor's request|0|||
161957115|NCT00566982|584891077|FG001|Overall Study|Other-family problems & doctor's request|2|||
161957116|NCT03053440|584891080|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
161957117|NCT03053440|584891081|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
161957118|NCT03053440|584891080|FG000|Overall Study|Death|18|||
161699396|NCT02002975|583948480|FG000|Overall Study|Case Report Forms Uncollected|135|||
161699397|NCT02002975|583948480|FG000|Overall Study|Protocol Deviation|437|||
161699398|NCT02810964|583948481|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
161957119|NCT03053440|584891081|FG001|Overall Study|Death|14|||
161957120|NCT03053440|584891080|FG000|Overall Study|Withdrawal by Subject|9|||
161699399|NCT02810964|583948482|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
161699400|NCT02810964|583948481|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
161699401|NCT02810964|583948482|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
161699402|NCT02810964|583948481|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
161699403|NCT02810964|583948482|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
161699404|NCT02810964|583948481|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
161699405|NCT02810964|583948482|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
161699406|NCT02472847|583948483|FG000|Overall Study|Withdrawal by Subject|1|||
161699407|NCT02472847|583948484|FG001|Overall Study|Withdrawal by Subject|5|||
161699408|NCT04656990|583948485|FG000|Baseline|pandemic|20|||
161699409|NCT04656990|583948486|FG001|Baseline|pandemic|24|||
161699410|NCT04656990|583948485|FG000|Follow Up Period|Lost to Follow-up|61|||
161699411|NCT04656990|583948486|FG001|Follow Up Period|Lost to Follow-up|73|||
161699412|NCT03244059|583948487|FG000|Specific Aim 1|Physician Decision|1|||
161699413|NCT03244059|583948488|FG001|Specific Aim 1|Physician Decision|0|||
161699414|NCT03244059|583948487|FG000|Specific Aim 2|Physician Decision|1|||
161699415|NCT03244059|583948488|FG001|Specific Aim 2|Physician Decision|0|||
161699416|NCT01613326|583948489|FG000|Overall Study|Adverse Event|7|||
161699417|NCT01613326|583948490|FG001|Overall Study|Adverse Event|5|||
161699418|NCT01613326|583948489|FG000|Overall Study|Withdrawal by Subject|3|||
161699419|NCT01613326|583948490|FG001|Overall Study|Withdrawal by Subject|4|||
161699420|NCT01613326|583948489|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161699421|NCT01613326|583948490|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161699422|NCT01613326|583948489|FG000|Overall Study|inability to use device|1|||
161699423|NCT01613326|583948490|FG001|Overall Study|inability to use device|0|||
161699424|NCT01613326|583948489|FG000|Overall Study|Lack of Efficacy|0|||
161699425|NCT01613326|583948490|FG001|Overall Study|Lack of Efficacy|1|||
161699426|NCT01613326|583948489|FG000|Overall Study|Lost to Follow-up|0|||
161699427|NCT01613326|583948490|FG001|Overall Study|Lost to Follow-up|1|||
161699428|NCT01613326|583948489|FG000|Overall Study|Administrative|0|||
161699429|NCT01613326|583948490|FG001|Overall Study|Administrative|2|||
161699430|NCT01613326|583948489|FG000|Overall Study|Protocol Violation|0|||
161699431|NCT01613326|583948490|FG001|Overall Study|Protocol Violation|1|||
161699432|NCT01940484|583948491|FG000|Overall Study|Withdrawal by Subject|3|||
161699433|NCT01940484|583948491|FG000|Overall Study|Underwent transplantation|4|||
161699434|NCT01940484|583948491|FG000|Overall Study|Death|2|||
161699435|NCT01940484|583948491|FG000|Overall Study|Adverse Event|1|||
161699436|NCT01705691|583948493|FG000|Overall Study|Death|1|||
161699437|NCT01705691|583948494|FG001|Overall Study|Death|2|||
161699438|NCT01705691|583948493|FG000|Overall Study|Withdrawal by Subject|1|||
161699439|NCT01705691|583948494|FG001|Overall Study|Withdrawal by Subject|2|||
161699440|NCT01705691|583948493|FG000|Overall Study|Lost to Follow-up|1|||
161699441|NCT01705691|583948494|FG001|Overall Study|Lost to Follow-up|1|||
161699442|NCT01705691|583948493|FG000|Overall Study|Other|0|||
161699443|NCT01705691|583948494|FG001|Overall Study|Other|1|||
161699444|NCT02658448|583948495|FG000|Overall Study|Lost to Follow-up|1|||
161699445|NCT03106779|583948496|FG000|Overall Study|Lack of Efficacy|33|||
161699446|NCT03106779|583948497|FG001|Overall Study|Lack of Efficacy|24|||
161699447|NCT03106779|583948496|FG000|Overall Study|Adverse Event|8|||
161699448|NCT03106779|583948497|FG001|Overall Study|Adverse Event|16|||
161699449|NCT03106779|583948496|FG000|Overall Study|Physician Decision|10|||
161699450|NCT03106779|583948497|FG001|Overall Study|Physician Decision|6|||
161699451|NCT03106779|583948496|FG000|Overall Study|Patient/guardian decision|4|||
161699452|NCT03106779|583948497|FG001|Overall Study|Patient/guardian decision|3|||
161699453|NCT03106779|583948496|FG000|Overall Study|Progressive disease|1|||
161699454|NCT03106779|583948497|FG001|Overall Study|Progressive disease|3|||
161699455|NCT03106779|583948496|FG000|Overall Study|Lost to Follow-up|1|||
161699456|NCT03106779|583948497|FG001|Overall Study|Lost to Follow-up|2|||
161699457|NCT03106779|583948496|FG000|Overall Study|Death|1|||
161699458|NCT03106779|583948497|FG001|Overall Study|Death|0|||
161699459|NCT03106779|583948496|FG000|Overall Study|Protocol Violation|1|||
161699460|NCT03106779|583948497|FG001|Overall Study|Protocol Violation|0|||
161699461|NCT03106779|583948496|FG000|Overall Study|Not treated|1|||
161699462|NCT03106779|583948497|FG001|Overall Study|Not treated|0|||
161836819|NCT01583218|584445041|FG000|Overall Study|Patient was assessed via phone in person|1|||
161836820|NCT01583218|584445042|FG001|Overall Study|Patient was assessed via phone in person|0|||
161699463|NCT04233229|583948498|FG000|Overall Study|Withdrawal by Subject|0|||
161699464|NCT04233229|583948499|FG001|Overall Study|Withdrawal by Subject|1|||
161699465|NCT04233229|583948498|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
161699466|NCT04233229|583948499|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
161699467|NCT04233229|583948498|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
161699468|NCT04233229|583948499|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
161699469|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
161699470|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
161699471|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
161699472|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
161699473|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
161699474|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
161699475|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
161699476|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
161699477|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
161699478|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
161699479|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
161699480|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
161699481|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
161699482|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
161699483|NCT02288247|583948500|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
161699484|NCT02288247|583948501|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
161699485|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
161699486|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
161699487|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
161699488|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
161699489|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
161699490|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
161699491|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
161699492|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
161699493|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
161699494|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
161699495|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
161699496|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
161699497|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
161699498|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
161699499|NCT02288247|583948500|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
161699500|NCT02288247|583948501|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
161699501|NCT04652804|583948502|FG000|Overall Study|Ineligible post randomization|1|||
161699502|NCT04652804|583948503|FG001|Overall Study|Ineligible post randomization|0|||
161699503|NCT04652804|583948504|FG002|Overall Study|Ineligible post randomization|1|||
161699504|NCT04652804|583948505|FG003|Overall Study|Ineligible post randomization|0|||
161699505|NCT04652804|583948506|FG004|Overall Study|Ineligible post randomization|1|||
161699506|NCT04652804|583948507|FG005|Overall Study|Ineligible post randomization|1|||
161699507|NCT04652804|583948502|FG000|Overall Study|Missing SVR lab results|2|||
161699508|NCT04652804|583948503|FG001|Overall Study|Missing SVR lab results|0|||
161699509|NCT04652804|583948504|FG002|Overall Study|Missing SVR lab results|0|||
161699510|NCT04652804|583948505|FG003|Overall Study|Missing SVR lab results|0|||
161699511|NCT04652804|583948506|FG004|Overall Study|Missing SVR lab results|0|||
161699512|NCT04652804|583948507|FG005|Overall Study|Missing SVR lab results|0|||
161699513|NCT00584194|583948508|FG000|Overall Study|Other|135|||
161699514|NCT04093531|583948509|FG000|Overall Study|failed screening|4|||
161699515|NCT03222349|583948510|FG000|Overall Study|Treatment B not done|5|||
161699516|NCT03222349|583948511|FG001|Overall Study|Treatment B not done|0|||
161699517|NCT03222349|583948510|FG000|Overall Study|Lost to Follow-up|1|||
161699518|NCT03222349|583948511|FG001|Overall Study|Lost to Follow-up|2|||
161699519|NCT03222349|583948510|FG000|Overall Study|Withdrawal by Subject|1|||
161699520|NCT03222349|583948511|FG001|Overall Study|Withdrawal by Subject|0|||
161699521|NCT03222349|583948510|FG000|Overall Study|Treatment A not done|0|||
161699522|NCT03222349|583948511|FG001|Overall Study|Treatment A not done|5|||
161699523|NCT03222349|583948510|FG000|Overall Study|Study terminated by sponsor|1|||
161699524|NCT03222349|583948511|FG001|Overall Study|Study terminated by sponsor|0|||
161699525|NCT03665285|583948512|FG000|Overall Study|Started New Anticancer Treatment|1|||
161699526|NCT03665285|583948513|FG001|Overall Study|Started New Anticancer Treatment|1|||
161699527|NCT03665285|583948514|FG002|Overall Study|Started New Anticancer Treatment|2|||
161699528|NCT03665285|583948515|FG003|Overall Study|Started New Anticancer Treatment|4|||
161699529|NCT03665285|583948516|FG004|Overall Study|Started New Anticancer Treatment|1|||
161699530|NCT03665285|583948517|FG005|Overall Study|Started New Anticancer Treatment|1|||
161699531|NCT03665285|583948518|FG006|Overall Study|Started New Anticancer Treatment|2|||
161699532|NCT03665285|583948519|FG007|Overall Study|Started New Anticancer Treatment|15|||
161699533|NCT03665285|583948520|FG008|Overall Study|Started New Anticancer Treatment|1|||
161699534|NCT03665285|583948512|FG000|Overall Study|Disease Progression|0|||
161699535|NCT03665285|583948513|FG001|Overall Study|Disease Progression|0|||
161699536|NCT03665285|583948514|FG002|Overall Study|Disease Progression|3|||
161699537|NCT03665285|583948515|FG003|Overall Study|Disease Progression|1|||
161699538|NCT03665285|583948516|FG004|Overall Study|Disease Progression|0|||
161699539|NCT03665285|583948517|FG005|Overall Study|Disease Progression|0|||
161699540|NCT03665285|583948518|FG006|Overall Study|Disease Progression|0|||
161699541|NCT03665285|583948519|FG007|Overall Study|Disease Progression|7|||
161957121|NCT03053440|584891081|FG001|Overall Study|Withdrawal by Subject|8|||
161957122|NCT03053440|584891080|FG000|Overall Study|Lost to Follow-up|1|||
161957123|NCT03053440|584891081|FG001|Overall Study|Lost to Follow-up|0|||
161957124|NCT03053440|584891080|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
161957125|NCT03053440|584891081|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
161957126|NCT03053440|584891080|FG000|Overall Study|Physician Decision|2|||
161957127|NCT03053440|584891081|FG001|Overall Study|Physician Decision|1|||
161957128|NCT03053440|584891080|FG000|Overall Study|Participant Randomized but died before dosing|1|||
161957129|NCT03053440|584891081|FG001|Overall Study|Participant Randomized but died before dosing|0|||
161957130|NCT00391053|584891087|FG000|Overall Study|Serious Adverse Events|1|||
161957131|NCT00391053|584891088|FG001|Overall Study|Serious Adverse Events|0|||
161957132|NCT00391053|584891089|FG002|Overall Study|Serious Adverse Events|1|||
161957133|NCT00391053|584891090|FG003|Overall Study|Serious Adverse Events|4|||
161957134|NCT00391053|584891087|FG000|Overall Study|Protocol Violation|2|||
161699542|NCT03665285|583948520|FG008|Overall Study|Disease Progression|1|||
161699543|NCT03665285|583948512|FG000|Overall Study|Hospice|0|||
161699544|NCT03665285|583948513|FG001|Overall Study|Hospice|0|||
161699545|NCT03665285|583948514|FG002|Overall Study|Hospice|0|||
161699546|NCT03665285|583948515|FG003|Overall Study|Hospice|0|||
161699547|NCT03665285|583948516|FG004|Overall Study|Hospice|0|||
161699548|NCT03665285|583948517|FG005|Overall Study|Hospice|0|||
161699549|NCT03665285|583948518|FG006|Overall Study|Hospice|0|||
161699550|NCT03665285|583948519|FG007|Overall Study|Hospice|2|||
161699551|NCT03665285|583948520|FG008|Overall Study|Hospice|0|||
161699552|NCT03665285|583948512|FG000|Overall Study|Withdrawal by Subject|0|||
161699553|NCT03665285|583948513|FG001|Overall Study|Withdrawal by Subject|0|||
161699554|NCT03665285|583948514|FG002|Overall Study|Withdrawal by Subject|0|||
161699555|NCT03665285|583948515|FG003|Overall Study|Withdrawal by Subject|0|||
161699556|NCT03665285|583948516|FG004|Overall Study|Withdrawal by Subject|1|||
161699557|NCT03665285|583948517|FG005|Overall Study|Withdrawal by Subject|0|||
161699558|NCT03665285|583948518|FG006|Overall Study|Withdrawal by Subject|0|||
161699559|NCT03665285|583948519|FG007|Overall Study|Withdrawal by Subject|2|||
161699560|NCT03665285|583948520|FG008|Overall Study|Withdrawal by Subject|0|||
161699561|NCT03665285|583948512|FG000|Overall Study|Physician Decision|0|||
161699562|NCT03665285|583948513|FG001|Overall Study|Physician Decision|0|||
161699563|NCT03665285|583948514|FG002|Overall Study|Physician Decision|0|||
161699564|NCT03665285|583948515|FG003|Overall Study|Physician Decision|0|||
161699565|NCT03665285|583948516|FG004|Overall Study|Physician Decision|0|||
161699566|NCT03665285|583948517|FG005|Overall Study|Physician Decision|0|||
161699567|NCT03665285|583948518|FG006|Overall Study|Physician Decision|0|||
161699568|NCT03665285|583948519|FG007|Overall Study|Physician Decision|2|||
161699569|NCT03665285|583948520|FG008|Overall Study|Physician Decision|0|||
161699570|NCT03543410|583948521|FG000|Overall Study|Adverse Event|10|||
161699571|NCT03543410|583948522|FG001|Overall Study|Adverse Event|8|||
161699572|NCT03543410|583948523|FG002|Overall Study|Adverse Event|2|||
161699573|NCT03543410|583948521|FG000|Overall Study|Lack of Efficacy|0|||
161699574|NCT03543410|583948522|FG001|Overall Study|Lack of Efficacy|1|||
161699575|NCT03543410|583948523|FG002|Overall Study|Lack of Efficacy|0|||
161699576|NCT03543410|583948521|FG000|Overall Study|Lost to Follow-up|0|||
161699577|NCT03543410|583948522|FG001|Overall Study|Lost to Follow-up|1|||
161699578|NCT03543410|583948523|FG002|Overall Study|Lost to Follow-up|0|||
161699579|NCT03543410|583948521|FG000|Overall Study|Withdrawal by Subject|5|||
161699580|NCT03543410|583948522|FG001|Overall Study|Withdrawal by Subject|2|||
161699581|NCT03543410|583948523|FG002|Overall Study|Withdrawal by Subject|8|||
161699582|NCT03543410|583948521|FG000|Overall Study|Protocol Violation|0|||
161699583|NCT03543410|583948522|FG001|Overall Study|Protocol Violation|1|||
161699584|NCT03543410|583948523|FG002|Overall Study|Protocol Violation|0|||
161699585|NCT03543410|583948521|FG000|Overall Study|Due to COVID-19|4|||
161699586|NCT03543410|583948522|FG001|Overall Study|Due to COVID-19|0|||
161699587|NCT03543410|583948523|FG002|Overall Study|Due to COVID-19|2|||
161699588|NCT03543410|583948521|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
161699589|NCT03543410|583948522|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
161699590|NCT03543410|583948523|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
161699591|NCT03543410|583948521|FG000|Overall Study|Not Due to COVID-19|2|||
161699592|NCT03543410|583948522|FG001|Overall Study|Not Due to COVID-19|0|||
161699593|NCT03543410|583948523|FG002|Overall Study|Not Due to COVID-19|1|||
161699594|NCT01318122|583948524|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161699595|NCT01318122|583948525|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161957135|NCT00391053|584891088|FG001|Overall Study|Protocol Violation|0|||
161957136|NCT00391053|584891089|FG002|Overall Study|Protocol Violation|0|||
162030802|NCT03400956|585169490|FG000|Treatment Period 1|Protocol Violation|0|||
161699596|NCT01318122|583948526|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
161699597|NCT01318122|583948527|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
161699598|NCT01318122|583948524|FG000|Enrolled - Long-Term Extension Study|Other|1|||
161699599|NCT01318122|583948525|FG001|Enrolled - Long-Term Extension Study|Other|0|||
161699600|NCT01318122|583948526|FG002|Enrolled - Long-Term Extension Study|Other|0|||
161699601|NCT01318122|583948527|FG003|Enrolled - Long-Term Extension Study|Other|0|||
161957137|NCT00391053|584891090|FG003|Overall Study|Protocol Violation|0|||
161957138|NCT00391053|584891087|FG000|Overall Study|Lost to Follow-up|1|||
161957139|NCT00391053|584891088|FG001|Overall Study|Lost to Follow-up|0|||
161957140|NCT00391053|584891089|FG002|Overall Study|Lost to Follow-up|0|||
161699602|NCT01318122|583948524|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
161699603|NCT01318122|583948525|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
161699604|NCT01318122|583948526|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
161699605|NCT01318122|583948527|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
161699606|NCT01318122|583948524|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
161699607|NCT01318122|583948525|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161699608|NCT01318122|583948526|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161699609|NCT01318122|583948527|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161699610|NCT01318122|583948524|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161699611|NCT01318122|583948525|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
161699612|NCT01318122|583948526|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161699613|NCT01318122|583948527|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161699614|NCT01318122|583948524|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161699615|NCT01318122|583948525|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
161699616|NCT01318122|583948526|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
161699617|NCT01318122|583948527|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161699618|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
161699619|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
161699620|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
161699621|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Death|28|||
161699622|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Death|0|||
161699623|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Death|0|||
161699624|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
161699625|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
161699626|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
161699627|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
161699628|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
161699629|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
161699630|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
161699631|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
161699632|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
161699633|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
161699634|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
161699635|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
161699636|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
161699637|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
161699638|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
161699639|NCT00820755|583948528|FG000|Period 1: Combination Therapy Phase|Other|11|||
161699640|NCT00820755|583948529|FG001|Period 1: Combination Therapy Phase|Other|0|||
161699641|NCT00820755|583948530|FG002|Period 1: Combination Therapy Phase|Other|0|||
161699642|NCT00820755|583948528|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
161699643|NCT00820755|583948529|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
161699644|NCT00820755|583948530|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
161699645|NCT01486199|583948531|FG000|Two Year Period Between Study Days|Physician Decision|1|||
161699646|NCT01486199|583948532|FG001|Two Year Period Between Study Days|Physician Decision|0|||
161699647|NCT03604445|583948536|FG000|Overall Study|Death|0|||
161699648|NCT03604445|583948537|FG001|Overall Study|Death|0|||
161699649|NCT03604445|583948538|FG002|Overall Study|Death|0|||
161699650|NCT03604445|583948539|FG003|Overall Study|Death|0|||
161699651|NCT03604445|583948540|FG004|Overall Study|Death|0|||
161699652|NCT03604445|583948541|FG005|Overall Study|Death|0|||
161699653|NCT03604445|583948542|FG006|Overall Study|Death|0|||
161699654|NCT03604445|583948543|FG007|Overall Study|Death|0|||
161699655|NCT03604445|583948544|FG008|Overall Study|Death|1|||
161699656|NCT03604445|583948536|FG000|Overall Study|Withdrawal by Subject|0|||
161836821|NCT01583218|584445041|FG000|Overall Study|Patient deemed ineligible after random|2|||
161836822|NCT01583218|584445042|FG001|Overall Study|Patient deemed ineligible after random|0|||
161957141|NCT00391053|584891090|FG003|Overall Study|Lost to Follow-up|5|||
161957142|NCT00391053|584891087|FG000|Overall Study|Withdrawal by Subject|5|||
161957143|NCT00391053|584891088|FG001|Overall Study|Withdrawal by Subject|1|||
161957144|NCT00391053|584891089|FG002|Overall Study|Withdrawal by Subject|1|||
161957145|NCT00391053|584891090|FG003|Overall Study|Withdrawal by Subject|1|||
161957146|NCT00473889|584891092|FG000|Overall Study|Did not receive study medication|1|||
161836823|NCT01583218|584445041|FG000|Overall Study|Patient was early terminated from study|0|||
161836824|NCT01583218|584445042|FG001|Overall Study|Patient was early terminated from study|1|||
161957147|NCT00473889|584891093|FG001|Overall Study|Did not receive study medication|4|||
161699657|NCT03604445|583948537|FG001|Overall Study|Withdrawal by Subject|0|||
161699658|NCT03604445|583948538|FG002|Overall Study|Withdrawal by Subject|0|||
161699659|NCT03604445|583948539|FG003|Overall Study|Withdrawal by Subject|0|||
161699660|NCT03604445|583948540|FG004|Overall Study|Withdrawal by Subject|0|||
161699661|NCT03604445|583948541|FG005|Overall Study|Withdrawal by Subject|0|||
161699662|NCT03604445|583948542|FG006|Overall Study|Withdrawal by Subject|1|||
161699663|NCT03604445|583948543|FG007|Overall Study|Withdrawal by Subject|0|||
161699664|NCT03604445|583948544|FG008|Overall Study|Withdrawal by Subject|0|||
161699665|NCT03604445|583948536|FG000|Overall Study|Missing visit|0|||
161699666|NCT03604445|583948537|FG001|Overall Study|Missing visit|0|||
161699667|NCT03604445|583948538|FG002|Overall Study|Missing visit|0|||
161699668|NCT03604445|583948539|FG003|Overall Study|Missing visit|0|||
161699669|NCT03604445|583948540|FG004|Overall Study|Missing visit|0|||
161699670|NCT03604445|583948541|FG005|Overall Study|Missing visit|1|||
161699671|NCT03604445|583948542|FG006|Overall Study|Missing visit|0|||
161699672|NCT03604445|583948543|FG007|Overall Study|Missing visit|1|||
161699673|NCT03604445|583948544|FG008|Overall Study|Missing visit|0|||
161699674|NCT03604445|583948536|FG000|Overall Study|Adverse Event|0|||
161699675|NCT03604445|583948537|FG001|Overall Study|Adverse Event|0|||
161699676|NCT03604445|583948538|FG002|Overall Study|Adverse Event|0|||
161699677|NCT03604445|583948539|FG003|Overall Study|Adverse Event|1|||
161699678|NCT03604445|583948540|FG004|Overall Study|Adverse Event|0|||
161699679|NCT03604445|583948541|FG005|Overall Study|Adverse Event|0|||
161699680|NCT03604445|583948542|FG006|Overall Study|Adverse Event|0|||
161699681|NCT03604445|583948543|FG007|Overall Study|Adverse Event|0|||
161699682|NCT03604445|583948544|FG008|Overall Study|Adverse Event|1|||
161699683|NCT02154425|583948545|FG000|Screening Period|Adverse Event|1|||
161699684|NCT00480857|583948548|FG000|Overall Study|Lack of Efficacy|2|||
161699685|NCT00611247|583948551|FG000|Overall Study|Death|1|||
161699686|NCT00611247|583948552|FG001|Overall Study|Death|5|||
161699687|NCT00611247|583948551|FG000|Overall Study|Lack of Efficacy|1|||
161699688|NCT00611247|583948552|FG001|Overall Study|Lack of Efficacy|16|||
161699689|NCT02551159|583948553|FG000|Overall Study|Death|352|||
161699690|NCT02551159|583948554|FG001|Overall Study|Death|174|||
161699691|NCT02551159|583948555|FG002|Overall Study|Death|161|||
161699692|NCT02551159|583948553|FG000|Overall Study|Withdrawal by Subject|8|||
161699693|NCT02551159|583948554|FG001|Overall Study|Withdrawal by Subject|5|||
161699694|NCT02551159|583948555|FG002|Overall Study|Withdrawal by Subject|16|||
161699695|NCT02551159|583948553|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
161699696|NCT02551159|583948554|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
161699697|NCT02551159|583948555|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
161699698|NCT00243659|583948556|FG000|Overall Study|Withdrawal by Subject|1|||
161699699|NCT00243659|583948557|FG001|Overall Study|Withdrawal by Subject|1|||
161699700|NCT00243659|583948556|FG000|Overall Study|Protocol Violation|1|||
161699701|NCT00243659|583948557|FG001|Overall Study|Protocol Violation|2|||
161699702|NCT00268242|583948563|FG000|Overall Study|Death|1|||
161699703|NCT02175680|583948565|FG000|Overall Study|non-compliance|1|||
161699704|NCT02175680|583948565|FG000|Overall Study|other non-medical reason|1|||
161699705|NCT01913483|583948566|FG000|Overall Study|Withdrawal by Subject|1|||
161699706|NCT01913483|583948567|FG001|Overall Study|Withdrawal by Subject|2|||
161699707|NCT01913483|583948566|FG000|Overall Study|Lost to Follow-up|6|||
161699708|NCT01913483|583948567|FG001|Overall Study|Lost to Follow-up|3|||
161699709|NCT01913483|583948566|FG000|Overall Study|Death|14|||
161699710|NCT01913483|583948567|FG001|Overall Study|Death|17|||
161699711|NCT03969888|583948568|FG000|Overall Study|Never Received Study Drug|0|||
161699712|NCT03969888|583948569|FG001|Overall Study|Never Received Study Drug|0|||
161699713|NCT03969888|583948570|FG002|Overall Study|Never Received Study Drug|1|||
161699714|NCT03969888|583948571|FG003|Overall Study|Never Received Study Drug|0|||
161699715|NCT03969888|583948572|FG004|Overall Study|Never Received Study Drug|0|||
161699716|NCT03969888|583948573|FG005|Overall Study|Never Received Study Drug|0|||
161699717|NCT03969888|583948574|FG006|Overall Study|Never Received Study Drug|1|||
161699718|NCT03969888|583948575|FG007|Overall Study|Never Received Study Drug|0|||
161699719|NCT03969888|583948568|FG000|Overall Study|Reason Not Specified|0|||
161699720|NCT03969888|583948569|FG001|Overall Study|Reason Not Specified|0|||
161699721|NCT03969888|583948570|FG002|Overall Study|Reason Not Specified|0|||
161699722|NCT03969888|583948571|FG003|Overall Study|Reason Not Specified|0|||
161699723|NCT03969888|583948572|FG004|Overall Study|Reason Not Specified|0|||
161699724|NCT03969888|583948573|FG005|Overall Study|Reason Not Specified|0|||
161699725|NCT03969888|583948574|FG006|Overall Study|Reason Not Specified|0|||
161699726|NCT03969888|583948575|FG007|Overall Study|Reason Not Specified|1|||
161699727|NCT00464178|583948580|FG000|Overall Study|Protocol Violation|1|||
161699728|NCT00464178|583948580|FG000|Overall Study|Withdrawal by Subject|1|||
161699729|NCT04506294|583948583|FG000|Overall Study|Lost to Follow-up|70|||
161699730|NCT04506294|583948584|FG001|Overall Study|Lost to Follow-up|20|||
161699731|NCT04506294|583948583|FG000|Overall Study|Withdrawal by Subject|16|||
161699732|NCT04506294|583948584|FG001|Overall Study|Withdrawal by Subject|2|||
161699733|NCT01469000|583948586|FG000|Overall Study|Withdrawal by Subject|16|||
161699734|NCT01469000|583948587|FG001|Overall Study|Withdrawal by Subject|3|||
161699735|NCT01469000|583948586|FG000|Overall Study|Sponsor Decision|4|||
161699736|NCT01469000|583948587|FG001|Overall Study|Sponsor Decision|1|||
161699737|NCT00769119|583948590|FG000|Overall Study|Voluntary discontinuation|0|||
161699738|NCT00769119|583948591|FG001|Overall Study|Voluntary discontinuation|2|||
161699739|NCT00769119|583948590|FG000|Overall Study|Adverse Event|1|||
161699740|NCT00769119|583948591|FG001|Overall Study|Adverse Event|1|||
161699741|NCT00769119|583948590|FG000|Overall Study|Disallowed medication|1|||
161699742|NCT00769119|583948591|FG001|Overall Study|Disallowed medication|0|||
161699743|NCT01116544|583948594|FG000|Overall Study|Protocol Violation|1|||
161699744|NCT01116544|583948595|FG001|Overall Study|Protocol Violation|0|||
161699745|NCT01116544|583948594|FG000|Overall Study|Withdrawal by Subject|1|||
161699746|NCT01116544|583948595|FG001|Overall Study|Withdrawal by Subject|1|||
161699747|NCT05168267|583948596|FG000|Overall Study|Withdrawal by Subject|2|||
161699748|NCT05168267|583948597|FG001|Overall Study|Withdrawal by Subject|1|||
161699749|NCT05168267|583948596|FG000|Overall Study|Withdrawn by Therapist|1|||
161699750|NCT05168267|583948597|FG001|Overall Study|Withdrawn by Therapist|1|||
161699751|NCT05168267|583948596|FG000|Overall Study|Left Facility|1|||
161699752|NCT05168267|583948597|FG001|Overall Study|Left Facility|0|||
161699753|NCT02419508|583948598|FG000|Overall Study|Adverse Event|9|||
161699754|NCT02419508|583948599|FG001|Overall Study|Adverse Event|3|||
161699755|NCT02419508|583948598|FG000|Overall Study|Withdrawal by Subject|1|||
161699756|NCT02419508|583948599|FG001|Overall Study|Withdrawal by Subject|0|||
161699757|NCT02419508|583948598|FG000|Overall Study|Other - Reason not specified|0|||
161699758|NCT02419508|583948599|FG001|Overall Study|Other - Reason not specified|1|||
161699759|NCT01738971|583948602|FG000|Overall Study|Lost to Follow-up|19|||
161699760|NCT01738971|583948603|FG001|Overall Study|Lost to Follow-up|30|||
161699761|NCT01738971|583948604|FG002|Overall Study|Lost to Follow-up|17|||
161699762|NCT04698629|583948616|FG000|Overall Study|Adverse Event|1|||
161699763|NCT02949128|583950968|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
161699764|NCT02949128|583950968|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
161699765|NCT02949128|583950968|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
161699766|NCT02949128|583950968|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
161699767|NCT02949128|583950968|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
161699768|NCT02949128|583950968|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
161699769|NCT02949128|583950968|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
161699770|NCT02949128|583950968|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
161699771|NCT02949128|583950968|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
161699772|NCT02949128|583950968|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
161699773|NCT00670007|583950975|FG000|Overall Study|Drug abuse|1|||
161699774|NCT00670007|583950975|FG000|Overall Study|Lung transplant|1|||
161699775|NCT00670007|583950975|FG000|Overall Study|Travel/Vacation|1|||
161699776|NCT00670007|583950975|FG000|Overall Study|Adverse event, serious fatal|1|||
161699777|NCT00670007|583950975|FG000|Overall Study|Adverse Event|1|||
161699778|NCT00670007|583950975|FG000|Overall Study|Withdrawal by Subject|4|||
161699779|NCT00618722|583950976|FG000|Overall Study|Refusal of Treatment|0|||
161699780|NCT00618722|583950977|FG001|Overall Study|Refusal of Treatment|0|||
161699781|NCT00618722|583950978|FG002|Overall Study|Refusal of Treatment|1|||
161699782|NCT00618722|583950979|FG003|Overall Study|Refusal of Treatment|0|||
161699783|NCT00618722|583950976|FG000|Overall Study|Patient Request|1|||
161699784|NCT00618722|583950977|FG001|Overall Study|Patient Request|1|||
161699785|NCT00618722|583950978|FG002|Overall Study|Patient Request|1|||
161699786|NCT00618722|583950979|FG003|Overall Study|Patient Request|1|||
161699787|NCT00618722|583950976|FG000|Overall Study|Inability to Complete Study Procedure|0|||
161699788|NCT00618722|583950977|FG001|Overall Study|Inability to Complete Study Procedure|1|||
161699789|NCT00618722|583950978|FG002|Overall Study|Inability to Complete Study Procedure|0|||
161699790|NCT00618722|583950979|FG003|Overall Study|Inability to Complete Study Procedure|0|||
161699791|NCT00618722|583950976|FG000|Overall Study|Lost to Follow-up|2|||
161699792|NCT00618722|583950977|FG001|Overall Study|Lost to Follow-up|0|||
161699793|NCT00618722|583950978|FG002|Overall Study|Lost to Follow-up|0|||
161699794|NCT00618722|583950979|FG003|Overall Study|Lost to Follow-up|2|||
161699795|NCT00618722|583950976|FG000|Overall Study|Miscellaneous Reasons|0|||
161836825|NCT01583218|584445041|FG000|Overall Study|Patient was randomized due to mistake|1|||
161836826|NCT01583218|584445042|FG001|Overall Study|Patient was randomized due to mistake|0|||
161699796|NCT00618722|583950977|FG001|Overall Study|Miscellaneous Reasons|0|||
161699797|NCT00618722|583950978|FG002|Overall Study|Miscellaneous Reasons|1|||
161699798|NCT00618722|583950979|FG003|Overall Study|Miscellaneous Reasons|1|||
161699799|NCT00925600|583950980|FG000|Overall Study|Withdrawal by Subject|16|||
161699800|NCT00925600|583950981|FG001|Overall Study|Withdrawal by Subject|14|||
161699801|NCT00925600|583950980|FG000|Overall Study|Death|4|||
161699802|NCT00925600|583950981|FG001|Overall Study|Death|3|||
161699803|NCT00925600|583950980|FG000|Overall Study|Lost to Follow-up|2|||
161699804|NCT00925600|583950981|FG001|Overall Study|Lost to Follow-up|2|||
161699805|NCT00925600|583950980|FG000|Overall Study|Disease Progression|1|||
161699806|NCT00925600|583950981|FG001|Overall Study|Disease Progression|3|||
161699807|NCT00925600|583950980|FG000|Overall Study|Administrative Decision|1|||
161699808|NCT00925600|583950981|FG001|Overall Study|Administrative Decision|1|||
161699809|NCT00925600|583950980|FG000|Overall Study|Noncompliance|2|||
161699810|NCT00925600|583950981|FG001|Overall Study|Noncompliance|0|||
161699811|NCT00925600|583950980|FG000|Overall Study|Ineligibility Determined|2|||
161699812|NCT00925600|583950981|FG001|Overall Study|Ineligibility Determined|0|||
161699813|NCT00925600|583950980|FG000|Overall Study|Protocol Deviation|0|||
161699814|NCT00925600|583950981|FG001|Overall Study|Protocol Deviation|1|||
161699815|NCT00925600|583950980|FG000|Overall Study|Requirement for Alternative Therapy|0|||
161699816|NCT00925600|583950981|FG001|Overall Study|Requirement for Alternative Therapy|1|||
161699817|NCT00925600|583950980|FG000|Overall Study|Other|3|||
161699818|NCT00925600|583950981|FG001|Overall Study|Other|1|||
161699819|NCT00925600|583950980|FG000|Overall Study|Adverse Event|1|||
161699820|NCT00925600|583950981|FG001|Overall Study|Adverse Event|2|||
161699821|NCT00127127|583950986|FG000|Overall Study|Adverse Event|0|||
161699822|NCT00127127|583950987|FG001|Overall Study|Adverse Event|2|||
161699823|NCT00127127|583950988|FG002|Overall Study|Adverse Event|0|||
161699824|NCT00127127|583950989|FG003|Overall Study|Adverse Event|1|||
161699825|NCT00127127|583950986|FG000|Overall Study|Lack of Efficacy|1|||
161699826|NCT00127127|583950987|FG001|Overall Study|Lack of Efficacy|3|||
161699827|NCT00127127|583950988|FG002|Overall Study|Lack of Efficacy|0|||
161699828|NCT00127127|583950989|FG003|Overall Study|Lack of Efficacy|2|||
161699829|NCT00200057|583950990|FG000|Overall Study|Lack of Efficacy|3|||
161699830|NCT00200057|583950990|FG000|Overall Study|Exited due to terminal illness of PI|2|||
161699831|NCT00200057|583950990|FG000|Overall Study|Withdrawal by Subject|1|||
161699832|NCT00200057|583950990|FG000|Overall Study|Change in medical condition|1|||
161699833|NCT00200057|583950990|FG000|Overall Study|Infection|1|||
161699834|NCT00200057|583950990|FG000|Overall Study|Death|1|||
161699835|NCT01059448|583950992|FG000|Overall Study|Adverse Event|1|||
161699836|NCT01059448|583950993|FG001|Overall Study|Adverse Event|3|||
161699837|NCT01059448|583950994|FG002|Overall Study|Adverse Event|0|||
161699838|NCT01059448|583950995|FG003|Overall Study|Adverse Event|1|||
161699839|NCT01059448|583950992|FG000|Overall Study|Withdrawal by Subject|2|||
161699840|NCT01059448|583950993|FG001|Overall Study|Withdrawal by Subject|0|||
161699841|NCT01059448|583950994|FG002|Overall Study|Withdrawal by Subject|2|||
161699842|NCT01059448|583950995|FG003|Overall Study|Withdrawal by Subject|4|||
161699843|NCT01059448|583950992|FG000|Overall Study|Disease Progression|2|||
161699844|NCT01059448|583950993|FG001|Overall Study|Disease Progression|1|||
161699845|NCT01059448|583950994|FG002|Overall Study|Disease Progression|4|||
161699846|NCT01059448|583950995|FG003|Overall Study|Disease Progression|2|||
161699847|NCT01059448|583950992|FG000|Overall Study|Administrative Decision|43|||
161699848|NCT01059448|583950993|FG001|Overall Study|Administrative Decision|49|||
161699849|NCT01059448|583950994|FG002|Overall Study|Administrative Decision|45|||
161699850|NCT01059448|583950995|FG003|Overall Study|Administrative Decision|46|||
161699851|NCT01059448|583950992|FG000|Overall Study|Lost to Follow-up|0|||
161699852|NCT01059448|583950993|FG001|Overall Study|Lost to Follow-up|0|||
161699853|NCT01059448|583950994|FG002|Overall Study|Lost to Follow-up|2|||
161699854|NCT01059448|583950995|FG003|Overall Study|Lost to Follow-up|0|||
161699855|NCT01059448|583950992|FG000|Overall Study|Death|0|||
161699856|NCT01059448|583950993|FG001|Overall Study|Death|1|||
161699857|NCT01059448|583950994|FG002|Overall Study|Death|0|||
161699858|NCT01059448|583950995|FG003|Overall Study|Death|0|||
161699859|NCT01059448|583950992|FG000|Overall Study|Other|1|||
161699860|NCT01059448|583950993|FG001|Overall Study|Other|1|||
161836827|NCT01583218|584445041|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
161836828|NCT01583218|584445042|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
161836829|NCT01583218|584445041|FG000|Overall Study|Withdraw of consent on day of random|1|||
161836830|NCT01583218|584445042|FG001|Overall Study|Withdraw of consent on day of random|0|||
161836831|NCT02013375|584445045|FG000|Overall Study|Did not engraft|1|||
161836832|NCT02013375|584445045|FG000|Overall Study|Did not engraft|1|||
161836833|NCT00712985|584445046|FG000|Overall Study|1 withdrew prior to start of drug|1|||
161836834|NCT00712985|584445046|FG000|Overall Study|1 patient moved out of state|1|||
161836835|NCT00712985|584445046|FG000|Overall Study|Lack of Efficacy|3|||
161836836|NCT02674061|584445047|FG000|Overall Study|Death|229|||
161836837|NCT02674061|584445048|FG001|Overall Study|Death|77|||
161836838|NCT02674061|584445047|FG000|Overall Study|Lost to Follow-up|3|||
161836839|NCT02674061|584445048|FG001|Overall Study|Lost to Follow-up|3|||
162030803|NCT03400956|585169491|FG001|Treatment Period 1|Protocol Violation|2|||
161699861|NCT01059448|583950994|FG002|Overall Study|Other|0|||
162030804|NCT03400956|585169492|FG002|Treatment Period 1|Protocol Violation|0|||
161699862|NCT01059448|583950995|FG003|Overall Study|Other|1|||
161699863|NCT00778830|583950996|FG000|Overall Study|Ongoing at data cut-off|0|||
161699864|NCT00778830|583950997|FG001|Overall Study|Ongoing at data cut-off|1|||
161699865|NCT05512949|583950998|FG000|Overall Study|Lost to Follow-up|4|||
161699866|NCT05512949|583950999|FG001|Overall Study|Lost to Follow-up|6|||
161699867|NCT05512949|583951000|FG002|Overall Study|Lost to Follow-up|2|||
161699868|NCT05512949|583950998|FG000|Overall Study|Protocol Violation|0|||
161699869|NCT05512949|583950999|FG001|Overall Study|Protocol Violation|0|||
161699870|NCT05512949|583951000|FG002|Overall Study|Protocol Violation|1|||
161699871|NCT05512949|583950998|FG000|Overall Study|Withdrawal by Subject|1|||
161699872|NCT05512949|583950999|FG001|Overall Study|Withdrawal by Subject|1|||
161699873|NCT05512949|583951000|FG002|Overall Study|Withdrawal by Subject|2|||
161699874|NCT05512949|583950998|FG000|Overall Study|Completion status unknown|1|||
161699875|NCT05512949|583950999|FG001|Overall Study|Completion status unknown|3|||
161699876|NCT05512949|583951000|FG002|Overall Study|Completion status unknown|0|||
161699877|NCT01891643|583951001|FG000|Overall Study|Adverse event unrelated to study drug|2|||
161699878|NCT01891643|583951002|FG001|Overall Study|Adverse event unrelated to study drug|5|||
161699879|NCT01891643|583951001|FG000|Overall Study|Disease Progression|4|||
161699880|NCT01891643|583951002|FG001|Overall Study|Disease Progression|3|||
161699881|NCT01891643|583951001|FG000|Overall Study|Study Drug Toxicity|3|||
161699882|NCT01891643|583951002|FG001|Overall Study|Study Drug Toxicity|0|||
161699883|NCT01891643|583951001|FG000|Overall Study|Maximum Clinical Benefit|0|||
161699884|NCT01891643|583951002|FG001|Overall Study|Maximum Clinical Benefit|1|||
161699885|NCT01891643|583951001|FG000|Overall Study|Poor/Non-compliance|0|||
161699886|NCT01891643|583951002|FG001|Overall Study|Poor/Non-compliance|1|||
161699887|NCT01891643|583951001|FG000|Overall Study|Participant request to discontinue|1|||
161699888|NCT01891643|583951002|FG001|Overall Study|Participant request to discontinue|0|||
161699889|NCT04047797|583951005|FG000|Overall Study|Progressive Disease|1|||
161699890|NCT01430442|583951006|FG000|Overall Study|Subject Withdrew Consent|3|||
161699891|NCT01430442|583951007|FG001|Overall Study|Subject Withdrew Consent|0|||
161699892|NCT01430442|583951008|FG002|Overall Study|Subject Withdrew Consent|1|||
161699893|NCT01430442|583951009|FG003|Overall Study|Subject Withdrew Consent|0|||
161699894|NCT01430442|583951010|FG004|Overall Study|Subject Withdrew Consent|2|||
161699895|NCT01430442|583951011|FG005|Overall Study|Subject Withdrew Consent|1|||
161699896|NCT01430442|583951012|FG006|Overall Study|Subject Withdrew Consent|5|||
161699897|NCT01430442|583951013|FG007|Overall Study|Subject Withdrew Consent|2|||
161699898|NCT01430442|583951006|FG000|Overall Study|Lost to Follow-up|2|||
161699899|NCT01430442|583951007|FG001|Overall Study|Lost to Follow-up|0|||
161699900|NCT01430442|583951008|FG002|Overall Study|Lost to Follow-up|1|||
161699901|NCT01430442|583951009|FG003|Overall Study|Lost to Follow-up|2|||
161699902|NCT01430442|583951010|FG004|Overall Study|Lost to Follow-up|2|||
161699903|NCT01430442|583951011|FG005|Overall Study|Lost to Follow-up|1|||
161699904|NCT01430442|583951012|FG006|Overall Study|Lost to Follow-up|5|||
161699905|NCT01430442|583951013|FG007|Overall Study|Lost to Follow-up|1|||
161699906|NCT01430442|583951006|FG000|Overall Study|Pregnancy|1|||
161699907|NCT01430442|583951007|FG001|Overall Study|Pregnancy|0|||
161699908|NCT01430442|583951008|FG002|Overall Study|Pregnancy|0|||
161699909|NCT01430442|583951009|FG003|Overall Study|Pregnancy|0|||
161699910|NCT01430442|583951010|FG004|Overall Study|Pregnancy|0|||
161699911|NCT01430442|583951011|FG005|Overall Study|Pregnancy|1|||
161699912|NCT01430442|583951012|FG006|Overall Study|Pregnancy|0|||
161699913|NCT01430442|583951013|FG007|Overall Study|Pregnancy|0|||
161699914|NCT01430442|583951006|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
161699915|NCT01430442|583951007|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
161699916|NCT01430442|583951008|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
161699917|NCT01430442|583951009|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
161699918|NCT01430442|583951010|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
161699919|NCT01430442|583951011|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
161699920|NCT01430442|583951012|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
161699921|NCT01430442|583951013|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
161699922|NCT00772629|583951015|FG000|Overall Study|Subject was not vaccinated|1|||
161699923|NCT00772629|583951016|FG001|Overall Study|Subject was not vaccinated|0|||
161836840|NCT02674061|584445047|FG000|Overall Study|Withdrawal by Subject|9|||
161836841|NCT02674061|584445048|FG001|Overall Study|Withdrawal by Subject|1|||
161836842|NCT02674061|584445047|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
161836843|NCT02674061|584445048|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
161836844|NCT03334721|584445051|FG000|Overall Study|Withdrawal by Subject|1|||
161836845|NCT03334721|584445052|FG001|Overall Study|Withdrawal by Subject|0|||
161836846|NCT03334721|584445051|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
162030805|NCT03400956|585169490|FG000|Treatment Period 1|Study terminated by sponsor|3|||
162030806|NCT03400956|585169491|FG001|Treatment Period 1|Study terminated by sponsor|1|||
161699924|NCT00947531|583951025|FG000|Overall Study|Withdrawal by Subject|10|||
161699925|NCT00947531|583951026|FG001|Overall Study|Withdrawal by Subject|7|||
161699926|NCT00947531|583951025|FG000|Overall Study|Administrative Reason|0|||
161699927|NCT00947531|583951026|FG001|Overall Study|Administrative Reason|1|||
161699928|NCT00947531|583951025|FG000|Overall Study|Adverse Event|2|||
161699929|NCT00947531|583951026|FG001|Overall Study|Adverse Event|2|||
161699930|NCT00947531|583951025|FG000|Overall Study|Lack of Efficacy|1|||
161699931|NCT00947531|583951026|FG001|Overall Study|Lack of Efficacy|0|||
161699932|NCT00947531|583951025|FG000|Overall Study|Other|1|||
161836847|NCT03334721|584445052|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
161699933|NCT00947531|583951026|FG001|Overall Study|Other|1|||
161699934|NCT02327260|583951027|FG000|Overall Study|Lost to Follow-up|2|||
161699935|NCT02327260|583951028|FG001|Overall Study|Lost to Follow-up|3|||
161699936|NCT02327260|583951029|FG002|Overall Study|Lost to Follow-up|2|||
161699937|NCT02327260|583951027|FG000|Overall Study|invalid phone number|1|||
161699938|NCT02327260|583951028|FG001|Overall Study|invalid phone number|1|||
161699939|NCT02327260|583951029|FG002|Overall Study|invalid phone number|0|||
161699940|NCT02327260|583951027|FG000|Overall Study|non-adherence to protocol|2|||
161699941|NCT02327260|583951028|FG001|Overall Study|non-adherence to protocol|0|||
161699942|NCT02327260|583951029|FG002|Overall Study|non-adherence to protocol|0|||
161699943|NCT02327260|583951027|FG000|Overall Study|cognitive concerns|1|||
161699944|NCT02327260|583951028|FG001|Overall Study|cognitive concerns|0|||
161699945|NCT02327260|583951029|FG002|Overall Study|cognitive concerns|0|||
161699946|NCT03502330|583951030|FG000|Overall Study|Adverse Event|2|||
161699947|NCT03502330|583951031|FG001|Overall Study|Adverse Event|1|||
161699948|NCT03502330|583951032|FG002|Overall Study|Adverse Event|0|||
161699949|NCT03502330|583951033|FG003|Overall Study|Adverse Event|0|||
161699950|NCT03502330|583951034|FG004|Overall Study|Adverse Event|1|||
161699951|NCT03502330|583951035|FG005|Overall Study|Adverse Event|0|||
161699952|NCT03502330|583951036|FG006|Overall Study|Adverse Event|1|||
161699953|NCT03502330|583951037|FG007|Overall Study|Adverse Event|1|||
161699954|NCT03502330|583951038|FG008|Overall Study|Adverse Event|0|||
161699955|NCT03502330|583951030|FG000|Overall Study|Lack of Efficacy|1|||
161699956|NCT03502330|583951031|FG001|Overall Study|Lack of Efficacy|5|||
161699957|NCT03502330|583951032|FG002|Overall Study|Lack of Efficacy|3|||
161699958|NCT03502330|583951033|FG003|Overall Study|Lack of Efficacy|5|||
161699959|NCT03502330|583951034|FG004|Overall Study|Lack of Efficacy|1|||
161699960|NCT03502330|583951035|FG005|Overall Study|Lack of Efficacy|5|||
161699961|NCT03502330|583951036|FG006|Overall Study|Lack of Efficacy|5|||
161699962|NCT03502330|583951037|FG007|Overall Study|Lack of Efficacy|6|||
161699963|NCT03502330|583951038|FG008|Overall Study|Lack of Efficacy|0|||
161699964|NCT03502330|583951030|FG000|Overall Study|Physician Decision|0|||
161699965|NCT03502330|583951031|FG001|Overall Study|Physician Decision|0|||
161699966|NCT03502330|583951032|FG002|Overall Study|Physician Decision|0|||
161699967|NCT03502330|583951033|FG003|Overall Study|Physician Decision|0|||
161699968|NCT03502330|583951034|FG004|Overall Study|Physician Decision|1|||
161699969|NCT03502330|583951035|FG005|Overall Study|Physician Decision|0|||
161699970|NCT03502330|583951036|FG006|Overall Study|Physician Decision|0|||
161699971|NCT03502330|583951037|FG007|Overall Study|Physician Decision|0|||
161699972|NCT03502330|583951038|FG008|Overall Study|Physician Decision|0|||
161699973|NCT03502330|583951030|FG000|Overall Study|Withdrawal by Subject|0|||
161699974|NCT03502330|583951031|FG001|Overall Study|Withdrawal by Subject|0|||
161699975|NCT03502330|583951032|FG002|Overall Study|Withdrawal by Subject|0|||
161699976|NCT03502330|583951033|FG003|Overall Study|Withdrawal by Subject|0|||
161699977|NCT03502330|583951034|FG004|Overall Study|Withdrawal by Subject|0|||
161699978|NCT03502330|583951035|FG005|Overall Study|Withdrawal by Subject|1|||
161699979|NCT03502330|583951036|FG006|Overall Study|Withdrawal by Subject|0|||
161699980|NCT03502330|583951037|FG007|Overall Study|Withdrawal by Subject|1|||
161699981|NCT03502330|583951038|FG008|Overall Study|Withdrawal by Subject|0|||
161699982|NCT03502330|583951030|FG000|Overall Study|Death|0|||
161699983|NCT03502330|583951031|FG001|Overall Study|Death|0|||
161699984|NCT03502330|583951032|FG002|Overall Study|Death|0|||
161699985|NCT03502330|583951033|FG003|Overall Study|Death|0|||
161699986|NCT03502330|583951034|FG004|Overall Study|Death|0|||
161699987|NCT03502330|583951035|FG005|Overall Study|Death|0|||
161699988|NCT03502330|583951036|FG006|Overall Study|Death|2|||
161699989|NCT03502330|583951037|FG007|Overall Study|Death|0|||
161699990|NCT03502330|583951038|FG008|Overall Study|Death|0|||
161699991|NCT02804763|583951039|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
161699992|NCT02804763|583951040|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
161699993|NCT02804763|583951041|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
161699994|NCT02804763|583951042|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
161699995|NCT02804763|583951039|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
161699996|NCT02804763|583951040|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
161699997|NCT02804763|583951041|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
161699998|NCT02804763|583951042|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
161699999|NCT02804763|583951039|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
161700000|NCT02804763|583951040|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
161700001|NCT02804763|583951041|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
161700002|NCT02804763|583951042|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
161700003|NCT02804763|583951039|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
161700004|NCT02804763|583951040|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
161700005|NCT02804763|583951041|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
161700006|NCT02804763|583951042|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
161700007|NCT02804763|583951039|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
161700008|NCT02804763|583951040|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
161700009|NCT02804763|583951041|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
161700010|NCT02804763|583951042|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
161836848|NCT01663727|584445054|FG000|Overall Study|Death|161|||
161700011|NCT02804763|583951039|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
161700012|NCT02804763|583951040|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
161700013|NCT02804763|583951041|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
161700014|NCT02804763|583951042|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
161700015|NCT05499520|583951043|FG000|Overall Study|Lost to Follow-up|0|||
161700016|NCT05499520|583951044|FG001|Overall Study|Lost to Follow-up|0|||
161700017|NCT05499520|583951045|FG002|Overall Study|Lost to Follow-up|38|||
161700018|NCT05499520|583951046|FG003|Overall Study|Lost to Follow-up|41|||
161700019|NCT05499520|583951047|FG004|Overall Study|Lost to Follow-up|46|||
161700020|NCT05499520|583951048|FG005|Overall Study|Lost to Follow-up|0|||
161700021|NCT05499520|583951049|FG006|Overall Study|Lost to Follow-up|31|||
161836849|NCT01663727|584445055|FG001|Overall Study|Death|155|||
161836850|NCT01663727|584445054|FG000|Overall Study|Lost to Follow-up|10|||
161836851|NCT01663727|584445055|FG001|Overall Study|Lost to Follow-up|8|||
161836852|NCT01663727|584445054|FG000|Overall Study|Withdrawal by Subject|18|||
161836853|NCT01663727|584445055|FG001|Overall Study|Withdrawal by Subject|25|||
161836854|NCT01663727|584445054|FG000|Overall Study|Study Terminated|51|||
161836855|NCT01663727|584445055|FG001|Overall Study|Study Terminated|50|||
161836856|NCT01663727|584445054|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
161836857|NCT01663727|584445055|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
161836858|NCT01663727|584445054|FG000|Overall Study|Withdrawal prior to dosing.|1|||
161836859|NCT01663727|584445055|FG001|Overall Study|Withdrawal prior to dosing.|0|||
161836860|NCT01902628|584445056|FG000|Overall Study|Withdrawal of participant's consent|7|||
161836861|NCT01902628|584445056|FG000|Overall Study|Adverse Event|41|||
161836862|NCT01902628|584445056|FG000|Overall Study|Lost to Follow-up|35|||
161836863|NCT01232491|584445057|FG000|Overall Study|Adverse Event|13|||
161836864|NCT01232491|584445058|FG001|Overall Study|Adverse Event|8|||
161836865|NCT01232491|584445057|FG000|Overall Study|Lack of Efficacy|1|||
161836866|NCT01232491|584445058|FG001|Overall Study|Lack of Efficacy|5|||
161836867|NCT01232491|584445057|FG000|Overall Study|Protocol Violation|13|||
161836868|NCT01232491|584445058|FG001|Overall Study|Protocol Violation|11|||
161836869|NCT01232491|584445057|FG000|Overall Study|Withdrawal Criteria|12|||
161836870|NCT01232491|584445058|FG001|Overall Study|Withdrawal Criteria|21|||
161836871|NCT01232491|584445057|FG000|Overall Study|Other|21|||
161836872|NCT01232491|584445058|FG001|Overall Study|Other|18|||
161836873|NCT02932228|584445059|FG000|Overall Study|Death|8|||
161836874|NCT02932228|584445060|FG001|Overall Study|Death|23|||
161836875|NCT02932228|584445059|FG000|Overall Study|not eligible upon chart review|2|||
161836876|NCT02932228|584445060|FG001|Overall Study|not eligible upon chart review|5|||
161957148|NCT00473889|584891092|FG000|Overall Study|Adverse Event|30|||
161957149|NCT00473889|584891093|FG001|Overall Study|Adverse Event|17|||
161957150|NCT00473889|584891092|FG000|Overall Study|Protocol Violation|4|||
161957151|NCT00473889|584891093|FG001|Overall Study|Protocol Violation|2|||
161957152|NCT00473889|584891092|FG000|Overall Study|Lack of Efficacy|28|||
161957153|NCT00473889|584891093|FG001|Overall Study|Lack of Efficacy|29|||
161957154|NCT00473889|584891092|FG000|Overall Study|Lost to Follow-up|2|||
161957155|NCT00473889|584891093|FG001|Overall Study|Lost to Follow-up|1|||
161957156|NCT00473889|584891092|FG000|Overall Study|Physician Decision|10|||
161957157|NCT00473889|584891093|FG001|Overall Study|Physician Decision|5|||
161957158|NCT00473889|584891092|FG000|Overall Study|Trial Terminated|3|||
161957159|NCT00473889|584891093|FG001|Overall Study|Trial Terminated|6|||
161957160|NCT00473889|584891092|FG000|Overall Study|Withdrawal by Subject|5|||
161957161|NCT00473889|584891093|FG001|Overall Study|Withdrawal by Subject|0|||
161957162|NCT02140970|584891094|FG000|Overall Study|Lost to Follow-up|1|||
161957163|NCT02140970|584891095|FG001|Overall Study|Lost to Follow-up|2|||
161957164|NCT02140970|584891094|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
161957165|NCT02140970|584891095|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
161957166|NCT02140970|584891094|FG000|Overall Study|Did not meet inclusion criteria|0|||
161957167|NCT02140970|584891095|FG001|Overall Study|Did not meet inclusion criteria|1|||
161957168|NCT00430989|584891099|FG000|Overall Study|Lost to Follow-up|2|||
161957169|NCT00430989|584891100|FG001|Overall Study|Lost to Follow-up|3|||
161957170|NCT00430989|584891099|FG000|Overall Study|Withdrawal by Subject|15|||
161957171|NCT00430989|584891100|FG001|Overall Study|Withdrawal by Subject|14|||
161957172|NCT00430989|584891099|FG000|Overall Study|Protocol Violation|30|||
161700022|NCT05499520|583951050|FG007|Overall Study|Lost to Follow-up|45|||
161957173|NCT00430989|584891100|FG001|Overall Study|Protocol Violation|37|||
161700023|NCT05499520|583951051|FG008|Overall Study|Lost to Follow-up|42|||
161700024|NCT05499520|583951052|FG009|Overall Study|Lost to Follow-up|0|||
161957174|NCT00430989|584891099|FG000|Overall Study|Not eligible|13|||
161957175|NCT00430989|584891100|FG001|Overall Study|Not eligible|6|||
161957176|NCT00460655|584891101|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
161957177|NCT00460655|584891102|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161957178|NCT00460655|584891103|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161957179|NCT00460655|584891104|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161957180|NCT00460655|584891101|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
161957181|NCT00460655|584891102|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161700025|NCT05499520|583951053|FG010|Overall Study|Lost to Follow-up|0|||
161700026|NCT05499520|583951054|FG011|Overall Study|Lost to Follow-up|37|||
161700027|NCT05499520|583951055|FG012|Overall Study|Lost to Follow-up|53|||
161700028|NCT05499520|583951056|FG013|Overall Study|Lost to Follow-up|49|||
161700029|NCT05499520|583951057|FG014|Overall Study|Lost to Follow-up|0|||
161700030|NCT05499520|583951058|FG015|Overall Study|Lost to Follow-up|36|||
161700031|NCT05499520|583951059|FG016|Overall Study|Lost to Follow-up|58|||
161700032|NCT05499520|583951060|FG017|Overall Study|Lost to Follow-up|53|||
161700033|NCT00605267|583951061|FG000|Overall Study|Adverse Event|0|||
161700034|NCT00605267|583951062|FG001|Overall Study|Adverse Event|1|||
161700035|NCT00605267|583951061|FG000|Overall Study|Lack of Efficacy|1|||
161700036|NCT00605267|583951062|FG001|Overall Study|Lack of Efficacy|5|||
161700037|NCT00605267|583951061|FG000|Overall Study|Withdrawal by Subject|2|||
161700038|NCT00605267|583951062|FG001|Overall Study|Withdrawal by Subject|3|||
161700039|NCT00793793|583951063|FG000|Overall Study|Adverse Event|0|||
161700040|NCT00793793|583951064|FG001|Overall Study|Adverse Event|0|||
161700041|NCT00793793|583951065|FG002|Overall Study|Adverse Event|1|||
161700042|NCT00793793|583951066|FG003|Overall Study|Adverse Event|1|||
161700043|NCT00793793|583951067|FG004|Overall Study|Adverse Event|0|||
161700044|NCT00793793|583951068|FG005|Overall Study|Adverse Event|1|||
161700045|NCT00793793|583951069|FG006|Overall Study|Adverse Event|2|||
161700046|NCT00793793|583951070|FG007|Overall Study|Adverse Event|0|||
161700047|NCT00793793|583951071|FG008|Overall Study|Adverse Event|0|||
161700048|NCT00793793|583951072|FG009|Overall Study|Adverse Event|0|||
161700049|NCT00793793|583951073|FG010|Overall Study|Adverse Event|0|||
161700050|NCT00793793|583951074|FG011|Overall Study|Adverse Event|2|||
161700051|NCT00793793|583951063|FG000|Overall Study|Protocol Violation|0|||
161700052|NCT00793793|583951064|FG001|Overall Study|Protocol Violation|0|||
161700053|NCT00793793|583951065|FG002|Overall Study|Protocol Violation|0|||
161700054|NCT00793793|583951066|FG003|Overall Study|Protocol Violation|1|||
161700055|NCT00793793|583951067|FG004|Overall Study|Protocol Violation|0|||
161700056|NCT00793793|583951068|FG005|Overall Study|Protocol Violation|0|||
161700057|NCT00793793|583951069|FG006|Overall Study|Protocol Violation|0|||
161700058|NCT00793793|583951070|FG007|Overall Study|Protocol Violation|0|||
161700059|NCT00793793|583951071|FG008|Overall Study|Protocol Violation|0|||
161700060|NCT00793793|583951072|FG009|Overall Study|Protocol Violation|0|||
161700061|NCT00793793|583951073|FG010|Overall Study|Protocol Violation|0|||
161700062|NCT00793793|583951074|FG011|Overall Study|Protocol Violation|0|||
161700063|NCT00793793|583951063|FG000|Overall Study|Lost to Follow-up|0|||
161700064|NCT00793793|583951064|FG001|Overall Study|Lost to Follow-up|0|||
161700065|NCT00793793|583951065|FG002|Overall Study|Lost to Follow-up|1|||
161700066|NCT00793793|583951066|FG003|Overall Study|Lost to Follow-up|0|||
161700067|NCT00793793|583951067|FG004|Overall Study|Lost to Follow-up|0|||
161700068|NCT00793793|583951068|FG005|Overall Study|Lost to Follow-up|0|||
161700069|NCT00793793|583951069|FG006|Overall Study|Lost to Follow-up|0|||
161700070|NCT00793793|583951070|FG007|Overall Study|Lost to Follow-up|0|||
161836877|NCT04062448|584446475|FG000|Overall Study|Lost to Follow-up|1|||
161836878|NCT04062448|584446475|FG000|Overall Study|Withdrawal by Subject|2|||
161836879|NCT04385277|584446476|FG000|Overall Study|Physician Decision|2|||
161836880|NCT04385277|584446476|FG000|Overall Study|Ineligible|1|||
161836881|NCT04385277|584446476|FG000|Overall Study|Patient/Parent Refusal|2|||
161836882|NCT04905290|584446477|FG000|Overall Study|Adverse Event|4|||
161700071|NCT00793793|583951071|FG008|Overall Study|Lost to Follow-up|1|||
161700072|NCT00793793|583951072|FG009|Overall Study|Lost to Follow-up|3|||
161700073|NCT00793793|583951073|FG010|Overall Study|Lost to Follow-up|1|||
161700074|NCT00793793|583951074|FG011|Overall Study|Lost to Follow-up|0|||
161700075|NCT00793793|583951063|FG000|Overall Study|Withdrawal by Subject|0|||
161700076|NCT00793793|583951064|FG001|Overall Study|Withdrawal by Subject|0|||
161700077|NCT00793793|583951065|FG002|Overall Study|Withdrawal by Subject|0|||
161700078|NCT00793793|583951066|FG003|Overall Study|Withdrawal by Subject|0|||
161700079|NCT00793793|583951067|FG004|Overall Study|Withdrawal by Subject|1|||
161700080|NCT00793793|583951068|FG005|Overall Study|Withdrawal by Subject|0|||
161700081|NCT00793793|583951069|FG006|Overall Study|Withdrawal by Subject|0|||
161700082|NCT00793793|583951070|FG007|Overall Study|Withdrawal by Subject|0|||
161700083|NCT00793793|583951071|FG008|Overall Study|Withdrawal by Subject|1|||
162030807|NCT03400956|585169492|FG002|Treatment Period 1|Study terminated by sponsor|1|||
161700084|NCT00793793|583951072|FG009|Overall Study|Withdrawal by Subject|0|||
161700085|NCT00793793|583951073|FG010|Overall Study|Withdrawal by Subject|0|||
161700086|NCT00793793|583951074|FG011|Overall Study|Withdrawal by Subject|0|||
161700087|NCT00793793|583951063|FG000|Overall Study|reason not specified|0|||
161700088|NCT00793793|583951064|FG001|Overall Study|reason not specified|1|||
161700089|NCT00793793|583951065|FG002|Overall Study|reason not specified|0|||
161700090|NCT00793793|583951066|FG003|Overall Study|reason not specified|1|||
161700091|NCT00793793|583951067|FG004|Overall Study|reason not specified|1|||
161700092|NCT00793793|583951068|FG005|Overall Study|reason not specified|1|||
161700093|NCT00793793|583951069|FG006|Overall Study|reason not specified|2|||
161700094|NCT00793793|583951070|FG007|Overall Study|reason not specified|0|||
161836883|NCT04905290|584446477|FG000|Overall Study|Death|2|||
161836884|NCT04905290|584446477|FG000|Overall Study|Withdrawal by Subject|4|||
161957182|NCT00460655|584891103|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161957183|NCT00460655|584891104|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161700095|NCT00793793|583951071|FG008|Overall Study|reason not specified|7|||
161700096|NCT00793793|583951072|FG009|Overall Study|reason not specified|6|||
161700097|NCT00793793|583951073|FG010|Overall Study|reason not specified|2|||
161700098|NCT00793793|583951074|FG011|Overall Study|reason not specified|4|||
161700099|NCT00840827|583951075|FG000|Overall Study|Adverse Event|1|||
161700100|NCT00840827|583951075|FG000|Overall Study|Lack of Efficacy|4|||
161700101|NCT00840827|583951075|FG000|Overall Study|Physician Decision|1|||
161700102|NCT01505894|583951077|FG000|Overall Study|Adverse Event|1|||
161700103|NCT01505894|583951078|FG001|Overall Study|Adverse Event|0|||
161700104|NCT01505894|583951079|FG002|Overall Study|Adverse Event|0|||
161700105|NCT01505894|583951080|FG003|Overall Study|Adverse Event|0|||
161700106|NCT01505894|583951081|FG004|Overall Study|Adverse Event|0|||
161700107|NCT01505894|583951082|FG005|Overall Study|Adverse Event|0|||
161700108|NCT01505894|583951083|FG006|Overall Study|Adverse Event|0|||
161700109|NCT01505894|583951084|FG007|Overall Study|Adverse Event|0|||
161700110|NCT01505894|583951085|FG008|Overall Study|Adverse Event|0|||
161700111|NCT01505894|583951077|FG000|Overall Study|Other than specified|0|||
161700112|NCT01505894|583951078|FG001|Overall Study|Other than specified|0|||
161700113|NCT01505894|583951079|FG002|Overall Study|Other than specified|0|||
161700114|NCT01505894|583951080|FG003|Overall Study|Other than specified|0|||
161700115|NCT01505894|583951081|FG004|Overall Study|Other than specified|1|||
161700116|NCT01505894|583951082|FG005|Overall Study|Other than specified|0|||
161700117|NCT01505894|583951083|FG006|Overall Study|Other than specified|0|||
161700118|NCT01505894|583951084|FG007|Overall Study|Other than specified|0|||
161700119|NCT01505894|583951085|FG008|Overall Study|Other than specified|0|||
161700120|NCT04088409|583951087|FG000|Part A|Withdrawal by Subject|2|||
161700121|NCT04088409|583951088|FG001|Part A|Withdrawal by Subject|1|||
161700122|NCT04088409|583951087|FG000|Part A|Did Not Meet Randomization Criteria|2|||
161700123|NCT04088409|583951088|FG001|Part A|Did Not Meet Randomization Criteria|0|||
161700124|NCT04088409|583951087|FG000|Part A|Lack of Efficacy|9|||
161700125|NCT04088409|583951088|FG001|Part A|Lack of Efficacy|0|||
161700126|NCT04088409|583951087|FG000|Part A|Lost to Follow-up|1|||
161700127|NCT04088409|583951088|FG001|Part A|Lost to Follow-up|0|||
161700128|NCT04088409|583951087|FG000|Part A|Adverse Event|1|||
161700129|NCT04088409|583951088|FG001|Part A|Adverse Event|0|||
161700130|NCT04088409|583951087|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
161700131|NCT04088409|583951088|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
161700132|NCT04088409|583951087|FG000|Part B|Ongoing Treatment|10|||
161700133|NCT04088409|583951088|FG001|Part B|Ongoing Treatment|0|||
161700134|NCT00648167|583951089|FG000|Overall Study|Adverse Event|6|||
161700135|NCT00648167|583951089|FG000|Overall Study|unable to swallow tablets|1|||
161700136|NCT00927368|583951090|FG000|Overall Study|enrollment in another study|1|||
161700137|NCT00927368|583951091|FG001|Overall Study|enrollment in another study|1|||
161700138|NCT00927368|583951092|FG002|Overall Study|enrollment in another study|2|||
161700139|NCT00927368|583951090|FG000|Overall Study|Lost to Follow-up|4|||
161700140|NCT00927368|583951091|FG001|Overall Study|Lost to Follow-up|0|||
161700141|NCT00927368|583951092|FG002|Overall Study|Lost to Follow-up|0|||
161700142|NCT00927368|583951090|FG000|Overall Study|equipment failure|1|||
161700143|NCT00927368|583951091|FG001|Overall Study|equipment failure|0|||
161700144|NCT00927368|583951092|FG002|Overall Study|equipment failure|0|||
161700145|NCT00927368|583951090|FG000|Overall Study|ineligible post randomization|0|||
161700146|NCT00927368|583951091|FG001|Overall Study|ineligible post randomization|3|||
161700147|NCT00927368|583951092|FG002|Overall Study|ineligible post randomization|1|||
161700148|NCT00927368|583951090|FG000|Overall Study|cancellation of surgery|0|||
161700149|NCT00927368|583951091|FG001|Overall Study|cancellation of surgery|1|||
161700150|NCT00927368|583951092|FG002|Overall Study|cancellation of surgery|2|||
161700151|NCT00191451|583951093|FG000|Overall Study|Withdrawal by Subject|2|||
161700152|NCT00191451|583951094|FG001|Overall Study|Withdrawal by Subject|3|||
161700153|NCT00191451|583951095|FG002|Overall Study|Withdrawal by Subject|5|||
161700154|NCT00191451|583951093|FG000|Overall Study|Physician Decision|2|||
161700155|NCT00191451|583951094|FG001|Overall Study|Physician Decision|9|||
161957184|NCT00460655|584891101|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
161700156|NCT00191451|583951095|FG002|Overall Study|Physician Decision|6|||
161700157|NCT00191451|583951093|FG000|Overall Study|Sponsor Decision|1|||
161700158|NCT00191451|583951094|FG001|Overall Study|Sponsor Decision|0|||
161700159|NCT00191451|583951095|FG002|Overall Study|Sponsor Decision|0|||
161700160|NCT00191451|583951093|FG000|Overall Study|Ineligible|0|||
161700161|NCT00191451|583951094|FG001|Overall Study|Ineligible|1|||
161700162|NCT00191451|583951095|FG002|Overall Study|Ineligible|0|||
161700163|NCT00191451|583951093|FG000|Overall Study|Reason Not Specified|2|||
161700164|NCT00191451|583951094|FG001|Overall Study|Reason Not Specified|1|||
161700165|NCT00191451|583951095|FG002|Overall Study|Reason Not Specified|3|||
161700166|NCT00272987|583951103|FG000|Overall Study|Adverse Event|1|||
161700167|NCT00272987|583951104|FG001|Overall Study|Adverse Event|0|||
161700168|NCT00272987|583951105|FG002|Overall Study|Adverse Event|0|||
161700169|NCT00272987|583951103|FG000|Overall Study|Lost to Follow-up|3|||
161836885|NCT04905290|584446477|FG000|Overall Study|Physician Decision|2|||
161836886|NCT04905290|584446477|FG000|Overall Study|Lost to Follow-up|2|||
161836887|NCT04905290|584446477|FG000|Overall Study|Screen Failure|2|||
161836888|NCT04905290|584446477|FG000|Overall Study|Unsuccessful Procedure|2|||
161957185|NCT00460655|584891102|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
161700170|NCT00272987|583951104|FG001|Overall Study|Lost to Follow-up|1|||
161700171|NCT00272987|583951105|FG002|Overall Study|Lost to Follow-up|1|||
161700172|NCT00272987|583951103|FG000|Overall Study|Withdrawal by Subject|1|||
161700173|NCT00272987|583951104|FG001|Overall Study|Withdrawal by Subject|0|||
161700174|NCT00272987|583951105|FG002|Overall Study|Withdrawal by Subject|3|||
161700175|NCT00272987|583951103|FG000|Overall Study|Sponsor Terminated study|0|||
161700176|NCT00272987|583951104|FG001|Overall Study|Sponsor Terminated study|1|||
161700177|NCT00272987|583951105|FG002|Overall Study|Sponsor Terminated study|1|||
161700178|NCT00272987|583951103|FG000|Overall Study|Disease progression|1|||
161700179|NCT00272987|583951104|FG001|Overall Study|Disease progression|1|||
161700180|NCT00272987|583951105|FG002|Overall Study|Disease progression|2|||
161700181|NCT00272987|583951103|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
161700182|NCT00272987|583951104|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
161700183|NCT00272987|583951105|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
161700184|NCT00272987|583951103|FG000|Overall Study|Death|1|||
161700185|NCT00272987|583951104|FG001|Overall Study|Death|0|||
161700186|NCT00272987|583951105|FG002|Overall Study|Death|0|||
161700187|NCT00331409|583951106|FG000|Overall Study|Lack of Efficacy|4|||
161700188|NCT01482910|583951107|FG000|Overall Study|Adverse Event|6|||
161700189|NCT01482910|583951108|FG001|Overall Study|Adverse Event|5|||
161700190|NCT01482910|583951107|FG000|Overall Study|Lost to Follow-up|0|||
161700191|NCT01482910|583951108|FG001|Overall Study|Lost to Follow-up|1|||
161700192|NCT01482910|583951107|FG000|Overall Study|Protocol Violation|1|||
161700193|NCT01482910|583951108|FG001|Overall Study|Protocol Violation|1|||
161700194|NCT01482910|583951107|FG000|Overall Study|Withdrawal by Subject|7|||
161700195|NCT01482910|583951108|FG001|Overall Study|Withdrawal by Subject|2|||
161700196|NCT01482910|583951107|FG000|Overall Study|Death|1|||
161700197|NCT01482910|583951108|FG001|Overall Study|Death|0|||
161700198|NCT02614079|583951112|FG000|Overall Study|Withdrawal by Subject|1|||
161700199|NCT03739528|583951115|FG000|Overall Study|Not treated|8|||
161700200|NCT03739528|583951116|FG001|Overall Study|Not treated|12|||
161700201|NCT03739528|583951115|FG000|Overall Study|Treatment and study discontinued|6|||
161700202|NCT03739528|583951116|FG001|Overall Study|Treatment and study discontinued|2|||
161700203|NCT03739528|583951115|FG000|Overall Study|Treatment discontinued + study completed|1|||
161700204|NCT03739528|583951116|FG001|Overall Study|Treatment discontinued + study completed|3|||
161700205|NCT01058096|583951117|FG000|Double-blind Treatment Phase|Adverse Event|11|||
161700206|NCT01058096|583951118|FG001|Double-blind Treatment Phase|Adverse Event|15|||
161700207|NCT01058096|583951117|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
161700208|NCT01058096|583951118|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
161700209|NCT01058096|583951117|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
161700210|NCT01058096|583951118|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
161700211|NCT01058096|583951117|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
161700212|NCT01058096|583951118|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
161700213|NCT01058096|583951117|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
161700214|NCT01058096|583951118|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
161700215|NCT01058096|583951117|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
161700216|NCT01058096|583951118|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
161700217|NCT05655377|583951119|FG000|Overall Study|Withdrawal by Subject|2|||
161700218|NCT04451330|583951120|FG000|Overall Study|Adverse Event|1|||
161700219|NCT04451330|583951121|FG001|Overall Study|Adverse Event|2|||
161700220|NCT04451330|583951120|FG000|Overall Study|Lost to Follow-up|5|||
161700221|NCT04451330|583951121|FG001|Overall Study|Lost to Follow-up|0|||
161700222|NCT04451330|583951120|FG000|Overall Study|Withdrawal by Subject|3|||
161700223|NCT04451330|583951121|FG001|Overall Study|Withdrawal by Subject|1|||
161700224|NCT04451330|583951120|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161700225|NCT04451330|583951121|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161700226|NCT04451330|583951120|FG000|Overall Study|Other than specified|0|||
161957186|NCT00460655|584891103|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
161957187|NCT00460655|584891104|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
161957188|NCT00460655|584891101|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161700227|NCT04451330|583951121|FG001|Overall Study|Other than specified|1|||
161700228|NCT05099640|583951122|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
161700229|NCT05099640|583951123|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
161700230|NCT05099640|583951124|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
161700231|NCT05099640|583951122|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
161700232|NCT05099640|583951123|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
161957189|NCT00460655|584891102|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161700233|NCT05099640|583951124|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
161836889|NCT01045421|584446481|FG000|Phase 1|Progressive Disease|0|||
161700234|NCT05099640|583951122|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
161700235|NCT05099640|583951123|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
161700236|NCT05099640|583951124|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
161700237|NCT05099640|583951122|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
161700238|NCT05099640|583951123|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
161700239|NCT05099640|583951124|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
161700240|NCT05099640|583951122|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
161700241|NCT05099640|583951123|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
161700242|NCT05099640|583951124|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
161700243|NCT05099640|583951122|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
161700244|NCT05099640|583951123|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
161700245|NCT05099640|583951124|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
161700246|NCT00179959|583951125|FG000|Overall Study|Lost to Follow-up|3|||
161700247|NCT00179959|583951126|FG001|Overall Study|Lost to Follow-up|1|||
161700248|NCT00179959|583951125|FG000|Overall Study|Withdrawal by Subject|3|||
161700249|NCT00179959|583951126|FG001|Overall Study|Withdrawal by Subject|2|||
161700250|NCT01552681|583951131|FG000|Overall Study|Withdrawal by Subject|4|||
161700251|NCT01552681|583951132|FG001|Overall Study|Withdrawal by Subject|0|||
161700252|NCT01552681|583951131|FG000|Overall Study|Physician Decision|1|||
161700253|NCT01552681|583951132|FG001|Overall Study|Physician Decision|0|||
161700254|NCT01552681|583951131|FG000|Overall Study|Subject moved away|0|||
161700255|NCT01552681|583951132|FG001|Overall Study|Subject moved away|1|||
161700256|NCT03075163|583951133|FG000|Overall Study|not eligible for treatment limb|138|||
161700257|NCT03075163|583951134|FG001|Overall Study|not eligible for treatment limb|138|||
161700258|NCT00236080|583951135|FG000|Overall Study|Adverse Event|0|||
161700259|NCT00236080|583951136|FG001|Overall Study|Adverse Event|0|||
161700260|NCT00236080|583951137|FG002|Overall Study|Adverse Event|3|||
161700261|NCT00236080|583951138|FG003|Overall Study|Adverse Event|1|||
161700262|NCT00236080|583951139|FG004|Overall Study|Adverse Event|0|||
161700263|NCT00236080|583951135|FG000|Overall Study|Lost to Follow-up|0|||
161700264|NCT00236080|583951136|FG001|Overall Study|Lost to Follow-up|1|||
161700265|NCT00236080|583951137|FG002|Overall Study|Lost to Follow-up|0|||
161700266|NCT00236080|583951138|FG003|Overall Study|Lost to Follow-up|0|||
161700267|NCT00236080|583951139|FG004|Overall Study|Lost to Follow-up|0|||
161700268|NCT00236080|583951135|FG000|Overall Study|Physician Decision|1|||
161700269|NCT00236080|583951136|FG001|Overall Study|Physician Decision|0|||
161700270|NCT00236080|583951137|FG002|Overall Study|Physician Decision|1|||
161700271|NCT00236080|583951138|FG003|Overall Study|Physician Decision|1|||
161700272|NCT00236080|583951139|FG004|Overall Study|Physician Decision|1|||
161700273|NCT00236080|583951135|FG000|Overall Study|Withdrawal by Subject|1|||
161700274|NCT00236080|583951136|FG001|Overall Study|Withdrawal by Subject|0|||
161700275|NCT00236080|583951137|FG002|Overall Study|Withdrawal by Subject|0|||
161700276|NCT00236080|583951138|FG003|Overall Study|Withdrawal by Subject|0|||
161700277|NCT00236080|583951139|FG004|Overall Study|Withdrawal by Subject|0|||
161700278|NCT00236080|583951135|FG000|Overall Study|Miscellaneous|0|||
161700279|NCT00236080|583951136|FG001|Overall Study|Miscellaneous|0|||
161700280|NCT00236080|583951137|FG002|Overall Study|Miscellaneous|1|||
161700281|NCT00236080|583951138|FG003|Overall Study|Miscellaneous|0|||
161700282|NCT00236080|583951139|FG004|Overall Study|Miscellaneous|0|||
161700283|NCT01214044|583951140|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
161700284|NCT01214044|583951140|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
161700285|NCT01214044|583951140|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
161700286|NCT01214044|583951140|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
161700287|NCT01214044|583951140|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
161700288|NCT01214044|583951140|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
161700289|NCT04698525|583951141|FG000|Overall Study|Lost to Follow-up|1|||
161700290|NCT04698525|583951142|FG001|Overall Study|Lost to Follow-up|2|||
161700291|NCT04698525|583951141|FG000|Overall Study|Three suffered of Covid-19|2|||
161700292|NCT04698525|583951142|FG001|Overall Study|Three suffered of Covid-19|1|||
161700293|NCT01961544|583951143|FG000|Overall Study|Protocol Violation|1|||
161700294|NCT01961544|583951143|FG000|Overall Study|Withdrawal by Subject|7|||
161700295|NCT01961544|583951143|FG000|Overall Study|Adverse Event|1|||
161700296|NCT01961544|583951143|FG000|Overall Study|Physician Decision|2|||
161700297|NCT01961544|583951143|FG000|Overall Study|Poor Tolerance|1|||
161700298|NCT01961544|583951143|FG000|Overall Study|Aggravation of Steral Pain|1|||
161700299|NCT03157531|583951146|FG000|Overall Study|Death|2|||
161700300|NCT03157531|583951146|FG000|Overall Study|Lost to Follow-up|4|||
161700301|NCT02211261|583951154|FG000|Overall Study|Withdrawal by Subject|0|||
161700302|NCT02211261|583951155|FG001|Overall Study|Withdrawal by Subject|0|||
161700303|NCT02211261|583951156|FG002|Overall Study|Withdrawal by Subject|1|||
161700304|NCT02211261|583951157|FG003|Overall Study|Withdrawal by Subject|0|||
161700305|NCT02211261|583951158|FG004|Overall Study|Withdrawal by Subject|2|||
161700306|NCT02211261|583951159|FG005|Overall Study|Withdrawal by Subject|0|||
161700307|NCT02211261|583951160|FG006|Overall Study|Withdrawal by Subject|0|||
161700308|NCT02211261|583951161|FG007|Overall Study|Withdrawal by Subject|0|||
161700309|NCT02211261|583951162|FG008|Overall Study|Withdrawal by Subject|0|||
161700310|NCT02211261|583951163|FG009|Overall Study|Withdrawal by Subject|0|||
161700311|NCT02211261|583951164|FG010|Overall Study|Withdrawal by Subject|0|||
161700312|NCT02211261|583951154|FG000|Overall Study|Other|0|||
161700313|NCT02211261|583951155|FG001|Overall Study|Other|0|||
161700314|NCT02211261|583951156|FG002|Overall Study|Other|0|||
161700315|NCT02211261|583951157|FG003|Overall Study|Other|0|||
161700316|NCT02211261|583951158|FG004|Overall Study|Other|0|||
161700317|NCT02211261|583951159|FG005|Overall Study|Other|1|||
161700318|NCT02211261|583951160|FG006|Overall Study|Other|0|||
161700319|NCT02211261|583951161|FG007|Overall Study|Other|0|||
161700320|NCT02211261|583951162|FG008|Overall Study|Other|0|||
161700321|NCT02211261|583951163|FG009|Overall Study|Other|2|||
161700322|NCT02211261|583951164|FG010|Overall Study|Other|0|||
161700323|NCT02211261|583951154|FG000|Overall Study|Lost to Follow-up|0|||
161700324|NCT02211261|583951155|FG001|Overall Study|Lost to Follow-up|0|||
161700325|NCT02211261|583951156|FG002|Overall Study|Lost to Follow-up|0|||
161700326|NCT02211261|583951157|FG003|Overall Study|Lost to Follow-up|0|||
161700327|NCT02211261|583951158|FG004|Overall Study|Lost to Follow-up|0|||
161700328|NCT02211261|583951159|FG005|Overall Study|Lost to Follow-up|0|||
161700329|NCT02211261|583951160|FG006|Overall Study|Lost to Follow-up|0|||
161700330|NCT02211261|583951161|FG007|Overall Study|Lost to Follow-up|1|||
161700331|NCT02211261|583951162|FG008|Overall Study|Lost to Follow-up|0|||
161700332|NCT02211261|583951163|FG009|Overall Study|Lost to Follow-up|0|||
161700333|NCT02211261|583951164|FG010|Overall Study|Lost to Follow-up|0|||
161700334|NCT01573910|583951165|FG000|Overall Study|Adverse Event|4|||
161700335|NCT01573910|583951166|FG001|Overall Study|Adverse Event|4|||
161700336|NCT01573910|583951165|FG000|Overall Study|Lost to Follow-up|2|||
161700337|NCT01573910|583951166|FG001|Overall Study|Lost to Follow-up|1|||
161700338|NCT01573910|583951165|FG000|Overall Study|Withdrawal by Subject|0|||
161700339|NCT01573910|583951166|FG001|Overall Study|Withdrawal by Subject|1|||
161700340|NCT01573910|583951165|FG000|Overall Study|Protocol Violation|3|||
161700341|NCT01573910|583951166|FG001|Overall Study|Protocol Violation|0|||
161700342|NCT01573910|583951165|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
161700343|NCT01573910|583951166|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
161700344|NCT02251912|583951167|FG000|Overall Study|Withdrawal by Subject|2|||
161700345|NCT02251912|583951168|FG001|Overall Study|Withdrawal by Subject|3|||
161700346|NCT02251912|583951167|FG000|Overall Study|Adverse Event|0|||
161700347|NCT02251912|583951168|FG001|Overall Study|Adverse Event|2|||
161700348|NCT04062214|583951170|FG000|Week 12|Death|1|||
161700349|NCT04062214|583951171|FG001|Week 12|Death|1|||
161700350|NCT04062214|583951170|FG000|Week 12|Withdrawal by Subject|14|||
161700351|NCT04062214|583951171|FG001|Week 12|Withdrawal by Subject|13|||
161700352|NCT04062214|583951170|FG000|Week 12|Lost to Follow-up|55|||
161700353|NCT04062214|583951171|FG001|Week 12|Lost to Follow-up|68|||
161700354|NCT04062214|583951170|FG000|Week 12|Intermittent missing|31|||
161700355|NCT04062214|583951171|FG001|Week 12|Intermittent missing|29|||
161700356|NCT04062214|583951170|FG000|Week 36|Withdrawal by Subject|4|||
161700357|NCT04062214|583951171|FG001|Week 36|Withdrawal by Subject|5|||
161700358|NCT04062214|583951170|FG000|Week 36|Lost to Follow-up|50|||
161700359|NCT04062214|583951171|FG001|Week 36|Lost to Follow-up|46|||
161700360|NCT04062214|583951170|FG000|Week 36|Death|0|||
161700361|NCT04062214|583951171|FG001|Week 36|Death|1|||
161700362|NCT06228586|583951178|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
161700363|NCT06228586|583951179|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
161700364|NCT00865020|583951190|FG000|Overall Study|Withdrawal by Subject|22|||
161700365|NCT00865020|583951191|FG001|Overall Study|Withdrawal by Subject|16|||
161700366|NCT00865020|583951190|FG000|Overall Study|Adverse Event|9|||
161700367|NCT00865020|583951191|FG001|Overall Study|Adverse Event|14|||
161700368|NCT00865020|583951190|FG000|Overall Study|Abnormal test procedure result(s)|6|||
161700369|NCT00865020|583951191|FG001|Overall Study|Abnormal test procedure result(s)|8|||
161700370|NCT00865020|583951190|FG000|Overall Study|Lost to Follow-up|6|||
161700371|NCT00865020|583951191|FG001|Overall Study|Lost to Follow-up|4|||
161700372|NCT00865020|583951190|FG000|Overall Study|Protocol deviation|4|||
161700373|NCT00865020|583951191|FG001|Overall Study|Protocol deviation|1|||
161836890|NCT01045421|584446482|FG001|Phase 1|Progressive Disease|0|||
161836891|NCT01045421|584446483|FG002|Phase 1|Progressive Disease|0|||
161836892|NCT01045421|584446484|FG003|Phase 1|Progressive Disease|0|||
162030808|NCT03400956|585169490|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161700374|NCT00865020|583951190|FG000|Overall Study|Administrative problems|0|||
161700375|NCT00865020|583951191|FG001|Overall Study|Administrative problems|2|||
161700376|NCT00865020|583951190|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161700377|NCT00865020|583951191|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161700378|NCT00865020|583951190|FG000|Overall Study|Death|0|||
161700379|NCT00865020|583951191|FG001|Overall Study|Death|1|||
161700380|NCT00865020|583951190|FG000|Overall Study|Randomized but discontinued|2|||
161700381|NCT00865020|583951191|FG001|Overall Study|Randomized but discontinued|4|||
161700382|NCT00132041|583953421|FG000|Baseline|Ineligible|6|||
161700383|NCT00132041|583953421|FG000|3 Months Post Ablation|Transplant|1|||
161836893|NCT01045421|584446485|FG004|Phase 1|Progressive Disease|1|||
161957190|NCT00460655|584891103|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
161957191|NCT00460655|584891104|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
161957192|NCT00460655|584891101|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161957193|NCT00460655|584891102|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161957194|NCT00460655|584891103|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
161957195|NCT00460655|584891104|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
161957196|NCT00460655|584891101|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
161957197|NCT00460655|584891102|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
161957198|NCT00460655|584891103|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
161957199|NCT00460655|584891104|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
161957200|NCT00590122|584891105|FG000|Overall Study|swallowed oral dissolving dose|1|||
161957201|NCT00590122|584891106|FG001|Overall Study|swallowed oral dissolving dose|0|||
161957202|NCT03050450|584891107|FG000|Overall Study|Physician Decision|1|||
161957203|NCT03050450|584891108|FG001|Overall Study|Physician Decision|0|||
161957204|NCT03050450|584891109|FG002|Overall Study|Physician Decision|0|||
161957205|NCT03050450|584891110|FG003|Overall Study|Physician Decision|0|||
161957206|NCT03050450|584891111|FG004|Overall Study|Physician Decision|0|||
161957207|NCT00735553|584891115|FG000|Overall Study|Study prematurely terminated|77|||
161957208|NCT02705105|584891116|FG000|Treatment|Objective Disease Progression|1|||
161957209|NCT02705105|584891117|FG001|Treatment|Objective Disease Progression|50|||
161957210|NCT02705105|584891116|FG000|Treatment|Withdrawal by Subject|3|||
161957211|NCT02705105|584891117|FG001|Treatment|Withdrawal by Subject|5|||
161957212|NCT02705105|584891116|FG000|Treatment|Adverse Event|0|||
161957213|NCT02705105|584891117|FG001|Treatment|Adverse Event|17|||
161957214|NCT02705105|584891116|FG000|Treatment|Clinical Disease Progression|0|||
161957215|NCT02705105|584891117|FG001|Treatment|Clinical Disease Progression|32|||
161957216|NCT02705105|584891116|FG000|Treatment|Physician Decision|0|||
161957217|NCT02705105|584891117|FG001|Treatment|Physician Decision|3|||
161957218|NCT02705105|584891116|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
161957219|NCT02705105|584891117|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
161957220|NCT02705105|584891116|FG000|Follow-Up|Death|3|||
161957221|NCT02705105|584891117|FG001|Follow-Up|Death|68|||
161957222|NCT02705105|584891116|FG000|Follow-Up|Withdrawal by Subject|1|||
161957223|NCT02705105|584891117|FG001|Follow-Up|Withdrawal by Subject|14|||
161957224|NCT02705105|584891116|FG000|Follow-Up|Study Terminated|0|||
161957225|NCT02705105|584891117|FG001|Follow-Up|Study Terminated|26|||
161700384|NCT00132041|583953421|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
161700385|NCT00132041|583953421|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
161700386|NCT00132041|583953421|FG000|6 Months Post Ablation|Death|2|||
161700387|NCT00132041|583953421|FG000|6 Months Post Ablation|Transplant|6|||
161700388|NCT00132041|583953421|FG000|9 Months Post Ablation|Death|1|||
161700389|NCT00132041|583953421|FG000|9 Months Post Ablation|Transplant|1|||
161700390|NCT00132041|583953421|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
161700391|NCT00132041|583953421|FG000|12 Months Post Ablation|Death|1|||
161700392|NCT00132041|583953421|FG000|12 Months Post Ablation|Transplant|1|||
161700393|NCT00132041|583953421|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
161700394|NCT00132041|583953421|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
161700395|NCT00132041|583953421|FG000|15 Months Post Ablation|Death|1|||
161700396|NCT00132041|583953421|FG000|15 Months Post Ablation|Transplant|5|||
161700397|NCT00132041|583953421|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
161700398|NCT00132041|583953421|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
161700399|NCT00132041|583953421|FG000|18 Months Post Ablation|Transplant|1|||
161700400|NCT00132041|583953421|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
161700401|NCT00132041|583953421|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
161700402|NCT01171820|583953423|FG000|Overall Study|Death|3|||
161700403|NCT01171820|583953424|FG001|Overall Study|Death|3|||
161700404|NCT01171820|583953423|FG000|Overall Study|Lost to Follow-up|0|||
161700405|NCT01171820|583953424|FG001|Overall Study|Lost to Follow-up|1|||
161700406|NCT01171820|583953423|FG000|Overall Study|Withdrawal by Subject|2|||
161700407|NCT01171820|583953424|FG001|Overall Study|Withdrawal by Subject|0|||
161700408|NCT01171820|583953423|FG000|Overall Study|Physician Decision|0|||
161700409|NCT01171820|583953424|FG001|Overall Study|Physician Decision|1|||
161700410|NCT01171820|583953423|FG000|Overall Study|1-Year Missed Visit|1|||
161700411|NCT01171820|583953424|FG001|Overall Study|1-Year Missed Visit|1|||
161700412|NCT03969875|583953425|FG000|Overall Study|did not receive allocated intervention|3|||
161700413|NCT03969875|583953426|FG001|Overall Study|did not receive allocated intervention|3|||
161700414|NCT03969875|583953427|FG002|Overall Study|did not receive allocated intervention|4|||
161700415|NCT03969875|583953425|FG000|Overall Study|Protocol Violation|4|||
161700416|NCT03969875|583953426|FG001|Overall Study|Protocol Violation|2|||
161700417|NCT03969875|583953427|FG002|Overall Study|Protocol Violation|2|||
161700418|NCT00167245|583953428|FG000|Overall Study|Lost to Follow-up|20|||
161700419|NCT00167245|583953429|FG001|Overall Study|Lost to Follow-up|31|||
161700420|NCT00167245|583953428|FG000|Overall Study|Withdrawal by Subject|5|||
161700421|NCT00167245|583953429|FG001|Overall Study|Withdrawal by Subject|8|||
161700422|NCT00167245|583953428|FG000|Overall Study|Incarcerated|3|||
161700423|NCT00167245|583953429|FG001|Overall Study|Incarcerated|2|||
161700424|NCT00167245|583953428|FG000|Overall Study|Drowsy|1|||
161700425|NCT00167245|583953429|FG001|Overall Study|Drowsy|0|||
161700426|NCT01871090|583953430|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
161700427|NCT01871090|583953431|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
161700428|NCT01871090|583953430|FG000|Overall Study|Interrogation not completed correctly|1|||
161700429|NCT01871090|583953431|FG001|Overall Study|Interrogation not completed correctly|0|||
161700430|NCT01871090|583953430|FG000|Overall Study|Subject Non-Compliance|0|||
161700431|NCT01871090|583953431|FG001|Overall Study|Subject Non-Compliance|1|||
161700432|NCT02911688|583953435|FG000|Washout|Lost to Follow-up|1|||
161700433|NCT02911688|583953436|FG001|Washout|Lost to Follow-up|1|||
161700434|NCT02911688|583953435|FG000|Washout|Withdrawal by Subject|0|||
161700435|NCT02911688|583953436|FG001|Washout|Withdrawal by Subject|1|||
161700436|NCT01307033|583953439|FG000|8-week Double-blind Period|Adverse Event|2|||
161700437|NCT01307033|583953440|FG001|8-week Double-blind Period|Adverse Event|0|||
162030809|NCT03400956|585169491|FG001|Treatment Period 1|Withdrawal by Subject|2|||
161700438|NCT01307033|583953441|FG002|8-week Double-blind Period|Adverse Event|0|||
161700439|NCT01307033|583953442|FG003|8-week Double-blind Period|Adverse Event|0|||
161700440|NCT01307033|583953439|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
161700441|NCT01307033|583953440|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
161700442|NCT01307033|583953441|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
161700443|NCT01307033|583953442|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
161700444|NCT01307033|583953439|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
161836894|NCT01045421|584446486|FG005|Phase 1|Progressive Disease|0|||
161700445|NCT01307033|583953440|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
161700446|NCT01307033|583953441|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
161700447|NCT01307033|583953442|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
161836895|NCT01045421|584446487|FG006|Phase 1|Progressive Disease|0|||
162030810|NCT03400956|585169492|FG002|Treatment Period 1|Withdrawal by Subject|4|||
161700448|NCT01307033|583953439|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
162030811|NCT03400956|585169490|FG000|Treatment Period 1|Other|1|||
161836896|NCT01045421|584446488|FG007|Phase 1|Progressive Disease|0|||
162030812|NCT03400956|585169491|FG001|Treatment Period 1|Other|2|||
161700449|NCT01307033|583953440|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
161700450|NCT01307033|583953441|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
161836897|NCT01045421|584446489|FG008|Phase 1|Progressive Disease|0|||
161700451|NCT01307033|583953442|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
161700452|NCT01307033|583953439|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
161700453|NCT01307033|583953440|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
161700454|NCT01307033|583953441|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
161700455|NCT01307033|583953442|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
161700456|NCT01307033|583953439|FG000|44-week Open-label Extension|Adverse Event|0|||
161700457|NCT01307033|583953440|FG001|44-week Open-label Extension|Adverse Event|0|||
161700458|NCT01307033|583953441|FG002|44-week Open-label Extension|Adverse Event|2|||
161700459|NCT01307033|583953442|FG003|44-week Open-label Extension|Adverse Event|1|||
161700460|NCT01307033|583953439|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
161700461|NCT01307033|583953440|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
161700462|NCT01307033|583953441|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
161700463|NCT01307033|583953442|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
161700464|NCT01307033|583953439|FG000|44-week Open-label Extension|Physician Decision|0|||
161700465|NCT01307033|583953440|FG001|44-week Open-label Extension|Physician Decision|0|||
161700466|NCT01307033|583953441|FG002|44-week Open-label Extension|Physician Decision|1|||
161700467|NCT01307033|583953442|FG003|44-week Open-label Extension|Physician Decision|0|||
161700468|NCT01307033|583953439|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
161700469|NCT01307033|583953440|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
161700470|NCT01307033|583953441|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
161700471|NCT01307033|583953442|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
161700472|NCT01307033|583953439|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
161836898|NCT01045421|584446490|FG009|Phase 1|Progressive Disease|0|||
161836899|NCT01045421|584446491|FG010|Phase 1|Progressive Disease|0|||
161836900|NCT01045421|584446481|FG000|Phase 1|Withdrawal by Subject|0|||
162030813|NCT03400956|585169492|FG002|Treatment Period 1|Other|3|||
161836901|NCT01045421|584446482|FG001|Phase 1|Withdrawal by Subject|0|||
161957226|NCT02705105|584891116|FG000|Follow-Up|Discontinued per Amendment 3|0|||
161700473|NCT01307033|583953440|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
161700474|NCT01307033|583953441|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
161700475|NCT01307033|583953442|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
161700476|NCT01307033|583953439|FG000|44-week Open-label Extension|Death|0|||
161700477|NCT01307033|583953440|FG001|44-week Open-label Extension|Death|0|||
161700478|NCT01307033|583953441|FG002|44-week Open-label Extension|Death|0|||
161700479|NCT01307033|583953442|FG003|44-week Open-label Extension|Death|1|||
161700480|NCT01773421|583953444|FG000|Treatment Phase|Other|0|||
161700481|NCT01773421|583953445|FG001|Treatment Phase|Other|0|||
161700482|NCT01773421|583953446|FG002|Treatment Phase|Other|2|||
161700483|NCT01773421|583953447|FG003|Treatment Phase|Other|0|||
161700484|NCT01773421|583953448|FG004|Treatment Phase|Other|0|||
161700485|NCT01773421|583953449|FG005|Treatment Phase|Other|0|||
161700486|NCT01773421|583953450|FG006|Treatment Phase|Other|0|||
161700487|NCT01773421|583953444|FG000|Treatment Phase|Adverse Event|0|||
161957227|NCT02705105|584891117|FG001|Follow-Up|Discontinued per Amendment 3|2|||
161957228|NCT02707965|584891118|FG000|Overall Study|Withdrawal by Subject|0|||
161957229|NCT02707965|584891119|FG001|Overall Study|Withdrawal by Subject|0|||
161957230|NCT02707965|584891120|FG002|Overall Study|Withdrawal by Subject|1|||
161957231|NCT02707965|584891121|FG003|Overall Study|Withdrawal by Subject|0|||
161957232|NCT02707965|584891122|FG004|Overall Study|Withdrawal by Subject|0|||
161957233|NCT02707965|584891123|FG005|Overall Study|Withdrawal by Subject|0|||
161957234|NCT02707965|584891124|FG006|Overall Study|Withdrawal by Subject|0|||
161957235|NCT02707965|584891125|FG007|Overall Study|Withdrawal by Subject|2|||
161957236|NCT02707965|584891126|FG008|Overall Study|Withdrawal by Subject|0|||
161957237|NCT02707965|584891127|FG009|Overall Study|Withdrawal by Subject|0|||
161957238|NCT02707965|584891128|FG010|Overall Study|Withdrawal by Subject|0|||
161957239|NCT02707965|584891129|FG011|Overall Study|Withdrawal by Subject|0|||
161957240|NCT02707965|584891130|FG012|Overall Study|Withdrawal by Subject|0|||
161957241|NCT02707965|584891131|FG013|Overall Study|Withdrawal by Subject|0|||
161957242|NCT02707965|584891132|FG014|Overall Study|Withdrawal by Subject|0|||
161957243|NCT02707965|584891133|FG015|Overall Study|Withdrawal by Subject|0|||
161957244|NCT02707965|584891118|FG000|Overall Study|PI decisions|0|||
161957245|NCT02707965|584891119|FG001|Overall Study|PI decisions|0|||
161957246|NCT02707965|584891120|FG002|Overall Study|PI decisions|0|||
161957247|NCT02707965|584891121|FG003|Overall Study|PI decisions|0|||
161957248|NCT02707965|584891122|FG004|Overall Study|PI decisions|0|||
161957249|NCT02707965|584891123|FG005|Overall Study|PI decisions|0|||
161957250|NCT02707965|584891124|FG006|Overall Study|PI decisions|0|||
161957251|NCT02707965|584891125|FG007|Overall Study|PI decisions|0|||
161957252|NCT02707965|584891126|FG008|Overall Study|PI decisions|0|||
161957253|NCT02707965|584891127|FG009|Overall Study|PI decisions|0|||
161957254|NCT02707965|584891128|FG010|Overall Study|PI decisions|0|||
161957255|NCT02707965|584891129|FG011|Overall Study|PI decisions|0|||
161957256|NCT02707965|584891130|FG012|Overall Study|PI decisions|0|||
161957257|NCT02707965|584891131|FG013|Overall Study|PI decisions|0|||
161957258|NCT02707965|584891132|FG014|Overall Study|PI decisions|2|||
161957259|NCT02707965|584891133|FG015|Overall Study|PI decisions|0|||
161957260|NCT02707965|584891118|FG000|Overall Study|Protocol deviation|1|||
161957261|NCT02707965|584891119|FG001|Overall Study|Protocol deviation|1|||
161957262|NCT02707965|584891120|FG002|Overall Study|Protocol deviation|0|||
161957263|NCT02707965|584891121|FG003|Overall Study|Protocol deviation|0|||
161957264|NCT02707965|584891122|FG004|Overall Study|Protocol deviation|0|||
161957265|NCT02707965|584891123|FG005|Overall Study|Protocol deviation|0|||
161957266|NCT02707965|584891124|FG006|Overall Study|Protocol deviation|0|||
161957267|NCT02707965|584891125|FG007|Overall Study|Protocol deviation|1|||
161957268|NCT02707965|584891126|FG008|Overall Study|Protocol deviation|0|||
161957269|NCT02707965|584891127|FG009|Overall Study|Protocol deviation|0|||
161957270|NCT02707965|584891128|FG010|Overall Study|Protocol deviation|0|||
161957271|NCT02707965|584891129|FG011|Overall Study|Protocol deviation|0|||
161957272|NCT02707965|584891130|FG012|Overall Study|Protocol deviation|0|||
161957273|NCT02707965|584891131|FG013|Overall Study|Protocol deviation|0|||
161957274|NCT02707965|584891132|FG014|Overall Study|Protocol deviation|0|||
161957275|NCT02707965|584891133|FG015|Overall Study|Protocol deviation|0|||
161957276|NCT00711594|584891135|FG000|Overall Study|Progressive disease|2|||
161957277|NCT00711594|584891136|FG001|Overall Study|Progressive disease|2|||
161957278|NCT00711594|584891137|FG002|Overall Study|Progressive disease|6|||
161957279|NCT00711594|584891138|FG003|Overall Study|Progressive disease|44|||
161957280|NCT00711594|584891135|FG000|Overall Study|Other Adverse Event|1|||
161957281|NCT00711594|584891136|FG001|Overall Study|Other Adverse Event|0|||
161957282|NCT00711594|584891137|FG002|Overall Study|Other Adverse Event|0|||
161957283|NCT00711594|584891138|FG003|Overall Study|Other Adverse Event|16|||
161957284|NCT00711594|584891135|FG000|Overall Study|Withdrawal by Subject|0|||
161957285|NCT00711594|584891136|FG001|Overall Study|Withdrawal by Subject|1|||
161957286|NCT00711594|584891137|FG002|Overall Study|Withdrawal by Subject|0|||
161957287|NCT00711594|584891138|FG003|Overall Study|Withdrawal by Subject|2|||
161700488|NCT01773421|583953445|FG001|Treatment Phase|Adverse Event|0|||
161700489|NCT01773421|583953446|FG002|Treatment Phase|Adverse Event|3|||
161700490|NCT01773421|583953447|FG003|Treatment Phase|Adverse Event|1|||
161700491|NCT01773421|583953448|FG004|Treatment Phase|Adverse Event|0|||
161700492|NCT01773421|583953449|FG005|Treatment Phase|Adverse Event|0|||
161700493|NCT01773421|583953450|FG006|Treatment Phase|Adverse Event|0|||
161700494|NCT01773421|583953444|FG000|Treatment Phase|Withdrawal by Subject|0|||
161700495|NCT01773421|583953445|FG001|Treatment Phase|Withdrawal by Subject|0|||
161700496|NCT01773421|583953446|FG002|Treatment Phase|Withdrawal by Subject|1|||
161700497|NCT01773421|583953447|FG003|Treatment Phase|Withdrawal by Subject|1|||
161700498|NCT01773421|583953448|FG004|Treatment Phase|Withdrawal by Subject|0|||
161700499|NCT01773421|583953449|FG005|Treatment Phase|Withdrawal by Subject|0|||
161700500|NCT01773421|583953450|FG006|Treatment Phase|Withdrawal by Subject|0|||
161700501|NCT01773421|583953444|FG000|Extension Phase|Other|0|||
161700502|NCT01773421|583953445|FG001|Extension Phase|Other|0|||
161700503|NCT01773421|583953446|FG002|Extension Phase|Other|0|||
161700504|NCT01773421|583953447|FG003|Extension Phase|Other|0|||
161700505|NCT01773421|583953448|FG004|Extension Phase|Other|1|||
161700506|NCT01773421|583953449|FG005|Extension Phase|Other|2|||
161700507|NCT01773421|583953450|FG006|Extension Phase|Other|0|||
161700508|NCT01773421|583953444|FG000|Extension Phase|Adverse Event|0|||
161700509|NCT01773421|583953445|FG001|Extension Phase|Adverse Event|0|||
161700510|NCT01773421|583953446|FG002|Extension Phase|Adverse Event|0|||
161700511|NCT01773421|583953447|FG003|Extension Phase|Adverse Event|0|||
161700512|NCT01773421|583953448|FG004|Extension Phase|Adverse Event|2|||
161700513|NCT01773421|583953449|FG005|Extension Phase|Adverse Event|0|||
161700514|NCT01773421|583953450|FG006|Extension Phase|Adverse Event|0|||
161700515|NCT01400932|583953458|FG000|Overall Study|Adverse Event|10|||
161700516|NCT01400932|583953459|FG001|Overall Study|Adverse Event|5|||
161700517|NCT01400932|583953458|FG000|Overall Study|Lack of Efficacy|0|||
161700518|NCT01400932|583953459|FG001|Overall Study|Lack of Efficacy|3|||
161700519|NCT01400932|583953458|FG000|Overall Study|Withdrawal by Subject|2|||
161700520|NCT01400932|583953459|FG001|Overall Study|Withdrawal by Subject|6|||
161700521|NCT01400932|583953458|FG000|Overall Study|Lost to Follow-up|1|||
161700522|NCT01400932|583953459|FG001|Overall Study|Lost to Follow-up|0|||
161700523|NCT01400932|583953458|FG000|Overall Study|Protocol Deviation|0|||
161700524|NCT01400932|583953459|FG001|Overall Study|Protocol Deviation|1|||
161700525|NCT01400932|583953458|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161700526|NCT01400932|583953459|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161700527|NCT00860158|583953460|FG000|Overall Study|Study Terminated|1|||
161700528|NCT00282243|583953463|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
161700529|NCT00282243|583953463|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
161700530|NCT00282243|583953463|FG000|Extension Treatment Period|Adverse Event|15|||
161700531|NCT00282243|583953463|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
161700532|NCT00282243|583953463|FG000|Extension Treatment Period|Non-compliance|2|||
161700533|NCT00282243|583953463|FG000|Extension Treatment Period|Physician Decision|1|||
161700534|NCT00270894|583953464|FG000|Overall Study|Adverse Event|1|||
161700535|NCT00270894|583953464|FG000|Overall Study|Withdrawal by Subject|1|||
161700536|NCT01070329|583953465|FG000|Overall Study|Adverse Event|13|||
161700537|NCT01070329|583953466|FG001|Overall Study|Adverse Event|10|||
161700538|NCT01070329|583953465|FG000|Overall Study|Lost to Follow-up|22|||
161700539|NCT01070329|583953466|FG001|Overall Study|Lost to Follow-up|12|||
161700540|NCT01070329|583953465|FG000|Overall Study|Withdrawal by Subject|9|||
161700541|NCT01070329|583953466|FG001|Overall Study|Withdrawal by Subject|11|||
161700542|NCT01070329|583953465|FG000|Overall Study|Protocol Violation|3|||
161700543|NCT01070329|583953466|FG001|Overall Study|Protocol Violation|8|||
161700544|NCT01070329|583953465|FG000|Overall Study|Lack of Efficacy|2|||
161700545|NCT01070329|583953466|FG001|Overall Study|Lack of Efficacy|6|||
161700546|NCT01070329|583953465|FG000|Overall Study|Physician Decision|2|||
161700547|NCT01070329|583953466|FG001|Overall Study|Physician Decision|1|||
161700548|NCT01070329|583953465|FG000|Overall Study|Entry Criteria Not Met|1|||
161700549|NCT01070329|583953466|FG001|Overall Study|Entry Criteria Not Met|0|||
161700550|NCT01070329|583953465|FG000|Overall Study|Sponsor Decision|0|||
161700551|NCT01070329|583953466|FG001|Overall Study|Sponsor Decision|1|||
161700552|NCT02863848|583953467|FG000|Overall Study|Lost to Follow-up|1|||
161700553|NCT02863848|583953468|FG001|Overall Study|Lost to Follow-up|1|||
161700554|NCT02863848|583953467|FG000|Overall Study|Protocol Violation|1|||
161700555|NCT02863848|583953468|FG001|Overall Study|Protocol Violation|2|||
161836902|NCT01045421|584446483|FG002|Phase 1|Withdrawal by Subject|0|||
161957288|NCT00485758|584891141|FG000|Overall Study|Adverse Event|102|||
161957289|NCT00485758|584891142|FG001|Overall Study|Adverse Event|31|||
161700556|NCT03980938|583953472|FG000|Treatment Period 1|Study Terminated|1|||
161700557|NCT03980938|583953473|FG001|Treatment Period 1|Study Terminated|1|||
161700558|NCT03980938|583953472|FG000|Treatment Period 2|Study Terminated|2|||
161700559|NCT03980938|583953473|FG001|Treatment Period 2|Study Terminated|2|||
161700560|NCT03706365|583953475|FG000|Overall Study|Lost to Follow-up|7|||
161700561|NCT03706365|583953476|FG001|Overall Study|Lost to Follow-up|0|||
161700562|NCT03706365|583953475|FG000|Overall Study|Withdrawal by Subject|17|||
161700563|NCT03706365|583953476|FG001|Overall Study|Withdrawal by Subject|15|||
161700564|NCT03706365|583953475|FG000|Overall Study|On Study Treatment|51|||
161836903|NCT01045421|584446484|FG003|Phase 1|Withdrawal by Subject|1|||
161700565|NCT03706365|583953476|FG001|Overall Study|On Study Treatment|51|||
161700566|NCT00883493|583953477|FG000|Overall Study|Adverse Event|11|||
161700567|NCT00883493|583953478|FG001|Overall Study|Adverse Event|12|||
161700568|NCT00883493|583953477|FG000|Overall Study|Lack of Efficacy|4|||
161700569|NCT00883493|583953478|FG001|Overall Study|Lack of Efficacy|3|||
161700570|NCT00883493|583953477|FG000|Overall Study|Lost to Follow-up|7|||
161700571|NCT00883493|583953478|FG001|Overall Study|Lost to Follow-up|6|||
161700572|NCT00883493|583953477|FG000|Overall Study|Withdrawal by Subject|11|||
161700573|NCT00883493|583953478|FG001|Overall Study|Withdrawal by Subject|20|||
161700574|NCT00883493|583953477|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
161700575|NCT00883493|583953478|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
161700576|NCT00883493|583953477|FG000|Overall Study|Study specific disc. criteria|2|||
161700577|NCT00883493|583953478|FG001|Overall Study|Study specific disc. criteria|0|||
161700578|NCT00883493|583953477|FG000|Overall Study|Other|5|||
161700579|NCT00883493|583953478|FG001|Overall Study|Other|3|||
161700580|NCT04557384|583953479|FG000|Overall Study|Study Terminated by Sponsor|1|||
161700581|NCT04557384|583953479|FG000|Overall Study|Death|1|||
161700582|NCT00168831|583953484|FG000|Overall Study|Adverse Event|36|||
161700583|NCT00168831|583953485|FG001|Overall Study|Adverse Event|47|||
161700584|NCT00168831|583953486|FG002|Overall Study|Adverse Event|74|||
161700585|NCT00168831|583953484|FG000|Overall Study|Lost to Follow-up|5|||
161700586|NCT00168831|583953485|FG001|Overall Study|Lost to Follow-up|6|||
161700587|NCT00168831|583953486|FG002|Overall Study|Lost to Follow-up|4|||
161700588|NCT00168831|583953484|FG000|Overall Study|Withdrawal by Subject|7|||
161700589|NCT00168831|583953485|FG001|Overall Study|Withdrawal by Subject|14|||
161700590|NCT00168831|583953486|FG002|Overall Study|Withdrawal by Subject|19|||
161700591|NCT00168831|583953484|FG000|Overall Study|Protocol Violation|6|||
161700592|NCT00168831|583953485|FG001|Overall Study|Protocol Violation|11|||
161700593|NCT00168831|583953486|FG002|Overall Study|Protocol Violation|11|||
161700594|NCT00168831|583953484|FG000|Overall Study|Other|6|||
161700595|NCT00168831|583953485|FG001|Overall Study|Other|3|||
161700596|NCT00168831|583953486|FG002|Overall Study|Other|6|||
161700597|NCT01622569|583953487|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
161700598|NCT01622569|583953488|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
161700599|NCT01622569|583953489|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
161700600|NCT01622569|583953490|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
161700601|NCT01622569|583953487|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
161700602|NCT01622569|583953488|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
161700603|NCT01622569|583953489|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
161700604|NCT01622569|583953490|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
161700605|NCT01622569|583953487|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
161700606|NCT01622569|583953488|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
161700607|NCT01622569|583953489|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
161957290|NCT00485758|584891141|FG000|Overall Study|Death|0|||
161957291|NCT00485758|584891142|FG001|Overall Study|Death|1|||
161957292|NCT00485758|584891141|FG000|Overall Study|Lost to Follow-up|5|||
161957293|NCT00485758|584891142|FG001|Overall Study|Lost to Follow-up|1|||
161957294|NCT00485758|584891141|FG000|Overall Study|Physician Decision|3|||
161957295|NCT00485758|584891142|FG001|Overall Study|Physician Decision|3|||
161957296|NCT00485758|584891141|FG000|Overall Study|Protocol Violation|11|||
161957297|NCT00485758|584891142|FG001|Overall Study|Protocol Violation|2|||
161957298|NCT00485758|584891141|FG000|Overall Study|Withdrawal by Subject|32|||
161957299|NCT00485758|584891142|FG001|Overall Study|Withdrawal by Subject|27|||
161957300|NCT00485758|584891141|FG000|Overall Study|Study Terminated by Sponsor|3|||
161957301|NCT00485758|584891142|FG001|Overall Study|Study Terminated by Sponsor|0|||
161957302|NCT04556591|584891143|FG000|Overall Study|Lost to Follow-up|1|||
161957303|NCT04556591|584891144|FG001|Overall Study|Lost to Follow-up|0|||
161957304|NCT04556591|584891143|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
161957305|NCT04556591|584891144|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
161957306|NCT00135330|584891146|FG000|Overall Study|Adverse Event|2|||
161700608|NCT01622569|583953490|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
161700609|NCT01622569|583953487|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161700610|NCT01622569|583953488|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
161700611|NCT01622569|583953489|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161700612|NCT01622569|583953490|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
161700613|NCT01622569|583953487|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
161700614|NCT01622569|583953488|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
161700615|NCT01622569|583953489|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
161700616|NCT01622569|583953490|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
161836904|NCT01045421|584446485|FG004|Phase 1|Withdrawal by Subject|0|||
161957307|NCT00135330|584891147|FG001|Overall Study|Adverse Event|5|||
161957308|NCT00135330|584891148|FG002|Overall Study|Adverse Event|1|||
161957309|NCT00135330|584891146|FG000|Overall Study|Lost to Follow-up|0|||
161700617|NCT01622569|583953487|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
161700618|NCT01622569|583953488|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
161700619|NCT01622569|583953489|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
161700620|NCT01622569|583953490|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
161700621|NCT01622569|583953487|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
161700622|NCT01622569|583953488|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
161700623|NCT01622569|583953489|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
161700624|NCT01622569|583953490|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
161700625|NCT01622569|583953487|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161700626|NCT01622569|583953488|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161700627|NCT01622569|583953489|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161700628|NCT01622569|583953490|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
161700629|NCT04173741|583953492|FG000|Overall Study|IVC measurement cannot be done|1|||
161700630|NCT04173741|583953493|FG001|Overall Study|IVC measurement cannot be done|1|||
161700631|NCT02522767|583953494|FG000|Double-blind|Withdrawal by Subject|8|||
161700632|NCT02522767|583953495|FG001|Double-blind|Withdrawal by Subject|11|||
161700633|NCT02522767|583953494|FG000|Double-blind|Lost to Follow-up|1|||
161700634|NCT02522767|583953495|FG001|Double-blind|Lost to Follow-up|0|||
161700635|NCT02522767|583953494|FG000|Double-blind|Adverse Event|1|||
161700636|NCT02522767|583953495|FG001|Double-blind|Adverse Event|10|||
161700637|NCT02522767|583953494|FG000|Double-blind|Protocol Violation|0|||
161700638|NCT02522767|583953495|FG001|Double-blind|Protocol Violation|1|||
161700639|NCT02522767|583953494|FG000|Double-blind|Lack of Efficacy|0|||
161700640|NCT02522767|583953495|FG001|Double-blind|Lack of Efficacy|2|||
161700641|NCT02522767|583953494|FG000|Double-blind|Protocol Deviation|1|||
161700642|NCT02522767|583953495|FG001|Double-blind|Protocol Deviation|0|||
161700643|NCT02522767|583953494|FG000|Open-label|Withdrawal by Subject|2|||
161700644|NCT02522767|583953495|FG001|Open-label|Withdrawal by Subject|3|||
161700645|NCT02522767|583953494|FG000|Open-label|Lost to Follow-up|0|||
161700646|NCT02522767|583953495|FG001|Open-label|Lost to Follow-up|1|||
161700647|NCT02522767|583953494|FG000|Open-label|Adverse Event|2|||
161700648|NCT02522767|583953495|FG001|Open-label|Adverse Event|1|||
161700649|NCT02522767|583953494|FG000|Open-label|Lack of Efficacy|1|||
161700650|NCT02522767|583953495|FG001|Open-label|Lack of Efficacy|1|||
161700651|NCT02522767|583953494|FG000|Open-label|Protocol Violation|0|||
161700652|NCT02522767|583953495|FG001|Open-label|Protocol Violation|1|||
161700653|NCT00254566|583953497|FG000|Overall Study|Death|1|||
161700654|NCT00254566|583953498|FG001|Overall Study|Death|0|||
161700655|NCT00254566|583953497|FG000|Overall Study|Adverse Event|5|||
161700656|NCT00254566|583953498|FG001|Overall Study|Adverse Event|4|||
161700657|NCT00254566|583953497|FG000|Overall Study|Lack of Efficacy|12|||
161700658|NCT00254566|583953498|FG001|Overall Study|Lack of Efficacy|9|||
161700659|NCT00254566|583953497|FG000|Overall Study|Other|1|||
161700660|NCT00254566|583953498|FG001|Overall Study|Other|5|||
161700661|NCT00254566|583953497|FG000|Overall Study|Withdrawal by Subject|5|||
161700662|NCT00254566|583953498|FG001|Overall Study|Withdrawal by Subject|6|||
161700663|NCT00254566|583953497|FG000|Overall Study|Lost to Follow-up|7|||
161700664|NCT00254566|583953498|FG001|Overall Study|Lost to Follow-up|2|||
161700665|NCT00059202|583953500|FG000|Overall Study|Withdrawal by Subject|5|||
161700666|NCT00059202|583953501|FG001|Overall Study|Withdrawal by Subject|9|||
161700667|NCT00059202|583953500|FG000|Overall Study|Protocol Violation|1|||
161700668|NCT00059202|583953501|FG001|Overall Study|Protocol Violation|3|||
161700669|NCT00059202|583953500|FG000|Overall Study|drug toxicity|0|||
161700670|NCT00059202|583953501|FG001|Overall Study|drug toxicity|3|||
161700671|NCT00548548|583953504|FG000|Overall Study|Death|345|||
161700672|NCT00548548|583953505|FG001|Overall Study|Death|348|||
161700673|NCT00548548|583953504|FG000|Overall Study|Lost to Follow-up|17|||
161700674|NCT00548548|583953505|FG001|Overall Study|Lost to Follow-up|18|||
161700675|NCT00841763|583953506|FG000|Overall Study|Withdrawal by Subject|60|||
161700676|NCT00841763|583953507|FG001|Overall Study|Withdrawal by Subject|17|||
161700677|NCT00841763|583953508|FG002|Overall Study|Withdrawal by Subject|4|||
161700678|NCT00841763|583953509|FG003|Overall Study|Withdrawal by Subject|1|||
161700679|NCT00841763|583953506|FG000|Overall Study|Adverse Event|9|||
161700680|NCT00841763|583953507|FG001|Overall Study|Adverse Event|10|||
161700681|NCT00841763|583953508|FG002|Overall Study|Adverse Event|3|||
161700682|NCT00841763|583953509|FG003|Overall Study|Adverse Event|2|||
161700683|NCT00841763|583953506|FG000|Overall Study|Lost to Follow-up|63|||
161700684|NCT00841763|583953507|FG001|Overall Study|Lost to Follow-up|25|||
161700685|NCT00841763|583953508|FG002|Overall Study|Lost to Follow-up|0|||
161700686|NCT00841763|583953509|FG003|Overall Study|Lost to Follow-up|0|||
161700687|NCT00841763|583953506|FG000|Overall Study|Protocol Violation|20|||
161700688|NCT00841763|583953507|FG001|Overall Study|Protocol Violation|3|||
161700689|NCT00841763|583953508|FG002|Overall Study|Protocol Violation|1|||
161700690|NCT00841763|583953509|FG003|Overall Study|Protocol Violation|0|||
161700691|NCT00841763|583953506|FG000|Overall Study|Administrative Reasons|3|||
161700692|NCT00841763|583953507|FG001|Overall Study|Administrative Reasons|1|||
161700693|NCT00841763|583953508|FG002|Overall Study|Administrative Reasons|0|||
161700694|NCT00841763|583953509|FG003|Overall Study|Administrative Reasons|0|||
161700695|NCT00841763|583953506|FG000|Overall Study|Unable to Classify|7|||
161700696|NCT00841763|583953507|FG001|Overall Study|Unable to Classify|1|||
161700697|NCT00841763|583953508|FG002|Overall Study|Unable to Classify|0|||
161700698|NCT00841763|583953509|FG003|Overall Study|Unable to Classify|0|||
161700699|NCT00400400|583953510|FG000|Overall Study|Adverse Event|9|||
161700700|NCT00400400|583953511|FG001|Overall Study|Adverse Event|8|||
161700701|NCT00400400|583953510|FG000|Overall Study|Protocol Violation|2|||
161700702|NCT00400400|583953511|FG001|Overall Study|Protocol Violation|0|||
161700703|NCT00400400|583953510|FG000|Overall Study|Withdrawal by Subject|1|||
161700704|NCT00400400|583953511|FG001|Overall Study|Withdrawal by Subject|3|||
161700705|NCT00400400|583953510|FG000|Overall Study|Administrative Problem|1|||
161700706|NCT00400400|583953511|FG001|Overall Study|Administrative Problem|0|||
161700707|NCT00400400|583953510|FG000|Overall Study|Lost to Follow-up|0|||
161700708|NCT00400400|583953511|FG001|Overall Study|Lost to Follow-up|1|||
161700709|NCT00400400|583953510|FG000|Overall Study|Did not receive study drug|1|||
161700710|NCT00400400|583953511|FG001|Overall Study|Did not receive study drug|3|||
161700711|NCT01688050|583953512|FG000|Overall Study|Death|7|||
161700712|NCT01688050|583953512|FG000|Overall Study|Conversion to open repair|1|||
161700713|NCT01688050|583953512|FG000|Overall Study|Lost to Follow-up|13|||
161700714|NCT01688050|583953512|FG000|Overall Study|Withdrawal by Subject|10|||
161700715|NCT01848145|583953513|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
161700716|NCT01848145|583953513|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
161700717|NCT01848145|583953513|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
161700718|NCT01848145|583953513|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
161700719|NCT01848145|583953513|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
161700720|NCT01848145|583953513|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
161700721|NCT01848145|583953513|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
161700722|NCT04426695|583953520|FG000|Overall Study|Death|2|||
161700723|NCT04426695|583953521|FG001|Overall Study|Death|0|||
161700724|NCT04426695|583953522|FG002|Overall Study|Death|1|||
161700725|NCT04426695|583953523|FG003|Overall Study|Death|27|||
161700726|NCT04426695|583953524|FG004|Overall Study|Death|25|||
161700727|NCT04426695|583953525|FG005|Overall Study|Death|21|||
161700728|NCT04426695|583953526|FG006|Overall Study|Death|42|||
161700729|NCT04426695|583953527|FG007|Overall Study|Death|23|||
161700730|NCT04426695|583953528|FG008|Overall Study|Death|37|||
161700731|NCT04426695|583953529|FG009|Overall Study|Death|14|||
161700732|NCT04426695|583953530|FG010|Overall Study|Death|8|||
161700733|NCT04426695|583953531|FG011|Overall Study|Death|7|||
161700734|NCT04426695|583953532|FG012|Overall Study|Death|13|||
161700735|NCT04426695|583953533|FG013|Overall Study|Death|25|||
161700736|NCT04426695|583953534|FG014|Overall Study|Death|19|||
161700737|NCT04426695|583953535|FG015|Overall Study|Death|7|||
161700738|NCT04426695|583953536|FG016|Overall Study|Death|8|||
161700739|NCT04426695|583953537|FG017|Overall Study|Death|4|||
161700740|NCT04426695|583953520|FG000|Overall Study|Lost to Follow-up|2|||
161700741|NCT04426695|583953521|FG001|Overall Study|Lost to Follow-up|4|||
161700742|NCT04426695|583953522|FG002|Overall Study|Lost to Follow-up|1|||
161700743|NCT04426695|583953523|FG003|Overall Study|Lost to Follow-up|19|||
161700744|NCT04426695|583953524|FG004|Overall Study|Lost to Follow-up|10|||
161700745|NCT04426695|583953525|FG005|Overall Study|Lost to Follow-up|14|||
161700746|NCT04426695|583953526|FG006|Overall Study|Lost to Follow-up|5|||
161700747|NCT04426695|583953527|FG007|Overall Study|Lost to Follow-up|14|||
161700748|NCT04426695|583953528|FG008|Overall Study|Lost to Follow-up|10|||
161700749|NCT04426695|583953529|FG009|Overall Study|Lost to Follow-up|11|||
161700750|NCT04426695|583953530|FG010|Overall Study|Lost to Follow-up|12|||
161700751|NCT04426695|583953531|FG011|Overall Study|Lost to Follow-up|6|||
161700752|NCT04426695|583953532|FG012|Overall Study|Lost to Follow-up|2|||
161700753|NCT04426695|583953533|FG013|Overall Study|Lost to Follow-up|2|||
161700754|NCT04426695|583953534|FG014|Overall Study|Lost to Follow-up|2|||
161836905|NCT01045421|584446486|FG005|Phase 1|Withdrawal by Subject|0|||
161700755|NCT04426695|583953535|FG015|Overall Study|Lost to Follow-up|0|||
161700756|NCT04426695|583953536|FG016|Overall Study|Lost to Follow-up|0|||
161957310|NCT00135330|584891147|FG001|Overall Study|Lost to Follow-up|2|||
161700757|NCT04426695|583953537|FG017|Overall Study|Lost to Follow-up|0|||
161700758|NCT04426695|583953520|FG000|Overall Study|Participant Decision|1|||
161700759|NCT04426695|583953521|FG001|Overall Study|Participant Decision|2|||
161700760|NCT04426695|583953522|FG002|Overall Study|Participant Decision|2|||
161700761|NCT04426695|583953523|FG003|Overall Study|Participant Decision|12|||
161957311|NCT00135330|584891148|FG002|Overall Study|Lost to Follow-up|3|||
161700762|NCT04426695|583953524|FG004|Overall Study|Participant Decision|18|||
161836906|NCT01045421|584446487|FG006|Phase 1|Withdrawal by Subject|0|||
161836907|NCT01045421|584446488|FG007|Phase 1|Withdrawal by Subject|0|||
161700763|NCT04426695|583953525|FG005|Overall Study|Participant Decision|22|||
161700764|NCT04426695|583953526|FG006|Overall Study|Participant Decision|13|||
161700765|NCT04426695|583953527|FG007|Overall Study|Participant Decision|13|||
161700766|NCT04426695|583953528|FG008|Overall Study|Participant Decision|10|||
161700767|NCT04426695|583953529|FG009|Overall Study|Participant Decision|15|||
161957312|NCT00135330|584891146|FG000|Overall Study|Physician Decision|1|||
161700768|NCT04426695|583953530|FG010|Overall Study|Participant Decision|16|||
161700769|NCT04426695|583953531|FG011|Overall Study|Participant Decision|17|||
161700770|NCT04426695|583953532|FG012|Overall Study|Participant Decision|2|||
161700771|NCT04426695|583953533|FG013|Overall Study|Participant Decision|1|||
161700772|NCT04426695|583953534|FG014|Overall Study|Participant Decision|2|||
161700773|NCT04426695|583953535|FG015|Overall Study|Participant Decision|0|||
161700774|NCT04426695|583953536|FG016|Overall Study|Participant Decision|0|||
161700775|NCT04426695|583953537|FG017|Overall Study|Participant Decision|0|||
161700776|NCT04426695|583953520|FG000|Overall Study|Adverse Event|0|||
161700777|NCT04426695|583953521|FG001|Overall Study|Adverse Event|0|||
161700778|NCT04426695|583953522|FG002|Overall Study|Adverse Event|0|||
161700779|NCT04426695|583953523|FG003|Overall Study|Adverse Event|0|||
161700780|NCT04426695|583953524|FG004|Overall Study|Adverse Event|0|||
161700781|NCT04426695|583953525|FG005|Overall Study|Adverse Event|0|||
161700782|NCT04426695|583953526|FG006|Overall Study|Adverse Event|0|||
161700783|NCT04426695|583953527|FG007|Overall Study|Adverse Event|1|||
161700784|NCT04426695|583953528|FG008|Overall Study|Adverse Event|0|||
161700785|NCT04426695|583953529|FG009|Overall Study|Adverse Event|0|||
161700786|NCT04426695|583953530|FG010|Overall Study|Adverse Event|1|||
161700787|NCT04426695|583953531|FG011|Overall Study|Adverse Event|1|||
161700788|NCT04426695|583953532|FG012|Overall Study|Adverse Event|0|||
161700789|NCT04426695|583953533|FG013|Overall Study|Adverse Event|0|||
161700790|NCT04426695|583953534|FG014|Overall Study|Adverse Event|0|||
161700791|NCT04426695|583953535|FG015|Overall Study|Adverse Event|0|||
161700792|NCT04426695|583953536|FG016|Overall Study|Adverse Event|0|||
161700793|NCT04426695|583953537|FG017|Overall Study|Adverse Event|0|||
161700794|NCT04426695|583953520|FG000|Overall Study|Sponsor Request|0|||
161700795|NCT04426695|583953521|FG001|Overall Study|Sponsor Request|0|||
161700796|NCT04426695|583953522|FG002|Overall Study|Sponsor Request|0|||
161700797|NCT04426695|583953523|FG003|Overall Study|Sponsor Request|0|||
161700798|NCT04426695|583953524|FG004|Overall Study|Sponsor Request|0|||
161700799|NCT04426695|583953525|FG005|Overall Study|Sponsor Request|0|||
161700800|NCT04426695|583953526|FG006|Overall Study|Sponsor Request|1|||
161700801|NCT04426695|583953527|FG007|Overall Study|Sponsor Request|0|||
161700802|NCT04426695|583953528|FG008|Overall Study|Sponsor Request|0|||
161700803|NCT04426695|583953529|FG009|Overall Study|Sponsor Request|0|||
161700804|NCT04426695|583953530|FG010|Overall Study|Sponsor Request|0|||
161700805|NCT04426695|583953531|FG011|Overall Study|Sponsor Request|0|||
161700806|NCT04426695|583953532|FG012|Overall Study|Sponsor Request|0|||
161700807|NCT04426695|583953533|FG013|Overall Study|Sponsor Request|0|||
161700808|NCT04426695|583953534|FG014|Overall Study|Sponsor Request|0|||
161700809|NCT04426695|583953535|FG015|Overall Study|Sponsor Request|0|||
161700810|NCT04426695|583953536|FG016|Overall Study|Sponsor Request|0|||
161700811|NCT04426695|583953537|FG017|Overall Study|Sponsor Request|0|||
161700812|NCT04426695|583953520|FG000|Overall Study|Physician Decision|0|||
161700813|NCT04426695|583953521|FG001|Overall Study|Physician Decision|0|||
161700814|NCT04426695|583953522|FG002|Overall Study|Physician Decision|0|||
161700815|NCT04426695|583953523|FG003|Overall Study|Physician Decision|0|||
161700816|NCT04426695|583953524|FG004|Overall Study|Physician Decision|0|||
161700817|NCT04426695|583953525|FG005|Overall Study|Physician Decision|0|||
161700818|NCT04426695|583953526|FG006|Overall Study|Physician Decision|0|||
161700819|NCT04426695|583953527|FG007|Overall Study|Physician Decision|0|||
161700820|NCT04426695|583953528|FG008|Overall Study|Physician Decision|0|||
161700821|NCT04426695|583953529|FG009|Overall Study|Physician Decision|1|||
161700822|NCT04426695|583953530|FG010|Overall Study|Physician Decision|0|||
161700823|NCT04426695|583953531|FG011|Overall Study|Physician Decision|0|||
161700824|NCT04426695|583953532|FG012|Overall Study|Physician Decision|1|||
161700825|NCT04426695|583953533|FG013|Overall Study|Physician Decision|0|||
161700826|NCT04426695|583953534|FG014|Overall Study|Physician Decision|0|||
161700827|NCT04426695|583953535|FG015|Overall Study|Physician Decision|0|||
161700828|NCT04426695|583953536|FG016|Overall Study|Physician Decision|0|||
161700829|NCT04426695|583953537|FG017|Overall Study|Physician Decision|0|||
161700830|NCT04426695|583953520|FG000|Overall Study|Randomized but Never Treated|3|||
161700831|NCT04426695|583953521|FG001|Overall Study|Randomized but Never Treated|1|||
161700832|NCT04426695|583953522|FG002|Overall Study|Randomized but Never Treated|0|||
161700833|NCT04426695|583953523|FG003|Overall Study|Randomized but Never Treated|4|||
161700834|NCT04426695|583953524|FG004|Overall Study|Randomized but Never Treated|5|||
161700835|NCT04426695|583953525|FG005|Overall Study|Randomized but Never Treated|5|||
161700836|NCT04426695|583953526|FG006|Overall Study|Randomized but Never Treated|4|||
161700837|NCT04426695|583953527|FG007|Overall Study|Randomized but Never Treated|6|||
161700838|NCT04426695|583953528|FG008|Overall Study|Randomized but Never Treated|6|||
161700839|NCT04426695|583953529|FG009|Overall Study|Randomized but Never Treated|3|||
161700840|NCT04426695|583953530|FG010|Overall Study|Randomized but Never Treated|3|||
161700841|NCT04426695|583953531|FG011|Overall Study|Randomized but Never Treated|6|||
161700842|NCT04426695|583953532|FG012|Overall Study|Randomized but Never Treated|1|||
161836908|NCT01045421|584446489|FG008|Phase 1|Withdrawal by Subject|0|||
161836909|NCT01045421|584446490|FG009|Phase 1|Withdrawal by Subject|0|||
161700843|NCT04426695|583953533|FG013|Overall Study|Randomized but Never Treated|2|||
161700844|NCT04426695|583953534|FG014|Overall Study|Randomized but Never Treated|0|||
161700845|NCT04426695|583953535|FG015|Overall Study|Randomized but Never Treated|0|||
161700846|NCT04426695|583953536|FG016|Overall Study|Randomized but Never Treated|0|||
161700847|NCT04426695|583953537|FG017|Overall Study|Randomized but Never Treated|0|||
161700848|NCT04303000|583953538|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
161700849|NCT04303000|583953539|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
161700850|NCT04303000|583953540|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
161700851|NCT03118947|583953543|FG000|Overall Study|Adverse Event|7|||
161700852|NCT03118947|583953543|FG000|Overall Study|Death|3|||
161700853|NCT03118947|583953543|FG000|Overall Study|Lack of Efficacy|4|||
161700854|NCT03118947|583953543|FG000|Overall Study|Non-compliance with study drug|1|||
161700855|NCT03118947|583953543|FG000|Overall Study|Protocol Violation|2|||
161700856|NCT03118947|583953543|FG000|Overall Study|Withdrawal by Subject|3|||
161700857|NCT03118947|583953543|FG000|Overall Study|Withdrawal by caregiver|3|||
161700858|NCT03118947|583953543|FG000|Overall Study|Change in patient's living situation|4|||
161700859|NCT03118947|583953543|FG000|Overall Study|Lost to Follow-up|2|||
161700860|NCT02769624|583953544|FG000|Overall Study|Lost to Follow-up|0|||
161700861|NCT02769624|583953545|FG001|Overall Study|Lost to Follow-up|1|||
161700862|NCT01987908|583953554|FG000|Placebo Lead-in Period|Adverse Event|2|||
161700863|NCT01987908|583953555|FG001|Placebo Lead-in Period|Adverse Event|0|||
161700864|NCT01987908|583953556|FG002|Placebo Lead-in Period|Adverse Event|0|||
161700865|NCT01987908|583953554|FG000|Placebo Lead-in Period|Physician Decision|2|||
161700866|NCT01987908|583953555|FG001|Placebo Lead-in Period|Physician Decision|0|||
161700867|NCT01987908|583953556|FG002|Placebo Lead-in Period|Physician Decision|0|||
161700868|NCT01987908|583953554|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
161957313|NCT00135330|584891147|FG001|Overall Study|Physician Decision|1|||
161957314|NCT00135330|584891148|FG002|Overall Study|Physician Decision|0|||
161836910|NCT01045421|584446491|FG010|Phase 1|Withdrawal by Subject|0|||
161836911|NCT01045421|584446481|FG000|Phase 2|Progressive Disease|0|||
161957315|NCT00135330|584891146|FG000|Overall Study|Protocol Violation|4|||
161957316|NCT00135330|584891147|FG001|Overall Study|Protocol Violation|3|||
161957317|NCT00135330|584891148|FG002|Overall Study|Protocol Violation|3|||
161957318|NCT00135330|584891146|FG000|Overall Study|Patient Decision|5|||
161957319|NCT00135330|584891147|FG001|Overall Study|Patient Decision|1|||
161957320|NCT00135330|584891148|FG002|Overall Study|Patient Decision|4|||
161957321|NCT00135330|584891146|FG000|Overall Study|Sponsor Decision|0|||
161957322|NCT00135330|584891147|FG001|Overall Study|Sponsor Decision|1|||
161957323|NCT00135330|584891148|FG002|Overall Study|Sponsor Decision|0|||
161957324|NCT02253433|584891156|FG000|Overall Study|Unable to Contact|9|||
161957325|NCT02253433|584891157|FG001|Overall Study|Unable to Contact|16|||
161957326|NCT02253433|584891156|FG000|Overall Study|Death|1|||
161957327|NCT02253433|584891157|FG001|Overall Study|Death|1|||
161957328|NCT02253433|584891156|FG000|Overall Study|No Longer Interested|3|||
161957329|NCT02253433|584891157|FG001|Overall Study|No Longer Interested|15|||
161957330|NCT02253433|584891156|FG000|Overall Study|Out of Study Area|2|||
161957331|NCT02253433|584891157|FG001|Overall Study|Out of Study Area|7|||
161957332|NCT02253433|584891156|FG000|Overall Study|Uncomfortable with home visitors|0|||
161957333|NCT02253433|584891157|FG001|Overall Study|Uncomfortable with home visitors|3|||
161957334|NCT02253433|584891156|FG000|Overall Study|Unstable Housing/Homeless|0|||
161957335|NCT02253433|584891157|FG001|Overall Study|Unstable Housing/Homeless|7|||
161957336|NCT02253433|584891156|FG000|Overall Study|Too Busy|0|||
161957337|NCT02253433|584891157|FG001|Overall Study|Too Busy|4|||
161957338|NCT02253433|584891156|FG000|Overall Study|Medical or Other Concerns|1|||
161957339|NCT02253433|584891157|FG001|Overall Study|Medical or Other Concerns|2|||
161957340|NCT02229825|584891160|FG000|Overall Study|Personal Reasons|0|||
161957341|NCT02229825|584891161|FG001|Overall Study|Personal Reasons|1|||
161957342|NCT02229825|584891160|FG000|Overall Study|Refused continuing medication|7|||
161957343|NCT02229825|584891161|FG001|Overall Study|Refused continuing medication|6|||
161957344|NCT02229825|584891160|FG000|Overall Study|Lost to Follow-up|1|||
161957345|NCT02229825|584891161|FG001|Overall Study|Lost to Follow-up|2|||
161957346|NCT02229825|584891160|FG000|Overall Study|Protocol Violation|1|||
161957347|NCT02229825|584891161|FG001|Overall Study|Protocol Violation|1|||
161957348|NCT02229825|584891160|FG000|Overall Study|Lack of Efficacy|4|||
161957349|NCT02229825|584891161|FG001|Overall Study|Lack of Efficacy|10|||
161957350|NCT02229825|584891160|FG000|Overall Study|Adverse Event|11|||
161957351|NCT02229825|584891161|FG001|Overall Study|Adverse Event|9|||
161957352|NCT02229825|584891160|FG000|Overall Study|Not treated|0|||
161957353|NCT02229825|584891161|FG001|Overall Study|Not treated|1|||
161957354|NCT02526212|584891162|FG000|Overall Study|Incarceration|1|||
161700869|NCT01987908|583953555|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
161700870|NCT01987908|583953556|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
161700871|NCT01987908|583953554|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
161700872|NCT01987908|583953555|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
161957355|NCT02526212|584891163|FG001|Overall Study|Incarceration|0|||
161957356|NCT02526212|584891162|FG000|Overall Study|Lost to Follow-up|1|||
161957357|NCT02526212|584891163|FG001|Overall Study|Lost to Follow-up|0|||
161957358|NCT02526212|584891162|FG000|Overall Study|Death|0|||
161957359|NCT02526212|584891163|FG001|Overall Study|Death|1|||
161700873|NCT01987908|583953556|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
161700874|NCT01987908|583953554|FG000|Treatment Period|Adverse Event|0|||
161700875|NCT01987908|583953555|FG001|Treatment Period|Adverse Event|1|||
161700876|NCT01987908|583953556|FG002|Treatment Period|Adverse Event|1|||
161700877|NCT01987908|583953554|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
161700878|NCT01987908|583953555|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
161700879|NCT01987908|583953556|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
161700880|NCT01987908|583953554|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
161700881|NCT01987908|583953555|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
161700882|NCT01987908|583953556|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
161700883|NCT01869348|583953557|FG000|Overall Study|Withdrawal by Subject|1|||
161700884|NCT01869348|583953558|FG001|Overall Study|Withdrawal by Subject|1|||
161700885|NCT02789657|583953560|FG000|Overall Study|Withdrawal by Subject|2|||
161700886|NCT02789657|583953561|FG001|Overall Study|Withdrawal by Subject|0|||
161700887|NCT02789657|583953562|FG002|Overall Study|Withdrawal by Subject|0|||
161700888|NCT02789657|583953563|FG003|Overall Study|Withdrawal by Subject|0|||
161700889|NCT01728779|583953564|FG000|Overall Study|Withdrawal by Subject|1|||
161700890|NCT00448708|583953565|FG000|Overall Study|Death|21|||
161700891|NCT00448708|583953566|FG001|Overall Study|Death|17|||
161700892|NCT00448708|583953565|FG000|Overall Study|Withdrawal by Subject|8|||
161700893|NCT00448708|583953566|FG001|Overall Study|Withdrawal by Subject|4|||
161700894|NCT00448708|583953565|FG000|Overall Study|Lost to Follow-up|6|||
161836912|NCT01045421|584446482|FG001|Phase 2|Progressive Disease|0|||
161836913|NCT01045421|584446483|FG002|Phase 2|Progressive Disease|0|||
161836914|NCT01045421|584446484|FG003|Phase 2|Progressive Disease|0|||
161700895|NCT00448708|583953566|FG001|Overall Study|Lost to Follow-up|8|||
161700896|NCT00448708|583953565|FG000|Overall Study|not listed|0|||
161700897|NCT00448708|583953566|FG001|Overall Study|not listed|2|||
161836915|NCT01045421|584446485|FG004|Phase 2|Progressive Disease|0|||
161836916|NCT01045421|584446486|FG005|Phase 2|Progressive Disease|0|||
161836917|NCT01045421|584446487|FG006|Phase 2|Progressive Disease|0|||
161836918|NCT01045421|584446488|FG007|Phase 2|Progressive Disease|1|||
161836919|NCT01045421|584446489|FG008|Phase 2|Progressive Disease|1|||
161836920|NCT01045421|584446490|FG009|Phase 2|Progressive Disease|1|||
161836921|NCT01045421|584446491|FG010|Phase 2|Progressive Disease|1|||
161836922|NCT01045421|584446481|FG000|Phase 2|Death|0|||
161836923|NCT01045421|584446482|FG001|Phase 2|Death|0|||
161836924|NCT01045421|584446483|FG002|Phase 2|Death|0|||
161836925|NCT01045421|584446484|FG003|Phase 2|Death|0|||
161836926|NCT01045421|584446485|FG004|Phase 2|Death|0|||
161836927|NCT01045421|584446486|FG005|Phase 2|Death|0|||
161836928|NCT01045421|584446487|FG006|Phase 2|Death|0|||
161836929|NCT01045421|584446488|FG007|Phase 2|Death|1|||
161836930|NCT01045421|584446489|FG008|Phase 2|Death|1|||
161836931|NCT01045421|584446490|FG009|Phase 2|Death|2|||
161836932|NCT01045421|584446491|FG010|Phase 2|Death|0|||
161836933|NCT01045421|584446481|FG000|Phase 2|Other|0|||
161836934|NCT01045421|584446482|FG001|Phase 2|Other|0|||
161836935|NCT01045421|584446483|FG002|Phase 2|Other|0|||
161836936|NCT01045421|584446484|FG003|Phase 2|Other|0|||
161836937|NCT01045421|584446485|FG004|Phase 2|Other|0|||
161836938|NCT01045421|584446486|FG005|Phase 2|Other|0|||
161836939|NCT01045421|584446487|FG006|Phase 2|Other|0|||
161836940|NCT01045421|584446488|FG007|Phase 2|Other|3|||
161836941|NCT01045421|584446489|FG008|Phase 2|Other|0|||
161836942|NCT01045421|584446490|FG009|Phase 2|Other|0|||
161836943|NCT01045421|584446491|FG010|Phase 2|Other|1|||
161836944|NCT03340064|584446492|FG000|First Period|Adverse Event, non-fatal|2|||
161836945|NCT03340064|584446493|FG001|First Period|Adverse Event, non-fatal|0|||
161836946|NCT03340064|584446492|FG000|First Period|Lack of Efficacy|3|||
161836947|NCT03340064|584446493|FG001|First Period|Lack of Efficacy|0|||
161836948|NCT03340064|584446492|FG000|Second Period|Adverse Event, non-fatal|1|||
161836949|NCT03340064|584446493|FG001|Second Period|Adverse Event, non-fatal|1|||
161836950|NCT03340064|584446492|FG000|Second Period|Lack of Efficacy|11|||
161836951|NCT03340064|584446493|FG001|Second Period|Lack of Efficacy|0|||
161836952|NCT03340064|584446492|FG000|Second Period|Physician Decision|3|||
161700898|NCT01925209|583953567|FG000|Treatment Epoch|Physician Decision|1|||
161700899|NCT01925209|583953568|FG001|Treatment Epoch|Physician Decision|0|||
161700900|NCT01925209|583953569|FG002|Treatment Epoch|Physician Decision|0|||
161700901|NCT01925209|583953570|FG003|Treatment Epoch|Physician Decision|0|||
161836953|NCT03340064|584446493|FG001|Second Period|Physician Decision|0|||
161836954|NCT03340064|584446492|FG000|Second Period|Withdrawal by Subject|2|||
161836955|NCT03340064|584446493|FG001|Second Period|Withdrawal by Subject|1|||
161836956|NCT03340064|584446492|FG000|Second Period|Approved Drug Available For Indication|1|||
161836957|NCT03340064|584446493|FG001|Second Period|Approved Drug Available For Indication|0|||
161836958|NCT03340064|584446492|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
161836959|NCT03340064|584446493|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
161836960|NCT00856973|584446494|FG000|Overall Study|Adverse Event|5|||
161836961|NCT00856973|584446495|FG001|Overall Study|Adverse Event|5|||
161836962|NCT00856973|584446496|FG002|Overall Study|Adverse Event|3|||
161957360|NCT02443337|584891165|FG000|Overall Study|Adverse Event|0|||
161957361|NCT02443337|584891166|FG001|Overall Study|Adverse Event|1|||
161957362|NCT02443337|584891165|FG000|Overall Study|Clinical Progressive Disease|3|||
161957363|NCT02443337|584891166|FG001|Overall Study|Clinical Progressive Disease|0|||
161957364|NCT02443337|584891165|FG000|Overall Study|Withdrawal by Subject|2|||
161957365|NCT02443337|584891166|FG001|Overall Study|Withdrawal by Subject|1|||
161957366|NCT02096952|584891167|FG000|Overall Study|Adverse Event|1|||
161957367|NCT00040742|584891168|FG000|Overall Study|Death|0|||
161957368|NCT00040742|584891169|FG001|Overall Study|Death|0|||
161957369|NCT00040742|584891170|FG002|Overall Study|Death|1|||
161957370|NCT00040742|584891171|FG003|Overall Study|Death|0|||
161957371|NCT00040742|584891168|FG000|Overall Study|Adverse Event|15|||
161957372|NCT00040742|584891169|FG001|Overall Study|Adverse Event|16|||
161957373|NCT00040742|584891170|FG002|Overall Study|Adverse Event|21|||
161957374|NCT00040742|584891171|FG003|Overall Study|Adverse Event|9|||
161957375|NCT00040742|584891168|FG000|Overall Study|Withdrawal by Subject|7|||
161957376|NCT00040742|584891169|FG001|Overall Study|Withdrawal by Subject|15|||
161957377|NCT00040742|584891170|FG002|Overall Study|Withdrawal by Subject|10|||
161836963|NCT00856973|584446494|FG000|Overall Study|Lost to Follow-up|6|||
161836964|NCT00856973|584446495|FG001|Overall Study|Lost to Follow-up|3|||
161836965|NCT00856973|584446496|FG002|Overall Study|Lost to Follow-up|5|||
161836966|NCT00856973|584446494|FG000|Overall Study|Physician Decision|0|||
161836967|NCT00856973|584446495|FG001|Overall Study|Physician Decision|3|||
161836968|NCT00856973|584446496|FG002|Overall Study|Physician Decision|1|||
161836969|NCT00856973|584446494|FG000|Overall Study|Protocol Violation|1|||
161836970|NCT00856973|584446495|FG001|Overall Study|Protocol Violation|2|||
161836971|NCT00856973|584446496|FG002|Overall Study|Protocol Violation|1|||
161836972|NCT00856973|584446494|FG000|Overall Study|Withdrawal by Subject|13|||
161836973|NCT00856973|584446495|FG001|Overall Study|Withdrawal by Subject|16|||
161836974|NCT00856973|584446496|FG002|Overall Study|Withdrawal by Subject|15|||
161836975|NCT00856973|584446494|FG000|Overall Study|Other|11|||
161836976|NCT00856973|584446495|FG001|Overall Study|Other|12|||
161836977|NCT00856973|584446496|FG002|Overall Study|Other|13|||
161836978|NCT03955471|584446497|FG000|Overall Study|Death|22|||
161836979|NCT03955471|584446497|FG000|Overall Study|Lost to Follow-up|1|||
161836980|NCT03955471|584446497|FG000|Overall Study|Withdrawal by Subject|6|||
161836981|NCT03955471|584446497|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
161836982|NCT01030341|584446498|FG000|Overall Study|Withdrawal by Subject|1|||
161836983|NCT01030341|584446498|FG000|Overall Study|Lost to Follow-up|2|||
161836984|NCT01884311|584446499|FG000|Overall Study|Withdrawal by Subject|3|||
161836985|NCT01884311|584446499|FG000|Overall Study|withdrew consent due to AEs|1|||
161836986|NCT01884311|584446499|FG000|Overall Study|Precautionary measure|1|||
161836987|NCT03853148|584446501|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
161836988|NCT03853148|584446502|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
161836989|NCT03853148|584446503|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
161836990|NCT03853148|584446504|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
161836991|NCT00090610|584446505|FG000|Overall Study|Withdrawal by Subject|1|||
161836992|NCT00090610|584446506|FG001|Overall Study|Withdrawal by Subject|1|||
161836993|NCT03623386|584446509|FG000|Overall Study|Protocol Violation|3|||
161836994|NCT03623386|584446510|FG001|Overall Study|Protocol Violation|2|||
161836995|NCT03623386|584446511|FG002|Overall Study|Protocol Violation|0|||
161836996|NCT03623386|584446509|FG000|Overall Study|Physician Decision|1|||
161836997|NCT03623386|584446510|FG001|Overall Study|Physician Decision|1|||
161836998|NCT03623386|584446511|FG002|Overall Study|Physician Decision|0|||
161836999|NCT03623386|584446509|FG000|Overall Study|Lost to Follow-up|0|||
161837000|NCT03623386|584446510|FG001|Overall Study|Lost to Follow-up|2|||
161837001|NCT03623386|584446511|FG002|Overall Study|Lost to Follow-up|0|||
161837002|NCT03623386|584446509|FG000|Overall Study|COVID-19|0|||
161837003|NCT03623386|584446510|FG001|Overall Study|COVID-19|1|||
161837004|NCT03623386|584446511|FG002|Overall Study|COVID-19|0|||
161837005|NCT00599521|584446514|FG000|Overall Study|Lack of Efficacy|4|||
161837006|NCT00599521|584446515|FG001|Overall Study|Lack of Efficacy|8|||
161837007|NCT00599521|584446514|FG000|Overall Study|Adverse Event|4|||
161837008|NCT00599521|584446515|FG001|Overall Study|Adverse Event|1|||
161837009|NCT00599521|584446514|FG000|Overall Study|Withdrawal by Subject|28|||
161837010|NCT00599521|584446515|FG001|Overall Study|Withdrawal by Subject|34|||
161957378|NCT00040742|584891171|FG003|Overall Study|Withdrawal by Subject|13|||
161837011|NCT00599521|584446514|FG000|Overall Study|Protocol Violation|1|||
161837012|NCT00599521|584446515|FG001|Overall Study|Protocol Violation|1|||
161837013|NCT00599521|584446514|FG000|Overall Study|Lost to Follow-up|23|||
161837014|NCT00599521|584446515|FG001|Overall Study|Lost to Follow-up|23|||
161837015|NCT00599521|584446514|FG000|Overall Study|Pregnancy|0|||
161837016|NCT00599521|584446515|FG001|Overall Study|Pregnancy|2|||
161957379|NCT00040742|584891168|FG000|Overall Study|Chemotoxicity|4|||
161957380|NCT00040742|584891169|FG001|Overall Study|Chemotoxicity|3|||
161957381|NCT00040742|584891170|FG002|Overall Study|Chemotoxicity|5|||
161957382|NCT00040742|584891171|FG003|Overall Study|Chemotoxicity|2|||
161700902|NCT01925209|583953567|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
161700903|NCT01925209|583953568|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
161700904|NCT01925209|583953569|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
161700905|NCT01925209|583953570|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
161700906|NCT01925209|583953567|FG000|Treatment Epoch|Death|1|||
161700907|NCT01925209|583953568|FG001|Treatment Epoch|Death|0|||
161700908|NCT01925209|583953569|FG002|Treatment Epoch|Death|0|||
161700909|NCT01925209|583953570|FG003|Treatment Epoch|Death|0|||
161700910|NCT01925209|583953567|FG000|Treatment Epoch|Protocol deviation|0|||
161700911|NCT01925209|583953568|FG001|Treatment Epoch|Protocol deviation|0|||
161700912|NCT01925209|583953569|FG002|Treatment Epoch|Protocol deviation|1|||
161700913|NCT01925209|583953570|FG003|Treatment Epoch|Protocol deviation|1|||
161700914|NCT01925209|583953567|FG000|Treatment Epoch|Withdrawal by Subject|4|||
161700915|NCT01925209|583953568|FG001|Treatment Epoch|Withdrawal by Subject|3|||
161700916|NCT01925209|583953569|FG002|Treatment Epoch|Withdrawal by Subject|3|||
161700917|NCT01925209|583953570|FG003|Treatment Epoch|Withdrawal by Subject|2|||
161700918|NCT01925209|583953567|FG000|Treatment Epoch|Adverse Event|3|||
161700919|NCT01925209|583953568|FG001|Treatment Epoch|Adverse Event|5|||
161700920|NCT01925209|583953569|FG002|Treatment Epoch|Adverse Event|3|||
161700921|NCT01925209|583953570|FG003|Treatment Epoch|Adverse Event|1|||
161700922|NCT01925209|583953567|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
161700923|NCT01925209|583953568|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
161700924|NCT01925209|583953569|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
161700925|NCT01925209|583953570|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
161700926|NCT01925209|583953567|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
161700927|NCT01925209|583953568|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
161700928|NCT01925209|583953569|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
161700929|NCT01925209|583953570|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
161700930|NCT01925209|583953567|FG000|Follow-up|Adverse Event|1|||
161700931|NCT01925209|583953568|FG001|Follow-up|Adverse Event|4|||
161700932|NCT01925209|583953569|FG002|Follow-up|Adverse Event|0|||
161700933|NCT01925209|583953570|FG003|Follow-up|Adverse Event|1|||
161700934|NCT01925209|583953567|FG000|Follow-up|Physician Decision|0|||
161700935|NCT01925209|583953568|FG001|Follow-up|Physician Decision|0|||
161700936|NCT01925209|583953569|FG002|Follow-up|Physician Decision|1|||
161700937|NCT01925209|583953570|FG003|Follow-up|Physician Decision|0|||
161700938|NCT01925209|583953567|FG000|Follow-up|Non-compliance with study treatment|0|||
161700939|NCT01925209|583953568|FG001|Follow-up|Non-compliance with study treatment|0|||
161700940|NCT01925209|583953569|FG002|Follow-up|Non-compliance with study treatment|0|||
161700941|NCT01925209|583953570|FG003|Follow-up|Non-compliance with study treatment|1|||
161700942|NCT01925209|583953567|FG000|Follow-up|Withdrawal by Subject|0|||
161700943|NCT01925209|583953568|FG001|Follow-up|Withdrawal by Subject|2|||
161700944|NCT01925209|583953569|FG002|Follow-up|Withdrawal by Subject|0|||
161700945|NCT01925209|583953570|FG003|Follow-up|Withdrawal by Subject|2|||
161700946|NCT01299727|583953571|FG000|Overall Study|Withdrawal by Subject|1|||
161700947|NCT01299727|583953572|FG001|Overall Study|Withdrawal by Subject|0|||
161700948|NCT01299727|583953573|FG002|Overall Study|Withdrawal by Subject|0|||
161700949|NCT01299727|583953571|FG000|Overall Study|Adverse Event|0|||
161700950|NCT01299727|583953572|FG001|Overall Study|Adverse Event|0|||
161700951|NCT01299727|583953573|FG002|Overall Study|Adverse Event|1|||
161700952|NCT01299727|583953571|FG000|Overall Study|Completed the Treatment Period|3|||
161700953|NCT01299727|583953572|FG001|Overall Study|Completed the Treatment Period|4|||
161700954|NCT01299727|583953573|FG002|Overall Study|Completed the Treatment Period|3|||
161700955|NCT03882424|583953575|FG000|Overall Study|Lost to Follow-up|3|||
161700956|NCT03882424|583953576|FG001|Overall Study|Lost to Follow-up|0|||
161700957|NCT03882424|583953577|FG002|Overall Study|Lost to Follow-up|0|||
161700958|NCT03882424|583953575|FG000|Overall Study|schedule conflict|1|||
161700959|NCT03882424|583953576|FG001|Overall Study|schedule conflict|0|||
161700960|NCT03882424|583953577|FG002|Overall Study|schedule conflict|0|||
161700961|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Adverse Event|21|||
161700962|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Adverse Event|6|||
161700963|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
161700964|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
161700965|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
161700966|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
161700967|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
161700968|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
161700969|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Physician Decision|0|||
161700970|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Physician Decision|3|||
161700971|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
161700972|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
161700973|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
161700974|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
161700975|NCT00510276|583953587|FG000|Acute Double-Blind Phase|Subject Decision|26|||
161700976|NCT00510276|583953588|FG001|Acute Double-Blind Phase|Subject Decision|28|||
161700977|NCT00510276|583953587|FG000|Extension Open-Label Phase|Adverse Event|9|||
161700978|NCT00510276|583953588|FG001|Extension Open-Label Phase|Adverse Event|18|||
161700979|NCT00510276|583953587|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
161700980|NCT00510276|583953588|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
161700981|NCT00510276|583953587|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
161700982|NCT00510276|583953588|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
161700983|NCT00510276|583953587|FG000|Extension Open-Label Phase|Physician Decision|2|||
161700984|NCT00510276|583953588|FG001|Extension Open-Label Phase|Physician Decision|3|||
161700985|NCT00510276|583953587|FG000|Extension Open-Label Phase|Protocol Violation|0|||
161700986|NCT00510276|583953588|FG001|Extension Open-Label Phase|Protocol Violation|1|||
161700987|NCT00510276|583953587|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
161700988|NCT00510276|583953588|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
161700989|NCT00510276|583953587|FG000|Extension Open-Label Phase|Subject Decision|7|||
161700990|NCT00510276|583953588|FG001|Extension Open-Label Phase|Subject Decision|9|||
161700991|NCT00441792|583953589|FG000|Overall Study|Lost to Follow-up|0|||
161700992|NCT00441792|583953590|FG001|Overall Study|Lost to Follow-up|2|||
161700993|NCT01731678|583953591|FG000|Overall Study|Withdrawal by Subject|3|||
161700994|NCT01731678|583953591|FG000|Overall Study|Did not meet inclusion criteria|1|||
161700995|NCT01731678|583953591|FG000|Overall Study|RMT too high, making TMS difficult|3|||
161700996|NCT00888355|583953594|FG000|Overall Study|Adverse Event|10|||
161700997|NCT00888355|583953595|FG001|Overall Study|Adverse Event|0|||
161700998|NCT00888355|583953596|FG002|Overall Study|Adverse Event|3|||
161700999|NCT00888355|583953597|FG003|Overall Study|Adverse Event|3|||
161701000|NCT00888355|583953594|FG000|Overall Study|Lack of Efficacy|9|||
161701001|NCT00888355|583953595|FG001|Overall Study|Lack of Efficacy|2|||
161701002|NCT00888355|583953596|FG002|Overall Study|Lack of Efficacy|5|||
161701003|NCT00888355|583953597|FG003|Overall Study|Lack of Efficacy|2|||
161701004|NCT00888355|583953594|FG000|Overall Study|Lost to Follow-up|0|||
161701005|NCT00888355|583953595|FG001|Overall Study|Lost to Follow-up|2|||
161701006|NCT00888355|583953596|FG002|Overall Study|Lost to Follow-up|2|||
161701007|NCT00888355|583953597|FG003|Overall Study|Lost to Follow-up|0|||
161701008|NCT00888355|583953594|FG000|Overall Study|Protocol Violation|3|||
161701009|NCT00888355|583953595|FG001|Overall Study|Protocol Violation|2|||
161701010|NCT00888355|583953596|FG002|Overall Study|Protocol Violation|1|||
161701011|NCT00888355|583953597|FG003|Overall Study|Protocol Violation|2|||
161701012|NCT00888355|583953594|FG000|Overall Study|Withdrawal by Subject|0|||
161701013|NCT00888355|583953595|FG001|Overall Study|Withdrawal by Subject|3|||
161701014|NCT00888355|583953596|FG002|Overall Study|Withdrawal by Subject|1|||
161701015|NCT00888355|583953597|FG003|Overall Study|Withdrawal by Subject|3|||
161701016|NCT04025632|583955512|FG000|Overall Study|Adverse Event|1|||
161701017|NCT04025632|583955513|FG001|Overall Study|Adverse Event|1|||
161701018|NCT04025632|583955512|FG000|Overall Study|Withdrawal by Subject|1|||
161701019|NCT04025632|583955513|FG001|Overall Study|Withdrawal by Subject|1|||
161701020|NCT04025632|583955512|FG000|Overall Study|Study Terminated by Sponsor|10|||
161701021|NCT04025632|583955513|FG001|Overall Study|Study Terminated by Sponsor|9|||
161701022|NCT04025632|583955512|FG000|Overall Study|Physician Decision|3|||
161701023|NCT04025632|583955513|FG001|Overall Study|Physician Decision|1|||
161701024|NCT00376961|583955514|FG000|Initial Registration|Adverse Event|1|||
161701025|NCT00376961|583955515|FG001|Initial Registration|Adverse Event|0|||
161701026|NCT00376961|583955514|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
161701027|NCT00376961|583955515|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161701028|NCT00376961|583955514|FG000|Initial Registration|Progression/relapse|1|||
161701029|NCT00376961|583955515|FG001|Initial Registration|Progression/relapse|0|||
161701030|NCT00376961|583955514|FG000|Initial Registration|Ineligible|3|||
161701031|NCT00376961|583955515|FG001|Initial Registration|Ineligible|0|||
161701032|NCT00376961|583955514|FG000|Maintenance|Adverse Event|0|||
161701033|NCT00376961|583955515|FG001|Maintenance|Adverse Event|1|||
161701034|NCT00376961|583955514|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
161701035|NCT00376961|583955515|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
161701036|NCT00376961|583955514|FG000|Maintenance|Progression/relapse|0|||
161701037|NCT00376961|583955515|FG001|Maintenance|Progression/relapse|18|||
161701038|NCT00376961|583955514|FG000|Maintenance|Ineligible|0|||
161701039|NCT00376961|583955515|FG001|Maintenance|Ineligible|3|||
161701040|NCT02591615|583955522|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
161701041|NCT02591615|583955523|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
161701042|NCT02591615|583955524|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
161701043|NCT02591615|583955525|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
161701044|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
161701045|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
161701046|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
161701047|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
161701048|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
161701049|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
161701050|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
161701051|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
161957383|NCT00040742|584891168|FG000|Overall Study|Incomplete Forms|6|||
161957384|NCT00040742|584891169|FG001|Overall Study|Incomplete Forms|10|||
161957385|NCT00040742|584891170|FG002|Overall Study|Incomplete Forms|4|||
161957386|NCT00040742|584891171|FG003|Overall Study|Incomplete Forms|5|||
161957387|NCT00040742|584891168|FG000|Overall Study|Other medical|7|||
161957388|NCT00040742|584891169|FG001|Overall Study|Other medical|5|||
161957389|NCT00040742|584891170|FG002|Overall Study|Other medical|5|||
161701052|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
161701053|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
161701054|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
161701055|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
161957390|NCT00040742|584891171|FG003|Overall Study|Other medical|5|||
161957391|NCT00624468|584891172|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
161957392|NCT00624468|584891173|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
161957393|NCT00624468|584891174|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
161957394|NCT00624468|584891175|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
161957395|NCT00624468|584891172|FG000|Double-blind Period|Withdrew Prematurely|1|||
161957396|NCT00624468|584891173|FG001|Double-blind Period|Withdrew Prematurely|1|||
161957397|NCT00624468|584891174|FG002|Double-blind Period|Withdrew Prematurely|0|||
161957398|NCT00624468|584891175|FG003|Double-blind Period|Withdrew Prematurely|0|||
161957399|NCT00624468|584891172|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
161957400|NCT00624468|584891173|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
161957401|NCT00624468|584891174|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
161957402|NCT00624468|584891175|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
161957403|NCT00624468|584891172|FG000|Safety Follow-up (SFU) Period|Other|0|||
161957404|NCT00624468|584891173|FG001|Safety Follow-up (SFU) Period|Other|0|||
161957405|NCT00624468|584891174|FG002|Safety Follow-up (SFU) Period|Other|1|||
161957406|NCT00624468|584891175|FG003|Safety Follow-up (SFU) Period|Other|1|||
161957407|NCT03520920|584891176|FG000|Overall Study|Death|13|||
161957408|NCT03520920|584891177|FG001|Overall Study|Death|1|||
161957409|NCT03520920|584891178|FG002|Overall Study|Death|0|||
161957410|NCT03520920|584891176|FG000|Overall Study|Withdrawal by Subject|2|||
161957411|NCT03520920|584891177|FG001|Overall Study|Withdrawal by Subject|1|||
161957412|NCT03520920|584891178|FG002|Overall Study|Withdrawal by Subject|0|||
161957413|NCT03520920|584891176|FG000|Overall Study|Study Terminated by the Sponsor|5|||
161957414|NCT03520920|584891177|FG001|Overall Study|Study Terminated by the Sponsor|14|||
161957415|NCT03520920|584891178|FG002|Overall Study|Study Terminated by the Sponsor|5|||
161957416|NCT01523743|584891179|FG000|Period 1|Adverse Event|1|||
161957417|NCT01523743|584891180|FG001|Period 1|Adverse Event|0|||
161957418|NCT01523743|584891179|FG000|Period 1|Withdrawal by Subject|6|||
161957419|NCT01523743|584891180|FG001|Period 1|Withdrawal by Subject|2|||
161957420|NCT01523743|584891179|FG000|Period 1|Lost to Follow-up|1|||
161957421|NCT01523743|584891180|FG001|Period 1|Lost to Follow-up|0|||
161957422|NCT01523743|584891179|FG000|Period 1|Lack of Efficacy|1|||
161957423|NCT01523743|584891180|FG001|Period 1|Lack of Efficacy|0|||
161957424|NCT01523743|584891179|FG000|Period 1|Felt unable to empty bladder|1|||
161957425|NCT01523743|584891180|FG001|Period 1|Felt unable to empty bladder|0|||
161957426|NCT01523743|584891179|FG000|Period 2|Withdrawal by Subject|0|||
161957427|NCT01523743|584891180|FG001|Period 2|Withdrawal by Subject|2|||
161957428|NCT01523743|584891179|FG000|Period 2|Adverse Event|1|||
161957429|NCT01523743|584891180|FG001|Period 2|Adverse Event|0|||
161957430|NCT02446769|584891183|FG000|Screening Period|Screen Failure|11|||
161957431|NCT02446769|584891184|FG001|Screening Period|Screen Failure|0|||
161957432|NCT02446769|584891185|FG002|Screening Period|Screen Failure|0|||
161957433|NCT02446769|584891183|FG000|Study Period|Randomized in Error|0|||
161957434|NCT02446769|584891184|FG001|Study Period|Randomized in Error|2|||
161957435|NCT02446769|584891185|FG002|Study Period|Randomized in Error|0|||
161957436|NCT02441101|584891187|FG000|Overall Study|Withdrawal by Subject|1|||
161957437|NCT02441101|584891188|FG001|Overall Study|Withdrawal by Subject|0|||
161957438|NCT02441101|584891187|FG000|Overall Study|Lost to Follow-up|1|||
161957439|NCT02441101|584891188|FG001|Overall Study|Lost to Follow-up|0|||
161957440|NCT02441101|584891187|FG000|Overall Study|PI relocated and study terminated|1|||
161957441|NCT02441101|584891188|FG001|Overall Study|PI relocated and study terminated|0|||
161957442|NCT02528942|584891189|FG000|Overall Study|Did not meet imaging criteria|9|||
161957443|NCT02528942|584891189|FG000|Overall Study|Lost to Follow-up|25|||
161957444|NCT03035864|584891190|FG000|Treatment Period|Adverse Event|1|||
161957445|NCT03035864|584891191|FG001|Treatment Period|Adverse Event|0|||
161957446|NCT03035864|584891190|FG000|Treatment Period|Other|3|||
161957447|NCT03035864|584891191|FG001|Treatment Period|Other|1|||
161701056|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
161701057|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
161701058|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
161701059|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
161957448|NCT03035864|584891190|FG000|Follow-up Period|Adverse Event|1|||
161957449|NCT03035864|584891191|FG001|Follow-up Period|Adverse Event|0|||
161957450|NCT03035864|584891190|FG000|Follow-up Period|Lost to Follow-up|6|||
161957451|NCT03035864|584891191|FG001|Follow-up Period|Lost to Follow-up|2|||
161957452|NCT03035864|584891190|FG000|Follow-up Period|Physician Decision|1|||
161957453|NCT03035864|584891191|FG001|Follow-up Period|Physician Decision|0|||
161957454|NCT03035864|584891190|FG000|Follow-up Period|Other|3|||
161957455|NCT03035864|584891191|FG001|Follow-up Period|Other|2|||
161957456|NCT00100802|584891194|FG000|Overall Study|Adverse Event|9|||
161957457|NCT00100802|584891194|FG000|Overall Study|Death|1|||
161957458|NCT00100802|584891194|FG000|Overall Study|Lack of Efficacy|47|||
161957459|NCT00100802|584891194|FG000|Overall Study|Physician Decision|5|||
161957460|NCT00100802|584891194|FG000|Overall Study|Protocol Violation|1|||
161701060|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
161701061|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
161701062|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
161701063|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
161701064|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
161701065|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
161701066|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
161701067|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
161701068|NCT02591615|583955522|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
161701069|NCT02591615|583955523|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
161701070|NCT02591615|583955524|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
161701071|NCT02591615|583955525|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
161701072|NCT02591615|583955522|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
161701073|NCT02591615|583955523|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
161701074|NCT02591615|583955524|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
161701075|NCT02591615|583955525|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
161701076|NCT02591615|583955522|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
161701077|NCT02591615|583955523|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
161701078|NCT02591615|583955524|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
161701079|NCT02591615|583955525|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
161701080|NCT02591615|583955522|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
161701081|NCT02591615|583955523|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
161701082|NCT02591615|583955524|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
161701083|NCT02591615|583955525|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
161701084|NCT02591615|583955522|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
161701085|NCT02591615|583955523|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
161701086|NCT02591615|583955524|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
161701087|NCT02591615|583955525|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
161701088|NCT02591615|583955522|FG000|Maintenance MK-3475|Adverse Event|0|||
161701089|NCT02591615|583955523|FG001|Maintenance MK-3475|Adverse Event|3|||
161701090|NCT02591615|583955524|FG002|Maintenance MK-3475|Adverse Event|1|||
161701091|NCT02591615|583955525|FG003|Maintenance MK-3475|Adverse Event|2|||
161701092|NCT02591615|583955522|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
161701093|NCT02591615|583955523|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
161701094|NCT02591615|583955524|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
161701095|NCT02591615|583955525|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
161701096|NCT02591615|583955522|FG000|Maintenance MK-3475|Death|0|||
161701097|NCT02591615|583955523|FG001|Maintenance MK-3475|Death|1|||
161701098|NCT02591615|583955524|FG002|Maintenance MK-3475|Death|1|||
161701099|NCT02591615|583955525|FG003|Maintenance MK-3475|Death|0|||
161701100|NCT02591615|583955522|FG000|Maintenance MK-3475|Physician discretion|0|||
161701101|NCT02591615|583955523|FG001|Maintenance MK-3475|Physician discretion|0|||
161701102|NCT02591615|583955524|FG002|Maintenance MK-3475|Physician discretion|1|||
161701103|NCT02591615|583955525|FG003|Maintenance MK-3475|Physician discretion|0|||
161701104|NCT02591615|583955522|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
161701105|NCT02591615|583955523|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
161701106|NCT02591615|583955524|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
161701107|NCT02591615|583955525|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
161701108|NCT02591615|583955522|FG000|Maintenance MK-3475|In active treatment|2|||
161701109|NCT02591615|583955523|FG001|Maintenance MK-3475|In active treatment|0|||
161701110|NCT02591615|583955524|FG002|Maintenance MK-3475|In active treatment|0|||
161701111|NCT02591615|583955525|FG003|Maintenance MK-3475|In active treatment|1|||
161701112|NCT01793792|583955526|FG000|Overall Study|Death|5|||
161701113|NCT01793792|583955526|FG000|Overall Study|Lost to Follow-up|5|||
161701114|NCT01793792|583955526|FG000|Overall Study|Withdrawal by Subject|1|||
161701115|NCT01793792|583955526|FG000|Overall Study|Device Not Implanted|1|||
161701116|NCT00851903|583955529|FG000|Overall Study|Withdrawal by Subject|2|||
161701117|NCT00686127|583955532|FG000|Overall Study|Withdrawal by Subject|14|||
161837017|NCT05855616|584446516|FG000|Overall Study|Lost to Follow-up|1|||
161837018|NCT05855616|584446517|FG001|Overall Study|Lost to Follow-up|2|||
161837019|NCT01388166|584446518|FG000|Overall Study|Adverse Event|16|||
161837020|NCT01388166|584446518|FG000|Overall Study|Lost to Follow-up|30|||
161701118|NCT00686127|583955533|FG001|Overall Study|Withdrawal by Subject|6|||
161701119|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
161701120|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
161701121|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
161701122|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
161701123|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
161701124|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
161837021|NCT01388166|584446518|FG000|Overall Study|Others than specified above|13|||
161837022|NCT02751359|584446524|FG000|Overall Study|Lost to Follow-up|1|||
161701125|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
161701126|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
161701127|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161701128|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161701129|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161701130|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
161701131|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
161701132|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161701133|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161701134|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
161701135|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
161701136|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
161701137|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
161701138|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
161701139|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
161701140|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
161701141|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
161701142|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
161701143|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
161701144|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
161701145|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
161701146|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
161701147|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
161701148|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
161701149|NCT05195528|583955539|FG000|Placebo-controlled Treatment Period|Other|0|||
161701150|NCT05195528|583955540|FG001|Placebo-controlled Treatment Period|Other|0|||
161701151|NCT05195528|583955541|FG002|Placebo-controlled Treatment Period|Other|1|||
161701152|NCT05195528|583955542|FG003|Placebo-controlled Treatment Period|Other|0|||
161701153|NCT05195528|583955543|FG004|Placebo-controlled Treatment Period|Other|0|||
161701154|NCT05195528|583955539|FG000|Extension Period|PTE or AE or SAE|0|||
161701155|NCT05195528|583955540|FG001|Extension Period|PTE or AE or SAE|4|||
161701156|NCT05195528|583955541|FG002|Extension Period|PTE or AE or SAE|5|||
161701157|NCT05195528|583955542|FG003|Extension Period|PTE or AE or SAE|4|||
161701158|NCT05195528|583955543|FG004|Extension Period|PTE or AE or SAE|4|||
161701159|NCT05195528|583955539|FG000|Extension Period|Protocol Violation|0|||
161701160|NCT05195528|583955540|FG001|Extension Period|Protocol Violation|2|||
161701161|NCT05195528|583955541|FG002|Extension Period|Protocol Violation|1|||
161701162|NCT05195528|583955542|FG003|Extension Period|Protocol Violation|0|||
161701163|NCT05195528|583955543|FG004|Extension Period|Protocol Violation|1|||
161701164|NCT05195528|583955539|FG000|Extension Period|Lost to Follow-up|0|||
161701165|NCT05195528|583955540|FG001|Extension Period|Lost to Follow-up|6|||
161701166|NCT05195528|583955541|FG002|Extension Period|Lost to Follow-up|13|||
161701167|NCT05195528|583955542|FG003|Extension Period|Lost to Follow-up|3|||
161701168|NCT05195528|583955543|FG004|Extension Period|Lost to Follow-up|7|||
161701169|NCT05195528|583955539|FG000|Extension Period|Withdrawal by Subject|0|||
161701170|NCT05195528|583955540|FG001|Extension Period|Withdrawal by Subject|12|||
161701171|NCT05195528|583955541|FG002|Extension Period|Withdrawal by Subject|9|||
161701172|NCT05195528|583955542|FG003|Extension Period|Withdrawal by Subject|6|||
161701173|NCT05195528|583955543|FG004|Extension Period|Withdrawal by Subject|5|||
161701174|NCT05195528|583955539|FG000|Extension Period|Lack of Efficacy|0|||
161701175|NCT05195528|583955540|FG001|Extension Period|Lack of Efficacy|3|||
161701176|NCT05195528|583955541|FG002|Extension Period|Lack of Efficacy|0|||
161701177|NCT05195528|583955542|FG003|Extension Period|Lack of Efficacy|0|||
161701178|NCT05195528|583955543|FG004|Extension Period|Lack of Efficacy|2|||
161701179|NCT05195528|583955539|FG000|Extension Period|Not Treated|0|||
161701180|NCT05195528|583955540|FG001|Extension Period|Not Treated|0|||
161701181|NCT05195528|583955541|FG002|Extension Period|Not Treated|2|||
161701182|NCT05195528|583955542|FG003|Extension Period|Not Treated|3|||
161837023|NCT01196078|584446525|FG000|Overall Study|Withdrawal by Subject|3|||
161837024|NCT01196078|584446526|FG001|Overall Study|Withdrawal by Subject|5|||
161837025|NCT01196078|584446525|FG000|Overall Study|Adverse Event|4|||
161837026|NCT01196078|584446526|FG001|Overall Study|Adverse Event|4|||
161837027|NCT01196078|584446525|FG000|Overall Study|Protocol Violation|2|||
161701183|NCT05195528|583955543|FG004|Extension Period|Not Treated|0|||
161701184|NCT05195528|583955539|FG000|Extension Period|Other|0|||
161701185|NCT05195528|583955540|FG001|Extension Period|Other|1|||
161701186|NCT05195528|583955541|FG002|Extension Period|Other|1|||
161701187|NCT05195528|583955542|FG003|Extension Period|Other|0|||
161837028|NCT01196078|584446526|FG001|Overall Study|Protocol Violation|1|||
161837029|NCT01196078|584446525|FG000|Overall Study|Lack of Efficacy|17|||
161957461|NCT00100802|584891194|FG000|Overall Study|Withdrawal by Subject|5|||
161957462|NCT00100802|584891194|FG000|Overall Study|Ineligible|12|||
161701188|NCT05195528|583955543|FG004|Extension Period|Other|0|||
161701189|NCT01552902|583955544|FG000|Overall Study|Adverse Event|1|||
161701190|NCT01552902|583955545|FG001|Overall Study|Adverse Event|15|||
161701191|NCT01552902|583955546|FG002|Overall Study|Adverse Event|14|||
161701192|NCT01552902|583955544|FG000|Overall Study|Protocol Violation|3|||
161701193|NCT01552902|583955545|FG001|Overall Study|Protocol Violation|3|||
161701194|NCT01552902|583955546|FG002|Overall Study|Protocol Violation|3|||
161701195|NCT01552902|583955544|FG000|Overall Study|Lack of Efficacy|4|||
161701196|NCT01552902|583955545|FG001|Overall Study|Lack of Efficacy|3|||
161701197|NCT01552902|583955546|FG002|Overall Study|Lack of Efficacy|1|||
161701198|NCT01552902|583955544|FG000|Overall Study|Withdrawal by Subject|1|||
161701199|NCT01552902|583955545|FG001|Overall Study|Withdrawal by Subject|9|||
161701200|NCT01552902|583955546|FG002|Overall Study|Withdrawal by Subject|6|||
161701201|NCT01552902|583955544|FG000|Overall Study|Lost to Follow-up|1|||
161701202|NCT01552902|583955545|FG001|Overall Study|Lost to Follow-up|3|||
161701203|NCT01552902|583955546|FG002|Overall Study|Lost to Follow-up|6|||
161701204|NCT01552902|583955544|FG000|Overall Study|Other|3|||
161701205|NCT01552902|583955545|FG001|Overall Study|Other|4|||
161701206|NCT01552902|583955546|FG002|Overall Study|Other|3|||
161837030|NCT01196078|584446526|FG001|Overall Study|Lack of Efficacy|23|||
161837031|NCT01196078|584446525|FG000|Overall Study|Lost to Follow-up|1|||
162030814|NCT03400956|585169490|FG000|Post-treatment Period 1|Adverse Event|0|||
162030815|NCT03400956|585169491|FG001|Post-treatment Period 1|Adverse Event|0|||
161701207|NCT02487108|583955547|FG000|Overall Study|Adverse Event|1|||
161701208|NCT02487108|583955548|FG001|Overall Study|Adverse Event|6|||
161701209|NCT02487108|583955549|FG002|Overall Study|Adverse Event|12|||
162030816|NCT03400956|585169492|FG002|Post-treatment Period 1|Adverse Event|1|||
161701210|NCT02487108|583955550|FG003|Overall Study|Adverse Event|6|||
161701211|NCT02487108|583955547|FG000|Overall Study|Withdrawal by Subject|8|||
161701212|NCT02487108|583955548|FG001|Overall Study|Withdrawal by Subject|5|||
161701213|NCT02487108|583955549|FG002|Overall Study|Withdrawal by Subject|5|||
161701214|NCT02487108|583955550|FG003|Overall Study|Withdrawal by Subject|0|||
161701215|NCT02487108|583955547|FG000|Overall Study|Non-compliance to study medication|3|||
161701216|NCT02487108|583955548|FG001|Overall Study|Non-compliance to study medication|2|||
161701217|NCT02487108|583955549|FG002|Overall Study|Non-compliance to study medication|5|||
161701218|NCT02487108|583955550|FG003|Overall Study|Non-compliance to study medication|4|||
161701219|NCT02487108|583955547|FG000|Overall Study|Protocol Violation|1|||
161701220|NCT02487108|583955548|FG001|Overall Study|Protocol Violation|1|||
161701221|NCT02487108|583955549|FG002|Overall Study|Protocol Violation|2|||
161701222|NCT02487108|583955550|FG003|Overall Study|Protocol Violation|0|||
161701223|NCT02487108|583955547|FG000|Overall Study|Non-compliance to study procedures|0|||
161701224|NCT02487108|583955548|FG001|Overall Study|Non-compliance to study procedures|0|||
161701225|NCT02487108|583955549|FG002|Overall Study|Non-compliance to study procedures|0|||
161701226|NCT02487108|583955550|FG003|Overall Study|Non-compliance to study procedures|1|||
161701227|NCT02487108|583955547|FG000|Overall Study|Other than specified|3|||
161701228|NCT02487108|583955548|FG001|Overall Study|Other than specified|2|||
161701229|NCT02487108|583955549|FG002|Overall Study|Other than specified|2|||
161701230|NCT02487108|583955550|FG003|Overall Study|Other than specified|0|||
161701231|NCT00469612|583955551|FG000|Overall Study|Study terminated before data collected|2|||
161701232|NCT00469612|583955552|FG001|Overall Study|Study terminated before data collected|0|||
161701233|NCT02720757|583955553|FG000|Overall Study|Other reason|5|||
161701234|NCT02720757|583955553|FG000|Overall Study|Loss of contact|4|||
161701235|NCT02720757|583955553|FG000|Overall Study|Informed consent withdrawal|1|||
161701236|NCT02720757|583955553|FG000|Overall Study|Patients wish to withdraw|2|||
161701237|NCT02720757|583955553|FG000|Overall Study|Missing|3|||
161701238|NCT02720757|583955553|FG000|Overall Study|General exclusion|3|||
161701239|NCT02357420|583955554|FG000|Overall Study|Adverse Event|3|||
161957463|NCT03381287|584891196|FG000|Overall Study|Withdrawal by Subject|0|||
161957464|NCT03381287|584891197|FG001|Overall Study|Withdrawal by Subject|1|||
161957465|NCT03381287|584891198|FG002|Overall Study|Withdrawal by Subject|0|||
161957466|NCT03381287|584891199|FG003|Overall Study|Withdrawal by Subject|0|||
161957467|NCT03381287|584891196|FG000|Overall Study|Adverse Event|0|||
161957468|NCT03381287|584891197|FG001|Overall Study|Adverse Event|0|||
161957469|NCT03381287|584891198|FG002|Overall Study|Adverse Event|0|||
161957470|NCT03381287|584891199|FG003|Overall Study|Adverse Event|1|||
161957471|NCT03381287|584891196|FG000|Overall Study|Physician Decision|0|||
161957472|NCT03381287|584891197|FG001|Overall Study|Physician Decision|0|||
161957473|NCT03381287|584891198|FG002|Overall Study|Physician Decision|0|||
161957474|NCT03381287|584891199|FG003|Overall Study|Physician Decision|1|||
161957475|NCT03744910|584892612|FG000|Overall Study|Withdrew Consent|1|||
161957476|NCT03744910|584892613|FG001|Overall Study|Withdrew Consent|8|||
161957477|NCT03744910|584892612|FG000|Overall Study|Physician Decision|5|||
161957478|NCT03744910|584892613|FG001|Overall Study|Physician Decision|4|||
161957479|NCT03744910|584892612|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
161957480|NCT03744910|584892613|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
161957481|NCT03744910|584892612|FG000|Overall Study|Lost to Follow-up|0|||
161957482|NCT03744910|584892613|FG001|Overall Study|Lost to Follow-up|1|||
161957483|NCT03744910|584892612|FG000|Overall Study|Other-unspecified|4|||
161957484|NCT03744910|584892613|FG001|Overall Study|Other-unspecified|1|||
161957485|NCT03430843|584892615|FG000|Overall Study|Death|233|||
161957486|NCT03430843|584892616|FG001|Overall Study|Death|233|||
161957487|NCT03430843|584892615|FG000|Overall Study|Sponsor Decision|17|||
161957488|NCT03430843|584892616|FG001|Overall Study|Sponsor Decision|6|||
161957489|NCT03430843|584892615|FG000|Overall Study|Withdrawal by Subject|5|||
161957490|NCT03430843|584892616|FG001|Overall Study|Withdrawal by Subject|14|||
161957491|NCT03430843|584892615|FG000|Overall Study|Lost to Follow-up|1|||
161957492|NCT03430843|584892616|FG001|Overall Study|Lost to Follow-up|3|||
161957493|NCT05360966|584892627|FG000|Overall Study|Adverse Event|5|||
161957494|NCT05360966|584892628|FG001|Overall Study|Adverse Event|5|||
161957495|NCT05360966|584892627|FG000|Overall Study|Withdrawal of Consent|5|||
161957496|NCT05360966|584892628|FG001|Overall Study|Withdrawal of Consent|3|||
161701240|NCT02357420|583955555|FG001|Overall Study|Adverse Event|3|||
161957497|NCT05360966|584892627|FG000|Overall Study|Noncompliance|2|||
161957498|NCT05360966|584892628|FG001|Overall Study|Noncompliance|1|||
161957499|NCT05360966|584892627|FG000|Overall Study|Lost to Follow-up|2|||
161957500|NCT05360966|584892628|FG001|Overall Study|Lost to Follow-up|3|||
161701241|NCT02357420|583955556|FG002|Overall Study|Adverse Event|8|||
161701242|NCT02357420|583955557|FG003|Overall Study|Adverse Event|9|||
161701243|NCT02357420|583955554|FG000|Overall Study|Investigator Decision|1|||
161701244|NCT02357420|583955555|FG001|Overall Study|Investigator Decision|0|||
161701245|NCT02357420|583955556|FG002|Overall Study|Investigator Decision|0|||
161837032|NCT01196078|584446526|FG001|Overall Study|Lost to Follow-up|0|||
161957501|NCT05360966|584892627|FG000|Overall Study|Protocol Deviation|2|||
161957502|NCT05360966|584892628|FG001|Overall Study|Protocol Deviation|1|||
161957503|NCT05360966|584892627|FG000|Overall Study|As specified in the Clinical Study Report|1|||
161957504|NCT05360966|584892628|FG001|Overall Study|As specified in the Clinical Study Report|3|||
161701246|NCT02357420|583955557|FG003|Overall Study|Investigator Decision|0|||
161701247|NCT02357420|583955554|FG000|Overall Study|Prohibited Medication|1|||
161701248|NCT02357420|583955555|FG001|Overall Study|Prohibited Medication|1|||
161701249|NCT02357420|583955556|FG002|Overall Study|Prohibited Medication|0|||
161701250|NCT02357420|583955557|FG003|Overall Study|Prohibited Medication|0|||
161701251|NCT02357420|583955554|FG000|Overall Study|Protocol Non-compliance|0|||
161701252|NCT02357420|583955555|FG001|Overall Study|Protocol Non-compliance|0|||
161701253|NCT02357420|583955556|FG002|Overall Study|Protocol Non-compliance|0|||
161701254|NCT02357420|583955557|FG003|Overall Study|Protocol Non-compliance|1|||
161701255|NCT02357420|583955554|FG000|Overall Study|Withdrawn Consent|4|||
161701256|NCT02357420|583955555|FG001|Overall Study|Withdrawn Consent|8|||
161701257|NCT02357420|583955556|FG002|Overall Study|Withdrawn Consent|6|||
161701258|NCT02357420|583955557|FG003|Overall Study|Withdrawn Consent|6|||
161701259|NCT02357420|583955554|FG000|Overall Study|Lost to Follow-up|3|||
161701260|NCT02357420|583955555|FG001|Overall Study|Lost to Follow-up|0|||
161701261|NCT02357420|583955556|FG002|Overall Study|Lost to Follow-up|2|||
161701262|NCT02357420|583955557|FG003|Overall Study|Lost to Follow-up|3|||
161701263|NCT00214461|583955558|FG000|Overall Study|Adverse Event|0|||
161701264|NCT00214461|583955559|FG001|Overall Study|Adverse Event|0|||
161701265|NCT00214461|583955560|FG002|Overall Study|Adverse Event|1|||
161701266|NCT00214461|583955561|FG003|Overall Study|Adverse Event|1|||
161701267|NCT00214461|583955558|FG000|Overall Study|Withdrawal by Subject|0|||
161701268|NCT00214461|583955559|FG001|Overall Study|Withdrawal by Subject|0|||
161701269|NCT00214461|583955560|FG002|Overall Study|Withdrawal by Subject|1|||
161701270|NCT00214461|583955561|FG003|Overall Study|Withdrawal by Subject|0|||
161701271|NCT00364689|583955562|FG000|Overall Study|Lost to Follow-up|1|||
161701272|NCT00234039|583955565|FG000|Overall Study|Adverse Event|2|||
161701273|NCT00234039|583955565|FG000|Overall Study|Progression/relapse|34|||
161701274|NCT00234039|583955565|FG000|Overall Study|Other - Not Protocol Specified|3|||
161701275|NCT00234039|583955565|FG000|Overall Study|Ineligible|9|||
161701276|NCT00234039|583955565|FG000|Overall Study|No Protocol Treatment Received|2|||
161701277|NCT01808612|583955566|FG000|Treatment Period|Adverse Event|8|||
161701278|NCT01808612|583955567|FG001|Treatment Period|Adverse Event|4|||
161701279|NCT01808612|583955568|FG002|Treatment Period|Adverse Event|3|||
161701280|NCT01808612|583955566|FG000|Treatment Period|Lost to Follow-up|2|||
161701281|NCT01808612|583955567|FG001|Treatment Period|Lost to Follow-up|2|||
161701282|NCT01808612|583955568|FG002|Treatment Period|Lost to Follow-up|1|||
161701283|NCT01808612|583955566|FG000|Treatment Period|Protocol Violation|1|||
161701284|NCT01808612|583955567|FG001|Treatment Period|Protocol Violation|0|||
161701285|NCT01808612|583955568|FG002|Treatment Period|Protocol Violation|0|||
161701286|NCT01808612|583955566|FG000|Treatment Period|Withdrawal by Subject|1|||
161701287|NCT01808612|583955567|FG001|Treatment Period|Withdrawal by Subject|0|||
161701288|NCT01808612|583955568|FG002|Treatment Period|Withdrawal by Subject|4|||
161701289|NCT01808612|583955566|FG000|Treatment Period|Physician Decision|1|||
161701290|NCT01808612|583955567|FG001|Treatment Period|Physician Decision|0|||
161701291|NCT01808612|583955568|FG002|Treatment Period|Physician Decision|4|||
161701292|NCT01808612|583955566|FG000|Treatment Period|Sponsor Decision|1|||
161701293|NCT01808612|583955567|FG001|Treatment Period|Sponsor Decision|0|||
161701294|NCT01808612|583955568|FG002|Treatment Period|Sponsor Decision|0|||
161701295|NCT01808612|583955566|FG000|Treatment Period|Lack of Efficacy|1|||
161701296|NCT01808612|583955567|FG001|Treatment Period|Lack of Efficacy|1|||
161701297|NCT01808612|583955568|FG002|Treatment Period|Lack of Efficacy|2|||
161701298|NCT01808612|583955566|FG000|Discontinuation Period|Adverse Event|1|||
161701299|NCT01808612|583955567|FG001|Discontinuation Period|Adverse Event|0|||
161701300|NCT01808612|583955568|FG002|Discontinuation Period|Adverse Event|0|||
161701301|NCT01808612|583955566|FG000|Discontinuation Period|Physician Decision|1|||
161701302|NCT01808612|583955567|FG001|Discontinuation Period|Physician Decision|0|||
161701303|NCT01808612|583955568|FG002|Discontinuation Period|Physician Decision|0|||
161701304|NCT01808612|583955566|FG000|Discontinuation Period|Lost to Follow-up|0|||
161701305|NCT01808612|583955567|FG001|Discontinuation Period|Lost to Follow-up|1|||
161701306|NCT01808612|583955568|FG002|Discontinuation Period|Lost to Follow-up|0|||
161957505|NCT05396014|584892629|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
161957506|NCT05396014|584892630|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957507|NCT05396014|584892631|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161701307|NCT03683394|583955569|FG000|Overall Study|Withdrawal by Subject|4|||
161701308|NCT03683394|583955570|FG001|Overall Study|Withdrawal by Subject|8|||
161701309|NCT03683394|583955569|FG000|Overall Study|Lost to Follow-up|7|||
161701310|NCT03683394|583955570|FG001|Overall Study|Lost to Follow-up|0|||
161957508|NCT05396014|584892632|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161701311|NCT03683394|583955569|FG000|Overall Study|Death|3|||
161701312|NCT03683394|583955570|FG001|Overall Study|Death|1|||
161701313|NCT02239263|583955573|FG000|Overall Study|Protocol Violation|6|||
161701314|NCT01109940|583955577|FG000|Overall Study|Administrative problems|2|||
161701315|NCT01109940|583955578|FG001|Overall Study|Administrative problems|0|||
161701316|NCT01109940|583955579|FG002|Overall Study|Administrative problems|0|||
161701317|NCT01109940|583955580|FG003|Overall Study|Administrative problems|0|||
161701318|NCT01109940|583955577|FG000|Overall Study|Serious Adverse Event|2|||
161701319|NCT01109940|583955578|FG001|Overall Study|Serious Adverse Event|1|||
161701320|NCT01109940|583955579|FG002|Overall Study|Serious Adverse Event|0|||
161701321|NCT01109940|583955580|FG003|Overall Study|Serious Adverse Event|0|||
161701322|NCT01109940|583955577|FG000|Overall Study|Lost to Follow-up|1|||
161701323|NCT01109940|583955578|FG001|Overall Study|Lost to Follow-up|0|||
161701324|NCT01109940|583955579|FG002|Overall Study|Lost to Follow-up|0|||
161701325|NCT01109940|583955580|FG003|Overall Study|Lost to Follow-up|0|||
161701326|NCT01109940|583955577|FG000|Overall Study|Patient withdrew consent|1|||
161701327|NCT01109940|583955578|FG001|Overall Study|Patient withdrew consent|1|||
161701328|NCT01109940|583955579|FG002|Overall Study|Patient withdrew consent|0|||
161957509|NCT05396014|584892633|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957510|NCT05396014|584892634|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957511|NCT05396014|584892635|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957512|NCT05396014|584892636|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957513|NCT05396014|584892637|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957514|NCT05396014|584892638|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957515|NCT05396014|584892639|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957516|NCT05396014|584892640|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957517|NCT05396014|584892641|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957518|NCT05396014|584892642|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
161957519|NCT05396014|584892643|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957520|NCT05396014|584892644|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161701329|NCT01109940|583955580|FG003|Overall Study|Patient withdrew consent|0|||
161701330|NCT01109940|583955577|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161701331|NCT01109940|583955578|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161701332|NCT01109940|583955579|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
161701333|NCT01109940|583955580|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161701334|NCT03653390|583955581|FG000|Overall Study|Lost to Follow-up|12|||
161701335|NCT03653390|583955582|FG001|Overall Study|Lost to Follow-up|8|||
161701336|NCT03653390|583955583|FG002|Overall Study|Lost to Follow-up|7|||
161701337|NCT03653390|583955581|FG000|Overall Study|Withdrawal by Subject|6|||
161701338|NCT03653390|583955582|FG001|Overall Study|Withdrawal by Subject|1|||
161701339|NCT03653390|583955583|FG002|Overall Study|Withdrawal by Subject|1|||
161701340|NCT03653390|583955581|FG000|Overall Study|Death|1|||
161957521|NCT05396014|584892645|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957522|NCT05396014|584892646|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957523|NCT05396014|584892647|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957524|NCT05396014|584892648|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957525|NCT05396014|584892649|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957526|NCT05396014|584892650|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957527|NCT05396014|584892651|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957528|NCT05396014|584892652|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957529|NCT05396014|584892653|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957530|NCT05396014|584892654|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957531|NCT05396014|584892655|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
161957532|NCT05396014|584892656|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161701341|NCT03653390|583955582|FG001|Overall Study|Death|0|||
161701342|NCT03653390|583955583|FG002|Overall Study|Death|0|||
161701343|NCT03653390|583955581|FG000|Overall Study|Paper Survey Lost|1|||
161701344|NCT03653390|583955582|FG001|Overall Study|Paper Survey Lost|0|||
161701345|NCT03653390|583955583|FG002|Overall Study|Paper Survey Lost|0|||
161701346|NCT00849667|583955587|FG000|Overall Study|Withdrawal by Subject|16|||
161701347|NCT00849667|583955588|FG001|Overall Study|Withdrawal by Subject|33|||
161701348|NCT00849667|583955589|FG002|Overall Study|Withdrawal by Subject|35|||
161701349|NCT00849667|583955587|FG000|Overall Study|Lost to Follow-up|8|||
161701350|NCT00849667|583955588|FG001|Overall Study|Lost to Follow-up|8|||
161701351|NCT00849667|583955589|FG002|Overall Study|Lost to Follow-up|8|||
161701352|NCT00849667|583955587|FG000|Overall Study|Adverse Event|1|||
161701353|NCT00849667|583955588|FG001|Overall Study|Adverse Event|2|||
161837033|NCT01196078|584446525|FG000|Overall Study|Death|6|||
161837034|NCT01196078|584446526|FG001|Overall Study|Death|4|||
161837035|NCT02667288|584446527|FG000|Overall Study|Protocol Violation|5|||
161837036|NCT02667288|584446527|FG000|Overall Study|Lost to Follow-up|3|||
161837037|NCT02667288|584446527|FG000|Overall Study|Withdrawal by Subject|5|||
161837038|NCT02400671|584446528|FG000|Overall Study|Death|5|||
161837039|NCT02400671|584446529|FG001|Overall Study|Death|3|||
161957533|NCT05396014|584892657|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957534|NCT05396014|584892658|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957535|NCT05396014|584892659|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161701354|NCT00849667|583955589|FG002|Overall Study|Adverse Event|0|||
161837040|NCT02400671|584446530|FG002|Overall Study|Death|4|||
161837041|NCT02400671|584446528|FG000|Overall Study|Lost to Follow-up|20|||
161837042|NCT02400671|584446529|FG001|Overall Study|Lost to Follow-up|27|||
161701355|NCT00849667|583955587|FG000|Overall Study|Other|18|||
161837043|NCT02400671|584446530|FG002|Overall Study|Lost to Follow-up|24|||
161701356|NCT00849667|583955588|FG001|Overall Study|Other|19|||
161701357|NCT00849667|583955589|FG002|Overall Study|Other|18|||
161701358|NCT00849667|583955587|FG000|Overall Study|Progressive disease|119|||
161701359|NCT00849667|583955588|FG001|Overall Study|Progressive disease|100|||
161701360|NCT00849667|583955589|FG002|Overall Study|Progressive disease|112|||
161701361|NCT00849667|583955587|FG000|Overall Study|Sponsor decision|208|||
161701362|NCT00849667|583955588|FG001|Overall Study|Sponsor decision|204|||
161701363|NCT00849667|583955589|FG002|Overall Study|Sponsor decision|190|||
161701364|NCT00849667|583955587|FG000|Overall Study|Investigator discretion|0|||
161701365|NCT00849667|583955588|FG001|Overall Study|Investigator discretion|0|||
161701366|NCT00849667|583955589|FG002|Overall Study|Investigator discretion|1|||
161701367|NCT00189462|583955590|FG000|Overall Study|Lack of Efficacy|5|||
161701368|NCT00189462|583955591|FG001|Overall Study|Lack of Efficacy|1|||
161701369|NCT00189462|583955590|FG000|Overall Study|Lost to Follow-up|18|||
161701370|NCT00189462|583955591|FG001|Overall Study|Lost to Follow-up|20|||
161701371|NCT00553462|583955594|FG000|Overall Study|Adverse Event|4|||
161701372|NCT00553462|583955594|FG000|Overall Study|Progression|4|||
161701373|NCT00553462|583955594|FG000|Overall Study|Withdrawal by Subject|5|||
161701374|NCT00553462|583955594|FG000|Overall Study|Physician Decision|1|||
161701375|NCT01262625|583955595|FG000|Overall Study|Administrative Error|1|||
161701376|NCT01262625|583955596|FG001|Overall Study|Administrative Error|1|||
161701377|NCT01262625|583955595|FG000|Overall Study|Site Closed|1|||
161701378|NCT01262625|583955596|FG001|Overall Study|Site Closed|0|||
161701379|NCT00110994|583955597|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
161701380|NCT00110994|583955598|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
161701381|NCT00110994|583955597|FG000|Double-blind (DB) Treatment|Death|1|||
161701382|NCT00110994|583955598|FG001|Double-blind (DB) Treatment|Death|0|||
161701383|NCT00110994|583955597|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
161701384|NCT00110994|583955598|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
161701385|NCT00110994|583955597|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
161701386|NCT00110994|583955598|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
161701387|NCT00110994|583955597|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
161701388|NCT00110994|583955598|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
161701389|NCT00110994|583955597|FG000|Double-blind (DB) Treatment|other reasons|2|||
161701390|NCT00110994|583955598|FG001|Double-blind (DB) Treatment|other reasons|3|||
161701391|NCT00110994|583955597|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
161701392|NCT00110994|583955598|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
161701393|NCT00110994|583955597|FG000|Active Follow-up|Other reasons|0|||
161701394|NCT00110994|583955598|FG001|Active Follow-up|Other reasons|2|||
161701395|NCT00110994|583955597|FG000|Long Term Follow-up|Death|19|||
161701396|NCT00110994|583955598|FG001|Long Term Follow-up|Death|17|||
161701397|NCT04398732|583955599|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
161701398|NCT02772757|583955602|FG000|Overall Study|Withdrawal by Subject|1|||
161701399|NCT02772757|583955603|FG001|Overall Study|Withdrawal by Subject|0|||
161701400|NCT02772757|583955604|FG002|Overall Study|Withdrawal by Subject|1|||
161701401|NCT02772757|583955602|FG000|Overall Study|Protocol Violation|0|||
161701402|NCT02772757|583955603|FG001|Overall Study|Protocol Violation|0|||
161701403|NCT02772757|583955604|FG002|Overall Study|Protocol Violation|1|||
161701404|NCT02772757|583955602|FG000|Overall Study|Physician Decision|0|||
161701405|NCT02772757|583955603|FG001|Overall Study|Physician Decision|3|||
161701406|NCT02772757|583955604|FG002|Overall Study|Physician Decision|3|||
161701407|NCT00354601|583955611|FG000|Overall Study|Protocol Violation|1|||
161701408|NCT00354601|583955611|FG000|Overall Study|progression|1|||
161701409|NCT02532855|583955614|FG000|Overall Study|Lost to Follow-up|4|||
161701410|NCT02532855|583955615|FG001|Overall Study|Lost to Follow-up|3|||
161701411|NCT02532855|583955614|FG000|Overall Study|Withdrawal by Subject|4|||
161701412|NCT02532855|583955615|FG001|Overall Study|Withdrawal by Subject|8|||
161701413|NCT00666926|583955616|FG000|Overall Study|Adverse Event|0|||
161701414|NCT00666926|583955617|FG001|Overall Study|Adverse Event|0|||
161701415|NCT00666926|583955618|FG002|Overall Study|Adverse Event|0|||
161701416|NCT00666926|583955619|FG003|Overall Study|Adverse Event|0|||
161701417|NCT00666926|583955620|FG004|Overall Study|Adverse Event|0|||
161701418|NCT00666926|583955621|FG005|Overall Study|Adverse Event|0|||
161701419|NCT00666926|583955622|FG006|Overall Study|Adverse Event|0|||
161701420|NCT00666926|583955623|FG007|Overall Study|Adverse Event|0|||
161701421|NCT00666926|583955624|FG008|Overall Study|Adverse Event|0|||
161701422|NCT00666926|583955625|FG009|Overall Study|Adverse Event|2|||
161701423|NCT00666926|583955626|FG010|Overall Study|Adverse Event|2|||
161701424|NCT00666926|583955627|FG011|Overall Study|Adverse Event|2|||
161701425|NCT00666926|583955628|FG012|Overall Study|Adverse Event|0|||
161701426|NCT00666926|583955629|FG013|Overall Study|Adverse Event|1|||
161701427|NCT00666926|583955630|FG014|Overall Study|Adverse Event|0|||
161701428|NCT00666926|583955631|FG015|Overall Study|Adverse Event|0|||
161701429|NCT00666926|583955616|FG000|Overall Study|Laboratory abnormality|0|||
161701430|NCT00666926|583955617|FG001|Overall Study|Laboratory abnormality|0|||
161701431|NCT00666926|583955618|FG002|Overall Study|Laboratory abnormality|0|||
161701432|NCT00666926|583955619|FG003|Overall Study|Laboratory abnormality|0|||
161701433|NCT00666926|583955620|FG004|Overall Study|Laboratory abnormality|0|||
161957536|NCT05396014|584892660|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957537|NCT05396014|584892661|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957538|NCT05396014|584892662|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957539|NCT05396014|584892663|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957540|NCT05396014|584892664|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957541|NCT05396014|584892665|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957542|NCT05396014|584892666|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957543|NCT05396014|584892667|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957544|NCT05396014|584892668|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
161957545|NCT05396014|584892669|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957546|NCT05396014|584892670|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957547|NCT05396014|584892671|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
161957548|NCT05396014|584892629|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
161957549|NCT05396014|584892630|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957550|NCT05396014|584892631|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957551|NCT05396014|584892632|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957552|NCT05396014|584892633|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957553|NCT05396014|584892634|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957554|NCT05396014|584892635|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957555|NCT05396014|584892636|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957556|NCT05396014|584892637|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957557|NCT05396014|584892638|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957558|NCT05396014|584892639|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957559|NCT05396014|584892640|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957560|NCT05396014|584892641|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957561|NCT05396014|584892642|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
161701434|NCT00666926|583955621|FG005|Overall Study|Laboratory abnormality|0|||
161701435|NCT00666926|583955622|FG006|Overall Study|Laboratory abnormality|0|||
161701436|NCT00666926|583955623|FG007|Overall Study|Laboratory abnormality|0|||
161701437|NCT00666926|583955624|FG008|Overall Study|Laboratory abnormality|0|||
161701438|NCT00666926|583955625|FG009|Overall Study|Laboratory abnormality|0|||
161701439|NCT00666926|583955626|FG010|Overall Study|Laboratory abnormality|1|||
161701440|NCT00666926|583955627|FG011|Overall Study|Laboratory abnormality|0|||
161701441|NCT00666926|583955628|FG012|Overall Study|Laboratory abnormality|0|||
161701442|NCT00666926|583955629|FG013|Overall Study|Laboratory abnormality|0|||
161701443|NCT00666926|583955630|FG014|Overall Study|Laboratory abnormality|0|||
161701444|NCT00666926|583955631|FG015|Overall Study|Laboratory abnormality|1|||
161701445|NCT00666926|583955616|FG000|Overall Study|Lack of Efficacy|0|||
161701446|NCT00666926|583955617|FG001|Overall Study|Lack of Efficacy|0|||
161701447|NCT00666926|583955618|FG002|Overall Study|Lack of Efficacy|0|||
161701448|NCT00666926|583955619|FG003|Overall Study|Lack of Efficacy|0|||
161701449|NCT00666926|583955620|FG004|Overall Study|Lack of Efficacy|0|||
161701450|NCT00666926|583955621|FG005|Overall Study|Lack of Efficacy|1|||
161701451|NCT00666926|583955622|FG006|Overall Study|Lack of Efficacy|0|||
161701452|NCT00666926|583955623|FG007|Overall Study|Lack of Efficacy|0|||
161701453|NCT00666926|583955624|FG008|Overall Study|Lack of Efficacy|0|||
161701454|NCT00666926|583955625|FG009|Overall Study|Lack of Efficacy|0|||
161701455|NCT00666926|583955626|FG010|Overall Study|Lack of Efficacy|0|||
161701456|NCT00666926|583955627|FG011|Overall Study|Lack of Efficacy|1|||
161701457|NCT00666926|583955628|FG012|Overall Study|Lack of Efficacy|0|||
161701458|NCT00666926|583955629|FG013|Overall Study|Lack of Efficacy|0|||
161701459|NCT00666926|583955630|FG014|Overall Study|Lack of Efficacy|0|||
161701460|NCT00666926|583955631|FG015|Overall Study|Lack of Efficacy|0|||
161701461|NCT00666926|583955616|FG000|Overall Study|Lost to Follow-up|0|||
161701462|NCT00666926|583955617|FG001|Overall Study|Lost to Follow-up|0|||
161701463|NCT00666926|583955618|FG002|Overall Study|Lost to Follow-up|0|||
161701464|NCT00666926|583955619|FG003|Overall Study|Lost to Follow-up|1|||
161701465|NCT00666926|583955620|FG004|Overall Study|Lost to Follow-up|0|||
161701466|NCT00666926|583955621|FG005|Overall Study|Lost to Follow-up|0|||
161701467|NCT00666926|583955622|FG006|Overall Study|Lost to Follow-up|0|||
161837044|NCT02400671|584446528|FG000|Overall Study|Withdrawal by Subject|2|||
161837045|NCT02400671|584446529|FG001|Overall Study|Withdrawal by Subject|2|||
161837046|NCT02400671|584446530|FG002|Overall Study|Withdrawal by Subject|0|||
161957562|NCT05396014|584892643|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957563|NCT05396014|584892644|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957564|NCT05396014|584892645|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957565|NCT05396014|584892646|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957566|NCT05396014|584892647|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957567|NCT05396014|584892648|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957568|NCT05396014|584892649|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957569|NCT05396014|584892650|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957570|NCT05396014|584892651|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957571|NCT05396014|584892652|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957572|NCT05396014|584892653|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957573|NCT05396014|584892654|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957574|NCT05396014|584892655|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
161957575|NCT05396014|584892656|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957576|NCT05396014|584892657|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957577|NCT05396014|584892658|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957578|NCT05396014|584892659|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957579|NCT05396014|584892660|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957580|NCT05396014|584892661|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957581|NCT05396014|584892662|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957582|NCT05396014|584892663|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957583|NCT05396014|584892664|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957584|NCT05396014|584892665|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957585|NCT05396014|584892666|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161701468|NCT00666926|583955623|FG007|Overall Study|Lost to Follow-up|0|||
161701469|NCT00666926|583955624|FG008|Overall Study|Lost to Follow-up|0|||
161701470|NCT00666926|583955625|FG009|Overall Study|Lost to Follow-up|0|||
161701471|NCT00666926|583955626|FG010|Overall Study|Lost to Follow-up|0|||
161701472|NCT00666926|583955627|FG011|Overall Study|Lost to Follow-up|0|||
161701473|NCT00666926|583955628|FG012|Overall Study|Lost to Follow-up|0|||
161701474|NCT00666926|583955629|FG013|Overall Study|Lost to Follow-up|0|||
161701475|NCT00666926|583955630|FG014|Overall Study|Lost to Follow-up|0|||
161701476|NCT00666926|583955631|FG015|Overall Study|Lost to Follow-up|0|||
161701477|NCT00666926|583955616|FG000|Overall Study|Other|2|||
161701478|NCT00666926|583955617|FG001|Overall Study|Other|4|||
161701479|NCT00666926|583955618|FG002|Overall Study|Other|3|||
161701480|NCT00666926|583955619|FG003|Overall Study|Other|3|||
161701481|NCT00666926|583955620|FG004|Overall Study|Other|3|||
161701482|NCT00666926|583955621|FG005|Overall Study|Other|3|||
161701483|NCT00666926|583955622|FG006|Overall Study|Other|4|||
161701484|NCT00666926|583955623|FG007|Overall Study|Other|0|||
161701485|NCT00666926|583955624|FG008|Overall Study|Other|3|||
161701486|NCT00666926|583955625|FG009|Overall Study|Other|5|||
161701487|NCT00666926|583955626|FG010|Overall Study|Other|3|||
161701488|NCT00666926|583955627|FG011|Overall Study|Other|26|||
161701489|NCT00666926|583955628|FG012|Overall Study|Other|3|||
161957586|NCT05396014|584892667|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957587|NCT05396014|584892668|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
161957588|NCT05396014|584892669|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957589|NCT05396014|584892670|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161957590|NCT05396014|584892671|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
161701490|NCT00666926|583955629|FG013|Overall Study|Other|2|||
161701491|NCT00666926|583955630|FG014|Overall Study|Other|4|||
161701492|NCT00666926|583955631|FG015|Overall Study|Other|4|||
161957591|NCT05396014|584892629|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
161701493|NCT00666926|583955616|FG000|Overall Study|Withdrawal by Subject|0|||
161701494|NCT00666926|583955617|FG001|Overall Study|Withdrawal by Subject|0|||
161701495|NCT00666926|583955618|FG002|Overall Study|Withdrawal by Subject|0|||
161701496|NCT00666926|583955619|FG003|Overall Study|Withdrawal by Subject|0|||
161701497|NCT00666926|583955620|FG004|Overall Study|Withdrawal by Subject|0|||
161701498|NCT00666926|583955621|FG005|Overall Study|Withdrawal by Subject|0|||
161701499|NCT00666926|583955622|FG006|Overall Study|Withdrawal by Subject|0|||
161701500|NCT00666926|583955623|FG007|Overall Study|Withdrawal by Subject|1|||
161701501|NCT00666926|583955624|FG008|Overall Study|Withdrawal by Subject|0|||
161701502|NCT00666926|583955625|FG009|Overall Study|Withdrawal by Subject|3|||
161701503|NCT00666926|583955626|FG010|Overall Study|Withdrawal by Subject|0|||
161701504|NCT00666926|583955627|FG011|Overall Study|Withdrawal by Subject|3|||
161701505|NCT00666926|583955628|FG012|Overall Study|Withdrawal by Subject|0|||
161837047|NCT01429051|584446531|FG000|Titration Phase|Death|1|||
161957592|NCT05396014|584892630|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957593|NCT05396014|584892631|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957594|NCT05396014|584892632|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957595|NCT05396014|584892633|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957596|NCT05396014|584892634|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957597|NCT05396014|584892635|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161701506|NCT00666926|583955629|FG013|Overall Study|Withdrawal by Subject|1|||
161701507|NCT00666926|583955630|FG014|Overall Study|Withdrawal by Subject|3|||
161701508|NCT00666926|583955631|FG015|Overall Study|Withdrawal by Subject|3|||
161701509|NCT00666926|583955616|FG000|Overall Study|Death|0|||
161701510|NCT00666926|583955617|FG001|Overall Study|Death|0|||
161701511|NCT00666926|583955618|FG002|Overall Study|Death|0|||
161701512|NCT00666926|583955619|FG003|Overall Study|Death|0|||
161701513|NCT00666926|583955620|FG004|Overall Study|Death|0|||
161701514|NCT00666926|583955621|FG005|Overall Study|Death|0|||
161701515|NCT00666926|583955622|FG006|Overall Study|Death|0|||
161701516|NCT00666926|583955623|FG007|Overall Study|Death|0|||
161701517|NCT00666926|583955624|FG008|Overall Study|Death|0|||
161701518|NCT00666926|583955625|FG009|Overall Study|Death|0|||
161701519|NCT00666926|583955626|FG010|Overall Study|Death|0|||
161701520|NCT00666926|583955627|FG011|Overall Study|Death|1|||
161701521|NCT00666926|583955628|FG012|Overall Study|Death|0|||
161701522|NCT00666926|583955629|FG013|Overall Study|Death|0|||
161701523|NCT00666926|583955630|FG014|Overall Study|Death|0|||
161701524|NCT00666926|583955631|FG015|Overall Study|Death|0|||
161701525|NCT01960855|583955632|FG000|Overall Study|Subject noncompliant|1|||
161701526|NCT01960855|583955633|FG001|Overall Study|Subject noncompliant|0|||
161701527|NCT01960855|583955634|FG002|Overall Study|Subject noncompliant|0|||
161701528|NCT01960855|583955635|FG003|Overall Study|Subject noncompliant|0|||
161701529|NCT01960855|583955636|FG004|Overall Study|Subject noncompliant|0|||
161701530|NCT01960855|583955632|FG000|Overall Study|Adverse Event|2|||
161701531|NCT01960855|583955633|FG001|Overall Study|Adverse Event|0|||
161701532|NCT01960855|583955634|FG002|Overall Study|Adverse Event|6|||
161701533|NCT01960855|583955635|FG003|Overall Study|Adverse Event|2|||
161701534|NCT01960855|583955636|FG004|Overall Study|Adverse Event|2|||
161701535|NCT01960855|583955632|FG000|Overall Study|Lack of Efficacy|1|||
161701536|NCT01960855|583955633|FG001|Overall Study|Lack of Efficacy|1|||
161701537|NCT01960855|583955634|FG002|Overall Study|Lack of Efficacy|0|||
161701538|NCT01960855|583955635|FG003|Overall Study|Lack of Efficacy|0|||
161701539|NCT01960855|583955636|FG004|Overall Study|Lack of Efficacy|0|||
161701540|NCT01960855|583955632|FG000|Overall Study|Other|2|||
161701541|NCT01960855|583955633|FG001|Overall Study|Other|1|||
161701542|NCT01960855|583955634|FG002|Overall Study|Other|1|||
161701543|NCT01960855|583955635|FG003|Overall Study|Other|1|||
161701544|NCT01960855|583955636|FG004|Overall Study|Other|0|||
161701545|NCT01960855|583955632|FG000|Overall Study|Consent withdrawn by subject|3|||
161701546|NCT01960855|583955633|FG001|Overall Study|Consent withdrawn by subject|1|||
161701547|NCT01960855|583955634|FG002|Overall Study|Consent withdrawn by subject|2|||
161837048|NCT01429051|584446531|FG000|Titration Phase|Withdrawal by Subject|7|||
161957598|NCT05396014|584892636|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957599|NCT05396014|584892637|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957600|NCT05396014|584892638|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957601|NCT05396014|584892639|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957602|NCT05396014|584892640|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161701548|NCT01960855|583955635|FG003|Overall Study|Consent withdrawn by subject|1|||
161701549|NCT01960855|583955636|FG004|Overall Study|Consent withdrawn by subject|1|||
161701550|NCT01960855|583955632|FG000|Overall Study|Lost to Follow-up|2|||
161701551|NCT01960855|583955633|FG001|Overall Study|Lost to Follow-up|1|||
161701552|NCT01960855|583955634|FG002|Overall Study|Lost to Follow-up|0|||
161701553|NCT01960855|583955635|FG003|Overall Study|Lost to Follow-up|0|||
161701554|NCT01960855|583955636|FG004|Overall Study|Lost to Follow-up|2|||
161701555|NCT02471716|583955638|FG000|Overall Study|Withdrawal by Subject|0|||
161701556|NCT02471716|583955639|FG001|Overall Study|Withdrawal by Subject|1|||
161701557|NCT02471716|583955640|FG002|Overall Study|Withdrawal by Subject|0|||
161701558|NCT02471716|583955641|FG003|Overall Study|Withdrawal by Subject|2|||
161701559|NCT02471716|583955642|FG004|Overall Study|Withdrawal by Subject|5|||
161701560|NCT02471716|583955638|FG000|Overall Study|Study Terminiated by sponsor|0|||
161701561|NCT02471716|583955639|FG001|Overall Study|Study Terminiated by sponsor|0|||
161701562|NCT02471716|583955640|FG002|Overall Study|Study Terminiated by sponsor|0|||
161701563|NCT02471716|583955641|FG003|Overall Study|Study Terminiated by sponsor|1|||
161701564|NCT02471716|583955642|FG004|Overall Study|Study Terminiated by sponsor|0|||
161701565|NCT02471716|583955638|FG000|Overall Study|Lost to Follow-up|0|||
161701566|NCT02471716|583955639|FG001|Overall Study|Lost to Follow-up|0|||
161837049|NCT01429051|584446531|FG000|Titration Phase|Physician Decision|1|||
162030817|NCT03400956|585169490|FG000|Post-treatment Period 1|Physician Decision|2|||
161701567|NCT02471716|583955640|FG002|Overall Study|Lost to Follow-up|0|||
161701568|NCT02471716|583955641|FG003|Overall Study|Lost to Follow-up|3|||
161701569|NCT02471716|583955642|FG004|Overall Study|Lost to Follow-up|2|||
161701570|NCT02471716|583955638|FG000|Overall Study|Death|0|||
161701571|NCT02471716|583955639|FG001|Overall Study|Death|0|||
161701572|NCT02471716|583955640|FG002|Overall Study|Death|0|||
161701573|NCT02471716|583955641|FG003|Overall Study|Death|1|||
161701574|NCT02471716|583955642|FG004|Overall Study|Death|0|||
161957603|NCT05396014|584892641|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957604|NCT05396014|584892642|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
161957605|NCT05396014|584892643|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957606|NCT05396014|584892644|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957607|NCT05396014|584892645|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957608|NCT05396014|584892646|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957609|NCT05396014|584892647|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957610|NCT05396014|584892648|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957611|NCT05396014|584892649|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957612|NCT05396014|584892650|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957613|NCT05396014|584892651|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957614|NCT05396014|584892652|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957615|NCT05396014|584892653|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957616|NCT05396014|584892654|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957617|NCT05396014|584892655|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
161957618|NCT05396014|584892656|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957619|NCT05396014|584892657|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957620|NCT05396014|584892658|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957621|NCT05396014|584892659|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957622|NCT05396014|584892660|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957623|NCT05396014|584892661|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957624|NCT05396014|584892662|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957625|NCT05396014|584892663|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957626|NCT05396014|584892664|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
162030818|NCT03400956|585169491|FG001|Post-treatment Period 1|Physician Decision|3|||
162030819|NCT03400956|585169492|FG002|Post-treatment Period 1|Physician Decision|0|||
161701575|NCT02471716|583955638|FG000|Overall Study|Other|0|||
161701576|NCT02471716|583955639|FG001|Overall Study|Other|0|||
161701577|NCT02471716|583955640|FG002|Overall Study|Other|0|||
161701578|NCT02471716|583955641|FG003|Overall Study|Other|8|||
161701579|NCT02471716|583955642|FG004|Overall Study|Other|9|||
161701580|NCT00330187|583955655|FG000|Overall Study|Lost to Follow-up|12|||
161701581|NCT00330187|583955656|FG001|Overall Study|Lost to Follow-up|13|||
161701582|NCT00330187|583955657|FG002|Overall Study|Lost to Follow-up|14|||
161701583|NCT00330187|583955658|FG003|Overall Study|Lost to Follow-up|10|||
161701584|NCT00330187|583955655|FG000|Overall Study|Withdrawal by Subject|8|||
161701585|NCT00330187|583955656|FG001|Overall Study|Withdrawal by Subject|5|||
161701586|NCT00330187|583955657|FG002|Overall Study|Withdrawal by Subject|4|||
161701587|NCT00330187|583955658|FG003|Overall Study|Withdrawal by Subject|4|||
161701588|NCT01162421|583955664|FG000|Overall Study|Did not receive study drug|2|||
161701589|NCT01162421|583955665|FG001|Overall Study|Did not receive study drug|1|||
161701590|NCT01162421|583955664|FG000|Overall Study|Adverse Event|2|||
161701591|NCT01162421|583955665|FG001|Overall Study|Adverse Event|5|||
161701592|NCT01162421|583955664|FG000|Overall Study|Lost to Follow-up|0|||
161701593|NCT01162421|583955665|FG001|Overall Study|Lost to Follow-up|2|||
161701594|NCT01162421|583955664|FG000|Overall Study|Lack of Efficacy|2|||
161701595|NCT01162421|583955665|FG001|Overall Study|Lack of Efficacy|2|||
161701596|NCT01162421|583955664|FG000|Overall Study|Other|2|||
161701597|NCT01162421|583955665|FG001|Overall Study|Other|3|||
161701598|NCT01133171|583955669|FG000|Overall Study|Withdrawal by Subject|1|||
161701599|NCT01133171|583955670|FG001|Overall Study|Withdrawal by Subject|2|||
161701600|NCT01133171|583955671|FG002|Overall Study|Withdrawal by Subject|0|||
161701601|NCT02526550|583955672|FG000|Overall Study|Lost to Follow-up|1|||
161701602|NCT03434379|583955676|FG000|Global Period|Lost to Follow-up|3|||
161701603|NCT03434379|583955677|FG001|Global Period|Lost to Follow-up|6|||
161701604|NCT03434379|583955678|FG002|Global Period|Lost to Follow-up|0|||
161701605|NCT03434379|583955679|FG003|Global Period|Lost to Follow-up|0|||
161701606|NCT03434379|583955676|FG000|Global Period|Death|115|||
161701607|NCT03434379|583955677|FG001|Global Period|Death|228|||
161701608|NCT03434379|583955678|FG002|Global Period|Death|0|||
161957627|NCT05396014|584892665|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957628|NCT05396014|584892666|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
162030820|NCT03400956|585169490|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
161701609|NCT03434379|583955679|FG003|Global Period|Death|0|||
161701610|NCT03434379|583955676|FG000|Global Period|Withdrawal by Subject|20|||
161701611|NCT03434379|583955677|FG001|Global Period|Withdrawal by Subject|21|||
161701612|NCT03434379|583955678|FG002|Global Period|Withdrawal by Subject|0|||
161701613|NCT03434379|583955679|FG003|Global Period|Withdrawal by Subject|0|||
161701614|NCT03434379|583955676|FG000|Global Period|Reason Unspecified|0|||
161701615|NCT03434379|583955677|FG001|Global Period|Reason Unspecified|1|||
161701616|NCT03434379|583955678|FG002|Global Period|Reason Unspecified|0|||
161701617|NCT03434379|583955679|FG003|Global Period|Reason Unspecified|0|||
161701618|NCT03434379|583955676|FG000|Global Period|Study Ended by Sponsor|26|||
161701619|NCT03434379|583955677|FG001|Global Period|Study Ended by Sponsor|80|||
161701620|NCT03434379|583955678|FG002|Global Period|Study Ended by Sponsor|0|||
161701621|NCT03434379|583955679|FG003|Global Period|Study Ended by Sponsor|0|||
161837050|NCT01429051|584446531|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
161837051|NCT01429051|584446531|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
162030821|NCT03400956|585169491|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
162030822|NCT03400956|585169492|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
161701622|NCT03434379|583955676|FG000|Global Period|Physician Decision|1|||
161701623|NCT03434379|583955677|FG001|Global Period|Physician Decision|0|||
161701624|NCT03434379|583955678|FG002|Global Period|Physician Decision|0|||
161701625|NCT03434379|583955679|FG003|Global Period|Physician Decision|0|||
161701626|NCT03434379|583955676|FG000|China Extension Period|Lost to Follow-up|0|||
161701627|NCT03434379|583955677|FG001|China Extension Period|Lost to Follow-up|0|||
161701628|NCT03434379|583955678|FG002|China Extension Period|Lost to Follow-up|2|||
161701629|NCT03434379|583955679|FG003|China Extension Period|Lost to Follow-up|3|||
161701630|NCT03434379|583955676|FG000|China Extension Period|Death|0|||
161701631|NCT03434379|583955677|FG001|China Extension Period|Death|0|||
161701632|NCT03434379|583955678|FG002|China Extension Period|Death|46|||
161701633|NCT03434379|583955679|FG003|China Extension Period|Death|88|||
161701634|NCT03434379|583955676|FG000|China Extension Period|Withdrawal by Subject|0|||
161701635|NCT03434379|583955677|FG001|China Extension Period|Withdrawal by Subject|0|||
161701636|NCT03434379|583955678|FG002|China Extension Period|Withdrawal by Subject|8|||
161701637|NCT03434379|583955679|FG003|China Extension Period|Withdrawal by Subject|6|||
161701638|NCT03434379|583955676|FG000|China Extension Period|Study Ended by Sponsor|0|||
161701639|NCT03434379|583955677|FG001|China Extension Period|Study Ended by Sponsor|0|||
161701640|NCT03434379|583955678|FG002|China Extension Period|Study Ended by Sponsor|5|||
161701641|NCT03434379|583955679|FG003|China Extension Period|Study Ended by Sponsor|36|||
161701642|NCT00686647|583955683|FG000|Overall Study|Lost to Follow-up|1|||
161701643|NCT00686647|583955683|FG000|Overall Study|Death|1|||
161701644|NCT00578643|583955684|FG000|Overall Study|Death|1|||
161701645|NCT00578643|583955684|FG000|Overall Study|Lost to Follow-up|1|||
161701646|NCT01725750|583955685|FG000|Overall Study|Adverse Event|1|||
161701647|NCT01725750|583955686|FG001|Overall Study|Adverse Event|0|||
161701648|NCT01725750|583955685|FG000|Overall Study|Lost to Follow-up|1|||
161701649|NCT01725750|583955686|FG001|Overall Study|Lost to Follow-up|1|||
161701650|NCT01725750|583955685|FG000|Overall Study|Withdrawal by Subject|0|||
161701651|NCT01725750|583955686|FG001|Overall Study|Withdrawal by Subject|9|||
161701652|NCT03179436|583955689|FG000|Overall Study|Withdrawal by Subject|1|||
161701653|NCT03179436|583955690|FG001|Overall Study|Withdrawal by Subject|0|||
161701654|NCT03179436|583955691|FG002|Overall Study|Withdrawal by Subject|0|||
161701655|NCT03179436|583955692|FG003|Overall Study|Withdrawal by Subject|4|||
161701656|NCT03179436|583955693|FG004|Overall Study|Withdrawal by Subject|2|||
161701657|NCT03179436|583955694|FG005|Overall Study|Withdrawal by Subject|2|||
161701658|NCT03179436|583955695|FG006|Overall Study|Withdrawal by Subject|5|||
161701659|NCT03179436|583955696|FG007|Overall Study|Withdrawal by Subject|0|||
161701660|NCT03179436|583955697|FG008|Overall Study|Withdrawal by Subject|3|||
161701661|NCT03179436|583955698|FG009|Overall Study|Withdrawal by Subject|0|||
161837052|NCT01429051|584446531|FG000|Efficacy Phase|Adverse Event|1|||
161837053|NCT01429051|584446531|FG000|Efficacy Phase|Death|1|||
161837054|NCT01429051|584446531|FG000|Tolerability Phase|Death|5|||
161837055|NCT01429051|584446531|FG000|Tolerability Phase|Adverse Event|2|||
161837056|NCT01429051|584446531|FG000|Tolerability Phase|Withdrawal by Subject|5|||
161837057|NCT01429051|584446531|FG000|Tolerability Phase|Physician Decision|1|||
161837058|NCT01429051|584446531|FG000|Tolerability Phase|Other|2|||
162030823|NCT03400956|585169490|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
162030824|NCT03400956|585169491|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
161701662|NCT03179436|583955699|FG010|Overall Study|Withdrawal by Subject|0|||
161701663|NCT03179436|583955700|FG011|Overall Study|Withdrawal by Subject|0|||
161701664|NCT03179436|583955689|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161701665|NCT03179436|583955690|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161701666|NCT03179436|583955691|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161701667|NCT03179436|583955692|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161701668|NCT03179436|583955693|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161701669|NCT03179436|583955694|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161701670|NCT03179436|583955695|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
161701671|NCT03179436|583955696|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
161701672|NCT03179436|583955697|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
161701673|NCT03179436|583955698|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
161701674|NCT03179436|583955699|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
161701675|NCT03179436|583955700|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
161701676|NCT03179436|583955689|FG000|Overall Study|Sponsor Decision|0|||
161701677|NCT03179436|583955690|FG001|Overall Study|Sponsor Decision|0|||
161701678|NCT03179436|583955691|FG002|Overall Study|Sponsor Decision|1|||
161701679|NCT03179436|583955692|FG003|Overall Study|Sponsor Decision|3|||
161701680|NCT03179436|583955693|FG004|Overall Study|Sponsor Decision|9|||
161701681|NCT03179436|583955694|FG005|Overall Study|Sponsor Decision|7|||
161701682|NCT03179436|583955695|FG006|Overall Study|Sponsor Decision|2|||
161701683|NCT03179436|583955696|FG007|Overall Study|Sponsor Decision|4|||
161701684|NCT03179436|583955697|FG008|Overall Study|Sponsor Decision|23|||
161701685|NCT03179436|583955698|FG009|Overall Study|Sponsor Decision|6|||
161701686|NCT03179436|583955699|FG010|Overall Study|Sponsor Decision|7|||
161701687|NCT03179436|583955700|FG011|Overall Study|Sponsor Decision|5|||
161701688|NCT03179436|583955689|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701689|NCT03179436|583955690|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
161701690|NCT03179436|583955691|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701691|NCT03179436|583955692|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701692|NCT03179436|583955693|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701693|NCT03179436|583955694|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
161701694|NCT03179436|583955695|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701695|NCT03179436|583955696|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701696|NCT03179436|583955697|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701697|NCT03179436|583955698|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701698|NCT03179436|583955699|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701699|NCT03179436|583955700|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
161701700|NCT03179436|583955689|FG000|Overall Study|Lost to Follow-up|1|||
161701701|NCT03179436|583955690|FG001|Overall Study|Lost to Follow-up|0|||
161701702|NCT03179436|583955691|FG002|Overall Study|Lost to Follow-up|0|||
161701703|NCT03179436|583955692|FG003|Overall Study|Lost to Follow-up|1|||
161701704|NCT03179436|583955693|FG004|Overall Study|Lost to Follow-up|0|||
161701705|NCT03179436|583955694|FG005|Overall Study|Lost to Follow-up|1|||
161701706|NCT03179436|583955695|FG006|Overall Study|Lost to Follow-up|0|||
161701707|NCT03179436|583955696|FG007|Overall Study|Lost to Follow-up|0|||
161701708|NCT03179436|583955697|FG008|Overall Study|Lost to Follow-up|1|||
161701709|NCT03179436|583955698|FG009|Overall Study|Lost to Follow-up|1|||
161701710|NCT03179436|583955699|FG010|Overall Study|Lost to Follow-up|0|||
161701711|NCT03179436|583955700|FG011|Overall Study|Lost to Follow-up|0|||
161701712|NCT03179436|583955689|FG000|Overall Study|Death|12|||
161701713|NCT03179436|583955690|FG001|Overall Study|Death|17|||
161701714|NCT03179436|583955691|FG002|Overall Study|Death|7|||
161701715|NCT03179436|583955692|FG003|Overall Study|Death|32|||
161701716|NCT03179436|583955693|FG004|Overall Study|Death|29|||
161701717|NCT03179436|583955694|FG005|Overall Study|Death|30|||
161701718|NCT03179436|583955695|FG006|Overall Study|Death|33|||
161701719|NCT03179436|583955696|FG007|Overall Study|Death|9|||
161701720|NCT03179436|583955697|FG008|Overall Study|Death|84|||
161701721|NCT03179436|583955698|FG009|Overall Study|Death|33|||
161701722|NCT03179436|583955699|FG010|Overall Study|Death|22|||
161701723|NCT03179436|583955700|FG011|Overall Study|Death|15|||
161701724|NCT02474329|583955701|FG000|Overall Study|Withdraw or did not contribute data.|13|||
161701725|NCT01634555|583955702|FG000|Overall Study|Adverse Event|3|||
161701726|NCT01634555|583955702|FG000|Overall Study|Physician Decision|1|||
161701727|NCT01506882|583955703|FG000|Overall Study|Lack of Efficacy|4|||
161701728|NCT01506882|583955704|FG001|Overall Study|Lack of Efficacy|3|||
161701729|NCT01506882|583955703|FG000|Overall Study|Lost to Follow-up|1|||
161701730|NCT01506882|583955704|FG001|Overall Study|Lost to Follow-up|0|||
161701731|NCT01506882|583955703|FG000|Overall Study|Withdrawal by Subject|9|||
161701732|NCT01506882|583955704|FG001|Overall Study|Withdrawal by Subject|3|||
161701733|NCT01506882|583955703|FG000|Overall Study|SAE, non-fatal|2|||
161701734|NCT01506882|583955704|FG001|Overall Study|SAE, non-fatal|0|||
161701735|NCT01506882|583955703|FG000|Overall Study|AE, non-serious non-fatal|3|||
161701736|NCT01506882|583955704|FG001|Overall Study|AE, non-serious non-fatal|1|||
161701737|NCT01506882|583955703|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
161701738|NCT01506882|583955704|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
161701739|NCT01506882|583955703|FG000|Overall Study|Other Reason|2|||
161701740|NCT01506882|583955704|FG001|Overall Study|Other Reason|0|||
161701741|NCT03617705|583957308|FG000|Overall Study|Withdrawal by Subject|2|||
161701742|NCT03617705|583957308|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
161701743|NCT03617705|583957308|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
161701744|NCT03502187|583957309|FG000|Overall Study|Withdrawal by Subject|4|||
161701745|NCT03502187|583957310|FG001|Overall Study|Withdrawal by Subject|3|||
161837059|NCT00857792|584446533|FG000|Overall Study|inadequate image quality for analysis|12|||
161837060|NCT03733210|584446535|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
161837061|NCT03733210|584446536|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
161701746|NCT03502187|583957311|FG002|Overall Study|Withdrawal by Subject|3|||
161701747|NCT03502187|583957309|FG000|Overall Study|Lost to Follow-up|5|||
161701748|NCT03502187|583957310|FG001|Overall Study|Lost to Follow-up|4|||
161701749|NCT03502187|583957311|FG002|Overall Study|Lost to Follow-up|5|||
161701750|NCT06118385|583957312|FG000|Overall Study|Protocol Violation|0|||
161701751|NCT06118385|583957313|FG001|Overall Study|Protocol Violation|0|||
161701752|NCT06118385|583957314|FG002|Overall Study|Protocol Violation|0|||
161701753|NCT06118385|583957315|FG003|Overall Study|Protocol Violation|0|||
161701754|NCT06118385|583957316|FG004|Overall Study|Protocol Violation|0|||
161701755|NCT06118385|583957317|FG005|Overall Study|Protocol Violation|0|||
161701756|NCT06118385|583957318|FG006|Overall Study|Protocol Violation|0|||
161701757|NCT06118385|583957319|FG007|Overall Study|Protocol Violation|0|||
161701758|NCT06118385|583957320|FG008|Overall Study|Protocol Violation|1|||
161701759|NCT06118385|583957321|FG009|Overall Study|Protocol Violation|0|||
161701760|NCT06118385|583957322|FG010|Overall Study|Protocol Violation|0|||
161701761|NCT06118385|583957323|FG011|Overall Study|Protocol Violation|0|||
161701762|NCT06118385|583957312|FG000|Overall Study|Out-of-range blood tests|0|||
161701763|NCT06118385|583957313|FG001|Overall Study|Out-of-range blood tests|0|||
161701764|NCT06118385|583957314|FG002|Overall Study|Out-of-range blood tests|0|||
161701765|NCT06118385|583957315|FG003|Overall Study|Out-of-range blood tests|0|||
161701766|NCT06118385|583957316|FG004|Overall Study|Out-of-range blood tests|0|||
161957629|NCT05396014|584892667|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957630|NCT05396014|584892668|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
161957631|NCT05396014|584892669|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957632|NCT05396014|584892670|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161957633|NCT05396014|584892671|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
161701767|NCT06118385|583957317|FG005|Overall Study|Out-of-range blood tests|0|||
161701768|NCT06118385|583957318|FG006|Overall Study|Out-of-range blood tests|0|||
161701769|NCT06118385|583957319|FG007|Overall Study|Out-of-range blood tests|0|||
161701770|NCT06118385|583957320|FG008|Overall Study|Out-of-range blood tests|1|||
161701771|NCT06118385|583957321|FG009|Overall Study|Out-of-range blood tests|0|||
161701772|NCT06118385|583957322|FG010|Overall Study|Out-of-range blood tests|0|||
161701773|NCT06118385|583957323|FG011|Overall Study|Out-of-range blood tests|0|||
161701774|NCT01554579|583957324|FG000|Overall Study|Adverse Event|6|||
161701775|NCT01554579|583957325|FG001|Overall Study|Adverse Event|25|||
161701776|NCT01554579|583957324|FG000|Overall Study|Lack of Efficacy|2|||
161701777|NCT01554579|583957325|FG001|Overall Study|Lack of Efficacy|1|||
161701778|NCT01554579|583957324|FG000|Overall Study|Withdrawal by Subject|2|||
161701779|NCT01554579|583957325|FG001|Overall Study|Withdrawal by Subject|1|||
161701780|NCT03072160|583957326|FG000|Overall Study|Adverse Event|3|||
161701781|NCT03072160|583957327|FG001|Overall Study|Adverse Event|1|||
161701782|NCT03072160|583957326|FG000|Overall Study|Refused further treatment|6|||
161701783|NCT03072160|583957327|FG001|Overall Study|Refused further treatment|1|||
161701784|NCT03072160|583957326|FG000|Overall Study|Physician Decision|1|||
161701785|NCT03072160|583957327|FG001|Overall Study|Physician Decision|0|||
161701786|NCT03072160|583957326|FG000|Overall Study|Disease progression on study|1|||
161701787|NCT03072160|583957327|FG001|Overall Study|Disease progression on study|1|||
161701788|NCT03072160|583957326|FG000|Overall Study|No contact|0|||
161701789|NCT03072160|583957327|FG001|Overall Study|No contact|1|||
161701790|NCT01046695|583957328|FG000|Overall Study|Subject had a pacemaker|0|||
161701791|NCT01046695|583957329|FG001|Overall Study|Subject had a pacemaker|1|||
161701792|NCT01046695|583957328|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
161701793|NCT01046695|583957329|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
161701794|NCT00559273|583957330|FG000|Correction Period (20 Weeks)|Death|3|||
161701795|NCT00559273|583957331|FG001|Correction Period (20 Weeks)|Death|4|||
161701796|NCT00559273|583957330|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
161701797|NCT00559273|583957331|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
161701798|NCT00559273|583957330|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
161701799|NCT00559273|583957331|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
161701800|NCT00559273|583957330|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
161701801|NCT00559273|583957331|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
161701802|NCT00559273|583957330|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
161701803|NCT00559273|583957331|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
161701804|NCT00559273|583957330|FG000|Evaluation Period (8 Weeks)|Death|1|||
161701805|NCT00559273|583957331|FG001|Evaluation Period (8 Weeks)|Death|3|||
161701806|NCT00559273|583957330|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
161701807|NCT00559273|583957331|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
161701808|NCT00559273|583957330|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
161701809|NCT00559273|583957331|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
161701810|NCT00559273|583957330|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
161701811|NCT00559273|583957331|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
161701812|NCT01500057|583957332|FG000|Overall Study|Lost to Follow-up|6|||
161701813|NCT01500057|583957333|FG001|Overall Study|Lost to Follow-up|4|||
161701814|NCT03213366|583957335|FG000|Overall Study|Lost to Follow-up|9|||
161701815|NCT03213366|583957336|FG001|Overall Study|Lost to Follow-up|4|||
161701816|NCT02058147|583957337|FG000|Overall Study|Randomized but not treated|0|||
161701817|NCT02058147|583957338|FG001|Overall Study|Randomized but not treated|0|||
161701818|NCT02058147|583957339|FG002|Overall Study|Randomized but not treated|1|||
161701819|NCT02058147|583957337|FG000|Overall Study|Adverse Event|12|||
161701820|NCT02058147|583957338|FG001|Overall Study|Adverse Event|9|||
161701821|NCT02058147|583957339|FG002|Overall Study|Adverse Event|21|||
161701822|NCT02058147|583957337|FG000|Overall Study|Lack of Efficacy|1|||
161957634|NCT05396014|584892629|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161837062|NCT03760250|584446537|FG000|Overall Study|Withdrawal by Subject|1|||
161837063|NCT03760250|584446537|FG000|Overall Study|Physician Decision|1|||
161701823|NCT02058147|583957338|FG001|Overall Study|Lack of Efficacy|0|||
161837064|NCT04421586|584446538|FG000|Overall Study|Death|0|||
161837065|NCT04421586|584446539|FG001|Overall Study|Death|1|||
161701824|NCT02058147|583957339|FG002|Overall Study|Lack of Efficacy|3|||
161701825|NCT02058147|583957337|FG000|Overall Study|Poor compliance to protocol|8|||
161701826|NCT02058147|583957338|FG001|Overall Study|Poor compliance to protocol|9|||
161701827|NCT02058147|583957339|FG002|Overall Study|Poor compliance to protocol|4|||
161701828|NCT02058147|583957337|FG000|Overall Study|Other than specified|8|||
161701829|NCT02058147|583957338|FG001|Overall Study|Other than specified|9|||
161701830|NCT02058147|583957339|FG002|Overall Study|Other than specified|0|||
161957635|NCT05396014|584892630|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957636|NCT05396014|584892631|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957637|NCT05396014|584892632|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957638|NCT05396014|584892633|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957639|NCT05396014|584892634|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957640|NCT05396014|584892635|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957641|NCT05396014|584892636|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957642|NCT05396014|584892637|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161701831|NCT01014585|583957342|FG000|Overall Study|Adverse Event|0|||
161701832|NCT01014585|583957343|FG001|Overall Study|Adverse Event|2|||
161701833|NCT01014585|583957344|FG002|Overall Study|Adverse Event|0|||
161701834|NCT01014585|583957345|FG003|Overall Study|Adverse Event|3|||
161701835|NCT01014585|583957342|FG000|Overall Study|Withdrawal by Subject|2|||
161701836|NCT01014585|583957343|FG001|Overall Study|Withdrawal by Subject|0|||
161701837|NCT01014585|583957344|FG002|Overall Study|Withdrawal by Subject|1|||
161701838|NCT01014585|583957345|FG003|Overall Study|Withdrawal by Subject|3|||
161701839|NCT01014585|583957342|FG000|Overall Study|Lost to Follow-up|0|||
161701840|NCT01014585|583957343|FG001|Overall Study|Lost to Follow-up|0|||
161701841|NCT01014585|583957344|FG002|Overall Study|Lost to Follow-up|0|||
161701842|NCT01014585|583957345|FG003|Overall Study|Lost to Follow-up|2|||
161701843|NCT01014585|583957342|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
161701844|NCT01014585|583957343|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
161701845|NCT01014585|583957344|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
161701846|NCT01014585|583957345|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
161701847|NCT04178772|583957349|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
161701848|NCT04178772|583957349|FG000|Overall Study|study terminated early due to COVID-19|7|||
161701849|NCT00773279|583957350|FG000|Period 1|Adverse Event|2|||
161701850|NCT00773279|583957351|FG001|Period 1|Adverse Event|1|||
161701851|NCT00773279|583957350|FG000|Period 1|Lack of Efficacy|0|||
161701852|NCT00773279|583957351|FG001|Period 1|Lack of Efficacy|2|||
161701853|NCT00773279|583957350|FG000|Period 1|Unclassified|5|||
161701854|NCT00773279|583957351|FG001|Period 1|Unclassified|1|||
161701855|NCT00773279|583957350|FG000|Period 2|Adverse Event|0|||
161701856|NCT00773279|583957351|FG001|Period 2|Adverse Event|1|||
161701857|NCT00773279|583957350|FG000|Period 2|Lack of Efficacy|1|||
161701858|NCT00773279|583957351|FG001|Period 2|Lack of Efficacy|0|||
161701859|NCT00773279|583957350|FG000|Period 2|Protocol Violation|0|||
161701860|NCT00773279|583957351|FG001|Period 2|Protocol Violation|3|||
161701861|NCT00773279|583957350|FG000|Period 2|Unclassified|2|||
161701862|NCT00773279|583957351|FG001|Period 2|Unclassified|2|||
161701863|NCT01737931|583957355|FG000|Overall Study|Withdrawal by Subject|0|||
161701864|NCT01737931|583957356|FG001|Overall Study|Withdrawal by Subject|1|||
161701865|NCT01737931|583957357|FG002|Overall Study|Withdrawal by Subject|1|||
161701866|NCT01737931|583957355|FG000|Overall Study|Physician Decision|0|||
161701867|NCT01737931|583957356|FG001|Overall Study|Physician Decision|1|||
161701868|NCT01737931|583957357|FG002|Overall Study|Physician Decision|0|||
161701869|NCT04897867|583957358|FG000|Overall Study|Withdrawal of Consent|1|||
161701870|NCT04897867|583957358|FG000|Overall Study|Pregnancy|1|||
161701871|NCT04897867|583957358|FG000|Overall Study|Lost to Follow-up|7|||
161701872|NCT04897867|583957358|FG000|Overall Study|Reason not Specified|2|||
161701873|NCT01838044|583957359|FG000|Overall Study|Adverse Event|4|||
161701874|NCT01838044|583957360|FG001|Overall Study|Adverse Event|6|||
161701875|NCT01838044|583957359|FG000|Overall Study|Protocol Violation|3|||
161701876|NCT01838044|583957360|FG001|Overall Study|Protocol Violation|3|||
161701877|NCT01838044|583957359|FG000|Overall Study|Withdrawal by Subject|0|||
161701878|NCT01838044|583957360|FG001|Overall Study|Withdrawal by Subject|2|||
161701879|NCT01838044|583957359|FG000|Overall Study|Insufficient clinical response|1|||
161701880|NCT01838044|583957360|FG001|Overall Study|Insufficient clinical response|2|||
161701881|NCT01838044|583957359|FG000|Overall Study|Medication error without associated AE|0|||
161701882|NCT01838044|583957360|FG001|Overall Study|Medication error without associated AE|1|||
161701883|NCT01838044|583957359|FG000|Overall Study|Lost to Follow-up|0|||
161701884|NCT01838044|583957360|FG001|Overall Study|Lost to Follow-up|2|||
161701885|NCT01481896|583957361|FG000|Overall Study|Lost to Follow-up|12|||
161701886|NCT00364182|583957367|FG000|First Intervention|Secondary prophylaxis|1|||
161701887|NCT00364182|583957368|FG001|First Intervention|Secondary prophylaxis|0|||
161701888|NCT00364182|583957369|FG002|First Intervention|Secondary prophylaxis|0|||
161701889|NCT00364182|583957367|FG000|First Intervention|Withdrawal by Subject|2|||
161957643|NCT05396014|584892638|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161701890|NCT00364182|583957368|FG001|First Intervention|Withdrawal by Subject|0|||
161701891|NCT00364182|583957369|FG002|First Intervention|Withdrawal by Subject|0|||
161701892|NCT00364182|583957367|FG000|Second Intervention|non-compliance|0|||
161701893|NCT00364182|583957368|FG001|Second Intervention|non-compliance|1|||
161701894|NCT00364182|583957369|FG002|Second Intervention|non-compliance|1|||
161701895|NCT00364182|583957367|FG000|Second Intervention|Protocol Violation|0|||
161701896|NCT00364182|583957368|FG001|Second Intervention|Protocol Violation|1|||
161701897|NCT00364182|583957369|FG002|Second Intervention|Protocol Violation|0|||
161701898|NCT00364182|583957367|FG000|Second Intervention|Adverse Event|0|||
161701899|NCT00364182|583957368|FG001|Second Intervention|Adverse Event|0|||
161701900|NCT00364182|583957369|FG002|Second Intervention|Adverse Event|1|||
161701901|NCT00364182|583957367|FG000|Third Intervention|non-compliance|0|||
161701902|NCT00364182|583957368|FG001|Third Intervention|non-compliance|1|||
161701903|NCT00364182|583957369|FG002|Third Intervention|non-compliance|0|||
161701904|NCT00364182|583957367|FG000|Third Intervention|Lost to Follow-up|0|||
161701905|NCT00364182|583957368|FG001|Third Intervention|Lost to Follow-up|0|||
161701906|NCT00364182|583957369|FG002|Third Intervention|Lost to Follow-up|1|||
161957644|NCT05396014|584892639|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957645|NCT05396014|584892640|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957646|NCT05396014|584892641|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957647|NCT05396014|584892642|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957648|NCT05396014|584892643|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957649|NCT05396014|584892644|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957650|NCT05396014|584892645|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957651|NCT05396014|584892646|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957652|NCT05396014|584892647|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957653|NCT05396014|584892648|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957654|NCT05396014|584892649|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957655|NCT05396014|584892650|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957656|NCT05396014|584892651|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957657|NCT05396014|584892652|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957658|NCT05396014|584892653|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161701907|NCT03336502|583957371|FG000|Overall Study|Physician Decision|0|||
161701908|NCT03336502|583957372|FG001|Overall Study|Physician Decision|1|||
161701909|NCT03336502|583957371|FG000|Overall Study|Prohibited Drugs|1|||
161701910|NCT03336502|583957372|FG001|Overall Study|Prohibited Drugs|1|||
161701911|NCT03336502|583957371|FG000|Overall Study|Death|1|||
161701912|NCT03336502|583957372|FG001|Overall Study|Death|2|||
161701913|NCT03336502|583957371|FG000|Overall Study|Adverse Event|2|||
161701914|NCT03336502|583957372|FG001|Overall Study|Adverse Event|5|||
161701915|NCT02601573|583957373|FG000|Overall Study|Lost to Follow-up|0|||
161701916|NCT02601573|583957374|FG001|Overall Study|Lost to Follow-up|3|||
161701917|NCT02601573|583957375|FG002|Overall Study|Lost to Follow-up|1|||
161701918|NCT02601573|583957376|FG003|Overall Study|Lost to Follow-up|0|||
161701919|NCT02601573|583957377|FG004|Overall Study|Lost to Follow-up|2|||
161701920|NCT02601573|583957373|FG000|Overall Study|Withdrawal by Subject|0|||
161701921|NCT02601573|583957374|FG001|Overall Study|Withdrawal by Subject|1|||
161701922|NCT02601573|583957375|FG002|Overall Study|Withdrawal by Subject|0|||
161701923|NCT02601573|583957376|FG003|Overall Study|Withdrawal by Subject|1|||
161701924|NCT02601573|583957377|FG004|Overall Study|Withdrawal by Subject|0|||
161701925|NCT01850615|583957378|FG000|Overall Study|Protocol Violation|4|||
161701926|NCT01850615|583957379|FG001|Overall Study|Protocol Violation|1|||
161701927|NCT01850615|583957378|FG000|Overall Study|Adverse Event|2|||
161701928|NCT01850615|583957379|FG001|Overall Study|Adverse Event|1|||
161701929|NCT01850615|583957378|FG000|Overall Study|Withdrawal by Subject|3|||
161701930|NCT01850615|583957379|FG001|Overall Study|Withdrawal by Subject|1|||
161701931|NCT01850615|583957378|FG000|Overall Study|Lost to Follow-up|0|||
161701932|NCT01850615|583957379|FG001|Overall Study|Lost to Follow-up|1|||
161701933|NCT01850615|583957378|FG000|Overall Study|Unclassified|0|||
161701934|NCT01850615|583957379|FG001|Overall Study|Unclassified|1|||
161701935|NCT00706628|583957380|FG000|Overall Study|Other Adverse Event|16|||
161701936|NCT00706628|583957381|FG001|Overall Study|Other Adverse Event|5|||
161701937|NCT00706628|583957382|FG002|Overall Study|Other Adverse Event|5|||
161701938|NCT00706628|583957383|FG003|Overall Study|Other Adverse Event|2|||
161701939|NCT00706628|583957380|FG000|Overall Study|Non compliant with protocol|0|||
161701940|NCT00706628|583957381|FG001|Overall Study|Non compliant with protocol|1|||
161701941|NCT00706628|583957382|FG002|Overall Study|Non compliant with protocol|0|||
161701942|NCT00706628|583957383|FG003|Overall Study|Non compliant with protocol|0|||
161701943|NCT00706628|583957380|FG000|Overall Study|Consent withdrawn|6|||
161701944|NCT00706628|583957381|FG001|Overall Study|Consent withdrawn|1|||
161701945|NCT00706628|583957382|FG002|Overall Study|Consent withdrawn|3|||
161701946|NCT00706628|583957383|FG003|Overall Study|Consent withdrawn|0|||
161701947|NCT00706628|583957380|FG000|Overall Study|Progressive disease|20|||
161701948|NCT00706628|583957381|FG001|Overall Study|Progressive disease|13|||
161701949|NCT00706628|583957382|FG002|Overall Study|Progressive disease|8|||
161701950|NCT00706628|583957383|FG003|Overall Study|Progressive disease|1|||
161701951|NCT00706628|583957380|FG000|Overall Study|Other than those stated above|4|||
161701952|NCT00706628|583957381|FG001|Overall Study|Other than those stated above|0|||
161701953|NCT00706628|583957382|FG002|Overall Study|Other than those stated above|0|||
161701954|NCT00706628|583957383|FG003|Overall Study|Other than those stated above|0|||
161701955|NCT00706628|583957380|FG000|Overall Study|Not treated|1|||
161701956|NCT00706628|583957381|FG001|Overall Study|Not treated|1|||
161701957|NCT00706628|583957382|FG002|Overall Study|Not treated|0|||
161701958|NCT00706628|583957383|FG003|Overall Study|Not treated|0|||
161701959|NCT02921425|583957384|FG000|Overall Study|Protocol Violation|9|||
161701960|NCT01227967|583957385|FG000|Overall Study|Protocol Violation|3|||
161701961|NCT01227967|583957386|FG001|Overall Study|Protocol Violation|1|||
161701962|NCT01227967|583957385|FG000|Overall Study|Death|0|||
161701963|NCT01227967|583957386|FG001|Overall Study|Death|1|||
161957659|NCT05396014|584892654|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161701964|NCT01227967|583957385|FG000|Overall Study|Lost to Follow-up|8|||
161701965|NCT01227967|583957386|FG001|Overall Study|Lost to Follow-up|3|||
161701966|NCT01227967|583957385|FG000|Overall Study|Withdrawal by Subject|4|||
161957660|NCT05396014|584892655|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
161957661|NCT05396014|584892656|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161837066|NCT04421586|584446538|FG000|Overall Study|Lost to Follow-up|2|||
161837067|NCT04421586|584446539|FG001|Overall Study|Lost to Follow-up|2|||
161837068|NCT04421586|584446538|FG000|Overall Study|Withdrawn by PI|1|||
161837069|NCT04421586|584446539|FG001|Overall Study|Withdrawn by PI|0|||
161837070|NCT04421586|584446538|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
161837071|NCT04421586|584446539|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
161837072|NCT02963441|584446540|FG000|Overall Study|Protocol violation or withdrawn|8|||
161837073|NCT02963441|584446540|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
161837074|NCT02963441|584446540|FG000|Overall Study|IDx-DR insufficient quality|33|||
161837075|NCT04920916|584446541|FG000|Phase IIa 60 Day Study|Death|2|||
161837076|NCT04920916|584446542|FG001|Phase IIa 60 Day Study|Death|5|||
161837077|NCT04920916|584446541|FG000|1 Year Follow up (Phone Call)|Death|1|||
161701967|NCT01227967|583957386|FG001|Overall Study|Withdrawal by Subject|3|||
161701968|NCT01227967|583957385|FG000|Overall Study|Physician Decision|0|||
161701969|NCT01227967|583957386|FG001|Overall Study|Physician Decision|1|||
161701970|NCT01227967|583957385|FG000|Overall Study|Never Started Treatment|0|||
161701971|NCT01227967|583957386|FG001|Overall Study|Never Started Treatment|4|||
161701972|NCT01227967|583957385|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
161701973|NCT01227967|583957386|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
161701974|NCT03403400|583957387|FG000|Overall Study|Lost to Follow-up|1|||
161701975|NCT03403400|583957388|FG001|Overall Study|Lost to Follow-up|0|||
161701976|NCT03403400|583957389|FG002|Overall Study|Lost to Follow-up|1|||
161701977|NCT03403400|583957387|FG000|Overall Study|Hospitalization|1|||
161701978|NCT03403400|583957388|FG001|Overall Study|Hospitalization|0|||
161701979|NCT03403400|583957389|FG002|Overall Study|Hospitalization|0|||
161701980|NCT03403400|583957387|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
161701981|NCT03403400|583957388|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
161701982|NCT03403400|583957389|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
161701983|NCT01107444|583957393|FG000|Overall Study|Withdrawal by Subject|8|||
161701984|NCT01107444|583957394|FG001|Overall Study|Withdrawal by Subject|12|||
161701985|NCT01107444|583957393|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
161701986|NCT01107444|583957394|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
161701987|NCT00737529|583957395|FG000|Overall Study|Disease Progression|95|||
161701988|NCT00737529|583957395|FG000|Overall Study|Adverse Event|24|||
161701989|NCT00737529|583957395|FG000|Overall Study|Withdrawal by Subject|5|||
161701990|NCT00737529|583957395|FG000|Overall Study|Death|4|||
161701991|NCT00737529|583957395|FG000|Overall Study|Protocol Violation|1|||
161701992|NCT00737529|583957395|FG000|Overall Study|Other|4|||
161701993|NCT01948830|583957396|FG000|Overall Study|Physician Decision|1|||
161701994|NCT01948830|583957397|FG001|Overall Study|Physician Decision|3|||
161701995|NCT01948830|583957396|FG000|Overall Study|Protocol deviation|1|||
161701996|NCT01948830|583957397|FG001|Overall Study|Protocol deviation|2|||
161701997|NCT01948830|583957396|FG000|Overall Study|Lost to Follow-up|5|||
161701998|NCT01948830|583957397|FG001|Overall Study|Lost to Follow-up|4|||
161701999|NCT01948830|583957396|FG000|Overall Study|Withdrawal by Subject|14|||
161702000|NCT01948830|583957397|FG001|Overall Study|Withdrawal by Subject|17|||
161702001|NCT01948830|583957396|FG000|Overall Study|Adverse Event|9|||
161702002|NCT01948830|583957397|FG001|Overall Study|Adverse Event|2|||
161702003|NCT01948830|583957396|FG000|Overall Study|Death|3|||
161702004|NCT01948830|583957397|FG001|Overall Study|Death|4|||
161702005|NCT01145560|583957398|FG000|Overall Study|Withdrawal by Subject|2|||
161702006|NCT01145560|583957399|FG001|Overall Study|Withdrawal by Subject|1|||
161702007|NCT01145560|583957400|FG002|Overall Study|Withdrawal by Subject|0|||
161702008|NCT01145560|583957398|FG000|Overall Study|Lost to Follow-up|1|||
161702009|NCT01145560|583957399|FG001|Overall Study|Lost to Follow-up|1|||
161702010|NCT01145560|583957400|FG002|Overall Study|Lost to Follow-up|1|||
161702011|NCT01145560|583957398|FG000|Overall Study|No study drug by 24h after organ failure|1|||
161702012|NCT01145560|583957399|FG001|Overall Study|No study drug by 24h after organ failure|0|||
161702013|NCT01145560|583957400|FG002|Overall Study|No study drug by 24h after organ failure|0|||
161702014|NCT01145560|583957398|FG000|Overall Study|Accidental unblinding of study treatment|0|||
161702015|NCT01145560|583957399|FG001|Overall Study|Accidental unblinding of study treatment|1|||
161702016|NCT01145560|583957400|FG002|Overall Study|Accidental unblinding of study treatment|0|||
161702017|NCT01145560|583957398|FG000|Overall Study|False insurance information|0|||
161702018|NCT01145560|583957399|FG001|Overall Study|False insurance information|1|||
161702019|NCT01145560|583957400|FG002|Overall Study|False insurance information|0|||
161702020|NCT01145560|583957398|FG000|Overall Study|Withdrawal of therapy|0|||
161702021|NCT01145560|583957399|FG001|Overall Study|Withdrawal of therapy|0|||
161702022|NCT01145560|583957400|FG002|Overall Study|Withdrawal of therapy|1|||
161702023|NCT00712348|583957401|FG000|Overall Study|Withdrawal by Subject|1|||
161702024|NCT03310970|583957405|FG000|Overall Study|Withdrawal by Subject|0|||
161702025|NCT03310970|583957406|FG001|Overall Study|Withdrawal by Subject|1|||
161702026|NCT00091832|583957409|FG000|Overall Study|Physician Decision|1|||
161702027|NCT00091832|583957410|FG001|Overall Study|Physician Decision|0|||
161702028|NCT00091832|583957411|FG002|Overall Study|Physician Decision|0|||
161702029|NCT00091832|583957412|FG003|Overall Study|Physician Decision|0|||
161702030|NCT00091832|583957413|FG004|Overall Study|Physician Decision|0|||
161702031|NCT00091832|583957414|FG005|Overall Study|Physician Decision|0|||
161702032|NCT00091832|583957409|FG000|Overall Study|Adverse Event|0|||
161702033|NCT00091832|583957410|FG001|Overall Study|Adverse Event|0|||
161702034|NCT00091832|583957411|FG002|Overall Study|Adverse Event|0|||
161702035|NCT00091832|583957412|FG003|Overall Study|Adverse Event|1|||
161702036|NCT00091832|583957413|FG004|Overall Study|Adverse Event|3|||
161702037|NCT00091832|583957414|FG005|Overall Study|Adverse Event|0|||
161702038|NCT00091832|583957409|FG000|Overall Study|Withdrawal by Subject|4|||
161702039|NCT00091832|583957410|FG001|Overall Study|Withdrawal by Subject|5|||
161702040|NCT00091832|583957411|FG002|Overall Study|Withdrawal by Subject|0|||
161702041|NCT00091832|583957412|FG003|Overall Study|Withdrawal by Subject|1|||
161702042|NCT00091832|583957413|FG004|Overall Study|Withdrawal by Subject|3|||
161702043|NCT00091832|583957414|FG005|Overall Study|Withdrawal by Subject|1|||
161702044|NCT00091832|583957409|FG000|Overall Study|Death|6|||
161702045|NCT00091832|583957410|FG001|Overall Study|Death|4|||
161702046|NCT00091832|583957411|FG002|Overall Study|Death|5|||
161702047|NCT00091832|583957412|FG003|Overall Study|Death|8|||
161702048|NCT00091832|583957413|FG004|Overall Study|Death|5|||
161702049|NCT00091832|583957414|FG005|Overall Study|Death|6|||
161702050|NCT00091832|583957409|FG000|Overall Study|Disease Progression|2|||
161702051|NCT00091832|583957410|FG001|Overall Study|Disease Progression|0|||
161702052|NCT00091832|583957411|FG002|Overall Study|Disease Progression|0|||
161702053|NCT00091832|583957412|FG003|Overall Study|Disease Progression|1|||
161702054|NCT00091832|583957413|FG004|Overall Study|Disease Progression|1|||
161702055|NCT00091832|583957414|FG005|Overall Study|Disease Progression|2|||
161702056|NCT00091832|583957409|FG000|Overall Study|Ineligibility Determined|0|||
161702057|NCT00091832|583957410|FG001|Overall Study|Ineligibility Determined|0|||
161702058|NCT00091832|583957411|FG002|Overall Study|Ineligibility Determined|1|||
161702059|NCT00091832|583957412|FG003|Overall Study|Ineligibility Determined|0|||
161702060|NCT00091832|583957413|FG004|Overall Study|Ineligibility Determined|1|||
161702061|NCT00091832|583957414|FG005|Overall Study|Ineligibility Determined|0|||
161702062|NCT00091832|583957409|FG000|Overall Study|Lost to Follow-up|1|||
161702063|NCT00091832|583957410|FG001|Overall Study|Lost to Follow-up|0|||
161702064|NCT00091832|583957411|FG002|Overall Study|Lost to Follow-up|3|||
161702065|NCT00091832|583957412|FG003|Overall Study|Lost to Follow-up|3|||
161702066|NCT00091832|583957413|FG004|Overall Study|Lost to Follow-up|2|||
161702067|NCT00091832|583957414|FG005|Overall Study|Lost to Follow-up|1|||
161702068|NCT00091832|583957409|FG000|Overall Study|Noncompliance|0|||
161702069|NCT00091832|583957410|FG001|Overall Study|Noncompliance|1|||
161702070|NCT00091832|583957411|FG002|Overall Study|Noncompliance|0|||
161702071|NCT00091832|583957412|FG003|Overall Study|Noncompliance|0|||
161702072|NCT00091832|583957413|FG004|Overall Study|Noncompliance|0|||
161702073|NCT00091832|583957414|FG005|Overall Study|Noncompliance|0|||
161702074|NCT00091832|583957409|FG000|Overall Study|Other|0|||
161702075|NCT00091832|583957410|FG001|Overall Study|Other|1|||
161702076|NCT00091832|583957411|FG002|Overall Study|Other|2|||
161702077|NCT00091832|583957412|FG003|Overall Study|Other|0|||
161702078|NCT00091832|583957413|FG004|Overall Study|Other|0|||
161702079|NCT00091832|583957414|FG005|Overall Study|Other|0|||
161702080|NCT00091832|583957409|FG000|Overall Study|Protocol Violation|0|||
161702081|NCT00091832|583957410|FG001|Overall Study|Protocol Violation|0|||
161702082|NCT00091832|583957411|FG002|Overall Study|Protocol Violation|1|||
161702083|NCT00091832|583957412|FG003|Overall Study|Protocol Violation|0|||
161702084|NCT00091832|583957413|FG004|Overall Study|Protocol Violation|0|||
161702085|NCT00091832|583957414|FG005|Overall Study|Protocol Violation|1|||
161702086|NCT01446419|583957417|FG000|Overall Study|Death|1|||
161702087|NCT01446419|583957418|FG001|Overall Study|Death|0|||
161702088|NCT01446419|583957417|FG000|Overall Study|Withdrawal by Subject|1|||
161702089|NCT01446419|583957418|FG001|Overall Study|Withdrawal by Subject|1|||
161702090|NCT01446419|583957417|FG000|Overall Study|Terminated per protocol|3|||
161702091|NCT01446419|583957418|FG001|Overall Study|Terminated per protocol|0|||
161702092|NCT01557166|583957419|FG000|Overall Study|Adverse Event|20|||
161702093|NCT01557166|583957420|FG001|Overall Study|Adverse Event|6|||
161702094|NCT01557166|583957419|FG000|Overall Study|Lack of Efficacy|2|||
161702095|NCT01557166|583957420|FG001|Overall Study|Lack of Efficacy|1|||
161702096|NCT01557166|583957419|FG000|Overall Study|Protocol Violation|8|||
161702097|NCT01557166|583957420|FG001|Overall Study|Protocol Violation|5|||
161702098|NCT01557166|583957419|FG000|Overall Study|Withdrawn consent|12|||
161702099|NCT01557166|583957420|FG001|Overall Study|Withdrawn consent|20|||
161702100|NCT01557166|583957419|FG000|Overall Study|Target dose not tolerated|1|||
161702101|NCT01557166|583957420|FG001|Overall Study|Target dose not tolerated|0|||
161957662|NCT05396014|584892657|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161702102|NCT01557166|583957419|FG000|Overall Study|Psychiatric disorder|1|||
161702103|NCT01557166|583957420|FG001|Overall Study|Psychiatric disorder|0|||
161702104|NCT01557166|583957419|FG000|Overall Study|Unclassified|2|||
161702105|NCT01557166|583957420|FG001|Overall Study|Unclassified|5|||
161702106|NCT00946309|583957421|FG000|Overall Study|Protocol Violation|1|||
161702107|NCT00946309|583957422|FG001|Overall Study|Protocol Violation|0|||
161702108|NCT00946309|583957421|FG000|Overall Study|Lost to Follow-up|0|||
161702109|NCT00946309|583957422|FG001|Overall Study|Lost to Follow-up|1|||
161837078|NCT04920916|584446542|FG001|1 Year Follow up (Phone Call)|Death|3|||
161837079|NCT04920916|584446541|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
161837080|NCT04920916|584446542|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
161837081|NCT02011113|584446543|FG000|Overall Study|Adverse Event|4|||
161837082|NCT02011113|584446543|FG000|Overall Study|Disease Progression (DP)|16|||
161837083|NCT02011113|584446543|FG000|Overall Study|Death|1|||
161837084|NCT02011113|584446543|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
161837085|NCT02011113|584446543|FG000|Overall Study|Investigator's judgement- DP|3|||
161702110|NCT00946309|583957421|FG000|Overall Study|Procedure cancelled/discontinued|0|||
161702111|NCT00946309|583957422|FG001|Overall Study|Procedure cancelled/discontinued|3|||
161702112|NCT01465659|583957423|FG000|Completed 1 Cycle of Treatment|Death|0|||
161702113|NCT01465659|583957424|FG001|Completed 1 Cycle of Treatment|Death|1|||
161837086|NCT02011113|584446543|FG000|Overall Study|Study terminated by sponsor|11|||
161837087|NCT04688931|584446546|FG000|Overall Study|Adverse Event|4|||
161837088|NCT04688931|584446547|FG001|Overall Study|Adverse Event|1|||
161837089|NCT04688931|584446546|FG000|Overall Study|Withdrawal by Subject|5|||
161837090|NCT04688931|584446547|FG001|Overall Study|Withdrawal by Subject|16|||
161837091|NCT04688931|584446546|FG000|Overall Study|Physician Decision|3|||
161837092|NCT04688931|584446547|FG001|Overall Study|Physician Decision|5|||
161837093|NCT04688931|584446546|FG000|Overall Study|Noncompliance|0|||
161837094|NCT04688931|584446547|FG001|Overall Study|Noncompliance|1|||
161837095|NCT04688931|584446546|FG000|Overall Study|Lost to Follow-up|1|||
161702114|NCT01465659|583957425|FG002|Completed 1 Cycle of Treatment|Death|0|||
161702115|NCT01465659|583957426|FG003|Completed 1 Cycle of Treatment|Death|0|||
161702116|NCT01465659|583957423|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
161702117|NCT01465659|583957424|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
161702118|NCT01465659|583957425|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
161702119|NCT01465659|583957426|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
161702120|NCT01465659|583957423|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
161702121|NCT01465659|583957424|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
161702122|NCT01465659|583957425|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
161702123|NCT01465659|583957426|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
161702124|NCT01465659|583957423|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
161702125|NCT01465659|583957424|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
161702126|NCT01465659|583957425|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
161702127|NCT01465659|583957426|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
161702128|NCT01465659|583957423|FG000|Completed Follow for 1 Year|Death|6|||
161702129|NCT01465659|583957424|FG001|Completed Follow for 1 Year|Death|3|||
161702130|NCT01465659|583957425|FG002|Completed Follow for 1 Year|Death|2|||
161957663|NCT05396014|584892658|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957664|NCT05396014|584892659|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957665|NCT05396014|584892660|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957666|NCT05396014|584892661|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957667|NCT05396014|584892662|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957668|NCT05396014|584892663|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957669|NCT05396014|584892664|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957670|NCT05396014|584892665|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957671|NCT05396014|584892666|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957672|NCT05396014|584892667|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161957673|NCT05396014|584892668|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
161702131|NCT01465659|583957426|FG003|Completed Follow for 1 Year|Death|4|||
161702132|NCT02411747|583957429|FG000|Overall Study|Withdrawal by Subject|1|||
161702133|NCT02411747|583957430|FG001|Overall Study|Withdrawal by Subject|0|||
161702134|NCT02411747|583957429|FG000|Overall Study|Protocol Violation|2|||
161702135|NCT02411747|583957430|FG001|Overall Study|Protocol Violation|4|||
161702136|NCT02149810|583957431|FG000|Overall Study|Physician Decision|1|||
161702137|NCT02149810|583957432|FG001|Overall Study|Physician Decision|2|||
161702138|NCT02149810|583957431|FG000|Overall Study|Lost to Follow-up|2|||
161702139|NCT02149810|583957432|FG001|Overall Study|Lost to Follow-up|1|||
161702140|NCT02149810|583957431|FG000|Overall Study|Withdrawal by Subject|5|||
161702141|NCT02149810|583957432|FG001|Overall Study|Withdrawal by Subject|1|||
161702142|NCT00428597|583957433|FG000|Overall Study|Randomized but not treated|3|||
161702143|NCT00428597|583957434|FG001|Overall Study|Randomized but not treated|3|||
161702144|NCT00428597|583957433|FG000|Overall Study|Objective Progression or Relapse|19|||
161837096|NCT04688931|584446547|FG001|Overall Study|Lost to Follow-up|3|||
161837097|NCT04688931|584446546|FG000|Overall Study|Randomization Error|3|||
161837098|NCT04688931|584446547|FG001|Overall Study|Randomization Error|0|||
161837099|NCT04688931|584446546|FG000|Overall Study|Not Eligible|1|||
161837100|NCT04688931|584446547|FG001|Overall Study|Not Eligible|3|||
161837101|NCT04688931|584446546|FG000|Overall Study|Disease Progression|0|||
161837102|NCT04688931|584446547|FG001|Overall Study|Disease Progression|2|||
161837103|NCT04688931|584446546|FG000|Overall Study|Sponsor Requirement|1|||
161837104|NCT04688931|584446547|FG001|Overall Study|Sponsor Requirement|1|||
161837105|NCT04688931|584446546|FG000|Overall Study|Other Reason|1|||
161837106|NCT04688931|584446547|FG001|Overall Study|Other Reason|2|||
161837107|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Adverse Event|9|||
161837108|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Adverse Event|4|||
161837109|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Adverse Event|5|||
161837110|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Adverse Event|9|||
161837111|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Adverse Event|8|||
161957674|NCT05396014|584892669|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161702145|NCT00428597|583957434|FG001|Overall Study|Objective Progression or Relapse|47|||
161702146|NCT00428597|583957433|FG000|Overall Study|Study Terminated by Sponsor|41|||
161702147|NCT00428597|583957434|FG001|Overall Study|Study Terminated by Sponsor|16|||
161837112|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Adverse Event|0|||
161702148|NCT00428597|583957433|FG000|Overall Study|Adverse Event|15|||
161702149|NCT00428597|583957434|FG001|Overall Study|Adverse Event|7|||
161702150|NCT00428597|583957433|FG000|Overall Study|Global Deterioration of Health Status|1|||
161702151|NCT00428597|583957434|FG001|Overall Study|Global Deterioration of Health Status|5|||
161702152|NCT00428597|583957433|FG000|Overall Study|Protocol Violation|2|||
161702153|NCT00428597|583957434|FG001|Overall Study|Protocol Violation|1|||
161702154|NCT00428597|583957433|FG000|Overall Study|Withdrawal by Subject|2|||
161702155|NCT00428597|583957434|FG001|Overall Study|Withdrawal by Subject|1|||
161702156|NCT00428597|583957433|FG000|Overall Study|Other|1|||
161702157|NCT00428597|583957434|FG001|Overall Study|Other|1|||
161702158|NCT00428597|583957433|FG000|Overall Study|Lost to Follow-up|0|||
161702159|NCT00428597|583957434|FG001|Overall Study|Lost to Follow-up|1|||
161702160|NCT00428597|583957433|FG000|Overall Study|Pregnancy|1|||
161702161|NCT00428597|583957434|FG001|Overall Study|Pregnancy|0|||
161702162|NCT00428597|583957433|FG000|Overall Study|Death|1|||
161702163|NCT00428597|583957434|FG001|Overall Study|Death|3|||
161702164|NCT00675597|583957435|FG000|Overall Study|Withdrawal by Subject|3|||
161702165|NCT00560755|583957437|FG000|Overall Study|Protocol Violation|15|||
161702166|NCT00560755|583957437|FG000|Overall Study|Withdrawal by Subject|26|||
161702167|NCT00560755|583957437|FG000|Overall Study|Lost to Follow-up|9|||
161702168|NCT00560755|583957437|FG000|Overall Study|Adverse Event|8|||
161702169|NCT00560755|583957437|FG000|Overall Study|Physician Decision|2|||
161702170|NCT03828487|583957442|FG000|Overall Study|Physician Decision|1|||
161702171|NCT05032950|583957444|FG000|Overall Study|Adverse Event|0|||
161702172|NCT05032950|583957445|FG001|Overall Study|Adverse Event|0|||
161702173|NCT05032950|583957446|FG002|Overall Study|Adverse Event|1|||
161702174|NCT05032950|583957447|FG003|Overall Study|Adverse Event|1|||
161702175|NCT05032950|583957448|FG004|Overall Study|Adverse Event|0|||
161702176|NCT05032950|583957449|FG005|Overall Study|Adverse Event|0|||
161702177|NCT01356589|583957452|FG000|Overall Study|Enrolled, but not treated|3|||
161702178|NCT01356589|583957452|FG000|Overall Study|Dose data not recorded|2|||
161702179|NCT02447848|583957453|FG000|Overall Study|Patient discharged|3|||
161702180|NCT02447848|583957453|FG000|Overall Study|Lack of Efficacy|4|||
161702181|NCT02447848|583957453|FG000|Overall Study|Withdrawal by Subject|4|||
161702182|NCT02307370|583957454|FG000|Overall Study|Death|5|||
161702183|NCT02307370|583957454|FG000|Overall Study|Lost to Follow-up|1|||
161702184|NCT02307370|583957454|FG000|Overall Study|Withdrawal by Subject|1|||
161702185|NCT02307370|583957454|FG000|Overall Study|Declined Addendum ICF|6|||
161702186|NCT02307370|583957454|FG000|Overall Study|No response during telephone contact|5|||
161702187|NCT02307370|583957454|FG000|Overall Study|Protocol Violation|1|||
161702188|NCT03219164|583959196|FG000|Overall Study|Study Terminated by Sponsor|16|||
161702189|NCT03219164|583959197|FG001|Overall Study|Study Terminated by Sponsor|12|||
161702190|NCT03219164|583959196|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
161702191|NCT03219164|583959197|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
161702192|NCT03219164|583959196|FG000|Overall Study|Lost to Follow-up|1|||
161702193|NCT03219164|583959197|FG001|Overall Study|Lost to Follow-up|1|||
161702194|NCT03219164|583959196|FG000|Overall Study|Adverse Event|1|||
161702195|NCT03219164|583959197|FG001|Overall Study|Adverse Event|0|||
161702196|NCT03219164|583959196|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161702197|NCT03219164|583959197|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161702198|NCT03219164|583959196|FG000|Overall Study|Protocol Violation|0|||
161702199|NCT03219164|583959197|FG001|Overall Study|Protocol Violation|1|||
161702200|NCT03219164|583959196|FG000|Overall Study|Withdrew Assent|1|||
161702201|NCT03219164|583959197|FG001|Overall Study|Withdrew Assent|0|||
161702202|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
161702203|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
161702204|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
161702205|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161702206|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161702207|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161702208|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161702209|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161702210|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
161702211|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
161702212|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
161702213|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161702214|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161702215|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161702216|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
162030825|NCT03400956|585169492|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
161702217|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161702218|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
161702219|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
161702220|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
161702221|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161702222|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161702223|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161702224|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161702225|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161702226|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
161702227|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
161702228|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
161702229|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161702230|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161702231|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161702232|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161702233|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161702234|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
161702235|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
161702236|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
161702237|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161702238|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161702239|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161702240|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161702241|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161702242|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
161702243|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
161702244|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161702245|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161702246|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161702247|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161702248|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161702249|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161702250|NCT01097629|583959208|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
161702251|NCT01097629|583959209|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
161702252|NCT01097629|583959210|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
161702253|NCT01097629|583959211|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161702254|NCT01097629|583959212|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161702255|NCT01097629|583959213|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161702256|NCT01097629|583959214|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161702257|NCT01097629|583959215|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161702258|NCT01097629|583959208|FG000|DB RO Phase|Withdrawal by Subject|0|||
161702259|NCT01097629|583959209|FG001|DB RO Phase|Withdrawal by Subject|0|||
161702260|NCT01097629|583959210|FG002|DB RO Phase|Withdrawal by Subject|0|||
161702261|NCT01097629|583959211|FG003|DB RO Phase|Withdrawal by Subject|0|||
161702262|NCT01097629|583959212|FG004|DB RO Phase|Withdrawal by Subject|0|||
161702263|NCT01097629|583959213|FG005|DB RO Phase|Withdrawal by Subject|0|||
161702264|NCT01097629|583959214|FG006|DB RO Phase|Withdrawal by Subject|0|||
161702265|NCT01097629|583959215|FG007|DB RO Phase|Withdrawal by Subject|1|||
161702266|NCT01097629|583959208|FG000|DB RO Phase|Protocol Violation|0|||
161702267|NCT01097629|583959209|FG001|DB RO Phase|Protocol Violation|0|||
161702268|NCT01097629|583959210|FG002|DB RO Phase|Protocol Violation|0|||
161702269|NCT01097629|583959211|FG003|DB RO Phase|Protocol Violation|1|||
161702270|NCT01097629|583959212|FG004|DB RO Phase|Protocol Violation|0|||
161702271|NCT01097629|583959213|FG005|DB RO Phase|Protocol Violation|1|||
161702272|NCT01097629|583959214|FG006|DB RO Phase|Protocol Violation|1|||
161702273|NCT01097629|583959215|FG007|DB RO Phase|Protocol Violation|0|||
161702274|NCT01097629|583959208|FG000|DB RO Phase|Lost to Follow-up|0|||
161702275|NCT01097629|583959209|FG001|DB RO Phase|Lost to Follow-up|0|||
161702276|NCT01097629|583959210|FG002|DB RO Phase|Lost to Follow-up|0|||
161702277|NCT01097629|583959211|FG003|DB RO Phase|Lost to Follow-up|0|||
161702278|NCT01097629|583959212|FG004|DB RO Phase|Lost to Follow-up|0|||
161702279|NCT01097629|583959213|FG005|DB RO Phase|Lost to Follow-up|0|||
161702280|NCT01097629|583959214|FG006|DB RO Phase|Lost to Follow-up|2|||
161702281|NCT01097629|583959215|FG007|DB RO Phase|Lost to Follow-up|0|||
161702282|NCT00956943|583959216|FG000|Overall Study|Lost to Follow-up|9|||
161702283|NCT00956943|583959217|FG001|Overall Study|Lost to Follow-up|10|||
161702284|NCT02613208|583959218|FG000|Overall Study|Withdrawal by Subject|1|||
161702285|NCT02613208|583959218|FG000|Overall Study|Change of address|2|||
161702286|NCT02613208|583959218|FG000|Overall Study|Physician Decision|2|||
161702287|NCT02613208|583959218|FG000|Overall Study|Lost to Follow-up|5|||
161702288|NCT02613208|583959218|FG000|Overall Study|Death|37|||
161702289|NCT02663895|583959219|FG000|Overall Study|Adverse Event|3|||
161837113|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Adverse Event|0|||
161957675|NCT05396014|584892670|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161702290|NCT02663895|583959219|FG000|Overall Study|Physician Decision|2|||
161702291|NCT02663895|583959219|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
161702292|NCT02663895|583959219|FG000|Overall Study|Withdrawal by Subject|1|||
161702293|NCT00809328|583959220|FG000|Overall Study|Lack of Efficacy|18|||
161702294|NCT00809328|583959220|FG000|Overall Study|Adverse Event|6|||
161702295|NCT00809328|583959220|FG000|Overall Study|Protocol Violation|3|||
161702296|NCT00809328|583959220|FG000|Overall Study|Withdrawal by Subject|2|||
161702297|NCT00008385|583959223|FG000|Overall Study|Off treatment reasons not reported|79|||
161702298|NCT00008385|583959224|FG001|Overall Study|Off treatment reasons not reported|70|||
161702299|NCT00008385|583959223|FG000|Overall Study|Progressive disease|52|||
161702300|NCT00008385|583959224|FG001|Overall Study|Progressive disease|117|||
161702301|NCT00008385|583959223|FG000|Overall Study|Adverse Event|8|||
161702302|NCT00008385|583959224|FG001|Overall Study|Adverse Event|20|||
161702303|NCT00008385|583959223|FG000|Overall Study|Death|12|||
161702304|NCT00008385|583959224|FG001|Overall Study|Death|18|||
161702305|NCT00008385|583959223|FG000|Overall Study|Withdrawal by Subject|67|||
161702306|NCT00008385|583959224|FG001|Overall Study|Withdrawal by Subject|157|||
161702307|NCT00008385|583959223|FG000|Overall Study|Start non-protocol therapy|3|||
161702308|NCT00008385|583959224|FG001|Overall Study|Start non-protocol therapy|1|||
161702309|NCT00008385|583959223|FG000|Overall Study|Other complicating disease|17|||
161702310|NCT00008385|583959224|FG001|Overall Study|Other complicating disease|30|||
161702311|NCT00008385|583959223|FG000|Overall Study|Maximum dose reached|0|||
161702312|NCT00008385|583959224|FG001|Overall Study|Maximum dose reached|2|||
161702313|NCT00008385|583959223|FG000|Overall Study|Other|105|||
161702314|NCT00008385|583959224|FG001|Overall Study|Other|212|||
161702315|NCT00008385|583959223|FG000|Overall Study|Not start protocol therapy|44|||
161702316|NCT00008385|583959224|FG001|Overall Study|Not start protocol therapy|175|||
161702317|NCT05148884|583959225|FG000|Overall Study|Withdrawal by Subject|3|||
161702318|NCT05148884|583959226|FG001|Overall Study|Withdrawal by Subject|0|||
161702319|NCT05148884|583959225|FG000|Overall Study|Deep brain stimulation operation|0|||
161702320|NCT05148884|583959226|FG001|Overall Study|Deep brain stimulation operation|1|||
161702321|NCT01341457|583959229|FG000|Overall Study|Adverse Event|2|||
161702322|NCT01341457|583959230|FG001|Overall Study|Adverse Event|0|||
161702323|NCT00317044|583959231|FG000|Overall Study|Protocol Violation|28|||
161702324|NCT00317044|583959232|FG001|Overall Study|Protocol Violation|22|||
161702325|NCT00317044|583959233|FG002|Overall Study|Protocol Violation|20|||
161702326|NCT00317044|583959231|FG000|Overall Study|Adverse Event|4|||
161702327|NCT00317044|583959232|FG001|Overall Study|Adverse Event|7|||
161702328|NCT00317044|583959233|FG002|Overall Study|Adverse Event|4|||
161702329|NCT00317044|583959231|FG000|Overall Study|Withdrawal by Subject|10|||
161702330|NCT00317044|583959232|FG001|Overall Study|Withdrawal by Subject|7|||
161702331|NCT00317044|583959233|FG002|Overall Study|Withdrawal by Subject|12|||
161702332|NCT00317044|583959231|FG000|Overall Study|Lost to Follow-up|0|||
161702333|NCT00317044|583959232|FG001|Overall Study|Lost to Follow-up|2|||
161702334|NCT00317044|583959233|FG002|Overall Study|Lost to Follow-up|3|||
161702335|NCT00317044|583959231|FG000|Overall Study|Multiple Reasons|6|||
161702336|NCT00317044|583959232|FG001|Overall Study|Multiple Reasons|2|||
161702337|NCT00317044|583959233|FG002|Overall Study|Multiple Reasons|6|||
161702338|NCT04317690|583959236|FG000|Overall Study|did not have complete information for primary outcome|0|||
161702339|NCT04317690|583959237|FG001|Overall Study|did not have complete information for primary outcome|4|||
161702340|NCT04317690|583959238|FG002|Overall Study|did not have complete information for primary outcome|0|||
161702341|NCT04317690|583959239|FG003|Overall Study|did not have complete information for primary outcome|2|||
161702342|NCT04317690|583959240|FG004|Overall Study|did not have complete information for primary outcome|0|||
161702343|NCT02318095|583959241|FG000|Overall Study|Adverse Event|1|||
161702344|NCT01717638|583959242|FG000|Overall Study|Lost to Follow-up|0|||
161702345|NCT01717638|583959243|FG001|Overall Study|Lost to Follow-up|0|||
161702346|NCT01717638|583959244|FG002|Overall Study|Lost to Follow-up|0|||
161702347|NCT01717638|583959245|FG003|Overall Study|Lost to Follow-up|0|||
161702348|NCT01717638|583959246|FG004|Overall Study|Lost to Follow-up|0|||
161702349|NCT01717638|583959247|FG005|Overall Study|Lost to Follow-up|1|||
161702350|NCT01717638|583959248|FG006|Overall Study|Lost to Follow-up|0|||
161702351|NCT01717638|583959249|FG007|Overall Study|Lost to Follow-up|0|||
161702352|NCT01717638|583959250|FG008|Overall Study|Lost to Follow-up|0|||
161702353|NCT01717638|583959251|FG009|Overall Study|Lost to Follow-up|0|||
161702354|NCT01717638|583959252|FG010|Overall Study|Lost to Follow-up|0|||
161702355|NCT01717638|583959253|FG011|Overall Study|Lost to Follow-up|0|||
161702356|NCT01717638|583959254|FG012|Overall Study|Lost to Follow-up|0|||
161702357|NCT01717638|583959242|FG000|Overall Study|Father in hospital|0|||
161702358|NCT01717638|583959243|FG001|Overall Study|Father in hospital|0|||
161702359|NCT01717638|583959244|FG002|Overall Study|Father in hospital|0|||
161702360|NCT01717638|583959245|FG003|Overall Study|Father in hospital|0|||
161702361|NCT01717638|583959246|FG004|Overall Study|Father in hospital|0|||
161702362|NCT01717638|583959247|FG005|Overall Study|Father in hospital|0|||
161702363|NCT01717638|583959248|FG006|Overall Study|Father in hospital|0|||
161702364|NCT01717638|583959249|FG007|Overall Study|Father in hospital|0|||
161702365|NCT01717638|583959250|FG008|Overall Study|Father in hospital|0|||
161702366|NCT01717638|583959251|FG009|Overall Study|Father in hospital|0|||
161702367|NCT01717638|583959252|FG010|Overall Study|Father in hospital|0|||
161702368|NCT01717638|583959253|FG011|Overall Study|Father in hospital|0|||
161702369|NCT01717638|583959254|FG012|Overall Study|Father in hospital|1|||
161702370|NCT01717638|583959242|FG000|Overall Study|Withdrawal by Subject|0|||
161702371|NCT01717638|583959243|FG001|Overall Study|Withdrawal by Subject|1|||
161702372|NCT01717638|583959244|FG002|Overall Study|Withdrawal by Subject|1|||
161702373|NCT01717638|583959245|FG003|Overall Study|Withdrawal by Subject|0|||
161702374|NCT01717638|583959246|FG004|Overall Study|Withdrawal by Subject|1|||
161702375|NCT01717638|583959247|FG005|Overall Study|Withdrawal by Subject|0|||
161702376|NCT01717638|583959248|FG006|Overall Study|Withdrawal by Subject|2|||
161702377|NCT01717638|583959249|FG007|Overall Study|Withdrawal by Subject|1|||
161702378|NCT01717638|583959250|FG008|Overall Study|Withdrawal by Subject|2|||
161702379|NCT01717638|583959251|FG009|Overall Study|Withdrawal by Subject|1|||
161702380|NCT01717638|583959252|FG010|Overall Study|Withdrawal by Subject|0|||
161702381|NCT01717638|583959253|FG011|Overall Study|Withdrawal by Subject|0|||
161702382|NCT01717638|583959254|FG012|Overall Study|Withdrawal by Subject|18|||
161702383|NCT00600171|583959258|FG000|Overall Study|Adverse Event|0|||
161702384|NCT00600171|583959259|FG001|Overall Study|Adverse Event|1|||
161702385|NCT00600171|583959260|FG002|Overall Study|Adverse Event|0|||
161702386|NCT00600171|583959261|FG003|Overall Study|Adverse Event|0|||
161702387|NCT00600171|583959262|FG004|Overall Study|Adverse Event|1|||
161702388|NCT00600171|583959263|FG005|Overall Study|Adverse Event|0|||
161702389|NCT00600171|583959258|FG000|Overall Study|Lack of Efficacy|9|||
161702390|NCT00600171|583959259|FG001|Overall Study|Lack of Efficacy|12|||
161702391|NCT00600171|583959260|FG002|Overall Study|Lack of Efficacy|3|||
161702392|NCT00600171|583959261|FG003|Overall Study|Lack of Efficacy|5|||
161702393|NCT00600171|583959262|FG004|Overall Study|Lack of Efficacy|4|||
161702394|NCT00600171|583959263|FG005|Overall Study|Lack of Efficacy|0|||
161702395|NCT00600171|583959258|FG000|Overall Study|Protocol Violation|1|||
161702396|NCT00600171|583959259|FG001|Overall Study|Protocol Violation|2|||
161702397|NCT00600171|583959260|FG002|Overall Study|Protocol Violation|0|||
161702398|NCT00600171|583959261|FG003|Overall Study|Protocol Violation|1|||
161702399|NCT00600171|583959262|FG004|Overall Study|Protocol Violation|0|||
161702400|NCT00600171|583959263|FG005|Overall Study|Protocol Violation|0|||
161702401|NCT00600171|583959258|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
161702402|NCT00600171|583959259|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161702403|NCT00600171|583959260|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
161702404|NCT00600171|583959261|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
161702405|NCT00600171|583959262|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
161702406|NCT00600171|583959263|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
161702407|NCT00600171|583959258|FG000|Overall Study|Withdrawal by Subject|3|||
161702408|NCT00600171|583959259|FG001|Overall Study|Withdrawal by Subject|0|||
161702409|NCT00600171|583959260|FG002|Overall Study|Withdrawal by Subject|0|||
161702410|NCT00600171|583959261|FG003|Overall Study|Withdrawal by Subject|1|||
161702411|NCT00600171|583959262|FG004|Overall Study|Withdrawal by Subject|1|||
161702412|NCT00600171|583959263|FG005|Overall Study|Withdrawal by Subject|1|||
161702413|NCT00600171|583959258|FG000|Overall Study|Physician Decision|0|||
161702414|NCT00600171|583959259|FG001|Overall Study|Physician Decision|1|||
161702415|NCT00600171|583959260|FG002|Overall Study|Physician Decision|0|||
161702416|NCT00600171|583959261|FG003|Overall Study|Physician Decision|1|||
161702417|NCT00600171|583959262|FG004|Overall Study|Physician Decision|0|||
161702418|NCT00600171|583959263|FG005|Overall Study|Physician Decision|2|||
161702419|NCT00600171|583959258|FG000|Overall Study|Lost to Follow-up|0|||
161702420|NCT00600171|583959259|FG001|Overall Study|Lost to Follow-up|0|||
161702421|NCT00600171|583959260|FG002|Overall Study|Lost to Follow-up|0|||
161702422|NCT00600171|583959261|FG003|Overall Study|Lost to Follow-up|1|||
161702423|NCT00600171|583959262|FG004|Overall Study|Lost to Follow-up|0|||
161702424|NCT00600171|583959263|FG005|Overall Study|Lost to Follow-up|0|||
161702425|NCT02367521|583959264|FG000|Overall Study|severe headache after intervention|2|||
161702426|NCT02367521|583959265|FG001|Overall Study|severe headache after intervention|0|||
161702427|NCT02367521|583959264|FG000|Overall Study|unable to find transportation|2|||
161837114|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
161702428|NCT02367521|583959265|FG001|Overall Study|unable to find transportation|0|||
161702429|NCT00542191|583959269|FG000|Overall Study|Death|3|||
161702430|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702431|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
161702432|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702433|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702434|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702435|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
161702436|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
161702437|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
161702438|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
161702439|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
161702440|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161702441|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161702442|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702443|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161702444|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161702445|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
161702446|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
161702447|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
161702448|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
161702449|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
161702450|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702451|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702452|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702453|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
161702454|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702455|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
161702456|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
161702457|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161702458|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161702459|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161702460|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
161702461|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
161702462|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
161702463|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
161702464|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
161702465|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161702466|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
161702467|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
161702468|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
161702469|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161702470|NCT00289913|583959270|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
161702471|NCT00289913|583959271|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702472|NCT00289913|583959272|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
161702473|NCT00289913|583959273|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702474|NCT00289913|583959274|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702475|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702476|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702477|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
161702478|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702479|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702480|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
161702481|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
161702482|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
161702483|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
161702484|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
161702485|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
161702486|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
161702487|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
161702488|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
161702489|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
161702490|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
161702491|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161702492|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
161702493|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702494|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702495|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
161702496|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702497|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
161702498|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702499|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702500|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161702501|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
161702502|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
161702503|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
161702504|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161702505|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
161702506|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
161702507|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
161702508|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
161702509|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
161702510|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
161702511|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
161702512|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
161702513|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
161702514|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
161702515|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
161702516|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
161702517|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
161702518|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
161702519|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
161702520|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
161702521|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
161702522|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
161702523|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
161702524|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
161702525|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
161702526|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
161702527|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
161702528|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
161702529|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
161702530|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
161702531|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
161702532|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
161702533|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
161702534|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
161702535|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
161702536|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
161702537|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
161702538|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
161702539|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
161702540|NCT00289913|583959270|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
161702541|NCT00289913|583959271|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
161702542|NCT00289913|583959272|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
161702543|NCT00289913|583959273|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
161702544|NCT00289913|583959274|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
161702545|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702546|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
161702547|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702548|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702549|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161702550|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
161702551|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
161702552|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
161702553|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
161702554|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
161702555|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702556|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702557|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702558|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
161702559|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161702560|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702561|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702562|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161702563|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161957676|NCT05396014|584892671|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
161702564|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
161702565|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
161702566|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
161702567|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
161702568|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
162030826|NCT03400956|585169490|FG000|Post-treatment Period 1|Other|4|||
161702569|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
161702570|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161702571|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
161702572|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
161702573|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161702574|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161702575|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
161702576|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
161702577|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
161702578|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
161702579|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
161702580|NCT00289913|583959270|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702581|NCT00289913|583959271|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
161702582|NCT00289913|583959272|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702583|NCT00289913|583959273|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702584|NCT00289913|583959274|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161702585|NCT03822884|583959275|FG000|Overall Study|Withdrawal by Subject|0|||
161702586|NCT03822884|583959276|FG001|Overall Study|Withdrawal by Subject|0|||
161702587|NCT03822884|583959277|FG002|Overall Study|Withdrawal by Subject|0|||
161702588|NCT03822884|583959278|FG003|Overall Study|Withdrawal by Subject|0|||
161702589|NCT03822884|583959279|FG004|Overall Study|Withdrawal by Subject|1|||
161702590|NCT03822884|583959280|FG005|Overall Study|Withdrawal by Subject|0|||
161702591|NCT00434967|583959283|FG000|Overall Study|Adverse Event|2|||
161702592|NCT00434967|583959284|FG001|Overall Study|Adverse Event|4|||
161702593|NCT00434967|583959285|FG002|Overall Study|Adverse Event|3|||
161702594|NCT00434967|583959286|FG003|Overall Study|Adverse Event|3|||
161702595|NCT00434967|583959283|FG000|Overall Study|Lost to Follow-up|0|||
161702596|NCT00434967|583959284|FG001|Overall Study|Lost to Follow-up|0|||
161702597|NCT00434967|583959285|FG002|Overall Study|Lost to Follow-up|1|||
161702598|NCT00434967|583959286|FG003|Overall Study|Lost to Follow-up|0|||
161702599|NCT00434967|583959283|FG000|Overall Study|Withdrawal by Subject|2|||
161702600|NCT00434967|583959284|FG001|Overall Study|Withdrawal by Subject|2|||
161702601|NCT00434967|583959285|FG002|Overall Study|Withdrawal by Subject|4|||
161702602|NCT00434967|583959286|FG003|Overall Study|Withdrawal by Subject|6|||
161702603|NCT00434967|583959283|FG000|Overall Study|Randomized in error|0|||
161702604|NCT00434967|583959284|FG001|Overall Study|Randomized in error|0|||
161702605|NCT00434967|583959285|FG002|Overall Study|Randomized in error|0|||
161702606|NCT00434967|583959286|FG003|Overall Study|Randomized in error|1|||
161702607|NCT00434967|583959283|FG000|Overall Study|Protocol Violation|0|||
161702608|NCT00434967|583959284|FG001|Overall Study|Protocol Violation|1|||
161702609|NCT00434967|583959285|FG002|Overall Study|Protocol Violation|0|||
161702610|NCT00434967|583959286|FG003|Overall Study|Protocol Violation|1|||
161702611|NCT00434967|583959283|FG000|Overall Study|Physician Decision|1|||
161702612|NCT00434967|583959284|FG001|Overall Study|Physician Decision|1|||
161702613|NCT00434967|583959285|FG002|Overall Study|Physician Decision|1|||
161702614|NCT00434967|583959286|FG003|Overall Study|Physician Decision|0|||
161702615|NCT00434967|583959283|FG000|Overall Study|Patient Disposition Challenges|2|||
161702616|NCT00434967|583959284|FG001|Overall Study|Patient Disposition Challenges|0|||
161702617|NCT00434967|583959285|FG002|Overall Study|Patient Disposition Challenges|0|||
161702618|NCT00434967|583959286|FG003|Overall Study|Patient Disposition Challenges|3|||
161702619|NCT00110019|583959292|FG000|Overall Study|Lack of Efficacy|253|||
161702620|NCT00110019|583959293|FG001|Overall Study|Lack of Efficacy|285|||
161702621|NCT00110019|583959292|FG000|Overall Study|Adverse Event|61|||
161702622|NCT00110019|583959293|FG001|Overall Study|Adverse Event|40|||
161702623|NCT00110019|583959292|FG000|Overall Study|Death|13|||
161702624|NCT00110019|583959293|FG001|Overall Study|Death|15|||
161702625|NCT00110019|583959292|FG000|Overall Study|Withdrawal by Subject|21|||
161837115|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
161702626|NCT00110019|583959293|FG001|Overall Study|Withdrawal by Subject|9|||
161702627|NCT00110019|583959292|FG000|Overall Study|alternative therapy|5|||
161702628|NCT00110019|583959293|FG001|Overall Study|alternative therapy|1|||
161702629|NCT00110019|583959292|FG000|Overall Study|complicating disease|1|||
161702630|NCT00110019|583959293|FG001|Overall Study|complicating disease|1|||
161702631|NCT00110019|583959292|FG000|Overall Study|symptom deterioration|13|||
161702632|NCT00110019|583959293|FG001|Overall Study|symptom deterioration|16|||
161702633|NCT00110019|583959292|FG000|Overall Study|Not start protocol therapy|17|||
161702634|NCT00110019|583959293|FG001|Overall Study|Not start protocol therapy|16|||
161702635|NCT00110019|583959292|FG000|Overall Study|other reasons|22|||
161702636|NCT00110019|583959293|FG001|Overall Study|other reasons|30|||
161702637|NCT04276207|583959294|FG000|Period 1|Withdrawal by Subject|0|||
161702638|NCT04276207|583959295|FG001|Period 1|Withdrawal by Subject|1|||
161702639|NCT01256177|583959296|FG000|Overall Study|Withdrawal by Subject|23|||
161702640|NCT01256177|583959297|FG001|Overall Study|Withdrawal by Subject|22|||
161702641|NCT01256177|583959296|FG000|Overall Study|Lost to Follow-up|2|||
161702642|NCT01256177|583959297|FG001|Overall Study|Lost to Follow-up|2|||
161702643|NCT01256177|583959296|FG000|Overall Study|Adverse Event|8|||
161702644|NCT01256177|583959297|FG001|Overall Study|Adverse Event|9|||
161702645|NCT01256177|583959296|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
161702646|NCT01256177|583959297|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
161702647|NCT01256177|583959296|FG000|Overall Study|Condition under Investigation Worsened|1|||
161702648|NCT01256177|583959297|FG001|Overall Study|Condition under Investigation Worsened|0|||
161702649|NCT01256177|583959296|FG000|Overall Study|Lack of Efficacy|11|||
161702650|NCT01256177|583959297|FG001|Overall Study|Lack of Efficacy|2|||
161702651|NCT01256177|583959296|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
161702652|NCT01256177|583959297|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
161702653|NCT01596257|583959299|FG000|Overall Study|Inadequate Collection|23|||
161702654|NCT01596257|583959300|FG001|Overall Study|Inadequate Collection|19|||
161702655|NCT00531960|583959301|FG000|Overall Study|Adverse Event|5|||
161702656|NCT00531960|583959302|FG001|Overall Study|Adverse Event|4|||
161702657|NCT00531960|583959301|FG000|Overall Study|Death|3|||
161702658|NCT00531960|583959302|FG001|Overall Study|Death|2|||
161702659|NCT00531960|583959301|FG000|Overall Study|Lack of Efficacy|42|||
161702660|NCT00531960|583959302|FG001|Overall Study|Lack of Efficacy|41|||
161702661|NCT00531960|583959301|FG000|Overall Study|Violation of Selection Criteria|2|||
161702662|NCT00531960|583959302|FG001|Overall Study|Violation of Selection Criteria|0|||
161702663|NCT00531960|583959301|FG000|Overall Study|Refused Treatment|5|||
161702664|NCT00531960|583959302|FG001|Overall Study|Refused Treatment|6|||
161702665|NCT00531960|583959301|FG000|Overall Study|Other|4|||
161702666|NCT00531960|583959302|FG001|Overall Study|Other|10|||
161702667|NCT02318784|583959305|FG000|Overall Study|Adverse Event|13|||
161702668|NCT02318784|583959305|FG000|Overall Study|Death|2|||
161702669|NCT02318784|583959305|FG000|Overall Study|Progressive Disease|37|||
161702670|NCT02318784|583959305|FG000|Overall Study|Withdrawal by Subject|10|||
161702671|NCT03603652|583959309|FG000|Overall Study|Death|2|||
161702672|NCT01879410|583959317|FG000|Overall Study|Adverse Event|9|||
161702673|NCT01879410|583959318|FG001|Overall Study|Adverse Event|14|||
161702674|NCT01879410|583959317|FG000|Overall Study|Lack of Efficacy|4|||
161702675|NCT01879410|583959318|FG001|Overall Study|Lack of Efficacy|6|||
161702676|NCT01879410|583959317|FG000|Overall Study|Protocol Violation|1|||
161702677|NCT01879410|583959318|FG001|Overall Study|Protocol Violation|7|||
161702678|NCT01879410|583959317|FG000|Overall Study|Lost to Follow-up|2|||
161702679|NCT01879410|583959318|FG001|Overall Study|Lost to Follow-up|1|||
161702680|NCT01879410|583959317|FG000|Overall Study|Withdrawal by Subject|7|||
161702681|NCT01879410|583959318|FG001|Overall Study|Withdrawal by Subject|8|||
161702682|NCT01879410|583959317|FG000|Overall Study|Randomised in Error|1|||
161702683|NCT01879410|583959318|FG001|Overall Study|Randomised in Error|2|||
161702684|NCT00238264|583959319|FG000|Overall Study|Death|7|||
161702685|NCT00238264|583959319|FG000|Overall Study|Lost to Follow-up|18|||
161702686|NCT00238264|583959319|FG000|Overall Study|Withdrawal by Subject|4|||
161702687|NCT00238264|583959319|FG000|Overall Study|Ineligible|7|||
161702688|NCT00508391|583959320|FG000|First Treatment|Withdrawal by Subject|6|||
161702689|NCT00508391|583959321|FG001|First Treatment|Withdrawal by Subject|3|||
161702690|NCT00508391|583959320|FG000|Second Treatment|Withdrawal by Subject|2|||
161702691|NCT00508391|583959321|FG001|Second Treatment|Withdrawal by Subject|0|||
161837116|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
161837117|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
161957677|NCT05396014|584892629|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957678|NCT05396014|584892630|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957679|NCT05396014|584892631|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957680|NCT05396014|584892632|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957681|NCT05396014|584892633|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957682|NCT05396014|584892634|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161702692|NCT00880256|583959322|FG000|Overall Study|Lost to Follow-up|28|||
161702693|NCT02041962|583959326|FG000|Overall Study|Lost Aetna Coverage|43|||
161702694|NCT02041962|583959327|FG001|Overall Study|Lost Aetna Coverage|40|||
161702695|NCT02041962|583959326|FG000|Overall Study|Death|1|||
161702696|NCT02041962|583959327|FG001|Overall Study|Death|1|||
161702697|NCT02041962|583959326|FG000|Overall Study|Lost to Follow-up|37|||
161702698|NCT02041962|583959327|FG001|Overall Study|Lost to Follow-up|32|||
161702699|NCT02041962|583959326|FG000|Overall Study|Withdrawal by Subject|0|||
161702700|NCT02041962|583959327|FG001|Overall Study|Withdrawal by Subject|11|||
161702701|NCT01686568|583959328|FG000|Main Study|Withdrawal by Subject|1|||
161702702|NCT01686568|583959329|FG001|Main Study|Withdrawal by Subject|3|||
161702703|NCT01686568|583959328|FG000|Main Study|Noncompliance with protocol|0|||
161702704|NCT01686568|583959329|FG001|Main Study|Noncompliance with protocol|1|||
161702705|NCT01686568|583959328|FG000|Main Study|Liver enzymes above range of exclusion|1|||
161702706|NCT01686568|583959329|FG001|Main Study|Liver enzymes above range of exclusion|0|||
161702707|NCT01686568|583959328|FG000|Sub-Study|Not consented for sub-study|2|||
161702708|NCT01686568|583959329|FG001|Sub-Study|Not consented for sub-study|2|||
161702709|NCT00974220|583959330|FG000|Treatment Period 1|Adverse Event|2|||
161702710|NCT00974220|583959331|FG001|Treatment Period 1|Adverse Event|1|||
161702711|NCT00974220|583959330|FG000|Treatment Period 1|noncompliant subjects|0|||
161702712|NCT00974220|583959331|FG001|Treatment Period 1|noncompliant subjects|1|||
161702713|NCT02959814|583959350|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
161702714|NCT02959814|583959350|FG000|Overall Study|Excluded based on anatomical criteria|2|||
161702715|NCT02959814|583959350|FG000|Overall Study|Protocol Violation|7|||
161702716|NCT02959814|583959350|FG000|Overall Study|FFR not measured|2|||
161702717|NCT02959814|583959350|FG000|Overall Study|In-procedure QFR not computed|6|||
161702718|NCT02959814|583959350|FG000|Overall Study|Excluded by FFR core-lab|24|||
161702719|NCT04343651|583959354|FG000|Overall Study|Physician Decision|2|||
161702720|NCT04343651|583959355|FG001|Overall Study|Physician Decision|1|||
161702721|NCT04343651|583959354|FG000|Overall Study|Lost to Follow-up|2|||
161702722|NCT04343651|583959355|FG001|Overall Study|Lost to Follow-up|1|||
161702723|NCT04343651|583959354|FG000|Overall Study|Protocol Violation|4|||
161702724|NCT04343651|583959355|FG001|Overall Study|Protocol Violation|6|||
161702725|NCT04343651|583959354|FG000|Overall Study|Missing|3|||
161702726|NCT04343651|583959355|FG001|Overall Study|Missing|9|||
161702727|NCT04343651|583959354|FG000|Overall Study|Withdrawal by Subject|0|||
161702728|NCT04343651|583959355|FG001|Overall Study|Withdrawal by Subject|4|||
161702729|NCT04343651|583959354|FG000|Overall Study|Death|0|||
161702730|NCT04343651|583959355|FG001|Overall Study|Death|1|||
161702731|NCT04343651|583959354|FG000|Overall Study|Did not start treatment|1|||
161702732|NCT04343651|583959355|FG001|Overall Study|Did not start treatment|1|||
161702733|NCT04343651|583959354|FG000|Overall Study|Patient did not complete visits 3-6|0|||
161702734|NCT04343651|583959355|FG001|Overall Study|Patient did not complete visits 3-6|1|||
161702735|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
161702736|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
161702737|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
161702738|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161702739|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161702740|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161702741|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161702742|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161702743|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161702744|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
161702745|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
161702746|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
161702747|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161702748|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161702749|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161702750|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161702751|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161702752|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161702753|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
161702754|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
161702755|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702756|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702757|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702758|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702759|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702760|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702761|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161702762|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
161702763|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
161702764|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
161702765|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161702766|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161702767|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161702768|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161702769|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161702770|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161837118|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
161702771|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
161702772|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
161702773|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702774|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702775|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702776|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702777|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702778|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702779|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161702780|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702781|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702782|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
161702783|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702784|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702785|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702786|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702787|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702788|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161702789|NCT01583374|583959359|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702790|NCT01583374|583959360|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
161702791|NCT01583374|583959361|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702792|NCT01583374|583959362|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702793|NCT01583374|583959363|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702794|NCT01583374|583959364|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702795|NCT01583374|583959365|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702796|NCT01583374|583959366|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702797|NCT01583374|583959367|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
161702798|NCT01583374|583959359|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702799|NCT01583374|583959360|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161837119|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
161837120|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
161837121|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Death|1|||
161837122|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Death|1|||
161837123|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Death|1|||
161837124|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Death|1|||
161837125|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Death|0|||
161837126|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Death|0|||
161837127|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Death|0|||
161837128|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
161837129|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
161837130|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
161837131|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
161837132|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
161837133|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
161837134|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
161837135|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161837136|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161702800|NCT01583374|583959361|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702801|NCT01583374|583959362|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702802|NCT01583374|583959363|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702803|NCT01583374|583959364|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702804|NCT01583374|583959365|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702805|NCT01583374|583959366|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
161702806|NCT01583374|583959367|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161702807|NCT01583374|583959359|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
161702808|NCT01583374|583959360|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161702809|NCT01583374|583959361|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
161702810|NCT01583374|583959362|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
161702811|NCT01583374|583959363|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161702812|NCT01583374|583959364|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161702813|NCT01583374|583959365|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
161702814|NCT01583374|583959366|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161702815|NCT01583374|583959367|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
161702816|NCT01583374|583959359|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
161702817|NCT01583374|583959360|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
161702818|NCT01583374|583959361|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
161837137|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
161837138|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161702819|NCT01583374|583959362|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
161702820|NCT01583374|583959363|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
161702821|NCT01583374|583959364|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
161702822|NCT01583374|583959365|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
161702823|NCT01583374|583959366|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
161702824|NCT01583374|583959367|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
161702825|NCT01583374|583959359|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161702826|NCT01583374|583959360|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
161702827|NCT01583374|583959361|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
161702828|NCT01583374|583959362|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161702829|NCT01583374|583959363|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
161702830|NCT01583374|583959364|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161702831|NCT01583374|583959365|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161702832|NCT01583374|583959366|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161702833|NCT01583374|583959367|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161702834|NCT01583374|583959359|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161702835|NCT01583374|583959360|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161702836|NCT01583374|583959361|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
161702837|NCT01583374|583959362|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161702838|NCT01583374|583959363|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
161702839|NCT01583374|583959364|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
161702840|NCT01583374|583959365|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161702841|NCT01583374|583959366|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161702842|NCT01583374|583959367|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161702843|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
161702844|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
161702845|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
161702846|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
161702847|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
161702848|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
161702849|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
161702850|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
161702851|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
161702852|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
161702853|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
161702854|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
161702855|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
161702856|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
161702857|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
161702858|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
161702859|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
161702860|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
161702861|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161702862|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161702863|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161837139|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161837140|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161837141|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161837142|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
161837143|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
161837144|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
161837145|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
161837146|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
161837147|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
161837148|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
161837149|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Other|2|||
161837150|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Other|9|||
161837151|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Other|9|||
161837152|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Other|3|||
161837153|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Other|2|||
161837154|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Other|0|||
161837155|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Other|0|||
161837156|NCT00361335|584446550|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
161837157|NCT00361335|584446551|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
162030827|NCT03400956|585169491|FG001|Post-treatment Period 1|Other|3|||
161837158|NCT00361335|584446552|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
161837159|NCT00361335|584446553|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
161837160|NCT00361335|584446554|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
161702864|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161702865|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
161702866|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161702867|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161702868|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
161702869|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
161702870|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
161702871|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
161702872|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
161702873|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
161702874|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
161702875|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
161702876|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
161702877|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
161702878|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
161702879|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702880|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702881|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702882|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702883|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
161702884|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702885|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
161702886|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702887|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
161702888|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161702889|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
161702890|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161702891|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
161702892|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
161702893|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161702894|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
161702895|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161702896|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161702897|NCT01583374|583959359|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
161702898|NCT01583374|583959360|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
161702899|NCT01583374|583959361|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
161702900|NCT01583374|583959362|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
161702901|NCT01583374|583959363|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
161702902|NCT01583374|583959364|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
161702903|NCT01583374|583959365|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
161702904|NCT01583374|583959366|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
161702905|NCT01583374|583959367|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
161702906|NCT01292057|583959370|FG000|Overall Study|Protocol Violation|1|||
161702907|NCT01292057|583959371|FG001|Overall Study|Protocol Violation|1|||
161702908|NCT01292057|583959370|FG000|Overall Study|Lost to Follow-up|1|||
161702909|NCT01292057|583959371|FG001|Overall Study|Lost to Follow-up|1|||
161702910|NCT03658889|583961479|FG000|Overall Study|Protocol Violation|2|||
161702911|NCT03658889|583961480|FG001|Overall Study|Protocol Violation|0|||
161702912|NCT04188197|583961481|FG000|Overall Study|Lost to Follow-up|4|||
161702913|NCT04188197|583961482|FG001|Overall Study|Lost to Follow-up|1|||
161702914|NCT04188197|583961481|FG000|Overall Study|Withdrawal by Subject|1|||
161702915|NCT04188197|583961482|FG001|Overall Study|Withdrawal by Subject|1|||
161702916|NCT04188197|583961481|FG000|Overall Study|Pregnancy|0|||
161702917|NCT04188197|583961482|FG001|Overall Study|Pregnancy|1|||
161702918|NCT01524991|583961485|FG000|Overall Study|Adverse Event|12|||
161702919|NCT01524991|583961485|FG000|Overall Study|Death|1|||
161702920|NCT01524991|583961485|FG000|Overall Study|Disease ProgressionDu|17|||
161702921|NCT01524991|583961485|FG000|Overall Study|Other complicating disease|1|||
161702922|NCT01524991|583961485|FG000|Overall Study|Withdrawal by Subject|2|||
161702923|NCT01524991|583961485|FG000|Overall Study|Symptomatic Deterioration|1|||
161702924|NCT04574999|583961486|FG000|Overall Study|Adverse Event|1|||
161702925|NCT04574999|583961487|FG001|Overall Study|Adverse Event|0|||
161702926|NCT04574999|583961486|FG000|Overall Study|Lack of Efficacy|2|||
161702927|NCT04574999|583961487|FG001|Overall Study|Lack of Efficacy|3|||
161702928|NCT04574999|583961486|FG000|Overall Study|Protocol Violation|1|||
161702929|NCT04574999|583961487|FG001|Overall Study|Protocol Violation|0|||
161702930|NCT04574999|583961486|FG000|Overall Study|Withdrawal by Subject|2|||
161702931|NCT04574999|583961487|FG001|Overall Study|Withdrawal by Subject|2|||
161702932|NCT04574999|583961486|FG000|Overall Study|Lost to Follow-up|1|||
161702933|NCT04574999|583961487|FG001|Overall Study|Lost to Follow-up|0|||
161702934|NCT04574999|583961486|FG000|Overall Study|Personal problems|1|||
161702935|NCT04574999|583961487|FG001|Overall Study|Personal problems|0|||
161702936|NCT04574999|583961486|FG000|Overall Study|Previous planned surgery|1|||
161702937|NCT04574999|583961487|FG001|Overall Study|Previous planned surgery|0|||
161702938|NCT00206726|583961489|FG000|Overall Study|Delayed recovery of blood counts|1|||
161702939|NCT00206726|583961489|FG000|Overall Study|Progressive disease or relapsed disease|18|||
161702940|NCT00206726|583961489|FG000|Overall Study|Placed on new protocol|1|||
161702941|NCT00206726|583961489|FG000|Overall Study|Bone marrow transplant|1|||
161702942|NCT00206726|583961489|FG000|Overall Study|Adverse Event|17|||
161702943|NCT00206726|583961489|FG000|Overall Study|Death|4|||
161702944|NCT00206726|583961489|FG000|Overall Study|Protocol Violation|1|||
161702945|NCT00206726|583961489|FG000|Overall Study|Withdrawal by Subject|8|||
161702946|NCT00365989|583961490|FG000|Overall Study|Withdrawal by Subject|1|||
161702947|NCT00365989|583961490|FG000|Overall Study|Non-compliance|1|||
161702948|NCT00832819|583961493|FG000|Overall Study|Adverse Event|0|||
161702949|NCT00832819|583961494|FG001|Overall Study|Adverse Event|1|||
161702950|NCT00832819|583961495|FG002|Overall Study|Adverse Event|0|||
161702951|NCT00832819|583961493|FG000|Overall Study|Protocol Violation|0|||
161702952|NCT00832819|583961494|FG001|Overall Study|Protocol Violation|0|||
161702953|NCT00832819|583961495|FG002|Overall Study|Protocol Violation|1|||
161702954|NCT01719757|583961496|FG000|Overall Study|Adverse Event|38|||
161702955|NCT01719757|583961496|FG000|Overall Study|Withdrawal by Subject|15|||
161702956|NCT01719757|583961496|FG000|Overall Study|Lost to Follow-up|20|||
161702957|NCT01719757|583961496|FG000|Overall Study|Protocol Violation|1|||
161702958|NCT01719757|583961496|FG000|Overall Study|well controlled pain|27|||
161702959|NCT02626338|583961497|FG000|Overall Study|Lack of Efficacy|3|||
161702960|NCT02626338|583961498|FG001|Overall Study|Lack of Efficacy|2|||
161702961|NCT02626338|583961499|FG002|Overall Study|Lack of Efficacy|0|||
161702962|NCT03312218|583961505|FG000|Overall Study|Never signed in to access the app|54|||
161702963|NCT03312218|583961506|FG001|Overall Study|Never signed in to access the app|58|||
161702964|NCT01901224|583961507|FG000|Overall Study|study was not funded and terminated|2|||
161702965|NCT06441877|583961508|FG000|Overall Study|Withdrawal by Subject|0|||
161702966|NCT06441877|583961509|FG001|Overall Study|Withdrawal by Subject|2|||
161702967|NCT06441877|583961510|FG002|Overall Study|Withdrawal by Subject|0|||
161702968|NCT06441877|583961511|FG003|Overall Study|Withdrawal by Subject|0|||
161702969|NCT05742984|583961512|FG000|Overall Study|Adverse Event|0|||
161702970|NCT05742984|583961513|FG001|Overall Study|Adverse Event|0|||
161702971|NCT05742984|583961514|FG002|Overall Study|Adverse Event|1|||
161702972|NCT05742984|583961515|FG003|Overall Study|Adverse Event|0|||
161702973|NCT05742984|583961516|FG004|Overall Study|Adverse Event|1|||
161702974|NCT05742984|583961517|FG005|Overall Study|Adverse Event|1|||
161702975|NCT05742984|583961512|FG000|Overall Study|Withdrawal by Subject|0|||
161702976|NCT05742984|583961513|FG001|Overall Study|Withdrawal by Subject|1|||
161702977|NCT05742984|583961514|FG002|Overall Study|Withdrawal by Subject|0|||
161702978|NCT05742984|583961515|FG003|Overall Study|Withdrawal by Subject|0|||
161702979|NCT05742984|583961516|FG004|Overall Study|Withdrawal by Subject|0|||
161702980|NCT05742984|583961517|FG005|Overall Study|Withdrawal by Subject|2|||
161702981|NCT02162862|583961518|FG000|Overall Study|Lost to Follow-up|0|||
161702982|NCT02162862|583961519|FG001|Overall Study|Lost to Follow-up|11|||
161702983|NCT02162862|583961520|FG002|Overall Study|Lost to Follow-up|0|||
161702984|NCT02162862|583961518|FG000|Overall Study|Subject did not feel the med was needed|0|||
161702985|NCT02162862|583961519|FG001|Overall Study|Subject did not feel the med was needed|0|||
161702986|NCT02162862|583961520|FG002|Overall Study|Subject did not feel the med was needed|4|||
161702987|NCT03116113|583961521|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161702988|NCT03116113|583961522|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161837161|NCT00361335|584446555|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
161837162|NCT00361335|584446556|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
161837163|NCT00361335|584446550|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
161837164|NCT00361335|584446551|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
161837165|NCT00361335|584446552|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
161702989|NCT03116113|583961523|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161702990|NCT03116113|583961524|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161702991|NCT03116113|583961525|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161702992|NCT03116113|583961526|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161702993|NCT03116113|583961527|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161702994|NCT03116113|583961528|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
161702995|NCT03116113|583961529|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
161702996|NCT02159807|583961530|FG000|Overall Study|Adverse Event|0|||
161702997|NCT02159807|583961531|FG001|Overall Study|Adverse Event|0|||
161702998|NCT02159807|583961532|FG002|Overall Study|Adverse Event|1|||
161702999|NCT02159807|583961530|FG000|Overall Study|No CSF|1|||
161703000|NCT02159807|583961531|FG001|Overall Study|No CSF|1|||
161703001|NCT02159807|583961532|FG002|Overall Study|No CSF|1|||
161703002|NCT02159807|583961530|FG000|Overall Study|elevated blood pressure|0|||
161703003|NCT02159807|583961531|FG001|Overall Study|elevated blood pressure|0|||
161703004|NCT02159807|583961532|FG002|Overall Study|elevated blood pressure|1|||
161703005|NCT00950170|583961533|FG000|Overall Study|Parent/Legal Guardian Request|1|||
161703006|NCT00950170|583961533|FG000|Overall Study|Adverse Event|2|||
161703007|NCT00950170|583961533|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
161703008|NCT01254669|583961536|FG000|Overall Study|Withdrawal by Subject|0|||
161703009|NCT01254669|583961537|FG001|Overall Study|Withdrawal by Subject|1|||
161703010|NCT01254669|583961536|FG000|Overall Study|time constraint|2|||
161703011|NCT01254669|583961537|FG001|Overall Study|time constraint|2|||
161703012|NCT01254669|583961536|FG000|Overall Study|called to clinic during intervention|1|||
161703013|NCT01254669|583961537|FG001|Overall Study|called to clinic during intervention|1|||
161703014|NCT00103012|583961538|FG000|Overall Study|Withdrawal by Subject|2|||
161703015|NCT00103012|583961539|FG001|Overall Study|Withdrawal by Subject|1|||
161703016|NCT00103012|583961540|FG002|Overall Study|Withdrawal by Subject|2|||
161703017|NCT00103012|583961538|FG000|Overall Study|Pregnancy|1|||
161703018|NCT00103012|583961539|FG001|Overall Study|Pregnancy|0|||
161703019|NCT00103012|583961540|FG002|Overall Study|Pregnancy|0|||
161703020|NCT00103012|583961538|FG000|Overall Study|Adverse Event|0|||
161703021|NCT00103012|583961539|FG001|Overall Study|Adverse Event|0|||
161703022|NCT00103012|583961540|FG002|Overall Study|Adverse Event|1|||
161703023|NCT00103012|583961538|FG000|Overall Study|Subject non-compliant with medications|0|||
161703024|NCT00103012|583961539|FG001|Overall Study|Subject non-compliant with medications|0|||
161703025|NCT00103012|583961540|FG002|Overall Study|Subject non-compliant with medications|1|||
161703026|NCT00393718|583961547|FG000|Overall Study|Adverse Event|20|||
161703027|NCT00393718|583961548|FG001|Overall Study|Adverse Event|8|||
161703028|NCT00393718|583961547|FG000|Overall Study|Protocol Violation|1|||
161703029|NCT00393718|583961548|FG001|Overall Study|Protocol Violation|2|||
161703030|NCT00393718|583961547|FG000|Overall Study|Lack of Efficacy|10|||
161703031|NCT00393718|583961548|FG001|Overall Study|Lack of Efficacy|9|||
161703032|NCT00393718|583961547|FG000|Overall Study|Hypoglycaemia|3|||
161703033|NCT00393718|583961548|FG001|Overall Study|Hypoglycaemia|2|||
161703034|NCT00393718|583961547|FG000|Overall Study|Subject decision|5|||
161703035|NCT00393718|583961548|FG001|Overall Study|Subject decision|0|||
161703036|NCT00393718|583961547|FG000|Overall Study|Withdrawal of consent|2|||
161703037|NCT00393718|583961548|FG001|Overall Study|Withdrawal of consent|1|||
161703038|NCT00393718|583961547|FG000|Overall Study|Missed measurement|1|||
161703039|NCT00393718|583961548|FG001|Overall Study|Missed measurement|0|||
161703040|NCT00393718|583961547|FG000|Overall Study|Move|1|||
161703041|NCT00393718|583961548|FG001|Overall Study|Move|0|||
161703042|NCT01084551|583961553|FG000|Overall Study|Adverse Event|2|||
161703043|NCT01084551|583961554|FG001|Overall Study|Adverse Event|9|||
161703044|NCT01084551|583961555|FG002|Overall Study|Adverse Event|4|||
161703045|NCT01084551|583961553|FG000|Overall Study|Lack of Efficacy|2|||
161703046|NCT01084551|583961554|FG001|Overall Study|Lack of Efficacy|0|||
161703047|NCT01084551|583961555|FG002|Overall Study|Lack of Efficacy|1|||
161703048|NCT01084551|583961553|FG000|Overall Study|Withdrawal by Subject|2|||
161703049|NCT01084551|583961554|FG001|Overall Study|Withdrawal by Subject|1|||
161703050|NCT01084551|583961555|FG002|Overall Study|Withdrawal by Subject|0|||
161703051|NCT01084551|583961553|FG000|Overall Study|Protocol Violation|2|||
161703052|NCT01084551|583961554|FG001|Overall Study|Protocol Violation|4|||
161703053|NCT01084551|583961555|FG002|Overall Study|Protocol Violation|0|||
161703054|NCT01084551|583961553|FG000|Overall Study|Lost to Follow-up|0|||
161703055|NCT01084551|583961554|FG001|Overall Study|Lost to Follow-up|0|||
161703056|NCT01084551|583961555|FG002|Overall Study|Lost to Follow-up|3|||
161703057|NCT01084551|583961553|FG000|Overall Study|Physician Decision|1|||
161703058|NCT01084551|583961554|FG001|Overall Study|Physician Decision|0|||
161703059|NCT01084551|583961555|FG002|Overall Study|Physician Decision|0|||
161703060|NCT03902080|583961556|FG000|Overall Study|Adverse Event|17|||
161703061|NCT03902080|583961557|FG001|Overall Study|Adverse Event|15|||
161703062|NCT03902080|583961556|FG000|Overall Study|Withdrawal by Subject|28|||
161837166|NCT00361335|584446553|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
161837167|NCT00361335|584446554|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
161957683|NCT05396014|584892635|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161703063|NCT03902080|583961557|FG001|Overall Study|Withdrawal by Subject|35|||
161703064|NCT03902080|583961556|FG000|Overall Study|Lost to Follow-up|6|||
161837168|NCT00361335|584446555|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
161957684|NCT05396014|584892636|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161703065|NCT03902080|583961557|FG001|Overall Study|Lost to Follow-up|7|||
161703066|NCT03902080|583961556|FG000|Overall Study|Other|3|||
161703067|NCT03902080|583961557|FG001|Overall Study|Other|5|||
161703068|NCT03902080|583961556|FG000|Overall Study|Non compliance|4|||
161703069|NCT03902080|583961557|FG001|Overall Study|Non compliance|3|||
161703070|NCT03902080|583961556|FG000|Overall Study|Physician Decision|5|||
161703071|NCT03902080|583961557|FG001|Overall Study|Physician Decision|1|||
161703072|NCT03902080|583961556|FG000|Overall Study|Protocol Violation|3|||
161703073|NCT03902080|583961557|FG001|Overall Study|Protocol Violation|3|||
161703074|NCT03902080|583961556|FG000|Overall Study|Lack of Efficacy|1|||
161703075|NCT03902080|583961557|FG001|Overall Study|Lack of Efficacy|3|||
161703076|NCT03902080|583961556|FG000|Overall Study|Withdrawn prior to dosing|0|||
161703077|NCT03902080|583961557|FG001|Overall Study|Withdrawn prior to dosing|1|||
161703078|NCT01703000|583961558|FG000|Overall Study|Death|1|||
161703079|NCT01279057|583961559|FG000|Overall Study|Adverse Event|1|||
161703080|NCT01279057|583961560|FG001|Overall Study|Adverse Event|0|||
161703081|NCT01279057|583961561|FG002|Overall Study|Adverse Event|1|||
161703082|NCT01279057|583961559|FG000|Overall Study|Insufficient therapeutic response|0|||
161703083|NCT01279057|583961560|FG001|Overall Study|Insufficient therapeutic response|0|||
161703084|NCT01279057|583961561|FG002|Overall Study|Insufficient therapeutic response|1|||
161703085|NCT01279057|583961559|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
161703086|NCT01279057|583961560|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
161703087|NCT01279057|583961561|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
161703088|NCT01279057|583961559|FG000|Overall Study|Withdrew consent|2|||
161703089|NCT01279057|583961560|FG001|Overall Study|Withdrew consent|0|||
161703090|NCT01279057|583961561|FG002|Overall Study|Withdrew consent|1|||
161703091|NCT01279057|583961559|FG000|Overall Study|Pregnancy|0|||
161703092|NCT01279057|583961560|FG001|Overall Study|Pregnancy|1|||
161703093|NCT01279057|583961561|FG002|Overall Study|Pregnancy|0|||
161703094|NCT01279057|583961559|FG000|Overall Study|Other|3|||
161703095|NCT01279057|583961560|FG001|Overall Study|Other|3|||
161703096|NCT01279057|583961561|FG002|Overall Study|Other|0|||
161703097|NCT01427309|583961562|FG000|Overall Study|Lost to Follow-up|130|||
161703098|NCT01427309|583961563|FG001|Overall Study|Lost to Follow-up|145|||
161703099|NCT01427309|583961564|FG002|Overall Study|Lost to Follow-up|122|||
161703100|NCT01427309|583961565|FG003|Overall Study|Lost to Follow-up|135|||
161703101|NCT01427309|583961562|FG000|Overall Study|Protocol Violation|42|||
161703102|NCT01427309|583961563|FG001|Overall Study|Protocol Violation|69|||
161703103|NCT01427309|583961564|FG002|Overall Study|Protocol Violation|125|||
161703104|NCT01427309|583961565|FG003|Overall Study|Protocol Violation|124|||
161703105|NCT01427309|583961562|FG000|Overall Study|Adverse Event|0|||
161703106|NCT01427309|583961563|FG001|Overall Study|Adverse Event|0|||
161703107|NCT01427309|583961564|FG002|Overall Study|Adverse Event|3|||
161703108|NCT01427309|583961565|FG003|Overall Study|Adverse Event|1|||
161703109|NCT01427309|583961562|FG000|Overall Study|Serious adverse event|52|||
161703110|NCT01427309|583961563|FG001|Overall Study|Serious adverse event|45|||
161703111|NCT01427309|583961564|FG002|Overall Study|Serious adverse event|50|||
161703112|NCT01427309|583961565|FG003|Overall Study|Serious adverse event|61|||
161703113|NCT01427309|583961562|FG000|Overall Study|Withdrawal by Subject|148|||
161703114|NCT01427309|583961563|FG001|Overall Study|Withdrawal by Subject|148|||
161703115|NCT01427309|583961564|FG002|Overall Study|Withdrawal by Subject|61|||
161703116|NCT01427309|583961565|FG003|Overall Study|Withdrawal by Subject|55|||
161703117|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
161703118|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
161703119|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
161703120|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
161703121|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
161703122|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
161703123|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
161703124|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
161703125|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
161703126|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
161703127|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
161703128|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
161703129|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
161703130|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
161703131|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
161703132|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
161703133|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
161703134|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
161703135|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
161703136|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
161703137|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
161703138|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
161703139|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
161703140|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
161703141|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
161703142|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
161703143|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
161703144|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
161703145|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
161703146|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
161703147|NCT00849017|583961568|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
162030828|NCT03400956|585169492|FG002|Post-treatment Period 1|Other|4|||
161957685|NCT05396014|584892637|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957686|NCT05396014|584892638|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957687|NCT05396014|584892639|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957688|NCT05396014|584892640|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957689|NCT05396014|584892641|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957690|NCT05396014|584892642|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957691|NCT05396014|584892643|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957692|NCT05396014|584892644|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957693|NCT05396014|584892645|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957694|NCT05396014|584892646|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957695|NCT05396014|584892647|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957696|NCT05396014|584892648|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957697|NCT05396014|584892649|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957698|NCT05396014|584892650|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957699|NCT05396014|584892651|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957700|NCT05396014|584892652|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957701|NCT05396014|584892653|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957702|NCT05396014|584892654|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957703|NCT05396014|584892655|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
161957704|NCT05396014|584892656|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957705|NCT05396014|584892657|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957706|NCT05396014|584892658|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957707|NCT05396014|584892659|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957708|NCT05396014|584892660|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957709|NCT05396014|584892661|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161703148|NCT00849017|583961569|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
161703149|NCT00849017|583961570|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
161703150|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
161703151|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
161703152|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
161703153|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
161703154|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
161703155|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
161703156|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
161703157|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
161703158|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
161703159|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
161703160|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
161703161|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
161703162|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
161703163|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
161703164|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
161703165|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
161703166|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
161703167|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
161703168|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
161703169|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
161703170|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
161703171|NCT00849017|583961568|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
161703172|NCT00849017|583961569|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
161703173|NCT00849017|583961570|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
161703174|NCT02913313|583961571|FG000|Overall Study|DISEASE PROGRESSION|1|||
161703175|NCT02913313|583961572|FG001|Overall Study|DISEASE PROGRESSION|2|||
161703176|NCT02913313|583961573|FG002|Overall Study|DISEASE PROGRESSION|2|||
161703177|NCT02913313|583961574|FG003|Overall Study|DISEASE PROGRESSION|4|||
161703178|NCT02913313|583961575|FG004|Overall Study|DISEASE PROGRESSION|6|||
161703179|NCT02913313|583961576|FG005|Overall Study|DISEASE PROGRESSION|4|||
161703180|NCT02913313|583961577|FG006|Overall Study|DISEASE PROGRESSION|19|||
161703181|NCT02913313|583961578|FG007|Overall Study|DISEASE PROGRESSION|3|||
161703182|NCT02913313|583961579|FG008|Overall Study|DISEASE PROGRESSION|4|||
161703183|NCT02913313|583961580|FG009|Overall Study|DISEASE PROGRESSION|4|||
161703184|NCT02913313|583961581|FG010|Overall Study|DISEASE PROGRESSION|11|||
161703185|NCT02913313|583961582|FG011|Overall Study|DISEASE PROGRESSION|5|||
161703186|NCT02913313|583961583|FG012|Overall Study|DISEASE PROGRESSION|14|||
161703187|NCT02913313|583961584|FG013|Overall Study|DISEASE PROGRESSION|3|||
161703188|NCT02913313|583961571|FG000|Overall Study|Not Reported|0|||
161703189|NCT02913313|583961572|FG001|Overall Study|Not Reported|0|||
161703190|NCT02913313|583961573|FG002|Overall Study|Not Reported|0|||
161703191|NCT02913313|583961574|FG003|Overall Study|Not Reported|0|||
161703192|NCT02913313|583961575|FG004|Overall Study|Not Reported|1|||
161703193|NCT02913313|583961576|FG005|Overall Study|Not Reported|0|||
161703194|NCT02913313|583961577|FG006|Overall Study|Not Reported|0|||
161703195|NCT02913313|583961578|FG007|Overall Study|Not Reported|0|||
161703196|NCT02913313|583961579|FG008|Overall Study|Not Reported|0|||
161703197|NCT02913313|583961580|FG009|Overall Study|Not Reported|0|||
161703198|NCT02913313|583961581|FG010|Overall Study|Not Reported|4|||
161703199|NCT02913313|583961582|FG011|Overall Study|Not Reported|0|||
161703200|NCT02913313|583961583|FG012|Overall Study|Not Reported|0|||
161703201|NCT02913313|583961584|FG013|Overall Study|Not Reported|0|||
161703202|NCT02913313|583961571|FG000|Overall Study|Other reasons|0|||
161703203|NCT02913313|583961572|FG001|Overall Study|Other reasons|0|||
161703204|NCT02913313|583961573|FG002|Overall Study|Other reasons|0|||
161703205|NCT02913313|583961574|FG003|Overall Study|Other reasons|0|||
161957710|NCT05396014|584892662|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957711|NCT05396014|584892663|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957712|NCT05396014|584892664|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957713|NCT05396014|584892665|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957714|NCT05396014|584892666|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161703206|NCT02913313|583961575|FG004|Overall Study|Other reasons|1|||
161703207|NCT02913313|583961576|FG005|Overall Study|Other reasons|0|||
161703208|NCT02913313|583961577|FG006|Overall Study|Other reasons|0|||
161703209|NCT02913313|583961578|FG007|Overall Study|Other reasons|0|||
161703210|NCT02913313|583961579|FG008|Overall Study|Other reasons|0|||
161703211|NCT02913313|583961580|FG009|Overall Study|Other reasons|0|||
161703212|NCT02913313|583961581|FG010|Overall Study|Other reasons|1|||
161703213|NCT02913313|583961582|FG011|Overall Study|Other reasons|0|||
161703214|NCT02913313|583961583|FG012|Overall Study|Other reasons|0|||
161957715|NCT05396014|584892667|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957716|NCT05396014|584892668|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957717|NCT05396014|584892669|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957718|NCT05396014|584892670|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161957719|NCT05396014|584892671|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
162030829|NCT03400956|585169490|FG000|Treatment Period 2|Adverse Event|2|||
161703215|NCT02913313|583961584|FG013|Overall Study|Other reasons|0|||
161703216|NCT02913313|583961571|FG000|Overall Study|Withdrawal by Subject|0|||
161703217|NCT02913313|583961572|FG001|Overall Study|Withdrawal by Subject|0|||
161703218|NCT02913313|583961573|FG002|Overall Study|Withdrawal by Subject|1|||
161703219|NCT02913313|583961574|FG003|Overall Study|Withdrawal by Subject|0|||
161703220|NCT02913313|583961575|FG004|Overall Study|Withdrawal by Subject|0|||
161703221|NCT02913313|583961576|FG005|Overall Study|Withdrawal by Subject|0|||
161703222|NCT02913313|583961577|FG006|Overall Study|Withdrawal by Subject|1|||
161703223|NCT02913313|583961578|FG007|Overall Study|Withdrawal by Subject|1|||
161703224|NCT02913313|583961579|FG008|Overall Study|Withdrawal by Subject|0|||
161703225|NCT02913313|583961580|FG009|Overall Study|Withdrawal by Subject|0|||
161703226|NCT02913313|583961581|FG010|Overall Study|Withdrawal by Subject|1|||
161703227|NCT02913313|583961582|FG011|Overall Study|Withdrawal by Subject|0|||
161703228|NCT02913313|583961583|FG012|Overall Study|Withdrawal by Subject|0|||
161703229|NCT02913313|583961584|FG013|Overall Study|Withdrawal by Subject|0|||
161703230|NCT02913313|583961571|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703231|NCT02913313|583961572|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703232|NCT02913313|583961573|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703233|NCT02913313|583961574|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703234|NCT02913313|583961575|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703235|NCT02913313|583961576|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703236|NCT02913313|583961577|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703237|NCT02913313|583961578|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703238|NCT02913313|583961579|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703239|NCT02913313|583961580|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703240|NCT02913313|583961581|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161703241|NCT02913313|583961582|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161703242|NCT02913313|583961583|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161703243|NCT02913313|583961584|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161703244|NCT02913313|583961571|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
161703245|NCT02913313|583961572|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
161703246|NCT02913313|583961573|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
161703247|NCT02913313|583961574|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
161703248|NCT02913313|583961575|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
161703249|NCT02913313|583961576|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
161703250|NCT02913313|583961577|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
161703251|NCT02913313|583961578|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
161703252|NCT02913313|583961579|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
161703253|NCT02913313|583961580|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
161703254|NCT02913313|583961581|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
161703255|NCT02913313|583961582|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
161703256|NCT02913313|583961583|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
161703257|NCT02913313|583961584|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
161703258|NCT01061008|583961585|FG000|Overall Study|Badiocephalic fistula failed|3|||
161703259|NCT01061008|583961586|FG001|Overall Study|Badiocephalic fistula failed|2|||
161703260|NCT01061008|583961585|FG000|Overall Study|Death|1|||
161703261|NCT01061008|583961586|FG001|Overall Study|Death|0|||
161703262|NCT01061008|583961585|FG000|Overall Study|Withdrawal by Subject|1|||
161703263|NCT01061008|583961586|FG001|Overall Study|Withdrawal by Subject|3|||
161703264|NCT01061008|583961585|FG000|Overall Study|Unable to exercise following surgery|1|||
161703265|NCT01061008|583961586|FG001|Overall Study|Unable to exercise following surgery|0|||
161703266|NCT01061008|583961585|FG000|Overall Study|Adverse Event|0|||
161703267|NCT01061008|583961586|FG001|Overall Study|Adverse Event|1|||
161703268|NCT02024971|583961589|FG000|Overall Study|Data Not Available|30|||
161703269|NCT02024971|583961589|FG000|Overall Study|Lost to Follow-up|6|||
161703270|NCT02908100|583961590|FG000|Overall Study|Adverse Event|7|||
161703271|NCT02908100|583961591|FG001|Overall Study|Adverse Event|6|||
161703272|NCT02908100|583961592|FG002|Overall Study|Adverse Event|9|||
161703273|NCT02908100|583961590|FG000|Overall Study|Death|2|||
161703274|NCT02908100|583961591|FG001|Overall Study|Death|0|||
161703275|NCT02908100|583961592|FG002|Overall Study|Death|0|||
161703276|NCT02908100|583961590|FG000|Overall Study|Lack of Efficacy|2|||
161703277|NCT02908100|583961591|FG001|Overall Study|Lack of Efficacy|3|||
161703278|NCT02908100|583961592|FG002|Overall Study|Lack of Efficacy|3|||
161703279|NCT02908100|583961590|FG000|Overall Study|Lost to Follow-up|0|||
161703280|NCT02908100|583961591|FG001|Overall Study|Lost to Follow-up|1|||
161703281|NCT02908100|583961592|FG002|Overall Study|Lost to Follow-up|2|||
161703282|NCT02908100|583961590|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161703283|NCT02908100|583961591|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161703284|NCT02908100|583961592|FG002|Overall Study|Non-Compliance With Study Drug|2|||
161703285|NCT02908100|583961590|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
161703286|NCT02908100|583961591|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
161703287|NCT02908100|583961592|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
161703288|NCT02908100|583961590|FG000|Overall Study|Physician Decision|0|||
161703289|NCT02908100|583961591|FG001|Overall Study|Physician Decision|1|||
161703290|NCT02908100|583961592|FG002|Overall Study|Physician Decision|0|||
161703291|NCT02908100|583961590|FG000|Overall Study|Pregnancy|1|||
161703292|NCT02908100|583961591|FG001|Overall Study|Pregnancy|2|||
161703293|NCT02908100|583961592|FG002|Overall Study|Pregnancy|0|||
161703294|NCT02908100|583961590|FG000|Overall Study|Withdrawal by Subject|8|||
161703295|NCT02908100|583961591|FG001|Overall Study|Withdrawal by Subject|7|||
161703296|NCT02908100|583961592|FG002|Overall Study|Withdrawal by Subject|5|||
161703297|NCT02908100|583961590|FG000|Overall Study|Randomised in Error|1|||
161703298|NCT02908100|583961591|FG001|Overall Study|Randomised in Error|0|||
161703299|NCT02908100|583961592|FG002|Overall Study|Randomised in Error|0|||
161703300|NCT05254418|583961593|FG000|Overall Study|Adverse Event|2|||
162030830|NCT03400956|585169491|FG001|Treatment Period 2|Adverse Event|1|||
162030831|NCT03400956|585169492|FG002|Treatment Period 2|Adverse Event|1|||
162030832|NCT03400956|585169490|FG000|Treatment Period 2|Lost to Follow-up|1|||
162030833|NCT03400956|585169491|FG001|Treatment Period 2|Lost to Follow-up|1|||
162030834|NCT03400956|585169492|FG002|Treatment Period 2|Lost to Follow-up|0|||
162030835|NCT03400956|585169490|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162030836|NCT03400956|585169491|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162030837|NCT03400956|585169492|FG002|Treatment Period 2|Withdrawal by Subject|3|||
162030838|NCT03400956|585169490|FG000|Treatment Period 2|Other|1|||
162030839|NCT03400956|585169491|FG001|Treatment Period 2|Other|1|||
162030840|NCT03400956|585169492|FG002|Treatment Period 2|Other|0|||
162030841|NCT03400956|585169490|FG000|Follow-up Period|Withdrawal by Subject|0|||
161703313|NCT02631538|583961597|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
161703314|NCT02631538|583961598|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
161703315|NCT02631538|583961599|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
161703316|NCT02631538|583961600|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
161703317|NCT02631538|583961597|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
161703318|NCT02631538|583961598|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
161703319|NCT02631538|583961599|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
161703320|NCT02631538|583961600|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
161703321|NCT02631538|583961597|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
161703322|NCT02631538|583961598|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
161703323|NCT02631538|583961599|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
161703324|NCT02631538|583961600|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
161703325|NCT02631538|583961597|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
161703326|NCT02631538|583961598|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
161703327|NCT02631538|583961599|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
161703328|NCT02631538|583961600|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
161703329|NCT02631538|583961597|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
161703330|NCT02631538|583961598|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
161703331|NCT02631538|583961599|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
161703332|NCT02631538|583961600|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
161703333|NCT02631538|583961597|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
161703334|NCT02631538|583961598|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
161703335|NCT02631538|583961599|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
161703336|NCT02631538|583961600|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
161703337|NCT00440726|583961601|FG000|Phase 1|Dose-Limiting Toxicity|0|||
161703338|NCT00440726|583961602|FG001|Phase 1|Dose-Limiting Toxicity|1|||
161703339|NCT00440726|583961603|FG002|Phase 1|Dose-Limiting Toxicity|0|||
161703340|NCT00440726|583961601|FG000|Phase 1|Physician Decision|1|||
161703341|NCT00440726|583961602|FG001|Phase 1|Physician Decision|0|||
161703342|NCT00440726|583961603|FG002|Phase 1|Physician Decision|0|||
161837169|NCT00361335|584446556|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
161837170|NCT00361335|584446550|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
161703343|NCT00440726|583961601|FG000|Phase 2|Death|0|||
161703344|NCT00440726|583961602|FG001|Phase 2|Death|0|||
161703345|NCT00440726|583961603|FG002|Phase 2|Death|1|||
161703346|NCT00440726|583961601|FG000|Phase 2|Adverse Event|0|||
161703347|NCT00440726|583961602|FG001|Phase 2|Adverse Event|0|||
161703348|NCT00440726|583961603|FG002|Phase 2|Adverse Event|1|||
161703349|NCT04067518|583961604|FG000|Overall Study|Adverse Event|1|||
161703350|NCT04067518|583961605|FG001|Overall Study|Adverse Event|3|||
161703351|NCT04067518|583961604|FG000|Overall Study|Screen failures|0|||
161703352|NCT04067518|583961605|FG001|Overall Study|Screen failures|1|||
161703353|NCT04067518|583961604|FG000|Overall Study|Enrolled but not treated|0|||
161837171|NCT00361335|584446551|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
162030842|NCT03400956|585169491|FG001|Follow-up Period|Withdrawal by Subject|0|||
161703354|NCT04067518|583961605|FG001|Overall Study|Enrolled but not treated|1|||
161703355|NCT03624946|583961609|FG000|Overall Study|Lost to Follow-up|0|||
161703356|NCT03624946|583961610|FG001|Overall Study|Lost to Follow-up|1|||
161703357|NCT00862251|583961614|FG000|Overall Study|Adverse Event|8|||
161703358|NCT00862251|583961615|FG001|Overall Study|Adverse Event|3|||
161703359|NCT00862251|583961616|FG002|Overall Study|Adverse Event|1|||
161703360|NCT00862251|583961614|FG000|Overall Study|Lost to Follow-up|0|||
161703361|NCT00862251|583961615|FG001|Overall Study|Lost to Follow-up|0|||
161703362|NCT00862251|583961616|FG002|Overall Study|Lost to Follow-up|1|||
161703363|NCT00862251|583961614|FG000|Overall Study|Protocol Violation|2|||
161703364|NCT00862251|583961615|FG001|Overall Study|Protocol Violation|0|||
161703365|NCT00862251|583961616|FG002|Overall Study|Protocol Violation|1|||
161703366|NCT00862251|583961614|FG000|Overall Study|Withdrawal by Subject|9|||
161703367|NCT00862251|583961615|FG001|Overall Study|Withdrawal by Subject|2|||
161703368|NCT00862251|583961616|FG002|Overall Study|Withdrawal by Subject|6|||
161703369|NCT02796755|583961617|FG000|Overall Study|Adverse Event|2|||
161703370|NCT02796755|583961618|FG001|Overall Study|Adverse Event|0|||
161703371|NCT00675025|583961619|FG000|Overall Study|Study Terminated by Sponsor|38|||
161703372|NCT00675025|583961620|FG001|Overall Study|Study Terminated by Sponsor|42|||
161703373|NCT00675025|583961619|FG000|Overall Study|Adverse Event|6|||
161703374|NCT00675025|583961620|FG001|Overall Study|Adverse Event|11|||
161703375|NCT00675025|583961619|FG000|Overall Study|Lost to Follow-up|6|||
161703376|NCT00675025|583961620|FG001|Overall Study|Lost to Follow-up|4|||
161703377|NCT00675025|583961619|FG000|Overall Study|Withdrawal by Subject|4|||
161703378|NCT00675025|583961620|FG001|Overall Study|Withdrawal by Subject|6|||
161703379|NCT00944034|583961622|FG000|Overall Study|Inappropriate enrollment|0|||
161703380|NCT00944034|583961623|FG001|Overall Study|Inappropriate enrollment|1|||
161703381|NCT00944034|583961624|FG002|Overall Study|Inappropriate enrollment|0|||
161703382|NCT00944034|583961625|FG003|Overall Study|Inappropriate enrollment|1|||
161703383|NCT00944034|583961626|FG004|Overall Study|Inappropriate enrollment|2|||
161703384|NCT00944034|583961627|FG005|Overall Study|Inappropriate enrollment|1|||
161703385|NCT00944034|583961628|FG006|Overall Study|Inappropriate enrollment|0|||
161703386|NCT00944034|583961629|FG007|Overall Study|Inappropriate enrollment|0|||
161703387|NCT00944034|583961630|FG008|Overall Study|Inappropriate enrollment|1|||
161703388|NCT00944034|583961631|FG009|Overall Study|Inappropriate enrollment|1|||
161703389|NCT00944034|583961632|FG010|Overall Study|Inappropriate enrollment|0|||
161703390|NCT00944034|583961633|FG011|Overall Study|Inappropriate enrollment|0|||
161703391|NCT00944034|583961622|FG000|Overall Study|Withdrawal by Subject|3|||
161703392|NCT00944034|583961623|FG001|Overall Study|Withdrawal by Subject|2|||
161703393|NCT00944034|583961624|FG002|Overall Study|Withdrawal by Subject|6|||
161703394|NCT00944034|583961625|FG003|Overall Study|Withdrawal by Subject|2|||
161703395|NCT00944034|583961626|FG004|Overall Study|Withdrawal by Subject|5|||
161703396|NCT00944034|583961627|FG005|Overall Study|Withdrawal by Subject|8|||
161703397|NCT00944034|583961628|FG006|Overall Study|Withdrawal by Subject|2|||
161703398|NCT00944034|583961629|FG007|Overall Study|Withdrawal by Subject|2|||
161703399|NCT00944034|583961630|FG008|Overall Study|Withdrawal by Subject|3|||
161703400|NCT00944034|583961631|FG009|Overall Study|Withdrawal by Subject|4|||
161703401|NCT00944034|583961632|FG010|Overall Study|Withdrawal by Subject|0|||
161703402|NCT00944034|583961633|FG011|Overall Study|Withdrawal by Subject|4|||
161703403|NCT00944034|583961622|FG000|Overall Study|Lost to Follow-up|0|||
161703404|NCT00944034|583961623|FG001|Overall Study|Lost to Follow-up|4|||
161703405|NCT00944034|583961624|FG002|Overall Study|Lost to Follow-up|2|||
161703406|NCT00944034|583961625|FG003|Overall Study|Lost to Follow-up|0|||
161703407|NCT00944034|583961626|FG004|Overall Study|Lost to Follow-up|5|||
161703408|NCT00944034|583961627|FG005|Overall Study|Lost to Follow-up|7|||
161703409|NCT00944034|583961628|FG006|Overall Study|Lost to Follow-up|0|||
161703410|NCT00944034|583961629|FG007|Overall Study|Lost to Follow-up|1|||
161703411|NCT00944034|583961630|FG008|Overall Study|Lost to Follow-up|5|||
161703412|NCT00944034|583961631|FG009|Overall Study|Lost to Follow-up|1|||
161703413|NCT00944034|583961632|FG010|Overall Study|Lost to Follow-up|1|||
161703414|NCT00944034|583961633|FG011|Overall Study|Lost to Follow-up|0|||
161703415|NCT00944034|583961622|FG000|Overall Study|Death|0|||
161703416|NCT00944034|583961623|FG001|Overall Study|Death|0|||
161703417|NCT00944034|583961624|FG002|Overall Study|Death|1|||
161703418|NCT00944034|583961625|FG003|Overall Study|Death|0|||
161703419|NCT00944034|583961626|FG004|Overall Study|Death|0|||
161703420|NCT00944034|583961627|FG005|Overall Study|Death|0|||
161703421|NCT00944034|583961628|FG006|Overall Study|Death|0|||
161703422|NCT00944034|583961629|FG007|Overall Study|Death|0|||
161703423|NCT00944034|583961630|FG008|Overall Study|Death|0|||
161703424|NCT00944034|583961631|FG009|Overall Study|Death|0|||
161703425|NCT00944034|583961632|FG010|Overall Study|Death|0|||
161703426|NCT00944034|583961633|FG011|Overall Study|Death|0|||
161703427|NCT00944034|583961622|FG000|Overall Study|Protocol Violation|2|||
161703428|NCT00944034|583961623|FG001|Overall Study|Protocol Violation|0|||
161703429|NCT00944034|583961624|FG002|Overall Study|Protocol Violation|0|||
161703430|NCT00944034|583961625|FG003|Overall Study|Protocol Violation|1|||
161703431|NCT00944034|583961626|FG004|Overall Study|Protocol Violation|2|||
161703432|NCT00944034|583961627|FG005|Overall Study|Protocol Violation|3|||
161703433|NCT00944034|583961628|FG006|Overall Study|Protocol Violation|0|||
161703434|NCT00944034|583961629|FG007|Overall Study|Protocol Violation|1|||
161703435|NCT00944034|583961630|FG008|Overall Study|Protocol Violation|1|||
161703436|NCT00944034|583961631|FG009|Overall Study|Protocol Violation|4|||
161703437|NCT00944034|583961632|FG010|Overall Study|Protocol Violation|0|||
161703438|NCT00944034|583961633|FG011|Overall Study|Protocol Violation|0|||
161703439|NCT00944034|583961622|FG000|Overall Study|Unable to classify|0|||
161703440|NCT00944034|583961623|FG001|Overall Study|Unable to classify|0|||
161703441|NCT00944034|583961624|FG002|Overall Study|Unable to classify|0|||
161703442|NCT00944034|583961625|FG003|Overall Study|Unable to classify|0|||
161703443|NCT00944034|583961626|FG004|Overall Study|Unable to classify|0|||
161703444|NCT00944034|583961627|FG005|Overall Study|Unable to classify|1|||
161703445|NCT00944034|583961628|FG006|Overall Study|Unable to classify|1|||
161703446|NCT00944034|583961629|FG007|Overall Study|Unable to classify|1|||
161703447|NCT00944034|583961630|FG008|Overall Study|Unable to classify|0|||
161703448|NCT00944034|583961631|FG009|Overall Study|Unable to classify|0|||
161703449|NCT00944034|583961632|FG010|Overall Study|Unable to classify|0|||
161703450|NCT00944034|583961633|FG011|Overall Study|Unable to classify|0|||
161703451|NCT00944034|583961622|FG000|Overall Study|Administrative reason|0|||
161703452|NCT00944034|583961623|FG001|Overall Study|Administrative reason|0|||
161703453|NCT00944034|583961624|FG002|Overall Study|Administrative reason|0|||
161703454|NCT00944034|583961625|FG003|Overall Study|Administrative reason|0|||
161703455|NCT00944034|583961626|FG004|Overall Study|Administrative reason|0|||
161703456|NCT00944034|583961627|FG005|Overall Study|Administrative reason|0|||
161703457|NCT00944034|583961628|FG006|Overall Study|Administrative reason|1|||
161703458|NCT00944034|583961629|FG007|Overall Study|Administrative reason|0|||
161703459|NCT00944034|583961630|FG008|Overall Study|Administrative reason|0|||
161703460|NCT00944034|583961631|FG009|Overall Study|Administrative reason|0|||
161703461|NCT00944034|583961632|FG010|Overall Study|Administrative reason|0|||
161703462|NCT00944034|583961633|FG011|Overall Study|Administrative reason|0|||
161703463|NCT04258579|583961634|FG000|Overall Study|Withdrawal by Subject|7|||
161703464|NCT04258579|583961634|FG000|Overall Study|Lost to Follow-up|3|||
161703465|NCT04258579|583961634|FG000|Overall Study|Protocol Violation|2|||
161703466|NCT04258579|583961634|FG000|Overall Study|Adverse Event|1|||
161703467|NCT04007159|583961635|FG000|Induction Phase|(missed study visits)|16|||
161703468|NCT04007159|583961635|FG000|Induction Phase|Withdrawal by Subject|4|||
161703469|NCT04007159|583961635|FG000|Induction Phase|Adverse Event|2|||
161703470|NCT04007159|583961635|FG000|Challenge Phase|missed study visits|3|||
161703471|NCT00331006|583961637|FG000|Screening Phase|Withdrawal by Subject|1|||
161703472|NCT00331006|583961637|FG000|Screening Phase|enrollment halted|1|||
161703473|NCT00331006|583961637|FG000|Screening Phase|Lost to Follow-up|1|||
161703474|NCT00331006|583961637|FG000|Screening Phase|Ineligible for treatment phase|4|||
161703475|NCT00331006|583961637|FG000|Treatment Phase|Withdrawal by Subject|1|||
161703476|NCT00331006|583961637|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
161703477|NCT00331006|583961637|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
161703478|NCT03804684|583961638|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
161703479|NCT03804684|583961639|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
161703480|NCT01950819|583961640|FG000|Overall Study|Graft Loss|35|||
161703481|NCT01950819|583961641|FG001|Overall Study|Graft Loss|30|||
161703482|NCT01950819|583961640|FG000|Overall Study|Death|29|||
161703483|NCT01950819|583961641|FG001|Overall Study|Death|34|||
161703484|NCT01950819|583961640|FG000|Overall Study|Subject / Gardian decision|54|||
161703485|NCT01950819|583961641|FG001|Overall Study|Subject / Gardian decision|51|||
161703486|NCT01950819|583961640|FG000|Overall Study|technical problems|2|||
161703487|NCT01950819|583961641|FG001|Overall Study|technical problems|0|||
161703488|NCT01950819|583961640|FG000|Overall Study|Pregnancy|0|||
161703489|NCT01950819|583961641|FG001|Overall Study|Pregnancy|2|||
161703490|NCT01950819|583961640|FG000|Overall Study|Lost to Follow-up|9|||
161703491|NCT01950819|583961641|FG001|Overall Study|Lost to Follow-up|17|||
161703492|NCT03183128|583961642|FG000|Overall Study|Adverse Event|1|||
161703493|NCT03183128|583961643|FG001|Overall Study|Adverse Event|2|||
161703494|NCT03183128|583961642|FG000|Overall Study|Withdrawal by Subject|1|||
161703495|NCT03183128|583961643|FG001|Overall Study|Withdrawal by Subject|8|||
161703496|NCT03183128|583961642|FG000|Overall Study|Protocol Violation|2|||
161703497|NCT03183128|583961643|FG001|Overall Study|Protocol Violation|0|||
161703498|NCT03183128|583961642|FG000|Overall Study|Lack of Efficacy|4|||
161703499|NCT03183128|583961643|FG001|Overall Study|Lack of Efficacy|27|||
161837172|NCT00361335|584446552|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
161837173|NCT00361335|584446553|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
161837174|NCT00361335|584446554|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
161703500|NCT03183128|583961642|FG000|Overall Study|Lost to Follow-up|1|||
161703501|NCT03183128|583961643|FG001|Overall Study|Lost to Follow-up|0|||
161837175|NCT00361335|584446555|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
161703502|NCT03183128|583961642|FG000|Overall Study|Death|2|||
161703503|NCT03183128|583961643|FG001|Overall Study|Death|0|||
161703504|NCT03183128|583961642|FG000|Overall Study|Physician Decision|1|||
161703505|NCT03183128|583961643|FG001|Overall Study|Physician Decision|0|||
161703506|NCT01413958|583961644|FG000|Overall Study|Lost to Follow-up|0|||
161703507|NCT01413958|583961645|FG001|Overall Study|Lost to Follow-up|1|||
161703508|NCT02908516|583961648|FG000|Overall Study|Study Terminated|3|||
161703509|NCT02908516|583961649|FG001|Overall Study|Study Terminated|3|||
161957720|NCT05396014|584892629|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957721|NCT05396014|584892630|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957722|NCT05396014|584892631|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957723|NCT05396014|584892632|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161703510|NCT01225562|583961650|FG000|Overall Study|Withdrawal by Subject|52|||
161703511|NCT01225562|583961651|FG001|Overall Study|Withdrawal by Subject|50|||
161703512|NCT01225562|583961652|FG002|Overall Study|Withdrawal by Subject|52|||
161703513|NCT01225562|583961650|FG000|Overall Study|Lost to Follow-up|3|||
161703514|NCT01225562|583961651|FG001|Overall Study|Lost to Follow-up|6|||
161703515|NCT01225562|583961652|FG002|Overall Study|Lost to Follow-up|1|||
161703516|NCT02928952|583961653|FG000|Overall Study|Lost to Follow-up|5|||
161703517|NCT02928952|583961654|FG001|Overall Study|Lost to Follow-up|5|||
161703518|NCT02928952|583961653|FG000|Overall Study|Withdrawal by Subject|5|||
161703519|NCT02928952|583961654|FG001|Overall Study|Withdrawal by Subject|1|||
161703520|NCT02928952|583961653|FG000|Overall Study|Physician Decision|0|||
161703521|NCT02928952|583961654|FG001|Overall Study|Physician Decision|1|||
161703522|NCT02266433|583961655|FG000|Overall Study|Lost to Follow-up|54|||
161703523|NCT02266433|583961656|FG001|Overall Study|Lost to Follow-up|46|||
161703524|NCT02266433|583961655|FG000|Overall Study|Withdrawal by Subject|5|||
161703525|NCT02266433|583961656|FG001|Overall Study|Withdrawal by Subject|7|||
161703526|NCT01375764|583961658|FG000|Overall Study|Lost to Follow-up|0|||
161703527|NCT01375764|583961659|FG001|Overall Study|Lost to Follow-up|1|||
161703528|NCT01375764|583961660|FG002|Overall Study|Lost to Follow-up|0|||
161703529|NCT01375764|583961661|FG003|Overall Study|Lost to Follow-up|0|||
161703530|NCT01375764|583961662|FG004|Overall Study|Lost to Follow-up|0|||
161703531|NCT01375764|583961658|FG000|Overall Study|Withdrawal by Subject|2|||
161703532|NCT01375764|583961659|FG001|Overall Study|Withdrawal by Subject|0|||
161703533|NCT01375764|583961660|FG002|Overall Study|Withdrawal by Subject|0|||
161703534|NCT01375764|583961661|FG003|Overall Study|Withdrawal by Subject|0|||
161703535|NCT01375764|583961662|FG004|Overall Study|Withdrawal by Subject|1|||
161703536|NCT01375764|583961658|FG000|Overall Study|Other|0|||
161703537|NCT01375764|583961659|FG001|Overall Study|Other|0|||
161703538|NCT01375764|583961660|FG002|Overall Study|Other|0|||
161703539|NCT01375764|583961661|FG003|Overall Study|Other|1|||
161703540|NCT01375764|583961662|FG004|Overall Study|Other|0|||
161703541|NCT02445586|583961665|FG000|Overall Study|Death|14|||
161703542|NCT02445586|583961665|FG000|Overall Study|Withdrawal by Subject|13|||
161703543|NCT02445586|583961665|FG000|Overall Study|Disease Progression|10|||
161703544|NCT02445586|583961665|FG000|Overall Study|Protocol Violation|1|||
161703545|NCT02445586|583961665|FG000|Overall Study|Medical Condition|1|||
161703546|NCT01194440|583961666|FG000|Baseline (First Dose)|Reason not specified|4|||
161703547|NCT01194440|583961666|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
161703548|NCT01194440|583961666|FG000|Baseline (First Dose)|Change in therapy|1|||
161703549|NCT01194440|583961666|FG000|Baseline (First Dose)|Adverse Event|1|||
161703550|NCT01194440|583961666|FG000|6-months (2nd Dose)|Change in therapy|4|||
161703551|NCT02732951|583963676|FG000|Overall Study|Other than listed|1|||
161703552|NCT02732951|583963677|FG001|Overall Study|Other than listed|0|||
161703553|NCT02732951|583963676|FG000|Overall Study|Lost to Follow-up|0|||
161703554|NCT02732951|583963677|FG001|Overall Study|Lost to Follow-up|1|||
161703555|NCT02732951|583963676|FG000|Overall Study|Adverse Event|4|||
161703556|NCT02732951|583963677|FG001|Overall Study|Adverse Event|4|||
161703557|NCT02732951|583963676|FG000|Overall Study|Protocol Violation|0|||
161703558|NCT02732951|583963677|FG001|Overall Study|Protocol Violation|1|||
161703559|NCT01974817|583963678|FG000|Overall Study|Death|4|||
161703560|NCT01974817|583963678|FG000|Overall Study|Lost to Follow-up|2|||
161703561|NCT01974817|583963678|FG000|Overall Study|Protocol Violation|2|||
161703562|NCT05047523|583963683|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161703563|NCT05047523|583963684|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161703564|NCT05047523|583963685|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
161703565|NCT05047523|583963686|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161703566|NCT05047523|583963687|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161703567|NCT05047523|583963688|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161703568|NCT05047523|583963683|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161703569|NCT05047523|583963684|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
161703570|NCT05047523|583963685|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161703571|NCT05047523|583963686|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161703572|NCT05047523|583963687|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161703573|NCT05047523|583963688|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161703574|NCT05047523|583963683|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
161703575|NCT05047523|583963684|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
161703576|NCT05047523|583963685|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
161703577|NCT05047523|583963686|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
161703578|NCT05047523|583963687|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
161703579|NCT05047523|583963688|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
161703580|NCT05047523|583963683|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
161703581|NCT05047523|583963684|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161703582|NCT05047523|583963685|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161703583|NCT05047523|583963686|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161703584|NCT05047523|583963687|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161703585|NCT05047523|583963688|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161703586|NCT05047523|583963683|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
161703587|NCT05047523|583963684|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
161703588|NCT05047523|583963685|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
161703589|NCT05047523|583963686|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
161703590|NCT05047523|583963687|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
161703591|NCT05047523|583963688|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
161703592|NCT05047523|583963683|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
161957724|NCT05396014|584892633|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957725|NCT05396014|584892634|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957726|NCT05396014|584892635|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957727|NCT05396014|584892636|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161703593|NCT05047523|583963684|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
161703594|NCT05047523|583963685|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
161703595|NCT05047523|583963686|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
161703596|NCT05047523|583963687|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
161703597|NCT05047523|583963688|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
161703598|NCT01805180|583963691|FG000|Lead-in Donor Phase|screen failure|1|||
161703599|NCT01805180|583963692|FG001|Lead-in Donor Phase|screen failure|0|||
161703600|NCT01805180|583963693|FG002|Lead-in Donor Phase|screen failure|0|||
161703601|NCT04684420|583963698|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161703602|NCT04684420|583963699|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161703603|NCT04684420|583963700|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
161703604|NCT04684420|583963701|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
161703605|NCT04684420|583963698|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
161703606|NCT04684420|583963699|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
161703607|NCT04684420|583963700|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
161703608|NCT04684420|583963701|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
161703609|NCT00463476|583963702|FG000|Overall Study|Withdrawal by Subject|1|||
161703610|NCT00463476|583963703|FG001|Overall Study|Withdrawal by Subject|2|||
161703611|NCT00463476|583963702|FG000|Overall Study|Lost to Follow-up|1|||
161703612|NCT00463476|583963703|FG001|Overall Study|Lost to Follow-up|1|||
161703613|NCT00928070|583963708|FG000|Overall Study|Lost to Follow-up|1|||
161703614|NCT00928070|583963709|FG001|Overall Study|Lost to Follow-up|2|||
161703615|NCT00928070|583963708|FG000|Overall Study|Withdrawal by Subject|10|||
161703616|NCT00928070|583963709|FG001|Overall Study|Withdrawal by Subject|3|||
161703617|NCT00928070|583963708|FG000|Overall Study|Adverse Event|14|||
161703618|NCT00928070|583963709|FG001|Overall Study|Adverse Event|26|||
161703619|NCT00928070|583963708|FG000|Overall Study|Lack of Efficacy|9|||
161703620|NCT00928070|583963709|FG001|Overall Study|Lack of Efficacy|5|||
161703621|NCT00928070|583963708|FG000|Overall Study|Did not meet entrance criteria|16|||
161703622|NCT00928070|583963709|FG001|Overall Study|Did not meet entrance criteria|9|||
161703623|NCT00928070|583963708|FG000|Overall Study|Protocol Violation|6|||
161703624|NCT00928070|583963709|FG001|Overall Study|Protocol Violation|5|||
161703625|NCT00928070|583963708|FG000|Overall Study|Randomized but not treated|2|||
161703626|NCT00928070|583963709|FG001|Overall Study|Randomized but not treated|2|||
161703627|NCT00928070|583963708|FG000|Overall Study|Other|5|||
161703628|NCT00928070|583963709|FG001|Overall Study|Other|5|||
161703629|NCT02690194|583963714|FG000|Overall Study|Withdrawal by Subject|1|||
161703630|NCT02690194|583963715|FG001|Overall Study|Withdrawal by Subject|4|||
161703631|NCT02690194|583963716|FG002|Overall Study|Withdrawal by Subject|0|||
161703632|NCT00624520|583963717|FG000|Overall Study|Withdrawal by Subject|12|||
161703633|NCT00624520|583963718|FG001|Overall Study|Withdrawal by Subject|7|||
161703634|NCT00624520|583963717|FG000|Overall Study|Death|0|||
161703635|NCT00624520|583963718|FG001|Overall Study|Death|1|||
161703636|NCT01570244|583963722|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
161703637|NCT03486392|583963723|FG000|Overall Study|Lost to Follow-up|0|||
161703638|NCT03486392|583963724|FG001|Overall Study|Lost to Follow-up|0|||
161703639|NCT03486392|583963725|FG002|Overall Study|Lost to Follow-up|8|||
161703640|NCT03486392|583963726|FG003|Overall Study|Lost to Follow-up|5|||
161703641|NCT03486392|583963727|FG004|Overall Study|Lost to Follow-up|2|||
161703642|NCT03486392|583963723|FG000|Overall Study|Withdrawal by Subject|3|||
161703643|NCT03486392|583963724|FG001|Overall Study|Withdrawal by Subject|0|||
161703644|NCT03486392|583963725|FG002|Overall Study|Withdrawal by Subject|6|||
161703645|NCT03486392|583963726|FG003|Overall Study|Withdrawal by Subject|4|||
161703646|NCT03486392|583963727|FG004|Overall Study|Withdrawal by Subject|1|||
161703647|NCT03486392|583963723|FG000|Overall Study|Death|0|||
161703648|NCT03486392|583963724|FG001|Overall Study|Death|0|||
161703649|NCT03486392|583963725|FG002|Overall Study|Death|0|||
161703650|NCT03486392|583963726|FG003|Overall Study|Death|0|||
161703651|NCT03486392|583963727|FG004|Overall Study|Death|1|||
161703652|NCT02347631|583963728|FG000|First Intervention (2 Months)|Adverse Event|1|||
161703653|NCT02347631|583963729|FG001|First Intervention (2 Months)|Adverse Event|1|||
161703654|NCT02347631|583963728|FG000|First Intervention (2 Months)|Pregnancy|1|||
161703655|NCT02347631|583963729|FG001|First Intervention (2 Months)|Pregnancy|0|||
161703656|NCT02347631|583963728|FG000|First Intervention (2 Months)|Moved out of area|0|||
161703657|NCT02347631|583963729|FG001|First Intervention (2 Months)|Moved out of area|2|||
161703658|NCT02347631|583963728|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
161703659|NCT02347631|583963729|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
161703660|NCT02347631|583963728|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
161703661|NCT02347631|583963729|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
161703662|NCT02347631|583963728|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
161703663|NCT02347631|583963729|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
161703664|NCT02347631|583963728|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
161703665|NCT02347631|583963729|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
161703666|NCT02347631|583963728|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
161703667|NCT02347631|583963729|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
161703668|NCT02304926|583963730|FG000|Overall Study|Lost to Follow-up|2|||
161703669|NCT02304926|583963731|FG001|Overall Study|Lost to Follow-up|1|||
161703670|NCT02076165|583963733|FG000|Overall Study|Lost to Follow-up|7|||
161703671|NCT02076165|583963734|FG001|Overall Study|Lost to Follow-up|5|||
161703672|NCT02076165|583963733|FG000|Overall Study|Refused follow-up assessment|1|||
161703673|NCT02076165|583963734|FG001|Overall Study|Refused follow-up assessment|1|||
161703674|NCT01360645|583963739|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
161703675|NCT01360645|583963740|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
161703676|NCT01360645|583963741|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
161703677|NCT01360645|583963742|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
161703678|NCT01360645|583963739|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
161703679|NCT01360645|583963740|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
161703680|NCT01360645|583963741|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
161703681|NCT01360645|583963742|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
161703682|NCT01360645|583963739|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
161703683|NCT01360645|583963740|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
161703684|NCT01360645|583963741|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
161703685|NCT01360645|583963742|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
161703686|NCT01360645|583963739|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
161703687|NCT01360645|583963740|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
161703688|NCT01360645|583963741|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
161703689|NCT01360645|583963742|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
161703690|NCT01360645|583963739|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
161703691|NCT01360645|583963740|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
161703692|NCT01360645|583963741|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
161703693|NCT01360645|583963742|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
161703694|NCT01360645|583963739|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
161703695|NCT01360645|583963740|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
161703696|NCT01360645|583963741|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
161703697|NCT01360645|583963742|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
161703698|NCT01360645|583963739|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
161703699|NCT01360645|583963740|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
161703700|NCT01360645|583963741|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
161703701|NCT01360645|583963742|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
161703702|NCT01360645|583963739|FG000|Phase B (6 Weeks)|Adverse Event|0|||
161703703|NCT01360645|583963740|FG001|Phase B (6 Weeks)|Adverse Event|6|||
161703704|NCT01360645|583963741|FG002|Phase B (6 Weeks)|Adverse Event|0|||
161703705|NCT01360645|583963742|FG003|Phase B (6 Weeks)|Adverse Event|0|||
161703706|NCT01360645|583963739|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161703707|NCT01360645|583963740|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
161703708|NCT01360645|583963741|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
161703709|NCT01360645|583963742|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161703710|NCT01360645|583963739|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
161703711|NCT01360645|583963740|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
161703712|NCT01360645|583963741|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
161703713|NCT01360645|583963742|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
161703714|NCT01360645|583963739|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
161703715|NCT01360645|583963740|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
161703716|NCT01360645|583963741|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
161703717|NCT01360645|583963742|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
161703718|NCT01360645|583963739|FG000|Phase A+|Lost to Follow-up|0|||
161703719|NCT01360645|583963740|FG001|Phase A+|Lost to Follow-up|0|||
161703720|NCT01360645|583963741|FG002|Phase A+|Lost to Follow-up|0|||
161703721|NCT01360645|583963742|FG003|Phase A+|Lost to Follow-up|7|||
161703722|NCT01360645|583963739|FG000|Phase A+|Adverse Event|0|||
161703723|NCT01360645|583963740|FG001|Phase A+|Adverse Event|0|||
161703724|NCT01360645|583963741|FG002|Phase A+|Adverse Event|0|||
161703725|NCT01360645|583963742|FG003|Phase A+|Adverse Event|2|||
161703726|NCT01360645|583963739|FG000|Phase A+|Met Withdrawal Criteria|0|||
161703727|NCT01360645|583963740|FG001|Phase A+|Met Withdrawal Criteria|0|||
161703728|NCT01360645|583963741|FG002|Phase A+|Met Withdrawal Criteria|0|||
161703729|NCT01360645|583963742|FG003|Phase A+|Met Withdrawal Criteria|4|||
161703730|NCT01360645|583963739|FG000|Phase A+|Physician Decision|0|||
161703731|NCT01360645|583963740|FG001|Phase A+|Physician Decision|0|||
161703732|NCT01360645|583963741|FG002|Phase A+|Physician Decision|0|||
161703733|NCT01360645|583963742|FG003|Phase A+|Physician Decision|2|||
161703734|NCT01360645|583963739|FG000|Phase A+|Withdrawal by Subject|0|||
161703735|NCT01360645|583963740|FG001|Phase A+|Withdrawal by Subject|0|||
161703736|NCT01360645|583963741|FG002|Phase A+|Withdrawal by Subject|0|||
161703737|NCT01360645|583963742|FG003|Phase A+|Withdrawal by Subject|5|||
161703738|NCT01360645|583963739|FG000|Phase A+|Protocol Deviation|0|||
161703739|NCT01360645|583963740|FG001|Phase A+|Protocol Deviation|0|||
161703740|NCT01360645|583963741|FG002|Phase A+|Protocol Deviation|0|||
161703741|NCT01360645|583963742|FG003|Phase A+|Protocol Deviation|4|||
161703742|NCT00713219|583963743|FG000|Overall Study|Death|1|||
161703743|NCT00713219|583963743|FG000|Overall Study|Protocol Violation|1|||
161703744|NCT02978222|583963744|FG000|Overall Study|Withdrawal by Subject|2|||
161703745|NCT02978222|583963745|FG001|Overall Study|Withdrawal by Subject|2|||
161703746|NCT02978222|583963744|FG000|Overall Study|Physician Decision|2|||
161703747|NCT02978222|583963745|FG001|Overall Study|Physician Decision|0|||
161703748|NCT02978222|583963744|FG000|Overall Study|Adverse Event|0|||
161703749|NCT02978222|583963745|FG001|Overall Study|Adverse Event|1|||
161703750|NCT02978222|583963744|FG000|Overall Study|Death|1|||
161703751|NCT02978222|583963745|FG001|Overall Study|Death|0|||
161703752|NCT02978222|583963744|FG000|Overall Study|Disease Progression|32|||
161703753|NCT02978222|583963745|FG001|Overall Study|Disease Progression|32|||
161703754|NCT02978222|583963744|FG000|Overall Study|Early Study Termination|24|||
161703755|NCT02978222|583963745|FG001|Overall Study|Early Study Termination|21|||
161703756|NCT03258814|583963746|FG000|Overall Study|Early Termination|4|||
161703757|NCT03258814|583963747|FG001|Overall Study|Early Termination|3|||
161703758|NCT03258814|583963748|FG002|Overall Study|Early Termination|10|||
161703759|NCT00348140|583963753|FG000|Overall Study|Adverse Event|46|||
161703760|NCT00348140|583963754|FG001|Overall Study|Adverse Event|49|||
161703761|NCT00348140|583963755|FG002|Overall Study|Adverse Event|78|||
161703762|NCT00348140|583963753|FG000|Overall Study|Lost to Follow-up|4|||
161703763|NCT00348140|583963754|FG001|Overall Study|Lost to Follow-up|4|||
161703764|NCT00348140|583963755|FG002|Overall Study|Lost to Follow-up|4|||
161703765|NCT00348140|583963753|FG000|Overall Study|Protocol Violation|12|||
161703766|NCT00348140|583963754|FG001|Overall Study|Protocol Violation|13|||
161703767|NCT00348140|583963755|FG002|Overall Study|Protocol Violation|14|||
161703768|NCT00348140|583963753|FG000|Overall Study|Withdrawal by Subject|32|||
161703769|NCT00348140|583963754|FG001|Overall Study|Withdrawal by Subject|40|||
161703770|NCT00348140|583963755|FG002|Overall Study|Withdrawal by Subject|40|||
161703771|NCT00348140|583963753|FG000|Overall Study|Non-compliance|8|||
161703772|NCT00348140|583963754|FG001|Overall Study|Non-compliance|13|||
161703773|NCT00348140|583963755|FG002|Overall Study|Non-compliance|5|||
161703774|NCT00348140|583963753|FG000|Overall Study|Participant at risk due to study drug|2|||
161703775|NCT00348140|583963754|FG001|Overall Study|Participant at risk due to study drug|0|||
161703776|NCT00348140|583963755|FG002|Overall Study|Participant at risk due to study drug|0|||
161703777|NCT00348140|583963753|FG000|Overall Study|Conditional medication increased dose|1|||
161703778|NCT00348140|583963754|FG001|Overall Study|Conditional medication increased dose|0|||
161837176|NCT00361335|584446556|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
161957728|NCT05396014|584892637|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957729|NCT05396014|584892638|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957730|NCT05396014|584892639|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957731|NCT05396014|584892640|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957732|NCT05396014|584892641|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161703779|NCT00348140|583963755|FG002|Overall Study|Conditional medication increased dose|0|||
161703780|NCT00348140|583963753|FG000|Overall Study|Caregiver related|4|||
161957733|NCT05396014|584892642|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
161957734|NCT05396014|584892643|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
162030843|NCT03400956|585169492|FG002|Follow-up Period|Withdrawal by Subject|1|||
162030844|NCT03400956|585169490|FG000|Follow-up Period|Other|0|||
162030845|NCT03400956|585169491|FG001|Follow-up Period|Other|0|||
161703781|NCT00348140|583963754|FG001|Overall Study|Caregiver related|7|||
161703782|NCT00348140|583963755|FG002|Overall Study|Caregiver related|3|||
161703783|NCT00348140|583963753|FG000|Overall Study|Participant hospitalised|3|||
161703784|NCT00348140|583963754|FG001|Overall Study|Participant hospitalised|0|||
161703785|NCT00348140|583963755|FG002|Overall Study|Participant hospitalised|0|||
161703786|NCT00348140|583963753|FG000|Overall Study|Efficacy related|1|||
161703787|NCT00348140|583963754|FG001|Overall Study|Efficacy related|1|||
161703788|NCT00348140|583963755|FG002|Overall Study|Efficacy related|0|||
161703789|NCT00348140|583963753|FG000|Overall Study|Administration related|3|||
161703790|NCT00348140|583963754|FG001|Overall Study|Administration related|1|||
161703791|NCT00348140|583963755|FG002|Overall Study|Administration related|1|||
161703792|NCT00348140|583963753|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
161703793|NCT00348140|583963754|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
161703794|NCT00348140|583963755|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
161703795|NCT00348140|583963753|FG000|Overall Study|Participant unwell|1|||
161703796|NCT00348140|583963754|FG001|Overall Study|Participant unwell|0|||
161703797|NCT00348140|583963755|FG002|Overall Study|Participant unwell|0|||
161703798|NCT00348140|583963753|FG000|Overall Study|Screen failure|1|||
161703799|NCT00348140|583963754|FG001|Overall Study|Screen failure|0|||
161703800|NCT00348140|583963755|FG002|Overall Study|Screen failure|0|||
161703801|NCT00348140|583963753|FG000|Overall Study|Investigator decided to discontinue|4|||
161703802|NCT00348140|583963754|FG001|Overall Study|Investigator decided to discontinue|1|||
161703803|NCT00348140|583963755|FG002|Overall Study|Investigator decided to discontinue|4|||
161837177|NCT00361335|584446550|FG000|SC Period: Week E0 to Week E24|Death|0|||
161837178|NCT00361335|584446551|FG001|SC Period: Week E0 to Week E24|Death|0|||
161837179|NCT00361335|584446552|FG002|SC Period: Week E0 to Week E24|Death|0|||
161837180|NCT00361335|584446553|FG003|SC Period: Week E0 to Week E24|Death|0|||
161837181|NCT00361335|584446554|FG004|SC Period: Week E0 to Week E24|Death|0|||
161837182|NCT00361335|584446555|FG005|SC Period: Week E0 to Week E24|Death|0|||
161837183|NCT00361335|584446556|FG006|SC Period: Week E0 to Week E24|Death|1|||
161837184|NCT00361335|584446550|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
161837185|NCT00361335|584446551|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
161837186|NCT00361335|584446552|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
161837187|NCT00361335|584446553|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
161837188|NCT00361335|584446554|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
161837189|NCT00361335|584446555|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
161837190|NCT00361335|584446556|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
161837191|NCT00361335|584446550|FG000|SC Period: Week E0 to Week E24|Other|1|||
161837192|NCT00361335|584446551|FG001|SC Period: Week E0 to Week E24|Other|0|||
161837193|NCT00361335|584446552|FG002|SC Period: Week E0 to Week E24|Other|0|||
161837194|NCT00361335|584446553|FG003|SC Period: Week E0 to Week E24|Other|1|||
161837195|NCT00361335|584446554|FG004|SC Period: Week E0 to Week E24|Other|0|||
161837196|NCT00361335|584446555|FG005|SC Period: Week E0 to Week E24|Other|1|||
161837197|NCT00361335|584446556|FG006|SC Period: Week E0 to Week E24|Other|2|||
161837198|NCT00361335|584446550|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161837199|NCT00361335|584446551|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161837200|NCT00361335|584446552|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
161837201|NCT00361335|584446553|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161837202|NCT00361335|584446554|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161837203|NCT00361335|584446555|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161837204|NCT00361335|584446556|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
161703804|NCT00348140|583963753|FG000|Overall Study|Decided to discontinue on their own|1|||
161837205|NCT01765582|584446565|FG000|Overall Study|Other|3|||
161837206|NCT01765582|584446566|FG001|Overall Study|Other|6|||
161837207|NCT01765582|584446567|FG002|Overall Study|Other|9|||
161957735|NCT05396014|584892644|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957736|NCT05396014|584892645|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957737|NCT05396014|584892646|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957738|NCT05396014|584892647|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957739|NCT05396014|584892648|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957740|NCT05396014|584892649|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957741|NCT05396014|584892650|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957742|NCT05396014|584892651|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957743|NCT05396014|584892652|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957744|NCT05396014|584892653|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957745|NCT05396014|584892654|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957746|NCT05396014|584892655|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957747|NCT05396014|584892656|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957748|NCT05396014|584892657|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957749|NCT05396014|584892658|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957750|NCT05396014|584892659|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957751|NCT05396014|584892660|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957752|NCT05396014|584892661|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957753|NCT05396014|584892662|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957754|NCT05396014|584892663|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957755|NCT05396014|584892664|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957756|NCT05396014|584892665|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957757|NCT05396014|584892666|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
162030846|NCT03400956|585169492|FG002|Follow-up Period|Other|1|||
161837208|NCT01765582|584446565|FG000|Overall Study|Lost to Follow-up|2|||
161957758|NCT05396014|584892667|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957759|NCT05396014|584892668|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957760|NCT05396014|584892669|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957761|NCT05396014|584892670|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957762|NCT05396014|584892671|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
161957763|NCT05396014|584892629|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
161957764|NCT05396014|584892630|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957765|NCT05396014|584892631|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957766|NCT05396014|584892632|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957767|NCT05396014|584892633|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957768|NCT05396014|584892634|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957769|NCT05396014|584892635|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957770|NCT05396014|584892636|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957771|NCT05396014|584892637|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957772|NCT05396014|584892638|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957773|NCT05396014|584892639|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957774|NCT05396014|584892640|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957775|NCT05396014|584892641|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957776|NCT05396014|584892642|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
161957777|NCT05396014|584892643|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957778|NCT05396014|584892644|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957779|NCT05396014|584892645|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957780|NCT05396014|584892646|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957781|NCT05396014|584892647|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957782|NCT05396014|584892648|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957783|NCT05396014|584892649|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957784|NCT05396014|584892650|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957785|NCT05396014|584892651|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957786|NCT05396014|584892652|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957787|NCT05396014|584892653|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957788|NCT05396014|584892654|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957789|NCT05396014|584892655|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957790|NCT05396014|584892656|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957791|NCT05396014|584892657|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957792|NCT05396014|584892658|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957793|NCT05396014|584892659|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957794|NCT05396014|584892660|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957795|NCT05396014|584892661|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957796|NCT05396014|584892662|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957797|NCT05396014|584892663|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957798|NCT05396014|584892664|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957799|NCT05396014|584892665|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957800|NCT05396014|584892666|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957801|NCT05396014|584892667|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957802|NCT05396014|584892668|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
161957803|NCT05396014|584892669|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957804|NCT05396014|584892670|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957805|NCT05396014|584892671|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
161957806|NCT05396014|584892629|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
161957807|NCT05396014|584892630|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161703805|NCT00348140|583963754|FG001|Overall Study|Decided to discontinue on their own|4|||
161703806|NCT00348140|583963755|FG002|Overall Study|Decided to discontinue on their own|1|||
161703807|NCT00348140|583963753|FG000|Overall Study|Use of prohibited drug|1|||
161703808|NCT00348140|583963754|FG001|Overall Study|Use of prohibited drug|0|||
161703809|NCT00348140|583963755|FG002|Overall Study|Use of prohibited drug|2|||
161703810|NCT00348140|583963753|FG000|Overall Study|Disease progression|1|||
161703811|NCT00348140|583963754|FG001|Overall Study|Disease progression|2|||
161703812|NCT00348140|583963755|FG002|Overall Study|Disease progression|5|||
161703813|NCT00348140|583963753|FG000|Overall Study|Increased risk of cardiac infarction|0|||
161703814|NCT00348140|583963754|FG001|Overall Study|Increased risk of cardiac infarction|1|||
161703815|NCT00348140|583963755|FG002|Overall Study|Increased risk of cardiac infarction|0|||
161703816|NCT00348140|583963753|FG000|Overall Study|Serious adverse event|0|||
161703817|NCT00348140|583963754|FG001|Overall Study|Serious adverse event|1|||
161703818|NCT00348140|583963755|FG002|Overall Study|Serious adverse event|0|||
161703819|NCT00348140|583963753|FG000|Overall Study|Abnormal ECG|0|||
161703820|NCT00348140|583963754|FG001|Overall Study|Abnormal ECG|1|||
161703821|NCT00348140|583963755|FG002|Overall Study|Abnormal ECG|3|||
161703822|NCT00348140|583963753|FG000|Overall Study|Participant died|0|||
161703823|NCT00348140|583963754|FG001|Overall Study|Participant died|1|||
161703824|NCT00348140|583963755|FG002|Overall Study|Participant died|0|||
161703825|NCT00348140|583963753|FG000|Overall Study|Exclusion criteria met|0|||
161703826|NCT00348140|583963754|FG001|Overall Study|Exclusion criteria met|0|||
161703827|NCT00348140|583963755|FG002|Overall Study|Exclusion criteria met|1|||
161703828|NCT00348140|583963753|FG000|Overall Study|Memory declined|0|||
161703829|NCT00348140|583963754|FG001|Overall Study|Memory declined|0|||
161703830|NCT00348140|583963755|FG002|Overall Study|Memory declined|1|||
161703831|NCT00868790|583963756|FG000|Period 1|Adverse Event|1|||
161703832|NCT00868790|583963757|FG001|Period 1|Adverse Event|0|||
161703833|NCT00868790|583963758|FG002|Period 1|Adverse Event|0|||
161703834|NCT00868790|583963759|FG003|Period 1|Adverse Event|0|||
161703835|NCT00868790|583963760|FG004|Period 1|Adverse Event|0|||
161703836|NCT00868790|583963761|FG005|Period 1|Adverse Event|0|||
161703837|NCT00868790|583963762|FG006|Period 1|Adverse Event|0|||
161703838|NCT00868790|583963763|FG007|Period 1|Adverse Event|3|||
161703839|NCT00868790|583963764|FG008|Period 1|Adverse Event|1|||
161703840|NCT00868790|583963765|FG009|Period 1|Adverse Event|0|||
161703841|NCT00868790|583963766|FG010|Period 1|Adverse Event|0|||
161703842|NCT00868790|583963767|FG011|Period 1|Adverse Event|0|||
161703843|NCT00868790|583963768|FG012|Period 1|Adverse Event|0|||
161703844|NCT00868790|583963769|FG013|Period 1|Adverse Event|1|||
161703845|NCT00868790|583963756|FG000|Period 1|Protocol Violation|1|||
161703846|NCT00868790|583963757|FG001|Period 1|Protocol Violation|0|||
161703847|NCT00868790|583963758|FG002|Period 1|Protocol Violation|0|||
161703848|NCT00868790|583963759|FG003|Period 1|Protocol Violation|0|||
161703849|NCT00868790|583963760|FG004|Period 1|Protocol Violation|0|||
161703850|NCT00868790|583963761|FG005|Period 1|Protocol Violation|0|||
161703851|NCT00868790|583963762|FG006|Period 1|Protocol Violation|0|||
161703852|NCT00868790|583963763|FG007|Period 1|Protocol Violation|0|||
161703853|NCT00868790|583963764|FG008|Period 1|Protocol Violation|0|||
161703854|NCT00868790|583963765|FG009|Period 1|Protocol Violation|0|||
161703855|NCT00868790|583963766|FG010|Period 1|Protocol Violation|0|||
161957808|NCT05396014|584892631|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957809|NCT05396014|584892632|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957810|NCT05396014|584892633|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957811|NCT05396014|584892634|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957812|NCT05396014|584892635|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957813|NCT05396014|584892636|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957814|NCT05396014|584892637|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161703856|NCT00868790|583963767|FG011|Period 1|Protocol Violation|0|||
161703857|NCT00868790|583963768|FG012|Period 1|Protocol Violation|0|||
161703858|NCT00868790|583963769|FG013|Period 1|Protocol Violation|0|||
161703859|NCT00868790|583963756|FG000|Period 1|Withdrawal by Subject|0|||
161703860|NCT00868790|583963757|FG001|Period 1|Withdrawal by Subject|1|||
161703861|NCT00868790|583963758|FG002|Period 1|Withdrawal by Subject|0|||
161703862|NCT00868790|583963759|FG003|Period 1|Withdrawal by Subject|0|||
161703863|NCT00868790|583963760|FG004|Period 1|Withdrawal by Subject|0|||
161703864|NCT00868790|583963761|FG005|Period 1|Withdrawal by Subject|0|||
161703865|NCT00868790|583963762|FG006|Period 1|Withdrawal by Subject|0|||
161703866|NCT00868790|583963763|FG007|Period 1|Withdrawal by Subject|0|||
161703867|NCT00868790|583963764|FG008|Period 1|Withdrawal by Subject|0|||
161703868|NCT00868790|583963765|FG009|Period 1|Withdrawal by Subject|0|||
161703869|NCT00868790|583963766|FG010|Period 1|Withdrawal by Subject|0|||
161703870|NCT00868790|583963767|FG011|Period 1|Withdrawal by Subject|0|||
161703871|NCT00868790|583963768|FG012|Period 1|Withdrawal by Subject|0|||
161703872|NCT00868790|583963769|FG013|Period 1|Withdrawal by Subject|1|||
161703873|NCT00868790|583963756|FG000|Period 1|Abnormal Triglycerides|0|||
161703874|NCT00868790|583963757|FG001|Period 1|Abnormal Triglycerides|0|||
161703875|NCT00868790|583963758|FG002|Period 1|Abnormal Triglycerides|0|||
161703876|NCT00868790|583963759|FG003|Period 1|Abnormal Triglycerides|0|||
161703877|NCT00868790|583963760|FG004|Period 1|Abnormal Triglycerides|1|||
161703878|NCT00868790|583963761|FG005|Period 1|Abnormal Triglycerides|0|||
161703879|NCT00868790|583963762|FG006|Period 1|Abnormal Triglycerides|0|||
161703880|NCT00868790|583963763|FG007|Period 1|Abnormal Triglycerides|0|||
161703881|NCT00868790|583963764|FG008|Period 1|Abnormal Triglycerides|0|||
161703882|NCT00868790|583963765|FG009|Period 1|Abnormal Triglycerides|0|||
161703883|NCT00868790|583963766|FG010|Period 1|Abnormal Triglycerides|0|||
161703884|NCT00868790|583963767|FG011|Period 1|Abnormal Triglycerides|0|||
161703885|NCT00868790|583963768|FG012|Period 1|Abnormal Triglycerides|0|||
161703886|NCT00868790|583963769|FG013|Period 1|Abnormal Triglycerides|0|||
161703887|NCT00868790|583963756|FG000|Period 1|Lost to Follow-up|0|||
161703888|NCT00868790|583963757|FG001|Period 1|Lost to Follow-up|0|||
161703889|NCT00868790|583963758|FG002|Period 1|Lost to Follow-up|0|||
161703890|NCT00868790|583963759|FG003|Period 1|Lost to Follow-up|0|||
161703891|NCT00868790|583963760|FG004|Period 1|Lost to Follow-up|0|||
161703892|NCT00868790|583963761|FG005|Period 1|Lost to Follow-up|1|||
161703893|NCT00868790|583963762|FG006|Period 1|Lost to Follow-up|0|||
161703894|NCT00868790|583963763|FG007|Period 1|Lost to Follow-up|0|||
161703895|NCT00868790|583963764|FG008|Period 1|Lost to Follow-up|0|||
161703896|NCT00868790|583963765|FG009|Period 1|Lost to Follow-up|0|||
161703897|NCT00868790|583963766|FG010|Period 1|Lost to Follow-up|0|||
161703898|NCT00868790|583963767|FG011|Period 1|Lost to Follow-up|0|||
161703899|NCT00868790|583963768|FG012|Period 1|Lost to Follow-up|0|||
161703900|NCT00868790|583963769|FG013|Period 1|Lost to Follow-up|0|||
161703901|NCT00868790|583963756|FG000|Period 2|Adverse Event|0|||
161703902|NCT00868790|583963757|FG001|Period 2|Adverse Event|0|||
161703903|NCT00868790|583963758|FG002|Period 2|Adverse Event|0|||
161703904|NCT00868790|583963759|FG003|Period 2|Adverse Event|0|||
161703905|NCT00868790|583963760|FG004|Period 2|Adverse Event|0|||
161703906|NCT00868790|583963761|FG005|Period 2|Adverse Event|0|||
161703907|NCT00868790|583963762|FG006|Period 2|Adverse Event|0|||
161703908|NCT00868790|583963763|FG007|Period 2|Adverse Event|0|||
161703909|NCT00868790|583963764|FG008|Period 2|Adverse Event|1|||
161703910|NCT00868790|583963765|FG009|Period 2|Adverse Event|0|||
161703911|NCT00868790|583963766|FG010|Period 2|Adverse Event|0|||
161703912|NCT00868790|583963767|FG011|Period 2|Adverse Event|0|||
161703913|NCT00868790|583963768|FG012|Period 2|Adverse Event|0|||
161703914|NCT00868790|583963769|FG013|Period 2|Adverse Event|0|||
161703915|NCT00868790|583963756|FG000|Period 2|Lost to Follow-up|0|||
161703916|NCT00868790|583963757|FG001|Period 2|Lost to Follow-up|1|||
161703917|NCT00868790|583963758|FG002|Period 2|Lost to Follow-up|0|||
161703918|NCT00868790|583963759|FG003|Period 2|Lost to Follow-up|0|||
161703919|NCT00868790|583963760|FG004|Period 2|Lost to Follow-up|0|||
161703920|NCT00868790|583963761|FG005|Period 2|Lost to Follow-up|1|||
161703921|NCT00868790|583963762|FG006|Period 2|Lost to Follow-up|0|||
161703922|NCT00868790|583963763|FG007|Period 2|Lost to Follow-up|0|||
161703923|NCT00868790|583963764|FG008|Period 2|Lost to Follow-up|0|||
161703924|NCT00868790|583963765|FG009|Period 2|Lost to Follow-up|0|||
161703925|NCT00868790|583963766|FG010|Period 2|Lost to Follow-up|0|||
161703926|NCT00868790|583963767|FG011|Period 2|Lost to Follow-up|0|||
161703927|NCT00868790|583963768|FG012|Period 2|Lost to Follow-up|0|||
161703928|NCT00868790|583963769|FG013|Period 2|Lost to Follow-up|0|||
161703929|NCT00868790|583963756|FG000|Period 2|Withdrawal by Subject|0|||
161703930|NCT00868790|583963757|FG001|Period 2|Withdrawal by Subject|0|||
161703931|NCT00868790|583963758|FG002|Period 2|Withdrawal by Subject|0|||
161703932|NCT00868790|583963759|FG003|Period 2|Withdrawal by Subject|0|||
161703933|NCT00868790|583963760|FG004|Period 2|Withdrawal by Subject|0|||
161703934|NCT00868790|583963761|FG005|Period 2|Withdrawal by Subject|0|||
161703935|NCT00868790|583963762|FG006|Period 2|Withdrawal by Subject|0|||
161703936|NCT00868790|583963763|FG007|Period 2|Withdrawal by Subject|0|||
161703937|NCT00868790|583963764|FG008|Period 2|Withdrawal by Subject|1|||
161703938|NCT00868790|583963765|FG009|Period 2|Withdrawal by Subject|0|||
161703939|NCT00868790|583963766|FG010|Period 2|Withdrawal by Subject|0|||
161703940|NCT00868790|583963767|FG011|Period 2|Withdrawal by Subject|0|||
161703941|NCT00868790|583963768|FG012|Period 2|Withdrawal by Subject|0|||
161703942|NCT00868790|583963769|FG013|Period 2|Withdrawal by Subject|1|||
161703943|NCT00868790|583963756|FG000|Period 3|Adverse Event|0|||
161703944|NCT00868790|583963757|FG001|Period 3|Adverse Event|0|||
161703945|NCT00868790|583963758|FG002|Period 3|Adverse Event|0|||
161703946|NCT00868790|583963759|FG003|Period 3|Adverse Event|0|||
161703947|NCT00868790|583963760|FG004|Period 3|Adverse Event|0|||
161703948|NCT00868790|583963761|FG005|Period 3|Adverse Event|0|||
161703949|NCT00868790|583963762|FG006|Period 3|Adverse Event|0|||
161703950|NCT00868790|583963763|FG007|Period 3|Adverse Event|0|||
161703951|NCT00868790|583963764|FG008|Period 3|Adverse Event|0|||
161703952|NCT00868790|583963765|FG009|Period 3|Adverse Event|1|||
161703953|NCT00868790|583963766|FG010|Period 3|Adverse Event|0|||
161703954|NCT00868790|583963767|FG011|Period 3|Adverse Event|0|||
161703955|NCT00868790|583963768|FG012|Period 3|Adverse Event|0|||
161703956|NCT00868790|583963769|FG013|Period 3|Adverse Event|0|||
161703957|NCT00868790|583963756|FG000|Period 3|Protocol Violation|0|||
161703958|NCT00868790|583963757|FG001|Period 3|Protocol Violation|0|||
161703959|NCT00868790|583963758|FG002|Period 3|Protocol Violation|0|||
161703960|NCT00868790|583963759|FG003|Period 3|Protocol Violation|0|||
161703961|NCT00868790|583963760|FG004|Period 3|Protocol Violation|0|||
161703962|NCT00868790|583963761|FG005|Period 3|Protocol Violation|0|||
161703963|NCT00868790|583963762|FG006|Period 3|Protocol Violation|0|||
161703964|NCT00868790|583963763|FG007|Period 3|Protocol Violation|0|||
161703965|NCT00868790|583963764|FG008|Period 3|Protocol Violation|0|||
161703966|NCT00868790|583963765|FG009|Period 3|Protocol Violation|0|||
161703967|NCT00868790|583963766|FG010|Period 3|Protocol Violation|1|||
161703968|NCT00868790|583963767|FG011|Period 3|Protocol Violation|0|||
161703969|NCT00868790|583963768|FG012|Period 3|Protocol Violation|0|||
161703970|NCT00868790|583963769|FG013|Period 3|Protocol Violation|0|||
161703971|NCT00868790|583963756|FG000|Period 3|Study Terminated by Sponsor|0|||
161703972|NCT00868790|583963757|FG001|Period 3|Study Terminated by Sponsor|0|||
161703973|NCT00868790|583963758|FG002|Period 3|Study Terminated by Sponsor|0|||
161703974|NCT00868790|583963759|FG003|Period 3|Study Terminated by Sponsor|1|||
161703975|NCT00868790|583963760|FG004|Period 3|Study Terminated by Sponsor|0|||
161703976|NCT00868790|583963761|FG005|Period 3|Study Terminated by Sponsor|0|||
161703977|NCT00868790|583963762|FG006|Period 3|Study Terminated by Sponsor|0|||
161703978|NCT00868790|583963763|FG007|Period 3|Study Terminated by Sponsor|0|||
161703979|NCT00868790|583963764|FG008|Period 3|Study Terminated by Sponsor|0|||
161703980|NCT00868790|583963765|FG009|Period 3|Study Terminated by Sponsor|0|||
161703981|NCT00868790|583963766|FG010|Period 3|Study Terminated by Sponsor|0|||
161703982|NCT00868790|583963767|FG011|Period 3|Study Terminated by Sponsor|0|||
161703983|NCT00868790|583963768|FG012|Period 3|Study Terminated by Sponsor|0|||
161703984|NCT00868790|583963769|FG013|Period 3|Study Terminated by Sponsor|0|||
161703985|NCT00868790|583963756|FG000|Period 4|Adverse Event|0|||
161703986|NCT00868790|583963757|FG001|Period 4|Adverse Event|0|||
161703987|NCT00868790|583963758|FG002|Period 4|Adverse Event|0|||
161703988|NCT00868790|583963759|FG003|Period 4|Adverse Event|0|||
161703989|NCT00868790|583963760|FG004|Period 4|Adverse Event|0|||
161703990|NCT00868790|583963761|FG005|Period 4|Adverse Event|0|||
161703991|NCT00868790|583963762|FG006|Period 4|Adverse Event|0|||
161703992|NCT00868790|583963763|FG007|Period 4|Adverse Event|1|||
161703993|NCT00868790|583963764|FG008|Period 4|Adverse Event|0|||
161703994|NCT00868790|583963765|FG009|Period 4|Adverse Event|0|||
161703995|NCT00868790|583963766|FG010|Period 4|Adverse Event|1|||
161703996|NCT00868790|583963767|FG011|Period 4|Adverse Event|0|||
161703997|NCT00868790|583963768|FG012|Period 4|Adverse Event|1|||
161703998|NCT00868790|583963769|FG013|Period 4|Adverse Event|0|||
161703999|NCT00868790|583963756|FG000|Period 4|Lost to Follow-up|0|||
161704000|NCT00868790|583963757|FG001|Period 4|Lost to Follow-up|0|||
161704001|NCT00868790|583963758|FG002|Period 4|Lost to Follow-up|0|||
161704002|NCT00868790|583963759|FG003|Period 4|Lost to Follow-up|0|||
161704003|NCT00868790|583963760|FG004|Period 4|Lost to Follow-up|0|||
161704004|NCT00868790|583963761|FG005|Period 4|Lost to Follow-up|0|||
161704005|NCT00868790|583963762|FG006|Period 4|Lost to Follow-up|0|||
161704006|NCT00868790|583963763|FG007|Period 4|Lost to Follow-up|1|||
161704007|NCT00868790|583963764|FG008|Period 4|Lost to Follow-up|0|||
161704008|NCT00868790|583963765|FG009|Period 4|Lost to Follow-up|0|||
161704009|NCT00868790|583963766|FG010|Period 4|Lost to Follow-up|0|||
161704010|NCT00868790|583963767|FG011|Period 4|Lost to Follow-up|0|||
161704011|NCT00868790|583963768|FG012|Period 4|Lost to Follow-up|0|||
161704012|NCT00868790|583963769|FG013|Period 4|Lost to Follow-up|0|||
161704013|NCT00868790|583963756|FG000|Period 4|Study Terminated by Sponsor|2|||
161704014|NCT00868790|583963757|FG001|Period 4|Study Terminated by Sponsor|0|||
161704015|NCT00868790|583963758|FG002|Period 4|Study Terminated by Sponsor|0|||
161704016|NCT00868790|583963759|FG003|Period 4|Study Terminated by Sponsor|0|||
161704017|NCT00868790|583963760|FG004|Period 4|Study Terminated by Sponsor|0|||
161704018|NCT00868790|583963761|FG005|Period 4|Study Terminated by Sponsor|0|||
161704019|NCT00868790|583963762|FG006|Period 4|Study Terminated by Sponsor|0|||
161704020|NCT00868790|583963763|FG007|Period 4|Study Terminated by Sponsor|1|||
161704021|NCT00868790|583963764|FG008|Period 4|Study Terminated by Sponsor|2|||
161704022|NCT00868790|583963765|FG009|Period 4|Study Terminated by Sponsor|0|||
161704023|NCT00868790|583963766|FG010|Period 4|Study Terminated by Sponsor|2|||
161704024|NCT00868790|583963767|FG011|Period 4|Study Terminated by Sponsor|1|||
161704025|NCT00868790|583963768|FG012|Period 4|Study Terminated by Sponsor|0|||
161704026|NCT00868790|583963769|FG013|Period 4|Study Terminated by Sponsor|1|||
161704027|NCT00868790|583963756|FG000|Period 4|Abnormal ALT/AST|0|||
161704028|NCT00868790|583963757|FG001|Period 4|Abnormal ALT/AST|0|||
161704029|NCT00868790|583963758|FG002|Period 4|Abnormal ALT/AST|1|||
161704030|NCT00868790|583963759|FG003|Period 4|Abnormal ALT/AST|0|||
161704031|NCT00868790|583963760|FG004|Period 4|Abnormal ALT/AST|0|||
161704032|NCT00868790|583963761|FG005|Period 4|Abnormal ALT/AST|0|||
161704033|NCT00868790|583963762|FG006|Period 4|Abnormal ALT/AST|0|||
161704034|NCT00868790|583963763|FG007|Period 4|Abnormal ALT/AST|0|||
161704035|NCT00868790|583963764|FG008|Period 4|Abnormal ALT/AST|0|||
161704036|NCT00868790|583963765|FG009|Period 4|Abnormal ALT/AST|0|||
161704037|NCT00868790|583963766|FG010|Period 4|Abnormal ALT/AST|0|||
161704038|NCT00868790|583963767|FG011|Period 4|Abnormal ALT/AST|0|||
161957815|NCT05396014|584892638|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957816|NCT05396014|584892639|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957817|NCT05396014|584892640|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957818|NCT05396014|584892641|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957819|NCT05396014|584892642|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957820|NCT05396014|584892643|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957821|NCT05396014|584892644|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957822|NCT05396014|584892645|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957823|NCT05396014|584892646|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957824|NCT05396014|584892647|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957825|NCT05396014|584892648|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957826|NCT05396014|584892649|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957827|NCT05396014|584892650|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957828|NCT05396014|584892651|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957829|NCT05396014|584892652|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957830|NCT05396014|584892653|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957831|NCT05396014|584892654|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957832|NCT05396014|584892655|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
161957833|NCT05396014|584892656|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957834|NCT05396014|584892657|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957835|NCT05396014|584892658|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957836|NCT05396014|584892659|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957837|NCT05396014|584892660|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957838|NCT05396014|584892661|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957839|NCT05396014|584892662|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957840|NCT05396014|584892663|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957841|NCT05396014|584892664|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161704039|NCT00868790|583963768|FG012|Period 4|Abnormal ALT/AST|0|||
161957842|NCT05396014|584892665|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957843|NCT05396014|584892666|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957844|NCT05396014|584892667|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957845|NCT05396014|584892668|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161704040|NCT00868790|583963769|FG013|Period 4|Abnormal ALT/AST|0|||
161704041|NCT00868790|583963756|FG000|Post-study|Withdrawal by Subject|0|||
161704042|NCT00868790|583963757|FG001|Post-study|Withdrawal by Subject|0|||
161704043|NCT00868790|583963758|FG002|Post-study|Withdrawal by Subject|0|||
161704044|NCT00868790|583963759|FG003|Post-study|Withdrawal by Subject|0|||
161704045|NCT00868790|583963760|FG004|Post-study|Withdrawal by Subject|1|||
161704046|NCT00868790|583963761|FG005|Post-study|Withdrawal by Subject|0|||
161704047|NCT00868790|583963762|FG006|Post-study|Withdrawal by Subject|0|||
161704048|NCT00868790|583963763|FG007|Post-study|Withdrawal by Subject|0|||
161704049|NCT00868790|583963764|FG008|Post-study|Withdrawal by Subject|0|||
161704050|NCT00868790|583963765|FG009|Post-study|Withdrawal by Subject|0|||
161704051|NCT00868790|583963766|FG010|Post-study|Withdrawal by Subject|0|||
161704052|NCT00868790|583963767|FG011|Post-study|Withdrawal by Subject|0|||
161704053|NCT00868790|583963768|FG012|Post-study|Withdrawal by Subject|0|||
161704054|NCT00868790|583963769|FG013|Post-study|Withdrawal by Subject|0|||
161704055|NCT00868790|583963756|FG000|Post-study|Excluded Medication|0|||
161704056|NCT00868790|583963757|FG001|Post-study|Excluded Medication|0|||
161704057|NCT00868790|583963758|FG002|Post-study|Excluded Medication|0|||
161704058|NCT00868790|583963759|FG003|Post-study|Excluded Medication|0|||
161704059|NCT00868790|583963760|FG004|Post-study|Excluded Medication|0|||
161704060|NCT00868790|583963761|FG005|Post-study|Excluded Medication|0|||
161704061|NCT00868790|583963762|FG006|Post-study|Excluded Medication|0|||
161704062|NCT00868790|583963763|FG007|Post-study|Excluded Medication|2|||
161704063|NCT00868790|583963764|FG008|Post-study|Excluded Medication|0|||
161704064|NCT00868790|583963765|FG009|Post-study|Excluded Medication|1|||
161704065|NCT00868790|583963766|FG010|Post-study|Excluded Medication|0|||
161704066|NCT00868790|583963767|FG011|Post-study|Excluded Medication|0|||
161704067|NCT00868790|583963768|FG012|Post-study|Excluded Medication|0|||
161704068|NCT00868790|583963769|FG013|Post-study|Excluded Medication|0|||
161704069|NCT02909153|583963774|FG000|Overall Study|Withdrawal by Subject|0|||
161704070|NCT02909153|583963775|FG001|Overall Study|Withdrawal by Subject|1|||
161704071|NCT02909153|583963776|FG002|Overall Study|Withdrawal by Subject|0|||
161704072|NCT02909153|583963777|FG003|Overall Study|Withdrawal by Subject|0|||
161704073|NCT02909153|583963778|FG004|Overall Study|Withdrawal by Subject|0|||
161704074|NCT01273064|583963779|FG000|Overall Study|Adverse Event|5|||
161704075|NCT01273064|583963780|FG001|Overall Study|Adverse Event|1|||
161704076|NCT01273064|583963781|FG002|Overall Study|Adverse Event|3|||
161704077|NCT01273064|583963782|FG003|Overall Study|Adverse Event|2|||
161704078|NCT01273064|583963783|FG004|Overall Study|Adverse Event|1|||
161704079|NCT01273064|583963779|FG000|Overall Study|Withdrawal by Subject|4|||
161704080|NCT01273064|583963780|FG001|Overall Study|Withdrawal by Subject|2|||
161704081|NCT01273064|583963781|FG002|Overall Study|Withdrawal by Subject|2|||
161704082|NCT01273064|583963782|FG003|Overall Study|Withdrawal by Subject|2|||
161704083|NCT01273064|583963783|FG004|Overall Study|Withdrawal by Subject|0|||
161704084|NCT01273064|583963779|FG000|Overall Study|Study Termination|13|||
161704085|NCT01273064|583963780|FG001|Overall Study|Study Termination|27|||
161704086|NCT01273064|583963781|FG002|Overall Study|Study Termination|26|||
161704087|NCT01273064|583963782|FG003|Overall Study|Study Termination|16|||
161704088|NCT01273064|583963783|FG004|Overall Study|Study Termination|8|||
161704089|NCT01273064|583963779|FG000|Overall Study|Lost to Follow-up|1|||
161704090|NCT01273064|583963780|FG001|Overall Study|Lost to Follow-up|0|||
161704091|NCT01273064|583963781|FG002|Overall Study|Lost to Follow-up|0|||
161704092|NCT01273064|583963782|FG003|Overall Study|Lost to Follow-up|0|||
161704093|NCT01273064|583963783|FG004|Overall Study|Lost to Follow-up|0|||
161957846|NCT05396014|584892669|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957847|NCT05396014|584892670|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161957848|NCT05396014|584892671|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
161704094|NCT01273064|583963779|FG000|Overall Study|Physician Decision|0|||
161704095|NCT01273064|583963780|FG001|Overall Study|Physician Decision|0|||
161704096|NCT01273064|583963781|FG002|Overall Study|Physician Decision|0|||
161704097|NCT01273064|583963782|FG003|Overall Study|Physician Decision|0|||
161704098|NCT01273064|583963783|FG004|Overall Study|Physician Decision|1|||
161704099|NCT04666038|583963784|FG000|Overall Study|Progressive Disease|2|||
161704100|NCT04666038|583963785|FG001|Overall Study|Progressive Disease|0|||
161704101|NCT04666038|583963784|FG000|Overall Study|Death|38|||
161704102|NCT04666038|583963785|FG001|Overall Study|Death|32|||
161704103|NCT04666038|583963784|FG000|Overall Study|Withdrawal by Subject|10|||
161957849|NCT05396014|584892629|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161704104|NCT04666038|583963785|FG001|Overall Study|Withdrawal by Subject|19|||
161957850|NCT05396014|584892630|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161704105|NCT04666038|583963784|FG000|Overall Study|Lost to Follow-up|0|||
161704106|NCT04666038|583963785|FG001|Overall Study|Lost to Follow-up|2|||
161704107|NCT04666038|583963784|FG000|Overall Study|On Study Treatment|46|||
161704108|NCT04666038|583963785|FG001|Overall Study|On Study Treatment|5|||
161704109|NCT04666038|583963784|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
161704110|NCT04666038|583963785|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
161704111|NCT02867761|583963791|FG000|Overall Study|Participant withdrawn by investigator|0|||
161704112|NCT02867761|583963792|FG001|Overall Study|Participant withdrawn by investigator|1|||
161704113|NCT02867761|583963791|FG000|Overall Study|Lost to Follow-up|25|||
161704114|NCT02867761|583963792|FG001|Overall Study|Lost to Follow-up|18|||
161704115|NCT02867761|583963791|FG000|Overall Study|Unable to complete protocol|3|||
161704116|NCT02867761|583963792|FG001|Overall Study|Unable to complete protocol|7|||
161704117|NCT03595280|583963793|FG000|Overall Study|Lost to Follow-up|6|||
161704118|NCT03595280|583963794|FG001|Overall Study|Lost to Follow-up|9|||
161704119|NCT03595280|583963795|FG002|Overall Study|Lost to Follow-up|15|||
161704120|NCT01512264|583963796|FG000|Overall Study|Lost to Follow-up|0|||
161704121|NCT01512264|583963797|FG001|Overall Study|Lost to Follow-up|0|||
161704122|NCT01512264|583963798|FG002|Overall Study|Lost to Follow-up|0|||
161704123|NCT01512264|583963799|FG003|Overall Study|Lost to Follow-up|1|||
161704124|NCT01931059|583963800|FG000|Day 1|Pregnancy|0|||
161704125|NCT01931059|583963801|FG001|Day 1|Pregnancy|1|||
161704126|NCT01931059|583963800|FG000|Day3|Lost to Follow-up|1|||
161704127|NCT01931059|583963801|FG001|Day3|Lost to Follow-up|0|||
161704128|NCT02675075|583963811|FG000|Overall Study|Lost to Follow-up|3|||
161704129|NCT02675075|583963812|FG001|Overall Study|Lost to Follow-up|0|||
161704130|NCT02292212|583963813|FG000|ViE Phase|Withdrawal by Subject|1|||
161704131|NCT02292212|583963813|FG000|ViE Phase|Protocol Violation|2|||
161704132|NCT04957290|583963814|FG000|Overall Study|Progressive disease|3|||
161704133|NCT04957290|583963815|FG001|Overall Study|Progressive disease|3|||
161704134|NCT04957290|583963816|FG002|Overall Study|Progressive disease|2|||
161704135|NCT04957290|583963817|FG003|Overall Study|Progressive disease|0|||
161704136|NCT04957290|583963818|FG004|Overall Study|Progressive disease|0|||
161704137|NCT04957290|583963819|FG005|Overall Study|Progressive disease|0|||
161704138|NCT04957290|583963814|FG000|Overall Study|Withdrawal by Subject|1|||
161704139|NCT04957290|583963815|FG001|Overall Study|Withdrawal by Subject|0|||
161704140|NCT04957290|583963816|FG002|Overall Study|Withdrawal by Subject|1|||
161704141|NCT04957290|583963817|FG003|Overall Study|Withdrawal by Subject|0|||
161704142|NCT04957290|583963818|FG004|Overall Study|Withdrawal by Subject|0|||
161704143|NCT04957290|583963819|FG005|Overall Study|Withdrawal by Subject|0|||
161704144|NCT04957290|583963814|FG000|Overall Study|Death|0|||
161704145|NCT04957290|583963815|FG001|Overall Study|Death|2|||
161704146|NCT04957290|583963816|FG002|Overall Study|Death|1|||
161704147|NCT04957290|583963817|FG003|Overall Study|Death|0|||
161704148|NCT04957290|583963818|FG004|Overall Study|Death|0|||
161704149|NCT04957290|583963819|FG005|Overall Study|Death|0|||
161704150|NCT04957290|583963814|FG000|Overall Study|non compliance with study drug|0|||
161704151|NCT04957290|583963815|FG001|Overall Study|non compliance with study drug|1|||
161704152|NCT04957290|583963816|FG002|Overall Study|non compliance with study drug|0|||
161704153|NCT04957290|583963817|FG003|Overall Study|non compliance with study drug|0|||
161704154|NCT04957290|583963818|FG004|Overall Study|non compliance with study drug|0|||
161704155|NCT04957290|583963819|FG005|Overall Study|non compliance with study drug|0|||
161704156|NCT04957290|583963814|FG000|Overall Study|none specified.|0|||
161704157|NCT04957290|583963815|FG001|Overall Study|none specified.|1|||
161704158|NCT04957290|583963816|FG002|Overall Study|none specified.|2|||
161704159|NCT04957290|583963817|FG003|Overall Study|none specified.|0|||
161704160|NCT04957290|583963818|FG004|Overall Study|none specified.|0|||
161704161|NCT04957290|583963819|FG005|Overall Study|none specified.|0|||
161704162|NCT04957290|583963814|FG000|Overall Study|unacceptable toxicity|0|||
161704163|NCT04957290|583963815|FG001|Overall Study|unacceptable toxicity|0|||
161704164|NCT04957290|583963816|FG002|Overall Study|unacceptable toxicity|1|||
161704165|NCT04957290|583963817|FG003|Overall Study|unacceptable toxicity|0|||
161704166|NCT04957290|583963818|FG004|Overall Study|unacceptable toxicity|0|||
161704167|NCT04957290|583963819|FG005|Overall Study|unacceptable toxicity|0|||
161704168|NCT04957290|583963814|FG000|Overall Study|Adverse Event|0|||
161704169|NCT04957290|583963815|FG001|Overall Study|Adverse Event|0|||
161704170|NCT04957290|583963816|FG002|Overall Study|Adverse Event|1|||
161837209|NCT01765582|584446566|FG001|Overall Study|Lost to Follow-up|2|||
161957851|NCT05396014|584892631|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957852|NCT05396014|584892632|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957853|NCT05396014|584892633|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957854|NCT05396014|584892634|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957855|NCT05396014|584892635|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161704171|NCT04957290|583963817|FG003|Overall Study|Adverse Event|0|||
161704172|NCT04957290|583963818|FG004|Overall Study|Adverse Event|0|||
161704173|NCT04957290|583963819|FG005|Overall Study|Adverse Event|0|||
161704174|NCT04957290|583963814|FG000|Overall Study|study terminated by sponsor|0|||
161957856|NCT05396014|584892636|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161704175|NCT04957290|583963815|FG001|Overall Study|study terminated by sponsor|0|||
161704176|NCT04957290|583963816|FG002|Overall Study|study terminated by sponsor|2|||
161704177|NCT04957290|583963817|FG003|Overall Study|study terminated by sponsor|0|||
161704178|NCT04957290|583963818|FG004|Overall Study|study terminated by sponsor|0|||
161704179|NCT04957290|583963819|FG005|Overall Study|study terminated by sponsor|0|||
161704180|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704181|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704182|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704183|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
161704184|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704185|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
161704186|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704187|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704188|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704189|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704190|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704191|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704192|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704193|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704194|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704195|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704196|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704197|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704198|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704199|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704200|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704201|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704202|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161704203|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161704204|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
161704205|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161704206|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
161704207|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161704208|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161704209|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161704210|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704211|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704212|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704213|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704214|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704215|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704216|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704217|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704218|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704219|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704220|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704221|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704222|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704223|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704224|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704225|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161704226|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
161704227|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
161704228|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
161704229|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
161704230|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
161704231|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
161957857|NCT05396014|584892637|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957858|NCT05396014|584892638|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957859|NCT05396014|584892639|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957860|NCT05396014|584892640|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957861|NCT05396014|584892641|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957862|NCT05396014|584892642|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
161957863|NCT05396014|584892643|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957864|NCT05396014|584892644|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957865|NCT05396014|584892645|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
162030847|NCT02048241|585169494|FG000|Overall Study|Withdrawal by Subject|0|||
162030848|NCT02048241|585169495|FG001|Overall Study|Withdrawal by Subject|1|||
161704232|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
161957866|NCT05396014|584892646|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957867|NCT05396014|584892647|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957868|NCT05396014|584892648|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957869|NCT05396014|584892649|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957870|NCT05396014|584892650|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161704233|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
161704234|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704235|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704236|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704237|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704238|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704239|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704240|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704241|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704242|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704243|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704244|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704245|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704246|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704247|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704248|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161704249|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704250|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704251|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
161704252|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704253|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
161704254|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704255|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704256|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704257|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704258|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704259|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704260|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704261|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704262|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704263|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161837210|NCT01765582|584446567|FG002|Overall Study|Lost to Follow-up|1|||
161837211|NCT01765582|584446565|FG000|Overall Study|Death|31|||
161837212|NCT01765582|584446566|FG001|Overall Study|Death|36|||
161837213|NCT01765582|584446567|FG002|Overall Study|Death|33|||
161837214|NCT01765582|584446565|FG000|Overall Study|Sponsor Decision|46|||
161837215|NCT01765582|584446566|FG001|Overall Study|Sponsor Decision|42|||
161837216|NCT01765582|584446567|FG002|Overall Study|Sponsor Decision|42|||
161837217|NCT01765582|584446565|FG000|Overall Study|Withdrawal of Consent|11|||
161837218|NCT01765582|584446566|FG001|Overall Study|Withdrawal of Consent|6|||
161837219|NCT01765582|584446567|FG002|Overall Study|Withdrawal of Consent|10|||
161837220|NCT03251963|584446570|FG000|Overall Study|inappropriate Xa level timing|6|||
161837221|NCT03251963|584446571|FG001|Overall Study|inappropriate Xa level timing|3|||
161837222|NCT03251963|584446570|FG000|Overall Study|no peak Xa level drawn|2|||
161837223|NCT03251963|584446571|FG001|Overall Study|no peak Xa level drawn|0|||
161837224|NCT03251963|584446570|FG000|Overall Study|bled prior to Xa level|1|||
161837225|NCT03251963|584446571|FG001|Overall Study|bled prior to Xa level|2|||
161837226|NCT00714493|584446579|FG000|Overall Study|Adverse Event|11|||
161837227|NCT00714493|584446579|FG000|Overall Study|Death|3|||
161837228|NCT00714493|584446579|FG000|Overall Study|Lack of Efficacy|10|||
161837229|NCT00714493|584446579|FG000|Overall Study|Lost to Follow-up|3|||
161957871|NCT05396014|584892651|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957872|NCT05396014|584892652|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957873|NCT05396014|584892653|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
162030849|NCT00534313|585169496|FG000|Short-term Period|Adverse Event|1|||
161704264|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704265|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704266|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704267|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704268|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704269|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704270|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704271|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161704272|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
161704273|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161957874|NCT05396014|584892654|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161704274|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704275|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
161704276|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704277|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704278|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704279|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704280|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704281|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704282|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704283|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704284|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704285|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704286|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704287|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704288|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704289|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704290|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704291|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704292|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704293|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704294|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161704295|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704296|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704297|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
161704298|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704299|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704300|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704301|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704302|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704303|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704304|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704305|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704306|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704307|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704308|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704309|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704310|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704311|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704312|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704313|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704314|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704315|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161957875|NCT05396014|584892655|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957876|NCT05396014|584892656|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161704316|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704317|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161704318|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161957877|NCT05396014|584892657|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957878|NCT05396014|584892658|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957879|NCT05396014|584892659|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957880|NCT05396014|584892660|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957881|NCT05396014|584892661|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957882|NCT05396014|584892662|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957883|NCT05396014|584892663|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957884|NCT05396014|584892664|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957885|NCT05396014|584892665|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957886|NCT05396014|584892666|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957887|NCT05396014|584892667|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957888|NCT05396014|584892668|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957889|NCT05396014|584892669|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957890|NCT05396014|584892670|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957891|NCT05396014|584892671|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161957892|NCT05396014|584892629|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957893|NCT05396014|584892630|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957894|NCT05396014|584892631|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957895|NCT05396014|584892632|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
161957896|NCT05396014|584892633|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957897|NCT05396014|584892634|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161957898|NCT05396014|584892635|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161957899|NCT05396014|584892636|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957900|NCT05396014|584892637|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
161957901|NCT05396014|584892638|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161957902|NCT05396014|584892639|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957903|NCT05396014|584892640|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957904|NCT05396014|584892641|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957905|NCT05396014|584892642|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957906|NCT05396014|584892643|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957907|NCT05396014|584892644|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161957908|NCT05396014|584892645|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957909|NCT05396014|584892646|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161704319|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704320|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
161704321|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704322|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704323|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704324|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704325|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704326|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704327|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704328|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704329|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704330|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704331|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704332|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704333|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704334|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704335|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704336|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704337|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704338|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704339|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704340|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161704341|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704342|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704343|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704344|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
161704345|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704346|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704347|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704348|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704349|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161957910|NCT05396014|584892647|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957911|NCT05396014|584892648|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161704350|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161837230|NCT00714493|584446579|FG000|Overall Study|Protocol Violation|12|||
161957912|NCT05396014|584892649|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957913|NCT05396014|584892650|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957914|NCT05396014|584892651|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161957915|NCT05396014|584892652|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161957916|NCT05396014|584892653|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161957917|NCT05396014|584892654|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
161957918|NCT05396014|584892655|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957919|NCT05396014|584892656|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957920|NCT05396014|584892657|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957921|NCT05396014|584892658|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957922|NCT05396014|584892659|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161957923|NCT05396014|584892660|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
162030850|NCT00534313|585169497|FG001|Short-term Period|Adverse Event|2|||
162030851|NCT00534313|585169498|FG002|Short-term Period|Adverse Event|1|||
161704351|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704352|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704353|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704354|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704355|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704356|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704357|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704358|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704359|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704360|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704361|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704362|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704363|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161704364|NCT00896532|583963820|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704365|NCT00896532|583963821|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
161704366|NCT00896532|583963822|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704367|NCT00896532|583963823|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
161704368|NCT00896532|583963824|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
161704369|NCT00896532|583963825|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704370|NCT00896532|583963826|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704371|NCT00896532|583963827|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704372|NCT00896532|583963828|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704373|NCT00896532|583963829|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704374|NCT00896532|583963830|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704375|NCT00896532|583963831|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704376|NCT00896532|583963832|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704377|NCT00896532|583963833|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704378|NCT00896532|583963834|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704379|NCT00896532|583963835|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704380|NCT00896532|583963836|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704381|NCT00896532|583963837|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704382|NCT00896532|583963838|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704383|NCT00896532|583963839|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704384|NCT00896532|583963840|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704385|NCT00896532|583963841|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704386|NCT00896532|583963842|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161704387|NCT00896532|583963820|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704388|NCT00896532|583963821|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704389|NCT00896532|583963822|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704390|NCT00896532|583963823|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704391|NCT00896532|583963824|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704392|NCT00896532|583963825|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704393|NCT00896532|583963826|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704394|NCT00896532|583963827|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704395|NCT00896532|583963828|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
161704396|NCT00896532|583963829|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704397|NCT00896532|583963830|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704398|NCT00896532|583963831|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704399|NCT00896532|583963832|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704400|NCT00896532|583963833|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704401|NCT00896532|583963834|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704402|NCT00896532|583963835|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704403|NCT00896532|583963836|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704404|NCT00896532|583963837|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704405|NCT00896532|583963838|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704406|NCT00896532|583963839|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704407|NCT00896532|583963840|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704408|NCT00896532|583963841|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704409|NCT00896532|583963842|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161704410|NCT00896532|583963820|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161837231|NCT00714493|584446579|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
161837232|NCT00714493|584446579|FG000|Overall Study|OTHER|2|||
161957924|NCT05396014|584892661|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957925|NCT05396014|584892662|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161704411|NCT00896532|583963821|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704412|NCT00896532|583963822|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704413|NCT00896532|583963823|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704414|NCT00896532|583963824|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704415|NCT00896532|583963825|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704416|NCT00896532|583963826|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704417|NCT00896532|583963827|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704418|NCT00896532|583963828|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704419|NCT00896532|583963829|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704420|NCT00896532|583963830|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704421|NCT00896532|583963831|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704422|NCT00896532|583963832|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
161704423|NCT00896532|583963833|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704424|NCT00896532|583963834|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704425|NCT00896532|583963835|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704426|NCT00896532|583963836|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704427|NCT00896532|583963837|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704428|NCT00896532|583963838|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704429|NCT00896532|583963839|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704430|NCT00896532|583963840|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704431|NCT00896532|583963841|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704432|NCT00896532|583963842|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161704433|NCT00896532|583963820|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704434|NCT00896532|583963821|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704435|NCT00896532|583963822|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704436|NCT00896532|583963823|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704437|NCT00896532|583963824|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704438|NCT00896532|583963825|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704439|NCT00896532|583963826|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704440|NCT00896532|583963827|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704441|NCT00896532|583963828|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704442|NCT00896532|583963829|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704443|NCT00896532|583963830|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
161704444|NCT00896532|583963831|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704445|NCT00896532|583963832|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
161704446|NCT00896532|583963833|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704447|NCT00896532|583963834|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704448|NCT00896532|583963835|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704449|NCT00896532|583963836|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704450|NCT00896532|583963837|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704451|NCT00896532|583963838|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704452|NCT00896532|583963839|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704453|NCT00896532|583963840|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704454|NCT00896532|583963841|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704455|NCT00896532|583963842|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161704456|NCT00896532|583963820|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704457|NCT00896532|583963821|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704458|NCT00896532|583963822|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704459|NCT00896532|583963823|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704460|NCT00896532|583963824|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704461|NCT00896532|583963825|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704462|NCT00896532|583963826|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704463|NCT00896532|583963827|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704464|NCT00896532|583963828|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161957926|NCT05396014|584892663|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161957927|NCT05396014|584892664|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957928|NCT05396014|584892665|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957929|NCT05396014|584892666|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957930|NCT05396014|584892667|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
161957931|NCT05396014|584892668|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
162030852|NCT00534313|585169499|FG003|Short-term Period|Adverse Event|3|||
161704465|NCT00896532|583963829|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704466|NCT00896532|583963830|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704467|NCT00896532|583963831|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704468|NCT00896532|583963832|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
161704469|NCT00896532|583963833|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
161704470|NCT00896532|583963834|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704471|NCT00896532|583963835|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704472|NCT00896532|583963836|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704473|NCT00896532|583963837|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704474|NCT00896532|583963838|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704475|NCT00896532|583963839|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704476|NCT00896532|583963840|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704477|NCT00896532|583963841|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704478|NCT00896532|583963842|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161704479|NCT00896532|583963820|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
161704480|NCT00896532|583963821|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
161704481|NCT00896532|583963822|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
161704482|NCT00896532|583963823|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
161704483|NCT00896532|583963824|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
161704484|NCT00896532|583963825|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
161704485|NCT00896532|583963826|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
161704486|NCT00896532|583963827|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
161704487|NCT00896532|583963828|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
161704488|NCT00896532|583963829|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
161704489|NCT00896532|583963830|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
161704490|NCT00896532|583963831|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
161704491|NCT00896532|583963832|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
161704492|NCT00896532|583963833|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
161704493|NCT00896532|583963834|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
161704494|NCT00896532|583963835|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
161704495|NCT00896532|583963836|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
161704496|NCT00896532|583963837|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
161704497|NCT00896532|583963838|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
161704498|NCT00896532|583963839|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
161704499|NCT00896532|583963840|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
161704500|NCT00896532|583963841|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
161704501|NCT00896532|583963842|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
161704502|NCT00896532|583963820|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704503|NCT00896532|583963821|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704504|NCT00896532|583963822|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704505|NCT00896532|583963823|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704506|NCT00896532|583963824|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704507|NCT00896532|583963825|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704508|NCT00896532|583963826|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704509|NCT00896532|583963827|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704510|NCT00896532|583963828|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704511|NCT00896532|583963829|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704512|NCT00896532|583963830|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704513|NCT00896532|583963831|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704514|NCT00896532|583963832|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704515|NCT00896532|583963833|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704516|NCT00896532|583963834|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704517|NCT00896532|583963835|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
161704518|NCT00896532|583963836|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
161704519|NCT00896532|583963837|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704520|NCT00896532|583963838|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704521|NCT00896532|583963839|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704522|NCT00896532|583963840|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704523|NCT00896532|583963841|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704524|NCT00896532|583963842|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161704525|NCT00896532|583963820|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704526|NCT00896532|583963821|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704527|NCT00896532|583963822|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704528|NCT00896532|583963823|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704529|NCT00896532|583963824|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704530|NCT00896532|583963825|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704531|NCT00896532|583963826|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704532|NCT00896532|583963827|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704533|NCT00896532|583963828|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704534|NCT00896532|583963829|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704535|NCT00896532|583963830|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704536|NCT00896532|583963831|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704537|NCT00896532|583963832|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704538|NCT00896532|583963833|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704539|NCT00896532|583963834|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704540|NCT00896532|583963835|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
161704541|NCT00896532|583963836|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
161704542|NCT00896532|583963837|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
161704543|NCT00896532|583963838|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704544|NCT00896532|583963839|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704545|NCT00896532|583963840|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704546|NCT00896532|583963841|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704547|NCT00896532|583963842|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161704548|NCT00896532|583963820|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704549|NCT00896532|583963821|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704550|NCT00896532|583963822|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704551|NCT00896532|583963823|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704552|NCT00896532|583963824|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704553|NCT00896532|583963825|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704554|NCT00896532|583963826|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704555|NCT00896532|583963827|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704556|NCT00896532|583963828|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704557|NCT00896532|583963829|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704558|NCT00896532|583963830|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704559|NCT00896532|583963831|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704560|NCT00896532|583963832|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704561|NCT00896532|583963833|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704562|NCT00896532|583963834|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704563|NCT00896532|583963835|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704564|NCT00896532|583963836|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
161704565|NCT00896532|583963837|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704566|NCT00896532|583963838|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704567|NCT00896532|583963839|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704568|NCT00896532|583963840|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704569|NCT00896532|583963841|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704570|NCT00896532|583963842|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161704571|NCT00896532|583963820|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
161704572|NCT00896532|583963821|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
161704573|NCT00896532|583963822|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
161704574|NCT00896532|583963823|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
161704575|NCT00896532|583963824|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
161704576|NCT00896532|583963825|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
161704577|NCT00896532|583963826|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
161704578|NCT00896532|583963827|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
161704579|NCT00896532|583963828|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
161704580|NCT00896532|583963829|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
161704581|NCT00896532|583963830|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
161704582|NCT00896532|583963831|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
161704583|NCT00896532|583963832|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
161704584|NCT00896532|583963833|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
161704585|NCT00896532|583963834|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
161704586|NCT00896532|583963835|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
161704587|NCT00896532|583963836|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
161704588|NCT00896532|583963837|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
161704589|NCT00896532|583963838|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
161704590|NCT00896532|583963839|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
161704591|NCT00896532|583963840|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
161837233|NCT00354341|584446582|FG000|Overall Study|Adverse Event|1|||
161957932|NCT05396014|584892669|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
161957933|NCT05396014|584892670|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
161957934|NCT05396014|584892671|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
161957935|NCT05396014|584892629|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161704592|NCT00896532|583963841|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
161704593|NCT00896532|583963842|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
161704594|NCT00896532|583963820|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704595|NCT00896532|583963821|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704596|NCT00896532|583963822|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704597|NCT00896532|583963823|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704598|NCT00896532|583963824|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704599|NCT00896532|583963825|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704600|NCT00896532|583963826|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704601|NCT00896532|583963827|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704602|NCT00896532|583963828|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704603|NCT00896532|583963829|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704604|NCT00896532|583963830|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704605|NCT00896532|583963831|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704606|NCT00896532|583963832|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704607|NCT00896532|583963833|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704608|NCT00896532|583963834|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704609|NCT00896532|583963835|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704610|NCT00896532|583963836|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
161704611|NCT00896532|583963837|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704612|NCT00896532|583963838|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704613|NCT00896532|583963839|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704614|NCT00896532|583963840|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704615|NCT00896532|583963841|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704616|NCT00896532|583963842|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161704617|NCT00896532|583963820|FG000|Months 48-72: Follow-on Phase|Death|0|||
161704618|NCT00896532|583963821|FG001|Months 48-72: Follow-on Phase|Death|0|||
161704619|NCT00896532|583963822|FG002|Months 48-72: Follow-on Phase|Death|0|||
161704620|NCT00896532|583963823|FG003|Months 48-72: Follow-on Phase|Death|0|||
161704621|NCT00896532|583963824|FG004|Months 48-72: Follow-on Phase|Death|0|||
161704622|NCT00896532|583963825|FG005|Months 48-72: Follow-on Phase|Death|0|||
161704623|NCT00896532|583963826|FG006|Months 48-72: Follow-on Phase|Death|0|||
161704624|NCT00896532|583963827|FG007|Months 48-72: Follow-on Phase|Death|0|||
161704625|NCT00896532|583963828|FG008|Months 48-72: Follow-on Phase|Death|0|||
161704626|NCT00896532|583963829|FG009|Months 48-72: Follow-on Phase|Death|0|||
161704627|NCT00896532|583963830|FG010|Months 48-72: Follow-on Phase|Death|0|||
161704628|NCT00896532|583963831|FG011|Months 48-72: Follow-on Phase|Death|0|||
161704629|NCT00896532|583963832|FG012|Months 48-72: Follow-on Phase|Death|0|||
161704630|NCT00896532|583963833|FG013|Months 48-72: Follow-on Phase|Death|0|||
161704631|NCT00896532|583963834|FG014|Months 48-72: Follow-on Phase|Death|0|||
161704632|NCT00896532|583963835|FG015|Months 48-72: Follow-on Phase|Death|0|||
161704633|NCT00896532|583963836|FG016|Months 48-72: Follow-on Phase|Death|0|||
161704634|NCT00896532|583963837|FG017|Months 48-72: Follow-on Phase|Death|0|||
161704635|NCT00896532|583963838|FG018|Months 48-72: Follow-on Phase|Death|1|||
161704636|NCT00896532|583963839|FG019|Months 48-72: Follow-on Phase|Death|0|||
161704637|NCT00896532|583963840|FG020|Months 48-72: Follow-on Phase|Death|0|||
161704638|NCT00896532|583963841|FG021|Months 48-72: Follow-on Phase|Death|0|||
161704639|NCT00896532|583963842|FG022|Months 48-72: Follow-on Phase|Death|0|||
161704640|NCT00896532|583963820|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704641|NCT00896532|583963821|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704642|NCT00896532|583963822|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704643|NCT00896532|583963823|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704644|NCT00896532|583963824|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704645|NCT00896532|583963825|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704646|NCT00896532|583963826|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704647|NCT00896532|583963827|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704648|NCT00896532|583963828|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704649|NCT00896532|583963829|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704650|NCT00896532|583963830|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704651|NCT00896532|583963831|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704652|NCT00896532|583963832|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704653|NCT00896532|583963833|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704654|NCT00896532|583963834|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704655|NCT00896532|583963835|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704656|NCT00896532|583963836|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704657|NCT00896532|583963837|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704658|NCT00896532|583963838|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704659|NCT00896532|583963839|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704660|NCT00896532|583963840|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704661|NCT00896532|583963841|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
161957936|NCT05396014|584892630|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957937|NCT05396014|584892631|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957938|NCT05396014|584892632|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957939|NCT05396014|584892633|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161704662|NCT00896532|583963842|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161704663|NCT00896532|583963820|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704664|NCT00896532|583963821|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161957940|NCT05396014|584892634|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957941|NCT05396014|584892635|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957942|NCT05396014|584892636|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957943|NCT05396014|584892637|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
161957944|NCT05396014|584892638|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957945|NCT05396014|584892639|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957946|NCT05396014|584892640|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957947|NCT05396014|584892641|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957948|NCT05396014|584892642|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957949|NCT05396014|584892643|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957950|NCT05396014|584892644|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957951|NCT05396014|584892645|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957952|NCT05396014|584892646|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957953|NCT05396014|584892647|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957954|NCT05396014|584892648|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957955|NCT05396014|584892649|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957956|NCT05396014|584892650|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957957|NCT05396014|584892651|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
161957958|NCT05396014|584892652|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957959|NCT05396014|584892653|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957960|NCT05396014|584892654|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957961|NCT05396014|584892655|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957962|NCT05396014|584892656|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957963|NCT05396014|584892657|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957964|NCT05396014|584892658|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957965|NCT05396014|584892659|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957966|NCT05396014|584892660|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957967|NCT05396014|584892661|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957968|NCT05396014|584892662|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957969|NCT05396014|584892663|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957970|NCT05396014|584892664|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
161957971|NCT05396014|584892665|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957972|NCT05396014|584892666|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957973|NCT05396014|584892667|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957974|NCT05396014|584892668|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
161957975|NCT05396014|584892669|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957976|NCT05396014|584892670|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
161704665|NCT00896532|583963822|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161957977|NCT05396014|584892671|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
161957978|NCT05396014|584892629|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957979|NCT05396014|584892630|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161704666|NCT00896532|583963823|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704667|NCT00896532|583963824|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704668|NCT00896532|583963825|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704669|NCT00896532|583963826|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704670|NCT00896532|583963827|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704671|NCT00896532|583963828|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704672|NCT00896532|583963829|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704673|NCT00896532|583963830|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704674|NCT00896532|583963831|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704675|NCT00896532|583963832|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704676|NCT00896532|583963833|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704677|NCT00896532|583963834|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704678|NCT00896532|583963835|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704679|NCT00896532|583963836|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704680|NCT00896532|583963837|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704681|NCT00896532|583963838|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704682|NCT00896532|583963839|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704683|NCT00896532|583963840|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704684|NCT00896532|583963841|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
161704685|NCT00896532|583963842|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161704686|NCT01176916|583963843|FG000|Overall Study|Adverse Event|61|||
161704687|NCT01176916|583963843|FG000|Overall Study|Death|1|||
161704688|NCT01176916|583963843|FG000|Overall Study|Lost to Follow-up|15|||
161704689|NCT01176916|583963843|FG000|Overall Study|Objective progression or relapse|17|||
161704690|NCT01176916|583963843|FG000|Overall Study|Protocol Violation|24|||
161704691|NCT01176916|583963843|FG000|Overall Study|Withdrawal by Subject|37|||
161704692|NCT01176916|583963843|FG000|Overall Study|Other|6|||
161704693|NCT01176916|583963843|FG000|Overall Study|Withdrawal prior to Treatment|6|||
161704694|NCT03158220|583963846|FG000|Overall Study|Screen Failure|0|||
161704695|NCT03158220|583963847|FG001|Overall Study|Screen Failure|1|||
161704696|NCT03158220|583963846|FG000|Overall Study|Withdrawal by Subject|8|||
161704697|NCT03158220|583963847|FG001|Overall Study|Withdrawal by Subject|9|||
161704698|NCT03158220|583963846|FG000|Overall Study|Status unknown|0|||
161704699|NCT03158220|583963847|FG001|Overall Study|Status unknown|1|||
161704700|NCT03158220|583963846|FG000|Overall Study|Lost to Follow-up|8|||
161704701|NCT03158220|583963847|FG001|Overall Study|Lost to Follow-up|5|||
161704702|NCT03158220|583963846|FG000|Overall Study|Physician Decision|1|||
161704703|NCT03158220|583963847|FG001|Overall Study|Physician Decision|0|||
161704704|NCT01961115|583963860|FG000|Overall Study|Disease Progression|1|||
161704705|NCT01961115|583963861|FG001|Overall Study|Disease Progression|0|||
161704706|NCT01961115|583963862|FG002|Overall Study|Disease Progression|3|||
161704707|NCT01961115|583963860|FG000|Overall Study|Adverse Event|1|||
161704708|NCT01961115|583963861|FG001|Overall Study|Adverse Event|0|||
161704709|NCT01961115|583963862|FG002|Overall Study|Adverse Event|1|||
161704710|NCT03887130|583963866|FG000|Overall Study|Progressive disease|23|||
161704711|NCT03887130|583963867|FG001|Overall Study|Progressive disease|14|||
161704712|NCT03887130|583963868|FG002|Overall Study|Progressive disease|7|||
161704713|NCT03887130|583963866|FG000|Overall Study|Protocol Violation|3|||
161704714|NCT03887130|583963867|FG001|Overall Study|Protocol Violation|1|||
161704715|NCT03887130|583963868|FG002|Overall Study|Protocol Violation|2|||
161957980|NCT05396014|584892631|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957981|NCT05396014|584892632|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161704716|NCT03887130|583963866|FG000|Overall Study|Drug related toxicity|7|||
161704717|NCT03887130|583963867|FG001|Overall Study|Drug related toxicity|7|||
161704718|NCT03887130|583963868|FG002|Overall Study|Drug related toxicity|13|||
161957982|NCT05396014|584892633|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957983|NCT05396014|584892634|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957984|NCT05396014|584892635|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161704719|NCT03887130|583963866|FG000|Overall Study|Non drug related toxicity|3|||
161704720|NCT03887130|583963867|FG001|Overall Study|Non drug related toxicity|0|||
161704721|NCT03887130|583963868|FG002|Overall Study|Non drug related toxicity|0|||
161704722|NCT03887130|583963866|FG000|Overall Study|Death|2|||
161704723|NCT03887130|583963867|FG001|Overall Study|Death|2|||
161704724|NCT03887130|583963868|FG002|Overall Study|Death|1|||
161704725|NCT03887130|583963866|FG000|Overall Study|Withdrawal by Subject|7|||
161704726|NCT03887130|583963867|FG001|Overall Study|Withdrawal by Subject|6|||
161704727|NCT03887130|583963868|FG002|Overall Study|Withdrawal by Subject|11|||
161704728|NCT03887130|583963866|FG000|Overall Study|other reason|6|||
161704729|NCT03887130|583963867|FG001|Overall Study|other reason|20|||
161704730|NCT03887130|583963868|FG002|Overall Study|other reason|17|||
161957985|NCT05396014|584892636|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161704731|NCT01439945|583963869|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
161704732|NCT01439945|583963870|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
161704733|NCT01439945|583963871|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
161704734|NCT01439945|583963872|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
161704735|NCT01439945|583963869|FG000|Double-Blind Treatment Phase|Ineligible|1|||
161704736|NCT01439945|583963870|FG001|Double-Blind Treatment Phase|Ineligible|2|||
161704737|NCT01439945|583963871|FG002|Double-Blind Treatment Phase|Ineligible|0|||
161704738|NCT01439945|583963872|FG003|Double-Blind Treatment Phase|Ineligible|1|||
161704739|NCT04082663|583963873|FG000|Overall Study|Adverse Event|6|||
161704740|NCT04082663|583963873|FG000|Overall Study|Lost to Follow-up|1|||
161704741|NCT00705263|583963876|FG000|Overall Study|Withdrawal by Subject|2|||
161704742|NCT01752023|583963877|FG000|Overall Study|Physician Decision|2|||
161704743|NCT01752023|583963878|FG001|Overall Study|Physician Decision|1|||
161704744|NCT02542072|583963879|FG000|First Intervention (1 Month)|Adverse Event|1|||
161704745|NCT02542072|583963880|FG001|First Intervention (1 Month)|Adverse Event|1|||
161704746|NCT02542072|583963879|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
161704747|NCT02542072|583963880|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
161704748|NCT02542072|583963879|FG000|First Intervention (1 Month)|Lens discomfort|1|||
161704749|NCT02542072|583963880|FG001|First Intervention (1 Month)|Lens discomfort|2|||
161704750|NCT02542072|583963879|FG000|First Intervention (1 Month)|Protocol Violation|1|||
161704751|NCT02542072|583963880|FG001|First Intervention (1 Month)|Protocol Violation|0|||
161704752|NCT02542072|583963879|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
161704753|NCT02542072|583963880|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
161704754|NCT02542072|583963879|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
161704755|NCT02542072|583963880|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
161704756|NCT02899156|583963881|FG000|Overall Study|Death|1|||
161704757|NCT02899156|583963882|FG001|Overall Study|Death|0|||
161957986|NCT05396014|584892637|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957987|NCT05396014|584892638|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957988|NCT05396014|584892639|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957989|NCT05396014|584892640|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161704758|NCT02899156|583963881|FG000|Overall Study|Physician Decision|0|||
161704759|NCT02899156|583963882|FG001|Overall Study|Physician Decision|1|||
161704760|NCT00654498|583963883|FG000|Overall Study|Not Treated|1|||
161704761|NCT00654498|583963884|FG001|Overall Study|Not Treated|0|||
161704762|NCT00654498|583963883|FG000|Overall Study|Adverse Event|6|||
161704763|NCT00654498|583963884|FG001|Overall Study|Adverse Event|1|||
161704764|NCT00654498|583963883|FG000|Overall Study|Protocol Violation|1|||
161704765|NCT00654498|583963884|FG001|Overall Study|Protocol Violation|1|||
161704766|NCT00654498|583963883|FG000|Overall Study|Lost to Follow-up|1|||
161704767|NCT00654498|583963884|FG001|Overall Study|Lost to Follow-up|5|||
161704768|NCT00654498|583963883|FG000|Overall Study|Withdrawal by Subject|1|||
161704769|NCT00654498|583963884|FG001|Overall Study|Withdrawal by Subject|0|||
161704770|NCT00654498|583963883|FG000|Overall Study|Other reason not defined above|4|||
161704771|NCT00654498|583963884|FG001|Overall Study|Other reason not defined above|5|||
161704772|NCT01990261|583963886|FG000|Overall Study|Death Before Treatment Start|2|||
161704773|NCT01990261|583963886|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
161704774|NCT01990261|583963886|FG000|Overall Study|Death From other Causes|1|||
161704775|NCT01990261|583963886|FG000|Overall Study|Disease Progression (PD)|8|||
161704776|NCT01990261|583963886|FG000|Overall Study|PD Before Treatment Start|1|||
161704777|NCT01990261|583963886|FG000|Overall Study|Dossier not Approved|1|||
161704778|NCT01990261|583963886|FG000|Overall Study|Lost to Follow-up|2|||
161704779|NCT01078805|583963889|FG000|Overall Study|Clinically significant abnormal lab|5|||
161704780|NCT01078805|583963889|FG000|Overall Study|Death|134|||
161704781|NCT01078805|583963889|FG000|Overall Study|Lost to Follow-up|676|||
161704782|NCT01078805|583963889|FG000|Overall Study|Physician Decision|169|||
161704783|NCT01078805|583963889|FG000|Overall Study|Serious adverse event|26|||
161704784|NCT01078805|583963889|FG000|Overall Study|Sponsor decision|46|||
161704785|NCT01078805|583963889|FG000|Overall Study|Withdrawal by Subject|739|||
161704786|NCT01078805|583963889|FG000|Overall Study|Other|173|||
161704787|NCT01078805|583963889|FG000|Overall Study|Didn't take study drug|82|||
161704788|NCT01609842|583963890|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
161704789|NCT01609842|583963891|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
161837234|NCT00354341|584446583|FG001|Overall Study|Adverse Event|0|||
161837235|NCT00354341|584446582|FG000|Overall Study|Death|0|||
161704790|NCT04722991|583963892|FG000|Overall Study|Adverse Event|12|||
161704791|NCT04722991|583963893|FG001|Overall Study|Adverse Event|4|||
161704792|NCT04722991|583963892|FG000|Overall Study|Death|2|||
161704793|NCT04722991|583963893|FG001|Overall Study|Death|0|||
161704794|NCT04722991|583963892|FG000|Overall Study|Lost to Follow-up|1|||
161704795|NCT04722991|583963893|FG001|Overall Study|Lost to Follow-up|1|||
161704796|NCT04722991|583963892|FG000|Overall Study|Withdrawal cirterion met|2|||
161704797|NCT04722991|583963893|FG001|Overall Study|Withdrawal cirterion met|2|||
161704798|NCT04722991|583963892|FG000|Overall Study|Other|1|||
161704799|NCT04722991|583963893|FG001|Overall Study|Other|0|||
161704800|NCT04722991|583963892|FG000|Overall Study|Non-compliance|0|||
161957990|NCT05396014|584892641|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957991|NCT05396014|584892642|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
161957992|NCT05396014|584892643|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957993|NCT05396014|584892644|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957994|NCT05396014|584892645|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957995|NCT05396014|584892646|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957996|NCT05396014|584892647|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957997|NCT05396014|584892648|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957998|NCT05396014|584892649|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161957999|NCT05396014|584892650|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958000|NCT05396014|584892651|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958001|NCT05396014|584892652|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958002|NCT05396014|584892653|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958003|NCT05396014|584892654|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958004|NCT05396014|584892655|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
161958005|NCT05396014|584892656|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958006|NCT05396014|584892657|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958007|NCT05396014|584892658|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958008|NCT05396014|584892659|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958009|NCT05396014|584892660|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958010|NCT05396014|584892661|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958011|NCT05396014|584892662|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958012|NCT05396014|584892663|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
161958013|NCT05396014|584892664|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958014|NCT05396014|584892665|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958015|NCT05396014|584892666|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958016|NCT05396014|584892667|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958017|NCT05396014|584892668|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958018|NCT05396014|584892669|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958019|NCT05396014|584892670|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
161958020|NCT05396014|584892671|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
161958021|NCT05396014|584892629|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958022|NCT05396014|584892630|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161704801|NCT04722991|583963893|FG001|Overall Study|Non-compliance|1|||
161704802|NCT04722991|583963892|FG000|Overall Study|Withdrawal by Subject|0|||
161704803|NCT04722991|583963893|FG001|Overall Study|Withdrawal by Subject|1|||
161704804|NCT03186989|583963894|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704805|NCT03186989|583963895|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704806|NCT03186989|583963896|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
161704807|NCT03186989|583963897|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
161704808|NCT03186989|583963898|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
161704809|NCT03186989|583963899|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704810|NCT03186989|583963900|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704811|NCT03186989|583963901|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704812|NCT03186989|583963902|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704813|NCT03186989|583963903|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704814|NCT03186989|583963904|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161704815|NCT03186989|583963894|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704816|NCT03186989|583963895|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704817|NCT03186989|583963896|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704818|NCT03186989|583963897|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704819|NCT03186989|583963898|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704820|NCT03186989|583963899|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
161704821|NCT03186989|583963900|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704822|NCT03186989|583963901|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704823|NCT03186989|583963902|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704824|NCT03186989|583963903|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161837236|NCT00354341|584446583|FG001|Overall Study|Death|2|||
161837237|NCT00354341|584446582|FG000|Overall Study|Refused treatment|1|||
161837238|NCT00354341|584446583|FG001|Overall Study|Refused treatment|2|||
161837239|NCT00354341|584446582|FG000|Overall Study|Failure to return|0|||
161837240|NCT00354341|584446583|FG001|Overall Study|Failure to return|1|||
161837241|NCT00354341|584446582|FG000|Overall Study|Other|1|||
161837242|NCT00354341|584446583|FG001|Overall Study|Other|2|||
161837243|NCT00251719|584446584|FG000|Overall Study|Adverse Event|14|||
161837244|NCT00251719|584446585|FG001|Overall Study|Adverse Event|8|||
161837245|NCT00251719|584446586|FG002|Overall Study|Adverse Event|7|||
161837246|NCT00251719|584446584|FG000|Overall Study|Protocol Violation|1|||
161837247|NCT00251719|584446585|FG001|Overall Study|Protocol Violation|1|||
161837248|NCT00251719|584446586|FG002|Overall Study|Protocol Violation|1|||
161837249|NCT00251719|584446584|FG000|Overall Study|Lost to Follow-up|5|||
161837250|NCT00251719|584446585|FG001|Overall Study|Lost to Follow-up|11|||
161837251|NCT00251719|584446586|FG002|Overall Study|Lost to Follow-up|8|||
161837252|NCT00251719|584446584|FG000|Overall Study|Withdrawal by Subject|14|||
161837253|NCT00251719|584446585|FG001|Overall Study|Withdrawal by Subject|12|||
161837254|NCT00251719|584446586|FG002|Overall Study|Withdrawal by Subject|11|||
161837255|NCT00251719|584446584|FG000|Overall Study|Lack of Efficacy|2|||
161837256|NCT00251719|584446585|FG001|Overall Study|Lack of Efficacy|1|||
161837257|NCT00251719|584446586|FG002|Overall Study|Lack of Efficacy|0|||
161837258|NCT00251719|584446584|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
161837259|NCT00251719|584446585|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
161837260|NCT00251719|584446586|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
161837261|NCT00251719|584446584|FG000|Overall Study|Investigator decision|1|||
161837262|NCT00251719|584446585|FG001|Overall Study|Investigator decision|1|||
161837263|NCT00251719|584446586|FG002|Overall Study|Investigator decision|0|||
161837264|NCT00251719|584446584|FG000|Overall Study|Noncompliance|2|||
161837265|NCT00251719|584446585|FG001|Overall Study|Noncompliance|3|||
161837266|NCT00251719|584446586|FG002|Overall Study|Noncompliance|1|||
161837267|NCT00251719|584446584|FG000|Overall Study|Barrett's esophagus|2|||
161837268|NCT00251719|584446585|FG001|Overall Study|Barrett's esophagus|2|||
161837269|NCT00251719|584446586|FG002|Overall Study|Barrett's esophagus|0|||
161837270|NCT01449279|584446587|FG000|Overall Study|Lack of Efficacy|5|||
161837271|NCT01449279|584446587|FG000|Overall Study|Toxicity|2|||
161837272|NCT01732874|584446589|FG000|Overall Study|Withdrawal by Subject|5|||
161837273|NCT01732874|584446590|FG001|Overall Study|Withdrawal by Subject|1|||
161837274|NCT01732874|584446589|FG000|Overall Study|Death of Infant|3|||
161837275|NCT01732874|584446590|FG001|Overall Study|Death of Infant|2|||
161837276|NCT02792959|584446591|FG000|Overall Study|Protocol Violation|1|||
161837277|NCT01249365|584446592|FG000|Overall Study|Lost to Follow-up|1|||
161837278|NCT03579966|584446593|FG000|Overall Study|Adverse Event|6|||
161837279|NCT03579966|584446593|FG000|Overall Study|Lost to Follow-up|4|||
161958023|NCT05396014|584892631|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161837280|NCT03579966|584446593|FG000|Overall Study|Physician Decision|10|||
161837281|NCT03579966|584446593|FG000|Overall Study|Pregnancy|1|||
161837282|NCT03579966|584446593|FG000|Overall Study|Withdrawal by Subject|16|||
161837283|NCT03579966|584446593|FG000|Overall Study|Study terminated by Sponsor|22|||
161837284|NCT03579966|584446593|FG000|Overall Study|Protocol Violation|1|||
161704825|NCT03186989|583963904|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161704826|NCT03186989|583963894|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704827|NCT03186989|583963895|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704828|NCT03186989|583963896|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704829|NCT03186989|583963897|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704830|NCT03186989|583963898|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704831|NCT03186989|583963899|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704832|NCT03186989|583963900|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
161704833|NCT03186989|583963901|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704834|NCT03186989|583963902|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704835|NCT03186989|583963903|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704836|NCT03186989|583963904|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161704837|NCT03186989|583963894|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704838|NCT03186989|583963895|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704839|NCT03186989|583963896|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704840|NCT03186989|583963897|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704841|NCT03186989|583963898|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704842|NCT03186989|583963899|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
161704843|NCT03186989|583963900|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
161704844|NCT03186989|583963901|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704845|NCT03186989|583963902|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
161704846|NCT03186989|583963903|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704847|NCT03186989|583963904|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161704848|NCT02246621|583963908|FG000|Overall Study|Withdrawal by Subject|28|||
161704849|NCT02246621|583963909|FG001|Overall Study|Withdrawal by Subject|16|||
161704850|NCT02246621|583963908|FG000|Overall Study|Lost to Follow-up|1|||
161704851|NCT02246621|583963909|FG001|Overall Study|Lost to Follow-up|0|||
161704852|NCT02246621|583963908|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
161704853|NCT02246621|583963909|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
161704854|NCT00821678|583963910|FG000|Overall Study|Withdrawal by Subject|8|||
161704855|NCT00821678|583963911|FG001|Overall Study|Withdrawal by Subject|0|||
161704856|NCT00821678|583963910|FG000|Overall Study|Lost to Follow-up|13|||
161704857|NCT00821678|583963911|FG001|Overall Study|Lost to Follow-up|12|||
161704858|NCT00821678|583963910|FG000|Overall Study|Death|0|||
161704859|NCT00821678|583963911|FG001|Overall Study|Death|2|||
161704860|NCT03641560|583963917|FG000|Overall Study|Withdrawal by Subject|6|||
161704861|NCT03641560|583963917|FG000|Overall Study|Progressive disease|40|||
161704862|NCT03641560|583963917|FG000|Overall Study|Death|6|||
161704863|NCT04439279|583965836|FG000|Overall Study|Adverse Event|7|||
161837285|NCT02408068|584446594|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
161837286|NCT02408068|584446595|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
161837287|NCT02408068|584446596|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
161704864|NCT04439279|583965836|FG000|Overall Study|Death|4|||
161704865|NCT04439279|583965836|FG000|Overall Study|Disease progression|17|||
161704866|NCT04439279|583965836|FG000|Overall Study|Complicating disease|3|||
161704867|NCT04439279|583965836|FG000|Overall Study|Withdrawal by Subject|2|||
161704868|NCT04439279|583965836|FG000|Overall Study|Ineligible|1|||
161704869|NCT04439279|583965836|FG000|Overall Study|Treatment still ongoing|1|||
161704870|NCT02689492|583965837|FG000|Overall Study|Lost to Follow-up|61|||
161704871|NCT02689492|583965837|FG000|Overall Study|Withdrawal by Subject|11|||
161704872|NCT02689492|583965837|FG000|Overall Study|Death|9|||
161704873|NCT02689492|583965837|FG000|Overall Study|Physician Decision|2|||
161837288|NCT02408068|584446597|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
161837289|NCT02408068|584446598|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
161837290|NCT02408068|584446599|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
161837291|NCT03484117|584446600|FG000|Overall Study|Lost to Follow-up|1|||
161837292|NCT03484117|584446601|FG001|Overall Study|Lost to Follow-up|3|||
161837293|NCT03484117|584446600|FG000|Overall Study|Declined participation in exit assess|1|||
161958024|NCT05396014|584892632|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161704874|NCT02689492|583965837|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
161704875|NCT02689492|583965837|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
161704876|NCT02689492|583965837|FG000|Overall Study|Other than listed|1|||
161704877|NCT01750918|583965838|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
161704878|NCT01750918|583965839|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
161704879|NCT01750918|583965840|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
161704880|NCT01750918|583965841|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
161704881|NCT01750918|583965842|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
161837294|NCT03484117|584446601|FG001|Overall Study|Declined participation in exit assess|1|||
161958025|NCT05396014|584892633|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161704882|NCT01750918|583965843|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
161704883|NCT01750918|583965844|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
161704884|NCT01750918|583965845|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
161704885|NCT01750918|583965838|FG000|Overall Study|Lost to Follow-up|0|||
161704886|NCT01750918|583965839|FG001|Overall Study|Lost to Follow-up|0|||
161704887|NCT01750918|583965840|FG002|Overall Study|Lost to Follow-up|2|||
161704888|NCT01750918|583965841|FG003|Overall Study|Lost to Follow-up|2|||
161704889|NCT01750918|583965842|FG004|Overall Study|Lost to Follow-up|0|||
161704890|NCT01750918|583965843|FG005|Overall Study|Lost to Follow-up|0|||
161704891|NCT01750918|583965844|FG006|Overall Study|Lost to Follow-up|0|||
161704892|NCT01750918|583965845|FG007|Overall Study|Lost to Follow-up|1|||
161704893|NCT01750918|583965838|FG000|Overall Study|Withdrawal by Subject|0|||
161704894|NCT01750918|583965839|FG001|Overall Study|Withdrawal by Subject|0|||
161704895|NCT01750918|583965840|FG002|Overall Study|Withdrawal by Subject|1|||
161704896|NCT01750918|583965841|FG003|Overall Study|Withdrawal by Subject|2|||
161704897|NCT01750918|583965842|FG004|Overall Study|Withdrawal by Subject|1|||
161704898|NCT01750918|583965843|FG005|Overall Study|Withdrawal by Subject|1|||
161704899|NCT01750918|583965844|FG006|Overall Study|Withdrawal by Subject|2|||
161704900|NCT01750918|583965845|FG007|Overall Study|Withdrawal by Subject|2|||
161704901|NCT02031679|583965848|FG000|Overall Study|Protocol Violation|0|||
161704902|NCT02031679|583965849|FG001|Overall Study|Protocol Violation|1|||
161837295|NCT03551496|584446605|FG000|Overall Study|Death|11|||
161837296|NCT03551496|584446606|FG001|Overall Study|Death|7|||
161837297|NCT03551496|584446605|FG000|Overall Study|Withdrawal by Subject|4|||
161837298|NCT03551496|584446606|FG001|Overall Study|Withdrawal by Subject|3|||
161837299|NCT03551496|584446605|FG000|Overall Study|Other Reasons|1|||
161837300|NCT03551496|584446606|FG001|Overall Study|Other Reasons|0|||
161837301|NCT02303041|584446609|FG000|Overall Study|Adverse Event|1|||
161837302|NCT02303041|584446610|FG001|Overall Study|Adverse Event|2|||
161837303|NCT00886288|584446611|FG000|Overall Study|no respect of the 12 weeks period|657|||
161837304|NCT00886288|584446612|FG001|Overall Study|no respect of the 12 weeks period|227|||
161837305|NCT00886288|584446611|FG000|Overall Study|Lost to Follow-up|86|||
161837306|NCT00886288|584446612|FG001|Overall Study|Lost to Follow-up|0|||
161837307|NCT04319718|584448506|FG000|Overall Study|Adverse Event|0|||
161837308|NCT04319718|584448507|FG001|Overall Study|Adverse Event|2|||
161837309|NCT04319718|584448506|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
161837310|NCT04319718|584448507|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
161837311|NCT02221037|584448508|FG000|Overall Study|Physician Decision|0|||
161837312|NCT02221037|584448509|FG001|Overall Study|Physician Decision|0|||
161837313|NCT02221037|584448510|FG002|Overall Study|Physician Decision|1|||
161837314|NCT02221037|584448511|FG003|Overall Study|Physician Decision|0|||
161837315|NCT01293539|584448514|FG000|Overall Study|Physician Decision|1|||
161837316|NCT00609518|584448516|FG000|Overall Study|Death from Study Disease|32|||
161837317|NCT00609518|584448517|FG001|Overall Study|Death from Study Disease|32|||
161837318|NCT00609518|584448516|FG000|Overall Study|Withdrawal by Subject|5|||
161837319|NCT00609518|584448517|FG001|Overall Study|Withdrawal by Subject|3|||
161837320|NCT00609518|584448516|FG000|Overall Study|Lost to Follow-up|3|||
161837321|NCT00609518|584448517|FG001|Overall Study|Lost to Follow-up|0|||
161837322|NCT00609518|584448516|FG000|Overall Study|Physician Decision|1|||
161837323|NCT00609518|584448517|FG001|Overall Study|Physician Decision|3|||
161837324|NCT00609518|584448516|FG000|Overall Study|Death from Adverse Event|2|||
161837325|NCT00609518|584448517|FG001|Overall Study|Death from Adverse Event|2|||
161837326|NCT04032158|584448518|FG000|Overall Study|Study Termination|2|||
161837327|NCT04032158|584448519|FG001|Overall Study|Study Termination|1|||
161837328|NCT00059787|584448520|FG000|Overall Study|Adverse Event|13|||
161837329|NCT00059787|584448520|FG000|Overall Study|disease progression|2|||
161837330|NCT00059787|584448520|FG000|Overall Study|ineligible|1|||
161837331|NCT00059787|584448520|FG000|Overall Study|Other|4|||
161837332|NCT01248013|584448523|FG000|Overall Study|Withdrawal by Subject|14|||
161837333|NCT04325204|584448526|FG000|Overall Study|Death|0|||
161837334|NCT04325204|584448527|FG001|Overall Study|Death|1|||
161837335|NCT04325204|584448526|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
161837336|NCT04325204|584448527|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
161837337|NCT04325204|584448526|FG000|Overall Study|Lost to Follow-up|8|||
161837338|NCT04325204|584448527|FG001|Overall Study|Lost to Follow-up|8|||
161704903|NCT02031679|583965848|FG000|Overall Study|Lack of Efficacy|0|||
161704904|NCT02031679|583965849|FG001|Overall Study|Lack of Efficacy|1|||
161704905|NCT02338843|583965853|FG000|Overall Study|Adverse Event|2|||
161837339|NCT04325204|584448526|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
161837340|NCT04325204|584448527|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
161704906|NCT02338843|583965854|FG001|Overall Study|Adverse Event|1|||
161704907|NCT02338843|583965853|FG000|Overall Study|Death|40|||
161704908|NCT02338843|583965854|FG001|Overall Study|Death|53|||
161704909|NCT02338843|583965853|FG000|Overall Study|Physician Decision|1|||
161704910|NCT02338843|583965854|FG001|Overall Study|Physician Decision|0|||
161704911|NCT02338843|583965853|FG000|Overall Study|Withdrawal by Subject|0|||
161704912|NCT02338843|583965854|FG001|Overall Study|Withdrawal by Subject|2|||
161704913|NCT02338843|583965853|FG000|Overall Study|Subject Recovered|0|||
161704914|NCT02338843|583965854|FG001|Overall Study|Subject Recovered|2|||
161704915|NCT02338843|583965853|FG000|Overall Study|Discontinued prior to randomizat|1|||
161704916|NCT02338843|583965854|FG001|Overall Study|Discontinued prior to randomizat|0|||
161704917|NCT00110305|583965855|FG000|Overall Study|Adverse Event|46|||
161704918|NCT00110305|583965856|FG001|Overall Study|Adverse Event|13|||
161704919|NCT00110305|583965855|FG000|Overall Study|Sponsors Decision|1|||
161704920|NCT00110305|583965856|FG001|Overall Study|Sponsors Decision|0|||
161704921|NCT00110305|583965855|FG000|Overall Study|Subject Non-Compliant|9|||
161704922|NCT00110305|583965856|FG001|Overall Study|Subject Non-Compliant|2|||
161704923|NCT00110305|583965855|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
161704924|NCT00110305|583965856|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
161704925|NCT00110305|583965855|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
161704926|NCT00110305|583965856|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
161704927|NCT00110305|583965855|FG000|Overall Study|Protocol Violation|0|||
161704928|NCT00110305|583965856|FG001|Overall Study|Protocol Violation|1|||
161704929|NCT00110305|583965855|FG000|Overall Study|Withdrawal by Subject|7|||
161704930|NCT00110305|583965856|FG001|Overall Study|Withdrawal by Subject|7|||
161704931|NCT00110305|583965855|FG000|Overall Study|Lost to Follow-up|20|||
161704932|NCT00110305|583965856|FG001|Overall Study|Lost to Follow-up|3|||
161704933|NCT00110305|583965855|FG000|Overall Study|Other|8|||
161704934|NCT00110305|583965856|FG001|Overall Study|Other|2|||
161704935|NCT00224016|583965860|FG000|Titration Period|Withdrawal by Subject|0|||
161704936|NCT00224016|583965861|FG001|Titration Period|Withdrawal by Subject|1|||
161704937|NCT00224016|583965860|FG000|Titration Period|Lost to Follow-up|1|||
161704938|NCT00224016|583965861|FG001|Titration Period|Lost to Follow-up|0|||
161704939|NCT00224016|583965860|FG000|Maintenance Period|Withdrawal by Subject|2|||
161704940|NCT00224016|583965861|FG001|Maintenance Period|Withdrawal by Subject|0|||
161704941|NCT00224016|583965860|FG000|Maintenance Period|Lost to Follow-up|0|||
161704942|NCT00224016|583965861|FG001|Maintenance Period|Lost to Follow-up|1|||
161704943|NCT01609933|583965862|FG000|Overall Study|Adverse Event|1|||
161704944|NCT01609933|583965862|FG000|Overall Study|Withdrawal by Subject|3|||
161704945|NCT01252966|583965863|FG000|Overall Study|Lost to Follow-up|16|||
161704946|NCT01252966|583965864|FG001|Overall Study|Lost to Follow-up|10|||
161704947|NCT01252966|583965863|FG000|Overall Study|Withdrawal by Subject|7|||
161704948|NCT01252966|583965864|FG001|Overall Study|Withdrawal by Subject|3|||
161704949|NCT00522392|583965888|FG000|Overall Study|Disease progression|0|||
161704950|NCT00522392|583965889|FG001|Overall Study|Disease progression|3|||
161704951|NCT00522392|583965888|FG000|Overall Study|Adverse Event|7|||
161704952|NCT00522392|583965889|FG001|Overall Study|Adverse Event|7|||
161704953|NCT00522392|583965888|FG000|Overall Study|Withdrawal by Subject|1|||
161704954|NCT00522392|583965889|FG001|Overall Study|Withdrawal by Subject|1|||
161704955|NCT00522392|583965888|FG000|Overall Study|Physician Decision|0|||
161837341|NCT00841906|584448528|FG000|Overall Study|Withdrawal by Subject|2|||
161837342|NCT00841906|584448529|FG001|Overall Study|Withdrawal by Subject|0|||
161837343|NCT04710979|584448532|FG000|Overall Study|Lost to Follow-up|2|||
161837344|NCT04710979|584448533|FG001|Overall Study|Lost to Follow-up|4|||
161837345|NCT04710979|584448532|FG000|Overall Study|Withdrawal by Subject|1|||
161837346|NCT04710979|584448533|FG001|Overall Study|Withdrawal by Subject|0|||
161837347|NCT04397445|584448541|FG000|Overall Study|Withdrawal by Subject|1|||
161837348|NCT04397445|584448542|FG001|Overall Study|Withdrawal by Subject|0|||
161837349|NCT04397445|584448543|FG002|Overall Study|Withdrawal by Subject|0|||
161837350|NCT04397445|584448544|FG003|Overall Study|Withdrawal by Subject|0|||
161837351|NCT00891371|584448545|FG000|Pre-assignment|Inclusion/exclusion|5|||
161837352|NCT00891371|584448545|FG000|Pre-assignment|Consent withdrawal|1|||
161837353|NCT00891371|584448545|FG000|Treatment|Lack of Efficacy|5|||
161837354|NCT00891371|584448545|FG000|Treatment|Adverse Event|2|||
161837355|NCT00891371|584448545|FG000|Treatment|Death|1|||
161837356|NCT00891371|584448545|FG000|Treatment|Lost to Follow-up|1|||
161837357|NCT00307034|584448546|FG000|Overall Study|Adverse Event|1|||
161837358|NCT00307034|584448547|FG001|Overall Study|Adverse Event|2|||
161704956|NCT00522392|583965889|FG001|Overall Study|Physician Decision|1|||
161704957|NCT00522392|583965888|FG000|Overall Study|Non-compliance|0|||
161704958|NCT00522392|583965889|FG001|Overall Study|Non-compliance|1|||
161704959|NCT00430755|583965892|FG000|Overall Study|Withdrawal by Subject|53|||
161704960|NCT01154101|583965893|FG000|Overall Study|Adverse Event|0|||
161704961|NCT01154101|583965894|FG001|Overall Study|Adverse Event|2|||
161837359|NCT00307034|584448546|FG000|Overall Study|Withdrawal by Subject|1|||
161837360|NCT00307034|584448547|FG001|Overall Study|Withdrawal by Subject|2|||
161837361|NCT00307034|584448546|FG000|Overall Study|Lost to Follow-up|0|||
161704962|NCT01154101|583965895|FG002|Overall Study|Adverse Event|1|||
161704963|NCT01154101|583965896|FG003|Overall Study|Adverse Event|1|||
161704964|NCT01154101|583965897|FG004|Overall Study|Adverse Event|0|||
161837362|NCT00307034|584448547|FG001|Overall Study|Lost to Follow-up|3|||
161837363|NCT02034058|584448556|FG000|Overall Study|Death|3|||
161704965|NCT01154101|583965893|FG000|Overall Study|Lost to Follow-up|0|||
161704966|NCT01154101|583965894|FG001|Overall Study|Lost to Follow-up|1|||
161704967|NCT01154101|583965895|FG002|Overall Study|Lost to Follow-up|0|||
161704968|NCT01154101|583965896|FG003|Overall Study|Lost to Follow-up|1|||
161704969|NCT01154101|583965897|FG004|Overall Study|Lost to Follow-up|0|||
161704970|NCT01154101|583965893|FG000|Overall Study|Withdrawal by Subject|0|||
161704971|NCT01154101|583965894|FG001|Overall Study|Withdrawal by Subject|1|||
161704972|NCT01154101|583965895|FG002|Overall Study|Withdrawal by Subject|2|||
161704973|NCT01154101|583965896|FG003|Overall Study|Withdrawal by Subject|0|||
161704974|NCT01154101|583965897|FG004|Overall Study|Withdrawal by Subject|1|||
161704975|NCT05019131|583965898|FG000|Overall Study|Lost to Follow-up|0|||
161704976|NCT05019131|583965899|FG001|Overall Study|Lost to Follow-up|3|||
161704977|NCT03575104|583965900|FG000|Overall Study|Adverse Event|4|||
161704978|NCT03575104|583965901|FG001|Overall Study|Adverse Event|3|||
161704979|NCT03575104|583965902|FG002|Overall Study|Adverse Event|4|||
161704980|NCT03575104|583965900|FG000|Overall Study|Withdrawal by Subject|13|||
161704981|NCT03575104|583965901|FG001|Overall Study|Withdrawal by Subject|16|||
161704982|NCT03575104|583965902|FG002|Overall Study|Withdrawal by Subject|11|||
161704983|NCT03575104|583965900|FG000|Overall Study|Other reasons|6|||
161704984|NCT03575104|583965901|FG001|Overall Study|Other reasons|8|||
161704985|NCT03575104|583965902|FG002|Overall Study|Other reasons|6|||
161704986|NCT03575104|583965900|FG000|Overall Study|Lost to Follow-up|1|||
161704987|NCT03575104|583965901|FG001|Overall Study|Lost to Follow-up|2|||
161704988|NCT03575104|583965902|FG002|Overall Study|Lost to Follow-up|1|||
161704989|NCT02360098|583965903|FG000|Overall Study|Physician Decision|7|||
161704990|NCT01919307|583965906|FG000|Overall Study|Withdrawal by Subject|9|||
161704991|NCT05052723|583965908|FG000|Overall Study|Death|19|||
161704992|NCT02771522|583965911|FG000|Overall Study|Lost to Follow-up|3|||
161704993|NCT02771522|583965911|FG000|Overall Study|Withdrawal by Subject|2|||
161704994|NCT02771522|583965911|FG000|Overall Study|No white spot lesions|3|||
161704995|NCT00556426|583965917|FG000|Overall Study|Withdrawal by Subject|3|||
161704996|NCT00556426|583965917|FG000|Overall Study|Death|6|||
161704997|NCT03049449|583965918|FG000|Overall Study|Did not receive treatment.|0|||
161704998|NCT03049449|583965919|FG001|Overall Study|Did not receive treatment.|0|||
161704999|NCT03049449|583965920|FG002|Overall Study|Did not receive treatment.|0|||
161705000|NCT03049449|583965921|FG003|Overall Study|Did not receive treatment.|0|||
161705001|NCT03049449|583965922|FG004|Overall Study|Did not receive treatment.|0|||
161705002|NCT03049449|583965923|FG005|Overall Study|Did not receive treatment.|0|||
161705003|NCT03049449|583965924|FG006|Overall Study|Did not receive treatment.|0|||
161705004|NCT03049449|583965925|FG007|Overall Study|Did not receive treatment.|0|||
161705005|NCT03049449|583965926|FG008|Overall Study|Did not receive treatment.|1|||
161705006|NCT03049449|583965927|FG009|Overall Study|Did not receive treatment.|0|||
161705007|NCT03049449|583965918|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
161705008|NCT03049449|583965919|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
161705009|NCT03049449|583965920|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
161705010|NCT03049449|583965921|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
161705011|NCT03049449|583965922|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
161705012|NCT03049449|583965923|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
161705013|NCT03049449|583965924|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
161705014|NCT03049449|583965925|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
161705015|NCT03049449|583965926|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
161705016|NCT03049449|583965927|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
161705017|NCT03049449|583965918|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705018|NCT03049449|583965919|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705019|NCT03049449|583965920|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705020|NCT03049449|583965921|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705021|NCT03049449|583965922|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705022|NCT03049449|583965923|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705023|NCT03049449|583965924|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705024|NCT03049449|583965925|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
161705025|NCT03049449|583965926|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161705026|NCT03049449|583965927|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
161705027|NCT02054702|583965933|FG000|Overall Study|Lost to Follow-up|3|||
161705028|NCT02054702|583965934|FG001|Overall Study|Lost to Follow-up|5|||
161705029|NCT02054702|583965933|FG000|Overall Study|Adverse Event|3|||
161705030|NCT02054702|583965934|FG001|Overall Study|Adverse Event|1|||
161705031|NCT02054702|583965933|FG000|Overall Study|Met Withdrawal Criteria|4|||
161705032|NCT02054702|583965934|FG001|Overall Study|Met Withdrawal Criteria|1|||
161705033|NCT02054702|583965933|FG000|Overall Study|Physician Decision|0|||
161705034|NCT02054702|583965934|FG001|Overall Study|Physician Decision|1|||
161705035|NCT02054702|583965933|FG000|Overall Study|Withdrawal by Subject|14|||
161705036|NCT02054702|583965934|FG001|Overall Study|Withdrawal by Subject|4|||
161705037|NCT01262898|583965941|FG000|Overall Study|Protocol Violation|1|||
161705038|NCT01262898|583965942|FG001|Overall Study|Protocol Violation|1|||
161705039|NCT01262898|583965943|FG002|Overall Study|Protocol Violation|0|||
161705040|NCT01262898|583965944|FG003|Overall Study|Protocol Violation|0|||
161705041|NCT01262898|583965941|FG000|Overall Study|Lost to Follow-up|1|||
161705042|NCT01262898|583965942|FG001|Overall Study|Lost to Follow-up|0|||
161705043|NCT01262898|583965943|FG002|Overall Study|Lost to Follow-up|0|||
161705044|NCT01262898|583965944|FG003|Overall Study|Lost to Follow-up|0|||
161705045|NCT01262898|583965941|FG000|Overall Study|Withdrawal by Subject|1|||
161705046|NCT01262898|583965942|FG001|Overall Study|Withdrawal by Subject|1|||
161705047|NCT01262898|583965943|FG002|Overall Study|Withdrawal by Subject|0|||
161705048|NCT01262898|583965944|FG003|Overall Study|Withdrawal by Subject|0|||
161705049|NCT02388295|583965950|FG000|Dose Escalation Week 1|Adverse Event|1|||
161705050|NCT02388295|583965951|FG001|Dose Escalation Week 1|Adverse Event|2|||
161705051|NCT02388295|583965952|FG002|Dose Escalation Week 1|Adverse Event|1|||
161705052|NCT02388295|583965950|FG000|Dose Escalation Week 1|Determined not eligible|1|||
161705053|NCT02388295|583965951|FG001|Dose Escalation Week 1|Determined not eligible|1|||
161705054|NCT02388295|583965952|FG002|Dose Escalation Week 1|Determined not eligible|1|||
161705055|NCT02388295|583965950|FG000|Dose Escalation Week 2|Protocol Violation|0|||
161705056|NCT02388295|583965951|FG001|Dose Escalation Week 2|Protocol Violation|1|||
161705057|NCT02388295|583965952|FG002|Dose Escalation Week 2|Protocol Violation|0|||
161705058|NCT02388295|583965950|FG000|Dose Escalation Week 2|Determined not eligible|1|||
161705059|NCT02388295|583965951|FG001|Dose Escalation Week 2|Determined not eligible|1|||
161705060|NCT02388295|583965952|FG002|Dose Escalation Week 2|Determined not eligible|1|||
161705061|NCT02388295|583965950|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
161705062|NCT02388295|583965951|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
161705063|NCT02388295|583965952|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
161705064|NCT01551693|583965954|FG000|Overall Study|Disease Progression|1|||
161705065|NCT01551693|583965955|FG001|Overall Study|Disease Progression|0|||
161705066|NCT01551693|583965954|FG000|Overall Study|Adverse Event|0|||
161705067|NCT01551693|583965955|FG001|Overall Study|Adverse Event|1|||
161705068|NCT01551693|583965954|FG000|Overall Study|Withdrawal by Subject|0|||
161705069|NCT01551693|583965955|FG001|Overall Study|Withdrawal by Subject|1|||
161705070|NCT02429856|583965956|FG000|Overall Study|Death|12|||
161705071|NCT02429856|583965957|FG001|Overall Study|Death|13|||
161705072|NCT02429856|583965956|FG000|Overall Study|Lost to Follow-up|6|||
161705073|NCT02429856|583965957|FG001|Overall Study|Lost to Follow-up|5|||
161705074|NCT02429856|583965956|FG000|Overall Study|Withdrawal by Subject|1|||
161705075|NCT02429856|583965957|FG001|Overall Study|Withdrawal by Subject|1|||
161705076|NCT04134494|583965961|FG000|Overall Study|Lost to Follow-up|2|||
161705077|NCT00781365|583965962|FG000|Overall Study|Withdrawal by Subject|13|||
161705078|NCT00781365|583965963|FG001|Overall Study|Withdrawal by Subject|8|||
161705079|NCT00781365|583965962|FG000|Overall Study|Did Not Attend Visit|20|||
161705080|NCT00781365|583965963|FG001|Overall Study|Did Not Attend Visit|28|||
161705081|NCT00781365|583965962|FG000|Overall Study|Language barrier|1|||
161705082|NCT00781365|583965963|FG001|Overall Study|Language barrier|0|||
161705083|NCT01900002|583965964|FG000|Overall Study|Withdrawal by Subject|2|||
161705084|NCT01900002|583965964|FG000|Overall Study|ineligible for Y-90|4|||
161705085|NCT01662648|583965965|FG000|Overall Study|Death|1|||
161705086|NCT01662648|583965966|FG001|Overall Study|Death|3|||
161705087|NCT01662648|583965965|FG000|Overall Study|Adverse Event|40|||
161705088|NCT01662648|583965966|FG001|Overall Study|Adverse Event|37|||
161705089|NCT01662648|583965965|FG000|Overall Study|Lack of Efficacy|17|||
161958026|NCT05396014|584892634|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958027|NCT05396014|584892635|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161705090|NCT01662648|583965966|FG001|Overall Study|Lack of Efficacy|16|||
161705091|NCT01662648|583965965|FG000|Overall Study|Participant ineligible to continue trial|1|||
161705092|NCT01662648|583965966|FG001|Overall Study|Participant ineligible to continue trial|1|||
161705093|NCT01662648|583965965|FG000|Overall Study|Lost to Follow-up|24|||
161705094|NCT01662648|583965966|FG001|Overall Study|Lost to Follow-up|36|||
161705095|NCT01662648|583965965|FG000|Overall Study|Withdrawal by Subject|36|||
161705096|NCT01662648|583965966|FG001|Overall Study|Withdrawal by Subject|53|||
161958028|NCT05396014|584892636|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161705097|NCT01662648|583965965|FG000|Overall Study|Participant non-compliant|16|||
161705098|NCT01662648|583965966|FG001|Overall Study|Participant non-compliant|20|||
161705099|NCT01662648|583965965|FG000|Overall Study|Other|8|||
161705100|NCT01662648|583965966|FG001|Overall Study|Other|11|||
161705101|NCT01662648|583965965|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
161705102|NCT01662648|583965966|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
161705103|NCT01662648|583965965|FG000|Overall Study|LOE and other reason unspecified|1|||
161705104|NCT01662648|583965966|FG001|Overall Study|LOE and other reason unspecified|0|||
161705105|NCT01662648|583965965|FG000|Overall Study|LOE and Participant non-compliant|0|||
161705106|NCT01662648|583965966|FG001|Overall Study|LOE and Participant non-compliant|1|||
161705107|NCT03040024|583965968|FG000|Overall Study|Adverse Event|0|||
161705108|NCT03040024|583965969|FG001|Overall Study|Adverse Event|1|||
161705109|NCT03040024|583965970|FG002|Overall Study|Adverse Event|0|||
161705110|NCT03040024|583965968|FG000|Overall Study|Death|0|||
161705111|NCT03040024|583965969|FG001|Overall Study|Death|1|||
161705112|NCT03040024|583965970|FG002|Overall Study|Death|0|||
161705113|NCT03040024|583965968|FG000|Overall Study|Physician Decision|0|||
161705114|NCT03040024|583965969|FG001|Overall Study|Physician Decision|0|||
161705115|NCT03040024|583965970|FG002|Overall Study|Physician Decision|1|||
161705116|NCT02658812|583965971|FG000|Overall Study|Disease Progression|7|||
161705117|NCT02658812|583965971|FG000|Overall Study|Unrelated to study treatment|1|||
161705118|NCT02658812|583965971|FG000|Overall Study|Adverse Event|1|||
161705119|NCT00854828|583965974|FG000|Overall Study|Death|1|||
161705120|NCT00854828|583965975|FG001|Overall Study|Death|0|||
161705121|NCT00854828|583965976|FG002|Overall Study|Death|0|||
161705122|NCT00854828|583965977|FG003|Overall Study|Death|0|||
161705123|NCT00854828|583965974|FG000|Overall Study|Withdrawal by Subject|1|||
161705124|NCT00854828|583965975|FG001|Overall Study|Withdrawal by Subject|1|||
161705125|NCT00854828|583965976|FG002|Overall Study|Withdrawal by Subject|0|||
161705126|NCT00854828|583965977|FG003|Overall Study|Withdrawal by Subject|9|||
161705127|NCT00854828|583965974|FG000|Overall Study|Missed 24mo visit|1|||
161705128|NCT00854828|583965975|FG001|Overall Study|Missed 24mo visit|1|||
161705129|NCT00854828|583965976|FG002|Overall Study|Missed 24mo visit|8|||
161705130|NCT00854828|583965977|FG003|Overall Study|Missed 24mo visit|8|||
161837364|NCT00616941|584448557|FG000|Overall Study|Progressive Disease|1|||
161837365|NCT00616941|584448558|FG001|Overall Study|Progressive Disease|2|||
161837366|NCT00616941|584448559|FG002|Overall Study|Progressive Disease|1|||
161837367|NCT00616941|584448557|FG000|Overall Study|Adverse Event|0|||
161837368|NCT00616941|584448558|FG001|Overall Study|Adverse Event|1|||
161837369|NCT00616941|584448559|FG002|Overall Study|Adverse Event|1|||
161837370|NCT00616941|584448557|FG000|Overall Study|Subject Non-compliance|0|||
161837371|NCT00616941|584448558|FG001|Overall Study|Subject Non-compliance|0|||
161837372|NCT00616941|584448559|FG002|Overall Study|Subject Non-compliance|1|||
161837373|NCT00616941|584448557|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
161837374|NCT00616941|584448558|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
161837375|NCT00616941|584448559|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
161837376|NCT00616941|584448557|FG000|Overall Study|Vaccination Suspended|0|||
161837377|NCT00616941|584448558|FG001|Overall Study|Vaccination Suspended|0|||
161837378|NCT00616941|584448559|FG002|Overall Study|Vaccination Suspended|3|||
161837379|NCT00076804|584448570|FG000|Overall Study|Death|9|||
161837380|NCT00076804|584448571|FG001|Overall Study|Death|20|||
161837381|NCT00076804|584448570|FG000|Overall Study|Lost to Follow-up|9|||
161705131|NCT01282229|583965978|FG000|Overall Study|Protocol Violation|2|||
161705132|NCT03686969|583965979|FG000|Overall Study|Study terminated|1|||
161705133|NCT03686969|583965980|FG001|Overall Study|Study terminated|0|||
161705134|NCT00848120|583965981|FG000|Overall Study|Adverse Event|1|||
161705135|NCT01988090|583965985|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
161705136|NCT01988090|583965986|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
161705137|NCT01988090|583965985|FG000|Start Treament After Randomization|Protocol Violation|0|||
161705138|NCT01988090|583965986|FG001|Start Treament After Randomization|Protocol Violation|1|||
161705139|NCT01988090|583965985|FG000|Complete Study After Start|Withdrawal by Subject|2|||
161705140|NCT01988090|583965986|FG001|Complete Study After Start|Withdrawal by Subject|0|||
161705141|NCT01988090|583965985|FG000|Complete Study After Start|Protocol Violation|1|||
161705142|NCT01988090|583965986|FG001|Complete Study After Start|Protocol Violation|1|||
161705143|NCT00927563|583965990|FG000|Overall Study|Lost to Follow-up|1|||
161705144|NCT00927563|583965990|FG000|Overall Study|Withdrawal by Subject|1|||
161705145|NCT02497001|583965991|FG000|Overall Study|Lost to Follow-up|10|||
161705146|NCT02497001|583965992|FG001|Overall Study|Lost to Follow-up|2|||
161705147|NCT02497001|583965993|FG002|Overall Study|Lost to Follow-up|0|||
161837382|NCT00076804|584448571|FG001|Overall Study|Lost to Follow-up|9|||
161837383|NCT00076804|584448570|FG000|Overall Study|Withdrawal by Subject|10|||
161837384|NCT00076804|584448571|FG001|Overall Study|Withdrawal by Subject|8|||
161837385|NCT00076804|584448570|FG000|Overall Study|Early study Closure|32|||
161837386|NCT00076804|584448571|FG001|Overall Study|Early study Closure|32|||
161837387|NCT03709823|584448572|FG000|Overall Study|Adverse Event|0|||
161705148|NCT02497001|583965994|FG003|Overall Study|Lost to Follow-up|2|||
161705149|NCT02497001|583965991|FG000|Overall Study|Adverse Event|28|||
161837388|NCT03709823|584448573|FG001|Overall Study|Adverse Event|0|||
161837389|NCT03709823|584448574|FG002|Overall Study|Adverse Event|1|||
161837390|NCT03709823|584448575|FG003|Overall Study|Adverse Event|0|||
161837391|NCT03709823|584448576|FG004|Overall Study|Adverse Event|0|||
161958029|NCT05396014|584892637|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161705150|NCT02497001|583965992|FG001|Overall Study|Adverse Event|30|||
161705151|NCT02497001|583965993|FG002|Overall Study|Adverse Event|11|||
161705152|NCT02497001|583965994|FG003|Overall Study|Adverse Event|11|||
161705153|NCT02497001|583965991|FG000|Overall Study|Withdrawal by Subject|14|||
161705154|NCT02497001|583965992|FG001|Overall Study|Withdrawal by Subject|37|||
161705155|NCT02497001|583965993|FG002|Overall Study|Withdrawal by Subject|19|||
161705156|NCT02497001|583965994|FG003|Overall Study|Withdrawal by Subject|15|||
161705157|NCT02497001|583965991|FG000|Overall Study|Physician Decision|5|||
161705158|NCT02497001|583965992|FG001|Overall Study|Physician Decision|11|||
161705159|NCT02497001|583965993|FG002|Overall Study|Physician Decision|5|||
161705160|NCT02497001|583965994|FG003|Overall Study|Physician Decision|1|||
161705161|NCT02497001|583965991|FG000|Overall Study|subjects that were not treated|1|||
161705162|NCT02497001|583965992|FG001|Overall Study|subjects that were not treated|2|||
161705163|NCT02497001|583965993|FG002|Overall Study|subjects that were not treated|2|||
161705164|NCT02497001|583965994|FG003|Overall Study|subjects that were not treated|1|||
161705165|NCT02497001|583965991|FG000|Overall Study|Major Protocol Deviation|3|||
161705166|NCT02497001|583965992|FG001|Overall Study|Major Protocol Deviation|4|||
161705167|NCT02497001|583965993|FG002|Overall Study|Major Protocol Deviation|4|||
161705168|NCT02497001|583965994|FG003|Overall Study|Major Protocol Deviation|4|||
161705169|NCT02497001|583965991|FG000|Overall Study|Lack of Efficacy|10|||
161705170|NCT02497001|583965992|FG001|Overall Study|Lack of Efficacy|16|||
161705171|NCT02497001|583965993|FG002|Overall Study|Lack of Efficacy|6|||
161837392|NCT03709823|584448577|FG005|Overall Study|Adverse Event|0|||
161837393|NCT03709823|584448572|FG000|Overall Study|Lost to Follow-up|2|||
161837394|NCT03709823|584448573|FG001|Overall Study|Lost to Follow-up|2|||
161837395|NCT03709823|584448574|FG002|Overall Study|Lost to Follow-up|2|||
161837396|NCT03709823|584448575|FG003|Overall Study|Lost to Follow-up|1|||
161837397|NCT03709823|584448576|FG004|Overall Study|Lost to Follow-up|1|||
161837398|NCT03709823|584448577|FG005|Overall Study|Lost to Follow-up|0|||
161837399|NCT03709823|584448572|FG000|Overall Study|Withdrawal by Subject|1|||
161837400|NCT03709823|584448573|FG001|Overall Study|Withdrawal by Subject|3|||
161837401|NCT03709823|584448574|FG002|Overall Study|Withdrawal by Subject|0|||
161837402|NCT03709823|584448575|FG003|Overall Study|Withdrawal by Subject|0|||
161837403|NCT03709823|584448576|FG004|Overall Study|Withdrawal by Subject|0|||
161837404|NCT03709823|584448577|FG005|Overall Study|Withdrawal by Subject|0|||
161837405|NCT03709823|584448572|FG000|Overall Study|Other, Not Specified|0|||
161837406|NCT03709823|584448573|FG001|Overall Study|Other, Not Specified|0|||
161837407|NCT03709823|584448574|FG002|Overall Study|Other, Not Specified|0|||
161837408|NCT03709823|584448575|FG003|Overall Study|Other, Not Specified|1|||
161837409|NCT03709823|584448576|FG004|Overall Study|Other, Not Specified|0|||
161837410|NCT03709823|584448577|FG005|Overall Study|Other, Not Specified|0|||
161837411|NCT00688376|584448578|FG000|Double-Blind Phase|Adverse Event|4|||
161837412|NCT00688376|584448579|FG001|Double-Blind Phase|Adverse Event|4|||
161837413|NCT00688376|584448578|FG000|Double-Blind Phase|Protocol Violation|1|||
161837414|NCT00688376|584448579|FG001|Double-Blind Phase|Protocol Violation|2|||
161837415|NCT00688376|584448578|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
161837416|NCT00688376|584448579|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
161837417|NCT00688376|584448578|FG000|Double-Blind Phase|Not treated|0|||
161837418|NCT00688376|584448579|FG001|Double-Blind Phase|Not treated|1|||
161837419|NCT00688376|584448578|FG000|Blinded Extension Phase|Adverse Event|3|||
161837420|NCT00688376|584448579|FG001|Blinded Extension Phase|Adverse Event|4|||
161837421|NCT00688376|584448578|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
161837422|NCT00688376|584448579|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
161837423|NCT00688376|584448578|FG000|Blinded Extension Phase|Physician Decision|1|||
161837424|NCT00688376|584448579|FG001|Blinded Extension Phase|Physician Decision|0|||
161837425|NCT00688376|584448578|FG000|Blinded Extension Phase|Other|1|||
161837426|NCT00688376|584448579|FG001|Blinded Extension Phase|Other|0|||
161837427|NCT00557076|584448580|FG000|Overall Study|Unblinding|0|||
161837428|NCT00557076|584448581|FG001|Overall Study|Unblinding|1|||
161837429|NCT00846521|584448582|FG000|Overall Study|Withdrawal by Subject|5|||
161837430|NCT00846521|584448582|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
161837431|NCT00846521|584448582|FG000|Overall Study|Protocol Violation|1|||
161837432|NCT03201250|584448584|FG000|Overall Study|screen failures|3|||
161837433|NCT03201250|584448585|FG001|Overall Study|screen failures|0|||
161837434|NCT03201250|584448586|FG002|Overall Study|screen failures|0|||
161705172|NCT02497001|583965994|FG003|Overall Study|Lack of Efficacy|6|||
161705173|NCT02497001|583965991|FG000|Overall Study|Protocol Violation|3|||
161837435|NCT02575911|584448589|FG000|Overall Study|Lost to Follow-up|1|||
161837436|NCT02335983|584448590|FG000|Overall Study|Sponsor Decision|0|||
161837437|NCT02335983|584448591|FG001|Overall Study|Sponsor Decision|0|||
161837438|NCT02335983|584448592|FG002|Overall Study|Sponsor Decision|1|||
161837439|NCT02335983|584448593|FG003|Overall Study|Sponsor Decision|1|||
161837440|NCT02335983|584448594|FG004|Overall Study|Sponsor Decision|0|||
161837441|NCT02335983|584448595|FG005|Overall Study|Sponsor Decision|1|||
161837442|NCT02335983|584448590|FG000|Overall Study|Withdrawal by Subject|3|||
161837443|NCT02335983|584448591|FG001|Overall Study|Withdrawal by Subject|2|||
161705174|NCT02497001|583965992|FG001|Overall Study|Protocol Violation|1|||
161705175|NCT02497001|583965993|FG002|Overall Study|Protocol Violation|3|||
161705176|NCT02497001|583965994|FG003|Overall Study|Protocol Violation|1|||
161705177|NCT05501119|583965995|FG000|Overall Study|Withdrawal by Subject|2|||
161837444|NCT02335983|584448592|FG002|Overall Study|Withdrawal by Subject|2|||
161837445|NCT02335983|584448593|FG003|Overall Study|Withdrawal by Subject|1|||
161837446|NCT02335983|584448594|FG004|Overall Study|Withdrawal by Subject|3|||
161837447|NCT02335983|584448595|FG005|Overall Study|Withdrawal by Subject|9|||
161837448|NCT02335983|584448590|FG000|Overall Study|Death|0|||
161837449|NCT02335983|584448591|FG001|Overall Study|Death|0|||
161837450|NCT02335983|584448592|FG002|Overall Study|Death|2|||
161837451|NCT02335983|584448593|FG003|Overall Study|Death|0|||
161837452|NCT02335983|584448594|FG004|Overall Study|Death|0|||
161837453|NCT02335983|584448595|FG005|Overall Study|Death|0|||
161837454|NCT02335983|584448590|FG000|Overall Study|Lost to Follow-up|0|||
161837455|NCT02335983|584448591|FG001|Overall Study|Lost to Follow-up|0|||
161837456|NCT02335983|584448592|FG002|Overall Study|Lost to Follow-up|0|||
161837457|NCT02335983|584448593|FG003|Overall Study|Lost to Follow-up|0|||
161837458|NCT02335983|584448594|FG004|Overall Study|Lost to Follow-up|0|||
161837459|NCT02335983|584448595|FG005|Overall Study|Lost to Follow-up|1|||
161837460|NCT02335983|584448590|FG000|Overall Study|Protocol Specified Criteria|5|||
161837461|NCT02335983|584448591|FG001|Overall Study|Protocol Specified Criteria|7|||
161837462|NCT02335983|584448592|FG002|Overall Study|Protocol Specified Criteria|27|||
161837463|NCT02335983|584448593|FG003|Overall Study|Protocol Specified Criteria|7|||
161837464|NCT02335983|584448594|FG004|Overall Study|Protocol Specified Criteria|5|||
161837465|NCT02335983|584448595|FG005|Overall Study|Protocol Specified Criteria|21|||
161837466|NCT00629265|584448600|FG000|Overall Study|Lost to Follow-up|4|||
161837467|NCT00629265|584448601|FG001|Overall Study|Lost to Follow-up|5|||
161837468|NCT00629265|584448600|FG000|Overall Study|Withdrawal by Subject|11|||
161837469|NCT00629265|584448601|FG001|Overall Study|Withdrawal by Subject|8|||
161837470|NCT00629265|584448600|FG000|Overall Study|Death|1|||
161837471|NCT00629265|584448601|FG001|Overall Study|Death|0|||
161837472|NCT00629265|584448600|FG000|Overall Study|Adverse Event|2|||
161837473|NCT00629265|584448601|FG001|Overall Study|Adverse Event|0|||
161837474|NCT00629265|584448600|FG000|Overall Study|HNC Recurrence|4|||
161837475|NCT00629265|584448601|FG001|Overall Study|HNC Recurrence|0|||
161837476|NCT00629265|584448600|FG000|Overall Study|Other CA Requiring Treatment|1|||
161837477|NCT00629265|584448601|FG001|Overall Study|Other CA Requiring Treatment|3|||
161837478|NCT00629265|584448600|FG000|Overall Study|Needed Esophageal Dilation|4|||
161837479|NCT00629265|584448601|FG001|Overall Study|Needed Esophageal Dilation|1|||
161837480|NCT00629265|584448600|FG000|Overall Study|Unrelated Medical Complications|3|||
161837481|NCT00629265|584448601|FG001|Overall Study|Unrelated Medical Complications|1|||
161837482|NCT00629265|584448600|FG000|Overall Study|Unknown Reason|2|||
161837483|NCT00629265|584448601|FG001|Overall Study|Unknown Reason|2|||
161837484|NCT04465630|584448602|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
161837485|NCT04465630|584448602|FG000|Overall Study|Screen failure|8|||
161705178|NCT05501119|583965995|FG000|Overall Study|Lost to Follow-up|5|||
161705179|NCT02440581|583966001|FG000|Overall Study|Death|0|||
161705180|NCT02440581|583966002|FG001|Overall Study|Death|0|||
161705181|NCT02440581|583966003|FG002|Overall Study|Death|7|||
161705182|NCT02440581|583966004|FG003|Overall Study|Death|5|||
161705183|NCT02440581|583966001|FG000|Overall Study|Transplanted|1|||
161705184|NCT02440581|583966002|FG001|Overall Study|Transplanted|0|||
161705185|NCT02440581|583966003|FG002|Overall Study|Transplanted|3|||
161705186|NCT02440581|583966004|FG003|Overall Study|Transplanted|2|||
161705187|NCT02440581|583966001|FG000|Overall Study|Withdrawal by Subject|4|||
161705188|NCT02440581|583966002|FG001|Overall Study|Withdrawal by Subject|11|||
161705189|NCT02440581|583966003|FG002|Overall Study|Withdrawal by Subject|3|||
161705190|NCT02440581|583966004|FG003|Overall Study|Withdrawal by Subject|7|||
161705191|NCT01468987|583966005|FG000|Overall Study|Adverse Event|12|||
161705192|NCT01468987|583966006|FG001|Overall Study|Adverse Event|9|||
161705193|NCT01468987|583966005|FG000|Overall Study|Death|4|||
161705194|NCT01468987|583966006|FG001|Overall Study|Death|1|||
161705195|NCT01468987|583966005|FG000|Overall Study|Lost to Follow-up|10|||
161705196|NCT01468987|583966006|FG001|Overall Study|Lost to Follow-up|5|||
161705197|NCT01468987|583966005|FG000|Overall Study|Protocol Violation|8|||
161837486|NCT04465630|584448602|FG000|Overall Study|Baseline failure|16|||
161837487|NCT01732484|584448606|FG000|Overall Study|Death|7|||
161837488|NCT01732484|584448606|FG000|Overall Study|Lost to Follow-up|14|||
161837489|NCT01732484|584448606|FG000|Overall Study|chronical illness|5|||
161705198|NCT01468987|583966006|FG001|Overall Study|Protocol Violation|2|||
161705199|NCT01468987|583966005|FG000|Overall Study|Withdrawal by Subject|28|||
161705200|NCT01468987|583966006|FG001|Overall Study|Withdrawal by Subject|28|||
161705201|NCT01468987|583966005|FG000|Overall Study|Physician Decision|8|||
161837490|NCT00289874|584448607|FG000|Overall Study|Adverse Event|1|||
161837491|NCT00289874|584448608|FG001|Overall Study|Adverse Event|5|||
161837492|NCT00289874|584448607|FG000|Overall Study|Lost to Follow-up|1|||
161958030|NCT05396014|584892638|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161705202|NCT01468987|583966006|FG001|Overall Study|Physician Decision|15|||
161705203|NCT01468987|583966005|FG000|Overall Study|Sponsor Decision|1|||
161705204|NCT01468987|583966006|FG001|Overall Study|Sponsor Decision|0|||
161705205|NCT00787787|583966007|FG000|Overall Study|Lack of Efficacy|4|||
161837493|NCT00289874|584448608|FG001|Overall Study|Lost to Follow-up|1|||
161837494|NCT00289874|584448607|FG000|Overall Study|Protocol Violation|3|||
161958031|NCT05396014|584892639|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161705206|NCT00787787|583966007|FG000|Overall Study|Adverse Event|3|||
161705207|NCT00484315|583966009|FG000|12-Month Clinical Follow-up|Death|6|||
161705208|NCT00484315|583966010|FG001|12-Month Clinical Follow-up|Death|2|||
161705209|NCT00484315|583966009|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
161705210|NCT00484315|583966010|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
161705211|NCT00484315|583966009|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
161705212|NCT00484315|583966010|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
161705213|NCT00484315|583966009|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
161705214|NCT00484315|583966010|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
161705215|NCT00484315|583966009|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
161705216|NCT00484315|583966010|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
161705217|NCT00484315|583966009|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
161837495|NCT00289874|584448608|FG001|Overall Study|Protocol Violation|2|||
161837496|NCT00289874|584448607|FG000|Overall Study|Did not meet eligibility|1|||
161837497|NCT00289874|584448608|FG001|Overall Study|Did not meet eligibility|0|||
161837498|NCT01087489|584448609|FG000|Overall Study|enrolled in another VA study|0|||
161837499|NCT01087489|584448610|FG001|Overall Study|enrolled in another VA study|1|||
161837500|NCT01087489|584448609|FG000|Overall Study|Death|0|||
161837501|NCT01087489|584448610|FG001|Overall Study|Death|1|||
161837502|NCT01087489|584448609|FG000|Overall Study|unable to survey by telephone|0|||
161837503|NCT01087489|584448610|FG001|Overall Study|unable to survey by telephone|1|||
161837504|NCT05070546|584448618|FG000|Overall Study|Death|0|||
161837505|NCT05070546|584448619|FG001|Overall Study|Death|0|||
161837506|NCT05070546|584448620|FG002|Overall Study|Death|0|||
161837507|NCT05070546|584448621|FG003|Overall Study|Death|0|||
161837508|NCT05070546|584448622|FG004|Overall Study|Death|0|||
161837509|NCT05070546|584448623|FG005|Overall Study|Death|1|||
161837510|NCT05070546|584448618|FG000|Overall Study|Lost to Follow-up|8|||
161837511|NCT05070546|584448619|FG001|Overall Study|Lost to Follow-up|2|||
161837512|NCT05070546|584448620|FG002|Overall Study|Lost to Follow-up|7|||
161837513|NCT05070546|584448621|FG003|Overall Study|Lost to Follow-up|1|||
161958032|NCT05396014|584892640|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958033|NCT05396014|584892641|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958034|NCT05396014|584892642|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958035|NCT05396014|584892643|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958036|NCT05396014|584892644|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958037|NCT05396014|584892645|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958038|NCT05396014|584892646|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161705218|NCT00484315|583966010|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
161705219|NCT00484315|583966009|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
161837514|NCT05070546|584448622|FG004|Overall Study|Lost to Follow-up|2|||
161837515|NCT05070546|584448623|FG005|Overall Study|Lost to Follow-up|0|||
161837516|NCT05070546|584448618|FG000|Overall Study|Withdrawal by Subject|1|||
161837517|NCT05070546|584448619|FG001|Overall Study|Withdrawal by Subject|1|||
161837518|NCT05070546|584448620|FG002|Overall Study|Withdrawal by Subject|3|||
161837519|NCT05070546|584448621|FG003|Overall Study|Withdrawal by Subject|0|||
161837520|NCT05070546|584448622|FG004|Overall Study|Withdrawal by Subject|0|||
161837521|NCT05070546|584448623|FG005|Overall Study|Withdrawal by Subject|0|||
161837522|NCT05070546|584448618|FG000|Overall Study|Other|0|||
161837523|NCT05070546|584448619|FG001|Overall Study|Other|0|||
161837524|NCT05070546|584448620|FG002|Overall Study|Other|0|||
161837525|NCT05070546|584448621|FG003|Overall Study|Other|0|||
161837526|NCT05070546|584448622|FG004|Overall Study|Other|3|||
161837527|NCT05070546|584448623|FG005|Overall Study|Other|0|||
161837528|NCT05070546|584448618|FG000|Overall Study|Randomized but not vaccinated|1|||
161837529|NCT05070546|584448619|FG001|Overall Study|Randomized but not vaccinated|0|||
161837530|NCT05070546|584448620|FG002|Overall Study|Randomized but not vaccinated|1|||
161837531|NCT05070546|584448621|FG003|Overall Study|Randomized but not vaccinated|1|||
161837532|NCT05070546|584448622|FG004|Overall Study|Randomized but not vaccinated|3|||
161837533|NCT05070546|584448623|FG005|Overall Study|Randomized but not vaccinated|0|||
161837534|NCT02643355|584448624|FG000|Overall Study|Withdrawal by Subject|1|||
161837535|NCT02643355|584448625|FG001|Overall Study|Withdrawal by Subject|3|||
161837536|NCT02643355|584448624|FG000|Overall Study|Protocol Violation|0|||
161837537|NCT02643355|584448625|FG001|Overall Study|Protocol Violation|2|||
161837538|NCT01615263|584448637|FG000|Overall Study|Post-randomization exclusion|0|||
161837539|NCT01615263|584448638|FG001|Overall Study|Post-randomization exclusion|2|||
161837540|NCT00988065|584448643|FG000|Overall Study|Adverse Event|4|||
161837541|NCT00988065|584448644|FG001|Overall Study|Adverse Event|10|||
161837542|NCT00988065|584448645|FG002|Overall Study|Adverse Event|2|||
161837543|NCT00988065|584448643|FG000|Overall Study|Lost to Follow-up|1|||
161837544|NCT00988065|584448644|FG001|Overall Study|Lost to Follow-up|2|||
161837545|NCT00988065|584448645|FG002|Overall Study|Lost to Follow-up|2|||
161837546|NCT00988065|584448643|FG000|Overall Study|Subject withdrew consent|3|||
161837547|NCT00988065|584448644|FG001|Overall Study|Subject withdrew consent|5|||
161837548|NCT00988065|584448645|FG002|Overall Study|Subject withdrew consent|2|||
161837549|NCT00988065|584448643|FG000|Overall Study|Noncompliance with protocol|5|||
161837550|NCT00988065|584448644|FG001|Overall Study|Noncompliance with protocol|6|||
161837551|NCT00988065|584448645|FG002|Overall Study|Noncompliance with protocol|9|||
161837552|NCT03096847|584448651|FG000|Overall Study|Other|2|||
161837553|NCT03096847|584448652|FG001|Overall Study|Other|1|||
161837554|NCT03096847|584448653|FG002|Overall Study|Other|2|||
161837555|NCT03096847|584448651|FG000|Overall Study|Lost to Follow-up|1|||
161837556|NCT03096847|584448652|FG001|Overall Study|Lost to Follow-up|0|||
161837557|NCT03096847|584448653|FG002|Overall Study|Lost to Follow-up|1|||
161705220|NCT00484315|583966010|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
161705221|NCT00943683|583966011|FG000|Overall Study|Adverse Event|3|||
161705222|NCT00943683|583966012|FG001|Overall Study|Adverse Event|3|||
161705223|NCT00943683|583966011|FG000|Overall Study|Lost to Follow-up|1|||
161705224|NCT00943683|583966012|FG001|Overall Study|Lost to Follow-up|1|||
161705225|NCT00943683|583966011|FG000|Overall Study|Protocol Violation|1|||
161705226|NCT00943683|583966012|FG001|Overall Study|Protocol Violation|2|||
161705227|NCT00943683|583966011|FG000|Overall Study|Withdrawal by Subject|1|||
161705228|NCT00943683|583966012|FG001|Overall Study|Withdrawal by Subject|0|||
161705229|NCT00943683|583966011|FG000|Overall Study|Patient Moved|1|||
161705230|NCT00943683|583966012|FG001|Overall Study|Patient Moved|0|||
161705231|NCT01245673|583966013|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
161705232|NCT01445678|583966025|FG000|Overall Study|Adverse Event|12|||
161705233|NCT01445678|583966026|FG001|Overall Study|Adverse Event|8|||
161705234|NCT01445678|583966025|FG000|Overall Study|Lack of Efficacy|0|||
161705235|NCT01445678|583966026|FG001|Overall Study|Lack of Efficacy|2|||
161705236|NCT01445678|583966025|FG000|Overall Study|Lost to Follow-up|8|||
161705237|NCT01445678|583966026|FG001|Overall Study|Lost to Follow-up|5|||
161705238|NCT01445678|583966025|FG000|Overall Study|Protocol Violation|1|||
161705239|NCT01445678|583966026|FG001|Overall Study|Protocol Violation|1|||
161705240|NCT01445678|583966025|FG000|Overall Study|Withdrawal by Subject|9|||
161705241|NCT01445678|583966026|FG001|Overall Study|Withdrawal by Subject|5|||
161705242|NCT01459614|583966029|FG000|Overall Study|Adverse Event|1|||
161837558|NCT03096847|584448651|FG000|Overall Study|Death|6|||
161705243|NCT01459614|583966030|FG001|Overall Study|Adverse Event|0|||
161705244|NCT01565980|583966031|FG000|Overall Study|Death|1|||
161837559|NCT03096847|584448652|FG001|Overall Study|Death|0|||
161705245|NCT01565980|583966032|FG001|Overall Study|Death|0|||
161837560|NCT03096847|584448653|FG002|Overall Study|Death|2|||
161837561|NCT03096847|584448651|FG000|Overall Study|Protocol Violation|3|||
161837562|NCT03096847|584448652|FG001|Overall Study|Protocol Violation|0|||
161705246|NCT01565980|583966031|FG000|Overall Study|Lost to Follow-up|1|||
161705247|NCT01565980|583966032|FG001|Overall Study|Lost to Follow-up|0|||
161705248|NCT01565980|583966031|FG000|Overall Study|health complications|1|||
161705249|NCT01565980|583966032|FG001|Overall Study|health complications|1|||
161837563|NCT03096847|584448653|FG002|Overall Study|Protocol Violation|6|||
161837564|NCT03096847|584448651|FG000|Overall Study|Physician Decision|12|||
161837565|NCT03096847|584448652|FG001|Overall Study|Physician Decision|2|||
161837566|NCT03096847|584448653|FG002|Overall Study|Physician Decision|8|||
161837567|NCT03096847|584448651|FG000|Overall Study|Withdrawal by Subject|24|||
161958039|NCT05396014|584892647|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958040|NCT05396014|584892648|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958041|NCT05396014|584892649|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958042|NCT05396014|584892650|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958043|NCT05396014|584892651|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958044|NCT05396014|584892652|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958045|NCT05396014|584892653|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958046|NCT05396014|584892654|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958047|NCT05396014|584892655|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
161958048|NCT05396014|584892656|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958049|NCT05396014|584892657|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958050|NCT05396014|584892658|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958051|NCT05396014|584892659|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958052|NCT05396014|584892660|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958053|NCT05396014|584892661|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958054|NCT05396014|584892662|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958055|NCT05396014|584892663|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958056|NCT05396014|584892664|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958057|NCT05396014|584892665|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958058|NCT05396014|584892666|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958059|NCT05396014|584892667|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958060|NCT05396014|584892668|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958061|NCT05396014|584892669|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958062|NCT05396014|584892670|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958063|NCT05396014|584892671|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161958064|NCT05258890|584892673|FG000|Overall Study|Patient withdrawal|6|||
161958065|NCT05258890|584892674|FG001|Overall Study|Patient withdrawal|7|||
161958066|NCT05258890|584892673|FG000|Overall Study|Patient lost to follow-up|10|||
161958067|NCT05258890|584892674|FG001|Overall Study|Patient lost to follow-up|3|||
161958068|NCT05258890|584892673|FG000|Overall Study|Social network member withdrawal|1|||
161958069|NCT05258890|584892674|FG001|Overall Study|Social network member withdrawal|0|||
161958070|NCT05258890|584892673|FG000|Overall Study|Social network member lost to follow-up|5|||
161958071|NCT05258890|584892674|FG001|Overall Study|Social network member lost to follow-up|0|||
161958072|NCT01498692|584892679|FG000|Overall Study|Death|4|||
161958073|NCT01498692|584892679|FG000|Overall Study|Withdrawal by Subject|1|||
161958074|NCT01498692|584892679|FG000|Overall Study|Missed 12-month visit|3|||
161958075|NCT01947283|584892680|FG000|Overall Study|Death|1|||
161958076|NCT01947283|584892681|FG001|Overall Study|Death|1|||
161958077|NCT01947283|584892682|FG002|Overall Study|Death|1|||
161958078|NCT01947283|584892683|FG003|Overall Study|Death|0|||
161958079|NCT01947283|584892684|FG004|Overall Study|Death|0|||
161958080|NCT01947283|584892685|FG005|Overall Study|Death|0|||
161958081|NCT01947283|584892686|FG006|Overall Study|Death|0|||
161958082|NCT01947283|584892680|FG000|Overall Study|Lost to Follow-up|4|||
161958083|NCT01947283|584892681|FG001|Overall Study|Lost to Follow-up|6|||
161958084|NCT01947283|584892682|FG002|Overall Study|Lost to Follow-up|5|||
161958085|NCT01947283|584892683|FG003|Overall Study|Lost to Follow-up|5|||
161958086|NCT01947283|584892684|FG004|Overall Study|Lost to Follow-up|0|||
161958087|NCT01947283|584892685|FG005|Overall Study|Lost to Follow-up|2|||
161958088|NCT01947283|584892686|FG006|Overall Study|Lost to Follow-up|5|||
161958089|NCT01947283|584892680|FG000|Overall Study|Withdrawal by Subject|10|||
161958090|NCT01947283|584892681|FG001|Overall Study|Withdrawal by Subject|8|||
161958091|NCT01947283|584892682|FG002|Overall Study|Withdrawal by Subject|4|||
161958092|NCT01947283|584892683|FG003|Overall Study|Withdrawal by Subject|1|||
161958093|NCT01947283|584892684|FG004|Overall Study|Withdrawal by Subject|0|||
161958094|NCT01947283|584892685|FG005|Overall Study|Withdrawal by Subject|0|||
161958095|NCT01947283|584892686|FG006|Overall Study|Withdrawal by Subject|2|||
161958096|NCT01947283|584892680|FG000|Overall Study|No Clinical Recording|12|||
161958097|NCT01947283|584892681|FG001|Overall Study|No Clinical Recording|6|||
161958098|NCT01947283|584892682|FG002|Overall Study|No Clinical Recording|8|||
161958099|NCT01947283|584892683|FG003|Overall Study|No Clinical Recording|10|||
161958100|NCT01947283|584892684|FG004|Overall Study|No Clinical Recording|0|||
161958101|NCT01947283|584892685|FG005|Overall Study|No Clinical Recording|0|||
161958102|NCT01947283|584892686|FG006|Overall Study|No Clinical Recording|0|||
161705250|NCT01565980|583966031|FG000|Overall Study|stopped medical treatment|1|||
161705251|NCT01565980|583966032|FG001|Overall Study|stopped medical treatment|0|||
161705252|NCT01565980|583966031|FG000|Overall Study|Withdrawal by Subject|0|||
161705253|NCT01565980|583966032|FG001|Overall Study|Withdrawal by Subject|3|||
161705254|NCT02078219|583966035|FG000|Overall Study|Other|2|||
161705255|NCT02078219|583966036|FG001|Overall Study|Other|2|||
161705256|NCT02078219|583966037|FG002|Overall Study|Other|3|||
161705257|NCT02078219|583966038|FG003|Overall Study|Other|0|||
161705258|NCT02078219|583966039|FG004|Overall Study|Other|1|||
161705259|NCT02078219|583966035|FG000|Overall Study|Withdrawal by Subject|0|||
161705260|NCT02078219|583966036|FG001|Overall Study|Withdrawal by Subject|1|||
161705261|NCT02078219|583966037|FG002|Overall Study|Withdrawal by Subject|0|||
161705262|NCT02078219|583966038|FG003|Overall Study|Withdrawal by Subject|1|||
161705263|NCT02078219|583966039|FG004|Overall Study|Withdrawal by Subject|1|||
161705264|NCT02078219|583966035|FG000|Overall Study|Protocol Violation|0|||
161705265|NCT02078219|583966036|FG001|Overall Study|Protocol Violation|0|||
161705266|NCT02078219|583966037|FG002|Overall Study|Protocol Violation|0|||
161705267|NCT02078219|583966038|FG003|Overall Study|Protocol Violation|1|||
161705268|NCT02078219|583966039|FG004|Overall Study|Protocol Violation|0|||
161705269|NCT02078219|583966035|FG000|Overall Study|Death|0|||
161705270|NCT02078219|583966036|FG001|Overall Study|Death|0|||
161705271|NCT02078219|583966037|FG002|Overall Study|Death|0|||
161705272|NCT02078219|583966038|FG003|Overall Study|Death|1|||
161705273|NCT02078219|583966039|FG004|Overall Study|Death|0|||
161705274|NCT02078219|583966035|FG000|Overall Study|Adverse Event|1|||
161705275|NCT02078219|583966036|FG001|Overall Study|Adverse Event|1|||
161705276|NCT02078219|583966037|FG002|Overall Study|Adverse Event|3|||
161705277|NCT02078219|583966038|FG003|Overall Study|Adverse Event|1|||
161705278|NCT02078219|583966039|FG004|Overall Study|Adverse Event|0|||
161705279|NCT00891202|583966040|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
161705280|NCT00891202|583966041|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
161705281|NCT00891202|583966042|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
161705282|NCT00891202|583966043|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
161705283|NCT00891202|583966040|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
161705284|NCT00891202|583966041|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
161705285|NCT00891202|583966042|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
161705286|NCT00891202|583966043|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
161705287|NCT00891202|583966040|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
161705288|NCT00891202|583966041|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
161705289|NCT00891202|583966042|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
161705290|NCT00891202|583966043|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
161705291|NCT00891202|583966040|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
161705292|NCT00891202|583966041|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
161705293|NCT00891202|583966042|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
161705294|NCT00891202|583966043|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
161705295|NCT00398112|583967806|FG000|Overall Study|Adverse Event|4|||
161705296|NCT00398112|583967806|FG000|Overall Study|Disease progression|9|||
161705297|NCT00398112|583967806|FG000|Overall Study|Alternative treatment|1|||
161705298|NCT00398112|583967806|FG000|Overall Study|Withdrawal by Subject|3|||
161705299|NCT00398112|583967806|FG000|Overall Study|Death|1|||
161705300|NCT00582556|583967807|FG000|Overall Study|Withdrawal by Subject|0|||
161705301|NCT00582556|583967808|FG001|Overall Study|Withdrawal by Subject|1|||
161705302|NCT00582556|583967809|FG002|Overall Study|Withdrawal by Subject|1|||
161705303|NCT00582556|583967807|FG000|Overall Study|Physician Decision|0|||
161705304|NCT00582556|583967808|FG001|Overall Study|Physician Decision|0|||
161705305|NCT00582556|583967809|FG002|Overall Study|Physician Decision|1|||
161705306|NCT01993888|583967810|FG000|Overall Study|Death|1|||
161705307|NCT01993888|583967811|FG001|Overall Study|Death|1|||
161705308|NCT01993888|583967810|FG000|Overall Study|Lost to Follow-up|1|||
161705309|NCT01993888|583967811|FG001|Overall Study|Lost to Follow-up|1|||
161705310|NCT01993888|583967810|FG000|Overall Study|Withdrawal by Subject|0|||
161705311|NCT01993888|583967811|FG001|Overall Study|Withdrawal by Subject|1|||
161705312|NCT03124459|583967812|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161837568|NCT03096847|584448652|FG001|Overall Study|Withdrawal by Subject|1|||
161837569|NCT03096847|584448653|FG002|Overall Study|Withdrawal by Subject|12|||
161705313|NCT03124459|583967813|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161705314|NCT03124459|583967814|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161705315|NCT03124459|583967815|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161705316|NCT03124459|583967816|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
161705317|NCT03124459|583967817|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161705318|NCT03124459|583967812|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161705319|NCT03124459|583967813|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161705320|NCT03124459|583967814|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161705321|NCT03124459|583967815|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161705322|NCT03124459|583967816|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
161958103|NCT01947283|584892680|FG000|Overall Study|Non-coding Clinical Recording language|0|||
161958104|NCT01947283|584892681|FG001|Overall Study|Non-coding Clinical Recording language|0|||
161705323|NCT03124459|583967817|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161705324|NCT03124459|583967812|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
161705325|NCT03124459|583967813|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
161705326|NCT03124459|583967814|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
161705327|NCT03124459|583967815|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
161705328|NCT03124459|583967816|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
161705329|NCT03124459|583967817|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
161705330|NCT03124459|583967812|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
161705331|NCT03124459|583967813|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
161705332|NCT03124459|583967814|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
161705333|NCT03124459|583967815|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
161705334|NCT03124459|583967816|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
161705335|NCT03124459|583967817|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
161705336|NCT03124459|583967812|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161705337|NCT03124459|583967813|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161705338|NCT03124459|583967814|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161705339|NCT03124459|583967815|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161705340|NCT03124459|583967816|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161705341|NCT03124459|583967817|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
161705342|NCT03124459|583967812|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161705343|NCT03124459|583967813|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161705344|NCT03124459|583967814|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161705345|NCT03124459|583967815|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161705346|NCT03124459|583967816|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161705347|NCT03124459|583967817|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
161705348|NCT03932812|583967818|FG000|Overall Study|Lost to Follow-up|12|||
161705349|NCT03932812|583967819|FG001|Overall Study|Lost to Follow-up|14|||
161705350|NCT03932812|583967818|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
161705351|NCT03932812|583967819|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
161705352|NCT03293654|583967820|FG000|Overall Study|Lost to Follow-up|0|||
161705353|NCT03293654|583967821|FG001|Overall Study|Lost to Follow-up|1|||
161705354|NCT03293654|583967822|FG002|Overall Study|Lost to Follow-up|0|||
161705355|NCT01355289|583967825|FG000|Core Study|Adverse Event, Non-Fatal|1|||
161705356|NCT01355289|583967826|FG001|Core Study|Adverse Event, Non-Fatal|0|||
161705357|NCT01355289|583967827|FG002|Core Study|Adverse Event, Non-Fatal|0|||
161705358|NCT01355289|583967828|FG003|Core Study|Adverse Event, Non-Fatal|0|||
161705359|NCT01355289|583967829|FG004|Core Study|Adverse Event, Non-Fatal|0|||
161705360|NCT01355289|583967825|FG000|Core Study|Inadequate Therapeutic Effect|0|||
161705361|NCT01355289|583967826|FG001|Core Study|Inadequate Therapeutic Effect|0|||
161705362|NCT01355289|583967827|FG002|Core Study|Inadequate Therapeutic Effect|0|||
161705363|NCT01355289|583967828|FG003|Core Study|Inadequate Therapeutic Effect|1|||
161705364|NCT01355289|583967829|FG004|Core Study|Inadequate Therapeutic Effect|0|||
161705365|NCT01355289|583967825|FG000|Core Study|Other|0|||
161705366|NCT01355289|583967826|FG001|Core Study|Other|0|||
161705367|NCT01355289|583967827|FG002|Core Study|Other|0|||
161705368|NCT01355289|583967828|FG003|Core Study|Other|1|||
161705369|NCT01355289|583967829|FG004|Core Study|Other|0|||
161705370|NCT01355289|583967825|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
161705371|NCT01355289|583967826|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
161705372|NCT01355289|583967827|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
161705373|NCT01355289|583967828|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
161705374|NCT01355289|583967829|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
161705375|NCT01355289|583967825|FG000|Open Label Extension|Lost to Follow-up|0|||
161705376|NCT01355289|583967826|FG001|Open Label Extension|Lost to Follow-up|0|||
161705377|NCT01355289|583967827|FG002|Open Label Extension|Lost to Follow-up|0|||
161958105|NCT01947283|584892682|FG002|Overall Study|Non-coding Clinical Recording language|0|||
161958106|NCT01947283|584892683|FG003|Overall Study|Non-coding Clinical Recording language|1|||
161958107|NCT01947283|584892684|FG004|Overall Study|Non-coding Clinical Recording language|0|||
161958108|NCT01947283|584892685|FG005|Overall Study|Non-coding Clinical Recording language|0|||
161958109|NCT01947283|584892686|FG006|Overall Study|Non-coding Clinical Recording language|0|||
161958110|NCT01947283|584892680|FG000|Overall Study|Missing Follow-up Assessment|2|||
161958111|NCT01947283|584892681|FG001|Overall Study|Missing Follow-up Assessment|2|||
161958112|NCT01947283|584892682|FG002|Overall Study|Missing Follow-up Assessment|3|||
161705378|NCT01355289|583967828|FG003|Open Label Extension|Lost to Follow-up|0|||
161705379|NCT01355289|583967829|FG004|Open Label Extension|Lost to Follow-up|1|||
161705380|NCT01355289|583967825|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
161705381|NCT01355289|583967826|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
161705382|NCT01355289|583967827|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
161705383|NCT01355289|583967828|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
161705384|NCT01355289|583967829|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
161705385|NCT01355289|583967825|FG000|Open Label Extension|Other|0|||
161705386|NCT01355289|583967826|FG001|Open Label Extension|Other|0|||
161705387|NCT01355289|583967827|FG002|Open Label Extension|Other|0|||
161705388|NCT01355289|583967828|FG003|Open Label Extension|Other|0|||
161705389|NCT01355289|583967829|FG004|Open Label Extension|Other|3|||
161705390|NCT00802360|583967832|FG000|Overall Study|Stimulation failure|4|||
161705391|NCT00802360|583967833|FG001|Overall Study|Stimulation failure|0|||
161705392|NCT00802360|583967834|FG002|Overall Study|Stimulation failure|3|||
161705393|NCT00802360|583967835|FG003|Overall Study|Stimulation failure|3|||
161705394|NCT00802360|583967832|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
161705395|NCT00802360|583967833|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
161705396|NCT00802360|583967834|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
161705397|NCT00802360|583967835|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
161705398|NCT00802360|583967832|FG000|Overall Study|Cycle cancelled|0|||
161705399|NCT00802360|583967833|FG001|Overall Study|Cycle cancelled|1|||
161705400|NCT00802360|583967834|FG002|Overall Study|Cycle cancelled|1|||
161705401|NCT00802360|583967835|FG003|Overall Study|Cycle cancelled|1|||
161705402|NCT00802360|583967832|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
161705403|NCT00802360|583967833|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
161705404|NCT00802360|583967834|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
161705405|NCT00802360|583967835|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
161705406|NCT00802360|583967832|FG000|Overall Study|No positive serum pregnancy|17|||
161705407|NCT00802360|583967833|FG001|Overall Study|No positive serum pregnancy|20|||
161705408|NCT00802360|583967834|FG002|Overall Study|No positive serum pregnancy|14|||
161705409|NCT00802360|583967835|FG003|Overall Study|No positive serum pregnancy|10|||
161705410|NCT00802360|583967832|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
161705411|NCT00802360|583967833|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
161705412|NCT00802360|583967834|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
161705413|NCT00802360|583967835|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
161705414|NCT00802360|583967832|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
161837570|NCT03096847|584448651|FG000|Overall Study|Adverse Event|72|||
161837571|NCT03096847|584448652|FG001|Overall Study|Adverse Event|6|||
161837572|NCT03096847|584448653|FG002|Overall Study|Adverse Event|28|||
161837573|NCT03096847|584448651|FG000|Overall Study|Progressive disease|97|||
161837574|NCT03096847|584448652|FG001|Overall Study|Progressive disease|10|||
161837575|NCT03096847|584448653|FG002|Overall Study|Progressive disease|78|||
161837576|NCT03096847|584448651|FG000|Overall Study|Non-compliance with study medication|1|||
161837577|NCT03096847|584448652|FG001|Overall Study|Non-compliance with study medication|0|||
161837578|NCT03096847|584448653|FG002|Overall Study|Non-compliance with study medication|0|||
161837579|NCT03096847|584448651|FG000|Overall Study|New therapy for study indication|1|||
161705415|NCT00802360|583967833|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
161705416|NCT00802360|583967834|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
161705417|NCT00802360|583967835|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
161705418|NCT00802360|583967832|FG000|Overall Study|Other|2|||
161705419|NCT00802360|583967833|FG001|Overall Study|Other|3|||
161705420|NCT00802360|583967834|FG002|Overall Study|Other|6|||
161705421|NCT00802360|583967835|FG003|Overall Study|Other|3|||
161705422|NCT03838484|583967846|FG000|Overall Study|Lost to Follow-up|0|||
161705423|NCT03838484|583967847|FG001|Overall Study|Lost to Follow-up|1|||
161705424|NCT03838484|583967848|FG002|Overall Study|Lost to Follow-up|0|||
161705425|NCT03838484|583967849|FG003|Overall Study|Lost to Follow-up|0|||
161705426|NCT01614964|583967850|FG000|Overall Study|Withdrawal by Subject|2|||
161705427|NCT01614964|583967851|FG001|Overall Study|Withdrawal by Subject|0|||
161705428|NCT01614964|583967850|FG000|Overall Study|Lost to Follow-up|3|||
161705429|NCT01614964|583967851|FG001|Overall Study|Lost to Follow-up|0|||
161705430|NCT00860470|583967860|FG000|Overall Study|Death|6|||
161705431|NCT00860470|583967861|FG001|Overall Study|Death|10|||
161705432|NCT00860470|583967860|FG000|Overall Study|Moved away|8|||
161705433|NCT00860470|583967861|FG001|Overall Study|Moved away|10|||
161705434|NCT00860470|583967860|FG000|Overall Study|Lost to Follow-up|34|||
161705435|NCT00860470|583967861|FG001|Overall Study|Lost to Follow-up|39|||
161705436|NCT01032629|583967863|FG000|Overall Study|Closed Site|21|||
161705437|NCT01032629|583967864|FG001|Overall Study|Closed Site|18|||
161705438|NCT01032629|583967865|FG002|Overall Study|Closed Site|16|||
161705439|NCT01032629|583967863|FG000|Overall Study|Withdrawal by Subject|50|||
161837580|NCT03096847|584448652|FG001|Overall Study|New therapy for study indication|0|||
161705440|NCT01032629|583967864|FG001|Overall Study|Withdrawal by Subject|36|||
161705441|NCT01032629|583967865|FG002|Overall Study|Withdrawal by Subject|35|||
161705442|NCT01032629|583967863|FG000|Overall Study|Lost to Follow-up|74|||
161705443|NCT01032629|583967864|FG001|Overall Study|Lost to Follow-up|47|||
161837581|NCT03096847|584448653|FG002|Overall Study|New therapy for study indication|1|||
161837582|NCT00359632|584448657|FG000|Overall Study|Death|2|||
161837583|NCT00359632|584448658|FG001|Overall Study|Death|0|||
161705444|NCT01032629|583967865|FG002|Overall Study|Lost to Follow-up|37|||
161705445|NCT03371355|583967868|FG000|Overall Study|Investigator judgment|0|||
161705446|NCT03371355|583967869|FG001|Overall Study|Investigator judgment|0|||
161705447|NCT03371355|583967870|FG002|Overall Study|Investigator judgment|1|||
161705448|NCT03371355|583967871|FG003|Overall Study|Investigator judgment|1|||
161705449|NCT03371355|583967868|FG000|Overall Study|Voluntary withdrawal|1|||
161705450|NCT03371355|583967869|FG001|Overall Study|Voluntary withdrawal|0|||
161705451|NCT03371355|583967870|FG002|Overall Study|Voluntary withdrawal|1|||
161705452|NCT03371355|583967871|FG003|Overall Study|Voluntary withdrawal|2|||
161705453|NCT03371355|583967868|FG000|Overall Study|Adverse Event|0|||
161705454|NCT03371355|583967869|FG001|Overall Study|Adverse Event|1|||
161705455|NCT03371355|583967870|FG002|Overall Study|Adverse Event|2|||
161705456|NCT03371355|583967871|FG003|Overall Study|Adverse Event|3|||
161705457|NCT03371355|583967868|FG000|Overall Study|Reason not Specified|0|||
161705458|NCT03371355|583967869|FG001|Overall Study|Reason not Specified|1|||
161705459|NCT03371355|583967870|FG002|Overall Study|Reason not Specified|0|||
161705460|NCT03371355|583967871|FG003|Overall Study|Reason not Specified|1|||
161705461|NCT00619957|583967875|FG000|Month 24 Double-Blind|Adverse Event|9|||
161705462|NCT00619957|583967876|FG001|Month 24 Double-Blind|Adverse Event|7|||
161705463|NCT00619957|583967875|FG000|Month 24 Double-Blind|Protocol Violation|1|||
161705464|NCT00619957|583967876|FG001|Month 24 Double-Blind|Protocol Violation|0|||
161705465|NCT00619957|583967875|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
161705466|NCT00619957|583967876|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
161705467|NCT00619957|583967875|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
161705468|NCT00619957|583967876|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
161705469|NCT00619957|583967875|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
161705470|NCT00619957|583967876|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
161705471|NCT00619957|583967875|FG000|Month 48 Open-Label|Adverse Event|4|||
161705472|NCT00619957|583967876|FG001|Month 48 Open-Label|Adverse Event|4|||
161705473|NCT00619957|583967875|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
161705474|NCT00619957|583967876|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
161705475|NCT00619957|583967875|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
161705476|NCT00619957|583967876|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
161705477|NCT00723957|583967877|FG000|Overall Study|Adverse event unrelated to study drug|1|||
161705478|NCT00723957|583967878|FG001|Overall Study|Adverse event unrelated to study drug|4|||
161705479|NCT00723957|583967877|FG000|Overall Study|Death|3|||
161705480|NCT00723957|583967878|FG001|Overall Study|Death|4|||
161705481|NCT00723957|583967877|FG000|Overall Study|Disease progression|27|||
161705482|NCT00723957|583967878|FG001|Overall Study|Disease progression|25|||
161705483|NCT00723957|583967877|FG000|Overall Study|Maximum clinical benefit|4|||
161705484|NCT00723957|583967878|FG001|Overall Study|Maximum clinical benefit|5|||
161705485|NCT00723957|583967877|FG000|Overall Study|Investigator decision|1|||
161705486|NCT00723957|583967878|FG001|Overall Study|Investigator decision|1|||
161705487|NCT00723957|583967877|FG000|Overall Study|Study drug toxicity|4|||
161705488|NCT00723957|583967878|FG001|Overall Study|Study drug toxicity|6|||
161705489|NCT00723957|583967877|FG000|Overall Study|Withdrawal by Subject|7|||
161705490|NCT00723957|583967878|FG001|Overall Study|Withdrawal by Subject|5|||
161705491|NCT00723957|583967877|FG000|Overall Study|Reason not analyzed|1|||
161705492|NCT00723957|583967878|FG001|Overall Study|Reason not analyzed|0|||
161705493|NCT00723957|583967877|FG000|Overall Study|Never received treatment|3|||
161705494|NCT00723957|583967878|FG001|Overall Study|Never received treatment|3|||
161705495|NCT01763164|583967880|FG000|Treatment Phase|Participant/Guardian decision|26|||
161705496|NCT01763164|583967881|FG001|Treatment Phase|Participant/Guardian decision|14|||
161705497|NCT01763164|583967880|FG000|Treatment Phase|Protocol Violation|1|||
161705498|NCT01763164|583967881|FG001|Treatment Phase|Protocol Violation|1|||
161705499|NCT01763164|583967880|FG000|Treatment Phase|Progressive Disease|142|||
161705500|NCT01763164|583967881|FG001|Treatment Phase|Progressive Disease|76|||
161705501|NCT01763164|583967880|FG000|Treatment Phase|Physician Decision|24|||
161705502|NCT01763164|583967881|FG001|Treatment Phase|Physician Decision|13|||
161705503|NCT01763164|583967880|FG000|Treatment Phase|Death|10|||
161705504|NCT01763164|583967881|FG001|Treatment Phase|Death|1|||
161705505|NCT01763164|583967880|FG000|Treatment Phase|Adverse Event|66|||
161705506|NCT01763164|583967881|FG001|Treatment Phase|Adverse Event|8|||
161705507|NCT01763164|583967880|FG000|Treatment Phase|Randomized but not Treated|0|||
161705508|NCT01763164|583967881|FG001|Treatment Phase|Randomized but not Treated|19|||
161705509|NCT01763164|583967880|FG000|Treatment Phase|Other|0|||
161705510|NCT01763164|583967881|FG001|Treatment Phase|Other|1|||
161705511|NCT01763164|583967880|FG000|Follow up Phase|New therapy for study indication|12|||
161705512|NCT01763164|583967881|FG001|Follow up Phase|New therapy for study indication|3|||
161705513|NCT01763164|583967880|FG000|Follow up Phase|Death|21|||
161705514|NCT01763164|583967881|FG001|Follow up Phase|Death|4|||
161705515|NCT01763164|583967880|FG000|Follow up Phase|Subject/guardian decision|9|||
161958113|NCT01947283|584892683|FG003|Overall Study|Missing Follow-up Assessment|0|||
161958114|NCT01947283|584892684|FG004|Overall Study|Missing Follow-up Assessment|0|||
161958115|NCT01947283|584892685|FG005|Overall Study|Missing Follow-up Assessment|2|||
161705516|NCT01763164|583967881|FG001|Follow up Phase|Subject/guardian decision|2|||
161705517|NCT01763164|583967880|FG000|Follow up Phase|Progressive disease|127|||
161705518|NCT01763164|583967881|FG001|Follow up Phase|Progressive disease|62|||
161837584|NCT00359632|584448657|FG000|Overall Study|Adverse Event|1|||
161705519|NCT01763164|583967880|FG000|Follow up Phase|Physician Decision|10|||
161705520|NCT01763164|583967881|FG001|Follow up Phase|Physician Decision|3|||
161705521|NCT01763164|583967880|FG000|Follow up Phase|Lost to Follow-up|1|||
161705522|NCT01763164|583967881|FG001|Follow up Phase|Lost to Follow-up|0|||
161705523|NCT01763164|583967880|FG000|Follow up Phase|Adverse Event|17|||
161705524|NCT01763164|583967881|FG001|Follow up Phase|Adverse Event|1|||
161705525|NCT01264939|583967882|FG000|Overall Study|Adverse Event|1|||
161705526|NCT01264939|583967883|FG001|Overall Study|Adverse Event|3|||
161705527|NCT01264939|583967882|FG000|Overall Study|Lost to Follow-up|0|||
161705528|NCT01264939|583967883|FG001|Overall Study|Lost to Follow-up|3|||
161705529|NCT01264939|583967882|FG000|Overall Study|Physician Decision|1|||
161705530|NCT01264939|583967883|FG001|Overall Study|Physician Decision|1|||
161705531|NCT01264939|583967882|FG000|Overall Study|Patient/Guardian Decision|8|||
161705532|NCT01264939|583967883|FG001|Overall Study|Patient/Guardian Decision|10|||
161705533|NCT01264939|583967882|FG000|Overall Study|Disease Progression|8|||
161705534|NCT01264939|583967883|FG001|Overall Study|Disease Progression|11|||
161705535|NCT04964258|583967884|FG000|Overall Study|Lost to Follow-up|1|||
161705536|NCT04964258|583967885|FG001|Overall Study|Lost to Follow-up|0|||
161705537|NCT04964258|583967886|FG002|Overall Study|Lost to Follow-up|0|||
161705538|NCT04964258|583967887|FG003|Overall Study|Lost to Follow-up|0|||
161705539|NCT04964258|583967888|FG004|Overall Study|Lost to Follow-up|0|||
161705540|NCT04964258|583967889|FG005|Overall Study|Lost to Follow-up|1|||
161705541|NCT04964258|583967890|FG006|Overall Study|Lost to Follow-up|0|||
161705542|NCT04964258|583967891|FG007|Overall Study|Lost to Follow-up|0|||
161705543|NCT04964258|583967892|FG008|Overall Study|Lost to Follow-up|0|||
161705544|NCT04964258|583967893|FG009|Overall Study|Lost to Follow-up|0|||
161705545|NCT04964258|583967894|FG010|Overall Study|Lost to Follow-up|0|||
161705546|NCT02965378|583967895|FG000|Overall Study|Progression|16|||
161705547|NCT02965378|583967896|FG001|Overall Study|Progression|4|||
161705548|NCT02965378|583967895|FG000|Overall Study|Adverse Event|5|||
161705549|NCT02965378|583967896|FG001|Overall Study|Adverse Event|2|||
161705550|NCT02965378|583967895|FG000|Overall Study|Death|2|||
161705551|NCT02965378|583967896|FG001|Overall Study|Death|0|||
161705552|NCT02965378|583967895|FG000|Overall Study|Refusal|2|||
161705553|NCT02965378|583967896|FG001|Overall Study|Refusal|1|||
161705554|NCT02965378|583967895|FG000|Overall Study|Not protocol specified|0|||
161705555|NCT02965378|583967896|FG001|Overall Study|Not protocol specified|2|||
161705556|NCT01384292|583967899|FG000|Part B|Severe non-compliance to protocol|1|||
161705557|NCT01384292|583967900|FG001|Part B|Severe non-compliance to protocol|0|||
161705558|NCT01384292|583967901|FG002|Part B|Severe non-compliance to protocol|0|||
161705559|NCT01171612|583967903|FG000|Overall Study|Lost to Follow-up|51|||
161705560|NCT04525703|583967904|FG000|Overall Study|Lost to Follow-up|6|||
161705561|NCT04525703|583967905|FG001|Overall Study|Lost to Follow-up|15|||
161705562|NCT04525703|583967906|FG002|Overall Study|Lost to Follow-up|8|||
161705563|NCT01285349|583967907|FG000|Overall Study|Lost to Follow-up|27|||
161705564|NCT01285349|583967908|FG001|Overall Study|Lost to Follow-up|20|||
161705565|NCT01285349|583967909|FG002|Overall Study|Lost to Follow-up|27|||
161705566|NCT00565617|583967910|FG000|Overall Study|Withdrawal by Subject|1|||
161705567|NCT01526148|583967916|FG000|Overall Study|Adverse Event|6|||
161705568|NCT01526148|583967917|FG001|Overall Study|Adverse Event|5|||
161705569|NCT01526148|583967916|FG000|Overall Study|Lost to Follow-up|3|||
161705570|NCT01526148|583967917|FG001|Overall Study|Lost to Follow-up|6|||
161705571|NCT01526148|583967916|FG000|Overall Study|Withdrawal by Subject|2|||
161705572|NCT01526148|583967917|FG001|Overall Study|Withdrawal by Subject|0|||
161705573|NCT01526148|583967916|FG000|Overall Study|Unstable Medical Condition|1|||
161705574|NCT01526148|583967917|FG001|Overall Study|Unstable Medical Condition|0|||
161705575|NCT01526148|583967916|FG000|Overall Study|Unable to discontinue concomitant med|1|||
161705576|NCT01526148|583967917|FG001|Overall Study|Unable to discontinue concomitant med|0|||
161705577|NCT01526148|583967916|FG000|Overall Study|Moved out of state|1|||
161705578|NCT01526148|583967917|FG001|Overall Study|Moved out of state|0|||
161705579|NCT01526148|583967916|FG000|Overall Study|Incarcerated|0|||
161705580|NCT01526148|583967917|FG001|Overall Study|Incarcerated|2|||
161705581|NCT01173653|583967918|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
161705582|NCT01173653|583967919|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
161705583|NCT00996203|583967922|FG000|Overall Study|Adverse Event|3|||
161705584|NCT00996203|583967922|FG000|Overall Study|Lost to Follow-up|1|||
161705585|NCT00996203|583967922|FG000|Overall Study|Lack of Efficacy|1|||
161705586|NCT00996203|583967922|FG000|Overall Study|Protocol Violation|2|||
161705587|NCT01671280|583967923|FG000|Overall Study|Withdrawal by Subject|2|||
161705588|NCT01959165|583967924|FG000|Overall Study|Adverse Event|0|||
161705589|NCT01959165|583967925|FG001|Overall Study|Adverse Event|0|||
161705590|NCT01959165|583967926|FG002|Overall Study|Adverse Event|0|||
161705591|NCT01959165|583967927|FG003|Overall Study|Adverse Event|1|||
161705592|NCT01959165|583967924|FG000|Overall Study|Lack of Efficacy|1|||
161705593|NCT01959165|583967925|FG001|Overall Study|Lack of Efficacy|0|||
161705594|NCT01959165|583967926|FG002|Overall Study|Lack of Efficacy|0|||
161705595|NCT01959165|583967927|FG003|Overall Study|Lack of Efficacy|0|||
161705596|NCT01959165|583967924|FG000|Overall Study|overdose|0|||
161705597|NCT01959165|583967925|FG001|Overall Study|overdose|0|||
161705598|NCT01959165|583967926|FG002|Overall Study|overdose|0|||
161705599|NCT01959165|583967927|FG003|Overall Study|overdose|1|||
161705600|NCT01959165|583967924|FG000|Overall Study|Welfare recipient|0|||
161705601|NCT01959165|583967925|FG001|Overall Study|Welfare recipient|1|||
161705602|NCT01959165|583967926|FG002|Overall Study|Welfare recipient|0|||
161705603|NCT01959165|583967927|FG003|Overall Study|Welfare recipient|0|||
161705604|NCT03529409|583967937|FG000|Randomized|Lost to Follow-up|0|||
161705605|NCT03529409|583967938|FG001|Randomized|Lost to Follow-up|0|||
161705606|NCT03529409|583967939|FG002|Randomized|Lost to Follow-up|4|||
161705607|NCT03529409|583967937|FG000|Randomized|Excluded|0|||
161705608|NCT03529409|583967938|FG001|Randomized|Excluded|0|||
161705609|NCT03529409|583967939|FG002|Randomized|Excluded|1|||
161705610|NCT03529409|583967937|FG000|Post-treatment Assessment|Death|1|||
161705611|NCT03529409|583967938|FG001|Post-treatment Assessment|Death|0|||
161705612|NCT03529409|583967939|FG002|Post-treatment Assessment|Death|0|||
161705613|NCT03529409|583967937|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
161705614|NCT03529409|583967938|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
161705615|NCT03529409|583967939|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
161705616|NCT03529409|583967937|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
161705617|NCT03529409|583967938|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
161705618|NCT03529409|583967939|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
161705619|NCT03529409|583967937|FG000|Follow-up Assessment|Death|1|||
161705620|NCT03529409|583967938|FG001|Follow-up Assessment|Death|0|||
161705621|NCT03529409|583967939|FG002|Follow-up Assessment|Death|0|||
161705622|NCT03529409|583967937|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
161705623|NCT03529409|583967938|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
161705624|NCT03529409|583967939|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
161705625|NCT01497262|583967940|FG000|Overall Study|Abnormal Lab Values|4|||
161705626|NCT01497262|583967940|FG000|Overall Study|Abnormal Test Procedure Result|1|||
161705627|NCT01497262|583967940|FG000|Overall Study|Physician Decision|1|||
161705628|NCT01497262|583967940|FG000|Overall Study|Withdrawal by Subject|2|||
161705629|NCT01497262|583967940|FG000|Overall Study|Adverse Event|2|||
161705630|NCT01497262|583967940|FG000|Overall Study|Protocol Violation|1|||
161705631|NCT03898063|583967943|FG000|Overall Study|Withdrawal by Subject|10|||
161705632|NCT03898063|583967944|FG001|Overall Study|Withdrawal by Subject|8|||
161705633|NCT03430986|583967947|FG000|24-week Control Period|Adverse Event|1|||
161705634|NCT03430986|583967948|FG001|24-week Control Period|Adverse Event|0|||
161705635|NCT03430986|583967947|FG000|24-week Control Period|Lost to Follow-up|2|||
161705636|NCT03430986|583967948|FG001|24-week Control Period|Lost to Follow-up|2|||
161705637|NCT03430986|583967947|FG000|24-week Control Period|Withdrawal by Participant|5|||
161705638|NCT03430986|583967948|FG001|24-week Control Period|Withdrawal by Participant|0|||
161705639|NCT03430986|583967947|FG000|24-week Control Period|Protocol Deviation|0|||
161705640|NCT03430986|583967948|FG001|24-week Control Period|Protocol Deviation|2|||
161705641|NCT03430986|583967947|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
161705642|NCT03430986|583967948|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
161705643|NCT03430986|583967947|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
161705644|NCT03430986|583967948|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
161705645|NCT01889602|583967951|FG000|First Intervention|Adverse Event|1|||
161705646|NCT01889602|583967952|FG001|First Intervention|Adverse Event|1|||
161837585|NCT00359632|584448658|FG001|Overall Study|Adverse Event|0|||
161837586|NCT00359632|584448657|FG000|Overall Study|Non-compliance with visit schedule|1|||
161837587|NCT00359632|584448658|FG001|Overall Study|Non-compliance with visit schedule|0|||
161837588|NCT03978091|584448659|FG000|Overall Study|Lost to Follow-up|0|||
161837589|NCT03978091|584448660|FG001|Overall Study|Lost to Follow-up|0|||
161837590|NCT03978091|584448661|FG002|Overall Study|Lost to Follow-up|1|||
161837591|NCT03978091|584448662|FG003|Overall Study|Lost to Follow-up|0|||
161837592|NCT03978091|584448663|FG004|Overall Study|Lost to Follow-up|0|||
161837593|NCT03978091|584448664|FG005|Overall Study|Lost to Follow-up|0|||
161837594|NCT03978091|584448659|FG000|Overall Study|Withdrawal by Subject|0|||
161837595|NCT03978091|584448660|FG001|Overall Study|Withdrawal by Subject|0|||
161837596|NCT03978091|584448661|FG002|Overall Study|Withdrawal by Subject|0|||
161837597|NCT03978091|584448662|FG003|Overall Study|Withdrawal by Subject|1|||
161837598|NCT03978091|584448663|FG004|Overall Study|Withdrawal by Subject|1|||
161837599|NCT03978091|584448664|FG005|Overall Study|Withdrawal by Subject|0|||
161837600|NCT04700280|584448668|FG000|Overall Study|Adverse Event|4|||
161837601|NCT04700280|584448669|FG001|Overall Study|Adverse Event|0|||
161837602|NCT04700280|584448668|FG000|Overall Study|Lack of Efficacy|1|||
161837603|NCT04700280|584448669|FG001|Overall Study|Lack of Efficacy|0|||
161837604|NCT04700280|584448668|FG000|Overall Study|Study terminated by sponsor|5|||
161837605|NCT04700280|584448669|FG001|Overall Study|Study terminated by sponsor|3|||
161837606|NCT04700280|584448668|FG000|Overall Study|Other than specified|1|||
161837607|NCT04700280|584448669|FG001|Overall Study|Other than specified|0|||
161837608|NCT02093221|584448670|FG000|Overall Study|Adverse Event|1|||
161837609|NCT02093221|584448671|FG001|Overall Study|Adverse Event|0|||
161837610|NCT02093221|584448672|FG002|Overall Study|Adverse Event|0|||
161837611|NCT02093221|584448673|FG003|Overall Study|Adverse Event|0|||
161837612|NCT02093221|584448674|FG004|Overall Study|Adverse Event|0|||
161705647|NCT01889602|583967953|FG002|First Intervention|Adverse Event|1|||
161705648|NCT01889602|583967951|FG000|First Intervention|Protocol Violation|0|||
161705649|NCT01889602|583967952|FG001|First Intervention|Protocol Violation|1|||
161705650|NCT01889602|583967953|FG002|First Intervention|Protocol Violation|1|||
161705651|NCT01889602|583967951|FG000|First Intervention|Study ending|0|||
161705652|NCT01889602|583967952|FG001|First Intervention|Study ending|1|||
161705653|NCT01889602|583967953|FG002|First Intervention|Study ending|0|||
161705654|NCT01889602|583967951|FG000|Second Intervention|Adverse Event|0|||
161705655|NCT01889602|583967952|FG001|Second Intervention|Adverse Event|0|||
161705656|NCT01889602|583967953|FG002|Second Intervention|Adverse Event|1|||
161705657|NCT01889602|583967951|FG000|Second Intervention|Study ending|1|||
161705658|NCT01889602|583967952|FG001|Second Intervention|Study ending|0|||
161705659|NCT01889602|583967953|FG002|Second Intervention|Study ending|0|||
161705660|NCT01889602|583967951|FG000|Second Intervention|Withdrawal by Subject|0|||
161705661|NCT01889602|583967952|FG001|Second Intervention|Withdrawal by Subject|0|||
161705662|NCT01889602|583967953|FG002|Second Intervention|Withdrawal by Subject|1|||
161705663|NCT01889602|583967951|FG000|Third Intervention|Protocol Violation|1|||
161705664|NCT01889602|583967952|FG001|Third Intervention|Protocol Violation|0|||
161705665|NCT01889602|583967953|FG002|Third Intervention|Protocol Violation|0|||
161705666|NCT01889602|583967951|FG000|Third Intervention|Withdrawal by Subject|2|||
161705667|NCT01889602|583967952|FG001|Third Intervention|Withdrawal by Subject|2|||
161705668|NCT01889602|583967953|FG002|Third Intervention|Withdrawal by Subject|0|||
161705669|NCT00961961|583967954|FG000|Phase I|Withdrawal by Subject|7|||
161705670|NCT00961961|583967955|FG001|Phase I|Withdrawal by Subject|0|||
161705671|NCT00961961|583967956|FG002|Phase I|Withdrawal by Subject|0|||
161705672|NCT00961961|583967957|FG003|Phase I|Withdrawal by Subject|0|||
161705673|NCT00961961|583967954|FG000|Phase I|Lost to Follow-up|10|||
161705674|NCT00961961|583967955|FG001|Phase I|Lost to Follow-up|0|||
161705675|NCT00961961|583967956|FG002|Phase I|Lost to Follow-up|0|||
161705676|NCT00961961|583967957|FG003|Phase I|Lost to Follow-up|0|||
161705677|NCT00961961|583967954|FG000|Phase I|Lack of Efficacy|94|||
161705678|NCT00961961|583967955|FG001|Phase I|Lack of Efficacy|0|||
161705679|NCT00961961|583967956|FG002|Phase I|Lack of Efficacy|0|||
161705680|NCT00961961|583967957|FG003|Phase I|Lack of Efficacy|0|||
161705681|NCT00961961|583967954|FG000|Phase I|Adverse Event|7|||
161705682|NCT00961961|583967955|FG001|Phase I|Adverse Event|0|||
161705683|NCT00961961|583967956|FG002|Phase I|Adverse Event|0|||
161705684|NCT00961961|583967957|FG003|Phase I|Adverse Event|0|||
161705685|NCT00961961|583967954|FG000|Phase I|Physician Decision|8|||
161705686|NCT00961961|583967955|FG001|Phase I|Physician Decision|0|||
161705687|NCT00961961|583967956|FG002|Phase I|Physician Decision|0|||
161705688|NCT00961961|583967957|FG003|Phase I|Physician Decision|0|||
161705689|NCT00961961|583967954|FG000|Phase II|Lost to Follow-up|0|||
161705690|NCT00961961|583967955|FG001|Phase II|Lost to Follow-up|0|||
161705691|NCT00961961|583967956|FG002|Phase II|Lost to Follow-up|10|||
161705692|NCT00961961|583967957|FG003|Phase II|Lost to Follow-up|7|||
161705693|NCT00961961|583967954|FG000|Phase II|Adverse Event|0|||
161705694|NCT00961961|583967955|FG001|Phase II|Adverse Event|0|||
161705695|NCT00961961|583967956|FG002|Phase II|Adverse Event|0|||
161705696|NCT00961961|583967957|FG003|Phase II|Adverse Event|1|||
161705697|NCT00961961|583967954|FG000|Phase II|Physician Decision|0|||
161705698|NCT00961961|583967955|FG001|Phase II|Physician Decision|0|||
161705699|NCT00961961|583967956|FG002|Phase II|Physician Decision|1|||
161705700|NCT00961961|583967957|FG003|Phase II|Physician Decision|0|||
161705701|NCT00961961|583967954|FG000|Phase II|Withdrawal by Subject|0|||
161705702|NCT00961961|583967955|FG001|Phase II|Withdrawal by Subject|0|||
161705703|NCT00961961|583967956|FG002|Phase II|Withdrawal by Subject|1|||
161705704|NCT00961961|583967957|FG003|Phase II|Withdrawal by Subject|0|||
161705705|NCT01412957|583967958|FG000|Overall Study|Withdrawal by Subject|6|||
161837613|NCT02093221|584448670|FG000|Overall Study|Withdrawal by Subject|1|||
161837614|NCT02093221|584448671|FG001|Overall Study|Withdrawal by Subject|1|||
161837615|NCT02093221|584448672|FG002|Overall Study|Withdrawal by Subject|4|||
161837616|NCT02093221|584448673|FG003|Overall Study|Withdrawal by Subject|1|||
161837617|NCT02093221|584448674|FG004|Overall Study|Withdrawal by Subject|1|||
161837618|NCT02093221|584448670|FG000|Overall Study|Lost to Follow-up|2|||
161837619|NCT02093221|584448671|FG001|Overall Study|Lost to Follow-up|0|||
161837620|NCT02093221|584448672|FG002|Overall Study|Lost to Follow-up|1|||
161705706|NCT01412957|583967959|FG001|Overall Study|Withdrawal by Subject|22|||
161705707|NCT01412957|583967958|FG000|Overall Study|Lost to Follow-up|7|||
161705708|NCT01412957|583967959|FG001|Overall Study|Lost to Follow-up|2|||
161837621|NCT02093221|584448673|FG003|Overall Study|Lost to Follow-up|1|||
161705709|NCT01412957|583967958|FG000|Overall Study|Death|136|||
161837622|NCT02093221|584448674|FG004|Overall Study|Lost to Follow-up|0|||
161837623|NCT02093221|584448670|FG000|Overall Study|Death|0|||
161705710|NCT01412957|583967959|FG001|Overall Study|Death|133|||
161705711|NCT01870739|583967965|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
161705712|NCT01870739|583967966|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
161705713|NCT01870739|583967965|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
161837624|NCT02093221|584448671|FG001|Overall Study|Death|1|||
161837625|NCT02093221|584448672|FG002|Overall Study|Death|0|||
161705714|NCT01870739|583967966|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
161705715|NCT01870739|583967965|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
161705716|NCT01870739|583967966|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
161705717|NCT01870739|583967965|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
161705718|NCT01870739|583967966|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
161705719|NCT01870739|583967965|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
161705720|NCT01870739|583967966|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
161705721|NCT01870739|583967965|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
161705722|NCT01870739|583967966|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
161705723|NCT01870739|583967965|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
161705724|NCT01870739|583967966|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
161705725|NCT02425098|583967968|FG000|Overall Study|Lost to Follow-up|7|||
161705726|NCT02425098|583967969|FG001|Overall Study|Lost to Follow-up|7|||
161705727|NCT02425098|583967968|FG000|Overall Study|Withdrawal by Subject|4|||
161705728|NCT02425098|583967969|FG001|Overall Study|Withdrawal by Subject|8|||
161705729|NCT02425098|583967968|FG000|Overall Study|Pregnancy|2|||
161705730|NCT02425098|583967969|FG001|Overall Study|Pregnancy|0|||
161705731|NCT02425098|583967968|FG000|Overall Study|Reason not Specified|0|||
161705732|NCT02425098|583967969|FG001|Overall Study|Reason not Specified|1|||
161705733|NCT01926626|583967979|FG000|Overall Study|Withdrawal by Subject|15|||
161705734|NCT01926626|583967979|FG000|Overall Study|Lost to Follow-up|7|||
161705735|NCT03283085|583967980|FG000|Overall Study|Adverse Event|18|||
161705736|NCT03283085|583967981|FG001|Overall Study|Adverse Event|3|||
161705737|NCT03283085|583967982|FG002|Overall Study|Adverse Event|13|||
161705738|NCT03283085|583967983|FG003|Overall Study|Adverse Event|0|||
161705739|NCT03283085|583967984|FG004|Overall Study|Adverse Event|0|||
161705740|NCT03283085|583967985|FG005|Overall Study|Adverse Event|5|||
161705741|NCT03283085|583967980|FG000|Overall Study|Death|0|||
161705742|NCT03283085|583967981|FG001|Overall Study|Death|0|||
161705743|NCT03283085|583967982|FG002|Overall Study|Death|3|||
161705744|NCT03283085|583967983|FG003|Overall Study|Death|1|||
161705745|NCT03283085|583967984|FG004|Overall Study|Death|0|||
161705746|NCT03283085|583967985|FG005|Overall Study|Death|0|||
161705747|NCT03283085|583967980|FG000|Overall Study|Withdrawal by Subject|42|||
161705748|NCT03283085|583967981|FG001|Overall Study|Withdrawal by Subject|21|||
161705749|NCT03283085|583967982|FG002|Overall Study|Withdrawal by Subject|66|||
161705750|NCT03283085|583967983|FG003|Overall Study|Withdrawal by Subject|3|||
161705751|NCT03283085|583967984|FG004|Overall Study|Withdrawal by Subject|3|||
161705752|NCT03283085|583967985|FG005|Overall Study|Withdrawal by Subject|5|||
161705753|NCT03283085|583967980|FG000|Overall Study|Physician Decision|14|||
161705754|NCT03283085|583967981|FG001|Overall Study|Physician Decision|8|||
161705755|NCT03283085|583967982|FG002|Overall Study|Physician Decision|19|||
161705756|NCT03283085|583967983|FG003|Overall Study|Physician Decision|0|||
161705757|NCT03283085|583967984|FG004|Overall Study|Physician Decision|0|||
161705758|NCT03283085|583967985|FG005|Overall Study|Physician Decision|2|||
161705759|NCT03283085|583967980|FG000|Overall Study|Site Terminated by Sponsor|1|||
161705760|NCT03283085|583967981|FG001|Overall Study|Site Terminated by Sponsor|0|||
161705761|NCT03283085|583967982|FG002|Overall Study|Site Terminated by Sponsor|3|||
161705762|NCT03283085|583967983|FG003|Overall Study|Site Terminated by Sponsor|0|||
161705763|NCT03283085|583967984|FG004|Overall Study|Site Terminated by Sponsor|0|||
161705764|NCT03283085|583967985|FG005|Overall Study|Site Terminated by Sponsor|0|||
161705765|NCT03283085|583967980|FG000|Overall Study|Lost to Follow-up|2|||
161705766|NCT03283085|583967981|FG001|Overall Study|Lost to Follow-up|0|||
161705767|NCT03283085|583967982|FG002|Overall Study|Lost to Follow-up|2|||
161705768|NCT03283085|583967983|FG003|Overall Study|Lost to Follow-up|0|||
161705769|NCT03283085|583967984|FG004|Overall Study|Lost to Follow-up|0|||
161705770|NCT03283085|583967985|FG005|Overall Study|Lost to Follow-up|1|||
161705771|NCT03283085|583967980|FG000|Overall Study|Pregnancy|0|||
161705772|NCT03283085|583967981|FG001|Overall Study|Pregnancy|0|||
161705773|NCT03283085|583967982|FG002|Overall Study|Pregnancy|1|||
161705774|NCT03283085|583967983|FG003|Overall Study|Pregnancy|0|||
161705775|NCT03283085|583967984|FG004|Overall Study|Pregnancy|0|||
161705776|NCT03283085|583967985|FG005|Overall Study|Pregnancy|0|||
161705777|NCT03283085|583967980|FG000|Overall Study|Lack of Efficacy|12|||
161705778|NCT03283085|583967981|FG001|Overall Study|Lack of Efficacy|6|||
161958116|NCT01947283|584892686|FG006|Overall Study|Missing Follow-up Assessment|0|||
161705779|NCT03283085|583967982|FG002|Overall Study|Lack of Efficacy|24|||
161705780|NCT03283085|583967983|FG003|Overall Study|Lack of Efficacy|1|||
161705781|NCT03283085|583967984|FG004|Overall Study|Lack of Efficacy|1|||
161705782|NCT03283085|583967985|FG005|Overall Study|Lack of Efficacy|0|||
161705783|NCT03283085|583967980|FG000|Overall Study|Reason not Specified|0|||
161705784|NCT03283085|583967981|FG001|Overall Study|Reason not Specified|4|||
161705785|NCT03283085|583967982|FG002|Overall Study|Reason not Specified|8|||
161705786|NCT03283085|583967983|FG003|Overall Study|Reason not Specified|0|||
161958117|NCT01947283|584892680|FG000|Overall Study|No patients were enrolled in study|0|||
161958118|NCT01947283|584892681|FG001|Overall Study|No patients were enrolled in study|0|||
161705787|NCT03283085|583967984|FG004|Overall Study|Reason not Specified|0|||
161705788|NCT03283085|583967985|FG005|Overall Study|Reason not Specified|1|||
161705789|NCT03636906|583967986|FG000|Overall Study|Adverse Event|0|||
161705790|NCT03636906|583967987|FG001|Overall Study|Adverse Event|0|||
161705791|NCT03636906|583967988|FG002|Overall Study|Adverse Event|1|||
161705792|NCT03636906|583967986|FG000|Overall Study|Lost to Follow-up|1|||
161705793|NCT03636906|583967987|FG001|Overall Study|Lost to Follow-up|0|||
161705794|NCT03636906|583967988|FG002|Overall Study|Lost to Follow-up|0|||
161705795|NCT03636906|583967986|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
161705796|NCT03636906|583967987|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
161705797|NCT03636906|583967988|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
161705798|NCT03636906|583967986|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
161705799|NCT03636906|583967987|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161705800|NCT03636906|583967988|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
161705801|NCT03636906|583967986|FG000|Overall Study|Other|0|||
161705802|NCT03636906|583967987|FG001|Overall Study|Other|0|||
161705803|NCT03636906|583967988|FG002|Overall Study|Other|1|||
161705804|NCT02292771|583967994|FG000|Overall Study|Withdrawal by Subject|2|||
161705805|NCT02292771|583967995|FG001|Overall Study|Withdrawal by Subject|1|||
161705806|NCT02292771|583967994|FG000|Overall Study|Lost to Follow-up|2|||
161705807|NCT02292771|583967995|FG001|Overall Study|Lost to Follow-up|1|||
161705808|NCT04280081|583967997|FG000|Overall Study|Adverse Event|4|||
161705809|NCT04280081|583967997|FG000|Overall Study|Death|2|||
161705810|NCT04280081|583967997|FG000|Overall Study|Progressive Disease|6|||
161705811|NCT01468311|583967998|FG000|Overall Study|mobilization failure|1|||
161705812|NCT01468311|583967998|FG000|Overall Study|Withdrawal by Subject|1|||
161705813|NCT06001307|583969203|FG000|Overall Study|Lost to Follow-up|1|||
161705814|NCT06001307|583969204|FG001|Overall Study|Lost to Follow-up|2|||
161705815|NCT03532100|583969207|FG000|Overall Study|Intervention malfunction|1|||
161705816|NCT03896581|583969208|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
161705817|NCT03896581|583969209|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
161705818|NCT03896581|583969208|FG000|Overall Study|Withdrawal by Subject|4|||
161705819|NCT03896581|583969209|FG001|Overall Study|Withdrawal by Subject|1|||
161705820|NCT03896581|583969208|FG000|Overall Study|Lost to Follow-up|1|||
161705821|NCT03896581|583969209|FG001|Overall Study|Lost to Follow-up|0|||
161705822|NCT03896581|583969208|FG000|Overall Study|Lack of Efficacy|2|||
161705823|NCT03896581|583969209|FG001|Overall Study|Lack of Efficacy|1|||
161705824|NCT03896581|583969208|FG000|Overall Study|Adverse event, non-fatal|0|||
161705825|NCT03896581|583969209|FG001|Overall Study|Adverse event, non-fatal|2|||
161705826|NCT00162773|583969216|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
161705827|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
161705828|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
161705829|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
161705830|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
161705831|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
161705832|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
161705833|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
161705834|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
161705835|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
161705836|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
161837626|NCT02093221|584448673|FG003|Overall Study|Death|0|||
161837627|NCT02093221|584448674|FG004|Overall Study|Death|0|||
161837628|NCT02093221|584448670|FG000|Overall Study|Protocol Violation|0|||
161837629|NCT02093221|584448671|FG001|Overall Study|Protocol Violation|1|||
161837630|NCT02093221|584448672|FG002|Overall Study|Protocol Violation|0|||
161837631|NCT02093221|584448673|FG003|Overall Study|Protocol Violation|0|||
161837632|NCT02093221|584448674|FG004|Overall Study|Protocol Violation|0|||
161837633|NCT02093221|584448670|FG000|Overall Study|Study termination|6|||
161837634|NCT02093221|584448671|FG001|Overall Study|Study termination|5|||
161837635|NCT02093221|584448672|FG002|Overall Study|Study termination|4|||
161837636|NCT02093221|584448673|FG003|Overall Study|Study termination|6|||
161837637|NCT02093221|584448674|FG004|Overall Study|Study termination|7|||
161837638|NCT00725621|584448675|FG000|Overall Study|Adverse Event|25|||
161837639|NCT00725621|584448675|FG000|Overall Study|Lack of Efficacy|46|||
161837640|NCT00725621|584448675|FG000|Overall Study|Withdrawal by Subject|57|||
161837641|NCT00725621|584448675|FG000|Overall Study|Physician Decision|19|||
161837642|NCT00725621|584448675|FG000|Overall Study|Lost to Follow-up|52|||
161705837|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
161705838|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
161705839|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
161705840|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
161705841|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
161837643|NCT00725621|584448675|FG000|Overall Study|Non-compliance|8|||
161837644|NCT00725621|584448675|FG000|Overall Study|Continued treatment by other physician|6|||
161837645|NCT00725621|584448675|FG000|Overall Study|Switched to other study|1|||
161958119|NCT01947283|584892682|FG002|Overall Study|No patients were enrolled in study|0|||
161705842|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
161705843|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
161705844|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
161705845|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
161705846|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
161705847|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
161705848|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
161705849|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
161705850|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
161705851|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
161705852|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
161705853|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
161705854|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
161705855|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
161705856|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
161705857|NCT02660580|583969228|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
161705858|NCT02660580|583969229|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
161705859|NCT02660580|583969230|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
161705860|NCT02660580|583969231|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
161705861|NCT02660580|583969232|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
161705862|NCT02660580|583969228|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
161705863|NCT02660580|583969229|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
161705864|NCT02660580|583969230|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
161705865|NCT02660580|583969231|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
161705866|NCT02660580|583969232|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
161705867|NCT02660580|583969228|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
161705868|NCT02660580|583969229|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
161958120|NCT01947283|584892683|FG003|Overall Study|No patients were enrolled in study|0|||
161958121|NCT01947283|584892684|FG004|Overall Study|No patients were enrolled in study|0|||
161958122|NCT01947283|584892685|FG005|Overall Study|No patients were enrolled in study|3|||
161958123|NCT01947283|584892686|FG006|Overall Study|No patients were enrolled in study|1|||
161958124|NCT04729972|584892687|FG000|Overall Study|Adverse Event|1|||
161958125|NCT05002985|584892688|FG000|Overall Study|Withdrawal by Subject|1|||
161958126|NCT03782259|584892689|FG000|Overall Study|Lost to Follow-up|1|||
161958127|NCT03782259|584892690|FG001|Overall Study|Lost to Follow-up|1|||
161958128|NCT03782259|584892689|FG000|Overall Study|Moved out of state|0|||
161958129|NCT03782259|584892690|FG001|Overall Study|Moved out of state|2|||
161958130|NCT03782259|584892689|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
161958131|NCT03782259|584892690|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
161958132|NCT03782259|584892689|FG000|Overall Study|Subject discontinued intervention|1|||
161958133|NCT03782259|584892690|FG001|Overall Study|Subject discontinued intervention|0|||
161958134|NCT00603941|584892691|FG000|Overall Study|Disease progression|6|||
161958135|NCT00603941|584892692|FG001|Overall Study|Disease progression|7|||
161958136|NCT00603941|584892693|FG002|Overall Study|Disease progression|1|||
161958137|NCT00603941|584892691|FG000|Overall Study|Adverse Event|1|||
161958138|NCT00603941|584892692|FG001|Overall Study|Adverse Event|0|||
161958139|NCT00603941|584892693|FG002|Overall Study|Adverse Event|1|||
161958140|NCT00603941|584892691|FG000|Overall Study|Physician Decision|0|||
161958141|NCT00603941|584892692|FG001|Overall Study|Physician Decision|1|||
161958142|NCT00603941|584892693|FG002|Overall Study|Physician Decision|0|||
161958143|NCT00603941|584892691|FG000|Overall Study|Withdrawal by Subject|0|||
161958144|NCT00603941|584892692|FG001|Overall Study|Withdrawal by Subject|2|||
161958145|NCT00603941|584892693|FG002|Overall Study|Withdrawal by Subject|0|||
161705869|NCT02660580|583969230|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
161705870|NCT02660580|583969231|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
161705871|NCT02660580|583969232|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
161705872|NCT02660580|583969228|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
161705873|NCT02660580|583969229|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
161705874|NCT02660580|583969230|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
161705875|NCT02660580|583969231|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
161705876|NCT02660580|583969232|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
161958146|NCT00249808|584892694|FG000|Overall Study|Other|27|||
161958147|NCT00249808|584892694|FG000|Overall Study|Protocol Violation|3|||
161958148|NCT00249808|584892694|FG000|Overall Study|Lost to Follow-up|8|||
161958149|NCT00249808|584892694|FG000|Overall Study|Adverse Event|81|||
161705877|NCT02660580|583969228|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
161958150|NCT00249808|584892694|FG000|Overall Study|Lack of Efficacy|52|||
161958151|NCT00249808|584892694|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
161705878|NCT02660580|583969229|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
161705879|NCT02660580|583969230|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
161705880|NCT02660580|583969231|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
161705881|NCT02660580|583969232|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
161705882|NCT02660580|583969228|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
161705883|NCT02660580|583969229|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
161705884|NCT02660580|583969230|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
161705885|NCT02660580|583969231|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
161705886|NCT02660580|583969232|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
161958152|NCT01309997|584892699|FG000|Overall Study|Adverse Event|1|||
161958153|NCT01309997|584892700|FG001|Overall Study|Adverse Event|0|||
161958154|NCT01309997|584892699|FG000|Overall Study|Death|1|||
161958155|NCT01309997|584892700|FG001|Overall Study|Death|3|||
161958156|NCT01309997|584892699|FG000|Overall Study|Lack of Efficacy|2|||
161958157|NCT01309997|584892700|FG001|Overall Study|Lack of Efficacy|2|||
161958158|NCT01309997|584892699|FG000|Overall Study|Withdrawal by Subject|1|||
161958159|NCT01309997|584892700|FG001|Overall Study|Withdrawal by Subject|1|||
161958160|NCT01532921|584892701|FG000|Overall Study|Death|3|||
161958161|NCT01532921|584892701|FG000|Overall Study|Withdrawal by Subject|2|||
161958162|NCT01532921|584892701|FG000|Overall Study|Lost to Follow-up|3|||
161958163|NCT01532921|584892701|FG000|Overall Study|Physician Decision|7|||
161958164|NCT01532921|584892701|FG000|Overall Study|Device was explanted during procedure|1|||
161958165|NCT05420961|584892718|FG000|Overall Study|Withdrawal by Subject|2|||
161958166|NCT05420961|584892719|FG001|Overall Study|Withdrawal by Subject|1|||
161705887|NCT02660580|583969228|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
161705888|NCT02660580|583969229|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
161705889|NCT02660580|583969230|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
161705890|NCT02660580|583969231|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
161705891|NCT02660580|583969232|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
161705892|NCT04854499|583969234|FG000|Overall Study|Study Terminated by Sponsor|5|||
161705893|NCT04854499|583969235|FG001|Overall Study|Study Terminated by Sponsor|27|||
161705894|NCT04854499|583969236|FG002|Overall Study|Study Terminated by Sponsor|28|||
161705895|NCT04854499|583969237|FG003|Overall Study|Study Terminated by Sponsor|19|||
161705896|NCT04854499|583969238|FG004|Overall Study|Study Terminated by Sponsor|1|||
161705897|NCT04854499|583969239|FG005|Overall Study|Study Terminated by Sponsor|10|||
161705898|NCT04854499|583969234|FG000|Overall Study|Death|1|||
161705899|NCT04854499|583969235|FG001|Overall Study|Death|23|||
161705900|NCT04854499|583969236|FG002|Overall Study|Death|21|||
161705901|NCT04854499|583969237|FG003|Overall Study|Death|7|||
161705902|NCT04854499|583969238|FG004|Overall Study|Death|6|||
161705903|NCT04854499|583969239|FG005|Overall Study|Death|24|||
161705904|NCT04854499|583969234|FG000|Overall Study|Investigator's Discretion|0|||
161705905|NCT04854499|583969235|FG001|Overall Study|Investigator's Discretion|1|||
161705906|NCT04854499|583969236|FG002|Overall Study|Investigator's Discretion|3|||
161705907|NCT04854499|583969237|FG003|Overall Study|Investigator's Discretion|4|||
161705908|NCT04854499|583969238|FG004|Overall Study|Investigator's Discretion|1|||
161705909|NCT04854499|583969239|FG005|Overall Study|Investigator's Discretion|5|||
161705910|NCT04854499|583969234|FG000|Overall Study|Withdrew Consent|0|||
161705911|NCT04854499|583969235|FG001|Overall Study|Withdrew Consent|1|||
161705912|NCT04854499|583969236|FG002|Overall Study|Withdrew Consent|2|||
161705913|NCT04854499|583969237|FG003|Overall Study|Withdrew Consent|2|||
161705914|NCT04854499|583969238|FG004|Overall Study|Withdrew Consent|0|||
161705915|NCT04854499|583969239|FG005|Overall Study|Withdrew Consent|1|||
161705916|NCT04854499|583969234|FG000|Overall Study|Lost to Follow-up|0|||
161705917|NCT04854499|583969235|FG001|Overall Study|Lost to Follow-up|0|||
161705918|NCT04854499|583969236|FG002|Overall Study|Lost to Follow-up|0|||
161705919|NCT04854499|583969237|FG003|Overall Study|Lost to Follow-up|0|||
161705920|NCT04854499|583969238|FG004|Overall Study|Lost to Follow-up|0|||
161705921|NCT04854499|583969239|FG005|Overall Study|Lost to Follow-up|1|||
161705922|NCT05415449|583969240|FG000|Overall Study|Lost to Follow-up|2|||
161958167|NCT05420961|584892720|FG002|Overall Study|Withdrawal by Subject|1|||
161958168|NCT05420961|584892721|FG003|Overall Study|Withdrawal by Subject|0|||
161705923|NCT05415449|583969240|FG000|Overall Study|Withdrawal by Subject|4|||
161958169|NCT05420961|584892722|FG004|Overall Study|Withdrawal by Subject|0|||
161958170|NCT05420961|584892718|FG000|Overall Study|Lost to Follow-up|0|||
161705924|NCT02185521|583969243|FG000|Overall Study|Withdrawal by Subject|1|||
161705925|NCT02185521|583969243|FG000|Overall Study|Protocol Violation|1|||
161705926|NCT01028352|583969247|FG000|Overall Study|Ineligible due to baseline average pain|5|||
161705927|NCT01028352|583969247|FG000|Overall Study|Withdrawal by Subject|1|||
161705928|NCT01903876|583969248|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
161705929|NCT01903876|583969249|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
161958171|NCT05420961|584892719|FG001|Overall Study|Lost to Follow-up|0|||
161958172|NCT05420961|584892720|FG002|Overall Study|Lost to Follow-up|1|||
161958173|NCT05420961|584892721|FG003|Overall Study|Lost to Follow-up|0|||
161958174|NCT05420961|584892722|FG004|Overall Study|Lost to Follow-up|0|||
161958175|NCT05420961|584892718|FG000|Overall Study|Randomized by mistake without study treatment|0|||
161958176|NCT05420961|584892719|FG001|Overall Study|Randomized by mistake without study treatment|0|||
161958177|NCT05420961|584892720|FG002|Overall Study|Randomized by mistake without study treatment|1|||
161837646|NCT00725621|584448675|FG000|Overall Study|Switched to other drug|1|||
161837647|NCT00725621|584448675|FG000|Overall Study|Prepared for elective surgery|1|||
161958178|NCT05420961|584892721|FG003|Overall Study|Randomized by mistake without study treatment|0|||
161958179|NCT05420961|584892722|FG004|Overall Study|Randomized by mistake without study treatment|1|||
161958180|NCT04283656|584892723|FG000|Overall Study|Adverse Event|1|||
161958181|NCT04283656|584892724|FG001|Overall Study|Adverse Event|0|||
161958182|NCT04283656|584892723|FG000|Overall Study|Lost to Follow-up|0|||
161958183|NCT04283656|584892724|FG001|Overall Study|Lost to Follow-up|1|||
161958184|NCT00803361|584892725|FG000|Overall Study|Adverse Event|13|||
161958185|NCT00803361|584892726|FG001|Overall Study|Adverse Event|3|||
161958186|NCT00803361|584892725|FG000|Overall Study|Lack of Efficacy|4|||
161958187|NCT00803361|584892726|FG001|Overall Study|Lack of Efficacy|13|||
161958188|NCT00803361|584892725|FG000|Overall Study|Lost to Follow-up|1|||
161958189|NCT00803361|584892726|FG001|Overall Study|Lost to Follow-up|2|||
161958190|NCT00803361|584892725|FG000|Overall Study|Physician Decision|1|||
161958191|NCT00803361|584892726|FG001|Overall Study|Physician Decision|0|||
161958192|NCT00803361|584892725|FG000|Overall Study|Protocol Violation|2|||
161958193|NCT00803361|584892726|FG001|Overall Study|Protocol Violation|4|||
161958194|NCT00803361|584892725|FG000|Overall Study|Withdrawal by Subject|5|||
161958195|NCT00803361|584892726|FG001|Overall Study|Withdrawal by Subject|6|||
161958196|NCT04445519|584892727|FG000|Overall Study|Due to adaptive design|3|||
161958197|NCT04445519|584892728|FG001|Overall Study|Due to adaptive design|0|||
161958198|NCT04445519|584892729|FG002|Overall Study|Due to adaptive design|0|||
161958199|NCT04445519|584892727|FG000|Overall Study|Lost to Follow-up|0|||
161958200|NCT04445519|584892728|FG001|Overall Study|Lost to Follow-up|1|||
161958201|NCT04445519|584892729|FG002|Overall Study|Lost to Follow-up|4|||
161958202|NCT04445519|584892727|FG000|Overall Study|Sponsor or IRB Decision|0|||
161958203|NCT04445519|584892728|FG001|Overall Study|Sponsor or IRB Decision|1|||
161958204|NCT04445519|584892729|FG002|Overall Study|Sponsor or IRB Decision|2|||
161958205|NCT04445519|584892727|FG000|Overall Study|Withdrawal by Subject|0|||
161958206|NCT04445519|584892728|FG001|Overall Study|Withdrawal by Subject|3|||
161958207|NCT04445519|584892729|FG002|Overall Study|Withdrawal by Subject|3|||
161958208|NCT04445519|584892727|FG000|Overall Study|Adverse Event|0|||
161958209|NCT04445519|584892728|FG001|Overall Study|Adverse Event|8|||
161958210|NCT04445519|584892729|FG002|Overall Study|Adverse Event|6|||
161958211|NCT04445519|584892727|FG000|Overall Study|Other Reason|0|||
161958212|NCT04445519|584892728|FG001|Overall Study|Other Reason|1|||
161958213|NCT04445519|584892729|FG002|Overall Study|Other Reason|1|||
161958214|NCT04445519|584892727|FG000|Overall Study|Protocol Violation|0|||
161958215|NCT04445519|584892728|FG001|Overall Study|Protocol Violation|0|||
161958216|NCT04445519|584892729|FG002|Overall Study|Protocol Violation|1|||
161958217|NCT04482439|584892734|FG000|Overall Study|Lost to Follow-up|1|||
161958218|NCT04482439|584892734|FG000|Overall Study|Unrelated illness|1|||
161958219|NCT03072043|584892735|FG000|Overall Study|Death|0|||
161958220|NCT03072043|584892736|FG001|Overall Study|Death|0|||
161958221|NCT03072043|584892737|FG002|Overall Study|Death|3|||
161958222|NCT03072043|584892735|FG000|Overall Study|Adverse Event|0|||
161958223|NCT03072043|584892736|FG001|Overall Study|Adverse Event|0|||
161958224|NCT03072043|584892737|FG002|Overall Study|Adverse Event|2|||
161705930|NCT01903876|583969248|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
161705931|NCT01903876|583969249|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
161705932|NCT00826748|583969260|FG000|Overall Study|Withdrawal by Subject|0|||
161705933|NCT00826748|583969261|FG001|Overall Study|Withdrawal by Subject|0|||
161705934|NCT00826748|583969262|FG002|Overall Study|Withdrawal by Subject|2|||
161705935|NCT00826748|583969260|FG000|Overall Study|Physician Decision|0|||
161705936|NCT00826748|583969261|FG001|Overall Study|Physician Decision|0|||
161705937|NCT00826748|583969262|FG002|Overall Study|Physician Decision|1|||
161705938|NCT00826748|583969260|FG000|Overall Study|Samples Did Not pass QC|0|||
161705939|NCT00826748|583969261|FG001|Overall Study|Samples Did Not pass QC|0|||
161705940|NCT00826748|583969262|FG002|Overall Study|Samples Did Not pass QC|1|||
161705941|NCT02300129|583969264|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
161705942|NCT02300129|583969265|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
161705943|NCT02300129|583969266|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
161705944|NCT02300129|583969267|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
161705945|NCT02300129|583969264|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
161705946|NCT02300129|583969265|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
161705947|NCT02300129|583969266|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
161705948|NCT02300129|583969267|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
161705949|NCT02300129|583969264|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
161705950|NCT02300129|583969265|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
161705951|NCT02300129|583969266|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
161705952|NCT02300129|583969267|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
161705953|NCT01887912|583969268|FG000|Overall Study|Serious adverse event|400|||
161705954|NCT01887912|583969269|FG001|Overall Study|Serious adverse event|198|||
161705955|NCT01887912|583969268|FG000|Overall Study|Other Adverse Event|34|||
161705956|NCT01887912|583969269|FG001|Overall Study|Other Adverse Event|15|||
161705957|NCT01887912|583969268|FG000|Overall Study|Protocol Violation|67|||
161705958|NCT01887912|583969269|FG001|Overall Study|Protocol Violation|37|||
161705959|NCT01887912|583969268|FG000|Overall Study|Lost to Follow-up|163|||
161705960|NCT01887912|583969269|FG001|Overall Study|Lost to Follow-up|74|||
161705961|NCT01887912|583969268|FG000|Overall Study|Withdrawal by Subject|606|||
161705962|NCT01887912|583969269|FG001|Overall Study|Withdrawal by Subject|349|||
161705963|NCT01887912|583969268|FG000|Overall Study|Other|122|||
161705964|NCT01887912|583969269|FG001|Overall Study|Other|58|||
161705965|NCT04462536|583969270|FG000|Overall Study|Withdrawal by Subject|3|||
161705966|NCT04462536|583969271|FG001|Overall Study|Withdrawal by Subject|9|||
161705967|NCT04462536|583969270|FG000|Overall Study|Lost to Follow-up|2|||
161705968|NCT04462536|583969271|FG001|Overall Study|Lost to Follow-up|4|||
161705969|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
161705970|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
161705971|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
161705972|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
161705973|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
161705974|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
161705975|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
161705976|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
161705977|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
161705978|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
161705979|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
161705980|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
161705981|NCT02747927|583969272|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
161705982|NCT02747927|583969273|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
161705983|NCT02747927|583969272|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
161705984|NCT02747927|583969273|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
161705985|NCT02747927|583969272|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
161705986|NCT02747927|583969273|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
161705987|NCT02747927|583969272|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
161705988|NCT02747927|583969273|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
161705989|NCT02747927|583969272|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
161705990|NCT02747927|583969273|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
161705991|NCT02747927|583969272|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
161705992|NCT02747927|583969273|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
161705993|NCT02747927|583969272|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
161705994|NCT02747927|583969273|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
161705995|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
161705996|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
161705997|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
161705998|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
161705999|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
161706000|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
161706001|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
161706002|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
161706003|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
161706004|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
161706005|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
161706006|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
161706007|NCT02747927|583969272|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
161706008|NCT02747927|583969273|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
161706009|NCT02747927|583969272|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
161706010|NCT02747927|583969273|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
161706011|NCT02747927|583969272|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
161706012|NCT02747927|583969273|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
161706013|NCT02747927|583969272|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
161706014|NCT02747927|583969273|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
161706015|NCT02747927|583969272|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
161706016|NCT02747927|583969273|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
161706017|NCT02747927|583969272|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
161706018|NCT02747927|583969273|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
161706019|NCT02747927|583969272|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
161706020|NCT02747927|583969273|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
161706021|NCT02747927|583969272|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
161706022|NCT02747927|583969273|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
161706023|NCT02747927|583969272|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
161706024|NCT02747927|583969273|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
161706025|NCT02747927|583969272|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
161706026|NCT02747927|583969273|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
161706027|NCT02747927|583969272|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
161706028|NCT02747927|583969273|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
161706029|NCT02747927|583969272|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
161706030|NCT02747927|583969273|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
161706031|NCT02747927|583969272|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
161706032|NCT02747927|583969273|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
161706033|NCT00450580|583969276|FG000|Overall Study|Adverse Event|5|||
161706034|NCT00450580|583969277|FG001|Overall Study|Adverse Event|7|||
161706035|NCT00450580|583969276|FG000|Overall Study|Lost to Follow-up|4|||
161706036|NCT00450580|583969277|FG001|Overall Study|Lost to Follow-up|5|||
161706037|NCT00450580|583969276|FG000|Overall Study|Withdrawal by Subject|2|||
161706038|NCT00450580|583969277|FG001|Overall Study|Withdrawal by Subject|2|||
161706039|NCT00450580|583969276|FG000|Overall Study|Protocol Violation|1|||
161706040|NCT00450580|583969277|FG001|Overall Study|Protocol Violation|1|||
161706041|NCT00450580|583969276|FG000|Overall Study|Protocol-defined virologic failure|1|||
161706042|NCT00450580|583969277|FG001|Overall Study|Protocol-defined virologic failure|0|||
161706043|NCT00450580|583969276|FG000|Overall Study|Could not comply with scheduled visits|1|||
161706044|NCT00450580|583969277|FG001|Overall Study|Could not comply with scheduled visits|0|||
161706045|NCT00450580|583969276|FG000|Overall Study|Patient went to Brazil|1|||
161706046|NCT00450580|583969277|FG001|Overall Study|Patient went to Brazil|0|||
161706047|NCT00450580|583969276|FG000|Overall Study|Patient could not swallow Norvir|1|||
161706048|NCT00450580|583969277|FG001|Overall Study|Patient could not swallow Norvir|0|||
161706049|NCT00450580|583969276|FG000|Overall Study|Withdrawal due to pregnancy|0|||
161706050|NCT00450580|583969277|FG001|Overall Study|Withdrawal due to pregnancy|1|||
161706051|NCT00332709|583969286|FG000|Overall Study|Adverse Event|11|||
161706052|NCT00332709|583969287|FG001|Overall Study|Adverse Event|14|||
161706053|NCT00332709|583969286|FG000|Overall Study|Withdrawal by Subject|2|||
161706054|NCT00332709|583969287|FG001|Overall Study|Withdrawal by Subject|3|||
161706055|NCT00332709|583969286|FG000|Overall Study|Lost to Follow-up|2|||
161706056|NCT00332709|583969287|FG001|Overall Study|Lost to Follow-up|0|||
161706057|NCT00332709|583969286|FG000|Overall Study|Administrative Problems|0|||
161706058|NCT00332709|583969287|FG001|Overall Study|Administrative Problems|3|||
161706059|NCT00332709|583969286|FG000|Overall Study|Abnormal test procedure result|1|||
161706060|NCT00332709|583969287|FG001|Overall Study|Abnormal test procedure result|0|||
161706061|NCT00988247|583969288|FG000|Overall Study|Adverse Event|17|||
161706062|NCT00988247|583969289|FG001|Overall Study|Adverse Event|3|||
161706063|NCT00988247|583969288|FG000|Overall Study|Withdrawal by Subject|44|||
161706064|NCT00988247|583969289|FG001|Overall Study|Withdrawal by Subject|13|||
161706065|NCT00988247|583969288|FG000|Overall Study|Pregnancy|1|||
161706066|NCT00988247|583969289|FG001|Overall Study|Pregnancy|2|||
161706067|NCT00988247|583969288|FG000|Overall Study|Lost to Follow-up|11|||
161706068|NCT00988247|583969289|FG001|Overall Study|Lost to Follow-up|2|||
161706069|NCT00988247|583969288|FG000|Overall Study|Protocol Violation|4|||
161706070|NCT00988247|583969289|FG001|Overall Study|Protocol Violation|5|||
161706071|NCT00988247|583969288|FG000|Overall Study|Sponsor requested withdrawal|3|||
161706072|NCT00988247|583969289|FG001|Overall Study|Sponsor requested withdrawal|1|||
161706073|NCT00988247|583969288|FG000|Overall Study|Other|3|||
161706074|NCT00988247|583969289|FG001|Overall Study|Other|0|||
161706075|NCT01409928|583969290|FG000|Overall Study|Physician Decision|12|||
161706076|NCT02661594|583969291|FG000|Overall Study|Protocol Violation|1|||
161706077|NCT02661594|583969292|FG001|Overall Study|Protocol Violation|0|||
161706078|NCT02661594|583969293|FG002|Overall Study|Protocol Violation|1|||
161706079|NCT02661594|583969294|FG003|Overall Study|Protocol Violation|0|||
161706080|NCT01169779|583969297|FG000|Overall Study|Adverse Event|3|||
161706081|NCT01169779|583969298|FG001|Overall Study|Adverse Event|11|||
161706082|NCT01169779|583969297|FG000|Overall Study|Lack of Efficacy|1|||
161706083|NCT01169779|583969298|FG001|Overall Study|Lack of Efficacy|0|||
161706084|NCT01169779|583969297|FG000|Overall Study|Protocol Violation|1|||
161706085|NCT01169779|583969298|FG001|Overall Study|Protocol Violation|1|||
161706086|NCT01169779|583969297|FG000|Overall Study|Withdrawal by Subject|3|||
161706087|NCT01169779|583969298|FG001|Overall Study|Withdrawal by Subject|2|||
161706088|NCT01169779|583969297|FG000|Overall Study|Familial and personal reasons|3|||
161706089|NCT01169779|583969298|FG001|Overall Study|Familial and personal reasons|3|||
161706090|NCT00432237|583969301|FG000|Overall Study|Adverse Event|0|||
161706091|NCT00432237|583969302|FG001|Overall Study|Adverse Event|0|||
161706092|NCT00432237|583969303|FG002|Overall Study|Adverse Event|0|||
161706093|NCT00432237|583969304|FG003|Overall Study|Adverse Event|1|||
161706094|NCT00432237|583969301|FG000|Overall Study|Lack of Efficacy|0|||
161706095|NCT00432237|583969302|FG001|Overall Study|Lack of Efficacy|0|||
161706096|NCT00432237|583969303|FG002|Overall Study|Lack of Efficacy|0|||
161706097|NCT00432237|583969304|FG003|Overall Study|Lack of Efficacy|1|||
161706098|NCT00432237|583969301|FG000|Overall Study|Lost to Follow-up|10|||
161706099|NCT00432237|583969302|FG001|Overall Study|Lost to Follow-up|10|||
161706100|NCT00432237|583969303|FG002|Overall Study|Lost to Follow-up|18|||
161706101|NCT00432237|583969304|FG003|Overall Study|Lost to Follow-up|18|||
161706102|NCT00432237|583969301|FG000|Overall Study|Physician Decision|1|||
161706103|NCT00432237|583969302|FG001|Overall Study|Physician Decision|3|||
161706104|NCT00432237|583969303|FG002|Overall Study|Physician Decision|2|||
161706105|NCT00432237|583969304|FG003|Overall Study|Physician Decision|1|||
161706106|NCT00432237|583969301|FG000|Overall Study|Pregnancy|0|||
161706107|NCT00432237|583969302|FG001|Overall Study|Pregnancy|1|||
161706108|NCT00432237|583969303|FG002|Overall Study|Pregnancy|0|||
161706109|NCT00432237|583969304|FG003|Overall Study|Pregnancy|0|||
161706110|NCT00432237|583969301|FG000|Overall Study|Protocol Violation|13|||
161706111|NCT00432237|583969302|FG001|Overall Study|Protocol Violation|10|||
161706112|NCT00432237|583969303|FG002|Overall Study|Protocol Violation|11|||
161706113|NCT00432237|583969304|FG003|Overall Study|Protocol Violation|8|||
161706114|NCT00432237|583969301|FG000|Overall Study|Withdrawal by Subject|5|||
161706115|NCT00432237|583969302|FG001|Overall Study|Withdrawal by Subject|6|||
161706116|NCT00432237|583969303|FG002|Overall Study|Withdrawal by Subject|9|||
161706117|NCT00432237|583969304|FG003|Overall Study|Withdrawal by Subject|11|||
161706118|NCT00432237|583969301|FG000|Overall Study|Lack of Qualifying Event|38|||
161706119|NCT00432237|583969302|FG001|Overall Study|Lack of Qualifying Event|71|||
161706120|NCT00432237|583969303|FG002|Overall Study|Lack of Qualifying Event|69|||
161706121|NCT00432237|583969304|FG003|Overall Study|Lack of Qualifying Event|84|||
161706122|NCT01354132|583969305|FG000|Randomization|Physician Decision|1|||
161706123|NCT01354132|583969306|FG001|Randomization|Physician Decision|0|||
161706124|NCT01354132|583969305|FG000|Randomization|Withdrawal by Subject|0|||
161706125|NCT01354132|583969306|FG001|Randomization|Withdrawal by Subject|1|||
161706126|NCT01354132|583969305|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
161706127|NCT01354132|583969306|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
161706128|NCT01354132|583969305|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
161706129|NCT01354132|583969306|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
161706130|NCT01354132|583969305|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
161706131|NCT01354132|583969306|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
161706132|NCT00191854|583969309|FG000|Overall Study|Death|26|||
161706133|NCT00191854|583969310|FG001|Overall Study|Death|23|||
161706134|NCT00191854|583969311|FG002|Overall Study|Death|29|||
161706135|NCT00191854|583969309|FG000|Overall Study|Lost to Follow-up|7|||
161706136|NCT00191854|583969310|FG001|Overall Study|Lost to Follow-up|5|||
161706137|NCT00191854|583969311|FG002|Overall Study|Lost to Follow-up|5|||
161706138|NCT00191854|583969309|FG000|Overall Study|Withdrawal by Subject|4|||
161706139|NCT00191854|583969310|FG001|Overall Study|Withdrawal by Subject|2|||
161706140|NCT00191854|583969311|FG002|Overall Study|Withdrawal by Subject|3|||
161706141|NCT00191854|583969309|FG000|Overall Study|Sponsor Decision|0|||
161706142|NCT00191854|583969310|FG001|Overall Study|Sponsor Decision|0|||
161706143|NCT00191854|583969311|FG002|Overall Study|Sponsor Decision|1|||
161706144|NCT00191854|583969309|FG000|Overall Study|Screen Failure|0|||
161706145|NCT00191854|583969310|FG001|Overall Study|Screen Failure|0|||
161706146|NCT00191854|583969311|FG002|Overall Study|Screen Failure|1|||
161706147|NCT01933932|583969314|FG000|Overall Study|Death|173|||
161706148|NCT01933932|583969315|FG001|Overall Study|Death|163|||
161706149|NCT01933932|583969314|FG000|Overall Study|Withdrawal by Subject|11|||
161706150|NCT01933932|583969315|FG001|Overall Study|Withdrawal by Subject|14|||
161706151|NCT01933932|583969314|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161706152|NCT01933932|583969315|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161706153|NCT00763009|583969319|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
161706154|NCT02013544|583969320|FG000|Overall Study|Adverse Event|5|||
161706155|NCT02013544|583969321|FG001|Overall Study|Adverse Event|5|||
161706156|NCT02013544|583969320|FG000|Overall Study|Lost to Follow-up|2|||
161706157|NCT02013544|583969321|FG001|Overall Study|Lost to Follow-up|3|||
161706158|NCT02013544|583969320|FG000|Overall Study|Withdrawal by Subject|2|||
161706159|NCT02013544|583969321|FG001|Overall Study|Withdrawal by Subject|8|||
161706160|NCT02013544|583969320|FG000|Overall Study|Physician Decision|0|||
161706161|NCT02013544|583969321|FG001|Overall Study|Physician Decision|1|||
161706162|NCT02013544|583969320|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
161706163|NCT02013544|583969321|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
161706164|NCT01295125|583969322|FG000|Overall Study|Study stopped prematurely|9|||
161706165|NCT00891735|583969323|FG000|Overall Study|Adverse Event|2|||
161706166|NCT00891735|583969324|FG001|Overall Study|Adverse Event|0|||
161706167|NCT00891735|583969325|FG002|Overall Study|Adverse Event|2|||
161706168|NCT00891735|583969326|FG003|Overall Study|Adverse Event|0|||
161706169|NCT00891735|583969323|FG000|Overall Study|Death|8|||
161706170|NCT00891735|583969324|FG001|Overall Study|Death|5|||
161706171|NCT00891735|583969325|FG002|Overall Study|Death|4|||
161706172|NCT00891735|583969326|FG003|Overall Study|Death|5|||
161706173|NCT00891735|583969323|FG000|Overall Study|Lost to Follow-up|2|||
161706174|NCT00891735|583969324|FG001|Overall Study|Lost to Follow-up|2|||
161706175|NCT00891735|583969325|FG002|Overall Study|Lost to Follow-up|2|||
161706176|NCT00891735|583969326|FG003|Overall Study|Lost to Follow-up|2|||
161706177|NCT00891735|583969323|FG000|Overall Study|Physician's decision to withdraw patient|1|||
161706178|NCT00891735|583969324|FG001|Overall Study|Physician's decision to withdraw patient|0|||
161706179|NCT00891735|583969325|FG002|Overall Study|Physician's decision to withdraw patient|0|||
161706180|NCT00891735|583969326|FG003|Overall Study|Physician's decision to withdraw patient|0|||
161706181|NCT00891735|583969323|FG000|Overall Study|Patient's decision to withdraw|4|||
161706182|NCT00891735|583969324|FG001|Overall Study|Patient's decision to withdraw|9|||
161706183|NCT00891735|583969325|FG002|Overall Study|Patient's decision to withdraw|4|||
161706184|NCT00891735|583969326|FG003|Overall Study|Patient's decision to withdraw|8|||
161706185|NCT00888238|583969332|FG000|Washout Period After Period 2|Adverse Event|0|||
161706186|NCT00888238|583969333|FG001|Washout Period After Period 2|Adverse Event|0|||
161706187|NCT00888238|583969334|FG002|Washout Period After Period 2|Adverse Event|1|||
161706188|NCT03480802|583971504|FG000|Overall Study|Lost to Follow-up|5|||
161706189|NCT03480802|583971505|FG001|Overall Study|Lost to Follow-up|1|||
161706190|NCT03480802|583971504|FG000|Overall Study|Withdrawal by Subject|2|||
161706191|NCT03480802|583971505|FG001|Overall Study|Withdrawal by Subject|1|||
161706192|NCT03480802|583971504|FG000|Overall Study|Relocated|0|||
161706193|NCT03480802|583971505|FG001|Overall Study|Relocated|1|||
161706194|NCT02601950|583971510|FG000|Overall Study|Participant enrolled in rollover study|0|||
161706195|NCT02601950|583971511|FG001|Overall Study|Participant enrolled in rollover study|0|||
161706196|NCT02601950|583971512|FG002|Overall Study|Participant enrolled in rollover study|1|||
161706197|NCT02601950|583971513|FG003|Overall Study|Participant enrolled in rollover study|0|||
161706198|NCT02601950|583971514|FG004|Overall Study|Participant enrolled in rollover study|1|||
161706199|NCT02601950|583971515|FG005|Overall Study|Participant enrolled in rollover study|1|||
161706200|NCT02601950|583971516|FG006|Overall Study|Participant enrolled in rollover study|1|||
161706201|NCT02601950|583971517|FG007|Overall Study|Participant enrolled in rollover study|0|||
161706202|NCT02601950|583971510|FG000|Overall Study|Disease progression - radiological|21|||
161706203|NCT02601950|583971511|FG001|Overall Study|Disease progression - radiological|26|||
161706204|NCT02601950|583971512|FG002|Overall Study|Disease progression - radiological|22|||
161706205|NCT02601950|583971513|FG003|Overall Study|Disease progression - radiological|11|||
161706206|NCT02601950|583971514|FG004|Overall Study|Disease progression - radiological|46|||
161706207|NCT02601950|583971515|FG005|Overall Study|Disease progression - radiological|52|||
161706208|NCT02601950|583971516|FG006|Overall Study|Disease progression - radiological|7|||
161706209|NCT02601950|583971517|FG007|Overall Study|Disease progression - radiological|5|||
161706210|NCT02601950|583971510|FG000|Overall Study|Disease progression - clinical|3|||
161706211|NCT02601950|583971511|FG001|Overall Study|Disease progression - clinical|5|||
161706212|NCT02601950|583971512|FG002|Overall Study|Disease progression - clinical|4|||
161706213|NCT02601950|583971513|FG003|Overall Study|Disease progression - clinical|2|||
161706214|NCT02601950|583971514|FG004|Overall Study|Disease progression - clinical|6|||
161706215|NCT02601950|583971515|FG005|Overall Study|Disease progression - clinical|6|||
161706216|NCT02601950|583971516|FG006|Overall Study|Disease progression - clinical|5|||
161706217|NCT02601950|583971517|FG007|Overall Study|Disease progression - clinical|1|||
161706218|NCT02601950|583971510|FG000|Overall Study|Death|6|||
161706219|NCT02601950|583971511|FG001|Overall Study|Death|0|||
161706220|NCT02601950|583971512|FG002|Overall Study|Death|3|||
161706221|NCT02601950|583971513|FG003|Overall Study|Death|1|||
161706222|NCT02601950|583971514|FG004|Overall Study|Death|4|||
161706223|NCT02601950|583971515|FG005|Overall Study|Death|1|||
161706224|NCT02601950|583971516|FG006|Overall Study|Death|0|||
161706225|NCT02601950|583971517|FG007|Overall Study|Death|0|||
161706226|NCT02601950|583971510|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706227|NCT02601950|583971511|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706228|NCT02601950|583971512|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706229|NCT02601950|583971513|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706230|NCT02601950|583971514|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706231|NCT02601950|583971515|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
161706232|NCT02601950|583971516|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706233|NCT02601950|583971517|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161706234|NCT02601950|583971510|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
161706235|NCT02601950|583971511|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
161706236|NCT02601950|583971512|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
161706237|NCT02601950|583971513|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
161706238|NCT02601950|583971514|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
161706239|NCT02601950|583971515|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
161706240|NCT02601950|583971516|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
161706241|NCT02601950|583971517|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
161706242|NCT02601950|583971510|FG000|Overall Study|Non-compliance|0|||
161706243|NCT02601950|583971511|FG001|Overall Study|Non-compliance|1|||
161706244|NCT02601950|583971512|FG002|Overall Study|Non-compliance|0|||
161706245|NCT02601950|583971513|FG003|Overall Study|Non-compliance|0|||
161706246|NCT02601950|583971514|FG004|Overall Study|Non-compliance|0|||
161706247|NCT02601950|583971515|FG005|Overall Study|Non-compliance|1|||
161706248|NCT02601950|583971516|FG006|Overall Study|Non-compliance|1|||
161706249|NCT02601950|583971517|FG007|Overall Study|Non-compliance|0|||
161706250|NCT02601950|583971510|FG000|Overall Study|Participant refused further study treatment|0|||
161706251|NCT02601950|583971511|FG001|Overall Study|Participant refused further study treatment|1|||
161706252|NCT02601950|583971512|FG002|Overall Study|Participant refused further study treatment|1|||
161706253|NCT02601950|583971513|FG003|Overall Study|Participant refused further study treatment|0|||
161706254|NCT02601950|583971514|FG004|Overall Study|Participant refused further study treatment|2|||
161706255|NCT02601950|583971515|FG005|Overall Study|Participant refused further study treatment|2|||
161706256|NCT02601950|583971516|FG006|Overall Study|Participant refused further study treatment|2|||
161706257|NCT02601950|583971517|FG007|Overall Study|Participant refused further study treatment|1|||
161706258|NCT02601950|583971510|FG000|Overall Study|Investigator discretion|1|||
161706259|NCT02601950|583971511|FG001|Overall Study|Investigator discretion|0|||
161706260|NCT02601950|583971512|FG002|Overall Study|Investigator discretion|1|||
161706261|NCT02601950|583971513|FG003|Overall Study|Investigator discretion|0|||
161706262|NCT02601950|583971514|FG004|Overall Study|Investigator discretion|1|||
161706263|NCT02601950|583971515|FG005|Overall Study|Investigator discretion|1|||
161706264|NCT02601950|583971516|FG006|Overall Study|Investigator discretion|1|||
161706265|NCT02601950|583971517|FG007|Overall Study|Investigator discretion|0|||
161706266|NCT02601950|583971510|FG000|Overall Study|Other|0|||
161706267|NCT02601950|583971511|FG001|Overall Study|Other|0|||
161706268|NCT02601950|583971512|FG002|Overall Study|Other|0|||
161706269|NCT02601950|583971513|FG003|Overall Study|Other|0|||
161706270|NCT02601950|583971514|FG004|Overall Study|Other|2|||
161706271|NCT02601950|583971515|FG005|Overall Study|Other|2|||
161706272|NCT02601950|583971516|FG006|Overall Study|Other|1|||
161706273|NCT02601950|583971517|FG007|Overall Study|Other|0|||
161706274|NCT02157883|583971518|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
161706275|NCT02157883|583971518|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
161706276|NCT02157883|583971518|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
161706277|NCT02157883|583971518|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
161706278|NCT02157883|583971518|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
161958225|NCT03072043|584892735|FG000|Overall Study|Withdrawal by Subject|0|||
161958226|NCT03072043|584892736|FG001|Overall Study|Withdrawal by Subject|0|||
161958227|NCT03072043|584892737|FG002|Overall Study|Withdrawal by Subject|4|||
161958228|NCT00645840|584892738|FG000|Overall Study|Protocol Violation|3|||
161958229|NCT02625220|584892739|FG000|Overall Study|Adverse Event|2|||
161706279|NCT01701258|583971519|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
161706280|NCT01701258|583971520|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
161706281|NCT01701258|583971521|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
161706282|NCT01701258|583971522|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
161706283|NCT01701258|583971523|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
161706284|NCT01701258|583971524|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
161706285|NCT01701258|583971525|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
161958230|NCT02625220|584892739|FG000|Overall Study|Lost to Follow-up|2|||
161706286|NCT01701258|583971526|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
161706287|NCT01701258|583971527|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
161706288|NCT01701258|583971528|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
161706289|NCT01701258|583971529|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
161706290|NCT01701258|583971530|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
161706291|NCT01701258|583971531|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
161706292|NCT01701258|583971519|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
161706293|NCT01701258|583971520|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
161706294|NCT01701258|583971521|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
161706295|NCT01701258|583971522|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
161706296|NCT01701258|583971523|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
161706297|NCT01701258|583971524|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
161706298|NCT01701258|583971525|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
161706299|NCT01701258|583971526|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
161706300|NCT01701258|583971527|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
161706301|NCT01701258|583971528|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
161706302|NCT01701258|583971529|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
161706303|NCT01701258|583971530|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
161706304|NCT01701258|583971531|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
161706305|NCT01701258|583971519|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
161706306|NCT01701258|583971520|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
161706307|NCT01701258|583971521|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
161706308|NCT01701258|583971522|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
161706309|NCT01701258|583971523|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
161706310|NCT01701258|583971524|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
161706311|NCT01701258|583971525|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
161706312|NCT01701258|583971526|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
161706313|NCT01701258|583971527|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
161706314|NCT01701258|583971528|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
161706315|NCT01701258|583971529|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
161706316|NCT01701258|583971530|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
161706317|NCT01701258|583971531|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
161706318|NCT01701258|583971519|FG000|Assessment and Scheduling|Investigator Terminated|2|||
161706319|NCT01701258|583971520|FG001|Assessment and Scheduling|Investigator Terminated|0|||
161706320|NCT01701258|583971521|FG002|Assessment and Scheduling|Investigator Terminated|0|||
161706321|NCT01701258|583971522|FG003|Assessment and Scheduling|Investigator Terminated|0|||
161706322|NCT01701258|583971523|FG004|Assessment and Scheduling|Investigator Terminated|0|||
161706323|NCT01701258|583971524|FG005|Assessment and Scheduling|Investigator Terminated|0|||
161706324|NCT01701258|583971525|FG006|Assessment and Scheduling|Investigator Terminated|0|||
161706325|NCT01701258|583971526|FG007|Assessment and Scheduling|Investigator Terminated|0|||
161706326|NCT01701258|583971527|FG008|Assessment and Scheduling|Investigator Terminated|0|||
161706327|NCT01701258|583971528|FG009|Assessment and Scheduling|Investigator Terminated|0|||
161706328|NCT01701258|583971529|FG010|Assessment and Scheduling|Investigator Terminated|0|||
161706329|NCT01701258|583971530|FG011|Assessment and Scheduling|Investigator Terminated|0|||
161706330|NCT01701258|583971531|FG012|Assessment and Scheduling|Investigator Terminated|0|||
161706331|NCT01323478|583971532|FG000|Overall Study|Adverse Event|7|||
161706332|NCT01323478|583971532|FG000|Overall Study|Lack of Efficacy|4|||
161706333|NCT01323478|583971532|FG000|Overall Study|Non-compliance With Study Product|3|||
161706334|NCT01323478|583971532|FG000|Overall Study|Protocol Violation|1|||
161706335|NCT01323478|583971532|FG000|Overall Study|Withdrawal of Consent|1|||
161706336|NCT01323478|583971532|FG000|Overall Study|Administrative or Other Reasons|8|||
161706337|NCT00934102|583971536|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
161706338|NCT00934102|583971537|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
161706339|NCT00934102|583971538|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
161706340|NCT00792298|583971539|FG000|Treatment Period 1|Adverse Event|0|||
161706341|NCT00792298|583971540|FG001|Treatment Period 1|Adverse Event|1|||
161706342|NCT00792298|583971541|FG002|Treatment Period 1|Adverse Event|0|||
161706343|NCT00792298|583971542|FG003|Treatment Period 1|Adverse Event|1|||
161706344|NCT00792298|583971543|FG004|Treatment Period 1|Adverse Event|0|||
161706345|NCT00792298|583971544|FG005|Treatment Period 1|Adverse Event|1|||
161706346|NCT00792298|583971545|FG006|Treatment Period 1|Adverse Event|1|||
161706347|NCT00792298|583971546|FG007|Treatment Period 1|Adverse Event|0|||
161706348|NCT00792298|583971539|FG000|Treatment Period 1|Lack of Efficacy|0|||
161706349|NCT00792298|583971540|FG001|Treatment Period 1|Lack of Efficacy|0|||
161706350|NCT00792298|583971541|FG002|Treatment Period 1|Lack of Efficacy|1|||
161706351|NCT00792298|583971542|FG003|Treatment Period 1|Lack of Efficacy|0|||
161706352|NCT00792298|583971543|FG004|Treatment Period 1|Lack of Efficacy|0|||
161706353|NCT00792298|583971544|FG005|Treatment Period 1|Lack of Efficacy|0|||
161706354|NCT00792298|583971545|FG006|Treatment Period 1|Lack of Efficacy|0|||
161706355|NCT00792298|583971546|FG007|Treatment Period 1|Lack of Efficacy|0|||
161706356|NCT00792298|583971539|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161706357|NCT00792298|583971540|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161706358|NCT00792298|583971541|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161706359|NCT00792298|583971542|FG003|Treatment Period 1|Withdrawal by Subject|2|||
161706360|NCT00792298|583971543|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161706361|NCT00792298|583971544|FG005|Treatment Period 1|Withdrawal by Subject|2|||
161706362|NCT00792298|583971545|FG006|Treatment Period 1|Withdrawal by Subject|1|||
161706363|NCT00792298|583971546|FG007|Treatment Period 1|Withdrawal by Subject|0|||
161706364|NCT00792298|583971539|FG000|Treatment Period 1|Lost to Follow-up|0|||
161706365|NCT00792298|583971540|FG001|Treatment Period 1|Lost to Follow-up|0|||
161706366|NCT00792298|583971541|FG002|Treatment Period 1|Lost to Follow-up|0|||
161706367|NCT00792298|583971542|FG003|Treatment Period 1|Lost to Follow-up|0|||
161706368|NCT00792298|583971543|FG004|Treatment Period 1|Lost to Follow-up|0|||
161706369|NCT00792298|583971544|FG005|Treatment Period 1|Lost to Follow-up|0|||
161706370|NCT00792298|583971545|FG006|Treatment Period 1|Lost to Follow-up|1|||
161706371|NCT00792298|583971546|FG007|Treatment Period 1|Lost to Follow-up|0|||
161706372|NCT00792298|583971539|FG000|Treatment Period 1|Physician Decision|0|||
161706373|NCT00792298|583971540|FG001|Treatment Period 1|Physician Decision|0|||
161706374|NCT00792298|583971541|FG002|Treatment Period 1|Physician Decision|0|||
161706375|NCT00792298|583971542|FG003|Treatment Period 1|Physician Decision|1|||
161706376|NCT00792298|583971543|FG004|Treatment Period 1|Physician Decision|0|||
161706377|NCT00792298|583971544|FG005|Treatment Period 1|Physician Decision|0|||
161706378|NCT00792298|583971545|FG006|Treatment Period 1|Physician Decision|1|||
161706379|NCT00792298|583971546|FG007|Treatment Period 1|Physician Decision|0|||
161706380|NCT00792298|583971539|FG000|Treatment Period 1|Protocol Violation|0|||
161706381|NCT00792298|583971540|FG001|Treatment Period 1|Protocol Violation|0|||
161706382|NCT00792298|583971541|FG002|Treatment Period 1|Protocol Violation|0|||
161706383|NCT00792298|583971542|FG003|Treatment Period 1|Protocol Violation|0|||
161706384|NCT00792298|583971543|FG004|Treatment Period 1|Protocol Violation|0|||
161706385|NCT00792298|583971544|FG005|Treatment Period 1|Protocol Violation|0|||
161706386|NCT00792298|583971545|FG006|Treatment Period 1|Protocol Violation|0|||
161706387|NCT00792298|583971546|FG007|Treatment Period 1|Protocol Violation|1|||
161706388|NCT00792298|583971539|FG000|Washout|Adverse Event|0|||
161706389|NCT00792298|583971540|FG001|Washout|Adverse Event|0|||
161706390|NCT00792298|583971541|FG002|Washout|Adverse Event|0|||
161706391|NCT00792298|583971542|FG003|Washout|Adverse Event|0|||
161706392|NCT00792298|583971543|FG004|Washout|Adverse Event|0|||
161706393|NCT00792298|583971544|FG005|Washout|Adverse Event|1|||
161837648|NCT00725621|584448675|FG000|Overall Study|Reason not specified|55|||
161837649|NCT01189500|584448676|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
161837650|NCT01189500|584448676|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
161837651|NCT00062751|584448677|FG000|Overall Study|Disease progression|24|||
161837652|NCT00062751|584448678|FG001|Overall Study|Disease progression|17|||
161837653|NCT00062751|584448679|FG002|Overall Study|Disease progression|24|||
161837654|NCT00062751|584448680|FG003|Overall Study|Disease progression|2|||
161837655|NCT00062751|584448681|FG004|Overall Study|Disease progression|2|||
161958231|NCT02625220|584892739|FG000|Overall Study|Protocol Violation|1|||
161958232|NCT02625220|584892739|FG000|Overall Study|Study discontinued at site|2|||
161958233|NCT04677543|584892740|FG000|Overall Study|Withdrawal by Subject|4|||
161958234|NCT04677543|584892741|FG001|Overall Study|Withdrawal by Subject|1|||
161958235|NCT04677543|584892740|FG000|Overall Study|Physician Decision|0|||
161958236|NCT04677543|584892741|FG001|Overall Study|Physician Decision|1|||
161958237|NCT04677543|584892740|FG000|Overall Study|Adverse Event|0|||
161958238|NCT04677543|584892741|FG001|Overall Study|Adverse Event|1|||
161958239|NCT00995436|584892742|FG000|Overall Study|Withdrawal by Subject|2|||
161958240|NCT00995436|584892743|FG001|Overall Study|Withdrawal by Subject|5|||
161958241|NCT00995436|584892744|FG002|Overall Study|Withdrawal by Subject|0|||
161958242|NCT02342288|584892746|FG000|Overall Study|no protocol anesthesiologist available|3|||
161706394|NCT00792298|583971545|FG006|Washout|Adverse Event|0|||
161706395|NCT00792298|583971546|FG007|Washout|Adverse Event|0|||
161706396|NCT00792298|583971539|FG000|Washout|Withdrawal by Subject|0|||
161706397|NCT00792298|583971540|FG001|Washout|Withdrawal by Subject|0|||
161706398|NCT00792298|583971541|FG002|Washout|Withdrawal by Subject|1|||
161706399|NCT00792298|583971542|FG003|Washout|Withdrawal by Subject|0|||
161706400|NCT00792298|583971543|FG004|Washout|Withdrawal by Subject|0|||
161706401|NCT00792298|583971544|FG005|Washout|Withdrawal by Subject|1|||
161837656|NCT00062751|584448677|FG000|Overall Study|Adverse Event|4|||
161958243|NCT02342288|584892747|FG001|Overall Study|no protocol anesthesiologist available|2|||
161958244|NCT02342288|584892746|FG000|Overall Study|anesthesia leak in system|1|||
161958245|NCT02342288|584892747|FG001|Overall Study|anesthesia leak in system|0|||
161706402|NCT00792298|583971545|FG006|Washout|Withdrawal by Subject|0|||
161706403|NCT00792298|583971546|FG007|Washout|Withdrawal by Subject|0|||
161706404|NCT00792298|583971539|FG000|Treatment Period 2|Lack of Efficacy|0|||
161706405|NCT00792298|583971540|FG001|Treatment Period 2|Lack of Efficacy|0|||
161706406|NCT00792298|583971541|FG002|Treatment Period 2|Lack of Efficacy|0|||
161706407|NCT00792298|583971542|FG003|Treatment Period 2|Lack of Efficacy|0|||
161706408|NCT00792298|583971543|FG004|Treatment Period 2|Lack of Efficacy|1|||
161706409|NCT00792298|583971544|FG005|Treatment Period 2|Lack of Efficacy|0|||
161837657|NCT00062751|584448678|FG001|Overall Study|Adverse Event|7|||
161706410|NCT00792298|583971545|FG006|Treatment Period 2|Lack of Efficacy|0|||
161706411|NCT00792298|583971546|FG007|Treatment Period 2|Lack of Efficacy|0|||
161706412|NCT00792298|583971539|FG000|Treatment Period 2|Physician Decision|0|||
161706413|NCT00792298|583971540|FG001|Treatment Period 2|Physician Decision|0|||
161706414|NCT00792298|583971541|FG002|Treatment Period 2|Physician Decision|0|||
161706415|NCT00792298|583971542|FG003|Treatment Period 2|Physician Decision|0|||
161706416|NCT00792298|583971543|FG004|Treatment Period 2|Physician Decision|0|||
161706417|NCT00792298|583971544|FG005|Treatment Period 2|Physician Decision|0|||
161706418|NCT00792298|583971545|FG006|Treatment Period 2|Physician Decision|1|||
161706419|NCT00792298|583971546|FG007|Treatment Period 2|Physician Decision|0|||
161706420|NCT00792298|583971539|FG000|Treatment Period 2|Pregnancy|0|||
161706421|NCT00792298|583971540|FG001|Treatment Period 2|Pregnancy|0|||
161706422|NCT00792298|583971541|FG002|Treatment Period 2|Pregnancy|1|||
161706423|NCT00792298|583971542|FG003|Treatment Period 2|Pregnancy|0|||
161706424|NCT00792298|583971543|FG004|Treatment Period 2|Pregnancy|0|||
161706425|NCT00792298|583971544|FG005|Treatment Period 2|Pregnancy|0|||
161706426|NCT00792298|583971545|FG006|Treatment Period 2|Pregnancy|0|||
161706427|NCT00792298|583971546|FG007|Treatment Period 2|Pregnancy|0|||
161706428|NCT00792298|583971539|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161706429|NCT00792298|583971540|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161706430|NCT00792298|583971541|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161706431|NCT00792298|583971542|FG003|Treatment Period 2|Withdrawal by Subject|2|||
161706432|NCT00792298|583971543|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161706433|NCT00792298|583971544|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161706434|NCT00792298|583971545|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161706435|NCT00792298|583971546|FG007|Treatment Period 2|Withdrawal by Subject|2|||
161706436|NCT00486603|583971548|FG000|Overall Study|Withdrawal by Subject|1|||
161706437|NCT00486603|583971549|FG001|Overall Study|Withdrawal by Subject|0|||
161706438|NCT00486603|583971550|FG002|Overall Study|Withdrawal by Subject|0|||
161706439|NCT00486603|583971551|FG003|Overall Study|Withdrawal by Subject|0|||
161706440|NCT00486603|583971552|FG004|Overall Study|Withdrawal by Subject|0|||
161706441|NCT00486603|583971548|FG000|Overall Study|Physician Decision|0|||
161706442|NCT00486603|583971549|FG001|Overall Study|Physician Decision|1|||
161706443|NCT00486603|583971550|FG002|Overall Study|Physician Decision|0|||
161706444|NCT00486603|583971551|FG003|Overall Study|Physician Decision|0|||
161706445|NCT00486603|583971552|FG004|Overall Study|Physician Decision|0|||
161706446|NCT02649634|583971553|FG000|Overall Study|Withdrawal by Subject|3|||
161706447|NCT02649634|583971554|FG001|Overall Study|Withdrawal by Subject|5|||
161706448|NCT02649634|583971553|FG000|Overall Study|Lost to Follow-up|0|||
161706449|NCT02649634|583971554|FG001|Overall Study|Lost to Follow-up|1|||
161837658|NCT00062751|584448679|FG002|Overall Study|Adverse Event|2|||
161837659|NCT00062751|584448680|FG003|Overall Study|Adverse Event|2|||
161837660|NCT00062751|584448681|FG004|Overall Study|Adverse Event|2|||
161837661|NCT00062751|584448677|FG000|Overall Study|Other|2|||
161837662|NCT00062751|584448678|FG001|Overall Study|Other|3|||
161837663|NCT00062751|584448679|FG002|Overall Study|Other|1|||
161837664|NCT00062751|584448680|FG003|Overall Study|Other|0|||
161837665|NCT00062751|584448681|FG004|Overall Study|Other|1|||
161837666|NCT00062751|584448677|FG000|Overall Study|Withdrawal by Subject|1|||
161837667|NCT00062751|584448678|FG001|Overall Study|Withdrawal by Subject|2|||
161958246|NCT02342288|584892746|FG000|Overall Study|Withdrawal by Subject|1|||
161837668|NCT00062751|584448679|FG002|Overall Study|Withdrawal by Subject|2|||
161837669|NCT00062751|584448680|FG003|Overall Study|Withdrawal by Subject|1|||
161837670|NCT00062751|584448681|FG004|Overall Study|Withdrawal by Subject|0|||
161837671|NCT00062751|584448677|FG000|Overall Study|Symptomatic deterioration|1|||
162030853|NCT00534313|585169496|FG000|Short-term Period|Lack of Efficacy|3|||
162030854|NCT00534313|585169497|FG001|Short-term Period|Lack of Efficacy|4|||
161706450|NCT01670994|583971556|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
161706451|NCT01670994|583971557|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
161706452|NCT01670994|583971556|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
161706453|NCT01670994|583971557|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
161706454|NCT01670994|583971556|FG000|Overall Study|Patient experienced DLT|0|||
161706455|NCT01670994|583971557|FG001|Overall Study|Patient experienced DLT|1|||
161706456|NCT02706938|583971562|FG000|First Period, 6 Weeks|Adverse Event|8|||
161706457|NCT02706938|583971563|FG001|First Period, 6 Weeks|Adverse Event|0|||
161706458|NCT02706938|583971562|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
161706459|NCT02706938|583971563|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
161706460|NCT02706938|583971562|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
161706461|NCT02706938|583971563|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
161706462|NCT02706938|583971562|FG000|Second Period, 6 Weeks|Adverse Event|0|||
161706463|NCT02706938|583971563|FG001|Second Period, 6 Weeks|Adverse Event|7|||
161706464|NCT02706938|583971562|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
161706465|NCT02706938|583971563|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
161706466|NCT01756456|583971564|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
161706467|NCT01756456|583971565|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
161706468|NCT01756456|583971566|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
161706469|NCT01756456|583971567|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
161706470|NCT01756456|583971568|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
161706471|NCT01756456|583971569|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
161706472|NCT01756456|583971564|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
161706473|NCT01756456|583971565|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
161706474|NCT01756456|583971566|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
161706475|NCT01756456|583971567|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
161706476|NCT01756456|583971568|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
161706477|NCT01756456|583971569|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
161706478|NCT01756456|583971564|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161706479|NCT01756456|583971565|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
161706480|NCT01756456|583971566|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161706481|NCT01756456|583971567|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161706482|NCT01756456|583971568|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161706483|NCT01756456|583971569|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161706484|NCT01756456|583971564|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
161706485|NCT01756456|583971565|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
161706486|NCT01756456|583971566|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
161706487|NCT01756456|583971567|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
161706488|NCT01756456|583971568|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
161706489|NCT01756456|583971569|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
161706490|NCT01756456|583971564|FG000|Treatment Period: Phase I/II|Other causes|0|||
161706491|NCT01756456|583971565|FG001|Treatment Period: Phase I/II|Other causes|0|||
161706492|NCT01756456|583971566|FG002|Treatment Period: Phase I/II|Other causes|0|||
161706493|NCT01756456|583971567|FG003|Treatment Period: Phase I/II|Other causes|1|||
161706494|NCT01756456|583971568|FG004|Treatment Period: Phase I/II|Other causes|2|||
161706495|NCT01756456|583971569|FG005|Treatment Period: Phase I/II|Other causes|2|||
161706496|NCT01756456|583971564|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
161706497|NCT01756456|583971565|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
161837672|NCT00062751|584448678|FG001|Overall Study|Symptomatic deterioration|1|||
161837673|NCT00062751|584448679|FG002|Overall Study|Symptomatic deterioration|0|||
161837674|NCT00062751|584448680|FG003|Overall Study|Symptomatic deterioration|0|||
161837675|NCT00062751|584448681|FG004|Overall Study|Symptomatic deterioration|1|||
161837676|NCT00062751|584448677|FG000|Overall Study|Death|1|||
161837677|NCT00062751|584448678|FG001|Overall Study|Death|0|||
161837678|NCT00062751|584448679|FG002|Overall Study|Death|1|||
161837679|NCT00062751|584448680|FG003|Overall Study|Death|0|||
161837680|NCT00062751|584448681|FG004|Overall Study|Death|0|||
161837681|NCT03097588|584448688|FG000|Overall Study|Adverse Event|1|||
161837682|NCT01144364|584448689|FG000|Induction Phase|Disease progression|14|||
161837683|NCT01144364|584448690|FG001|Induction Phase|Disease progression|0|||
161837684|NCT01144364|584448691|FG002|Induction Phase|Disease progression|0|||
161706498|NCT01756456|583971566|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
161706499|NCT01756456|583971567|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
161706500|NCT01756456|583971568|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
161706501|NCT01756456|583971569|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
161706502|NCT01756456|583971564|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161706503|NCT01756456|583971565|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
161837685|NCT01144364|584448689|FG000|Induction Phase|Adverse Event|9|||
161837686|NCT01144364|584448690|FG001|Induction Phase|Adverse Event|0|||
161706504|NCT01756456|583971566|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161706505|NCT01756456|583971567|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161706506|NCT01756456|583971568|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161706507|NCT01756456|583971569|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161706508|NCT01756456|583971564|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161706509|NCT01756456|583971565|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161706510|NCT01756456|583971566|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161706511|NCT01756456|583971567|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161706512|NCT01756456|583971568|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161706513|NCT01756456|583971569|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
161706514|NCT01756456|583971564|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
161706515|NCT01756456|583971565|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
161706516|NCT01756456|583971566|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
161706517|NCT01756456|583971567|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
161706518|NCT01756456|583971568|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
161706519|NCT01756456|583971569|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
161706520|NCT01756456|583971564|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
161706521|NCT01756456|583971565|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
161706522|NCT01756456|583971566|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
161706523|NCT01756456|583971567|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
161706524|NCT01756456|583971568|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
161706525|NCT01756456|583971569|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
161706526|NCT01756456|583971564|FG000|Follow Up Period Phase I/II|Other causes|0|||
161706527|NCT01756456|583971565|FG001|Follow Up Period Phase I/II|Other causes|0|||
161706528|NCT01756456|583971566|FG002|Follow Up Period Phase I/II|Other causes|0|||
161706529|NCT01756456|583971567|FG003|Follow Up Period Phase I/II|Other causes|1|||
161706530|NCT01756456|583971568|FG004|Follow Up Period Phase I/II|Other causes|3|||
161706531|NCT01756456|583971569|FG005|Follow Up Period Phase I/II|Other causes|5|||
161706532|NCT00813995|583971572|FG000|Overall Study|Clinical adverse event|9|||
161706533|NCT00813995|583971573|FG001|Overall Study|Clinical adverse event|3|||
161706534|NCT00813995|583971572|FG000|Overall Study|Laboratory adverse event|0|||
161706535|NCT00813995|583971573|FG001|Overall Study|Laboratory adverse event|2|||
161706536|NCT00813995|583971572|FG000|Overall Study|Lack of Efficacy|1|||
161706537|NCT00813995|583971573|FG001|Overall Study|Lack of Efficacy|0|||
161706538|NCT00813995|583971572|FG000|Overall Study|Lost to Follow-up|4|||
161706539|NCT00813995|583971573|FG001|Overall Study|Lost to Follow-up|2|||
161706540|NCT00813995|583971572|FG000|Overall Study|Other reason|2|||
161706541|NCT00813995|583971573|FG001|Overall Study|Other reason|2|||
161706542|NCT00813995|583971572|FG000|Overall Study|Protocol Violation|3|||
161706543|NCT00813995|583971573|FG001|Overall Study|Protocol Violation|2|||
161706544|NCT00813995|583971572|FG000|Overall Study|Subject moved|4|||
161706545|NCT00813995|583971573|FG001|Overall Study|Subject moved|0|||
161706546|NCT00813995|583971572|FG000|Overall Study|Withdrawal by Subject|0|||
161706547|NCT00813995|583971573|FG001|Overall Study|Withdrawal by Subject|5|||
161706548|NCT02507349|583971574|FG000|Overall Study|Death|12|||
161706549|NCT02507349|583971575|FG001|Overall Study|Death|16|||
161706550|NCT02507349|583971574|FG000|Overall Study|Withdrawal by Subject|1|||
161706551|NCT02507349|583971575|FG001|Overall Study|Withdrawal by Subject|1|||
161706552|NCT02507349|583971574|FG000|Overall Study|Lost to Follow-up|174|||
161706553|NCT02507349|583971575|FG001|Overall Study|Lost to Follow-up|144|||
161706554|NCT02700984|583971576|FG000|Overall Study|Death|2|||
161706555|NCT02700984|583971577|FG001|Overall Study|Death|1|||
161706556|NCT02700984|583971576|FG000|Overall Study|Lost to Follow-up|2|||
161706557|NCT02700984|583971577|FG001|Overall Study|Lost to Follow-up|1|||
161706558|NCT02700984|583971576|FG000|Overall Study|Physician Decision|0|||
161706559|NCT02700984|583971577|FG001|Overall Study|Physician Decision|1|||
161706560|NCT02700984|583971576|FG000|Overall Study|Withdrawal by Subject|8|||
161706561|NCT02700984|583971577|FG001|Overall Study|Withdrawal by Subject|9|||
161706562|NCT02700984|583971576|FG000|Overall Study|Reason not specified|3|||
161706563|NCT02700984|583971577|FG001|Overall Study|Reason not specified|2|||
161706564|NCT02868892|583971578|FG000|Overall Study|Investigator left site and no follow-up|6|||
161706565|NCT01360996|583971586|FG000|Overall Study|Withdrawal by Subject|4|||
161837687|NCT01144364|584448691|FG002|Induction Phase|Adverse Event|0|||
161706566|NCT01360996|583971587|FG001|Overall Study|Withdrawal by Subject|3|||
161706567|NCT01360996|583971588|FG002|Overall Study|Withdrawal by Subject|2|||
161706568|NCT01360996|583971586|FG000|Overall Study|Noncompliant|2|||
161706569|NCT01360996|583971587|FG001|Overall Study|Noncompliant|0|||
161706570|NCT01360996|583971588|FG002|Overall Study|Noncompliant|0|||
161706571|NCT03377634|583971589|FG000|Study Period|Adverse Event|1|||
161706572|NCT03377634|583971590|FG001|Study Period|Adverse Event|0|||
161706573|NCT03377634|583971589|FG000|Study Period|Withdrawal by Subject|1|||
161706574|NCT03377634|583971590|FG001|Study Period|Withdrawal by Subject|0|||
161706575|NCT01454076|583971591|FG000|Overall Study|Other|2|||
161706576|NCT01454076|583971592|FG001|Overall Study|Other|0|||
161837688|NCT01144364|584448689|FG000|Induction Phase|Death|1|||
161706577|NCT01454076|583971593|FG002|Overall Study|Other|0|||
161958247|NCT02342288|584892747|FG001|Overall Study|Withdrawal by Subject|0|||
161958248|NCT02342288|584892746|FG000|Overall Study|coordinator contaminated with blood|0|||
161958249|NCT02342288|584892747|FG001|Overall Study|coordinator contaminated with blood|1|||
161958250|NCT02342288|584892746|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
161958251|NCT02342288|584892747|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
161958252|NCT02342288|584892746|FG000|Overall Study|coordinator not available|0|||
161958253|NCT02342288|584892747|FG001|Overall Study|coordinator not available|2|||
161958254|NCT00407602|584892749|FG000|Overall Study|Death - unrelated to device|1|||
161837689|NCT01144364|584448690|FG001|Induction Phase|Death|0|||
161837690|NCT01144364|584448691|FG002|Induction Phase|Death|0|||
161837691|NCT01144364|584448689|FG000|Induction Phase|Withdrawal by Subject|1|||
161837692|NCT01144364|584448690|FG001|Induction Phase|Withdrawal by Subject|0|||
161837693|NCT01144364|584448691|FG002|Induction Phase|Withdrawal by Subject|0|||
161837694|NCT01144364|584448689|FG000|Induction Phase|Lost to Follow-up|2|||
161837695|NCT01144364|584448690|FG001|Induction Phase|Lost to Follow-up|0|||
161958255|NCT00407602|584892749|FG000|Overall Study|Device explanted|5|||
161958256|NCT00407602|584892749|FG000|Overall Study|Withdrawal by Subject|1|||
161706578|NCT01454076|583971594|FG003|Overall Study|Other|1|||
161706579|NCT01454076|583971595|FG004|Overall Study|Other|2|||
161706580|NCT01454076|583971591|FG000|Overall Study|Withdrawal by Subject|3|||
161706581|NCT01454076|583971592|FG001|Overall Study|Withdrawal by Subject|4|||
161706582|NCT01454076|583971593|FG002|Overall Study|Withdrawal by Subject|2|||
161706583|NCT01454076|583971594|FG003|Overall Study|Withdrawal by Subject|1|||
161706584|NCT01454076|583971595|FG004|Overall Study|Withdrawal by Subject|2|||
161706585|NCT01454076|583971591|FG000|Overall Study|Adverse Event|8|||
161706586|NCT01454076|583971592|FG001|Overall Study|Adverse Event|2|||
161706587|NCT01454076|583971593|FG002|Overall Study|Adverse Event|7|||
161706588|NCT01454076|583971594|FG003|Overall Study|Adverse Event|0|||
161706589|NCT01454076|583971595|FG004|Overall Study|Adverse Event|2|||
161706590|NCT00291551|583971598|FG000|Overall Study|Death|7|||
161706591|NCT00291551|583971598|FG000|Overall Study|Withdrawal by Subject|6|||
161706592|NCT02452762|583971599|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
161706593|NCT02452762|583971600|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
161706594|NCT02452762|583971599|FG000|Overall Study|Withdrawal by Subject|1|||
161706595|NCT02452762|583971600|FG001|Overall Study|Withdrawal by Subject|0|||
161706596|NCT00584870|583971601|FG000|Overall Study|Adverse Event|4|||
161706597|NCT00584870|583971602|FG001|Overall Study|Adverse Event|3|||
161706598|NCT00584870|583971603|FG002|Overall Study|Adverse Event|2|||
161706599|NCT00584870|583971601|FG000|Overall Study|Lost to Follow-up|4|||
161706600|NCT00584870|583971602|FG001|Overall Study|Lost to Follow-up|1|||
161706601|NCT00584870|583971603|FG002|Overall Study|Lost to Follow-up|1|||
161706602|NCT00584870|583971601|FG000|Overall Study|Lack of Efficacy|7|||
161706603|NCT00584870|583971602|FG001|Overall Study|Lack of Efficacy|14|||
161706604|NCT00584870|583971603|FG002|Overall Study|Lack of Efficacy|8|||
161706605|NCT00584870|583971601|FG000|Overall Study|Withdrawal by Subject|10|||
161706606|NCT00584870|583971602|FG001|Overall Study|Withdrawal by Subject|5|||
161706607|NCT00584870|583971603|FG002|Overall Study|Withdrawal by Subject|3|||
161706608|NCT00584870|583971601|FG000|Overall Study|Protocol Violation|1|||
161706609|NCT00584870|583971602|FG001|Overall Study|Protocol Violation|1|||
161706610|NCT00584870|583971603|FG002|Overall Study|Protocol Violation|2|||
161706611|NCT00584870|583971601|FG000|Overall Study|Did not met entrance criteria|1|||
161706612|NCT00584870|583971602|FG001|Overall Study|Did not met entrance criteria|0|||
161706613|NCT00584870|583971603|FG002|Overall Study|Did not met entrance criteria|0|||
161706614|NCT00584870|583971601|FG000|Overall Study|Other|2|||
161706615|NCT00584870|583971602|FG001|Overall Study|Other|0|||
161706616|NCT00584870|583971603|FG002|Overall Study|Other|0|||
161706617|NCT00584870|583971601|FG000|Overall Study|Randomized but not treated|0|||
161706618|NCT00584870|583971602|FG001|Overall Study|Randomized but not treated|1|||
161706619|NCT00584870|583971603|FG002|Overall Study|Randomized but not treated|2|||
161706620|NCT00631137|583971604|FG000|Overall Study|Withdrawal by Subject|1|||
161706621|NCT00631137|583971605|FG001|Overall Study|Withdrawal by Subject|0|||
161706622|NCT03682120|583971606|FG000|Overall Study|Lost to Follow-up|11|||
161706623|NCT03682120|583971607|FG001|Overall Study|Lost to Follow-up|4|||
161706624|NCT03682120|583971608|FG002|Overall Study|Lost to Follow-up|5|||
161706625|NCT03682120|583971609|FG003|Overall Study|Lost to Follow-up|2|||
161706626|NCT03682120|583971606|FG000|Overall Study|Physician Decision|1|||
161706627|NCT03682120|583971607|FG001|Overall Study|Physician Decision|0|||
161706628|NCT03682120|583971608|FG002|Overall Study|Physician Decision|0|||
161706629|NCT03682120|583971609|FG003|Overall Study|Physician Decision|0|||
161706630|NCT03682120|583971606|FG000|Overall Study|Withdrawal by Subject|1|||
161706631|NCT03682120|583971607|FG001|Overall Study|Withdrawal by Subject|2|||
161706632|NCT03682120|583971608|FG002|Overall Study|Withdrawal by Subject|3|||
161706633|NCT03682120|583971609|FG003|Overall Study|Withdrawal by Subject|0|||
161706634|NCT03682120|583971606|FG000|Overall Study|Death|0|||
161706635|NCT03682120|583971607|FG001|Overall Study|Death|1|||
161706636|NCT03682120|583971608|FG002|Overall Study|Death|0|||
161706637|NCT03682120|583971609|FG003|Overall Study|Death|0|||
161706638|NCT03682120|583971606|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
161706639|NCT03682120|583971607|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
161706640|NCT03682120|583971608|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
161706641|NCT03682120|583971609|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
161706642|NCT01015833|583971610|FG000|Overall Study|Death|1|||
161706643|NCT01015833|583971611|FG001|Overall Study|Death|0|||
161706644|NCT01015833|583971610|FG000|Overall Study|Withdrawal by Subject|3|||
161706645|NCT01015833|583971611|FG001|Overall Study|Withdrawal by Subject|2|||
161706646|NCT01015833|583971610|FG000|Overall Study|Adverse Event|0|||
161706647|NCT01015833|583971611|FG001|Overall Study|Adverse Event|1|||
161706648|NCT01015833|583971610|FG000|Overall Study|Physician Decision|2|||
161706649|NCT01015833|583971611|FG001|Overall Study|Physician Decision|0|||
161706650|NCT01015833|583971610|FG000|Overall Study|Symptomatic deterioration|0|||
161706651|NCT01015833|583971611|FG001|Overall Study|Symptomatic deterioration|1|||
161706652|NCT01015833|583971610|FG000|Overall Study|Other|5|||
161706653|NCT01015833|583971611|FG001|Overall Study|Other|1|||
161706654|NCT01015833|583971610|FG000|Overall Study|Motor Vehicle Accidents|1|||
161706655|NCT01015833|583971611|FG001|Overall Study|Motor Vehicle Accidents|0|||
161958257|NCT04188834|584892750|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
161958258|NCT00553436|584892751|FG000|Overall Study|Conversion to another procedure|1|||
161958259|NCT02455336|584892752|FG000|Overall Study|Withdrawal by Subject|0|||
161958260|NCT02455336|584892753|FG001|Overall Study|Withdrawal by Subject|2|||
161706656|NCT01015833|583971610|FG000|Overall Study|Did not start treatment|1|||
161706657|NCT01015833|583971611|FG001|Overall Study|Did not start treatment|0|||
161706658|NCT02040142|583971612|FG000|Overall Study|Lost to Follow-up|5|||
161706659|NCT02040142|583971612|FG000|Overall Study|Death|17|||
161706660|NCT02040142|583971612|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
161706661|NCT04439331|583971616|FG000|Overall Study|Never Start Protocol Therapy|2|||
161706662|NCT04439331|583971616|FG000|Overall Study|Ineligible|2|||
161706663|NCT04439331|583971616|FG000|Overall Study|Mutation Status Not Confirmed|1|||
161706664|NCT04439331|583971616|FG000|Overall Study|Adverse Event|1|||
161706665|NCT04439331|583971616|FG000|Overall Study|Death|1|||
161706666|NCT04439331|583971616|FG000|Overall Study|Disease Progression|20|||
161706667|NCT04439331|583971616|FG000|Overall Study|Withdrawal by Subject|6|||
161706668|NCT04439331|583971616|FG000|Overall Study|Physician Decision|1|||
161706669|NCT04439331|583971616|FG000|Overall Study|Other Complicating Disease|1|||
161706670|NCT03726268|583971618|FG000|Overall Study|Physician Decision|2|||
161706671|NCT03726268|583971619|FG001|Overall Study|Physician Decision|8|||
161706672|NCT03726268|583971620|FG002|Overall Study|Physician Decision|6|||
161706673|NCT03726268|583971621|FG003|Overall Study|Physician Decision|3|||
161706674|NCT03726268|583971618|FG000|Overall Study|Withdrawal by Subject|11|||
161706675|NCT03726268|583971619|FG001|Overall Study|Withdrawal by Subject|5|||
161706676|NCT03726268|583971620|FG002|Overall Study|Withdrawal by Subject|9|||
161706677|NCT03726268|583971621|FG003|Overall Study|Withdrawal by Subject|8|||
161706678|NCT04370509|583971623|FG000|Overall Study|Adverse Event|1|||
161706679|NCT04370509|583971624|FG001|Overall Study|Adverse Event|0|||
161706680|NCT04370509|583971623|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
161706681|NCT04370509|583971624|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
161706682|NCT04743856|583971625|FG000|Overall Study|Lost to Follow-up|6|||
161706683|NCT04743856|583971626|FG001|Overall Study|Lost to Follow-up|7|||
161706684|NCT04743856|583971625|FG000|Overall Study|Withdrawal by Subject|1|||
161706685|NCT04743856|583971626|FG001|Overall Study|Withdrawal by Subject|0|||
161706686|NCT04696861|583971627|FG000|Overall Study|Death|1|||
161706687|NCT04696861|583971628|FG001|Overall Study|Death|0|||
161706688|NCT04696861|583971627|FG000|Overall Study|Lost to Follow-up|3|||
161706689|NCT04696861|583971628|FG001|Overall Study|Lost to Follow-up|0|||
161706690|NCT04439188|583971629|FG000|Overall Study|Ineligible|3|||
161706691|NCT04439188|583971629|FG000|Overall Study|Adverse Event|4|||
161706692|NCT04439188|583971629|FG000|Overall Study|Death|1|||
161706693|NCT04439188|583971629|FG000|Overall Study|Disease Progression|25|||
161706694|NCT04439188|583971629|FG000|Overall Study|Withdrawal by Subject|2|||
161706695|NCT00413959|583971630|FG000|Overall Study|Pt had only one cycle.|1|||
161706696|NCT01813890|583971633|FG000|Overall Study|Adverse Event|0|||
161706697|NCT01813890|583971634|FG001|Overall Study|Adverse Event|3|||
161706698|NCT01813890|583971635|FG002|Overall Study|Adverse Event|4|||
161706699|NCT01813890|583971633|FG000|Overall Study|Lack of Efficacy|9|||
161706700|NCT01813890|583971634|FG001|Overall Study|Lack of Efficacy|1|||
161706701|NCT01813890|583971635|FG002|Overall Study|Lack of Efficacy|2|||
161706702|NCT04482647|583971636|FG000|Overall Study|Time constraints|2|||
161706703|NCT04482647|583971636|FG000|Overall Study|Health issues|1|||
161706704|NCT04482647|583971636|FG000|Overall Study|Death in the family|1|||
161706705|NCT04482647|583971636|FG000|Overall Study|Disliked the intervention|1|||
161706706|NCT04482647|583971636|FG000|Overall Study|No reasons specified|7|||
161706707|NCT03952559|583971637|FG000|Double Blind Treatment Period|Adverse Event|0|||
161958261|NCT02455336|584892752|FG000|Overall Study|Adverse Event|3|||
161958262|NCT02455336|584892753|FG001|Overall Study|Adverse Event|0|||
161958263|NCT02455336|584892752|FG000|Overall Study|Non-responder to treatment|2|||
161958264|NCT02455336|584892753|FG001|Overall Study|Non-responder to treatment|0|||
161706708|NCT03952559|583971638|FG001|Double Blind Treatment Period|Adverse Event|2|||
161706709|NCT03952559|583971639|FG002|Double Blind Treatment Period|Adverse Event|1|||
161706710|NCT03952559|583971640|FG003|Double Blind Treatment Period|Adverse Event|0|||
161706711|NCT03952559|583971641|FG004|Double Blind Treatment Period|Adverse Event|1|||
161958265|NCT00391430|584892754|FG000|Overall Study|Withdrawal by Subject|3|||
161958266|NCT00391430|584892755|FG001|Overall Study|Withdrawal by Subject|0|||
161706712|NCT03952559|583971637|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
161706713|NCT03952559|583971638|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
161706714|NCT03952559|583971639|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
161706715|NCT03952559|583971640|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
161706716|NCT03952559|583971641|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
161706717|NCT03952559|583971637|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
161706718|NCT03952559|583971638|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
161706719|NCT03952559|583971639|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
161706720|NCT03952559|583971640|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
161706721|NCT03952559|583971641|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
161706722|NCT03952559|583971637|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
161706723|NCT03952559|583971638|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
161706724|NCT03952559|583971639|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
161706725|NCT03952559|583971640|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
161706726|NCT03952559|583971641|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
161706727|NCT03538743|583971642|FG000|Overall Study|Adverse Event|0|||
161706728|NCT03538743|583971643|FG001|Overall Study|Adverse Event|0|||
161706729|NCT03538743|583971644|FG002|Overall Study|Adverse Event|1|||
161706730|NCT03538743|583971645|FG003|Overall Study|Adverse Event|1|||
161706731|NCT03538743|583971646|FG004|Overall Study|Adverse Event|0|||
161706732|NCT03538743|583971647|FG005|Overall Study|Adverse Event|0|||
161706733|NCT03538743|583971648|FG006|Overall Study|Adverse Event|0|||
161706734|NCT03538743|583971649|FG007|Overall Study|Adverse Event|0|||
161706735|NCT03538743|583971650|FG008|Overall Study|Adverse Event|0|||
161706736|NCT03538743|583971642|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
161706737|NCT03538743|583971643|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
161706738|NCT03538743|583971644|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
161706739|NCT03538743|583971645|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
161706740|NCT03538743|583971646|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
161706741|NCT03538743|583971647|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
161706742|NCT03538743|583971648|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
161706743|NCT03538743|583971649|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
161706744|NCT03538743|583971650|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
161706745|NCT03538743|583971642|FG000|Overall Study|Withdrawal by Subject|0|||
161706746|NCT03538743|583971643|FG001|Overall Study|Withdrawal by Subject|0|||
161706747|NCT03538743|583971644|FG002|Overall Study|Withdrawal by Subject|0|||
161706748|NCT03538743|583971645|FG003|Overall Study|Withdrawal by Subject|1|||
161706749|NCT03538743|583971646|FG004|Overall Study|Withdrawal by Subject|0|||
161706750|NCT03538743|583971647|FG005|Overall Study|Withdrawal by Subject|0|||
161706751|NCT03538743|583971648|FG006|Overall Study|Withdrawal by Subject|0|||
161706752|NCT03538743|583971649|FG007|Overall Study|Withdrawal by Subject|0|||
161706753|NCT03538743|583971650|FG008|Overall Study|Withdrawal by Subject|0|||
161706754|NCT00630331|583971654|FG000|Overall Study|Death|2|||
161706755|NCT00630331|583971655|FG001|Overall Study|Death|1|||
161706756|NCT00630331|583971656|FG002|Overall Study|Death|1|||
161706757|NCT00630331|583971654|FG000|Overall Study|Adverse Event|1|||
161706758|NCT00630331|583971655|FG001|Overall Study|Adverse Event|0|||
161706759|NCT00630331|583971656|FG002|Overall Study|Adverse Event|0|||
161706760|NCT00630331|583971654|FG000|Overall Study|Withdrawal by Subject|12|||
161706761|NCT00630331|583971655|FG001|Overall Study|Withdrawal by Subject|7|||
161706762|NCT00630331|583971656|FG002|Overall Study|Withdrawal by Subject|5|||
161958267|NCT00391430|584892756|FG002|Overall Study|Withdrawal by Subject|12|||
161706763|NCT00630331|583971654|FG000|Overall Study|Lost to Follow-up|175|||
161706764|NCT00630331|583971655|FG001|Overall Study|Lost to Follow-up|143|||
161706765|NCT00630331|583971656|FG002|Overall Study|Lost to Follow-up|170|||
161706766|NCT00630331|583971654|FG000|Overall Study|Inappropriate enrollment|3|||
161706767|NCT00630331|583971655|FG001|Overall Study|Inappropriate enrollment|6|||
161706768|NCT00630331|583971656|FG002|Overall Study|Inappropriate enrollment|3|||
161706769|NCT00630331|583971654|FG000|Overall Study|Unable to classify|9|||
161706770|NCT00630331|583971655|FG001|Overall Study|Unable to classify|4|||
161706771|NCT00630331|583971656|FG002|Overall Study|Unable to classify|3|||
161706772|NCT00630331|583971654|FG000|Overall Study|Protocol Violation|4|||
161706773|NCT00630331|583971655|FG001|Overall Study|Protocol Violation|5|||
161706774|NCT00630331|583971656|FG002|Overall Study|Protocol Violation|6|||
161706775|NCT01929135|583971664|FG000|Overall Study|Lost to Follow-up|1|||
161706776|NCT01929135|583971665|FG001|Overall Study|Lost to Follow-up|1|||
161706777|NCT03136107|583971668|FG000|Overall Study|Other (Not specified)|1|||
161958268|NCT00577707|584892759|FG000|Overall Study|Withdrawal by Subject|3|||
161706778|NCT01955707|583971669|FG000|Overall Study|Adverse Event|1|||
161706779|NCT01955707|583971670|FG001|Overall Study|Adverse Event|2|||
161706780|NCT01955707|583971669|FG000|Overall Study|Lost to Follow-up|2|||
161706781|NCT01955707|583971670|FG001|Overall Study|Lost to Follow-up|1|||
161958269|NCT03299244|584892760|FG000|Overall Study|Withdrawal by Subject|34|||
161706782|NCT01955707|583971669|FG000|Overall Study|Withdrawal by Subject|0|||
161706783|NCT01955707|583971670|FG001|Overall Study|Withdrawal by Subject|3|||
161706784|NCT01955707|583971669|FG000|Overall Study|Death|13|||
161706785|NCT01955707|583971670|FG001|Overall Study|Death|14|||
161706786|NCT01955707|583971669|FG000|Overall Study|Other|4|||
161706787|NCT01955707|583971670|FG001|Overall Study|Other|2|||
161706788|NCT01817790|583971675|FG000|Overall Study|Adverse Event|0|||
161706789|NCT01817790|583971676|FG001|Overall Study|Adverse Event|2|||
161706790|NCT01817790|583971675|FG000|Overall Study|Lost to Follow-up|0|||
161706791|NCT01817790|583971676|FG001|Overall Study|Lost to Follow-up|1|||
161958270|NCT03299244|584892761|FG001|Overall Study|Withdrawal by Subject|29|||
161706792|NCT01817790|583971675|FG000|Overall Study|Protocol Violation|2|||
161706793|NCT01817790|583971676|FG001|Overall Study|Protocol Violation|1|||
161706794|NCT01817790|583971675|FG000|Overall Study|Withdrawal by Subject|1|||
161706795|NCT01817790|583971676|FG001|Overall Study|Withdrawal by Subject|3|||
161706796|NCT01817790|583971675|FG000|Overall Study|Other: Could not attend appointment|1|||
161706797|NCT01817790|583971676|FG001|Overall Study|Other: Could not attend appointment|1|||
161706798|NCT01671345|583971677|FG000|Overall Study|Lost to Follow-up|10|||
161706799|NCT01671345|583971678|FG001|Overall Study|Lost to Follow-up|6|||
161706800|NCT01671345|583971677|FG000|Overall Study|visit with non-participating physician|3|||
161706801|NCT01671345|583971678|FG001|Overall Study|visit with non-participating physician|3|||
161706802|NCT02847598|583971681|FG000|Overall Study|Adverse Event|0|||
161706803|NCT02847598|583971682|FG001|Overall Study|Adverse Event|0|||
161706804|NCT02847598|583971683|FG002|Overall Study|Adverse Event|0|||
161706805|NCT02847598|583971684|FG003|Overall Study|Adverse Event|0|||
161706806|NCT02847598|583971685|FG004|Overall Study|Adverse Event|0|||
161706807|NCT02847598|583971686|FG005|Overall Study|Adverse Event|0|||
161706808|NCT02847598|583971687|FG006|Overall Study|Adverse Event|0|||
161706809|NCT02847598|583971688|FG007|Overall Study|Adverse Event|1|||
161706810|NCT02847598|583971681|FG000|Overall Study|Consent withdrawn|2|||
161706811|NCT02847598|583971682|FG001|Overall Study|Consent withdrawn|0|||
161706812|NCT02847598|583971683|FG002|Overall Study|Consent withdrawn|0|||
161706813|NCT02847598|583971684|FG003|Overall Study|Consent withdrawn|4|||
161706814|NCT02847598|583971685|FG004|Overall Study|Consent withdrawn|3|||
161706815|NCT02847598|583971686|FG005|Overall Study|Consent withdrawn|2|||
161706816|NCT02847598|583971687|FG006|Overall Study|Consent withdrawn|1|||
161706817|NCT02847598|583971688|FG007|Overall Study|Consent withdrawn|3|||
161706818|NCT02847598|583971681|FG000|Overall Study|Death|3|||
161706819|NCT02847598|583971682|FG001|Overall Study|Death|0|||
161706820|NCT02847598|583971683|FG002|Overall Study|Death|0|||
161706821|NCT02847598|583971684|FG003|Overall Study|Death|0|||
161706822|NCT02847598|583971685|FG004|Overall Study|Death|0|||
161706823|NCT02847598|583971686|FG005|Overall Study|Death|0|||
161706824|NCT02847598|583971687|FG006|Overall Study|Death|0|||
161706825|NCT02847598|583971688|FG007|Overall Study|Death|0|||
161706826|NCT02847598|583971681|FG000|Overall Study|Lost to Follow-up|0|||
161706827|NCT02847598|583971682|FG001|Overall Study|Lost to Follow-up|0|||
161706828|NCT02847598|583971683|FG002|Overall Study|Lost to Follow-up|0|||
161706829|NCT02847598|583971684|FG003|Overall Study|Lost to Follow-up|0|||
161706830|NCT02847598|583971685|FG004|Overall Study|Lost to Follow-up|0|||
161706831|NCT02847598|583971686|FG005|Overall Study|Lost to Follow-up|1|||
161706832|NCT02847598|583971687|FG006|Overall Study|Lost to Follow-up|1|||
161706833|NCT02847598|583971688|FG007|Overall Study|Lost to Follow-up|0|||
161706834|NCT03690869|583971689|FG000|Overall Study|Adverse Event|0|||
161706835|NCT03690869|583971690|FG001|Overall Study|Adverse Event|0|||
161706836|NCT03690869|583971691|FG002|Overall Study|Adverse Event|0|||
161706837|NCT03690869|583971692|FG003|Overall Study|Adverse Event|1|||
161706838|NCT03690869|583971693|FG004|Overall Study|Adverse Event|0|||
161706839|NCT03690869|583971694|FG005|Overall Study|Adverse Event|0|||
161706840|NCT03690869|583971695|FG006|Overall Study|Adverse Event|0|||
161706841|NCT03690869|583971696|FG007|Overall Study|Adverse Event|1|||
161706842|NCT03690869|583971697|FG008|Overall Study|Adverse Event|0|||
161706843|NCT03690869|583971698|FG009|Overall Study|Adverse Event|1|||
161706844|NCT03690869|583971689|FG000|Overall Study|Death|1|||
161706845|NCT03690869|583971690|FG001|Overall Study|Death|1|||
161706846|NCT03690869|583971691|FG002|Overall Study|Death|1|||
161706847|NCT03690869|583971692|FG003|Overall Study|Death|4|||
161706848|NCT03690869|583971693|FG004|Overall Study|Death|2|||
161706849|NCT03690869|583971694|FG005|Overall Study|Death|5|||
161706850|NCT03690869|583971695|FG006|Overall Study|Death|3|||
161706851|NCT03690869|583971696|FG007|Overall Study|Death|2|||
161706852|NCT03690869|583971697|FG008|Overall Study|Death|0|||
161706853|NCT03690869|583971698|FG009|Overall Study|Death|3|||
161706854|NCT03690869|583971689|FG000|Overall Study|Lost to Follow-up|0|||
161706855|NCT03690869|583971690|FG001|Overall Study|Lost to Follow-up|0|||
161706856|NCT03690869|583971691|FG002|Overall Study|Lost to Follow-up|1|||
161837696|NCT01144364|584448691|FG002|Induction Phase|Lost to Follow-up|0|||
161706857|NCT03690869|583971692|FG003|Overall Study|Lost to Follow-up|0|||
161706858|NCT03690869|583971693|FG004|Overall Study|Lost to Follow-up|0|||
161706859|NCT03690869|583971694|FG005|Overall Study|Lost to Follow-up|0|||
161837697|NCT01144364|584448689|FG000|Induction Phase|Physician Decision|1|||
161837698|NCT01144364|584448690|FG001|Induction Phase|Physician Decision|0|||
161706860|NCT03690869|583971695|FG006|Overall Study|Lost to Follow-up|0|||
161706861|NCT03690869|583971696|FG007|Overall Study|Lost to Follow-up|0|||
161706862|NCT03690869|583971697|FG008|Overall Study|Lost to Follow-up|0|||
161837699|NCT01144364|584448691|FG002|Induction Phase|Physician Decision|0|||
161958271|NCT03299244|584892760|FG000|Overall Study|Decision by Sponsor|4|||
161706863|NCT03690869|583971698|FG009|Overall Study|Lost to Follow-up|0|||
161706864|NCT03690869|583971689|FG000|Overall Study|Other Treatment|1|||
161706865|NCT03690869|583971690|FG001|Overall Study|Other Treatment|1|||
161706866|NCT03690869|583971691|FG002|Overall Study|Other Treatment|1|||
161706867|NCT03690869|583971692|FG003|Overall Study|Other Treatment|2|||
161706868|NCT03690869|583971693|FG004|Overall Study|Other Treatment|3|||
161706869|NCT03690869|583971694|FG005|Overall Study|Other Treatment|1|||
161706870|NCT03690869|583971695|FG006|Overall Study|Other Treatment|2|||
161706871|NCT03690869|583971696|FG007|Overall Study|Other Treatment|7|||
161706872|NCT03690869|583971697|FG008|Overall Study|Other Treatment|0|||
161706873|NCT03690869|583971698|FG009|Overall Study|Other Treatment|3|||
161706874|NCT03690869|583971689|FG000|Overall Study|Physician Decision|0|||
161706875|NCT03690869|583971690|FG001|Overall Study|Physician Decision|1|||
161706876|NCT03690869|583971691|FG002|Overall Study|Physician Decision|0|||
161706877|NCT03690869|583971692|FG003|Overall Study|Physician Decision|0|||
161706878|NCT03690869|583971693|FG004|Overall Study|Physician Decision|0|||
161706879|NCT03690869|583971694|FG005|Overall Study|Physician Decision|0|||
161706880|NCT03690869|583971695|FG006|Overall Study|Physician Decision|0|||
161706881|NCT03690869|583971696|FG007|Overall Study|Physician Decision|0|||
161706882|NCT03690869|583971697|FG008|Overall Study|Physician Decision|0|||
161706883|NCT03690869|583971698|FG009|Overall Study|Physician Decision|0|||
161706884|NCT03690869|583971689|FG000|Overall Study|Progressive Disease|1|||
161706885|NCT03690869|583971690|FG001|Overall Study|Progressive Disease|2|||
161706886|NCT03690869|583971691|FG002|Overall Study|Progressive Disease|0|||
161706887|NCT03690869|583971692|FG003|Overall Study|Progressive Disease|1|||
161706888|NCT03690869|583971693|FG004|Overall Study|Progressive Disease|0|||
161706889|NCT03690869|583971694|FG005|Overall Study|Progressive Disease|0|||
161706890|NCT03690869|583971695|FG006|Overall Study|Progressive Disease|0|||
161706891|NCT03690869|583971696|FG007|Overall Study|Progressive Disease|0|||
161706892|NCT03690869|583971697|FG008|Overall Study|Progressive Disease|1|||
161706893|NCT03690869|583971698|FG009|Overall Study|Progressive Disease|1|||
161706894|NCT03690869|583971689|FG000|Overall Study|Subject Decision|0|||
161706895|NCT03690869|583971690|FG001|Overall Study|Subject Decision|0|||
161706896|NCT03690869|583971691|FG002|Overall Study|Subject Decision|0|||
161706897|NCT03690869|583971692|FG003|Overall Study|Subject Decision|1|||
161706898|NCT03690869|583971693|FG004|Overall Study|Subject Decision|0|||
161706899|NCT03690869|583971694|FG005|Overall Study|Subject Decision|0|||
161706900|NCT03690869|583971695|FG006|Overall Study|Subject Decision|0|||
161706901|NCT03690869|583971696|FG007|Overall Study|Subject Decision|1|||
161706902|NCT03690869|583971697|FG008|Overall Study|Subject Decision|0|||
161706903|NCT03690869|583971698|FG009|Overall Study|Subject Decision|0|||
161706904|NCT00960076|583973362|FG000|Overall Study|Adverse Event|1|||
161706905|NCT00960076|583973363|FG001|Overall Study|Adverse Event|7|||
161706906|NCT00960076|583973362|FG000|Overall Study|No longer met study criteria|1|||
161706907|NCT00960076|583973363|FG001|Overall Study|No longer met study criteria|5|||
161706908|NCT00960076|583973362|FG000|Overall Study|Withdrawal by Subject|1|||
161706909|NCT00960076|583973363|FG001|Overall Study|Withdrawal by Subject|2|||
161706910|NCT00960076|583973362|FG000|Overall Study|Lost to Follow-up|3|||
161706911|NCT00960076|583973363|FG001|Overall Study|Lost to Follow-up|3|||
161706912|NCT00960076|583973362|FG000|Overall Study|Severe non-compliance to protocol|1|||
161706913|NCT00960076|583973363|FG001|Overall Study|Severe non-compliance to protocol|2|||
161706914|NCT00960076|583973362|FG000|Overall Study|Hyperglycemia|1|||
161706915|NCT00960076|583973363|FG001|Overall Study|Hyperglycemia|5|||
161706916|NCT00960076|583973362|FG000|Overall Study|Did not attend the termination visit|0|||
161706917|NCT00960076|583973363|FG001|Overall Study|Did not attend the termination visit|1|||
161706918|NCT02029976|583973364|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
161706919|NCT02029976|583973365|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
161706920|NCT02029976|583973364|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
161706921|NCT02029976|583973365|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
161706922|NCT02029976|583973364|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
161706923|NCT02029976|583973365|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
161706924|NCT02029976|583973364|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
161706925|NCT02029976|583973365|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
161706926|NCT03263806|583973366|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
161706927|NCT03263806|583973367|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
161706928|NCT03263806|583973366|FG000|Overall Study|Withdrawal by Subject|0|||
161706929|NCT03263806|583973367|FG001|Overall Study|Withdrawal by Subject|1|||
161706930|NCT03263806|583973366|FG000|Overall Study|Study Termination|5|||
161706931|NCT03263806|583973367|FG001|Overall Study|Study Termination|6|||
161706932|NCT04840667|583973368|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
161958272|NCT03299244|584892761|FG001|Overall Study|Decision by Sponsor|5|||
161958273|NCT03299244|584892760|FG000|Overall Study|Death|9|||
161958274|NCT03299244|584892761|FG001|Overall Study|Death|4|||
161706933|NCT01445171|583973369|FG000|Overall Study|Lost to Follow-up|11|||
161706934|NCT01445171|583973369|FG000|Overall Study|Withdrawal by Subject|16|||
161706935|NCT01445171|583973369|FG000|Overall Study|Death|51|||
161706936|NCT01445171|583973369|FG000|Overall Study|Subjects declined to return for followup|9|||
161706937|NCT01445171|583973369|FG000|Overall Study|Consented but did not receive device|8|||
161706938|NCT00023322|583973370|FG000|Overall Study|Lost to Follow-up|1|||
161958275|NCT03706430|584892772|FG000|Overall Study|No A-Line placed|5|||
161958276|NCT03706430|584892772|FG000|Overall Study|Subject had gel nail polish|1|||
161706939|NCT05194345|583973373|FG000|Overall Study|Withdrawal by Subject|6|||
161958277|NCT03706430|584892772|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
161706940|NCT05194345|583973374|FG001|Overall Study|Withdrawal by Subject|4|||
161706941|NCT05194345|583973375|FG002|Overall Study|Withdrawal by Subject|0|||
161706942|NCT05194345|583973373|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
161706943|NCT05194345|583973374|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
161706944|NCT05194345|583973375|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
161706945|NCT02612909|583973376|FG000|Phase 2|Withdrawal by Subject|2|||
161706946|NCT02612909|583973377|FG001|Phase 2|Withdrawal by Subject|5|||
161706947|NCT02612909|583973378|FG002|Phase 2|Withdrawal by Subject|0|||
161706948|NCT02612909|583973379|FG003|Phase 2|Withdrawal by Subject|0|||
161706949|NCT02612909|583973380|FG004|Phase 2|Withdrawal by Subject|0|||
161706950|NCT02612909|583973376|FG000|Phase 2|Pregnancy|0|||
161706951|NCT02612909|583973377|FG001|Phase 2|Pregnancy|0|||
161706952|NCT02612909|583973378|FG002|Phase 2|Pregnancy|1|||
161706953|NCT02612909|583973379|FG003|Phase 2|Pregnancy|0|||
161706954|NCT02612909|583973380|FG004|Phase 2|Pregnancy|0|||
161706955|NCT02612909|583973376|FG000|Phase 3|Withdrawal by Subject|0|||
161706956|NCT02612909|583973377|FG001|Phase 3|Withdrawal by Subject|0|||
161706957|NCT02612909|583973378|FG002|Phase 3|Withdrawal by Subject|0|||
161706958|NCT02612909|583973379|FG003|Phase 3|Withdrawal by Subject|1|||
161706959|NCT02612909|583973380|FG004|Phase 3|Withdrawal by Subject|0|||
161706960|NCT05067127|583973385|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
161706961|NCT05067127|583973386|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
161706962|NCT05067127|583973387|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
161706963|NCT05067127|583973388|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
161706964|NCT05067127|583973385|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
161706965|NCT05067127|583973386|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
161706966|NCT05067127|583973387|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
161706967|NCT05067127|583973388|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
161706968|NCT05067127|583973385|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
161706969|NCT05067127|583973386|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161706970|NCT05067127|583973387|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161706971|NCT05067127|583973388|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161706972|NCT05067127|583973385|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
161706973|NCT05067127|583973386|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
161706974|NCT05067127|583973387|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
161706975|NCT05067127|583973388|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
161706976|NCT05067127|583973385|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
161706977|NCT05067127|583973386|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
161706978|NCT05067127|583973387|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
161706979|NCT05067127|583973388|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
161706980|NCT05067127|583973385|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
161706981|NCT05067127|583973386|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
161706982|NCT05067127|583973387|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
161706983|NCT05067127|583973388|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
161706984|NCT05067127|583973385|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161706985|NCT05067127|583973386|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161706986|NCT05067127|583973387|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
161706987|NCT05067127|583973388|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
161706988|NCT03615222|583973390|FG000|Overall Study|Ineligible|26|||
161706989|NCT03615222|583973390|FG000|Overall Study|Withdrawal by Subject|7|||
161706990|NCT03615222|583973390|FG000|Overall Study|Death|1|||
161706991|NCT04572633|583973391|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
161706992|NCT03155997|583973394|FG000|Overall Study|Withdrawal by Subject|119|||
161706993|NCT03155997|583973395|FG001|Overall Study|Withdrawal by Subject|134|||
161706994|NCT03155997|583973394|FG000|Overall Study|Lost to Follow-up|12|||
161706995|NCT03155997|583973395|FG001|Overall Study|Lost to Follow-up|13|||
161706996|NCT03155997|583973394|FG000|Overall Study|Missing disposition data|0|||
161706997|NCT03155997|583973395|FG001|Overall Study|Missing disposition data|1|||
161706998|NCT03155997|583973394|FG000|Overall Study|On study treatment|2027|||
161706999|NCT03155997|583973395|FG001|Overall Study|On study treatment|2074|||
161707000|NCT03304522|583973398|FG000|Overall Study|Adverse Event|0|||
161707001|NCT03304522|583973399|FG001|Overall Study|Adverse Event|4|||
161707002|NCT03304522|583973398|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
161707003|NCT03304522|583973399|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
161707004|NCT03304522|583973398|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
161707005|NCT03304522|583973399|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
161707006|NCT03304522|583973398|FG000|Overall Study|Other|0|||
161707007|NCT03304522|583973399|FG001|Overall Study|Other|1|||
161707008|NCT03367871|583973402|FG000|Overall Study|Lost to Follow-up|1|||
161707009|NCT01111604|583973404|FG000|Overall Study|Lost to Follow-up|0|||
161707010|NCT01111604|583973405|FG001|Overall Study|Lost to Follow-up|0|||
161707011|NCT01111604|583973406|FG002|Overall Study|Lost to Follow-up|1|||
161958278|NCT03706430|584892772|FG000|Overall Study|Cancelled Case|6|||
161958279|NCT03706430|584892772|FG000|Overall Study|Physician Decision|2|||
161958280|NCT01928433|584892773|FG000|Overall Study|Adverse Event|5|||
161958281|NCT01928433|584892774|FG001|Overall Study|Adverse Event|2|||
161958282|NCT01928433|584892775|FG002|Overall Study|Adverse Event|5|||
161958283|NCT01928433|584892773|FG000|Overall Study|Protocol Violation|0|||
161958284|NCT01928433|584892774|FG001|Overall Study|Protocol Violation|0|||
161958285|NCT01928433|584892775|FG002|Overall Study|Protocol Violation|2|||
161958286|NCT01928433|584892773|FG000|Overall Study|Lack of Efficacy|5|||
161958287|NCT01928433|584892774|FG001|Overall Study|Lack of Efficacy|4|||
161958288|NCT01928433|584892775|FG002|Overall Study|Lack of Efficacy|4|||
161958289|NCT01928433|584892773|FG000|Overall Study|Withdrawal by Subject|0|||
161958290|NCT01928433|584892774|FG001|Overall Study|Withdrawal by Subject|4|||
161958291|NCT01928433|584892775|FG002|Overall Study|Withdrawal by Subject|0|||
161958292|NCT01928433|584892773|FG000|Overall Study|Negative screening urine culture|7|||
161958293|NCT01928433|584892774|FG001|Overall Study|Negative screening urine culture|6|||
161958294|NCT01928433|584892775|FG002|Overall Study|Negative screening urine culture|10|||
161958295|NCT01928433|584892773|FG000|Overall Study|Lost to Follow-up|0|||
161958296|NCT01928433|584892774|FG001|Overall Study|Lost to Follow-up|2|||
161958297|NCT01928433|584892775|FG002|Overall Study|Lost to Follow-up|3|||
161958298|NCT01928433|584892773|FG000|Overall Study|Other reasons|3|||
161958299|NCT01928433|584892774|FG001|Overall Study|Other reasons|3|||
161958300|NCT01928433|584892775|FG002|Overall Study|Other reasons|4|||
161958301|NCT00145626|584892776|FG000|Overall Study|Did not have NK infusions|2|||
161958302|NCT00145626|584892776|FG000|Overall Study|Turned 2 years old before treatment|1|||
161958303|NCT00145626|584892776|FG000|Overall Study|Death|1|||
161958304|NCT00145626|584892776|FG000|Overall Study|Withdrawal by Subject|1|||
161958305|NCT02709720|584892777|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
161958306|NCT02709720|584892777|FG000|Overall Study|Protocol Violation|1|||
161958307|NCT02709720|584892777|FG000|Overall Study|Not take study medication|1|||
161958308|NCT01198574|584892779|FG000|Overall Study|Resigned from schools|4|||
161958309|NCT01198574|584892780|FG001|Overall Study|Resigned from schools|1|||
161958310|NCT01198574|584892781|FG002|Overall Study|Resigned from schools|1|||
161958311|NCT01198574|584892782|FG003|Overall Study|Resigned from schools|4|||
161958312|NCT00980460|584892789|FG000|Overall Study|Death|0|||
161958313|NCT00980460|584892790|FG001|Overall Study|Death|0|||
161958314|NCT00980460|584892791|FG002|Overall Study|Death|1|||
161958315|NCT00980460|584892792|FG003|Overall Study|Death|2|||
161958316|NCT00980460|584892793|FG004|Overall Study|Death|1|||
161958317|NCT00980460|584892789|FG000|Overall Study|Lack of Efficacy|0|||
161958318|NCT00980460|584892790|FG001|Overall Study|Lack of Efficacy|0|||
161707012|NCT01111604|583973404|FG000|Overall Study|Withdrew Consent|3|||
161707013|NCT01111604|583973405|FG001|Overall Study|Withdrew Consent|0|||
161707014|NCT01111604|583973406|FG002|Overall Study|Withdrew Consent|2|||
161707015|NCT01111604|583973404|FG000|Overall Study|Withdrawal by Subject|2|||
161707016|NCT01111604|583973405|FG001|Overall Study|Withdrawal by Subject|0|||
161707017|NCT01111604|583973406|FG002|Overall Study|Withdrawal by Subject|0|||
161707018|NCT01111604|583973404|FG000|Overall Study|Death|1|||
161707019|NCT01111604|583973405|FG001|Overall Study|Death|0|||
161707020|NCT01111604|583973406|FG002|Overall Study|Death|0|||
161707021|NCT01111604|583973404|FG000|Overall Study|Met Exclusion Criteria|2|||
161707022|NCT01111604|583973405|FG001|Overall Study|Met Exclusion Criteria|0|||
161707023|NCT01111604|583973406|FG002|Overall Study|Met Exclusion Criteria|0|||
161707024|NCT00885365|583973409|FG000|4 Weeks ON Treatment|Adverse Event|2|||
161707025|NCT00885365|583973410|FG001|4 Weeks ON Treatment|Adverse Event|4|||
161707026|NCT00885365|583973409|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
161707027|NCT00885365|583973410|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
161707028|NCT00885365|583973409|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
161707029|NCT00885365|583973410|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
161707030|NCT01824979|583973411|FG000|Overall Study|Withdrawal by Subject|5|||
161707031|NCT01824979|583973412|FG001|Overall Study|Withdrawal by Subject|0|||
161707032|NCT01824979|583973411|FG000|Overall Study|Physician Decision|2|||
161958319|NCT00980460|584892791|FG002|Overall Study|Lack of Efficacy|10|||
161707033|NCT01824979|583973412|FG001|Overall Study|Physician Decision|0|||
161707034|NCT01824979|583973411|FG000|Overall Study|Protocol Violation|6|||
161958320|NCT00980460|584892792|FG003|Overall Study|Lack of Efficacy|6|||
161958321|NCT00980460|584892793|FG004|Overall Study|Lack of Efficacy|8|||
161958322|NCT00980460|584892789|FG000|Overall Study|Lost to Follow-up|0|||
161958323|NCT00980460|584892790|FG001|Overall Study|Lost to Follow-up|0|||
161958324|NCT00980460|584892791|FG002|Overall Study|Lost to Follow-up|0|||
161958325|NCT00980460|584892792|FG003|Overall Study|Lost to Follow-up|1|||
161707035|NCT01824979|583973412|FG001|Overall Study|Protocol Violation|13|||
161958326|NCT00980460|584892793|FG004|Overall Study|Lost to Follow-up|0|||
161707036|NCT03094195|583973415|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
161707037|NCT03094195|583973416|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
161958327|NCT00980460|584892789|FG000|Overall Study|Physician Decision|0|||
161958328|NCT00980460|584892790|FG001|Overall Study|Physician Decision|0|||
161958329|NCT00980460|584892791|FG002|Overall Study|Physician Decision|11|||
161958330|NCT00980460|584892792|FG003|Overall Study|Physician Decision|5|||
161958331|NCT00980460|584892793|FG004|Overall Study|Physician Decision|3|||
161958332|NCT00980460|584892789|FG000|Overall Study|Withdrawal by Subject|0|||
161958333|NCT00980460|584892790|FG001|Overall Study|Withdrawal by Subject|0|||
161958334|NCT00980460|584892791|FG002|Overall Study|Withdrawal by Subject|1|||
161958335|NCT00980460|584892792|FG003|Overall Study|Withdrawal by Subject|0|||
161958336|NCT00980460|584892793|FG004|Overall Study|Withdrawal by Subject|0|||
161958337|NCT00980460|584892789|FG000|Overall Study|Ineligible|0|||
161958338|NCT00980460|584892790|FG001|Overall Study|Ineligible|2|||
161958339|NCT00980460|584892791|FG002|Overall Study|Ineligible|3|||
161958340|NCT00980460|584892792|FG003|Overall Study|Ineligible|1|||
161958341|NCT00980460|584892793|FG004|Overall Study|Ineligible|4|||
161958342|NCT00980460|584892789|FG000|Overall Study|Refusal of further therapy|0|||
161958343|NCT00980460|584892790|FG001|Overall Study|Refusal of further therapy|2|||
161958344|NCT00980460|584892791|FG002|Overall Study|Refusal of further therapy|3|||
161958345|NCT00980460|584892792|FG003|Overall Study|Refusal of further therapy|2|||
161958346|NCT00980460|584892793|FG004|Overall Study|Refusal of further therapy|0|||
161958347|NCT00980460|584892789|FG000|Overall Study|No therapy within 42 days of resection|0|||
161958348|NCT00980460|584892790|FG001|Overall Study|No therapy within 42 days of resection|0|||
161958349|NCT00980460|584892791|FG002|Overall Study|No therapy within 42 days of resection|3|||
161958350|NCT00980460|584892792|FG003|Overall Study|No therapy within 42 days of resection|1|||
161958351|NCT00980460|584892793|FG004|Overall Study|No therapy within 42 days of resection|0|||
161958352|NCT00980460|584892789|FG000|Overall Study|No transplant by protocol timepoints|0|||
161958353|NCT00980460|584892790|FG001|Overall Study|No transplant by protocol timepoints|0|||
161958354|NCT00980460|584892791|FG002|Overall Study|No transplant by protocol timepoints|3|||
161958355|NCT00980460|584892792|FG003|Overall Study|No transplant by protocol timepoints|0|||
161958356|NCT00980460|584892793|FG004|Overall Study|No transplant by protocol timepoints|0|||
161958357|NCT02842086|584892794|FG000|Overall Study|Randomized but Never Treated|6|||
161958358|NCT02842086|584892795|FG001|Overall Study|Randomized but Never Treated|6|||
161958359|NCT02842086|584892794|FG000|Overall Study|Still in Double-Blind Phase|7|||
161958360|NCT02842086|584892795|FG001|Overall Study|Still in Double-Blind Phase|3|||
161958361|NCT02842086|584892794|FG000|Overall Study|Adverse Event|18|||
161958362|NCT02842086|584892795|FG001|Overall Study|Adverse Event|20|||
161958363|NCT02842086|584892794|FG000|Overall Study|Death|3|||
161958364|NCT02842086|584892795|FG001|Overall Study|Death|3|||
161707038|NCT03094195|583973417|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
161707039|NCT03094195|583973418|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161707040|NCT03094195|583973419|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161707041|NCT03094195|583973420|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161707042|NCT03094195|583973421|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161707043|NCT03094195|583973422|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161707044|NCT03094195|583973415|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
161707045|NCT03094195|583973416|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
161707046|NCT03094195|583973417|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
161707047|NCT03094195|583973418|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161707048|NCT03094195|583973419|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161707049|NCT03094195|583973420|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161707050|NCT03094195|583973421|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161707051|NCT03094195|583973422|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161707052|NCT03094195|583973415|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707053|NCT03094195|583973416|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707054|NCT03094195|583973417|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
161707055|NCT03094195|583973418|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707056|NCT03094195|583973419|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707057|NCT03094195|583973420|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707058|NCT03094195|583973421|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707059|NCT03094195|583973422|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161707060|NCT03094195|583973415|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161707061|NCT03094195|583973416|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
161707062|NCT03094195|583973417|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
161707063|NCT03094195|583973418|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161958365|NCT02842086|584892794|FG000|Overall Study|Investigator's Discretion|9|||
161707064|NCT03094195|583973419|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161707065|NCT03094195|583973420|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161707066|NCT03094195|583973421|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161707067|NCT03094195|583973422|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161958366|NCT02842086|584892795|FG001|Overall Study|Investigator's Discretion|13|||
161958367|NCT02842086|584892794|FG000|Overall Study|Non-Compliance with Study Drug|9|||
161958368|NCT02842086|584892795|FG001|Overall Study|Non-Compliance with Study Drug|8|||
161958369|NCT02842086|584892794|FG000|Overall Study|Protocol Violation|8|||
161958370|NCT02842086|584892795|FG001|Overall Study|Protocol Violation|4|||
161707068|NCT01651780|583973423|FG000|Overall Study|Physician decision: No 30-day visit|2|||
161707069|NCT01651780|583973424|FG001|Overall Study|Physician decision: No 30-day visit|1|||
161707070|NCT01651780|583973423|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
161707071|NCT01651780|583973424|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
161707072|NCT01651780|583973423|FG000|Overall Study|Withdrawal by Subject|2|||
161707073|NCT01651780|583973424|FG001|Overall Study|Withdrawal by Subject|0|||
161707074|NCT01651780|583973423|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
161707075|NCT01651780|583973424|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161707076|NCT01651780|583973423|FG000|Overall Study|Lost to Follow-up|1|||
161707077|NCT01651780|583973424|FG001|Overall Study|Lost to Follow-up|2|||
161707078|NCT01651780|583973423|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
161707079|NCT01651780|583973424|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
161707080|NCT00054132|583973425|FG000|Overall Study|Not Treated|1|||
161707081|NCT02949830|583973426|FG000|Overall Study|Adverse Event|1|||
161707082|NCT02949830|583973426|FG000|Overall Study|Withdrawal by Subject|1|||
161707083|NCT01290887|583973427|FG000|Overall Study|Adverse Event|6|||
161707084|NCT01290887|583973428|FG001|Overall Study|Adverse Event|11|||
161707085|NCT01290887|583973427|FG000|Overall Study|Lack of Efficacy|4|||
161707086|NCT01290887|583973428|FG001|Overall Study|Lack of Efficacy|5|||
161707087|NCT01290887|583973427|FG000|Overall Study|Withdrawal by Subject|26|||
161707088|NCT01290887|583973428|FG001|Overall Study|Withdrawal by Subject|32|||
161707089|NCT01290887|583973427|FG000|Overall Study|Protocol Violation|2|||
161707090|NCT01290887|583973428|FG001|Overall Study|Protocol Violation|1|||
161707091|NCT01290887|583973427|FG000|Overall Study|Lost to Follow-up|4|||
161707092|NCT01290887|583973428|FG001|Overall Study|Lost to Follow-up|4|||
161707093|NCT01290887|583973427|FG000|Overall Study|Non-compliance to study procedures|0|||
161707094|NCT01290887|583973428|FG001|Overall Study|Non-compliance to study procedures|1|||
161707095|NCT01290887|583973427|FG000|Overall Study|Non-compliance to study medications|1|||
161707096|NCT01290887|583973428|FG001|Overall Study|Non-compliance to study medications|0|||
161707097|NCT01290887|583973427|FG000|Overall Study|Sponsor closure of study|420|||
161707098|NCT01290887|583973428|FG001|Overall Study|Sponsor closure of study|476|||
161707099|NCT01290887|583973427|FG000|Overall Study|Other|3|||
161707100|NCT01290887|583973428|FG001|Overall Study|Other|6|||
161707101|NCT01628926|583973429|FG000|Overall Study|Adverse Event|13|||
161707102|NCT01628926|583973430|FG001|Overall Study|Adverse Event|11|||
161707103|NCT01628926|583973431|FG002|Overall Study|Adverse Event|9|||
161707104|NCT01628926|583973429|FG000|Overall Study|Lack of Efficacy|2|||
161707105|NCT01628926|583973430|FG001|Overall Study|Lack of Efficacy|1|||
161707106|NCT01628926|583973431|FG002|Overall Study|Lack of Efficacy|5|||
161707107|NCT01628926|583973429|FG000|Overall Study|Withdrawal by Subject|6|||
161707108|NCT01628926|583973430|FG001|Overall Study|Withdrawal by Subject|4|||
161707109|NCT01628926|583973431|FG002|Overall Study|Withdrawal by Subject|2|||
161707110|NCT01628926|583973429|FG000|Overall Study|Protocol Violation|0|||
161707111|NCT01628926|583973430|FG001|Overall Study|Protocol Violation|1|||
161707112|NCT01628926|583973431|FG002|Overall Study|Protocol Violation|0|||
161707113|NCT01628926|583973429|FG000|Overall Study|Discontinuation criteria|3|||
161707114|NCT01628926|583973430|FG001|Overall Study|Discontinuation criteria|4|||
161707115|NCT01628926|583973431|FG002|Overall Study|Discontinuation criteria|0|||
161707116|NCT01628926|583973429|FG000|Overall Study|Physician Decision|2|||
161707117|NCT01628926|583973430|FG001|Overall Study|Physician Decision|2|||
161707118|NCT01628926|583973431|FG002|Overall Study|Physician Decision|1|||
161707119|NCT03029832|583973432|FG000|Overall Study|Safety Follow-Up Completed|2|||
161707120|NCT03029832|583973433|FG001|Overall Study|Safety Follow-Up Completed|0|||
161707121|NCT03029832|583973432|FG000|Overall Study|Death due to Disease Progression|1|||
161707122|NCT03029832|583973433|FG001|Overall Study|Death due to Disease Progression|0|||
161707123|NCT03029832|583973432|FG000|Overall Study|Study Terminated By Sponsor|1|||
161707124|NCT03029832|583973433|FG001|Overall Study|Study Terminated By Sponsor|1|||
161707125|NCT04373460|583973434|FG000|Overall Study|Did not receive tranfusion|18|||
161707126|NCT04373460|583973435|FG001|Overall Study|Did not receive tranfusion|26|||
161707127|NCT01412229|583973436|FG000|Overall Study|Physician Decision|1|||
161707128|NCT00454207|583973437|FG000|Overall Study|Adverse Event|3|||
161707129|NCT00454207|583973438|FG001|Overall Study|Adverse Event|1|||
161707130|NCT00454207|583973437|FG000|Overall Study|Lack of Efficacy|1|||
161707131|NCT00454207|583973438|FG001|Overall Study|Lack of Efficacy|0|||
161707132|NCT00454207|583973437|FG000|Overall Study|Protocol Violation|0|||
161707133|NCT00454207|583973438|FG001|Overall Study|Protocol Violation|1|||
161707134|NCT01672957|583973439|FG000|Overall Study|Protocol Violation|48|||
161707135|NCT01672957|583973439|FG000|Overall Study|Death|2|||
161837700|NCT01144364|584448689|FG000|Induction Phase|Stable disease|2|||
161837701|NCT01144364|584448690|FG001|Induction Phase|Stable disease|0|||
161837702|NCT01144364|584448691|FG002|Induction Phase|Stable disease|0|||
161837703|NCT01144364|584448689|FG000|Induction Phase|Secondary neoplasia|1|||
161707136|NCT01672957|583973439|FG000|Overall Study|ICF Signed After Transplantation|5|||
161707137|NCT01795547|583973444|FG000|Overall Study|Adverse Event|16|||
161707138|NCT01795547|583973445|FG001|Overall Study|Adverse Event|27|||
161707139|NCT01795547|583973444|FG000|Overall Study|Lack of Efficacy|8|||
161837704|NCT01144364|584448690|FG001|Induction Phase|Secondary neoplasia|0|||
161958371|NCT02842086|584892794|FG000|Overall Study|Withdrew Consent|205|||
161958372|NCT02842086|584892795|FG001|Overall Study|Withdrew Consent|194|||
161958373|NCT02842086|584892794|FG000|Overall Study|Lost to Follow-up|274|||
161958374|NCT02842086|584892795|FG001|Overall Study|Lost to Follow-up|236|||
161958375|NCT02842086|584892794|FG000|Overall Study|HIV-1 Infection|5|||
161958376|NCT02842086|584892795|FG001|Overall Study|HIV-1 Infection|6|||
161958377|NCT00928187|584892796|FG000|Overall Study|Death|1|||
161958378|NCT00928187|584892797|FG001|Overall Study|Death|2|||
161958379|NCT00928187|584892798|FG002|Overall Study|Death|3|||
161958380|NCT00928187|584892796|FG000|Overall Study|Lost to Follow-up|1|||
161958381|NCT00928187|584892797|FG001|Overall Study|Lost to Follow-up|2|||
161958382|NCT00928187|584892798|FG002|Overall Study|Lost to Follow-up|1|||
161958383|NCT00928187|584892796|FG000|Overall Study|Withdrawal by Subject|0|||
161958384|NCT00928187|584892797|FG001|Overall Study|Withdrawal by Subject|1|||
161958385|NCT00928187|584892798|FG002|Overall Study|Withdrawal by Subject|1|||
161958386|NCT00928187|584892796|FG000|Overall Study|Protocol Violation|0|||
161958387|NCT00928187|584892797|FG001|Overall Study|Protocol Violation|1|||
161958388|NCT00928187|584892798|FG002|Overall Study|Protocol Violation|0|||
161958389|NCT05696444|584892799|FG000|Treatment|Physician Decision|0|||
161958390|NCT05696444|584892800|FG001|Treatment|Physician Decision|1|||
161707140|NCT01795547|583973445|FG001|Overall Study|Lack of Efficacy|3|||
161707141|NCT01795547|583973444|FG000|Overall Study|Protocol Violation|6|||
161707142|NCT01795547|583973445|FG001|Overall Study|Protocol Violation|4|||
161707143|NCT01795547|583973444|FG000|Overall Study|Lost to Follow-up|2|||
161707144|NCT01795547|583973445|FG001|Overall Study|Lost to Follow-up|5|||
161707145|NCT01795547|583973444|FG000|Overall Study|Withdrawal of consent|7|||
161707146|NCT01795547|583973445|FG001|Overall Study|Withdrawal of consent|12|||
161707147|NCT01795547|583973444|FG000|Overall Study|Not Treated|4|||
161707148|NCT01795547|583973445|FG001|Overall Study|Not Treated|10|||
161707149|NCT01795547|583973444|FG000|Overall Study|Non-compliance with IMP|1|||
161707150|NCT01795547|583973445|FG001|Overall Study|Non-compliance with IMP|1|||
161707151|NCT01795547|583973444|FG000|Overall Study|Others|4|||
161707152|NCT01795547|583973445|FG001|Overall Study|Others|1|||
161707153|NCT01795547|583973444|FG000|Overall Study|Not stated|0|||
161707154|NCT01795547|583973445|FG001|Overall Study|Not stated|1|||
161707155|NCT00642642|583973447|FG000|Treatment & Follow Up|Adverse Event|2|||
161707156|NCT00642642|583973447|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
161707157|NCT00642642|583973447|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
161707158|NCT02116621|583973448|FG000|Baseline|Withdrawal by Subject|0|||
161707159|NCT02116621|583973449|FG001|Baseline|Withdrawal by Subject|4|||
161707160|NCT02116621|583973448|FG000|Three Month Follow-up|Death|1|||
161707161|NCT02116621|583973449|FG001|Three Month Follow-up|Death|1|||
161707162|NCT02116621|583973448|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
161707163|NCT02116621|583973449|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
161707164|NCT02116621|583973448|FG000|Three Month Follow-up|Lost to Follow-up|0|||
161707165|NCT02116621|583973449|FG001|Three Month Follow-up|Lost to Follow-up|1|||
161707166|NCT02116621|583973448|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
161707167|NCT02116621|583973449|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
161707168|NCT02116621|583973448|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
161707169|NCT02116621|583973449|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
161707170|NCT02116621|583973448|FG000|Six Month Follow-up|Lost to Follow-up|2|||
161707171|NCT02116621|583973449|FG001|Six Month Follow-up|Lost to Follow-up|1|||
161707172|NCT02116621|583973448|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
161707173|NCT02116621|583973449|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
161707174|NCT02116621|583973448|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
161707175|NCT02116621|583973449|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
161707176|NCT02116621|583973448|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
161707177|NCT02116621|583973449|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
161707178|NCT02116621|583973448|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
161958391|NCT05696444|584892801|FG002|Treatment|Physician Decision|0|||
161958392|NCT05696444|584892799|FG000|30 Days|Death|1|||
161958393|NCT05696444|584892800|FG001|30 Days|Death|1|||
161958394|NCT05696444|584892801|FG002|30 Days|Death|0|||
161958395|NCT05696444|584892799|FG000|30 Days|Missed Visit|1|||
161958396|NCT05696444|584892800|FG001|30 Days|Missed Visit|1|||
161958397|NCT05696444|584892801|FG002|30 Days|Missed Visit|1|||
161707179|NCT02116621|583973449|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
161707180|NCT02116621|583973448|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
161707181|NCT02116621|583973449|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
161707182|NCT00151892|583973450|FG000|Overall Study|Lack of Efficacy|50|||
161707183|NCT00151892|583973451|FG001|Overall Study|Lack of Efficacy|57|||
161707184|NCT00151892|583973450|FG000|Overall Study|Patient request|10|||
161707185|NCT00151892|583973451|FG001|Overall Study|Patient request|7|||
161707186|NCT00151892|583973450|FG000|Overall Study|Lost to Follow-up|5|||
161707187|NCT00151892|583973451|FG001|Overall Study|Lost to Follow-up|10|||
161837705|NCT01144364|584448691|FG002|Induction Phase|Secondary neoplasia|0|||
161958398|NCT02712983|584894908|FG000|Treatment Phase|Adverse Event|3|||
161707188|NCT00151892|583973450|FG000|Overall Study|Adverse Event|6|||
161837706|NCT01144364|584448689|FG000|Induction Phase|Protocol Violation|1|||
161707189|NCT00151892|583973451|FG001|Overall Study|Adverse Event|3|||
161707190|NCT00151892|583973450|FG000|Overall Study|Protocol Violation|3|||
161707191|NCT00151892|583973451|FG001|Overall Study|Protocol Violation|3|||
161707192|NCT00151892|583973450|FG000|Overall Study|Non-compliance|0|||
161707193|NCT00151892|583973451|FG001|Overall Study|Non-compliance|1|||
161707194|NCT00151892|583973450|FG000|Overall Study|Pregnancy|0|||
161707195|NCT00151892|583973451|FG001|Overall Study|Pregnancy|1|||
161958399|NCT02712983|584894909|FG001|Treatment Phase|Adverse Event|1|||
161707196|NCT00151892|583973450|FG000|Overall Study|Did not return for a visit|1|||
161707197|NCT00151892|583973451|FG001|Overall Study|Did not return for a visit|0|||
161707198|NCT00151892|583973450|FG000|Overall Study|Used prohibited corticosteroids|1|||
161707199|NCT00151892|583973451|FG001|Overall Study|Used prohibited corticosteroids|0|||
161707200|NCT00151892|583973450|FG000|Overall Study|Lack of study medication at center|0|||
161707201|NCT00151892|583973451|FG001|Overall Study|Lack of study medication at center|1|||
161707202|NCT04223609|583973454|FG000|Overall Study|Adverse Event|0|||
161707203|NCT04223609|583973455|FG001|Overall Study|Adverse Event|1|||
161707204|NCT04223609|583973454|FG000|Overall Study|Missed last visit|0|||
161707205|NCT04223609|583973455|FG001|Overall Study|Missed last visit|1|||
161707206|NCT03437447|583973456|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161707207|NCT03437447|583973457|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161707208|NCT03437447|583973458|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161707209|NCT03440944|583973461|FG000|Overall Study|Physician Decision|1|||
161707210|NCT03440944|583973462|FG001|Overall Study|Physician Decision|0|||
161707211|NCT03440944|583973461|FG000|Overall Study|No Acceptable Vasculature|0|||
161707212|NCT03440944|583973462|FG001|Overall Study|No Acceptable Vasculature|1|||
161707213|NCT00591734|583973463|FG000|Overall Study|Lack of Efficacy|35|||
161707214|NCT00591734|583973463|FG000|Overall Study|Adverse Event|5|||
161707215|NCT00591734|583973463|FG000|Overall Study|Physician Decision|5|||
161707216|NCT00591734|583973463|FG000|Overall Study|Intercurrent Illness|8|||
161707217|NCT04672083|583973464|FG000|Overall Study|Lost to Follow-up|1|||
161707218|NCT04672083|583973465|FG001|Overall Study|Lost to Follow-up|0|||
161707219|NCT04672083|583973466|FG002|Overall Study|Lost to Follow-up|0|||
161707220|NCT04672083|583973467|FG003|Overall Study|Lost to Follow-up|0|||
161707221|NCT04672083|583973468|FG004|Overall Study|Lost to Follow-up|0|||
161707222|NCT01551745|583973469|FG000|Overall Study|Withdrawal by Subject|1|||
161707223|NCT01551745|583973469|FG000|Overall Study|Disease Progression|2|||
161707224|NCT01661790|583973470|FG000|Overall Study|Lost to Follow-up|0|||
161707225|NCT01661790|583973471|FG001|Overall Study|Lost to Follow-up|2|||
161707226|NCT02764541|583973472|FG000|Overall Study|Withdrawal by Subject|0|||
161707227|NCT02764541|583973473|FG001|Overall Study|Withdrawal by Subject|0|||
161707228|NCT02764541|583973474|FG002|Overall Study|Withdrawal by Subject|0|||
161707229|NCT02764541|583973475|FG003|Overall Study|Withdrawal by Subject|0|||
161707230|NCT02764541|583973476|FG004|Overall Study|Withdrawal by Subject|1|||
161707231|NCT02764541|583973477|FG005|Overall Study|Withdrawal by Subject|1|||
161707232|NCT02764541|583973478|FG006|Overall Study|Withdrawal by Subject|0|||
161707233|NCT02764541|583973479|FG007|Overall Study|Withdrawal by Subject|1|||
161707234|NCT02764541|583973472|FG000|Overall Study|Adverse Event|1|||
161707235|NCT02764541|583973473|FG001|Overall Study|Adverse Event|0|||
161707236|NCT02764541|583973474|FG002|Overall Study|Adverse Event|0|||
161707237|NCT02764541|583973475|FG003|Overall Study|Adverse Event|0|||
161707238|NCT02764541|583973476|FG004|Overall Study|Adverse Event|0|||
161707239|NCT02764541|583973477|FG005|Overall Study|Adverse Event|0|||
161707240|NCT02764541|583973478|FG006|Overall Study|Adverse Event|1|||
161707241|NCT02764541|583973479|FG007|Overall Study|Adverse Event|0|||
161707242|NCT02764541|583973472|FG000|Overall Study|Metastasis|1|||
161707243|NCT02764541|583973473|FG001|Overall Study|Metastasis|0|||
161707244|NCT02764541|583973474|FG002|Overall Study|Metastasis|0|||
161707245|NCT02764541|583973475|FG003|Overall Study|Metastasis|0|||
161707246|NCT02764541|583973476|FG004|Overall Study|Metastasis|0|||
161707247|NCT02764541|583973477|FG005|Overall Study|Metastasis|0|||
161707248|NCT02764541|583973478|FG006|Overall Study|Metastasis|0|||
161707249|NCT02764541|583973479|FG007|Overall Study|Metastasis|0|||
161707250|NCT02764541|583973472|FG000|Overall Study|Disease progression|1|||
161707251|NCT02764541|583973473|FG001|Overall Study|Disease progression|1|||
161707252|NCT02764541|583973474|FG002|Overall Study|Disease progression|0|||
161707253|NCT02764541|583973475|FG003|Overall Study|Disease progression|0|||
161707254|NCT02764541|583973476|FG004|Overall Study|Disease progression|0|||
161707255|NCT02764541|583973477|FG005|Overall Study|Disease progression|0|||
161707256|NCT02764541|583973478|FG006|Overall Study|Disease progression|0|||
161707257|NCT02764541|583973479|FG007|Overall Study|Disease progression|1|||
161707258|NCT02764541|583973472|FG000|Overall Study|Protocol Violation|0|||
161707259|NCT02764541|583973473|FG001|Overall Study|Protocol Violation|0|||
161707260|NCT02764541|583973474|FG002|Overall Study|Protocol Violation|0|||
161707261|NCT02764541|583973475|FG003|Overall Study|Protocol Violation|1|||
161707262|NCT02764541|583973476|FG004|Overall Study|Protocol Violation|0|||
161707263|NCT02764541|583973477|FG005|Overall Study|Protocol Violation|1|||
161707264|NCT02764541|583973478|FG006|Overall Study|Protocol Violation|0|||
161707265|NCT02764541|583973479|FG007|Overall Study|Protocol Violation|0|||
161707266|NCT02764541|583973472|FG000|Overall Study|Physician Decision|0|||
161707267|NCT02764541|583973473|FG001|Overall Study|Physician Decision|0|||
161707268|NCT02764541|583973474|FG002|Overall Study|Physician Decision|0|||
161707269|NCT02764541|583973475|FG003|Overall Study|Physician Decision|1|||
161707270|NCT02764541|583973476|FG004|Overall Study|Physician Decision|0|||
161707271|NCT02764541|583973477|FG005|Overall Study|Physician Decision|0|||
161707272|NCT02764541|583973478|FG006|Overall Study|Physician Decision|0|||
161707273|NCT02764541|583973479|FG007|Overall Study|Physician Decision|1|||
161707274|NCT02764541|583973472|FG000|Overall Study|Three Cycles completed before surgery|0|||
161958400|NCT02712983|584894910|FG002|Treatment Phase|Adverse Event|1|||
161707275|NCT02764541|583973473|FG001|Overall Study|Three Cycles completed before surgery|0|||
161707276|NCT02764541|583973474|FG002|Overall Study|Three Cycles completed before surgery|0|||
161707277|NCT02764541|583973475|FG003|Overall Study|Three Cycles completed before surgery|1|||
161707278|NCT02764541|583973476|FG004|Overall Study|Three Cycles completed before surgery|0|||
161707279|NCT02764541|583973477|FG005|Overall Study|Three Cycles completed before surgery|0|||
161707280|NCT02764541|583973478|FG006|Overall Study|Three Cycles completed before surgery|0|||
161707281|NCT02764541|583973479|FG007|Overall Study|Three Cycles completed before surgery|0|||
161707282|NCT02764541|583973472|FG000|Overall Study|Patient Compliance|0|||
161707283|NCT02764541|583973473|FG001|Overall Study|Patient Compliance|0|||
161707284|NCT02764541|583973474|FG002|Overall Study|Patient Compliance|1|||
161707285|NCT02764541|583973475|FG003|Overall Study|Patient Compliance|0|||
161707286|NCT02764541|583973476|FG004|Overall Study|Patient Compliance|0|||
161707287|NCT02764541|583973477|FG005|Overall Study|Patient Compliance|0|||
161707288|NCT02764541|583973478|FG006|Overall Study|Patient Compliance|0|||
161707289|NCT02764541|583973479|FG007|Overall Study|Patient Compliance|0|||
161707290|NCT02764541|583973472|FG000|Overall Study|Death|0|||
161707291|NCT02764541|583973473|FG001|Overall Study|Death|0|||
161707292|NCT02764541|583973474|FG002|Overall Study|Death|0|||
161707293|NCT02764541|583973475|FG003|Overall Study|Death|0|||
161707294|NCT02764541|583973476|FG004|Overall Study|Death|0|||
161707295|NCT02764541|583973477|FG005|Overall Study|Death|0|||
161707296|NCT02764541|583973478|FG006|Overall Study|Death|1|||
161707297|NCT02764541|583973479|FG007|Overall Study|Death|0|||
161707298|NCT02764541|583973472|FG000|Overall Study|Insurance reasons|0|||
161707299|NCT02764541|583973473|FG001|Overall Study|Insurance reasons|0|||
161707300|NCT02764541|583973474|FG002|Overall Study|Insurance reasons|0|||
161707301|NCT02764541|583973475|FG003|Overall Study|Insurance reasons|0|||
161707302|NCT02764541|583973476|FG004|Overall Study|Insurance reasons|0|||
161707303|NCT02764541|583973477|FG005|Overall Study|Insurance reasons|0|||
161707304|NCT02764541|583973478|FG006|Overall Study|Insurance reasons|1|||
161707305|NCT02764541|583973479|FG007|Overall Study|Insurance reasons|0|||
161707306|NCT02048904|583973482|FG000|Overall Study|Withdrawal by Subject|7|||
161707307|NCT02048904|583973482|FG000|Overall Study|Physician Decision|70|||
161707308|NCT00749190|583973485|FG000|Overall Study|Adverse Event|0|||
161707309|NCT00749190|583973486|FG001|Overall Study|Adverse Event|2|||
161707310|NCT00749190|583973487|FG002|Overall Study|Adverse Event|0|||
161707311|NCT00749190|583973488|FG003|Overall Study|Adverse Event|4|||
161707312|NCT00749190|583973489|FG004|Overall Study|Adverse Event|0|||
161707313|NCT00749190|583973490|FG005|Overall Study|Adverse Event|3|||
161707314|NCT00749190|583973491|FG006|Overall Study|Adverse Event|0|||
161707315|NCT00749190|583973485|FG000|Overall Study|Lack of Efficacy|3|||
161707316|NCT00749190|583973486|FG001|Overall Study|Lack of Efficacy|1|||
161707317|NCT00749190|583973487|FG002|Overall Study|Lack of Efficacy|1|||
161707318|NCT00749190|583973488|FG003|Overall Study|Lack of Efficacy|0|||
161707319|NCT00749190|583973489|FG004|Overall Study|Lack of Efficacy|0|||
161707320|NCT00749190|583973490|FG005|Overall Study|Lack of Efficacy|1|||
161707321|NCT00749190|583973491|FG006|Overall Study|Lack of Efficacy|0|||
161707322|NCT00749190|583973485|FG000|Overall Study|Withdrawal by Subject|2|||
161707323|NCT00749190|583973486|FG001|Overall Study|Withdrawal by Subject|1|||
161707324|NCT00749190|583973487|FG002|Overall Study|Withdrawal by Subject|0|||
161707325|NCT00749190|583973488|FG003|Overall Study|Withdrawal by Subject|0|||
161707326|NCT00749190|583973489|FG004|Overall Study|Withdrawal by Subject|0|||
161707327|NCT00749190|583973490|FG005|Overall Study|Withdrawal by Subject|1|||
161707328|NCT00749190|583973491|FG006|Overall Study|Withdrawal by Subject|0|||
161707329|NCT00749190|583973485|FG000|Overall Study|Protocol Violation|0|||
161707330|NCT00749190|583973486|FG001|Overall Study|Protocol Violation|1|||
161707331|NCT00749190|583973487|FG002|Overall Study|Protocol Violation|0|||
161707332|NCT00749190|583973488|FG003|Overall Study|Protocol Violation|0|||
161707333|NCT00749190|583973489|FG004|Overall Study|Protocol Violation|0|||
161707334|NCT00749190|583973490|FG005|Overall Study|Protocol Violation|0|||
161707335|NCT00749190|583973491|FG006|Overall Study|Protocol Violation|1|||
161707336|NCT00749190|583973485|FG000|Overall Study|Other reason not defined above|0|||
161837707|NCT01144364|584448690|FG001|Induction Phase|Protocol Violation|0|||
161837708|NCT01144364|584448691|FG002|Induction Phase|Protocol Violation|0|||
161958401|NCT02712983|584894911|FG003|Treatment Phase|Adverse Event|4|||
161707337|NCT00749190|583973486|FG001|Overall Study|Other reason not defined above|0|||
161707338|NCT00749190|583973487|FG002|Overall Study|Other reason not defined above|0|||
161707339|NCT00749190|583973488|FG003|Overall Study|Other reason not defined above|1|||
161707340|NCT00749190|583973489|FG004|Overall Study|Other reason not defined above|0|||
161707341|NCT00749190|583973490|FG005|Overall Study|Other reason not defined above|0|||
161707342|NCT00749190|583973491|FG006|Overall Study|Other reason not defined above|0|||
161707343|NCT04752384|583973493|FG000|Overall Study|Withdrawal by Subject|1|||
161707344|NCT04752384|583973493|FG000|Overall Study|Death|1|||
161707345|NCT00490542|583973497|FG000|Overall Study|Lost to Follow-up|3|||
161707346|NCT00490542|583973498|FG001|Overall Study|Lost to Follow-up|0|||
161707347|NCT00490542|583973497|FG000|Overall Study|Adverse Event|3|||
161707348|NCT00490542|583973498|FG001|Overall Study|Adverse Event|3|||
161707349|NCT00490542|583973497|FG000|Overall Study|Lack of Efficacy|1|||
161707350|NCT00490542|583973498|FG001|Overall Study|Lack of Efficacy|1|||
161707351|NCT02875223|583973499|FG000|Overall Study|Other reasons|0|||
161707352|NCT02875223|583973500|FG001|Overall Study|Other reasons|0|||
161707353|NCT02875223|583973501|FG002|Overall Study|Other reasons|1|||
161707354|NCT02875223|583973502|FG003|Overall Study|Other reasons|0|||
161707355|NCT02875223|583973503|FG004|Overall Study|Other reasons|1|||
161707356|NCT02875223|583973504|FG005|Overall Study|Other reasons|2|||
161707357|NCT02875223|583973505|FG006|Overall Study|Other reasons|0|||
161707358|NCT02875223|583973506|FG007|Overall Study|Other reasons|2|||
161707359|NCT02875223|583973507|FG008|Overall Study|Other reasons|0|||
161707360|NCT02875223|583973508|FG009|Overall Study|Other reasons|0|||
161707361|NCT02875223|583973509|FG010|Overall Study|Other reasons|0|||
161707362|NCT02875223|583973510|FG011|Overall Study|Other reasons|0|||
161707363|NCT02875223|583973511|FG012|Overall Study|Other reasons|0|||
161707364|NCT02875223|583973499|FG000|Overall Study|Withdrawal by Subject|0|||
161707365|NCT02875223|583973500|FG001|Overall Study|Withdrawal by Subject|0|||
161707366|NCT02875223|583973501|FG002|Overall Study|Withdrawal by Subject|0|||
161707367|NCT02875223|583973502|FG003|Overall Study|Withdrawal by Subject|0|||
161707368|NCT02875223|583973503|FG004|Overall Study|Withdrawal by Subject|1|||
161707369|NCT02875223|583973504|FG005|Overall Study|Withdrawal by Subject|1|||
161707370|NCT02875223|583973505|FG006|Overall Study|Withdrawal by Subject|0|||
161707371|NCT02875223|583973506|FG007|Overall Study|Withdrawal by Subject|0|||
161707372|NCT02875223|583973507|FG008|Overall Study|Withdrawal by Subject|1|||
161707373|NCT02875223|583973508|FG009|Overall Study|Withdrawal by Subject|0|||
161707374|NCT02875223|583973509|FG010|Overall Study|Withdrawal by Subject|0|||
161707375|NCT02875223|583973510|FG011|Overall Study|Withdrawal by Subject|0|||
161707376|NCT02875223|583973511|FG012|Overall Study|Withdrawal by Subject|0|||
161707377|NCT02875223|583973499|FG000|Overall Study|Progressive disease|0|||
161707378|NCT02875223|583973500|FG001|Overall Study|Progressive disease|0|||
161837709|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
161837710|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
161958402|NCT02712983|584894912|FG004|Treatment Phase|Adverse Event|3|||
161958403|NCT02712983|584894913|FG005|Treatment Phase|Adverse Event|0|||
161958404|NCT02712983|584894914|FG006|Treatment Phase|Adverse Event|6|||
161958405|NCT02712983|584894915|FG007|Treatment Phase|Adverse Event|6|||
161958406|NCT02712983|584894916|FG008|Treatment Phase|Adverse Event|1|||
161958407|NCT02712983|584894908|FG000|Treatment Phase|Protocol Deviation|0|||
161958408|NCT02712983|584894909|FG001|Treatment Phase|Protocol Deviation|0|||
161958409|NCT02712983|584894910|FG002|Treatment Phase|Protocol Deviation|0|||
161958410|NCT02712983|584894911|FG003|Treatment Phase|Protocol Deviation|2|||
161958411|NCT02712983|584894912|FG004|Treatment Phase|Protocol Deviation|0|||
161958412|NCT02712983|584894913|FG005|Treatment Phase|Protocol Deviation|0|||
161958413|NCT02712983|584894914|FG006|Treatment Phase|Protocol Deviation|1|||
161958414|NCT02712983|584894915|FG007|Treatment Phase|Protocol Deviation|0|||
161958415|NCT02712983|584894916|FG008|Treatment Phase|Protocol Deviation|0|||
161958416|NCT02712983|584894908|FG000|Treatment Phase|Technical Problems|0|||
161958417|NCT02712983|584894909|FG001|Treatment Phase|Technical Problems|0|||
161958418|NCT02712983|584894910|FG002|Treatment Phase|Technical Problems|0|||
161958419|NCT02712983|584894911|FG003|Treatment Phase|Technical Problems|0|||
161958420|NCT02712983|584894912|FG004|Treatment Phase|Technical Problems|0|||
161958421|NCT02712983|584894913|FG005|Treatment Phase|Technical Problems|0|||
161958422|NCT02712983|584894914|FG006|Treatment Phase|Technical Problems|1|||
161958423|NCT02712983|584894915|FG007|Treatment Phase|Technical Problems|0|||
161958424|NCT02712983|584894916|FG008|Treatment Phase|Technical Problems|0|||
161958425|NCT02712983|584894908|FG000|Treatment Phase|Physician Decision|0|||
161958426|NCT02712983|584894909|FG001|Treatment Phase|Physician Decision|0|||
161958427|NCT02712983|584894910|FG002|Treatment Phase|Physician Decision|0|||
161958428|NCT02712983|584894911|FG003|Treatment Phase|Physician Decision|0|||
161958429|NCT02712983|584894912|FG004|Treatment Phase|Physician Decision|0|||
162030855|NCT00534313|585169498|FG002|Short-term Period|Lack of Efficacy|0|||
161707379|NCT02875223|583973501|FG002|Overall Study|Progressive disease|1|||
161707380|NCT02875223|583973502|FG003|Overall Study|Progressive disease|0|||
161837711|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
161958430|NCT02712983|584894913|FG005|Treatment Phase|Physician Decision|0|||
161958431|NCT02712983|584894914|FG006|Treatment Phase|Physician Decision|0|||
162030856|NCT00534313|585169499|FG003|Short-term Period|Lack of Efficacy|3|||
161958432|NCT02712983|584894915|FG007|Treatment Phase|Physician Decision|1|||
161958433|NCT02712983|584894916|FG008|Treatment Phase|Physician Decision|1|||
161958434|NCT02712983|584894908|FG000|Treatment Phase|Subject Decision|2|||
161958435|NCT02712983|584894909|FG001|Treatment Phase|Subject Decision|0|||
161958436|NCT02712983|584894910|FG002|Treatment Phase|Subject Decision|0|||
162030857|NCT00534313|585169496|FG000|Short-term Period|Participant not meeting study criteria|0|||
161707381|NCT02875223|583973503|FG004|Overall Study|Progressive disease|0|||
161707382|NCT02875223|583973504|FG005|Overall Study|Progressive disease|0|||
161707383|NCT02875223|583973505|FG006|Overall Study|Progressive disease|0|||
161707384|NCT02875223|583973506|FG007|Overall Study|Progressive disease|0|||
161707385|NCT02875223|583973507|FG008|Overall Study|Progressive disease|0|||
161707386|NCT02875223|583973508|FG009|Overall Study|Progressive disease|12|||
161707387|NCT02875223|583973509|FG010|Overall Study|Progressive disease|2|||
161707388|NCT02875223|583973510|FG011|Overall Study|Progressive disease|3|||
161707389|NCT02875223|583973511|FG012|Overall Study|Progressive disease|6|||
161707390|NCT02875223|583973499|FG000|Overall Study|Death|4|||
161707391|NCT02875223|583973500|FG001|Overall Study|Death|4|||
161707392|NCT02875223|583973501|FG002|Overall Study|Death|3|||
161707393|NCT02875223|583973502|FG003|Overall Study|Death|4|||
161707394|NCT02875223|583973503|FG004|Overall Study|Death|2|||
161707395|NCT02875223|583973504|FG005|Overall Study|Death|3|||
161707396|NCT02875223|583973505|FG006|Overall Study|Death|5|||
161707397|NCT02875223|583973506|FG007|Overall Study|Death|7|||
161707398|NCT02875223|583973507|FG008|Overall Study|Death|3|||
161707399|NCT02875223|583973508|FG009|Overall Study|Death|2|||
161707400|NCT02875223|583973509|FG010|Overall Study|Death|0|||
161707401|NCT02875223|583973510|FG011|Overall Study|Death|0|||
161707402|NCT02875223|583973511|FG012|Overall Study|Death|0|||
161707403|NCT02875223|583973499|FG000|Overall Study|Lost to Follow-up|0|||
161707404|NCT02875223|583973500|FG001|Overall Study|Lost to Follow-up|1|||
161707405|NCT02875223|583973501|FG002|Overall Study|Lost to Follow-up|1|||
161707406|NCT02875223|583973502|FG003|Overall Study|Lost to Follow-up|0|||
161707407|NCT02875223|583973503|FG004|Overall Study|Lost to Follow-up|1|||
161707408|NCT02875223|583973504|FG005|Overall Study|Lost to Follow-up|0|||
161707409|NCT02875223|583973505|FG006|Overall Study|Lost to Follow-up|1|||
161707410|NCT02875223|583973506|FG007|Overall Study|Lost to Follow-up|1|||
161707411|NCT02875223|583973507|FG008|Overall Study|Lost to Follow-up|0|||
161707412|NCT02875223|583973508|FG009|Overall Study|Lost to Follow-up|0|||
161707413|NCT02875223|583973509|FG010|Overall Study|Lost to Follow-up|0|||
161707414|NCT02875223|583973510|FG011|Overall Study|Lost to Follow-up|0|||
161707415|NCT02875223|583973511|FG012|Overall Study|Lost to Follow-up|0|||
161707416|NCT01986062|583973514|FG000|Overall Study|Lost to Follow-up|1|||
161707417|NCT01986062|583973515|FG001|Overall Study|Lost to Follow-up|0|||
161707418|NCT01986062|583973514|FG000|Overall Study|Withdrawal by Subject|0|||
161707419|NCT01986062|583973515|FG001|Overall Study|Withdrawal by Subject|1|||
161707420|NCT01827384|583973516|FG000|Overall Study|Switched to alternative treatment|0|||
161707421|NCT01827384|583973517|FG001|Overall Study|Switched to alternative treatment|0|||
161707422|NCT01827384|583973518|FG002|Overall Study|Switched to alternative treatment|0|||
161707423|NCT01827384|583973519|FG003|Overall Study|Switched to alternative treatment|0|||
161707424|NCT01827384|583973520|FG004|Overall Study|Switched to alternative treatment|0|||
161707425|NCT01827384|583973521|FG005|Overall Study|Switched to alternative treatment|0|||
161707426|NCT01827384|583973522|FG006|Overall Study|Switched to alternative treatment|0|||
161707427|NCT01827384|583973523|FG007|Overall Study|Switched to alternative treatment|0|||
161707428|NCT01827384|583973524|FG008|Overall Study|Switched to alternative treatment|0|||
161707429|NCT01827384|583973525|FG009|Overall Study|Switched to alternative treatment|0|||
161707430|NCT01827384|583973526|FG010|Overall Study|Switched to alternative treatment|0|||
161707431|NCT01827384|583973527|FG011|Overall Study|Switched to alternative treatment|0|||
161707432|NCT01827384|583973528|FG012|Overall Study|Switched to alternative treatment|0|||
161707433|NCT01827384|583973529|FG013|Overall Study|Switched to alternative treatment|2|||
161707434|NCT01827384|583973516|FG000|Overall Study|Disease progression before treatment|0|||
161707435|NCT01827384|583973517|FG001|Overall Study|Disease progression before treatment|0|||
161707436|NCT01827384|583973518|FG002|Overall Study|Disease progression before treatment|0|||
161707437|NCT01827384|583973519|FG003|Overall Study|Disease progression before treatment|0|||
161707438|NCT01827384|583973520|FG004|Overall Study|Disease progression before treatment|0|||
161707439|NCT01827384|583973521|FG005|Overall Study|Disease progression before treatment|0|||
161707440|NCT01827384|583973522|FG006|Overall Study|Disease progression before treatment|0|||
161707441|NCT01827384|583973523|FG007|Overall Study|Disease progression before treatment|0|||
161707442|NCT01827384|583973524|FG008|Overall Study|Disease progression before treatment|0|||
161707443|NCT01827384|583973525|FG009|Overall Study|Disease progression before treatment|0|||
161707444|NCT01827384|583973526|FG010|Overall Study|Disease progression before treatment|0|||
161707445|NCT01827384|583973527|FG011|Overall Study|Disease progression before treatment|0|||
161707446|NCT01827384|583973528|FG012|Overall Study|Disease progression before treatment|0|||
161707447|NCT01827384|583973529|FG013|Overall Study|Disease progression before treatment|4|||
161707448|NCT01827384|583973516|FG000|Overall Study|Ineligible|0|||
161707449|NCT01827384|583973517|FG001|Overall Study|Ineligible|0|||
161707450|NCT01827384|583973518|FG002|Overall Study|Ineligible|0|||
161707451|NCT01827384|583973519|FG003|Overall Study|Ineligible|0|||
161707452|NCT01827384|583973520|FG004|Overall Study|Ineligible|0|||
161707453|NCT01827384|583973521|FG005|Overall Study|Ineligible|0|||
161707454|NCT01827384|583973522|FG006|Overall Study|Ineligible|0|||
161958437|NCT02712983|584894911|FG003|Treatment Phase|Subject Decision|2|||
161958438|NCT02712983|584894912|FG004|Treatment Phase|Subject Decision|1|||
161958439|NCT02712983|584894913|FG005|Treatment Phase|Subject Decision|0|||
161958440|NCT02712983|584894914|FG006|Treatment Phase|Subject Decision|1|||
161958441|NCT02712983|584894915|FG007|Treatment Phase|Subject Decision|2|||
161958442|NCT02712983|584894916|FG008|Treatment Phase|Subject Decision|0|||
161958443|NCT02712983|584894908|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161707455|NCT01827384|583973523|FG007|Overall Study|Ineligible|0|||
161707456|NCT01827384|583973524|FG008|Overall Study|Ineligible|0|||
161707457|NCT01827384|583973525|FG009|Overall Study|Ineligible|0|||
161707458|NCT01827384|583973526|FG010|Overall Study|Ineligible|0|||
161707459|NCT01827384|583973527|FG011|Overall Study|Ineligible|0|||
161707460|NCT01827384|583973528|FG012|Overall Study|Ineligible|0|||
161707461|NCT01827384|583973529|FG013|Overall Study|Ineligible|19|||
161707462|NCT01827384|583973516|FG000|Overall Study|Participant died before treatment|0|||
161707463|NCT01827384|583973517|FG001|Overall Study|Participant died before treatment|0|||
161707464|NCT01827384|583973518|FG002|Overall Study|Participant died before treatment|0|||
161707465|NCT01827384|583973519|FG003|Overall Study|Participant died before treatment|0|||
161707466|NCT01827384|583973520|FG004|Overall Study|Participant died before treatment|0|||
161707467|NCT01827384|583973521|FG005|Overall Study|Participant died before treatment|0|||
161707468|NCT01827384|583973522|FG006|Overall Study|Participant died before treatment|0|||
161707469|NCT01827384|583973523|FG007|Overall Study|Participant died before treatment|0|||
161707470|NCT01827384|583973524|FG008|Overall Study|Participant died before treatment|0|||
161707471|NCT01827384|583973525|FG009|Overall Study|Participant died before treatment|0|||
161707472|NCT01827384|583973526|FG010|Overall Study|Participant died before treatment|0|||
161707473|NCT01827384|583973527|FG011|Overall Study|Participant died before treatment|0|||
161707474|NCT01827384|583973528|FG012|Overall Study|Participant died before treatment|0|||
161707475|NCT01827384|583973529|FG013|Overall Study|Participant died before treatment|5|||
161707476|NCT01827384|583973516|FG000|Overall Study|Insufficient tumor cells|0|||
161707477|NCT01827384|583973517|FG001|Overall Study|Insufficient tumor cells|0|||
161707478|NCT01827384|583973518|FG002|Overall Study|Insufficient tumor cells|0|||
161707479|NCT01827384|583973519|FG003|Overall Study|Insufficient tumor cells|0|||
161707480|NCT01827384|583973520|FG004|Overall Study|Insufficient tumor cells|0|||
161707481|NCT01827384|583973521|FG005|Overall Study|Insufficient tumor cells|0|||
161707482|NCT01827384|583973522|FG006|Overall Study|Insufficient tumor cells|0|||
161707483|NCT01827384|583973523|FG007|Overall Study|Insufficient tumor cells|0|||
161707484|NCT01827384|583973524|FG008|Overall Study|Insufficient tumor cells|0|||
161707485|NCT01827384|583973525|FG009|Overall Study|Insufficient tumor cells|0|||
161707486|NCT01827384|583973526|FG010|Overall Study|Insufficient tumor cells|0|||
161707487|NCT01827384|583973527|FG011|Overall Study|Insufficient tumor cells|0|||
161707488|NCT01827384|583973528|FG012|Overall Study|Insufficient tumor cells|0|||
161707489|NCT01827384|583973529|FG013|Overall Study|Insufficient tumor cells|13|||
161707490|NCT01827384|583973516|FG000|Overall Study|No actionable mutation|0|||
161707491|NCT01827384|583973517|FG001|Overall Study|No actionable mutation|0|||
161707492|NCT01827384|583973518|FG002|Overall Study|No actionable mutation|0|||
161707493|NCT01827384|583973519|FG003|Overall Study|No actionable mutation|0|||
161707494|NCT01827384|583973520|FG004|Overall Study|No actionable mutation|0|||
161707495|NCT01827384|583973521|FG005|Overall Study|No actionable mutation|0|||
161707496|NCT01827384|583973522|FG006|Overall Study|No actionable mutation|0|||
161707497|NCT01827384|583973523|FG007|Overall Study|No actionable mutation|0|||
161707498|NCT01827384|583973524|FG008|Overall Study|No actionable mutation|0|||
161707499|NCT01827384|583973525|FG009|Overall Study|No actionable mutation|0|||
161707500|NCT01827384|583973526|FG010|Overall Study|No actionable mutation|0|||
161707501|NCT01827384|583973527|FG011|Overall Study|No actionable mutation|0|||
161707502|NCT01827384|583973528|FG012|Overall Study|No actionable mutation|0|||
161707503|NCT01827384|583973529|FG013|Overall Study|No actionable mutation|73|||
161707504|NCT01827384|583973516|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
161707505|NCT01827384|583973517|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
161707506|NCT01827384|583973518|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
161707507|NCT01827384|583973519|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
161707508|NCT01827384|583973520|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
161707509|NCT01827384|583973521|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
161958444|NCT02712983|584894909|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
161958445|NCT02712983|584894910|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161958446|NCT02712983|584894911|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161958447|NCT02712983|584894912|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161707510|NCT01827384|583973522|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
161707511|NCT01827384|583973523|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
161707512|NCT01827384|583973524|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
161707513|NCT01827384|583973525|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
161707514|NCT01827384|583973526|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
161707515|NCT01827384|583973527|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
161707516|NCT01827384|583973528|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
161707517|NCT01827384|583973529|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
161707518|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
161837712|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
161958448|NCT02712983|584894913|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161707519|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
161707520|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
161707521|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
161707522|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
161707523|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
161707524|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
161707525|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
161707526|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
161707527|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
161707528|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
161707529|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
161707530|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
161707531|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
161707532|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
161707533|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
161707534|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
161707535|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
161707536|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
161707537|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161707538|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161707539|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161707540|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161707541|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161707542|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
161707543|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
161707544|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
161707545|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
161707546|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
161707547|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
161707548|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
161707549|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
161707550|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
161707551|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
161707552|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
161707553|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
161707554|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
161707555|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
161707556|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
161707557|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
161707558|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
161707559|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
161707560|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
161707561|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
161707562|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
161707563|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
161707564|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
161707565|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
161707566|NCT01707992|583973531|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
161707567|NCT01707992|583973532|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
161707568|NCT01707992|583973533|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
161707569|NCT01707992|583973534|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
161707570|NCT01707992|583973535|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
161707571|NCT01707992|583973536|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
161707572|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
161707573|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
161707574|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
161707575|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
161707576|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
161707577|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
161707578|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
161707579|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
161958449|NCT02712983|584894914|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
161958450|NCT02712983|584894915|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
161958451|NCT02712983|584894916|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161958452|NCT02712983|584894908|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161958453|NCT02712983|584894909|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161707580|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
161707581|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
161707582|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
161707583|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
161707584|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
161707585|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
161707586|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
161707587|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
161707588|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
161707589|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
161707590|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
161707591|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
161707592|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
161707593|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
161707594|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
161707595|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
161707596|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
161707597|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
161707598|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
161707599|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
161707600|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
161707601|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
161707602|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Death|0|||
161707603|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Death|0|||
161707604|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Death|0|||
161707605|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Death|2|||
161707606|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Death|0|||
161707607|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Death|0|||
161707608|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
161707609|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
161707610|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
161707611|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
161707612|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
161707613|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
161707614|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
161707615|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
161707616|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
161707617|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
161707618|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
161707619|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
161707620|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
161707621|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
161707622|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
161707623|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
161707624|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
161707625|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
161707626|NCT01707992|583973531|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161707627|NCT01707992|583973532|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161707628|NCT01707992|583973533|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161707629|NCT01707992|583973534|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161707630|NCT01707992|583973535|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
161707631|NCT01707992|583973536|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161707632|NCT01552057|583975092|FG000|Overall Study|Adverse Event|14|||
161707633|NCT01552057|583975093|FG001|Overall Study|Adverse Event|15|||
161707634|NCT01552057|583975092|FG000|Overall Study|Lack of Efficacy|8|||
161707635|NCT01552057|583975093|FG001|Overall Study|Lack of Efficacy|23|||
161707636|NCT01552057|583975092|FG000|Overall Study|Withdrawal by Subject|5|||
161707637|NCT01552057|583975093|FG001|Overall Study|Withdrawal by Subject|8|||
161707638|NCT01552057|583975092|FG000|Overall Study|Entry Criteria Not Met|2|||
161707639|NCT01552057|583975093|FG001|Overall Study|Entry Criteria Not Met|2|||
161707640|NCT01552057|583975092|FG000|Overall Study|Physician Decision|1|||
161707641|NCT01552057|583975093|FG001|Overall Study|Physician Decision|0|||
161707642|NCT00476086|583975094|FG000|Overall Study|Alternative therapy|1|||
161707643|NCT00476086|583975094|FG000|Overall Study|Progressive Disease|4|||
161707644|NCT02900092|583975095|FG000|Overall Study|Adverse Event|1|||
161707645|NCT03895203|583975096|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
161707646|NCT03895203|583975097|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
161707647|NCT03895203|583975098|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
161707648|NCT03895203|583975099|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
161707649|NCT03895203|583975100|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
161707650|NCT03895203|583975101|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
161707651|NCT03895203|583975096|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
161707652|NCT03895203|583975097|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161707653|NCT03895203|583975098|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161707654|NCT03895203|583975099|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161707655|NCT03895203|583975100|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161707656|NCT03895203|583975101|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161707657|NCT03895203|583975096|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
161707658|NCT03895203|583975097|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161707659|NCT03895203|583975098|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161707660|NCT03895203|583975099|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161707661|NCT03895203|583975100|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161707662|NCT03895203|583975101|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161707663|NCT03895203|583975096|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
161707664|NCT03895203|583975097|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
161707665|NCT03895203|583975098|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
161707666|NCT03895203|583975099|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
161707667|NCT03895203|583975100|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
161707668|NCT03895203|583975101|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
161707669|NCT03895203|583975096|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161707670|NCT03895203|583975097|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
161707671|NCT03895203|583975098|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161707672|NCT03895203|583975099|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161707673|NCT03895203|583975100|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161707674|NCT03895203|583975101|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161707675|NCT03895203|583975096|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161707676|NCT03895203|583975097|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
161707677|NCT03895203|583975098|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161707678|NCT03895203|583975099|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161707679|NCT03895203|583975100|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161707680|NCT03895203|583975101|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161707681|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161707682|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161707683|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161707684|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
161707685|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161707686|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161707687|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
161707688|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
161707689|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
161707690|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
161707691|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
161707692|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
161707693|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
161707694|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
161707695|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
161707696|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
161707697|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
161707698|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
161707699|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
161837713|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
161837714|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
161837715|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Death|0|||
161837716|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Death|2|||
161837717|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Death|0|||
161837718|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
161958454|NCT02712983|584894910|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161958455|NCT02712983|584894911|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
161707700|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
161707701|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
161707702|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
161707703|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
161837719|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
161707704|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
161707705|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
161707706|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
161707707|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
161707708|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
161707709|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
161707710|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
161707711|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161707712|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161707713|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161707714|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
161707715|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161707716|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161707717|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161707718|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161707719|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161707720|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
161707721|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161707722|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161707723|NCT03895203|583975096|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161707724|NCT03895203|583975097|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161707725|NCT03895203|583975098|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161707726|NCT03895203|583975099|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161707727|NCT03895203|583975100|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161707728|NCT03895203|583975101|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
161707729|NCT01389245|583975102|FG000|Overall Study|Protocol Violation|10|||
161707730|NCT01389245|583975102|FG000|Overall Study|Lost to Follow-up|3|||
161707731|NCT01389245|583975102|FG000|Overall Study|Withdrawal by Subject|2|||
161707732|NCT05540652|583975103|FG000|Overall Study|Withdrawal by Subject|1|||
161707733|NCT05424276|583975104|FG000|Overall Study|Adverse Event|1|||
161707734|NCT05424276|583975105|FG001|Overall Study|Adverse Event|0|||
161707735|NCT05424276|583975106|FG002|Overall Study|Adverse Event|0|||
161707736|NCT05424276|583975107|FG003|Overall Study|Adverse Event|2|||
161707737|NCT05424276|583975104|FG000|Overall Study|Withdrawal by Subject|0|||
161707738|NCT05424276|583975105|FG001|Overall Study|Withdrawal by Subject|0|||
161707739|NCT05424276|583975106|FG002|Overall Study|Withdrawal by Subject|2|||
161707740|NCT05424276|583975107|FG003|Overall Study|Withdrawal by Subject|0|||
161707741|NCT05424276|583975104|FG000|Overall Study|Protocol Violation|0|||
161707742|NCT05424276|583975105|FG001|Overall Study|Protocol Violation|1|||
161707743|NCT05424276|583975106|FG002|Overall Study|Protocol Violation|0|||
161707744|NCT05424276|583975107|FG003|Overall Study|Protocol Violation|0|||
161707745|NCT05424276|583975104|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
161707746|NCT05424276|583975105|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
161707747|NCT05424276|583975106|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
161707748|NCT05424276|583975107|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
161707749|NCT05113940|583975108|FG000|Part A (18 Days)|Adverse Event|0|||
161707750|NCT05113940|583975109|FG001|Part A (18 Days)|Adverse Event|0|||
161707751|NCT05113940|583975110|FG002|Part A (18 Days)|Adverse Event|1|||
161707752|NCT05113940|583975111|FG003|Part A (18 Days)|Adverse Event|1|||
161707753|NCT05113940|583975112|FG004|Part A (18 Days)|Adverse Event|1|||
161707754|NCT05113940|583975113|FG005|Part A (18 Days)|Adverse Event|0|||
161707755|NCT05113940|583975114|FG006|Part A (18 Days)|Adverse Event|0|||
161707756|NCT05113940|583975115|FG007|Part A (18 Days)|Adverse Event|0|||
161707757|NCT05113940|583975116|FG008|Part A (18 Days)|Adverse Event|0|||
161707758|NCT05113940|583975117|FG009|Part A (18 Days)|Adverse Event|0|||
161707759|NCT05113940|583975118|FG010|Part A (18 Days)|Adverse Event|0|||
161707760|NCT05113940|583975119|FG011|Part A (18 Days)|Adverse Event|2|||
161707761|NCT05113940|583975120|FG012|Part A (18 Days)|Adverse Event|0|||
161707762|NCT05113940|583975121|FG013|Part A (18 Days)|Adverse Event|0|||
161707763|NCT05113940|583975122|FG014|Part A (18 Days)|Adverse Event|0|||
161707764|NCT05113940|583975108|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707765|NCT05113940|583975109|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707766|NCT05113940|583975110|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707767|NCT05113940|583975111|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707768|NCT05113940|583975112|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707769|NCT05113940|583975113|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707770|NCT05113940|583975114|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707771|NCT05113940|583975115|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707772|NCT05113940|583975116|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707773|NCT05113940|583975117|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707774|NCT05113940|583975118|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707775|NCT05113940|583975119|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707776|NCT05113940|583975120|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707777|NCT05113940|583975121|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
161707778|NCT05113940|583975122|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
161707779|NCT04454489|583975123|FG000|Overall Study|Disease progression|12|||
161707780|NCT04454489|583975123|FG000|Overall Study|Death|4|||
161707781|NCT04454489|583975123|FG000|Overall Study|Adverse Event|1|||
161707782|NCT04454489|583975123|FG000|Overall Study|Physician Decision|1|||
161707783|NCT01756274|583975129|FG000|Overall Study|Protocol Violation|2|||
161707784|NCT01756274|583975129|FG000|Overall Study|Laboratory error|1|||
161707785|NCT03514914|583975130|FG000|Overall Study|Death|3|||
161707786|NCT03514914|583975131|FG001|Overall Study|Death|3|||
161707787|NCT03514914|583975130|FG000|Overall Study|Lost to Follow-up|117|||
161707788|NCT03514914|583975131|FG001|Overall Study|Lost to Follow-up|89|||
161707789|NCT03926143|583975137|FG000|Overall Study|Physician Decision|3|||
161707790|NCT03926143|583975137|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
161707791|NCT03926143|583975137|FG000|Overall Study|Adverse Event|2|||
161707792|NCT03926143|583975137|FG000|Overall Study|Progressive disease|3|||
161707793|NCT01071070|583975144|FG000|Overall Study|Adverse Event|0|||
161707794|NCT01071070|583975145|FG001|Overall Study|Adverse Event|3|||
161707795|NCT01071070|583975144|FG000|Overall Study|Withdrawal by Subject|1|||
161707796|NCT01071070|583975145|FG001|Overall Study|Withdrawal by Subject|0|||
161707797|NCT01071070|583975144|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
161707798|NCT01071070|583975145|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
161707799|NCT01071070|583975144|FG000|Overall Study|Hypercalcemia|1|||
161707800|NCT01071070|583975145|FG001|Overall Study|Hypercalcemia|0|||
161707801|NCT00473876|583975151|FG000|Overall Study|Lost to Follow-up|3|||
161707802|NCT00473876|583975152|FG001|Overall Study|Lost to Follow-up|1|||
161707803|NCT02393209|583975155|FG000|Overall Study|Study Terminated by Sponsor|1|||
161707804|NCT02393209|583975156|FG001|Overall Study|Study Terminated by Sponsor|1|||
161707805|NCT02393209|583975157|FG002|Overall Study|Study Terminated by Sponsor|0|||
161707806|NCT02393209|583975158|FG003|Overall Study|Study Terminated by Sponsor|0|||
161707807|NCT02393209|583975155|FG000|Overall Study|Withdrawal by Patient|1|||
161707808|NCT02393209|583975156|FG001|Overall Study|Withdrawal by Patient|0|||
161707809|NCT02393209|583975157|FG002|Overall Study|Withdrawal by Patient|0|||
161707810|NCT02393209|583975158|FG003|Overall Study|Withdrawal by Patient|0|||
161707811|NCT02393209|583975155|FG000|Overall Study|Death|2|||
161707812|NCT02393209|583975156|FG001|Overall Study|Death|2|||
161707813|NCT02393209|583975157|FG002|Overall Study|Death|0|||
161707814|NCT02393209|583975158|FG003|Overall Study|Death|0|||
161707815|NCT02393209|583975155|FG000|Overall Study|Death due to Disease Progression|2|||
161707816|NCT02393209|583975156|FG001|Overall Study|Death due to Disease Progression|2|||
161707817|NCT02393209|583975157|FG002|Overall Study|Death due to Disease Progression|0|||
161707818|NCT02393209|583975158|FG003|Overall Study|Death due to Disease Progression|0|||
161707819|NCT02393209|583975155|FG000|Overall Study|Death from Legionella Infection|0|||
161707820|NCT02393209|583975156|FG001|Overall Study|Death from Legionella Infection|1|||
161707821|NCT02393209|583975157|FG002|Overall Study|Death from Legionella Infection|0|||
161707822|NCT02393209|583975158|FG003|Overall Study|Death from Legionella Infection|0|||
161707823|NCT02393209|583975155|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
161707824|NCT02393209|583975156|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
161707825|NCT02393209|583975157|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
161707826|NCT02393209|583975158|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
161707827|NCT02393209|583975155|FG000|Overall Study|Lost to Follow-up|0|||
161707828|NCT02393209|583975156|FG001|Overall Study|Lost to Follow-up|1|||
161707829|NCT02393209|583975157|FG002|Overall Study|Lost to Follow-up|0|||
161707830|NCT02393209|583975158|FG003|Overall Study|Lost to Follow-up|0|||
161958456|NCT02712983|584894912|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161707831|NCT00727402|583975159|FG000|Overall Study|Physician Decision|116|||
161707832|NCT00755079|583975160|FG000|Overall Study|Lost to Follow-up|1|||
161707833|NCT00755079|583975161|FG001|Overall Study|Lost to Follow-up|3|||
161707834|NCT00755079|583975160|FG000|Overall Study|Adverse Event|0|||
161707835|NCT00755079|583975161|FG001|Overall Study|Adverse Event|1|||
161707836|NCT00755079|583975160|FG000|Overall Study|Withdrawal by Subject|0|||
161707837|NCT00755079|583975161|FG001|Overall Study|Withdrawal by Subject|2|||
161707838|NCT03545282|583975162|FG000|Overall Study|Lost to Follow-up|15|||
161707839|NCT03545282|583975163|FG001|Overall Study|Lost to Follow-up|10|||
161707840|NCT03545282|583975162|FG000|Overall Study|Withdrawal by Subject|2|||
161707841|NCT03545282|583975163|FG001|Overall Study|Withdrawal by Subject|2|||
161707842|NCT03751111|583975164|FG000|Overall Study|Lack of Efficacy|9|||
161707843|NCT03751111|583975165|FG001|Overall Study|Lack of Efficacy|30|||
161707844|NCT03751111|583975164|FG000|Overall Study|Adverse Event|3|||
161707845|NCT03751111|583975165|FG001|Overall Study|Adverse Event|2|||
161707846|NCT02582671|583975166|FG000|Overall Study|Failure to return|1|||
161707847|NCT02582671|583975166|FG000|Overall Study|Other, not specified|1|||
161707848|NCT01287104|583975171|FG000|Overall Study|Patient developed progressive disease|1|||
161707849|NCT01287104|583975172|FG001|Overall Study|Patient developed progressive disease|1|||
161707850|NCT01287104|583975173|FG002|Overall Study|Patient developed progressive disease|3|||
161707851|NCT01287104|583975174|FG003|Overall Study|Patient developed progressive disease|2|||
161707852|NCT01287104|583975171|FG000|Overall Study|Donor anaphylaxis|0|||
161707853|NCT01287104|583975172|FG001|Overall Study|Donor anaphylaxis|1|||
161707854|NCT01287104|583975173|FG002|Overall Study|Donor anaphylaxis|0|||
161707855|NCT01287104|583975174|FG003|Overall Study|Donor anaphylaxis|1|||
161707856|NCT01287104|583975171|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
162030858|NCT00534313|585169497|FG001|Short-term Period|Participant not meeting study criteria|0|||
161707857|NCT01287104|583975172|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
161707858|NCT01287104|583975173|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
161707859|NCT01287104|583975174|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
161707860|NCT01287104|583975171|FG000|Overall Study|Low donor chimerism|0|||
161707861|NCT01287104|583975172|FG001|Overall Study|Low donor chimerism|1|||
161707862|NCT01287104|583975173|FG002|Overall Study|Low donor chimerism|0|||
161707863|NCT01287104|583975174|FG003|Overall Study|Low donor chimerism|0|||
161707864|NCT01287104|583975171|FG000|Overall Study|NK cells did not meet release criteria|0|||
161707865|NCT01287104|583975172|FG001|Overall Study|NK cells did not meet release criteria|1|||
161707866|NCT01287104|583975173|FG002|Overall Study|NK cells did not meet release criteria|0|||
161707867|NCT01287104|583975174|FG003|Overall Study|NK cells did not meet release criteria|0|||
161707868|NCT00998738|583975177|FG000|Overall Study|Uknown|1|||
161707869|NCT03498521|583975178|FG000|Overall Study|Death|227|||
161707870|NCT03498521|583975179|FG001|Overall Study|Death|79|||
161707871|NCT03498521|583975180|FG002|Overall Study|Death|84|||
161707872|NCT03498521|583975178|FG000|Overall Study|Exclusion criteria|1|||
161707873|NCT03498521|583975179|FG001|Overall Study|Exclusion criteria|0|||
161707874|NCT03498521|583975180|FG002|Overall Study|Exclusion criteria|0|||
161707875|NCT03498521|583975178|FG000|Overall Study|Lost to Follow-up|4|||
161707876|NCT03498521|583975179|FG001|Overall Study|Lost to Follow-up|3|||
161707877|NCT03498521|583975180|FG002|Overall Study|Lost to Follow-up|3|||
161707878|NCT03498521|583975178|FG000|Overall Study|No profile due to technical failure|1|||
161707879|NCT03498521|583975179|FG001|Overall Study|No profile due to technical failure|0|||
161707880|NCT03498521|583975180|FG002|Overall Study|No profile due to technical failure|0|||
161707881|NCT03498521|583975178|FG000|Overall Study|Physician Decision|3|||
161707882|NCT03498521|583975179|FG001|Overall Study|Physician Decision|1|||
161707883|NCT03498521|583975180|FG002|Overall Study|Physician Decision|0|||
161707884|NCT03498521|583975178|FG000|Overall Study|Withdrawal by Subject|11|||
161707885|NCT03498521|583975179|FG001|Overall Study|Withdrawal by Subject|6|||
161707886|NCT03498521|583975180|FG002|Overall Study|Withdrawal by Subject|2|||
161707887|NCT03498521|583975178|FG000|Overall Study|Study terminated by sponsor|79|||
161707888|NCT03498521|583975179|FG001|Overall Study|Study terminated by sponsor|21|||
161707889|NCT03498521|583975180|FG002|Overall Study|Study terminated by sponsor|4|||
161707890|NCT02848833|583975189|FG000|Overall Study|subject who are duplicated|1|||
161707891|NCT02848833|583975189|FG000|Overall Study|have not taken the study drug|11|||
161707892|NCT02848833|583975189|FG000|Overall Study|follow-up failure|6|||
161707893|NCT02848833|583975189|FG000|Overall Study|Protocol Violation|119|||
161707894|NCT04980391|583975190|FG000|Overall Study|Death|0|||
161707895|NCT04980391|583975191|FG001|Overall Study|Death|0|||
161707896|NCT04980391|583975192|FG002|Overall Study|Death|1|||
161707897|NCT04980391|583975193|FG003|Overall Study|Death|1|||
161707898|NCT04980391|583975190|FG000|Overall Study|Lost to Follow-up|3|||
161707899|NCT04980391|583975191|FG001|Overall Study|Lost to Follow-up|3|||
161707900|NCT04980391|583975192|FG002|Overall Study|Lost to Follow-up|2|||
161707901|NCT04980391|583975193|FG003|Overall Study|Lost to Follow-up|3|||
161707902|NCT04980391|583975190|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
161707903|NCT04980391|583975191|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
161707904|NCT04980391|583975192|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
161707905|NCT04980391|583975193|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
161707906|NCT04980391|583975190|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161707907|NCT04980391|583975191|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161707908|NCT04980391|583975192|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161707909|NCT04980391|583975193|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161707910|NCT04980391|583975190|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
161707911|NCT04980391|583975191|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
161707912|NCT04980391|583975192|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
161707913|NCT04980391|583975193|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
161707914|NCT04167345|583975194|FG000|Overall Study|Other|1|||
161707915|NCT04167345|583975195|FG001|Overall Study|Other|1|||
161707916|NCT04167345|583975196|FG002|Overall Study|Other|0|||
161707917|NCT04167345|583975197|FG003|Overall Study|Other|0|||
161707918|NCT04167345|583975198|FG004|Overall Study|Other|0|||
161837720|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
161707919|NCT04375761|583977287|FG000|Overall Study|Death|1|||
161707920|NCT04375761|583977288|FG001|Overall Study|Death|2|||
161707921|NCT04375761|583977287|FG000|Overall Study|Lost to Follow-up|203|||
161707922|NCT04375761|583977288|FG001|Overall Study|Lost to Follow-up|380|||
161707923|NCT04375761|583977287|FG000|Overall Study|Withdrawal by Subject|47|||
161707924|NCT04375761|583977288|FG001|Overall Study|Withdrawal by Subject|98|||
161707925|NCT04375761|583977287|FG000|Overall Study|Noncompliance with study procedure|121|||
161707926|NCT04375761|583977288|FG001|Overall Study|Noncompliance with study procedure|251|||
161707927|NCT04375761|583977287|FG000|Overall Study|Reimbursement not enough|1|||
161707928|NCT04375761|583977288|FG001|Overall Study|Reimbursement not enough|2|||
161707929|NCT04375761|583977287|FG000|Overall Study|Unforeseen family circumstances|1|||
161707930|NCT04375761|583977288|FG001|Overall Study|Unforeseen family circumstances|3|||
161707931|NCT04375761|583977287|FG000|Overall Study|Test too painful|1|||
161707932|NCT04375761|583977288|FG001|Overall Study|Test too painful|1|||
161707933|NCT04375761|583977287|FG000|Overall Study|Moved|0|||
161707934|NCT04375761|583977288|FG001|Overall Study|Moved|2|||
161707935|NCT04375761|583977287|FG000|Overall Study|Nonresponsive|0|||
161707936|NCT04375761|583977288|FG001|Overall Study|Nonresponsive|5|||
161707937|NCT03797001|583977289|FG000|Overall Study|Withdrawn due to COVID19|4|||
161707938|NCT03797001|583977290|FG001|Overall Study|Withdrawn due to COVID19|0|||
161707939|NCT03797001|583977289|FG000|Overall Study|Withdrawal by Subject|7|||
161707940|NCT03797001|583977290|FG001|Overall Study|Withdrawal by Subject|6|||
161707941|NCT03797001|583977289|FG000|Overall Study|Adverse Event|0|||
161707942|NCT03797001|583977290|FG001|Overall Study|Adverse Event|1|||
161707943|NCT00500266|583977302|FG000|Overall Study|Death|3|||
161707944|NCT00500266|583977302|FG000|Overall Study|Lost to Follow-up|3|||
161707945|NCT00500266|583977302|FG000|Overall Study|Withdrawal by Subject|3|||
161707946|NCT00500266|583977302|FG000|Overall Study|Assigned, not treated|4|||
161707947|NCT02251743|583977303|FG000|Overall Study|Withdrawal by Subject|1|||
161707948|NCT02251743|583977304|FG001|Overall Study|Withdrawal by Subject|1|||
161707949|NCT00824564|583977305|FG000|Overall Study|Lost to Follow-up|5|||
161707950|NCT00824564|583977306|FG001|Overall Study|Lost to Follow-up|7|||
161707951|NCT00824564|583977305|FG000|Overall Study|Withdrawal by Subject|1|||
161707952|NCT00824564|583977306|FG001|Overall Study|Withdrawal by Subject|1|||
161707953|NCT00824564|583977305|FG000|Overall Study|Other|1|||
161707954|NCT00824564|583977306|FG001|Overall Study|Other|2|||
161707955|NCT00824564|583977305|FG000|Overall Study|Randomized, but not treated|1|||
161707956|NCT00824564|583977306|FG001|Overall Study|Randomized, but not treated|0|||
161707957|NCT01725165|583977308|FG000|Overall Study|Death|11|||
161707958|NCT01725165|583977309|FG001|Overall Study|Death|18|||
161707959|NCT00442598|583977313|FG000|Overall Study|Adverse Event|1|||
161707960|NCT00442598|583977314|FG001|Overall Study|Adverse Event|0|||
161707961|NCT00442598|583977315|FG002|Overall Study|Adverse Event|0|||
161707962|NCT00442598|583977313|FG000|Overall Study|Tumor progression|3|||
161707963|NCT00442598|583977314|FG001|Overall Study|Tumor progression|4|||
161707964|NCT00442598|583977315|FG002|Overall Study|Tumor progression|0|||
161707965|NCT00442598|583977313|FG000|Overall Study|Clinical deterioration|1|||
161707966|NCT00442598|583977314|FG001|Overall Study|Clinical deterioration|2|||
161707967|NCT00442598|583977315|FG002|Overall Study|Clinical deterioration|0|||
161707968|NCT00442598|583977313|FG000|Overall Study|CA125 progression|0|||
161707969|NCT00442598|583977314|FG001|Overall Study|CA125 progression|1|||
161707970|NCT00442598|583977315|FG002|Overall Study|CA125 progression|0|||
161707971|NCT00442598|583977313|FG000|Overall Study|Reduced creatinine clearance|1|||
161707972|NCT00442598|583977314|FG001|Overall Study|Reduced creatinine clearance|0|||
161707973|NCT00442598|583977315|FG002|Overall Study|Reduced creatinine clearance|0|||
161707974|NCT00442598|583977313|FG000|Overall Study|Death|0|||
161707975|NCT00442598|583977314|FG001|Overall Study|Death|1|||
161707976|NCT00442598|583977315|FG002|Overall Study|Death|0|||
161707977|NCT02886702|583977316|FG000|Overall Study|Other|4|||
161958457|NCT02712983|584894913|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161958458|NCT02712983|584894914|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161707978|NCT02886702|583977317|FG001|Overall Study|Other|3|||
161707979|NCT02886702|583977318|FG002|Overall Study|Other|9|||
161707980|NCT02886702|583977316|FG000|Overall Study|Withdrawal by Subject|24|||
161707981|NCT02886702|583977317|FG001|Overall Study|Withdrawal by Subject|18|||
161707982|NCT02886702|583977318|FG002|Overall Study|Withdrawal by Subject|22|||
161707983|NCT02886702|583977316|FG000|Overall Study|Significant Worsening of Condition|0|||
161707984|NCT02886702|583977317|FG001|Overall Study|Significant Worsening of Condition|1|||
161707985|NCT02886702|583977318|FG002|Overall Study|Significant Worsening of Condition|0|||
161958459|NCT02712983|584894915|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161958460|NCT02712983|584894916|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
161958461|NCT02712983|584894908|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
161707986|NCT02886702|583977316|FG000|Overall Study|Protocol Violation|2|||
161707987|NCT02886702|583977317|FG001|Overall Study|Protocol Violation|2|||
161707988|NCT02886702|583977318|FG002|Overall Study|Protocol Violation|1|||
161707989|NCT02886702|583977316|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161707990|NCT02886702|583977317|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161707991|NCT02886702|583977318|FG002|Overall Study|Non-Compliance With Study Drug|4|||
161707992|NCT02886702|583977316|FG000|Overall Study|Lost to Follow-up|11|||
161707993|NCT02886702|583977317|FG001|Overall Study|Lost to Follow-up|13|||
161707994|NCT02886702|583977318|FG002|Overall Study|Lost to Follow-up|8|||
161707995|NCT02886702|583977316|FG000|Overall Study|Lack of Efficacy|3|||
161707996|NCT02886702|583977317|FG001|Overall Study|Lack of Efficacy|4|||
161707997|NCT02886702|583977318|FG002|Overall Study|Lack of Efficacy|5|||
161707998|NCT02886702|583977316|FG000|Overall Study|Adverse Event|4|||
161707999|NCT02886702|583977317|FG001|Overall Study|Adverse Event|9|||
161708000|NCT02886702|583977318|FG002|Overall Study|Adverse Event|3|||
161708001|NCT02886702|583977316|FG000|Overall Study|Administrative Reasons|0|||
161708002|NCT02886702|583977317|FG001|Overall Study|Administrative Reasons|0|||
161708003|NCT02886702|583977318|FG002|Overall Study|Administrative Reasons|1|||
161708004|NCT01147926|583977326|FG000|Overall Study|Subject Withdrew Consent|9|||
161708005|NCT01147926|583977327|FG001|Overall Study|Subject Withdrew Consent|10|||
161708006|NCT01147926|583977326|FG000|Overall Study|Adverse Event|7|||
161708007|NCT01147926|583977327|FG001|Overall Study|Adverse Event|6|||
161708008|NCT01147926|583977326|FG000|Overall Study|Subject Non-Compliant|5|||
161708009|NCT01147926|583977327|FG001|Overall Study|Subject Non-Compliant|4|||
161708010|NCT01147926|583977326|FG000|Overall Study|Principal investigator left hospital|1|||
161708011|NCT01147926|583977327|FG001|Overall Study|Principal investigator left hospital|3|||
161708012|NCT01147926|583977326|FG000|Overall Study|Selection criteria not met|3|||
161708013|NCT01147926|583977327|FG001|Overall Study|Selection criteria not met|1|||
161708014|NCT01147926|583977326|FG000|Overall Study|Lost to Follow-up|0|||
161708015|NCT01147926|583977327|FG001|Overall Study|Lost to Follow-up|2|||
161708016|NCT01147926|583977326|FG000|Overall Study|Sponsor's Decision|0|||
161708017|NCT01147926|583977327|FG001|Overall Study|Sponsor's Decision|1|||
161708018|NCT01147926|583977326|FG000|Overall Study|Lack of Efficacy|1|||
161708019|NCT01147926|583977327|FG001|Overall Study|Lack of Efficacy|0|||
161708020|NCT01147926|583977326|FG000|Overall Study|Too busy, no time for study|1|||
161708021|NCT01147926|583977327|FG001|Overall Study|Too busy, no time for study|0|||
161708022|NCT01147926|583977326|FG000|Overall Study|Went on holiday|0|||
161708023|NCT01147926|583977327|FG001|Overall Study|Went on holiday|1|||
161708024|NCT01147926|583977326|FG000|Overall Study|Colonoscopy result|0|||
161708025|NCT01147926|583977327|FG001|Overall Study|Colonoscopy result|1|||
161708026|NCT01085682|583977328|FG000|Overall Study|Withdrawal by Subject|25|||
161708027|NCT01085682|583977329|FG001|Overall Study|Withdrawal by Subject|25|||
161708028|NCT02561156|583977332|FG000|Part 2|Adverse Event|0|||
161708029|NCT02561156|583977333|FG001|Part 2|Adverse Event|0|||
161708030|NCT02561156|583977334|FG002|Part 2|Adverse Event|0|||
161708031|NCT02561156|583977335|FG003|Part 2|Adverse Event|0|||
161708032|NCT02561156|583977336|FG004|Part 2|Adverse Event|0|||
161708033|NCT02561156|583977337|FG005|Part 2|Adverse Event|0|||
161708034|NCT02561156|583977338|FG006|Part 2|Adverse Event|0|||
161708035|NCT02561156|583977339|FG007|Part 2|Adverse Event|0|||
161708036|NCT02561156|583977340|FG008|Part 2|Adverse Event|0|||
161708037|NCT02561156|583977341|FG009|Part 2|Adverse Event|0|||
161708038|NCT02561156|583977342|FG010|Part 2|Adverse Event|0|||
161708039|NCT02561156|583977343|FG011|Part 2|Adverse Event|1|||
161708040|NCT02561156|583977344|FG012|Part 2|Adverse Event|0|||
161708041|NCT02207907|583977345|FG000|Overall Study|Lost to Follow-up|3|||
161708042|NCT02207907|583977346|FG001|Overall Study|Lost to Follow-up|1|||
161708043|NCT02207907|583977345|FG000|Overall Study|Withdrawal by Subject|5|||
161708044|NCT02207907|583977346|FG001|Overall Study|Withdrawal by Subject|6|||
161708045|NCT02207907|583977345|FG000|Overall Study|Did not meet study criteria|3|||
161708046|NCT02207907|583977346|FG001|Overall Study|Did not meet study criteria|0|||
161708047|NCT02207907|583977345|FG000|Overall Study|Pregnancy|0|||
161708048|NCT02207907|583977346|FG001|Overall Study|Pregnancy|1|||
161708049|NCT00158184|583977347|FG000|Overall Study|personal issues|3|||
161708050|NCT00158184|583977348|FG001|Overall Study|personal issues|1|||
161708051|NCT00158184|583977347|FG000|Overall Study|failed for follow unit/study rules|2|||
161708052|NCT00158184|583977348|FG001|Overall Study|failed for follow unit/study rules|0|||
161708053|NCT00158184|583977347|FG000|Overall Study|Adverse Event|1|||
161708054|NCT00158184|583977348|FG001|Overall Study|Adverse Event|1|||
161708055|NCT01025635|583977352|FG000|Overall Study|Withdrawal by Subject|6|||
161708056|NCT01025635|583977353|FG001|Overall Study|Withdrawal by Subject|7|||
161708057|NCT01025635|583977352|FG000|Overall Study|Protocol Violation|4|||
161708058|NCT01025635|583977353|FG001|Overall Study|Protocol Violation|2|||
161708059|NCT01025635|583977352|FG000|Overall Study|Lack of Efficacy|0|||
161708060|NCT01025635|583977353|FG001|Overall Study|Lack of Efficacy|1|||
161958462|NCT02712983|584894909|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
161958463|NCT02712983|584894910|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
161958464|NCT02712983|584894911|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
161708061|NCT01025635|583977352|FG000|Overall Study|Lost to Follow-up|9|||
161708062|NCT01025635|583977353|FG001|Overall Study|Lost to Follow-up|13|||
161708063|NCT01025635|583977352|FG000|Overall Study|Reason not known|4|||
161708064|NCT01025635|583977353|FG001|Overall Study|Reason not known|2|||
161708065|NCT00929240|583977354|FG000|Initial Treatment Phase|Adverse Event|31|||
161708066|NCT00929240|583977355|FG001|Initial Treatment Phase|Adverse Event|0|||
161708067|NCT00929240|583977356|FG002|Initial Treatment Phase|Adverse Event|0|||
161708068|NCT00929240|583977354|FG000|Initial Treatment Phase|Disease progression|41|||
161708069|NCT00929240|583977355|FG001|Initial Treatment Phase|Disease progression|0|||
161958465|NCT02712983|584894912|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
161958466|NCT02712983|584894913|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
161708070|NCT00929240|583977356|FG002|Initial Treatment Phase|Disease progression|0|||
161708071|NCT00929240|583977354|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
161708072|NCT00929240|583977355|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
161708073|NCT00929240|583977356|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
161708074|NCT00929240|583977354|FG000|Initial Treatment Phase|Protocol Violation|5|||
161708075|NCT00929240|583977355|FG001|Initial Treatment Phase|Protocol Violation|0|||
161708076|NCT00929240|583977356|FG002|Initial Treatment Phase|Protocol Violation|0|||
161708077|NCT00929240|583977354|FG000|Initial Treatment Phase|Death|2|||
161708078|NCT00929240|583977355|FG001|Initial Treatment Phase|Death|0|||
161708079|NCT00929240|583977356|FG002|Initial Treatment Phase|Death|0|||
161708080|NCT00929240|583977354|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
161708081|NCT00929240|583977355|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
161708082|NCT00929240|583977356|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
161708083|NCT00929240|583977354|FG000|Initial Treatment Phase|Physician Decision|4|||
161708084|NCT00929240|583977355|FG001|Initial Treatment Phase|Physician Decision|0|||
161708085|NCT00929240|583977356|FG002|Initial Treatment Phase|Physician Decision|0|||
161708086|NCT00929240|583977354|FG000|Maintenance Phase|Disease progression|0|||
161708087|NCT00929240|583977355|FG001|Maintenance Phase|Disease progression|73|||
161708088|NCT00929240|583977356|FG002|Maintenance Phase|Disease progression|60|||
161708089|NCT00929240|583977354|FG000|Maintenance Phase|Adverse Event|0|||
161708090|NCT00929240|583977355|FG001|Maintenance Phase|Adverse Event|9|||
161708091|NCT00929240|583977356|FG002|Maintenance Phase|Adverse Event|12|||
161708092|NCT00929240|583977354|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161708093|NCT00929240|583977355|FG001|Maintenance Phase|Withdrawal by Subject|2|||
161708094|NCT00929240|583977356|FG002|Maintenance Phase|Withdrawal by Subject|6|||
161708095|NCT00929240|583977354|FG000|Maintenance Phase|Protocol Violation|0|||
161708096|NCT00929240|583977355|FG001|Maintenance Phase|Protocol Violation|1|||
161708097|NCT00929240|583977356|FG002|Maintenance Phase|Protocol Violation|0|||
161708098|NCT00929240|583977354|FG000|Maintenance Phase|Health authority/Study termination|0|||
161708099|NCT00929240|583977355|FG001|Maintenance Phase|Health authority/Study termination|1|||
161708100|NCT00929240|583977356|FG002|Maintenance Phase|Health authority/Study termination|2|||
161708101|NCT00929240|583977354|FG000|Maintenance Phase|Physician Decision|0|||
161708102|NCT00929240|583977355|FG001|Maintenance Phase|Physician Decision|2|||
161708103|NCT00929240|583977356|FG002|Maintenance Phase|Physician Decision|1|||
161708104|NCT00929240|583977354|FG000|Maintenance Phase|Change of treatment|0|||
161708105|NCT00929240|583977355|FG001|Maintenance Phase|Change of treatment|4|||
161708106|NCT00929240|583977356|FG002|Maintenance Phase|Change of treatment|0|||
161708107|NCT00929240|583977354|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
161708108|NCT00929240|583977355|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
161708109|NCT00929240|583977356|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
161708110|NCT00929240|583977354|FG000|Maintenance Phase|Participant not treated|0|||
161708111|NCT00929240|583977355|FG001|Maintenance Phase|Participant not treated|2|||
161708112|NCT00929240|583977356|FG002|Maintenance Phase|Participant not treated|0|||
161708113|NCT01276288|583977359|FG000|Overall Study|Adverse Event|1|||
161708114|NCT01276288|583977360|FG001|Overall Study|Adverse Event|1|||
161708115|NCT01276288|583977361|FG002|Overall Study|Adverse Event|0|||
161708116|NCT01276288|583977362|FG003|Overall Study|Adverse Event|0|||
161708117|NCT01276288|583977359|FG000|Overall Study|not treated|1|||
161708118|NCT01276288|583977360|FG001|Overall Study|not treated|0|||
161708119|NCT01276288|583977361|FG002|Overall Study|not treated|0|||
161708120|NCT01276288|583977362|FG003|Overall Study|not treated|0|||
161708121|NCT00629083|583977369|FG000|Overall Study|Adverse Event|0|||
161708122|NCT00629083|583977370|FG001|Overall Study|Adverse Event|2|||
161708123|NCT00629083|583977369|FG000|Overall Study|Lack of Efficacy|3|||
161708124|NCT00629083|583977370|FG001|Overall Study|Lack of Efficacy|1|||
161708125|NCT00629083|583977369|FG000|Overall Study|Withdrawal by Subject|10|||
161708126|NCT00629083|583977370|FG001|Overall Study|Withdrawal by Subject|2|||
161958467|NCT02712983|584894914|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
161958468|NCT02712983|584894915|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
161958469|NCT02712983|584894916|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
161958470|NCT03280303|584894917|FG000|Overall Study|Death|505|||
161708127|NCT00629083|583977369|FG000|Overall Study|Lost to Follow-up|12|||
161708128|NCT00629083|583977370|FG001|Overall Study|Lost to Follow-up|8|||
161708129|NCT00629083|583977369|FG000|Overall Study|Moved out of country/state|2|||
161708130|NCT00629083|583977370|FG001|Overall Study|Moved out of country/state|1|||
161708131|NCT00629083|583977369|FG000|Overall Study|Refused to return for 12 month visit|1|||
161708132|NCT00629083|583977370|FG001|Overall Study|Refused to return for 12 month visit|0|||
161708133|NCT01478958|583977371|FG000|Overall Study|Withdrawal by Subject|1|||
161708134|NCT01478958|583977372|FG001|Overall Study|Withdrawal by Subject|1|||
161708135|NCT01478958|583977373|FG002|Overall Study|Withdrawal by Subject|1|||
161708136|NCT01478958|583977371|FG000|Overall Study|Weight loss|1|||
161708137|NCT01478958|583977372|FG001|Overall Study|Weight loss|0|||
161708138|NCT01478958|583977373|FG002|Overall Study|Weight loss|0|||
161708139|NCT01478958|583977371|FG000|Overall Study|Re-located|0|||
161708140|NCT01478958|583977372|FG001|Overall Study|Re-located|1|||
161708141|NCT01478958|583977373|FG002|Overall Study|Re-located|0|||
161708142|NCT01478958|583977371|FG000|Overall Study|Unable to comply|0|||
161708143|NCT01478958|583977372|FG001|Overall Study|Unable to comply|0|||
161708144|NCT01478958|583977373|FG002|Overall Study|Unable to comply|2|||
161708145|NCT01193686|583977374|FG000|Overall Study|Withdrawal by Subject|4|||
161708146|NCT01193686|583977375|FG001|Overall Study|Withdrawal by Subject|1|||
161708147|NCT01193686|583977374|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
161708148|NCT01193686|583977375|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
161708149|NCT03401749|583977376|FG000|Overall Study|Lost to Follow-up|20|||
161708150|NCT03401749|583977377|FG001|Overall Study|Lost to Follow-up|16|||
161708151|NCT03401749|583977378|FG002|Overall Study|Lost to Follow-up|26|||
161708152|NCT01147809|583977381|FG000|Phase I (168 Days)|Adverse Event|0|||
161708153|NCT01147809|583977382|FG001|Phase I (168 Days)|Adverse Event|0|||
161708154|NCT01147809|583977383|FG002|Phase I (168 Days)|Adverse Event|0|||
161708155|NCT01147809|583977384|FG003|Phase I (168 Days)|Adverse Event|1|||
161708156|NCT01147809|583977385|FG004|Phase I (168 Days)|Adverse Event|0|||
161708157|NCT01147809|583977386|FG005|Phase I (168 Days)|Adverse Event|0|||
161708158|NCT01147809|583977381|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
161708159|NCT01147809|583977382|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
161708160|NCT01147809|583977383|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
161708161|NCT01147809|583977384|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
161708162|NCT01147809|583977385|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
161708163|NCT01147809|583977386|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
161708164|NCT01147809|583977381|FG000|Phase I (168 Days)|Physician Decision|0|||
161708165|NCT01147809|583977382|FG001|Phase I (168 Days)|Physician Decision|1|||
161708166|NCT01147809|583977383|FG002|Phase I (168 Days)|Physician Decision|2|||
161708167|NCT01147809|583977384|FG003|Phase I (168 Days)|Physician Decision|0|||
161708168|NCT01147809|583977385|FG004|Phase I (168 Days)|Physician Decision|0|||
161708169|NCT01147809|583977386|FG005|Phase I (168 Days)|Physician Decision|0|||
161708170|NCT01147809|583977381|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
161708171|NCT01147809|583977382|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
161708172|NCT01147809|583977383|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
161708173|NCT01147809|583977384|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
161708174|NCT01147809|583977385|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
161708175|NCT01147809|583977386|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
161708176|NCT01147809|583977381|FG000|Phase II (168 Days)|Adverse Event|0|||
161708177|NCT01147809|583977382|FG001|Phase II (168 Days)|Adverse Event|0|||
161708178|NCT01147809|583977383|FG002|Phase II (168 Days)|Adverse Event|0|||
161708179|NCT01147809|583977384|FG003|Phase II (168 Days)|Adverse Event|0|||
161708180|NCT01147809|583977385|FG004|Phase II (168 Days)|Adverse Event|3|||
161708181|NCT01147809|583977386|FG005|Phase II (168 Days)|Adverse Event|6|||
161708182|NCT01147809|583977381|FG000|Phase II (168 Days)|Protocol Violation|0|||
161708183|NCT01147809|583977382|FG001|Phase II (168 Days)|Protocol Violation|0|||
161708184|NCT01147809|583977383|FG002|Phase II (168 Days)|Protocol Violation|0|||
161708185|NCT01147809|583977384|FG003|Phase II (168 Days)|Protocol Violation|0|||
161708186|NCT01147809|583977385|FG004|Phase II (168 Days)|Protocol Violation|0|||
161708187|NCT01147809|583977386|FG005|Phase II (168 Days)|Protocol Violation|1|||
161708188|NCT01147809|583977381|FG000|Phase II (168 Days)|Physician Decision|0|||
161708189|NCT01147809|583977382|FG001|Phase II (168 Days)|Physician Decision|0|||
161708190|NCT01147809|583977383|FG002|Phase II (168 Days)|Physician Decision|0|||
161708191|NCT01147809|583977384|FG003|Phase II (168 Days)|Physician Decision|0|||
161708192|NCT01147809|583977385|FG004|Phase II (168 Days)|Physician Decision|5|||
161708193|NCT01147809|583977386|FG005|Phase II (168 Days)|Physician Decision|11|||
161708194|NCT01147809|583977381|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
161708195|NCT01147809|583977382|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
161708196|NCT01147809|583977383|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
161708197|NCT01147809|583977384|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
161708198|NCT01147809|583977385|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
161708199|NCT01147809|583977386|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
161708200|NCT01147809|583977381|FG000|Phase II (168 Days)|Ongoing|0|||
161708201|NCT01147809|583977382|FG001|Phase II (168 Days)|Ongoing|0|||
161708202|NCT01147809|583977383|FG002|Phase II (168 Days)|Ongoing|0|||
161708203|NCT01147809|583977384|FG003|Phase II (168 Days)|Ongoing|0|||
161708204|NCT01147809|583977385|FG004|Phase II (168 Days)|Ongoing|1|||
161708205|NCT01147809|583977386|FG005|Phase II (168 Days)|Ongoing|0|||
161708206|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
161708207|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
161708208|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
161708209|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161708210|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161708211|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161708212|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161708213|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161708214|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161708215|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
161708216|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
161708217|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
161708218|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161708219|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161708220|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161708221|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161708222|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161708223|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161708224|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
161708225|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
161708226|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
161708227|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161708228|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161708229|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161708230|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161708231|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161708232|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161708233|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708234|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708235|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
161708236|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708237|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708238|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708239|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708240|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708241|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161708242|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
161708243|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
161708244|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
161708245|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161708246|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161708247|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161708248|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161708249|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161708250|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161708251|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
161708252|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708253|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708254|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708255|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708256|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708257|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708258|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708259|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161708260|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
161708261|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
161708262|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708263|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708264|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708265|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708266|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708267|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708268|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161708269|NCT01307423|583977387|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161708270|NCT01307423|583977388|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
161708271|NCT01307423|583977389|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
161708272|NCT01307423|583977390|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161708273|NCT01307423|583977391|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161708274|NCT01307423|583977392|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161708275|NCT01307423|583977393|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161708276|NCT01307423|583977394|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161708277|NCT01307423|583977395|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161837721|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
161837722|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
161708278|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161708279|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
161708280|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
161708281|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
161708282|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
161708283|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161708284|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161708285|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161708286|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161708287|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161708288|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
161708289|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
161708290|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
161708291|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
161708292|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161708293|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161708294|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161708295|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161708296|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708297|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708298|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708299|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708300|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708301|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
161708302|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708303|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708304|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161708305|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161708306|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
161708307|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
161708308|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161708309|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161708310|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
161708311|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
161708312|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161708313|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161708314|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708315|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708316|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708317|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
161708318|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708319|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708320|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708321|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708322|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161708323|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
161708324|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
161708325|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
161708326|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
161708327|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
161708328|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
161708329|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
161708330|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
161708331|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
161708332|NCT01307423|583977387|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708333|NCT01307423|583977388|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708334|NCT01307423|583977389|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161837723|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
161837724|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
161837725|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
161837726|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
161837727|NCT01144364|584448689|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
161837728|NCT01144364|584448690|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
161837729|NCT01144364|584448691|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
161837730|NCT04932941|584448692|FG000|Overall Study|Lost to Follow-up|3|||
161708335|NCT01307423|583977390|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708336|NCT01307423|583977391|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708337|NCT01307423|583977392|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
161708338|NCT01307423|583977393|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708339|NCT01307423|583977394|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708340|NCT01307423|583977395|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161708341|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161708342|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
161708343|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
161708344|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161708345|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161708346|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161708347|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161708348|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
161708349|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
161708350|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161708351|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
161708352|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
161708353|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161708354|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161708355|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161708356|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161708357|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
161708358|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
161708359|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708360|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708361|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
161708362|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708363|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708364|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708365|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708366|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708367|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161708368|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161708369|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
161708370|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
161708371|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161708372|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161708373|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161708374|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161708375|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
161708376|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
161708377|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161708378|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
161708379|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161708380|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161708381|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161708382|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161708383|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161708384|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
161708385|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
161708386|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161708387|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
161708388|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
161708389|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161708390|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161708391|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161837731|NCT04932941|584448693|FG001|Overall Study|Lost to Follow-up|1|||
161837732|NCT04932941|584448692|FG000|Overall Study|Withdrawal by Subject|7|||
161837733|NCT04932941|584448693|FG001|Overall Study|Withdrawal by Subject|4|||
161837734|NCT04932941|584448692|FG000|Overall Study|Other|4|||
161837735|NCT04932941|584448693|FG001|Overall Study|Other|2|||
161837736|NCT03510182|584448696|FG000|Overall Study|Withdrawal by Subject|2|||
161837737|NCT00375492|584448697|FG000|Overall Study|Adverse Event|4|||
161837738|NCT00375492|584448698|FG001|Overall Study|Adverse Event|5|||
161837739|NCT00375492|584448697|FG000|Overall Study|Entry Criteria Not Met|0|||
161837740|NCT00375492|584448698|FG001|Overall Study|Entry Criteria Not Met|1|||
161837741|NCT00375492|584448697|FG000|Overall Study|Loss of Glucose Control|0|||
161958471|NCT03280303|584894917|FG000|Overall Study|Study terminated by sponsor|383|||
161708392|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161708393|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
161708394|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
161708395|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161708396|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
161708397|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
161708398|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161708399|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161708400|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161708401|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161708402|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
161708403|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
161708404|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708405|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
161708406|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
161708407|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708408|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708409|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708410|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708411|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708412|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161708413|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161708414|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
161708415|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
161708416|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161708417|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161708418|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161708419|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161708420|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
161708421|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
161708422|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161708423|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
161708424|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
161708425|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161708426|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161708427|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161708428|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161708429|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
161708430|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
161708431|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708432|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
161708433|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708434|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708435|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708436|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708437|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708438|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
161708439|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161708440|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708441|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
161708442|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708443|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708444|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708445|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708446|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708447|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708448|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161708449|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708450|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
161708451|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708452|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708453|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708454|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708455|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161958472|NCT03280303|584894917|FG000|Overall Study|Other|148|||
161958473|NCT03280303|584894917|FG000|Overall Study|No longer willing to participate in study|101|||
161958474|NCT03280303|584894917|FG000|Overall Study|Lost to follow up|39|||
161708456|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161708457|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
161708458|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161708459|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
161708460|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
161708461|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161708462|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161708463|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161708464|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161708465|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
161708466|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
161708467|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708468|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708469|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
161708470|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708471|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708472|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708473|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708474|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708475|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161708476|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708477|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708478|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708479|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708480|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708481|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708482|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708483|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
161708484|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161708485|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161708486|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
161708487|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
161708488|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161708489|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161708490|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161708491|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161708492|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161708493|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
161708494|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708495|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
161708496|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
161708497|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708498|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708499|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708500|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708501|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708502|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161708503|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161708504|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
161708505|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
161708506|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161708507|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161708508|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161708509|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161708510|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161708511|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
161708512|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708513|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
161708514|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708515|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708516|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708517|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708518|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708519|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708520|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161708521|NCT01307423|583977387|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161708522|NCT01307423|583977388|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161708523|NCT01307423|583977389|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
161708524|NCT01307423|583977390|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161708525|NCT01307423|583977391|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161708526|NCT01307423|583977392|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161708527|NCT01307423|583977393|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161708528|NCT01307423|583977394|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
161708529|NCT01307423|583977395|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
161708530|NCT01499290|583977398|FG000|Overall Study|Withdrawal by Subject|22|||
161708531|NCT01499290|583977399|FG001|Overall Study|Withdrawal by Subject|15|||
161708532|NCT01499290|583977398|FG000|Overall Study|Not specified in study report|11|||
161708533|NCT01499290|583977399|FG001|Overall Study|Not specified in study report|5|||
161708534|NCT01499290|583977398|FG000|Overall Study|Condition improved/subject recovered|1|||
161708535|NCT01499290|583977399|FG001|Overall Study|Condition improved/subject recovered|0|||
161708536|NCT01499290|583977398|FG000|Overall Study|Lack of Efficacy|7|||
161708537|NCT01499290|583977399|FG001|Overall Study|Lack of Efficacy|8|||
161708538|NCT01499290|583977398|FG000|Overall Study|Adverse Event|14|||
161708539|NCT01499290|583977399|FG001|Overall Study|Adverse Event|7|||
161708540|NCT03406962|583977400|FG000|Overall Study|Death|2|||
161708541|NCT03406962|583977400|FG000|Overall Study|Adverse Event|1|||
161708542|NCT03853694|583977401|FG000|Overall Study|Protocol Violation|3|||
161708543|NCT03853694|583977402|FG001|Overall Study|Protocol Violation|5|||
161708544|NCT03853694|583977403|FG002|Overall Study|Protocol Violation|3|||
161708545|NCT03853694|583977401|FG000|Overall Study|Delivered early|0|||
161708546|NCT03853694|583977402|FG001|Overall Study|Delivered early|1|||
161708547|NCT03853694|583977403|FG002|Overall Study|Delivered early|0|||
161708548|NCT03853694|583977401|FG000|Overall Study|not suitable to proceed|0|||
161708549|NCT03853694|583977402|FG001|Overall Study|not suitable to proceed|1|||
161708550|NCT03853694|583977403|FG002|Overall Study|not suitable to proceed|0|||
161708551|NCT03853694|583977401|FG000|Overall Study|difficult surgery|0|||
161708552|NCT03853694|583977402|FG001|Overall Study|difficult surgery|0|||
161708553|NCT03853694|583977403|FG002|Overall Study|difficult surgery|1|||
161708554|NCT03853694|583977401|FG000|Overall Study|Lost to Follow-up|0|||
161708555|NCT03853694|583977402|FG001|Overall Study|Lost to Follow-up|1|||
161708556|NCT03853694|583977403|FG002|Overall Study|Lost to Follow-up|0|||
161708557|NCT03853694|583977401|FG000|Overall Study|Withdrawal by Subject|0|||
161708558|NCT03853694|583977402|FG001|Overall Study|Withdrawal by Subject|1|||
161708559|NCT03853694|583977403|FG002|Overall Study|Withdrawal by Subject|0|||
161708560|NCT02209766|583977404|FG000|Overall Study|Withdrawal by Subject|0|||
161708561|NCT02209766|583977405|FG001|Overall Study|Withdrawal by Subject|0|||
161708562|NCT02209766|583977406|FG002|Overall Study|Withdrawal by Subject|0|||
161708563|NCT02209766|583977407|FG003|Overall Study|Withdrawal by Subject|1|||
161708564|NCT02209766|583977408|FG004|Overall Study|Withdrawal by Subject|0|||
161708565|NCT00805207|583977409|FG000|Overall Study|Protocol Violation|0|||
161708566|NCT00805207|583977410|FG001|Overall Study|Protocol Violation|0|||
161708567|NCT00805207|583977411|FG002|Overall Study|Protocol Violation|1|||
161708568|NCT00805207|583977412|FG003|Overall Study|Protocol Violation|0|||
161708569|NCT00805207|583977413|FG004|Overall Study|Protocol Violation|0|||
161708570|NCT00805207|583977414|FG005|Overall Study|Protocol Violation|0|||
161708571|NCT00805207|583977415|FG006|Overall Study|Protocol Violation|0|||
161708572|NCT00805207|583977416|FG007|Overall Study|Protocol Violation|0|||
161708573|NCT00805207|583977417|FG008|Overall Study|Protocol Violation|0|||
161708574|NCT00805207|583977409|FG000|Overall Study|Physician Decision|0|||
161708575|NCT00805207|583977410|FG001|Overall Study|Physician Decision|1|||
161708576|NCT00805207|583977411|FG002|Overall Study|Physician Decision|0|||
161708577|NCT00805207|583977412|FG003|Overall Study|Physician Decision|0|||
161708578|NCT00805207|583977413|FG004|Overall Study|Physician Decision|0|||
161708579|NCT00805207|583977414|FG005|Overall Study|Physician Decision|1|||
161708580|NCT00805207|583977415|FG006|Overall Study|Physician Decision|0|||
161708581|NCT00805207|583977416|FG007|Overall Study|Physician Decision|0|||
161708582|NCT00805207|583977417|FG008|Overall Study|Physician Decision|0|||
161708583|NCT00805207|583977409|FG000|Overall Study|Withdrawal by Subject|0|||
161708584|NCT00805207|583977410|FG001|Overall Study|Withdrawal by Subject|1|||
161708585|NCT00805207|583977411|FG002|Overall Study|Withdrawal by Subject|0|||
161708586|NCT00805207|583977412|FG003|Overall Study|Withdrawal by Subject|0|||
161708587|NCT00805207|583977413|FG004|Overall Study|Withdrawal by Subject|1|||
161708588|NCT00805207|583977414|FG005|Overall Study|Withdrawal by Subject|2|||
161708589|NCT00805207|583977415|FG006|Overall Study|Withdrawal by Subject|0|||
161708590|NCT00805207|583977416|FG007|Overall Study|Withdrawal by Subject|0|||
161708591|NCT00805207|583977417|FG008|Overall Study|Withdrawal by Subject|0|||
161708592|NCT00064701|583977418|FG000|One Year Post-transplant|Did not receive study drug|7|||
161708593|NCT00064701|583977419|FG001|One Year Post-transplant|Did not receive study drug|12|||
161708594|NCT00064701|583977420|FG002|One Year Post-transplant|Did not receive study drug|11|||
161708595|NCT00064701|583977418|FG000|One Year Post-transplant|Adverse Event|23|||
161708596|NCT00064701|583977419|FG001|One Year Post-transplant|Adverse Event|19|||
161708597|NCT00064701|583977420|FG002|One Year Post-transplant|Adverse Event|37|||
161708598|NCT00064701|583977418|FG000|One Year Post-transplant|Rejection|0|||
161708599|NCT00064701|583977419|FG001|One Year Post-transplant|Rejection|1|||
161708600|NCT00064701|583977420|FG002|One Year Post-transplant|Rejection|16|||
161708601|NCT00064701|583977418|FG000|One Year Post-transplant|Non-compliance|4|||
161708602|NCT00064701|583977419|FG001|One Year Post-transplant|Non-compliance|2|||
161708603|NCT00064701|583977420|FG002|One Year Post-transplant|Non-compliance|5|||
161708604|NCT00064701|583977418|FG000|One Year Post-transplant|Graft Failure|3|||
161708605|NCT00064701|583977419|FG001|One Year Post-transplant|Graft Failure|2|||
161708606|NCT00064701|583977420|FG002|One Year Post-transplant|Graft Failure|1|||
161708607|NCT00064701|583977418|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
161708608|NCT00064701|583977419|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
161708609|NCT00064701|583977420|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
161708610|NCT00064701|583977418|FG000|One Year Post-transplant|Lost to Follow-up|1|||
161708611|NCT00064701|583977419|FG001|One Year Post-transplant|Lost to Follow-up|0|||
161708612|NCT00064701|583977420|FG002|One Year Post-transplant|Lost to Follow-up|0|||
161708613|NCT00064701|583977418|FG000|One Year Post-transplant|Converted to rapamycin|1|||
161708614|NCT00064701|583977419|FG001|One Year Post-transplant|Converted to rapamycin|0|||
161708615|NCT00064701|583977420|FG002|One Year Post-transplant|Converted to rapamycin|0|||
161708616|NCT00064701|583977418|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
161708617|NCT00064701|583977419|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
161708618|NCT00064701|583977420|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
161708619|NCT00064701|583977418|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
161708620|NCT00064701|583977419|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
161708621|NCT00064701|583977420|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
161708622|NCT00064701|583977418|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
161708623|NCT00064701|583977419|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
161708624|NCT00064701|583977420|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
161708625|NCT00064701|583977418|FG000|One Year Post-transplant|Poor absorption|0|||
161708626|NCT00064701|583977419|FG001|One Year Post-transplant|Poor absorption|1|||
161708627|NCT00064701|583977420|FG002|One Year Post-transplant|Poor absorption|0|||
161708628|NCT00064701|583977418|FG000|One Year Post-transplant|Pancreas transplant|0|||
161708629|NCT00064701|583977419|FG001|One Year Post-transplant|Pancreas transplant|0|||
161708630|NCT00064701|583977420|FG002|One Year Post-transplant|Pancreas transplant|1|||
161708631|NCT00064701|583977418|FG000|Clinical Continuation Phase|Adverse Event|12|||
161708632|NCT00064701|583977419|FG001|Clinical Continuation Phase|Adverse Event|21|||
161708633|NCT00064701|583977420|FG002|Clinical Continuation Phase|Adverse Event|14|||
161708634|NCT00064701|583977418|FG000|Clinical Continuation Phase|Non-compliance|8|||
161708635|NCT00064701|583977419|FG001|Clinical Continuation Phase|Non-compliance|6|||
161708636|NCT00064701|583977420|FG002|Clinical Continuation Phase|Non-compliance|7|||
161708637|NCT00064701|583977418|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
161708638|NCT00064701|583977419|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
161708639|NCT00064701|583977420|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
161708640|NCT00064701|583977418|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
161708641|NCT00064701|583977419|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
161708642|NCT00064701|583977420|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
161708643|NCT00064701|583977418|FG000|Clinical Continuation Phase|Graft Failure|5|||
161708644|NCT00064701|583977419|FG001|Clinical Continuation Phase|Graft Failure|5|||
161708645|NCT00064701|583977420|FG002|Clinical Continuation Phase|Graft Failure|2|||
161708646|NCT00064701|583977418|FG000|Clinical Continuation Phase|Rejection|1|||
161708647|NCT00064701|583977419|FG001|Clinical Continuation Phase|Rejection|2|||
161708648|NCT00064701|583977420|FG002|Clinical Continuation Phase|Rejection|2|||
161708649|NCT00064701|583977418|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
161708650|NCT00064701|583977419|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
161708651|NCT00064701|583977420|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
161708652|NCT00064701|583977418|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
161708653|NCT00064701|583977419|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
161708654|NCT00064701|583977420|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
161708655|NCT00064701|583977418|FG000|Clinical Continuation Phase|Physician Decision|1|||
161708656|NCT00064701|583977419|FG001|Clinical Continuation Phase|Physician Decision|3|||
161708657|NCT00064701|583977420|FG002|Clinical Continuation Phase|Physician Decision|0|||
161708658|NCT00064701|583977418|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
161708659|NCT00064701|583977419|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
161708660|NCT00064701|583977420|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
161958475|NCT03280303|584894917|FG000|Overall Study|Adverse Event|20|||
161958476|NCT00064259|584894918|FG000|Overall Study|Adverse Event|1|||
161958477|NCT00064259|584894919|FG001|Overall Study|Adverse Event|0|||
161958478|NCT00064259|584894920|FG002|Overall Study|Adverse Event|0|||
161708661|NCT00064701|583977418|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
161958479|NCT00064259|584894921|FG003|Overall Study|Adverse Event|1|||
161958480|NCT01132651|584894924|FG000|Overall Study|Lost to Follow-up|1|||
161708662|NCT00064701|583977419|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
161708663|NCT00064701|583977420|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
161708664|NCT00064701|583977418|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
161958481|NCT01132651|584894925|FG001|Overall Study|Lost to Follow-up|1|||
161958482|NCT00948857|584894926|FG000|Overall Study|Lost to Follow-up|1|||
161708665|NCT00064701|583977419|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
161708666|NCT00064701|583977420|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
161708667|NCT00064701|583977418|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
161708668|NCT00064701|583977419|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
161708669|NCT00064701|583977420|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
161708670|NCT00064701|583977418|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
161708671|NCT00064701|583977419|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
161708672|NCT00064701|583977420|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
161708673|NCT00064701|583977418|FG000|Clinical Continuation Phase|Patient opted out|0|||
161708674|NCT00064701|583977419|FG001|Clinical Continuation Phase|Patient opted out|0|||
161708675|NCT00064701|583977420|FG002|Clinical Continuation Phase|Patient opted out|1|||
161708676|NCT01818297|583977421|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
161708677|NCT01818297|583977422|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
161708678|NCT01818297|583977421|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
161708679|NCT01818297|583977422|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
161708680|NCT01818297|583977421|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
161708681|NCT01818297|583977422|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
161708682|NCT03308188|583977423|FG000|Overall Study|Withdrawal by Subject|0|||
161708683|NCT03308188|583977424|FG001|Overall Study|Withdrawal by Subject|3|||
161708684|NCT03308188|583977423|FG000|Overall Study|Death|0|||
161708685|NCT03308188|583977424|FG001|Overall Study|Death|1|||
161708686|NCT01791855|583977425|FG000|Overall Study|Adverse Event|0|||
161708687|NCT01791855|583977426|FG001|Overall Study|Adverse Event|0|||
161708688|NCT01791855|583977427|FG002|Overall Study|Adverse Event|0|||
161708689|NCT01791855|583977428|FG003|Overall Study|Adverse Event|1|||
161708690|NCT01791855|583977425|FG000|Overall Study|Randomized, not treated|0|||
161708691|NCT01791855|583977426|FG001|Overall Study|Randomized, not treated|1|||
161708692|NCT01791855|583977427|FG002|Overall Study|Randomized, not treated|0|||
161708693|NCT01791855|583977428|FG003|Overall Study|Randomized, not treated|0|||
161708694|NCT00481065|583977429|FG000|Overall Study|Adverse event or death|1|||
161708695|NCT00481065|583977430|FG001|Overall Study|Adverse event or death|1|||
161708696|NCT00481065|583977431|FG002|Overall Study|Adverse event or death|3|||
161708697|NCT00481065|583977432|FG003|Overall Study|Adverse event or death|0|||
161708698|NCT00481065|583977433|FG004|Overall Study|Adverse event or death|2|||
161708699|NCT00481065|583977434|FG005|Overall Study|Adverse event or death|0|||
161708700|NCT00481065|583977435|FG006|Overall Study|Adverse event or death|1|||
161708701|NCT00481065|583977436|FG007|Overall Study|Adverse event or death|1|||
161708702|NCT00481065|583977429|FG000|Overall Study|Withdrawal by Subject|11|||
161708703|NCT00481065|583977430|FG001|Overall Study|Withdrawal by Subject|12|||
161708704|NCT00481065|583977431|FG002|Overall Study|Withdrawal by Subject|7|||
161708705|NCT00481065|583977432|FG003|Overall Study|Withdrawal by Subject|11|||
161708706|NCT00481065|583977433|FG004|Overall Study|Withdrawal by Subject|13|||
161708707|NCT00481065|583977434|FG005|Overall Study|Withdrawal by Subject|12|||
161708708|NCT00481065|583977435|FG006|Overall Study|Withdrawal by Subject|9|||
161708709|NCT00481065|583977436|FG007|Overall Study|Withdrawal by Subject|10|||
161708710|NCT00481065|583977429|FG000|Overall Study|Lost to Follow-up|4|||
161708711|NCT00481065|583977430|FG001|Overall Study|Lost to Follow-up|2|||
161708712|NCT00481065|583977431|FG002|Overall Study|Lost to Follow-up|4|||
161708713|NCT00481065|583977432|FG003|Overall Study|Lost to Follow-up|3|||
161708714|NCT00481065|583977433|FG004|Overall Study|Lost to Follow-up|3|||
161708715|NCT00481065|583977434|FG005|Overall Study|Lost to Follow-up|3|||
161708716|NCT00481065|583977435|FG006|Overall Study|Lost to Follow-up|2|||
161708717|NCT00481065|583977436|FG007|Overall Study|Lost to Follow-up|5|||
161708718|NCT00481065|583977429|FG000|Overall Study|Inappropriate enrollment|4|||
161708719|NCT00481065|583977430|FG001|Overall Study|Inappropriate enrollment|0|||
161708720|NCT00481065|583977431|FG002|Overall Study|Inappropriate enrollment|2|||
161708721|NCT00481065|583977432|FG003|Overall Study|Inappropriate enrollment|0|||
161708722|NCT00481065|583977433|FG004|Overall Study|Inappropriate enrollment|2|||
161708723|NCT00481065|583977434|FG005|Overall Study|Inappropriate enrollment|1|||
161708724|NCT00481065|583977435|FG006|Overall Study|Inappropriate enrollment|0|||
161708725|NCT00481065|583977436|FG007|Overall Study|Inappropriate enrollment|1|||
161708726|NCT00481065|583977429|FG000|Overall Study|Administrative reason|0|||
161708727|NCT00481065|583977430|FG001|Overall Study|Administrative reason|0|||
161708728|NCT00481065|583977431|FG002|Overall Study|Administrative reason|0|||
161708729|NCT00481065|583977432|FG003|Overall Study|Administrative reason|0|||
161708730|NCT00481065|583977433|FG004|Overall Study|Administrative reason|0|||
161708731|NCT00481065|583977434|FG005|Overall Study|Administrative reason|2|||
161708732|NCT00481065|583977435|FG006|Overall Study|Administrative reason|1|||
161708733|NCT00481065|583977436|FG007|Overall Study|Administrative reason|0|||
161708734|NCT00481065|583977429|FG000|Overall Study|Protocol Violation|2|||
161708735|NCT00481065|583977430|FG001|Overall Study|Protocol Violation|1|||
161708736|NCT00481065|583977431|FG002|Overall Study|Protocol Violation|1|||
161837742|NCT00375492|584448698|FG001|Overall Study|Loss of Glucose Control|1|||
162030859|NCT00534313|585169498|FG002|Short-term Period|Participant not meeting study criteria|0|||
161708737|NCT00481065|583977432|FG003|Overall Study|Protocol Violation|1|||
161708738|NCT00481065|583977433|FG004|Overall Study|Protocol Violation|2|||
161708739|NCT00481065|583977434|FG005|Overall Study|Protocol Violation|6|||
161708740|NCT00481065|583977435|FG006|Overall Study|Protocol Violation|3|||
161708741|NCT00481065|583977436|FG007|Overall Study|Protocol Violation|2|||
161708742|NCT00481065|583977429|FG000|Overall Study|Unable to classify|0|||
161708743|NCT00481065|583977430|FG001|Overall Study|Unable to classify|1|||
161708744|NCT00481065|583977431|FG002|Overall Study|Unable to classify|2|||
161708745|NCT00481065|583977432|FG003|Overall Study|Unable to classify|0|||
161708746|NCT00481065|583977433|FG004|Overall Study|Unable to classify|1|||
161708747|NCT00481065|583977434|FG005|Overall Study|Unable to classify|0|||
161708748|NCT00481065|583977435|FG006|Overall Study|Unable to classify|0|||
161708749|NCT00481065|583977436|FG007|Overall Study|Unable to classify|0|||
161837743|NCT00375492|584448697|FG000|Overall Study|Lost to Follow-up|10|||
161837744|NCT00375492|584448698|FG001|Overall Study|Lost to Follow-up|5|||
161837745|NCT00375492|584448697|FG000|Overall Study|Physician Decision|0|||
161837746|NCT00375492|584448698|FG001|Overall Study|Physician Decision|4|||
161837747|NCT00375492|584448697|FG000|Overall Study|Protocol Violation|6|||
161837748|NCT00375492|584448698|FG001|Overall Study|Protocol Violation|3|||
161837749|NCT00375492|584448697|FG000|Overall Study|Sponsor Decision|0|||
161837750|NCT00375492|584448698|FG001|Overall Study|Sponsor Decision|1|||
161837751|NCT00375492|584448697|FG000|Overall Study|Withdrawal by Subject|6|||
161837752|NCT00375492|584448698|FG001|Overall Study|Withdrawal by Subject|6|||
161837753|NCT03295318|584450181|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
161837754|NCT03295318|584450182|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
161837755|NCT03295318|584450183|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
161837756|NCT03295318|584450181|FG000|Overall Study|Death|1|||
161837757|NCT03295318|584450182|FG001|Overall Study|Death|1|||
161837758|NCT03295318|584450183|FG002|Overall Study|Death|1|||
161837759|NCT03295318|584450181|FG000|Overall Study|Protocol Violation|4|||
161837760|NCT03295318|584450182|FG001|Overall Study|Protocol Violation|3|||
161837761|NCT03295318|584450183|FG002|Overall Study|Protocol Violation|3|||
161837762|NCT03295318|584450181|FG000|Overall Study|Withdrawal by Subject|0|||
161837763|NCT03295318|584450182|FG001|Overall Study|Withdrawal by Subject|0|||
161837764|NCT03295318|584450183|FG002|Overall Study|Withdrawal by Subject|1|||
161837765|NCT03295318|584450181|FG000|Overall Study|Subject discontinued due to travel|0|||
161837766|NCT03295318|584450182|FG001|Overall Study|Subject discontinued due to travel|1|||
161837767|NCT03295318|584450183|FG002|Overall Study|Subject discontinued due to travel|0|||
161837768|NCT03747601|584450184|FG000|Overall Study|COVID halt to visits|4|||
161837769|NCT02307266|584450187|FG000|Overall Study|Adverse Event|3|||
161837770|NCT02307266|584450188|FG001|Overall Study|Adverse Event|1|||
161837771|NCT02307266|584450189|FG002|Overall Study|Adverse Event|5|||
161837772|NCT02307266|584450187|FG000|Overall Study|Withdrawal by Subject|2|||
161837773|NCT02307266|584450188|FG001|Overall Study|Withdrawal by Subject|0|||
161837774|NCT02307266|584450189|FG002|Overall Study|Withdrawal by Subject|1|||
161837775|NCT02307266|584450187|FG000|Overall Study|Lost to Follow-up|3|||
161837776|NCT02307266|584450188|FG001|Overall Study|Lost to Follow-up|0|||
161837777|NCT02307266|584450189|FG002|Overall Study|Lost to Follow-up|0|||
161837778|NCT00793780|584450190|FG000|Overall Study|Withdrawal by Subject|2|||
161837779|NCT00793780|584450191|FG001|Overall Study|Withdrawal by Subject|1|||
161837780|NCT00573157|584450192|FG000|Overall Study|Adverse Event|3|||
161837781|NCT00573157|584450193|FG001|Overall Study|Adverse Event|1|||
161837782|NCT00573157|584450192|FG000|Overall Study|Other|1|||
161837783|NCT00573157|584450193|FG001|Overall Study|Other|1|||
161837784|NCT01032018|584450194|FG000|Overall Study|Lost to Follow-up|6|||
161837785|NCT01032018|584450195|FG001|Overall Study|Lost to Follow-up|5|||
161837786|NCT01032018|584450194|FG000|Overall Study|Death|0|||
161837787|NCT01032018|584450195|FG001|Overall Study|Death|1|||
161837788|NCT00858143|584450197|FG000|Overall Study|Adverse Event|16|||
161837789|NCT00858143|584450197|FG000|Overall Study|Lack of Efficacy|4|||
161837790|NCT00858143|584450197|FG000|Overall Study|Death|7|||
161837791|NCT00858143|584450197|FG000|Overall Study|Other|23|||
161837792|NCT02621034|584450201|FG000|Overall Study|Lost to Follow-up|3|||
161837793|NCT02621034|584450202|FG001|Overall Study|Lost to Follow-up|2|||
161837794|NCT02621034|584450203|FG002|Overall Study|Lost to Follow-up|5|||
161837795|NCT00974974|584450212|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
161708750|NCT01709331|583977437|FG000|Overall Study|Adverse Event|1|||
161708751|NCT04439344|583977438|FG000|Overall Study|Never started threapy|3|||
161708752|NCT04439344|583977438|FG000|Overall Study|Ineligible|3|||
161708753|NCT04439344|583977438|FG000|Overall Study|Adverse Event|13|||
161708754|NCT04439344|583977438|FG000|Overall Study|Death|2|||
161837796|NCT00974974|584450213|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
161837797|NCT00974974|584450212|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
161837798|NCT00974974|584450213|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
161837799|NCT00974974|584450212|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
161837800|NCT00974974|584450213|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
161837801|NCT00974974|584450212|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
161837802|NCT00974974|584450213|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
161708755|NCT04439344|583977438|FG000|Overall Study|Disease progression|29|||
161708756|NCT04439344|583977438|FG000|Overall Study|Withdrawal by Subject|2|||
161708757|NCT04439344|583977438|FG000|Overall Study|Alternative therapy|1|||
161708758|NCT00772447|583977439|FG000|Overall Study|Withdrawal by Subject|9|||
161708759|NCT00772447|583977440|FG001|Overall Study|Withdrawal by Subject|5|||
161708760|NCT00772447|583977439|FG000|Overall Study|Physician Decision|4|||
161708761|NCT00772447|583977440|FG001|Overall Study|Physician Decision|8|||
161708762|NCT00772447|583977439|FG000|Overall Study|Lost to Follow-up|2|||
161708763|NCT00772447|583977440|FG001|Overall Study|Lost to Follow-up|4|||
161708764|NCT00772447|583977439|FG000|Overall Study|incorrect enrolment|3|||
161708765|NCT00772447|583977440|FG001|Overall Study|incorrect enrolment|4|||
161958483|NCT00948857|584894927|FG001|Overall Study|Lost to Follow-up|0|||
161708766|NCT00772447|583977439|FG000|Overall Study|Protocol Violation|0|||
161708767|NCT00772447|583977440|FG001|Overall Study|Protocol Violation|1|||
161708768|NCT00772447|583977439|FG000|Overall Study|all others|2|||
161708769|NCT00772447|583977440|FG001|Overall Study|all others|2|||
161708770|NCT03770403|583977446|FG000|Overall Study|Adverse Event|8|||
161708771|NCT03770403|583977446|FG000|Overall Study|Death|5|||
161708772|NCT03770403|583977446|FG000|Overall Study|Physician Decision|1|||
161708773|NCT03770403|583977446|FG000|Overall Study|Sponsor decision|1|||
161708774|NCT03770403|583977446|FG000|Overall Study|Study terminated by Sponsor|1|||
161708775|NCT03770403|583977446|FG000|Overall Study|Withdrawal by Subject|13|||
161708776|NCT03770403|583977446|FG000|Overall Study|Other|88|||
161708777|NCT03896295|583977447|FG000|Overall Study|Adverse Event|0|||
161708778|NCT03896295|583977448|FG001|Overall Study|Adverse Event|1|||
161708779|NCT03896295|583977447|FG000|Overall Study|COVID-19|7|||
161708780|NCT03896295|583977448|FG001|Overall Study|COVID-19|29|||
161708781|NCT01957137|583977449|FG000|Randomized Portion|Adverse Event|1|||
161708782|NCT01957137|583977449|FG000|Randomized Portion|Withdrawal by Subject|1|||
161708783|NCT00552110|583977450|FG000|Overall Study|Serious or Life-Threatening AE|0|||
161708784|NCT00552110|583977451|FG001|Overall Study|Serious or Life-Threatening AE|0|||
161708785|NCT00552110|583977452|FG002|Overall Study|Serious or Life-Threatening AE|1|||
161708786|NCT00552110|583977453|FG003|Overall Study|Serious or Life-Threatening AE|0|||
161708787|NCT00552110|583977454|FG004|Overall Study|Serious or Life-Threatening AE|0|||
161708788|NCT00552110|583977450|FG000|Overall Study|Lack of Efficacy|1|||
161708789|NCT00552110|583977451|FG001|Overall Study|Lack of Efficacy|0|||
161708790|NCT00552110|583977452|FG002|Overall Study|Lack of Efficacy|0|||
161708791|NCT00552110|583977453|FG003|Overall Study|Lack of Efficacy|1|||
161708792|NCT00552110|583977454|FG004|Overall Study|Lack of Efficacy|4|||
161708793|NCT00552110|583977450|FG000|Overall Study|Withdrawal by Subject|0|||
161708794|NCT00552110|583977451|FG001|Overall Study|Withdrawal by Subject|2|||
161708795|NCT00552110|583977452|FG002|Overall Study|Withdrawal by Subject|0|||
161958484|NCT04439539|584894928|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
161958485|NCT04439539|584894929|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
161958486|NCT04439539|584894930|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
161958487|NCT04439539|584894928|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
161958488|NCT04439539|584894929|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
161958489|NCT04439539|584894930|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
161958490|NCT04439539|584894928|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
161958491|NCT04439539|584894929|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
161958492|NCT04439539|584894930|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
161958493|NCT02013778|584894933|FG000|Overall Study|Death|4|||
161958494|NCT02013778|584894933|FG000|Overall Study|Withdrawal by Subject|1|||
161958495|NCT02013778|584894933|FG000|Overall Study|Physician Decision|1|||
161958496|NCT02013778|584894933|FG000|Overall Study|Adverse Event|1|||
161958497|NCT02719691|584894934|FG000|Overall Study|Physician Decision|0|||
161958498|NCT02719691|584894935|FG001|Overall Study|Physician Decision|0|||
161958499|NCT02719691|584894936|FG002|Overall Study|Physician Decision|1|||
161958500|NCT02719691|584894937|FG003|Overall Study|Physician Decision|0|||
161958501|NCT02719691|584894938|FG004|Overall Study|Physician Decision|0|||
161958502|NCT02719691|584894939|FG005|Overall Study|Physician Decision|0|||
161708796|NCT00552110|583977453|FG003|Overall Study|Withdrawal by Subject|3|||
161708797|NCT00552110|583977454|FG004|Overall Study|Withdrawal by Subject|2|||
161708798|NCT00552110|583977450|FG000|Overall Study|Lost to Follow-up|0|||
161708799|NCT00552110|583977451|FG001|Overall Study|Lost to Follow-up|0|||
161708800|NCT00552110|583977452|FG002|Overall Study|Lost to Follow-up|0|||
161708801|NCT00552110|583977453|FG003|Overall Study|Lost to Follow-up|1|||
161708802|NCT00552110|583977454|FG004|Overall Study|Lost to Follow-up|1|||
161708803|NCT00552110|583977450|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
161708804|NCT00552110|583977451|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
161708805|NCT00552110|583977452|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
161958503|NCT02719691|584894940|FG006|Overall Study|Physician Decision|0|||
161958504|NCT02719691|584894934|FG000|Overall Study|Withdrawal by Subject|0|||
161708806|NCT00552110|583977453|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
161708807|NCT00552110|583977454|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
161708808|NCT00552110|583977450|FG000|Overall Study|Withdrawn per Sponsor|0|||
161708809|NCT00552110|583977451|FG001|Overall Study|Withdrawn per Sponsor|1|||
161708810|NCT00552110|583977452|FG002|Overall Study|Withdrawn per Sponsor|0|||
161708811|NCT00552110|583977453|FG003|Overall Study|Withdrawn per Sponsor|0|||
161708812|NCT00552110|583977454|FG004|Overall Study|Withdrawn per Sponsor|1|||
161708813|NCT00552110|583977450|FG000|Overall Study|Use of Prohibited Medication|1|||
161708814|NCT00552110|583977451|FG001|Overall Study|Use of Prohibited Medication|1|||
161708815|NCT00552110|583977452|FG002|Overall Study|Use of Prohibited Medication|0|||
161708816|NCT00552110|583977453|FG003|Overall Study|Use of Prohibited Medication|0|||
161708817|NCT00552110|583977454|FG004|Overall Study|Use of Prohibited Medication|0|||
161708818|NCT00552110|583977450|FG000|Overall Study|Delay of Study due to Relabeling|0|||
161708819|NCT00552110|583977451|FG001|Overall Study|Delay of Study due to Relabeling|0|||
161708820|NCT00552110|583977452|FG002|Overall Study|Delay of Study due to Relabeling|0|||
161708821|NCT00552110|583977453|FG003|Overall Study|Delay of Study due to Relabeling|1|||
161708822|NCT00552110|583977454|FG004|Overall Study|Delay of Study due to Relabeling|0|||
161708823|NCT00552110|583977450|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
161708824|NCT00552110|583977451|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
161708825|NCT00552110|583977452|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
161708826|NCT00552110|583977453|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
161708827|NCT00552110|583977454|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
161708828|NCT00552110|583977450|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
161708829|NCT00552110|583977451|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
161708830|NCT00552110|583977452|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
161708831|NCT00552110|583977453|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
161708832|NCT00552110|583977454|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
161708833|NCT00700804|583977467|FG000|Overall Study|Withdrawal by Subject|1|||
161708834|NCT00700804|583977468|FG001|Overall Study|Withdrawal by Subject|2|||
161708835|NCT00700804|583977467|FG000|Overall Study|Protocol Violation|1|||
161708836|NCT00700804|583977468|FG001|Overall Study|Protocol Violation|1|||
161708837|NCT00700804|583977467|FG000|Overall Study|Loose Stools|1|||
161708838|NCT00700804|583977468|FG001|Overall Study|Loose Stools|1|||
161708839|NCT02901431|583977469|FG000|PK Part|Adverse Event|0|||
161708840|NCT02901431|583977470|FG001|PK Part|Adverse Event|1|||
161708841|NCT02901431|583977471|FG002|PK Part|Adverse Event|0|||
161708842|NCT02901431|583977472|FG003|PK Part|Adverse Event|0|||
161708843|NCT02901431|583977473|FG004|PK Part|Adverse Event|0|||
161708844|NCT02901431|583977474|FG005|PK Part|Adverse Event|0|||
161708845|NCT02901431|583977475|FG006|PK Part|Adverse Event|0|||
161708846|NCT02901431|583977476|FG007|PK Part|Adverse Event|0|||
161708847|NCT02901431|583977477|FG008|PK Part|Adverse Event|0|||
161708848|NCT02901431|583977478|FG009|PK Part|Adverse Event|0|||
161708849|NCT02901431|583977479|FG010|PK Part|Adverse Event|0|||
161708850|NCT02901431|583977480|FG011|PK Part|Adverse Event|0|||
161708851|NCT02901431|583977481|FG012|PK Part|Adverse Event|0|||
161708852|NCT02901431|583977469|FG000|PK Part|Lost to Follow-up|0|||
161708853|NCT02901431|583977470|FG001|PK Part|Lost to Follow-up|0|||
161708854|NCT02901431|583977471|FG002|PK Part|Lost to Follow-up|1|||
161708855|NCT02901431|583977472|FG003|PK Part|Lost to Follow-up|0|||
161708856|NCT02901431|583977473|FG004|PK Part|Lost to Follow-up|0|||
161708857|NCT02901431|583977474|FG005|PK Part|Lost to Follow-up|0|||
161708858|NCT02901431|583977475|FG006|PK Part|Lost to Follow-up|0|||
161708859|NCT02901431|583977476|FG007|PK Part|Lost to Follow-up|0|||
161708860|NCT02901431|583977477|FG008|PK Part|Lost to Follow-up|0|||
161708861|NCT02901431|583977478|FG009|PK Part|Lost to Follow-up|0|||
161708862|NCT02901431|583977479|FG010|PK Part|Lost to Follow-up|0|||
161708863|NCT02901431|583977480|FG011|PK Part|Lost to Follow-up|0|||
161708864|NCT02901431|583977481|FG012|PK Part|Lost to Follow-up|0|||
161708865|NCT02901431|583977469|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
161708866|NCT02901431|583977470|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708867|NCT02901431|583977471|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161958505|NCT02719691|584894935|FG001|Overall Study|Withdrawal by Subject|0|||
161958506|NCT02719691|584894936|FG002|Overall Study|Withdrawal by Subject|0|||
161958507|NCT02719691|584894937|FG003|Overall Study|Withdrawal by Subject|0|||
161958508|NCT02719691|584894938|FG004|Overall Study|Withdrawal by Subject|0|||
161958509|NCT02719691|584894939|FG005|Overall Study|Withdrawal by Subject|1|||
161708868|NCT02901431|583977472|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161837803|NCT00974974|584450212|FG000|IR CD-LD Dose Adjustment|Various|0|||
161837804|NCT00974974|584450213|FG001|IR CD-LD Dose Adjustment|Various|9|||
161837805|NCT00974974|584450212|FG000|IPX066 Dose Conversion|Adverse Event|23|||
161958510|NCT02719691|584894940|FG006|Overall Study|Withdrawal by Subject|0|||
161708869|NCT02901431|583977473|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708870|NCT02901431|583977474|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708871|NCT02901431|583977475|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708872|NCT02901431|583977476|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708873|NCT02901431|583977477|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708874|NCT02901431|583977478|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708875|NCT02901431|583977479|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708876|NCT02901431|583977480|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708877|NCT02901431|583977481|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161708878|NCT02901431|583977469|FG000|PK Part|Pending dose confirmation|0|||
161708879|NCT02901431|583977470|FG001|PK Part|Pending dose confirmation|1|||
161708880|NCT02901431|583977471|FG002|PK Part|Pending dose confirmation|0|||
161708881|NCT02901431|583977472|FG003|PK Part|Pending dose confirmation|0|||
161708882|NCT02901431|583977473|FG004|PK Part|Pending dose confirmation|0|||
161708883|NCT02901431|583977474|FG005|PK Part|Pending dose confirmation|0|||
161708884|NCT02901431|583977475|FG006|PK Part|Pending dose confirmation|0|||
161708885|NCT02901431|583977476|FG007|PK Part|Pending dose confirmation|0|||
161708886|NCT02901431|583977477|FG008|PK Part|Pending dose confirmation|0|||
161708887|NCT02901431|583977478|FG009|PK Part|Pending dose confirmation|0|||
161708888|NCT02901431|583977479|FG010|PK Part|Pending dose confirmation|0|||
161708889|NCT02901431|583977480|FG011|PK Part|Pending dose confirmation|0|||
161708890|NCT02901431|583977481|FG012|PK Part|Pending dose confirmation|0|||
161708891|NCT02901431|583977469|FG000|PK Part|8 weeks of treatment ran out|2|||
161708892|NCT02901431|583977470|FG001|PK Part|8 weeks of treatment ran out|0|||
161708893|NCT02901431|583977471|FG002|PK Part|8 weeks of treatment ran out|0|||
161708894|NCT02901431|583977472|FG003|PK Part|8 weeks of treatment ran out|0|||
161708895|NCT02901431|583977473|FG004|PK Part|8 weeks of treatment ran out|0|||
161708896|NCT02901431|583977474|FG005|PK Part|8 weeks of treatment ran out|0|||
161708897|NCT02901431|583977475|FG006|PK Part|8 weeks of treatment ran out|0|||
161708898|NCT02901431|583977476|FG007|PK Part|8 weeks of treatment ran out|0|||
161708899|NCT02901431|583977477|FG008|PK Part|8 weeks of treatment ran out|0|||
161708900|NCT02901431|583977478|FG009|PK Part|8 weeks of treatment ran out|0|||
161708901|NCT02901431|583977479|FG010|PK Part|8 weeks of treatment ran out|0|||
161708902|NCT02901431|583977480|FG011|PK Part|8 weeks of treatment ran out|0|||
161708903|NCT02901431|583977481|FG012|PK Part|8 weeks of treatment ran out|0|||
161708904|NCT02901431|583977469|FG000|PK Part|Stopped treatment after 8 weeks|1|||
161708905|NCT02901431|583977470|FG001|PK Part|Stopped treatment after 8 weeks|0|||
161708906|NCT02901431|583977471|FG002|PK Part|Stopped treatment after 8 weeks|1|||
161708907|NCT02901431|583977472|FG003|PK Part|Stopped treatment after 8 weeks|0|||
161708908|NCT02901431|583977473|FG004|PK Part|Stopped treatment after 8 weeks|0|||
161708909|NCT02901431|583977474|FG005|PK Part|Stopped treatment after 8 weeks|0|||
161708910|NCT02901431|583977475|FG006|PK Part|Stopped treatment after 8 weeks|0|||
161708911|NCT02901431|583977476|FG007|PK Part|Stopped treatment after 8 weeks|0|||
161708912|NCT02901431|583977477|FG008|PK Part|Stopped treatment after 8 weeks|0|||
161708913|NCT02901431|583977478|FG009|PK Part|Stopped treatment after 8 weeks|0|||
161708914|NCT02901431|583977479|FG010|PK Part|Stopped treatment after 8 weeks|0|||
161708915|NCT02901431|583977480|FG011|PK Part|Stopped treatment after 8 weeks|0|||
161708916|NCT02901431|583977481|FG012|PK Part|Stopped treatment after 8 weeks|0|||
161708917|NCT02901431|583977469|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
161708918|NCT02901431|583977470|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708919|NCT02901431|583977471|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
161708920|NCT02901431|583977472|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708921|NCT02901431|583977473|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708922|NCT02901431|583977474|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708923|NCT02901431|583977475|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708924|NCT02901431|583977476|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708925|NCT02901431|583977477|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708926|NCT02901431|583977478|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708927|NCT02901431|583977479|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708928|NCT02901431|583977480|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708929|NCT02901431|583977481|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161708930|NCT02901431|583977469|FG000|PK Part|Discontinued per Sponsor|0|||
161708931|NCT02901431|583977470|FG001|PK Part|Discontinued per Sponsor|3|||
161708932|NCT02901431|583977471|FG002|PK Part|Discontinued per Sponsor|0|||
161708933|NCT02901431|583977472|FG003|PK Part|Discontinued per Sponsor|0|||
161708934|NCT02901431|583977473|FG004|PK Part|Discontinued per Sponsor|0|||
161708935|NCT02901431|583977474|FG005|PK Part|Discontinued per Sponsor|0|||
161708936|NCT02901431|583977475|FG006|PK Part|Discontinued per Sponsor|0|||
161708937|NCT02901431|583977476|FG007|PK Part|Discontinued per Sponsor|0|||
161708938|NCT02901431|583977477|FG008|PK Part|Discontinued per Sponsor|0|||
161708939|NCT02901431|583977478|FG009|PK Part|Discontinued per Sponsor|0|||
161708940|NCT02901431|583977479|FG010|PK Part|Discontinued per Sponsor|0|||
161708941|NCT02901431|583977480|FG011|PK Part|Discontinued per Sponsor|0|||
161708942|NCT02901431|583977481|FG012|PK Part|Discontinued per Sponsor|0|||
161708943|NCT02901431|583977469|FG000|PK Part|Withdrawal by Subject|1|||
161708944|NCT02901431|583977470|FG001|PK Part|Withdrawal by Subject|1|||
161708945|NCT02901431|583977471|FG002|PK Part|Withdrawal by Subject|3|||
161708946|NCT02901431|583977472|FG003|PK Part|Withdrawal by Subject|0|||
161708947|NCT02901431|583977473|FG004|PK Part|Withdrawal by Subject|0|||
161708948|NCT02901431|583977474|FG005|PK Part|Withdrawal by Subject|0|||
161708949|NCT02901431|583977475|FG006|PK Part|Withdrawal by Subject|0|||
161708950|NCT02901431|583977476|FG007|PK Part|Withdrawal by Subject|0|||
161708951|NCT02901431|583977477|FG008|PK Part|Withdrawal by Subject|0|||
161708952|NCT02901431|583977478|FG009|PK Part|Withdrawal by Subject|0|||
161708953|NCT02901431|583977479|FG010|PK Part|Withdrawal by Subject|0|||
161708954|NCT02901431|583977480|FG011|PK Part|Withdrawal by Subject|0|||
161708955|NCT02901431|583977481|FG012|PK Part|Withdrawal by Subject|0|||
161708956|NCT02901431|583977469|FG000|Main Treatment Part|Adverse Event|0|||
161958511|NCT00861757|584894943|FG000|Overall Study|Adverse Event|1|||
161958512|NCT00861757|584894944|FG001|Overall Study|Adverse Event|5|||
161958513|NCT00861757|584894945|FG002|Overall Study|Adverse Event|7|||
161958514|NCT00861757|584894946|FG003|Overall Study|Adverse Event|2|||
161708957|NCT02901431|583977470|FG001|Main Treatment Part|Adverse Event|0|||
161708958|NCT02901431|583977471|FG002|Main Treatment Part|Adverse Event|0|||
161708959|NCT02901431|583977472|FG003|Main Treatment Part|Adverse Event|3|||
161708960|NCT02901431|583977473|FG004|Main Treatment Part|Adverse Event|3|||
161708961|NCT02901431|583977474|FG005|Main Treatment Part|Adverse Event|4|||
161708962|NCT02901431|583977475|FG006|Main Treatment Part|Adverse Event|1|||
161708963|NCT02901431|583977476|FG007|Main Treatment Part|Adverse Event|0|||
161708964|NCT02901431|583977477|FG008|Main Treatment Part|Adverse Event|0|||
161708965|NCT02901431|583977478|FG009|Main Treatment Part|Adverse Event|0|||
161708966|NCT02901431|583977479|FG010|Main Treatment Part|Adverse Event|0|||
161708967|NCT02901431|583977480|FG011|Main Treatment Part|Adverse Event|0|||
161708968|NCT02901431|583977481|FG012|Main Treatment Part|Adverse Event|0|||
161708969|NCT02901431|583977469|FG000|Main Treatment Part|Lack of Efficacy|0|||
161708970|NCT02901431|583977470|FG001|Main Treatment Part|Lack of Efficacy|0|||
161708971|NCT02901431|583977471|FG002|Main Treatment Part|Lack of Efficacy|0|||
161708972|NCT02901431|583977472|FG003|Main Treatment Part|Lack of Efficacy|1|||
161708973|NCT02901431|583977473|FG004|Main Treatment Part|Lack of Efficacy|0|||
161708974|NCT02901431|583977474|FG005|Main Treatment Part|Lack of Efficacy|0|||
161708975|NCT02901431|583977475|FG006|Main Treatment Part|Lack of Efficacy|0|||
161708976|NCT02901431|583977476|FG007|Main Treatment Part|Lack of Efficacy|0|||
161708977|NCT02901431|583977477|FG008|Main Treatment Part|Lack of Efficacy|0|||
161708978|NCT02901431|583977478|FG009|Main Treatment Part|Lack of Efficacy|0|||
161708979|NCT02901431|583977479|FG010|Main Treatment Part|Lack of Efficacy|0|||
161708980|NCT02901431|583977480|FG011|Main Treatment Part|Lack of Efficacy|0|||
161708981|NCT02901431|583977481|FG012|Main Treatment Part|Lack of Efficacy|0|||
161708982|NCT02901431|583977469|FG000|Main Treatment Part|Lost to Follow-up|0|||
161708983|NCT02901431|583977470|FG001|Main Treatment Part|Lost to Follow-up|0|||
161708984|NCT02901431|583977471|FG002|Main Treatment Part|Lost to Follow-up|0|||
161708985|NCT02901431|583977472|FG003|Main Treatment Part|Lost to Follow-up|3|||
161708986|NCT02901431|583977473|FG004|Main Treatment Part|Lost to Follow-up|1|||
161708987|NCT02901431|583977474|FG005|Main Treatment Part|Lost to Follow-up|2|||
161708988|NCT02901431|583977475|FG006|Main Treatment Part|Lost to Follow-up|3|||
161708989|NCT02901431|583977476|FG007|Main Treatment Part|Lost to Follow-up|0|||
161708990|NCT02901431|583977477|FG008|Main Treatment Part|Lost to Follow-up|0|||
161708991|NCT02901431|583977478|FG009|Main Treatment Part|Lost to Follow-up|0|||
161708992|NCT02901431|583977479|FG010|Main Treatment Part|Lost to Follow-up|0|||
161708993|NCT02901431|583977480|FG011|Main Treatment Part|Lost to Follow-up|0|||
161708994|NCT02901431|583977481|FG012|Main Treatment Part|Lost to Follow-up|0|||
161708995|NCT02901431|583977469|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
161708996|NCT02901431|583977470|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
161708997|NCT02901431|583977471|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
161708998|NCT02901431|583977472|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
161708999|NCT02901431|583977473|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
161709000|NCT02901431|583977474|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
161709001|NCT02901431|583977475|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
161709002|NCT02901431|583977476|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
161709003|NCT02901431|583977477|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
161709004|NCT02901431|583977478|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
161709005|NCT02901431|583977479|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
161709006|NCT02901431|583977480|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
161709007|NCT02901431|583977481|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
161709008|NCT02901431|583977469|FG000|Main Treatment Part|Physician Decision|0|||
161709009|NCT02901431|583977470|FG001|Main Treatment Part|Physician Decision|0|||
161709010|NCT02901431|583977471|FG002|Main Treatment Part|Physician Decision|0|||
161709011|NCT02901431|583977472|FG003|Main Treatment Part|Physician Decision|1|||
161958515|NCT00861757|584894943|FG000|Overall Study|Entry Criteria Not Met|1|||
161709012|NCT02901431|583977473|FG004|Main Treatment Part|Physician Decision|0|||
161709013|NCT02901431|583977474|FG005|Main Treatment Part|Physician Decision|0|||
161709014|NCT02901431|583977475|FG006|Main Treatment Part|Physician Decision|1|||
161709015|NCT02901431|583977476|FG007|Main Treatment Part|Physician Decision|0|||
161709016|NCT02901431|583977477|FG008|Main Treatment Part|Physician Decision|0|||
161709017|NCT02901431|583977478|FG009|Main Treatment Part|Physician Decision|0|||
161709018|NCT02901431|583977479|FG010|Main Treatment Part|Physician Decision|0|||
161709019|NCT02901431|583977480|FG011|Main Treatment Part|Physician Decision|0|||
161709020|NCT02901431|583977481|FG012|Main Treatment Part|Physician Decision|0|||
161709021|NCT02901431|583977469|FG000|Main Treatment Part|Withdrawal by Subject|0|||
161709022|NCT02901431|583977470|FG001|Main Treatment Part|Withdrawal by Subject|0|||
161958516|NCT00861757|584894944|FG001|Overall Study|Entry Criteria Not Met|2|||
161709023|NCT02901431|583977471|FG002|Main Treatment Part|Withdrawal by Subject|0|||
161709024|NCT02901431|583977472|FG003|Main Treatment Part|Withdrawal by Subject|18|||
161709025|NCT02901431|583977473|FG004|Main Treatment Part|Withdrawal by Subject|3|||
161709026|NCT02901431|583977474|FG005|Main Treatment Part|Withdrawal by Subject|5|||
161709027|NCT02901431|583977475|FG006|Main Treatment Part|Withdrawal by Subject|6|||
161709028|NCT02901431|583977476|FG007|Main Treatment Part|Withdrawal by Subject|0|||
161709029|NCT02901431|583977477|FG008|Main Treatment Part|Withdrawal by Subject|0|||
161709030|NCT02901431|583977478|FG009|Main Treatment Part|Withdrawal by Subject|0|||
161709031|NCT02901431|583977479|FG010|Main Treatment Part|Withdrawal by Subject|0|||
161709032|NCT02901431|583977480|FG011|Main Treatment Part|Withdrawal by Subject|0|||
161709033|NCT02901431|583977481|FG012|Main Treatment Part|Withdrawal by Subject|0|||
161709034|NCT02901431|583977469|FG000|Open Label Part|Adverse Event|0|||
161709035|NCT02901431|583977470|FG001|Open Label Part|Adverse Event|0|||
161709036|NCT02901431|583977471|FG002|Open Label Part|Adverse Event|0|||
161709037|NCT02901431|583977472|FG003|Open Label Part|Adverse Event|0|||
161709038|NCT02901431|583977473|FG004|Open Label Part|Adverse Event|0|||
161709039|NCT02901431|583977474|FG005|Open Label Part|Adverse Event|0|||
161709040|NCT02901431|583977475|FG006|Open Label Part|Adverse Event|0|||
161709041|NCT02901431|583977476|FG007|Open Label Part|Adverse Event|0|||
161709042|NCT02901431|583977477|FG008|Open Label Part|Adverse Event|4|||
161709043|NCT02901431|583977478|FG009|Open Label Part|Adverse Event|4|||
161709044|NCT02901431|583977479|FG010|Open Label Part|Adverse Event|0|||
161709045|NCT02901431|583977480|FG011|Open Label Part|Adverse Event|4|||
161709046|NCT02901431|583977481|FG012|Open Label Part|Adverse Event|1|||
161709047|NCT02901431|583977469|FG000|Open Label Part|Lost to Follow-up|0|||
161709048|NCT02901431|583977470|FG001|Open Label Part|Lost to Follow-up|0|||
161709049|NCT02901431|583977471|FG002|Open Label Part|Lost to Follow-up|0|||
161709050|NCT02901431|583977472|FG003|Open Label Part|Lost to Follow-up|0|||
161709051|NCT02901431|583977473|FG004|Open Label Part|Lost to Follow-up|0|||
161709052|NCT02901431|583977474|FG005|Open Label Part|Lost to Follow-up|0|||
161709053|NCT02901431|583977475|FG006|Open Label Part|Lost to Follow-up|0|||
161709054|NCT02901431|583977476|FG007|Open Label Part|Lost to Follow-up|0|||
161709055|NCT02901431|583977477|FG008|Open Label Part|Lost to Follow-up|2|||
161709056|NCT02901431|583977478|FG009|Open Label Part|Lost to Follow-up|2|||
161709057|NCT02901431|583977479|FG010|Open Label Part|Lost to Follow-up|1|||
161709058|NCT02901431|583977480|FG011|Open Label Part|Lost to Follow-up|1|||
161709059|NCT02901431|583977481|FG012|Open Label Part|Lost to Follow-up|1|||
161709060|NCT02901431|583977469|FG000|Open Label Part|Physician Decision|0|||
161709061|NCT02901431|583977470|FG001|Open Label Part|Physician Decision|0|||
161709062|NCT02901431|583977471|FG002|Open Label Part|Physician Decision|0|||
161709063|NCT02901431|583977472|FG003|Open Label Part|Physician Decision|0|||
161709064|NCT02901431|583977473|FG004|Open Label Part|Physician Decision|0|||
161709065|NCT02901431|583977474|FG005|Open Label Part|Physician Decision|0|||
161709066|NCT02901431|583977475|FG006|Open Label Part|Physician Decision|0|||
161709067|NCT02901431|583977476|FG007|Open Label Part|Physician Decision|0|||
161709068|NCT02901431|583977477|FG008|Open Label Part|Physician Decision|1|||
161709069|NCT02901431|583977478|FG009|Open Label Part|Physician Decision|1|||
161709070|NCT02901431|583977479|FG010|Open Label Part|Physician Decision|0|||
161709071|NCT02901431|583977480|FG011|Open Label Part|Physician Decision|0|||
161709072|NCT02901431|583977481|FG012|Open Label Part|Physician Decision|0|||
161709073|NCT02901431|583977469|FG000|Open Label Part|Study Terminated By Sponsor|0|||
161709074|NCT02901431|583977470|FG001|Open Label Part|Study Terminated By Sponsor|0|||
161709075|NCT02901431|583977471|FG002|Open Label Part|Study Terminated By Sponsor|0|||
161709076|NCT02901431|583977472|FG003|Open Label Part|Study Terminated By Sponsor|0|||
161709077|NCT02901431|583977473|FG004|Open Label Part|Study Terminated By Sponsor|0|||
161958517|NCT00861757|584894945|FG002|Overall Study|Entry Criteria Not Met|1|||
161709078|NCT02901431|583977474|FG005|Open Label Part|Study Terminated By Sponsor|0|||
161709079|NCT02901431|583977475|FG006|Open Label Part|Study Terminated By Sponsor|0|||
161709080|NCT02901431|583977476|FG007|Open Label Part|Study Terminated By Sponsor|0|||
161709081|NCT02901431|583977477|FG008|Open Label Part|Study Terminated By Sponsor|35|||
161709082|NCT02901431|583977478|FG009|Open Label Part|Study Terminated By Sponsor|12|||
161709083|NCT02901431|583977479|FG010|Open Label Part|Study Terminated By Sponsor|21|||
161709084|NCT02901431|583977480|FG011|Open Label Part|Study Terminated By Sponsor|31|||
161958518|NCT00861757|584894946|FG003|Overall Study|Entry Criteria Not Met|1|||
161958519|NCT00861757|584894943|FG000|Overall Study|Lack of Efficacy|3|||
161709085|NCT02901431|583977481|FG012|Open Label Part|Study Terminated By Sponsor|0|||
161709086|NCT02901431|583977469|FG000|Open Label Part|Withdrawal by Subject|0|||
161709087|NCT02901431|583977470|FG001|Open Label Part|Withdrawal by Subject|0|||
161709088|NCT02901431|583977471|FG002|Open Label Part|Withdrawal by Subject|0|||
161709089|NCT02901431|583977472|FG003|Open Label Part|Withdrawal by Subject|0|||
161709090|NCT02901431|583977473|FG004|Open Label Part|Withdrawal by Subject|0|||
161709091|NCT02901431|583977474|FG005|Open Label Part|Withdrawal by Subject|0|||
161709092|NCT02901431|583977475|FG006|Open Label Part|Withdrawal by Subject|0|||
161958520|NCT00861757|584894944|FG001|Overall Study|Lack of Efficacy|1|||
161709093|NCT02901431|583977476|FG007|Open Label Part|Withdrawal by Subject|0|||
161709094|NCT02901431|583977477|FG008|Open Label Part|Withdrawal by Subject|6|||
161709095|NCT02901431|583977478|FG009|Open Label Part|Withdrawal by Subject|5|||
161709096|NCT02901431|583977479|FG010|Open Label Part|Withdrawal by Subject|7|||
161709097|NCT02901431|583977480|FG011|Open Label Part|Withdrawal by Subject|3|||
161709098|NCT02901431|583977481|FG012|Open Label Part|Withdrawal by Subject|1|||
161709099|NCT02500537|583977482|FG000|Overall Study|Death|2|||
161709100|NCT02500537|583977483|FG001|Overall Study|Death|0|||
161709101|NCT02500537|583977482|FG000|Overall Study|Lost to Follow-up|0|||
161709102|NCT02500537|583977483|FG001|Overall Study|Lost to Follow-up|1|||
161709103|NCT02500537|583977482|FG000|Overall Study|Withdrawal by Subject|1|||
161709104|NCT02500537|583977483|FG001|Overall Study|Withdrawal by Subject|0|||
161709105|NCT03832387|583977486|FG000|Overall Study|Protocol Violation|2|||
161709106|NCT03832387|583977487|FG001|Overall Study|Protocol Violation|6|||
161709107|NCT03832387|583977486|FG000|Overall Study|EXCLUSION CRITERIA|3|||
161709108|NCT03832387|583977487|FG001|Overall Study|EXCLUSION CRITERIA|1|||
161709109|NCT00355121|583977488|FG000|Overall Study|Did not receive study vaccine|1|||
161709110|NCT00355121|583977489|FG001|Overall Study|Did not receive study vaccine|0|||
161709111|NCT00355121|583977490|FG002|Overall Study|Did not receive study vaccine|1|||
161709112|NCT00355121|583977488|FG000|Overall Study|Adverse Event|0|||
161709113|NCT00355121|583977489|FG001|Overall Study|Adverse Event|1|||
161709114|NCT00355121|583977490|FG002|Overall Study|Adverse Event|0|||
161709115|NCT00355121|583977488|FG000|Overall Study|Protocol Violation|7|||
161709116|NCT00355121|583977489|FG001|Overall Study|Protocol Violation|9|||
161709117|NCT00355121|583977490|FG002|Overall Study|Protocol Violation|1|||
161709118|NCT00355121|583977488|FG000|Overall Study|Lost to Follow-up|4|||
161709119|NCT00355121|583977489|FG001|Overall Study|Lost to Follow-up|7|||
161709120|NCT00355121|583977490|FG002|Overall Study|Lost to Follow-up|1|||
161709121|NCT00355121|583977488|FG000|Overall Study|Withdrawal by Subject|9|||
161709122|NCT00355121|583977489|FG001|Overall Study|Withdrawal by Subject|10|||
161709123|NCT00355121|583977490|FG002|Overall Study|Withdrawal by Subject|2|||
161709124|NCT00355121|583977488|FG000|Overall Study|Serious adverse events|0|||
161709125|NCT00355121|583977489|FG001|Overall Study|Serious adverse events|2|||
161709126|NCT00355121|583977490|FG002|Overall Study|Serious adverse events|0|||
161709127|NCT00784758|583977491|FG000|Overall Study|Withdrawal by Subject|3|||
161709128|NCT00784758|583977492|FG001|Overall Study|Withdrawal by Subject|0|||
161709129|NCT00784758|583977491|FG000|Overall Study|Adverse Event|1|||
161709130|NCT00784758|583977492|FG001|Overall Study|Adverse Event|0|||
161709131|NCT05775289|583977493|FG000|Overall Study|Study Ongoing|20|||
161709132|NCT05775289|583977494|FG001|Overall Study|Study Ongoing|53|||
161709133|NCT05775289|583977495|FG002|Overall Study|Study Ongoing|15|||
161709134|NCT05775289|583977496|FG003|Overall Study|Study Ongoing|55|||
161709135|NCT05775289|583977493|FG000|Overall Study|Death|4|||
161709136|NCT05775289|583977494|FG001|Overall Study|Death|11|||
161709137|NCT05775289|583977495|FG002|Overall Study|Death|8|||
161709138|NCT05775289|583977496|FG003|Overall Study|Death|12|||
161709139|NCT05775289|583977493|FG000|Overall Study|Lost to Follow-up|0|||
161709140|NCT05775289|583977494|FG001|Overall Study|Lost to Follow-up|1|||
161709141|NCT05775289|583977495|FG002|Overall Study|Lost to Follow-up|0|||
161709142|NCT05775289|583977496|FG003|Overall Study|Lost to Follow-up|0|||
161709143|NCT05775289|583977493|FG000|Overall Study|Progressive Disease|0|||
161709144|NCT05775289|583977494|FG001|Overall Study|Progressive Disease|0|||
161709145|NCT05775289|583977495|FG002|Overall Study|Progressive Disease|1|||
161709146|NCT05775289|583977496|FG003|Overall Study|Progressive Disease|0|||
161709147|NCT05775289|583977493|FG000|Overall Study|Withdrawal by Subject|1|||
161709148|NCT05775289|583977494|FG001|Overall Study|Withdrawal by Subject|1|||
161709149|NCT05775289|583977495|FG002|Overall Study|Withdrawal by Subject|0|||
161709150|NCT05775289|583977496|FG003|Overall Study|Withdrawal by Subject|0|||
161709151|NCT02330419|583977501|FG000|Overall Study|Lost to Follow-up|3|||
161709152|NCT02330419|583977502|FG001|Overall Study|Lost to Follow-up|7|||
161709153|NCT00215150|583980123|FG000|Open Label Phase|Lost to Follow-up|7|||
161709154|NCT00215150|583980123|FG000|Open Label Phase|Withdrawal by Subject|1|||
161709155|NCT00215150|583980123|FG000|Open Label Phase|Did not complete a post base visit|13|||
161709156|NCT00215150|583980123|FG000|Open Label Phase|Did not meet randomization criteria|9|||
161709157|NCT00215150|583980123|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
161709158|NCT00215150|583980123|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
161709159|NCT00215150|583980123|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
161709160|NCT02091440|583980127|FG000|Overall Study|Death|2|||
161709161|NCT00278629|583980134|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
161709162|NCT03323749|583980135|FG000|Double-blind Period|Lost to Follow-up|4|||
161709163|NCT03323749|583980136|FG001|Double-blind Period|Lost to Follow-up|5|||
161709164|NCT03323749|583980135|FG000|Double-blind Period|Adverse Event|3|||
161709165|NCT03323749|583980136|FG001|Double-blind Period|Adverse Event|1|||
161709166|NCT03323749|583980135|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
161709167|NCT03323749|583980136|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
161709168|NCT03323749|583980135|FG000|Open-Label Period|Adverse Event|3|||
161709169|NCT03323749|583980136|FG001|Open-Label Period|Adverse Event|10|||
161709170|NCT03323749|583980135|FG000|Open-Label Period|Withdrawal by Subject|7|||
161709171|NCT03323749|583980136|FG001|Open-Label Period|Withdrawal by Subject|5|||
161709172|NCT01821963|583980137|FG000|Overall Study|Adverse Event|1|||
161709173|NCT00783289|583980138|FG000|Overall Study|Protocol Violation|0|||
161709174|NCT00783289|583980139|FG001|Overall Study|Protocol Violation|1|||
161709175|NCT00783289|583980140|FG002|Overall Study|Protocol Violation|0|||
161709176|NCT00783289|583980141|FG003|Overall Study|Protocol Violation|0|||
161709177|NCT00506389|583980142|FG000|In-treatment Period|Other|3|||
161709178|NCT00506389|583980143|FG001|In-treatment Period|Other|3|||
161709179|NCT00506389|583980144|FG002|In-treatment Period|Other|4|||
161709180|NCT00506389|583980142|FG000|In-treatment Period|Lost to Follow-up|0|||
161709181|NCT00506389|583980143|FG001|In-treatment Period|Lost to Follow-up|0|||
161709182|NCT00506389|583980144|FG002|In-treatment Period|Lost to Follow-up|1|||
161709183|NCT00506389|583980142|FG000|In-treatment Period|Lack of compliance|1|||
161709184|NCT00506389|583980143|FG001|In-treatment Period|Lack of compliance|0|||
161709185|NCT00506389|583980144|FG002|In-treatment Period|Lack of compliance|0|||
161709186|NCT00506389|583980142|FG000|In-treatment Period|Reasons not related to trial|4|||
161709187|NCT00506389|583980143|FG001|In-treatment Period|Reasons not related to trial|1|||
161709188|NCT00506389|583980144|FG002|In-treatment Period|Reasons not related to trial|0|||
161709189|NCT00506389|583980142|FG000|In-treatment Period|Withdrawal by Subject|3|||
161709190|NCT00506389|583980143|FG001|In-treatment Period|Withdrawal by Subject|3|||
161709191|NCT00506389|583980144|FG002|In-treatment Period|Withdrawal by Subject|4|||
161709192|NCT00506389|583980142|FG000|In-treatment Period|Lack of Efficacy|0|||
161709193|NCT00506389|583980143|FG001|In-treatment Period|Lack of Efficacy|2|||
161709194|NCT00506389|583980144|FG002|In-treatment Period|Lack of Efficacy|0|||
161709195|NCT00506389|583980142|FG000|In-treatment Period|Adverse Event|11|||
161709196|NCT00506389|583980143|FG001|In-treatment Period|Adverse Event|5|||
161709197|NCT00506389|583980144|FG002|In-treatment Period|Adverse Event|2|||
161709198|NCT00506389|583980142|FG000|In-treatment Period|Randomized but not treated|4|||
161709199|NCT00506389|583980143|FG001|In-treatment Period|Randomized but not treated|1|||
161709200|NCT00506389|583980144|FG002|In-treatment Period|Randomized but not treated|1|||
161709201|NCT05224258|583980146|FG000|Overall Study|Withdrawal by Subject|1|||
161709202|NCT05224258|583980147|FG001|Overall Study|Withdrawal by Subject|1|||
161709203|NCT05224258|583980146|FG000|Overall Study|Physician Decision|1|||
161709204|NCT05224258|583980147|FG001|Overall Study|Physician Decision|1|||
161709205|NCT05224258|583980146|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161709206|NCT05224258|583980147|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161709207|NCT05224258|583980146|FG000|Overall Study|Study Product No Longer in Use|1|||
161709208|NCT05224258|583980147|FG001|Overall Study|Study Product No Longer in Use|0|||
161709209|NCT05224258|583980146|FG000|Overall Study|Adverse Event|0|||
161709210|NCT05224258|583980147|FG001|Overall Study|Adverse Event|1|||
161709211|NCT05224258|583980146|FG000|Overall Study|Protocol Deviation|0|||
161709212|NCT05224258|583980147|FG001|Overall Study|Protocol Deviation|1|||
161709213|NCT03095703|583980149|FG000|Overall Study|Withdrawal by Subject|1|||
161709214|NCT03539432|583980150|FG000|Overall Study|Lost to Follow-up|0|||
161709215|NCT03539432|583980151|FG001|Overall Study|Lost to Follow-up|1|||
161709216|NCT01381094|583980152|FG000|Overall Study|Adverse Event|1|||
161709217|NCT01381094|583980153|FG001|Overall Study|Adverse Event|2|||
161709218|NCT01381094|583980154|FG002|Overall Study|Adverse Event|0|||
161709219|NCT01381094|583980155|FG003|Overall Study|Adverse Event|1|||
161709220|NCT01381094|583980156|FG004|Overall Study|Adverse Event|0|||
161709221|NCT01381094|583980152|FG000|Overall Study|Lost to Follow-up|0|||
161709222|NCT01381094|583980153|FG001|Overall Study|Lost to Follow-up|0|||
161709223|NCT01381094|583980154|FG002|Overall Study|Lost to Follow-up|0|||
161709224|NCT01381094|583980155|FG003|Overall Study|Lost to Follow-up|0|||
161709225|NCT01381094|583980156|FG004|Overall Study|Lost to Follow-up|1|||
161709226|NCT01381094|583980152|FG000|Overall Study|Withdrawal of informed consent|0|||
161709227|NCT01381094|583980153|FG001|Overall Study|Withdrawal of informed consent|1|||
161709228|NCT01381094|583980154|FG002|Overall Study|Withdrawal of informed consent|0|||
161709229|NCT01381094|583980155|FG003|Overall Study|Withdrawal of informed consent|0|||
161709230|NCT01381094|583980156|FG004|Overall Study|Withdrawal of informed consent|0|||
161709231|NCT01381094|583980152|FG000|Overall Study|Participant given Aranesp injection|1|||
161709232|NCT01381094|583980153|FG001|Overall Study|Participant given Aranesp injection|0|||
161709233|NCT01381094|583980154|FG002|Overall Study|Participant given Aranesp injection|0|||
161709234|NCT01381094|583980155|FG003|Overall Study|Participant given Aranesp injection|0|||
161709235|NCT01381094|583980156|FG004|Overall Study|Participant given Aranesp injection|0|||
161709236|NCT02443402|583980159|FG000|Overall Study|Withdrawal by Subject|3|||
161709237|NCT02443402|583980160|FG001|Overall Study|Withdrawal by Subject|1|||
161709238|NCT02443402|583980159|FG000|Overall Study|Screen Failure|1|||
161709239|NCT02443402|583980160|FG001|Overall Study|Screen Failure|2|||
161709240|NCT01934504|583980162|FG000|Overall Study|Protocol Deviation|0|||
161709241|NCT01934504|583980163|FG001|Overall Study|Protocol Deviation|0|||
161709242|NCT01934504|583980164|FG002|Overall Study|Protocol Deviation|0|||
161709243|NCT01934504|583980165|FG003|Overall Study|Protocol Deviation|2|||
161709244|NCT01934504|583980162|FG000|Overall Study|Study Terminated by Sponsor|1|||
161709245|NCT01934504|583980163|FG001|Overall Study|Study Terminated by Sponsor|0|||
161709246|NCT01934504|583980164|FG002|Overall Study|Study Terminated by Sponsor|5|||
161709247|NCT01934504|583980165|FG003|Overall Study|Study Terminated by Sponsor|5|||
161709248|NCT02665689|583980166|FG000|Overall Study|Adverse Event|1|||
161709249|NCT02665689|583980167|FG001|Overall Study|Adverse Event|0|||
161709250|NCT02665689|583980166|FG000|Overall Study|Trial termination|1|||
161709251|NCT02665689|583980167|FG001|Overall Study|Trial termination|1|||
161709252|NCT02665689|583980166|FG000|Overall Study|Lost to Follow-up|0|||
161709253|NCT02665689|583980167|FG001|Overall Study|Lost to Follow-up|1|||
161709254|NCT00996840|583980174|FG000|Overall Study|Adverse Event|0|||
161709255|NCT00996840|583980175|FG001|Overall Study|Adverse Event|1|||
161709256|NCT00996840|583980176|FG002|Overall Study|Adverse Event|0|||
161709257|NCT00996840|583980177|FG003|Overall Study|Adverse Event|0|||
161709258|NCT00996840|583980178|FG004|Overall Study|Adverse Event|0|||
161709259|NCT00996840|583980174|FG000|Overall Study|Physician Decision|0|||
161709260|NCT00996840|583980175|FG001|Overall Study|Physician Decision|0|||
161709261|NCT00996840|583980176|FG002|Overall Study|Physician Decision|1|||
161709262|NCT00996840|583980177|FG003|Overall Study|Physician Decision|1|||
161709263|NCT00996840|583980178|FG004|Overall Study|Physician Decision|2|||
161709264|NCT00996840|583980174|FG000|Overall Study|Withdrawal by Subject|1|||
161709265|NCT00996840|583980175|FG001|Overall Study|Withdrawal by Subject|1|||
161709266|NCT00996840|583980176|FG002|Overall Study|Withdrawal by Subject|0|||
161709267|NCT00996840|583980177|FG003|Overall Study|Withdrawal by Subject|0|||
161709268|NCT00996840|583980178|FG004|Overall Study|Withdrawal by Subject|0|||
161709269|NCT02292849|583980179|FG000|Overall Study|Lost to Follow-up|0|||
161709270|NCT02292849|583980180|FG001|Overall Study|Lost to Follow-up|2|||
161709271|NCT02292849|583980181|FG002|Overall Study|Lost to Follow-up|2|||
161709272|NCT02292849|583980179|FG000|Overall Study|Physician Decision|4|||
161709273|NCT02292849|583980180|FG001|Overall Study|Physician Decision|0|||
161709274|NCT02292849|583980181|FG002|Overall Study|Physician Decision|0|||
161709275|NCT01562028|583980183|FG000|Overall Study|Withdrawal by Subject|1|||
161709276|NCT01562028|583980184|FG001|Overall Study|Withdrawal by Subject|1|||
161709277|NCT01562028|583980183|FG000|Overall Study|Lost to Follow-up|2|||
161709278|NCT01562028|583980184|FG001|Overall Study|Lost to Follow-up|1|||
161709279|NCT04938648|583980185|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
161709280|NCT04938648|583980186|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
161709281|NCT04938648|583980185|FG000|Overall Study|Patient too ill|0|||
161709282|NCT04938648|583980186|FG001|Overall Study|Patient too ill|1|||
161709283|NCT04938648|583980185|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
161709284|NCT04938648|583980186|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
161709285|NCT04938648|583980185|FG000|Overall Study|Patient did not have memory problems|1|||
161709286|NCT04938648|583980186|FG001|Overall Study|Patient did not have memory problems|1|||
161709287|NCT04938648|583980185|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
161709288|NCT04938648|583980186|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
161709289|NCT04938648|583980185|FG000|Overall Study|Care partner could not be reached|0|||
161709290|NCT04938648|583980186|FG001|Overall Study|Care partner could not be reached|1|||
161709291|NCT04938648|583980185|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
161709292|NCT04938648|583980186|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
161709293|NCT04938648|583980185|FG000|Overall Study|Withdrawal by Subject|2|||
161709294|NCT04938648|583980186|FG001|Overall Study|Withdrawal by Subject|1|||
161709295|NCT05127486|583980187|FG000|Overall Study|Adverse Event|2|||
161709296|NCT05127486|583980188|FG001|Overall Study|Adverse Event|4|||
161709297|NCT05127486|583980187|FG000|Overall Study|Lack of Efficacy|1|||
161709298|NCT05127486|583980188|FG001|Overall Study|Lack of Efficacy|0|||
161709299|NCT05127486|583980187|FG000|Overall Study|Pregnancy|0|||
161709300|NCT05127486|583980188|FG001|Overall Study|Pregnancy|1|||
161709301|NCT05127486|583980187|FG000|Overall Study|Physician Decision|4|||
161709302|NCT05127486|583980188|FG001|Overall Study|Physician Decision|1|||
161709303|NCT05127486|583980187|FG000|Overall Study|Withdrawal by Subject|14|||
161709304|NCT05127486|583980188|FG001|Overall Study|Withdrawal by Subject|13|||
161709305|NCT05127486|583980187|FG000|Overall Study|Lost to Follow-up|5|||
161709306|NCT05127486|583980188|FG001|Overall Study|Lost to Follow-up|8|||
161709307|NCT00775021|583980189|FG000|First Intervention|Lost to Follow-up|1|||
161709308|NCT00775021|583980190|FG001|First Intervention|Lost to Follow-up|0|||
161709309|NCT00775021|583980189|FG000|Second Intervention|Adverse Event|0|||
161709310|NCT00775021|583980190|FG001|Second Intervention|Adverse Event|1|||
161709311|NCT01287754|583980191|FG000|Overall Study|Death|2|||
161709312|NCT01287754|583980192|FG001|Overall Study|Death|12|||
161709313|NCT01287754|583980191|FG000|Overall Study|Lost to Follow-up|1|||
161709314|NCT01287754|583980192|FG001|Overall Study|Lost to Follow-up|6|||
161709315|NCT01287754|583980191|FG000|Overall Study|Protocol Violation|0|||
161709316|NCT01287754|583980192|FG001|Overall Study|Protocol Violation|3|||
161709317|NCT04439266|583980203|FG000|Overall Study|Ineligible|1|||
161709318|NCT04439266|583980203|FG000|Overall Study|Adverse Event|1|||
161709319|NCT04439266|583980203|FG000|Overall Study|Death|1|||
161709320|NCT04439266|583980203|FG000|Overall Study|Disease progression|1|||
161709321|NCT04439266|583980203|FG000|Overall Study|Still on treatment|1|||
161709322|NCT05027802|583980205|FG000|Overall Study|Adverse Event|2|||
161709323|NCT05027802|583980205|FG000|Overall Study|Withdrawal by Subject|18|||
161709324|NCT05027802|583980205|FG000|Overall Study|Death|2|||
161709325|NCT05027802|583980205|FG000|Overall Study|Other|1|||
161709326|NCT00001337|583980212|FG000|Overall Study|Switched to alternate treatment|2|||
161709327|NCT00001337|583980213|FG001|Overall Study|Switched to alternate treatment|2|||
161709328|NCT00001337|583980214|FG002|Overall Study|Switched to alternate treatment|0|||
161958521|NCT00861757|584894945|FG002|Overall Study|Lack of Efficacy|0|||
161958522|NCT00861757|584894946|FG003|Overall Study|Lack of Efficacy|1|||
161958523|NCT00861757|584894943|FG000|Overall Study|Lost to Follow-up|1|||
161958524|NCT00861757|584894944|FG001|Overall Study|Lost to Follow-up|0|||
161958525|NCT00861757|584894945|FG002|Overall Study|Lost to Follow-up|1|||
161958526|NCT00861757|584894946|FG003|Overall Study|Lost to Follow-up|1|||
161958527|NCT00861757|584894943|FG000|Overall Study|Physician Decision|0|||
161958528|NCT00861757|584894944|FG001|Overall Study|Physician Decision|0|||
161958529|NCT00861757|584894945|FG002|Overall Study|Physician Decision|0|||
161958530|NCT00861757|584894946|FG003|Overall Study|Physician Decision|1|||
161958531|NCT00861757|584894943|FG000|Overall Study|Protocol Violation|2|||
161958532|NCT00861757|584894944|FG001|Overall Study|Protocol Violation|2|||
161958533|NCT00861757|584894945|FG002|Overall Study|Protocol Violation|4|||
161958534|NCT00861757|584894946|FG003|Overall Study|Protocol Violation|1|||
161958535|NCT00861757|584894943|FG000|Overall Study|Withdrawal by Subject|1|||
161958536|NCT00861757|584894944|FG001|Overall Study|Withdrawal by Subject|5|||
161958537|NCT00861757|584894945|FG002|Overall Study|Withdrawal by Subject|5|||
161958538|NCT00861757|584894946|FG003|Overall Study|Withdrawal by Subject|2|||
161958539|NCT03308968|584894947|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
161958540|NCT03308968|584894948|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
161958541|NCT03308968|584894949|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
161958542|NCT03308968|584894947|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
161958543|NCT03308968|584894948|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
161958544|NCT03308968|584894949|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
161958545|NCT03308968|584894947|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
161958546|NCT03308968|584894948|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
161958547|NCT03308968|584894949|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
161958548|NCT03308968|584894947|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
161958549|NCT03308968|584894948|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
161958550|NCT03308968|584894949|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
161958551|NCT03308968|584894947|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
161958552|NCT03308968|584894948|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
161709329|NCT00001337|583980212|FG000|Overall Study|Refused further treatment|2|||
161709330|NCT00001337|583980213|FG001|Overall Study|Refused further treatment|1|||
161709331|NCT00001337|583980214|FG002|Overall Study|Refused further treatment|0|||
161709332|NCT00001337|583980212|FG000|Overall Study|Began other Tx|1|||
161709333|NCT00001337|583980213|FG001|Overall Study|Began other Tx|0|||
161709334|NCT00001337|583980214|FG002|Overall Study|Began other Tx|0|||
161709335|NCT00001337|583980212|FG000|Overall Study|Physician Decision|3|||
161709336|NCT00001337|583980213|FG001|Overall Study|Physician Decision|1|||
161709337|NCT00001337|583980214|FG002|Overall Study|Physician Decision|0|||
161709338|NCT00001337|583980212|FG000|Overall Study|Doesn't have NHL|0|||
161709339|NCT00001337|583980213|FG001|Overall Study|Doesn't have NHL|1|||
161709340|NCT00001337|583980214|FG002|Overall Study|Doesn't have NHL|0|||
161709341|NCT00001337|583980212|FG000|Overall Study|Non protocol tx needed|3|||
161709342|NCT00001337|583980213|FG001|Overall Study|Non protocol tx needed|1|||
161709343|NCT00001337|583980214|FG002|Overall Study|Non protocol tx needed|0|||
161709344|NCT00001337|583980212|FG000|Overall Study|Protocol change|1|||
161709345|NCT00001337|583980213|FG001|Overall Study|Protocol change|0|||
161709346|NCT00001337|583980214|FG002|Overall Study|Protocol change|0|||
161709347|NCT00001337|583980212|FG000|Overall Study|2nd primary disease|0|||
161709348|NCT00001337|583980213|FG001|Overall Study|2nd primary disease|0|||
161709349|NCT00001337|583980214|FG002|Overall Study|2nd primary disease|1|||
161709350|NCT00001337|583980212|FG000|Overall Study|Death during follow up period|9|||
161958553|NCT03308968|584894949|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
161958554|NCT03308968|584894947|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
161709351|NCT00001337|583980213|FG001|Overall Study|Death during follow up period|4|||
161709352|NCT00001337|583980214|FG002|Overall Study|Death during follow up period|0|||
161709353|NCT00001337|583980212|FG000|Overall Study|Death on study|19|||
161709354|NCT00001337|583980213|FG001|Overall Study|Death on study|9|||
161709355|NCT00001337|583980214|FG002|Overall Study|Death on study|0|||
161709356|NCT00001337|583980212|FG000|Overall Study|Disease progression during follow-up period|3|||
161709357|NCT00001337|583980213|FG001|Overall Study|Disease progression during follow-up period|1|||
161709358|NCT00001337|583980214|FG002|Overall Study|Disease progression during follow-up period|0|||
161709359|NCT00001337|583980212|FG000|Overall Study|Disease progression on study|33|||
161709360|NCT00001337|583980213|FG001|Overall Study|Disease progression on study|41|||
161958555|NCT03308968|584894948|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
161958556|NCT03308968|584894949|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
161709361|NCT00001337|583980214|FG002|Overall Study|Disease progression on study|0|||
161709362|NCT00001337|583980212|FG000|Overall Study|Lost to further follow-up|10|||
161709363|NCT00001337|583980213|FG001|Overall Study|Lost to further follow-up|6|||
161709364|NCT00001337|583980214|FG002|Overall Study|Lost to further follow-up|0|||
161709365|NCT00001337|583980212|FG000|Overall Study|2nd malignancy|1|||
161709366|NCT00001337|583980213|FG001|Overall Study|2nd malignancy|0|||
161709367|NCT00001337|583980214|FG002|Overall Study|2nd malignancy|0|||
161709368|NCT00001337|583980212|FG000|Overall Study|Treatment for second lymphoma|0|||
161709369|NCT00001337|583980213|FG001|Overall Study|Treatment for second lymphoma|1|||
161709370|NCT00001337|583980214|FG002|Overall Study|Treatment for second lymphoma|0|||
161709371|NCT00001337|583980212|FG000|Overall Study|Transfer to transplant|0|||
161709372|NCT00001337|583980213|FG001|Overall Study|Transfer to transplant|1|||
161709373|NCT00001337|583980214|FG002|Overall Study|Transfer to transplant|0|||
161709374|NCT06161012|583980215|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
161709375|NCT06161012|583980216|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
161709376|NCT00408005|583980221|FG000|Induction|Adverse Event|19|||
161709377|NCT00408005|583980222|FG001|Induction|Adverse Event|3|||
161709378|NCT00408005|583980223|FG002|Induction|Adverse Event|0|||
161709379|NCT00408005|583980224|FG003|Induction|Adverse Event|0|||
161709380|NCT00408005|583980225|FG004|Induction|Adverse Event|0|||
161709381|NCT00408005|583980226|FG005|Induction|Adverse Event|0|||
161709382|NCT00408005|583980227|FG006|Induction|Adverse Event|0|||
161709383|NCT00408005|583980228|FG007|Induction|Adverse Event|0|||
161709384|NCT00408005|583980221|FG000|Induction|Death|6|||
161709385|NCT00408005|583980222|FG001|Induction|Death|0|||
161709386|NCT00408005|583980223|FG002|Induction|Death|0|||
161709387|NCT00408005|583980224|FG003|Induction|Death|0|||
161709388|NCT00408005|583980225|FG004|Induction|Death|0|||
161709389|NCT00408005|583980226|FG005|Induction|Death|0|||
161709390|NCT00408005|583980227|FG006|Induction|Death|0|||
161709391|NCT00408005|583980228|FG007|Induction|Death|0|||
161709392|NCT00408005|583980221|FG000|Induction|Physician Decision|83|||
161709393|NCT00408005|583980222|FG001|Induction|Physician Decision|9|||
161709394|NCT00408005|583980223|FG002|Induction|Physician Decision|0|||
161709395|NCT00408005|583980224|FG003|Induction|Physician Decision|0|||
161709396|NCT00408005|583980225|FG004|Induction|Physician Decision|0|||
161709397|NCT00408005|583980226|FG005|Induction|Physician Decision|0|||
161709398|NCT00408005|583980227|FG006|Induction|Physician Decision|0|||
161709399|NCT00408005|583980228|FG007|Induction|Physician Decision|0|||
161709400|NCT00408005|583980221|FG000|Induction|Withdrawal by Subject|2|||
161709401|NCT00408005|583980222|FG001|Induction|Withdrawal by Subject|4|||
161709402|NCT00408005|583980223|FG002|Induction|Withdrawal by Subject|0|||
161709403|NCT00408005|583980224|FG003|Induction|Withdrawal by Subject|0|||
161709404|NCT00408005|583980225|FG004|Induction|Withdrawal by Subject|0|||
161709405|NCT00408005|583980226|FG005|Induction|Withdrawal by Subject|0|||
161709406|NCT00408005|583980227|FG006|Induction|Withdrawal by Subject|0|||
161709407|NCT00408005|583980228|FG007|Induction|Withdrawal by Subject|0|||
161709408|NCT00408005|583980221|FG000|Induction|Ineligible|33|||
161709409|NCT00408005|583980222|FG001|Induction|Ineligible|14|||
161709410|NCT00408005|583980223|FG002|Induction|Ineligible|0|||
161709411|NCT00408005|583980224|FG003|Induction|Ineligible|0|||
161709412|NCT00408005|583980225|FG004|Induction|Ineligible|0|||
161709413|NCT00408005|583980226|FG005|Induction|Ineligible|0|||
161709414|NCT00408005|583980227|FG006|Induction|Ineligible|0|||
161709415|NCT00408005|583980228|FG007|Induction|Ineligible|0|||
161709416|NCT00408005|583980221|FG000|Induction|Refusal of Further Protocol Therapy|225|||
161709417|NCT00408005|583980222|FG001|Induction|Refusal of Further Protocol Therapy|44|||
161709418|NCT00408005|583980223|FG002|Induction|Refusal of Further Protocol Therapy|0|||
161709419|NCT00408005|583980224|FG003|Induction|Refusal of Further Protocol Therapy|0|||
161709420|NCT00408005|583980225|FG004|Induction|Refusal of Further Protocol Therapy|0|||
161709421|NCT00408005|583980226|FG005|Induction|Refusal of Further Protocol Therapy|0|||
161709422|NCT00408005|583980227|FG006|Induction|Refusal of Further Protocol Therapy|0|||
161709423|NCT00408005|583980228|FG007|Induction|Refusal of Further Protocol Therapy|0|||
161709424|NCT00408005|583980221|FG000|Induction|Entered another COG therapeutic protocol|4|||
161709425|NCT00408005|583980222|FG001|Induction|Entered another COG therapeutic protocol|0|||
161709426|NCT00408005|583980223|FG002|Induction|Entered another COG therapeutic protocol|0|||
161709427|NCT00408005|583980224|FG003|Induction|Entered another COG therapeutic protocol|0|||
161709428|NCT00408005|583980225|FG004|Induction|Entered another COG therapeutic protocol|0|||
161709429|NCT00408005|583980226|FG005|Induction|Entered another COG therapeutic protocol|0|||
161709430|NCT00408005|583980227|FG006|Induction|Entered another COG therapeutic protocol|0|||
161709431|NCT00408005|583980228|FG007|Induction|Entered another COG therapeutic protocol|0|||
161709432|NCT00408005|583980221|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
161709433|NCT00408005|583980222|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
161709434|NCT00408005|583980223|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
161709435|NCT00408005|583980224|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
161709436|NCT00408005|583980225|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
161709437|NCT00408005|583980226|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
161709438|NCT00408005|583980227|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
161709439|NCT00408005|583980228|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
161709440|NCT00408005|583980221|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
161709441|NCT00408005|583980222|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
161709442|NCT00408005|583980223|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
161709443|NCT00408005|583980224|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
161709444|NCT00408005|583980225|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
161709445|NCT00408005|583980226|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
161709446|NCT00408005|583980227|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
161709447|NCT00408005|583980228|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
161709448|NCT00408005|583980221|FG000|Induction|Progressive Disease|0|||
161709449|NCT00408005|583980222|FG001|Induction|Progressive Disease|1|||
161709450|NCT00408005|583980223|FG002|Induction|Progressive Disease|0|||
161709451|NCT00408005|583980224|FG003|Induction|Progressive Disease|0|||
161709452|NCT00408005|583980225|FG004|Induction|Progressive Disease|0|||
161709453|NCT00408005|583980226|FG005|Induction|Progressive Disease|0|||
161709454|NCT00408005|583980227|FG006|Induction|Progressive Disease|0|||
161709455|NCT00408005|583980228|FG007|Induction|Progressive Disease|0|||
161709456|NCT00408005|583980221|FG000|Induction|Inevaluable|18|||
161709457|NCT00408005|583980222|FG001|Induction|Inevaluable|14|||
161709458|NCT00408005|583980223|FG002|Induction|Inevaluable|0|||
161709459|NCT00408005|583980224|FG003|Induction|Inevaluable|0|||
161709460|NCT00408005|583980225|FG004|Induction|Inevaluable|0|||
161709461|NCT00408005|583980226|FG005|Induction|Inevaluable|0|||
161709462|NCT00408005|583980227|FG006|Induction|Inevaluable|0|||
161709463|NCT00408005|583980228|FG007|Induction|Inevaluable|0|||
161709464|NCT00408005|583980221|FG000|Induction|Failed to Complete Randomization|3|||
161709465|NCT00408005|583980222|FG001|Induction|Failed to Complete Randomization|2|||
161709466|NCT00408005|583980223|FG002|Induction|Failed to Complete Randomization|0|||
161709467|NCT00408005|583980224|FG003|Induction|Failed to Complete Randomization|0|||
161709468|NCT00408005|583980225|FG004|Induction|Failed to Complete Randomization|0|||
161709469|NCT00408005|583980226|FG005|Induction|Failed to Complete Randomization|0|||
161709470|NCT00408005|583980227|FG006|Induction|Failed to Complete Randomization|0|||
161709471|NCT00408005|583980228|FG007|Induction|Failed to Complete Randomization|0|||
161709472|NCT00408005|583980221|FG000|Induction|Protocol Deviation|3|||
161709473|NCT00408005|583980222|FG001|Induction|Protocol Deviation|1|||
161709474|NCT00408005|583980223|FG002|Induction|Protocol Deviation|0|||
161709475|NCT00408005|583980224|FG003|Induction|Protocol Deviation|0|||
161709476|NCT00408005|583980225|FG004|Induction|Protocol Deviation|0|||
161709477|NCT00408005|583980226|FG005|Induction|Protocol Deviation|0|||
161709478|NCT00408005|583980227|FG006|Induction|Protocol Deviation|0|||
161709479|NCT00408005|583980228|FG007|Induction|Protocol Deviation|0|||
161709480|NCT00408005|583980221|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
161709481|NCT00408005|583980222|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709482|NCT00408005|583980223|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709483|NCT00408005|583980224|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709484|NCT00408005|583980225|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709485|NCT00408005|583980226|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709486|NCT00408005|583980227|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709487|NCT00408005|583980228|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
161709488|NCT00408005|583980221|FG000|Induction|Recurrent leukemia|1|||
161709489|NCT00408005|583980222|FG001|Induction|Recurrent leukemia|0|||
161709490|NCT00408005|583980223|FG002|Induction|Recurrent leukemia|0|||
161709491|NCT00408005|583980224|FG003|Induction|Recurrent leukemia|0|||
161709492|NCT00408005|583980225|FG004|Induction|Recurrent leukemia|0|||
161709493|NCT00408005|583980226|FG005|Induction|Recurrent leukemia|0|||
161709494|NCT00408005|583980227|FG006|Induction|Recurrent leukemia|0|||
161709495|NCT00408005|583980228|FG007|Induction|Recurrent leukemia|0|||
161709496|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161709497|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161709498|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
161837806|NCT00974974|584450213|FG001|IPX066 Dose Conversion|Adverse Event|0|||
161837807|NCT00974974|584450212|FG000|IPX066 Dose Conversion|Death|2|||
161837808|NCT00974974|584450213|FG001|IPX066 Dose Conversion|Death|0|||
161837809|NCT00974974|584450212|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
161709499|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
161709500|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
161709501|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
161709502|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
161709503|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161709504|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
161837810|NCT00974974|584450213|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
161837811|NCT00974974|584450212|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
161837812|NCT00974974|584450213|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
161709505|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
161709506|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
161709507|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
161837813|NCT00974974|584450212|FG000|IPX066 Dose Conversion|Various|3|||
161709508|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
161709509|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
161709510|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
161709511|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
161709512|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161709513|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161709514|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
161709515|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161709516|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
161709517|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161709518|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161709519|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161709520|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
161958557|NCT03308968|584894947|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
161958558|NCT03308968|584894948|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
161958559|NCT03308968|584894949|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
161958560|NCT03308968|584894947|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
161958561|NCT03308968|584894948|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
161958562|NCT03308968|584894949|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
161958563|NCT03308968|584894947|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
161958564|NCT03308968|584894948|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
161958565|NCT03308968|584894949|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
161958566|NCT03308968|584894947|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
161958567|NCT03308968|584894948|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
161958568|NCT03308968|584894949|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
161958569|NCT03308968|584894947|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
161958570|NCT03308968|584894948|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
161958571|NCT03308968|584894949|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
161958572|NCT03308968|584894947|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
161958573|NCT03308968|584894948|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
161958574|NCT03308968|584894949|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
161958575|NCT03308968|584894947|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
161958576|NCT03308968|584894948|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
161958577|NCT03308968|584894949|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
161958578|NCT03308968|584894947|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
161958579|NCT03308968|584894948|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
161958580|NCT03308968|584894949|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
161958581|NCT01521923|584894955|FG000|Overall Study|AE, serious fatal|1|||
161958582|NCT01521923|584894956|FG001|Overall Study|AE, serious fatal|0|||
161958583|NCT01521923|584894957|FG002|Overall Study|AE, serious fatal|0|||
161958584|NCT01521923|584894958|FG003|Overall Study|AE, serious fatal|0|||
161958585|NCT01521923|584894955|FG000|Overall Study|SAE, non-fatal|0|||
161958586|NCT01521923|584894956|FG001|Overall Study|SAE, non-fatal|2|||
161958587|NCT01521923|584894957|FG002|Overall Study|SAE, non-fatal|2|||
161958588|NCT01521923|584894958|FG003|Overall Study|SAE, non-fatal|0|||
161958589|NCT01521923|584894955|FG000|Overall Study|AE, non-serious, non-fatal|1|||
161958590|NCT01521923|584894956|FG001|Overall Study|AE, non-serious, non-fatal|3|||
161958591|NCT01521923|584894957|FG002|Overall Study|AE, non-serious, non-fatal|6|||
161958592|NCT01521923|584894958|FG003|Overall Study|AE, non-serious, non-fatal|2|||
161709521|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
161709522|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
161709523|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
161709524|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
161709525|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
161709526|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
161709527|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
161709528|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161958593|NCT01521923|584894955|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
161958594|NCT01521923|584894956|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
161709529|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161709530|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
161709531|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
161709532|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161709533|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
161958595|NCT01521923|584894957|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
161958596|NCT01521923|584894958|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
161958597|NCT01521923|584894955|FG000|Overall Study|Lack of Efficacy|1|||
161958598|NCT01521923|584894956|FG001|Overall Study|Lack of Efficacy|1|||
161709534|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161709535|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161709536|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
161709537|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
161709538|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
161709539|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
161709540|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
161709541|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
161709542|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
161709543|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
161709544|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709545|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709546|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709547|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709548|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
161709549|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709550|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709551|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161709552|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
161709553|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
161709554|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
161709555|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
161709556|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
161709557|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
161709558|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
161709559|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
161709560|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161709561|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161709562|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161709563|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161709564|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
161709565|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161709566|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
161709567|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
161709568|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709569|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709570|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709571|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709572|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709573|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
161709574|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709575|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161709576|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
161709577|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
161709578|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
161709579|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
161709580|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
161709581|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
161709582|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
161709583|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
161709584|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161709585|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161709586|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161709587|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161709588|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
161709589|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
161709590|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161837814|NCT00974974|584450213|FG001|IPX066 Dose Conversion|Various|0|||
161837815|NCT00974974|584450212|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
161709591|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161709592|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
161709593|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
161709594|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
161709595|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
161709596|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
161709597|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
161709598|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
161709599|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
161709600|NCT00408005|583980221|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
161709601|NCT00408005|583980222|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
161709602|NCT00408005|583980223|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
161709603|NCT00408005|583980224|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
161709604|NCT00408005|583980225|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
161709605|NCT00408005|583980226|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
161709606|NCT00408005|583980227|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
161709607|NCT00408005|583980228|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
161709608|NCT05817045|583980229|FG000|Overall Study|Protocol Violation|0|||
161709609|NCT05817045|583980230|FG001|Overall Study|Protocol Violation|3|||
161709610|NCT05817045|583980229|FG000|Overall Study|Withdrawal by Subject|10|||
161709611|NCT05817045|583980230|FG001|Overall Study|Withdrawal by Subject|7|||
161709612|NCT05817045|583980229|FG000|Overall Study|Physician Decision|3|||
161709613|NCT05817045|583980230|FG001|Overall Study|Physician Decision|0|||
161709614|NCT05817045|583980229|FG000|Overall Study|Lost to Follow-up|0|||
161709615|NCT05817045|583980230|FG001|Overall Study|Lost to Follow-up|1|||
161709616|NCT05817045|583980229|FG000|Overall Study|Device Deficiency|1|||
161709617|NCT05817045|583980230|FG001|Overall Study|Device Deficiency|0|||
161709618|NCT05817045|583980229|FG000|Overall Study|System Error|1|||
161709619|NCT05817045|583980230|FG001|Overall Study|System Error|0|||
161709620|NCT01506141|583980231|FG000|Overall Study|Adverse Event|0|||
161709621|NCT01506141|583980232|FG001|Overall Study|Adverse Event|2|||
161709622|NCT01506141|583980231|FG000|Overall Study|Participation Terminated by Investigator|1|||
161709623|NCT01506141|583980232|FG001|Overall Study|Participation Terminated by Investigator|1|||
161709624|NCT01506141|583980231|FG000|Overall Study|Site Terminated by Sponsor|2|||
161709625|NCT01506141|583980232|FG001|Overall Study|Site Terminated by Sponsor|0|||
161709626|NCT01506141|583980231|FG000|Overall Study|Reason Not Specified|4|||
161709627|NCT01506141|583980232|FG001|Overall Study|Reason Not Specified|2|||
161709628|NCT04889209|583980233|FG000|All Cohorts Except 15E|Adverse Event|0|||
161709629|NCT04889209|583980234|FG001|All Cohorts Except 15E|Adverse Event|0|||
161709630|NCT04889209|583980235|FG002|All Cohorts Except 15E|Adverse Event|0|||
161709631|NCT04889209|583980236|FG003|All Cohorts Except 15E|Adverse Event|0|||
161709632|NCT04889209|583980237|FG004|All Cohorts Except 15E|Adverse Event|0|||
161709633|NCT04889209|583980238|FG005|All Cohorts Except 15E|Adverse Event|0|||
161709634|NCT04889209|583980239|FG006|All Cohorts Except 15E|Adverse Event|1|||
161709635|NCT04889209|583980240|FG007|All Cohorts Except 15E|Adverse Event|0|||
161709636|NCT04889209|583980241|FG008|All Cohorts Except 15E|Adverse Event|0|||
161709637|NCT04889209|583980242|FG009|All Cohorts Except 15E|Adverse Event|0|||
161709638|NCT04889209|583980243|FG010|All Cohorts Except 15E|Adverse Event|0|||
161709639|NCT04889209|583980244|FG011|All Cohorts Except 15E|Adverse Event|0|||
161709640|NCT04889209|583980245|FG012|All Cohorts Except 15E|Adverse Event|0|||
161709641|NCT04889209|583980246|FG013|All Cohorts Except 15E|Adverse Event|0|||
161709642|NCT04889209|583980247|FG014|All Cohorts Except 15E|Adverse Event|0|||
161709643|NCT04889209|583980248|FG015|All Cohorts Except 15E|Adverse Event|0|||
161709644|NCT04889209|583980249|FG016|All Cohorts Except 15E|Adverse Event|0|||
161709645|NCT04889209|583980250|FG017|All Cohorts Except 15E|Adverse Event|0|||
161709646|NCT04889209|583980233|FG000|All Cohorts Except 15E|Death|0|||
161709647|NCT04889209|583980234|FG001|All Cohorts Except 15E|Death|1|||
161709648|NCT04889209|583980235|FG002|All Cohorts Except 15E|Death|0|||
161958599|NCT01521923|584894957|FG002|Overall Study|Lack of Efficacy|0|||
161709649|NCT04889209|583980236|FG003|All Cohorts Except 15E|Death|0|||
161709650|NCT04889209|583980237|FG004|All Cohorts Except 15E|Death|0|||
161709651|NCT04889209|583980238|FG005|All Cohorts Except 15E|Death|0|||
161709652|NCT04889209|583980239|FG006|All Cohorts Except 15E|Death|0|||
161837816|NCT00974974|584450213|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
161709653|NCT04889209|583980240|FG007|All Cohorts Except 15E|Death|0|||
161709654|NCT04889209|583980241|FG008|All Cohorts Except 15E|Death|0|||
161709655|NCT04889209|583980242|FG009|All Cohorts Except 15E|Death|0|||
161709656|NCT04889209|583980243|FG010|All Cohorts Except 15E|Death|0|||
161709657|NCT04889209|583980244|FG011|All Cohorts Except 15E|Death|0|||
161709658|NCT04889209|583980245|FG012|All Cohorts Except 15E|Death|0|||
161709659|NCT04889209|583980246|FG013|All Cohorts Except 15E|Death|0|||
161958600|NCT01521923|584894958|FG003|Overall Study|Lack of Efficacy|0|||
161709660|NCT04889209|583980247|FG014|All Cohorts Except 15E|Death|0|||
161709661|NCT04889209|583980248|FG015|All Cohorts Except 15E|Death|0|||
161709662|NCT04889209|583980249|FG016|All Cohorts Except 15E|Death|0|||
161709663|NCT04889209|583980250|FG017|All Cohorts Except 15E|Death|0|||
161709664|NCT04889209|583980233|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
161709665|NCT04889209|583980234|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
161709666|NCT04889209|583980235|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
161709667|NCT04889209|583980236|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
161709668|NCT04889209|583980237|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
161709669|NCT04889209|583980238|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
161709670|NCT04889209|583980239|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
161709671|NCT04889209|583980240|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
161709672|NCT04889209|583980241|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
161709673|NCT04889209|583980242|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
161709674|NCT04889209|583980243|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
161709675|NCT04889209|583980244|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
161709676|NCT04889209|583980245|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
161709677|NCT04889209|583980246|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
161709678|NCT04889209|583980247|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
161709679|NCT04889209|583980248|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
161709680|NCT04889209|583980249|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
161709681|NCT04889209|583980250|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
161709682|NCT04889209|583980233|FG000|All Cohorts Except 15E|Physician Decision|0|||
161709683|NCT04889209|583980234|FG001|All Cohorts Except 15E|Physician Decision|0|||
161709684|NCT04889209|583980235|FG002|All Cohorts Except 15E|Physician Decision|0|||
161709685|NCT04889209|583980236|FG003|All Cohorts Except 15E|Physician Decision|0|||
161709686|NCT04889209|583980237|FG004|All Cohorts Except 15E|Physician Decision|1|||
161709687|NCT04889209|583980238|FG005|All Cohorts Except 15E|Physician Decision|0|||
161709688|NCT04889209|583980239|FG006|All Cohorts Except 15E|Physician Decision|0|||
161709689|NCT04889209|583980240|FG007|All Cohorts Except 15E|Physician Decision|1|||
161837817|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
161837818|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
161709690|NCT04889209|583980241|FG008|All Cohorts Except 15E|Physician Decision|0|||
161709691|NCT04889209|583980242|FG009|All Cohorts Except 15E|Physician Decision|1|||
161709692|NCT04889209|583980243|FG010|All Cohorts Except 15E|Physician Decision|0|||
161709693|NCT04889209|583980244|FG011|All Cohorts Except 15E|Physician Decision|1|||
161709694|NCT04889209|583980245|FG012|All Cohorts Except 15E|Physician Decision|1|||
161709695|NCT04889209|583980246|FG013|All Cohorts Except 15E|Physician Decision|0|||
161709696|NCT04889209|583980247|FG014|All Cohorts Except 15E|Physician Decision|0|||
161709697|NCT04889209|583980248|FG015|All Cohorts Except 15E|Physician Decision|0|||
161709698|NCT04889209|583980249|FG016|All Cohorts Except 15E|Physician Decision|0|||
161709699|NCT04889209|583980250|FG017|All Cohorts Except 15E|Physician Decision|0|||
161709700|NCT04889209|583980233|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
161709701|NCT04889209|583980234|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
161709702|NCT04889209|583980235|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
161709703|NCT04889209|583980236|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
161709704|NCT04889209|583980237|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
161709705|NCT04889209|583980238|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
161958601|NCT01521923|584894955|FG000|Overall Study|Protocol Violation|0|||
161958602|NCT01521923|584894956|FG001|Overall Study|Protocol Violation|0|||
161958603|NCT01521923|584894957|FG002|Overall Study|Protocol Violation|1|||
161958604|NCT01521923|584894958|FG003|Overall Study|Protocol Violation|0|||
161958605|NCT01521923|584894955|FG000|Overall Study|Lost to Follow-up|1|||
161958606|NCT01521923|584894956|FG001|Overall Study|Lost to Follow-up|0|||
161837819|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
161837820|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
161837821|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
161837822|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
161958607|NCT01521923|584894957|FG002|Overall Study|Lost to Follow-up|2|||
161958608|NCT01521923|584894958|FG003|Overall Study|Lost to Follow-up|1|||
161837823|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
161958609|NCT01521923|584894955|FG000|Overall Study|Withdrawal by Subject|1|||
161958610|NCT01521923|584894956|FG001|Overall Study|Withdrawal by Subject|1|||
161958611|NCT01521923|584894957|FG002|Overall Study|Withdrawal by Subject|1|||
161958612|NCT01521923|584894958|FG003|Overall Study|Withdrawal by Subject|2|||
161709706|NCT04889209|583980239|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709707|NCT04889209|583980240|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
161709708|NCT04889209|583980241|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709709|NCT04889209|583980242|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709710|NCT04889209|583980243|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709711|NCT04889209|583980244|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709712|NCT04889209|583980245|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709713|NCT04889209|583980246|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
161709714|NCT04889209|583980247|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
161709715|NCT04889209|583980248|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
161709716|NCT04889209|583980249|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
161709717|NCT04889209|583980250|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
161709718|NCT04889209|583980233|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
161709719|NCT04889209|583980234|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
161709720|NCT04889209|583980235|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709721|NCT04889209|583980236|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709722|NCT04889209|583980237|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709723|NCT04889209|583980238|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
161709724|NCT04889209|583980239|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709725|NCT04889209|583980240|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
161709726|NCT04889209|583980241|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709727|NCT04889209|583980242|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
161709728|NCT04889209|583980243|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709729|NCT04889209|583980244|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709730|NCT04889209|583980245|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709731|NCT04889209|583980246|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709732|NCT04889209|583980247|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709733|NCT04889209|583980248|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709734|NCT04889209|583980249|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161709735|NCT04889209|583980250|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
161709736|NCT04889209|583980233|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709737|NCT04889209|583980234|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709738|NCT04889209|583980235|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709739|NCT04889209|583980236|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
161709740|NCT04889209|583980237|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709741|NCT04889209|583980238|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709742|NCT04889209|583980239|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709743|NCT04889209|583980240|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709744|NCT04889209|583980241|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709745|NCT04889209|583980242|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709746|NCT04889209|583980243|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709747|NCT04889209|583980244|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709748|NCT04889209|583980245|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709749|NCT04889209|583980246|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709750|NCT04889209|583980247|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709751|NCT04889209|583980248|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709752|NCT04889209|583980249|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709753|NCT04889209|583980250|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161709754|NCT04889209|583980233|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709755|NCT04889209|583980234|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709756|NCT04889209|583980235|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709757|NCT04889209|583980236|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709758|NCT04889209|583980237|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709759|NCT04889209|583980238|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709760|NCT04889209|583980239|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709761|NCT04889209|583980240|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709762|NCT04889209|583980241|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709763|NCT04889209|583980242|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709764|NCT04889209|583980243|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709765|NCT04889209|583980244|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709766|NCT04889209|583980245|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161709767|NCT04889209|583980246|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709768|NCT04889209|583980247|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709769|NCT04889209|583980248|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709770|NCT04889209|583980249|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161958613|NCT01521923|584894955|FG000|Overall Study|Other|2|||
161709771|NCT04889209|583980250|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161709772|NCT04889209|583980233|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709773|NCT04889209|583980234|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709774|NCT04889209|583980235|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709775|NCT04889209|583980236|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709776|NCT04889209|583980237|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709777|NCT04889209|583980238|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709778|NCT04889209|583980239|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709779|NCT04889209|583980240|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709780|NCT04889209|583980241|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709781|NCT04889209|583980242|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709782|NCT04889209|583980243|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709783|NCT04889209|583980244|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709784|NCT04889209|583980245|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709785|NCT04889209|583980246|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709786|NCT04889209|583980247|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709787|NCT04889209|583980248|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709788|NCT04889209|583980249|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161709789|NCT04889209|583980250|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
161709790|NCT04889209|583980233|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709791|NCT04889209|583980234|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709792|NCT04889209|583980235|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709793|NCT04889209|583980236|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709794|NCT04889209|583980237|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709795|NCT04889209|583980238|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709796|NCT04889209|583980239|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709797|NCT04889209|583980240|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709798|NCT04889209|583980241|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709799|NCT04889209|583980242|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709800|NCT04889209|583980243|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709801|NCT04889209|583980244|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709802|NCT04889209|583980245|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709803|NCT04889209|583980246|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709804|NCT04889209|583980247|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709805|NCT04889209|583980248|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709806|NCT04889209|583980249|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161709807|NCT04889209|583980250|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
161709808|NCT04889209|583980233|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709809|NCT04889209|583980234|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709810|NCT04889209|583980235|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709811|NCT04889209|583980236|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709812|NCT04889209|583980237|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709813|NCT04889209|583980238|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709814|NCT04889209|583980239|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709815|NCT04889209|583980240|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709816|NCT04889209|583980241|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709817|NCT04889209|583980242|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709818|NCT04889209|583980243|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709819|NCT04889209|583980244|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709820|NCT04889209|583980245|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709821|NCT04889209|583980246|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709822|NCT04889209|583980247|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
161709823|NCT04889209|583980248|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709824|NCT04889209|583980249|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709825|NCT04889209|583980250|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161709826|NCT04607408|583980251|FG000|Overall Study|Lost to Follow-up|0|||
161709827|NCT04607408|583980252|FG001|Overall Study|Lost to Follow-up|0|||
161709828|NCT04607408|583980253|FG002|Overall Study|Lost to Follow-up|0|||
161709829|NCT04607408|583980254|FG003|Overall Study|Lost to Follow-up|1|||
161709830|NCT04607408|583980255|FG004|Overall Study|Lost to Follow-up|0|||
161709831|NCT04607408|583980251|FG000|Overall Study|Withdrawal by Subject|0|||
161709832|NCT04607408|583980252|FG001|Overall Study|Withdrawal by Subject|1|||
161709833|NCT04607408|583980253|FG002|Overall Study|Withdrawal by Subject|0|||
161709834|NCT04607408|583980254|FG003|Overall Study|Withdrawal by Subject|1|||
161837824|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
161837825|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
161958614|NCT01521923|584894956|FG001|Overall Study|Other|1|||
161958615|NCT01521923|584894957|FG002|Overall Study|Other|3|||
161958616|NCT01521923|584894958|FG003|Overall Study|Other|6|||
161958617|NCT01521923|584894955|FG000|Overall Study|AE, captured in Period 1|0|||
161958618|NCT01521923|584894956|FG001|Overall Study|AE, captured in Period 1|1|||
161958619|NCT01521923|584894957|FG002|Overall Study|AE, captured in Period 1|0|||
161958620|NCT01521923|584894958|FG003|Overall Study|AE, captured in Period 1|1|||
161958621|NCT03037476|584894959|FG000|Overall Study|Lost to Follow-up|63|||
161958622|NCT03037476|584894960|FG001|Overall Study|Lost to Follow-up|46|||
161958623|NCT02141633|584894961|FG000|Overall Study|Physician Decision|1|||
161958624|NCT02141633|584894962|FG001|Overall Study|Physician Decision|0|||
161958625|NCT02403817|584894963|FG000|Overall Study|Withdrawal by Subject|5|||
161958626|NCT02403817|584894964|FG001|Overall Study|Withdrawal by Subject|0|||
161958627|NCT01208324|584894970|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
161958628|NCT01208324|584894971|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
161958629|NCT01208324|584894972|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
161958630|NCT01208324|584894973|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
161958631|NCT00984165|584894974|FG000|Overall Study|Death on study|2|||
161958632|NCT00984165|584894975|FG001|Overall Study|Death on study|0|||
161958633|NCT00984165|584894976|FG002|Overall Study|Death on study|0|||
161958634|NCT00984165|584894977|FG003|Overall Study|Death on study|0|||
161958635|NCT00984165|584894974|FG000|Overall Study|Disease progression on study|5|||
161958636|NCT00984165|584894975|FG001|Overall Study|Disease progression on study|1|||
161958637|NCT00984165|584894976|FG002|Overall Study|Disease progression on study|0|||
161958638|NCT00984165|584894977|FG003|Overall Study|Disease progression on study|0|||
161958639|NCT00984165|584894974|FG000|Overall Study|Death of recipient|0|||
161958640|NCT00984165|584894975|FG001|Overall Study|Death of recipient|0|||
161958641|NCT00984165|584894976|FG002|Overall Study|Death of recipient|0|||
161958642|NCT00984165|584894977|FG003|Overall Study|Death of recipient|1|||
161958643|NCT00984165|584894974|FG000|Overall Study|New protocol|0|||
161958644|NCT00984165|584894975|FG001|Overall Study|New protocol|0|||
161958645|NCT00984165|584894976|FG002|Overall Study|New protocol|0|||
161958646|NCT00984165|584894977|FG003|Overall Study|New protocol|1|||
161958647|NCT00984165|584894974|FG000|Overall Study|P+/donor pair removed from protocol|0|||
161958648|NCT00984165|584894975|FG001|Overall Study|P+/donor pair removed from protocol|0|||
161709835|NCT04607408|583980255|FG004|Overall Study|Withdrawal by Subject|0|||
161709836|NCT03619213|583980262|FG000|Overall Study|Lost to Follow-up|2|||
161709837|NCT03619213|583980263|FG001|Overall Study|Lost to Follow-up|1|||
161709838|NCT03619213|583980262|FG000|Overall Study|Withdrawal by Subject|8|||
161709839|NCT03619213|583980263|FG001|Overall Study|Withdrawal by Subject|10|||
161709840|NCT00382967|583980264|FG000|Overall Study|Protocol Violation|1|||
161709841|NCT00382967|583980265|FG001|Overall Study|Protocol Violation|1|||
161709842|NCT00501228|583980267|FG000|Overall Study|Withdrawal by Subject|1|||
161709843|NCT00461175|583980268|FG000|Overall Study|Protocol Violation|522|||
161709844|NCT00461175|583980269|FG001|Overall Study|Protocol Violation|365|||
161709845|NCT00316264|583980271|FG000|Overall Study|Lost to Follow-up|0|||
161709846|NCT00316264|583980272|FG001|Overall Study|Lost to Follow-up|1|||
161709847|NCT00316264|583980273|FG002|Overall Study|Lost to Follow-up|0|||
161709848|NCT00316264|583980271|FG000|Overall Study|Withdrawal of Consent|3|||
161709849|NCT00316264|583980272|FG001|Overall Study|Withdrawal of Consent|5|||
161709850|NCT00316264|583980273|FG002|Overall Study|Withdrawal of Consent|6|||
161709851|NCT00316264|583980271|FG000|Overall Study|Death|2|||
161709852|NCT00316264|583980272|FG001|Overall Study|Death|0|||
161709853|NCT00316264|583980273|FG002|Overall Study|Death|0|||
161709854|NCT00316264|583980271|FG000|Overall Study|Other|1|||
161709855|NCT00316264|583980272|FG001|Overall Study|Other|1|||
161709856|NCT00316264|583980273|FG002|Overall Study|Other|0|||
161709857|NCT02209506|583980276|FG000|Overall Study|Withdrawal by Subject|0|||
161709858|NCT02209506|583980277|FG001|Overall Study|Withdrawal by Subject|0|||
161709859|NCT02209506|583980278|FG002|Overall Study|Withdrawal by Subject|0|||
161958649|NCT00984165|584894976|FG002|Overall Study|P+/donor pair removed from protocol|0|||
161958650|NCT00984165|584894977|FG003|Overall Study|P+/donor pair removed from protocol|1|||
161709860|NCT02209506|583980279|FG003|Overall Study|Withdrawal by Subject|0|||
161709861|NCT02209506|583980280|FG004|Overall Study|Withdrawal by Subject|1|||
161958651|NCT00984165|584894974|FG000|Overall Study|removed with a pair recipient|0|||
161958652|NCT00984165|584894975|FG001|Overall Study|removed with a pair recipient|0|||
161958653|NCT00984165|584894976|FG002|Overall Study|removed with a pair recipient|0|||
162030860|NCT00534313|585169499|FG003|Short-term Period|Participant not meeting study criteria|1|||
161958654|NCT00984165|584894977|FG003|Overall Study|removed with a pair recipient|1|||
161958655|NCT04474197|584894978|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
161958656|NCT04474197|584894979|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
161958657|NCT04474197|584894980|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
161958658|NCT04474197|584894981|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
161709862|NCT01587989|583980281|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
161709863|NCT01587989|583980282|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
161709864|NCT01587989|583980283|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
161958659|NCT01390298|584894984|FG000|Overall Study|Death|1|||
161958660|NCT01390298|584894984|FG000|Overall Study|long term ICU admission|1|||
161958661|NCT01390298|584894984|FG000|Overall Study|Withdrawal by Subject|14|||
161958662|NCT01390298|584894984|FG000|Overall Study|Lost to Follow-up|7|||
161958663|NCT01390298|584894984|FG000|Overall Study|Surgery cancelled|1|||
161958664|NCT00588237|584894985|FG000|Overall Study|Evaluable for toxicity only|3|||
161958665|NCT00588237|584894985|FG000|Overall Study|Patien not treated|1|||
161958666|NCT00066222|584894990|FG000|Overall Study|No protocol treatment received|1|||
161958667|NCT00635349|584894991|FG000|Overall Study|Other|8|||
161958668|NCT00635349|584894992|FG001|Overall Study|Other|6|||
161958669|NCT00635349|584894991|FG000|Overall Study|Protocol Violation|18|||
161958670|NCT00635349|584894992|FG001|Overall Study|Protocol Violation|22|||
161958671|NCT00635349|584894991|FG000|Overall Study|Withdrawal by Subject|3|||
161958672|NCT00635349|584894992|FG001|Overall Study|Withdrawal by Subject|8|||
161958673|NCT00635349|584894991|FG000|Overall Study|Lost to Follow-up|4|||
161958674|NCT00635349|584894992|FG001|Overall Study|Lost to Follow-up|3|||
161958675|NCT00635349|584894991|FG000|Overall Study|Adverse Event|11|||
161958676|NCT00635349|584894992|FG001|Overall Study|Adverse Event|9|||
161958677|NCT02550288|584894994|FG000|Overall Study|Adverse Event|0|||
161958678|NCT02550288|584894995|FG001|Overall Study|Adverse Event|1|||
161958679|NCT02550288|584894996|FG002|Overall Study|Adverse Event|0|||
161958680|NCT02550288|584894997|FG003|Overall Study|Adverse Event|0|||
161709865|NCT01587989|583980281|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
161709866|NCT01587989|583980282|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
161709867|NCT01587989|583980283|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
161709868|NCT01587989|583980281|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
161709869|NCT01587989|583980282|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
161709870|NCT01587989|583980283|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
161709871|NCT01587989|583980281|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
161709872|NCT01587989|583980282|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
161709873|NCT01587989|583980283|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
161709874|NCT01587989|583980281|FG000|Randomized Study Treatment|Screening failure|0|||
161709875|NCT01587989|583980282|FG001|Randomized Study Treatment|Screening failure|1|||
161709876|NCT01587989|583980283|FG002|Randomized Study Treatment|Screening failure|0|||
161709877|NCT01587989|583980281|FG000|Randomized Study Treatment|Physician Decision|0|||
161709878|NCT01587989|583980282|FG001|Randomized Study Treatment|Physician Decision|0|||
161709879|NCT01587989|583980283|FG002|Randomized Study Treatment|Physician Decision|1|||
161709880|NCT03313050|583980284|FG000|Stage 2: 12 Months|Adverse Event|0|||
161709881|NCT03313050|583980285|FG001|Stage 2: 12 Months|Adverse Event|0|||
161709882|NCT03313050|583980286|FG002|Stage 2: 12 Months|Adverse Event|0|||
161709883|NCT03313050|583980287|FG003|Stage 2: 12 Months|Adverse Event|1|||
161709884|NCT03313050|583980284|FG000|Stage 2: 12 Months|Death|0|||
161709885|NCT03313050|583980285|FG001|Stage 2: 12 Months|Death|0|||
161709886|NCT03313050|583980286|FG002|Stage 2: 12 Months|Death|3|||
161709887|NCT03313050|583980287|FG003|Stage 2: 12 Months|Death|0|||
161709888|NCT03313050|583980284|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
161709889|NCT03313050|583980285|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
161709890|NCT03313050|583980286|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
161709891|NCT03313050|583980287|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
161709892|NCT03313050|583980284|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
161709893|NCT03313050|583980285|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
161709894|NCT03313050|583980286|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
161709895|NCT03313050|583980287|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
161709896|NCT03313050|583980284|FG000|Stage 2: 12 Months|Protocol deviation|0|||
161709897|NCT03313050|583980285|FG001|Stage 2: 12 Months|Protocol deviation|0|||
161709898|NCT03313050|583980286|FG002|Stage 2: 12 Months|Protocol deviation|7|||
161709899|NCT03313050|583980287|FG003|Stage 2: 12 Months|Protocol deviation|7|||
161709900|NCT03313050|583980284|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
161958681|NCT02550288|584894998|FG004|Overall Study|Adverse Event|0|||
161958682|NCT02550288|584894994|FG000|Overall Study|Physician Decision|0|||
161958683|NCT02550288|584894995|FG001|Overall Study|Physician Decision|0|||
161709901|NCT03313050|583980285|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
161709902|NCT03313050|583980286|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
161958684|NCT02550288|584894996|FG002|Overall Study|Physician Decision|0|||
161958685|NCT02550288|584894997|FG003|Overall Study|Physician Decision|1|||
161958686|NCT02550288|584894998|FG004|Overall Study|Physician Decision|0|||
161958687|NCT02550288|584894994|FG000|Overall Study|Protocol Violation|2|||
161709903|NCT03313050|583980287|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
161709904|NCT03313050|583980284|FG000|Stage 2: 12 Months|Other|0|||
161709905|NCT03313050|583980285|FG001|Stage 2: 12 Months|Other|0|||
161709906|NCT03313050|583980286|FG002|Stage 2: 12 Months|Other|0|||
161709907|NCT03313050|583980287|FG003|Stage 2: 12 Months|Other|1|||
161709908|NCT04211337|583980288|FG000|Overall Study|On Treatment|175|||
161958688|NCT02550288|584894995|FG001|Overall Study|Protocol Violation|2|||
161958689|NCT02550288|584894996|FG002|Overall Study|Protocol Violation|1|||
161958690|NCT02550288|584894997|FG003|Overall Study|Protocol Violation|0|||
161958691|NCT02550288|584894998|FG004|Overall Study|Protocol Violation|3|||
161958692|NCT02550288|584894994|FG000|Overall Study|Participant moved|0|||
161958693|NCT02550288|584894995|FG001|Overall Study|Participant moved|0|||
161958694|NCT02550288|584894996|FG002|Overall Study|Participant moved|0|||
161958695|NCT02550288|584894997|FG003|Overall Study|Participant moved|1|||
161958696|NCT02550288|584894998|FG004|Overall Study|Participant moved|0|||
161958697|NCT02550288|584894994|FG000|Overall Study|Withdrawal by Subject|0|||
161958698|NCT02550288|584894995|FG001|Overall Study|Withdrawal by Subject|0|||
161958699|NCT02550288|584894996|FG002|Overall Study|Withdrawal by Subject|0|||
161958700|NCT02550288|584894997|FG003|Overall Study|Withdrawal by Subject|1|||
161958701|NCT02550288|584894998|FG004|Overall Study|Withdrawal by Subject|0|||
162030861|NCT00534313|585169496|FG000|Short-term Period|Participant withdrew consent|2|||
162030862|NCT00534313|585169497|FG001|Short-term Period|Participant withdrew consent|0|||
161709909|NCT04211337|583980289|FG001|Overall Study|On Treatment|40|||
161709910|NCT04211337|583980288|FG000|Overall Study|Withdrawal by Subject|0|||
161709911|NCT04211337|583980289|FG001|Overall Study|Withdrawal by Subject|2|||
161709912|NCT01291017|583980290|FG000|Overall Study|Lost to Follow-up|2|||
162030863|NCT00534313|585169498|FG002|Short-term Period|Participant withdrew consent|0|||
161709913|NCT01291017|583980290|FG000|Overall Study|Withdrawal by Subject|3|||
161709914|NCT05630846|583982306|FG000|Overall Study|Death|1|||
161709915|NCT05630846|583982307|FG001|Overall Study|Death|0|||
161709916|NCT05630846|583982308|FG002|Overall Study|Death|0|||
161709917|NCT05630846|583982309|FG003|Overall Study|Death|0|||
162030864|NCT00534313|585169499|FG003|Short-term Period|Participant withdrew consent|2|||
162030865|NCT00534313|585169496|FG000|Short-term Period|Pregnancy|0|||
162030866|NCT00534313|585169497|FG001|Short-term Period|Pregnancy|0|||
162030867|NCT00534313|585169498|FG002|Short-term Period|Pregnancy|1|||
162030868|NCT00534313|585169499|FG003|Short-term Period|Pregnancy|0|||
162030869|NCT00534313|585169496|FG000|Long-term Period|Adverse Event|2|||
161709918|NCT05630846|583982306|FG000|Overall Study|Withdrawal by Subject|3|||
161709919|NCT05630846|583982307|FG001|Overall Study|Withdrawal by Subject|3|||
161709920|NCT05630846|583982308|FG002|Overall Study|Withdrawal by Subject|4|||
161709921|NCT05630846|583982309|FG003|Overall Study|Withdrawal by Subject|1|||
161709922|NCT05630846|583982306|FG000|Overall Study|Lost to Follow-up|6|||
161709923|NCT05630846|583982307|FG001|Overall Study|Lost to Follow-up|5|||
161709924|NCT05630846|583982308|FG002|Overall Study|Lost to Follow-up|2|||
161709925|NCT05630846|583982309|FG003|Overall Study|Lost to Follow-up|5|||
161709926|NCT05630846|583982306|FG000|Overall Study|Other|1|||
161709927|NCT05630846|583982307|FG001|Overall Study|Other|0|||
161709928|NCT05630846|583982308|FG002|Overall Study|Other|0|||
161709929|NCT05630846|583982309|FG003|Overall Study|Other|0|||
161709930|NCT01431287|583982310|FG000|Overall Study|not treated|0|||
161709931|NCT01431287|583982311|FG001|Overall Study|not treated|0|||
161709932|NCT01431287|583982312|FG002|Overall Study|not treated|1|||
161709933|NCT01431287|583982313|FG003|Overall Study|not treated|0|||
161709934|NCT01431287|583982314|FG004|Overall Study|not treated|0|||
161709935|NCT01431287|583982310|FG000|Overall Study|Adverse Event|59|||
161709936|NCT01431287|583982311|FG001|Overall Study|Adverse Event|57|||
161709937|NCT01431287|583982312|FG002|Overall Study|Adverse Event|53|||
161709938|NCT01431287|583982313|FG003|Overall Study|Adverse Event|33|||
161709939|NCT01431287|583982314|FG004|Overall Study|Adverse Event|41|||
161709940|NCT01431287|583982310|FG000|Overall Study|Non compliant with protocol|6|||
161709941|NCT01431287|583982311|FG001|Overall Study|Non compliant with protocol|6|||
161709942|NCT01431287|583982312|FG002|Overall Study|Non compliant with protocol|5|||
161709943|NCT01431287|583982313|FG003|Overall Study|Non compliant with protocol|6|||
161709944|NCT01431287|583982314|FG004|Overall Study|Non compliant with protocol|5|||
161709945|NCT01431287|583982310|FG000|Overall Study|Lost to Follow-up|0|||
161709946|NCT01431287|583982311|FG001|Overall Study|Lost to Follow-up|3|||
161709947|NCT01431287|583982312|FG002|Overall Study|Lost to Follow-up|2|||
161709948|NCT01431287|583982313|FG003|Overall Study|Lost to Follow-up|3|||
161709949|NCT01431287|583982314|FG004|Overall Study|Lost to Follow-up|1|||
161709950|NCT01431287|583982310|FG000|Overall Study|Consent withdrawn not due to AE|29|||
161709951|NCT01431287|583982311|FG001|Overall Study|Consent withdrawn not due to AE|30|||
161709952|NCT01431287|583982312|FG002|Overall Study|Consent withdrawn not due to AE|34|||
161709953|NCT01431287|583982313|FG003|Overall Study|Consent withdrawn not due to AE|19|||
161709954|NCT01431287|583982314|FG004|Overall Study|Consent withdrawn not due to AE|29|||
161709955|NCT01431287|583982310|FG000|Overall Study|not stated above|4|||
161709956|NCT01431287|583982311|FG001|Overall Study|not stated above|2|||
161709957|NCT01431287|583982312|FG002|Overall Study|not stated above|2|||
161709958|NCT01431287|583982313|FG003|Overall Study|not stated above|2|||
161709959|NCT01431287|583982314|FG004|Overall Study|not stated above|1|||
161709960|NCT03019549|583982315|FG000|Washout|DId not meet genotype criteria|11|||
161958702|NCT01524224|584895001|FG000|Overall Study|Progressive Disease|1|||
161958703|NCT01524224|584895002|FG001|Overall Study|Progressive Disease|0|||
161709961|NCT03019549|583982315|FG000|Period 2|Adverse Event|2|||
161709962|NCT03019549|583982315|FG000|Period 2|Physician Decision|2|||
161709963|NCT03019549|583982315|FG000|Period 2|Withdrawal by Subject|1|||
161958704|NCT01524224|584895003|FG002|Overall Study|Progressive Disease|2|||
161958705|NCT01524224|584895004|FG003|Overall Study|Progressive Disease|1|||
161958706|NCT01524224|584895005|FG004|Overall Study|Progressive Disease|2|||
161709964|NCT01412879|583982316|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
161709965|NCT01412879|583982317|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
161709966|NCT01412879|583982318|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
161709967|NCT01412879|583982316|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
161709968|NCT01412879|583982317|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
161709969|NCT01412879|583982318|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
161709970|NCT01412879|583982316|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
161709971|NCT01412879|583982317|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
161709972|NCT01412879|583982318|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
161709973|NCT01412879|583982316|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
161709974|NCT01412879|583982317|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
161709975|NCT01412879|583982318|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
161709976|NCT01412879|583982316|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
161709977|NCT01412879|583982317|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
161709978|NCT01412879|583982318|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
161709979|NCT04030195|583982319|FG000|Overall Study|Withdrawal by Subject|2|||
161709980|NCT04030195|583982320|FG001|Overall Study|Withdrawal by Subject|0|||
161709981|NCT04030195|583982321|FG002|Overall Study|Withdrawal by Subject|0|||
161709982|NCT01056107|583982323|FG000|Overall Study|Withdrawal by Subject|0|||
161709983|NCT01056107|583982324|FG001|Overall Study|Withdrawal by Subject|1|||
161709984|NCT01056107|583982325|FG002|Overall Study|Withdrawal by Subject|3|||
161709985|NCT01056107|583982326|FG003|Overall Study|Withdrawal by Subject|0|||
161709986|NCT00603239|583982336|FG000|Overall Study|Adverse Event|4|||
161709987|NCT00603239|583982337|FG001|Overall Study|Adverse Event|1|||
161709988|NCT00603239|583982336|FG000|Overall Study|Entry criteria not met|0|||
161709989|NCT00603239|583982337|FG001|Overall Study|Entry criteria not met|1|||
161709990|NCT00603239|583982336|FG000|Overall Study|Loss of glucose control|3|||
161709991|NCT00603239|583982337|FG001|Overall Study|Loss of glucose control|0|||
161709992|NCT00603239|583982336|FG000|Overall Study|Lost to Follow-up|2|||
161709993|NCT00603239|583982337|FG001|Overall Study|Lost to Follow-up|1|||
161709994|NCT00603239|583982336|FG000|Overall Study|Physician Decision|2|||
161709995|NCT00603239|583982337|FG001|Overall Study|Physician Decision|0|||
161709996|NCT00603239|583982336|FG000|Overall Study|Protocol Violation|2|||
161709997|NCT00603239|583982337|FG001|Overall Study|Protocol Violation|0|||
161709998|NCT00603239|583982336|FG000|Overall Study|Subject decision|2|||
161709999|NCT00603239|583982337|FG001|Overall Study|Subject decision|1|||
161710000|NCT02210780|583982338|FG000|Overall Study|Adverse Event|0|||
161710001|NCT02210780|583982339|FG001|Overall Study|Adverse Event|5|||
161710002|NCT02210780|583982338|FG000|Overall Study|Lost to Follow-up|2|||
161710003|NCT02210780|583982339|FG001|Overall Study|Lost to Follow-up|1|||
161710004|NCT02210780|583982338|FG000|Overall Study|Withdrawal by Subject|1|||
161710005|NCT02210780|583982339|FG001|Overall Study|Withdrawal by Subject|1|||
161710006|NCT02210780|583982338|FG000|Overall Study|Physician Decision|1|||
161710007|NCT02210780|583982339|FG001|Overall Study|Physician Decision|0|||
161710008|NCT02210780|583982338|FG000|Overall Study|Protocol Violation|1|||
161710009|NCT02210780|583982339|FG001|Overall Study|Protocol Violation|0|||
161710010|NCT02210780|583982338|FG000|Overall Study|Other than specified above|0|||
161710011|NCT02210780|583982339|FG001|Overall Study|Other than specified above|1|||
161710012|NCT00097539|583982340|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
161710013|NCT00097539|583982341|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
161710014|NCT00097539|583982342|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
161710015|NCT00097539|583982343|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
161710016|NCT00097539|583982344|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
161710017|NCT00097539|583982345|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
161710018|NCT00097539|583982346|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
161710019|NCT00097539|583982340|FG000|Overall Study|Withdrawal by Subject|925|||
161710020|NCT00097539|583982341|FG001|Overall Study|Withdrawal by Subject|323|||
161710021|NCT00097539|583982342|FG002|Overall Study|Withdrawal by Subject|346|||
161710022|NCT00097539|583982343|FG003|Overall Study|Withdrawal by Subject|217|||
161710023|NCT00097539|583982344|FG004|Overall Study|Withdrawal by Subject|68|||
161710024|NCT00097539|583982345|FG005|Overall Study|Withdrawal by Subject|229|||
161710025|NCT00097539|583982346|FG006|Overall Study|Withdrawal by Subject|3|||
161710026|NCT00097539|583982340|FG000|Overall Study|Participant Non-compliant|2140|||
161710027|NCT00097539|583982341|FG001|Overall Study|Participant Non-compliant|567|||
161710028|NCT00097539|583982342|FG002|Overall Study|Participant Non-compliant|1067|||
161710029|NCT00097539|583982343|FG003|Overall Study|Participant Non-compliant|353|||
161710030|NCT00097539|583982344|FG004|Overall Study|Participant Non-compliant|136|||
161710031|NCT00097539|583982345|FG005|Overall Study|Participant Non-compliant|543|||
161710032|NCT00097539|583982346|FG006|Overall Study|Participant Non-compliant|18|||
161710033|NCT00097539|583982340|FG000|Overall Study|Lack of Efficacy|249|||
161710034|NCT00097539|583982341|FG001|Overall Study|Lack of Efficacy|122|||
161710035|NCT00097539|583982342|FG002|Overall Study|Lack of Efficacy|202|||
161710036|NCT00097539|583982343|FG003|Overall Study|Lack of Efficacy|105|||
161958707|NCT01524224|584895006|FG005|Overall Study|Progressive Disease|1|||
161710037|NCT00097539|583982344|FG004|Overall Study|Lack of Efficacy|45|||
161958708|NCT01524224|584895007|FG006|Overall Study|Progressive Disease|1|||
161958709|NCT01524224|584895008|FG007|Overall Study|Progressive Disease|5|||
161710038|NCT00097539|583982345|FG005|Overall Study|Lack of Efficacy|228|||
161710039|NCT00097539|583982346|FG006|Overall Study|Lack of Efficacy|5|||
161837826|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
161837827|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
161837828|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
161958710|NCT01524224|584895001|FG000|Overall Study|Withdrawal by Subject|2|||
161958711|NCT01524224|584895002|FG001|Overall Study|Withdrawal by Subject|0|||
161958712|NCT01524224|584895003|FG002|Overall Study|Withdrawal by Subject|0|||
161958713|NCT01524224|584895004|FG003|Overall Study|Withdrawal by Subject|0|||
161958714|NCT01524224|584895005|FG004|Overall Study|Withdrawal by Subject|0|||
161958715|NCT01524224|584895006|FG005|Overall Study|Withdrawal by Subject|0|||
161958716|NCT01524224|584895007|FG006|Overall Study|Withdrawal by Subject|2|||
161958717|NCT01524224|584895008|FG007|Overall Study|Withdrawal by Subject|0|||
161958718|NCT01524224|584895001|FG000|Overall Study|Adverse Event|0|||
161958719|NCT01524224|584895002|FG001|Overall Study|Adverse Event|1|||
161958720|NCT01524224|584895003|FG002|Overall Study|Adverse Event|0|||
161958721|NCT01524224|584895004|FG003|Overall Study|Adverse Event|0|||
161958722|NCT01524224|584895005|FG004|Overall Study|Adverse Event|0|||
161958723|NCT01524224|584895006|FG005|Overall Study|Adverse Event|1|||
161958724|NCT01524224|584895007|FG006|Overall Study|Adverse Event|0|||
161958725|NCT01524224|584895008|FG007|Overall Study|Adverse Event|0|||
161958726|NCT01524224|584895001|FG000|Overall Study|Physician Decision|0|||
161958727|NCT01524224|584895002|FG001|Overall Study|Physician Decision|0|||
161837829|NCT00974974|584450212|FG000|Maintenance - Double Blind Treatment|Various|4|||
161958728|NCT01524224|584895003|FG002|Overall Study|Physician Decision|0|||
161958729|NCT01524224|584895004|FG003|Overall Study|Physician Decision|1|||
161958730|NCT01524224|584895005|FG004|Overall Study|Physician Decision|1|||
161958731|NCT01524224|584895006|FG005|Overall Study|Physician Decision|0|||
161958732|NCT01524224|584895007|FG006|Overall Study|Physician Decision|0|||
161958733|NCT01524224|584895008|FG007|Overall Study|Physician Decision|1|||
161958734|NCT01524224|584895001|FG000|Overall Study|Sponsor Decision|0|||
161958735|NCT01524224|584895002|FG001|Overall Study|Sponsor Decision|0|||
161958736|NCT01524224|584895003|FG002|Overall Study|Sponsor Decision|0|||
161958737|NCT01524224|584895004|FG003|Overall Study|Sponsor Decision|0|||
161958738|NCT01524224|584895005|FG004|Overall Study|Sponsor Decision|1|||
161958739|NCT01524224|584895006|FG005|Overall Study|Sponsor Decision|0|||
161958740|NCT01524224|584895007|FG006|Overall Study|Sponsor Decision|0|||
161958741|NCT01524224|584895008|FG007|Overall Study|Sponsor Decision|0|||
161958742|NCT01119066|584895015|FG000|Overall Study|Withdrawal by Subject|4|||
161958743|NCT01119066|584895016|FG001|Overall Study|Withdrawal by Subject|6|||
161837830|NCT00974974|584450213|FG001|Maintenance - Double Blind Treatment|Various|0|||
161958744|NCT01119066|584895017|FG002|Overall Study|Withdrawal by Subject|0|||
161837831|NCT01959035|584450214|FG000|Overall Study|Adverse Event|5|||
161958745|NCT01119066|584895018|FG003|Overall Study|Withdrawal by Subject|0|||
161958746|NCT01119066|584895015|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
161958747|NCT01119066|584895016|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
161710040|NCT00097539|583982340|FG000|Overall Study|Adverse Event|78|||
161958748|NCT01119066|584895017|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
161958749|NCT01119066|584895018|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
161958750|NCT01119066|584895015|FG000|Overall Study|Relapse identified before transplant|1|||
161958751|NCT01119066|584895016|FG001|Overall Study|Relapse identified before transplant|0|||
162030870|NCT00534313|585169497|FG001|Long-term Period|Adverse Event|1|||
161710041|NCT00097539|583982341|FG001|Overall Study|Adverse Event|133|||
161958752|NCT01119066|584895017|FG002|Overall Study|Relapse identified before transplant|0|||
161958753|NCT01119066|584895018|FG003|Overall Study|Relapse identified before transplant|0|||
161958754|NCT01119066|584895015|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
161958755|NCT01119066|584895016|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
161710042|NCT00097539|583982342|FG002|Overall Study|Adverse Event|37|||
161837832|NCT01959035|584450214|FG000|Overall Study|Withdrawal by Subject|4|||
161837833|NCT01959035|584450214|FG000|Overall Study|Lost to Follow-up|1|||
161837834|NCT01959035|584450214|FG000|Overall Study|Other (no primary reason given)|1|||
161837835|NCT03254602|584450215|FG000|Overall Study|Lost to Follow-up|4|||
161837836|NCT01691820|584450218|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
161837837|NCT01691820|584450219|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
161837838|NCT01691820|584450218|FG000|Overall Study|Migrated/moved from study area|7|||
161837839|NCT01691820|584450219|FG001|Overall Study|Migrated/moved from study area|4|||
161837840|NCT01691820|584450218|FG000|Overall Study|Lost to Follow-up|6|||
161837841|NCT01691820|584450219|FG001|Overall Study|Lost to Follow-up|17|||
161837842|NCT01691820|584450218|FG000|Overall Study|Other (unspecified)|4|||
161837843|NCT01691820|584450219|FG001|Overall Study|Other (unspecified)|1|||
161837844|NCT01968694|584450220|FG000|Washout (1 Month)|Lost to Follow-up|0|||
161837845|NCT01968694|584450221|FG001|Washout (1 Month)|Lost to Follow-up|1|||
161837846|NCT02836496|584450222|FG000|Overall Study|Adverse Event|2|||
161837847|NCT02836496|584450223|FG001|Overall Study|Adverse Event|1|||
161837848|NCT02836496|584450222|FG000|Overall Study|Withdrawal by Subject|0|||
161837849|NCT02836496|584450223|FG001|Overall Study|Withdrawal by Subject|1|||
161837850|NCT01400919|584450224|FG000|Overall Study|Withdrawal by Subject|4|||
161837851|NCT01400919|584450224|FG000|Overall Study|Lost to Follow-up|2|||
161837852|NCT01400919|584450224|FG000|Overall Study|Missed visit|2|||
161837853|NCT01246011|584450225|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
161958756|NCT01119066|584895017|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
161958757|NCT01119066|584895018|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
161958758|NCT01119066|584895015|FG000|Overall Study|Relapse identified before transplant|0|||
161958759|NCT01119066|584895016|FG001|Overall Study|Relapse identified before transplant|4|||
161958760|NCT01119066|584895017|FG002|Overall Study|Relapse identified before transplant|0|||
161958761|NCT01119066|584895018|FG003|Overall Study|Relapse identified before transplant|0|||
161958762|NCT00783835|584895019|FG000|Overall Study|Adverse Event|3|||
161958763|NCT00783835|584895019|FG000|Overall Study|Medical Criteria|1|||
161958764|NCT00783835|584895019|FG000|Overall Study|Withdrawal by Subject|2|||
161958765|NCT00783835|584895019|FG000|Overall Study|Lost to Follow-up|1|||
161958766|NCT00783835|584895019|FG000|Overall Study|Participant not Adherent|3|||
161958767|NCT00295646|584895020|FG000|Overall Study|Protocol Violation|18|||
161958768|NCT00295646|584895021|FG001|Overall Study|Protocol Violation|20|||
161958769|NCT00295646|584895022|FG002|Overall Study|Protocol Violation|20|||
161958770|NCT00295646|584895023|FG003|Overall Study|Protocol Violation|18|||
161958771|NCT00295646|584895020|FG000|Overall Study|Withdrawal by Subject|8|||
161958772|NCT00295646|584895021|FG001|Overall Study|Withdrawal by Subject|9|||
161958773|NCT00295646|584895022|FG002|Overall Study|Withdrawal by Subject|11|||
161958774|NCT00295646|584895023|FG003|Overall Study|Withdrawal by Subject|14|||
161958775|NCT00295646|584895020|FG000|Overall Study|Lost to Follow-up|0|||
161958776|NCT00295646|584895021|FG001|Overall Study|Lost to Follow-up|5|||
161958777|NCT00295646|584895022|FG002|Overall Study|Lost to Follow-up|1|||
161958778|NCT00295646|584895023|FG003|Overall Study|Lost to Follow-up|5|||
161958779|NCT00295646|584895020|FG000|Overall Study|Death|9|||
161958780|NCT00295646|584895021|FG001|Overall Study|Death|7|||
161958781|NCT00295646|584895022|FG002|Overall Study|Death|18|||
161958782|NCT00295646|584895023|FG003|Overall Study|Death|8|||
161958783|NCT01970241|584895024|FG000|Overall Study|Withdrawal by Subject|2|||
161958784|NCT01970241|584895025|FG001|Overall Study|Withdrawal by Subject|0|||
161958785|NCT01970241|584895024|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
161958786|NCT01970241|584895025|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
161958787|NCT01232127|584895027|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
161958788|NCT01232127|584895028|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
161958789|NCT01232127|584895029|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
161958790|NCT02623205|584895033|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
161958791|NCT02623205|584895034|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
161958792|NCT03162796|584895038|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
161958793|NCT03162796|584895039|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
161958794|NCT03162796|584895040|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
161958795|NCT03162796|584895038|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
161958796|NCT03162796|584895039|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
161958797|NCT03162796|584895040|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
161958798|NCT03162796|584895038|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
161958799|NCT03162796|584895039|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
161958800|NCT03162796|584895040|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
161958801|NCT03162796|584895038|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
161958802|NCT03162796|584895039|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
161710043|NCT00097539|583982343|FG003|Overall Study|Adverse Event|27|||
161710044|NCT00097539|583982344|FG004|Overall Study|Adverse Event|30|||
161710045|NCT00097539|583982345|FG005|Overall Study|Adverse Event|59|||
161710046|NCT00097539|583982346|FG006|Overall Study|Adverse Event|1|||
161710047|NCT00097539|583982340|FG000|Overall Study|Death|2|||
161710048|NCT00097539|583982341|FG001|Overall Study|Death|7|||
161710049|NCT00097539|583982342|FG002|Overall Study|Death|0|||
161710050|NCT00097539|583982343|FG003|Overall Study|Death|0|||
161710051|NCT00097539|583982344|FG004|Overall Study|Death|1|||
161710052|NCT00097539|583982345|FG005|Overall Study|Death|3|||
161710053|NCT00097539|583982346|FG006|Overall Study|Death|0|||
161710054|NCT00097539|583982340|FG000|Overall Study|Reasons Other Than Above|3602|||
161710055|NCT00097539|583982341|FG001|Overall Study|Reasons Other Than Above|1382|||
161710056|NCT00097539|583982342|FG002|Overall Study|Reasons Other Than Above|1757|||
161710057|NCT00097539|583982343|FG003|Overall Study|Reasons Other Than Above|692|||
161710058|NCT00097539|583982344|FG004|Overall Study|Reasons Other Than Above|361|||
161710059|NCT00097539|583982345|FG005|Overall Study|Reasons Other Than Above|1244|||
161710060|NCT00097539|583982346|FG006|Overall Study|Reasons Other Than Above|34|||
161710061|NCT00097539|583982340|FG000|Overall Study|Reason not Specified|111|||
161710062|NCT00097539|583982341|FG001|Overall Study|Reason not Specified|49|||
161710063|NCT00097539|583982342|FG002|Overall Study|Reason not Specified|53|||
161710064|NCT00097539|583982343|FG003|Overall Study|Reason not Specified|21|||
161710065|NCT00097539|583982344|FG004|Overall Study|Reason not Specified|11|||
161710066|NCT00097539|583982345|FG005|Overall Study|Reason not Specified|40|||
161710067|NCT00097539|583982346|FG006|Overall Study|Reason not Specified|2|||
161710068|NCT00364793|583982347|FG000|Overall Study|Adverse Event|2|||
161710069|NCT00364793|583982348|FG001|Overall Study|Adverse Event|0|||
161710070|NCT00364793|583982349|FG002|Overall Study|Adverse Event|0|||
161710071|NCT00364793|583982350|FG003|Overall Study|Adverse Event|0|||
161958803|NCT03162796|584895040|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
161958804|NCT03162796|584895038|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
161958805|NCT03162796|584895039|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
161958806|NCT03162796|584895040|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
161958807|NCT03162796|584895038|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
161958808|NCT03162796|584895039|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
161710072|NCT00364793|583982347|FG000|Overall Study|Death|1|||
161710073|NCT00364793|583982348|FG001|Overall Study|Death|0|||
161710074|NCT00364793|583982349|FG002|Overall Study|Death|1|||
161710075|NCT00364793|583982350|FG003|Overall Study|Death|0|||
161710076|NCT00364793|583982347|FG000|Overall Study|Lack of Efficacy|3|||
161710077|NCT00364793|583982348|FG001|Overall Study|Lack of Efficacy|3|||
161710078|NCT00364793|583982349|FG002|Overall Study|Lack of Efficacy|1|||
161710079|NCT00364793|583982350|FG003|Overall Study|Lack of Efficacy|1|||
161710080|NCT00364793|583982347|FG000|Overall Study|Lost to Follow-up|1|||
161710081|NCT00364793|583982348|FG001|Overall Study|Lost to Follow-up|0|||
162030871|NCT00534313|585169498|FG002|Long-term Period|Adverse Event|0|||
161958809|NCT03162796|584895040|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
161958810|NCT03162796|584895038|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
161958811|NCT03162796|584895039|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
161958812|NCT03162796|584895040|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
161958813|NCT03162796|584895038|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
161958814|NCT03162796|584895039|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
161958815|NCT03162796|584895040|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
161958816|NCT03162796|584895038|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
161958817|NCT03162796|584895039|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
161958818|NCT03162796|584895040|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
161958819|NCT03162796|584895038|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
161958820|NCT03162796|584895039|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
161958821|NCT03162796|584895040|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
161958822|NCT03162796|584895038|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
161958823|NCT03162796|584895039|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
161958824|NCT03162796|584895040|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
161958825|NCT02375373|584895041|FG000|Overall Study|Withdrawal by Subject|11|||
161958826|NCT02725476|584895042|FG000|Overall Study|Physician Decision|2|||
161958827|NCT02725476|584895043|FG001|Overall Study|Physician Decision|0|||
161958828|NCT02725476|584895042|FG000|Overall Study|Adverse Event|1|||
161958829|NCT02725476|584895043|FG001|Overall Study|Adverse Event|1|||
161958830|NCT00289289|584895045|FG000|Overall Study|Withdrawal by Subject|5|||
161710082|NCT00364793|583982349|FG002|Overall Study|Lost to Follow-up|2|||
161958831|NCT00289289|584895046|FG001|Overall Study|Withdrawal by Subject|3|||
161958832|NCT00289289|584895047|FG002|Overall Study|Withdrawal by Subject|15|||
161958833|NCT00289289|584895045|FG000|Overall Study|Lost to Follow-up|1|||
161958834|NCT00289289|584895046|FG001|Overall Study|Lost to Follow-up|0|||
161958835|NCT00289289|584895047|FG002|Overall Study|Lost to Follow-up|1|||
161958836|NCT00289289|584895045|FG000|Overall Study|Death|4|||
161958837|NCT00289289|584895046|FG001|Overall Study|Death|2|||
161958838|NCT00289289|584895047|FG002|Overall Study|Death|5|||
161958839|NCT00289289|584895045|FG000|Overall Study|No implant attempted|0|||
161958840|NCT00289289|584895046|FG001|Overall Study|No implant attempted|0|||
161958841|NCT00289289|584895047|FG002|Overall Study|No implant attempted|1|||
161958842|NCT00289289|584895045|FG000|Overall Study|Physician Decision|1|||
161958843|NCT00289289|584895046|FG001|Overall Study|Physician Decision|0|||
161958844|NCT00289289|584895047|FG002|Overall Study|Physician Decision|6|||
161958845|NCT00289289|584895045|FG000|Overall Study|Non-study device implanted|2|||
161958846|NCT00289289|584895046|FG001|Overall Study|Non-study device implanted|1|||
161958847|NCT00289289|584895047|FG002|Overall Study|Non-study device implanted|3|||
161958848|NCT00289289|584895045|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
161958849|NCT00289289|584895046|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
162030872|NCT00534313|585169499|FG003|Long-term Period|Adverse Event|1|||
162030873|NCT00534313|585169496|FG000|Long-term Period|Lack of Efficacy|14|||
162030874|NCT00534313|585169497|FG001|Long-term Period|Lack of Efficacy|10|||
162030875|NCT00534313|585169498|FG002|Long-term Period|Lack of Efficacy|14|||
162030876|NCT00534313|585169499|FG003|Long-term Period|Lack of Efficacy|12|||
162030877|NCT00534313|585169496|FG000|Long-term Period|Lost to Follow-up|1|||
162030878|NCT00534313|585169497|FG001|Long-term Period|Lost to Follow-up|2|||
162030879|NCT00534313|585169498|FG002|Long-term Period|Lost to Follow-up|0|||
162030880|NCT00534313|585169499|FG003|Long-term Period|Lost to Follow-up|0|||
162030881|NCT00534313|585169496|FG000|Long-term Period|Withdrawal by Subject|2|||
162030882|NCT00534313|585169497|FG001|Long-term Period|Withdrawal by Subject|2|||
162030883|NCT00534313|585169498|FG002|Long-term Period|Withdrawal by Subject|0|||
162030884|NCT00534313|585169499|FG003|Long-term Period|Withdrawal by Subject|0|||
162030885|NCT00534313|585169496|FG000|Long-term Period|No longer meets study criteria|0|||
162030886|NCT00534313|585169497|FG001|Long-term Period|No longer meets study criteria|1|||
162030887|NCT00534313|585169498|FG002|Long-term Period|No longer meets study criteria|0|||
162030888|NCT00534313|585169499|FG003|Long-term Period|No longer meets study criteria|0|||
162030889|NCT00534313|585169496|FG000|Long-term Period|Poor compliance/noncompliance|0|||
162030890|NCT00534313|585169497|FG001|Long-term Period|Poor compliance/noncompliance|1|||
162030891|NCT00534313|585169498|FG002|Long-term Period|Poor compliance/noncompliance|1|||
162030892|NCT00534313|585169499|FG003|Long-term Period|Poor compliance/noncompliance|0|||
162030893|NCT00534313|585169496|FG000|Long-term Period|Administrative reason by sponsor|17|||
162030894|NCT00534313|585169497|FG001|Long-term Period|Administrative reason by sponsor|15|||
162030895|NCT00534313|585169498|FG002|Long-term Period|Administrative reason by sponsor|26|||
162030896|NCT00534313|585169499|FG003|Long-term Period|Administrative reason by sponsor|18|||
162030897|NCT00534313|585169496|FG000|Long-term Period|Other|1|||
161958850|NCT00289289|584895047|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
161958851|NCT00289289|584895045|FG000|Overall Study|Other Exit Reason|6|||
162030898|NCT00534313|585169497|FG001|Long-term Period|Other|2|||
162030899|NCT00534313|585169498|FG002|Long-term Period|Other|2|||
162030900|NCT00534313|585169499|FG003|Long-term Period|Other|2|||
161958852|NCT00289289|584895046|FG001|Overall Study|Other Exit Reason|4|||
161958853|NCT00289289|584895047|FG002|Overall Study|Other Exit Reason|12|||
161958854|NCT01445613|584895048|FG000|30-day Follow-up|Withdrawal by Subject|6|||
162030901|NCT00402233|585169500|FG000|Overall Study|Adverse Event|1|||
162030902|NCT00402233|585169501|FG001|Overall Study|Adverse Event|7|||
161958855|NCT01445613|584895048|FG000|30-day Follow-up|Physician Decision|3|||
161958856|NCT01445613|584895048|FG000|30-day Follow-up|Missed visit|23|||
161958857|NCT01445613|584895048|FG000|30-day Follow-up|Death|3|||
161958858|NCT01445613|584895048|FG000|1-year Follow-up|Withdrawal by Subject|12|||
161958859|NCT01445613|584895048|FG000|1-year Follow-up|Missed visit|29|||
161958860|NCT01445613|584895048|FG000|1-year Follow-up|Lost to Follow-up|2|||
161958861|NCT01445613|584895048|FG000|1-year Follow-up|Death|30|||
161958862|NCT01445613|584895048|FG000|1-year Follow-up|Physician Decision|2|||
161958863|NCT01445613|584895048|FG000|1-year Follow-up|Received a non-study stent|2|||
161958864|NCT01169701|584895049|FG000|Overall Study|Lost to Follow-up|1|||
161958865|NCT01169701|584895050|FG001|Overall Study|Lost to Follow-up|1|||
161958866|NCT01169701|584895049|FG000|Overall Study|Withdrawal by Subject|1|||
161958867|NCT01169701|584895050|FG001|Overall Study|Withdrawal by Subject|3|||
161958868|NCT01169701|584895049|FG000|Overall Study|Adverse Event|1|||
161958869|NCT01169701|584895050|FG001|Overall Study|Adverse Event|2|||
161958870|NCT01169701|584895049|FG000|Overall Study|Exclusion criteria|2|||
161958871|NCT01169701|584895050|FG001|Overall Study|Exclusion criteria|0|||
161958872|NCT01169701|584895049|FG000|Overall Study|Death|0|||
161958873|NCT01169701|584895050|FG001|Overall Study|Death|1|||
161958874|NCT01169701|584895049|FG000|Overall Study|Administrative problems|0|||
161958875|NCT01169701|584895050|FG001|Overall Study|Administrative problems|1|||
161958876|NCT01169701|584895049|FG000|Overall Study|Serious adverse event|0|||
161958877|NCT01169701|584895050|FG001|Overall Study|Serious adverse event|1|||
161958878|NCT01169701|584895049|FG000|Overall Study|Sponsor decision|0|||
161958879|NCT01169701|584895050|FG001|Overall Study|Sponsor decision|1|||
161958880|NCT00130039|584895054|FG000|Overall Study|Withdrawal by Subject|15|||
161958881|NCT00130039|584895055|FG001|Overall Study|Withdrawal by Subject|11|||
161958882|NCT00130039|584895054|FG000|Overall Study|Lost to Follow-up|3|||
161958883|NCT00130039|584895055|FG001|Overall Study|Lost to Follow-up|1|||
161958884|NCT00130039|584895054|FG000|Overall Study|Adverse Event|4|||
161958885|NCT00130039|584895055|FG001|Overall Study|Adverse Event|2|||
161958886|NCT00130039|584895054|FG000|Overall Study|Physician Decision|3|||
161958887|NCT00130039|584895055|FG001|Overall Study|Physician Decision|0|||
161958888|NCT00130039|584895054|FG000|Overall Study|clinical events without follow up MRI|5|||
161958889|NCT00130039|584895055|FG001|Overall Study|clinical events without follow up MRI|4|||
161958890|NCT01740687|584895056|FG000|Overall Study|Lost to Follow-up|11|||
161958891|NCT01740687|584895056|FG000|Overall Study|Withdrawal by Subject|2|||
161958892|NCT01740687|584895056|FG000|Overall Study|other reason|22|||
161837854|NCT01246011|584450226|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
161837855|NCT01246011|584450227|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
161958893|NCT01740687|584895056|FG000|Overall Study|treatment not received|2|||
161958894|NCT00200967|584895058|FG000|First Treatment Period|Withdrawal by Subject|5|||
161958895|NCT00200967|584895059|FG001|First Treatment Period|Withdrawal by Subject|1|||
161958896|NCT00200967|584895058|FG000|First Treatment Period|Pregnancy|1|||
161837856|NCT01246011|584450225|FG000|Overall Study|Withdrawal by Subject|0|||
161958897|NCT00200967|584895059|FG001|First Treatment Period|Pregnancy|0|||
161958898|NCT00200967|584895058|FG000|Wash-out Period|Lost to Follow-up|0|||
161958899|NCT00200967|584895059|FG001|Wash-out Period|Lost to Follow-up|1|||
161958900|NCT00200967|584895058|FG000|Second Treatment Period|Withdrawal by Subject|1|||
161958901|NCT00200967|584895059|FG001|Second Treatment Period|Withdrawal by Subject|2|||
161958902|NCT00200967|584895058|FG000|Run-out Period|Lost to Follow-up|1|||
161710083|NCT00364793|583982350|FG003|Overall Study|Lost to Follow-up|0|||
161710084|NCT00364793|583982347|FG000|Overall Study|Poor or non-compliance|1|||
161710085|NCT00364793|583982348|FG001|Overall Study|Poor or non-compliance|1|||
161710086|NCT00364793|583982349|FG002|Overall Study|Poor or non-compliance|0|||
161958903|NCT00200967|584895059|FG001|Run-out Period|Lost to Follow-up|0|||
161958904|NCT00078806|584896432|FG000|Part 1A|Adverse Event|2|||
161958905|NCT00078806|584896433|FG001|Part 1A|Adverse Event|0|||
161958906|NCT00078806|584896434|FG002|Part 1A|Adverse Event|0|||
161710087|NCT00364793|583982350|FG003|Overall Study|Poor or non-compliance|1|||
161958907|NCT00078806|584896435|FG003|Part 1A|Adverse Event|0|||
161958908|NCT00078806|584896432|FG000|Part 1A|Lack of Efficacy|7|||
161958909|NCT00078806|584896433|FG001|Part 1A|Lack of Efficacy|0|||
161710088|NCT00364793|583982347|FG000|Overall Study|No longer meets criteria|0|||
161710089|NCT00364793|583982348|FG001|Overall Study|No longer meets criteria|0|||
161710090|NCT00364793|583982349|FG002|Overall Study|No longer meets criteria|0|||
161837857|NCT01246011|584450226|FG001|Overall Study|Withdrawal by Subject|0|||
161837858|NCT01246011|584450227|FG002|Overall Study|Withdrawal by Subject|1|||
161837859|NCT04392583|584450228|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
161958910|NCT00078806|584896434|FG002|Part 1A|Lack of Efficacy|0|||
161958911|NCT00078806|584896435|FG003|Part 1A|Lack of Efficacy|0|||
161958912|NCT00078806|584896432|FG000|Part 1A|Other|1|||
161958913|NCT00078806|584896433|FG001|Part 1A|Other|0|||
161958914|NCT00078806|584896434|FG002|Part 1A|Other|0|||
161958915|NCT00078806|584896435|FG003|Part 1A|Other|0|||
161958916|NCT00078806|584896432|FG000|Part 1B|Adverse Event|1|||
161958917|NCT00078806|584896433|FG001|Part 1B|Adverse Event|0|||
161958918|NCT00078806|584896434|FG002|Part 1B|Adverse Event|0|||
161958919|NCT00078806|584896435|FG003|Part 1B|Adverse Event|0|||
161958920|NCT00078806|584896432|FG000|Part 1B|Lack of Efficacy|7|||
161958921|NCT00078806|584896433|FG001|Part 1B|Lack of Efficacy|0|||
161958922|NCT00078806|584896434|FG002|Part 1B|Lack of Efficacy|0|||
161958923|NCT00078806|584896435|FG003|Part 1B|Lack of Efficacy|0|||
161958924|NCT00078806|584896432|FG000|Part 2|Adverse Event|0|||
161958925|NCT00078806|584896433|FG001|Part 2|Adverse Event|1|||
161958926|NCT00078806|584896434|FG002|Part 2|Adverse Event|0|||
161958927|NCT00078806|584896435|FG003|Part 2|Adverse Event|0|||
161958928|NCT00161616|584896436|FG000|Overall Study|Withdrawal by Subject|6|||
161958929|NCT00161616|584896437|FG001|Overall Study|Withdrawal by Subject|5|||
161958930|NCT00161616|584896436|FG000|Overall Study|Physician Decision|1|||
161958931|NCT00161616|584896437|FG001|Overall Study|Physician Decision|0|||
161958932|NCT00161616|584896436|FG000|Overall Study|Death|1|||
161958933|NCT00161616|584896437|FG001|Overall Study|Death|1|||
161958934|NCT00161616|584896436|FG000|Overall Study|Lost to Follow-up|17|||
161958935|NCT00161616|584896437|FG001|Overall Study|Lost to Follow-up|13|||
161958936|NCT00161616|584896436|FG000|Overall Study|Protocol deviation|1|||
161958937|NCT00161616|584896437|FG001|Overall Study|Protocol deviation|0|||
161958938|NCT04908384|584896438|FG000|Overall Study|Lost to Follow-up|4|||
161958939|NCT04908384|584896439|FG001|Overall Study|Lost to Follow-up|4|||
161958940|NCT04908384|584896440|FG002|Overall Study|Lost to Follow-up|0|||
161958941|NCT04908384|584896441|FG003|Overall Study|Lost to Follow-up|0|||
161958942|NCT00833469|584896442|FG000|Overall Study|Withdrawal by Subject|1|||
161958943|NCT00833469|584896442|FG000|Overall Study|Lost to Follow-up|1|||
161958944|NCT02943070|584896443|FG000|Overall Study|Physician Decision|1|||
161958945|NCT02943070|584896443|FG000|Overall Study|Adverse Event|2|||
161958946|NCT02943070|584896443|FG000|Overall Study|Death|2|||
161958947|NCT02943070|584896443|FG000|Overall Study|Withdrawal by Subject|3|||
162030903|NCT00402233|585169502|FG002|Overall Study|Adverse Event|9|||
161837860|NCT01340768|584450229|FG000|Overall Study|Lost to Follow-up|10|||
161837861|NCT01340768|584450230|FG001|Overall Study|Lost to Follow-up|4|||
161958948|NCT02943070|584896443|FG000|Overall Study|Lost to Follow-up|4|||
161958949|NCT02943070|584896443|FG000|Overall Study|Retreatment or TURP|13|||
161958950|NCT02943070|584896443|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
161958951|NCT01701362|584896444|FG000|Overall Study|Adverse events not related to study drug|1|||
161958952|NCT01701362|584896445|FG001|Overall Study|Adverse events not related to study drug|6|||
161958953|NCT01701362|584896444|FG000|Overall Study|Adverse events related to study drug|12|||
161958954|NCT01701362|584896445|FG001|Overall Study|Adverse events related to study drug|10|||
161958955|NCT01701362|584896444|FG000|Overall Study|Protocol Violation|5|||
161710091|NCT00364793|583982350|FG003|Overall Study|No longer meets criteria|1|||
161710092|NCT00364793|583982347|FG000|Overall Study|Withdrawal by Subject|0|||
161710093|NCT00364793|583982348|FG001|Overall Study|Withdrawal by Subject|1|||
161710094|NCT00364793|583982349|FG002|Overall Study|Withdrawal by Subject|0|||
161710095|NCT00364793|583982350|FG003|Overall Study|Withdrawal by Subject|0|||
161710096|NCT00363415|583982354|FG000|Overall Study|Progressive Disease|196|||
161710097|NCT00363415|583982355|FG001|Overall Study|Progressive Disease|107|||
161710098|NCT00363415|583982354|FG000|Overall Study|Sponsor Decision|67|||
161710099|NCT00363415|583982355|FG001|Overall Study|Sponsor Decision|31|||
161710100|NCT00363415|583982354|FG000|Overall Study|Death|32|||
161710101|NCT00363415|583982355|FG001|Overall Study|Death|29|||
161958956|NCT01701362|584896445|FG001|Overall Study|Protocol Violation|3|||
161958957|NCT01701362|584896444|FG000|Overall Study|No longer willing to participate|8|||
161958958|NCT01701362|584896445|FG001|Overall Study|No longer willing to participate|14|||
161958959|NCT01701362|584896444|FG000|Overall Study|Lost to Follow-up|6|||
161958960|NCT01701362|584896445|FG001|Overall Study|Lost to Follow-up|9|||
161958961|NCT01701362|584896444|FG000|Overall Study|Insufficient clinical response|6|||
161710102|NCT00363415|583982354|FG000|Overall Study|Adverse Event|24|||
161710103|NCT00363415|583982355|FG001|Overall Study|Adverse Event|15|||
161710104|NCT00363415|583982354|FG000|Overall Study|Physician Decision|18|||
161958962|NCT01701362|584896445|FG001|Overall Study|Insufficient clinical response|6|||
161958963|NCT01701362|584896444|FG000|Overall Study|Death|0|||
161958964|NCT01701362|584896445|FG001|Overall Study|Death|1|||
161958965|NCT01701362|584896444|FG000|Overall Study|Randomized but not treated|1|||
161958966|NCT01701362|584896445|FG001|Overall Study|Randomized but not treated|2|||
161958967|NCT01701362|584896444|FG000|Overall Study|Reasons other than those mentioned above|3|||
161958968|NCT01701362|584896445|FG001|Overall Study|Reasons other than those mentioned above|5|||
161958969|NCT00570778|584896446|FG000|Overall Study|Protocol deviation|2|||
161710105|NCT00363415|583982355|FG001|Overall Study|Physician Decision|35|||
162030904|NCT00402233|585169503|FG003|Overall Study|Adverse Event|9|||
161958970|NCT00570778|584896447|FG001|Overall Study|Protocol deviation|1|||
161958971|NCT00570778|584896448|FG002|Overall Study|Protocol deviation|2|||
161958972|NCT00570778|584896449|FG003|Overall Study|Protocol deviation|2|||
161958973|NCT00570778|584896446|FG000|Overall Study|Adverse Event|0|||
161958974|NCT00570778|584896447|FG001|Overall Study|Adverse Event|1|||
161958975|NCT00570778|584896448|FG002|Overall Study|Adverse Event|4|||
161958976|NCT00570778|584896449|FG003|Overall Study|Adverse Event|1|||
161958977|NCT00570778|584896446|FG000|Overall Study|Subject withdrew consent|0|||
161958978|NCT00570778|584896447|FG001|Overall Study|Subject withdrew consent|1|||
161958979|NCT00570778|584896448|FG002|Overall Study|Subject withdrew consent|0|||
161958980|NCT00570778|584896449|FG003|Overall Study|Subject withdrew consent|1|||
161958981|NCT00570778|584896446|FG000|Overall Study|Abnormal test procedure|1|||
161958982|NCT00570778|584896447|FG001|Overall Study|Abnormal test procedure|0|||
161958983|NCT00570778|584896448|FG002|Overall Study|Abnormal test procedure|0|||
161958984|NCT00570778|584896449|FG003|Overall Study|Abnormal test procedure|0|||
161958985|NCT00570778|584896446|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161958986|NCT00570778|584896447|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161958987|NCT00570778|584896448|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161958988|NCT00570778|584896449|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161958989|NCT00570778|584896446|FG000|Overall Study|Lost to Follow-up|0|||
161710106|NCT00363415|583982354|FG000|Overall Study|Entry Criteria Not Met|11|||
161710107|NCT00363415|583982355|FG001|Overall Study|Entry Criteria Not Met|10|||
161710108|NCT00363415|583982354|FG000|Overall Study|Withdrawal by Subject|9|||
161958990|NCT00570778|584896447|FG001|Overall Study|Lost to Follow-up|0|||
161958991|NCT00570778|584896448|FG002|Overall Study|Lost to Follow-up|1|||
161958992|NCT00570778|584896449|FG003|Overall Study|Lost to Follow-up|0|||
161958993|NCT00570778|584896446|FG000|Overall Study|Subject no longer requires study drug|0|||
161958994|NCT00570778|584896447|FG001|Overall Study|Subject no longer requires study drug|1|||
161710109|NCT00363415|583982355|FG001|Overall Study|Withdrawal by Subject|15|||
161710110|NCT00363415|583982354|FG000|Overall Study|Lost to Follow-up|3|||
161710111|NCT00363415|583982355|FG001|Overall Study|Lost to Follow-up|3|||
161710112|NCT00363415|583982354|FG000|Overall Study|Protocol Violation|1|||
161710113|NCT00363415|583982355|FG001|Overall Study|Protocol Violation|4|||
161710114|NCT02688647|583982364|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
161958995|NCT00570778|584896448|FG002|Overall Study|Subject no longer requires study drug|0|||
161958996|NCT00570778|584896449|FG003|Overall Study|Subject no longer requires study drug|0|||
161710115|NCT02688647|583982365|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
161958997|NCT00443872|584896452|FG000|Overall Study|Protocol Violation|7|||
161958998|NCT00443872|584896452|FG000|Overall Study|Lost to Follow-up|2|||
161710116|NCT02688647|583982364|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
161710117|NCT02688647|583982365|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
161710118|NCT02688647|583982364|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
161710119|NCT02688647|583982365|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
161710120|NCT02688647|583982364|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
161710121|NCT02688647|583982365|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
161710122|NCT02688647|583982364|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
161837862|NCT01340768|584450229|FG000|Overall Study|Withdrawal by Subject|5|||
161710123|NCT02688647|583982365|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
161710124|NCT02688647|583982364|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
161710125|NCT02688647|583982365|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
161710126|NCT02688647|583982364|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
161710127|NCT02688647|583982365|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
161710128|NCT02542267|583982366|FG000|Overall Study|Withdrawal by Subject|10|||
161710129|NCT02542267|583982366|FG000|Overall Study|Physician Decision|6|||
161710130|NCT02542267|583982366|FG000|Overall Study|Lost to Follow-up|4|||
161710131|NCT02542267|583982366|FG000|Overall Study|Death|13|||
161710132|NCT02542267|583982366|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
161710133|NCT02542267|583982366|FG000|Overall Study|Other|9|||
161710134|NCT03093402|583982367|FG000|Overall Study|Lost to Follow-up|1|||
161710135|NCT03093402|583982368|FG001|Overall Study|Lost to Follow-up|0|||
161710136|NCT03093402|583982369|FG002|Overall Study|Lost to Follow-up|0|||
161710137|NCT03093402|583982370|FG003|Overall Study|Lost to Follow-up|0|||
161710138|NCT03093402|583982367|FG000|Overall Study|Withdrawal by Subject|3|||
161710139|NCT03093402|583982368|FG001|Overall Study|Withdrawal by Subject|3|||
161710140|NCT03093402|583982369|FG002|Overall Study|Withdrawal by Subject|0|||
161710141|NCT03093402|583982370|FG003|Overall Study|Withdrawal by Subject|1|||
161710142|NCT03093402|583982367|FG000|Overall Study|Withdrew prior to dosing|2|||
161958999|NCT00443872|584896452|FG000|Overall Study|Adverse Event|8|||
161959000|NCT01014767|584896453|FG000|Overall Study|PI left institution, data unavailable|12|||
162030905|NCT00402233|585169500|FG000|Overall Study|Protocol Violation|0|||
161959001|NCT01014767|584896454|FG001|Overall Study|PI left institution, data unavailable|1|||
161959002|NCT01014767|584896455|FG002|Overall Study|PI left institution, data unavailable|4|||
161959003|NCT01014767|584896456|FG003|Overall Study|PI left institution, data unavailable|1|||
161959004|NCT00700622|584896457|FG000|Overall Study|Adverse Event|4|||
161959005|NCT00700622|584896458|FG001|Overall Study|Adverse Event|0|||
161959006|NCT00700622|584896457|FG000|Overall Study|Lost to Follow-up|0|||
161959007|NCT00700622|584896458|FG001|Overall Study|Lost to Follow-up|1|||
161959008|NCT00700622|584896457|FG000|Overall Study|Physician Decision|2|||
161959009|NCT00700622|584896458|FG001|Overall Study|Physician Decision|1|||
161959010|NCT00700622|584896457|FG000|Overall Study|Protocol Violation|0|||
161959011|NCT00700622|584896458|FG001|Overall Study|Protocol Violation|1|||
161959012|NCT00700622|584896457|FG000|Overall Study|Withdrawal by Subject|4|||
161959013|NCT00700622|584896458|FG001|Overall Study|Withdrawal by Subject|1|||
161959014|NCT00700622|584896457|FG000|Overall Study|Other|3|||
161959015|NCT00700622|584896458|FG001|Overall Study|Other|1|||
161959016|NCT00282087|584896459|FG000|Overall Study|Death|1|||
161959017|NCT00405392|584896460|FG000|Overall Study|Adverse Event|15|||
161959018|NCT00405392|584896461|FG001|Overall Study|Adverse Event|14|||
161959019|NCT00405392|584896460|FG000|Overall Study|Did not meet Eligibility criteria|7|||
161959020|NCT00405392|584896461|FG001|Overall Study|Did not meet Eligibility criteria|2|||
161959021|NCT00405392|584896460|FG000|Overall Study|Withdrawal by Subject|4|||
161959022|NCT00405392|584896461|FG001|Overall Study|Withdrawal by Subject|3|||
161959023|NCT00405392|584896460|FG000|Overall Study|Lost to Follow-up|1|||
161959024|NCT00405392|584896461|FG001|Overall Study|Lost to Follow-up|2|||
161959025|NCT00405392|584896460|FG000|Overall Study|Data missing|2|||
161959026|NCT00405392|584896461|FG001|Overall Study|Data missing|0|||
161959027|NCT00405392|584896460|FG000|Overall Study|Non-compliance|0|||
161959028|NCT00405392|584896461|FG001|Overall Study|Non-compliance|1|||
161959029|NCT00405392|584896460|FG000|Overall Study|Other|1|||
161959030|NCT00405392|584896461|FG001|Overall Study|Other|5|||
161959031|NCT01703091|584896464|FG000|Overall Study|Adverse Event|5|||
161959032|NCT01703091|584896465|FG001|Overall Study|Adverse Event|3|||
161959033|NCT01703091|584896464|FG000|Overall Study|Physician Decision|2|||
161959034|NCT01703091|584896465|FG001|Overall Study|Physician Decision|1|||
161959035|NCT01703091|584896464|FG000|Overall Study|Withdrawal by Subject|1|||
161959036|NCT01703091|584896465|FG001|Overall Study|Withdrawal by Subject|0|||
161959037|NCT01703091|584896464|FG000|Overall Study|Sponsor Decision|1|||
161959038|NCT01703091|584896465|FG001|Overall Study|Sponsor Decision|0|||
161959039|NCT00988052|584896466|FG000|Overall Study|Missing|1|||
161959040|NCT00988052|584896467|FG001|Overall Study|Missing|0|||
161959041|NCT00988052|584896466|FG000|Overall Study|Teva requested subject withdrawal|3|||
161959042|NCT00988052|584896467|FG001|Overall Study|Teva requested subject withdrawal|1|||
161959043|NCT00988052|584896466|FG000|Overall Study|Death|1|||
161959044|NCT00988052|584896467|FG001|Overall Study|Death|3|||
162030906|NCT00402233|585169501|FG001|Overall Study|Protocol Violation|1|||
161959045|NCT00988052|584896466|FG000|Overall Study|Protocol Violation|6|||
161959046|NCT00988052|584896467|FG001|Overall Study|Protocol Violation|5|||
161959047|NCT00988052|584896466|FG000|Overall Study|Pregnancy|6|||
161959048|NCT00988052|584896467|FG001|Overall Study|Pregnancy|6|||
161959049|NCT00988052|584896466|FG000|Overall Study|Lack of Efficacy|8|||
161959050|NCT00988052|584896467|FG001|Overall Study|Lack of Efficacy|7|||
161959051|NCT00988052|584896466|FG000|Overall Study|Lost to Follow-up|6|||
161959052|NCT00988052|584896467|FG001|Overall Study|Lost to Follow-up|11|||
161959053|NCT00988052|584896466|FG000|Overall Study|Physician Decision|27|||
161710143|NCT03093402|583982368|FG001|Overall Study|Withdrew prior to dosing|1|||
161710144|NCT03093402|583982369|FG002|Overall Study|Withdrew prior to dosing|2|||
161710145|NCT03093402|583982370|FG003|Overall Study|Withdrew prior to dosing|3|||
161710146|NCT03093402|583982367|FG000|Overall Study|Ineligible for study|1|||
161710147|NCT03093402|583982368|FG001|Overall Study|Ineligible for study|0|||
161710148|NCT03093402|583982369|FG002|Overall Study|Ineligible for study|0|||
161710149|NCT03093402|583982370|FG003|Overall Study|Ineligible for study|0|||
161710150|NCT03093402|583982367|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
161959054|NCT00988052|584896467|FG001|Overall Study|Physician Decision|28|||
161959055|NCT00988052|584896466|FG000|Overall Study|Adverse Event|35|||
161959056|NCT00988052|584896467|FG001|Overall Study|Adverse Event|28|||
161959057|NCT00988052|584896466|FG000|Overall Study|Withdrawal by Subject|90|||
161959058|NCT00988052|584896467|FG001|Overall Study|Withdrawal by Subject|91|||
161959059|NCT00988052|584896466|FG000|Overall Study|Study terminated by sponsor|240|||
161959060|NCT00988052|584896467|FG001|Overall Study|Study terminated by sponsor|236|||
161959061|NCT00842153|584896468|FG000|Overall Study|Adverse Event|0|||
161959062|NCT00842153|584896469|FG001|Overall Study|Adverse Event|1|||
161959063|NCT00842153|584896468|FG000|Overall Study|Lost to Follow-up|1|||
161959064|NCT00842153|584896469|FG001|Overall Study|Lost to Follow-up|2|||
161959065|NCT05312697|584896471|FG000|Overall Study|Sponsor Terminated Trial|2|||
161959066|NCT02858440|584896472|FG000|Overall Study|Lost to Follow-up|3|||
161959067|NCT02858440|584896472|FG000|Overall Study|Protocol Violation|2|||
161959068|NCT02858440|584896472|FG000|Overall Study|Consent withdrawal|3|||
161959069|NCT02858440|584896472|FG000|Overall Study|Migrated/moved from study area|4|||
161959070|NCT00402324|584896473|FG000|Overall Study|Lost to Follow-up|11|||
161959071|NCT00402324|584896474|FG001|Overall Study|Lost to Follow-up|11|||
161959072|NCT00402324|584896473|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
161959073|NCT00402324|584896474|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
161959074|NCT00402324|584896473|FG000|Overall Study|Protocol Violation|8|||
161959075|NCT00402324|584896474|FG001|Overall Study|Protocol Violation|7|||
161959076|NCT00402324|584896473|FG000|Overall Study|Withdrawal by Subject|5|||
161959077|NCT00402324|584896474|FG001|Overall Study|Withdrawal by Subject|2|||
161959078|NCT00402324|584896473|FG000|Overall Study|Physician Decision|2|||
161959079|NCT00402324|584896474|FG001|Overall Study|Physician Decision|4|||
161959080|NCT00402324|584896473|FG000|Overall Study|Sponsor Decision|4|||
161959081|NCT00402324|584896474|FG001|Overall Study|Sponsor Decision|5|||
161959082|NCT00402324|584896473|FG000|Overall Study|Lack of Efficacy|1|||
161959083|NCT00402324|584896474|FG001|Overall Study|Lack of Efficacy|4|||
161959084|NCT00402324|584896473|FG000|Overall Study|Adverse Event|6|||
161959085|NCT00402324|584896474|FG001|Overall Study|Adverse Event|4|||
161959086|NCT00402324|584896473|FG000|Overall Study|Death|1|||
161959087|NCT00402324|584896474|FG001|Overall Study|Death|0|||
161959088|NCT01277822|584896475|FG000|Overall Study|Adverse Event|2|||
161710151|NCT03093402|583982368|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
161959089|NCT01277822|584896476|FG001|Overall Study|Adverse Event|1|||
161959090|NCT01277822|584896475|FG000|Overall Study|Withdrawal by Subject|6|||
161959091|NCT01277822|584896476|FG001|Overall Study|Withdrawal by Subject|7|||
161959092|NCT01277822|584896475|FG000|Overall Study|Physician Decision|1|||
161959093|NCT01277822|584896476|FG001|Overall Study|Physician Decision|1|||
161959094|NCT01277822|584896475|FG000|Overall Study|Protocol Violation|1|||
161959095|NCT01277822|584896476|FG001|Overall Study|Protocol Violation|0|||
161959096|NCT01277822|584896475|FG000|Overall Study|Lost to Follow-up|2|||
161959097|NCT01277822|584896476|FG001|Overall Study|Lost to Follow-up|1|||
162030907|NCT00402233|585169502|FG002|Overall Study|Protocol Violation|0|||
161710152|NCT03093402|583982369|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
161710153|NCT03093402|583982370|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
161710154|NCT01147497|583982375|FG000|Overall Study|failed insertion|2|||
161710155|NCT01147497|583982376|FG001|Overall Study|failed insertion|0|||
161710156|NCT02731742|583982377|FG000|Overall Study|Death|1|||
161710157|NCT02731742|583982378|FG001|Overall Study|Death|2|||
161710158|NCT02731742|583982379|FG002|Overall Study|Death|5|||
161710159|NCT02731742|583982380|FG003|Overall Study|Death|0|||
161710160|NCT02731742|583982377|FG000|Overall Study|Physician Decision|0|||
161710161|NCT02731742|583982378|FG001|Overall Study|Physician Decision|0|||
161710162|NCT02731742|583982379|FG002|Overall Study|Physician Decision|0|||
161959098|NCT01277822|584896475|FG000|Overall Study|Contraindicated medication used|2|||
161959099|NCT01277822|584896476|FG001|Overall Study|Contraindicated medication used|1|||
161959100|NCT01277822|584896475|FG000|Overall Study|Participant moved|1|||
161710163|NCT02731742|583982380|FG003|Overall Study|Physician Decision|1|||
161710164|NCT02731742|583982377|FG000|Overall Study|Study Terminated by Sponsor|2|||
161959101|NCT01277822|584896476|FG001|Overall Study|Participant moved|0|||
161837863|NCT01340768|584450230|FG001|Overall Study|Withdrawal by Subject|1|||
161837864|NCT01340768|584450229|FG000|Overall Study|Other|2|||
161837865|NCT01340768|584450230|FG001|Overall Study|Other|0|||
161837866|NCT03052959|584450235|FG000|Overall Study|Lost to Follow-up|4|||
161837867|NCT03052959|584450236|FG001|Overall Study|Lost to Follow-up|5|||
161837868|NCT02397408|584450237|FG000|Overall Study|Physician Decision|4|||
161837869|NCT02397408|584450237|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
161837870|NCT01683838|584450238|FG000|Overall Study|Adverse Event|12|||
161837871|NCT01683838|584450239|FG001|Overall Study|Adverse Event|2|||
161837872|NCT01683838|584450238|FG000|Overall Study|Protocol Violation|3|||
161837873|NCT01683838|584450239|FG001|Overall Study|Protocol Violation|1|||
161837874|NCT01683838|584450238|FG000|Overall Study|Withdrawal by Subject|6|||
161837875|NCT01683838|584450239|FG001|Overall Study|Withdrawal by Subject|5|||
161837876|NCT01683838|584450238|FG000|Overall Study|Lost to Follow-up|1|||
161837877|NCT01683838|584450239|FG001|Overall Study|Lost to Follow-up|1|||
161837878|NCT01683838|584450238|FG000|Overall Study|Other|4|||
161837879|NCT01683838|584450239|FG001|Overall Study|Other|3|||
161837880|NCT01646138|584450240|FG000|Overall Study|Lost to Follow-up|0|||
161837881|NCT01646138|584450241|FG001|Overall Study|Lost to Follow-up|0|||
161837882|NCT01646138|584450242|FG002|Overall Study|Lost to Follow-up|0|||
161837883|NCT01646138|584450243|FG003|Overall Study|Lost to Follow-up|0|||
161837884|NCT01646138|584450244|FG004|Overall Study|Lost to Follow-up|2|||
161959102|NCT02923531|584896477|FG000|Overall Study|Adverse Event|4|||
161837885|NCT04049617|584450245|FG000|Overall Study|Adverse Event|0|||
161837886|NCT04049617|584450246|FG001|Overall Study|Adverse Event|0|||
161837887|NCT04049617|584450247|FG002|Overall Study|Adverse Event|0|||
161710165|NCT02731742|583982378|FG001|Overall Study|Study Terminated by Sponsor|1|||
161710166|NCT02731742|583982379|FG002|Overall Study|Study Terminated by Sponsor|1|||
161710167|NCT02731742|583982380|FG003|Overall Study|Study Terminated by Sponsor|1|||
161710168|NCT04026568|583982381|FG000|Overall Study|study terminated|0|||
161710169|NCT04026568|583982382|FG001|Overall Study|study terminated|1|||
161710170|NCT01974323|583982383|FG000|Overall Study|Other Reasons|25|||
162030908|NCT00402233|585169503|FG003|Overall Study|Protocol Violation|0|||
161710171|NCT01974323|583982384|FG001|Overall Study|Other Reasons|28|||
161837888|NCT04049617|584450248|FG003|Overall Study|Adverse Event|1|||
162030909|NCT00402233|585169500|FG000|Overall Study|Withdrawal by Subject|2|||
161710172|NCT01974323|583982383|FG000|Overall Study|Protocol Violation|2|||
161959103|NCT02923531|584896477|FG000|Overall Study|Clinical Deterioration|1|||
161959104|NCT02923531|584896477|FG000|Overall Study|Disease Progression|3|||
161959105|NCT02923531|584896477|FG000|Overall Study|Study Termination|1|||
161959106|NCT02201329|584896478|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
161959107|NCT02201329|584896478|FG000|Overall Study|Withdrawal by Subject|2|||
161959108|NCT00997984|584896479|FG000|Overall Study|Adverse Event|1|||
162030910|NCT00402233|585169501|FG001|Overall Study|Withdrawal by Subject|1|||
162030911|NCT00402233|585169502|FG002|Overall Study|Withdrawal by Subject|2|||
161837889|NCT04049617|584450249|FG004|Overall Study|Adverse Event|0|||
161959109|NCT00997984|584896480|FG001|Overall Study|Adverse Event|8|||
161959110|NCT00997984|584896481|FG002|Overall Study|Adverse Event|8|||
161837890|NCT04049617|584450250|FG005|Overall Study|Adverse Event|0|||
161959111|NCT00997984|584896479|FG000|Overall Study|Protocol Violation|1|||
161837891|NCT04049617|584450245|FG000|Overall Study|Death|0|||
161959112|NCT00997984|584896480|FG001|Overall Study|Protocol Violation|3|||
161959113|NCT00997984|584896481|FG002|Overall Study|Protocol Violation|0|||
161959114|NCT00997984|584896479|FG000|Overall Study|Withdrawal by Subject|6|||
161959115|NCT00997984|584896480|FG001|Overall Study|Withdrawal by Subject|9|||
161959116|NCT00997984|584896481|FG002|Overall Study|Withdrawal by Subject|5|||
161959117|NCT00997984|584896479|FG000|Overall Study|Lost to Follow-up|8|||
161959118|NCT00997984|584896480|FG001|Overall Study|Lost to Follow-up|5|||
161959119|NCT00997984|584896481|FG002|Overall Study|Lost to Follow-up|4|||
161959120|NCT00997984|584896479|FG000|Overall Study|Lack of Efficacy|20|||
161959121|NCT00997984|584896480|FG001|Overall Study|Lack of Efficacy|6|||
161959122|NCT00997984|584896481|FG002|Overall Study|Lack of Efficacy|3|||
161959123|NCT00997984|584896479|FG000|Overall Study|Met exclusion criteria|1|||
161710173|NCT01974323|583982384|FG001|Overall Study|Protocol Violation|2|||
161959124|NCT00997984|584896480|FG001|Overall Study|Met exclusion criteria|0|||
161959125|NCT00997984|584896481|FG002|Overall Study|Met exclusion criteria|0|||
161837892|NCT04049617|584450246|FG001|Overall Study|Death|0|||
161837893|NCT04049617|584450247|FG002|Overall Study|Death|0|||
161837894|NCT04049617|584450248|FG003|Overall Study|Death|0|||
161837895|NCT04049617|584450249|FG004|Overall Study|Death|0|||
161837896|NCT04049617|584450250|FG005|Overall Study|Death|1|||
161837897|NCT04049617|584450245|FG000|Overall Study|Lost to Follow-up|0|||
161837898|NCT04049617|584450246|FG001|Overall Study|Lost to Follow-up|0|||
161837899|NCT04049617|584450247|FG002|Overall Study|Lost to Follow-up|0|||
161837900|NCT04049617|584450248|FG003|Overall Study|Lost to Follow-up|1|||
161837901|NCT04049617|584450249|FG004|Overall Study|Lost to Follow-up|0|||
161837902|NCT04049617|584450250|FG005|Overall Study|Lost to Follow-up|0|||
161837903|NCT04049617|584450245|FG000|Overall Study|Withdrew consent|0|||
161837904|NCT04049617|584450246|FG001|Overall Study|Withdrew consent|0|||
161837905|NCT04049617|584450247|FG002|Overall Study|Withdrew consent|1|||
161837906|NCT04049617|584450248|FG003|Overall Study|Withdrew consent|0|||
161837907|NCT04049617|584450249|FG004|Overall Study|Withdrew consent|0|||
161837908|NCT04049617|584450250|FG005|Overall Study|Withdrew consent|0|||
161837909|NCT01524679|584450251|FG000|Overall Study|Lost to Follow-up|1|||
161837910|NCT01524679|584450252|FG001|Overall Study|Lost to Follow-up|4|||
161837911|NCT01524679|584450251|FG000|Overall Study|Withdrawal by Subject|4|||
161837912|NCT01524679|584450252|FG001|Overall Study|Withdrawal by Subject|4|||
161837913|NCT01524679|584450251|FG000|Overall Study|Adverse Event|9|||
161837914|NCT01524679|584450252|FG001|Overall Study|Adverse Event|0|||
161837915|NCT01524679|584450251|FG000|Overall Study|Protocol Violation|1|||
161837916|NCT01524679|584450252|FG001|Overall Study|Protocol Violation|0|||
161959126|NCT00997984|584896479|FG000|Overall Study|non-compliance|0|||
161959127|NCT00997984|584896480|FG001|Overall Study|non-compliance|2|||
161959128|NCT00997984|584896481|FG002|Overall Study|non-compliance|3|||
161959129|NCT00997984|584896479|FG000|Overall Study|Wrong medication dispensed|0|||
161959130|NCT00997984|584896480|FG001|Overall Study|Wrong medication dispensed|1|||
161959131|NCT00997984|584896481|FG002|Overall Study|Wrong medication dispensed|0|||
161959132|NCT00997984|584896479|FG000|Overall Study|Suicidal ideation|0|||
161959133|NCT00997984|584896480|FG001|Overall Study|Suicidal ideation|0|||
161959134|NCT00997984|584896481|FG002|Overall Study|Suicidal ideation|1|||
161959135|NCT00997984|584896479|FG000|Overall Study|Work schedule|0|||
161959136|NCT00997984|584896480|FG001|Overall Study|Work schedule|0|||
161959137|NCT00997984|584896481|FG002|Overall Study|Work schedule|2|||
161959138|NCT02997865|584896483|FG000|Overall Study|Death|2|||
161959139|NCT02997865|584896484|FG001|Overall Study|Death|1|||
161959140|NCT02997865|584896483|FG000|Overall Study|Lost to Follow-up|6|||
161959141|NCT02997865|584896484|FG001|Overall Study|Lost to Follow-up|3|||
161959142|NCT02997865|584896483|FG000|Overall Study|Withdrawal by Subject|5|||
161959143|NCT02997865|584896484|FG001|Overall Study|Withdrawal by Subject|0|||
161959144|NCT01945996|584896485|FG000|Overall Study|Lost to Follow-up|3|||
161959145|NCT01945996|584896486|FG001|Overall Study|Lost to Follow-up|5|||
161959146|NCT04660552|584896488|FG000|Overall Study|Withdrawal by Subject|3|||
161959147|NCT04660552|584896489|FG001|Overall Study|Withdrawal by Subject|1|||
161959148|NCT03012828|584896490|FG000|Overall Study|Lost to Follow-up|1|||
161959149|NCT03012828|584896491|FG001|Overall Study|Lost to Follow-up|0|||
161959150|NCT03012828|584896492|FG002|Overall Study|Lost to Follow-up|1|||
161959151|NCT03012828|584896493|FG003|Overall Study|Lost to Follow-up|0|||
161959152|NCT03012828|584896494|FG004|Overall Study|Lost to Follow-up|1|||
161959153|NCT03012828|584896495|FG005|Overall Study|Lost to Follow-up|0|||
161959154|NCT03012828|584896490|FG000|Overall Study|Withdrawal by Subject|0|||
161959155|NCT03012828|584896491|FG001|Overall Study|Withdrawal by Subject|0|||
161959156|NCT03012828|584896492|FG002|Overall Study|Withdrawal by Subject|1|||
161959157|NCT03012828|584896493|FG003|Overall Study|Withdrawal by Subject|0|||
161959158|NCT03012828|584896494|FG004|Overall Study|Withdrawal by Subject|0|||
161959159|NCT03012828|584896495|FG005|Overall Study|Withdrawal by Subject|1|||
161959160|NCT03012828|584896490|FG000|Overall Study|Non-compliance with protocol|0|||
161959161|NCT03012828|584896491|FG001|Overall Study|Non-compliance with protocol|0|||
161959162|NCT03012828|584896492|FG002|Overall Study|Non-compliance with protocol|0|||
161959163|NCT03012828|584896493|FG003|Overall Study|Non-compliance with protocol|0|||
161959164|NCT03012828|584896494|FG004|Overall Study|Non-compliance with protocol|1|||
161959165|NCT03012828|584896495|FG005|Overall Study|Non-compliance with protocol|0|||
161837917|NCT01524679|584450251|FG000|Overall Study|Lack of Efficacy|2|||
161837918|NCT01524679|584450252|FG001|Overall Study|Lack of Efficacy|0|||
161837919|NCT01524679|584450251|FG000|Overall Study|e.g.wish for children, relocation|6|||
161837920|NCT01524679|584450252|FG001|Overall Study|e.g.wish for children, relocation|1|||
161837921|NCT00801099|584450253|FG000|Overall Study|Lost to Follow-up|101|||
161837922|NCT01780987|584450254|FG000|Overall Study|Adverse Event|0|||
161837923|NCT01780987|584450255|FG001|Overall Study|Adverse Event|4|||
161837924|NCT01780987|584450254|FG000|Overall Study|Withdrawal by Subject|2|||
161837925|NCT01780987|584450255|FG001|Overall Study|Withdrawal by Subject|0|||
161837926|NCT01780987|584450254|FG000|Overall Study|Request of Changing Hospital|0|||
161837927|NCT01780987|584450255|FG001|Overall Study|Request of Changing Hospital|1|||
161959166|NCT03012828|584896490|FG000|Overall Study|Delay to last visit would delay DBL|0|||
161959167|NCT03012828|584896491|FG001|Overall Study|Delay to last visit would delay DBL|0|||
161959168|NCT03012828|584896492|FG002|Overall Study|Delay to last visit would delay DBL|0|||
161837928|NCT01780987|584450254|FG000|Overall Study|Changing Residence|1|||
161837929|NCT01780987|584450255|FG001|Overall Study|Changing Residence|0|||
161837930|NCT01780987|584450254|FG000|Overall Study|Not Receiving any Study Medication|0|||
161959169|NCT03012828|584896493|FG003|Overall Study|Delay to last visit would delay DBL|0|||
161710174|NCT01974323|583982383|FG000|Overall Study|Personal Reasons|15|||
161710175|NCT01974323|583982384|FG001|Overall Study|Personal Reasons|19|||
161710176|NCT01974323|583982383|FG000|Overall Study|Lost to Follow-up|45|||
161959170|NCT03012828|584896494|FG004|Overall Study|Delay to last visit would delay DBL|0|||
161959171|NCT03012828|584896495|FG005|Overall Study|Delay to last visit would delay DBL|1|||
161959172|NCT01509846|584896496|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
161959173|NCT01509846|584896497|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
161959174|NCT01509846|584896498|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
161959175|NCT01509846|584896499|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
161959176|NCT01509846|584896500|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
161959177|NCT01509846|584896496|FG000|Received Vaccination 2|Illness|0|||
161959178|NCT01509846|584896497|FG001|Received Vaccination 2|Illness|0|||
161959179|NCT01509846|584896498|FG002|Received Vaccination 2|Illness|0|||
161959180|NCT01509846|584896499|FG003|Received Vaccination 2|Illness|0|||
161959181|NCT01509846|584896500|FG004|Received Vaccination 2|Illness|1|||
161959182|NCT01509846|584896496|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
161959183|NCT01509846|584896497|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
161959184|NCT01509846|584896498|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
161959185|NCT01509846|584896499|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
161959186|NCT01509846|584896500|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
161959187|NCT01509846|584896496|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
161959188|NCT01509846|584896497|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
161959189|NCT01509846|584896498|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
161959190|NCT01509846|584896499|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
161959191|NCT01509846|584896500|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
161959192|NCT01509846|584896496|FG000|Received Vaccination 3|Pregnancy|0|||
161959193|NCT01509846|584896497|FG001|Received Vaccination 3|Pregnancy|0|||
161959194|NCT01509846|584896498|FG002|Received Vaccination 3|Pregnancy|0|||
161959195|NCT01509846|584896499|FG003|Received Vaccination 3|Pregnancy|1|||
161959196|NCT01509846|584896500|FG004|Received Vaccination 3|Pregnancy|0|||
161959197|NCT01509846|584896496|FG000|Received Vaccination 3|Lost to Follow-up|0|||
161959198|NCT01509846|584896497|FG001|Received Vaccination 3|Lost to Follow-up|0|||
161959199|NCT01509846|584896498|FG002|Received Vaccination 3|Lost to Follow-up|1|||
161959200|NCT01509846|584896499|FG003|Received Vaccination 3|Lost to Follow-up|0|||
161959201|NCT01509846|584896500|FG004|Received Vaccination 3|Lost to Follow-up|0|||
161959202|NCT04396795|584896502|FG000|Month 1|Lost to Follow-up|2|||
161959203|NCT04396795|584896503|FG001|Month 1|Lost to Follow-up|3|||
161959204|NCT04396795|584896502|FG000|Month 3|Lost to Follow-up|1|||
161959205|NCT04396795|584896503|FG001|Month 3|Lost to Follow-up|3|||
161959206|NCT04396795|584896502|FG000|Month 6|Lost to Follow-up|3|||
161959207|NCT04396795|584896503|FG001|Month 6|Lost to Follow-up|3|||
161959208|NCT01637584|584896504|FG000|Overall Study|Withdrawal by Subject|1|||
161959209|NCT01637584|584896505|FG001|Overall Study|Withdrawal by Subject|3|||
161710177|NCT01974323|583982384|FG001|Overall Study|Lost to Follow-up|40|||
161959210|NCT02366923|584896506|FG000|Overall Study|Withdrawal by Subject|1|||
161959211|NCT02366923|584896506|FG000|Overall Study|Positive Slit Lamp Findings|2|||
161959212|NCT02366923|584896506|FG000|Overall Study|High Astigmatism|3|||
161959213|NCT02484443|584896507|FG000|Overall Study|Lack of Efficacy|28|||
161959214|NCT02484443|584896507|FG000|Overall Study|Physician Decision|2|||
161959215|NCT02484443|584896507|FG000|Overall Study|Ineligible|2|||
161959216|NCT02595866|584896508|FG000|Overall Study|Adverse Event|2|||
162030912|NCT00402233|585169503|FG003|Overall Study|Withdrawal by Subject|2|||
162030913|NCT00402233|585169500|FG000|Overall Study|Worsening of disease under study|2|||
162030914|NCT00402233|585169501|FG001|Overall Study|Worsening of disease under study|0|||
162030915|NCT00402233|585169502|FG002|Overall Study|Worsening of disease under study|0|||
162030916|NCT00402233|585169503|FG003|Overall Study|Worsening of disease under study|0|||
162030917|NCT00402233|585169500|FG000|Overall Study|Worsening of other pre-existing disease|0|||
162030918|NCT00402233|585169501|FG001|Overall Study|Worsening of other pre-existing disease|1|||
162030919|NCT00402233|585169502|FG002|Overall Study|Worsening of other pre-existing disease|0|||
162030920|NCT00402233|585169503|FG003|Overall Study|Worsening of other pre-existing disease|0|||
162030921|NCT03007888|585169505|FG000|First Intervention (14 Days)|Adverse Event|1|||
162030922|NCT03007888|585169506|FG001|First Intervention (14 Days)|Adverse Event|0|||
162030923|NCT00927940|585169507|FG000|Overall Study|Death|1|||
162030924|NCT04658940|585169508|FG000|Overall Study|Withdrawal by Subject|1|||
162030925|NCT00827931|585169510|FG000|Overall Study|Death|3|||
162030926|NCT00827931|585169511|FG001|Overall Study|Death|5|||
162030927|NCT00827931|585169510|FG000|Overall Study|Adverse Event|1|||
162030928|NCT00827931|585169511|FG001|Overall Study|Adverse Event|0|||
162030929|NCT00827931|585169510|FG000|Overall Study|Lost to Follow-up|1|||
162030930|NCT00827931|585169511|FG001|Overall Study|Lost to Follow-up|0|||
162030931|NCT00827931|585169510|FG000|Overall Study|Withdrawal by Subject|0|||
162030932|NCT00827931|585169511|FG001|Overall Study|Withdrawal by Subject|1|||
162030933|NCT00827931|585169510|FG000|Overall Study|Other|1|||
162030934|NCT00827931|585169511|FG001|Overall Study|Other|0|||
162030935|NCT03579602|585169512|FG000|Overall Study|Subject unable to receive study drug|0|||
162030936|NCT03579602|585169513|FG001|Overall Study|Subject unable to receive study drug|2|||
162030937|NCT03579602|585169512|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
162030938|NCT03579602|585169513|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
162030939|NCT00492063|585169514|FG000|Overall Study|Death|0|||
162030940|NCT00492063|585169515|FG001|Overall Study|Death|0|||
162030941|NCT00492063|585169516|FG002|Overall Study|Death|1|||
162030942|NCT00492063|585169517|FG003|Overall Study|Death|2|||
162030943|NCT00492063|585169514|FG000|Overall Study|Withdrawal by Subject|4|||
162030944|NCT00492063|585169515|FG001|Overall Study|Withdrawal by Subject|3|||
162030945|NCT00492063|585169516|FG002|Overall Study|Withdrawal by Subject|5|||
162030946|NCT00492063|585169517|FG003|Overall Study|Withdrawal by Subject|4|||
162030947|NCT00492063|585169514|FG000|Overall Study|Lost to Follow-up|6|||
162030948|NCT00492063|585169515|FG001|Overall Study|Lost to Follow-up|11|||
162030949|NCT00492063|585169516|FG002|Overall Study|Lost to Follow-up|5|||
162030950|NCT00492063|585169517|FG003|Overall Study|Lost to Follow-up|3|||
162030951|NCT00492063|585169514|FG000|Overall Study|Protocol Violation|0|||
162030952|NCT00492063|585169515|FG001|Overall Study|Protocol Violation|0|||
162030953|NCT00492063|585169516|FG002|Overall Study|Protocol Violation|0|||
162030954|NCT00492063|585169517|FG003|Overall Study|Protocol Violation|1|||
162030955|NCT00495040|585169523|FG000|Overall Study|Withdrawal by Subject|3|||
162030956|NCT01894568|585169524|FG000|Overall Study|Adverse Event|2|||
162030957|NCT01894568|585169525|FG001|Overall Study|Adverse Event|3|||
162030958|NCT01894568|585169524|FG000|Overall Study|Protocol required discontinuation|2|||
162030959|NCT01894568|585169525|FG001|Overall Study|Protocol required discontinuation|1|||
162030960|NCT01894568|585169524|FG000|Overall Study|Withdrawal by Subject|5|||
162030961|NCT01894568|585169525|FG001|Overall Study|Withdrawal by Subject|5|||
162030962|NCT01894568|585169524|FG000|Overall Study|Physician Decision|1|||
162030963|NCT01894568|585169525|FG001|Overall Study|Physician Decision|0|||
161710178|NCT01974323|583982383|FG000|Overall Study|Pregnancy|2|||
161710179|NCT01974323|583982384|FG001|Overall Study|Pregnancy|1|||
161710180|NCT01974323|583982383|FG000|Overall Study|Lack of Efficacy|1|||
161710181|NCT01974323|583982384|FG001|Overall Study|Lack of Efficacy|1|||
161710182|NCT01974323|583982383|FG000|Overall Study|Adverse Event|2|||
162030964|NCT01894568|585169524|FG000|Overall Study|Lost to Follow-up|0|||
162030965|NCT01894568|585169525|FG001|Overall Study|Lost to Follow-up|1|||
162030966|NCT00807573|585169526|FG000|Overall Study|Withdrawal by Subject|1|||
162030967|NCT00807573|585169526|FG000|Overall Study|Adverse Event|1|||
162030968|NCT01089361|585169529|FG000|Overall Study|Death|1|||
161710183|NCT01974323|583982384|FG001|Overall Study|Adverse Event|2|||
162030969|NCT01089361|585169530|FG001|Overall Study|Death|0|||
161837931|NCT01780987|584450255|FG001|Overall Study|Not Receiving any Study Medication|1|||
161837932|NCT03321630|584450256|FG000|Overall Study|Adverse Event|1|||
161837933|NCT03321630|584450256|FG000|Overall Study|Investigator Discretion|2|||
161837934|NCT03321630|584450256|FG000|Overall Study|Withdrawal by Subject|1|||
161837935|NCT00140426|584450257|FG000|Overall Study|Withdrawal by Subject|0|||
161837936|NCT00140426|584450258|FG001|Overall Study|Withdrawal by Subject|3|||
161837937|NCT04168190|584450259|FG000|Overall Study|Lost to Follow-up|0|||
161837938|NCT04168190|584450260|FG001|Overall Study|Lost to Follow-up|1|||
161837939|NCT04168190|584450261|FG002|Overall Study|Lost to Follow-up|0|||
161837940|NCT04168190|584450262|FG003|Overall Study|Lost to Follow-up|7|||
161837941|NCT04168190|584450263|FG004|Overall Study|Lost to Follow-up|5|||
161837942|NCT04168190|584450259|FG000|Overall Study|Withdrawal by Subject|1|||
161837943|NCT04168190|584450260|FG001|Overall Study|Withdrawal by Subject|0|||
161837944|NCT04168190|584450261|FG002|Overall Study|Withdrawal by Subject|0|||
161837945|NCT04168190|584450262|FG003|Overall Study|Withdrawal by Subject|2|||
161837946|NCT04168190|584450263|FG004|Overall Study|Withdrawal by Subject|4|||
161837947|NCT04168190|584450259|FG000|Overall Study|Death|0|||
161837948|NCT04168190|584450260|FG001|Overall Study|Death|0|||
161837949|NCT04168190|584450261|FG002|Overall Study|Death|0|||
161837950|NCT04168190|584450262|FG003|Overall Study|Death|1|||
161837951|NCT04168190|584450263|FG004|Overall Study|Death|0|||
161837952|NCT02325518|584450264|FG000|Overall Study|Adverse Event|4|||
161837953|NCT02325518|584450265|FG001|Overall Study|Adverse Event|1|||
161837954|NCT02325518|584450264|FG000|Overall Study|Physician Decision|0|||
161837955|NCT02325518|584450265|FG001|Overall Study|Physician Decision|1|||
161837956|NCT02325518|584450264|FG000|Overall Study|Withdrawal by Subject|0|||
161837957|NCT02325518|584450265|FG001|Overall Study|Withdrawal by Subject|1|||
161837958|NCT04765384|584450266|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
161837959|NCT04765384|584450267|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
161837960|NCT04765384|584450268|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
161837961|NCT04765384|584450269|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
161837962|NCT04765384|584450270|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
161837963|NCT04765384|584450271|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
161837964|NCT04765384|584450266|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
161959217|NCT02595866|584896509|FG001|Overall Study|Adverse Event|5|||
161959218|NCT02595866|584896508|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
161959219|NCT02595866|584896509|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
161959220|NCT02595866|584896508|FG000|Overall Study|Death|0|||
161959221|NCT02595866|584896509|FG001|Overall Study|Death|1|||
161710184|NCT00331760|583982385|FG000|Overall Study|Ineligible / no protocol treatment|15|||
161710185|NCT00331760|583982386|FG001|Overall Study|Ineligible / no protocol treatment|8|||
161710186|NCT00833092|583982387|FG000|Overall Study|Withdrawal by Subject|2|||
161710187|NCT00833092|583982388|FG001|Overall Study|Withdrawal by Subject|3|||
161710188|NCT00833092|583982387|FG000|Overall Study|Protocol Violation|2|||
161710189|NCT00833092|583982388|FG001|Overall Study|Protocol Violation|1|||
161710190|NCT00833092|583982387|FG000|Overall Study|Diarrhea|0|||
161710191|NCT00833092|583982388|FG001|Overall Study|Diarrhea|2|||
161710192|NCT00833092|583982387|FG000|Overall Study|constipation|0|||
161710193|NCT00833092|583982388|FG001|Overall Study|constipation|1|||
161710194|NCT00619229|583982391|FG000|Overall Study|Withdrawal by Subject|1|||
161710195|NCT00619229|583982392|FG001|Overall Study|Withdrawal by Subject|1|||
161710196|NCT00619229|583982391|FG000|Overall Study|Lost to Follow-up|1|||
161710197|NCT00619229|583982392|FG001|Overall Study|Lost to Follow-up|0|||
161710198|NCT00619229|583982391|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
161959222|NCT02595866|584896508|FG000|Overall Study|Incarceration|1|||
161959223|NCT02595866|584896509|FG001|Overall Study|Incarceration|0|||
161959224|NCT02595866|584896508|FG000|Overall Study|Lack of Efficacy|17|||
161959225|NCT02595866|584896509|FG001|Overall Study|Lack of Efficacy|7|||
161959226|NCT02595866|584896508|FG000|Overall Study|Physician Decision|4|||
161959227|NCT02595866|584896509|FG001|Overall Study|Physician Decision|3|||
161959228|NCT02595866|584896508|FG000|Overall Study|Switched to Alternative Treatment|1|||
161959229|NCT02595866|584896509|FG001|Overall Study|Switched to Alternative Treatment|0|||
161710199|NCT00619229|583982392|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
161710200|NCT00619229|583982391|FG000|Overall Study|Investigator planned Cataract Operation|1|||
161837965|NCT04765384|584450267|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
161837966|NCT04765384|584450268|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
161837967|NCT04765384|584450269|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
161837968|NCT04765384|584450270|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
161837969|NCT04765384|584450271|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
161837970|NCT04765384|584450266|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161837971|NCT04765384|584450267|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161837972|NCT04765384|584450268|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161959230|NCT02595866|584896508|FG000|Overall Study|Study Terminated|0|||
161959231|NCT02595866|584896509|FG001|Overall Study|Study Terminated|4|||
161959232|NCT02595866|584896508|FG000|Overall Study|Withdrawal by Subject|6|||
161959233|NCT02595866|584896509|FG001|Overall Study|Withdrawal by Subject|1|||
161959234|NCT01107392|584896513|FG000|Overall Study|Adverse Event|2|||
161959235|NCT01107392|584896514|FG001|Overall Study|Adverse Event|0|||
161959236|NCT01107392|584896513|FG000|Overall Study|Personal Reasons|2|||
161959237|NCT01107392|584896514|FG001|Overall Study|Personal Reasons|3|||
161959238|NCT01107392|584896513|FG000|Overall Study|Administrative decision|1|||
161959239|NCT01107392|584896514|FG001|Overall Study|Administrative decision|0|||
161959240|NCT00851552|584896515|FG000|Overall Study|Death|2|||
161959241|NCT00851552|584896515|FG000|Overall Study|Adverse Event|1|||
161959242|NCT00851552|584896515|FG000|Overall Study|Disease Progression|4|||
161959243|NCT02689206|584896518|FG000|Overall Study|Adverse Event|0|||
161959244|NCT02689206|584896519|FG001|Overall Study|Adverse Event|0|||
161959245|NCT02689206|584896520|FG002|Overall Study|Adverse Event|1|||
161959246|NCT02689206|584896521|FG003|Overall Study|Adverse Event|0|||
161959247|NCT02689206|584896522|FG004|Overall Study|Adverse Event|2|||
161959248|NCT02689206|584896518|FG000|Overall Study|Protocol Violation|1|||
161959249|NCT02689206|584896519|FG001|Overall Study|Protocol Violation|0|||
161959250|NCT02689206|584896520|FG002|Overall Study|Protocol Violation|0|||
161959251|NCT02689206|584896521|FG003|Overall Study|Protocol Violation|1|||
161959252|NCT02689206|584896522|FG004|Overall Study|Protocol Violation|2|||
161959253|NCT02689206|584896518|FG000|Overall Study|Other: Reached stopping criteria|0|||
161959254|NCT02689206|584896519|FG001|Overall Study|Other: Reached stopping criteria|1|||
161959255|NCT02689206|584896520|FG002|Overall Study|Other: Reached stopping criteria|2|||
161959256|NCT02689206|584896521|FG003|Overall Study|Other: Reached stopping criteria|3|||
161959257|NCT02689206|584896522|FG004|Overall Study|Other: Reached stopping criteria|4|||
161959258|NCT02689206|584896518|FG000|Overall Study|Physician Decision|1|||
161959259|NCT02689206|584896519|FG001|Overall Study|Physician Decision|0|||
161959260|NCT02689206|584896520|FG002|Overall Study|Physician Decision|0|||
161959261|NCT02689206|584896521|FG003|Overall Study|Physician Decision|0|||
161959262|NCT02689206|584896522|FG004|Overall Study|Physician Decision|0|||
161959263|NCT02689206|584896518|FG000|Overall Study|Withdrawal by Subject|1|||
161959264|NCT02689206|584896519|FG001|Overall Study|Withdrawal by Subject|0|||
161959265|NCT02689206|584896520|FG002|Overall Study|Withdrawal by Subject|1|||
161959266|NCT02689206|584896521|FG003|Overall Study|Withdrawal by Subject|0|||
161959267|NCT02689206|584896522|FG004|Overall Study|Withdrawal by Subject|0|||
161959268|NCT02520388|584896523|FG000|Overall Study|Physician Decision|1|||
161959269|NCT02520388|584896524|FG001|Overall Study|Physician Decision|0|||
161959270|NCT02520388|584896523|FG000|Overall Study|Subject or parent/guardian request|0|||
161959271|NCT02520388|584896524|FG001|Overall Study|Subject or parent/guardian request|6|||
161959272|NCT02520388|584896523|FG000|Overall Study|Adverse Event|1|||
161959273|NCT02520388|584896524|FG001|Overall Study|Adverse Event|4|||
161959274|NCT02520388|584896523|FG000|Overall Study|Lost to Follow-up|3|||
161959275|NCT02520388|584896524|FG001|Overall Study|Lost to Follow-up|2|||
161959276|NCT02520388|584896523|FG000|Overall Study|Other (reason not defined)|4|||
161959277|NCT02520388|584896524|FG001|Overall Study|Other (reason not defined)|4|||
161959278|NCT01437111|584896525|FG000|Overall Study|Adverse Event|2|||
161959279|NCT01437111|584896525|FG000|Overall Study|Withdrawal by Subject|4|||
161959280|NCT01437111|584896525|FG000|Overall Study|Not reported|5|||
161959281|NCT01437111|584896525|FG000|Overall Study|Physician Decision|1|||
161959282|NCT01437111|584896525|FG000|Overall Study|Lost to Follow-up|5|||
161959283|NCT01437111|584896525|FG000|Overall Study|Protocol Violation|1|||
161959284|NCT02131311|584896526|FG000|Overall Study|Adverse Event|2|||
161959285|NCT02131311|584896526|FG000|Overall Study|Protocol Violation|1|||
161959286|NCT02131311|584896526|FG000|Overall Study|Lost to Follow-up|1|||
161959287|NCT01479764|584896527|FG000|Randomized|Adverse Event|1|||
161710201|NCT00619229|583982392|FG001|Overall Study|Investigator planned Cataract Operation|0|||
161710202|NCT03417440|583982393|FG000|Overall Study|Lost to Follow-up|0|||
161959288|NCT01479764|584896528|FG001|Randomized|Adverse Event|1|||
161959289|NCT01479764|584896527|FG000|Randomized|Withdrawal by Subject|1|||
161959290|NCT01479764|584896528|FG001|Randomized|Withdrawal by Subject|0|||
162030970|NCT01514370|585169531|FG000|Overall Study|Protocol Violation|2|||
161710203|NCT03417440|583982394|FG001|Overall Study|Lost to Follow-up|1|||
161710204|NCT03417440|583982395|FG002|Overall Study|Lost to Follow-up|0|||
161710205|NCT03417440|583982396|FG003|Overall Study|Lost to Follow-up|0|||
161710206|NCT03417440|583982397|FG004|Overall Study|Lost to Follow-up|1|||
161710207|NCT03417440|583982398|FG005|Overall Study|Lost to Follow-up|0|||
161710208|NCT03417440|583982399|FG006|Overall Study|Lost to Follow-up|0|||
161959291|NCT01479764|584896527|FG000|Treated|Lost to Follow-up|0|||
161959292|NCT01479764|584896528|FG001|Treated|Lost to Follow-up|2|||
161959293|NCT00255723|584896534|FG000|Overall Study|Adverse Event|1|||
161959294|NCT00255723|584896535|FG001|Overall Study|Adverse Event|1|||
161959295|NCT00255723|584896534|FG000|Overall Study|Death|0|||
161959296|NCT00255723|584896535|FG001|Overall Study|Death|1|||
161959297|NCT00255723|584896534|FG000|Overall Study|Response Data Not Available|1|||
161959298|NCT00255723|584896535|FG001|Overall Study|Response Data Not Available|0|||
161959299|NCT03711370|584896536|FG000|Overall Study|Lost to Follow-up|16|||
161959300|NCT03711370|584896537|FG001|Overall Study|Lost to Follow-up|10|||
161959301|NCT03711370|584896536|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
161959302|NCT03711370|584896537|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
161959303|NCT01536561|584896540|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
161710209|NCT03417440|583982400|FG007|Overall Study|Lost to Follow-up|0|||
161710210|NCT03417440|583982393|FG000|Overall Study|Withdrawal by Subject|2|||
161710211|NCT03417440|583982394|FG001|Overall Study|Withdrawal by Subject|0|||
162030971|NCT01514370|585169532|FG001|Overall Study|Protocol Violation|3|||
162030972|NCT01514370|585169531|FG000|Overall Study|Lost to Follow-up|0|||
162030973|NCT01514370|585169532|FG001|Overall Study|Lost to Follow-up|2|||
162030974|NCT01514370|585169531|FG000|Overall Study|Withdrawal by Subject|2|||
162030975|NCT01514370|585169532|FG001|Overall Study|Withdrawal by Subject|1|||
162030976|NCT01514370|585169531|FG000|Overall Study|Adverse Event|1|||
162030977|NCT01514370|585169532|FG001|Overall Study|Adverse Event|3|||
162030978|NCT01514370|585169531|FG000|Overall Study|Other|6|||
162030979|NCT01514370|585169532|FG001|Overall Study|Other|7|||
162030980|NCT03353740|585169535|FG000|Overall Study|Images for these participants not viable|52|||
162030981|NCT02232880|585169537|FG000|Overall Study|study stopped prior to randomization|1|||
162030982|NCT03976648|585169540|FG000|Overall Study|Adverse Event|0|||
162030983|NCT03976648|585169541|FG001|Overall Study|Adverse Event|2|||
162030984|NCT03976648|585169540|FG000|Overall Study|Study terminated by sponsor|21|||
162030985|NCT03976648|585169541|FG001|Overall Study|Study terminated by sponsor|8|||
162030986|NCT03645434|585169542|FG000|Period 1|Adverse Event|0|||
162030987|NCT03645434|585169543|FG001|Period 1|Adverse Event|0|||
162030988|NCT03645434|585169544|FG002|Period 1|Adverse Event|0|||
162030989|NCT03645434|585169545|FG003|Period 1|Adverse Event|1|||
161710212|NCT03417440|583982395|FG002|Overall Study|Withdrawal by Subject|2|||
161710213|NCT03417440|583982396|FG003|Overall Study|Withdrawal by Subject|1|||
161710214|NCT03417440|583982397|FG004|Overall Study|Withdrawal by Subject|1|||
161710215|NCT03417440|583982398|FG005|Overall Study|Withdrawal by Subject|0|||
161710216|NCT03417440|583982399|FG006|Overall Study|Withdrawal by Subject|0|||
161710217|NCT03417440|583982400|FG007|Overall Study|Withdrawal by Subject|1|||
161710218|NCT02786901|583982401|FG000|Overall Study|Adverse Event|1|||
161710219|NCT02786901|583982402|FG001|Overall Study|Adverse Event|1|||
161959304|NCT01536561|584896540|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
161959305|NCT01536561|584896540|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
161959306|NCT01536561|584896540|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
161959307|NCT01536561|584896540|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
161959308|NCT01536561|584896540|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
161959309|NCT00431444|584896544|FG000|Overall Study|Protocol Violation|1|||
161959310|NCT00431444|584896545|FG001|Overall Study|Protocol Violation|4|||
161959311|NCT00431444|584896544|FG000|Overall Study|Adverse Event|2|||
161959312|NCT00431444|584896545|FG001|Overall Study|Adverse Event|1|||
161959313|NCT00431444|584896544|FG000|Overall Study|Withdrawal by Subject|1|||
161959314|NCT00431444|584896545|FG001|Overall Study|Withdrawal by Subject|1|||
161959315|NCT00431444|584896544|FG000|Overall Study|Lost to Follow-up|1|||
161959316|NCT00431444|584896545|FG001|Overall Study|Lost to Follow-up|0|||
161959317|NCT00431444|584896544|FG000|Overall Study|Administrative Problems|0|||
161959318|NCT00431444|584896545|FG001|Overall Study|Administrative Problems|1|||
161959319|NCT03583359|584896548|FG000|Overall Study|Withdrawal by Subject|15|||
161959320|NCT03583359|584896549|FG001|Overall Study|Withdrawal by Subject|6|||
161959321|NCT03583359|584896548|FG000|Overall Study|Lost to Follow-up|12|||
161959322|NCT03583359|584896549|FG001|Overall Study|Lost to Follow-up|3|||
161959323|NCT03583359|584896548|FG000|Overall Study|Adverse Event|0|||
161959324|NCT03583359|584896549|FG001|Overall Study|Adverse Event|1|||
161959325|NCT03583359|584896548|FG000|Overall Study|Protocol Violation|0|||
161959326|NCT03583359|584896549|FG001|Overall Study|Protocol Violation|1|||
161959327|NCT03583359|584896548|FG000|Overall Study|Other|2|||
161959328|NCT03583359|584896549|FG001|Overall Study|Other|1|||
161959329|NCT03497039|584896550|FG000|Overall Study|Withdrawal by Subject|1|||
161959330|NCT03497039|584896551|FG001|Overall Study|Withdrawal by Subject|0|||
161959331|NCT03497039|584896550|FG000|Overall Study|Protocol Violation|0|||
162030990|NCT03645434|585169546|FG004|Period 1|Adverse Event|0|||
162030991|NCT03645434|585169547|FG005|Period 1|Adverse Event|0|||
162030992|NCT03645434|585169542|FG000|Period 1|COPD exacerbation|0|||
161710220|NCT02786901|583982403|FG002|Overall Study|Adverse Event|2|||
161710221|NCT02786901|583982401|FG000|Overall Study|Physician Decision|1|||
162030993|NCT03645434|585169543|FG001|Period 1|COPD exacerbation|0|||
162030994|NCT03645434|585169544|FG002|Period 1|COPD exacerbation|0|||
161710222|NCT02786901|583982402|FG001|Overall Study|Physician Decision|0|||
161710223|NCT02786901|583982403|FG002|Overall Study|Physician Decision|0|||
161710224|NCT02786901|583982401|FG000|Overall Study|Rescue Therapy Use|71|||
161710225|NCT02786901|583982402|FG001|Overall Study|Rescue Therapy Use|49|||
161710226|NCT02786901|583982403|FG002|Overall Study|Rescue Therapy Use|33|||
161959332|NCT03497039|584896551|FG001|Overall Study|Protocol Violation|1|||
161959333|NCT03554018|584896552|FG000|Overall Study|Lost to Follow-up|3|||
161959334|NCT03554018|584896553|FG001|Overall Study|Lost to Follow-up|7|||
161959335|NCT02131662|584896554|FG000|Overall Study|Protocol Violation|1|||
161959336|NCT02131662|584896555|FG001|Overall Study|Protocol Violation|0|||
161959337|NCT02131662|584896556|FG002|Overall Study|Protocol Violation|0|||
161959338|NCT02131662|584896557|FG003|Overall Study|Protocol Violation|0|||
161959339|NCT02131662|584896558|FG004|Overall Study|Protocol Violation|0|||
161959340|NCT02131662|584896554|FG000|Overall Study|Other|2|||
162030995|NCT03645434|585169545|FG003|Period 1|COPD exacerbation|0|||
162030996|NCT03645434|585169546|FG004|Period 1|COPD exacerbation|1|||
162030997|NCT03645434|585169547|FG005|Period 1|COPD exacerbation|0|||
162030998|NCT00881868|585169548|FG000|Overall Study|Adverse Event|0|||
162030999|NCT00881868|585169549|FG001|Overall Study|Adverse Event|1|||
162031000|NCT00881868|585169548|FG000|Overall Study|Lost to Follow-up|2|||
162031001|NCT00881868|585169549|FG001|Overall Study|Lost to Follow-up|1|||
162031002|NCT00881868|585169548|FG000|Overall Study|Physician Decision|4|||
162031003|NCT00881868|585169549|FG001|Overall Study|Physician Decision|0|||
162031004|NCT00881868|585169548|FG000|Overall Study|Protocol Violation|2|||
162031005|NCT00881868|585169549|FG001|Overall Study|Protocol Violation|0|||
162031006|NCT02880956|585169552|FG000|Overall Study|Adverse Event|3|||
162031007|NCT02880956|585169553|FG001|Overall Study|Adverse Event|6|||
162031008|NCT02880956|585169554|FG002|Overall Study|Adverse Event|5|||
162031009|NCT02880956|585169555|FG003|Overall Study|Adverse Event|4|||
162031010|NCT02880956|585169552|FG000|Overall Study|Withdrawal by Subject|9|||
162031011|NCT02880956|585169553|FG001|Overall Study|Withdrawal by Subject|4|||
162031012|NCT02880956|585169554|FG002|Overall Study|Withdrawal by Subject|6|||
162031013|NCT02880956|585169555|FG003|Overall Study|Withdrawal by Subject|11|||
162031014|NCT02880956|585169552|FG000|Overall Study|Lost to Follow-up|0|||
162031015|NCT02880956|585169553|FG001|Overall Study|Lost to Follow-up|1|||
162031016|NCT02880956|585169554|FG002|Overall Study|Lost to Follow-up|0|||
162031017|NCT02880956|585169555|FG003|Overall Study|Lost to Follow-up|0|||
162031018|NCT02880956|585169552|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
162031019|NCT02880956|585169553|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
162031020|NCT02880956|585169554|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
162031021|NCT02880956|585169555|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
162031022|NCT02880956|585169552|FG000|Overall Study|Other, Not Specified|4|||
162031023|NCT02880956|585169553|FG001|Overall Study|Other, Not Specified|2|||
162031024|NCT02880956|585169554|FG002|Overall Study|Other, Not Specified|0|||
162031025|NCT02880956|585169555|FG003|Overall Study|Other, Not Specified|3|||
162031026|NCT02081859|585169556|FG000|Overall Study|No fertilization|2|||
162031027|NCT02081859|585169557|FG001|Overall Study|No fertilization|2|||
162031028|NCT02081859|585169556|FG000|Overall Study|No sperm|1|||
162031029|NCT02081859|585169557|FG001|Overall Study|No sperm|0|||
162031030|NCT02081859|585169556|FG000|Overall Study|Unanticipated freeze all cycle|2|||
162031031|NCT02081859|585169557|FG001|Overall Study|Unanticipated freeze all cycle|6|||
162031032|NCT02081859|585169556|FG000|Overall Study|< 4 embryos|27|||
162031033|NCT02081859|585169557|FG001|Overall Study|< 4 embryos|23|||
162031034|NCT02081859|585169556|FG000|Overall Study|Other reasons|2|||
162031035|NCT02081859|585169557|FG001|Overall Study|Other reasons|0|||
162031036|NCT00706849|585170919|FG000|Treatment Period|Adverse Event|0|||
162031037|NCT00706849|585170920|FG001|Treatment Period|Adverse Event|9|||
162031038|NCT00706849|585170919|FG000|Treatment Period|Other|0|||
162031039|NCT00706849|585170920|FG001|Treatment Period|Other|1|||
162031040|NCT00706849|585170919|FG000|Follow-up Period|Withdrawal by Subject|0|||
162031041|NCT00706849|585170920|FG001|Follow-up Period|Withdrawal by Subject|2|||
162031042|NCT00706849|585170919|FG000|Follow-up Period|Protocol non-compliance|0|||
162031043|NCT00706849|585170920|FG001|Follow-up Period|Protocol non-compliance|1|||
162031044|NCT01611454|585170922|FG000|Overall Study|Lack of Efficacy|18|||
162031045|NCT01611454|585170923|FG001|Overall Study|Lack of Efficacy|10|||
162031046|NCT01275339|585170926|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
162031047|NCT01275339|585170927|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
162031048|NCT01275339|585170928|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
162031049|NCT01275339|585170929|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
162031050|NCT01275339|585170926|FG000|Overall Study|Withdrawal by Subject|0|||
162031051|NCT01275339|585170927|FG001|Overall Study|Withdrawal by Subject|0|||
162031052|NCT01275339|585170928|FG002|Overall Study|Withdrawal by Subject|1|||
162031053|NCT01275339|585170929|FG003|Overall Study|Withdrawal by Subject|0|||
162031054|NCT03718299|585170930|FG000|Overall Study|Adverse Event|1|||
162031055|NCT03718299|585170930|FG000|Overall Study|Withdrawal by Subject|6|||
162031056|NCT03718299|585170930|FG000|Overall Study|Physician Decision|2|||
162031057|NCT03718299|585170930|FG000|Overall Study|Lost to Follow-up|1|||
162031058|NCT04389970|585170932|FG000|Overall Study|Lost to Follow-up|1|||
162031059|NCT03123185|585170933|FG000|Overall Study|Withdrawal by Subject|0|||
162031060|NCT03123185|585170934|FG001|Overall Study|Withdrawal by Subject|0|||
162031061|NCT03123185|585170935|FG002|Overall Study|Withdrawal by Subject|0|||
162031062|NCT03123185|585170936|FG003|Overall Study|Withdrawal by Subject|0|||
161837973|NCT04765384|584450269|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161837974|NCT04765384|584450270|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161837975|NCT04765384|584450271|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
161837976|NCT04765384|584450266|FG000|Post-natal: Neonates and Infants|Death|0|||
161837977|NCT04765384|584450267|FG001|Post-natal: Neonates and Infants|Death|0|||
161837978|NCT04765384|584450268|FG002|Post-natal: Neonates and Infants|Death|0|||
161837979|NCT04765384|584450269|FG003|Post-natal: Neonates and Infants|Death|1|||
161837980|NCT04765384|584450270|FG004|Post-natal: Neonates and Infants|Death|0|||
161837981|NCT04765384|584450271|FG005|Post-natal: Neonates and Infants|Death|0|||
161837982|NCT04765384|584450266|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161837983|NCT04765384|584450267|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161837984|NCT04765384|584450268|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161837985|NCT04765384|584450269|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161837986|NCT04765384|584450270|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161837987|NCT04765384|584450271|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
161837988|NCT03246126|584450272|FG000|Overall Study|Withdrawal by Subject|0|||
161837989|NCT03246126|584450273|FG001|Overall Study|Withdrawal by Subject|1|||
161837990|NCT01006135|584450276|FG000|Overall Study|Adverse Event|22|||
161837991|NCT01006135|584450276|FG000|Overall Study|Protocol Violation|14|||
161837992|NCT01006135|584450276|FG000|Overall Study|Lost to Follow-up|32|||
161837993|NCT01006135|584450276|FG000|Overall Study|Other|72|||
161837994|NCT05297578|584450277|FG000|Overall Study|Lost to Follow-up|1|||
161837995|NCT05297578|584450278|FG001|Overall Study|Lost to Follow-up|1|||
161837996|NCT05297578|584450279|FG002|Overall Study|Lost to Follow-up|2|||
161837997|NCT05297578|584450280|FG003|Overall Study|Lost to Follow-up|1|||
161837998|NCT05297578|584450277|FG000|Overall Study|Death|0|||
161837999|NCT05297578|584450278|FG001|Overall Study|Death|1|||
161838000|NCT05297578|584450279|FG002|Overall Study|Death|0|||
161710227|NCT02786901|583982401|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
161710228|NCT02786901|583982402|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
161710229|NCT02786901|583982403|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
161710230|NCT02786901|583982401|FG000|Overall Study|Disallowed medication|1|||
161710231|NCT02786901|583982402|FG001|Overall Study|Disallowed medication|1|||
161710232|NCT02786901|583982403|FG002|Overall Study|Disallowed medication|0|||
161710233|NCT02786901|583982401|FG000|Overall Study|Randomized in error|2|||
161710234|NCT02786901|583982402|FG001|Overall Study|Randomized in error|0|||
161710235|NCT02786901|583982403|FG002|Overall Study|Randomized in error|1|||
161710236|NCT00607048|583982404|FG000|Overall Study|Adverse Event|0|||
161710237|NCT00607048|583982405|FG001|Overall Study|Adverse Event|1|||
161710238|NCT00607048|583982406|FG002|Overall Study|Adverse Event|0|||
161710239|NCT00607048|583982407|FG003|Overall Study|Adverse Event|0|||
161710240|NCT00607048|583982408|FG004|Overall Study|Adverse Event|4|||
161710241|NCT00607048|583982409|FG005|Overall Study|Adverse Event|0|||
161710242|NCT00607048|583982404|FG000|Overall Study|Global deterioration of health|1|||
161710243|NCT00607048|583982405|FG001|Overall Study|Global deterioration of health|0|||
161710244|NCT00607048|583982406|FG002|Overall Study|Global deterioration of health|0|||
161710245|NCT00607048|583982407|FG003|Overall Study|Global deterioration of health|0|||
161710246|NCT00607048|583982408|FG004|Overall Study|Global deterioration of health|0|||
161710247|NCT00607048|583982409|FG005|Overall Study|Global deterioration of health|0|||
161959341|NCT02131662|584896555|FG001|Overall Study|Other|4|||
161710248|NCT00607048|583982404|FG000|Overall Study|Objective disease progression - relapse|1|||
161710249|NCT00607048|583982405|FG001|Overall Study|Objective disease progression - relapse|2|||
161838001|NCT05297578|584450280|FG003|Overall Study|Death|0|||
161838002|NCT05297578|584450277|FG000|Overall Study|Withdrawal by Subject|0|||
161838003|NCT05297578|584450278|FG001|Overall Study|Withdrawal by Subject|0|||
161959342|NCT02131662|584896556|FG002|Overall Study|Other|3|||
161959343|NCT02131662|584896557|FG003|Overall Study|Other|3|||
161959344|NCT02131662|584896558|FG004|Overall Study|Other|4|||
161959345|NCT02131662|584896554|FG000|Overall Study|Adverse Event|0|||
161959346|NCT02131662|584896555|FG001|Overall Study|Adverse Event|1|||
161959347|NCT02131662|584896556|FG002|Overall Study|Adverse Event|1|||
161959348|NCT02131662|584896557|FG003|Overall Study|Adverse Event|1|||
161959349|NCT02131662|584896558|FG004|Overall Study|Adverse Event|3|||
161959350|NCT02131662|584896554|FG000|Overall Study|Pregnancy|0|||
161959351|NCT02131662|584896555|FG001|Overall Study|Pregnancy|1|||
161959352|NCT02131662|584896556|FG002|Overall Study|Pregnancy|0|||
161959353|NCT02131662|584896557|FG003|Overall Study|Pregnancy|1|||
161959354|NCT02131662|584896558|FG004|Overall Study|Pregnancy|0|||
161959355|NCT02131662|584896554|FG000|Overall Study|Wish for pregnancy|0|||
161959356|NCT02131662|584896555|FG001|Overall Study|Wish for pregnancy|0|||
161959357|NCT02131662|584896556|FG002|Overall Study|Wish for pregnancy|0|||
161959358|NCT02131662|584896557|FG003|Overall Study|Wish for pregnancy|0|||
161959359|NCT02131662|584896558|FG004|Overall Study|Wish for pregnancy|1|||
161959360|NCT02131662|584896554|FG000|Overall Study|Lack of Efficacy|1|||
161959361|NCT02131662|584896555|FG001|Overall Study|Lack of Efficacy|0|||
161959362|NCT02131662|584896556|FG002|Overall Study|Lack of Efficacy|0|||
161959363|NCT02131662|584896557|FG003|Overall Study|Lack of Efficacy|0|||
161959364|NCT02131662|584896558|FG004|Overall Study|Lack of Efficacy|1|||
161959365|NCT02131662|584896554|FG000|Overall Study|Withdrawal by Subject|1|||
161959366|NCT02131662|584896555|FG001|Overall Study|Withdrawal by Subject|5|||
161959367|NCT02131662|584896556|FG002|Overall Study|Withdrawal by Subject|1|||
161959368|NCT02131662|584896557|FG003|Overall Study|Withdrawal by Subject|5|||
161959369|NCT02131662|584896558|FG004|Overall Study|Withdrawal by Subject|6|||
161959370|NCT02131662|584896554|FG000|Overall Study|Lost to Follow-up|1|||
161959371|NCT02131662|584896555|FG001|Overall Study|Lost to Follow-up|3|||
161959372|NCT02131662|584896556|FG002|Overall Study|Lost to Follow-up|0|||
161959373|NCT02131662|584896557|FG003|Overall Study|Lost to Follow-up|9|||
161959374|NCT02131662|584896558|FG004|Overall Study|Lost to Follow-up|0|||
161959375|NCT02131662|584896554|FG000|Overall Study|Not treated|2|||
161959376|NCT02131662|584896555|FG001|Overall Study|Not treated|0|||
161959377|NCT02131662|584896556|FG002|Overall Study|Not treated|2|||
161959378|NCT02131662|584896557|FG003|Overall Study|Not treated|2|||
161959379|NCT02131662|584896558|FG004|Overall Study|Not treated|3|||
161959380|NCT01016132|584896559|FG000|Overall Study|Discomfort|1|||
161959381|NCT02949024|584896560|FG000|Overall Study|Withdrawal by Subject|0|||
161959382|NCT02949024|584896561|FG001|Overall Study|Withdrawal by Subject|1|||
161959383|NCT03062280|584898270|FG000|Overall Study|Adverse Event|1|||
161959384|NCT03062280|584898270|FG000|Overall Study|Death|1|||
161959385|NCT03062280|584898270|FG000|Overall Study|Fertility Treatment|2|||
161959386|NCT03062280|584898270|FG000|Overall Study|Physician Decision|2|||
161959387|NCT03062280|584898270|FG000|Overall Study|Pregnancy|5|||
161959388|NCT03062280|584898270|FG000|Overall Study|Withdrawal by Subject|11|||
161959389|NCT00336284|584898271|FG000|Overall Study|Death|52|||
161959390|NCT00336284|584898272|FG001|Overall Study|Death|26|||
161959391|NCT00336284|584898271|FG000|Overall Study|Lost to Follow-up|82|||
161959392|NCT00336284|584898272|FG001|Overall Study|Lost to Follow-up|61|||
161959393|NCT00336284|584898271|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
161959394|NCT00336284|584898272|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
162031063|NCT03123185|585170937|FG004|Overall Study|Withdrawal by Subject|0|||
162031064|NCT03123185|585170938|FG005|Overall Study|Withdrawal by Subject|0|||
162031065|NCT03123185|585170939|FG006|Overall Study|Withdrawal by Subject|0|||
162031066|NCT03123185|585170940|FG007|Overall Study|Withdrawal by Subject|0|||
162031067|NCT03123185|585170941|FG008|Overall Study|Withdrawal by Subject|0|||
161710250|NCT00607048|583982406|FG002|Overall Study|Objective disease progression - relapse|4|||
161710251|NCT00607048|583982407|FG003|Overall Study|Objective disease progression - relapse|2|||
161710252|NCT00607048|583982408|FG004|Overall Study|Objective disease progression - relapse|2|||
161959395|NCT04123093|584898273|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
161959396|NCT04123093|584898274|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
161959397|NCT04123093|584898273|FG000|Phase 2|Physician Decision|0|||
161959398|NCT04123093|584898274|FG001|Phase 2|Physician Decision|1|||
161959399|NCT04123093|584898273|FG000|Phase 2|Withdrawal by Subject|0|||
161959400|NCT04123093|584898274|FG001|Phase 2|Withdrawal by Subject|1|||
161959401|NCT03286543|584898275|FG000|Consented|Screen failure before randomization|2|||
161959402|NCT03286543|584898276|FG001|Consented|Screen failure before randomization|0|||
161959403|NCT03286543|584898277|FG002|Consented|Screen failure before randomization|0|||
161959404|NCT03286543|584898275|FG000|Consented|Screen failure before enrollment|4|||
161959405|NCT03286543|584898276|FG001|Consented|Screen failure before enrollment|0|||
161959406|NCT03286543|584898277|FG002|Consented|Screen failure before enrollment|0|||
161959407|NCT03286543|584898275|FG000|Consented|TKA cancelled after enrollment|1|||
161959408|NCT03286543|584898276|FG001|Consented|TKA cancelled after enrollment|0|||
161959409|NCT03286543|584898277|FG002|Consented|TKA cancelled after enrollment|0|||
161959410|NCT03286543|584898275|FG000|Consented|Withdrawn from study|12|||
161959411|NCT03286543|584898276|FG001|Consented|Withdrawn from study|0|||
161959412|NCT03286543|584898277|FG002|Consented|Withdrawn from study|0|||
161959413|NCT03286543|584898275|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
161959414|NCT03286543|584898276|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
161959415|NCT03286543|584898277|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
161959416|NCT03286543|584898275|FG000|Study Enrollment|Withdrawn from study|0|||
161959417|NCT03286543|584898276|FG001|Study Enrollment|Withdrawn from study|6|||
161959418|NCT03286543|584898277|FG002|Study Enrollment|Withdrawn from study|6|||
161959419|NCT03462641|584898281|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
161959420|NCT03462641|584898282|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
161959421|NCT03462641|584898281|FG000|Visit 2|Withdrawal by Subject|0|||
161959422|NCT03462641|584898282|FG001|Visit 2|Withdrawal by Subject|1|||
161959423|NCT01164891|584898305|FG000|Overall Study|Disease Progression|5|||
161959424|NCT01164891|584898305|FG000|Overall Study|Adverse Event|1|||
161959425|NCT00441142|584898306|FG000|Overall Study|Adverse Event|2|||
161959426|NCT00441142|584898307|FG001|Overall Study|Adverse Event|3|||
161959427|NCT00441142|584898308|FG002|Overall Study|Adverse Event|3|||
161959428|NCT00441142|584898309|FG003|Overall Study|Adverse Event|22|||
161959429|NCT00441142|584898306|FG000|Overall Study|Lack of Efficacy|3|||
161959430|NCT00441142|584898307|FG001|Overall Study|Lack of Efficacy|3|||
161959431|NCT00441142|584898308|FG002|Overall Study|Lack of Efficacy|17|||
161959432|NCT00441142|584898309|FG003|Overall Study|Lack of Efficacy|32|||
161959433|NCT00441142|584898306|FG000|Overall Study|Withdrawal by Subject|0|||
161959434|NCT00441142|584898307|FG001|Overall Study|Withdrawal by Subject|0|||
161959435|NCT00441142|584898308|FG002|Overall Study|Withdrawal by Subject|2|||
161959436|NCT00441142|584898309|FG003|Overall Study|Withdrawal by Subject|10|||
161959437|NCT00441142|584898306|FG000|Overall Study|Patient still receiving active study tx|1|||
161959438|NCT00441142|584898307|FG001|Overall Study|Patient still receiving active study tx|0|||
161959439|NCT00441142|584898308|FG002|Overall Study|Patient still receiving active study tx|0|||
161959440|NCT00441142|584898309|FG003|Overall Study|Patient still receiving active study tx|2|||
161959441|NCT00441142|584898306|FG000|Overall Study|Physician Decision|0|||
161959442|NCT00441142|584898307|FG001|Overall Study|Physician Decision|1|||
161959443|NCT00441142|584898308|FG002|Overall Study|Physician Decision|0|||
161959444|NCT00441142|584898309|FG003|Overall Study|Physician Decision|1|||
161959445|NCT00441142|584898306|FG000|Overall Study|Death|0|||
161959446|NCT00441142|584898307|FG001|Overall Study|Death|0|||
161959447|NCT00441142|584898308|FG002|Overall Study|Death|0|||
161959448|NCT00441142|584898309|FG003|Overall Study|Death|1|||
161959449|NCT00338286|584898310|FG000|Overall Study|Withdrawal by Subject|50|||
161959450|NCT00338286|584898311|FG001|Overall Study|Withdrawal by Subject|54|||
161959451|NCT00338286|584898310|FG000|Overall Study|Lost to Follow-up|80|||
162031068|NCT03123185|585170942|FG009|Overall Study|Withdrawal by Subject|0|||
162031069|NCT03123185|585170943|FG010|Overall Study|Withdrawal by Subject|0|||
161710253|NCT00607048|583982409|FG005|Overall Study|Objective disease progression - relapse|2|||
161959452|NCT00338286|584898311|FG001|Overall Study|Lost to Follow-up|66|||
161959453|NCT00338286|584898310|FG000|Overall Study|Other|103|||
161959454|NCT00338286|584898311|FG001|Overall Study|Other|93|||
161959455|NCT01265563|584898312|FG000|Overall Study|Withdrawal by Subject|0|||
161959456|NCT01265563|584898313|FG001|Overall Study|Withdrawal by Subject|1|||
161959457|NCT01265563|584898314|FG002|Overall Study|Withdrawal by Subject|1|||
161959458|NCT01265563|584898315|FG003|Overall Study|Withdrawal by Subject|0|||
161959459|NCT01265563|584898316|FG004|Overall Study|Withdrawal by Subject|2|||
161959460|NCT00022763|584898320|FG000|Overall Study|Adverse Event|1|||
161959461|NCT00022763|584898321|FG001|Overall Study|Adverse Event|2|||
161959462|NCT00022763|584898320|FG000|Overall Study|Injection Site Reactions|0|||
161959463|NCT00022763|584898321|FG001|Overall Study|Injection Site Reactions|2|||
161710254|NCT00607048|583982404|FG000|Overall Study|Withdrawal by Subject|0|||
161710255|NCT00607048|583982405|FG001|Overall Study|Withdrawal by Subject|0|||
161710256|NCT00607048|583982406|FG002|Overall Study|Withdrawal by Subject|0|||
161710257|NCT00607048|583982407|FG003|Overall Study|Withdrawal by Subject|1|||
161710258|NCT00607048|583982408|FG004|Overall Study|Withdrawal by Subject|0|||
161710259|NCT00607048|583982409|FG005|Overall Study|Withdrawal by Subject|2|||
161710260|NCT00607048|583982404|FG000|Overall Study|Other|1|||
161710261|NCT00607048|583982405|FG001|Overall Study|Other|1|||
161710262|NCT00607048|583982406|FG002|Overall Study|Other|0|||
161710263|NCT00607048|583982407|FG003|Overall Study|Other|0|||
161710264|NCT00607048|583982408|FG004|Overall Study|Other|0|||
161710265|NCT00607048|583982409|FG005|Overall Study|Other|1|||
161710266|NCT00355264|583982410|FG000|Extension (Variable Duration)|Adverse Event|1|||
161710267|NCT00355264|583982410|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
161710268|NCT00466505|583982411|FG000|Overall Study|disease progression|13|||
161710269|NCT00466505|583982411|FG000|Overall Study|Adverse Event|4|||
161710270|NCT00699192|583982412|FG000|Overall Study|Missing|1|||
161710271|NCT00699192|583982413|FG001|Overall Study|Missing|1|||
161710272|NCT00699192|583982414|FG002|Overall Study|Missing|1|||
161710273|NCT00699192|583982412|FG000|Overall Study|Adverse Event|9|||
161710274|NCT00699192|583982413|FG001|Overall Study|Adverse Event|4|||
161710275|NCT00699192|583982414|FG002|Overall Study|Adverse Event|3|||
161710276|NCT00699192|583982412|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161959464|NCT00022763|584898320|FG000|Overall Study|Death|0|||
161959465|NCT00022763|584898321|FG001|Overall Study|Death|1|||
161959466|NCT00022763|584898320|FG000|Overall Study|Lost to Follow-up|0|||
161959467|NCT00022763|584898321|FG001|Overall Study|Lost to Follow-up|3|||
161959468|NCT00022763|584898320|FG000|Overall Study|Withdrawal by Subject|4|||
161959469|NCT00022763|584898321|FG001|Overall Study|Withdrawal by Subject|7|||
161959470|NCT00022763|584898320|FG000|Overall Study|Insufficient Therapy|1|||
161959471|NCT00022763|584898321|FG001|Overall Study|Insufficient Therapy|0|||
161959472|NCT00022763|584898320|FG000|Overall Study|Admin|3|||
161959473|NCT00022763|584898321|FG001|Overall Study|Admin|2|||
161959474|NCT03248531|584898322|FG000|Overall Study|Adverse Event|0|||
161959475|NCT03248531|584898323|FG001|Overall Study|Adverse Event|0|||
161959476|NCT03248531|584898324|FG002|Overall Study|Adverse Event|1|||
161959477|NCT03248531|584898322|FG000|Overall Study|Lost to Follow-up|1|||
161959478|NCT03248531|584898323|FG001|Overall Study|Lost to Follow-up|0|||
161959479|NCT03248531|584898324|FG002|Overall Study|Lost to Follow-up|5|||
161959480|NCT03248531|584898322|FG000|Overall Study|Withdrawal by Subject|3|||
161959481|NCT03248531|584898323|FG001|Overall Study|Withdrawal by Subject|3|||
161959482|NCT03248531|584898324|FG002|Overall Study|Withdrawal by Subject|2|||
161959483|NCT03248531|584898322|FG000|Overall Study|Sponsor Request|0|||
161959484|NCT03248531|584898323|FG001|Overall Study|Sponsor Request|2|||
161959485|NCT03248531|584898324|FG002|Overall Study|Sponsor Request|0|||
161959486|NCT04908865|584898325|FG000|Overall Study|Adverse Event|2|||
161959487|NCT04908865|584898325|FG000|Overall Study|Lack of Efficacy|5|||
161959488|NCT04908865|584898325|FG000|Overall Study|Lost to Follow-up|1|||
161959489|NCT05286658|584898326|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
161959490|NCT05286658|584898326|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
161959491|NCT02122146|584898329|FG000|Part 1: Dose Escalation|Death|0|||
161959492|NCT02122146|584898330|FG001|Part 1: Dose Escalation|Death|1|||
161959493|NCT02122146|584898331|FG002|Part 1: Dose Escalation|Death|1|||
161959494|NCT02122146|584898332|FG003|Part 1: Dose Escalation|Death|0|||
161959495|NCT02122146|584898333|FG004|Part 1: Dose Escalation|Death|0|||
161959496|NCT02122146|584898334|FG005|Part 1: Dose Escalation|Death|0|||
162031070|NCT03123185|585170944|FG011|Overall Study|Withdrawal by Subject|0|||
162031071|NCT03123185|585170945|FG012|Overall Study|Withdrawal by Subject|1|||
162031072|NCT03123185|585170946|FG013|Overall Study|Withdrawal by Subject|0|||
161959497|NCT02122146|584898335|FG006|Part 1: Dose Escalation|Death|0|||
161959498|NCT02122146|584898336|FG007|Part 1: Dose Escalation|Death|0|||
161710277|NCT00699192|583982413|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161710278|NCT00699192|583982414|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161710279|NCT00699192|583982412|FG000|Overall Study|Lack of Efficacy|0|||
161710280|NCT00699192|583982413|FG001|Overall Study|Lack of Efficacy|0|||
161710281|NCT00699192|583982414|FG002|Overall Study|Lack of Efficacy|1|||
161710282|NCT00699192|583982412|FG000|Overall Study|Withdrawal by Subject|3|||
161710283|NCT00699192|583982413|FG001|Overall Study|Withdrawal by Subject|2|||
161710284|NCT00699192|583982414|FG002|Overall Study|Withdrawal by Subject|4|||
161710285|NCT00699192|583982412|FG000|Overall Study|Administrative problems|1|||
161710286|NCT00699192|583982413|FG001|Overall Study|Administrative problems|3|||
161710287|NCT00699192|583982414|FG002|Overall Study|Administrative problems|1|||
161710288|NCT00699192|583982412|FG000|Overall Study|Protocol Violation|2|||
161710289|NCT00699192|583982413|FG001|Overall Study|Protocol Violation|2|||
161710290|NCT00699192|583982414|FG002|Overall Study|Protocol Violation|0|||
161710291|NCT01773473|583982415|FG000|Overall Study|Adverse Event|3|||
161710292|NCT01773473|583982416|FG001|Overall Study|Adverse Event|2|||
161710293|NCT01773473|583982415|FG000|Overall Study|Protocol Violation|0|||
161710294|NCT01773473|583982416|FG001|Overall Study|Protocol Violation|4|||
161710295|NCT01773473|583982415|FG000|Overall Study|Physician Decision|3|||
161710296|NCT01773473|583982416|FG001|Overall Study|Physician Decision|5|||
161710297|NCT01773473|583982415|FG000|Overall Study|Sponsor Decision|2|||
161710298|NCT01773473|583982416|FG001|Overall Study|Sponsor Decision|0|||
161710299|NCT01773473|583982415|FG000|Overall Study|Lack of Efficacy|0|||
161710300|NCT01773473|583982416|FG001|Overall Study|Lack of Efficacy|1|||
161710301|NCT01773473|583982415|FG000|Overall Study|Non-Compliance with study drug|1|||
161710302|NCT01773473|583982416|FG001|Overall Study|Non-Compliance with study drug|4|||
161710303|NCT01773473|583982415|FG000|Overall Study|Withdrawal by Subject|5|||
161710304|NCT01773473|583982416|FG001|Overall Study|Withdrawal by Subject|3|||
161710305|NCT01773473|583982415|FG000|Overall Study|Lost to Follow-up|2|||
161710306|NCT01773473|583982416|FG001|Overall Study|Lost to Follow-up|0|||
161710307|NCT00826514|583982417|FG000|Overall Study|Adverse Event|1|||
161710308|NCT00826514|583982418|FG001|Overall Study|Adverse Event|1|||
161710309|NCT00826514|583982417|FG000|Overall Study|Lack of Efficacy|0|||
161710310|NCT00826514|583982418|FG001|Overall Study|Lack of Efficacy|1|||
161710311|NCT00826514|583982417|FG000|Overall Study|Withdrawal by Subject|2|||
161710312|NCT00826514|583982418|FG001|Overall Study|Withdrawal by Subject|3|||
161710313|NCT01451645|583982419|FG000|Overall Study|Protocol Violation|1|||
161710314|NCT01451645|583982420|FG001|Overall Study|Protocol Violation|0|||
161710315|NCT01451645|583982419|FG000|Overall Study|Adverse Event|0|||
161710316|NCT01451645|583982420|FG001|Overall Study|Adverse Event|3|||
161710317|NCT01451645|583982419|FG000|Overall Study|Withdrawal by Subject|4|||
161710318|NCT01451645|583982420|FG001|Overall Study|Withdrawal by Subject|2|||
161710319|NCT01451645|583982419|FG000|Overall Study|Lost to Follow-up|4|||
161710320|NCT01451645|583982420|FG001|Overall Study|Lost to Follow-up|3|||
161710321|NCT03663166|583982423|FG000|Overall Study|Withdrawal by Subject|1|||
161710322|NCT02620020|583982429|FG000|Overall Study|Adverse Event|8|||
161710323|NCT02620020|583982430|FG001|Overall Study|Adverse Event|4|||
161710324|NCT02620020|583982431|FG002|Overall Study|Adverse Event|3|||
161710325|NCT02620020|583982432|FG003|Overall Study|Adverse Event|5|||
161710326|NCT02620020|583982429|FG000|Overall Study|Lost to Follow-up|4|||
161710327|NCT02620020|583982430|FG001|Overall Study|Lost to Follow-up|8|||
161710328|NCT02620020|583982431|FG002|Overall Study|Lost to Follow-up|1|||
161710329|NCT02620020|583982432|FG003|Overall Study|Lost to Follow-up|4|||
161710330|NCT02620020|583982429|FG000|Overall Study|Physician Decision|7|||
161710331|NCT02620020|583982430|FG001|Overall Study|Physician Decision|4|||
161710332|NCT02620020|583982431|FG002|Overall Study|Physician Decision|3|||
161710333|NCT02620020|583982432|FG003|Overall Study|Physician Decision|4|||
161710334|NCT02620020|583982429|FG000|Overall Study|Protocol Violation|5|||
161710335|NCT02620020|583982430|FG001|Overall Study|Protocol Violation|2|||
161710336|NCT02620020|583982431|FG002|Overall Study|Protocol Violation|1|||
161710337|NCT02620020|583982432|FG003|Overall Study|Protocol Violation|1|||
161710338|NCT02620020|583982429|FG000|Overall Study|Withdrawal by Subject|20|||
161710339|NCT02620020|583982430|FG001|Overall Study|Withdrawal by Subject|16|||
161710340|NCT02620020|583982431|FG002|Overall Study|Withdrawal by Subject|17|||
161710341|NCT02620020|583982432|FG003|Overall Study|Withdrawal by Subject|12|||
161710342|NCT02620020|583982429|FG000|Overall Study|Death|0|||
161710343|NCT02620020|583982430|FG001|Overall Study|Death|1|||
161710344|NCT02620020|583982431|FG002|Overall Study|Death|0|||
161710345|NCT02620020|583982432|FG003|Overall Study|Death|0|||
161710346|NCT00098787|583982434|FG000|Overall Study|Never started treatment|3|||
161710347|NCT00098787|583982435|FG001|Overall Study|Never started treatment|2|||
161710348|NCT00098787|583982436|FG002|Overall Study|Never started treatment|1|||
161710349|NCT00098787|583982434|FG000|Overall Study|Ineligible|9|||
161710350|NCT00098787|583982435|FG001|Overall Study|Ineligible|7|||
161710351|NCT00098787|583982436|FG002|Overall Study|Ineligible|3|||
161710352|NCT00098787|583982434|FG000|Overall Study|Disease progression|28|||
161710353|NCT00098787|583982435|FG001|Overall Study|Disease progression|17|||
161710354|NCT00098787|583982436|FG002|Overall Study|Disease progression|23|||
161710355|NCT00098787|583982434|FG000|Overall Study|Adverse Event|8|||
161710356|NCT00098787|583982435|FG001|Overall Study|Adverse Event|17|||
162031073|NCT01993836|585170951|FG000|Overall Study|Surgery Cancelled|3|||
162031074|NCT01993836|585170952|FG001|Overall Study|Surgery Cancelled|0|||
162031075|NCT01993836|585170953|FG002|Overall Study|Surgery Cancelled|0|||
162031076|NCT01993836|585170951|FG000|Overall Study|Physician Decision|2|||
162031077|NCT01993836|585170952|FG001|Overall Study|Physician Decision|1|||
162031078|NCT01993836|585170953|FG002|Overall Study|Physician Decision|0|||
162031079|NCT01993836|585170951|FG000|Overall Study|Death|0|||
161710357|NCT00098787|583982436|FG002|Overall Study|Adverse Event|8|||
161710358|NCT00098787|583982434|FG000|Overall Study|Death|6|||
161710359|NCT00098787|583982435|FG001|Overall Study|Death|1|||
161710360|NCT00098787|583982436|FG002|Overall Study|Death|0|||
161710361|NCT00098787|583982434|FG000|Overall Study|Withdrawal by Subject|4|||
161710362|NCT00098787|583982435|FG001|Overall Study|Withdrawal by Subject|12|||
161710363|NCT00098787|583982436|FG002|Overall Study|Withdrawal by Subject|6|||
161710364|NCT00098787|583982434|FG000|Overall Study|Alternative therapy|8|||
161710365|NCT00098787|583982435|FG001|Overall Study|Alternative therapy|13|||
161710366|NCT00098787|583982436|FG002|Overall Study|Alternative therapy|13|||
161959499|NCT02122146|584898329|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
161959500|NCT02122146|584898330|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
161959501|NCT02122146|584898331|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
161959502|NCT02122146|584898332|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
161959503|NCT02122146|584898333|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
161959504|NCT02122146|584898334|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
161959505|NCT02122146|584898335|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
161959506|NCT02122146|584898336|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
161959507|NCT02122146|584898329|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161959508|NCT02122146|584898330|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161959509|NCT02122146|584898331|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161959510|NCT02122146|584898332|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
161959511|NCT02122146|584898333|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161959512|NCT02122146|584898334|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161959513|NCT02122146|584898335|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161959514|NCT02122146|584898336|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161959515|NCT02122146|584898329|FG000|Part 1: Dose Escalation|Other|1|||
161959516|NCT02122146|584898330|FG001|Part 1: Dose Escalation|Other|0|||
161959517|NCT02122146|584898331|FG002|Part 1: Dose Escalation|Other|0|||
161959518|NCT02122146|584898332|FG003|Part 1: Dose Escalation|Other|0|||
161959519|NCT02122146|584898333|FG004|Part 1: Dose Escalation|Other|0|||
161959520|NCT02122146|584898334|FG005|Part 1: Dose Escalation|Other|1|||
161959521|NCT02122146|584898335|FG006|Part 1: Dose Escalation|Other|1|||
161959522|NCT02122146|584898336|FG007|Part 1: Dose Escalation|Other|2|||
161959523|NCT03472495|584898337|FG000|Overall Study|Treatment no longer indicated|1|||
161959524|NCT03472495|584898338|FG001|Overall Study|Treatment no longer indicated|2|||
161959525|NCT03472495|584898337|FG000|Overall Study|Physician Decision|0|||
161959526|NCT03472495|584898338|FG001|Overall Study|Physician Decision|2|||
161959527|NCT00992056|584898341|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
161959528|NCT00992056|584898342|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
161959529|NCT00992056|584898341|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
161959530|NCT00992056|584898342|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
161959531|NCT01001767|584898343|FG000|Overall Study|no baseline study performed|1|||
161959532|NCT01001767|584898344|FG001|Overall Study|no baseline study performed|0|||
161959533|NCT01001767|584898343|FG000|Overall Study|Protocol Violation|1|||
161959534|NCT01001767|584898344|FG001|Overall Study|Protocol Violation|0|||
161959535|NCT01001767|584898343|FG000|Overall Study|Lost to Follow-up|1|||
161959536|NCT01001767|584898344|FG001|Overall Study|Lost to Follow-up|0|||
161959537|NCT01001767|584898343|FG000|Overall Study|Physician Decision|1|||
161959538|NCT01001767|584898344|FG001|Overall Study|Physician Decision|0|||
161959539|NCT02584452|584898345|FG000|Overall Study|Physician Decision|1|||
161959540|NCT02584452|584898346|FG001|Overall Study|Physician Decision|1|||
161959541|NCT02584452|584898345|FG000|Overall Study|Lost to Follow-up|1|||
161959542|NCT02584452|584898346|FG001|Overall Study|Lost to Follow-up|1|||
161959543|NCT00177294|584898347|FG000|Overall Study|Withdrawal by Subject|7|||
161959544|NCT00177294|584898348|FG001|Overall Study|Withdrawal by Subject|5|||
161959545|NCT02038946|584898349|FG000|Overall Study|Death|5|||
161959546|NCT02038946|584898349|FG000|Overall Study|Withdrawal by Subject|3|||
161710367|NCT00098787|583982434|FG000|Overall Study|Other|7|||
161959547|NCT02038946|584898349|FG000|Overall Study|Lost to Follow-up|2|||
161959548|NCT02038946|584898349|FG000|Overall Study|Other reasons|2|||
162031080|NCT01993836|585170952|FG001|Overall Study|Death|2|||
161959549|NCT02473471|584898350|FG000|Overall Study|poor oral hygiene|2|||
161959550|NCT02473471|584898350|FG000|Overall Study|Lost to Follow-up|1|||
161959551|NCT03082677|584898351|FG000|Overall Study|Not Treated|2|||
161959552|NCT01667133|584898352|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
161959553|NCT01667133|584898353|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
162031081|NCT01993836|585170953|FG002|Overall Study|Death|0|||
161710368|NCT00098787|583982435|FG001|Overall Study|Other|6|||
161710369|NCT00098787|583982436|FG002|Overall Study|Other|9|||
161710370|NCT02203149|583982437|FG000|Part 1|Adverse Event|0|||
162031082|NCT01993836|585170951|FG000|Overall Study|Withdrawal by Subject|12|||
162031083|NCT01993836|585170952|FG001|Overall Study|Withdrawal by Subject|10|||
162031084|NCT01993836|585170953|FG002|Overall Study|Withdrawal by Subject|5|||
161710371|NCT02203149|583982438|FG001|Part 1|Adverse Event|1|||
161959554|NCT01667133|584898354|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
161959555|NCT01667133|584898355|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
161959556|NCT01667133|584898356|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
161959557|NCT01667133|584898357|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
161959558|NCT01667133|584898358|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
161959559|NCT01667133|584898359|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
161959560|NCT01667133|584898360|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
161959561|NCT01667133|584898361|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
161959562|NCT01667133|584898362|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
161959563|NCT01667133|584898363|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
161959564|NCT01667133|584898352|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161959565|NCT01667133|584898353|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161959566|NCT01667133|584898354|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
161959567|NCT01667133|584898355|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161959568|NCT01667133|584898356|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161959569|NCT01667133|584898357|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161959570|NCT01667133|584898358|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161959571|NCT01667133|584898359|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161959572|NCT01667133|584898360|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161959573|NCT01667133|584898361|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161959574|NCT01667133|584898362|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161959575|NCT01667133|584898363|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
161959576|NCT01667133|584898352|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
161959577|NCT01667133|584898353|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
161959578|NCT01667133|584898354|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
161959579|NCT01667133|584898355|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
161959580|NCT01667133|584898356|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
161959581|NCT01667133|584898357|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
161959582|NCT01667133|584898358|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
161959583|NCT01667133|584898359|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
162031085|NCT00686634|585170954|FG000|Overall Study|Protocol Violation|6|||
162031086|NCT04369924|585170956|FG000|Overall Study|Lost to Follow-up|302|||
162031087|NCT04369924|585170957|FG001|Overall Study|Lost to Follow-up|339|||
162031088|NCT01653132|585170960|FG000|First Intervention|Protocol Violation|1|||
162031089|NCT01653132|585170961|FG001|First Intervention|Protocol Violation|0|||
162031090|NCT03828370|585170962|FG000|3 Month Follow-up|Lost to Follow-up|4|||
162031091|NCT03828370|585170963|FG001|3 Month Follow-up|Lost to Follow-up|12|||
162031092|NCT03828370|585170962|FG000|9 Month Follow up|Lost to Follow-up|12|||
162031093|NCT03828370|585170963|FG001|9 Month Follow up|Lost to Follow-up|20|||
162031094|NCT01209832|585170964|FG000|Period 1|Sponsor Decision and was not dosed|1|||
162031095|NCT01209832|585170964|FG000|Period 2|Sponsor Decision|1|||
162031096|NCT00761150|585170965|FG000|Open-label Period|Adverse Event|36|||
162031097|NCT00761150|585170966|FG001|Open-label Period|Adverse Event|0|||
162031098|NCT00761150|585170967|FG002|Open-label Period|Adverse Event|0|||
162031099|NCT00761150|585170965|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
162031100|NCT00761150|585170966|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
162031101|NCT00761150|585170967|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
162031102|NCT00761150|585170965|FG000|Open-label Period|Lost to Follow-up|7|||
162031103|NCT00761150|585170966|FG001|Open-label Period|Lost to Follow-up|0|||
162031104|NCT00761150|585170967|FG002|Open-label Period|Lost to Follow-up|0|||
162031105|NCT00761150|585170965|FG000|Open-label Period|Lack of Efficacy|4|||
162031106|NCT00761150|585170966|FG001|Open-label Period|Lack of Efficacy|0|||
162031107|NCT00761150|585170967|FG002|Open-label Period|Lack of Efficacy|0|||
162031108|NCT00761150|585170965|FG000|Open-label Period|Withdrawal by Subject|5|||
162031109|NCT00761150|585170966|FG001|Open-label Period|Withdrawal by Subject|0|||
162031110|NCT00761150|585170967|FG002|Open-label Period|Withdrawal by Subject|0|||
162031111|NCT00761150|585170965|FG000|Open-label Period|Noncompliance|2|||
162031112|NCT00761150|585170966|FG001|Open-label Period|Noncompliance|0|||
162031113|NCT00761150|585170967|FG002|Open-label Period|Noncompliance|0|||
162031114|NCT00761150|585170965|FG000|Open-label Period|Other|5|||
162031115|NCT00761150|585170966|FG001|Open-label Period|Other|0|||
162031116|NCT00761150|585170967|FG002|Open-label Period|Other|0|||
162031117|NCT00761150|585170965|FG000|Double-blind Period|Lack of Efficacy|0|||
162031118|NCT00761150|585170966|FG001|Double-blind Period|Lack of Efficacy|2|||
162031119|NCT00761150|585170967|FG002|Double-blind Period|Lack of Efficacy|19|||
162031120|NCT00761150|585170965|FG000|Double-blind Period|Adverse Event|0|||
161959584|NCT01667133|584898360|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
161959585|NCT01667133|584898361|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
161959586|NCT01667133|584898362|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
162031121|NCT00761150|585170966|FG001|Double-blind Period|Adverse Event|3|||
162031122|NCT00761150|585170967|FG002|Double-blind Period|Adverse Event|3|||
161710372|NCT02203149|583982439|FG002|Part 1|Adverse Event|0|||
161710373|NCT02203149|583982440|FG003|Part 1|Adverse Event|0|||
161710374|NCT02203149|583982441|FG004|Part 1|Adverse Event|0|||
161710375|NCT02203149|583982437|FG000|Part 2|Death|0|||
161710376|NCT02203149|583982438|FG001|Part 2|Death|0|||
161710377|NCT02203149|583982439|FG002|Part 2|Death|1|||
161710378|NCT02203149|583982440|FG003|Part 2|Death|1|||
161710379|NCT02203149|583982441|FG004|Part 2|Death|0|||
161710380|NCT02203149|583982437|FG000|Part 2|Withdrawal by Subject|0|||
161710381|NCT02203149|583982438|FG001|Part 2|Withdrawal by Subject|0|||
161710382|NCT02203149|583982439|FG002|Part 2|Withdrawal by Subject|0|||
161710383|NCT02203149|583982440|FG003|Part 2|Withdrawal by Subject|1|||
161710384|NCT02203149|583982441|FG004|Part 2|Withdrawal by Subject|0|||
161710385|NCT02203149|583982437|FG000|Part 2|Adverse Event|0|||
161710386|NCT02203149|583982438|FG001|Part 2|Adverse Event|0|||
161710387|NCT02203149|583982439|FG002|Part 2|Adverse Event|0|||
161710388|NCT02203149|583982440|FG003|Part 2|Adverse Event|1|||
161710389|NCT02203149|583982441|FG004|Part 2|Adverse Event|1|||
161710390|NCT00684814|583982442|FG000|Washout Period of 7 Days|Adverse Event|1|||
161710391|NCT00684814|583982443|FG001|Washout Period of 7 Days|Adverse Event|2|||
161710392|NCT00684814|583982442|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
161710393|NCT00684814|583982443|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
161710394|NCT00684814|583982442|FG000|Second Intervention|Adverse Event|1|||
161710395|NCT00684814|583982443|FG001|Second Intervention|Adverse Event|0|||
161710396|NCT02537678|583982444|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
161710397|NCT02537678|583982445|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
161710398|NCT02537678|583982444|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
161710399|NCT02537678|583982445|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
161710400|NCT02537678|583982444|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
161710401|NCT02537678|583982445|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
161959587|NCT01667133|584898363|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
161959588|NCT01667133|584898352|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161710402|NCT02537678|583982444|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
161710403|NCT02537678|583982445|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
161959589|NCT01667133|584898353|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161710404|NCT02537678|583982444|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
161710405|NCT02537678|583982445|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
161710406|NCT02537678|583982444|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
161710407|NCT02537678|583982445|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
161959590|NCT01667133|584898354|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161959591|NCT01667133|584898355|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
161959592|NCT01667133|584898356|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161959593|NCT01667133|584898357|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161959594|NCT01667133|584898358|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161959595|NCT01667133|584898359|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161710408|NCT02537678|583982444|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
161710409|NCT02537678|583982445|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
161710410|NCT04348851|583982446|FG000|Post-Test 1|Withdrawal by Subject|0|||
161710411|NCT04348851|583982447|FG001|Post-Test 1|Withdrawal by Subject|1|||
161710412|NCT04348851|583982448|FG002|Post-Test 1|Withdrawal by Subject|0|||
161710413|NCT04348851|583982449|FG003|Post-Test 1|Withdrawal by Subject|0|||
161710414|NCT04348851|583982446|FG000|Post-Test 1|Lost to Follow-up|0|||
161710415|NCT04348851|583982447|FG001|Post-Test 1|Lost to Follow-up|1|||
161959596|NCT01667133|584898360|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161959597|NCT01667133|584898361|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161959598|NCT01667133|584898362|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161959599|NCT01667133|584898363|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161959600|NCT01667133|584898352|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
161959601|NCT01667133|584898353|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
161959602|NCT01667133|584898354|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
161959603|NCT01667133|584898355|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
161710416|NCT04348851|583982448|FG002|Post-Test 1|Lost to Follow-up|0|||
161959604|NCT01667133|584898356|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
161710417|NCT04348851|583982449|FG003|Post-Test 1|Lost to Follow-up|0|||
161710418|NCT04348851|583982446|FG000|Post-Test 2|Stroke survivor death|0|||
161710419|NCT04348851|583982447|FG001|Post-Test 2|Stroke survivor death|1|||
161710420|NCT04348851|583982448|FG002|Post-Test 2|Stroke survivor death|0|||
161710421|NCT04348851|583982449|FG003|Post-Test 2|Stroke survivor death|1|||
161710422|NCT00195650|583982450|FG000|Overall Study|Adverse Event|194|||
161710423|NCT00195650|583982450|FG000|Overall Study|Lack of Efficacy|99|||
161710424|NCT00195650|583982450|FG000|Overall Study|Withdrawal by Subject|67|||
161710425|NCT00195650|583982450|FG000|Overall Study|Lost to Follow-up|44|||
161710426|NCT00195650|583982450|FG000|Overall Study|Death|23|||
161710427|NCT00195650|583982450|FG000|Overall Study|Protocol Violation|15|||
161710428|NCT00195650|583982450|FG000|Overall Study|Administrative reasons|83|||
161710429|NCT00432809|583982451|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
161710430|NCT00432809|583982452|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
161710431|NCT00432809|583982453|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
161710432|NCT00432809|583982451|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
161710433|NCT00432809|583982452|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
161710434|NCT00432809|583982453|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
161710435|NCT00655928|583982455|FG000|Overall Study|Withdrawal by Subject|2|||
161710436|NCT00655928|583982456|FG001|Overall Study|Withdrawal by Subject|1|||
161710437|NCT00655928|583982455|FG000|Overall Study|Physician Decision|1|||
161710438|NCT00655928|583982456|FG001|Overall Study|Physician Decision|1|||
161710439|NCT00275561|583982460|FG000|Overall Study|Withdrawal by Subject|0|||
161710440|NCT00275561|583982461|FG001|Overall Study|Withdrawal by Subject|1|||
161710441|NCT00275561|583982460|FG000|Overall Study|Travel|1|||
161710442|NCT00275561|583982461|FG001|Overall Study|Travel|1|||
161710443|NCT00275561|583982460|FG000|Overall Study|Scheduling|1|||
161710444|NCT00275561|583982461|FG001|Overall Study|Scheduling|2|||
161710445|NCT00275561|583982460|FG000|Overall Study|Family Issues|0|||
161710446|NCT00275561|583982461|FG001|Overall Study|Family Issues|2|||
161710447|NCT01769105|583982462|FG000|First Intervention|Protocol Violation|2|||
161710448|NCT01769105|583982463|FG001|First Intervention|Protocol Violation|2|||
161710449|NCT01769105|583982462|FG000|Cross-over|Lost to Follow-up|5|||
161710450|NCT01769105|583982463|FG001|Cross-over|Lost to Follow-up|0|||
161710451|NCT02109029|583984067|FG000|Part B|Adverse Event|0|||
161710452|NCT02109029|583984068|FG001|Part B|Adverse Event|0|||
161710453|NCT02109029|583984069|FG002|Part B|Adverse Event|0|||
161710454|NCT02109029|583984070|FG003|Part B|Adverse Event|0|||
161710455|NCT02109029|583984071|FG004|Part B|Adverse Event|1|||
161710456|NCT02109029|583984072|FG005|Part B|Adverse Event|1|||
161710457|NCT03195894|583984073|FG000|Overall Study|"An example is Started other treatment."|4|||
161710458|NCT03195894|583984074|FG001|Overall Study|"An example is Started other treatment."|5|||
161710459|NCT03195894|583984073|FG000|Overall Study|Withdrawal by Subject|15|||
161710460|NCT03195894|583984074|FG001|Overall Study|Withdrawal by Subject|4|||
161710461|NCT03195894|583984073|FG000|Overall Study|Lost to Follow-up|14|||
161710462|NCT03195894|583984074|FG001|Overall Study|Lost to Follow-up|19|||
161710463|NCT00377962|583984075|FG000|Core Study: 0-12 Months|Adverse Event|18|||
161710464|NCT00377962|583984076|FG001|Core Study: 0-12 Months|Adverse Event|2|||
161710465|NCT00377962|583984075|FG000|Core Study: 0-12 Months|Death|3|||
161710466|NCT00377962|583984076|FG001|Core Study: 0-12 Months|Death|0|||
161710467|NCT00377962|583984075|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
161710468|NCT00377962|583984076|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
161710469|NCT00377962|583984075|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
161710470|NCT00377962|583984076|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
161710471|NCT00377962|583984075|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
161710472|NCT00377962|583984076|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
161710473|NCT00377962|583984075|FG000|Extension Study: 12-24 Months|Death|1|||
161710474|NCT00377962|583984076|FG001|Extension Study: 12-24 Months|Death|1|||
161710475|NCT00377962|583984075|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
161710476|NCT00377962|583984076|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
161710477|NCT00377962|583984075|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
161710478|NCT00377962|583984076|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
161710479|NCT00377962|583984075|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
161710480|NCT00377962|583984076|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
161710481|NCT00496366|583984083|FG000|Overall Study|Death|1|||
161710482|NCT00260208|583984084|FG000|Overall Study|Subject withdrew consent|11|||
161710483|NCT00260208|583984085|FG001|Overall Study|Subject withdrew consent|7|||
161710484|NCT00260208|583984084|FG000|Overall Study|Lost to Follow-up|6|||
161710485|NCT00260208|583984085|FG001|Overall Study|Lost to Follow-up|1|||
161710486|NCT00260208|583984084|FG000|Overall Study|Death|12|||
161710487|NCT00260208|583984085|FG001|Overall Study|Death|10|||
161710488|NCT00260208|583984084|FG000|Overall Study|Missing|18|||
161710489|NCT00260208|583984085|FG001|Overall Study|Missing|16|||
161710490|NCT00768222|583984086|FG000|Overall Study|Lost to Follow-up|1|||
161710491|NCT00768222|583984087|FG001|Overall Study|Lost to Follow-up|1|||
161710492|NCT00768222|583984086|FG000|Overall Study|Withdrawal by Subject|3|||
161710493|NCT00768222|583984087|FG001|Overall Study|Withdrawal by Subject|1|||
161710494|NCT00768222|583984086|FG000|Overall Study|Protocol Violation|0|||
161710495|NCT00768222|583984087|FG001|Overall Study|Protocol Violation|2|||
162031123|NCT00761150|585170965|FG000|Double-blind Period|Withdrawal by Subject|0|||
162031124|NCT00761150|585170966|FG001|Double-blind Period|Withdrawal by Subject|3|||
162031125|NCT00761150|585170967|FG002|Double-blind Period|Withdrawal by Subject|2|||
162031126|NCT00761150|585170965|FG000|Double-blind Period|Lost to Follow-up|0|||
162031127|NCT00761150|585170966|FG001|Double-blind Period|Lost to Follow-up|2|||
162031128|NCT00761150|585170967|FG002|Double-blind Period|Lost to Follow-up|1|||
162031129|NCT00761150|585170965|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
162031130|NCT00761150|585170966|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
162031131|NCT00761150|585170967|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
162031132|NCT00761150|585170965|FG000|Double-blind Period|Noncompliance|0|||
162031133|NCT00761150|585170966|FG001|Double-blind Period|Noncompliance|1|||
162031134|NCT00761150|585170967|FG002|Double-blind Period|Noncompliance|0|||
162031135|NCT00761150|585170965|FG000|Double-blind Period|Other|0|||
162031136|NCT00761150|585170966|FG001|Double-blind Period|Other|3|||
162031137|NCT00761150|585170967|FG002|Double-blind Period|Other|3|||
162031138|NCT02536404|585170969|FG000|Overall Study|Adverse Event|5|||
162031139|NCT02536404|585170970|FG001|Overall Study|Adverse Event|0|||
162031140|NCT02536404|585170969|FG000|Overall Study|Withdrawal by Subject|4|||
162031141|NCT02536404|585170970|FG001|Overall Study|Withdrawal by Subject|1|||
162031142|NCT02536404|585170969|FG000|Overall Study|Physician Decision|10|||
161710496|NCT03263091|583984089|FG000|OL Component|Withdrawal by Subject|1|||
161710497|NCT03263091|583984090|FG001|OL Component|Withdrawal by Subject|1|||
161710498|NCT03263091|583984091|FG002|OL Component|Withdrawal by Subject|0|||
161710499|NCT03263091|583984092|FG003|OL Component|Withdrawal by Subject|0|||
161710500|NCT03263091|583984093|FG004|OL Component|Withdrawal by Subject|0|||
161710501|NCT03263091|583984094|FG005|OL Component|Withdrawal by Subject|0|||
161710502|NCT03263091|583984089|FG000|OL Component|Physician Decision|0|||
161710503|NCT03263091|583984090|FG001|OL Component|Physician Decision|1|||
161959605|NCT01667133|584898357|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
161959606|NCT01667133|584898358|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
161959607|NCT01667133|584898359|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
161959608|NCT01667133|584898360|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
161959609|NCT01667133|584898361|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
161959610|NCT01667133|584898362|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
161959611|NCT01667133|584898363|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
161959612|NCT01667133|584898352|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161959613|NCT01667133|584898353|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161959614|NCT01667133|584898354|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161959615|NCT01667133|584898355|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161959616|NCT01667133|584898356|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161959617|NCT01667133|584898357|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161959618|NCT01667133|584898358|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161959619|NCT01667133|584898359|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161959620|NCT01667133|584898360|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161959621|NCT01667133|584898361|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
161959622|NCT01667133|584898362|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161959623|NCT01667133|584898363|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161959624|NCT01667133|584898352|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
161959625|NCT01667133|584898353|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
161959626|NCT01667133|584898354|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
161959627|NCT01667133|584898355|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
161959628|NCT01667133|584898356|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
161959629|NCT01667133|584898357|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
161959630|NCT01667133|584898358|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
161959631|NCT01667133|584898359|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
161959632|NCT01667133|584898360|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
161710504|NCT03263091|583984091|FG002|OL Component|Physician Decision|2|||
161710505|NCT03263091|583984092|FG003|OL Component|Physician Decision|0|||
161710506|NCT03263091|583984093|FG004|OL Component|Physician Decision|0|||
161710507|NCT03263091|583984094|FG005|OL Component|Physician Decision|0|||
161710508|NCT03263091|583984089|FG000|OL Component|Death|1|||
161710509|NCT03263091|583984090|FG001|OL Component|Death|0|||
161710510|NCT03263091|583984091|FG002|OL Component|Death|0|||
161710511|NCT03263091|583984092|FG003|OL Component|Death|0|||
161710512|NCT03263091|583984093|FG004|OL Component|Death|0|||
161710513|NCT03263091|583984094|FG005|OL Component|Death|0|||
161710514|NCT03263091|583984089|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
161710515|NCT03263091|583984090|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
161710516|NCT03263091|583984091|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
161959633|NCT01667133|584898361|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
161959634|NCT01667133|584898362|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
161959635|NCT01667133|584898363|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
161959636|NCT01667133|584898352|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161959637|NCT01667133|584898353|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161959638|NCT01667133|584898354|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161959639|NCT01667133|584898355|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161959640|NCT01667133|584898356|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161959641|NCT01667133|584898357|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161959642|NCT01667133|584898358|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161959643|NCT01667133|584898359|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161959644|NCT01667133|584898360|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161959645|NCT01667133|584898361|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
161959646|NCT01667133|584898362|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161959647|NCT01667133|584898363|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
161959648|NCT01667133|584898352|FG000|Phase 2: Dose-expansion|Death|0|||
161959649|NCT01667133|584898353|FG001|Phase 2: Dose-expansion|Death|0|||
161959650|NCT01667133|584898354|FG002|Phase 2: Dose-expansion|Death|0|||
161959651|NCT01667133|584898355|FG003|Phase 2: Dose-expansion|Death|0|||
161959652|NCT01667133|584898356|FG004|Phase 2: Dose-expansion|Death|0|||
161710517|NCT03263091|583984092|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
161710518|NCT03263091|583984093|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
161710519|NCT03263091|583984094|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
161710520|NCT03263091|583984089|FG000|OL High-EPO Component|Physician Decision|0|||
161959653|NCT01667133|584898357|FG005|Phase 2: Dose-expansion|Death|0|||
161959654|NCT01667133|584898358|FG006|Phase 2: Dose-expansion|Death|0|||
161959655|NCT01667133|584898359|FG007|Phase 2: Dose-expansion|Death|0|||
161959656|NCT01667133|584898360|FG008|Phase 2: Dose-expansion|Death|0|||
161959657|NCT01667133|584898361|FG009|Phase 2: Dose-expansion|Death|1|||
161959658|NCT01667133|584898362|FG010|Phase 2: Dose-expansion|Death|0|||
161959659|NCT01667133|584898363|FG011|Phase 2: Dose-expansion|Death|0|||
161959660|NCT01667133|584898352|FG000|Phase 2: Dose-expansion|Other|0|||
161959661|NCT01667133|584898353|FG001|Phase 2: Dose-expansion|Other|0|||
161959662|NCT01667133|584898354|FG002|Phase 2: Dose-expansion|Other|0|||
161959663|NCT01667133|584898355|FG003|Phase 2: Dose-expansion|Other|0|||
161959664|NCT01667133|584898356|FG004|Phase 2: Dose-expansion|Other|0|||
161959665|NCT01667133|584898357|FG005|Phase 2: Dose-expansion|Other|0|||
161959666|NCT01667133|584898358|FG006|Phase 2: Dose-expansion|Other|0|||
161959667|NCT01667133|584898359|FG007|Phase 2: Dose-expansion|Other|0|||
161959668|NCT01667133|584898360|FG008|Phase 2: Dose-expansion|Other|0|||
161959669|NCT01667133|584898361|FG009|Phase 2: Dose-expansion|Other|0|||
161959670|NCT01667133|584898362|FG010|Phase 2: Dose-expansion|Other|0|||
161959671|NCT01667133|584898363|FG011|Phase 2: Dose-expansion|Other|1|||
161959672|NCT01916824|584898366|FG000|Overall Study|Lost to Follow-up|3|||
161959673|NCT01916824|584898367|FG001|Overall Study|Lost to Follow-up|6|||
161959674|NCT01916824|584898366|FG000|Overall Study|Physician Decision|2|||
161959675|NCT01916824|584898367|FG001|Overall Study|Physician Decision|0|||
161959676|NCT01916824|584898366|FG000|Overall Study|Withdrawal by Subject|2|||
161959677|NCT01916824|584898367|FG001|Overall Study|Withdrawal by Subject|3|||
161959678|NCT03835481|584898370|FG000|Double-blind Period|Other not stated below|0|||
161959679|NCT03835481|584898371|FG001|Double-blind Period|Other not stated below|0|||
161959680|NCT03835481|584898372|FG002|Double-blind Period|Other not stated below|0|||
161959681|NCT03835481|584898373|FG003|Double-blind Period|Other not stated below|1|||
161959682|NCT03835481|584898374|FG004|Double-blind Period|Other not stated below|1|||
161959683|NCT03835481|584898370|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
161959684|NCT03835481|584898371|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
161959685|NCT03835481|584898372|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
161959686|NCT03835481|584898373|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
161959687|NCT03835481|584898374|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
161959688|NCT03835481|584898370|FG000|Double-blind Period|Withdrawal by Subject|0|||
161959689|NCT03835481|584898371|FG001|Double-blind Period|Withdrawal by Subject|0|||
161959690|NCT03835481|584898372|FG002|Double-blind Period|Withdrawal by Subject|1|||
161959691|NCT03835481|584898373|FG003|Double-blind Period|Withdrawal by Subject|0|||
161959692|NCT03835481|584898374|FG004|Double-blind Period|Withdrawal by Subject|5|||
161959693|NCT03835481|584898370|FG000|Double-blind Period|Lost to Follow-up|0|||
161959694|NCT03835481|584898371|FG001|Double-blind Period|Lost to Follow-up|0|||
161959695|NCT03835481|584898372|FG002|Double-blind Period|Lost to Follow-up|0|||
161959696|NCT03835481|584898373|FG003|Double-blind Period|Lost to Follow-up|1|||
161959697|NCT03835481|584898374|FG004|Double-blind Period|Lost to Follow-up|0|||
161959698|NCT03835481|584898370|FG000|Double-blind Period|Protocol Violation|0|||
161959699|NCT03835481|584898371|FG001|Double-blind Period|Protocol Violation|2|||
161959700|NCT03835481|584898372|FG002|Double-blind Period|Protocol Violation|0|||
161959701|NCT03835481|584898373|FG003|Double-blind Period|Protocol Violation|1|||
161959702|NCT03835481|584898374|FG004|Double-blind Period|Protocol Violation|0|||
161959703|NCT03835481|584898370|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
161959704|NCT03835481|584898371|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
161959705|NCT03835481|584898372|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
161959706|NCT03835481|584898373|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
161959707|NCT03835481|584898374|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
161959708|NCT03835481|584898370|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
161959709|NCT03835481|584898371|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
161959710|NCT03835481|584898372|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
161959711|NCT03835481|584898373|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
161959712|NCT03835481|584898374|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
161959713|NCT03835481|584898370|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
161959714|NCT03835481|584898371|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
161959715|NCT03835481|584898372|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
161959716|NCT03835481|584898373|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
161959717|NCT03835481|584898374|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
161959718|NCT03835481|584898370|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
161959719|NCT03835481|584898371|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
161959720|NCT03835481|584898372|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
161959721|NCT03835481|584898373|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
161959722|NCT03835481|584898374|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
161959723|NCT03835481|584898370|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
161959724|NCT03835481|584898371|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
161959725|NCT03835481|584898372|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
161959726|NCT03835481|584898373|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
161959727|NCT03835481|584898374|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
161710521|NCT03263091|583984090|FG001|OL High-EPO Component|Physician Decision|0|||
161710522|NCT03263091|583984091|FG002|OL High-EPO Component|Physician Decision|0|||
161710523|NCT03263091|583984092|FG003|OL High-EPO Component|Physician Decision|1|||
161710524|NCT03263091|583984093|FG004|OL High-EPO Component|Physician Decision|0|||
161710525|NCT03263091|583984094|FG005|OL High-EPO Component|Physician Decision|0|||
161710526|NCT03263091|583984089|FG000|OL High-EPO Component|Death|0|||
161710527|NCT03263091|583984090|FG001|OL High-EPO Component|Death|0|||
161710528|NCT03263091|583984091|FG002|OL High-EPO Component|Death|0|||
161710529|NCT03263091|583984092|FG003|OL High-EPO Component|Death|3|||
161710530|NCT03263091|583984093|FG004|OL High-EPO Component|Death|0|||
161710531|NCT03263091|583984094|FG005|OL High-EPO Component|Death|0|||
161710532|NCT03263091|583984089|FG000|DB Component|Withdrawal by Subject|0|||
161710533|NCT03263091|583984090|FG001|DB Component|Withdrawal by Subject|0|||
161710534|NCT03263091|583984091|FG002|DB Component|Withdrawal by Subject|0|||
161710535|NCT03263091|583984092|FG003|DB Component|Withdrawal by Subject|0|||
161710536|NCT03263091|583984093|FG004|DB Component|Withdrawal by Subject|22|||
161710537|NCT03263091|583984094|FG005|DB Component|Withdrawal by Subject|8|||
161710538|NCT03263091|583984089|FG000|DB Component|Physician Decision|0|||
161710539|NCT03263091|583984090|FG001|DB Component|Physician Decision|0|||
161710540|NCT03263091|583984091|FG002|DB Component|Physician Decision|0|||
161710541|NCT03263091|583984092|FG003|DB Component|Physician Decision|0|||
161959728|NCT03835481|584898370|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
161959729|NCT03835481|584898371|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
161710542|NCT03263091|583984093|FG004|DB Component|Physician Decision|3|||
161710543|NCT03263091|583984094|FG005|DB Component|Physician Decision|1|||
161710544|NCT03263091|583984089|FG000|DB Component|Adverse Event|0|||
161710545|NCT03263091|583984090|FG001|DB Component|Adverse Event|0|||
161710546|NCT03263091|583984091|FG002|DB Component|Adverse Event|0|||
161710547|NCT03263091|583984092|FG003|DB Component|Adverse Event|0|||
161710548|NCT03263091|583984093|FG004|DB Component|Adverse Event|2|||
161710549|NCT03263091|583984094|FG005|DB Component|Adverse Event|1|||
161959730|NCT03835481|584898372|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
161959731|NCT03835481|584898373|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
161959732|NCT03835481|584898374|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
161959733|NCT00191945|584898375|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
161959734|NCT00191945|584898376|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
161959735|NCT00191945|584898375|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
161959736|NCT00191945|584898376|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
161959737|NCT00191945|584898375|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
161959738|NCT00191945|584898376|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
161959739|NCT00191945|584898375|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
161959740|NCT00191945|584898376|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
161959741|NCT02063984|584898378|FG000|Overall Study|Lost to Follow-up|6|||
161959742|NCT02063984|584898379|FG001|Overall Study|Lost to Follow-up|5|||
161959743|NCT01030952|584898386|FG000|Overall Study|Protocol Violation|0|||
161959744|NCT01030952|584898387|FG001|Overall Study|Protocol Violation|1|||
161959745|NCT01030952|584898386|FG000|Overall Study|Informed consent withdrawal|1|||
161959746|NCT01030952|584898387|FG001|Overall Study|Informed consent withdrawal|0|||
161959747|NCT01030952|584898386|FG000|Overall Study|Lost to Follow-up|0|||
161959748|NCT01030952|584898387|FG001|Overall Study|Lost to Follow-up|1|||
161959749|NCT01030952|584898386|FG000|Overall Study|Unexplained|1|||
161959750|NCT01030952|584898387|FG001|Overall Study|Unexplained|1|||
161959751|NCT01831466|584898393|FG000|Overall Study|Protocol Violation|1|||
161959752|NCT01831466|584898394|FG001|Overall Study|Protocol Violation|1|||
161959753|NCT01831466|584898395|FG002|Overall Study|Protocol Violation|2|||
161959754|NCT01831466|584898396|FG003|Overall Study|Protocol Violation|0|||
161959755|NCT01831466|584898397|FG004|Overall Study|Protocol Violation|0|||
161959756|NCT01831466|584898398|FG005|Overall Study|Protocol Violation|1|||
161959757|NCT01831466|584898399|FG006|Overall Study|Protocol Violation|0|||
161959758|NCT01831466|584898400|FG007|Overall Study|Protocol Violation|0|||
161959759|NCT01831466|584898401|FG008|Overall Study|Protocol Violation|0|||
161959760|NCT01831466|584898402|FG009|Overall Study|Protocol Violation|0|||
161959761|NCT01831466|584898403|FG010|Overall Study|Protocol Violation|0|||
161959762|NCT01831466|584898404|FG011|Overall Study|Protocol Violation|0|||
161959763|NCT01831466|584898393|FG000|Overall Study|Other|2|||
161959764|NCT01831466|584898394|FG001|Overall Study|Other|3|||
161959765|NCT01831466|584898395|FG002|Overall Study|Other|2|||
161959766|NCT01831466|584898396|FG003|Overall Study|Other|2|||
161959767|NCT01831466|584898397|FG004|Overall Study|Other|2|||
161959768|NCT01831466|584898398|FG005|Overall Study|Other|1|||
161959769|NCT01831466|584898399|FG006|Overall Study|Other|0|||
161959770|NCT01831466|584898400|FG007|Overall Study|Other|0|||
161959771|NCT01831466|584898401|FG008|Overall Study|Other|0|||
161959772|NCT01831466|584898402|FG009|Overall Study|Other|0|||
161959773|NCT01831466|584898403|FG010|Overall Study|Other|0|||
161959774|NCT01831466|584898404|FG011|Overall Study|Other|0|||
161959775|NCT01831466|584898393|FG000|Overall Study|Non-compliance with study treatment|2|||
161959776|NCT01831466|584898394|FG001|Overall Study|Non-compliance with study treatment|1|||
161959777|NCT01831466|584898395|FG002|Overall Study|Non-compliance with study treatment|1|||
161959778|NCT01831466|584898396|FG003|Overall Study|Non-compliance with study treatment|0|||
161959779|NCT01831466|584898397|FG004|Overall Study|Non-compliance with study treatment|0|||
161959780|NCT01831466|584898398|FG005|Overall Study|Non-compliance with study treatment|1|||
161959781|NCT01831466|584898399|FG006|Overall Study|Non-compliance with study treatment|0|||
162031143|NCT02536404|585170970|FG001|Overall Study|Physician Decision|0|||
162031144|NCT02536404|585170969|FG000|Overall Study|Sponsor decision|1|||
161959782|NCT01831466|584898400|FG007|Overall Study|Non-compliance with study treatment|0|||
161959783|NCT01831466|584898401|FG008|Overall Study|Non-compliance with study treatment|0|||
161959784|NCT01831466|584898402|FG009|Overall Study|Non-compliance with study treatment|0|||
161959785|NCT01831466|584898403|FG010|Overall Study|Non-compliance with study treatment|0|||
161959786|NCT01831466|584898404|FG011|Overall Study|Non-compliance with study treatment|0|||
161959787|NCT01831466|584898393|FG000|Overall Study|Death|0|||
161959788|NCT01831466|584898394|FG001|Overall Study|Death|1|||
161959789|NCT01831466|584898395|FG002|Overall Study|Death|0|||
161959790|NCT01831466|584898396|FG003|Overall Study|Death|0|||
162031145|NCT02536404|585170970|FG001|Overall Study|Sponsor decision|0|||
162031146|NCT03901456|585170971|FG000|Overall Study|Withdrawal by Subject|0|||
162031147|NCT03901456|585170972|FG001|Overall Study|Withdrawal by Subject|0|||
161959791|NCT01831466|584898397|FG004|Overall Study|Death|0|||
161959792|NCT01831466|584898398|FG005|Overall Study|Death|0|||
161959793|NCT01831466|584898399|FG006|Overall Study|Death|0|||
161959794|NCT01831466|584898400|FG007|Overall Study|Death|0|||
161959795|NCT01831466|584898401|FG008|Overall Study|Death|0|||
161959796|NCT01831466|584898402|FG009|Overall Study|Death|0|||
161959797|NCT01831466|584898403|FG010|Overall Study|Death|0|||
161959798|NCT01831466|584898404|FG011|Overall Study|Death|0|||
161959799|NCT01831466|584898393|FG000|Overall Study|Withdrawal by Subject|6|||
161959800|NCT01831466|584898394|FG001|Overall Study|Withdrawal by Subject|3|||
161959801|NCT01831466|584898395|FG002|Overall Study|Withdrawal by Subject|3|||
161959802|NCT01831466|584898396|FG003|Overall Study|Withdrawal by Subject|3|||
161710550|NCT03263091|583984089|FG000|DB Component|Lost to Follow-up|0|||
161710551|NCT03263091|583984090|FG001|DB Component|Lost to Follow-up|0|||
161710552|NCT03263091|583984091|FG002|DB Component|Lost to Follow-up|0|||
161710553|NCT03263091|583984092|FG003|DB Component|Lost to Follow-up|0|||
161710554|NCT03263091|583984093|FG004|DB Component|Lost to Follow-up|2|||
161710555|NCT03263091|583984094|FG005|DB Component|Lost to Follow-up|1|||
161710556|NCT03263091|583984089|FG000|DB Component|Death|0|||
161710557|NCT03263091|583984090|FG001|DB Component|Death|0|||
161710558|NCT03263091|583984091|FG002|DB Component|Death|0|||
161710559|NCT03263091|583984092|FG003|DB Component|Death|0|||
161710560|NCT03263091|583984093|FG004|DB Component|Death|7|||
161710561|NCT03263091|583984094|FG005|DB Component|Death|4|||
161710562|NCT03263091|583984089|FG000|DB Component|Other than specified|0|||
161710563|NCT03263091|583984090|FG001|DB Component|Other than specified|0|||
161710564|NCT03263091|583984091|FG002|DB Component|Other than specified|0|||
161710565|NCT03263091|583984092|FG003|DB Component|Other than specified|0|||
161710566|NCT03263091|583984093|FG004|DB Component|Other than specified|8|||
161710567|NCT03263091|583984094|FG005|DB Component|Other than specified|6|||
161710568|NCT00265941|583984104|FG000|Overall Study|Protocol Violation|22|||
161710569|NCT00265941|583984105|FG001|Overall Study|Protocol Violation|25|||
161710570|NCT00265941|583984104|FG000|Overall Study|Lost to Follow-up|1|||
161710571|NCT00265941|583984105|FG001|Overall Study|Lost to Follow-up|1|||
161710572|NCT01217606|583984112|FG000|Initial Treatment Phase|Other Reasons|0|||
161710573|NCT01217606|583984113|FG001|Initial Treatment Phase|Other Reasons|2|||
161710574|NCT01217606|583984112|FG000|Initial Treatment Phase|Protocol Violation|3|||
161710575|NCT01217606|583984113|FG001|Initial Treatment Phase|Protocol Violation|2|||
161710576|NCT01217606|583984112|FG000|Initial Treatment Phase|Personal Reasons|0|||
161710577|NCT01217606|583984113|FG001|Initial Treatment Phase|Personal Reasons|2|||
161710578|NCT01217606|583984112|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
161710579|NCT01217606|583984113|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
161710580|NCT01217606|583984112|FG000|Initial Treatment Phase|Adverse Event|10|||
161710581|NCT01217606|583984113|FG001|Initial Treatment Phase|Adverse Event|6|||
161710582|NCT01217606|583984112|FG000|9-Month Masked Extension|Adverse Event|3|||
161710583|NCT01217606|583984113|FG001|9-Month Masked Extension|Adverse Event|6|||
161710584|NCT01217606|583984112|FG000|9-Month Masked Extension|Other Reasons|4|||
161710585|NCT01217606|583984113|FG001|9-Month Masked Extension|Other Reasons|4|||
161710586|NCT01217606|583984112|FG000|9-Month Masked Extension|Personal Reasons|2|||
161710587|NCT01217606|583984113|FG001|9-Month Masked Extension|Personal Reasons|1|||
161710588|NCT01217606|583984112|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
161959803|NCT01831466|584898397|FG004|Overall Study|Withdrawal by Subject|3|||
161959804|NCT01831466|584898398|FG005|Overall Study|Withdrawal by Subject|5|||
161959805|NCT01831466|584898399|FG006|Overall Study|Withdrawal by Subject|0|||
161959806|NCT01831466|584898400|FG007|Overall Study|Withdrawal by Subject|0|||
161959807|NCT01831466|584898401|FG008|Overall Study|Withdrawal by Subject|0|||
161959808|NCT01831466|584898402|FG009|Overall Study|Withdrawal by Subject|1|||
161959809|NCT01831466|584898403|FG010|Overall Study|Withdrawal by Subject|0|||
161710589|NCT01217606|583984113|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
161710590|NCT01217606|583984112|FG000|9-Month Masked Extension|Pregnancy|1|||
161959810|NCT01831466|584898404|FG011|Overall Study|Withdrawal by Subject|1|||
161959811|NCT01831466|584898393|FG000|Overall Study|Lost to Follow-up|0|||
161959812|NCT01831466|584898394|FG001|Overall Study|Lost to Follow-up|1|||
161959813|NCT01831466|584898395|FG002|Overall Study|Lost to Follow-up|4|||
161959814|NCT01831466|584898396|FG003|Overall Study|Lost to Follow-up|2|||
161959815|NCT01831466|584898397|FG004|Overall Study|Lost to Follow-up|0|||
161959816|NCT01831466|584898398|FG005|Overall Study|Lost to Follow-up|3|||
161959817|NCT01831466|584898399|FG006|Overall Study|Lost to Follow-up|0|||
161959818|NCT01831466|584898400|FG007|Overall Study|Lost to Follow-up|0|||
161959819|NCT01831466|584898401|FG008|Overall Study|Lost to Follow-up|0|||
161959820|NCT01831466|584898402|FG009|Overall Study|Lost to Follow-up|1|||
161959821|NCT01831466|584898403|FG010|Overall Study|Lost to Follow-up|0|||
161959822|NCT01831466|584898404|FG011|Overall Study|Lost to Follow-up|1|||
161959823|NCT01831466|584898393|FG000|Overall Study|Lack of Efficacy|5|||
161959824|NCT01831466|584898394|FG001|Overall Study|Lack of Efficacy|8|||
161959825|NCT01831466|584898395|FG002|Overall Study|Lack of Efficacy|7|||
161959826|NCT01831466|584898396|FG003|Overall Study|Lack of Efficacy|6|||
161959827|NCT01831466|584898397|FG004|Overall Study|Lack of Efficacy|9|||
161959828|NCT01831466|584898398|FG005|Overall Study|Lack of Efficacy|8|||
161959829|NCT01831466|584898399|FG006|Overall Study|Lack of Efficacy|1|||
161959830|NCT01831466|584898400|FG007|Overall Study|Lack of Efficacy|1|||
161959831|NCT01831466|584898401|FG008|Overall Study|Lack of Efficacy|2|||
161959832|NCT01831466|584898402|FG009|Overall Study|Lack of Efficacy|2|||
161959833|NCT01831466|584898403|FG010|Overall Study|Lack of Efficacy|2|||
161959834|NCT01831466|584898404|FG011|Overall Study|Lack of Efficacy|0|||
161959835|NCT01831466|584898393|FG000|Overall Study|Adverse Event|0|||
161959836|NCT01831466|584898394|FG001|Overall Study|Adverse Event|0|||
161959837|NCT01831466|584898395|FG002|Overall Study|Adverse Event|4|||
161959838|NCT01831466|584898396|FG003|Overall Study|Adverse Event|6|||
161959839|NCT01831466|584898397|FG004|Overall Study|Adverse Event|3|||
161959840|NCT01831466|584898398|FG005|Overall Study|Adverse Event|7|||
161959841|NCT01831466|584898399|FG006|Overall Study|Adverse Event|0|||
161959842|NCT01831466|584898400|FG007|Overall Study|Adverse Event|1|||
161959843|NCT01831466|584898401|FG008|Overall Study|Adverse Event|1|||
161959844|NCT01831466|584898402|FG009|Overall Study|Adverse Event|1|||
161959845|NCT01831466|584898403|FG010|Overall Study|Adverse Event|0|||
161959846|NCT01831466|584898404|FG011|Overall Study|Adverse Event|2|||
161959847|NCT02567799|584898406|FG000|Concurrent Chemoradiotherapy|Death|1|||
161710591|NCT01217606|583984113|FG001|9-Month Masked Extension|Pregnancy|0|||
161710592|NCT01217606|583984112|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
161710593|NCT01217606|583984113|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
161710594|NCT02432807|583984120|FG000|Overall Study|Adverse Event|0|||
161710595|NCT02432807|583984121|FG001|Overall Study|Adverse Event|2|||
161710596|NCT02432807|583984120|FG000|Overall Study|Lost to Follow-up|1|||
161710597|NCT02432807|583984121|FG001|Overall Study|Lost to Follow-up|0|||
161710598|NCT02432807|583984120|FG000|Overall Study|Withdrawal by Subject|1|||
161710599|NCT02432807|583984121|FG001|Overall Study|Withdrawal by Subject|1|||
161710600|NCT02432807|583984120|FG000|Overall Study|Other|1|||
161710601|NCT02432807|583984121|FG001|Overall Study|Other|1|||
161710602|NCT03976401|583984122|FG000|Overall Study|Adverse Event|2|||
161710603|NCT03976401|583984123|FG001|Overall Study|Adverse Event|0|||
161710604|NCT03976401|583984124|FG002|Overall Study|Adverse Event|4|||
161710605|NCT03976401|583984125|FG003|Overall Study|Adverse Event|1|||
161710606|NCT03976401|583984126|FG004|Overall Study|Adverse Event|1|||
161710607|NCT03976401|583984127|FG005|Overall Study|Adverse Event|0|||
161710608|NCT03976401|583984122|FG000|Overall Study|Withdrawal by Subject|0|||
161710609|NCT03976401|583984123|FG001|Overall Study|Withdrawal by Subject|1|||
161710610|NCT03976401|583984124|FG002|Overall Study|Withdrawal by Subject|0|||
161710611|NCT03976401|583984125|FG003|Overall Study|Withdrawal by Subject|0|||
161710612|NCT03976401|583984126|FG004|Overall Study|Withdrawal by Subject|0|||
161710613|NCT03976401|583984127|FG005|Overall Study|Withdrawal by Subject|1|||
161710614|NCT03976401|583984122|FG000|Overall Study|Physician Decision|0|||
161710615|NCT03976401|583984123|FG001|Overall Study|Physician Decision|0|||
161710616|NCT03976401|583984124|FG002|Overall Study|Physician Decision|1|||
161710617|NCT03976401|583984125|FG003|Overall Study|Physician Decision|0|||
161710618|NCT03976401|583984126|FG004|Overall Study|Physician Decision|0|||
161710619|NCT03976401|583984127|FG005|Overall Study|Physician Decision|0|||
161710620|NCT03976401|583984122|FG000|Overall Study|Lost to Follow-up|1|||
161710621|NCT03976401|583984123|FG001|Overall Study|Lost to Follow-up|2|||
161710622|NCT03976401|583984124|FG002|Overall Study|Lost to Follow-up|0|||
161710623|NCT03976401|583984125|FG003|Overall Study|Lost to Follow-up|0|||
161710624|NCT03976401|583984126|FG004|Overall Study|Lost to Follow-up|0|||
161710625|NCT03976401|583984127|FG005|Overall Study|Lost to Follow-up|0|||
161710626|NCT03976401|583984122|FG000|Overall Study|Protocol Violation|0|||
161710627|NCT03976401|583984123|FG001|Overall Study|Protocol Violation|1|||
161710628|NCT03976401|583984124|FG002|Overall Study|Protocol Violation|0|||
161710629|NCT03976401|583984125|FG003|Overall Study|Protocol Violation|0|||
161710630|NCT03976401|583984126|FG004|Overall Study|Protocol Violation|0|||
161710631|NCT03976401|583984127|FG005|Overall Study|Protocol Violation|0|||
161710632|NCT03976401|583984122|FG000|Overall Study|Withdrew Consent|0|||
161710633|NCT03976401|583984123|FG001|Overall Study|Withdrew Consent|0|||
161710634|NCT03976401|583984124|FG002|Overall Study|Withdrew Consent|0|||
161710635|NCT03976401|583984125|FG003|Overall Study|Withdrew Consent|1|||
161710636|NCT03976401|583984126|FG004|Overall Study|Withdrew Consent|0|||
161710637|NCT03976401|583984127|FG005|Overall Study|Withdrew Consent|0|||
161710638|NCT04125680|583984129|FG000|Overall Study|Lost to Follow-up|15|||
161710639|NCT02966314|583984132|FG000|Overall Study|Lost to Follow-up|1|||
161710640|NCT02966314|583984133|FG001|Overall Study|Lost to Follow-up|0|||
161710641|NCT00391976|583984134|FG000|Overall Study|Adverse Event|0|||
161710642|NCT00391976|583984135|FG001|Overall Study|Adverse Event|0|||
161710643|NCT00391976|583984136|FG002|Overall Study|Adverse Event|1|||
161710644|NCT00391976|583984134|FG000|Overall Study|Withdrawal of consent|0|||
161710645|NCT00391976|583984135|FG001|Overall Study|Withdrawal of consent|1|||
161710646|NCT00391976|583984136|FG002|Overall Study|Withdrawal of consent|1|||
161710647|NCT00391976|583984134|FG000|Overall Study|Lost to Follow-up|1|||
161710648|NCT00391976|583984135|FG001|Overall Study|Lost to Follow-up|2|||
161710649|NCT00391976|583984136|FG002|Overall Study|Lost to Follow-up|0|||
161710650|NCT00391976|583984134|FG000|Overall Study|Inappropriate enrollment|1|||
161710651|NCT00391976|583984135|FG001|Overall Study|Inappropriate enrollment|1|||
161710652|NCT00391976|583984136|FG002|Overall Study|Inappropriate enrollment|0|||
161710653|NCT00391976|583984134|FG000|Overall Study|Protocol deviation/violation|4|||
161710654|NCT00391976|583984135|FG001|Overall Study|Protocol deviation/violation|2|||
161710655|NCT00391976|583984136|FG002|Overall Study|Protocol deviation/violation|1|||
161710656|NCT00391976|583984134|FG000|Overall Study|Recurrence/no eradication of infection|21|||
161710657|NCT00391976|583984135|FG001|Overall Study|Recurrence/no eradication of infection|19|||
161710658|NCT00391976|583984136|FG002|Overall Study|Recurrence/no eradication of infection|0|||
161710659|NCT00391976|583984134|FG000|Overall Study|Unable to classify|0|||
161710660|NCT00391976|583984135|FG001|Overall Study|Unable to classify|0|||
161959848|NCT02567799|584898407|FG001|Concurrent Chemoradiotherapy|Death|0|||
161959849|NCT02567799|584898408|FG002|Concurrent Chemoradiotherapy|Death|0|||
161959850|NCT02567799|584898406|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
161959851|NCT02567799|584898407|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
161959852|NCT02567799|584898408|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
161959853|NCT02567799|584898406|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
161959854|NCT02567799|584898407|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
161959855|NCT02567799|584898408|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
161959856|NCT02567799|584898406|FG000|Follow-up|Death|1|||
161959857|NCT02567799|584898407|FG001|Follow-up|Death|0|||
161959858|NCT02567799|584898408|FG002|Follow-up|Death|1|||
161959859|NCT02567799|584898406|FG000|Follow-up|Progressive Disease|1|||
161959860|NCT02567799|584898407|FG001|Follow-up|Progressive Disease|1|||
161959861|NCT02567799|584898408|FG002|Follow-up|Progressive Disease|3|||
161959862|NCT00556439|584898418|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
161959863|NCT00556439|584898419|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
161959864|NCT00556439|584898420|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
161959865|NCT00556439|584898421|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
161959866|NCT00556439|584898418|FG000|Study Entry to Week 12|Physician Decision|1|||
161959867|NCT00556439|584898419|FG001|Study Entry to Week 12|Physician Decision|0|||
161959868|NCT00556439|584898420|FG002|Study Entry to Week 12|Physician Decision|0|||
161959869|NCT00556439|584898421|FG003|Study Entry to Week 12|Physician Decision|0|||
161959870|NCT00556439|584898418|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
161959871|NCT00556439|584898419|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
161959872|NCT00556439|584898420|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
161959873|NCT00556439|584898421|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
161959874|NCT00556439|584898418|FG000|Study Entry to Week 12|Recurrent infection|1|||
161959875|NCT00556439|584898419|FG001|Study Entry to Week 12|Recurrent infection|0|||
161710661|NCT00391976|583984136|FG002|Overall Study|Unable to classify|1|||
161959876|NCT00556439|584898420|FG002|Study Entry to Week 12|Recurrent infection|0|||
161959877|NCT00556439|584898421|FG003|Study Entry to Week 12|Recurrent infection|0|||
161959878|NCT00556439|584898418|FG000|Study Entry to Week 12|Malignancy|0|||
161959879|NCT00556439|584898419|FG001|Study Entry to Week 12|Malignancy|0|||
161959880|NCT00556439|584898420|FG002|Study Entry to Week 12|Malignancy|1|||
161959881|NCT00556439|584898421|FG003|Study Entry to Week 12|Malignancy|0|||
161959882|NCT00556439|584898418|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
161959883|NCT00556439|584898419|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
161959884|NCT00556439|584898420|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
161959885|NCT00556439|584898421|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
161959886|NCT00556439|584898418|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
161959887|NCT00556439|584898419|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
161959888|NCT00556439|584898420|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
161959889|NCT00556439|584898421|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
161959890|NCT00556439|584898418|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
161959891|NCT00556439|584898419|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
161959892|NCT00556439|584898420|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
161959893|NCT00556439|584898421|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
161959894|NCT00556439|584898418|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
161959895|NCT00556439|584898419|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
161959896|NCT00556439|584898420|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
161959897|NCT00556439|584898421|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
161959898|NCT02100423|584898422|FG000|Overall Study|Death|1|||
161959899|NCT02100423|584898422|FG000|Overall Study|Withdrawal by Subject|3|||
161959900|NCT02100423|584898422|FG000|Overall Study|Adverse Event|1|||
161959901|NCT02100423|584898422|FG000|Overall Study|Physician Decision|1|||
161959902|NCT00703846|584898423|FG000|Overall Study|Adverse Event|8|||
161959903|NCT00703846|584898423|FG000|Overall Study|Lost to Follow-up|55|||
161959904|NCT00703846|584898423|FG000|Overall Study|Lack of Efficacy|15|||
161959905|NCT00703846|584898423|FG000|Overall Study|Noncompliance with Study Treatment|2|||
161959906|NCT00703846|584898423|FG000|Overall Study|Withdrawal by Subject|40|||
161959907|NCT00703846|584898423|FG000|Overall Study|Death|1|||
161959908|NCT00703846|584898423|FG000|Overall Study|Other|14|||
161959909|NCT00703846|584898423|FG000|Overall Study|Did Not Receive Study Drug|2|||
161959910|NCT02195700|584898424|FG000|Overall Study|Protocol Violation|0|||
161959911|NCT02195700|584898425|FG001|Overall Study|Protocol Violation|2|||
161959912|NCT02195700|584898424|FG000|Overall Study|Noncompliance|1|||
161959913|NCT02195700|584898425|FG001|Overall Study|Noncompliance|0|||
161959914|NCT02195700|584898424|FG000|Overall Study|Adverse Event|1|||
161959915|NCT02195700|584898425|FG001|Overall Study|Adverse Event|2|||
161959916|NCT02195700|584898424|FG000|Overall Study|Withdrawal by Subject|3|||
161959917|NCT02195700|584898425|FG001|Overall Study|Withdrawal by Subject|2|||
161959918|NCT02195700|584898424|FG000|Overall Study|Lost to Follow-up|1|||
161959919|NCT02195700|584898425|FG001|Overall Study|Lost to Follow-up|1|||
161959920|NCT04601532|584898426|FG000|Overall Study|Lost to Follow-up|1|||
161959921|NCT04601532|584898427|FG001|Overall Study|Lost to Follow-up|2|||
161959922|NCT04601532|584898426|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
161959923|NCT04601532|584898427|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
161959924|NCT01352221|584898428|FG000|Double-blind Phase|Adverse Event|6|||
161959925|NCT01352221|584898429|FG001|Double-blind Phase|Adverse Event|4|||
161959926|NCT01352221|584898430|FG002|Double-blind Phase|Adverse Event|0|||
161959927|NCT01352221|584898431|FG003|Double-blind Phase|Adverse Event|0|||
161959928|NCT01352221|584898428|FG000|Double-blind Phase|Withdrawal by Subject|3|||
161959929|NCT01352221|584898429|FG001|Double-blind Phase|Withdrawal by Subject|5|||
161959930|NCT01352221|584898430|FG002|Double-blind Phase|Withdrawal by Subject|0|||
161959931|NCT01352221|584898431|FG003|Double-blind Phase|Withdrawal by Subject|0|||
161959932|NCT01352221|584898428|FG000|Double-blind Phase|Lost to Follow-up|0|||
161959933|NCT01352221|584898429|FG001|Double-blind Phase|Lost to Follow-up|1|||
161959934|NCT01352221|584898430|FG002|Double-blind Phase|Lost to Follow-up|0|||
161959935|NCT01352221|584898431|FG003|Double-blind Phase|Lost to Follow-up|0|||
161959936|NCT01352221|584898428|FG000|Double-blind Phase|Protocol Violation|0|||
161959937|NCT01352221|584898429|FG001|Double-blind Phase|Protocol Violation|1|||
161959938|NCT01352221|584898430|FG002|Double-blind Phase|Protocol Violation|0|||
161959939|NCT01352221|584898431|FG003|Double-blind Phase|Protocol Violation|0|||
161959940|NCT01352221|584898428|FG000|Open-label Phase|Physician Decision|0|||
161959941|NCT01352221|584898429|FG001|Open-label Phase|Physician Decision|0|||
161959942|NCT01352221|584898430|FG002|Open-label Phase|Physician Decision|2|||
161959943|NCT01352221|584898431|FG003|Open-label Phase|Physician Decision|1|||
161959944|NCT01352221|584898428|FG000|Open-label Phase|Pregnancy|0|||
161959945|NCT01352221|584898429|FG001|Open-label Phase|Pregnancy|0|||
161959946|NCT01352221|584898430|FG002|Open-label Phase|Pregnancy|1|||
161959947|NCT01352221|584898431|FG003|Open-label Phase|Pregnancy|0|||
161959948|NCT01352221|584898428|FG000|Open-label Phase|Adverse Event|0|||
161959949|NCT01352221|584898429|FG001|Open-label Phase|Adverse Event|0|||
161959950|NCT01352221|584898430|FG002|Open-label Phase|Adverse Event|8|||
161959951|NCT01352221|584898431|FG003|Open-label Phase|Adverse Event|4|||
161959952|NCT01352221|584898428|FG000|Open-label Phase|Withdrawal by Subject|0|||
161959953|NCT01352221|584898429|FG001|Open-label Phase|Withdrawal by Subject|0|||
161959954|NCT01352221|584898430|FG002|Open-label Phase|Withdrawal by Subject|1|||
161959955|NCT01352221|584898431|FG003|Open-label Phase|Withdrawal by Subject|6|||
161959956|NCT01352221|584898428|FG000|Open-label Phase|Worsening of IBD|0|||
161959957|NCT01352221|584898429|FG001|Open-label Phase|Worsening of IBD|0|||
161959958|NCT01352221|584898430|FG002|Open-label Phase|Worsening of IBD|1|||
161959959|NCT01352221|584898431|FG003|Open-label Phase|Worsening of IBD|0|||
161959960|NCT02547038|584899918|FG000|Overall Study|Lost to Follow-up|3|||
161959961|NCT02547038|584899919|FG001|Overall Study|Lost to Follow-up|2|||
161959962|NCT01340625|584899922|FG000|First Intervention|Adverse Event|1|||
161959963|NCT01340625|584899923|FG001|First Intervention|Adverse Event|0|||
161959964|NCT01340625|584899922|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
161959965|NCT01340625|584899923|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
161959966|NCT00854724|584899924|FG000|First Intervention|Withdrawal by Subject|1|||
161959967|NCT00854724|584899925|FG001|First Intervention|Withdrawal by Subject|1|||
161959968|NCT00854724|584899924|FG000|Washout|Protocol Violation|1|||
161959969|NCT00854724|584899925|FG001|Washout|Protocol Violation|0|||
161959970|NCT00854724|584899924|FG000|Washout|Withdrawal by Subject|0|||
161959971|NCT00854724|584899925|FG001|Washout|Withdrawal by Subject|1|||
161959972|NCT00854724|584899924|FG000|Second Intervention|Protocol Violation|1|||
161959973|NCT00854724|584899925|FG001|Second Intervention|Protocol Violation|0|||
161959974|NCT00854724|584899924|FG000|Second Intervention|Physician Decision|0|||
161959975|NCT00854724|584899925|FG001|Second Intervention|Physician Decision|1|||
161959976|NCT00933608|584899927|FG000|Overall Study|Adverse Event|4|||
161959977|NCT00933608|584899928|FG001|Overall Study|Adverse Event|2|||
161959978|NCT00933608|584899927|FG000|Overall Study|Physician Decision|1|||
161959979|NCT00933608|584899928|FG001|Overall Study|Physician Decision|0|||
161959980|NCT00576628|584899936|FG000|Overall Study|Adverse Event|11|||
161959981|NCT00576628|584899936|FG000|Overall Study|Death|2|||
161959982|NCT00576628|584899936|FG000|Overall Study|Failure to return|1|||
161959983|NCT00576628|584899936|FG000|Overall Study|Refused Treatment|8|||
161959984|NCT00576628|584899936|FG000|Overall Study|Pregnancy|1|||
161959985|NCT00576628|584899936|FG000|Overall Study|RBC transfusion|1|||
161959986|NCT00576628|584899936|FG000|Overall Study|Progression of Kidney Disease|1|||
161959987|NCT00576628|584899936|FG000|Overall Study|Progression of Renal Failure|1|||
161959988|NCT00576628|584899936|FG000|Overall Study|The patient move into other town|1|||
161959989|NCT00576628|584899936|FG000|Overall Study|Transplantation|1|||
161959990|NCT00576628|584899936|FG000|Overall Study|Dialysis|15|||
161959991|NCT03206970|584899937|FG000|Overall Study|Death|21|||
161959992|NCT03206970|584899937|FG000|Overall Study|Withdrawal by Subject|13|||
161959993|NCT03206970|584899937|FG000|Overall Study|Lost to Follow-up|3|||
161959994|NCT03206970|584899937|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
161959995|NCT03654040|584899944|FG000|Overall Study|Death|1|||
161959996|NCT03654040|584899945|FG001|Overall Study|Death|0|||
161959997|NCT03654040|584899944|FG000|Overall Study|Withdrawal by Subject|1|||
161959998|NCT03654040|584899945|FG001|Overall Study|Withdrawal by Subject|0|||
161959999|NCT03654040|584899944|FG000|Overall Study|Study terminated by sponsor|8|||
161960000|NCT03654040|584899945|FG001|Overall Study|Study terminated by sponsor|2|||
161960001|NCT03654040|584899944|FG000|Overall Study|Failure to initiate study therapy|2|||
161960002|NCT03654040|584899945|FG001|Overall Study|Failure to initiate study therapy|0|||
161960003|NCT03654040|584899944|FG000|Overall Study|Transplanted at another center|2|||
161960004|NCT03654040|584899945|FG001|Overall Study|Transplanted at another center|0|||
161960005|NCT03654040|584899944|FG000|Overall Study|Failure to meet eligibility criteria|14|||
161960006|NCT03654040|584899945|FG001|Overall Study|Failure to meet eligibility criteria|2|||
161960007|NCT03654040|584899944|FG000|Overall Study|No longer transplant candidate|1|||
161960008|NCT03654040|584899945|FG001|Overall Study|No longer transplant candidate|0|||
161960009|NCT03654040|584899944|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
161960010|NCT03654040|584899945|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
161960011|NCT03654040|584899944|FG000|Overall Study|Recipient ineligible|0|||
161960012|NCT03654040|584899945|FG001|Overall Study|Recipient ineligible|2|||
161960013|NCT03654040|584899944|FG000|Overall Study|Received deceased liver|0|||
161960014|NCT03654040|584899945|FG001|Overall Study|Received deceased liver|1|||
161960015|NCT01951586|584899950|FG000|Overall Study|Death|61|||
161960016|NCT01951586|584899951|FG001|Overall Study|Death|120|||
161960017|NCT01951586|584899950|FG000|Overall Study|Withdrawal by Subject|8|||
161960018|NCT01951586|584899951|FG001|Overall Study|Withdrawal by Subject|17|||
161960019|NCT01951586|584899950|FG000|Overall Study|Lost to Follow-up|0|||
161960020|NCT01951586|584899951|FG001|Overall Study|Lost to Follow-up|1|||
161960021|NCT01951586|584899950|FG000|Overall Study|Sponsor Decision|9|||
161960022|NCT01951586|584899951|FG001|Overall Study|Sponsor Decision|10|||
161960023|NCT01709110|584899952|FG000|Overall Study|Adverse Event|56|||
161960024|NCT01709110|584899953|FG001|Overall Study|Adverse Event|48|||
161960025|NCT01709110|584899952|FG000|Overall Study|Death|14|||
161960026|NCT01709110|584899953|FG001|Overall Study|Death|6|||
161960027|NCT01709110|584899952|FG000|Overall Study|Lost to Follow-up|7|||
161960028|NCT01709110|584899953|FG001|Overall Study|Lost to Follow-up|5|||
161960029|NCT01709110|584899952|FG000|Overall Study|Protocol Violation|4|||
161960030|NCT01709110|584899953|FG001|Overall Study|Protocol Violation|6|||
161960031|NCT01709110|584899952|FG000|Overall Study|Withdrawal by Subject|96|||
161960032|NCT01709110|584899953|FG001|Overall Study|Withdrawal by Subject|89|||
161960033|NCT01709110|584899952|FG000|Overall Study|Physician Decision|4|||
161960034|NCT01709110|584899953|FG001|Overall Study|Physician Decision|10|||
161960035|NCT01709110|584899952|FG000|Overall Study|Sponsor Decision|2|||
161960036|NCT01709110|584899953|FG001|Overall Study|Sponsor Decision|2|||
161960037|NCT01709110|584899952|FG000|Overall Study|Lack of Efficacy|1|||
161960038|NCT01709110|584899953|FG001|Overall Study|Lack of Efficacy|1|||
161960039|NCT01709110|584899952|FG000|Overall Study|Caregiver Decision|1|||
161960040|NCT01709110|584899953|FG001|Overall Study|Caregiver Decision|1|||
161960041|NCT02789345|584899954|FG000|Overall Study|Adverse Event|0|||
161960042|NCT02789345|584899955|FG001|Overall Study|Adverse Event|0|||
161960043|NCT02789345|584899956|FG002|Overall Study|Adverse Event|1|||
161960044|NCT02789345|584899954|FG000|Overall Study|Death|0|||
161960045|NCT02789345|584899955|FG001|Overall Study|Death|0|||
161960046|NCT02789345|584899956|FG002|Overall Study|Death|1|||
161960047|NCT02789345|584899954|FG000|Overall Study|Physician Decision|2|||
161960048|NCT02789345|584899955|FG001|Overall Study|Physician Decision|0|||
161960049|NCT02789345|584899956|FG002|Overall Study|Physician Decision|1|||
161960050|NCT02789345|584899954|FG000|Overall Study|Progressive Disease|1|||
161960051|NCT02789345|584899955|FG001|Overall Study|Progressive Disease|3|||
161960052|NCT02789345|584899956|FG002|Overall Study|Progressive Disease|14|||
161960053|NCT03645421|584899965|FG000|Overall Study|Adverse Event|0|||
161960054|NCT03645421|584899966|FG001|Overall Study|Adverse Event|0|||
161960055|NCT03645421|584899967|FG002|Overall Study|Adverse Event|4|||
161960056|NCT03645421|584899968|FG003|Overall Study|Adverse Event|1|||
161960057|NCT03645421|584899965|FG000|Overall Study|Withdrawal by patient|0|||
161960058|NCT03645421|584899966|FG001|Overall Study|Withdrawal by patient|0|||
161960059|NCT03645421|584899967|FG002|Overall Study|Withdrawal by patient|0|||
161960060|NCT03645421|584899968|FG003|Overall Study|Withdrawal by patient|3|||
161960061|NCT03645421|584899965|FG000|Overall Study|Study specific withdrawal criteria|0|||
161960062|NCT03645421|584899966|FG001|Overall Study|Study specific withdrawal criteria|0|||
161960063|NCT03645421|584899967|FG002|Overall Study|Study specific withdrawal criteria|1|||
161960064|NCT03645421|584899968|FG003|Overall Study|Study specific withdrawal criteria|0|||
161960065|NCT02120781|584899969|FG000|Overall Study|Physician Decision|2|||
161960066|NCT02120781|584899970|FG001|Overall Study|Physician Decision|0|||
161960067|NCT02120781|584899969|FG000|Overall Study|Completion not documented|2|||
161960068|NCT02120781|584899970|FG001|Overall Study|Completion not documented|1|||
161960069|NCT05332392|584899976|FG000|Overall Study|Did not meet inclusion criteria|25|||
161960070|NCT05332392|584899976|FG000|Overall Study|Principal Investigator's decision|17|||
161960071|NCT05332392|584899976|FG000|Overall Study|Adverse Event|1|||
161960072|NCT05332392|584899976|FG000|Overall Study|Subject's decision|1|||
161960073|NCT03850093|584899977|FG000|Overall Study|Withdrawal by Subject|1|||
161960074|NCT03850093|584899978|FG001|Overall Study|Withdrawal by Subject|0|||
161960075|NCT03850093|584899979|FG002|Overall Study|Withdrawal by Subject|2|||
161960076|NCT02836717|584899983|FG000|Test Phase|Lack of Efficacy|14|||
161960077|NCT02836717|584899984|FG001|Test Phase|Lack of Efficacy|8|||
161960078|NCT02836717|584899985|FG002|Test Phase|Lack of Efficacy|0|||
161960079|NCT02836717|584899983|FG000|Study Phase|Adverse Event|2|||
161960080|NCT02836717|584899984|FG001|Study Phase|Adverse Event|0|||
161960081|NCT02836717|584899985|FG002|Study Phase|Adverse Event|0|||
161960082|NCT02836717|584899983|FG000|Study Phase|Lack of Efficacy|8|||
161960083|NCT02836717|584899984|FG001|Study Phase|Lack of Efficacy|6|||
161960084|NCT02836717|584899985|FG002|Study Phase|Lack of Efficacy|1|||
161960085|NCT02836717|584899983|FG000|Study Phase|Withdrawal by Subject|1|||
161960086|NCT02836717|584899984|FG001|Study Phase|Withdrawal by Subject|0|||
161960087|NCT02836717|584899985|FG002|Study Phase|Withdrawal by Subject|0|||
161960088|NCT02836717|584899983|FG000|Study Phase|Death|1|||
161960089|NCT02836717|584899984|FG001|Study Phase|Death|0|||
162031148|NCT03901456|585170973|FG002|Overall Study|Withdrawal by Subject|1|||
161960090|NCT02836717|584899985|FG002|Study Phase|Death|0|||
161960091|NCT02836717|584899983|FG000|Study Phase|abdominal surgeries|2|||
161960092|NCT02836717|584899984|FG001|Study Phase|abdominal surgeries|1|||
162031149|NCT03901456|585170971|FG000|Overall Study|Lost to Follow-up|0|||
162031150|NCT03901456|585170972|FG001|Overall Study|Lost to Follow-up|1|||
161960093|NCT02836717|584899985|FG002|Study Phase|abdominal surgeries|0|||
161960094|NCT00224120|584899986|FG000|Overall Study|Adverse Event|10|||
161960095|NCT00224120|584899987|FG001|Overall Study|Adverse Event|4|||
161960096|NCT00224120|584899986|FG000|Overall Study|Protocol Violation|1|||
161960097|NCT00224120|584899987|FG001|Overall Study|Protocol Violation|0|||
161960098|NCT00224120|584899986|FG000|Overall Study|Withdrawal by Subject|5|||
161960099|NCT00224120|584899987|FG001|Overall Study|Withdrawal by Subject|10|||
161960100|NCT00224120|584899986|FG000|Overall Study|Lack of Efficacy|0|||
161960101|NCT00224120|584899987|FG001|Overall Study|Lack of Efficacy|2|||
161960102|NCT00224120|584899986|FG000|Overall Study|Lost to Follow-up|2|||
161960103|NCT00224120|584899987|FG001|Overall Study|Lost to Follow-up|3|||
161960104|NCT00224120|584899986|FG000|Overall Study|Other|4|||
161960105|NCT00224120|584899987|FG001|Overall Study|Other|5|||
161960106|NCT00104416|584899990|FG000|Double-Blind Phase|Adverse Event|2|||
161960107|NCT00104416|584899991|FG001|Double-Blind Phase|Adverse Event|1|||
161960108|NCT00104416|584899992|FG002|Double-Blind Phase|Adverse Event|0|||
161960109|NCT00104416|584899993|FG003|Double-Blind Phase|Adverse Event|0|||
161960110|NCT00104416|584899994|FG004|Double-Blind Phase|Adverse Event|0|||
161960111|NCT00104416|584899990|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161960112|NCT00104416|584899991|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161960113|NCT00104416|584899992|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161960114|NCT00104416|584899993|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161960115|NCT00104416|584899994|FG004|Double-Blind Phase|Lost to Follow-up|0|||
161960116|NCT00104416|584899990|FG000|Double-Blind Phase|Protocol Violation|0|||
161960117|NCT00104416|584899991|FG001|Double-Blind Phase|Protocol Violation|1|||
161960118|NCT00104416|584899992|FG002|Double-Blind Phase|Protocol Violation|0|||
161960119|NCT00104416|584899993|FG003|Double-Blind Phase|Protocol Violation|0|||
161960120|NCT00104416|584899994|FG004|Double-Blind Phase|Protocol Violation|0|||
161960121|NCT00104416|584899990|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
161960122|NCT00104416|584899991|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
161960123|NCT00104416|584899992|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161960124|NCT00104416|584899993|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
161960125|NCT00104416|584899994|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161960126|NCT00104416|584899990|FG000|Double-Blind Phase|Pregnancy|1|||
161960127|NCT00104416|584899991|FG001|Double-Blind Phase|Pregnancy|0|||
161960128|NCT00104416|584899992|FG002|Double-Blind Phase|Pregnancy|0|||
161960129|NCT00104416|584899993|FG003|Double-Blind Phase|Pregnancy|0|||
161960130|NCT00104416|584899994|FG004|Double-Blind Phase|Pregnancy|0|||
161960131|NCT00104416|584899990|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
161960132|NCT00104416|584899991|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
161960133|NCT00104416|584899992|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
161960134|NCT00104416|584899993|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
161960135|NCT00104416|584899994|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
161960136|NCT00104416|584899990|FG000|Continuation Phase|Adverse Event|0|||
161960137|NCT00104416|584899991|FG001|Continuation Phase|Adverse Event|0|||
161960138|NCT00104416|584899992|FG002|Continuation Phase|Adverse Event|2|||
161960139|NCT00104416|584899993|FG003|Continuation Phase|Adverse Event|0|||
161960140|NCT00104416|584899994|FG004|Continuation Phase|Adverse Event|2|||
161960141|NCT00104416|584899990|FG000|Continuation Phase|Lost to Follow-up|0|||
161960142|NCT00104416|584899991|FG001|Continuation Phase|Lost to Follow-up|0|||
161960143|NCT00104416|584899992|FG002|Continuation Phase|Lost to Follow-up|1|||
161960144|NCT00104416|584899993|FG003|Continuation Phase|Lost to Follow-up|0|||
161960145|NCT00104416|584899994|FG004|Continuation Phase|Lost to Follow-up|1|||
161960146|NCT00104416|584899990|FG000|Continuation Phase|Withdrawal by Subject|0|||
161960147|NCT00104416|584899991|FG001|Continuation Phase|Withdrawal by Subject|0|||
161960148|NCT00104416|584899992|FG002|Continuation Phase|Withdrawal by Subject|2|||
161960149|NCT00104416|584899993|FG003|Continuation Phase|Withdrawal by Subject|1|||
161960150|NCT00104416|584899994|FG004|Continuation Phase|Withdrawal by Subject|1|||
161960151|NCT00104416|584899990|FG000|Continuation Phase|Pregnancy|0|||
161960152|NCT00104416|584899991|FG001|Continuation Phase|Pregnancy|0|||
161960153|NCT00104416|584899992|FG002|Continuation Phase|Pregnancy|1|||
161960154|NCT00104416|584899993|FG003|Continuation Phase|Pregnancy|1|||
161960155|NCT00104416|584899994|FG004|Continuation Phase|Pregnancy|0|||
161960156|NCT00104416|584899990|FG000|Continuation Phase|Non-compliance|0|||
161960157|NCT00104416|584899991|FG001|Continuation Phase|Non-compliance|0|||
161960158|NCT00104416|584899992|FG002|Continuation Phase|Non-compliance|0|||
161960159|NCT00104416|584899993|FG003|Continuation Phase|Non-compliance|0|||
161960160|NCT00104416|584899994|FG004|Continuation Phase|Non-compliance|1|||
161960161|NCT00438360|584899995|FG000|Overall Study|Adverse Event|6|||
161960162|NCT00438360|584899996|FG001|Overall Study|Adverse Event|1|||
161960163|NCT00438360|584899995|FG000|Overall Study|Lack of Efficacy|42|||
161960164|NCT00438360|584899996|FG001|Overall Study|Lack of Efficacy|27|||
161960165|NCT00438360|584899995|FG000|Overall Study|Other|24|||
161960166|NCT00438360|584899996|FG001|Overall Study|Other|15|||
161960167|NCT03226249|584899997|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
161960168|NCT03226249|584899997|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
161960169|NCT03226249|584899997|FG000|Survival Follow-up|Patients still in follow-up.|30|||
161960170|NCT01804049|584899998|FG000|Overall Study|Adverse Event|2|||
161960171|NCT01804049|584899999|FG001|Overall Study|Adverse Event|10|||
161960172|NCT01804049|584899998|FG000|Overall Study|Lost to Follow-up|2|||
161960173|NCT01804049|584899999|FG001|Overall Study|Lost to Follow-up|1|||
161960174|NCT01804049|584899998|FG000|Overall Study|Decreased interest/personal|4|||
161960175|NCT01804049|584899999|FG001|Overall Study|Decreased interest/personal|5|||
161960176|NCT01804049|584899998|FG000|Overall Study|Other health concerns|2|||
161960177|NCT01804049|584899999|FG001|Overall Study|Other health concerns|7|||
161960178|NCT01804049|584899998|FG000|Overall Study|Moved out of area|0|||
161960179|NCT01804049|584899999|FG001|Overall Study|Moved out of area|7|||
161960180|NCT01804049|584899998|FG000|Overall Study|other MD recommended|1|||
161960181|NCT01804049|584899999|FG001|Overall Study|other MD recommended|1|||
161960182|NCT01804049|584899998|FG000|Overall Study|Enrollment in dual studies|0|||
161960183|NCT01804049|584899999|FG001|Overall Study|Enrollment in dual studies|1|||
161960184|NCT00070109|584900000|FG000|Overall Study|Death|1|||
161960185|NCT00070109|584900001|FG001|Overall Study|Death|1|||
161960186|NCT00070109|584900002|FG002|Overall Study|Death|0|||
161960187|NCT00070109|584900003|FG003|Overall Study|Death|0|||
161960188|NCT00070109|584900004|FG004|Overall Study|Death|1|||
161960189|NCT00070109|584900000|FG000|Overall Study|Lack of Efficacy|6|||
161960190|NCT00070109|584900001|FG001|Overall Study|Lack of Efficacy|4|||
161960191|NCT00070109|584900002|FG002|Overall Study|Lack of Efficacy|5|||
161960192|NCT00070109|584900003|FG003|Overall Study|Lack of Efficacy|15|||
161960193|NCT00070109|584900004|FG004|Overall Study|Lack of Efficacy|5|||
161960194|NCT00070109|584900000|FG000|Overall Study|Physician Decision|1|||
161960195|NCT00070109|584900001|FG001|Overall Study|Physician Decision|0|||
161960196|NCT00070109|584900002|FG002|Overall Study|Physician Decision|0|||
161960197|NCT00070109|584900003|FG003|Overall Study|Physician Decision|0|||
161960198|NCT00070109|584900004|FG004|Overall Study|Physician Decision|0|||
161960199|NCT00070109|584900000|FG000|Overall Study|Withdrawal by Subject|0|||
161960200|NCT00070109|584900001|FG001|Overall Study|Withdrawal by Subject|1|||
161960201|NCT00070109|584900002|FG002|Overall Study|Withdrawal by Subject|1|||
161960202|NCT00070109|584900003|FG003|Overall Study|Withdrawal by Subject|0|||
161960203|NCT00070109|584900004|FG004|Overall Study|Withdrawal by Subject|0|||
161960204|NCT00070109|584900000|FG000|Overall Study|Adverse Event|0|||
161960205|NCT00070109|584900001|FG001|Overall Study|Adverse Event|0|||
161960206|NCT00070109|584900002|FG002|Overall Study|Adverse Event|2|||
161960207|NCT00070109|584900003|FG003|Overall Study|Adverse Event|4|||
161960208|NCT00070109|584900004|FG004|Overall Study|Adverse Event|2|||
161960209|NCT00070109|584900000|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
161960210|NCT00070109|584900001|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
161960211|NCT00070109|584900002|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
161960212|NCT00070109|584900003|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
161960213|NCT00070109|584900004|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
161960214|NCT03629223|584900005|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
161960215|NCT03629223|584900006|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
161960216|NCT03629223|584900007|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
161960217|NCT03629223|584900008|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
161960218|NCT03629223|584900009|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
161960219|NCT03629223|584900010|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
161960220|NCT03629223|584900005|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
161960221|NCT03629223|584900006|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
161960222|NCT03629223|584900007|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
161960223|NCT03629223|584900008|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
161960224|NCT03629223|584900009|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
161960225|NCT03629223|584900010|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
161960226|NCT03629223|584900005|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
161960227|NCT03629223|584900006|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
161960228|NCT03629223|584900007|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
161960229|NCT03629223|584900008|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
161960230|NCT03629223|584900009|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
161960231|NCT03629223|584900010|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
161960232|NCT03629223|584900005|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
161960233|NCT03629223|584900006|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
161960234|NCT03629223|584900007|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
161960235|NCT03629223|584900008|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
161960236|NCT03629223|584900009|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
161960237|NCT03629223|584900010|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
161960238|NCT03629223|584900005|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
161960239|NCT03629223|584900006|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
161960240|NCT03629223|584900007|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
161960241|NCT03629223|584900008|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
161960242|NCT03629223|584900009|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
161960243|NCT03629223|584900010|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
161960244|NCT01534351|584900011|FG000|Overall Study|Study Terminated Early|1|||
161960245|NCT01534351|584900012|FG001|Overall Study|Study Terminated Early|0|||
161960246|NCT01534351|584900013|FG002|Overall Study|Study Terminated Early|0|||
161960247|NCT00470262|584900014|FG000|Overall Study|Withdrawal by Subject|2|||
161960248|NCT00470262|584900015|FG001|Overall Study|Withdrawal by Subject|0|||
161960249|NCT03248167|584900016|FG000|Overall Study|Withdrawal by Subject|2|||
161960250|NCT03248167|584900017|FG001|Overall Study|Withdrawal by Subject|2|||
161960251|NCT03248167|584900016|FG000|Overall Study|Physician Decision|0|||
162031151|NCT03901456|585170973|FG002|Overall Study|Lost to Follow-up|0|||
162031152|NCT06400251|585170975|FG000|Overall Study|Never Start Protocol Therapy|1|||
162031153|NCT06400251|585170975|FG000|Overall Study|Ineligible|2|||
162031154|NCT06400251|585170975|FG000|Overall Study|Mutation Status Not Confirmed|3|||
162031155|NCT06400251|585170975|FG000|Overall Study|Disease Progression|25|||
161960252|NCT03248167|584900017|FG001|Overall Study|Physician Decision|1|||
161960253|NCT03248167|584900016|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
162031156|NCT06400251|585170975|FG000|Overall Study|Adverse Event|1|||
161710662|NCT00391976|583984134|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
161960254|NCT03248167|584900017|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
161960255|NCT03248167|584900016|FG000|Overall Study|Lost to Follow-up|1|||
161960256|NCT03248167|584900017|FG001|Overall Study|Lost to Follow-up|0|||
161960257|NCT02998671|584900020|FG000|Period 1|Study Terminated By Sponsor|2|||
161960258|NCT02998671|584900021|FG001|Period 1|Study Terminated By Sponsor|1|||
161960259|NCT02998671|584900022|FG002|Period 1|Study Terminated By Sponsor|0|||
161960260|NCT02998671|584900023|FG003|Period 1|Study Terminated By Sponsor|0|||
161960261|NCT02998671|584900024|FG004|Period 1|Study Terminated By Sponsor|1|||
161960262|NCT02998671|584900020|FG000|Period 1|Withdrawal by Subject|1|||
161960263|NCT02998671|584900021|FG001|Period 1|Withdrawal by Subject|2|||
161960264|NCT02998671|584900022|FG002|Period 1|Withdrawal by Subject|0|||
161960265|NCT02998671|584900023|FG003|Period 1|Withdrawal by Subject|0|||
161960266|NCT02998671|584900024|FG004|Period 1|Withdrawal by Subject|2|||
161960267|NCT02998671|584900020|FG000|Period 1|Pregnancy|1|||
161960268|NCT02998671|584900021|FG001|Period 1|Pregnancy|0|||
161960269|NCT02998671|584900022|FG002|Period 1|Pregnancy|0|||
161960270|NCT02998671|584900023|FG003|Period 1|Pregnancy|0|||
161960271|NCT02998671|584900024|FG004|Period 1|Pregnancy|0|||
161960272|NCT02998671|584900020|FG000|Period 1|Adverse Event|0|||
161960273|NCT02998671|584900021|FG001|Period 1|Adverse Event|0|||
161960274|NCT02998671|584900022|FG002|Period 1|Adverse Event|0|||
161960275|NCT02998671|584900023|FG003|Period 1|Adverse Event|0|||
161960276|NCT02998671|584900024|FG004|Period 1|Adverse Event|1|||
161960277|NCT02998671|584900020|FG000|Period 2|Adverse Event|0|||
161960278|NCT02998671|584900021|FG001|Period 2|Adverse Event|1|||
161960279|NCT02998671|584900022|FG002|Period 2|Adverse Event|0|||
161960280|NCT02998671|584900023|FG003|Period 2|Adverse Event|0|||
161960281|NCT02998671|584900024|FG004|Period 2|Adverse Event|0|||
161960282|NCT02998671|584900020|FG000|Period 2|Study Terminated By Sponsor|3|||
161960283|NCT02998671|584900021|FG001|Period 2|Study Terminated By Sponsor|5|||
161960284|NCT02998671|584900022|FG002|Period 2|Study Terminated By Sponsor|1|||
161960285|NCT02998671|584900023|FG003|Period 2|Study Terminated By Sponsor|3|||
161960286|NCT02998671|584900024|FG004|Period 2|Study Terminated By Sponsor|0|||
161960287|NCT02998671|584900020|FG000|Period 2|Withdrawal by Subject|0|||
161960288|NCT02998671|584900021|FG001|Period 2|Withdrawal by Subject|1|||
161960289|NCT02998671|584900022|FG002|Period 2|Withdrawal by Subject|0|||
161960290|NCT02998671|584900023|FG003|Period 2|Withdrawal by Subject|0|||
161960291|NCT02998671|584900024|FG004|Period 2|Withdrawal by Subject|0|||
161960292|NCT02998671|584900020|FG000|Period 2|Lost to Follow-up|0|||
161960293|NCT02998671|584900021|FG001|Period 2|Lost to Follow-up|0|||
161960294|NCT02998671|584900022|FG002|Period 2|Lost to Follow-up|0|||
161960295|NCT02998671|584900023|FG003|Period 2|Lost to Follow-up|1|||
161960296|NCT02998671|584900024|FG004|Period 2|Lost to Follow-up|0|||
161960297|NCT01558596|584900028|FG000|Overall Study|Withdrawal by Subject|1|||
161960298|NCT01558596|584900029|FG001|Overall Study|Withdrawal by Subject|0|||
161960299|NCT01558596|584900028|FG000|Overall Study|surgery elsewhere or cancelled|1|||
161960300|NCT01558596|584900029|FG001|Overall Study|surgery elsewhere or cancelled|1|||
161960301|NCT01558596|584900028|FG000|Overall Study|Protocol Violation|1|||
161960302|NCT01558596|584900029|FG001|Overall Study|Protocol Violation|0|||
161960303|NCT00260832|584900031|FG000|Overall Study|Adverse Event|26|||
161960304|NCT00260832|584900032|FG001|Overall Study|Adverse Event|19|||
161960305|NCT00260832|584900031|FG000|Overall Study|Progression|116|||
161960306|NCT00260832|584900032|FG001|Overall Study|Progression|96|||
161960307|NCT00260832|584900031|FG000|Overall Study|Withdrawal by Subject|15|||
161960308|NCT00260832|584900032|FG001|Overall Study|Withdrawal by Subject|17|||
161960309|NCT00260832|584900031|FG000|Overall Study|Physician Decision|15|||
161960310|NCT00260832|584900032|FG001|Overall Study|Physician Decision|9|||
161960311|NCT00260832|584900031|FG000|Overall Study|Death|43|||
161960312|NCT00260832|584900032|FG001|Overall Study|Death|62|||
161960313|NCT00260832|584900031|FG000|Overall Study|Other|10|||
161960314|NCT00260832|584900032|FG001|Overall Study|Other|7|||
161960315|NCT00260832|584900031|FG000|Overall Study|Protocol Violation|3|||
161960316|NCT00260832|584900032|FG001|Overall Study|Protocol Violation|1|||
161960317|NCT00771927|584900033|FG000|Overall Study|Adverse Event|100|||
161960318|NCT00771927|584900034|FG001|Overall Study|Adverse Event|105|||
161960319|NCT00771927|584900033|FG000|Overall Study|Lack of Efficacy|70|||
161960320|NCT00771927|584900034|FG001|Overall Study|Lack of Efficacy|42|||
161960321|NCT00771927|584900033|FG000|Overall Study|Lost to Follow-up|46|||
161960322|NCT00771927|584900034|FG001|Overall Study|Lost to Follow-up|46|||
161960323|NCT00771927|584900033|FG000|Overall Study|Withdrawal by Subject|16|||
161960324|NCT00771927|584900034|FG001|Overall Study|Withdrawal by Subject|17|||
161960325|NCT00771927|584900033|FG000|Overall Study|Other reason|23|||
161960326|NCT00771927|584900034|FG001|Overall Study|Other reason|27|||
161960327|NCT04222699|584900038|FG000|Overall Study|Lost to Follow-up|2|||
161960328|NCT00790582|584900075|FG000|Overall Study|Death|14|||
161960329|NCT00790582|584900076|FG001|Overall Study|Death|32|||
161960330|NCT00790582|584900075|FG000|Overall Study|Physician Decision|7|||
161960331|NCT00790582|584900076|FG001|Overall Study|Physician Decision|1|||
161960332|NCT00790582|584900075|FG000|Overall Study|Lost to Follow-up|3|||
161960333|NCT00790582|584900076|FG001|Overall Study|Lost to Follow-up|3|||
161960334|NCT00790582|584900075|FG000|Overall Study|Withdrawal by Subject|7|||
161960335|NCT00790582|584900076|FG001|Overall Study|Withdrawal by Subject|51|||
161960336|NCT00803595|584900077|FG000|Overall Study|Adverse Event|3|||
161960337|NCT00803595|584900078|FG001|Overall Study|Adverse Event|4|||
161960338|NCT00803595|584900079|FG002|Overall Study|Adverse Event|1|||
161960339|NCT00803595|584900077|FG000|Overall Study|Protocol Violation|7|||
161960340|NCT00803595|584900078|FG001|Overall Study|Protocol Violation|2|||
161960341|NCT00803595|584900079|FG002|Overall Study|Protocol Violation|12|||
161960342|NCT00803595|584900077|FG000|Overall Study|Withdrawal by Subject|5|||
161960343|NCT00803595|584900078|FG001|Overall Study|Withdrawal by Subject|2|||
161960344|NCT00803595|584900079|FG002|Overall Study|Withdrawal by Subject|3|||
161960345|NCT02566785|584900080|FG000|Overall Study|Lost to Follow-up|0|||
161960346|NCT02566785|584900081|FG001|Overall Study|Lost to Follow-up|2|||
161960347|NCT02566785|584900080|FG000|Overall Study|Worsening condition|1|||
161960348|NCT02566785|584900081|FG001|Overall Study|Worsening condition|1|||
161960349|NCT01597908|584900082|FG000|Randomized Phase|Death|217|||
161960350|NCT01597908|584900083|FG001|Randomized Phase|Death|238|||
161960351|NCT01597908|584900084|FG002|Randomized Phase|Death|0|||
161960352|NCT01597908|584900082|FG000|Randomized Phase|Sponsor Decision|93|||
161960353|NCT01597908|584900083|FG001|Randomized Phase|Sponsor Decision|39|||
161960354|NCT01597908|584900084|FG002|Randomized Phase|Sponsor Decision|0|||
161960355|NCT01597908|584900082|FG000|Randomized Phase|Lost to Follow-up|9|||
161960356|NCT01597908|584900083|FG001|Randomized Phase|Lost to Follow-up|16|||
161960357|NCT01597908|584900084|FG002|Randomized Phase|Lost to Follow-up|0|||
161960358|NCT01597908|584900082|FG000|Randomized Phase|Physician Decision|6|||
161960359|NCT01597908|584900083|FG001|Randomized Phase|Physician Decision|3|||
161960360|NCT01597908|584900084|FG002|Randomized Phase|Physician Decision|0|||
161960361|NCT01597908|584900082|FG000|Randomized Phase|Withdrawal by Subject|26|||
161960362|NCT01597908|584900083|FG001|Randomized Phase|Withdrawal by Subject|22|||
161960363|NCT01597908|584900084|FG002|Randomized Phase|Withdrawal by Subject|0|||
161960364|NCT01597908|584900082|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
161960365|NCT01597908|584900083|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
161960366|NCT01597908|584900084|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
161960367|NCT01597908|584900082|FG000|Crossover Phase|Death|0|||
161960368|NCT01597908|584900083|FG001|Crossover Phase|Death|0|||
161960369|NCT01597908|584900084|FG002|Crossover Phase|Death|11|||
161960370|NCT01597908|584900082|FG000|Crossover Phase|Withdrawal by Subject|0|||
161960371|NCT01597908|584900083|FG001|Crossover Phase|Withdrawal by Subject|0|||
161960372|NCT01597908|584900084|FG002|Crossover Phase|Withdrawal by Subject|3|||
161960373|NCT01597908|584900082|FG000|Crossover Phase|Sponsor Decision|0|||
161960374|NCT01597908|584900083|FG001|Crossover Phase|Sponsor Decision|0|||
161960375|NCT01597908|584900084|FG002|Crossover Phase|Sponsor Decision|20|||
161960376|NCT00451958|584900087|FG000|CS21A (NCT00451958)|Adverse Event|21|||
161710663|NCT00391976|583984135|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
161710664|NCT00391976|583984136|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
161710665|NCT00049127|583984137|FG000|Overall Study|Withdrawal by Subject|0|||
161710666|NCT00049127|583984138|FG001|Overall Study|Withdrawal by Subject|0|||
161960377|NCT00451958|584900088|FG001|CS21A (NCT00451958)|Adverse Event|34|||
161960378|NCT00451958|584900089|FG002|CS21A (NCT00451958)|Adverse Event|14|||
161960379|NCT00451958|584900090|FG003|CS21A (NCT00451958)|Adverse Event|17|||
161960380|NCT00451958|584900091|FG004|CS21A (NCT00451958)|Adverse Event|0|||
161960381|NCT00451958|584900087|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
161960382|NCT00451958|584900088|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
161960383|NCT00451958|584900089|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
161960384|NCT00451958|584900090|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
161960385|NCT00451958|584900091|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
161960386|NCT00451958|584900087|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
161960387|NCT00451958|584900088|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
161960388|NCT00451958|584900089|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
161960389|NCT00451958|584900090|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
161960390|NCT00451958|584900091|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
161960391|NCT00451958|584900087|FG000|CS21A (NCT00451958)|Physician Decision|2|||
161960392|NCT00451958|584900088|FG001|CS21A (NCT00451958)|Physician Decision|4|||
161960393|NCT00451958|584900089|FG002|CS21A (NCT00451958)|Physician Decision|4|||
161960394|NCT00451958|584900090|FG003|CS21A (NCT00451958)|Physician Decision|4|||
161960395|NCT00451958|584900091|FG004|CS21A (NCT00451958)|Physician Decision|0|||
161960396|NCT00451958|584900087|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
161960397|NCT00451958|584900088|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
161960398|NCT00451958|584900089|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
161960399|NCT00451958|584900090|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
161960400|NCT00451958|584900091|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
161960401|NCT00451958|584900087|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
161960402|NCT00451958|584900088|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
161960403|NCT00451958|584900089|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
161960404|NCT00451958|584900090|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
161960405|NCT00451958|584900091|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
161960406|NCT01027650|584900094|FG000|Overall Study|Personal Reasons|0|||
161960407|NCT01027650|584900095|FG001|Overall Study|Personal Reasons|0|||
161960408|NCT01027650|584900096|FG002|Overall Study|Personal Reasons|0|||
161960409|NCT01027650|584900097|FG003|Overall Study|Personal Reasons|0|||
161960410|NCT01027650|584900098|FG004|Overall Study|Personal Reasons|2|||
161960411|NCT01027650|584900099|FG005|Overall Study|Personal Reasons|1|||
161960412|NCT01027650|584900100|FG006|Overall Study|Personal Reasons|0|||
161960413|NCT01027650|584900101|FG007|Overall Study|Personal Reasons|0|||
161960414|NCT01027650|584900094|FG000|Overall Study|Lost to Follow-up|0|||
161960415|NCT01027650|584900095|FG001|Overall Study|Lost to Follow-up|0|||
161960416|NCT01027650|584900096|FG002|Overall Study|Lost to Follow-up|0|||
161960417|NCT01027650|584900097|FG003|Overall Study|Lost to Follow-up|0|||
161960418|NCT01027650|584900098|FG004|Overall Study|Lost to Follow-up|0|||
161960419|NCT01027650|584900099|FG005|Overall Study|Lost to Follow-up|0|||
161960420|NCT01027650|584900100|FG006|Overall Study|Lost to Follow-up|1|||
161960421|NCT01027650|584900101|FG007|Overall Study|Lost to Follow-up|0|||
161960422|NCT01027650|584900094|FG000|Overall Study|Lack of Efficacy|0|||
161960423|NCT01027650|584900095|FG001|Overall Study|Lack of Efficacy|0|||
161960424|NCT01027650|584900096|FG002|Overall Study|Lack of Efficacy|0|||
161960425|NCT01027650|584900097|FG003|Overall Study|Lack of Efficacy|0|||
161960426|NCT01027650|584900098|FG004|Overall Study|Lack of Efficacy|0|||
161960427|NCT01027650|584900099|FG005|Overall Study|Lack of Efficacy|1|||
161960428|NCT01027650|584900100|FG006|Overall Study|Lack of Efficacy|0|||
161960429|NCT01027650|584900101|FG007|Overall Study|Lack of Efficacy|0|||
161960430|NCT00670930|584900102|FG000|Overall Study|Adminstrative Problem|0|||
161960431|NCT00670930|584900103|FG001|Overall Study|Adminstrative Problem|1|||
161960432|NCT00670930|584900102|FG000|Overall Study|Lost to Follow-up|1|||
161960433|NCT00670930|584900103|FG001|Overall Study|Lost to Follow-up|0|||
161960434|NCT00782171|584902060|FG000|Overall Study|Lost to Follow-up|2|||
161960435|NCT00782171|584902061|FG001|Overall Study|Lost to Follow-up|2|||
161960436|NCT00782171|584902060|FG000|Overall Study|Withdrawal by Subject|2|||
161960437|NCT00782171|584902061|FG001|Overall Study|Withdrawal by Subject|1|||
161960438|NCT00782171|584902060|FG000|Overall Study|complications|3|||
161960439|NCT00782171|584902061|FG001|Overall Study|complications|1|||
161960440|NCT00782171|584902060|FG000|Overall Study|others|7|||
161960441|NCT00782171|584902061|FG001|Overall Study|others|9|||
161960442|NCT00782171|584902060|FG000|Overall Study|not eligible|8|||
161960443|NCT00782171|584902061|FG001|Overall Study|not eligible|6|||
161960444|NCT01691014|584902062|FG000|Overall Study|Premature Termination|1|||
161960445|NCT01691014|584902063|FG001|Overall Study|Premature Termination|6|||
161960446|NCT01691014|584902064|FG002|Overall Study|Premature Termination|0|||
161960447|NCT01691014|584902065|FG003|Overall Study|Premature Termination|3|||
161960448|NCT01691014|584902062|FG000|Overall Study|Other|0|||
161960449|NCT01691014|584902063|FG001|Overall Study|Other|0|||
161960450|NCT01691014|584902064|FG002|Overall Study|Other|2|||
161960451|NCT01691014|584902065|FG003|Overall Study|Other|0|||
161960452|NCT01691014|584902062|FG000|Overall Study|Withdrawal by Subject|0|||
161960453|NCT01691014|584902063|FG001|Overall Study|Withdrawal by Subject|1|||
161960454|NCT01691014|584902064|FG002|Overall Study|Withdrawal by Subject|1|||
161960455|NCT01691014|584902065|FG003|Overall Study|Withdrawal by Subject|1|||
161960456|NCT01691014|584902062|FG000|Overall Study|Adverse Event|0|||
161960457|NCT01691014|584902063|FG001|Overall Study|Adverse Event|5|||
161960458|NCT01691014|584902064|FG002|Overall Study|Adverse Event|1|||
161960459|NCT01691014|584902065|FG003|Overall Study|Adverse Event|1|||
161960460|NCT01691014|584902062|FG000|Overall Study|Lack of Efficacy|2|||
162031157|NCT06400251|585170975|FG000|Overall Study|Complicating Disease|1|||
162031158|NCT06400251|585170975|FG000|Overall Study|Physician Decision|2|||
162031159|NCT04098224|585170976|FG000|Overall Study|Adverse Event|1|||
162031160|NCT04098224|585170977|FG001|Overall Study|Adverse Event|0|||
162031161|NCT04098224|585170976|FG000|Overall Study|Physician Decision|1|||
162031162|NCT04098224|585170977|FG001|Overall Study|Physician Decision|0|||
161710667|NCT00049127|583984139|FG002|Overall Study|Withdrawal by Subject|1|||
161710668|NCT00049127|583984140|FG003|Overall Study|Withdrawal by Subject|0|||
161710669|NCT00049127|583984141|FG004|Overall Study|Withdrawal by Subject|0|||
161710670|NCT02582515|583984144|FG000|Overall Study|Withdrawal by Subject|0|||
161710671|NCT02582515|583984145|FG001|Overall Study|Withdrawal by Subject|1|||
161710672|NCT02725788|583984148|FG000|Overall Study|Lost to Follow-up|1|||
161710673|NCT02725788|583984149|FG001|Overall Study|Lost to Follow-up|1|||
161710674|NCT02725788|583984148|FG000|Overall Study|Protocol Violation|0|||
161710675|NCT02725788|583984149|FG001|Overall Study|Protocol Violation|1|||
161710676|NCT04927312|583984150|FG000|Overall Study|Adverse Event|1|||
161710677|NCT04927312|583984150|FG000|Overall Study|Death|1|||
161710678|NCT04927312|583984150|FG000|Overall Study|Withdrawal by Subject|1|||
161710679|NCT04927312|583984150|FG000|Overall Study|Other|1|||
161960461|NCT01691014|584902063|FG001|Overall Study|Lack of Efficacy|3|||
161960462|NCT01691014|584902064|FG002|Overall Study|Lack of Efficacy|7|||
162031163|NCT04098224|585170976|FG000|Overall Study|Patient not required enteral feeding|1|||
162031164|NCT04098224|585170977|FG001|Overall Study|Patient not required enteral feeding|0|||
161710680|NCT04919564|583984156|FG000|Overall Study|Lost to Follow-up|1|||
161710681|NCT04919564|583984157|FG001|Overall Study|Lost to Follow-up|0|||
161960463|NCT01691014|584902065|FG003|Overall Study|Lack of Efficacy|0|||
161960464|NCT05897242|584902068|FG000|Overall Study|Lost to Follow-up|6|||
161960465|NCT05897242|584902069|FG001|Overall Study|Lost to Follow-up|1|||
161960466|NCT05897242|584902068|FG000|Overall Study|Incomplete|1|||
161960467|NCT05897242|584902069|FG001|Overall Study|Incomplete|0|||
161960468|NCT05897242|584902068|FG000|Overall Study|Withdrawal by Subject|1|||
161960469|NCT05897242|584902069|FG001|Overall Study|Withdrawal by Subject|0|||
161960470|NCT03522246|584902070|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
161960471|NCT03522246|584902071|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
161960472|NCT03522246|584902072|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
161960473|NCT03522246|584902073|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
161960474|NCT03522246|584902074|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
161960475|NCT00814580|584902075|FG000|Overall Study|Adverse Event|6|||
161960476|NCT00814580|584902076|FG001|Overall Study|Adverse Event|15|||
161960477|NCT00814580|584902075|FG000|Overall Study|Lack of Efficacy|18|||
161960478|NCT00814580|584902076|FG001|Overall Study|Lack of Efficacy|25|||
161710682|NCT04919564|583984156|FG000|Overall Study|Physician Decision|1|||
161710683|NCT04919564|583984157|FG001|Overall Study|Physician Decision|1|||
161710684|NCT05292755|583984161|FG000|Overall Study|Lost to Follow-up|5|||
161710685|NCT05292755|583984162|FG001|Overall Study|Lost to Follow-up|9|||
161710686|NCT04052139|583984163|FG000|Overall Study|Lost to Follow-up|2|||
161710687|NCT04052139|583984164|FG001|Overall Study|Lost to Follow-up|0|||
161710688|NCT04052139|583984165|FG002|Overall Study|Lost to Follow-up|0|||
161710689|NCT04052139|583984163|FG000|Overall Study|Withdrawal by Subject|1|||
161710690|NCT04052139|583984164|FG001|Overall Study|Withdrawal by Subject|0|||
161710691|NCT04052139|583984165|FG002|Overall Study|Withdrawal by Subject|0|||
161710692|NCT00707577|583984166|FG000|Overall Study|Withdrawal by Subject|3|||
161710693|NCT00707577|583984167|FG001|Overall Study|Withdrawal by Subject|2|||
161710694|NCT00707577|583984166|FG000|Overall Study|Lost to Follow-up|34|||
161710695|NCT00707577|583984167|FG001|Overall Study|Lost to Follow-up|25|||
161710696|NCT00707577|583984166|FG000|Overall Study|Left employment|13|||
161710697|NCT00707577|583984167|FG001|Overall Study|Left employment|10|||
161710698|NCT00707577|583984166|FG000|Overall Study|Pregnancy|4|||
161710699|NCT00707577|583984167|FG001|Overall Study|Pregnancy|1|||
161960479|NCT00814580|584902075|FG000|Overall Study|Protocol Violation|2|||
161960480|NCT00814580|584902076|FG001|Overall Study|Protocol Violation|0|||
161960481|NCT00814580|584902075|FG000|Overall Study|Withdrawal by Subject|2|||
161960482|NCT00814580|584902076|FG001|Overall Study|Withdrawal by Subject|2|||
161960483|NCT00814580|584902075|FG000|Overall Study|Other|1|||
161960484|NCT00814580|584902076|FG001|Overall Study|Other|3|||
161960485|NCT00814580|584902075|FG000|Overall Study|Did Not Take Drug|2|||
161960486|NCT00814580|584902076|FG001|Overall Study|Did Not Take Drug|2|||
161960487|NCT02482428|584902077|FG000|Overall Study|Lost to Follow-up|4|||
161960488|NCT02482428|584902078|FG001|Overall Study|Lost to Follow-up|9|||
161960489|NCT02482428|584902079|FG002|Overall Study|Lost to Follow-up|1|||
161960490|NCT02482428|584902080|FG003|Overall Study|Lost to Follow-up|2|||
161710700|NCT00190775|583984168|FG000|Overall Study|Adverse Event|57|||
161710701|NCT00190775|583984169|FG001|Overall Study|Adverse Event|22|||
161710702|NCT00190775|583984168|FG000|Overall Study|Satisfactory Response|1|||
161710703|NCT00190775|583984169|FG001|Overall Study|Satisfactory Response|0|||
161960491|NCT02482428|584902081|FG004|Overall Study|Lost to Follow-up|4|||
161960492|NCT02482428|584902077|FG000|Overall Study|Physician Decision|0|||
161960493|NCT02482428|584902078|FG001|Overall Study|Physician Decision|0|||
161960494|NCT02482428|584902079|FG002|Overall Study|Physician Decision|0|||
161960495|NCT02482428|584902080|FG003|Overall Study|Physician Decision|0|||
161960496|NCT02482428|584902081|FG004|Overall Study|Physician Decision|1|||
161960497|NCT02482428|584902077|FG000|Overall Study|protocol deviation|1|||
161960498|NCT02482428|584902078|FG001|Overall Study|protocol deviation|1|||
161960499|NCT02482428|584902079|FG002|Overall Study|protocol deviation|0|||
161960500|NCT02482428|584902080|FG003|Overall Study|protocol deviation|0|||
161960501|NCT02482428|584902081|FG004|Overall Study|protocol deviation|0|||
161960502|NCT02482428|584902077|FG000|Overall Study|subject/guardian decision|4|||
161960503|NCT02482428|584902078|FG001|Overall Study|subject/guardian decision|2|||
161960504|NCT02482428|584902079|FG002|Overall Study|subject/guardian decision|0|||
161960505|NCT02482428|584902080|FG003|Overall Study|subject/guardian decision|0|||
161960506|NCT02482428|584902081|FG004|Overall Study|subject/guardian decision|2|||
161960507|NCT00809835|584902084|FG000|Overall Study|Lost to Follow-up|7|||
161960508|NCT00809835|584902085|FG001|Overall Study|Lost to Follow-up|6|||
161960509|NCT00809835|584902086|FG002|Overall Study|Lost to Follow-up|10|||
161960510|NCT00809835|584902087|FG003|Overall Study|Lost to Follow-up|2|||
161960511|NCT00809835|584902084|FG000|Overall Study|Withdrawal by Subject|1|||
161960512|NCT00809835|584902085|FG001|Overall Study|Withdrawal by Subject|1|||
161960513|NCT00809835|584902086|FG002|Overall Study|Withdrawal by Subject|1|||
161960514|NCT00809835|584902087|FG003|Overall Study|Withdrawal by Subject|0|||
161960515|NCT00516893|584902088|FG000|Overall Study|Lost to Follow-up|4|||
161960516|NCT00516893|584902088|FG000|Overall Study|Adverse Event|3|||
161960517|NCT00516893|584902088|FG000|Overall Study|Withdrawal by Subject|2|||
161960518|NCT00516893|584902088|FG000|Overall Study|Noncompliance|2|||
161960519|NCT00516893|584902088|FG000|Overall Study|Death|1|||
161960520|NCT00516893|584902088|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
161960521|NCT00516893|584902088|FG000|Overall Study|Relocated|1|||
161960522|NCT00516893|584902088|FG000|Overall Study|Pregnancy|1|||
161960523|NCT00516893|584902088|FG000|Overall Study|Received Medication From Another Study|1|||
161960524|NCT05160415|584902089|FG000|Overall Study|Withdrawal by Subject|3|||
161960525|NCT01519791|584902091|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
161960526|NCT01519791|584902092|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
161960527|NCT01519791|584902091|FG000|Overall Study|Protocol Violation|6|||
161960528|NCT01519791|584902092|FG001|Overall Study|Protocol Violation|19|||
161960529|NCT01519791|584902091|FG000|Overall Study|Other Reason|87|||
161960530|NCT01519791|584902092|FG001|Overall Study|Other Reason|222|||
161960531|NCT01519791|584902091|FG000|Overall Study|subjects randomized in error|2|||
161960532|NCT01519791|584902092|FG001|Overall Study|subjects randomized in error|0|||
161960533|NCT01519791|584902091|FG000|Overall Study|Lack of Efficacy|16|||
161960534|NCT01519791|584902092|FG001|Overall Study|Lack of Efficacy|20|||
161960535|NCT01519791|584902091|FG000|Overall Study|SAE, non-fatal|6|||
161960536|NCT01519791|584902092|FG001|Overall Study|SAE, non-fatal|22|||
161960537|NCT01519791|584902091|FG000|Overall Study|AE, serious fatal|0|||
161960538|NCT01519791|584902092|FG001|Overall Study|AE, serious fatal|1|||
161960539|NCT01519791|584902091|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
161960540|NCT01519791|584902092|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
161960541|NCT01519791|584902091|FG000|Overall Study|AE, non-serious non-fatal|12|||
161960542|NCT01519791|584902092|FG001|Overall Study|AE, non-serious non-fatal|31|||
161960543|NCT01519791|584902091|FG000|Overall Study|Withdrawal by Subject|15|||
161960544|NCT01519791|584902092|FG001|Overall Study|Withdrawal by Subject|37|||
161960545|NCT01519791|584902091|FG000|Overall Study|Lost to Follow-up|6|||
161960546|NCT01519791|584902092|FG001|Overall Study|Lost to Follow-up|14|||
161960547|NCT00623233|584902093|FG000|Overall Study|Adverse Event|10|||
161960548|NCT00623233|584902093|FG000|Overall Study|Physician Decision|10|||
161960549|NCT00623233|584902093|FG000|Overall Study|Lost to Follow-up|1|||
161960550|NCT00623233|584902093|FG000|Overall Study|Withdrawal by Subject|3|||
161960551|NCT00559845|584902094|FG000|Overall Study|Withdrew Consent|1|||
161960552|NCT00559845|584902094|FG000|Overall Study|Disease Progression|1|||
161960553|NCT00559845|584902094|FG000|Overall Study|Adverse Event|3|||
161960554|NCT00559845|584902094|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
161960555|NCT00559845|584902094|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
161960556|NCT00459875|584902095|FG000|Overall Study|Ineligible participant|1|||
161960557|NCT00459875|584902095|FG000|Overall Study|Adverse Event|2|||
161960558|NCT01977729|584902097|FG000|Overall Study|Study terminated|1|||
161960559|NCT01268046|584902098|FG000|Overall Study|Withdrawal by Subject|1|||
161960560|NCT01268046|584902099|FG001|Overall Study|Withdrawal by Subject|0|||
161960561|NCT01268046|584902100|FG002|Overall Study|Withdrawal by Subject|0|||
161960562|NCT01268046|584902101|FG003|Overall Study|Withdrawal by Subject|1|||
161960563|NCT01268046|584902098|FG000|Overall Study|Lost to Follow-up|0|||
161960564|NCT01268046|584902099|FG001|Overall Study|Lost to Follow-up|0|||
161960565|NCT01268046|584902100|FG002|Overall Study|Lost to Follow-up|1|||
161960566|NCT01268046|584902101|FG003|Overall Study|Lost to Follow-up|0|||
161960567|NCT03636893|584902102|FG000|Overall Study|Death|0|||
161960568|NCT03636893|584902103|FG001|Overall Study|Death|1|||
161960569|NCT03636893|584902102|FG000|Overall Study|Protocol Violation|0|||
161960570|NCT03636893|584902103|FG001|Overall Study|Protocol Violation|3|||
161960571|NCT03636893|584902102|FG000|Overall Study|Withdrawal by Subject|1|||
161960572|NCT03636893|584902103|FG001|Overall Study|Withdrawal by Subject|2|||
161960573|NCT03636893|584902102|FG000|Overall Study|Refusal to surgery|4|||
161960574|NCT03636893|584902103|FG001|Overall Study|Refusal to surgery|3|||
161960575|NCT03636893|584902102|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
161960576|NCT03636893|584902103|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
161960577|NCT03636893|584902102|FG000|Overall Study|Adverse Event|1|||
161960578|NCT03636893|584902103|FG001|Overall Study|Adverse Event|1|||
161960579|NCT02314156|584902104|FG000|Overall Study|Adverse Event|1|||
161960580|NCT02314156|584902105|FG001|Overall Study|Adverse Event|0|||
161960581|NCT02314156|584902104|FG000|Overall Study|Withdrawal by Subject|1|||
161960582|NCT02314156|584902105|FG001|Overall Study|Withdrawal by Subject|0|||
161960583|NCT00758069|584902108|FG000|Overall Study|Lack of Efficacy|0|||
161960584|NCT00758069|584902109|FG001|Overall Study|Lack of Efficacy|0|||
161960585|NCT00758069|584902110|FG002|Overall Study|Lack of Efficacy|1|||
161960586|NCT00758069|584902108|FG000|Overall Study|Incorrect Study Drug|1|||
161960587|NCT00758069|584902109|FG001|Overall Study|Incorrect Study Drug|0|||
161960588|NCT00758069|584902110|FG002|Overall Study|Incorrect Study Drug|0|||
161960589|NCT04560816|584902111|FG000|Overall Study|Withdrawal by Subject|1|||
161960590|NCT04560816|584902112|FG001|Overall Study|Withdrawal by Subject|1|||
161960591|NCT04560816|584902113|FG002|Overall Study|Withdrawal by Subject|1|||
161960592|NCT04560816|584902114|FG003|Overall Study|Withdrawal by Subject|0|||
161960593|NCT04560816|584902115|FG004|Overall Study|Withdrawal by Subject|3|||
161960594|NCT04560816|584902116|FG005|Overall Study|Withdrawal by Subject|0|||
161960595|NCT04560816|584902111|FG000|Overall Study|Lost to Follow-up|1|||
161960596|NCT04560816|584902112|FG001|Overall Study|Lost to Follow-up|0|||
161960597|NCT04560816|584902113|FG002|Overall Study|Lost to Follow-up|0|||
161960598|NCT04560816|584902114|FG003|Overall Study|Lost to Follow-up|0|||
161960599|NCT04560816|584902115|FG004|Overall Study|Lost to Follow-up|0|||
161960600|NCT04560816|584902116|FG005|Overall Study|Lost to Follow-up|0|||
161960601|NCT04560816|584902111|FG000|Overall Study|Protocol Violation|1|||
161960602|NCT04560816|584902112|FG001|Overall Study|Protocol Violation|0|||
161960603|NCT04560816|584902113|FG002|Overall Study|Protocol Violation|0|||
161960604|NCT04560816|584902114|FG003|Overall Study|Protocol Violation|0|||
161960605|NCT04560816|584902115|FG004|Overall Study|Protocol Violation|0|||
161960606|NCT04560816|584902116|FG005|Overall Study|Protocol Violation|0|||
161960607|NCT02277691|584902119|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
161960608|NCT02277691|584902119|FG000|Overall Study|Voluntary Withdrawal|7|||
161960609|NCT02277691|584902119|FG000|Overall Study|Lack of Efficacy|5|||
161960610|NCT02277691|584902119|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
161960611|NCT02846389|584902120|FG000|Overall Study|Withdrawal by Subject|1|||
161960612|NCT02846389|584902121|FG001|Overall Study|Withdrawal by Subject|1|||
161960613|NCT03985943|584902124|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
161960614|NCT03985943|584902125|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
161960615|NCT03985943|584902126|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
161960616|NCT03985943|584902127|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
161960617|NCT03985943|584902128|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
161960618|NCT03985943|584902129|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
161960619|NCT03985943|584902124|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
161960620|NCT03985943|584902125|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
161960621|NCT03985943|584902126|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161960622|NCT03985943|584902127|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161960623|NCT03985943|584902128|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161960624|NCT03985943|584902129|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161960625|NCT03985943|584902124|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
161960626|NCT03985943|584902125|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
161960627|NCT03985943|584902126|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161960628|NCT03985943|584902127|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161960629|NCT03985943|584902128|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161960630|NCT03985943|584902129|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161960631|NCT03985943|584902124|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
161960632|NCT03985943|584902125|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
161960633|NCT03985943|584902126|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
161960634|NCT03985943|584902127|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
161960635|NCT03985943|584902128|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
161960636|NCT03985943|584902129|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
161960637|NCT03985943|584902124|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161960638|NCT03985943|584902125|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
162031165|NCT04098224|585170976|FG000|Overall Study|Patient failure nasogastric tube|1|||
162031166|NCT04098224|585170977|FG001|Overall Study|Patient failure nasogastric tube|0|||
162031167|NCT04098224|585170976|FG000|Overall Study|Patient early extubation|1|||
162031168|NCT04098224|585170977|FG001|Overall Study|Patient early extubation|3|||
162031169|NCT02217527|585170978|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
161960639|NCT03985943|584902126|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161960640|NCT03985943|584902127|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161960641|NCT03985943|584902128|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161960642|NCT03985943|584902129|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161960643|NCT03985943|584902124|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
161960644|NCT03985943|584902125|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
161960645|NCT03985943|584902126|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
161960646|NCT03985943|584902127|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
161960647|NCT03985943|584902128|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
161960648|NCT03985943|584902129|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
161960649|NCT03985943|584902124|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
162031170|NCT02217527|585170979|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
161960650|NCT03985943|584902125|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
161960651|NCT03985943|584902126|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
161960652|NCT03985943|584902127|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
161960653|NCT03985943|584902128|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
161960654|NCT03985943|584902129|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
161960655|NCT03985943|584902124|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
161960656|NCT03985943|584902125|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
161960657|NCT03985943|584902126|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
161960658|NCT03985943|584902127|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
161960659|NCT03985943|584902128|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
161960660|NCT03985943|584902129|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
161960661|NCT03985943|584902124|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161960662|NCT03985943|584902125|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161960663|NCT03985943|584902126|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
161960664|NCT03985943|584902127|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
161960665|NCT03985943|584902128|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
161960666|NCT03985943|584902129|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
161960667|NCT03985943|584902124|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161960668|NCT03985943|584902125|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161960669|NCT03985943|584902126|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
161960670|NCT03985943|584902127|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
161960671|NCT03985943|584902128|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
161960672|NCT03985943|584902129|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
161960673|NCT03985943|584902124|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
161960674|NCT03985943|584902125|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
161960675|NCT03985943|584902126|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
161960676|NCT03985943|584902127|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
161960677|NCT03985943|584902128|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
161960678|NCT03985943|584902129|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
161960679|NCT03985943|584902124|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161960680|NCT03985943|584902125|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161960681|NCT03985943|584902126|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161960682|NCT03985943|584902127|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
161960683|NCT03985943|584902128|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
161960684|NCT03985943|584902129|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
161960685|NCT03985943|584902124|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
161960686|NCT03985943|584902125|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
161960687|NCT03985943|584902126|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
161960688|NCT03985943|584902127|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
161960689|NCT03985943|584902128|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
161960690|NCT03985943|584902129|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
161960691|NCT03985943|584902124|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
161960692|NCT03985943|584902125|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
161960693|NCT03985943|584902126|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
161960694|NCT03985943|584902127|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
161960695|NCT03985943|584902128|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
161960696|NCT03985943|584902129|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
161960697|NCT03985943|584902124|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
161960698|NCT03985943|584902125|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
161960699|NCT03985943|584902126|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
161960700|NCT03985943|584902127|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
161960701|NCT03985943|584902128|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
161960702|NCT03985943|584902129|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
161960703|NCT04075513|584902132|FG000|Overall Study|Withdrawal by Subject|2|||
161960704|NCT04075513|584902133|FG001|Overall Study|Withdrawal by Subject|2|||
161960705|NCT04075513|584902132|FG000|Overall Study|Lack of Efficacy|1|||
161960706|NCT04075513|584902133|FG001|Overall Study|Lack of Efficacy|0|||
161960707|NCT04075513|584902132|FG000|Overall Study|Lost to Follow-up|4|||
161960708|NCT04075513|584902133|FG001|Overall Study|Lost to Follow-up|2|||
161960709|NCT04075513|584902132|FG000|Overall Study|Switch to insulin pump|1|||
161960710|NCT04075513|584902133|FG001|Overall Study|Switch to insulin pump|0|||
161960711|NCT05730335|584902134|FG000|Overall Study|Lost to Follow-up|8|||
162031171|NCT02217527|585170978|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
162031172|NCT02217527|585170979|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
162031173|NCT01738477|585170982|FG000|Overall Study|Lost to Follow-up|1|||
162031174|NCT01738477|585170983|FG001|Overall Study|Lost to Follow-up|4|||
162031175|NCT00510653|585170989|FG000|Overall Study|Withdrawal by Subject|8|||
162031176|NCT00510653|585170989|FG000|Overall Study|Monetary|3|||
162031177|NCT01947855|585170990|FG000|Overall Study|Withdrawal by Subject|1|||
162031178|NCT01947855|585170991|FG001|Overall Study|Withdrawal by Subject|0|||
162031179|NCT01947855|585170992|FG002|Overall Study|Withdrawal by Subject|0|||
162031180|NCT00710762|585170993|FG000|Overall Study|Progressive disease|27|||
162031181|NCT00710762|585170994|FG001|Overall Study|Progressive disease|30|||
162031182|NCT00710762|585170993|FG000|Overall Study|Adverse Event other disease worsening|2|||
162031183|NCT00710762|585170994|FG001|Overall Study|Adverse Event other disease worsening|1|||
162031184|NCT00710762|585170993|FG000|Overall Study|Other Adverse Event|7|||
162031185|NCT00710762|585170994|FG001|Overall Study|Other Adverse Event|7|||
162031186|NCT00710762|585170993|FG000|Overall Study|Lost to Follow-up|1|||
162031187|NCT00710762|585170994|FG001|Overall Study|Lost to Follow-up|0|||
162031188|NCT00710762|585170993|FG000|Overall Study|Reason other than listed above|2|||
162031189|NCT00710762|585170994|FG001|Overall Study|Reason other than listed above|2|||
162031190|NCT00592774|585170998|FG000|Overall Study|Adverse Event|5|||
162031191|NCT00592774|585170999|FG001|Overall Study|Adverse Event|19|||
162031192|NCT00592774|585171000|FG002|Overall Study|Adverse Event|2|||
162031193|NCT00592774|585171001|FG003|Overall Study|Adverse Event|14|||
162031194|NCT00592774|585171002|FG004|Overall Study|Adverse Event|8|||
162031195|NCT00592774|585170998|FG000|Overall Study|Protocol Violation|0|||
162031196|NCT00592774|585170999|FG001|Overall Study|Protocol Violation|1|||
162031197|NCT00592774|585171000|FG002|Overall Study|Protocol Violation|0|||
162031198|NCT00592774|585171001|FG003|Overall Study|Protocol Violation|0|||
162031199|NCT00592774|585171002|FG004|Overall Study|Protocol Violation|1|||
162031200|NCT00592774|585170998|FG000|Overall Study|Withdrawal by Subject|3|||
162031201|NCT00592774|585170999|FG001|Overall Study|Withdrawal by Subject|7|||
162031202|NCT00592774|585171000|FG002|Overall Study|Withdrawal by Subject|0|||
162031203|NCT00592774|585171001|FG003|Overall Study|Withdrawal by Subject|0|||
162031204|NCT00592774|585171002|FG004|Overall Study|Withdrawal by Subject|0|||
161960712|NCT05730335|584902134|FG000|Overall Study|Withdrawal by Subject|6|||
161960713|NCT01369199|584902137|FG000|Overall Study|Withdrawal by Subject|1|||
161960714|NCT01369199|584902137|FG000|Overall Study|Lost to Follow-up|2|||
161960715|NCT01071252|584902138|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
161960716|NCT01071252|584902139|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
161960717|NCT01071252|584902140|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
161960718|NCT01071252|584902141|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
161960719|NCT01071252|584902142|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
162031205|NCT00592774|585170998|FG000|Overall Study|Lack of Efficacy|3|||
161960720|NCT01071252|584902138|FG000|Overall Study|Withdrawal by Subject|8|||
161960721|NCT01071252|584902139|FG001|Overall Study|Withdrawal by Subject|2|||
162031206|NCT00592774|585170999|FG001|Overall Study|Lack of Efficacy|3|||
162031207|NCT00592774|585171000|FG002|Overall Study|Lack of Efficacy|0|||
162031208|NCT00592774|585171001|FG003|Overall Study|Lack of Efficacy|0|||
162031209|NCT00592774|585171002|FG004|Overall Study|Lack of Efficacy|2|||
161960722|NCT01071252|584902140|FG002|Overall Study|Withdrawal by Subject|1|||
162031210|NCT00592774|585170998|FG000|Overall Study|Physician Decision|0|||
161960723|NCT01071252|584902141|FG003|Overall Study|Withdrawal by Subject|2|||
161960724|NCT01071252|584902142|FG004|Overall Study|Withdrawal by Subject|3|||
161960725|NCT01071252|584902138|FG000|Overall Study|administrative problems|1|||
161960726|NCT01071252|584902139|FG001|Overall Study|administrative problems|1|||
161960727|NCT01071252|584902140|FG002|Overall Study|administrative problems|0|||
161960728|NCT01071252|584902141|FG003|Overall Study|administrative problems|2|||
161960729|NCT01071252|584902142|FG004|Overall Study|administrative problems|1|||
161960730|NCT01071252|584902138|FG000|Overall Study|Lost to Follow-up|1|||
161710704|NCT00190775|583984168|FG000|Overall Study|Lack of Efficacy|28|||
161710705|NCT00190775|583984169|FG001|Overall Study|Lack of Efficacy|32|||
161710706|NCT00190775|583984168|FG000|Overall Study|Lost to Follow-up|31|||
161710707|NCT00190775|583984169|FG001|Overall Study|Lost to Follow-up|23|||
161710708|NCT00190775|583984168|FG000|Overall Study|Participant Moved|0|||
161710709|NCT00190775|583984169|FG001|Overall Study|Participant Moved|1|||
161710710|NCT00190775|583984168|FG000|Overall Study|Withdrawal by Subject|24|||
161710711|NCT00190775|583984169|FG001|Overall Study|Withdrawal by Subject|13|||
161710712|NCT00190775|583984168|FG000|Overall Study|Sponsor Decision|1|||
161710713|NCT00190775|583984169|FG001|Overall Study|Sponsor Decision|0|||
161710714|NCT00190775|583984168|FG000|Overall Study|Physician Decision|3|||
161710715|NCT00190775|583984169|FG001|Overall Study|Physician Decision|0|||
161710716|NCT00190775|583984168|FG000|Overall Study|Noncompliance|3|||
161960731|NCT01071252|584902139|FG001|Overall Study|Lost to Follow-up|0|||
161960732|NCT01071252|584902140|FG002|Overall Study|Lost to Follow-up|1|||
161960733|NCT01071252|584902141|FG003|Overall Study|Lost to Follow-up|2|||
161960734|NCT01071252|584902142|FG004|Overall Study|Lost to Follow-up|0|||
161960735|NCT01071252|584902138|FG000|Overall Study|Adverse Event|1|||
161960736|NCT01071252|584902139|FG001|Overall Study|Adverse Event|1|||
161960737|NCT01071252|584902140|FG002|Overall Study|Adverse Event|0|||
161960738|NCT01071252|584902141|FG003|Overall Study|Adverse Event|1|||
161960739|NCT01071252|584902142|FG004|Overall Study|Adverse Event|0|||
161960740|NCT01071252|584902138|FG000|Overall Study|Death|0|||
161960741|NCT01071252|584902139|FG001|Overall Study|Death|0|||
161960742|NCT01071252|584902140|FG002|Overall Study|Death|0|||
161960743|NCT01071252|584902141|FG003|Overall Study|Death|0|||
162031211|NCT00592774|585170999|FG001|Overall Study|Physician Decision|1|||
161960744|NCT01071252|584902142|FG004|Overall Study|Death|1|||
161960745|NCT01066104|584902143|FG000|Overall Study|Adverse Event|1|||
161960746|NCT01066104|584902144|FG001|Overall Study|Adverse Event|1|||
161960747|NCT01066104|584902143|FG000|Overall Study|Protocol Violation|1|||
161710717|NCT00190775|583984169|FG001|Overall Study|Noncompliance|5|||
161960748|NCT01066104|584902144|FG001|Overall Study|Protocol Violation|0|||
161960749|NCT03902392|584902151|FG000|Overall Study|Lost to Follow-up|7|||
161960750|NCT03902392|584902152|FG001|Overall Study|Lost to Follow-up|7|||
161960751|NCT03745638|584902155|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
161960752|NCT03745638|584902156|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
161960753|NCT03745638|584902157|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
161960754|NCT03745638|584902158|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161960755|NCT03745638|584902159|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161960756|NCT03745638|584902160|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161960757|NCT03745638|584902161|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161960758|NCT03745638|584902155|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
161960759|NCT03745638|584902156|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161960760|NCT03745638|584902157|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161960761|NCT03745638|584902158|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161960762|NCT03745638|584902159|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161960763|NCT03745638|584902160|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161960764|NCT03745638|584902161|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161960765|NCT03745638|584902155|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
161960766|NCT03745638|584902156|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
161960767|NCT03745638|584902157|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
161960768|NCT03745638|584902158|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161960769|NCT03745638|584902159|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161960770|NCT03745638|584902160|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161960771|NCT03745638|584902161|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162031212|NCT00592774|585171000|FG002|Overall Study|Physician Decision|1|||
162031213|NCT00592774|585171001|FG003|Overall Study|Physician Decision|0|||
162031214|NCT00592774|585171002|FG004|Overall Study|Physician Decision|1|||
162031215|NCT00592774|585170998|FG000|Overall Study|Other|0|||
162031216|NCT00592774|585170999|FG001|Overall Study|Other|1|||
162031217|NCT00592774|585171000|FG002|Overall Study|Other|1|||
162031218|NCT00592774|585171001|FG003|Overall Study|Other|0|||
162031219|NCT00592774|585171002|FG004|Overall Study|Other|2|||
162031220|NCT01700439|585171003|FG000|Overall Study|Lost to Follow-up|47|||
162031221|NCT01700439|585171003|FG000|Overall Study|Withdrawal by Subject|183|||
162031222|NCT01700439|585171003|FG000|Overall Study|Death|186|||
162031223|NCT01892384|585171004|FG000|Overall Study|Withdrawal by Subject|1|||
162031224|NCT01892384|585171005|FG001|Overall Study|Withdrawal by Subject|1|||
162031225|NCT01892384|585171006|FG002|Overall Study|Withdrawal by Subject|0|||
162031226|NCT01892384|585171007|FG003|Overall Study|Withdrawal by Subject|0|||
162031227|NCT00621621|585171008|FG000|Overall Study|Subjects were exited at EP study|30|||
162031228|NCT00621621|585171009|FG001|Overall Study|Subjects were exited at EP study|0|||
162031229|NCT00053898|585171013|FG000|Overall Study|No follow-up data from any source|9|||
162031230|NCT00053898|585171014|FG001|Overall Study|No follow-up data from any source|12|||
162031231|NCT00053898|585171013|FG000|Overall Study|Follow-up from telephone contact only|5|||
162031232|NCT00053898|585171014|FG001|Overall Study|Follow-up from telephone contact only|1|||
162031233|NCT03985878|585171018|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
162031234|NCT03985878|585171018|FG000|Overall Study|Study Terminated by Sponsor|12|||
162031235|NCT03985878|585171018|FG000|Overall Study|Withdrawal by Subject|1|||
162031236|NCT02889562|585171019|FG000|Overall Study|Physician Decision|0|||
162031237|NCT02889562|585171020|FG001|Overall Study|Physician Decision|1|||
162031238|NCT02889562|585171019|FG000|Overall Study|Withdrawal by Subject|0|||
162031239|NCT02889562|585171020|FG001|Overall Study|Withdrawal by Subject|1|||
162031240|NCT04054947|585171024|FG000|Overall Study|Withdrawal by Subject|1|||
162031241|NCT04054947|585171025|FG001|Overall Study|Withdrawal by Subject|0|||
162031242|NCT04054947|585171024|FG000|Overall Study|Lost to Follow-up|2|||
162031243|NCT04054947|585171025|FG001|Overall Study|Lost to Follow-up|5|||
162031244|NCT01606878|585171026|FG000|Overall Study|Adverse Event|1|||
162031245|NCT01606878|585171027|FG001|Overall Study|Adverse Event|1|||
162031246|NCT01606878|585171028|FG002|Overall Study|Adverse Event|0|||
162031247|NCT01606878|585171029|FG003|Overall Study|Adverse Event|0|||
162031248|NCT01606878|585171030|FG004|Overall Study|Adverse Event|0|||
162031249|NCT01606878|585171031|FG005|Overall Study|Adverse Event|0|||
162031250|NCT01606878|585171032|FG006|Overall Study|Adverse Event|1|||
162031251|NCT01606878|585171033|FG007|Overall Study|Adverse Event|0|||
162031252|NCT01606878|585171034|FG008|Overall Study|Adverse Event|1|||
162031253|NCT01606878|585171035|FG009|Overall Study|Adverse Event|3|||
162031254|NCT01606878|585171036|FG010|Overall Study|Adverse Event|0|||
162031255|NCT01606878|585171026|FG000|Overall Study|Lack of Efficacy|1|||
162031256|NCT01606878|585171027|FG001|Overall Study|Lack of Efficacy|1|||
162031257|NCT01606878|585171028|FG002|Overall Study|Lack of Efficacy|1|||
162031258|NCT01606878|585171029|FG003|Overall Study|Lack of Efficacy|2|||
162031259|NCT01606878|585171030|FG004|Overall Study|Lack of Efficacy|1|||
161710718|NCT00190775|583984168|FG000|Overall Study|Protocol Violation|0|||
162031260|NCT01606878|585171031|FG005|Overall Study|Lack of Efficacy|2|||
162031261|NCT01606878|585171032|FG006|Overall Study|Lack of Efficacy|1|||
162031262|NCT01606878|585171033|FG007|Overall Study|Lack of Efficacy|2|||
162031263|NCT01606878|585171034|FG008|Overall Study|Lack of Efficacy|2|||
162031264|NCT01606878|585171035|FG009|Overall Study|Lack of Efficacy|0|||
162031265|NCT01606878|585171036|FG010|Overall Study|Lack of Efficacy|1|||
162031266|NCT01606878|585171026|FG000|Overall Study|Physician Decision|1|||
162031267|NCT01606878|585171027|FG001|Overall Study|Physician Decision|0|||
162031268|NCT01606878|585171028|FG002|Overall Study|Physician Decision|2|||
162031269|NCT01606878|585171029|FG003|Overall Study|Physician Decision|1|||
162031270|NCT01606878|585171030|FG004|Overall Study|Physician Decision|1|||
162031271|NCT01606878|585171031|FG005|Overall Study|Physician Decision|1|||
162031272|NCT01606878|585171032|FG006|Overall Study|Physician Decision|2|||
162031273|NCT01606878|585171033|FG007|Overall Study|Physician Decision|0|||
162031274|NCT01606878|585171034|FG008|Overall Study|Physician Decision|1|||
162031275|NCT01606878|585171035|FG009|Overall Study|Physician Decision|0|||
162031276|NCT01606878|585171036|FG010|Overall Study|Physician Decision|0|||
162031277|NCT01606878|585171026|FG000|Overall Study|Withdrawal by Subject|3|||
162031278|NCT01606878|585171027|FG001|Overall Study|Withdrawal by Subject|2|||
162031279|NCT01606878|585171028|FG002|Overall Study|Withdrawal by Subject|2|||
161710719|NCT00190775|583984169|FG001|Overall Study|Protocol Violation|1|||
161710720|NCT00190775|583984168|FG000|Overall Study|Exclusion Criteria Met|1|||
161710721|NCT00190775|583984169|FG001|Overall Study|Exclusion Criteria Met|3|||
161710722|NCT01794780|583984170|FG000|Overall Study|Adverse Event|0|||
161710723|NCT01794780|583984171|FG001|Overall Study|Adverse Event|1|||
161710724|NCT01794780|583984172|FG002|Overall Study|Adverse Event|2|||
161710725|NCT01794780|583984173|FG003|Overall Study|Adverse Event|0|||
161710726|NCT01794780|583984174|FG004|Overall Study|Adverse Event|0|||
161710727|NCT01794780|583984175|FG005|Overall Study|Adverse Event|0|||
161710728|NCT01794780|583984176|FG006|Overall Study|Adverse Event|0|||
161710729|NCT01794780|583984177|FG007|Overall Study|Adverse Event|0|||
161710730|NCT01794780|583984170|FG000|Overall Study|Death|0|||
161710731|NCT01794780|583984171|FG001|Overall Study|Death|2|||
161710732|NCT01794780|583984172|FG002|Overall Study|Death|14|||
161710733|NCT01794780|583984173|FG003|Overall Study|Death|1|||
161710734|NCT01794780|583984174|FG004|Overall Study|Death|0|||
161710735|NCT01794780|583984175|FG005|Overall Study|Death|9|||
161710736|NCT01794780|583984176|FG006|Overall Study|Death|4|||
161710737|NCT01794780|583984177|FG007|Overall Study|Death|0|||
161710738|NCT01794780|583984170|FG000|Overall Study|Lost to Follow-up|10|||
161710739|NCT01794780|583984171|FG001|Overall Study|Lost to Follow-up|64|||
161710740|NCT01794780|583984172|FG002|Overall Study|Lost to Follow-up|165|||
161710741|NCT01794780|583984173|FG003|Overall Study|Lost to Follow-up|53|||
161710742|NCT01794780|583984174|FG004|Overall Study|Lost to Follow-up|2|||
161710743|NCT01794780|583984175|FG005|Overall Study|Lost to Follow-up|99|||
161710744|NCT01794780|583984176|FG006|Overall Study|Lost to Follow-up|30|||
161710745|NCT01794780|583984177|FG007|Overall Study|Lost to Follow-up|5|||
161710746|NCT01794780|583984170|FG000|Overall Study|Withdrew informed consent|7|||
161710747|NCT01794780|583984171|FG001|Overall Study|Withdrew informed consent|17|||
161710748|NCT01794780|583984172|FG002|Overall Study|Withdrew informed consent|36|||
161710749|NCT01794780|583984173|FG003|Overall Study|Withdrew informed consent|9|||
161710750|NCT01794780|583984174|FG004|Overall Study|Withdrew informed consent|0|||
161710751|NCT01794780|583984175|FG005|Overall Study|Withdrew informed consent|48|||
161960772|NCT03745638|584902155|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
161710752|NCT01794780|583984176|FG006|Overall Study|Withdrew informed consent|4|||
161710753|NCT01794780|583984177|FG007|Overall Study|Withdrew informed consent|3|||
161710754|NCT01794780|583984170|FG000|Overall Study|Other|0|||
161710755|NCT01794780|583984171|FG001|Overall Study|Other|12|||
161710756|NCT01794780|583984172|FG002|Overall Study|Other|25|||
161710757|NCT01794780|583984173|FG003|Overall Study|Other|20|||
161710758|NCT01794780|583984174|FG004|Overall Study|Other|1|||
161710759|NCT01794780|583984175|FG005|Overall Study|Other|24|||
161960773|NCT03745638|584902156|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
161960774|NCT03745638|584902157|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161960775|NCT03745638|584902158|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161960776|NCT03745638|584902159|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161960777|NCT03745638|584902160|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161960778|NCT03745638|584902161|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161960779|NCT03745638|584902155|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
161960780|NCT03745638|584902156|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
161960781|NCT03745638|584902157|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
161960782|NCT03745638|584902158|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
161960783|NCT03745638|584902159|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
161960784|NCT03745638|584902160|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
161960785|NCT03745638|584902161|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
161960786|NCT03745638|584902155|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161960787|NCT03745638|584902156|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
161960788|NCT03745638|584902157|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161960789|NCT03745638|584902158|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161960790|NCT03745638|584902159|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161960791|NCT03745638|584902160|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161960792|NCT03745638|584902161|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161960793|NCT03745638|584902155|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
161960794|NCT03745638|584902156|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
161960795|NCT03745638|584902157|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
161960796|NCT03745638|584902158|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161960797|NCT03745638|584902159|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161960798|NCT03745638|584902160|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161960799|NCT03745638|584902161|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161960800|NCT03745638|584902155|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
161960801|NCT03745638|584902156|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
161960802|NCT03745638|584902157|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
161960803|NCT03745638|584902158|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
161960804|NCT03745638|584902159|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
161960805|NCT03745638|584902160|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
161960806|NCT03745638|584902161|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
161960807|NCT03745638|584902155|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161960808|NCT03745638|584902156|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161960809|NCT03745638|584902157|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161960810|NCT03745638|584902158|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161960811|NCT03745638|584902159|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161960812|NCT03745638|584902160|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
161960813|NCT03745638|584902161|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
161960814|NCT03745638|584902155|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161960815|NCT03745638|584902156|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161960816|NCT03745638|584902157|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161960817|NCT03745638|584902158|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
161960818|NCT03745638|584902159|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161960819|NCT03745638|584902160|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
161960820|NCT03745638|584902161|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
161960821|NCT03745638|584902155|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161960822|NCT03745638|584902156|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161960823|NCT03745638|584902157|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161960824|NCT03745638|584902158|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
161960825|NCT03745638|584902159|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
161960826|NCT03745638|584902160|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
161960827|NCT03745638|584902161|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
161960828|NCT03745638|584902155|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161960829|NCT03745638|584902156|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161710760|NCT01794780|583984176|FG006|Overall Study|Other|4|||
161710761|NCT01794780|583984177|FG007|Overall Study|Other|1|||
161710762|NCT00519077|583984178|FG000|Overall Study|Death|6|||
161710763|NCT00519077|583984178|FG000|Overall Study|Other|2|||
161710764|NCT02286102|583984180|FG000|Overall Study|Screen Failure|1|||
161710765|NCT02286102|583984181|FG001|Overall Study|Screen Failure|1|||
161710766|NCT01967225|583984182|FG000|Overall Study|Adverse Event|3|||
161710767|NCT01967225|583984183|FG001|Overall Study|Adverse Event|1|||
161960830|NCT03745638|584902157|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161960831|NCT03745638|584902158|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161960832|NCT03745638|584902159|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
161960833|NCT03745638|584902160|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
161960834|NCT03745638|584902161|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161960835|NCT03745638|584902155|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161960836|NCT03745638|584902156|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161960837|NCT03745638|584902157|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161960838|NCT03745638|584902158|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161960839|NCT03745638|584902159|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161960840|NCT03745638|584902160|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
161710768|NCT01967225|583984182|FG000|Overall Study|Withdrawal by Subject|2|||
161960841|NCT03745638|584902161|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161960842|NCT03745638|584902155|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161960843|NCT03745638|584902156|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161960844|NCT03745638|584902157|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161960845|NCT03745638|584902158|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
161960846|NCT03745638|584902159|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
161960847|NCT03745638|584902160|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
161960848|NCT03745638|584902161|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
161960849|NCT03745638|584902155|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
161960850|NCT03745638|584902156|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
161960851|NCT03745638|584902157|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
161960852|NCT03745638|584902158|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
161960853|NCT03745638|584902159|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
161960854|NCT03745638|584902160|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
161960855|NCT03745638|584902161|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
161960856|NCT02467192|584902170|FG000|Overall Study|Death|1|||
161710769|NCT01967225|583984183|FG001|Overall Study|Withdrawal by Subject|1|||
161710770|NCT01967225|583984182|FG000|Overall Study|Lack of Efficacy|1|||
161710771|NCT01967225|583984183|FG001|Overall Study|Lack of Efficacy|1|||
161710772|NCT01967225|583984182|FG000|Overall Study|Switching to other therapy|2|||
161710773|NCT01967225|583984183|FG001|Overall Study|Switching to other therapy|0|||
161710774|NCT01967225|583984182|FG000|Overall Study|Protocol driven decision point|1|||
161710775|NCT01967225|583984183|FG001|Overall Study|Protocol driven decision point|0|||
161710776|NCT01967225|583984182|FG000|Overall Study|Logistical difficulties|1|||
161710777|NCT01967225|583984183|FG001|Overall Study|Logistical difficulties|0|||
161710778|NCT01967225|583984182|FG000|Overall Study|Protocol Violation|2|||
161710779|NCT01967225|583984183|FG001|Overall Study|Protocol Violation|0|||
161710780|NCT00327444|583984184|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
161710781|NCT00327444|583984185|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
161710782|NCT00327444|583984184|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
161710783|NCT00327444|583984185|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
161710784|NCT00327444|583984184|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
161710785|NCT00327444|583984185|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
161710786|NCT00327444|583984184|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
161960857|NCT02467192|584902170|FG000|Overall Study|revealed to have pneumonia before|2|||
161960858|NCT03213938|584902171|FG000|Overall Study|Lost to Follow-up|4|||
161960859|NCT03213938|584902172|FG001|Overall Study|Lost to Follow-up|3|||
161960860|NCT03213938|584902171|FG000|Overall Study|Lack of Efficacy|1|||
161960861|NCT03213938|584902172|FG001|Overall Study|Lack of Efficacy|0|||
161960862|NCT03213938|584902171|FG000|Overall Study|Decline to participate|5|||
161960863|NCT03213938|584902172|FG001|Overall Study|Decline to participate|4|||
161960864|NCT03213938|584902171|FG000|Overall Study|Without reason|4|||
161960865|NCT03213938|584902172|FG001|Overall Study|Without reason|5|||
161960866|NCT01814046|584902174|FG000|Drug Administration|Death due to complications of RSV|1|||
161960867|NCT01814046|584902175|FG001|Drug Administration|Death due to complications of RSV|0|||
161960868|NCT01814046|584902176|FG002|Drug Administration|Death due to complications of RSV|0|||
161960869|NCT00958347|584902177|FG000|Overall Study|Death|43|||
161960870|NCT00958347|584902177|FG000|Overall Study|Withdrawal by Subject|23|||
161960871|NCT00958347|584902177|FG000|Overall Study|Lost to Follow-up|15|||
161960872|NCT00958347|584902177|FG000|Overall Study|revision/removal|10|||
161960873|NCT00958347|584902177|FG000|Overall Study|study termination|135|||
161960874|NCT04552288|584902180|FG000|Overall Study|Death|3|||
161960875|NCT04552288|584902180|FG000|Overall Study|Lost to Follow-up|6|||
161960876|NCT04552288|584902180|FG000|Overall Study|Physician Decision|3|||
162031280|NCT01606878|585171029|FG003|Overall Study|Withdrawal by Subject|0|||
162031281|NCT01606878|585171030|FG004|Overall Study|Withdrawal by Subject|1|||
161710787|NCT00327444|583984185|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
161710788|NCT00327444|583984184|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
161710789|NCT00327444|583984185|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
161710790|NCT00327444|583984184|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
161710791|NCT00327444|583984185|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
161710792|NCT00327444|583984184|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
161710793|NCT00327444|583984185|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
161710794|NCT00327444|583984184|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
161710795|NCT00327444|583984185|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
161710796|NCT01658514|583984187|FG000|Overall Study|Protocol Violation|1|||
161710797|NCT01658514|583984188|FG001|Overall Study|Protocol Violation|0|||
161710798|NCT01658514|583984189|FG002|Overall Study|Protocol Violation|2|||
161710799|NCT00144170|583984191|FG000|Overall Study|Adverse Event|84|||
161710800|NCT00144170|583984192|FG001|Overall Study|Adverse Event|41|||
161710801|NCT00144170|583984191|FG000|Overall Study|Protocol Violation|23|||
161710802|NCT00144170|583984192|FG001|Overall Study|Protocol Violation|16|||
161710803|NCT00144170|583984191|FG000|Overall Study|Lost to Follow-up|5|||
161710804|NCT00144170|583984192|FG001|Overall Study|Lost to Follow-up|10|||
161710805|NCT00144170|583984191|FG000|Overall Study|Withdrawal by Subject|29|||
161710806|NCT00144170|583984192|FG001|Overall Study|Withdrawal by Subject|13|||
161710807|NCT00144170|583984191|FG000|Overall Study|Other reason not defined above|211|||
161710808|NCT00144170|583984192|FG001|Overall Study|Other reason not defined above|316|||
161710809|NCT00981526|583984193|FG000|Overall Study|Withdrawal by Subject|0|||
161710810|NCT00981526|583984194|FG001|Overall Study|Withdrawal by Subject|2|||
161710811|NCT00981526|583984193|FG000|Overall Study|Physician Decision|4|||
161710812|NCT00981526|583984194|FG001|Overall Study|Physician Decision|4|||
161710813|NCT00332202|583984195|FG000|Overall Study|Adverse Event|72|||
161710814|NCT00332202|583984196|FG001|Overall Study|Adverse Event|28|||
161710815|NCT00332202|583984195|FG000|Overall Study|Lost to Follow-up|2|||
161710816|NCT00332202|583984196|FG001|Overall Study|Lost to Follow-up|1|||
161710817|NCT00332202|583984195|FG000|Overall Study|Physician Decision|6|||
161710818|NCT00332202|583984196|FG001|Overall Study|Physician Decision|8|||
161710819|NCT00332202|583984195|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
161710820|NCT00332202|583984196|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
161710821|NCT00332202|583984195|FG000|Overall Study|Protocol Violation|7|||
161710822|NCT00332202|583984196|FG001|Overall Study|Protocol Violation|2|||
161710823|NCT00332202|583984195|FG000|Overall Study|Sponsor Decision|1|||
161710824|NCT00332202|583984196|FG001|Overall Study|Sponsor Decision|2|||
161710825|NCT00332202|583984195|FG000|Overall Study|Withdrawal by Subject|36|||
161710826|NCT00332202|583984196|FG001|Overall Study|Withdrawal by Subject|17|||
161710827|NCT00332202|583984195|FG000|Overall Study|Progressive Disease|106|||
161710828|NCT00332202|583984196|FG001|Overall Study|Progressive Disease|60|||
161710829|NCT00332202|583984195|FG000|Overall Study|Death|5|||
161710830|NCT00332202|583984196|FG001|Overall Study|Death|2|||
161710831|NCT00957853|583984197|FG000|Overall Study|Withdrawal by Subject|1|||
161710832|NCT00957853|583984198|FG001|Overall Study|Withdrawal by Subject|0|||
161710833|NCT00957853|583984199|FG002|Overall Study|Withdrawal by Subject|0|||
161710834|NCT02370121|583984200|FG000|Overall Study|Lost to Follow-up|1|||
161710835|NCT02370121|583984201|FG001|Overall Study|Lost to Follow-up|1|||
161710836|NCT02654002|583984208|FG000|Overall Study|Adverse Event|0|||
161710837|NCT02654002|583984209|FG001|Overall Study|Adverse Event|0|||
161710838|NCT02654002|583984210|FG002|Overall Study|Adverse Event|0|||
161710839|NCT02654002|583984211|FG003|Overall Study|Adverse Event|0|||
161960877|NCT04552288|584902180|FG000|Overall Study|Protocol Violation|9|||
161960878|NCT04552288|584902180|FG000|Overall Study|Withdrawal by Subject|6|||
161960879|NCT04552288|584902180|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
161960880|NCT00375505|584902181|FG000|Overall Study|Adverse Event|1|||
161960881|NCT00375505|584902182|FG001|Overall Study|Adverse Event|2|||
161960882|NCT00005947|584902183|FG000|Overall Study|Death|54|||
161710840|NCT02654002|583984212|FG004|Overall Study|Adverse Event|0|||
161710841|NCT02654002|583984213|FG005|Overall Study|Adverse Event|0|||
161710842|NCT02654002|583984214|FG006|Overall Study|Adverse Event|1|||
161710843|NCT02654002|583984215|FG007|Overall Study|Adverse Event|0|||
161710844|NCT02654002|583984216|FG008|Overall Study|Adverse Event|0|||
161710845|NCT02654002|583984208|FG000|Overall Study|Withdrew Consent|0|||
161710846|NCT02654002|583984209|FG001|Overall Study|Withdrew Consent|0|||
161710847|NCT02654002|583984210|FG002|Overall Study|Withdrew Consent|0|||
161710848|NCT02654002|583984211|FG003|Overall Study|Withdrew Consent|0|||
161710849|NCT02654002|583984212|FG004|Overall Study|Withdrew Consent|0|||
161710850|NCT02654002|583984213|FG005|Overall Study|Withdrew Consent|1|||
161710851|NCT02654002|583984214|FG006|Overall Study|Withdrew Consent|0|||
161710852|NCT02654002|583984215|FG007|Overall Study|Withdrew Consent|1|||
161710853|NCT02654002|583984216|FG008|Overall Study|Withdrew Consent|0|||
161710854|NCT05262764|583984217|FG000|Overall Study|Case report form not collected|9|||
161710855|NCT05262764|583984217|FG000|Overall Study|No patient visits after entry|23|||
161710856|NCT05262764|583984217|FG000|Overall Study|Registration rule not followed|2|||
161710857|NCT05262764|583984217|FG000|Overall Study|Patient of non-chronic heart failure|1|||
161710858|NCT01392183|583984218|FG000|First Drug Administration|Adverse Event|3|||
161710859|NCT01392183|583984219|FG001|First Drug Administration|Adverse Event|2|||
161710860|NCT01392183|583984218|FG000|First Drug Administration|Death|1|||
161710861|NCT01392183|583984219|FG001|First Drug Administration|Death|0|||
161710862|NCT01392183|583984218|FG000|First Drug Administration|Withdrawal by Subject|10|||
161710863|NCT01392183|583984219|FG001|First Drug Administration|Withdrawal by Subject|17|||
161710864|NCT00963807|583984222|FG000|Overall Study|Physician Decision|2|||
161710865|NCT00963807|583984222|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
161710866|NCT00963807|583984222|FG000|Overall Study|Disease progression|15|||
161960883|NCT00005947|584902184|FG001|Overall Study|Death|40|||
161960884|NCT00005947|584902183|FG000|Overall Study|Patient Refused to Continue|2|||
161960885|NCT00005947|584902184|FG001|Overall Study|Patient Refused to Continue|1|||
161960886|NCT00005947|584902183|FG000|Overall Study|Site Closure|1|||
161960887|NCT00005947|584902184|FG001|Overall Study|Site Closure|0|||
161960888|NCT00429182|584902185|FG000|Overall Study|Not evaluable, Disease Progression|2|||
161960889|NCT00429182|584902185|FG000|Overall Study|Not eligible|5|||
161960890|NCT02146131|584902186|FG000|Overall Study|Physician Decision|61|||
161960891|NCT02146131|584902187|FG001|Overall Study|Physician Decision|56|||
161960892|NCT03335150|584902190|FG000|Overall Study|Withdrawal by Subject|10|||
161960893|NCT03335150|584902191|FG001|Overall Study|Withdrawal by Subject|4|||
161960894|NCT03335150|584902190|FG000|Overall Study|Adverse Event|0|||
161960895|NCT03335150|584902191|FG001|Overall Study|Adverse Event|1|||
161960896|NCT02218697|584902196|FG000|Overall Study|Adverse Event|0|||
161960897|NCT02218697|584902197|FG001|Overall Study|Adverse Event|2|||
162031282|NCT01606878|585171031|FG005|Overall Study|Withdrawal by Subject|1|||
161710867|NCT00684177|583984225|FG000|Overall Study|Adverse Event|4|||
161710868|NCT00684177|583984226|FG001|Overall Study|Adverse Event|3|||
161710869|NCT00684177|583984225|FG000|Overall Study|Lack of Efficacy|10|||
161710870|NCT00684177|583984226|FG001|Overall Study|Lack of Efficacy|15|||
161710871|NCT00684177|583984225|FG000|Overall Study|Protocol Violation|1|||
161710872|NCT00684177|583984226|FG001|Overall Study|Protocol Violation|0|||
161710873|NCT00684177|583984225|FG000|Overall Study|Lost to Follow-up|2|||
161960898|NCT02218697|584902196|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
161960899|NCT02218697|584902197|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
161960900|NCT02218697|584902196|FG000|Overall Study|Withdrawal by Subject|2|||
161960901|NCT02218697|584902197|FG001|Overall Study|Withdrawal by Subject|3|||
161960902|NCT02142803|584902200|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
161960903|NCT02142803|584902201|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
161960904|NCT02142803|584902202|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
161960905|NCT02142803|584902203|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
161960906|NCT05111002|584902206|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
161960907|NCT05111002|584902207|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
161960908|NCT05111002|584902206|FG000|Secondary Outcome|Lost to Follow-up|1|||
161960909|NCT05111002|584902207|FG001|Secondary Outcome|Lost to Follow-up|0|||
161960910|NCT04380753|584902208|FG000|Overall Study|Participants continuing study|4|||
161960911|NCT04380753|584902208|FG000|Overall Study|Death|2|||
161960912|NCT00809926|584902209|FG000|Overall Study|Adverse Event|18|||
161960913|NCT00809926|584902210|FG001|Overall Study|Adverse Event|10|||
161960914|NCT00809926|584902209|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
161960915|NCT00809926|584902210|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161960916|NCT00809926|584902209|FG000|Overall Study|Patient withdrew consent|8|||
161960917|NCT00809926|584902210|FG001|Overall Study|Patient withdrew consent|6|||
161960918|NCT00809926|584902209|FG000|Overall Study|Lost to Follow-up|2|||
161960919|NCT00809926|584902210|FG001|Overall Study|Lost to Follow-up|1|||
161960920|NCT00809926|584902209|FG000|Overall Study|Administrative Problems|0|||
161960921|NCT00809926|584902210|FG001|Overall Study|Administrative Problems|1|||
161710874|NCT00684177|583984226|FG001|Overall Study|Lost to Follow-up|1|||
161960922|NCT00809926|584902209|FG000|Overall Study|Protocol deviation|0|||
161960923|NCT00809926|584902210|FG001|Overall Study|Protocol deviation|2|||
161960924|NCT04776720|584902215|FG000|Overall Study|COVID Related|4|||
161960925|NCT04776720|584902216|FG001|Overall Study|COVID Related|2|||
161960926|NCT04776720|584902215|FG000|Overall Study|Adverse Event|2|||
161960927|NCT04776720|584902216|FG001|Overall Study|Adverse Event|0|||
161960928|NCT04776720|584902215|FG000|Overall Study|Serious Adverse Event|0|||
161960929|NCT04776720|584902216|FG001|Overall Study|Serious Adverse Event|1|||
161960930|NCT04776720|584902215|FG000|Overall Study|Too Busy|3|||
161960931|NCT04776720|584902216|FG001|Overall Study|Too Busy|1|||
161960932|NCT04776720|584902215|FG000|Overall Study|Lost to Follow-up|1|||
161960933|NCT04776720|584902216|FG001|Overall Study|Lost to Follow-up|2|||
161960934|NCT04776720|584902215|FG000|Overall Study|Family|2|||
161960935|NCT04776720|584902216|FG001|Overall Study|Family|2|||
161960936|NCT04776720|584902215|FG000|Overall Study|No remote technology access|0|||
161960937|NCT04776720|584902216|FG001|Overall Study|No remote technology access|1|||
161960938|NCT04776720|584902215|FG000|Overall Study|Withdrawal by Subject|1|||
161960939|NCT04776720|584902216|FG001|Overall Study|Withdrawal by Subject|0|||
161960940|NCT04776720|584902215|FG000|Overall Study|Cannot tolerate intervention|1|||
161960941|NCT04776720|584902216|FG001|Overall Study|Cannot tolerate intervention|0|||
161960942|NCT04776720|584902215|FG000|Overall Study|Incomplete outcome data|6|||
161960943|NCT04776720|584902216|FG001|Overall Study|Incomplete outcome data|1|||
161960944|NCT05356910|584902217|FG000|Overall Study|Lost to Follow-up|10|||
161960945|NCT05356910|584902218|FG001|Overall Study|Lost to Follow-up|19|||
161960946|NCT05356910|584902219|FG002|Overall Study|Lost to Follow-up|0|||
161960947|NCT05356910|584902220|FG003|Overall Study|Lost to Follow-up|0|||
161960948|NCT05356910|584902217|FG000|Overall Study|Withdrawal by Subject|4|||
161960949|NCT05356910|584902218|FG001|Overall Study|Withdrawal by Subject|2|||
161960950|NCT05356910|584902219|FG002|Overall Study|Withdrawal by Subject|0|||
161710875|NCT00684177|583984225|FG000|Overall Study|Physician Decision|2|||
161710876|NCT00684177|583984226|FG001|Overall Study|Physician Decision|0|||
161710877|NCT00684177|583984225|FG000|Overall Study|Withdrawal by Subject|1|||
161710878|NCT00684177|583984226|FG001|Overall Study|Withdrawal by Subject|2|||
161710879|NCT00684177|583984225|FG000|Overall Study|Other|1|||
161710880|NCT00684177|583984226|FG001|Overall Study|Other|2|||
161710881|NCT00075881|583985741|FG000|Overall Study|Lack of Efficacy|18|||
161710882|NCT00075881|583985741|FG000|Overall Study|Adverse Event|7|||
161710883|NCT00075881|583985741|FG000|Overall Study|Death|1|||
161710884|NCT00075881|583985741|FG000|Overall Study|Withdrawal by Subject|2|||
161710885|NCT00075881|583985741|FG000|Overall Study|Protocol Violation|4|||
161710886|NCT00075881|583985741|FG000|Overall Study|other complicating disease|3|||
161710887|NCT00075881|583985741|FG000|Overall Study|other|4|||
161710888|NCT00075881|583985741|FG000|Overall Study|missing data|2|||
161710889|NCT00075881|583985741|FG000|Overall Study|Ineligible|1|||
161710890|NCT00075881|583985741|FG000|Overall Study|never start protocol therapy|1|||
161710891|NCT02224664|583985742|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
161710892|NCT02224664|583985743|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
161710893|NCT02224664|583985744|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
161710894|NCT02224664|583985745|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
161710895|NCT02224664|583985746|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
161710896|NCT02224664|583985742|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
161710897|NCT02224664|583985743|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
161710898|NCT02224664|583985744|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
161710899|NCT02224664|583985745|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
161710900|NCT02224664|583985746|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
161710901|NCT02224664|583985742|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
161710902|NCT02224664|583985743|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
161960951|NCT05356910|584902220|FG003|Overall Study|Withdrawal by Subject|0|||
161960952|NCT02712996|584902224|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
161960953|NCT02712996|584902225|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
161960954|NCT01451749|584902226|FG000|Overall Study|Protocol Violation|14|||
161710903|NCT02224664|583985744|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
161710904|NCT02224664|583985745|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
161710905|NCT02224664|583985746|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
161710906|NCT00828464|583985756|FG000|Overall Study|Withdrawal by Subject|1|||
161960955|NCT01451749|584902227|FG001|Overall Study|Protocol Violation|7|||
161960956|NCT01451749|584902226|FG000|Overall Study|Lost to Follow-up|15|||
161710907|NCT00474240|583985757|FG000|Overall Study|Withdrawal by Subject|1|||
161710908|NCT00474240|583985758|FG001|Overall Study|Withdrawal by Subject|1|||
161710909|NCT00474240|583985759|FG002|Overall Study|Withdrawal by Subject|0|||
161710910|NCT00474240|583985760|FG003|Overall Study|Withdrawal by Subject|2|||
161710911|NCT00474240|583985761|FG004|Overall Study|Withdrawal by Subject|3|||
161710912|NCT00474240|583985762|FG005|Overall Study|Withdrawal by Subject|1|||
161710913|NCT00474240|583985757|FG000|Overall Study|Adverse Event|0|||
161710914|NCT00474240|583985758|FG001|Overall Study|Adverse Event|0|||
161710915|NCT00474240|583985759|FG002|Overall Study|Adverse Event|9|||
161710916|NCT00474240|583985760|FG003|Overall Study|Adverse Event|14|||
161710917|NCT00474240|583985761|FG004|Overall Study|Adverse Event|5|||
161710918|NCT00474240|583985762|FG005|Overall Study|Adverse Event|16|||
161710919|NCT00474240|583985757|FG000|Overall Study|Removed due to lab value|0|||
161710920|NCT00474240|583985758|FG001|Overall Study|Removed due to lab value|0|||
161710921|NCT00474240|583985759|FG002|Overall Study|Removed due to lab value|0|||
161710922|NCT00474240|583985760|FG003|Overall Study|Removed due to lab value|0|||
161710923|NCT00474240|583985761|FG004|Overall Study|Removed due to lab value|0|||
161710924|NCT00474240|583985762|FG005|Overall Study|Removed due to lab value|1|||
161710925|NCT02197377|583985763|FG000|Overall Study|Insertion Failure|0|||
161710926|NCT02197377|583985764|FG001|Overall Study|Insertion Failure|3|||
161710927|NCT00502840|583985765|FG000|Overall Study|Adverse Event|5|||
161710928|NCT00502840|583985765|FG000|Overall Study|Additional or changed therapy|48|||
161710929|NCT00502840|583985765|FG000|Overall Study|Lack of Efficacy|11|||
161710930|NCT00502840|583985765|FG000|Overall Study|Protocol Violation|4|||
161710931|NCT00502840|583985765|FG000|Overall Study|Withdrawal by Subject|5|||
161710932|NCT00502840|583985765|FG000|Overall Study|Lost to Follow-up|6|||
161710933|NCT00502840|583985765|FG000|Overall Study|Administrative problems|1|||
161710934|NCT00502840|583985765|FG000|Overall Study|Other|20|||
161710935|NCT00809133|583985766|FG000|Overall Study|Progressive disease|2|||
161710936|NCT00809133|583985767|FG001|Overall Study|Progressive disease|5|||
161710937|NCT00809133|583985768|FG002|Overall Study|Progressive disease|5|||
161710938|NCT00809133|583985769|FG003|Overall Study|Progressive disease|3|||
161710939|NCT00809133|583985770|FG004|Overall Study|Progressive disease|4|||
161710940|NCT00809133|583985771|FG005|Overall Study|Progressive disease|1|||
161710941|NCT00809133|583985772|FG006|Overall Study|Progressive disease|3|||
161710942|NCT00809133|583985773|FG007|Overall Study|Progressive disease|3|||
161710943|NCT00809133|583985774|FG008|Overall Study|Progressive disease|3|||
161710944|NCT00809133|583985775|FG009|Overall Study|Progressive disease|9|||
161710945|NCT00809133|583985776|FG010|Overall Study|Progressive disease|5|||
161710946|NCT00809133|583985777|FG011|Overall Study|Progressive disease|7|||
161710947|NCT00809133|583985778|FG012|Overall Study|Progressive disease|5|||
161710948|NCT00809133|583985779|FG013|Overall Study|Progressive disease|4|||
161710949|NCT00809133|583985766|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710950|NCT00809133|583985767|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710951|NCT00809133|583985768|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710952|NCT00809133|583985769|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710953|NCT00809133|583985770|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710954|NCT00809133|583985771|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161710955|NCT00809133|583985772|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161710956|NCT00809133|583985773|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161710957|NCT00809133|583985774|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710958|NCT00809133|583985775|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710959|NCT00809133|583985776|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710960|NCT00809133|583985777|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161710961|NCT00809133|583985778|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162031283|NCT01606878|585171032|FG006|Overall Study|Withdrawal by Subject|2|||
162031284|NCT01606878|585171033|FG007|Overall Study|Withdrawal by Subject|1|||
162031285|NCT01606878|585171034|FG008|Overall Study|Withdrawal by Subject|2|||
162031286|NCT01606878|585171035|FG009|Overall Study|Withdrawal by Subject|0|||
162031287|NCT01606878|585171036|FG010|Overall Study|Withdrawal by Subject|2|||
162031288|NCT03720652|585171037|FG000|Overall Study|Withdrawal by Subject|2|||
162031289|NCT03720652|585171038|FG001|Overall Study|Withdrawal by Subject|7|||
162031290|NCT03720652|585171037|FG000|Overall Study|Lost to Follow-up|0|||
162031291|NCT03720652|585171038|FG001|Overall Study|Lost to Follow-up|4|||
162031292|NCT00604214|585171041|FG000|Baseline to Day 28|Death|223|||
162031293|NCT00604214|585171042|FG001|Baseline to Day 28|Death|202|||
162031294|NCT00604214|585171041|FG000|Baseline to Day 28|Lost to Follow-up|2|||
162031295|NCT00604214|585171042|FG001|Baseline to Day 28|Lost to Follow-up|4|||
162031296|NCT00604214|585171041|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
162031297|NCT00604214|585171042|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
162031298|NCT00604214|585171041|FG000|Day 29 to Day 90|Death|64|||
162031299|NCT00604214|585171042|FG001|Day 29 to Day 90|Death|67|||
161710962|NCT00809133|583985779|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161710963|NCT00809133|583985766|FG000|Overall Study|Other adverse event|1|||
162031300|NCT00604214|585171041|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
162031301|NCT00604214|585171042|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
162031302|NCT00604214|585171041|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
162031303|NCT00604214|585171042|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
162031304|NCT00604214|585171041|FG000|Day 91 to Day 180|Death|19|||
162031305|NCT00604214|585171042|FG001|Day 91 to Day 180|Death|23|||
162031306|NCT00604214|585171041|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
162031307|NCT00604214|585171042|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
161710964|NCT00809133|583985767|FG001|Overall Study|Other adverse event|1|||
161710965|NCT00809133|583985768|FG002|Overall Study|Other adverse event|1|||
161710966|NCT00809133|583985769|FG003|Overall Study|Other adverse event|0|||
161710967|NCT00809133|583985770|FG004|Overall Study|Other adverse event|0|||
161710968|NCT00809133|583985771|FG005|Overall Study|Other adverse event|3|||
161710969|NCT00809133|583985772|FG006|Overall Study|Other adverse event|2|||
161710970|NCT00809133|583985773|FG007|Overall Study|Other adverse event|4|||
161710971|NCT00809133|583985774|FG008|Overall Study|Other adverse event|0|||
161710972|NCT00809133|583985775|FG009|Overall Study|Other adverse event|0|||
161710973|NCT00809133|583985776|FG010|Overall Study|Other adverse event|1|||
161710974|NCT00809133|583985777|FG011|Overall Study|Other adverse event|1|||
161710975|NCT00809133|583985778|FG012|Overall Study|Other adverse event|0|||
161710976|NCT00809133|583985779|FG013|Overall Study|Other adverse event|1|||
161710977|NCT00809133|583985766|FG000|Overall Study|Lost to Follow-up|0|||
161710978|NCT00809133|583985767|FG001|Overall Study|Lost to Follow-up|0|||
161710979|NCT00809133|583985768|FG002|Overall Study|Lost to Follow-up|0|||
161710980|NCT00809133|583985769|FG003|Overall Study|Lost to Follow-up|0|||
161710981|NCT00809133|583985770|FG004|Overall Study|Lost to Follow-up|0|||
161710982|NCT00809133|583985771|FG005|Overall Study|Lost to Follow-up|1|||
161710983|NCT00809133|583985772|FG006|Overall Study|Lost to Follow-up|0|||
161710984|NCT00809133|583985773|FG007|Overall Study|Lost to Follow-up|0|||
161710985|NCT00809133|583985774|FG008|Overall Study|Lost to Follow-up|0|||
161710986|NCT00809133|583985775|FG009|Overall Study|Lost to Follow-up|0|||
161710987|NCT00809133|583985776|FG010|Overall Study|Lost to Follow-up|0|||
161710988|NCT00809133|583985777|FG011|Overall Study|Lost to Follow-up|0|||
161710989|NCT00809133|583985778|FG012|Overall Study|Lost to Follow-up|0|||
161710990|NCT00809133|583985779|FG013|Overall Study|Lost to Follow-up|0|||
161710991|NCT00809133|583985766|FG000|Overall Study|Consent withdrawn|0|||
161710992|NCT00809133|583985767|FG001|Overall Study|Consent withdrawn|0|||
161710993|NCT00809133|583985768|FG002|Overall Study|Consent withdrawn|0|||
161710994|NCT00809133|583985769|FG003|Overall Study|Consent withdrawn|0|||
161710995|NCT00809133|583985770|FG004|Overall Study|Consent withdrawn|1|||
161710996|NCT00809133|583985771|FG005|Overall Study|Consent withdrawn|0|||
161710997|NCT00809133|583985772|FG006|Overall Study|Consent withdrawn|0|||
161710998|NCT00809133|583985773|FG007|Overall Study|Consent withdrawn|0|||
161710999|NCT00809133|583985774|FG008|Overall Study|Consent withdrawn|0|||
161711000|NCT00809133|583985775|FG009|Overall Study|Consent withdrawn|0|||
161711001|NCT00809133|583985776|FG010|Overall Study|Consent withdrawn|0|||
161711002|NCT00809133|583985777|FG011|Overall Study|Consent withdrawn|0|||
161711003|NCT00809133|583985778|FG012|Overall Study|Consent withdrawn|0|||
161711004|NCT00809133|583985779|FG013|Overall Study|Consent withdrawn|0|||
161711005|NCT00809133|583985766|FG000|Overall Study|Other not mentioned above|0|||
161711006|NCT00809133|583985767|FG001|Overall Study|Other not mentioned above|1|||
161711007|NCT00809133|583985768|FG002|Overall Study|Other not mentioned above|0|||
161711008|NCT00809133|583985769|FG003|Overall Study|Other not mentioned above|0|||
161711009|NCT00809133|583985770|FG004|Overall Study|Other not mentioned above|0|||
161711010|NCT00809133|583985771|FG005|Overall Study|Other not mentioned above|1|||
161711011|NCT00809133|583985772|FG006|Overall Study|Other not mentioned above|0|||
161711012|NCT00809133|583985773|FG007|Overall Study|Other not mentioned above|0|||
161711013|NCT00809133|583985774|FG008|Overall Study|Other not mentioned above|0|||
161711014|NCT00809133|583985775|FG009|Overall Study|Other not mentioned above|0|||
161960957|NCT01451749|584902227|FG001|Overall Study|Lost to Follow-up|5|||
161960958|NCT01451749|584902226|FG000|Overall Study|Meet the exclusion criteria,and|1|||
161960959|NCT01451749|584902227|FG001|Overall Study|Meet the exclusion criteria,and|1|||
161960960|NCT01451749|584902226|FG000|Overall Study|Adverse Event|2|||
161960961|NCT01451749|584902227|FG001|Overall Study|Adverse Event|0|||
161960962|NCT01451749|584902226|FG000|Overall Study|Withdrawal by Subject|0|||
161960963|NCT01451749|584902227|FG001|Overall Study|Withdrawal by Subject|1|||
161960964|NCT00972517|584902230|FG000|Overall Study|Adverse Event|0|||
161960965|NCT00972517|584902231|FG001|Overall Study|Adverse Event|0|||
161960966|NCT00972517|584902232|FG002|Overall Study|Adverse Event|0|||
161960967|NCT00972517|584902233|FG003|Overall Study|Adverse Event|1|||
161960968|NCT00972517|584902234|FG004|Overall Study|Adverse Event|0|||
161960969|NCT00972517|584902235|FG005|Overall Study|Adverse Event|0|||
161711015|NCT00809133|583985776|FG010|Overall Study|Other not mentioned above|0|||
161711016|NCT00809133|583985777|FG011|Overall Study|Other not mentioned above|0|||
161711017|NCT00809133|583985778|FG012|Overall Study|Other not mentioned above|0|||
161711018|NCT00809133|583985779|FG013|Overall Study|Other not mentioned above|0|||
161711019|NCT03093155|583985781|FG000|Overall Study|Not Eligible|1|||
161711020|NCT03093155|583985782|FG001|Overall Study|Not Eligible|0|||
161960970|NCT00972517|584902230|FG000|Overall Study|Withdrawal by Subject|0|||
161960971|NCT00972517|584902231|FG001|Overall Study|Withdrawal by Subject|1|||
161711021|NCT03093155|583985781|FG000|Overall Study|Withdrawal by Subject|0|||
161711022|NCT03093155|583985782|FG001|Overall Study|Withdrawal by Subject|1|||
161711023|NCT01700829|583985783|FG000|Overall Study|Withdrawal by Subject|1|||
161711024|NCT01700829|583985784|FG001|Overall Study|Withdrawal by Subject|1|||
161711025|NCT01075178|583985785|FG000|Subject Matching|eligible but not matched|130|||
161711026|NCT01075178|583985786|FG001|Subject Matching|eligible but not matched|403|||
161711027|NCT01075178|583985785|FG000|Subject Chart Review|died before chart review period|0|||
161711028|NCT01075178|583985786|FG001|Subject Chart Review|died before chart review period|2|||
161711029|NCT01075178|583985785|FG000|Subject Chart Review|no data collected due to site closure|3|||
161711030|NCT01075178|583985786|FG001|Subject Chart Review|no data collected due to site closure|4|||
161711031|NCT01075178|583985785|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
161711032|NCT01075178|583985786|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
161711033|NCT02983604|583985787|FG000|Overall Study|Enrolled but not Treated|0|||
161711034|NCT02983604|583985788|FG001|Overall Study|Enrolled but not Treated|0|||
161711035|NCT02983604|583985789|FG002|Overall Study|Enrolled but not Treated|1|||
161711036|NCT02983604|583985790|FG003|Overall Study|Enrolled but not Treated|0|||
161711037|NCT04336163|583985792|FG000|Overall Study|Lost to Follow-up|55|||
161711038|NCT04336163|583985793|FG001|Overall Study|Lost to Follow-up|0|||
161711039|NCT01241786|583985794|FG000|Overall Study|Lack of Efficacy|5|||
161711040|NCT03182738|583985805|FG000|Overall Study|Lost to Follow-up|9|||
161711041|NCT03182738|583985806|FG001|Overall Study|Lost to Follow-up|3|||
161711042|NCT03182738|583985805|FG000|Overall Study|Pregnancy|0|||
161711043|NCT03182738|583985806|FG001|Overall Study|Pregnancy|1|||
161711044|NCT03182738|583985805|FG000|Overall Study|Withdrawal by Subject|0|||
161711045|NCT03182738|583985806|FG001|Overall Study|Withdrawal by Subject|1|||
161711046|NCT02886715|583985809|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161711047|NCT02886715|583985810|FG001|Overall Study|Non-Compliance With Study Drug|2|||
161711048|NCT02886715|583985811|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161711049|NCT02886715|583985809|FG000|Overall Study|Adverse Event|4|||
161711050|NCT02886715|583985810|FG001|Overall Study|Adverse Event|2|||
161711051|NCT02886715|583985811|FG002|Overall Study|Adverse Event|0|||
161711052|NCT02886715|583985809|FG000|Overall Study|Lack of Efficacy|0|||
161711053|NCT02886715|583985810|FG001|Overall Study|Lack of Efficacy|2|||
161711054|NCT02886715|583985811|FG002|Overall Study|Lack of Efficacy|1|||
161711055|NCT02886715|583985809|FG000|Overall Study|Lost to Follow-up|29|||
161711056|NCT02886715|583985810|FG001|Overall Study|Lost to Follow-up|26|||
161711057|NCT02886715|583985811|FG002|Overall Study|Lost to Follow-up|10|||
161711058|NCT02886715|583985809|FG000|Overall Study|Pregnancy|1|||
161711059|NCT02886715|583985810|FG001|Overall Study|Pregnancy|1|||
161711060|NCT02886715|583985811|FG002|Overall Study|Pregnancy|1|||
161711061|NCT02886715|583985809|FG000|Overall Study|Protocol Violation|3|||
161711062|NCT02886715|583985810|FG001|Overall Study|Protocol Violation|2|||
161711063|NCT02886715|583985811|FG002|Overall Study|Protocol Violation|1|||
161711064|NCT02886715|583985809|FG000|Overall Study|Withdrawal by Subject|20|||
161711065|NCT02886715|583985810|FG001|Overall Study|Withdrawal by Subject|18|||
161711066|NCT02886715|583985811|FG002|Overall Study|Withdrawal by Subject|5|||
161711067|NCT02886715|583985809|FG000|Overall Study|missing|7|||
161711068|NCT02886715|583985810|FG001|Overall Study|missing|2|||
161711069|NCT02886715|583985811|FG002|Overall Study|missing|2|||
161711070|NCT00503399|583985812|FG000|Overall Study|Death|2|||
161711071|NCT00503399|583985813|FG001|Overall Study|Death|1|||
161711072|NCT00503399|583985812|FG000|Overall Study|Protocol Violation|1|||
161711073|NCT00503399|583985813|FG001|Overall Study|Protocol Violation|0|||
161711074|NCT00503399|583985812|FG000|Overall Study|Withdrawal by Subject|4|||
161711075|NCT00503399|583985813|FG001|Overall Study|Withdrawal by Subject|2|||
161711076|NCT00503399|583985812|FG000|Overall Study|Adverse Event|0|||
161711077|NCT00503399|583985813|FG001|Overall Study|Adverse Event|3|||
161711078|NCT00503399|583985812|FG000|Overall Study|Lost to Follow-up|0|||
161711079|NCT00503399|583985813|FG001|Overall Study|Lost to Follow-up|2|||
161711080|NCT01676961|583985814|FG000|Overall Study|Death|3|||
161711081|NCT01676961|583985814|FG000|Overall Study|Lost to Follow-up|1|||
161711082|NCT01676961|583985814|FG000|Overall Study|Withdrawal by Subject|1|||
161711083|NCT01128387|583985815|FG000|Overall Study|Physician Decision|0|||
161711084|NCT01128387|583985816|FG001|Overall Study|Physician Decision|1|||
161711085|NCT02499952|583985817|FG000|Overall Study|Lost to Follow-up|1|||
161711086|NCT02499952|583985817|FG000|Overall Study|Death|9|||
161711087|NCT02120417|583985818|FG000|Overall Study|Death|5|||
161711088|NCT02120417|583985819|FG001|Overall Study|Death|1|||
161711089|NCT02120417|583985818|FG000|Overall Study|Adverse Event|3|||
161711090|NCT02120417|583985819|FG001|Overall Study|Adverse Event|9|||
161711091|NCT02120417|583985818|FG000|Overall Study|Participant decision|4|||
161711092|NCT02120417|583985819|FG001|Overall Study|Participant decision|4|||
161711093|NCT02120417|583985818|FG000|Overall Study|Disease progression|41|||
161711094|NCT02120417|583985819|FG001|Overall Study|Disease progression|45|||
161711095|NCT02120417|583985818|FG000|Overall Study|Noncompliance with study treatment|0|||
161711096|NCT02120417|583985819|FG001|Overall Study|Noncompliance with study treatment|2|||
161711097|NCT02120417|583985818|FG000|Overall Study|Physician Decision|2|||
161711098|NCT02120417|583985819|FG001|Overall Study|Physician Decision|3|||
161711099|NCT02120417|583985818|FG000|Overall Study|Other unspecified|5|||
161711100|NCT02120417|583985819|FG001|Overall Study|Other unspecified|4|||
161711101|NCT00927485|583985820|FG000|Overall Study|Adverse Event|4|||
161711102|NCT00927485|583985821|FG001|Overall Study|Adverse Event|2|||
161711103|NCT00927485|583985820|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
161711104|NCT00927485|583985821|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
161711105|NCT01440101|583985822|FG000|Overall Study|Adverse Event|2|||
162031308|NCT00604214|585171041|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
162031309|NCT00604214|585171042|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
162031310|NCT00534599|585171043|FG000|Overall Study|Adverse Event|25|||
162031311|NCT00534599|585171044|FG001|Overall Study|Adverse Event|4|||
162031312|NCT00534599|585171043|FG000|Overall Study|Incorrect enrollment|2|||
162031313|NCT00534599|585171044|FG001|Overall Study|Incorrect enrollment|1|||
162031314|NCT00534599|585171043|FG000|Overall Study|Mis-randomization|2|||
162031315|NCT00534599|585171044|FG001|Overall Study|Mis-randomization|2|||
162031316|NCT00534599|585171043|FG000|Overall Study|Developed study-specific d/c criteria|5|||
162031317|NCT00534599|585171044|FG001|Overall Study|Developed study-specific d/c criteria|0|||
162031318|NCT00534599|585171043|FG000|Overall Study|Lack of Efficacy|0|||
162031319|NCT00534599|585171044|FG001|Overall Study|Lack of Efficacy|1|||
162031320|NCT00534599|585171043|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
162031321|NCT00534599|585171044|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
162031322|NCT00534599|585171043|FG000|Overall Study|Protocol Violation|1|||
162031323|NCT00534599|585171044|FG001|Overall Study|Protocol Violation|3|||
162031324|NCT00534599|585171043|FG000|Overall Study|Lost to Follow-up|11|||
162031325|NCT00534599|585171044|FG001|Overall Study|Lost to Follow-up|14|||
162031326|NCT00534599|585171043|FG000|Overall Study|Withdrawal by Subject|4|||
161711106|NCT01440101|583985823|FG001|Overall Study|Adverse Event|0|||
161711107|NCT01440101|583985824|FG002|Overall Study|Adverse Event|0|||
161711108|NCT01440101|583985822|FG000|Overall Study|Withdrawal by Subject|0|||
161711109|NCT01440101|583985823|FG001|Overall Study|Withdrawal by Subject|3|||
161711110|NCT01440101|583985824|FG002|Overall Study|Withdrawal by Subject|1|||
161711111|NCT01440101|583985822|FG000|Overall Study|Other|0|||
161711112|NCT01440101|583985823|FG001|Overall Study|Other|1|||
161711113|NCT01440101|583985824|FG002|Overall Study|Other|0|||
161711114|NCT02305563|583985828|FG000|Treatment Period|Disease progression|0|||
161711115|NCT02305563|583985829|FG001|Treatment Period|Disease progression|0|||
161711116|NCT02305563|583985830|FG002|Treatment Period|Disease progression|15|||
161711117|NCT02305563|583985831|FG003|Treatment Period|Disease progression|6|||
161711118|NCT02305563|583985832|FG004|Treatment Period|Disease progression|6|||
161711119|NCT02305563|583985828|FG000|Treatment Period|Study drug toxicity|0|||
161711120|NCT02305563|583985829|FG001|Treatment Period|Study drug toxicity|0|||
161711121|NCT02305563|583985830|FG002|Treatment Period|Study drug toxicity|0|||
161711122|NCT02305563|583985831|FG003|Treatment Period|Study drug toxicity|1|||
161711123|NCT02305563|583985832|FG004|Treatment Period|Study drug toxicity|2|||
161711124|NCT02305563|583985828|FG000|Treatment Period|Death|0|||
161711125|NCT02305563|583985829|FG001|Treatment Period|Death|0|||
161711126|NCT02305563|583985830|FG002|Treatment Period|Death|1|||
161711127|NCT02305563|583985831|FG003|Treatment Period|Death|2|||
161711128|NCT02305563|583985832|FG004|Treatment Period|Death|1|||
161711129|NCT02305563|583985828|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
161711130|NCT02305563|583985829|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
161711131|NCT02305563|583985830|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
161711132|NCT02305563|583985831|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
161711133|NCT02305563|583985832|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
161711134|NCT02305563|583985828|FG000|Treatment Period|Participant request to stop therapy|0|||
161711135|NCT02305563|583985829|FG001|Treatment Period|Participant request to stop therapy|2|||
161711136|NCT02305563|583985830|FG002|Treatment Period|Participant request to stop therapy|0|||
161711137|NCT02305563|583985831|FG003|Treatment Period|Participant request to stop therapy|1|||
162031327|NCT00534599|585171044|FG001|Overall Study|Withdrawal by Subject|6|||
162031328|NCT00534599|585171043|FG000|Overall Study|Other|7|||
162031329|NCT00534599|585171044|FG001|Overall Study|Other|0|||
162031330|NCT01155167|585171049|FG000|Overall Study|Insufficient ultrasound data|2|||
162031331|NCT01155167|585171050|FG001|Overall Study|Insufficient ultrasound data|0|||
162031332|NCT01155167|585171049|FG000|Overall Study|Access site changed to femoral artery|1|||
162031333|NCT01155167|585171050|FG001|Overall Study|Access site changed to femoral artery|0|||
161960972|NCT00972517|584902232|FG002|Overall Study|Withdrawal by Subject|0|||
161960973|NCT00972517|584902233|FG003|Overall Study|Withdrawal by Subject|2|||
161960974|NCT00972517|584902234|FG004|Overall Study|Withdrawal by Subject|1|||
161960975|NCT00972517|584902235|FG005|Overall Study|Withdrawal by Subject|0|||
161960976|NCT02311881|584902236|FG000|Overall Study|Did not meet the study criteria|2|||
161960977|NCT02311881|584902237|FG001|Overall Study|Did not meet the study criteria|2|||
161960978|NCT02311881|584902238|FG002|Overall Study|Did not meet the study criteria|0|||
161960979|NCT02311881|584902236|FG000|Overall Study|Adverse Event|7|||
161960980|NCT02311881|584902237|FG001|Overall Study|Adverse Event|15|||
161960981|NCT02311881|584902238|FG002|Overall Study|Adverse Event|8|||
161960982|NCT02311881|584902236|FG000|Overall Study|Lost to Follow-up|3|||
161960983|NCT02311881|584902237|FG001|Overall Study|Lost to Follow-up|3|||
161960984|NCT02311881|584902238|FG002|Overall Study|Lost to Follow-up|2|||
161960985|NCT02311881|584902236|FG000|Overall Study|Protocol Violation|1|||
161960986|NCT02311881|584902237|FG001|Overall Study|Protocol Violation|2|||
161960987|NCT02311881|584902238|FG002|Overall Study|Protocol Violation|3|||
161960988|NCT02311881|584902236|FG000|Overall Study|Withdrawal of consent|14|||
161960989|NCT02311881|584902237|FG001|Overall Study|Withdrawal of consent|16|||
161960990|NCT02311881|584902238|FG002|Overall Study|Withdrawal of consent|17|||
161960991|NCT02311881|584902236|FG000|Overall Study|Other|0|||
161960992|NCT02311881|584902237|FG001|Overall Study|Other|0|||
161960993|NCT02311881|584902238|FG002|Overall Study|Other|1|||
161960994|NCT02311881|584902236|FG000|Overall Study|Lack of Efficacy|1|||
161960995|NCT02311881|584902237|FG001|Overall Study|Lack of Efficacy|2|||
161960996|NCT02311881|584902238|FG002|Overall Study|Lack of Efficacy|0|||
161960997|NCT02311881|584902236|FG000|Overall Study|Subject has border line pregnancy test|1|||
161960998|NCT02311881|584902237|FG001|Overall Study|Subject has border line pregnancy test|0|||
161960999|NCT02311881|584902238|FG002|Overall Study|Subject has border line pregnancy test|0|||
161961000|NCT02311881|584902236|FG000|Overall Study|Withdrawal by Subject|3|||
161961001|NCT02311881|584902237|FG001|Overall Study|Withdrawal by Subject|1|||
161961002|NCT02311881|584902238|FG002|Overall Study|Withdrawal by Subject|4|||
161961003|NCT02311881|584902236|FG000|Overall Study|Sponsor Decision|1|||
161961004|NCT02311881|584902237|FG001|Overall Study|Sponsor Decision|1|||
161961005|NCT02311881|584902238|FG002|Overall Study|Sponsor Decision|1|||
161961006|NCT02311881|584902236|FG000|Overall Study|Protocol Deviation|1|||
161711138|NCT02305563|583985832|FG004|Treatment Period|Participant request to stop therapy|0|||
161711139|NCT02305563|583985828|FG000|Treatment Period|Participant withdrew consent|0|||
161711140|NCT02305563|583985829|FG001|Treatment Period|Participant withdrew consent|0|||
161711141|NCT02305563|583985830|FG002|Treatment Period|Participant withdrew consent|1|||
161711142|NCT02305563|583985831|FG003|Treatment Period|Participant withdrew consent|1|||
161711143|NCT02305563|583985832|FG004|Treatment Period|Participant withdrew consent|1|||
161711144|NCT02305563|583985828|FG000|Treatment Period|Maximum clinical benefit|0|||
161711145|NCT02305563|583985829|FG001|Treatment Period|Maximum clinical benefit|0|||
161711146|NCT02305563|583985830|FG002|Treatment Period|Maximum clinical benefit|0|||
161711147|NCT02305563|583985831|FG003|Treatment Period|Maximum clinical benefit|0|||
161711148|NCT02305563|583985832|FG004|Treatment Period|Maximum clinical benefit|1|||
161711149|NCT02305563|583985828|FG000|Treatment Period|Poor/non-compliance|0|||
161711150|NCT02305563|583985829|FG001|Treatment Period|Poor/non-compliance|0|||
161711151|NCT02305563|583985830|FG002|Treatment Period|Poor/non-compliance|0|||
161711152|NCT02305563|583985831|FG003|Treatment Period|Poor/non-compliance|0|||
161711153|NCT02305563|583985832|FG004|Treatment Period|Poor/non-compliance|1|||
161711154|NCT02305563|583985828|FG000|Treatment Period|Administrative reason by Sponsor|0|||
161711155|NCT02305563|583985829|FG001|Treatment Period|Administrative reason by Sponsor|0|||
161711156|NCT02305563|583985830|FG002|Treatment Period|Administrative reason by Sponsor|0|||
161711157|NCT02305563|583985831|FG003|Treatment Period|Administrative reason by Sponsor|0|||
161711158|NCT02305563|583985832|FG004|Treatment Period|Administrative reason by Sponsor|1|||
161711159|NCT02305563|583985828|FG000|Treatment Period|other reason|2|||
161711160|NCT02305563|583985829|FG001|Treatment Period|other reason|0|||
161961007|NCT02311881|584902237|FG001|Overall Study|Protocol Deviation|0|||
161711161|NCT02305563|583985830|FG002|Treatment Period|other reason|2|||
161711162|NCT02305563|583985831|FG003|Treatment Period|other reason|2|||
161711163|NCT02305563|583985832|FG004|Treatment Period|other reason|1|||
161711164|NCT02305563|583985828|FG000|Treatment Period|Randomized but not treated|0|||
161711165|NCT02305563|583985829|FG001|Treatment Period|Randomized but not treated|0|||
161711166|NCT02305563|583985830|FG002|Treatment Period|Randomized but not treated|0|||
161711167|NCT02305563|583985831|FG003|Treatment Period|Randomized but not treated|0|||
161711168|NCT02305563|583985832|FG004|Treatment Period|Randomized but not treated|2|||
161711169|NCT02305563|583985828|FG000|Treatment Period|added ULO, then disease progression|0|||
161711170|NCT02305563|583985829|FG001|Treatment Period|added ULO, then disease progression|0|||
161711171|NCT02305563|583985830|FG002|Treatment Period|added ULO, then disease progression|0|||
161711172|NCT02305563|583985831|FG003|Treatment Period|added ULO, then disease progression|0|||
161711173|NCT02305563|583985832|FG004|Treatment Period|added ULO, then disease progression|4|||
161711174|NCT02305563|583985828|FG000|Treatment Period|added ULO; then other reason|0|||
161711175|NCT02305563|583985829|FG001|Treatment Period|added ULO; then other reason|0|||
161711176|NCT02305563|583985830|FG002|Treatment Period|added ULO; then other reason|0|||
161711177|NCT02305563|583985831|FG003|Treatment Period|added ULO; then other reason|0|||
161711178|NCT02305563|583985832|FG004|Treatment Period|added ULO; then other reason|1|||
161711179|NCT02305563|583985828|FG000|Treatment Period|added ULO, then request to stop|0|||
161711180|NCT02305563|583985829|FG001|Treatment Period|added ULO, then request to stop|0|||
161711181|NCT02305563|583985830|FG002|Treatment Period|added ULO, then request to stop|0|||
161711182|NCT02305563|583985831|FG003|Treatment Period|added ULO, then request to stop|0|||
161711183|NCT02305563|583985832|FG004|Treatment Period|added ULO, then request to stop|1|||
161711184|NCT02305563|583985828|FG000|Follow-up Period|Death|0|||
161711185|NCT02305563|583985829|FG001|Follow-up Period|Death|0|||
161711186|NCT02305563|583985830|FG002|Follow-up Period|Death|5|||
161711187|NCT02305563|583985831|FG003|Follow-up Period|Death|4|||
161711188|NCT02305563|583985832|FG004|Follow-up Period|Death|7|||
161711189|NCT02305563|583985828|FG000|Follow-up Period|Participant withdrew consent|0|||
161711190|NCT02305563|583985829|FG001|Follow-up Period|Participant withdrew consent|0|||
161711191|NCT02305563|583985830|FG002|Follow-up Period|Participant withdrew consent|2|||
161711192|NCT02305563|583985831|FG003|Follow-up Period|Participant withdrew consent|1|||
161711193|NCT02305563|583985832|FG004|Follow-up Period|Participant withdrew consent|0|||
161711194|NCT02305563|583985828|FG000|Follow-up Period|other reason|0|||
161711195|NCT02305563|583985829|FG001|Follow-up Period|other reason|0|||
161711196|NCT02305563|583985830|FG002|Follow-up Period|other reason|0|||
161711197|NCT02305563|583985831|FG003|Follow-up Period|other reason|0|||
161711198|NCT02305563|583985832|FG004|Follow-up Period|other reason|1|||
161711199|NCT02305563|583985828|FG000|Follow-up Period|Followup no longer required per protocol|3|||
161711200|NCT02305563|583985829|FG001|Follow-up Period|Followup no longer required per protocol|3|||
161711201|NCT02305563|583985830|FG002|Follow-up Period|Followup no longer required per protocol|4|||
161711202|NCT02305563|583985831|FG003|Follow-up Period|Followup no longer required per protocol|1|||
161711203|NCT02305563|583985832|FG004|Follow-up Period|Followup no longer required per protocol|4|||
161711204|NCT01275222|583985839|FG000|Phase l by Treatment|Adverse Event|1|||
161711205|NCT01275222|583985840|FG001|Phase l by Treatment|Adverse Event|4|||
161711206|NCT01275222|583985841|FG002|Phase l by Treatment|Adverse Event|2|||
161711207|NCT01275222|583985842|FG003|Phase l by Treatment|Adverse Event|3|||
161711208|NCT01275222|583985843|FG004|Phase l by Treatment|Adverse Event|0|||
161711209|NCT01275222|583985844|FG005|Phase l by Treatment|Adverse Event|0|||
161711210|NCT01275222|583985839|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161711211|NCT01275222|583985840|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161711212|NCT01275222|583985841|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
161711213|NCT01275222|583985842|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161711214|NCT01275222|583985843|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161711215|NCT01275222|583985844|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161711216|NCT01275222|583985839|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
161711217|NCT01275222|583985840|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
161711218|NCT01275222|583985841|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
161711219|NCT01275222|583985842|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
161711220|NCT01275222|583985843|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
161711221|NCT01275222|583985844|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
162031334|NCT01981551|585171051|FG000|Overall Study|Refused further treatment|8|||
161711222|NCT01275222|583985839|FG000|Phase l by Treatment|Disease progression|12|||
161711223|NCT01275222|583985840|FG001|Phase l by Treatment|Disease progression|8|||
161711224|NCT01275222|583985841|FG002|Phase l by Treatment|Disease progression|2|||
161711225|NCT01275222|583985842|FG003|Phase l by Treatment|Disease progression|5|||
161711226|NCT01275222|583985843|FG004|Phase l by Treatment|Disease progression|0|||
161711227|NCT01275222|583985844|FG005|Phase l by Treatment|Disease progression|0|||
161711228|NCT01275222|583985839|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
161711229|NCT01275222|583985840|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
161711230|NCT01275222|583985841|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
161711231|NCT01275222|583985842|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
161711232|NCT01275222|583985843|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
161711233|NCT01275222|583985844|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
161711234|NCT01275222|583985839|FG000|Phase l by Treatment|Death|0|||
161711235|NCT01275222|583985840|FG001|Phase l by Treatment|Death|1|||
161711236|NCT01275222|583985841|FG002|Phase l by Treatment|Death|0|||
161711237|NCT01275222|583985842|FG003|Phase l by Treatment|Death|1|||
161711238|NCT01275222|583985843|FG004|Phase l by Treatment|Death|0|||
161711239|NCT01275222|583985844|FG005|Phase l by Treatment|Death|0|||
161711240|NCT01275222|583985839|FG000|Phase ll by Stratum|Adverse Event|0|||
161711241|NCT01275222|583985840|FG001|Phase ll by Stratum|Adverse Event|0|||
161711242|NCT01275222|583985841|FG002|Phase ll by Stratum|Adverse Event|0|||
161711243|NCT01275222|583985842|FG003|Phase ll by Stratum|Adverse Event|0|||
161711244|NCT01275222|583985843|FG004|Phase ll by Stratum|Adverse Event|2|||
161711245|NCT01275222|583985844|FG005|Phase ll by Stratum|Adverse Event|10|||
161711246|NCT01275222|583985839|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
161711247|NCT01275222|583985840|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
161711248|NCT01275222|583985841|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
161711249|NCT01275222|583985842|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
161711250|NCT01275222|583985843|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
161711251|NCT01275222|583985844|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
161711252|NCT01275222|583985839|FG000|Phase ll by Stratum|Disease progression|0|||
161711253|NCT01275222|583985840|FG001|Phase ll by Stratum|Disease progression|0|||
161711254|NCT01275222|583985841|FG002|Phase ll by Stratum|Disease progression|0|||
161711255|NCT01275222|583985842|FG003|Phase ll by Stratum|Disease progression|0|||
161711256|NCT01275222|583985843|FG004|Phase ll by Stratum|Disease progression|23|||
161711257|NCT01275222|583985844|FG005|Phase ll by Stratum|Disease progression|31|||
161711258|NCT01275222|583985839|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
161711259|NCT01275222|583985840|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
161711260|NCT01275222|583985841|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
161711261|NCT01275222|583985842|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
161711262|NCT01275222|583985843|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
161711263|NCT01275222|583985844|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
161711264|NCT01275222|583985839|FG000|Phase ll by Stratum|Death|0|||
161711265|NCT01275222|583985840|FG001|Phase ll by Stratum|Death|0|||
161711266|NCT01275222|583985841|FG002|Phase ll by Stratum|Death|0|||
161711267|NCT01275222|583985842|FG003|Phase ll by Stratum|Death|0|||
161711268|NCT01275222|583985843|FG004|Phase ll by Stratum|Death|1|||
161711269|NCT01275222|583985844|FG005|Phase ll by Stratum|Death|1|||
161711270|NCT05202808|583985845|FG000|Overall Study|Lost to Follow-up|3|||
161711271|NCT05202808|583985846|FG001|Overall Study|Lost to Follow-up|1|||
161711272|NCT02495948|583985849|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
161711273|NCT02495948|583985850|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
161711274|NCT02495948|583985849|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
161711275|NCT02495948|583985850|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
161711276|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
161711277|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
161711278|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
161711279|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
161711280|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
161711281|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
161711282|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
161711283|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
161711284|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
161711285|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
161711286|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
161711287|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
161711288|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
161711289|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
161711290|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
161711291|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
161711292|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
161711293|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
161711294|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
161711295|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
161711296|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
161961008|NCT02311881|584902238|FG002|Overall Study|Protocol Deviation|0|||
161711297|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
161711298|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
161711299|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
161711300|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
161711301|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
161711302|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
161711303|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
161711304|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
161711305|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
161711306|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
161711307|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
161711308|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
161711309|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
161711310|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
161711311|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
161711312|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
161711313|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
161711314|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
161711315|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
161711316|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
161711317|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
161711318|NCT00100048|583985852|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161711319|NCT00100048|583985853|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161711320|NCT00100048|583985854|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161711321|NCT00100048|583985855|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
161711322|NCT00100048|583985856|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161711323|NCT00100048|583985857|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161711324|NCT02722044|583985859|FG000|Overall Study|Adverse Event|2|||
161711325|NCT02722044|583985859|FG000|Overall Study|Physician Decision|1|||
161711326|NCT02722044|583985859|FG000|Overall Study|Withdrawal by Subject|1|||
161711327|NCT02722044|583985859|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
161711328|NCT04885257|583985863|FG000|Overall Study|Withdrawal by Subject|1|||
161711329|NCT04885257|583985864|FG001|Overall Study|Withdrawal by Subject|0|||
161711330|NCT00818259|583985865|FG000|Part I|Withdrawal by Subject|1|||
161711331|NCT00818259|583985866|FG001|Part I|Withdrawal by Subject|0|||
161711332|NCT00818259|583985867|FG002|Part I|Withdrawal by Subject|0|||
161711333|NCT00818259|583985868|FG003|Part I|Withdrawal by Subject|0|||
161711334|NCT00818259|583985869|FG004|Part I|Withdrawal by Subject|0|||
161711335|NCT00818259|583985870|FG005|Part I|Withdrawal by Subject|0|||
161711336|NCT00818259|583985871|FG006|Part I|Withdrawal by Subject|0|||
161711337|NCT00818259|583985872|FG007|Part I|Withdrawal by Subject|0|||
161711338|NCT00818259|583985873|FG008|Part I|Withdrawal by Subject|0|||
161711339|NCT00818259|583985865|FG000|Part II|Physician Decision|0|||
161711340|NCT00818259|583985866|FG001|Part II|Physician Decision|0|||
161711341|NCT00818259|583985867|FG002|Part II|Physician Decision|1|||
161711342|NCT00818259|583985868|FG003|Part II|Physician Decision|0|||
161711343|NCT00818259|583985869|FG004|Part II|Physician Decision|0|||
161711344|NCT00818259|583985870|FG005|Part II|Physician Decision|0|||
161711345|NCT00818259|583985871|FG006|Part II|Physician Decision|0|||
161711346|NCT00818259|583985872|FG007|Part II|Physician Decision|0|||
161711347|NCT00818259|583985873|FG008|Part II|Physician Decision|0|||
161711348|NCT00818259|583985865|FG000|Part II|Lack of Efficacy|0|||
161711349|NCT00818259|583985866|FG001|Part II|Lack of Efficacy|0|||
161711350|NCT00818259|583985867|FG002|Part II|Lack of Efficacy|0|||
161711351|NCT00818259|583985868|FG003|Part II|Lack of Efficacy|1|||
161711352|NCT00818259|583985869|FG004|Part II|Lack of Efficacy|0|||
161711353|NCT00818259|583985870|FG005|Part II|Lack of Efficacy|0|||
161711354|NCT00818259|583985871|FG006|Part II|Lack of Efficacy|0|||
161711355|NCT00818259|583985872|FG007|Part II|Lack of Efficacy|0|||
161711356|NCT00818259|583985873|FG008|Part II|Lack of Efficacy|0|||
161711357|NCT00818259|583985865|FG000|Part II|Not Treated|0|||
161711358|NCT00818259|583985866|FG001|Part II|Not Treated|0|||
161711359|NCT00818259|583985867|FG002|Part II|Not Treated|0|||
161711360|NCT00818259|583985868|FG003|Part II|Not Treated|1|||
161711361|NCT00818259|583985869|FG004|Part II|Not Treated|0|||
161711362|NCT00818259|583985870|FG005|Part II|Not Treated|0|||
161711363|NCT00818259|583985871|FG006|Part II|Not Treated|0|||
161711364|NCT00818259|583985872|FG007|Part II|Not Treated|0|||
161711365|NCT00818259|583985873|FG008|Part II|Not Treated|0|||
161711366|NCT00818259|583985865|FG000|Part IV|Physician Decision|0|||
161711367|NCT00818259|583985866|FG001|Part IV|Physician Decision|0|||
161711368|NCT00818259|583985867|FG002|Part IV|Physician Decision|0|||
161711369|NCT00818259|583985868|FG003|Part IV|Physician Decision|0|||
161711370|NCT00818259|583985869|FG004|Part IV|Physician Decision|0|||
161711371|NCT00818259|583985870|FG005|Part IV|Physician Decision|1|||
161711372|NCT00818259|583985871|FG006|Part IV|Physician Decision|0|||
161711373|NCT00818259|583985872|FG007|Part IV|Physician Decision|0|||
161711374|NCT00818259|583985873|FG008|Part IV|Physician Decision|0|||
161711375|NCT00818259|583985865|FG000|Part V|Adverse Event|0|||
161711376|NCT00818259|583985866|FG001|Part V|Adverse Event|0|||
161711377|NCT00818259|583985867|FG002|Part V|Adverse Event|0|||
161711378|NCT00818259|583985868|FG003|Part V|Adverse Event|0|||
161711379|NCT00818259|583985869|FG004|Part V|Adverse Event|0|||
161711380|NCT00818259|583985870|FG005|Part V|Adverse Event|0|||
161711381|NCT00818259|583985871|FG006|Part V|Adverse Event|0|||
161711382|NCT00818259|583985872|FG007|Part V|Adverse Event|1|||
161711383|NCT00818259|583985873|FG008|Part V|Adverse Event|0|||
161711384|NCT04640766|583985874|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
161711385|NCT00609622|583985875|FG000|Overall Study|Adverse Event|14|||
161711386|NCT00609622|583985876|FG001|Overall Study|Adverse Event|10|||
161711387|NCT00609622|583985875|FG000|Overall Study|Withdrawal by Subject|4|||
161711388|NCT00609622|583985876|FG001|Overall Study|Withdrawal by Subject|20|||
161711389|NCT00609622|583985875|FG000|Overall Study|Death|1|||
161711390|NCT00609622|583985876|FG001|Overall Study|Death|4|||
161711391|NCT00609622|583985875|FG000|Overall Study|Protocol Violation|1|||
161711392|NCT00609622|583985876|FG001|Overall Study|Protocol Violation|1|||
161711393|NCT00609622|583985875|FG000|Overall Study|Objective progression or relapse|47|||
161711394|NCT00609622|583985876|FG001|Overall Study|Objective progression or relapse|41|||
161711395|NCT00609622|583985875|FG000|Overall Study|Study terminated by sponsor|16|||
161711396|NCT00609622|583985876|FG001|Overall Study|Study terminated by sponsor|3|||
161711397|NCT00609622|583985875|FG000|Overall Study|Other|7|||
161711398|NCT00609622|583985876|FG001|Overall Study|Other|14|||
161711399|NCT00609622|583985875|FG000|Overall Study|Global deterioration of health status|6|||
161711400|NCT00609622|583985876|FG001|Overall Study|Global deterioration of health status|2|||
161711401|NCT01237951|583985877|FG000|Overall Study|Death|1|||
161711402|NCT01708057|583985880|FG000|Overall Study|Withdrawal due to study termination.|1|||
161711403|NCT01708057|583985881|FG001|Overall Study|Withdrawal due to study termination.|1|||
161711404|NCT01708057|583985882|FG002|Overall Study|Withdrawal due to study termination.|1|||
161711405|NCT02970929|583985887|FG000|Overall Study|Adverse Event|18|||
161711406|NCT02970929|583985887|FG000|Overall Study|Lack of Efficacy|8|||
161711407|NCT02970929|583985887|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
161711408|NCT02970929|583985887|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
161711409|NCT02970929|583985887|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
161711410|NCT02970929|583985887|FG000|Overall Study|LOST TO FOLLOWUP|6|||
161711411|NCT02970929|583985887|FG000|Overall Study|MOVED OUT OF STATE|1|||
161711412|NCT02970929|583985887|FG000|Overall Study|Withdrawal by Subject|16|||
161711413|NCT00666562|583985890|FG000|Overall Study|Withdrawal by Subject|0|||
161711414|NCT00666562|583985891|FG001|Overall Study|Withdrawal by Subject|1|||
161711415|NCT00666562|583985892|FG002|Overall Study|Withdrawal by Subject|0|||
161711416|NCT00666562|583985890|FG000|Overall Study|Concomitant Medication|0|||
161711417|NCT00666562|583985891|FG001|Overall Study|Concomitant Medication|1|||
161711418|NCT00666562|583985892|FG002|Overall Study|Concomitant Medication|0|||
161711419|NCT01024244|583987428|FG000|Overall Study|Adverse Event|1|||
161711420|NCT01024244|583987429|FG001|Overall Study|Adverse Event|2|||
161711421|NCT01024244|583987430|FG002|Overall Study|Adverse Event|0|||
161711422|NCT01024244|583987431|FG003|Overall Study|Adverse Event|1|||
161961009|NCT02311881|584902236|FG000|Overall Study|Non-Compliance|1|||
161961010|NCT02311881|584902237|FG001|Overall Study|Non-Compliance|0|||
161961011|NCT02311881|584902238|FG002|Overall Study|Non-Compliance|2|||
161961012|NCT02311881|584902236|FG000|Overall Study|Physician Decision|0|||
161961013|NCT02311881|584902237|FG001|Overall Study|Physician Decision|0|||
161961014|NCT02311881|584902238|FG002|Overall Study|Physician Decision|1|||
161961015|NCT02311881|584902236|FG000|Overall Study|Medical Monitor Discretion|0|||
161961016|NCT02311881|584902237|FG001|Overall Study|Medical Monitor Discretion|0|||
161711423|NCT01024244|583987432|FG004|Overall Study|Adverse Event|2|||
161711424|NCT01024244|583987428|FG000|Overall Study|Entry Criteria Not Met|0|||
161711425|NCT01024244|583987429|FG001|Overall Study|Entry Criteria Not Met|1|||
161711426|NCT01024244|583987430|FG002|Overall Study|Entry Criteria Not Met|0|||
161711427|NCT01024244|583987431|FG003|Overall Study|Entry Criteria Not Met|0|||
161711428|NCT01024244|583987432|FG004|Overall Study|Entry Criteria Not Met|0|||
161711429|NCT01024244|583987428|FG000|Overall Study|Lack of Efficacy|1|||
161711430|NCT01024244|583987429|FG001|Overall Study|Lack of Efficacy|0|||
161711431|NCT01024244|583987430|FG002|Overall Study|Lack of Efficacy|0|||
161711432|NCT01024244|583987431|FG003|Overall Study|Lack of Efficacy|0|||
161711433|NCT01024244|583987432|FG004|Overall Study|Lack of Efficacy|0|||
161711434|NCT01024244|583987428|FG000|Overall Study|Protocol Violation|1|||
161711435|NCT01024244|583987429|FG001|Overall Study|Protocol Violation|0|||
161711436|NCT01024244|583987430|FG002|Overall Study|Protocol Violation|0|||
162031335|NCT01981551|585171051|FG000|Overall Study|Adverse Event|1|||
162031336|NCT00167778|585171052|FG000|Overall Study|Withdrawal by Subject|1|||
162031337|NCT02654717|585171053|FG000|Overall Study|Adverse Event|2|||
162031338|NCT02654717|585171054|FG001|Overall Study|Adverse Event|2|||
162031339|NCT02654717|585171053|FG000|Overall Study|Protocol Violation|1|||
162031340|NCT02654717|585171054|FG001|Overall Study|Protocol Violation|2|||
162031341|NCT02654717|585171053|FG000|Overall Study|Withdrawal by Subject|0|||
162031342|NCT02654717|585171054|FG001|Overall Study|Withdrawal by Subject|1|||
162031343|NCT02654717|585171053|FG000|Overall Study|Non-permitted medication|3|||
162031344|NCT02654717|585171054|FG001|Overall Study|Non-permitted medication|0|||
162031345|NCT00960570|585171057|FG000|21 Day Washout Period|Adverse Event|1|||
162031346|NCT00960570|585171057|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
162031347|NCT00960570|585171057|FG000|1 Day Period Between Dosing|Adverse Event|2|||
162031348|NCT00960570|585171057|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
162031349|NCT01451437|585171058|FG000|Overall Study|Adverse Event|0|||
162031350|NCT01451437|585171059|FG001|Overall Study|Adverse Event|0|||
162031351|NCT01451437|585171060|FG002|Overall Study|Adverse Event|0|||
162031352|NCT01451437|585171061|FG003|Overall Study|Adverse Event|0|||
162031353|NCT01451437|585171062|FG004|Overall Study|Adverse Event|0|||
162031354|NCT01451437|585171063|FG005|Overall Study|Adverse Event|1|||
162031355|NCT01451437|585171064|FG006|Overall Study|Adverse Event|1|||
162031356|NCT01451437|585171065|FG007|Overall Study|Adverse Event|2|||
162031357|NCT01451437|585171066|FG008|Overall Study|Adverse Event|1|||
162031358|NCT01451437|585171058|FG000|Overall Study|Physician Decision|1|||
162031359|NCT01451437|585171059|FG001|Overall Study|Physician Decision|1|||
162031360|NCT01451437|585171060|FG002|Overall Study|Physician Decision|2|||
162031361|NCT01451437|585171061|FG003|Overall Study|Physician Decision|0|||
162031362|NCT01451437|585171062|FG004|Overall Study|Physician Decision|0|||
162031363|NCT01451437|585171063|FG005|Overall Study|Physician Decision|0|||
162031364|NCT01451437|585171064|FG006|Overall Study|Physician Decision|0|||
162031365|NCT01451437|585171065|FG007|Overall Study|Physician Decision|0|||
162031366|NCT01451437|585171066|FG008|Overall Study|Physician Decision|0|||
162031367|NCT01451437|585171058|FG000|Overall Study|Disease Progression|0|||
162031368|NCT01451437|585171059|FG001|Overall Study|Disease Progression|0|||
162031369|NCT01451437|585171060|FG002|Overall Study|Disease Progression|1|||
162031370|NCT01451437|585171061|FG003|Overall Study|Disease Progression|1|||
162031371|NCT01451437|585171062|FG004|Overall Study|Disease Progression|3|||
162031372|NCT01451437|585171063|FG005|Overall Study|Disease Progression|2|||
162031373|NCT01451437|585171064|FG006|Overall Study|Disease Progression|3|||
162031374|NCT01451437|585171065|FG007|Overall Study|Disease Progression|1|||
162031375|NCT01451437|585171066|FG008|Overall Study|Disease Progression|3|||
162031376|NCT01451437|585171058|FG000|Overall Study|Protocol Violation|0|||
162031377|NCT01451437|585171059|FG001|Overall Study|Protocol Violation|0|||
162031378|NCT01451437|585171060|FG002|Overall Study|Protocol Violation|0|||
162031379|NCT01451437|585171061|FG003|Overall Study|Protocol Violation|0|||
162031380|NCT01451437|585171062|FG004|Overall Study|Protocol Violation|0|||
162031381|NCT01451437|585171063|FG005|Overall Study|Protocol Violation|0|||
162031382|NCT01451437|585171064|FG006|Overall Study|Protocol Violation|1|||
162031383|NCT01451437|585171065|FG007|Overall Study|Protocol Violation|0|||
162031384|NCT01451437|585171066|FG008|Overall Study|Protocol Violation|0|||
162031385|NCT01451437|585171058|FG000|Overall Study|Withdrawal by Subject|0|||
162031386|NCT01451437|585171059|FG001|Overall Study|Withdrawal by Subject|0|||
162031387|NCT01451437|585171060|FG002|Overall Study|Withdrawal by Subject|0|||
162031388|NCT01451437|585171061|FG003|Overall Study|Withdrawal by Subject|0|||
162031389|NCT01451437|585171062|FG004|Overall Study|Withdrawal by Subject|1|||
162031390|NCT01451437|585171063|FG005|Overall Study|Withdrawal by Subject|0|||
162031391|NCT01451437|585171064|FG006|Overall Study|Withdrawal by Subject|1|||
162031392|NCT01451437|585171065|FG007|Overall Study|Withdrawal by Subject|0|||
162031393|NCT01451437|585171066|FG008|Overall Study|Withdrawal by Subject|0|||
162031394|NCT00853970|585171072|FG000|Overall Study|Withdrawal by Subject|2|||
162031395|NCT00853970|585171073|FG001|Overall Study|Withdrawal by Subject|1|||
162031396|NCT00853970|585171072|FG000|Overall Study|Cancelled surgery|4|||
162031397|NCT00853970|585171073|FG001|Overall Study|Cancelled surgery|2|||
162031398|NCT00910247|585172341|FG000|Overall Study|Adverse Event|15|||
162031399|NCT00910247|585172341|FG000|Overall Study|Death|2|||
162031400|NCT00910247|585172341|FG000|Overall Study|Lost to Follow-up|10|||
162031401|NCT00910247|585172341|FG000|Overall Study|Physician Decision|3|||
162031402|NCT00910247|585172341|FG000|Overall Study|Protocol Violation|10|||
162031403|NCT00910247|585172341|FG000|Overall Study|Withdrawal by Subject|25|||
162031404|NCT00910247|585172341|FG000|Overall Study|Not collected|4|||
162031405|NCT02519855|585172342|FG000|Overall Study|Adverse Event|0|||
162031406|NCT02519855|585172343|FG001|Overall Study|Adverse Event|1|||
161711437|NCT01024244|583987431|FG003|Overall Study|Protocol Violation|0|||
161711438|NCT01024244|583987432|FG004|Overall Study|Protocol Violation|2|||
161711439|NCT01024244|583987428|FG000|Overall Study|Sponsor Decision|14|||
161711440|NCT01024244|583987429|FG001|Overall Study|Sponsor Decision|7|||
161711441|NCT01024244|583987430|FG002|Overall Study|Sponsor Decision|14|||
161711442|NCT01024244|583987431|FG003|Overall Study|Sponsor Decision|12|||
161711443|NCT01024244|583987432|FG004|Overall Study|Sponsor Decision|10|||
161711444|NCT01024244|583987428|FG000|Overall Study|Withdrawal by Subject|0|||
161711445|NCT01024244|583987429|FG001|Overall Study|Withdrawal by Subject|1|||
161711446|NCT01024244|583987430|FG002|Overall Study|Withdrawal by Subject|0|||
161711447|NCT01024244|583987431|FG003|Overall Study|Withdrawal by Subject|0|||
161711448|NCT01024244|583987432|FG004|Overall Study|Withdrawal by Subject|0|||
161711449|NCT03874234|583987437|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711450|NCT03874234|583987438|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711451|NCT03874234|583987439|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711452|NCT03874234|583987440|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
161711453|NCT03874234|583987441|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711454|NCT03874234|583987442|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711455|NCT03874234|583987443|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711456|NCT03874234|583987444|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711457|NCT03874234|583987445|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711458|NCT03874234|583987446|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711459|NCT03874234|583987447|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711460|NCT03874234|583987448|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711461|NCT03874234|583987449|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161711462|NCT03874234|583987437|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
161711463|NCT03874234|583987438|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711464|NCT03874234|583987439|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711465|NCT03874234|583987440|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711466|NCT03874234|583987441|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711467|NCT03874234|583987442|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711468|NCT03874234|583987443|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711469|NCT03874234|583987444|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711470|NCT03874234|583987445|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711471|NCT03874234|583987446|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711472|NCT03874234|583987447|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711473|NCT03874234|583987448|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711474|NCT03874234|583987449|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161711475|NCT03874234|583987437|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711476|NCT03874234|583987438|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711477|NCT03874234|583987439|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711478|NCT03874234|583987440|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
161711479|NCT03874234|583987441|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711480|NCT03874234|583987442|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711481|NCT03874234|583987443|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711482|NCT03874234|583987444|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711483|NCT03874234|583987445|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711484|NCT03874234|583987446|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711485|NCT03874234|583987447|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711486|NCT03874234|583987448|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711487|NCT03874234|583987449|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161711488|NCT03874234|583987437|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711489|NCT03874234|583987438|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711490|NCT03874234|583987439|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711491|NCT03874234|583987440|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711492|NCT03874234|583987441|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
161711493|NCT03874234|583987442|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711494|NCT03874234|583987443|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711495|NCT03874234|583987444|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711496|NCT03874234|583987445|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711497|NCT03874234|583987446|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711498|NCT03874234|583987447|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711499|NCT03874234|583987448|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711500|NCT03874234|583987449|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161711501|NCT03874234|583987437|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711502|NCT03874234|583987438|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711503|NCT03874234|583987439|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161961017|NCT02311881|584902238|FG002|Overall Study|Medical Monitor Discretion|1|||
162031407|NCT02519855|585172342|FG000|Overall Study|Lost to Follow-up|3|||
161711504|NCT03874234|583987440|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711505|NCT03874234|583987441|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711506|NCT03874234|583987442|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711507|NCT03874234|583987443|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711508|NCT03874234|583987444|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
161711509|NCT03874234|583987445|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711510|NCT03874234|583987446|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711511|NCT03874234|583987447|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711512|NCT03874234|583987448|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711513|NCT03874234|583987449|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161711514|NCT03874234|583987437|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711515|NCT03874234|583987438|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711516|NCT03874234|583987439|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711517|NCT03874234|583987440|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711518|NCT03874234|583987441|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
161711519|NCT03874234|583987442|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
161711520|NCT03874234|583987443|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711521|NCT03874234|583987444|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711522|NCT03874234|583987445|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711523|NCT03874234|583987446|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711524|NCT03874234|583987447|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711525|NCT03874234|583987448|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711526|NCT03874234|583987449|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161711527|NCT03874234|583987437|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711528|NCT03874234|583987438|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711529|NCT03874234|583987439|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711530|NCT03874234|583987440|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711531|NCT03874234|583987441|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711532|NCT03874234|583987442|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711533|NCT03874234|583987443|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
161711534|NCT03874234|583987444|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711535|NCT03874234|583987445|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711536|NCT03874234|583987446|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711537|NCT03874234|583987447|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711538|NCT03874234|583987448|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711539|NCT03874234|583987449|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161711540|NCT03874234|583987437|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711541|NCT03874234|583987438|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711542|NCT03874234|583987439|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711543|NCT03874234|583987440|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711544|NCT03874234|583987441|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
161711545|NCT03874234|583987442|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711546|NCT03874234|583987443|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711547|NCT03874234|583987444|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711548|NCT03874234|583987445|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711549|NCT03874234|583987446|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711550|NCT03874234|583987447|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161961018|NCT02311881|584902236|FG000|Overall Study|Participant taking another medication|0|||
161961019|NCT02311881|584902237|FG001|Overall Study|Participant taking another medication|0|||
161961020|NCT02311881|584902238|FG002|Overall Study|Participant taking another medication|1|||
161961021|NCT02311881|584902236|FG000|Overall Study|Serious Adverse Event|0|||
161961022|NCT02311881|584902237|FG001|Overall Study|Serious Adverse Event|1|||
161961023|NCT02311881|584902238|FG002|Overall Study|Serious Adverse Event|0|||
161961024|NCT03306433|584902239|FG000|Overall Study|Lost to Follow-up|3|||
161711551|NCT03874234|583987448|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711552|NCT03874234|583987449|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161711553|NCT01896232|583987455|FG000|Overall Study|Death|6|||
161711554|NCT01896232|583987456|FG001|Overall Study|Death|10|||
161711555|NCT01896232|583987455|FG000|Overall Study|Withdrawal by Subject|32|||
161711556|NCT01896232|583987456|FG001|Overall Study|Withdrawal by Subject|31|||
161711557|NCT01896232|583987455|FG000|Overall Study|Sponsor Decision|2|||
161711558|NCT01896232|583987456|FG001|Overall Study|Sponsor Decision|0|||
161711559|NCT01896232|583987455|FG000|Overall Study|Lost to Follow-up|9|||
161711560|NCT01896232|583987456|FG001|Overall Study|Lost to Follow-up|12|||
161711561|NCT00686205|583987457|FG000|Overall Study|Protocol Violation|127|||
161711562|NCT00686205|583987458|FG001|Overall Study|Protocol Violation|0|||
161711563|NCT00686205|583987457|FG000|Overall Study|Withdrawal by Subject|2|||
161711564|NCT00686205|583987458|FG001|Overall Study|Withdrawal by Subject|0|||
161711565|NCT00686205|583987457|FG000|Overall Study|Specimen handling procedure altered|5878|||
161711566|NCT00686205|583987458|FG001|Overall Study|Specimen handling procedure altered|0|||
161711567|NCT00686205|583987457|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
161711568|NCT00686205|583987458|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
161711569|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
161711570|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
161711571|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
161711572|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
161711573|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
161711574|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
161711575|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
161711576|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
161711577|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
161711578|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
161711579|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
161711580|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
161711581|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
161711582|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
161711583|NCT00446030|583987471|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
161711584|NCT00446030|583987472|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
161711585|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
161711586|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
161711587|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
161711588|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
161711589|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
161711590|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
161711591|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
161711592|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
161711593|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
161711594|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
161711595|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
161711596|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
161711597|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
161711598|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
161711599|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
161711600|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
161711601|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
161711602|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
161711603|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
161711604|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
161711605|NCT00446030|583987471|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
161711606|NCT00446030|583987472|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
161711607|NCT03168867|583987473|FG000|Overall Study|Withdrawal by Subject|1|||
161711608|NCT03168867|583987474|FG001|Overall Study|Withdrawal by Subject|5|||
161711609|NCT03812510|583987475|FG000|Overall Study|Lost to Follow-up|39|||
161711610|NCT03812510|583987475|FG000|Overall Study|Withdrawal by Subject|42|||
161711611|NCT03812510|583987475|FG000|Overall Study|Physician Decision|2|||
161711612|NCT03812510|583987475|FG000|Overall Study|Study Terminated by Sponsor|9|||
161711613|NCT03812510|583987475|FG000|Overall Study|Did Not Start Study Medication|55|||
161711614|NCT03812510|583987475|FG000|Overall Study|Adverse Event|5|||
161711615|NCT01535235|583987476|FG000|Overall Study|Adverse Event|1|||
161711616|NCT01535235|583987477|FG001|Overall Study|Adverse Event|0|||
161711617|NCT00858832|583987478|FG000|Overall Study|became ineligible: delivered vaginally|1|||
161711618|NCT00858832|583987479|FG001|Overall Study|became ineligible: delivered vaginally|0|||
161711619|NCT00858832|583987478|FG000|Overall Study|Adverse Event|0|||
161711620|NCT00858832|583987479|FG001|Overall Study|Adverse Event|1|||
161711621|NCT03075839|583987487|FG000|Overall Study|Lost to Follow-up|4|||
161711622|NCT05421754|583987492|FG000|Overall Study|Technical issue with sensor|1|||
161711623|NCT04433117|583987493|FG000|Overall Study|Withdrawal by Subject|1|||
161711624|NCT04433117|583987494|FG001|Overall Study|Withdrawal by Subject|0|||
161711625|NCT01051739|583987495|FG000|Overall Study|Death|3|||
161711626|NCT01051739|583987496|FG001|Overall Study|Death|3|||
161711627|NCT01051739|583987495|FG000|Overall Study|Withdrawal by Subject|25|||
161711628|NCT01051739|583987496|FG001|Overall Study|Withdrawal by Subject|10|||
161961025|NCT03306433|584902239|FG000|Overall Study|Patient did not have teeth extracted|1|||
161961026|NCT03306433|584902239|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
161961027|NCT00819156|584902240|FG000|Overall Study|Adverse Event|1|||
161961028|NCT00819156|584902241|FG001|Overall Study|Adverse Event|4|||
161961029|NCT00819156|584902242|FG002|Overall Study|Adverse Event|2|||
161961030|NCT00819156|584902243|FG003|Overall Study|Adverse Event|1|||
161961031|NCT00819156|584902244|FG004|Overall Study|Adverse Event|2|||
161711629|NCT00824421|583987497|FG000|Overall Study|Adverse Event|6|||
161711630|NCT00824421|583987498|FG001|Overall Study|Adverse Event|6|||
161711631|NCT00824421|583987499|FG002|Overall Study|Adverse Event|6|||
161711632|NCT00824421|583987497|FG000|Overall Study|Death|0|||
161711633|NCT00824421|583987498|FG001|Overall Study|Death|1|||
161711634|NCT00824421|583987499|FG002|Overall Study|Death|0|||
161711635|NCT00824421|583987497|FG000|Overall Study|Lack of Efficacy|5|||
161711636|NCT00824421|583987498|FG001|Overall Study|Lack of Efficacy|7|||
161711637|NCT00824421|583987499|FG002|Overall Study|Lack of Efficacy|4|||
161711638|NCT00824421|583987497|FG000|Overall Study|Lost to Follow-up|2|||
161711639|NCT00824421|583987498|FG001|Overall Study|Lost to Follow-up|3|||
161711640|NCT00824421|583987499|FG002|Overall Study|Lost to Follow-up|0|||
161711641|NCT00824421|583987497|FG000|Overall Study|Pregnancy|1|||
161711642|NCT00824421|583987498|FG001|Overall Study|Pregnancy|0|||
161711643|NCT00824421|583987499|FG002|Overall Study|Pregnancy|1|||
161711644|NCT00824421|583987497|FG000|Overall Study|Withdrawal by Subject|2|||
161711645|NCT00824421|583987498|FG001|Overall Study|Withdrawal by Subject|3|||
161711646|NCT00824421|583987499|FG002|Overall Study|Withdrawal by Subject|3|||
161711647|NCT00824421|583987497|FG000|Overall Study|Randomized but not Treated|1|||
161711648|NCT00824421|583987498|FG001|Overall Study|Randomized but not Treated|1|||
161711649|NCT00824421|583987499|FG002|Overall Study|Randomized but not Treated|0|||
161711650|NCT00824421|583987497|FG000|Overall Study|Other|0|||
161711651|NCT00824421|583987498|FG001|Overall Study|Other|1|||
161711652|NCT00824421|583987499|FG002|Overall Study|Other|0|||
161711653|NCT05089708|583987501|FG000|Overall Study|Lost to Follow-up|9|||
161711654|NCT05089708|583987502|FG001|Overall Study|Lost to Follow-up|7|||
161711655|NCT05089708|583987501|FG000|Overall Study|Withdrawal by Subject|3|||
161711656|NCT05089708|583987502|FG001|Overall Study|Withdrawal by Subject|1|||
161711657|NCT05089708|583987501|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
161711658|NCT05089708|583987502|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
161711659|NCT05089708|583987501|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
161711660|NCT05089708|583987502|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
161711661|NCT00659438|583987503|FG000|Overall Study|Withdrawal by Subject|2|||
161711662|NCT00659438|583987504|FG001|Overall Study|Withdrawal by Subject|2|||
161711663|NCT00659438|583987503|FG000|Overall Study|Death|11|||
161711664|NCT00659438|583987504|FG001|Overall Study|Death|6|||
161711665|NCT00659438|583987503|FG000|Overall Study|Lost to Follow-up|1|||
161711666|NCT00659438|583987504|FG001|Overall Study|Lost to Follow-up|0|||
161711667|NCT00201851|583987505|FG000|Overall Study|Lost to Follow-up|2|||
161711668|NCT00201851|583987506|FG001|Overall Study|Lost to Follow-up|1|||
161711669|NCT00201851|583987507|FG002|Overall Study|Lost to Follow-up|0|||
161711670|NCT00201851|583987505|FG000|Overall Study|Ineligible post enrollment|6|||
161711671|NCT00201851|583987506|FG001|Overall Study|Ineligible post enrollment|1|||
161711672|NCT00201851|583987507|FG002|Overall Study|Ineligible post enrollment|1|||
161711673|NCT02469246|583987508|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
161711674|NCT02469246|583987509|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
161711675|NCT02469246|583987508|FG000|Double-Blind Phase|Adverse Event|12|||
161711676|NCT02469246|583987509|FG001|Double-Blind Phase|Adverse Event|9|||
161711677|NCT02469246|583987508|FG000|Double-Blind Phase|Death|2|||
161711678|NCT02469246|583987509|FG001|Double-Blind Phase|Death|0|||
161711679|NCT02469246|583987508|FG000|Double-Blind Phase|Lack of Efficacy|2|||
161711680|NCT02469246|583987509|FG001|Double-Blind Phase|Lack of Efficacy|1|||
161711681|NCT02469246|583987508|FG000|Double-Blind Phase|Investigator's Discretion|8|||
161711682|NCT02469246|583987509|FG001|Double-Blind Phase|Investigator's Discretion|8|||
161711683|NCT02469246|583987508|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
161711684|NCT02469246|583987509|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
161711685|NCT02469246|583987508|FG000|Double-Blind Phase|Protocol Violation|1|||
161711686|NCT02469246|583987509|FG001|Double-Blind Phase|Protocol Violation|1|||
161711687|NCT02469246|583987508|FG000|Double-Blind Phase|Withdrew Consent|25|||
161711688|NCT02469246|583987509|FG001|Double-Blind Phase|Withdrew Consent|25|||
161711689|NCT02469246|583987508|FG000|Double-Blind Phase|Lost to Follow-up|9|||
161711690|NCT02469246|583987509|FG001|Double-Blind Phase|Lost to Follow-up|5|||
161711691|NCT02690701|583987513|FG000|Treatment Period 1|Adverse Event|2|||
161711692|NCT02690701|583987514|FG001|Treatment Period 1|Adverse Event|2|||
161711693|NCT02690701|583987513|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161711694|NCT02690701|583987514|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161711695|NCT02690701|583987513|FG000|Treatment Period 2|Adverse Event|2|||
161711696|NCT02690701|583987514|FG001|Treatment Period 2|Adverse Event|0|||
161711697|NCT02690701|583987513|FG000|Treatment Period 2|Lack of Efficacy|1|||
161711698|NCT02690701|583987514|FG001|Treatment Period 2|Lack of Efficacy|0|||
161711699|NCT02690701|583987513|FG000|Treatment Period 2|Lost to Follow-up|0|||
161711700|NCT02690701|583987514|FG001|Treatment Period 2|Lost to Follow-up|2|||
161711701|NCT02690701|583987513|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161711702|NCT02690701|583987514|FG001|Treatment Period 2|Withdrawal by Subject|2|||
161711703|NCT02690701|583987513|FG000|Treatment Period 2|Protocol Violation|0|||
161711704|NCT02690701|583987514|FG001|Treatment Period 2|Protocol Violation|1|||
161711705|NCT00404092|583987518|FG000|Overall Study|Death|1|||
161711706|NCT00404092|583987519|FG001|Overall Study|Death|0|||
161961032|NCT00819156|584902245|FG005|Overall Study|Adverse Event|3|||
161711707|NCT00404092|583987520|FG002|Overall Study|Death|0|||
161711708|NCT00404092|583987521|FG003|Overall Study|Death|0|||
161711709|NCT00404092|583987518|FG000|Overall Study|Adverse Event|0|||
161711710|NCT00404092|583987519|FG001|Overall Study|Adverse Event|0|||
161711711|NCT00404092|583987520|FG002|Overall Study|Adverse Event|1|||
161711712|NCT00404092|583987521|FG003|Overall Study|Adverse Event|0|||
161711713|NCT02344576|583987525|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
161711714|NCT02344576|583987526|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
161711715|NCT02344576|583987527|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
161711716|NCT02344576|583987528|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
161711717|NCT02344576|583987525|FG000|1-Month Follow-Up|Death|13|||
161711718|NCT02344576|583987526|FG001|1-Month Follow-Up|Death|8|||
161711719|NCT02344576|583987527|FG002|1-Month Follow-Up|Death|0|||
161711720|NCT02344576|583987528|FG003|1-Month Follow-Up|Death|0|||
161711721|NCT02344576|583987525|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
161711722|NCT02344576|583987526|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
161711723|NCT02344576|583987527|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
161711724|NCT02344576|583987528|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
161711725|NCT02344576|583987525|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
161711726|NCT02344576|583987526|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
161711727|NCT02344576|583987527|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
161711728|NCT02344576|583987528|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
161711729|NCT02344576|583987525|FG000|6-Month Follow-Up|Death|14|||
161711730|NCT02344576|583987526|FG001|6-Month Follow-Up|Death|14|||
161711731|NCT02344576|583987527|FG002|6-Month Follow-Up|Death|0|||
161711732|NCT02344576|583987528|FG003|6-Month Follow-Up|Death|0|||
161711733|NCT02344576|583987525|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
161711734|NCT02344576|583987526|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
161711735|NCT02344576|583987527|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
161711736|NCT02344576|583987528|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
161711737|NCT02344576|583987525|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
161711738|NCT02344576|583987526|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
161711739|NCT02344576|583987527|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
161711740|NCT02344576|583987528|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
161711741|NCT04325503|583987530|FG000|Overall Study|Withdrawal by Subject|1|||
161711742|NCT04325503|583987530|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
161711743|NCT02337387|583987531|FG000|Overall Study|Adverse Event|0|||
161711744|NCT02337387|583987532|FG001|Overall Study|Adverse Event|1|||
161711745|NCT02337387|583987533|FG002|Overall Study|Adverse Event|0|||
161711746|NCT02337387|583987534|FG003|Overall Study|Adverse Event|0|||
161711747|NCT02337387|583987531|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
161711748|NCT02337387|583987532|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
161711749|NCT02337387|583987533|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
161711750|NCT02337387|583987534|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
161711751|NCT01243268|583987535|FG000|Overall Study|Lost to Follow-up|4|||
161711752|NCT01243268|583987535|FG000|Overall Study|Protocol Violation|51|||
161711753|NCT01243268|583987535|FG000|Overall Study|Deviation with contract date|7|||
161711754|NCT01243268|583987535|FG000|Overall Study|Duplicate subject|2|||
161711755|NCT00702143|583987536|FG000|Overall Study|Lost to Follow-up|0|||
161711756|NCT00702143|583987537|FG001|Overall Study|Lost to Follow-up|0|||
161711757|NCT00702143|583987538|FG002|Overall Study|Lost to Follow-up|1|||
161711758|NCT03871491|583987541|FG000|Overall Study|Withdrawal by Subject|14|||
161711759|NCT03871491|583987542|FG001|Overall Study|Withdrawal by Subject|14|||
161711760|NCT03871491|583987543|FG002|Overall Study|Withdrawal by Subject|14|||
161711761|NCT03871491|583987544|FG003|Overall Study|Withdrawal by Subject|14|||
161711762|NCT03871491|583987541|FG000|Overall Study|Physician Decision|0|||
161711763|NCT03871491|583987542|FG001|Overall Study|Physician Decision|0|||
161711764|NCT03871491|583987543|FG002|Overall Study|Physician Decision|1|||
161711765|NCT03871491|583987544|FG003|Overall Study|Physician Decision|1|||
161711766|NCT03871491|583987541|FG000|Overall Study|Lost to Follow-up|50|||
161711767|NCT03871491|583987542|FG001|Overall Study|Lost to Follow-up|15|||
161711768|NCT03871491|583987543|FG002|Overall Study|Lost to Follow-up|36|||
161711769|NCT03871491|583987544|FG003|Overall Study|Lost to Follow-up|11|||
161711770|NCT04996797|583987545|FG000|Overall Study|Adverse Event|0|||
161711771|NCT04996797|583987546|FG001|Overall Study|Adverse Event|2|||
161711772|NCT04996797|583987547|FG002|Overall Study|Adverse Event|0|||
161711773|NCT04996797|583987548|FG003|Overall Study|Adverse Event|1|||
161711774|NCT04996797|583987545|FG000|Overall Study|Lack of Efficacy|0|||
161711775|NCT04996797|583987546|FG001|Overall Study|Lack of Efficacy|2|||
161711776|NCT04996797|583987547|FG002|Overall Study|Lack of Efficacy|0|||
161711777|NCT04996797|583987548|FG003|Overall Study|Lack of Efficacy|0|||
161711778|NCT04996797|583987545|FG000|Overall Study|Prohibited Medication|0|||
161711779|NCT04996797|583987546|FG001|Overall Study|Prohibited Medication|1|||
161711780|NCT04996797|583987547|FG002|Overall Study|Prohibited Medication|0|||
161711781|NCT04996797|583987548|FG003|Overall Study|Prohibited Medication|0|||
161711782|NCT04996797|583987545|FG000|Overall Study|Ongoing|68|||
161711783|NCT04996797|583987546|FG001|Overall Study|Ongoing|60|||
161711784|NCT04996797|583987547|FG002|Overall Study|Ongoing|22|||
162031408|NCT02519855|585172343|FG001|Overall Study|Lost to Follow-up|3|||
162031409|NCT02919969|585172344|FG000|Overall Study|Lack of Efficacy|22|||
162031410|NCT02919969|585172344|FG000|Overall Study|Death|4|||
162031411|NCT02919969|585172344|FG000|Overall Study|Physician Decision|3|||
162031412|NCT02919969|585172344|FG000|Overall Study|Withdrawal by Subject|2|||
162031413|NCT01842633|585172345|FG000|Overall Study|Screen Failure|1|||
162031414|NCT01842633|585172346|FG001|Overall Study|Screen Failure|0|||
162031415|NCT01842633|585172347|FG002|Overall Study|Screen Failure|0|||
162031416|NCT01842633|585172345|FG000|Overall Study|Adverse Event|1|||
162031417|NCT01842633|585172346|FG001|Overall Study|Adverse Event|1|||
162031418|NCT01842633|585172347|FG002|Overall Study|Adverse Event|0|||
162031419|NCT01842633|585172345|FG000|Overall Study|Withdrawal by Subject|0|||
162031420|NCT01842633|585172346|FG001|Overall Study|Withdrawal by Subject|1|||
162031421|NCT01842633|585172347|FG002|Overall Study|Withdrawal by Subject|0|||
162031422|NCT01842633|585172345|FG000|Overall Study|Technical issues|1|||
162031423|NCT01842633|585172346|FG001|Overall Study|Technical issues|0|||
162031424|NCT01842633|585172347|FG002|Overall Study|Technical issues|0|||
162031425|NCT02093351|585172351|FG000|Part A|Adverse Event|0|||
162031426|NCT02093351|585172352|FG001|Part A|Adverse Event|1|||
162031427|NCT02093351|585172353|FG002|Part A|Adverse Event|1|||
162031428|NCT02093351|585172354|FG003|Part A|Adverse Event|0|||
162031429|NCT02093351|585172351|FG000|Part A|Condition under investigation worsened|2|||
162031430|NCT02093351|585172352|FG001|Part A|Condition under investigation worsened|0|||
162031431|NCT02093351|585172353|FG002|Part A|Condition under investigation worsened|2|||
162031432|NCT02093351|585172354|FG003|Part A|Condition under investigation worsened|0|||
162031433|NCT02093351|585172351|FG000|Part A|Death|0|||
162031434|NCT02093351|585172352|FG001|Part A|Death|1|||
162031435|NCT02093351|585172353|FG002|Part A|Death|0|||
162031436|NCT02093351|585172354|FG003|Part A|Death|0|||
162031437|NCT02093351|585172351|FG000|Part B|Patient decision|0|||
162031438|NCT02093351|585172352|FG001|Part B|Patient decision|0|||
162031439|NCT02093351|585172353|FG002|Part B|Patient decision|0|||
162031440|NCT02093351|585172354|FG003|Part B|Patient decision|3|||
162031441|NCT02093351|585172351|FG000|Part B|Disease progression|0|||
162031442|NCT02093351|585172352|FG001|Part B|Disease progression|0|||
162031443|NCT02093351|585172353|FG002|Part B|Disease progression|0|||
162031444|NCT02093351|585172354|FG003|Part B|Disease progression|4|||
162031445|NCT02093351|585172351|FG000|Part B|Complete response|0|||
162031446|NCT02093351|585172352|FG001|Part B|Complete response|0|||
162031447|NCT02093351|585172353|FG002|Part B|Complete response|0|||
162031448|NCT02093351|585172354|FG003|Part B|Complete response|1|||
162031449|NCT02093351|585172351|FG000|Part B|Adverse event + disease progression|0|||
162031450|NCT02093351|585172352|FG001|Part B|Adverse event + disease progression|0|||
162031451|NCT02093351|585172353|FG002|Part B|Adverse event + disease progression|0|||
162031452|NCT02093351|585172354|FG003|Part B|Adverse event + disease progression|1|||
162031453|NCT02093351|585172351|FG000|Part B|Lack of therapeutic response|0|||
162031454|NCT02093351|585172352|FG001|Part B|Lack of therapeutic response|0|||
162031455|NCT02093351|585172353|FG002|Part B|Lack of therapeutic response|0|||
162031456|NCT02093351|585172354|FG003|Part B|Lack of therapeutic response|12|||
162031457|NCT02093351|585172351|FG000|Part B|Condition under investigation worsened|0|||
162031458|NCT02093351|585172352|FG001|Part B|Condition under investigation worsened|0|||
162031459|NCT02093351|585172353|FG002|Part B|Condition under investigation worsened|0|||
162031460|NCT02093351|585172354|FG003|Part B|Condition under investigation worsened|39|||
161711785|NCT04996797|583987548|FG003|Overall Study|Ongoing|20|||
161711786|NCT04996797|583987545|FG000|Overall Study|Withdrawal by Subject|0|||
161711787|NCT04996797|583987546|FG001|Overall Study|Withdrawal by Subject|2|||
161711788|NCT04996797|583987547|FG002|Overall Study|Withdrawal by Subject|0|||
161711789|NCT04996797|583987548|FG003|Overall Study|Withdrawal by Subject|0|||
161711790|NCT02793544|583987549|FG000|Overall Study|Death|10|||
161711791|NCT02793544|583987550|FG001|Overall Study|Death|8|||
161711792|NCT02793544|583987549|FG000|Overall Study|Lost to Follow-up|2|||
161711793|NCT02793544|583987550|FG001|Overall Study|Lost to Follow-up|0|||
161711794|NCT02793544|583987549|FG000|Overall Study|Withdrawal by Subject|1|||
161711795|NCT02793544|583987550|FG001|Overall Study|Withdrawal by Subject|0|||
161711796|NCT04091217|583987553|FG000|Overall Study|Lost to Follow-up|2|||
161711797|NCT01822561|583987554|FG000|Overall Study|Withdrawal by Subject|2|||
161711798|NCT02747004|583987555|FG000|Overall Study|Withdrawal by Subject|8|||
161711799|NCT02747004|583987556|FG001|Overall Study|Withdrawal by Subject|5|||
161711800|NCT02747004|583987557|FG002|Overall Study|Withdrawal by Subject|4|||
161711801|NCT02747004|583987555|FG000|Overall Study|Lost to Follow-up|1|||
161711802|NCT02747004|583987556|FG001|Overall Study|Lost to Follow-up|2|||
161711803|NCT02747004|583987557|FG002|Overall Study|Lost to Follow-up|2|||
161711804|NCT02747004|583987555|FG000|Overall Study|on study treatment/follow-up|48|||
161711805|NCT02747004|583987556|FG001|Overall Study|on study treatment/follow-up|42|||
161711806|NCT02747004|583987557|FG002|Overall Study|on study treatment/follow-up|41|||
161711807|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
161711808|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
161711809|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
161711810|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
161711811|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
161711812|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
161711813|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
161711814|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
161711815|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
161711816|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
161711817|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
161711818|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161711819|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161711820|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161711821|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161711822|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
161711823|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
161711824|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
161711825|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
161711826|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
161711827|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Death|0|||
161711828|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Death|1|||
161711829|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Death|0|||
161711830|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Death|0|||
161961033|NCT00819156|584902240|FG000|Overall Study|Withdrawal by Subject|0|||
161711831|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Death|0|||
161711832|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
161711833|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
161711834|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
161711835|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
161711836|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
161711837|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
161711838|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
161711839|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
161711840|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
161711841|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
161961034|NCT00819156|584902241|FG001|Overall Study|Withdrawal by Subject|3|||
161961035|NCT00819156|584902242|FG002|Overall Study|Withdrawal by Subject|2|||
161961036|NCT00819156|584902243|FG003|Overall Study|Withdrawal by Subject|0|||
161961037|NCT00819156|584902244|FG004|Overall Study|Withdrawal by Subject|1|||
161961038|NCT00819156|584902245|FG005|Overall Study|Withdrawal by Subject|0|||
161961039|NCT00819156|584902240|FG000|Overall Study|Protocol Violation|1|||
161961040|NCT00819156|584902241|FG001|Overall Study|Protocol Violation|0|||
161961041|NCT00819156|584902242|FG002|Overall Study|Protocol Violation|1|||
161961042|NCT00819156|584902243|FG003|Overall Study|Protocol Violation|0|||
161961043|NCT00819156|584902244|FG004|Overall Study|Protocol Violation|0|||
161961044|NCT00819156|584902245|FG005|Overall Study|Protocol Violation|1|||
161961045|NCT00819156|584902240|FG000|Overall Study|Lost to Follow-up|0|||
161961046|NCT00819156|584902241|FG001|Overall Study|Lost to Follow-up|1|||
161961047|NCT00819156|584902242|FG002|Overall Study|Lost to Follow-up|0|||
161961048|NCT00819156|584902243|FG003|Overall Study|Lost to Follow-up|0|||
161961049|NCT00819156|584902244|FG004|Overall Study|Lost to Follow-up|0|||
161961050|NCT00819156|584902245|FG005|Overall Study|Lost to Follow-up|2|||
161961051|NCT00819156|584902240|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
161961052|NCT00819156|584902241|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
161961053|NCT00819156|584902242|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
161961054|NCT00819156|584902243|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
161961055|NCT00819156|584902244|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
161961056|NCT00819156|584902245|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
161961057|NCT00819156|584902240|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
161961058|NCT00819156|584902241|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
161961059|NCT00819156|584902242|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
161961060|NCT00819156|584902243|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
161961061|NCT00819156|584902244|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
161961062|NCT00819156|584902245|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
161961063|NCT00819156|584902240|FG000|Overall Study|Prostate-specific antigen progression|0|||
161961064|NCT00819156|584902241|FG001|Overall Study|Prostate-specific antigen progression|0|||
161961065|NCT00819156|584902242|FG002|Overall Study|Prostate-specific antigen progression|0|||
161961066|NCT00819156|584902243|FG003|Overall Study|Prostate-specific antigen progression|0|||
161961067|NCT00819156|584902244|FG004|Overall Study|Prostate-specific antigen progression|1|||
161961068|NCT00819156|584902245|FG005|Overall Study|Prostate-specific antigen progression|0|||
161961069|NCT02175277|584902246|FG000|Overall Study|Protocol-specified Criteria|1|||
161961070|NCT01082081|584902247|FG000|Overall Study|Lost to Follow-up|0|||
161961071|NCT01082081|584902248|FG001|Overall Study|Lost to Follow-up|0|||
161961072|NCT01082081|584902249|FG002|Overall Study|Lost to Follow-up|1|||
161961073|NCT01082081|584902247|FG000|Overall Study|Withdrawal by Subject|0|||
161961074|NCT01082081|584902248|FG001|Overall Study|Withdrawal by Subject|0|||
161961075|NCT01082081|584902249|FG002|Overall Study|Withdrawal by Subject|1|||
161961076|NCT01082081|584902247|FG000|Overall Study|Other Reason|0|||
161961077|NCT01082081|584902248|FG001|Overall Study|Other Reason|1|||
161961078|NCT01082081|584902249|FG002|Overall Study|Other Reason|0|||
161961079|NCT01042158|584902250|FG000|Overall Study|Physician Decision|1|||
161961080|NCT01575808|584902251|FG000|Overall Study|Death|2|||
161711842|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
161961081|NCT01575808|584902252|FG001|Overall Study|Death|0|||
161961082|NCT01575808|584902251|FG000|Overall Study|Withdrawal by Subject|1|||
161961083|NCT01575808|584902252|FG001|Overall Study|Withdrawal by Subject|0|||
161961084|NCT03159468|584902253|FG000|Overall Study|Withdrawal by Subject|0|||
161961085|NCT03159468|584902254|FG001|Overall Study|Withdrawal by Subject|0|||
161961086|NCT03159468|584902255|FG002|Overall Study|Withdrawal by Subject|3|||
161961087|NCT03159468|584902256|FG003|Overall Study|Withdrawal by Subject|0|||
161961088|NCT03159468|584902257|FG004|Overall Study|Withdrawal by Subject|0|||
161961089|NCT03159468|584902258|FG005|Overall Study|Withdrawal by Subject|0|||
161961090|NCT00875485|584903984|FG000|Challenge Dose Epoch|Pregnancy|1|||
161961091|NCT00875485|584903985|FG001|Challenge Dose Epoch|Pregnancy|0|||
161961092|NCT01271010|584903986|FG000|Overall Study|Reason not specified|11|||
161711843|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
161711844|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
161711845|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
161711846|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
161711847|NCT05087030|583987558|FG000|Main Period (Week 0 to Week 52)|Other|1|||
161711848|NCT05087030|583987559|FG001|Main Period (Week 0 to Week 52)|Other|2|||
161711849|NCT05087030|583987560|FG002|Main Period (Week 0 to Week 52)|Other|0|||
161711850|NCT05087030|583987561|FG003|Main Period (Week 0 to Week 52)|Other|0|||
161711851|NCT05087030|583987562|FG004|Main Period (Week 0 to Week 52)|Other|0|||
161711852|NCT05087030|583987558|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161711853|NCT05087030|583987559|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161711854|NCT05087030|583987560|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161711855|NCT05087030|583987561|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161711856|NCT05087030|583987562|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
161711857|NCT01444300|583987563|FG000|Overall Study|Adverse Event|4|||
161711858|NCT01444300|583987564|FG001|Overall Study|Adverse Event|0|||
161711859|NCT01523873|583987570|FG000|Overall Study|Protocol Violation|422|||
161711860|NCT00942409|583989001|FG000|Overall Study|Lack of Efficacy|1|||
161711861|NCT00942409|583989001|FG000|Overall Study|study drug unavailable|2|||
161711862|NCT01697215|583989002|FG000|Overall Study|Physician Decision|5|||
161711863|NCT01697215|583989002|FG000|Overall Study|Malfunction|9|||
161711864|NCT01697215|583989002|FG000|Overall Study|CXR not available|9|||
161711865|NCT01929083|583989003|FG000|Intervention 1|Lost to Follow-up|2|||
161711866|NCT01929083|583989004|FG001|Intervention 1|Lost to Follow-up|0|||
161711867|NCT01929083|583989003|FG000|Intervention 1|Nonadherent to study medications|1|||
161711868|NCT01929083|583989004|FG001|Intervention 1|Nonadherent to study medications|0|||
161711869|NCT01929083|583989003|FG000|Intervention 2|Adverse Event|0|||
161711870|NCT01929083|583989004|FG001|Intervention 2|Adverse Event|1|||
161711871|NCT02599402|583989005|FG000|Overall Study|Disease progression|153|||
161711872|NCT02599402|583989005|FG000|Overall Study|Study drug toxicity|201|||
161711873|NCT02599402|583989005|FG000|Overall Study|Death|26|||
161711874|NCT02599402|583989005|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
161711875|NCT02599402|583989005|FG000|Overall Study|Participant request to discontinue study treatment|13|||
161711876|NCT02599402|583989005|FG000|Overall Study|Participant withdrew consent|5|||
161711877|NCT02599402|583989005|FG000|Overall Study|Lost to Follow-up|1|||
161711878|NCT02599402|583989005|FG000|Overall Study|Maximum Clinical Benefit|7|||
161711879|NCT02599402|583989005|FG000|Overall Study|Poor/non-compliance|1|||
161711880|NCT02599402|583989005|FG000|Overall Study|Pregnancy|1|||
161711881|NCT02599402|583989005|FG000|Overall Study|Participant no longer met study criteria|7|||
161711882|NCT02599402|583989005|FG000|Overall Study|Other Reasons|95|||
161711883|NCT02945657|583989006|FG000|Overall Study|Adverse Event|1|||
161711884|NCT02945657|583989006|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
161711885|NCT00087438|583989011|FG000|Overall Study|Ineligible / No protocol treatment|4|||
162031461|NCT02093351|585172351|FG000|Part B|Adverse Event|0|||
162031462|NCT02093351|585172352|FG001|Part B|Adverse Event|0|||
162031463|NCT02093351|585172353|FG002|Part B|Adverse Event|0|||
162031464|NCT02093351|585172354|FG003|Part B|Adverse Event|2|||
162031465|NCT02093351|585172351|FG000|Part B|Death|0|||
162031466|NCT02093351|585172352|FG001|Part B|Death|0|||
162031467|NCT02093351|585172353|FG002|Part B|Death|0|||
162031468|NCT02093351|585172354|FG003|Part B|Death|1|||
162031469|NCT03565367|585172355|FG000|Overall Study|No scan due to technical issues|4|||
162031470|NCT03565367|585172356|FG001|Overall Study|No scan due to technical issues|0|||
162031471|NCT01099709|585172359|FG000|Period 1|Withdrawal by Subject|0|||
162031472|NCT01099709|585172360|FG001|Period 1|Withdrawal by Subject|1|||
162031473|NCT01099709|585172359|FG000|Period 1|Positive cotinine test|0|||
162031474|NCT01099709|585172360|FG001|Period 1|Positive cotinine test|1|||
162031475|NCT01099709|585172359|FG000|Period 1|Adverse Event|1|||
162031476|NCT01099709|585172360|FG001|Period 1|Adverse Event|0|||
162031477|NCT00923364|585172362|FG000|Overall Study|Death|3|||
162031478|NCT00923364|585172363|FG001|Overall Study|Death|0|||
162031479|NCT00923364|585172362|FG000|Overall Study|Did not go to transplant|1|||
162031480|NCT00923364|585172363|FG001|Overall Study|Did not go to transplant|0|||
162031481|NCT01397825|585172367|FG000|Overall Study|Progressive Disease|10|||
162031482|NCT01397825|585172368|FG001|Overall Study|Progressive Disease|3|||
162031483|NCT01397825|585172369|FG002|Overall Study|Progressive Disease|11|||
162031484|NCT01397825|585172370|FG003|Overall Study|Progressive Disease|1|||
162031485|NCT01397825|585172371|FG004|Overall Study|Progressive Disease|0|||
162031486|NCT01397825|585172367|FG000|Overall Study|Symptomatic Deterioration|2|||
162031487|NCT01397825|585172368|FG001|Overall Study|Symptomatic Deterioration|0|||
162031488|NCT01397825|585172369|FG002|Overall Study|Symptomatic Deterioration|4|||
162031489|NCT01397825|585172370|FG003|Overall Study|Symptomatic Deterioration|0|||
162031490|NCT01397825|585172371|FG004|Overall Study|Symptomatic Deterioration|0|||
162031491|NCT01397825|585172367|FG000|Overall Study|Adverse Event|0|||
162031492|NCT01397825|585172368|FG001|Overall Study|Adverse Event|1|||
161711886|NCT00283387|583989012|FG000|First Intervention|Subject non-compliant|1|||
161711887|NCT00283387|583989013|FG001|First Intervention|Subject non-compliant|1|||
161711888|NCT00283387|583989012|FG000|First Intervention|Withdrawal by Subject|0|||
161711889|NCT00283387|583989013|FG001|First Intervention|Withdrawal by Subject|1|||
161711890|NCT05340504|583989014|FG000|Overall Study|Withdrawal by Subject|1|||
161711891|NCT05340504|583989015|FG001|Overall Study|Withdrawal by Subject|0|||
161711892|NCT03068715|583989019|FG000|Overall Study|No longer met inclusion criteria|1|||
161711893|NCT03068715|583989020|FG001|Overall Study|No longer met inclusion criteria|0|||
161711894|NCT00728416|583989021|FG000|Overall Study|Adverse Event|1|||
161711895|NCT00728416|583989022|FG001|Overall Study|Adverse Event|1|||
161711896|NCT00728416|583989021|FG000|Overall Study|Treatment Failure|0|||
161711897|NCT00728416|583989022|FG001|Overall Study|Treatment Failure|1|||
161711898|NCT00728416|583989021|FG000|Overall Study|Withdrawal by Subject|1|||
161711899|NCT00728416|583989022|FG001|Overall Study|Withdrawal by Subject|0|||
161711900|NCT00117312|583989023|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
161711901|NCT00117312|583989024|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
161711902|NCT00117312|583989025|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
161711903|NCT00117312|583989026|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
161711904|NCT00117312|583989023|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
161711905|NCT00117312|583989024|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
161711906|NCT00117312|583989025|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
161711907|NCT00117312|583989026|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
161711908|NCT00117312|583989023|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
161711909|NCT00117312|583989024|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
161711910|NCT00117312|583989025|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
161711911|NCT00117312|583989026|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
161711912|NCT00117312|583989023|FG000|Overall Study|Other|0|||
161711913|NCT00117312|583989024|FG001|Overall Study|Other|1|||
161711914|NCT00117312|583989025|FG002|Overall Study|Other|3|||
161711915|NCT00117312|583989026|FG003|Overall Study|Other|1|||
161711916|NCT00117312|583989023|FG000|Overall Study|Patient choice|0|||
161711917|NCT00117312|583989024|FG001|Overall Study|Patient choice|0|||
161711918|NCT00117312|583989025|FG002|Overall Study|Patient choice|2|||
161711919|NCT00117312|583989026|FG003|Overall Study|Patient choice|1|||
161711920|NCT00117312|583989023|FG000|Overall Study|Adverse Event|0|||
161711921|NCT00117312|583989024|FG001|Overall Study|Adverse Event|2|||
162031493|NCT01397825|585172369|FG002|Overall Study|Adverse Event|5|||
162031494|NCT01397825|585172370|FG003|Overall Study|Adverse Event|1|||
162031495|NCT01397825|585172371|FG004|Overall Study|Adverse Event|0|||
162031496|NCT01397825|585172367|FG000|Overall Study|Withdrawal by Subject|1|||
162031497|NCT01397825|585172368|FG001|Overall Study|Withdrawal by Subject|0|||
162031498|NCT01397825|585172369|FG002|Overall Study|Withdrawal by Subject|5|||
162031499|NCT01397825|585172370|FG003|Overall Study|Withdrawal by Subject|1|||
162031500|NCT01397825|585172371|FG004|Overall Study|Withdrawal by Subject|0|||
162031501|NCT01931670|585172372|FG000|Treatment Period|Exclusionary Medication Received|1|||
162031502|NCT01931670|585172373|FG001|Treatment Period|Exclusionary Medication Received|1|||
162031503|NCT01931670|585172374|FG002|Treatment Period|Exclusionary Medication Received|1|||
161711922|NCT00117312|583989025|FG002|Overall Study|Adverse Event|0|||
161711923|NCT00117312|583989026|FG003|Overall Study|Adverse Event|0|||
161711924|NCT00117312|583989023|FG000|Overall Study|Protocol Violation|0|||
161711925|NCT00117312|583989024|FG001|Overall Study|Protocol Violation|1|||
161711926|NCT00117312|583989025|FG002|Overall Study|Protocol Violation|3|||
161711927|NCT00117312|583989026|FG003|Overall Study|Protocol Violation|0|||
161711928|NCT00117312|583989023|FG000|Overall Study|PSA decrease <=50%|0|||
161711929|NCT00117312|583989024|FG001|Overall Study|PSA decrease <=50%|2|||
161711930|NCT00117312|583989025|FG002|Overall Study|PSA decrease <=50%|2|||
161711931|NCT00117312|583989026|FG003|Overall Study|PSA decrease <=50%|4|||
161711932|NCT00117312|583989023|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
161711933|NCT00117312|583989024|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
161711934|NCT00117312|583989025|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
161711935|NCT00117312|583989026|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
161711936|NCT00117312|583989023|FG000|Overall Study|Hepatic abnormality|0|||
161711937|NCT00117312|583989024|FG001|Overall Study|Hepatic abnormality|1|||
161711938|NCT00117312|583989025|FG002|Overall Study|Hepatic abnormality|0|||
161711939|NCT00117312|583989026|FG003|Overall Study|Hepatic abnormality|1|||
161711940|NCT00117312|583989023|FG000|Overall Study|Withdrawal by Subject|0|||
161711941|NCT00117312|583989024|FG001|Overall Study|Withdrawal by Subject|2|||
161711942|NCT00117312|583989025|FG002|Overall Study|Withdrawal by Subject|0|||
161711943|NCT00117312|583989026|FG003|Overall Study|Withdrawal by Subject|0|||
161711944|NCT01120626|583989027|FG000|Overall Study|Withdrawal by Subject|1|||
161711945|NCT01120626|583989028|FG001|Overall Study|Withdrawal by Subject|0|||
161711946|NCT00509106|583989030|FG000|Overall Study|Adverse Event|3|||
161711947|NCT00509106|583989031|FG001|Overall Study|Adverse Event|2|||
161711948|NCT00509106|583989030|FG000|Overall Study|Noncompliance|0|||
161711949|NCT00509106|583989031|FG001|Overall Study|Noncompliance|1|||
161711950|NCT00509106|583989030|FG000|Overall Study|At the request of sponsor/investigator|1|||
161711951|NCT00509106|583989031|FG001|Overall Study|At the request of sponsor/investigator|2|||
161711952|NCT00509106|583989030|FG000|Overall Study|Withdrew consent|4|||
161711953|NCT00509106|583989031|FG001|Overall Study|Withdrew consent|8|||
161711954|NCT00509106|583989030|FG000|Overall Study|Lost to Follow-up|16|||
161711955|NCT00509106|583989031|FG001|Overall Study|Lost to Follow-up|10|||
161711956|NCT00509106|583989030|FG000|Overall Study|Other|1|||
161711957|NCT00509106|583989031|FG001|Overall Study|Other|0|||
161711958|NCT00509106|583989030|FG000|Overall Study|Death|6|||
161711959|NCT00509106|583989031|FG001|Overall Study|Death|6|||
161711960|NCT03527043|583989034|FG000|Overall Study|Withdrawal by Subject|1|||
161711961|NCT03527043|583989035|FG001|Overall Study|Withdrawal by Subject|0|||
161711962|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
161711963|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
161711964|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
161711965|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
161711966|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
161711967|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
161711968|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Personal issues|2|||
161711969|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Personal issues|0|||
161711970|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Personal issues|0|||
161711971|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Too busy|7|||
161711972|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Too busy|1|||
161711973|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Too busy|0|||
161711974|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Pain|2|||
161711975|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Pain|0|||
161711976|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Pain|0|||
161711977|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Moved|1|||
161711978|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Moved|0|||
161711979|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Moved|0|||
161711980|NCT00594399|583989037|FG000|Initial 3 Month Counseling|Family illness|1|||
161711981|NCT00594399|583989038|FG001|Initial 3 Month Counseling|Family illness|0|||
161711982|NCT00594399|583989039|FG002|Initial 3 Month Counseling|Family illness|0|||
161961093|NCT01271010|584903986|FG000|Overall Study|Start of new CLL therapy|1|||
161961094|NCT01271010|584903986|FG000|Overall Study|Protocol Violation|1|||
161961095|NCT01271010|584903986|FG000|Overall Study|Death|2|||
161961096|NCT01271010|584903986|FG000|Overall Study|Progression and relapse of disease|1|||
161711983|NCT00594399|583989037|FG000|Rerandomization Arm 1 Only|Death|2|||
161961097|NCT01271010|584903986|FG000|Overall Study|Withdrawal by Subject|18|||
161711984|NCT00594399|583989038|FG001|Rerandomization Arm 1 Only|Death|1|||
161961098|NCT01271010|584903986|FG000|Overall Study|Disease progression|27|||
161711985|NCT00594399|583989039|FG002|Rerandomization Arm 1 Only|Death|0|||
161711986|NCT00594399|583989037|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
161711987|NCT00594399|583989038|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
161711988|NCT00594399|583989039|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
161711989|NCT03830281|583989040|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
161711990|NCT03830281|583989041|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
161711991|NCT03830281|583989040|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
161961099|NCT01631747|584903987|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
161711992|NCT03830281|583989041|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
161711993|NCT03830281|583989040|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
161711994|NCT03830281|583989041|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
161711995|NCT03830281|583989040|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
161711996|NCT03830281|583989041|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
161711997|NCT03830281|583989040|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
161711998|NCT03830281|583989041|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
161711999|NCT03830281|583989040|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
161712000|NCT03830281|583989041|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
161712001|NCT03830281|583989040|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
161712002|NCT03830281|583989041|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
161712003|NCT03830281|583989040|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
161712004|NCT03830281|583989041|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
161712005|NCT03830281|583989040|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
161712006|NCT03830281|583989041|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
161712007|NCT00922935|583989042|FG000|Overall Study|Protocol Violation|0|||
161712008|NCT00922935|583989043|FG001|Overall Study|Protocol Violation|3|||
161712009|NCT00922935|583989044|FG002|Overall Study|Protocol Violation|0|||
161712010|NCT00922935|583989042|FG000|Overall Study|Physician Decision|1|||
161712011|NCT00922935|583989043|FG001|Overall Study|Physician Decision|1|||
161712012|NCT00922935|583989044|FG002|Overall Study|Physician Decision|0|||
161712013|NCT00922935|583989042|FG000|Overall Study|Lost to Follow-up|0|||
161712014|NCT00922935|583989043|FG001|Overall Study|Lost to Follow-up|1|||
161712015|NCT00922935|583989044|FG002|Overall Study|Lost to Follow-up|0|||
161712016|NCT01491945|583989045|FG000|Overall Study|Death|30|||
161712017|NCT01491945|583989045|FG000|Overall Study|Withdrwan/LTF|16|||
161712018|NCT01491945|583989045|FG000|Overall Study|Conversion|4|||
161712019|NCT01491945|583989045|FG000|Overall Study|Missed Visit|1|||
161712020|NCT02201940|583989046|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
161712021|NCT02201940|583989047|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
161712022|NCT02201940|583989046|FG000|Overall Study|Lack of Efficacy|2|||
161712023|NCT02201940|583989047|FG001|Overall Study|Lack of Efficacy|113|||
161712024|NCT02201940|583989046|FG000|Overall Study|Lost to Follow-up|5|||
161712025|NCT02201940|583989047|FG001|Overall Study|Lost to Follow-up|0|||
161712026|NCT02201940|583989046|FG000|Overall Study|Withdrew Consent|2|||
161712027|NCT02201940|583989047|FG001|Overall Study|Withdrew Consent|1|||
161712028|NCT02201940|583989046|FG000|Overall Study|Investigator's Discretion|1|||
161712029|NCT02201940|583989047|FG001|Overall Study|Investigator's Discretion|1|||
161712030|NCT02201940|583989046|FG000|Overall Study|Death|1|||
161712031|NCT02201940|583989047|FG001|Overall Study|Death|0|||
161712032|NCT02201940|583989046|FG000|Overall Study|Adverse Event|0|||
161712033|NCT02201940|583989047|FG001|Overall Study|Adverse Event|1|||
161712034|NCT00074958|583989049|FG000|Overall Study|Adverse Event|1|||
161712035|NCT02700451|583989053|FG000|Overall Study|Protocol Violation|2|||
161712036|NCT02700451|583989054|FG001|Overall Study|Protocol Violation|2|||
161712037|NCT02700451|583989055|FG002|Overall Study|Protocol Violation|3|||
161712038|NCT02700451|583989053|FG000|Overall Study|Discontinued intervention|14|||
161712039|NCT02700451|583989054|FG001|Overall Study|Discontinued intervention|15|||
161712040|NCT02700451|583989055|FG002|Overall Study|Discontinued intervention|14|||
161712041|NCT01511445|583989056|FG000|Overall Study|Lost to Follow-up|3|||
161712042|NCT01511445|583989057|FG001|Overall Study|Lost to Follow-up|1|||
161712043|NCT01511445|583989056|FG000|Overall Study|Protocol Violation|1|||
161712044|NCT01511445|583989057|FG001|Overall Study|Protocol Violation|3|||
161712045|NCT01511445|583989056|FG000|Overall Study|Protocol Violation|1|||
161712046|NCT01511445|583989057|FG001|Overall Study|Protocol Violation|0|||
161712047|NCT00709202|583989058|FG000|Overall Study|Withdrawal by Subject|6|||
161712048|NCT00709202|583989059|FG001|Overall Study|Withdrawal by Subject|6|||
161712049|NCT03133767|583989060|FG000|Overall Study|Lost to Follow-up|38|||
161712050|NCT03133767|583989061|FG001|Overall Study|Lost to Follow-up|24|||
161712051|NCT03133767|583989060|FG000|Overall Study|Protocol Violation|0|||
161712052|NCT03133767|583989061|FG001|Overall Study|Protocol Violation|1|||
161712053|NCT01856114|583989075|FG000|Overall Study|Withdrawal by Subject|1|||
161712054|NCT01856114|583989076|FG001|Overall Study|Withdrawal by Subject|0|||
161712055|NCT01856114|583989075|FG000|Overall Study|Adverse Event|1|||
161712056|NCT01856114|583989076|FG001|Overall Study|Adverse Event|0|||
161712057|NCT02853760|583989077|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
161712058|NCT02853760|583989078|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
161712059|NCT02853760|583989079|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
161712060|NCT02853760|583989080|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
161712061|NCT02853760|583989081|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
161712062|NCT02853760|583989082|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
161712063|NCT01642212|583989083|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
161712064|NCT01642212|583989084|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
161712065|NCT01642212|583989085|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
161712066|NCT01642212|583989086|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
161712067|NCT01642212|583989087|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
161712068|NCT01642212|583989083|FG000|Double-blind Treatment|Other|0|||
161712069|NCT01642212|583989084|FG001|Double-blind Treatment|Other|2|||
161712070|NCT01642212|583989085|FG002|Double-blind Treatment|Other|1|||
161712071|NCT01642212|583989086|FG003|Double-blind Treatment|Other|0|||
161712072|NCT01642212|583989087|FG004|Double-blind Treatment|Other|0|||
161712073|NCT01642212|583989083|FG000|Double-blind Treatment|Non-compliance|0|||
161712074|NCT01642212|583989084|FG001|Double-blind Treatment|Non-compliance|1|||
161712075|NCT01642212|583989085|FG002|Double-blind Treatment|Non-compliance|0|||
161712076|NCT01642212|583989086|FG003|Double-blind Treatment|Non-compliance|0|||
161712077|NCT01642212|583989087|FG004|Double-blind Treatment|Non-compliance|0|||
161712078|NCT01642212|583989083|FG000|Double-blind Treatment|Adverse Event|0|||
161712079|NCT01642212|583989084|FG001|Double-blind Treatment|Adverse Event|0|||
161712080|NCT01642212|583989085|FG002|Double-blind Treatment|Adverse Event|1|||
161712081|NCT01642212|583989086|FG003|Double-blind Treatment|Adverse Event|0|||
161712082|NCT01642212|583989087|FG004|Double-blind Treatment|Adverse Event|0|||
161712083|NCT01642212|583989083|FG000|Open-label Extension|Adverse Event|0|||
161712084|NCT01642212|583989084|FG001|Open-label Extension|Adverse Event|0|||
161712085|NCT01642212|583989085|FG002|Open-label Extension|Adverse Event|0|||
161712086|NCT01642212|583989086|FG003|Open-label Extension|Adverse Event|3|||
161712087|NCT01642212|583989087|FG004|Open-label Extension|Adverse Event|0|||
161712088|NCT01642212|583989083|FG000|Open-label Extension|Sponsor Decision|0|||
161712089|NCT01642212|583989084|FG001|Open-label Extension|Sponsor Decision|0|||
161712090|NCT01642212|583989085|FG002|Open-label Extension|Sponsor Decision|0|||
161712091|NCT01642212|583989086|FG003|Open-label Extension|Sponsor Decision|7|||
161712092|NCT01642212|583989087|FG004|Open-label Extension|Sponsor Decision|4|||
161712093|NCT01642212|583989083|FG000|Open-label Extension|Consent Withdrawn|0|||
161712094|NCT01642212|583989084|FG001|Open-label Extension|Consent Withdrawn|0|||
161712095|NCT01642212|583989085|FG002|Open-label Extension|Consent Withdrawn|0|||
161712096|NCT01642212|583989086|FG003|Open-label Extension|Consent Withdrawn|0|||
161712097|NCT01642212|583989087|FG004|Open-label Extension|Consent Withdrawn|2|||
161712098|NCT01642212|583989083|FG000|Open-label Extension|Lost to Follow-up|0|||
161712099|NCT01642212|583989084|FG001|Open-label Extension|Lost to Follow-up|0|||
161712100|NCT01642212|583989085|FG002|Open-label Extension|Lost to Follow-up|0|||
161712101|NCT01642212|583989086|FG003|Open-label Extension|Lost to Follow-up|0|||
161712102|NCT01642212|583989087|FG004|Open-label Extension|Lost to Follow-up|1|||
161712103|NCT01642212|583989083|FG000|Open-label Extension|Other|0|||
161712104|NCT01642212|583989084|FG001|Open-label Extension|Other|0|||
161712105|NCT01642212|583989085|FG002|Open-label Extension|Other|0|||
161712106|NCT01642212|583989086|FG003|Open-label Extension|Other|0|||
161712107|NCT01642212|583989087|FG004|Open-label Extension|Other|1|||
161712108|NCT01624142|583989089|FG000|Overall Study|Withdrawal by Subject|14|||
161712109|NCT01624142|583989090|FG001|Overall Study|Withdrawal by Subject|4|||
161712110|NCT01624142|583989089|FG000|Overall Study|Death|3|||
161712111|NCT01624142|583989090|FG001|Overall Study|Death|6|||
161712112|NCT01624142|583989089|FG000|Overall Study|Study Closure|12|||
161712113|NCT01624142|583989090|FG001|Overall Study|Study Closure|6|||
161712114|NCT01624142|583989089|FG000|Overall Study|Lost to Follow-up|2|||
161712115|NCT01624142|583989090|FG001|Overall Study|Lost to Follow-up|0|||
161712116|NCT01624142|583989089|FG000|Overall Study|Other|1|||
161712117|NCT01624142|583989090|FG001|Overall Study|Other|0|||
161712118|NCT00667277|583989091|FG000|Overall Study|Withdrawal by Subject|2|||
161712119|NCT04826900|583989092|FG000|Overall Study|Family factor|1|||
161712120|NCT04826900|583989093|FG001|Overall Study|Family factor|1|||
161712121|NCT02597062|583989095|FG000|Overall Study|Ineligible|1|||
161712122|NCT03372941|583989096|FG000|Overall Study|Lost to Follow-up|2|||
161712123|NCT03372941|583989097|FG001|Overall Study|Lost to Follow-up|4|||
161712124|NCT00741819|583989098|FG000|Overall Study|Adverse Event|3|||
161712125|NCT00741819|583989098|FG000|Overall Study|Withdrawal by Subject|3|||
161712126|NCT00741819|583989098|FG000|Overall Study|Death|1|||
161712127|NCT00741819|583989098|FG000|Overall Study|Disease progression|1|||
161712128|NCT00686543|583989101|FG000|Overall Study|Adverse Event|9|||
161712129|NCT00686543|583989102|FG001|Overall Study|Adverse Event|1|||
161712130|NCT00686543|583989103|FG002|Overall Study|Adverse Event|3|||
161712131|NCT00686543|583989104|FG003|Overall Study|Adverse Event|2|||
161712132|NCT00686543|583989101|FG000|Overall Study|Withdrawal by Subject|2|||
161712133|NCT00686543|583989102|FG001|Overall Study|Withdrawal by Subject|0|||
161712134|NCT00686543|583989103|FG002|Overall Study|Withdrawal by Subject|0|||
161712135|NCT00686543|583989104|FG003|Overall Study|Withdrawal by Subject|0|||
161712136|NCT00686543|583989101|FG000|Overall Study|Protocol Violation|3|||
161712137|NCT00686543|583989102|FG001|Overall Study|Protocol Violation|0|||
161712138|NCT00686543|583989103|FG002|Overall Study|Protocol Violation|2|||
161712139|NCT00686543|583989104|FG003|Overall Study|Protocol Violation|1|||
161712140|NCT01053429|583989105|FG000|Overall Study|Adverse Event|64|||
161712141|NCT01053429|583989105|FG000|Overall Study|Other|309|||
161712142|NCT00752986|583989106|FG000|Overall Study|Withdrawal by Subject|2|||
161712143|NCT00752986|583989107|FG001|Overall Study|Withdrawal by Subject|1|||
161712144|NCT00752986|583989108|FG002|Overall Study|Withdrawal by Subject|2|||
162031504|NCT01931670|585172372|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
162031505|NCT01931670|585172373|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
162031506|NCT01931670|585172374|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
162031507|NCT01931670|585172372|FG000|Treatment Period|Subject Noncompliant|4|||
162031508|NCT01931670|585172373|FG001|Treatment Period|Subject Noncompliant|9|||
162031509|NCT01931670|585172374|FG002|Treatment Period|Subject Noncompliant|5|||
162031510|NCT01931670|585172372|FG000|Treatment Period|Adverse Event|19|||
162031511|NCT01931670|585172373|FG001|Treatment Period|Adverse Event|8|||
162031512|NCT01931670|585172374|FG002|Treatment Period|Adverse Event|21|||
162031513|NCT01931670|585172372|FG000|Treatment Period|Lack of Efficacy|11|||
162031514|NCT01931670|585172373|FG001|Treatment Period|Lack of Efficacy|2|||
162031515|NCT01931670|585172374|FG002|Treatment Period|Lack of Efficacy|2|||
162031516|NCT01931670|585172372|FG000|Treatment Period|Pregnancy|7|||
162031517|NCT01931670|585172373|FG001|Treatment Period|Pregnancy|2|||
162031518|NCT01931670|585172374|FG002|Treatment Period|Pregnancy|0|||
162031519|NCT01931670|585172372|FG000|Treatment Period|Other|8|||
162031520|NCT01931670|585172373|FG001|Treatment Period|Other|7|||
162031521|NCT01931670|585172374|FG002|Treatment Period|Other|2|||
162031522|NCT01931670|585172372|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
162031523|NCT01931670|585172373|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
162031524|NCT01931670|585172374|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
162031525|NCT01931670|585172372|FG000|Treatment Period|Lost to Follow-up|19|||
162031526|NCT01931670|585172373|FG001|Treatment Period|Lost to Follow-up|5|||
162031527|NCT01931670|585172374|FG002|Treatment Period|Lost to Follow-up|7|||
162031528|NCT01931670|585172372|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
162031529|NCT01931670|585172373|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
162031530|NCT01931670|585172374|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
161712145|NCT00752986|583989106|FG000|Overall Study|Protocol Violation|3|||
161712146|NCT00752986|583989107|FG001|Overall Study|Protocol Violation|0|||
161712147|NCT00752986|583989108|FG002|Overall Study|Protocol Violation|0|||
161712148|NCT01697345|583989109|FG000|Overall Study|Withdrawal by Subject|1|||
161712149|NCT00924703|583989110|FG000|Overall Study|Withdrawal by Subject|11|||
161712150|NCT00924703|583989110|FG000|Overall Study|Physician Decision|5|||
161712151|NCT00924703|583989110|FG000|Overall Study|Lost to Follow-up|3|||
161712152|NCT00924703|583989110|FG000|Overall Study|Adverse Event|2|||
161712153|NCT00924703|583989110|FG000|Overall Study|Withdrawal by Sponsor|1|||
161712154|NCT04906707|583989111|FG000|Overall Study|Withdrawal by Subject|2|||
161712155|NCT04906707|583989112|FG001|Overall Study|Withdrawal by Subject|0|||
161712156|NCT04906707|583989111|FG000|Overall Study|Withdrawal due to PI decision|1|||
161712157|NCT04906707|583989112|FG001|Overall Study|Withdrawal due to PI decision|0|||
161712158|NCT04906707|583989111|FG000|Overall Study|Lost to Follow-up|0|||
161712159|NCT04906707|583989112|FG001|Overall Study|Lost to Follow-up|1|||
161712160|NCT01976806|583989113|FG000|Overall Study|Lost to Follow-up|1|||
161712161|NCT01976806|583989114|FG001|Overall Study|Lost to Follow-up|4|||
161712162|NCT01976806|583989113|FG000|Overall Study|Adverse Event|1|||
161712163|NCT01976806|583989114|FG001|Overall Study|Adverse Event|1|||
161712164|NCT01976806|583989113|FG000|Overall Study|Withdrawal by Subject|1|||
161712165|NCT01976806|583989114|FG001|Overall Study|Withdrawal by Subject|1|||
161712166|NCT03929250|583989117|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
161712167|NCT03929250|583989118|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
161712168|NCT04429022|583989121|FG000|Overall Study|Protocol Violation|18|||
161712169|NCT04429022|583989122|FG001|Overall Study|Protocol Violation|1|||
161712170|NCT00045032|583989127|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
161712171|NCT00045032|583989128|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
161712172|NCT00045032|583989129|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
161712173|NCT00045032|583989127|FG000|Overall Study|Death|22|||
161712174|NCT00045032|583989128|FG001|Overall Study|Death|24|||
161712175|NCT00045032|583989129|FG002|Overall Study|Death|17|||
161712176|NCT00045032|583989127|FG000|Overall Study|Insufficient Therapeutic Response|542|||
161712177|NCT00045032|583989128|FG001|Overall Study|Insufficient Therapeutic Response|437|||
161712178|NCT00045032|583989129|FG002|Overall Study|Insufficient Therapeutic Response|445|||
161712179|NCT00045032|583989127|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
161712180|NCT00045032|583989128|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
161712181|NCT00045032|583989129|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
161712182|NCT00045032|583989127|FG000|Overall Study|Other Protocol Violation|2|||
161712183|NCT00045032|583989128|FG001|Overall Study|Other Protocol Violation|0|||
161712184|NCT00045032|583989129|FG002|Overall Study|Other Protocol Violation|1|||
161712185|NCT00045032|583989127|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
161712186|NCT00045032|583989128|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
161712187|NCT00045032|583989129|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
161712188|NCT00045032|583989127|FG000|Overall Study|Failure to Return|57|||
161712189|NCT00045032|583989128|FG001|Overall Study|Failure to Return|62|||
161712190|NCT00045032|583989129|FG002|Overall Study|Failure to Return|61|||
161712191|NCT00045032|583989127|FG000|Overall Study|Other|93|||
161712192|NCT00045032|583989128|FG001|Overall Study|Other|84|||
161712193|NCT00045032|583989129|FG002|Overall Study|Other|105|||
161712194|NCT02582658|583989130|FG000|Overall Study|Failure to Return|10|||
161712195|NCT02582658|583989130|FG000|Overall Study|Insufficient Virological Response|2|||
161712196|NCT02582658|583989130|FG000|Overall Study|Withdrawn Consent|1|||
161712197|NCT02582658|583989130|FG000|Overall Study|Death|1|||
161712198|NCT02582658|583989130|FG000|Overall Study|Not further specified|11|||
161712199|NCT02581995|583989131|FG000|Overall Study|Unspecified other|3|||
161712200|NCT02581995|583989131|FG000|Overall Study|Adverse Event|6|||
161712201|NCT02581995|583989131|FG000|Overall Study|Lost to Follow-up|5|||
161712202|NCT02581995|583989131|FG000|Overall Study|Withdrawal by participant|12|||
161712203|NCT02581995|583989131|FG000|Overall Study|Physician Decision|1|||
161712204|NCT02581995|583989131|FG000|Overall Study|Death|4|||
161712205|NCT04909463|583991181|FG000|Overall Study|Withdrawal by Subject|0|||
161712206|NCT04909463|583991182|FG001|Overall Study|Withdrawal by Subject|1|||
161712207|NCT04909463|583991183|FG002|Overall Study|Withdrawal by Subject|0|||
161712208|NCT04909463|583991184|FG003|Overall Study|Withdrawal by Subject|0|||
161712209|NCT04909463|583991181|FG000|Overall Study|Lost to Follow-up|2|||
161712210|NCT04909463|583991182|FG001|Overall Study|Lost to Follow-up|1|||
161712211|NCT04909463|583991183|FG002|Overall Study|Lost to Follow-up|1|||
161712212|NCT04909463|583991184|FG003|Overall Study|Lost to Follow-up|0|||
161712213|NCT04364854|583991185|FG000|Overall Study|Withdrawal by Subject|1|||
161712214|NCT04364854|583991186|FG001|Overall Study|Withdrawal by Subject|0|||
161712215|NCT04364854|583991187|FG002|Overall Study|Withdrawal by Subject|1|||
161712216|NCT04364854|583991188|FG003|Overall Study|Withdrawal by Subject|3|||
161712217|NCT04364854|583991185|FG000|Overall Study|Death|1|||
161712218|NCT04364854|583991186|FG001|Overall Study|Death|0|||
161712219|NCT04364854|583991187|FG002|Overall Study|Death|0|||
161712220|NCT04364854|583991188|FG003|Overall Study|Death|0|||
161712221|NCT04364854|583991185|FG000|Overall Study|Lost to Follow-up|0|||
161712222|NCT04364854|583991186|FG001|Overall Study|Lost to Follow-up|0|||
161712223|NCT04364854|583991187|FG002|Overall Study|Lost to Follow-up|0|||
161712224|NCT04364854|583991188|FG003|Overall Study|Lost to Follow-up|1|||
161712225|NCT03528681|583991193|FG000|Open-Label Phase|Physician Decision|2|||
161712226|NCT03528681|583991194|FG001|Open-Label Phase|Physician Decision|0|||
161712227|NCT03528681|583991195|FG002|Open-Label Phase|Physician Decision|0|||
161712228|NCT03528681|583991196|FG003|Open-Label Phase|Physician Decision|0|||
161712229|NCT03528681|583991193|FG000|Open-Label Phase|Withdrawal by Subject|8|||
161712230|NCT03528681|583991194|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161712231|NCT03528681|583991195|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161712232|NCT03528681|583991196|FG003|Open-Label Phase|Withdrawal by Subject|0|||
161712233|NCT03528681|583991193|FG000|Open-Label Phase|(Not collected)|4|||
161712234|NCT03528681|583991194|FG001|Open-Label Phase|(Not collected)|0|||
161712235|NCT03528681|583991195|FG002|Open-Label Phase|(Not collected)|0|||
161712236|NCT03528681|583991196|FG003|Open-Label Phase|(Not collected)|0|||
161712237|NCT03528681|583991193|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
161712238|NCT03528681|583991194|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
161712239|NCT03528681|583991195|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
161712240|NCT03528681|583991196|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
161712241|NCT03528681|583991193|FG000|Randomized Treatment Phase|Physician Decision|0|||
161712242|NCT03528681|583991194|FG001|Randomized Treatment Phase|Physician Decision|5|||
161712243|NCT03528681|583991195|FG002|Randomized Treatment Phase|Physician Decision|1|||
161712244|NCT03528681|583991196|FG003|Randomized Treatment Phase|Physician Decision|2|||
161712245|NCT03528681|583991193|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
161712246|NCT03528681|583991194|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
161712247|NCT03528681|583991195|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
161712248|NCT03528681|583991196|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
161712249|NCT03528681|583991193|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
161712250|NCT03528681|583991194|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
161712251|NCT03528681|583991195|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
161712252|NCT03528681|583991196|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
161712253|NCT03528681|583991193|FG000|Randomized Treatment Phase|(Not collected)|0|||
161712254|NCT03528681|583991194|FG001|Randomized Treatment Phase|(Not collected)|4|||
161712255|NCT03528681|583991195|FG002|Randomized Treatment Phase|(Not collected)|6|||
161712256|NCT03528681|583991196|FG003|Randomized Treatment Phase|(Not collected)|5|||
161712257|NCT01614457|583991203|FG000|Overall Study|Non-Compliance|1|||
161712258|NCT01614457|583991204|FG001|Overall Study|Non-Compliance|0|||
161712259|NCT01614457|583991203|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
161712260|NCT01614457|583991204|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
161712261|NCT03518840|583991207|FG000|Overall Study|Lost to Follow-up|6|||
161712262|NCT00374556|583991212|FG000|Overall Study|Lost to Follow-up|1|||
161712263|NCT00374556|583991213|FG001|Overall Study|Lost to Follow-up|0|||
161712264|NCT00374556|583991212|FG000|Overall Study|Removed at baseline due to medical cond|0|||
161712265|NCT00374556|583991213|FG001|Overall Study|Removed at baseline due to medical cond|1|||
161712266|NCT00473694|583991214|FG000|Overall Study|Adverse Event|0|||
161712267|NCT00473694|583991215|FG001|Overall Study|Adverse Event|1|||
161712268|NCT00473694|583991216|FG002|Overall Study|Adverse Event|0|||
161712269|NCT00473694|583991217|FG003|Overall Study|Adverse Event|0|||
161712270|NCT00473694|583991214|FG000|Overall Study|Participants did not receive treatment|11|||
161712271|NCT00473694|583991215|FG001|Overall Study|Participants did not receive treatment|3|||
161712272|NCT00473694|583991216|FG002|Overall Study|Participants did not receive treatment|5|||
161712273|NCT00473694|583991217|FG003|Overall Study|Participants did not receive treatment|6|||
161712274|NCT00473694|583991214|FG000|Overall Study|Lost to Follow-up|0|||
161712275|NCT00473694|583991215|FG001|Overall Study|Lost to Follow-up|0|||
161712276|NCT00473694|583991216|FG002|Overall Study|Lost to Follow-up|0|||
161961100|NCT01631747|584903988|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
161961101|NCT01631747|584903987|FG000|Live Birth|Pregnancy Termination|1|||
161961102|NCT01631747|584903988|FG001|Live Birth|Pregnancy Termination|0|||
161961103|NCT01631747|584903987|FG000|Live Birth|MIscarriage|2|||
161961104|NCT01631747|584903988|FG001|Live Birth|MIscarriage|0|||
161712277|NCT00473694|583991217|FG003|Overall Study|Lost to Follow-up|1|||
161961105|NCT01631747|584903987|FG000|Live Birth|Stillbirth|1|||
161712278|NCT02468193|583991218|FG000|Overall Study|Adverse Event|4|||
161712279|NCT02468193|583991218|FG000|Overall Study|Subject/ Guardian decision|2|||
161712280|NCT00742781|583991219|FG000|Overall Study|Withdrawal by Subject|3|||
161712281|NCT01416181|583991220|FG000|Part 1|Other|10|||
161712282|NCT01416181|583991221|FG001|Part 1|Other|24|||
161712283|NCT01416181|583991220|FG000|Part 1|Death|0|||
161712284|NCT01416181|583991221|FG001|Part 1|Death|1|||
161712285|NCT01416181|583991220|FG000|Part 1|Investigator Decision|7|||
161712286|NCT01416181|583991221|FG001|Part 1|Investigator Decision|6|||
161712287|NCT01416181|583991220|FG000|Part 1|Withdrawal by Subject|74|||
161712288|NCT01416181|583991221|FG001|Part 1|Withdrawal by Subject|48|||
161712289|NCT01416181|583991220|FG000|Part 1|Lack of Efficacy|16|||
161961106|NCT01631747|584903988|FG001|Live Birth|Stillbirth|1|||
161961107|NCT01631747|584903987|FG000|One Year Infant Outcomes|Patient Refused|13|||
161712290|NCT01416181|583991221|FG001|Part 1|Lack of Efficacy|8|||
161712291|NCT01416181|583991220|FG000|Part 1|Lost to Follow-up|1|||
161712292|NCT01416181|583991221|FG001|Part 1|Lost to Follow-up|1|||
161712293|NCT01416181|583991220|FG000|Part 1|Adverse Event|15|||
161712294|NCT01416181|583991221|FG001|Part 1|Adverse Event|18|||
161712295|NCT01416181|583991220|FG000|Part 1|Ongoing in Follow-Up|14|||
161712296|NCT01416181|583991221|FG001|Part 1|Ongoing in Follow-Up|8|||
161712297|NCT01416181|583991220|FG000|Part 2|Adverse Event|11|||
161712298|NCT01416181|583991221|FG001|Part 2|Adverse Event|4|||
161712299|NCT01416181|583991220|FG000|Part 2|Other|234|||
161712300|NCT01416181|583991221|FG001|Part 2|Other|267|||
161712301|NCT01416181|583991220|FG000|Part 2|Investigator Decision|6|||
161712302|NCT01416181|583991221|FG001|Part 2|Investigator Decision|7|||
161712303|NCT01416181|583991220|FG000|Part 2|Withdrawal by Subject|14|||
161712304|NCT01416181|583991221|FG001|Part 2|Withdrawal by Subject|5|||
161712305|NCT01416181|583991220|FG000|Part 2|Lack of Efficacy|4|||
161712306|NCT01416181|583991221|FG001|Part 2|Lack of Efficacy|1|||
161712307|NCT01416181|583991220|FG000|Part 2|Lost to Follow-up|2|||
161712308|NCT01416181|583991221|FG001|Part 2|Lost to Follow-up|2|||
161712309|NCT03816995|583991224|FG000|Overall Study|Withdrawal by Subject|3|||
161712310|NCT03816995|583991225|FG001|Overall Study|Withdrawal by Subject|1|||
161712311|NCT03816995|583991224|FG000|Overall Study|Cancelled Surgery|8|||
161712312|NCT03816995|583991225|FG001|Overall Study|Cancelled Surgery|12|||
161712313|NCT03816995|583991224|FG000|Overall Study|No wound protector used|11|||
161712314|NCT03816995|583991225|FG001|Overall Study|No wound protector used|17|||
161712315|NCT03816995|583991224|FG000|Overall Study|Protocol Violation|2|||
161712316|NCT03816995|583991225|FG001|Overall Study|Protocol Violation|3|||
161712317|NCT00486902|583991226|FG000|Overall Study|Withdrawal by Subject|1|||
161712318|NCT00486902|583991227|FG001|Overall Study|Withdrawal by Subject|2|||
161712319|NCT00486902|583991226|FG000|Overall Study|decision for postpartum tubal ligation|3|||
161712320|NCT00486902|583991227|FG001|Overall Study|decision for postpartum tubal ligation|1|||
161712321|NCT00486902|583991226|FG000|Overall Study|spinal anesthetic protocal violation|1|||
161712322|NCT00486902|583991227|FG001|Overall Study|spinal anesthetic protocal violation|1|||
161712323|NCT00486902|583991226|FG000|Overall Study|Did not meet inclusion criteria|1|||
161712324|NCT00486902|583991227|FG001|Overall Study|Did not meet inclusion criteria|0|||
161712325|NCT00486902|583991226|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
161712326|NCT00486902|583991227|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
161712327|NCT00541307|583991228|FG000|Overall Study|Death|5|||
161712328|NCT00541307|583991228|FG000|Overall Study|Physician Decision|3|||
161712329|NCT00541307|583991228|FG000|Overall Study|Withdrawal by Subject|6|||
161712330|NCT00541307|583991228|FG000|Overall Study|Lost to Follow-up|4|||
161712331|NCT00541307|583991228|FG000|Overall Study|Subject returned early (outside window)|1|||
161712332|NCT00541307|583991228|FG000|Overall Study|Surgical Bypass|5|||
161712333|NCT04178590|583991229|FG000|Overall Study|Pregnancy|1|||
161712334|NCT04178590|583991229|FG000|Overall Study|Lost to Follow-up|1|||
161712335|NCT04723537|583991230|FG000|Overall Study|Withdrawal by Subject|3|||
161712336|NCT04723537|583991231|FG001|Overall Study|Withdrawal by Subject|0|||
161712337|NCT04723537|583991232|FG002|Overall Study|Withdrawal by Subject|0|||
161712338|NCT04723537|583991230|FG000|Overall Study|Physician Decision|0|||
161712339|NCT04723537|583991231|FG001|Overall Study|Physician Decision|0|||
161712340|NCT04723537|583991232|FG002|Overall Study|Physician Decision|1|||
161712341|NCT04723537|583991230|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
161712342|NCT04723537|583991231|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
161712343|NCT04723537|583991232|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
161712344|NCT01845025|583991233|FG000|Overall Study|Adverse Event|6|||
161712345|NCT01845025|583991234|FG001|Overall Study|Adverse Event|3|||
161712346|NCT01845025|583991233|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161712347|NCT01845025|583991234|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161712348|NCT01845025|583991233|FG000|Overall Study|Withdrawal by Subject|48|||
161712349|NCT01845025|583991234|FG001|Overall Study|Withdrawal by Subject|44|||
161712350|NCT01845025|583991233|FG000|Overall Study|Lost to Follow-up|13|||
161712351|NCT01845025|583991234|FG001|Overall Study|Lost to Follow-up|13|||
161712352|NCT01845025|583991233|FG000|Overall Study|Administrative problems|8|||
161712353|NCT01845025|583991234|FG001|Overall Study|Administrative problems|8|||
161712354|NCT01845025|583991233|FG000|Overall Study|Death|2|||
161712355|NCT01845025|583991234|FG001|Overall Study|Death|0|||
161712356|NCT01845025|583991233|FG000|Overall Study|Protocol deviation|3|||
161712357|NCT01845025|583991234|FG001|Overall Study|Protocol deviation|6|||
161712358|NCT01845025|583991233|FG000|Overall Study|Missing|1|||
161712359|NCT01845025|583991234|FG001|Overall Study|Missing|1|||
161712360|NCT01485614|583991241|FG000|Randomization|Not Treated|1|||
161712361|NCT01485614|583991242|FG001|Randomization|Not Treated|0|||
161712362|NCT01485614|583991243|FG002|Randomization|Not Treated|0|||
161712363|NCT01485614|583991244|FG003|Randomization|Not Treated|0|||
161712364|NCT01485614|583991241|FG000|Weeks 0-20|Lost to Follow-up|2|||
161712365|NCT01485614|583991242|FG001|Weeks 0-20|Lost to Follow-up|0|||
161712366|NCT01485614|583991243|FG002|Weeks 0-20|Lost to Follow-up|0|||
161712367|NCT01485614|583991244|FG003|Weeks 0-20|Lost to Follow-up|0|||
161712368|NCT01485614|583991241|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
161712369|NCT01485614|583991242|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
161712370|NCT01485614|583991243|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
161712371|NCT01485614|583991244|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
161712372|NCT01485614|583991241|FG000|Weeks 0-20|Withdrawal by Subject|3|||
161712373|NCT01485614|583991242|FG001|Weeks 0-20|Withdrawal by Subject|2|||
161712374|NCT01485614|583991243|FG002|Weeks 0-20|Withdrawal by Subject|1|||
161712375|NCT01485614|583991244|FG003|Weeks 0-20|Withdrawal by Subject|0|||
161712376|NCT01485614|583991241|FG000|Weeks 20-54|Lost to Follow-up|4|||
161712377|NCT01485614|583991242|FG001|Weeks 20-54|Lost to Follow-up|3|||
161712378|NCT01485614|583991243|FG002|Weeks 20-54|Lost to Follow-up|1|||
161712379|NCT01485614|583991244|FG003|Weeks 20-54|Lost to Follow-up|0|||
161712380|NCT01485614|583991241|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
161712381|NCT01485614|583991242|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
161712382|NCT01485614|583991243|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
161712383|NCT01485614|583991244|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
161712384|NCT01485614|583991241|FG000|Weeks 20-54|Withdrawal by Subject|5|||
161712385|NCT01485614|583991242|FG001|Weeks 20-54|Withdrawal by Subject|3|||
161712386|NCT01485614|583991243|FG002|Weeks 20-54|Withdrawal by Subject|0|||
161712387|NCT01485614|583991244|FG003|Weeks 20-54|Withdrawal by Subject|0|||
161712388|NCT00733902|583991245|FG000|Overall Study|Death|0|||
161712389|NCT00733902|583991246|FG001|Overall Study|Death|0|||
161712390|NCT00733902|583991247|FG002|Overall Study|Death|0|||
161712391|NCT00733902|583991248|FG003|Overall Study|Death|1|||
161712392|NCT00733902|583991245|FG000|Overall Study|Adverse Event|3|||
161712393|NCT00733902|583991246|FG001|Overall Study|Adverse Event|4|||
161712394|NCT00733902|583991247|FG002|Overall Study|Adverse Event|7|||
161712395|NCT00733902|583991248|FG003|Overall Study|Adverse Event|11|||
161712396|NCT00733902|583991245|FG000|Overall Study|Lack of Efficacy|56|||
161712397|NCT00733902|583991246|FG001|Overall Study|Lack of Efficacy|21|||
161712398|NCT00733902|583991247|FG002|Overall Study|Lack of Efficacy|34|||
161712399|NCT00733902|583991248|FG003|Overall Study|Lack of Efficacy|23|||
161712400|NCT00733902|583991245|FG000|Overall Study|Protocol Violation|4|||
161712401|NCT00733902|583991246|FG001|Overall Study|Protocol Violation|6|||
161712402|NCT00733902|583991247|FG002|Overall Study|Protocol Violation|3|||
161712403|NCT00733902|583991248|FG003|Overall Study|Protocol Violation|3|||
161712404|NCT00733902|583991245|FG000|Overall Study|Withdrawal by Subject|10|||
161712405|NCT00733902|583991246|FG001|Overall Study|Withdrawal by Subject|5|||
161712406|NCT00733902|583991247|FG002|Overall Study|Withdrawal by Subject|4|||
161712407|NCT00733902|583991248|FG003|Overall Study|Withdrawal by Subject|16|||
161712408|NCT00733902|583991245|FG000|Overall Study|Entered extension study|89|||
161712409|NCT00733902|583991246|FG001|Overall Study|Entered extension study|124|||
161712410|NCT00733902|583991247|FG002|Overall Study|Entered extension study|111|||
161712411|NCT00733902|583991248|FG003|Overall Study|Entered extension study|109|||
161712412|NCT00733902|583991245|FG000|Overall Study|Randomized but not treated|2|||
161712413|NCT00733902|583991246|FG001|Overall Study|Randomized but not treated|2|||
161712414|NCT00733902|583991247|FG002|Overall Study|Randomized but not treated|2|||
161712415|NCT00733902|583991248|FG003|Overall Study|Randomized but not treated|1|||
161712416|NCT01503021|583991253|FG000|Overall Study|Adverse Event|7|||
161712417|NCT01503021|583991254|FG001|Overall Study|Adverse Event|6|||
161712418|NCT01503021|583991253|FG000|Overall Study|Death|0|||
161961108|NCT01631747|584903988|FG001|One Year Infant Outcomes|Patient Refused|9|||
161712419|NCT01503021|583991254|FG001|Overall Study|Death|2|||
161712420|NCT01503021|583991253|FG000|Overall Study|Lost to Follow-up|2|||
161712421|NCT01503021|583991254|FG001|Overall Study|Lost to Follow-up|0|||
161712422|NCT01503021|583991253|FG000|Overall Study|Physician Decision|3|||
161712423|NCT01503021|583991254|FG001|Overall Study|Physician Decision|0|||
161712424|NCT01503021|583991253|FG000|Overall Study|Protocol Violation|1|||
161712425|NCT01503021|583991254|FG001|Overall Study|Protocol Violation|3|||
161712426|NCT01503021|583991253|FG000|Overall Study|Withdrawal by Subject|9|||
161712427|NCT01503021|583991254|FG001|Overall Study|Withdrawal by Subject|8|||
161712428|NCT01503021|583991253|FG000|Overall Study|Moved, received transplant, etc.|5|||
161712429|NCT01503021|583991254|FG001|Overall Study|Moved, received transplant, etc.|7|||
161712430|NCT03941548|583991255|FG000|Overall Study|Adverse Event|0|||
161712431|NCT03941548|583991256|FG001|Overall Study|Adverse Event|1|||
161712432|NCT03941548|583991255|FG000|Overall Study|Lost to Follow-up|0|||
161712433|NCT03941548|583991256|FG001|Overall Study|Lost to Follow-up|1|||
161712434|NCT03941548|583991255|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
161712435|NCT03941548|583991256|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
161712436|NCT01242111|583991258|FG000|Overall Study|Adverse Event|1|||
161712437|NCT01242111|583991258|FG000|Overall Study|Withdrawal by Subject|1|||
161712438|NCT01242111|583991258|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
161712439|NCT00870688|583991259|FG000|Overall Study|Lost to Follow-up|2|||
161712440|NCT00870688|583991259|FG000|Overall Study|Death, Unrelated|1|||
161712441|NCT00870688|583991259|FG000|Overall Study|Granules in the Stools|1|||
161712442|NCT02015819|583991260|FG000|Overall Study|Rickham catheter was misaligned|0|||
161712443|NCT02015819|583991261|FG001|Overall Study|Rickham catheter was misaligned|0|||
161712444|NCT02015819|583991262|FG002|Overall Study|Rickham catheter was misaligned|0|||
161712445|NCT02015819|583991263|FG003|Overall Study|Rickham catheter was misaligned|1|||
161712446|NCT01486264|583991270|FG000|Overall Study|Death|1|||
161712447|NCT01486264|583991271|FG001|Overall Study|Death|1|||
161712448|NCT01486264|583991270|FG000|Overall Study|Adverse Event|3|||
161712449|NCT01486264|583991271|FG001|Overall Study|Adverse Event|3|||
161712450|NCT01486264|583991270|FG000|Overall Study|Lack of Efficacy|6|||
161712451|NCT01486264|583991271|FG001|Overall Study|Lack of Efficacy|10|||
161712452|NCT01486264|583991270|FG000|Overall Study|Withdrawal by Subject|7|||
161712453|NCT01486264|583991271|FG001|Overall Study|Withdrawal by Subject|18|||
161712454|NCT01486264|583991270|FG000|Overall Study|Physician Decision|1|||
161712455|NCT01486264|583991271|FG001|Overall Study|Physician Decision|1|||
161712456|NCT01486264|583991270|FG000|Overall Study|Protocol Violation|3|||
161712457|NCT01486264|583991271|FG001|Overall Study|Protocol Violation|0|||
161712458|NCT01486264|583991270|FG000|Overall Study|Lost to Follow-up|3|||
161712459|NCT01486264|583991271|FG001|Overall Study|Lost to Follow-up|2|||
161712460|NCT01486264|583991270|FG000|Overall Study|Other|5|||
161712461|NCT01486264|583991271|FG001|Overall Study|Other|11|||
161712462|NCT01486264|583991270|FG000|Overall Study|Not treated|0|||
161712463|NCT01486264|583991271|FG001|Overall Study|Not treated|1|||
161712464|NCT03584009|583991272|FG000|Overall Study|Death|25|||
161712465|NCT03584009|583991273|FG001|Overall Study|Death|18|||
161712466|NCT03584009|583991272|FG000|Overall Study|Lost to Follow-up|0|||
161712467|NCT03584009|583991273|FG001|Overall Study|Lost to Follow-up|1|||
161712468|NCT03584009|583991272|FG000|Overall Study|Physician Decision|1|||
161712469|NCT03584009|583991273|FG001|Overall Study|Physician Decision|1|||
161712470|NCT03584009|583991272|FG000|Overall Study|Study Terminated by Sponsor|22|||
161712471|NCT03584009|583991273|FG001|Overall Study|Study Terminated by Sponsor|30|||
161712472|NCT03584009|583991272|FG000|Overall Study|Withdrawal by Subject|3|||
161712473|NCT03584009|583991273|FG001|Overall Study|Withdrawal by Subject|2|||
161712474|NCT04112914|583991274|FG000|Overall Study|Lost to Follow-up|13|||
161712475|NCT04112914|583991275|FG001|Overall Study|Lost to Follow-up|9|||
161712476|NCT04112914|583991274|FG000|Overall Study|Withdrawal by Subject|1|||
161712477|NCT04112914|583991275|FG001|Overall Study|Withdrawal by Subject|0|||
161712478|NCT00768560|583991276|FG000|Intervention Set 1|Adverse Event|0|||
161961109|NCT02908685|584903989|FG000|Part 1 OLE|Withdrawal by Subject|0|||
161961110|NCT02908685|584903990|FG001|Part 1 OLE|Withdrawal by Subject|0|||
161712479|NCT00768560|583991277|FG001|Intervention Set 1|Adverse Event|1|||
161712480|NCT00768560|583991278|FG002|Intervention Set 1|Adverse Event|0|||
161712481|NCT00768560|583991279|FG003|Intervention Set 1|Adverse Event|0|||
161712482|NCT00768560|583991280|FG004|Intervention Set 1|Adverse Event|0|||
161712483|NCT00768560|583991281|FG005|Intervention Set 1|Adverse Event|0|||
161712484|NCT02635204|583991282|FG000|Overall Study|Adverse Event|1|||
161712485|NCT02635204|583991283|FG001|Overall Study|Adverse Event|0|||
161712486|NCT02635204|583991282|FG000|Overall Study|Lost to Follow-up|1|||
161712487|NCT02635204|583991283|FG001|Overall Study|Lost to Follow-up|1|||
161712488|NCT01772134|583991289|FG000|Overall Study|Adverse Event|6|||
161712489|NCT01772134|583991290|FG001|Overall Study|Adverse Event|5|||
161712490|NCT01772134|583991291|FG002|Overall Study|Adverse Event|10|||
161712491|NCT01772134|583991289|FG000|Overall Study|Withdrew Consent|3|||
161712492|NCT01772134|583991290|FG001|Overall Study|Withdrew Consent|1|||
161712493|NCT01772134|583991291|FG002|Overall Study|Withdrew Consent|5|||
161961111|NCT02908685|584903991|FG002|Part 1 OLE|Withdrawal by Subject|0|||
161712494|NCT01772134|583991289|FG000|Overall Study|Lost to Follow-up|2|||
161712495|NCT01772134|583991290|FG001|Overall Study|Lost to Follow-up|0|||
161712496|NCT01772134|583991291|FG002|Overall Study|Lost to Follow-up|0|||
161712497|NCT01772134|583991289|FG000|Overall Study|Protocol Deviation|4|||
161712498|NCT01772134|583991290|FG001|Overall Study|Protocol Deviation|3|||
161712499|NCT01772134|583991291|FG002|Overall Study|Protocol Deviation|3|||
161712500|NCT01772134|583991289|FG000|Overall Study|Lack of Efficacy|11|||
161712501|NCT01772134|583991290|FG001|Overall Study|Lack of Efficacy|5|||
161712502|NCT01772134|583991291|FG002|Overall Study|Lack of Efficacy|3|||
161712503|NCT01772134|583991289|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
161712504|NCT01772134|583991290|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
161712505|NCT01772134|583991291|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
161712506|NCT01772134|583991289|FG000|Overall Study|Randomized Study Medication Not Received|2|||
161712507|NCT01772134|583991290|FG001|Overall Study|Randomized Study Medication Not Received|0|||
161712508|NCT01772134|583991291|FG002|Overall Study|Randomized Study Medication Not Received|1|||
161712509|NCT02500550|583991292|FG000|Overall Study|Death|7|||
161712510|NCT03293680|583991297|FG000|Overall Study|Death|1|||
161712511|NCT03293680|583991297|FG000|Overall Study|Did not meet inclusion criteria|8|||
161712512|NCT00636818|583991298|FG000|Overall Study|Adverse Event|1|||
161712513|NCT00636818|583991298|FG000|Overall Study|Lost to Follow-up|2|||
161712514|NCT00636818|583991298|FG000|Overall Study|Entry Criteria Exclusion|3|||
161712515|NCT00636818|583991298|FG000|Overall Study|Protocol Violation|1|||
161712516|NCT00636818|583991298|FG000|Overall Study|Withdrawal by Subject|4|||
161712517|NCT02604264|583991299|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
161712518|NCT02604264|583991300|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
161712519|NCT03192904|583991302|FG000|Overall Study|Physician Decision|3|||
161712520|NCT03192904|583991303|FG001|Overall Study|Physician Decision|1|||
161712521|NCT03192904|583991302|FG000|Overall Study|Lost to Follow-up|0|||
161712522|NCT03192904|583991303|FG001|Overall Study|Lost to Follow-up|1|||
161712523|NCT03301857|583991310|FG000|Overall Study|Death|0|||
161712524|NCT03301857|583991311|FG001|Overall Study|Death|2|||
161712525|NCT03301857|583991310|FG000|Overall Study|Lost to Follow-up|4|||
161712526|NCT03301857|583991311|FG001|Overall Study|Lost to Follow-up|2|||
161712527|NCT03301857|583991310|FG000|Overall Study|Decision by Sponsor|6|||
161712528|NCT03301857|583991311|FG001|Overall Study|Decision by Sponsor|0|||
161712529|NCT03301857|583991310|FG000|Overall Study|Withdrawal by Subject|12|||
161712530|NCT03301857|583991311|FG001|Overall Study|Withdrawal by Subject|4|||
161712531|NCT01126580|583991316|FG000|Overall Study|Adverse Event|14|||
161712532|NCT01126580|583991317|FG001|Overall Study|Adverse Event|8|||
161712533|NCT01126580|583991318|FG002|Overall Study|Adverse Event|12|||
161712534|NCT01126580|583991316|FG000|Overall Study|Withdrawal by Subject|11|||
161712535|NCT01126580|583991317|FG001|Overall Study|Withdrawal by Subject|19|||
161712536|NCT01126580|583991318|FG002|Overall Study|Withdrawal by Subject|14|||
161712537|NCT01126580|583991316|FG000|Overall Study|Sponsor Decision|5|||
161712538|NCT01126580|583991317|FG001|Overall Study|Sponsor Decision|4|||
161712539|NCT01126580|583991318|FG002|Overall Study|Sponsor Decision|7|||
161712540|NCT01126580|583991316|FG000|Overall Study|Physician Decision|1|||
161712541|NCT01126580|583991317|FG001|Overall Study|Physician Decision|1|||
161961112|NCT02908685|584903992|FG003|Part 1 OLE|Withdrawal by Subject|0|||
161712542|NCT01126580|583991318|FG002|Overall Study|Physician Decision|2|||
161712543|NCT01126580|583991316|FG000|Overall Study|Entry Criteria Not Met|1|||
161712544|NCT01126580|583991317|FG001|Overall Study|Entry Criteria Not Met|1|||
161712545|NCT01126580|583991318|FG002|Overall Study|Entry Criteria Not Met|2|||
161712546|NCT01126580|583991316|FG000|Overall Study|Lack of Efficacy|2|||
161712547|NCT01126580|583991317|FG001|Overall Study|Lack of Efficacy|3|||
161961113|NCT02908685|584903993|FG004|Part 1 OLE|Withdrawal by Subject|0|||
161712548|NCT01126580|583991318|FG002|Overall Study|Lack of Efficacy|4|||
161712549|NCT01126580|583991316|FG000|Overall Study|Protocol Violation|0|||
161712550|NCT01126580|583991317|FG001|Overall Study|Protocol Violation|1|||
161712551|NCT01126580|583991318|FG002|Overall Study|Protocol Violation|2|||
161961114|NCT02908685|584903994|FG005|Part 1 OLE|Withdrawal by Subject|0|||
161961115|NCT02908685|584903995|FG006|Part 1 OLE|Withdrawal by Subject|0|||
161712552|NCT01126580|583991316|FG000|Overall Study|Lost to Follow-up|15|||
161712553|NCT01126580|583991317|FG001|Overall Study|Lost to Follow-up|13|||
161712554|NCT01126580|583991318|FG002|Overall Study|Lost to Follow-up|9|||
161712555|NCT01126580|583991316|FG000|Overall Study|Treatment Non-compliance|0|||
161712556|NCT01126580|583991317|FG001|Overall Study|Treatment Non-compliance|2|||
161712557|NCT01126580|583991318|FG002|Overall Study|Treatment Non-compliance|3|||
161712558|NCT01731002|583991328|FG000|Overall Study|Adverse Event|0|||
161712559|NCT01731002|583991329|FG001|Overall Study|Adverse Event|2|||
161712560|NCT01731002|583991330|FG002|Overall Study|Adverse Event|2|||
161712561|NCT01731002|583991328|FG000|Overall Study|Non-Compliant|0|||
161712562|NCT01731002|583991329|FG001|Overall Study|Non-Compliant|1|||
161712563|NCT01731002|583991330|FG002|Overall Study|Non-Compliant|0|||
161712564|NCT01731002|583991328|FG000|Overall Study|Lost to Follow-up|1|||
161712565|NCT01731002|583991329|FG001|Overall Study|Lost to Follow-up|0|||
161712566|NCT01731002|583991330|FG002|Overall Study|Lost to Follow-up|0|||
161712567|NCT01731002|583991328|FG000|Overall Study|Test Agent Discontinuation|0|||
161712568|NCT01731002|583991329|FG001|Overall Study|Test Agent Discontinuation|1|||
161712569|NCT01731002|583991330|FG002|Overall Study|Test Agent Discontinuation|0|||
161712570|NCT01731002|583991328|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
161712571|NCT01731002|583991329|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
161712572|NCT01731002|583991330|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
161712573|NCT01731002|583991328|FG000|Overall Study|Elevated IOP|1|||
161712574|NCT01731002|583991329|FG001|Overall Study|Elevated IOP|0|||
161712575|NCT01731002|583991330|FG002|Overall Study|Elevated IOP|0|||
161712576|NCT01731002|583991328|FG000|Overall Study|Inappropriate use of study medications|0|||
161712577|NCT01731002|583991329|FG001|Overall Study|Inappropriate use of study medications|0|||
161712578|NCT01731002|583991330|FG002|Overall Study|Inappropriate use of study medications|1|||
161712579|NCT02382133|583991333|FG000|Overall Study|Death|22|||
161712580|NCT02382133|583991333|FG000|Overall Study|transfer out of ICU|4|||
161712581|NCT02382133|583991333|FG000|Overall Study|Physician Decision|2|||
161712582|NCT02382133|583991333|FG000|Overall Study|arterial catheter loss|4|||
161712583|NCT02382133|583991333|FG000|Overall Study|pressure injury both sites|1|||
161712584|NCT04321343|583991335|FG000|Overall Study|Adverse Event|0|||
161712585|NCT04321343|583991336|FG001|Overall Study|Adverse Event|0|||
161712586|NCT04321343|583991337|FG002|Overall Study|Adverse Event|1|||
161712587|NCT04321343|583991338|FG003|Overall Study|Adverse Event|0|||
161712588|NCT04321343|583991335|FG000|Overall Study|Death|0|||
161712589|NCT04321343|583991336|FG001|Overall Study|Death|0|||
161712590|NCT04321343|583991337|FG002|Overall Study|Death|0|||
161712591|NCT04321343|583991338|FG003|Overall Study|Death|1|||
161712592|NCT04321343|583991335|FG000|Overall Study|Pregnancy|1|||
161712593|NCT04321343|583991336|FG001|Overall Study|Pregnancy|0|||
161712594|NCT04321343|583991337|FG002|Overall Study|Pregnancy|0|||
161712595|NCT04321343|583991338|FG003|Overall Study|Pregnancy|0|||
161712596|NCT04321343|583991335|FG000|Overall Study|Protocol Violation|1|||
161712597|NCT04321343|583991336|FG001|Overall Study|Protocol Violation|1|||
161712598|NCT04321343|583991337|FG002|Overall Study|Protocol Violation|1|||
161712599|NCT04321343|583991338|FG003|Overall Study|Protocol Violation|1|||
161712600|NCT04321343|583991335|FG000|Overall Study|Withdrawal by Subject|0|||
161712601|NCT04321343|583991336|FG001|Overall Study|Withdrawal by Subject|6|||
161712602|NCT04321343|583991337|FG002|Overall Study|Withdrawal by Subject|0|||
161712603|NCT04321343|583991338|FG003|Overall Study|Withdrawal by Subject|2|||
161712604|NCT04321343|583991335|FG000|Overall Study|Lost to Follow-up|2|||
161712605|NCT04321343|583991336|FG001|Overall Study|Lost to Follow-up|2|||
161712606|NCT04321343|583991337|FG002|Overall Study|Lost to Follow-up|1|||
161712607|NCT04321343|583991338|FG003|Overall Study|Lost to Follow-up|3|||
161712608|NCT03430310|583991339|FG000|Overall Study|Protocol Violation|2|||
161712609|NCT03430310|583991340|FG001|Overall Study|Protocol Violation|0|||
161712610|NCT03430310|583991339|FG000|Overall Study|Withdrawal by Subject|3|||
161712611|NCT03430310|583991340|FG001|Overall Study|Withdrawal by Subject|2|||
161712612|NCT03430310|583991339|FG000|Overall Study|COVID shutdown March 2020|0|||
161712613|NCT03430310|583991340|FG001|Overall Study|COVID shutdown March 2020|1|||
161712614|NCT03972488|583991341|FG000|Overall Study|Progressive disease|42|||
161712615|NCT03972488|583991342|FG001|Overall Study|Progressive disease|44|||
161712616|NCT03972488|583991341|FG000|Overall Study|Physician Decision|13|||
161712617|NCT03972488|583991342|FG001|Overall Study|Physician Decision|7|||
161712618|NCT03972488|583991341|FG000|Overall Study|Adverse Event|8|||
161712619|NCT03972488|583991342|FG001|Overall Study|Adverse Event|1|||
161712620|NCT03972488|583991341|FG000|Overall Study|Death|4|||
161712621|NCT03972488|583991342|FG001|Overall Study|Death|4|||
161712622|NCT03972488|583991341|FG000|Overall Study|Withdrawal by Subject|3|||
161712623|NCT03972488|583991342|FG001|Overall Study|Withdrawal by Subject|4|||
161712624|NCT03972488|583991341|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
161712625|NCT03972488|583991342|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
161712626|NCT03277196|583991343|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
161712627|NCT03277196|583991343|FG000|Overall Study|Lost to Follow-up|3|||
161712628|NCT03277196|583991343|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
161712629|NCT03277196|583991343|FG000|Overall Study|Other|2|||
161712630|NCT06119191|583991344|FG000|Overall Study|Adverse Event|0|||
161712631|NCT06119191|583991345|FG001|Overall Study|Adverse Event|1|||
161712632|NCT06119191|583991344|FG000|Overall Study|Protocol Violation|1|||
161712633|NCT06119191|583991345|FG001|Overall Study|Protocol Violation|0|||
161712634|NCT01084252|583993761|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712635|NCT01084252|583993762|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712636|NCT01084252|583993763|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712637|NCT01084252|583993764|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712638|NCT01084252|583993765|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712639|NCT01084252|583993766|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712640|NCT01084252|583993767|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712641|NCT01084252|583993768|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712642|NCT01084252|583993769|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712643|NCT01084252|583993770|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161961116|NCT02908685|584903996|FG007|Part 1 OLE|Withdrawal by Subject|0|||
161961117|NCT02908685|584903997|FG008|Part 1 OLE|Withdrawal by Subject|0|||
161961118|NCT02908685|584903998|FG009|Part 1 OLE|Withdrawal by Subject|0|||
161961119|NCT02908685|584903999|FG010|Part 1 OLE|Withdrawal by Subject|2|||
161961120|NCT02908685|584904000|FG011|Part 1 OLE|Withdrawal by Subject|1|||
161961121|NCT02908685|584904001|FG012|Part 1 OLE|Withdrawal by Subject|0|||
161961122|NCT02908685|584904002|FG013|Part 1 OLE|Withdrawal by Subject|0|||
161961123|NCT02908685|584903989|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161961124|NCT02908685|584903990|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161961125|NCT02908685|584903991|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161961126|NCT02908685|584903992|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161961127|NCT02908685|584903993|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161961128|NCT02908685|584903994|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161961129|NCT02908685|584903995|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161961130|NCT02908685|584903996|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161961131|NCT02908685|584903997|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161961132|NCT02908685|584903998|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161961133|NCT02908685|584903999|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161961134|NCT02908685|584904000|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161961135|NCT02908685|584904001|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
161961136|NCT02908685|584904002|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
161961137|NCT02908685|584903989|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961138|NCT02908685|584903990|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961139|NCT02908685|584903991|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961140|NCT02908685|584903992|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961141|NCT02908685|584903993|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961142|NCT02908685|584903994|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961143|NCT02908685|584903995|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961144|NCT02908685|584903996|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961145|NCT02908685|584903997|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961146|NCT02908685|584903998|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961147|NCT02908685|584903999|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961148|NCT02908685|584904000|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961149|NCT02908685|584904001|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
161961150|NCT02908685|584904002|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
161961151|NCT02908685|584903989|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161961152|NCT02908685|584903990|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161961153|NCT02908685|584903991|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161961154|NCT02908685|584903992|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161961155|NCT02908685|584903993|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161961156|NCT02908685|584903994|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161961157|NCT02908685|584903995|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161961158|NCT02908685|584903996|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161961159|NCT02908685|584903997|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161961160|NCT02908685|584903998|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161961161|NCT02908685|584903999|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161961162|NCT02908685|584904000|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161961163|NCT02908685|584904001|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
161961164|NCT02908685|584904002|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161712644|NCT01084252|583993771|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712645|NCT01084252|583993772|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712646|NCT01084252|583993773|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
161712647|NCT01084252|583993774|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161712648|NCT00853632|583993775|FG000|Overall Study|Death|88|||
161712649|NCT00853632|583993775|FG000|Overall Study|Withdrawal by Subject|45|||
161712650|NCT00853632|583993775|FG000|Overall Study|Lost to Follow-up|30|||
161712651|NCT00853632|583993775|FG000|Overall Study|Reoperation/Explant|17|||
161712652|NCT00853632|583993775|FG000|Overall Study|Exit with other reason|22|||
161712653|NCT04493619|583993776|FG000|Overall Study|Death|4|||
161712654|NCT04493619|583993777|FG001|Overall Study|Death|3|||
161712655|NCT04493619|583993778|FG002|Overall Study|Death|3|||
161712656|NCT04493619|583993779|FG003|Overall Study|Death|4|||
161712657|NCT04493619|583993776|FG000|Overall Study|Study discontinued early|10|||
161712658|NCT04493619|583993777|FG001|Overall Study|Study discontinued early|0|||
161712659|NCT04493619|583993778|FG002|Overall Study|Study discontinued early|4|||
161712660|NCT04493619|583993779|FG003|Overall Study|Study discontinued early|8|||
161712661|NCT04493619|583993776|FG000|Overall Study|Lost to Follow-up|0|||
161961165|NCT02908685|584903989|FG000|Part 2 OLE: > Month 24|Death|0|||
161961166|NCT02908685|584903990|FG001|Part 2 OLE: > Month 24|Death|0|||
161961167|NCT02908685|584903991|FG002|Part 2 OLE: > Month 24|Death|0|||
161961168|NCT02908685|584903992|FG003|Part 2 OLE: > Month 24|Death|0|||
161961169|NCT02908685|584903993|FG004|Part 2 OLE: > Month 24|Death|0|||
161961170|NCT02908685|584903994|FG005|Part 2 OLE: > Month 24|Death|0|||
161961171|NCT02908685|584903995|FG006|Part 2 OLE: > Month 24|Death|0|||
161961172|NCT02908685|584903996|FG007|Part 2 OLE: > Month 24|Death|0|||
161712662|NCT04493619|583993777|FG001|Overall Study|Lost to Follow-up|0|||
161712663|NCT04493619|583993778|FG002|Overall Study|Lost to Follow-up|0|||
161712664|NCT04493619|583993779|FG003|Overall Study|Lost to Follow-up|1|||
161712665|NCT02017444|583993786|FG000|Overall Study|Physician Decision|1|||
161712666|NCT02017444|583993787|FG001|Overall Study|Physician Decision|0|||
161712667|NCT02017444|583993786|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
161712668|NCT02017444|583993787|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
161712669|NCT02342171|583993790|FG000|Overall Study|Death|4|||
161712670|NCT02342171|583993791|FG001|Overall Study|Death|87|||
161712671|NCT02342171|583993790|FG000|Overall Study|Received favipiravir|10|||
161712672|NCT02342171|583993791|FG001|Overall Study|Received favipiravir|0|||
161712673|NCT02342171|583993790|FG000|Overall Study|Missing cycle treshold value|1|||
161712674|NCT02342171|583993791|FG001|Overall Study|Missing cycle treshold value|0|||
161961173|NCT02908685|584903997|FG008|Part 2 OLE: > Month 24|Death|0|||
161961174|NCT02908685|584903998|FG009|Part 2 OLE: > Month 24|Death|0|||
161961175|NCT02908685|584903999|FG010|Part 2 OLE: > Month 24|Death|0|||
161961176|NCT02908685|584904000|FG011|Part 2 OLE: > Month 24|Death|0|||
161961177|NCT02908685|584904001|FG012|Part 2 OLE: > Month 24|Death|1|||
161961178|NCT02908685|584904002|FG013|Part 2 OLE: > Month 24|Death|0|||
161961179|NCT02908685|584903989|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
161961180|NCT02908685|584903990|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
161961181|NCT02908685|584903991|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
161961182|NCT02908685|584903992|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
161961183|NCT02908685|584903993|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
161961184|NCT02908685|584903994|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
161961185|NCT02908685|584903995|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
161961186|NCT02908685|584903996|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
161961187|NCT02908685|584903997|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
161961188|NCT02908685|584903998|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
161961189|NCT02908685|584903999|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
161961190|NCT02908685|584904000|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
161961191|NCT02908685|584904001|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
161961192|NCT02908685|584904002|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
161961193|NCT02908685|584903989|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161961194|NCT02908685|584903990|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161961195|NCT02908685|584903991|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161961196|NCT02908685|584903992|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161961197|NCT02908685|584903993|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161712675|NCT02342171|583993790|FG000|Overall Study|Unknown outcome|0|||
161712676|NCT02342171|583993791|FG001|Overall Study|Unknown outcome|1|||
161712677|NCT02342171|583993790|FG000|Overall Study|Missing age data|0|||
161712678|NCT02342171|583993791|FG001|Overall Study|Missing age data|1|||
161712679|NCT00875420|583993792|FG000|Overall Study|Adverse Event|0|||
161712680|NCT00875420|583993793|FG001|Overall Study|Adverse Event|1|||
161712681|NCT00875420|583993794|FG002|Overall Study|Adverse Event|1|||
161712682|NCT00875420|583993795|FG003|Overall Study|Adverse Event|0|||
161712683|NCT00875420|583993796|FG004|Overall Study|Adverse Event|0|||
161712684|NCT00875420|583993792|FG000|Overall Study|Inability to complete study procedures|1|||
161712685|NCT00875420|583993793|FG001|Overall Study|Inability to complete study procedures|0|||
161712686|NCT00875420|583993794|FG002|Overall Study|Inability to complete study procedures|1|||
161712687|NCT00875420|583993795|FG003|Overall Study|Inability to complete study procedures|1|||
161712688|NCT00875420|583993796|FG004|Overall Study|Inability to complete study procedures|1|||
161712689|NCT00875420|583993792|FG000|Overall Study|Lost to Follow-up|1|||
161712690|NCT00875420|583993793|FG001|Overall Study|Lost to Follow-up|0|||
161712691|NCT00875420|583993794|FG002|Overall Study|Lost to Follow-up|0|||
161961198|NCT02908685|584903994|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161961199|NCT02908685|584903995|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161961200|NCT02908685|584903996|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161961201|NCT02908685|584903997|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161712692|NCT00875420|583993795|FG003|Overall Study|Lost to Follow-up|0|||
161712693|NCT00875420|583993796|FG004|Overall Study|Lost to Follow-up|0|||
161712694|NCT00875420|583993792|FG000|Overall Study|Personal reason|0|||
161712695|NCT00875420|583993793|FG001|Overall Study|Personal reason|0|||
161712696|NCT00875420|583993794|FG002|Overall Study|Personal reason|0|||
161712697|NCT00875420|583993795|FG003|Overall Study|Personal reason|0|||
161961202|NCT02908685|584903998|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161961203|NCT02908685|584903999|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161961204|NCT02908685|584904000|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161961205|NCT02908685|584904001|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
161961206|NCT02908685|584904002|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
161961207|NCT02954406|584904003|FG000|Overall Study|Adverse Event|0|||
161961208|NCT02954406|584904004|FG001|Overall Study|Adverse Event|1|||
161961209|NCT02954406|584904005|FG002|Overall Study|Adverse Event|0|||
161961210|NCT02954406|584904006|FG003|Overall Study|Adverse Event|0|||
161961211|NCT02954406|584904007|FG004|Overall Study|Adverse Event|1|||
161961212|NCT02954406|584904008|FG005|Overall Study|Adverse Event|0|||
161961213|NCT02954406|584904009|FG006|Overall Study|Adverse Event|0|||
161961214|NCT02954406|584904010|FG007|Overall Study|Adverse Event|0|||
161961215|NCT02954406|584904011|FG008|Overall Study|Adverse Event|1|||
161961216|NCT02954406|584904012|FG009|Overall Study|Adverse Event|1|||
161961217|NCT02954406|584904013|FG010|Overall Study|Adverse Event|0|||
161961218|NCT02954406|584904003|FG000|Overall Study|Progressive Disease|3|||
161961219|NCT02954406|584904004|FG001|Overall Study|Progressive Disease|4|||
161961220|NCT02954406|584904005|FG002|Overall Study|Progressive Disease|3|||
161961221|NCT02954406|584904006|FG003|Overall Study|Progressive Disease|4|||
161961222|NCT02954406|584904007|FG004|Overall Study|Progressive Disease|3|||
161961223|NCT02954406|584904008|FG005|Overall Study|Progressive Disease|3|||
161961224|NCT02954406|584904009|FG006|Overall Study|Progressive Disease|2|||
161961225|NCT02954406|584904010|FG007|Overall Study|Progressive Disease|2|||
161961226|NCT02954406|584904011|FG008|Overall Study|Progressive Disease|1|||
161961227|NCT02954406|584904012|FG009|Overall Study|Progressive Disease|1|||
161961228|NCT02954406|584904013|FG010|Overall Study|Progressive Disease|0|||
161961229|NCT02954406|584904003|FG000|Overall Study|Symptomatic Deterioration|0|||
161961230|NCT02954406|584904004|FG001|Overall Study|Symptomatic Deterioration|1|||
161961231|NCT02954406|584904005|FG002|Overall Study|Symptomatic Deterioration|0|||
161961232|NCT02954406|584904006|FG003|Overall Study|Symptomatic Deterioration|0|||
161961233|NCT02954406|584904007|FG004|Overall Study|Symptomatic Deterioration|0|||
161961234|NCT02954406|584904008|FG005|Overall Study|Symptomatic Deterioration|0|||
161961235|NCT02954406|584904009|FG006|Overall Study|Symptomatic Deterioration|0|||
161961236|NCT02954406|584904010|FG007|Overall Study|Symptomatic Deterioration|0|||
161961237|NCT02954406|584904011|FG008|Overall Study|Symptomatic Deterioration|0|||
161961238|NCT02954406|584904012|FG009|Overall Study|Symptomatic Deterioration|0|||
161961239|NCT02954406|584904013|FG010|Overall Study|Symptomatic Deterioration|0|||
161961240|NCT02954406|584904003|FG000|Overall Study|Death|0|||
161961241|NCT02954406|584904004|FG001|Overall Study|Death|0|||
161961242|NCT02954406|584904005|FG002|Overall Study|Death|0|||
161961243|NCT02954406|584904006|FG003|Overall Study|Death|0|||
161961244|NCT02954406|584904007|FG004|Overall Study|Death|1|||
161961245|NCT02954406|584904008|FG005|Overall Study|Death|0|||
161961246|NCT02954406|584904009|FG006|Overall Study|Death|0|||
161961247|NCT02954406|584904010|FG007|Overall Study|Death|0|||
161961248|NCT02954406|584904011|FG008|Overall Study|Death|1|||
161961249|NCT02954406|584904012|FG009|Overall Study|Death|1|||
161961250|NCT02954406|584904013|FG010|Overall Study|Death|0|||
161961251|NCT02954406|584904003|FG000|Overall Study|Reason Not Specified|0|||
161961252|NCT02954406|584904004|FG001|Overall Study|Reason Not Specified|0|||
161961253|NCT02954406|584904005|FG002|Overall Study|Reason Not Specified|3|||
161961254|NCT02954406|584904006|FG003|Overall Study|Reason Not Specified|2|||
161961255|NCT02954406|584904007|FG004|Overall Study|Reason Not Specified|2|||
161961256|NCT02954406|584904008|FG005|Overall Study|Reason Not Specified|0|||
161961257|NCT02954406|584904009|FG006|Overall Study|Reason Not Specified|1|||
161961258|NCT02954406|584904010|FG007|Overall Study|Reason Not Specified|0|||
161961259|NCT02954406|584904011|FG008|Overall Study|Reason Not Specified|1|||
161961260|NCT02954406|584904012|FG009|Overall Study|Reason Not Specified|0|||
161961261|NCT02954406|584904013|FG010|Overall Study|Reason Not Specified|0|||
161961262|NCT04308239|584904014|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
161961263|NCT04308239|584904015|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
161961264|NCT04308239|584904014|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
162031531|NCT01931670|585172372|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
162031532|NCT01931670|585172373|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
162031533|NCT01931670|585172374|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
162031534|NCT01931670|585172372|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
162031535|NCT01931670|585172373|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
162031536|NCT01931670|585172374|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
162031537|NCT01931670|585172372|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
162031538|NCT01931670|585172373|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
162031539|NCT01931670|585172374|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
162031540|NCT01931670|585172372|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
162031541|NCT01931670|585172373|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
162031542|NCT01931670|585172374|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
162031543|NCT01931670|585172372|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
162031544|NCT01931670|585172373|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
162031545|NCT01931670|585172374|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
162031546|NCT00976508|585172378|FG000|Overall Study|Death|7|||
162031547|NCT00976508|585172379|FG001|Overall Study|Death|1|||
162031548|NCT00976508|585172378|FG000|Overall Study|Lost to Follow-up|1|||
162031549|NCT00976508|585172379|FG001|Overall Study|Lost to Follow-up|0|||
162031550|NCT00976508|585172378|FG000|Overall Study|Withdrawal by Subject|1|||
162031551|NCT00976508|585172379|FG001|Overall Study|Withdrawal by Subject|0|||
162031552|NCT00976508|585172378|FG000|Overall Study|Disease Progression|4|||
162031553|NCT00976508|585172379|FG001|Overall Study|Disease Progression|4|||
162031554|NCT00976508|585172378|FG000|Overall Study|Subject Enrolled in Hospice|1|||
162031555|NCT00976508|585172379|FG001|Overall Study|Subject Enrolled in Hospice|0|||
162031556|NCT00976508|585172378|FG000|Overall Study|Terminated by the Sponsor|0|||
162031557|NCT00976508|585172379|FG001|Overall Study|Terminated by the Sponsor|1|||
162031558|NCT04352127|585172380|FG000|Overall Study|Unable to obtain readings|4|||
162031559|NCT04352127|585172381|FG001|Overall Study|Unable to obtain readings|1|||
162031560|NCT03023046|585172384|FG000|Overall Study|Withdrawal by Subject|1|||
162031561|NCT00640835|585172390|FG000|Overall Study|Adverse Event|5|||
162031562|NCT00640835|585172391|FG001|Overall Study|Adverse Event|3|||
162031563|NCT00640835|585172390|FG000|Overall Study|Withdrawal by Subject|12|||
162031564|NCT00640835|585172391|FG001|Overall Study|Withdrawal by Subject|14|||
162031565|NCT00640835|585172390|FG000|Overall Study|Physician Decision|10|||
162031566|NCT00640835|585172391|FG001|Overall Study|Physician Decision|14|||
162031567|NCT00640835|585172390|FG000|Overall Study|Sponsor's Decision|11|||
162031568|NCT00640835|585172391|FG001|Overall Study|Sponsor's Decision|7|||
162031569|NCT00640835|585172390|FG000|Overall Study|Protocol Violation|2|||
162031570|NCT00640835|585172391|FG001|Overall Study|Protocol Violation|2|||
162031571|NCT00640835|585172390|FG000|Overall Study|Lost to Follow-up|17|||
162031572|NCT00640835|585172391|FG001|Overall Study|Lost to Follow-up|13|||
162031573|NCT00640835|585172390|FG000|Overall Study|Other Reason|19|||
162031574|NCT00640835|585172391|FG001|Overall Study|Other Reason|4|||
162031575|NCT05954143|585172396|FG000|Overall Study|Progressive Disease|1|||
162031576|NCT05954143|585172397|FG001|Overall Study|Progressive Disease|0|||
162031577|NCT05954143|585172396|FG000|Overall Study|Physician Decision|1|||
162031578|NCT05954143|585172397|FG001|Overall Study|Physician Decision|0|||
162031579|NCT05954143|585172396|FG000|Overall Study|Study Terminated by Sponsor|2|||
162031580|NCT05954143|585172397|FG001|Overall Study|Study Terminated by Sponsor|4|||
162031581|NCT05954143|585172396|FG000|Overall Study|Death|1|||
162031582|NCT05954143|585172397|FG001|Overall Study|Death|0|||
162031583|NCT05954143|585172396|FG000|Overall Study|Withdrawal by Subject|0|||
161712698|NCT00875420|583993796|FG004|Overall Study|Personal reason|1|||
161712699|NCT00875420|583993792|FG000|Overall Study|Prohibited medication|0|||
161712700|NCT00875420|583993793|FG001|Overall Study|Prohibited medication|0|||
162031584|NCT05954143|585172397|FG001|Overall Study|Withdrawal by Subject|1|||
161712701|NCT00875420|583993794|FG002|Overall Study|Prohibited medication|0|||
161712702|NCT00875420|583993795|FG003|Overall Study|Prohibited medication|1|||
161712703|NCT00875420|583993796|FG004|Overall Study|Prohibited medication|0|||
161712704|NCT00875420|583993792|FG000|Overall Study|Sponsor decision|0|||
161712705|NCT00875420|583993793|FG001|Overall Study|Sponsor decision|1|||
161712706|NCT00875420|583993794|FG002|Overall Study|Sponsor decision|0|||
161712707|NCT00875420|583993795|FG003|Overall Study|Sponsor decision|0|||
161712708|NCT00875420|583993796|FG004|Overall Study|Sponsor decision|0|||
161712709|NCT00875420|583993792|FG000|Overall Study|Withdrawal by Subject|0|||
161712710|NCT00875420|583993793|FG001|Overall Study|Withdrawal by Subject|0|||
162031585|NCT05954143|585172396|FG000|Overall Study|Other|1|||
162031586|NCT05954143|585172397|FG001|Overall Study|Other|0|||
162031587|NCT00713310|585172398|FG000|Overall Study|Adverse Event|5|||
162031588|NCT00713310|585172399|FG001|Overall Study|Adverse Event|2|||
162031589|NCT00713310|585172398|FG000|Overall Study|Lack of Efficacy|0|||
162031590|NCT00713310|585172399|FG001|Overall Study|Lack of Efficacy|2|||
161712711|NCT00875420|583993794|FG002|Overall Study|Withdrawal by Subject|1|||
161712712|NCT00875420|583993795|FG003|Overall Study|Withdrawal by Subject|0|||
162031591|NCT00713310|585172398|FG000|Overall Study|Withdrawal by Subject|0|||
162031592|NCT00713310|585172399|FG001|Overall Study|Withdrawal by Subject|2|||
162031593|NCT00329901|585172400|FG000|Overall Study|Withdrawal by Subject|4|||
162031594|NCT00329901|585172401|FG001|Overall Study|Withdrawal by Subject|3|||
162031595|NCT00329901|585172402|FG002|Overall Study|Withdrawal by Subject|2|||
162031596|NCT00329901|585172400|FG000|Overall Study|Lost to Follow-up|2|||
162031597|NCT00329901|585172401|FG001|Overall Study|Lost to Follow-up|0|||
162031598|NCT00329901|585172402|FG002|Overall Study|Lost to Follow-up|1|||
162031599|NCT00329901|585172400|FG000|Overall Study|Protocol Violation|1|||
162031600|NCT00329901|585172401|FG001|Overall Study|Protocol Violation|0|||
162031601|NCT00329901|585172402|FG002|Overall Study|Protocol Violation|1|||
162031602|NCT00329901|585172400|FG000|Overall Study|Unable to classify|2|||
162031603|NCT00329901|585172401|FG001|Overall Study|Unable to classify|2|||
162031604|NCT00329901|585172402|FG002|Overall Study|Unable to classify|0|||
162031605|NCT05028361|585172403|FG000|Overall Study|Withdrawal by Subject|1|||
162031606|NCT05028361|585172404|FG001|Overall Study|Withdrawal by Subject|0|||
162031607|NCT02195687|585172405|FG000|Overall Study|Personal Reasons|1|||
162031608|NCT02195687|585172406|FG001|Overall Study|Personal Reasons|1|||
162031609|NCT02195687|585172405|FG000|Overall Study|Lost to Follow-up|4|||
162031610|NCT02195687|585172406|FG001|Overall Study|Lost to Follow-up|1|||
162031611|NCT00779259|585172407|FG000|Quinine Alone|Adverse Event|2|||
162031612|NCT01925989|585172413|FG000|Period 1|Sponsor Decision|1|||
162031613|NCT01925989|585172414|FG001|Period 1|Sponsor Decision|1|||
161712713|NCT00875420|583993796|FG004|Overall Study|Withdrawal by Subject|0|||
161712714|NCT00914628|583993797|FG000|Overall Study|Death|35|||
161712715|NCT00914628|583993798|FG001|Overall Study|Death|17|||
161712716|NCT00914628|583993797|FG000|Overall Study|Medical decision|4|||
161712717|NCT00914628|583993798|FG001|Overall Study|Medical decision|0|||
161712718|NCT00914628|583993797|FG000|Overall Study|Protocol Violation|1|||
161712719|NCT00914628|583993798|FG001|Overall Study|Protocol Violation|0|||
161712720|NCT00914628|583993797|FG000|Overall Study|Lack of Efficacy|1|||
161712721|NCT00914628|583993798|FG001|Overall Study|Lack of Efficacy|0|||
161712722|NCT00914628|583993797|FG000|Overall Study|non-randomized|1|||
161712723|NCT00914628|583993798|FG001|Overall Study|non-randomized|0|||
161712724|NCT00914628|583993797|FG000|Overall Study|Relapse|1|||
161712725|NCT00914628|583993798|FG001|Overall Study|Relapse|2|||
161712726|NCT00914628|583993797|FG000|Overall Study|Study terminated by Sponsor|14|||
161712727|NCT00914628|583993798|FG001|Overall Study|Study terminated by Sponsor|8|||
161712728|NCT00914628|583993797|FG000|Overall Study|Patients who did not receive a single dose|7|||
161712729|NCT00914628|583993798|FG001|Overall Study|Patients who did not receive a single dose|1|||
161712730|NCT01756157|583993799|FG000|First Intervention Period|Withdrawal by Subject|1|||
161712731|NCT01756157|583993800|FG001|First Intervention Period|Withdrawal by Subject|0|||
161712732|NCT01756157|583993799|FG000|First Intervention Period|Lost to Follow-up|0|||
161712733|NCT01756157|583993800|FG001|First Intervention Period|Lost to Follow-up|2|||
161712734|NCT02799381|583993803|FG000|Overall Study|Withdrew consent|3|||
161712735|NCT02799381|583993804|FG001|Overall Study|Withdrew consent|2|||
161712736|NCT02799381|583993803|FG000|Overall Study|Adverse Event|0|||
161712737|NCT02799381|583993804|FG001|Overall Study|Adverse Event|1|||
161712738|NCT02799381|583993803|FG000|Overall Study|Participant did not take any study drug|1|||
161712739|NCT02799381|583993804|FG001|Overall Study|Participant did not take any study drug|0|||
161712740|NCT02698410|583993807|FG000|Overall Study|Adverse Event|2|||
161712741|NCT02698410|583993807|FG000|Overall Study|Withdrawal by Subject|1|||
161712742|NCT02698410|583993807|FG000|Overall Study|Other|1|||
161712743|NCT03952130|583993808|FG000|Overall Study|Adverse Event|0|||
161712744|NCT03952130|583993809|FG001|Overall Study|Adverse Event|1|||
161712745|NCT03952130|583993808|FG000|Overall Study|Lost to Follow-up|1|||
161712746|NCT03952130|583993809|FG001|Overall Study|Lost to Follow-up|0|||
161712747|NCT03952130|583993808|FG000|Overall Study|Withdrawal by Subject|1|||
161712748|NCT03952130|583993809|FG001|Overall Study|Withdrawal by Subject|5|||
161712749|NCT01713348|583993810|FG000|Overall Study|Withdrawal by Subject|3|||
161712750|NCT01713348|583993811|FG001|Overall Study|Withdrawal by Subject|2|||
161712751|NCT01713348|583993812|FG002|Overall Study|Withdrawal by Subject|2|||
162031614|NCT01925989|585172415|FG002|Period 1|Sponsor Decision|0|||
162031615|NCT01925989|585172413|FG000|Period 1|Withdrawal by Subject|0|||
161712752|NCT01713348|583993813|FG003|Overall Study|Withdrawal by Subject|0|||
161712753|NCT01713348|583993810|FG000|Overall Study|Lost to Follow-up|1|||
161712754|NCT01713348|583993811|FG001|Overall Study|Lost to Follow-up|0|||
161712755|NCT01713348|583993812|FG002|Overall Study|Lost to Follow-up|0|||
161712756|NCT01713348|583993813|FG003|Overall Study|Lost to Follow-up|0|||
161712757|NCT02638012|583993814|FG000|Overall Study|Lost to Follow-up|1|||
161712758|NCT00621023|583993815|FG000|Overall Study|Death|5|||
162031616|NCT01925989|585172414|FG001|Period 1|Withdrawal by Subject|1|||
161712759|NCT00621023|583993815|FG000|Overall Study|Follow up discontinued|1|||
161712760|NCT03199911|583993822|FG000|Overall Study|Lost to Follow-up|5|||
161712761|NCT03199911|583993823|FG001|Overall Study|Lost to Follow-up|5|||
161712762|NCT03199911|583993822|FG000|Overall Study|Did not proceed with surgery|2|||
162031617|NCT01925989|585172415|FG002|Period 1|Withdrawal by Subject|0|||
162031618|NCT02496676|585172417|FG000|Phase 1 - Period 1|Adverse Event|0|||
162031619|NCT02496676|585172418|FG001|Phase 1 - Period 1|Adverse Event|1|||
161712763|NCT03199911|583993823|FG001|Overall Study|Did not proceed with surgery|1|||
161712764|NCT04331899|583993824|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
161712765|NCT04331899|583993825|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
161712766|NCT01062399|583993828|FG000|Overall Study|Protocol Violation|0|||
161712767|NCT01062399|583993829|FG001|Overall Study|Protocol Violation|1|||
161712768|NCT01062399|583993830|FG002|Overall Study|Protocol Violation|0|||
161712769|NCT01062399|583993831|FG003|Overall Study|Protocol Violation|6|||
161712770|NCT01062399|583993832|FG004|Overall Study|Protocol Violation|4|||
161712771|NCT02424539|583993833|FG000|Overall Study|Adverse Event|0|||
161712772|NCT02424539|583993834|FG001|Overall Study|Adverse Event|0|||
161712773|NCT02424539|583993835|FG002|Overall Study|Adverse Event|1|||
161712774|NCT02424539|583993833|FG000|Overall Study|Physician Decision|0|||
161712775|NCT02424539|583993834|FG001|Overall Study|Physician Decision|0|||
161712776|NCT02424539|583993835|FG002|Overall Study|Physician Decision|1|||
161712777|NCT02424539|583993833|FG000|Overall Study|Withdrawal by Subject|3|||
161712778|NCT02424539|583993834|FG001|Overall Study|Withdrawal by Subject|1|||
161712779|NCT02424539|583993835|FG002|Overall Study|Withdrawal by Subject|0|||
161712780|NCT02424539|583993833|FG000|Overall Study|Other: Reached stopping criteria|11|||
161712781|NCT02424539|583993834|FG001|Overall Study|Other: Reached stopping criteria|7|||
161712782|NCT02424539|583993835|FG002|Overall Study|Other: Reached stopping criteria|6|||
161712783|NCT00813748|583993836|FG000|Skin Test Substudy|Physician Decision|0|||
161712784|NCT00813748|583993837|FG001|Skin Test Substudy|Physician Decision|1|||
161712785|NCT01829048|583993838|FG000|Overall Study|Withdrawal by Subject|0|||
161712786|NCT01829048|583993839|FG001|Overall Study|Withdrawal by Subject|0|||
161712787|NCT01829048|583993840|FG002|Overall Study|Withdrawal by Subject|0|||
161712788|NCT01829048|583993841|FG003|Overall Study|Withdrawal by Subject|2|||
161712789|NCT01829048|583993842|FG004|Overall Study|Withdrawal by Subject|0|||
161712790|NCT00500071|583993850|FG000|Screening and Washout Phase|Protocol Violation|1|||
161712791|NCT00500071|583993850|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
161712792|NCT00500071|583993850|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
161712793|NCT00500071|583993850|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
161712794|NCT00500071|583993850|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
161712795|NCT00500071|583993850|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
161712796|NCT00500071|583993850|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
161712797|NCT00389207|583993851|FG000|Overall Study|Adverse Event|26|||
161712798|NCT00389207|583993852|FG001|Overall Study|Adverse Event|32|||
161712799|NCT00389207|583993853|FG002|Overall Study|Adverse Event|10|||
161712800|NCT00389207|583993851|FG000|Overall Study|Protocol Violation|3|||
161712801|NCT00389207|583993852|FG001|Overall Study|Protocol Violation|1|||
161712802|NCT00389207|583993853|FG002|Overall Study|Protocol Violation|4|||
161712803|NCT00389207|583993851|FG000|Overall Study|Lost to Follow-up|12|||
161712804|NCT00389207|583993852|FG001|Overall Study|Lost to Follow-up|9|||
161712805|NCT00389207|583993853|FG002|Overall Study|Lost to Follow-up|7|||
161712806|NCT00389207|583993851|FG000|Overall Study|Withdrawal by Subject|5|||
161712807|NCT00389207|583993852|FG001|Overall Study|Withdrawal by Subject|7|||
161712808|NCT00389207|583993853|FG002|Overall Study|Withdrawal by Subject|11|||
161712809|NCT00389207|583993851|FG000|Overall Study|Other|17|||
161712810|NCT00389207|583993852|FG001|Overall Study|Other|23|||
161712811|NCT00389207|583993853|FG002|Overall Study|Other|9|||
161712812|NCT00424398|583993857|FG000|Overall Study|Withdrawal by Subject|2|||
161712813|NCT00424398|583993858|FG001|Overall Study|Withdrawal by Subject|1|||
161712814|NCT00424398|583993859|FG002|Overall Study|Withdrawal by Subject|0|||
161712815|NCT00424398|583993857|FG000|Overall Study|Subject met exclusion criteria|1|||
161712816|NCT00424398|583993858|FG001|Overall Study|Subject met exclusion criteria|0|||
161712817|NCT00424398|583993859|FG002|Overall Study|Subject met exclusion criteria|0|||
161712818|NCT01023789|583993860|FG000|3 - Year Visit|Death|29|||
161712819|NCT01023789|583993860|FG000|3 - Year Visit|Withdrawal of consent|1|||
161712820|NCT01023789|583993860|FG000|3 - Year Visit|Lost to Follow-up|13|||
161712821|NCT02115308|583993871|FG000|Overall Study|Safety Screening|2|||
161712822|NCT02115308|583993872|FG001|Overall Study|Safety Screening|2|||
161712823|NCT01309737|583993873|FG000|Week 0 to 16|Death|1|||
161712824|NCT01309737|583993874|FG001|Week 0 to 16|Death|0|||
161712825|NCT01309737|583993875|FG002|Week 0 to 16|Death|1|||
161712826|NCT01309737|583993876|FG003|Week 0 to 16|Death|0|||
161712827|NCT01309737|583993877|FG004|Week 0 to 16|Death|0|||
161712828|NCT01309737|583993873|FG000|Week 0 to 16|Adverse Event|11|||
161712829|NCT01309737|583993874|FG001|Week 0 to 16|Adverse Event|10|||
161712830|NCT01309737|583993875|FG002|Week 0 to 16|Adverse Event|5|||
161712831|NCT01309737|583993876|FG003|Week 0 to 16|Adverse Event|0|||
161712832|NCT01309737|583993877|FG004|Week 0 to 16|Adverse Event|0|||
161712833|NCT01309737|583993873|FG000|Week 0 to 16|Lack of Efficacy|15|||
161712834|NCT01309737|583993874|FG001|Week 0 to 16|Lack of Efficacy|2|||
161712835|NCT01309737|583993875|FG002|Week 0 to 16|Lack of Efficacy|24|||
161712836|NCT01309737|583993876|FG003|Week 0 to 16|Lack of Efficacy|0|||
161712837|NCT01309737|583993877|FG004|Week 0 to 16|Lack of Efficacy|0|||
161712838|NCT01309737|583993873|FG000|Week 0 to 16|Lost to Follow-up|7|||
161712839|NCT01309737|583993874|FG001|Week 0 to 16|Lost to Follow-up|8|||
161712840|NCT01309737|583993875|FG002|Week 0 to 16|Lost to Follow-up|3|||
161712841|NCT01309737|583993876|FG003|Week 0 to 16|Lost to Follow-up|0|||
161712842|NCT01309737|583993877|FG004|Week 0 to 16|Lost to Follow-up|0|||
161712843|NCT01309737|583993873|FG000|Week 0 to 16|Withdrawal by Subject|7|||
161712844|NCT01309737|583993874|FG001|Week 0 to 16|Withdrawal by Subject|6|||
161712845|NCT01309737|583993875|FG002|Week 0 to 16|Withdrawal by Subject|7|||
161712846|NCT01309737|583993876|FG003|Week 0 to 16|Withdrawal by Subject|0|||
161712847|NCT01309737|583993877|FG004|Week 0 to 16|Withdrawal by Subject|0|||
161712848|NCT01309737|583993873|FG000|Week 0 to 16|Other|10|||
161712849|NCT01309737|583993874|FG001|Week 0 to 16|Other|14|||
161712850|NCT01309737|583993875|FG002|Week 0 to 16|Other|4|||
161712851|NCT01309737|583993876|FG003|Week 0 to 16|Other|0|||
161712852|NCT01309737|583993877|FG004|Week 0 to 16|Other|0|||
161712853|NCT01309737|583993873|FG000|Week 0 to 16|Randomized, but not treated|1|||
161712854|NCT01309737|583993874|FG001|Week 0 to 16|Randomized, but not treated|0|||
161712855|NCT01309737|583993875|FG002|Week 0 to 16|Randomized, but not treated|0|||
161712856|NCT01309737|583993876|FG003|Week 0 to 16|Randomized, but not treated|0|||
161712857|NCT01309737|583993877|FG004|Week 0 to 16|Randomized, but not treated|0|||
161712858|NCT01309737|583993873|FG000|Week 16 to 52|Death|0|||
161712859|NCT01309737|583993874|FG001|Week 16 to 52|Death|0|||
161712860|NCT01309737|583993875|FG002|Week 16 to 52|Death|0|||
161712861|NCT01309737|583993876|FG003|Week 16 to 52|Death|0|||
161712862|NCT01309737|583993877|FG004|Week 16 to 52|Death|1|||
161712863|NCT01309737|583993873|FG000|Week 16 to 52|Adverse Event|7|||
161712864|NCT01309737|583993874|FG001|Week 16 to 52|Adverse Event|7|||
161712865|NCT01309737|583993875|FG002|Week 16 to 52|Adverse Event|0|||
161712866|NCT01309737|583993876|FG003|Week 16 to 52|Adverse Event|6|||
161712867|NCT01309737|583993877|FG004|Week 16 to 52|Adverse Event|5|||
161712868|NCT01309737|583993873|FG000|Week 16 to 52|Lack of Efficacy|107|||
161712869|NCT01309737|583993874|FG001|Week 16 to 52|Lack of Efficacy|76|||
161712870|NCT01309737|583993875|FG002|Week 16 to 52|Lack of Efficacy|0|||
161712871|NCT01309737|583993876|FG003|Week 16 to 52|Lack of Efficacy|25|||
161712872|NCT01309737|583993877|FG004|Week 16 to 52|Lack of Efficacy|21|||
161712873|NCT01309737|583993873|FG000|Week 16 to 52|Lost to Follow-up|4|||
161712874|NCT01309737|583993874|FG001|Week 16 to 52|Lost to Follow-up|2|||
161712875|NCT01309737|583993875|FG002|Week 16 to 52|Lost to Follow-up|0|||
161712876|NCT01309737|583993876|FG003|Week 16 to 52|Lost to Follow-up|1|||
161712877|NCT01309737|583993877|FG004|Week 16 to 52|Lost to Follow-up|4|||
161712878|NCT01309737|583993873|FG000|Week 16 to 52|Withdrawal by Subject|5|||
161712879|NCT01309737|583993874|FG001|Week 16 to 52|Withdrawal by Subject|6|||
161712880|NCT01309737|583993875|FG002|Week 16 to 52|Withdrawal by Subject|0|||
161712881|NCT01309737|583993876|FG003|Week 16 to 52|Withdrawal by Subject|0|||
161712882|NCT01309737|583993877|FG004|Week 16 to 52|Withdrawal by Subject|2|||
161712883|NCT01309737|583993873|FG000|Week 16 to 52|Other|10|||
161712884|NCT01309737|583993874|FG001|Week 16 to 52|Other|12|||
161712885|NCT01309737|583993875|FG002|Week 16 to 52|Other|0|||
161712886|NCT01309737|583993876|FG003|Week 16 to 52|Other|2|||
161712887|NCT01309737|583993877|FG004|Week 16 to 52|Other|0|||
161712888|NCT01442181|583993879|FG000|Overall Study|patient refused surgery|1|||
161712889|NCT01442181|583993880|FG001|Overall Study|patient refused surgery|0|||
161712890|NCT01442181|583993879|FG000|Overall Study|no insurance for surgery|1|||
162031620|NCT02496676|585172417|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
161712891|NCT01442181|583993880|FG001|Overall Study|no insurance for surgery|0|||
161712892|NCT01442181|583993879|FG000|Overall Study|low ejection factor|0|||
161712893|NCT01442181|583993880|FG001|Overall Study|low ejection factor|1|||
161712894|NCT01442181|583993879|FG000|Overall Study|Lost to Follow-up|1|||
161712895|NCT01442181|583993880|FG001|Overall Study|Lost to Follow-up|1|||
161712896|NCT01442181|583993879|FG000|Overall Study|patient in an additional study|1|||
161712897|NCT01442181|583993880|FG001|Overall Study|patient in an additional study|0|||
161712898|NCT01442181|583993879|FG000|Overall Study|atrial fibrillation not noted|0|||
161712899|NCT01442181|583993880|FG001|Overall Study|atrial fibrillation not noted|1|||
161712900|NCT00749203|583993881|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
161712901|NCT00749203|583993882|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
161712902|NCT00749203|583993881|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
161712903|NCT00749203|583993882|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
161712904|NCT00749203|583993881|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
161712905|NCT00749203|583993882|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
161712906|NCT00749203|583993881|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
161712907|NCT00749203|583993882|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
161712908|NCT00749203|583993881|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
161712909|NCT00749203|583993882|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
161712910|NCT00749203|583993881|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
161712911|NCT00749203|583993882|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
161712912|NCT02034123|583993883|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712913|NCT02034123|583993884|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712914|NCT02034123|583993885|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712915|NCT02034123|583993886|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712916|NCT02034123|583993887|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
161712917|NCT02034123|583993888|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712918|NCT02034123|583993889|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712919|NCT02034123|583993890|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
161712920|NCT02034123|583993891|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
161712921|NCT02034123|583993892|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712922|NCT02034123|583993893|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712923|NCT02034123|583993894|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712924|NCT02034123|583993895|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712925|NCT02034123|583993896|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161961265|NCT04308239|584904015|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
161961266|NCT04308239|584904014|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
161961267|NCT04308239|584904015|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
161961268|NCT04308239|584904014|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
161961269|NCT04308239|584904015|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
161961270|NCT05791565|584904018|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
161961271|NCT05791565|584904019|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
161961272|NCT00880269|584904020|FG000|Overall Study|Protocol Violation|1|||
161961273|NCT00880269|584904021|FG001|Overall Study|Protocol Violation|0|||
161961274|NCT00880269|584904020|FG000|Overall Study|Disease Progression|13|||
161961275|NCT00880269|584904021|FG001|Overall Study|Disease Progression|11|||
161961276|NCT00880269|584904020|FG000|Overall Study|New Cancer Therapy|1|||
161961277|NCT00880269|584904021|FG001|Overall Study|New Cancer Therapy|0|||
161961278|NCT00880269|584904020|FG000|Overall Study|Death|4|||
161961279|NCT00880269|584904021|FG001|Overall Study|Death|2|||
161961280|NCT00880269|584904020|FG000|Overall Study|Lost to Follow-up|0|||
161961281|NCT00880269|584904021|FG001|Overall Study|Lost to Follow-up|1|||
161961282|NCT00880269|584904020|FG000|Overall Study|Withdrawal by Subject|3|||
161961283|NCT00880269|584904021|FG001|Overall Study|Withdrawal by Subject|4|||
161961284|NCT00880269|584904020|FG000|Overall Study|Adverse Event|10|||
161961285|NCT00880269|584904021|FG001|Overall Study|Adverse Event|9|||
161961286|NCT02516982|584904022|FG000|Overall Study|Called in to antenatal appointment|32|||
161961287|NCT02516982|584904023|FG001|Overall Study|Called in to antenatal appointment|35|||
161961288|NCT02516982|584904024|FG002|Overall Study|Called in to antenatal appointment|0|||
161961289|NCT02516982|584904025|FG003|Overall Study|Called in to antenatal appointment|0|||
161961290|NCT02516982|584904022|FG000|Overall Study|Withdrawal by Subject|0|||
161961291|NCT02516982|584904023|FG001|Overall Study|Withdrawal by Subject|0|||
161961292|NCT02516982|584904024|FG002|Overall Study|Withdrawal by Subject|1|||
161961293|NCT02516982|584904025|FG003|Overall Study|Withdrawal by Subject|2|||
161961294|NCT02516982|584904022|FG000|Overall Study|Protocol Violation|0|||
161961295|NCT02516982|584904023|FG001|Overall Study|Protocol Violation|0|||
161961296|NCT02516982|584904024|FG002|Overall Study|Protocol Violation|1|||
161961297|NCT02516982|584904025|FG003|Overall Study|Protocol Violation|1|||
161961298|NCT02516982|584904022|FG000|Overall Study|Did not install the app|0|||
161961299|NCT02516982|584904023|FG001|Overall Study|Did not install the app|0|||
161961300|NCT02516982|584904024|FG002|Overall Study|Did not install the app|46|||
161961301|NCT02516982|584904025|FG003|Overall Study|Did not install the app|47|||
161961302|NCT03379259|584904027|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
161961303|NCT03379259|584904028|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
161961304|NCT03379259|584904029|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
161961305|NCT03379259|584904030|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
161961306|NCT03379259|584904031|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
161712926|NCT02034123|583993897|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712927|NCT02034123|583993898|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712928|NCT02034123|583993899|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712929|NCT02034123|583993900|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161712930|NCT02034123|583993883|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161961307|NCT03379259|584904032|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
161961308|NCT03379259|584904027|FG000|Overall Study|Death|0|||
161961309|NCT03379259|584904028|FG001|Overall Study|Death|1|||
161712931|NCT02034123|583993884|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712932|NCT02034123|583993885|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712933|NCT02034123|583993886|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
161712934|NCT02034123|583993887|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712935|NCT02034123|583993888|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712936|NCT02034123|583993889|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712937|NCT02034123|583993890|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712938|NCT02034123|583993891|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712939|NCT02034123|583993892|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712940|NCT02034123|583993893|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712941|NCT02034123|583993894|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712942|NCT02034123|583993895|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712943|NCT02034123|583993896|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712944|NCT02034123|583993897|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712945|NCT02034123|583993898|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712946|NCT02034123|583993899|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712947|NCT02034123|583993900|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161712948|NCT02034123|583993883|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712949|NCT02034123|583993884|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712950|NCT02034123|583993885|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712951|NCT02034123|583993886|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712952|NCT02034123|583993887|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712953|NCT02034123|583993888|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712954|NCT02034123|583993889|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712955|NCT02034123|583993890|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712956|NCT02034123|583993891|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
161712957|NCT02034123|583993892|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712958|NCT02034123|583993893|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712959|NCT02034123|583993894|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712960|NCT02034123|583993895|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712961|NCT02034123|583993896|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712962|NCT02034123|583993897|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712963|NCT02034123|583993898|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712964|NCT02034123|583993899|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712965|NCT02034123|583993900|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161712966|NCT02034123|583993883|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712967|NCT02034123|583993884|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712968|NCT02034123|583993885|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712969|NCT02034123|583993886|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
161712970|NCT02034123|583993887|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
161712971|NCT02034123|583993888|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712972|NCT02034123|583993889|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712973|NCT02034123|583993890|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712974|NCT02034123|583993891|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712975|NCT02034123|583993892|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712976|NCT02034123|583993893|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712977|NCT02034123|583993894|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712978|NCT02034123|583993895|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712979|NCT02034123|583993896|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712980|NCT02034123|583993897|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712981|NCT02034123|583993898|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712982|NCT02034123|583993899|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712983|NCT02034123|583993900|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161712984|NCT04233424|583993901|FG000|Overall Study|Death|15|||
161712985|NCT04233424|583993902|FG001|Overall Study|Death|16|||
162031621|NCT02496676|585172418|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
162031622|NCT05442775|585172419|FG000|Overall Study|Trial terminated|61|||
162031623|NCT05442775|585172419|FG000|Overall Study|Lack of Efficacy|4|||
162031624|NCT05442775|585172419|FG000|Overall Study|Withdrawal by Subject|4|||
162031625|NCT05442775|585172419|FG000|Overall Study|Death|1|||
162031626|NCT05442775|585172419|FG000|Overall Study|Participant removed at Sponsor request|1|||
162031627|NCT03459690|585172421|FG000|Overall Study|Lost to Follow-up|0|||
162031628|NCT03459690|585172422|FG001|Overall Study|Lost to Follow-up|1|||
162031629|NCT03459690|585172421|FG000|Overall Study|Withdrawal by Subject|1|||
161712986|NCT04233424|583993901|FG000|Overall Study|Withdrawal by Subject|2|||
161712987|NCT04233424|583993902|FG001|Overall Study|Withdrawal by Subject|8|||
161712988|NCT04233424|583993901|FG000|Overall Study|Physician Decision|1|||
161712989|NCT04233424|583993902|FG001|Overall Study|Physician Decision|3|||
161712990|NCT04233424|583993901|FG000|Overall Study|Protocol Violation|3|||
161712991|NCT04233424|583993902|FG001|Overall Study|Protocol Violation|1|||
161712992|NCT04233424|583993901|FG000|Overall Study|Lost to Follow-up|1|||
161712993|NCT04233424|583993902|FG001|Overall Study|Lost to Follow-up|3|||
161712994|NCT04233424|583993901|FG000|Overall Study|subject refuse to visit site|2|||
161712995|NCT04233424|583993902|FG001|Overall Study|subject refuse to visit site|0|||
161712996|NCT02698189|583993903|FG000|Overall Study|Physician Decision|3|||
161712997|NCT02698189|583993904|FG001|Overall Study|Physician Decision|0|||
161712998|NCT02698189|583993903|FG000|Overall Study|Progressive disease|0|||
161712999|NCT02698189|583993904|FG001|Overall Study|Progressive disease|5|||
161713000|NCT02698189|583993903|FG000|Overall Study|Study terminated by sponsor|0|||
161713001|NCT02698189|583993904|FG001|Overall Study|Study terminated by sponsor|1|||
161713002|NCT02240706|583993905|FG000|Overall Study|Lack of Efficacy|2|||
161713003|NCT02240706|583993906|FG001|Overall Study|Lack of Efficacy|2|||
161713004|NCT02240706|583993907|FG002|Overall Study|Lack of Efficacy|2|||
161713005|NCT02240706|583993908|FG003|Overall Study|Lack of Efficacy|2|||
161713006|NCT02240706|583993909|FG004|Overall Study|Lack of Efficacy|5|||
161713007|NCT02240706|583993910|FG005|Overall Study|Lack of Efficacy|0|||
161713008|NCT02240706|583993911|FG006|Overall Study|Lack of Efficacy|0|||
161713009|NCT02240706|583993905|FG000|Overall Study|Adverse Event|1|||
161713010|NCT02240706|583993906|FG001|Overall Study|Adverse Event|0|||
161713011|NCT02240706|583993907|FG002|Overall Study|Adverse Event|1|||
161713012|NCT02240706|583993908|FG003|Overall Study|Adverse Event|0|||
161713013|NCT02240706|583993909|FG004|Overall Study|Adverse Event|2|||
161713014|NCT02240706|583993910|FG005|Overall Study|Adverse Event|0|||
161713015|NCT02240706|583993911|FG006|Overall Study|Adverse Event|0|||
161713016|NCT02240706|583993905|FG000|Overall Study|Progressive disease|0|||
161713017|NCT02240706|583993906|FG001|Overall Study|Progressive disease|0|||
161713018|NCT02240706|583993907|FG002|Overall Study|Progressive disease|0|||
161713019|NCT02240706|583993908|FG003|Overall Study|Progressive disease|0|||
161713020|NCT02240706|583993909|FG004|Overall Study|Progressive disease|1|||
161713021|NCT02240706|583993910|FG005|Overall Study|Progressive disease|0|||
161713022|NCT02240706|583993911|FG006|Overall Study|Progressive disease|0|||
161713023|NCT02240706|583993905|FG000|Overall Study|Dose limiting toxicity|0|||
161713024|NCT02240706|583993906|FG001|Overall Study|Dose limiting toxicity|0|||
161713025|NCT02240706|583993907|FG002|Overall Study|Dose limiting toxicity|0|||
161713026|NCT02240706|583993908|FG003|Overall Study|Dose limiting toxicity|0|||
161713027|NCT02240706|583993909|FG004|Overall Study|Dose limiting toxicity|1|||
161713028|NCT02240706|583993910|FG005|Overall Study|Dose limiting toxicity|0|||
161713029|NCT02240706|583993911|FG006|Overall Study|Dose limiting toxicity|0|||
161713030|NCT02240706|583993905|FG000|Overall Study|Refused to continue taking medication|0|||
161713031|NCT02240706|583993906|FG001|Overall Study|Refused to continue taking medication|1|||
161713032|NCT02240706|583993907|FG002|Overall Study|Refused to continue taking medication|3|||
161713033|NCT02240706|583993908|FG003|Overall Study|Refused to continue taking medication|1|||
161713034|NCT02240706|583993909|FG004|Overall Study|Refused to continue taking medication|2|||
161713035|NCT02240706|583993910|FG005|Overall Study|Refused to continue taking medication|0|||
161713036|NCT02240706|583993911|FG006|Overall Study|Refused to continue taking medication|0|||
161713037|NCT02240706|583993905|FG000|Overall Study|Insurance billing concerns|0|||
161713038|NCT02240706|583993906|FG001|Overall Study|Insurance billing concerns|0|||
161713039|NCT02240706|583993907|FG002|Overall Study|Insurance billing concerns|0|||
161713040|NCT02240706|583993908|FG003|Overall Study|Insurance billing concerns|1|||
161713041|NCT02240706|583993909|FG004|Overall Study|Insurance billing concerns|0|||
161713042|NCT02240706|583993910|FG005|Overall Study|Insurance billing concerns|0|||
161713043|NCT02240706|583993911|FG006|Overall Study|Insurance billing concerns|0|||
161713044|NCT00855439|583993916|FG000|Overall Study|Withdrawal by Subject|2|||
161713045|NCT00855439|583993917|FG001|Overall Study|Withdrawal by Subject|0|||
161713046|NCT00855439|583993916|FG000|Overall Study|Pregnancy|1|||
161713047|NCT00855439|583993917|FG001|Overall Study|Pregnancy|0|||
161713048|NCT05502289|583993918|FG000|Period 1|Out Of Window|1|||
161713049|NCT05502289|583993919|FG001|Period 1|Out Of Window|0|||
161713050|NCT02333227|583993929|FG000|Overall Study|Lost to Follow-up|137|||
161713051|NCT02333227|583993930|FG001|Overall Study|Lost to Follow-up|106|||
161713052|NCT02333227|583993929|FG000|Overall Study|Pregnancy Interrupted|42|||
161713053|NCT02333227|583993930|FG001|Overall Study|Pregnancy Interrupted|89|||
161713054|NCT02333227|583993929|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
161713055|NCT02333227|583993930|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
161713056|NCT01564784|583993931|FG000|Overall Study|Other|1|||
161713057|NCT01564784|583993932|FG001|Overall Study|Other|0|||
161713058|NCT01564784|583993931|FG000|Overall Study|Subject refused further follow-up|1|||
161713059|NCT01564784|583993932|FG001|Overall Study|Subject refused further follow-up|6|||
161713060|NCT01564784|583993931|FG000|Overall Study|Lost to Follow-up|1|||
161713061|NCT01564784|583993932|FG001|Overall Study|Lost to Follow-up|1|||
161713062|NCT01564784|583993931|FG000|Overall Study|Death|131|||
161713063|NCT01564784|583993932|FG001|Overall Study|Death|126|||
161713064|NCT01076179|583993933|FG000|Overall Study|Withdrawal by Subject|1|||
161713065|NCT03459040|583993934|FG000|Overall Study|Death|8|||
161713066|NCT03459040|583993934|FG000|Overall Study|Withdrawal by Subject|1|||
161713067|NCT00488631|583993935|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
161713068|NCT00488631|583993936|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
161713069|NCT00488631|583993937|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
161713070|NCT00488631|583993938|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
161713071|NCT00488631|583993939|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
161713072|NCT00488631|583993940|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
161713073|NCT00488631|583993941|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
161713074|NCT00488631|583993942|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
161713075|NCT00488631|583993943|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
161713076|NCT00488631|583993944|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
161713077|NCT00488631|583993935|FG000|Double Blind Period (Week 0-54)|Death|0|||
161713078|NCT00488631|583993936|FG001|Double Blind Period (Week 0-54)|Death|0|||
161713079|NCT00488631|583993937|FG002|Double Blind Period (Week 0-54)|Death|0|||
161713080|NCT00488631|583993938|FG003|Double Blind Period (Week 0-54)|Death|0|||
161713081|NCT00488631|583993939|FG004|Double Blind Period (Week 0-54)|Death|0|||
161713082|NCT00488631|583993940|FG005|Double Blind Period (Week 0-54)|Death|1|||
161713083|NCT00488631|583993941|FG006|Double Blind Period (Week 0-54)|Death|0|||
161713084|NCT00488631|583993942|FG007|Double Blind Period (Week 0-54)|Death|0|||
161713085|NCT00488631|583993943|FG008|Double Blind Period (Week 0-54)|Death|0|||
161713086|NCT00488631|583993944|FG009|Double Blind Period (Week 0-54)|Death|0|||
161713087|NCT00488631|583993935|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
161713088|NCT00488631|583993936|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
161713089|NCT00488631|583993937|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
161713090|NCT00488631|583993938|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
161713091|NCT00488631|583993939|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
161713092|NCT00488631|583993940|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
161713093|NCT00488631|583993941|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
161713094|NCT00488631|583993942|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
161713095|NCT00488631|583993943|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
161713096|NCT00488631|583993944|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
161713097|NCT00488631|583993935|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
161713098|NCT00488631|583993936|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
161713099|NCT00488631|583993937|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
161713100|NCT00488631|583993938|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161713101|NCT00488631|583993939|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
161713102|NCT00488631|583993940|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
161713103|NCT00488631|583993941|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161713104|NCT00488631|583993942|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161713105|NCT00488631|583993943|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161713106|NCT00488631|583993944|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161713107|NCT00488631|583993935|FG000|Double Blind Period (Week 0-54)|Other|6|||
161713108|NCT00488631|583993936|FG001|Double Blind Period (Week 0-54)|Other|12|||
161713109|NCT00488631|583993937|FG002|Double Blind Period (Week 0-54)|Other|10|||
161713110|NCT00488631|583993938|FG003|Double Blind Period (Week 0-54)|Other|11|||
161713111|NCT00488631|583993939|FG004|Double Blind Period (Week 0-54)|Other|14|||
161713112|NCT00488631|583993940|FG005|Double Blind Period (Week 0-54)|Other|34|||
161713113|NCT00488631|583993941|FG006|Double Blind Period (Week 0-54)|Other|0|||
161713114|NCT00488631|583993942|FG007|Double Blind Period (Week 0-54)|Other|0|||
161713115|NCT00488631|583993943|FG008|Double Blind Period (Week 0-54)|Other|0|||
161713116|NCT00488631|583993944|FG009|Double Blind Period (Week 0-54)|Other|0|||
161713117|NCT00488631|583993935|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713118|NCT00488631|583993936|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713119|NCT00488631|583993937|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713120|NCT00488631|583993938|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713121|NCT00488631|583993939|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713122|NCT00488631|583993940|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713123|NCT00488631|583993941|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
161713124|NCT00488631|583993942|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
161713125|NCT00488631|583993943|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
161713126|NCT00488631|583993944|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161713127|NCT00488631|583993935|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
161713128|NCT00488631|583993936|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
161713129|NCT00488631|583993937|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
161713130|NCT00488631|583993938|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
161713131|NCT00488631|583993939|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
161713132|NCT00488631|583993940|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
161713133|NCT00488631|583993941|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
161713134|NCT00488631|583993942|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
161713135|NCT00488631|583993943|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
161713136|NCT00488631|583993944|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
161713137|NCT00488631|583993935|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161713138|NCT00488631|583993936|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161713139|NCT00488631|583993937|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161713140|NCT00488631|583993938|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161713141|NCT00488631|583993939|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161713142|NCT00488631|583993940|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161713143|NCT00488631|583993941|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
161713144|NCT00488631|583993942|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
161713145|NCT00488631|583993943|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
161713146|NCT00488631|583993944|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
161713147|NCT00488631|583993935|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713148|NCT00488631|583993936|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713149|NCT00488631|583993937|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713150|NCT00488631|583993938|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713151|NCT00488631|583993939|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713152|NCT00488631|583993940|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713153|NCT00488631|583993941|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
161713154|NCT00488631|583993942|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713155|NCT00488631|583993943|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
161713156|NCT00488631|583993944|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161713157|NCT00488631|583993935|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713158|NCT00488631|583993936|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713159|NCT00488631|583993937|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713160|NCT00488631|583993938|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713161|NCT00488631|583993939|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713162|NCT00488631|583993940|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713163|NCT00488631|583993941|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
161713164|NCT00488631|583993942|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
161713165|NCT00488631|583993943|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
161713166|NCT00488631|583993944|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161713167|NCT05300087|583993945|FG000|Overall Study|Withdrawal by Subject|0|||
161713168|NCT05300087|583993946|FG001|Overall Study|Withdrawal by Subject|1|||
161713169|NCT03248128|583993947|FG000|Overall Study|Lost to Follow-up|1|||
161713170|NCT03248128|583993948|FG001|Overall Study|Lost to Follow-up|0|||
161713171|NCT03248128|583993947|FG000|Overall Study|Withdrawal by Subject|16|||
161713172|NCT03248128|583993948|FG001|Overall Study|Withdrawal by Subject|14|||
161713173|NCT03248128|583993947|FG000|Overall Study|Site Closed|4|||
161713174|NCT03248128|583993948|FG001|Overall Study|Site Closed|3|||
161713175|NCT03248128|583993947|FG000|Overall Study|Randomized, but did not receive treatment|1|||
161713176|NCT03248128|583993948|FG001|Overall Study|Randomized, but did not receive treatment|3|||
161713177|NCT01914679|583993949|FG000|Overall Study|Lack of Efficacy|1|||
161713178|NCT01914679|583993949|FG000|Overall Study|Sponsor terminated study|4|||
161713179|NCT00256295|583993950|FG000|Overall Study|Withdrawal by Subject|3|||
161713180|NCT00256295|583993950|FG000|Overall Study|Death|1|||
161713181|NCT00947349|583993951|FG000|Triple Treatment Combination Period|Adverse Event|0|||
161713182|NCT00947349|583993952|FG001|Triple Treatment Combination Period|Adverse Event|1|||
161713183|NCT00947349|583993953|FG002|Triple Treatment Combination Period|Adverse Event|0|||
161713184|NCT00947349|583993954|FG003|Triple Treatment Combination Period|Adverse Event|0|||
161713185|NCT00947349|583993951|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
161713186|NCT00947349|583993952|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
161713187|NCT00947349|583993953|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
161713188|NCT00947349|583993954|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
161713189|NCT00947349|583993951|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
161713190|NCT00947349|583993952|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
161713191|NCT00947349|583993953|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
161713192|NCT00947349|583993954|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
161961310|NCT03379259|584904029|FG002|Overall Study|Death|2|||
161961311|NCT03379259|584904030|FG003|Overall Study|Death|1|||
161961312|NCT03379259|584904031|FG004|Overall Study|Death|4|||
161961313|NCT03379259|584904032|FG005|Overall Study|Death|2|||
161961314|NCT03379259|584904027|FG000|Overall Study|Withdrawal by Subject|0|||
161961315|NCT03379259|584904028|FG001|Overall Study|Withdrawal by Subject|0|||
161713193|NCT00947349|583993951|FG000|Overall Study Standard of Care|Other|0|||
161713194|NCT00947349|583993952|FG001|Overall Study Standard of Care|Other|0|||
161713195|NCT00947349|583993953|FG002|Overall Study Standard of Care|Other|0|||
161713196|NCT00947349|583993954|FG003|Overall Study Standard of Care|Other|1|||
161713197|NCT00538681|583993955|FG000|Overall Study|Progressive Disease|7|||
161713198|NCT00538681|583993956|FG001|Overall Study|Progressive Disease|0|||
161713199|NCT00538681|583993957|FG002|Overall Study|Progressive Disease|1|||
161713200|NCT00538681|583993958|FG003|Overall Study|Progressive Disease|0|||
161713201|NCT00538681|583993955|FG000|Overall Study|Sponsor Decision|1|||
161713202|NCT00538681|583993956|FG001|Overall Study|Sponsor Decision|3|||
161713203|NCT00538681|583993957|FG002|Overall Study|Sponsor Decision|8|||
161713204|NCT00538681|583993958|FG003|Overall Study|Sponsor Decision|9|||
161713205|NCT00538681|583993955|FG000|Overall Study|Adverse Event|1|||
161713206|NCT00538681|583993956|FG001|Overall Study|Adverse Event|1|||
161713207|NCT00538681|583993957|FG002|Overall Study|Adverse Event|1|||
161713208|NCT00538681|583993958|FG003|Overall Study|Adverse Event|0|||
161713209|NCT00538681|583993955|FG000|Overall Study|Death|0|||
161713210|NCT00538681|583993956|FG001|Overall Study|Death|0|||
161713211|NCT00538681|583993957|FG002|Overall Study|Death|1|||
161713212|NCT00538681|583993958|FG003|Overall Study|Death|1|||
161713213|NCT00538681|583993955|FG000|Overall Study|Investigator Decision|0|||
161713214|NCT00538681|583993956|FG001|Overall Study|Investigator Decision|0|||
161713215|NCT00538681|583993957|FG002|Overall Study|Investigator Decision|0|||
161713216|NCT00538681|583993958|FG003|Overall Study|Investigator Decision|1|||
161713217|NCT05369806|583993959|FG000|Overall Study|Lost to Follow-up|1|||
161713218|NCT00628355|583993960|FG000|Overall Study|Withdrawal by Subject|1|||
161713219|NCT00628355|583993961|FG001|Overall Study|Withdrawal by Subject|1|||
161713220|NCT01446809|583993963|FG000|Overall Study|Adverse Event|0|||
161713221|NCT01446809|583993964|FG001|Overall Study|Adverse Event|0|||
161713222|NCT01446809|583993965|FG002|Overall Study|Adverse Event|1|||
161713223|NCT01446809|583993963|FG000|Overall Study|Failure to complete study procedures|0|||
161713224|NCT01446809|583993964|FG001|Overall Study|Failure to complete study procedures|0|||
161713225|NCT01446809|583993965|FG002|Overall Study|Failure to complete study procedures|1|||
161713226|NCT01331161|583993966|FG000|Overall Study|Physician Decision|1|||
161713227|NCT01331161|583993967|FG001|Overall Study|Physician Decision|0|||
161713228|NCT01331161|583993966|FG000|Overall Study|Lost to Follow-up|0|||
161713229|NCT01331161|583993967|FG001|Overall Study|Lost to Follow-up|1|||
161713230|NCT01331161|583993966|FG000|Overall Study|Pregnancy|0|||
161713231|NCT01331161|583993967|FG001|Overall Study|Pregnancy|1|||
161713232|NCT02770807|583993969|FG000|Overall Study|Adverse Event|3|||
161713233|NCT02770807|583993970|FG001|Overall Study|Adverse Event|3|||
161713234|NCT02770807|583993971|FG002|Overall Study|Adverse Event|1|||
161713235|NCT02770807|583993969|FG000|Overall Study|Withdrawal by Subject|7|||
161713236|NCT02770807|583993970|FG001|Overall Study|Withdrawal by Subject|3|||
161713237|NCT02770807|583993971|FG002|Overall Study|Withdrawal by Subject|4|||
161713238|NCT02770807|583993969|FG000|Overall Study|Other|0|||
161713239|NCT02770807|583993970|FG001|Overall Study|Other|1|||
161713240|NCT02770807|583993971|FG002|Overall Study|Other|0|||
161713241|NCT02770807|583993969|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
161713242|NCT02770807|583993970|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
161713243|NCT02770807|583993971|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
161713244|NCT02770807|583993969|FG000|Overall Study|Physician Decision|0|||
161713245|NCT02770807|583993970|FG001|Overall Study|Physician Decision|0|||
161961316|NCT03379259|584904029|FG002|Overall Study|Withdrawal by Subject|1|||
161713246|NCT02770807|583993971|FG002|Overall Study|Physician Decision|1|||
161713247|NCT05738486|583996232|FG000|Overall Study|Continuing Study|194|||
161713248|NCT05738486|583996233|FG001|Overall Study|Continuing Study|196|||
161713249|NCT05738486|583996234|FG002|Overall Study|Continuing Study|193|||
161713250|NCT05738486|583996235|FG003|Overall Study|Continuing Study|191|||
161713251|NCT05738486|583996232|FG000|Overall Study|Withdrawal by Subject|8|||
161713252|NCT05738486|583996233|FG001|Overall Study|Withdrawal by Subject|5|||
161713253|NCT05738486|583996234|FG002|Overall Study|Withdrawal by Subject|7|||
161713254|NCT05738486|583996235|FG003|Overall Study|Withdrawal by Subject|13|||
161713255|NCT05738486|583996232|FG000|Overall Study|Adverse Event|4|||
161713256|NCT05738486|583996233|FG001|Overall Study|Adverse Event|6|||
161713257|NCT05738486|583996234|FG002|Overall Study|Adverse Event|4|||
161713258|NCT05738486|583996235|FG003|Overall Study|Adverse Event|5|||
161713259|NCT05738486|583996232|FG000|Overall Study|Physician Decision|0|||
161713260|NCT05738486|583996233|FG001|Overall Study|Physician Decision|2|||
161713261|NCT05738486|583996234|FG002|Overall Study|Physician Decision|4|||
161713262|NCT05738486|583996235|FG003|Overall Study|Physician Decision|1|||
161713263|NCT05738486|583996232|FG000|Overall Study|Lost to Follow-up|1|||
161713264|NCT05738486|583996233|FG001|Overall Study|Lost to Follow-up|1|||
161713265|NCT05738486|583996234|FG002|Overall Study|Lost to Follow-up|2|||
161713266|NCT05738486|583996235|FG003|Overall Study|Lost to Follow-up|1|||
161713267|NCT05738486|583996232|FG000|Overall Study|Participant was Non-ambulatory|0|||
161713268|NCT05738486|583996233|FG001|Overall Study|Participant was Non-ambulatory|0|||
161713269|NCT05738486|583996234|FG002|Overall Study|Participant was Non-ambulatory|1|||
161713270|NCT05738486|583996235|FG003|Overall Study|Participant was Non-ambulatory|0|||
161713271|NCT05738486|583996232|FG000|Overall Study|Participant had Poor Venous Access|0|||
161713272|NCT05738486|583996233|FG001|Overall Study|Participant had Poor Venous Access|0|||
161713273|NCT05738486|583996234|FG002|Overall Study|Participant had Poor Venous Access|0|||
161713274|NCT05738486|583996235|FG003|Overall Study|Participant had Poor Venous Access|1|||
161713275|NCT05738486|583996232|FG000|Overall Study|Assigned Treatment by Mistake|0|||
161713276|NCT05738486|583996233|FG001|Overall Study|Assigned Treatment by Mistake|0|||
161713277|NCT05738486|583996234|FG002|Overall Study|Assigned Treatment by Mistake|0|||
161713278|NCT05738486|583996235|FG003|Overall Study|Assigned Treatment by Mistake|1|||
161713279|NCT05738486|583996232|FG000|Overall Study|Death|0|||
161713280|NCT05738486|583996233|FG001|Overall Study|Death|0|||
161713281|NCT05738486|583996234|FG002|Overall Study|Death|1|||
161713282|NCT05738486|583996235|FG003|Overall Study|Death|0|||
161713283|NCT05738486|583996232|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
161713284|NCT05738486|583996233|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161713285|NCT05738486|583996234|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161961317|NCT03379259|584904030|FG003|Overall Study|Withdrawal by Subject|0|||
161961318|NCT03379259|584904031|FG004|Overall Study|Withdrawal by Subject|2|||
161961319|NCT03379259|584904032|FG005|Overall Study|Withdrawal by Subject|0|||
161961320|NCT03379259|584904027|FG000|Overall Study|Study terminated by sponsor|0|||
161961321|NCT03379259|584904028|FG001|Overall Study|Study terminated by sponsor|0|||
161961322|NCT03379259|584904029|FG002|Overall Study|Study terminated by sponsor|0|||
161961323|NCT03379259|584904030|FG003|Overall Study|Study terminated by sponsor|1|||
161961324|NCT03379259|584904031|FG004|Overall Study|Study terminated by sponsor|1|||
161961325|NCT03379259|584904032|FG005|Overall Study|Study terminated by sponsor|4|||
161961326|NCT03379259|584904027|FG000|Overall Study|Disease progression|0|||
161961327|NCT03379259|584904028|FG001|Overall Study|Disease progression|0|||
161961328|NCT03379259|584904029|FG002|Overall Study|Disease progression|0|||
161961329|NCT03379259|584904030|FG003|Overall Study|Disease progression|1|||
161961330|NCT03379259|584904031|FG004|Overall Study|Disease progression|0|||
161961331|NCT03379259|584904032|FG005|Overall Study|Disease progression|1|||
161961332|NCT03379259|584904027|FG000|Overall Study|Lost to Follow-up|0|||
161961333|NCT03379259|584904028|FG001|Overall Study|Lost to Follow-up|0|||
161961334|NCT03379259|584904029|FG002|Overall Study|Lost to Follow-up|0|||
161713286|NCT05738486|583996235|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161713287|NCT00886821|583996236|FG000|Stage 2|Adverse Event|0|||
161713288|NCT00886821|583996237|FG001|Stage 2|Adverse Event|0|||
161713289|NCT00886821|583996238|FG002|Stage 2|Adverse Event|0|||
161713290|NCT00886821|583996239|FG003|Stage 2|Adverse Event|0|||
161713291|NCT00886821|583996240|FG004|Stage 2|Adverse Event|0|||
161961335|NCT03379259|584904030|FG003|Overall Study|Lost to Follow-up|0|||
161961336|NCT03379259|584904031|FG004|Overall Study|Lost to Follow-up|1|||
161713292|NCT00886821|583996241|FG005|Stage 2|Adverse Event|0|||
161713293|NCT00886821|583996242|FG006|Stage 2|Adverse Event|0|||
161713294|NCT00886821|583996243|FG007|Stage 2|Adverse Event|0|||
161713295|NCT00886821|583996244|FG008|Stage 2|Adverse Event|0|||
161713296|NCT00886821|583996245|FG009|Stage 2|Adverse Event|0|||
161713297|NCT00886821|583996246|FG010|Stage 2|Adverse Event|0|||
161713298|NCT00886821|583996247|FG011|Stage 2|Adverse Event|1|||
161713299|NCT00886821|583996248|FG012|Stage 2|Adverse Event|3|||
161713300|NCT00886821|583996249|FG013|Stage 2|Adverse Event|0|||
161713301|NCT00886821|583996236|FG000|Stage 2|Lost to Follow-up|0|||
161713302|NCT00886821|583996237|FG001|Stage 2|Lost to Follow-up|0|||
161961337|NCT03379259|584904032|FG005|Overall Study|Lost to Follow-up|0|||
162031630|NCT03459690|585172422|FG001|Overall Study|Withdrawal by Subject|1|||
162031631|NCT02963831|585172424|FG000|Overall Study|Progressive Disease|3|||
162031632|NCT02963831|585172425|FG001|Overall Study|Progressive Disease|3|||
162031633|NCT02963831|585172426|FG002|Overall Study|Progressive Disease|16|||
162031634|NCT02963831|585172427|FG003|Overall Study|Progressive Disease|27|||
162031635|NCT02963831|585172424|FG000|Overall Study|Withdrawal by Subject|1|||
162031636|NCT02963831|585172425|FG001|Overall Study|Withdrawal by Subject|0|||
162031637|NCT02963831|585172426|FG002|Overall Study|Withdrawal by Subject|2|||
162031638|NCT02963831|585172427|FG003|Overall Study|Withdrawal by Subject|4|||
162031639|NCT02963831|585172424|FG000|Overall Study|Adverse Event|0|||
162031640|NCT02963831|585172425|FG001|Overall Study|Adverse Event|1|||
162031641|NCT02963831|585172426|FG002|Overall Study|Adverse Event|1|||
162031642|NCT02963831|585172427|FG003|Overall Study|Adverse Event|2|||
162031643|NCT02963831|585172424|FG000|Overall Study|Death|0|||
162031644|NCT02963831|585172425|FG001|Overall Study|Death|0|||
162031645|NCT02963831|585172426|FG002|Overall Study|Death|0|||
162031646|NCT02963831|585172427|FG003|Overall Study|Death|2|||
162031647|NCT01966432|585172428|FG000|Overall Study|Lost to Follow-up|3|||
162031648|NCT01966432|585172429|FG001|Overall Study|Lost to Follow-up|2|||
162031649|NCT01966432|585172430|FG002|Overall Study|Lost to Follow-up|5|||
162031650|NCT01966432|585172428|FG000|Overall Study|Withdrawal by Subject|1|||
162031651|NCT01966432|585172429|FG001|Overall Study|Withdrawal by Subject|3|||
162031652|NCT01966432|585172430|FG002|Overall Study|Withdrawal by Subject|0|||
162031653|NCT01966432|585172428|FG000|Overall Study|Subject Incarcerated|0|||
162031654|NCT01966432|585172429|FG001|Overall Study|Subject Incarcerated|0|||
162031655|NCT01966432|585172430|FG002|Overall Study|Subject Incarcerated|1|||
162031656|NCT01966432|585172428|FG000|Overall Study|SBIRT program ended|1|||
162031657|NCT01966432|585172429|FG001|Overall Study|SBIRT program ended|8|||
162031658|NCT01966432|585172430|FG002|Overall Study|SBIRT program ended|20|||
162031659|NCT02514473|585172434|FG000|Overall Study|Adverse Event|0|||
162031660|NCT02514473|585172435|FG001|Overall Study|Adverse Event|2|||
162031661|NCT02514473|585172434|FG000|Overall Study|Withdrawal by Subject|2|||
162031662|NCT02514473|585172435|FG001|Overall Study|Withdrawal by Subject|1|||
162031663|NCT02514473|585172434|FG000|Overall Study|Lost to Follow-up|0|||
162031664|NCT02514473|585172435|FG001|Overall Study|Lost to Follow-up|1|||
162031665|NCT02514473|585172434|FG000|Overall Study|Other|1|||
162031666|NCT02514473|585172435|FG001|Overall Study|Other|1|||
162031667|NCT04381988|585172436|FG000|Overall Study|The study was terminated|4|||
162031668|NCT04381988|585172437|FG001|Overall Study|The study was terminated|0|||
162031669|NCT02106923|585172438|FG000|Overall Study|Protocol Violation|0|||
162031670|NCT02106923|585172439|FG001|Overall Study|Protocol Violation|0|||
162031671|NCT02106923|585172440|FG002|Overall Study|Protocol Violation|0|||
162031672|NCT02106923|585172441|FG003|Overall Study|Protocol Violation|0|||
162031673|NCT02106923|585172442|FG004|Overall Study|Protocol Violation|0|||
162031674|NCT02106923|585172443|FG005|Overall Study|Protocol Violation|1|||
162031675|NCT03485495|585172444|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
162031676|NCT03485495|585172445|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
162031677|NCT03915860|585172446|FG000|Overall Study|Adverse Event|3|||
162031678|NCT03915860|585172446|FG000|Overall Study|Withdrawal by Subject|6|||
162031679|NCT03915860|585172446|FG000|Overall Study|Lost to Follow-up|2|||
162031680|NCT03915860|585172446|FG000|Overall Study|Other than specified|3|||
162031681|NCT01107379|585172450|FG000|Overall Study|Withdrawal by Subject|18|||
161713303|NCT00886821|583996238|FG002|Stage 2|Lost to Follow-up|0|||
161713304|NCT00886821|583996239|FG003|Stage 2|Lost to Follow-up|0|||
161713305|NCT00886821|583996240|FG004|Stage 2|Lost to Follow-up|0|||
161713306|NCT00886821|583996241|FG005|Stage 2|Lost to Follow-up|0|||
161713307|NCT00886821|583996242|FG006|Stage 2|Lost to Follow-up|0|||
161713308|NCT00886821|583996243|FG007|Stage 2|Lost to Follow-up|0|||
161713309|NCT00886821|583996244|FG008|Stage 2|Lost to Follow-up|0|||
161713310|NCT00886821|583996245|FG009|Stage 2|Lost to Follow-up|0|||
161713311|NCT00886821|583996246|FG010|Stage 2|Lost to Follow-up|0|||
161713312|NCT00886821|583996247|FG011|Stage 2|Lost to Follow-up|0|||
161713313|NCT00886821|583996248|FG012|Stage 2|Lost to Follow-up|2|||
161713314|NCT00886821|583996249|FG013|Stage 2|Lost to Follow-up|1|||
161713315|NCT03716726|583996250|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
161713316|NCT03716726|583996251|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
161713317|NCT03716726|583996250|FG000|12 Months Followup|Lost to Follow-up|10|||
161713318|NCT03716726|583996251|FG001|12 Months Followup|Lost to Follow-up|17|||
161713319|NCT02579603|583996252|FG000|Overall Study|Not treated|1|||
161713320|NCT02579603|583996253|FG001|Overall Study|Not treated|0|||
161713321|NCT02579603|583996252|FG000|Overall Study|Adverse Event|2|||
161713322|NCT02579603|583996253|FG001|Overall Study|Adverse Event|2|||
161713323|NCT02579603|583996252|FG000|Overall Study|Other than stated|1|||
161713324|NCT02579603|583996253|FG001|Overall Study|Other than stated|0|||
161713325|NCT00469079|583996254|FG000|Overall Study|Lack of Efficacy|3|||
161713326|NCT00469079|583996255|FG001|Overall Study|Lack of Efficacy|8|||
161713327|NCT00469079|583996256|FG002|Overall Study|Lack of Efficacy|5|||
161713328|NCT00469079|583996254|FG000|Overall Study|Adverse Event|1|||
161713329|NCT00469079|583996255|FG001|Overall Study|Adverse Event|3|||
161713330|NCT00469079|583996256|FG002|Overall Study|Adverse Event|2|||
161961338|NCT03379259|584904027|FG000|Overall Study|Deteriorating condition|0|||
161961339|NCT03379259|584904028|FG001|Overall Study|Deteriorating condition|0|||
161961340|NCT03379259|584904029|FG002|Overall Study|Deteriorating condition|0|||
161961341|NCT03379259|584904030|FG003|Overall Study|Deteriorating condition|0|||
161961342|NCT03379259|584904031|FG004|Overall Study|Deteriorating condition|1|||
161961343|NCT03379259|584904032|FG005|Overall Study|Deteriorating condition|0|||
161961344|NCT03195660|584904033|FG000|Overall Study|The study was terminated|2|||
161961345|NCT00375427|584904034|FG000|Overall Study|Adverse Event|21|||
161961346|NCT00375427|584904035|FG001|Overall Study|Adverse Event|27|||
161961347|NCT00375427|584904034|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161961348|NCT00375427|584904035|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161961349|NCT00375427|584904034|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161961350|NCT00375427|584904035|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161961351|NCT00375427|584904034|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161961352|NCT00375427|584904035|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
161961353|NCT00375427|584904034|FG000|Overall Study|Patient no longer requires study drug|3|||
161961354|NCT00375427|584904035|FG001|Overall Study|Patient no longer requires study drug|7|||
161961355|NCT00375427|584904034|FG000|Overall Study|Protocol Violation|10|||
161961356|NCT00375427|584904035|FG001|Overall Study|Protocol Violation|8|||
161961357|NCT00375427|584904034|FG000|Overall Study|Withdrawal by Subject|9|||
161961358|NCT00375427|584904035|FG001|Overall Study|Withdrawal by Subject|13|||
161961359|NCT00375427|584904034|FG000|Overall Study|Lost to Follow-up|1|||
161961360|NCT00375427|584904035|FG001|Overall Study|Lost to Follow-up|1|||
161961361|NCT00375427|584904034|FG000|Overall Study|Administrative reasons|0|||
161961362|NCT00375427|584904035|FG001|Overall Study|Administrative reasons|1|||
161961363|NCT00375427|584904034|FG000|Overall Study|Death|11|||
161961364|NCT00375427|584904035|FG001|Overall Study|Death|10|||
161961365|NCT03818607|584904041|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
161961366|NCT03818607|584904042|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
161961367|NCT03818607|584904041|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
161961368|NCT03818607|584904042|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
161961369|NCT03818607|584904041|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
161961370|NCT03818607|584904042|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
161961371|NCT01147250|584904046|FG000|Overall Study|Lost to Follow-up|14|||
161713331|NCT00469079|583996254|FG000|Overall Study|Lost to Follow-up|4|||
161713332|NCT00469079|583996255|FG001|Overall Study|Lost to Follow-up|8|||
161713333|NCT00469079|583996256|FG002|Overall Study|Lost to Follow-up|10|||
161713334|NCT00469079|583996254|FG000|Overall Study|Withdrawal by Subject|1|||
161713335|NCT00469079|583996255|FG001|Overall Study|Withdrawal by Subject|2|||
161713336|NCT00469079|583996256|FG002|Overall Study|Withdrawal by Subject|2|||
161713337|NCT00469079|583996254|FG000|Overall Study|Ineligible|0|||
161713338|NCT00469079|583996255|FG001|Overall Study|Ineligible|1|||
161713339|NCT00469079|583996256|FG002|Overall Study|Ineligible|0|||
161713340|NCT00942162|583996257|FG000|Overall Study|Death|45|||
161713341|NCT00942162|583996258|FG001|Overall Study|Death|35|||
161713342|NCT00942162|583996259|FG002|Overall Study|Death|0|||
161713343|NCT00942162|583996257|FG000|Overall Study|Withdrawal by Subject|7|||
161713344|NCT00942162|583996258|FG001|Overall Study|Withdrawal by Subject|2|||
161713345|NCT00942162|583996259|FG002|Overall Study|Withdrawal by Subject|0|||
161713346|NCT00942162|583996257|FG000|Overall Study|Lost to Follow-up|4|||
161713347|NCT00942162|583996258|FG001|Overall Study|Lost to Follow-up|0|||
161713348|NCT00942162|583996259|FG002|Overall Study|Lost to Follow-up|0|||
161713349|NCT00942162|583996257|FG000|Overall Study|Other|14|||
161713350|NCT00942162|583996258|FG001|Overall Study|Other|13|||
161713351|NCT00942162|583996259|FG002|Overall Study|Other|2|||
161713352|NCT01126619|583996260|FG000|Overall Study|Not eligible for the study|2|||
161713353|NCT01126619|583996260|FG000|Overall Study|Investigator decision|4|||
161713354|NCT01126619|583996260|FG000|Overall Study|Serious adverse event|1|||
161713355|NCT01126619|583996260|FG000|Overall Study|Withdrawal by Subject|9|||
161713356|NCT01126619|583996260|FG000|Overall Study|Non-compliance|1|||
161713357|NCT04876391|583996261|FG000|Overall Study|Withdrawal by Subject|1|||
161713358|NCT04876391|583996262|FG001|Overall Study|Withdrawal by Subject|10|||
161713359|NCT04876391|583996261|FG000|Overall Study|Lost to Follow-up|2|||
161713360|NCT04876391|583996262|FG001|Overall Study|Lost to Follow-up|4|||
161713361|NCT04876391|583996261|FG000|Overall Study|Lack of Efficacy|0|||
161713362|NCT04876391|583996262|FG001|Overall Study|Lack of Efficacy|2|||
161713363|NCT04876391|583996261|FG000|Overall Study|Adverse Event|3|||
161713364|NCT04876391|583996262|FG001|Overall Study|Adverse Event|1|||
161713365|NCT04876391|583996261|FG000|Overall Study|Patient non-compliance|0|||
161713366|NCT04876391|583996262|FG001|Overall Study|Patient non-compliance|1|||
161713367|NCT04876391|583996261|FG000|Overall Study|Personal reasons|0|||
161713368|NCT04876391|583996262|FG001|Overall Study|Personal reasons|1|||
161713369|NCT04876391|583996261|FG000|Overall Study|Withdrawn as per protocol|2|||
161713370|NCT04876391|583996262|FG001|Overall Study|Withdrawn as per protocol|2|||
161713371|NCT00811252|583996265|FG000|Overall Study|Adverse Event|6|||
161713372|NCT00811252|583996266|FG001|Overall Study|Adverse Event|10|||
161713373|NCT00811252|583996267|FG002|Overall Study|Adverse Event|15|||
161713374|NCT00811252|583996265|FG000|Overall Study|Lack of Efficacy|7|||
161713375|NCT00811252|583996266|FG001|Overall Study|Lack of Efficacy|2|||
161713376|NCT00811252|583996267|FG002|Overall Study|Lack of Efficacy|0|||
161713377|NCT00811252|583996265|FG000|Overall Study|Protocol Violation|3|||
161713378|NCT00811252|583996266|FG001|Overall Study|Protocol Violation|3|||
161713379|NCT00811252|583996267|FG002|Overall Study|Protocol Violation|2|||
161713380|NCT00811252|583996265|FG000|Overall Study|Withdrawal of Consent|1|||
161713381|NCT00811252|583996266|FG001|Overall Study|Withdrawal of Consent|2|||
161713382|NCT00811252|583996267|FG002|Overall Study|Withdrawal of Consent|2|||
161713383|NCT00811252|583996265|FG000|Overall Study|Lost to Follow-up|0|||
161713384|NCT00811252|583996266|FG001|Overall Study|Lost to Follow-up|0|||
161713385|NCT00811252|583996267|FG002|Overall Study|Lost to Follow-up|2|||
161713386|NCT00811252|583996265|FG000|Overall Study|Administrative or Other Reasons|0|||
161713387|NCT00811252|583996266|FG001|Overall Study|Administrative or Other Reasons|3|||
161713388|NCT00811252|583996267|FG002|Overall Study|Administrative or Other Reasons|2|||
161713389|NCT01931865|583996271|FG000|Overall Study|Lost to Follow-up|2|||
161713390|NCT01931865|583996271|FG000|Overall Study|Withdrawal by Subject|2|||
161713391|NCT01121406|583996272|FG000|Overall Study|Progressive disease RECIST|44|||
161713392|NCT01121406|583996273|FG001|Overall Study|Progressive disease RECIST|28|||
161713393|NCT01121406|583996272|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
161713394|NCT01121406|583996273|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
161713395|NCT01121406|583996272|FG000|Overall Study|Other AE|3|||
161713396|NCT01121406|583996273|FG001|Overall Study|Other AE|10|||
161713397|NCT01121406|583996272|FG000|Overall Study|Non-compliant with protocol|0|||
161713398|NCT01121406|583996273|FG001|Overall Study|Non-compliant with protocol|2|||
161713399|NCT01121406|583996272|FG000|Overall Study|Lost to Follow-up|0|||
161713400|NCT01121406|583996273|FG001|Overall Study|Lost to Follow-up|1|||
161713401|NCT01121406|583996272|FG000|Overall Study|Refused continuation of study med.|1|||
161713402|NCT01121406|583996273|FG001|Overall Study|Refused continuation of study med.|2|||
161713403|NCT01121406|583996272|FG000|Overall Study|Reason other than specified above|2|||
161713404|NCT01121406|583996273|FG001|Overall Study|Reason other than specified above|6|||
161713405|NCT01121406|583996272|FG000|Overall Study|Not treated|1|||
161713406|NCT01121406|583996273|FG001|Overall Study|Not treated|0|||
161713407|NCT00504257|583996274|FG000|Overall Study|Withdrawal by Subject|2|||
161713408|NCT00504257|583996274|FG000|Overall Study|ineligible histology|2|||
161713409|NCT00892437|583996275|FG000|Randomized Phase|Randomized but not treated|6|||
161713410|NCT00892437|583996276|FG001|Randomized Phase|Randomized but not treated|0|||
161713411|NCT00892437|583996275|FG000|Randomized Phase|Adverse Event|2|||
161713412|NCT00892437|583996276|FG001|Randomized Phase|Adverse Event|2|||
161713413|NCT00892437|583996275|FG000|Randomized Phase|Lost to Follow-up|1|||
161713414|NCT00892437|583996276|FG001|Randomized Phase|Lost to Follow-up|3|||
161713415|NCT00892437|583996275|FG000|Randomized Phase|Investigator's Discretion|1|||
161713416|NCT00892437|583996276|FG001|Randomized Phase|Investigator's Discretion|0|||
161713417|NCT00892437|583996275|FG000|Randomized Phase|Withdrew Consent|1|||
161713418|NCT00892437|583996276|FG001|Randomized Phase|Withdrew Consent|0|||
161713419|NCT00892437|583996275|FG000|Open-Label Extension Phase|Adverse Event|4|||
161713420|NCT00892437|583996276|FG001|Open-Label Extension Phase|Adverse Event|2|||
161713421|NCT00892437|583996275|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
161713422|NCT00892437|583996276|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
161713423|NCT00892437|583996275|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
161713424|NCT00892437|583996276|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
161713425|NCT00892437|583996275|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
161713426|NCT00892437|583996276|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
161713427|NCT00892437|583996275|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
161713428|NCT00892437|583996276|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
161713429|NCT03185130|583996277|FG000|Overall Study|Withdrawal by Subject|0|||
161713430|NCT03185130|583996278|FG001|Overall Study|Withdrawal by Subject|2|||
161713431|NCT02286960|583996279|FG000|Overall Study|Lost to Follow-up|3|||
161713432|NCT02286960|583996280|FG001|Overall Study|Lost to Follow-up|3|||
161713433|NCT02750410|583996282|FG000|Double-Blind Treatment Period|Adverse Event|2|||
161713434|NCT02750410|583996283|FG001|Double-Blind Treatment Period|Adverse Event|2|||
161713435|NCT02750410|583996282|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161713436|NCT02750410|583996283|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161713437|NCT02750410|583996282|FG000|Open-Label Extension Period|Adverse Event|5|||
161713438|NCT02750410|583996283|FG001|Open-Label Extension Period|Adverse Event|3|||
161713439|NCT02750410|583996282|FG000|Open-Label Extension Period|Protocol Violation|0|||
161713440|NCT02750410|583996283|FG001|Open-Label Extension Period|Protocol Violation|1|||
161713441|NCT02750410|583996282|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
161713442|NCT02750410|583996283|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
161713443|NCT02504541|583996284|FG000|Overall Study|Adverse Event|4|||
161713444|NCT02504541|583996284|FG000|Overall Study|Withdrawal by Subject|4|||
161713445|NCT02504541|583996284|FG000|Overall Study|Lost to Follow-up|1|||
161713446|NCT02504541|583996284|FG000|Overall Study|Met Stopping Criteria|1|||
161713447|NCT02504541|583996284|FG000|Overall Study|Protocol Violation|2|||
161713448|NCT02504541|583996284|FG000|Overall Study|Termination by Sponsor|1|||
161713449|NCT02504541|583996284|FG000|Overall Study|Other|2|||
161713450|NCT02504541|583996284|FG000|Overall Study|Multiple|5|||
161713451|NCT03215277|583996296|FG000|Overall Study|Adverse Event|2|||
161713452|NCT03215277|583996297|FG001|Overall Study|Adverse Event|3|||
161713453|NCT03215277|583996296|FG000|Overall Study|Death|1|||
161713454|NCT03215277|583996297|FG001|Overall Study|Death|0|||
161713455|NCT03215277|583996296|FG000|Overall Study|Lost to Follow-up|0|||
161713456|NCT03215277|583996297|FG001|Overall Study|Lost to Follow-up|1|||
161713457|NCT03215277|583996296|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
161713458|NCT03215277|583996297|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
161713459|NCT03596164|583996298|FG000|Overall Study|Adverse Event|0|||
161713460|NCT03596164|583996299|FG001|Overall Study|Adverse Event|1|||
161713461|NCT03596164|583996298|FG000|Overall Study|Death|1|||
161713462|NCT03596164|583996299|FG001|Overall Study|Death|0|||
161713463|NCT03427073|583996300|FG000|Overall Study|Disease Progression|1|||
161713464|NCT03427073|583996301|FG001|Overall Study|Disease Progression|1|||
161713465|NCT03427073|583996302|FG002|Overall Study|Disease Progression|1|||
161713466|NCT03427073|583996303|FG003|Overall Study|Disease Progression|3|||
161713467|NCT03427073|583996304|FG004|Overall Study|Disease Progression|3|||
161713468|NCT03427073|583996305|FG005|Overall Study|Disease Progression|4|||
161713469|NCT03427073|583996306|FG006|Overall Study|Disease Progression|2|||
161713470|NCT03427073|583996307|FG007|Overall Study|Disease Progression|3|||
161713471|NCT03427073|583996300|FG000|Overall Study|Physician Decision|0|||
161713472|NCT03427073|583996301|FG001|Overall Study|Physician Decision|0|||
161713473|NCT03427073|583996302|FG002|Overall Study|Physician Decision|0|||
161713474|NCT03427073|583996303|FG003|Overall Study|Physician Decision|0|||
161961372|NCT01147250|584904047|FG001|Overall Study|Lost to Follow-up|11|||
161961373|NCT01147250|584904046|FG000|Overall Study|Withdrawal by Subject|83|||
161961374|NCT01147250|584904047|FG001|Overall Study|Withdrawal by Subject|88|||
161961375|NCT01147250|584904046|FG000|Overall Study|Site termination by sponsor|13|||
161713475|NCT03427073|583996304|FG004|Overall Study|Physician Decision|0|||
161713476|NCT03427073|583996305|FG005|Overall Study|Physician Decision|0|||
161713477|NCT03427073|583996306|FG006|Overall Study|Physician Decision|1|||
161713478|NCT03427073|583996307|FG007|Overall Study|Physician Decision|1|||
161713479|NCT02835495|583996310|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
161713480|NCT02835495|583996311|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
161713481|NCT02835495|583996310|FG000|Overall Study|Declined in-person follow-up visit|4|||
161713482|NCT02835495|583996311|FG001|Overall Study|Declined in-person follow-up visit|2|||
161713483|NCT02580058|583996313|FG000|Overall Study|Adverse Event|16|||
161713484|NCT02580058|583996314|FG001|Overall Study|Adverse Event|30|||
161713485|NCT02580058|583996315|FG002|Overall Study|Adverse Event|20|||
161713486|NCT02580058|583996313|FG000|Overall Study|Death|4|||
162031682|NCT01107379|585172450|FG000|Overall Study|Lost to Follow-up|3|||
162031683|NCT04559529|585172451|FG000|First Intervention (1 Day)|Adverse Event|0|||
162031684|NCT04559529|585172452|FG001|First Intervention (1 Day)|Adverse Event|0|||
162031685|NCT04559529|585172453|FG002|First Intervention (1 Day)|Adverse Event|0|||
162031686|NCT04559529|585172454|FG003|First Intervention (1 Day)|Adverse Event|1|||
162031687|NCT04559529|585172451|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
162031688|NCT04559529|585172452|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
161713487|NCT02580058|583996314|FG001|Overall Study|Death|4|||
161713488|NCT02580058|583996315|FG002|Overall Study|Death|5|||
161713489|NCT02580058|583996313|FG000|Overall Study|Physician Decision|1|||
161713490|NCT02580058|583996314|FG001|Overall Study|Physician Decision|3|||
161713491|NCT02580058|583996315|FG002|Overall Study|Physician Decision|11|||
161713492|NCT02580058|583996313|FG000|Overall Study|Other|5|||
161713493|NCT02580058|583996314|FG001|Overall Study|Other|1|||
161713494|NCT02580058|583996315|FG002|Overall Study|Other|3|||
161713495|NCT02580058|583996313|FG000|Overall Study|Withdrawal by Subject|4|||
161713496|NCT02580058|583996314|FG001|Overall Study|Withdrawal by Subject|7|||
161713497|NCT02580058|583996315|FG002|Overall Study|Withdrawal by Subject|31|||
161713498|NCT02580058|583996313|FG000|Overall Study|Global Deterioration of Health Status|19|||
161713499|NCT02580058|583996314|FG001|Overall Study|Global Deterioration of Health Status|18|||
161713500|NCT02580058|583996315|FG002|Overall Study|Global Deterioration of Health Status|24|||
161713501|NCT02580058|583996313|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
161713502|NCT02580058|583996314|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161713503|NCT02580058|583996315|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
161713504|NCT02580058|583996313|FG000|Overall Study|Progressive Disease|137|||
161713505|NCT02580058|583996314|FG001|Overall Study|Progressive Disease|125|||
161713506|NCT02580058|583996315|FG002|Overall Study|Progressive Disease|94|||
161713507|NCT02580058|583996313|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161713508|NCT02580058|583996314|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161713509|NCT02580058|583996315|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161713510|NCT04283461|583996316|FG000|Overall Study|Enrolled in separate trial|0|||
161713511|NCT04283461|583996317|FG001|Overall Study|Enrolled in separate trial|0|||
161713512|NCT04283461|583996318|FG002|Overall Study|Enrolled in separate trial|8|||
161713513|NCT04283461|583996319|FG003|Overall Study|Enrolled in separate trial|13|||
161713514|NCT04283461|583996320|FG004|Overall Study|Enrolled in separate trial|12|||
161713515|NCT04283461|583996321|FG005|Overall Study|Enrolled in separate trial|0|||
161713516|NCT04283461|583996322|FG006|Overall Study|Enrolled in separate trial|0|||
161713517|NCT04283461|583996323|FG007|Overall Study|Enrolled in separate trial|8|||
161713518|NCT04283461|583996324|FG008|Overall Study|Enrolled in separate trial|0|||
161713519|NCT04283461|583996325|FG009|Overall Study|Enrolled in separate trial|0|||
161713520|NCT04283461|583996326|FG010|Overall Study|Enrolled in separate trial|0|||
161713521|NCT04283461|583996327|FG011|Overall Study|Enrolled in separate trial|7|||
161713522|NCT04283461|583996328|FG012|Overall Study|Enrolled in separate trial|0|||
161713523|NCT05490771|583996329|FG000|Overall Study|Disease progression|18|||
161713524|NCT05490771|583996329|FG000|Overall Study|Adverse Event|3|||
161713525|NCT05490771|583996329|FG000|Overall Study|Other complicating disease|1|||
161713526|NCT05490771|583996329|FG000|Overall Study|Withdrawal by Subject|3|||
161713527|NCT05490771|583996329|FG000|Overall Study|Physician Decision|1|||
161713528|NCT05490771|583996329|FG000|Overall Study|Still on treatment|2|||
161713529|NCT05490771|583996329|FG000|Overall Study|Never start protocol therapy|5|||
161713530|NCT05490771|583996329|FG000|Overall Study|Ineligible|2|||
161713531|NCT00246259|583996333|FG000|Overall Study|Other|3|||
161713532|NCT00246259|583996334|FG001|Overall Study|Other|3|||
161713533|NCT00246259|583996333|FG000|Overall Study|Not stable by Week 18|2|||
161713534|NCT00246259|583996334|FG001|Overall Study|Not stable by Week 18|1|||
161713535|NCT00246259|583996333|FG000|Overall Study|Participant non-compliant|4|||
161713536|NCT00246259|583996334|FG001|Overall Study|Participant non-compliant|9|||
161713537|NCT00246259|583996333|FG000|Overall Study|Lack of Efficacy|2|||
161713538|NCT00246259|583996334|FG001|Overall Study|Lack of Efficacy|2|||
161713539|NCT00246259|583996333|FG000|Overall Study|Investigator withdrew participant|2|||
162031689|NCT04559529|585172453|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
162031690|NCT04559529|585172454|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
161713540|NCT00246259|583996334|FG001|Overall Study|Investigator withdrew participant|0|||
161713541|NCT00246259|583996333|FG000|Overall Study|Adverse Event|5|||
161713542|NCT00246259|583996334|FG001|Overall Study|Adverse Event|0|||
161713543|NCT00246259|583996333|FG000|Overall Study|Lost to Follow-up|3|||
161713544|NCT00246259|583996334|FG001|Overall Study|Lost to Follow-up|4|||
161713545|NCT00246259|583996333|FG000|Overall Study|Withdrawal by Subject|5|||
161713546|NCT00246259|583996334|FG001|Overall Study|Withdrawal by Subject|1|||
161713547|NCT00246259|583996333|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
161713548|NCT00246259|583996334|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
161713549|NCT02272790|583996335|FG000|Overall Study|Physician Decision|0|||
161713550|NCT02272790|583996336|FG001|Overall Study|Physician Decision|1|||
161713551|NCT02272790|583996337|FG002|Overall Study|Physician Decision|0|||
161713552|NCT02272790|583996338|FG003|Overall Study|Physician Decision|0|||
161713553|NCT02272790|583996339|FG004|Overall Study|Physician Decision|0|||
161713554|NCT02272790|583996340|FG005|Overall Study|Physician Decision|0|||
161713555|NCT04375878|583996341|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
161713556|NCT04375878|583996342|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
161713557|NCT04375878|583996343|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
161713558|NCT04375878|583996344|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
161961376|NCT01147250|584904047|FG001|Overall Study|Site termination by sponsor|5|||
161961377|NCT01147250|584904046|FG000|Overall Study|Other than specified|0|||
161961378|NCT01147250|584904047|FG001|Overall Study|Other than specified|1|||
161961379|NCT02249091|584904049|FG000|Overall Study|Lack of Efficacy|8|||
161961380|NCT02249091|584904050|FG001|Overall Study|Lack of Efficacy|3|||
161961381|NCT02249091|584904049|FG000|Overall Study|Physician Decision|4|||
161961382|NCT02249091|584904050|FG001|Overall Study|Physician Decision|1|||
161961383|NCT02249091|584904049|FG000|Overall Study|Withdrawal by Subject|2|||
161961384|NCT02249091|584904050|FG001|Overall Study|Withdrawal by Subject|2|||
161961385|NCT02249091|584904049|FG000|Overall Study|Death|3|||
161961386|NCT02249091|584904050|FG001|Overall Study|Death|4|||
161961387|NCT02249091|584904049|FG000|Overall Study|Adverse Event|1|||
161961388|NCT02249091|584904050|FG001|Overall Study|Adverse Event|0|||
161961389|NCT02249091|584904049|FG000|Overall Study|Stable disease with following SCT|0|||
161961390|NCT02249091|584904050|FG001|Overall Study|Stable disease with following SCT|1|||
161961391|NCT02249091|584904049|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
161961392|NCT02249091|584904050|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
161961393|NCT02249091|584904049|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
161961394|NCT02249091|584904050|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
161961395|NCT02249091|584904049|FG000|Overall Study|Refractory AML|1|||
161961396|NCT02249091|584904050|FG001|Overall Study|Refractory AML|1|||
161961397|NCT00716482|584904054|FG000|Overall Study|Lost to Follow-up|6|||
161961398|NCT00716482|584904054|FG000|Overall Study|Inadequate acquisition or analysis|50|||
161961399|NCT00716482|584904054|FG000|Overall Study|no pathology obtained|10|||
161961400|NCT00716482|584904054|FG000|Overall Study|technical/machine error|28|||
161961401|NCT00716482|584904054|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
161961402|NCT03249909|584904055|FG000|Overall Study|Withdrawal by Subject|3|||
161961403|NCT03249909|584904056|FG001|Overall Study|Withdrawal by Subject|0|||
161713559|NCT04375878|583996345|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
161713560|NCT04375878|583996346|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
161713561|NCT04375878|583996341|FG000|Crossover First and Second Interventions|Adverse Event|0|||
161713562|NCT04375878|583996342|FG001|Crossover First and Second Interventions|Adverse Event|0|||
161713563|NCT04375878|583996343|FG002|Crossover First and Second Interventions|Adverse Event|1|||
161713564|NCT04375878|583996344|FG003|Crossover First and Second Interventions|Adverse Event|0|||
161713565|NCT04375878|583996345|FG004|Crossover First and Second Interventions|Adverse Event|0|||
161713566|NCT04375878|583996346|FG005|Crossover First and Second Interventions|Adverse Event|0|||
161713567|NCT04375878|583996341|FG000|Extension Phase|Withdrawal by Subject|0|||
161713568|NCT04375878|583996342|FG001|Extension Phase|Withdrawal by Subject|0|||
161713569|NCT04375878|583996343|FG002|Extension Phase|Withdrawal by Subject|0|||
161713570|NCT04375878|583996344|FG003|Extension Phase|Withdrawal by Subject|0|||
161713571|NCT04375878|583996345|FG004|Extension Phase|Withdrawal by Subject|1|||
161713572|NCT04375878|583996346|FG005|Extension Phase|Withdrawal by Subject|0|||
161713573|NCT03022461|583996347|FG000|Overall Study|Death|3|||
161713574|NCT01982630|583996348|FG000|Overall Study|Adverse Event|2|||
161713575|NCT01982630|583996349|FG001|Overall Study|Adverse Event|0|||
161713576|NCT01982630|583996350|FG002|Overall Study|Adverse Event|1|||
161713577|NCT01982630|583996351|FG003|Overall Study|Adverse Event|0|||
161713578|NCT01982630|583996352|FG004|Overall Study|Adverse Event|1|||
161713579|NCT01982630|583996353|FG005|Overall Study|Adverse Event|2|||
161713580|NCT01982630|583996354|FG006|Overall Study|Adverse Event|1|||
161713581|NCT01982630|583996355|FG007|Overall Study|Adverse Event|0|||
161713582|NCT01982630|583996348|FG000|Overall Study|Physician Decision|1|||
161713583|NCT01982630|583996349|FG001|Overall Study|Physician Decision|0|||
161713584|NCT01982630|583996350|FG002|Overall Study|Physician Decision|2|||
161713585|NCT01982630|583996351|FG003|Overall Study|Physician Decision|1|||
161713586|NCT01982630|583996352|FG004|Overall Study|Physician Decision|2|||
161713587|NCT01982630|583996353|FG005|Overall Study|Physician Decision|0|||
161713588|NCT01982630|583996354|FG006|Overall Study|Physician Decision|0|||
161713589|NCT01982630|583996355|FG007|Overall Study|Physician Decision|0|||
161713590|NCT01982630|583996348|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713591|NCT01982630|583996349|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713592|NCT01982630|583996350|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
161713593|NCT01982630|583996351|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713594|NCT01982630|583996352|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161961404|NCT03249909|584904057|FG002|Overall Study|Withdrawal by Subject|0|||
161961405|NCT03249909|584904055|FG000|Overall Study|Adverse Event|3|||
161961406|NCT03249909|584904056|FG001|Overall Study|Adverse Event|0|||
161961407|NCT03249909|584904057|FG002|Overall Study|Adverse Event|0|||
161961408|NCT03249909|584904055|FG000|Overall Study|Lost to Follow-up|0|||
161961409|NCT03249909|584904056|FG001|Overall Study|Lost to Follow-up|1|||
161961410|NCT03249909|584904057|FG002|Overall Study|Lost to Follow-up|0|||
161961411|NCT03517371|584904058|FG000|Overall Study|Adverse Event|8|||
161961412|NCT03517371|584904059|FG001|Overall Study|Adverse Event|9|||
161961413|NCT03517371|584904058|FG000|Overall Study|Lost to Follow-up|1|||
161961414|NCT03517371|584904059|FG001|Overall Study|Lost to Follow-up|2|||
161961415|NCT03517371|584904058|FG000|Overall Study|Withdrawal by Subject|4|||
161961416|NCT03517371|584904059|FG001|Overall Study|Withdrawal by Subject|4|||
161961417|NCT03517371|584904058|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
161961418|NCT03517371|584904059|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
161961419|NCT03517371|584904058|FG000|Overall Study|COVID restrictions|2|||
161961420|NCT03517371|584904059|FG001|Overall Study|COVID restrictions|0|||
161961421|NCT03517371|584904058|FG000|Overall Study|Receiving DBS Surgery|0|||
161961422|NCT03517371|584904059|FG001|Overall Study|Receiving DBS Surgery|1|||
161961423|NCT05411822|584904060|FG000|Overall Study|Withdrawal by Subject|2|||
162031691|NCT04559529|585172451|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
162031692|NCT04559529|585172452|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
161713595|NCT01982630|583996353|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713596|NCT01982630|583996354|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713597|NCT01982630|583996355|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161713598|NCT01982630|583996348|FG000|Overall Study|Withdrawal by Subject|0|||
161713599|NCT01982630|583996349|FG001|Overall Study|Withdrawal by Subject|0|||
161713600|NCT01982630|583996350|FG002|Overall Study|Withdrawal by Subject|0|||
161713601|NCT01982630|583996351|FG003|Overall Study|Withdrawal by Subject|0|||
161713602|NCT01982630|583996352|FG004|Overall Study|Withdrawal by Subject|0|||
161713603|NCT01982630|583996353|FG005|Overall Study|Withdrawal by Subject|1|||
161713604|NCT01982630|583996354|FG006|Overall Study|Withdrawal by Subject|0|||
161713605|NCT01982630|583996355|FG007|Overall Study|Withdrawal by Subject|0|||
161713606|NCT00986349|583996356|FG000|Overall Study|Unsuccessful implant procedure|3|||
161713607|NCT00986349|583996356|FG000|Overall Study|Adverse Event|2|||
161713608|NCT00986349|583996356|FG000|Overall Study|Physician Decision|1|||
161713609|NCT00986349|583996356|FG000|Overall Study|device migration|1|||
161713610|NCT02299934|583996357|FG000|Overall Study|Termination of study|13|||
161713611|NCT00561353|583996358|FG000|Overall Study|Subject reached a virologic endpoint|2|||
161713612|NCT00561353|583996359|FG001|Overall Study|Subject reached a virologic endpoint|1|||
161713613|NCT00561353|583996360|FG002|Overall Study|Subject reached a virologic endpoint|1|||
161713614|NCT00561353|583996361|FG003|Overall Study|Subject reached a virologic endpoint|4|||
161713615|NCT00561353|583996362|FG004|Overall Study|Subject reached a virologic endpoint|1|||
161713616|NCT00561353|583996363|FG005|Overall Study|Subject reached a virologic endpoint|3|||
161713617|NCT00561353|583996364|FG006|Overall Study|Subject reached a virologic endpoint|4|||
161713618|NCT00561353|583996365|FG007|Overall Study|Subject reached a virologic endpoint|4|||
161713619|NCT00561353|583996366|FG008|Overall Study|Subject reached a virologic endpoint|5|||
161713620|NCT00561353|583996367|FG009|Overall Study|Subject reached a virologic endpoint|0|||
161713621|NCT00561353|583996358|FG000|Overall Study|Subject ineligible to continue the trial|0|||
161713622|NCT00561353|583996359|FG001|Overall Study|Subject ineligible to continue the trial|0|||
161713623|NCT00561353|583996360|FG002|Overall Study|Subject ineligible to continue the trial|0|||
161713624|NCT00561353|583996361|FG003|Overall Study|Subject ineligible to continue the trial|0|||
161713625|NCT00561353|583996362|FG004|Overall Study|Subject ineligible to continue the trial|0|||
161713626|NCT00561353|583996363|FG005|Overall Study|Subject ineligible to continue the trial|1|||
161713627|NCT00561353|583996364|FG006|Overall Study|Subject ineligible to continue the trial|1|||
161713628|NCT00561353|583996365|FG007|Overall Study|Subject ineligible to continue the trial|0|||
161713629|NCT00561353|583996366|FG008|Overall Study|Subject ineligible to continue the trial|2|||
161713630|NCT00561353|583996367|FG009|Overall Study|Subject ineligible to continue the trial|1|||
161713631|NCT00561353|583996358|FG000|Overall Study|Other|1|||
161713632|NCT00561353|583996359|FG001|Overall Study|Other|0|||
161713633|NCT00561353|583996360|FG002|Overall Study|Other|1|||
161713634|NCT00561353|583996361|FG003|Overall Study|Other|0|||
161713635|NCT00561353|583996362|FG004|Overall Study|Other|0|||
161713636|NCT00561353|583996363|FG005|Overall Study|Other|2|||
161713637|NCT00561353|583996364|FG006|Overall Study|Other|0|||
161713638|NCT00561353|583996365|FG007|Overall Study|Other|0|||
161713639|NCT00561353|583996366|FG008|Overall Study|Other|0|||
161713640|NCT00561353|583996367|FG009|Overall Study|Other|0|||
161713641|NCT00561353|583996358|FG000|Overall Study|Adverse Event|0|||
161713642|NCT00561353|583996359|FG001|Overall Study|Adverse Event|0|||
161713643|NCT00561353|583996360|FG002|Overall Study|Adverse Event|0|||
161713644|NCT00561353|583996361|FG003|Overall Study|Adverse Event|2|||
161713645|NCT00561353|583996362|FG004|Overall Study|Adverse Event|0|||
161713646|NCT00561353|583996363|FG005|Overall Study|Adverse Event|0|||
161713647|NCT00561353|583996364|FG006|Overall Study|Adverse Event|1|||
161713648|NCT00561353|583996365|FG007|Overall Study|Adverse Event|0|||
161713649|NCT00561353|583996366|FG008|Overall Study|Adverse Event|0|||
161713650|NCT00561353|583996367|FG009|Overall Study|Adverse Event|1|||
161713651|NCT00561353|583996358|FG000|Overall Study|Lost to Follow-up|2|||
161961424|NCT05411822|584904061|FG001|Overall Study|Withdrawal by Subject|1|||
161713652|NCT00561353|583996359|FG001|Overall Study|Lost to Follow-up|0|||
161713653|NCT00561353|583996360|FG002|Overall Study|Lost to Follow-up|1|||
161713654|NCT00561353|583996361|FG003|Overall Study|Lost to Follow-up|0|||
161713655|NCT00561353|583996362|FG004|Overall Study|Lost to Follow-up|0|||
161713656|NCT00561353|583996363|FG005|Overall Study|Lost to Follow-up|0|||
161713657|NCT00561353|583996364|FG006|Overall Study|Lost to Follow-up|0|||
161713658|NCT00561353|583996365|FG007|Overall Study|Lost to Follow-up|0|||
161713659|NCT00561353|583996366|FG008|Overall Study|Lost to Follow-up|0|||
161713660|NCT00561353|583996367|FG009|Overall Study|Lost to Follow-up|0|||
161713661|NCT00561353|583996358|FG000|Overall Study|Withdrawal by Subject|0|||
161713662|NCT00561353|583996359|FG001|Overall Study|Withdrawal by Subject|2|||
161713663|NCT00561353|583996360|FG002|Overall Study|Withdrawal by Subject|0|||
161713664|NCT00561353|583996361|FG003|Overall Study|Withdrawal by Subject|0|||
161713665|NCT00561353|583996362|FG004|Overall Study|Withdrawal by Subject|0|||
161713666|NCT00561353|583996363|FG005|Overall Study|Withdrawal by Subject|0|||
161713667|NCT00561353|583996364|FG006|Overall Study|Withdrawal by Subject|0|||
161713668|NCT00561353|583996365|FG007|Overall Study|Withdrawal by Subject|0|||
161713669|NCT00561353|583996366|FG008|Overall Study|Withdrawal by Subject|0|||
161713670|NCT00561353|583996367|FG009|Overall Study|Withdrawal by Subject|0|||
161713671|NCT01273818|583996368|FG000|Overall Study|Physician Decision|13|||
161713672|NCT01273818|583996369|FG001|Overall Study|Physician Decision|2|||
161713673|NCT01273818|583996370|FG002|Overall Study|Physician Decision|9|||
161713674|NCT03815175|583996371|FG000|Overall Study|Subject Lost to Follow-up|6|||
161713675|NCT03815175|583996371|FG000|Overall Study|Subject Withdrew Consent|48|||
161713676|NCT03815175|583996371|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
161713677|NCT03815175|583996371|FG000|Overall Study|Death|86|||
161713678|NCT03815175|583996371|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
161713679|NCT03815175|583996371|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
161713680|NCT03815175|583996371|FG000|Overall Study|Other Status Change Reason|1|||
161713681|NCT03815175|583996371|FG000|Overall Study|Missed Visit|12|||
161713682|NCT03577990|583996372|FG000|Overall Study|Lost to Follow-up|4|||
161713683|NCT03577990|583996373|FG001|Overall Study|Lost to Follow-up|6|||
161713684|NCT03577990|583996372|FG000|Overall Study|Withdrawal by Subject|4|||
161713685|NCT03577990|583996373|FG001|Overall Study|Withdrawal by Subject|7|||
161713686|NCT03934684|583996378|FG000|Overall Study|Participants continuing in study|11|||
161713687|NCT03934684|583996379|FG001|Overall Study|Participants continuing in study|4|||
161713688|NCT03934684|583996378|FG000|Overall Study|Discontinuation of carfilzomib|20|||
161713689|NCT03934684|583996379|FG001|Overall Study|Discontinuation of carfilzomib|30|||
161713690|NCT03934684|583996378|FG000|Overall Study|Death|2|||
161713691|NCT03934684|583996379|FG001|Overall Study|Death|2|||
161713692|NCT03934684|583996378|FG000|Overall Study|Lost to Follow-up|2|||
161713693|NCT03934684|583996379|FG001|Overall Study|Lost to Follow-up|5|||
161713694|NCT03934684|583996378|FG000|Overall Study|Withdrawal by Subject|7|||
161713695|NCT03934684|583996379|FG001|Overall Study|Withdrawal by Subject|8|||
161713696|NCT01073943|583996380|FG000|Overall Study|Withdrawal by Subject|8|||
161713697|NCT01073943|583996381|FG001|Overall Study|Withdrawal by Subject|2|||
161713698|NCT01073943|583996380|FG000|Overall Study|Protocol Violation|2|||
161713699|NCT01073943|583996381|FG001|Overall Study|Protocol Violation|1|||
161713700|NCT01073943|583996380|FG000|Overall Study|Adverse Event|1|||
161713701|NCT01073943|583996381|FG001|Overall Study|Adverse Event|1|||
161713702|NCT01073943|583996380|FG000|Overall Study|Lost to Follow-up|0|||
161713703|NCT01073943|583996381|FG001|Overall Study|Lost to Follow-up|2|||
161713704|NCT01073943|583996380|FG000|Overall Study|Power outage; colonoscopy not done|1|||
161713705|NCT01073943|583996381|FG001|Overall Study|Power outage; colonoscopy not done|0|||
161713706|NCT01073943|583996380|FG000|Overall Study|Subject forgot|0|||
161713707|NCT01073943|583996381|FG001|Overall Study|Subject forgot|1|||
161713708|NCT01073943|583996380|FG000|Overall Study|Unable to return for follow-up|0|||
161713709|NCT01073943|583996381|FG001|Overall Study|Unable to return for follow-up|1|||
161713710|NCT01073943|583996380|FG000|Overall Study|Could not tolerate prep|1|||
161713711|NCT01073943|583996381|FG001|Overall Study|Could not tolerate prep|0|||
161713712|NCT00761215|583996382|FG000|Overall Study|Randomized but didn't receive drug|1|||
161713713|NCT00761215|583996383|FG001|Overall Study|Randomized but didn't receive drug|1|||
161713714|NCT00761215|583996384|FG002|Overall Study|Randomized but didn't receive drug|2|||
161713715|NCT00761215|583996382|FG000|Overall Study|Lost to Follow-up|6|||
161713716|NCT00761215|583996383|FG001|Overall Study|Lost to Follow-up|3|||
161713717|NCT00761215|583996384|FG002|Overall Study|Lost to Follow-up|6|||
161713718|NCT00761215|583996382|FG000|Overall Study|Withdrawal by Subject|1|||
161713719|NCT00761215|583996383|FG001|Overall Study|Withdrawal by Subject|0|||
161713720|NCT00761215|583996384|FG002|Overall Study|Withdrawal by Subject|0|||
161713721|NCT00761215|583996382|FG000|Overall Study|Bacteremia|1|||
161713722|NCT00761215|583996383|FG001|Overall Study|Bacteremia|0|||
161713723|NCT00761215|583996384|FG002|Overall Study|Bacteremia|0|||
161713724|NCT05662332|583996385|FG000|Overall Study|Death|3|||
161713725|NCT05662332|583996386|FG001|Overall Study|Death|3|||
161713726|NCT05662332|583996385|FG000|Overall Study|Lost to Follow-up|3|||
161713727|NCT05662332|583996386|FG001|Overall Study|Lost to Follow-up|8|||
161713728|NCT05662332|583996385|FG000|Overall Study|Physician Decision|1|||
161713729|NCT05662332|583996386|FG001|Overall Study|Physician Decision|2|||
161713730|NCT05662332|583996385|FG000|Overall Study|Protocol Deviation|2|||
161713731|NCT05662332|583996386|FG001|Overall Study|Protocol Deviation|1|||
161713732|NCT05662332|583996385|FG000|Overall Study|Withdrawal by Subject|14|||
161713733|NCT05662332|583996386|FG001|Overall Study|Withdrawal by Subject|14|||
161713734|NCT05662332|583996385|FG000|Overall Study|Assigned Treatment by Mistake|5|||
161713735|NCT05662332|583996386|FG001|Overall Study|Assigned Treatment by Mistake|7|||
161713736|NCT05662332|583996385|FG000|Overall Study|Non-compliance with study drug|4|||
161713737|NCT05662332|583996386|FG001|Overall Study|Non-compliance with study drug|1|||
161713738|NCT05662332|583996385|FG000|Overall Study|Due to Bariatric surgery|1|||
161713739|NCT05662332|583996386|FG001|Overall Study|Due to Bariatric surgery|0|||
161713740|NCT05662332|583996385|FG000|Overall Study|Subject Moving out of State|0|||
161713741|NCT05662332|583996386|FG001|Overall Study|Subject Moving out of State|1|||
161713742|NCT05662332|583996385|FG000|Overall Study|Subject Missed the Schedule|1|||
161713743|NCT05662332|583996386|FG001|Overall Study|Subject Missed the Schedule|0|||
161713744|NCT05662332|583996385|FG000|Overall Study|The Patient Moved to Another City|1|||
161713745|NCT05662332|583996386|FG001|Overall Study|The Patient Moved to Another City|0|||
161713746|NCT01097044|583996396|FG000|Overall Study|Withdrawal by Subject|4|||
161713747|NCT01097044|583996397|FG001|Overall Study|Withdrawal by Subject|4|||
161713748|NCT01097044|583996396|FG000|Overall Study|Lost to Follow-up|1|||
161713749|NCT01097044|583996397|FG001|Overall Study|Lost to Follow-up|0|||
161713750|NCT01097044|583996396|FG000|Overall Study|Withdrawal by Sponsor|0|||
161713751|NCT01097044|583996397|FG001|Overall Study|Withdrawal by Sponsor|1|||
161713752|NCT02452359|583996399|FG000|Overall Study|Adverse Event|1|||
161713753|NCT02452359|583996399|FG000|Overall Study|Lost to Follow-up|15|||
161713754|NCT02452359|583996399|FG000|Overall Study|Pregnancy|1|||
161713755|NCT02452359|583996399|FG000|Overall Study|Withdrawal by Subject|4|||
161713756|NCT03414359|583996400|FG000|Overall Study|Lack of Efficacy|1|||
161713757|NCT03414359|583996401|FG001|Overall Study|Lack of Efficacy|1|||
161713758|NCT03414359|583996400|FG000|Overall Study|Protocol Violation|0|||
161713759|NCT03414359|583996401|FG001|Overall Study|Protocol Violation|1|||
161713760|NCT04865731|583996402|FG000|Overall Study|Physician Decision|2|||
161713761|NCT04865731|583996403|FG001|Overall Study|Physician Decision|1|||
161713762|NCT04865731|583996402|FG000|Overall Study|Adverse Event|1|||
161713763|NCT04865731|583996403|FG001|Overall Study|Adverse Event|0|||
161713764|NCT04865731|583996402|FG000|Overall Study|Withdrawal by Subject|0|||
161713765|NCT04865731|583996403|FG001|Overall Study|Withdrawal by Subject|1|||
161713766|NCT00222105|583996406|FG000|Overall Study|Removed due to wrong diagnosis|1|||
161713767|NCT00222105|583996406|FG000|Overall Study|Withdrawal by Subject|1|||
161713768|NCT00222105|583996406|FG000|Overall Study|Adverse Event|8|||
161713769|NCT00222105|583996406|FG000|Overall Study|Treatment delays|2|||
161713770|NCT00222105|583996406|FG000|Overall Study|Death|2|||
161713771|NCT03395210|583998185|FG000|Overall Study|Other|0|||
161713772|NCT03395210|583998186|FG001|Overall Study|Other|0|||
161713773|NCT03395210|583998187|FG002|Overall Study|Other|0|||
161713774|NCT03395210|583998188|FG003|Overall Study|Other|0|||
161713775|NCT03395210|583998189|FG004|Overall Study|Other|1|||
161713776|NCT03395210|583998185|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
161713777|NCT03395210|583998186|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
161713778|NCT03395210|583998187|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
161713779|NCT03395210|583998188|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
161713780|NCT03395210|583998189|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
161713781|NCT03395210|583998185|FG000|Overall Study|Adverse Event|1|||
161713782|NCT03395210|583998186|FG001|Overall Study|Adverse Event|0|||
161713783|NCT03395210|583998187|FG002|Overall Study|Adverse Event|2|||
161713784|NCT03395210|583998188|FG003|Overall Study|Adverse Event|4|||
161713785|NCT03395210|583998189|FG004|Overall Study|Adverse Event|3|||
161713786|NCT03395210|583998185|FG000|Overall Study|Need of Rescue Medication|1|||
161713787|NCT03395210|583998186|FG001|Overall Study|Need of Rescue Medication|0|||
161713788|NCT03395210|583998187|FG002|Overall Study|Need of Rescue Medication|1|||
161713789|NCT03395210|583998188|FG003|Overall Study|Need of Rescue Medication|4|||
161713790|NCT03395210|583998189|FG004|Overall Study|Need of Rescue Medication|0|||
161713791|NCT03395210|583998185|FG000|Overall Study|Lack of Response|0|||
161838004|NCT05297578|584450279|FG002|Overall Study|Withdrawal by Subject|1|||
161713792|NCT03395210|583998186|FG001|Overall Study|Lack of Response|0|||
161713793|NCT03395210|583998187|FG002|Overall Study|Lack of Response|0|||
161713794|NCT03395210|583998188|FG003|Overall Study|Lack of Response|5|||
161838005|NCT05297578|584450280|FG003|Overall Study|Withdrawal by Subject|0|||
161838006|NCT03127644|584450281|FG000|Overall Study|Study-specific withdrawal criteria|0|||
161713795|NCT03395210|583998189|FG004|Overall Study|Lack of Response|5|||
161713796|NCT03395210|583998185|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
161713797|NCT03395210|583998186|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
161713798|NCT03395210|583998187|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
161713799|NCT03395210|583998188|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
161713800|NCT03395210|583998189|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
161713801|NCT03395210|583998185|FG000|Overall Study|Participant Decision|1|||
161961425|NCT01345929|584904062|FG000|Overall Study|Withdrawal by Subject|9|||
161961426|NCT01345929|584904063|FG001|Overall Study|Withdrawal by Subject|8|||
161961427|NCT01345929|584904062|FG000|Overall Study|Lost to Follow-up|9|||
161961428|NCT01345929|584904063|FG001|Overall Study|Lost to Follow-up|9|||
161961429|NCT01345929|584904062|FG000|Overall Study|Adverse Event|0|||
161961430|NCT01345929|584904063|FG001|Overall Study|Adverse Event|1|||
161961431|NCT01345929|584904062|FG000|Overall Study|Didn't meet eligibility criteria|2|||
161961432|NCT01345929|584904063|FG001|Overall Study|Didn't meet eligibility criteria|0|||
161961433|NCT01345929|584904062|FG000|Overall Study|40,000 CFU/ML|1|||
161961434|NCT01345929|584904063|FG001|Overall Study|40,000 CFU/ML|0|||
161961435|NCT01345929|584904062|FG000|Overall Study|Patient withdrawal|0|||
161961436|NCT01345929|584904063|FG001|Overall Study|Patient withdrawal|1|||
161961437|NCT02819297|584904064|FG000|Overall Study|Withdrawal by Subject|25|||
161961438|NCT02819297|584904065|FG001|Overall Study|Withdrawal by Subject|13|||
161961439|NCT02819297|584904064|FG000|Overall Study|Lost to Follow-up|12|||
161961440|NCT02819297|584904065|FG001|Overall Study|Lost to Follow-up|14|||
161961441|NCT02819297|584904064|FG000|Overall Study|Adverse Event|12|||
161961442|NCT02819297|584904065|FG001|Overall Study|Adverse Event|10|||
161961443|NCT02819297|584904064|FG000|Overall Study|Physician Decision|5|||
161961444|NCT02819297|584904065|FG001|Overall Study|Physician Decision|5|||
161961445|NCT02819297|584904064|FG000|Overall Study|Lack of Efficacy|5|||
161713802|NCT03395210|583998186|FG001|Overall Study|Participant Decision|1|||
161713803|NCT03395210|583998187|FG002|Overall Study|Participant Decision|0|||
161713804|NCT03395210|583998188|FG003|Overall Study|Participant Decision|4|||
161713805|NCT03395210|583998189|FG004|Overall Study|Participant Decision|0|||
161713806|NCT03395210|583998185|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
161713807|NCT03395210|583998186|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
161713808|NCT03395210|583998187|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
161713809|NCT03395210|583998188|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
161713810|NCT03395210|583998189|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
161713811|NCT01006356|583998193|FG000|Overall Study|Adverse Event|6|||
161713812|NCT01006356|583998193|FG000|Overall Study|Physician Decision|1|||
161713813|NCT01006356|583998193|FG000|Overall Study|Paticipants did not cooperate|6|||
161713814|NCT01006356|583998193|FG000|Overall Study|Withdrawal by Subject|1|||
161713815|NCT01006356|583998193|FG000|Overall Study|Choice by participants|2|||
161713816|NCT01006356|583998193|FG000|Overall Study|Protocol Violation|3|||
161713817|NCT01006356|583998193|FG000|Overall Study|Other|23|||
161713818|NCT02981472|583998195|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
161713819|NCT02981472|583998196|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
161713820|NCT02981472|583998195|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161713821|NCT02981472|583998196|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161713822|NCT02981472|583998195|FG000|Treatment Period|Adverse Event|6|||
161713823|NCT02981472|583998196|FG001|Treatment Period|Adverse Event|1|||
161713824|NCT02981472|583998195|FG000|Treatment Period|Participant withdrew consent|1|||
161713825|NCT02981472|583998196|FG001|Treatment Period|Participant withdrew consent|0|||
161713826|NCT02981472|583998195|FG000|Treatment Period|Lost to Follow-up|0|||
161713827|NCT02981472|583998196|FG001|Treatment Period|Lost to Follow-up|1|||
161713828|NCT03368859|583998199|FG000|Overall Study|Withdrew Consent|5|||
161713829|NCT03368859|583998200|FG001|Overall Study|Withdrew Consent|4|||
161713830|NCT03368859|583998199|FG000|Overall Study|Death|12|||
161713831|NCT03368859|583998200|FG001|Overall Study|Death|6|||
161713832|NCT03368859|583998199|FG000|Overall Study|Study terminated by Sponsor|18|||
161713833|NCT03368859|583998200|FG001|Overall Study|Study terminated by Sponsor|23|||
161713834|NCT03368859|583998199|FG000|Overall Study|Other|1|||
161713835|NCT03368859|583998200|FG001|Overall Study|Other|1|||
161713836|NCT02559505|583998206|FG000|Overall Study|Lost to Follow-up|23|||
161713837|NCT02559505|583998207|FG001|Overall Study|Lost to Follow-up|20|||
161713838|NCT02559505|583998206|FG000|Overall Study|Withdrawal by Subject|4|||
161713839|NCT02559505|583998207|FG001|Overall Study|Withdrawal by Subject|2|||
161713840|NCT03523585|583998208|FG000|Overall Study|Progressive Disease|174|||
161713841|NCT03523585|583998209|FG001|Overall Study|Progressive Disease|64|||
161713842|NCT03523585|583998210|FG002|Overall Study|Progressive Disease|77|||
161713843|NCT03523585|583998208|FG000|Overall Study|Adverse Event|74|||
161713844|NCT03523585|583998209|FG001|Overall Study|Adverse Event|5|||
161713845|NCT03523585|583998210|FG002|Overall Study|Adverse Event|9|||
161713846|NCT03523585|583998208|FG000|Overall Study|Withdrawal by Subject|30|||
161713847|NCT03523585|583998209|FG001|Overall Study|Withdrawal by Subject|11|||
161713848|NCT03523585|583998210|FG002|Overall Study|Withdrawal by Subject|6|||
161961446|NCT02819297|584904065|FG001|Overall Study|Lack of Efficacy|8|||
161961447|NCT02819297|584904064|FG000|Overall Study|Protocol Violation|1|||
161961448|NCT02819297|584904065|FG001|Overall Study|Protocol Violation|2|||
161961449|NCT01670279|584904066|FG000|Overall Study|Adverse Event|0|||
161961450|NCT01670279|584904067|FG001|Overall Study|Adverse Event|1|||
161961451|NCT01670279|584904068|FG002|Overall Study|Adverse Event|0|||
161961452|NCT01670279|584904069|FG003|Overall Study|Adverse Event|0|||
161713849|NCT03523585|583998208|FG000|Overall Study|Clinical Progression|23|||
161713850|NCT03523585|583998209|FG001|Overall Study|Clinical Progression|5|||
161713851|NCT03523585|583998210|FG002|Overall Study|Clinical Progression|10|||
161713852|NCT03523585|583998208|FG000|Overall Study|Death|4|||
161713853|NCT03523585|583998209|FG001|Overall Study|Death|0|||
161713854|NCT03523585|583998210|FG002|Overall Study|Death|1|||
161713855|NCT03523585|583998208|FG000|Overall Study|Physician Decision|2|||
161713856|NCT03523585|583998209|FG001|Overall Study|Physician Decision|1|||
161713857|NCT03523585|583998210|FG002|Overall Study|Physician Decision|0|||
161713858|NCT03523585|583998208|FG000|Overall Study|Lost to Follow-up|1|||
161713859|NCT03523585|583998209|FG001|Overall Study|Lost to Follow-up|0|||
161961453|NCT01670279|584904066|FG000|Overall Study|Physician Decision|0|||
161961454|NCT01670279|584904067|FG001|Overall Study|Physician Decision|1|||
161961455|NCT01670279|584904068|FG002|Overall Study|Physician Decision|0|||
161961456|NCT01670279|584904069|FG003|Overall Study|Physician Decision|0|||
161961457|NCT01670279|584904066|FG000|Overall Study|Participant met withdrawal criteria|0|||
161961458|NCT01670279|584904067|FG001|Overall Study|Participant met withdrawal criteria|0|||
161961459|NCT01670279|584904068|FG002|Overall Study|Participant met withdrawal criteria|0|||
161961460|NCT01670279|584904069|FG003|Overall Study|Participant met withdrawal criteria|1|||
161961461|NCT02318368|584904070|FG000|Overall Study|Withdrawal by Subject|2|||
161961462|NCT02318368|584904071|FG001|Overall Study|Withdrawal by Subject|0|||
161961463|NCT02318368|584904070|FG000|Overall Study|Study terminated by the sponsor|5|||
161961464|NCT02318368|584904071|FG001|Overall Study|Study terminated by the sponsor|2|||
161961465|NCT02318368|584904070|FG000|Overall Study|Death|0|||
161961466|NCT02318368|584904071|FG001|Overall Study|Death|1|||
161961467|NCT01901614|584904072|FG000|Overall Study|Adverse Event|0|||
161961468|NCT01901614|584904073|FG001|Overall Study|Adverse Event|1|||
161961469|NCT01901614|584904072|FG000|Overall Study|Lost to Follow-up|1|||
161961470|NCT01901614|584904073|FG001|Overall Study|Lost to Follow-up|0|||
161961471|NCT01901614|584904072|FG000|Overall Study|Screen Fail|1|||
161961472|NCT01901614|584904073|FG001|Overall Study|Screen Fail|0|||
161961473|NCT02702609|584904074|FG000|Overall Study|Lost to Follow-up|8|||
161961474|NCT02702609|584904075|FG001|Overall Study|Lost to Follow-up|4|||
161961475|NCT02702609|584904074|FG000|Overall Study|Physician Decision|1|||
161961476|NCT02702609|584904075|FG001|Overall Study|Physician Decision|0|||
161961477|NCT02674464|584904076|FG000|Overall Study|Death|10|||
161961478|NCT02674464|584904077|FG001|Overall Study|Death|21|||
161961479|NCT02674464|584904076|FG000|Overall Study|Withdrawal by Subject|24|||
161961480|NCT02674464|584904077|FG001|Overall Study|Withdrawal by Subject|44|||
161961481|NCT02674464|584904076|FG000|Overall Study|Lost to Follow-up|97|||
161961482|NCT02674464|584904077|FG001|Overall Study|Lost to Follow-up|92|||
161961483|NCT02674464|584904076|FG000|Overall Study|Outside survey window|6|||
161961484|NCT02674464|584904077|FG001|Overall Study|Outside survey window|3|||
161961485|NCT04153981|584904078|FG000|Overall Study|Death|1|||
161961486|NCT04153981|584904078|FG000|Overall Study|Withdrawal by Subject|24|||
161961487|NCT04153981|584904078|FG000|Overall Study|Lost to Follow-up|1|||
161961488|NCT04153981|584904078|FG000|Overall Study|Physician Decision|1|||
161961489|NCT04153981|584904078|FG000|Overall Study|Due to Unavailable Glucometer|1|||
161961490|NCT04153981|584904078|FG000|Overall Study|Covid 19|52|||
161961491|NCT04153981|584904078|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
161961492|NCT04153981|584904078|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
161961493|NCT01555073|584904079|FG000|Overall Study|Lost to Follow-up|1|||
161961494|NCT01555073|584904080|FG001|Overall Study|Lost to Follow-up|2|||
161961495|NCT01555073|584904081|FG002|Overall Study|Lost to Follow-up|0|||
161961496|NCT01555073|584904082|FG003|Overall Study|Lost to Follow-up|5|||
161961497|NCT01262638|584904083|FG000|Overall Study|Adverse Event|3|||
161961498|NCT01262638|584904084|FG001|Overall Study|Adverse Event|4|||
161961499|NCT01262638|584904085|FG002|Overall Study|Adverse Event|3|||
161961500|NCT01262638|584904086|FG003|Overall Study|Adverse Event|4|||
161961501|NCT01262638|584904083|FG000|Overall Study|Protocol Violation|1|||
161961502|NCT01262638|584904084|FG001|Overall Study|Protocol Violation|0|||
161961503|NCT01262638|584904085|FG002|Overall Study|Protocol Violation|0|||
161961504|NCT01262638|584904086|FG003|Overall Study|Protocol Violation|1|||
162031693|NCT04559529|585172453|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
162031694|NCT04559529|585172454|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
161961505|NCT01262638|584904083|FG000|Overall Study|Withdrawal by Subject|2|||
161961506|NCT01262638|584904084|FG001|Overall Study|Withdrawal by Subject|1|||
161961507|NCT01262638|584904085|FG002|Overall Study|Withdrawal by Subject|0|||
161961508|NCT01262638|584904086|FG003|Overall Study|Withdrawal by Subject|1|||
161961509|NCT01262638|584904083|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
161961510|NCT01262638|584904084|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
161961511|NCT01262638|584904085|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
161961512|NCT01262638|584904086|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
161961513|NCT01262638|584904083|FG000|Overall Study|Lost to Follow-up|1|||
161961514|NCT01262638|584904084|FG001|Overall Study|Lost to Follow-up|1|||
161961515|NCT01262638|584904085|FG002|Overall Study|Lost to Follow-up|1|||
161961516|NCT01262638|584904086|FG003|Overall Study|Lost to Follow-up|1|||
161961517|NCT01262638|584904083|FG000|Overall Study|Participant Went Out of Town|0|||
161961518|NCT01262638|584904084|FG001|Overall Study|Participant Went Out of Town|0|||
161961519|NCT01262638|584904085|FG002|Overall Study|Participant Went Out of Town|1|||
161961520|NCT01262638|584904086|FG003|Overall Study|Participant Went Out of Town|0|||
161961521|NCT00506454|584904088|FG000|Overall Study|Withdrawal by Subject|1|||
161961522|NCT00506454|584904089|FG001|Overall Study|Withdrawal by Subject|1|||
161961523|NCT01104545|584904090|FG000|Overall Study|Adverse Event|0|||
161961524|NCT01104545|584904091|FG001|Overall Study|Adverse Event|1|||
161961525|NCT01104545|584904092|FG002|Overall Study|Adverse Event|2|||
161961526|NCT00976716|584904093|FG000|Overall Study|Adverse Event|1|||
161961527|NCT00564902|584904094|FG000|Overall Study|Withdrawal by Subject|0|||
161961528|NCT00564902|584904095|FG001|Overall Study|Withdrawal by Subject|3|||
161961529|NCT00564902|584904096|FG002|Overall Study|Withdrawal by Subject|4|||
161961530|NCT00564902|584904094|FG000|Overall Study|Death|1|||
161961531|NCT00564902|584904095|FG001|Overall Study|Death|1|||
161961532|NCT00564902|584904096|FG002|Overall Study|Death|0|||
161961533|NCT01917929|584904097|FG000|Overall Study|Death|8|||
161961534|NCT01917929|584904097|FG000|Overall Study|Lost to Follow-up|19|||
161961535|NCT01917929|584904097|FG000|Overall Study|Withdrawal by Subject|33|||
161961536|NCT01917929|584904097|FG000|Overall Study|Adverse Event|6|||
161961537|NCT01917929|584904097|FG000|Overall Study|Investigative Site Terminated|35|||
161961538|NCT01917929|584904097|FG000|Overall Study|Censored because study device not implanted|6|||
161961539|NCT01917929|584904097|FG000|Overall Study|Censored because surgery not performed|3|||
161961540|NCT01917929|584904097|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
161961541|NCT01917929|584904097|FG000|Overall Study|Sponsor terminated study|175|||
161961542|NCT04532294|584904098|FG000|Overall Study|Withdrawal by Subject|0|||
161961543|NCT04532294|584904099|FG001|Overall Study|Withdrawal by Subject|0|||
161961544|NCT04532294|584904100|FG002|Overall Study|Withdrawal by Subject|1|||
161961545|NCT04532294|584904098|FG000|Overall Study|Participants Not Dosed|0|||
161961546|NCT04532294|584904099|FG001|Overall Study|Participants Not Dosed|0|||
161961547|NCT04532294|584904100|FG002|Overall Study|Participants Not Dosed|2|||
161961548|NCT03089047|584904101|FG000|Overall Study|Lost to Follow-up|1|||
161961549|NCT03089047|584904102|FG001|Overall Study|Lost to Follow-up|0|||
161961550|NCT03599518|584904103|FG000|Overall Study|Clinical progression|0|||
161961551|NCT03599518|584904104|FG001|Overall Study|Clinical progression|0|||
161961552|NCT03599518|584904105|FG002|Overall Study|Clinical progression|0|||
161961553|NCT03599518|584904106|FG003|Overall Study|Clinical progression|0|||
161961554|NCT03599518|584904107|FG004|Overall Study|Clinical progression|1|||
161961555|NCT03599518|584904103|FG000|Overall Study|Adverse Event|0|||
161961556|NCT03599518|584904104|FG001|Overall Study|Adverse Event|0|||
161961557|NCT03599518|584904105|FG002|Overall Study|Adverse Event|0|||
161961558|NCT03599518|584904106|FG003|Overall Study|Adverse Event|0|||
161961559|NCT03599518|584904107|FG004|Overall Study|Adverse Event|1|||
161961560|NCT03599518|584904103|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
161961561|NCT03599518|584904104|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
161961562|NCT03599518|584904105|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
161961563|NCT03599518|584904106|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
161961564|NCT03599518|584904107|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
161961565|NCT03599518|584904103|FG000|Overall Study|Participant withdrawal from study treatment|0|||
161961566|NCT03599518|584904104|FG001|Overall Study|Participant withdrawal from study treatment|0|||
161961567|NCT03599518|584904105|FG002|Overall Study|Participant withdrawal from study treatment|1|||
161961568|NCT03599518|584904106|FG003|Overall Study|Participant withdrawal from study treatment|0|||
161961569|NCT03599518|584904107|FG004|Overall Study|Participant withdrawal from study treatment|0|||
161961570|NCT02097719|584904108|FG000|Overall Study|Subject Withdrew Consent|1|||
161961571|NCT02097719|584904109|FG001|Overall Study|Subject Withdrew Consent|0|||
161961572|NCT02097719|584904108|FG000|Overall Study|Lost to Follow-up|0|||
161713860|NCT03523585|583998210|FG002|Overall Study|Lost to Follow-up|0|||
161713861|NCT03523585|583998208|FG000|Overall Study|Miscellaneous|1|||
161713862|NCT03523585|583998209|FG001|Overall Study|Miscellaneous|0|||
161713863|NCT03523585|583998210|FG002|Overall Study|Miscellaneous|0|||
161713864|NCT03523585|583998208|FG000|Overall Study|Protocol Deviation|1|||
161713865|NCT03523585|583998209|FG001|Overall Study|Protocol Deviation|0|||
161713866|NCT03523585|583998210|FG002|Overall Study|Protocol Deviation|1|||
161713867|NCT03523585|583998208|FG000|Overall Study|Randomized But Not Treated|2|||
161713868|NCT03523585|583998209|FG001|Overall Study|Randomized But Not Treated|4|||
161713869|NCT03523585|583998210|FG002|Overall Study|Randomized But Not Treated|3|||
161713870|NCT02874794|583998213|FG000|Overall Study|Physician Decision|3|||
161713871|NCT02874794|583998214|FG001|Overall Study|Physician Decision|2|||
161713872|NCT02874794|583998213|FG000|Overall Study|Withdrawal by Subject|2|||
161713873|NCT02874794|583998214|FG001|Overall Study|Withdrawal by Subject|8|||
161713874|NCT02874794|583998213|FG000|Overall Study|Death|2|||
161713875|NCT02874794|583998214|FG001|Overall Study|Death|1|||
161713876|NCT01473004|583998215|FG000|Overall Study|Incomplete Lobar Treatment|1|||
161713877|NCT01473004|583998216|FG001|Overall Study|Incomplete Lobar Treatment|0|||
161713878|NCT00698516|583998217|FG000|Overall Study|Study Termination|2|||
161713879|NCT00698516|583998217|FG000|Overall Study|Withdrawal by Subject|3|||
161713880|NCT05882890|583998218|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
161713881|NCT01584024|583998227|FG000|Overall Study|Lost to Follow-up|10|||
161713882|NCT01584024|583998227|FG000|Overall Study|Withdrawal by Subject|3|||
161713883|NCT00613314|583998228|FG000|Overall Study|Adverse Event|5|||
161713884|NCT00613314|583998228|FG000|Overall Study|Protocol Violation|14|||
161713885|NCT00613314|583998228|FG000|Overall Study|Lost to Follow-up|46|||
161713886|NCT00613314|583998228|FG000|Overall Study|Other reason not defined above|90|||
161713887|NCT00719810|583998234|FG000|Overall Study|Adverse Event|0|||
161713888|NCT00719810|583998235|FG001|Overall Study|Adverse Event|2|||
161713889|NCT00719810|583998236|FG002|Overall Study|Adverse Event|3|||
161713890|NCT00719810|583998234|FG000|Overall Study|Lost to Follow-up|2|||
161713891|NCT00719810|583998235|FG001|Overall Study|Lost to Follow-up|0|||
161713892|NCT00719810|583998236|FG002|Overall Study|Lost to Follow-up|3|||
161713893|NCT00719810|583998234|FG000|Overall Study|Physician Decision|0|||
161713894|NCT00719810|583998235|FG001|Overall Study|Physician Decision|1|||
161713895|NCT00719810|583998236|FG002|Overall Study|Physician Decision|0|||
161713896|NCT00719810|583998234|FG000|Overall Study|Withdrawal by Subject|1|||
161713897|NCT00719810|583998235|FG001|Overall Study|Withdrawal by Subject|1|||
161713898|NCT00719810|583998236|FG002|Overall Study|Withdrawal by Subject|2|||
161713899|NCT04893265|583998259|FG000|Overall Study|Withdrawal by Subject|2|||
161713900|NCT04893265|583998260|FG001|Overall Study|Withdrawal by Subject|5|||
161713901|NCT04893265|583998259|FG000|Overall Study|Lost to Follow-up|0|||
161713902|NCT04893265|583998260|FG001|Overall Study|Lost to Follow-up|4|||
161713903|NCT02465034|583998261|FG000|Overall Study|Withdrawal by Subject|1|||
161713904|NCT02465034|583998262|FG001|Overall Study|Withdrawal by Subject|1|||
161713905|NCT02465034|583998261|FG000|Overall Study|Screen fail|2|||
161713906|NCT02465034|583998262|FG001|Overall Study|Screen fail|0|||
161713907|NCT02465034|583998261|FG000|Overall Study|Could not be scheduled for study visit|0|||
161713908|NCT02465034|583998262|FG001|Overall Study|Could not be scheduled for study visit|5|||
161713909|NCT03090191|583998263|FG000|Overall Study|Adverse Event|90|||
161713910|NCT03090191|583998264|FG001|Overall Study|Adverse Event|72|||
161713911|NCT03090191|583998263|FG000|Overall Study|Death|365|||
161713912|NCT03090191|583998264|FG001|Overall Study|Death|358|||
161713913|NCT03090191|583998263|FG000|Overall Study|Lost to Follow-up|382|||
161713914|NCT03090191|583998264|FG001|Overall Study|Lost to Follow-up|394|||
161713915|NCT03090191|583998263|FG000|Overall Study|Physician Decision|77|||
161713916|NCT03090191|583998264|FG001|Overall Study|Physician Decision|66|||
161713917|NCT03090191|583998263|FG000|Overall Study|Protocol Violation|43|||
161713918|NCT03090191|583998264|FG001|Overall Study|Protocol Violation|52|||
161713919|NCT03090191|583998263|FG000|Overall Study|Withdrawal by Subject|2160|||
161713920|NCT03090191|583998264|FG001|Overall Study|Withdrawal by Subject|2133|||
161713921|NCT03090191|583998263|FG000|Overall Study|Site terminated|7|||
161713922|NCT03090191|583998264|FG001|Overall Study|Site terminated|8|||
161713923|NCT03090191|583998263|FG000|Overall Study|Other|66|||
161713924|NCT03090191|583998264|FG001|Overall Study|Other|60|||
161713925|NCT03090191|583998263|FG000|Overall Study|Withdrawn before any study vaccination|43|||
161713926|NCT03090191|583998264|FG001|Overall Study|Withdrawn before any study vaccination|52|||
161713927|NCT04419506|583998267|FG000|Overall Study|Adverse Event|0|||
161713928|NCT04419506|583998268|FG001|Overall Study|Adverse Event|10|||
161713929|NCT04419506|583998269|FG002|Overall Study|Adverse Event|0|||
161713930|NCT04419506|583998270|FG003|Overall Study|Adverse Event|3|||
161713931|NCT04419506|583998267|FG000|Overall Study|Withdrawal by Subject|0|||
161713932|NCT04419506|583998268|FG001|Overall Study|Withdrawal by Subject|0|||
161713933|NCT04419506|583998269|FG002|Overall Study|Withdrawal by Subject|0|||
161713934|NCT04419506|583998270|FG003|Overall Study|Withdrawal by Subject|1|||
161713935|NCT04419506|583998267|FG000|Overall Study|poor-compliance|0|||
161713936|NCT04419506|583998268|FG001|Overall Study|poor-compliance|0|||
161713937|NCT04419506|583998269|FG002|Overall Study|poor-compliance|0|||
161713938|NCT04419506|583998270|FG003|Overall Study|poor-compliance|1|||
161713939|NCT04329949|583998271|FG000|Overall Study|Death|36|||
161713940|NCT04329949|583998271|FG000|Overall Study|Withdrawal by Subject|4|||
161713941|NCT04329949|583998271|FG000|Overall Study|Termination of study by sponsor|3|||
161713942|NCT04645797|583998272|FG000|Overall Study|Disease Progression|3|||
161838007|NCT03127644|584450282|FG001|Overall Study|Study-specific withdrawal criteria|0|||
162031695|NCT01009281|585172455|FG000|Overall Study|Administrative problems|7|||
161713943|NCT04645797|583998273|FG001|Overall Study|Disease Progression|3|||
161713944|NCT04645797|583998274|FG002|Overall Study|Disease Progression|1|||
161713945|NCT04645797|583998275|FG003|Overall Study|Disease Progression|0|||
161713946|NCT04645797|583998276|FG004|Overall Study|Disease Progression|0|||
161713947|NCT04645797|583998277|FG005|Overall Study|Disease Progression|0|||
161713948|NCT04645797|583998278|FG006|Overall Study|Disease Progression|0|||
161713949|NCT04645797|583998272|FG000|Overall Study|Death|3|||
161713950|NCT04645797|583998273|FG001|Overall Study|Death|1|||
161713951|NCT04645797|583998274|FG002|Overall Study|Death|0|||
162031696|NCT00924170|585172456|FG000|Overall Study|Refused further treatment|0|||
161713952|NCT04645797|583998275|FG003|Overall Study|Death|0|||
161713953|NCT04645797|583998276|FG004|Overall Study|Death|0|||
161713954|NCT04645797|583998277|FG005|Overall Study|Death|0|||
161713955|NCT04645797|583998278|FG006|Overall Study|Death|0|||
161713956|NCT00345605|583998283|FG000|Arm 1|Adverse Event|0|||
161713957|NCT00345605|583998284|FG001|Arm 1|Adverse Event|1|||
161713958|NCT00345605|583998283|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
161713959|NCT00345605|583998284|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
161713960|NCT01324830|583998285|FG000|Overall Study|Progressive Disease|3|||
161713961|NCT01324830|583998286|FG001|Overall Study|Progressive Disease|2|||
161713962|NCT01324830|583998287|FG002|Overall Study|Progressive Disease|3|||
161713963|NCT01324830|583998288|FG003|Overall Study|Progressive Disease|3|||
161713964|NCT01324830|583998289|FG004|Overall Study|Progressive Disease|6|||
161713965|NCT01324830|583998290|FG005|Overall Study|Progressive Disease|6|||
161713966|NCT01324830|583998291|FG006|Overall Study|Progressive Disease|3|||
161713967|NCT01324830|583998292|FG007|Overall Study|Progressive Disease|3|||
161713968|NCT01324830|583998293|FG008|Overall Study|Progressive Disease|3|||
161713969|NCT01324830|583998294|FG009|Overall Study|Progressive Disease|6|||
161713970|NCT01324830|583998295|FG010|Overall Study|Progressive Disease|2|||
161713971|NCT01324830|583998296|FG011|Overall Study|Progressive Disease|1|||
161713972|NCT01324830|583998297|FG012|Overall Study|Progressive Disease|1|||
161713973|NCT01324830|583998298|FG013|Overall Study|Progressive Disease|1|||
161713974|NCT01324830|583998299|FG014|Overall Study|Progressive Disease|1|||
161713975|NCT01324830|583998300|FG015|Overall Study|Progressive Disease|3|||
161713976|NCT01324830|583998301|FG016|Overall Study|Progressive Disease|2|||
161713977|NCT01324830|583998302|FG017|Overall Study|Progressive Disease|3|||
161713978|NCT01324830|583998303|FG018|Overall Study|Progressive Disease|4|||
161713979|NCT01324830|583998285|FG000|Overall Study|Dose limiting toxicity|0|||
161713980|NCT01324830|583998286|FG001|Overall Study|Dose limiting toxicity|0|||
161713981|NCT01324830|583998287|FG002|Overall Study|Dose limiting toxicity|0|||
161713982|NCT01324830|583998288|FG003|Overall Study|Dose limiting toxicity|0|||
161713983|NCT01324830|583998289|FG004|Overall Study|Dose limiting toxicity|1|||
161713984|NCT01324830|583998290|FG005|Overall Study|Dose limiting toxicity|0|||
161713985|NCT01324830|583998291|FG006|Overall Study|Dose limiting toxicity|0|||
161713986|NCT01324830|583998292|FG007|Overall Study|Dose limiting toxicity|0|||
161713987|NCT01324830|583998293|FG008|Overall Study|Dose limiting toxicity|0|||
161713988|NCT01324830|583998294|FG009|Overall Study|Dose limiting toxicity|0|||
161713989|NCT01324830|583998295|FG010|Overall Study|Dose limiting toxicity|0|||
161713990|NCT01324830|583998296|FG011|Overall Study|Dose limiting toxicity|0|||
161713991|NCT01324830|583998297|FG012|Overall Study|Dose limiting toxicity|0|||
161713992|NCT01324830|583998298|FG013|Overall Study|Dose limiting toxicity|0|||
161713993|NCT01324830|583998299|FG014|Overall Study|Dose limiting toxicity|0|||
161713994|NCT01324830|583998300|FG015|Overall Study|Dose limiting toxicity|0|||
161713995|NCT01324830|583998301|FG016|Overall Study|Dose limiting toxicity|1|||
161713996|NCT01324830|583998302|FG017|Overall Study|Dose limiting toxicity|1|||
161713997|NCT01324830|583998303|FG018|Overall Study|Dose limiting toxicity|1|||
161713998|NCT01324830|583998285|FG000|Overall Study|Reason not mentioned above|0|||
161713999|NCT01324830|583998286|FG001|Overall Study|Reason not mentioned above|0|||
161714000|NCT01324830|583998287|FG002|Overall Study|Reason not mentioned above|0|||
161714001|NCT01324830|583998288|FG003|Overall Study|Reason not mentioned above|0|||
161714002|NCT01324830|583998289|FG004|Overall Study|Reason not mentioned above|0|||
161714003|NCT01324830|583998290|FG005|Overall Study|Reason not mentioned above|0|||
161714004|NCT01324830|583998291|FG006|Overall Study|Reason not mentioned above|0|||
161714005|NCT01324830|583998292|FG007|Overall Study|Reason not mentioned above|0|||
161714006|NCT01324830|583998293|FG008|Overall Study|Reason not mentioned above|0|||
161714007|NCT01324830|583998294|FG009|Overall Study|Reason not mentioned above|0|||
161714008|NCT01324830|583998295|FG010|Overall Study|Reason not mentioned above|0|||
161714009|NCT01324830|583998296|FG011|Overall Study|Reason not mentioned above|0|||
161714010|NCT01324830|583998297|FG012|Overall Study|Reason not mentioned above|0|||
161714011|NCT01324830|583998298|FG013|Overall Study|Reason not mentioned above|0|||
161714012|NCT01324830|583998299|FG014|Overall Study|Reason not mentioned above|0|||
161714013|NCT01324830|583998300|FG015|Overall Study|Reason not mentioned above|0|||
161714014|NCT01324830|583998301|FG016|Overall Study|Reason not mentioned above|0|||
161714015|NCT01324830|583998302|FG017|Overall Study|Reason not mentioned above|1|||
161714016|NCT01324830|583998303|FG018|Overall Study|Reason not mentioned above|0|||
161714017|NCT01324830|583998285|FG000|Overall Study|Adverse Event, serious fatal|0|||
161838008|NCT03127644|584450283|FG002|Overall Study|Study-specific withdrawal criteria|2|||
161714018|NCT01324830|583998286|FG001|Overall Study|Adverse Event, serious fatal|1|||
161714019|NCT01324830|583998287|FG002|Overall Study|Adverse Event, serious fatal|0|||
161714020|NCT01324830|583998288|FG003|Overall Study|Adverse Event, serious fatal|0|||
161714021|NCT01324830|583998289|FG004|Overall Study|Adverse Event, serious fatal|0|||
161714022|NCT01324830|583998290|FG005|Overall Study|Adverse Event, serious fatal|0|||
161714023|NCT01324830|583998291|FG006|Overall Study|Adverse Event, serious fatal|0|||
161714024|NCT01324830|583998292|FG007|Overall Study|Adverse Event, serious fatal|0|||
161714025|NCT01324830|583998293|FG008|Overall Study|Adverse Event, serious fatal|0|||
161714026|NCT01324830|583998294|FG009|Overall Study|Adverse Event, serious fatal|0|||
161714027|NCT01324830|583998295|FG010|Overall Study|Adverse Event, serious fatal|0|||
162031697|NCT00924170|585172457|FG001|Overall Study|Refused further treatment|1|||
162031698|NCT00924170|585172456|FG000|Overall Study|Physician Decision|0|||
162031699|NCT00924170|585172457|FG001|Overall Study|Physician Decision|1|||
162031700|NCT00924170|585172456|FG000|Overall Study|Progressive disease|3|||
162031701|NCT00924170|585172457|FG001|Overall Study|Progressive disease|6|||
162031702|NCT00924170|585172456|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
162031703|NCT00924170|585172457|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
162031704|NCT00924170|585172456|FG000|Overall Study|Death|1|||
162031705|NCT00924170|585172457|FG001|Overall Study|Death|0|||
162031706|NCT05318183|585172460|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
162031707|NCT05318183|585172461|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
162031708|NCT05318183|585172460|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
162031709|NCT05318183|585172461|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
162031710|NCT05318183|585172460|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
162031711|NCT05318183|585172461|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
162031712|NCT05318183|585172460|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
162031713|NCT05318183|585172461|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
161714028|NCT01324830|583998296|FG011|Overall Study|Adverse Event, serious fatal|0|||
161714029|NCT01324830|583998297|FG012|Overall Study|Adverse Event, serious fatal|0|||
161714030|NCT01324830|583998298|FG013|Overall Study|Adverse Event, serious fatal|0|||
161714031|NCT01324830|583998299|FG014|Overall Study|Adverse Event, serious fatal|0|||
161714032|NCT01324830|583998300|FG015|Overall Study|Adverse Event, serious fatal|0|||
161714033|NCT01324830|583998301|FG016|Overall Study|Adverse Event, serious fatal|0|||
161714034|NCT01324830|583998302|FG017|Overall Study|Adverse Event, serious fatal|0|||
161714035|NCT01324830|583998303|FG018|Overall Study|Adverse Event, serious fatal|0|||
161714036|NCT01324830|583998285|FG000|Overall Study|Adverse Event, non-fatal|0|||
161714037|NCT01324830|583998286|FG001|Overall Study|Adverse Event, non-fatal|0|||
161714038|NCT01324830|583998287|FG002|Overall Study|Adverse Event, non-fatal|0|||
161714039|NCT01324830|583998288|FG003|Overall Study|Adverse Event, non-fatal|0|||
161714040|NCT01324830|583998289|FG004|Overall Study|Adverse Event, non-fatal|0|||
161714041|NCT01324830|583998290|FG005|Overall Study|Adverse Event, non-fatal|0|||
161714042|NCT01324830|583998291|FG006|Overall Study|Adverse Event, non-fatal|0|||
161714043|NCT01324830|583998292|FG007|Overall Study|Adverse Event, non-fatal|0|||
161714044|NCT01324830|583998293|FG008|Overall Study|Adverse Event, non-fatal|2|||
161714045|NCT01324830|583998294|FG009|Overall Study|Adverse Event, non-fatal|0|||
161714046|NCT01324830|583998295|FG010|Overall Study|Adverse Event, non-fatal|1|||
161714047|NCT01324830|583998296|FG011|Overall Study|Adverse Event, non-fatal|0|||
161714048|NCT01324830|583998297|FG012|Overall Study|Adverse Event, non-fatal|0|||
161714049|NCT01324830|583998298|FG013|Overall Study|Adverse Event, non-fatal|0|||
161714050|NCT01324830|583998299|FG014|Overall Study|Adverse Event, non-fatal|0|||
161714051|NCT01324830|583998300|FG015|Overall Study|Adverse Event, non-fatal|0|||
161714052|NCT01324830|583998301|FG016|Overall Study|Adverse Event, non-fatal|0|||
161714053|NCT01324830|583998302|FG017|Overall Study|Adverse Event, non-fatal|1|||
161714054|NCT01324830|583998303|FG018|Overall Study|Adverse Event, non-fatal|0|||
161714055|NCT01324830|583998285|FG000|Overall Study|Withdrawal by Subject|0|||
161714056|NCT01324830|583998286|FG001|Overall Study|Withdrawal by Subject|0|||
161714057|NCT01324830|583998287|FG002|Overall Study|Withdrawal by Subject|0|||
161714058|NCT01324830|583998288|FG003|Overall Study|Withdrawal by Subject|0|||
161714059|NCT01324830|583998289|FG004|Overall Study|Withdrawal by Subject|0|||
161714060|NCT01324830|583998290|FG005|Overall Study|Withdrawal by Subject|1|||
161714061|NCT01324830|583998291|FG006|Overall Study|Withdrawal by Subject|0|||
161714062|NCT01324830|583998292|FG007|Overall Study|Withdrawal by Subject|0|||
161714063|NCT01324830|583998293|FG008|Overall Study|Withdrawal by Subject|0|||
161714064|NCT01324830|583998294|FG009|Overall Study|Withdrawal by Subject|0|||
161714065|NCT01324830|583998295|FG010|Overall Study|Withdrawal by Subject|1|||
161714066|NCT01324830|583998296|FG011|Overall Study|Withdrawal by Subject|0|||
161714067|NCT01324830|583998297|FG012|Overall Study|Withdrawal by Subject|0|||
161714068|NCT01324830|583998298|FG013|Overall Study|Withdrawal by Subject|0|||
161714069|NCT01324830|583998299|FG014|Overall Study|Withdrawal by Subject|0|||
162031714|NCT01203852|585172465|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
162031715|NCT01203852|585172465|FG000|Washout 2 Weeks|Physician Decision|46|||
161714070|NCT01324830|583998300|FG015|Overall Study|Withdrawal by Subject|0|||
161714071|NCT01324830|583998301|FG016|Overall Study|Withdrawal by Subject|0|||
161714072|NCT01324830|583998302|FG017|Overall Study|Withdrawal by Subject|0|||
161838009|NCT02032706|584450286|FG000|Overall Study|Did not qualify|5|||
162031716|NCT00899392|585172466|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
162031717|NCT00899392|585172467|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
162031718|NCT03709576|585172468|FG000|Overall Study|progression prior to enrollment|1|||
162031719|NCT00890045|585172473|FG000|Overall Study|Death|0|||
161714073|NCT01324830|583998303|FG018|Overall Study|Withdrawal by Subject|1|||
161714074|NCT01973283|583998304|FG000|Overall Study|Lost to Follow-up|4|||
161714075|NCT00817414|583998305|FG000|Overall Study|Adverse Event|1|||
161714076|NCT00817414|583998306|FG001|Overall Study|Adverse Event|1|||
161714077|NCT00817414|583998307|FG002|Overall Study|Adverse Event|1|||
161961573|NCT02097719|584904109|FG001|Overall Study|Lost to Follow-up|1|||
161961574|NCT02097719|584904108|FG000|Overall Study|Adverse Event|2|||
161961575|NCT02097719|584904109|FG001|Overall Study|Adverse Event|0|||
161961576|NCT01108731|584904117|FG000|Overall Study|Withdrawal by Subject|1|||
161961577|NCT01108731|584904118|FG001|Overall Study|Withdrawal by Subject|1|||
161961578|NCT01108731|584904117|FG000|Overall Study|Adverse Event|3|||
161961579|NCT01108731|584904118|FG001|Overall Study|Adverse Event|3|||
161961580|NCT00984594|584904119|FG000|Overall Study|Lost to Follow-up|1|||
161961581|NCT00984594|584904120|FG001|Overall Study|Lost to Follow-up|0|||
161961582|NCT00984594|584904119|FG000|Overall Study|Withdrawal by Subject|0|||
161961583|NCT00984594|584904120|FG001|Overall Study|Withdrawal by Subject|1|||
161961584|NCT01063062|584904121|FG000|Overall Study|Patient withdrew consent|0|||
161961585|NCT01063062|584904122|FG001|Overall Study|Patient withdrew consent|1|||
162031720|NCT00890045|585172474|FG001|Overall Study|Death|1|||
161714078|NCT00817414|583998308|FG003|Overall Study|Adverse Event|0|||
161714079|NCT00817414|583998309|FG004|Overall Study|Adverse Event|0|||
161714080|NCT00817414|583998305|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
161714081|NCT00817414|583998306|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
161714082|NCT00817414|583998307|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
161714083|NCT00817414|583998308|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
161714084|NCT00817414|583998309|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
161714085|NCT00817414|583998305|FG000|Overall Study|Withdrawal by Subject|1|||
161714086|NCT00817414|583998306|FG001|Overall Study|Withdrawal by Subject|1|||
161714087|NCT00817414|583998307|FG002|Overall Study|Withdrawal by Subject|0|||
161714088|NCT00817414|583998308|FG003|Overall Study|Withdrawal by Subject|0|||
161714089|NCT00817414|583998309|FG004|Overall Study|Withdrawal by Subject|0|||
161714090|NCT00817414|583998305|FG000|Overall Study|Lost to Follow-up|0|||
161714091|NCT00817414|583998306|FG001|Overall Study|Lost to Follow-up|0|||
161714092|NCT00817414|583998307|FG002|Overall Study|Lost to Follow-up|1|||
161714093|NCT00817414|583998308|FG003|Overall Study|Lost to Follow-up|1|||
161714094|NCT00817414|583998309|FG004|Overall Study|Lost to Follow-up|1|||
161714095|NCT00817414|583998305|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
161714096|NCT00817414|583998306|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
161714097|NCT00817414|583998307|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
161714098|NCT00817414|583998308|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
161714099|NCT00817414|583998309|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
161714100|NCT00817414|583998305|FG000|Overall Study|Protocol Violation|0|||
161714101|NCT00817414|583998306|FG001|Overall Study|Protocol Violation|0|||
161714102|NCT00817414|583998307|FG002|Overall Study|Protocol Violation|0|||
161714103|NCT00817414|583998308|FG003|Overall Study|Protocol Violation|0|||
161714104|NCT00817414|583998309|FG004|Overall Study|Protocol Violation|1|||
161714105|NCT03717922|583998316|FG000|Overall Study|Lost to Follow-up|2|||
161714106|NCT03717922|583998317|FG001|Overall Study|Lost to Follow-up|2|||
161714107|NCT03126227|583998320|FG000|Overall Study|Adverse Event|43|||
161714108|NCT03126227|583998321|FG001|Overall Study|Adverse Event|4|||
161714109|NCT03126227|583998320|FG000|Overall Study|Death|0|||
161714110|NCT03126227|583998321|FG001|Overall Study|Death|1|||
161714111|NCT03126227|583998320|FG000|Overall Study|Lost to Follow-up|0|||
161714112|NCT03126227|583998321|FG001|Overall Study|Lost to Follow-up|1|||
161714113|NCT03126227|583998320|FG000|Overall Study|Physician Decision|2|||
161714114|NCT03126227|583998321|FG001|Overall Study|Physician Decision|0|||
161714115|NCT03126227|583998320|FG000|Overall Study|Protocol Violation|1|||
161714116|NCT03126227|583998321|FG001|Overall Study|Protocol Violation|0|||
161714117|NCT03126227|583998320|FG000|Overall Study|Withdrawal by Subject|19|||
161714118|NCT03126227|583998321|FG001|Overall Study|Withdrawal by Subject|3|||
161714119|NCT03126227|583998320|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
161714120|NCT03126227|583998321|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
161714121|NCT03126227|583998320|FG000|Overall Study|Lack of dosing compliance|2|||
161714122|NCT03126227|583998321|FG001|Overall Study|Lack of dosing compliance|0|||
161714123|NCT03126227|583998320|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
161714124|NCT03126227|583998321|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
162031721|NCT00890045|585172473|FG000|Overall Study|Did not receive HeRO Graft|0|||
162031722|NCT00890045|585172474|FG001|Overall Study|Did not receive HeRO Graft|2|||
161714125|NCT03126227|583998320|FG000|Overall Study|Scheduling conflict|1|||
161714126|NCT03126227|583998321|FG001|Overall Study|Scheduling conflict|0|||
161714127|NCT02586805|583998327|FG000|Overall Study|Withdrawal by Subject|3|||
161714128|NCT02586805|583998328|FG001|Overall Study|Withdrawal by Subject|1|||
161714129|NCT02586805|583998329|FG002|Overall Study|Withdrawal by Subject|1|||
161714130|NCT02586805|583998330|FG003|Overall Study|Withdrawal by Subject|2|||
161961586|NCT01063062|584904121|FG000|Overall Study|Adverse Event|2|||
161961587|NCT01063062|584904122|FG001|Overall Study|Adverse Event|4|||
161961588|NCT01063062|584904121|FG000|Overall Study|Protocol Violation|5|||
161961589|NCT01063062|584904122|FG001|Overall Study|Protocol Violation|4|||
162031723|NCT00890045|585172473|FG000|Overall Study|Lost to Follow-up|5|||
161714131|NCT02586805|583998327|FG000|Overall Study|Adverse Event|2|||
161714132|NCT02586805|583998328|FG001|Overall Study|Adverse Event|0|||
161714133|NCT02586805|583998329|FG002|Overall Study|Adverse Event|1|||
161714134|NCT02586805|583998330|FG003|Overall Study|Adverse Event|0|||
161961590|NCT01063062|584904121|FG000|Overall Study|Investigator's request|1|||
161961591|NCT01063062|584904122|FG001|Overall Study|Investigator's request|0|||
161961592|NCT01063062|584904121|FG000|Overall Study|Lost to Follow-up|0|||
161961593|NCT01063062|584904122|FG001|Overall Study|Lost to Follow-up|2|||
161961594|NCT01063062|584904121|FG000|Overall Study|Miscellaneous reason|0|||
161961595|NCT01063062|584904122|FG001|Overall Study|Miscellaneous reason|1|||
161961596|NCT00281099|584904125|FG000|Overall Study|Death|46|||
161961597|NCT00281099|584904126|FG001|Overall Study|Death|57|||
161961598|NCT00281099|584904125|FG000|Overall Study|Lost to Follow-up|10|||
161961599|NCT00281099|584904126|FG001|Overall Study|Lost to Follow-up|19|||
161961600|NCT00281099|584904125|FG000|Overall Study|Withdrawal by Subject|65|||
161961601|NCT00281099|584904126|FG001|Overall Study|Withdrawal by Subject|70|||
161961602|NCT00281099|584904125|FG000|Overall Study|Physician Decision|79|||
161961603|NCT00281099|584904126|FG001|Overall Study|Physician Decision|72|||
161961604|NCT00281099|584904125|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
161961605|NCT00281099|584904126|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
161961606|NCT00837161|584904127|FG000|Overall Study|refused hysterectomy|2|||
161961607|NCT02931838|584904128|FG000|Overall Study|Reason not provided by investigator|1|||
161961608|NCT02931838|584904129|FG001|Overall Study|Reason not provided by investigator|0|||
161961609|NCT02931838|584904130|FG002|Overall Study|Reason not provided by investigator|1|||
161961610|NCT02931838|584904131|FG003|Overall Study|Reason not provided by investigator|0|||
161961611|NCT02931838|584904132|FG004|Overall Study|Reason not provided by investigator|0|||
161961612|NCT02931838|584904133|FG005|Overall Study|Reason not provided by investigator|0|||
161961613|NCT02931838|584904128|FG000|Overall Study|Poor/non-compliance|0|||
161961614|NCT02931838|584904129|FG001|Overall Study|Poor/non-compliance|0|||
161961615|NCT02931838|584904130|FG002|Overall Study|Poor/non-compliance|1|||
161961616|NCT02931838|584904131|FG003|Overall Study|Poor/non-compliance|0|||
161961617|NCT02931838|584904132|FG004|Overall Study|Poor/non-compliance|0|||
161961618|NCT02931838|584904133|FG005|Overall Study|Poor/non-compliance|0|||
161961619|NCT02931838|584904128|FG000|Overall Study|Lack of Efficacy|5|||
161961620|NCT02931838|584904129|FG001|Overall Study|Lack of Efficacy|4|||
161961621|NCT02931838|584904130|FG002|Overall Study|Lack of Efficacy|0|||
161961622|NCT02931838|584904131|FG003|Overall Study|Lack of Efficacy|0|||
161961623|NCT02931838|584904132|FG004|Overall Study|Lack of Efficacy|0|||
161961624|NCT02931838|584904133|FG005|Overall Study|Lack of Efficacy|1|||
161961625|NCT02931838|584904128|FG000|Overall Study|Lost to Follow-up|1|||
161961626|NCT02931838|584904129|FG001|Overall Study|Lost to Follow-up|0|||
161961627|NCT02931838|584904130|FG002|Overall Study|Lost to Follow-up|1|||
161961628|NCT02931838|584904131|FG003|Overall Study|Lost to Follow-up|1|||
161961629|NCT02931838|584904132|FG004|Overall Study|Lost to Follow-up|2|||
161961630|NCT02931838|584904133|FG005|Overall Study|Lost to Follow-up|0|||
161961631|NCT02931838|584904128|FG000|Overall Study|Subject request to discontinue treatment|4|||
161961632|NCT02931838|584904129|FG001|Overall Study|Subject request to discontinue treatment|3|||
161961633|NCT02931838|584904130|FG002|Overall Study|Subject request to discontinue treatment|3|||
161961634|NCT02931838|584904131|FG003|Overall Study|Subject request to discontinue treatment|0|||
161961635|NCT02931838|584904132|FG004|Overall Study|Subject request to discontinue treatment|1|||
161961636|NCT02931838|584904133|FG005|Overall Study|Subject request to discontinue treatment|0|||
161961637|NCT02931838|584904128|FG000|Overall Study|Withdrawal by Subject|1|||
161961638|NCT02931838|584904129|FG001|Overall Study|Withdrawal by Subject|2|||
161961639|NCT02931838|584904130|FG002|Overall Study|Withdrawal by Subject|0|||
161961640|NCT02931838|584904131|FG003|Overall Study|Withdrawal by Subject|1|||
161961641|NCT02931838|584904132|FG004|Overall Study|Withdrawal by Subject|0|||
161961642|NCT02931838|584904133|FG005|Overall Study|Withdrawal by Subject|0|||
161961643|NCT02931838|584904128|FG000|Overall Study|Adverse Event|2|||
161961644|NCT02931838|584904129|FG001|Overall Study|Adverse Event|1|||
161961645|NCT02931838|584904130|FG002|Overall Study|Adverse Event|2|||
161961646|NCT02931838|584904131|FG003|Overall Study|Adverse Event|1|||
161961647|NCT02931838|584904132|FG004|Overall Study|Adverse Event|3|||
161961648|NCT02931838|584904133|FG005|Overall Study|Adverse Event|1|||
161961649|NCT00104728|584904134|FG000|Overall Study|screen failures|19|||
161961650|NCT06899737|584904139|FG000|Overall Study|Lost to Follow-up|19|||
161961651|NCT06899737|584904140|FG001|Overall Study|Lost to Follow-up|7|||
161961652|NCT00375674|584904141|FG000|Overall Study|Other|26|||
161714135|NCT02586805|583998327|FG000|Overall Study|Lost to Follow-up|0|||
161961653|NCT00375674|584904142|FG001|Overall Study|Other|18|||
161961654|NCT00375674|584904141|FG000|Overall Study|Death|67|||
161961655|NCT00375674|584904142|FG001|Overall Study|Death|76|||
161961656|NCT00375674|584904141|FG000|Overall Study|Participants refused further follow-up|31|||
161961657|NCT00375674|584904142|FG001|Overall Study|Participants refused further follow-up|30|||
161961658|NCT00375674|584904141|FG000|Overall Study|Lost to Follow-up|17|||
161961659|NCT00375674|584904142|FG001|Overall Study|Lost to Follow-up|15|||
161961660|NCT00375674|584904141|FG000|Overall Study|Enrolled but not treated|3|||
161961661|NCT00375674|584904142|FG001|Overall Study|Enrolled but not treated|2|||
161714136|NCT02586805|583998328|FG001|Overall Study|Lost to Follow-up|0|||
161714137|NCT02586805|583998329|FG002|Overall Study|Lost to Follow-up|1|||
161714138|NCT02586805|583998330|FG003|Overall Study|Lost to Follow-up|0|||
161714139|NCT02586805|583998327|FG000|Overall Study|Physician Decision|1|||
161714140|NCT02586805|583998328|FG001|Overall Study|Physician Decision|0|||
161714141|NCT02586805|583998329|FG002|Overall Study|Physician Decision|0|||
161714142|NCT02586805|583998330|FG003|Overall Study|Physician Decision|0|||
161714143|NCT01859403|583998331|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
161714144|NCT01859403|583998332|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
161714145|NCT01859403|583998331|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
161714146|NCT01859403|583998332|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
161714147|NCT01859403|583998331|FG000|Primary Endpoint Measure|Physician Decision|0|||
161714148|NCT01859403|583998332|FG001|Primary Endpoint Measure|Physician Decision|1|||
161714149|NCT01859403|583998331|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
161714150|NCT01859403|583998332|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
161714151|NCT01157117|583998333|FG000|Overall Study|Dosing Symptoms|0|||
161714152|NCT01157117|583998334|FG001|Overall Study|Dosing Symptoms|4|||
161714153|NCT01157117|583998335|FG002|Overall Study|Dosing Symptoms|0|||
161714154|NCT01157117|583998333|FG000|Overall Study|Withdrawal by Subject|4|||
161714155|NCT01157117|583998334|FG001|Overall Study|Withdrawal by Subject|1|||
161714156|NCT01157117|583998335|FG002|Overall Study|Withdrawal by Subject|1|||
161714157|NCT01157117|583998333|FG000|Overall Study|Lack of Efficacy|1|||
161714158|NCT01157117|583998334|FG001|Overall Study|Lack of Efficacy|1|||
161714159|NCT01157117|583998335|FG002|Overall Study|Lack of Efficacy|0|||
161714160|NCT01157117|583998333|FG000|Overall Study|Lost to Follow-up|0|||
161714161|NCT01157117|583998334|FG001|Overall Study|Lost to Follow-up|0|||
161714162|NCT01157117|583998335|FG002|Overall Study|Lost to Follow-up|1|||
161714163|NCT01157117|583998333|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
161714164|NCT01157117|583998334|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
161714165|NCT01157117|583998335|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
161714166|NCT01531725|583998337|FG000|Overall Study|Protocol Violation|5|||
161714167|NCT02317510|583998338|FG000|Overall Study|Adverse Event|0|||
161714168|NCT02317510|583998339|FG001|Overall Study|Adverse Event|1|||
161714169|NCT00472303|583998340|FG000|Titration Phase|Adverse Event|22|||
161714170|NCT00472303|583998341|FG001|Titration Phase|Adverse Event|12|||
161714171|NCT00472303|583998342|FG002|Titration Phase|Adverse Event|0|||
161714172|NCT00472303|583998340|FG000|Titration Phase|Death|4|||
161714173|NCT00472303|583998341|FG001|Titration Phase|Death|2|||
161714174|NCT00472303|583998342|FG002|Titration Phase|Death|0|||
161714175|NCT00472303|583998340|FG000|Titration Phase|Lack of Efficacy|10|||
161714176|NCT00472303|583998341|FG001|Titration Phase|Lack of Efficacy|0|||
161714177|NCT00472303|583998342|FG002|Titration Phase|Lack of Efficacy|0|||
161714178|NCT00472303|583998340|FG000|Titration Phase|Withdrawal by Subject|16|||
161714179|NCT00472303|583998341|FG001|Titration Phase|Withdrawal by Subject|13|||
161714180|NCT00472303|583998342|FG002|Titration Phase|Withdrawal by Subject|0|||
161714181|NCT00472303|583998340|FG000|Titration Phase|Trial Medication non-compliant|4|||
161714182|NCT00472303|583998341|FG001|Titration Phase|Trial Medication non-compliant|1|||
161714183|NCT00472303|583998342|FG002|Titration Phase|Trial Medication non-compliant|0|||
161714184|NCT00472303|583998340|FG000|Titration Phase|Other|3|||
161714185|NCT00472303|583998341|FG001|Titration Phase|Other|1|||
161714186|NCT00472303|583998342|FG002|Titration Phase|Other|0|||
161714187|NCT00472303|583998340|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
161714188|NCT00472303|583998341|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
161714189|NCT00472303|583998342|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
161714190|NCT00472303|583998340|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
161714191|NCT00472303|583998341|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
161714192|NCT00472303|583998342|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
161714193|NCT00472303|583998340|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
161714194|NCT00472303|583998341|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
161714195|NCT00472303|583998342|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
161714196|NCT00472303|583998340|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
161714197|NCT00472303|583998341|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
161714198|NCT00472303|583998342|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
161714199|NCT00472303|583998340|FG000|Discontinuations After Titration Phase|Other|5|||
161714200|NCT00472303|583998341|FG001|Discontinuations After Titration Phase|Other|0|||
161714201|NCT00472303|583998342|FG002|Discontinuations After Titration Phase|Other|0|||
161714202|NCT00472303|583998340|FG000|Maintenance Phase|Adverse Event|5|||
161714203|NCT00472303|583998341|FG001|Maintenance Phase|Adverse Event|6|||
161714204|NCT00472303|583998342|FG002|Maintenance Phase|Adverse Event|6|||
161714205|NCT00472303|583998340|FG000|Maintenance Phase|Death|3|||
161714206|NCT00472303|583998341|FG001|Maintenance Phase|Death|0|||
161714207|NCT00472303|583998342|FG002|Maintenance Phase|Death|2|||
161714208|NCT00472303|583998340|FG000|Maintenance Phase|Lack of Efficacy|2|||
161714209|NCT00472303|583998341|FG001|Maintenance Phase|Lack of Efficacy|2|||
161714210|NCT00472303|583998342|FG002|Maintenance Phase|Lack of Efficacy|4|||
161961662|NCT00912782|584904143|FG000|Overall Study|Death|2|||
161961663|NCT00912782|584904144|FG001|Overall Study|Death|1|||
161961664|NCT00912782|584904143|FG000|Overall Study|Lost to Follow-up|0|||
161961665|NCT00912782|584904144|FG001|Overall Study|Lost to Follow-up|1|||
161961666|NCT00912782|584904143|FG000|Overall Study|Did not receive vascular access type|1|||
161961667|NCT00912782|584904144|FG001|Overall Study|Did not receive vascular access type|2|||
161961668|NCT00912782|584904143|FG000|Overall Study|Relocated before study completion|0|||
161961669|NCT00912782|584904144|FG001|Overall Study|Relocated before study completion|1|||
161961670|NCT05924165|584905515|FG000|Overall Study|Physician Decision|2|||
161714211|NCT00472303|583998340|FG000|Maintenance Phase|Withdrawal by Subject|6|||
162031724|NCT00890045|585172474|FG001|Overall Study|Lost to Follow-up|7|||
161714212|NCT00472303|583998341|FG001|Maintenance Phase|Withdrawal by Subject|7|||
161714213|NCT00472303|583998342|FG002|Maintenance Phase|Withdrawal by Subject|3|||
161961671|NCT05924165|584905516|FG001|Overall Study|Physician Decision|3|||
161961672|NCT01681186|584905517|FG000|Washout Period From Second Intervention|Adverse Event|0|||
161961673|NCT01681186|584905518|FG001|Washout Period From Second Intervention|Adverse Event|0|||
161961674|NCT01681186|584905519|FG002|Washout Period From Second Intervention|Adverse Event|0|||
161961675|NCT01681186|584905520|FG003|Washout Period From Second Intervention|Adverse Event|0|||
161961676|NCT01681186|584905521|FG004|Washout Period From Second Intervention|Adverse Event|0|||
161961677|NCT01681186|584905522|FG005|Washout Period From Second Intervention|Adverse Event|0|||
161961678|NCT01681186|584905523|FG006|Washout Period From Second Intervention|Adverse Event|1|||
161961679|NCT01681186|584905524|FG007|Washout Period From Second Intervention|Adverse Event|0|||
161961680|NCT01681186|584905517|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
161961681|NCT01681186|584905518|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
161961682|NCT01681186|584905519|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
161961683|NCT01681186|584905520|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
161961684|NCT01681186|584905521|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
161961685|NCT01681186|584905522|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
161961686|NCT01681186|584905523|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
161961687|NCT01681186|584905524|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
161961688|NCT01681186|584905517|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
161961689|NCT01681186|584905518|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
161961690|NCT01681186|584905519|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
161961691|NCT01681186|584905520|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
161961692|NCT01681186|584905521|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
161961693|NCT01681186|584905522|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
161961694|NCT01681186|584905523|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
161961695|NCT01681186|584905524|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
161961696|NCT01681186|584905517|FG000|Fourth Intervention|Protocol Violation|0|||
161961697|NCT01681186|584905518|FG001|Fourth Intervention|Protocol Violation|0|||
161961698|NCT01681186|584905519|FG002|Fourth Intervention|Protocol Violation|0|||
161961699|NCT01681186|584905520|FG003|Fourth Intervention|Protocol Violation|0|||
161961700|NCT01681186|584905521|FG004|Fourth Intervention|Protocol Violation|0|||
161961701|NCT01681186|584905522|FG005|Fourth Intervention|Protocol Violation|0|||
161961702|NCT01681186|584905523|FG006|Fourth Intervention|Protocol Violation|0|||
161961703|NCT01681186|584905524|FG007|Fourth Intervention|Protocol Violation|1|||
161961704|NCT00606034|584905529|FG000|Overall Study|incarceration|1|||
161961705|NCT01734395|584905530|FG000|Overall Study|Other|65|||
161961706|NCT01734395|584905530|FG000|Overall Study|Lost to Follow-up|287|||
161961707|NCT01734395|584905530|FG000|Overall Study|Lack of Efficacy|5|||
161961708|NCT01734395|584905530|FG000|Overall Study|Adverse Event|40|||
161961709|NCT01734395|584905530|FG000|Overall Study|Withdrawal by Subject|10|||
161961710|NCT01734395|584905530|FG000|Overall Study|Missing the reasons for not completed|3|||
161961711|NCT00765037|584905531|FG000|Overall Study|Lost to Follow-up|5|||
161961712|NCT00765037|584905531|FG000|Overall Study|Adverse Event|1|||
161961713|NCT00935493|584905534|FG000|Overall Study|Lost to Follow-up|1|||
161961714|NCT00935493|584905535|FG001|Overall Study|Lost to Follow-up|1|||
161961715|NCT00935493|584905536|FG002|Overall Study|Lost to Follow-up|1|||
161961716|NCT00935493|584905534|FG000|Overall Study|Treatment Discontinued|0|||
161961717|NCT00935493|584905535|FG001|Overall Study|Treatment Discontinued|1|||
161714214|NCT00472303|583998340|FG000|Maintenance Phase|Trial medication non-compliant|0|||
161714215|NCT00472303|583998341|FG001|Maintenance Phase|Trial medication non-compliant|0|||
161714216|NCT00472303|583998342|FG002|Maintenance Phase|Trial medication non-compliant|1|||
161714217|NCT00472303|583998340|FG000|Maintenance Phase|Resolution of pain|0|||
161714218|NCT00472303|583998341|FG001|Maintenance Phase|Resolution of pain|0|||
161714219|NCT00472303|583998342|FG002|Maintenance Phase|Resolution of pain|1|||
161714220|NCT00472303|583998340|FG000|Maintenance Phase|Other|1|||
161714221|NCT00472303|583998341|FG001|Maintenance Phase|Other|1|||
161714222|NCT00472303|583998342|FG002|Maintenance Phase|Other|0|||
161714223|NCT01122927|583998343|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
161714224|NCT01122927|583998344|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
161714225|NCT01122927|583998343|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
161714226|NCT01122927|583998344|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
161714227|NCT01122927|583998343|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
161714228|NCT01122927|583998344|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
161714229|NCT01122927|583998343|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
161961718|NCT00935493|584905536|FG002|Overall Study|Treatment Discontinued|0|||
161961719|NCT02125838|584905537|FG000|Overall Study|Lost to Follow-up|4|||
161961720|NCT02125838|584905538|FG001|Overall Study|Lost to Follow-up|4|||
161714230|NCT01122927|583998344|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
161714231|NCT01122927|583998343|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
161961721|NCT02565147|584905539|FG000|Overall Study|Withdrawal by Subject|5|||
161961722|NCT02565147|584905540|FG001|Overall Study|Withdrawal by Subject|1|||
161961723|NCT02565147|584905539|FG000|Overall Study|Lost to Follow-up|0|||
161961724|NCT02565147|584905540|FG001|Overall Study|Lost to Follow-up|1|||
161961725|NCT02565147|584905539|FG000|Overall Study|Death|1|||
161961726|NCT02565147|584905540|FG001|Overall Study|Death|1|||
161961727|NCT00787839|584905541|FG000|Overall Study|Failure to have the OGTT was most common|404|||
161961728|NCT00244725|584905551|FG000|Overall Study|Lost to Follow-up|3|||
161961729|NCT00244725|584905552|FG001|Overall Study|Lost to Follow-up|4|||
161714232|NCT01122927|583998344|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
161714233|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
161714234|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
161714235|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
161714236|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
161714237|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
161714238|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
161714239|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
161714240|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
161714241|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
161714242|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
161714243|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
161714244|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
161714245|NCT01122927|583998343|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
161714246|NCT01122927|583998344|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
161714247|NCT01672892|583999618|FG000|Overall Study|Protocol Violation|7|||
161714248|NCT01672892|583999619|FG001|Overall Study|Protocol Violation|3|||
161714249|NCT00573131|583999636|FG000|Overall Study|Withdrawal by Subject|10|||
161714250|NCT00573131|583999637|FG001|Overall Study|Withdrawal by Subject|8|||
161714251|NCT02401256|583999643|FG000|Overall Study|Adverse Event|5|||
161714252|NCT02401256|583999643|FG000|Overall Study|Withdrawal by Subject|12|||
161714253|NCT00893789|583999645|FG000|Overall Study|Withdrawal by Subject|3|||
161714254|NCT00893789|583999646|FG001|Overall Study|Withdrawal by Subject|1|||
161714255|NCT00893789|583999647|FG002|Overall Study|Withdrawal by Subject|3|||
161714256|NCT00893789|583999648|FG003|Overall Study|Withdrawal by Subject|1|||
161714257|NCT00893789|583999645|FG000|Overall Study|Noncompliance With Study Drug|1|||
161714258|NCT00893789|583999646|FG001|Overall Study|Noncompliance With Study Drug|0|||
161714259|NCT00893789|583999647|FG002|Overall Study|Noncompliance With Study Drug|1|||
161714260|NCT00893789|583999648|FG003|Overall Study|Noncompliance With Study Drug|2|||
161714261|NCT00893789|583999645|FG000|Overall Study|Noncompliance With Study Procedures|1|||
161714262|NCT00893789|583999646|FG001|Overall Study|Noncompliance With Study Procedures|0|||
161714263|NCT00893789|583999647|FG002|Overall Study|Noncompliance With Study Procedures|0|||
161714264|NCT00893789|583999648|FG003|Overall Study|Noncompliance With Study Procedures|0|||
161714265|NCT00893789|583999645|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
161714266|NCT00893789|583999646|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
161714267|NCT00893789|583999647|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
161714268|NCT00893789|583999648|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
161714269|NCT00893789|583999645|FG000|Overall Study|Adverse Event|0|||
161714270|NCT00893789|583999646|FG001|Overall Study|Adverse Event|2|||
161714271|NCT00893789|583999647|FG002|Overall Study|Adverse Event|1|||
161714272|NCT00893789|583999648|FG003|Overall Study|Adverse Event|5|||
161714273|NCT00893789|583999645|FG000|Overall Study|Protocol Violation|0|||
161714274|NCT00893789|583999646|FG001|Overall Study|Protocol Violation|1|||
161714275|NCT00893789|583999647|FG002|Overall Study|Protocol Violation|1|||
161714276|NCT00893789|583999648|FG003|Overall Study|Protocol Violation|4|||
161714277|NCT00893789|583999645|FG000|Overall Study|Lost to Follow-up|0|||
161714278|NCT00893789|583999646|FG001|Overall Study|Lost to Follow-up|0|||
161714279|NCT00893789|583999647|FG002|Overall Study|Lost to Follow-up|0|||
161714280|NCT00893789|583999648|FG003|Overall Study|Lost to Follow-up|1|||
161714281|NCT02024464|583999649|FG000|Overall Study|Discontinued|5|||
161714282|NCT02024464|583999650|FG001|Overall Study|Discontinued|4|||
161714283|NCT02024464|583999649|FG000|Overall Study|Missed Visits|1|||
161714284|NCT02024464|583999650|FG001|Overall Study|Missed Visits|0|||
161714285|NCT02024464|583999649|FG000|Overall Study|Lost to Follow-up|4|||
161714286|NCT02024464|583999650|FG001|Overall Study|Lost to Follow-up|7|||
161714287|NCT01575548|583999653|FG000|Overall Study|Adverse Event|15|||
161714288|NCT01575548|583999654|FG001|Overall Study|Adverse Event|2|||
161714289|NCT01575548|583999653|FG000|Overall Study|Disease progression|12|||
161714290|NCT01575548|583999654|FG001|Overall Study|Disease progression|25|||
161714291|NCT01575548|583999653|FG000|Overall Study|Death|1|||
161961730|NCT00244725|584905553|FG002|Overall Study|Lost to Follow-up|9|||
161961731|NCT00244725|584905554|FG003|Overall Study|Lost to Follow-up|2|||
161714292|NCT01575548|583999654|FG001|Overall Study|Death|0|||
161714293|NCT01575548|583999653|FG000|Overall Study|Other complicating disease|1|||
161714294|NCT01575548|583999654|FG001|Overall Study|Other complicating disease|0|||
161714295|NCT01575548|583999653|FG000|Overall Study|Withdrawal by Subject|7|||
161714296|NCT01575548|583999654|FG001|Overall Study|Withdrawal by Subject|3|||
161961732|NCT00244725|584905551|FG000|Overall Study|Withdrawal by Subject|9|||
161714297|NCT01575548|583999653|FG000|Overall Study|Noncompliance|1|||
161714298|NCT01575548|583999654|FG001|Overall Study|Noncompliance|0|||
161714299|NCT01575548|583999653|FG000|Overall Study|Anticipated surgery|0|||
161714300|NCT01575548|583999654|FG001|Overall Study|Anticipated surgery|1|||
161714301|NCT01575548|583999653|FG000|Overall Study|Never started protocol therapy|3|||
161961733|NCT00244725|584905552|FG001|Overall Study|Withdrawal by Subject|7|||
161961734|NCT00244725|584905553|FG002|Overall Study|Withdrawal by Subject|7|||
161961735|NCT00244725|584905554|FG003|Overall Study|Withdrawal by Subject|8|||
161961736|NCT00244725|584905551|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
161714302|NCT01575548|583999654|FG001|Overall Study|Never started protocol therapy|2|||
161714303|NCT03872180|583999657|FG000|Overall Study|Adverse Event|4|||
161714304|NCT03872180|583999657|FG000|Overall Study|Lack of Efficacy|2|||
161714305|NCT01244737|583999659|FG000|Overall Study|Physician Decision|2|||
161714306|NCT01244737|583999660|FG001|Overall Study|Physician Decision|18|||
161714307|NCT01244737|583999661|FG002|Overall Study|Physician Decision|5|||
161714308|NCT01244737|583999659|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
161714309|NCT01244737|583999660|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
161714310|NCT01244737|583999661|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
161714311|NCT01244737|583999659|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
161714312|NCT01244737|583999660|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
161714313|NCT01244737|583999661|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
161714314|NCT01244737|583999659|FG000|Overall Study|MIB immunopathology results not available|3|||
161714315|NCT01244737|583999660|FG001|Overall Study|MIB immunopathology results not available|2|||
161714316|NCT01244737|583999661|FG002|Overall Study|MIB immunopathology results not available|0|||
161714317|NCT01244737|583999659|FG000|Overall Study|PET data failure|0|||
161714318|NCT01244737|583999660|FG001|Overall Study|PET data failure|1|||
161714319|NCT01244737|583999661|FG002|Overall Study|PET data failure|0|||
161714320|NCT01244737|583999659|FG000|Overall Study|Withdrawal by Subject|0|||
161714321|NCT01244737|583999660|FG001|Overall Study|Withdrawal by Subject|0|||
161714322|NCT01244737|583999661|FG002|Overall Study|Withdrawal by Subject|1|||
161714323|NCT00356915|583999668|FG000|Overall Study|Non compliance|1|||
161714324|NCT00356915|583999669|FG001|Overall Study|Non compliance|2|||
161714325|NCT00356915|583999670|FG002|Overall Study|Non compliance|1|||
161714326|NCT00356915|583999668|FG000|Overall Study|Protocol Violation|2|||
161714327|NCT00356915|583999669|FG001|Overall Study|Protocol Violation|3|||
161714328|NCT00356915|583999670|FG002|Overall Study|Protocol Violation|2|||
161714329|NCT00356915|583999668|FG000|Overall Study|Withdrawal by Subject|14|||
161714330|NCT00356915|583999669|FG001|Overall Study|Withdrawal by Subject|14|||
161714331|NCT00356915|583999670|FG002|Overall Study|Withdrawal by Subject|10|||
161714332|NCT00356915|583999668|FG000|Overall Study|Lack of Efficacy|0|||
161714333|NCT00356915|583999669|FG001|Overall Study|Lack of Efficacy|0|||
161714334|NCT00356915|583999670|FG002|Overall Study|Lack of Efficacy|3|||
161714335|NCT00356915|583999668|FG000|Overall Study|Lost to Follow-up|27|||
161714336|NCT00356915|583999669|FG001|Overall Study|Lost to Follow-up|34|||
161714337|NCT00356915|583999670|FG002|Overall Study|Lost to Follow-up|14|||
161714338|NCT00356915|583999668|FG000|Overall Study|Administrative Decision|0|||
161714339|NCT00356915|583999669|FG001|Overall Study|Administrative Decision|0|||
161714340|NCT00356915|583999670|FG002|Overall Study|Administrative Decision|1|||
161714341|NCT00356915|583999668|FG000|Overall Study|Physician Decision|0|||
161714342|NCT00356915|583999669|FG001|Overall Study|Physician Decision|2|||
161714343|NCT00356915|583999670|FG002|Overall Study|Physician Decision|0|||
161714344|NCT00356915|583999668|FG000|Overall Study|Adverse Event|21|||
161714345|NCT00356915|583999669|FG001|Overall Study|Adverse Event|31|||
161714346|NCT00356915|583999670|FG002|Overall Study|Adverse Event|8|||
161714347|NCT00356915|583999668|FG000|Overall Study|Miscellaneous reasons|11|||
161714348|NCT00356915|583999669|FG001|Overall Study|Miscellaneous reasons|8|||
161714349|NCT00356915|583999670|FG002|Overall Study|Miscellaneous reasons|3|||
161714350|NCT02371629|583999679|FG000|Overall Study|Patient decision|14|||
161714351|NCT02371629|583999680|FG001|Overall Study|Patient decision|10|||
161714352|NCT02371629|583999679|FG000|Overall Study|Adverse Event|8|||
161714353|NCT02371629|583999680|FG001|Overall Study|Adverse Event|8|||
161714354|NCT02371629|583999679|FG000|Overall Study|Physician Decision|2|||
161714355|NCT02371629|583999680|FG001|Overall Study|Physician Decision|3|||
161714356|NCT02371629|583999679|FG000|Overall Study|Death|1|||
161714357|NCT02371629|583999680|FG001|Overall Study|Death|1|||
161714358|NCT02371629|583999679|FG000|Overall Study|Noncompliance with study treatment|1|||
161714359|NCT02371629|583999680|FG001|Overall Study|Noncompliance with study treatment|0|||
161714360|NCT02371629|583999679|FG000|Overall Study|Lack of Efficacy|0|||
161714361|NCT02371629|583999680|FG001|Overall Study|Lack of Efficacy|2|||
161714362|NCT02371629|583999679|FG000|Overall Study|Protocol deviation|0|||
161714363|NCT02371629|583999680|FG001|Overall Study|Protocol deviation|1|||
161714364|NCT01193335|583999682|FG000|After Infant Series|Lost to Follow-up|1|||
161714365|NCT01193335|583999683|FG001|After Infant Series|Lost to Follow-up|2|||
161961737|NCT00244725|584905552|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
161714366|NCT01193335|583999682|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
161714367|NCT01193335|583999683|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
161714368|NCT01193335|583999682|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
161714369|NCT01193335|583999683|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
161714370|NCT01193335|583999682|FG000|1-Year Follow-up|Lost to Follow-up|4|||
161961738|NCT00244725|584905553|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
161714371|NCT01193335|583999683|FG001|1-Year Follow-up|Lost to Follow-up|0|||
161714372|NCT01193335|583999682|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
161714373|NCT01193335|583999683|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
161714374|NCT01193335|583999682|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
161714375|NCT01193335|583999683|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
161714376|NCT03486314|583999685|FG000|Part A|Adverse Event|1|||
161714377|NCT03486314|583999686|FG001|Part A|Adverse Event|0|||
161714378|NCT03486314|583999687|FG002|Part A|Adverse Event|0|||
161714379|NCT03486314|583999685|FG000|Part A|Symptomatic Deterioration|2|||
161714380|NCT03486314|583999686|FG001|Part A|Symptomatic Deterioration|0|||
161714381|NCT03486314|583999687|FG002|Part A|Symptomatic Deterioration|0|||
161714382|NCT01985321|583999688|FG000|Overall Study|Protocol Violation|4|||
161714383|NCT01985321|583999689|FG001|Overall Study|Protocol Violation|3|||
161714384|NCT01985321|583999688|FG000|Overall Study|Withdrawal by Subject|1|||
161714385|NCT01985321|583999689|FG001|Overall Study|Withdrawal by Subject|0|||
161714386|NCT01985321|583999688|FG000|Overall Study|Lost to Follow-up|5|||
161714387|NCT01985321|583999689|FG001|Overall Study|Lost to Follow-up|2|||
161714388|NCT01985321|583999688|FG000|Overall Study|Subject treated wrong type of sore|1|||
161714389|NCT01985321|583999689|FG001|Overall Study|Subject treated wrong type of sore|0|||
161714390|NCT01364467|583999690|FG000|Overall Study|Lost to Follow-up|1|||
161714391|NCT01364467|583999691|FG001|Overall Study|Lost to Follow-up|2|||
161714392|NCT02502864|583999694|FG000|Overall Study|Withdrawal by Subject|1|||
161714393|NCT00184054|583999698|FG000|Overall Study|Adverse Event|1|||
161714394|NCT02296840|583999699|FG000|Overall Study|Adverse Event|1|||
161714395|NCT02296840|583999700|FG001|Overall Study|Adverse Event|1|||
161714396|NCT02296840|583999699|FG000|Overall Study|Protocol Violation|2|||
161714397|NCT02296840|583999700|FG001|Overall Study|Protocol Violation|1|||
161714398|NCT02296840|583999699|FG000|Overall Study|Lost to Follow-up|6|||
161714399|NCT02296840|583999700|FG001|Overall Study|Lost to Follow-up|17|||
161961739|NCT00244725|584905554|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
161961740|NCT00244725|584905551|FG000|Overall Study|Physician Decision|3|||
161961741|NCT00244725|584905552|FG001|Overall Study|Physician Decision|0|||
161961742|NCT00244725|584905553|FG002|Overall Study|Physician Decision|1|||
161961743|NCT00244725|584905554|FG003|Overall Study|Physician Decision|2|||
161961744|NCT00244725|584905551|FG000|Overall Study|Adverse Events|3|||
161961745|NCT00244725|584905552|FG001|Overall Study|Adverse Events|1|||
161961746|NCT00244725|584905553|FG002|Overall Study|Adverse Events|4|||
161961747|NCT00244725|584905554|FG003|Overall Study|Adverse Events|4|||
161961748|NCT00244725|584905551|FG000|Overall Study|Withdrwal by participant|1|||
161961749|NCT00244725|584905552|FG001|Overall Study|Withdrwal by participant|0|||
161961750|NCT00244725|584905553|FG002|Overall Study|Withdrwal by participant|0|||
161961751|NCT00244725|584905554|FG003|Overall Study|Withdrwal by participant|1|||
161961752|NCT00244725|584905551|FG000|Overall Study|Liver function test abnormality|2|||
161961753|NCT00244725|584905552|FG001|Overall Study|Liver function test abnormality|0|||
161961754|NCT00244725|584905553|FG002|Overall Study|Liver function test abnormality|0|||
161961755|NCT00244725|584905554|FG003|Overall Study|Liver function test abnormality|1|||
161961756|NCT00244725|584905551|FG000|Overall Study|Sponsor withdrew the participant|1|||
161961757|NCT00244725|584905552|FG001|Overall Study|Sponsor withdrew the participant|0|||
161961758|NCT00244725|584905553|FG002|Overall Study|Sponsor withdrew the participant|0|||
161961759|NCT00244725|584905554|FG003|Overall Study|Sponsor withdrew the participant|1|||
161961760|NCT00244725|584905551|FG000|Overall Study|Mediciation Error|0|||
161961761|NCT00244725|584905552|FG001|Overall Study|Mediciation Error|1|||
161961762|NCT00244725|584905553|FG002|Overall Study|Mediciation Error|0|||
161961763|NCT00244725|584905554|FG003|Overall Study|Mediciation Error|0|||
161961764|NCT00244725|584905551|FG000|Overall Study|Rehab Refused to allow participantion|0|||
161961765|NCT00244725|584905552|FG001|Overall Study|Rehab Refused to allow participantion|1|||
161961766|NCT00244725|584905553|FG002|Overall Study|Rehab Refused to allow participantion|0|||
161961767|NCT00244725|584905554|FG003|Overall Study|Rehab Refused to allow participantion|0|||
161961768|NCT00244725|584905551|FG000|Overall Study|Headache|0|||
161961769|NCT00244725|584905552|FG001|Overall Study|Headache|1|||
161961770|NCT00244725|584905553|FG002|Overall Study|Headache|0|||
161961771|NCT00244725|584905554|FG003|Overall Study|Headache|0|||
161961772|NCT00244725|584905551|FG000|Overall Study|Received prohibited medication|0|||
161961773|NCT00244725|584905552|FG001|Overall Study|Received prohibited medication|1|||
161961774|NCT00244725|584905553|FG002|Overall Study|Received prohibited medication|0|||
161961775|NCT00244725|584905554|FG003|Overall Study|Received prohibited medication|1|||
161961776|NCT00244725|584905551|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
161961777|NCT00244725|584905552|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
161961778|NCT00244725|584905553|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
161714400|NCT02485717|583999701|FG000|Overall Study|Lost to Follow-up|6|||
161714401|NCT02485717|583999702|FG001|Overall Study|Lost to Follow-up|0|||
161714402|NCT02485717|583999703|FG002|Overall Study|Lost to Follow-up|0|||
161714403|NCT02485717|583999701|FG000|Overall Study|Withdrawal by Subject|0|||
161714404|NCT02485717|583999702|FG001|Overall Study|Withdrawal by Subject|0|||
161714405|NCT02485717|583999703|FG002|Overall Study|Withdrawal by Subject|1|||
161961779|NCT00244725|584905554|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
161714406|NCT02485717|583999701|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
161714407|NCT02485717|583999702|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
161714408|NCT02485717|583999703|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
161714409|NCT02485717|583999701|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
161714410|NCT02485717|583999702|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
161714411|NCT02485717|583999703|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
161714412|NCT02827877|583999704|FG000|Overall Study|Withdrawal by Subject|1|||
161714413|NCT00519532|583999707|FG000|Overall Study|Adverse Event|11|||
161714414|NCT00519532|583999707|FG000|Overall Study|Withdrawal by Subject|5|||
161714415|NCT00519532|583999707|FG000|Overall Study|Lost to Follow-up|2|||
161714416|NCT00814710|583999708|FG000|Overall Study|Adverse Event|1|||
161714417|NCT00814710|583999709|FG001|Overall Study|Adverse Event|0|||
161714418|NCT00814710|583999708|FG000|Overall Study|Lost to Follow-up|7|||
161714419|NCT00814710|583999709|FG001|Overall Study|Lost to Follow-up|3|||
161714420|NCT01450540|583999710|FG000|Overall Study|Withdrawal by Subject|19|||
161714421|NCT01450540|583999711|FG001|Overall Study|Withdrawal by Subject|13|||
161714422|NCT01450540|583999710|FG000|Overall Study|protocol deviation|3|||
161714423|NCT01450540|583999711|FG001|Overall Study|protocol deviation|23|||
161714424|NCT00140855|583999712|FG000|Overall Study|Progressive disease|2|||
161714425|NCT03542682|583999713|FG000|Overall Study|COVID-19 Protocol|0|||
161714426|NCT03542682|583999714|FG001|Overall Study|COVID-19 Protocol|1|||
161714427|NCT01682044|583999724|FG000|Overall Study|Death|1|||
161714428|NCT01682044|583999724|FG000|Overall Study|Progression|3|||
161714429|NCT04090164|583999725|FG000|Overall Study|incomplete data on file|245|||
161714430|NCT04090164|583999726|FG001|Overall Study|incomplete data on file|0|||
161714431|NCT00840463|583999731|FG000|Overall Study|Adverse Event|1|||
161714432|NCT00840463|583999732|FG001|Overall Study|Adverse Event|0|||
161714433|NCT01887210|583999736|FG000|Overall Study|Withdrawal by Subject|1|||
161714434|NCT01887210|583999737|FG001|Overall Study|Withdrawal by Subject|3|||
161714435|NCT01887210|583999736|FG000|Overall Study|Lost to Follow-up|0|||
161714436|NCT01887210|583999737|FG001|Overall Study|Lost to Follow-up|1|||
161714437|NCT02515669|583999744|FG000|228 Week Open-Label Phase|Other|0|||
161714438|NCT02515669|583999745|FG001|228 Week Open-Label Phase|Other|0|||
161714439|NCT02515669|583999746|FG002|228 Week Open-Label Phase|Other|1|||
161714440|NCT02515669|583999747|FG003|228 Week Open-Label Phase|Other|4|||
161714441|NCT02515669|583999744|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
161714442|NCT02515669|583999745|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
161714443|NCT02515669|583999746|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
161714444|NCT02515669|583999747|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
161714445|NCT02515669|583999744|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
161714446|NCT02515669|583999745|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
161714447|NCT02515669|583999746|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
161714448|NCT02515669|583999747|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
161714449|NCT02515669|583999744|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
161714450|NCT02515669|583999745|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
161714451|NCT02515669|583999746|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
161714452|NCT02515669|583999747|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
161714453|NCT02515669|583999744|FG000|228 Week Open-Label Phase|Missing|0|||
161714454|NCT02515669|583999745|FG001|228 Week Open-Label Phase|Missing|2|||
161714455|NCT02515669|583999746|FG002|228 Week Open-Label Phase|Missing|2|||
161714456|NCT02515669|583999747|FG003|228 Week Open-Label Phase|Missing|2|||
161714457|NCT00957372|583999748|FG000|PART I|Lost to Follow-up|0|||
161714458|NCT00957372|583999749|FG001|PART I|Lost to Follow-up|0|||
161714459|NCT00957372|583999750|FG002|PART I|Lost to Follow-up|1|||
161714460|NCT00957372|583999751|FG003|PART I|Lost to Follow-up|0|||
161714461|NCT00957372|583999748|FG000|PART II|Withdrawal by Subject|0|||
161714462|NCT00957372|583999749|FG001|PART II|Withdrawal by Subject|0|||
161714463|NCT00957372|583999750|FG002|PART II|Withdrawal by Subject|0|||
161714464|NCT00957372|583999751|FG003|PART II|Withdrawal by Subject|8|||
161714465|NCT00957372|583999748|FG000|PART II|Physician Decision|0|||
161714466|NCT00957372|583999749|FG001|PART II|Physician Decision|0|||
161714467|NCT00957372|583999750|FG002|PART II|Physician Decision|0|||
161714468|NCT00957372|583999751|FG003|PART II|Physician Decision|1|||
161714469|NCT00957372|583999748|FG000|PART II|Pregnancy|0|||
161961780|NCT00244725|584905551|FG000|Overall Study|Administrative reason|0|||
161961781|NCT00244725|584905552|FG001|Overall Study|Administrative reason|0|||
161714470|NCT00957372|583999749|FG001|PART II|Pregnancy|0|||
161714471|NCT00957372|583999750|FG002|PART II|Pregnancy|0|||
161714472|NCT00957372|583999751|FG003|PART II|Pregnancy|1|||
161714473|NCT00957372|583999748|FG000|PART II|Not Know|0|||
161961782|NCT00244725|584905553|FG002|Overall Study|Administrative reason|1|||
161961783|NCT00244725|584905554|FG003|Overall Study|Administrative reason|0|||
161714474|NCT00957372|583999749|FG001|PART II|Not Know|0|||
161714475|NCT00957372|583999750|FG002|PART II|Not Know|0|||
161714476|NCT00957372|583999751|FG003|PART II|Not Know|20|||
161714477|NCT00957372|583999748|FG000|PART II|Adverse Event|0|||
161714478|NCT00957372|583999749|FG001|PART II|Adverse Event|0|||
161714479|NCT00957372|583999750|FG002|PART II|Adverse Event|0|||
161714480|NCT00957372|583999751|FG003|PART II|Adverse Event|10|||
161961784|NCT00244725|584905551|FG000|Overall Study|Vomit|0|||
161961785|NCT00244725|584905552|FG001|Overall Study|Vomit|0|||
161961786|NCT00244725|584905553|FG002|Overall Study|Vomit|1|||
161961787|NCT00244725|584905554|FG003|Overall Study|Vomit|0|||
161961788|NCT00244725|584905551|FG000|Overall Study|Failed to follow-up|0|||
161961789|NCT00244725|584905552|FG001|Overall Study|Failed to follow-up|0|||
161961790|NCT00244725|584905553|FG002|Overall Study|Failed to follow-up|1|||
161961791|NCT00244725|584905554|FG003|Overall Study|Failed to follow-up|1|||
161961792|NCT04004221|584905559|FG000|Overall Study|Death|89|||
161961793|NCT04004221|584905559|FG000|Overall Study|Withdrawal by Subject|5|||
161961794|NCT04004221|584905559|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
161961795|NCT04004221|584905559|FG000|Overall Study|Sponsor Decision|9|||
161961796|NCT04004221|584905559|FG000|Overall Study|Participant refused to enter LTE|1|||
161961797|NCT03423238|584905560|FG000|Overall Study|Lost to Follow-up|1|||
161961798|NCT03423238|584905561|FG001|Overall Study|Lost to Follow-up|0|||
161961799|NCT03423238|584905560|FG000|Overall Study|Withdrawal by Subject|1|||
161961800|NCT03423238|584905561|FG001|Overall Study|Withdrawal by Subject|0|||
161961801|NCT02993822|584905569|FG000|Overall Study|Lack of Efficacy|1|||
161961802|NCT02993822|584905570|FG001|Overall Study|Lack of Efficacy|1|||
161961803|NCT02993822|584905571|FG002|Overall Study|Lack of Efficacy|0|||
161961804|NCT02993822|584905572|FG003|Overall Study|Lack of Efficacy|0|||
161961805|NCT02993822|584905569|FG000|Overall Study|Protocol Violation|1|||
161961806|NCT02993822|584905570|FG001|Overall Study|Protocol Violation|0|||
161961807|NCT02993822|584905571|FG002|Overall Study|Protocol Violation|0|||
161961808|NCT02993822|584905572|FG003|Overall Study|Protocol Violation|0|||
161961809|NCT02993822|584905569|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
161961810|NCT02993822|584905570|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
161961811|NCT02993822|584905571|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
161714481|NCT00957372|583999748|FG000|PART II|Patient non-compliance|0|||
161714482|NCT00957372|583999749|FG001|PART II|Patient non-compliance|0|||
161714483|NCT00957372|583999750|FG002|PART II|Patient non-compliance|0|||
161714484|NCT00957372|583999751|FG003|PART II|Patient non-compliance|4|||
161714485|NCT01444391|583999752|FG000|Overall Study|Death|1|||
161714486|NCT05847881|583999756|FG000|Overall Study|Principal Investigator Decision|8|||
161714487|NCT05847881|583999756|FG000|Overall Study|Withdrawal by Subject|2|||
161714488|NCT03439345|584001285|FG000|Overall Study|Lost to Follow-up|0|||
161714489|NCT03439345|584001286|FG001|Overall Study|Lost to Follow-up|1|||
161714490|NCT03439345|584001285|FG000|Overall Study|Consent withdrawn|0|||
161714491|NCT03439345|584001286|FG001|Overall Study|Consent withdrawn|1|||
161714492|NCT01386385|584001287|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
161714493|NCT01386385|584001288|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714494|NCT01386385|584001289|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714495|NCT01386385|584001290|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714496|NCT01386385|584001291|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714497|NCT01386385|584001292|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714498|NCT01386385|584001293|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714499|NCT01386385|584001294|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161714500|NCT01386385|584001287|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
161714501|NCT01386385|584001288|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714502|NCT01386385|584001289|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714503|NCT01386385|584001290|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714504|NCT01386385|584001291|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714505|NCT01386385|584001292|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714506|NCT01386385|584001293|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714507|NCT01386385|584001294|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161714508|NCT01386385|584001287|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714509|NCT01386385|584001288|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714510|NCT01386385|584001289|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
161714511|NCT01386385|584001290|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714512|NCT01386385|584001291|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714513|NCT01386385|584001292|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714514|NCT01386385|584001293|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714515|NCT01386385|584001294|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161714516|NCT01386385|584001287|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714517|NCT01386385|584001288|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714518|NCT01386385|584001289|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161961812|NCT02993822|584905572|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
161961813|NCT02993822|584905569|FG000|Overall Study|Adverse Event|3|||
161961814|NCT02993822|584905570|FG001|Overall Study|Adverse Event|1|||
161961815|NCT02993822|584905571|FG002|Overall Study|Adverse Event|7|||
161961816|NCT02993822|584905572|FG003|Overall Study|Adverse Event|0|||
161961817|NCT02993822|584905569|FG000|Overall Study|Withdrawal by Subject|4|||
161714519|NCT01386385|584001290|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714520|NCT01386385|584001291|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
161714521|NCT01386385|584001292|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714522|NCT01386385|584001293|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714523|NCT01386385|584001294|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161714524|NCT01386385|584001287|FG000|Phase II Concurrent CRT|Adverse Event|0|||
161714525|NCT01386385|584001288|FG001|Phase II Concurrent CRT|Adverse Event|0|||
161714526|NCT01386385|584001289|FG002|Phase II Concurrent CRT|Adverse Event|0|||
161714527|NCT01386385|584001290|FG003|Phase II Concurrent CRT|Adverse Event|0|||
161714528|NCT01386385|584001291|FG004|Phase II Concurrent CRT|Adverse Event|0|||
161714529|NCT01386385|584001292|FG005|Phase II Concurrent CRT|Adverse Event|0|||
161714530|NCT01386385|584001293|FG006|Phase II Concurrent CRT|Adverse Event|3|||
161714531|NCT01386385|584001294|FG007|Phase II Concurrent CRT|Adverse Event|3|||
161714532|NCT01386385|584001287|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714533|NCT01386385|584001288|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714534|NCT01386385|584001289|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714535|NCT01386385|584001290|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714536|NCT01386385|584001291|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714537|NCT01386385|584001292|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714538|NCT01386385|584001293|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
161714539|NCT01386385|584001294|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161714540|NCT01386385|584001287|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
161714541|NCT01386385|584001288|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
161714542|NCT01386385|584001289|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
161714543|NCT01386385|584001290|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
161714544|NCT01386385|584001291|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
161714545|NCT01386385|584001292|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
161714546|NCT01386385|584001293|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
161714547|NCT01386385|584001294|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
161714548|NCT01386385|584001287|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714549|NCT01386385|584001288|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714550|NCT01386385|584001289|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714551|NCT01386385|584001290|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714552|NCT01386385|584001291|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714553|NCT01386385|584001292|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714554|NCT01386385|584001293|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
161714555|NCT01386385|584001294|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161714556|NCT01386385|584001287|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
161714557|NCT01386385|584001288|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
161714558|NCT01386385|584001289|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
161714559|NCT01386385|584001290|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
161714560|NCT01386385|584001291|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
161714561|NCT01386385|584001292|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
161714562|NCT01386385|584001293|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
161714563|NCT01386385|584001294|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
161714564|NCT03746080|584001296|FG000|Overall Study|In follow up|2|||
161714565|NCT03746080|584001296|FG000|Overall Study|Death|15|||
161714566|NCT02128490|584001300|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161714567|NCT02128490|584001301|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
161714568|NCT02128490|584001302|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
161714569|NCT02128490|584001303|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
161714570|NCT02128490|584001304|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
161714571|NCT02128490|584001300|FG000|Overall Study|Major Protocol Deviation|1|||
161714572|NCT02128490|584001301|FG001|Overall Study|Major Protocol Deviation|2|||
161714573|NCT02128490|584001302|FG002|Overall Study|Major Protocol Deviation|0|||
161714574|NCT02128490|584001303|FG003|Overall Study|Major Protocol Deviation|2|||
161714575|NCT02128490|584001304|FG004|Overall Study|Major Protocol Deviation|2|||
161714576|NCT02128490|584001300|FG000|Overall Study|Lost to Follow-up|0|||
161714577|NCT02128490|584001301|FG001|Overall Study|Lost to Follow-up|0|||
161714578|NCT02128490|584001302|FG002|Overall Study|Lost to Follow-up|1|||
161714579|NCT02128490|584001303|FG003|Overall Study|Lost to Follow-up|1|||
161714580|NCT02128490|584001304|FG004|Overall Study|Lost to Follow-up|1|||
161714581|NCT02128490|584001300|FG000|Overall Study|Voluntary Withdrawal|3|||
161714582|NCT02128490|584001301|FG001|Overall Study|Voluntary Withdrawal|3|||
161714583|NCT02128490|584001302|FG002|Overall Study|Voluntary Withdrawal|1|||
161714584|NCT02128490|584001303|FG003|Overall Study|Voluntary Withdrawal|1|||
161714585|NCT02128490|584001304|FG004|Overall Study|Voluntary Withdrawal|2|||
161714586|NCT02128490|584001300|FG000|Overall Study|Lack of Efficacy|0|||
161714587|NCT02128490|584001301|FG001|Overall Study|Lack of Efficacy|1|||
161714588|NCT02128490|584001302|FG002|Overall Study|Lack of Efficacy|0|||
161714589|NCT02128490|584001303|FG003|Overall Study|Lack of Efficacy|0|||
161714590|NCT02128490|584001304|FG004|Overall Study|Lack of Efficacy|0|||
161838010|NCT02032706|584450286|FG000|Overall Study|Protocol Violation|1|||
161714591|NCT02128490|584001300|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
161714592|NCT02128490|584001301|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
161714593|NCT02128490|584001302|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
161714594|NCT02128490|584001303|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
161714595|NCT02128490|584001304|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
161714596|NCT02128490|584001300|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161714597|NCT02128490|584001301|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161714598|NCT02128490|584001302|FG002|Overall Study|Other Miscellaneous Reasons|2|||
161714599|NCT02128490|584001303|FG003|Overall Study|Other Miscellaneous Reasons|1|||
161714600|NCT02128490|584001304|FG004|Overall Study|Other Miscellaneous Reasons|1|||
161714601|NCT02243176|584001305|FG000|Overall Study|Other reason|1|||
161714602|NCT02243176|584001306|FG001|Overall Study|Other reason|2|||
161714603|NCT02243176|584001305|FG000|Overall Study|protocol specified withdrawal critera|1|||
161714604|NCT02243176|584001306|FG001|Overall Study|protocol specified withdrawal critera|3|||
161714605|NCT02243176|584001305|FG000|Overall Study|Protocol Violation|2|||
161714606|NCT02243176|584001306|FG001|Overall Study|Protocol Violation|1|||
161714607|NCT02243176|584001305|FG000|Overall Study|Withdrawal by Subject|8|||
161714608|NCT02243176|584001306|FG001|Overall Study|Withdrawal by Subject|7|||
161714609|NCT02243176|584001305|FG000|Overall Study|Adverse Event|2|||
161714610|NCT02243176|584001306|FG001|Overall Study|Adverse Event|2|||
161714611|NCT03311126|584001308|FG000|Induction|Death|1|||
161714612|NCT03311126|584001308|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
161714613|NCT03113500|584001309|FG000|Overall Study|Withdrawal by Subject|1|||
161714614|NCT01348919|584001312|FG000|Overall Study|Adverse Event|3|||
161714615|NCT01348919|584001313|FG001|Overall Study|Adverse Event|1|||
161714616|NCT01348919|584001314|FG002|Overall Study|Adverse Event|0|||
161714617|NCT01348919|584001312|FG000|Overall Study|Withdrawal by Subject|0|||
161714618|NCT01348919|584001313|FG001|Overall Study|Withdrawal by Subject|1|||
161714619|NCT01348919|584001314|FG002|Overall Study|Withdrawal by Subject|0|||
161714620|NCT01348919|584001312|FG000|Overall Study|Disease progression|0|||
161714621|NCT01348919|584001313|FG001|Overall Study|Disease progression|1|||
161714622|NCT01348919|584001314|FG002|Overall Study|Disease progression|1|||
161714623|NCT02517515|584001315|FG000|Overall Study|Adverse Event|0|||
161714624|NCT02517515|584001316|FG001|Overall Study|Adverse Event|1|||
161714625|NCT02517515|584001315|FG000|Overall Study|Withdrew Consent|0|||
161714626|NCT02517515|584001316|FG001|Overall Study|Withdrew Consent|1|||
161714627|NCT02517515|584001315|FG000|Overall Study|Lost to Follow-up|1|||
161714628|NCT02517515|584001316|FG001|Overall Study|Lost to Follow-up|0|||
161714629|NCT02517515|584001315|FG000|Overall Study|Other|1|||
161714630|NCT02517515|584001316|FG001|Overall Study|Other|0|||
161714631|NCT03839524|584001320|FG000|Overall Study|Adverse Event|1|||
161714632|NCT05408858|584001321|FG000|Overall Study|no longer met eligibility criteria|1|||
161714633|NCT02037919|584001322|FG000|Overall Study|Lost to Follow-up|30|||
161714634|NCT02037919|584001323|FG001|Overall Study|Lost to Follow-up|45|||
161961818|NCT02993822|584905570|FG001|Overall Study|Withdrawal by Subject|2|||
161961819|NCT02993822|584905571|FG002|Overall Study|Withdrawal by Subject|2|||
161714635|NCT00886938|584001324|FG000|Overall Study|Adverse Event|1|||
161714636|NCT00886938|584001324|FG000|Overall Study|Withdrawal by Subject|1|||
161961820|NCT02993822|584905572|FG003|Overall Study|Withdrawal by Subject|3|||
161714637|NCT00917384|584001325|FG000|Overall Study|Lost to Follow-up|4|||
161714638|NCT00917384|584001326|FG001|Overall Study|Lost to Follow-up|2|||
161714639|NCT00917384|584001325|FG000|Overall Study|Withdrawal by Subject|10|||
161714640|NCT00917384|584001326|FG001|Overall Study|Withdrawal by Subject|2|||
161714641|NCT01458340|584001329|FG000|Overall Study|Adverse Event|5|||
161714642|NCT01458340|584001330|FG001|Overall Study|Adverse Event|4|||
161714643|NCT01458340|584001331|FG002|Overall Study|Adverse Event|2|||
161714644|NCT01458340|584001329|FG000|Overall Study|Lost to Follow-up|3|||
161714645|NCT01458340|584001330|FG001|Overall Study|Lost to Follow-up|3|||
161714646|NCT01458340|584001331|FG002|Overall Study|Lost to Follow-up|10|||
161714647|NCT01458340|584001329|FG000|Overall Study|Miscellaneous|0|||
161714648|NCT01458340|584001330|FG001|Overall Study|Miscellaneous|1|||
161714649|NCT01458340|584001331|FG002|Overall Study|Miscellaneous|0|||
161714650|NCT01458340|584001329|FG000|Overall Study|Physician Decision|1|||
161961821|NCT02993822|584905569|FG000|Overall Study|Lost to Follow-up|1|||
161714651|NCT01458340|584001330|FG001|Overall Study|Physician Decision|1|||
161961822|NCT02993822|584905570|FG001|Overall Study|Lost to Follow-up|0|||
161961823|NCT02993822|584905571|FG002|Overall Study|Lost to Follow-up|1|||
161961824|NCT02993822|584905572|FG003|Overall Study|Lost to Follow-up|0|||
161961825|NCT01221753|584905576|FG000|Overall Study|Adverse Event|1|||
161961826|NCT01939977|584905577|FG000|Overall Study|Adverse Event|4|||
161961827|NCT01939977|584905578|FG001|Overall Study|Adverse Event|3|||
161961828|NCT01939977|584905577|FG000|Overall Study|Lack of Efficacy|3|||
161961829|NCT01939977|584905578|FG001|Overall Study|Lack of Efficacy|0|||
161961830|NCT01939977|584905577|FG000|Overall Study|Physician Decision|1|||
161961831|NCT01939977|584905578|FG001|Overall Study|Physician Decision|1|||
161961832|NCT01939977|584905577|FG000|Overall Study|Withdrawal by Subject|0|||
161961833|NCT01939977|584905578|FG001|Overall Study|Withdrawal by Subject|2|||
161961834|NCT01939977|584905577|FG000|Overall Study|Did not meet inclusion criteria|1|||
161961835|NCT01939977|584905578|FG001|Overall Study|Did not meet inclusion criteria|0|||
161961836|NCT01939977|584905577|FG000|Overall Study|Did not receive study medication|0|||
161961837|NCT01939977|584905578|FG001|Overall Study|Did not receive study medication|1|||
161961838|NCT01603043|584905582|FG000|Overall Study|Study Futility|7|||
161961839|NCT01603043|584905583|FG001|Overall Study|Study Futility|3|||
161961840|NCT01696981|584905584|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
161961841|NCT01696981|584905585|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
161961842|NCT01696981|584905584|FG000|Overall Study|Died Before Randomization|3|||
161961843|NCT01696981|584905585|FG001|Overall Study|Died Before Randomization|8|||
161961844|NCT01696981|584905584|FG000|Overall Study|Died Before ASU (Control)|278|||
161961845|NCT01696981|584905585|FG001|Overall Study|Died Before ASU (Control)|0|||
161961846|NCT01696981|584905584|FG000|Overall Study|Refused ASU (Control)|920|||
161961847|NCT01696981|584905585|FG001|Overall Study|Refused ASU (Control)|0|||
161961848|NCT01696981|584905584|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
161961849|NCT01696981|584905585|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
161961850|NCT02798315|584905588|FG000|Overall Study|Failure to return|1|||
161961851|NCT00465972|584905589|FG000|Overall Study|Withdrawal by Subject|2|||
161961852|NCT00465972|584905590|FG001|Overall Study|Withdrawal by Subject|1|||
161961853|NCT03292640|584905591|FG000|Overall Study|Withdrawal by Subject|17|||
161961854|NCT03292640|584905592|FG001|Overall Study|Withdrawal by Subject|16|||
161961855|NCT03292640|584905591|FG000|Overall Study|Adverse Event|20|||
161961856|NCT03292640|584905592|FG001|Overall Study|Adverse Event|2|||
161961857|NCT03292640|584905591|FG000|Overall Study|Lost to Follow-up|24|||
161961858|NCT03292640|584905592|FG001|Overall Study|Lost to Follow-up|24|||
161961859|NCT00851890|584905593|FG000|Overall Study|Lost to Follow-up|0|||
161961860|NCT00851890|584905594|FG001|Overall Study|Lost to Follow-up|1|||
161961861|NCT00851890|584905595|FG002|Overall Study|Lost to Follow-up|0|||
161961862|NCT00851890|584905596|FG003|Overall Study|Lost to Follow-up|1|||
161961863|NCT03135431|584905597|FG000|Overall Study|Study Surgeon not available|2|||
161961864|NCT03135431|584905598|FG001|Overall Study|Study Surgeon not available|0|||
161961865|NCT02015481|584905599|FG000|Overall Study|Death|1|||
161961866|NCT02597452|584905601|FG000|Overall Study|testing incomplete|30|||
161961867|NCT03122145|584905602|FG000|Overall Study|Concurrent respiratory disease|3|||
161961868|NCT03122145|584905603|FG001|Overall Study|Concurrent respiratory disease|0|||
161961869|NCT02016716|584905608|FG000|Overall Study|Withdrawal by Subject|5|||
161961870|NCT02016716|584905609|FG001|Overall Study|Withdrawal by Subject|5|||
161961871|NCT02016716|584905610|FG002|Overall Study|Withdrawal by Subject|5|||
161961872|NCT02016716|584905608|FG000|Overall Study|Protocol-specified Criteria|0|||
161961873|NCT02016716|584905609|FG001|Overall Study|Protocol-specified Criteria|1|||
161961874|NCT02016716|584905610|FG002|Overall Study|Protocol-specified Criteria|0|||
161961875|NCT02016716|584905608|FG000|Overall Study|Lost to Follow-up|1|||
161961876|NCT02016716|584905609|FG001|Overall Study|Lost to Follow-up|2|||
161961877|NCT02016716|584905610|FG002|Overall Study|Lost to Follow-up|1|||
161961878|NCT00079391|584905611|FG000|Overall Study|Withdrawal by Subject|1|||
161961879|NCT01963767|584905612|FG000|Overall Study|Withdrawal by Subject|4|||
161961880|NCT01963767|584905613|FG001|Overall Study|Withdrawal by Subject|2|||
161961881|NCT01963767|584905612|FG000|Overall Study|Adverse Event|2|||
161961882|NCT01963767|584905613|FG001|Overall Study|Adverse Event|0|||
161961883|NCT01659996|584905614|FG000|Overall Study|Protocol Violation|3|||
161961884|NCT01659996|584905615|FG001|Overall Study|Protocol Violation|3|||
161961885|NCT01659996|584905616|FG002|Overall Study|Protocol Violation|3|||
161961886|NCT01659996|584905614|FG000|Overall Study|Lost to Follow-up|1|||
161961887|NCT01659996|584905615|FG001|Overall Study|Lost to Follow-up|3|||
161961888|NCT01659996|584905616|FG002|Overall Study|Lost to Follow-up|2|||
161961889|NCT01659996|584905614|FG000|Overall Study|Adverse Event|0|||
161961890|NCT01659996|584905615|FG001|Overall Study|Adverse Event|0|||
161961891|NCT01659996|584905616|FG002|Overall Study|Adverse Event|1|||
161961892|NCT01659996|584905614|FG000|Overall Study|Withdrawal by Subject|4|||
162031725|NCT02520089|585172479|FG000|Overall Study|Lost to Follow-up|3|||
161961893|NCT01659996|584905615|FG001|Overall Study|Withdrawal by Subject|1|||
161961894|NCT01659996|584905616|FG002|Overall Study|Withdrawal by Subject|5|||
161961895|NCT03206918|584905617|FG000|Overall Study|Death|11|||
161961896|NCT03206918|584905617|FG000|Overall Study|Withdrawal by Subject|5|||
162031726|NCT02520089|585172480|FG001|Overall Study|Lost to Follow-up|4|||
162031727|NCT04085367|585174059|FG000|Overall Study|Adverse Event|1|||
162031728|NCT04085367|585174060|FG001|Overall Study|Adverse Event|1|||
162031729|NCT04085367|585174059|FG000|Overall Study|Withdrawal by Subject|13|||
162031730|NCT04085367|585174060|FG001|Overall Study|Withdrawal by Subject|4|||
162031731|NCT04085367|585174059|FG000|Overall Study|Lost to Follow-up|3|||
162031732|NCT04085367|585174060|FG001|Overall Study|Lost to Follow-up|1|||
162031733|NCT04085367|585174059|FG000|Overall Study|Other unspecified|2|||
162031734|NCT04085367|585174060|FG001|Overall Study|Other unspecified|1|||
162031735|NCT04085367|585174059|FG000|Overall Study|Status Unknown|1|||
162031736|NCT04085367|585174060|FG001|Overall Study|Status Unknown|1|||
162031737|NCT00130442|585174064|FG000|Overall Study|Withdrawal by Subject|0|||
162031738|NCT00130442|585174065|FG001|Overall Study|Withdrawal by Subject|1|||
162031739|NCT00130442|585174064|FG000|Overall Study|did not meet criteria|1|||
162031740|NCT00130442|585174065|FG001|Overall Study|did not meet criteria|1|||
162031741|NCT00814333|585174066|FG000|Enrollment|Lost to Follow-up|1|||
162031742|NCT00814333|585174067|FG001|Enrollment|Lost to Follow-up|0|||
162031743|NCT02233946|585174068|FG000|Baseline|Withdrawal by Subject|2|||
162031744|NCT02233946|585174069|FG001|Baseline|Withdrawal by Subject|0|||
162031745|NCT02233946|585174068|FG000|3-months Follow-up|Lost to Follow-up|53|||
162031746|NCT02233946|585174069|FG001|3-months Follow-up|Lost to Follow-up|29|||
162031747|NCT02233946|585174068|FG000|6-months Follow-up|Lost to Follow-up|21|||
162031748|NCT02233946|585174069|FG001|6-months Follow-up|Lost to Follow-up|2|||
162031749|NCT02233946|585174068|FG000|9-month Follow-up|Lost to Follow-up|20|||
162031750|NCT02233946|585174069|FG001|9-month Follow-up|Lost to Follow-up|11|||
162031751|NCT02233946|585174068|FG000|12-month Follow-up|Lost to Follow-up|28|||
162031752|NCT02233946|585174069|FG001|12-month Follow-up|Lost to Follow-up|11|||
162031753|NCT01527357|585174070|FG000|Overall Study|Death|8|||
162031754|NCT01527357|585174071|FG001|Overall Study|Death|2|||
162031755|NCT01527357|585174070|FG000|Overall Study|Lost to Follow-up|6|||
162031756|NCT01527357|585174071|FG001|Overall Study|Lost to Follow-up|4|||
162031757|NCT01527357|585174070|FG000|Overall Study|Withdrew Consent|1|||
162031758|NCT01527357|585174071|FG001|Overall Study|Withdrew Consent|1|||
162031759|NCT01527357|585174070|FG000|Overall Study|Non-compliance|0|||
162031760|NCT01527357|585174071|FG001|Overall Study|Non-compliance|1|||
162031761|NCT01527357|585174070|FG000|Overall Study|No Day 29 Visit|0|||
161714652|NCT01458340|584001331|FG002|Overall Study|Physician Decision|2|||
161714653|NCT01458340|584001329|FG000|Overall Study|Protocol Violation|6|||
162031762|NCT01527357|585174071|FG001|Overall Study|No Day 29 Visit|1|||
162031763|NCT01527357|585174070|FG000|Overall Study|Did Not Receive Treatment|2|||
161714654|NCT01458340|584001330|FG001|Overall Study|Protocol Violation|6|||
161714655|NCT01458340|584001331|FG002|Overall Study|Protocol Violation|5|||
161714656|NCT01458340|584001329|FG000|Overall Study|Withdrawal by Subject|12|||
161714657|NCT01458340|584001330|FG001|Overall Study|Withdrawal by Subject|6|||
161714658|NCT01458340|584001331|FG002|Overall Study|Withdrawal by Subject|4|||
161714659|NCT01021007|584001334|FG000|Overall Study|Lost to Follow-up|1|||
161714660|NCT01021007|584001335|FG001|Overall Study|Lost to Follow-up|1|||
161961897|NCT03206918|584905617|FG000|Overall Study|Study terminated by sponsor|12|||
161961898|NCT03206918|584905617|FG000|Overall Study|Lost to Follow-up|3|||
161961899|NCT03206918|584905617|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
161961900|NCT02709577|584905618|FG000|Overall Study|non-accommodating anatomy|0|||
161961901|NCT02709577|584905619|FG001|Overall Study|non-accommodating anatomy|1|||
161961902|NCT02709577|584905620|FG002|Overall Study|non-accommodating anatomy|0|||
161961903|NCT02709577|584905621|FG003|Overall Study|non-accommodating anatomy|0|||
161961904|NCT02709577|584905618|FG000|Overall Study|procedural complication|0|||
161961905|NCT02709577|584905619|FG001|Overall Study|procedural complication|1|||
161961906|NCT02709577|584905620|FG002|Overall Study|procedural complication|0|||
161961907|NCT02709577|584905621|FG003|Overall Study|procedural complication|0|||
161961908|NCT02709577|584905618|FG000|Overall Study|Withdrawal by Subject|2|||
161961909|NCT02709577|584905619|FG001|Overall Study|Withdrawal by Subject|3|||
161961910|NCT02709577|584905620|FG002|Overall Study|Withdrawal by Subject|2|||
161961911|NCT02709577|584905621|FG003|Overall Study|Withdrawal by Subject|0|||
161961912|NCT02701764|584905622|FG000|Overall Study|Lost to Follow-up|0|||
161961913|NCT02701764|584905623|FG001|Overall Study|Lost to Follow-up|1|||
161961914|NCT03108521|584905626|FG000|Overall Study|Lost to Follow-up|3|||
161961915|NCT03108521|584905627|FG001|Overall Study|Lost to Follow-up|0|||
161961916|NCT03108521|584905626|FG000|Overall Study|Lack of Efficacy|2|||
161961917|NCT03108521|584905627|FG001|Overall Study|Lack of Efficacy|0|||
161961918|NCT03108521|584905626|FG000|Overall Study|Physician Decision|4|||
161961919|NCT03108521|584905627|FG001|Overall Study|Physician Decision|0|||
161961920|NCT03108521|584905626|FG000|Overall Study|Adverse Event|3|||
161961921|NCT03108521|584905627|FG001|Overall Study|Adverse Event|0|||
161961922|NCT03281629|584905634|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
161961923|NCT03281629|584905635|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
161961924|NCT03281629|584905634|FG000|Overall Study|Death|0|||
161961925|NCT03281629|584905635|FG001|Overall Study|Death|1|||
161961926|NCT03281629|584905634|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
161961927|NCT03281629|584905635|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
161961928|NCT01170273|584905641|FG000|Overall Study|Lost to Follow-up|6|||
161961929|NCT01170273|584905642|FG001|Overall Study|Lost to Follow-up|8|||
161961930|NCT01170273|584905641|FG000|Overall Study|Protocol Violation|1|||
161961931|NCT01170273|584905642|FG001|Overall Study|Protocol Violation|0|||
161961932|NCT01170273|584905641|FG000|Overall Study|Death|1|||
161961933|NCT01170273|584905642|FG001|Overall Study|Death|0|||
161961934|NCT01170273|584905641|FG000|Overall Study|Adverse Event|0|||
161961935|NCT01170273|584905642|FG001|Overall Study|Adverse Event|1|||
161961936|NCT00301262|584907517|FG000|Double Blind Phase (DB)|Adverse Event|1|||
161961937|NCT00301262|584907518|FG001|Double Blind Phase (DB)|Adverse Event|0|||
161961938|NCT00301262|584907517|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
161961939|NCT00301262|584907518|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
161961940|NCT00301262|584907517|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
161961941|NCT00301262|584907518|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
161961942|NCT00301262|584907517|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
161961943|NCT00301262|584907518|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
161961944|NCT00301262|584907517|FG000|Double Blind Phase (DB)|Other|1|||
161961945|NCT00301262|584907518|FG001|Double Blind Phase (DB)|Other|4|||
161961946|NCT00301262|584907517|FG000|Open Label Phase (OL)|Adverse Event|1|||
161961947|NCT00301262|584907518|FG001|Open Label Phase (OL)|Adverse Event|0|||
161961948|NCT00301262|584907517|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
161961949|NCT00301262|584907518|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
161961950|NCT00301262|584907517|FG000|Open Label Phase (OL)|Other|2|||
161961951|NCT00301262|584907518|FG001|Open Label Phase (OL)|Other|0|||
161961952|NCT03530995|584907519|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
161961953|NCT03530995|584907520|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
161961954|NCT03530995|584907519|FG000|Part 1 Period 3|Protocol Violation|1|||
161961955|NCT03530995|584907520|FG001|Part 1 Period 3|Protocol Violation|0|||
161961956|NCT03530995|584907519|FG000|Part 1 Period 4|Physician Decision|1|||
161961957|NCT03530995|584907520|FG001|Part 1 Period 4|Physician Decision|0|||
161961958|NCT03530995|584907519|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
161714661|NCT01021007|584001334|FG000|Overall Study|Adverse Event|1|||
161961959|NCT03530995|584907520|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
161961960|NCT01443364|584907528|FG000|Overall Study|Lack of Efficacy|14|||
161961961|NCT01443364|584907528|FG000|Overall Study|Lost to Follow-up|3|||
161961962|NCT01443364|584907528|FG000|Overall Study|Withdrawal by Subject|5|||
161961963|NCT01443364|584907528|FG000|Overall Study|Other Reason|4|||
161961964|NCT01443364|584907528|FG000|Overall Study|SAE, non-fatal|6|||
161714662|NCT01021007|584001335|FG001|Overall Study|Adverse Event|3|||
161714663|NCT00947154|584001338|FG000|Overall Study|Lost to Follow-up|1|||
161714664|NCT03293030|584001341|FG000|Overall Study|Withdrawal by Subject|3|||
161714665|NCT04899271|584001342|FG000|Overall Study|Lost to Follow-up|1|||
161961965|NCT01443364|584907528|FG000|Overall Study|AE, non-serious non-fatal|8|||
161961966|NCT01443364|584907528|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161961967|NCT02650804|584907529|FG000|Overall Study|Adverse Event|3|||
161961968|NCT02650804|584907530|FG001|Overall Study|Adverse Event|2|||
161961969|NCT02650804|584907529|FG000|Overall Study|Death|1|||
161961970|NCT02650804|584907530|FG001|Overall Study|Death|2|||
161961971|NCT02650804|584907529|FG000|Overall Study|Progressive Disease|7|||
161961972|NCT02650804|584907530|FG001|Overall Study|Progressive Disease|10|||
161961973|NCT02650804|584907529|FG000|Overall Study|Physician Decision|0|||
161961974|NCT02650804|584907530|FG001|Overall Study|Physician Decision|2|||
161961975|NCT02650804|584907529|FG000|Overall Study|Withdrawal by Subject|1|||
161961976|NCT02650804|584907530|FG001|Overall Study|Withdrawal by Subject|4|||
161961977|NCT02650804|584907529|FG000|Overall Study|Symptomatic deterioration|5|||
161961978|NCT02650804|584907530|FG001|Overall Study|Symptomatic deterioration|7|||
161961979|NCT02650804|584907529|FG000|Overall Study|Protocol Violation|0|||
161961980|NCT02650804|584907530|FG001|Overall Study|Protocol Violation|1|||
161961981|NCT01986231|584907535|FG000|Overall Study|Adverse Event|1|||
161961982|NCT02150057|584907536|FG000|Overall Study|Lost to Follow-up|6|||
161961983|NCT02150057|584907537|FG001|Overall Study|Lost to Follow-up|4|||
161961984|NCT02388165|584907538|FG000|Overall Study|Study terminated by sponsor|5|||
161961985|NCT02388165|584907539|FG001|Overall Study|Study terminated by sponsor|5|||
161961986|NCT02388165|584907538|FG000|Overall Study|Other|11|||
161961987|NCT02388165|584907539|FG001|Overall Study|Other|13|||
161961988|NCT02388165|584907538|FG000|Overall Study|No longer meet eligibility criteria|40|||
161961989|NCT02388165|584907539|FG001|Overall Study|No longer meet eligibility criteria|43|||
161961990|NCT02388165|584907538|FG000|Overall Study|Withdrawal of consent|31|||
161961991|NCT02388165|584907539|FG001|Overall Study|Withdrawal of consent|32|||
161961992|NCT02388165|584907538|FG000|Overall Study|Lost to Follow-up|19|||
161961993|NCT02388165|584907539|FG001|Overall Study|Lost to Follow-up|20|||
161961994|NCT02388165|584907538|FG000|Overall Study|Death|13|||
161961995|NCT02388165|584907539|FG001|Overall Study|Death|10|||
161961996|NCT02388165|584907538|FG000|Overall Study|Adverse Event|3|||
161961997|NCT02388165|584907539|FG001|Overall Study|Adverse Event|5|||
161961998|NCT02388165|584907538|FG000|Overall Study|Did not meet entrance criteria|5|||
161961999|NCT02388165|584907539|FG001|Overall Study|Did not meet entrance criteria|2|||
161962000|NCT04551963|584907543|FG000|Overall Study|Physician Decision|1|||
161962001|NCT04551963|584907544|FG001|Overall Study|Physician Decision|1|||
161962002|NCT04551963|584907543|FG000|Overall Study|Death|1|||
161962003|NCT04551963|584907544|FG001|Overall Study|Death|0|||
161962004|NCT02974855|584907545|FG000|Overall Study|Adverse Event|0|||
161962005|NCT02974855|584907546|FG001|Overall Study|Adverse Event|1|||
161962006|NCT02974855|584907547|FG002|Overall Study|Adverse Event|0|||
161962007|NCT02974855|584907548|FG003|Overall Study|Adverse Event|1|||
161962008|NCT01474772|584907549|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
161962009|NCT01474772|584907550|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
161962010|NCT01474772|584907549|FG000|Period 1|AE not Related to Study Drug|1|||
161962011|NCT01474772|584907550|FG001|Period 1|AE not Related to Study Drug|0|||
161962012|NCT01474772|584907549|FG000|Period 1|Withdrawal by Subject|3|||
161962013|NCT01474772|584907550|FG001|Period 1|Withdrawal by Subject|1|||
161962014|NCT01474772|584907549|FG000|Period 1|Lost to Follow-up|1|||
161962015|NCT01474772|584907550|FG001|Period 1|Lost to Follow-up|0|||
161962016|NCT01474772|584907549|FG000|Period 1|Reason not Specified|1|||
161962017|NCT01474772|584907550|FG001|Period 1|Reason not Specified|1|||
161714666|NCT04899271|584001343|FG001|Overall Study|Lost to Follow-up|0|||
161714667|NCT04899271|584001342|FG000|Overall Study|Subject request/consent withdrawal|2|||
161714668|NCT04899271|584001343|FG001|Overall Study|Subject request/consent withdrawal|0|||
161714669|NCT00900796|584001344|FG000|Phase 1|Lacked sufficient information|4|||
161962018|NCT01474772|584907549|FG000|Washout|AE not Related to Study Drug|2|||
161962019|NCT01474772|584907550|FG001|Washout|AE not Related to Study Drug|0|||
161962020|NCT01474772|584907549|FG000|Washout|Withdrawal by Subject|1|||
161962021|NCT01474772|584907550|FG001|Washout|Withdrawal by Subject|0|||
161962022|NCT01474772|584907549|FG000|Washout|Lost to Follow-up|0|||
161962023|NCT01474772|584907550|FG001|Washout|Lost to Follow-up|1|||
161962024|NCT01474772|584907549|FG000|Washout|Reason not Specified|0|||
161962025|NCT01474772|584907550|FG001|Washout|Reason not Specified|1|||
161962026|NCT01474772|584907549|FG000|Period 2|Death|0|||
161962027|NCT01474772|584907550|FG001|Period 2|Death|1|||
161962028|NCT01474772|584907549|FG000|Period 2|AE Related to Study Drug|0|||
161962029|NCT01474772|584907550|FG001|Period 2|AE Related to Study Drug|1|||
161962030|NCT01474772|584907549|FG000|Period 2|AE not Related to Study Drug|4|||
161962031|NCT01474772|584907550|FG001|Period 2|AE not Related to Study Drug|1|||
161714670|NCT00900796|584001344|FG000|Phase 1|Missing information at Week 16|7|||
161962032|NCT01474772|584907549|FG000|Period 2|Lack of Efficacy|1|||
161962033|NCT01474772|584907550|FG001|Period 2|Lack of Efficacy|0|||
161962034|NCT01474772|584907549|FG000|Period 2|Withdrawal by Subject|3|||
161962035|NCT01474772|584907550|FG001|Period 2|Withdrawal by Subject|4|||
161714671|NCT00900796|584001344|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
161714672|NCT00900796|584001344|FG000|Phase 2|Lost to Follow-up|5|||
161714673|NCT02318602|584001346|FG000|Overall Study|Adverse Event|0|||
161714674|NCT02318602|584001347|FG001|Overall Study|Adverse Event|1|||
161714675|NCT02318602|584001348|FG002|Overall Study|Adverse Event|1|||
161714676|NCT02318602|584001346|FG000|Overall Study|Withdrawal by Subject|0|||
161714677|NCT02318602|584001347|FG001|Overall Study|Withdrawal by Subject|3|||
161714678|NCT02318602|584001348|FG002|Overall Study|Withdrawal by Subject|0|||
161714679|NCT02318602|584001346|FG000|Overall Study|Death|1|||
161714680|NCT02318602|584001347|FG001|Overall Study|Death|0|||
161714681|NCT02318602|584001348|FG002|Overall Study|Death|0|||
161714682|NCT02318602|584001346|FG000|Overall Study|Guardian decision to withdraw|0|||
161714683|NCT02318602|584001347|FG001|Overall Study|Guardian decision to withdraw|0|||
161714684|NCT02318602|584001348|FG002|Overall Study|Guardian decision to withdraw|1|||
161714685|NCT00693706|584001349|FG000|Overall Study|Protocol Violation|0|||
161714686|NCT00693706|584001350|FG001|Overall Study|Protocol Violation|1|||
161714687|NCT01733329|584001351|FG000|Overall Study|Protocol Violation|1|||
161714688|NCT01733329|584001352|FG001|Overall Study|Protocol Violation|1|||
161714689|NCT01733329|584001351|FG000|Overall Study|Uterine artery injury|1|||
161714690|NCT01733329|584001352|FG001|Overall Study|Uterine artery injury|0|||
161714691|NCT00730236|584001353|FG000|Overall Study|Adverse Event|4|||
161714692|NCT00730236|584001353|FG000|Overall Study|Withdrawal by Subject|1|||
161714693|NCT00730236|584001353|FG000|Overall Study|Non-compliance|1|||
161714694|NCT00498173|584001356|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
161714695|NCT00498173|584001357|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
161714696|NCT00498173|584001358|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
161714697|NCT00542828|584001361|FG000|Overall Study|Physician Decision|1|||
161714698|NCT00542828|584001361|FG000|Overall Study|Need for Prohibited Treatment|3|||
161714699|NCT00542828|584001361|FG000|Overall Study|Study Prematurely Discontinued|7|||
161714700|NCT00542828|584001361|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
161714701|NCT00095303|584001362|FG000|Main Study|Lost to Follow-up|91|||
161714702|NCT00095303|584001363|FG001|Main Study|Lost to Follow-up|87|||
161714703|NCT00095303|584001362|FG000|Follow Up Study|Lost to Follow-up|59|||
161714704|NCT00095303|584001363|FG001|Follow Up Study|Lost to Follow-up|58|||
161714705|NCT03228186|584001364|FG000|Overall Study|Patient never started treatment|1|||
161714706|NCT01634243|584001367|FG000|Overall Study|Adverse Event|5|||
161714707|NCT01634243|584001368|FG001|Overall Study|Adverse Event|5|||
161714708|NCT01634243|584001367|FG000|Overall Study|Lack of Efficacy|1|||
161714709|NCT01634243|584001368|FG001|Overall Study|Lack of Efficacy|0|||
161714710|NCT03953118|584001369|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
161714711|NCT03953118|584001370|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
161714712|NCT00258154|584001371|FG000|Overall Study|Adverse Event|1|||
161714713|NCT00258154|584001372|FG001|Overall Study|Adverse Event|0|||
161714714|NCT00258154|584001371|FG000|Overall Study|Lost to Follow-up|0|||
161714715|NCT00258154|584001372|FG001|Overall Study|Lost to Follow-up|1|||
161714716|NCT00258154|584001371|FG000|Overall Study|Protocol Violation|2|||
161714717|NCT00258154|584001372|FG001|Overall Study|Protocol Violation|1|||
161714718|NCT00258154|584001371|FG000|Overall Study|Withdrawal by Subject|3|||
161714719|NCT00258154|584001372|FG001|Overall Study|Withdrawal by Subject|4|||
161714720|NCT00258154|584001371|FG000|Overall Study|Patient Moved|3|||
161714721|NCT00258154|584001372|FG001|Overall Study|Patient Moved|1|||
161714722|NCT05139030|584001375|FG000|Overall Study|Withdrawal by Subject|1|||
161714723|NCT05139030|584001376|FG001|Overall Study|Withdrawal by Subject|3|||
161714724|NCT05139030|584001375|FG000|Overall Study|Adverse Event|0|||
161714725|NCT05139030|584001376|FG001|Overall Study|Adverse Event|1|||
161714726|NCT05139030|584001375|FG000|Overall Study|Failure to meet continuation criteria|0|||
161714727|NCT05139030|584001376|FG001|Overall Study|Failure to meet continuation criteria|1|||
161714728|NCT00613626|584001384|FG000|Overall Study|Ineligible|0|||
161714729|NCT00613626|584001385|FG001|Overall Study|Ineligible|1|||
161714730|NCT00613626|584001386|FG002|Overall Study|Ineligible|0|||
161714731|NCT00816036|584001387|FG000|Overall Study|Death|47|||
161714732|NCT00816036|584001388|FG001|Overall Study|Death|28|||
161962036|NCT01474772|584907549|FG000|Period 2|Lost to Follow-up|1|||
161962037|NCT01474772|584907550|FG001|Period 2|Lost to Follow-up|1|||
161962038|NCT01474772|584907549|FG000|Period 2|Reason not Specified|0|||
161962039|NCT01474772|584907550|FG001|Period 2|Reason not Specified|2|||
161962040|NCT01474772|584907549|FG000|Follow-up|AE not Related to Study Drug|0|||
161962041|NCT01474772|584907550|FG001|Follow-up|AE not Related to Study Drug|1|||
161962042|NCT00633074|584907551|FG000|Overall Study|Adverse Event|1|||
161962043|NCT00633074|584907552|FG001|Overall Study|Adverse Event|0|||
161962044|NCT00365105|584907553|FG000|Overall Study|Protocol Violation|5|||
161962045|NCT00365105|584907554|FG001|Overall Study|Protocol Violation|8|||
161962046|NCT00748618|584907555|FG000|Overall Study|Adverse Event|1|||
161962047|NCT00748618|584907556|FG001|Overall Study|Adverse Event|0|||
161962048|NCT06004895|584907557|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
161962049|NCT06004895|584907557|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
161962050|NCT00466947|584907558|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
161962051|NCT00466947|584907559|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
161962052|NCT00466947|584907558|FG000|Study End Analysis Period|Adverse Event|35|||
161962053|NCT00466947|584907559|FG001|Study End Analysis Period|Adverse Event|43|||
161962054|NCT00466947|584907558|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
161962055|NCT00466947|584907559|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
161962056|NCT00466947|584907558|FG000|Study End Analysis Period|Physician Decision|29|||
161962057|NCT00466947|584907559|FG001|Study End Analysis Period|Physician Decision|29|||
161714733|NCT00816036|584001387|FG000|Overall Study|Lost to Follow-up|75|||
161714734|NCT00816036|584001388|FG001|Overall Study|Lost to Follow-up|57|||
161714735|NCT00816036|584001387|FG000|Overall Study|Withdrawal by Subject|54|||
161714736|NCT00816036|584001388|FG001|Overall Study|Withdrawal by Subject|23|||
161714737|NCT00004980|584001389|FG000|Overall Study|Withdrawal by Subject|1|||
161714738|NCT00004980|584001390|FG001|Overall Study|Withdrawal by Subject|0|||
161714739|NCT00004980|584001389|FG000|Overall Study|memory difficulties|1|||
161714740|NCT00004980|584001390|FG001|Overall Study|memory difficulties|1|||
161714741|NCT00004980|584001389|FG000|Overall Study|Physician Decision|0|||
161714742|NCT00004980|584001390|FG001|Overall Study|Physician Decision|1|||
161962058|NCT00466947|584907558|FG000|Study End Analysis Period|Protocol Violation|9|||
161962059|NCT00466947|584907559|FG001|Study End Analysis Period|Protocol Violation|17|||
161962060|NCT00466947|584907558|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
161962061|NCT00466947|584907559|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
161714743|NCT01299025|584001391|FG000|Overall Study|Withdrawal by Subject|2|||
161714744|NCT01299025|584001392|FG001|Overall Study|Withdrawal by Subject|1|||
161714745|NCT01299025|584001391|FG000|Overall Study|Lost to Follow-up|1|||
161714746|NCT01299025|584001392|FG001|Overall Study|Lost to Follow-up|0|||
161714747|NCT01624194|584001393|FG000|Overall Study|Lost to Follow-up|1|||
161714748|NCT01624194|584001394|FG001|Overall Study|Lost to Follow-up|0|||
161714749|NCT01624194|584001393|FG000|Overall Study|Withdrawal by Subject|1|||
161714750|NCT01624194|584001394|FG001|Overall Study|Withdrawal by Subject|0|||
161714751|NCT03212261|584001398|FG000|Overall Study|Became ineligible d/t tech|2|||
161714752|NCT03212261|584001398|FG000|Overall Study|Tech Trouble- No first study visit|1|||
161714753|NCT03212261|584001398|FG000|Overall Study|Lost to Follow-up|7|||
161714754|NCT03212261|584001398|FG000|Overall Study|Family Emergency|1|||
161714755|NCT03212261|584001398|FG000|Overall Study|Too busy/ No time|5|||
161714756|NCT05480514|584001399|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
161714757|NCT05480514|584001400|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
161714758|NCT05480514|584001399|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
161714759|NCT05480514|584001400|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
161714760|NCT05480514|584001399|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
161714761|NCT05480514|584001400|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
161714762|NCT05480514|584001399|FG000|Period 1|Covid-19 Related|1|||
161714763|NCT05480514|584001400|FG001|Period 1|Covid-19 Related|0|||
161714764|NCT05480514|584001399|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
161714765|NCT05480514|584001400|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
161714766|NCT00820040|584001407|FG000|Overall Study|Death|1|||
161714767|NCT00820040|584001407|FG000|Overall Study|Sponsor terminated study|1|||
161714768|NCT00820040|584001407|FG000|Overall Study|Screen failure|1|||
161714769|NCT01259466|584001410|FG000|Overall Study|Withdrawal by Subject|1|||
161714770|NCT01259466|584001411|FG001|Overall Study|Withdrawal by Subject|9|||
161714771|NCT03914300|584001412|FG000|Overall Study|Adverse Event|1|||
161714772|NCT00457639|584001418|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
161714773|NCT00457639|584001419|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
161714774|NCT00457639|584001418|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
161714775|NCT00457639|584001419|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
161714776|NCT00457639|584001418|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
161714777|NCT00457639|584001419|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
161962062|NCT00466947|584907558|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
161962063|NCT00466947|584907559|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
161962064|NCT00466947|584907558|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
161962065|NCT00466947|584907559|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
161962066|NCT00466947|584907558|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
161962067|NCT00466947|584907559|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
161962068|NCT00878254|584907560|FG000|Overall Study|Physician Decision|1|||
161962069|NCT00878254|584907560|FG000|Overall Study|Death|1|||
161962070|NCT00878254|584907560|FG000|Overall Study|Withdrawal by Subject|1|||
161962071|NCT01995526|584907561|FG000|Overall Study|Physician Decision|1|||
161962072|NCT03367403|584907566|FG000|Overall Study|Adverse Event|20|||
161714778|NCT03885284|584001420|FG000|Overall Study|Disease Progression|1|||
161714779|NCT03885284|584001421|FG001|Overall Study|Disease Progression|3|||
161714780|NCT03885284|584001420|FG000|Overall Study|Physician Decision|0|||
161714781|NCT03885284|584001421|FG001|Overall Study|Physician Decision|1|||
161714782|NCT00002850|584001426|FG000|Overall Study|Death|4|||
161714783|NCT00002850|584001427|FG001|Overall Study|Death|1|||
161714784|NCT00002850|584001428|FG002|Overall Study|Death|3|||
161714785|NCT00002850|584001426|FG000|Overall Study|Protocol Violation|1|||
161714786|NCT00002850|584001427|FG001|Overall Study|Protocol Violation|0|||
161714787|NCT00002850|584001428|FG002|Overall Study|Protocol Violation|1|||
161714788|NCT00002850|584001426|FG000|Overall Study|Withdrawal by Subject|0|||
161962073|NCT03367403|584907567|FG001|Overall Study|Adverse Event|6|||
161714789|NCT00002850|584001427|FG001|Overall Study|Withdrawal by Subject|1|||
161714790|NCT00002850|584001428|FG002|Overall Study|Withdrawal by Subject|0|||
161962074|NCT03367403|584907568|FG002|Overall Study|Adverse Event|2|||
161714791|NCT02932267|584001429|FG000|Overall Study|Withdrawal by Subject|3|||
161714792|NCT02932267|584001429|FG000|Overall Study|Lost to Follow-up|4|||
161714793|NCT02932267|584001429|FG000|Overall Study|Pregnancy|1|||
161714794|NCT03476239|584001430|FG000|Overall Study|Withdrawal by Subject|10|||
161962075|NCT03367403|584907566|FG000|Overall Study|Withdrawal by Subject|12|||
161962076|NCT03367403|584907567|FG001|Overall Study|Withdrawal by Subject|13|||
161962077|NCT03367403|584907568|FG002|Overall Study|Withdrawal by Subject|1|||
161962078|NCT03367403|584907566|FG000|Overall Study|Death|1|||
161962079|NCT03367403|584907567|FG001|Overall Study|Death|2|||
161962080|NCT03367403|584907568|FG002|Overall Study|Death|0|||
161962081|NCT03367403|584907566|FG000|Overall Study|Physician Decision|0|||
161962082|NCT03367403|584907567|FG001|Overall Study|Physician Decision|1|||
161962083|NCT03367403|584907568|FG002|Overall Study|Physician Decision|0|||
161962084|NCT03367403|584907566|FG000|Overall Study|Protocol Violation|1|||
161962085|NCT03367403|584907567|FG001|Overall Study|Protocol Violation|1|||
161962086|NCT03367403|584907568|FG002|Overall Study|Protocol Violation|0|||
161962087|NCT03367403|584907566|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161962088|NCT03367403|584907567|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
161962089|NCT03367403|584907568|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161962090|NCT03367403|584907566|FG000|Overall Study|COVID-19|3|||
161962091|NCT03367403|584907567|FG001|Overall Study|COVID-19|6|||
161962092|NCT03367403|584907568|FG002|Overall Study|COVID-19|0|||
161962093|NCT03367403|584907566|FG000|Overall Study|Abuse of Alcohol Intake|0|||
161962094|NCT03367403|584907567|FG001|Overall Study|Abuse of Alcohol Intake|1|||
161962095|NCT03367403|584907568|FG002|Overall Study|Abuse of Alcohol Intake|0|||
161962096|NCT03367403|584907566|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
161962097|NCT03367403|584907567|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
161962098|NCT03367403|584907568|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
161962099|NCT02321319|584907573|FG000|Overall Study|Product discontinued|5|||
161962100|NCT03497975|584907576|FG000|Overall Study|Withdrew Consent|34|||
161962101|NCT03497975|584907577|FG001|Overall Study|Withdrew Consent|35|||
161962102|NCT03497975|584907576|FG000|Overall Study|Lost to Follow-up|7|||
161962103|NCT03497975|584907577|FG001|Overall Study|Lost to Follow-up|7|||
161962104|NCT03497975|584907576|FG000|Overall Study|Physician Decision|4|||
161962105|NCT03497975|584907577|FG001|Overall Study|Physician Decision|5|||
161962106|NCT03497975|584907576|FG000|Overall Study|Discontinued|42|||
161962107|NCT03497975|584907577|FG001|Overall Study|Discontinued|39|||
161962108|NCT03497975|584907576|FG000|Overall Study|Reason Not Specified|15|||
161962109|NCT03497975|584907577|FG001|Overall Study|Reason Not Specified|14|||
161962110|NCT02141399|584907580|FG000|Overall Study|Adverse Event|158|||
161962111|NCT02141399|584907580|FG000|Overall Study|Lack of Efficacy|62|||
161962112|NCT02141399|584907580|FG000|Overall Study|Lost to Follow-up|151|||
161962113|NCT02141399|584907580|FG000|Overall Study|Non-compliance with study drug|18|||
161962114|NCT02141399|584907580|FG000|Overall Study|Other|45|||
161962115|NCT02141399|584907580|FG000|Overall Study|Physician Decision|17|||
161962116|NCT02141399|584907580|FG000|Overall Study|Pregnancy|3|||
161962117|NCT02141399|584907580|FG000|Overall Study|Protocol Violation|38|||
161962118|NCT02141399|584907580|FG000|Overall Study|Withdrawal by Subject|238|||
161962119|NCT02141399|584907580|FG000|Overall Study|Failure to meet eligibility criteria|14|||
161962120|NCT02516098|584907586|FG000|Period 1|Protocol Violation|1|||
161962121|NCT02516098|584907587|FG001|Period 1|Protocol Violation|0|||
161962122|NCT02516098|584907586|FG000|Washout After Period 1|Adverse Event|0|||
161962123|NCT02516098|584907587|FG001|Washout After Period 1|Adverse Event|1|||
161962124|NCT02516098|584907586|FG000|Period 2|Withdrawal by Subject|0|||
161962125|NCT02516098|584907587|FG001|Period 2|Withdrawal by Subject|1|||
161714795|NCT03476239|584001430|FG000|Overall Study|Death|80|||
161714796|NCT03476239|584001430|FG000|Overall Study|Lost to Follow-up|8|||
161714797|NCT03750838|584001433|FG000|Overall Study|Lost to Follow-up|10|||
161962126|NCT01092780|584907588|FG000|Washout Period 1|Adverse Event|0|||
161962127|NCT01092780|584907589|FG001|Washout Period 1|Adverse Event|1|||
161962128|NCT01092780|584907590|FG002|Washout Period 1|Adverse Event|0|||
161962129|NCT01092780|584907591|FG003|Washout Period 1|Adverse Event|0|||
161962130|NCT01092780|584907588|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
161714798|NCT03750838|584001434|FG001|Overall Study|Lost to Follow-up|6|||
161714799|NCT00630032|584001437|FG000|Overall Study|Death|55|||
161962131|NCT01092780|584907589|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
161714800|NCT00630032|584001438|FG001|Overall Study|Death|49|||
161962132|NCT01092780|584907590|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
161962133|NCT01092780|584907591|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
161962134|NCT01092780|584907588|FG000|Washout Period 2|Adverse Event|0|||
161962135|NCT01092780|584907589|FG001|Washout Period 2|Adverse Event|1|||
161962136|NCT01092780|584907590|FG002|Washout Period 2|Adverse Event|1|||
161962137|NCT01092780|584907591|FG003|Washout Period 2|Adverse Event|0|||
161962138|NCT01257230|584907592|FG000|Overall Study|Not Treated|0|||
161962139|NCT01257230|584907593|FG001|Overall Study|Not Treated|0|||
161962140|NCT01257230|584907594|FG002|Overall Study|Not Treated|1|||
161962141|NCT01257230|584907592|FG000|Overall Study|Adverse Event|2|||
161714801|NCT00630032|584001437|FG000|Overall Study|Withdrawal by Subject|3|||
161714802|NCT00630032|584001438|FG001|Overall Study|Withdrawal by Subject|2|||
161714803|NCT00630032|584001437|FG000|Overall Study|Lost to Follow-up|18|||
161714804|NCT00630032|584001438|FG001|Overall Study|Lost to Follow-up|31|||
161714805|NCT00630032|584001437|FG000|Overall Study|Protocol Violation|1|||
161714806|NCT00630032|584001438|FG001|Overall Study|Protocol Violation|0|||
161714807|NCT00630032|584001437|FG000|Overall Study|Patient has moved|1|||
161714808|NCT00630032|584001438|FG001|Overall Study|Patient has moved|1|||
161714809|NCT00630032|584001437|FG000|Overall Study|Disease progression|1|||
161714810|NCT00630032|584001438|FG001|Overall Study|Disease progression|1|||
161714811|NCT00630032|584001437|FG000|Overall Study|End of monitoring in US centers|11|||
161714812|NCT00630032|584001438|FG001|Overall Study|End of monitoring in US centers|11|||
161714813|NCT02332915|584001439|FG000|Overall Study|Moved out of region|3|||
161714814|NCT02332915|584001440|FG001|Overall Study|Moved out of region|0|||
161714815|NCT02332915|584001439|FG000|Overall Study|Unrelated illness|1|||
161714816|NCT02332915|584001440|FG001|Overall Study|Unrelated illness|1|||
161714817|NCT02332915|584001439|FG000|Overall Study|Travel distance prohibitive|0|||
161714818|NCT02332915|584001440|FG001|Overall Study|Travel distance prohibitive|1|||
161714819|NCT02332915|584001439|FG000|Overall Study|did not meet inclusion criteria|2|||
161714820|NCT02332915|584001440|FG001|Overall Study|did not meet inclusion criteria|4|||
161714821|NCT03232073|584001441|FG000|Overall Study|Death|1|||
161714822|NCT03232073|584001442|FG001|Overall Study|Death|0|||
161714823|NCT03232073|584001441|FG000|Overall Study|Adverse Event|7|||
161714824|NCT03232073|584001442|FG001|Overall Study|Adverse Event|12|||
161714825|NCT03232073|584001441|FG000|Overall Study|Lost to Follow-up|6|||
161714826|NCT03232073|584001442|FG001|Overall Study|Lost to Follow-up|6|||
161714827|NCT03232073|584001441|FG000|Overall Study|Lack of Efficacy|10|||
161714828|NCT03232073|584001442|FG001|Overall Study|Lack of Efficacy|8|||
161714829|NCT03232073|584001441|FG000|Overall Study|Physician Decision|9|||
161714830|NCT03232073|584001442|FG001|Overall Study|Physician Decision|2|||
161714831|NCT03232073|584001441|FG000|Overall Study|Withdrawal by Subject|54|||
161714832|NCT03232073|584001442|FG001|Overall Study|Withdrawal by Subject|39|||
161714833|NCT02032875|584001443|FG000|Treatment Period|Adverse Event|1|||
161714834|NCT02032875|584001444|FG001|Treatment Period|Adverse Event|0|||
161714835|NCT02032875|584001443|FG000|Treatment Period|Liver transplant, No extension needed|0|||
161714836|NCT02032875|584001444|FG001|Treatment Period|Liver transplant, No extension needed|1|||
161714837|NCT02032875|584001443|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
161714838|NCT02032875|584001444|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
161714839|NCT02032875|584001443|FG000|Follow-up Period|Death|0|||
161714840|NCT02032875|584001444|FG001|Follow-up Period|Death|1|||
161714841|NCT02032875|584001443|FG000|Follow-up Period|Virologic Relapse|3|||
161714842|NCT02032875|584001444|FG001|Follow-up Period|Virologic Relapse|10|||
161714843|NCT03191786|584001449|FG000|Overall Study|Death|236|||
161714844|NCT03191786|584001450|FG001|Overall Study|Death|127|||
161714845|NCT03191786|584001449|FG000|Overall Study|Lost to Follow-up|9|||
161714846|NCT03191786|584001450|FG001|Overall Study|Lost to Follow-up|3|||
161714847|NCT03191786|584001449|FG000|Overall Study|Physician Decision|1|||
161714848|NCT03191786|584001450|FG001|Overall Study|Physician Decision|0|||
161714849|NCT03191786|584001449|FG000|Overall Study|Moved to Post Trial Access Program|30|||
161714850|NCT03191786|584001450|FG001|Overall Study|Moved to Post Trial Access Program|5|||
161714851|NCT03191786|584001449|FG000|Overall Study|Withdrawal by Subject|26|||
161714852|NCT03191786|584001450|FG001|Overall Study|Withdrawal by Subject|16|||
161714853|NCT05781542|584002842|FG000|Overall Study|Lost to Follow-up|1|||
161714854|NCT05781542|584002843|FG001|Overall Study|Lost to Follow-up|0|||
161714855|NCT05781542|584002844|FG002|Overall Study|Lost to Follow-up|1|||
161714856|NCT05405166|584002847|FG000|Overall Study|Death|49|||
161714857|NCT05405166|584002848|FG001|Overall Study|Death|50|||
161714858|NCT05405166|584002847|FG000|Overall Study|Withdrawal by Subject|10|||
161714859|NCT05405166|584002848|FG001|Overall Study|Withdrawal by Subject|3|||
161714860|NCT05405166|584002847|FG000|Overall Study|Ongoing at the time of PCD|209|||
161714861|NCT05405166|584002848|FG001|Overall Study|Ongoing at the time of PCD|210|||
161714862|NCT01843374|584002851|FG000|Overall Study|Death|155|||
161714863|NCT01843374|584002852|FG001|Overall Study|Death|313|||
161714864|NCT01843374|584002851|FG000|Overall Study|Withdrawal by Subject|14|||
161714865|NCT01843374|584002852|FG001|Overall Study|Withdrawal by Subject|20|||
161714866|NCT01843374|584002851|FG000|Overall Study|Withdrawing due to Other reason|20|||
161714867|NCT01843374|584002852|FG001|Overall Study|Withdrawing due to Other reason|46|||
161714868|NCT01826214|584002853|FG000|Overall Study|Adverse Event|7|||
161714869|NCT01826214|584002854|FG001|Overall Study|Adverse Event|6|||
161714870|NCT01826214|584002853|FG000|Overall Study|Death|3|||
161714871|NCT01826214|584002854|FG001|Overall Study|Death|1|||
161714872|NCT01826214|584002853|FG000|Overall Study|Lost to Follow-up|1|||
161714873|NCT01826214|584002854|FG001|Overall Study|Lost to Follow-up|0|||
161714874|NCT01826214|584002853|FG000|Overall Study|Physician Decision|0|||
161714875|NCT01826214|584002854|FG001|Overall Study|Physician Decision|2|||
161714876|NCT01826214|584002853|FG000|Overall Study|Progressive disease|22|||
161714877|NCT01826214|584002854|FG001|Overall Study|Progressive disease|21|||
161714878|NCT01826214|584002853|FG000|Overall Study|Study terminated by Sponsor|0|||
161962142|NCT01257230|584907593|FG001|Overall Study|Adverse Event|0|||
161962143|NCT01257230|584907594|FG002|Overall Study|Adverse Event|0|||
161962144|NCT01257230|584907592|FG000|Overall Study|Lack of Efficacy|0|||
161962145|NCT01257230|584907593|FG001|Overall Study|Lack of Efficacy|1|||
161962146|NCT01257230|584907594|FG002|Overall Study|Lack of Efficacy|0|||
161962147|NCT01257230|584907592|FG000|Overall Study|Protocol Violation|3|||
161962148|NCT01257230|584907593|FG001|Overall Study|Protocol Violation|0|||
161962149|NCT01257230|584907594|FG002|Overall Study|Protocol Violation|1|||
161962150|NCT01257230|584907592|FG000|Overall Study|Withdrawal by Subject|0|||
161962151|NCT01257230|584907593|FG001|Overall Study|Withdrawal by Subject|4|||
161962152|NCT01257230|584907594|FG002|Overall Study|Withdrawal by Subject|1|||
161962153|NCT01257230|584907592|FG000|Overall Study|Other reason not defined above|1|||
161962154|NCT01257230|584907593|FG001|Overall Study|Other reason not defined above|5|||
161962155|NCT01257230|584907594|FG002|Overall Study|Other reason not defined above|3|||
161962156|NCT00615719|584907600|FG000|Overall Study|Physician Decision|5|||
161962157|NCT02300558|584907601|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
161962158|NCT02300558|584907601|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
161962159|NCT02300558|584907601|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
161962160|NCT02300558|584907601|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
161962161|NCT01471028|584907602|FG000|VTI-208|Adverse Event|39|||
161962162|NCT01471028|584907603|FG001|VTI-208|Adverse Event|41|||
161962163|NCT01471028|584907602|FG000|VTI-208|Withdrawal by Subject|0|||
161962164|NCT01471028|584907603|FG001|VTI-208|Withdrawal by Subject|2|||
161962165|NCT01471028|584907602|FG000|VTI-208|Lost to Follow-up|1|||
161962166|NCT01471028|584907603|FG001|VTI-208|Lost to Follow-up|1|||
162031764|NCT01527357|585174071|FG001|Overall Study|Did Not Receive Treatment|0|||
161962167|NCT01471028|584907602|FG000|VTI-208E|Death|7|||
161962168|NCT01471028|584907603|FG001|VTI-208E|Death|10|||
161962169|NCT01471028|584907602|FG000|VTI-208E|Withdrawal by Subject|1|||
161962170|NCT01471028|584907603|FG001|VTI-208E|Withdrawal by Subject|0|||
161714879|NCT01826214|584002854|FG001|Overall Study|Study terminated by Sponsor|1|||
161714880|NCT01826214|584002853|FG000|Overall Study|Subject/guardian decision|2|||
161714881|NCT01826214|584002854|FG001|Overall Study|Subject/guardian decision|3|||
161714882|NCT00955110|584002855|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
161714883|NCT00955110|584002855|FG000|Treatment Phase|Adverse Event|2|||
161714884|NCT00955110|584002855|FG000|Treatment Phase|Administrative reasons|2|||
161714885|NCT00955110|584002855|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
161714886|NCT00955110|584002855|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
161714887|NCT03704051|584002860|FG000|Overall Study|Withdrawal by Subject|4|||
161714888|NCT03704051|584002861|FG001|Overall Study|Withdrawal by Subject|0|||
161714889|NCT03167619|584002872|FG000|Overall Study|Death|11|||
161714890|NCT03167619|584002873|FG001|Overall Study|Death|8|||
161714891|NCT03167619|584002872|FG000|Overall Study|Withdrawal by Subject|1|||
161714892|NCT03167619|584002873|FG001|Overall Study|Withdrawal by Subject|2|||
161714893|NCT03167619|584002872|FG000|Overall Study|Physician Decision|0|||
161714894|NCT03167619|584002873|FG001|Overall Study|Physician Decision|1|||
161714895|NCT06400238|584002875|FG000|Overall Study|Started Protocol Therapy|2|||
161714896|NCT06400238|584002875|FG000|Overall Study|Adverse Event|1|||
161714897|NCT06400238|584002875|FG000|Overall Study|Death|1|||
161714898|NCT06400238|584002875|FG000|Overall Study|Disease Progression|27|||
161714899|NCT06400238|584002875|FG000|Overall Study|Withdrawal by Subject|2|||
161714900|NCT06400238|584002875|FG000|Overall Study|Physician Decision|2|||
161714901|NCT01362322|584002879|FG000|Overall Study|Withdrawal by Subject|3|||
161714902|NCT01362322|584002880|FG001|Overall Study|Withdrawal by Subject|1|||
161714903|NCT01362322|584002879|FG000|Overall Study|Lost to Follow-up|2|||
161714904|NCT01362322|584002880|FG001|Overall Study|Lost to Follow-up|6|||
161714905|NCT01009463|584002885|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
161714906|NCT01009463|584002886|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161714907|NCT01009463|584002887|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161714908|NCT01009463|584002888|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161714909|NCT01009463|584002889|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161714910|NCT01009463|584002885|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
161714911|NCT01009463|584002886|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
161714912|NCT01009463|584002887|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
161714913|NCT01009463|584002888|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
161714914|NCT01009463|584002889|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
161714915|NCT01009463|584002885|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
161714916|NCT01009463|584002886|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161714917|NCT01009463|584002887|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161714918|NCT01009463|584002888|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161714919|NCT01009463|584002889|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161714920|NCT01009463|584002885|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
161714921|NCT01009463|584002886|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
161714922|NCT01009463|584002887|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
161714923|NCT01009463|584002888|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
161714924|NCT01009463|584002889|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
161714925|NCT01009463|584002885|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
161714926|NCT01009463|584002886|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161714927|NCT01009463|584002887|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161962171|NCT01471028|584907602|FG000|VTI-208E|Lost to Follow-up|0|||
161962172|NCT01471028|584907603|FG001|VTI-208E|Lost to Follow-up|2|||
161962173|NCT01355679|584907604|FG000|Overall Study|benign tumor types found at biopsy|2|||
161962174|NCT02091362|584907612|FG000|Period 1|Protocol Violation|1|||
161962175|NCT02091362|584907613|FG001|Period 1|Protocol Violation|0|||
161962176|NCT02091362|584907612|FG000|Period 1|Withdrawal by Subject|2|||
161962177|NCT02091362|584907613|FG001|Period 1|Withdrawal by Subject|3|||
161714928|NCT01009463|584002888|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161714929|NCT01009463|584002889|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161714930|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
161714931|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
161714932|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
161714933|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
161714934|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
161714935|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161714936|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
161714937|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
161714938|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
161714939|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
161714940|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
161714941|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
161714942|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
161714943|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
161714944|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
161714945|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
161714946|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
161714947|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
161714948|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
161714949|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
161714950|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161714951|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
161714952|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
161714953|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
161714954|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
161714955|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161714956|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
161714957|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161714958|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
161714959|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161714960|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161714961|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
161714962|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
161714963|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
161714964|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
161714965|NCT01009463|584002885|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
161714966|NCT01009463|584002886|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
161714967|NCT01009463|584002887|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
161714968|NCT01009463|584002888|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
161714969|NCT01009463|584002889|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
161714970|NCT04430348|584002890|FG000|Overall Study|Death|3|||
161714971|NCT04430348|584002891|FG001|Overall Study|Death|2|||
161714972|NCT04430348|584002892|FG002|Overall Study|Death|2|||
161714973|NCT04430348|584002893|FG003|Overall Study|Death|2|||
161714974|NCT04430348|584002894|FG004|Overall Study|Death|2|||
161714975|NCT04430348|584002895|FG005|Overall Study|Death|3|||
161714976|NCT04430348|584002890|FG000|Overall Study|Lost to Follow-up|0|||
161714977|NCT04430348|584002891|FG001|Overall Study|Lost to Follow-up|0|||
161714978|NCT04430348|584002892|FG002|Overall Study|Lost to Follow-up|0|||
161714979|NCT04430348|584002893|FG003|Overall Study|Lost to Follow-up|1|||
161714980|NCT04430348|584002894|FG004|Overall Study|Lost to Follow-up|0|||
161714981|NCT04430348|584002895|FG005|Overall Study|Lost to Follow-up|0|||
161714982|NCT04430348|584002890|FG000|Overall Study|Adverse Event|0|||
161714983|NCT04430348|584002891|FG001|Overall Study|Adverse Event|0|||
161714984|NCT04430348|584002892|FG002|Overall Study|Adverse Event|0|||
161714985|NCT04430348|584002893|FG003|Overall Study|Adverse Event|0|||
161714986|NCT04430348|584002894|FG004|Overall Study|Adverse Event|0|||
161714987|NCT04430348|584002895|FG005|Overall Study|Adverse Event|1|||
161714988|NCT04430348|584002890|FG000|Overall Study|Withdrawal by Subject|0|||
161714989|NCT04430348|584002891|FG001|Overall Study|Withdrawal by Subject|1|||
161714990|NCT04430348|584002892|FG002|Overall Study|Withdrawal by Subject|0|||
161714991|NCT04430348|584002893|FG003|Overall Study|Withdrawal by Subject|0|||
161714992|NCT04430348|584002894|FG004|Overall Study|Withdrawal by Subject|0|||
161714993|NCT04430348|584002895|FG005|Overall Study|Withdrawal by Subject|1|||
161714994|NCT04430348|584002890|FG000|Overall Study|Study Terminated by Sponsor|0|||
161962178|NCT02091362|584907612|FG000|Period 1|Lost to Follow-up|0|||
161962179|NCT02091362|584907613|FG001|Period 1|Lost to Follow-up|1|||
161714995|NCT04430348|584002891|FG001|Overall Study|Study Terminated by Sponsor|0|||
161714996|NCT04430348|584002892|FG002|Overall Study|Study Terminated by Sponsor|2|||
161714997|NCT04430348|584002893|FG003|Overall Study|Study Terminated by Sponsor|0|||
161714998|NCT04430348|584002894|FG004|Overall Study|Study Terminated by Sponsor|1|||
161714999|NCT04430348|584002895|FG005|Overall Study|Study Terminated by Sponsor|1|||
161715000|NCT00384956|584002898|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
161715001|NCT01824602|584002906|FG000|Overall Study|Withdrawal by Subject|0|||
161715002|NCT01824602|584002907|FG001|Overall Study|Withdrawal by Subject|0|||
161715003|NCT01824602|584002908|FG002|Overall Study|Withdrawal by Subject|1|||
161715004|NCT01824602|584002909|FG003|Overall Study|Withdrawal by Subject|2|||
161715005|NCT01824602|584002906|FG000|Overall Study|Patient non-compliance|0|||
161715006|NCT01824602|584002907|FG001|Overall Study|Patient non-compliance|0|||
161715007|NCT01824602|584002908|FG002|Overall Study|Patient non-compliance|1|||
161715008|NCT01824602|584002909|FG003|Overall Study|Patient non-compliance|0|||
161715009|NCT01824602|584002906|FG000|Overall Study|Adverse Event|1|||
161715010|NCT01824602|584002907|FG001|Overall Study|Adverse Event|0|||
161715011|NCT01824602|584002908|FG002|Overall Study|Adverse Event|2|||
161715012|NCT01824602|584002909|FG003|Overall Study|Adverse Event|2|||
161715013|NCT01824602|584002906|FG000|Overall Study|Treatment failure|0|||
161715014|NCT01824602|584002907|FG001|Overall Study|Treatment failure|0|||
161715015|NCT01824602|584002908|FG002|Overall Study|Treatment failure|0|||
161715016|NCT01824602|584002909|FG003|Overall Study|Treatment failure|1|||
161715017|NCT00104871|584002910|FG000|Overall Study|Not evaluable|1|||
161715018|NCT02192359|584002913|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
161715019|NCT02192359|584002914|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
161715020|NCT02192359|584002915|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
161715021|NCT02192359|584002916|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
161715022|NCT02192359|584002913|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
161715023|NCT02192359|584002914|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
161715024|NCT02192359|584002915|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
162031765|NCT01879579|585174072|FG000|Overall Study|Phone incompatible with texting platform|3|||
162031766|NCT01879579|585174073|FG001|Overall Study|Phone incompatible with texting platform|0|||
162031767|NCT01879579|585174072|FG000|Overall Study|Did not enroll in texting platform|1|||
162031768|NCT01879579|585174073|FG001|Overall Study|Did not enroll in texting platform|0|||
162031769|NCT01879579|585174072|FG000|Overall Study|Did not initiate insulin treatment|1|||
162031770|NCT01879579|585174073|FG001|Overall Study|Did not initiate insulin treatment|0|||
162031771|NCT01879579|585174072|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
162031772|NCT01879579|585174073|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
162031773|NCT01879579|585174072|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
162031774|NCT01879579|585174073|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
162031775|NCT02927067|585174074|FG000|Overall Study|Withdrawn Consent|20|||
162031776|NCT02927067|585174075|FG001|Overall Study|Withdrawn Consent|12|||
162031777|NCT02927067|585174074|FG000|Overall Study|Death|18|||
162031778|NCT02927067|585174075|FG001|Overall Study|Death|31|||
162031779|NCT02927067|585174074|FG000|Overall Study|Adverse Event|13|||
162031780|NCT02927067|585174075|FG001|Overall Study|Adverse Event|10|||
162031781|NCT02927067|585174074|FG000|Overall Study|Noncompliance|5|||
162031782|NCT02927067|585174075|FG001|Overall Study|Noncompliance|2|||
162031783|NCT02927067|585174074|FG000|Overall Study|Reason not Specified|4|||
162031784|NCT02927067|585174075|FG001|Overall Study|Reason not Specified|6|||
162031785|NCT02292784|585174078|FG000|Overall Study|Lost to Follow-up|1|||
162031786|NCT02292784|585174079|FG001|Overall Study|Lost to Follow-up|17|||
162031787|NCT02292784|585174080|FG002|Overall Study|Lost to Follow-up|18|||
162031788|NCT02292784|585174078|FG000|Overall Study|Withdrawal by Subject|0|||
162031789|NCT02292784|585174079|FG001|Overall Study|Withdrawal by Subject|3|||
162031790|NCT02292784|585174080|FG002|Overall Study|Withdrawal by Subject|3|||
162031791|NCT00622739|585174081|FG000|Overall Study|Physician Decision|1|||
162031792|NCT00622739|585174082|FG001|Overall Study|Physician Decision|0|||
162031793|NCT00622739|585174081|FG000|Overall Study|Adverse Event|1|||
162031794|NCT00622739|585174082|FG001|Overall Study|Adverse Event|2|||
162031795|NCT00622739|585174081|FG000|Overall Study|Lack of Efficacy|0|||
162031796|NCT00622739|585174082|FG001|Overall Study|Lack of Efficacy|2|||
162031797|NCT00622739|585174081|FG000|Overall Study|Withdrawal by Subject|0|||
162031798|NCT00622739|585174082|FG001|Overall Study|Withdrawal by Subject|1|||
162031799|NCT00622739|585174081|FG000|Overall Study|Lost to Follow-up|0|||
162031800|NCT00622739|585174082|FG001|Overall Study|Lost to Follow-up|1|||
162031801|NCT00134784|585174083|FG000|Overall Study|Withdrawal by Subject|2|||
162031802|NCT00134784|585174084|FG001|Overall Study|Withdrawal by Subject|2|||
162031803|NCT00134784|585174085|FG002|Overall Study|Withdrawal by Subject|2|||
162031804|NCT00134784|585174086|FG003|Overall Study|Withdrawal by Subject|1|||
162031805|NCT00625742|585174087|FG000|Overall Study|Disease Progression|2|||
162031806|NCT00625742|585174087|FG000|Overall Study|Withdrawal by Subject|1|||
162031807|NCT00625742|585174087|FG000|Overall Study|Adverse Event|4|||
162031808|NCT00625742|585174087|FG000|Overall Study|Lost to Follow-up|4|||
162031809|NCT00625742|585174087|FG000|Overall Study|Ineligible|1|||
162031810|NCT03384693|585174088|FG000|Overall Study|Adverse Event|3|||
162031811|NCT03387150|585174089|FG000|Overall Study|Withdrawal by Subject|3|||
162031812|NCT03387150|585174090|FG001|Overall Study|Withdrawal by Subject|0|||
161962180|NCT02091362|584907612|FG000|Period 1|Adverse Event|2|||
161962181|NCT02091362|584907613|FG001|Period 1|Adverse Event|0|||
161962182|NCT02091362|584907612|FG000|Wash-out|Lost to Follow-up|1|||
161962183|NCT02091362|584907613|FG001|Wash-out|Lost to Follow-up|1|||
161962184|NCT02091362|584907612|FG000|Wash-out|Withdrawal by Subject|0|||
161962185|NCT02091362|584907613|FG001|Wash-out|Withdrawal by Subject|2|||
161962186|NCT02091362|584907612|FG000|Period 2|Adverse Event|1|||
161962187|NCT02091362|584907613|FG001|Period 2|Adverse Event|0|||
161962188|NCT02091362|584907612|FG000|Period 2|Lost to Follow-up|0|||
161962189|NCT02091362|584907613|FG001|Period 2|Lost to Follow-up|1|||
161962190|NCT02091362|584907612|FG000|Period 2|Withdrawal by Subject|1|||
162031813|NCT03387150|585174091|FG002|Overall Study|Withdrawal by Subject|3|||
162031814|NCT03387150|585174092|FG003|Overall Study|Withdrawal by Subject|4|||
161962191|NCT02091362|584907613|FG001|Period 2|Withdrawal by Subject|1|||
162031815|NCT03387150|585174093|FG004|Overall Study|Withdrawal by Subject|1|||
162031816|NCT03387150|585174094|FG005|Overall Study|Withdrawal by Subject|2|||
162031817|NCT03387150|585174095|FG006|Overall Study|Withdrawal by Subject|0|||
162031818|NCT03387150|585174089|FG000|Overall Study|Lost to Follow-up|3|||
162031819|NCT03387150|585174090|FG001|Overall Study|Lost to Follow-up|2|||
162031820|NCT03387150|585174091|FG002|Overall Study|Lost to Follow-up|2|||
162031821|NCT03387150|585174092|FG003|Overall Study|Lost to Follow-up|3|||
161715025|NCT02192359|584002916|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
161962192|NCT00286091|584907614|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
161962193|NCT00286091|584907615|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
162031822|NCT03387150|585174093|FG004|Overall Study|Lost to Follow-up|3|||
162031823|NCT03387150|585174094|FG005|Overall Study|Lost to Follow-up|3|||
162031824|NCT03387150|585174095|FG006|Overall Study|Lost to Follow-up|0|||
162031825|NCT03387150|585174089|FG000|Overall Study|Participant unable to adhere to visit|0|||
162031826|NCT03387150|585174090|FG001|Overall Study|Participant unable to adhere to visit|1|||
161715026|NCT02192359|584002913|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
161715027|NCT02192359|584002914|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
161715028|NCT02192359|584002915|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
161715029|NCT02192359|584002916|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
161715030|NCT02117687|584002922|FG000|Overall Study|Lost to Follow-up|0|||
161715031|NCT02117687|584002923|FG001|Overall Study|Lost to Follow-up|1|||
161715032|NCT02117687|584002922|FG000|Overall Study|Adverse Event|0|||
161715033|NCT02117687|584002923|FG001|Overall Study|Adverse Event|2|||
161715034|NCT02117687|584002922|FG000|Overall Study|Other Reasons|1|||
161715035|NCT02117687|584002923|FG001|Overall Study|Other Reasons|1|||
161715036|NCT01687673|584002933|FG000|Overall Study|Physician Decision|1|||
161715037|NCT02234622|584002934|FG000|Overall Study|Withdrawal by Subject|16|||
161715038|NCT02234622|584002935|FG001|Overall Study|Withdrawal by Subject|22|||
161715039|NCT02234622|584002934|FG000|Overall Study|Lost to Follow-up|27|||
161715040|NCT02234622|584002935|FG001|Overall Study|Lost to Follow-up|14|||
161715041|NCT00618956|584002936|FG000|Overall Study|Adverse Event|10|||
161715042|NCT00618956|584002937|FG001|Overall Study|Adverse Event|34|||
161715043|NCT00618956|584002936|FG000|Overall Study|Lack of Efficacy|2|||
161715044|NCT00618956|584002937|FG001|Overall Study|Lack of Efficacy|1|||
161715045|NCT00618956|584002936|FG000|Overall Study|Withdrawal by Subject|5|||
161715046|NCT00618956|584002937|FG001|Overall Study|Withdrawal by Subject|7|||
161715047|NCT00618956|584002936|FG000|Overall Study|Lost to Follow-up|4|||
161715048|NCT00618956|584002937|FG001|Overall Study|Lost to Follow-up|5|||
161715049|NCT00618956|584002936|FG000|Overall Study|Protocol Violation|2|||
161715050|NCT00618956|584002937|FG001|Overall Study|Protocol Violation|2|||
161715051|NCT00618956|584002936|FG000|Overall Study|did not meet criteria, non-compliance|2|||
161715052|NCT00618956|584002937|FG001|Overall Study|did not meet criteria, non-compliance|1|||
161715053|NCT03598777|584002938|FG000|Overall Study|Study Terminated by Sponsor|3|||
161715054|NCT03598777|584002939|FG001|Overall Study|Study Terminated by Sponsor|0|||
161715055|NCT03598777|584002940|FG002|Overall Study|Study Terminated by Sponsor|0|||
161715056|NCT03598777|584002941|FG003|Overall Study|Study Terminated by Sponsor|0|||
161715057|NCT03598777|584002942|FG004|Overall Study|Study Terminated by Sponsor|15|||
161715058|NCT03598777|584002938|FG000|Overall Study|Withdrawal by Subject|1|||
161715059|NCT03598777|584002939|FG001|Overall Study|Withdrawal by Subject|1|||
161715060|NCT03598777|584002940|FG002|Overall Study|Withdrawal by Subject|0|||
161715061|NCT03598777|584002941|FG003|Overall Study|Withdrawal by Subject|0|||
161715062|NCT03598777|584002942|FG004|Overall Study|Withdrawal by Subject|0|||
161715063|NCT03598777|584002938|FG000|Overall Study|Adverse Event|1|||
161715064|NCT03598777|584002939|FG001|Overall Study|Adverse Event|0|||
161715065|NCT03598777|584002940|FG002|Overall Study|Adverse Event|0|||
161715066|NCT03598777|584002941|FG003|Overall Study|Adverse Event|0|||
161715067|NCT03598777|584002942|FG004|Overall Study|Adverse Event|0|||
161715068|NCT03598777|584002938|FG000|Overall Study|Lost to Follow-up|1|||
161715069|NCT03598777|584002939|FG001|Overall Study|Lost to Follow-up|0|||
161715070|NCT03598777|584002940|FG002|Overall Study|Lost to Follow-up|0|||
161715071|NCT03598777|584002941|FG003|Overall Study|Lost to Follow-up|0|||
161715072|NCT03598777|584002942|FG004|Overall Study|Lost to Follow-up|0|||
161715073|NCT02006576|584002943|FG000|Overall Study|Withdrawal by Subject|4|||
161715074|NCT02006576|584002944|FG001|Overall Study|Withdrawal by Subject|6|||
161715075|NCT02006576|584002945|FG002|Overall Study|Withdrawal by Subject|2|||
161715076|NCT02006576|584002943|FG000|Overall Study|Death|0|||
161715077|NCT02006576|584002944|FG001|Overall Study|Death|0|||
161715078|NCT02006576|584002945|FG002|Overall Study|Death|1|||
161715079|NCT02006576|584002943|FG000|Overall Study|Lost to Follow-up|1|||
161715080|NCT02006576|584002944|FG001|Overall Study|Lost to Follow-up|0|||
161715081|NCT02006576|584002945|FG002|Overall Study|Lost to Follow-up|1|||
161715082|NCT02006576|584002943|FG000|Overall Study|Screen Failure, too sick, other|13|||
161715083|NCT02006576|584002944|FG001|Overall Study|Screen Failure, too sick, other|1|||
161715084|NCT02006576|584002945|FG002|Overall Study|Screen Failure, too sick, other|13|||
161715085|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
161715086|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
161715087|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
161715088|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
161715089|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
161715090|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161715091|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161715092|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161715093|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161838011|NCT01156142|584450287|FG000|Overall Study|Withdrawal by Subject|8|||
161715094|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
161715095|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
161715096|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
161715097|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
161715098|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
161962194|NCT00286091|584907614|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
161962195|NCT00286091|584907615|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
161962196|NCT00286091|584907614|FG000|Double-blind Treatment Phase|Death|58|||
161962197|NCT00286091|584907615|FG001|Double-blind Treatment Phase|Death|65|||
161962198|NCT00286091|584907614|FG000|Double-blind Treatment Phase|Adverse Event|28|||
161962199|NCT00286091|584907615|FG001|Double-blind Treatment Phase|Adverse Event|40|||
161962200|NCT00286091|584907614|FG000|Double-blind Treatment Phase|Disease Progression|22|||
161962201|NCT00286091|584907615|FG001|Double-blind Treatment Phase|Disease Progression|35|||
161962202|NCT00286091|584907614|FG000|Double-blind Treatment Phase|Other|25|||
161962203|NCT00286091|584907615|FG001|Double-blind Treatment Phase|Other|33|||
161962204|NCT00286091|584907614|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
161962205|NCT00286091|584907615|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
161962206|NCT00286091|584907614|FG000|Double-blind Treatment Phase|Noncompliance|8|||
161962207|NCT00286091|584907615|FG001|Double-blind Treatment Phase|Noncompliance|8|||
161962208|NCT00286091|584907614|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
161962209|NCT00286091|584907615|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
161962210|NCT00286091|584907614|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
161962211|NCT00286091|584907615|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
161962212|NCT00286091|584907614|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
161962213|NCT00286091|584907615|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
161962214|NCT00286091|584907614|FG000|Open-label Treatment Phase|Physician Decision|24|||
161962215|NCT00286091|584907615|FG001|Open-label Treatment Phase|Physician Decision|21|||
161962216|NCT00286091|584907614|FG000|Open-label Treatment Phase|Adverse Event|5|||
161962217|NCT00286091|584907615|FG001|Open-label Treatment Phase|Adverse Event|16|||
161962218|NCT00286091|584907614|FG000|Open-label Treatment Phase|Other|11|||
161962219|NCT00286091|584907615|FG001|Open-label Treatment Phase|Other|11|||
161962220|NCT00286091|584907614|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
161962221|NCT00286091|584907615|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
161962222|NCT00286091|584907614|FG000|Open-label Treatment Phase|Death|10|||
161962223|NCT00286091|584907615|FG001|Open-label Treatment Phase|Death|7|||
161962224|NCT00286091|584907614|FG000|Open-label Treatment Phase|Disease Progression|9|||
161962225|NCT00286091|584907615|FG001|Open-label Treatment Phase|Disease Progression|3|||
161962226|NCT00286091|584907614|FG000|Open-label Treatment Phase|Noncompliance|3|||
161962227|NCT00286091|584907615|FG001|Open-label Treatment Phase|Noncompliance|1|||
161962228|NCT00286091|584907614|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
161962229|NCT00286091|584907615|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
161962230|NCT00286091|584907614|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
161962231|NCT00286091|584907615|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
161962232|NCT00286091|584907614|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
161962233|NCT00286091|584907615|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
161962234|NCT02936869|584907616|FG000|Overall Study|Lost to Follow-up|1|||
161962235|NCT02936869|584907617|FG001|Overall Study|Lost to Follow-up|3|||
161962236|NCT02936869|584907616|FG000|Overall Study|Death|0|||
161962237|NCT02936869|584907617|FG001|Overall Study|Death|1|||
161962238|NCT02936869|584907616|FG000|Overall Study|Legal Case|0|||
161962239|NCT02936869|584907617|FG001|Overall Study|Legal Case|1|||
161962240|NCT02936869|584907616|FG000|Overall Study|Protocol Violation|1|||
161962241|NCT02936869|584907617|FG001|Overall Study|Protocol Violation|0|||
161962242|NCT03799952|584907618|FG000|Overall Study|Program was too easy, discontinued|1|||
161962243|NCT03799952|584907619|FG001|Overall Study|Program was too easy, discontinued|0|||
161962244|NCT03799952|584907618|FG000|Overall Study|Lost to Follow-up|0|||
161962245|NCT03799952|584907619|FG001|Overall Study|Lost to Follow-up|2|||
161962246|NCT00335738|584907620|FG000|Overall Study|Physician Decision|6|||
161962247|NCT00335738|584907621|FG001|Overall Study|Physician Decision|0|||
161962248|NCT00335738|584907620|FG000|Overall Study|Withdrawal by Subject|2|||
161962249|NCT00335738|584907621|FG001|Overall Study|Withdrawal by Subject|0|||
161962250|NCT00335738|584907620|FG000|Overall Study|Ineligible|3|||
161962251|NCT00335738|584907621|FG001|Overall Study|Ineligible|4|||
161962252|NCT02036580|584907624|FG000|Overall Study|Withdrawal by Subject|0|||
161962253|NCT02036580|584907625|FG001|Overall Study|Withdrawal by Subject|1|||
161962254|NCT02036580|584907626|FG002|Overall Study|Withdrawal by Subject|0|||
161715099|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
161715100|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
161715101|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
161962255|NCT02036580|584907624|FG000|Overall Study|Adverse Event|1|||
161962256|NCT02036580|584907625|FG001|Overall Study|Adverse Event|0|||
161962257|NCT02036580|584907626|FG002|Overall Study|Adverse Event|0|||
161962258|NCT00902850|584907628|FG000|Overall Study|Physician Decision|2|||
161962259|NCT00902850|584907629|FG001|Overall Study|Physician Decision|2|||
161962260|NCT03585764|584907632|FG000|Overall Study|Death|3|||
161962261|NCT03585764|584907633|FG001|Overall Study|Death|2|||
161962262|NCT03585764|584907634|FG002|Overall Study|Death|3|||
161962263|NCT03585764|584907635|FG003|Overall Study|Death|0|||
161715102|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
161962264|NCT03585764|584907632|FG000|Overall Study|Lost to Follow-up|0|||
161962265|NCT03585764|584907633|FG001|Overall Study|Lost to Follow-up|1|||
161962266|NCT03585764|584907634|FG002|Overall Study|Lost to Follow-up|0|||
161962267|NCT03585764|584907635|FG003|Overall Study|Lost to Follow-up|0|||
161962268|NCT03585764|584907632|FG000|Overall Study|Physician Decision|0|||
161962269|NCT03585764|584907633|FG001|Overall Study|Physician Decision|0|||
161962270|NCT03585764|584907634|FG002|Overall Study|Physician Decision|2|||
161962271|NCT03585764|584907635|FG003|Overall Study|Physician Decision|0|||
161962272|NCT01581021|584907637|FG000|Overall Study|Lost to Follow-up|4|||
161962273|NCT01581021|584907638|FG001|Overall Study|Lost to Follow-up|6|||
161962274|NCT01581021|584907637|FG000|Overall Study|More than 2 hooks in thoracic|3|||
161962275|NCT01581021|584907638|FG001|Overall Study|More than 2 hooks in thoracic|0|||
161962276|NCT01581021|584907637|FG000|Overall Study|Neuromuscular|2|||
161962277|NCT01581021|584907638|FG001|Overall Study|Neuromuscular|1|||
161962278|NCT01581021|584907637|FG000|Overall Study|Not Randomized|1|||
161962279|NCT01581021|584907638|FG001|Overall Study|Not Randomized|2|||
161962280|NCT01581021|584907637|FG000|Overall Study|Lenke 6 Classification|0|||
161962281|NCT01581021|584907638|FG001|Overall Study|Lenke 6 Classification|1|||
161962282|NCT01581021|584907637|FG000|Overall Study|Lack of Efficacy|0|||
161962283|NCT01581021|584907638|FG001|Overall Study|Lack of Efficacy|1|||
161962284|NCT03604172|584907641|FG000|Overall Study|Lost to Follow-up|1|||
161962285|NCT03604172|584907642|FG001|Overall Study|Lost to Follow-up|2|||
161962286|NCT00054327|584907643|FG000|Overall Study|Engraftment failure|1|||
161962287|NCT00054327|584907644|FG001|Overall Study|Engraftment failure|0|||
161962288|NCT00054327|584907645|FG002|Overall Study|Engraftment failure|0|||
161962289|NCT00054327|584907646|FG003|Overall Study|Engraftment failure|0|||
161962290|NCT00054327|584907647|FG004|Overall Study|Engraftment failure|0|||
161962291|NCT00054327|584907648|FG005|Overall Study|Engraftment failure|0|||
161962292|NCT03028129|584907651|FG000|Overall Study|Adverse Event|13|||
161962293|NCT03028129|584907652|FG001|Overall Study|Adverse Event|2|||
161962294|NCT03028129|584907651|FG000|Overall Study|Lost to Follow-up|50|||
161962295|NCT03028129|584907652|FG001|Overall Study|Lost to Follow-up|38|||
161962296|NCT03028129|584907651|FG000|Overall Study|Physician Decision|0|||
161962297|NCT03028129|584907652|FG001|Overall Study|Physician Decision|1|||
161962298|NCT03028129|584907651|FG000|Overall Study|Protocol Violation|1|||
161962299|NCT03028129|584907652|FG001|Overall Study|Protocol Violation|1|||
161962300|NCT03028129|584907651|FG000|Overall Study|Withdrawal by Subject|62|||
161962301|NCT03028129|584907652|FG001|Overall Study|Withdrawal by Subject|45|||
161962302|NCT00923351|584907653|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
161962303|NCT00923351|584907654|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
161962304|NCT00923351|584907655|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
161962305|NCT03823287|584907661|FG000|Overall Study|Withdrawal by Subject|25|||
161962306|NCT03823287|584907662|FG001|Overall Study|Withdrawal by Subject|17|||
161715103|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
161715104|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
161715105|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
161715106|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
161715107|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
161715108|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
161715109|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
161715110|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
161715111|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
161715112|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
161715113|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
161715114|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
161715115|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
161715116|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
161715117|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
161715118|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
161715119|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
161715120|NCT00785577|584002946|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
161715121|NCT00785577|584002947|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
161962307|NCT03823287|584907661|FG000|Overall Study|Death|13|||
161962308|NCT03823287|584907662|FG001|Overall Study|Death|7|||
161962309|NCT03823287|584907661|FG000|Overall Study|Lost to Follow-up|7|||
161962310|NCT03823287|584907662|FG001|Overall Study|Lost to Follow-up|8|||
161962311|NCT03823287|584907661|FG000|Overall Study|Adverse Event|6|||
161962312|NCT03823287|584907662|FG001|Overall Study|Adverse Event|8|||
161962313|NCT03823287|584907661|FG000|Overall Study|Physician Decision|5|||
161962314|NCT03823287|584907662|FG001|Overall Study|Physician Decision|2|||
161962315|NCT03823287|584907661|FG000|Overall Study|Lack of Efficacy|2|||
161962316|NCT03823287|584907662|FG001|Overall Study|Lack of Efficacy|0|||
161962317|NCT03823287|584907661|FG000|Overall Study|Other|2|||
161962318|NCT03823287|584907662|FG001|Overall Study|Other|4|||
161962319|NCT01059864|584907663|FG000|Open-Label Run-In Phase|Adverse Event|7|||
161962320|NCT01059864|584907664|FG001|Open-Label Run-In Phase|Adverse Event|0|||
161962321|NCT01059864|584907665|FG002|Open-Label Run-In Phase|Adverse Event|0|||
161962322|NCT01059864|584907663|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
161962323|NCT01059864|584907664|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
161962324|NCT01059864|584907665|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
161962325|NCT01059864|584907663|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
161962326|NCT01059864|584907664|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
161962327|NCT01059864|584907665|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
161962328|NCT01059864|584907663|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
161962329|NCT01059864|584907664|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
161962330|NCT01059864|584907665|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
161962331|NCT01059864|584907663|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
161962332|NCT01059864|584907664|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
161962333|NCT01059864|584907665|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
161962334|NCT01059864|584907663|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161962335|NCT01059864|584907664|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
161962336|NCT01059864|584907665|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
161962337|NCT01456195|584909744|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161962338|NCT01456195|584909745|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
161962339|NCT01456195|584909746|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
161962340|NCT01456195|584909744|FG000|Overall Study|Lost to Follow-up|3|||
161962341|NCT01456195|584909745|FG001|Overall Study|Lost to Follow-up|1|||
161962342|NCT01456195|584909746|FG002|Overall Study|Lost to Follow-up|3|||
161962343|NCT01456195|584909744|FG000|Overall Study|Voluntary Withdrawal|5|||
161962344|NCT01456195|584909745|FG001|Overall Study|Voluntary Withdrawal|3|||
161962345|NCT01456195|584909746|FG002|Overall Study|Voluntary Withdrawal|7|||
161962346|NCT01456195|584909744|FG000|Overall Study|Lack of Efficacy|0|||
161962347|NCT01456195|584909745|FG001|Overall Study|Lack of Efficacy|1|||
161962348|NCT01456195|584909746|FG002|Overall Study|Lack of Efficacy|0|||
161962349|NCT01456195|584909744|FG000|Overall Study|Other Reasons|2|||
161962350|NCT01456195|584909745|FG001|Overall Study|Other Reasons|1|||
161962351|NCT01456195|584909746|FG002|Overall Study|Other Reasons|3|||
161962352|NCT02109432|584909747|FG000|Overall Study|Withdrawal by Subject|1|||
161962353|NCT03372551|584909754|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
161962354|NCT03372551|584909755|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
161962355|NCT04683029|584909765|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
161962356|NCT04683029|584909766|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
161962357|NCT04683029|584909767|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
161962358|NCT04683029|584909768|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
161962359|NCT04683029|584909765|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
161962360|NCT04683029|584909766|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
161962361|NCT04683029|584909767|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
161962362|NCT04683029|584909768|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
161962363|NCT04683029|584909765|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
161962364|NCT04683029|584909766|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
161962365|NCT04683029|584909767|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
161962366|NCT04683029|584909768|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
161962367|NCT04299308|584909769|FG000|Overall Study|Withdrawal by Subject|1|||
161962368|NCT04299308|584909770|FG001|Overall Study|Withdrawal by Subject|0|||
161962369|NCT04299308|584909769|FG000|Overall Study|issue with PET image (1)|1|||
161962370|NCT04299308|584909770|FG001|Overall Study|issue with PET image (1)|0|||
161715122|NCT00785577|584002948|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
161715123|NCT00785577|584002949|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
161715124|NCT00785577|584002950|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
161715125|NCT00785577|584002946|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
161715126|NCT00785577|584002947|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
161715127|NCT00785577|584002948|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
161715128|NCT00785577|584002949|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
161715129|NCT00785577|584002950|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
161962371|NCT02920528|584909773|FG000|Overall Study|Incomplete Data|1|||
161962372|NCT02920528|584909774|FG001|Overall Study|Incomplete Data|1|||
161962373|NCT02920528|584909775|FG002|Overall Study|Incomplete Data|1|||
161962374|NCT02920528|584909773|FG000|Overall Study|Adverse Event|0|||
161962375|NCT02920528|584909774|FG001|Overall Study|Adverse Event|0|||
161962376|NCT02920528|584909775|FG002|Overall Study|Adverse Event|3|||
161962377|NCT02920528|584909773|FG000|Overall Study|Did not meet inclusion criteria|2|||
161962378|NCT02920528|584909774|FG001|Overall Study|Did not meet inclusion criteria|0|||
161962379|NCT02920528|584909775|FG002|Overall Study|Did not meet inclusion criteria|1|||
161962380|NCT03596047|584909777|FG000|Overall Study|Withdrawal by Subject|7|||
161962381|NCT03596047|584909778|FG001|Overall Study|Withdrawal by Subject|4|||
161962382|NCT03596047|584909777|FG000|Overall Study|Lost to Follow-up|0|||
161962383|NCT03596047|584909778|FG001|Overall Study|Lost to Follow-up|2|||
161962384|NCT00066703|584909779|FG000|Overall Study|Adverse Event|80|||
161962385|NCT00066703|584909780|FG001|Overall Study|Adverse Event|111|||
161715130|NCT00785577|584002946|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
161715131|NCT00785577|584002947|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
161715132|NCT00785577|584002948|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
161715133|NCT00785577|584002949|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
161715134|NCT00785577|584002950|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
161715135|NCT01650805|584002955|FG000|Overall Study|Withdrawal by Subject|1|||
161715136|NCT01650805|584002956|FG001|Overall Study|Withdrawal by Subject|0|||
161715137|NCT04070378|584002962|FG000|Overall Study|Withdrawal by Subject|2|||
161715138|NCT04070378|584002962|FG000|Overall Study|Screen Failure|6|||
161715139|NCT04070378|584002962|FG000|Overall Study|Physician Decision|1|||
161715140|NCT04070378|584002962|FG000|Overall Study|Adverse Event|1|||
161715141|NCT01901328|584002963|FG000|Overall Study|Lost to Follow-up|1|||
161715142|NCT01901328|584002964|FG001|Overall Study|Lost to Follow-up|0|||
161715143|NCT01901328|584002963|FG000|Overall Study|Physician Decision|0|||
161715144|NCT01901328|584002964|FG001|Overall Study|Physician Decision|1|||
161715145|NCT01901328|584002963|FG000|Overall Study|Protocol Violation|1|||
161715146|NCT01901328|584002964|FG001|Overall Study|Protocol Violation|1|||
161715147|NCT01901328|584002963|FG000|Overall Study|Study Terminated by Sponsor|19|||
161715148|NCT01901328|584002964|FG001|Overall Study|Study Terminated by Sponsor|16|||
161715149|NCT01901328|584002963|FG000|Overall Study|Withdrawal by Subject|1|||
161715150|NCT01901328|584002964|FG001|Overall Study|Withdrawal by Subject|2|||
161715151|NCT01901328|584002963|FG000|Overall Study|Lack of Efficacy|0|||
161715152|NCT01901328|584002964|FG001|Overall Study|Lack of Efficacy|1|||
161715153|NCT02462889|584002965|FG000|Overall Study|Withdrawal by Subject|2|||
161715154|NCT02462889|584002966|FG001|Overall Study|Withdrawal by Subject|6|||
161715155|NCT02462889|584002965|FG000|Overall Study|Death|1|||
161715156|NCT02462889|584002966|FG001|Overall Study|Death|5|||
161715157|NCT04358458|584002969|FG000|Overall Study|Death|1|||
161715158|NCT04358458|584002970|FG001|Overall Study|Death|1|||
161715159|NCT04358458|584002971|FG002|Overall Study|Death|3|||
161715160|NCT04358458|584002972|FG003|Overall Study|Death|8|||
161715161|NCT04358458|584002973|FG004|Overall Study|Death|1|||
161715162|NCT04358458|584002974|FG005|Overall Study|Death|6|||
161715163|NCT04358458|584002975|FG006|Overall Study|Death|2|||
161715164|NCT04358458|584002976|FG007|Overall Study|Death|3|||
161715165|NCT04358458|584002969|FG000|Overall Study|Lost to Follow-up|0|||
161715166|NCT04358458|584002970|FG001|Overall Study|Lost to Follow-up|0|||
161715167|NCT04358458|584002971|FG002|Overall Study|Lost to Follow-up|0|||
161715168|NCT04358458|584002972|FG003|Overall Study|Lost to Follow-up|0|||
161715169|NCT04358458|584002973|FG004|Overall Study|Lost to Follow-up|0|||
161715170|NCT04358458|584002974|FG005|Overall Study|Lost to Follow-up|0|||
161715171|NCT04358458|584002975|FG006|Overall Study|Lost to Follow-up|0|||
161715172|NCT04358458|584002976|FG007|Overall Study|Lost to Follow-up|1|||
161715173|NCT04358458|584002969|FG000|Overall Study|Site is closing study participation|0|||
161715174|NCT04358458|584002970|FG001|Overall Study|Site is closing study participation|0|||
161715175|NCT04358458|584002971|FG002|Overall Study|Site is closing study participation|0|||
161715176|NCT04358458|584002972|FG003|Overall Study|Site is closing study participation|1|||
161715177|NCT04358458|584002973|FG004|Overall Study|Site is closing study participation|0|||
161715178|NCT04358458|584002974|FG005|Overall Study|Site is closing study participation|0|||
161715179|NCT04358458|584002975|FG006|Overall Study|Site is closing study participation|0|||
161715180|NCT04358458|584002976|FG007|Overall Study|Site is closing study participation|0|||
161715181|NCT04358458|584002969|FG000|Overall Study|Sponsor request|2|||
161715182|NCT04358458|584002970|FG001|Overall Study|Sponsor request|3|||
161715183|NCT04358458|584002971|FG002|Overall Study|Sponsor request|3|||
161715184|NCT04358458|584002972|FG003|Overall Study|Sponsor request|0|||
161715185|NCT04358458|584002973|FG004|Overall Study|Sponsor request|2|||
161715186|NCT04358458|584002974|FG005|Overall Study|Sponsor request|3|||
161715187|NCT04358458|584002975|FG006|Overall Study|Sponsor request|1|||
161715188|NCT04358458|584002976|FG007|Overall Study|Sponsor request|1|||
161715189|NCT04358458|584002969|FG000|Overall Study|Withdrawal by Subject|0|||
161715190|NCT04358458|584002970|FG001|Overall Study|Withdrawal by Subject|0|||
161715191|NCT04358458|584002971|FG002|Overall Study|Withdrawal by Subject|1|||
161715192|NCT04358458|584002972|FG003|Overall Study|Withdrawal by Subject|1|||
161715193|NCT04358458|584002973|FG004|Overall Study|Withdrawal by Subject|0|||
161715194|NCT04358458|584002974|FG005|Overall Study|Withdrawal by Subject|1|||
161715195|NCT04358458|584002975|FG006|Overall Study|Withdrawal by Subject|0|||
161715196|NCT04358458|584002976|FG007|Overall Study|Withdrawal by Subject|1|||
161715197|NCT01981187|584004562|FG000|Overall Study|Participant/guardian decision|2|||
161715198|NCT01981187|584004562|FG000|Overall Study|Physician Decision|1|||
161715199|NCT01981187|584004562|FG000|Overall Study|Disease progression|2|||
161715200|NCT01981187|584004562|FG000|Overall Study|Adverse Event|7|||
161715201|NCT02082184|584004564|FG000|Overall Study|Adverse Event|1|||
161715202|NCT02082184|584004565|FG001|Overall Study|Adverse Event|0|||
161715203|NCT02082184|584004564|FG000|Overall Study|Medical diagnosis|1|||
161715204|NCT02082184|584004565|FG001|Overall Study|Medical diagnosis|2|||
161715205|NCT02082184|584004564|FG000|Overall Study|Device associated symptoms|5|||
161715206|NCT02082184|584004565|FG001|Overall Study|Device associated symptoms|0|||
161715207|NCT02082184|584004564|FG000|Overall Study|Withdrawal by Subject|3|||
161962386|NCT00066703|584909779|FG000|Overall Study|Death|3|||
161962387|NCT00066703|584909780|FG001|Overall Study|Death|0|||
161962388|NCT00066703|584909779|FG000|Overall Study|Lack of Efficacy|114|||
161962389|NCT00066703|584909780|FG001|Overall Study|Lack of Efficacy|69|||
161962390|NCT00066703|584909779|FG000|Overall Study|Lost to Follow-up|31|||
161962391|NCT00066703|584909780|FG001|Overall Study|Lost to Follow-up|28|||
161962392|NCT00066703|584909779|FG000|Overall Study|Withdrawal by Subject|38|||
161962393|NCT00066703|584909780|FG001|Overall Study|Withdrawal by Subject|63|||
161962394|NCT00066703|584909779|FG000|Overall Study|Treatment ongoing|346|||
161962395|NCT00066703|584909780|FG001|Overall Study|Treatment ongoing|311|||
161962396|NCT01696968|584909781|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
161962397|NCT01696968|584909782|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
161962398|NCT01696968|584909781|FG000|Overall Study|Died Before Randomization|3|||
161962399|NCT01696968|584909782|FG001|Overall Study|Died Before Randomization|8|||
161962400|NCT01696968|584909781|FG000|Overall Study|Died Before ASU (Control)|278|||
161962401|NCT01696968|584909782|FG001|Overall Study|Died Before ASU (Control)|0|||
161962402|NCT01696968|584909781|FG000|Overall Study|Refused ASU (Control)|920|||
161962403|NCT01696968|584909782|FG001|Overall Study|Refused ASU (Control)|0|||
161962404|NCT01696968|584909781|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
161962405|NCT01696968|584909782|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
161962406|NCT00734604|584909783|FG000|Overall Study|Adverse Event|0|||
161962407|NCT00734604|584909784|FG001|Overall Study|Adverse Event|2|||
161962408|NCT00734604|584909785|FG002|Overall Study|Adverse Event|0|||
161962409|NCT00734604|584909786|FG003|Overall Study|Adverse Event|2|||
161962410|NCT00734604|584909787|FG004|Overall Study|Adverse Event|1|||
161962411|NCT00734604|584909788|FG005|Overall Study|Adverse Event|1|||
161962412|NCT00734604|584909783|FG000|Overall Study|Serious Adverse Event|1|||
161962413|NCT00734604|584909784|FG001|Overall Study|Serious Adverse Event|0|||
161962414|NCT00734604|584909785|FG002|Overall Study|Serious Adverse Event|1|||
161962415|NCT00734604|584909786|FG003|Overall Study|Serious Adverse Event|2|||
161962416|NCT00734604|584909787|FG004|Overall Study|Serious Adverse Event|0|||
161962417|NCT00734604|584909788|FG005|Overall Study|Serious Adverse Event|1|||
161962418|NCT00734604|584909783|FG000|Overall Study|Lost to Follow-up|1|||
161962419|NCT00734604|584909784|FG001|Overall Study|Lost to Follow-up|2|||
161962420|NCT00734604|584909785|FG002|Overall Study|Lost to Follow-up|2|||
161962421|NCT00734604|584909786|FG003|Overall Study|Lost to Follow-up|4|||
161962422|NCT00734604|584909787|FG004|Overall Study|Lost to Follow-up|2|||
161962423|NCT00734604|584909788|FG005|Overall Study|Lost to Follow-up|3|||
161962424|NCT00734604|584909783|FG000|Overall Study|Physician Decision|0|||
161962425|NCT00734604|584909784|FG001|Overall Study|Physician Decision|1|||
161962426|NCT00734604|584909785|FG002|Overall Study|Physician Decision|1|||
161962427|NCT00734604|584909786|FG003|Overall Study|Physician Decision|0|||
161962428|NCT00734604|584909787|FG004|Overall Study|Physician Decision|0|||
161962429|NCT00734604|584909788|FG005|Overall Study|Physician Decision|0|||
161962430|NCT00734604|584909783|FG000|Overall Study|Protocol Violation|0|||
161962431|NCT00734604|584909784|FG001|Overall Study|Protocol Violation|2|||
161962432|NCT00734604|584909785|FG002|Overall Study|Protocol Violation|0|||
161962433|NCT00734604|584909786|FG003|Overall Study|Protocol Violation|0|||
161962434|NCT00734604|584909787|FG004|Overall Study|Protocol Violation|1|||
161962435|NCT00734604|584909788|FG005|Overall Study|Protocol Violation|0|||
161962436|NCT00734604|584909783|FG000|Overall Study|Sponsor Decision|1|||
161962437|NCT00734604|584909784|FG001|Overall Study|Sponsor Decision|2|||
161962438|NCT00734604|584909785|FG002|Overall Study|Sponsor Decision|1|||
161962439|NCT00734604|584909786|FG003|Overall Study|Sponsor Decision|0|||
161962440|NCT00734604|584909787|FG004|Overall Study|Sponsor Decision|2|||
161962441|NCT00734604|584909788|FG005|Overall Study|Sponsor Decision|0|||
161962442|NCT00734604|584909783|FG000|Overall Study|Withdrawal by Subject|0|||
161962443|NCT00734604|584909784|FG001|Overall Study|Withdrawal by Subject|2|||
161962444|NCT00734604|584909785|FG002|Overall Study|Withdrawal by Subject|0|||
161962445|NCT00734604|584909786|FG003|Overall Study|Withdrawal by Subject|1|||
161962446|NCT00734604|584909787|FG004|Overall Study|Withdrawal by Subject|2|||
161962447|NCT00734604|584909788|FG005|Overall Study|Withdrawal by Subject|1|||
161962448|NCT00734604|584909783|FG000|Overall Study|Lack of Efficacy|0|||
161962449|NCT00734604|584909784|FG001|Overall Study|Lack of Efficacy|1|||
161962450|NCT00734604|584909785|FG002|Overall Study|Lack of Efficacy|1|||
161962451|NCT00734604|584909786|FG003|Overall Study|Lack of Efficacy|0|||
161962452|NCT00734604|584909787|FG004|Overall Study|Lack of Efficacy|0|||
161962453|NCT00734604|584909788|FG005|Overall Study|Lack of Efficacy|0|||
161962454|NCT02199314|584909789|FG000|Overall Study|Withdrawal by Subject|6|||
161962455|NCT02199314|584909789|FG000|Overall Study|Physician Decision|10|||
161962456|NCT04848220|584909790|FG000|Overall Study|Unable to proceed to study procedure|0|||
161962457|NCT04848220|584909791|FG001|Overall Study|Unable to proceed to study procedure|1|||
161962458|NCT04848220|584909792|FG002|Overall Study|Unable to proceed to study procedure|0|||
161962459|NCT04848220|584909790|FG000|Overall Study|Fractional flow not significant|0|||
161962460|NCT04848220|584909791|FG001|Overall Study|Fractional flow not significant|1|||
161962461|NCT04848220|584909792|FG002|Overall Study|Fractional flow not significant|0|||
161962462|NCT02557100|584909797|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
161962463|NCT02557100|584909798|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
161962464|NCT02557100|584909799|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
161962465|NCT02557100|584909797|FG000|Single Blind Treatment Period|Death|0|||
161962466|NCT02557100|584909798|FG001|Single Blind Treatment Period|Death|1|||
161962467|NCT02557100|584909799|FG002|Single Blind Treatment Period|Death|0|||
161962468|NCT02557100|584909797|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
161962469|NCT02557100|584909798|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
161962470|NCT02557100|584909799|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
161962471|NCT02557100|584909797|FG000|Single Blind Treatment Period|Adverse Event|0|||
161962472|NCT02557100|584909798|FG001|Single Blind Treatment Period|Adverse Event|1|||
161962473|NCT02557100|584909799|FG002|Single Blind Treatment Period|Adverse Event|0|||
161962474|NCT02557100|584909797|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
161715208|NCT02082184|584004565|FG001|Overall Study|Withdrawal by Subject|2|||
161715209|NCT02082184|584004564|FG000|Overall Study|Protocol Violation|0|||
161715210|NCT02082184|584004565|FG001|Overall Study|Protocol Violation|6|||
161715211|NCT02082184|584004564|FG000|Overall Study|Lost to Follow-up|0|||
161715212|NCT02082184|584004565|FG001|Overall Study|Lost to Follow-up|2|||
161715213|NCT02082184|584004564|FG000|Overall Study|Subject non-compliance|0|||
161715214|NCT02082184|584004565|FG001|Overall Study|Subject non-compliance|1|||
161715215|NCT01943539|584004568|FG000|Overall Study|Non-compliance with at-home intervention|4|||
161715216|NCT01943539|584004569|FG001|Overall Study|Non-compliance with at-home intervention|0|||
161715217|NCT02413398|584004570|FG000|Overall Study|Lost to Follow-up|2|||
161715218|NCT02413398|584004571|FG001|Overall Study|Lost to Follow-up|4|||
161715219|NCT02413398|584004570|FG000|Overall Study|Withdrawal by Subject|1|||
161715220|NCT02413398|584004571|FG001|Overall Study|Withdrawal by Subject|1|||
161715221|NCT02413398|584004570|FG000|Overall Study|Other Eligibility criteria|1|||
161715222|NCT02413398|584004571|FG001|Overall Study|Other Eligibility criteria|2|||
161715223|NCT03715465|584004572|FG000|Overall Study|Withdrawal by Subject|1|||
161715224|NCT03715465|584004573|FG001|Overall Study|Withdrawal by Subject|2|||
161715225|NCT02158533|584004574|FG000|Stage 1|Adverse Event|6|||
161715226|NCT02158533|584004575|FG001|Stage 1|Adverse Event|4|||
161715227|NCT02158533|584004576|FG002|Stage 1|Adverse Event|7|||
161715228|NCT02158533|584004577|FG003|Stage 1|Adverse Event|0|||
161715229|NCT02158533|584004578|FG004|Stage 1|Adverse Event|0|||
161715230|NCT02158533|584004579|FG005|Stage 1|Adverse Event|0|||
161715231|NCT02158533|584004574|FG000|Stage 1|Withdrawal by Subject|3|||
161715232|NCT02158533|584004575|FG001|Stage 1|Withdrawal by Subject|2|||
161715233|NCT02158533|584004576|FG002|Stage 1|Withdrawal by Subject|1|||
161715234|NCT02158533|584004577|FG003|Stage 1|Withdrawal by Subject|0|||
161715235|NCT02158533|584004578|FG004|Stage 1|Withdrawal by Subject|0|||
161715236|NCT02158533|584004579|FG005|Stage 1|Withdrawal by Subject|0|||
161715237|NCT02158533|584004574|FG000|Stage 1|Lack of Efficacy|1|||
161715238|NCT02158533|584004575|FG001|Stage 1|Lack of Efficacy|0|||
161715239|NCT02158533|584004576|FG002|Stage 1|Lack of Efficacy|0|||
161715240|NCT02158533|584004577|FG003|Stage 1|Lack of Efficacy|0|||
161715241|NCT02158533|584004578|FG004|Stage 1|Lack of Efficacy|0|||
161715242|NCT02158533|584004579|FG005|Stage 1|Lack of Efficacy|0|||
161715243|NCT02158533|584004574|FG000|Stage 1|Lost to Follow-up|3|||
161715244|NCT02158533|584004575|FG001|Stage 1|Lost to Follow-up|1|||
161715245|NCT02158533|584004576|FG002|Stage 1|Lost to Follow-up|0|||
161715246|NCT02158533|584004577|FG003|Stage 1|Lost to Follow-up|0|||
161715247|NCT02158533|584004578|FG004|Stage 1|Lost to Follow-up|0|||
161715248|NCT02158533|584004579|FG005|Stage 1|Lost to Follow-up|0|||
161715249|NCT02158533|584004574|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
161715250|NCT02158533|584004575|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
161962475|NCT02557100|584909798|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
161962476|NCT02557100|584909799|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
161715251|NCT02158533|584004576|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
161715252|NCT02158533|584004577|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
161962477|NCT02557100|584909797|FG000|Cumulative Abatacept Period|Other Reasons|0|||
161962478|NCT02557100|584909798|FG001|Cumulative Abatacept Period|Other Reasons|0|||
161962479|NCT02557100|584909799|FG002|Cumulative Abatacept Period|Other Reasons|1|||
161962480|NCT02557100|584909797|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
161715253|NCT02158533|584004578|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
161715254|NCT02158533|584004579|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
161715255|NCT02158533|584004574|FG000|Stage 1|Non-compliance with study visits|1|||
161715256|NCT02158533|584004575|FG001|Stage 1|Non-compliance with study visits|0|||
161715257|NCT02158533|584004576|FG002|Stage 1|Non-compliance with study visits|0|||
161715258|NCT02158533|584004577|FG003|Stage 1|Non-compliance with study visits|0|||
161715259|NCT02158533|584004578|FG004|Stage 1|Non-compliance with study visits|0|||
161715260|NCT02158533|584004579|FG005|Stage 1|Non-compliance with study visits|0|||
161715261|NCT02158533|584004574|FG000|Stage 2|Adverse Event|0|||
161715262|NCT02158533|584004575|FG001|Stage 2|Adverse Event|0|||
161715263|NCT02158533|584004576|FG002|Stage 2|Adverse Event|0|||
161715264|NCT02158533|584004577|FG003|Stage 2|Adverse Event|0|||
161715265|NCT02158533|584004578|FG004|Stage 2|Adverse Event|0|||
161715266|NCT02158533|584004579|FG005|Stage 2|Adverse Event|1|||
161715267|NCT02158533|584004574|FG000|Stage 2|Lack of Efficacy|0|||
161715268|NCT02158533|584004575|FG001|Stage 2|Lack of Efficacy|0|||
161715269|NCT02158533|584004576|FG002|Stage 2|Lack of Efficacy|0|||
161715270|NCT02158533|584004577|FG003|Stage 2|Lack of Efficacy|0|||
161715271|NCT02158533|584004578|FG004|Stage 2|Lack of Efficacy|1|||
161715272|NCT02158533|584004579|FG005|Stage 2|Lack of Efficacy|0|||
161715273|NCT02158533|584004574|FG000|Stage 2|Lost to Follow-up|0|||
161715274|NCT02158533|584004575|FG001|Stage 2|Lost to Follow-up|0|||
161715275|NCT02158533|584004576|FG002|Stage 2|Lost to Follow-up|0|||
161715276|NCT02158533|584004577|FG003|Stage 2|Lost to Follow-up|1|||
161715277|NCT02158533|584004578|FG004|Stage 2|Lost to Follow-up|1|||
161715278|NCT02158533|584004579|FG005|Stage 2|Lost to Follow-up|2|||
161715279|NCT02158533|584004574|FG000|Stage 2|Withdrawal by Subject|0|||
161715280|NCT02158533|584004575|FG001|Stage 2|Withdrawal by Subject|0|||
161715281|NCT02158533|584004576|FG002|Stage 2|Withdrawal by Subject|0|||
161715282|NCT02158533|584004577|FG003|Stage 2|Withdrawal by Subject|0|||
161715283|NCT02158533|584004578|FG004|Stage 2|Withdrawal by Subject|1|||
161715284|NCT02158533|584004579|FG005|Stage 2|Withdrawal by Subject|2|||
161715285|NCT02158533|584004574|FG000|Stage 2|Physician Decision|0|||
161715286|NCT02158533|584004575|FG001|Stage 2|Physician Decision|0|||
161715287|NCT02158533|584004576|FG002|Stage 2|Physician Decision|0|||
161715288|NCT02158533|584004577|FG003|Stage 2|Physician Decision|0|||
161715289|NCT02158533|584004578|FG004|Stage 2|Physician Decision|1|||
161715290|NCT02158533|584004579|FG005|Stage 2|Physician Decision|0|||
161715291|NCT02158533|584004574|FG000|Stage 2|Pregnancy|0|||
161715292|NCT02158533|584004575|FG001|Stage 2|Pregnancy|0|||
161715293|NCT02158533|584004576|FG002|Stage 2|Pregnancy|0|||
161715294|NCT02158533|584004577|FG003|Stage 2|Pregnancy|1|||
161715295|NCT02158533|584004578|FG004|Stage 2|Pregnancy|0|||
161715296|NCT02158533|584004579|FG005|Stage 2|Pregnancy|0|||
161715297|NCT02158533|584004574|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
161715298|NCT02158533|584004575|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
161715299|NCT02158533|584004576|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
161715300|NCT02158533|584004577|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
161715301|NCT02158533|584004578|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
161715302|NCT02158533|584004579|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
161715303|NCT02158533|584004574|FG000|Stage 2|Non-adherence with study visits|0|||
161715304|NCT02158533|584004575|FG001|Stage 2|Non-adherence with study visits|0|||
161715305|NCT02158533|584004576|FG002|Stage 2|Non-adherence with study visits|0|||
161715306|NCT02158533|584004577|FG003|Stage 2|Non-adherence with study visits|0|||
161715307|NCT02158533|584004578|FG004|Stage 2|Non-adherence with study visits|0|||
161715308|NCT02158533|584004579|FG005|Stage 2|Non-adherence with study visits|1|||
161715309|NCT00881205|584004590|FG000|Overall Study|Adverse Event|8|||
161715310|NCT00881205|584004591|FG001|Overall Study|Adverse Event|3|||
161715311|NCT00881205|584004590|FG000|Overall Study|Withdrawal by Subject|1|||
161715312|NCT00881205|584004591|FG001|Overall Study|Withdrawal by Subject|2|||
161715313|NCT00881205|584004590|FG000|Overall Study|Lost to Follow-up|0|||
161715314|NCT00881205|584004591|FG001|Overall Study|Lost to Follow-up|1|||
161715315|NCT00881205|584004590|FG000|Overall Study|Administrative problems|1|||
161715316|NCT00881205|584004591|FG001|Overall Study|Administrative problems|1|||
161715317|NCT00881205|584004590|FG000|Overall Study|Condition no longer requires drug|1|||
161715318|NCT00881205|584004591|FG001|Overall Study|Condition no longer requires drug|0|||
161838012|NCT01156142|584450288|FG001|Overall Study|Withdrawal by Subject|6|||
161838013|NCT01156142|584450287|FG000|Overall Study|Ineligible|0|||
161838014|NCT01156142|584450288|FG001|Overall Study|Ineligible|1|||
161838015|NCT00893737|584450289|FG000|Overall Study|Adverse Event|4|||
161838016|NCT00893737|584450289|FG000|Overall Study|Withdrawal by Subject|2|||
161715319|NCT02498652|584004596|FG000|Overall Study|Protocol Violation|0|||
161715320|NCT02498652|584004597|FG001|Overall Study|Protocol Violation|1|||
161715321|NCT01184989|584004602|FG000|Overall Study|Adverse Event|11|||
161715322|NCT01184989|584004602|FG000|Overall Study|Withdrawal by Subject|1|||
161715323|NCT00465569|584004603|FG000|Overall Study|persistent eczema during dose escalation|1|||
161715324|NCT00465569|584004604|FG001|Overall Study|persistent eczema during dose escalation|0|||
161715325|NCT00482001|584004606|FG000|Overall Study|Protocol Violation|1|||
161715326|NCT00482001|584004607|FG001|Overall Study|Protocol Violation|1|||
161715327|NCT04786210|584004608|FG000|Overall Study|Lost to Follow-up|2|||
161715328|NCT04786210|584004608|FG000|Overall Study|Withdrawal by Subject|4|||
161715329|NCT03826914|584004609|FG000|Overall Study|Withdrawal by Subject|1|||
161715330|NCT03826914|584004610|FG001|Overall Study|Withdrawal by Subject|1|||
161715331|NCT04334148|584004612|FG000|Overall Study|positive nasal swab at baseline|0|||
161715332|NCT04334148|584004613|FG001|Overall Study|positive nasal swab at baseline|1|||
161715333|NCT05370157|584004614|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
161715334|NCT05370157|584004615|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
161715335|NCT05370157|584004614|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
161715336|NCT05370157|584004615|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
161715337|NCT01508676|584004616|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
161715338|NCT01508676|584004617|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
161715339|NCT01508676|584004616|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
161715340|NCT01508676|584004617|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
161715341|NCT01508676|584004616|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
161715342|NCT01508676|584004617|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
161715343|NCT01508676|584004616|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
161715344|NCT01508676|584004617|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
161715345|NCT01508676|584004616|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
161715346|NCT01508676|584004617|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
161715347|NCT06129487|584004618|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
161715348|NCT06129487|584004619|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
161715349|NCT03772327|584004620|FG000|Overall Study|Lost to Follow-up|3|||
161715350|NCT03772327|584004621|FG001|Overall Study|Lost to Follow-up|4|||
161715351|NCT03772327|584004620|FG000|Overall Study|Withdrawal by Subject|2|||
161715352|NCT03772327|584004621|FG001|Overall Study|Withdrawal by Subject|3|||
161715353|NCT04689828|584004622|FG000|Overall Study|Subject decision|5|||
161715354|NCT04689828|584004623|FG001|Overall Study|Subject decision|5|||
161715355|NCT04689828|584004622|FG000|Overall Study|Adverse Event|12|||
161715356|NCT04689828|584004623|FG001|Overall Study|Adverse Event|12|||
161715357|NCT04689828|584004622|FG000|Overall Study|Physician Decision|24|||
161715358|NCT04689828|584004623|FG001|Overall Study|Physician Decision|32|||
161715359|NCT04689828|584004622|FG000|Overall Study|Progressive disease|54|||
161715360|NCT04689828|584004623|FG001|Overall Study|Progressive disease|173|||
161715361|NCT04689828|584004622|FG000|Overall Study|Death|0|||
161715362|NCT04689828|584004623|FG001|Overall Study|Death|1|||
161715363|NCT04689828|584004622|FG000|Overall Study|Lost to Follow-up|1|||
161715364|NCT04689828|584004623|FG001|Overall Study|Lost to Follow-up|0|||
161715365|NCT04689828|584004622|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
161715366|NCT04689828|584004623|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
161715367|NCT04689828|584004622|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
161715368|NCT04689828|584004623|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
161715369|NCT04689828|584004622|FG000|Overall Study|Participants not treated|7|||
161715370|NCT04689828|584004623|FG001|Overall Study|Participants not treated|2|||
161715371|NCT00195351|584004628|FG000|Overall Study|Lost to Follow-up|9|||
161715372|NCT00195351|584004629|FG001|Overall Study|Lost to Follow-up|9|||
161715373|NCT00195351|584004628|FG000|Overall Study|Withdrawal by Subject|6|||
161715374|NCT00195351|584004629|FG001|Overall Study|Withdrawal by Subject|3|||
161715375|NCT00195351|584004628|FG000|Overall Study|Protocol Deviation|3|||
161715376|NCT00195351|584004629|FG001|Overall Study|Protocol Deviation|2|||
161715377|NCT00195351|584004628|FG000|Overall Study|Death|3|||
161715378|NCT00195351|584004629|FG001|Overall Study|Death|1|||
161715379|NCT00195351|584004628|FG000|Overall Study|Lack of Efficacy|0|||
161715380|NCT00195351|584004629|FG001|Overall Study|Lack of Efficacy|1|||
161715381|NCT04332419|584004632|FG000|Overall Study|Withdrawal by Subject|1|||
161715382|NCT02493751|584004633|FG000|Overall Study|Withdrawal by Subject|2|||
161715383|NCT02493751|584004634|FG001|Overall Study|Withdrawal by Subject|8|||
161715384|NCT02493751|584004633|FG000|Overall Study|Death|6|||
161715385|NCT02493751|584004634|FG001|Overall Study|Death|13|||
161715386|NCT02493751|584004633|FG000|Overall Study|Lost to Follow-up|2|||
161715387|NCT02493751|584004634|FG001|Overall Study|Lost to Follow-up|3|||
161715388|NCT02493751|584004633|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
161715389|NCT02493751|584004634|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
161715390|NCT01480180|584004635|FG000|Main Phase|Withdrawal criteria|12|||
161715391|NCT01480180|584004636|FG001|Main Phase|Withdrawal criteria|1|||
161715392|NCT01480180|584004637|FG002|Main Phase|Withdrawal criteria|0|||
161715393|NCT01480180|584004638|FG003|Main Phase|Withdrawal criteria|0|||
161715394|NCT01480180|584004639|FG004|Main Phase|Withdrawal criteria|0|||
161715395|NCT01480180|584004640|FG005|Main Phase|Withdrawal criteria|0|||
161715396|NCT01480180|584004635|FG000|Main Phase|Lack of Efficacy|1|||
161715397|NCT01480180|584004636|FG001|Main Phase|Lack of Efficacy|0|||
161715398|NCT01480180|584004637|FG002|Main Phase|Lack of Efficacy|0|||
161715399|NCT01480180|584004638|FG003|Main Phase|Lack of Efficacy|0|||
161715400|NCT01480180|584004639|FG004|Main Phase|Lack of Efficacy|0|||
161715401|NCT01480180|584004640|FG005|Main Phase|Lack of Efficacy|0|||
161715402|NCT01480180|584004635|FG000|Main Phase|Non-compliance|3|||
161715403|NCT01480180|584004636|FG001|Main Phase|Non-compliance|0|||
161715404|NCT01480180|584004637|FG002|Main Phase|Non-compliance|0|||
161715405|NCT01480180|584004638|FG003|Main Phase|Non-compliance|0|||
161715406|NCT01480180|584004639|FG004|Main Phase|Non-compliance|0|||
161715407|NCT01480180|584004640|FG005|Main Phase|Non-compliance|0|||
161962481|NCT02557100|584909798|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
161962482|NCT02557100|584909799|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
161962483|NCT02557100|584909797|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
161962484|NCT02557100|584909798|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
161962485|NCT02557100|584909799|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
161962486|NCT02513485|584909803|FG000|Overall Study|Adverse Event|1|||
161962487|NCT02513485|584909804|FG001|Overall Study|Adverse Event|0|||
161962488|NCT01406938|584909820|FG000|Induction Period|Subject/guardian decision|6|||
161962489|NCT01406938|584909821|FG001|Induction Period|Subject/guardian decision|8|||
161962490|NCT01406938|584909822|FG002|Induction Period|Subject/guardian decision|0|||
161962491|NCT01406938|584909823|FG003|Induction Period|Subject/guardian decision|0|||
161962492|NCT01406938|584909824|FG004|Induction Period|Subject/guardian decision|0|||
161962493|NCT01406938|584909825|FG005|Induction Period|Subject/guardian decision|0|||
161962494|NCT01406938|584909820|FG000|Induction Period|Protocol deviation|1|||
161962495|NCT01406938|584909821|FG001|Induction Period|Protocol deviation|0|||
161962496|NCT01406938|584909822|FG002|Induction Period|Protocol deviation|0|||
161962497|NCT01406938|584909823|FG003|Induction Period|Protocol deviation|0|||
161962498|NCT01406938|584909824|FG004|Induction Period|Protocol deviation|0|||
161962499|NCT01406938|584909825|FG005|Induction Period|Protocol deviation|0|||
161962500|NCT01406938|584909820|FG000|Induction Period|Adverse Event|8|||
161962501|NCT01406938|584909821|FG001|Induction Period|Adverse Event|9|||
161962502|NCT01406938|584909822|FG002|Induction Period|Adverse Event|0|||
161962503|NCT01406938|584909823|FG003|Induction Period|Adverse Event|0|||
161962504|NCT01406938|584909824|FG004|Induction Period|Adverse Event|0|||
161962505|NCT01406938|584909825|FG005|Induction Period|Adverse Event|0|||
161962506|NCT01406938|584909820|FG000|Induction Period|Lack of Efficacy|1|||
161962507|NCT01406938|584909821|FG001|Induction Period|Lack of Efficacy|0|||
161962508|NCT01406938|584909822|FG002|Induction Period|Lack of Efficacy|0|||
161962509|NCT01406938|584909823|FG003|Induction Period|Lack of Efficacy|0|||
161962510|NCT01406938|584909824|FG004|Induction Period|Lack of Efficacy|0|||
161962511|NCT01406938|584909825|FG005|Induction Period|Lack of Efficacy|0|||
161962512|NCT01406938|584909820|FG000|Induction Period|Lost to Follow-up|2|||
161962513|NCT01406938|584909821|FG001|Induction Period|Lost to Follow-up|3|||
161962514|NCT01406938|584909822|FG002|Induction Period|Lost to Follow-up|0|||
161962515|NCT01406938|584909823|FG003|Induction Period|Lost to Follow-up|0|||
161715408|NCT01480180|584004635|FG000|Main Phase|Unclassified|3|||
161715409|NCT01480180|584004636|FG001|Main Phase|Unclassified|0|||
161715410|NCT01480180|584004637|FG002|Main Phase|Unclassified|0|||
161715411|NCT01480180|584004638|FG003|Main Phase|Unclassified|0|||
161715412|NCT01480180|584004639|FG004|Main Phase|Unclassified|0|||
161715413|NCT01480180|584004640|FG005|Main Phase|Unclassified|0|||
161715414|NCT01480180|584004635|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
161715415|NCT01480180|584004636|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
161715416|NCT01480180|584004637|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
161715417|NCT01480180|584004638|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
161715418|NCT01480180|584004639|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
161715419|NCT01480180|584004640|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
161715420|NCT01480180|584004635|FG000|Extension Phase, Part 1|Unclassified|0|||
161715421|NCT01480180|584004636|FG001|Extension Phase, Part 1|Unclassified|0|||
161715422|NCT01480180|584004637|FG002|Extension Phase, Part 1|Unclassified|1|||
161715423|NCT01480180|584004638|FG003|Extension Phase, Part 1|Unclassified|0|||
161715424|NCT01480180|584004639|FG004|Extension Phase, Part 1|Unclassified|0|||
161715425|NCT01480180|584004640|FG005|Extension Phase, Part 1|Unclassified|0|||
161715426|NCT01480180|584004635|FG000|Extension Phase, Part 1|Adverse Event|0|||
161715427|NCT01480180|584004636|FG001|Extension Phase, Part 1|Adverse Event|0|||
161715428|NCT01480180|584004637|FG002|Extension Phase, Part 1|Adverse Event|4|||
161715429|NCT01480180|584004638|FG003|Extension Phase, Part 1|Adverse Event|1|||
161715430|NCT01480180|584004639|FG004|Extension Phase, Part 1|Adverse Event|0|||
161715431|NCT01480180|584004640|FG005|Extension Phase, Part 1|Adverse Event|0|||
161715432|NCT01480180|584004635|FG000|Extension Phase, Part 1|Change of treatment|0|||
161715433|NCT01480180|584004636|FG001|Extension Phase, Part 1|Change of treatment|0|||
161715434|NCT01480180|584004637|FG002|Extension Phase, Part 1|Change of treatment|0|||
161715435|NCT01480180|584004638|FG003|Extension Phase, Part 1|Change of treatment|9|||
161715436|NCT01480180|584004639|FG004|Extension Phase, Part 1|Change of treatment|0|||
161962516|NCT01406938|584909824|FG004|Induction Period|Lost to Follow-up|0|||
161962517|NCT01406938|584909825|FG005|Induction Period|Lost to Follow-up|0|||
161962518|NCT01406938|584909820|FG000|Maintenance Period|Adverse Event|0|||
161962519|NCT01406938|584909821|FG001|Maintenance Period|Adverse Event|0|||
161962520|NCT01406938|584909822|FG002|Maintenance Period|Adverse Event|2|||
161962521|NCT01406938|584909823|FG003|Maintenance Period|Adverse Event|8|||
161962522|NCT01406938|584909824|FG004|Maintenance Period|Adverse Event|4|||
161962523|NCT01406938|584909825|FG005|Maintenance Period|Adverse Event|2|||
161962524|NCT01406938|584909820|FG000|Maintenance Period|Death|0|||
161962525|NCT01406938|584909821|FG001|Maintenance Period|Death|0|||
161962526|NCT01406938|584909822|FG002|Maintenance Period|Death|0|||
161962527|NCT01406938|584909823|FG003|Maintenance Period|Death|0|||
161715437|NCT01480180|584004640|FG005|Extension Phase, Part 1|Change of treatment|0|||
161715438|NCT01480180|584004635|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
161715439|NCT01480180|584004636|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
161715440|NCT01480180|584004637|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
161715441|NCT01480180|584004638|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
161715442|NCT01480180|584004639|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
161715443|NCT01480180|584004640|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
161715444|NCT01480180|584004635|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
161715445|NCT01480180|584004636|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
161715446|NCT01480180|584004637|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
161715447|NCT01480180|584004638|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
161715448|NCT01480180|584004639|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
161715449|NCT01480180|584004640|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
161715450|NCT01480180|584004635|FG000|Extension Phase, Part 2|Unclassified|0|||
161715451|NCT01480180|584004636|FG001|Extension Phase, Part 2|Unclassified|0|||
161715452|NCT01480180|584004637|FG002|Extension Phase, Part 2|Unclassified|3|||
161715453|NCT01480180|584004638|FG003|Extension Phase, Part 2|Unclassified|1|||
161715454|NCT01480180|584004639|FG004|Extension Phase, Part 2|Unclassified|1|||
161715455|NCT01480180|584004640|FG005|Extension Phase, Part 2|Unclassified|0|||
161715456|NCT00519623|584004641|FG000|Overall Study|Adverse Event|1|||
161715457|NCT04222725|584004644|FG000|Overall Study|Adverse Event|0|||
161715458|NCT04222725|584004645|FG001|Overall Study|Adverse Event|1|||
161715459|NCT04222725|584004646|FG002|Overall Study|Adverse Event|0|||
161715460|NCT04222725|584004647|FG003|Overall Study|Adverse Event|0|||
161715461|NCT03819140|584004648|FG000|Overall Study|Lost to Follow-up|1|||
161715462|NCT03819140|584004649|FG001|Overall Study|Lost to Follow-up|2|||
161715463|NCT03819140|584004648|FG000|Overall Study|Withdrawal by Subject|3|||
161715464|NCT03819140|584004649|FG001|Overall Study|Withdrawal by Subject|2|||
161715465|NCT03819140|584004648|FG000|Overall Study|Adverse Event|0|||
161715466|NCT03819140|584004649|FG001|Overall Study|Adverse Event|1|||
161715467|NCT03819140|584004648|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
161715468|NCT03819140|584004649|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
161715469|NCT03819140|584004648|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
161715470|NCT03819140|584004649|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
161715471|NCT00658333|584004650|FG000|Overall Study|Adverse Event|2|||
161715472|NCT00658333|584004651|FG001|Overall Study|Adverse Event|1|||
161715473|NCT00828451|584004654|FG000|Overall Study|Death|2|||
161715474|NCT00828451|584004654|FG000|Overall Study|Lack of intravenous line|7|||
161715475|NCT00828451|584004654|FG000|Overall Study|Withdrawal by Subject|1|||
161715476|NCT00828451|584004654|FG000|Overall Study|Deterioration in clinical status|1|||
161715477|NCT03256539|584004655|FG000|Overall Study|Withdrawal by Subject|0|||
161715478|NCT03256539|584004656|FG001|Overall Study|Withdrawal by Subject|3|||
161715479|NCT03256539|584004655|FG000|Overall Study|Unexpected closure of study components|8|||
161715480|NCT03256539|584004656|FG001|Overall Study|Unexpected closure of study components|4|||
161715481|NCT05755438|584004659|FG000|12-week DBVC Period|Adverse Event|4|||
161715482|NCT05755438|584004660|FG001|12-week DBVC Period|Adverse Event|1|||
161715483|NCT05755438|584004659|FG000|12-week DBVC Period|Physician Decision|1|||
161715484|NCT05755438|584004660|FG001|12-week DBVC Period|Physician Decision|1|||
161715485|NCT05755438|584004659|FG000|12-week DBVC Period|Protocol Violation|4|||
161715486|NCT05755438|584004660|FG001|12-week DBVC Period|Protocol Violation|2|||
161715487|NCT05755438|584004659|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
161715488|NCT05755438|584004660|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
161715489|NCT05755438|584004659|FG000|12-week DBVC Period|Sponsor Decision|1|||
161715490|NCT05755438|584004660|FG001|12-week DBVC Period|Sponsor Decision|0|||
161715491|NCT05755438|584004659|FG000|40-week OLE Period|Adverse Event|0|||
161715492|NCT05755438|584004660|FG001|40-week OLE Period|Adverse Event|2|||
161715493|NCT05755438|584004659|FG000|40-week OLE Period|Lack of Efficacy|1|||
161715494|NCT05755438|584004660|FG001|40-week OLE Period|Lack of Efficacy|1|||
161715495|NCT05755438|584004659|FG000|40-week OLE Period|Lost to Follow-up|1|||
161715496|NCT05755438|584004660|FG001|40-week OLE Period|Lost to Follow-up|0|||
161715497|NCT05755438|584004659|FG000|40-week OLE Period|Physician Decision|1|||
161962528|NCT01406938|584909824|FG004|Maintenance Period|Death|1|||
161715498|NCT05755438|584004660|FG001|40-week OLE Period|Physician Decision|1|||
161715499|NCT05755438|584004659|FG000|40-week OLE Period|Protocol Violation|1|||
161715500|NCT05755438|584004660|FG001|40-week OLE Period|Protocol Violation|1|||
161715501|NCT05755438|584004659|FG000|40-week OLE Period|Withdrawal by Subject|6|||
161715502|NCT05755438|584004660|FG001|40-week OLE Period|Withdrawal by Subject|6|||
161715503|NCT05755438|584004659|FG000|40-week OLE Period|Sponsor Decision|3|||
161715504|NCT05755438|584004660|FG001|40-week OLE Period|Sponsor Decision|0|||
161715505|NCT05755438|584004659|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
161715506|NCT05755438|584004660|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
161715507|NCT05755438|584004659|FG000|40-week OLE Period|Ongoing|46|||
161715508|NCT05755438|584004660|FG001|40-week OLE Period|Ongoing|58|||
161838017|NCT00893737|584450289|FG000|Overall Study|Lost to Follow-up|6|||
162031827|NCT03387150|585174091|FG002|Overall Study|Participant unable to adhere to visit|0|||
162031828|NCT03387150|585174092|FG003|Overall Study|Participant unable to adhere to visit|0|||
162031829|NCT03387150|585174093|FG004|Overall Study|Participant unable to adhere to visit|2|||
162031830|NCT03387150|585174094|FG005|Overall Study|Participant unable to adhere to visit|2|||
162031831|NCT03387150|585174095|FG006|Overall Study|Participant unable to adhere to visit|0|||
162031832|NCT04006119|585174096|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
162031833|NCT04006119|585174096|FG000|End of Treatment Veledimex|Adverse Event|2|||
162031834|NCT04006119|585174096|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
162031835|NCT04006119|585174096|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
162031836|NCT04006119|585174096|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
162031837|NCT04006119|585174096|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
162031838|NCT03621475|585174097|FG000|Overall Study|No longer required restraints at initiation|0|||
162031839|NCT03621475|585174098|FG001|Overall Study|No longer required restraints at initiation|1|||
162031840|NCT00920907|585174103|FG000|Induction Period|Adverse Event|0|||
162031841|NCT00920907|585174104|FG001|Induction Period|Adverse Event|2|||
162031842|NCT00920907|585174103|FG000|Induction Period|Death|1|||
162031843|NCT00920907|585174104|FG001|Induction Period|Death|1|||
162031844|NCT00920907|585174103|FG000|Induction Period|Disease Progression|12|||
162031845|NCT00920907|585174104|FG001|Induction Period|Disease Progression|11|||
162031846|NCT00920907|585174103|FG000|Induction Period|Study Drug Toxicity|8|||
162031847|NCT00920907|585174104|FG001|Induction Period|Study Drug Toxicity|6|||
162031848|NCT00920907|585174103|FG000|Induction Period|No longer meets study criteria|0|||
162031849|NCT00920907|585174104|FG001|Induction Period|No longer meets study criteria|1|||
162031850|NCT00920907|585174103|FG000|Induction Period|Withdrawal by Subject|1|||
162031851|NCT00920907|585174104|FG001|Induction Period|Withdrawal by Subject|1|||
162031852|NCT00920907|585174103|FG000|Maintenance Period|Disease Progression|3|||
162031853|NCT00920907|585174104|FG001|Maintenance Period|Disease Progression|7|||
162031854|NCT00920907|585174103|FG000|Maintenance Period|Administrative (study closure)|7|||
162031855|NCT00920907|585174104|FG001|Maintenance Period|Administrative (study closure)|2|||
162031856|NCT00920907|585174103|FG000|Maintenance Period|Study Drug Toxicity|0|||
162031857|NCT00920907|585174104|FG001|Maintenance Period|Study Drug Toxicity|2|||
162031858|NCT00920907|585174103|FG000|Maintenance Period|Death|1|||
162031859|NCT00920907|585174104|FG001|Maintenance Period|Death|1|||
162031860|NCT00920907|585174103|FG000|Maintenance Period|Withdrawal by Subject|1|||
162031861|NCT00920907|585174104|FG001|Maintenance Period|Withdrawal by Subject|0|||
162031862|NCT00920907|585174103|FG000|Maintenance Period|Adverse Event|0|||
162031863|NCT00920907|585174104|FG001|Maintenance Period|Adverse Event|1|||
162031864|NCT02616601|585174105|FG000|Overall Study|Withdrawal by Subject|4|||
162031865|NCT02616601|585174106|FG001|Overall Study|Withdrawal by Subject|4|||
162031866|NCT02616601|585174107|FG002|Overall Study|Withdrawal by Subject|3|||
162031867|NCT02616601|585174105|FG000|Overall Study|Adverse Event|2|||
162031868|NCT02616601|585174106|FG001|Overall Study|Adverse Event|0|||
162031869|NCT02616601|585174107|FG002|Overall Study|Adverse Event|2|||
162031870|NCT02616601|585174105|FG000|Overall Study|Death|1|||
162031871|NCT02616601|585174106|FG001|Overall Study|Death|0|||
162031872|NCT02616601|585174107|FG002|Overall Study|Death|0|||
162031873|NCT02616601|585174105|FG000|Overall Study|Lost to Follow-up|1|||
162031874|NCT02616601|585174106|FG001|Overall Study|Lost to Follow-up|0|||
162031875|NCT02616601|585174107|FG002|Overall Study|Lost to Follow-up|1|||
162031876|NCT02616601|585174105|FG000|Overall Study|Non-Compliance with Test Article|1|||
162031877|NCT02616601|585174106|FG001|Overall Study|Non-Compliance with Test Article|0|||
162031878|NCT02616601|585174107|FG002|Overall Study|Non-Compliance with Test Article|1|||
162031879|NCT00371761|585174108|FG000|Overall Study|Adverse Event|1|||
162031880|NCT00371761|585174109|FG001|Overall Study|Adverse Event|1|||
162031881|NCT00371761|585174108|FG000|Overall Study|Withdrawal by Subject|1|||
162031882|NCT00371761|585174109|FG001|Overall Study|Withdrawal by Subject|3|||
162031883|NCT00371761|585174108|FG000|Overall Study|Investigator Judgment|2|||
162031884|NCT00371761|585174109|FG001|Overall Study|Investigator Judgment|3|||
162031885|NCT00371761|585174108|FG000|Overall Study|Study termination|4|||
162031886|NCT00371761|585174109|FG001|Overall Study|Study termination|3|||
162031887|NCT00718081|585174110|FG000|Overall Study|Adverse Event|0|||
162031888|NCT00718081|585174111|FG001|Overall Study|Adverse Event|1|||
162031889|NCT00718081|585174112|FG002|Overall Study|Adverse Event|0|||
162031890|NCT00718081|585174110|FG000|Overall Study|Lack of Efficacy|7|||
162031891|NCT00718081|585174111|FG001|Overall Study|Lack of Efficacy|3|||
162031892|NCT00718081|585174112|FG002|Overall Study|Lack of Efficacy|21|||
162031893|NCT00470158|585174113|FG000|Overall Study|Death|0|||
162031894|NCT00470158|585174114|FG001|Overall Study|Death|0|||
162031895|NCT00470158|585174115|FG002|Overall Study|Death|0|||
161715509|NCT00624338|584004665|FG000|Overall Study|Adverse Event|14|||
162031896|NCT00470158|585174116|FG003|Overall Study|Death|0|||
162031897|NCT00470158|585174117|FG004|Overall Study|Death|2|||
162031898|NCT00470158|585174113|FG000|Overall Study|Lost to Follow-up|7|||
162031899|NCT00470158|585174114|FG001|Overall Study|Lost to Follow-up|8|||
162031900|NCT00470158|585174115|FG002|Overall Study|Lost to Follow-up|8|||
161715510|NCT00624338|584004666|FG001|Overall Study|Adverse Event|14|||
161715511|NCT00624338|584004667|FG002|Overall Study|Adverse Event|18|||
161715512|NCT00624338|584004665|FG000|Overall Study|Lost to Follow-up|1|||
161715513|NCT00624338|584004666|FG001|Overall Study|Lost to Follow-up|0|||
161715514|NCT00624338|584004667|FG002|Overall Study|Lost to Follow-up|0|||
161715515|NCT00624338|584004665|FG000|Overall Study|Lack of Efficacy|11|||
161715516|NCT00624338|584004666|FG001|Overall Study|Lack of Efficacy|3|||
161715517|NCT00624338|584004667|FG002|Overall Study|Lack of Efficacy|14|||
161715518|NCT00624338|584004665|FG000|Overall Study|Protocol Violation|3|||
161715519|NCT00624338|584004666|FG001|Overall Study|Protocol Violation|3|||
161715520|NCT00624338|584004667|FG002|Overall Study|Protocol Violation|2|||
161715521|NCT00624338|584004665|FG000|Overall Study|Death|0|||
161715522|NCT00624338|584004666|FG001|Overall Study|Death|2|||
161715523|NCT00624338|584004667|FG002|Overall Study|Death|0|||
161715524|NCT00624338|584004665|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
161715525|NCT00624338|584004666|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
161715526|NCT00624338|584004667|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
161715527|NCT00624338|584004665|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
161715528|NCT00624338|584004666|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
161715529|NCT00624338|584004667|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
161715530|NCT00624338|584004665|FG000|Overall Study|Other|15|||
161715531|NCT00624338|584004666|FG001|Overall Study|Other|5|||
161715532|NCT00624338|584004667|FG002|Overall Study|Other|9|||
161715533|NCT00624338|584004665|FG000|Overall Study|Randomized but not treated|2|||
161715534|NCT00624338|584004666|FG001|Overall Study|Randomized but not treated|1|||
161715535|NCT00624338|584004667|FG002|Overall Study|Randomized but not treated|3|||
161715536|NCT01548638|584004668|FG000|Overall Study|Protocol Violation|3|||
161715537|NCT01548638|584004668|FG000|Overall Study|Withdrawal by Subject|1|||
161715538|NCT01476787|584004672|FG000|Treatment|Progression|64|||
161715539|NCT01476787|584004673|FG001|Treatment|Progression|71|||
161715540|NCT01476787|584004672|FG000|Treatment|Toxicity|44|||
161715541|NCT01476787|584004673|FG001|Treatment|Toxicity|16|||
161715542|NCT01476787|584004672|FG000|Treatment|Death|0|||
161715543|NCT01476787|584004673|FG001|Treatment|Death|1|||
161715544|NCT01476787|584004672|FG000|Treatment|Withdrawal by Subject|3|||
161715545|NCT01476787|584004673|FG001|Treatment|Withdrawal by Subject|14|||
161715546|NCT01476787|584004672|FG000|Treatment|Major protocol violation|1|||
161715547|NCT01476787|584004673|FG001|Treatment|Major protocol violation|6|||
161715548|NCT01476787|584004672|FG000|Treatment|Other reasons|10|||
161715549|NCT01476787|584004673|FG001|Treatment|Other reasons|22|||
161715550|NCT01476787|584004672|FG000|Treatment|Concurrent illness|12|||
161715551|NCT01476787|584004673|FG001|Treatment|Concurrent illness|9|||
161715552|NCT01476787|584004672|FG000|Treatment|Insufficient response|15|||
161715553|NCT01476787|584004673|FG001|Treatment|Insufficient response|3|||
161715554|NCT01476787|584004672|FG000|Treatment|Voluntary treatment discontinuation|8|||
161715555|NCT01476787|584004673|FG001|Treatment|Voluntary treatment discontinuation|4|||
161715556|NCT01919411|584004684|FG000|Overall Study|Lost to Follow-up|2|||
161715557|NCT01919411|584004685|FG001|Overall Study|Lost to Follow-up|4|||
161715558|NCT01919411|584004684|FG000|Overall Study|Physician Decision|1|||
161715559|NCT01919411|584004685|FG001|Overall Study|Physician Decision|0|||
161715560|NCT01919411|584004684|FG000|Overall Study|Protocol Violation|2|||
161715561|NCT01919411|584004685|FG001|Overall Study|Protocol Violation|1|||
161715562|NCT02403206|584004687|FG000|Overall Study|Lost to Follow-up|4|||
161715563|NCT02403206|584004688|FG001|Overall Study|Lost to Follow-up|3|||
161715564|NCT02403206|584004687|FG000|Overall Study|Physician Decision|2|||
161715565|NCT02403206|584004688|FG001|Overall Study|Physician Decision|0|||
161715566|NCT02403206|584004687|FG000|Overall Study|Withdrawal by Subject|3|||
161715567|NCT02403206|584004688|FG001|Overall Study|Withdrawal by Subject|3|||
161715568|NCT02403206|584004687|FG000|Overall Study|Reason not given|2|||
161715569|NCT02403206|584004688|FG001|Overall Study|Reason not given|4|||
161715570|NCT03567187|584004694|FG000|Overall Study|Lost to Follow-up|18|||
161715571|NCT04636177|584004697|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
161715572|NCT04636177|584004698|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
161715573|NCT04636177|584004697|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
161715574|NCT04636177|584004698|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
161715575|NCT04636177|584004697|FG000|Single-arm portion|Withdrawal by Subject|1|||
161715576|NCT04636177|584004698|FG001|Single-arm portion|Withdrawal by Subject|0|||
161715577|NCT04636177|584004697|FG000|Single-arm portion|Adverse Event|1|||
161715578|NCT04636177|584004698|FG001|Single-arm portion|Adverse Event|0|||
161715579|NCT00443560|584006305|FG000|Overall Study|No intrathecal dose|58|||
161715580|NCT00443560|584006306|FG001|Overall Study|No intrathecal dose|26|||
161715581|NCT00443560|584006305|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
161715582|NCT00443560|584006306|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
161715583|NCT01494038|584006311|FG000|Overall Study|Protocol Violation|1|||
161715584|NCT01494038|584006312|FG001|Overall Study|Protocol Violation|1|||
161715585|NCT01494038|584006311|FG000|Overall Study|Lost to Follow-up|18|||
161715586|NCT01494038|584006312|FG001|Overall Study|Lost to Follow-up|20|||
161715587|NCT01494038|584006311|FG000|Overall Study|Withdrawal by Subject|44|||
161715588|NCT01494038|584006312|FG001|Overall Study|Withdrawal by Subject|34|||
161715589|NCT01494038|584006311|FG000|Overall Study|Not able to get to clinic|21|||
161715590|NCT01494038|584006312|FG001|Overall Study|Not able to get to clinic|15|||
161715591|NCT01494038|584006311|FG000|Overall Study|Not willing to adhere to reqs|2|||
161715592|NCT01494038|584006312|FG001|Overall Study|Not willing to adhere to reqs|9|||
161715593|NCT01494038|584006311|FG000|Overall Study|Death|2|||
161715594|NCT01494038|584006312|FG001|Overall Study|Death|4|||
161715595|NCT00537940|584006313|FG000|Overall Study|Adverse Event|20|||
161715596|NCT00537940|584006314|FG001|Overall Study|Adverse Event|19|||
161962529|NCT01406938|584909825|FG005|Maintenance Period|Death|0|||
161962530|NCT01406938|584909820|FG000|Maintenance Period|Subject/guardian decision|0|||
161962531|NCT01406938|584909821|FG001|Maintenance Period|Subject/guardian decision|0|||
161962532|NCT01406938|584909822|FG002|Maintenance Period|Subject/guardian decision|11|||
161962533|NCT01406938|584909823|FG003|Maintenance Period|Subject/guardian decision|7|||
161962534|NCT01406938|584909824|FG004|Maintenance Period|Subject/guardian decision|10|||
161962535|NCT01406938|584909825|FG005|Maintenance Period|Subject/guardian decision|7|||
161962536|NCT01406938|584909820|FG000|Maintenance Period|Protocol Violation|0|||
161962537|NCT01406938|584909821|FG001|Maintenance Period|Protocol Violation|0|||
161962538|NCT01406938|584909822|FG002|Maintenance Period|Protocol Violation|2|||
161962539|NCT01406938|584909823|FG003|Maintenance Period|Protocol Violation|2|||
161962540|NCT01406938|584909824|FG004|Maintenance Period|Protocol Violation|2|||
161962541|NCT01406938|584909825|FG005|Maintenance Period|Protocol Violation|2|||
161962542|NCT01406938|584909820|FG000|Maintenance Period|Pregnancy|0|||
161962543|NCT01406938|584909821|FG001|Maintenance Period|Pregnancy|0|||
161962544|NCT01406938|584909822|FG002|Maintenance Period|Pregnancy|0|||
161962545|NCT01406938|584909823|FG003|Maintenance Period|Pregnancy|0|||
161962546|NCT01406938|584909824|FG004|Maintenance Period|Pregnancy|1|||
161962547|NCT01406938|584909825|FG005|Maintenance Period|Pregnancy|0|||
161962548|NCT01406938|584909820|FG000|Maintenance Period|Lost to Follow-up|0|||
161962549|NCT01406938|584909821|FG001|Maintenance Period|Lost to Follow-up|0|||
161962550|NCT01406938|584909822|FG002|Maintenance Period|Lost to Follow-up|0|||
161962551|NCT01406938|584909823|FG003|Maintenance Period|Lost to Follow-up|0|||
161962552|NCT01406938|584909824|FG004|Maintenance Period|Lost to Follow-up|4|||
161962553|NCT01406938|584909825|FG005|Maintenance Period|Lost to Follow-up|0|||
161962554|NCT01406938|584909820|FG000|Maintenance Period|Lack of Efficacy|0|||
161962555|NCT01406938|584909821|FG001|Maintenance Period|Lack of Efficacy|0|||
161962556|NCT01406938|584909822|FG002|Maintenance Period|Lack of Efficacy|2|||
161962557|NCT01406938|584909823|FG003|Maintenance Period|Lack of Efficacy|1|||
161962558|NCT01406938|584909824|FG004|Maintenance Period|Lack of Efficacy|3|||
161962559|NCT01406938|584909825|FG005|Maintenance Period|Lack of Efficacy|5|||
161962560|NCT01406938|584909820|FG000|Follow up|Lack of Efficacy|3|||
162031901|NCT00470158|585174116|FG003|Overall Study|Lost to Follow-up|5|||
161838018|NCT00928707|584450290|FG000|Overall Study|Protocol Violation|1|||
161962561|NCT01406938|584909821|FG001|Follow up|Lack of Efficacy|2|||
161962562|NCT01406938|584909822|FG002|Follow up|Lack of Efficacy|1|||
161962563|NCT01406938|584909823|FG003|Follow up|Lack of Efficacy|0|||
161962564|NCT01406938|584909824|FG004|Follow up|Lack of Efficacy|0|||
161715597|NCT00537940|584006313|FG000|Overall Study|Lack of Efficacy|8|||
161715598|NCT00537940|584006314|FG001|Overall Study|Lack of Efficacy|16|||
161715599|NCT00537940|584006313|FG000|Overall Study|Lost to Follow-up|23|||
161715600|NCT00537940|584006314|FG001|Overall Study|Lost to Follow-up|29|||
161715601|NCT00537940|584006313|FG000|Overall Study|Withdrawal by Subject|113|||
161715602|NCT00537940|584006314|FG001|Overall Study|Withdrawal by Subject|95|||
161715603|NCT00537940|584006313|FG000|Overall Study|Protocol Violation|6|||
161715604|NCT00537940|584006314|FG001|Overall Study|Protocol Violation|4|||
161715605|NCT00537940|584006313|FG000|Overall Study|Pregnancy|1|||
161715606|NCT00537940|584006314|FG001|Overall Study|Pregnancy|1|||
161715607|NCT00537940|584006313|FG000|Overall Study|Study terminated by sponsor|2|||
161715608|NCT00537940|584006314|FG001|Overall Study|Study terminated by sponsor|3|||
161715609|NCT00537940|584006313|FG000|Overall Study|Other|10|||
161715610|NCT00537940|584006314|FG001|Overall Study|Other|12|||
161715611|NCT02138110|584006319|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
161715612|NCT02138110|584006319|FG000|Overall Scaffold Implantation|Death|3|||
161715613|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
161715614|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
161715615|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
161715616|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
161715617|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
161715618|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
161715619|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
161715620|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
161715621|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
161715622|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
161715623|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
161715624|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
161715625|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
161715626|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
161715627|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
161715628|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
161715629|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
161715630|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
161715631|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Death|0|||
161715632|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Death|1|||
161715633|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Death|0|||
161715634|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
161715635|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
161715636|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
161715637|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
161715638|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
161715639|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
161715640|NCT00430781|584006321|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
161715641|NCT00430781|584006322|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
161715642|NCT00430781|584006323|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
161715643|NCT00430781|584006321|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
161715644|NCT00430781|584006322|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
161715645|NCT00430781|584006323|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
161715646|NCT00430781|584006321|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
161715647|NCT00430781|584006322|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
161715648|NCT00430781|584006323|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
161715649|NCT00430781|584006321|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
161715650|NCT00430781|584006322|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
161715651|NCT00430781|584006323|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
161715652|NCT00430781|584006321|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
161715653|NCT00430781|584006322|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
161962565|NCT01406938|584909825|FG005|Follow up|Lack of Efficacy|0|||
161715654|NCT00430781|584006323|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
161715655|NCT00430781|584006321|FG000|Final Analysis; 31 July 2008|Other|0|||
161715656|NCT00430781|584006322|FG001|Final Analysis; 31 July 2008|Other|1|||
161715657|NCT00430781|584006323|FG002|Final Analysis; 31 July 2008|Other|0|||
161838019|NCT00928707|584450291|FG001|Overall Study|Protocol Violation|0|||
161962566|NCT01406938|584909820|FG000|Follow up|Patient/guardian decision|4|||
161962567|NCT01406938|584909821|FG001|Follow up|Patient/guardian decision|2|||
161962568|NCT01406938|584909822|FG002|Follow up|Patient/guardian decision|4|||
161962569|NCT01406938|584909823|FG003|Follow up|Patient/guardian decision|2|||
161962570|NCT01406938|584909824|FG004|Follow up|Patient/guardian decision|4|||
161962571|NCT01406938|584909825|FG005|Follow up|Patient/guardian decision|1|||
161962572|NCT01406938|584909820|FG000|Follow up|Protocol Violation|0|||
161962573|NCT01406938|584909821|FG001|Follow up|Protocol Violation|0|||
161962574|NCT01406938|584909822|FG002|Follow up|Protocol Violation|1|||
161962575|NCT01406938|584909823|FG003|Follow up|Protocol Violation|0|||
161962576|NCT01406938|584909824|FG004|Follow up|Protocol Violation|0|||
161962577|NCT01406938|584909825|FG005|Follow up|Protocol Violation|0|||
161962578|NCT01406938|584909820|FG000|Follow up|Physician Decision|0|||
161962579|NCT01406938|584909821|FG001|Follow up|Physician Decision|0|||
161962580|NCT01406938|584909822|FG002|Follow up|Physician Decision|2|||
161962581|NCT01406938|584909823|FG003|Follow up|Physician Decision|0|||
161962582|NCT01406938|584909824|FG004|Follow up|Physician Decision|3|||
161715658|NCT00430781|584006321|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
161962583|NCT01406938|584909825|FG005|Follow up|Physician Decision|1|||
161962584|NCT01406938|584909820|FG000|Follow up|Lost to Follow-up|1|||
161962585|NCT01406938|584909821|FG001|Follow up|Lost to Follow-up|1|||
161962586|NCT01406938|584909822|FG002|Follow up|Lost to Follow-up|0|||
161962587|NCT01406938|584909823|FG003|Follow up|Lost to Follow-up|1|||
161962588|NCT01406938|584909824|FG004|Follow up|Lost to Follow-up|2|||
161962589|NCT01406938|584909825|FG005|Follow up|Lost to Follow-up|1|||
161962590|NCT01576146|584909828|FG000|Extension Period 1|Adverse Event|2|||
161962591|NCT01576146|584909828|FG000|Extension Period 1|Death|2|||
161962592|NCT01576146|584909828|FG000|Extension Period 1|Physician Decision|2|||
161962593|NCT01576146|584909828|FG000|Extension Period 1|Withdrawal by Subject|1|||
161962594|NCT01576146|584909828|FG000|Extension Period 1|Lost to Follow-up|1|||
161962595|NCT01576146|584909828|FG000|Extension Period 1|Parathyroidectomy|1|||
161962596|NCT01576146|584909828|FG000|Extension Period 1|Renal Transplant|1|||
161962597|NCT01576146|584909828|FG000|Extension Period 2|Sponsor Decision|13|||
161962598|NCT01576146|584909828|FG000|Extension Period 2|Death|1|||
161962599|NCT01576146|584909828|FG000|Extension Period 2|Adverse Event|1|||
161962600|NCT01576146|584909828|FG000|Extension Period 2|Renal Transplant|1|||
161962601|NCT01576146|584909828|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
161962602|NCT01667224|584909831|FG000|Overall Study|Withdrawal by Subject|3|||
161962603|NCT01667224|584909832|FG001|Overall Study|Withdrawal by Subject|1|||
161962604|NCT01667224|584909831|FG000|Overall Study|Protocol Violation|1|||
161962605|NCT01667224|584909832|FG001|Overall Study|Protocol Violation|1|||
161962606|NCT00962741|584909833|FG000|Overall Study|Failed to return|3|||
161962607|NCT00962741|584909833|FG000|Overall Study|Lost to Follow-up|2|||
161962608|NCT00962741|584909833|FG000|Overall Study|Withdrawal by Subject|1|||
161962609|NCT00962741|584909833|FG000|Overall Study|Lack of Efficacy|1|||
161962610|NCT00962741|584909833|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
161962611|NCT03350035|584909834|FG000|Overall Study|Lack of Efficacy|2|||
161962612|NCT03350035|584909835|FG001|Overall Study|Lack of Efficacy|0|||
161962613|NCT03350035|584909836|FG002|Overall Study|Lack of Efficacy|0|||
161962614|NCT03350035|584909834|FG000|Overall Study|Subject discharged to hospice|0|||
161962615|NCT03350035|584909835|FG001|Overall Study|Subject discharged to hospice|0|||
161962616|NCT03350035|584909836|FG002|Overall Study|Subject discharged to hospice|1|||
161962617|NCT01811485|584909837|FG000|Overall Study|Adverse Event|1|||
161962618|NCT01811485|584909838|FG001|Overall Study|Adverse Event|3|||
161962619|NCT01811485|584909839|FG002|Overall Study|Adverse Event|2|||
161962620|NCT01811485|584909837|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161962621|NCT01811485|584909838|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161962622|NCT01811485|584909839|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
161962623|NCT01811485|584909837|FG000|Overall Study|Administrative problems|1|||
161962624|NCT01811485|584909838|FG001|Overall Study|Administrative problems|0|||
161962625|NCT01811485|584909839|FG002|Overall Study|Administrative problems|0|||
161962626|NCT01811485|584909837|FG000|Overall Study|Protocol Deviation|0|||
161962627|NCT01811485|584909838|FG001|Overall Study|Protocol Deviation|1|||
161962628|NCT01811485|584909839|FG002|Overall Study|Protocol Deviation|0|||
161962629|NCT03654404|584909840|FG000|Overall Study|Death|1|||
161962630|NCT03654404|584909840|FG000|Overall Study|Lost to Follow-up|2|||
161962631|NCT03654404|584909840|FG000|Overall Study|Withdrawal by Subject|5|||
161715659|NCT00430781|584006322|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
161715660|NCT00430781|584006323|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
161715661|NCT00430781|584006321|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
161715662|NCT00430781|584006322|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
161715663|NCT00430781|584006323|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
161715664|NCT00430781|584006321|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
161715665|NCT00430781|584006322|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
161715666|NCT00430781|584006323|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
161715667|NCT00430781|584006321|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
161715668|NCT00430781|584006322|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
161715669|NCT00430781|584006323|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
161715670|NCT00430781|584006321|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
161715671|NCT00430781|584006322|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
161715672|NCT00430781|584006323|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
161715673|NCT00430781|584006321|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
161715674|NCT00430781|584006322|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
161715675|NCT00430781|584006323|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
161715676|NCT00430781|584006321|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
161715677|NCT00430781|584006322|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
161962632|NCT00654745|584909843|FG000|Overall Study|Adverse Event|12|||
161962633|NCT00654745|584909843|FG000|Overall Study|Lost to Follow-up|7|||
161962634|NCT00654745|584909843|FG000|Overall Study|Protocol Violation|11|||
161962635|NCT00654745|584909843|FG000|Overall Study|Withdrawal by Subject|10|||
161962636|NCT00654745|584909843|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
161962637|NCT00194077|584909846|FG000|Overall Study|Lack of Efficacy|22|||
161962638|NCT00194077|584909847|FG001|Overall Study|Lack of Efficacy|29|||
161962639|NCT00194077|584909846|FG000|Overall Study|Study nonadherence|1|||
161962640|NCT00194077|584909847|FG001|Overall Study|Study nonadherence|0|||
161962641|NCT00194077|584909846|FG000|Overall Study|Withdrawal by Subject|1|||
161962642|NCT00194077|584909847|FG001|Overall Study|Withdrawal by Subject|1|||
161715678|NCT00430781|584006323|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
161715679|NCT01389128|584006326|FG000|Overall Study|Fetal distress|1|||
161715680|NCT01389128|584006327|FG001|Overall Study|Fetal distress|0|||
161715681|NCT01389128|584006326|FG000|Overall Study|Cervix dilation stop|1|||
161715682|NCT01389128|584006327|FG001|Overall Study|Cervix dilation stop|2|||
161715683|NCT01389128|584006326|FG000|Overall Study|Rapid labor evolution|3|||
161715684|NCT01389128|584006327|FG001|Overall Study|Rapid labor evolution|2|||
161715685|NCT01389128|584006326|FG000|Overall Study|Intolerance to procedure|0|||
161715686|NCT01389128|584006327|FG001|Overall Study|Intolerance to procedure|2|||
161715687|NCT01451515|584006328|FG000|Overall Study|Death|0|||
161715688|NCT01451515|584006329|FG001|Overall Study|Death|1|||
161715689|NCT01451515|584006330|FG002|Overall Study|Death|0|||
161715690|NCT01451515|584006328|FG000|Overall Study|Withdrawal by Subject|0|||
161715691|NCT01451515|584006329|FG001|Overall Study|Withdrawal by Subject|1|||
161715692|NCT01451515|584006330|FG002|Overall Study|Withdrawal by Subject|0|||
161715693|NCT01451515|584006328|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
161715694|NCT01451515|584006329|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
161715695|NCT01451515|584006330|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
161715696|NCT01451515|584006328|FG000|Overall Study|Relapse (except CNS)|1|||
161715697|NCT01451515|584006329|FG001|Overall Study|Relapse (except CNS)|1|||
161715698|NCT01451515|584006330|FG002|Overall Study|Relapse (except CNS)|0|||
161715699|NCT00174941|584006334|FG000|Overall Study|Adverse Event|1|||
161715700|NCT00174941|584006335|FG001|Overall Study|Adverse Event|10|||
161715701|NCT00174941|584006336|FG002|Overall Study|Adverse Event|2|||
161715702|NCT00174941|584006337|FG003|Overall Study|Adverse Event|13|||
161715703|NCT00174941|584006334|FG000|Overall Study|Protocol Violation|0|||
161715704|NCT00174941|584006335|FG001|Overall Study|Protocol Violation|1|||
161715705|NCT00174941|584006336|FG002|Overall Study|Protocol Violation|0|||
161715706|NCT00174941|584006337|FG003|Overall Study|Protocol Violation|1|||
161715707|NCT00174941|584006334|FG000|Overall Study|Lost to Follow-up|0|||
161715708|NCT00174941|584006335|FG001|Overall Study|Lost to Follow-up|3|||
161715709|NCT00174941|584006336|FG002|Overall Study|Lost to Follow-up|2|||
161715710|NCT00174941|584006337|FG003|Overall Study|Lost to Follow-up|5|||
161715711|NCT00174941|584006334|FG000|Overall Study|Personal Reason(s)|0|||
161715712|NCT00174941|584006335|FG001|Overall Study|Personal Reason(s)|14|||
161715713|NCT00174941|584006336|FG002|Overall Study|Personal Reason(s)|8|||
161715714|NCT00174941|584006337|FG003|Overall Study|Personal Reason(s)|22|||
161715715|NCT00174941|584006334|FG000|Overall Study|Gout Flare|0|||
161715716|NCT00174941|584006335|FG001|Overall Study|Gout Flare|4|||
161715717|NCT00174941|584006336|FG002|Overall Study|Gout Flare|4|||
161715718|NCT00174941|584006337|FG003|Overall Study|Gout Flare|8|||
161715719|NCT00174941|584006334|FG000|Overall Study|Reason Not Specified|1|||
161715720|NCT00174941|584006335|FG001|Overall Study|Reason Not Specified|6|||
161715721|NCT00174941|584006336|FG002|Overall Study|Reason Not Specified|2|||
161715722|NCT00174941|584006337|FG003|Overall Study|Reason Not Specified|9|||
161715723|NCT03230097|584006342|FG000|Overall Study|Adverse Event|2|||
161715724|NCT03230097|584006343|FG001|Overall Study|Adverse Event|1|||
161715725|NCT03230097|584006342|FG000|Overall Study|non-compliance|0|||
161715726|NCT03230097|584006343|FG001|Overall Study|non-compliance|1|||
161715727|NCT03230097|584006342|FG000|Overall Study|Lost to Follow-up|2|||
161715728|NCT03230097|584006343|FG001|Overall Study|Lost to Follow-up|4|||
161715729|NCT03230097|584006342|FG000|Overall Study|Withdrawal by Subject|7|||
161715730|NCT03230097|584006343|FG001|Overall Study|Withdrawal by Subject|3|||
161715731|NCT03230097|584006342|FG000|Overall Study|Trial termination|4|||
161715732|NCT03230097|584006343|FG001|Overall Study|Trial termination|5|||
161715733|NCT03230097|584006342|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
161715734|NCT03230097|584006343|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
161715735|NCT03230097|584006342|FG000|Overall Study|outcome event|0|||
161715736|NCT03230097|584006343|FG001|Overall Study|outcome event|1|||
161715737|NCT01588197|584006360|FG000|Overall Study|Lack of Efficacy|0|||
161715738|NCT01588197|584006361|FG001|Overall Study|Lack of Efficacy|1|||
161715739|NCT01588197|584006360|FG000|Overall Study|No MRI|1|||
161715740|NCT01588197|584006361|FG001|Overall Study|No MRI|0|||
161715741|NCT01844076|584006368|FG000|Overall Study|Adverse Event|1|||
161715742|NCT01844076|584006369|FG001|Overall Study|Adverse Event|0|||
161715743|NCT01844076|584006370|FG002|Overall Study|Adverse Event|0|||
161715744|NCT01844076|584006371|FG003|Overall Study|Adverse Event|0|||
161715745|NCT01844076|584006368|FG000|Overall Study|Withdrawal by Subject|1|||
161715746|NCT01844076|584006369|FG001|Overall Study|Withdrawal by Subject|0|||
161715747|NCT01844076|584006370|FG002|Overall Study|Withdrawal by Subject|0|||
161715748|NCT01844076|584006371|FG003|Overall Study|Withdrawal by Subject|0|||
161715749|NCT00635102|584006379|FG000|Overall Study|Withdrawal by Subject|7|||
161715750|NCT00635102|584006380|FG001|Overall Study|Withdrawal by Subject|8|||
161715751|NCT00440401|584006382|FG000|Overall Study|Adverse Event|2|||
161715752|NCT00440401|584006383|FG001|Overall Study|Adverse Event|1|||
161715753|NCT00440401|584006382|FG000|Overall Study|Other|2|||
161715754|NCT00440401|584006383|FG001|Overall Study|Other|5|||
161715755|NCT01925703|584006384|FG000|Overall Study|Physician Decision|1|||
161715756|NCT01925703|584006384|FG000|Overall Study|Lost to Follow-up|2|||
161715757|NCT01925703|584006384|FG000|Overall Study|Discharge prior to full iron repletion|1|||
161715758|NCT01938625|584006385|FG000|Overall Study|Withdrawal by Subject|0|||
161715759|NCT01938625|584006386|FG001|Overall Study|Withdrawal by Subject|1|||
161715760|NCT01938625|584006385|FG000|Overall Study|Adverse Event|0|||
161715761|NCT01938625|584006386|FG001|Overall Study|Adverse Event|1|||
161715762|NCT02088034|584006387|FG000|Overall Study|Lost to Follow-up|1|||
161715763|NCT02088034|584006388|FG001|Overall Study|Lost to Follow-up|1|||
161715764|NCT02088034|584006389|FG002|Overall Study|Lost to Follow-up|0|||
161715765|NCT02088034|584006387|FG000|Overall Study|Pregnancy|2|||
161715766|NCT02088034|584006388|FG001|Overall Study|Pregnancy|1|||
161715767|NCT02088034|584006389|FG002|Overall Study|Pregnancy|2|||
161715768|NCT01937312|584006390|FG000|Overall Study|Adverse Event|10|||
161715769|NCT01937312|584006391|FG001|Overall Study|Adverse Event|1|||
161715770|NCT01937312|584006390|FG000|Overall Study|Lack of Efficacy|0|||
161715771|NCT01937312|584006391|FG001|Overall Study|Lack of Efficacy|1|||
161715772|NCT01937312|584006390|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
161715773|NCT01937312|584006391|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
161715774|NCT00091793|584006392|FG000|Overall Study|Adverse Event|1|||
161715775|NCT00091793|584006393|FG001|Overall Study|Adverse Event|2|||
161715776|NCT00091793|584006392|FG000|Overall Study|Withdrawal by Subject|10|||
161715777|NCT00091793|584006393|FG001|Overall Study|Withdrawal by Subject|15|||
161715778|NCT00091793|584006392|FG000|Overall Study|Ineligibility determined|2|||
161715779|NCT00091793|584006393|FG001|Overall Study|Ineligibility determined|0|||
161715780|NCT00091793|584006392|FG000|Overall Study|Lost to Follow-up|7|||
161715781|NCT00091793|584006393|FG001|Overall Study|Lost to Follow-up|5|||
161715782|NCT00091793|584006392|FG000|Overall Study|Noncompliance|2|||
161715783|NCT00091793|584006393|FG001|Overall Study|Noncompliance|0|||
161715784|NCT00091793|584006392|FG000|Overall Study|Other|2|||
161715785|NCT00091793|584006393|FG001|Overall Study|Other|0|||
161715786|NCT00308620|584006396|FG000|Overall Study|Death|1|||
161715787|NCT00308620|584006397|FG001|Overall Study|Death|1|||
161715788|NCT00308620|584006398|FG002|Overall Study|Death|0|||
161715789|NCT00308620|584006396|FG000|Overall Study|Lost to Follow-up|0|||
161715790|NCT00308620|584006397|FG001|Overall Study|Lost to Follow-up|0|||
161962643|NCT03470194|584909848|FG000|Overall Study|Lost to Follow-up|11|||
161962644|NCT03470194|584909849|FG001|Overall Study|Lost to Follow-up|17|||
161962645|NCT01822899|584909850|FG000|Overall Study|Adverse Event|6|||
161715791|NCT00308620|584006398|FG002|Overall Study|Lost to Follow-up|1|||
161715792|NCT02424149|584006401|FG000|Overall Study|surgery cancelled|2|||
161962646|NCT01822899|584909851|FG001|Overall Study|Adverse Event|5|||
161962647|NCT01822899|584909850|FG000|Overall Study|Lack of Efficacy|6|||
161715793|NCT02424149|584006402|FG001|Overall Study|surgery cancelled|0|||
161715794|NCT02424149|584006401|FG000|Overall Study|Withdrawal by Subject|0|||
161715795|NCT02424149|584006402|FG001|Overall Study|Withdrawal by Subject|1|||
161715796|NCT05309083|584006403|FG000|Overall Study|Withdrawal by Subject|2|||
161715797|NCT01238120|584006404|FG000|Overall Study|Withdrawal by Subject|4|||
161715798|NCT01238120|584006405|FG001|Overall Study|Withdrawal by Subject|1|||
161715799|NCT01238120|584006406|FG002|Overall Study|Withdrawal by Subject|2|||
161715800|NCT01238120|584006407|FG003|Overall Study|Withdrawal by Subject|5|||
161715801|NCT01238120|584006404|FG000|Overall Study|Lost to Follow-up|2|||
161715802|NCT01238120|584006405|FG001|Overall Study|Lost to Follow-up|0|||
161715803|NCT01238120|584006406|FG002|Overall Study|Lost to Follow-up|1|||
161715804|NCT01238120|584006407|FG003|Overall Study|Lost to Follow-up|1|||
161715805|NCT01238120|584006404|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
161962648|NCT01822899|584909851|FG001|Overall Study|Lack of Efficacy|3|||
161962649|NCT01822899|584909850|FG000|Overall Study|Protocol Violation|6|||
161962650|NCT01822899|584909851|FG001|Overall Study|Protocol Violation|3|||
161962651|NCT01822899|584909850|FG000|Overall Study|Lost to Follow-up|1|||
161962652|NCT01822899|584909851|FG001|Overall Study|Lost to Follow-up|0|||
161962653|NCT01822899|584909850|FG000|Overall Study|Withdrawal by Subject|5|||
161962654|NCT01822899|584909851|FG001|Overall Study|Withdrawal by Subject|7|||
161962655|NCT00759876|584909853|FG000|Overall Study|Sponsor terminated study early|36|||
161962656|NCT01450696|584909854|FG000|Overall Study|Never Treated|1|||
162031902|NCT00470158|585174117|FG004|Overall Study|Lost to Follow-up|4|||
162031903|NCT00470158|585174113|FG000|Overall Study|Protocol Violation|1|||
161715806|NCT01238120|584006405|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
161715807|NCT01238120|584006406|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
161715808|NCT01238120|584006407|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
161715809|NCT02388776|584006408|FG000|Overall Study|Death|1|||
161715810|NCT02388776|584006408|FG000|Overall Study|Lost to Follow-up|1|||
161715811|NCT04246047|584006415|FG000|Overall Study|Death|50|||
161715812|NCT04246047|584006416|FG001|Overall Study|Death|77|||
161715813|NCT04246047|584006415|FG000|Overall Study|Lost to Follow-up|1|||
161715814|NCT04246047|584006416|FG001|Overall Study|Lost to Follow-up|3|||
161715815|NCT04246047|584006415|FG000|Overall Study|Physician Decision|4|||
161715816|NCT04246047|584006416|FG001|Overall Study|Physician Decision|10|||
161838020|NCT00132028|584450292|FG000|Overall Study|Adverse Event|7|||
161962657|NCT01450696|584909855|FG001|Overall Study|Never Treated|1|||
161962658|NCT01450696|584909854|FG000|Overall Study|Death|77|||
161715817|NCT04246047|584006415|FG000|Overall Study|Withdrawal by Subject|19|||
161715818|NCT04246047|584006416|FG001|Overall Study|Withdrawal by Subject|26|||
161715819|NCT04246047|584006415|FG000|Overall Study|Ongoing|169|||
161715820|NCT04246047|584006416|FG001|Overall Study|Ongoing|135|||
161715821|NCT00845429|584006426|FG000|Overall Study|Protocol Violation|5|||
161715822|NCT00845429|584006427|FG001|Overall Study|Protocol Violation|4|||
161715823|NCT00845429|584006428|FG002|Overall Study|Protocol Violation|7|||
161715824|NCT00845429|584006426|FG000|Overall Study|Lost to Follow-up|7|||
161715825|NCT00845429|584006427|FG001|Overall Study|Lost to Follow-up|9|||
161715826|NCT00845429|584006428|FG002|Overall Study|Lost to Follow-up|10|||
161715827|NCT00845429|584006426|FG000|Overall Study|Withdrawal by Subject|2|||
161715828|NCT00845429|584006427|FG001|Overall Study|Withdrawal by Subject|2|||
161715829|NCT00845429|584006428|FG002|Overall Study|Withdrawal by Subject|2|||
161715830|NCT00845429|584006426|FG000|Overall Study|Serious adverse event|0|||
161715831|NCT00845429|584006427|FG001|Overall Study|Serious adverse event|0|||
161715832|NCT00845429|584006428|FG002|Overall Study|Serious adverse event|1|||
161715833|NCT00587223|584006431|FG000|Overall Study|Adverse Event|1|||
161715834|NCT03519178|584006432|FG000|PF-06873600 Treatment|Adverse Event|0|||
161715835|NCT03519178|584006433|FG001|PF-06873600 Treatment|Adverse Event|0|||
161715836|NCT03519178|584006434|FG002|PF-06873600 Treatment|Adverse Event|0|||
161715837|NCT03519178|584006435|FG003|PF-06873600 Treatment|Adverse Event|0|||
161715838|NCT03519178|584006436|FG004|PF-06873600 Treatment|Adverse Event|0|||
161715839|NCT03519178|584006437|FG005|PF-06873600 Treatment|Adverse Event|0|||
161715840|NCT03519178|584006438|FG006|PF-06873600 Treatment|Adverse Event|0|||
161715841|NCT03519178|584006439|FG007|PF-06873600 Treatment|Adverse Event|2|||
161715842|NCT03519178|584006440|FG008|PF-06873600 Treatment|Adverse Event|1|||
161715843|NCT03519178|584006441|FG009|PF-06873600 Treatment|Adverse Event|0|||
161715844|NCT03519178|584006442|FG010|PF-06873600 Treatment|Adverse Event|0|||
161715845|NCT03519178|584006443|FG011|PF-06873600 Treatment|Adverse Event|0|||
161715846|NCT03519178|584006444|FG012|PF-06873600 Treatment|Adverse Event|1|||
161715847|NCT03519178|584006445|FG013|PF-06873600 Treatment|Adverse Event|3|||
161715848|NCT03519178|584006446|FG014|PF-06873600 Treatment|Adverse Event|2|||
161715849|NCT03519178|584006432|FG000|PF-06873600 Treatment|Death|0|||
161715850|NCT03519178|584006433|FG001|PF-06873600 Treatment|Death|0|||
161715851|NCT03519178|584006434|FG002|PF-06873600 Treatment|Death|0|||
161715852|NCT03519178|584006435|FG003|PF-06873600 Treatment|Death|0|||
161715853|NCT03519178|584006436|FG004|PF-06873600 Treatment|Death|0|||
161715854|NCT03519178|584006437|FG005|PF-06873600 Treatment|Death|0|||
161715855|NCT03519178|584006438|FG006|PF-06873600 Treatment|Death|0|||
161715856|NCT03519178|584006439|FG007|PF-06873600 Treatment|Death|0|||
161715857|NCT03519178|584006440|FG008|PF-06873600 Treatment|Death|1|||
161715858|NCT03519178|584006441|FG009|PF-06873600 Treatment|Death|1|||
161715859|NCT03519178|584006442|FG010|PF-06873600 Treatment|Death|0|||
161715860|NCT03519178|584006443|FG011|PF-06873600 Treatment|Death|0|||
161715861|NCT03519178|584006444|FG012|PF-06873600 Treatment|Death|0|||
161715862|NCT03519178|584006445|FG013|PF-06873600 Treatment|Death|0|||
161715863|NCT03519178|584006446|FG014|PF-06873600 Treatment|Death|1|||
161715864|NCT03519178|584006432|FG000|PF-06873600 Treatment|Physician Decision|0|||
161715865|NCT03519178|584006433|FG001|PF-06873600 Treatment|Physician Decision|0|||
161715866|NCT03519178|584006434|FG002|PF-06873600 Treatment|Physician Decision|0|||
161715867|NCT03519178|584006435|FG003|PF-06873600 Treatment|Physician Decision|0|||
161715868|NCT03519178|584006436|FG004|PF-06873600 Treatment|Physician Decision|0|||
161715869|NCT03519178|584006437|FG005|PF-06873600 Treatment|Physician Decision|0|||
161715870|NCT03519178|584006438|FG006|PF-06873600 Treatment|Physician Decision|0|||
161715871|NCT03519178|584006439|FG007|PF-06873600 Treatment|Physician Decision|1|||
161715872|NCT03519178|584006440|FG008|PF-06873600 Treatment|Physician Decision|0|||
161715873|NCT03519178|584006441|FG009|PF-06873600 Treatment|Physician Decision|0|||
161715874|NCT03519178|584006442|FG010|PF-06873600 Treatment|Physician Decision|1|||
161715875|NCT03519178|584006443|FG011|PF-06873600 Treatment|Physician Decision|0|||
161715876|NCT03519178|584006444|FG012|PF-06873600 Treatment|Physician Decision|0|||
161715877|NCT03519178|584006445|FG013|PF-06873600 Treatment|Physician Decision|4|||
161715878|NCT03519178|584006446|FG014|PF-06873600 Treatment|Physician Decision|1|||
161715879|NCT03519178|584006432|FG000|PF-06873600 Treatment|Progressive disease|1|||
161715880|NCT03519178|584006433|FG001|PF-06873600 Treatment|Progressive disease|1|||
161715881|NCT03519178|584006434|FG002|PF-06873600 Treatment|Progressive disease|1|||
161715882|NCT03519178|584006435|FG003|PF-06873600 Treatment|Progressive disease|1|||
161715883|NCT03519178|584006436|FG004|PF-06873600 Treatment|Progressive disease|6|||
161715884|NCT03519178|584006437|FG005|PF-06873600 Treatment|Progressive disease|7|||
161715885|NCT03519178|584006438|FG006|PF-06873600 Treatment|Progressive disease|3|||
161962659|NCT01450696|584909855|FG001|Overall Study|Death|84|||
161962660|NCT01450696|584909854|FG000|Overall Study|Lost to Follow-up|3|||
161962661|NCT01450696|584909855|FG001|Overall Study|Lost to Follow-up|3|||
161962662|NCT01450696|584909854|FG000|Overall Study|Non-Compliance|1|||
161962663|NCT01450696|584909855|FG001|Overall Study|Non-Compliance|0|||
161962664|NCT01450696|584909854|FG000|Overall Study|Withdrawal by Subject|13|||
161962665|NCT01450696|584909855|FG001|Overall Study|Withdrawal by Subject|2|||
161962666|NCT01450696|584909854|FG000|Overall Study|Study Terminated by Sponsor|53|||
161962667|NCT01450696|584909855|FG001|Overall Study|Study Terminated by Sponsor|58|||
161962668|NCT02570152|584909856|FG000|Overall Study|Protocol Violation|2|||
161962669|NCT02570152|584909856|FG000|Overall Study|Migrated/moved from study area|13|||
161962670|NCT02684617|584909857|FG000|Overall Study|Adverse Event|1|||
161962671|NCT02684617|584909858|FG001|Overall Study|Adverse Event|0|||
161962672|NCT02684617|584909859|FG002|Overall Study|Adverse Event|1|||
161962673|NCT02684617|584909857|FG000|Overall Study|Death|8|||
161715886|NCT03519178|584006439|FG007|PF-06873600 Treatment|Progressive disease|7|||
161715887|NCT03519178|584006440|FG008|PF-06873600 Treatment|Progressive disease|3|||
161715888|NCT03519178|584006441|FG009|PF-06873600 Treatment|Progressive disease|5|||
161715889|NCT03519178|584006442|FG010|PF-06873600 Treatment|Progressive disease|4|||
161715890|NCT03519178|584006443|FG011|PF-06873600 Treatment|Progressive disease|3|||
161715891|NCT03519178|584006444|FG012|PF-06873600 Treatment|Progressive disease|4|||
161715892|NCT03519178|584006445|FG013|PF-06873600 Treatment|Progressive disease|28|||
161715893|NCT03519178|584006446|FG014|PF-06873600 Treatment|Progressive disease|8|||
161715894|NCT03519178|584006432|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
161715895|NCT03519178|584006433|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
161715896|NCT03519178|584006434|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
161715897|NCT03519178|584006435|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
161715898|NCT03519178|584006436|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
161715899|NCT03519178|584006437|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
161715900|NCT03519178|584006438|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
161715901|NCT03519178|584006439|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
161715902|NCT03519178|584006440|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
161715903|NCT03519178|584006441|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
161715904|NCT03519178|584006442|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
161715905|NCT03519178|584006443|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
161715906|NCT03519178|584006444|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
161715907|NCT03519178|584006445|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
161715908|NCT03519178|584006446|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
161715909|NCT03519178|584006432|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
161715910|NCT03519178|584006433|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
161715911|NCT03519178|584006434|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
161715912|NCT03519178|584006435|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
161715913|NCT03519178|584006436|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
161715914|NCT03519178|584006437|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
161715915|NCT03519178|584006438|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
161715916|NCT03519178|584006439|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
161962674|NCT02684617|584909858|FG001|Overall Study|Death|16|||
161962675|NCT02684617|584909859|FG002|Overall Study|Death|28|||
161962676|NCT02684617|584909857|FG000|Overall Study|Withdrawal by Subject|2|||
161715917|NCT03519178|584006440|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
161715918|NCT03519178|584006441|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
161715919|NCT03519178|584006442|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
161715920|NCT03519178|584006443|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
161715921|NCT03519178|584006444|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
161715922|NCT03519178|584006445|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
161715923|NCT03519178|584006446|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
161715924|NCT03519178|584006432|FG000|PF-06873600 Treatment|Refused further treatment|0|||
161715925|NCT03519178|584006433|FG001|PF-06873600 Treatment|Refused further treatment|1|||
161715926|NCT03519178|584006434|FG002|PF-06873600 Treatment|Refused further treatment|0|||
161715927|NCT03519178|584006435|FG003|PF-06873600 Treatment|Refused further treatment|0|||
161715928|NCT03519178|584006436|FG004|PF-06873600 Treatment|Refused further treatment|1|||
161715929|NCT03519178|584006437|FG005|PF-06873600 Treatment|Refused further treatment|0|||
161715930|NCT03519178|584006438|FG006|PF-06873600 Treatment|Refused further treatment|0|||
161715931|NCT03519178|584006439|FG007|PF-06873600 Treatment|Refused further treatment|0|||
161715932|NCT03519178|584006440|FG008|PF-06873600 Treatment|Refused further treatment|0|||
161715933|NCT03519178|584006441|FG009|PF-06873600 Treatment|Refused further treatment|0|||
161838021|NCT00132028|584450292|FG000|Overall Study|Death|2|||
161962677|NCT02684617|584909858|FG001|Overall Study|Withdrawal by Subject|0|||
161962678|NCT02684617|584909859|FG002|Overall Study|Withdrawal by Subject|4|||
161962679|NCT02684617|584909857|FG000|Overall Study|Screen Failure|1|||
161962680|NCT02684617|584909858|FG001|Overall Study|Screen Failure|0|||
161715934|NCT03519178|584006442|FG010|PF-06873600 Treatment|Refused further treatment|0|||
161715935|NCT03519178|584006443|FG011|PF-06873600 Treatment|Refused further treatment|0|||
161715936|NCT03519178|584006444|FG012|PF-06873600 Treatment|Refused further treatment|0|||
161715937|NCT03519178|584006445|FG013|PF-06873600 Treatment|Refused further treatment|0|||
161715938|NCT03519178|584006446|FG014|PF-06873600 Treatment|Refused further treatment|1|||
161715939|NCT03519178|584006432|FG000|PF-06873600 Treatment|Other|0|||
161715940|NCT03519178|584006433|FG001|PF-06873600 Treatment|Other|0|||
161715941|NCT03519178|584006434|FG002|PF-06873600 Treatment|Other|0|||
161715942|NCT03519178|584006435|FG003|PF-06873600 Treatment|Other|0|||
161715943|NCT03519178|584006436|FG004|PF-06873600 Treatment|Other|0|||
161715944|NCT03519178|584006437|FG005|PF-06873600 Treatment|Other|0|||
161715945|NCT03519178|584006438|FG006|PF-06873600 Treatment|Other|0|||
161715946|NCT03519178|584006439|FG007|PF-06873600 Treatment|Other|0|||
161715947|NCT03519178|584006440|FG008|PF-06873600 Treatment|Other|1|||
161715948|NCT03519178|584006441|FG009|PF-06873600 Treatment|Other|0|||
161715949|NCT03519178|584006442|FG010|PF-06873600 Treatment|Other|0|||
161715950|NCT03519178|584006443|FG011|PF-06873600 Treatment|Other|0|||
161715951|NCT03519178|584006444|FG012|PF-06873600 Treatment|Other|0|||
161715952|NCT03519178|584006445|FG013|PF-06873600 Treatment|Other|1|||
161715953|NCT03519178|584006446|FG014|PF-06873600 Treatment|Other|3|||
161715954|NCT03519178|584006432|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
161715955|NCT03519178|584006433|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
161715956|NCT03519178|584006434|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
161715957|NCT03519178|584006435|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
161715958|NCT03519178|584006436|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
161715959|NCT03519178|584006437|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
161715960|NCT03519178|584006438|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
161715961|NCT03519178|584006439|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
161715962|NCT03519178|584006440|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
161715963|NCT03519178|584006441|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
161715964|NCT03519178|584006442|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
161715965|NCT03519178|584006443|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
161715966|NCT03519178|584006444|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
161715967|NCT03519178|584006445|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
161715968|NCT03519178|584006446|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
161715969|NCT03519178|584006432|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715970|NCT03519178|584006433|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715971|NCT03519178|584006434|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715972|NCT03519178|584006435|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715973|NCT03519178|584006436|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715974|NCT03519178|584006437|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715975|NCT03519178|584006438|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715976|NCT03519178|584006439|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715977|NCT03519178|584006440|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715978|NCT03519178|584006441|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715979|NCT03519178|584006442|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715980|NCT03519178|584006443|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715981|NCT03519178|584006444|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
161715982|NCT03519178|584006445|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
161715983|NCT03519178|584006446|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
161715984|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Adverse Event|0|||
161715985|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Adverse Event|0|||
161715986|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Adverse Event|0|||
161715987|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Adverse Event|0|||
161715988|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Adverse Event|0|||
161715989|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Adverse Event|0|||
161715990|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Adverse Event|0|||
161715991|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Adverse Event|0|||
161715992|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Adverse Event|0|||
161715993|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Adverse Event|0|||
161715994|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Adverse Event|0|||
161715995|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Adverse Event|0|||
161715996|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Adverse Event|0|||
161715997|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Adverse Event|1|||
161715998|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Adverse Event|0|||
161715999|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Death|0|||
161716000|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Death|0|||
161716001|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Death|0|||
161716002|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Death|0|||
161716003|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Death|0|||
161716004|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Death|0|||
161716005|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Death|0|||
161716006|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Death|0|||
161716007|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Death|0|||
161716008|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Death|1|||
161716009|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Death|0|||
161716010|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Death|0|||
161716011|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Death|0|||
161716012|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Death|0|||
161716013|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Death|1|||
161716014|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716015|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716016|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716017|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716018|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716019|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716020|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
161962681|NCT02684617|584909859|FG002|Overall Study|Screen Failure|2|||
161962682|NCT02684617|584909857|FG000|Overall Study|Study Terminated by Sponsor|6|||
161962683|NCT02684617|584909858|FG001|Overall Study|Study Terminated by Sponsor|1|||
161962684|NCT02684617|584909859|FG002|Overall Study|Study Terminated by Sponsor|5|||
161962685|NCT00853242|584909860|FG000|Overall Study|Adverse Event|0|||
161962686|NCT00853242|584909861|FG001|Overall Study|Adverse Event|1|||
161962687|NCT00853242|584909862|FG002|Overall Study|Adverse Event|1|||
161962688|NCT00853242|584909863|FG003|Overall Study|Adverse Event|0|||
161962689|NCT00853242|584909864|FG004|Overall Study|Adverse Event|3|||
161962690|NCT00853242|584909865|FG005|Overall Study|Adverse Event|1|||
161962691|NCT00853242|584909866|FG006|Overall Study|Adverse Event|1|||
161962692|NCT00853242|584909860|FG000|Overall Study|Noncompliant|0|||
161716021|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
161962693|NCT00853242|584909861|FG001|Overall Study|Noncompliant|0|||
161962694|NCT00853242|584909862|FG002|Overall Study|Noncompliant|0|||
161962695|NCT00853242|584909863|FG003|Overall Study|Noncompliant|0|||
161716022|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716023|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716024|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716025|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716026|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716027|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
161716028|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
161716029|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Physician Decision|0|||
161716030|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Physician Decision|0|||
161716031|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Physician Decision|0|||
161716032|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Physician Decision|0|||
161716033|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Physician Decision|0|||
161716034|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Physician Decision|0|||
161716035|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Physician Decision|0|||
161716036|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Physician Decision|0|||
161716037|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Physician Decision|0|||
161716038|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Physician Decision|0|||
161716039|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Physician Decision|0|||
161716040|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Physician Decision|0|||
161716041|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Physician Decision|0|||
161716042|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Physician Decision|4|||
161716043|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Physician Decision|2|||
161716044|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Progressive disease|0|||
161716045|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Progressive disease|0|||
161716046|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Progressive disease|0|||
161716047|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Progressive disease|0|||
161716048|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Progressive disease|0|||
161716049|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Progressive disease|0|||
161716050|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Progressive disease|0|||
161716051|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Progressive disease|0|||
161716052|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Progressive disease|0|||
161716053|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Progressive disease|5|||
161716054|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Progressive disease|0|||
161716055|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Progressive disease|0|||
161716056|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Progressive disease|0|||
161716057|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Progressive disease|30|||
161716058|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Progressive disease|8|||
161716059|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716060|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716061|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716062|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716063|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716064|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716065|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716066|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716067|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716068|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716069|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716070|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716071|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161716072|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
161716073|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
161716074|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716075|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716076|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716077|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716078|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716079|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716080|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716081|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716082|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716083|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
161716084|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716085|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716086|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161716087|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
161716088|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
161716089|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716090|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716091|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716092|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716093|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716094|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716095|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716096|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716097|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716098|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
161716099|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716100|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716101|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716102|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
161716103|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
161716104|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
161716105|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
161716106|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
161716107|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
161716108|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
161716109|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
161716110|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
161716111|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
161716112|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
161716113|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
161716114|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
161716115|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
161716116|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
161716117|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
161716118|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
161716119|NCT03519178|584006432|FG000|Fulvestrant. Treatment|Other|0|||
161716120|NCT03519178|584006433|FG001|Fulvestrant. Treatment|Other|0|||
161716121|NCT03519178|584006434|FG002|Fulvestrant. Treatment|Other|0|||
161716122|NCT03519178|584006435|FG003|Fulvestrant. Treatment|Other|0|||
161716123|NCT03519178|584006436|FG004|Fulvestrant. Treatment|Other|0|||
161716124|NCT03519178|584006437|FG005|Fulvestrant. Treatment|Other|0|||
161716125|NCT03519178|584006438|FG006|Fulvestrant. Treatment|Other|0|||
161716126|NCT03519178|584006439|FG007|Fulvestrant. Treatment|Other|0|||
161716127|NCT03519178|584006440|FG008|Fulvestrant. Treatment|Other|0|||
161716128|NCT03519178|584006441|FG009|Fulvestrant. Treatment|Other|0|||
161716129|NCT03519178|584006442|FG010|Fulvestrant. Treatment|Other|0|||
161716130|NCT03519178|584006443|FG011|Fulvestrant. Treatment|Other|0|||
161716131|NCT03519178|584006444|FG012|Fulvestrant. Treatment|Other|0|||
161716132|NCT03519178|584006445|FG013|Fulvestrant. Treatment|Other|1|||
161716133|NCT03519178|584006446|FG014|Fulvestrant. Treatment|Other|3|||
161716134|NCT03519178|584006432|FG000|Letrozole Treatment|Physician Decision|0|||
161716135|NCT03519178|584006433|FG001|Letrozole Treatment|Physician Decision|0|||
161716136|NCT03519178|584006434|FG002|Letrozole Treatment|Physician Decision|0|||
161716137|NCT03519178|584006435|FG003|Letrozole Treatment|Physician Decision|0|||
161716138|NCT03519178|584006436|FG004|Letrozole Treatment|Physician Decision|0|||
161716139|NCT03519178|584006437|FG005|Letrozole Treatment|Physician Decision|0|||
161716140|NCT03519178|584006438|FG006|Letrozole Treatment|Physician Decision|0|||
161716141|NCT03519178|584006439|FG007|Letrozole Treatment|Physician Decision|0|||
161716142|NCT03519178|584006440|FG008|Letrozole Treatment|Physician Decision|0|||
161716143|NCT03519178|584006441|FG009|Letrozole Treatment|Physician Decision|0|||
161716144|NCT03519178|584006442|FG010|Letrozole Treatment|Physician Decision|1|||
161716145|NCT03519178|584006443|FG011|Letrozole Treatment|Physician Decision|0|||
161716146|NCT03519178|584006444|FG012|Letrozole Treatment|Physician Decision|0|||
161716147|NCT03519178|584006445|FG013|Letrozole Treatment|Physician Decision|0|||
161716148|NCT03519178|584006446|FG014|Letrozole Treatment|Physician Decision|0|||
161716149|NCT03519178|584006432|FG000|Letrozole Treatment|Progressive disease|0|||
161716150|NCT03519178|584006433|FG001|Letrozole Treatment|Progressive disease|0|||
161716151|NCT03519178|584006434|FG002|Letrozole Treatment|Progressive disease|0|||
161716152|NCT03519178|584006435|FG003|Letrozole Treatment|Progressive disease|0|||
161716153|NCT03519178|584006436|FG004|Letrozole Treatment|Progressive disease|0|||
161962696|NCT00853242|584909864|FG004|Overall Study|Noncompliant|1|||
161716154|NCT03519178|584006437|FG005|Letrozole Treatment|Progressive disease|0|||
161716155|NCT03519178|584006438|FG006|Letrozole Treatment|Progressive disease|0|||
161716156|NCT03519178|584006439|FG007|Letrozole Treatment|Progressive disease|0|||
161716157|NCT03519178|584006440|FG008|Letrozole Treatment|Progressive disease|0|||
161716158|NCT03519178|584006441|FG009|Letrozole Treatment|Progressive disease|0|||
161716159|NCT03519178|584006442|FG010|Letrozole Treatment|Progressive disease|4|||
161716160|NCT03519178|584006443|FG011|Letrozole Treatment|Progressive disease|0|||
161716161|NCT03519178|584006444|FG012|Letrozole Treatment|Progressive disease|0|||
161962697|NCT00853242|584909865|FG005|Overall Study|Noncompliant|0|||
161962698|NCT00853242|584909866|FG006|Overall Study|Noncompliant|0|||
162031904|NCT00470158|585174114|FG001|Overall Study|Protocol Violation|0|||
161716162|NCT03519178|584006445|FG013|Letrozole Treatment|Progressive disease|0|||
161716163|NCT03519178|584006446|FG014|Letrozole Treatment|Progressive disease|0|||
161716164|NCT03519178|584006432|FG000|Letrozole Treatment|Global deterioration of health status|0|||
161716165|NCT03519178|584006433|FG001|Letrozole Treatment|Global deterioration of health status|0|||
161716166|NCT03519178|584006434|FG002|Letrozole Treatment|Global deterioration of health status|0|||
161716167|NCT03519178|584006435|FG003|Letrozole Treatment|Global deterioration of health status|0|||
161716168|NCT03519178|584006436|FG004|Letrozole Treatment|Global deterioration of health status|0|||
161716169|NCT03519178|584006437|FG005|Letrozole Treatment|Global deterioration of health status|0|||
161716170|NCT03519178|584006438|FG006|Letrozole Treatment|Global deterioration of health status|0|||
161716171|NCT03519178|584006439|FG007|Letrozole Treatment|Global deterioration of health status|0|||
161716172|NCT03519178|584006440|FG008|Letrozole Treatment|Global deterioration of health status|0|||
161716173|NCT03519178|584006441|FG009|Letrozole Treatment|Global deterioration of health status|0|||
161716174|NCT03519178|584006442|FG010|Letrozole Treatment|Global deterioration of health status|2|||
161716175|NCT03519178|584006443|FG011|Letrozole Treatment|Global deterioration of health status|0|||
161716176|NCT03519178|584006444|FG012|Letrozole Treatment|Global deterioration of health status|0|||
161716177|NCT03519178|584006445|FG013|Letrozole Treatment|Global deterioration of health status|0|||
161716178|NCT03519178|584006446|FG014|Letrozole Treatment|Global deterioration of health status|0|||
161716179|NCT03519178|584006432|FG000|Follow-Up|Death|0|||
161716180|NCT03519178|584006433|FG001|Follow-Up|Death|0|||
161716181|NCT03519178|584006434|FG002|Follow-Up|Death|0|||
161716182|NCT03519178|584006435|FG003|Follow-Up|Death|0|||
161716183|NCT03519178|584006436|FG004|Follow-Up|Death|0|||
161716184|NCT03519178|584006437|FG005|Follow-Up|Death|0|||
161716185|NCT03519178|584006438|FG006|Follow-Up|Death|0|||
161716186|NCT03519178|584006439|FG007|Follow-Up|Death|0|||
161716187|NCT03519178|584006440|FG008|Follow-Up|Death|3|||
161716188|NCT03519178|584006441|FG009|Follow-Up|Death|1|||
161716189|NCT03519178|584006442|FG010|Follow-Up|Death|0|||
161716190|NCT03519178|584006443|FG011|Follow-Up|Death|0|||
161716191|NCT03519178|584006444|FG012|Follow-Up|Death|2|||
161716192|NCT03519178|584006445|FG013|Follow-Up|Death|0|||
161716193|NCT03519178|584006446|FG014|Follow-Up|Death|0|||
161716194|NCT03519178|584006432|FG000|Follow-Up|Lost to Follow-up|0|||
161716195|NCT03519178|584006433|FG001|Follow-Up|Lost to Follow-up|0|||
161716196|NCT03519178|584006434|FG002|Follow-Up|Lost to Follow-up|0|||
161716197|NCT03519178|584006435|FG003|Follow-Up|Lost to Follow-up|0|||
161716198|NCT03519178|584006436|FG004|Follow-Up|Lost to Follow-up|0|||
161716199|NCT03519178|584006437|FG005|Follow-Up|Lost to Follow-up|3|||
161716200|NCT03519178|584006438|FG006|Follow-Up|Lost to Follow-up|1|||
161716201|NCT03519178|584006439|FG007|Follow-Up|Lost to Follow-up|4|||
161716202|NCT03519178|584006440|FG008|Follow-Up|Lost to Follow-up|1|||
161716203|NCT03519178|584006441|FG009|Follow-Up|Lost to Follow-up|0|||
161716204|NCT03519178|584006442|FG010|Follow-Up|Lost to Follow-up|0|||
161716205|NCT03519178|584006443|FG011|Follow-Up|Lost to Follow-up|0|||
161716206|NCT03519178|584006444|FG012|Follow-Up|Lost to Follow-up|0|||
161716207|NCT03519178|584006445|FG013|Follow-Up|Lost to Follow-up|0|||
161716208|NCT03519178|584006446|FG014|Follow-Up|Lost to Follow-up|0|||
161716209|NCT03519178|584006432|FG000|Follow-Up|Withdrawal by Subject|1|||
161716210|NCT03519178|584006433|FG001|Follow-Up|Withdrawal by Subject|2|||
161716211|NCT03519178|584006434|FG002|Follow-Up|Withdrawal by Subject|2|||
161716212|NCT03519178|584006435|FG003|Follow-Up|Withdrawal by Subject|3|||
161716213|NCT03519178|584006436|FG004|Follow-Up|Withdrawal by Subject|5|||
161716214|NCT03519178|584006437|FG005|Follow-Up|Withdrawal by Subject|1|||
161716215|NCT03519178|584006438|FG006|Follow-Up|Withdrawal by Subject|2|||
161716216|NCT03519178|584006439|FG007|Follow-Up|Withdrawal by Subject|6|||
161716217|NCT03519178|584006440|FG008|Follow-Up|Withdrawal by Subject|5|||
161716218|NCT03519178|584006441|FG009|Follow-Up|Withdrawal by Subject|2|||
161716219|NCT03519178|584006442|FG010|Follow-Up|Withdrawal by Subject|3|||
161716220|NCT03519178|584006443|FG011|Follow-Up|Withdrawal by Subject|5|||
161716221|NCT03519178|584006444|FG012|Follow-Up|Withdrawal by Subject|2|||
161716222|NCT03519178|584006445|FG013|Follow-Up|Withdrawal by Subject|0|||
161716223|NCT03519178|584006446|FG014|Follow-Up|Withdrawal by Subject|0|||
161716224|NCT03519178|584006432|FG000|Follow-Up|Other|0|||
161716225|NCT03519178|584006433|FG001|Follow-Up|Other|0|||
161716226|NCT03519178|584006434|FG002|Follow-Up|Other|0|||
161716227|NCT03519178|584006435|FG003|Follow-Up|Other|0|||
161716228|NCT03519178|584006436|FG004|Follow-Up|Other|0|||
161716229|NCT03519178|584006437|FG005|Follow-Up|Other|0|||
161716230|NCT03519178|584006438|FG006|Follow-Up|Other|0|||
161716231|NCT03519178|584006439|FG007|Follow-Up|Other|1|||
162031905|NCT00470158|585174115|FG002|Overall Study|Protocol Violation|0|||
161716232|NCT03519178|584006440|FG008|Follow-Up|Other|0|||
161716233|NCT03519178|584006441|FG009|Follow-Up|Other|0|||
161716234|NCT03519178|584006442|FG010|Follow-Up|Other|0|||
161716235|NCT03519178|584006443|FG011|Follow-Up|Other|0|||
161716236|NCT03519178|584006444|FG012|Follow-Up|Other|0|||
161716237|NCT03519178|584006445|FG013|Follow-Up|Other|0|||
161716238|NCT03519178|584006446|FG014|Follow-Up|Other|0|||
161716239|NCT03519178|584006432|FG000|Long-term Follow-up|Death|0|||
161716240|NCT03519178|584006433|FG001|Long-term Follow-up|Death|0|||
161716241|NCT03519178|584006434|FG002|Long-term Follow-up|Death|0|||
161716242|NCT03519178|584006435|FG003|Long-term Follow-up|Death|0|||
161716243|NCT03519178|584006436|FG004|Long-term Follow-up|Death|0|||
161716244|NCT03519178|584006437|FG005|Long-term Follow-up|Death|0|||
161716245|NCT03519178|584006438|FG006|Long-term Follow-up|Death|0|||
161716246|NCT03519178|584006439|FG007|Long-term Follow-up|Death|0|||
161716247|NCT03519178|584006440|FG008|Long-term Follow-up|Death|0|||
161716248|NCT03519178|584006441|FG009|Long-term Follow-up|Death|0|||
161716249|NCT03519178|584006442|FG010|Long-term Follow-up|Death|0|||
161716250|NCT03519178|584006443|FG011|Long-term Follow-up|Death|0|||
161716251|NCT03519178|584006444|FG012|Long-term Follow-up|Death|0|||
161716252|NCT03519178|584006445|FG013|Long-term Follow-up|Death|4|||
161716253|NCT03519178|584006446|FG014|Long-term Follow-up|Death|4|||
161716254|NCT03519178|584006432|FG000|Long-term Follow-up|Lost to Follow-up|0|||
161716255|NCT03519178|584006433|FG001|Long-term Follow-up|Lost to Follow-up|0|||
161716256|NCT03519178|584006434|FG002|Long-term Follow-up|Lost to Follow-up|0|||
161716257|NCT03519178|584006435|FG003|Long-term Follow-up|Lost to Follow-up|0|||
161716258|NCT03519178|584006436|FG004|Long-term Follow-up|Lost to Follow-up|0|||
161716259|NCT03519178|584006437|FG005|Long-term Follow-up|Lost to Follow-up|0|||
161716260|NCT03519178|584006438|FG006|Long-term Follow-up|Lost to Follow-up|0|||
161716261|NCT03519178|584006439|FG007|Long-term Follow-up|Lost to Follow-up|0|||
161716262|NCT03519178|584006440|FG008|Long-term Follow-up|Lost to Follow-up|0|||
161716263|NCT03519178|584006441|FG009|Long-term Follow-up|Lost to Follow-up|0|||
161716264|NCT03519178|584006442|FG010|Long-term Follow-up|Lost to Follow-up|0|||
161716265|NCT03519178|584006443|FG011|Long-term Follow-up|Lost to Follow-up|0|||
161716266|NCT03519178|584006444|FG012|Long-term Follow-up|Lost to Follow-up|0|||
161716267|NCT03519178|584006445|FG013|Long-term Follow-up|Lost to Follow-up|1|||
161716268|NCT03519178|584006446|FG014|Long-term Follow-up|Lost to Follow-up|1|||
161716269|NCT03519178|584006432|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
161716270|NCT03519178|584006433|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
161716271|NCT03519178|584006434|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
161716272|NCT03519178|584006435|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
161716273|NCT03519178|584006436|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
161716274|NCT03519178|584006437|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
161716275|NCT03519178|584006438|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
161716276|NCT03519178|584006439|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
161716277|NCT03519178|584006440|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
161716278|NCT03519178|584006441|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
161716279|NCT03519178|584006442|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
161716280|NCT03519178|584006443|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
161716281|NCT03519178|584006444|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
161716282|NCT03519178|584006445|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
161716283|NCT03519178|584006446|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
161716284|NCT03519178|584006432|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
161716285|NCT03519178|584006433|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
161716286|NCT03519178|584006434|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
161716287|NCT03519178|584006435|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
161716288|NCT03519178|584006436|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
161716289|NCT03519178|584006437|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
161716290|NCT03519178|584006438|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
161716291|NCT03519178|584006439|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
161716292|NCT03519178|584006440|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
161716293|NCT03519178|584006441|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
161716294|NCT03519178|584006442|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
161716295|NCT03519178|584006443|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
161716296|NCT03519178|584006444|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
161716297|NCT03519178|584006445|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
161716298|NCT03519178|584006446|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
161716299|NCT03519178|584006432|FG000|Long-term Follow-up|Other|0|||
161716300|NCT03519178|584006433|FG001|Long-term Follow-up|Other|0|||
161962699|NCT00853242|584909860|FG000|Overall Study|Withdrawal by Subject|1|||
161962700|NCT00853242|584909861|FG001|Overall Study|Withdrawal by Subject|2|||
161962701|NCT00853242|584909862|FG002|Overall Study|Withdrawal by Subject|0|||
161962702|NCT00853242|584909863|FG003|Overall Study|Withdrawal by Subject|4|||
161962703|NCT00853242|584909864|FG004|Overall Study|Withdrawal by Subject|0|||
161962704|NCT00853242|584909865|FG005|Overall Study|Withdrawal by Subject|0|||
161962705|NCT00853242|584909866|FG006|Overall Study|Withdrawal by Subject|2|||
161962706|NCT00853242|584909860|FG000|Overall Study|Other|2|||
161962707|NCT00853242|584909861|FG001|Overall Study|Other|0|||
161716301|NCT03519178|584006434|FG002|Long-term Follow-up|Other|0|||
161962708|NCT00853242|584909862|FG002|Overall Study|Other|2|||
161962709|NCT00853242|584909863|FG003|Overall Study|Other|0|||
162031906|NCT00470158|585174116|FG003|Overall Study|Protocol Violation|0|||
161716302|NCT03519178|584006435|FG003|Long-term Follow-up|Other|0|||
161716303|NCT03519178|584006436|FG004|Long-term Follow-up|Other|0|||
161716304|NCT03519178|584006437|FG005|Long-term Follow-up|Other|0|||
161716305|NCT03519178|584006438|FG006|Long-term Follow-up|Other|0|||
161962710|NCT00853242|584909864|FG004|Overall Study|Other|0|||
162031907|NCT00470158|585174117|FG004|Overall Study|Protocol Violation|0|||
161716306|NCT03519178|584006439|FG007|Long-term Follow-up|Other|0|||
161716307|NCT03519178|584006440|FG008|Long-term Follow-up|Other|0|||
161716308|NCT03519178|584006441|FG009|Long-term Follow-up|Other|0|||
161716309|NCT03519178|584006442|FG010|Long-term Follow-up|Other|0|||
161716310|NCT03519178|584006443|FG011|Long-term Follow-up|Other|0|||
161716311|NCT03519178|584006444|FG012|Long-term Follow-up|Other|0|||
161716312|NCT03519178|584006445|FG013|Long-term Follow-up|Other|0|||
161716313|NCT03519178|584006446|FG014|Long-term Follow-up|Other|1|||
161716314|NCT03519178|584006432|FG000|Long-term Follow-up|Global deterioration of health status|0|||
161716315|NCT03519178|584006433|FG001|Long-term Follow-up|Global deterioration of health status|0|||
161716316|NCT03519178|584006434|FG002|Long-term Follow-up|Global deterioration of health status|0|||
161716317|NCT03519178|584006435|FG003|Long-term Follow-up|Global deterioration of health status|0|||
161716318|NCT03519178|584006436|FG004|Long-term Follow-up|Global deterioration of health status|0|||
161716319|NCT03519178|584006437|FG005|Long-term Follow-up|Global deterioration of health status|0|||
161716320|NCT03519178|584006438|FG006|Long-term Follow-up|Global deterioration of health status|0|||
161716321|NCT03519178|584006439|FG007|Long-term Follow-up|Global deterioration of health status|0|||
161716322|NCT03519178|584006440|FG008|Long-term Follow-up|Global deterioration of health status|0|||
161716323|NCT03519178|584006441|FG009|Long-term Follow-up|Global deterioration of health status|0|||
161716324|NCT03519178|584006442|FG010|Long-term Follow-up|Global deterioration of health status|0|||
161716325|NCT03519178|584006443|FG011|Long-term Follow-up|Global deterioration of health status|0|||
161716326|NCT03519178|584006444|FG012|Long-term Follow-up|Global deterioration of health status|0|||
161716327|NCT03519178|584006445|FG013|Long-term Follow-up|Global deterioration of health status|1|||
161716328|NCT03519178|584006446|FG014|Long-term Follow-up|Global deterioration of health status|0|||
161716329|NCT03497689|584006449|FG000|Overall Study|Adverse Event|2|||
161716330|NCT03497689|584006449|FG000|Overall Study|Death|1|||
161716331|NCT03497689|584006449|FG000|Overall Study|Physician Decision|1|||
161716332|NCT03497689|584006449|FG000|Overall Study|Withdrawal by Subject|1|||
161716333|NCT03497689|584006449|FG000|Overall Study|Protocol Violation|2|||
161716334|NCT05165394|584007837|FG000|Overall Study|Withdrawal by Subject|5|||
161716335|NCT05165394|584007838|FG001|Overall Study|Withdrawal by Subject|1|||
161962711|NCT00853242|584909865|FG005|Overall Study|Other|1|||
161716336|NCT05165394|584007837|FG000|Overall Study|Lost to Follow-up|1|||
161716337|NCT05165394|584007838|FG001|Overall Study|Lost to Follow-up|2|||
161716338|NCT05165394|584007837|FG000|Overall Study|Other Than Specified|0|||
161716339|NCT05165394|584007838|FG001|Overall Study|Other Than Specified|1|||
161716340|NCT03705494|584007839|FG000|Overall Study|Lost to Follow-up|2|||
161716341|NCT03705494|584007840|FG001|Overall Study|Lost to Follow-up|1|||
161716342|NCT03705494|584007839|FG000|Overall Study|Withdrawal by Subject|5|||
161716343|NCT03705494|584007840|FG001|Overall Study|Withdrawal by Subject|2|||
161716344|NCT02495077|584007841|FG000|Overall Study|Adverse Event|0|||
161716345|NCT02495077|584007842|FG001|Overall Study|Adverse Event|1|||
161716346|NCT02495077|584007843|FG002|Overall Study|Adverse Event|1|||
161716347|NCT02495077|584007844|FG003|Overall Study|Adverse Event|0|||
161716348|NCT02495077|584007841|FG000|Overall Study|Death|3|||
161716349|NCT02495077|584007842|FG001|Overall Study|Death|5|||
161716350|NCT02495077|584007843|FG002|Overall Study|Death|0|||
161716351|NCT02495077|584007844|FG003|Overall Study|Death|0|||
161716352|NCT02495077|584007841|FG000|Overall Study|Lost to Follow-up|6|||
161716353|NCT02495077|584007842|FG001|Overall Study|Lost to Follow-up|4|||
161716354|NCT02495077|584007843|FG002|Overall Study|Lost to Follow-up|0|||
161716355|NCT02495077|584007844|FG003|Overall Study|Lost to Follow-up|0|||
161716356|NCT02495077|584007841|FG000|Overall Study|Physician Decision|2|||
161716357|NCT02495077|584007842|FG001|Overall Study|Physician Decision|1|||
161716358|NCT02495077|584007843|FG002|Overall Study|Physician Decision|4|||
161716359|NCT02495077|584007844|FG003|Overall Study|Physician Decision|0|||
161716360|NCT02495077|584007841|FG000|Overall Study|Protocol Violation|0|||
161962712|NCT00853242|584909866|FG006|Overall Study|Other|2|||
161716361|NCT02495077|584007842|FG001|Overall Study|Protocol Violation|1|||
161716362|NCT02495077|584007843|FG002|Overall Study|Protocol Violation|0|||
161716363|NCT02495077|584007844|FG003|Overall Study|Protocol Violation|0|||
161716364|NCT02495077|584007841|FG000|Overall Study|Screen Failure|0|||
161716365|NCT02495077|584007842|FG001|Overall Study|Screen Failure|0|||
161962713|NCT01205061|584909867|FG000|Overall Study|Adverse Event|4|||
161962714|NCT01205061|584909867|FG000|Overall Study|Withdrawal by Subject|11|||
161716366|NCT02495077|584007843|FG002|Overall Study|Screen Failure|0|||
161716367|NCT02495077|584007844|FG003|Overall Study|Screen Failure|48|||
161716368|NCT02495077|584007841|FG000|Overall Study|Withdrawal by Subject|7|||
161716369|NCT02495077|584007842|FG001|Overall Study|Withdrawal by Subject|7|||
161716370|NCT02495077|584007843|FG002|Overall Study|Withdrawal by Subject|7|||
161716371|NCT02495077|584007844|FG003|Overall Study|Withdrawal by Subject|0|||
161716372|NCT02495077|584007841|FG000|Overall Study|Covid-19 research restrictions|1|||
161716373|NCT02495077|584007842|FG001|Overall Study|Covid-19 research restrictions|0|||
161716374|NCT02495077|584007843|FG002|Overall Study|Covid-19 research restrictions|0|||
161716375|NCT02495077|584007844|FG003|Overall Study|Covid-19 research restrictions|0|||
161716376|NCT02495077|584007841|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
161716377|NCT02495077|584007842|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
161716378|NCT02495077|584007843|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
161716379|NCT02495077|584007844|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
161716380|NCT02495077|584007841|FG000|Overall Study|Incarcerated|0|||
161716381|NCT02495077|584007842|FG001|Overall Study|Incarcerated|1|||
161716382|NCT02495077|584007843|FG002|Overall Study|Incarcerated|0|||
161716383|NCT02495077|584007844|FG003|Overall Study|Incarcerated|0|||
161716384|NCT02495077|584007841|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
161716385|NCT02495077|584007842|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
161716386|NCT02495077|584007843|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
161716387|NCT02495077|584007844|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
161716388|NCT02495077|584007841|FG000|Overall Study|Timing of transplant and randomization|0|||
161716389|NCT02495077|584007842|FG001|Overall Study|Timing of transplant and randomization|0|||
161716390|NCT02495077|584007843|FG002|Overall Study|Timing of transplant and randomization|5|||
161716391|NCT02495077|584007844|FG003|Overall Study|Timing of transplant and randomization|0|||
161716392|NCT02742649|584007845|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
161716393|NCT02742649|584007846|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
161716394|NCT02742649|584007847|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
161716395|NCT02742649|584007848|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
161716396|NCT02742649|584007849|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
161716397|NCT02742649|584007845|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161716398|NCT02742649|584007846|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161716399|NCT02742649|584007847|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161716400|NCT02742649|584007848|FG003|Double-Blind Treatment Period|Adverse Event|0|||
161716401|NCT02742649|584007849|FG004|Double-Blind Treatment Period|Adverse Event|0|||
161716402|NCT02742649|584007845|FG000|Open-Label Period|Lost to Follow-up|0|||
161716403|NCT02742649|584007846|FG001|Open-Label Period|Lost to Follow-up|0|||
161716404|NCT02742649|584007847|FG002|Open-Label Period|Lost to Follow-up|0|||
161716405|NCT02742649|584007848|FG003|Open-Label Period|Lost to Follow-up|0|||
161716406|NCT02742649|584007849|FG004|Open-Label Period|Lost to Follow-up|1|||
161716407|NCT03937986|584007850|FG000|Overall Study|COVID-19 Pandemic|1|||
161716408|NCT02839746|584007851|FG000|Overall Study|Not met selection criteria|12|||
161716409|NCT02089737|584007852|FG000|Overall Study|Survey form not completed|5|||
161716410|NCT02089737|584007852|FG000|Overall Study|Not treated|1|||
161716411|NCT00744055|584007853|FG000|Overall Study|Withdrawal by Subject|6|||
161716412|NCT00744055|584007854|FG001|Overall Study|Withdrawal by Subject|9|||
161716413|NCT00744055|584007853|FG000|Overall Study|Lack of Efficacy|0|||
162031908|NCT01249118|585174118|FG000|First Washout Period|Physician Decision|0|||
162031909|NCT01249118|585174119|FG001|First Washout Period|Physician Decision|1|||
162031910|NCT01249118|585174120|FG002|First Washout Period|Physician Decision|0|||
162031911|NCT00880685|585174121|FG000|Memantine 10mg|Lost to Follow-up|2|||
162031912|NCT00880685|585174121|FG000|Memantine 20mg|Withdrawal by Subject|1|||
162031913|NCT04179890|585174122|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
162031914|NCT04179890|585174123|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
162031915|NCT04179890|585174122|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
162031916|NCT04179890|585174123|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
162031917|NCT04179890|585174122|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
162031918|NCT04179890|585174123|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
162031919|NCT04179890|585174122|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
162031920|NCT04179890|585174123|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
162031921|NCT04179890|585174122|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
161716414|NCT00744055|584007854|FG001|Overall Study|Lack of Efficacy|1|||
161716415|NCT00744055|584007853|FG000|Overall Study|Physician Decision|0|||
161716416|NCT00744055|584007854|FG001|Overall Study|Physician Decision|2|||
161716417|NCT00744055|584007853|FG000|Overall Study|Protocol Violation|1|||
161716418|NCT00744055|584007854|FG001|Overall Study|Protocol Violation|1|||
161716419|NCT00744055|584007853|FG000|Overall Study|Lost to Follow-up|0|||
161716420|NCT00744055|584007854|FG001|Overall Study|Lost to Follow-up|1|||
161716421|NCT04426630|584007855|FG000|Overall Study|Death|4|||
161716422|NCT04426630|584007855|FG000|Overall Study|Lost to Follow-up|2|||
161716423|NCT01123889|584007856|FG000|Overall Study|Lost to Follow-up|3|||
161716424|NCT01123889|584007857|FG001|Overall Study|Lost to Follow-up|1|||
161716425|NCT02333331|584007858|FG000|Overall Study|Adverse Event|1|||
161716426|NCT02333331|584007859|FG001|Overall Study|Adverse Event|0|||
161716427|NCT02333331|584007860|FG002|Overall Study|Adverse Event|4|||
161716428|NCT02333331|584007861|FG003|Overall Study|Adverse Event|1|||
161716429|NCT02333331|584007858|FG000|Overall Study|Death|0|||
161716430|NCT02333331|584007859|FG001|Overall Study|Death|0|||
161716431|NCT02333331|584007860|FG002|Overall Study|Death|2|||
161716432|NCT02333331|584007861|FG003|Overall Study|Death|0|||
161716433|NCT02333331|584007858|FG000|Overall Study|Lost to Follow-up|0|||
161716434|NCT02333331|584007859|FG001|Overall Study|Lost to Follow-up|0|||
161716435|NCT02333331|584007860|FG002|Overall Study|Lost to Follow-up|1|||
161716436|NCT02333331|584007861|FG003|Overall Study|Lost to Follow-up|0|||
161716437|NCT02333331|584007858|FG000|Overall Study|Physician Decision|0|||
161716438|NCT02333331|584007859|FG001|Overall Study|Physician Decision|1|||
161716439|NCT02333331|584007860|FG002|Overall Study|Physician Decision|0|||
161716440|NCT02333331|584007861|FG003|Overall Study|Physician Decision|0|||
161716441|NCT02333331|584007858|FG000|Overall Study|Protocol Deviation|0|||
161716442|NCT02333331|584007859|FG001|Overall Study|Protocol Deviation|3|||
161716443|NCT02333331|584007860|FG002|Overall Study|Protocol Deviation|2|||
161716444|NCT02333331|584007861|FG003|Overall Study|Protocol Deviation|1|||
161716445|NCT02333331|584007858|FG000|Overall Study|Patient/Guardian Decision|1|||
161716446|NCT02333331|584007859|FG001|Overall Study|Patient/Guardian Decision|2|||
161716447|NCT02333331|584007860|FG002|Overall Study|Patient/Guardian Decision|9|||
161716448|NCT02333331|584007861|FG003|Overall Study|Patient/Guardian Decision|1|||
161716449|NCT00685178|584007867|FG000|Overall Study|Adverse Event|1|||
161716450|NCT00685178|584007868|FG001|Overall Study|Adverse Event|5|||
161716451|NCT00685178|584007869|FG002|Overall Study|Adverse Event|2|||
161716452|NCT00685178|584007870|FG003|Overall Study|Adverse Event|4|||
161716453|NCT00685178|584007867|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
161716454|NCT00685178|584007868|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
161716455|NCT00685178|584007869|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
161716456|NCT00685178|584007870|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
161716457|NCT00685178|584007867|FG000|Overall Study|voluntary study discharge|4|||
161716458|NCT00685178|584007868|FG001|Overall Study|voluntary study discharge|5|||
161716459|NCT00685178|584007869|FG002|Overall Study|voluntary study discharge|1|||
161716460|NCT00685178|584007870|FG003|Overall Study|voluntary study discharge|1|||
161716461|NCT00685178|584007867|FG000|Overall Study|incarcerated|1|||
161716462|NCT00685178|584007868|FG001|Overall Study|incarcerated|3|||
161716463|NCT00685178|584007869|FG002|Overall Study|incarcerated|7|||
161716464|NCT00685178|584007870|FG003|Overall Study|incarcerated|0|||
161716465|NCT00685178|584007867|FG000|Overall Study|administrative (disciplinary) discharge|0|||
161716466|NCT00685178|584007868|FG001|Overall Study|administrative (disciplinary) discharge|1|||
161716467|NCT00685178|584007869|FG002|Overall Study|administrative (disciplinary) discharge|0|||
161716468|NCT00685178|584007870|FG003|Overall Study|administrative (disciplinary) discharge|2|||
161716469|NCT00685178|584007867|FG000|Overall Study|Pregnancy|0|||
161716470|NCT00685178|584007868|FG001|Overall Study|Pregnancy|0|||
161716471|NCT00685178|584007869|FG002|Overall Study|Pregnancy|0|||
161716472|NCT00685178|584007870|FG003|Overall Study|Pregnancy|1|||
161716473|NCT05299892|584007884|FG000|Overall Study|Withdrawal by Subject|2|||
161716474|NCT01059812|584007885|FG000|Overall Study|Adverse Event|9|||
161716475|NCT01059812|584007886|FG001|Overall Study|Adverse Event|5|||
161716476|NCT01059812|584007885|FG000|Overall Study|Lack of Efficacy|2|||
161716477|NCT01059812|584007886|FG001|Overall Study|Lack of Efficacy|2|||
161716478|NCT01059812|584007885|FG000|Overall Study|Protocol Violation|3|||
161716479|NCT01059812|584007886|FG001|Overall Study|Protocol Violation|1|||
161716480|NCT01059812|584007885|FG000|Overall Study|Withdrawal Criteria|9|||
161716481|NCT01059812|584007886|FG001|Overall Study|Withdrawal Criteria|4|||
161716482|NCT01059812|584007885|FG000|Overall Study|Unclassified|14|||
161716483|NCT01059812|584007886|FG001|Overall Study|Unclassified|4|||
161716484|NCT00149214|584007887|FG000|Overall Study|Adverse Event|12|||
161716485|NCT00149214|584007888|FG001|Overall Study|Adverse Event|9|||
161716486|NCT00149214|584007887|FG000|Overall Study|Withdrawal by Subject|4|||
161716487|NCT00149214|584007888|FG001|Overall Study|Withdrawal by Subject|1|||
161716488|NCT00149214|584007887|FG000|Overall Study|Physician Decision|3|||
161716489|NCT00149214|584007888|FG001|Overall Study|Physician Decision|3|||
161962715|NCT01205061|584909867|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
161716490|NCT00149214|584007887|FG000|Overall Study|Sponsor Decision|0|||
161716491|NCT00149214|584007888|FG001|Overall Study|Sponsor Decision|1|||
161716492|NCT00149214|584007887|FG000|Overall Study|Progressive Disease|7|||
161962716|NCT01205061|584909867|FG000|Overall Study|Lost to Follow-up|9|||
161716493|NCT00149214|584007888|FG001|Overall Study|Progressive Disease|3|||
161716494|NCT00756002|584007892|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
161716495|NCT00756002|584007893|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
161716496|NCT00756002|584007892|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161716497|NCT00756002|584007893|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
161716498|NCT00756002|584007892|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
161716499|NCT00756002|584007893|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
161716500|NCT00756002|584007892|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
161716501|NCT00756002|584007893|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
161716502|NCT00756002|584007892|FG000|Double-Blind Treatment Period|Other|2|||
161716503|NCT00756002|584007893|FG001|Double-Blind Treatment Period|Other|2|||
161716504|NCT04329923|584007897|FG000|Overall Study|Withdrawal by Subject|1|||
161716505|NCT04329923|584007898|FG001|Overall Study|Withdrawal by Subject|4|||
161716506|NCT04329923|584007899|FG002|Overall Study|Withdrawal by Subject|1|||
161716507|NCT04329923|584007900|FG003|Overall Study|Withdrawal by Subject|1|||
161716508|NCT04329923|584007901|FG004|Overall Study|Withdrawal by Subject|1|||
161716509|NCT04329923|584007902|FG005|Overall Study|Withdrawal by Subject|1|||
161716510|NCT04329923|584007897|FG000|Overall Study|early termination of study|0|||
161716511|NCT04329923|584007898|FG001|Overall Study|early termination of study|0|||
161716512|NCT04329923|584007899|FG002|Overall Study|early termination of study|0|||
161716513|NCT04329923|584007900|FG003|Overall Study|early termination of study|0|||
161716514|NCT04329923|584007901|FG004|Overall Study|early termination of study|1|||
161716515|NCT04329923|584007902|FG005|Overall Study|early termination of study|2|||
161716516|NCT04329923|584007897|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161716517|NCT04329923|584007898|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161716518|NCT04329923|584007899|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161716519|NCT04329923|584007900|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161716520|NCT04329923|584007901|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161716521|NCT04329923|584007902|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
161716522|NCT01272180|584007903|FG000|Overall Study|Adverse Event|0|||
161716523|NCT01272180|584007904|FG001|Overall Study|Adverse Event|0|||
161716524|NCT01272180|584007905|FG002|Overall Study|Adverse Event|1|||
161716525|NCT01272180|584007906|FG003|Overall Study|Adverse Event|0|||
161716526|NCT01272180|584007903|FG000|Overall Study|Withdrawal by Subject|2|||
161716527|NCT01272180|584007904|FG001|Overall Study|Withdrawal by Subject|6|||
161716528|NCT01272180|584007905|FG002|Overall Study|Withdrawal by Subject|3|||
161716529|NCT01272180|584007906|FG003|Overall Study|Withdrawal by Subject|2|||
161716530|NCT01272180|584007903|FG000|Overall Study|Lost to Follow-up|15|||
161716531|NCT01272180|584007904|FG001|Overall Study|Lost to Follow-up|14|||
161716532|NCT01272180|584007905|FG002|Overall Study|Lost to Follow-up|8|||
161716533|NCT01272180|584007906|FG003|Overall Study|Lost to Follow-up|10|||
161716534|NCT01272180|584007903|FG000|Overall Study|Inappropriate enrollment|0|||
161716535|NCT01272180|584007904|FG001|Overall Study|Inappropriate enrollment|0|||
161716536|NCT01272180|584007905|FG002|Overall Study|Inappropriate enrollment|1|||
161716537|NCT01272180|584007906|FG003|Overall Study|Inappropriate enrollment|1|||
161716538|NCT01272180|584007903|FG000|Overall Study|Protocol Violation|0|||
161716539|NCT01272180|584007904|FG001|Overall Study|Protocol Violation|1|||
161716540|NCT01272180|584007905|FG002|Overall Study|Protocol Violation|0|||
161716541|NCT01272180|584007906|FG003|Overall Study|Protocol Violation|1|||
161716542|NCT03334214|584007907|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
161716543|NCT03334214|584007908|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
161716544|NCT03334214|584007907|FG000|Overall Study|Withdrawal by Subject|0|||
161716545|NCT03334214|584007908|FG001|Overall Study|Withdrawal by Subject|1|||
161716546|NCT03334214|584007907|FG000|Overall Study|Other|1|||
161716547|NCT03334214|584007908|FG001|Overall Study|Other|0|||
161716548|NCT01702805|584007913|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
161716549|NCT01702805|584007914|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
161716550|NCT01702805|584007913|FG000|Overall Study|Incomplete Follow-up|18|||
161716551|NCT01702805|584007914|FG001|Overall Study|Incomplete Follow-up|15|||
161716552|NCT01702805|584007913|FG000|Overall Study|Vital Status Assessment Only|40|||
161716553|NCT01702805|584007914|FG001|Overall Study|Vital Status Assessment Only|39|||
161716554|NCT01702805|584007913|FG000|Overall Study|Lost to Follow-up|5|||
161716555|NCT01702805|584007914|FG001|Overall Study|Lost to Follow-up|5|||
161716556|NCT03056287|584007915|FG000|Overall Study|Withdrawal by Subject|0|||
161716557|NCT03056287|584007916|FG001|Overall Study|Withdrawal by Subject|1|||
161716558|NCT03056287|584007917|FG002|Overall Study|Withdrawal by Subject|0|||
161716559|NCT03056287|584007918|FG003|Overall Study|Withdrawal by Subject|0|||
161716560|NCT03056287|584007915|FG000|Overall Study|move out of area|0|||
161716561|NCT03056287|584007916|FG001|Overall Study|move out of area|0|||
161716562|NCT03056287|584007917|FG002|Overall Study|move out of area|1|||
161962717|NCT01205061|584909867|FG000|Overall Study|Other|1|||
161716563|NCT03056287|584007918|FG003|Overall Study|move out of area|1|||
161716564|NCT01025336|584007923|FG000|Overall Study|Protocol Violation|0|||
161716565|NCT01025336|584007924|FG001|Overall Study|Protocol Violation|0|||
161716566|NCT01025336|584007925|FG002|Overall Study|Protocol Violation|0|||
161716567|NCT01025336|584007926|FG003|Overall Study|Protocol Violation|2|||
161716568|NCT01025336|584007927|FG004|Overall Study|Protocol Violation|0|||
161716569|NCT03794986|584007928|FG000|Overall Study|0 Sessions Attended|34|||
161716570|NCT03794986|584007929|FG001|Overall Study|0 Sessions Attended|37|||
161716571|NCT03794986|584007928|FG000|Overall Study|Withdrawal by Subject|4|||
162031922|NCT04179890|585174123|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
162031923|NCT04179890|585174122|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
162031924|NCT04179890|585174123|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
162031925|NCT04179890|585174122|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
162031926|NCT04179890|585174123|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
162031927|NCT04179890|585174122|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
161716572|NCT03794986|584007929|FG001|Overall Study|Withdrawal by Subject|6|||
161716573|NCT03794986|584007928|FG000|Overall Study|Protocol Violation|1|||
161716574|NCT03794986|584007929|FG001|Overall Study|Protocol Violation|0|||
161716575|NCT00550238|584007935|FG000|Overall Study|Adverse Event|88|||
161716576|NCT00550238|584007935|FG000|Overall Study|Death|34|||
161716577|NCT00550238|584007935|FG000|Overall Study|Disease progression|46|||
161716578|NCT00550238|584007935|FG000|Overall Study|Withdrawal by Subject|167|||
161716579|NCT00550238|584007935|FG000|Overall Study|Physician Decision|31|||
161716580|NCT00550238|584007935|FG000|Overall Study|Patient noncompliance|25|||
161716581|NCT00550238|584007935|FG000|Overall Study|Lost to Follow-up|13|||
161716582|NCT00550238|584007935|FG000|Overall Study|Sponsor decision|55|||
161716583|NCT01486238|584007941|FG000|Overall Study|Death|0|||
161716584|NCT01486238|584007942|FG001|Overall Study|Death|2|||
161716585|NCT01486238|584007941|FG000|Overall Study|Withdrawal by Subject|2|||
161716586|NCT01486238|584007942|FG001|Overall Study|Withdrawal by Subject|1|||
161716587|NCT01486238|584007941|FG000|Overall Study|Lost to Follow-up|0|||
161716588|NCT01486238|584007942|FG001|Overall Study|Lost to Follow-up|3|||
161716589|NCT01050062|584007943|FG000|Overall Study|Adverse Event|75|||
161716590|NCT01050062|584007944|FG001|Overall Study|Adverse Event|22|||
161838022|NCT00132028|584450292|FG000|Overall Study|Lack of Efficacy|11|||
161838023|NCT00132028|584450292|FG000|Overall Study|Withdrawal by Subject|2|||
161838024|NCT00132028|584450292|FG000|Overall Study|not eligible|2|||
161838025|NCT00132028|584450292|FG000|Overall Study|Physician Decision|3|||
161716591|NCT01050062|584007943|FG000|Overall Study|Lost to Follow-up|83|||
161716592|NCT01050062|584007944|FG001|Overall Study|Lost to Follow-up|35|||
161838026|NCT02140411|584450293|FG000|Overall Study|Adverse Event|1|||
161838027|NCT03981419|584450296|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
161838028|NCT03981419|584450297|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
161838029|NCT01330459|584450298|FG000|Overall Study|Physician Decision|0|||
161838030|NCT01330459|584450299|FG001|Overall Study|Physician Decision|2|||
161838031|NCT02272634|584450307|FG000|Overall Study|Adverse Event|1|||
161838032|NCT02272634|584450308|FG001|Overall Study|Adverse Event|0|||
161838033|NCT02272634|584450309|FG002|Overall Study|Adverse Event|0|||
161716593|NCT01050062|584007943|FG000|Overall Study|Lack of Efficacy|22|||
161716594|NCT01050062|584007944|FG001|Overall Study|Lack of Efficacy|35|||
161838034|NCT02272634|584450307|FG000|Overall Study|Protocol Violation|0|||
161716595|NCT01050062|584007943|FG000|Overall Study|Physician Decision|74|||
161716596|NCT01050062|584007944|FG001|Overall Study|Physician Decision|9|||
161716597|NCT01050062|584007943|FG000|Overall Study|Others|17|||
161716598|NCT01050062|584007944|FG001|Overall Study|Others|11|||
161716599|NCT03894540|584007945|FG000|Overall Study|Adverse Event|0|||
161716600|NCT03894540|584007946|FG001|Overall Study|Adverse Event|0|||
161716601|NCT03894540|584007947|FG002|Overall Study|Adverse Event|0|||
161716602|NCT03894540|584007948|FG003|Overall Study|Adverse Event|0|||
161716603|NCT03894540|584007949|FG004|Overall Study|Adverse Event|1|||
161716604|NCT03894540|584007950|FG005|Overall Study|Adverse Event|0|||
161716605|NCT03894540|584007945|FG000|Overall Study|Withdrawal by Subject|0|||
161716606|NCT03894540|584007946|FG001|Overall Study|Withdrawal by Subject|0|||
161716607|NCT03894540|584007947|FG002|Overall Study|Withdrawal by Subject|0|||
161716608|NCT03894540|584007948|FG003|Overall Study|Withdrawal by Subject|0|||
161716609|NCT03894540|584007949|FG004|Overall Study|Withdrawal by Subject|1|||
161716610|NCT03894540|584007950|FG005|Overall Study|Withdrawal by Subject|0|||
161716611|NCT03894540|584007945|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
161716612|NCT03894540|584007946|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
161716613|NCT03894540|584007947|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
161716614|NCT03894540|584007948|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
161716615|NCT03894540|584007949|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
161716616|NCT03894540|584007950|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
161716617|NCT03894540|584007945|FG000|Overall Study|Progressive Disease Clinical|1|||
161838035|NCT02272634|584450308|FG001|Overall Study|Protocol Violation|0|||
161838036|NCT02272634|584450309|FG002|Overall Study|Protocol Violation|1|||
161716618|NCT03894540|584007946|FG001|Overall Study|Progressive Disease Clinical|1|||
161716619|NCT03894540|584007947|FG002|Overall Study|Progressive Disease Clinical|0|||
161716620|NCT03894540|584007948|FG003|Overall Study|Progressive Disease Clinical|1|||
161716621|NCT03894540|584007949|FG004|Overall Study|Progressive Disease Clinical|5|||
161716622|NCT03894540|584007950|FG005|Overall Study|Progressive Disease Clinical|1|||
161716623|NCT03894540|584007945|FG000|Overall Study|Study termination by sponsor|0|||
161716624|NCT03894540|584007946|FG001|Overall Study|Study termination by sponsor|0|||
161716625|NCT03894540|584007947|FG002|Overall Study|Study termination by sponsor|0|||
161716626|NCT03894540|584007948|FG003|Overall Study|Study termination by sponsor|0|||
161716627|NCT03894540|584007949|FG004|Overall Study|Study termination by sponsor|2|||
161716628|NCT03894540|584007950|FG005|Overall Study|Study termination by sponsor|0|||
161716629|NCT03000452|584007951|FG000|Treatment Period|Death|1|||
161716630|NCT03000452|584007951|FG000|Treatment Period|Progressive Disease (PD)|14|||
161716631|NCT03000452|584007951|FG000|Treatment Period|Physician Decision|1|||
161716632|NCT03000452|584007951|FG000|Treatment Period|Miscellaneous|2|||
161716633|NCT03000452|584007951|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
161716634|NCT03000452|584007951|FG000|Follow-Up Period|Death|3|||
161716635|NCT03000452|584007951|FG000|Follow-Up Period|Withdrawal by Subject|3|||
161716636|NCT03043365|584007952|FG000|Weeks 0 to Week 8|Adverse Event|1|||
161716637|NCT03043365|584007953|FG001|Weeks 0 to Week 8|Adverse Event|3|||
161716638|NCT03043365|584007952|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
161716639|NCT03043365|584007953|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
161716640|NCT03043365|584007952|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
161716641|NCT03043365|584007953|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
161716642|NCT00593112|584007954|FG000|Overall Study|Scan Anxiety|3|||
161716643|NCT00593112|584007955|FG001|Overall Study|Scan Anxiety|0|||
161716644|NCT00593112|584007954|FG000|Overall Study|Abnormal Scan|1|||
161716645|NCT00593112|584007955|FG001|Overall Study|Abnormal Scan|0|||
161716646|NCT00593112|584007954|FG000|Overall Study|Unreadable Scan|1|||
161716647|NCT00593112|584007955|FG001|Overall Study|Unreadable Scan|0|||
161716648|NCT00593112|584007954|FG000|Overall Study|Withdrawal by Subject|5|||
161716649|NCT00593112|584007955|FG001|Overall Study|Withdrawal by Subject|0|||
161716650|NCT02723630|584007956|FG000|Intervention Period 1|Adverse Event|1|||
161716651|NCT02723630|584007957|FG001|Intervention Period 1|Adverse Event|0|||
161716652|NCT02723630|584007958|FG002|Intervention Period 1|Adverse Event|0|||
161716653|NCT02723630|584007959|FG003|Intervention Period 1|Adverse Event|0|||
161716654|NCT02723630|584007960|FG004|Intervention Period 1|Adverse Event|0|||
161716655|NCT02723630|584007961|FG005|Intervention Period 1|Adverse Event|0|||
161716656|NCT02723630|584007956|FG000|Intervention Period 3|consumption of restricted item|0|||
161716657|NCT02723630|584007957|FG001|Intervention Period 3|consumption of restricted item|1|||
161716658|NCT02723630|584007958|FG002|Intervention Period 3|consumption of restricted item|0|||
161716659|NCT02723630|584007959|FG003|Intervention Period 3|consumption of restricted item|0|||
161716660|NCT02723630|584007960|FG004|Intervention Period 3|consumption of restricted item|0|||
161716661|NCT02723630|584007961|FG005|Intervention Period 3|consumption of restricted item|0|||
161716662|NCT00852930|584007962|FG000|Overall Study|Withdrawal by Subject|1|||
161716663|NCT00852930|584007963|FG001|Overall Study|Withdrawal by Subject|1|||
161716664|NCT00852930|584007964|FG002|Overall Study|Withdrawal by Subject|1|||
161716665|NCT00852930|584007962|FG000|Overall Study|Physician Decision|0|||
161716666|NCT00852930|584007963|FG001|Overall Study|Physician Decision|0|||
161716667|NCT00852930|584007964|FG002|Overall Study|Physician Decision|1|||
161716668|NCT00537745|584007967|FG000|Overall Study|Did not meet eligibility criteria|2|||
161716669|NCT00537745|584007967|FG000|Overall Study|Withdrawal by Subject|2|||
161716670|NCT00537745|584007967|FG000|Overall Study|Subject unable to provide Interlock info|1|||
161716671|NCT00923091|584007971|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
161716672|NCT00923091|584007972|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
161716673|NCT00923091|584007973|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
161716674|NCT00923091|584007974|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
161716675|NCT00923091|584007975|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
161716676|NCT00923091|584007976|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
161716677|NCT00923091|584007977|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
161716678|NCT00923091|584007978|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
161716679|NCT00923091|584007979|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161716680|NCT00923091|584007980|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161716681|NCT00923091|584007981|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161716682|NCT00923091|584007982|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161716683|NCT00923091|584007983|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161716684|NCT00923091|584007971|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
161716685|NCT00923091|584007972|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
161716686|NCT00923091|584007973|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
161716687|NCT00923091|584007974|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
161716688|NCT00923091|584007975|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
161716689|NCT00923091|584007976|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
161716690|NCT00923091|584007977|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
161716691|NCT00923091|584007978|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
161716692|NCT00923091|584007979|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161716693|NCT00923091|584007980|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161716694|NCT00923091|584007981|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161716695|NCT00923091|584007982|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161716696|NCT00923091|584007983|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161716697|NCT00923091|584007971|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
161716698|NCT00923091|584007972|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
161716699|NCT00923091|584007973|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
161716700|NCT00923091|584007974|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
161716701|NCT00923091|584007975|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
161716702|NCT00923091|584007976|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
161716703|NCT00923091|584007977|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
161716704|NCT00923091|584007978|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
161716705|NCT00923091|584007979|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161716706|NCT00923091|584007980|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161716707|NCT00923091|584007981|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161716708|NCT00923091|584007982|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161716709|NCT00923091|584007983|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161716710|NCT00923091|584007971|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716711|NCT00923091|584007972|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716712|NCT00923091|584007973|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716713|NCT00923091|584007974|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716714|NCT00923091|584007975|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716715|NCT00923091|584007976|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
161716716|NCT00923091|584007977|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716717|NCT00923091|584007978|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716718|NCT00923091|584007979|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716719|NCT00923091|584007980|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716720|NCT00923091|584007981|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716721|NCT00923091|584007982|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716722|NCT00923091|584007983|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161716723|NCT00923091|584007971|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716724|NCT00923091|584007972|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
161716725|NCT00923091|584007973|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716726|NCT00923091|584007974|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
161716727|NCT00923091|584007975|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716728|NCT00923091|584007976|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
161716729|NCT00923091|584007977|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716730|NCT00923091|584007978|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716731|NCT00923091|584007979|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716732|NCT00923091|584007980|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716733|NCT00923091|584007981|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716734|NCT00923091|584007982|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716735|NCT00923091|584007983|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161716736|NCT00923091|584007971|FG000|Period III (Single-Blind)|Adverse Event|5|||
161716737|NCT00923091|584007972|FG001|Period III (Single-Blind)|Adverse Event|0|||
161716738|NCT00923091|584007973|FG002|Period III (Single-Blind)|Adverse Event|0|||
161716739|NCT00923091|584007974|FG003|Period III (Single-Blind)|Adverse Event|0|||
161716740|NCT00923091|584007975|FG004|Period III (Single-Blind)|Adverse Event|0|||
161716741|NCT00923091|584007976|FG005|Period III (Single-Blind)|Adverse Event|0|||
161716742|NCT00923091|584007977|FG006|Period III (Single-Blind)|Adverse Event|0|||
161716743|NCT00923091|584007978|FG007|Period III (Single-Blind)|Adverse Event|0|||
161716744|NCT00923091|584007979|FG008|Period III (Single-Blind)|Adverse Event|0|||
161716745|NCT00923091|584007980|FG009|Period III (Single-Blind)|Adverse Event|0|||
161716746|NCT00923091|584007981|FG010|Period III (Single-Blind)|Adverse Event|0|||
161716747|NCT00923091|584007982|FG011|Period III (Single-Blind)|Adverse Event|0|||
161716748|NCT00923091|584007983|FG012|Period III (Single-Blind)|Adverse Event|0|||
161716749|NCT00923091|584007971|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
161716750|NCT00923091|584007972|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716751|NCT00923091|584007973|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716752|NCT00923091|584007974|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716753|NCT00923091|584007975|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716754|NCT00923091|584007976|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716755|NCT00923091|584007977|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716756|NCT00923091|584007978|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716757|NCT00923091|584007979|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716758|NCT00923091|584007980|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716759|NCT00923091|584007981|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716760|NCT00923091|584007982|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716761|NCT00923091|584007983|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
161716762|NCT00923091|584007971|FG000|Period III (Single-Blind)|Protocol Violation|3|||
161716763|NCT00923091|584007972|FG001|Period III (Single-Blind)|Protocol Violation|0|||
161716764|NCT00923091|584007973|FG002|Period III (Single-Blind)|Protocol Violation|0|||
161716765|NCT00923091|584007974|FG003|Period III (Single-Blind)|Protocol Violation|0|||
161716766|NCT00923091|584007975|FG004|Period III (Single-Blind)|Protocol Violation|0|||
161716767|NCT00923091|584007976|FG005|Period III (Single-Blind)|Protocol Violation|0|||
161716768|NCT00923091|584007977|FG006|Period III (Single-Blind)|Protocol Violation|0|||
161716769|NCT00923091|584007978|FG007|Period III (Single-Blind)|Protocol Violation|0|||
161716770|NCT00923091|584007979|FG008|Period III (Single-Blind)|Protocol Violation|0|||
161716771|NCT00923091|584007980|FG009|Period III (Single-Blind)|Protocol Violation|0|||
161716772|NCT00923091|584007981|FG010|Period III (Single-Blind)|Protocol Violation|0|||
161716773|NCT00923091|584007982|FG011|Period III (Single-Blind)|Protocol Violation|0|||
161716774|NCT00923091|584007983|FG012|Period III (Single-Blind)|Protocol Violation|0|||
161716775|NCT00923091|584007971|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
161716776|NCT00923091|584007972|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
161716777|NCT00923091|584007973|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
161716778|NCT00923091|584007974|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
161716779|NCT00923091|584007975|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
161716780|NCT00923091|584007976|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
161716781|NCT00923091|584007977|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
161716782|NCT00923091|584007978|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
161716783|NCT00923091|584007979|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
161716784|NCT00923091|584007980|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
161716785|NCT00923091|584007981|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
161716786|NCT00923091|584007982|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
161716787|NCT00923091|584007983|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
161716788|NCT00923091|584007971|FG000|Period IV (Double-Blind)|Adverse Event|2|||
161716789|NCT00923091|584007972|FG001|Period IV (Double-Blind)|Adverse Event|0|||
161716790|NCT00923091|584007973|FG002|Period IV (Double-Blind)|Adverse Event|0|||
161716791|NCT00923091|584007974|FG003|Period IV (Double-Blind)|Adverse Event|0|||
161716792|NCT00923091|584007975|FG004|Period IV (Double-Blind)|Adverse Event|0|||
161716793|NCT00923091|584007976|FG005|Period IV (Double-Blind)|Adverse Event|0|||
161716794|NCT00923091|584007977|FG006|Period IV (Double-Blind)|Adverse Event|0|||
161716795|NCT00923091|584007978|FG007|Period IV (Double-Blind)|Adverse Event|0|||
161716796|NCT00923091|584007979|FG008|Period IV (Double-Blind)|Adverse Event|0|||
161716797|NCT00923091|584007980|FG009|Period IV (Double-Blind)|Adverse Event|0|||
161716798|NCT00923091|584007981|FG010|Period IV (Double-Blind)|Adverse Event|0|||
161716799|NCT00923091|584007982|FG011|Period IV (Double-Blind)|Adverse Event|0|||
161716800|NCT00923091|584007983|FG012|Period IV (Double-Blind)|Adverse Event|0|||
161716801|NCT00923091|584007971|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716802|NCT00923091|584007972|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
161716803|NCT00923091|584007973|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716804|NCT00923091|584007974|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716805|NCT00923091|584007975|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716806|NCT00923091|584007976|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716807|NCT00923091|584007977|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716808|NCT00923091|584007978|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716809|NCT00923091|584007979|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716810|NCT00923091|584007980|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716811|NCT00923091|584007981|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716812|NCT00923091|584007982|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716813|NCT00923091|584007983|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161716814|NCT00923091|584007971|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
161716815|NCT00923091|584007972|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
161716816|NCT00923091|584007973|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
161716817|NCT00923091|584007974|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
161716818|NCT00923091|584007975|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
161716819|NCT00923091|584007976|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
161716820|NCT00923091|584007977|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
161716821|NCT00923091|584007978|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
161716822|NCT00923091|584007979|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
161716823|NCT00923091|584007980|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
161716824|NCT00923091|584007981|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
161716825|NCT00923091|584007982|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
161716826|NCT00923091|584007983|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
161962718|NCT04026009|584909868|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161962719|NCT04026009|584909869|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161962720|NCT04026009|584909870|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
161962721|NCT04026009|584909871|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
161962722|NCT04026009|584909872|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
161962723|NCT04026009|584909868|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
162031928|NCT04179890|585174123|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
161716827|NCT00923091|584007971|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716828|NCT00923091|584007972|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716829|NCT00923091|584007973|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716830|NCT00923091|584007974|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716831|NCT00923091|584007975|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716832|NCT00923091|584007976|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716833|NCT00923091|584007977|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716834|NCT00923091|584007978|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716835|NCT00923091|584007979|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
161716836|NCT00923091|584007980|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716837|NCT00923091|584007981|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716838|NCT00923091|584007982|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
161716839|NCT00923091|584007983|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
161716840|NCT00923091|584007971|FG000|Period V (Double -Blind)|Protocol Violation|0|||
162031929|NCT04179890|585174122|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
162031930|NCT04179890|585174123|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
162031931|NCT00997438|585174125|FG000|Overall Study|Blood draw difficulty|2|||
162031932|NCT00997438|585174126|FG001|Overall Study|Blood draw difficulty|0|||
162031933|NCT00997438|585174127|FG002|Overall Study|Blood draw difficulty|1|||
162031934|NCT00997438|585174125|FG000|Overall Study|Withdrawal by Subject|1|||
162031935|NCT00997438|585174126|FG001|Overall Study|Withdrawal by Subject|1|||
162031936|NCT00997438|585174127|FG002|Overall Study|Withdrawal by Subject|0|||
162031937|NCT00997438|585174125|FG000|Overall Study|Exclusion criteria at visit 1|2|||
162031938|NCT00997438|585174126|FG001|Overall Study|Exclusion criteria at visit 1|2|||
162031939|NCT00997438|585174127|FG002|Overall Study|Exclusion criteria at visit 1|3|||
162031940|NCT01236118|585174128|FG000|Overall Study|Adverse Event|2|||
162031941|NCT01236118|585174129|FG001|Overall Study|Adverse Event|0|||
162031942|NCT01236118|585174130|FG002|Overall Study|Adverse Event|2|||
162031943|NCT01236118|585174128|FG000|Overall Study|Physician Decision|0|||
162031944|NCT01236118|585174129|FG001|Overall Study|Physician Decision|1|||
162031945|NCT01236118|585174130|FG002|Overall Study|Physician Decision|0|||
162031946|NCT01236118|585174128|FG000|Overall Study|Withdrawal by Subject|0|||
162031947|NCT01236118|585174129|FG001|Overall Study|Withdrawal by Subject|0|||
161716841|NCT00923091|584007972|FG001|Period V (Double -Blind)|Protocol Violation|0|||
161716842|NCT00923091|584007973|FG002|Period V (Double -Blind)|Protocol Violation|0|||
161716843|NCT00923091|584007974|FG003|Period V (Double -Blind)|Protocol Violation|0|||
161716844|NCT00923091|584007975|FG004|Period V (Double -Blind)|Protocol Violation|0|||
161716845|NCT00923091|584007976|FG005|Period V (Double -Blind)|Protocol Violation|0|||
161716846|NCT00923091|584007977|FG006|Period V (Double -Blind)|Protocol Violation|0|||
161716847|NCT00923091|584007978|FG007|Period V (Double -Blind)|Protocol Violation|0|||
161716848|NCT00923091|584007979|FG008|Period V (Double -Blind)|Protocol Violation|0|||
161716849|NCT00923091|584007980|FG009|Period V (Double -Blind)|Protocol Violation|0|||
161716850|NCT00923091|584007981|FG010|Period V (Double -Blind)|Protocol Violation|0|||
162031948|NCT01236118|585174130|FG002|Overall Study|Withdrawal by Subject|1|||
162031949|NCT04535167|585174131|FG000|Treatment|Adverse Event|0|||
162031950|NCT04535167|585174132|FG001|Treatment|Adverse Event|0|||
162031951|NCT04535167|585174133|FG002|Treatment|Adverse Event|0|||
162031952|NCT04535167|585174134|FG003|Treatment|Adverse Event|0|||
162031953|NCT04535167|585174135|FG004|Treatment|Adverse Event|0|||
162031954|NCT04535167|585174136|FG005|Treatment|Adverse Event|0|||
162031955|NCT04535167|585174137|FG006|Treatment|Adverse Event|1|||
162031956|NCT04535167|585174131|FG000|Follow-Up|Death|0|||
162031957|NCT04535167|585174132|FG001|Follow-Up|Death|0|||
162031958|NCT04535167|585174133|FG002|Follow-Up|Death|0|||
162031959|NCT04535167|585174134|FG003|Follow-Up|Death|0|||
162031960|NCT04535167|585174135|FG004|Follow-Up|Death|0|||
162031961|NCT04535167|585174136|FG005|Follow-Up|Death|0|||
162031962|NCT04535167|585174137|FG006|Follow-Up|Death|1|||
162031963|NCT04535167|585174131|FG000|Follow-Up|Lost to Follow-up|0|||
162031964|NCT04535167|585174132|FG001|Follow-Up|Lost to Follow-up|0|||
162031965|NCT04535167|585174133|FG002|Follow-Up|Lost to Follow-up|0|||
162031966|NCT04535167|585174134|FG003|Follow-Up|Lost to Follow-up|1|||
162031967|NCT04535167|585174135|FG004|Follow-Up|Lost to Follow-up|0|||
162031968|NCT04535167|585174136|FG005|Follow-Up|Lost to Follow-up|0|||
162031969|NCT04535167|585174137|FG006|Follow-Up|Lost to Follow-up|0|||
162031970|NCT00978432|585174138|FG000|Overall Study|Withdrawal by Subject|0|||
162031971|NCT00978432|585174139|FG001|Overall Study|Withdrawal by Subject|0|||
162031972|NCT00978432|585174140|FG002|Overall Study|Withdrawal by Subject|1|||
162031973|NCT00978432|585174138|FG000|Overall Study|Lack of Efficacy|1|||
162031974|NCT00978432|585174139|FG001|Overall Study|Lack of Efficacy|1|||
162031975|NCT00978432|585174140|FG002|Overall Study|Lack of Efficacy|3|||
161716851|NCT00923091|584007982|FG011|Period V (Double -Blind)|Protocol Violation|0|||
161716852|NCT00923091|584007983|FG012|Period V (Double -Blind)|Protocol Violation|1|||
161716853|NCT00923091|584007971|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
161716854|NCT00923091|584007972|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
161962724|NCT04026009|584909869|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
161962725|NCT04026009|584909870|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
161962726|NCT04026009|584909871|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
161962727|NCT04026009|584909872|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
161962728|NCT01988662|584909873|FG000|Overall Study|Subject/guardian decision|1|||
161962729|NCT01988662|584909874|FG001|Overall Study|Subject/guardian decision|1|||
161962730|NCT01988662|584909873|FG000|Overall Study|Adverse Event|3|||
161962731|NCT01988662|584909874|FG001|Overall Study|Adverse Event|1|||
161962732|NCT02957747|584909875|FG000|Overall Study|Withdrawal by Subject|0|||
161962733|NCT02957747|584909876|FG001|Overall Study|Withdrawal by Subject|3|||
161962734|NCT02957747|584909875|FG000|Overall Study|Lost to Follow-up|10|||
161962735|NCT02957747|584909876|FG001|Overall Study|Lost to Follow-up|5|||
161962736|NCT02027311|584909881|FG000|Overall Study|Protocol Violation|3|||
161962737|NCT02027311|584909882|FG001|Overall Study|Protocol Violation|2|||
161962738|NCT00964002|584909883|FG000|Overall Study|Protocol Violation|8|||
161962739|NCT03768089|584909884|FG000|Part A|Lost to Follow-up|0|||
161962740|NCT03768089|584909885|FG001|Part A|Lost to Follow-up|0|||
161962741|NCT03768089|584909886|FG002|Part A|Lost to Follow-up|0|||
161962742|NCT03768089|584909887|FG003|Part A|Lost to Follow-up|0|||
161962743|NCT03768089|584909888|FG004|Part A|Lost to Follow-up|1|||
161962744|NCT03768089|584909889|FG005|Part A|Lost to Follow-up|0|||
161962745|NCT03768089|584909890|FG006|Part A|Lost to Follow-up|0|||
161962746|NCT03768089|584909891|FG007|Part A|Lost to Follow-up|0|||
161962747|NCT03768089|584909892|FG008|Part A|Lost to Follow-up|0|||
161962748|NCT03768089|584909893|FG009|Part A|Lost to Follow-up|0|||
161962749|NCT03768089|584909894|FG010|Part A|Lost to Follow-up|0|||
161962750|NCT03768089|584909895|FG011|Part A|Lost to Follow-up|0|||
161962751|NCT03768089|584909896|FG012|Part A|Lost to Follow-up|0|||
161962752|NCT03768089|584909897|FG013|Part A|Lost to Follow-up|0|||
161962753|NCT03768089|584909898|FG014|Part A|Lost to Follow-up|0|||
161962754|NCT03768089|584909899|FG015|Part A|Lost to Follow-up|0|||
161962755|NCT03768089|584909900|FG016|Part A|Lost to Follow-up|0|||
162031976|NCT00978432|585174138|FG000|Overall Study|Adverse Event|2|||
162031977|NCT00978432|585174139|FG001|Overall Study|Adverse Event|0|||
162031978|NCT00978432|585174140|FG002|Overall Study|Adverse Event|1|||
161716855|NCT00923091|584007973|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
161716856|NCT00923091|584007974|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
161716857|NCT00923091|584007975|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
161962756|NCT03768089|584909901|FG017|Part A|Lost to Follow-up|0|||
161962757|NCT03768089|584909884|FG000|Part C|Randomized, Never Dosed|0|||
162031979|NCT02579928|585174141|FG000|Overall Study|Withdrawal by Subject|1|||
162031980|NCT02579928|585174142|FG001|Overall Study|Withdrawal by Subject|0|||
161716858|NCT00923091|584007976|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
162031981|NCT04300751|585174145|FG000|Overall Study|Withdrawal by Subject|1|||
162031982|NCT04656275|585174151|FG000|Overall Study|Study terminated by sponsor|2|||
161962758|NCT03768089|584909885|FG001|Part C|Randomized, Never Dosed|0|||
161962759|NCT03768089|584909886|FG002|Part C|Randomized, Never Dosed|0|||
161962760|NCT03768089|584909887|FG003|Part C|Randomized, Never Dosed|0|||
161962761|NCT03768089|584909888|FG004|Part C|Randomized, Never Dosed|0|||
161962762|NCT03768089|584909889|FG005|Part C|Randomized, Never Dosed|0|||
161962763|NCT03768089|584909890|FG006|Part C|Randomized, Never Dosed|0|||
162031983|NCT04656275|585174152|FG001|Overall Study|Study terminated by sponsor|4|||
162031984|NCT00924781|585174154|FG000|Overall Study|Study terminated by sponsor|12|||
162031985|NCT00924781|585174155|FG001|Overall Study|Study terminated by sponsor|10|||
162031986|NCT01155479|585174160|FG000|Part I|Adverse Event|13|||
162031987|NCT01155479|585174161|FG001|Part I|Adverse Event|8|||
162031988|NCT01155479|585174162|FG002|Part I|Adverse Event|18|||
162031989|NCT01155479|585174163|FG003|Part I|Adverse Event|7|||
162031990|NCT01155479|585174164|FG004|Part I|Adverse Event|6|||
162031991|NCT01155479|585174160|FG000|Part I|Administrative|2|||
161716859|NCT00923091|584007977|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
161716860|NCT00923091|584007978|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
161716861|NCT00923091|584007979|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
161716862|NCT00923091|584007980|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
161716863|NCT00923091|584007981|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
161716864|NCT00923091|584007982|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
161716865|NCT00923091|584007983|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
161716866|NCT00923091|584007971|FG000|Period VI (Open-Label)|Adverse Event|17|||
161716867|NCT00923091|584007972|FG001|Period VI (Open-Label)|Adverse Event|0|||
161716868|NCT00923091|584007973|FG002|Period VI (Open-Label)|Adverse Event|4|||
161716869|NCT00923091|584007974|FG003|Period VI (Open-Label)|Adverse Event|1|||
161716870|NCT00923091|584007975|FG004|Period VI (Open-Label)|Adverse Event|1|||
161716871|NCT00923091|584007976|FG005|Period VI (Open-Label)|Adverse Event|0|||
161716872|NCT00923091|584007977|FG006|Period VI (Open-Label)|Adverse Event|0|||
161716873|NCT00923091|584007978|FG007|Period VI (Open-Label)|Adverse Event|0|||
161716874|NCT00923091|584007979|FG008|Period VI (Open-Label)|Adverse Event|0|||
161716875|NCT00923091|584007980|FG009|Period VI (Open-Label)|Adverse Event|0|||
161716876|NCT00923091|584007981|FG010|Period VI (Open-Label)|Adverse Event|0|||
161716877|NCT00923091|584007982|FG011|Period VI (Open-Label)|Adverse Event|0|||
161716878|NCT00923091|584007983|FG012|Period VI (Open-Label)|Adverse Event|0|||
161716879|NCT00923091|584007971|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
161716880|NCT00923091|584007972|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
161716881|NCT00923091|584007973|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
161716882|NCT00923091|584007974|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716883|NCT00923091|584007975|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
161716884|NCT00923091|584007976|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716885|NCT00923091|584007977|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716886|NCT00923091|584007978|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716887|NCT00923091|584007979|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716888|NCT00923091|584007980|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716889|NCT00923091|584007981|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716890|NCT00923091|584007982|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716891|NCT00923091|584007983|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
161716892|NCT00923091|584007971|FG000|Period VI (Open-Label)|Protocol Violation|6|||
161716893|NCT00923091|584007972|FG001|Period VI (Open-Label)|Protocol Violation|1|||
161716894|NCT00923091|584007973|FG002|Period VI (Open-Label)|Protocol Violation|3|||
161716895|NCT00923091|584007974|FG003|Period VI (Open-Label)|Protocol Violation|1|||
161716896|NCT00923091|584007975|FG004|Period VI (Open-Label)|Protocol Violation|4|||
161716897|NCT00923091|584007976|FG005|Period VI (Open-Label)|Protocol Violation|0|||
161716898|NCT00923091|584007977|FG006|Period VI (Open-Label)|Protocol Violation|0|||
161716899|NCT00923091|584007978|FG007|Period VI (Open-Label)|Protocol Violation|0|||
161716900|NCT00923091|584007979|FG008|Period VI (Open-Label)|Protocol Violation|0|||
161716901|NCT00923091|584007980|FG009|Period VI (Open-Label)|Protocol Violation|0|||
161716902|NCT00923091|584007981|FG010|Period VI (Open-Label)|Protocol Violation|0|||
161716903|NCT00923091|584007982|FG011|Period VI (Open-Label)|Protocol Violation|0|||
161716904|NCT00923091|584007983|FG012|Period VI (Open-Label)|Protocol Violation|0|||
161716905|NCT00923091|584007971|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
161716906|NCT00923091|584007972|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
161716907|NCT00923091|584007973|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
161716908|NCT00923091|584007974|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
161716909|NCT00923091|584007975|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
161716910|NCT00923091|584007976|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
161716911|NCT00923091|584007977|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
161716912|NCT00923091|584007978|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
161716913|NCT00923091|584007979|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
161716914|NCT00923091|584007980|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
161716915|NCT00923091|584007981|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
161716916|NCT00923091|584007982|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
161716917|NCT00923091|584007983|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
161716918|NCT00923091|584007971|FG000|Period VI (Open-Label)|Other Reason|0|||
161716919|NCT00923091|584007972|FG001|Period VI (Open-Label)|Other Reason|0|||
161716920|NCT00923091|584007973|FG002|Period VI (Open-Label)|Other Reason|0|||
161716921|NCT00923091|584007974|FG003|Period VI (Open-Label)|Other Reason|1|||
161716922|NCT00923091|584007975|FG004|Period VI (Open-Label)|Other Reason|1|||
161716923|NCT00923091|584007976|FG005|Period VI (Open-Label)|Other Reason|0|||
161962764|NCT03768089|584909891|FG007|Part C|Randomized, Never Dosed|0|||
161716924|NCT00923091|584007977|FG006|Period VI (Open-Label)|Other Reason|0|||
161716925|NCT00923091|584007978|FG007|Period VI (Open-Label)|Other Reason|0|||
161716926|NCT00923091|584007979|FG008|Period VI (Open-Label)|Other Reason|0|||
161716927|NCT00923091|584007980|FG009|Period VI (Open-Label)|Other Reason|0|||
161716928|NCT00923091|584007981|FG010|Period VI (Open-Label)|Other Reason|0|||
161716929|NCT00923091|584007982|FG011|Period VI (Open-Label)|Other Reason|0|||
161716930|NCT00923091|584007983|FG012|Period VI (Open-Label)|Other Reason|0|||
161716931|NCT02111369|584007985|FG000|Overall Study|Lost to Follow-up|2|||
161962765|NCT03768089|584909892|FG008|Part C|Randomized, Never Dosed|0|||
161962766|NCT03768089|584909893|FG009|Part C|Randomized, Never Dosed|0|||
161962767|NCT03768089|584909894|FG010|Part C|Randomized, Never Dosed|0|||
161962768|NCT03768089|584909895|FG011|Part C|Randomized, Never Dosed|0|||
161962769|NCT03768089|584909896|FG012|Part C|Randomized, Never Dosed|0|||
161962770|NCT03768089|584909897|FG013|Part C|Randomized, Never Dosed|0|||
161716932|NCT02111369|584007985|FG000|Overall Study|Withdrawal by Subject|1|||
161716933|NCT00144300|584007988|FG000|Overall Study|Adverse Event|18|||
161716934|NCT00144300|584007989|FG001|Overall Study|Adverse Event|16|||
161716935|NCT00144300|584007988|FG000|Overall Study|Protocol Violation|1|||
161716936|NCT00144300|584007989|FG001|Overall Study|Protocol Violation|3|||
161716937|NCT00144300|584007988|FG000|Overall Study|Lost to Follow-up|3|||
161716938|NCT00144300|584007989|FG001|Overall Study|Lost to Follow-up|0|||
161716939|NCT00144300|584007988|FG000|Overall Study|Withdrawal by Subject|6|||
161716940|NCT00144300|584007989|FG001|Overall Study|Withdrawal by Subject|6|||
161716941|NCT00144300|584007988|FG000|Overall Study|Other reason (not specified)|1|||
161716942|NCT00144300|584007989|FG001|Overall Study|Other reason (not specified)|3|||
161716943|NCT01933672|584007990|FG000|Metformin Run-in Period|Adverse Event|1|||
161716944|NCT01933672|584007991|FG001|Metformin Run-in Period|Adverse Event|0|||
161716945|NCT01933672|584007992|FG002|Metformin Run-in Period|Adverse Event|0|||
161716946|NCT01933672|584007993|FG003|Metformin Run-in Period|Adverse Event|0|||
161716947|NCT01933672|584007994|FG004|Metformin Run-in Period|Adverse Event|0|||
161716948|NCT01933672|584007995|FG005|Metformin Run-in Period|Adverse Event|0|||
161716949|NCT01933672|584007996|FG006|Metformin Run-in Period|Adverse Event|0|||
161716950|NCT01933672|584007990|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
161716951|NCT01933672|584007991|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161716952|NCT01933672|584007992|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161716953|NCT01933672|584007993|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161716954|NCT01933672|584007994|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161716955|NCT01933672|584007995|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161716956|NCT01933672|584007996|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161716957|NCT01933672|584007990|FG000|Metformin Run-in Period|Other|5|||
161716958|NCT01933672|584007991|FG001|Metformin Run-in Period|Other|0|||
161716959|NCT01933672|584007992|FG002|Metformin Run-in Period|Other|0|||
161716960|NCT01933672|584007993|FG003|Metformin Run-in Period|Other|0|||
161716961|NCT01933672|584007994|FG004|Metformin Run-in Period|Other|0|||
161716962|NCT01933672|584007995|FG005|Metformin Run-in Period|Other|0|||
161962771|NCT03768089|584909898|FG014|Part C|Randomized, Never Dosed|1|||
161962772|NCT03768089|584909899|FG015|Part C|Randomized, Never Dosed|0|||
161962773|NCT03768089|584909900|FG016|Part C|Randomized, Never Dosed|0|||
161962774|NCT03768089|584909901|FG017|Part C|Randomized, Never Dosed|0|||
161962775|NCT05141175|584909902|FG000|Overall Study|Withdrawal by Subject|1|||
161962776|NCT04470050|584909906|FG000|Double-blind Treatment Phase|Adverse Event|0|||
161962777|NCT04470050|584909907|FG001|Double-blind Treatment Phase|Adverse Event|0|||
161962778|NCT04470050|584909908|FG002|Double-blind Treatment Phase|Adverse Event|0|||
161962779|NCT04470050|584909909|FG003|Double-blind Treatment Phase|Adverse Event|1|||
161962780|NCT04470050|584909910|FG004|Double-blind Treatment Phase|Adverse Event|0|||
161962781|NCT04470050|584909911|FG005|Double-blind Treatment Phase|Adverse Event|0|||
161962782|NCT04470050|584909912|FG006|Double-blind Treatment Phase|Adverse Event|0|||
161962783|NCT04470050|584909906|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
161962784|NCT04470050|584909907|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
162031992|NCT01155479|585174161|FG001|Part I|Administrative|2|||
162031993|NCT01155479|585174162|FG002|Part I|Administrative|2|||
161716963|NCT01933672|584007996|FG006|Metformin Run-in Period|Other|0|||
161716964|NCT01933672|584007990|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716965|NCT01933672|584007991|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716966|NCT01933672|584007992|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716967|NCT01933672|584007993|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716968|NCT01933672|584007994|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
161962785|NCT04470050|584909908|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
161962786|NCT04470050|584909909|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
161716969|NCT01933672|584007995|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716970|NCT01933672|584007996|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716971|NCT01933672|584007990|FG000|First Intervention Period (12-16 Days)|Other|0|||
161716972|NCT01933672|584007991|FG001|First Intervention Period (12-16 Days)|Other|0|||
161716973|NCT01933672|584007992|FG002|First Intervention Period (12-16 Days)|Other|1|||
161716974|NCT01933672|584007993|FG003|First Intervention Period (12-16 Days)|Other|0|||
161716975|NCT01933672|584007994|FG004|First Intervention Period (12-16 Days)|Other|0|||
161716976|NCT01933672|584007995|FG005|First Intervention Period (12-16 Days)|Other|1|||
161716977|NCT01933672|584007996|FG006|First Intervention Period (12-16 Days)|Other|0|||
161716978|NCT01933672|584007990|FG000|Second Intervention Period (12-16 Days)|Other|0|||
161716979|NCT01933672|584007991|FG001|Second Intervention Period (12-16 Days)|Other|1|||
161716980|NCT01933672|584007992|FG002|Second Intervention Period (12-16 Days)|Other|1|||
161716981|NCT01933672|584007993|FG003|Second Intervention Period (12-16 Days)|Other|0|||
161716982|NCT01933672|584007994|FG004|Second Intervention Period (12-16 Days)|Other|0|||
161716983|NCT01933672|584007995|FG005|Second Intervention Period (12-16 Days)|Other|0|||
161716984|NCT01933672|584007996|FG006|Second Intervention Period (12-16 Days)|Other|0|||
161716985|NCT01933672|584007990|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716986|NCT01933672|584007991|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716987|NCT01933672|584007992|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716988|NCT01933672|584007993|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
161716989|NCT01933672|584007994|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716990|NCT01933672|584007995|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716991|NCT01933672|584007996|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161716992|NCT01933672|584007990|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161716993|NCT01933672|584007991|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
161716994|NCT01933672|584007992|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161716995|NCT01933672|584007993|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161716996|NCT01933672|584007994|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161716997|NCT01933672|584007995|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161716998|NCT01933672|584007996|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161716999|NCT01877655|584007997|FG000|Overall Study|Death|57|||
161717000|NCT01877655|584007998|FG001|Overall Study|Death|52|||
161717001|NCT01877655|584007997|FG000|Overall Study|Withdrawal by Subject|18|||
161717002|NCT01877655|584007998|FG001|Overall Study|Withdrawal by Subject|26|||
161717003|NCT01877655|584007997|FG000|Overall Study|Physician Decision|11|||
161717004|NCT01877655|584007998|FG001|Overall Study|Physician Decision|10|||
161717005|NCT01877655|584007997|FG000|Overall Study|Miscellaneous|4|||
161717006|NCT01877655|584007998|FG001|Overall Study|Miscellaneous|4|||
161717007|NCT01877655|584007997|FG000|Overall Study|Randomized but Never Received Drug|8|||
161717008|NCT01877655|584007998|FG001|Overall Study|Randomized but Never Received Drug|5|||
161717009|NCT00095121|584007999|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
161717010|NCT00095121|584008000|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
161717011|NCT00095121|584007999|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
161717012|NCT00095121|584008000|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
161717013|NCT00001259|584010427|FG000|Study 2|Adverse Event|0|||
161962787|NCT04470050|584909910|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
161962788|NCT04470050|584909911|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
161962789|NCT04470050|584909912|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
161962790|NCT04470050|584909906|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
161962791|NCT04470050|584909907|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
161962792|NCT04470050|584909908|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
161962793|NCT04470050|584909909|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
161962794|NCT04470050|584909910|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
161962795|NCT04470050|584909911|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
161962796|NCT04470050|584909912|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
161962797|NCT03098433|584909913|FG000|Overall Study|Withdrawal by Subject|10|||
161962798|NCT01813058|584909914|FG000|Overall Study|Withdrawal by Subject|5|||
161962799|NCT01813058|584909915|FG001|Overall Study|Withdrawal by Subject|4|||
161962800|NCT02676895|584909916|FG000|Overall Study|Administrative reason|1|||
161962801|NCT02676895|584909917|FG001|Overall Study|Administrative reason|0|||
161962802|NCT02676895|584909918|FG002|Overall Study|Administrative reason|0|||
161962803|NCT02676895|584909916|FG000|Overall Study|Protocol Violation|1|||
161962804|NCT02676895|584909917|FG001|Overall Study|Protocol Violation|0|||
161962805|NCT02676895|584909918|FG002|Overall Study|Protocol Violation|0|||
161962806|NCT02676895|584909916|FG000|Overall Study|Adverse Event|0|||
161717014|NCT00001259|584010428|FG001|Study 2|Adverse Event|0|||
161717015|NCT00001259|584010429|FG002|Study 2|Adverse Event|0|||
161717016|NCT00001259|584010430|FG003|Study 2|Adverse Event|0|||
161717017|NCT00001259|584010431|FG004|Study 2|Adverse Event|2|||
161717018|NCT00001259|584010432|FG005|Study 2|Adverse Event|0|||
161962807|NCT02676895|584909917|FG001|Overall Study|Adverse Event|3|||
161962808|NCT02676895|584909918|FG002|Overall Study|Adverse Event|1|||
161962809|NCT02676895|584909916|FG000|Overall Study|Lost to Follow-up|0|||
161962810|NCT02676895|584909917|FG001|Overall Study|Lost to Follow-up|0|||
161962811|NCT02676895|584909918|FG002|Overall Study|Lost to Follow-up|1|||
161962812|NCT02676895|584909916|FG000|Overall Study|Withdrawal by Subject|0|||
161962813|NCT02676895|584909917|FG001|Overall Study|Withdrawal by Subject|0|||
161962814|NCT02676895|584909918|FG002|Overall Study|Withdrawal by Subject|1|||
161962815|NCT01270880|584909919|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
161962816|NCT00344318|584909920|FG000|Overall Study|Adverse Event|0|||
161962817|NCT00344318|584909921|FG001|Overall Study|Adverse Event|3|||
161962818|NCT00344318|584909922|FG002|Overall Study|Adverse Event|0|||
161962819|NCT00344318|584909923|FG003|Overall Study|Adverse Event|1|||
161962820|NCT00344318|584909920|FG000|Overall Study|Withdrawal by Subject|2|||
161962821|NCT00344318|584909921|FG001|Overall Study|Withdrawal by Subject|2|||
161962822|NCT00344318|584909922|FG002|Overall Study|Withdrawal by Subject|0|||
161962823|NCT00344318|584909923|FG003|Overall Study|Withdrawal by Subject|2|||
161962824|NCT00344318|584909920|FG000|Overall Study|Lost to Follow-up|2|||
161962825|NCT00344318|584909921|FG001|Overall Study|Lost to Follow-up|0|||
161962826|NCT00344318|584909922|FG002|Overall Study|Lost to Follow-up|1|||
161962827|NCT00344318|584909923|FG003|Overall Study|Lost to Follow-up|0|||
161962828|NCT00395486|584909924|FG000|Overall Study|Adverse Event|1|||
161962829|NCT00395486|584909925|FG001|Overall Study|Adverse Event|2|||
161962830|NCT00395486|584909924|FG000|Overall Study|Withdrawal by Subject|5|||
161962831|NCT00395486|584909925|FG001|Overall Study|Withdrawal by Subject|2|||
161962832|NCT00395486|584909924|FG000|Overall Study|Lost to Follow-up|0|||
161962833|NCT00395486|584909925|FG001|Overall Study|Lost to Follow-up|1|||
161962834|NCT03403361|584909926|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
161962835|NCT02487654|584909927|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
161962836|NCT02487654|584909928|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
161962837|NCT02487654|584909927|FG000|Overall Study|Withdrawal by Subject|3|||
161962838|NCT02487654|584909928|FG001|Overall Study|Withdrawal by Subject|7|||
161962839|NCT02443116|584909931|FG000|Part 1|Adverse Event|2|||
161962840|NCT02443116|584909932|FG001|Part 1|Adverse Event|3|||
161962841|NCT02443116|584909933|FG002|Part 1|Adverse Event|0|||
161962842|NCT02443116|584909934|FG003|Part 1|Adverse Event|0|||
161962843|NCT02443116|584909935|FG004|Part 1|Adverse Event|0|||
161962844|NCT02443116|584909936|FG005|Part 1|Adverse Event|0|||
161962845|NCT02443116|584909937|FG006|Part 1|Adverse Event|0|||
161962846|NCT02443116|584909938|FG007|Part 1|Adverse Event|0|||
161962847|NCT02443116|584909939|FG008|Part 1|Adverse Event|0|||
161962848|NCT02443116|584909931|FG000|Part 1|Withdrew informed consent|0|||
161962849|NCT02443116|584909932|FG001|Part 1|Withdrew informed consent|1|||
161962850|NCT02443116|584909933|FG002|Part 1|Withdrew informed consent|0|||
161962851|NCT02443116|584909934|FG003|Part 1|Withdrew informed consent|0|||
161962852|NCT02443116|584909935|FG004|Part 1|Withdrew informed consent|0|||
161962853|NCT02443116|584909936|FG005|Part 1|Withdrew informed consent|0|||
161962854|NCT02443116|584909937|FG006|Part 1|Withdrew informed consent|0|||
161962855|NCT02443116|584909938|FG007|Part 1|Withdrew informed consent|0|||
161962856|NCT02443116|584909939|FG008|Part 1|Withdrew informed consent|0|||
161962857|NCT02443116|584909931|FG000|Part 1|Lost to Follow-up|0|||
161962858|NCT02443116|584909932|FG001|Part 1|Lost to Follow-up|0|||
161962859|NCT02443116|584909933|FG002|Part 1|Lost to Follow-up|2|||
161962860|NCT02443116|584909934|FG003|Part 1|Lost to Follow-up|0|||
161962861|NCT02443116|584909935|FG004|Part 1|Lost to Follow-up|0|||
161962862|NCT02443116|584909936|FG005|Part 1|Lost to Follow-up|0|||
161962863|NCT02443116|584909937|FG006|Part 1|Lost to Follow-up|0|||
161962864|NCT02443116|584909938|FG007|Part 1|Lost to Follow-up|0|||
161962865|NCT02443116|584909939|FG008|Part 1|Lost to Follow-up|0|||
161962866|NCT02443116|584909931|FG000|Part 1|Participant moved out of state|0|||
161962867|NCT02443116|584909932|FG001|Part 1|Participant moved out of state|0|||
161962868|NCT02443116|584909933|FG002|Part 1|Participant moved out of state|1|||
161962869|NCT02443116|584909934|FG003|Part 1|Participant moved out of state|0|||
161962870|NCT02443116|584909935|FG004|Part 1|Participant moved out of state|0|||
161962871|NCT02443116|584909936|FG005|Part 1|Participant moved out of state|0|||
161962872|NCT02443116|584909937|FG006|Part 1|Participant moved out of state|0|||
161962873|NCT02443116|584909938|FG007|Part 1|Participant moved out of state|0|||
161962874|NCT02443116|584909939|FG008|Part 1|Participant moved out of state|0|||
161962875|NCT02443116|584909931|FG000|Part 1|Participant enrolled in another clinical trial|0|||
161962876|NCT02443116|584909932|FG001|Part 1|Participant enrolled in another clinical trial|0|||
161962877|NCT02443116|584909933|FG002|Part 1|Participant enrolled in another clinical trial|1|||
161962878|NCT02443116|584909934|FG003|Part 1|Participant enrolled in another clinical trial|0|||
161962879|NCT02443116|584909935|FG004|Part 1|Participant enrolled in another clinical trial|0|||
161962880|NCT02443116|584909936|FG005|Part 1|Participant enrolled in another clinical trial|0|||
161962881|NCT02443116|584909937|FG006|Part 1|Participant enrolled in another clinical trial|0|||
161962882|NCT02443116|584909938|FG007|Part 1|Participant enrolled in another clinical trial|0|||
161962883|NCT02443116|584909939|FG008|Part 1|Participant enrolled in another clinical trial|0|||
161962884|NCT02443116|584909931|FG000|Part 2|Adverse Event|0|||
161717019|NCT00001259|584010433|FG006|Study 2|Adverse Event|0|||
161717020|NCT01582282|584010434|FG000|Overall Study|Adverse Event|1|||
161717021|NCT01582282|584010435|FG001|Overall Study|Adverse Event|1|||
161717022|NCT01582282|584010436|FG002|Overall Study|Adverse Event|0|||
161717023|NCT01582282|584010434|FG000|Overall Study|Lost to Follow-up|1|||
161717024|NCT01582282|584010435|FG001|Overall Study|Lost to Follow-up|0|||
161717025|NCT01582282|584010436|FG002|Overall Study|Lost to Follow-up|0|||
161717026|NCT01582282|584010434|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
161717027|NCT01582282|584010435|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
161717028|NCT01582282|584010436|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
161717029|NCT02413255|584010440|FG000|Overall Study|Voluntary Withdrawal|0|||
161717030|NCT02413255|584010441|FG001|Overall Study|Voluntary Withdrawal|0|||
161962885|NCT02443116|584909932|FG001|Part 2|Adverse Event|0|||
161962886|NCT02443116|584909933|FG002|Part 2|Adverse Event|0|||
161962887|NCT02443116|584909934|FG003|Part 2|Adverse Event|0|||
161962888|NCT02443116|584909935|FG004|Part 2|Adverse Event|1|||
161962889|NCT02443116|584909936|FG005|Part 2|Adverse Event|1|||
161962890|NCT02443116|584909937|FG006|Part 2|Adverse Event|2|||
161962891|NCT02443116|584909938|FG007|Part 2|Adverse Event|0|||
161962892|NCT02443116|584909939|FG008|Part 2|Adverse Event|0|||
161962893|NCT02443116|584909931|FG000|Part 2|Withdrew informed consent|0|||
161962894|NCT02443116|584909932|FG001|Part 2|Withdrew informed consent|0|||
161717031|NCT02413255|584010442|FG002|Overall Study|Voluntary Withdrawal|0|||
161717032|NCT02413255|584010443|FG003|Overall Study|Voluntary Withdrawal|0|||
161717033|NCT02413255|584010444|FG004|Overall Study|Voluntary Withdrawal|0|||
161717034|NCT02413255|584010445|FG005|Overall Study|Voluntary Withdrawal|0|||
161962895|NCT02443116|584909933|FG002|Part 2|Withdrew informed consent|0|||
161962896|NCT02443116|584909934|FG003|Part 2|Withdrew informed consent|0|||
161962897|NCT02443116|584909935|FG004|Part 2|Withdrew informed consent|0|||
161962898|NCT02443116|584909936|FG005|Part 2|Withdrew informed consent|1|||
161962899|NCT02443116|584909937|FG006|Part 2|Withdrew informed consent|1|||
161962900|NCT02443116|584909938|FG007|Part 2|Withdrew informed consent|0|||
161717035|NCT02413255|584010446|FG006|Overall Study|Voluntary Withdrawal|0|||
161717036|NCT02413255|584010447|FG007|Overall Study|Voluntary Withdrawal|0|||
161962901|NCT02443116|584909939|FG008|Part 2|Withdrew informed consent|0|||
161962902|NCT02443116|584909931|FG000|Part 2|Inability to comply with protocol|0|||
161962903|NCT02443116|584909932|FG001|Part 2|Inability to comply with protocol|0|||
161962904|NCT02443116|584909933|FG002|Part 2|Inability to comply with protocol|0|||
161962905|NCT02443116|584909934|FG003|Part 2|Inability to comply with protocol|1|||
161717037|NCT02413255|584010448|FG008|Overall Study|Voluntary Withdrawal|0|||
161717038|NCT02413255|584010449|FG009|Overall Study|Voluntary Withdrawal|0|||
161717039|NCT02413255|584010450|FG010|Overall Study|Voluntary Withdrawal|0|||
161717040|NCT02413255|584010451|FG011|Overall Study|Voluntary Withdrawal|0|||
161717041|NCT02413255|584010452|FG012|Overall Study|Voluntary Withdrawal|0|||
161717042|NCT02413255|584010453|FG013|Overall Study|Voluntary Withdrawal|0|||
161717043|NCT02413255|584010454|FG014|Overall Study|Voluntary Withdrawal|1|||
161717044|NCT02413255|584010455|FG015|Overall Study|Voluntary Withdrawal|0|||
161962906|NCT02443116|584909935|FG004|Part 2|Inability to comply with protocol|0|||
161962907|NCT02443116|584909936|FG005|Part 2|Inability to comply with protocol|0|||
161962908|NCT02443116|584909937|FG006|Part 2|Inability to comply with protocol|0|||
161962909|NCT02443116|584909938|FG007|Part 2|Inability to comply with protocol|0|||
161717045|NCT02413255|584010456|FG016|Overall Study|Voluntary Withdrawal|0|||
161717046|NCT00077623|584010457|FG000|Overall Study|Adverse Event|1|||
161717047|NCT00077623|584010458|FG001|Overall Study|Adverse Event|0|||
161717048|NCT00077623|584010459|FG002|Overall Study|Adverse Event|1|||
161717049|NCT00077623|584010457|FG000|Overall Study|Withdrawal by Subject|2|||
161717050|NCT00077623|584010458|FG001|Overall Study|Withdrawal by Subject|10|||
161717051|NCT00077623|584010459|FG002|Overall Study|Withdrawal by Subject|1|||
161717052|NCT00077623|584010457|FG000|Overall Study|Other-Non safety reason|18|||
161717053|NCT00077623|584010458|FG001|Overall Study|Other-Non safety reason|15|||
161717054|NCT00077623|584010459|FG002|Overall Study|Other-Non safety reason|19|||
161717055|NCT00077623|584010457|FG000|Overall Study|Insufficient therapeutic response|2|||
161717056|NCT00077623|584010458|FG001|Overall Study|Insufficient therapeutic response|0|||
161962910|NCT02443116|584909939|FG008|Part 2|Inability to comply with protocol|0|||
161962911|NCT02443116|584909931|FG000|Part 2|Lost to Follow-up|0|||
161962912|NCT02443116|584909932|FG001|Part 2|Lost to Follow-up|0|||
161962913|NCT02443116|584909933|FG002|Part 2|Lost to Follow-up|0|||
161962914|NCT02443116|584909934|FG003|Part 2|Lost to Follow-up|1|||
161962915|NCT02443116|584909935|FG004|Part 2|Lost to Follow-up|0|||
161717057|NCT00077623|584010459|FG002|Overall Study|Insufficient therapeutic response|0|||
161717058|NCT00077623|584010457|FG000|Overall Study|Death|12|||
161717059|NCT00077623|584010458|FG001|Overall Study|Death|18|||
161717060|NCT00077623|584010459|FG002|Overall Study|Death|11|||
161717061|NCT00077623|584010457|FG000|Overall Study|Failure to return|1|||
161717062|NCT00077623|584010458|FG001|Overall Study|Failure to return|0|||
161962916|NCT02443116|584909936|FG005|Part 2|Lost to Follow-up|0|||
161962917|NCT02443116|584909937|FG006|Part 2|Lost to Follow-up|0|||
161962918|NCT02443116|584909938|FG007|Part 2|Lost to Follow-up|0|||
161962919|NCT02443116|584909939|FG008|Part 2|Lost to Follow-up|0|||
161962920|NCT02443116|584909931|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161962921|NCT02443116|584909932|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161962922|NCT02443116|584909933|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161962923|NCT02443116|584909934|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161962924|NCT02443116|584909935|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161962925|NCT02443116|584909936|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
161962926|NCT02443116|584909937|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161962927|NCT02443116|584909938|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161962928|NCT02443116|584909939|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
161962929|NCT02443116|584909931|FG000|Part 3|Adverse Event|0|||
161962930|NCT02443116|584909932|FG001|Part 3|Adverse Event|0|||
161962931|NCT02443116|584909933|FG002|Part 3|Adverse Event|0|||
161962932|NCT02443116|584909934|FG003|Part 3|Adverse Event|0|||
161962933|NCT02443116|584909935|FG004|Part 3|Adverse Event|0|||
161962934|NCT02443116|584909936|FG005|Part 3|Adverse Event|0|||
161962935|NCT02443116|584909937|FG006|Part 3|Adverse Event|0|||
161962936|NCT02443116|584909938|FG007|Part 3|Adverse Event|0|||
161962937|NCT02443116|584909939|FG008|Part 3|Adverse Event|1|||
161962938|NCT02443116|584909931|FG000|Part 3|Withdrew informed consent|0|||
161962939|NCT02443116|584909932|FG001|Part 3|Withdrew informed consent|0|||
161962940|NCT02443116|584909933|FG002|Part 3|Withdrew informed consent|0|||
161962941|NCT02443116|584909934|FG003|Part 3|Withdrew informed consent|0|||
161962942|NCT02443116|584909935|FG004|Part 3|Withdrew informed consent|0|||
161962943|NCT02443116|584909936|FG005|Part 3|Withdrew informed consent|0|||
161962944|NCT02443116|584909937|FG006|Part 3|Withdrew informed consent|0|||
161962945|NCT02443116|584909938|FG007|Part 3|Withdrew informed consent|3|||
161962946|NCT02443116|584909939|FG008|Part 3|Withdrew informed consent|2|||
161962947|NCT02443116|584909931|FG000|Part 3|Lost to Follow-up|0|||
161962948|NCT02443116|584909932|FG001|Part 3|Lost to Follow-up|0|||
161962949|NCT02443116|584909933|FG002|Part 3|Lost to Follow-up|0|||
161962950|NCT02443116|584909934|FG003|Part 3|Lost to Follow-up|0|||
161962951|NCT02443116|584909935|FG004|Part 3|Lost to Follow-up|0|||
161962952|NCT02443116|584909936|FG005|Part 3|Lost to Follow-up|0|||
161962953|NCT02443116|584909937|FG006|Part 3|Lost to Follow-up|0|||
161962954|NCT02443116|584909938|FG007|Part 3|Lost to Follow-up|1|||
161962955|NCT02443116|584909939|FG008|Part 3|Lost to Follow-up|2|||
161962956|NCT03763656|584909947|FG000|Overall Study|Physician Decision|1|||
161962957|NCT03763656|584909947|FG000|Overall Study|Protocol Violation|1|||
161962958|NCT03763656|584909947|FG000|Overall Study|Withdrawal by Subject|7|||
161962959|NCT03479541|584909948|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
161962960|NCT03479541|584909949|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
161962961|NCT03479541|584909950|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
161962962|NCT03479541|584909951|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
161962963|NCT03479541|584909948|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
161962964|NCT03479541|584909949|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
161962965|NCT03479541|584909950|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
161962966|NCT03479541|584909951|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
161962967|NCT03479541|584909948|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
161962968|NCT03479541|584909949|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
161962969|NCT03479541|584909950|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
161962970|NCT03479541|584909951|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
161962971|NCT03479541|584909948|FG000|Home Monitoring|Lost to Follow-up|0|||
161962972|NCT03479541|584909949|FG001|Home Monitoring|Lost to Follow-up|0|||
161962973|NCT03479541|584909950|FG002|Home Monitoring|Lost to Follow-up|8|||
161962974|NCT03479541|584909951|FG003|Home Monitoring|Lost to Follow-up|12|||
161962975|NCT03479541|584909948|FG000|Home Monitoring|Withdrawal by Subject|0|||
161962976|NCT03479541|584909949|FG001|Home Monitoring|Withdrawal by Subject|0|||
161962977|NCT03479541|584909950|FG002|Home Monitoring|Withdrawal by Subject|17|||
161962978|NCT03479541|584909951|FG003|Home Monitoring|Withdrawal by Subject|30|||
161962979|NCT03479541|584909948|FG000|Home Monitoring|Early Termination - PI Decision|0|||
161962980|NCT03479541|584909949|FG001|Home Monitoring|Early Termination - PI Decision|0|||
161962981|NCT03479541|584909950|FG002|Home Monitoring|Early Termination - PI Decision|4|||
161962982|NCT03479541|584909951|FG003|Home Monitoring|Early Termination - PI Decision|6|||
161962983|NCT01673854|584909953|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
161962984|NCT01673854|584909953|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
161962985|NCT01673854|584909953|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
161962986|NCT01673854|584909953|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
161962987|NCT01673854|584909953|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
161962988|NCT01673854|584909953|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
161962989|NCT01673854|584909953|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
162031994|NCT01155479|585174163|FG003|Part I|Administrative|0|||
162031995|NCT01155479|585174164|FG004|Part I|Administrative|0|||
162031996|NCT01155479|585174160|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
162031997|NCT01155479|585174161|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
162031998|NCT01155479|585174162|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
162031999|NCT01155479|585174163|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
162032000|NCT01155479|585174164|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
162032001|NCT01155479|585174160|FG000|Part I|Withdrawal by Subject|11|||
162032002|NCT01155479|585174161|FG001|Part I|Withdrawal by Subject|13|||
162032003|NCT01155479|585174162|FG002|Part I|Withdrawal by Subject|8|||
162032004|NCT01155479|585174163|FG003|Part I|Withdrawal by Subject|8|||
162032005|NCT01155479|585174164|FG004|Part I|Withdrawal by Subject|9|||
162032006|NCT01155479|585174160|FG000|Part I|Lost to Follow-up|0|||
162032007|NCT01155479|585174161|FG001|Part I|Lost to Follow-up|0|||
162032008|NCT01155479|585174162|FG002|Part I|Lost to Follow-up|1|||
162032009|NCT01155479|585174163|FG003|Part I|Lost to Follow-up|1|||
162032010|NCT01155479|585174164|FG004|Part I|Lost to Follow-up|0|||
162032011|NCT01155479|585174160|FG000|Part I|Treatment Failure|3|||
162032012|NCT01155479|585174161|FG001|Part I|Treatment Failure|0|||
162032013|NCT01155479|585174162|FG002|Part I|Treatment Failure|3|||
162032014|NCT01155479|585174163|FG003|Part I|Treatment Failure|1|||
162032015|NCT01155479|585174164|FG004|Part I|Treatment Failure|2|||
162032016|NCT01155479|585174160|FG000|Part I|Did Not Receive Treatment|4|||
162032017|NCT01155479|585174161|FG001|Part I|Did Not Receive Treatment|2|||
162032018|NCT01155479|585174162|FG002|Part I|Did Not Receive Treatment|2|||
162032019|NCT01155479|585174163|FG003|Part I|Did Not Receive Treatment|6|||
162032020|NCT01155479|585174164|FG004|Part I|Did Not Receive Treatment|1|||
162032021|NCT01155479|585174160|FG000|Part I|Non-Compliance with Protocol|2|||
162032022|NCT01155479|585174161|FG001|Part I|Non-Compliance with Protocol|1|||
162032023|NCT01155479|585174162|FG002|Part I|Non-Compliance with Protocol|3|||
162032024|NCT01155479|585174163|FG003|Part I|Non-Compliance with Protocol|3|||
162032025|NCT01155479|585174164|FG004|Part I|Non-Compliance with Protocol|2|||
162032026|NCT01155479|585174160|FG000|Part II|Adverse Event|7|||
162032027|NCT01155479|585174161|FG001|Part II|Adverse Event|6|||
162032028|NCT01155479|585174162|FG002|Part II|Adverse Event|8|||
162032029|NCT01155479|585174163|FG003|Part II|Adverse Event|3|||
162032030|NCT01155479|585174164|FG004|Part II|Adverse Event|4|||
162032031|NCT01155479|585174160|FG000|Part II|Administrative|43|||
162032032|NCT01155479|585174161|FG001|Part II|Administrative|49|||
162032033|NCT01155479|585174162|FG002|Part II|Administrative|36|||
162032034|NCT01155479|585174163|FG003|Part II|Administrative|38|||
162032035|NCT01155479|585174164|FG004|Part II|Administrative|46|||
162032036|NCT01155479|585174160|FG000|Part II|Withdrawal by Subject|8|||
162032037|NCT01155479|585174161|FG001|Part II|Withdrawal by Subject|4|||
162032038|NCT01155479|585174162|FG002|Part II|Withdrawal by Subject|12|||
162032039|NCT01155479|585174163|FG003|Part II|Withdrawal by Subject|7|||
162032040|NCT01155479|585174164|FG004|Part II|Withdrawal by Subject|3|||
162032041|NCT01155479|585174160|FG000|Part II|Lost to Follow-up|1|||
162032042|NCT01155479|585174161|FG001|Part II|Lost to Follow-up|0|||
161962990|NCT01673854|584909953|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
161962991|NCT01673854|584909953|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
161962992|NCT01673854|584909953|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
161962993|NCT01673854|584909953|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
161962994|NCT01673854|584909953|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
161962995|NCT00334737|584909954|FG000|Hospital Phase|Death|1|||
161962996|NCT00334737|584909955|FG001|Hospital Phase|Death|2|||
161962997|NCT00334737|584909956|FG002|Hospital Phase|Death|3|||
161962998|NCT00334737|584909954|FG000|Hospital Phase|Withdrawal by Subject|0|||
162032043|NCT01155479|585174162|FG002|Part II|Lost to Follow-up|0|||
162032044|NCT01155479|585174163|FG003|Part II|Lost to Follow-up|0|||
162032045|NCT01155479|585174164|FG004|Part II|Lost to Follow-up|1|||
162032046|NCT01155479|585174160|FG000|Part II|Treatment Failure|0|||
162032047|NCT01155479|585174161|FG001|Part II|Treatment Failure|1|||
161717063|NCT00077623|584010459|FG002|Overall Study|Failure to return|0|||
161962999|NCT00334737|584909955|FG001|Hospital Phase|Withdrawal by Subject|0|||
161963000|NCT00334737|584909956|FG002|Hospital Phase|Withdrawal by Subject|1|||
161963001|NCT00334737|584909954|FG000|Hospital Phase|Did not receive study drug|1|||
161963002|NCT00334737|584909955|FG001|Hospital Phase|Did not receive study drug|0|||
161963003|NCT00334737|584909956|FG002|Hospital Phase|Did not receive study drug|0|||
162032048|NCT01155479|585174162|FG002|Part II|Treatment Failure|2|||
162032049|NCT01155479|585174163|FG003|Part II|Treatment Failure|0|||
162032050|NCT01155479|585174164|FG004|Part II|Treatment Failure|1|||
162032051|NCT01155479|585174160|FG000|Part II|Non-Compliance with Protocol|0|||
162032052|NCT01155479|585174161|FG001|Part II|Non-Compliance with Protocol|1|||
162032053|NCT01155479|585174162|FG002|Part II|Non-Compliance with Protocol|0|||
162032054|NCT01155479|585174163|FG003|Part II|Non-Compliance with Protocol|2|||
162032055|NCT01155479|585174164|FG004|Part II|Non-Compliance with Protocol|0|||
162032056|NCT01857310|585174165|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
162032057|NCT01857310|585174166|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
162032058|NCT02360605|585174167|FG000|Overall Study|Withdrawal by Subject|4|||
162032059|NCT02360605|585174168|FG001|Overall Study|Withdrawal by Subject|9|||
161717064|NCT01334125|584010460|FG000|Overall Study|Lost to Follow-up|3|||
161717065|NCT01334125|584010461|FG001|Overall Study|Lost to Follow-up|3|||
161717066|NCT00882713|584010464|FG000|Overall Study|Adverse Event|2|||
161717067|NCT00882713|584010464|FG000|Overall Study|Death|3|||
161717068|NCT00882713|584010464|FG000|Overall Study|Administrative reasons|4|||
161717069|NCT00882713|584010464|FG000|Overall Study|refused treatment/withdrew consent|4|||
161717070|NCT00882713|584010464|FG000|Overall Study|Blood transfusion|2|||
161717071|NCT00882713|584010464|FG000|Overall Study|Insufficient therapeutic response|3|||
161717072|NCT00882713|584010464|FG000|Overall Study|Failure to return|2|||
161717073|NCT00882713|584010464|FG000|Overall Study|Other - Reasons|2|||
161717074|NCT00401973|584010467|FG000|Overall Study|Adverse Event|2|||
161717075|NCT00401973|584010468|FG001|Overall Study|Adverse Event|8|||
161717076|NCT00401973|584010469|FG002|Overall Study|Adverse Event|4|||
161717077|NCT00401973|584010467|FG000|Overall Study|Clinical Relapse|0|||
161717078|NCT00401973|584010468|FG001|Overall Study|Clinical Relapse|1|||
161717079|NCT00401973|584010469|FG002|Overall Study|Clinical Relapse|1|||
161717080|NCT00401973|584010467|FG000|Overall Study|Lack of Efficacy|0|||
161717081|NCT00401973|584010468|FG001|Overall Study|Lack of Efficacy|0|||
161717082|NCT00401973|584010469|FG002|Overall Study|Lack of Efficacy|3|||
161717083|NCT00401973|584010467|FG000|Overall Study|Lost to Follow-up|2|||
161717084|NCT00401973|584010468|FG001|Overall Study|Lost to Follow-up|2|||
161717085|NCT00401973|584010469|FG002|Overall Study|Lost to Follow-up|2|||
161717086|NCT00401973|584010467|FG000|Overall Study|Physician Decision|2|||
161717087|NCT00401973|584010468|FG001|Overall Study|Physician Decision|0|||
161717088|NCT00401973|584010469|FG002|Overall Study|Physician Decision|1|||
161717089|NCT00401973|584010467|FG000|Overall Study|Protocol Violation|1|||
161717090|NCT00401973|584010468|FG001|Overall Study|Protocol Violation|2|||
161717091|NCT00401973|584010469|FG002|Overall Study|Protocol Violation|3|||
161717092|NCT00401973|584010467|FG000|Overall Study|Sponsor Decision|0|||
161717093|NCT00401973|584010468|FG001|Overall Study|Sponsor Decision|1|||
161717094|NCT00401973|584010469|FG002|Overall Study|Sponsor Decision|0|||
161717095|NCT00401973|584010467|FG000|Overall Study|Withdrawal by Subject|4|||
161717096|NCT00401973|584010468|FG001|Overall Study|Withdrawal by Subject|12|||
161717097|NCT00401973|584010469|FG002|Overall Study|Withdrawal by Subject|9|||
161717098|NCT03700892|584010470|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
161717099|NCT03700892|584010471|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
161717100|NCT03700892|584010472|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
161717101|NCT00849212|584010473|FG000|Overall Study|Lack of Efficacy|1|||
161717102|NCT00849212|584010473|FG000|Overall Study|Withdrawal by Subject|3|||
161717103|NCT00849212|584010473|FG000|Overall Study|Adverse Event|2|||
161717104|NCT00849212|584010473|FG000|Overall Study|Miscellaneous|1|||
161717105|NCT02117050|584010484|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
161717106|NCT02460822|584010487|FG000|Overall Study|Withdrawal by Subject|1|||
161717107|NCT00754390|584010488|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
161717108|NCT00754390|584010488|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
161717109|NCT00754390|584010488|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
161717110|NCT00754390|584010488|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
161717111|NCT00847613|584010489|FG000|Overall Study|Ongoing at cut-off date|250|||
161717112|NCT00847613|584010490|FG001|Overall Study|Ongoing at cut-off date|265|||
161717113|NCT00847613|584010491|FG002|Overall Study|Ongoing at cut-off date|64|||
161717114|NCT00847613|584010492|FG003|Overall Study|Ongoing at cut-off date|64|||
161717115|NCT00847613|584010489|FG000|Overall Study|Death|1|||
161717116|NCT00847613|584010490|FG001|Overall Study|Death|1|||
161717117|NCT00847613|584010491|FG002|Overall Study|Death|0|||
161717118|NCT00847613|584010492|FG003|Overall Study|Death|0|||
161717119|NCT00847613|584010489|FG000|Overall Study|Adverse Event|36|||
161717120|NCT00847613|584010490|FG001|Overall Study|Adverse Event|26|||
161717121|NCT00847613|584010491|FG002|Overall Study|Adverse Event|5|||
161717122|NCT00847613|584010492|FG003|Overall Study|Adverse Event|6|||
161717123|NCT00847613|584010489|FG000|Overall Study|Lack of Efficacy|7|||
161717124|NCT00847613|584010490|FG001|Overall Study|Lack of Efficacy|3|||
161717125|NCT00847613|584010491|FG002|Overall Study|Lack of Efficacy|3|||
161717126|NCT00847613|584010492|FG003|Overall Study|Lack of Efficacy|1|||
161717127|NCT00847613|584010489|FG000|Overall Study|Study terminated by Sponsor|1|||
161717128|NCT00847613|584010490|FG001|Overall Study|Study terminated by Sponsor|0|||
161717129|NCT00847613|584010491|FG002|Overall Study|Study terminated by Sponsor|2|||
161717130|NCT00847613|584010492|FG003|Overall Study|Study terminated by Sponsor|1|||
161717131|NCT00847613|584010489|FG000|Overall Study|Lost to Follow-up|5|||
161717132|NCT00847613|584010490|FG001|Overall Study|Lost to Follow-up|0|||
161717133|NCT00847613|584010491|FG002|Overall Study|Lost to Follow-up|0|||
161717134|NCT00847613|584010492|FG003|Overall Study|Lost to Follow-up|3|||
161717135|NCT00847613|584010489|FG000|Overall Study|Protocol Violation|6|||
161717136|NCT00847613|584010490|FG001|Overall Study|Protocol Violation|6|||
161717137|NCT00847613|584010491|FG002|Overall Study|Protocol Violation|3|||
161717138|NCT00847613|584010492|FG003|Overall Study|Protocol Violation|1|||
161717139|NCT00847613|584010489|FG000|Overall Study|Pregnancy|1|||
161717140|NCT00847613|584010490|FG001|Overall Study|Pregnancy|1|||
161717141|NCT00847613|584010491|FG002|Overall Study|Pregnancy|0|||
161717142|NCT00847613|584010492|FG003|Overall Study|Pregnancy|0|||
161717143|NCT00847613|584010489|FG000|Overall Study|Site closure|1|||
161717144|NCT00847613|584010490|FG001|Overall Study|Site closure|0|||
161717145|NCT00847613|584010491|FG002|Overall Study|Site closure|0|||
161717146|NCT00847613|584010492|FG003|Overall Study|Site closure|1|||
161717147|NCT00847613|584010489|FG000|Overall Study|Withdrawal by Subject|8|||
161717148|NCT00847613|584010490|FG001|Overall Study|Withdrawal by Subject|11|||
161717149|NCT00847613|584010491|FG002|Overall Study|Withdrawal by Subject|2|||
161717150|NCT00847613|584010492|FG003|Overall Study|Withdrawal by Subject|2|||
161717151|NCT00847613|584010489|FG000|Overall Study|Participant moved|4|||
161717152|NCT00847613|584010490|FG001|Overall Study|Participant moved|1|||
161717153|NCT00847613|584010491|FG002|Overall Study|Participant moved|0|||
161717154|NCT00847613|584010492|FG003|Overall Study|Participant moved|0|||
161717155|NCT00847613|584010489|FG000|Overall Study|Sponsor request|0|||
161717156|NCT00847613|584010490|FG001|Overall Study|Sponsor request|1|||
161717157|NCT00847613|584010491|FG002|Overall Study|Sponsor request|0|||
161717158|NCT00847613|584010492|FG003|Overall Study|Sponsor request|0|||
161717159|NCT00847613|584010489|FG000|Overall Study|Randomized, but not treated|0|||
161717160|NCT00847613|584010490|FG001|Overall Study|Randomized, but not treated|3|||
161717161|NCT00847613|584010491|FG002|Overall Study|Randomized, but not treated|0|||
161717162|NCT00847613|584010492|FG003|Overall Study|Randomized, but not treated|0|||
161717163|NCT00847613|584010489|FG000|Overall Study|Other|1|||
161717164|NCT00847613|584010490|FG001|Overall Study|Other|1|||
161717165|NCT00847613|584010491|FG002|Overall Study|Other|2|||
161717166|NCT00847613|584010492|FG003|Overall Study|Other|0|||
161717167|NCT03233048|584010493|FG000|Overall Study|Withdrawal by Subject|1|||
161717168|NCT00491530|584010494|FG000|Overall Study|Adverse Event|6|||
161717169|NCT00491530|584010495|FG001|Overall Study|Adverse Event|1|||
161717170|NCT00491530|584010496|FG002|Overall Study|Adverse Event|2|||
161717171|NCT00491530|584010494|FG000|Overall Study|Withdrawal by Subject|3|||
161717172|NCT00491530|584010495|FG001|Overall Study|Withdrawal by Subject|0|||
161717173|NCT00491530|584010496|FG002|Overall Study|Withdrawal by Subject|0|||
161717174|NCT00491530|584010494|FG000|Overall Study|Lost to Follow-up|3|||
161717175|NCT00491530|584010495|FG001|Overall Study|Lost to Follow-up|2|||
161717176|NCT00491530|584010496|FG002|Overall Study|Lost to Follow-up|2|||
161717177|NCT00491530|584010494|FG000|Overall Study|Lack of Efficacy|0|||
161717178|NCT00491530|584010495|FG001|Overall Study|Lack of Efficacy|1|||
161717179|NCT00491530|584010496|FG002|Overall Study|Lack of Efficacy|0|||
161717180|NCT00491530|584010494|FG000|Overall Study|Investigator Discretion|0|||
161717181|NCT00491530|584010495|FG001|Overall Study|Investigator Discretion|1|||
161717182|NCT00491530|584010496|FG002|Overall Study|Investigator Discretion|0|||
161717183|NCT00491530|584010494|FG000|Overall Study|Patient Request|0|||
161717184|NCT00491530|584010495|FG001|Overall Study|Patient Request|1|||
161717185|NCT00491530|584010496|FG002|Overall Study|Patient Request|0|||
161717186|NCT00491530|584010494|FG000|Overall Study|Use of Prohibited Medication|0|||
161717187|NCT00491530|584010495|FG001|Overall Study|Use of Prohibited Medication|0|||
161717188|NCT00491530|584010496|FG002|Overall Study|Use of Prohibited Medication|1|||
161717189|NCT01856673|584010497|FG000|Overall Study|Withdrawal by Subject|44|||
161717190|NCT01856673|584010498|FG001|Overall Study|Withdrawal by Subject|50|||
161717191|NCT01856673|584010499|FG002|Overall Study|Withdrawal by Subject|33|||
161717192|NCT01856673|584010497|FG000|Overall Study|Lost to Follow-up|31|||
161717193|NCT01856673|584010498|FG001|Overall Study|Lost to Follow-up|34|||
161717194|NCT01856673|584010499|FG002|Overall Study|Lost to Follow-up|0|||
161717195|NCT01856673|584010497|FG000|Overall Study|Unknown reasons|9|||
161717196|NCT01856673|584010498|FG001|Overall Study|Unknown reasons|0|||
161717197|NCT01856673|584010499|FG002|Overall Study|Unknown reasons|0|||
161963004|NCT00334737|584909954|FG000|Follow up Phase|Lost to Follow-up|5|||
161963005|NCT00334737|584909955|FG001|Follow up Phase|Lost to Follow-up|3|||
161963006|NCT00334737|584909956|FG002|Follow up Phase|Lost to Follow-up|6|||
161963007|NCT02316353|584909957|FG000|Overall Study|Pregnancy|1|||
161963008|NCT02316353|584909958|FG001|Overall Study|Pregnancy|3|||
161963009|NCT02316353|584909957|FG000|Overall Study|Adverse Event|1|||
161963010|NCT02316353|584909958|FG001|Overall Study|Adverse Event|3|||
161717198|NCT01856673|584010497|FG000|Overall Study|Psychologist decision|1|||
161717199|NCT01856673|584010498|FG001|Overall Study|Psychologist decision|0|||
161717200|NCT01856673|584010499|FG002|Overall Study|Psychologist decision|0|||
161963011|NCT02316353|584909957|FG000|Overall Study|Withdrawal by Subject|6|||
161717201|NCT01856673|584010497|FG000|Overall Study|Paperwork errors|8|||
161717202|NCT01856673|584010498|FG001|Overall Study|Paperwork errors|0|||
161717203|NCT01856673|584010499|FG002|Overall Study|Paperwork errors|0|||
161717204|NCT01856673|584010497|FG000|Overall Study|Death|1|||
161717205|NCT01856673|584010498|FG001|Overall Study|Death|1|||
161717206|NCT01856673|584010499|FG002|Overall Study|Death|0|||
161717207|NCT01856673|584010497|FG000|Overall Study|Protocol Violation|1|||
161963012|NCT02316353|584909958|FG001|Overall Study|Withdrawal by Subject|2|||
161717208|NCT01856673|584010498|FG001|Overall Study|Protocol Violation|0|||
161717209|NCT01856673|584010499|FG002|Overall Study|Protocol Violation|1|||
161717210|NCT02859415|584010500|FG000|Overall Study|Physician Decision|1|||
161717211|NCT02859415|584010501|FG001|Overall Study|Physician Decision|0|||
161963013|NCT01579565|584911877|FG000|Randomized|Adverse Event|1|||
161963014|NCT01579565|584911878|FG001|Randomized|Adverse Event|3|||
161963015|NCT01579565|584911877|FG000|Randomized|Withdrawal by Subject|3|||
161963016|NCT01579565|584911878|FG001|Randomized|Withdrawal by Subject|0|||
161963017|NCT01579565|584911877|FG000|Randomized|inadequate preoperative pupil dilation|0|||
161963018|NCT01579565|584911878|FG001|Randomized|inadequate preoperative pupil dilation|1|||
161963019|NCT01579565|584911877|FG000|Randomized|prohibited preoperative eating|1|||
161963020|NCT01579565|584911878|FG001|Randomized|prohibited preoperative eating|0|||
161963021|NCT01579565|584911877|FG000|Randomized|prohibited preoperative medication|0|||
161963022|NCT01579565|584911878|FG001|Randomized|prohibited preoperative medication|1|||
161963023|NCT01579565|584911877|FG000|Treated|Physician Decision|0|||
161963024|NCT01579565|584911878|FG001|Treated|Physician Decision|1|||
161963025|NCT01579565|584911877|FG000|Treated|Lost to Follow-up|2|||
161963026|NCT01579565|584911878|FG001|Treated|Lost to Follow-up|1|||
161963027|NCT01579565|584911877|FG000|Treated|declined to return for final visit|0|||
161963028|NCT01579565|584911878|FG001|Treated|declined to return for final visit|1|||
161963029|NCT01380535|584911879|FG000|Overall Study|Adverse Event|3|||
161963030|NCT01380535|584911880|FG001|Overall Study|Adverse Event|3|||
161963031|NCT01380535|584911879|FG000|Overall Study|Death|3|||
161963032|NCT01380535|584911880|FG001|Overall Study|Death|0|||
161963033|NCT01380535|584911879|FG000|Overall Study|Study site closed|0|||
161963034|NCT01380535|584911880|FG001|Overall Study|Study site closed|5|||
161963035|NCT01380535|584911879|FG000|Overall Study|Withdrawal by Subject|1|||
161963036|NCT01380535|584911880|FG001|Overall Study|Withdrawal by Subject|2|||
161963037|NCT01380535|584911879|FG000|Overall Study|Protocol Violation|0|||
161963038|NCT01380535|584911880|FG001|Overall Study|Protocol Violation|2|||
161963039|NCT01380535|584911879|FG000|Overall Study|Lack of Efficacy|0|||
161963040|NCT01380535|584911880|FG001|Overall Study|Lack of Efficacy|3|||
161963041|NCT00489424|584911886|FG000|Overall Study|Adverse Event|3|||
161963042|NCT00489424|584911887|FG001|Overall Study|Adverse Event|3|||
161963043|NCT00489424|584911888|FG002|Overall Study|Adverse Event|4|||
161963044|NCT00489424|584911886|FG000|Overall Study|Lack of Efficacy|1|||
161963045|NCT00489424|584911887|FG001|Overall Study|Lack of Efficacy|0|||
161963046|NCT00489424|584911888|FG002|Overall Study|Lack of Efficacy|0|||
161963047|NCT00489424|584911886|FG000|Overall Study|Administrative problems|0|||
161963048|NCT00489424|584911887|FG001|Overall Study|Administrative problems|2|||
161963049|NCT00489424|584911888|FG002|Overall Study|Administrative problems|1|||
161963050|NCT00394251|584911889|FG000|Overall Study|Adverse Event|7|||
161963051|NCT00394251|584911890|FG001|Overall Study|Adverse Event|5|||
161963052|NCT00394251|584911889|FG000|Overall Study|Unacceptable Toxicity|20|||
161963053|NCT00394251|584911890|FG001|Overall Study|Unacceptable Toxicity|18|||
161963054|NCT00394251|584911889|FG000|Overall Study|Physician Decision|1|||
161963055|NCT00394251|584911890|FG001|Overall Study|Physician Decision|1|||
161963056|NCT00394251|584911889|FG000|Overall Study|Protocol Violation|0|||
161717212|NCT02859415|584010500|FG000|Overall Study|Off treatment due to cardiac event|0|||
161717213|NCT02859415|584010501|FG001|Overall Study|Off treatment due to cardiac event|1|||
161717214|NCT01396525|584010502|FG000|Overall Study|Withdrawal by Subject|8|||
161717215|NCT01396525|584010502|FG000|Overall Study|Death|14|||
161717216|NCT01396525|584010502|FG000|Overall Study|Lost to Follow-up|4|||
161717217|NCT03114969|584010503|FG000|Overall Study|Lost to Follow-up|0|||
161717218|NCT03114969|584010504|FG001|Overall Study|Lost to Follow-up|0|||
161717219|NCT03114969|584010505|FG002|Overall Study|Lost to Follow-up|3|||
161717220|NCT03114969|584010506|FG003|Overall Study|Lost to Follow-up|2|||
161717221|NCT03114969|584010507|FG004|Overall Study|Lost to Follow-up|0|||
161717222|NCT03114969|584010508|FG005|Overall Study|Lost to Follow-up|0|||
161717223|NCT03114969|584010509|FG006|Overall Study|Lost to Follow-up|0|||
161717224|NCT03114969|584010510|FG007|Overall Study|Lost to Follow-up|0|||
161717225|NCT03114969|584010511|FG008|Overall Study|Lost to Follow-up|0|||
161963057|NCT00394251|584911890|FG001|Overall Study|Protocol Violation|1|||
161717226|NCT03114969|584010503|FG000|Overall Study|Adverse Event|0|||
161963058|NCT00394251|584911889|FG000|Overall Study|Withdrawal by Subject|7|||
161963059|NCT00394251|584911890|FG001|Overall Study|Withdrawal by Subject|11|||
161963060|NCT00394251|584911889|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
161963061|NCT00394251|584911890|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
161963062|NCT01558115|584911891|FG000|Overall Study|Withdrawal by Subject|3|||
161963063|NCT01558115|584911891|FG000|Overall Study|Study closed due to poor enrollment|4|||
161963064|NCT01436656|584911892|FG000|Dose Escalation|Death|1|||
161963065|NCT01436656|584911893|FG001|Dose Escalation|Death|3|||
161717227|NCT03114969|584010504|FG001|Overall Study|Adverse Event|0|||
161717228|NCT03114969|584010505|FG002|Overall Study|Adverse Event|1|||
161963066|NCT01436656|584911894|FG002|Dose Escalation|Death|1|||
161963067|NCT01436656|584911895|FG003|Dose Escalation|Death|0|||
161963068|NCT01436656|584911896|FG004|Dose Escalation|Death|2|||
161963069|NCT01436656|584911897|FG005|Dose Escalation|Death|1|||
161963070|NCT01436656|584911898|FG006|Dose Escalation|Death|1|||
161717229|NCT03114969|584010506|FG003|Overall Study|Adverse Event|0|||
161717230|NCT03114969|584010507|FG004|Overall Study|Adverse Event|0|||
161963071|NCT01436656|584911899|FG007|Dose Escalation|Death|1|||
161963072|NCT01436656|584911900|FG008|Dose Escalation|Death|1|||
161963073|NCT01436656|584911901|FG009|Dose Escalation|Death|0|||
161963074|NCT01436656|584911902|FG010|Dose Escalation|Death|0|||
162032060|NCT02360605|585174167|FG000|Overall Study|Lost to Follow-up|7|||
161717231|NCT03114969|584010508|FG005|Overall Study|Adverse Event|1|||
161963075|NCT01436656|584911903|FG011|Dose Escalation|Death|0|||
161963076|NCT01436656|584911904|FG012|Dose Escalation|Death|0|||
161963077|NCT01436656|584911905|FG013|Dose Escalation|Death|0|||
161963078|NCT01436656|584911906|FG014|Dose Escalation|Death|0|||
161963079|NCT01436656|584911907|FG015|Dose Escalation|Death|0|||
161963080|NCT01436656|584911908|FG016|Dose Escalation|Death|0|||
161963081|NCT01436656|584911909|FG017|Dose Escalation|Death|0|||
161963082|NCT01436656|584911892|FG000|Dose Escalation|Protocol Violation|0|||
161963083|NCT01436656|584911893|FG001|Dose Escalation|Protocol Violation|0|||
161963084|NCT01436656|584911894|FG002|Dose Escalation|Protocol Violation|0|||
161963085|NCT01436656|584911895|FG003|Dose Escalation|Protocol Violation|0|||
161963086|NCT01436656|584911896|FG004|Dose Escalation|Protocol Violation|0|||
161963087|NCT01436656|584911897|FG005|Dose Escalation|Protocol Violation|1|||
161963088|NCT01436656|584911898|FG006|Dose Escalation|Protocol Violation|0|||
161963089|NCT01436656|584911899|FG007|Dose Escalation|Protocol Violation|0|||
161963090|NCT01436656|584911900|FG008|Dose Escalation|Protocol Violation|0|||
161963091|NCT01436656|584911901|FG009|Dose Escalation|Protocol Violation|0|||
161963092|NCT01436656|584911902|FG010|Dose Escalation|Protocol Violation|0|||
161963093|NCT01436656|584911903|FG011|Dose Escalation|Protocol Violation|0|||
161963094|NCT01436656|584911904|FG012|Dose Escalation|Protocol Violation|0|||
161963095|NCT01436656|584911905|FG013|Dose Escalation|Protocol Violation|0|||
161963096|NCT01436656|584911906|FG014|Dose Escalation|Protocol Violation|0|||
161963097|NCT01436656|584911907|FG015|Dose Escalation|Protocol Violation|0|||
161963098|NCT01436656|584911908|FG016|Dose Escalation|Protocol Violation|0|||
161963099|NCT01436656|584911909|FG017|Dose Escalation|Protocol Violation|0|||
161963100|NCT01436656|584911892|FG000|Dose Escalation|Withdrawal by Subject|0|||
161717232|NCT03114969|584010509|FG006|Overall Study|Adverse Event|1|||
161717233|NCT03114969|584010510|FG007|Overall Study|Adverse Event|0|||
161717234|NCT03114969|584010511|FG008|Overall Study|Adverse Event|2|||
161717235|NCT00971321|584010512|FG000|Up to Month 7|Withdrawal by Subject|1|||
161717236|NCT00971321|584010513|FG001|Up to Month 7|Withdrawal by Subject|0|||
161963101|NCT01436656|584911893|FG001|Dose Escalation|Withdrawal by Subject|0|||
161963102|NCT01436656|584911894|FG002|Dose Escalation|Withdrawal by Subject|0|||
161963103|NCT01436656|584911895|FG003|Dose Escalation|Withdrawal by Subject|0|||
161963104|NCT01436656|584911896|FG004|Dose Escalation|Withdrawal by Subject|1|||
161963105|NCT01436656|584911897|FG005|Dose Escalation|Withdrawal by Subject|0|||
161963106|NCT01436656|584911898|FG006|Dose Escalation|Withdrawal by Subject|0|||
161963107|NCT01436656|584911899|FG007|Dose Escalation|Withdrawal by Subject|2|||
161963108|NCT01436656|584911900|FG008|Dose Escalation|Withdrawal by Subject|0|||
161963109|NCT01436656|584911901|FG009|Dose Escalation|Withdrawal by Subject|1|||
161963110|NCT01436656|584911902|FG010|Dose Escalation|Withdrawal by Subject|1|||
161963111|NCT01436656|584911903|FG011|Dose Escalation|Withdrawal by Subject|0|||
161963112|NCT01436656|584911904|FG012|Dose Escalation|Withdrawal by Subject|0|||
161963113|NCT01436656|584911905|FG013|Dose Escalation|Withdrawal by Subject|0|||
161963114|NCT01436656|584911906|FG014|Dose Escalation|Withdrawal by Subject|0|||
161963115|NCT01436656|584911907|FG015|Dose Escalation|Withdrawal by Subject|0|||
161963116|NCT01436656|584911908|FG016|Dose Escalation|Withdrawal by Subject|0|||
161963117|NCT01436656|584911909|FG017|Dose Escalation|Withdrawal by Subject|0|||
161963118|NCT01436656|584911892|FG000|Dose Escalation|Administrative problems|0|||
161963119|NCT01436656|584911893|FG001|Dose Escalation|Administrative problems|1|||
161963120|NCT01436656|584911894|FG002|Dose Escalation|Administrative problems|0|||
161963121|NCT01436656|584911895|FG003|Dose Escalation|Administrative problems|0|||
162032061|NCT02360605|585174168|FG001|Overall Study|Lost to Follow-up|8|||
162032062|NCT02360605|585174167|FG000|Overall Study|Death|0|||
162032063|NCT02360605|585174168|FG001|Overall Study|Death|1|||
162032064|NCT00290407|585174169|FG000|Overall Study|Physician Decision|2|||
162032065|NCT00868517|585174178|FG000|Overall Study|Withdrawal by Subject|3|||
162032066|NCT00868517|585174179|FG001|Overall Study|Withdrawal by Subject|3|||
162032067|NCT00868517|585174180|FG002|Overall Study|Withdrawal by Subject|2|||
162032068|NCT00868517|585174178|FG000|Overall Study|Protocol Violation|1|||
162032069|NCT00868517|585174179|FG001|Overall Study|Protocol Violation|1|||
162032070|NCT00868517|585174180|FG002|Overall Study|Protocol Violation|0|||
162032071|NCT01721577|585174181|FG000|Overall Study|Lack of Efficacy|1|||
162032072|NCT01721577|585174182|FG001|Overall Study|Lack of Efficacy|0|||
162032073|NCT01721577|585174181|FG000|Overall Study|Death|1|||
162032074|NCT01721577|585174182|FG001|Overall Study|Death|0|||
162032075|NCT01721577|585174181|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
162032076|NCT01721577|585174182|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
162032077|NCT01721577|585174181|FG000|Overall Study|Adverse Event|0|||
162032078|NCT01721577|585174182|FG001|Overall Study|Adverse Event|2|||
162032079|NCT01055496|585174183|FG000|Overall Study|Withdrawal by Subject|2|||
162032080|NCT01055496|585174184|FG001|Overall Study|Withdrawal by Subject|4|||
162032081|NCT01055496|585174183|FG000|Overall Study|Death|13|||
162032082|NCT01055496|585174184|FG001|Overall Study|Death|23|||
162032083|NCT01055496|585174183|FG000|Overall Study|Lost to Follow-up|0|||
162032084|NCT01055496|585174184|FG001|Overall Study|Lost to Follow-up|2|||
162032085|NCT01055496|585174183|FG000|Overall Study|Other - Unspecified|0|||
162032086|NCT01055496|585174184|FG001|Overall Study|Other - Unspecified|1|||
162032087|NCT00584740|585174185|FG000|Overall Study|Adverse Event|1|||
162032088|NCT00584740|585174186|FG001|Overall Study|Adverse Event|1|||
162032089|NCT00584740|585174185|FG000|Overall Study|Lack of Efficacy|8|||
162032090|NCT00584740|585174186|FG001|Overall Study|Lack of Efficacy|2|||
162032091|NCT00584740|585174185|FG000|Overall Study|Withdrawal by Subject|3|||
162032092|NCT00584740|585174186|FG001|Overall Study|Withdrawal by Subject|2|||
162032093|NCT00584740|585174185|FG000|Overall Study|Lost to Follow-up|0|||
162032094|NCT00584740|585174186|FG001|Overall Study|Lost to Follow-up|1|||
162032095|NCT02158364|585174187|FG000|Overall Study|Case report forms uncollected|10|||
162032096|NCT02158364|585174187|FG000|Overall Study|Protocol Deviation|50|||
162032097|NCT00732940|585174191|FG000|Overall Study|Withdrawal by Subject|1|||
162032098|NCT00732940|585174192|FG001|Overall Study|Withdrawal by Subject|2|||
162032099|NCT00732940|585174191|FG000|Overall Study|Adverse Event|0|||
162032100|NCT00732940|585174192|FG001|Overall Study|Adverse Event|1|||
162032101|NCT00732940|585174191|FG000|Overall Study|Lost to Follow-up|1|||
162032102|NCT00732940|585174192|FG001|Overall Study|Lost to Follow-up|0|||
162032103|NCT01642732|585174193|FG000|Overall Study|Withdrawal by Subject|1|||
162032104|NCT01589770|585174196|FG000|Overall Study|EGFR <60ml/min|6|||
161717237|NCT00971321|584010512|FG000|Up to Month 7|Migrated/moved from study area|3|||
161717238|NCT00971321|584010513|FG001|Up to Month 7|Migrated/moved from study area|2|||
161717239|NCT00971321|584010512|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
161717240|NCT00971321|584010513|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
161717241|NCT00971321|584010512|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
161717242|NCT00971321|584010513|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
161717243|NCT00971321|584010512|FG000|Up to Month 11-12|Lost to Follow-up|1|||
161717244|NCT00971321|584010513|FG001|Up to Month 11-12|Lost to Follow-up|0|||
161717245|NCT01591330|584010516|FG000|Period 1|Adverse Event|1|||
161963122|NCT01436656|584911896|FG004|Dose Escalation|Administrative problems|0|||
161963123|NCT01436656|584911897|FG005|Dose Escalation|Administrative problems|0|||
161963124|NCT01436656|584911898|FG006|Dose Escalation|Administrative problems|0|||
161963125|NCT01436656|584911899|FG007|Dose Escalation|Administrative problems|0|||
161963126|NCT01436656|584911900|FG008|Dose Escalation|Administrative problems|0|||
161963127|NCT01436656|584911901|FG009|Dose Escalation|Administrative problems|0|||
161963128|NCT01436656|584911902|FG010|Dose Escalation|Administrative problems|0|||
161963129|NCT01436656|584911903|FG011|Dose Escalation|Administrative problems|0|||
161963130|NCT01436656|584911904|FG012|Dose Escalation|Administrative problems|0|||
161963131|NCT01436656|584911905|FG013|Dose Escalation|Administrative problems|0|||
161963132|NCT01436656|584911906|FG014|Dose Escalation|Administrative problems|0|||
161963133|NCT01436656|584911907|FG015|Dose Escalation|Administrative problems|0|||
161963134|NCT01436656|584911908|FG016|Dose Escalation|Administrative problems|0|||
161963135|NCT01436656|584911909|FG017|Dose Escalation|Administrative problems|0|||
161963136|NCT01436656|584911892|FG000|Dose Escalation|Lost to Follow-up|1|||
161963137|NCT01436656|584911893|FG001|Dose Escalation|Lost to Follow-up|0|||
161963138|NCT01436656|584911894|FG002|Dose Escalation|Lost to Follow-up|0|||
161963139|NCT01436656|584911895|FG003|Dose Escalation|Lost to Follow-up|0|||
161963140|NCT01436656|584911896|FG004|Dose Escalation|Lost to Follow-up|1|||
161717246|NCT01591330|584010517|FG001|Period 1|Adverse Event|0|||
161717247|NCT01591330|584010518|FG002|Period 1|Adverse Event|0|||
161717248|NCT01591330|584010519|FG003|Period 1|Adverse Event|0|||
161717249|NCT01591330|584010516|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
161717250|NCT01591330|584010517|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
161717251|NCT01591330|584010518|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
161717252|NCT01591330|584010519|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
161717253|NCT01591330|584010516|FG000|Period 2|Adverse Event|1|||
161717254|NCT01591330|584010517|FG001|Period 2|Adverse Event|0|||
161717255|NCT01591330|584010518|FG002|Period 2|Adverse Event|0|||
161717256|NCT01591330|584010519|FG003|Period 2|Adverse Event|0|||
161717257|NCT02782715|584010520|FG000|Overall Study|Withdrawal by Subject|1|||
161717258|NCT01662999|584010531|FG000|Period 3|Withdrawal by Subject|0|||
161717259|NCT01662999|584010532|FG001|Period 3|Withdrawal by Subject|1|||
161717260|NCT01662999|584010533|FG002|Period 3|Withdrawal by Subject|0|||
161717261|NCT01662999|584010534|FG003|Period 3|Withdrawal by Subject|0|||
161717262|NCT01662999|584010535|FG004|Period 3|Withdrawal by Subject|0|||
161717263|NCT01662999|584010536|FG005|Period 3|Withdrawal by Subject|0|||
161717264|NCT00196937|584010537|FG000|Overall Study|Serious Adverse Event|1|||
161717265|NCT00196937|584010538|FG001|Overall Study|Serious Adverse Event|0|||
161717266|NCT00196937|584010539|FG002|Overall Study|Serious Adverse Event|0|||
161717267|NCT00196937|584010537|FG000|Overall Study|Non-serious adverse event|1|||
161717268|NCT00196937|584010538|FG001|Overall Study|Non-serious adverse event|1|||
161717269|NCT00196937|584010539|FG002|Overall Study|Non-serious adverse event|1|||
161717270|NCT00196937|584010537|FG000|Overall Study|Withdrawal by Subject|0|||
161717271|NCT00196937|584010538|FG001|Overall Study|Withdrawal by Subject|0|||
161717272|NCT00196937|584010539|FG002|Overall Study|Withdrawal by Subject|2|||
161717273|NCT00196937|584010537|FG000|Overall Study|Lost to Follow-up|4|||
161717274|NCT00196937|584010538|FG001|Overall Study|Lost to Follow-up|3|||
161717275|NCT00196937|584010539|FG002|Overall Study|Lost to Follow-up|3|||
161717276|NCT00196937|584010537|FG000|Overall Study|Other|3|||
161717277|NCT00196937|584010538|FG001|Overall Study|Other|1|||
161963141|NCT01436656|584911897|FG005|Dose Escalation|Lost to Follow-up|0|||
161963142|NCT01436656|584911898|FG006|Dose Escalation|Lost to Follow-up|0|||
161963143|NCT01436656|584911899|FG007|Dose Escalation|Lost to Follow-up|0|||
161963144|NCT01436656|584911900|FG008|Dose Escalation|Lost to Follow-up|0|||
161963145|NCT01436656|584911901|FG009|Dose Escalation|Lost to Follow-up|0|||
161717278|NCT00196937|584010539|FG002|Overall Study|Other|1|||
161717279|NCT03368404|584010546|FG000|Overall Study|Adverse Event|2|||
161717280|NCT03368404|584010547|FG001|Overall Study|Adverse Event|1|||
161717281|NCT03368404|584010546|FG000|Overall Study|Withdrawal by Subject|1|||
161717282|NCT03368404|584010547|FG001|Overall Study|Withdrawal by Subject|1|||
161717283|NCT04725682|584010548|FG000|Overall Study|Withdrawal by Subject|7|||
161717284|NCT04725682|584010549|FG001|Overall Study|Withdrawal by Subject|5|||
161717285|NCT04725682|584010548|FG000|Overall Study|Failed to comply with the requirements|2|||
161963146|NCT01436656|584911902|FG010|Dose Escalation|Lost to Follow-up|0|||
161717286|NCT04725682|584010549|FG001|Overall Study|Failed to comply with the requirements|1|||
161963147|NCT01436656|584911903|FG011|Dose Escalation|Lost to Follow-up|0|||
161963148|NCT01436656|584911904|FG012|Dose Escalation|Lost to Follow-up|0|||
161963149|NCT01436656|584911905|FG013|Dose Escalation|Lost to Follow-up|0|||
161717287|NCT04725682|584010548|FG000|Overall Study|Adverse Event|1|||
161717288|NCT04725682|584010549|FG001|Overall Study|Adverse Event|1|||
161717289|NCT04725682|584010548|FG000|Overall Study|Death|0|||
161717290|NCT04725682|584010549|FG001|Overall Study|Death|1|||
161717291|NCT00964795|584010550|FG000|Overall Study|Withdrawal by Subject|79|||
161717292|NCT00964795|584010550|FG000|Overall Study|Adverse Event|12|||
161717293|NCT00964795|584010550|FG000|Overall Study|Death|14|||
161717294|NCT00964795|584010550|FG000|Overall Study|Lost to Follow-up|7|||
161717295|NCT00964795|584010550|FG000|Overall Study|Termination of Study by Sponsor|169|||
161717296|NCT00964795|584010550|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
161717297|NCT00964795|584010550|FG000|Overall Study|Other|23|||
161717298|NCT00586690|584010558|FG000|Overall Study|Death|2|||
161717299|NCT00586690|584010559|FG001|Overall Study|Death|0|||
161717300|NCT00586690|584010558|FG000|Overall Study|Disease Progression|10|||
161717301|NCT00586690|584010559|FG001|Overall Study|Disease Progression|0|||
161717302|NCT00586690|584010558|FG000|Overall Study|Adverse Event|1|||
161717303|NCT00586690|584010559|FG001|Overall Study|Adverse Event|0|||
161717304|NCT00586690|584010558|FG000|Overall Study|Lack of Efficacy|2|||
161717305|NCT00586690|584010559|FG001|Overall Study|Lack of Efficacy|0|||
161717306|NCT00586690|584010558|FG000|Overall Study|Lab can't accommodate|1|||
161717307|NCT00586690|584010559|FG001|Overall Study|Lab can't accommodate|0|||
161717308|NCT02453841|584010560|FG000|Overall Study|Protocol Violation|1|||
161717309|NCT02453841|584010560|FG000|Overall Study|Unable to obtain blood samples|2|||
161717310|NCT01751646|584010561|FG000|Overall Study|Lost to Follow-up|5|||
161717311|NCT01751646|584010562|FG001|Overall Study|Lost to Follow-up|1|||
161717312|NCT01751646|584010561|FG000|Overall Study|Withdrawal by Subject|0|||
161717313|NCT01751646|584010562|FG001|Overall Study|Withdrawal by Subject|4|||
161717314|NCT01751646|584010561|FG000|Overall Study|Starting hormone therapy|1|||
161717315|NCT01751646|584010562|FG001|Overall Study|Starting hormone therapy|0|||
161717316|NCT01751646|584010561|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
161717317|NCT01751646|584010562|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
161717318|NCT01751646|584010561|FG000|Overall Study|Inadvertent enrollment|1|||
161717319|NCT01751646|584010562|FG001|Overall Study|Inadvertent enrollment|1|||
161717320|NCT01751646|584010561|FG000|Overall Study|Moved out of the area|1|||
161717321|NCT01751646|584010562|FG001|Overall Study|Moved out of the area|5|||
161717322|NCT01751646|584010561|FG000|Overall Study|Inability to attend required visits|0|||
161717323|NCT01751646|584010562|FG001|Overall Study|Inability to attend required visits|1|||
161717324|NCT01751646|584010561|FG000|Overall Study|Off study due to multiple obligations|0|||
161717325|NCT01751646|584010562|FG001|Overall Study|Off study due to multiple obligations|1|||
161717326|NCT01751646|584010561|FG000|Overall Study|Fails to comply with study requirements|0|||
161838037|NCT02272634|584450307|FG000|Overall Study|Withdrawal by Subject|0|||
161838038|NCT02272634|584450308|FG001|Overall Study|Withdrawal by Subject|1|||
161838039|NCT02272634|584450309|FG002|Overall Study|Withdrawal by Subject|0|||
161838040|NCT01437943|584450310|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
161838041|NCT01437943|584450311|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
161838042|NCT01437943|584450310|FG000|Overall Study|Subject expressed pregnancy plans|1|||
161838043|NCT01437943|584450311|FG001|Overall Study|Subject expressed pregnancy plans|0|||
161838044|NCT01437943|584450310|FG000|Overall Study|Adverse Event|2|||
161838045|NCT01437943|584450311|FG001|Overall Study|Adverse Event|0|||
161838046|NCT04647721|584450312|FG000|Overall Study|Withdrawal by Subject|0|||
161838047|NCT04647721|584450313|FG001|Overall Study|Withdrawal by Subject|2|||
161838048|NCT04647721|584450312|FG000|Overall Study|Lost to Follow-up|2|||
161838049|NCT04647721|584450313|FG001|Overall Study|Lost to Follow-up|0|||
161838050|NCT00136318|584450316|FG000|Overall Study|Adverse Event|5|||
161963150|NCT01436656|584911906|FG014|Dose Escalation|Lost to Follow-up|0|||
161963151|NCT01436656|584911907|FG015|Dose Escalation|Lost to Follow-up|0|||
161963152|NCT01436656|584911908|FG016|Dose Escalation|Lost to Follow-up|0|||
161963153|NCT01436656|584911909|FG017|Dose Escalation|Lost to Follow-up|0|||
161963154|NCT01436656|584911892|FG000|Dose Escalation|New anti-cancer therapy|1|||
161963155|NCT01436656|584911893|FG001|Dose Escalation|New anti-cancer therapy|0|||
161963156|NCT01436656|584911894|FG002|Dose Escalation|New anti-cancer therapy|0|||
161963157|NCT01436656|584911895|FG003|Dose Escalation|New anti-cancer therapy|0|||
161963158|NCT01436656|584911896|FG004|Dose Escalation|New anti-cancer therapy|0|||
161963159|NCT01436656|584911897|FG005|Dose Escalation|New anti-cancer therapy|0|||
161963160|NCT01436656|584911898|FG006|Dose Escalation|New anti-cancer therapy|0|||
161963161|NCT01436656|584911899|FG007|Dose Escalation|New anti-cancer therapy|0|||
161963162|NCT01436656|584911900|FG008|Dose Escalation|New anti-cancer therapy|1|||
161963163|NCT01436656|584911901|FG009|Dose Escalation|New anti-cancer therapy|1|||
161963164|NCT01436656|584911902|FG010|Dose Escalation|New anti-cancer therapy|0|||
161963165|NCT01436656|584911903|FG011|Dose Escalation|New anti-cancer therapy|0|||
161963166|NCT01436656|584911904|FG012|Dose Escalation|New anti-cancer therapy|0|||
161963167|NCT01436656|584911905|FG013|Dose Escalation|New anti-cancer therapy|0|||
161963168|NCT01436656|584911906|FG014|Dose Escalation|New anti-cancer therapy|0|||
161963169|NCT01436656|584911907|FG015|Dose Escalation|New anti-cancer therapy|0|||
161717327|NCT01751646|584010562|FG001|Overall Study|Fails to comply with study requirements|1|||
161717328|NCT01751646|584010561|FG000|Overall Study|Childcare issues|1|||
161717329|NCT01751646|584010562|FG001|Overall Study|Childcare issues|1|||
161717330|NCT02190591|584010563|FG000|Overall Study|Withdrawal by Subject|1|||
161717331|NCT02190591|584010564|FG001|Overall Study|Withdrawal by Subject|8|||
161717332|NCT02190591|584010563|FG000|Overall Study|Protocol Violation|1|||
161717333|NCT02190591|584010564|FG001|Overall Study|Protocol Violation|0|||
161717334|NCT02190591|584010563|FG000|Overall Study|did not use peanut ball as instructed|0|||
161717335|NCT02190591|584010564|FG001|Overall Study|did not use peanut ball as instructed|2|||
161717336|NCT02190591|584010563|FG000|Overall Study|face presentation so she was ineligible|0|||
161717337|NCT02190591|584010564|FG001|Overall Study|face presentation so she was ineligible|1|||
161717338|NCT01151137|584010567|FG000|Overall Study|Death|15|||
161717339|NCT01151137|584010568|FG001|Overall Study|Death|27|||
161717340|NCT01151137|584010567|FG000|Overall Study|Lost to Follow-up|1|||
161717341|NCT01151137|584010568|FG001|Overall Study|Lost to Follow-up|1|||
161717342|NCT00072189|584010569|FG000|Overall Study|Withdrawal by Subject|1|||
161717343|NCT02973815|584010573|FG000|Post Intervention|Death|1|||
161717344|NCT02973815|584010574|FG001|Post Intervention|Death|0|||
161717345|NCT02973815|584010573|FG000|Post Intervention|Lost to Follow-up|7|||
161717346|NCT02973815|584010574|FG001|Post Intervention|Lost to Follow-up|24|||
161717347|NCT02973815|584010573|FG000|Follow-up|Lost to Follow-up|2|||
161717348|NCT02973815|584010574|FG001|Follow-up|Lost to Follow-up|0|||
161717349|NCT00524303|584010575|FG000|Overall Study|Lost to Follow-up|6|||
161717350|NCT00524303|584010576|FG001|Overall Study|Lost to Follow-up|0|||
161717351|NCT00524303|584010577|FG002|Overall Study|Lost to Follow-up|3|||
161717352|NCT00524303|584010575|FG000|Overall Study|Protocol Violation|0|||
161717353|NCT00524303|584010576|FG001|Overall Study|Protocol Violation|1|||
161717354|NCT00524303|584010577|FG002|Overall Study|Protocol Violation|1|||
161717355|NCT00524303|584010575|FG000|Overall Study|Withdrawal by Subject|3|||
161717356|NCT00524303|584010576|FG001|Overall Study|Withdrawal by Subject|0|||
161717357|NCT00524303|584010577|FG002|Overall Study|Withdrawal by Subject|4|||
161717358|NCT00524303|584010575|FG000|Overall Study|Death|0|||
161717359|NCT00524303|584010576|FG001|Overall Study|Death|2|||
161717360|NCT00524303|584010577|FG002|Overall Study|Death|3|||
161717361|NCT00524303|584010575|FG000|Overall Study|Adverse Event|1|||
161717362|NCT00524303|584010576|FG001|Overall Study|Adverse Event|2|||
161717363|NCT00524303|584010577|FG002|Overall Study|Adverse Event|3|||
161717364|NCT00524303|584010575|FG000|Overall Study|Did not Complete Study Dosing|1|||
161717365|NCT00524303|584010576|FG001|Overall Study|Did not Complete Study Dosing|0|||
161717366|NCT00524303|584010577|FG002|Overall Study|Did not Complete Study Dosing|0|||
161717367|NCT00524303|584010575|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
161717368|NCT00524303|584010576|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
161717369|NCT00524303|584010577|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
161717370|NCT00524303|584010575|FG000|Overall Study|Disease Progression|0|||
161717371|NCT00524303|584010576|FG001|Overall Study|Disease Progression|4|||
161717372|NCT00524303|584010577|FG002|Overall Study|Disease Progression|1|||
161717373|NCT00524303|584010575|FG000|Overall Study|Disease Recurrence|0|||
161717374|NCT00524303|584010576|FG001|Overall Study|Disease Recurrence|1|||
161717375|NCT00524303|584010577|FG002|Overall Study|Disease Recurrence|0|||
161717376|NCT00524303|584010575|FG000|Overall Study|Sponsor Request|0|||
161717377|NCT00524303|584010576|FG001|Overall Study|Sponsor Request|0|||
162032105|NCT01589770|585174197|FG001|Overall Study|EGFR <60ml/min|4|||
162032106|NCT01589770|585174196|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
161717378|NCT00524303|584010577|FG002|Overall Study|Sponsor Request|1|||
161717379|NCT00524303|584010575|FG000|Overall Study|Physician Decision|0|||
161717380|NCT00524303|584010576|FG001|Overall Study|Physician Decision|0|||
161717381|NCT00524303|584010577|FG002|Overall Study|Physician Decision|1|||
161717382|NCT00524303|584010575|FG000|Overall Study|Completed 5 years|0|||
162032107|NCT01589770|585174197|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
161717383|NCT00524303|584010576|FG001|Overall Study|Completed 5 years|0|||
161717384|NCT00524303|584010577|FG002|Overall Study|Completed 5 years|1|||
161717385|NCT03478683|584010578|FG000|Overall Study|Adverse Event|5|||
161717386|NCT03478683|584010579|FG001|Overall Study|Adverse Event|3|||
161717387|NCT03478683|584010578|FG000|Overall Study|Lost to Follow-up|0|||
161717388|NCT03478683|584010579|FG001|Overall Study|Lost to Follow-up|5|||
161717389|NCT03478683|584010578|FG000|Overall Study|Physician Decision|1|||
161717390|NCT03478683|584010579|FG001|Overall Study|Physician Decision|3|||
161717391|NCT03478683|584010578|FG000|Overall Study|Withdrawal by Subject|7|||
161717392|NCT03478683|584010579|FG001|Overall Study|Withdrawal by Subject|7|||
161717393|NCT00970294|584010589|FG000|Overall Study|Physician Decision|4|||
161717394|NCT00970294|584010589|FG000|Overall Study|Withdrawal by Subject|1|||
161717395|NCT01607892|584010594|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
161717396|NCT01607892|584010595|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
161717397|NCT01607892|584010596|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
161717398|NCT01607892|584010597|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
161717399|NCT01607892|584010598|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
161717400|NCT01607892|584010594|FG000|Overall Study|Death|4|||
161717401|NCT01607892|584010595|FG001|Overall Study|Death|2|||
161717402|NCT01607892|584010596|FG002|Overall Study|Death|8|||
161717403|NCT01607892|584010597|FG003|Overall Study|Death|10|||
161717404|NCT01607892|584010598|FG004|Overall Study|Death|3|||
161717405|NCT01607892|584010594|FG000|Overall Study|Investigator discretion|2|||
161717406|NCT01607892|584010595|FG001|Overall Study|Investigator discretion|4|||
161717407|NCT01607892|584010596|FG002|Overall Study|Investigator discretion|4|||
161717408|NCT01607892|584010597|FG003|Overall Study|Investigator discretion|8|||
161717409|NCT01607892|584010598|FG004|Overall Study|Investigator discretion|0|||
161717410|NCT01607892|584010594|FG000|Overall Study|Other treatments became available|1|||
161717411|NCT01607892|584010595|FG001|Overall Study|Other treatments became available|1|||
161717412|NCT01607892|584010596|FG002|Overall Study|Other treatments became available|0|||
161717413|NCT01607892|584010597|FG003|Overall Study|Other treatments became available|0|||
161717414|NCT01607892|584010598|FG004|Overall Study|Other treatments became available|2|||
161717415|NCT01607892|584010594|FG000|Overall Study|Intercurrent illness|1|||
161717416|NCT01607892|584010595|FG001|Overall Study|Intercurrent illness|0|||
161717417|NCT01607892|584010596|FG002|Overall Study|Intercurrent illness|0|||
161717418|NCT01607892|584010597|FG003|Overall Study|Intercurrent illness|3|||
161717419|NCT01607892|584010598|FG004|Overall Study|Intercurrent illness|0|||
161717420|NCT01607892|584010594|FG000|Overall Study|Non-Compliance with study procedures|0|||
161717421|NCT01607892|584010595|FG001|Overall Study|Non-Compliance with study procedures|0|||
161717422|NCT01607892|584010596|FG002|Overall Study|Non-Compliance with study procedures|1|||
161717423|NCT01607892|584010597|FG003|Overall Study|Non-Compliance with study procedures|0|||
161717424|NCT01607892|584010598|FG004|Overall Study|Non-Compliance with study procedures|0|||
161717425|NCT01607892|584010594|FG000|Overall Study|Consent withdrawn by participant|9|||
161717426|NCT01607892|584010595|FG001|Overall Study|Consent withdrawn by participant|4|||
161717427|NCT01607892|584010596|FG002|Overall Study|Consent withdrawn by participant|24|||
161717428|NCT01607892|584010597|FG003|Overall Study|Consent withdrawn by participant|14|||
161717429|NCT01607892|584010598|FG004|Overall Study|Consent withdrawn by participant|4|||
161717430|NCT01607892|584010594|FG000|Overall Study|Disease progression|38|||
161717431|NCT01607892|584010595|FG001|Overall Study|Disease progression|13|||
161717432|NCT01607892|584010596|FG002|Overall Study|Disease progression|37|||
161717433|NCT01607892|584010597|FG003|Overall Study|Disease progression|57|||
161717434|NCT01607892|584010598|FG004|Overall Study|Disease progression|9|||
161717435|NCT01607892|584010594|FG000|Overall Study|Incidence or severity of Adverse events|3|||
161717436|NCT01607892|584010595|FG001|Overall Study|Incidence or severity of Adverse events|3|||
161717437|NCT01607892|584010596|FG002|Overall Study|Incidence or severity of Adverse events|7|||
161717438|NCT01607892|584010597|FG003|Overall Study|Incidence or severity of Adverse events|2|||
161717439|NCT01607892|584010598|FG004|Overall Study|Incidence or severity of Adverse events|6|||
161717440|NCT02273973|584010601|FG000|Overall Study|Adverse Event|4|||
161717441|NCT02273973|584010602|FG001|Overall Study|Adverse Event|0|||
161717442|NCT02273973|584010601|FG000|Overall Study|Withdrawal by Subject|2|||
161717443|NCT02273973|584010602|FG001|Overall Study|Withdrawal by Subject|3|||
161717444|NCT02273973|584010601|FG000|Overall Study|Death|1|||
161717445|NCT02273973|584010602|FG001|Overall Study|Death|0|||
161717446|NCT02273973|584010601|FG000|Overall Study|Non-compliance|1|||
161717447|NCT02273973|584010602|FG001|Overall Study|Non-compliance|0|||
161717448|NCT02273973|584010601|FG000|Overall Study|Protocol Violation|1|||
161717449|NCT02273973|584010602|FG001|Overall Study|Protocol Violation|0|||
161717450|NCT02273973|584010601|FG000|Overall Study|Progression of disease|0|||
161717451|NCT02273973|584010602|FG001|Overall Study|Progression of disease|2|||
161717452|NCT02273973|584010601|FG000|Overall Study|Lost to Follow-up|0|||
161717453|NCT02273973|584010602|FG001|Overall Study|Lost to Follow-up|1|||
161717454|NCT02273973|584010601|FG000|Overall Study|Physician Decision|0|||
161717455|NCT02273973|584010602|FG001|Overall Study|Physician Decision|1|||
161717456|NCT02273973|584010601|FG000|Overall Study|Reason not specified|0|||
161717457|NCT02273973|584010602|FG001|Overall Study|Reason not specified|1|||
161717458|NCT03022422|584010603|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
161717459|NCT03022422|584010604|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
161717460|NCT03022422|584010605|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
161717461|NCT03022422|584010606|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
161717462|NCT03022422|584010607|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
161717463|NCT03022422|584010608|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
161717464|NCT02104180|584010609|FG000|Overall Study|Protocol Violation|1|||
161717465|NCT02104180|584010610|FG001|Overall Study|Protocol Violation|0|||
161717466|NCT01676116|584010611|FG000|Overall Study|Withdrawal criteria|2|||
161717467|NCT01676116|584010612|FG001|Overall Study|Withdrawal criteria|14|||
161717468|NCT01676116|584010611|FG000|Overall Study|Adverse Event|1|||
161717469|NCT01676116|584010612|FG001|Overall Study|Adverse Event|2|||
161717470|NCT01676116|584010611|FG000|Overall Study|Unclassified|4|||
161717471|NCT01676116|584010612|FG001|Overall Study|Unclassified|10|||
161717472|NCT01676116|584010611|FG000|Overall Study|Protocol Violation|9|||
161717473|NCT01676116|584010612|FG001|Overall Study|Protocol Violation|3|||
161717474|NCT00793585|584010613|FG000|Overall Study|Adverse Event|1|||
161717475|NCT00793585|584010614|FG001|Overall Study|Adverse Event|1|||
161717476|NCT00793585|584010613|FG000|Overall Study|Protocol Violation|1|||
161717477|NCT00793585|584010614|FG001|Overall Study|Protocol Violation|2|||
161717478|NCT01821677|584010615|FG000|Overall Study|Adverse Event|4|||
161717479|NCT01821677|584010616|FG001|Overall Study|Adverse Event|6|||
161717480|NCT01821677|584010617|FG002|Overall Study|Adverse Event|5|||
161717481|NCT01821677|584010615|FG000|Overall Study|Physician Decision|1|||
161717482|NCT01821677|584010616|FG001|Overall Study|Physician Decision|4|||
161717483|NCT01821677|584010617|FG002|Overall Study|Physician Decision|1|||
161717484|NCT01821677|584010615|FG000|Overall Study|Non-compliance|0|||
161717485|NCT01821677|584010616|FG001|Overall Study|Non-compliance|1|||
161717486|NCT01821677|584010617|FG002|Overall Study|Non-compliance|2|||
161717487|NCT01821677|584010615|FG000|Overall Study|Lost to Follow-up|2|||
161717488|NCT01821677|584010616|FG001|Overall Study|Lost to Follow-up|1|||
161717489|NCT01821677|584010617|FG002|Overall Study|Lost to Follow-up|3|||
161717490|NCT01821677|584010615|FG000|Overall Study|Protocol Violation|0|||
161717491|NCT01821677|584010616|FG001|Overall Study|Protocol Violation|0|||
161717492|NCT01821677|584010617|FG002|Overall Study|Protocol Violation|2|||
161717493|NCT01821677|584010615|FG000|Overall Study|Withdrawal by Subject|7|||
161717494|NCT01821677|584010616|FG001|Overall Study|Withdrawal by Subject|3|||
161717495|NCT01821677|584010617|FG002|Overall Study|Withdrawal by Subject|2|||
161717496|NCT01821677|584010615|FG000|Overall Study|Other|9|||
161717497|NCT01821677|584010616|FG001|Overall Study|Other|0|||
161717498|NCT01821677|584010617|FG002|Overall Study|Other|0|||
161717499|NCT01769404|584010618|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
161717500|NCT01769404|584010619|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
161717501|NCT01769404|584010618|FG000|Treatment Period 1|Withdrawal by Subject|3|||
161717502|NCT01769404|584010619|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161717503|NCT01769404|584010618|FG000|Treatment Period 1|Sponsor decision|1|||
161717504|NCT01769404|584010619|FG001|Treatment Period 1|Sponsor decision|0|||
161717505|NCT01769404|584010618|FG000|Treatment Period 2|Sponsor decision|7|||
161717506|NCT01769404|584010619|FG001|Treatment Period 2|Sponsor decision|0|||
161717507|NCT00538733|584010620|FG000|Overall Study|Adverse Event|8|||
161717508|NCT00538733|584010620|FG000|Overall Study|Death|1|||
161717509|NCT00538733|584010620|FG000|Overall Study|declined to participate|2|||
161717510|NCT00538733|584010620|FG000|Overall Study|still on therapy|1|||
161717511|NCT04513158|584010629|FG000|Overall Study|Screen Failure|1|||
161717512|NCT05278104|584010630|FG000|Overall Study|Not treated|1|||
161717513|NCT05278104|584010631|FG001|Overall Study|Not treated|0|||
161717514|NCT05278104|584010630|FG000|Overall Study|Adverse Event|2|||
161717515|NCT05278104|584010631|FG001|Overall Study|Adverse Event|1|||
161717516|NCT05278104|584010630|FG000|Overall Study|Exclusion criteria not met|1|||
161717517|NCT05278104|584010631|FG001|Overall Study|Exclusion criteria not met|0|||
161717518|NCT02786537|584012577|FG000|As Randomized|Adverse Event|0|||
161717519|NCT02786537|584012578|FG001|As Randomized|Adverse Event|11|||
161717520|NCT02786537|584012579|FG002|As Randomized|Adverse Event|0|||
161717521|NCT02786537|584012580|FG003|As Randomized|Adverse Event|4|||
161717522|NCT02786537|584012581|FG004|As Randomized|Adverse Event|6|||
161717523|NCT02786537|584012582|FG005|As Randomized|Adverse Event|2|||
161717524|NCT02786537|584012577|FG000|As Randomized|Lack of Efficacy|0|||
161717525|NCT02786537|584012578|FG001|As Randomized|Lack of Efficacy|0|||
161717526|NCT02786537|584012579|FG002|As Randomized|Lack of Efficacy|0|||
161717527|NCT02786537|584012580|FG003|As Randomized|Lack of Efficacy|1|||
161717528|NCT02786537|584012581|FG004|As Randomized|Lack of Efficacy|0|||
161717529|NCT02786537|584012582|FG005|As Randomized|Lack of Efficacy|0|||
161717530|NCT02786537|584012577|FG000|As Randomized|Withdrawal by Subject|1|||
161717531|NCT02786537|584012578|FG001|As Randomized|Withdrawal by Subject|2|||
161717532|NCT02786537|584012579|FG002|As Randomized|Withdrawal by Subject|0|||
161717533|NCT02786537|584012580|FG003|As Randomized|Withdrawal by Subject|1|||
161717534|NCT02786537|584012581|FG004|As Randomized|Withdrawal by Subject|1|||
161717535|NCT02786537|584012582|FG005|As Randomized|Withdrawal by Subject|0|||
161717536|NCT02786537|584012577|FG000|As Randomized|Death|0|||
161717537|NCT02786537|584012578|FG001|As Randomized|Death|2|||
161717538|NCT02786537|584012579|FG002|As Randomized|Death|0|||
161717539|NCT02786537|584012580|FG003|As Randomized|Death|3|||
161717540|NCT02786537|584012581|FG004|As Randomized|Death|1|||
161717541|NCT02786537|584012582|FG005|As Randomized|Death|0|||
161717542|NCT02786537|584012577|FG000|As Randomized|Non-compliance with study drug|1|||
161717543|NCT02786537|584012578|FG001|As Randomized|Non-compliance with study drug|11|||
161717544|NCT02786537|584012579|FG002|As Randomized|Non-compliance with study drug|0|||
161717545|NCT02786537|584012580|FG003|As Randomized|Non-compliance with study drug|1|||
161717546|NCT02786537|584012581|FG004|As Randomized|Non-compliance with study drug|0|||
161717547|NCT02786537|584012582|FG005|As Randomized|Non-compliance with study drug|1|||
161717548|NCT02786537|584012577|FG000|As Randomized|Lost to treatment follow-up|4|||
161717549|NCT02786537|584012578|FG001|As Randomized|Lost to treatment follow-up|32|||
161717550|NCT02786537|584012579|FG002|As Randomized|Lost to treatment follow-up|0|||
161717551|NCT02786537|584012580|FG003|As Randomized|Lost to treatment follow-up|24|||
161717552|NCT02786537|584012581|FG004|As Randomized|Lost to treatment follow-up|4|||
161963170|NCT01436656|584911908|FG016|Dose Escalation|New anti-cancer therapy|0|||
161963171|NCT01436656|584911909|FG017|Dose Escalation|New anti-cancer therapy|0|||
161963172|NCT01436656|584911892|FG000|Dose Expansion|Adverse Event|0|||
161963173|NCT01436656|584911893|FG001|Dose Expansion|Adverse Event|0|||
161963174|NCT01436656|584911894|FG002|Dose Expansion|Adverse Event|0|||
161963175|NCT01436656|584911895|FG003|Dose Expansion|Adverse Event|0|||
161963176|NCT01436656|584911896|FG004|Dose Expansion|Adverse Event|0|||
161963177|NCT01436656|584911897|FG005|Dose Expansion|Adverse Event|0|||
161963178|NCT01436656|584911898|FG006|Dose Expansion|Adverse Event|0|||
161963179|NCT01436656|584911899|FG007|Dose Expansion|Adverse Event|0|||
161963180|NCT01436656|584911900|FG008|Dose Expansion|Adverse Event|0|||
161963181|NCT01436656|584911901|FG009|Dose Expansion|Adverse Event|0|||
161963182|NCT01436656|584911902|FG010|Dose Expansion|Adverse Event|0|||
161963183|NCT01436656|584911903|FG011|Dose Expansion|Adverse Event|1|||
161963184|NCT01436656|584911904|FG012|Dose Expansion|Adverse Event|0|||
161963185|NCT01436656|584911905|FG013|Dose Expansion|Adverse Event|0|||
161963186|NCT01436656|584911906|FG014|Dose Expansion|Adverse Event|0|||
161963187|NCT01436656|584911907|FG015|Dose Expansion|Adverse Event|0|||
161963188|NCT01436656|584911908|FG016|Dose Expansion|Adverse Event|0|||
161963189|NCT01436656|584911909|FG017|Dose Expansion|Adverse Event|0|||
161963190|NCT01436656|584911892|FG000|Dose Expansion|Withdrawal by Subject|0|||
161963191|NCT01436656|584911893|FG001|Dose Expansion|Withdrawal by Subject|0|||
161963192|NCT01436656|584911894|FG002|Dose Expansion|Withdrawal by Subject|0|||
161963193|NCT01436656|584911895|FG003|Dose Expansion|Withdrawal by Subject|0|||
161963194|NCT01436656|584911896|FG004|Dose Expansion|Withdrawal by Subject|0|||
161963195|NCT01436656|584911897|FG005|Dose Expansion|Withdrawal by Subject|0|||
161963196|NCT01436656|584911898|FG006|Dose Expansion|Withdrawal by Subject|0|||
161963197|NCT01436656|584911899|FG007|Dose Expansion|Withdrawal by Subject|0|||
161963198|NCT01436656|584911900|FG008|Dose Expansion|Withdrawal by Subject|0|||
161963199|NCT01436656|584911901|FG009|Dose Expansion|Withdrawal by Subject|0|||
161963200|NCT01436656|584911902|FG010|Dose Expansion|Withdrawal by Subject|0|||
161963201|NCT01436656|584911903|FG011|Dose Expansion|Withdrawal by Subject|1|||
161963202|NCT01436656|584911904|FG012|Dose Expansion|Withdrawal by Subject|3|||
161963203|NCT01436656|584911905|FG013|Dose Expansion|Withdrawal by Subject|1|||
161963204|NCT01436656|584911906|FG014|Dose Expansion|Withdrawal by Subject|2|||
161963205|NCT01436656|584911907|FG015|Dose Expansion|Withdrawal by Subject|0|||
161963206|NCT01436656|584911908|FG016|Dose Expansion|Withdrawal by Subject|1|||
161963207|NCT01436656|584911909|FG017|Dose Expansion|Withdrawal by Subject|1|||
161963208|NCT01436656|584911892|FG000|Dose Expansion|Death|0|||
161963209|NCT01436656|584911893|FG001|Dose Expansion|Death|0|||
161963210|NCT01436656|584911894|FG002|Dose Expansion|Death|0|||
161963211|NCT01436656|584911895|FG003|Dose Expansion|Death|0|||
161963212|NCT01436656|584911896|FG004|Dose Expansion|Death|0|||
161963213|NCT01436656|584911897|FG005|Dose Expansion|Death|0|||
161963214|NCT01436656|584911898|FG006|Dose Expansion|Death|0|||
161963215|NCT01436656|584911899|FG007|Dose Expansion|Death|0|||
161963216|NCT01436656|584911900|FG008|Dose Expansion|Death|0|||
161963217|NCT01436656|584911901|FG009|Dose Expansion|Death|0|||
161963218|NCT01436656|584911902|FG010|Dose Expansion|Death|0|||
161963219|NCT01436656|584911903|FG011|Dose Expansion|Death|0|||
162032108|NCT01077375|585174203|FG000|Overall Study|Adverse Event|2|||
162032109|NCT01077375|585174204|FG001|Overall Study|Adverse Event|15|||
162032110|NCT01077375|585174203|FG000|Overall Study|Lack of Efficacy|6|||
161717553|NCT02786537|584012582|FG005|As Randomized|Lost to treatment follow-up|4|||
161963220|NCT01436656|584911904|FG012|Dose Expansion|Death|1|||
162032111|NCT01077375|585174204|FG001|Overall Study|Lack of Efficacy|8|||
161717554|NCT02786537|584012577|FG000|As Randomized|Incarceration|0|||
161717555|NCT02786537|584012578|FG001|As Randomized|Incarceration|1|||
161963221|NCT01436656|584911905|FG013|Dose Expansion|Death|0|||
161963222|NCT01436656|584911906|FG014|Dose Expansion|Death|3|||
161963223|NCT01436656|584911907|FG015|Dose Expansion|Death|0|||
161963224|NCT01436656|584911908|FG016|Dose Expansion|Death|3|||
161963225|NCT01436656|584911909|FG017|Dose Expansion|Death|3|||
161963226|NCT01436656|584911892|FG000|Dose Expansion|Lost to Follow-up|0|||
161963227|NCT01436656|584911893|FG001|Dose Expansion|Lost to Follow-up|0|||
161963228|NCT01436656|584911894|FG002|Dose Expansion|Lost to Follow-up|0|||
161963229|NCT01436656|584911895|FG003|Dose Expansion|Lost to Follow-up|0|||
161963230|NCT01436656|584911896|FG004|Dose Expansion|Lost to Follow-up|0|||
161717556|NCT02786537|584012579|FG002|As Randomized|Incarceration|0|||
161963231|NCT01436656|584911897|FG005|Dose Expansion|Lost to Follow-up|0|||
161963232|NCT01436656|584911898|FG006|Dose Expansion|Lost to Follow-up|0|||
161963233|NCT01436656|584911899|FG007|Dose Expansion|Lost to Follow-up|0|||
161963234|NCT01436656|584911900|FG008|Dose Expansion|Lost to Follow-up|0|||
161963235|NCT01436656|584911901|FG009|Dose Expansion|Lost to Follow-up|0|||
161963236|NCT01436656|584911902|FG010|Dose Expansion|Lost to Follow-up|0|||
161963237|NCT01436656|584911903|FG011|Dose Expansion|Lost to Follow-up|0|||
161963238|NCT01436656|584911904|FG012|Dose Expansion|Lost to Follow-up|0|||
161963239|NCT01436656|584911905|FG013|Dose Expansion|Lost to Follow-up|0|||
161963240|NCT01436656|584911906|FG014|Dose Expansion|Lost to Follow-up|0|||
161963241|NCT01436656|584911907|FG015|Dose Expansion|Lost to Follow-up|0|||
161963242|NCT01436656|584911908|FG016|Dose Expansion|Lost to Follow-up|0|||
161963243|NCT01436656|584911909|FG017|Dose Expansion|Lost to Follow-up|3|||
161963244|NCT01436656|584911892|FG000|Dose Expansion|Disease progression|0|||
161963245|NCT01436656|584911893|FG001|Dose Expansion|Disease progression|0|||
161963246|NCT01436656|584911894|FG002|Dose Expansion|Disease progression|0|||
161963247|NCT01436656|584911895|FG003|Dose Expansion|Disease progression|0|||
161963248|NCT01436656|584911896|FG004|Dose Expansion|Disease progression|0|||
161963249|NCT01436656|584911897|FG005|Dose Expansion|Disease progression|0|||
161963250|NCT01436656|584911898|FG006|Dose Expansion|Disease progression|0|||
161963251|NCT01436656|584911899|FG007|Dose Expansion|Disease progression|0|||
161963252|NCT01436656|584911900|FG008|Dose Expansion|Disease progression|0|||
161963253|NCT01436656|584911901|FG009|Dose Expansion|Disease progression|0|||
161963254|NCT01436656|584911902|FG010|Dose Expansion|Disease progression|0|||
161963255|NCT01436656|584911903|FG011|Dose Expansion|Disease progression|3|||
161963256|NCT01436656|584911904|FG012|Dose Expansion|Disease progression|1|||
161963257|NCT01436656|584911905|FG013|Dose Expansion|Disease progression|0|||
161963258|NCT01436656|584911906|FG014|Dose Expansion|Disease progression|1|||
161963259|NCT01436656|584911907|FG015|Dose Expansion|Disease progression|0|||
161963260|NCT01436656|584911908|FG016|Dose Expansion|Disease progression|0|||
161963261|NCT01436656|584911909|FG017|Dose Expansion|Disease progression|1|||
161963262|NCT01436656|584911892|FG000|Dose Expansion|New cancer therapy|0|||
161963263|NCT01436656|584911893|FG001|Dose Expansion|New cancer therapy|0|||
161963264|NCT01436656|584911894|FG002|Dose Expansion|New cancer therapy|0|||
161963265|NCT01436656|584911895|FG003|Dose Expansion|New cancer therapy|0|||
161963266|NCT01436656|584911896|FG004|Dose Expansion|New cancer therapy|0|||
161963267|NCT01436656|584911897|FG005|Dose Expansion|New cancer therapy|0|||
161963268|NCT01436656|584911898|FG006|Dose Expansion|New cancer therapy|0|||
161963269|NCT01436656|584911899|FG007|Dose Expansion|New cancer therapy|0|||
161963270|NCT01436656|584911900|FG008|Dose Expansion|New cancer therapy|0|||
161963271|NCT01436656|584911901|FG009|Dose Expansion|New cancer therapy|0|||
161963272|NCT01436656|584911902|FG010|Dose Expansion|New cancer therapy|0|||
161963273|NCT01436656|584911903|FG011|Dose Expansion|New cancer therapy|1|||
161963274|NCT01436656|584911904|FG012|Dose Expansion|New cancer therapy|1|||
161963275|NCT01436656|584911905|FG013|Dose Expansion|New cancer therapy|0|||
161963276|NCT01436656|584911906|FG014|Dose Expansion|New cancer therapy|2|||
161963277|NCT01436656|584911907|FG015|Dose Expansion|New cancer therapy|0|||
161963278|NCT01436656|584911908|FG016|Dose Expansion|New cancer therapy|0|||
161963279|NCT01436656|584911909|FG017|Dose Expansion|New cancer therapy|0|||
162032112|NCT01077375|585174203|FG000|Overall Study|Withdrawal by Subject|0|||
162032113|NCT01077375|585174204|FG001|Overall Study|Withdrawal by Subject|6|||
162032114|NCT01077375|585174203|FG000|Overall Study|Lost to Follow-up|2|||
162032115|NCT01077375|585174204|FG001|Overall Study|Lost to Follow-up|5|||
162032116|NCT01077375|585174203|FG000|Overall Study|Other Reason|0|||
162032117|NCT01077375|585174204|FG001|Overall Study|Other Reason|1|||
162032118|NCT03021564|585174208|FG000|Overall Study|Death|84|||
162032119|NCT03021564|585174209|FG001|Overall Study|Death|466|||
161963280|NCT01696994|584911910|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
161963281|NCT01696994|584911911|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
161963282|NCT01696994|584911910|FG000|Overall Study|Died Before Randomization|1|||
161963283|NCT01696994|584911911|FG001|Overall Study|Died Before Randomization|2|||
162032120|NCT03021564|585174208|FG000|Overall Study|Lost to Follow-up|0|||
161963284|NCT01696994|584911910|FG000|Overall Study|Died Before ASU (Control)|73|||
162032121|NCT03021564|585174209|FG001|Overall Study|Lost to Follow-up|2|||
161963285|NCT01696994|584911911|FG001|Overall Study|Died Before ASU (Control)|0|||
161963286|NCT01696994|584911910|FG000|Overall Study|No Ovaries at Baseline|4807|||
161963287|NCT01696994|584911911|FG001|Overall Study|No Ovaries at Baseline|4851|||
161963288|NCT01696994|584911910|FG000|Overall Study|Refused ASU (Control)|311|||
161963289|NCT01696994|584911911|FG001|Overall Study|Refused ASU (Control)|0|||
161963290|NCT01696994|584911910|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
162032122|NCT00969280|585174210|FG000|Overall Study|Protocol Violation|2|||
162032123|NCT00969280|585174211|FG001|Overall Study|Protocol Violation|1|||
161717557|NCT02786537|584012580|FG003|As Randomized|Incarceration|0|||
161963291|NCT01696994|584911911|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
161963292|NCT04644276|584911912|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
161963293|NCT04644276|584911913|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
162032124|NCT00969280|585174210|FG000|Overall Study|Withdrawal by Subject|0|||
161717558|NCT02786537|584012581|FG004|As Randomized|Incarceration|0|||
161717559|NCT02786537|584012582|FG005|As Randomized|Incarceration|0|||
161717560|NCT02786537|584012577|FG000|As Randomized|Opiate Dependency Relapse|0|||
161717561|NCT02786537|584012578|FG001|As Randomized|Opiate Dependency Relapse|1|||
161717562|NCT02786537|584012579|FG002|As Randomized|Opiate Dependency Relapse|0|||
161717563|NCT02786537|584012580|FG003|As Randomized|Opiate Dependency Relapse|0|||
161717564|NCT02786537|584012581|FG004|As Randomized|Opiate Dependency Relapse|0|||
161717565|NCT02786537|584012582|FG005|As Randomized|Opiate Dependency Relapse|0|||
161717566|NCT02786537|584012577|FG000|As Randomized|HCV drugs stolen from pt|0|||
161717567|NCT02786537|584012578|FG001|As Randomized|HCV drugs stolen from pt|1|||
161717568|NCT02786537|584012579|FG002|As Randomized|HCV drugs stolen from pt|0|||
161717569|NCT02786537|584012580|FG003|As Randomized|HCV drugs stolen from pt|0|||
161717570|NCT02786537|584012581|FG004|As Randomized|HCV drugs stolen from pt|0|||
161717571|NCT02786537|584012582|FG005|As Randomized|HCV drugs stolen from pt|0|||
161717572|NCT02786537|584012577|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
161717573|NCT02786537|584012578|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
161717574|NCT02786537|584012579|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
161717575|NCT02786537|584012580|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
161717576|NCT02786537|584012581|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
161717577|NCT02786537|584012582|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
161717578|NCT02786537|584012577|FG000|As Randomized|Subject lost insurance|0|||
161717579|NCT02786537|584012578|FG001|As Randomized|Subject lost insurance|0|||
161717580|NCT02786537|584012579|FG002|As Randomized|Subject lost insurance|0|||
161717581|NCT02786537|584012580|FG003|As Randomized|Subject lost insurance|1|||
161717582|NCT02786537|584012581|FG004|As Randomized|Subject lost insurance|0|||
161717583|NCT02786537|584012582|FG005|As Randomized|Subject lost insurance|0|||
161717584|NCT02786537|584012577|FG000|As Treated|Adverse Event|0|||
161717585|NCT02786537|584012578|FG001|As Treated|Adverse Event|11|||
161717586|NCT02786537|584012579|FG002|As Treated|Adverse Event|0|||
161717587|NCT02786537|584012580|FG003|As Treated|Adverse Event|4|||
161717588|NCT02786537|584012581|FG004|As Treated|Adverse Event|6|||
161717589|NCT02786537|584012582|FG005|As Treated|Adverse Event|2|||
161717590|NCT02786537|584012577|FG000|As Treated|Death|0|||
161717591|NCT02786537|584012578|FG001|As Treated|Death|2|||
161717592|NCT02786537|584012579|FG002|As Treated|Death|0|||
161717593|NCT02786537|584012580|FG003|As Treated|Death|3|||
161717594|NCT02786537|584012581|FG004|As Treated|Death|1|||
161717595|NCT02786537|584012582|FG005|As Treated|Death|0|||
161717596|NCT02786537|584012577|FG000|As Treated|Lack of Efficacy|0|||
161717597|NCT02786537|584012578|FG001|As Treated|Lack of Efficacy|0|||
161717598|NCT02786537|584012579|FG002|As Treated|Lack of Efficacy|0|||
161717599|NCT02786537|584012580|FG003|As Treated|Lack of Efficacy|1|||
161717600|NCT02786537|584012581|FG004|As Treated|Lack of Efficacy|0|||
161717601|NCT02786537|584012582|FG005|As Treated|Lack of Efficacy|0|||
161717602|NCT02786537|584012577|FG000|As Treated|Lost to Follow-up|4|||
161717603|NCT02786537|584012578|FG001|As Treated|Lost to Follow-up|32|||
161717604|NCT02786537|584012579|FG002|As Treated|Lost to Follow-up|0|||
161717605|NCT02786537|584012580|FG003|As Treated|Lost to Follow-up|25|||
161717606|NCT02786537|584012581|FG004|As Treated|Lost to Follow-up|4|||
161717607|NCT02786537|584012582|FG005|As Treated|Lost to Follow-up|4|||
161717608|NCT02786537|584012577|FG000|As Treated|Non-compliance with study drug|1|||
161717609|NCT02786537|584012578|FG001|As Treated|Non-compliance with study drug|11|||
161717610|NCT02786537|584012579|FG002|As Treated|Non-compliance with study drug|0|||
161717611|NCT02786537|584012580|FG003|As Treated|Non-compliance with study drug|1|||
161717612|NCT02786537|584012581|FG004|As Treated|Non-compliance with study drug|0|||
161717613|NCT02786537|584012582|FG005|As Treated|Non-compliance with study drug|1|||
161717614|NCT02786537|584012577|FG000|As Treated|Lost insurance|0|||
161717615|NCT02786537|584012578|FG001|As Treated|Lost insurance|0|||
161717616|NCT02786537|584012579|FG002|As Treated|Lost insurance|0|||
161717617|NCT02786537|584012580|FG003|As Treated|Lost insurance|1|||
161717618|NCT02786537|584012581|FG004|As Treated|Lost insurance|0|||
161717619|NCT02786537|584012582|FG005|As Treated|Lost insurance|0|||
161717620|NCT02786537|584012577|FG000|As Treated|Withdrawal by Subject|1|||
161717621|NCT02786537|584012578|FG001|As Treated|Withdrawal by Subject|2|||
161717622|NCT02786537|584012579|FG002|As Treated|Withdrawal by Subject|0|||
161963294|NCT04644276|584911914|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
161963295|NCT00705250|584911915|FG000|Overall Study|Withdrawal by Subject|1|||
161963296|NCT00705250|584911915|FG000|Overall Study|Patient died in car accident|1|||
161963297|NCT00316225|584911916|FG000|Overall Study|Adverse Event|2|||
161963298|NCT00316225|584911916|FG000|Overall Study|Physician Decision|3|||
161963299|NCT00316225|584911916|FG000|Overall Study|Progressive Disease|15|||
161963300|NCT00316225|584911916|FG000|Overall Study|Withdrawal by Subject|3|||
161963301|NCT00316225|584911916|FG000|Overall Study|Death|2|||
161963302|NCT01814878|584911917|FG000|Overall Study|Adverse Event|16|||
161963303|NCT01814878|584911918|FG001|Overall Study|Adverse Event|5|||
161963304|NCT01814878|584911917|FG000|Overall Study|Withdrawal by Subject|20|||
161963305|NCT01814878|584911918|FG001|Overall Study|Withdrawal by Subject|16|||
161963306|NCT01814878|584911917|FG000|Overall Study|Protocol Violation|5|||
161963307|NCT01814878|584911918|FG001|Overall Study|Protocol Violation|5|||
161963308|NCT01814878|584911917|FG000|Overall Study|Physician Decision|3|||
161963309|NCT01814878|584911918|FG001|Overall Study|Physician Decision|1|||
161963310|NCT01814878|584911917|FG000|Overall Study|Screening failure (drop-out)|0|||
161963311|NCT01814878|584911918|FG001|Overall Study|Screening failure (drop-out)|3|||
161963312|NCT01814878|584911917|FG000|Overall Study|Other|2|||
161963313|NCT01814878|584911918|FG001|Overall Study|Other|0|||
161963314|NCT01545934|584911919|FG000|Overall Study|Withdrawal by Subject|4|||
161963315|NCT01545934|584911920|FG001|Overall Study|Withdrawal by Subject|3|||
161963316|NCT01545934|584911919|FG000|Overall Study|Lost to Follow-up|1|||
161963317|NCT01545934|584911920|FG001|Overall Study|Lost to Follow-up|0|||
161963318|NCT01200407|584911925|FG000|Overall Study|Lost to Follow-up|56|||
161963319|NCT01200407|584911925|FG000|Overall Study|Adverse Event|3|||
161963320|NCT01200407|584911925|FG000|Overall Study|Withdrawal by Subject|4|||
161963321|NCT01200407|584911925|FG000|Overall Study|Other|19|||
161963322|NCT01843673|584911926|FG000|Overall Study|Lack of Efficacy|2|||
161963323|NCT01843673|584911926|FG000|Overall Study|Withdrawal by Subject|4|||
161963324|NCT00425698|584911927|FG000|Overall Study|Adverse Event|3|||
161963325|NCT00425698|584911928|FG001|Overall Study|Adverse Event|1|||
161963326|NCT00425698|584911927|FG000|Overall Study|Withdrawal by Subject|0|||
161963327|NCT00425698|584911928|FG001|Overall Study|Withdrawal by Subject|1|||
161963328|NCT03831191|584911935|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
161963329|NCT03831191|584911936|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
161963330|NCT03831191|584911937|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
161963331|NCT03831191|584911938|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
161963332|NCT03831191|584911939|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
161963333|NCT03831191|584911940|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
161963334|NCT03831191|584911941|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
161963335|NCT03831191|584911942|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
161963336|NCT03831191|584911943|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
161963337|NCT03831191|584911944|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
161963338|NCT03831191|584911945|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
161963339|NCT03831191|584911946|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
161963340|NCT03831191|584911947|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
161963341|NCT03831191|584911948|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
161963342|NCT03831191|584911949|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
161963343|NCT03831191|584911935|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
161963344|NCT03831191|584911936|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
161963345|NCT03831191|584911937|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963346|NCT03831191|584911938|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963347|NCT03831191|584911939|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963348|NCT03831191|584911940|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963349|NCT03831191|584911941|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963350|NCT03831191|584911942|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963351|NCT03831191|584911943|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963352|NCT03831191|584911944|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963353|NCT03831191|584911945|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963354|NCT03831191|584911946|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963355|NCT03831191|584911947|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963356|NCT03831191|584911948|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963357|NCT03831191|584911949|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161963358|NCT03831191|584911935|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
161963359|NCT03831191|584911936|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
161963360|NCT03831191|584911937|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
161963361|NCT03831191|584911938|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
161963362|NCT03831191|584911939|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
161717623|NCT02786537|584012580|FG003|As Treated|Withdrawal by Subject|0|||
161717624|NCT02786537|584012581|FG004|As Treated|Withdrawal by Subject|1|||
161717625|NCT02786537|584012582|FG005|As Treated|Withdrawal by Subject|0|||
161963363|NCT03831191|584911940|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
161963364|NCT03831191|584911941|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
161963365|NCT03831191|584911942|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
161963366|NCT03831191|584911943|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
161963367|NCT03831191|584911944|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
161963368|NCT03831191|584911945|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
161963369|NCT03831191|584911946|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
161963370|NCT03831191|584911947|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
161963371|NCT03831191|584911948|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
161963372|NCT03831191|584911949|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
161963373|NCT03831191|584911935|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
161963374|NCT03831191|584911936|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
161963375|NCT03831191|584911937|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
161963376|NCT03831191|584911938|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
161963377|NCT03831191|584911939|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
161963378|NCT03831191|584911940|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
161963379|NCT03831191|584911941|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
161963380|NCT03831191|584911942|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
161963381|NCT03831191|584911943|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
161963382|NCT03831191|584911944|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
161963383|NCT03831191|584911945|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
161963384|NCT03831191|584911946|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
161963385|NCT03831191|584911947|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
161963386|NCT03831191|584911948|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
161963387|NCT03831191|584911949|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
161963388|NCT03831191|584911935|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
161963389|NCT03831191|584911936|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
161963390|NCT03831191|584911937|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
161963391|NCT03831191|584911938|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
161963392|NCT03831191|584911939|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161963393|NCT03831191|584911940|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161963394|NCT03831191|584911941|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161963395|NCT03831191|584911942|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161963396|NCT03831191|584911943|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161963397|NCT03831191|584911944|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161963398|NCT03831191|584911945|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161963399|NCT03831191|584911946|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161963400|NCT03831191|584911947|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161963401|NCT03831191|584911948|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161963402|NCT03831191|584911949|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161963403|NCT03831191|584911935|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
161963404|NCT03831191|584911936|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
161963405|NCT03831191|584911937|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
161963406|NCT03831191|584911938|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
161963407|NCT03831191|584911939|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161963408|NCT03831191|584911940|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161963409|NCT03831191|584911941|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161963410|NCT03831191|584911942|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161963411|NCT03831191|584911943|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161963412|NCT03831191|584911944|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161963413|NCT03831191|584911945|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161963414|NCT03831191|584911946|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161963415|NCT03831191|584911947|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161963416|NCT03831191|584911948|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161963417|NCT03831191|584911949|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
161963418|NCT03831191|584911935|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
161963419|NCT03831191|584911936|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
161963420|NCT03831191|584911937|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
161717626|NCT02786537|584012577|FG000|As Treated|Incarceration|0|||
161717627|NCT02786537|584012578|FG001|As Treated|Incarceration|1|||
161717628|NCT02786537|584012579|FG002|As Treated|Incarceration|0|||
161963421|NCT03831191|584911938|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
161963422|NCT03831191|584911939|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
161963423|NCT03831191|584911940|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
161963424|NCT03831191|584911941|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
161963425|NCT03831191|584911942|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
161963426|NCT03831191|584911943|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
161717629|NCT02786537|584012580|FG003|As Treated|Incarceration|0|||
161717630|NCT02786537|584012581|FG004|As Treated|Incarceration|0|||
161717631|NCT02786537|584012582|FG005|As Treated|Incarceration|0|||
161717632|NCT02786537|584012577|FG000|As Treated|Opiate dependency relapse|0|||
161717633|NCT02786537|584012578|FG001|As Treated|Opiate dependency relapse|1|||
161717634|NCT02786537|584012579|FG002|As Treated|Opiate dependency relapse|0|||
161717635|NCT02786537|584012580|FG003|As Treated|Opiate dependency relapse|0|||
161717636|NCT02786537|584012581|FG004|As Treated|Opiate dependency relapse|0|||
161717637|NCT02786537|584012582|FG005|As Treated|Opiate dependency relapse|0|||
161717638|NCT02786537|584012577|FG000|As Treated|Drugs stolen from patient|0|||
161717639|NCT02786537|584012578|FG001|As Treated|Drugs stolen from patient|1|||
161717640|NCT02786537|584012579|FG002|As Treated|Drugs stolen from patient|0|||
161717641|NCT02786537|584012580|FG003|As Treated|Drugs stolen from patient|0|||
161717642|NCT02786537|584012581|FG004|As Treated|Drugs stolen from patient|0|||
161717643|NCT02786537|584012582|FG005|As Treated|Drugs stolen from patient|0|||
161717644|NCT02786537|584012577|FG000|As Treated|Advised to stop tx after loss of meds|0|||
161717645|NCT02786537|584012578|FG001|As Treated|Advised to stop tx after loss of meds|1|||
161717646|NCT02786537|584012579|FG002|As Treated|Advised to stop tx after loss of meds|0|||
161717647|NCT02786537|584012580|FG003|As Treated|Advised to stop tx after loss of meds|0|||
161717648|NCT02786537|584012581|FG004|As Treated|Advised to stop tx after loss of meds|0|||
161717649|NCT02786537|584012582|FG005|As Treated|Advised to stop tx after loss of meds|0|||
161717650|NCT01330381|584012583|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
161717651|NCT01330381|584012584|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
161717652|NCT01330381|584012585|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
161717653|NCT01330381|584012583|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
161717654|NCT01330381|584012584|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
161717655|NCT01330381|584012585|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
161717656|NCT01330381|584012583|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
161717657|NCT01330381|584012584|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
161963427|NCT03831191|584911944|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
161963428|NCT03831191|584911945|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
161963429|NCT03831191|584911946|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
161963430|NCT03831191|584911947|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
161963431|NCT03831191|584911948|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
161963432|NCT03831191|584911949|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
161963433|NCT03831191|584911935|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
161963434|NCT03831191|584911936|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
161963435|NCT03831191|584911937|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
161963436|NCT03831191|584911938|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
161963437|NCT03831191|584911939|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
161963438|NCT03831191|584911940|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
161963439|NCT03831191|584911941|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
161963440|NCT03831191|584911942|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
161963441|NCT03831191|584911943|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
161963442|NCT03831191|584911944|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
161963443|NCT03831191|584911945|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
161963444|NCT03831191|584911946|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
161963445|NCT03831191|584911947|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
161963446|NCT03831191|584911948|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
161963447|NCT03831191|584911949|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
161963448|NCT03831191|584911935|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161963449|NCT03831191|584911936|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161963450|NCT03831191|584911937|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161963451|NCT03831191|584911938|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161963452|NCT03831191|584911939|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161963453|NCT03831191|584911940|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161963454|NCT03831191|584911941|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161963455|NCT03831191|584911942|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161963456|NCT03831191|584911943|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161717658|NCT01330381|584012585|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
161717659|NCT01330381|584012583|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
161963457|NCT03831191|584911944|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161963458|NCT03831191|584911945|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161717660|NCT01330381|584012584|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
161717661|NCT01330381|584012585|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
161717662|NCT01330381|584012583|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
161717663|NCT01330381|584012584|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
161717664|NCT01330381|584012585|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
161717665|NCT01330381|584012583|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
161717666|NCT01330381|584012584|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
161717667|NCT01330381|584012585|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
161717668|NCT01330381|584012583|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
161717669|NCT01330381|584012584|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
161717670|NCT01330381|584012585|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
161717671|NCT01330381|584012583|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
161717672|NCT01330381|584012584|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
161717673|NCT01330381|584012585|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
161717674|NCT01330381|584012583|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
161717675|NCT01330381|584012584|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
161717676|NCT01330381|584012585|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
161717677|NCT01330381|584012583|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
161717678|NCT01330381|584012584|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
161717679|NCT01330381|584012585|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
161717680|NCT02584634|584012586|FG000|Overall Study|Adverse Event|3|||
161717681|NCT02584634|584012587|FG001|Overall Study|Adverse Event|5|||
161717682|NCT02584634|584012586|FG000|Overall Study|Death|0|||
161717683|NCT02584634|584012587|FG001|Overall Study|Death|1|||
161717684|NCT02584634|584012586|FG000|Overall Study|Lost to Follow-up|0|||
161717685|NCT02584634|584012587|FG001|Overall Study|Lost to Follow-up|1|||
161717686|NCT02584634|584012586|FG000|Overall Study|Physician Decision|1|||
161717687|NCT02584634|584012587|FG001|Overall Study|Physician Decision|2|||
161717688|NCT02584634|584012586|FG000|Overall Study|Progressive disease|7|||
161717689|NCT02584634|584012587|FG001|Overall Study|Progressive disease|15|||
161717690|NCT02584634|584012586|FG000|Overall Study|Withdrawal by Subject|1|||
161717691|NCT02584634|584012587|FG001|Overall Study|Withdrawal by Subject|1|||
161717692|NCT02584634|584012586|FG000|Overall Study|Other|0|||
161717693|NCT02584634|584012587|FG001|Overall Study|Other|6|||
161717694|NCT05523362|584012588|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
161717695|NCT05523362|584012588|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
161717696|NCT05523362|584012588|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
161717697|NCT05523362|584012588|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
161717698|NCT04075604|584012590|FG000|Overall Study|Adverse Event|0|||
161717699|NCT04075604|584012591|FG001|Overall Study|Adverse Event|0|||
161717700|NCT04075604|584012592|FG002|Overall Study|Adverse Event|3|||
161717701|NCT04075604|584012590|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161717702|NCT04075604|584012591|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161717703|NCT04075604|584012592|FG002|Overall Study|Participant request to discontinue study treatment|1|||
161963459|NCT03831191|584911946|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161963460|NCT03831191|584911947|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161963461|NCT03831191|584911948|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161963462|NCT03831191|584911949|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
161963463|NCT03831191|584911935|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963464|NCT03831191|584911936|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963465|NCT03831191|584911937|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963466|NCT03831191|584911938|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963467|NCT03831191|584911939|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963468|NCT03831191|584911940|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963469|NCT03831191|584911941|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963470|NCT03831191|584911942|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963471|NCT03831191|584911943|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963472|NCT03831191|584911944|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963473|NCT03831191|584911945|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963474|NCT03831191|584911946|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161717704|NCT04075604|584012590|FG000|Overall Study|Participant withdrew consent|0|||
161717705|NCT04075604|584012591|FG001|Overall Study|Participant withdrew consent|0|||
162032125|NCT00969280|585174211|FG001|Overall Study|Withdrawal by Subject|1|||
162032126|NCT00969280|585174210|FG000|Overall Study|infection of influenza A(H1N1)|0|||
162032127|NCT00969280|585174211|FG001|Overall Study|infection of influenza A(H1N1)|1|||
162032128|NCT00821327|585174212|FG000|Overall Study|Adverse Event|13|||
161963475|NCT03831191|584911947|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963476|NCT03831191|584911948|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161963477|NCT03831191|584911949|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
162032129|NCT00821327|585174212|FG000|Overall Study|Patient Request|1|||
161717706|NCT04075604|584012592|FG002|Overall Study|Participant withdrew consent|1|||
161717707|NCT04075604|584012590|FG000|Overall Study|Other reasons|1|||
161717708|NCT04075604|584012591|FG001|Overall Study|Other reasons|0|||
161717709|NCT04075604|584012592|FG002|Overall Study|Other reasons|0|||
161717710|NCT04075604|584012590|FG000|Overall Study|Disease progression|0|||
161717711|NCT04075604|584012591|FG001|Overall Study|Disease progression|1|||
161717712|NCT04075604|584012592|FG002|Overall Study|Disease progression|0|||
161717713|NCT04075604|584012590|FG000|Overall Study|Study drug toxicity|0|||
161717714|NCT04075604|584012591|FG001|Overall Study|Study drug toxicity|5|||
161717715|NCT04075604|584012592|FG002|Overall Study|Study drug toxicity|1|||
161717716|NCT02760602|584012593|FG000|Overall Study|Withdrawal by Subject|1|||
161717717|NCT02760602|584012594|FG001|Overall Study|Withdrawal by Subject|0|||
161717718|NCT02760602|584012593|FG000|Overall Study|Terminated by sponsor|12|||
161717719|NCT02760602|584012594|FG001|Overall Study|Terminated by sponsor|13|||
161717720|NCT01335971|584012601|FG000|Overall Study|Withdrawal by Subject|1|||
161717721|NCT01335971|584012602|FG001|Overall Study|Withdrawal by Subject|0|||
161717722|NCT01335971|584012603|FG002|Overall Study|Withdrawal by Subject|0|||
161717723|NCT01335971|584012601|FG000|Overall Study|Did not complete bronchoscopy|1|||
161717724|NCT01335971|584012602|FG001|Overall Study|Did not complete bronchoscopy|1|||
161717725|NCT01335971|584012603|FG002|Overall Study|Did not complete bronchoscopy|1|||
161717726|NCT01260181|584012604|FG000|Overall Study|Decision of Investigator|1|||
161717727|NCT03351244|584012605|FG000|Overall Study|Adverse Event|7|||
161717728|NCT03351244|584012606|FG001|Overall Study|Adverse Event|11|||
161717729|NCT03351244|584012607|FG002|Overall Study|Adverse Event|12|||
161717730|NCT03351244|584012605|FG000|Overall Study|Investigator's decision|0|||
161717731|NCT03351244|584012606|FG001|Overall Study|Investigator's decision|0|||
161717732|NCT03351244|584012607|FG002|Overall Study|Investigator's decision|2|||
161717733|NCT03351244|584012605|FG000|Overall Study|System error|0|||
161717734|NCT03351244|584012606|FG001|Overall Study|System error|0|||
161717735|NCT03351244|584012607|FG002|Overall Study|System error|2|||
161717736|NCT03351244|584012605|FG000|Overall Study|COVID-19 restrictions|3|||
161717737|NCT03351244|584012606|FG001|Overall Study|COVID-19 restrictions|0|||
161717738|NCT03351244|584012607|FG002|Overall Study|COVID-19 restrictions|1|||
161717739|NCT03351244|584012605|FG000|Overall Study|Non-compliance|2|||
161717740|NCT03351244|584012606|FG001|Overall Study|Non-compliance|5|||
161717741|NCT03351244|584012607|FG002|Overall Study|Non-compliance|0|||
161717742|NCT03351244|584012605|FG000|Overall Study|Withdrawal by Subject|11|||
161717743|NCT03351244|584012606|FG001|Overall Study|Withdrawal by Subject|16|||
161717744|NCT03351244|584012607|FG002|Overall Study|Withdrawal by Subject|13|||
161717745|NCT03351244|584012605|FG000|Overall Study|Lost to Follow-up|2|||
161717746|NCT03351244|584012606|FG001|Overall Study|Lost to Follow-up|6|||
161717747|NCT03351244|584012607|FG002|Overall Study|Lost to Follow-up|4|||
161717748|NCT03351244|584012605|FG000|Overall Study|Protocol Violation|2|||
161717749|NCT03351244|584012606|FG001|Overall Study|Protocol Violation|2|||
161717750|NCT03351244|584012607|FG002|Overall Study|Protocol Violation|0|||
161717751|NCT00474253|584012610|FG000|Overall Study|Withdrew consent|2|||
161717752|NCT00474253|584012611|FG001|Overall Study|Withdrew consent|0|||
161717753|NCT00474253|584012610|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
161717754|NCT00474253|584012611|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
161717755|NCT00474253|584012610|FG000|Overall Study|Lost to Follow-up|1|||
161717756|NCT00474253|584012611|FG001|Overall Study|Lost to Follow-up|0|||
161717757|NCT00474253|584012610|FG000|Overall Study|Discharged prior to study completion|0|||
161717758|NCT00474253|584012611|FG001|Overall Study|Discharged prior to study completion|1|||
161717759|NCT01165229|584012612|FG000|Overall Study|Serious Adverse Event|456|||
161717760|NCT01165229|584012613|FG001|Overall Study|Serious Adverse Event|487|||
161717761|NCT01165229|584012612|FG000|Overall Study|Non-Serious Adverse Event|47|||
161717762|NCT01165229|584012613|FG001|Overall Study|Non-Serious Adverse Event|15|||
161717763|NCT01165229|584012612|FG000|Overall Study|Protocol Violation|6|||
161717764|NCT01165229|584012613|FG001|Overall Study|Protocol Violation|8|||
161717765|NCT01165229|584012612|FG000|Overall Study|Withdrawal by Subject|387|||
161717766|NCT01165229|584012613|FG001|Overall Study|Withdrawal by Subject|396|||
161717767|NCT01165229|584012612|FG000|Overall Study|Migrated/moved from study area|51|||
161717768|NCT01165229|584012613|FG001|Overall Study|Migrated/moved from study area|46|||
161717769|NCT01165229|584012612|FG000|Overall Study|Lost to Follow-up|123|||
161717770|NCT01165229|584012613|FG001|Overall Study|Lost to Follow-up|133|||
161717771|NCT01165229|584012612|FG000|Overall Study|Suspected HZ Episode|2|||
161717772|NCT01165229|584012613|FG001|Overall Study|Suspected HZ Episode|2|||
161717773|NCT01165229|584012612|FG000|Overall Study|No reason from the subject|108|||
161717774|NCT01165229|584012613|FG001|Overall Study|No reason from the subject|102|||
161717775|NCT01165229|584012612|FG000|Overall Study|Unknown completion status|0|||
161717776|NCT01165229|584012613|FG001|Overall Study|Unknown completion status|1|||
161717777|NCT01357239|584012614|FG000|Stratum: All Patients|Adverse Event|0|||
161717778|NCT01357239|584012615|FG001|Stratum: All Patients|Adverse Event|0|||
161717779|NCT01357239|584012616|FG002|Stratum: All Patients|Adverse Event|1|||
161717780|NCT01357239|584012617|FG003|Stratum: All Patients|Adverse Event|1|||
161717781|NCT01357239|584012614|FG000|Stratum: All Patients|Subject withdrew consent|0|||
161963478|NCT00695955|584911950|FG000|Cohort 1|Adverse Event|26|||
161963479|NCT00695955|584911950|FG000|Cohort 1|Protocol Violation|2|||
161963480|NCT00695955|584911950|FG000|Cohort 1|Lost to Follow-up|30|||
161963481|NCT00695955|584911950|FG000|Cohort 1|Withdrawal by Subject|25|||
161963482|NCT00695955|584911950|FG000|Cohort 1|Lack of Efficacy|3|||
161963483|NCT00695955|584911950|FG000|Cohort 1|Other|16|||
161963484|NCT00695955|584911950|FG000|Cohort 2|Adverse Event|24|||
161963485|NCT00695955|584911950|FG000|Cohort 2|Protocol Violation|5|||
161963486|NCT00695955|584911950|FG000|Cohort 2|Lost to Follow-up|38|||
161963487|NCT00695955|584911950|FG000|Cohort 2|Withdrawal by Subject|28|||
161963488|NCT00695955|584911950|FG000|Cohort 2|Lack of Efficacy|4|||
161963489|NCT00695955|584911950|FG000|Cohort 2|Other|5|||
161963490|NCT01177553|584911951|FG000|Overall Study|babies not yet 6 months of age|1|||
161963491|NCT01177553|584911952|FG001|Overall Study|babies not yet 6 months of age|0|||
161963492|NCT00888329|584911954|FG000|Overall Study|Physician Decision|6|||
161963493|NCT00888329|584911955|FG001|Overall Study|Physician Decision|9|||
161963494|NCT04826094|584911956|FG000|Overall Study|Lost to Follow-up|2|||
161963495|NCT04826094|584911957|FG001|Overall Study|Lost to Follow-up|1|||
161963496|NCT04826094|584911958|FG002|Overall Study|Lost to Follow-up|0|||
161963497|NCT04826094|584911959|FG003|Overall Study|Lost to Follow-up|0|||
161963498|NCT04826094|584911960|FG004|Overall Study|Lost to Follow-up|1|||
161963499|NCT04826094|584911961|FG005|Overall Study|Lost to Follow-up|3|||
161963500|NCT04826094|584911962|FG006|Overall Study|Lost to Follow-up|1|||
161963501|NCT04826094|584911963|FG007|Overall Study|Lost to Follow-up|1|||
161963502|NCT04826094|584911956|FG000|Overall Study|Participant withdrew consent|1|||
161963503|NCT04826094|584911957|FG001|Overall Study|Participant withdrew consent|0|||
161963504|NCT04826094|584911958|FG002|Overall Study|Participant withdrew consent|0|||
161963505|NCT04826094|584911959|FG003|Overall Study|Participant withdrew consent|1|||
161963506|NCT04826094|584911960|FG004|Overall Study|Participant withdrew consent|1|||
161963507|NCT04826094|584911961|FG005|Overall Study|Participant withdrew consent|1|||
161963508|NCT04826094|584911962|FG006|Overall Study|Participant withdrew consent|0|||
161963509|NCT04826094|584911963|FG007|Overall Study|Participant withdrew consent|1|||
161963510|NCT04826094|584911956|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
161963511|NCT04826094|584911957|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
161963512|NCT04826094|584911958|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
161963513|NCT04826094|584911959|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
161963514|NCT04826094|584911960|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
161963515|NCT04826094|584911961|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
161963516|NCT04826094|584911962|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
161963517|NCT04826094|584911963|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
161838051|NCT00136318|584450317|FG001|Overall Study|Adverse Event|5|||
161963518|NCT04826094|584911956|FG000|Overall Study|Withdrawn by Investigator|0|||
161963519|NCT04826094|584911957|FG001|Overall Study|Withdrawn by Investigator|0|||
161963520|NCT04826094|584911958|FG002|Overall Study|Withdrawn by Investigator|0|||
161963521|NCT04826094|584911959|FG003|Overall Study|Withdrawn by Investigator|0|||
161963522|NCT04826094|584911960|FG004|Overall Study|Withdrawn by Investigator|0|||
161963523|NCT04826094|584911961|FG005|Overall Study|Withdrawn by Investigator|1|||
161963524|NCT04826094|584911962|FG006|Overall Study|Withdrawn by Investigator|0|||
161963525|NCT04826094|584911963|FG007|Overall Study|Withdrawn by Investigator|1|||
161963526|NCT04826094|584911956|FG000|Overall Study|Other: Moved from area|1|||
161963527|NCT04826094|584911957|FG001|Overall Study|Other: Moved from area|1|||
161963528|NCT04826094|584911958|FG002|Overall Study|Other: Moved from area|1|||
161963529|NCT04826094|584911959|FG003|Overall Study|Other: Moved from area|0|||
161963530|NCT04826094|584911960|FG004|Overall Study|Other: Moved from area|0|||
161963531|NCT04826094|584911961|FG005|Overall Study|Other: Moved from area|0|||
161963532|NCT04826094|584911962|FG006|Overall Study|Other: Moved from area|0|||
161963533|NCT04826094|584911963|FG007|Overall Study|Other: Moved from area|0|||
161963534|NCT04826094|584911956|FG000|Overall Study|Other: Declined|0|||
161963535|NCT04826094|584911957|FG001|Overall Study|Other: Declined|0|||
161963536|NCT04826094|584911958|FG002|Overall Study|Other: Declined|0|||
161963537|NCT04826094|584911959|FG003|Overall Study|Other: Declined|0|||
161963538|NCT04826094|584911960|FG004|Overall Study|Other: Declined|1|||
161963539|NCT04826094|584911961|FG005|Overall Study|Other: Declined|0|||
161963540|NCT04826094|584911962|FG006|Overall Study|Other: Declined|0|||
161963541|NCT04826094|584911963|FG007|Overall Study|Other: Declined|0|||
161963542|NCT04826094|584911956|FG000|Overall Study|Other: Vaccine not administered|0|||
161963543|NCT04826094|584911957|FG001|Overall Study|Other: Vaccine not administered|0|||
161963544|NCT04826094|584911958|FG002|Overall Study|Other: Vaccine not administered|1|||
161963545|NCT04826094|584911959|FG003|Overall Study|Other: Vaccine not administered|0|||
161963546|NCT04826094|584911960|FG004|Overall Study|Other: Vaccine not administered|0|||
161963547|NCT04826094|584911961|FG005|Overall Study|Other: Vaccine not administered|1|||
161963548|NCT04826094|584911962|FG006|Overall Study|Other: Vaccine not administered|1|||
161963549|NCT04826094|584911963|FG007|Overall Study|Other: Vaccine not administered|3|||
161963550|NCT01864148|584911965|FG000|Overall Study|Other|2|||
161963551|NCT01864148|584911966|FG001|Overall Study|Other|1|||
161963552|NCT01864148|584911967|FG002|Overall Study|Other|1|||
161963553|NCT01864148|584911968|FG003|Overall Study|Other|3|||
161963554|NCT01864148|584911969|FG004|Overall Study|Other|1|||
161963555|NCT01864148|584911965|FG000|Overall Study|Death|0|||
161963556|NCT01864148|584911966|FG001|Overall Study|Death|0|||
161963557|NCT01864148|584911967|FG002|Overall Study|Death|0|||
161963558|NCT01864148|584911968|FG003|Overall Study|Death|1|||
161963559|NCT01864148|584911969|FG004|Overall Study|Death|0|||
161963560|NCT01864148|584911965|FG000|Overall Study|Investigator Decision|5|||
161963561|NCT01864148|584911966|FG001|Overall Study|Investigator Decision|0|||
161963562|NCT01864148|584911967|FG002|Overall Study|Investigator Decision|0|||
161963563|NCT01864148|584911968|FG003|Overall Study|Investigator Decision|4|||
161963564|NCT01864148|584911969|FG004|Overall Study|Investigator Decision|6|||
161963565|NCT01864148|584911965|FG000|Overall Study|Withdrawal by Subject|9|||
161963566|NCT01864148|584911966|FG001|Overall Study|Withdrawal by Subject|2|||
161963567|NCT01864148|584911967|FG002|Overall Study|Withdrawal by Subject|6|||
161963568|NCT01864148|584911968|FG003|Overall Study|Withdrawal by Subject|8|||
161963569|NCT01864148|584911969|FG004|Overall Study|Withdrawal by Subject|8|||
161963570|NCT01864148|584911965|FG000|Overall Study|Lost to Follow-up|0|||
161963571|NCT01864148|584911966|FG001|Overall Study|Lost to Follow-up|0|||
161963572|NCT01864148|584911967|FG002|Overall Study|Lost to Follow-up|0|||
161963573|NCT01864148|584911968|FG003|Overall Study|Lost to Follow-up|2|||
161963574|NCT01864148|584911969|FG004|Overall Study|Lost to Follow-up|1|||
161963575|NCT01864148|584911965|FG000|Overall Study|Adverse Event|4|||
161963576|NCT01864148|584911966|FG001|Overall Study|Adverse Event|2|||
161963577|NCT01864148|584911967|FG002|Overall Study|Adverse Event|4|||
161963578|NCT01864148|584911968|FG003|Overall Study|Adverse Event|7|||
161963579|NCT01864148|584911969|FG004|Overall Study|Adverse Event|7|||
161963580|NCT01864148|584911965|FG000|Overall Study|Not Dosed|0|||
162032130|NCT00821327|585174212|FG000|Overall Study|Investigator Request|2|||
162032131|NCT00821327|585174212|FG000|Overall Study|Sponsor Request|1|||
162032132|NCT00821327|585174212|FG000|Overall Study|Disease Progression|13|||
162032133|NCT00821327|585174212|FG000|Overall Study|Other/Unknown|5|||
161963581|NCT01864148|584911966|FG001|Overall Study|Not Dosed|0|||
161963582|NCT01864148|584911967|FG002|Overall Study|Not Dosed|0|||
161963583|NCT01864148|584911968|FG003|Overall Study|Not Dosed|1|||
161963584|NCT01864148|584911969|FG004|Overall Study|Not Dosed|0|||
161963585|NCT03928418|584911972|FG000|Overall Study|Lost to Follow-up|5|||
161963586|NCT03928418|584911973|FG001|Overall Study|Lost to Follow-up|3|||
161963587|NCT03928418|584911974|FG002|Overall Study|Lost to Follow-up|5|||
161963588|NCT03928418|584911972|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
162032134|NCT00217464|585174213|FG000|Overall Study|Progression|15|||
161717782|NCT01357239|584012615|FG001|Stratum: All Patients|Subject withdrew consent|0|||
161717783|NCT01357239|584012616|FG002|Stratum: All Patients|Subject withdrew consent|1|||
161717784|NCT01357239|584012617|FG003|Stratum: All Patients|Subject withdrew consent|1|||
161717785|NCT01357239|584012614|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
161717786|NCT01357239|584012615|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
161717787|NCT01357239|584012616|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
161717788|NCT01357239|584012617|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
161717789|NCT01357239|584012614|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
161717790|NCT01357239|584012615|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
161717791|NCT01357239|584012616|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
161717792|NCT01357239|584012617|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
161963589|NCT03928418|584911973|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
161963590|NCT03928418|584911974|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
161963591|NCT01421303|584911975|FG000|Overall Study|Lost to Follow-up|13|||
161963592|NCT01421303|584911975|FG000|Overall Study|Non compliance with study procedure|1|||
161963593|NCT01421303|584911975|FG000|Overall Study|Other|7|||
161963594|NCT01421303|584911975|FG000|Overall Study|Withdrawal by Subject|1|||
161963595|NCT06003777|584911976|FG000|Period 1|Adverse Event|0|||
161963596|NCT06003777|584911977|FG001|Period 1|Adverse Event|0|||
161963597|NCT06003777|584911978|FG002|Period 1|Adverse Event|1|||
161963598|NCT06003777|584911979|FG003|Period 1|Adverse Event|0|||
161963599|NCT06003777|584911980|FG004|Period 1|Adverse Event|0|||
161963600|NCT06003777|584911981|FG005|Period 1|Adverse Event|0|||
161963601|NCT06003777|584911982|FG006|Period 1|Adverse Event|0|||
161963602|NCT06003777|584911983|FG007|Period 1|Adverse Event|0|||
161963603|NCT06003777|584911984|FG008|Period 1|Adverse Event|0|||
161963604|NCT06003777|584911985|FG009|Period 1|Adverse Event|0|||
161963605|NCT06003777|584911986|FG010|Period 1|Adverse Event|0|||
161963606|NCT06003777|584911987|FG011|Period 1|Adverse Event|0|||
161963607|NCT06003777|584911976|FG000|Period 1|Withdrawal by Subject|0|||
161963608|NCT06003777|584911977|FG001|Period 1|Withdrawal by Subject|0|||
161963609|NCT06003777|584911978|FG002|Period 1|Withdrawal by Subject|0|||
161963610|NCT06003777|584911979|FG003|Period 1|Withdrawal by Subject|0|||
161963611|NCT06003777|584911980|FG004|Period 1|Withdrawal by Subject|1|||
161963612|NCT06003777|584911981|FG005|Period 1|Withdrawal by Subject|0|||
161963613|NCT06003777|584911982|FG006|Period 1|Withdrawal by Subject|0|||
161963614|NCT06003777|584911983|FG007|Period 1|Withdrawal by Subject|0|||
161963615|NCT06003777|584911984|FG008|Period 1|Withdrawal by Subject|0|||
161717793|NCT01357239|584012614|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
161717794|NCT01357239|584012615|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
161717795|NCT01357239|584012616|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
161963616|NCT06003777|584911985|FG009|Period 1|Withdrawal by Subject|0|||
161963617|NCT06003777|584911986|FG010|Period 1|Withdrawal by Subject|0|||
161963618|NCT06003777|584911987|FG011|Period 1|Withdrawal by Subject|0|||
161963619|NCT06003777|584911976|FG000|Period 2|Withdrawal by Subject|0|||
161963620|NCT06003777|584911977|FG001|Period 2|Withdrawal by Subject|0|||
161963621|NCT06003777|584911978|FG002|Period 2|Withdrawal by Subject|0|||
161963622|NCT06003777|584911979|FG003|Period 2|Withdrawal by Subject|0|||
161717796|NCT01357239|584012617|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
161717797|NCT03133481|584012620|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
161717798|NCT03133481|584012621|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
161717799|NCT00637728|584012625|FG000|Double-blind Phase|Adverse Event|1|||
161717800|NCT00637728|584012626|FG001|Double-blind Phase|Adverse Event|0|||
161717801|NCT00637728|584012627|FG002|Double-blind Phase|Adverse Event|0|||
161717802|NCT00637728|584012625|FG000|Double-blind Phase|Non-compliance|2|||
161717803|NCT00637728|584012626|FG001|Double-blind Phase|Non-compliance|0|||
161717804|NCT00637728|584012627|FG002|Double-blind Phase|Non-compliance|0|||
161963623|NCT06003777|584911980|FG004|Period 2|Withdrawal by Subject|0|||
161963624|NCT06003777|584911981|FG005|Period 2|Withdrawal by Subject|0|||
161963625|NCT06003777|584911982|FG006|Period 2|Withdrawal by Subject|0|||
161963626|NCT06003777|584911983|FG007|Period 2|Withdrawal by Subject|0|||
161963627|NCT06003777|584911984|FG008|Period 2|Withdrawal by Subject|1|||
162032135|NCT00217464|585174213|FG000|Overall Study|Other|2|||
161717805|NCT00637728|584012625|FG000|Double-blind Phase|Study Discontinued|1|||
161717806|NCT00637728|584012626|FG001|Double-blind Phase|Study Discontinued|1|||
161717807|NCT00637728|584012627|FG002|Double-blind Phase|Study Discontinued|0|||
161963628|NCT06003777|584911985|FG009|Period 2|Withdrawal by Subject|0|||
161963629|NCT06003777|584911986|FG010|Period 2|Withdrawal by Subject|0|||
161963630|NCT06003777|584911987|FG011|Period 2|Withdrawal by Subject|0|||
161963631|NCT06003777|584911976|FG000|Period 3|Adverse Event|0|||
161963632|NCT06003777|584911977|FG001|Period 3|Adverse Event|0|||
161963633|NCT06003777|584911978|FG002|Period 3|Adverse Event|0|||
161963634|NCT06003777|584911979|FG003|Period 3|Adverse Event|0|||
161963635|NCT06003777|584911980|FG004|Period 3|Adverse Event|0|||
161717808|NCT01873950|584012630|FG000|Period 5|Withdrawal by Subject|0|||
161717809|NCT01873950|584012631|FG001|Period 5|Withdrawal by Subject|0|||
161717810|NCT01873950|584012632|FG002|Period 5|Withdrawal by Subject|0|||
161717811|NCT01873950|584012633|FG003|Period 5|Withdrawal by Subject|1|||
161963636|NCT06003777|584911981|FG005|Period 3|Adverse Event|0|||
161963637|NCT06003777|584911982|FG006|Period 3|Adverse Event|1|||
161963638|NCT06003777|584911983|FG007|Period 3|Adverse Event|0|||
161963639|NCT06003777|584911984|FG008|Period 3|Adverse Event|0|||
161963640|NCT06003777|584911985|FG009|Period 3|Adverse Event|0|||
161963641|NCT06003777|584911986|FG010|Period 3|Adverse Event|0|||
161963642|NCT06003777|584911987|FG011|Period 3|Adverse Event|0|||
161963643|NCT06003777|584911976|FG000|Period 4|No longer met eligibility criteria|0|||
161963644|NCT06003777|584911977|FG001|Period 4|No longer met eligibility criteria|0|||
161963645|NCT06003777|584911978|FG002|Period 4|No longer met eligibility criteria|1|||
161963646|NCT06003777|584911979|FG003|Period 4|No longer met eligibility criteria|0|||
161717812|NCT01873950|584012634|FG004|Period 5|Withdrawal by Subject|0|||
161717813|NCT05372315|584012636|FG000|Overall Study|Withdrawal by Subject|1|||
161717814|NCT05372315|584012637|FG001|Overall Study|Withdrawal by Subject|0|||
161717815|NCT01512368|584012639|FG000|Overall Study|Protocol Violation|3|||
161717816|NCT00328198|584012640|FG000|Treatment|Adverse Event|21|||
161717817|NCT00328198|584012640|FG000|Treatment|Death|1|||
161717818|NCT00328198|584012640|FG000|Treatment|Physician Decision|5|||
161717819|NCT00328198|584012640|FG000|Treatment|Withdrawal by Subject|5|||
161717820|NCT00328198|584012640|FG000|Treatment|Evidence of disease progression|2|||
161717821|NCT00328198|584012640|FG000|Treatment|Non-compliance|1|||
161717822|NCT00328198|584012640|FG000|Treatment|Confirmed complete response, MRD -|3|||
161717823|NCT00328198|584012640|FG000|Follow-up|Lost to Follow-up|4|||
161717824|NCT00328198|584012640|FG000|Follow-up|Death|31|||
161717825|NCT01570491|584012641|FG000|Overall Study|Lost to Follow-up|3|||
161717826|NCT01570491|584012642|FG001|Overall Study|Lost to Follow-up|1|||
161717827|NCT01570491|584012641|FG000|Overall Study|treatment: not given or discontinued|2|||
161717828|NCT01570491|584012642|FG001|Overall Study|treatment: not given or discontinued|0|||
161717829|NCT02532543|584012647|FG000|Overall Study|Lost to Follow-up|0|||
161717830|NCT02532543|584012648|FG001|Overall Study|Lost to Follow-up|0|||
161717831|NCT02532543|584012649|FG002|Overall Study|Lost to Follow-up|1|||
161717832|NCT02532543|584012650|FG003|Overall Study|Lost to Follow-up|0|||
161717833|NCT00650585|584012651|FG000|Overall Study|Lost to Follow-up|505|||
161717834|NCT00650585|584012652|FG001|Overall Study|Lost to Follow-up|482|||
161717835|NCT00650585|584012651|FG000|Overall Study|No parental consent|935|||
161717836|NCT00650585|584012652|FG001|Overall Study|No parental consent|866|||
161717837|NCT00650585|584012651|FG000|Overall Study|Excluded/ruled ineligible|357|||
161717838|NCT00650585|584012652|FG001|Overall Study|Excluded/ruled ineligible|129|||
161717839|NCT02640612|584012653|FG000|Overall Study|Adverse Event|6|||
161717840|NCT02640612|584012654|FG001|Overall Study|Adverse Event|7|||
161717841|NCT02640612|584012655|FG002|Overall Study|Adverse Event|2|||
161717842|NCT02640612|584012653|FG000|Overall Study|Death|1|||
161717843|NCT02640612|584012654|FG001|Overall Study|Death|0|||
161717844|NCT02640612|584012655|FG002|Overall Study|Death|0|||
161717845|NCT02640612|584012653|FG000|Overall Study|Withdrawal by Subject|10|||
161717846|NCT02640612|584012654|FG001|Overall Study|Withdrawal by Subject|3|||
161717847|NCT02640612|584012655|FG002|Overall Study|Withdrawal by Subject|3|||
161717848|NCT02640612|584012653|FG000|Overall Study|Lost to Follow-up|4|||
161717849|NCT02640612|584012654|FG001|Overall Study|Lost to Follow-up|1|||
161717850|NCT02640612|584012655|FG002|Overall Study|Lost to Follow-up|1|||
161717851|NCT02640612|584012653|FG000|Overall Study|Protocol Violation|0|||
161717852|NCT02640612|584012654|FG001|Overall Study|Protocol Violation|2|||
161717853|NCT02640612|584012655|FG002|Overall Study|Protocol Violation|0|||
161717854|NCT02640612|584012653|FG000|Overall Study|Lack of Efficacy|1|||
161717855|NCT02640612|584012654|FG001|Overall Study|Lack of Efficacy|1|||
161717856|NCT02640612|584012655|FG002|Overall Study|Lack of Efficacy|0|||
161717857|NCT01720667|584012658|FG000|Overall Study|Adverse Event|1|||
161717858|NCT01720667|584012659|FG001|Overall Study|Adverse Event|1|||
161717859|NCT01720667|584012658|FG000|Overall Study|Withdrawal by Subject|3|||
161717860|NCT01720667|584012659|FG001|Overall Study|Withdrawal by Subject|0|||
161717861|NCT04407507|584012660|FG000|Overall Study|Withdrawal by Subject|0|||
161717862|NCT04407507|584012661|FG001|Overall Study|Withdrawal by Subject|1|||
161717863|NCT03472534|584012663|FG000|Overall Study|Withdrawal by Subject|9|||
161717864|NCT03472534|584012663|FG000|Overall Study|Adverse Event|2|||
161717865|NCT02614794|584012664|FG000|Overall Study|Death|258|||
161717866|NCT02614794|584012665|FG001|Overall Study|Death|151|||
161717867|NCT02614794|584012664|FG000|Overall Study|Study closure by Sponsor|119|||
161717868|NCT02614794|584012665|FG001|Overall Study|Study closure by Sponsor|45|||
161717869|NCT02614794|584012664|FG000|Overall Study|Withdrawal by Subject|24|||
161717870|NCT02614794|584012665|FG001|Overall Study|Withdrawal by Subject|5|||
161717871|NCT02614794|584012664|FG000|Overall Study|Lost to Follow-up|7|||
161717872|NCT02614794|584012665|FG001|Overall Study|Lost to Follow-up|0|||
161717873|NCT02614794|584012664|FG000|Overall Study|Physician Decision|1|||
161717874|NCT02614794|584012665|FG001|Overall Study|Physician Decision|1|||
161717875|NCT02614794|584012664|FG000|Overall Study|Hospital closure|1|||
161717876|NCT02614794|584012665|FG001|Overall Study|Hospital closure|0|||
161717877|NCT01499576|584012667|FG000|Overall Study|Physician Decision|12|||
161717878|NCT01499576|584012667|FG000|Overall Study|Withdrawal by Subject|9|||
161717879|NCT03396471|584012673|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
161717880|NCT03396471|584012673|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
161963647|NCT06003777|584911980|FG004|Period 4|No longer met eligibility criteria|0|||
161963648|NCT06003777|584911981|FG005|Period 4|No longer met eligibility criteria|0|||
161963649|NCT06003777|584911982|FG006|Period 4|No longer met eligibility criteria|0|||
161963650|NCT06003777|584911983|FG007|Period 4|No longer met eligibility criteria|0|||
161963651|NCT06003777|584911984|FG008|Period 4|No longer met eligibility criteria|0|||
161963652|NCT06003777|584911985|FG009|Period 4|No longer met eligibility criteria|0|||
161963653|NCT06003777|584911986|FG010|Period 4|No longer met eligibility criteria|0|||
161963654|NCT06003777|584911987|FG011|Period 4|No longer met eligibility criteria|0|||
161963655|NCT06003777|584911976|FG000|Period 4|Withdrawal by Subject|0|||
161963656|NCT06003777|584911977|FG001|Period 4|Withdrawal by Subject|1|||
161963657|NCT06003777|584911978|FG002|Period 4|Withdrawal by Subject|0|||
161963658|NCT06003777|584911979|FG003|Period 4|Withdrawal by Subject|0|||
161963659|NCT06003777|584911980|FG004|Period 4|Withdrawal by Subject|0|||
161963660|NCT06003777|584911981|FG005|Period 4|Withdrawal by Subject|0|||
161963661|NCT06003777|584911982|FG006|Period 4|Withdrawal by Subject|0|||
161963662|NCT06003777|584911983|FG007|Period 4|Withdrawal by Subject|0|||
161963663|NCT06003777|584911984|FG008|Period 4|Withdrawal by Subject|0|||
161963664|NCT06003777|584911985|FG009|Period 4|Withdrawal by Subject|0|||
161963665|NCT06003777|584911986|FG010|Period 4|Withdrawal by Subject|0|||
161963666|NCT06003777|584911987|FG011|Period 4|Withdrawal by Subject|0|||
161963667|NCT05319600|584911988|FG000|Overall Study|Withdrawal by Subject|1|||
161963668|NCT05319600|584911989|FG001|Overall Study|Withdrawal by Subject|0|||
161963669|NCT05319600|584911988|FG000|Overall Study|Lost to Follow-up|0|||
161963670|NCT05319600|584911989|FG001|Overall Study|Lost to Follow-up|4|||
161963671|NCT00904670|584911990|FG000|Open Label Phase|Withdrawal by Subject|2|||
161963672|NCT00904670|584911991|FG001|Open Label Phase|Withdrawal by Subject|0|||
161963673|NCT00904670|584911990|FG000|Open Label Phase|Adverse Event|2|||
161963674|NCT00904670|584911991|FG001|Open Label Phase|Adverse Event|0|||
161963675|NCT00904670|584911990|FG000|Open Label Phase|Lack of Efficacy|1|||
161963676|NCT00904670|584911991|FG001|Open Label Phase|Lack of Efficacy|0|||
161963677|NCT00904670|584911990|FG000|Open Label Phase|Lost to Follow-up|1|||
161963678|NCT00904670|584911991|FG001|Open Label Phase|Lost to Follow-up|0|||
161963679|NCT00690430|584911997|FG000|Core Phase|Abnormal Laboratory value|0|||
161963680|NCT00690430|584911998|FG001|Core Phase|Abnormal Laboratory value|1|||
161963681|NCT00690430|584911999|FG002|Core Phase|Abnormal Laboratory value|0|||
161963682|NCT00690430|584911997|FG000|Core Phase|Adverse Event|5|||
161963683|NCT00690430|584911998|FG001|Core Phase|Adverse Event|1|||
161963684|NCT00690430|584911999|FG002|Core Phase|Adverse Event|0|||
161963685|NCT00690430|584911997|FG000|Core Phase|Death|0|||
161963686|NCT00690430|584911998|FG001|Core Phase|Death|2|||
161963687|NCT00690430|584911999|FG002|Core Phase|Death|0|||
161963688|NCT00690430|584911997|FG000|Core Phase|Protocol Violation|1|||
161963689|NCT00690430|584911998|FG001|Core Phase|Protocol Violation|0|||
161963690|NCT00690430|584911999|FG002|Core Phase|Protocol Violation|0|||
161963691|NCT00690430|584911997|FG000|Core Phase|Withdrawal by Subject|3|||
161963692|NCT00690430|584911998|FG001|Core Phase|Withdrawal by Subject|3|||
161963693|NCT00690430|584911999|FG002|Core Phase|Withdrawal by Subject|0|||
161717881|NCT03396471|584012673|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
161717882|NCT03396471|584012673|FG000|Study Treatment - Up to 22 Months|Death|2|||
161717883|NCT03396471|584012673|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
161717884|NCT03396471|584012673|FG000|Follow up - Up to 2 Years|Death|9|||
161717885|NCT03396471|584012673|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
161717886|NCT03396471|584012673|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
161717887|NCT03396471|584012673|FG000|Follow up - Up to 2 Years|study terminated|1|||
161717888|NCT03396471|584012673|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
161717889|NCT03396471|584012673|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
161717890|NCT01319929|584012676|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
161717891|NCT01319929|584012677|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
161717892|NCT01319929|584012676|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
161717893|NCT01319929|584012677|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
161963694|NCT00690430|584911997|FG000|Core Phase|Subject no longer requires study drug|1|||
161963695|NCT00690430|584911998|FG001|Core Phase|Subject no longer requires study drug|0|||
161963696|NCT00690430|584911999|FG002|Core Phase|Subject no longer requires study drug|0|||
161963697|NCT00690430|584911997|FG000|Core Phase|Lack of Efficacy|8|||
161963698|NCT00690430|584911998|FG001|Core Phase|Lack of Efficacy|10|||
161963699|NCT00690430|584911999|FG002|Core Phase|Lack of Efficacy|0|||
161963700|NCT00690430|584911997|FG000|Core Phase|Administrative Problems|0|||
161963701|NCT00690430|584911998|FG001|Core Phase|Administrative Problems|1|||
161963702|NCT00690430|584911999|FG002|Core Phase|Administrative Problems|0|||
161963703|NCT00690430|584911997|FG000|Core Phase|Early Termination|0|||
161963704|NCT00690430|584911998|FG001|Core Phase|Early Termination|5|||
161963705|NCT00690430|584911999|FG002|Core Phase|Early Termination|0|||
161963706|NCT00690430|584911997|FG000|Extension Phase|Lack of Efficacy|3|||
161963707|NCT00690430|584911998|FG001|Extension Phase|Lack of Efficacy|1|||
161963708|NCT00690430|584911999|FG002|Extension Phase|Lack of Efficacy|4|||
161963709|NCT00690430|584911997|FG000|Extension Phase|Abnormal Lab Values|1|||
161717894|NCT01319929|584012676|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
161717895|NCT01319929|584012677|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
161717896|NCT01319929|584012676|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
161717897|NCT01319929|584012677|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
161717898|NCT01319929|584012676|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
161717899|NCT01319929|584012677|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
161717900|NCT03237845|584012678|FG000|Overall Study|Adverse Event|0|||
161717901|NCT03237845|584012679|FG001|Overall Study|Adverse Event|1|||
161717902|NCT03237845|584012678|FG000|Overall Study|Lost to Follow-up|13|||
161717903|NCT03237845|584012679|FG001|Overall Study|Lost to Follow-up|10|||
161717904|NCT03237845|584012678|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
161717905|NCT03237845|584012679|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
161717906|NCT03237845|584012678|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
161717907|NCT03237845|584012679|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
161717908|NCT03237845|584012678|FG000|Overall Study|Physician Decision|1|||
161717909|NCT03237845|584012679|FG001|Overall Study|Physician Decision|2|||
161717910|NCT03237845|584012678|FG000|Overall Study|Pregnancy|1|||
161717911|NCT03237845|584012679|FG001|Overall Study|Pregnancy|0|||
161717912|NCT03237845|584012678|FG000|Overall Study|Protocol Deviation|0|||
161717913|NCT03237845|584012679|FG001|Overall Study|Protocol Deviation|1|||
161717914|NCT03237845|584012678|FG000|Overall Study|Technical Problems|8|||
161717915|NCT03237845|584012679|FG001|Overall Study|Technical Problems|1|||
161717916|NCT03237845|584012678|FG000|Overall Study|Withdrawal by Subject|3|||
161717917|NCT03237845|584012679|FG001|Overall Study|Withdrawal by Subject|3|||
161717918|NCT03237845|584012678|FG000|Overall Study|Other Reasons|4|||
161717919|NCT03237845|584012679|FG001|Overall Study|Other Reasons|0|||
161717920|NCT01221233|584012680|FG000|Overall Study|Withdrawal by Subject|3|||
161717921|NCT01221233|584012681|FG001|Overall Study|Withdrawal by Subject|1|||
161717922|NCT03865407|584012683|FG000|Overall Study|Adverse Event|1|||
161717923|NCT03865407|584012684|FG001|Overall Study|Adverse Event|0|||
161717924|NCT03865407|584012683|FG000|Overall Study|Withdrawal by Subject|1|||
161717925|NCT03865407|584012684|FG001|Overall Study|Withdrawal by Subject|0|||
161717926|NCT03865407|584012683|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
161717927|NCT03865407|584012684|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
161717928|NCT01645280|584012685|FG000|Overall Study|Death|0|||
161717929|NCT01645280|584012686|FG001|Overall Study|Death|1|||
161717930|NCT01645280|584012687|FG002|Overall Study|Death|0|||
161717931|NCT01645280|584012688|FG003|Overall Study|Death|0|||
161717932|NCT01645280|584012689|FG004|Overall Study|Death|0|||
161717933|NCT01645280|584012685|FG000|Overall Study|Withdrawal by Subject|4|||
161717934|NCT01645280|584012686|FG001|Overall Study|Withdrawal by Subject|0|||
161717935|NCT01645280|584012687|FG002|Overall Study|Withdrawal by Subject|2|||
161717936|NCT01645280|584012688|FG003|Overall Study|Withdrawal by Subject|4|||
161717937|NCT01645280|584012689|FG004|Overall Study|Withdrawal by Subject|5|||
161717938|NCT01645280|584012685|FG000|Overall Study|Lost to Follow-up|0|||
161717939|NCT01645280|584012686|FG001|Overall Study|Lost to Follow-up|0|||
161717940|NCT01645280|584012687|FG002|Overall Study|Lost to Follow-up|0|||
161717941|NCT01645280|584012688|FG003|Overall Study|Lost to Follow-up|2|||
161717942|NCT01645280|584012689|FG004|Overall Study|Lost to Follow-up|1|||
161963710|NCT00690430|584911998|FG001|Extension Phase|Abnormal Lab Values|0|||
161963711|NCT00690430|584911999|FG002|Extension Phase|Abnormal Lab Values|0|||
161963712|NCT00690430|584911997|FG000|Extension Phase|Abnormal test procedure results|1|||
161963713|NCT00690430|584911998|FG001|Extension Phase|Abnormal test procedure results|0|||
161717943|NCT01645280|584012685|FG000|Overall Study|Other|1|||
161717944|NCT01645280|584012686|FG001|Overall Study|Other|1|||
161717945|NCT01645280|584012687|FG002|Overall Study|Other|2|||
161717946|NCT01645280|584012688|FG003|Overall Study|Other|0|||
161717947|NCT01645280|584012689|FG004|Overall Study|Other|0|||
161717948|NCT01645280|584012685|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
161717949|NCT01645280|584012686|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
161717950|NCT01645280|584012687|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
161717951|NCT01645280|584012688|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
161717952|NCT01645280|584012689|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
161963714|NCT00690430|584911999|FG002|Extension Phase|Abnormal test procedure results|0|||
161963715|NCT00690430|584911997|FG000|Extension Phase|Administrative Problems|0|||
161717953|NCT00234104|584012694|FG000|Overall Study|Adverse Event|4|||
161717954|NCT00234104|584012695|FG001|Overall Study|Adverse Event|0|||
161717955|NCT00234104|584012696|FG002|Overall Study|Adverse Event|3|||
161717956|NCT00234104|584012697|FG003|Overall Study|Adverse Event|5|||
161717957|NCT00234104|584012694|FG000|Overall Study|Protocol Violation|0|||
161717958|NCT00234104|584012695|FG001|Overall Study|Protocol Violation|0|||
161717959|NCT00234104|584012696|FG002|Overall Study|Protocol Violation|0|||
161963716|NCT00690430|584911998|FG001|Extension Phase|Administrative Problems|1|||
161717960|NCT00234104|584012697|FG003|Overall Study|Protocol Violation|1|||
161717961|NCT00234104|584012694|FG000|Overall Study|Physician Decision|0|||
161717962|NCT00234104|584012695|FG001|Overall Study|Physician Decision|1|||
161717963|NCT00234104|584012696|FG002|Overall Study|Physician Decision|2|||
161717964|NCT00234104|584012697|FG003|Overall Study|Physician Decision|2|||
161717965|NCT00546819|584012698|FG000|Overall Study|Adverse Event|2|||
161717966|NCT00546819|584012699|FG001|Overall Study|Adverse Event|3|||
161717967|NCT00546819|584012698|FG000|Overall Study|Lost to Follow-up|2|||
161717968|NCT00546819|584012699|FG001|Overall Study|Lost to Follow-up|1|||
161717969|NCT00546819|584012698|FG000|Overall Study|Withdrawal by Subject|4|||
161963717|NCT00690430|584911999|FG002|Extension Phase|Administrative Problems|1|||
161963718|NCT00690430|584911997|FG000|Extension Phase|Adverse Event|2|||
161963719|NCT00690430|584911998|FG001|Extension Phase|Adverse Event|1|||
161963720|NCT00690430|584911999|FG002|Extension Phase|Adverse Event|2|||
161963721|NCT00690430|584911997|FG000|Extension Phase|Death|1|||
161963722|NCT00690430|584911998|FG001|Extension Phase|Death|1|||
161963723|NCT00690430|584911999|FG002|Extension Phase|Death|1|||
161963724|NCT00690430|584911997|FG000|Extension Phase|Withdrawal by Subject|0|||
161963725|NCT00690430|584911998|FG001|Extension Phase|Withdrawal by Subject|0|||
161963726|NCT00690430|584911999|FG002|Extension Phase|Withdrawal by Subject|2|||
161963727|NCT00690430|584911997|FG000|Extension Phase|Early Termination|10|||
161963728|NCT00690430|584911998|FG001|Extension Phase|Early Termination|1|||
161963729|NCT00690430|584911999|FG002|Extension Phase|Early Termination|3|||
161963730|NCT02466425|584912000|FG000|Overall Study|Adverse Event|3|||
161963731|NCT02466425|584912001|FG001|Overall Study|Adverse Event|11|||
161963732|NCT02466425|584912000|FG000|Overall Study|Lack of Efficacy|4|||
161963733|NCT02466425|584912001|FG001|Overall Study|Lack of Efficacy|1|||
161963734|NCT02466425|584912000|FG000|Overall Study|Lost to Follow-up|3|||
161963735|NCT02466425|584912001|FG001|Overall Study|Lost to Follow-up|0|||
161963736|NCT02466425|584912000|FG000|Overall Study|Protocol Violation|1|||
161963737|NCT02466425|584912001|FG001|Overall Study|Protocol Violation|0|||
161963738|NCT02466425|584912000|FG000|Overall Study|Withdrawal by Subject|0|||
161963739|NCT02466425|584912001|FG001|Overall Study|Withdrawal by Subject|1|||
161963740|NCT02466425|584912000|FG000|Overall Study|Other|1|||
161963741|NCT02466425|584912001|FG001|Overall Study|Other|3|||
161963742|NCT02466425|584912000|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161963743|NCT02466425|584912001|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161963744|NCT02120300|584912002|FG000|Overall Study|Enrolled but Never Treated|2|||
161963745|NCT02120300|584912003|FG001|Overall Study|Enrolled but Never Treated|0|||
161963746|NCT02120300|584912004|FG002|Overall Study|Enrolled but Never Treated|0|||
161963747|NCT02120300|584912005|FG003|Overall Study|Enrolled but Never Treated|0|||
161963748|NCT02120300|584912002|FG000|Overall Study|Lack of Efficacy|0|||
161963749|NCT02120300|584912003|FG001|Overall Study|Lack of Efficacy|0|||
161963750|NCT02120300|584912004|FG002|Overall Study|Lack of Efficacy|0|||
161963751|NCT02120300|584912005|FG003|Overall Study|Lack of Efficacy|1|||
161963752|NCT02120300|584912002|FG000|Overall Study|Lost to Follow-up|1|||
161963753|NCT02120300|584912003|FG001|Overall Study|Lost to Follow-up|0|||
161963754|NCT02120300|584912004|FG002|Overall Study|Lost to Follow-up|0|||
161963755|NCT02120300|584912005|FG003|Overall Study|Lost to Follow-up|0|||
161963756|NCT01721486|584912014|FG000|Overall Study|Protocol Violation|1|||
161963757|NCT01721486|584912015|FG001|Overall Study|Protocol Violation|0|||
161963758|NCT01721486|584912014|FG000|Overall Study|Physician Decision|0|||
161963759|NCT01721486|584912015|FG001|Overall Study|Physician Decision|1|||
161963760|NCT00182078|584912025|FG000|Overall Study|Withdrawal by Subject|1|||
161963761|NCT00182078|584912026|FG001|Overall Study|Withdrawal by Subject|0|||
161963762|NCT01076205|584912027|FG000|Overall Study|Adverse Drug Reaction|299|||
161963763|NCT01076205|584912027|FG000|Overall Study|Lack of Effectiveness|1423|||
161963764|NCT01076205|584912027|FG000|Overall Study|Other Reason|1075|||
161963765|NCT01076205|584912027|FG000|Overall Study|Unknown Reason|71|||
161963766|NCT01076205|584912027|FG000|Overall Study|Lost to Follow-up|3151|||
161963767|NCT00361231|584912028|FG000|Overall Study|Physician Decision|3|||
161717970|NCT00546819|584012699|FG001|Overall Study|Withdrawal by Subject|2|||
161963768|NCT00361231|584912028|FG000|Overall Study|Symptomatic deterioration|5|||
161963769|NCT00361231|584912028|FG000|Overall Study|Radiographic disease progression|16|||
161963770|NCT00361231|584912028|FG000|Overall Study|Withdrawal by Subject|4|||
161717971|NCT02052960|584012701|FG000|Overall Study|Adverse Event|19|||
161717972|NCT02052960|584012702|FG001|Overall Study|Adverse Event|17|||
161963771|NCT00361231|584912028|FG000|Overall Study|Adverse Event|6|||
161963772|NCT01732510|584912031|FG000|Overall Study|Adverse Event|0|||
161963773|NCT01732510|584912032|FG001|Overall Study|Adverse Event|1|||
161963774|NCT01732510|584912033|FG002|Overall Study|Adverse Event|1|||
161963775|NCT01732510|584912034|FG003|Overall Study|Adverse Event|0|||
161963776|NCT01732510|584912035|FG004|Overall Study|Adverse Event|0|||
161963777|NCT01732510|584912036|FG005|Overall Study|Adverse Event|0|||
161963778|NCT01732510|584912037|FG006|Overall Study|Adverse Event|1|||
161963779|NCT01732510|584912031|FG000|Overall Study|Protocol Violation|0|||
161963780|NCT01732510|584912032|FG001|Overall Study|Protocol Violation|0|||
161963781|NCT01732510|584912033|FG002|Overall Study|Protocol Violation|0|||
161963782|NCT01732510|584912034|FG003|Overall Study|Protocol Violation|1|||
161963783|NCT01732510|584912035|FG004|Overall Study|Protocol Violation|0|||
161963784|NCT01732510|584912036|FG005|Overall Study|Protocol Violation|0|||
161963785|NCT01732510|584912037|FG006|Overall Study|Protocol Violation|0|||
161717973|NCT02052960|584012701|FG000|Overall Study|Protocol Violation|4|||
161963786|NCT01732510|584912031|FG000|Overall Study|Withdrawal by Subject|1|||
161963787|NCT01732510|584912032|FG001|Overall Study|Withdrawal by Subject|3|||
161717974|NCT02052960|584012702|FG001|Overall Study|Protocol Violation|3|||
161717975|NCT02052960|584012701|FG000|Overall Study|Withdrawal by Subject|6|||
161717976|NCT02052960|584012702|FG001|Overall Study|Withdrawal by Subject|11|||
161717977|NCT02052960|584012701|FG000|Overall Study|Other|25|||
161717978|NCT02052960|584012702|FG001|Overall Study|Other|15|||
161717979|NCT03849560|584012703|FG000|Overall Study|Withdrawal by Subject|1|||
161717980|NCT03849560|584012704|FG001|Overall Study|Withdrawal by Subject|0|||
161717981|NCT03849560|584012705|FG002|Overall Study|Withdrawal by Subject|0|||
161717982|NCT04045613|584012706|FG000|Overall Study|Adverse Event|2|||
161717983|NCT04045613|584012707|FG001|Overall Study|Adverse Event|2|||
161717984|NCT04045613|584012708|FG002|Overall Study|Adverse Event|1|||
161717985|NCT04045613|584012709|FG003|Overall Study|Adverse Event|1|||
161717986|NCT04045613|584012710|FG004|Overall Study|Adverse Event|0|||
161717987|NCT04045613|584012711|FG005|Overall Study|Adverse Event|0|||
161717988|NCT04045613|584012712|FG006|Overall Study|Adverse Event|1|||
161717989|NCT04045613|584012706|FG000|Overall Study|Withdrawal by Subject|0|||
161717990|NCT04045613|584012707|FG001|Overall Study|Withdrawal by Subject|5|||
161717991|NCT04045613|584012708|FG002|Overall Study|Withdrawal by Subject|0|||
161717992|NCT04045613|584012709|FG003|Overall Study|Withdrawal by Subject|0|||
161717993|NCT04045613|584012710|FG004|Overall Study|Withdrawal by Subject|0|||
161717994|NCT04045613|584012711|FG005|Overall Study|Withdrawal by Subject|1|||
161717995|NCT04045613|584012712|FG006|Overall Study|Withdrawal by Subject|0|||
161717996|NCT04045613|584012706|FG000|Overall Study|Physician Decision|2|||
161717997|NCT04045613|584012707|FG001|Overall Study|Physician Decision|0|||
161717998|NCT04045613|584012708|FG002|Overall Study|Physician Decision|0|||
161717999|NCT04045613|584012709|FG003|Overall Study|Physician Decision|0|||
161718000|NCT04045613|584012710|FG004|Overall Study|Physician Decision|1|||
161718001|NCT04045613|584012711|FG005|Overall Study|Physician Decision|0|||
161718002|NCT04045613|584012712|FG006|Overall Study|Physician Decision|0|||
161718003|NCT04045613|584012706|FG000|Overall Study|Death|3|||
161718004|NCT04045613|584012707|FG001|Overall Study|Death|0|||
161718005|NCT04045613|584012708|FG002|Overall Study|Death|0|||
161718006|NCT04045613|584012709|FG003|Overall Study|Death|0|||
161718007|NCT04045613|584012710|FG004|Overall Study|Death|0|||
161718008|NCT04045613|584012711|FG005|Overall Study|Death|0|||
161718009|NCT04045613|584012712|FG006|Overall Study|Death|1|||
161718010|NCT04045613|584012706|FG000|Overall Study|Other reasons|0|||
161718011|NCT04045613|584012707|FG001|Overall Study|Other reasons|1|||
161718012|NCT04045613|584012708|FG002|Overall Study|Other reasons|0|||
161718013|NCT04045613|584012709|FG003|Overall Study|Other reasons|0|||
161718014|NCT04045613|584012710|FG004|Overall Study|Other reasons|0|||
161718015|NCT04045613|584012711|FG005|Overall Study|Other reasons|0|||
161718016|NCT04045613|584012712|FG006|Overall Study|Other reasons|1|||
161718017|NCT04045613|584012706|FG000|Overall Study|Progressive disease: Clinical progression|1|||
161718018|NCT04045613|584012707|FG001|Overall Study|Progressive disease: Clinical progression|0|||
161718019|NCT04045613|584012708|FG002|Overall Study|Progressive disease: Clinical progression|3|||
161718020|NCT04045613|584012709|FG003|Overall Study|Progressive disease: Clinical progression|1|||
161718021|NCT04045613|584012710|FG004|Overall Study|Progressive disease: Clinical progression|1|||
161718022|NCT04045613|584012711|FG005|Overall Study|Progressive disease: Clinical progression|3|||
161718023|NCT04045613|584012712|FG006|Overall Study|Progressive disease: Clinical progression|3|||
161718024|NCT04045613|584012706|FG000|Overall Study|Progressive disease: Radiological progression|24|||
161718025|NCT04045613|584012707|FG001|Overall Study|Progressive disease: Radiological progression|6|||
161718026|NCT04045613|584012708|FG002|Overall Study|Progressive disease: Radiological progression|8|||
161963788|NCT01732510|584912033|FG002|Overall Study|Withdrawal by Subject|2|||
161963789|NCT01732510|584912034|FG003|Overall Study|Withdrawal by Subject|1|||
161963790|NCT01732510|584912035|FG004|Overall Study|Withdrawal by Subject|5|||
161963791|NCT01732510|584912036|FG005|Overall Study|Withdrawal by Subject|0|||
161963792|NCT01732510|584912037|FG006|Overall Study|Withdrawal by Subject|1|||
161963793|NCT01732510|584912031|FG000|Overall Study|Lost to Follow-up|0|||
161963794|NCT01732510|584912032|FG001|Overall Study|Lost to Follow-up|0|||
161718027|NCT04045613|584012709|FG003|Overall Study|Progressive disease: Radiological progression|0|||
161718028|NCT04045613|584012710|FG004|Overall Study|Progressive disease: Radiological progression|6|||
161718029|NCT04045613|584012711|FG005|Overall Study|Progressive disease: Radiological progression|6|||
161718030|NCT04045613|584012712|FG006|Overall Study|Progressive disease: Radiological progression|11|||
161718031|NCT01254344|584012722|FG000|Overall Study|Adverse Event|2|||
161718032|NCT01254344|584012723|FG001|Overall Study|Adverse Event|5|||
161963795|NCT01732510|584912033|FG002|Overall Study|Lost to Follow-up|1|||
161718033|NCT01254344|584012722|FG000|Overall Study|Physician Decision|7|||
161718034|NCT01254344|584012723|FG001|Overall Study|Physician Decision|4|||
161718035|NCT01254344|584012722|FG000|Overall Study|Protocol Violation|1|||
161718036|NCT01254344|584012723|FG001|Overall Study|Protocol Violation|4|||
161718037|NCT01254344|584012722|FG000|Overall Study|Withdrawal by Subject|3|||
161718038|NCT01254344|584012723|FG001|Overall Study|Withdrawal by Subject|6|||
161718039|NCT00467649|584012724|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
161963796|NCT01732510|584912034|FG003|Overall Study|Lost to Follow-up|1|||
161963797|NCT01732510|584912035|FG004|Overall Study|Lost to Follow-up|0|||
161718040|NCT00467649|584012725|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
161718041|NCT00467649|584012726|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
161718042|NCT00467649|584012727|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
161718043|NCT00467649|584012728|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
161718044|NCT00467649|584012729|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
161718045|NCT00467649|584012724|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
161718046|NCT00467649|584012725|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
161718047|NCT00467649|584012726|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
161718048|NCT00467649|584012727|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
161718049|NCT00467649|584012728|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
161718050|NCT00467649|584012729|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
161718051|NCT00467649|584012724|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
161718052|NCT00467649|584012725|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
161718053|NCT00467649|584012726|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
161718054|NCT00467649|584012727|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
161718055|NCT00467649|584012728|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
161718056|NCT00467649|584012729|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
161718057|NCT00467649|584012724|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
161718058|NCT00467649|584012725|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
161718059|NCT00467649|584012726|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
161718060|NCT00467649|584012727|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
161718061|NCT00467649|584012728|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
161718062|NCT00467649|584012729|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
161718063|NCT00467649|584012724|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161718064|NCT00467649|584012725|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161718065|NCT00467649|584012726|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161718066|NCT00467649|584012727|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
161718067|NCT00467649|584012728|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161718068|NCT00467649|584012729|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161718069|NCT00467649|584012724|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161718070|NCT00467649|584012725|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161718071|NCT00467649|584012726|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161718072|NCT00467649|584012727|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
161718073|NCT00467649|584012728|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161718074|NCT00467649|584012729|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161718075|NCT00467649|584012724|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161718076|NCT00467649|584012725|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161718077|NCT00467649|584012726|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161718078|NCT00467649|584012727|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161718079|NCT00467649|584012728|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161718080|NCT00467649|584012729|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
161718081|NCT01633060|584012730|FG000|Randomization Phase|Protocol deviation|1|||
161718082|NCT01633060|584012731|FG001|Randomization Phase|Protocol deviation|2|||
161718083|NCT01633060|584012730|FG000|Randomization Phase|Technical problem|0|||
161718084|NCT01633060|584012731|FG001|Randomization Phase|Technical problem|1|||
161718085|NCT01633060|584012730|FG000|Treatment Phase|Adverse Event|24|||
161718086|NCT01633060|584012731|FG001|Treatment Phase|Adverse Event|3|||
161718087|NCT01633060|584012730|FG000|Treatment Phase|Lost to Follow-up|1|||
161718088|NCT01633060|584012731|FG001|Treatment Phase|Lost to Follow-up|0|||
161718089|NCT01633060|584012730|FG000|Treatment Phase|Physician Decision|16|||
161718090|NCT01633060|584012731|FG001|Treatment Phase|Physician Decision|7|||
161718091|NCT01633060|584012730|FG000|Treatment Phase|Progressive Disease|210|||
161718092|NCT01633060|584012731|FG001|Treatment Phase|Progressive Disease|120|||
161718093|NCT01633060|584012730|FG000|Treatment Phase|Protocol Deviation|1|||
161718094|NCT01633060|584012731|FG001|Treatment Phase|Protocol Deviation|0|||
161718095|NCT01633060|584012730|FG000|Treatment Phase|Study Terminated by sponsor|7|||
161718096|NCT01633060|584012731|FG001|Treatment Phase|Study Terminated by sponsor|3|||
161718097|NCT01633060|584012730|FG000|Treatment Phase|Subject/guardian decision|25|||
161718098|NCT01633060|584012731|FG001|Treatment Phase|Subject/guardian decision|4|||
161718099|NCT01633060|584012730|FG000|Treatment Phase|Death|4|||
161718100|NCT01633060|584012731|FG001|Treatment Phase|Death|3|||
161718101|NCT01633060|584012730|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
161718102|NCT01633060|584012731|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161718103|NCT01633060|584012730|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
161718104|NCT01633060|584012731|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
161718105|NCT01633060|584012730|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
161718106|NCT01633060|584012731|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
161718107|NCT01633060|584012730|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
161718108|NCT01633060|584012731|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
161718109|NCT01633060|584012730|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
161718110|NCT01633060|584012731|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
161718111|NCT01633060|584012730|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
161963798|NCT01732510|584912036|FG005|Overall Study|Lost to Follow-up|1|||
161963799|NCT01732510|584912037|FG006|Overall Study|Lost to Follow-up|0|||
161963800|NCT01732510|584912031|FG000|Overall Study|Physician Decision|0|||
161963801|NCT01732510|584912032|FG001|Overall Study|Physician Decision|1|||
161963802|NCT01732510|584912033|FG002|Overall Study|Physician Decision|0|||
161963803|NCT01732510|584912034|FG003|Overall Study|Physician Decision|0|||
161963804|NCT01732510|584912035|FG004|Overall Study|Physician Decision|0|||
161963805|NCT01732510|584912036|FG005|Overall Study|Physician Decision|0|||
161963806|NCT01732510|584912037|FG006|Overall Study|Physician Decision|0|||
161963807|NCT01732510|584912031|FG000|Overall Study|Pregnancy|0|||
161963808|NCT01732510|584912032|FG001|Overall Study|Pregnancy|0|||
161963809|NCT01732510|584912033|FG002|Overall Study|Pregnancy|0|||
161963810|NCT01732510|584912034|FG003|Overall Study|Pregnancy|1|||
161718112|NCT01633060|584012731|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
161718113|NCT00883753|584012734|FG000|Overall Study|Adverse Event|37|||
161718114|NCT00883753|584012734|FG000|Overall Study|Death|2|||
161718115|NCT00883753|584012734|FG000|Overall Study|Insufficient therapeutic response|16|||
161718116|NCT00883753|584012734|FG000|Overall Study|Lost to Follow-up|4|||
161718117|NCT00883753|584012734|FG000|Overall Study|Violation of selection criteria at entry|7|||
161718118|NCT00883753|584012734|FG000|Overall Study|Protocol Violation|2|||
161718119|NCT00883753|584012734|FG000|Overall Study|Refused treatment|4|||
161718120|NCT00883753|584012734|FG000|Overall Study|Withdrew consent|10|||
161718121|NCT00883753|584012734|FG000|Overall Study|Investigator's decision|17|||
161718122|NCT00883753|584012734|FG000|Overall Study|Administrative/Other|8|||
161718123|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Adverse Event|12|||
161718124|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Adverse Event|3|||
161718125|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Adverse Event|4|||
161718126|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Adverse Event|2|||
161718127|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
161718128|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
161718129|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
161718130|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
161718131|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
161718132|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
161718133|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
161718134|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
161718135|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
161718136|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
161718137|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
161718138|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
161718139|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
161718140|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
161718141|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
161718142|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
161718143|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
161718144|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
161718145|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
161718146|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
161718147|NCT02436239|584012738|FG000|Open-Lable Treatment Period|Other Reason|1|||
161718148|NCT02436239|584012739|FG001|Open-Lable Treatment Period|Other Reason|1|||
161718149|NCT02436239|584012740|FG002|Open-Lable Treatment Period|Other Reason|0|||
161718150|NCT02436239|584012741|FG003|Open-Lable Treatment Period|Other Reason|0|||
161718151|NCT02436239|584012738|FG000|Down-Taper Period|Withdrawal by Subject|4|||
161963811|NCT01732510|584912035|FG004|Overall Study|Pregnancy|0|||
161963812|NCT01732510|584912036|FG005|Overall Study|Pregnancy|0|||
161718152|NCT02436239|584012739|FG001|Down-Taper Period|Withdrawal by Subject|4|||
161718153|NCT02436239|584012740|FG002|Down-Taper Period|Withdrawal by Subject|1|||
161718154|NCT02436239|584012741|FG003|Down-Taper Period|Withdrawal by Subject|2|||
161718155|NCT02168946|584012742|FG000|Overall Study|Adverse Event|8|||
161718156|NCT02168946|584012743|FG001|Overall Study|Adverse Event|5|||
161718157|NCT02168946|584012742|FG000|Overall Study|Lost to Follow-up|3|||
161718158|NCT02168946|584012743|FG001|Overall Study|Lost to Follow-up|0|||
161718159|NCT02168946|584012742|FG000|Overall Study|Subject unable to come back for visits|1|||
161718160|NCT02168946|584012743|FG001|Overall Study|Subject unable to come back for visits|0|||
161718161|NCT00450866|584012751|FG000|Overall Study|Adverse Event|0|||
161718162|NCT00450866|584012752|FG001|Overall Study|Adverse Event|1|||
161718163|NCT00450866|584012751|FG000|Overall Study|Withdrawal by Subject|5|||
161963813|NCT01732510|584912037|FG006|Overall Study|Pregnancy|0|||
161963814|NCT01732510|584912031|FG000|Overall Study|Study Terminated By Sponsor|0|||
161963815|NCT01732510|584912032|FG001|Overall Study|Study Terminated By Sponsor|0|||
161718164|NCT00450866|584012752|FG001|Overall Study|Withdrawal by Subject|2|||
161963816|NCT01732510|584912033|FG002|Overall Study|Study Terminated By Sponsor|0|||
161963817|NCT01732510|584912034|FG003|Overall Study|Study Terminated By Sponsor|1|||
161718165|NCT00450866|584012751|FG000|Overall Study|Death|1|||
161963818|NCT01732510|584912035|FG004|Overall Study|Study Terminated By Sponsor|0|||
161963819|NCT01732510|584912036|FG005|Overall Study|Study Terminated By Sponsor|12|||
161963820|NCT01732510|584912037|FG006|Overall Study|Study Terminated By Sponsor|6|||
161963821|NCT00313144|584912038|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
161963822|NCT00313144|584912038|FG000|Overall Study|Death|7|||
161963823|NCT00313144|584912038|FG000|Overall Study|Lost to Follow-up|5|||
161963824|NCT00313144|584912038|FG000|Overall Study|Withdrawal by Subject|4|||
161963825|NCT00313144|584912038|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
161963826|NCT00313144|584912038|FG000|Overall Study|Physician Decision|4|||
161963827|NCT00313144|584912038|FG000|Overall Study|Adverse event - transient|5|||
161963828|NCT00313144|584912038|FG000|Overall Study|Liver transplant|1|||
161963829|NCT00313144|584912038|FG000|Overall Study|Insurance (homecare provider) change|1|||
161963830|NCT00313144|584912038|FG000|Overall Study|Change to different product|1|||
161963831|NCT00313144|584912038|FG000|Overall Study|Due to termination of the study|66|||
161963832|NCT01932372|584912040|FG000|Overall Study|Not meeting eligibility criteria|33|||
161963833|NCT01932372|584912041|FG001|Overall Study|Not meeting eligibility criteria|179|||
161963834|NCT03594747|584912046|FG000|Overall Study|Death|78|||
161963835|NCT03594747|584912047|FG001|Overall Study|Death|86|||
161963836|NCT03594747|584912048|FG002|Overall Study|Death|87|||
161963837|NCT03594747|584912046|FG000|Overall Study|Withdrawal by Subject|5|||
161963838|NCT03594747|584912047|FG001|Overall Study|Withdrawal by Subject|2|||
161963839|NCT03594747|584912048|FG002|Overall Study|Withdrawal by Subject|11|||
161963840|NCT03594747|584912046|FG000|Overall Study|Lost to Follow-up|4|||
161963841|NCT03594747|584912047|FG001|Overall Study|Lost to Follow-up|1|||
161963842|NCT03594747|584912048|FG002|Overall Study|Lost to Follow-up|1|||
161963843|NCT03594747|584912046|FG000|Overall Study|Physician Decision|0|||
161963844|NCT03594747|584912047|FG001|Overall Study|Physician Decision|1|||
161963845|NCT03594747|584912048|FG002|Overall Study|Physician Decision|0|||
161963846|NCT03594747|584912046|FG000|Overall Study|Sponsor decision|23|||
161963847|NCT03594747|584912047|FG001|Overall Study|Sponsor decision|17|||
161963848|NCT03594747|584912048|FG002|Overall Study|Sponsor decision|16|||
161963849|NCT03594747|584912046|FG000|Overall Study|Did not meet inclusion criteria|0|||
161963850|NCT03594747|584912047|FG001|Overall Study|Did not meet inclusion criteria|0|||
161963851|NCT03594747|584912048|FG002|Overall Study|Did not meet inclusion criteria|1|||
161963852|NCT03594747|584912046|FG000|Overall Study|Transfer to long term extension study|10|||
161963853|NCT03594747|584912047|FG001|Overall Study|Transfer to long term extension study|12|||
161963854|NCT03594747|584912048|FG002|Overall Study|Transfer to long term extension study|5|||
161963855|NCT04382586|584912049|FG000|Overall Study|Death|3|||
161963856|NCT04382586|584912050|FG001|Overall Study|Death|4|||
161963857|NCT04382586|584912049|FG000|Overall Study|Lost to Follow-up|11|||
161963858|NCT04382586|584912050|FG001|Overall Study|Lost to Follow-up|8|||
161963859|NCT04382586|584912049|FG000|Overall Study|Withdrawal by Subject|3|||
161963860|NCT04382586|584912050|FG001|Overall Study|Withdrawal by Subject|1|||
161963861|NCT04382586|584912049|FG000|Overall Study|Physician Decision|0|||
161963862|NCT04382586|584912050|FG001|Overall Study|Physician Decision|3|||
161963863|NCT02265536|584912051|FG000|Overall Study|Adverse Event|1|||
161963864|NCT02265536|584912052|FG001|Overall Study|Adverse Event|0|||
161963865|NCT02265536|584912053|FG002|Overall Study|Adverse Event|0|||
161963866|NCT02265536|584912054|FG003|Overall Study|Adverse Event|0|||
162032136|NCT00459979|585174214|FG000|Overall Study|Withdrawal by Subject|1|||
161718166|NCT00450866|584012752|FG001|Overall Study|Death|0|||
161718167|NCT00450866|584012751|FG000|Overall Study|Physician Decision|1|||
161718168|NCT00450866|584012752|FG001|Overall Study|Physician Decision|0|||
161718169|NCT01743027|584012753|FG000|Overall Study|Adverse Event|2|||
161718170|NCT01743027|584012754|FG001|Overall Study|Adverse Event|0|||
161718171|NCT01743027|584012755|FG002|Overall Study|Adverse Event|0|||
161718172|NCT01743027|584012756|FG003|Overall Study|Adverse Event|0|||
161718173|NCT01743027|584012753|FG000|Overall Study|Lost to Follow-up|0|||
161718174|NCT01743027|584012754|FG001|Overall Study|Lost to Follow-up|0|||
161718175|NCT01743027|584012755|FG002|Overall Study|Lost to Follow-up|2|||
161718176|NCT01743027|584012756|FG003|Overall Study|Lost to Follow-up|0|||
161718177|NCT01743027|584012753|FG000|Overall Study|Progressive Disease|1|||
161718178|NCT01743027|584012754|FG001|Overall Study|Progressive Disease|4|||
161718179|NCT01743027|584012755|FG002|Overall Study|Progressive Disease|3|||
161718180|NCT01743027|584012756|FG003|Overall Study|Progressive Disease|0|||
161718181|NCT01743027|584012753|FG000|Overall Study|Protocol Violation|1|||
161718182|NCT01743027|584012754|FG001|Overall Study|Protocol Violation|1|||
161718183|NCT01743027|584012755|FG002|Overall Study|Protocol Violation|1|||
161718184|NCT01743027|584012756|FG003|Overall Study|Protocol Violation|0|||
161718185|NCT01743027|584012753|FG000|Overall Study|Withdrawal by Subject|1|||
161718186|NCT01743027|584012754|FG001|Overall Study|Withdrawal by Subject|0|||
161718187|NCT01743027|584012755|FG002|Overall Study|Withdrawal by Subject|3|||
161718188|NCT01743027|584012756|FG003|Overall Study|Withdrawal by Subject|1|||
161963867|NCT02265536|584912055|FG004|Overall Study|Adverse Event|1|||
161963868|NCT02265536|584912056|FG005|Overall Study|Adverse Event|0|||
161963869|NCT02265536|584912051|FG000|Overall Study|Physician Decision|0|||
161963870|NCT02265536|584912052|FG001|Overall Study|Physician Decision|0|||
162032137|NCT00459979|585174214|FG000|Overall Study|Protocol Violation|1|||
161718189|NCT02675517|584012759|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
161718190|NCT02675517|584012759|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
161718191|NCT02277444|584012765|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
161718192|NCT02277444|584012765|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
161718193|NCT02277444|584012765|FG000|Treatment Period (Week 0-52)|Other|1|||
161718194|NCT02277444|584012765|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
161718195|NCT02277444|584012765|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
161718196|NCT02277444|584012765|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
161718197|NCT02277444|584012765|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
161718198|NCT02277444|584012765|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
161718199|NCT02277444|584012765|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
161718200|NCT02699515|584014318|FG000|Overall Study|Death|3|||
161718201|NCT02699515|584014319|FG001|Overall Study|Death|3|||
161718202|NCT02699515|584014320|FG002|Overall Study|Death|3|||
161718203|NCT02699515|584014321|FG003|Overall Study|Death|23|||
161718204|NCT02699515|584014322|FG004|Overall Study|Death|22|||
161718205|NCT02699515|584014323|FG005|Overall Study|Death|23|||
161718206|NCT02699515|584014324|FG006|Overall Study|Death|3|||
161718207|NCT02699515|584014325|FG007|Overall Study|Death|5|||
161718208|NCT02699515|584014318|FG000|Overall Study|Withdrawal by Subject|0|||
161718209|NCT02699515|584014319|FG001|Overall Study|Withdrawal by Subject|0|||
161718210|NCT02699515|584014320|FG002|Overall Study|Withdrawal by Subject|3|||
161718211|NCT02699515|584014321|FG003|Overall Study|Withdrawal by Subject|1|||
161718212|NCT02699515|584014322|FG004|Overall Study|Withdrawal by Subject|5|||
161718213|NCT02699515|584014323|FG005|Overall Study|Withdrawal by Subject|3|||
161718214|NCT02699515|584014324|FG006|Overall Study|Withdrawal by Subject|0|||
161718215|NCT02699515|584014325|FG007|Overall Study|Withdrawal by Subject|1|||
161718216|NCT02699515|584014318|FG000|Overall Study|Other|1|||
161718217|NCT02699515|584014319|FG001|Overall Study|Other|0|||
161718218|NCT02699515|584014320|FG002|Overall Study|Other|1|||
161718219|NCT02699515|584014321|FG003|Overall Study|Other|6|||
161718220|NCT02699515|584014322|FG004|Overall Study|Other|4|||
161718221|NCT02699515|584014323|FG005|Overall Study|Other|3|||
161718222|NCT02699515|584014324|FG006|Overall Study|Other|0|||
161718223|NCT02699515|584014325|FG007|Overall Study|Other|0|||
161718224|NCT05243550|584014326|FG000|Overall Study|Ongoing in the Study|171|||
161718225|NCT05243550|584014326|FG000|Overall Study|Withdrawal by Subject|10|||
161718226|NCT05243550|584014326|FG000|Overall Study|Lost to Follow-up|7|||
161718227|NCT05243550|584014326|FG000|Overall Study|Adverse Event|3|||
161718228|NCT05243550|584014326|FG000|Overall Study|Noncompliance|1|||
161718229|NCT05243550|584014326|FG000|Overall Study|Physician Decision|1|||
161718230|NCT05243550|584014326|FG000|Overall Study|Other Reason|4|||
161718231|NCT02031146|584014329|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
161718232|NCT02031146|584014330|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
161718233|NCT02031146|584014331|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
161718234|NCT02031146|584014332|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
161718235|NCT02031146|584014333|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
161718236|NCT02031146|584014334|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
161718237|NCT02031146|584014335|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
161718238|NCT02452970|584014338|FG000|Overall Study|Adverse Event|1|||
161718239|NCT02100657|584014339|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
161718240|NCT02100657|584014340|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
161718241|NCT02100657|584014341|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
161718242|NCT02100657|584014339|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
161718243|NCT02100657|584014340|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
161718244|NCT02100657|584014341|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
161718245|NCT02100657|584014339|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
161718246|NCT02100657|584014340|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
161718247|NCT02100657|584014341|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
161718248|NCT02100657|584014339|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
161718249|NCT02100657|584014340|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
161718250|NCT02100657|584014341|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
161718251|NCT02100657|584014339|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
161718252|NCT02100657|584014340|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
161718253|NCT02100657|584014341|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
161718254|NCT02100657|584014339|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
161718255|NCT02100657|584014340|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
161718256|NCT02100657|584014341|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
161718257|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
161718258|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
161718259|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
161718260|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Death|0|||
161718261|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Death|0|||
161718262|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Death|1|||
161718263|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
161718264|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
161718265|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
161718266|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
161718267|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
161718268|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
161718269|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
161718270|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
161718271|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
161718272|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
161718273|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
161718274|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
161718275|NCT02100657|584014339|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
161718276|NCT02100657|584014340|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
161718277|NCT02100657|584014341|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
161718278|NCT02629393|584014343|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
161718279|NCT02629393|584014343|FG000|Overall Study|Physician Decision|1|||
161718280|NCT01269125|584014347|FG000|Overall Study|Adverse Event|3|||
161718281|NCT01269125|584014348|FG001|Overall Study|Adverse Event|5|||
161718282|NCT01269125|584014349|FG002|Overall Study|Adverse Event|0|||
161718283|NCT01269125|584014347|FG000|Overall Study|Lost to Follow-up|4|||
161718284|NCT01269125|584014348|FG001|Overall Study|Lost to Follow-up|0|||
161718285|NCT01269125|584014349|FG002|Overall Study|Lost to Follow-up|0|||
161718286|NCT01040832|584014350|FG000|Overall Study|Adverse Event|4|||
161718287|NCT01040832|584014351|FG001|Overall Study|Adverse Event|5|||
161718288|NCT01040832|584014350|FG000|Overall Study|Death|4|||
161718289|NCT01040832|584014351|FG001|Overall Study|Death|6|||
161718290|NCT01040832|584014350|FG000|Overall Study|Withdrawal by Subject|2|||
161718291|NCT01040832|584014351|FG001|Overall Study|Withdrawal by Subject|3|||
161718292|NCT01040832|584014350|FG000|Overall Study|Progressive disease|32|||
161718293|NCT01040832|584014351|FG001|Overall Study|Progressive disease|17|||
161718294|NCT01040832|584014350|FG000|Overall Study|Symptomatic deterioration|2|||
161718295|NCT01040832|584014351|FG001|Overall Study|Symptomatic deterioration|5|||
161718296|NCT01040832|584014350|FG000|Overall Study|Other|2|||
161718297|NCT01040832|584014351|FG001|Overall Study|Other|1|||
161718298|NCT00151411|584014352|FG000|Overall Study|Lost to Follow-up|15|||
161718299|NCT00151411|584014353|FG001|Overall Study|Lost to Follow-up|19|||
161718300|NCT00151411|584014352|FG000|Overall Study|Withdrawal by Subject|12|||
161718301|NCT00151411|584014353|FG001|Overall Study|Withdrawal by Subject|20|||
161718302|NCT00151411|584014352|FG000|Overall Study|Adverse Event|6|||
161718303|NCT00151411|584014353|FG001|Overall Study|Adverse Event|0|||
161718304|NCT00151411|584014352|FG000|Overall Study|Pregnancy|0|||
161718305|NCT00151411|584014353|FG001|Overall Study|Pregnancy|4|||
161718306|NCT00417612|584014354|FG000|Overall Study|Errant diagnosis|0|||
161718307|NCT00417612|584014355|FG001|Overall Study|Errant diagnosis|1|||
161718308|NCT00417612|584014354|FG000|Overall Study|Adverse Event|2|||
161718309|NCT00417612|584014355|FG001|Overall Study|Adverse Event|0|||
161718310|NCT00417612|584014354|FG000|Overall Study|Protocol Violation|0|||
161718311|NCT00417612|584014355|FG001|Overall Study|Protocol Violation|2|||
161718312|NCT00417612|584014354|FG000|Overall Study|Lost to Follow-up|1|||
161718313|NCT00417612|584014355|FG001|Overall Study|Lost to Follow-up|0|||
161718314|NCT01283581|584014358|FG000|Overall Study|Lost to Follow-up|8|||
161718315|NCT01283581|584014359|FG001|Overall Study|Lost to Follow-up|6|||
161718316|NCT01283581|584014360|FG002|Overall Study|Lost to Follow-up|8|||
161718317|NCT01283581|584014358|FG000|Overall Study|Withdrawal by Subject|2|||
161718318|NCT01283581|584014359|FG001|Overall Study|Withdrawal by Subject|5|||
161718319|NCT01283581|584014360|FG002|Overall Study|Withdrawal by Subject|2|||
161718320|NCT01283581|584014358|FG000|Overall Study|Adverse Event|1|||
161718321|NCT01283581|584014359|FG001|Overall Study|Adverse Event|1|||
161718322|NCT01283581|584014360|FG002|Overall Study|Adverse Event|4|||
161718323|NCT01283581|584014358|FG000|Overall Study|Physician Decision|0|||
161718324|NCT01283581|584014359|FG001|Overall Study|Physician Decision|1|||
161718325|NCT01283581|584014360|FG002|Overall Study|Physician Decision|2|||
161718326|NCT01283581|584014358|FG000|Overall Study|Protocol Violation|0|||
161718327|NCT01283581|584014359|FG001|Overall Study|Protocol Violation|1|||
161718328|NCT01283581|584014360|FG002|Overall Study|Protocol Violation|2|||
161718329|NCT01283581|584014358|FG000|Overall Study|Noncompliance|1|||
161718330|NCT01283581|584014359|FG001|Overall Study|Noncompliance|0|||
161718331|NCT01283581|584014360|FG002|Overall Study|Noncompliance|0|||
161718332|NCT01283581|584014358|FG000|Overall Study|Investigator unblinded|0|||
161718333|NCT01283581|584014359|FG001|Overall Study|Investigator unblinded|0|||
161718334|NCT01283581|584014360|FG002|Overall Study|Investigator unblinded|1|||
161718335|NCT01283581|584014358|FG000|Overall Study|"Early termination"|0|||
161718336|NCT01283581|584014359|FG001|Overall Study|"Early termination"|0|||
161718337|NCT01283581|584014360|FG002|Overall Study|"Early termination"|1|||
161718338|NCT01712438|584014361|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
161718339|NCT01712438|584014361|FG000|Overall Study|Ongoing ITI treatment|6|||
161718340|NCT01712438|584014361|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
161718341|NCT01712438|584014361|FG000|Overall Study|Prematurely Discontinued|25|||
161718342|NCT01183858|584014364|FG000|Overall Study|Death not related to Progressive Disease|5|||
161718343|NCT01183858|584014365|FG001|Overall Study|Death not related to Progressive Disease|6|||
161718344|NCT01183858|584014364|FG000|Overall Study|Adverse Event|14|||
161718345|NCT01183858|584014365|FG001|Overall Study|Adverse Event|11|||
161718346|NCT01183858|584014364|FG000|Overall Study|Investigator's Decision|0|||
161718347|NCT01183858|584014365|FG001|Overall Study|Investigator's Decision|3|||
161718348|NCT01183858|584014364|FG000|Overall Study|Insufficient Therapeutic Response|2|||
161718349|NCT01183858|584014365|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161718350|NCT01183858|584014364|FG000|Overall Study|Refused Treatment|1|||
161718351|NCT01183858|584014365|FG001|Overall Study|Refused Treatment|4|||
161718352|NCT01183858|584014364|FG000|Overall Study|Withdrew Consent|4|||
161718353|NCT01183858|584014365|FG001|Overall Study|Withdrew Consent|4|||
161718354|NCT01183858|584014364|FG000|Overall Study|Discontinued Smoking|3|||
161718355|NCT01183858|584014365|FG001|Overall Study|Discontinued Smoking|1|||
161718356|NCT01183858|584014364|FG000|Overall Study|Protocol Violation|1|||
161718357|NCT01183858|584014365|FG001|Overall Study|Protocol Violation|0|||
161718358|NCT01183858|584014364|FG000|Overall Study|Administrative/Other|6|||
161718359|NCT01183858|584014365|FG001|Overall Study|Administrative/Other|6|||
162032138|NCT00278915|585174215|FG000|Overall Study|Disease progression|1|||
162032139|NCT05214573|585174216|FG000|Overall Study|Physician Decision|5924|||
162032140|NCT05214573|585174217|FG001|Overall Study|Physician Decision|0|||
161718360|NCT01183858|584014364|FG000|Overall Study|Progressive Disease|112|||
161718361|NCT01183858|584014365|FG001|Overall Study|Progressive Disease|115|||
161718362|NCT01183858|584014364|FG000|Overall Study|Death related to Progressive Disease|4|||
161718363|NCT01183858|584014365|FG001|Overall Study|Death related to Progressive Disease|5|||
161718364|NCT01183858|584014364|FG000|Overall Study|Lost to Follow-up|1|||
161718365|NCT01183858|584014365|FG001|Overall Study|Lost to Follow-up|1|||
161718366|NCT00098345|584014366|FG000|Overall Study|Adverse Event|7|||
161718367|NCT00098345|584014366|FG000|Overall Study|Withdrawal by Subject|2|||
161718368|NCT00098345|584014366|FG000|Overall Study|progression|4|||
161718369|NCT00414440|584014370|FG000|Core Period|Withdrawal by Subject|70|||
161718370|NCT00414440|584014371|FG001|Core Period|Withdrawal by Subject|32|||
161718371|NCT00414440|584014370|FG000|Extension Period|Lost to Follow-up|44|||
161718372|NCT00414440|584014371|FG001|Extension Period|Lost to Follow-up|52|||
161718373|NCT00414440|584014370|FG000|Extension Period|Did not consent to continue follow up|61|||
161718374|NCT00414440|584014371|FG001|Extension Period|Did not consent to continue follow up|54|||
161718375|NCT00414440|584014370|FG000|Extension Period|Other|1|||
161718376|NCT00414440|584014371|FG001|Extension Period|Other|1|||
161718377|NCT00414440|584014370|FG000|Extension Period|Administrative|16|||
161718378|NCT00414440|584014371|FG001|Extension Period|Administrative|16|||
161718379|NCT00414440|584014370|FG000|Extension Period|Death|1|||
161718380|NCT00414440|584014371|FG001|Extension Period|Death|2|||
161718381|NCT00414440|584014370|FG000|Extension Period|Withdrawal by Subject|9|||
161718382|NCT00414440|584014371|FG001|Extension Period|Withdrawal by Subject|7|||
161718383|NCT00414440|584014370|FG000|Extension Period|Not included in follow up period|18|||
161718384|NCT00414440|584014371|FG001|Extension Period|Not included in follow up period|8|||
161718385|NCT00138151|584014372|FG000|Overall Study|Withdrawal by Subject|3|||
161718386|NCT00138151|584014372|FG000|Overall Study|Physician Decision|1|||
161718387|NCT04925570|584014373|FG000|Overall Study|Protocol Violation|24|||
161718388|NCT04925570|584014374|FG001|Overall Study|Protocol Violation|30|||
161718389|NCT04925570|584014373|FG000|Overall Study|Withdrawal by Subject|0|||
161718390|NCT04925570|584014374|FG001|Overall Study|Withdrawal by Subject|2|||
161718391|NCT01088412|584014375|FG000|Overall Study|Adverse Event|38|||
161718392|NCT01088412|584014376|FG001|Overall Study|Adverse Event|0|||
161718393|NCT01088412|584014377|FG002|Overall Study|Adverse Event|0|||
161718394|NCT01088412|584014375|FG000|Overall Study|Death|42|||
161718395|NCT01088412|584014376|FG001|Overall Study|Death|6|||
161718396|NCT01088412|584014377|FG002|Overall Study|Death|0|||
161718397|NCT01088412|584014375|FG000|Overall Study|Other Reason per Case Report Form|2089|||
161718398|NCT01088412|584014376|FG001|Overall Study|Other Reason per Case Report Form|103|||
161718399|NCT01088412|584014377|FG002|Overall Study|Other Reason per Case Report Form|9|||
161718400|NCT01088412|584014375|FG000|Overall Study|Withdrawal by Subject|1761|||
161718401|NCT01088412|584014376|FG001|Overall Study|Withdrawal by Subject|25|||
161718402|NCT01088412|584014377|FG002|Overall Study|Withdrawal by Subject|1|||
161718403|NCT01088412|584014375|FG000|Overall Study|Received Another GH Product|79|||
161718404|NCT01088412|584014376|FG001|Overall Study|Received Another GH Product|0|||
161718405|NCT01088412|584014377|FG002|Overall Study|Received Another GH Product|0|||
161718406|NCT01088412|584014375|FG000|Overall Study|Participant Moved|601|||
161718407|NCT01088412|584014376|FG001|Overall Study|Participant Moved|21|||
161718408|NCT01088412|584014377|FG002|Overall Study|Participant Moved|2|||
161718409|NCT01088412|584014375|FG000|Overall Study|Physician Decision|1041|||
161718410|NCT01088412|584014376|FG001|Overall Study|Physician Decision|8|||
161718411|NCT01088412|584014377|FG002|Overall Study|Physician Decision|4|||
161718412|NCT01088412|584014375|FG000|Overall Study|Sponsor Decision|4467|||
161718413|NCT01088412|584014376|FG001|Overall Study|Sponsor Decision|79|||
161718414|NCT01088412|584014377|FG002|Overall Study|Sponsor Decision|23|||
161718415|NCT01088412|584014375|FG000|Overall Study|Third Party Required to Change Brand|487|||
161718416|NCT01088412|584014376|FG001|Overall Study|Third Party Required to Change Brand|0|||
161718417|NCT01088412|584014377|FG002|Overall Study|Third Party Required to Change Brand|0|||
161718418|NCT01088412|584014375|FG000|Overall Study|Lost to Follow-up|3052|||
161718419|NCT01088412|584014376|FG001|Overall Study|Lost to Follow-up|130|||
161718420|NCT01088412|584014377|FG002|Overall Study|Lost to Follow-up|11|||
161718421|NCT01088412|584014375|FG000|Overall Study|Study Summary Not Completed|4360|||
161718422|NCT01088412|584014376|FG001|Overall Study|Study Summary Not Completed|64|||
161718423|NCT01088412|584014377|FG002|Overall Study|Study Summary Not Completed|22|||
161718424|NCT00793104|584014378|FG000|Overall Study|Lost to Follow-up|1|||
161718425|NCT03494725|584014381|FG000|Overall Study|Withdrawal by Subject|0|||
161718426|NCT03494725|584014382|FG001|Overall Study|Withdrawal by Subject|2|||
161718427|NCT03494725|584014381|FG000|Overall Study|Antibiotic use|1|||
161718428|NCT03494725|584014382|FG001|Overall Study|Antibiotic use|0|||
161718429|NCT02619253|584014383|FG000|Overall Study|Adverse Event|0|||
161718430|NCT02619253|584014384|FG001|Overall Study|Adverse Event|0|||
161718431|NCT02619253|584014385|FG002|Overall Study|Adverse Event|1|||
161718432|NCT02619253|584014386|FG003|Overall Study|Adverse Event|1|||
161718433|NCT02619253|584014387|FG004|Overall Study|Adverse Event|3|||
161718434|NCT02619253|584014383|FG000|Overall Study|Alternative Therapy|0|||
161718435|NCT02619253|584014384|FG001|Overall Study|Alternative Therapy|0|||
161718436|NCT02619253|584014385|FG002|Overall Study|Alternative Therapy|1|||
161718437|NCT02619253|584014386|FG003|Overall Study|Alternative Therapy|0|||
161718438|NCT02619253|584014387|FG004|Overall Study|Alternative Therapy|0|||
161718439|NCT02619253|584014383|FG000|Overall Study|Death|0|||
161718440|NCT02619253|584014384|FG001|Overall Study|Death|0|||
161718441|NCT02619253|584014385|FG002|Overall Study|Death|0|||
161718442|NCT02619253|584014386|FG003|Overall Study|Death|1|||
161718443|NCT02619253|584014387|FG004|Overall Study|Death|0|||
161718444|NCT02619253|584014383|FG000|Overall Study|Disease Progression|4|||
161718445|NCT02619253|584014384|FG001|Overall Study|Disease Progression|2|||
161718446|NCT02619253|584014385|FG002|Overall Study|Disease Progression|8|||
161718447|NCT02619253|584014386|FG003|Overall Study|Disease Progression|9|||
161718448|NCT02619253|584014387|FG004|Overall Study|Disease Progression|10|||
161718449|NCT02619253|584014383|FG000|Overall Study|Needed a disqualifying therapy|0|||
161718450|NCT02619253|584014384|FG001|Overall Study|Needed a disqualifying therapy|0|||
161718451|NCT02619253|584014385|FG002|Overall Study|Needed a disqualifying therapy|1|||
161718452|NCT02619253|584014386|FG003|Overall Study|Needed a disqualifying therapy|0|||
161718453|NCT02619253|584014387|FG004|Overall Study|Needed a disqualifying therapy|0|||
161718454|NCT02619253|584014383|FG000|Overall Study|Transferred to hospice|0|||
161718455|NCT02619253|584014384|FG001|Overall Study|Transferred to hospice|0|||
161718456|NCT02619253|584014385|FG002|Overall Study|Transferred to hospice|1|||
161718457|NCT02619253|584014386|FG003|Overall Study|Transferred to hospice|0|||
161718458|NCT02619253|584014387|FG004|Overall Study|Transferred to hospice|0|||
161718459|NCT02619253|584014383|FG000|Overall Study|Physician Decision|0|||
161718460|NCT02619253|584014384|FG001|Overall Study|Physician Decision|1|||
161718461|NCT02619253|584014385|FG002|Overall Study|Physician Decision|2|||
161718462|NCT02619253|584014386|FG003|Overall Study|Physician Decision|3|||
161718463|NCT02619253|584014387|FG004|Overall Study|Physician Decision|0|||
161718464|NCT02619253|584014383|FG000|Overall Study|Withdrawal by Subject|0|||
161718465|NCT02619253|584014384|FG001|Overall Study|Withdrawal by Subject|1|||
161718466|NCT02619253|584014385|FG002|Overall Study|Withdrawal by Subject|0|||
161718467|NCT02619253|584014386|FG003|Overall Study|Withdrawal by Subject|0|||
161718468|NCT02619253|584014387|FG004|Overall Study|Withdrawal by Subject|2|||
161718469|NCT02111811|584014388|FG000|Treatment Phase|Lost to Follow-up|22|||
161718470|NCT02111811|584014389|FG001|Treatment Phase|Lost to Follow-up|18|||
161718471|NCT02111811|584014388|FG000|Treatment Phase|Death|2|||
161718472|NCT02111811|584014389|FG001|Treatment Phase|Death|0|||
161718473|NCT02111811|584014388|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
161718474|NCT02111811|584014389|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
161718475|NCT02111811|584014388|FG000|Follow up Period (Aim 2)|Death|2|||
161963871|NCT02265536|584912053|FG002|Overall Study|Physician Decision|0|||
161963872|NCT02265536|584912054|FG003|Overall Study|Physician Decision|0|||
161963873|NCT02265536|584912055|FG004|Overall Study|Physician Decision|2|||
161718476|NCT02111811|584014389|FG001|Follow up Period (Aim 2)|Death|0|||
161718477|NCT03443024|584014392|FG000|Overall Study|Adverse Event|2|||
161718478|NCT03443024|584014393|FG001|Overall Study|Adverse Event|4|||
161718479|NCT03443024|584014394|FG002|Overall Study|Adverse Event|3|||
161718480|NCT03443024|584014395|FG003|Overall Study|Adverse Event|1|||
161718481|NCT03443024|584014392|FG000|Overall Study|Lost to Follow-up|9|||
161718482|NCT03443024|584014393|FG001|Overall Study|Lost to Follow-up|9|||
161718483|NCT03443024|584014394|FG002|Overall Study|Lost to Follow-up|7|||
161718484|NCT03443024|584014395|FG003|Overall Study|Lost to Follow-up|5|||
161718485|NCT03443024|584014392|FG000|Overall Study|Withdrawal by Subject|8|||
161963874|NCT02265536|584912056|FG005|Overall Study|Physician Decision|0|||
161718486|NCT03443024|584014393|FG001|Overall Study|Withdrawal by Subject|15|||
161718487|NCT03443024|584014394|FG002|Overall Study|Withdrawal by Subject|9|||
161718488|NCT03443024|584014395|FG003|Overall Study|Withdrawal by Subject|23|||
161718489|NCT03443024|584014392|FG000|Overall Study|Physician Decision|1|||
161963875|NCT02265536|584912051|FG000|Overall Study|Withdrawal by Subject|0|||
161718490|NCT03443024|584014393|FG001|Overall Study|Physician Decision|2|||
161718491|NCT03443024|584014394|FG002|Overall Study|Physician Decision|0|||
161718492|NCT03443024|584014395|FG003|Overall Study|Physician Decision|1|||
161718493|NCT03443024|584014392|FG000|Overall Study|Sponsor Decision|1|||
161718494|NCT03443024|584014393|FG001|Overall Study|Sponsor Decision|1|||
161718495|NCT03443024|584014394|FG002|Overall Study|Sponsor Decision|0|||
161718496|NCT03443024|584014395|FG003|Overall Study|Sponsor Decision|0|||
161718497|NCT03443024|584014392|FG000|Overall Study|Protocol Deviation|0|||
161718498|NCT03443024|584014393|FG001|Overall Study|Protocol Deviation|0|||
161718499|NCT03443024|584014394|FG002|Overall Study|Protocol Deviation|0|||
161718500|NCT03443024|584014395|FG003|Overall Study|Protocol Deviation|2|||
161718501|NCT00301067|584014396|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
161718502|NCT00301067|584014397|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
161718503|NCT00301067|584014398|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
161718504|NCT00301067|584014399|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
161718505|NCT00301067|584014396|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
161718506|NCT00301067|584014397|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
161718507|NCT00301067|584014398|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
161718508|NCT00301067|584014399|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
161718509|NCT00301067|584014396|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
161718510|NCT00301067|584014397|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
161718511|NCT00301067|584014398|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
161718512|NCT00301067|584014399|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
161718513|NCT00301067|584014396|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
161718514|NCT00301067|584014397|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
161718515|NCT00301067|584014398|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
161718516|NCT00301067|584014399|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
161718517|NCT00301067|584014396|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
161718518|NCT00301067|584014397|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
161718519|NCT00301067|584014398|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
161718520|NCT00301067|584014399|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
161718521|NCT00301067|584014396|FG000|Follow up Until Death|Alive at last data cut point|1|||
161718522|NCT00301067|584014397|FG001|Follow up Until Death|Alive at last data cut point|0|||
161718523|NCT00301067|584014398|FG002|Follow up Until Death|Alive at last data cut point|0|||
161718524|NCT00301067|584014399|FG003|Follow up Until Death|Alive at last data cut point|1|||
161718525|NCT00149825|584014400|FG000|Overall Study|Intolerance to medication side effects|1|||
161718526|NCT00149825|584014401|FG001|Overall Study|Intolerance to medication side effects|2|||
161718527|NCT00149825|584014400|FG000|Overall Study|Time commitments|2|||
161718528|NCT00149825|584014401|FG001|Overall Study|Time commitments|1|||
161718529|NCT00149825|584014400|FG000|Overall Study|Not liking insomnia therapy|1|||
161718530|NCT00149825|584014401|FG001|Overall Study|Not liking insomnia therapy|0|||
161718531|NCT00149825|584014400|FG000|Overall Study|Other|1|||
161718532|NCT00149825|584014401|FG001|Overall Study|Other|0|||
161718533|NCT01359982|584014402|FG000|Overall Study|Adverse Event|2|||
161718534|NCT01359982|584014403|FG001|Overall Study|Adverse Event|0|||
161718535|NCT01359982|584014404|FG002|Overall Study|Adverse Event|0|||
161718536|NCT01359982|584014405|FG003|Overall Study|Adverse Event|1|||
161718537|NCT01359982|584014406|FG004|Overall Study|Adverse Event|0|||
161718538|NCT01359982|584014407|FG005|Overall Study|Adverse Event|0|||
161718539|NCT01359982|584014402|FG000|Overall Study|Death|1|||
161718540|NCT01359982|584014403|FG001|Overall Study|Death|0|||
161718541|NCT01359982|584014404|FG002|Overall Study|Death|0|||
161718542|NCT01359982|584014405|FG003|Overall Study|Death|0|||
161718543|NCT01359982|584014406|FG004|Overall Study|Death|0|||
161718544|NCT01359982|584014407|FG005|Overall Study|Death|0|||
161718545|NCT05593432|584014408|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
161718546|NCT05593432|584014409|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
161718547|NCT05593432|584014410|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
161718548|NCT05593432|584014411|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
161718549|NCT05593432|584014408|FG000|16-Week OLE Period|Lack of Efficacy|0|||
161718550|NCT05593432|584014409|FG001|16-Week OLE Period|Lack of Efficacy|0|||
161718551|NCT05593432|584014410|FG002|16-Week OLE Period|Lack of Efficacy|0|||
161718552|NCT05593432|584014411|FG003|16-Week OLE Period|Lack of Efficacy|1|||
161718553|NCT05593432|584014408|FG000|16-Week OLE Period|Lost to Follow-up|0|||
161718554|NCT05593432|584014409|FG001|16-Week OLE Period|Lost to Follow-up|0|||
161718555|NCT05593432|584014410|FG002|16-Week OLE Period|Lost to Follow-up|1|||
161718556|NCT05593432|584014411|FG003|16-Week OLE Period|Lost to Follow-up|2|||
161718557|NCT05593432|584014408|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
161718558|NCT05593432|584014409|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
161718559|NCT05593432|584014410|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
161718560|NCT05593432|584014411|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
161718561|NCT01450137|584014413|FG000|Up to Week 12|Adverse Event|2|||
161718562|NCT01450137|584014414|FG001|Up to Week 12|Adverse Event|1|||
161718563|NCT01450137|584014413|FG000|Up to Week 12|Withdrawal by Subject|0|||
161718564|NCT01450137|584014414|FG001|Up to Week 12|Withdrawal by Subject|2|||
161718565|NCT01450137|584014413|FG000|Week 12 to Study End|Death|0|||
161718566|NCT01450137|584014414|FG001|Week 12 to Study End|Death|1|||
161718567|NCT01450137|584014413|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
161718568|NCT01450137|584014414|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
161718569|NCT01926886|584014415|FG000|Overall Study|Administrative/other|1|||
161718570|NCT01926886|584014416|FG001|Overall Study|Administrative/other|0|||
161718571|NCT01926886|584014415|FG000|Overall Study|Adverse event/intercurrent illness|4|||
161718572|NCT01926886|584014416|FG001|Overall Study|Adverse event/intercurrent illness|0|||
161718573|NCT01926886|584014415|FG000|Overall Study|Disease progression/recurrence|4|||
161718574|NCT01926886|584014416|FG001|Overall Study|Disease progression/recurrence|0|||
161718575|NCT01926886|584014415|FG000|Overall Study|Withdrawal by Subject|15|||
161718576|NCT01926886|584014416|FG001|Overall Study|Withdrawal by Subject|0|||
161718577|NCT01926886|584014415|FG000|Overall Study|Failure to return|3|||
161718578|NCT01926886|584014416|FG001|Overall Study|Failure to return|0|||
161718579|NCT01926886|584014415|FG000|Overall Study|Recurrence of disease|1|||
161718580|NCT01926886|584014416|FG001|Overall Study|Recurrence of disease|0|||
161718581|NCT01926886|584014415|FG000|Overall Study|Progression of disease|2|||
161718582|NCT01926886|584014416|FG001|Overall Study|Progression of disease|0|||
161718583|NCT01926886|584014415|FG000|Overall Study|Death|1|||
161718584|NCT01926886|584014416|FG001|Overall Study|Death|0|||
161718585|NCT01926886|584014415|FG000|Overall Study|Did not cooperate|1|||
161718586|NCT01926886|584014416|FG001|Overall Study|Did not cooperate|0|||
161718587|NCT02986373|584014417|FG000|Overall Study|Adverse Event|4|||
161718588|NCT02986373|584014417|FG000|Overall Study|Lost to Follow-up|1|||
161718589|NCT02986373|584014417|FG000|Overall Study|Withdrawal by Subject|10|||
161718590|NCT02986373|584014417|FG000|Overall Study|Other|24|||
161718591|NCT00069121|584014418|FG000|Overall Study|Death|286|||
161718592|NCT00069121|584014419|FG001|Overall Study|Death|242|||
161718593|NCT00069121|584014418|FG000|Overall Study|Withdrawal by Subject|18|||
161718594|NCT00069121|584014419|FG001|Overall Study|Withdrawal by Subject|20|||
161718595|NCT00069121|584014418|FG000|Overall Study|Lost to Follow-up|63|||
161718596|NCT00069121|584014419|FG001|Overall Study|Lost to Follow-up|63|||
161718597|NCT04800315|584014420|FG000|Randomization|Did not receive study treatment|1|||
161718598|NCT04800315|584014421|FG001|Randomization|Did not receive study treatment|0|||
161718599|NCT04800315|584014422|FG002|Randomization|Did not receive study treatment|0|||
161718600|NCT04800315|584014423|FG003|Randomization|Did not receive study treatment|0|||
161718601|NCT04800315|584014420|FG000|Treatment Period|Adverse Event|4|||
161718602|NCT04800315|584014421|FG001|Treatment Period|Adverse Event|2|||
161718603|NCT04800315|584014422|FG002|Treatment Period|Adverse Event|1|||
161718604|NCT04800315|584014423|FG003|Treatment Period|Adverse Event|2|||
161718605|NCT04800315|584014420|FG000|Treatment Period|Lack of Efficacy|1|||
161718606|NCT04800315|584014421|FG001|Treatment Period|Lack of Efficacy|0|||
161718607|NCT04800315|584014422|FG002|Treatment Period|Lack of Efficacy|0|||
161718608|NCT04800315|584014423|FG003|Treatment Period|Lack of Efficacy|3|||
161718609|NCT04800315|584014420|FG000|Treatment Period|Lost to Follow-up|0|||
161718610|NCT04800315|584014421|FG001|Treatment Period|Lost to Follow-up|1|||
161718611|NCT04800315|584014422|FG002|Treatment Period|Lost to Follow-up|2|||
161718612|NCT04800315|584014423|FG003|Treatment Period|Lost to Follow-up|2|||
161718613|NCT04800315|584014420|FG000|Treatment Period|Withdrawal by participant|0|||
161718614|NCT04800315|584014421|FG001|Treatment Period|Withdrawal by participant|0|||
161718615|NCT04800315|584014422|FG002|Treatment Period|Withdrawal by participant|0|||
161718616|NCT04800315|584014423|FG003|Treatment Period|Withdrawal by participant|4|||
161718617|NCT04800315|584014420|FG000|Treatment Period|Other Reasons|0|||
161718618|NCT04800315|584014421|FG001|Treatment Period|Other Reasons|2|||
161963876|NCT02265536|584912052|FG001|Overall Study|Withdrawal by Subject|3|||
161963877|NCT02265536|584912053|FG002|Overall Study|Withdrawal by Subject|0|||
161963878|NCT02265536|584912054|FG003|Overall Study|Withdrawal by Subject|0|||
161718619|NCT04800315|584014422|FG002|Treatment Period|Other Reasons|0|||
161718620|NCT04800315|584014423|FG003|Treatment Period|Other Reasons|1|||
161718621|NCT00753922|584014424|FG000|Overall Study|Lost to Follow-up|155|||
161718622|NCT00753922|584014425|FG001|Overall Study|Lost to Follow-up|24|||
161718623|NCT00753922|584014426|FG002|Overall Study|Lost to Follow-up|28|||
161718624|NCT00753922|584014427|FG003|Overall Study|Lost to Follow-up|5|||
161718625|NCT00753922|584014424|FG000|Overall Study|Withdrawal by Subject|9|||
161718626|NCT00753922|584014425|FG001|Overall Study|Withdrawal by Subject|11|||
161718627|NCT00753922|584014426|FG002|Overall Study|Withdrawal by Subject|4|||
161718628|NCT00753922|584014427|FG003|Overall Study|Withdrawal by Subject|2|||
161718629|NCT00753922|584014424|FG000|Overall Study|Patient Non-compliance|55|||
161718630|NCT00753922|584014425|FG001|Overall Study|Patient Non-compliance|22|||
161718631|NCT00753922|584014426|FG002|Overall Study|Patient Non-compliance|14|||
161718632|NCT00753922|584014427|FG003|Overall Study|Patient Non-compliance|11|||
161718633|NCT00753922|584014424|FG000|Overall Study|Patients Not Completing Visit|11|||
161718634|NCT00753922|584014425|FG001|Overall Study|Patients Not Completing Visit|0|||
161718635|NCT00753922|584014426|FG002|Overall Study|Patients Not Completing Visit|1|||
161718636|NCT00753922|584014427|FG003|Overall Study|Patients Not Completing Visit|0|||
161718637|NCT00753922|584014424|FG000|Overall Study|Death|2|||
161718638|NCT00753922|584014425|FG001|Overall Study|Death|23|||
161718639|NCT00753922|584014426|FG002|Overall Study|Death|2|||
161718640|NCT00753922|584014427|FG003|Overall Study|Death|1|||
161718641|NCT00753922|584014424|FG000|Overall Study|Discontinuation Due to Explantation|14|||
161718642|NCT00753922|584014425|FG001|Overall Study|Discontinuation Due to Explantation|14|||
161718643|NCT00753922|584014426|FG002|Overall Study|Discontinuation Due to Explantation|14|||
161718644|NCT00753922|584014427|FG003|Overall Study|Discontinuation Due to Explantation|4|||
161718645|NCT02983292|584014432|FG000|Overall Study|Participant unwell & cannot travel|2|||
161718646|NCT02983292|584014432|FG000|Overall Study|Lost to Follow-up|3|||
161718647|NCT02983292|584014432|FG000|Overall Study|Participant withdrew consent|2|||
161718648|NCT02983292|584014432|FG000|Overall Study|Revision|7|||
161718649|NCT02983292|584014432|FG000|Overall Study|Death|1|||
161718650|NCT02983292|584014432|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
161718651|NCT02983292|584014432|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
161718652|NCT02983292|584014432|FG000|Overall Study|Participant relocation|1|||
161718653|NCT00857246|584014433|FG000|Induction Regimen|Adverse Event|1|||
161718654|NCT00857246|584014433|FG000|Induction Regimen|disease-related complications|1|||
161718655|NCT00857246|584014433|FG000|Induction Regimen|Withdrawal by Subject|1|||
161718656|NCT00857246|584014433|FG000|Surgery (Curative)|disease progression|6|||
161718657|NCT00857246|584014433|FG000|ChemoRT|Withdrawal by Subject|1|||
161718658|NCT00857246|584014433|FG000|ChemoRT|Adverse Event|2|||
161718659|NCT03851510|584014434|FG000|Overall Study|Screen Fail|1|||
161718660|NCT03851510|584014434|FG000|Overall Study|Adverse Event|1|||
161718661|NCT03851510|584014434|FG000|Overall Study|Withdrawal by Subject|1|||
161718662|NCT02426086|584014435|FG000|Overall Study|Death|33|||
161718663|NCT02426086|584014436|FG001|Overall Study|Death|36|||
161718664|NCT02426086|584014435|FG000|Overall Study|Lost to Follow-up|2|||
161718665|NCT02426086|584014436|FG001|Overall Study|Lost to Follow-up|0|||
161718666|NCT02426086|584014435|FG000|Overall Study|Study Terminated by Sponsor|5|||
161718667|NCT02426086|584014436|FG001|Overall Study|Study Terminated by Sponsor|14|||
161718668|NCT02426086|584014435|FG000|Overall Study|Withdrawal by Subject|8|||
161718669|NCT02426086|584014436|FG001|Overall Study|Withdrawal by Subject|9|||
161718670|NCT04542291|584014437|FG000|Overall Study|Adverse Event|1|||
161718671|NCT04542291|584014437|FG000|Overall Study|Physician Decision|2|||
161718672|NCT01287117|584014438|FG000|Overall Study|Adverse Event|2|||
161718673|NCT01287117|584014439|FG001|Overall Study|Adverse Event|1|||
161718674|NCT01287117|584014440|FG002|Overall Study|Adverse Event|1|||
161718675|NCT01287117|584014441|FG003|Overall Study|Adverse Event|1|||
161718676|NCT01287117|584014438|FG000|Overall Study|Lost to Follow-up|1|||
161718677|NCT01287117|584014439|FG001|Overall Study|Lost to Follow-up|1|||
161718678|NCT01287117|584014440|FG002|Overall Study|Lost to Follow-up|0|||
161718679|NCT01287117|584014441|FG003|Overall Study|Lost to Follow-up|0|||
161718680|NCT01287117|584014438|FG000|Overall Study|Physician Decision|0|||
161718681|NCT01287117|584014439|FG001|Overall Study|Physician Decision|1|||
161718682|NCT01287117|584014440|FG002|Overall Study|Physician Decision|1|||
161718683|NCT01287117|584014441|FG003|Overall Study|Physician Decision|1|||
161718684|NCT01287117|584014438|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
161718685|NCT01287117|584014439|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
161718686|NCT01287117|584014440|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
161718687|NCT01287117|584014441|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
161718688|NCT01287117|584014438|FG000|Overall Study|Disease Progression|10|||
161718689|NCT01287117|584014439|FG001|Overall Study|Disease Progression|5|||
161718690|NCT01287117|584014440|FG002|Overall Study|Disease Progression|6|||
161718691|NCT01287117|584014441|FG003|Overall Study|Disease Progression|5|||
161718692|NCT00035815|584014449|FG000|Overall Study|Withdrawal by Subject|17|||
161718693|NCT00035815|584014450|FG001|Overall Study|Withdrawal by Subject|11|||
161718694|NCT02606877|584014456|FG000|Overall Study|Adverse Event|3|||
161718695|NCT02606877|584014457|FG001|Overall Study|Adverse Event|0|||
161718696|NCT02606877|584014456|FG000|Overall Study|Non-compliance with protocol|0|||
161718697|NCT02606877|584014457|FG001|Overall Study|Non-compliance with protocol|1|||
161718698|NCT02606877|584014456|FG000|Overall Study|Other than listed above|1|||
161718699|NCT02606877|584014457|FG001|Overall Study|Other than listed above|0|||
161718700|NCT04952389|584014460|FG000|Overall Study|Withdrawal by Subject|8|||
161718701|NCT04952389|584014461|FG001|Overall Study|Withdrawal by Subject|4|||
161718702|NCT04285723|584014464|FG000|Overall Study|Subject decision|1|||
161718703|NCT04285723|584014465|FG001|Overall Study|Subject decision|2|||
161718704|NCT04285723|584014464|FG000|Overall Study|Physician Decision|1|||
161718705|NCT04285723|584014465|FG001|Overall Study|Physician Decision|0|||
161718706|NCT04285723|584014464|FG000|Overall Study|No efficiency|1|||
161718707|NCT04285723|584014465|FG001|Overall Study|No efficiency|0|||
161718708|NCT00778999|584014466|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
161718709|NCT00778999|584014467|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
161718710|NCT00778999|584014466|FG000|Overall Study|Did not receive recFSH|14|||
161718711|NCT00778999|584014467|FG001|Overall Study|Did not receive recFSH|20|||
161718712|NCT02032524|584014468|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
161718713|NCT02032524|584014469|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
161718714|NCT02032524|584014470|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
161718715|NCT02032524|584014471|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
161718716|NCT02032524|584014472|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
161718717|NCT02032524|584014473|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
161718718|NCT02032524|584014468|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
161718719|NCT02032524|584014469|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
161718720|NCT02032524|584014470|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
161718721|NCT02032524|584014471|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
161718722|NCT02032524|584014472|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
161718723|NCT02032524|584014473|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
161718724|NCT02032524|584014468|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
161718725|NCT02032524|584014469|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
161718726|NCT02032524|584014470|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
161718727|NCT02032524|584014471|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
161718728|NCT02032524|584014472|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
161718729|NCT02032524|584014473|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
161718730|NCT02032524|584014468|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
161963879|NCT02265536|584912055|FG004|Overall Study|Withdrawal by Subject|0|||
161963880|NCT02265536|584912056|FG005|Overall Study|Withdrawal by Subject|0|||
161963881|NCT00349349|584912059|FG000|Overall Study|Adverse Event|5|||
161963882|NCT00349349|584912060|FG001|Overall Study|Adverse Event|6|||
161963883|NCT00349349|584912061|FG002|Overall Study|Adverse Event|2|||
161963884|NCT00349349|584912059|FG000|Overall Study|Withdrawal by Subject|5|||
161963885|NCT00349349|584912060|FG001|Overall Study|Withdrawal by Subject|2|||
161963886|NCT00349349|584912061|FG002|Overall Study|Withdrawal by Subject|1|||
161963887|NCT00349349|584912059|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
161963888|NCT00349349|584912060|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
161963889|NCT00349349|584912061|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
161963890|NCT00349349|584912059|FG000|Overall Study|Death|13|||
161963891|NCT00349349|584912060|FG001|Overall Study|Death|10|||
161963892|NCT00349349|584912061|FG002|Overall Study|Death|1|||
161963893|NCT00349349|584912059|FG000|Overall Study|Other Treatment Selected|2|||
161963894|NCT00349349|584912060|FG001|Overall Study|Other Treatment Selected|0|||
161963895|NCT00349349|584912061|FG002|Overall Study|Other Treatment Selected|0|||
161963896|NCT00349349|584912059|FG000|Overall Study|Participant Reduced General Condition|0|||
161718731|NCT02032524|584014469|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
161718732|NCT02032524|584014470|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
161718733|NCT02032524|584014471|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
161718734|NCT02032524|584014472|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
161718735|NCT02032524|584014473|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
161718736|NCT02032524|584014468|FG000|Period 2: LTS13769 Study|Other|0|||
161718737|NCT02032524|584014469|FG001|Period 2: LTS13769 Study|Other|0|||
161718738|NCT02032524|584014470|FG002|Period 2: LTS13769 Study|Other|0|||
161718739|NCT02032524|584014471|FG003|Period 2: LTS13769 Study|Other|0|||
161718740|NCT02032524|584014472|FG004|Period 2: LTS13769 Study|Other|0|||
161718741|NCT02032524|584014473|FG005|Period 2: LTS13769 Study|Other|1|||
161718742|NCT05635838|584015816|FG000|16-Week DBVC Period|Adverse Event|2|||
161718743|NCT05635838|584015817|FG001|16-Week DBVC Period|Adverse Event|0|||
161718744|NCT05635838|584015818|FG002|16-Week DBVC Period|Adverse Event|0|||
161718745|NCT05635838|584015819|FG003|16-Week DBVC Period|Adverse Event|0|||
161718746|NCT05635838|584015816|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
161718747|NCT05635838|584015817|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
161718748|NCT05635838|584015818|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
161718749|NCT05635838|584015819|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
161718750|NCT05635838|584015816|FG000|16-Week DBVC Period|Physician Decision|0|||
161718751|NCT05635838|584015817|FG001|16-Week DBVC Period|Physician Decision|1|||
161718752|NCT05635838|584015818|FG002|16-Week DBVC Period|Physician Decision|0|||
161718753|NCT05635838|584015819|FG003|16-Week DBVC Period|Physician Decision|0|||
161718754|NCT05635838|584015816|FG000|16-Week DBVC Period|Protocol Violation|1|||
161718755|NCT05635838|584015817|FG001|16-Week DBVC Period|Protocol Violation|0|||
161718756|NCT05635838|584015818|FG002|16-Week DBVC Period|Protocol Violation|0|||
161718757|NCT05635838|584015819|FG003|16-Week DBVC Period|Protocol Violation|0|||
161718758|NCT05635838|584015816|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
161718759|NCT05635838|584015817|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
161718760|NCT05635838|584015818|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
161963897|NCT00349349|584912060|FG001|Overall Study|Participant Reduced General Condition|1|||
161963898|NCT00349349|584912061|FG002|Overall Study|Participant Reduced General Condition|0|||
161963899|NCT00349349|584912059|FG000|Overall Study|Physician Decision|1|||
161963900|NCT00349349|584912060|FG001|Overall Study|Physician Decision|2|||
161963901|NCT00349349|584912061|FG002|Overall Study|Physician Decision|1|||
161963902|NCT00349349|584912059|FG000|Overall Study|No Response|0|||
161963903|NCT00349349|584912060|FG001|Overall Study|No Response|3|||
161963904|NCT00349349|584912061|FG002|Overall Study|No Response|0|||
161963905|NCT00349349|584912059|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
161963906|NCT00349349|584912060|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
161718761|NCT05635838|584015819|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
161718762|NCT05635838|584015816|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
161718763|NCT05635838|584015817|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
161718764|NCT05635838|584015818|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
161718765|NCT05635838|584015819|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
161718766|NCT05635838|584015816|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
161718767|NCT05635838|584015817|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
161718768|NCT05635838|584015818|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
161718769|NCT05635838|584015819|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
161718770|NCT05635838|584015816|FG000|16-Week OLE Period|Adverse Event|0|||
161718771|NCT05635838|584015817|FG001|16-Week OLE Period|Adverse Event|0|||
161718772|NCT05635838|584015818|FG002|16-Week OLE Period|Adverse Event|0|||
161718773|NCT05635838|584015819|FG003|16-Week OLE Period|Adverse Event|2|||
161718774|NCT05635838|584015816|FG000|16-Week OLE Period|Lost to Follow-up|0|||
161718775|NCT05635838|584015817|FG001|16-Week OLE Period|Lost to Follow-up|0|||
161718776|NCT05635838|584015818|FG002|16-Week OLE Period|Lost to Follow-up|1|||
161718777|NCT05635838|584015819|FG003|16-Week OLE Period|Lost to Follow-up|3|||
161718778|NCT05635838|584015816|FG000|16-Week OLE Period|Physician Decision|0|||
161718779|NCT05635838|584015817|FG001|16-Week OLE Period|Physician Decision|0|||
161718780|NCT05635838|584015818|FG002|16-Week OLE Period|Physician Decision|0|||
161718781|NCT05635838|584015819|FG003|16-Week OLE Period|Physician Decision|1|||
161718782|NCT05635838|584015816|FG000|16-Week OLE Period|Protocol Violation|0|||
161718783|NCT05635838|584015817|FG001|16-Week OLE Period|Protocol Violation|0|||
161718784|NCT05635838|584015818|FG002|16-Week OLE Period|Protocol Violation|1|||
161963907|NCT00349349|584912061|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
161963908|NCT02907216|584912062|FG000|Overall Study|No benefit to be obtained by continuing|0|||
161963909|NCT02907216|584912063|FG001|Overall Study|No benefit to be obtained by continuing|1|||
161963910|NCT02907216|584912062|FG000|Overall Study|Withdrawal by Subject|1|||
161963911|NCT02907216|584912063|FG001|Overall Study|Withdrawal by Subject|0|||
161963912|NCT02485639|584912066|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
161963913|NCT02485639|584912066|FG000|Overall Study|Early termination|4|||
161718785|NCT05635838|584015819|FG003|16-Week OLE Period|Protocol Violation|1|||
161718786|NCT05635838|584015816|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
161718787|NCT05635838|584015817|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
161718788|NCT05635838|584015818|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
161718789|NCT05635838|584015819|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
161718790|NCT05635838|584015816|FG000|16-Week OLE Period|Pregnancy|0|||
161718791|NCT05635838|584015817|FG001|16-Week OLE Period|Pregnancy|0|||
161718792|NCT05635838|584015818|FG002|16-Week OLE Period|Pregnancy|1|||
161718793|NCT05635838|584015819|FG003|16-Week OLE Period|Pregnancy|0|||
161718794|NCT01486316|584015820|FG000|Overall Study|Device explanted with/without re-implant|3|||
161718795|NCT01486316|584015821|FG001|Overall Study|Device explanted with/without re-implant|2|||
161718796|NCT01486316|584015822|FG002|Overall Study|Device explanted with/without re-implant|0|||
161718797|NCT01486316|584015823|FG003|Overall Study|Device explanted with/without re-implant|2|||
161718798|NCT01486316|584015820|FG000|Overall Study|Not meeting eligibility criteria|0|||
161718799|NCT01486316|584015821|FG001|Overall Study|Not meeting eligibility criteria|0|||
161718800|NCT01486316|584015822|FG002|Overall Study|Not meeting eligibility criteria|1|||
161718801|NCT01486316|584015823|FG003|Overall Study|Not meeting eligibility criteria|0|||
161718802|NCT01486316|584015820|FG000|Overall Study|Withdrawal by Subject|1|||
161718803|NCT01486316|584015821|FG001|Overall Study|Withdrawal by Subject|0|||
161718804|NCT01486316|584015822|FG002|Overall Study|Withdrawal by Subject|3|||
161718805|NCT01486316|584015823|FG003|Overall Study|Withdrawal by Subject|0|||
161718806|NCT01486316|584015820|FG000|Overall Study|Physician Decision|0|||
161718807|NCT01486316|584015821|FG001|Overall Study|Physician Decision|0|||
161718808|NCT01486316|584015822|FG002|Overall Study|Physician Decision|1|||
161718809|NCT01486316|584015823|FG003|Overall Study|Physician Decision|0|||
161718810|NCT01486316|584015820|FG000|Overall Study|Death|0|||
161718811|NCT01486316|584015821|FG001|Overall Study|Death|1|||
161718812|NCT01486316|584015822|FG002|Overall Study|Death|0|||
161718813|NCT01486316|584015823|FG003|Overall Study|Death|0|||
161718814|NCT05094154|584015831|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
161718815|NCT05094154|584015832|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
161718816|NCT05094154|584015831|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
161718817|NCT05094154|584015832|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
161718818|NCT01266148|584015839|FG000|Overall Study|Adverse Event|2|||
161718819|NCT01266148|584015840|FG001|Overall Study|Adverse Event|0|||
161718820|NCT01266148|584015839|FG000|Overall Study|Ongoing rejection|1|||
161718821|NCT01266148|584015840|FG001|Overall Study|Ongoing rejection|0|||
161718822|NCT01266148|584015839|FG000|Overall Study|2 2R rejections|1|||
161718823|NCT01266148|584015840|FG001|Overall Study|2 2R rejections|0|||
161718824|NCT01266148|584015839|FG000|Overall Study|Death|2|||
161718825|NCT01266148|584015840|FG001|Overall Study|Death|3|||
161963914|NCT02485639|584912066|FG000|Overall Study|Withdrawal by Subject|4|||
161718826|NCT01266148|584015839|FG000|Overall Study|missing mGFR value + AE|1|||
161718827|NCT01266148|584015840|FG001|Overall Study|missing mGFR value + AE|0|||
161718828|NCT02531035|584015841|FG000|Overall Study|Death|0|||
161963915|NCT02640625|584914941|FG000|Overall Study|Adverse Event|1|||
161963916|NCT00197145|584914942|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
161963917|NCT00197145|584914943|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
161963918|NCT00197145|584914942|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
161963919|NCT00197145|584914943|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
161963920|NCT00197145|584914942|FG000|Period 1: Randomized Treatment Phase|Other|2|||
161963921|NCT00197145|584914943|FG001|Period 1: Randomized Treatment Phase|Other|2|||
161963922|NCT00197145|584914942|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
161963923|NCT00197145|584914943|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
161963924|NCT00197145|584914942|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
161963925|NCT00197145|584914943|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
161963926|NCT00197145|584914942|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
161963927|NCT00197145|584914943|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
161963928|NCT00197145|584914942|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
161963929|NCT00197145|584914943|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
161963930|NCT00197145|584914942|FG000|Period 2 : Open Label Phase|Other|1|||
161963931|NCT00197145|584914943|FG001|Period 2 : Open Label Phase|Other|0|||
161963932|NCT00790868|584914944|FG000|Overall Study|Withdrawal by Subject|4|||
161963933|NCT00790868|584914945|FG001|Overall Study|Withdrawal by Subject|5|||
161963934|NCT00790868|584914944|FG000|Overall Study|Lost to Follow-up|2|||
161963935|NCT00790868|584914945|FG001|Overall Study|Lost to Follow-up|12|||
161963936|NCT02013206|584914949|FG000|Overall Study|Progressive disease (PD)|14|||
161963937|NCT02013206|584914950|FG001|Overall Study|Progressive disease (PD)|17|||
161963938|NCT02013206|584914949|FG000|Overall Study|Symptomatic deterioration|3|||
161963939|NCT02013206|584914950|FG001|Overall Study|Symptomatic deterioration|1|||
161963940|NCT02013206|584914949|FG000|Overall Study|Adverse Event|1|||
161963941|NCT02013206|584914950|FG001|Overall Study|Adverse Event|0|||
161963942|NCT02013206|584914949|FG000|Overall Study|Patient refusal|2|||
161963943|NCT02013206|584914950|FG001|Overall Study|Patient refusal|0|||
161963944|NCT02013206|584914949|FG000|Overall Study|Patient non-compliance|1|||
161963945|NCT02013206|584914950|FG001|Overall Study|Patient non-compliance|0|||
161963946|NCT02013206|584914949|FG000|Overall Study|Death|1|||
161963947|NCT02013206|584914950|FG001|Overall Study|Death|2|||
161963948|NCT02013206|584914949|FG000|Overall Study|Other reasons off treatment|5|||
161963949|NCT02013206|584914950|FG001|Overall Study|Other reasons off treatment|2|||
161963950|NCT02867813|584914951|FG000|Overall Study|Withdrawal by Subject|57|||
161963951|NCT02867813|584914952|FG001|Overall Study|Withdrawal by Subject|56|||
161963952|NCT02867813|584914951|FG000|Overall Study|Decision by Sponsor|7|||
161963953|NCT02867813|584914952|FG001|Overall Study|Decision by Sponsor|7|||
161963954|NCT02867813|584914951|FG000|Overall Study|Lost to Follow-up|91|||
161718829|NCT02531035|584015842|FG001|Overall Study|Death|1|||
161718830|NCT02531035|584015841|FG000|Overall Study|Protocol Violation|1|||
161718831|NCT02531035|584015842|FG001|Overall Study|Protocol Violation|1|||
161718832|NCT02531035|584015841|FG000|Overall Study|Noncompliance with study drug|8|||
161718833|NCT02531035|584015842|FG001|Overall Study|Noncompliance with study drug|3|||
161718834|NCT02531035|584015841|FG000|Overall Study|Physician Decision|1|||
161718835|NCT02531035|584015842|FG001|Overall Study|Physician Decision|0|||
161718836|NCT02531035|584015841|FG000|Overall Study|Adverse Event|16|||
161718837|NCT02531035|584015842|FG001|Overall Study|Adverse Event|45|||
161718838|NCT02531035|584015841|FG000|Overall Study|Other|3|||
161718839|NCT02531035|584015842|FG001|Overall Study|Other|2|||
161718840|NCT02531035|584015841|FG000|Overall Study|Withdrawal by Subject|42|||
161718841|NCT02531035|584015842|FG001|Overall Study|Withdrawal by Subject|32|||
161718842|NCT02531035|584015841|FG000|Overall Study|Lost to Follow-up|8|||
161963955|NCT02867813|584914952|FG001|Overall Study|Lost to Follow-up|78|||
161963956|NCT02867813|584914951|FG000|Overall Study|Missing|2|||
161963957|NCT02867813|584914952|FG001|Overall Study|Missing|1|||
161963958|NCT02867813|584914951|FG000|Overall Study|Death|294|||
161963959|NCT02867813|584914952|FG001|Overall Study|Death|268|||
161963960|NCT05425732|584914953|FG000|Overall Study|Death|4|||
161963961|NCT05425732|584914954|FG001|Overall Study|Death|2|||
161963962|NCT05425732|584914955|FG002|Overall Study|Death|0|||
161963963|NCT05425732|584914956|FG003|Overall Study|Death|0|||
161963964|NCT05425732|584914953|FG000|Overall Study|Lost to Follow-up|10|||
161963965|NCT05425732|584914954|FG001|Overall Study|Lost to Follow-up|15|||
162032141|NCT00814801|585174218|FG000|Overall Study|Adverse Event|15|||
161718843|NCT02531035|584015842|FG001|Overall Study|Lost to Follow-up|10|||
161963966|NCT05425732|584914955|FG002|Overall Study|Lost to Follow-up|5|||
161963967|NCT05425732|584914956|FG003|Overall Study|Lost to Follow-up|3|||
161963968|NCT05425732|584914953|FG000|Overall Study|Physician Decision|0|||
161963969|NCT05425732|584914954|FG001|Overall Study|Physician Decision|2|||
161963970|NCT05425732|584914955|FG002|Overall Study|Physician Decision|0|||
161963971|NCT05425732|584914956|FG003|Overall Study|Physician Decision|0|||
161718844|NCT02531035|584015841|FG000|Overall Study|Randomized, not treated|2|||
161718845|NCT02531035|584015842|FG001|Overall Study|Randomized, not treated|1|||
161718846|NCT01543490|584015843|FG000|Overall Study|Adverse Event|4|||
161718847|NCT01543490|584015844|FG001|Overall Study|Adverse Event|0|||
161718848|NCT01543490|584015843|FG000|Overall Study|Physician Decision|1|||
161718849|NCT01543490|584015844|FG001|Overall Study|Physician Decision|0|||
161718850|NCT01543490|584015843|FG000|Overall Study|Lack of Efficacy|3|||
161718851|NCT01543490|584015844|FG001|Overall Study|Lack of Efficacy|3|||
161718852|NCT01543490|584015843|FG000|Overall Study|Lost to Follow-up|5|||
161718853|NCT01543490|584015844|FG001|Overall Study|Lost to Follow-up|0|||
161718854|NCT01543490|584015843|FG000|Overall Study|Withdrawal by Subject|2|||
161718855|NCT01543490|584015844|FG001|Overall Study|Withdrawal by Subject|0|||
161718856|NCT01543490|584015843|FG000|Overall Study|Other-Various Administrative Reasons|1|||
161718857|NCT01543490|584015844|FG001|Overall Study|Other-Various Administrative Reasons|2|||
161718858|NCT01853228|584015848|FG000|Phase 1|Lack of Efficacy|8|||
161718859|NCT01853228|584015849|FG001|Phase 1|Lack of Efficacy|0|||
161718860|NCT01853228|584015848|FG000|Phase 1|Other|1|||
161718861|NCT01853228|584015849|FG001|Phase 1|Other|0|||
161718862|NCT01853228|584015848|FG000|Phase 2|Physician Decision|0|||
161718863|NCT01853228|584015849|FG001|Phase 2|Physician Decision|1|||
161718864|NCT01853228|584015848|FG000|Phase 2|Proceed To Transplant|0|||
161963972|NCT05425732|584914953|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161963973|NCT05425732|584914954|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
161963974|NCT05425732|584914955|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161963975|NCT05425732|584914956|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161963976|NCT05425732|584914953|FG000|Overall Study|Withdrawal by Subject|4|||
161963977|NCT05425732|584914954|FG001|Overall Study|Withdrawal by Subject|8|||
161963978|NCT05425732|584914955|FG002|Overall Study|Withdrawal by Subject|1|||
161963979|NCT05425732|584914956|FG003|Overall Study|Withdrawal by Subject|1|||
161963980|NCT05425732|584914953|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
161963981|NCT05425732|584914954|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
161963982|NCT05425732|584914955|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
161963983|NCT05425732|584914956|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
161963984|NCT02582814|584914957|FG000|Overall Study|Study-specific withdrawal criteria|1|||
161963985|NCT02582814|584914958|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161963986|NCT02582814|584914957|FG000|Overall Study|Withdrawal by Subject|4|||
161963987|NCT02582814|584914958|FG001|Overall Study|Withdrawal by Subject|3|||
161963988|NCT02582814|584914957|FG000|Overall Study|Adverse Event|4|||
161963989|NCT02582814|584914958|FG001|Overall Study|Adverse Event|4|||
161963990|NCT00306293|584914959|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
161963991|NCT00306293|584914960|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
161963992|NCT00306293|584914959|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
161963993|NCT00306293|584914960|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
161963994|NCT00306293|584914959|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
161963995|NCT00306293|584914960|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
161963996|NCT00306293|584914959|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
161963997|NCT00306293|584914960|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
161963998|NCT00306293|584914959|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
161963999|NCT00306293|584914960|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
161964000|NCT00306293|584914959|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
161964001|NCT00306293|584914960|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
161964002|NCT00306293|584914959|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
161964003|NCT00306293|584914960|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
161964004|NCT00306293|584914959|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
161964005|NCT00306293|584914960|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
161964006|NCT02242435|584914961|FG000|Overall Study|Lost to Follow-up|3|||
161964007|NCT02242435|584914962|FG001|Overall Study|Lost to Follow-up|4|||
161964008|NCT02242435|584914961|FG000|Overall Study|Adverse Event|3|||
161964009|NCT02242435|584914962|FG001|Overall Study|Adverse Event|2|||
161964010|NCT02242435|584914961|FG000|Overall Study|Withdrawal by Subject|13|||
161964011|NCT02242435|584914962|FG001|Overall Study|Withdrawal by Subject|8|||
161964012|NCT02242435|584914961|FG000|Overall Study|Death|0|||
161718865|NCT01853228|584015849|FG001|Phase 2|Proceed To Transplant|3|||
161964013|NCT02242435|584914962|FG001|Overall Study|Death|1|||
161964014|NCT02242435|584914961|FG000|Overall Study|Protocol Violation|1|||
161964015|NCT02242435|584914962|FG001|Overall Study|Protocol Violation|0|||
161964016|NCT02242435|584914961|FG000|Overall Study|Physician Decision|0|||
161964017|NCT02242435|584914962|FG001|Overall Study|Physician Decision|1|||
161718866|NCT01853228|584015848|FG000|Phase 2|Lack of Efficacy|0|||
161718867|NCT01853228|584015849|FG001|Phase 2|Lack of Efficacy|4|||
161718868|NCT02400346|584015855|FG000|Overall Study|Adverse Event|24|||
162032142|NCT00814801|585174219|FG001|Overall Study|Adverse Event|16|||
162032143|NCT00814801|585174220|FG002|Overall Study|Adverse Event|19|||
162032144|NCT00814801|585174218|FG000|Overall Study|Withdrawal by Subject|9|||
162032145|NCT00814801|585174219|FG001|Overall Study|Withdrawal by Subject|11|||
161718869|NCT02400346|584015855|FG000|Overall Study|Lack of Efficacy|9|||
161718870|NCT02400346|584015855|FG000|Overall Study|Non-compliance with IMP|1|||
161718871|NCT02400346|584015855|FG000|Overall Study|Withdrawal by Subject|7|||
161964018|NCT00510718|584914971|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
161718872|NCT02400346|584015855|FG000|Overall Study|Administrative or other reason(s)|2|||
161718873|NCT02400346|584015855|FG000|Overall Study|Lost to Follow-up|1|||
161718874|NCT01300286|584015856|FG000|Overall Study|did not get dosed|1|||
161718875|NCT03635190|584015857|FG000|Overall Study|Lost to Follow-up|4|||
161718876|NCT03635190|584015857|FG000|Overall Study|Death|3|||
161718877|NCT03635190|584015857|FG000|Overall Study|Withdrawal by Subject|1|||
161718878|NCT03635190|584015857|FG000|Overall Study|Patient moved and did not return for follow up|1|||
161718879|NCT02767570|584015860|FG000|Overall Study|Lost to Follow-up|3|||
161718880|NCT02767570|584015861|FG001|Overall Study|Lost to Follow-up|0|||
161718881|NCT02767570|584015860|FG000|Overall Study|COVID shutdown|2|||
161718882|NCT02767570|584015861|FG001|Overall Study|COVID shutdown|5|||
161718883|NCT02767570|584015860|FG000|Overall Study|Increased pain|2|||
161718884|NCT02767570|584015861|FG001|Overall Study|Increased pain|0|||
161718885|NCT02767570|584015860|FG000|Overall Study|Withdrawal by Subject|1|||
161718886|NCT02767570|584015861|FG001|Overall Study|Withdrawal by Subject|3|||
161718887|NCT02767570|584015860|FG000|Overall Study|Unrelated medical issue|1|||
161718888|NCT02767570|584015861|FG001|Overall Study|Unrelated medical issue|1|||
161718889|NCT02767570|584015860|FG000|Overall Study|Received intra-articular injection|0|||
161718890|NCT02767570|584015861|FG001|Overall Study|Received intra-articular injection|1|||
161718891|NCT03692910|584015863|FG000|Overall Study|Lost to Follow-up|4|||
161718892|NCT03692910|584015864|FG001|Overall Study|Lost to Follow-up|0|||
161718893|NCT03692910|584015865|FG002|Overall Study|Lost to Follow-up|0|||
161718894|NCT03692910|584015863|FG000|Overall Study|Withdrawal by Subject|2|||
161718895|NCT03692910|584015864|FG001|Overall Study|Withdrawal by Subject|0|||
161718896|NCT03692910|584015865|FG002|Overall Study|Withdrawal by Subject|0|||
161718897|NCT03846947|584015870|FG000|Overall Study|technical issues with imaging sequence|2|||
161718898|NCT03060577|584015871|FG000|Overall Study|Withdrawal by Subject|25|||
161718899|NCT03060577|584015872|FG001|Overall Study|Withdrawal by Subject|5|||
161718900|NCT03060577|584015871|FG000|Overall Study|Physician Decision|4|||
161718901|NCT03060577|584015872|FG001|Overall Study|Physician Decision|3|||
161718902|NCT03060577|584015871|FG000|Overall Study|Lost to Follow-up|3|||
161718903|NCT03060577|584015872|FG001|Overall Study|Lost to Follow-up|0|||
161718904|NCT03060577|584015871|FG000|Overall Study|Death|7|||
161718905|NCT03060577|584015872|FG001|Overall Study|Death|1|||
161718906|NCT03060577|584015871|FG000|Overall Study|Adverse Event|9|||
161718907|NCT03060577|584015872|FG001|Overall Study|Adverse Event|1|||
161718908|NCT03060577|584015871|FG000|Overall Study|Inclusion/Exclusion|1|||
161718909|NCT03060577|584015872|FG001|Overall Study|Inclusion/Exclusion|0|||
161718910|NCT03060577|584015871|FG000|Overall Study|Other|8|||
161718911|NCT03060577|584015872|FG001|Overall Study|Other|2|||
161718912|NCT03216265|584015873|FG000|Overall Study|Adverse Event|2|||
161718913|NCT03216265|584015874|FG001|Overall Study|Adverse Event|0|||
161718914|NCT03216265|584015875|FG002|Overall Study|Adverse Event|2|||
161718915|NCT03216265|584015873|FG000|Overall Study|Lost to Follow-up|0|||
161718916|NCT03216265|584015874|FG001|Overall Study|Lost to Follow-up|1|||
161718917|NCT03216265|584015875|FG002|Overall Study|Lost to Follow-up|0|||
161718918|NCT03216265|584015873|FG000|Overall Study|Withdrawal by Subject|0|||
161718919|NCT03216265|584015874|FG001|Overall Study|Withdrawal by Subject|0|||
161718920|NCT03216265|584015875|FG002|Overall Study|Withdrawal by Subject|1|||
161718921|NCT01306058|584015876|FG000|Overall Study|Death|1|||
161718922|NCT01306058|584015876|FG000|Overall Study|Enrolled but did not get treatment|1|||
161718923|NCT01539837|584015877|FG000|Overall Study|reduce neutrophil level|0|||
161718924|NCT01539837|584015878|FG001|Overall Study|reduce neutrophil level|1|||
161718925|NCT01539837|584015879|FG002|Overall Study|reduce neutrophil level|1|||
161718926|NCT01539837|584015877|FG000|Overall Study|bad compliance|0|||
161718927|NCT01539837|584015878|FG001|Overall Study|bad compliance|0|||
161964019|NCT00510718|584914972|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
161964020|NCT00510718|584914971|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
161964021|NCT00510718|584914972|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
161964022|NCT00510718|584914971|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
161964023|NCT00510718|584914972|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
161964024|NCT00510718|584914971|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
161964025|NCT00510718|584914972|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
161718928|NCT01539837|584015879|FG002|Overall Study|bad compliance|1|||
161718929|NCT00849693|584015880|FG000|Acute Treatment Phase|Adverse Event|12|||
161718930|NCT00849693|584015881|FG001|Acute Treatment Phase|Adverse Event|7|||
161718931|NCT00849693|584015882|FG002|Acute Treatment Phase|Adverse Event|6|||
161718932|NCT00849693|584015883|FG003|Acute Treatment Phase|Adverse Event|4|||
161718933|NCT00849693|584015880|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
161718934|NCT00849693|584015881|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
161718935|NCT00849693|584015882|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
161718936|NCT00849693|584015883|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
161964026|NCT00510718|584914971|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
161718937|NCT00849693|584015880|FG000|Acute Treatment Phase|Protocol Violation|1|||
161718938|NCT00849693|584015881|FG001|Acute Treatment Phase|Protocol Violation|5|||
161718939|NCT00849693|584015882|FG002|Acute Treatment Phase|Protocol Violation|2|||
161718940|NCT00849693|584015883|FG003|Acute Treatment Phase|Protocol Violation|6|||
161718941|NCT00849693|584015880|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
161718942|NCT00849693|584015881|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
161718943|NCT00849693|584015882|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
161718944|NCT00849693|584015883|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
161718945|NCT00849693|584015880|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
161718946|NCT00849693|584015881|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
161718947|NCT00849693|584015882|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
161718948|NCT00849693|584015883|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
161718949|NCT00849693|584015880|FG000|Acute Treatment Phase|Physician Decision|2|||
161718950|NCT00849693|584015881|FG001|Acute Treatment Phase|Physician Decision|1|||
161718951|NCT00849693|584015882|FG002|Acute Treatment Phase|Physician Decision|2|||
161718952|NCT00849693|584015883|FG003|Acute Treatment Phase|Physician Decision|1|||
161718953|NCT00849693|584015880|FG000|Acute Treatment Phase|Sponsor decision|0|||
161718954|NCT00849693|584015881|FG001|Acute Treatment Phase|Sponsor decision|0|||
161718955|NCT00849693|584015882|FG002|Acute Treatment Phase|Sponsor decision|1|||
161718956|NCT00849693|584015883|FG003|Acute Treatment Phase|Sponsor decision|0|||
161718957|NCT00849693|584015880|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
161718958|NCT00849693|584015881|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
161718959|NCT00849693|584015882|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
161718960|NCT00849693|584015883|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
161718961|NCT00849693|584015880|FG000|Extension Phase|Adverse Event|4|||
161718962|NCT00849693|584015881|FG001|Extension Phase|Adverse Event|6|||
161718963|NCT00849693|584015882|FG002|Extension Phase|Adverse Event|3|||
161718964|NCT00849693|584015883|FG003|Extension Phase|Adverse Event|7|||
161718965|NCT00849693|584015880|FG000|Extension Phase|Lost to Follow-up|7|||
161718966|NCT00849693|584015881|FG001|Extension Phase|Lost to Follow-up|5|||
161718967|NCT00849693|584015882|FG002|Extension Phase|Lost to Follow-up|6|||
161718968|NCT00849693|584015883|FG003|Extension Phase|Lost to Follow-up|6|||
161718969|NCT00849693|584015880|FG000|Extension Phase|Protocol Violation|0|||
161718970|NCT00849693|584015881|FG001|Extension Phase|Protocol Violation|3|||
161718971|NCT00849693|584015882|FG002|Extension Phase|Protocol Violation|2|||
161718972|NCT00849693|584015883|FG003|Extension Phase|Protocol Violation|3|||
161718973|NCT00849693|584015880|FG000|Extension Phase|Withdrawal by Subject|6|||
161718974|NCT00849693|584015881|FG001|Extension Phase|Withdrawal by Subject|9|||
161718975|NCT00849693|584015882|FG002|Extension Phase|Withdrawal by Subject|10|||
161718976|NCT00849693|584015883|FG003|Extension Phase|Withdrawal by Subject|15|||
161718977|NCT00849693|584015880|FG000|Extension Phase|Parent or caregiver decision|9|||
161718978|NCT00849693|584015881|FG001|Extension Phase|Parent or caregiver decision|4|||
161718979|NCT00849693|584015882|FG002|Extension Phase|Parent or caregiver decision|10|||
161718980|NCT00849693|584015883|FG003|Extension Phase|Parent or caregiver decision|5|||
161718981|NCT00849693|584015880|FG000|Extension Phase|Physician Decision|1|||
161718982|NCT00849693|584015881|FG001|Extension Phase|Physician Decision|1|||
161718983|NCT00849693|584015882|FG002|Extension Phase|Physician Decision|2|||
161718984|NCT00849693|584015883|FG003|Extension Phase|Physician Decision|0|||
161718985|NCT00849693|584015880|FG000|Extension Phase|Sponsor decision|1|||
161718986|NCT00849693|584015881|FG001|Extension Phase|Sponsor decision|0|||
161718987|NCT00849693|584015882|FG002|Extension Phase|Sponsor decision|0|||
161718988|NCT00849693|584015883|FG003|Extension Phase|Sponsor decision|1|||
161718989|NCT00849693|584015880|FG000|Extension Phase|Lack of Efficacy|2|||
161718990|NCT00849693|584015881|FG001|Extension Phase|Lack of Efficacy|2|||
161718991|NCT00849693|584015882|FG002|Extension Phase|Lack of Efficacy|2|||
161718992|NCT00849693|584015883|FG003|Extension Phase|Lack of Efficacy|1|||
161718993|NCT01978912|584015886|FG000|Overall Study|Adverse Event|0|||
161718994|NCT01978912|584015887|FG001|Overall Study|Adverse Event|1|||
161718995|NCT01978912|584015888|FG002|Overall Study|Adverse Event|0|||
161718996|NCT01978912|584015889|FG003|Overall Study|Adverse Event|0|||
161718997|NCT01978912|584015886|FG000|Overall Study|Lost to Follow-up|1|||
161718998|NCT01978912|584015887|FG001|Overall Study|Lost to Follow-up|1|||
161718999|NCT01978912|584015888|FG002|Overall Study|Lost to Follow-up|0|||
161719000|NCT01978912|584015889|FG003|Overall Study|Lost to Follow-up|1|||
161719001|NCT01978912|584015886|FG000|Overall Study|Withdrawal by Subject|1|||
161719002|NCT01978912|584015887|FG001|Overall Study|Withdrawal by Subject|0|||
161719003|NCT01978912|584015888|FG002|Overall Study|Withdrawal by Subject|2|||
161719004|NCT01978912|584015889|FG003|Overall Study|Withdrawal by Subject|2|||
161719005|NCT01978912|584015886|FG000|Overall Study|Lumbar Surgery|1|||
161719006|NCT01978912|584015887|FG001|Overall Study|Lumbar Surgery|0|||
161719007|NCT01978912|584015888|FG002|Overall Study|Lumbar Surgery|1|||
161719008|NCT01978912|584015889|FG003|Overall Study|Lumbar Surgery|0|||
161719009|NCT01978912|584015886|FG000|Overall Study|Intradiscal Steroid Injection|0|||
161719010|NCT01978912|584015887|FG001|Overall Study|Intradiscal Steroid Injection|1|||
161719011|NCT01978912|584015888|FG002|Overall Study|Intradiscal Steroid Injection|0|||
161719012|NCT01978912|584015889|FG003|Overall Study|Intradiscal Steroid Injection|0|||
161719013|NCT00224107|584015890|FG000|Overall Study|Adverse Event|20|||
161719014|NCT00224107|584015891|FG001|Overall Study|Adverse Event|6|||
161719015|NCT00224107|584015890|FG000|Overall Study|Protocol Violation|2|||
161719016|NCT00224107|584015891|FG001|Overall Study|Protocol Violation|3|||
161719017|NCT00224107|584015890|FG000|Overall Study|Withdrawal by Subject|1|||
161719018|NCT00224107|584015891|FG001|Overall Study|Withdrawal by Subject|4|||
161719019|NCT00224107|584015890|FG000|Overall Study|Lack of Efficacy|2|||
161719020|NCT00224107|584015891|FG001|Overall Study|Lack of Efficacy|0|||
161719021|NCT00224107|584015890|FG000|Overall Study|Lost to Follow-up|4|||
161719022|NCT00224107|584015891|FG001|Overall Study|Lost to Follow-up|0|||
161719023|NCT00224107|584015890|FG000|Overall Study|Physician Decision|1|||
161719024|NCT00224107|584015891|FG001|Overall Study|Physician Decision|0|||
161719025|NCT00224107|584015890|FG000|Overall Study|Other|1|||
161719026|NCT00224107|584015891|FG001|Overall Study|Other|1|||
161719027|NCT01408537|584015892|FG000|Overall Study|Withdrawal by Subject|2|||
161719028|NCT01408537|584015892|FG000|Overall Study|Protocol Violation|3|||
161719029|NCT01408537|584015892|FG000|Overall Study|Lost to Follow-up|3|||
161719030|NCT03707977|584015897|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
161719031|NCT03707977|584015898|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
161719032|NCT03707977|584015899|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
161719033|NCT03707977|584015897|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
161719034|NCT03707977|584015898|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
161719035|NCT03707977|584015899|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
161964027|NCT00510718|584914972|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
161964028|NCT00510718|584914971|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
161719036|NCT03069690|584015900|FG000|Pregnancy Intervention|Pregnancy loss|9|||
161719037|NCT03069690|584015901|FG001|Pregnancy Intervention|Pregnancy loss|4|||
161719038|NCT03069690|584015902|FG002|Pregnancy Intervention|Pregnancy loss|0|||
161719039|NCT03069690|584015903|FG003|Pregnancy Intervention|Pregnancy loss|0|||
161719040|NCT03069690|584015904|FG004|Pregnancy Intervention|Pregnancy loss|0|||
161719041|NCT03069690|584015905|FG005|Pregnancy Intervention|Pregnancy loss|0|||
161719042|NCT03069690|584015900|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
161719043|NCT03069690|584015901|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
161719044|NCT03069690|584015902|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
161719045|NCT03069690|584015903|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
161719046|NCT03069690|584015904|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
161719047|NCT03069690|584015905|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
161719048|NCT03069690|584015900|FG000|Postpartum Intervention|Lost to Follow-up|0|||
161719049|NCT03069690|584015901|FG001|Postpartum Intervention|Lost to Follow-up|0|||
161719050|NCT03069690|584015902|FG002|Postpartum Intervention|Lost to Follow-up|5|||
161719051|NCT03069690|584015903|FG003|Postpartum Intervention|Lost to Follow-up|5|||
161719052|NCT03069690|584015904|FG004|Postpartum Intervention|Lost to Follow-up|2|||
161719053|NCT03069690|584015905|FG005|Postpartum Intervention|Lost to Follow-up|4|||
161719054|NCT02564120|584015906|FG000|Overall Study|Did not return release forms|160|||
161719055|NCT02564120|584015906|FG000|Overall Study|Death|58|||
161719056|NCT02564120|584015906|FG000|Overall Study|Withdrawal by Subject|204|||
161719057|NCT02564120|584015906|FG000|Overall Study|Other medical condition|24|||
161719058|NCT03842709|584015907|FG000|Overall Study|Withdrawal by Subject|3|||
161719059|NCT03842709|584015908|FG001|Overall Study|Withdrawal by Subject|3|||
161719060|NCT03842709|584015907|FG000|Overall Study|Lost to Follow-up|1|||
161719061|NCT03842709|584015908|FG001|Overall Study|Lost to Follow-up|0|||
161719062|NCT00641147|584015909|FG000|Completed 4 Months.|Physician Decision|1|||
161719063|NCT00641147|584015910|FG001|Completed 4 Months.|Physician Decision|0|||
161719064|NCT00641147|584015909|FG000|Completed 4 Months.|Adverse Event|1|||
161719065|NCT00641147|584015910|FG001|Completed 4 Months.|Adverse Event|0|||
161719066|NCT00641147|584015909|FG000|Completed 8 Months.|Physician Decision|2|||
161719067|NCT00641147|584015910|FG001|Completed 8 Months.|Physician Decision|1|||
161719068|NCT00641147|584015909|FG000|Completed 8 Months.|non compliance|1|||
161719069|NCT00641147|584015910|FG001|Completed 8 Months.|non compliance|0|||
161719070|NCT00641147|584015909|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
161719071|NCT00641147|584015910|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
161719072|NCT00641147|584015909|FG000|Completed 12 Months.|Physician Decision|1|||
161719073|NCT00641147|584015910|FG001|Completed 12 Months.|Physician Decision|1|||
161719074|NCT00641147|584015909|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
161719075|NCT00641147|584015910|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
161719076|NCT00641147|584015909|FG000|Completed 16 Months.|Physician Decision|1|||
161719077|NCT00641147|584015910|FG001|Completed 16 Months.|Physician Decision|0|||
161719078|NCT00641147|584015909|FG000|Completed 16 Months.|Lost to Follow-up|1|||
161719079|NCT00641147|584015910|FG001|Completed 16 Months.|Lost to Follow-up|0|||
161719080|NCT00791128|584015911|FG000|Overall Study|Adverse Event|4|||
161719081|NCT00791128|584015911|FG000|Overall Study|Device migration|2|||
161719082|NCT00791128|584015911|FG000|Overall Study|non-compliance by subject|2|||
161719083|NCT00791128|584015911|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
161719084|NCT01629667|584015912|FG000|Overall Study|Lost to Follow-up|0|||
161719085|NCT01629667|584015913|FG001|Overall Study|Lost to Follow-up|1|||
161719086|NCT01629667|584015914|FG002|Overall Study|Lost to Follow-up|1|||
161719087|NCT01629667|584015912|FG000|Overall Study|Withdrawal by Subject|31|||
161719088|NCT01629667|584015913|FG001|Overall Study|Withdrawal by Subject|20|||
161719089|NCT01629667|584015914|FG002|Overall Study|Withdrawal by Subject|28|||
161719090|NCT01629667|584015912|FG000|Overall Study|Death|1|||
161719091|NCT01629667|584015913|FG001|Overall Study|Death|5|||
161719092|NCT01629667|584015914|FG002|Overall Study|Death|3|||
161719093|NCT01629667|584015912|FG000|Overall Study|Randomized, not treated|2|||
161719094|NCT01629667|584015913|FG001|Overall Study|Randomized, not treated|1|||
161719095|NCT01629667|584015914|FG002|Overall Study|Randomized, not treated|0|||
161719096|NCT01629667|584015912|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
161719097|NCT01629667|584015913|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
161719098|NCT01629667|584015914|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
161719099|NCT01629667|584015912|FG000|Overall Study|Requiring lung transplant|2|||
161719100|NCT01629667|584015913|FG001|Overall Study|Requiring lung transplant|1|||
161719101|NCT01629667|584015914|FG002|Overall Study|Requiring lung transplant|3|||
161964029|NCT00510718|584914972|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
161964030|NCT01089413|584914978|FG000|Overall Study|Lost to Follow-up|1|||
161964031|NCT01089413|584914978|FG000|Overall Study|Progressive Disease|93|||
161964032|NCT01089413|584914978|FG000|Overall Study|Participant Withdrew Consent|1|||
161964033|NCT01089413|584914978|FG000|Overall Study|Unacceptable Toxicity|12|||
161964034|NCT01089413|584914978|FG000|Overall Study|Death|10|||
161964035|NCT01089413|584914978|FG000|Overall Study|Metastasectomy|13|||
161964036|NCT01089413|584914978|FG000|Overall Study|Other|71|||
161964037|NCT01610557|584914983|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
161964038|NCT01610557|584914984|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
161964039|NCT01610557|584914985|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
161964040|NCT01610557|584914986|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
161964041|NCT01610557|584914987|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
161964042|NCT01610557|584914983|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
161964043|NCT01610557|584914984|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
161964044|NCT01610557|584914985|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
161964045|NCT01610557|584914986|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
161964046|NCT01610557|584914987|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
162032146|NCT00814801|585174220|FG002|Overall Study|Withdrawal by Subject|14|||
161719102|NCT01629667|584015912|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
161719103|NCT01629667|584015913|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
161719104|NCT01629667|584015914|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
161719105|NCT01629667|584015912|FG000|Overall Study|Started other medicine|1|||
161719106|NCT01629667|584015913|FG001|Overall Study|Started other medicine|0|||
161719107|NCT01629667|584015914|FG002|Overall Study|Started other medicine|1|||
161719108|NCT01629667|584015912|FG000|Overall Study|Site error in safety follow-up|0|||
161719109|NCT01629667|584015913|FG001|Overall Study|Site error in safety follow-up|0|||
161719110|NCT01629667|584015914|FG002|Overall Study|Site error in safety follow-up|1|||
161719111|NCT01629667|584015912|FG000|Overall Study|Enrolled in another clinical study|0|||
161719112|NCT01629667|584015913|FG001|Overall Study|Enrolled in another clinical study|1|||
161719113|NCT01629667|584015914|FG002|Overall Study|Enrolled in another clinical study|0|||
161719114|NCT01629667|584015912|FG000|Overall Study|Code break|1|||
161719115|NCT01629667|584015913|FG001|Overall Study|Code break|0|||
161719116|NCT01629667|584015914|FG002|Overall Study|Code break|0|||
161719117|NCT00984659|584015915|FG000|2-week Run-in Period|Adverse Event|8|||
161719118|NCT00984659|584015916|FG001|2-week Run-in Period|Adverse Event|0|||
161719119|NCT00984659|584015917|FG002|2-week Run-in Period|Adverse Event|0|||
161719120|NCT00984659|584015918|FG003|2-week Run-in Period|Adverse Event|0|||
161719121|NCT00984659|584015915|FG000|2-week Run-in Period|Protocol Violation|5|||
161719122|NCT00984659|584015916|FG001|2-week Run-in Period|Protocol Violation|0|||
161719123|NCT00984659|584015917|FG002|2-week Run-in Period|Protocol Violation|0|||
161719124|NCT00984659|584015918|FG003|2-week Run-in Period|Protocol Violation|0|||
161719125|NCT00984659|584015915|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
161719126|NCT00984659|584015916|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
161719127|NCT00984659|584015917|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
161719128|NCT00984659|584015918|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
161719129|NCT00984659|584015915|FG000|2-week Run-in Period|Lost to Follow-up|3|||
161719130|NCT00984659|584015916|FG001|2-week Run-in Period|Lost to Follow-up|0|||
161719131|NCT00984659|584015917|FG002|2-week Run-in Period|Lost to Follow-up|0|||
161719132|NCT00984659|584015918|FG003|2-week Run-in Period|Lost to Follow-up|0|||
161719133|NCT00984659|584015915|FG000|2-week Run-in Period|Physician Decision|10|||
161719134|NCT00984659|584015916|FG001|2-week Run-in Period|Physician Decision|0|||
161719135|NCT00984659|584015917|FG002|2-week Run-in Period|Physician Decision|0|||
161719136|NCT00984659|584015918|FG003|2-week Run-in Period|Physician Decision|0|||
161719137|NCT00984659|584015915|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
161719138|NCT00984659|584015916|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161719139|NCT00984659|584015917|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161719140|NCT00984659|584015918|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
161719141|NCT00984659|584015915|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
161719142|NCT00984659|584015916|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
161719143|NCT00984659|584015917|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
161719144|NCT00984659|584015918|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
161719145|NCT00984659|584015915|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
161719146|NCT00984659|584015916|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
161719147|NCT00984659|584015917|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
161719148|NCT00984659|584015918|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
161719149|NCT00984659|584015915|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
161719150|NCT00984659|584015916|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
161719151|NCT00984659|584015917|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
161719152|NCT00984659|584015918|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
161719153|NCT00984659|584015915|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
161719154|NCT00984659|584015916|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
161719155|NCT00984659|584015917|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
161719156|NCT00984659|584015918|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
161719157|NCT00984659|584015915|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
161719158|NCT00984659|584015916|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
161719159|NCT00984659|584015917|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
161719160|NCT00984659|584015918|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
161719161|NCT00984659|584015915|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161719162|NCT00984659|584015916|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
161719163|NCT00984659|584015917|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
161719164|NCT00984659|584015918|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
161719165|NCT00891657|584015921|FG000|Overall Study|Withdrawal by Subject|1|||
161719166|NCT00891657|584015922|FG001|Overall Study|Withdrawal by Subject|1|||
161719167|NCT00537823|584015930|FG000|Overall Study|Adverse Event|2|||
161719168|NCT00537823|584015931|FG001|Overall Study|Adverse Event|0|||
161719169|NCT03455543|584015932|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
161719170|NCT03455543|584015933|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
161719171|NCT03455543|584015934|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
161719172|NCT03455543|584015932|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
161719173|NCT03455543|584015933|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
161719174|NCT03455543|584015934|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
161719175|NCT03455543|584015932|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
161719176|NCT03455543|584015933|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
161719177|NCT03455543|584015934|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
161719178|NCT03455543|584015932|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
161719179|NCT03455543|584015933|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
161719180|NCT03455543|584015934|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
161719181|NCT03455543|584015932|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
161719182|NCT03455543|584015933|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
161719183|NCT03455543|584015934|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
161719184|NCT03455543|584015932|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
161719185|NCT03455543|584015933|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
161719186|NCT03455543|584015934|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
161719187|NCT03455543|584015932|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
161719188|NCT03455543|584015933|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
161719189|NCT03455543|584015934|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
161719190|NCT03455543|584015932|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
161719191|NCT03455543|584015933|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
161719192|NCT03455543|584015934|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
161719193|NCT03455543|584015932|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
161719194|NCT03455543|584015933|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
161719195|NCT03455543|584015934|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
161719196|NCT00779038|584015935|FG000|Overall Study|Study Prematurely Terminated|13|||
161719197|NCT02717546|584015936|FG000|Overall Study|Lost to Follow-up|12|||
161719198|NCT00909090|584015937|FG000|Overall Study|Lost to Follow-up|17|||
161719199|NCT00909090|584015938|FG001|Overall Study|Lost to Follow-up|17|||
161719200|NCT02926573|584015940|FG000|Overall Study|Nausea|1|||
161719201|NCT02926573|584015941|FG001|Overall Study|Nausea|0|||
161719202|NCT02926573|584015940|FG000|Overall Study|Remain intubated|2|||
161719203|NCT02926573|584015941|FG001|Overall Study|Remain intubated|2|||
161719204|NCT02926573|584015940|FG000|Overall Study|Change in surgery plan|3|||
161964047|NCT02003638|584914995|FG000|Overall Study|Withdrawal by Subject|1|||
161964048|NCT02003638|584914996|FG001|Overall Study|Withdrawal by Subject|0|||
161719205|NCT02926573|584015941|FG001|Overall Study|Change in surgery plan|1|||
161719206|NCT02926573|584015940|FG000|Overall Study|Change to outpatient status|5|||
161719207|NCT02926573|584015941|FG001|Overall Study|Change to outpatient status|1|||
161719208|NCT02926573|584015940|FG000|Overall Study|Withdrawal by Subject|0|||
161719209|NCT02926573|584015941|FG001|Overall Study|Withdrawal by Subject|2|||
161719210|NCT02926573|584015940|FG000|Overall Study|Return to operating room|0|||
161719211|NCT02926573|584015941|FG001|Overall Study|Return to operating room|2|||
161719212|NCT02926573|584015940|FG000|Overall Study|Delirium|0|||
161719213|NCT02926573|584015941|FG001|Overall Study|Delirium|1|||
161719214|NCT03633331|584015949|FG000|Overall Study|Withdrawal by Subject|1|||
161719215|NCT01009294|584015950|FG000|Overall Study|Study discontinued by Sponsor|6|||
161719216|NCT00949650|584015951|FG000|Overall Study|Progressive disease|188|||
161719217|NCT00949650|584015952|FG001|Overall Study|Progressive disease|19|||
161719218|NCT00949650|584015951|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
161719219|NCT00949650|584015952|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
161719220|NCT00949650|584015951|FG000|Overall Study|Other Adverse Event (AE)|28|||
161719221|NCT00949650|584015952|FG001|Overall Study|Other Adverse Event (AE)|17|||
161719222|NCT00949650|584015951|FG000|Overall Study|Protocol Violation|1|||
161719223|NCT00949650|584015952|FG001|Overall Study|Protocol Violation|4|||
161719224|NCT00949650|584015951|FG000|Overall Study|Refusal to continue medication|7|||
161719225|NCT00949650|584015952|FG001|Overall Study|Refusal to continue medication|11|||
161719226|NCT00949650|584015951|FG000|Overall Study|Not treated|1|||
161719227|NCT00949650|584015952|FG001|Overall Study|Not treated|4|||
161719228|NCT00949650|584015951|FG000|Overall Study|Other not specified above|5|||
161719229|NCT00949650|584015952|FG001|Overall Study|Other not specified above|0|||
161719230|NCT00940342|584015955|FG000|Overall Study|Adverse Event|0|||
161719231|NCT00940342|584015956|FG001|Overall Study|Adverse Event|2|||
161719232|NCT00940342|584015957|FG002|Overall Study|Adverse Event|1|||
161719233|NCT03249350|584015960|FG000|Overall Study|Participant did not initiate treatment|5|||
161719234|NCT03249350|584015961|FG001|Overall Study|Participant did not initiate treatment|8|||
161719235|NCT01716169|584015963|FG000|Overall Study|Adverse Event|1|||
161719236|NCT01716169|584015963|FG000|Overall Study|Lost to Follow-up|1|||
161719237|NCT01716169|584015963|FG000|Overall Study|Withdrawal by Subject|1|||
161719238|NCT01716169|584015963|FG000|Overall Study|inconsistent dressing application|1|||
161719239|NCT00553787|584015964|FG000|Overall Study|Adverse Event|34|||
161719240|NCT00553787|584015965|FG001|Overall Study|Adverse Event|21|||
161719241|NCT00553787|584015966|FG002|Overall Study|Adverse Event|67|||
161719242|NCT00553787|584015964|FG000|Overall Study|Lost to Follow-up|132|||
161719243|NCT00553787|584015965|FG001|Overall Study|Lost to Follow-up|44|||
161719244|NCT00553787|584015966|FG002|Overall Study|Lost to Follow-up|78|||
161719245|NCT00553787|584015964|FG000|Overall Study|Withdrawal by Subject|151|||
161719246|NCT00553787|584015965|FG001|Overall Study|Withdrawal by Subject|40|||
161719247|NCT00553787|584015966|FG002|Overall Study|Withdrawal by Subject|83|||
161719248|NCT00553787|584015964|FG000|Overall Study|Lack of Efficacy|31|||
161719249|NCT00553787|584015965|FG001|Overall Study|Lack of Efficacy|1|||
161719250|NCT00553787|584015966|FG002|Overall Study|Lack of Efficacy|3|||
161719251|NCT00553787|584015964|FG000|Overall Study|Pregnancy|0|||
161719252|NCT00553787|584015965|FG001|Overall Study|Pregnancy|1|||
161719253|NCT00553787|584015966|FG002|Overall Study|Pregnancy|2|||
161719254|NCT00553787|584015964|FG000|Overall Study|non compliance|4|||
161719255|NCT00553787|584015965|FG001|Overall Study|non compliance|0|||
161719256|NCT00553787|584015966|FG002|Overall Study|non compliance|11|||
161719257|NCT00553787|584015964|FG000|Overall Study|Requirement for restricted medication|8|||
161719258|NCT00553787|584015965|FG001|Overall Study|Requirement for restricted medication|7|||
161719259|NCT00553787|584015966|FG002|Overall Study|Requirement for restricted medication|5|||
161719260|NCT00553787|584015964|FG000|Overall Study|Other|18|||
161719261|NCT00553787|584015965|FG001|Overall Study|Other|10|||
161719262|NCT00553787|584015966|FG002|Overall Study|Other|13|||
161719263|NCT01894516|584017415|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
161719264|NCT01894516|584017416|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
161719265|NCT01894516|584017417|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
161719266|NCT01894516|584017418|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
161719267|NCT01894516|584017415|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
161719268|NCT01894516|584017416|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161719269|NCT01894516|584017417|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161719270|NCT01894516|584017418|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161719271|NCT01894516|584017415|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
161719272|NCT01894516|584017416|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
161719273|NCT01894516|584017417|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
161719274|NCT01894516|584017418|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
161719275|NCT01894516|584017415|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
161719276|NCT01894516|584017416|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
161719277|NCT01894516|584017417|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
161719278|NCT01894516|584017418|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
161719279|NCT01894516|584017415|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
161719280|NCT01894516|584017416|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
161719281|NCT01894516|584017417|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
161719282|NCT01894516|584017418|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
161719283|NCT01894516|584017415|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
161719284|NCT01894516|584017416|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
161719285|NCT01894516|584017417|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
161964049|NCT01126268|584915000|FG000|Overall Study|Adverse Event|1|||
161964050|NCT01626118|584915004|FG000|Overall Study|Lack of Efficacy|1|||
161964051|NCT01626118|584915005|FG001|Overall Study|Lack of Efficacy|0|||
161964052|NCT01626118|584915006|FG002|Overall Study|Lack of Efficacy|1|||
161719286|NCT01894516|584017418|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
161719287|NCT01894516|584017415|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
161719288|NCT01894516|584017416|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
161719289|NCT01894516|584017417|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
161719290|NCT01894516|584017418|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
161719291|NCT01894516|584017415|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161719292|NCT01894516|584017416|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161719293|NCT01894516|584017417|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
161719294|NCT01894516|584017418|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161719295|NCT00893113|584017426|FG000|Overall Study|Lost to Follow-up|4|||
161719296|NCT00893113|584017427|FG001|Overall Study|Lost to Follow-up|8|||
161719297|NCT00893113|584017426|FG000|Overall Study|Early Termination|1|||
161719298|NCT00893113|584017427|FG001|Overall Study|Early Termination|1|||
161719299|NCT00893113|584017426|FG000|Overall Study|Withdrew Consent|8|||
161719300|NCT00893113|584017427|FG001|Overall Study|Withdrew Consent|7|||
161719301|NCT01240811|584017430|FG000|Overall Study|Physician Decision|0|||
161719302|NCT01240811|584017431|FG001|Overall Study|Physician Decision|1|||
161719303|NCT01240811|584017432|FG002|Overall Study|Physician Decision|0|||
161719304|NCT01240811|584017430|FG000|Overall Study|Withdrawal by Subject|0|||
161719305|NCT01240811|584017431|FG001|Overall Study|Withdrawal by Subject|0|||
161719306|NCT01240811|584017432|FG002|Overall Study|Withdrawal by Subject|1|||
161719307|NCT04168645|584017442|FG000|Overall Study|Lost to Follow-up|23|||
161719308|NCT04168645|584017443|FG001|Overall Study|Lost to Follow-up|28|||
161719309|NCT04168645|584017444|FG002|Overall Study|Lost to Follow-up|15|||
161719310|NCT04168645|584017445|FG003|Overall Study|Lost to Follow-up|12|||
161719311|NCT04168645|584017442|FG000|Overall Study|Death|1|||
161719312|NCT04168645|584017443|FG001|Overall Study|Death|1|||
161719313|NCT04168645|584017444|FG002|Overall Study|Death|0|||
161719314|NCT04168645|584017445|FG003|Overall Study|Death|0|||
161719315|NCT04168645|584017442|FG000|Overall Study|Withdrawal by Subject|5|||
161719316|NCT04168645|584017443|FG001|Overall Study|Withdrawal by Subject|2|||
161719317|NCT04168645|584017444|FG002|Overall Study|Withdrawal by Subject|2|||
161719318|NCT04168645|584017445|FG003|Overall Study|Withdrawal by Subject|2|||
161719319|NCT04168645|584017442|FG000|Overall Study|Administrative Withdrawal|3|||
161719320|NCT04168645|584017443|FG001|Overall Study|Administrative Withdrawal|1|||
161719321|NCT04168645|584017444|FG002|Overall Study|Administrative Withdrawal|1|||
161719322|NCT04168645|584017445|FG003|Overall Study|Administrative Withdrawal|3|||
161719323|NCT02114203|584017446|FG000|Overall Study|Adverse Event|0|||
161964053|NCT01626118|584915007|FG003|Overall Study|Lack of Efficacy|3|||
161964054|NCT01626118|584915004|FG000|Overall Study|Lost to Follow-up|1|||
161964055|NCT01626118|584915005|FG001|Overall Study|Lost to Follow-up|0|||
161964056|NCT01626118|584915006|FG002|Overall Study|Lost to Follow-up|0|||
161964057|NCT01626118|584915007|FG003|Overall Study|Lost to Follow-up|0|||
161964058|NCT01626118|584915004|FG000|Overall Study|Adverse Event|0|||
161964059|NCT01626118|584915005|FG001|Overall Study|Adverse Event|1|||
161719324|NCT02114203|584017447|FG001|Overall Study|Adverse Event|1|||
161964060|NCT01626118|584915006|FG002|Overall Study|Adverse Event|1|||
161964061|NCT01626118|584915007|FG003|Overall Study|Adverse Event|0|||
161964062|NCT01626118|584915004|FG000|Overall Study|Investigator Decision|0|||
161964063|NCT01626118|584915005|FG001|Overall Study|Investigator Decision|1|||
161719325|NCT02114203|584017448|FG002|Overall Study|Adverse Event|0|||
161719326|NCT02114203|584017446|FG000|Overall Study|Withdrawal by Subject|0|||
161719327|NCT02114203|584017447|FG001|Overall Study|Withdrawal by Subject|1|||
161719328|NCT02114203|584017448|FG002|Overall Study|Withdrawal by Subject|0|||
161964064|NCT01626118|584915006|FG002|Overall Study|Investigator Decision|0|||
161719329|NCT01518699|584017449|FG000|Period 2|Protocol Violation|1|||
161719330|NCT01518699|584017450|FG001|Period 2|Protocol Violation|1|||
161719331|NCT01518699|584017451|FG002|Period 2|Protocol Violation|0|||
161719332|NCT01518699|584017452|FG003|Period 2|Protocol Violation|0|||
161719333|NCT01518699|584017453|FG004|Period 2|Protocol Violation|0|||
161719334|NCT01518699|584017454|FG005|Period 2|Protocol Violation|0|||
161719335|NCT01518699|584017449|FG000|Period 2|Lost to Follow-up|0|||
161964065|NCT01626118|584915007|FG003|Overall Study|Investigator Decision|0|||
161964066|NCT00002540|584915008|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
161964067|NCT00002540|584915009|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
161719336|NCT01518699|584017450|FG001|Period 2|Lost to Follow-up|1|||
161719337|NCT01518699|584017451|FG002|Period 2|Lost to Follow-up|0|||
161719338|NCT01518699|584017452|FG003|Period 2|Lost to Follow-up|0|||
161719339|NCT01518699|584017453|FG004|Period 2|Lost to Follow-up|0|||
161719340|NCT01518699|584017454|FG005|Period 2|Lost to Follow-up|0|||
161719341|NCT01518699|584017449|FG000|Period 2|Adverse Event|1|||
161719342|NCT01518699|584017450|FG001|Period 2|Adverse Event|0|||
161719343|NCT01518699|584017451|FG002|Period 2|Adverse Event|0|||
161719344|NCT01518699|584017452|FG003|Period 2|Adverse Event|0|||
161719345|NCT01518699|584017453|FG004|Period 2|Adverse Event|0|||
161719346|NCT01518699|584017454|FG005|Period 2|Adverse Event|0|||
161719347|NCT01259492|584017456|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
161719348|NCT01259492|584017457|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
161719349|NCT01259492|584017458|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
161719350|NCT01259492|584017459|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
161719351|NCT01259492|584017456|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
161719352|NCT01259492|584017457|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
161719353|NCT01259492|584017458|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
161719354|NCT01259492|584017459|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
161719355|NCT01259492|584017456|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
161719356|NCT01259492|584017457|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
161719357|NCT01259492|584017458|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
161719358|NCT01259492|584017459|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
161719359|NCT01259492|584017456|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
161719360|NCT01259492|584017457|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
161719361|NCT01259492|584017458|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
161719362|NCT01259492|584017459|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
161719363|NCT01259492|584017456|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
161719364|NCT01259492|584017457|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
161719365|NCT01259492|584017458|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
161719366|NCT01259492|584017459|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
161719367|NCT01259492|584017456|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
161719368|NCT01259492|584017457|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
161719369|NCT01259492|584017458|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
161719370|NCT01259492|584017459|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
161719371|NCT01259492|584017456|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
161719372|NCT01259492|584017457|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
161719373|NCT01259492|584017458|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
161719374|NCT01259492|584017459|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
161719375|NCT01259492|584017456|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
161719376|NCT01259492|584017457|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
161719377|NCT01259492|584017458|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
161719378|NCT01259492|584017459|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
161719379|NCT01259492|584017456|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
161719380|NCT01259492|584017457|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
161719381|NCT01259492|584017458|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
161719382|NCT01259492|584017459|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
161719383|NCT01259492|584017456|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
161719384|NCT01259492|584017457|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
161719385|NCT01259492|584017458|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
161719386|NCT01259492|584017459|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
161719387|NCT01259492|584017456|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
161719388|NCT01259492|584017457|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
161719389|NCT01259492|584017458|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
161719390|NCT01259492|584017459|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
161719391|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
161719392|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
161719393|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
161719394|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
161719395|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
161719396|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
161719397|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
161719398|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
161719399|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
161719400|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
161719401|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
161719402|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
161964068|NCT00002540|584915008|FG000|Overall Study|Died Before Randomization|2|||
161719403|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
161719404|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
161964069|NCT00002540|584915009|FG001|Overall Study|Died Before Randomization|6|||
161964070|NCT00002540|584915008|FG000|Overall Study|Died Before ASU (Control)|202|||
161719405|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
161719406|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
161719407|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
161719408|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
161719409|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
161719410|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
161719411|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
161719412|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
161719413|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
161719414|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
161719415|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
161719416|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
161719417|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
161719418|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
161719419|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
161719420|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
161719421|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
161719422|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
161719423|NCT01259492|584017456|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
161719424|NCT01259492|584017457|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
161719425|NCT01259492|584017458|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
161719426|NCT01259492|584017459|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
161719427|NCT01981122|584017464|FG000|Overall Study|Withdrawal by Subject|0|||
161719428|NCT01981122|584017465|FG001|Overall Study|Withdrawal by Subject|2|||
161719429|NCT01981122|584017464|FG000|Overall Study|Protocol Violation|0|||
161719430|NCT01981122|584017465|FG001|Overall Study|Protocol Violation|1|||
161719431|NCT01981122|584017464|FG000|Overall Study|Lost to Follow-up|0|||
161719432|NCT01981122|584017465|FG001|Overall Study|Lost to Follow-up|1|||
161719433|NCT01981122|584017464|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
161719434|NCT01981122|584017465|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
161719435|NCT01981122|584017464|FG000|Overall Study|Death|14|||
161719436|NCT01981122|584017465|FG001|Overall Study|Death|15|||
161719437|NCT00089843|584017471|FG000|Overall Study|Withdrawal by Subject|1|||
161719438|NCT00089843|584017472|FG001|Overall Study|Withdrawal by Subject|4|||
161719439|NCT00089843|584017473|FG002|Overall Study|Withdrawal by Subject|5|||
161719440|NCT00089843|584017474|FG003|Overall Study|Withdrawal by Subject|6|||
161719441|NCT00089843|584017471|FG000|Overall Study|Physician Decision|1|||
161719442|NCT00089843|584017472|FG001|Overall Study|Physician Decision|0|||
161719443|NCT00089843|584017473|FG002|Overall Study|Physician Decision|0|||
161719444|NCT00089843|584017474|FG003|Overall Study|Physician Decision|1|||
161719445|NCT01295905|584017481|FG000|Overall Study|Did not meet inclusion criteria|1|||
161719446|NCT01295905|584017482|FG001|Overall Study|Did not meet inclusion criteria|0|||
161719447|NCT01295905|584017481|FG000|Overall Study|Met exclusion criteria|1|||
161719448|NCT01295905|584017482|FG001|Overall Study|Met exclusion criteria|0|||
161719449|NCT00553059|584017483|FG000|Overall Study|Deemed ineligible|1|||
161719450|NCT00553059|584017484|FG001|Overall Study|Deemed ineligible|1|||
161719451|NCT00553059|584017483|FG000|Overall Study|Drug supply not available|0|||
161719452|NCT00553059|584017484|FG001|Overall Study|Drug supply not available|1|||
161719453|NCT01966731|584017485|FG000|Overall Study|Death|2|||
161719454|NCT01966731|584017485|FG000|Overall Study|Lost to Follow-up|1|||
161719455|NCT01966731|584017485|FG000|Overall Study|Physician Decision|2|||
161719456|NCT01966731|584017485|FG000|Overall Study|Follow up is not complete|600|||
161719457|NCT01966731|584017485|FG000|Overall Study|Screening Failure|29|||
161719458|NCT01966731|584017485|FG000|Overall Study|Found to be ineligible|1|||
161719459|NCT00592683|584017486|FG000|Overall Study|Found ineligible|0|||
161719460|NCT00592683|584017487|FG001|Overall Study|Found ineligible|1|||
161719461|NCT00592683|584017486|FG000|Overall Study|Withdrawal by Subject|1|||
161719462|NCT00592683|584017487|FG001|Overall Study|Withdrawal by Subject|0|||
161719463|NCT00592683|584017486|FG000|Overall Study|Adverse Event|0|||
161719464|NCT00592683|584017487|FG001|Overall Study|Adverse Event|2|||
161719465|NCT00592683|584017486|FG000|Overall Study|Protocol Violation|1|||
161719466|NCT00592683|584017487|FG001|Overall Study|Protocol Violation|0|||
161719467|NCT00592683|584017486|FG000|Overall Study|Study drug expired|1|||
161719468|NCT00592683|584017487|FG001|Overall Study|Study drug expired|0|||
161719469|NCT00592683|584017486|FG000|Overall Study|Other|1|||
161719470|NCT00592683|584017487|FG001|Overall Study|Other|0|||
162032147|NCT00814801|585174218|FG000|Overall Study|Inappropriate as a subject|1|||
161719471|NCT00592683|584017486|FG000|Overall Study|Lost to Follow-up|0|||
161719472|NCT00592683|584017487|FG001|Overall Study|Lost to Follow-up|1|||
161719473|NCT00201201|584017488|FG000|Overall Study|Death|0|||
161719474|NCT00201201|584017489|FG001|Overall Study|Death|2|||
161719475|NCT00201201|584017488|FG000|Overall Study|Withdrawal by Subject|5|||
161719476|NCT00201201|584017489|FG001|Overall Study|Withdrawal by Subject|5|||
161964071|NCT00002540|584915009|FG001|Overall Study|Died Before ASU (Control)|0|||
161964072|NCT00002540|584915008|FG000|Overall Study|Refused ASU (Control)|597|||
161964073|NCT00002540|584915009|FG001|Overall Study|Refused ASU (Control)|0|||
161964074|NCT00002540|584915008|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
161964075|NCT00002540|584915009|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
161964076|NCT03931382|584915010|FG000|Overall Study|Equipment malfunction|2|||
161964077|NCT03931382|584915011|FG001|Overall Study|Equipment malfunction|0|||
161964078|NCT03931382|584915012|FG002|Overall Study|Equipment malfunction|2|||
161964079|NCT03931382|584915010|FG000|Overall Study|Withdrawal by Subject|0|||
161964080|NCT03931382|584915011|FG001|Overall Study|Withdrawal by Subject|1|||
161964081|NCT03931382|584915012|FG002|Overall Study|Withdrawal by Subject|0|||
161964082|NCT02151903|584915013|FG000|Overall Study|Withdrawal by Subject|1|||
161964083|NCT02151903|584915014|FG001|Overall Study|Withdrawal by Subject|0|||
161964084|NCT02151903|584915013|FG000|Overall Study|Progressive disease|2|||
161964085|NCT02151903|584915014|FG001|Overall Study|Progressive disease|1|||
161964086|NCT01500252|584915017|FG000|Overall Study|Death|4|||
161964087|NCT01500252|584915018|FG001|Overall Study|Death|2|||
161964088|NCT01500252|584915017|FG000|Overall Study|Lost to Follow-up|5|||
161964089|NCT01500252|584915018|FG001|Overall Study|Lost to Follow-up|4|||
161964090|NCT00778375|584915019|FG000|Overall Study|Ineligible|3|||
161964091|NCT03490292|584915020|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
161964092|NCT03490292|584915021|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
161964093|NCT03490292|584915020|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
161964094|NCT03490292|584915021|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
161964095|NCT03490292|584915020|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
161964096|NCT03490292|584915021|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
161964097|NCT03490292|584915020|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
161964098|NCT03490292|584915021|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
161964099|NCT03490292|584915020|FG000|1 Year Follow Up Post Last Dose|Death|1|||
161964100|NCT03490292|584915021|FG001|1 Year Follow Up Post Last Dose|Death|1|||
161964101|NCT01106651|584915022|FG000|Overall Study|Adverse Event|17|||
161719477|NCT00611455|584017497|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
161719478|NCT00611455|584017498|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
161719479|NCT00611455|584017499|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161719480|NCT00611455|584017497|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
161719481|NCT00611455|584017498|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161719482|NCT00611455|584017499|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161964102|NCT01106651|584915023|FG001|Overall Study|Adverse Event|9|||
161964103|NCT01106651|584915024|FG002|Overall Study|Adverse Event|23|||
161964104|NCT01106651|584915022|FG000|Overall Study|Lost to Follow-up|8|||
161964105|NCT01106651|584915023|FG001|Overall Study|Lost to Follow-up|2|||
161964106|NCT01106651|584915024|FG002|Overall Study|Lost to Follow-up|6|||
161964107|NCT01106651|584915022|FG000|Overall Study|Physician Decision|4|||
161964108|NCT01106651|584915023|FG001|Overall Study|Physician Decision|3|||
161964109|NCT01106651|584915024|FG002|Overall Study|Physician Decision|1|||
161964110|NCT01106651|584915022|FG000|Overall Study|Protocol Violation|1|||
161964111|NCT01106651|584915023|FG001|Overall Study|Protocol Violation|2|||
161964112|NCT01106651|584915024|FG002|Overall Study|Protocol Violation|1|||
161964113|NCT01106651|584915022|FG000|Overall Study|Withdrawal by Subject|14|||
161964114|NCT01106651|584915023|FG001|Overall Study|Withdrawal by Subject|7|||
161964115|NCT01106651|584915024|FG002|Overall Study|Withdrawal by Subject|4|||
161964116|NCT01106651|584915022|FG000|Overall Study|Noncompliance with study drug|1|||
161964117|NCT01106651|584915023|FG001|Overall Study|Noncompliance with study drug|0|||
161964118|NCT01106651|584915024|FG002|Overall Study|Noncompliance with study drug|2|||
161964119|NCT01106651|584915022|FG000|Overall Study|Other|34|||
161964120|NCT01106651|584915023|FG001|Overall Study|Other|31|||
161964121|NCT01106651|584915024|FG002|Overall Study|Other|21|||
162032148|NCT00814801|585174219|FG001|Overall Study|Inappropriate as a subject|1|||
161719483|NCT00611455|584017497|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
161719484|NCT00611455|584017498|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
161719485|NCT00611455|584017499|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161719486|NCT00611455|584017497|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
161719487|NCT00611455|584017498|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161964122|NCT01106651|584915022|FG000|Overall Study|Death|0|||
161964123|NCT01106651|584915023|FG001|Overall Study|Death|3|||
161964124|NCT01106651|584915024|FG002|Overall Study|Death|0|||
161964125|NCT00582712|584915029|FG000|Overall Study|Adverse Event|1|||
161964126|NCT00582712|584915029|FG000|Overall Study|Lack of Efficacy|1|||
161964127|NCT00582712|584915029|FG000|Overall Study|Withdrawal by Subject|1|||
161964128|NCT00582712|584915029|FG000|Overall Study|Complicating disease requiring treatment|1|||
161964129|NCT03640507|584915030|FG000|Overall Study|Withdrawal by Subject|0|||
161964130|NCT03640507|584915031|FG001|Overall Study|Withdrawal by Subject|0|||
161964131|NCT03640507|584915032|FG002|Overall Study|Withdrawal by Subject|1|||
161964132|NCT03525600|584915033|FG000|Overall Study|Adverse Event|9|||
161964133|NCT03525600|584915034|FG001|Overall Study|Adverse Event|6|||
161964134|NCT03525600|584915035|FG002|Overall Study|Adverse Event|5|||
161964135|NCT03525600|584915036|FG003|Overall Study|Adverse Event|3|||
161964136|NCT03525600|584915033|FG000|Overall Study|Lost to Follow-up|2|||
161964137|NCT03525600|584915034|FG001|Overall Study|Lost to Follow-up|4|||
161964138|NCT03525600|584915035|FG002|Overall Study|Lost to Follow-up|4|||
161964139|NCT03525600|584915036|FG003|Overall Study|Lost to Follow-up|0|||
161964140|NCT03525600|584915033|FG000|Overall Study|Physician Decision|1|||
161964141|NCT03525600|584915034|FG001|Overall Study|Physician Decision|0|||
161964142|NCT03525600|584915035|FG002|Overall Study|Physician Decision|2|||
161964143|NCT03525600|584915036|FG003|Overall Study|Physician Decision|0|||
161964144|NCT03525600|584915033|FG000|Overall Study|Consent withdrawal|36|||
161964145|NCT03525600|584915034|FG001|Overall Study|Consent withdrawal|20|||
161964146|NCT03525600|584915035|FG002|Overall Study|Consent withdrawal|6|||
161964147|NCT03525600|584915036|FG003|Overall Study|Consent withdrawal|13|||
161964148|NCT03525600|584915033|FG000|Overall Study|Death|7|||
161964149|NCT03525600|584915034|FG001|Overall Study|Death|6|||
161964150|NCT03525600|584915035|FG002|Overall Study|Death|4|||
161964151|NCT03525600|584915036|FG003|Overall Study|Death|3|||
161964152|NCT03525600|584915033|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
161964153|NCT03525600|584915034|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
161964154|NCT03525600|584915035|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
161964155|NCT03525600|584915036|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
161964156|NCT03525600|584915033|FG000|Overall Study|Other|0|||
161964157|NCT03525600|584915034|FG001|Overall Study|Other|1|||
161964158|NCT03525600|584915035|FG002|Overall Study|Other|0|||
161964159|NCT03525600|584915036|FG003|Overall Study|Other|0|||
161964160|NCT00613327|584915040|FG000|Overall Study|Adverse Event|38|||
161964161|NCT00613327|584915040|FG000|Overall Study|Lost to Follow-up|8|||
161964162|NCT00613327|584915040|FG000|Overall Study|Withdrawal by Subject|6|||
161964163|NCT00613327|584915040|FG000|Overall Study|Protocol Violation|2|||
161964164|NCT00613327|584915040|FG000|Overall Study|Other|47|||
161964165|NCT00700882|584915043|FG000|Overall Study|Never received treatment|6|||
161719488|NCT00611455|584017499|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161719489|NCT00611455|584017497|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
161719490|NCT00611455|584017498|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
161719491|NCT00611455|584017499|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
161719492|NCT00611455|584017497|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
161719493|NCT00611455|584017498|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
161719494|NCT00611455|584017499|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
161719495|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
161719496|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
161719497|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
161719498|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
161719499|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
161719500|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
161719501|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
161719502|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
161719503|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
161719504|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
161719505|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
161719506|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
161719507|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
161719508|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
161719509|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
161719510|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
161719511|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
161719512|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
161719513|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
161719514|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
161719515|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
161719516|NCT00611455|584017497|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
161719517|NCT00611455|584017498|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
161719518|NCT00611455|584017499|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
161719519|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
161719520|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
161719521|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
161719522|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
161719523|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
161719524|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
161964166|NCT00700882|584915043|FG000|Overall Study|Ineligible|2|||
161964167|NCT00700882|584915043|FG000|Overall Study|No KIT mutation|51|||
161719525|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
161719526|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
161719527|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
161719528|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
161719529|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
161719530|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
161719531|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
161719532|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
161719533|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
161719534|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
161719535|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
161719536|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
161719537|NCT00611455|584017497|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
161719538|NCT00611455|584017498|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
161719539|NCT00611455|584017499|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
161719540|NCT03240081|584017500|FG000|Overall Study|Withdrawal by Subject|0|||
161719541|NCT03240081|584017501|FG001|Overall Study|Withdrawal by Subject|2|||
161719542|NCT03240081|584017500|FG000|Overall Study|Lost to Follow-up|0|||
161719543|NCT03240081|584017501|FG001|Overall Study|Lost to Follow-up|1|||
161719544|NCT04601272|584017502|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
161964168|NCT01832493|584915047|FG000|Overall Study|Physician Decision|2|||
161964169|NCT01832493|584915047|FG000|Overall Study|Protocol Violation|4|||
161964170|NCT01832493|584915047|FG000|Overall Study|Unable to place LV lead|2|||
161964171|NCT01814397|584915054|FG000|Overall Study|Adverse Event|7|||
161964172|NCT01814397|584915054|FG000|Overall Study|Withdrawal by Subject|7|||
161964173|NCT00290771|584915055|FG000|Overall Study|Disease progression|95|||
161964174|NCT00290771|584915056|FG001|Overall Study|Disease progression|73|||
161964175|NCT00290771|584915055|FG000|Overall Study|Death|11|||
161964176|NCT00290771|584915056|FG001|Overall Study|Death|10|||
161964177|NCT00290771|584915055|FG000|Overall Study|Adverse Event|12|||
161964178|NCT00290771|584915056|FG001|Overall Study|Adverse Event|6|||
161964179|NCT00290771|584915055|FG000|Overall Study|Withdrawal by Subject|5|||
161964180|NCT00290771|584915056|FG001|Overall Study|Withdrawal by Subject|6|||
161964181|NCT00290771|584915055|FG000|Overall Study|Administrative problems|2|||
161964182|NCT00290771|584915056|FG001|Overall Study|Administrative problems|1|||
161964183|NCT00290771|584915055|FG000|Overall Study|Protocol Violation|2|||
161964184|NCT00290771|584915056|FG001|Overall Study|Protocol Violation|0|||
161964185|NCT00290771|584915055|FG000|Overall Study|Lost to Follow-up|0|||
161964186|NCT00290771|584915056|FG001|Overall Study|Lost to Follow-up|1|||
161964187|NCT04154293|584915059|FG000|Overall Study|Withdrawal by Subject|2|||
161964188|NCT04154293|584915060|FG001|Overall Study|Withdrawal by Subject|3|||
161964189|NCT04154293|584915061|FG002|Overall Study|Withdrawal by Subject|1|||
161964190|NCT04154293|584915059|FG000|Overall Study|Physician Decision|0|||
161964191|NCT04154293|584915060|FG001|Overall Study|Physician Decision|0|||
161964192|NCT04154293|584915061|FG002|Overall Study|Physician Decision|1|||
161964193|NCT04731298|584915062|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
161964194|NCT04731298|584915063|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
161719545|NCT04601272|584017503|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
161719546|NCT04601272|584017504|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
161719547|NCT03671369|584017507|FG000|Overall Study|Other|1|||
161719548|NCT03671369|584017507|FG000|Overall Study|Withdrawal by Subject|289|||
161719549|NCT03671369|584017507|FG000|Overall Study|Not willing to be vaccinated|1|||
161719550|NCT04382651|584017508|FG000|Overall Study|Death|26|||
161719551|NCT04382651|584017509|FG001|Overall Study|Death|23|||
161719552|NCT04382651|584017508|FG000|Overall Study|Lost to Follow-up|3|||
161719553|NCT04382651|584017509|FG001|Overall Study|Lost to Follow-up|4|||
161719554|NCT04382651|584017508|FG000|Overall Study|Withdrawal by Subject|2|||
161719555|NCT04382651|584017509|FG001|Overall Study|Withdrawal by Subject|0|||
161719556|NCT04382651|584017508|FG000|Overall Study|Physician Decision|0|||
161719557|NCT04382651|584017509|FG001|Overall Study|Physician Decision|1|||
161719558|NCT01507545|584017515|FG000|Overall Study|Withdrawal by Subject|6|||
161719559|NCT01507545|584017516|FG001|Overall Study|Withdrawal by Subject|2|||
161719560|NCT01507545|584017515|FG000|Overall Study|Lost to Follow-up|1|||
161719561|NCT01507545|584017516|FG001|Overall Study|Lost to Follow-up|0|||
161719562|NCT01507545|584017515|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
161719563|NCT01507545|584017516|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
161964195|NCT01208961|584915064|FG000|High-Fat Period III|Protocol Violation|1|||
161964196|NCT01208961|584915065|FG001|High-Fat Period III|Protocol Violation|0|||
161964197|NCT01262560|584915066|FG000|Overall Study|Protocol Violation|0|||
161964198|NCT01262560|584915067|FG001|Overall Study|Protocol Violation|1|||
161964199|NCT01262560|584915068|FG002|Overall Study|Protocol Violation|2|||
161719564|NCT01507545|584017515|FG000|Overall Study|Progressive disease|60|||
161719565|NCT01507545|584017516|FG001|Overall Study|Progressive disease|27|||
161719566|NCT01507545|584017515|FG000|Overall Study|Other|6|||
161719567|NCT01507545|584017516|FG001|Overall Study|Other|4|||
161719568|NCT00790296|584017518|FG000|Overall Study|Did not meet study eligibility criteria|1|||
161719569|NCT00790296|584017519|FG001|Overall Study|Did not meet study eligibility criteria|1|||
161719570|NCT00790296|584017518|FG000|Overall Study|Adverse Event|0|||
161719571|NCT00790296|584017519|FG001|Overall Study|Adverse Event|1|||
161719572|NCT02612077|584017520|FG000|Overall Study|Adverse Event|3|||
161719573|NCT02612077|584017520|FG000|Overall Study|Withdrawal by Subject|9|||
161719574|NCT02612077|584017520|FG000|Overall Study|Protocol Violation|28|||
161719575|NCT02612077|584017520|FG000|Overall Study|Lost to Follow-up|20|||
161719576|NCT02612077|584017520|FG000|Overall Study|Death|377|||
161719577|NCT02612077|584017520|FG000|Overall Study|Moved or Changed Medical Team|23|||
161719578|NCT02612077|584017520|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
161719579|NCT02612077|584017520|FG000|Overall Study|Disease Progression|3|||
161719580|NCT02612077|584017520|FG000|Overall Study|Unknown reason|2|||
161719581|NCT01753518|584017521|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
161719582|NCT01753518|584017522|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
161719583|NCT01753518|584017521|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
161719584|NCT01753518|584017522|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
161719585|NCT01753518|584017521|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
161719586|NCT01753518|584017522|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
161719587|NCT01753518|584017521|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
161719588|NCT01753518|584017522|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
161719589|NCT01971476|584017523|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
161719590|NCT01971476|584017524|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
161719591|NCT01971476|584017525|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
161719592|NCT01971476|584017523|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
161719593|NCT01971476|584017524|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
161719594|NCT01971476|584017525|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
161719595|NCT01971476|584017523|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
161719596|NCT01971476|584017524|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
161719597|NCT01971476|584017525|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
161719598|NCT05121103|584017528|FG000|Overall Study|Progressive disease|2|||
161719599|NCT05121103|584017529|FG001|Overall Study|Progressive disease|1|||
161719600|NCT05121103|584017530|FG002|Overall Study|Progressive disease|6|||
161719601|NCT05121103|584017528|FG000|Overall Study|Physician Decision|2|||
161719602|NCT05121103|584017529|FG001|Overall Study|Physician Decision|1|||
161719603|NCT05121103|584017530|FG002|Overall Study|Physician Decision|0|||
161719604|NCT05121103|584017528|FG000|Overall Study|Withdrawal by Subject|0|||
161719605|NCT05121103|584017529|FG001|Overall Study|Withdrawal by Subject|1|||
161719606|NCT05121103|584017530|FG002|Overall Study|Withdrawal by Subject|0|||
161719607|NCT00514449|584017531|FG000|Overall Study|Withdrawal by Subject|1|||
161719608|NCT00514449|584017532|FG001|Overall Study|Withdrawal by Subject|2|||
161719609|NCT00514449|584017531|FG000|Overall Study|Protocol Violation|1|||
161719610|NCT00514449|584017532|FG001|Overall Study|Protocol Violation|2|||
161719611|NCT00514449|584017531|FG000|Overall Study|Lost to Follow-up|1|||
161719612|NCT00514449|584017532|FG001|Overall Study|Lost to Follow-up|0|||
161719613|NCT05897853|584017542|FG000|Overall Study|Lost to Follow-up|2|||
161719614|NCT05897853|584017543|FG001|Overall Study|Lost to Follow-up|0|||
161719615|NCT05897853|584017542|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
161719616|NCT05897853|584017543|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
161719617|NCT02609399|584017547|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
161719618|NCT02609399|584017548|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
161719619|NCT02609399|584017547|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
161719620|NCT02609399|584017548|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
161719621|NCT02609399|584017547|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
161719622|NCT02609399|584017548|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
161719623|NCT04458857|584017552|FG000|Overall Study|Adverse Event|0|||
161719624|NCT04458857|584017553|FG001|Overall Study|Adverse Event|1|||
161719625|NCT04458857|584017554|FG002|Overall Study|Adverse Event|0|||
161719626|NCT04458857|584017552|FG000|Overall Study|Withdrawal by Subject|2|||
161719627|NCT04458857|584017553|FG001|Overall Study|Withdrawal by Subject|0|||
161719628|NCT04458857|584017554|FG002|Overall Study|Withdrawal by Subject|0|||
161719629|NCT04458857|584017552|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161719630|NCT04458857|584017553|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161719631|NCT04458857|584017554|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161719632|NCT04458857|584017552|FG000|Overall Study|Non-compliance with study drug|0|||
161719633|NCT04458857|584017553|FG001|Overall Study|Non-compliance with study drug|1|||
161719634|NCT04458857|584017554|FG002|Overall Study|Non-compliance with study drug|0|||
161719635|NCT04458857|584017552|FG000|Overall Study|Lost to Follow-up|4|||
161719636|NCT04458857|584017553|FG001|Overall Study|Lost to Follow-up|1|||
161719637|NCT04458857|584017554|FG002|Overall Study|Lost to Follow-up|0|||
161719638|NCT00306891|584017555|FG000|Part A|Withdrawal by Subject|1|||
161719639|NCT00306891|584017556|FG001|Part A|Withdrawal by Subject|1|||
161719640|NCT00306891|584017557|FG002|Part A|Withdrawal by Subject|0|||
161719641|NCT00306891|584017558|FG003|Part A|Withdrawal by Subject|0|||
161719642|NCT00306891|584017555|FG000|Part A|Condition under investigation worsened|2|||
161719643|NCT00306891|584017556|FG001|Part A|Condition under investigation worsened|2|||
161719644|NCT00306891|584017557|FG002|Part A|Condition under investigation worsened|0|||
161719645|NCT00306891|584017558|FG003|Part A|Condition under investigation worsened|0|||
161719646|NCT00306891|584017555|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
161719647|NCT00306891|584017556|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
161719648|NCT00306891|584017557|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
161719649|NCT00306891|584017558|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
161719650|NCT00306891|584017555|FG000|Part A|Partial bowel obstruction|1|||
161719651|NCT00306891|584017556|FG001|Part A|Partial bowel obstruction|0|||
161719652|NCT00306891|584017557|FG002|Part A|Partial bowel obstruction|0|||
161719653|NCT00306891|584017558|FG003|Part A|Partial bowel obstruction|0|||
161719654|NCT00306891|584017555|FG000|Part A|Reaccumul. of ascites following drainage|0|||
161719655|NCT00306891|584017556|FG001|Part A|Reaccumul. of ascites following drainage|1|||
161719656|NCT00306891|584017557|FG002|Part A|Reaccumul. of ascites following drainage|0|||
161719657|NCT00306891|584017558|FG003|Part A|Reaccumul. of ascites following drainage|0|||
161719658|NCT00306891|584017555|FG000|Part A|Suspicion of second malignancy|0|||
161719659|NCT00306891|584017556|FG001|Part A|Suspicion of second malignancy|1|||
161719660|NCT00306891|584017557|FG002|Part A|Suspicion of second malignancy|0|||
161719661|NCT00306891|584017558|FG003|Part A|Suspicion of second malignancy|0|||
161719662|NCT00306891|584017555|FG000|Part A|QTC interval outwith elig. criteria|1|||
161719663|NCT00306891|584017556|FG001|Part A|QTC interval outwith elig. criteria|0|||
161719664|NCT00306891|584017557|FG002|Part A|QTC interval outwith elig. criteria|0|||
161719665|NCT00306891|584017558|FG003|Part A|QTC interval outwith elig. criteria|0|||
161719666|NCT00306891|584017555|FG000|Part B|Death|0|||
161719667|NCT00306891|584017556|FG001|Part B|Death|0|||
161719668|NCT00306891|584017557|FG002|Part B|Death|1|||
161719669|NCT00306891|584017558|FG003|Part B|Death|2|||
161719670|NCT00306891|584017555|FG000|Part B|Adverse Event|0|||
161719671|NCT00306891|584017556|FG001|Part B|Adverse Event|0|||
161719672|NCT00306891|584017557|FG002|Part B|Adverse Event|5|||
161719673|NCT00306891|584017558|FG003|Part B|Adverse Event|5|||
161719674|NCT00306891|584017555|FG000|Part B|Withdrawal by Subject|0|||
161719675|NCT00306891|584017556|FG001|Part B|Withdrawal by Subject|0|||
161719676|NCT00306891|584017557|FG002|Part B|Withdrawal by Subject|3|||
161719677|NCT00306891|584017558|FG003|Part B|Withdrawal by Subject|1|||
161719678|NCT00306891|584017555|FG000|Part B|Condition under investigation worsened|0|||
161719679|NCT00306891|584017556|FG001|Part B|Condition under investigation worsened|0|||
161719680|NCT00306891|584017557|FG002|Part B|Condition under investigation worsened|2|||
161719681|NCT00306891|584017558|FG003|Part B|Condition under investigation worsened|8|||
161719682|NCT00306891|584017555|FG000|Part B|Development of study specific disc crit.|0|||
161719683|NCT00306891|584017556|FG001|Part B|Development of study specific disc crit.|0|||
161719684|NCT00306891|584017557|FG002|Part B|Development of study specific disc crit.|0|||
161719685|NCT00306891|584017558|FG003|Part B|Development of study specific disc crit.|1|||
161719686|NCT00853905|584017562|FG000|Overall Study|Lost to Follow-up|1|||
161719687|NCT00853905|584017563|FG001|Overall Study|Lost to Follow-up|3|||
161719688|NCT00853905|584017562|FG000|Overall Study|Withdrawal by Subject|0|||
161719689|NCT00853905|584017563|FG001|Overall Study|Withdrawal by Subject|1|||
161719690|NCT00853905|584017562|FG000|Overall Study|never had surgery|1|||
161719691|NCT00853905|584017563|FG001|Overall Study|never had surgery|0|||
161719692|NCT00847561|584017566|FG000|Overall Study|Withdrawal by Subject|4|||
161719693|NCT00847561|584017567|FG001|Overall Study|Withdrawal by Subject|3|||
161719694|NCT00847561|584017566|FG000|Overall Study|Unable to schedule|9|||
161719695|NCT00847561|584017567|FG001|Overall Study|Unable to schedule|1|||
161719696|NCT01333189|584017568|FG000|Overall Study|Time constraints|1|||
161719697|NCT01333189|584017569|FG001|Overall Study|Time constraints|0|||
161719698|NCT01333189|584017568|FG000|Overall Study|Adverse Event|1|||
161719699|NCT01333189|584017569|FG001|Overall Study|Adverse Event|0|||
161719700|NCT01333189|584017568|FG000|Overall Study|Transportation difficulties|0|||
161719701|NCT01333189|584017569|FG001|Overall Study|Transportation difficulties|1|||
161719702|NCT01333189|584017568|FG000|Overall Study|Moved from region|0|||
161719703|NCT01333189|584017569|FG001|Overall Study|Moved from region|1|||
161964200|NCT00350870|584915071|FG000|Overall Study|Withdrawal by Subject|21|||
161964201|NCT00350870|584915072|FG001|Overall Study|Withdrawal by Subject|17|||
161719704|NCT01739595|584017571|FG000|Overall Study|Adverse Event|3|||
161719705|NCT01739595|584017572|FG001|Overall Study|Adverse Event|0|||
161964202|NCT00350870|584915073|FG002|Overall Study|Withdrawal by Subject|15|||
161719706|NCT01739595|584017573|FG002|Overall Study|Adverse Event|0|||
161719707|NCT01739595|584017571|FG000|Overall Study|Lost to Follow-up|2|||
161719708|NCT01739595|584017572|FG001|Overall Study|Lost to Follow-up|0|||
161719709|NCT01739595|584017573|FG002|Overall Study|Lost to Follow-up|0|||
161719710|NCT01739595|584017571|FG000|Overall Study|Withdrawal by Subject|2|||
161719711|NCT01739595|584017572|FG001|Overall Study|Withdrawal by Subject|1|||
161719712|NCT01739595|584017573|FG002|Overall Study|Withdrawal by Subject|2|||
161964203|NCT00350870|584915074|FG003|Overall Study|Withdrawal by Subject|14|||
161964204|NCT00350870|584915071|FG000|Overall Study|Physician Decision|1|||
161964205|NCT00350870|584915072|FG001|Overall Study|Physician Decision|0|||
161964206|NCT00350870|584915073|FG002|Overall Study|Physician Decision|1|||
161719713|NCT01739595|584017571|FG000|Overall Study|Eligibility issue|3|||
161719714|NCT01739595|584017572|FG001|Overall Study|Eligibility issue|0|||
161719715|NCT01739595|584017573|FG002|Overall Study|Eligibility issue|0|||
161719716|NCT01739595|584017571|FG000|Overall Study|Protocol Violation|1|||
161719717|NCT01739595|584017572|FG001|Overall Study|Protocol Violation|0|||
161719718|NCT01739595|584017573|FG002|Overall Study|Protocol Violation|0|||
161719719|NCT01739595|584017571|FG000|Overall Study|Lab assessment|1|||
161719720|NCT01739595|584017572|FG001|Overall Study|Lab assessment|0|||
161719721|NCT01739595|584017573|FG002|Overall Study|Lab assessment|0|||
161719722|NCT01739595|584017571|FG000|Overall Study|Drug discrepancy|1|||
161719723|NCT01739595|584017572|FG001|Overall Study|Drug discrepancy|0|||
161719724|NCT01739595|584017573|FG002|Overall Study|Drug discrepancy|0|||
161719725|NCT02725177|584017576|FG000|Overall Study|Physician Decision|4|||
161719726|NCT02725177|584017576|FG000|Overall Study|Adverse Event|1|||
161719727|NCT01089725|584017580|FG000|Overall Study|Adverse Event|1|||
161719728|NCT01089725|584017581|FG001|Overall Study|Adverse Event|1|||
161719729|NCT01089725|584017582|FG002|Overall Study|Adverse Event|0|||
161719730|NCT01089725|584017583|FG003|Overall Study|Adverse Event|0|||
161719731|NCT01089725|584017584|FG004|Overall Study|Adverse Event|2|||
161719732|NCT01089725|584017580|FG000|Overall Study|Lack of Efficacy|4|||
161719733|NCT01089725|584017581|FG001|Overall Study|Lack of Efficacy|3|||
161719734|NCT01089725|584017582|FG002|Overall Study|Lack of Efficacy|1|||
161719735|NCT01089725|584017583|FG003|Overall Study|Lack of Efficacy|0|||
161719736|NCT01089725|584017584|FG004|Overall Study|Lack of Efficacy|4|||
161719737|NCT01089725|584017580|FG000|Overall Study|Lost to Follow-up|2|||
161719738|NCT01089725|584017581|FG001|Overall Study|Lost to Follow-up|2|||
161719739|NCT01089725|584017582|FG002|Overall Study|Lost to Follow-up|0|||
161719740|NCT01089725|584017583|FG003|Overall Study|Lost to Follow-up|3|||
161719741|NCT01089725|584017584|FG004|Overall Study|Lost to Follow-up|0|||
161719742|NCT01089725|584017580|FG000|Overall Study|Protocol Violation|0|||
161719743|NCT01089725|584017581|FG001|Overall Study|Protocol Violation|0|||
161719744|NCT01089725|584017582|FG002|Overall Study|Protocol Violation|1|||
161719745|NCT01089725|584017583|FG003|Overall Study|Protocol Violation|1|||
161719746|NCT01089725|584017584|FG004|Overall Study|Protocol Violation|0|||
161719747|NCT01089725|584017580|FG000|Overall Study|Withdrawal by Subject|5|||
161719748|NCT01089725|584017581|FG001|Overall Study|Withdrawal by Subject|5|||
161719749|NCT01089725|584017582|FG002|Overall Study|Withdrawal by Subject|4|||
161719750|NCT01089725|584017583|FG003|Overall Study|Withdrawal by Subject|5|||
161719751|NCT01089725|584017584|FG004|Overall Study|Withdrawal by Subject|4|||
161719752|NCT01089725|584017580|FG000|Overall Study|Study Terminated by Sponsor|51|||
161719753|NCT01089725|584017581|FG001|Overall Study|Study Terminated by Sponsor|56|||
161719754|NCT01089725|584017582|FG002|Overall Study|Study Terminated by Sponsor|53|||
161719755|NCT01089725|584017583|FG003|Overall Study|Study Terminated by Sponsor|68|||
161719756|NCT01089725|584017584|FG004|Overall Study|Study Terminated by Sponsor|68|||
161719757|NCT01089725|584017580|FG000|Overall Study|Randomized, but not treated|0|||
161719758|NCT01089725|584017581|FG001|Overall Study|Randomized, but not treated|1|||
161719759|NCT01089725|584017582|FG002|Overall Study|Randomized, but not treated|2|||
161719760|NCT01089725|584017583|FG003|Overall Study|Randomized, but not treated|1|||
161719761|NCT01089725|584017584|FG004|Overall Study|Randomized, but not treated|2|||
161719762|NCT01089725|584017580|FG000|Overall Study|Other|3|||
161719763|NCT01089725|584017581|FG001|Overall Study|Other|0|||
161719764|NCT01089725|584017582|FG002|Overall Study|Other|0|||
161719765|NCT01089725|584017583|FG003|Overall Study|Other|1|||
161719766|NCT01089725|584017584|FG004|Overall Study|Other|0|||
161719767|NCT00375934|584018908|FG000|Overall Study|Adverse Event|1|||
161719768|NCT00375934|584018909|FG001|Overall Study|Adverse Event|1|||
161719769|NCT00375934|584018908|FG000|Overall Study|Withdrawal by Subject|2|||
161719770|NCT00375934|584018909|FG001|Overall Study|Withdrawal by Subject|2|||
161964207|NCT00350870|584915074|FG003|Overall Study|Physician Decision|1|||
161719771|NCT00375934|584018908|FG000|Overall Study|Lack of Efficacy|0|||
161719772|NCT00375934|584018909|FG001|Overall Study|Lack of Efficacy|2|||
161719773|NCT00375934|584018908|FG000|Overall Study|Physician Decision|0|||
161719774|NCT00375934|584018909|FG001|Overall Study|Physician Decision|1|||
161719775|NCT03191396|584018910|FG000|Overall Study|Lost to Follow-up|0|||
161719776|NCT03191396|584018911|FG001|Overall Study|Lost to Follow-up|3|||
161719777|NCT03191396|584018910|FG000|Overall Study|Withdrawal by Subject|3|||
161719778|NCT03191396|584018911|FG001|Overall Study|Withdrawal by Subject|2|||
161719779|NCT00486226|584018922|FG000|Overall Study|Death|3|||
161719780|NCT00486226|584018922|FG000|Overall Study|Adverse Event|1|||
161719781|NCT00486226|584018922|FG000|Overall Study|Withdrawal by Subject|1|||
161719782|NCT00486226|584018922|FG000|Overall Study|Lost to Follow-up|8|||
161719783|NCT00500149|584018923|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
161719784|NCT00500149|584018924|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
161719785|NCT00500149|584018923|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
161964208|NCT02095873|584915076|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
161964209|NCT02095873|584915077|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
161964210|NCT02095873|584915076|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
161964211|NCT02095873|584915077|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
161964212|NCT02095873|584915076|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
161964213|NCT02095873|584915077|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
161964214|NCT00792740|584915081|FG000|Overall Study|Disease Worsening|3|||
161964215|NCT00792740|584915082|FG001|Overall Study|Disease Worsening|2|||
161964216|NCT00792740|584915081|FG000|Overall Study|Personal Reason|1|||
161964217|NCT00792740|584915082|FG001|Overall Study|Personal Reason|0|||
161964218|NCT00792740|584915081|FG000|Overall Study|Adverse Event|1|||
161964219|NCT00792740|584915082|FG001|Overall Study|Adverse Event|3|||
161964220|NCT00792740|584915081|FG000|Overall Study|Patient's withdrawal of consent|0|||
161964221|NCT00792740|584915082|FG001|Overall Study|Patient's withdrawal of consent|1|||
161964222|NCT00792740|584915081|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
161964223|NCT00792740|584915082|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
161964224|NCT00792740|584915081|FG000|Overall Study|Other reasons|0|||
161719786|NCT00500149|584018924|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
161719787|NCT00500149|584018923|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
161719788|NCT00500149|584018924|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
161719789|NCT00500149|584018923|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
161719790|NCT00500149|584018924|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
161719791|NCT00500149|584018923|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
161719792|NCT00500149|584018924|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
161719793|NCT00500149|584018923|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
161719794|NCT00500149|584018924|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
161719795|NCT00500149|584018923|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
161719796|NCT00500149|584018924|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
161719797|NCT01157169|584018925|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
161719798|NCT01157169|584018926|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
161719799|NCT01157169|584018925|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
161719800|NCT01157169|584018926|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
161719801|NCT02940886|584018927|FG000|Overall Study|Adverse Event|7|||
161719802|NCT02940886|584018928|FG001|Overall Study|Adverse Event|3|||
161719803|NCT02940886|584018927|FG000|Overall Study|Protocol Violation|0|||
161719804|NCT02940886|584018928|FG001|Overall Study|Protocol Violation|2|||
161719805|NCT02940886|584018927|FG000|Overall Study|Withdrawal by Subject|28|||
161719806|NCT02940886|584018928|FG001|Overall Study|Withdrawal by Subject|20|||
161719807|NCT02940886|584018927|FG000|Overall Study|Death|1|||
161719808|NCT02940886|584018928|FG001|Overall Study|Death|0|||
161719809|NCT02940886|584018927|FG000|Overall Study|Lack of Efficacy|1|||
161719810|NCT02940886|584018928|FG001|Overall Study|Lack of Efficacy|0|||
161719811|NCT02940886|584018927|FG000|Overall Study|Lost to Follow-up|49|||
161719812|NCT02940886|584018928|FG001|Overall Study|Lost to Follow-up|21|||
161719813|NCT02940886|584018927|FG000|Overall Study|Physician Decision|9|||
161719814|NCT02940886|584018928|FG001|Overall Study|Physician Decision|4|||
161719815|NCT02940886|584018927|FG000|Overall Study|Sponsor decision|0|||
161719816|NCT02940886|584018928|FG001|Overall Study|Sponsor decision|1|||
161719817|NCT02940886|584018927|FG000|Overall Study|No treatment|7|||
161719818|NCT02940886|584018928|FG001|Overall Study|No treatment|2|||
161719819|NCT02940886|584018927|FG000|Overall Study|Enrolment error|0|||
161719820|NCT02940886|584018928|FG001|Overall Study|Enrolment error|1|||
161719821|NCT03042611|584018929|FG000|Core Phase|Withdrawal by Subject|13|||
161719822|NCT03042611|584018930|FG001|Core Phase|Withdrawal by Subject|4|||
161719823|NCT03042611|584018931|FG002|Core Phase|Withdrawal by Subject|0|||
161719824|NCT03042611|584018932|FG003|Core Phase|Withdrawal by Subject|0|||
161719825|NCT03042611|584018929|FG000|Core Phase|Death|232|||
161719826|NCT03042611|584018930|FG001|Core Phase|Death|110|||
161719827|NCT03042611|584018931|FG002|Core Phase|Death|0|||
161719828|NCT03042611|584018932|FG003|Core Phase|Death|0|||
161964225|NCT00792740|584915082|FG001|Overall Study|Other reasons|1|||
161964226|NCT02791516|584915085|FG000|Overall Study|Withdrawal by Subject|1|||
161964227|NCT02791516|584915086|FG001|Overall Study|Withdrawal by Subject|1|||
161964228|NCT02524275|584915087|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
161964229|NCT01439971|584915088|FG000|Overall Study|Required number in cohort dosed|0|||
161964230|NCT01439971|584915089|FG001|Overall Study|Required number in cohort dosed|1|||
161964231|NCT01439971|584915090|FG002|Overall Study|Required number in cohort dosed|2|||
161719829|NCT03042611|584018929|FG000|Core Phase|Lost to Follow-up|4|||
161719830|NCT03042611|584018930|FG001|Core Phase|Lost to Follow-up|7|||
161719831|NCT03042611|584018931|FG002|Core Phase|Lost to Follow-up|0|||
161719832|NCT03042611|584018932|FG003|Core Phase|Lost to Follow-up|0|||
161719833|NCT03042611|584018929|FG000|Core Phase|Physician Decision|7|||
161719834|NCT03042611|584018930|FG001|Core Phase|Physician Decision|2|||
161719835|NCT03042611|584018931|FG002|Core Phase|Physician Decision|0|||
161964232|NCT01439971|584915091|FG003|Overall Study|Required number in cohort dosed|0|||
161964233|NCT01439971|584915092|FG004|Overall Study|Required number in cohort dosed|1|||
161964234|NCT02628600|584915093|FG000|Overall Study|Death|2|||
161964235|NCT02628600|584915094|FG001|Overall Study|Death|1|||
161964236|NCT02628600|584915093|FG000|Overall Study|Adverse Event|3|||
161719836|NCT03042611|584018932|FG003|Core Phase|Physician Decision|0|||
161719837|NCT03042611|584018929|FG000|Core Phase|Study Closed|0|||
161719838|NCT03042611|584018930|FG001|Core Phase|Study Closed|1|||
161719839|NCT03042611|584018931|FG002|Core Phase|Study Closed|0|||
161719840|NCT03042611|584018932|FG003|Core Phase|Study Closed|0|||
161719841|NCT03042611|584018929|FG000|Extension Phase|Death|0|||
161719842|NCT03042611|584018930|FG001|Extension Phase|Death|0|||
161719843|NCT03042611|584018931|FG002|Extension Phase|Death|34|||
161719844|NCT03042611|584018932|FG003|Extension Phase|Death|16|||
161719845|NCT03042611|584018929|FG000|Extension Phase|Lost to Follow-up|0|||
161719846|NCT03042611|584018930|FG001|Extension Phase|Lost to Follow-up|0|||
161719847|NCT03042611|584018931|FG002|Extension Phase|Lost to Follow-up|1|||
161719848|NCT03042611|584018932|FG003|Extension Phase|Lost to Follow-up|1|||
161719849|NCT03042611|584018929|FG000|Extension Phase|Study Closed|0|||
161719850|NCT03042611|584018930|FG001|Extension Phase|Study Closed|0|||
161719851|NCT03042611|584018931|FG002|Extension Phase|Study Closed|17|||
161719852|NCT03042611|584018932|FG003|Extension Phase|Study Closed|11|||
161719853|NCT02397655|584018935|FG000|Overall Study|data not completed|1301|||
161719854|NCT00545818|584018943|FG000|Overall Study|Protocol Violation|1|||
161719855|NCT00545818|584018944|FG001|Overall Study|Protocol Violation|0|||
161719856|NCT00545818|584018943|FG000|Overall Study|Adverse Event|1|||
161719857|NCT00545818|584018944|FG001|Overall Study|Adverse Event|1|||
161719858|NCT00545818|584018943|FG000|Overall Study|Lost to Follow-up|1|||
161719859|NCT00545818|584018944|FG001|Overall Study|Lost to Follow-up|6|||
161719860|NCT02623361|584018945|FG000|Overall Study|Protocol Violation|0|||
161719861|NCT02623361|584018946|FG001|Overall Study|Protocol Violation|1|||
161719862|NCT02623361|584018945|FG000|Overall Study|Withdrawal by Subject|0|||
161719863|NCT02623361|584018946|FG001|Overall Study|Withdrawal by Subject|1|||
161719864|NCT02732912|584018949|FG000|Overall Study|Discharged before night|2|||
161719865|NCT02732912|584018950|FG001|Overall Study|Discharged before night|6|||
161719866|NCT02732912|584018949|FG000|Overall Study|Incomplete completion of questionnaire|2|||
161719867|NCT02732912|584018950|FG001|Overall Study|Incomplete completion of questionnaire|3|||
161719868|NCT02732912|584018949|FG000|Overall Study|No outcome; discharged or refused|6|||
161719869|NCT02732912|584018950|FG001|Overall Study|No outcome; discharged or refused|9|||
161719870|NCT01873742|584018951|FG000|Overall Study|Lost to Follow-up|68|||
161719871|NCT01873742|584018952|FG001|Overall Study|Lost to Follow-up|76|||
161719872|NCT02498821|584018953|FG000|Overall Study|Screen failure|3|||
161719873|NCT02498821|584018954|FG001|Overall Study|Screen failure|5|||
161719874|NCT00942708|584018956|FG000|Overall Study|Withdrawal by Subject|1|||
161719875|NCT01457339|584018957|FG000|Period 3 (100 mg)|Adverse Event|0|||
161719876|NCT01457339|584018958|FG001|Period 3 (100 mg)|Adverse Event|1|||
161719877|NCT01457339|584018957|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
161719878|NCT01457339|584018958|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
161719879|NCT01457339|584018957|FG000|Period 6 (250 mg)|Family Emergency|1|||
161719880|NCT01457339|584018958|FG001|Period 6 (250 mg)|Family Emergency|0|||
161719881|NCT01457339|584018957|FG000|Period 6 (250 mg)|Personal appointment|0|||
161719882|NCT01457339|584018958|FG001|Period 6 (250 mg)|Personal appointment|1|||
161719883|NCT00995371|584018959|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
161719884|NCT00995371|584018960|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
161719885|NCT00673673|584018961|FG000|Overall Study|Progressive disease|27|||
161719886|NCT00673673|584018961|FG000|Overall Study|Adverse Event|4|||
161719887|NCT00673673|584018961|FG000|Overall Study|Withdrawal by Subject|3|||
161719888|NCT00673673|584018961|FG000|Overall Study|Investigators' discretion|2|||
161719889|NCT00206518|584018967|FG000|Overall Study|Lack of Efficacy|6|||
161719890|NCT00206518|584018968|FG001|Overall Study|Lack of Efficacy|4|||
161719891|NCT00206518|584018967|FG000|Overall Study|Adverse Event|2|||
161719892|NCT00206518|584018968|FG001|Overall Study|Adverse Event|1|||
161719893|NCT00206518|584018967|FG000|Overall Study|Physician Decision|1|||
161964237|NCT02628600|584915094|FG001|Overall Study|Adverse Event|20|||
161964238|NCT02628600|584915093|FG000|Overall Study|Protocol Violation|0|||
161964239|NCT02628600|584915094|FG001|Overall Study|Protocol Violation|1|||
161719894|NCT00206518|584018968|FG001|Overall Study|Physician Decision|0|||
161719895|NCT00206518|584018967|FG000|Overall Study|Protocol Violation|1|||
161719896|NCT00206518|584018968|FG001|Overall Study|Protocol Violation|1|||
161719897|NCT02335450|584018969|FG000|Overall Study|Pregnancy|1|||
161719898|NCT02613572|584018970|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
161719899|NCT02613572|584018971|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
161719900|NCT02613572|584018972|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
161719901|NCT02613572|584018970|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
161719902|NCT02613572|584018971|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
161719903|NCT02613572|584018972|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
161719904|NCT00231478|584018978|FG000|Overall Study|Protocol Violation|3|||
161964240|NCT02628600|584915093|FG000|Overall Study|Lack of Efficacy|2|||
161964241|NCT02628600|584915094|FG001|Overall Study|Lack of Efficacy|0|||
161964242|NCT02628600|584915093|FG000|Overall Study|Withdrawal by Subject|13|||
161964243|NCT02628600|584915094|FG001|Overall Study|Withdrawal by Subject|8|||
161964244|NCT02628600|584915093|FG000|Overall Study|Lost to Follow-up|1|||
161964245|NCT02628600|584915094|FG001|Overall Study|Lost to Follow-up|0|||
161964246|NCT02628600|584915093|FG000|Overall Study|Physician Decision|2|||
161964247|NCT02628600|584915094|FG001|Overall Study|Physician Decision|2|||
161964248|NCT02628600|584915093|FG000|Overall Study|Other not specified|1|||
161964249|NCT02628600|584915094|FG001|Overall Study|Other not specified|0|||
161964250|NCT03110029|584915099|FG000|Overall Study|Withdrawal by Subject|1|||
161964251|NCT03110029|584915100|FG001|Overall Study|Withdrawal by Subject|1|||
161964252|NCT00107900|584915104|FG000|Overall Study|Adverse Event|3|||
161964253|NCT00107900|584915105|FG001|Overall Study|Adverse Event|2|||
161964254|NCT00107900|584915106|FG002|Overall Study|Adverse Event|10|||
161964255|NCT00107900|584915107|FG003|Overall Study|Adverse Event|3|||
161964256|NCT00107900|584915108|FG004|Overall Study|Adverse Event|5|||
161964257|NCT00107900|584915109|FG005|Overall Study|Adverse Event|3|||
161964258|NCT00107900|584915104|FG000|Overall Study|Death|0|||
161964259|NCT00107900|584915105|FG001|Overall Study|Death|0|||
161964260|NCT00107900|584915106|FG002|Overall Study|Death|0|||
161964261|NCT00107900|584915107|FG003|Overall Study|Death|0|||
161964262|NCT00107900|584915108|FG004|Overall Study|Death|1|||
161964263|NCT00107900|584915109|FG005|Overall Study|Death|0|||
161964264|NCT00107900|584915104|FG000|Overall Study|Lost to Follow-up|4|||
161964265|NCT00107900|584915105|FG001|Overall Study|Lost to Follow-up|1|||
161964266|NCT00107900|584915106|FG002|Overall Study|Lost to Follow-up|3|||
161964267|NCT00107900|584915107|FG003|Overall Study|Lost to Follow-up|2|||
161964268|NCT00107900|584915108|FG004|Overall Study|Lost to Follow-up|5|||
161964269|NCT00107900|584915109|FG005|Overall Study|Lost to Follow-up|5|||
161964270|NCT00107900|584915104|FG000|Overall Study|Protocol Violation|1|||
161964271|NCT00107900|584915105|FG001|Overall Study|Protocol Violation|0|||
161964272|NCT00107900|584915106|FG002|Overall Study|Protocol Violation|5|||
161964273|NCT00107900|584915107|FG003|Overall Study|Protocol Violation|5|||
161964274|NCT00107900|584915108|FG004|Overall Study|Protocol Violation|7|||
161964275|NCT00107900|584915109|FG005|Overall Study|Protocol Violation|0|||
161964276|NCT00107900|584915104|FG000|Overall Study|Withdrawal by Subject|1|||
161964277|NCT00107900|584915105|FG001|Overall Study|Withdrawal by Subject|0|||
161964278|NCT00107900|584915106|FG002|Overall Study|Withdrawal by Subject|5|||
161964279|NCT00107900|584915107|FG003|Overall Study|Withdrawal by Subject|0|||
161964280|NCT00107900|584915108|FG004|Overall Study|Withdrawal by Subject|1|||
161719905|NCT00231478|584018979|FG001|Overall Study|Protocol Violation|2|||
161719906|NCT00231478|584018978|FG000|Overall Study|Refused Treatment|1|||
161719907|NCT00231478|584018979|FG001|Overall Study|Refused Treatment|1|||
161719908|NCT00231478|584018978|FG000|Overall Study|Withdrawal by Subject|1|||
161719909|NCT00231478|584018979|FG001|Overall Study|Withdrawal by Subject|0|||
161719910|NCT00231478|584018978|FG000|Overall Study|Adverse Event|0|||
161719911|NCT00231478|584018979|FG001|Overall Study|Adverse Event|1|||
161719912|NCT00231478|584018978|FG000|Overall Study|Administrative|3|||
161719913|NCT00231478|584018979|FG001|Overall Study|Administrative|2|||
161719914|NCT04538950|584018980|FG000|Overall Study|Pulmonary Issues|2|||
161719915|NCT04538950|584018980|FG000|Overall Study|illness|2|||
161719916|NCT05258058|584018981|FG000|Overall Study|Withdrawal by Subject|2|||
161719917|NCT04579393|584018984|FG000|Overall Study|Withdrawal by Subject|2|||
161719918|NCT04579393|584018985|FG001|Overall Study|Withdrawal by Subject|2|||
161719919|NCT04579393|584018984|FG000|Overall Study|Death|1|||
161719920|NCT04579393|584018985|FG001|Overall Study|Death|3|||
161719921|NCT00393458|584018988|FG000|Overall Study|Adverse Event|35|||
161719922|NCT00393458|584018989|FG001|Overall Study|Adverse Event|24|||
161719923|NCT00393458|584018990|FG002|Overall Study|Adverse Event|40|||
161719924|NCT00393458|584018991|FG003|Overall Study|Adverse Event|35|||
161719925|NCT00393458|584018988|FG000|Overall Study|Subject withdrew consent|27|||
161719926|NCT00393458|584018989|FG001|Overall Study|Subject withdrew consent|40|||
161719927|NCT00393458|584018990|FG002|Overall Study|Subject withdrew consent|33|||
161719928|NCT00393458|584018991|FG003|Overall Study|Subject withdrew consent|50|||
161719929|NCT00393458|584018988|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
161719930|NCT00393458|584018989|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
161719931|NCT00393458|584018990|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
161719932|NCT00393458|584018991|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
161719933|NCT00393458|584018988|FG000|Overall Study|Protocol deviation|11|||
161719934|NCT00393458|584018989|FG001|Overall Study|Protocol deviation|11|||
161964281|NCT00107900|584915109|FG005|Overall Study|Withdrawal by Subject|1|||
161964282|NCT00107900|584915104|FG000|Overall Study|Administrative Reasons|1|||
161964283|NCT00107900|584915105|FG001|Overall Study|Administrative Reasons|0|||
161964284|NCT00107900|584915106|FG002|Overall Study|Administrative Reasons|2|||
161964285|NCT00107900|584915107|FG003|Overall Study|Administrative Reasons|2|||
161964286|NCT00107900|584915108|FG004|Overall Study|Administrative Reasons|2|||
161964287|NCT00107900|584915109|FG005|Overall Study|Administrative Reasons|0|||
161964288|NCT03724981|584917659|FG000|First Device|Protocol Violation|1|||
161964289|NCT03724981|584917660|FG001|First Device|Protocol Violation|1|||
161719935|NCT00393458|584018990|FG002|Overall Study|Protocol deviation|11|||
161719936|NCT00393458|584018991|FG003|Overall Study|Protocol deviation|10|||
161719937|NCT00393458|584018988|FG000|Overall Study|Administrative problems|7|||
161719938|NCT00393458|584018989|FG001|Overall Study|Administrative problems|8|||
161719939|NCT00393458|584018990|FG002|Overall Study|Administrative problems|5|||
161719940|NCT00393458|584018991|FG003|Overall Study|Administrative problems|2|||
161719941|NCT00393458|584018988|FG000|Overall Study|Lost to Follow-up|5|||
161719942|NCT00393458|584018989|FG001|Overall Study|Lost to Follow-up|6|||
161719943|NCT00393458|584018990|FG002|Overall Study|Lost to Follow-up|5|||
161719944|NCT00393458|584018991|FG003|Overall Study|Lost to Follow-up|3|||
161719945|NCT00393458|584018988|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161719946|NCT00393458|584018989|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161719947|NCT00393458|584018990|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161719948|NCT00393458|584018991|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161719949|NCT00393458|584018988|FG000|Overall Study|Death|1|||
161719950|NCT00393458|584018989|FG001|Overall Study|Death|1|||
161719951|NCT00393458|584018990|FG002|Overall Study|Death|5|||
161719952|NCT00393458|584018991|FG003|Overall Study|Death|5|||
161719953|NCT00393458|584018988|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161719954|NCT00393458|584018989|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161719955|NCT00393458|584018990|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161719956|NCT00393458|584018991|FG003|Overall Study|Abnormal test procedure result(s)|2|||
161719957|NCT00393458|584018988|FG000|Overall Study|Subject no longer requires study drug|0|||
161719958|NCT00393458|584018989|FG001|Overall Study|Subject no longer requires study drug|1|||
161719959|NCT00393458|584018990|FG002|Overall Study|Subject no longer requires study drug|0|||
161719960|NCT00393458|584018991|FG003|Overall Study|Subject no longer requires study drug|0|||
161719961|NCT01282814|584018998|FG000|First Intervention|Emesis During Dosing Interval|0|||
161719962|NCT01282814|584018999|FG001|First Intervention|Emesis During Dosing Interval|3|||
161719963|NCT01282814|584018998|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
161719964|NCT01282814|584018999|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161719965|NCT01524289|584019000|FG000|Overall Study|Lost to Follow-up|0|||
161719966|NCT01524289|584019001|FG001|Overall Study|Lost to Follow-up|1|||
161719967|NCT01524289|584019000|FG000|Overall Study|Physician Decision|1|||
161719968|NCT01524289|584019001|FG001|Overall Study|Physician Decision|0|||
161719969|NCT01524289|584019000|FG000|Overall Study|Protocol Violation|5|||
161719970|NCT01524289|584019001|FG001|Overall Study|Protocol Violation|1|||
161719971|NCT01524289|584019000|FG000|Overall Study|Withdrawal by Subject|11|||
161719972|NCT01524289|584019001|FG001|Overall Study|Withdrawal by Subject|7|||
161719973|NCT01524289|584019000|FG000|Overall Study|Adverse Event|12|||
161719974|NCT01524289|584019001|FG001|Overall Study|Adverse Event|5|||
161719975|NCT01524289|584019000|FG000|Overall Study|Did not take study medication|1|||
161719976|NCT01524289|584019001|FG001|Overall Study|Did not take study medication|0|||
161719977|NCT02704429|584019004|FG000|Part A: 24 Weeks|Adverse Event|3|||
161719978|NCT02704429|584019005|FG001|Part A: 24 Weeks|Adverse Event|0|||
161719979|NCT02704429|584019004|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
161719980|NCT02704429|584019005|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
161719981|NCT02519231|584019006|FG000|Overall Study|Lost to Follow-up|2|||
161719982|NCT02519231|584019007|FG001|Overall Study|Lost to Follow-up|5|||
161719983|NCT02519231|584019006|FG000|Overall Study|Withdrawal by Subject|0|||
161719984|NCT02519231|584019007|FG001|Overall Study|Withdrawal by Subject|1|||
161719985|NCT00104104|584019008|FG000|Overall Study|Adverse Event|8|||
161719986|NCT00104104|584019009|FG001|Overall Study|Adverse Event|8|||
161719987|NCT00104104|584019008|FG000|Overall Study|Abnormal laboratory value(s)|20|||
161719988|NCT00104104|584019009|FG001|Overall Study|Abnormal laboratory value(s)|14|||
161719989|NCT00104104|584019008|FG000|Overall Study|Lack of Efficacy|0|||
161719990|NCT00104104|584019009|FG001|Overall Study|Lack of Efficacy|3|||
161719991|NCT00104104|584019008|FG000|Overall Study|Condition no longer requires study drug|7|||
161719992|NCT00104104|584019009|FG001|Overall Study|Condition no longer requires study drug|4|||
161719993|NCT00104104|584019008|FG000|Overall Study|Protocol Violation|5|||
161719994|NCT00104104|584019009|FG001|Overall Study|Protocol Violation|2|||
161719995|NCT00104104|584019008|FG000|Overall Study|Withdrawal by Subject|11|||
161719996|NCT00104104|584019009|FG001|Overall Study|Withdrawal by Subject|15|||
161719997|NCT00104104|584019008|FG000|Overall Study|Lost to Follow-up|3|||
161719998|NCT00104104|584019009|FG001|Overall Study|Lost to Follow-up|7|||
161719999|NCT00104104|584019008|FG000|Overall Study|Administrative problems|12|||
161720000|NCT00104104|584019009|FG001|Overall Study|Administrative problems|13|||
161720001|NCT00104104|584019008|FG000|Overall Study|Death|9|||
161720002|NCT00104104|584019009|FG001|Overall Study|Death|6|||
161720003|NCT00447421|584019011|FG000|Overall Study|Lack of Efficacy|1|||
161720004|NCT00447421|584019011|FG000|Overall Study|Adverse Event|3|||
161720005|NCT00447421|584019011|FG000|Overall Study|Sponsor Decision|2|||
161720006|NCT01707147|584019012|FG000|Overall Study|Administered Trajenta prior to contract|5|||
161720007|NCT01707147|584019012|FG000|Overall Study|Patients who have not taken Trajenta|1|||
161720008|NCT01707147|584019012|FG000|Overall Study|Follow-up failure|17|||
161720009|NCT01707147|584019012|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
161720010|NCT01326962|584019016|FG000|Overall Study|Adverse Event|1|||
161720011|NCT01326962|584019016|FG000|Overall Study|Withdrawal by Subject|1|||
161720012|NCT01326962|584019016|FG000|Overall Study|Lost to Follow-up|3|||
161964290|NCT00511433|584917661|FG000|Overall Study|Adverse Event|5|||
161964291|NCT00511433|584917662|FG001|Overall Study|Adverse Event|0|||
161964292|NCT00511433|584917661|FG000|Overall Study|Other Reason|1|||
161964293|NCT00511433|584917662|FG001|Overall Study|Other Reason|1|||
161964294|NCT02370537|584917663|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
161964295|NCT02370537|584917664|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
161964296|NCT02370537|584917665|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
161964297|NCT02370537|584917663|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
161964298|NCT02370537|584917664|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
161964299|NCT02370537|584917665|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
161964300|NCT02370537|584917663|FG000|Part B|Not randomised to receive treatment|1|||
161964301|NCT02370537|584917664|FG001|Part B|Not randomised to receive treatment|2|||
161964302|NCT02370537|584917665|FG002|Part B|Not randomised to receive treatment|259|||
161964303|NCT02370537|584917663|FG000|Part B|Withdrawal by Subject|0|||
161964304|NCT02370537|584917664|FG001|Part B|Withdrawal by Subject|1|||
161964305|NCT02370537|584917665|FG002|Part B|Withdrawal by Subject|0|||
161964306|NCT01952665|584917666|FG000|Overall Study|Physician Decision|3|||
161964307|NCT01952665|584917667|FG001|Overall Study|Physician Decision|2|||
161964308|NCT01952665|584917666|FG000|Overall Study|Lost to Follow-up|1|||
161964309|NCT01952665|584917667|FG001|Overall Study|Lost to Follow-up|2|||
161964310|NCT01952665|584917666|FG000|Overall Study|Adverse Event|2|||
161964311|NCT01952665|584917667|FG001|Overall Study|Adverse Event|1|||
161964312|NCT01952665|584917666|FG000|Overall Study|Protocol Violation|0|||
161964313|NCT01952665|584917667|FG001|Overall Study|Protocol Violation|1|||
161964314|NCT02578680|584917670|FG000|Overall Study|Death|329|||
161964315|NCT02578680|584917671|FG001|Overall Study|Death|181|||
161720013|NCT01326962|584019016|FG000|Overall Study|Other|2|||
161720014|NCT02053246|584019017|FG000|Overall Study|Withdrawal by Subject|3|||
161720015|NCT02053246|584019017|FG000|Overall Study|Physician Decision|1|||
161720016|NCT02903511|584019021|FG000|Overall Study|Withdrawal by Subject|1|||
161720017|NCT02903511|584019022|FG001|Overall Study|Withdrawal by Subject|0|||
161720018|NCT02903511|584019021|FG000|Overall Study|Lost to Follow-up|3|||
161720019|NCT02903511|584019022|FG001|Overall Study|Lost to Follow-up|2|||
161720020|NCT00969618|584019023|FG000|Overall Study|Adverse Event|29|||
161720021|NCT00969618|584019023|FG000|Overall Study|Entry Criteria Not Met|3|||
161720022|NCT00969618|584019023|FG000|Overall Study|Lack of Efficacy|2|||
161720023|NCT00969618|584019023|FG000|Overall Study|Lost to Follow-up|7|||
161720024|NCT00969618|584019023|FG000|Overall Study|Physician Decision|1|||
161720025|NCT00969618|584019023|FG000|Overall Study|Protocol Violation|9|||
161720026|NCT00969618|584019023|FG000|Overall Study|Withdrawal by Subject|27|||
161720027|NCT01318902|584019024|FG000|Overall Study|Symptomatic Deterioration|0|||
161720028|NCT01318902|584019025|FG001|Overall Study|Symptomatic Deterioration|1|||
161720029|NCT01318902|584019026|FG002|Overall Study|Symptomatic Deterioration|1|||
161720030|NCT01318902|584019027|FG003|Overall Study|Symptomatic Deterioration|2|||
161720031|NCT01318902|584019024|FG000|Overall Study|Withdrawal by Patient|0|||
161720032|NCT01318902|584019025|FG001|Overall Study|Withdrawal by Patient|1|||
161720033|NCT01318902|584019026|FG002|Overall Study|Withdrawal by Patient|0|||
161720034|NCT01318902|584019027|FG003|Overall Study|Withdrawal by Patient|3|||
161720035|NCT01318902|584019024|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
161720036|NCT01318902|584019025|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
161720037|NCT01318902|584019026|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
161720038|NCT01318902|584019027|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
161720039|NCT01318902|584019024|FG000|Overall Study|Adverse Event|0|||
161720040|NCT01318902|584019025|FG001|Overall Study|Adverse Event|1|||
161720041|NCT01318902|584019026|FG002|Overall Study|Adverse Event|0|||
161720042|NCT01318902|584019027|FG003|Overall Study|Adverse Event|0|||
161720043|NCT01318902|584019024|FG000|Overall Study|Terminated by Sponsor|0|||
161720044|NCT01318902|584019025|FG001|Overall Study|Terminated by Sponsor|0|||
161964316|NCT02578680|584917670|FG000|Overall Study|Lost to Follow-up|3|||
161964317|NCT02578680|584917671|FG001|Overall Study|Lost to Follow-up|1|||
161964318|NCT02578680|584917670|FG000|Overall Study|Physician Decision|0|||
161964319|NCT02578680|584917671|FG001|Overall Study|Physician Decision|1|||
161964320|NCT02578680|584917670|FG000|Overall Study|Protocol Violation|1|||
161720045|NCT01318902|584019026|FG002|Overall Study|Terminated by Sponsor|1|||
161720046|NCT01318902|584019027|FG003|Overall Study|Terminated by Sponsor|0|||
161720047|NCT00663858|584020549|FG000|Overall Study|Adverse Event|9|||
161720048|NCT00663858|584020550|FG001|Overall Study|Adverse Event|1|||
161720049|NCT00663858|584020551|FG002|Overall Study|Adverse Event|6|||
161720050|NCT00663858|584020549|FG000|Overall Study|Lack of Efficacy|5|||
161720051|NCT00663858|584020550|FG001|Overall Study|Lack of Efficacy|1|||
161720052|NCT00663858|584020551|FG002|Overall Study|Lack of Efficacy|3|||
161964321|NCT02578680|584917671|FG001|Overall Study|Protocol Violation|1|||
161964322|NCT02578680|584917670|FG000|Overall Study|Sponsor Decision|64|||
161964323|NCT02578680|584917671|FG001|Overall Study|Sponsor Decision|13|||
161964324|NCT02578680|584917670|FG000|Overall Study|Withdrawal by Subject|13|||
161964325|NCT02578680|584917671|FG001|Overall Study|Withdrawal by Subject|9|||
161964326|NCT02596958|584917673|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
161720053|NCT00663858|584020549|FG000|Overall Study|Withdrawal by Subject|7|||
161720054|NCT00663858|584020550|FG001|Overall Study|Withdrawal by Subject|3|||
161720055|NCT00663858|584020551|FG002|Overall Study|Withdrawal by Subject|3|||
161720056|NCT00663858|584020549|FG000|Overall Study|Protocol Violation|5|||
161720057|NCT00663858|584020550|FG001|Overall Study|Protocol Violation|3|||
161720058|NCT00663858|584020551|FG002|Overall Study|Protocol Violation|4|||
161720059|NCT00663858|584020549|FG000|Overall Study|Other|8|||
161720060|NCT00663858|584020550|FG001|Overall Study|Other|2|||
161720061|NCT00663858|584020551|FG002|Overall Study|Other|4|||
161720062|NCT01666444|584020554|FG000|Overall Study|Did not initiate treatment|2|||
161720063|NCT01666444|584020555|FG001|Overall Study|Did not initiate treatment|1|||
161720064|NCT00950690|584020556|FG000|Overall Study|Death|4|||
161720065|NCT00950690|584020556|FG000|Overall Study|Adverse Event|15|||
161720066|NCT00950690|584020556|FG000|Overall Study|Lack of Efficacy|22|||
161720067|NCT00950690|584020556|FG000|Overall Study|Lost to Follow-up|40|||
161720068|NCT00950690|584020556|FG000|Overall Study|Other|163|||
161720069|NCT01713036|584020557|FG000|Overall Study|Death|1|||
161720070|NCT00592358|584020558|FG000|Overall Study|Withdrawal by Subject|2|||
161720071|NCT00592358|584020558|FG000|Overall Study|Adverse Event|1|||
161720072|NCT00592358|584020558|FG000|Overall Study|Lack of Efficacy|2|||
161720073|NCT00592358|584020558|FG000|Overall Study|Inability to swallow pills|1|||
161720074|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
161720075|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
161720076|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
161720077|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
161720078|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
161720079|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
161720080|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
161720081|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
161720082|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
161720083|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
161720084|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
161720085|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
161720086|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
161720087|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
161720088|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
161720089|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
161720090|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
161720091|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
161720092|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
161720093|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
161720094|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
161720095|NCT00092547|584020559|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
161720096|NCT00092547|584020560|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
161720097|NCT00092547|584020561|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
161720098|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
161720099|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
161720100|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
161720101|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
161720102|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
161720103|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
161720104|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
161720105|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
161720106|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
161720107|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
161720108|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
161720109|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
161720110|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
161720111|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
161720112|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
161720113|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
161720114|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
161964327|NCT02596958|584917673|FG000|Overall Study|Cancer Progression|441|||
161964328|NCT02596958|584917673|FG000|Overall Study|Death From Cancer|112|||
161720115|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
161720116|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
161720117|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
161720118|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
161964329|NCT02596958|584917673|FG000|Overall Study|Death From Other Cause|33|||
161720119|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
161720120|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
161720121|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
161720122|NCT00092547|584020559|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
161720123|NCT00092547|584020560|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
161720124|NCT00092547|584020561|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
161720125|NCT00092547|584020559|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
161720126|NCT00092547|584020560|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
161720127|NCT00092547|584020561|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
161720128|NCT00092547|584020559|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
161720129|NCT00092547|584020560|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
161720130|NCT00092547|584020561|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
161720131|NCT00092547|584020559|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
161720132|NCT00092547|584020560|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
161720133|NCT00092547|584020561|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
161720134|NCT00092547|584020559|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
161720135|NCT00092547|584020560|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
161720136|NCT00092547|584020561|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
161720137|NCT00084682|584020562|FG000|Overall Study|Withdrawal by Subject|1|||
161720138|NCT01166659|584020563|FG000|Overall Study|Subject Decision|8|||
161720139|NCT01166659|584020563|FG000|Overall Study|Investigator Decision|2|||
161720140|NCT01166659|584020563|FG000|Overall Study|Death|1|||
161720141|NCT01166659|584020563|FG000|Overall Study|Lost to Follow-up|1|||
161720142|NCT01166659|584020563|FG000|Overall Study|Study Closed at Site|1|||
161720143|NCT00474630|584020569|FG000|Overall Study|Adverse Event|98|||
161720144|NCT00474630|584020570|FG001|Overall Study|Adverse Event|26|||
161720145|NCT00474630|584020569|FG000|Overall Study|Lost to Follow-up|22|||
161720146|NCT00474630|584020570|FG001|Overall Study|Lost to Follow-up|15|||
161720147|NCT00474630|584020569|FG000|Overall Study|Withdrawal by Subject|21|||
161720148|NCT00474630|584020570|FG001|Overall Study|Withdrawal by Subject|15|||
161720149|NCT00474630|584020569|FG000|Overall Study|Protocol Violation|3|||
161720150|NCT00474630|584020570|FG001|Overall Study|Protocol Violation|4|||
161720151|NCT00474630|584020569|FG000|Overall Study|Lack of Efficacy|5|||
161720152|NCT00474630|584020570|FG001|Overall Study|Lack of Efficacy|6|||
161720153|NCT00474630|584020569|FG000|Overall Study|Drug noncompliance, other|11|||
161720154|NCT00474630|584020570|FG001|Overall Study|Drug noncompliance, other|4|||
161720155|NCT01650779|584020578|FG000|Overall Study|Withdrawal by Subject|1|||
161720156|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
161720157|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
161720158|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
161720159|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
161720160|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
161720161|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
161720162|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
161720163|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
161720164|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
161720165|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
161720166|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
161720167|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
161720168|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
161720169|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
161720170|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
161720171|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
161720172|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
161720173|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
161720174|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
161720175|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
161720176|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
161720177|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
161720178|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
161720179|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
161720180|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
161720181|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
161720182|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
161720183|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
161720184|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
161720185|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
161720186|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
161720187|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
161964330|NCT02596958|584917673|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
161964331|NCT02596958|584917673|FG000|Overall Study|Administrative Reasons/Other|231|||
161964332|NCT02596958|584917673|FG000|Overall Study|Lost to Follow-up|33|||
161964333|NCT02596958|584917673|FG000|Overall Study|Missing|32|||
161964334|NCT02596958|584917673|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
161964335|NCT01559259|584917674|FG000|Overall Study|Withdrawal by Subject|0|||
161964336|NCT01559259|584917675|FG001|Overall Study|Withdrawal by Subject|0|||
161964337|NCT01559259|584917676|FG002|Overall Study|Withdrawal by Subject|0|||
161964338|NCT01559259|584917677|FG003|Overall Study|Withdrawal by Subject|1|||
161964339|NCT01559259|584917678|FG004|Overall Study|Withdrawal by Subject|0|||
161964340|NCT01559259|584917674|FG000|Overall Study|Adverse Event|0|||
161964341|NCT01559259|584917675|FG001|Overall Study|Adverse Event|1|||
161964342|NCT01559259|584917676|FG002|Overall Study|Adverse Event|1|||
161964343|NCT01559259|584917677|FG003|Overall Study|Adverse Event|0|||
161964344|NCT01559259|584917678|FG004|Overall Study|Adverse Event|0|||
161964345|NCT01995669|584917679|FG000|Overall Study|Progression|2|||
161964346|NCT01995669|584917680|FG001|Overall Study|Progression|1|||
161964347|NCT01995669|584917681|FG002|Overall Study|Progression|1|||
161964348|NCT01995669|584917682|FG003|Overall Study|Progression|13|||
161964349|NCT01995669|584917679|FG000|Overall Study|Adverse Event|0|||
161964350|NCT01995669|584917680|FG001|Overall Study|Adverse Event|0|||
161720188|NCT00958568|584020580|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
161720189|NCT00958568|584020581|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
161720190|NCT00958568|584020582|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
161720191|NCT00958568|584020583|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
161720192|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
161720193|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
161720194|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
161720195|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
161720196|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
161720197|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
161720198|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
161720199|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
161720200|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
161720201|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
161720202|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
161720203|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
161720204|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
161720205|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
161720206|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
161720207|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
161720208|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
161720209|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
161720210|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
161720211|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
161720212|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
161720213|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
161720214|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
161720215|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
161720216|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
161720217|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
161720218|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
161720219|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
161720220|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
161720221|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
161720222|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
161720223|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
161720224|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
161720225|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
161720226|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
161720227|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
161720228|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
161720229|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
161720230|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
161964351|NCT01995669|584917681|FG002|Overall Study|Adverse Event|0|||
161964352|NCT01995669|584917682|FG003|Overall Study|Adverse Event|3|||
161964353|NCT01995669|584917679|FG000|Overall Study|Death|0|||
161720231|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
161720232|NCT00958568|584020580|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
161720233|NCT00958568|584020581|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
161720234|NCT00958568|584020582|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
161720235|NCT00958568|584020583|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
161720236|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
161720237|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
161720238|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
161720239|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
161720240|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
161720241|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
161720242|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
161720243|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
161720244|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
161720245|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
161720246|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
161720247|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
161720248|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
161720249|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
161720250|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
161720251|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
161720252|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
161720253|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
161720254|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
161720255|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
161720256|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
161720257|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
161720258|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
161720259|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
161720260|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
161720261|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
161720262|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
161720263|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
161720264|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
161720265|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
161720266|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
161720267|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
161720268|NCT00958568|584020580|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
161720269|NCT00958568|584020581|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
161720270|NCT00958568|584020582|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
161720271|NCT00958568|584020583|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
161720272|NCT00915005|584020584|FG000|Overall Study|Withdrawal by Subject|4|||
161720273|NCT00915005|584020585|FG001|Overall Study|Withdrawal by Subject|4|||
161720274|NCT00915005|584020584|FG000|Overall Study|Patient preferred protons therapy|6|||
161720275|NCT00915005|584020585|FG001|Overall Study|Patient preferred protons therapy|0|||
161720276|NCT00915005|584020584|FG000|Overall Study|Insurance denial|3|||
161720277|NCT00915005|584020585|FG001|Overall Study|Insurance denial|15|||
161720278|NCT00589472|584020596|FG000|Overall Study|Adverse Event|1|||
161720279|NCT00117338|584020597|FG000|Overall Study|Adverse Event|0|||
161720280|NCT00117338|584020598|FG001|Overall Study|Adverse Event|1|||
161720281|NCT00117338|584020597|FG000|Overall Study|Protocol Violation|3|||
161720282|NCT00117338|584020598|FG001|Overall Study|Protocol Violation|2|||
161720283|NCT00117338|584020597|FG000|Overall Study|Withdrawal by Subject|1|||
161720284|NCT00117338|584020598|FG001|Overall Study|Withdrawal by Subject|0|||
161720285|NCT00117338|584020597|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
161720286|NCT00117338|584020598|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
161720287|NCT00117338|584020597|FG000|Overall Study|Lack of Efficacy|0|||
161720288|NCT00117338|584020598|FG001|Overall Study|Lack of Efficacy|1|||
161720289|NCT01380093|584020599|FG000|Naloxone Challenge Phase|Screen failures|21|||
161720290|NCT01380093|584020600|FG001|Naloxone Challenge Phase|Screen failures|0|||
161720291|NCT01380093|584020601|FG002|Naloxone Challenge Phase|Screen failures|0|||
161720292|NCT01380093|584020602|FG003|Naloxone Challenge Phase|Screen failures|0|||
161720293|NCT01380093|584020603|FG004|Naloxone Challenge Phase|Screen failures|0|||
161720294|NCT01380093|584020604|FG005|Naloxone Challenge Phase|Screen failures|0|||
161720295|NCT01380093|584020605|FG006|Naloxone Challenge Phase|Screen failures|0|||
161964354|NCT01995669|584917680|FG001|Overall Study|Death|0|||
161720296|NCT01380093|584020606|FG007|Naloxone Challenge Phase|Screen failures|0|||
161720297|NCT01380093|584020607|FG008|Naloxone Challenge Phase|Screen failures|0|||
161964355|NCT01995669|584917681|FG002|Overall Study|Death|0|||
161964356|NCT01995669|584917682|FG003|Overall Study|Death|6|||
161964357|NCT01995669|584917679|FG000|Overall Study|Withdrawal by Subject|0|||
161964358|NCT01995669|584917680|FG001|Overall Study|Withdrawal by Subject|0|||
161964359|NCT01995669|584917681|FG002|Overall Study|Withdrawal by Subject|0|||
161964360|NCT01995669|584917682|FG003|Overall Study|Withdrawal by Subject|6|||
161964361|NCT01995669|584917679|FG000|Overall Study|Insurance Expired|0|||
161964362|NCT01995669|584917680|FG001|Overall Study|Insurance Expired|0|||
161964363|NCT01995669|584917681|FG002|Overall Study|Insurance Expired|0|||
161964364|NCT01995669|584917682|FG003|Overall Study|Insurance Expired|1|||
161964365|NCT03727646|584917683|FG000|Overall Study|Adverse Event|1|||
161964366|NCT03727646|584917684|FG001|Overall Study|Adverse Event|0|||
161964367|NCT05659719|584917685|FG000|Overall Study|At sponsor's request|0|||
161964368|NCT05659719|584917686|FG001|Overall Study|At sponsor's request|0|||
161964369|NCT05659719|584917687|FG002|Overall Study|At sponsor's request|0|||
161964370|NCT05659719|584917688|FG003|Overall Study|At sponsor's request|95|||
161964371|NCT05659719|584917685|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
161964372|NCT05659719|584917686|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
161964373|NCT05659719|584917687|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
161964374|NCT05659719|584917688|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
161964375|NCT05659719|584917685|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
161964376|NCT05659719|584917686|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
161964377|NCT05659719|584917687|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
161964378|NCT05659719|584917688|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
161964379|NCT05659719|584917685|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
161964380|NCT05659719|584917686|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
161964381|NCT05659719|584917687|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
161964382|NCT05659719|584917688|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
161964383|NCT05659719|584917685|FG000|Overall Study|Lost to Follow-up|0|||
161964384|NCT05659719|584917686|FG001|Overall Study|Lost to Follow-up|0|||
161964385|NCT05659719|584917687|FG002|Overall Study|Lost to Follow-up|0|||
161964386|NCT05659719|584917688|FG003|Overall Study|Lost to Follow-up|2|||
161964387|NCT05659719|584917685|FG000|Overall Study|Moved to another observational study|0|||
161964388|NCT05659719|584917686|FG001|Overall Study|Moved to another observational study|0|||
161964389|NCT05659719|584917687|FG002|Overall Study|Moved to another observational study|0|||
161964390|NCT05659719|584917688|FG003|Overall Study|Moved to another observational study|1|||
161720298|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720299|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
161720300|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720301|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720302|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720303|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720304|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720305|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720306|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161720307|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720308|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
161720309|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
161720310|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720311|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720312|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720313|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720314|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720315|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161720316|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720317|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
161720318|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720319|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720320|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720321|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720322|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720323|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720324|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161720325|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720326|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
161720327|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
161720328|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720329|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720330|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720331|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720332|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720333|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161720334|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720335|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
161720336|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
161720337|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720338|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720339|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720340|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720341|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720342|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161720343|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720344|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720345|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
161720346|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720347|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
161964391|NCT05659719|584917685|FG000|Overall Study|The child was enrolled in an interventional study|0|||
161964392|NCT05659719|584917686|FG001|Overall Study|The child was enrolled in an interventional study|0|||
161964393|NCT05659719|584917687|FG002|Overall Study|The child was enrolled in an interventional study|0|||
161964394|NCT05659719|584917688|FG003|Overall Study|The child was enrolled in an interventional study|55|||
161720348|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720349|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720350|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720351|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
161720352|NCT01380093|584020599|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720353|NCT01380093|584020600|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720354|NCT01380093|584020601|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
161720355|NCT01380093|584020602|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720356|NCT01380093|584020603|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720357|NCT01380093|584020604|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720358|NCT01380093|584020605|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720359|NCT01380093|584020606|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720360|NCT01380093|584020607|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161720361|NCT01380093|584020599|FG000|Treatment Phase: Second Intervention|Other|0|||
161720362|NCT01380093|584020600|FG001|Treatment Phase: Second Intervention|Other|0|||
161720363|NCT01380093|584020601|FG002|Treatment Phase: Second Intervention|Other|0|||
161720364|NCT01380093|584020602|FG003|Treatment Phase: Second Intervention|Other|1|||
161720365|NCT01380093|584020603|FG004|Treatment Phase: Second Intervention|Other|0|||
161720366|NCT01380093|584020604|FG005|Treatment Phase: Second Intervention|Other|0|||
161720367|NCT01380093|584020605|FG006|Treatment Phase: Second Intervention|Other|0|||
161720368|NCT01380093|584020606|FG007|Treatment Phase: Second Intervention|Other|0|||
161720369|NCT01380093|584020607|FG008|Treatment Phase: Second Intervention|Other|0|||
161720370|NCT01380093|584020599|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
161720371|NCT01380093|584020600|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
161720372|NCT01380093|584020601|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
161720373|NCT01380093|584020602|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
161720374|NCT01380093|584020603|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
161720375|NCT01380093|584020604|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
161720376|NCT01380093|584020605|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
161720377|NCT01380093|584020606|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
161720378|NCT01380093|584020607|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
161720379|NCT01380093|584020599|FG000|Treatment Phase: Third Intervention|Other|0|||
161720380|NCT01380093|584020600|FG001|Treatment Phase: Third Intervention|Other|0|||
161720381|NCT01380093|584020601|FG002|Treatment Phase: Third Intervention|Other|0|||
161720382|NCT01380093|584020602|FG003|Treatment Phase: Third Intervention|Other|0|||
161720383|NCT01380093|584020603|FG004|Treatment Phase: Third Intervention|Other|0|||
161720384|NCT01380093|584020604|FG005|Treatment Phase: Third Intervention|Other|0|||
161720385|NCT01380093|584020605|FG006|Treatment Phase: Third Intervention|Other|0|||
161720386|NCT01380093|584020606|FG007|Treatment Phase: Third Intervention|Other|0|||
161720387|NCT01380093|584020607|FG008|Treatment Phase: Third Intervention|Other|1|||
161720388|NCT03952650|584020608|FG000|Overall Study|TRAVEL|0|||
161720389|NCT03952650|584020609|FG001|Overall Study|TRAVEL|4|||
161720390|NCT03952650|584020610|FG002|Overall Study|TRAVEL|0|||
161720391|NCT03952650|584020611|FG003|Overall Study|TRAVEL|4|||
161720392|NCT03952650|584020612|FG004|Overall Study|TRAVEL|0|||
161720393|NCT03952650|584020613|FG005|Overall Study|TRAVEL|3|||
161720394|NCT03952650|584020614|FG006|Overall Study|TRAVEL|2|||
161720395|NCT03952650|584020608|FG000|Overall Study|Withdrawal by Subject|0|||
161720396|NCT03952650|584020609|FG001|Overall Study|Withdrawal by Subject|2|||
161720397|NCT03952650|584020610|FG002|Overall Study|Withdrawal by Subject|0|||
161720398|NCT03952650|584020611|FG003|Overall Study|Withdrawal by Subject|3|||
161720399|NCT03952650|584020612|FG004|Overall Study|Withdrawal by Subject|0|||
161720400|NCT03952650|584020613|FG005|Overall Study|Withdrawal by Subject|1|||
161720401|NCT03952650|584020614|FG006|Overall Study|Withdrawal by Subject|1|||
161720402|NCT03952650|584020608|FG000|Overall Study|Lost to Follow-up|0|||
161720403|NCT03952650|584020609|FG001|Overall Study|Lost to Follow-up|1|||
161720404|NCT03952650|584020610|FG002|Overall Study|Lost to Follow-up|0|||
161720405|NCT03952650|584020611|FG003|Overall Study|Lost to Follow-up|0|||
161720406|NCT03952650|584020612|FG004|Overall Study|Lost to Follow-up|0|||
161720407|NCT03952650|584020613|FG005|Overall Study|Lost to Follow-up|1|||
161720408|NCT03952650|584020614|FG006|Overall Study|Lost to Follow-up|1|||
161720409|NCT03952650|584020608|FG000|Overall Study|Received wrong vaccine and travelled|0|||
161720410|NCT03952650|584020609|FG001|Overall Study|Received wrong vaccine and travelled|0|||
161720411|NCT03952650|584020610|FG002|Overall Study|Received wrong vaccine and travelled|0|||
161964395|NCT05659719|584917685|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
161720412|NCT03952650|584020611|FG003|Overall Study|Received wrong vaccine and travelled|0|||
161720413|NCT03952650|584020612|FG004|Overall Study|Received wrong vaccine and travelled|0|||
161720414|NCT03952650|584020613|FG005|Overall Study|Received wrong vaccine and travelled|1|||
161720415|NCT03952650|584020614|FG006|Overall Study|Received wrong vaccine and travelled|0|||
161720416|NCT03952650|584020608|FG000|Overall Study|Unable to make study visit|0|||
161720417|NCT03952650|584020609|FG001|Overall Study|Unable to make study visit|0|||
161720418|NCT03952650|584020610|FG002|Overall Study|Unable to make study visit|0|||
161720419|NCT03952650|584020611|FG003|Overall Study|Unable to make study visit|0|||
161720420|NCT03952650|584020612|FG004|Overall Study|Unable to make study visit|0|||
161720421|NCT03952650|584020613|FG005|Overall Study|Unable to make study visit|1|||
161720422|NCT03952650|584020614|FG006|Overall Study|Unable to make study visit|0|||
161720423|NCT01342640|584020615|FG000|Overall Study|Adverse Event|3|||
161720424|NCT01342640|584020615|FG000|Overall Study|Protocol Violation|16|||
161720425|NCT01342640|584020615|FG000|Overall Study|Lost to Follow-up|21|||
161720426|NCT01342640|584020615|FG000|Overall Study|Other|1|||
161720427|NCT00670111|584020618|FG000|Enrollment to One Month|Testing Failure|0|||
161964396|NCT05659719|584917686|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
161964397|NCT05659719|584917687|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
161964398|NCT05659719|584917688|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
161964399|NCT05659719|584917685|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
161964400|NCT05659719|584917686|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
161964401|NCT05659719|584917687|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
161964402|NCT05659719|584917688|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
161964403|NCT02290691|584917692|FG000|Overall Study|Noncompliance|0|||
161964404|NCT02290691|584917693|FG001|Overall Study|Noncompliance|1|||
161964405|NCT02290691|584917692|FG000|Overall Study|Withdrawal by Subject|1|||
161964406|NCT02290691|584917693|FG001|Overall Study|Withdrawal by Subject|1|||
161964407|NCT02290691|584917692|FG000|Overall Study|Lost to Follow-up|7|||
161964408|NCT02290691|584917693|FG001|Overall Study|Lost to Follow-up|7|||
161964409|NCT00185380|584917697|FG000|Overall Study|Adverse Event|41|||
161964410|NCT00185380|584917698|FG001|Overall Study|Adverse Event|43|||
161964411|NCT00185380|584917699|FG002|Overall Study|Adverse Event|48|||
161964412|NCT00185380|584917697|FG000|Overall Study|Lost to Follow-up|0|||
161964413|NCT00185380|584917698|FG001|Overall Study|Lost to Follow-up|4|||
161964414|NCT00185380|584917699|FG002|Overall Study|Lost to Follow-up|3|||
161964415|NCT00185380|584917697|FG000|Overall Study|Pregnancy|1|||
161964416|NCT00185380|584917698|FG001|Overall Study|Pregnancy|4|||
161964417|NCT00185380|584917699|FG002|Overall Study|Pregnancy|0|||
161964418|NCT00185380|584917697|FG000|Overall Study|Protocol Violation|2|||
161720428|NCT00670111|584020619|FG001|Enrollment to One Month|Testing Failure|0|||
161720429|NCT00670111|584020620|FG002|Enrollment to One Month|Testing Failure|13|||
161720430|NCT00670111|584020618|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
161720431|NCT00670111|584020619|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
161964419|NCT00185380|584917698|FG001|Overall Study|Protocol Violation|2|||
161964420|NCT00185380|584917699|FG002|Overall Study|Protocol Violation|1|||
161720432|NCT00670111|584020620|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
161720433|NCT00670111|584020618|FG000|Enrollment to One Month|Physician Decision|1|||
161720434|NCT00670111|584020619|FG001|Enrollment to One Month|Physician Decision|0|||
161720435|NCT00670111|584020620|FG002|Enrollment to One Month|Physician Decision|0|||
161720436|NCT02441803|584020621|FG000|Overall Study|Physician Decision|0|||
161720437|NCT02441803|584020622|FG001|Overall Study|Physician Decision|2|||
161720438|NCT02441803|584020623|FG002|Overall Study|Physician Decision|2|||
161720439|NCT02873221|584020624|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
161720440|NCT02873221|584020625|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
161720441|NCT02873221|584020626|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
161720442|NCT02873221|584020624|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
161720443|NCT02873221|584020625|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
161720444|NCT02873221|584020626|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
161720445|NCT02873221|584020624|FG000|Treatment Period|Protocol Violation|2|||
161720446|NCT02873221|584020625|FG001|Treatment Period|Protocol Violation|5|||
161720447|NCT02873221|584020626|FG002|Treatment Period|Protocol Violation|8|||
161720448|NCT02873221|584020624|FG000|Treatment Period|Pregnancy|4|||
161720449|NCT02873221|584020625|FG001|Treatment Period|Pregnancy|6|||
161720450|NCT02873221|584020626|FG002|Treatment Period|Pregnancy|3|||
161720451|NCT02873221|584020624|FG000|Treatment Period|Lack of Qualifying Event|0|||
161720452|NCT02873221|584020625|FG001|Treatment Period|Lack of Qualifying Event|3|||
161720453|NCT02873221|584020626|FG002|Treatment Period|Lack of Qualifying Event|1|||
161720454|NCT02873221|584020624|FG000|Treatment Period|Withdrawal of Consent|52|||
161720455|NCT02873221|584020625|FG001|Treatment Period|Withdrawal of Consent|51|||
161720456|NCT02873221|584020626|FG002|Treatment Period|Withdrawal of Consent|41|||
161720457|NCT02873221|584020624|FG000|Treatment Period|Lack of Efficacy|0|||
161720458|NCT02873221|584020625|FG001|Treatment Period|Lack of Efficacy|17|||
161720459|NCT02873221|584020626|FG002|Treatment Period|Lack of Efficacy|12|||
161720460|NCT02873221|584020624|FG000|Treatment Period|Adverse Event|4|||
161720461|NCT02873221|584020625|FG001|Treatment Period|Adverse Event|9|||
161720462|NCT02873221|584020626|FG002|Treatment Period|Adverse Event|11|||
161720463|NCT02873221|584020624|FG000|Treatment Period|Lost to Follow-up|26|||
161720464|NCT02873221|584020625|FG001|Treatment Period|Lost to Follow-up|30|||
161720465|NCT02873221|584020626|FG002|Treatment Period|Lost to Follow-up|26|||
161720466|NCT02873221|584020624|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
161720467|NCT02873221|584020625|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
161720468|NCT02873221|584020626|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
161720469|NCT02873221|584020624|FG000|Safety Follow-up Period|Protocol Violation|0|||
161720470|NCT02873221|584020625|FG001|Safety Follow-up Period|Protocol Violation|0|||
161720471|NCT02873221|584020626|FG002|Safety Follow-up Period|Protocol Violation|1|||
161720472|NCT02873221|584020624|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
161720473|NCT02873221|584020625|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
161720474|NCT02873221|584020626|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
161720475|NCT02873221|584020624|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
161720476|NCT02873221|584020625|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
161720477|NCT02873221|584020626|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
161720478|NCT01325493|584020627|FG000|Overall Study|Protocol Violation|0|||
161720479|NCT01325493|584020628|FG001|Overall Study|Protocol Violation|1|||
161720480|NCT01325493|584020627|FG000|Overall Study|loss of neuromonitoring signals|0|||
161720481|NCT01325493|584020628|FG001|Overall Study|loss of neuromonitoring signals|2|||
161720482|NCT01325493|584020627|FG000|Overall Study|Allergy|1|||
161720483|NCT01325493|584020628|FG001|Overall Study|Allergy|0|||
161720484|NCT01749735|584020629|FG000|Overall Study|Withdrawal by Subject|1|||
161720485|NCT01749735|584020630|FG001|Overall Study|Withdrawal by Subject|0|||
161720486|NCT02234583|584020635|FG000|Overall Study|Adverse Event|172|||
161720487|NCT02234583|584020636|FG001|Overall Study|Adverse Event|156|||
161720488|NCT02234583|584020635|FG000|Overall Study|Withdrawal by Subject|109|||
161720489|NCT02234583|584020636|FG001|Overall Study|Withdrawal by Subject|157|||
161720490|NCT02234583|584020635|FG000|Overall Study|Lost to Follow-up|0|||
161720491|NCT02234583|584020636|FG001|Overall Study|Lost to Follow-up|1|||
161720492|NCT02234583|584020635|FG000|Overall Study|Lack of Efficacy|58|||
161720493|NCT02234583|584020636|FG001|Overall Study|Lack of Efficacy|103|||
161720494|NCT02234583|584020635|FG000|Overall Study|Protocol Violation|35|||
161720495|NCT02234583|584020636|FG001|Overall Study|Protocol Violation|42|||
161720496|NCT02234583|584020635|FG000|Overall Study|Other|39|||
161720497|NCT02234583|584020636|FG001|Overall Study|Other|97|||
161720498|NCT01849250|584020637|FG000|Overall Study|Withdrawal by Subject|1|||
161720499|NCT01849250|584020638|FG001|Overall Study|Withdrawal by Subject|0|||
161720500|NCT01849250|584020637|FG000|Overall Study|Not Evaluable|5|||
161720501|NCT01849250|584020638|FG001|Overall Study|Not Evaluable|3|||
161720502|NCT01849250|584020637|FG000|Overall Study|Screen Failure|1|||
161720503|NCT01849250|584020638|FG001|Overall Study|Screen Failure|0|||
161720504|NCT04504032|584020641|FG000|Overall Study|Adverse Event|1|||
161720505|NCT04504032|584020642|FG001|Overall Study|Adverse Event|2|||
161720506|NCT04504032|584020641|FG000|Overall Study|Lost to Follow-up|6|||
161720507|NCT04504032|584020642|FG001|Overall Study|Lost to Follow-up|9|||
161720508|NCT04504032|584020641|FG000|Overall Study|Protocol Violation|2|||
161720509|NCT04504032|584020642|FG001|Overall Study|Protocol Violation|0|||
161720510|NCT04504032|584020641|FG000|Overall Study|Study terminated by sponsor|1|||
161720511|NCT04504032|584020642|FG001|Overall Study|Study terminated by sponsor|2|||
161720512|NCT04504032|584020641|FG000|Overall Study|Withdrawal by Subject|9|||
161720513|NCT04504032|584020642|FG001|Overall Study|Withdrawal by Subject|11|||
161720514|NCT04504032|584020641|FG000|Overall Study|Disease progression prior to dosing|15|||
161720515|NCT04504032|584020642|FG001|Overall Study|Disease progression prior to dosing|3|||
161720516|NCT04504032|584020641|FG000|Overall Study|Drug supply issues|1|||
161720517|NCT04504032|584020642|FG001|Overall Study|Drug supply issues|1|||
161720518|NCT04504032|584020641|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
161720519|NCT04504032|584020642|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
161720520|NCT00771030|584020643|FG000|Overall Study|Adverse Event|0|||
161720521|NCT00771030|584020644|FG001|Overall Study|Adverse Event|1|||
161720522|NCT00771030|584020645|FG002|Overall Study|Adverse Event|0|||
161720523|NCT00771030|584020646|FG003|Overall Study|Adverse Event|0|||
161720524|NCT00771030|584020647|FG004|Overall Study|Adverse Event|0|||
161720525|NCT00771030|584020648|FG005|Overall Study|Adverse Event|0|||
161720526|NCT00771030|584020649|FG006|Overall Study|Adverse Event|0|||
161720527|NCT04156646|584020655|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
161720528|NCT04156646|584020656|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
161720529|NCT01208181|584020657|FG000|Part 1|Withdrawal by Subject|11|||
161720530|NCT01208181|584020658|FG001|Part 1|Withdrawal by Subject|10|||
161720531|NCT01208181|584020659|FG002|Part 1|Withdrawal by Subject|0|||
161720532|NCT01208181|584020660|FG003|Part 1|Withdrawal by Subject|0|||
161720533|NCT01208181|584020661|FG004|Part 1|Withdrawal by Subject|0|||
161720534|NCT01208181|584020657|FG000|Part 1|Technical problem|5|||
161720535|NCT01208181|584020658|FG001|Part 1|Technical problem|0|||
161720536|NCT01208181|584020659|FG002|Part 1|Technical problem|0|||
161720537|NCT01208181|584020660|FG003|Part 1|Technical problem|0|||
161720538|NCT01208181|584020661|FG004|Part 1|Technical problem|0|||
161720539|NCT01208181|584020657|FG000|Part 1|Protocol Violation|10|||
161720540|NCT01208181|584020658|FG001|Part 1|Protocol Violation|5|||
161720541|NCT01208181|584020659|FG002|Part 1|Protocol Violation|0|||
161720542|NCT01208181|584020660|FG003|Part 1|Protocol Violation|0|||
161720543|NCT01208181|584020661|FG004|Part 1|Protocol Violation|0|||
161720544|NCT01208181|584020657|FG000|Part 1|Physician Decision|4|||
161720545|NCT01208181|584020658|FG001|Part 1|Physician Decision|0|||
161720546|NCT01208181|584020659|FG002|Part 1|Physician Decision|0|||
161720547|NCT01208181|584020660|FG003|Part 1|Physician Decision|0|||
161720548|NCT01208181|584020661|FG004|Part 1|Physician Decision|0|||
161720549|NCT01208181|584020657|FG000|Part 1|Non-compliance with study drug|1|||
161720550|NCT01208181|584020658|FG001|Part 1|Non-compliance with study drug|1|||
161720551|NCT01208181|584020659|FG002|Part 1|Non-compliance with study drug|0|||
161720552|NCT01208181|584020660|FG003|Part 1|Non-compliance with study drug|0|||
161720553|NCT01208181|584020661|FG004|Part 1|Non-compliance with study drug|0|||
161720554|NCT01208181|584020657|FG000|Part 1|Lost to Follow-up|5|||
161720555|NCT01208181|584020658|FG001|Part 1|Lost to Follow-up|3|||
161720556|NCT01208181|584020659|FG002|Part 1|Lost to Follow-up|0|||
161720557|NCT01208181|584020660|FG003|Part 1|Lost to Follow-up|0|||
161720558|NCT01208181|584020661|FG004|Part 1|Lost to Follow-up|1|||
161720559|NCT01208181|584020657|FG000|Part 1|Lack of Efficacy|37|||
161720560|NCT01208181|584020658|FG001|Part 1|Lack of Efficacy|12|||
161720561|NCT01208181|584020659|FG002|Part 1|Lack of Efficacy|0|||
161720562|NCT01208181|584020660|FG003|Part 1|Lack of Efficacy|0|||
161720563|NCT01208181|584020661|FG004|Part 1|Lack of Efficacy|17|||
161720564|NCT01208181|584020657|FG000|Part 1|Adverse Event|26|||
161720565|NCT01208181|584020658|FG001|Part 1|Adverse Event|24|||
161720566|NCT01208181|584020659|FG002|Part 1|Adverse Event|0|||
161720567|NCT01208181|584020660|FG003|Part 1|Adverse Event|0|||
161720568|NCT01208181|584020661|FG004|Part 1|Adverse Event|4|||
161720569|NCT01208181|584020657|FG000|Part 2|Adverse Event|0|||
161720570|NCT01208181|584020658|FG001|Part 2|Adverse Event|0|||
161720571|NCT01208181|584020659|FG002|Part 2|Adverse Event|6|||
161720572|NCT01208181|584020660|FG003|Part 2|Adverse Event|7|||
161720573|NCT01208181|584020661|FG004|Part 2|Adverse Event|0|||
161720574|NCT01208181|584020657|FG000|Part 2|Withdrawal by Subject|0|||
161720575|NCT01208181|584020658|FG001|Part 2|Withdrawal by Subject|0|||
161720576|NCT01208181|584020659|FG002|Part 2|Withdrawal by Subject|1|||
161720577|NCT01208181|584020660|FG003|Part 2|Withdrawal by Subject|1|||
161720578|NCT01208181|584020661|FG004|Part 2|Withdrawal by Subject|0|||
161720579|NCT01208181|584020657|FG000|Part 2|Protocol Violation|0|||
161720580|NCT01208181|584020658|FG001|Part 2|Protocol Violation|0|||
161720581|NCT01208181|584020659|FG002|Part 2|Protocol Violation|1|||
161720582|NCT01208181|584020660|FG003|Part 2|Protocol Violation|0|||
161720583|NCT01208181|584020661|FG004|Part 2|Protocol Violation|0|||
161720584|NCT01208181|584020657|FG000|Part 2|Physician Decision|0|||
161720585|NCT01208181|584020658|FG001|Part 2|Physician Decision|0|||
161720586|NCT01208181|584020659|FG002|Part 2|Physician Decision|1|||
161720587|NCT01208181|584020660|FG003|Part 2|Physician Decision|2|||
161720588|NCT01208181|584020661|FG004|Part 2|Physician Decision|0|||
161720589|NCT01208181|584020657|FG000|Part 2|Non-compliance with study drug|0|||
161720590|NCT01208181|584020658|FG001|Part 2|Non-compliance with study drug|0|||
161720591|NCT01208181|584020659|FG002|Part 2|Non-compliance with study drug|1|||
161720592|NCT01208181|584020660|FG003|Part 2|Non-compliance with study drug|1|||
161720593|NCT01208181|584020661|FG004|Part 2|Non-compliance with study drug|0|||
161720594|NCT01208181|584020657|FG000|Part 2|Lost to Follow-up|0|||
161720595|NCT01208181|584020658|FG001|Part 2|Lost to Follow-up|0|||
161720596|NCT01208181|584020659|FG002|Part 2|Lost to Follow-up|1|||
161964421|NCT00185380|584917697|FG000|Overall Study|Withdrawal by Subject|1|||
161964422|NCT00185380|584917698|FG001|Overall Study|Withdrawal by Subject|2|||
161964423|NCT00185380|584917699|FG002|Overall Study|Withdrawal by Subject|0|||
161964424|NCT00185380|584917697|FG000|Overall Study|Failed insertion|1|||
161964425|NCT00185380|584917698|FG001|Overall Study|Failed insertion|1|||
161964426|NCT00185380|584917699|FG002|Overall Study|Failed insertion|2|||
161964427|NCT00185380|584917697|FG000|Overall Study|Planned pregnancy|9|||
161964428|NCT00185380|584917698|FG001|Overall Study|Planned pregnancy|12|||
161964429|NCT00185380|584917699|FG002|Overall Study|Planned pregnancy|12|||
161964430|NCT00185380|584917697|FG000|Overall Study|No need for contraception|3|||
161964431|NCT00185380|584917698|FG001|Overall Study|No need for contraception|3|||
161964432|NCT00185380|584917699|FG002|Overall Study|No need for contraception|3|||
161964433|NCT00185380|584917697|FG000|Overall Study|Could not attend visits|2|||
161964434|NCT00185380|584917698|FG001|Overall Study|Could not attend visits|0|||
161964435|NCT00185380|584917699|FG002|Overall Study|Could not attend visits|4|||
161964436|NCT00185380|584917697|FG000|Overall Study|personal reason|6|||
161964437|NCT00185380|584917698|FG001|Overall Study|personal reason|1|||
161964438|NCT00185380|584917699|FG002|Overall Study|personal reason|1|||
161964439|NCT00218634|584917700|FG000|Overall Study|Lost to Follow-up|8|||
161964440|NCT00218634|584917701|FG001|Overall Study|Lost to Follow-up|15|||
161964441|NCT02589665|584917702|FG000|Induction Period|Did not receive drug|0|||
161964442|NCT02589665|584917703|FG001|Induction Period|Did not receive drug|0|||
161964443|NCT02589665|584917704|FG002|Induction Period|Did not receive drug|0|||
161964444|NCT02589665|584917705|FG003|Induction Period|Did not receive drug|1|||
161964445|NCT02589665|584917706|FG004|Induction Period|Did not receive drug|0|||
161964446|NCT02589665|584917707|FG005|Induction Period|Did not receive drug|0|||
161964447|NCT02589665|584917708|FG006|Induction Period|Did not receive drug|0|||
161964448|NCT02589665|584917709|FG007|Induction Period|Did not receive drug|0|||
161964449|NCT02589665|584917710|FG008|Induction Period|Did not receive drug|0|||
161964450|NCT02589665|584917711|FG009|Induction Period|Did not receive drug|0|||
161964451|NCT02589665|584917702|FG000|Induction Period|Adverse Event|3|||
161964452|NCT02589665|584917703|FG001|Induction Period|Adverse Event|0|||
161964453|NCT02589665|584917704|FG002|Induction Period|Adverse Event|2|||
161964454|NCT02589665|584917705|FG003|Induction Period|Adverse Event|2|||
161964455|NCT02589665|584917706|FG004|Induction Period|Adverse Event|0|||
161964456|NCT02589665|584917707|FG005|Induction Period|Adverse Event|0|||
161964457|NCT02589665|584917708|FG006|Induction Period|Adverse Event|0|||
161964458|NCT02589665|584917709|FG007|Induction Period|Adverse Event|0|||
161964459|NCT02589665|584917710|FG008|Induction Period|Adverse Event|0|||
161964460|NCT02589665|584917711|FG009|Induction Period|Adverse Event|0|||
161964461|NCT02589665|584917702|FG000|Induction Period|Withdrawal by Subject|0|||
161964462|NCT02589665|584917703|FG001|Induction Period|Withdrawal by Subject|1|||
161964463|NCT02589665|584917704|FG002|Induction Period|Withdrawal by Subject|0|||
161964464|NCT02589665|584917705|FG003|Induction Period|Withdrawal by Subject|1|||
161720597|NCT01208181|584020660|FG003|Part 2|Lost to Follow-up|2|||
161720598|NCT01208181|584020661|FG004|Part 2|Lost to Follow-up|0|||
161720599|NCT01208181|584020657|FG000|Part 2|Lack of Efficacy|0|||
161720600|NCT01208181|584020658|FG001|Part 2|Lack of Efficacy|0|||
161720601|NCT01208181|584020659|FG002|Part 2|Lack of Efficacy|5|||
161720602|NCT01208181|584020660|FG003|Part 2|Lack of Efficacy|7|||
161720603|NCT01208181|584020661|FG004|Part 2|Lack of Efficacy|0|||
161720604|NCT02707757|584020662|FG000|Overall Study|Protocol Violation|3|||
161720605|NCT02707757|584020663|FG001|Overall Study|Protocol Violation|2|||
161720606|NCT02707757|584020662|FG000|Overall Study|Withdrawal by Subject|2|||
161720607|NCT02707757|584020663|FG001|Overall Study|Withdrawal by Subject|0|||
161964465|NCT02589665|584917706|FG004|Induction Period|Withdrawal by Subject|0|||
161964466|NCT02589665|584917707|FG005|Induction Period|Withdrawal by Subject|0|||
161964467|NCT02589665|584917708|FG006|Induction Period|Withdrawal by Subject|0|||
161964468|NCT02589665|584917709|FG007|Induction Period|Withdrawal by Subject|0|||
161964469|NCT02589665|584917710|FG008|Induction Period|Withdrawal by Subject|0|||
161964470|NCT02589665|584917711|FG009|Induction Period|Withdrawal by Subject|0|||
161964471|NCT02589665|584917702|FG000|Induction Period|Protocol Violation|0|||
161964472|NCT02589665|584917703|FG001|Induction Period|Protocol Violation|1|||
161720608|NCT02707757|584020662|FG000|Overall Study|Death|0|||
161720609|NCT02707757|584020663|FG001|Overall Study|Death|1|||
161720610|NCT02707757|584020662|FG000|Overall Study|Adverse Event|6|||
161964473|NCT02589665|584917704|FG002|Induction Period|Protocol Violation|0|||
161964474|NCT02589665|584917705|FG003|Induction Period|Protocol Violation|0|||
161964475|NCT02589665|584917706|FG004|Induction Period|Protocol Violation|0|||
161964476|NCT02589665|584917707|FG005|Induction Period|Protocol Violation|0|||
161964477|NCT02589665|584917708|FG006|Induction Period|Protocol Violation|0|||
161964478|NCT02589665|584917709|FG007|Induction Period|Protocol Violation|0|||
161964479|NCT02589665|584917710|FG008|Induction Period|Protocol Violation|0|||
161720611|NCT02707757|584020663|FG001|Overall Study|Adverse Event|4|||
161720612|NCT02707757|584020662|FG000|Overall Study|Renal transplant/elective operation|1|||
161720613|NCT02707757|584020663|FG001|Overall Study|Renal transplant/elective operation|5|||
161720614|NCT00815308|584020664|FG000|Overall Study|Adverse Event|4|||
161720615|NCT00815308|584020664|FG000|Overall Study|Withdrawal by Subject|0|||
161720616|NCT00815308|584020664|FG000|Overall Study|Protocol Violation|6|||
161720617|NCT01056523|584020665|FG000|Overall Study|Death|1|||
161720618|NCT01056523|584020666|FG001|Overall Study|Death|0|||
161720619|NCT01056523|584020667|FG002|Overall Study|Death|2|||
161720620|NCT01056523|584020668|FG003|Overall Study|Death|3|||
161720621|NCT01056523|584020669|FG004|Overall Study|Death|0|||
161720622|NCT01056523|584020670|FG005|Overall Study|Death|0|||
161720623|NCT01056523|584020671|FG006|Overall Study|Death|1|||
161720624|NCT03429556|584020672|FG000|Overall Study|Lost to Follow-up|0|||
161720625|NCT03429556|584020673|FG001|Overall Study|Lost to Follow-up|1|||
161720626|NCT03429556|584020674|FG002|Overall Study|Lost to Follow-up|0|||
161720627|NCT03429556|584020675|FG003|Overall Study|Lost to Follow-up|0|||
161720628|NCT00377299|584020678|FG000|Overall Study|Lost to Follow-up|14|||
161720629|NCT00377299|584020679|FG001|Overall Study|Lost to Follow-up|19|||
161720630|NCT00377299|584020678|FG000|Overall Study|Adverse Event|0|||
161720631|NCT00377299|584020679|FG001|Overall Study|Adverse Event|1|||
161720632|NCT00377299|584020678|FG000|Overall Study|Withdrawal by Subject|5|||
161720633|NCT00377299|584020679|FG001|Overall Study|Withdrawal by Subject|4|||
161720634|NCT02209597|584020683|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
161720635|NCT02209597|584020683|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
161720636|NCT02209597|584020683|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
161720637|NCT02209597|584020683|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
161720638|NCT04799782|584020689|FG000|Washout|Physician Decision|2|||
161720639|NCT04799782|584020690|FG001|Washout|Physician Decision|0|||
161720640|NCT04799782|584020689|FG000|Washout|Withdrawal by Subject|0|||
161720641|NCT04799782|584020690|FG001|Washout|Withdrawal by Subject|2|||
161720642|NCT04799782|584020689|FG000|Washout|Lost to Follow-up|0|||
161720643|NCT04799782|584020690|FG001|Washout|Lost to Follow-up|1|||
161720644|NCT02050048|584020691|FG000|Overall Study|Lost to Follow-up|0|||
161720645|NCT02050048|584020692|FG001|Overall Study|Lost to Follow-up|1|||
161720646|NCT02050048|584020691|FG000|Overall Study|Death|1|||
161720647|NCT02050048|584020692|FG001|Overall Study|Death|0|||
161720648|NCT02050048|584020691|FG000|Overall Study|Ineligible after ERCP|4|||
161964480|NCT02589665|584917711|FG009|Induction Period|Protocol Violation|0|||
161964481|NCT02589665|584917702|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964482|NCT02589665|584917703|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964483|NCT02589665|584917704|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964484|NCT02589665|584917705|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964485|NCT02589665|584917706|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
161720649|NCT02050048|584020692|FG001|Overall Study|Ineligible after ERCP|1|||
161720650|NCT03067311|584020694|FG000|Overall Study|Lost to Follow-up|1|||
161720651|NCT03067311|584020695|FG001|Overall Study|Lost to Follow-up|1|||
161720652|NCT03067311|584020694|FG000|Overall Study|Moved away|1|||
161720653|NCT03067311|584020695|FG001|Overall Study|Moved away|1|||
161720654|NCT01589094|584020698|FG000|Overall Study|Did not receive treatment|2|||
161720655|NCT00907738|584020699|FG000|Overall Study|Adverse Event|2|||
161720656|NCT00907738|584020700|FG001|Overall Study|Adverse Event|0|||
161720657|NCT00907738|584020701|FG002|Overall Study|Adverse Event|1|||
161720658|NCT00907738|584020702|FG003|Overall Study|Adverse Event|0|||
161720659|NCT00907738|584020703|FG004|Overall Study|Adverse Event|0|||
161720660|NCT00907738|584020699|FG000|Overall Study|not specified or withdrew consent|3|||
161720661|NCT00907738|584020700|FG001|Overall Study|not specified or withdrew consent|0|||
161720662|NCT00907738|584020701|FG002|Overall Study|not specified or withdrew consent|0|||
161720663|NCT00907738|584020702|FG003|Overall Study|not specified or withdrew consent|0|||
161720664|NCT00907738|584020703|FG004|Overall Study|not specified or withdrew consent|0|||
161720665|NCT00907738|584020699|FG000|Overall Study|Disease progression|8|||
161720666|NCT00907738|584020700|FG001|Overall Study|Disease progression|1|||
161720667|NCT00907738|584020701|FG002|Overall Study|Disease progression|6|||
161720668|NCT00907738|584020702|FG003|Overall Study|Disease progression|4|||
161720669|NCT00907738|584020703|FG004|Overall Study|Disease progression|2|||
161720670|NCT05363293|584020704|FG000|Overall Study|Withdrawal by Subject|1|||
161720671|NCT05363293|584020705|FG001|Overall Study|Withdrawal by Subject|0|||
161720672|NCT05363293|584020706|FG002|Overall Study|Withdrawal by Subject|0|||
161720673|NCT05363293|584020707|FG003|Overall Study|Withdrawal by Subject|0|||
161720674|NCT05363293|584020708|FG004|Overall Study|Withdrawal by Subject|0|||
161720675|NCT05363293|584020709|FG005|Overall Study|Withdrawal by Subject|0|||
161720676|NCT05363293|584020710|FG006|Overall Study|Withdrawal by Subject|0|||
161720677|NCT05363293|584020711|FG007|Overall Study|Withdrawal by Subject|0|||
161720678|NCT05363293|584020712|FG008|Overall Study|Withdrawal by Subject|0|||
161720679|NCT05363293|584020713|FG009|Overall Study|Withdrawal by Subject|0|||
161720680|NCT04773041|584020714|FG000|Overall Study|Unable to data match|1|||
161720681|NCT04773041|584020715|FG001|Overall Study|Unable to data match|0|||
161720682|NCT04773041|584020716|FG002|Overall Study|Unable to data match|0|||
161720683|NCT01988012|584023247|FG000|Overall Study|Adverse Event|5|||
161720684|NCT01988012|584023247|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161720685|NCT01988012|584023247|FG000|Overall Study|Patient Withdrawal of Consent|4|||
161720686|NCT01988012|584023247|FG000|Overall Study|Lost to Follow-up|1|||
161964486|NCT02589665|584917707|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
161964487|NCT02589665|584917708|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
161964488|NCT02589665|584917709|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964489|NCT02589665|584917710|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964490|NCT02589665|584917711|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964491|NCT02589665|584917702|FG000|Maintenance Period|Withdrawal by Subject|0|||
161964492|NCT02589665|584917703|FG001|Maintenance Period|Withdrawal by Subject|0|||
161964493|NCT02589665|584917704|FG002|Maintenance Period|Withdrawal by Subject|0|||
161964494|NCT02589665|584917705|FG003|Maintenance Period|Withdrawal by Subject|0|||
161964495|NCT02589665|584917706|FG004|Maintenance Period|Withdrawal by Subject|4|||
161964496|NCT02589665|584917707|FG005|Maintenance Period|Withdrawal by Subject|2|||
161964497|NCT02589665|584917708|FG006|Maintenance Period|Withdrawal by Subject|4|||
161964498|NCT02589665|584917709|FG007|Maintenance Period|Withdrawal by Subject|0|||
161964499|NCT02589665|584917710|FG008|Maintenance Period|Withdrawal by Subject|0|||
161964500|NCT02589665|584917711|FG009|Maintenance Period|Withdrawal by Subject|0|||
161964501|NCT02589665|584917702|FG000|Maintenance Period|Lack of Efficacy|0|||
161964502|NCT02589665|584917703|FG001|Maintenance Period|Lack of Efficacy|0|||
161964503|NCT02589665|584917704|FG002|Maintenance Period|Lack of Efficacy|0|||
161964504|NCT02589665|584917705|FG003|Maintenance Period|Lack of Efficacy|0|||
161964505|NCT02589665|584917706|FG004|Maintenance Period|Lack of Efficacy|2|||
161964506|NCT02589665|584917707|FG005|Maintenance Period|Lack of Efficacy|1|||
161964507|NCT02589665|584917708|FG006|Maintenance Period|Lack of Efficacy|0|||
161964508|NCT02589665|584917709|FG007|Maintenance Period|Lack of Efficacy|0|||
161964509|NCT02589665|584917710|FG008|Maintenance Period|Lack of Efficacy|0|||
161964510|NCT02589665|584917711|FG009|Maintenance Period|Lack of Efficacy|0|||
161964511|NCT02589665|584917702|FG000|Maintenance Period|Adverse Event|0|||
161964512|NCT02589665|584917703|FG001|Maintenance Period|Adverse Event|0|||
161964513|NCT02589665|584917704|FG002|Maintenance Period|Adverse Event|0|||
161964514|NCT02589665|584917705|FG003|Maintenance Period|Adverse Event|0|||
161964515|NCT02589665|584917706|FG004|Maintenance Period|Adverse Event|0|||
161964516|NCT02589665|584917707|FG005|Maintenance Period|Adverse Event|0|||
161964517|NCT02589665|584917708|FG006|Maintenance Period|Adverse Event|2|||
161964518|NCT02589665|584917709|FG007|Maintenance Period|Adverse Event|0|||
161964519|NCT02589665|584917710|FG008|Maintenance Period|Adverse Event|0|||
161964520|NCT02589665|584917711|FG009|Maintenance Period|Adverse Event|0|||
161964521|NCT02589665|584917702|FG000|Maintenance Period|Lost to Follow-up|0|||
161964522|NCT02589665|584917703|FG001|Maintenance Period|Lost to Follow-up|0|||
161964523|NCT02589665|584917704|FG002|Maintenance Period|Lost to Follow-up|0|||
161964524|NCT02589665|584917705|FG003|Maintenance Period|Lost to Follow-up|0|||
161964525|NCT02589665|584917706|FG004|Maintenance Period|Lost to Follow-up|0|||
161964526|NCT02589665|584917707|FG005|Maintenance Period|Lost to Follow-up|1|||
161964527|NCT02589665|584917708|FG006|Maintenance Period|Lost to Follow-up|0|||
161964528|NCT02589665|584917709|FG007|Maintenance Period|Lost to Follow-up|0|||
161964529|NCT02589665|584917710|FG008|Maintenance Period|Lost to Follow-up|0|||
161964530|NCT02589665|584917711|FG009|Maintenance Period|Lost to Follow-up|0|||
161964531|NCT02589665|584917702|FG000|Maintenance Period|Physician Decision|0|||
161964532|NCT02589665|584917703|FG001|Maintenance Period|Physician Decision|0|||
161964533|NCT02589665|584917704|FG002|Maintenance Period|Physician Decision|0|||
161964534|NCT02589665|584917705|FG003|Maintenance Period|Physician Decision|0|||
161964535|NCT02589665|584917706|FG004|Maintenance Period|Physician Decision|0|||
161964536|NCT02589665|584917707|FG005|Maintenance Period|Physician Decision|1|||
161964537|NCT02589665|584917708|FG006|Maintenance Period|Physician Decision|0|||
161964538|NCT02589665|584917709|FG007|Maintenance Period|Physician Decision|0|||
161964539|NCT02589665|584917710|FG008|Maintenance Period|Physician Decision|0|||
161964540|NCT02589665|584917711|FG009|Maintenance Period|Physician Decision|0|||
161720687|NCT01988012|584023247|FG000|Overall Study|Physician Decision|1|||
161720688|NCT01988012|584023247|FG000|Overall Study|Protocol Violation|1|||
161720689|NCT01058369|584023248|FG000|Overall Study|Adverse Event|1|||
161964541|NCT02589665|584917702|FG000|Maintenance Period|Reason Not Collected|0|||
161964542|NCT02589665|584917703|FG001|Maintenance Period|Reason Not Collected|0|||
161964543|NCT02589665|584917704|FG002|Maintenance Period|Reason Not Collected|0|||
161964544|NCT02589665|584917705|FG003|Maintenance Period|Reason Not Collected|0|||
161964545|NCT02589665|584917706|FG004|Maintenance Period|Reason Not Collected|0|||
161964546|NCT02589665|584917707|FG005|Maintenance Period|Reason Not Collected|1|||
161964547|NCT02589665|584917708|FG006|Maintenance Period|Reason Not Collected|1|||
161964548|NCT02589665|584917709|FG007|Maintenance Period|Reason Not Collected|0|||
161964549|NCT02589665|584917710|FG008|Maintenance Period|Reason Not Collected|0|||
161964550|NCT02589665|584917711|FG009|Maintenance Period|Reason Not Collected|0|||
161964551|NCT02589665|584917702|FG000|Induction Extension Period|Adverse Event|0|||
161720690|NCT01058369|584023248|FG000|Overall Study|Early termination study|1|||
161964552|NCT02589665|584917703|FG001|Induction Extension Period|Adverse Event|0|||
161720691|NCT00634543|584023253|FG000|Overall Study|Other|1|||
161720692|NCT00634543|584023254|FG001|Overall Study|Other|2|||
161964553|NCT02589665|584917704|FG002|Induction Extension Period|Adverse Event|0|||
161964554|NCT02589665|584917705|FG003|Induction Extension Period|Adverse Event|0|||
161720693|NCT00634543|584023253|FG000|Overall Study|Protocol Violation|3|||
161720694|NCT00634543|584023254|FG001|Overall Study|Protocol Violation|3|||
161720695|NCT00634543|584023253|FG000|Overall Study|Adverse Event|11|||
161720696|NCT00634543|584023254|FG001|Overall Study|Adverse Event|11|||
161720697|NCT00634543|584023253|FG000|Overall Study|Withdrawal by Subject|4|||
161720698|NCT00634543|584023254|FG001|Overall Study|Withdrawal by Subject|4|||
161720699|NCT00634543|584023253|FG000|Overall Study|Lost to Follow-up|0|||
161720700|NCT00634543|584023254|FG001|Overall Study|Lost to Follow-up|1|||
161720701|NCT01371838|584023255|FG000|Overall Study|Withdrawal by Subject|27|||
161720702|NCT01371838|584023256|FG001|Overall Study|Withdrawal by Subject|33|||
161720703|NCT01371838|584023255|FG000|Overall Study|Lost to Follow-up|10|||
161720704|NCT01371838|584023256|FG001|Overall Study|Lost to Follow-up|20|||
161720705|NCT01371838|584023255|FG000|Overall Study|Death|3|||
161720706|NCT01371838|584023256|FG001|Overall Study|Death|4|||
161720707|NCT01371838|584023255|FG000|Overall Study|Protocol Violation|3|||
161720708|NCT01371838|584023256|FG001|Overall Study|Protocol Violation|0|||
161720709|NCT01371838|584023255|FG000|Overall Study|Investigator Decision|3|||
161720710|NCT01371838|584023256|FG001|Overall Study|Investigator Decision|8|||
161720711|NCT01371838|584023255|FG000|Overall Study|Last follow-up visit not conducted|2|||
161720712|NCT01371838|584023256|FG001|Overall Study|Last follow-up visit not conducted|0|||
161720713|NCT01371838|584023255|FG000|Overall Study|Lack of therapeutic response|0|||
161720714|NCT01371838|584023256|FG001|Overall Study|Lack of therapeutic response|1|||
161720715|NCT01371838|584023255|FG000|Overall Study|Surgery|1|||
161720716|NCT01371838|584023256|FG001|Overall Study|Surgery|0|||
161720717|NCT01103349|584023259|FG000|Overall Study|Adverse Event|8|||
161720718|NCT01103349|584023260|FG001|Overall Study|Adverse Event|5|||
161720719|NCT01103349|584023261|FG002|Overall Study|Adverse Event|3|||
161720720|NCT01103349|584023259|FG000|Overall Study|Consent withdrawn|1|||
161720721|NCT01103349|584023260|FG001|Overall Study|Consent withdrawn|0|||
161720722|NCT01103349|584023261|FG002|Overall Study|Consent withdrawn|0|||
161720723|NCT01103349|584023259|FG000|Overall Study|Incorrectly included in the trial|1|||
161720724|NCT01103349|584023260|FG001|Overall Study|Incorrectly included in the trial|0|||
161720725|NCT01103349|584023261|FG002|Overall Study|Incorrectly included in the trial|0|||
161720726|NCT01103349|584023259|FG000|Overall Study|Withdrawal by Subject|1|||
161720727|NCT01103349|584023260|FG001|Overall Study|Withdrawal by Subject|1|||
161720728|NCT01103349|584023261|FG002|Overall Study|Withdrawal by Subject|0|||
161720729|NCT01103349|584023259|FG000|Overall Study|did not want to take trial medication|0|||
161720730|NCT01103349|584023260|FG001|Overall Study|did not want to take trial medication|1|||
161720731|NCT01103349|584023261|FG002|Overall Study|did not want to take trial medication|0|||
161720732|NCT01103349|584023259|FG000|Overall Study|forgot to take medication|0|||
161720733|NCT01103349|584023260|FG001|Overall Study|forgot to take medication|0|||
161720734|NCT01103349|584023261|FG002|Overall Study|forgot to take medication|1|||
161720735|NCT00972244|584023265|FG000|Overall Study|Incorrect Enrolment|1|||
161720736|NCT00972244|584023266|FG001|Overall Study|Incorrect Enrolment|0|||
161720737|NCT00972244|584023267|FG002|Overall Study|Incorrect Enrolment|0|||
161720738|NCT00972244|584023268|FG003|Overall Study|Incorrect Enrolment|0|||
161720739|NCT00972244|584023269|FG004|Overall Study|Incorrect Enrolment|0|||
161720740|NCT00972244|584023265|FG000|Overall Study|Adverse Event|0|||
161720741|NCT00972244|584023266|FG001|Overall Study|Adverse Event|1|||
161720742|NCT00972244|584023267|FG002|Overall Study|Adverse Event|1|||
161720743|NCT00972244|584023268|FG003|Overall Study|Adverse Event|0|||
161720744|NCT00972244|584023269|FG004|Overall Study|Adverse Event|0|||
161720745|NCT00972244|584023265|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
161720746|NCT00972244|584023266|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
161720747|NCT00972244|584023267|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
161720748|NCT00972244|584023268|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
161964555|NCT02589665|584917706|FG004|Induction Extension Period|Adverse Event|0|||
161720749|NCT00972244|584023269|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
161720750|NCT00972244|584023265|FG000|Overall Study|Withdrawal by Subject|1|||
161720751|NCT00972244|584023266|FG001|Overall Study|Withdrawal by Subject|2|||
161720752|NCT00972244|584023267|FG002|Overall Study|Withdrawal by Subject|1|||
161720753|NCT00972244|584023268|FG003|Overall Study|Withdrawal by Subject|0|||
161720754|NCT00972244|584023269|FG004|Overall Study|Withdrawal by Subject|1|||
161720755|NCT00972244|584023265|FG000|Overall Study|Safety|0|||
161720756|NCT00972244|584023266|FG001|Overall Study|Safety|0|||
161720757|NCT00972244|584023267|FG002|Overall Study|Safety|0|||
161720758|NCT00972244|584023268|FG003|Overall Study|Safety|0|||
161720759|NCT00972244|584023269|FG004|Overall Study|Safety|1|||
161720760|NCT00972244|584023265|FG000|Overall Study|Death|1|||
161720761|NCT00972244|584023266|FG001|Overall Study|Death|0|||
161720762|NCT00972244|584023267|FG002|Overall Study|Death|0|||
161720763|NCT00972244|584023268|FG003|Overall Study|Death|0|||
161720764|NCT00972244|584023269|FG004|Overall Study|Death|0|||
161720765|NCT00972244|584023265|FG000|Overall Study|Various|0|||
161720766|NCT00972244|584023266|FG001|Overall Study|Various|0|||
161720767|NCT00972244|584023267|FG002|Overall Study|Various|0|||
161720768|NCT00972244|584023268|FG003|Overall Study|Various|0|||
161720769|NCT00972244|584023269|FG004|Overall Study|Various|2|||
161720770|NCT01736683|584023270|FG000|Overall Study|Disease Relapse|0|||
161720771|NCT01736683|584023271|FG001|Overall Study|Disease Relapse|0|||
161720772|NCT01736683|584023272|FG002|Overall Study|Disease Relapse|2|||
161720773|NCT01736683|584023273|FG003|Overall Study|Disease Relapse|1|||
161720774|NCT01736683|584023274|FG004|Overall Study|Disease Relapse|0|||
161720775|NCT01736683|584023270|FG000|Overall Study|Adverse Event|0|||
161720776|NCT01736683|584023271|FG001|Overall Study|Adverse Event|2|||
161720777|NCT01736683|584023272|FG002|Overall Study|Adverse Event|2|||
161720778|NCT01736683|584023273|FG003|Overall Study|Adverse Event|3|||
161720779|NCT01736683|584023274|FG004|Overall Study|Adverse Event|2|||
161720780|NCT01736683|584023270|FG000|Overall Study|Withdrawal by Subject|0|||
161720781|NCT01736683|584023271|FG001|Overall Study|Withdrawal by Subject|0|||
161720782|NCT01736683|584023272|FG002|Overall Study|Withdrawal by Subject|3|||
161720783|NCT01736683|584023273|FG003|Overall Study|Withdrawal by Subject|1|||
161720784|NCT01736683|584023274|FG004|Overall Study|Withdrawal by Subject|1|||
161720785|NCT01736683|584023270|FG000|Overall Study|Lack of Therapeutic Effect|7|||
161720786|NCT01736683|584023271|FG001|Overall Study|Lack of Therapeutic Effect|4|||
161720787|NCT01736683|584023272|FG002|Overall Study|Lack of Therapeutic Effect|13|||
161720788|NCT01736683|584023273|FG003|Overall Study|Lack of Therapeutic Effect|20|||
161720789|NCT01736683|584023274|FG004|Overall Study|Lack of Therapeutic Effect|1|||
161720790|NCT01736683|584023270|FG000|Overall Study|Progressive Disease|0|||
161720791|NCT01736683|584023271|FG001|Overall Study|Progressive Disease|0|||
161720792|NCT01736683|584023272|FG002|Overall Study|Progressive Disease|0|||
161720793|NCT01736683|584023273|FG003|Overall Study|Progressive Disease|1|||
161720794|NCT01736683|584023274|FG004|Overall Study|Progressive Disease|0|||
161720795|NCT01736683|584023270|FG000|Overall Study|Other|0|||
161720796|NCT01736683|584023271|FG001|Overall Study|Other|0|||
161720797|NCT01736683|584023272|FG002|Overall Study|Other|1|||
161720798|NCT01736683|584023273|FG003|Overall Study|Other|9|||
161720799|NCT01736683|584023274|FG004|Overall Study|Other|1|||
161720800|NCT00283712|584023280|FG000|Overall Study|Death|0|||
161720801|NCT00283712|584023281|FG001|Overall Study|Death|1|||
161720802|NCT00090285|584023283|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
161720803|NCT00090285|584023284|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
161720804|NCT00090285|584023285|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161720805|NCT00090285|584023286|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161720806|NCT00090285|584023287|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161720807|NCT00090285|584023288|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161720808|NCT00090285|584023283|FG000|Base Study Vaccination Period|Adverse Event|2|||
161720809|NCT00090285|584023284|FG001|Base Study Vaccination Period|Adverse Event|4|||
161720810|NCT00090285|584023285|FG002|Base Study Vaccination Period|Adverse Event|0|||
161720811|NCT00090285|584023286|FG003|Base Study Vaccination Period|Adverse Event|0|||
161720812|NCT00090285|584023287|FG004|Base Study Vaccination Period|Adverse Event|0|||
161720813|NCT00090285|584023288|FG005|Base Study Vaccination Period|Adverse Event|0|||
161720814|NCT00090285|584023283|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
161720815|NCT00090285|584023284|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
161720816|NCT00090285|584023285|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
161720817|NCT00090285|584023286|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
161720818|NCT00090285|584023287|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
161720819|NCT00090285|584023288|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
161720820|NCT00090285|584023283|FG000|Base Study Vaccination Period|Protocol Violation|2|||
161720821|NCT00090285|584023284|FG001|Base Study Vaccination Period|Protocol Violation|3|||
161720822|NCT00090285|584023285|FG002|Base Study Vaccination Period|Protocol Violation|0|||
161720823|NCT00090285|584023286|FG003|Base Study Vaccination Period|Protocol Violation|0|||
161720824|NCT00090285|584023287|FG004|Base Study Vaccination Period|Protocol Violation|0|||
161720825|NCT00090285|584023288|FG005|Base Study Vaccination Period|Protocol Violation|0|||
161720826|NCT00090285|584023283|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
161720827|NCT00090285|584023284|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
161720828|NCT00090285|584023285|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
161720829|NCT00090285|584023286|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
161720830|NCT00090285|584023287|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
161720831|NCT00090285|584023288|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
161720832|NCT00090285|584023283|FG000|Base Study Vaccination Period|Uncooperative|2|||
161720833|NCT00090285|584023284|FG001|Base Study Vaccination Period|Uncooperative|2|||
161720834|NCT00090285|584023285|FG002|Base Study Vaccination Period|Uncooperative|0|||
161720835|NCT00090285|584023286|FG003|Base Study Vaccination Period|Uncooperative|0|||
161720836|NCT00090285|584023287|FG004|Base Study Vaccination Period|Uncooperative|0|||
161720837|NCT00090285|584023288|FG005|Base Study Vaccination Period|Uncooperative|0|||
161720838|NCT00090285|584023283|FG000|Base Study Vaccination Period|Moved|20|||
161720839|NCT00090285|584023284|FG001|Base Study Vaccination Period|Moved|21|||
161720840|NCT00090285|584023285|FG002|Base Study Vaccination Period|Moved|0|||
161720841|NCT00090285|584023286|FG003|Base Study Vaccination Period|Moved|0|||
161720842|NCT00090285|584023287|FG004|Base Study Vaccination Period|Moved|0|||
161720843|NCT00090285|584023288|FG005|Base Study Vaccination Period|Moved|0|||
161964556|NCT02589665|584917707|FG005|Induction Extension Period|Adverse Event|0|||
161964557|NCT02589665|584917708|FG006|Induction Extension Period|Adverse Event|0|||
161964558|NCT02589665|584917709|FG007|Induction Extension Period|Adverse Event|0|||
161964559|NCT02589665|584917710|FG008|Induction Extension Period|Adverse Event|4|||
161964560|NCT02589665|584917711|FG009|Induction Extension Period|Adverse Event|0|||
161964561|NCT02589665|584917702|FG000|Induction Extension Period|Lack of Efficacy|0|||
161964562|NCT02589665|584917703|FG001|Induction Extension Period|Lack of Efficacy|0|||
161964563|NCT02589665|584917704|FG002|Induction Extension Period|Lack of Efficacy|0|||
161964564|NCT02589665|584917705|FG003|Induction Extension Period|Lack of Efficacy|0|||
161964565|NCT02589665|584917706|FG004|Induction Extension Period|Lack of Efficacy|0|||
161964566|NCT02589665|584917707|FG005|Induction Extension Period|Lack of Efficacy|0|||
161964567|NCT02589665|584917708|FG006|Induction Extension Period|Lack of Efficacy|0|||
161964568|NCT02589665|584917709|FG007|Induction Extension Period|Lack of Efficacy|0|||
161964569|NCT02589665|584917710|FG008|Induction Extension Period|Lack of Efficacy|3|||
161964570|NCT02589665|584917711|FG009|Induction Extension Period|Lack of Efficacy|0|||
161964571|NCT02589665|584917702|FG000|Induction Extension Period|Withdrawal by Subject|0|||
161964572|NCT02589665|584917703|FG001|Induction Extension Period|Withdrawal by Subject|0|||
161720844|NCT00090285|584023283|FG000|Base Study Vaccination Period|Site Terminated|1|||
161720845|NCT00090285|584023284|FG001|Base Study Vaccination Period|Site Terminated|0|||
161720846|NCT00090285|584023285|FG002|Base Study Vaccination Period|Site Terminated|0|||
161720847|NCT00090285|584023286|FG003|Base Study Vaccination Period|Site Terminated|0|||
161720848|NCT00090285|584023287|FG004|Base Study Vaccination Period|Site Terminated|0|||
161720849|NCT00090285|584023288|FG005|Base Study Vaccination Period|Site Terminated|0|||
161720850|NCT00090285|584023283|FG000|Base Study Vaccination Period|Other|2|||
161720851|NCT00090285|584023284|FG001|Base Study Vaccination Period|Other|2|||
161720852|NCT00090285|584023285|FG002|Base Study Vaccination Period|Other|0|||
161720853|NCT00090285|584023286|FG003|Base Study Vaccination Period|Other|0|||
161720854|NCT00090285|584023287|FG004|Base Study Vaccination Period|Other|0|||
161720855|NCT00090285|584023288|FG005|Base Study Vaccination Period|Other|0|||
161720856|NCT00090285|584023283|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
161720857|NCT00090285|584023284|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
161720858|NCT00090285|584023285|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
161720859|NCT00090285|584023286|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
161720860|NCT00090285|584023287|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
161720861|NCT00090285|584023288|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
161720862|NCT00090285|584023283|FG000|Base Study Vaccination Period|HIV positive|1|||
161720863|NCT00090285|584023284|FG001|Base Study Vaccination Period|HIV positive|1|||
161720864|NCT00090285|584023285|FG002|Base Study Vaccination Period|HIV positive|0|||
161720865|NCT00090285|584023286|FG003|Base Study Vaccination Period|HIV positive|0|||
161720866|NCT00090285|584023287|FG004|Base Study Vaccination Period|HIV positive|0|||
161720867|NCT00090285|584023288|FG005|Base Study Vaccination Period|HIV positive|0|||
161720868|NCT00090285|584023283|FG000|Base Study Follow-up Period|Adverse Event|3|||
161720869|NCT00090285|584023284|FG001|Base Study Follow-up Period|Adverse Event|10|||
161720870|NCT00090285|584023285|FG002|Base Study Follow-up Period|Adverse Event|0|||
161720871|NCT00090285|584023286|FG003|Base Study Follow-up Period|Adverse Event|0|||
161720872|NCT00090285|584023287|FG004|Base Study Follow-up Period|Adverse Event|0|||
161720873|NCT00090285|584023288|FG005|Base Study Follow-up Period|Adverse Event|0|||
161720874|NCT00090285|584023283|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
161720875|NCT00090285|584023284|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
161720876|NCT00090285|584023285|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
161720877|NCT00090285|584023286|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
161720878|NCT00090285|584023287|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
161720879|NCT00090285|584023288|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
161720880|NCT00090285|584023283|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
161720881|NCT00090285|584023284|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
161720882|NCT00090285|584023285|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
161720883|NCT00090285|584023286|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
161720884|NCT00090285|584023287|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
161720885|NCT00090285|584023288|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
161720886|NCT00090285|584023283|FG000|Base Study Follow-up Period|Moved|41|||
161720887|NCT00090285|584023284|FG001|Base Study Follow-up Period|Moved|36|||
161720888|NCT00090285|584023285|FG002|Base Study Follow-up Period|Moved|0|||
161720889|NCT00090285|584023286|FG003|Base Study Follow-up Period|Moved|0|||
161720890|NCT00090285|584023287|FG004|Base Study Follow-up Period|Moved|0|||
161720891|NCT00090285|584023288|FG005|Base Study Follow-up Period|Moved|0|||
161720892|NCT00090285|584023283|FG000|Base Study Follow-up Period|Other|2|||
161720893|NCT00090285|584023284|FG001|Base Study Follow-up Period|Other|0|||
161720894|NCT00090285|584023285|FG002|Base Study Follow-up Period|Other|0|||
161720895|NCT00090285|584023286|FG003|Base Study Follow-up Period|Other|0|||
161720896|NCT00090285|584023287|FG004|Base Study Follow-up Period|Other|0|||
161720897|NCT00090285|584023288|FG005|Base Study Follow-up Period|Other|0|||
161720898|NCT00090285|584023283|FG000|Base Study Follow-up Period|Protocol Violation|1|||
161964573|NCT02589665|584917704|FG002|Induction Extension Period|Withdrawal by Subject|0|||
161964574|NCT02589665|584917705|FG003|Induction Extension Period|Withdrawal by Subject|0|||
161964575|NCT02589665|584917706|FG004|Induction Extension Period|Withdrawal by Subject|0|||
161964576|NCT02589665|584917707|FG005|Induction Extension Period|Withdrawal by Subject|0|||
161964577|NCT02589665|584917708|FG006|Induction Extension Period|Withdrawal by Subject|0|||
161964578|NCT02589665|584917709|FG007|Induction Extension Period|Withdrawal by Subject|2|||
161964579|NCT02589665|584917710|FG008|Induction Extension Period|Withdrawal by Subject|3|||
161964580|NCT02589665|584917711|FG009|Induction Extension Period|Withdrawal by Subject|0|||
161964581|NCT02589665|584917702|FG000|Induction Extension Period|Physician Decision|0|||
161964582|NCT02589665|584917703|FG001|Induction Extension Period|Physician Decision|0|||
161964583|NCT02589665|584917704|FG002|Induction Extension Period|Physician Decision|0|||
161964584|NCT02589665|584917705|FG003|Induction Extension Period|Physician Decision|0|||
161964585|NCT02589665|584917706|FG004|Induction Extension Period|Physician Decision|0|||
161964586|NCT02589665|584917707|FG005|Induction Extension Period|Physician Decision|0|||
161964587|NCT02589665|584917708|FG006|Induction Extension Period|Physician Decision|0|||
161964588|NCT02589665|584917709|FG007|Induction Extension Period|Physician Decision|0|||
161964589|NCT02589665|584917710|FG008|Induction Extension Period|Physician Decision|1|||
161964590|NCT02589665|584917711|FG009|Induction Extension Period|Physician Decision|0|||
161964591|NCT02589665|584917702|FG000|Induction Extension Period|Reason Not Collected|0|||
161964592|NCT02589665|584917703|FG001|Induction Extension Period|Reason Not Collected|0|||
161964593|NCT02589665|584917704|FG002|Induction Extension Period|Reason Not Collected|0|||
161964594|NCT02589665|584917705|FG003|Induction Extension Period|Reason Not Collected|0|||
161964595|NCT02589665|584917706|FG004|Induction Extension Period|Reason Not Collected|0|||
161964596|NCT02589665|584917707|FG005|Induction Extension Period|Reason Not Collected|0|||
161964597|NCT02589665|584917708|FG006|Induction Extension Period|Reason Not Collected|0|||
161964598|NCT02589665|584917709|FG007|Induction Extension Period|Reason Not Collected|0|||
161964599|NCT02589665|584917710|FG008|Induction Extension Period|Reason Not Collected|1|||
161964600|NCT02589665|584917711|FG009|Induction Extension Period|Reason Not Collected|0|||
161964601|NCT02589665|584917702|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964602|NCT02589665|584917703|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964603|NCT02589665|584917704|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964604|NCT02589665|584917705|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964605|NCT02589665|584917706|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964606|NCT02589665|584917707|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964607|NCT02589665|584917708|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964608|NCT02589665|584917709|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964609|NCT02589665|584917710|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
161964610|NCT02589665|584917711|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
161964611|NCT02589665|584917702|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
161720899|NCT00090285|584023284|FG001|Base Study Follow-up Period|Protocol Violation|0|||
161720900|NCT00090285|584023285|FG002|Base Study Follow-up Period|Protocol Violation|0|||
161720901|NCT00090285|584023286|FG003|Base Study Follow-up Period|Protocol Violation|0|||
161720902|NCT00090285|584023287|FG004|Base Study Follow-up Period|Protocol Violation|0|||
161720903|NCT00090285|584023288|FG005|Base Study Follow-up Period|Protocol Violation|0|||
161720904|NCT00090285|584023283|FG000|Base Study Follow-up Period|Uncooperative|3|||
161720905|NCT00090285|584023284|FG001|Base Study Follow-up Period|Uncooperative|4|||
161720906|NCT00090285|584023285|FG002|Base Study Follow-up Period|Uncooperative|0|||
161720907|NCT00090285|584023286|FG003|Base Study Follow-up Period|Uncooperative|0|||
161720908|NCT00090285|584023287|FG004|Base Study Follow-up Period|Uncooperative|0|||
161964612|NCT02589665|584917703|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
161964613|NCT02589665|584917704|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
161964614|NCT02589665|584917705|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
161964615|NCT02589665|584917706|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
161964616|NCT02589665|584917707|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
161964617|NCT02589665|584917708|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
161964618|NCT02589665|584917709|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
161964619|NCT02589665|584917710|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
161964620|NCT02589665|584917711|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
161964621|NCT02589665|584917702|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
161964622|NCT02589665|584917703|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
161964623|NCT02589665|584917704|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
161720909|NCT00090285|584023288|FG005|Base Study Follow-up Period|Uncooperative|0|||
161720910|NCT00090285|584023283|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
161720911|NCT00090285|584023284|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
161720912|NCT00090285|584023285|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
161720913|NCT00090285|584023286|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
161720914|NCT00090285|584023287|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
161964624|NCT02589665|584917705|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
161964625|NCT02589665|584917706|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
161964626|NCT02589665|584917707|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
161964627|NCT02589665|584917708|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
161964628|NCT02589665|584917709|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
161964629|NCT02589665|584917710|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
161964630|NCT02589665|584917711|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
161964631|NCT02589665|584917702|FG000|Maintenance Extension Period|Adverse Event|0|||
161964632|NCT02589665|584917703|FG001|Maintenance Extension Period|Adverse Event|0|||
161964633|NCT02589665|584917704|FG002|Maintenance Extension Period|Adverse Event|0|||
161964634|NCT02589665|584917705|FG003|Maintenance Extension Period|Adverse Event|0|||
161964635|NCT02589665|584917706|FG004|Maintenance Extension Period|Adverse Event|0|||
161964636|NCT02589665|584917707|FG005|Maintenance Extension Period|Adverse Event|0|||
161964637|NCT02589665|584917708|FG006|Maintenance Extension Period|Adverse Event|0|||
161964638|NCT02589665|584917709|FG007|Maintenance Extension Period|Adverse Event|0|||
161964639|NCT02589665|584917710|FG008|Maintenance Extension Period|Adverse Event|0|||
161964640|NCT02589665|584917711|FG009|Maintenance Extension Period|Adverse Event|2|||
161964641|NCT02589665|584917702|FG000|Maintenance Extension Period|Non-responder|0|||
161964642|NCT02589665|584917703|FG001|Maintenance Extension Period|Non-responder|0|||
161964643|NCT02589665|584917704|FG002|Maintenance Extension Period|Non-responder|0|||
161964644|NCT02589665|584917705|FG003|Maintenance Extension Period|Non-responder|0|||
161964645|NCT02589665|584917706|FG004|Maintenance Extension Period|Non-responder|0|||
161964646|NCT02589665|584917707|FG005|Maintenance Extension Period|Non-responder|0|||
161964647|NCT02589665|584917708|FG006|Maintenance Extension Period|Non-responder|0|||
161964648|NCT02589665|584917709|FG007|Maintenance Extension Period|Non-responder|0|||
161964649|NCT02589665|584917710|FG008|Maintenance Extension Period|Non-responder|0|||
161964650|NCT02589665|584917711|FG009|Maintenance Extension Period|Non-responder|1|||
161964651|NCT00978380|584917712|FG000|Overall Study|Protocol Violation|2|||
161964652|NCT00978380|584917712|FG000|Overall Study|Withdrawal criteria|9|||
161964653|NCT00978380|584917712|FG000|Overall Study|Unclassified|8|||
161964654|NCT00176488|584917715|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
161964655|NCT00327015|584917716|FG000|Overall Study|Lack of Efficacy|18|||
161964656|NCT00327015|584917717|FG001|Overall Study|Lack of Efficacy|18|||
161720915|NCT00090285|584023288|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
161720916|NCT00090285|584023283|FG000|Extension 1|Adverse Event|0|||
161720917|NCT00090285|584023284|FG001|Extension 1|Adverse Event|0|||
161720918|NCT00090285|584023285|FG002|Extension 1|Adverse Event|2|||
161720919|NCT00090285|584023286|FG003|Extension 1|Adverse Event|0|||
161720920|NCT00090285|584023287|FG004|Extension 1|Adverse Event|0|||
161720921|NCT00090285|584023288|FG005|Extension 1|Adverse Event|0|||
161720922|NCT00090285|584023283|FG000|Extension 1|Lost to Follow-up|0|||
161720923|NCT00090285|584023284|FG001|Extension 1|Lost to Follow-up|0|||
161720924|NCT00090285|584023285|FG002|Extension 1|Lost to Follow-up|35|||
161720925|NCT00090285|584023286|FG003|Extension 1|Lost to Follow-up|0|||
161720926|NCT00090285|584023287|FG004|Extension 1|Lost to Follow-up|0|||
161720927|NCT00090285|584023288|FG005|Extension 1|Lost to Follow-up|0|||
161720928|NCT00090285|584023283|FG000|Extension 1|Withdrawal by Subject|0|||
161720929|NCT00090285|584023284|FG001|Extension 1|Withdrawal by Subject|0|||
161720930|NCT00090285|584023285|FG002|Extension 1|Withdrawal by Subject|13|||
161720931|NCT00090285|584023286|FG003|Extension 1|Withdrawal by Subject|1|||
161720932|NCT00090285|584023287|FG004|Extension 1|Withdrawal by Subject|0|||
161964657|NCT00327015|584917718|FG002|Overall Study|Lack of Efficacy|35|||
161964658|NCT00327015|584917719|FG003|Overall Study|Lack of Efficacy|29|||
161964659|NCT00327015|584917716|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
161964660|NCT00327015|584917717|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
161964661|NCT00327015|584917718|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
161964662|NCT00327015|584917719|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
161964663|NCT00327015|584917716|FG000|Overall Study|Lost to Follow-up|22|||
161964664|NCT00327015|584917717|FG001|Overall Study|Lost to Follow-up|23|||
161964665|NCT00327015|584917718|FG002|Overall Study|Lost to Follow-up|29|||
161720933|NCT00090285|584023288|FG005|Extension 1|Withdrawal by Subject|0|||
161720934|NCT00090285|584023283|FG000|Extension 1|Other|0|||
161720935|NCT00090285|584023284|FG001|Extension 1|Other|0|||
161720936|NCT00090285|584023285|FG002|Extension 1|Other|4|||
161964666|NCT00327015|584917719|FG003|Overall Study|Lost to Follow-up|22|||
161964667|NCT00327015|584917716|FG000|Overall Study|Adverse Event|14|||
161964668|NCT00327015|584917717|FG001|Overall Study|Adverse Event|10|||
161720937|NCT00090285|584023286|FG003|Extension 1|Other|0|||
161720938|NCT00090285|584023287|FG004|Extension 1|Other|0|||
161720939|NCT00090285|584023288|FG005|Extension 1|Other|0|||
161964669|NCT00327015|584917718|FG002|Overall Study|Adverse Event|14|||
161720940|NCT00090285|584023283|FG000|Extension 1|Moved|0|||
161720941|NCT00090285|584023284|FG001|Extension 1|Moved|0|||
161720942|NCT00090285|584023285|FG002|Extension 1|Moved|3|||
161720943|NCT00090285|584023286|FG003|Extension 1|Moved|0|||
161720944|NCT00090285|584023287|FG004|Extension 1|Moved|0|||
161720945|NCT00090285|584023288|FG005|Extension 1|Moved|0|||
161720946|NCT00090285|584023283|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
161964670|NCT00327015|584917719|FG003|Overall Study|Adverse Event|14|||
161964671|NCT00327015|584917716|FG000|Overall Study|Subject no longer meets study criteria|4|||
161964672|NCT00327015|584917717|FG001|Overall Study|Subject no longer meets study criteria|2|||
161964673|NCT00327015|584917718|FG002|Overall Study|Subject no longer meets study criteria|8|||
161964674|NCT00327015|584917719|FG003|Overall Study|Subject no longer meets study criteria|7|||
161964675|NCT00327015|584917716|FG000|Overall Study|Poor/Noncompliance|11|||
161964676|NCT00327015|584917717|FG001|Overall Study|Poor/Noncompliance|8|||
161964677|NCT00327015|584917718|FG002|Overall Study|Poor/Noncompliance|4|||
161964678|NCT00327015|584917719|FG003|Overall Study|Poor/Noncompliance|5|||
161964679|NCT00327015|584917716|FG000|Overall Study|Physician Decision|0|||
161964680|NCT00327015|584917717|FG001|Overall Study|Physician Decision|1|||
161964681|NCT00327015|584917718|FG002|Overall Study|Physician Decision|3|||
161964682|NCT00327015|584917719|FG003|Overall Study|Physician Decision|2|||
161964683|NCT00327015|584917716|FG000|Overall Study|Death|1|||
161964684|NCT00327015|584917717|FG001|Overall Study|Death|2|||
161964685|NCT00327015|584917718|FG002|Overall Study|Death|2|||
161964686|NCT00327015|584917719|FG003|Overall Study|Death|3|||
161964687|NCT00327015|584917716|FG000|Overall Study|Pregnancy|0|||
161964688|NCT00327015|584917717|FG001|Overall Study|Pregnancy|2|||
161964689|NCT00327015|584917718|FG002|Overall Study|Pregnancy|1|||
161964690|NCT00327015|584917719|FG003|Overall Study|Pregnancy|1|||
161964691|NCT00327015|584917716|FG000|Overall Study|Administrative Reason by Sponsor|1|||
161964692|NCT00327015|584917717|FG001|Overall Study|Administrative Reason by Sponsor|2|||
161964693|NCT00327015|584917718|FG002|Overall Study|Administrative Reason by Sponsor|2|||
161964694|NCT00327015|584917719|FG003|Overall Study|Administrative Reason by Sponsor|1|||
161964695|NCT04115748|584917720|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
161964696|NCT04115748|584917721|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
161964697|NCT04115748|584917722|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
161964698|NCT04115748|584917723|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
161964699|NCT04115748|584917724|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
161964700|NCT04115748|584917725|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
161964701|NCT04115748|584917726|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
161964702|NCT04115748|584917727|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
161964703|NCT04115748|584917728|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
161964704|NCT04115748|584917729|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
161964705|NCT04115748|584917720|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161964706|NCT04115748|584917721|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161964707|NCT04115748|584917722|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161964708|NCT04115748|584917723|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
161964709|NCT04115748|584917724|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161964710|NCT04115748|584917725|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161964711|NCT04115748|584917726|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161964712|NCT04115748|584917727|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161964713|NCT04115748|584917728|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161964714|NCT04115748|584917729|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
161964715|NCT04115748|584917720|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
161964716|NCT04115748|584917721|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
161964717|NCT04115748|584917722|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
161720947|NCT00090285|584023284|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
161720948|NCT00090285|584023285|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
161720949|NCT00090285|584023286|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
161720950|NCT00090285|584023287|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
161720951|NCT00090285|584023288|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
161720952|NCT00090285|584023283|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161720953|NCT00090285|584023284|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161720954|NCT00090285|584023285|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161720955|NCT00090285|584023286|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161720956|NCT00090285|584023287|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
161720957|NCT00090285|584023288|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
161720958|NCT00090285|584023283|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161720959|NCT00090285|584023284|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161720960|NCT00090285|584023285|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161720961|NCT00090285|584023286|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161720962|NCT00090285|584023287|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
161720963|NCT00090285|584023288|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
161720964|NCT00090285|584023283|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
161720965|NCT00090285|584023284|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
161720966|NCT00090285|584023285|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
161720967|NCT00090285|584023286|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
161720968|NCT00090285|584023287|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
161720969|NCT00090285|584023288|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
161964718|NCT04115748|584917723|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
161964719|NCT04115748|584917724|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
161964720|NCT04115748|584917725|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
161964721|NCT04115748|584917726|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
161964722|NCT04115748|584917727|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
161964723|NCT04115748|584917728|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
161964724|NCT04115748|584917729|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
162032149|NCT00814801|585174220|FG002|Overall Study|Inappropriate as a subject|1|||
162032150|NCT00814801|585174218|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
161720970|NCT02046564|584023291|FG000|Overall Study|Adverse Event|6|||
161720971|NCT02046564|584023292|FG001|Overall Study|Adverse Event|3|||
161720972|NCT02046564|584023291|FG000|Overall Study|Physician Decision|0|||
161720973|NCT02046564|584023292|FG001|Overall Study|Physician Decision|1|||
161720974|NCT02046564|584023291|FG000|Overall Study|Protocol Violation|3|||
161720975|NCT02046564|584023292|FG001|Overall Study|Protocol Violation|1|||
161720976|NCT02046564|584023291|FG000|Overall Study|Withdrawal by Subject|4|||
161720977|NCT02046564|584023292|FG001|Overall Study|Withdrawal by Subject|10|||
161720978|NCT02046564|584023291|FG000|Overall Study|Subject met withdrawal criteria|2|||
161720979|NCT02046564|584023292|FG001|Overall Study|Subject met withdrawal criteria|5|||
161720980|NCT00907478|584023293|FG000|Overall Study|Ineligibility determined|0|||
161720981|NCT00907478|584023294|FG001|Overall Study|Ineligibility determined|0|||
161720982|NCT00907478|584023295|FG002|Overall Study|Ineligibility determined|1|||
161720983|NCT00907478|584023293|FG000|Overall Study|Noncompliance|0|||
161720984|NCT00907478|584023294|FG001|Overall Study|Noncompliance|0|||
161720985|NCT00907478|584023295|FG002|Overall Study|Noncompliance|1|||
161720986|NCT00907478|584023293|FG000|Overall Study|Adverse Event|3|||
161720987|NCT00907478|584023294|FG001|Overall Study|Adverse Event|1|||
161720988|NCT00907478|584023295|FG002|Overall Study|Adverse Event|2|||
161720989|NCT00907478|584023293|FG000|Overall Study|Withdrawal by Subject|8|||
161720990|NCT00907478|584023294|FG001|Overall Study|Withdrawal by Subject|9|||
161720991|NCT00907478|584023295|FG002|Overall Study|Withdrawal by Subject|6|||
161720992|NCT00907478|584023293|FG000|Overall Study|Requirement for alternative therapy|1|||
161720993|NCT00907478|584023294|FG001|Overall Study|Requirement for alternative therapy|2|||
161720994|NCT00907478|584023295|FG002|Overall Study|Requirement for alternative therapy|3|||
161720995|NCT00907478|584023293|FG000|Overall Study|Physician Decision|2|||
161720996|NCT00907478|584023294|FG001|Overall Study|Physician Decision|0|||
161720997|NCT00907478|584023295|FG002|Overall Study|Physician Decision|3|||
161720998|NCT00907478|584023293|FG000|Overall Study|Death|4|||
161720999|NCT00907478|584023294|FG001|Overall Study|Death|2|||
161721000|NCT00907478|584023295|FG002|Overall Study|Death|1|||
161721001|NCT00907478|584023293|FG000|Overall Study|Protocol-specified criteria|5|||
161721002|NCT00907478|584023294|FG001|Overall Study|Protocol-specified criteria|2|||
161721003|NCT00907478|584023295|FG002|Overall Study|Protocol-specified criteria|3|||
161721004|NCT00907478|584023293|FG000|Overall Study|Pregnancy|0|||
161721005|NCT00907478|584023294|FG001|Overall Study|Pregnancy|1|||
161721006|NCT00907478|584023295|FG002|Overall Study|Pregnancy|1|||
161721007|NCT00907478|584023293|FG000|Overall Study|Lost to Follow-up|1|||
161721008|NCT00907478|584023294|FG001|Overall Study|Lost to Follow-up|0|||
161721009|NCT00907478|584023295|FG002|Overall Study|Lost to Follow-up|0|||
161721010|NCT00907478|584023293|FG000|Overall Study|Other|3|||
161721011|NCT00907478|584023294|FG001|Overall Study|Other|0|||
161721012|NCT00907478|584023295|FG002|Overall Study|Other|1|||
161721013|NCT02747043|584023296|FG000|Overall Study|Other|1|||
161721014|NCT02747043|584023297|FG001|Overall Study|Other|1|||
161721015|NCT02747043|584023296|FG000|Overall Study|Adverse Event|3|||
161721016|NCT02747043|584023297|FG001|Overall Study|Adverse Event|1|||
161721017|NCT02747043|584023296|FG000|Overall Study|Withdrawal by Subject|1|||
161721018|NCT02747043|584023297|FG001|Overall Study|Withdrawal by Subject|1|||
161721019|NCT02747043|584023296|FG000|Overall Study|Physician Decision|1|||
161721020|NCT02747043|584023297|FG001|Overall Study|Physician Decision|1|||
161721021|NCT02747043|584023296|FG000|Overall Study|Protocol Violation|0|||
161721022|NCT02747043|584023297|FG001|Overall Study|Protocol Violation|1|||
161721023|NCT02747043|584023296|FG000|Overall Study|Disease progression|4|||
161721024|NCT02747043|584023297|FG001|Overall Study|Disease progression|0|||
161721025|NCT01936649|584023302|FG000|Overall Study|Withdrawal by Subject|4|||
161721026|NCT01936649|584023302|FG000|Overall Study|Physician Decision|2|||
161721027|NCT01936649|584023302|FG000|Overall Study|Protocol Violation|2|||
161721028|NCT01936649|584023302|FG000|Overall Study|Other than specified above|5|||
161721029|NCT03554005|584023311|FG000|Overall Study|Not in participant's best interest|0|||
161721030|NCT03554005|584023312|FG001|Overall Study|Not in participant's best interest|0|||
161721031|NCT03554005|584023313|FG002|Overall Study|Not in participant's best interest|0|||
161721032|NCT03554005|584023314|FG003|Overall Study|Not in participant's best interest|0|||
161721033|NCT03554005|584023315|FG004|Overall Study|Not in participant's best interest|0|||
161721034|NCT03554005|584023316|FG005|Overall Study|Not in participant's best interest|1|||
161721035|NCT03554005|584023311|FG000|Overall Study|Disease Progression|1|||
161721036|NCT03554005|584023312|FG001|Overall Study|Disease Progression|1|||
161721037|NCT03554005|584023313|FG002|Overall Study|Disease Progression|1|||
161721038|NCT03554005|584023314|FG003|Overall Study|Disease Progression|1|||
161721039|NCT03554005|584023315|FG004|Overall Study|Disease Progression|5|||
161721040|NCT03554005|584023316|FG005|Overall Study|Disease Progression|6|||
161721041|NCT03554005|584023311|FG000|Overall Study|Adverse Event|0|||
161721042|NCT03554005|584023312|FG001|Overall Study|Adverse Event|0|||
161721043|NCT03554005|584023313|FG002|Overall Study|Adverse Event|0|||
161721044|NCT03554005|584023314|FG003|Overall Study|Adverse Event|0|||
161721045|NCT03554005|584023315|FG004|Overall Study|Adverse Event|0|||
161721046|NCT03554005|584023316|FG005|Overall Study|Adverse Event|3|||
161721047|NCT03554005|584023311|FG000|Overall Study|Physician Decision|0|||
161721048|NCT03554005|584023312|FG001|Overall Study|Physician Decision|0|||
161721049|NCT03554005|584023313|FG002|Overall Study|Physician Decision|0|||
161721050|NCT03554005|584023314|FG003|Overall Study|Physician Decision|0|||
161721051|NCT03554005|584023315|FG004|Overall Study|Physician Decision|1|||
161721052|NCT03554005|584023316|FG005|Overall Study|Physician Decision|0|||
161721053|NCT03554005|584023311|FG000|Overall Study|Other|0|||
161721054|NCT03554005|584023312|FG001|Overall Study|Other|0|||
161721055|NCT03554005|584023313|FG002|Overall Study|Other|0|||
161721056|NCT03554005|584023314|FG003|Overall Study|Other|0|||
161721057|NCT03554005|584023315|FG004|Overall Study|Other|0|||
161721058|NCT03554005|584023316|FG005|Overall Study|Other|1|||
161721059|NCT00631488|584023320|FG000|Overall Study|Adverse Event|1|||
161721060|NCT00631488|584023321|FG001|Overall Study|Adverse Event|0|||
161721061|NCT00631488|584023322|FG002|Overall Study|Adverse Event|0|||
161721062|NCT00631488|584023320|FG000|Overall Study|Lost to Follow-up|2|||
161721063|NCT00631488|584023321|FG001|Overall Study|Lost to Follow-up|2|||
161721064|NCT00631488|584023322|FG002|Overall Study|Lost to Follow-up|0|||
161721065|NCT00631488|584023320|FG000|Overall Study|Physician Decision|1|||
161721066|NCT00631488|584023321|FG001|Overall Study|Physician Decision|0|||
161721067|NCT00631488|584023322|FG002|Overall Study|Physician Decision|1|||
161721068|NCT00631488|584023320|FG000|Overall Study|Protocol Violation|0|||
161721069|NCT00631488|584023321|FG001|Overall Study|Protocol Violation|0|||
161721070|NCT00631488|584023322|FG002|Overall Study|Protocol Violation|1|||
161721071|NCT03648476|584023324|FG000|Overall Study|Withdrawal by Subject|2|||
161721072|NCT03648476|584023325|FG001|Overall Study|Withdrawal by Subject|1|||
161721073|NCT02855411|584023330|FG000|Overall Study|Study terminated by sponsor|21|||
161721074|NCT02855411|584023330|FG000|Overall Study|Does not meet entrance criteria|14|||
161721075|NCT00907881|584023331|FG000|Overall Study|Lost to Follow-up|59|||
161721076|NCT00907881|584023331|FG000|Overall Study|Noncompliance|5|||
161721077|NCT00907881|584023331|FG000|Overall Study|Withdrawal by Subject|5|||
161721078|NCT00907881|584023331|FG000|Overall Study|Protocol Violation|1|||
161721079|NCT00907881|584023331|FG000|Overall Study|Missing discontinuation information|15|||
161721080|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
161721081|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
161721082|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
161721083|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161721084|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161721085|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161721086|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161721087|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161721088|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
161721089|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
161721090|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
161721091|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161721092|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161721093|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161721094|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161721095|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161721096|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
161721097|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
161721098|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
161721099|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161721100|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161721101|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161721102|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161721103|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161721104|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
161721105|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
161721106|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161721107|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161721108|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161721109|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161721110|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161721111|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161721112|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
161721113|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
161721114|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
161721115|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161721116|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161721117|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161721118|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161721119|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161721120|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
161721121|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
161721122|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161721123|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161721124|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161721125|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161721126|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161721127|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161721128|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
161721129|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
161721130|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161721131|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161721132|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161721133|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161721134|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161721135|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161721136|NCT01097616|584023334|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721137|NCT01097616|584023335|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721138|NCT01097616|584023336|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
161721139|NCT01097616|584023337|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721140|NCT01097616|584023338|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721141|NCT01097616|584023339|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721142|NCT01097616|584023340|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721143|NCT01097616|584023341|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161721144|NCT01097616|584023334|FG000|Optional DB EXT Phase|Adverse Event|0|||
161721145|NCT01097616|584023335|FG001|Optional DB EXT Phase|Adverse Event|7|||
161721146|NCT01097616|584023336|FG002|Optional DB EXT Phase|Adverse Event|2|||
161721147|NCT01097616|584023337|FG003|Optional DB EXT Phase|Adverse Event|0|||
161721148|NCT01097616|584023338|FG004|Optional DB EXT Phase|Adverse Event|0|||
161721149|NCT01097616|584023339|FG005|Optional DB EXT Phase|Adverse Event|0|||
161721150|NCT01097616|584023340|FG006|Optional DB EXT Phase|Adverse Event|0|||
161721151|NCT01097616|584023341|FG007|Optional DB EXT Phase|Adverse Event|0|||
161721152|NCT01097616|584023334|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
161721153|NCT01097616|584023335|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
161721154|NCT01097616|584023336|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
161721155|NCT01097616|584023337|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
161721156|NCT01097616|584023338|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
161721157|NCT01097616|584023339|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
161721158|NCT01097616|584023340|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
161721159|NCT01097616|584023341|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
161721160|NCT01097616|584023334|FG000|Optional DB EXT Phase|Protocol Violation|0|||
161721161|NCT01097616|584023335|FG001|Optional DB EXT Phase|Protocol Violation|2|||
161721162|NCT01097616|584023336|FG002|Optional DB EXT Phase|Protocol Violation|3|||
161721163|NCT01097616|584023337|FG003|Optional DB EXT Phase|Protocol Violation|0|||
161721164|NCT01097616|584023338|FG004|Optional DB EXT Phase|Protocol Violation|0|||
161721165|NCT01097616|584023339|FG005|Optional DB EXT Phase|Protocol Violation|0|||
161721166|NCT01097616|584023340|FG006|Optional DB EXT Phase|Protocol Violation|0|||
161721167|NCT01097616|584023341|FG007|Optional DB EXT Phase|Protocol Violation|0|||
161721168|NCT01097616|584023334|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
161721169|NCT01097616|584023335|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
161721170|NCT01097616|584023336|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
161721171|NCT01097616|584023337|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
161721172|NCT01097616|584023338|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
161964725|NCT04115748|584917720|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161964726|NCT04115748|584917721|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161964727|NCT04115748|584917722|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161721173|NCT01097616|584023339|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
161721174|NCT01097616|584023340|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
161721175|NCT01097616|584023341|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
161964728|NCT04115748|584917723|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161721176|NCT01097616|584023334|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
161721177|NCT01097616|584023335|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
161721178|NCT01097616|584023336|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
161721179|NCT01097616|584023337|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
161721180|NCT01097616|584023338|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
161721181|NCT01097616|584023339|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
161721182|NCT01097616|584023340|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
161721183|NCT01097616|584023341|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
161721184|NCT01097616|584023334|FG000|Optional DB EXT Phase|Physician Decision|1|||
161721185|NCT01097616|584023335|FG001|Optional DB EXT Phase|Physician Decision|0|||
161721186|NCT01097616|584023336|FG002|Optional DB EXT Phase|Physician Decision|0|||
161721187|NCT01097616|584023337|FG003|Optional DB EXT Phase|Physician Decision|0|||
161721188|NCT01097616|584023338|FG004|Optional DB EXT Phase|Physician Decision|0|||
161721189|NCT01097616|584023339|FG005|Optional DB EXT Phase|Physician Decision|0|||
161721190|NCT01097616|584023340|FG006|Optional DB EXT Phase|Physician Decision|0|||
161721191|NCT01097616|584023341|FG007|Optional DB EXT Phase|Physician Decision|0|||
161721192|NCT01097616|584023334|FG000|DB RO Phase|Adverse Event|0|||
161721193|NCT01097616|584023335|FG001|DB RO Phase|Adverse Event|0|||
161721194|NCT01097616|584023336|FG002|DB RO Phase|Adverse Event|0|||
161721195|NCT01097616|584023337|FG003|DB RO Phase|Adverse Event|0|||
161721196|NCT01097616|584023338|FG004|DB RO Phase|Adverse Event|0|||
161721197|NCT01097616|584023339|FG005|DB RO Phase|Adverse Event|0|||
161721198|NCT01097616|584023340|FG006|DB RO Phase|Adverse Event|1|||
161721199|NCT01097616|584023341|FG007|DB RO Phase|Adverse Event|0|||
161721200|NCT01097616|584023334|FG000|DB RO Phase|Withdrawal by Subject|0|||
161721201|NCT01097616|584023335|FG001|DB RO Phase|Withdrawal by Subject|0|||
161721202|NCT01097616|584023336|FG002|DB RO Phase|Withdrawal by Subject|0|||
161721203|NCT01097616|584023337|FG003|DB RO Phase|Withdrawal by Subject|0|||
161721204|NCT01097616|584023338|FG004|DB RO Phase|Withdrawal by Subject|0|||
161721205|NCT01097616|584023339|FG005|DB RO Phase|Withdrawal by Subject|1|||
161721206|NCT01097616|584023340|FG006|DB RO Phase|Withdrawal by Subject|0|||
161721207|NCT01097616|584023341|FG007|DB RO Phase|Withdrawal by Subject|0|||
161721208|NCT01097616|584023334|FG000|DB RO Phase|Lost to Follow-up|0|||
161721209|NCT01097616|584023335|FG001|DB RO Phase|Lost to Follow-up|0|||
161721210|NCT01097616|584023336|FG002|DB RO Phase|Lost to Follow-up|0|||
161721211|NCT01097616|584023337|FG003|DB RO Phase|Lost to Follow-up|1|||
161721212|NCT01097616|584023338|FG004|DB RO Phase|Lost to Follow-up|1|||
161721213|NCT01097616|584023339|FG005|DB RO Phase|Lost to Follow-up|0|||
161721214|NCT01097616|584023340|FG006|DB RO Phase|Lost to Follow-up|0|||
161721215|NCT01097616|584023341|FG007|DB RO Phase|Lost to Follow-up|1|||
161721216|NCT01097616|584023334|FG000|DB RO Phase|Not Treated in RO|0|||
161721217|NCT01097616|584023335|FG001|DB RO Phase|Not Treated in RO|0|||
161721218|NCT01097616|584023336|FG002|DB RO Phase|Not Treated in RO|0|||
161721219|NCT01097616|584023337|FG003|DB RO Phase|Not Treated in RO|0|||
161721220|NCT01097616|584023338|FG004|DB RO Phase|Not Treated in RO|0|||
161721221|NCT01097616|584023339|FG005|DB RO Phase|Not Treated in RO|1|||
161721222|NCT01097616|584023340|FG006|DB RO Phase|Not Treated in RO|0|||
161721223|NCT01097616|584023341|FG007|DB RO Phase|Not Treated in RO|0|||
161721224|NCT03988751|584023342|FG000|Overall Study|Withdrawal by Subject|1|||
161721225|NCT03988751|584023343|FG001|Overall Study|Withdrawal by Subject|0|||
161721226|NCT03988751|584023342|FG000|Overall Study|Protocol Violation|0|||
161721227|NCT03988751|584023343|FG001|Overall Study|Protocol Violation|1|||
161721228|NCT00844883|584023344|FG000|Overall Study|Bridged to liver transplant|3|||
161721229|NCT00844883|584023344|FG000|Overall Study|Bridged to resection|1|||
161721230|NCT02927171|584023348|FG000|Overall Study|Lost to Follow-up|0|||
161964729|NCT04115748|584917724|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161721231|NCT02927171|584023349|FG001|Overall Study|Lost to Follow-up|1|||
161721232|NCT02240628|584023352|FG000|Overall Study|Physician Decision|6|||
161721233|NCT02240628|584023353|FG001|Overall Study|Physician Decision|5|||
161721234|NCT00850499|584023355|FG000|Overall Study|Adverse Event|3|||
161721235|NCT00850499|584023356|FG001|Overall Study|Adverse Event|1|||
161721236|NCT00850499|584023355|FG000|Overall Study|Lack of Efficacy|0|||
161721237|NCT00850499|584023356|FG001|Overall Study|Lack of Efficacy|1|||
161721238|NCT00552305|584023357|FG000|Overall Study|Adverse Event|43|||
161721239|NCT00552305|584023357|FG000|Overall Study|Lack of Efficacy|120|||
161721240|NCT00552305|584023357|FG000|Overall Study|Lost to Follow-up|4|||
161721241|NCT00552305|584023357|FG000|Overall Study|Protocol Violation|3|||
161721242|NCT00552305|584023357|FG000|Overall Study|Withdrawal by Subject|44|||
161964730|NCT04115748|584917725|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161721243|NCT00552305|584023357|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
161721244|NCT00552305|584023357|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
161721245|NCT00552305|584023357|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
161721246|NCT00552305|584023357|FG000|Overall Study|Unsatisfactory compliance|11|||
161964731|NCT04115748|584917726|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161721247|NCT00552305|584023357|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
161721248|NCT00552305|584023357|FG000|Overall Study|AE/Other: prohibited drug required|1|||
161721249|NCT00552305|584023357|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
161721250|NCT00552305|584023357|FG000|Overall Study|Other: Site closed|4|||
161721251|NCT00552305|584023357|FG000|Overall Study|Other: Personal problems|1|||
161721252|NCT00552305|584023357|FG000|Overall Study|Other: Unable to attend visits|1|||
161721253|NCT00552305|584023357|FG000|Overall Study|Other: Subject underwent surgery|4|||
161721254|NCT00552305|584023357|FG000|Overall Study|Other: Subject became pregnant|1|||
161721255|NCT00552305|584023357|FG000|Overall Study|Other: Health problems, not drug related|1|||
161721256|NCT00552305|584023357|FG000|Overall Study|Other: Subject moved from area|2|||
161721257|NCT00552305|584023357|FG000|Overall Study|Other: Subject incarcerated|1|||
161721258|NCT00552305|584023357|FG000|Overall Study|Other: Subject went to rehab|1|||
161721259|NCT00718861|584023360|FG000|Overall Study|Withdrawal by Subject|15|||
161721260|NCT00718861|584023361|FG001|Overall Study|Withdrawal by Subject|10|||
161721261|NCT00718861|584023360|FG000|Overall Study|Adverse Event|2|||
161721262|NCT00718861|584023361|FG001|Overall Study|Adverse Event|1|||
161721263|NCT00718861|584023360|FG000|Overall Study|Lost to Follow-up|2|||
161721264|NCT00718861|584023361|FG001|Overall Study|Lost to Follow-up|1|||
161721265|NCT00718861|584023360|FG000|Overall Study|Administrative Problems|1|||
161721266|NCT00718861|584023361|FG001|Overall Study|Administrative Problems|1|||
161721267|NCT00718861|584023360|FG000|Overall Study|Death|1|||
161721268|NCT00718861|584023361|FG001|Overall Study|Death|5|||
161721269|NCT01703819|584023362|FG000|Overall Study|Adverse Event|0|||
161721270|NCT01703819|584023363|FG001|Overall Study|Adverse Event|1|||
161721271|NCT01703819|584023362|FG000|Overall Study|Withdrawal by Subject|0|||
161721272|NCT01703819|584023363|FG001|Overall Study|Withdrawal by Subject|1|||
161721273|NCT04230486|584023370|FG000|Overall Study|Screen Failure|1|||
161721274|NCT01302041|584023371|FG000|Overall Study|Death|5|||
161721275|NCT01302041|584023371|FG000|Overall Study|Withdrawal by Subject|4|||
161721276|NCT01302041|584023371|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
161721277|NCT01302041|584023371|FG000|Overall Study|Other-Miscellaneous Reason|2|||
161721278|NCT01839188|584023372|FG000|Overall Study|Withdrawal by Subject|1|||
161721279|NCT04983901|584023373|FG000|Overall Study|Death|1|||
161721280|NCT04983901|584023374|FG001|Overall Study|Death|4|||
161721281|NCT04983901|584023373|FG000|Overall Study|Lost to Follow-up|3|||
161721282|NCT04983901|584023374|FG001|Overall Study|Lost to Follow-up|0|||
161721283|NCT04983901|584023373|FG000|Overall Study|Protocol Violation|1|||
161721284|NCT04983901|584023374|FG001|Overall Study|Protocol Violation|0|||
161721285|NCT04983901|584023373|FG000|Overall Study|Withdrawal by Subject|1|||
161721286|NCT04983901|584023374|FG001|Overall Study|Withdrawal by Subject|2|||
161721287|NCT01022853|584023381|FG000|Overall Study|Progressive disease|2|||
161721288|NCT01022853|584023382|FG001|Overall Study|Progressive disease|3|||
161721289|NCT01022853|584023383|FG002|Overall Study|Progressive disease|11|||
161721290|NCT01022853|584023384|FG003|Overall Study|Progressive disease|7|||
161721291|NCT01022853|584023385|FG004|Overall Study|Progressive disease|1|||
161721292|NCT01022853|584023381|FG000|Overall Study|Dose-limiting toxicity|0|||
161721293|NCT01022853|584023382|FG001|Overall Study|Dose-limiting toxicity|0|||
161721294|NCT01022853|584023383|FG002|Overall Study|Dose-limiting toxicity|0|||
161721295|NCT01022853|584023384|FG003|Overall Study|Dose-limiting toxicity|0|||
161721296|NCT01022853|584023385|FG004|Overall Study|Dose-limiting toxicity|1|||
161721297|NCT01022853|584023381|FG000|Overall Study|Withdrawal by Subject|0|||
161721298|NCT01022853|584023382|FG001|Overall Study|Withdrawal by Subject|1|||
161721299|NCT01022853|584023383|FG002|Overall Study|Withdrawal by Subject|1|||
161721300|NCT01022853|584023384|FG003|Overall Study|Withdrawal by Subject|1|||
161721301|NCT01022853|584023385|FG004|Overall Study|Withdrawal by Subject|0|||
161721302|NCT01022853|584023381|FG000|Overall Study|Other not stated above|1|||
161721303|NCT01022853|584023382|FG001|Overall Study|Other not stated above|0|||
161721304|NCT01022853|584023383|FG002|Overall Study|Other not stated above|1|||
161721305|NCT01022853|584023384|FG003|Overall Study|Other not stated above|0|||
161721306|NCT01022853|584023385|FG004|Overall Study|Other not stated above|0|||
161721307|NCT02416908|584023386|FG000|Dose Escalation Phase|Adverse Event|0|||
161721308|NCT02416908|584023387|FG001|Dose Escalation Phase|Adverse Event|0|||
161721309|NCT02416908|584023388|FG002|Dose Escalation Phase|Adverse Event|3|||
161721310|NCT02416908|584023389|FG003|Dose Escalation Phase|Adverse Event|0|||
161721311|NCT02416908|584023386|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
161721312|NCT02416908|584023387|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
161721313|NCT02416908|584023388|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
161721314|NCT02416908|584023389|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161721315|NCT01651052|584023390|FG000|Overall Study|Death|21|||
161721316|NCT01651052|584023390|FG000|Overall Study|Explant|1|||
161721317|NCT01651052|584023390|FG000|Overall Study|Withdrawal by Subject|1|||
161721318|NCT01651052|584023390|FG000|Overall Study|Lost to Follow-up|3|||
161721319|NCT03503773|584023391|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
161721320|NCT03503773|584023392|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
161721321|NCT03503773|584023391|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
161721322|NCT03503773|584023392|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
161721323|NCT03503773|584023391|FG000|Overall Study|Not completing the primary ABPM|3|||
161721324|NCT03503773|584023392|FG001|Overall Study|Not completing the primary ABPM|1|||
161721325|NCT03503773|584023391|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161721326|NCT03503773|584023392|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161721327|NCT02285010|584023396|FG000|Overall Study|not abdominal hysterectomy|2|||
161721328|NCT02285010|584023397|FG001|Overall Study|not abdominal hysterectomy|0|||
161721329|NCT02285010|584023396|FG000|Overall Study|Not spinal anesthesia|3|||
161721330|NCT02285010|584023397|FG001|Overall Study|Not spinal anesthesia|1|||
161721331|NCT01478347|584023407|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
161964732|NCT04115748|584917727|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161964733|NCT04115748|584917728|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
161964734|NCT04115748|584917729|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
161964735|NCT03299881|584917730|FG000|Overall Study|Study Termination|17|||
161964736|NCT03299881|584917731|FG001|Overall Study|Study Termination|13|||
161964737|NCT02752633|584917732|FG000|Overall Study|Withdrawal by Subject|1|||
161964738|NCT00245050|584917736|FG000|Overall Study|Adverse Event|3|||
161964739|NCT00245050|584917737|FG001|Overall Study|Adverse Event|2|||
161964740|NCT00152477|584917740|FG000|Chemotherapy Period|Adverse Event|9|||
161964741|NCT00152477|584917741|FG001|Chemotherapy Period|Adverse Event|4|||
161964742|NCT00152477|584917742|FG002|Chemotherapy Period|Adverse Event|5|||
161964743|NCT00152477|584917740|FG000|Chemotherapy Period|Death|1|||
161964744|NCT00152477|584917741|FG001|Chemotherapy Period|Death|3|||
161964745|NCT00152477|584917742|FG002|Chemotherapy Period|Death|3|||
161964746|NCT00152477|584917740|FG000|Chemotherapy Period|Lack of Efficacy|4|||
161964747|NCT00152477|584917741|FG001|Chemotherapy Period|Lack of Efficacy|5|||
161721332|NCT01478347|584023407|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
161721333|NCT01478347|584023407|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
161721334|NCT01645930|584023408|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
161721335|NCT01645930|584023408|FG000|Overall Study|Progressive Disease|12|||
161721336|NCT01645930|584023408|FG000|Overall Study|Adverse Event|4|||
161721337|NCT01645930|584023408|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
161721338|NCT01645930|584023408|FG000|Overall Study|Withdrawal by Participant|2|||
161721339|NCT01645930|584023408|FG000|Overall Study|Reason not Defined|1|||
161721340|NCT03245814|584023411|FG000|Overall Study|Lost to Follow-up|5|||
161721341|NCT03245814|584023412|FG001|Overall Study|Lost to Follow-up|8|||
161721342|NCT03245814|584023411|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
161721343|NCT03245814|584023412|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
161721344|NCT01164501|584023414|FG000|Overall Study|Not treated|2|||
161721345|NCT01164501|584023415|FG001|Overall Study|Not treated|0|||
161721346|NCT01164501|584023416|FG002|Overall Study|Not treated|1|||
161721347|NCT01164501|584023414|FG000|Overall Study|Adverse Event|18|||
161721348|NCT01164501|584023415|FG001|Overall Study|Adverse Event|4|||
161721349|NCT01164501|584023416|FG002|Overall Study|Adverse Event|21|||
161721350|NCT01164501|584023414|FG000|Overall Study|Lack of Efficacy|0|||
161721351|NCT01164501|584023415|FG001|Overall Study|Lack of Efficacy|0|||
161721352|NCT01164501|584023416|FG002|Overall Study|Lack of Efficacy|1|||
161721353|NCT01164501|584023414|FG000|Overall Study|Non compliant with protocol|1|||
161721354|NCT01164501|584023415|FG001|Overall Study|Non compliant with protocol|1|||
161721355|NCT01164501|584023416|FG002|Overall Study|Non compliant with protocol|4|||
161721356|NCT01164501|584023414|FG000|Overall Study|Lost to Follow-up|3|||
161721357|NCT01164501|584023415|FG001|Overall Study|Lost to Follow-up|0|||
161721358|NCT01164501|584023416|FG002|Overall Study|Lost to Follow-up|3|||
161721359|NCT01164501|584023414|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
161721360|NCT01164501|584023415|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
161721361|NCT01164501|584023416|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
161721362|NCT01164501|584023414|FG000|Overall Study|Other reason not defined above|9|||
161721363|NCT01164501|584023415|FG001|Overall Study|Other reason not defined above|1|||
161721364|NCT01164501|584023416|FG002|Overall Study|Other reason not defined above|4|||
161721365|NCT01096667|584023417|FG000|Overall Study|Lost to Follow-up|1|||
161964748|NCT00152477|584917742|FG002|Chemotherapy Period|Lack of Efficacy|6|||
161721366|NCT01096667|584023418|FG001|Overall Study|Lost to Follow-up|1|||
161721367|NCT01096667|584023419|FG002|Overall Study|Lost to Follow-up|1|||
161721368|NCT01096667|584023420|FG003|Overall Study|Lost to Follow-up|0|||
161721369|NCT01096667|584023421|FG004|Overall Study|Lost to Follow-up|0|||
161721370|NCT01096667|584023417|FG000|Overall Study|Withdrawal by Subject|1|||
161721371|NCT01096667|584023418|FG001|Overall Study|Withdrawal by Subject|0|||
161721372|NCT01096667|584023419|FG002|Overall Study|Withdrawal by Subject|0|||
161964749|NCT00152477|584917740|FG000|Chemotherapy Period|Lost to Follow-up|1|||
161964750|NCT00152477|584917741|FG001|Chemotherapy Period|Lost to Follow-up|0|||
161964751|NCT00152477|584917742|FG002|Chemotherapy Period|Lost to Follow-up|1|||
161721373|NCT01096667|584023420|FG003|Overall Study|Withdrawal by Subject|1|||
161721374|NCT01096667|584023421|FG004|Overall Study|Withdrawal by Subject|0|||
161721375|NCT01096667|584023417|FG000|Overall Study|Reason not available|0|||
161721376|NCT01096667|584023418|FG001|Overall Study|Reason not available|1|||
161721377|NCT01096667|584023419|FG002|Overall Study|Reason not available|1|||
161964752|NCT00152477|584917740|FG000|Chemotherapy Period|Protocol Violation|1|||
161964753|NCT00152477|584917741|FG001|Chemotherapy Period|Protocol Violation|1|||
161964754|NCT00152477|584917742|FG002|Chemotherapy Period|Protocol Violation|0|||
161721378|NCT01096667|584023420|FG003|Overall Study|Reason not available|1|||
161721379|NCT01096667|584023421|FG004|Overall Study|Reason not available|0|||
161721380|NCT01096667|584023417|FG000|Overall Study|Protocol Violation|0|||
161721381|NCT01096667|584023418|FG001|Overall Study|Protocol Violation|0|||
161721382|NCT01096667|584023419|FG002|Overall Study|Protocol Violation|0|||
161721383|NCT01096667|584023420|FG003|Overall Study|Protocol Violation|1|||
161721384|NCT01096667|584023421|FG004|Overall Study|Protocol Violation|0|||
161721385|NCT01096667|584023417|FG000|Overall Study|Not treated|1|||
161721386|NCT01096667|584023418|FG001|Overall Study|Not treated|0|||
161721387|NCT01096667|584023419|FG002|Overall Study|Not treated|0|||
161721388|NCT01096667|584023420|FG003|Overall Study|Not treated|0|||
161721389|NCT01096667|584023421|FG004|Overall Study|Not treated|0|||
161721390|NCT02263365|584023425|FG000|Overall Study|Physician Decision|22|||
161721391|NCT02263365|584023426|FG001|Overall Study|Physician Decision|18|||
161721392|NCT01845077|584023427|FG000|Washout Period|Lost to Follow-up|0|||
161721393|NCT01845077|584023428|FG001|Washout Period|Lost to Follow-up|1|||
161721394|NCT01845077|584023429|FG002|Washout Period|Lost to Follow-up|0|||
161721395|NCT01845077|584023430|FG003|Washout Period|Lost to Follow-up|1|||
161721396|NCT01845077|584023431|FG004|Washout Period|Lost to Follow-up|0|||
161721397|NCT01845077|584023432|FG005|Washout Period|Lost to Follow-up|1|||
161721398|NCT01845077|584023427|FG000|Washout Period|Adverse Event|1|||
161721399|NCT01845077|584023428|FG001|Washout Period|Adverse Event|0|||
161721400|NCT01845077|584023429|FG002|Washout Period|Adverse Event|0|||
161721401|NCT01845077|584023430|FG003|Washout Period|Adverse Event|0|||
161721402|NCT01845077|584023431|FG004|Washout Period|Adverse Event|0|||
161721403|NCT01845077|584023432|FG005|Washout Period|Adverse Event|0|||
161721404|NCT01845077|584023427|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
161721405|NCT01845077|584023428|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
161721406|NCT01845077|584023429|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
161721407|NCT01845077|584023430|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
161721408|NCT01845077|584023431|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
161721409|NCT01845077|584023432|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
161721410|NCT01845077|584023427|FG000|Washout Period|Protocol Violation|0|||
161721411|NCT01845077|584023428|FG001|Washout Period|Protocol Violation|0|||
161721412|NCT01845077|584023429|FG002|Washout Period|Protocol Violation|0|||
161721413|NCT01845077|584023430|FG003|Washout Period|Protocol Violation|1|||
161721414|NCT01845077|584023431|FG004|Washout Period|Protocol Violation|1|||
161721415|NCT01845077|584023432|FG005|Washout Period|Protocol Violation|0|||
161721416|NCT00312377|584023435|FG000|Overall Study|Death|403|||
161721417|NCT00312377|584023436|FG001|Overall Study|Death|418|||
161721418|NCT00312377|584023435|FG000|Overall Study|Withdrawal by Subject|23|||
161721419|NCT00312377|584023436|FG001|Overall Study|Withdrawal by Subject|30|||
161721420|NCT00312377|584023435|FG000|Overall Study|Lost to Follow-up|9|||
161721421|NCT00312377|584023436|FG001|Overall Study|Lost to Follow-up|12|||
161721422|NCT00312377|584023435|FG000|Overall Study|Non-compliance|0|||
161721423|NCT00312377|584023436|FG001|Overall Study|Non-compliance|2|||
161721424|NCT00312377|584023435|FG000|Overall Study|Randomised but never received treatment|6|||
161721425|NCT00312377|584023436|FG001|Overall Study|Randomised but never received treatment|6|||
161721426|NCT00312377|584023435|FG000|Overall Study|Discontinue treatment survival follow up|202|||
161721427|NCT00312377|584023436|FG001|Overall Study|Discontinue treatment survival follow up|200|||
161721428|NCT00312377|584023435|FG000|Overall Study|Site ended participation in study|1|||
161721429|NCT00312377|584023436|FG001|Overall Study|Site ended participation in study|0|||
161721430|NCT01001494|584023444|FG000|Overall Study|Adverse Event|8|||
161721431|NCT01001494|584023445|FG001|Overall Study|Adverse Event|4|||
161721432|NCT01001494|584023446|FG002|Overall Study|Adverse Event|6|||
161721433|NCT01001494|584023444|FG000|Overall Study|Protocol Violation|0|||
161721434|NCT01001494|584023445|FG001|Overall Study|Protocol Violation|1|||
161721435|NCT01001494|584023446|FG002|Overall Study|Protocol Violation|1|||
161721436|NCT01001494|584023444|FG000|Overall Study|Lost to Follow-up|2|||
161721437|NCT01001494|584023445|FG001|Overall Study|Lost to Follow-up|0|||
161721438|NCT01001494|584023446|FG002|Overall Study|Lost to Follow-up|1|||
161721439|NCT01001494|584023444|FG000|Overall Study|Withdrawal by Subject|9|||
161721440|NCT01001494|584023445|FG001|Overall Study|Withdrawal by Subject|7|||
161721441|NCT01001494|584023446|FG002|Overall Study|Withdrawal by Subject|17|||
161721442|NCT01001494|584023444|FG000|Overall Study|COPD exacerbation|3|||
161721443|NCT01001494|584023445|FG001|Overall Study|COPD exacerbation|4|||
161721444|NCT01001494|584023446|FG002|Overall Study|COPD exacerbation|5|||
161721445|NCT01001494|584023444|FG000|Overall Study|Lack of Efficacy|2|||
161721446|NCT01001494|584023445|FG001|Overall Study|Lack of Efficacy|0|||
161721447|NCT01001494|584023446|FG002|Overall Study|Lack of Efficacy|8|||
161721448|NCT01001494|584023444|FG000|Overall Study|Other|0|||
161721449|NCT01001494|584023445|FG001|Overall Study|Other|1|||
161721450|NCT01001494|584023446|FG002|Overall Study|Other|3|||
161721451|NCT02179398|584023447|FG000|Overall Study|Lack of obligatory data|3|||
161721452|NCT02179398|584023448|FG001|Overall Study|Lack of obligatory data|3|||
161721453|NCT02179398|584023447|FG000|Overall Study|Lost to Follow-up|0|||
161721454|NCT02179398|584023448|FG001|Overall Study|Lost to Follow-up|1|||
161721455|NCT00408681|584023452|FG000|Overall Study|Lack of Efficacy|2|||
161721456|NCT00408681|584023452|FG000|Overall Study|Adverse Event|7|||
161964755|NCT00152477|584917740|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
161964756|NCT00152477|584917741|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
161964757|NCT00152477|584917742|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
161964758|NCT00152477|584917740|FG000|Chemotherapy Period|Progression of Disease|6|||
161964759|NCT00152477|584917741|FG001|Chemotherapy Period|Progression of Disease|8|||
161964760|NCT00152477|584917742|FG002|Chemotherapy Period|Progression of Disease|4|||
161964761|NCT00152477|584917740|FG000|Chemotherapy Period|Investigator decision|0|||
161964762|NCT00152477|584917741|FG001|Chemotherapy Period|Investigator decision|0|||
161964763|NCT00152477|584917742|FG002|Chemotherapy Period|Investigator decision|1|||
161964764|NCT00152477|584917740|FG000|Chemotherapy Period|Patient condition worsened|1|||
161964765|NCT00152477|584917741|FG001|Chemotherapy Period|Patient condition worsened|0|||
161964766|NCT00152477|584917742|FG002|Chemotherapy Period|Patient condition worsened|0|||
161964767|NCT00152477|584917740|FG000|Monotherapy Period|Adverse Event|1|||
161964768|NCT00152477|584917741|FG001|Monotherapy Period|Adverse Event|0|||
161964769|NCT00152477|584917742|FG002|Monotherapy Period|Adverse Event|5|||
161964770|NCT00152477|584917740|FG000|Monotherapy Period|Death|2|||
161964771|NCT00152477|584917741|FG001|Monotherapy Period|Death|0|||
161964772|NCT00152477|584917742|FG002|Monotherapy Period|Death|1|||
161964773|NCT00152477|584917740|FG000|Monotherapy Period|Lack of Efficacy|7|||
161964774|NCT00152477|584917741|FG001|Monotherapy Period|Lack of Efficacy|16|||
161964775|NCT00152477|584917742|FG002|Monotherapy Period|Lack of Efficacy|10|||
161964776|NCT00152477|584917740|FG000|Monotherapy Period|Protocol Violation|0|||
161964777|NCT00152477|584917741|FG001|Monotherapy Period|Protocol Violation|1|||
161964778|NCT00152477|584917742|FG002|Monotherapy Period|Protocol Violation|0|||
161964779|NCT00152477|584917740|FG000|Monotherapy Period|Withdrawal by Subject|0|||
161964780|NCT00152477|584917741|FG001|Monotherapy Period|Withdrawal by Subject|0|||
161964781|NCT00152477|584917742|FG002|Monotherapy Period|Withdrawal by Subject|4|||
161964782|NCT00152477|584917740|FG000|Monotherapy Period|Progression of Disease|5|||
161964783|NCT00152477|584917741|FG001|Monotherapy Period|Progression of Disease|11|||
161964784|NCT00152477|584917742|FG002|Monotherapy Period|Progression of Disease|12|||
161964785|NCT00152477|584917740|FG000|Monotherapy Period|Patient decision|0|||
161964786|NCT00152477|584917741|FG001|Monotherapy Period|Patient decision|1|||
161964787|NCT00152477|584917742|FG002|Monotherapy Period|Patient decision|1|||
161964788|NCT00152477|584917740|FG000|Monotherapy Period|Study personel decision|0|||
161964789|NCT00152477|584917741|FG001|Monotherapy Period|Study personel decision|0|||
161964790|NCT00152477|584917742|FG002|Monotherapy Period|Study personel decision|1|||
161964791|NCT03275246|584917745|FG000|Overall Study|Protocol Violation|5|||
161964792|NCT03275246|584917745|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
161964793|NCT00730041|584917746|FG000|Overall Study|Lost to Follow-up|0|||
161964794|NCT00730041|584917747|FG001|Overall Study|Lost to Follow-up|2|||
161964795|NCT02301546|584917750|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
161964796|NCT02301546|584917751|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
161721457|NCT01787591|584023457|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
161721458|NCT01787591|584023458|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
161721459|NCT01787591|584023459|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
161721460|NCT01787591|584023460|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
161721461|NCT02489630|584023463|FG000|Overall Study|Oversedation|1|||
161721462|NCT02489630|584023464|FG001|Overall Study|Oversedation|1|||
161721463|NCT02489630|584023463|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
161721464|NCT02489630|584023464|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
161721465|NCT02975349|584023468|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161721466|NCT02975349|584023469|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161721467|NCT02975349|584023470|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161721468|NCT02975349|584023471|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161721469|NCT02975349|584023472|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161721470|NCT02975349|584023473|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161721471|NCT02975349|584023474|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161721472|NCT02975349|584023468|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161721473|NCT02975349|584023469|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161964797|NCT02301546|584917750|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
161964798|NCT02301546|584917751|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
161964799|NCT02301546|584917750|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
161964800|NCT02301546|584917751|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
161964801|NCT02301546|584917750|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
161964802|NCT02301546|584917751|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
161964803|NCT02301546|584917750|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
161964804|NCT02301546|584917751|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
161964805|NCT02301546|584917750|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
161964806|NCT02301546|584917751|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
161964807|NCT02301546|584917750|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
161964808|NCT02301546|584917751|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
161721474|NCT02975349|584023470|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161721475|NCT02975349|584023471|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161721476|NCT02975349|584023472|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161721477|NCT02975349|584023473|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161721478|NCT02975349|584023474|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161721479|NCT02975349|584023468|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
161721480|NCT02975349|584023469|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
161721481|NCT02975349|584023470|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
161721482|NCT02975349|584023471|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
161721483|NCT02975349|584023472|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
161721484|NCT02975349|584023473|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
161721485|NCT02975349|584023474|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
161721486|NCT02975349|584023468|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
161721487|NCT02975349|584023469|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
161721488|NCT02975349|584023470|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
161721489|NCT02975349|584023471|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
161721490|NCT02975349|584023472|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
161721491|NCT02975349|584023473|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
161721492|NCT02975349|584023474|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
161721493|NCT02975349|584023468|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
161721494|NCT02975349|584023469|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
161721495|NCT02975349|584023470|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
161721496|NCT02975349|584023471|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
161721497|NCT02975349|584023472|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
161721498|NCT02975349|584023473|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
161721499|NCT02975349|584023474|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
161721500|NCT02975349|584023468|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161721501|NCT02975349|584023469|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161721502|NCT02975349|584023470|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161721503|NCT02975349|584023471|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
161721504|NCT02975349|584023472|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161721505|NCT02975349|584023473|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161721506|NCT02975349|584023474|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161721507|NCT02975349|584023468|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161721508|NCT02975349|584023469|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
161721509|NCT02975349|584023470|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161721510|NCT02975349|584023471|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161721511|NCT02975349|584023472|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161721512|NCT02975349|584023473|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161721513|NCT02975349|584023474|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161721514|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
161721515|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
161721516|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
161721517|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
161721518|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
161721519|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
161721520|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
161721521|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161721522|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161721523|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161721524|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161721525|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
161721526|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161721527|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161721528|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161721529|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161721530|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161721531|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161721532|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
161721533|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161721534|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
161721535|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
161721536|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
161721537|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
161721538|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
161721539|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
161721540|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
161721541|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
161721542|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
161721543|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
161721544|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
161721545|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
161721546|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
161721547|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
161721548|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
161721549|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161721550|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161721551|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
161721552|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161721553|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161721554|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
161721555|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161721556|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
161721557|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
161721558|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
161721559|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
161721560|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
161721561|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
161721562|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
161721563|NCT02975349|584023468|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
161721564|NCT02975349|584023469|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
161721565|NCT02975349|584023470|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
161721566|NCT02975349|584023471|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
161721567|NCT02975349|584023472|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
161721568|NCT02975349|584023473|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
161721569|NCT02975349|584023474|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
161721570|NCT03270085|584025070|FG000|Overall Study|Withdrawal by Subject|1|||
161721571|NCT03270085|584025071|FG001|Overall Study|Withdrawal by Subject|0|||
161721572|NCT03825042|584025072|FG000|Overall Study|Adverse Event|1|||
161721573|NCT03825042|584025073|FG001|Overall Study|Adverse Event|0|||
161721574|NCT03825042|584025072|FG000|Overall Study|Withdrawal by Subject|1|||
161721575|NCT03825042|584025073|FG001|Overall Study|Withdrawal by Subject|0|||
161721576|NCT00521339|584025076|FG000|Treatment Phase|Adverse Event|2|||
161721577|NCT00521339|584025077|FG001|Treatment Phase|Adverse Event|0|||
161721578|NCT00521339|584025078|FG002|Treatment Phase|Adverse Event|0|||
161721579|NCT00521339|584025076|FG000|Treatment Phase|Intolerability to study drug|2|||
161721580|NCT00521339|584025077|FG001|Treatment Phase|Intolerability to study drug|0|||
161721581|NCT00521339|584025078|FG002|Treatment Phase|Intolerability to study drug|0|||
161721582|NCT00521339|584025076|FG000|Treatment Phase|Lack of Efficacy|3|||
161721583|NCT00521339|584025077|FG001|Treatment Phase|Lack of Efficacy|0|||
161721584|NCT00521339|584025078|FG002|Treatment Phase|Lack of Efficacy|0|||
161721585|NCT00521339|584025076|FG000|Treatment Phase|Withdrawal by Subject|3|||
161721586|NCT00521339|584025077|FG001|Treatment Phase|Withdrawal by Subject|0|||
161721587|NCT00521339|584025078|FG002|Treatment Phase|Withdrawal by Subject|0|||
161721588|NCT00521339|584025076|FG000|Treatment Phase|Lost to Follow-up|1|||
161721589|NCT00521339|584025077|FG001|Treatment Phase|Lost to Follow-up|0|||
161721590|NCT00521339|584025078|FG002|Treatment Phase|Lost to Follow-up|0|||
161721591|NCT00521339|584025076|FG000|Treatment Phase|Protocol Violation|1|||
161721592|NCT00521339|584025077|FG001|Treatment Phase|Protocol Violation|0|||
161721593|NCT00521339|584025078|FG002|Treatment Phase|Protocol Violation|0|||
161721594|NCT00521339|584025076|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
161721595|NCT00521339|584025077|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
161721596|NCT00521339|584025078|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
161721597|NCT00521339|584025076|FG000|Treatment Extension Phase|Death|0|||
161964809|NCT00433966|584917752|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
161721598|NCT00521339|584025077|FG001|Treatment Extension Phase|Death|0|||
161721599|NCT00521339|584025078|FG002|Treatment Extension Phase|Death|1|||
161721600|NCT03314519|584025079|FG000|Overall Study|Protocol Violation|3|||
161721601|NCT03314519|584025080|FG001|Overall Study|Protocol Violation|2|||
161721602|NCT04003155|584025083|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
161721603|NCT04003155|584025084|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
161721604|NCT04003155|584025085|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
161964810|NCT00433966|584917753|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
161721605|NCT04003155|584025086|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
161721606|NCT04003155|584025087|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
161721607|NCT04003155|584025083|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
161721608|NCT04003155|584025084|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
161721609|NCT04003155|584025085|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
161721610|NCT04003155|584025086|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
161721611|NCT04003155|584025087|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
161721612|NCT04003155|584025083|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
161721613|NCT04003155|584025084|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
161721614|NCT04003155|584025085|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
161721615|NCT04003155|584025086|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
161721616|NCT04003155|584025087|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
161721617|NCT04003155|584025083|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
161721618|NCT04003155|584025084|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
161721619|NCT04003155|584025085|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
161721620|NCT04003155|584025086|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
161721621|NCT04003155|584025087|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
161964811|NCT00433966|584917754|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
161964812|NCT00433966|584917755|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
161964813|NCT00433966|584917752|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
161964814|NCT00433966|584917753|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
161964815|NCT00433966|584917754|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
161964816|NCT00433966|584917755|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
161964817|NCT00433966|584917752|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
161964818|NCT00433966|584917753|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
161964819|NCT00433966|584917754|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
161964820|NCT00433966|584917755|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
161964821|NCT00433966|584917752|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
161964822|NCT00433966|584917753|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
161964823|NCT00433966|584917754|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
161964824|NCT00433966|584917755|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
161964825|NCT00433966|584917752|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
161964826|NCT00433966|584917753|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
161964827|NCT00433966|584917754|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
161964828|NCT00433966|584917755|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
161964829|NCT01296711|584917756|FG000|Overall Study|Adverse Event|3|||
161964830|NCT01296711|584917757|FG001|Overall Study|Adverse Event|1|||
161721622|NCT04003155|584025083|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
161721623|NCT04003155|584025084|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
161721624|NCT04003155|584025085|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
161964831|NCT01296711|584917758|FG002|Overall Study|Adverse Event|4|||
161964832|NCT01296711|584917759|FG003|Overall Study|Adverse Event|3|||
161964833|NCT01296711|584917760|FG004|Overall Study|Adverse Event|1|||
161964834|NCT01296711|584917761|FG005|Overall Study|Adverse Event|6|||
161964835|NCT01296711|584917762|FG006|Overall Study|Adverse Event|11|||
161964836|NCT01296711|584917763|FG007|Overall Study|Adverse Event|3|||
161964837|NCT01296711|584917756|FG000|Overall Study|Lack of Efficacy|1|||
161964838|NCT01296711|584917757|FG001|Overall Study|Lack of Efficacy|4|||
161964839|NCT01296711|584917758|FG002|Overall Study|Lack of Efficacy|1|||
161964840|NCT01296711|584917759|FG003|Overall Study|Lack of Efficacy|1|||
161964841|NCT01296711|584917760|FG004|Overall Study|Lack of Efficacy|1|||
161964842|NCT01296711|584917761|FG005|Overall Study|Lack of Efficacy|0|||
161964843|NCT01296711|584917762|FG006|Overall Study|Lack of Efficacy|2|||
161964844|NCT01296711|584917763|FG007|Overall Study|Lack of Efficacy|3|||
161964845|NCT01296711|584917756|FG000|Overall Study|Lost to Follow-up|0|||
161964846|NCT01296711|584917757|FG001|Overall Study|Lost to Follow-up|0|||
161964847|NCT01296711|584917758|FG002|Overall Study|Lost to Follow-up|1|||
161964848|NCT01296711|584917759|FG003|Overall Study|Lost to Follow-up|1|||
161964849|NCT01296711|584917760|FG004|Overall Study|Lost to Follow-up|2|||
161964850|NCT01296711|584917761|FG005|Overall Study|Lost to Follow-up|0|||
161964851|NCT01296711|584917762|FG006|Overall Study|Lost to Follow-up|4|||
161964852|NCT01296711|584917763|FG007|Overall Study|Lost to Follow-up|2|||
161721625|NCT04003155|584025086|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
161721626|NCT04003155|584025087|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
161964853|NCT01296711|584917756|FG000|Overall Study|Protocol Violation|0|||
161964854|NCT01296711|584917757|FG001|Overall Study|Protocol Violation|0|||
161964855|NCT01296711|584917758|FG002|Overall Study|Protocol Violation|0|||
161721627|NCT04003155|584025083|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
161964856|NCT01296711|584917759|FG003|Overall Study|Protocol Violation|1|||
161964857|NCT01296711|584917760|FG004|Overall Study|Protocol Violation|1|||
161964858|NCT01296711|584917761|FG005|Overall Study|Protocol Violation|0|||
161964859|NCT01296711|584917762|FG006|Overall Study|Protocol Violation|0|||
161964860|NCT01296711|584917763|FG007|Overall Study|Protocol Violation|0|||
161964861|NCT01296711|584917756|FG000|Overall Study|Withdrawal by Subject|4|||
161964862|NCT01296711|584917757|FG001|Overall Study|Withdrawal by Subject|2|||
161721628|NCT04003155|584025084|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
161721629|NCT04003155|584025085|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
161721630|NCT04003155|584025086|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
161721631|NCT04003155|584025087|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
161721632|NCT04003155|584025083|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
161721633|NCT04003155|584025084|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
161721634|NCT04003155|584025085|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
161721635|NCT04003155|584025086|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
161721636|NCT04003155|584025087|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
161721637|NCT04003155|584025083|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
161721638|NCT04003155|584025084|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
161721639|NCT04003155|584025085|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
161721640|NCT04003155|584025086|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
161721641|NCT04003155|584025087|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
161721642|NCT04003155|584025083|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
161721643|NCT04003155|584025084|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
161721644|NCT04003155|584025085|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
161721645|NCT04003155|584025086|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
161721646|NCT04003155|584025087|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
161721647|NCT01912872|584025088|FG000|Overall Study|Lost to Follow-up|2|||
161721648|NCT01912872|584025089|FG001|Overall Study|Lost to Follow-up|3|||
161721649|NCT01912872|584025090|FG002|Overall Study|Lost to Follow-up|5|||
161721650|NCT01912872|584025091|FG003|Overall Study|Lost to Follow-up|5|||
161721651|NCT01912872|584025088|FG000|Overall Study|Other unspecified|3|||
161721652|NCT01912872|584025089|FG001|Overall Study|Other unspecified|1|||
161721653|NCT01912872|584025090|FG002|Overall Study|Other unspecified|3|||
161721654|NCT01912872|584025091|FG003|Overall Study|Other unspecified|0|||
161721655|NCT01912872|584025088|FG000|Overall Study|Informed consent withdrawn|0|||
161721656|NCT01912872|584025089|FG001|Overall Study|Informed consent withdrawn|0|||
161721657|NCT01912872|584025090|FG002|Overall Study|Informed consent withdrawn|1|||
161721658|NCT01912872|584025091|FG003|Overall Study|Informed consent withdrawn|1|||
161721659|NCT01912872|584025088|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
161721660|NCT01912872|584025089|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
161721661|NCT01912872|584025090|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
161721662|NCT01912872|584025091|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
161721663|NCT01912872|584025088|FG000|Overall Study|Protocol Violation|0|||
161721664|NCT01912872|584025089|FG001|Overall Study|Protocol Violation|0|||
161721665|NCT01912872|584025090|FG002|Overall Study|Protocol Violation|1|||
161721666|NCT01912872|584025091|FG003|Overall Study|Protocol Violation|0|||
161721667|NCT01912872|584025088|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161721668|NCT01912872|584025089|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161721669|NCT01912872|584025090|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161721670|NCT01912872|584025091|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
161721671|NCT01912872|584025088|FG000|Overall Study|Withdrawal of study medication|0|||
161721672|NCT01912872|584025089|FG001|Overall Study|Withdrawal of study medication|0|||
161964863|NCT01296711|584917758|FG002|Overall Study|Withdrawal by Subject|2|||
161964864|NCT01296711|584917759|FG003|Overall Study|Withdrawal by Subject|1|||
161964865|NCT01296711|584917760|FG004|Overall Study|Withdrawal by Subject|1|||
161964866|NCT01296711|584917761|FG005|Overall Study|Withdrawal by Subject|1|||
161964867|NCT01296711|584917762|FG006|Overall Study|Withdrawal by Subject|2|||
161964868|NCT01296711|584917763|FG007|Overall Study|Withdrawal by Subject|1|||
161964869|NCT01296711|584917756|FG000|Overall Study|Study termination|8|||
161964870|NCT01296711|584917757|FG001|Overall Study|Study termination|1|||
161964871|NCT01296711|584917758|FG002|Overall Study|Study termination|5|||
161964872|NCT01296711|584917759|FG003|Overall Study|Study termination|4|||
161964873|NCT01296711|584917760|FG004|Overall Study|Study termination|4|||
161964874|NCT01296711|584917761|FG005|Overall Study|Study termination|4|||
161964875|NCT01296711|584917762|FG006|Overall Study|Study termination|8|||
161964876|NCT01296711|584917763|FG007|Overall Study|Study termination|10|||
161964877|NCT01296711|584917756|FG000|Overall Study|Continued elevated liver enzymes|0|||
161964878|NCT01296711|584917757|FG001|Overall Study|Continued elevated liver enzymes|0|||
161721673|NCT01912872|584025090|FG002|Overall Study|Withdrawal of study medication|0|||
161721674|NCT01912872|584025091|FG003|Overall Study|Withdrawal of study medication|2|||
161964879|NCT01296711|584917758|FG002|Overall Study|Continued elevated liver enzymes|0|||
161964880|NCT01296711|584917759|FG003|Overall Study|Continued elevated liver enzymes|1|||
161964881|NCT01296711|584917760|FG004|Overall Study|Continued elevated liver enzymes|0|||
161964882|NCT01296711|584917761|FG005|Overall Study|Continued elevated liver enzymes|0|||
161964883|NCT01296711|584917762|FG006|Overall Study|Continued elevated liver enzymes|0|||
161721675|NCT01912872|584025088|FG000|Overall Study|Missing|0|||
161721676|NCT01912872|584025089|FG001|Overall Study|Missing|0|||
161721677|NCT01912872|584025090|FG002|Overall Study|Missing|0|||
161721678|NCT01912872|584025091|FG003|Overall Study|Missing|1|||
161964884|NCT01296711|584917763|FG007|Overall Study|Continued elevated liver enzymes|0|||
161721679|NCT01277289|584025093|FG000|Overall Study|fragile vein|1|||
161721680|NCT01277289|584025094|FG001|Overall Study|fragile vein|0|||
161721681|NCT01277289|584025093|FG000|Overall Study|Physician Decision|1|||
161721682|NCT01277289|584025094|FG001|Overall Study|Physician Decision|0|||
161721683|NCT01277289|584025093|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
161721684|NCT01277289|584025094|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
161721685|NCT01277289|584025093|FG000|Overall Study|Protocol Violation|1|||
161721686|NCT01277289|584025094|FG001|Overall Study|Protocol Violation|1|||
161721687|NCT01277289|584025093|FG000|Overall Study|Adverse Event|2|||
161721688|NCT01277289|584025094|FG001|Overall Study|Adverse Event|1|||
161721689|NCT01277289|584025093|FG000|Overall Study|consent withdrawn|1|||
161721690|NCT01277289|584025094|FG001|Overall Study|consent withdrawn|1|||
161721691|NCT01277289|584025093|FG000|Overall Study|premature closure of the study|4|||
161721692|NCT01277289|584025094|FG001|Overall Study|premature closure of the study|2|||
161721693|NCT04760314|584025097|FG000|Induction Period|Withdrawal by Subject|0|||
161721694|NCT04760314|584025098|FG001|Induction Period|Withdrawal by Subject|1|||
161721695|NCT04760314|584025099|FG002|Induction Period|Withdrawal by Subject|1|||
161721696|NCT04760314|584025100|FG003|Induction Period|Withdrawal by Subject|0|||
161721697|NCT04760314|584025101|FG004|Induction Period|Withdrawal by Subject|0|||
161721698|NCT04760314|584025102|FG005|Induction Period|Withdrawal by Subject|0|||
161721699|NCT04760314|584025103|FG006|Induction Period|Withdrawal by Subject|0|||
161721700|NCT04760314|584025104|FG007|Induction Period|Withdrawal by Subject|0|||
161721701|NCT04760314|584025105|FG008|Induction Period|Withdrawal by Subject|0|||
161721702|NCT04760314|584025106|FG009|Induction Period|Withdrawal by Subject|0|||
161721703|NCT04760314|584025107|FG010|Induction Period|Withdrawal by Subject|0|||
161721704|NCT04760314|584025097|FG000|Induction Period|Adverse Event|0|||
161721705|NCT04760314|584025098|FG001|Induction Period|Adverse Event|0|||
161721706|NCT04760314|584025099|FG002|Induction Period|Adverse Event|2|||
161721707|NCT04760314|584025100|FG003|Induction Period|Adverse Event|0|||
161721708|NCT04760314|584025101|FG004|Induction Period|Adverse Event|0|||
161721709|NCT04760314|584025102|FG005|Induction Period|Adverse Event|0|||
161721710|NCT04760314|584025103|FG006|Induction Period|Adverse Event|0|||
161721711|NCT04760314|584025104|FG007|Induction Period|Adverse Event|0|||
161721712|NCT04760314|584025105|FG008|Induction Period|Adverse Event|0|||
161721713|NCT04760314|584025106|FG009|Induction Period|Adverse Event|0|||
161721714|NCT04760314|584025107|FG010|Induction Period|Adverse Event|0|||
161721715|NCT04760314|584025097|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721716|NCT04760314|584025098|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721717|NCT04760314|584025099|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721718|NCT04760314|584025100|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
161721719|NCT04760314|584025101|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
161721720|NCT04760314|584025102|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
161721721|NCT04760314|584025103|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
161721722|NCT04760314|584025104|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721723|NCT04760314|584025105|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721724|NCT04760314|584025106|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721725|NCT04760314|584025107|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
161721726|NCT04760314|584025097|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721727|NCT04760314|584025098|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721728|NCT04760314|584025099|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721729|NCT04760314|584025100|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
161721730|NCT04760314|584025101|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721731|NCT04760314|584025102|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
161721732|NCT04760314|584025103|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
161721733|NCT04760314|584025104|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161964885|NCT01296711|584917756|FG000|Overall Study|Methotrexate discontinued|0|||
161964886|NCT01296711|584917757|FG001|Overall Study|Methotrexate discontinued|0|||
161964887|NCT01296711|584917758|FG002|Overall Study|Methotrexate discontinued|0|||
161964888|NCT01296711|584917759|FG003|Overall Study|Methotrexate discontinued|1|||
161964889|NCT01296711|584917760|FG004|Overall Study|Methotrexate discontinued|0|||
161964890|NCT01296711|584917761|FG005|Overall Study|Methotrexate discontinued|0|||
161721734|NCT04760314|584025105|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721735|NCT04760314|584025106|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721736|NCT04760314|584025107|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161721737|NCT04760314|584025097|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721738|NCT04760314|584025098|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721739|NCT04760314|584025099|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721740|NCT04760314|584025100|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721741|NCT04760314|584025101|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
161721742|NCT04760314|584025102|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721743|NCT04760314|584025103|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721744|NCT04760314|584025104|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161964891|NCT01296711|584917762|FG006|Overall Study|Methotrexate discontinued|0|||
161721745|NCT04760314|584025105|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721746|NCT04760314|584025106|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721747|NCT04760314|584025107|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161721748|NCT04760314|584025097|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
161721749|NCT04760314|584025098|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
161721750|NCT04760314|584025099|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
161721751|NCT04760314|584025100|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
161721752|NCT04760314|584025101|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
161721753|NCT04760314|584025102|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
161721754|NCT04760314|584025103|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
161721755|NCT04760314|584025104|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
161721756|NCT04760314|584025105|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
161721757|NCT04760314|584025106|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
161721758|NCT04760314|584025107|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
161721759|NCT04760314|584025097|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721760|NCT04760314|584025098|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721761|NCT04760314|584025099|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721762|NCT04760314|584025100|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721763|NCT04760314|584025101|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161964892|NCT01296711|584917763|FG007|Overall Study|Methotrexate discontinued|0|||
161721764|NCT04760314|584025102|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721765|NCT04760314|584025103|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721766|NCT04760314|584025104|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
161721767|NCT04760314|584025105|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161721768|NCT04760314|584025106|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
161964893|NCT01296711|584917756|FG000|Overall Study|Investigator discretion|0|||
161964894|NCT01296711|584917757|FG001|Overall Study|Investigator discretion|0|||
161964895|NCT01296711|584917758|FG002|Overall Study|Investigator discretion|0|||
161964896|NCT01296711|584917759|FG003|Overall Study|Investigator discretion|0|||
161964897|NCT01296711|584917760|FG004|Overall Study|Investigator discretion|0|||
161964898|NCT01296711|584917761|FG005|Overall Study|Investigator discretion|0|||
161964899|NCT01296711|584917762|FG006|Overall Study|Investigator discretion|1|||
161721769|NCT04760314|584025107|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
161721770|NCT04760314|584025097|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721771|NCT04760314|584025098|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721772|NCT04760314|584025099|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721773|NCT04760314|584025100|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721774|NCT04760314|584025101|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721775|NCT04760314|584025102|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721776|NCT04760314|584025103|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721777|NCT04760314|584025104|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
161721778|NCT04760314|584025105|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
161721779|NCT04760314|584025106|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
161721780|NCT04760314|584025107|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161721781|NCT04760314|584025097|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721782|NCT04760314|584025098|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721783|NCT04760314|584025099|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721784|NCT04760314|584025100|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721785|NCT04760314|584025101|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721786|NCT04760314|584025102|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721787|NCT04760314|584025103|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721788|NCT04760314|584025104|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
161721789|NCT04760314|584025105|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721790|NCT04760314|584025106|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721791|NCT04760314|584025107|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161721792|NCT04760314|584025097|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721793|NCT04760314|584025098|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721794|NCT04760314|584025099|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
162032151|NCT00814801|585174219|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
161721795|NCT04760314|584025100|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721796|NCT04760314|584025101|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721797|NCT04760314|584025102|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721798|NCT04760314|584025103|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721799|NCT04760314|584025104|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721800|NCT04760314|584025105|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
161964900|NCT01296711|584917763|FG007|Overall Study|Investigator discretion|0|||
161964901|NCT01296711|584917756|FG000|Overall Study|Other|0|||
161964902|NCT01296711|584917757|FG001|Overall Study|Other|0|||
161964903|NCT01296711|584917758|FG002|Overall Study|Other|0|||
161964904|NCT01296711|584917759|FG003|Overall Study|Other|0|||
161964905|NCT01296711|584917760|FG004|Overall Study|Other|0|||
161964906|NCT01296711|584917761|FG005|Overall Study|Other|0|||
161964907|NCT01296711|584917762|FG006|Overall Study|Other|1|||
161964908|NCT01296711|584917763|FG007|Overall Study|Other|0|||
161964909|NCT01296711|584917756|FG000|Overall Study|Required restricted steroid injections|0|||
161964910|NCT01296711|584917757|FG001|Overall Study|Required restricted steroid injections|0|||
161964911|NCT01296711|584917758|FG002|Overall Study|Required restricted steroid injections|0|||
161964912|NCT01296711|584917759|FG003|Overall Study|Required restricted steroid injections|0|||
161964913|NCT01296711|584917760|FG004|Overall Study|Required restricted steroid injections|0|||
161964914|NCT01296711|584917761|FG005|Overall Study|Required restricted steroid injections|0|||
161964915|NCT01296711|584917762|FG006|Overall Study|Required restricted steroid injections|1|||
161964916|NCT01296711|584917763|FG007|Overall Study|Required restricted steroid injections|0|||
161964917|NCT01296711|584917756|FG000|Overall Study|Ongoing missed appointments|0|||
161964918|NCT01296711|584917757|FG001|Overall Study|Ongoing missed appointments|0|||
161964919|NCT01296711|584917758|FG002|Overall Study|Ongoing missed appointments|0|||
161964920|NCT01296711|584917759|FG003|Overall Study|Ongoing missed appointments|0|||
161964921|NCT01296711|584917760|FG004|Overall Study|Ongoing missed appointments|0|||
161964922|NCT01296711|584917761|FG005|Overall Study|Ongoing missed appointments|0|||
161964923|NCT01296711|584917762|FG006|Overall Study|Ongoing missed appointments|1|||
161964924|NCT01296711|584917763|FG007|Overall Study|Ongoing missed appointments|0|||
161964925|NCT01296711|584917756|FG000|Overall Study|Failure to comply with visits|0|||
161964926|NCT01296711|584917757|FG001|Overall Study|Failure to comply with visits|0|||
161964927|NCT01296711|584917758|FG002|Overall Study|Failure to comply with visits|0|||
161964928|NCT01296711|584917759|FG003|Overall Study|Failure to comply with visits|0|||
161964929|NCT01296711|584917760|FG004|Overall Study|Failure to comply with visits|0|||
161964930|NCT01296711|584917761|FG005|Overall Study|Failure to comply with visits|0|||
161964931|NCT01296711|584917762|FG006|Overall Study|Failure to comply with visits|0|||
161964932|NCT01296711|584917763|FG007|Overall Study|Failure to comply with visits|1|||
161964933|NCT01296711|584917756|FG000|Overall Study|Patient decision due to transport|0|||
161964934|NCT01296711|584917757|FG001|Overall Study|Patient decision due to transport|0|||
161964935|NCT01296711|584917758|FG002|Overall Study|Patient decision due to transport|0|||
161964936|NCT01296711|584917759|FG003|Overall Study|Patient decision due to transport|0|||
161964937|NCT01296711|584917760|FG004|Overall Study|Patient decision due to transport|0|||
161964938|NCT01296711|584917761|FG005|Overall Study|Patient decision due to transport|0|||
161964939|NCT01296711|584917762|FG006|Overall Study|Patient decision due to transport|0|||
161964940|NCT01296711|584917763|FG007|Overall Study|Patient decision due to transport|1|||
161964941|NCT01328535|584917764|FG000|Overall Study|Ineligible|1|||
161964942|NCT01035463|584917765|FG000|Overall Study|Adverse Event|0|||
161964943|NCT01035463|584917766|FG001|Overall Study|Adverse Event|0|||
161964944|NCT01035463|584917767|FG002|Overall Study|Adverse Event|4|||
161964945|NCT01035463|584917768|FG003|Overall Study|Adverse Event|1|||
161964946|NCT01035463|584917769|FG004|Overall Study|Adverse Event|5|||
161964947|NCT01035463|584917770|FG005|Overall Study|Adverse Event|7|||
161964948|NCT01035463|584917765|FG000|Overall Study|Withdrawal by Subject|0|||
161964949|NCT01035463|584917766|FG001|Overall Study|Withdrawal by Subject|2|||
161964950|NCT01035463|584917767|FG002|Overall Study|Withdrawal by Subject|1|||
161964951|NCT01035463|584917768|FG003|Overall Study|Withdrawal by Subject|0|||
161964952|NCT01035463|584917769|FG004|Overall Study|Withdrawal by Subject|1|||
161964953|NCT01035463|584917770|FG005|Overall Study|Withdrawal by Subject|4|||
161964954|NCT01035463|584917765|FG000|Overall Study|Disease progression|0|||
161964955|NCT01035463|584917766|FG001|Overall Study|Disease progression|0|||
161964956|NCT01035463|584917767|FG002|Overall Study|Disease progression|0|||
161721801|NCT04760314|584025106|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
161721802|NCT04760314|584025107|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
161721803|NCT01013883|584025110|FG000|Overall Study|Lost to Follow-up|2|||
161721804|NCT01013883|584025111|FG001|Overall Study|Lost to Follow-up|2|||
161721805|NCT02241512|584025114|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
161721806|NCT02241512|584025115|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
161964957|NCT01035463|584917768|FG003|Overall Study|Disease progression|0|||
161964958|NCT01035463|584917769|FG004|Overall Study|Disease progression|0|||
161964959|NCT01035463|584917770|FG005|Overall Study|Disease progression|3|||
161964960|NCT01035463|584917765|FG000|Overall Study|Other Malignancy|0|||
161721807|NCT00641043|584025118|FG000|Overall Study|Adverse Event|6|||
161721808|NCT00641043|584025119|FG001|Overall Study|Adverse Event|4|||
161964961|NCT01035463|584917766|FG001|Overall Study|Other Malignancy|0|||
161964962|NCT01035463|584917767|FG002|Overall Study|Other Malignancy|0|||
161964963|NCT01035463|584917768|FG003|Overall Study|Other Malignancy|0|||
161964964|NCT01035463|584917769|FG004|Overall Study|Other Malignancy|0|||
161964965|NCT01035463|584917770|FG005|Overall Study|Other Malignancy|2|||
161964966|NCT01035463|584917765|FG000|Overall Study|Other|0|||
161964967|NCT01035463|584917766|FG001|Overall Study|Other|0|||
161964968|NCT01035463|584917767|FG002|Overall Study|Other|0|||
161964969|NCT01035463|584917768|FG003|Overall Study|Other|1|||
161964970|NCT01035463|584917769|FG004|Overall Study|Other|0|||
161964971|NCT01035463|584917770|FG005|Overall Study|Other|2|||
161964972|NCT03425006|584917775|FG000|Overall Study|Withdrawal by Subject|1|||
161721809|NCT00641043|584025118|FG000|Overall Study|Protocol Violation|2|||
161721810|NCT00641043|584025119|FG001|Overall Study|Protocol Violation|3|||
161721811|NCT00641043|584025118|FG000|Overall Study|Lost to Follow-up|3|||
161721812|NCT00641043|584025119|FG001|Overall Study|Lost to Follow-up|2|||
161721813|NCT00641043|584025118|FG000|Overall Study|Withdrawal by Subject|4|||
161721814|NCT00641043|584025119|FG001|Overall Study|Withdrawal by Subject|4|||
161721815|NCT00641043|584025118|FG000|Overall Study|Other incl. lack of efficacy|4|||
161721816|NCT00641043|584025119|FG001|Overall Study|Other incl. lack of efficacy|2|||
161721817|NCT03515538|584025120|FG000|Overall Study|Lack of Efficacy|2|||
161721818|NCT03515538|584025121|FG001|Overall Study|Lack of Efficacy|0|||
161721819|NCT03515538|584025122|FG002|Overall Study|Lack of Efficacy|2|||
161721820|NCT03515538|584025123|FG003|Overall Study|Lack of Efficacy|0|||
161721821|NCT03515538|584025120|FG000|Overall Study|Death|0|||
161721822|NCT03515538|584025121|FG001|Overall Study|Death|0|||
161721823|NCT03515538|584025122|FG002|Overall Study|Death|1|||
161721824|NCT03515538|584025123|FG003|Overall Study|Death|0|||
161721825|NCT03515538|584025120|FG000|Overall Study|Protocol Violation|0|||
161721826|NCT03515538|584025121|FG001|Overall Study|Protocol Violation|0|||
161721827|NCT03515538|584025122|FG002|Overall Study|Protocol Violation|0|||
161721828|NCT03515538|584025123|FG003|Overall Study|Protocol Violation|1|||
161721829|NCT03515538|584025120|FG000|Overall Study|Screen failure (baseline dropout)|0|||
161721830|NCT03515538|584025121|FG001|Overall Study|Screen failure (baseline dropout)|1|||
161721831|NCT03515538|584025122|FG002|Overall Study|Screen failure (baseline dropout)|0|||
161721832|NCT03515538|584025123|FG003|Overall Study|Screen failure (baseline dropout)|0|||
161721833|NCT03515538|584025120|FG000|Overall Study|Withdrawal by Subject|2|||
161721834|NCT03515538|584025121|FG001|Overall Study|Withdrawal by Subject|2|||
161721835|NCT03515538|584025122|FG002|Overall Study|Withdrawal by Subject|1|||
161721836|NCT03515538|584025123|FG003|Overall Study|Withdrawal by Subject|3|||
161721837|NCT03515538|584025120|FG000|Overall Study|Physician Decision|1|||
161721838|NCT03515538|584025121|FG001|Overall Study|Physician Decision|0|||
161721839|NCT03515538|584025122|FG002|Overall Study|Physician Decision|0|||
161721840|NCT03515538|584025123|FG003|Overall Study|Physician Decision|1|||
161721841|NCT04275310|584025124|FG000|Overall Study|Non-randomized due to running out of funding|4|||
161721842|NCT04275310|584025125|FG001|Overall Study|Non-randomized due to running out of funding|0|||
161721843|NCT03088605|584025128|FG000|Overall Study|Withdrawal by Subject|1|||
161721844|NCT03088605|584025129|FG001|Overall Study|Withdrawal by Subject|0|||
161721845|NCT02345161|584025130|FG000|Overall Study|Withdrawal by Subject|25|||
161721846|NCT02345161|584025131|FG001|Overall Study|Withdrawal by Subject|33|||
161721847|NCT02345161|584025130|FG000|Overall Study|Adverse Event|16|||
161721848|NCT02345161|584025131|FG001|Overall Study|Adverse Event|19|||
161721849|NCT02345161|584025130|FG000|Overall Study|Physician Decision|4|||
161721850|NCT02345161|584025131|FG001|Overall Study|Physician Decision|4|||
161721851|NCT02345161|584025130|FG000|Overall Study|Lost to Follow-up|0|||
161721852|NCT02345161|584025131|FG001|Overall Study|Lost to Follow-up|1|||
161721853|NCT02225223|584025133|FG000|Overall Study|Death|10|||
161721854|NCT02225223|584025134|FG001|Overall Study|Death|1|||
161721855|NCT02225223|584025133|FG000|Overall Study|Lost to Follow-up|5|||
161721856|NCT02225223|584025134|FG001|Overall Study|Lost to Follow-up|0|||
161721857|NCT02225223|584025133|FG000|Overall Study|Other|1|||
161721858|NCT02225223|584025134|FG001|Overall Study|Other|2|||
161721859|NCT02225223|584025133|FG000|Overall Study|Physician Decision|1|||
161721860|NCT02225223|584025134|FG001|Overall Study|Physician Decision|0|||
161721861|NCT02225223|584025133|FG000|Overall Study|Withdrawal by Subject|2|||
161721862|NCT02225223|584025134|FG001|Overall Study|Withdrawal by Subject|2|||
161721863|NCT03567291|584025135|FG000|Period I|Adverse Event|14|||
161721864|NCT03567291|584025136|FG001|Period I|Adverse Event|0|||
161721865|NCT03567291|584025137|FG002|Period I|Adverse Event|0|||
161721866|NCT03567291|584025138|FG003|Period I|Adverse Event|0|||
161721867|NCT03567291|584025135|FG000|Period I|Protocol Violation|1|||
161721868|NCT03567291|584025136|FG001|Period I|Protocol Violation|0|||
161721869|NCT03567291|584025137|FG002|Period I|Protocol Violation|0|||
161721870|NCT03567291|584025138|FG003|Period I|Protocol Violation|0|||
161721871|NCT03567291|584025135|FG000|Period I|Withdrawal by Subject|23|||
161721872|NCT03567291|584025136|FG001|Period I|Withdrawal by Subject|0|||
161721873|NCT03567291|584025137|FG002|Period I|Withdrawal by Subject|0|||
161721874|NCT03567291|584025138|FG003|Period I|Withdrawal by Subject|0|||
161721875|NCT03567291|584025135|FG000|Period I|Lost to Follow-up|2|||
161721876|NCT03567291|584025136|FG001|Period I|Lost to Follow-up|0|||
161721877|NCT03567291|584025137|FG002|Period I|Lost to Follow-up|0|||
161721878|NCT03567291|584025138|FG003|Period I|Lost to Follow-up|0|||
161721879|NCT03567291|584025135|FG000|Period I|Terminated by sponsor|44|||
161721880|NCT03567291|584025136|FG001|Period I|Terminated by sponsor|0|||
161721881|NCT03567291|584025137|FG002|Period I|Terminated by sponsor|0|||
161721882|NCT03567291|584025138|FG003|Period I|Terminated by sponsor|0|||
161721883|NCT03567291|584025135|FG000|Period I|Missing or unknown|7|||
161721884|NCT03567291|584025136|FG001|Period I|Missing or unknown|0|||
161721885|NCT03567291|584025137|FG002|Period I|Missing or unknown|0|||
161964973|NCT03425006|584917775|FG000|Overall Study|Physician Decision|1|||
161964974|NCT03425006|584917775|FG000|Overall Study|Death|1|||
161964975|NCT03748706|584917779|FG000|Overall Study|Lost to Follow-up|1|||
161964976|NCT03070171|584917782|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
161964977|NCT03070171|584917783|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
161964978|NCT03070171|584917782|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
161964979|NCT03070171|584917783|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
161964980|NCT00610857|584917789|FG000|Overall Study|Not evaluable for response|2|||
161964981|NCT03655054|584917792|FG000|Overall Study|Lost to Follow-up|1|||
161964982|NCT00712725|584917796|FG000|Overall Study|Adverse Event|1|||
161964983|NCT00712725|584917797|FG001|Overall Study|Adverse Event|0|||
161964984|NCT00712725|584917798|FG002|Overall Study|Adverse Event|0|||
161964985|NCT00712725|584917799|FG003|Overall Study|Adverse Event|1|||
161964986|NCT00712725|584917800|FG004|Overall Study|Adverse Event|0|||
161964987|NCT00712725|584917801|FG005|Overall Study|Adverse Event|0|||
161964988|NCT00712725|584917802|FG006|Overall Study|Adverse Event|0|||
161721886|NCT03567291|584025138|FG003|Period I|Missing or unknown|0|||
161964989|NCT00712725|584917803|FG007|Overall Study|Adverse Event|0|||
161964990|NCT00712725|584917796|FG000|Overall Study|Lost to Follow-up|3|||
161964991|NCT00712725|584917797|FG001|Overall Study|Lost to Follow-up|2|||
161964992|NCT00712725|584917798|FG002|Overall Study|Lost to Follow-up|1|||
161964993|NCT00712725|584917799|FG003|Overall Study|Lost to Follow-up|1|||
161964994|NCT00712725|584917800|FG004|Overall Study|Lost to Follow-up|2|||
161964995|NCT00712725|584917801|FG005|Overall Study|Lost to Follow-up|2|||
161964996|NCT00712725|584917802|FG006|Overall Study|Lost to Follow-up|3|||
161721887|NCT03567291|584025135|FG000|Period II|Adverse Event|0|||
161721888|NCT03567291|584025136|FG001|Period II|Adverse Event|1|||
161721889|NCT03567291|584025137|FG002|Period II|Adverse Event|0|||
161964997|NCT00712725|584917803|FG007|Overall Study|Lost to Follow-up|1|||
161964998|NCT00712725|584917796|FG000|Overall Study|Physician Decision|2|||
161964999|NCT00712725|584917797|FG001|Overall Study|Physician Decision|0|||
161965000|NCT00712725|584917798|FG002|Overall Study|Physician Decision|0|||
161965001|NCT00712725|584917799|FG003|Overall Study|Physician Decision|0|||
161965002|NCT00712725|584917800|FG004|Overall Study|Physician Decision|1|||
161965003|NCT00712725|584917801|FG005|Overall Study|Physician Decision|0|||
161965004|NCT00712725|584917802|FG006|Overall Study|Physician Decision|2|||
161965005|NCT00712725|584917803|FG007|Overall Study|Physician Decision|0|||
161965006|NCT00712725|584917796|FG000|Overall Study|Pregnancy|0|||
161965007|NCT00712725|584917797|FG001|Overall Study|Pregnancy|1|||
161965008|NCT00712725|584917798|FG002|Overall Study|Pregnancy|0|||
161965009|NCT00712725|584917799|FG003|Overall Study|Pregnancy|0|||
161965010|NCT00712725|584917800|FG004|Overall Study|Pregnancy|1|||
161965011|NCT00712725|584917801|FG005|Overall Study|Pregnancy|0|||
161965012|NCT00712725|584917802|FG006|Overall Study|Pregnancy|2|||
161965013|NCT00712725|584917803|FG007|Overall Study|Pregnancy|0|||
161965014|NCT00712725|584917796|FG000|Overall Study|Protocol Violation|2|||
161965015|NCT00712725|584917797|FG001|Overall Study|Protocol Violation|0|||
161721890|NCT03567291|584025138|FG003|Period II|Adverse Event|0|||
161721891|NCT03567291|584025135|FG000|Period II|Missing or unknown|0|||
161721892|NCT03567291|584025136|FG001|Period II|Missing or unknown|2|||
161721893|NCT03567291|584025137|FG002|Period II|Missing or unknown|1|||
161721894|NCT03567291|584025138|FG003|Period II|Missing or unknown|0|||
161721895|NCT03567291|584025135|FG000|Period III|Adverse Event|0|||
161721896|NCT03567291|584025136|FG001|Period III|Adverse Event|0|||
161721897|NCT03567291|584025137|FG002|Period III|Adverse Event|0|||
161721898|NCT03567291|584025138|FG003|Period III|Adverse Event|4|||
161721899|NCT03567291|584025135|FG000|Period III|Withdrawal by Subject|0|||
161721900|NCT03567291|584025136|FG001|Period III|Withdrawal by Subject|0|||
161721901|NCT03567291|584025137|FG002|Period III|Withdrawal by Subject|0|||
161721902|NCT03567291|584025138|FG003|Period III|Withdrawal by Subject|4|||
161721903|NCT03567291|584025135|FG000|Period III|Lost to Follow-up|0|||
161721904|NCT03567291|584025136|FG001|Period III|Lost to Follow-up|0|||
161721905|NCT03567291|584025137|FG002|Period III|Lost to Follow-up|0|||
161721906|NCT03567291|584025138|FG003|Period III|Lost to Follow-up|1|||
161721907|NCT03567291|584025135|FG000|Period III|Terminated by sponsor|0|||
161721908|NCT03567291|584025136|FG001|Period III|Terminated by sponsor|0|||
161721909|NCT03567291|584025137|FG002|Period III|Terminated by sponsor|0|||
161721910|NCT03567291|584025138|FG003|Period III|Terminated by sponsor|68|||
161721911|NCT03567291|584025135|FG000|Period III|Missing or unknown|0|||
161721912|NCT03567291|584025136|FG001|Period III|Missing or unknown|0|||
161965016|NCT00712725|584917798|FG002|Overall Study|Protocol Violation|1|||
161721913|NCT03567291|584025137|FG002|Period III|Missing or unknown|0|||
161721914|NCT03567291|584025138|FG003|Period III|Missing or unknown|8|||
161721915|NCT03666143|584025139|FG000|Overall Study|Death|158|||
161721916|NCT03666143|584025139|FG000|Overall Study|Sponsor Decision|31|||
161965017|NCT00712725|584917799|FG003|Overall Study|Protocol Violation|3|||
161965018|NCT00712725|584917800|FG004|Overall Study|Protocol Violation|2|||
161965019|NCT00712725|584917801|FG005|Overall Study|Protocol Violation|0|||
161965020|NCT00712725|584917802|FG006|Overall Study|Protocol Violation|1|||
161965021|NCT00712725|584917803|FG007|Overall Study|Protocol Violation|1|||
161965022|NCT00712725|584917796|FG000|Overall Study|Withdrawal by Subject|2|||
161965023|NCT00712725|584917797|FG001|Overall Study|Withdrawal by Subject|1|||
161965024|NCT00712725|584917798|FG002|Overall Study|Withdrawal by Subject|1|||
161721917|NCT03666143|584025139|FG000|Overall Study|Withdrawal by Subject|11|||
161721918|NCT03666143|584025139|FG000|Overall Study|Lost to Follow-up|5|||
161721919|NCT03666143|584025139|FG000|Overall Study|Physician Decision|1|||
161721920|NCT03666143|584025139|FG000|Overall Study|Rolled into extension study|9|||
161721921|NCT03666143|584025139|FG000|Overall Study|Progressive Disease|1|||
161721922|NCT04530825|584025143|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
161721923|NCT04530825|584025144|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
161721924|NCT04530825|584025145|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
161721925|NCT04530825|584025146|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
161721926|NCT04530825|584025143|FG000|Overall Study|Did not complete follow-up|3|||
161721927|NCT04530825|584025144|FG001|Overall Study|Did not complete follow-up|0|||
161721928|NCT04530825|584025145|FG002|Overall Study|Did not complete follow-up|0|||
161721929|NCT04530825|584025146|FG003|Overall Study|Did not complete follow-up|0|||
161721930|NCT04101422|584025147|FG000|Overall Study|Ineligible|1|||
161721931|NCT04101422|584025148|FG001|Overall Study|Ineligible|0|||
161721932|NCT04101422|584025149|FG002|Overall Study|Ineligible|9|||
161721933|NCT04101422|584025150|FG003|Overall Study|Ineligible|0|||
161721934|NCT04101422|584025147|FG000|Overall Study|Withdrawal by Subject|0|||
161721935|NCT04101422|584025148|FG001|Overall Study|Withdrawal by Subject|0|||
161721936|NCT04101422|584025149|FG002|Overall Study|Withdrawal by Subject|1|||
161721937|NCT04101422|584025150|FG003|Overall Study|Withdrawal by Subject|0|||
161721938|NCT04101422|584025147|FG000|Overall Study|Not attending to the stimuli|0|||
161721939|NCT04101422|584025148|FG001|Overall Study|Not attending to the stimuli|0|||
161721940|NCT04101422|584025149|FG002|Overall Study|Not attending to the stimuli|4|||
161721941|NCT04101422|584025150|FG003|Overall Study|Not attending to the stimuli|0|||
161721942|NCT04101422|584025147|FG000|Overall Study|Did not download app|0|||
161721943|NCT04101422|584025148|FG001|Overall Study|Did not download app|0|||
161721944|NCT04101422|584025149|FG002|Overall Study|Did not download app|0|||
161721945|NCT04101422|584025150|FG003|Overall Study|Did not download app|17|||
161721946|NCT04101422|584025147|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
161721947|NCT04101422|584025148|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
161721948|NCT04101422|584025149|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
161721949|NCT04101422|584025150|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
161721950|NCT01174784|584025151|FG000|Overall Study|Screen fails|4|||
161721951|NCT01671488|584025154|FG000|Overall Study|Withdrawal by Subject|1|||
161721952|NCT00532883|584025155|FG000|Overall Study|Adverse Event|1|||
161721953|NCT00532883|584025156|FG001|Overall Study|Adverse Event|0|||
161721954|NCT00532883|584025157|FG002|Overall Study|Adverse Event|0|||
161721955|NCT00532883|584025158|FG003|Overall Study|Adverse Event|1|||
161721956|NCT00532883|584025155|FG000|Overall Study|Lost to Follow-up|1|||
161721957|NCT00532883|584025156|FG001|Overall Study|Lost to Follow-up|1|||
161721958|NCT00532883|584025157|FG002|Overall Study|Lost to Follow-up|1|||
161721959|NCT00532883|584025158|FG003|Overall Study|Lost to Follow-up|0|||
161721960|NCT00532883|584025155|FG000|Overall Study|Withdrawal by Subject|0|||
161721961|NCT00532883|584025156|FG001|Overall Study|Withdrawal by Subject|1|||
161721962|NCT00532883|584025157|FG002|Overall Study|Withdrawal by Subject|1|||
161721963|NCT00532883|584025158|FG003|Overall Study|Withdrawal by Subject|0|||
161721964|NCT00532883|584025155|FG000|Overall Study|Subject was Nonadherent|0|||
161965025|NCT00712725|584917799|FG003|Overall Study|Withdrawal by Subject|2|||
161965026|NCT00712725|584917800|FG004|Overall Study|Withdrawal by Subject|1|||
161965027|NCT00712725|584917801|FG005|Overall Study|Withdrawal by Subject|1|||
161965028|NCT00712725|584917802|FG006|Overall Study|Withdrawal by Subject|1|||
161965029|NCT00712725|584917803|FG007|Overall Study|Withdrawal by Subject|2|||
161965030|NCT00712725|584917796|FG000|Overall Study|Lack of Qualifying Event|16|||
161965031|NCT00712725|584917797|FG001|Overall Study|Lack of Qualifying Event|2|||
161965032|NCT00712725|584917798|FG002|Overall Study|Lack of Qualifying Event|6|||
161965033|NCT00712725|584917799|FG003|Overall Study|Lack of Qualifying Event|8|||
161965034|NCT00712725|584917800|FG004|Overall Study|Lack of Qualifying Event|11|||
161965035|NCT00712725|584917801|FG005|Overall Study|Lack of Qualifying Event|13|||
161965036|NCT00712725|584917802|FG006|Overall Study|Lack of Qualifying Event|11|||
161965037|NCT00712725|584917803|FG007|Overall Study|Lack of Qualifying Event|6|||
161721965|NCT00532883|584025156|FG001|Overall Study|Subject was Nonadherent|1|||
161721966|NCT00532883|584025157|FG002|Overall Study|Subject was Nonadherent|1|||
161721967|NCT00532883|584025158|FG003|Overall Study|Subject was Nonadherent|0|||
161721968|NCT00532883|584025155|FG000|Overall Study|Early Study Termination|4|||
161721969|NCT00532883|584025156|FG001|Overall Study|Early Study Termination|4|||
161721970|NCT00532883|584025157|FG002|Overall Study|Early Study Termination|1|||
161721971|NCT00532883|584025158|FG003|Overall Study|Early Study Termination|4|||
161721972|NCT01214434|584025161|FG000|Overall Study|Withdrawal by Subject|1|||
161721973|NCT01214434|584025162|FG001|Overall Study|Withdrawal by Subject|0|||
161721974|NCT01214434|584025161|FG000|Overall Study|Lost to Follow-up|2|||
161721975|NCT01214434|584025162|FG001|Overall Study|Lost to Follow-up|2|||
161721976|NCT01214434|584025161|FG000|Overall Study|Site error|1|||
161721977|NCT01214434|584025162|FG001|Overall Study|Site error|0|||
161965038|NCT00712725|584917796|FG000|Overall Study|Protocol Specified Criteria|3|||
161721978|NCT02075255|584025164|FG000|Overall Study|Study specific withdrawal criteria|0|||
161721979|NCT02075255|584025165|FG001|Overall Study|Study specific withdrawal criteria|1|||
161721980|NCT02075255|584025166|FG002|Overall Study|Study specific withdrawal criteria|1|||
161721981|NCT02075255|584025164|FG000|Overall Study|Withdrawal by Subject|4|||
161721982|NCT02075255|584025165|FG001|Overall Study|Withdrawal by Subject|1|||
161721983|NCT02075255|584025166|FG002|Overall Study|Withdrawal by Subject|0|||
161721984|NCT02075255|584025164|FG000|Overall Study|Lost to Follow-up|0|||
161721985|NCT02075255|584025165|FG001|Overall Study|Lost to Follow-up|0|||
161721986|NCT02075255|584025166|FG002|Overall Study|Lost to Follow-up|1|||
161965039|NCT00712725|584917797|FG001|Overall Study|Protocol Specified Criteria|0|||
161965040|NCT00712725|584917798|FG002|Overall Study|Protocol Specified Criteria|1|||
161965041|NCT00712725|584917799|FG003|Overall Study|Protocol Specified Criteria|2|||
161965042|NCT00712725|584917800|FG004|Overall Study|Protocol Specified Criteria|1|||
161965043|NCT00712725|584917801|FG005|Overall Study|Protocol Specified Criteria|0|||
161965044|NCT00712725|584917802|FG006|Overall Study|Protocol Specified Criteria|2|||
161965045|NCT00712725|584917803|FG007|Overall Study|Protocol Specified Criteria|1|||
161965046|NCT01901289|584917804|FG000|Overall Study|Death|32|||
161965047|NCT01901289|584917804|FG000|Overall Study|Lost to Follow-up|16|||
161965048|NCT01901289|584917804|FG000|Overall Study|Withdrawal by Subject|35|||
161965049|NCT01901289|584917804|FG000|Overall Study|Other type of endpoint met|2|||
161965050|NCT00889603|584917805|FG000|Overall Study|Adverse Event|7|||
161965051|NCT00889603|584917805|FG000|Overall Study|Death|3|||
161965052|NCT00889603|584917805|FG000|Overall Study|Lost to Follow-up|19|||
161965053|NCT00889603|584917805|FG000|Overall Study|No longer willing to participant in stud|4|||
161965054|NCT00889603|584917805|FG000|Overall Study|Other|4|||
161965055|NCT01606176|584917810|FG000|Overall Study|Adverse Event|2|||
161965056|NCT01606176|584917811|FG001|Overall Study|Adverse Event|3|||
161965057|NCT01606176|584917810|FG000|Overall Study|Disease progression|1|||
161965058|NCT01606176|584917811|FG001|Overall Study|Disease progression|0|||
161965059|NCT01606176|584917810|FG000|Overall Study|Withdrawal by Subject|1|||
161965060|NCT01606176|584917811|FG001|Overall Study|Withdrawal by Subject|0|||
161965061|NCT04238481|584917824|FG000|Overall Study|Miscellaneous|0|||
161965062|NCT04238481|584917825|FG001|Overall Study|Miscellaneous|1|||
161965063|NCT04238481|584917826|FG002|Overall Study|Miscellaneous|0|||
161965064|NCT04238481|584917827|FG003|Overall Study|Miscellaneous|0|||
161965065|NCT02247011|584917828|FG000|Overall Study|Poor quality of radiological results|125|||
161965066|NCT02152371|584917829|FG000|Overall Study|Adverse Event|6|||
161965067|NCT02152371|584917830|FG001|Overall Study|Adverse Event|2|||
161965068|NCT02152371|584917829|FG000|Overall Study|Withdrawal by Subject|3|||
161965069|NCT02152371|584917830|FG001|Overall Study|Withdrawal by Subject|7|||
161965070|NCT02152371|584917829|FG000|Overall Study|Protocol Violation|2|||
161965071|NCT02152371|584917830|FG001|Overall Study|Protocol Violation|3|||
161965072|NCT02152371|584917829|FG000|Overall Study|Lost to Follow-up|1|||
161965073|NCT02152371|584917830|FG001|Overall Study|Lost to Follow-up|0|||
161965074|NCT02152371|584917829|FG000|Overall Study|Lack of Efficacy|0|||
161721987|NCT02075255|584025164|FG000|Overall Study|Adverse Event|0|||
161721988|NCT02075255|584025165|FG001|Overall Study|Adverse Event|0|||
161721989|NCT02075255|584025166|FG002|Overall Study|Adverse Event|1|||
161721990|NCT02075255|584025164|FG000|Overall Study|Death|0|||
161721991|NCT02075255|584025165|FG001|Overall Study|Death|2|||
161721992|NCT02075255|584025166|FG002|Overall Study|Death|0|||
161721993|NCT03792750|584025167|FG000|Overall Study|Death|3|||
161721994|NCT01879618|584025168|FG000|Overall Study|Does not meet entrance criteria|1|||
161721995|NCT01879618|584025168|FG000|Overall Study|Withdrawal by Subject|1|||
161721996|NCT01879618|584025168|FG000|Overall Study|Surgery;changed schedule; not available|8|||
161721997|NCT01879618|584025168|FG000|Overall Study|Protocol Violation|6|||
161721998|NCT01879618|584025168|FG000|Overall Study|Adverse Event|5|||
161721999|NCT00394914|584025169|FG000|Treatment Period|Adverse Event|0|||
161722000|NCT00394914|584025170|FG001|Treatment Period|Adverse Event|3|||
161722001|NCT00394914|584025171|FG002|Treatment Period|Adverse Event|1|||
161722002|NCT00394914|584025169|FG000|Treatment Period|Lost to Follow-up|0|||
161722003|NCT00394914|584025170|FG001|Treatment Period|Lost to Follow-up|1|||
161965075|NCT02152371|584917830|FG001|Overall Study|Lack of Efficacy|1|||
161965076|NCT02152371|584917829|FG000|Overall Study|Physician Decision|0|||
161722004|NCT00394914|584025171|FG002|Treatment Period|Lost to Follow-up|0|||
161722005|NCT00394914|584025169|FG000|Treatment Period|Withdrawal by Subject|0|||
161965077|NCT02152371|584917830|FG001|Overall Study|Physician Decision|2|||
161722006|NCT00394914|584025170|FG001|Treatment Period|Withdrawal by Subject|2|||
161722007|NCT00394914|584025171|FG002|Treatment Period|Withdrawal by Subject|2|||
161722008|NCT00394914|584025169|FG000|Treatment Period|Noncompliance with protocol|0|||
161722009|NCT00394914|584025170|FG001|Treatment Period|Noncompliance with protocol|3|||
161965078|NCT02152371|584917829|FG000|Overall Study|Reason Not Given|0|||
161965079|NCT02152371|584917830|FG001|Overall Study|Reason Not Given|1|||
161965080|NCT00656058|584917832|FG000|Overall Study|Withdrawal by Subject|2|||
161965081|NCT00656058|584917832|FG000|Overall Study|Withdrawal by Subject|4|||
161965082|NCT00616018|584917833|FG000|Overall Study|Protocol Violation|3|||
161965083|NCT01818258|584917835|FG000|Overall Study|Death|3|||
161965084|NCT01818258|584917836|FG001|Overall Study|Death|0|||
161722010|NCT00394914|584025171|FG002|Treatment Period|Noncompliance with protocol|2|||
161722011|NCT00394914|584025169|FG000|Treatment Period|Did not meet protocol eligibility|0|||
161722012|NCT00394914|584025170|FG001|Treatment Period|Did not meet protocol eligibility|1|||
161722013|NCT00394914|584025171|FG002|Treatment Period|Did not meet protocol eligibility|1|||
161722014|NCT01004146|584025175|FG000|Overall Study|Withdrawal by Subject|4|||
161722015|NCT01004146|584025176|FG001|Overall Study|Withdrawal by Subject|5|||
161722016|NCT00465738|584025185|FG000|Overall Study|Lost to Follow-up|2|||
161722017|NCT00465738|584025186|FG001|Overall Study|Lost to Follow-up|0|||
161722018|NCT00465738|584025185|FG000|Overall Study|Adverse Event|0|||
161722019|NCT00465738|584025186|FG001|Overall Study|Adverse Event|1|||
161722020|NCT00465738|584025185|FG000|Overall Study|Withdrawal by Subject|2|||
161722021|NCT00465738|584025186|FG001|Overall Study|Withdrawal by Subject|0|||
161722022|NCT00465738|584025185|FG000|Overall Study|Other|2|||
161722023|NCT00465738|584025186|FG001|Overall Study|Other|5|||
161722024|NCT00734929|584025187|FG000|Overall Study|Lost to Follow-up|1|||
161722025|NCT00734929|584025188|FG001|Overall Study|Lost to Follow-up|2|||
161722026|NCT00734929|584025187|FG000|Overall Study|No intervention/ screen fail|5|||
161722027|NCT00734929|584025188|FG001|Overall Study|No intervention/ screen fail|3|||
161722028|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Adverse Event|37|||
161722029|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Adverse Event|0|||
161722030|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Adverse Event|0|||
161722031|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Adverse Event|0|||
161722032|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Death|2|||
161722033|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Death|0|||
161722034|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Death|0|||
161722035|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Death|0|||
161722036|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
161722037|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
161722038|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
161722039|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
161722040|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
161722041|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
161722042|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
161722043|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
161722044|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
161722045|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
161722046|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
161722047|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
161722048|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
161722049|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
161722050|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
161722051|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
161722052|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Physician Decision|4|||
161722053|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Physician Decision|0|||
161722054|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Physician Decision|0|||
161722055|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Physician Decision|0|||
161722056|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Pregnancy|1|||
161722057|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Pregnancy|0|||
161722058|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Pregnancy|0|||
161722059|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Pregnancy|0|||
161722060|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
161722061|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
161722062|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
161722063|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
161722064|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
161722065|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
161722066|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
161722067|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
161722068|NCT01855789|584025189|FG000|1) Baseline up to Week 24|Other|4|||
161965085|NCT01818258|584917835|FG000|Overall Study|Withdrawal by Subject|0|||
161965086|NCT01818258|584917836|FG001|Overall Study|Withdrawal by Subject|1|||
161965087|NCT01818258|584917835|FG000|Overall Study|Lost to Follow-up|0|||
161965088|NCT01818258|584917836|FG001|Overall Study|Lost to Follow-up|1|||
161965089|NCT01818258|584917835|FG000|Overall Study|Unable to Travel to Clinic|0|||
161965090|NCT01818258|584917836|FG001|Overall Study|Unable to Travel to Clinic|1|||
161965091|NCT02839720|584917837|FG000|Overall Study|Adverse Event|2|||
161965092|NCT02839720|584917837|FG000|Overall Study|Non-compliance|2|||
161722069|NCT01855789|584025190|FG001|1) Baseline up to Week 24|Other|0|||
161722070|NCT01855789|584025191|FG002|1) Baseline up to Week 24|Other|0|||
161722071|NCT01855789|584025192|FG003|1) Baseline up to Week 24|Other|0|||
161722072|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
161722073|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
161965093|NCT02839720|584917837|FG000|Overall Study|Intercurrent Illness|1|||
161722074|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
161722075|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
161722076|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
161722077|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
161722078|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
161722079|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
161722080|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
161722081|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
161722082|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
161722083|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
161722084|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
161722085|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
161722086|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
161722087|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
161722088|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
161722089|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
161722090|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
161722091|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
161722092|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
161722093|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
161722094|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
161722095|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
161722096|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
161722097|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
161722098|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
161722099|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
161722100|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
161722101|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
161722102|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
161722103|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
161722104|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
161722105|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
161722106|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
161722107|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
161722108|NCT01855789|584025189|FG000|2) Week 24 up to End of Study|Other|0|||
161722109|NCT01855789|584025190|FG001|2) Week 24 up to End of Study|Other|0|||
161722110|NCT01855789|584025191|FG002|2) Week 24 up to End of Study|Other|0|||
161722111|NCT01855789|584025192|FG003|2) Week 24 up to End of Study|Other|1|||
161722112|NCT01863758|584025193|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
161722113|NCT01863758|584025193|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
161722114|NCT02961764|584025194|FG000|Overall Study|Protocol Violation|0|||
161722115|NCT02961764|584025195|FG001|Overall Study|Protocol Violation|1|||
161722116|NCT02961764|584025194|FG000|Overall Study|Death|2|||
161722117|NCT02961764|584025195|FG001|Overall Study|Death|0|||
161722118|NCT02961764|584025194|FG000|Overall Study|Lost to Follow-up|35|||
161722119|NCT02961764|584025195|FG001|Overall Study|Lost to Follow-up|24|||
161722120|NCT02961764|584025194|FG000|Overall Study|Withdrawal by Subject|2|||
161722121|NCT02961764|584025195|FG001|Overall Study|Withdrawal by Subject|0|||
161722122|NCT02369510|584025196|FG000|Overall Study|Spilled Medication|1|||
161722123|NCT02369510|584025197|FG001|Overall Study|Spilled Medication|2|||
161722124|NCT02369510|584025198|FG002|Overall Study|Spilled Medication|1|||
161722125|NCT02369510|584025196|FG000|Overall Study|Epidural Activation|1|||
161722126|NCT02369510|584025197|FG001|Overall Study|Epidural Activation|1|||
161722127|NCT02369510|584025198|FG002|Overall Study|Epidural Activation|5|||
161722128|NCT02160977|584025199|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
161722129|NCT02160977|584025200|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
161722130|NCT02160977|584025199|FG000|Three Months After Surgery|Lost to Follow-up|0|||
161722131|NCT02160977|584025200|FG001|Three Months After Surgery|Lost to Follow-up|2|||
161722132|NCT02160977|584025199|FG000|Six Months After Surgery|Lost to Follow-up|2|||
161722133|NCT02160977|584025200|FG001|Six Months After Surgery|Lost to Follow-up|1|||
161722134|NCT01663740|584025201|FG000|Overall Study|Lost to Follow-up|1|||
161722135|NCT01663740|584025202|FG001|Overall Study|Lost to Follow-up|4|||
161722136|NCT01663740|584025201|FG000|Overall Study|Other|9|||
161722137|NCT01663740|584025202|FG001|Overall Study|Other|2|||
161722138|NCT01663740|584025201|FG000|Overall Study|Inclusion/Exclusion not met|1|||
161722139|NCT01663740|584025202|FG001|Overall Study|Inclusion/Exclusion not met|0|||
161722140|NCT01663740|584025201|FG000|Overall Study|Death|0|||
161722141|NCT01663740|584025202|FG001|Overall Study|Death|1|||
161722142|NCT01663740|584025201|FG000|Overall Study|Withdrawal by Subject|2|||
161722143|NCT01663740|584025202|FG001|Overall Study|Withdrawal by Subject|1|||
161722144|NCT01663740|584025201|FG000|Overall Study|No end of study status|3|||
161722145|NCT01663740|584025202|FG001|Overall Study|No end of study status|0|||
161722146|NCT02658656|584025205|FG000|Screening|Failed eligibility criteria|0|||
161722147|NCT02658656|584025206|FG001|Screening|Failed eligibility criteria|0|||
161722148|NCT02658656|584025207|FG002|Screening|Failed eligibility criteria|263|||
161722149|NCT02658656|584025205|FG000|Randomization|Withdrawal by Subject|8|||
161722150|NCT02658656|584025206|FG001|Randomization|Withdrawal by Subject|7|||
161722151|NCT02658656|584025207|FG002|Randomization|Withdrawal by Subject|0|||
161722152|NCT02658656|584025205|FG000|Randomization|Lost to Follow-up|1|||
161722153|NCT02658656|584025206|FG001|Randomization|Lost to Follow-up|3|||
161722154|NCT02658656|584025207|FG002|Randomization|Lost to Follow-up|0|||
161722155|NCT02658656|584025205|FG000|Randomization|Adverse Event|4|||
161722156|NCT02658656|584025206|FG001|Randomization|Adverse Event|0|||
161722157|NCT02658656|584025207|FG002|Randomization|Adverse Event|0|||
161722158|NCT02658656|584025205|FG000|Randomization|Administrative Termination|3|||
161722159|NCT02658656|584025206|FG001|Randomization|Administrative Termination|1|||
161722160|NCT02658656|584025207|FG002|Randomization|Administrative Termination|0|||
161722161|NCT02658656|584025205|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
161722162|NCT02658656|584025206|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
161722163|NCT02658656|584025207|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
161722164|NCT02658656|584025205|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
161722165|NCT02658656|584025206|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
161722166|NCT02658656|584025207|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
161722167|NCT02658656|584025205|FG000|Randomization|Not eligible for Randomization|1|||
161722168|NCT02658656|584025206|FG001|Randomization|Not eligible for Randomization|0|||
161722169|NCT02658656|584025207|FG002|Randomization|Not eligible for Randomization|0|||
161722170|NCT02658656|584025205|FG000|Randomization|Protocol Violation|1|||
161722171|NCT02658656|584025206|FG001|Randomization|Protocol Violation|0|||
161722172|NCT02658656|584025207|FG002|Randomization|Protocol Violation|0|||
161722173|NCT02112448|584025208|FG000|Overall Study|lab values precluding use of ketorolac|2|||
161722174|NCT02112448|584025209|FG001|Overall Study|lab values precluding use of ketorolac|2|||
161722175|NCT02112448|584025208|FG000|Overall Study|Protocol Violation|1|||
161722176|NCT02112448|584025209|FG001|Overall Study|Protocol Violation|2|||
161722177|NCT02112448|584025208|FG000|Overall Study|Physician Decision|4|||
161722178|NCT02112448|584025209|FG001|Overall Study|Physician Decision|6|||
161722179|NCT02112448|584025208|FG000|Overall Study|required heparin so could not use ketoro|1|||
161722180|NCT02112448|584025209|FG001|Overall Study|required heparin so could not use ketoro|0|||
161838052|NCT00136318|584450316|FG000|Overall Study|Withdrawal by Subject|2|||
161838053|NCT00136318|584450317|FG001|Overall Study|Withdrawal by Subject|2|||
161838054|NCT02005887|584450318|FG000|Overall Study|Protocol Violation|0|||
161838055|NCT02005887|584450319|FG001|Overall Study|Protocol Violation|2|||
161838056|NCT00160641|584450322|FG000|Overall Study|Adverse Event|102|||
161838057|NCT00160641|584450322|FG000|Overall Study|Withdrawal by Subject|87|||
161838058|NCT00160641|584450322|FG000|Overall Study|Lost to Follow-up|8|||
161838059|NCT00160641|584450322|FG000|Overall Study|Lack of Efficacy|12|||
161838060|NCT00160641|584450322|FG000|Overall Study|Protocol Violation|3|||
161838061|NCT00160641|584450322|FG000|Overall Study|Other|9|||
161838062|NCT00985712|584450324|FG000|Overall Study|Adverse Event|0|||
161838063|NCT00985712|584450325|FG001|Overall Study|Adverse Event|1|||
161838064|NCT00985712|584450324|FG000|Overall Study|Lost to Follow-up|2|||
161838065|NCT00985712|584450325|FG001|Overall Study|Lost to Follow-up|2|||
161838066|NCT00985712|584450324|FG000|Overall Study|Protocol Violation|0|||
161838067|NCT00985712|584450325|FG001|Overall Study|Protocol Violation|1|||
161838068|NCT00985712|584450324|FG000|Overall Study|Withdrawal by Subject|4|||
161838069|NCT00985712|584450325|FG001|Overall Study|Withdrawal by Subject|1|||
161838070|NCT00985712|584450324|FG000|Overall Study|Sponsor decision|0|||
161838071|NCT00985712|584450325|FG001|Overall Study|Sponsor decision|2|||
161838072|NCT01843348|584450328|FG000|Overall Study|Withdrawal by Subject|4|||
161838073|NCT01843348|584450329|FG001|Overall Study|Withdrawal by Subject|16|||
161838074|NCT01843348|584450330|FG002|Overall Study|Withdrawal by Subject|18|||
161838075|NCT01843348|584450328|FG000|Overall Study|Lost to Follow-up|5|||
161965094|NCT02839720|584917837|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
161838076|NCT01843348|584450329|FG001|Overall Study|Lost to Follow-up|4|||
161838077|NCT01843348|584450330|FG002|Overall Study|Lost to Follow-up|2|||
161838078|NCT01843348|584450328|FG000|Overall Study|Death|5|||
161838079|NCT01843348|584450329|FG001|Overall Study|Death|3|||
161838080|NCT01843348|584450330|FG002|Overall Study|Death|4|||
161838081|NCT01843348|584450328|FG000|Overall Study|Graft loss/retransplantation|5|||
161838082|NCT01843348|584450329|FG001|Overall Study|Graft loss/retransplantation|8|||
161838083|NCT01843348|584450330|FG002|Overall Study|Graft loss/retransplantation|11|||
161838084|NCT01843348|584450328|FG000|Overall Study|Various reasons|4|||
161838085|NCT01843348|584450329|FG001|Overall Study|Various reasons|9|||
161838086|NCT01843348|584450330|FG002|Overall Study|Various reasons|6|||
161838087|NCT00257920|584450331|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
161838088|NCT00257920|584450332|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
161838089|NCT00257920|584450331|FG000|Period: Second Intervention|Other|2|||
161838090|NCT00257920|584450332|FG001|Period: Second Intervention|Other|1|||
161965095|NCT00349921|584917838|FG000|First Spinal Injection|Physician Decision|1|||
161722181|NCT05270694|584026694|FG000|Overall Study|Death|1|||
161722182|NCT05270694|584026694|FG000|Overall Study|Medical issues impacted ability to participate|2|||
161722183|NCT05270694|584026694|FG000|Overall Study|Lost to Follow-up|3|||
161722184|NCT05270694|584026694|FG000|Overall Study|Withdrawal by Subject|3|||
161722185|NCT04267562|584026697|FG000|Assessed for Eligibility|Screen Failure|64|||
161722186|NCT04267562|584026697|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
161722187|NCT04267562|584026697|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
161722188|NCT04267562|584026697|FG000|Assessed for Eligibility|Site closure|6|||
161722189|NCT04267562|584026697|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
161722190|NCT04267562|584026697|FG000|Assessed for Eligibility|Physician Decision|1|||
161722191|NCT04267562|584026697|FG000|Month 24|Elective hysterectomy|1|||
161722192|NCT04267562|584026697|FG000|Month 24|Lost to Follow-up|1|||
161722193|NCT04267562|584026697|FG000|Month 36|Elective hysterectomy|2|||
161722194|NCT04267562|584026697|FG000|Month 36|Lost to Follow-up|3|||
161722195|NCT00128206|584026705|FG000|Overall Study|Lost to Follow-up|137|||
161722196|NCT00128206|584026706|FG001|Overall Study|Lost to Follow-up|118|||
161722197|NCT00128206|584026705|FG000|Overall Study|Adverse Event|0|||
161722198|NCT00128206|584026706|FG001|Overall Study|Adverse Event|2|||
161722199|NCT03032068|584026715|FG000|Overall Study|Adverse Event|1|||
161722200|NCT01597622|584026716|FG000|Overall Study|Adverse Event|7|||
161722201|NCT01597622|584026716|FG000|Overall Study|Lack of Efficacy|3|||
161722202|NCT01597622|584026716|FG000|Overall Study|Protocol Violation|1|||
161722203|NCT01597622|584026716|FG000|Overall Study|Lost to Follow-up|1|||
161722204|NCT01597622|584026716|FG000|Overall Study|Investigator Discretion|5|||
161722205|NCT01597622|584026716|FG000|Overall Study|Withdrawal by Subject|20|||
161722206|NCT01597622|584026716|FG000|Overall Study|Death|1|||
161722207|NCT00408421|584026719|FG000|Treatment Initial Randomization|Adverse Event|5|||
161722208|NCT00408421|584026720|FG001|Treatment Initial Randomization|Adverse Event|9|||
161722209|NCT00408421|584026721|FG002|Treatment Initial Randomization|Adverse Event|0|||
161722210|NCT00408421|584026719|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
161722211|NCT00408421|584026720|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
161722212|NCT00408421|584026721|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
161722213|NCT00408421|584026719|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
161722214|NCT00408421|584026720|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
161722215|NCT00408421|584026721|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
161722216|NCT00408421|584026719|FG000|Treatment Initial Randomization|Physician Decision|1|||
161722217|NCT00408421|584026720|FG001|Treatment Initial Randomization|Physician Decision|0|||
161722218|NCT00408421|584026721|FG002|Treatment Initial Randomization|Physician Decision|0|||
161722219|NCT00408421|584026719|FG000|Treatment Initial Randomization|Protocol Violation|0|||
161722220|NCT00408421|584026720|FG001|Treatment Initial Randomization|Protocol Violation|1|||
161722221|NCT00408421|584026721|FG002|Treatment Initial Randomization|Protocol Violation|0|||
161722222|NCT00408421|584026719|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
161722223|NCT00408421|584026720|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
161722224|NCT00408421|584026721|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
161965096|NCT00349921|584917839|FG001|First Spinal Injection|Physician Decision|0|||
161965097|NCT00349921|584917840|FG002|First Spinal Injection|Physician Decision|0|||
161722225|NCT00408421|584026719|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
161722226|NCT00408421|584026720|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
161722227|NCT00408421|584026721|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
161722228|NCT00408421|584026719|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
161722229|NCT00408421|584026720|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
161722230|NCT00408421|584026721|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
161722231|NCT00408421|584026719|FG000|Treatment Re-Randomization|Adverse Event|2|||
161722232|NCT00408421|584026720|FG001|Treatment Re-Randomization|Adverse Event|2|||
161722233|NCT00408421|584026721|FG002|Treatment Re-Randomization|Adverse Event|4|||
161722234|NCT00408421|584026719|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
161722235|NCT00408421|584026720|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
161722236|NCT00408421|584026721|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
161722237|NCT00408421|584026719|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
161722238|NCT00408421|584026720|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
161722239|NCT00408421|584026721|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
161722240|NCT00408421|584026719|FG000|Treatment Re-Randomization|Physician Decision|1|||
161722241|NCT00408421|584026720|FG001|Treatment Re-Randomization|Physician Decision|3|||
161722242|NCT00408421|584026721|FG002|Treatment Re-Randomization|Physician Decision|0|||
161722243|NCT00408421|584026719|FG000|Treatment Re-Randomization|Protocol Violation|1|||
161722244|NCT00408421|584026720|FG001|Treatment Re-Randomization|Protocol Violation|1|||
161722245|NCT00408421|584026721|FG002|Treatment Re-Randomization|Protocol Violation|0|||
161722246|NCT00408421|584026719|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
161722247|NCT00408421|584026720|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
161722248|NCT00408421|584026721|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
161965098|NCT00349921|584917841|FG003|First Spinal Injection|Physician Decision|0|||
161965099|NCT00349921|584917838|FG000|First Spinal Injection|Adverse Event|0|||
161722249|NCT00710034|584026724|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
161722250|NCT00710034|584026725|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
161722251|NCT00710034|584026724|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
161722252|NCT00710034|584026725|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
161722253|NCT00710034|584026724|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
161722254|NCT00710034|584026725|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
161722255|NCT00710034|584026724|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
161722256|NCT00710034|584026725|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
161722257|NCT00710034|584026724|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
161722258|NCT00710034|584026725|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
161722259|NCT00710034|584026724|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
161722260|NCT00710034|584026725|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
161722261|NCT00710034|584026724|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
161722262|NCT00710034|584026725|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
161722263|NCT00710034|584026724|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
161722264|NCT00710034|584026725|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
161722265|NCT00710034|584026724|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
161722266|NCT00710034|584026725|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
161722267|NCT00710034|584026724|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
161722268|NCT00710034|584026725|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
161722269|NCT00710034|584026724|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
161722270|NCT00710034|584026725|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
161722271|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
161722272|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
161722273|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
161722274|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
161722275|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Death|8|||
161722276|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Death|3|||
161722277|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
161722278|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
161722279|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
161722280|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
161722281|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
161722282|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
161722283|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
161722284|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
161722285|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
161722286|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
161722287|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
161722288|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
161722289|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
161722290|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
161722291|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
161722292|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
161722293|NCT00494871|584026726|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
161722294|NCT00494871|584026727|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
161722295|NCT00494871|584026726|FG000|Follow-up (FU) Period|Adverse Event|1|||
161722296|NCT00494871|584026727|FG001|Follow-up (FU) Period|Adverse Event|1|||
161722297|NCT00494871|584026726|FG000|Follow-up (FU) Period|Death|13|||
161722298|NCT00494871|584026727|FG001|Follow-up (FU) Period|Death|12|||
161722299|NCT00494871|584026726|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
161722300|NCT00494871|584026727|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
161722301|NCT00494871|584026726|FG000|Follow-up (FU) Period|Physician Decision|0|||
161722302|NCT00494871|584026727|FG001|Follow-up (FU) Period|Physician Decision|1|||
161722303|NCT00494871|584026726|FG000|Follow-up (FU) Period|Protocol Violation|1|||
161722304|NCT00494871|584026727|FG001|Follow-up (FU) Period|Protocol Violation|0|||
161722305|NCT00494871|584026726|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
161722306|NCT00494871|584026727|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
161722307|NCT00494871|584026726|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
161722308|NCT00494871|584026727|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
161722309|NCT03238248|584026736|FG000|Overall Study|Death|5|||
161722310|NCT03238248|584026736|FG000|Overall Study|Withdrawal by Subject|7|||
161722311|NCT03238248|584026736|FG000|Overall Study|Participant proceeding to transplant|10|||
161722312|NCT03238248|584026736|FG000|Overall Study|Lack of Efficacy|4|||
161722313|NCT03238248|584026736|FG000|Overall Study|Physician Decision|3|||
161722314|NCT03238248|584026736|FG000|Overall Study|Transitioning to another study|1|||
161722315|NCT03238248|584026736|FG000|Overall Study|No longer benefiting|1|||
161722316|NCT03238248|584026736|FG000|Overall Study|Other complicating disease|1|||
161722317|NCT03238248|584026736|FG000|Overall Study|Adverse Event|5|||
161722318|NCT03238248|584026736|FG000|Overall Study|Disease progression|26|||
161722319|NCT03238248|584026736|FG000|Overall Study|N/A participant is still on treatment|1|||
161722320|NCT03238248|584026736|FG000|Overall Study|Decline in condition|1|||
161722321|NCT03238248|584026736|FG000|Overall Study|Alternative therapy|2|||
161722322|NCT02639182|584026743|FG000|Overall Study|Disease Progression|50|||
161722323|NCT02639182|584026744|FG001|Overall Study|Disease Progression|49|||
161722324|NCT02639182|584026743|FG000|Overall Study|Adverse Event|7|||
161722325|NCT02639182|584026744|FG001|Overall Study|Adverse Event|5|||
161722326|NCT02639182|584026743|FG000|Overall Study|Physician Decision|3|||
161722327|NCT02639182|584026744|FG001|Overall Study|Physician Decision|3|||
161722328|NCT02639182|584026743|FG000|Overall Study|Withdrew Consent|5|||
161722329|NCT02639182|584026744|FG001|Overall Study|Withdrew Consent|4|||
161722330|NCT02639182|584026743|FG000|Overall Study|Lost to Follow-up|0|||
161722331|NCT02639182|584026744|FG001|Overall Study|Lost to Follow-up|1|||
161722332|NCT02639182|584026743|FG000|Overall Study|Study Closure|1|||
161722333|NCT02639182|584026744|FG001|Overall Study|Study Closure|2|||
161722334|NCT02639182|584026743|FG000|Overall Study|Sponsor Ended Study|0|||
161722335|NCT02639182|584026744|FG001|Overall Study|Sponsor Ended Study|1|||
161722336|NCT02639182|584026743|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
161722337|NCT02639182|584026744|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
161722338|NCT02546856|584026747|FG000|4 Months Evaluation|Death|2|||
161722339|NCT02546856|584026748|FG001|4 Months Evaluation|Death|3|||
161722340|NCT02546856|584026747|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
161722341|NCT02546856|584026748|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
161722342|NCT02546856|584026747|FG000|4 Months Evaluation|Lost to Follow-up|3|||
161722343|NCT02546856|584026748|FG001|4 Months Evaluation|Lost to Follow-up|3|||
161722344|NCT02546856|584026747|FG000|4 Months Evaluation|Physician Decision|3|||
161722345|NCT02546856|584026748|FG001|4 Months Evaluation|Physician Decision|0|||
161722346|NCT02546856|584026747|FG000|4 Months Evaluation|Working or living abroad|5|||
161722347|NCT02546856|584026748|FG001|4 Months Evaluation|Working or living abroad|1|||
161722348|NCT02546856|584026747|FG000|4 Months Evaluation|reasons not due to titration|4|||
161722349|NCT02546856|584026748|FG001|4 Months Evaluation|reasons not due to titration|1|||
161722350|NCT02546856|584026747|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
161722351|NCT02546856|584026748|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
161722352|NCT02546856|584026747|FG000|6 Months Evaluation|Death|1|||
161722353|NCT02546856|584026748|FG001|6 Months Evaluation|Death|1|||
161722354|NCT02546856|584026747|FG000|6 Months Evaluation|Lost to Follow-up|1|||
161722355|NCT02546856|584026748|FG001|6 Months Evaluation|Lost to Follow-up|1|||
161722356|NCT02546856|584026747|FG000|6 Months Evaluation|Working or living abroad|6|||
161722357|NCT02546856|584026748|FG001|6 Months Evaluation|Working or living abroad|4|||
161722358|NCT02546856|584026747|FG000|6 Months Evaluation|reasons not due to titration|0|||
161722359|NCT02546856|584026748|FG001|6 Months Evaluation|reasons not due to titration|1|||
161722360|NCT00130208|584026751|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
161722361|NCT00130208|584026752|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
161722362|NCT00130208|584026751|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
161722363|NCT00130208|584026752|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
161722364|NCT00130208|584026751|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
161722365|NCT00130208|584026752|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
161722366|NCT00130208|584026751|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
161722367|NCT00130208|584026752|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
161722368|NCT00130208|584026751|FG000|Maintenance Period (26 Weeks)|Other|1|||
161722369|NCT00130208|584026752|FG001|Maintenance Period (26 Weeks)|Other|1|||
161722370|NCT00130208|584026751|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
161722371|NCT00130208|584026752|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
161722372|NCT00130208|584026751|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
161722373|NCT00130208|584026752|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
161722374|NCT00130208|584026751|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
161722375|NCT00130208|584026752|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
161722376|NCT00130208|584026751|FG000|Washout Period (8 Weeks)|Other|1|||
161722377|NCT00130208|584026752|FG001|Washout Period (8 Weeks)|Other|1|||
161722378|NCT04655586|584026755|FG000|Overall Study|Physician Decision|1|||
161965100|NCT00349921|584917839|FG001|First Spinal Injection|Adverse Event|0|||
161722379|NCT04655586|584026756|FG001|Overall Study|Physician Decision|3|||
161722380|NCT04655586|584026757|FG002|Overall Study|Physician Decision|4|||
161722381|NCT04655586|584026755|FG000|Overall Study|Withdrawal by Subject|1|||
161722382|NCT04655586|584026756|FG001|Overall Study|Withdrawal by Subject|3|||
161722383|NCT04655586|584026757|FG002|Overall Study|Withdrawal by Subject|1|||
161722384|NCT03268746|584026761|FG000|Overall Study|Withdrawal by Subject|1|||
161722385|NCT01372878|584026762|FG000|Overall Study|Withdrawal by Subject|63|||
161722386|NCT01372878|584026762|FG000|Overall Study|Protocol Violation|17|||
161722387|NCT01372878|584026762|FG000|Overall Study|incomplete study procedure|104|||
161722388|NCT00546351|584026763|FG000|Overall Study|Adverse Event|76|||
161722389|NCT00546351|584026763|FG000|Overall Study|Lack of Efficacy|15|||
161722390|NCT00546351|584026763|FG000|Overall Study|Withdrawal by Subject|109|||
161722391|NCT00546351|584026763|FG000|Overall Study|Lost to Follow-up|9|||
161722392|NCT00546351|584026763|FG000|Overall Study|Protocol Deviation|1|||
161722393|NCT00546351|584026763|FG000|Overall Study|Unsatisfactory compliance|9|||
161722394|NCT00546351|584026763|FG000|Overall Study|Other reasons for premature termination|17|||
161722395|NCT04734873|584026765|FG000|Overall Study|Lost to Follow-up|1|||
161722396|NCT04734873|584026766|FG001|Overall Study|Lost to Follow-up|3|||
161722397|NCT04734873|584026767|FG002|Overall Study|Lost to Follow-up|2|||
161722398|NCT04734873|584026765|FG000|Overall Study|Randomized but not dosed|1|||
161722399|NCT04734873|584026766|FG001|Overall Study|Randomized but not dosed|0|||
161722400|NCT04734873|584026767|FG002|Overall Study|Randomized but not dosed|1|||
161722401|NCT02616029|584026771|FG000|Overall Study|Adverse Event|1|||
161722402|NCT02616029|584026772|FG001|Overall Study|Adverse Event|0|||
161722403|NCT02616029|584026771|FG000|Overall Study|Death|0|||
161722404|NCT02616029|584026772|FG001|Overall Study|Death|1|||
161722405|NCT02616029|584026771|FG000|Overall Study|Protocol Violation|1|||
161722406|NCT02616029|584026772|FG001|Overall Study|Protocol Violation|0|||
161722407|NCT02616029|584026771|FG000|Overall Study|Withdrew Consent|1|||
161722408|NCT02616029|584026772|FG001|Overall Study|Withdrew Consent|0|||
161722409|NCT02616029|584026771|FG000|Overall Study|Enrolled and Never Treated|1|||
161722410|NCT02616029|584026772|FG001|Overall Study|Enrolled and Never Treated|1|||
161722411|NCT00609609|584026773|FG000|Overall Study|Withdrawal by Subject|2|||
161722412|NCT00609609|584026774|FG001|Overall Study|Withdrawal by Subject|0|||
161722413|NCT00609609|584026773|FG000|Overall Study|Progression|4|||
161722414|NCT00609609|584026774|FG001|Overall Study|Progression|2|||
161722415|NCT03065530|584026775|FG000|Overall Study|Lack of Efficacy|1|||
161722416|NCT03065530|584026776|FG001|Overall Study|Lack of Efficacy|1|||
161722417|NCT03065530|584026777|FG002|Overall Study|Lack of Efficacy|0|||
161722418|NCT03065530|584026778|FG003|Overall Study|Lack of Efficacy|1|||
161722419|NCT03065530|584026775|FG000|Overall Study|Protocol Violation|1|||
161722420|NCT03065530|584026776|FG001|Overall Study|Protocol Violation|0|||
161722421|NCT03065530|584026777|FG002|Overall Study|Protocol Violation|1|||
161722422|NCT03065530|584026778|FG003|Overall Study|Protocol Violation|1|||
161722423|NCT00479466|584026781|FG000|Overall Study|Adverse Event|5|||
161722424|NCT00479466|584026782|FG001|Overall Study|Adverse Event|1|||
161722425|NCT00479466|584026783|FG002|Overall Study|Adverse Event|0|||
161722426|NCT00479466|584026784|FG003|Overall Study|Adverse Event|1|||
161722427|NCT00479466|584026785|FG004|Overall Study|Adverse Event|2|||
161722428|NCT00479466|584026786|FG005|Overall Study|Adverse Event|0|||
161722429|NCT00479466|584026781|FG000|Overall Study|Hyperglycemia|0|||
161722430|NCT00479466|584026782|FG001|Overall Study|Hyperglycemia|0|||
161722431|NCT00479466|584026783|FG002|Overall Study|Hyperglycemia|0|||
161722432|NCT00479466|584026784|FG003|Overall Study|Hyperglycemia|0|||
161722433|NCT00479466|584026785|FG004|Overall Study|Hyperglycemia|0|||
161722434|NCT00479466|584026786|FG005|Overall Study|Hyperglycemia|1|||
161722435|NCT00479466|584026781|FG000|Overall Study|Lack of Efficacy|2|||
161722436|NCT00479466|584026782|FG001|Overall Study|Lack of Efficacy|0|||
161722437|NCT00479466|584026783|FG002|Overall Study|Lack of Efficacy|1|||
161722438|NCT00479466|584026784|FG003|Overall Study|Lack of Efficacy|0|||
161722439|NCT00479466|584026785|FG004|Overall Study|Lack of Efficacy|0|||
161722440|NCT00479466|584026786|FG005|Overall Study|Lack of Efficacy|0|||
161722441|NCT00479466|584026781|FG000|Overall Study|Lost to Follow-up|0|||
161722442|NCT00479466|584026782|FG001|Overall Study|Lost to Follow-up|1|||
161722443|NCT00479466|584026783|FG002|Overall Study|Lost to Follow-up|1|||
161722444|NCT00479466|584026784|FG003|Overall Study|Lost to Follow-up|0|||
161722445|NCT00479466|584026785|FG004|Overall Study|Lost to Follow-up|2|||
161722446|NCT00479466|584026786|FG005|Overall Study|Lost to Follow-up|2|||
161722447|NCT00479466|584026781|FG000|Overall Study|Physician Decision|2|||
161722448|NCT00479466|584026782|FG001|Overall Study|Physician Decision|1|||
162032152|NCT00814801|585174220|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
162032153|NCT00814801|585174218|FG000|Overall Study|Missing or change of caregiver|6|||
162032154|NCT00814801|585174219|FG001|Overall Study|Missing or change of caregiver|2|||
162032155|NCT00814801|585174220|FG002|Overall Study|Missing or change of caregiver|4|||
161722449|NCT00479466|584026783|FG002|Overall Study|Physician Decision|1|||
161722450|NCT00479466|584026784|FG003|Overall Study|Physician Decision|0|||
161722451|NCT00479466|584026785|FG004|Overall Study|Physician Decision|0|||
161722452|NCT00479466|584026786|FG005|Overall Study|Physician Decision|0|||
161722453|NCT00479466|584026781|FG000|Overall Study|Pregnancy|0|||
161722454|NCT00479466|584026782|FG001|Overall Study|Pregnancy|0|||
161722455|NCT00479466|584026783|FG002|Overall Study|Pregnancy|0|||
161722456|NCT00479466|584026784|FG003|Overall Study|Pregnancy|0|||
161722457|NCT00479466|584026785|FG004|Overall Study|Pregnancy|1|||
161722458|NCT00479466|584026786|FG005|Overall Study|Pregnancy|0|||
161722459|NCT00479466|584026781|FG000|Overall Study|Protocol Violation|1|||
161722460|NCT00479466|584026782|FG001|Overall Study|Protocol Violation|0|||
161722461|NCT00479466|584026783|FG002|Overall Study|Protocol Violation|0|||
161722462|NCT00479466|584026784|FG003|Overall Study|Protocol Violation|0|||
161722463|NCT00479466|584026785|FG004|Overall Study|Protocol Violation|0|||
161722464|NCT00479466|584026786|FG005|Overall Study|Protocol Violation|0|||
161722465|NCT00479466|584026781|FG000|Overall Study|Withdrawal by Subject|3|||
161722466|NCT00479466|584026782|FG001|Overall Study|Withdrawal by Subject|5|||
161722467|NCT00479466|584026783|FG002|Overall Study|Withdrawal by Subject|0|||
161722468|NCT00479466|584026784|FG003|Overall Study|Withdrawal by Subject|2|||
161722469|NCT00479466|584026785|FG004|Overall Study|Withdrawal by Subject|3|||
161722470|NCT00479466|584026786|FG005|Overall Study|Withdrawal by Subject|1|||
161722471|NCT01469013|584026797|FG000|Part A (Treatment Period)|Adverse Event|1|||
161722472|NCT01469013|584026798|FG001|Part A (Treatment Period)|Adverse Event|0|||
161722473|NCT01469013|584026799|FG002|Part A (Treatment Period)|Adverse Event|0|||
161722474|NCT01469013|584026800|FG003|Part A (Treatment Period)|Adverse Event|0|||
161722475|NCT01469013|584026801|FG004|Part A (Treatment Period)|Adverse Event|1|||
161722476|NCT01469013|584026802|FG005|Part A (Treatment Period)|Adverse Event|0|||
161722477|NCT01469013|584026803|FG006|Part A (Treatment Period)|Adverse Event|0|||
161722478|NCT01469013|584026804|FG007|Part A (Treatment Period)|Adverse Event|0|||
161722479|NCT01469013|584026805|FG008|Part A (Treatment Period)|Adverse Event|0|||
161722480|NCT01469013|584026806|FG009|Part A (Treatment Period)|Adverse Event|0|||
161722481|NCT01469013|584026807|FG010|Part A (Treatment Period)|Adverse Event|0|||
161722482|NCT01469013|584026808|FG011|Part A (Treatment Period)|Adverse Event|0|||
161722483|NCT01469013|584026809|FG012|Part A (Treatment Period)|Adverse Event|0|||
161722484|NCT01469013|584026797|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722485|NCT01469013|584026798|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722486|NCT01469013|584026799|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
161722487|NCT01469013|584026800|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722488|NCT01469013|584026801|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722489|NCT01469013|584026802|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722490|NCT01469013|584026803|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722491|NCT01469013|584026804|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722492|NCT01469013|584026805|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722493|NCT01469013|584026806|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722494|NCT01469013|584026807|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722495|NCT01469013|584026808|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722496|NCT01469013|584026809|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
161722497|NCT01469013|584026797|FG000|Part B (Extension Period)|Adverse Event|0|||
161722498|NCT01469013|584026798|FG001|Part B (Extension Period)|Adverse Event|0|||
161722499|NCT01469013|584026799|FG002|Part B (Extension Period)|Adverse Event|0|||
161722500|NCT01469013|584026800|FG003|Part B (Extension Period)|Adverse Event|0|||
161722501|NCT01469013|584026801|FG004|Part B (Extension Period)|Adverse Event|0|||
161722502|NCT01469013|584026802|FG005|Part B (Extension Period)|Adverse Event|2|||
161722503|NCT01469013|584026803|FG006|Part B (Extension Period)|Adverse Event|5|||
161722504|NCT01469013|584026804|FG007|Part B (Extension Period)|Adverse Event|5|||
161722505|NCT01469013|584026805|FG008|Part B (Extension Period)|Adverse Event|3|||
161722506|NCT01469013|584026806|FG009|Part B (Extension Period)|Adverse Event|3|||
161722507|NCT01469013|584026807|FG010|Part B (Extension Period)|Adverse Event|1|||
161722508|NCT01469013|584026808|FG011|Part B (Extension Period)|Adverse Event|6|||
161722509|NCT01469013|584026809|FG012|Part B (Extension Period)|Adverse Event|3|||
161722510|NCT01469013|584026797|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
161722511|NCT01469013|584026798|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
161722512|NCT01469013|584026799|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
161965101|NCT00349921|584917840|FG002|First Spinal Injection|Adverse Event|1|||
161965102|NCT00349921|584917841|FG003|First Spinal Injection|Adverse Event|0|||
161965103|NCT05145322|584917842|FG000|Overall Study|Lost to Follow-up|4|||
161965104|NCT05145322|584917843|FG001|Overall Study|Lost to Follow-up|5|||
161965105|NCT04700540|584917844|FG000|Overall Study|Withdrawal by Subject|12|||
161965106|NCT04700540|584917845|FG001|Overall Study|Withdrawal by Subject|8|||
161965107|NCT04700540|584917844|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
161965108|NCT04700540|584917845|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
161965109|NCT03194568|584917846|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
161965110|NCT05285644|584917849|FG000|Overall Study|Adverse Event|3|||
161965111|NCT05285644|584917850|FG001|Overall Study|Adverse Event|3|||
161965112|NCT05285644|584917849|FG000|Overall Study|Withdrawal of Consent|2|||
161965113|NCT05285644|584917850|FG001|Overall Study|Withdrawal of Consent|5|||
161965114|NCT05285644|584917849|FG000|Overall Study|Noncompliance|0|||
161965115|NCT05285644|584917850|FG001|Overall Study|Noncompliance|4|||
161965116|NCT05285644|584917849|FG000|Overall Study|Lost to Follow-up|4|||
161722513|NCT01469013|584026800|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
161722514|NCT01469013|584026801|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
161722515|NCT01469013|584026802|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
161722516|NCT01469013|584026803|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
161965117|NCT05285644|584917850|FG001|Overall Study|Lost to Follow-up|6|||
161722517|NCT01469013|584026804|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
161722518|NCT01469013|584026805|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
161722519|NCT01469013|584026806|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
161722520|NCT01469013|584026807|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
161965118|NCT05285644|584917849|FG000|Overall Study|Disallowed Concurrent Medication|1|||
161965119|NCT05285644|584917850|FG001|Overall Study|Disallowed Concurrent Medication|1|||
161722521|NCT01469013|584026808|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
161722522|NCT01469013|584026809|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
161722523|NCT05232097|584026810|FG000|Overall Study|Physician Decision|1|||
161722524|NCT00425438|584026813|FG000|Overall Study|Termination by Sponsor|25|||
161722525|NCT00425438|584026814|FG001|Overall Study|Termination by Sponsor|27|||
161722526|NCT02902809|584026817|FG000|Overall Study|Discontinuation of asthma program|28|||
161722527|NCT00532259|584026818|FG000|Overall Study|Withdrawal by Subject|2|||
161722528|NCT00532259|584026818|FG000|Overall Study|Adverse Event|1|||
161722529|NCT00532259|584026818|FG000|Overall Study|Death|1|||
161722530|NCT00532259|584026818|FG000|Overall Study|Lack of Efficacy|21|||
161722531|NCT00532259|584026818|FG000|Overall Study|Lost to Follow-up|3|||
161722532|NCT00532259|584026818|FG000|Overall Study|Physician Decision|3|||
161722533|NCT00532259|584026818|FG000|Overall Study|Protocol Violation|1|||
161722534|NCT00871858|584026819|FG000|Overall Study|Protocol Violation|3|||
161722535|NCT00871858|584026820|FG001|Overall Study|Protocol Violation|4|||
161722536|NCT00871858|584026819|FG000|Overall Study|Adverse Event|1|||
161722537|NCT00871858|584026820|FG001|Overall Study|Adverse Event|1|||
161722538|NCT00871858|584026819|FG000|Overall Study|Withdrawal by Subject|1|||
161722539|NCT00871858|584026820|FG001|Overall Study|Withdrawal by Subject|1|||
161722540|NCT00871858|584026819|FG000|Overall Study|Lost to Follow-up|0|||
161722541|NCT00871858|584026820|FG001|Overall Study|Lost to Follow-up|1|||
161722542|NCT02795767|584026823|FG000|Overall Study|Received Commercial Emicizumab|1|||
161722543|NCT02795767|584026824|FG001|Overall Study|Received Commercial Emicizumab|0|||
161722544|NCT02795767|584026825|FG002|Overall Study|Received Commercial Emicizumab|0|||
161722545|NCT04983940|584026826|FG000|Overall Study|Lost to Follow-up|14|||
161722546|NCT04983940|584026826|FG000|Overall Study|Lack of Efficacy|2|||
161722547|NCT01748760|584026827|FG000|Overall Study|Withdrawal by Subject|1|||
161722548|NCT01748760|584026828|FG001|Overall Study|Withdrawal by Subject|1|||
161722549|NCT01748760|584026827|FG000|Overall Study|Lost to Follow-up|5|||
161722550|NCT01748760|584026828|FG001|Overall Study|Lost to Follow-up|1|||
161722551|NCT03009539|584028257|FG000|Overall Study|Lost to Follow-up|132|||
161722552|NCT03009539|584028258|FG001|Overall Study|Lost to Follow-up|113|||
161722553|NCT03009539|584028259|FG002|Overall Study|Lost to Follow-up|132|||
161722554|NCT03009539|584028260|FG003|Overall Study|Lost to Follow-up|113|||
161722555|NCT04543955|584028261|FG000|Overall Study|Company cancelled study|1|||
161722556|NCT04543955|584028262|FG001|Overall Study|Company cancelled study|0|||
161722557|NCT03918642|584028263|FG000|Overall Study|Lost to Follow-up|12|||
161722558|NCT03918642|584028264|FG001|Overall Study|Lost to Follow-up|10|||
161722559|NCT01158534|584028265|FG000|Overall Study|Withdrawal by Subject|1|||
161722560|NCT01158534|584028265|FG000|Overall Study|Death|1|||
161722561|NCT01158534|584028265|FG000|Overall Study|Other|1|||
161722562|NCT03504774|584028266|FG000|Overall Study|Adverse Event|2|||
161722563|NCT03504774|584028267|FG001|Overall Study|Adverse Event|0|||
161722564|NCT03504774|584028266|FG000|Overall Study|Lost to Follow-up|0|||
161722565|NCT03504774|584028267|FG001|Overall Study|Lost to Follow-up|1|||
161722566|NCT03504774|584028266|FG000|Overall Study|Protocol Violation|11|||
161722567|NCT03504774|584028267|FG001|Overall Study|Protocol Violation|3|||
161722568|NCT03504774|584028266|FG000|Overall Study|failed wk 52 DBPCFC|1|||
161722569|NCT03504774|584028267|FG001|Overall Study|failed wk 52 DBPCFC|0|||
161722570|NCT01781429|584028268|FG000|Overall Study|Death|0|||
161722571|NCT01781429|584028269|FG001|Overall Study|Death|0|||
161722572|NCT01781429|584028270|FG002|Overall Study|Death|0|||
161722573|NCT01781429|584028271|FG003|Overall Study|Death|0|||
161722574|NCT01781429|584028272|FG004|Overall Study|Death|0|||
161722575|NCT01781429|584028273|FG005|Overall Study|Death|0|||
161722576|NCT01781429|584028274|FG006|Overall Study|Death|0|||
161722577|NCT01781429|584028275|FG007|Overall Study|Death|0|||
161722578|NCT01781429|584028276|FG008|Overall Study|Death|0|||
161722579|NCT01781429|584028277|FG009|Overall Study|Death|1|||
161722580|NCT01781429|584028278|FG010|Overall Study|Death|0|||
161722581|NCT01781429|584028279|FG011|Overall Study|Death|0|||
161722582|NCT01781429|584028280|FG012|Overall Study|Death|1|||
161722583|NCT01781429|584028281|FG013|Overall Study|Death|0|||
161722584|NCT01781429|584028282|FG014|Overall Study|Death|1|||
161722585|NCT01781429|584028283|FG015|Overall Study|Death|0|||
161722586|NCT01781429|584028268|FG000|Overall Study|Withdrawal by Subject|0|||
161722587|NCT01781429|584028269|FG001|Overall Study|Withdrawal by Subject|0|||
161722588|NCT01781429|584028270|FG002|Overall Study|Withdrawal by Subject|0|||
161722589|NCT01781429|584028271|FG003|Overall Study|Withdrawal by Subject|0|||
161722590|NCT01781429|584028272|FG004|Overall Study|Withdrawal by Subject|0|||
161722591|NCT01781429|584028273|FG005|Overall Study|Withdrawal by Subject|0|||
161722592|NCT01781429|584028274|FG006|Overall Study|Withdrawal by Subject|0|||
161722593|NCT01781429|584028275|FG007|Overall Study|Withdrawal by Subject|0|||
161722594|NCT01781429|584028276|FG008|Overall Study|Withdrawal by Subject|1|||
161722595|NCT01781429|584028277|FG009|Overall Study|Withdrawal by Subject|3|||
161722596|NCT01781429|584028278|FG010|Overall Study|Withdrawal by Subject|1|||
161722597|NCT01781429|584028279|FG011|Overall Study|Withdrawal by Subject|1|||
161722598|NCT01781429|584028280|FG012|Overall Study|Withdrawal by Subject|5|||
161722599|NCT01781429|584028281|FG013|Overall Study|Withdrawal by Subject|2|||
161722600|NCT01781429|584028282|FG014|Overall Study|Withdrawal by Subject|3|||
161722601|NCT01781429|584028283|FG015|Overall Study|Withdrawal by Subject|0|||
161722602|NCT01781429|584028268|FG000|Overall Study|Disease Progression|1|||
161722603|NCT01781429|584028269|FG001|Overall Study|Disease Progression|0|||
161722604|NCT01781429|584028270|FG002|Overall Study|Disease Progression|1|||
161722605|NCT01781429|584028271|FG003|Overall Study|Disease Progression|1|||
161722606|NCT01781429|584028272|FG004|Overall Study|Disease Progression|1|||
161722607|NCT01781429|584028273|FG005|Overall Study|Disease Progression|4|||
161722608|NCT01781429|584028274|FG006|Overall Study|Disease Progression|7|||
161722609|NCT01781429|584028275|FG007|Overall Study|Disease Progression|4|||
161722610|NCT01781429|584028276|FG008|Overall Study|Disease Progression|6|||
161722611|NCT01781429|584028277|FG009|Overall Study|Disease Progression|15|||
161722612|NCT01781429|584028278|FG010|Overall Study|Disease Progression|15|||
161722613|NCT01781429|584028279|FG011|Overall Study|Disease Progression|15|||
161722614|NCT01781429|584028280|FG012|Overall Study|Disease Progression|15|||
161722615|NCT01781429|584028281|FG013|Overall Study|Disease Progression|4|||
161722616|NCT01781429|584028282|FG014|Overall Study|Disease Progression|11|||
161722617|NCT01781429|584028283|FG015|Overall Study|Disease Progression|0|||
161722618|NCT01781429|584028268|FG000|Overall Study|Unacceptable Toxicity|0|||
161722619|NCT01781429|584028269|FG001|Overall Study|Unacceptable Toxicity|0|||
161722620|NCT01781429|584028270|FG002|Overall Study|Unacceptable Toxicity|0|||
161722621|NCT01781429|584028271|FG003|Overall Study|Unacceptable Toxicity|0|||
161722622|NCT01781429|584028272|FG004|Overall Study|Unacceptable Toxicity|0|||
161722623|NCT01781429|584028273|FG005|Overall Study|Unacceptable Toxicity|0|||
161722624|NCT01781429|584028274|FG006|Overall Study|Unacceptable Toxicity|0|||
161722625|NCT01781429|584028275|FG007|Overall Study|Unacceptable Toxicity|0|||
161722626|NCT01781429|584028276|FG008|Overall Study|Unacceptable Toxicity|0|||
161722627|NCT01781429|584028277|FG009|Overall Study|Unacceptable Toxicity|0|||
161722628|NCT01781429|584028278|FG010|Overall Study|Unacceptable Toxicity|0|||
161722629|NCT01781429|584028279|FG011|Overall Study|Unacceptable Toxicity|2|||
161722630|NCT01781429|584028280|FG012|Overall Study|Unacceptable Toxicity|0|||
161722631|NCT01781429|584028281|FG013|Overall Study|Unacceptable Toxicity|0|||
161722632|NCT01781429|584028282|FG014|Overall Study|Unacceptable Toxicity|0|||
161722633|NCT01781429|584028283|FG015|Overall Study|Unacceptable Toxicity|0|||
161722634|NCT01781429|584028268|FG000|Overall Study|Patient Condition Changed|0|||
161722635|NCT01781429|584028269|FG001|Overall Study|Patient Condition Changed|0|||
161722636|NCT01781429|584028270|FG002|Overall Study|Patient Condition Changed|0|||
161722637|NCT01781429|584028271|FG003|Overall Study|Patient Condition Changed|0|||
161722638|NCT01781429|584028272|FG004|Overall Study|Patient Condition Changed|0|||
161722639|NCT01781429|584028273|FG005|Overall Study|Patient Condition Changed|0|||
161722640|NCT01781429|584028274|FG006|Overall Study|Patient Condition Changed|0|||
161722641|NCT01781429|584028275|FG007|Overall Study|Patient Condition Changed|0|||
161722642|NCT01781429|584028276|FG008|Overall Study|Patient Condition Changed|0|||
161722643|NCT01781429|584028277|FG009|Overall Study|Patient Condition Changed|4|||
161722644|NCT01781429|584028278|FG010|Overall Study|Patient Condition Changed|0|||
161722645|NCT01781429|584028279|FG011|Overall Study|Patient Condition Changed|1|||
161722646|NCT01781429|584028280|FG012|Overall Study|Patient Condition Changed|0|||
161722647|NCT01781429|584028281|FG013|Overall Study|Patient Condition Changed|1|||
161722648|NCT01781429|584028282|FG014|Overall Study|Patient Condition Changed|0|||
161722649|NCT01781429|584028283|FG015|Overall Study|Patient Condition Changed|0|||
161722650|NCT01781429|584028268|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
161722651|NCT01781429|584028269|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
161722652|NCT01781429|584028270|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
161722653|NCT01781429|584028271|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
161722654|NCT01781429|584028272|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
161722655|NCT01781429|584028273|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
161722656|NCT01781429|584028274|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
161965120|NCT05285644|584917849|FG000|Overall Study|Investigator Decision|2|||
161965121|NCT05285644|584917850|FG001|Overall Study|Investigator Decision|0|||
161965122|NCT05285644|584917849|FG000|Overall Study|Protocol Deviation|1|||
161965123|NCT05285644|584917850|FG001|Overall Study|Protocol Deviation|0|||
161965124|NCT05285644|584917849|FG000|Overall Study|As specified in the Clinical Study Report|7|||
161965125|NCT05285644|584917850|FG001|Overall Study|As specified in the Clinical Study Report|3|||
161965126|NCT01740089|584920198|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
161965127|NCT01740089|584920199|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
161965128|NCT01740089|584920200|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
161965129|NCT01740089|584920198|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
161965130|NCT01740089|584920199|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
161965131|NCT01740089|584920200|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
161722657|NCT01781429|584028275|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
161722658|NCT01781429|584028276|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
161722659|NCT01781429|584028277|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
161722660|NCT01781429|584028278|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
161722661|NCT01781429|584028279|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
161722662|NCT01781429|584028280|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
161722663|NCT01781429|584028281|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
161722664|NCT01781429|584028282|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
161722665|NCT01781429|584028283|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
161722666|NCT01781429|584028268|FG000|Overall Study|Enrolled, but not treated|0|||
161722667|NCT01781429|584028269|FG001|Overall Study|Enrolled, but not treated|0|||
161722668|NCT01781429|584028270|FG002|Overall Study|Enrolled, but not treated|0|||
161722669|NCT01781429|584028271|FG003|Overall Study|Enrolled, but not treated|0|||
161722670|NCT01781429|584028272|FG004|Overall Study|Enrolled, but not treated|0|||
161722671|NCT01781429|584028273|FG005|Overall Study|Enrolled, but not treated|0|||
161722672|NCT01781429|584028274|FG006|Overall Study|Enrolled, but not treated|0|||
161722673|NCT01781429|584028275|FG007|Overall Study|Enrolled, but not treated|0|||
161722674|NCT01781429|584028276|FG008|Overall Study|Enrolled, but not treated|0|||
161722675|NCT01781429|584028277|FG009|Overall Study|Enrolled, but not treated|0|||
161722676|NCT01781429|584028278|FG010|Overall Study|Enrolled, but not treated|1|||
161722677|NCT01781429|584028279|FG011|Overall Study|Enrolled, but not treated|0|||
161722678|NCT01781429|584028280|FG012|Overall Study|Enrolled, but not treated|0|||
161722679|NCT01781429|584028281|FG013|Overall Study|Enrolled, but not treated|0|||
161722680|NCT01781429|584028282|FG014|Overall Study|Enrolled, but not treated|0|||
161722681|NCT01781429|584028283|FG015|Overall Study|Enrolled, but not treated|0|||
161722682|NCT00986258|584028284|FG000|Observation Period|Not eligible to be dosed|11|||
161722683|NCT00986258|584028284|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
161722684|NCT00986258|584028284|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
161722685|NCT00986258|584028284|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
161722686|NCT00986258|584028284|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
161722687|NCT00986258|584028284|FG000|Titration and Optimal Dose Period|Other|1|||
161722688|NCT00986258|584028284|FG000|Maintenance Period|Adverse Event|5|||
161722689|NCT00986258|584028284|FG000|Maintenance Period|Lack of Efficacy|2|||
161722690|NCT00986258|584028284|FG000|Maintenance Period|Withdrawal by Subject|2|||
161722691|NCT03332667|584028285|FG000|Overall Study|Adverse Event|0|||
161722692|NCT03332667|584028286|FG001|Overall Study|Adverse Event|0|||
161722693|NCT03332667|584028287|FG002|Overall Study|Adverse Event|2|||
161722694|NCT03332667|584028288|FG003|Overall Study|Adverse Event|1|||
161722695|NCT03332667|584028285|FG000|Overall Study|Withdrawal by Subject|2|||
161722696|NCT03332667|584028286|FG001|Overall Study|Withdrawal by Subject|1|||
161722697|NCT03332667|584028287|FG002|Overall Study|Withdrawal by Subject|5|||
161722698|NCT03332667|584028288|FG003|Overall Study|Withdrawal by Subject|1|||
161722699|NCT03332667|584028285|FG000|Overall Study|Disease Progression or Relapse|2|||
161722700|NCT03332667|584028286|FG001|Overall Study|Disease Progression or Relapse|1|||
161722701|NCT03332667|584028287|FG002|Overall Study|Disease Progression or Relapse|3|||
161722702|NCT03332667|584028288|FG003|Overall Study|Disease Progression or Relapse|0|||
161722703|NCT03332667|584028285|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
161722704|NCT03332667|584028286|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
161722705|NCT03332667|584028287|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
161722706|NCT03332667|584028288|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
161722707|NCT03332667|584028285|FG000|Overall Study|No Treatment Received|0|||
161722708|NCT03332667|584028286|FG001|Overall Study|No Treatment Received|0|||
161722709|NCT03332667|584028287|FG002|Overall Study|No Treatment Received|1|||
161722710|NCT03332667|584028288|FG003|Overall Study|No Treatment Received|0|||
161722711|NCT01035606|584028289|FG000|Overall Study|change in health, job demands,family|3|||
161722712|NCT01035606|584028290|FG001|Overall Study|change in health, job demands,family|3|||
161722713|NCT01035606|584028291|FG002|Overall Study|change in health, job demands,family|4|||
161722714|NCT02385123|584028292|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
161722715|NCT04498910|584028293|FG000|Overall Study|Lost to Follow-up|0|||
161722716|NCT04498910|584028294|FG001|Overall Study|Lost to Follow-up|1|||
161722717|NCT04498910|584028293|FG000|Overall Study|Withdrawal by Subject|2|||
161722718|NCT04498910|584028294|FG001|Overall Study|Withdrawal by Subject|1|||
161722719|NCT04498910|584028293|FG000|Overall Study|Adverse Event|1|||
161722720|NCT04498910|584028294|FG001|Overall Study|Adverse Event|0|||
161722721|NCT01070303|584028295|FG000|Overall Study|Adverse Event|39|||
161722722|NCT01070303|584028295|FG000|Overall Study|Withdrawal by Subject|20|||
161722723|NCT01070303|584028295|FG000|Overall Study|Lost to Follow-up|9|||
161722724|NCT01070303|584028295|FG000|Overall Study|Protocol Violation|0|||
161722725|NCT01070303|584028295|FG000|Overall Study|Lack of Efficacy|2|||
161722726|NCT01070303|584028295|FG000|Overall Study|Administrative Reason|1|||
161965132|NCT01740089|584920198|FG000|After 12 Weeks|Lack of Efficacy|3|||
161965133|NCT01740089|584920199|FG001|After 12 Weeks|Lack of Efficacy|1|||
161722727|NCT01070303|584028295|FG000|Overall Study|Other|18|||
161722728|NCT01809262|584028296|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722729|NCT01809262|584028297|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
161965134|NCT01740089|584920200|FG002|After 12 Weeks|Lack of Efficacy|4|||
161965135|NCT01740089|584920198|FG000|After 12 Weeks|Adverse Event|2|||
161722730|NCT01809262|584028298|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722731|NCT01809262|584028299|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722732|NCT01809262|584028300|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
161965136|NCT01740089|584920199|FG001|After 12 Weeks|Adverse Event|0|||
161722733|NCT01809262|584028301|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722734|NCT01809262|584028302|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722735|NCT01809262|584028303|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722736|NCT01809262|584028304|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722737|NCT01809262|584028305|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
161722738|NCT01809262|584028296|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722739|NCT01809262|584028297|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
161722740|NCT01809262|584028298|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722741|NCT01809262|584028299|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722742|NCT01809262|584028300|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722743|NCT01809262|584028301|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722744|NCT01809262|584028302|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722745|NCT01809262|584028303|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722746|NCT01809262|584028304|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722747|NCT01809262|584028305|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161722748|NCT02345434|584028308|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
161722749|NCT02345434|584028309|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
161722750|NCT00859898|584028311|FG000|Overall Study|Lack of Efficacy|0|||
161722751|NCT00859898|584028312|FG001|Overall Study|Lack of Efficacy|1|||
161722752|NCT00859898|584028313|FG002|Overall Study|Lack of Efficacy|1|||
161722753|NCT00859898|584028311|FG000|Overall Study|Adverse Event|4|||
161722754|NCT00859898|584028312|FG001|Overall Study|Adverse Event|9|||
161722755|NCT00859898|584028313|FG002|Overall Study|Adverse Event|8|||
161722756|NCT00859898|584028311|FG000|Overall Study|Withdrawal by Subject|11|||
161722757|NCT00859898|584028312|FG001|Overall Study|Withdrawal by Subject|8|||
161722758|NCT00859898|584028313|FG002|Overall Study|Withdrawal by Subject|11|||
161722759|NCT00859898|584028311|FG000|Overall Study|Death|0|||
161722760|NCT00859898|584028312|FG001|Overall Study|Death|0|||
161722761|NCT00859898|584028313|FG002|Overall Study|Death|1|||
161722762|NCT00859898|584028311|FG000|Overall Study|Lost to Follow-up|10|||
161722763|NCT00859898|584028312|FG001|Overall Study|Lost to Follow-up|11|||
161722764|NCT00859898|584028313|FG002|Overall Study|Lost to Follow-up|5|||
161722765|NCT00859898|584028311|FG000|Overall Study|poor/non-compliance|2|||
161722766|NCT00859898|584028312|FG001|Overall Study|poor/non-compliance|0|||
161722767|NCT00859898|584028313|FG002|Overall Study|poor/non-compliance|0|||
161722768|NCT00859898|584028311|FG000|Overall Study|No longer meets criteria|0|||
161722769|NCT00859898|584028312|FG001|Overall Study|No longer meets criteria|1|||
161722770|NCT00859898|584028313|FG002|Overall Study|No longer meets criteria|0|||
161722771|NCT00859898|584028311|FG000|Overall Study|non-specified|1|||
161722772|NCT00859898|584028312|FG001|Overall Study|non-specified|1|||
161722773|NCT00859898|584028313|FG002|Overall Study|non-specified|1|||
161722774|NCT03215264|584028315|FG000|Dose Level 2|Adverse Event|0|||
161722775|NCT03215264|584028316|FG001|Dose Level 2|Adverse Event|1|||
161722776|NCT03215264|584028317|FG002|Dose Level 2|Adverse Event|0|||
161722777|NCT03215264|584028315|FG000|Dose Level 3|Withdrawal by Subject|0|||
161722778|NCT03215264|584028316|FG001|Dose Level 3|Withdrawal by Subject|0|||
161722779|NCT03215264|584028317|FG002|Dose Level 3|Withdrawal by Subject|1|||
161722780|NCT02145156|584028318|FG000|Overall Study|No match to vaccination records|60|||
161722781|NCT02145156|584028319|FG001|Overall Study|No match to vaccination records|52|||
161722782|NCT02145156|584028320|FG002|Overall Study|No match to vaccination records|41|||
161722783|NCT02064439|584028322|FG000|Overall Study|Adverse Event|51|||
161722784|NCT02064439|584028323|FG001|Overall Study|Adverse Event|47|||
161722785|NCT02064439|584028324|FG002|Overall Study|Adverse Event|46|||
161722786|NCT02064439|584028322|FG000|Overall Study|Death|0|||
161722787|NCT02064439|584028323|FG001|Overall Study|Death|2|||
161722788|NCT02064439|584028324|FG002|Overall Study|Death|3|||
161722789|NCT02064439|584028322|FG000|Overall Study|Withdrawal by Subject|29|||
161722790|NCT02064439|584028323|FG001|Overall Study|Withdrawal by Subject|18|||
161722791|NCT02064439|584028324|FG002|Overall Study|Withdrawal by Subject|26|||
161722792|NCT02064439|584028322|FG000|Overall Study|Protocol Violation|3|||
161722793|NCT02064439|584028323|FG001|Overall Study|Protocol Violation|5|||
161722794|NCT02064439|584028324|FG002|Overall Study|Protocol Violation|3|||
161722795|NCT02064439|584028322|FG000|Overall Study|Lost to Follow-up|1|||
161722796|NCT02064439|584028323|FG001|Overall Study|Lost to Follow-up|3|||
161722797|NCT02064439|584028324|FG002|Overall Study|Lost to Follow-up|4|||
161722798|NCT02064439|584028322|FG000|Overall Study|Non-compliance with study medication|21|||
161722799|NCT02064439|584028323|FG001|Overall Study|Non-compliance with study medication|19|||
161722800|NCT02064439|584028324|FG002|Overall Study|Non-compliance with study medication|23|||
161722801|NCT02064439|584028322|FG000|Overall Study|Physician Decision|0|||
161722802|NCT02064439|584028323|FG001|Overall Study|Physician Decision|1|||
161722803|NCT02064439|584028324|FG002|Overall Study|Physician Decision|1|||
161722804|NCT02064439|584028322|FG000|Overall Study|Logistical difficulties|6|||
161722805|NCT02064439|584028323|FG001|Overall Study|Logistical difficulties|5|||
161722806|NCT02064439|584028324|FG002|Overall Study|Logistical difficulties|2|||
161722807|NCT02064439|584028322|FG000|Overall Study|Efficacy outcome reached|18|||
161722808|NCT02064439|584028323|FG001|Overall Study|Efficacy outcome reached|16|||
161722809|NCT02064439|584028324|FG002|Overall Study|Efficacy outcome reached|57|||
161722810|NCT02064439|584028322|FG000|Overall Study|Safety outcome reached|12|||
161722811|NCT02064439|584028323|FG001|Overall Study|Safety outcome reached|20|||
161722812|NCT02064439|584028324|FG002|Overall Study|Safety outcome reached|10|||
161722813|NCT02064439|584028322|FG000|Overall Study|Other|2|||
161722814|NCT02064439|584028323|FG001|Overall Study|Other|2|||
161722815|NCT02064439|584028324|FG002|Overall Study|Other|7|||
161722816|NCT02433288|584028325|FG000|Overall Study|Severe non-compliance to protocol|13|||
161722817|NCT02433288|584028326|FG001|Overall Study|Severe non-compliance to protocol|7|||
161722818|NCT02433288|584028325|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
161722819|NCT02433288|584028326|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
161722820|NCT02433288|584028325|FG000|Overall Study|Withdrawal by Subject|101|||
161722821|NCT02433288|584028326|FG001|Overall Study|Withdrawal by Subject|99|||
161722822|NCT02433288|584028325|FG000|Overall Study|Lost to Follow-up|2|||
161722823|NCT02433288|584028326|FG001|Overall Study|Lost to Follow-up|14|||
161722824|NCT02433288|584028325|FG000|Overall Study|Death|0|||
161722825|NCT02433288|584028326|FG001|Overall Study|Death|3|||
161722826|NCT00858702|584028329|FG000|Overall Study|Lack of Efficacy|1|||
161722827|NCT00858702|584028330|FG001|Overall Study|Lack of Efficacy|0|||
161722828|NCT00858702|584028329|FG000|Overall Study|Protocol Violation|1|||
161722829|NCT00858702|584028330|FG001|Overall Study|Protocol Violation|1|||
161722830|NCT00858702|584028329|FG000|Overall Study|Other|2|||
161722831|NCT00858702|584028330|FG001|Overall Study|Other|1|||
161722832|NCT00858702|584028329|FG000|Overall Study|Withdrawal by Subject|1|||
161722833|NCT00858702|584028330|FG001|Overall Study|Withdrawal by Subject|0|||
161722834|NCT01740440|584028333|FG000|Overall Study|Lost to Follow-up|3|||
161722835|NCT00367640|584028334|FG000|Overall Study|Adverse Event|3|||
161722836|NCT00367640|584028335|FG001|Overall Study|Adverse Event|6|||
161722837|NCT00367640|584028336|FG002|Overall Study|Adverse Event|8|||
161722838|NCT00367640|584028337|FG003|Overall Study|Adverse Event|0|||
161722839|NCT00367640|584028334|FG000|Overall Study|Withdrawal by Subject|8|||
161722840|NCT00367640|584028335|FG001|Overall Study|Withdrawal by Subject|11|||
161722841|NCT00367640|584028336|FG002|Overall Study|Withdrawal by Subject|8|||
161722842|NCT00367640|584028337|FG003|Overall Study|Withdrawal by Subject|6|||
161722843|NCT00367640|584028334|FG000|Overall Study|Any other reason not above-mentioned|7|||
161722844|NCT00367640|584028335|FG001|Overall Study|Any other reason not above-mentioned|5|||
161722845|NCT00367640|584028336|FG002|Overall Study|Any other reason not above-mentioned|3|||
161722846|NCT00367640|584028337|FG003|Overall Study|Any other reason not above-mentioned|4|||
161722847|NCT02417233|584028338|FG000|Overall Study|Death|4|||
161722848|NCT02417233|584028339|FG001|Overall Study|Death|10|||
161722849|NCT02417233|584028340|FG002|Overall Study|Death|14|||
161722850|NCT02417233|584028338|FG000|Overall Study|Lost to Follow-up|27|||
161722851|NCT02417233|584028339|FG001|Overall Study|Lost to Follow-up|39|||
161722852|NCT02417233|584028340|FG002|Overall Study|Lost to Follow-up|34|||
161722853|NCT02417233|584028338|FG000|Overall Study|Protocol Violation|2|||
161722854|NCT02417233|584028339|FG001|Overall Study|Protocol Violation|0|||
161722855|NCT02417233|584028340|FG002|Overall Study|Protocol Violation|2|||
161722856|NCT02417233|584028338|FG000|Overall Study|Withdrawal by Subject|2|||
161722857|NCT02417233|584028339|FG001|Overall Study|Withdrawal by Subject|1|||
161722858|NCT02417233|584028340|FG002|Overall Study|Withdrawal by Subject|8|||
161722859|NCT02417233|584028338|FG000|Overall Study|Relocation out of study area|1|||
161722860|NCT02417233|584028339|FG001|Overall Study|Relocation out of study area|0|||
161722861|NCT02417233|584028340|FG002|Overall Study|Relocation out of study area|1|||
161722862|NCT02417233|584028338|FG000|Overall Study|Mentally unstable|0|||
161722863|NCT02417233|584028339|FG001|Overall Study|Mentally unstable|1|||
161722864|NCT02417233|584028340|FG002|Overall Study|Mentally unstable|0|||
161722865|NCT01063751|584028343|FG000|Overall Study|Censored from analyses|42|||
161722866|NCT01063751|584028343|FG000|Overall Study|Withdrawal by Subject|34|||
161722867|NCT01063751|584028343|FG000|Overall Study|Lost to Follow-up|30|||
161722868|NCT01063751|584028343|FG000|Overall Study|Death|13|||
161722869|NCT01063751|584028343|FG000|Overall Study|Sponsored Terminated Study|60|||
161722870|NCT01063751|584028343|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
161965137|NCT01740089|584920200|FG002|After 12 Weeks|Adverse Event|5|||
161965138|NCT01740089|584920198|FG000|After 12 Weeks|Protocol Violation|1|||
161965139|NCT01740089|584920199|FG001|After 12 Weeks|Protocol Violation|1|||
161722871|NCT01063751|584028343|FG000|Overall Study|Investigator site closed|10|||
161722872|NCT01063751|584028343|FG000|Overall Study|Revision|6|||
161722873|NCT01063751|584028343|FG000|Overall Study|Physician Decision|4|||
161722874|NCT02805907|584028349|FG000|Overall Study|Lost to Follow-up|3|||
161722875|NCT02805907|584028350|FG001|Overall Study|Lost to Follow-up|3|||
161722876|NCT03408873|584028355|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
161722877|NCT03408873|584028355|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
161722878|NCT03408873|584028355|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
161722879|NCT03408873|584028355|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
161722880|NCT03408873|584028355|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
161965140|NCT01740089|584920200|FG002|After 12 Weeks|Protocol Violation|1|||
161965141|NCT01740089|584920198|FG000|After 12 Weeks|Withdrawal by Subject|1|||
161722881|NCT03408873|584028355|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
161722882|NCT01264965|584028361|FG000|Overall Study|Withdrawal by Subject|10|||
161722883|NCT03799718|584028363|FG000|Overall Study|Adverse Event|2|||
161722884|NCT01327339|584028364|FG000|Overall Study|Protocol Violation|8|||
161722885|NCT01172288|584028365|FG000|Overall Study|Adverse Event|1|||
161722886|NCT01172288|584028366|FG001|Overall Study|Adverse Event|0|||
161722887|NCT01172288|584028365|FG000|Overall Study|Protocol Violation|0|||
161722888|NCT01172288|584028366|FG001|Overall Study|Protocol Violation|1|||
161722889|NCT00700752|584028369|FG000|First Intervention|Withdrawal by Subject|0|||
161722890|NCT00700752|584028370|FG001|First Intervention|Withdrawal by Subject|2|||
161722891|NCT03662334|584028371|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
161722892|NCT03662334|584028372|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
161722893|NCT01097330|584028373|FG000|Overall Study|Study terminated early|7|||
161722894|NCT01097330|584028374|FG001|Overall Study|Study terminated early|5|||
161722895|NCT03303339|584028380|FG000|Overall Study|Death|2|||
161722896|NCT03303339|584028381|FG001|Overall Study|Death|2|||
161722897|NCT03303339|584028382|FG002|Overall Study|Death|2|||
161722898|NCT03303339|584028383|FG003|Overall Study|Death|1|||
161722899|NCT03303339|584028384|FG004|Overall Study|Death|4|||
161722900|NCT03303339|584028385|FG005|Overall Study|Death|2|||
161722901|NCT03303339|584028386|FG006|Overall Study|Death|2|||
161722902|NCT03303339|584028387|FG007|Overall Study|Death|2|||
161722903|NCT03303339|584028388|FG008|Overall Study|Death|3|||
161722904|NCT03303339|584028389|FG009|Overall Study|Death|3|||
161722905|NCT03303339|584028390|FG010|Overall Study|Death|4|||
161722906|NCT03303339|584028391|FG011|Overall Study|Death|24|||
161722907|NCT03303339|584028380|FG000|Overall Study|Study Terminated by Sponsor|0|||
161722908|NCT03303339|584028381|FG001|Overall Study|Study Terminated by Sponsor|0|||
161722909|NCT03303339|584028382|FG002|Overall Study|Study Terminated by Sponsor|0|||
161722910|NCT03303339|584028383|FG003|Overall Study|Study Terminated by Sponsor|0|||
161722911|NCT03303339|584028384|FG004|Overall Study|Study Terminated by Sponsor|0|||
161722912|NCT03303339|584028385|FG005|Overall Study|Study Terminated by Sponsor|0|||
161722913|NCT03303339|584028386|FG006|Overall Study|Study Terminated by Sponsor|0|||
161722914|NCT03303339|584028387|FG007|Overall Study|Study Terminated by Sponsor|0|||
161722915|NCT03303339|584028388|FG008|Overall Study|Study Terminated by Sponsor|1|||
161722916|NCT03303339|584028389|FG009|Overall Study|Study Terminated by Sponsor|0|||
161722917|NCT03303339|584028390|FG010|Overall Study|Study Terminated by Sponsor|1|||
161722918|NCT03303339|584028391|FG011|Overall Study|Study Terminated by Sponsor|1|||
161722919|NCT03303339|584028380|FG000|Overall Study|Withdrawal by Subject|1|||
161722920|NCT03303339|584028381|FG001|Overall Study|Withdrawal by Subject|0|||
161722921|NCT03303339|584028382|FG002|Overall Study|Withdrawal by Subject|0|||
161722922|NCT03303339|584028383|FG003|Overall Study|Withdrawal by Subject|0|||
161722923|NCT03303339|584028384|FG004|Overall Study|Withdrawal by Subject|0|||
161722924|NCT03303339|584028385|FG005|Overall Study|Withdrawal by Subject|1|||
161722925|NCT03303339|584028386|FG006|Overall Study|Withdrawal by Subject|1|||
161722926|NCT03303339|584028387|FG007|Overall Study|Withdrawal by Subject|0|||
161722927|NCT03303339|584028388|FG008|Overall Study|Withdrawal by Subject|0|||
161722928|NCT03303339|584028389|FG009|Overall Study|Withdrawal by Subject|0|||
161965142|NCT01740089|584920199|FG001|After 12 Weeks|Withdrawal by Subject|1|||
161722929|NCT03303339|584028390|FG010|Overall Study|Withdrawal by Subject|0|||
161722930|NCT03303339|584028391|FG011|Overall Study|Withdrawal by Subject|2|||
161722931|NCT03303339|584028380|FG000|Overall Study|Physician Decision|0|||
161722932|NCT03303339|584028381|FG001|Overall Study|Physician Decision|0|||
161722933|NCT03303339|584028382|FG002|Overall Study|Physician Decision|0|||
161722934|NCT03303339|584028383|FG003|Overall Study|Physician Decision|0|||
161722935|NCT03303339|584028384|FG004|Overall Study|Physician Decision|1|||
161722936|NCT03303339|584028385|FG005|Overall Study|Physician Decision|0|||
161722937|NCT03303339|584028386|FG006|Overall Study|Physician Decision|0|||
161722938|NCT03303339|584028387|FG007|Overall Study|Physician Decision|0|||
161722939|NCT03303339|584028388|FG008|Overall Study|Physician Decision|0|||
161722940|NCT03303339|584028389|FG009|Overall Study|Physician Decision|0|||
161722941|NCT03303339|584028390|FG010|Overall Study|Physician Decision|0|||
161722942|NCT03303339|584028391|FG011|Overall Study|Physician Decision|0|||
161722943|NCT03303339|584028380|FG000|Overall Study|Safety/Non-compliance|0|||
161722944|NCT03303339|584028381|FG001|Overall Study|Safety/Non-compliance|0|||
161722945|NCT03303339|584028382|FG002|Overall Study|Safety/Non-compliance|0|||
161722946|NCT03303339|584028383|FG003|Overall Study|Safety/Non-compliance|0|||
161722947|NCT03303339|584028384|FG004|Overall Study|Safety/Non-compliance|0|||
161722948|NCT03303339|584028385|FG005|Overall Study|Safety/Non-compliance|0|||
161722949|NCT03303339|584028386|FG006|Overall Study|Safety/Non-compliance|0|||
161965143|NCT01740089|584920200|FG002|After 12 Weeks|Withdrawal by Subject|1|||
161965144|NCT02791191|584920203|FG000|Overall Study|Adverse Event|2|||
161722950|NCT03303339|584028387|FG007|Overall Study|Safety/Non-compliance|0|||
161722951|NCT03303339|584028388|FG008|Overall Study|Safety/Non-compliance|0|||
161722952|NCT03303339|584028389|FG009|Overall Study|Safety/Non-compliance|0|||
161722953|NCT03303339|584028390|FG010|Overall Study|Safety/Non-compliance|0|||
161722954|NCT03303339|584028391|FG011|Overall Study|Safety/Non-compliance|1|||
161722955|NCT00510692|584028393|FG000|Overall Study|Adverse Event|1|||
161722956|NCT00510692|584028394|FG001|Overall Study|Adverse Event|3|||
161722957|NCT00510692|584028393|FG000|Overall Study|Withdrawal by Subject|1|||
161722958|NCT00510692|584028394|FG001|Overall Study|Withdrawal by Subject|0|||
161722959|NCT02116972|584028395|FG000|Overall Study|Adverse Event|4|||
161722960|NCT02116972|584028396|FG001|Overall Study|Adverse Event|4|||
161722961|NCT02116972|584028397|FG002|Overall Study|Adverse Event|1|||
161722962|NCT02116972|584028395|FG000|Overall Study|Withdrawal by Subject|1|||
161722963|NCT02116972|584028396|FG001|Overall Study|Withdrawal by Subject|1|||
161722964|NCT02116972|584028397|FG002|Overall Study|Withdrawal by Subject|5|||
161722965|NCT02116972|584028395|FG000|Overall Study|Protocol Violation|1|||
161722966|NCT02116972|584028396|FG001|Overall Study|Protocol Violation|0|||
161722967|NCT02116972|584028397|FG002|Overall Study|Protocol Violation|1|||
161722968|NCT02116972|584028395|FG000|Overall Study|Lost to Follow-up|4|||
161722969|NCT02116972|584028396|FG001|Overall Study|Lost to Follow-up|3|||
161722970|NCT02116972|584028397|FG002|Overall Study|Lost to Follow-up|1|||
161722971|NCT02116972|584028395|FG000|Overall Study|Lack of Efficacy|6|||
161722972|NCT02116972|584028396|FG001|Overall Study|Lack of Efficacy|6|||
161722973|NCT02116972|584028397|FG002|Overall Study|Lack of Efficacy|5|||
161722974|NCT02116972|584028395|FG000|Overall Study|scheduling conflicts and relocation|3|||
161722975|NCT02116972|584028396|FG001|Overall Study|scheduling conflicts and relocation|3|||
161722976|NCT02116972|584028397|FG002|Overall Study|scheduling conflicts and relocation|6|||
161722977|NCT00784784|584028398|FG000|Overall Study|Withdrawal by Subject|2|||
161722978|NCT00784784|584028399|FG001|Overall Study|Withdrawal by Subject|2|||
161722979|NCT00872898|584028401|FG000|Part Two - Double Blind|Adverse Event|4|||
161722980|NCT00872898|584028402|FG001|Part Two - Double Blind|Adverse Event|3|||
161722981|NCT00872898|584028401|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
161722982|NCT00872898|584028402|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
161722983|NCT00872898|584028401|FG000|Part Two - Double Blind|Protocol Violation|1|||
161722984|NCT00872898|584028402|FG001|Part Two - Double Blind|Protocol Violation|0|||
161722985|NCT00872898|584028401|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
161722986|NCT00872898|584028402|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
161722987|NCT00872898|584028401|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
161722988|NCT00872898|584028402|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
161722989|NCT00872898|584028401|FG000|Part Two - Double Blind|Other reasons|2|||
161722990|NCT00872898|584028402|FG001|Part Two - Double Blind|Other reasons|0|||
161722991|NCT03176966|584028407|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
161722992|NCT03176966|584028408|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
161722993|NCT03176966|584028407|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
161722994|NCT03176966|584028408|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
161722995|NCT03176966|584028407|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
161722996|NCT03176966|584028408|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
161722997|NCT03176966|584028407|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
161722998|NCT03176966|584028408|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
161965145|NCT02791191|584920204|FG001|Overall Study|Adverse Event|4|||
161965146|NCT02791191|584920205|FG002|Overall Study|Adverse Event|5|||
161965147|NCT02791191|584920203|FG000|Overall Study|Lack of Efficacy|0|||
161965148|NCT02791191|584920204|FG001|Overall Study|Lack of Efficacy|1|||
161965149|NCT02791191|584920205|FG002|Overall Study|Lack of Efficacy|0|||
161965150|NCT02791191|584920203|FG000|Overall Study|Study Drug Non-Compliance|0|||
161965151|NCT02791191|584920204|FG001|Overall Study|Study Drug Non-Compliance|2|||
161965152|NCT02791191|584920205|FG002|Overall Study|Study Drug Non-Compliance|0|||
161965153|NCT02791191|584920203|FG000|Overall Study|Site Closed by Sponsor|1|||
161965154|NCT02791191|584920204|FG001|Overall Study|Site Closed by Sponsor|1|||
161722999|NCT03176966|584028407|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
161723000|NCT03176966|584028408|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
161723001|NCT03176966|584028407|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
161723002|NCT03176966|584028408|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
161723003|NCT03176966|584028407|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
161723004|NCT03176966|584028408|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
161723005|NCT01903434|584028413|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
161723006|NCT01903434|584028414|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
161723007|NCT01903434|584028413|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
161723008|NCT01903434|584028414|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
161723009|NCT00404768|584028415|FG000|Part A and B|Withdrawn due to labor progression|1|||
161723010|NCT00404768|584028416|FG001|Part A and B|Withdrawn due to labor progression|0|||
161723011|NCT00404768|584028417|FG002|Part A and B|Withdrawn due to labor progression|0|||
161723012|NCT00404768|584028418|FG003|Part A and B|Withdrawn due to labor progression|0|||
161723013|NCT00404768|584028415|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
161723014|NCT00404768|584028416|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
161723015|NCT00404768|584028417|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
161723016|NCT00404768|584028418|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
161965155|NCT02791191|584920205|FG002|Overall Study|Site Closed by Sponsor|3|||
161965156|NCT02791191|584920203|FG000|Overall Study|Progressive Disease|1|||
161723017|NCT00404768|584028415|FG000|Part C|Adverse Event|0|||
161723018|NCT00404768|584028416|FG001|Part C|Adverse Event|0|||
161723019|NCT00404768|584028417|FG002|Part C|Adverse Event|0|||
161723020|NCT00404768|584028418|FG003|Part C|Adverse Event|3|||
161723021|NCT00404768|584028415|FG000|Part C|Lost to Follow-up|0|||
161723022|NCT00404768|584028416|FG001|Part C|Lost to Follow-up|0|||
161723023|NCT00404768|584028417|FG002|Part C|Lost to Follow-up|3|||
161723024|NCT00404768|584028418|FG003|Part C|Lost to Follow-up|1|||
161723025|NCT00404768|584028415|FG000|Part C|Withdrawal by Subject|0|||
161723026|NCT00404768|584028416|FG001|Part C|Withdrawal by Subject|0|||
161723027|NCT00404768|584028417|FG002|Part C|Withdrawal by Subject|2|||
161723028|NCT00404768|584028418|FG003|Part C|Withdrawal by Subject|1|||
161723029|NCT00404768|584028415|FG000|Part C|Early withdrawal from study medication|0|||
161723030|NCT00404768|584028416|FG001|Part C|Early withdrawal from study medication|0|||
161723031|NCT00404768|584028417|FG002|Part C|Early withdrawal from study medication|1|||
161723032|NCT00404768|584028418|FG003|Part C|Early withdrawal from study medication|0|||
161723033|NCT00404768|584028415|FG000|Part C|Participant did not respond to therapy|0|||
161723034|NCT00404768|584028416|FG001|Part C|Participant did not respond to therapy|0|||
161723035|NCT00404768|584028417|FG002|Part C|Participant did not respond to therapy|1|||
161723036|NCT00404768|584028418|FG003|Part C|Participant did not respond to therapy|1|||
161723037|NCT00404768|584028415|FG000|Part C|Physician withdrew the study medication|0|||
161723038|NCT00404768|584028416|FG001|Part C|Physician withdrew the study medication|0|||
161723039|NCT00404768|584028417|FG002|Part C|Physician withdrew the study medication|1|||
161723040|NCT00404768|584028418|FG003|Part C|Physician withdrew the study medication|0|||
161723041|NCT00404768|584028415|FG000|Part C|Participant delivered baby|0|||
161723042|NCT00404768|584028416|FG001|Part C|Participant delivered baby|0|||
161723043|NCT00404768|584028417|FG002|Part C|Participant delivered baby|0|||
161723044|NCT00404768|584028418|FG003|Part C|Participant delivered baby|1|||
161723045|NCT00404768|584028415|FG000|Part C|Unsatisfactory uterine response to IP|0|||
161723046|NCT00404768|584028416|FG001|Part C|Unsatisfactory uterine response to IP|0|||
161723047|NCT00404768|584028417|FG002|Part C|Unsatisfactory uterine response to IP|0|||
161723048|NCT00404768|584028418|FG003|Part C|Unsatisfactory uterine response to IP|1|||
161723049|NCT00404768|584028415|FG000|Part C|Active labor|0|||
161723050|NCT00404768|584028416|FG001|Part C|Active labor|0|||
161723051|NCT00404768|584028417|FG002|Part C|Active labor|0|||
161723052|NCT00404768|584028418|FG003|Part C|Active labor|1|||
161723053|NCT00404768|584028415|FG000|Part C|Lack of Efficacy|0|||
161723054|NCT00404768|584028416|FG001|Part C|Lack of Efficacy|0|||
161723055|NCT00404768|584028417|FG002|Part C|Lack of Efficacy|0|||
161723056|NCT00404768|584028418|FG003|Part C|Lack of Efficacy|2|||
161723057|NCT00404768|584028415|FG000|Part C|Treatment failure|0|||
161723058|NCT00404768|584028416|FG001|Part C|Treatment failure|0|||
161723059|NCT00404768|584028417|FG002|Part C|Treatment failure|0|||
161723060|NCT00404768|584028418|FG003|Part C|Treatment failure|1|||
161723061|NCT00404768|584028415|FG000|Part C|Investigator discretion|0|||
161723062|NCT00404768|584028416|FG001|Part C|Investigator discretion|0|||
161723063|NCT00404768|584028417|FG002|Part C|Investigator discretion|0|||
161723064|NCT00404768|584028418|FG003|Part C|Investigator discretion|1|||
161723065|NCT00404768|584028415|FG000|Part C|Researcher suspended study medication|0|||
161723066|NCT00404768|584028416|FG001|Part C|Researcher suspended study medication|0|||
161723067|NCT00404768|584028417|FG002|Part C|Researcher suspended study medication|0|||
161723068|NCT00404768|584028418|FG003|Part C|Researcher suspended study medication|1|||
161723069|NCT01118143|584028419|FG000|Overall Study|Withdrawal by Subject|2|||
161723070|NCT01118143|584028420|FG001|Overall Study|Withdrawal by Subject|5|||
161723071|NCT03625986|584030366|FG000|Randomization Period|Lost to Follow-up|7|||
161723072|NCT03625986|584030367|FG001|Randomization Period|Lost to Follow-up|12|||
161723073|NCT03625986|584030366|FG000|Randomization Period|Withdrawal by Subject|10|||
161723074|NCT03625986|584030367|FG001|Randomization Period|Withdrawal by Subject|6|||
161723075|NCT04359823|584030368|FG000|Overall Study|Lost to Follow-up|0|||
162032156|NCT00814801|585174218|FG000|Overall Study|Non-compliance|0|||
162032157|NCT00814801|585174219|FG001|Overall Study|Non-compliance|1|||
161723076|NCT04359823|584030369|FG001|Overall Study|Lost to Follow-up|1|||
161723077|NCT04359823|584030368|FG000|Overall Study|Withdrawal by Subject|0|||
161723078|NCT04359823|584030369|FG001|Overall Study|Withdrawal by Subject|1|||
161723079|NCT01850563|584030370|FG000|Overall Study|Not eligible|3|||
161723080|NCT01850563|584030371|FG001|Overall Study|Not eligible|0|||
161723081|NCT03132805|584030372|FG000|Overall Study|Lost to Follow-up|142|||
161723082|NCT03132805|584030373|FG001|Overall Study|Lost to Follow-up|141|||
161723083|NCT03132805|584030374|FG002|Overall Study|Lost to Follow-up|113|||
161723084|NCT03151148|584030375|FG000|Overall Study|Lost to Follow-up|1|||
161723085|NCT03151148|584030376|FG001|Overall Study|Lost to Follow-up|0|||
161723086|NCT03151148|584030375|FG000|Overall Study|Withdrawal by Subject|1|||
161723087|NCT03151148|584030376|FG001|Overall Study|Withdrawal by Subject|0|||
161723088|NCT01115569|584030381|FG000|Conversion/Titration Phase|Adverse Event|59|||
161723089|NCT01115569|584030382|FG001|Conversion/Titration Phase|Adverse Event|0|||
161723090|NCT01115569|584030381|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
161723091|NCT01115569|584030382|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
161723092|NCT01115569|584030381|FG000|Conversion/Titration Phase|Physician Decision|5|||
161723093|NCT01115569|584030382|FG001|Conversion/Titration Phase|Physician Decision|0|||
161723094|NCT01115569|584030381|FG000|Conversion/Titration Phase|Protocol Violation|68|||
161723095|NCT01115569|584030382|FG001|Conversion/Titration Phase|Protocol Violation|0|||
161723096|NCT01115569|584030381|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
161723097|NCT01115569|584030382|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
161723098|NCT01115569|584030381|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
161723099|NCT01115569|584030382|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
161723100|NCT01115569|584030381|FG000|Maintenance Phase|Adverse Event|0|||
161723101|NCT01115569|584030382|FG001|Maintenance Phase|Adverse Event|43|||
161723102|NCT01115569|584030381|FG000|Maintenance Phase|Lost to Follow-up|0|||
161723103|NCT01115569|584030382|FG001|Maintenance Phase|Lost to Follow-up|8|||
161723104|NCT01115569|584030381|FG000|Maintenance Phase|Physician Decision|0|||
161723105|NCT01115569|584030382|FG001|Maintenance Phase|Physician Decision|3|||
161723106|NCT01115569|584030381|FG000|Maintenance Phase|Protocol Violation|0|||
161723107|NCT01115569|584030382|FG001|Maintenance Phase|Protocol Violation|9|||
161723108|NCT01115569|584030381|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161723109|NCT01115569|584030382|FG001|Maintenance Phase|Withdrawal by Subject|27|||
161723110|NCT01115569|584030381|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
161723111|NCT01115569|584030382|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
161723112|NCT01115569|584030381|FG000|Maintenance Phase|Administrative|0|||
161723113|NCT01115569|584030382|FG001|Maintenance Phase|Administrative|1|||
161723114|NCT01614769|584030383|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
161723115|NCT01614769|584030384|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
161723116|NCT01614769|584030385|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
161723117|NCT01614769|584030386|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
161723118|NCT01614769|584030387|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
161723119|NCT01614769|584030388|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
161723120|NCT01614769|584030383|FG000|Period 1|Protocol Violation|0|||
161723121|NCT01614769|584030384|FG001|Period 1|Protocol Violation|0|||
161723122|NCT01614769|584030385|FG002|Period 1|Protocol Violation|0|||
161723123|NCT01614769|584030386|FG003|Period 1|Protocol Violation|1|||
161723124|NCT01614769|584030387|FG004|Period 1|Protocol Violation|0|||
161723125|NCT01614769|584030388|FG005|Period 1|Protocol Violation|0|||
161723126|NCT01614769|584030383|FG000|Period 1|Withdrawal by Subject|1|||
161723127|NCT01614769|584030384|FG001|Period 1|Withdrawal by Subject|0|||
161723128|NCT01614769|584030385|FG002|Period 1|Withdrawal by Subject|0|||
161723129|NCT01614769|584030386|FG003|Period 1|Withdrawal by Subject|0|||
161723130|NCT01614769|584030387|FG004|Period 1|Withdrawal by Subject|0|||
161723131|NCT01614769|584030388|FG005|Period 1|Withdrawal by Subject|0|||
161723132|NCT01614769|584030383|FG000|Period 3|Withdrawal by Subject|0|||
161723133|NCT01614769|584030384|FG001|Period 3|Withdrawal by Subject|0|||
161723134|NCT01614769|584030385|FG002|Period 3|Withdrawal by Subject|1|||
161723135|NCT01614769|584030386|FG003|Period 3|Withdrawal by Subject|0|||
161723136|NCT01614769|584030387|FG004|Period 3|Withdrawal by Subject|0|||
161723137|NCT01614769|584030388|FG005|Period 3|Withdrawal by Subject|0|||
161723138|NCT01228071|584030389|FG000|Overall Study|Protocol Violation|1|||
161723139|NCT01228071|584030389|FG000|Overall Study|Withdrawal by Subject|1|||
161723140|NCT04439838|584030390|FG000|Overall Study|Withdrawal by Subject|0|||
161723141|NCT04439838|584030391|FG001|Overall Study|Withdrawal by Subject|0|||
161723142|NCT04439838|584030392|FG002|Overall Study|Withdrawal by Subject|0|||
161723143|NCT04439838|584030393|FG003|Overall Study|Withdrawal by Subject|0|||
161723144|NCT04439838|584030394|FG004|Overall Study|Withdrawal by Subject|0|||
161723145|NCT04439838|584030395|FG005|Overall Study|Withdrawal by Subject|0|||
161723146|NCT04439838|584030396|FG006|Overall Study|Withdrawal by Subject|0|||
161723147|NCT04439838|584030397|FG007|Overall Study|Withdrawal by Subject|0|||
161723148|NCT04439838|584030398|FG008|Overall Study|Withdrawal by Subject|1|||
161723149|NCT00960440|584030405|FG000|Overall Study|Death|0|||
161723150|NCT00960440|584030406|FG001|Overall Study|Death|0|||
161723151|NCT00960440|584030407|FG002|Overall Study|Death|0|||
161723152|NCT00960440|584030408|FG003|Overall Study|Death|1|||
161723153|NCT00960440|584030405|FG000|Overall Study|Adverse Event|12|||
161723154|NCT00960440|584030406|FG001|Overall Study|Adverse Event|12|||
161723155|NCT00960440|584030407|FG002|Overall Study|Adverse Event|4|||
161723156|NCT00960440|584030408|FG003|Overall Study|Adverse Event|4|||
161723157|NCT00960440|584030405|FG000|Overall Study|Lack of Efficacy|2|||
161723158|NCT00960440|584030406|FG001|Overall Study|Lack of Efficacy|5|||
161723159|NCT00960440|584030407|FG002|Overall Study|Lack of Efficacy|3|||
161723160|NCT00960440|584030408|FG003|Overall Study|Lack of Efficacy|8|||
161723161|NCT00960440|584030405|FG000|Overall Study|Protocol Violation|2|||
161723162|NCT00960440|584030406|FG001|Overall Study|Protocol Violation|8|||
161723163|NCT00960440|584030407|FG002|Overall Study|Protocol Violation|3|||
161723164|NCT00960440|584030408|FG003|Overall Study|Protocol Violation|4|||
161723165|NCT00960440|584030405|FG000|Overall Study|Withdrawal by Subject|9|||
161723166|NCT00960440|584030406|FG001|Overall Study|Withdrawal by Subject|5|||
161723167|NCT00960440|584030407|FG002|Overall Study|Withdrawal by Subject|2|||
161723168|NCT00960440|584030408|FG003|Overall Study|Withdrawal by Subject|1|||
161723169|NCT00960440|584030405|FG000|Overall Study|Other|1|||
161723170|NCT00960440|584030406|FG001|Overall Study|Other|1|||
161723171|NCT00960440|584030407|FG002|Overall Study|Other|1|||
161723172|NCT00960440|584030408|FG003|Overall Study|Other|0|||
161723173|NCT01188798|584030409|FG000|Overall Study|Death|0|||
161723174|NCT01188798|584030410|FG001|Overall Study|Death|1|||
161723175|NCT01188798|584030409|FG000|Overall Study|Required additional transplant|1|||
161723176|NCT01188798|584030410|FG001|Overall Study|Required additional transplant|1|||
161723177|NCT01188798|584030409|FG000|Overall Study|Protocol closure|1|||
161723178|NCT01188798|584030410|FG001|Overall Study|Protocol closure|1|||
161723179|NCT03964415|584030416|FG000|Overall Study|Sponsor's decision|1563|||
161723180|NCT03964415|584030417|FG001|Overall Study|Sponsor's decision|1528|||
161723181|NCT03964415|584030416|FG000|Overall Study|Lost to Follow-up|139|||
161723182|NCT03964415|584030417|FG001|Overall Study|Lost to Follow-up|146|||
161723183|NCT03964415|584030416|FG000|Overall Study|Withdrawal by Subject|68|||
161723184|NCT03964415|584030417|FG001|Overall Study|Withdrawal by Subject|72|||
161723185|NCT03964415|584030416|FG000|Overall Study|Physician Decision|34|||
161723186|NCT03964415|584030417|FG001|Overall Study|Physician Decision|48|||
161723187|NCT03964415|584030416|FG000|Overall Study|Adverse Event|3|||
161723188|NCT03964415|584030417|FG001|Overall Study|Adverse Event|0|||
161723189|NCT03964415|584030416|FG000|Overall Study|Death|4|||
161723190|NCT03964415|584030417|FG001|Overall Study|Death|6|||
161723191|NCT03964415|584030416|FG000|Overall Study|Protocol Violation|1|||
161723192|NCT03964415|584030417|FG001|Overall Study|Protocol Violation|4|||
161723193|NCT03964415|584030416|FG000|Overall Study|Other|35|||
161723194|NCT03964415|584030417|FG001|Overall Study|Other|38|||
161723195|NCT03964415|584030416|FG000|Overall Study|Randomized but not treated|6|||
161723196|NCT03964415|584030417|FG001|Overall Study|Randomized but not treated|7|||
161723197|NCT01302769|584030422|FG000|Overall Study|Lost to Follow-up|1|||
161723198|NCT01302769|584030423|FG001|Overall Study|Lost to Follow-up|1|||
161723199|NCT01734993|584030427|FG000|Overall Study|Adverse Event|1|||
161723200|NCT01734993|584030427|FG000|Overall Study|Lack of Efficacy|1|||
161723201|NCT00723840|584030428|FG000|Overall Study|Lost to Follow-up|2|||
161723202|NCT00723840|584030428|FG000|Overall Study|Failure to return|18|||
161723203|NCT00723840|584030428|FG000|Overall Study|Withdrawal by Subject|55|||
161723204|NCT00723840|584030428|FG000|Overall Study|Serious Adverse Events|3|||
161723205|NCT00723840|584030428|FG000|Overall Study|Other Medical Event|2|||
161723206|NCT00723840|584030428|FG000|Overall Study|Unspecified reason|2|||
161723207|NCT01426386|584030429|FG000|Overall Study|Adverse Event|0|||
161723208|NCT01426386|584030430|FG001|Overall Study|Adverse Event|1|||
161723209|NCT01426386|584030431|FG002|Overall Study|Adverse Event|0|||
161723210|NCT01426386|584030432|FG003|Overall Study|Adverse Event|0|||
161723211|NCT01426386|584030433|FG004|Overall Study|Adverse Event|0|||
161723212|NCT01426386|584030434|FG005|Overall Study|Adverse Event|0|||
161723213|NCT01426386|584030429|FG000|Overall Study|Did not attend scheduled visit|1|||
161723214|NCT01426386|584030430|FG001|Overall Study|Did not attend scheduled visit|4|||
161723215|NCT01426386|584030431|FG002|Overall Study|Did not attend scheduled visit|0|||
161723216|NCT01426386|584030432|FG003|Overall Study|Did not attend scheduled visit|0|||
161723217|NCT01426386|584030433|FG004|Overall Study|Did not attend scheduled visit|2|||
161723218|NCT01426386|584030434|FG005|Overall Study|Did not attend scheduled visit|1|||
161723219|NCT01426386|584030429|FG000|Overall Study|Poor response|2|||
161723220|NCT01426386|584030430|FG001|Overall Study|Poor response|1|||
161723221|NCT01426386|584030431|FG002|Overall Study|Poor response|2|||
161723222|NCT01426386|584030432|FG003|Overall Study|Poor response|0|||
161723223|NCT01426386|584030433|FG004|Overall Study|Poor response|1|||
161723224|NCT01426386|584030434|FG005|Overall Study|Poor response|0|||
161723225|NCT01426386|584030429|FG000|Overall Study|Personal reasons|0|||
161723226|NCT01426386|584030430|FG001|Overall Study|Personal reasons|0|||
161723227|NCT01426386|584030431|FG002|Overall Study|Personal reasons|0|||
161723228|NCT01426386|584030432|FG003|Overall Study|Personal reasons|0|||
161723229|NCT01426386|584030433|FG004|Overall Study|Personal reasons|1|||
161723230|NCT01426386|584030434|FG005|Overall Study|Personal reasons|0|||
161723231|NCT03694522|584030435|FG000|Overall Study|Withdrawal by Subject|8|||
161723232|NCT03694522|584030436|FG001|Overall Study|Withdrawal by Subject|10|||
161723233|NCT03694522|584030435|FG000|Overall Study|Physician Decision|53|||
161723234|NCT03694522|584030436|FG001|Overall Study|Physician Decision|54|||
161723235|NCT03694522|584030435|FG000|Overall Study|Other|1|||
161723236|NCT03694522|584030436|FG001|Overall Study|Other|1|||
161723237|NCT03694522|584030435|FG000|Overall Study|Lost to Follow-up|0|||
161723238|NCT03694522|584030436|FG001|Overall Study|Lost to Follow-up|1|||
161723239|NCT02760407|584030437|FG000|Overall Study|Death|2|||
161723240|NCT02760407|584030438|FG001|Overall Study|Death|3|||
161723241|NCT02760407|584030439|FG002|Overall Study|Death|1|||
161723242|NCT02760407|584030440|FG003|Overall Study|Death|1|||
161723243|NCT02760407|584030437|FG000|Overall Study|Lost to Follow-up|1|||
161723244|NCT02760407|584030438|FG001|Overall Study|Lost to Follow-up|7|||
161723245|NCT02760407|584030439|FG002|Overall Study|Lost to Follow-up|4|||
161723246|NCT02760407|584030440|FG003|Overall Study|Lost to Follow-up|6|||
161723247|NCT02760407|584030437|FG000|Overall Study|Withdrawal by Subject|25|||
161723248|NCT02760407|584030438|FG001|Overall Study|Withdrawal by Subject|31|||
161723249|NCT02760407|584030439|FG002|Overall Study|Withdrawal by Subject|37|||
161723250|NCT02760407|584030440|FG003|Overall Study|Withdrawal by Subject|25|||
161723251|NCT02760407|584030437|FG000|Overall Study|Violation of Eligibility criteria|0|||
161723252|NCT02760407|584030438|FG001|Overall Study|Violation of Eligibility criteria|0|||
161723253|NCT02760407|584030439|FG002|Overall Study|Violation of Eligibility criteria|1|||
161723254|NCT02760407|584030440|FG003|Overall Study|Violation of Eligibility criteria|1|||
161723255|NCT02760407|584030437|FG000|Overall Study|Personal reasons|0|||
161723256|NCT02760407|584030438|FG001|Overall Study|Personal reasons|0|||
161723257|NCT02760407|584030439|FG002|Overall Study|Personal reasons|0|||
161723258|NCT02760407|584030440|FG003|Overall Study|Personal reasons|1|||
161723259|NCT02760407|584030437|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
161723260|NCT02760407|584030438|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
161723261|NCT02760407|584030439|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
161723262|NCT02760407|584030440|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
161723263|NCT02760407|584030437|FG000|Overall Study|Use of prohibited Medication|0|||
161723264|NCT02760407|584030438|FG001|Overall Study|Use of prohibited Medication|0|||
161723265|NCT02760407|584030439|FG002|Overall Study|Use of prohibited Medication|1|||
161723266|NCT02760407|584030440|FG003|Overall Study|Use of prohibited Medication|0|||
161723267|NCT02760407|584030437|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
161723268|NCT02760407|584030438|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
161723269|NCT02760407|584030439|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
161723270|NCT02760407|584030440|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
161723271|NCT02760407|584030437|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
161723272|NCT02760407|584030438|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
161723273|NCT02760407|584030439|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
161723274|NCT02760407|584030440|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
161723275|NCT02760407|584030437|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
161723276|NCT02760407|584030438|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
161723277|NCT02760407|584030439|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
161723278|NCT02760407|584030440|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
161723279|NCT02760407|584030437|FG000|Overall Study|Inadequately Enrolled|0|||
161723280|NCT02760407|584030438|FG001|Overall Study|Inadequately Enrolled|0|||
161723281|NCT02760407|584030439|FG002|Overall Study|Inadequately Enrolled|0|||
161723282|NCT02760407|584030440|FG003|Overall Study|Inadequately Enrolled|1|||
161723283|NCT02760407|584030437|FG000|Overall Study|Withdrawal By PI's Decision|0|||
161723284|NCT02760407|584030438|FG001|Overall Study|Withdrawal By PI's Decision|1|||
161723285|NCT02760407|584030439|FG002|Overall Study|Withdrawal By PI's Decision|0|||
161723286|NCT02760407|584030440|FG003|Overall Study|Withdrawal By PI's Decision|0|||
161723287|NCT02760407|584030437|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
161723288|NCT02760407|584030438|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
161723289|NCT02760407|584030439|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
161723290|NCT02760407|584030440|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
161723291|NCT02760407|584030437|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
161723292|NCT02760407|584030438|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
161723293|NCT02760407|584030439|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
161723294|NCT02760407|584030440|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
161723295|NCT02760407|584030437|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
161723296|NCT02760407|584030438|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
161723297|NCT02760407|584030439|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
161723298|NCT02760407|584030440|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
161723299|NCT02760407|584030437|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
161723300|NCT02760407|584030438|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
161723301|NCT02760407|584030439|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
161723302|NCT02760407|584030440|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
161723303|NCT02760407|584030437|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
161723304|NCT02760407|584030438|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
161723305|NCT02760407|584030439|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
161723306|NCT02760407|584030440|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
161723307|NCT02760407|584030437|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
161723308|NCT02760407|584030438|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
161965157|NCT02791191|584920204|FG001|Overall Study|Progressive Disease|0|||
161723309|NCT02760407|584030439|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
161723310|NCT02760407|584030440|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
161723311|NCT02760407|584030437|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
161723312|NCT02760407|584030438|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
161723313|NCT02760407|584030439|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
161723314|NCT02760407|584030440|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
161723315|NCT02760407|584030437|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
161723316|NCT02760407|584030438|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
161723317|NCT02760407|584030439|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
161723318|NCT02760407|584030440|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
161723319|NCT02760407|584030437|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
161723320|NCT02760407|584030438|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
161723321|NCT02760407|584030439|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
161723322|NCT02760407|584030440|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
161723323|NCT02522377|584030441|FG000|Overall Study|Withdrawal by Subject|1|||
161723324|NCT02522377|584030442|FG001|Overall Study|Withdrawal by Subject|0|||
161723325|NCT02522377|584030441|FG000|Overall Study|Remission Achieved|3|||
161723326|NCT02522377|584030442|FG001|Overall Study|Remission Achieved|0|||
161723327|NCT01158950|584030443|FG000|1st Intervention (1 Day)|Physician Decision|1|||
161723328|NCT01158950|584030444|FG001|1st Intervention (1 Day)|Physician Decision|2|||
161723329|NCT00945191|584030445|FG000|Overall Study|Did not achieve a complete response|18|||
161723330|NCT00945191|584030445|FG000|Overall Study|Participant relocated to another state|1|||
161723331|NCT00945191|584030445|FG000|Overall Study|Disease progression|3|||
161723332|NCT00945191|584030445|FG000|Overall Study|Serious adverse event or adverse event|1|||
161723333|NCT00945191|584030445|FG000|Overall Study|Investigator's discretion|1|||
161723334|NCT02137772|584030453|FG000|Overall Study|Adverse Event|6|||
161723335|NCT02137772|584030454|FG001|Overall Study|Adverse Event|3|||
161723336|NCT02137772|584030453|FG000|Overall Study|Death|71|||
161723337|NCT02137772|584030454|FG001|Overall Study|Death|44|||
161723338|NCT02137772|584030453|FG000|Overall Study|Lost to Follow-up|8|||
161723339|NCT02137772|584030454|FG001|Overall Study|Lost to Follow-up|4|||
161723340|NCT02137772|584030453|FG000|Overall Study|Physician Decision|15|||
161723341|NCT02137772|584030454|FG001|Overall Study|Physician Decision|5|||
161723342|NCT02137772|584030453|FG000|Overall Study|Withdrawal by Subject|28|||
161723343|NCT02137772|584030454|FG001|Overall Study|Withdrawal by Subject|17|||
161723344|NCT02137772|584030453|FG000|Overall Study|Non-compliance with study drug|1|||
161723345|NCT02137772|584030454|FG001|Overall Study|Non-compliance with study drug|0|||
161723346|NCT02137772|584030453|FG000|Overall Study|Not treated|3|||
161723347|NCT02137772|584030454|FG001|Overall Study|Not treated|2|||
161723348|NCT01844700|584030456|FG000|Overall Study|Lack of Efficacy|1|||
161723349|NCT01844700|584030457|FG001|Overall Study|Lack of Efficacy|0|||
161723350|NCT01844700|584030456|FG000|Overall Study|refused medication switch|1|||
161723351|NCT01844700|584030457|FG001|Overall Study|refused medication switch|0|||
161723352|NCT01844700|584030456|FG000|Overall Study|Withdrawal by Subject|1|||
161723353|NCT01844700|584030457|FG001|Overall Study|Withdrawal by Subject|0|||
161723354|NCT01844700|584030456|FG000|Overall Study|stopped taking meds|0|||
161723355|NCT01844700|584030457|FG001|Overall Study|stopped taking meds|1|||
161723356|NCT00863928|584030458|FG000|Overall Study|Protocol Violation|26|||
161723357|NCT00863928|584030459|FG001|Overall Study|Protocol Violation|0|||
161723358|NCT00863928|584030458|FG000|Overall Study|Withdrawal by Subject|3|||
161723359|NCT00863928|584030459|FG001|Overall Study|Withdrawal by Subject|0|||
161723360|NCT00863928|584030458|FG000|Overall Study|surgery cancellation|4|||
161723361|NCT00863928|584030459|FG001|Overall Study|surgery cancellation|0|||
161723362|NCT00863928|584030458|FG000|Overall Study|medication allergy|3|||
161723363|NCT00863928|584030459|FG001|Overall Study|medication allergy|0|||
161723364|NCT03290300|584030460|FG000|Overall Study|Lost to Follow-up|3|||
161723365|NCT02124798|584030461|FG000|Overall Study|Adverse Event|3|||
161723366|NCT02124798|584030461|FG000|Overall Study|Lost to Follow-up|1|||
161723367|NCT01797432|584030462|FG000|Overall Study|Lost to Follow-up|1|||
161723368|NCT01797432|584030462|FG000|Overall Study|Adverse Event|1|||
161723369|NCT01797432|584030462|FG000|Overall Study|Withdrawal by Subject|1|||
161723370|NCT01797432|584030462|FG000|Overall Study|lived too far from study site|1|||
161723371|NCT02792777|584030463|FG000|Overall Study|Withdrawal by Subject|2|||
161723372|NCT02792777|584030464|FG001|Overall Study|Withdrawal by Subject|0|||
161723373|NCT02792777|584030463|FG000|Overall Study|Recording malfunction|2|||
161723374|NCT02792777|584030464|FG001|Overall Study|Recording malfunction|0|||
161723375|NCT02792777|584030463|FG000|Overall Study|Later determined to be ineligible|2|||
161723376|NCT02792777|584030464|FG001|Overall Study|Later determined to be ineligible|0|||
161723377|NCT02792777|584030463|FG000|Overall Study|Participant interviewed twice|1|||
161723378|NCT02792777|584030464|FG001|Overall Study|Participant interviewed twice|0|||
161723379|NCT02795156|584030465|FG000|Overall Study|Progressive Disease|22|||
161723380|NCT02795156|584030466|FG001|Overall Study|Progressive Disease|7|||
161723381|NCT02795156|584030467|FG002|Overall Study|Progressive Disease|34|||
161723382|NCT02795156|584030468|FG003|Overall Study|Progressive Disease|7|||
161723383|NCT02795156|584030465|FG000|Overall Study|Adverse Event|13|||
161723384|NCT02795156|584030466|FG001|Overall Study|Adverse Event|2|||
161723385|NCT02795156|584030467|FG002|Overall Study|Adverse Event|3|||
161723386|NCT02795156|584030468|FG003|Overall Study|Adverse Event|2|||
161723387|NCT02795156|584030465|FG000|Overall Study|Death|1|||
161723388|NCT02795156|584030466|FG001|Overall Study|Death|1|||
161723389|NCT02795156|584030467|FG002|Overall Study|Death|1|||
161723390|NCT02795156|584030468|FG003|Overall Study|Death|0|||
161723391|NCT02795156|584030465|FG000|Overall Study|Physician Decision|1|||
161723392|NCT02795156|584030466|FG001|Overall Study|Physician Decision|0|||
161723393|NCT02795156|584030467|FG002|Overall Study|Physician Decision|1|||
161723394|NCT02795156|584030468|FG003|Overall Study|Physician Decision|0|||
161723395|NCT02795156|584030465|FG000|Overall Study|Withdrawal by Subject|2|||
161723396|NCT02795156|584030466|FG001|Overall Study|Withdrawal by Subject|0|||
161723397|NCT02795156|584030467|FG002|Overall Study|Withdrawal by Subject|3|||
161723398|NCT02795156|584030468|FG003|Overall Study|Withdrawal by Subject|0|||
161723399|NCT00638846|584030472|FG000|Overall Study|Adverse Event|0|||
161723400|NCT00638846|584030473|FG001|Overall Study|Adverse Event|1|||
161723401|NCT00638846|584030472|FG000|Overall Study|Lost to Follow-up|3|||
161723402|NCT00638846|584030473|FG001|Overall Study|Lost to Follow-up|2|||
161723403|NCT00638846|584030472|FG000|Overall Study|lens issue|1|||
161723404|NCT00638846|584030473|FG001|Overall Study|lens issue|3|||
161723405|NCT02746679|584030481|FG000|Overall Study|Lost to Follow-up|4|||
161723406|NCT02746679|584030482|FG001|Overall Study|Lost to Follow-up|6|||
161723407|NCT00487279|584030483|FG000|Overall Study|Death|1|||
161723408|NCT00487279|584030484|FG001|Overall Study|Death|0|||
161723409|NCT00487279|584030483|FG000|Overall Study|Withdrawal by Subject|0|||
161723410|NCT00487279|584030484|FG001|Overall Study|Withdrawal by Subject|2|||
161723411|NCT01171521|584030487|FG000|Overall Study|Lost to Follow-up|5|||
161723412|NCT01171521|584030487|FG000|Overall Study|screen failure|1|||
161723413|NCT00492921|584030488|FG000|Overall Study|Death|1|||
161723414|NCT00492921|584030489|FG001|Overall Study|Death|0|||
161723415|NCT00492921|584030490|FG002|Overall Study|Death|1|||
161723416|NCT00652093|584030491|FG000|Overall Study|Withdrawal by Subject|0|||
161723417|NCT00652093|584030492|FG001|Overall Study|Withdrawal by Subject|0|||
161723418|NCT00652093|584030493|FG002|Overall Study|Withdrawal by Subject|1|||
161723419|NCT00652093|584030494|FG003|Overall Study|Withdrawal by Subject|0|||
161723420|NCT00652093|584030495|FG004|Overall Study|Withdrawal by Subject|1|||
161723421|NCT00652093|584030496|FG005|Overall Study|Withdrawal by Subject|0|||
161723422|NCT00652093|584030491|FG000|Overall Study|Physician Decision|0|||
161723423|NCT00652093|584030492|FG001|Overall Study|Physician Decision|0|||
161723424|NCT00652093|584030493|FG002|Overall Study|Physician Decision|0|||
161723425|NCT00652093|584030494|FG003|Overall Study|Physician Decision|0|||
161723426|NCT00652093|584030495|FG004|Overall Study|Physician Decision|1|||
161723427|NCT00652093|584030496|FG005|Overall Study|Physician Decision|0|||
161723428|NCT01520922|584030500|FG000|Treatment Phase|Physician Decision|2|||
161723429|NCT01520922|584030501|FG001|Treatment Phase|Physician Decision|1|||
161723430|NCT01520922|584030500|FG000|Treatment Phase|Progression|0|||
161723431|NCT01520922|584030501|FG001|Treatment Phase|Progression|2|||
161723432|NCT01520922|584030500|FG000|Treatment Phase|Adverse Event|3|||
161723433|NCT01520922|584030501|FG001|Treatment Phase|Adverse Event|5|||
161723434|NCT01520922|584030500|FG000|Follow up|Lost to Follow-up|0|||
161723435|NCT01520922|584030501|FG001|Follow up|Lost to Follow-up|1|||
161723436|NCT01520922|584030500|FG000|Survival Follow-up|Withdrawal by Subject|1|||
161723437|NCT01520922|584030501|FG001|Survival Follow-up|Withdrawal by Subject|0|||
161723438|NCT01696877|584030502|FG000|Overall Study|Adverse Event|0|||
161723439|NCT01696877|584030503|FG001|Overall Study|Adverse Event|1|||
161723440|NCT01422304|584030508|FG000|Overall Study|Adverse Event|0|||
161723441|NCT01422304|584030509|FG001|Overall Study|Adverse Event|1|||
161723442|NCT01422304|584030508|FG000|Overall Study|Lost to Follow-up|14|||
161723443|NCT01422304|584030509|FG001|Overall Study|Lost to Follow-up|20|||
161723444|NCT01422304|584030508|FG000|Overall Study|Never Entered Follow-up|2|||
161723445|NCT01422304|584030509|FG001|Overall Study|Never Entered Follow-up|1|||
161723446|NCT01422304|584030508|FG000|Overall Study|Protocol Violation|1|||
161723447|NCT01422304|584030509|FG001|Overall Study|Protocol Violation|0|||
161723448|NCT01422304|584030508|FG000|Overall Study|Withdrawal by Subject|4|||
161723449|NCT01422304|584030509|FG001|Overall Study|Withdrawal by Subject|2|||
161723450|NCT01422304|584030508|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
161723451|NCT01422304|584030509|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
161723452|NCT01422304|584030508|FG000|Overall Study|Not Treated|3|||
161723453|NCT01422304|584030509|FG001|Overall Study|Not Treated|11|||
161723454|NCT00469014|584030512|FG000|Initial Phase Randomization|Disease Progression|0|||
161723455|NCT00469014|584030513|FG001|Initial Phase Randomization|Disease Progression|1|||
161723456|NCT00469014|584030514|FG002|Initial Phase Randomization|Disease Progression|1|||
161723457|NCT00469014|584030515|FG003|Initial Phase Randomization|Disease Progression|0|||
161723458|NCT00469014|584030512|FG000|Initial Phase Randomization|No Response|1|||
161723459|NCT00469014|584030513|FG001|Initial Phase Randomization|No Response|0|||
161723460|NCT00469014|584030514|FG002|Initial Phase Randomization|No Response|0|||
161723461|NCT00469014|584030515|FG003|Initial Phase Randomization|No Response|1|||
161723462|NCT00469014|584030512|FG000|Adaptive Randomization|Not Evaluable|1|||
161723463|NCT00469014|584030513|FG001|Adaptive Randomization|Not Evaluable|0|||
161723464|NCT00469014|584030514|FG002|Adaptive Randomization|Not Evaluable|0|||
161723465|NCT00469014|584030515|FG003|Adaptive Randomization|Not Evaluable|1|||
161723466|NCT00469014|584030512|FG000|Adaptive Randomization|No Response|0|||
161723467|NCT00469014|584030513|FG001|Adaptive Randomization|No Response|1|||
161723468|NCT00469014|584030514|FG002|Adaptive Randomization|No Response|0|||
161723469|NCT00469014|584030515|FG003|Adaptive Randomization|No Response|0|||
161723470|NCT00469014|584030512|FG000|Adaptive Randomization|Death|0|||
161723471|NCT00469014|584030513|FG001|Adaptive Randomization|Death|0|||
161723472|NCT00469014|584030514|FG002|Adaptive Randomization|Death|1|||
161723473|NCT00469014|584030515|FG003|Adaptive Randomization|Death|0|||
161723474|NCT03461289|584030519|FG000|Overall Study|Death|1|||
161723475|NCT03241173|584030520|FG000|Overall Study|Death|3|||
161723476|NCT03241173|584030521|FG001|Overall Study|Death|2|||
161723477|NCT03241173|584030522|FG002|Overall Study|Death|4|||
161723478|NCT03241173|584030523|FG003|Overall Study|Death|4|||
161723479|NCT03241173|584030524|FG004|Overall Study|Death|2|||
161723480|NCT03241173|584030525|FG005|Overall Study|Death|2|||
161723481|NCT03241173|584030526|FG006|Overall Study|Death|3|||
161723482|NCT03241173|584030527|FG007|Overall Study|Death|1|||
161723483|NCT03241173|584030528|FG008|Overall Study|Death|0|||
161723484|NCT03241173|584030529|FG009|Overall Study|Death|5|||
161723485|NCT03241173|584030530|FG010|Overall Study|Death|4|||
161723486|NCT03241173|584030531|FG011|Overall Study|Death|3|||
161723487|NCT03241173|584030532|FG012|Overall Study|Death|0|||
161723488|NCT03241173|584030533|FG013|Overall Study|Death|0|||
161723489|NCT03241173|584030534|FG014|Overall Study|Death|0|||
161723490|NCT03241173|584030520|FG000|Overall Study|Withdrawal by Subject|0|||
161723491|NCT03241173|584030521|FG001|Overall Study|Withdrawal by Subject|0|||
161723492|NCT03241173|584030522|FG002|Overall Study|Withdrawal by Subject|1|||
161723493|NCT03241173|584030523|FG003|Overall Study|Withdrawal by Subject|0|||
161723494|NCT03241173|584030524|FG004|Overall Study|Withdrawal by Subject|0|||
161723495|NCT03241173|584030525|FG005|Overall Study|Withdrawal by Subject|1|||
161723496|NCT03241173|584030526|FG006|Overall Study|Withdrawal by Subject|0|||
161723497|NCT03241173|584030527|FG007|Overall Study|Withdrawal by Subject|0|||
161723498|NCT03241173|584030528|FG008|Overall Study|Withdrawal by Subject|0|||
161723499|NCT03241173|584030529|FG009|Overall Study|Withdrawal by Subject|0|||
161723500|NCT03241173|584030530|FG010|Overall Study|Withdrawal by Subject|0|||
161723501|NCT03241173|584030531|FG011|Overall Study|Withdrawal by Subject|0|||
161723502|NCT03241173|584030532|FG012|Overall Study|Withdrawal by Subject|0|||
161723503|NCT03241173|584030533|FG013|Overall Study|Withdrawal by Subject|0|||
161723504|NCT03241173|584030534|FG014|Overall Study|Withdrawal by Subject|0|||
161723505|NCT03241173|584030520|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
161723506|NCT03241173|584030521|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
161723507|NCT03241173|584030522|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161723508|NCT03241173|584030523|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
161723509|NCT03241173|584030524|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
161723510|NCT03241173|584030525|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
161723511|NCT03241173|584030526|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
161723512|NCT03241173|584030527|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
161723513|NCT03241173|584030528|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161723514|NCT03241173|584030529|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161723515|NCT03241173|584030530|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
161723516|NCT03241173|584030531|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
161723517|NCT03241173|584030532|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161723518|NCT03241173|584030533|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161723519|NCT03241173|584030534|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161723520|NCT03241173|584030520|FG000|Overall Study|Lost to Follow-up|0|||
161723521|NCT03241173|584030521|FG001|Overall Study|Lost to Follow-up|0|||
161723522|NCT03241173|584030522|FG002|Overall Study|Lost to Follow-up|0|||
161723523|NCT03241173|584030523|FG003|Overall Study|Lost to Follow-up|0|||
161723524|NCT03241173|584030524|FG004|Overall Study|Lost to Follow-up|1|||
161723525|NCT03241173|584030525|FG005|Overall Study|Lost to Follow-up|0|||
161723526|NCT03241173|584030526|FG006|Overall Study|Lost to Follow-up|0|||
161723527|NCT03241173|584030527|FG007|Overall Study|Lost to Follow-up|0|||
161723528|NCT03241173|584030528|FG008|Overall Study|Lost to Follow-up|0|||
161723529|NCT03241173|584030529|FG009|Overall Study|Lost to Follow-up|1|||
161723530|NCT03241173|584030530|FG010|Overall Study|Lost to Follow-up|0|||
161723531|NCT03241173|584030531|FG011|Overall Study|Lost to Follow-up|0|||
161723532|NCT03241173|584030532|FG012|Overall Study|Lost to Follow-up|0|||
161723533|NCT03241173|584030533|FG013|Overall Study|Lost to Follow-up|0|||
161723534|NCT03241173|584030534|FG014|Overall Study|Lost to Follow-up|0|||
161723535|NCT00564629|584030535|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
161723536|NCT00564629|584030536|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
161723537|NCT00515463|584030537|FG000|Overall Study|Physician Decision|4|||
161723538|NCT00515463|584030538|FG001|Overall Study|Physician Decision|2|||
161723539|NCT00515463|584030537|FG000|Overall Study|Adverse Event|1|||
161723540|NCT00515463|584030538|FG001|Overall Study|Adverse Event|2|||
161723541|NCT00515463|584030537|FG000|Overall Study|Withdrawal by Subject|3|||
161723542|NCT00515463|584030538|FG001|Overall Study|Withdrawal by Subject|4|||
161723543|NCT00515463|584030537|FG000|Overall Study|Lost to Follow-up|6|||
161723544|NCT00515463|584030538|FG001|Overall Study|Lost to Follow-up|5|||
161723545|NCT00515463|584030537|FG000|Overall Study|Other|0|||
161723546|NCT00515463|584030538|FG001|Overall Study|Other|1|||
161723547|NCT01519427|584030539|FG000|Overall Study|disease progression|2|||
161723548|NCT00633139|584030549|FG000|Overall Study|Non compliance|0|||
161723549|NCT00633139|584030550|FG001|Overall Study|Non compliance|0|||
161723550|NCT00633139|584030551|FG002|Overall Study|Non compliance|1|||
161723551|NCT00633139|584030549|FG000|Overall Study|Withdrawal by Subject|0|||
161723552|NCT00633139|584030550|FG001|Overall Study|Withdrawal by Subject|1|||
161723553|NCT00633139|584030551|FG002|Overall Study|Withdrawal by Subject|0|||
161723554|NCT02269319|584030552|FG000|Overall Study|Lost to Follow-up|4|||
161723555|NCT02269319|584030553|FG001|Overall Study|Lost to Follow-up|3|||
161723556|NCT02269319|584030552|FG000|Overall Study|Adverse Event|0|||
161723557|NCT02269319|584030553|FG001|Overall Study|Adverse Event|1|||
161723558|NCT02269319|584030552|FG000|Overall Study|Instructions not followed|1|||
161723559|NCT02269319|584030553|FG001|Overall Study|Instructions not followed|0|||
161723560|NCT01507246|584030554|FG000|Overall Study|Required different surgical procedures|2|||
161723561|NCT01507246|584030555|FG001|Overall Study|Required different surgical procedures|1|||
161723562|NCT03103750|584030556|FG000|Overall Study|Adverse Event|1|||
161723563|NCT03103750|584030557|FG001|Overall Study|Adverse Event|0|||
161723564|NCT03103750|584030556|FG000|Overall Study|Lost to Follow-up|1|||
161723565|NCT03103750|584030557|FG001|Overall Study|Lost to Follow-up|0|||
161723566|NCT03103750|584030556|FG000|Overall Study|PET Equipment Related|2|||
161723567|NCT03103750|584030557|FG001|Overall Study|PET Equipment Related|2|||
161723568|NCT03575468|584030561|FG000|Overall Study|Withdrawal by Subject|3|||
161723569|NCT03575468|584030562|FG001|Overall Study|Withdrawal by Subject|0|||
161723570|NCT03575468|584030561|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
161723571|NCT03575468|584030562|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
161723572|NCT03575468|584030561|FG000|Overall Study|Lost to Follow-up|13|||
161723573|NCT03575468|584030562|FG001|Overall Study|Lost to Follow-up|17|||
161723574|NCT01522651|584030565|FG000|Overall Study|Adverse Event|3|||
161723575|NCT01522651|584030566|FG001|Overall Study|Adverse Event|4|||
161723576|NCT01522651|584030567|FG002|Overall Study|Adverse Event|4|||
161723577|NCT01522651|584030568|FG003|Overall Study|Adverse Event|5|||
161723578|NCT01522651|584030569|FG004|Overall Study|Adverse Event|4|||
161723579|NCT01522651|584030565|FG000|Overall Study|Cardioversion|1|||
161723580|NCT01522651|584030566|FG001|Overall Study|Cardioversion|0|||
161723581|NCT01522651|584030567|FG002|Overall Study|Cardioversion|0|||
161723582|NCT01522651|584030568|FG003|Overall Study|Cardioversion|0|||
161723583|NCT01522651|584030569|FG004|Overall Study|Cardioversion|0|||
161723584|NCT01522651|584030565|FG000|Overall Study|Device Malfunction|0|||
161723585|NCT01522651|584030566|FG001|Overall Study|Device Malfunction|1|||
161723586|NCT01522651|584030567|FG002|Overall Study|Device Malfunction|0|||
161723587|NCT01522651|584030568|FG003|Overall Study|Device Malfunction|0|||
161723588|NCT01522651|584030569|FG004|Overall Study|Device Malfunction|0|||
161723589|NCT01522651|584030565|FG000|Overall Study|Investigator's Discretion|0|||
161723590|NCT01522651|584030566|FG001|Overall Study|Investigator's Discretion|1|||
161723591|NCT01522651|584030567|FG002|Overall Study|Investigator's Discretion|0|||
161723592|NCT01522651|584030568|FG003|Overall Study|Investigator's Discretion|0|||
161723593|NCT01522651|584030569|FG004|Overall Study|Investigator's Discretion|0|||
161723594|NCT01522651|584030565|FG000|Overall Study|Protocol Violation|3|||
161723595|NCT01522651|584030566|FG001|Overall Study|Protocol Violation|0|||
161723596|NCT01522651|584030567|FG002|Overall Study|Protocol Violation|0|||
161723597|NCT01522651|584030568|FG003|Overall Study|Protocol Violation|0|||
161723598|NCT01522651|584030569|FG004|Overall Study|Protocol Violation|0|||
161723599|NCT01522651|584030565|FG000|Overall Study|Reason Not Specified|0|||
161723600|NCT01522651|584030566|FG001|Overall Study|Reason Not Specified|0|||
161723601|NCT01522651|584030567|FG002|Overall Study|Reason Not Specified|0|||
161723602|NCT01522651|584030568|FG003|Overall Study|Reason Not Specified|1|||
161965158|NCT02791191|584920205|FG002|Overall Study|Progressive Disease|0|||
161723603|NCT01522651|584030569|FG004|Overall Study|Reason Not Specified|0|||
161723604|NCT01522651|584030565|FG000|Overall Study|Participant Non-Compliance|1|||
161723605|NCT01522651|584030566|FG001|Overall Study|Participant Non-Compliance|0|||
161723606|NCT01522651|584030567|FG002|Overall Study|Participant Non-Compliance|0|||
161723607|NCT01522651|584030568|FG003|Overall Study|Participant Non-Compliance|0|||
161723608|NCT01522651|584030569|FG004|Overall Study|Participant Non-Compliance|0|||
161965159|NCT02791191|584920203|FG000|Overall Study|Study Terminated by Sponsor|29|||
161965160|NCT02791191|584920204|FG001|Overall Study|Study Terminated by Sponsor|101|||
161965161|NCT02791191|584920205|FG002|Overall Study|Study Terminated by Sponsor|109|||
161965162|NCT02791191|584920203|FG000|Overall Study|Withdrawal by Subject|3|||
161965163|NCT02791191|584920204|FG001|Overall Study|Withdrawal by Subject|1|||
161965164|NCT02791191|584920205|FG002|Overall Study|Withdrawal by Subject|3|||
161965165|NCT02791191|584920203|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
161965166|NCT02791191|584920204|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
161965167|NCT02791191|584920205|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
161965168|NCT03100539|584920212|FG000|Overall Study|Lost to Follow-up|60|||
161965169|NCT03100539|584920213|FG001|Overall Study|Lost to Follow-up|54|||
161965170|NCT03100539|584920214|FG002|Overall Study|Lost to Follow-up|17|||
161965171|NCT03100539|584920212|FG000|Overall Study|Uncollected|8|||
161965172|NCT03100539|584920213|FG001|Overall Study|Uncollected|8|||
161965173|NCT03100539|584920214|FG002|Overall Study|Uncollected|0|||
161965174|NCT03100539|584920212|FG000|Overall Study|Ally Health|0|||
161965175|NCT03100539|584920213|FG001|Overall Study|Ally Health|0|||
161965176|NCT03100539|584920214|FG002|Overall Study|Ally Health|3|||
161965177|NCT03100539|584920212|FG000|Overall Study|Disinterest|0|||
161965178|NCT03100539|584920213|FG001|Overall Study|Disinterest|0|||
161965179|NCT03100539|584920214|FG002|Overall Study|Disinterest|22|||
161965180|NCT03100539|584920212|FG000|Overall Study|Veteran Health|0|||
161965181|NCT03100539|584920213|FG001|Overall Study|Veteran Health|0|||
161965182|NCT03100539|584920214|FG002|Overall Study|Veteran Health|8|||
161965183|NCT03100539|584920212|FG000|Overall Study|Moved|0|||
161965184|NCT03100539|584920213|FG001|Overall Study|Moved|0|||
161965185|NCT03100539|584920214|FG002|Overall Study|Moved|1|||
161965186|NCT03100539|584920212|FG000|Overall Study|Scheduling Conflicts|0|||
161965187|NCT03100539|584920213|FG001|Overall Study|Scheduling Conflicts|0|||
161965188|NCT03100539|584920214|FG002|Overall Study|Scheduling Conflicts|12|||
161965189|NCT04753658|584920224|FG000|Overall Study|Progressive disease|7|||
161965190|NCT04753658|584920224|FG000|Overall Study|Other|7|||
161965191|NCT04753658|584920224|FG000|Overall Study|Adverse Event|1|||
161965192|NCT01892436|584920225|FG000|Overall Study|Withdrawal by Subject|8|||
161965193|NCT01892436|584920226|FG001|Overall Study|Withdrawal by Subject|15|||
161965194|NCT01892436|584920227|FG002|Overall Study|Withdrawal by Subject|4|||
161965195|NCT01892436|584920228|FG003|Overall Study|Withdrawal by Subject|4|||
161965196|NCT01892436|584920225|FG000|Overall Study|Death|1|||
161965197|NCT01892436|584920226|FG001|Overall Study|Death|1|||
161965198|NCT01892436|584920227|FG002|Overall Study|Death|0|||
161965199|NCT01892436|584920228|FG003|Overall Study|Death|0|||
161965200|NCT01892436|584920225|FG000|Overall Study|Physician Decision|2|||
161965201|NCT01892436|584920226|FG001|Overall Study|Physician Decision|1|||
161965202|NCT01892436|584920227|FG002|Overall Study|Physician Decision|0|||
161965203|NCT01892436|584920228|FG003|Overall Study|Physician Decision|1|||
161965204|NCT01892436|584920225|FG000|Overall Study|Pregnancy|0|||
161965205|NCT01892436|584920226|FG001|Overall Study|Pregnancy|2|||
161965206|NCT01892436|584920227|FG002|Overall Study|Pregnancy|1|||
161965207|NCT01892436|584920228|FG003|Overall Study|Pregnancy|0|||
161965208|NCT01892436|584920225|FG000|Overall Study|Technical problems|2|||
161965209|NCT01892436|584920226|FG001|Overall Study|Technical problems|1|||
161965210|NCT01892436|584920227|FG002|Overall Study|Technical problems|1|||
161965211|NCT01892436|584920228|FG003|Overall Study|Technical problems|1|||
161965212|NCT01892436|584920225|FG000|Overall Study|Lack of Efficacy|1|||
161965213|NCT01892436|584920226|FG001|Overall Study|Lack of Efficacy|2|||
161965214|NCT01892436|584920227|FG002|Overall Study|Lack of Efficacy|2|||
161965215|NCT01892436|584920228|FG003|Overall Study|Lack of Efficacy|2|||
161965216|NCT01892436|584920225|FG000|Overall Study|Lost to Follow-up|1|||
161965217|NCT01892436|584920226|FG001|Overall Study|Lost to Follow-up|1|||
161965218|NCT01892436|584920227|FG002|Overall Study|Lost to Follow-up|1|||
161965219|NCT01892436|584920228|FG003|Overall Study|Lost to Follow-up|3|||
161965220|NCT01892436|584920225|FG000|Overall Study|non-compliance with treatment|1|||
161965221|NCT01892436|584920226|FG001|Overall Study|non-compliance with treatment|0|||
161965222|NCT01892436|584920227|FG002|Overall Study|non-compliance with treatment|0|||
161965223|NCT01892436|584920228|FG003|Overall Study|non-compliance with treatment|0|||
161965224|NCT01892436|584920225|FG000|Overall Study|Adverse Event|7|||
161965225|NCT01892436|584920226|FG001|Overall Study|Adverse Event|6|||
161965226|NCT01892436|584920227|FG002|Overall Study|Adverse Event|2|||
161965227|NCT01892436|584920228|FG003|Overall Study|Adverse Event|3|||
161965228|NCT02923830|584920232|FG000|Overall Study|Physician Decision|13|||
161965229|NCT02923830|584920233|FG001|Overall Study|Physician Decision|15|||
161965230|NCT00837265|584920234|FG000|Pilot Phase|Withdrawal by Subject|0|||
161965231|NCT00837265|584920235|FG001|Pilot Phase|Withdrawal by Subject|2|||
162032158|NCT00814801|585174220|FG002|Overall Study|Non-compliance|1|||
161965232|NCT00837265|584920236|FG002|Pilot Phase|Withdrawal by Subject|3|||
161965233|NCT00837265|584920237|FG003|Pilot Phase|Withdrawal by Subject|2|||
161965234|NCT00837265|584920238|FG004|Pilot Phase|Withdrawal by Subject|0|||
161965235|NCT00837265|584920239|FG005|Pilot Phase|Withdrawal by Subject|0|||
161965236|NCT00837265|584920240|FG006|Pilot Phase|Withdrawal by Subject|0|||
161965237|NCT00837265|584920234|FG000|Pilot Phase|Decision of the investigator|2|||
161965238|NCT00837265|584920235|FG001|Pilot Phase|Decision of the investigator|1|||
161965239|NCT00837265|584920236|FG002|Pilot Phase|Decision of the investigator|0|||
161965240|NCT00837265|584920237|FG003|Pilot Phase|Decision of the investigator|0|||
161965241|NCT00837265|584920238|FG004|Pilot Phase|Decision of the investigator|0|||
161965242|NCT00837265|584920239|FG005|Pilot Phase|Decision of the investigator|0|||
161965243|NCT00837265|584920240|FG006|Pilot Phase|Decision of the investigator|0|||
161965244|NCT00837265|584920234|FG000|Pilot Phase|Adverse Event|1|||
161965245|NCT00837265|584920235|FG001|Pilot Phase|Adverse Event|0|||
161965246|NCT00837265|584920236|FG002|Pilot Phase|Adverse Event|0|||
161965247|NCT00837265|584920237|FG003|Pilot Phase|Adverse Event|0|||
161965248|NCT00837265|584920238|FG004|Pilot Phase|Adverse Event|0|||
161965249|NCT00837265|584920239|FG005|Pilot Phase|Adverse Event|0|||
161965250|NCT00837265|584920240|FG006|Pilot Phase|Adverse Event|0|||
161965251|NCT00837265|584920234|FG000|Pilot Phase|Disease progression|0|||
161965252|NCT00837265|584920235|FG001|Pilot Phase|Disease progression|0|||
161965253|NCT00837265|584920236|FG002|Pilot Phase|Disease progression|0|||
161965254|NCT00837265|584920237|FG003|Pilot Phase|Disease progression|1|||
161965255|NCT00837265|584920238|FG004|Pilot Phase|Disease progression|0|||
161965256|NCT00837265|584920239|FG005|Pilot Phase|Disease progression|0|||
161965257|NCT00837265|584920240|FG006|Pilot Phase|Disease progression|0|||
161965258|NCT00837265|584920234|FG000|Pilot Phase|Participant left the city|0|||
161965259|NCT00837265|584920235|FG001|Pilot Phase|Participant left the city|0|||
161965260|NCT00837265|584920236|FG002|Pilot Phase|Participant left the city|0|||
161965261|NCT00837265|584920237|FG003|Pilot Phase|Participant left the city|1|||
161965262|NCT00837265|584920238|FG004|Pilot Phase|Participant left the city|0|||
161723609|NCT01522651|584030565|FG000|Overall Study|Withdrew Consent|1|||
161723610|NCT01522651|584030566|FG001|Overall Study|Withdrew Consent|1|||
161723611|NCT01522651|584030567|FG002|Overall Study|Withdrew Consent|0|||
161723612|NCT01522651|584030568|FG003|Overall Study|Withdrew Consent|1|||
161723613|NCT01522651|584030569|FG004|Overall Study|Withdrew Consent|1|||
161723614|NCT01522651|584030565|FG000|Overall Study|Randomized but Never Treated|0|||
161723615|NCT01522651|584030566|FG001|Overall Study|Randomized but Never Treated|1|||
161723616|NCT01522651|584030567|FG002|Overall Study|Randomized but Never Treated|0|||
161723617|NCT01522651|584030568|FG003|Overall Study|Randomized but Never Treated|1|||
161723618|NCT01522651|584030569|FG004|Overall Study|Randomized but Never Treated|1|||
161723619|NCT02115815|584032205|FG000|Overall Study|Withdrawal by Subject|2|||
161723620|NCT02115815|584032206|FG001|Overall Study|Withdrawal by Subject|0|||
161723621|NCT02115815|584032207|FG002|Overall Study|Withdrawal by Subject|0|||
161723622|NCT02115815|584032208|FG003|Overall Study|Withdrawal by Subject|0|||
161723623|NCT02115815|584032209|FG004|Overall Study|Withdrawal by Subject|0|||
161723624|NCT02115815|584032210|FG005|Overall Study|Withdrawal by Subject|0|||
161723625|NCT02115815|584032211|FG006|Overall Study|Withdrawal by Subject|0|||
161723626|NCT02115815|584032205|FG000|Overall Study|Not enough drug to dose participant|0|||
161723627|NCT02115815|584032206|FG001|Overall Study|Not enough drug to dose participant|0|||
161723628|NCT02115815|584032207|FG002|Overall Study|Not enough drug to dose participant|0|||
161723629|NCT02115815|584032208|FG003|Overall Study|Not enough drug to dose participant|0|||
161723630|NCT02115815|584032209|FG004|Overall Study|Not enough drug to dose participant|0|||
161723631|NCT02115815|584032210|FG005|Overall Study|Not enough drug to dose participant|1|||
161723632|NCT02115815|584032211|FG006|Overall Study|Not enough drug to dose participant|0|||
161723633|NCT02115815|584032205|FG000|Overall Study|Missed appointment, randomized in error|0|||
161723634|NCT02115815|584032206|FG001|Overall Study|Missed appointment, randomized in error|0|||
161723635|NCT02115815|584032207|FG002|Overall Study|Missed appointment, randomized in error|0|||
161723636|NCT02115815|584032208|FG003|Overall Study|Missed appointment, randomized in error|0|||
161723637|NCT02115815|584032209|FG004|Overall Study|Missed appointment, randomized in error|0|||
161723638|NCT02115815|584032210|FG005|Overall Study|Missed appointment, randomized in error|1|||
161723639|NCT02115815|584032211|FG006|Overall Study|Missed appointment, randomized in error|0|||
161723640|NCT01989546|584032212|FG000|Overall Study|Clinical Progression|1|||
161723641|NCT01989546|584032212|FG000|Overall Study|Disease progression on study|8|||
161723642|NCT02819310|584032213|FG000|Overall Study|Withdrawal by Subject|37|||
161723643|NCT02819310|584032213|FG000|Overall Study|Lost to Follow-up|16|||
161965263|NCT00837265|584920239|FG005|Pilot Phase|Participant left the city|0|||
161965264|NCT00837265|584920240|FG006|Pilot Phase|Participant left the city|0|||
161965265|NCT00837265|584920234|FG000|Main Phase|Withdrawal by Subject|0|||
161965266|NCT00837265|584920235|FG001|Main Phase|Withdrawal by Subject|0|||
161965267|NCT00837265|584920236|FG002|Main Phase|Withdrawal by Subject|0|||
161965268|NCT00837265|584920237|FG003|Main Phase|Withdrawal by Subject|0|||
161965269|NCT00837265|584920238|FG004|Main Phase|Withdrawal by Subject|4|||
161965270|NCT00837265|584920239|FG005|Main Phase|Withdrawal by Subject|2|||
161965271|NCT00837265|584920240|FG006|Main Phase|Withdrawal by Subject|1|||
161965272|NCT00837265|584920234|FG000|Main Phase|Decision of the investigator|0|||
161965273|NCT00837265|584920235|FG001|Main Phase|Decision of the investigator|0|||
161965274|NCT00837265|584920236|FG002|Main Phase|Decision of the investigator|0|||
161965275|NCT00837265|584920237|FG003|Main Phase|Decision of the investigator|0|||
161965276|NCT00837265|584920238|FG004|Main Phase|Decision of the investigator|0|||
162032159|NCT00814801|585174218|FG000|Overall Study|Other|2|||
161965277|NCT00837265|584920239|FG005|Main Phase|Decision of the investigator|2|||
161965278|NCT00837265|584920240|FG006|Main Phase|Decision of the investigator|1|||
161723644|NCT02819310|584032213|FG000|Overall Study|Adverse Event|13|||
161723645|NCT02819310|584032213|FG000|Overall Study|Lack of Efficacy|5|||
161723646|NCT02819310|584032213|FG000|Overall Study|Physician Decision|8|||
161723647|NCT02819310|584032213|FG000|Overall Study|Protocol Violation|30|||
161723648|NCT00059215|584032216|FG000|Overall Study|Adverse Event|5|||
161723649|NCT00059215|584032217|FG001|Overall Study|Adverse Event|5|||
161723650|NCT00059215|584032218|FG002|Overall Study|Adverse Event|9|||
161723651|NCT00059215|584032219|FG003|Overall Study|Adverse Event|9|||
161723652|NCT00059215|584032216|FG000|Overall Study|Death|0|||
161723653|NCT00059215|584032217|FG001|Overall Study|Death|0|||
161723654|NCT00059215|584032218|FG002|Overall Study|Death|3|||
161723655|NCT00059215|584032219|FG003|Overall Study|Death|0|||
161723656|NCT00059215|584032216|FG000|Overall Study|Lost to Follow-up|1|||
161723657|NCT00059215|584032217|FG001|Overall Study|Lost to Follow-up|2|||
161723658|NCT00059215|584032218|FG002|Overall Study|Lost to Follow-up|0|||
161723659|NCT00059215|584032219|FG003|Overall Study|Lost to Follow-up|0|||
161723660|NCT00059215|584032216|FG000|Overall Study|Withdrawal by Subject|4|||
161723661|NCT00059215|584032217|FG001|Overall Study|Withdrawal by Subject|4|||
161723662|NCT00059215|584032218|FG002|Overall Study|Withdrawal by Subject|1|||
161723663|NCT00059215|584032219|FG003|Overall Study|Withdrawal by Subject|3|||
161723664|NCT00059215|584032216|FG000|Overall Study|Protocol Violation|1|||
161723665|NCT00059215|584032217|FG001|Overall Study|Protocol Violation|0|||
161723666|NCT00059215|584032218|FG002|Overall Study|Protocol Violation|1|||
161723667|NCT00059215|584032219|FG003|Overall Study|Protocol Violation|0|||
161723668|NCT00059215|584032216|FG000|Overall Study|Protocol entry criteria not met|1|||
161723669|NCT00059215|584032217|FG001|Overall Study|Protocol entry criteria not met|1|||
161723670|NCT00059215|584032218|FG002|Overall Study|Protocol entry criteria not met|0|||
161723671|NCT00059215|584032219|FG003|Overall Study|Protocol entry criteria not met|2|||
161723672|NCT00059215|584032216|FG000|Overall Study|Physician Decision|1|||
161723673|NCT00059215|584032217|FG001|Overall Study|Physician Decision|2|||
161723674|NCT00059215|584032218|FG002|Overall Study|Physician Decision|1|||
161723675|NCT00059215|584032219|FG003|Overall Study|Physician Decision|1|||
161723676|NCT04494633|584032221|FG000|Overall Study|Lost to Follow-up|5|||
161723677|NCT04494633|584032222|FG001|Overall Study|Lost to Follow-up|3|||
161723678|NCT04494633|584032221|FG000|Overall Study|Protocol Violation|1|||
161723679|NCT04494633|584032222|FG001|Overall Study|Protocol Violation|1|||
161723680|NCT01254604|584032225|FG000|Overall Study|Lost to Follow-up|1|||
161723681|NCT01254604|584032226|FG001|Overall Study|Lost to Follow-up|1|||
161723682|NCT01254604|584032225|FG000|Overall Study|Protocol Violation|2|||
161723683|NCT01254604|584032226|FG001|Overall Study|Protocol Violation|2|||
161723684|NCT01254604|584032225|FG000|Overall Study|Withdrawal by Subject|2|||
161723685|NCT01254604|584032226|FG001|Overall Study|Withdrawal by Subject|4|||
161723686|NCT01254604|584032225|FG000|Overall Study|Adverse Event|3|||
161723687|NCT01254604|584032226|FG001|Overall Study|Adverse Event|2|||
161723688|NCT03074162|584032227|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161723689|NCT03074162|584032228|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161723690|NCT03074162|584032229|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
161723691|NCT03074162|584032230|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161723692|NCT03074162|584032231|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161723693|NCT03074162|584032232|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161965279|NCT00837265|584920234|FG000|Main Phase|Adverse Event|0|||
161965280|NCT00837265|584920235|FG001|Main Phase|Adverse Event|0|||
161965281|NCT00837265|584920236|FG002|Main Phase|Adverse Event|0|||
161723694|NCT03074162|584032227|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
161723695|NCT03074162|584032228|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
161723696|NCT03074162|584032229|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
161723697|NCT03074162|584032230|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
161723698|NCT03074162|584032231|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
161723699|NCT03074162|584032232|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
161965282|NCT00837265|584920237|FG003|Main Phase|Adverse Event|0|||
161965283|NCT00837265|584920238|FG004|Main Phase|Adverse Event|0|||
161723700|NCT03074162|584032227|FG000|Period 3|Withdrawal by Subject|1|||
161723701|NCT03074162|584032228|FG001|Period 3|Withdrawal by Subject|0|||
161723702|NCT03074162|584032229|FG002|Period 3|Withdrawal by Subject|0|||
161723703|NCT03074162|584032230|FG003|Period 3|Withdrawal by Subject|0|||
161723704|NCT03074162|584032231|FG004|Period 3|Withdrawal by Subject|1|||
161723705|NCT03074162|584032232|FG005|Period 3|Withdrawal by Subject|0|||
161723706|NCT01958671|584032233|FG000|Overall Study|Adverse Event|1|||
161723707|NCT01958671|584032234|FG001|Overall Study|Adverse Event|1|||
161723708|NCT01958671|584032235|FG002|Overall Study|Adverse Event|5|||
161723709|NCT01958671|584032233|FG000|Overall Study|Death|1|||
161723710|NCT01958671|584032234|FG001|Overall Study|Death|0|||
161723711|NCT01958671|584032235|FG002|Overall Study|Death|0|||
161723712|NCT01958671|584032233|FG000|Overall Study|Excluded medication|0|||
161723713|NCT01958671|584032234|FG001|Overall Study|Excluded medication|0|||
161723714|NCT01958671|584032235|FG002|Overall Study|Excluded medication|1|||
161965284|NCT00837265|584920239|FG005|Main Phase|Adverse Event|1|||
161965285|NCT00837265|584920240|FG006|Main Phase|Adverse Event|0|||
161723715|NCT01958671|584032233|FG000|Overall Study|Hyperglycemia|0|||
161723716|NCT01958671|584032234|FG001|Overall Study|Hyperglycemia|0|||
161723717|NCT01958671|584032235|FG002|Overall Study|Hyperglycemia|2|||
161723718|NCT01958671|584032233|FG000|Overall Study|Lost to Follow-up|7|||
161723719|NCT01958671|584032234|FG001|Overall Study|Lost to Follow-up|11|||
161723720|NCT01958671|584032235|FG002|Overall Study|Lost to Follow-up|7|||
161723721|NCT01958671|584032233|FG000|Overall Study|Non-compliance with study drug|1|||
161723722|NCT01958671|584032234|FG001|Overall Study|Non-compliance with study drug|1|||
161723723|NCT01958671|584032235|FG002|Overall Study|Non-compliance with study drug|1|||
161723724|NCT01958671|584032233|FG000|Overall Study|Pregnancy|0|||
161723725|NCT01958671|584032234|FG001|Overall Study|Pregnancy|0|||
161723726|NCT01958671|584032235|FG002|Overall Study|Pregnancy|1|||
161723727|NCT01958671|584032233|FG000|Overall Study|Protocol Violation|0|||
161723728|NCT01958671|584032234|FG001|Overall Study|Protocol Violation|1|||
161723729|NCT01958671|584032235|FG002|Overall Study|Protocol Violation|0|||
161723730|NCT01958671|584032233|FG000|Overall Study|Study site terminated by sponsor|1|||
161723731|NCT01958671|584032234|FG001|Overall Study|Study site terminated by sponsor|0|||
161723732|NCT01958671|584032235|FG002|Overall Study|Study site terminated by sponsor|1|||
161723733|NCT01958671|584032233|FG000|Overall Study|Participant moved|0|||
161723734|NCT01958671|584032234|FG001|Overall Study|Participant moved|0|||
161723735|NCT01958671|584032235|FG002|Overall Study|Participant moved|1|||
161723736|NCT01958671|584032233|FG000|Overall Study|Withdrawal by Subject|8|||
161723737|NCT01958671|584032234|FG001|Overall Study|Withdrawal by Subject|10|||
161723738|NCT01958671|584032235|FG002|Overall Study|Withdrawal by Subject|13|||
161723739|NCT02778867|584032236|FG000|Phase 1|Withdrawal by Subject|2|||
161723740|NCT02778867|584032237|FG001|Phase 1|Withdrawal by Subject|3|||
161723741|NCT02778867|584032238|FG002|Phase 1|Withdrawal by Subject|0|||
161723742|NCT02778867|584032239|FG003|Phase 1|Withdrawal by Subject|0|||
161723743|NCT02778867|584032236|FG000|Phase 2|Withdrawal by Subject|0|||
161723744|NCT02778867|584032237|FG001|Phase 2|Withdrawal by Subject|0|||
161723745|NCT02778867|584032238|FG002|Phase 2|Withdrawal by Subject|1|||
161723746|NCT02778867|584032239|FG003|Phase 2|Withdrawal by Subject|0|||
161723747|NCT02778867|584032236|FG000|Phase 2|Physician Decision|0|||
161723748|NCT02778867|584032237|FG001|Phase 2|Physician Decision|0|||
161723749|NCT02778867|584032238|FG002|Phase 2|Physician Decision|0|||
161723750|NCT02778867|584032239|FG003|Phase 2|Physician Decision|1|||
161723751|NCT02778867|584032236|FG000|Phase 2|Adverse Event|0|||
161723752|NCT02778867|584032237|FG001|Phase 2|Adverse Event|0|||
161723753|NCT02778867|584032238|FG002|Phase 2|Adverse Event|0|||
161723754|NCT02778867|584032239|FG003|Phase 2|Adverse Event|1|||
161723755|NCT02948777|584032240|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
161723756|NCT02311478|584032241|FG000|Overall Study|Withdrawal by Subject|1|||
161723757|NCT02311478|584032241|FG000|Overall Study|Lost to Follow-up|5|||
161723758|NCT02311478|584032241|FG000|Overall Study|Failed IUD Insertion|1|||
161723759|NCT03242928|584032243|FG000|Overall Study|Adverse Event|2|||
161723760|NCT03242928|584032244|FG001|Overall Study|Adverse Event|1|||
161723761|NCT03242928|584032243|FG000|Overall Study|Lost to Follow-up|2|||
161723762|NCT03242928|584032244|FG001|Overall Study|Lost to Follow-up|0|||
161723763|NCT03242928|584032243|FG000|Overall Study|Physician Decision|0|||
161723764|NCT03242928|584032244|FG001|Overall Study|Physician Decision|1|||
161723765|NCT03242928|584032243|FG000|Overall Study|Withdrawal by Subject|5|||
161723766|NCT03242928|584032244|FG001|Overall Study|Withdrawal by Subject|3|||
161723767|NCT03276936|584032245|FG000|Overall Study|Adverse Event|4|||
161723768|NCT03276936|584032246|FG001|Overall Study|Adverse Event|2|||
161723769|NCT03276936|584032245|FG000|Overall Study|Lost to Follow-up|16|||
161723770|NCT03276936|584032246|FG001|Overall Study|Lost to Follow-up|13|||
161723771|NCT03276936|584032245|FG000|Overall Study|Withdrawal by Subject|30|||
161723772|NCT03276936|584032246|FG001|Overall Study|Withdrawal by Subject|20|||
161723773|NCT03276936|584032245|FG000|Overall Study|Not mentioned|6|||
161723774|NCT03276936|584032246|FG001|Overall Study|Not mentioned|3|||
161723775|NCT00943319|584032247|FG000|Overall Study|Death|1|||
161723776|NCT02043301|584032248|FG000|Overall Study|Discontinued|0|||
161723777|NCT02043301|584032249|FG001|Overall Study|Discontinued|1|||
161723778|NCT02043301|584032250|FG002|Overall Study|Discontinued|0|||
161965286|NCT00837265|584920234|FG000|Main Phase|Death|0|||
161965287|NCT00837265|584920235|FG001|Main Phase|Death|0|||
161723779|NCT03703375|584032254|FG000|Randomization Period|Withdrawal by Subject|0|||
161723780|NCT03703375|584032255|FG001|Randomization Period|Withdrawal by Subject|0|||
161965288|NCT00837265|584920236|FG002|Main Phase|Death|0|||
161723781|NCT03703375|584032256|FG002|Randomization Period|Withdrawal by Subject|0|||
161723782|NCT03703375|584032257|FG003|Randomization Period|Withdrawal by Subject|1|||
161723783|NCT03703375|584032254|FG000|Randomization Period|Completed safety run-in treatment|7|||
161723784|NCT03703375|584032255|FG001|Randomization Period|Completed safety run-in treatment|0|||
161723785|NCT03703375|584032256|FG002|Randomization Period|Completed safety run-in treatment|0|||
161723786|NCT03703375|584032257|FG003|Randomization Period|Completed safety run-in treatment|0|||
161723787|NCT03703375|584032254|FG000|Treatment Period|Other Reasons|0|||
161723788|NCT03703375|584032255|FG001|Treatment Period|Other Reasons|1|||
161723789|NCT03703375|584032256|FG002|Treatment Period|Other Reasons|0|||
161965289|NCT00837265|584920237|FG003|Main Phase|Death|0|||
161965290|NCT00837265|584920238|FG004|Main Phase|Death|2|||
161723790|NCT03703375|584032257|FG003|Treatment Period|Other Reasons|3|||
161723791|NCT03703375|584032254|FG000|Treatment Period|Consent Withdrawal|0|||
161723792|NCT03703375|584032255|FG001|Treatment Period|Consent Withdrawal|0|||
161723793|NCT03703375|584032256|FG002|Treatment Period|Consent Withdrawal|0|||
161723794|NCT03703375|584032257|FG003|Treatment Period|Consent Withdrawal|1|||
161723795|NCT03703375|584032254|FG000|Treatment Period|Death|1|||
161723796|NCT03703375|584032255|FG001|Treatment Period|Death|0|||
161723797|NCT03703375|584032256|FG002|Treatment Period|Death|1|||
161723798|NCT03703375|584032257|FG003|Treatment Period|Death|2|||
161723799|NCT03703375|584032254|FG000|Treatment Period|Toxicity of Study Treatment|2|||
161723800|NCT03703375|584032255|FG001|Treatment Period|Toxicity of Study Treatment|0|||
161723801|NCT03703375|584032256|FG002|Treatment Period|Toxicity of Study Treatment|4|||
161723802|NCT03703375|584032257|FG003|Treatment Period|Toxicity of Study Treatment|1|||
161723803|NCT03703375|584032254|FG000|Treatment Period|Progression|32|||
161723804|NCT03703375|584032255|FG001|Treatment Period|Progression|1|||
161723805|NCT03703375|584032256|FG002|Treatment Period|Progression|7|||
161723806|NCT03703375|584032257|FG003|Treatment Period|Progression|11|||
161723807|NCT03703375|584032254|FG000|Treatment Period|Completed treatment|7|||
161723808|NCT03703375|584032255|FG001|Treatment Period|Completed treatment|2|||
161723809|NCT03703375|584032256|FG002|Treatment Period|Completed treatment|0|||
161723810|NCT03703375|584032257|FG003|Treatment Period|Completed treatment|0|||
161723811|NCT00625365|584032258|FG000|Overall Study|Withdrawal by Subject|1|||
161723812|NCT00625365|584032258|FG000|Overall Study|No IV access|5|||
161723813|NCT00625365|584032258|FG000|Overall Study|VSD|1|||
161723814|NCT01703286|584032260|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
161723815|NCT01703286|584032261|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
161723816|NCT01703286|584032262|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
161723817|NCT01703286|584032263|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
161723818|NCT01703286|584032264|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
161723819|NCT01703286|584032265|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
161723820|NCT01703286|584032260|FG000|Period 2 Including Washout|Adverse Event|0|||
161723821|NCT01703286|584032261|FG001|Period 2 Including Washout|Adverse Event|0|||
161723822|NCT01703286|584032262|FG002|Period 2 Including Washout|Adverse Event|0|||
161723823|NCT01703286|584032263|FG003|Period 2 Including Washout|Adverse Event|1|||
161723824|NCT01703286|584032264|FG004|Period 2 Including Washout|Adverse Event|0|||
161723825|NCT01703286|584032265|FG005|Period 2 Including Washout|Adverse Event|0|||
161723826|NCT00931892|584032266|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
161723827|NCT00931892|584032267|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
161723828|NCT02207530|584032270|FG000|Overall Study|Worsening condition under investigation|78|||
161723829|NCT02207530|584032270|FG000|Overall Study|Patient decision to stop study treatment|5|||
161723830|NCT02207530|584032270|FG000|Overall Study|Adverse Event|8|||
161723831|NCT03952468|584032279|FG000|Overall Study|Death|0|||
161723832|NCT03952468|584032280|FG001|Overall Study|Death|1|||
161723833|NCT03952468|584032279|FG000|Overall Study|Adverse Event|0|||
161723834|NCT03952468|584032280|FG001|Overall Study|Adverse Event|1|||
161723835|NCT03952468|584032279|FG000|Overall Study|Physician Decision|1|||
161723836|NCT03952468|584032280|FG001|Overall Study|Physician Decision|0|||
161723837|NCT03952468|584032279|FG000|Overall Study|Lost to Follow-up|3|||
161723838|NCT03952468|584032280|FG001|Overall Study|Lost to Follow-up|4|||
161723839|NCT03952468|584032279|FG000|Overall Study|Withdrawal by Subject|2|||
161723840|NCT03952468|584032280|FG001|Overall Study|Withdrawal by Subject|1|||
161723841|NCT06094296|584032281|FG000|Overall Study|Progressive Disease|1|||
161965291|NCT00837265|584920239|FG005|Main Phase|Death|0|||
161965292|NCT00837265|584920240|FG006|Main Phase|Death|1|||
161965293|NCT00837265|584920234|FG000|Main Phase|Lost to Follow-up|0|||
161965294|NCT00837265|584920235|FG001|Main Phase|Lost to Follow-up|0|||
161965295|NCT00837265|584920236|FG002|Main Phase|Lost to Follow-up|0|||
161965296|NCT00837265|584920237|FG003|Main Phase|Lost to Follow-up|0|||
161965297|NCT00837265|584920238|FG004|Main Phase|Lost to Follow-up|1|||
161965298|NCT00837265|584920239|FG005|Main Phase|Lost to Follow-up|0|||
161965299|NCT00837265|584920240|FG006|Main Phase|Lost to Follow-up|0|||
161723842|NCT06094296|584032282|FG001|Overall Study|Progressive Disease|0|||
161723843|NCT06094296|584032283|FG002|Overall Study|Progressive Disease|0|||
161723844|NCT06094296|584032284|FG003|Overall Study|Progressive Disease|0|||
161723845|NCT04964063|584032285|FG000|Overall Study|Adverse Event|4|||
161723846|NCT04964063|584032285|FG000|Overall Study|Lost to Follow-up|47|||
161723847|NCT04964063|584032285|FG000|Overall Study|Withdrawal by Subject|5|||
161723848|NCT04964063|584032285|FG000|Overall Study|Baseline Tasks Expired|41|||
161723849|NCT04964063|584032285|FG000|Overall Study|Participant withdrawn in error|1|||
161723850|NCT03350750|584032289|FG000|Overall Study|Death|1|||
161723851|NCT03350750|584032290|FG001|Overall Study|Death|1|||
161723852|NCT00406315|584032292|FG000|Overall Study|Death|1|||
161723853|NCT00406315|584032292|FG000|Overall Study|Adverse Event|39|||
161965300|NCT00837265|584920234|FG000|Main Phase|Principal investigator resignation|0|||
161723854|NCT00406315|584032292|FG000|Overall Study|Laboratory Abnormality|4|||
161965301|NCT00837265|584920235|FG001|Main Phase|Principal investigator resignation|0|||
161723855|NCT00406315|584032292|FG000|Overall Study|Lack of Efficacy|13|||
161965302|NCT00837265|584920236|FG002|Main Phase|Principal investigator resignation|0|||
161965303|NCT00837265|584920237|FG003|Main Phase|Principal investigator resignation|0|||
161965304|NCT00837265|584920238|FG004|Main Phase|Principal investigator resignation|2|||
161965305|NCT00837265|584920239|FG005|Main Phase|Principal investigator resignation|0|||
161965306|NCT00837265|584920240|FG006|Main Phase|Principal investigator resignation|0|||
161965307|NCT00837265|584920234|FG000|Main Phase|Participant's personal reason|0|||
161965308|NCT00837265|584920235|FG001|Main Phase|Participant's personal reason|0|||
161723856|NCT00406315|584032292|FG000|Overall Study|Other|33|||
161723857|NCT00406315|584032292|FG000|Overall Study|Lost to Follow-up|21|||
161723858|NCT00406315|584032292|FG000|Overall Study|Withdrawal by Subject|30|||
161723859|NCT01797783|584032295|FG000|Overall Study|Adverse Event|1|||
161965309|NCT00837265|584920236|FG002|Main Phase|Participant's personal reason|0|||
161965310|NCT00837265|584920237|FG003|Main Phase|Participant's personal reason|0|||
161965311|NCT00837265|584920238|FG004|Main Phase|Participant's personal reason|1|||
161965312|NCT00837265|584920239|FG005|Main Phase|Participant's personal reason|0|||
161965313|NCT00837265|584920240|FG006|Main Phase|Participant's personal reason|0|||
161965314|NCT00733291|584920242|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
161965315|NCT00733291|584920243|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
161965316|NCT00733291|584920244|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
161965317|NCT00733291|584920245|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
161965318|NCT01751906|584920246|FG000|Overall Study|Lost to Follow-up|151|||
161965319|NCT01751906|584920247|FG001|Overall Study|Lost to Follow-up|68|||
161965320|NCT01751906|584920246|FG000|Overall Study|Withdrawal by Subject|22|||
161965321|NCT01751906|584920247|FG001|Overall Study|Withdrawal by Subject|18|||
161965322|NCT01751906|584920246|FG000|Overall Study|Physician Decision|5|||
161965323|NCT01751906|584920247|FG001|Overall Study|Physician Decision|2|||
161965324|NCT01751906|584920246|FG000|Overall Study|Death|84|||
161965325|NCT01751906|584920247|FG001|Overall Study|Death|43|||
161723860|NCT01797783|584032296|FG001|Overall Study|Adverse Event|1|||
161723861|NCT01797783|584032295|FG000|Overall Study|Withdrawal by Subject|1|||
161723862|NCT01797783|584032296|FG001|Overall Study|Withdrawal by Subject|0|||
161723863|NCT02202031|584032298|FG000|Overall Study|Lost to Follow-up|1|||
161723864|NCT02202031|584032299|FG001|Overall Study|Lost to Follow-up|0|||
161723865|NCT02202031|584032298|FG000|Overall Study|Too Busy|1|||
161723866|NCT02202031|584032299|FG001|Overall Study|Too Busy|3|||
161723867|NCT02202031|584032298|FG000|Overall Study|Illness/Medical Reason|0|||
161723868|NCT02202031|584032299|FG001|Overall Study|Illness/Medical Reason|2|||
161723869|NCT02202031|584032298|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
161723870|NCT02202031|584032299|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
161723871|NCT02184143|584032300|FG000|Overall Study|Withdrawal by Subject|4|||
161723872|NCT02184143|584032301|FG001|Overall Study|Withdrawal by Subject|4|||
161723873|NCT02184143|584032300|FG000|Overall Study|Lost to Follow-up|5|||
161723874|NCT02184143|584032301|FG001|Overall Study|Lost to Follow-up|3|||
161723875|NCT02184143|584032300|FG000|Overall Study|Death|1|||
161723876|NCT02184143|584032301|FG001|Overall Study|Death|0|||
161723877|NCT00321984|584032302|FG000|Overall Study|Adverse Event|9|||
161723878|NCT00321984|584032303|FG001|Overall Study|Adverse Event|6|||
161723879|NCT00321984|584032304|FG002|Overall Study|Adverse Event|8|||
161723880|NCT00321984|584032302|FG000|Overall Study|Protocol Violation|0|||
161723881|NCT00321984|584032303|FG001|Overall Study|Protocol Violation|1|||
161723882|NCT00321984|584032304|FG002|Overall Study|Protocol Violation|1|||
161723883|NCT00321984|584032302|FG000|Overall Study|Lost to Follow-up|2|||
161723884|NCT00321984|584032303|FG001|Overall Study|Lost to Follow-up|4|||
161723885|NCT00321984|584032304|FG002|Overall Study|Lost to Follow-up|2|||
161723886|NCT00321984|584032302|FG000|Overall Study|Withdrawal by Subject|8|||
161723887|NCT00321984|584032303|FG001|Overall Study|Withdrawal by Subject|6|||
161723888|NCT00321984|584032304|FG002|Overall Study|Withdrawal by Subject|5|||
161723889|NCT00321984|584032302|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
161723890|NCT00321984|584032303|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
161723891|NCT00321984|584032304|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
161965326|NCT01751906|584920246|FG000|Overall Study|Denied on premises for follow-up by law|1|||
161965327|NCT01751906|584920247|FG001|Overall Study|Denied on premises for follow-up by law|0|||
161965328|NCT01110330|584920258|FG000|Overall Study|Adverse Event|0|||
161965329|NCT01110330|584920259|FG001|Overall Study|Adverse Event|4|||
161965330|NCT01110330|584920260|FG002|Overall Study|Adverse Event|3|||
161965331|NCT01110330|584920258|FG000|Overall Study|Lack of Efficacy|3|||
161965332|NCT01110330|584920259|FG001|Overall Study|Lack of Efficacy|1|||
161965333|NCT01110330|584920260|FG002|Overall Study|Lack of Efficacy|1|||
161723892|NCT00321984|584032302|FG000|Overall Study|Lack of Efficacy|3|||
161723893|NCT00321984|584032303|FG001|Overall Study|Lack of Efficacy|1|||
161723894|NCT00321984|584032304|FG002|Overall Study|Lack of Efficacy|3|||
161723895|NCT00321984|584032302|FG000|Overall Study|Noncompliant|0|||
161723896|NCT00321984|584032303|FG001|Overall Study|Noncompliant|0|||
161723897|NCT00321984|584032304|FG002|Overall Study|Noncompliant|2|||
161723898|NCT00321984|584032302|FG000|Overall Study|Pregnancy|0|||
161723899|NCT00321984|584032303|FG001|Overall Study|Pregnancy|1|||
161965334|NCT01110330|584920258|FG000|Overall Study|Lost to Follow-up|9|||
161965335|NCT01110330|584920259|FG001|Overall Study|Lost to Follow-up|10|||
161965336|NCT01110330|584920260|FG002|Overall Study|Lost to Follow-up|15|||
161965337|NCT01110330|584920258|FG000|Overall Study|Physician Decision|0|||
161965338|NCT01110330|584920259|FG001|Overall Study|Physician Decision|1|||
161965339|NCT01110330|584920260|FG002|Overall Study|Physician Decision|0|||
161965340|NCT01110330|584920258|FG000|Overall Study|Protocol Violation|2|||
161965341|NCT01110330|584920259|FG001|Overall Study|Protocol Violation|0|||
161965342|NCT01110330|584920260|FG002|Overall Study|Protocol Violation|4|||
161965343|NCT01110330|584920258|FG000|Overall Study|Withdrawal by Subject|0|||
161965344|NCT01110330|584920259|FG001|Overall Study|Withdrawal by Subject|6|||
161965345|NCT01110330|584920260|FG002|Overall Study|Withdrawal by Subject|2|||
161965346|NCT01110330|584920258|FG000|Overall Study|Other|1|||
161965347|NCT01110330|584920259|FG001|Overall Study|Other|1|||
161965348|NCT01110330|584920260|FG002|Overall Study|Other|1|||
161965349|NCT02759107|584920261|FG000|Overall Study|Adverse Event|0|||
161965350|NCT02759107|584920262|FG001|Overall Study|Adverse Event|0|||
161965351|NCT02759107|584920263|FG002|Overall Study|Adverse Event|0|||
161965352|NCT02759107|584920264|FG003|Overall Study|Adverse Event|0|||
161965353|NCT02759107|584920265|FG004|Overall Study|Adverse Event|0|||
161965354|NCT02759107|584920266|FG005|Overall Study|Adverse Event|0|||
161965355|NCT02759107|584920267|FG006|Overall Study|Adverse Event|0|||
161965356|NCT02759107|584920268|FG007|Overall Study|Adverse Event|0|||
161965357|NCT02759107|584920269|FG008|Overall Study|Adverse Event|0|||
161965358|NCT02759107|584920270|FG009|Overall Study|Adverse Event|0|||
161965359|NCT02759107|584920271|FG010|Overall Study|Adverse Event|0|||
161965360|NCT02759107|584920272|FG011|Overall Study|Adverse Event|0|||
161965361|NCT02759107|584920273|FG012|Overall Study|Adverse Event|2|||
161965362|NCT02759107|584920274|FG013|Overall Study|Adverse Event|0|||
161965363|NCT02759107|584920275|FG014|Overall Study|Adverse Event|0|||
161965364|NCT02759107|584920276|FG015|Overall Study|Adverse Event|1|||
161965365|NCT02759107|584920277|FG016|Overall Study|Adverse Event|0|||
161965366|NCT02759107|584920278|FG017|Overall Study|Adverse Event|2|||
161965367|NCT02759107|584920261|FG000|Overall Study|Scheduling Conflict|0|||
161965368|NCT02759107|584920262|FG001|Overall Study|Scheduling Conflict|0|||
161965369|NCT02759107|584920263|FG002|Overall Study|Scheduling Conflict|0|||
161965370|NCT02759107|584920264|FG003|Overall Study|Scheduling Conflict|0|||
161965371|NCT02759107|584920265|FG004|Overall Study|Scheduling Conflict|0|||
161965372|NCT02759107|584920266|FG005|Overall Study|Scheduling Conflict|0|||
161965373|NCT02759107|584920267|FG006|Overall Study|Scheduling Conflict|0|||
161965374|NCT02759107|584920268|FG007|Overall Study|Scheduling Conflict|0|||
161965375|NCT02759107|584920269|FG008|Overall Study|Scheduling Conflict|0|||
161965376|NCT02759107|584920270|FG009|Overall Study|Scheduling Conflict|1|||
161965377|NCT02759107|584920271|FG010|Overall Study|Scheduling Conflict|0|||
161965378|NCT02759107|584920272|FG011|Overall Study|Scheduling Conflict|0|||
161965379|NCT02759107|584920273|FG012|Overall Study|Scheduling Conflict|0|||
161723900|NCT00321984|584032304|FG002|Overall Study|Pregnancy|0|||
161723901|NCT00321984|584032302|FG000|Overall Study|Per Subject Request|1|||
161723902|NCT00321984|584032303|FG001|Overall Study|Per Subject Request|0|||
161723903|NCT00321984|584032304|FG002|Overall Study|Per Subject Request|0|||
161723904|NCT00321984|584032302|FG000|Overall Study|Per Investigator Request|1|||
161965380|NCT02759107|584920274|FG013|Overall Study|Scheduling Conflict|0|||
161965381|NCT02759107|584920275|FG014|Overall Study|Scheduling Conflict|0|||
161965382|NCT02759107|584920276|FG015|Overall Study|Scheduling Conflict|0|||
161965383|NCT02759107|584920277|FG016|Overall Study|Scheduling Conflict|0|||
161965384|NCT02759107|584920278|FG017|Overall Study|Scheduling Conflict|0|||
161965385|NCT00420004|584920285|FG000|Overall Study|Adverse Event|4|||
161965386|NCT00420004|584920286|FG001|Overall Study|Adverse Event|1|||
161723905|NCT00321984|584032303|FG001|Overall Study|Per Investigator Request|0|||
161723906|NCT00321984|584032304|FG002|Overall Study|Per Investigator Request|0|||
161723907|NCT00321984|584032302|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
161965387|NCT00420004|584920287|FG002|Overall Study|Adverse Event|1|||
161965388|NCT00420004|584920285|FG000|Overall Study|Lack of Efficacy|5|||
161965389|NCT00420004|584920286|FG001|Overall Study|Lack of Efficacy|4|||
161965390|NCT00420004|584920287|FG002|Overall Study|Lack of Efficacy|1|||
161965391|NCT00420004|584920285|FG000|Overall Study|Lost to Follow-up|31|||
161965392|NCT00420004|584920286|FG001|Overall Study|Lost to Follow-up|12|||
161965393|NCT00420004|584920287|FG002|Overall Study|Lost to Follow-up|10|||
161965394|NCT00420004|584920285|FG000|Overall Study|Entry Criteria Not Met|0|||
161965395|NCT00420004|584920286|FG001|Overall Study|Entry Criteria Not Met|1|||
161965396|NCT00420004|584920287|FG002|Overall Study|Entry Criteria Not Met|0|||
161723908|NCT00321984|584032303|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
161965397|NCT00420004|584920285|FG000|Overall Study|Physician Decision|14|||
161965398|NCT00420004|584920286|FG001|Overall Study|Physician Decision|4|||
161965399|NCT00420004|584920287|FG002|Overall Study|Physician Decision|2|||
161965400|NCT00420004|584920285|FG000|Overall Study|Protocol Violation|5|||
161965401|NCT00420004|584920286|FG001|Overall Study|Protocol Violation|4|||
161965402|NCT00420004|584920287|FG002|Overall Study|Protocol Violation|3|||
161965403|NCT00420004|584920285|FG000|Overall Study|Withdrawal by Subject|67|||
161965404|NCT00420004|584920286|FG001|Overall Study|Withdrawal by Subject|42|||
161723909|NCT00321984|584032304|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
161723910|NCT01024465|584032305|FG000|Overall Study|Adverse Event|2|||
161723911|NCT01024465|584032305|FG000|Overall Study|Physician Decision|1|||
161723912|NCT00525148|584032309|FG000|Overall Study|Other Adverse Event|3|||
161723913|NCT00525148|584032310|FG001|Overall Study|Other Adverse Event|5|||
161723914|NCT00525148|584032311|FG002|Overall Study|Other Adverse Event|1|||
161723915|NCT00525148|584032312|FG003|Overall Study|Other Adverse Event|8|||
161723916|NCT00525148|584032309|FG000|Overall Study|Progressive disease|18|||
161723917|NCT00525148|584032310|FG001|Overall Study|Progressive disease|30|||
161723918|NCT00525148|584032311|FG002|Overall Study|Progressive disease|6|||
161723919|NCT00525148|584032312|FG003|Overall Study|Progressive disease|49|||
161723920|NCT00525148|584032309|FG000|Overall Study|Refused continuation of study medication|0|||
161723921|NCT00525148|584032310|FG001|Overall Study|Refused continuation of study medication|2|||
161723922|NCT00525148|584032311|FG002|Overall Study|Refused continuation of study medication|0|||
161723923|NCT00525148|584032312|FG003|Overall Study|Refused continuation of study medication|1|||
161723924|NCT00525148|584032309|FG000|Overall Study|Other than stated|2|||
161723925|NCT00525148|584032310|FG001|Overall Study|Other than stated|1|||
161723926|NCT00525148|584032311|FG002|Overall Study|Other than stated|0|||
161723927|NCT00525148|584032312|FG003|Overall Study|Other than stated|3|||
161723928|NCT03078608|584032313|FG000|Overall Study|Death|1|||
161723929|NCT03078608|584032314|FG001|Overall Study|Death|2|||
161723930|NCT03078608|584032315|FG002|Overall Study|Death|0|||
161723931|NCT03078608|584032316|FG003|Overall Study|Death|0|||
161723932|NCT03078608|584032313|FG000|Overall Study|Withdrawal by Subject|8|||
161723933|NCT03078608|584032314|FG001|Overall Study|Withdrawal by Subject|1|||
161723934|NCT03078608|584032315|FG002|Overall Study|Withdrawal by Subject|0|||
161723935|NCT03078608|584032316|FG003|Overall Study|Withdrawal by Subject|0|||
161723936|NCT03078608|584032313|FG000|Overall Study|Lost to Follow-up|5|||
161723937|NCT03078608|584032314|FG001|Overall Study|Lost to Follow-up|8|||
161723938|NCT03078608|584032315|FG002|Overall Study|Lost to Follow-up|4|||
161723939|NCT03078608|584032316|FG003|Overall Study|Lost to Follow-up|1|||
161723940|NCT01905397|584032323|FG000|Overall Study|Death|0|||
161723941|NCT01905397|584032324|FG001|Overall Study|Death|1|||
161723942|NCT01905397|584032323|FG000|Overall Study|Withdrawal by Subject|2|||
161723943|NCT01905397|584032324|FG001|Overall Study|Withdrawal by Subject|0|||
161723944|NCT01905397|584032323|FG000|Overall Study|Surgery canceled/aborted|9|||
161723945|NCT01905397|584032324|FG001|Overall Study|Surgery canceled/aborted|5|||
161723946|NCT01905397|584032323|FG000|Overall Study|Incision < 7 cm|2|||
161723947|NCT01905397|584032324|FG001|Overall Study|Incision < 7 cm|0|||
161723948|NCT01905397|584032323|FG000|Overall Study|Wrong treatment|1|||
161723949|NCT01905397|584032324|FG001|Overall Study|Wrong treatment|1|||
161723950|NCT01905397|584032323|FG000|Overall Study|Device not applied|3|||
161723951|NCT01905397|584032324|FG001|Overall Study|Device not applied|0|||
161723952|NCT01905397|584032323|FG000|Overall Study|Dressing not applied in operating room|1|||
161723953|NCT01905397|584032324|FG001|Overall Study|Dressing not applied in operating room|0|||
161723954|NCT01905397|584032323|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
161723955|NCT01905397|584032324|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
161723956|NCT01921270|584032325|FG000|Overall Study|Withdrawal by Subject|1|||
161723957|NCT00864227|584032326|FG000|Overall Study|Withdrawal by Subject|1|||
161723958|NCT00864227|584032326|FG000|Overall Study|Disease Relapse/Progression|3|||
161723959|NCT01137435|584032327|FG000|Overall Study|Lost to Follow-up|24|||
161723960|NCT01137435|584032327|FG000|Overall Study|Off label usage|4|||
161723961|NCT00501852|584032328|FG000|Overall Study|Adverse Event|3|||
161723962|NCT00501852|584032328|FG000|Overall Study|Withdrawal by Subject|2|||
161723963|NCT01416610|584032329|FG000|Overall Study|Adverse Event|4|||
161723964|NCT01416610|584032329|FG000|Overall Study|Adverse Event -Patient decision|3|||
161723965|NCT01416610|584032329|FG000|Overall Study|Lack of Efficacy|4|||
161723966|NCT01416610|584032329|FG000|Overall Study|No reason given|5|||
161723967|NCT01416610|584032329|FG000|Overall Study|Withdrawal by Subject|13|||
161723968|NCT01416610|584032329|FG000|Overall Study|Lost to Follow-up|7|||
161723969|NCT01416610|584032329|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
161723970|NCT00399802|584032331|FG000|Overall Study|Adverse Event|0|||
161723971|NCT00399802|584032332|FG001|Overall Study|Adverse Event|2|||
161723972|NCT00399802|584032331|FG000|Overall Study|Participant discontinued by mistake|0|||
161723973|NCT00399802|584032332|FG001|Overall Study|Participant discontinued by mistake|1|||
161723974|NCT04172831|584032335|FG000|Overall Study|Adverse Event|21|||
161723975|NCT04172831|584032336|FG001|Overall Study|Adverse Event|9|||
161723976|NCT04172831|584032335|FG000|Overall Study|Lack of Efficacy|2|||
161723977|NCT04172831|584032336|FG001|Overall Study|Lack of Efficacy|8|||
161723978|NCT04172831|584032335|FG000|Overall Study|Physician Decision|0|||
161723979|NCT04172831|584032336|FG001|Overall Study|Physician Decision|1|||
161723980|NCT04172831|584032335|FG000|Overall Study|Withdrawal by Subject|12|||
161723981|NCT04172831|584032336|FG001|Overall Study|Withdrawal by Subject|11|||
161723982|NCT04172831|584032335|FG000|Overall Study|Lost to Follow-up|4|||
161723983|NCT04172831|584032336|FG001|Overall Study|Lost to Follow-up|9|||
161723984|NCT04172831|584032335|FG000|Overall Study|COVID-19 related crisis|3|||
161723985|NCT04172831|584032336|FG001|Overall Study|COVID-19 related crisis|3|||
161723986|NCT04172831|584032335|FG000|Overall Study|Subject non-compliance|1|||
161723987|NCT04172831|584032336|FG001|Overall Study|Subject non-compliance|1|||
161723988|NCT04172831|584032335|FG000|Overall Study|Family emergency|1|||
161723989|NCT04172831|584032336|FG001|Overall Study|Family emergency|0|||
161723990|NCT01899144|584032340|FG000|Treatment Period 2|Other|1|||
161723991|NCT01899144|584032340|FG000|Treatment Period 3|Other|2|||
161723992|NCT01899144|584032340|FG000|Treatment Period 5|Other|1|||
161723993|NCT00866294|584032341|FG000|Overall Study|Adverse Event|12|||
161723994|NCT00866294|584032342|FG001|Overall Study|Adverse Event|13|||
161723995|NCT00866294|584032343|FG002|Overall Study|Adverse Event|9|||
161723996|NCT00866294|584032341|FG000|Overall Study|Lack of Efficacy|7|||
161723997|NCT00866294|584032342|FG001|Overall Study|Lack of Efficacy|1|||
161723998|NCT00866294|584032343|FG002|Overall Study|Lack of Efficacy|0|||
161723999|NCT00866294|584032341|FG000|Overall Study|Protocol Violation|2|||
161724000|NCT00866294|584032342|FG001|Overall Study|Protocol Violation|0|||
161724001|NCT00866294|584032343|FG002|Overall Study|Protocol Violation|0|||
161724002|NCT00866294|584032341|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
161724003|NCT00866294|584032342|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161724004|NCT00866294|584032343|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161724005|NCT00866294|584032341|FG000|Overall Study|Lost to Follow-up|1|||
161724006|NCT00866294|584032342|FG001|Overall Study|Lost to Follow-up|3|||
161724007|NCT00866294|584032343|FG002|Overall Study|Lost to Follow-up|0|||
161724008|NCT00866294|584032341|FG000|Overall Study|Physician Decision|6|||
161724009|NCT00866294|584032342|FG001|Overall Study|Physician Decision|2|||
161724010|NCT00866294|584032343|FG002|Overall Study|Physician Decision|1|||
161724011|NCT00081289|584032344|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
161724012|NCT00081289|584032345|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
161724013|NCT00081289|584032344|FG000|Overall Study|Ineligible / no protocol treatment|3|||
161724014|NCT00081289|584032345|FG001|Overall Study|Ineligible / no protocol treatment|4|||
161724015|NCT00916721|584032348|FG000|Overall Study|Lost to Follow-up|0|||
161724016|NCT00916721|584032349|FG001|Overall Study|Lost to Follow-up|1|||
161724017|NCT00916721|584032348|FG000|Overall Study|Adverse Event|6|||
161724018|NCT00916721|584032349|FG001|Overall Study|Adverse Event|3|||
161724019|NCT00916721|584032348|FG000|Overall Study|Withdrawal by Subject|2|||
161724020|NCT00916721|584032349|FG001|Overall Study|Withdrawal by Subject|2|||
161724021|NCT00916721|584032348|FG000|Overall Study|Protocol Violation|2|||
161724022|NCT00916721|584032349|FG001|Overall Study|Protocol Violation|4|||
161724023|NCT00798967|584032352|FG000|Overall Study|Adverse Event|2|||
161724024|NCT00798967|584032353|FG001|Overall Study|Adverse Event|3|||
161724025|NCT00798967|584032352|FG000|Overall Study|Withdrawal by Subject|0|||
161724026|NCT00798967|584032353|FG001|Overall Study|Withdrawal by Subject|1|||
161724027|NCT00798967|584032352|FG000|Overall Study|Physician Decision|1|||
161724028|NCT00798967|584032353|FG001|Overall Study|Physician Decision|0|||
161724029|NCT00798967|584032352|FG000|Overall Study|Randomized in error by site|1|||
161724030|NCT00798967|584032353|FG001|Overall Study|Randomized in error by site|0|||
161724031|NCT04083222|584032359|FG000|Overall Study|Voluntary Withdrawal|0|||
161724032|NCT04083222|584032360|FG001|Overall Study|Voluntary Withdrawal|1|||
161724033|NCT04083222|584032359|FG000|Overall Study|Reason not Specified|0|||
161724034|NCT04083222|584032360|FG001|Overall Study|Reason not Specified|1|||
161724035|NCT04400318|584034133|FG000|Overall Study|Adverse Event|1|||
161724036|NCT04400318|584034134|FG001|Overall Study|Adverse Event|0|||
161724037|NCT04400318|584034133|FG000|Overall Study|Withdrawal by Subject|1|||
161724038|NCT04400318|584034134|FG001|Overall Study|Withdrawal by Subject|1|||
161724039|NCT04400318|584034133|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
161724040|NCT04400318|584034134|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
161724041|NCT02078713|584034135|FG000|Overall Study|Lost to Follow-up|49|||
161724042|NCT02078713|584034136|FG001|Overall Study|Lost to Follow-up|55|||
161724043|NCT02078713|584034137|FG002|Overall Study|Lost to Follow-up|0|||
161724044|NCT02078713|584034138|FG003|Overall Study|Lost to Follow-up|0|||
161724045|NCT02078713|584034135|FG000|Overall Study|Pregnant at baseline|3|||
161724046|NCT02078713|584034136|FG001|Overall Study|Pregnant at baseline|5|||
161724047|NCT02078713|584034137|FG002|Overall Study|Pregnant at baseline|0|||
161724048|NCT02078713|584034138|FG003|Overall Study|Pregnant at baseline|0|||
161724049|NCT02078713|584034135|FG000|Overall Study|Enrolled twice|0|||
161724050|NCT02078713|584034136|FG001|Overall Study|Enrolled twice|1|||
161724051|NCT02078713|584034137|FG002|Overall Study|Enrolled twice|0|||
161724052|NCT02078713|584034138|FG003|Overall Study|Enrolled twice|0|||
161724053|NCT01793051|584034149|FG000|Overall Study|Withdrawal by Subject|6|||
161724054|NCT01793051|584034150|FG001|Overall Study|Withdrawal by Subject|4|||
161724055|NCT01793051|584034149|FG000|Overall Study|Adverse Event|0|||
161724056|NCT01793051|584034150|FG001|Overall Study|Adverse Event|2|||
161724057|NCT01793051|584034149|FG000|Overall Study|Too ill to continue|1|||
161724058|NCT01793051|584034150|FG001|Overall Study|Too ill to continue|0|||
161724059|NCT01793051|584034149|FG000|Overall Study|Switched chemo|1|||
161724060|NCT01793051|584034150|FG001|Overall Study|Switched chemo|1|||
161724061|NCT01793051|584034149|FG000|Overall Study|Lack of compliance|1|||
161724062|NCT01793051|584034150|FG001|Overall Study|Lack of compliance|0|||
162032160|NCT00814801|585174219|FG001|Overall Study|Other|6|||
161965405|NCT00420004|584920287|FG002|Overall Study|Withdrawal by Subject|14|||
161965406|NCT00420004|584920285|FG000|Overall Study|Sponsor Decision|3|||
161965407|NCT00420004|584920286|FG001|Overall Study|Sponsor Decision|3|||
161965408|NCT00420004|584920287|FG002|Overall Study|Sponsor Decision|1|||
161965409|NCT00591149|584920288|FG000|Overall Study|Adverse Event|4|||
161965410|NCT00591149|584920288|FG000|Overall Study|Withdrawal by Subject|1|||
161965411|NCT03002818|584920289|FG000|Overall Study|Decision of the investigator|1|||
161965412|NCT01606787|584920291|FG000|Overall Study|Withdrawal by Subject|4|||
161965413|NCT01606787|584920292|FG001|Overall Study|Withdrawal by Subject|5|||
161965414|NCT01606787|584920291|FG000|Overall Study|Surgery canceled|0|||
161965415|NCT01606787|584920292|FG001|Overall Study|Surgery canceled|2|||
161965416|NCT00713349|584920294|FG000|Overall Study|Protocol Violation|1|||
161965417|NCT03764631|584920295|FG000|Overall Study|Personal Reasons|3|||
161965418|NCT03764631|584920296|FG001|Overall Study|Personal Reasons|2|||
161965419|NCT03764631|584920295|FG000|Overall Study|Switching Therapy|3|||
161965420|NCT03764631|584920296|FG001|Overall Study|Switching Therapy|3|||
161965421|NCT03764631|584920295|FG000|Overall Study|Adverse Event|0|||
161965422|NCT03764631|584920296|FG001|Overall Study|Adverse Event|1|||
161965423|NCT03764631|584920295|FG000|Overall Study|Lost to Follow-up|33|||
161965424|NCT03764631|584920296|FG001|Overall Study|Lost to Follow-up|41|||
161724063|NCT01793051|584034149|FG000|Overall Study|Requested to be removed from the study|1|||
161724064|NCT01793051|584034150|FG001|Overall Study|Requested to be removed from the study|1|||
161724065|NCT02421120|584034153|FG000|Overall Study|Adverse Event|1|||
161724066|NCT00372190|584034154|FG000|Overall Study|Lost to Follow-up|3|||
161724067|NCT00372190|584034155|FG001|Overall Study|Lost to Follow-up|1|||
161724068|NCT00623467|584034156|FG000|Overall Study|Lost to Follow-up|1|||
161724069|NCT00623467|584034156|FG000|Overall Study|Protocol Violation|4|||
161724070|NCT00623467|584034156|FG000|Overall Study|Withdrawal by Subject|2|||
161724071|NCT00273858|584034170|FG000|Overall Study|Not completed 24 month observation time|334|||
161724072|NCT00273858|584034170|FG000|Overall Study|Lost to Follow-up|101|||
161724073|NCT00273858|584034170|FG000|Overall Study|Withdrawal by Subject|21|||
161724074|NCT00273858|584034170|FG000|Overall Study|Adverse Event|81|||
161724075|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
161724076|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
161724077|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
161724078|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
161724079|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
161724080|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
161724081|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
161724082|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
161724083|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
161724084|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
161724085|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
161724086|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
161724087|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
161724088|NCT02232516|584034171|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
161724089|NCT02232516|584034171|FG000|Survival Follow-up|Death|15|||
161724090|NCT02232516|584034171|FG000|Survival Follow-up|Withdrawal by Subject|3|||
161724091|NCT02232516|584034171|FG000|Survival Follow-up|Lost to Follow-up|1|||
161965425|NCT03764631|584920295|FG000|Overall Study|No data as study site was closed|2|||
161724092|NCT02232516|584034171|FG000|Survival Follow-up|Still in follow-up|5|||
161724093|NCT01070550|584034172|FG000|Overall Study|Adverse Event|43|||
161724094|NCT01070550|584034173|FG001|Overall Study|Adverse Event|1|||
161724095|NCT01070550|584034174|FG002|Overall Study|Adverse Event|3|||
161724096|NCT01070550|584034175|FG003|Overall Study|Adverse Event|0|||
161724097|NCT01070550|584034176|FG004|Overall Study|Adverse Event|0|||
161724098|NCT01070550|584034177|FG005|Overall Study|Adverse Event|0|||
161724099|NCT01070550|584034172|FG000|Overall Study|Death|20|||
161724100|NCT01070550|584034173|FG001|Overall Study|Death|4|||
161724101|NCT01070550|584034174|FG002|Overall Study|Death|3|||
161724102|NCT01070550|584034175|FG003|Overall Study|Death|0|||
161724103|NCT01070550|584034176|FG004|Overall Study|Death|0|||
161724104|NCT01070550|584034177|FG005|Overall Study|Death|0|||
161724105|NCT01070550|584034172|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
161724106|NCT01070550|584034173|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161724107|NCT01070550|584034174|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161724108|NCT01070550|584034175|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161724109|NCT01070550|584034176|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161724110|NCT01070550|584034177|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161724111|NCT01070550|584034172|FG000|Overall Study|Early termination|3|||
161724112|NCT01070550|584034173|FG001|Overall Study|Early termination|0|||
161724113|NCT01070550|584034174|FG002|Overall Study|Early termination|0|||
161724114|NCT01070550|584034175|FG003|Overall Study|Early termination|0|||
161965426|NCT03764631|584920296|FG001|Overall Study|No data as study site was closed|6|||
161965427|NCT01289353|584920297|FG000|Overall Study|Lost to Follow-up|2|||
161724115|NCT01070550|584034176|FG004|Overall Study|Early termination|0|||
161724116|NCT01070550|584034177|FG005|Overall Study|Early termination|0|||
161724117|NCT01070550|584034172|FG000|Overall Study|Failed to return|450|||
161724118|NCT01070550|584034173|FG001|Overall Study|Failed to return|33|||
161724119|NCT01070550|584034174|FG002|Overall Study|Failed to return|144|||
161724120|NCT01070550|584034175|FG003|Overall Study|Failed to return|40|||
161724121|NCT01070550|584034176|FG004|Overall Study|Failed to return|1|||
161724122|NCT01070550|584034177|FG005|Overall Study|Failed to return|2|||
161724123|NCT01070550|584034172|FG000|Overall Study|Incomplete treatment|2|||
161724124|NCT01070550|584034173|FG001|Overall Study|Incomplete treatment|0|||
161724125|NCT01070550|584034174|FG002|Overall Study|Incomplete treatment|0|||
161724126|NCT01070550|584034175|FG003|Overall Study|Incomplete treatment|0|||
161724127|NCT01070550|584034176|FG004|Overall Study|Incomplete treatment|0|||
161724128|NCT01070550|584034177|FG005|Overall Study|Incomplete treatment|0|||
161724129|NCT01070550|584034172|FG000|Overall Study|Lab test not done|22|||
161724130|NCT01070550|584034173|FG001|Overall Study|Lab test not done|3|||
161724131|NCT01070550|584034174|FG002|Overall Study|Lab test not done|4|||
161724132|NCT01070550|584034175|FG003|Overall Study|Lab test not done|1|||
161724133|NCT01070550|584034176|FG004|Overall Study|Lab test not done|0|||
161724134|NCT01070550|584034177|FG005|Overall Study|Lab test not done|1|||
161724135|NCT01070550|584034172|FG000|Overall Study|Lack of Efficacy|65|||
161724136|NCT01070550|584034173|FG001|Overall Study|Lack of Efficacy|1|||
161724137|NCT01070550|584034174|FG002|Overall Study|Lack of Efficacy|5|||
161724138|NCT01070550|584034175|FG003|Overall Study|Lack of Efficacy|5|||
161724139|NCT01070550|584034176|FG004|Overall Study|Lack of Efficacy|0|||
161724140|NCT01070550|584034177|FG005|Overall Study|Lack of Efficacy|1|||
161724141|NCT01070550|584034172|FG000|Overall Study|Miscellaneous|12|||
161724142|NCT01070550|584034173|FG001|Overall Study|Miscellaneous|2|||
161724143|NCT01070550|584034174|FG002|Overall Study|Miscellaneous|3|||
161724144|NCT01070550|584034175|FG003|Overall Study|Miscellaneous|1|||
161724145|NCT01070550|584034176|FG004|Overall Study|Miscellaneous|0|||
161724146|NCT01070550|584034177|FG005|Overall Study|Miscellaneous|0|||
161724147|NCT01070550|584034172|FG000|Overall Study|New treatment started|3|||
161724148|NCT01070550|584034173|FG001|Overall Study|New treatment started|1|||
161724149|NCT01070550|584034174|FG002|Overall Study|New treatment started|0|||
161724150|NCT01070550|584034175|FG003|Overall Study|New treatment started|2|||
161724151|NCT01070550|584034176|FG004|Overall Study|New treatment started|0|||
161724152|NCT01070550|584034177|FG005|Overall Study|New treatment started|0|||
161724153|NCT01070550|584034172|FG000|Overall Study|Non-responders|493|||
161724154|NCT01070550|584034173|FG001|Overall Study|Non-responders|4|||
161724155|NCT01070550|584034174|FG002|Overall Study|Non-responders|21|||
161724156|NCT01070550|584034175|FG003|Overall Study|Non-responders|20|||
161724157|NCT01070550|584034176|FG004|Overall Study|Non-responders|0|||
161724158|NCT01070550|584034177|FG005|Overall Study|Non-responders|2|||
161724159|NCT01070550|584034172|FG000|Overall Study|Not categorized|33|||
161724160|NCT01070550|584034173|FG001|Overall Study|Not categorized|2|||
161724161|NCT01070550|584034174|FG002|Overall Study|Not categorized|6|||
161724162|NCT01070550|584034175|FG003|Overall Study|Not categorized|1|||
161724163|NCT01070550|584034176|FG004|Overall Study|Not categorized|0|||
161724164|NCT01070550|584034177|FG005|Overall Study|Not categorized|1|||
161724165|NCT01070550|584034172|FG000|Overall Study|Protocol Violation|15|||
161724166|NCT01070550|584034173|FG001|Overall Study|Protocol Violation|1|||
161724167|NCT01070550|584034174|FG002|Overall Study|Protocol Violation|1|||
161724168|NCT01070550|584034175|FG003|Overall Study|Protocol Violation|1|||
161724169|NCT01070550|584034176|FG004|Overall Study|Protocol Violation|0|||
161724170|NCT01070550|584034177|FG005|Overall Study|Protocol Violation|0|||
161724171|NCT01070550|584034172|FG000|Overall Study|Relapse|44|||
161724172|NCT01070550|584034173|FG001|Overall Study|Relapse|5|||
161724173|NCT01070550|584034174|FG002|Overall Study|Relapse|14|||
161724174|NCT01070550|584034175|FG003|Overall Study|Relapse|4|||
161724175|NCT01070550|584034176|FG004|Overall Study|Relapse|0|||
161724176|NCT01070550|584034177|FG005|Overall Study|Relapse|0|||
161724177|NCT01070550|584034172|FG000|Overall Study|Result not available|3|||
161724178|NCT01070550|584034173|FG001|Overall Study|Result not available|1|||
161724179|NCT01070550|584034174|FG002|Overall Study|Result not available|3|||
161724180|NCT01070550|584034175|FG003|Overall Study|Result not available|0|||
161724181|NCT01070550|584034176|FG004|Overall Study|Result not available|0|||
161724182|NCT01070550|584034177|FG005|Overall Study|Result not available|0|||
161724183|NCT01070550|584034172|FG000|Overall Study|Screen failure|1|||
161724184|NCT01070550|584034173|FG001|Overall Study|Screen failure|0|||
161724185|NCT01070550|584034174|FG002|Overall Study|Screen failure|0|||
161724186|NCT01070550|584034175|FG003|Overall Study|Screen failure|0|||
161724187|NCT01070550|584034176|FG004|Overall Study|Screen failure|0|||
161724188|NCT01070550|584034177|FG005|Overall Study|Screen failure|0|||
161724189|NCT01070550|584034172|FG000|Overall Study|Sponsor decision|1|||
161724190|NCT01070550|584034173|FG001|Overall Study|Sponsor decision|0|||
161724191|NCT01070550|584034174|FG002|Overall Study|Sponsor decision|0|||
161724192|NCT01070550|584034175|FG003|Overall Study|Sponsor decision|0|||
161724193|NCT01070550|584034176|FG004|Overall Study|Sponsor decision|0|||
161724194|NCT01070550|584034177|FG005|Overall Study|Sponsor decision|0|||
161724195|NCT01070550|584034172|FG000|Overall Study|Treatment duration shortened|1|||
161724196|NCT01070550|584034173|FG001|Overall Study|Treatment duration shortened|0|||
161724197|NCT01070550|584034174|FG002|Overall Study|Treatment duration shortened|0|||
161724198|NCT01070550|584034175|FG003|Overall Study|Treatment duration shortened|0|||
161724199|NCT01070550|584034176|FG004|Overall Study|Treatment duration shortened|0|||
161724200|NCT01070550|584034177|FG005|Overall Study|Treatment duration shortened|0|||
161724201|NCT01070550|584034172|FG000|Overall Study|Treatment interrupted|7|||
161724202|NCT01070550|584034173|FG001|Overall Study|Treatment interrupted|0|||
161724203|NCT01070550|584034174|FG002|Overall Study|Treatment interrupted|1|||
161724204|NCT01070550|584034175|FG003|Overall Study|Treatment interrupted|1|||
161724205|NCT01070550|584034176|FG004|Overall Study|Treatment interrupted|0|||
161724206|NCT01070550|584034177|FG005|Overall Study|Treatment interrupted|0|||
161724207|NCT01070550|584034172|FG000|Overall Study|Treatment not started|14|||
161724208|NCT01070550|584034173|FG001|Overall Study|Treatment not started|2|||
161724209|NCT01070550|584034174|FG002|Overall Study|Treatment not started|4|||
161724210|NCT01070550|584034175|FG003|Overall Study|Treatment not started|0|||
161724211|NCT01070550|584034176|FG004|Overall Study|Treatment not started|0|||
161724212|NCT01070550|584034177|FG005|Overall Study|Treatment not started|0|||
161724213|NCT01070550|584034172|FG000|Overall Study|Treatment restarted|0|||
161724214|NCT01070550|584034173|FG001|Overall Study|Treatment restarted|1|||
161724215|NCT01070550|584034174|FG002|Overall Study|Treatment restarted|0|||
161724216|NCT01070550|584034175|FG003|Overall Study|Treatment restarted|0|||
161724217|NCT01070550|584034176|FG004|Overall Study|Treatment restarted|0|||
161724218|NCT01070550|584034177|FG005|Overall Study|Treatment restarted|0|||
161724219|NCT01070550|584034172|FG000|Overall Study|Treatment stopped|3|||
161724220|NCT01070550|584034173|FG001|Overall Study|Treatment stopped|0|||
161724221|NCT01070550|584034174|FG002|Overall Study|Treatment stopped|0|||
161724222|NCT01070550|584034175|FG003|Overall Study|Treatment stopped|0|||
161724223|NCT01070550|584034176|FG004|Overall Study|Treatment stopped|0|||
161724224|NCT01070550|584034177|FG005|Overall Study|Treatment stopped|0|||
161724225|NCT01070550|584034172|FG000|Overall Study|Treatment unavailable|1|||
161724226|NCT01070550|584034173|FG001|Overall Study|Treatment unavailable|0|||
161724227|NCT01070550|584034174|FG002|Overall Study|Treatment unavailable|0|||
161724228|NCT01070550|584034175|FG003|Overall Study|Treatment unavailable|0|||
161724229|NCT01070550|584034176|FG004|Overall Study|Treatment unavailable|0|||
161724230|NCT01070550|584034177|FG005|Overall Study|Treatment unavailable|0|||
161724231|NCT01070550|584034172|FG000|Overall Study|Treatment was stopped early|7|||
161724232|NCT01070550|584034173|FG001|Overall Study|Treatment was stopped early|0|||
161724233|NCT01070550|584034174|FG002|Overall Study|Treatment was stopped early|0|||
161724234|NCT01070550|584034175|FG003|Overall Study|Treatment was stopped early|0|||
161724235|NCT01070550|584034176|FG004|Overall Study|Treatment was stopped early|0|||
161724236|NCT01070550|584034177|FG005|Overall Study|Treatment was stopped early|0|||
161724237|NCT01070550|584034172|FG000|Overall Study|Other|5|||
161724238|NCT01070550|584034173|FG001|Overall Study|Other|0|||
161724239|NCT01070550|584034174|FG002|Overall Study|Other|0|||
161724240|NCT01070550|584034175|FG003|Overall Study|Other|1|||
161724241|NCT01070550|584034176|FG004|Overall Study|Other|0|||
161724242|NCT01070550|584034177|FG005|Overall Study|Other|0|||
161724243|NCT01070550|584034172|FG000|Overall Study|Withdrawal by Subject|35|||
161724244|NCT01070550|584034173|FG001|Overall Study|Withdrawal by Subject|0|||
161724245|NCT01070550|584034174|FG002|Overall Study|Withdrawal by Subject|3|||
161724246|NCT01070550|584034175|FG003|Overall Study|Withdrawal by Subject|0|||
161724247|NCT01070550|584034176|FG004|Overall Study|Withdrawal by Subject|0|||
161724248|NCT01070550|584034177|FG005|Overall Study|Withdrawal by Subject|0|||
161724249|NCT01585961|584034179|FG000|Overall Study|Death|6|||
161724250|NCT01585961|584034179|FG000|Overall Study|Physician Decision|1|||
161724251|NCT01585961|584034179|FG000|Overall Study|Decision to use non-study catheter|1|||
161724252|NCT01585961|584034179|FG000|Overall Study|Withdrawal by Subject|1|||
161724253|NCT01585961|584034179|FG000|Overall Study|Lost to Follow-up|23|||
161724254|NCT01585961|584034179|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
161724255|NCT01258348|584034180|FG000|Overall Study|Adverse Event|1|||
161724256|NCT01258348|584034181|FG001|Overall Study|Adverse Event|1|||
161724257|NCT01258348|584034182|FG002|Overall Study|Adverse Event|3|||
161724258|NCT01258348|584034183|FG003|Overall Study|Adverse Event|2|||
161724259|NCT01258348|584034184|FG004|Overall Study|Adverse Event|4|||
161724260|NCT01258348|584034180|FG000|Overall Study|Progressive Disease|0|||
161724261|NCT01258348|584034181|FG001|Overall Study|Progressive Disease|3|||
161724262|NCT01258348|584034182|FG002|Overall Study|Progressive Disease|0|||
161724263|NCT01258348|584034183|FG003|Overall Study|Progressive Disease|2|||
161724264|NCT01258348|584034184|FG004|Overall Study|Progressive Disease|2|||
161724265|NCT01258348|584034180|FG000|Overall Study|Physician Decision|0|||
161724266|NCT01258348|584034181|FG001|Overall Study|Physician Decision|0|||
161724267|NCT01258348|584034182|FG002|Overall Study|Physician Decision|0|||
161724268|NCT01258348|584034183|FG003|Overall Study|Physician Decision|2|||
161724269|NCT01258348|584034184|FG004|Overall Study|Physician Decision|0|||
161724270|NCT01258348|584034180|FG000|Overall Study|Withdrawal by Subject|0|||
161724271|NCT01258348|584034181|FG001|Overall Study|Withdrawal by Subject|1|||
161724272|NCT01258348|584034182|FG002|Overall Study|Withdrawal by Subject|0|||
161724273|NCT01258348|584034183|FG003|Overall Study|Withdrawal by Subject|0|||
161724274|NCT01258348|584034184|FG004|Overall Study|Withdrawal by Subject|0|||
161724275|NCT01849848|584034186|FG000|Overall Study|Physician Decision|1|||
161724276|NCT01849848|584034186|FG000|Overall Study|Progression of the primary disease|3|||
161724277|NCT01505491|584034187|FG000|Overall Study|Other reason not listed|1|||
161724278|NCT01505491|584034188|FG001|Overall Study|Other reason not listed|0|||
161724279|NCT01505491|584034189|FG002|Overall Study|Other reason not listed|0|||
161724280|NCT01505491|584034187|FG000|Overall Study|Withdrawal by Subject|1|||
161724281|NCT01505491|584034188|FG001|Overall Study|Withdrawal by Subject|1|||
161724282|NCT01505491|584034189|FG002|Overall Study|Withdrawal by Subject|4|||
161724283|NCT01505491|584034187|FG000|Overall Study|Lost to Follow-up|0|||
161724284|NCT01505491|584034188|FG001|Overall Study|Lost to Follow-up|0|||
161724285|NCT01505491|584034189|FG002|Overall Study|Lost to Follow-up|1|||
161724286|NCT01120093|584034198|FG000|Treatment Period 1|Adverse Event|0|||
161724287|NCT01120093|584034199|FG001|Treatment Period 1|Adverse Event|0|||
161724288|NCT01120093|584034200|FG002|Treatment Period 1|Adverse Event|1|||
161724289|NCT01120093|584034201|FG003|Treatment Period 1|Adverse Event|0|||
161724290|NCT01120093|584034202|FG004|Treatment Period 1|Adverse Event|1|||
161724291|NCT01120093|584034198|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161724292|NCT01120093|584034199|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161724293|NCT01120093|584034200|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161724294|NCT01120093|584034201|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161724295|NCT01120093|584034202|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161724296|NCT01120093|584034198|FG000|Treatment Period 2|Adverse Event|0|||
161724297|NCT01120093|584034199|FG001|Treatment Period 2|Adverse Event|0|||
161724298|NCT01120093|584034200|FG002|Treatment Period 2|Adverse Event|0|||
161724299|NCT01120093|584034201|FG003|Treatment Period 2|Adverse Event|1|||
161724300|NCT01120093|584034202|FG004|Treatment Period 2|Adverse Event|0|||
161724301|NCT01120093|584034198|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161724302|NCT01120093|584034199|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161724303|NCT01120093|584034200|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161724304|NCT01120093|584034201|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161724305|NCT01120093|584034202|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161724306|NCT01120093|584034198|FG000|Treatment Period 3|Lack of Efficacy|0|||
161724307|NCT01120093|584034199|FG001|Treatment Period 3|Lack of Efficacy|0|||
161724308|NCT01120093|584034200|FG002|Treatment Period 3|Lack of Efficacy|0|||
161724309|NCT01120093|584034201|FG003|Treatment Period 3|Lack of Efficacy|1|||
161724310|NCT01120093|584034202|FG004|Treatment Period 3|Lack of Efficacy|0|||
161724311|NCT01120093|584034198|FG000|Treatment Period 3|Adverse Event|0|||
161724312|NCT01120093|584034199|FG001|Treatment Period 3|Adverse Event|0|||
161724313|NCT01120093|584034200|FG002|Treatment Period 3|Adverse Event|0|||
161724314|NCT01120093|584034201|FG003|Treatment Period 3|Adverse Event|0|||
161724315|NCT01120093|584034202|FG004|Treatment Period 3|Adverse Event|1|||
161724316|NCT01120093|584034198|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161724317|NCT01120093|584034199|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161724318|NCT01120093|584034200|FG002|Treatment Period 3|Withdrawal by Subject|1|||
161724319|NCT01120093|584034201|FG003|Treatment Period 3|Withdrawal by Subject|0|||
161724320|NCT01120093|584034202|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161724321|NCT01120093|584034198|FG000|Treatment Period 4|Adverse Event|1|||
161724322|NCT01120093|584034199|FG001|Treatment Period 4|Adverse Event|0|||
161724323|NCT01120093|584034200|FG002|Treatment Period 4|Adverse Event|0|||
161965428|NCT01549886|584920298|FG000|Overall Study|Sponsor's decision|2|||
161965429|NCT01549886|584920299|FG001|Overall Study|Sponsor's decision|3|||
161965430|NCT00473668|584920302|FG000|Overall Study|Withdrawal by Subject|0|||
161965431|NCT00473668|584920303|FG001|Overall Study|Withdrawal by Subject|2|||
161965432|NCT00473668|584920304|FG002|Overall Study|Withdrawal by Subject|0|||
161965433|NCT00473668|584920302|FG000|Overall Study|Migrated/moved from study area|3|||
161965434|NCT00473668|584920303|FG001|Overall Study|Migrated/moved from study area|2|||
161965435|NCT00473668|584920304|FG002|Overall Study|Migrated/moved from study area|0|||
161965436|NCT00473668|584920302|FG000|Overall Study|Lost to Follow-up|0|||
161965437|NCT00473668|584920303|FG001|Overall Study|Lost to Follow-up|4|||
161965438|NCT00473668|584920304|FG002|Overall Study|Lost to Follow-up|6|||
161965439|NCT00473668|584920302|FG000|Overall Study|Other|2|||
161965440|NCT00473668|584920303|FG001|Overall Study|Other|3|||
161965441|NCT00473668|584920304|FG002|Overall Study|Other|4|||
161965442|NCT02039219|584920305|FG000|Treatment|Withdrawal by Subject|1|||
161965443|NCT02039219|584920306|FG001|Treatment|Withdrawal by Subject|0|||
161724324|NCT01120093|584034201|FG003|Treatment Period 4|Adverse Event|0|||
161724325|NCT01120093|584034202|FG004|Treatment Period 4|Adverse Event|0|||
161724326|NCT01120093|584034198|FG000|Treatment Period 5|Adverse Event|0|||
161724327|NCT01120093|584034199|FG001|Treatment Period 5|Adverse Event|1|||
161724328|NCT01120093|584034200|FG002|Treatment Period 5|Adverse Event|0|||
161724329|NCT01120093|584034201|FG003|Treatment Period 5|Adverse Event|1|||
161724330|NCT01120093|584034202|FG004|Treatment Period 5|Adverse Event|0|||
161724331|NCT03649321|584034207|FG000|Overall Study|Withdrawal by Subject|1|||
161724332|NCT03649321|584034208|FG001|Overall Study|Withdrawal by Subject|0|||
161724333|NCT03649321|584034207|FG000|Overall Study|Death|1|||
161965444|NCT02039219|584920305|FG000|Treatment|Adverse Event|0|||
161965445|NCT02039219|584920306|FG001|Treatment|Adverse Event|1|||
161965446|NCT02039219|584920305|FG000|Treatment|Physician Decision|1|||
161965447|NCT02039219|584920306|FG001|Treatment|Physician Decision|0|||
161965448|NCT02039219|584920305|FG000|Treatment|Lost to Follow-up|0|||
161965449|NCT02039219|584920306|FG001|Treatment|Lost to Follow-up|1|||
161965450|NCT02039219|584920305|FG000|Treatment|Protocol Violation|1|||
161724334|NCT03649321|584034208|FG001|Overall Study|Death|0|||
161724335|NCT01702363|584034209|FG000|Overall Study|Adverse Event|14|||
161724336|NCT01702363|584034209|FG000|Overall Study|Lack of Efficacy|4|||
161724337|NCT01702363|584034209|FG000|Overall Study|Withdrawal by Subject|2|||
161724338|NCT01312428|584034210|FG000|Overall Study|Study Termination|3|||
161724339|NCT01312428|584034211|FG001|Overall Study|Study Termination|4|||
161724340|NCT02214186|584034217|FG000|Overall Study|Lost to Follow-up|1|||
161724341|NCT02214186|584034218|FG001|Overall Study|Lost to Follow-up|1|||
161724342|NCT02214186|584034217|FG000|Overall Study|Protocol Violation|1|||
161724343|NCT02214186|584034218|FG001|Overall Study|Protocol Violation|1|||
161724344|NCT01525849|584034222|FG000|Overall Study|Lost to Follow-up|3|||
161724345|NCT01525849|584034223|FG001|Overall Study|Lost to Follow-up|2|||
161724346|NCT01525849|584034222|FG000|Overall Study|Withdrawal by Subject|1|||
161724347|NCT01525849|584034223|FG001|Overall Study|Withdrawal by Subject|9|||
161724348|NCT01525849|584034222|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
161724349|NCT01525849|584034223|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
161724350|NCT01525849|584034222|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
161724351|NCT01525849|584034223|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
161724352|NCT00431847|584034224|FG000|Overall Study|completion of less than two study visits|6|||
161724353|NCT00431847|584034225|FG001|Overall Study|completion of less than two study visits|3|||
161724354|NCT00431847|584034226|FG002|Overall Study|completion of less than two study visits|4|||
161724355|NCT00431847|584034227|FG003|Overall Study|completion of less than two study visits|14|||
161724356|NCT00431847|584034228|FG004|Overall Study|completion of less than two study visits|0|||
161724357|NCT00431847|584034224|FG000|Overall Study|Protocol Violation|0|||
161724358|NCT00431847|584034225|FG001|Overall Study|Protocol Violation|0|||
161724359|NCT00431847|584034226|FG002|Overall Study|Protocol Violation|0|||
161724360|NCT00431847|584034227|FG003|Overall Study|Protocol Violation|0|||
161724361|NCT00431847|584034228|FG004|Overall Study|Protocol Violation|1|||
161724362|NCT00339183|584034231|FG000|Overall Study|Adverse Event|5|||
161724363|NCT00339183|584034232|FG001|Overall Study|Adverse Event|3|||
161724364|NCT00339183|584034231|FG000|Overall Study|Withdrawal by Subject|16|||
161724365|NCT00339183|584034232|FG001|Overall Study|Withdrawal by Subject|19|||
161724366|NCT00339183|584034231|FG000|Overall Study|Physician Decision|2|||
161724367|NCT00339183|584034232|FG001|Overall Study|Physician Decision|4|||
161724368|NCT00339183|584034231|FG000|Overall Study|Lost to Follow-up|17|||
161724369|NCT00339183|584034232|FG001|Overall Study|Lost to Follow-up|17|||
161724370|NCT00339183|584034231|FG000|Overall Study|Protocol-specified criteria|12|||
161724371|NCT00339183|584034232|FG001|Overall Study|Protocol-specified criteria|8|||
161724372|NCT00339183|584034231|FG000|Overall Study|Missing reason|3|||
161724373|NCT00339183|584034232|FG001|Overall Study|Missing reason|1|||
161724374|NCT00339183|584034231|FG000|Overall Study|Other|46|||
161724375|NCT00339183|584034232|FG001|Overall Study|Other|40|||
161724376|NCT00339183|584034231|FG000|Overall Study|Ongoing|20|||
161724377|NCT00339183|584034232|FG001|Overall Study|Ongoing|13|||
161724378|NCT00793819|584034233|FG000|Overall Study|Adverse Event|8|||
161724379|NCT00793819|584034234|FG001|Overall Study|Adverse Event|4|||
161724380|NCT00793819|584034233|FG000|Overall Study|Lack of Efficacy|1|||
161724381|NCT00793819|584034234|FG001|Overall Study|Lack of Efficacy|1|||
161724382|NCT00793819|584034233|FG000|Overall Study|Withdrawal by Subject|4|||
161724383|NCT00793819|584034234|FG001|Overall Study|Withdrawal by Subject|3|||
161724384|NCT00793819|584034233|FG000|Overall Study|Lost to Follow-up|1|||
161724385|NCT00793819|584034234|FG001|Overall Study|Lost to Follow-up|1|||
161724386|NCT00002663|584034235|FG000|Overall Study|Death|4|||
161724387|NCT00002663|584034236|FG001|Overall Study|Death|1|||
161724388|NCT00002663|584034237|FG002|Overall Study|Death|1|||
161724389|NCT00002663|584034238|FG003|Overall Study|Death|0|||
161724390|NCT00002663|584034239|FG004|Overall Study|Death|0|||
161724391|NCT00002663|584034240|FG005|Overall Study|Death|13|||
161724392|NCT00002663|584034241|FG006|Overall Study|Death|0|||
161724393|NCT00002663|584034242|FG007|Overall Study|Death|1|||
161724394|NCT00002663|584034243|FG008|Overall Study|Death|1|||
161724395|NCT00002663|584034244|FG009|Overall Study|Death|1|||
161724396|NCT00002663|584034235|FG000|Overall Study|Lost to Follow-up|3|||
161724397|NCT00002663|584034236|FG001|Overall Study|Lost to Follow-up|0|||
161724398|NCT00002663|584034237|FG002|Overall Study|Lost to Follow-up|0|||
161724399|NCT00002663|584034238|FG003|Overall Study|Lost to Follow-up|1|||
161724400|NCT00002663|584034239|FG004|Overall Study|Lost to Follow-up|0|||
161724401|NCT00002663|584034240|FG005|Overall Study|Lost to Follow-up|1|||
161724402|NCT00002663|584034241|FG006|Overall Study|Lost to Follow-up|0|||
161724403|NCT00002663|584034242|FG007|Overall Study|Lost to Follow-up|0|||
161724404|NCT00002663|584034243|FG008|Overall Study|Lost to Follow-up|0|||
161724405|NCT00002663|584034244|FG009|Overall Study|Lost to Follow-up|0|||
161965451|NCT02039219|584920306|FG001|Treatment|Protocol Violation|0|||
161965452|NCT02039219|584920305|FG000|Treatment|Death|1|||
161724406|NCT00002663|584034235|FG000|Overall Study|Other|0|||
161724407|NCT00002663|584034236|FG001|Overall Study|Other|1|||
161724408|NCT00002663|584034237|FG002|Overall Study|Other|0|||
161724409|NCT00002663|584034238|FG003|Overall Study|Other|0|||
161965453|NCT02039219|584920306|FG001|Treatment|Death|0|||
161965454|NCT02039219|584920305|FG000|Follow up|Adverse Event|0|||
161965455|NCT02039219|584920306|FG001|Follow up|Adverse Event|1|||
161724410|NCT00002663|584034239|FG004|Overall Study|Other|0|||
161724411|NCT00002663|584034240|FG005|Overall Study|Other|1|||
161724412|NCT00002663|584034241|FG006|Overall Study|Other|1|||
161724413|NCT00002663|584034242|FG007|Overall Study|Other|0|||
161724414|NCT00002663|584034243|FG008|Overall Study|Other|0|||
161724415|NCT00002663|584034244|FG009|Overall Study|Other|0|||
161724416|NCT00002663|584034235|FG000|Overall Study|Physician Decision|0|||
161724417|NCT00002663|584034236|FG001|Overall Study|Physician Decision|0|||
161724418|NCT00002663|584034237|FG002|Overall Study|Physician Decision|0|||
161724419|NCT00002663|584034238|FG003|Overall Study|Physician Decision|0|||
161724420|NCT00002663|584034239|FG004|Overall Study|Physician Decision|1|||
161724421|NCT00002663|584034240|FG005|Overall Study|Physician Decision|0|||
161724422|NCT00002663|584034241|FG006|Overall Study|Physician Decision|0|||
161724423|NCT00002663|584034242|FG007|Overall Study|Physician Decision|0|||
161724424|NCT00002663|584034243|FG008|Overall Study|Physician Decision|1|||
161724425|NCT00002663|584034244|FG009|Overall Study|Physician Decision|1|||
161724426|NCT00002663|584034235|FG000|Overall Study|Adverse Event|0|||
161724427|NCT00002663|584034236|FG001|Overall Study|Adverse Event|0|||
161724428|NCT00002663|584034237|FG002|Overall Study|Adverse Event|0|||
161724429|NCT00002663|584034238|FG003|Overall Study|Adverse Event|1|||
161724430|NCT00002663|584034239|FG004|Overall Study|Adverse Event|0|||
161724431|NCT00002663|584034240|FG005|Overall Study|Adverse Event|0|||
161724432|NCT00002663|584034241|FG006|Overall Study|Adverse Event|0|||
161724433|NCT00002663|584034242|FG007|Overall Study|Adverse Event|1|||
161724434|NCT00002663|584034243|FG008|Overall Study|Adverse Event|0|||
161724435|NCT00002663|584034244|FG009|Overall Study|Adverse Event|0|||
161724436|NCT00446446|584034248|FG000|Overall Study|Death|10|||
161724437|NCT00446446|584034248|FG000|Overall Study|Withdrawal by Subject|6|||
161724438|NCT00446446|584034248|FG000|Overall Study|Other|4|||
161724439|NCT00446446|584034248|FG000|Overall Study|Disease Progession|2|||
161724440|NCT00446446|584034248|FG000|Overall Study|Adverse Event|1|||
161724441|NCT00446446|584034248|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
161724442|NCT02142894|584034249|FG000|Overall Study|Protocol Violation|8|||
161724443|NCT00611130|584034255|FG000|Overall Study|Lost to Follow-up|25|||
161724444|NCT00611130|584034256|FG001|Overall Study|Lost to Follow-up|29|||
161724445|NCT00611130|584034255|FG000|Overall Study|Protocol noncompliance|7|||
161724446|NCT00611130|584034256|FG001|Overall Study|Protocol noncompliance|6|||
161724447|NCT00611130|584034255|FG000|Overall Study|Withdrawal by Subject|6|||
161724448|NCT00611130|584034256|FG001|Overall Study|Withdrawal by Subject|5|||
161724449|NCT00611130|584034255|FG000|Overall Study|Other|5|||
161724450|NCT00611130|584034256|FG001|Overall Study|Other|4|||
161724451|NCT00611130|584034255|FG000|Overall Study|Incarceration|3|||
161724452|NCT00611130|584034256|FG001|Overall Study|Incarceration|2|||
161724453|NCT00611130|584034255|FG000|Overall Study|Administrative|1|||
161724454|NCT00611130|584034256|FG001|Overall Study|Administrative|1|||
161724455|NCT00611130|584034255|FG000|Overall Study|Adverse Event|1|||
161724456|NCT00611130|584034256|FG001|Overall Study|Adverse Event|0|||
161724457|NCT00611130|584034255|FG000|Overall Study|Death|1|||
161724458|NCT00611130|584034256|FG001|Overall Study|Death|0|||
161724459|NCT05100199|584034262|FG000|Overall Study|Lost to Follow-up|5|||
161724460|NCT05100199|584034263|FG001|Overall Study|Lost to Follow-up|8|||
161724461|NCT05100199|584034264|FG002|Overall Study|Lost to Follow-up|3|||
161724462|NCT05100199|584034265|FG003|Overall Study|Lost to Follow-up|6|||
161724463|NCT05100199|584034262|FG000|Overall Study|Withdrawal by Subject|3|||
161724464|NCT05100199|584034263|FG001|Overall Study|Withdrawal by Subject|3|||
161724465|NCT05100199|584034264|FG002|Overall Study|Withdrawal by Subject|9|||
161724466|NCT05100199|584034265|FG003|Overall Study|Withdrawal by Subject|7|||
161724467|NCT05100199|584034262|FG000|Overall Study|Other|0|||
161724468|NCT05100199|584034263|FG001|Overall Study|Other|0|||
161965456|NCT02226562|584920307|FG000|Overall Study|Lost to Follow-up|0|||
161965457|NCT02226562|584920308|FG001|Overall Study|Lost to Follow-up|1|||
161724469|NCT05100199|584034264|FG002|Overall Study|Other|1|||
161724470|NCT05100199|584034265|FG003|Overall Study|Other|1|||
161724471|NCT01455428|584034266|FG000|Overall Study|Protocol Violation|2|||
161724472|NCT01455428|584034267|FG001|Overall Study|Protocol Violation|1|||
161724473|NCT01455428|584034266|FG000|Overall Study|Adverse Event|6|||
161724474|NCT01455428|584034267|FG001|Overall Study|Adverse Event|2|||
161724475|NCT01455428|584034266|FG000|Overall Study|Lost to Follow-up|1|||
161724476|NCT01455428|584034267|FG001|Overall Study|Lost to Follow-up|1|||
161724477|NCT01455428|584034266|FG000|Overall Study|Withdrawal by Subject|2|||
161724478|NCT01455428|584034267|FG001|Overall Study|Withdrawal by Subject|5|||
161724479|NCT01455428|584034266|FG000|Overall Study|Did not meet entrance criteria|0|||
161724480|NCT01455428|584034267|FG001|Overall Study|Did not meet entrance criteria|2|||
161965458|NCT04569136|584920314|FG000|Overall Study|Lost to Follow-up|2|||
161965459|NCT04569136|584920315|FG001|Overall Study|Lost to Follow-up|0|||
161724481|NCT01455428|584034266|FG000|Overall Study|Insufficient clinical response|0|||
161724482|NCT01455428|584034267|FG001|Overall Study|Insufficient clinical response|2|||
161724483|NCT01455428|584034266|FG000|Overall Study|Did not receive treatment|1|||
161724484|NCT01455428|584034267|FG001|Overall Study|Did not receive treatment|1|||
161724485|NCT01455428|584034266|FG000|Overall Study|Other|2|||
161724486|NCT01455428|584034267|FG001|Overall Study|Other|4|||
161724487|NCT00257192|584034271|FG000|Overall Study|Adverse Event|21|||
161724488|NCT00257192|584034272|FG001|Overall Study|Adverse Event|10|||
161724489|NCT00257192|584034271|FG000|Overall Study|Laboratory abnormality|1|||
161724490|NCT00257192|584034272|FG001|Overall Study|Laboratory abnormality|1|||
161724491|NCT00257192|584034271|FG000|Overall Study|Lost to Follow-up|3|||
161724492|NCT00257192|584034272|FG001|Overall Study|Lost to Follow-up|3|||
161724493|NCT00257192|584034271|FG000|Overall Study|Insufficient clinical response|18|||
161724494|NCT00257192|584034272|FG001|Overall Study|Insufficient clinical response|18|||
161724495|NCT00257192|584034271|FG000|Overall Study|Withdrawal by Subject|14|||
161724496|NCT00257192|584034272|FG001|Overall Study|Withdrawal by Subject|2|||
161724497|NCT00257192|584034271|FG000|Overall Study|Randomized but not treated|0|||
161724498|NCT00257192|584034272|FG001|Overall Study|Randomized but not treated|1|||
161724499|NCT00257192|584034271|FG000|Overall Study|Study terminated by sponsor|1|||
161724500|NCT00257192|584034272|FG001|Overall Study|Study terminated by sponsor|0|||
161724501|NCT00257192|584034271|FG000|Overall Study|Miscellaneous|0|||
161724502|NCT00257192|584034272|FG001|Overall Study|Miscellaneous|4|||
161724503|NCT02062151|584034273|FG000|Overall Study|screen failure|1|||
161724504|NCT02021812|584034276|FG000|Overall Study|Death|8|||
161724505|NCT02021812|584034276|FG000|Overall Study|Withdrawal by Subject|3|||
161724506|NCT02021812|584034276|FG000|Overall Study|Lost to Follow-up|2|||
161724507|NCT02021812|584034276|FG000|Overall Study|Refuse to return, COVD 19|2|||
161724508|NCT02119104|584034278|FG000|Overall Study|Protocol Violation|16|||
161724509|NCT01651260|584034279|FG000|Overall Study|unable to apply product|3|||
161724510|NCT01952015|584034282|FG000|Induction|Protocol Violation|1|||
161724511|NCT01952015|584034282|FG000|Maintenance|Adverse Event|2|||
161724512|NCT01952015|584034282|FG000|Treatment Period 3|Physician Decision|9|||
161724513|NCT02239094|584034283|FG000|Overall Study|Withdrawal by Subject|1|||
161724514|NCT02239094|584034283|FG000|Overall Study|Remitted before started|1|||
161724515|NCT01469052|584034288|FG000|Overall Study|Adverse Event|2|||
161724516|NCT01469052|584034289|FG001|Overall Study|Adverse Event|3|||
161724517|NCT01469052|584034290|FG002|Overall Study|Adverse Event|0|||
161724518|NCT01469052|584034291|FG003|Overall Study|Adverse Event|2|||
161724519|NCT01469052|584034292|FG004|Overall Study|Adverse Event|0|||
161724520|NCT01469052|584034293|FG005|Overall Study|Adverse Event|1|||
161724521|NCT01469052|584034288|FG000|Overall Study|Progressive disease|3|||
161724522|NCT01469052|584034289|FG001|Overall Study|Progressive disease|0|||
161724523|NCT01469052|584034290|FG002|Overall Study|Progressive disease|5|||
161724524|NCT01469052|584034291|FG003|Overall Study|Progressive disease|3|||
161724525|NCT01469052|584034292|FG004|Overall Study|Progressive disease|7|||
161724526|NCT01469052|584034293|FG005|Overall Study|Progressive disease|2|||
161724527|NCT01469052|584034288|FG000|Overall Study|Lack of Efficacy|0|||
161724528|NCT01469052|584034289|FG001|Overall Study|Lack of Efficacy|0|||
161724529|NCT01469052|584034290|FG002|Overall Study|Lack of Efficacy|0|||
161724530|NCT01469052|584034291|FG003|Overall Study|Lack of Efficacy|0|||
161724531|NCT01469052|584034292|FG004|Overall Study|Lack of Efficacy|0|||
161724532|NCT01469052|584034293|FG005|Overall Study|Lack of Efficacy|2|||
161724533|NCT01469052|584034288|FG000|Overall Study|Moved to rollover protocol|1|||
161724534|NCT01469052|584034289|FG001|Overall Study|Moved to rollover protocol|0|||
161724535|NCT01469052|584034290|FG002|Overall Study|Moved to rollover protocol|1|||
161724536|NCT01469052|584034291|FG003|Overall Study|Moved to rollover protocol|0|||
161724537|NCT01469052|584034292|FG004|Overall Study|Moved to rollover protocol|0|||
161724538|NCT01469052|584034293|FG005|Overall Study|Moved to rollover protocol|1|||
161724539|NCT01469052|584034288|FG000|Overall Study|Other|0|||
161724540|NCT01469052|584034289|FG001|Overall Study|Other|1|||
161724541|NCT01469052|584034290|FG002|Overall Study|Other|0|||
161724542|NCT01469052|584034291|FG003|Overall Study|Other|0|||
161724543|NCT01469052|584034292|FG004|Overall Study|Other|1|||
161724544|NCT01469052|584034293|FG005|Overall Study|Other|0|||
161724545|NCT02508701|584034294|FG000|Overall Study|Lost to Follow-up|9|||
161724546|NCT02508701|584034295|FG001|Overall Study|Lost to Follow-up|5|||
161724547|NCT02508701|584034296|FG002|Overall Study|Lost to Follow-up|5|||
161724548|NCT02508701|584034297|FG003|Overall Study|Lost to Follow-up|3|||
161724549|NCT03648996|584034299|FG000|Overall Study|Withdrawal by Subject|0|||
161724550|NCT03648996|584034300|FG001|Overall Study|Withdrawal by Subject|2|||
161724551|NCT03648996|584034301|FG002|Overall Study|Withdrawal by Subject|2|||
161724552|NCT03648996|584034299|FG000|Overall Study|Physician Decision|2|||
161965460|NCT04569136|584920316|FG002|Overall Study|Lost to Follow-up|1|||
161724553|NCT03648996|584034300|FG001|Overall Study|Physician Decision|0|||
161724554|NCT03648996|584034301|FG002|Overall Study|Physician Decision|0|||
161724555|NCT00365976|584034303|FG000|Overall Study|Withdrawal by Subject|1|||
161724556|NCT00365976|584034304|FG001|Overall Study|Withdrawal by Subject|5|||
161724557|NCT01415440|584034305|FG000|Overall Study|Lost to Follow-up|0|||
161724558|NCT01415440|584034306|FG001|Overall Study|Lost to Follow-up|1|||
161724559|NCT01415440|584034307|FG002|Overall Study|Lost to Follow-up|2|||
161724560|NCT01415440|584034305|FG000|Overall Study|Physician Decision|3|||
161724561|NCT01415440|584034306|FG001|Overall Study|Physician Decision|0|||
161724562|NCT01415440|584034307|FG002|Overall Study|Physician Decision|0|||
161724563|NCT01415440|584034305|FG000|Overall Study|Withdrawal by Subject|1|||
161724564|NCT01415440|584034306|FG001|Overall Study|Withdrawal by Subject|0|||
161724565|NCT01415440|584034307|FG002|Overall Study|Withdrawal by Subject|0|||
161724566|NCT01781026|584034308|FG000|Overall Study|Lack of Efficacy|2|||
161724567|NCT03141307|584034309|FG000|In-Hospital|Withdrawal by Subject|0|||
161724568|NCT03141307|584034310|FG001|In-Hospital|Withdrawal by Subject|2|||
161724569|NCT03141307|584034309|FG000|In-Hospital|Protocol Violation|4|||
161724570|NCT03141307|584034310|FG001|In-Hospital|Protocol Violation|0|||
161724571|NCT03141307|584034309|FG000|Follow-Up|Lost to Follow-up|97|||
161724572|NCT03141307|584034310|FG001|Follow-Up|Lost to Follow-up|54|||
161724573|NCT00227877|584034311|FG000|Pre-visit Assessment|Technical difficulties|7|||
161724574|NCT00227877|584034312|FG001|Pre-visit Assessment|Technical difficulties|3|||
161724575|NCT00227877|584034313|FG002|Pre-visit Assessment|Technical difficulties|0|||
161724576|NCT00227877|584034314|FG003|Pre-visit Assessment|Technical difficulties|0|||
161724577|NCT00227877|584034311|FG000|Post-visit Checklist|Lost to Follow-up|24|||
161724578|NCT00227877|584034312|FG001|Post-visit Checklist|Lost to Follow-up|13|||
161724579|NCT00227877|584034313|FG002|Post-visit Checklist|Lost to Follow-up|1|||
161724580|NCT00227877|584034314|FG003|Post-visit Checklist|Lost to Follow-up|0|||
161724581|NCT00227877|584034311|FG000|3-months Follow-up|Completed late|135|||
161724582|NCT00227877|584034312|FG001|3-months Follow-up|Completed late|128|||
161724583|NCT00227877|584034313|FG002|3-months Follow-up|Completed late|34|||
161724584|NCT00227877|584034314|FG003|3-months Follow-up|Completed late|8|||
161724585|NCT00227877|584034311|FG000|3-months Follow-up|Lost to Follow-up|178|||
161724586|NCT00227877|584034312|FG001|3-months Follow-up|Lost to Follow-up|139|||
161724587|NCT00227877|584034313|FG002|3-months Follow-up|Lost to Follow-up|18|||
161724588|NCT00227877|584034314|FG003|3-months Follow-up|Lost to Follow-up|13|||
161724589|NCT00227877|584034311|FG000|12-months Follow-up|Completed late|78|||
161724590|NCT00227877|584034312|FG001|12-months Follow-up|Completed late|74|||
161724591|NCT00227877|584034313|FG002|12-months Follow-up|Completed late|1|||
161724592|NCT00227877|584034314|FG003|12-months Follow-up|Completed late|0|||
161724593|NCT00227877|584034311|FG000|12-months Follow-up|Lost to Follow-up|232|||
161724594|NCT00227877|584034312|FG001|12-months Follow-up|Lost to Follow-up|189|||
161724595|NCT00227877|584034313|FG002|12-months Follow-up|Lost to Follow-up|30|||
161724596|NCT00227877|584034314|FG003|12-months Follow-up|Lost to Follow-up|26|||
161724597|NCT03090737|584034315|FG000|Overall Study|Other reasons|1|||
161724598|NCT03090737|584034315|FG000|Overall Study|Completed treatment as per protocol|17|||
161724599|NCT03090737|584034315|FG000|Overall Study|Maximum clinical benefit|2|||
161724600|NCT03090737|584034315|FG000|Overall Study|Adverse event unrelated to study drug|7|||
161724601|NCT03090737|584034315|FG000|Overall Study|Study drug toxicity|4|||
161724602|NCT03090737|584034315|FG000|Overall Study|Disease progression|98|||
161724603|NCT03596177|584034317|FG000|Single Blind Period|Withdrawal by Subject|1|||
161724604|NCT03596177|584034318|FG001|Single Blind Period|Withdrawal by Subject|1|||
161724605|NCT03596177|584034317|FG000|Single Blind Period|Other|1|||
161724606|NCT03596177|584034318|FG001|Single Blind Period|Other|0|||
161724607|NCT03596177|584034317|FG000|Double Blind Period|Withdrawal by Subject|0|||
161724608|NCT03596177|584034318|FG001|Double Blind Period|Withdrawal by Subject|1|||
161724609|NCT03596177|584034317|FG000|Double Blind Period|Other|0|||
161724610|NCT03596177|584034318|FG001|Double Blind Period|Other|4|||
161724611|NCT03596177|584034317|FG000|Double Blind Period|Death during safety follow-up|0|||
161724612|NCT03596177|584034318|FG001|Double Blind Period|Death during safety follow-up|1|||
161724613|NCT02522481|584034319|FG000|Overall Study|discontinued|1|||
161724614|NCT02522481|584034319|FG000|Overall Study|Not dosed|2|||
161724615|NCT03123939|584034320|FG000|Overall Study|Lack of Efficacy|6|||
161724616|NCT03123939|584034320|FG000|Overall Study|Death|5|||
161724617|NCT03123939|584034320|FG000|Overall Study|Physician Decision|2|||
161724618|NCT03123939|584034320|FG000|Overall Study|Subject/guardian decision|2|||
161724619|NCT03123939|584034320|FG000|Overall Study|Lost to Follow-up|1|||
161724620|NCT03123939|584034320|FG000|Overall Study|New therapy for study indication|1|||
161724621|NCT03123939|584034320|FG000|Overall Study|Protocol deviation|1|||
161724622|NCT03123939|584034320|FG000|Overall Study|Progressive disease|18|||
161724623|NCT03123939|584034320|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
161724624|NCT03123939|584034320|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
161724625|NCT02531373|584035977|FG000|Overall Study|Lack of Efficacy|0|||
161724626|NCT02531373|584035978|FG001|Overall Study|Lack of Efficacy|0|||
161724627|NCT02531373|584035979|FG002|Overall Study|Lack of Efficacy|0|||
161724628|NCT02531373|584035980|FG003|Overall Study|Lack of Efficacy|0|||
161724629|NCT02531373|584035981|FG004|Overall Study|Lack of Efficacy|3|||
161724630|NCT02531373|584035982|FG005|Overall Study|Lack of Efficacy|2|||
161724631|NCT02531373|584035983|FG006|Overall Study|Lack of Efficacy|4|||
161724632|NCT02531373|584035984|FG007|Overall Study|Lack of Efficacy|8|||
161724633|NCT02531373|584035985|FG008|Overall Study|Lack of Efficacy|5|||
161724634|NCT02531373|584035977|FG000|Overall Study|Lost to Follow-up|0|||
161724635|NCT02531373|584035978|FG001|Overall Study|Lost to Follow-up|0|||
161724636|NCT02531373|584035979|FG002|Overall Study|Lost to Follow-up|0|||
161724637|NCT02531373|584035980|FG003|Overall Study|Lost to Follow-up|0|||
161724638|NCT02531373|584035981|FG004|Overall Study|Lost to Follow-up|0|||
161724639|NCT02531373|584035982|FG005|Overall Study|Lost to Follow-up|2|||
161724640|NCT02531373|584035983|FG006|Overall Study|Lost to Follow-up|2|||
161724641|NCT02531373|584035984|FG007|Overall Study|Lost to Follow-up|0|||
161724642|NCT02531373|584035985|FG008|Overall Study|Lost to Follow-up|0|||
161724643|NCT02531373|584035977|FG000|Overall Study|Physician Decision|0|||
161724644|NCT02531373|584035978|FG001|Overall Study|Physician Decision|0|||
161724645|NCT02531373|584035979|FG002|Overall Study|Physician Decision|0|||
161724646|NCT02531373|584035980|FG003|Overall Study|Physician Decision|0|||
161724647|NCT02531373|584035981|FG004|Overall Study|Physician Decision|2|||
161724648|NCT02531373|584035982|FG005|Overall Study|Physician Decision|1|||
161724649|NCT02531373|584035983|FG006|Overall Study|Physician Decision|0|||
161724650|NCT02531373|584035984|FG007|Overall Study|Physician Decision|0|||
161724651|NCT02531373|584035985|FG008|Overall Study|Physician Decision|0|||
161724652|NCT02531373|584035977|FG000|Overall Study|Protocol Violation|0|||
161724653|NCT02531373|584035978|FG001|Overall Study|Protocol Violation|0|||
161724654|NCT02531373|584035979|FG002|Overall Study|Protocol Violation|0|||
161724655|NCT02531373|584035980|FG003|Overall Study|Protocol Violation|0|||
161724656|NCT02531373|584035981|FG004|Overall Study|Protocol Violation|0|||
161724657|NCT02531373|584035982|FG005|Overall Study|Protocol Violation|1|||
161724658|NCT02531373|584035983|FG006|Overall Study|Protocol Violation|1|||
161724659|NCT02531373|584035984|FG007|Overall Study|Protocol Violation|0|||
161724660|NCT02531373|584035985|FG008|Overall Study|Protocol Violation|1|||
161724661|NCT02531373|584035977|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161724662|NCT02531373|584035978|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161724663|NCT02531373|584035979|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161724664|NCT02531373|584035980|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161724665|NCT02531373|584035981|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161724666|NCT02531373|584035982|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
161724667|NCT02531373|584035983|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
161724668|NCT02531373|584035984|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
161724669|NCT02531373|584035985|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
161724670|NCT02531373|584035977|FG000|Overall Study|Withdrawal by Subject|0|||
161724671|NCT02531373|584035978|FG001|Overall Study|Withdrawal by Subject|0|||
161724672|NCT02531373|584035979|FG002|Overall Study|Withdrawal by Subject|0|||
161724673|NCT02531373|584035980|FG003|Overall Study|Withdrawal by Subject|0|||
161724674|NCT02531373|584035981|FG004|Overall Study|Withdrawal by Subject|3|||
161724675|NCT02531373|584035982|FG005|Overall Study|Withdrawal by Subject|0|||
161724676|NCT02531373|584035983|FG006|Overall Study|Withdrawal by Subject|0|||
161724677|NCT02531373|584035984|FG007|Overall Study|Withdrawal by Subject|0|||
161724678|NCT02531373|584035985|FG008|Overall Study|Withdrawal by Subject|0|||
161724679|NCT01675531|584035986|FG000|Overall Study|Adverse Event|9|||
161724680|NCT01675531|584035986|FG000|Overall Study|Withdrawal by Subject|7|||
161724681|NCT01675531|584035986|FG000|Overall Study|Lack of Efficacy|1|||
161724682|NCT01675531|584035986|FG000|Overall Study|Protocol Violation|8|||
161724683|NCT01623531|584035987|FG000|Overall Study|Death|1|||
161724684|NCT01623531|584035988|FG001|Overall Study|Death|0|||
161724685|NCT01623531|584035987|FG000|Overall Study|Protocol Violation|2|||
161724686|NCT01623531|584035988|FG001|Overall Study|Protocol Violation|1|||
161724687|NCT01623531|584035987|FG000|Overall Study|Missing data at primary outcome time poi|1|||
161724688|NCT01623531|584035988|FG001|Overall Study|Missing data at primary outcome time poi|1|||
161724689|NCT02834403|584035989|FG000|Overall Study|Physician Decision|2|||
161724690|NCT02834403|584035990|FG001|Overall Study|Physician Decision|1|||
161724691|NCT02834403|584035991|FG002|Overall Study|Physician Decision|2|||
161724692|NCT02834403|584035992|FG003|Overall Study|Physician Decision|1|||
161724693|NCT02834403|584035993|FG004|Overall Study|Physician Decision|1|||
161724694|NCT02834403|584035994|FG005|Overall Study|Physician Decision|2|||
161724695|NCT02834403|584035995|FG006|Overall Study|Physician Decision|12|||
161724696|NCT02834403|584035989|FG000|Overall Study|Adverse Event|0|||
161724697|NCT02834403|584035990|FG001|Overall Study|Adverse Event|0|||
161724698|NCT02834403|584035991|FG002|Overall Study|Adverse Event|0|||
161724699|NCT02834403|584035992|FG003|Overall Study|Adverse Event|0|||
161724700|NCT02834403|584035993|FG004|Overall Study|Adverse Event|1|||
161724701|NCT02834403|584035994|FG005|Overall Study|Adverse Event|1|||
161724702|NCT02834403|584035995|FG006|Overall Study|Adverse Event|3|||
161724703|NCT02834403|584035989|FG000|Overall Study|Withdrawal by Subject|0|||
161724704|NCT02834403|584035990|FG001|Overall Study|Withdrawal by Subject|1|||
161724705|NCT02834403|584035991|FG002|Overall Study|Withdrawal by Subject|0|||
161724706|NCT02834403|584035992|FG003|Overall Study|Withdrawal by Subject|0|||
161724707|NCT02834403|584035993|FG004|Overall Study|Withdrawal by Subject|1|||
161724708|NCT02834403|584035994|FG005|Overall Study|Withdrawal by Subject|0|||
161724709|NCT02834403|584035995|FG006|Overall Study|Withdrawal by Subject|0|||
161724710|NCT02834403|584035989|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
161724711|NCT02834403|584035990|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
161724712|NCT02834403|584035991|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
161724713|NCT02834403|584035992|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
161724714|NCT02834403|584035993|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
161724715|NCT02834403|584035994|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
161724716|NCT02834403|584035995|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
161724717|NCT04705597|584035996|FG000|Overall Study|Death|16|||
161724718|NCT04705597|584035997|FG001|Overall Study|Death|9|||
161724719|NCT04705597|584035996|FG000|Overall Study|Lost to Follow-up|1|||
161724720|NCT04705597|584035997|FG001|Overall Study|Lost to Follow-up|0|||
161724721|NCT04705597|584035996|FG000|Overall Study|Withdrawal by Subject|1|||
161724722|NCT04705597|584035997|FG001|Overall Study|Withdrawal by Subject|2|||
161724723|NCT02606045|584035998|FG000|Overall Study|Study closed before treament could begin|1|||
161724724|NCT02606045|584035999|FG001|Overall Study|Study closed before treament could begin|2|||
161724725|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
161724726|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
161724727|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161724728|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161724729|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161724730|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161724731|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161724732|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161724733|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
161724734|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161724735|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161724736|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
161724737|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161724738|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161724739|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
161724740|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
161724741|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
161724742|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
161724743|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
161724744|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
161724745|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
161724746|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Other|0|||
161724747|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Other|1|||
161724748|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Other|0|||
161724749|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Other|0|||
161724750|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Other|0|||
161724751|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Other|0|||
161724752|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Other|0|||
161724753|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
161724754|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
161724755|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
161724756|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
161724757|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
161724758|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
161724759|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
161724760|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
161724761|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
161724762|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
161724763|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
161724764|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
161724765|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
161724766|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
161724767|NCT00365716|584036000|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
161724768|NCT00365716|584036001|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
161724769|NCT00365716|584036002|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
161724770|NCT00365716|584036003|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
161724771|NCT00365716|584036004|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
161724772|NCT00365716|584036005|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
161724773|NCT00365716|584036006|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
161724774|NCT00365716|584036000|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
161724775|NCT00365716|584036001|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
161724776|NCT00365716|584036002|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
161724777|NCT00365716|584036003|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
161724778|NCT00365716|584036004|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
161724779|NCT00365716|584036005|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
161724780|NCT00365716|584036006|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
161724781|NCT00365716|584036000|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
161724782|NCT00365716|584036001|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
161724783|NCT00365716|584036002|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
161724784|NCT00365716|584036003|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
161724785|NCT00365716|584036004|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
161724786|NCT00365716|584036005|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
161724787|NCT00365716|584036006|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
161724788|NCT00365716|584036000|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
161724789|NCT00365716|584036001|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
161724790|NCT00365716|584036002|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
161724791|NCT00365716|584036003|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
161724792|NCT00365716|584036004|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
161724793|NCT00365716|584036005|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
161724794|NCT00365716|584036006|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
161724795|NCT00365716|584036000|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
161724796|NCT00365716|584036001|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161724797|NCT00365716|584036002|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161724798|NCT00365716|584036003|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161724799|NCT00365716|584036004|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
161724800|NCT00365716|584036005|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161724801|NCT00365716|584036006|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161724802|NCT00365716|584036000|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161724803|NCT00365716|584036001|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
161724804|NCT00365716|584036002|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
161724805|NCT00365716|584036003|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161724806|NCT00365716|584036004|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161724807|NCT00365716|584036005|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161724808|NCT00365716|584036006|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161724809|NCT00365716|584036000|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
161724810|NCT00365716|584036001|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
161724811|NCT00365716|584036002|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
161724812|NCT00365716|584036003|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
161724813|NCT00365716|584036004|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
161724814|NCT00365716|584036005|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
161724815|NCT00365716|584036006|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
161724816|NCT00365716|584036000|FG000|Extension 1|Lost to Follow-up|0|||
161724817|NCT00365716|584036001|FG001|Extension 1|Lost to Follow-up|0|||
161724818|NCT00365716|584036002|FG002|Extension 1|Lost to Follow-up|0|||
161724819|NCT00365716|584036003|FG003|Extension 1|Lost to Follow-up|0|||
161724820|NCT00365716|584036004|FG004|Extension 1|Lost to Follow-up|0|||
161724821|NCT00365716|584036005|FG005|Extension 1|Lost to Follow-up|1|||
161724822|NCT00365716|584036006|FG006|Extension 1|Lost to Follow-up|0|||
161724823|NCT00365716|584036000|FG000|Extension 1|Other|0|||
161724824|NCT00365716|584036001|FG001|Extension 1|Other|0|||
161724825|NCT00365716|584036002|FG002|Extension 1|Other|0|||
161724826|NCT00365716|584036003|FG003|Extension 1|Other|0|||
161724827|NCT00365716|584036004|FG004|Extension 1|Other|0|||
161724828|NCT00365716|584036005|FG005|Extension 1|Other|9|||
161724829|NCT00365716|584036006|FG006|Extension 1|Other|0|||
161724830|NCT00365716|584036000|FG000|Extension 1|Moved|0|||
161724831|NCT00365716|584036001|FG001|Extension 1|Moved|0|||
161724832|NCT00365716|584036002|FG002|Extension 1|Moved|0|||
161724833|NCT00365716|584036003|FG003|Extension 1|Moved|0|||
161724834|NCT00365716|584036004|FG004|Extension 1|Moved|0|||
161724835|NCT00365716|584036005|FG005|Extension 1|Moved|4|||
161724836|NCT00365716|584036006|FG006|Extension 1|Moved|0|||
161724837|NCT00365716|584036000|FG000|Extension 1|Withdrawal by Subject|0|||
161724838|NCT00365716|584036001|FG001|Extension 1|Withdrawal by Subject|0|||
161724839|NCT00365716|584036002|FG002|Extension 1|Withdrawal by Subject|0|||
161724840|NCT00365716|584036003|FG003|Extension 1|Withdrawal by Subject|0|||
161724841|NCT00365716|584036004|FG004|Extension 1|Withdrawal by Subject|0|||
161965461|NCT03576066|584920322|FG000|Overall Study|Noncompliance with study drug|0|||
161965462|NCT03576066|584920323|FG001|Overall Study|Noncompliance with study drug|1|||
161965463|NCT01466660|584920324|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
161965464|NCT01466660|584920325|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
161965465|NCT01466660|584920324|FG000|Overall Study|Worsening of underlying cancer disease|5|||
161965466|NCT01466660|584920325|FG001|Overall Study|Worsening of underlying cancer disease|2|||
161724842|NCT00365716|584036005|FG005|Extension 1|Withdrawal by Subject|3|||
161724843|NCT00365716|584036006|FG006|Extension 1|Withdrawal by Subject|0|||
161724844|NCT00365716|584036000|FG000|Extension 1|Pregnancy|0|||
161724845|NCT00365716|584036001|FG001|Extension 1|Pregnancy|0|||
161724846|NCT00365716|584036002|FG002|Extension 1|Pregnancy|0|||
161724847|NCT00365716|584036003|FG003|Extension 1|Pregnancy|0|||
161724848|NCT00365716|584036004|FG004|Extension 1|Pregnancy|0|||
161724849|NCT00365716|584036005|FG005|Extension 1|Pregnancy|4|||
161724850|NCT00365716|584036006|FG006|Extension 1|Pregnancy|0|||
161724851|NCT00365716|584036000|FG000|Extension 1|Protocol Violation|0|||
161724852|NCT00365716|584036001|FG001|Extension 1|Protocol Violation|0|||
161724853|NCT00365716|584036002|FG002|Extension 1|Protocol Violation|0|||
161724854|NCT00365716|584036003|FG003|Extension 1|Protocol Violation|0|||
161724855|NCT00365716|584036004|FG004|Extension 1|Protocol Violation|0|||
161724856|NCT00365716|584036005|FG005|Extension 1|Protocol Violation|1|||
161724857|NCT00365716|584036006|FG006|Extension 1|Protocol Violation|0|||
161724858|NCT00365716|584036000|FG000|Extension 2|Lost to Follow-up|0|||
161724859|NCT00365716|584036001|FG001|Extension 2|Lost to Follow-up|0|||
161724860|NCT00365716|584036002|FG002|Extension 2|Lost to Follow-up|0|||
161724861|NCT00365716|584036003|FG003|Extension 2|Lost to Follow-up|0|||
161724862|NCT00365716|584036004|FG004|Extension 2|Lost to Follow-up|0|||
161724863|NCT00365716|584036005|FG005|Extension 2|Lost to Follow-up|0|||
161724864|NCT00365716|584036006|FG006|Extension 2|Lost to Follow-up|2|||
161724865|NCT00365716|584036000|FG000|Extension 2|Other|0|||
161724866|NCT00365716|584036001|FG001|Extension 2|Other|0|||
161724867|NCT00365716|584036002|FG002|Extension 2|Other|0|||
161724868|NCT00365716|584036003|FG003|Extension 2|Other|0|||
161724869|NCT00365716|584036004|FG004|Extension 2|Other|0|||
161724870|NCT00365716|584036005|FG005|Extension 2|Other|0|||
161724871|NCT00365716|584036006|FG006|Extension 2|Other|3|||
161724872|NCT00365716|584036000|FG000|Extension 2|Withdrawal by Subject|0|||
161724873|NCT00365716|584036001|FG001|Extension 2|Withdrawal by Subject|0|||
161724874|NCT00365716|584036002|FG002|Extension 2|Withdrawal by Subject|0|||
161724875|NCT00365716|584036003|FG003|Extension 2|Withdrawal by Subject|0|||
161724876|NCT00365716|584036004|FG004|Extension 2|Withdrawal by Subject|0|||
161724877|NCT00365716|584036005|FG005|Extension 2|Withdrawal by Subject|0|||
161724878|NCT00365716|584036006|FG006|Extension 2|Withdrawal by Subject|5|||
161724879|NCT02853331|584036007|FG000|Overall Study|Death|59|||
161724880|NCT02853331|584036008|FG001|Overall Study|Death|95|||
161724881|NCT02853331|584036007|FG000|Overall Study|Withdrawal by Subject|5|||
161724882|NCT02853331|584036008|FG001|Overall Study|Withdrawal by Subject|9|||
161724883|NCT02853331|584036007|FG000|Overall Study|Ongoing in study|368|||
161724884|NCT02853331|584036008|FG001|Overall Study|Ongoing in study|325|||
161724885|NCT00751101|584036009|FG000|Overall Study|Withdrawal by Subject|1|||
161724886|NCT00751101|584036010|FG001|Overall Study|Withdrawal by Subject|0|||
161724887|NCT00751101|584036009|FG000|Overall Study|No HFS / Never Started Patch/|0|||
161724888|NCT00751101|584036010|FG001|Overall Study|No HFS / Never Started Patch/|4|||
161724889|NCT00751101|584036009|FG000|Overall Study|Never began capecitabine|1|||
161724890|NCT00751101|584036010|FG001|Overall Study|Never began capecitabine|0|||
161724891|NCT00751101|584036009|FG000|Overall Study|Physician Decision|0|||
161724892|NCT00751101|584036010|FG001|Overall Study|Physician Decision|1|||
161724893|NCT00844428|584036014|FG000|Screening Period|Screen Failure|3|||
161724894|NCT00844428|584036014|FG000|Extension Treatment Period|Death|1|||
161724895|NCT00844428|584036014|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
161724896|NCT00789477|584036015|FG000|Overall Study|Withdrawal by Subject|2|||
161724897|NCT00789477|584036016|FG001|Overall Study|Withdrawal by Subject|1|||
161724898|NCT00789477|584036017|FG002|Overall Study|Withdrawal by Subject|3|||
161724899|NCT00789477|584036018|FG003|Overall Study|Withdrawal by Subject|2|||
161724900|NCT00789477|584036019|FG004|Overall Study|Withdrawal by Subject|3|||
161965467|NCT01466660|584920324|FG000|Overall Study|Other adverse event|19|||
161965468|NCT01466660|584920325|FG001|Overall Study|Other adverse event|18|||
161724901|NCT00789477|584036015|FG000|Overall Study|Protocol Violation|1|||
161724902|NCT00789477|584036016|FG001|Overall Study|Protocol Violation|0|||
161724903|NCT00789477|584036017|FG002|Overall Study|Protocol Violation|0|||
161724904|NCT00789477|584036018|FG003|Overall Study|Protocol Violation|1|||
161724905|NCT00789477|584036019|FG004|Overall Study|Protocol Violation|0|||
161724906|NCT00789477|584036015|FG000|Overall Study|Adverse Event|3|||
161724907|NCT00789477|584036016|FG001|Overall Study|Adverse Event|3|||
161724908|NCT00789477|584036017|FG002|Overall Study|Adverse Event|1|||
161724909|NCT00789477|584036018|FG003|Overall Study|Adverse Event|0|||
161724910|NCT00789477|584036019|FG004|Overall Study|Adverse Event|0|||
161724911|NCT00789477|584036015|FG000|Overall Study|Death|1|||
161724912|NCT00789477|584036016|FG001|Overall Study|Death|1|||
161724913|NCT00789477|584036017|FG002|Overall Study|Death|2|||
161724914|NCT00789477|584036018|FG003|Overall Study|Death|2|||
161965469|NCT01466660|584920324|FG000|Overall Study|Protocol Violation|2|||
161724915|NCT00789477|584036019|FG004|Overall Study|Death|0|||
161724916|NCT00789477|584036015|FG000|Overall Study|Lost to Follow-up|0|||
161724917|NCT00789477|584036016|FG001|Overall Study|Lost to Follow-up|1|||
161724918|NCT00789477|584036017|FG002|Overall Study|Lost to Follow-up|4|||
161724919|NCT00789477|584036018|FG003|Overall Study|Lost to Follow-up|2|||
161724920|NCT00789477|584036019|FG004|Overall Study|Lost to Follow-up|4|||
161724921|NCT00789477|584036015|FG000|Overall Study|Lack of Efficacy|2|||
161724922|NCT00789477|584036016|FG001|Overall Study|Lack of Efficacy|0|||
161724923|NCT00789477|584036017|FG002|Overall Study|Lack of Efficacy|0|||
161724924|NCT00789477|584036018|FG003|Overall Study|Lack of Efficacy|0|||
161724925|NCT00789477|584036019|FG004|Overall Study|Lack of Efficacy|0|||
161724926|NCT00789477|584036015|FG000|Overall Study|Other|2|||
161724927|NCT00789477|584036016|FG001|Overall Study|Other|0|||
161724928|NCT00789477|584036017|FG002|Overall Study|Other|1|||
161724929|NCT00789477|584036018|FG003|Overall Study|Other|3|||
161724930|NCT00789477|584036019|FG004|Overall Study|Other|0|||
161724931|NCT00455858|584036020|FG000|Overall Study|Lost to Follow-up|2|||
161724932|NCT00455858|584036020|FG000|Overall Study|Protocol Violation|1|||
161724933|NCT00455858|584036020|FG000|Overall Study|Lack of Efficacy|1|||
161724934|NCT00455858|584036020|FG000|Overall Study|Well controlled FPG without insulin|1|||
161724935|NCT00455858|584036020|FG000|Overall Study|Withdrawal|1|||
161724936|NCT02092389|584036021|FG000|Overall Study|Adverse Event|1|||
161724937|NCT02092389|584036021|FG000|Overall Study|Other|5|||
161724938|NCT01242020|584036022|FG000|Overall Study|Withdrawal by Subject|2|||
161724939|NCT01242020|584036023|FG001|Overall Study|Withdrawal by Subject|0|||
161724940|NCT01242020|584036022|FG000|Overall Study|Failed screening|1|||
161724941|NCT01242020|584036023|FG001|Overall Study|Failed screening|0|||
161724942|NCT02680847|584036024|FG000|Overall Study|Other|2|||
161724943|NCT02680847|584036025|FG001|Overall Study|Other|0|||
161724944|NCT02680847|584036026|FG002|Overall Study|Other|0|||
161724945|NCT02680847|584036024|FG000|Overall Study|No longer met eligibility criteria|2|||
161724946|NCT02680847|584036025|FG001|Overall Study|No longer met eligibility criteria|2|||
161724947|NCT02680847|584036026|FG002|Overall Study|No longer met eligibility criteria|0|||
161724948|NCT02680847|584036024|FG000|Overall Study|Unwilling to participate in study|1|||
161724949|NCT02680847|584036025|FG001|Overall Study|Unwilling to participate in study|1|||
161724950|NCT02680847|584036026|FG002|Overall Study|Unwilling to participate in study|0|||
161724951|NCT02680847|584036024|FG000|Overall Study|Lack of Efficacy|0|||
161724952|NCT02680847|584036025|FG001|Overall Study|Lack of Efficacy|0|||
161724953|NCT02680847|584036026|FG002|Overall Study|Lack of Efficacy|2|||
161724954|NCT02680847|584036024|FG000|Overall Study|Adverse Event|0|||
161724955|NCT02680847|584036025|FG001|Overall Study|Adverse Event|0|||
161724956|NCT02680847|584036026|FG002|Overall Study|Adverse Event|1|||
161724957|NCT02375698|584036027|FG000|Overall Study|Withdrawal by Subject|0|||
161724958|NCT02375698|584036028|FG001|Overall Study|Withdrawal by Subject|2|||
161724959|NCT02375698|584036027|FG000|Overall Study|Physician Decision|2|||
161724960|NCT02375698|584036028|FG001|Overall Study|Physician Decision|0|||
161724961|NCT01927562|584036034|FG000|Overall Study|Lost to Follow-up|30|||
161724962|NCT01927562|584036034|FG000|Overall Study|Withdrawal by Subject|3|||
161724963|NCT01927562|584036034|FG000|Overall Study|Physician Decision|5|||
161724964|NCT00642616|584036035|FG000|Overall Study|Adverse Event|2|||
161724965|NCT00642616|584036036|FG001|Overall Study|Adverse Event|0|||
161724966|NCT00642616|584036037|FG002|Overall Study|Adverse Event|1|||
161724967|NCT00642616|584036038|FG003|Overall Study|Adverse Event|0|||
161724968|NCT00642616|584036035|FG000|Overall Study|Study Terminated by Sponsor|7|||
161724969|NCT00642616|584036036|FG001|Overall Study|Study Terminated by Sponsor|6|||
161724970|NCT00642616|584036037|FG002|Overall Study|Study Terminated by Sponsor|4|||
161724971|NCT00642616|584036038|FG003|Overall Study|Study Terminated by Sponsor|5|||
161724972|NCT00642616|584036035|FG000|Overall Study|Withdrawal by Subject|0|||
161724973|NCT00642616|584036036|FG001|Overall Study|Withdrawal by Subject|1|||
161724974|NCT00642616|584036037|FG002|Overall Study|Withdrawal by Subject|1|||
161724975|NCT00642616|584036038|FG003|Overall Study|Withdrawal by Subject|1|||
161724976|NCT00642616|584036035|FG000|Overall Study|Protocol Violation|0|||
161724977|NCT00642616|584036036|FG001|Overall Study|Protocol Violation|0|||
161724978|NCT00642616|584036037|FG002|Overall Study|Protocol Violation|2|||
161724979|NCT00642616|584036038|FG003|Overall Study|Protocol Violation|0|||
161724980|NCT00642616|584036035|FG000|Overall Study|Physician Decision|0|||
161724981|NCT00642616|584036036|FG001|Overall Study|Physician Decision|0|||
161724982|NCT00642616|584036037|FG002|Overall Study|Physician Decision|1|||
161724983|NCT00642616|584036038|FG003|Overall Study|Physician Decision|1|||
161724984|NCT02955186|584036039|FG000|Overall Study|Withdrawal by Subject|6|||
161724985|NCT02955186|584036040|FG001|Overall Study|Withdrawal by Subject|2|||
161724986|NCT02955186|584036039|FG000|Overall Study|Protocol Violation|1|||
161724987|NCT02955186|584036040|FG001|Overall Study|Protocol Violation|0|||
161724988|NCT01618656|584036041|FG000|Overall Study|Withdrawal by Subject|7|||
161724989|NCT01618656|584036042|FG001|Overall Study|Withdrawal by Subject|3|||
161724990|NCT01618656|584036041|FG000|Overall Study|Physician Decision|1|||
161724991|NCT01618656|584036042|FG001|Overall Study|Physician Decision|1|||
161724992|NCT01276847|584036043|FG000|Overall Study|Withdrawal by Subject|1|||
162032161|NCT00814801|585174220|FG002|Overall Study|Other|4|||
161724993|NCT01276847|584036044|FG001|Overall Study|Withdrawal by Subject|0|||
161724994|NCT01276847|584036045|FG002|Overall Study|Withdrawal by Subject|0|||
161724995|NCT00751881|584036046|FG000|Core Treatment Period|Not treated|1|||
161724996|NCT00751881|584036047|FG001|Core Treatment Period|Not treated|1|||
161724997|NCT00751881|584036048|FG002|Core Treatment Period|Not treated|2|||
161724998|NCT00751881|584036046|FG000|Core Treatment Period|Adverse Event|26|||
161724999|NCT00751881|584036047|FG001|Core Treatment Period|Adverse Event|54|||
161725000|NCT00751881|584036048|FG002|Core Treatment Period|Adverse Event|58|||
161725001|NCT00751881|584036046|FG000|Core Treatment Period|Lack of Efficacy|37|||
161725002|NCT00751881|584036047|FG001|Core Treatment Period|Lack of Efficacy|30|||
161725003|NCT00751881|584036048|FG002|Core Treatment Period|Lack of Efficacy|20|||
161725004|NCT00751881|584036046|FG000|Core Treatment Period|Poor compliance to protocol|15|||
161725005|NCT00751881|584036047|FG001|Core Treatment Period|Poor compliance to protocol|3|||
161965470|NCT01466660|584920325|FG001|Overall Study|Protocol Violation|1|||
161965471|NCT01466660|584920324|FG000|Overall Study|Refused continuation of trial medication|4|||
161965472|NCT01466660|584920325|FG001|Overall Study|Refused continuation of trial medication|3|||
161965473|NCT01466660|584920324|FG000|Overall Study|Other reason not defined above|10|||
161725006|NCT00751881|584036048|FG002|Core Treatment Period|Poor compliance to protocol|4|||
161725007|NCT00751881|584036046|FG000|Core Treatment Period|Lost to Follow-up|6|||
161725008|NCT00751881|584036047|FG001|Core Treatment Period|Lost to Follow-up|4|||
161725009|NCT00751881|584036048|FG002|Core Treatment Period|Lost to Follow-up|3|||
161725010|NCT00751881|584036046|FG000|Core Treatment Period|Other: protocol deviation|3|||
161725011|NCT00751881|584036047|FG001|Core Treatment Period|Other: protocol deviation|3|||
161725012|NCT00751881|584036048|FG002|Core Treatment Period|Other: protocol deviation|7|||
161725013|NCT00751881|584036046|FG000|Core Treatment Period|Other: wish to parent|5|||
161725014|NCT00751881|584036047|FG001|Core Treatment Period|Other: wish to parent|7|||
161725015|NCT00751881|584036048|FG002|Core Treatment Period|Other: wish to parent|4|||
161725016|NCT00751881|584036046|FG000|Core Treatment Period|Other: personal/family constraints|6|||
161725017|NCT00751881|584036047|FG001|Core Treatment Period|Other: personal/family constraints|7|||
161725018|NCT00751881|584036048|FG002|Core Treatment Period|Other: personal/family constraints|10|||
161725019|NCT00751881|584036046|FG000|Core Treatment Period|Other: MS treatment change|6|||
161725020|NCT00751881|584036047|FG001|Core Treatment Period|Other: MS treatment change|4|||
161725021|NCT00751881|584036048|FG002|Core Treatment Period|Other: MS treatment change|4|||
161725022|NCT00751881|584036046|FG000|Core Treatment Period|Other: tolerability complaints|2|||
161725023|NCT00751881|584036047|FG001|Core Treatment Period|Other: tolerability complaints|0|||
161725024|NCT00751881|584036048|FG002|Core Treatment Period|Other: tolerability complaints|0|||
161725025|NCT00751881|584036046|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
161725026|NCT00751881|584036047|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
161725027|NCT00751881|584036048|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
161725028|NCT00751881|584036046|FG000|Extension Study Period|Adverse Event|18|||
161725029|NCT00751881|584036047|FG001|Extension Study Period|Adverse Event|20|||
161725030|NCT00751881|584036048|FG002|Extension Study Period|Adverse Event|21|||
161725031|NCT00751881|584036046|FG000|Extension Study Period|Lack of Efficacy|14|||
161725032|NCT00751881|584036047|FG001|Extension Study Period|Lack of Efficacy|10|||
161725033|NCT00751881|584036048|FG002|Extension Study Period|Lack of Efficacy|20|||
161725034|NCT00751881|584036046|FG000|Extension Study Period|Lost to Follow-up|4|||
161725035|NCT00751881|584036047|FG001|Extension Study Period|Lost to Follow-up|9|||
161725036|NCT00751881|584036048|FG002|Extension Study Period|Lost to Follow-up|6|||
161725037|NCT00751881|584036046|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
161725038|NCT00751881|584036047|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
161725039|NCT00751881|584036048|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
161965474|NCT01466660|584920325|FG001|Overall Study|Other reason not defined above|8|||
161965475|NCT00129701|584920326|FG000|Overall Study|Withdrawal by Subject|33|||
161965476|NCT02750345|584920327|FG000|Intervention 1|Adverse Event|0|||
161965477|NCT02750345|584920328|FG001|Intervention 1|Adverse Event|0|||
161965478|NCT02750345|584920329|FG002|Intervention 1|Adverse Event|0|||
161965479|NCT02750345|584920330|FG003|Intervention 1|Adverse Event|0|||
161965480|NCT02750345|584920331|FG004|Intervention 1|Adverse Event|1|||
161965481|NCT02750345|584920332|FG005|Intervention 1|Adverse Event|0|||
161965482|NCT00006164|584920333|FG000|Overall Study|Withdrew or lost to follow-up|70|||
161965483|NCT00006164|584920334|FG001|Overall Study|Withdrew or lost to follow-up|81|||
161965484|NCT00223808|584920335|FG000|Overall Study|<5 hrs therapy before discharge|3|||
161965485|NCT00223808|584920336|FG001|Overall Study|<5 hrs therapy before discharge|5|||
162032162|NCT01037088|585174223|FG000|Overall Study|Withdrawal by Subject|3|||
161725040|NCT00751881|584036046|FG000|Extension Study Period|Other than specified above|26|||
161725041|NCT00751881|584036047|FG001|Extension Study Period|Other than specified above|30|||
161725042|NCT00751881|584036048|FG002|Extension Study Period|Other than specified above|18|||
161725043|NCT04770155|584036049|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725044|NCT04770155|584036050|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725045|NCT04770155|584036051|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725046|NCT04770155|584036052|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725047|NCT04770155|584036053|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725048|NCT04770155|584036054|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161838091|NCT00770692|584450333|FG000|Overall Study|Withdrawal by Subject|7|||
161965486|NCT00223808|584920337|FG002|Overall Study|<5 hrs therapy before discharge|5|||
161965487|NCT00191724|584920340|FG000|Overall Study|Adverse Event|0|||
161965488|NCT00191724|584920341|FG001|Overall Study|Adverse Event|0|||
161965489|NCT00191724|584920342|FG002|Overall Study|Adverse Event|1|||
161965490|NCT00191724|584920343|FG003|Overall Study|Adverse Event|0|||
161965491|NCT00191724|584920344|FG004|Overall Study|Adverse Event|0|||
161965492|NCT00191724|584920340|FG000|Overall Study|Lost to Follow-up|1|||
161725049|NCT04770155|584036055|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725050|NCT04770155|584036056|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161725051|NCT00530712|584036066|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
161725052|NCT00530712|584036066|FG000|30 Day Follow-up Visit|Missed Visit|5|||
161725053|NCT00530712|584036066|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
161725054|NCT00530712|584036066|FG000|6 Month Follow-up Visit|Missed Visit|3|||
161725055|NCT00530712|584036066|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
161725056|NCT00530712|584036066|FG000|6 Month Follow-up Visit|Death|2|||
161725057|NCT00530712|584036066|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
161725058|NCT00530712|584036066|FG000|12 Month Follow-up Visit|Missed Visit|3|||
161725059|NCT00530712|584036066|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
161725060|NCT00530712|584036066|FG000|12 Month Follow-up Visit|Death|9|||
161725061|NCT02749370|584036069|FG000|Overall Study|Withdrawal by Subject|11|||
161725062|NCT02749370|584036069|FG000|Overall Study|Lost to Follow-up|3|||
161725063|NCT03894904|584036073|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
161725064|NCT03894904|584036074|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
161725065|NCT03894904|584036073|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
161725066|NCT03894904|584036074|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
161725067|NCT03242759|584036075|FG000|Overall Study|Adverse Event|5|||
161725068|NCT03242759|584036076|FG001|Overall Study|Adverse Event|1|||
161725069|NCT03242759|584036075|FG000|Overall Study|Withdrawal by Subject|4|||
161725070|NCT03242759|584036076|FG001|Overall Study|Withdrawal by Subject|3|||
161725071|NCT03242759|584036075|FG000|Overall Study|Lost to Follow-up|3|||
161725072|NCT03242759|584036076|FG001|Overall Study|Lost to Follow-up|1|||
161725073|NCT03242759|584036075|FG000|Overall Study|Administrative problems|1|||
161725074|NCT03242759|584036076|FG001|Overall Study|Administrative problems|1|||
161725075|NCT03242759|584036075|FG000|Overall Study|Death|22|||
161725076|NCT03242759|584036076|FG001|Overall Study|Death|0|||
161725077|NCT03242759|584036075|FG000|Overall Study|Change visit schedule|0|||
161725078|NCT03242759|584036076|FG001|Overall Study|Change visit schedule|1|||
161725079|NCT00504166|584036082|FG000|Overall Study|Adverse Event|1|||
161725080|NCT00504166|584036083|FG001|Overall Study|Adverse Event|4|||
161725081|NCT00504166|584036082|FG000|Overall Study|Withdrawal by Subject|3|||
161725082|NCT00504166|584036083|FG001|Overall Study|Withdrawal by Subject|6|||
161725083|NCT00504166|584036082|FG000|Overall Study|Physician Decision|1|||
161725084|NCT00504166|584036083|FG001|Overall Study|Physician Decision|1|||
161725085|NCT00504166|584036082|FG000|Overall Study|Lost to Follow-up|1|||
161725086|NCT00504166|584036083|FG001|Overall Study|Lost to Follow-up|3|||
161725087|NCT00651118|584036084|FG000|Overall Study|Adverse Event|4|||
161725088|NCT00651118|584036085|FG001|Overall Study|Adverse Event|0|||
161725089|NCT00651118|584036086|FG002|Overall Study|Adverse Event|1|||
161725090|NCT00651118|584036087|FG003|Overall Study|Adverse Event|1|||
161725091|NCT00651118|584036084|FG000|Overall Study|Protocol Violation|2|||
161725092|NCT00651118|584036085|FG001|Overall Study|Protocol Violation|2|||
161725093|NCT00651118|584036086|FG002|Overall Study|Protocol Violation|6|||
161725094|NCT00651118|584036087|FG003|Overall Study|Protocol Violation|2|||
161725095|NCT00651118|584036084|FG000|Overall Study|Lost to Follow-up|2|||
161725096|NCT00651118|584036085|FG001|Overall Study|Lost to Follow-up|0|||
161725097|NCT00651118|584036086|FG002|Overall Study|Lost to Follow-up|1|||
161725098|NCT00651118|584036087|FG003|Overall Study|Lost to Follow-up|2|||
161725099|NCT00651118|584036084|FG000|Overall Study|administrative|1|||
161725100|NCT00651118|584036085|FG001|Overall Study|administrative|4|||
161725101|NCT00651118|584036086|FG002|Overall Study|administrative|2|||
161725102|NCT00651118|584036087|FG003|Overall Study|administrative|1|||
161725103|NCT00651118|584036084|FG000|Overall Study|Withdrawal by Subject|0|||
161725104|NCT00651118|584036085|FG001|Overall Study|Withdrawal by Subject|1|||
161725105|NCT00651118|584036086|FG002|Overall Study|Withdrawal by Subject|1|||
161725106|NCT00651118|584036087|FG003|Overall Study|Withdrawal by Subject|1|||
161725107|NCT03117049|584036088|FG000|Overall Study|Continued the follow-up period|109|||
161725108|NCT03117049|584036089|FG001|Overall Study|Continued the follow-up period|129|||
161725109|NCT03117049|584036088|FG000|Overall Study|Died|82|||
161725110|NCT03117049|584036089|FG001|Overall Study|Died|93|||
161725111|NCT03117049|584036088|FG000|Overall Study|Consent withdrawal|7|||
161725112|NCT03117049|584036089|FG001|Overall Study|Consent withdrawal|6|||
161725113|NCT03117049|584036088|FG000|Overall Study|Missing contact|3|||
161725114|NCT03117049|584036089|FG001|Overall Study|Missing contact|3|||
161725115|NCT01096550|584036090|FG000|Overall Study|discontinued site|10|||
161725116|NCT01096550|584036091|FG001|Overall Study|discontinued site|11|||
161725117|NCT01096550|584036090|FG000|Overall Study|non-regular treatment track at clinic|1|||
161725118|NCT01096550|584036091|FG001|Overall Study|non-regular treatment track at clinic|1|||
161725119|NCT01096550|584036090|FG000|Overall Study|clinic readmission|1|||
161725120|NCT01096550|584036091|FG001|Overall Study|clinic readmission|1|||
161725121|NCT01096550|584036090|FG000|Overall Study|Withdrawal by Subject|0|||
161725122|NCT01096550|584036091|FG001|Overall Study|Withdrawal by Subject|1|||
161725123|NCT01096550|584036090|FG000|Overall Study|non-African American participant|13|||
161725124|NCT01096550|584036091|FG001|Overall Study|non-African American participant|6|||
161725125|NCT01096550|584036090|FG000|Overall Study|Lost to Follow-up|12|||
161725126|NCT01096550|584036091|FG001|Overall Study|Lost to Follow-up|9|||
161725127|NCT00839098|584036094|FG000|Overall Study|Withdrawal by Subject|2|||
161725128|NCT00839098|584036095|FG001|Overall Study|Withdrawal by Subject|1|||
161725129|NCT00839098|584036096|FG002|Overall Study|Withdrawal by Subject|7|||
161725130|NCT01345786|584036097|FG000|Overall Study|Adverse Event|0|||
161725131|NCT01345786|584036098|FG001|Overall Study|Adverse Event|1|||
161725132|NCT01345786|584036099|FG002|Overall Study|Adverse Event|3|||
161725133|NCT01345786|584036100|FG003|Overall Study|Adverse Event|1|||
161725134|NCT01345786|584036097|FG000|Overall Study|Subject withdrew consent|2|||
161725135|NCT01345786|584036098|FG001|Overall Study|Subject withdrew consent|2|||
161725136|NCT01345786|584036099|FG002|Overall Study|Subject withdrew consent|1|||
161725137|NCT01345786|584036100|FG003|Overall Study|Subject withdrew consent|0|||
161725138|NCT01345786|584036097|FG000|Overall Study|Noncompliance with protocol|1|||
161725139|NCT01345786|584036098|FG001|Overall Study|Noncompliance with protocol|0|||
161725140|NCT01345786|584036099|FG002|Overall Study|Noncompliance with protocol|1|||
161725141|NCT01345786|584036100|FG003|Overall Study|Noncompliance with protocol|0|||
161725142|NCT01345786|584036097|FG000|Overall Study|Administrative|3|||
161725143|NCT01345786|584036098|FG001|Overall Study|Administrative|5|||
161725144|NCT01345786|584036099|FG002|Overall Study|Administrative|0|||
161725145|NCT01345786|584036100|FG003|Overall Study|Administrative|0|||
161725146|NCT01345786|584036097|FG000|Overall Study|Lost to Follow-up|0|||
161725147|NCT01345786|584036098|FG001|Overall Study|Lost to Follow-up|0|||
161725148|NCT01345786|584036099|FG002|Overall Study|Lost to Follow-up|0|||
161725149|NCT01345786|584036100|FG003|Overall Study|Lost to Follow-up|2|||
161725150|NCT02190435|584036101|FG000|Overall Study|First 12 patients were lead-ins|12|||
161725151|NCT02190435|584036102|FG001|Overall Study|First 12 patients were lead-ins|0|||
161725152|NCT02190435|584036101|FG000|Overall Study|3 consented screen fails|3|||
161725153|NCT02190435|584036102|FG001|Overall Study|3 consented screen fails|0|||
161725154|NCT02399475|584036111|FG000|Overall Study|Physician Decision|1|||
161725155|NCT02399475|584036112|FG001|Overall Study|Physician Decision|0|||
161725156|NCT02260193|584036113|FG000|Overall Study|Lack of Efficacy|0|||
161725157|NCT02260193|584036114|FG001|Overall Study|Lack of Efficacy|1|||
161725158|NCT02260193|584036115|FG002|Overall Study|Lack of Efficacy|6|||
161725159|NCT02260193|584036113|FG000|Overall Study|Adverse Event|3|||
161725160|NCT02260193|584036114|FG001|Overall Study|Adverse Event|4|||
161725161|NCT02260193|584036115|FG002|Overall Study|Adverse Event|1|||
161725162|NCT02260193|584036113|FG000|Overall Study|Protocol Violation|0|||
161725163|NCT02260193|584036114|FG001|Overall Study|Protocol Violation|4|||
161725164|NCT02260193|584036115|FG002|Overall Study|Protocol Violation|0|||
161725165|NCT02260193|584036113|FG000|Overall Study|Withdrawal by Subject|3|||
161725166|NCT02260193|584036114|FG001|Overall Study|Withdrawal by Subject|0|||
161725167|NCT02260193|584036115|FG002|Overall Study|Withdrawal by Subject|2|||
161725168|NCT02260193|584036113|FG000|Overall Study|Kidney Transplantation|0|||
161725169|NCT02260193|584036114|FG001|Overall Study|Kidney Transplantation|0|||
161725170|NCT02260193|584036115|FG002|Overall Study|Kidney Transplantation|1|||
161725171|NCT01963117|584036116|FG000|Overall Study|Death|1|||
161725172|NCT01070784|584036117|FG000|Overall Study|Withdrawal by Subject|6|||
161725173|NCT01070784|584036118|FG001|Overall Study|Withdrawal by Subject|9|||
161725174|NCT01070784|584036117|FG000|Overall Study|Adverse Event|14|||
161725175|NCT01070784|584036118|FG001|Overall Study|Adverse Event|9|||
161725176|NCT01780389|584036119|FG000|Overall Study|Adverse Event|1|||
161725177|NCT00935220|584036120|FG000|Overall Study|Adverse Event|1|||
161725178|NCT00935220|584036120|FG000|Overall Study|Other reason (not specified)|1|||
161725179|NCT01095250|584036121|FG000|Overall Study|administrative reasons|8|||
161725180|NCT01095250|584036122|FG001|Overall Study|administrative reasons|10|||
161725181|NCT01095250|584036123|FG002|Overall Study|administrative reasons|7|||
161725182|NCT01095250|584036124|FG003|Overall Study|administrative reasons|5|||
161725183|NCT01095250|584036121|FG000|Overall Study|Withdrawal by Subject|0|||
161725184|NCT01095250|584036122|FG001|Overall Study|Withdrawal by Subject|0|||
161725185|NCT01095250|584036123|FG002|Overall Study|Withdrawal by Subject|1|||
161725186|NCT01095250|584036124|FG003|Overall Study|Withdrawal by Subject|0|||
161725187|NCT01000064|584036125|FG000|Overall Study|Withdrawal by Subject|1|||
161725188|NCT01000064|584036126|FG001|Overall Study|Withdrawal by Subject|1|||
161725189|NCT02518620|584036127|FG000|Overall Study|Adverse Event|23|||
161965493|NCT00191724|584920341|FG001|Overall Study|Lost to Follow-up|1|||
161965494|NCT00191724|584920342|FG002|Overall Study|Lost to Follow-up|0|||
161725190|NCT02518620|584036128|FG001|Overall Study|Adverse Event|11|||
161725191|NCT02518620|584036127|FG000|Overall Study|Lack of Efficacy|2|||
161725192|NCT02518620|584036128|FG001|Overall Study|Lack of Efficacy|0|||
161725193|NCT02518620|584036127|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161725194|NCT02518620|584036128|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161965495|NCT00191724|584920343|FG003|Overall Study|Lost to Follow-up|2|||
161725195|NCT02518620|584036127|FG000|Overall Study|Physician Decision|1|||
161965496|NCT00191724|584920344|FG004|Overall Study|Lost to Follow-up|3|||
161965497|NCT00191724|584920340|FG000|Overall Study|Withdrawal by Subject|0|||
161725196|NCT02518620|584036128|FG001|Overall Study|Physician Decision|1|||
161725197|NCT02518620|584036127|FG000|Overall Study|Sponsor's Decision|0|||
161725198|NCT02518620|584036128|FG001|Overall Study|Sponsor's Decision|3|||
161725199|NCT02518620|584036127|FG000|Overall Study|Lost to Follow-up|1|||
161725200|NCT02518620|584036128|FG001|Overall Study|Lost to Follow-up|1|||
161725201|NCT02518620|584036127|FG000|Overall Study|Withdrawal by Subject|17|||
161725202|NCT02518620|584036128|FG001|Overall Study|Withdrawal by Subject|9|||
161725203|NCT02518620|584036127|FG000|Overall Study|Death|1|||
161725204|NCT02518620|584036128|FG001|Overall Study|Death|0|||
161725205|NCT02518620|584036127|FG000|Overall Study|Pregnancy Wish|3|||
161725206|NCT02518620|584036128|FG001|Overall Study|Pregnancy Wish|0|||
161725207|NCT02518620|584036127|FG000|Overall Study|Pregnancy|1|||
161725208|NCT02518620|584036128|FG001|Overall Study|Pregnancy|0|||
161725209|NCT02518620|584036127|FG000|Overall Study|Relocation|2|||
161725210|NCT02518620|584036128|FG001|Overall Study|Relocation|1|||
161725211|NCT03844633|584036132|FG000|1 Week FU|Lost to Follow-up|0|||
161725212|NCT03844633|584036133|FG001|1 Week FU|Lost to Follow-up|1|||
161725213|NCT03844633|584036134|FG002|1 Week FU|Lost to Follow-up|4|||
161725214|NCT03844633|584036132|FG000|12-month Follow-up|Lost to Follow-up|7|||
161725215|NCT03844633|584036133|FG001|12-month Follow-up|Lost to Follow-up|5|||
161725216|NCT03844633|584036134|FG002|12-month Follow-up|Lost to Follow-up|8|||
161725217|NCT02588248|584036139|FG000|Overall Study|Physician Decision|4|||
161725218|NCT02588248|584036140|FG001|Overall Study|Physician Decision|3|||
161725219|NCT01355068|584036141|FG000|First Intervention Period|Adverse Event|0|||
161725220|NCT01355068|584036142|FG001|First Intervention Period|Adverse Event|1|||
161725221|NCT01355068|584036141|FG000|First Intervention Period|Withdrawal by Subject|0|||
161725222|NCT01355068|584036142|FG001|First Intervention Period|Withdrawal by Subject|1|||
161725223|NCT00336492|584036145|FG000|Overall Study|Adverse Event|4|||
161725224|NCT00336492|584036146|FG001|Overall Study|Adverse Event|3|||
161725225|NCT00336492|584036147|FG002|Overall Study|Adverse Event|6|||
161725226|NCT00336492|584036145|FG000|Overall Study|Lack of Efficacy|6|||
161725227|NCT00336492|584036146|FG001|Overall Study|Lack of Efficacy|1|||
161725228|NCT00336492|584036147|FG002|Overall Study|Lack of Efficacy|4|||
161725229|NCT00336492|584036145|FG000|Overall Study|Other|5|||
161725230|NCT00336492|584036146|FG001|Overall Study|Other|0|||
161725231|NCT00336492|584036147|FG002|Overall Study|Other|1|||
161725232|NCT04229446|584036148|FG000|Overall Study|Death|12|||
161725233|NCT04229446|584036149|FG001|Overall Study|Death|10|||
161725234|NCT04229446|584036148|FG000|Overall Study|Lost to Follow-up|5|||
161725235|NCT04229446|584036149|FG001|Overall Study|Lost to Follow-up|8|||
161725236|NCT04191967|584037695|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
161725237|NCT04191967|584037695|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
161725238|NCT00953043|584037699|FG000|Overall Study|Withdrawal by Subject|4|||
161725239|NCT00953043|584037700|FG001|Overall Study|Withdrawal by Subject|0|||
161725240|NCT00953043|584037699|FG000|Overall Study|Physician Decision|0|||
161725241|NCT00953043|584037700|FG001|Overall Study|Physician Decision|2|||
161725242|NCT02322892|584037702|FG000|Overall Study|Surgery cancelled|1|||
161725243|NCT02322892|584037703|FG001|Overall Study|Surgery cancelled|2|||
161725244|NCT02322892|584037702|FG000|Overall Study|Met exclusion criteria|0|||
161725245|NCT02322892|584037703|FG001|Overall Study|Met exclusion criteria|1|||
161725246|NCT02322892|584037702|FG000|Overall Study|Protocol Violation|1|||
161725247|NCT02322892|584037703|FG001|Overall Study|Protocol Violation|0|||
161725248|NCT00747617|584037704|FG000|Overall Study|Lost to Follow-up|3|||
161725249|NCT00747617|584037705|FG001|Overall Study|Lost to Follow-up|1|||
161725250|NCT03509207|584037706|FG000|Overall Study|Death|2|||
161725251|NCT02125331|584037707|FG000|Overall Study|Protocol Violation|1|||
161725252|NCT02125331|584037708|FG001|Overall Study|Protocol Violation|0|||
161725253|NCT02125331|584037707|FG000|Overall Study|technical problem|2|||
161725254|NCT02125331|584037708|FG001|Overall Study|technical problem|0|||
161725255|NCT02125331|584037707|FG000|Overall Study|screen failure|2|||
161725256|NCT02125331|584037708|FG001|Overall Study|screen failure|0|||
161725257|NCT01432262|584037709|FG000|Overall Study|Withdrawal by Subject|2|||
161725258|NCT01432262|584037710|FG001|Overall Study|Withdrawal by Subject|1|||
161725259|NCT00165646|584037711|FG000|Overall Study|Adverse Event|1|||
161725260|NCT00165646|584037712|FG001|Overall Study|Adverse Event|1|||
161725261|NCT00165646|584037713|FG002|Overall Study|Adverse Event|1|||
161725262|NCT00165646|584037711|FG000|Overall Study|Lack of Efficacy|1|||
161725263|NCT00165646|584037712|FG001|Overall Study|Lack of Efficacy|2|||
161725264|NCT00165646|584037713|FG002|Overall Study|Lack of Efficacy|0|||
161725265|NCT00165646|584037711|FG000|Overall Study|Withdrawal by Subject|0|||
161725266|NCT00165646|584037712|FG001|Overall Study|Withdrawal by Subject|2|||
161725267|NCT00165646|584037713|FG002|Overall Study|Withdrawal by Subject|1|||
161725268|NCT00165646|584037711|FG000|Overall Study|Physician Decision|2|||
161725269|NCT00165646|584037712|FG001|Overall Study|Physician Decision|0|||
161725270|NCT00165646|584037713|FG002|Overall Study|Physician Decision|2|||
161725271|NCT00165646|584037711|FG000|Overall Study|Protocol Violation|1|||
161725272|NCT00165646|584037712|FG001|Overall Study|Protocol Violation|0|||
161725273|NCT00165646|584037713|FG002|Overall Study|Protocol Violation|0|||
161725274|NCT04657016|584037714|FG000|Overall Study|Adverse Event|2|||
161725275|NCT04657016|584037715|FG001|Overall Study|Adverse Event|4|||
161725276|NCT04657016|584037714|FG000|Overall Study|Death|1|||
161725277|NCT04657016|584037715|FG001|Overall Study|Death|1|||
161725278|NCT04657016|584037714|FG000|Overall Study|Lost to Follow-up|24|||
161725279|NCT04657016|584037715|FG001|Overall Study|Lost to Follow-up|12|||
161725280|NCT04657016|584037714|FG000|Overall Study|Physician Decision|1|||
161725281|NCT04657016|584037715|FG001|Overall Study|Physician Decision|2|||
161725282|NCT04657016|584037714|FG000|Overall Study|Pregnancy|2|||
161725283|NCT04657016|584037715|FG001|Overall Study|Pregnancy|2|||
161725284|NCT04657016|584037714|FG000|Overall Study|Protocol Deviation|1|||
161725285|NCT04657016|584037715|FG001|Overall Study|Protocol Deviation|0|||
161725286|NCT04657016|584037714|FG000|Overall Study|Withdrawal by Subject|28|||
161725287|NCT04657016|584037715|FG001|Overall Study|Withdrawal by Subject|14|||
161725288|NCT04657016|584037714|FG000|Overall Study|Other - as reported by the investigator|6|||
161725289|NCT04657016|584037715|FG001|Overall Study|Other - as reported by the investigator|0|||
161725290|NCT01104558|584037718|FG000|Overall Study|Protocol Violation|6|||
161725291|NCT01104558|584037718|FG000|Overall Study|Missing of primary efficacy assessment|10|||
161725292|NCT01104558|584037718|FG000|Overall Study|Missing of genetic analysis results|1|||
161725293|NCT00523341|584037722|FG000|Overall Study|Withdrawal by Subject|399|||
161725294|NCT00523341|584037723|FG001|Overall Study|Withdrawal by Subject|427|||
161725295|NCT00523341|584037722|FG000|Overall Study|Other|181|||
161725296|NCT00523341|584037723|FG001|Overall Study|Other|198|||
161725297|NCT00523341|584037722|FG000|Overall Study|Adverse Event|122|||
161725298|NCT00523341|584037723|FG001|Overall Study|Adverse Event|155|||
161725299|NCT00523341|584037722|FG000|Overall Study|Death|101|||
161725300|NCT00523341|584037723|FG001|Overall Study|Death|110|||
161725301|NCT00523341|584037722|FG000|Overall Study|Lost to Follow-up|73|||
161725302|NCT00523341|584037723|FG001|Overall Study|Lost to Follow-up|61|||
161725303|NCT00523341|584037722|FG000|Overall Study|Non-compliance|20|||
161725304|NCT00523341|584037723|FG001|Overall Study|Non-compliance|13|||
161725305|NCT00523341|584037722|FG000|Overall Study|Physician Decision|14|||
161725306|NCT00523341|584037723|FG001|Overall Study|Physician Decision|13|||
161725307|NCT00523341|584037722|FG000|Overall Study|Requirement for Alternative Therapy|4|||
161725308|NCT00523341|584037723|FG001|Overall Study|Requirement for Alternative Therapy|14|||
161725309|NCT00523341|584037722|FG000|Overall Study|Protocol Deviation|6|||
161725310|NCT00523341|584037723|FG001|Overall Study|Protocol Deviation|5|||
161725311|NCT00523341|584037722|FG000|Overall Study|Ineligibility Determined|3|||
161725312|NCT00523341|584037723|FG001|Overall Study|Ineligibility Determined|4|||
161725313|NCT00523341|584037722|FG000|Overall Study|Disease Progression|1|||
161725314|NCT00523341|584037723|FG001|Overall Study|Disease Progression|0|||
161725315|NCT02601001|584037724|FG000|Dosing Period 2|Adverse Event|0|||
161725316|NCT02601001|584037725|FG001|Dosing Period 2|Adverse Event|0|||
161725317|NCT02601001|584037726|FG002|Dosing Period 2|Adverse Event|0|||
161725318|NCT02601001|584037727|FG003|Dosing Period 2|Adverse Event|0|||
161725319|NCT02601001|584037728|FG004|Dosing Period 2|Adverse Event|0|||
161725320|NCT02601001|584037729|FG005|Dosing Period 2|Adverse Event|0|||
161725321|NCT02601001|584037730|FG006|Dosing Period 2|Adverse Event|1|||
161725322|NCT01790438|584037731|FG000|Overall Study|Adverse Event|3|||
161725323|NCT01790438|584037732|FG001|Overall Study|Adverse Event|2|||
161725324|NCT01790438|584037731|FG000|Overall Study|Death|4|||
161725325|NCT01790438|584037732|FG001|Overall Study|Death|0|||
161725326|NCT01790438|584037731|FG000|Overall Study|Lost to Follow-up|5|||
161725327|NCT01790438|584037732|FG001|Overall Study|Lost to Follow-up|2|||
161725328|NCT01790438|584037731|FG000|Overall Study|Withdrawal by Subject|13|||
161725329|NCT01790438|584037732|FG001|Overall Study|Withdrawal by Subject|2|||
161725330|NCT01790438|584037731|FG000|Overall Study|Physician Decision|3|||
161725331|NCT01790438|584037732|FG001|Overall Study|Physician Decision|1|||
161725332|NCT01790438|584037731|FG000|Overall Study|Sponsor Decision|0|||
161725333|NCT01790438|584037732|FG001|Overall Study|Sponsor Decision|3|||
161725334|NCT01790438|584037731|FG000|Overall Study|Protocol Required Discontinuation|7|||
161725335|NCT01790438|584037732|FG001|Overall Study|Protocol Required Discontinuation|1|||
161725336|NCT01356602|584037735|FG000|Overall Study|Protocol Deviation|0|||
161725337|NCT01356602|584037736|FG001|Overall Study|Protocol Deviation|1|||
161725338|NCT01356602|584037737|FG002|Overall Study|Protocol Deviation|1|||
161725339|NCT01356602|584037735|FG000|Overall Study|Administrative Problems|1|||
161725340|NCT01356602|584037736|FG001|Overall Study|Administrative Problems|4|||
162032163|NCT00815516|585175409|FG000|Overall Study|Death|3|||
161725341|NCT01356602|584037737|FG002|Overall Study|Administrative Problems|5|||
161725342|NCT01356602|584037735|FG000|Overall Study|Lost to Follow-up|4|||
161725343|NCT01356602|584037736|FG001|Overall Study|Lost to Follow-up|5|||
161725344|NCT01356602|584037737|FG002|Overall Study|Lost to Follow-up|6|||
161725345|NCT01356602|584037735|FG000|Overall Study|Withdrawal by Subject|4|||
161725346|NCT01356602|584037736|FG001|Overall Study|Withdrawal by Subject|3|||
161725347|NCT01356602|584037737|FG002|Overall Study|Withdrawal by Subject|7|||
161725348|NCT01356602|584037735|FG000|Overall Study|Lack of Efficacy|0|||
161725349|NCT01356602|584037736|FG001|Overall Study|Lack of Efficacy|1|||
161725350|NCT01356602|584037737|FG002|Overall Study|Lack of Efficacy|4|||
161725351|NCT01356602|584037735|FG000|Overall Study|Adverse Event|0|||
162032164|NCT00815516|585175410|FG001|Overall Study|Death|1|||
162032165|NCT00815516|585175409|FG000|Overall Study|Physician Decision|1|||
161725352|NCT01356602|584037736|FG001|Overall Study|Adverse Event|1|||
161725353|NCT01356602|584037737|FG002|Overall Study|Adverse Event|1|||
161725354|NCT03123354|584037738|FG000|Overall Study|Physician Decision|6|||
161725355|NCT01931462|584037739|FG000|Overall Study|Withdrawal by Subject|1|||
161725356|NCT04907539|584037740|FG000|Overall Study|Consent withdrawn|1|||
161725357|NCT04907539|584037741|FG001|Overall Study|Consent withdrawn|0|||
161725358|NCT04907539|584037740|FG000|Overall Study|Death|14|||
161725359|NCT04907539|584037741|FG001|Overall Study|Death|3|||
161725360|NCT01701583|584037742|FG000|Overall Study|Withdrawal by Subject|2|||
161725361|NCT01701583|584037743|FG001|Overall Study|Withdrawal by Subject|0|||
161725362|NCT05070429|584037749|FG000|Overall Study|Death|0|||
161725363|NCT05070429|584037750|FG001|Overall Study|Death|4|||
161725364|NCT05070429|584037749|FG000|Overall Study|Withdrawal by Subject|2|||
161725365|NCT05070429|584037750|FG001|Overall Study|Withdrawal by Subject|1|||
161725366|NCT05070429|584037749|FG000|Overall Study|Other|15|||
161725367|NCT05070429|584037750|FG001|Overall Study|Other|5|||
161725368|NCT03041116|584037751|FG000|Double-blind|Death|0|||
161725369|NCT03041116|584037752|FG001|Double-blind|Death|2|||
161725370|NCT03041116|584037751|FG000|Double-blind|Withdrawal by Subject|0|||
161725371|NCT03041116|584037752|FG001|Double-blind|Withdrawal by Subject|4|||
161725372|NCT03041116|584037751|FG000|Open-label|Death|1|||
161725373|NCT03041116|584037752|FG001|Open-label|Death|0|||
161725374|NCT03041116|584037751|FG000|Open-label|Termination of the study by Sponsor|39|||
161725375|NCT03041116|584037752|FG001|Open-label|Termination of the study by Sponsor|37|||
161725376|NCT03041116|584037751|FG000|Open-label|Withdrawal by Subject|1|||
161725377|NCT03041116|584037752|FG001|Open-label|Withdrawal by Subject|0|||
161725378|NCT01345123|584037753|FG000|Overall Study|participants no longer with health plan|79|||
161725379|NCT01345123|584037754|FG001|Overall Study|participants no longer with health plan|85|||
161725380|NCT01345123|584037755|FG002|Overall Study|participants no longer with health plan|88|||
161725381|NCT01798134|584037756|FG000|Overall Study|Lost to Follow-up|1|||
161725382|NCT01798134|584037756|FG000|Overall Study|Withdrawal by Subject|3|||
161725383|NCT01798134|584037756|FG000|Overall Study|Death|2|||
161725384|NCT01798134|584037756|FG000|Overall Study|Adverse Event|3|||
161725385|NCT01798134|584037756|FG000|Overall Study|Physician Decision|3|||
161725386|NCT01798134|584037756|FG000|Overall Study|Liver transplant/surgery|4|||
161725387|NCT02653976|584037757|FG000|Overall Study|Withdrawal by Subject|5|||
161725388|NCT02653976|584037757|FG000|Overall Study|Death|4|||
161725389|NCT02436577|584037758|FG000|Overall Study|Protocol Deviation|0|||
161725390|NCT02436577|584037759|FG001|Overall Study|Protocol Deviation|1|||
161725391|NCT02436577|584037760|FG002|Overall Study|Protocol Deviation|0|||
161725392|NCT02436577|584037761|FG003|Overall Study|Protocol Deviation|0|||
161725393|NCT02436577|584037762|FG004|Overall Study|Protocol Deviation|0|||
161725394|NCT02436577|584037763|FG005|Overall Study|Protocol Deviation|0|||
161725395|NCT01675011|584037764|FG000|Overall Study|Trial terminated by Sponsor|3|||
161725396|NCT01675011|584037765|FG001|Overall Study|Trial terminated by Sponsor|1|||
161725397|NCT00615290|584037766|FG000|Overall Study|Adverse Event|2|||
161725398|NCT00615290|584037766|FG000|Overall Study|Lost to Follow-up|3|||
161725399|NCT00615290|584037766|FG000|Overall Study|Withdrawal by Subject|1|||
161725400|NCT00615290|584037766|FG000|Overall Study|Other|2|||
161725401|NCT00366548|584037767|FG000|Infant Series|Adverse Event|1|||
161725402|NCT00366548|584037768|FG001|Infant Series|Adverse Event|3|||
161725403|NCT00366548|584037767|FG000|Infant Series|Protocol Violation|0|||
161725404|NCT00366548|584037768|FG001|Infant Series|Protocol Violation|1|||
161725405|NCT00366548|584037767|FG000|Infant Series|Withdrawal by Subject|3|||
161725406|NCT00366548|584037768|FG001|Infant Series|Withdrawal by Subject|1|||
161725407|NCT00366548|584037767|FG000|After Infant Series|Withdrawal by Subject|3|||
161725408|NCT00366548|584037768|FG001|After Infant Series|Withdrawal by Subject|1|||
161725409|NCT00366548|584037767|FG000|After Infant Series|Adverse Event|2|||
161725410|NCT00366548|584037768|FG001|After Infant Series|Adverse Event|0|||
161725411|NCT00366548|584037767|FG000|After Infant Series|Lost to Follow-up|1|||
161725412|NCT00366548|584037768|FG001|After Infant Series|Lost to Follow-up|0|||
161725413|NCT02849990|584037769|FG000|Overall Study|Adverse Event|1|||
161725414|NCT02849990|584037769|FG000|Overall Study|Withdrawal by Subject|1|||
161725415|NCT01252134|584037770|FG000|Period 1, 8 Hours|Personal Reasons|0|||
161725416|NCT01252134|584037771|FG001|Period 1, 8 Hours|Personal Reasons|1|||
161725417|NCT01252134|584037772|FG002|Period 1, 8 Hours|Personal Reasons|1|||
161725418|NCT01252134|584037773|FG003|Period 1, 8 Hours|Personal Reasons|0|||
161725419|NCT01252134|584037774|FG004|Period 1, 8 Hours|Personal Reasons|0|||
161725420|NCT01252134|584037775|FG005|Period 1, 8 Hours|Personal Reasons|0|||
161725421|NCT03650452|584037776|FG000|Overall Study|Physician Decision|1|||
161725422|NCT03650452|584037777|FG001|Overall Study|Physician Decision|0|||
161725423|NCT03650452|584037776|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
161725424|NCT03650452|584037777|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161725425|NCT03650452|584037776|FG000|Overall Study|Adverse Event|3|||
161725426|NCT03650452|584037777|FG001|Overall Study|Adverse Event|4|||
161725427|NCT03650452|584037776|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
161725428|NCT03650452|584037777|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
161725429|NCT02678741|584037779|FG000|Overall Study|Death|4|||
162032166|NCT00815516|585175410|FG001|Overall Study|Physician Decision|0|||
161725430|NCT02678741|584037779|FG000|Overall Study|Withdrawal by Subject|1|||
161725431|NCT02678741|584037779|FG000|Overall Study|ineligible|3|||
161725432|NCT02678741|584037779|FG000|Overall Study|Not RECIST Measurable|2|||
161725433|NCT02678741|584037779|FG000|Overall Study|Lack of Efficacy|10|||
161725434|NCT01795898|584037780|FG000|Overall Study|Adverse Event|27|||
161725435|NCT01795898|584037780|FG000|Overall Study|Lost to Follow-up|20|||
161725436|NCT01795898|584037780|FG000|Overall Study|Withdrawal of consent|6|||
161725437|NCT01795898|584037780|FG000|Overall Study|Diagnosed with metastasis|1|||
161725438|NCT01795898|584037780|FG000|Overall Study|No pain|1|||
161725439|NCT01795898|584037780|FG000|Overall Study|Death|1|||
161725440|NCT01795898|584037780|FG000|Overall Study|Withdrew consent & had adverse events|3|||
161725441|NCT01795898|584037780|FG000|Overall Study|Physician Decision|1|||
161725442|NCT00390780|584037795|FG000|Overall Study|Not completed|10|||
161725443|NCT00390780|584037796|FG001|Overall Study|Not completed|4|||
161725444|NCT00390780|584037795|FG000|Overall Study|Protocol Violation|6|||
161725445|NCT00390780|584037796|FG001|Overall Study|Protocol Violation|4|||
161725446|NCT00390780|584037795|FG000|Overall Study|Lost to Follow-up|3|||
161725447|NCT00390780|584037796|FG001|Overall Study|Lost to Follow-up|6|||
161725448|NCT00390780|584037795|FG000|Overall Study|Adverse Event|2|||
161725449|NCT00390780|584037796|FG001|Overall Study|Adverse Event|3|||
161725450|NCT00390780|584037795|FG000|Overall Study|Death|1|||
161725451|NCT00390780|584037796|FG001|Overall Study|Death|3|||
161725452|NCT00390780|584037795|FG000|Overall Study|Withdrawal by Subject|1|||
161725453|NCT00390780|584037796|FG001|Overall Study|Withdrawal by Subject|2|||
161725454|NCT00390780|584037795|FG000|Overall Study|Inclusion criteria not satisfied|0|||
161725455|NCT00390780|584037796|FG001|Overall Study|Inclusion criteria not satisfied|2|||
161725456|NCT00390780|584037795|FG000|Overall Study|Lost to follow up and other reasons|0|||
161725457|NCT00390780|584037796|FG001|Overall Study|Lost to follow up and other reasons|1|||
161725458|NCT00390780|584037795|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
161725459|NCT00390780|584037796|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
161725460|NCT00390780|584037795|FG000|Overall Study|SAE, death|0|||
161725461|NCT00390780|584037796|FG001|Overall Study|SAE, death|1|||
161725462|NCT00305006|584037797|FG000|Overall Study|Withdrawal by Subject|1|||
161725463|NCT00305006|584037798|FG001|Overall Study|Withdrawal by Subject|0|||
161725464|NCT00305006|584037797|FG000|Overall Study|Failure to complete pretest|0|||
161725465|NCT00305006|584037798|FG001|Overall Study|Failure to complete pretest|1|||
161725466|NCT01996319|584037799|FG000|Overall Study|Protocol Violation|1|||
161725467|NCT01996319|584037800|FG001|Overall Study|Protocol Violation|0|||
161725468|NCT01996319|584037799|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
161725469|NCT01996319|584037800|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
161725470|NCT01996319|584037799|FG000|Overall Study|Adverse Event|2|||
161725471|NCT01996319|584037800|FG001|Overall Study|Adverse Event|2|||
161725472|NCT01671085|584037802|FG000|Overall Study|Withdrawal by Subject|1|||
161725473|NCT01671085|584037803|FG001|Overall Study|Withdrawal by Subject|0|||
161725474|NCT00637273|584037804|FG000|Overall Study|Adverse Event|11|||
161725475|NCT00637273|584037805|FG001|Overall Study|Adverse Event|5|||
161725476|NCT00637273|584037806|FG002|Overall Study|Adverse Event|7|||
161725477|NCT00637273|584037804|FG000|Overall Study|Lost to Follow-up|8|||
161725478|NCT00637273|584037805|FG001|Overall Study|Lost to Follow-up|9|||
161725479|NCT00637273|584037806|FG002|Overall Study|Lost to Follow-up|13|||
161725480|NCT00637273|584037804|FG000|Overall Study|Protocol Violation|2|||
161725481|NCT00637273|584037805|FG001|Overall Study|Protocol Violation|4|||
161725482|NCT00637273|584037806|FG002|Overall Study|Protocol Violation|1|||
161725483|NCT00637273|584037804|FG000|Overall Study|Withdrawal of Consent|18|||
161725484|NCT00637273|584037805|FG001|Overall Study|Withdrawal of Consent|6|||
161725485|NCT00637273|584037806|FG002|Overall Study|Withdrawal of Consent|18|||
161725486|NCT00637273|584037804|FG000|Overall Study|Investigator Decision|1|||
161725487|NCT00637273|584037805|FG001|Overall Study|Investigator Decision|3|||
161725488|NCT00637273|584037806|FG002|Overall Study|Investigator Decision|1|||
161725489|NCT00637273|584037804|FG000|Overall Study|Administrative|2|||
161725490|NCT00637273|584037805|FG001|Overall Study|Administrative|0|||
161725491|NCT00637273|584037806|FG002|Overall Study|Administrative|0|||
161725492|NCT00637273|584037804|FG000|Overall Study|Loss of Glucose Control|1|||
161725493|NCT00637273|584037805|FG001|Overall Study|Loss of Glucose Control|1|||
161725494|NCT00637273|584037806|FG002|Overall Study|Loss of Glucose Control|1|||
161725495|NCT01595646|584037807|FG000|Overall Study|Withdrawal by Subject|1|||
161725496|NCT01595646|584037808|FG001|Overall Study|Withdrawal by Subject|0|||
161725497|NCT01595646|584037809|FG002|Overall Study|Withdrawal by Subject|0|||
161725498|NCT01161524|584037811|FG000|Core Study (23 Weeks)|Adverse Event|3|||
161725499|NCT01161524|584037812|FG001|Core Study (23 Weeks)|Adverse Event|0|||
161725500|NCT01161524|584037813|FG002|Core Study (23 Weeks)|Adverse Event|0|||
161725501|NCT01161524|584037811|FG000|Core Study (23 Weeks)|Other|1|||
161725502|NCT01161524|584037812|FG001|Core Study (23 Weeks)|Other|0|||
161725503|NCT01161524|584037813|FG002|Core Study (23 Weeks)|Other|0|||
161725504|NCT01161524|584037811|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
161725505|NCT01161524|584037812|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
161725506|NCT01161524|584037813|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
161725507|NCT01161524|584037811|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
161725508|NCT01161524|584037812|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
161725509|NCT01161524|584037813|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
161725510|NCT01161524|584037811|FG000|Core Study (23 Weeks)|Subject Choice|3|||
161725511|NCT01161524|584037812|FG001|Core Study (23 Weeks)|Subject Choice|2|||
161725512|NCT01161524|584037813|FG002|Core Study (23 Weeks)|Subject Choice|0|||
161725513|NCT01161524|584037811|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
161725514|NCT01161524|584037812|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
161725515|NCT01161524|584037813|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
161725516|NCT01161524|584037811|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
161725517|NCT01161524|584037812|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
161725518|NCT01161524|584037813|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
161725519|NCT01161524|584037811|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
161725520|NCT01161524|584037812|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
161725521|NCT01161524|584037813|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
161725522|NCT01161524|584037811|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
161725523|NCT01161524|584037812|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
161725524|NCT01161524|584037813|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
161725525|NCT01161524|584037811|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
161725526|NCT01161524|584037812|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
161725527|NCT01161524|584037813|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
161725528|NCT01632878|584037815|FG000|Screening|Physician Decision|268|||
161725529|NCT01632878|584037815|FG000|Treatment|Lost to Follow-up|41|||
161725530|NCT01632878|584037815|FG000|Treatment|Withdrawal by Subject|36|||
161725531|NCT01632878|584037815|FG000|Treatment|Physician Decision|34|||
161725532|NCT01632878|584037815|FG000|Treatment|missing information|4|||
161725533|NCT01632878|584037815|FG000|Treatment|no information on study completion|43|||
161725534|NCT02698423|584037816|FG000|Overall Study|Lost to Follow-up|19|||
161725535|NCT02698423|584037817|FG001|Overall Study|Lost to Follow-up|24|||
161725536|NCT01765764|584037818|FG000|Treatment Period|Adverse Event|1|||
161725537|NCT01765764|584037819|FG001|Treatment Period|Adverse Event|2|||
161725538|NCT01765764|584037820|FG002|Treatment Period|Adverse Event|1|||
161725539|NCT01765764|584037818|FG000|Treatment Period|Lost to Follow-up|0|||
161725540|NCT01765764|584037819|FG001|Treatment Period|Lost to Follow-up|3|||
161725541|NCT01765764|584037820|FG002|Treatment Period|Lost to Follow-up|2|||
161725542|NCT01765764|584037818|FG000|Treatment Period|Personal Reasons|1|||
161725543|NCT01765764|584037819|FG001|Treatment Period|Personal Reasons|2|||
161725544|NCT01765764|584037820|FG002|Treatment Period|Personal Reasons|1|||
161725545|NCT01765764|584037818|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
161725546|NCT01765764|584037819|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
161725547|NCT01765764|584037820|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
161725548|NCT00064662|584037823|FG000|Overall Study|Death|1|||
161725549|NCT00064662|584037824|FG001|Overall Study|Death|1|||
161725550|NCT00064662|584037823|FG000|Overall Study|Lost to Follow-up|57|||
161725551|NCT00064662|584037824|FG001|Overall Study|Lost to Follow-up|44|||
161725552|NCT00064662|584037823|FG000|Overall Study|Withdrawal by Subject|14|||
161725553|NCT00064662|584037824|FG001|Overall Study|Withdrawal by Subject|14|||
161725554|NCT00064662|584037823|FG000|Overall Study|Administratively withdrawn|2|||
161725555|NCT00064662|584037824|FG001|Overall Study|Administratively withdrawn|2|||
161725556|NCT01555463|584037829|FG000|Treatment|Adverse Event|6|||
161725557|NCT01555463|584037830|FG001|Treatment|Adverse Event|12|||
161725558|NCT01555463|584037829|FG000|Treatment|Withdrawal by Subject|24|||
161725559|NCT01555463|584037830|FG001|Treatment|Withdrawal by Subject|36|||
161725560|NCT01555463|584037829|FG000|Treatment|Lost to Follow-up|28|||
161725561|NCT01555463|584037830|FG001|Treatment|Lost to Follow-up|23|||
161725562|NCT01555463|584037829|FG000|Treatment|Protocol Violation|4|||
161725563|NCT01555463|584037830|FG001|Treatment|Protocol Violation|5|||
161725564|NCT01555463|584037829|FG000|Treatment|Other reason|2|||
161725565|NCT01555463|584037830|FG001|Treatment|Other reason|3|||
161725566|NCT01555463|584037829|FG000|Follow up|Adverse Event|2|||
161725567|NCT01555463|584037830|FG001|Follow up|Adverse Event|5|||
161725568|NCT01555463|584037829|FG000|Follow up|Death|0|||
161725569|NCT01555463|584037830|FG001|Follow up|Death|1|||
161725570|NCT01555463|584037829|FG000|Follow up|Withdrawal by Subject|22|||
161725571|NCT01555463|584037830|FG001|Follow up|Withdrawal by Subject|22|||
161725572|NCT01555463|584037829|FG000|Follow up|Lost to Follow-up|9|||
161725573|NCT01555463|584037830|FG001|Follow up|Lost to Follow-up|10|||
161725574|NCT01555463|584037829|FG000|Follow up|Protocol Violation|2|||
161725575|NCT01555463|584037830|FG001|Follow up|Protocol Violation|4|||
161725576|NCT01555463|584037829|FG000|Follow up|Other reason|3|||
161725577|NCT01555463|584037830|FG001|Follow up|Other reason|3|||
161725578|NCT01165203|584037833|FG000|Active Phase|Serious Adverse Event|1|||
161725579|NCT01165203|584037834|FG001|Active Phase|Serious Adverse Event|0|||
161725580|NCT01165203|584037833|FG000|Active Phase|Withdrawal by Subject|2|||
161725581|NCT01165203|584037834|FG001|Active Phase|Withdrawal by Subject|1|||
161725582|NCT01165203|584037833|FG000|Active Phase|Migrated/moved from study area|0|||
161725583|NCT01165203|584037834|FG001|Active Phase|Migrated/moved from study area|1|||
161725584|NCT01165203|584037833|FG000|Active Phase|Lost to Follow-up|2|||
161725585|NCT01165203|584037834|FG001|Active Phase|Lost to Follow-up|0|||
161725586|NCT01165203|584037833|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
161725587|NCT01165203|584037834|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
161725588|NCT01165203|584037833|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
161725589|NCT01165203|584037834|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
161725590|NCT01165203|584037833|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
161725591|NCT01165203|584037834|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
161725592|NCT01165203|584037833|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
161725593|NCT01165203|584037834|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
161725594|NCT01165203|584037833|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
161725595|NCT01165203|584037834|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
161725596|NCT01323673|584037836|FG000|Overall Study|Adverse Event|0|||
161725597|NCT01323673|584037837|FG001|Overall Study|Adverse Event|1|||
161725598|NCT01323673|584037836|FG000|Overall Study|Lost to Follow-up|0|||
161725599|NCT01323673|584037837|FG001|Overall Study|Lost to Follow-up|1|||
161725600|NCT01323673|584037836|FG000|Overall Study|Protocol Violation|1|||
161725601|NCT01323673|584037837|FG001|Overall Study|Protocol Violation|0|||
161725602|NCT01323673|584037836|FG000|Overall Study|Withdrawal by Subject|2|||
161725603|NCT01323673|584037837|FG001|Overall Study|Withdrawal by Subject|3|||
161725604|NCT01937130|584039801|FG000|Overall Study|Withdrawal by Subject|0|||
161725605|NCT01937130|584039802|FG001|Overall Study|Withdrawal by Subject|0|||
161725606|NCT01937130|584039803|FG002|Overall Study|Withdrawal by Subject|0|||
161725607|NCT01937130|584039804|FG003|Overall Study|Withdrawal by Subject|1|||
161725608|NCT01937130|584039801|FG000|Overall Study|Adverse Event|0|||
161725609|NCT01937130|584039802|FG001|Overall Study|Adverse Event|1|||
161725610|NCT01937130|584039803|FG002|Overall Study|Adverse Event|0|||
161725611|NCT01937130|584039804|FG003|Overall Study|Adverse Event|1|||
161725612|NCT01937130|584039801|FG000|Overall Study|Death|1|||
161725613|NCT01937130|584039802|FG001|Overall Study|Death|1|||
161725614|NCT01937130|584039803|FG002|Overall Study|Death|1|||
161725615|NCT01937130|584039804|FG003|Overall Study|Death|0|||
161725616|NCT01937130|584039801|FG000|Overall Study|Lost to Follow-up|2|||
161725617|NCT01937130|584039802|FG001|Overall Study|Lost to Follow-up|0|||
161725618|NCT01937130|584039803|FG002|Overall Study|Lost to Follow-up|2|||
161725619|NCT01937130|584039804|FG003|Overall Study|Lost to Follow-up|0|||
161725620|NCT01937130|584039801|FG000|Overall Study|Physician Decision|0|||
161725621|NCT01937130|584039802|FG001|Overall Study|Physician Decision|1|||
161725622|NCT01937130|584039803|FG002|Overall Study|Physician Decision|0|||
161725623|NCT01937130|584039804|FG003|Overall Study|Physician Decision|0|||
161725624|NCT01937130|584039801|FG000|Overall Study|Patients unable to swallow|0|||
161725625|NCT01937130|584039802|FG001|Overall Study|Patients unable to swallow|1|||
161725626|NCT01937130|584039803|FG002|Overall Study|Patients unable to swallow|0|||
161725627|NCT01937130|584039804|FG003|Overall Study|Patients unable to swallow|0|||
161725628|NCT01937130|584039801|FG000|Overall Study|Patient lost to FU due to death|2|||
161725629|NCT01937130|584039802|FG001|Overall Study|Patient lost to FU due to death|0|||
161725630|NCT01937130|584039803|FG002|Overall Study|Patient lost to FU due to death|0|||
161725631|NCT01937130|584039804|FG003|Overall Study|Patient lost to FU due to death|0|||
161725632|NCT01431144|584039805|FG000|Overall Study|Implant mobility and removal|2|||
161725633|NCT01431144|584039806|FG001|Overall Study|Implant mobility and removal|0|||
161725634|NCT01746732|584039812|FG000|Lead-In Period|Withdrawal by Subject|1|||
161725635|NCT01746732|584039813|FG001|Lead-In Period|Withdrawal by Subject|0|||
161725636|NCT01746732|584039814|FG002|Lead-In Period|Withdrawal by Subject|0|||
161725637|NCT01746732|584039812|FG000|Period 1|Physician Decision|0|||
161725638|NCT01746732|584039813|FG001|Period 1|Physician Decision|1|||
161725639|NCT01746732|584039814|FG002|Period 1|Physician Decision|0|||
161725640|NCT01746732|584039812|FG000|Period 2|Withdrawal by Subject|0|||
161725641|NCT01746732|584039813|FG001|Period 2|Withdrawal by Subject|0|||
161725642|NCT01746732|584039814|FG002|Period 2|Withdrawal by Subject|2|||
161725643|NCT01746732|584039812|FG000|Period 2|Adverse Event|0|||
161725644|NCT01746732|584039813|FG001|Period 2|Adverse Event|0|||
161725645|NCT01746732|584039814|FG002|Period 2|Adverse Event|1|||
161725646|NCT01746732|584039812|FG000|Period 2|Lost to Follow-up|0|||
161725647|NCT01746732|584039813|FG001|Period 2|Lost to Follow-up|0|||
161965498|NCT00191724|584920341|FG001|Overall Study|Withdrawal by Subject|0|||
161725648|NCT01746732|584039814|FG002|Period 2|Lost to Follow-up|1|||
161725649|NCT02817555|584039815|FG000|Overall Study|Death|1|||
161725650|NCT02817555|584039816|FG001|Overall Study|Death|3|||
161725651|NCT02817555|584039815|FG000|Overall Study|moved away|1|||
161725652|NCT02817555|584039816|FG001|Overall Study|moved away|0|||
161725653|NCT02817555|584039815|FG000|Overall Study|transplant|1|||
161725654|NCT02817555|584039816|FG001|Overall Study|transplant|1|||
161725655|NCT02817555|584039815|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
161725656|NCT02817555|584039816|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
161725657|NCT00137436|584039817|FG000|Overall Study|Adverse Event|13|||
161725658|NCT00137436|584039817|FG000|Overall Study|Death|2|||
161725659|NCT00137436|584039817|FG000|Overall Study|Lack of Efficacy|17|||
161725660|NCT00137436|584039817|FG000|Overall Study|Withdrawal by Subject|6|||
161725661|NCT00137436|584039817|FG000|Overall Study|Other|5|||
161725662|NCT00701727|584039818|FG000|First Treatment Period|Adverse Event|0|||
161725663|NCT00701727|584039819|FG001|First Treatment Period|Adverse Event|0|||
161725664|NCT00701727|584039818|FG000|First Treatment Period|Withdrawal by Subject|1|||
161725665|NCT00701727|584039819|FG001|First Treatment Period|Withdrawal by Subject|0|||
161725666|NCT00701727|584039818|FG000|First Treatment Period|sponsor decision|0|||
161725667|NCT00701727|584039819|FG001|First Treatment Period|sponsor decision|1|||
161725668|NCT00701727|584039818|FG000|First Treatment Period|Lost to Follow-up|0|||
161725669|NCT00701727|584039819|FG001|First Treatment Period|Lost to Follow-up|1|||
161725670|NCT00701727|584039818|FG000|Second Treatment Period|Withdrawal by Subject|2|||
161725671|NCT00701727|584039819|FG001|Second Treatment Period|Withdrawal by Subject|0|||
161725672|NCT00696657|584039820|FG000|Overall Study|Protocol Violation|0|||
161725673|NCT00696657|584039821|FG001|Overall Study|Protocol Violation|0|||
161725674|NCT00696657|584039822|FG002|Overall Study|Protocol Violation|0|||
161725675|NCT00696657|584039823|FG003|Overall Study|Protocol Violation|0|||
161725676|NCT00696657|584039824|FG004|Overall Study|Protocol Violation|0|||
161725677|NCT00696657|584039825|FG005|Overall Study|Protocol Violation|1|||
161725678|NCT00696657|584039826|FG006|Overall Study|Protocol Violation|0|||
161725679|NCT00696657|584039827|FG007|Overall Study|Protocol Violation|0|||
161725680|NCT00696657|584039828|FG008|Overall Study|Protocol Violation|1|||
161725681|NCT00696657|584039820|FG000|Overall Study|Lack of Efficacy|0|||
161725682|NCT00696657|584039821|FG001|Overall Study|Lack of Efficacy|1|||
161725683|NCT00696657|584039822|FG002|Overall Study|Lack of Efficacy|0|||
161725684|NCT00696657|584039823|FG003|Overall Study|Lack of Efficacy|0|||
161725685|NCT00696657|584039824|FG004|Overall Study|Lack of Efficacy|0|||
161725686|NCT00696657|584039825|FG005|Overall Study|Lack of Efficacy|0|||
161725687|NCT00696657|584039826|FG006|Overall Study|Lack of Efficacy|0|||
161725688|NCT00696657|584039827|FG007|Overall Study|Lack of Efficacy|0|||
161725689|NCT00696657|584039828|FG008|Overall Study|Lack of Efficacy|0|||
161725690|NCT00696657|584039820|FG000|Overall Study|Withdrawal criteria|1|||
161725691|NCT00696657|584039821|FG001|Overall Study|Withdrawal criteria|3|||
161725692|NCT00696657|584039822|FG002|Overall Study|Withdrawal criteria|2|||
161725693|NCT00696657|584039823|FG003|Overall Study|Withdrawal criteria|2|||
161725694|NCT00696657|584039824|FG004|Overall Study|Withdrawal criteria|0|||
161725695|NCT00696657|584039825|FG005|Overall Study|Withdrawal criteria|0|||
161725696|NCT00696657|584039826|FG006|Overall Study|Withdrawal criteria|1|||
161725697|NCT00696657|584039827|FG007|Overall Study|Withdrawal criteria|1|||
161725698|NCT00696657|584039828|FG008|Overall Study|Withdrawal criteria|2|||
161725699|NCT00696657|584039820|FG000|Overall Study|Unclassified|0|||
161725700|NCT00696657|584039821|FG001|Overall Study|Unclassified|1|||
161725701|NCT00696657|584039822|FG002|Overall Study|Unclassified|3|||
161725702|NCT00696657|584039823|FG003|Overall Study|Unclassified|2|||
161725703|NCT00696657|584039824|FG004|Overall Study|Unclassified|4|||
161725704|NCT00696657|584039825|FG005|Overall Study|Unclassified|2|||
161725705|NCT00696657|584039826|FG006|Overall Study|Unclassified|0|||
161725706|NCT00696657|584039827|FG007|Overall Study|Unclassified|0|||
161725707|NCT00696657|584039828|FG008|Overall Study|Unclassified|1|||
161725708|NCT00696657|584039820|FG000|Overall Study|Adverse Event|0|||
161725709|NCT00696657|584039821|FG001|Overall Study|Adverse Event|0|||
161725710|NCT00696657|584039822|FG002|Overall Study|Adverse Event|3|||
161725711|NCT00696657|584039823|FG003|Overall Study|Adverse Event|7|||
161725712|NCT00696657|584039824|FG004|Overall Study|Adverse Event|6|||
161725713|NCT00696657|584039825|FG005|Overall Study|Adverse Event|9|||
161725714|NCT00696657|584039826|FG006|Overall Study|Adverse Event|14|||
161725715|NCT00696657|584039827|FG007|Overall Study|Adverse Event|2|||
161725716|NCT00696657|584039828|FG008|Overall Study|Adverse Event|5|||
161725717|NCT00912015|584039831|FG000|Overall Study|Lack of Efficacy|1|||
161725718|NCT00912015|584039832|FG001|Overall Study|Lack of Efficacy|0|||
161725719|NCT00912015|584039833|FG002|Overall Study|Lack of Efficacy|0|||
161725720|NCT00912015|584039834|FG003|Overall Study|Lack of Efficacy|0|||
161725721|NCT00912015|584039831|FG000|Overall Study|Withdrawal by Subject|8|||
161725722|NCT00912015|584039832|FG001|Overall Study|Withdrawal by Subject|8|||
161725723|NCT00912015|584039833|FG002|Overall Study|Withdrawal by Subject|3|||
161725724|NCT00912015|584039834|FG003|Overall Study|Withdrawal by Subject|0|||
161725725|NCT00912015|584039831|FG000|Overall Study|Protocol Violation|1|||
161725726|NCT00912015|584039832|FG001|Overall Study|Protocol Violation|0|||
161725727|NCT00912015|584039833|FG002|Overall Study|Protocol Violation|0|||
161725728|NCT00912015|584039834|FG003|Overall Study|Protocol Violation|1|||
161725729|NCT00912015|584039831|FG000|Overall Study|Adverse Event|6|||
161725730|NCT00912015|584039832|FG001|Overall Study|Adverse Event|0|||
161725731|NCT00912015|584039833|FG002|Overall Study|Adverse Event|0|||
161725732|NCT00912015|584039834|FG003|Overall Study|Adverse Event|1|||
161725733|NCT05137041|584039835|FG000|Overall Study|Lost to Follow-up|1|||
161725734|NCT05137041|584039836|FG001|Overall Study|Lost to Follow-up|1|||
161725735|NCT05137041|584039835|FG000|Overall Study|Withdrawal by Subject|0|||
161725736|NCT05137041|584039836|FG001|Overall Study|Withdrawal by Subject|2|||
161725737|NCT05137041|584039835|FG000|Overall Study|Reason not Specified|0|||
161725738|NCT05137041|584039836|FG001|Overall Study|Reason not Specified|1|||
161725739|NCT02433210|584039837|FG000|Overall Study|Physician Decision|1|||
161725740|NCT02433210|584039838|FG001|Overall Study|Physician Decision|0|||
161725741|NCT02433210|584039839|FG002|Overall Study|Physician Decision|0|||
161725742|NCT02090114|584039840|FG000|Overall Study|Withdrawal by Subject|3|||
161725743|NCT02090114|584039841|FG001|Overall Study|Withdrawal by Subject|6|||
161725744|NCT02090114|584039842|FG002|Overall Study|Withdrawal by Subject|2|||
161725745|NCT02090114|584039843|FG003|Overall Study|Withdrawal by Subject|1|||
161725746|NCT02090114|584039840|FG000|Overall Study|Physician Decision|5|||
161725747|NCT02090114|584039841|FG001|Overall Study|Physician Decision|0|||
161725748|NCT02090114|584039842|FG002|Overall Study|Physician Decision|1|||
161725749|NCT02090114|584039843|FG003|Overall Study|Physician Decision|1|||
161725750|NCT02090114|584039840|FG000|Overall Study|Adverse Event|1|||
161725751|NCT02090114|584039841|FG001|Overall Study|Adverse Event|2|||
161725752|NCT02090114|584039842|FG002|Overall Study|Adverse Event|2|||
161725753|NCT02090114|584039843|FG003|Overall Study|Adverse Event|0|||
161725754|NCT02090114|584039840|FG000|Overall Study|Progressive Disease|20|||
161725755|NCT02090114|584039841|FG001|Overall Study|Progressive Disease|21|||
161725756|NCT02090114|584039842|FG002|Overall Study|Progressive Disease|23|||
161725757|NCT02090114|584039843|FG003|Overall Study|Progressive Disease|6|||
161725758|NCT02090114|584039840|FG000|Overall Study|Death|1|||
161725759|NCT02090114|584039841|FG001|Overall Study|Death|0|||
161725760|NCT02090114|584039842|FG002|Overall Study|Death|1|||
161725761|NCT02090114|584039843|FG003|Overall Study|Death|0|||
161725762|NCT01605071|584039844|FG000|Overall Study|Withdrawal by Subject|3|||
161725763|NCT01605071|584039845|FG001|Overall Study|Withdrawal by Subject|2|||
161725764|NCT00051558|584039848|FG000|Overall Study|Adverse Event|30|||
161725765|NCT00051558|584039849|FG001|Overall Study|Adverse Event|18|||
161725766|NCT00051558|584039848|FG000|Overall Study|Withdrawal by Subject|29|||
161725767|NCT00051558|584039849|FG001|Overall Study|Withdrawal by Subject|42|||
161725768|NCT00051558|584039848|FG000|Overall Study|Death|9|||
161725769|NCT00051558|584039849|FG001|Overall Study|Death|15|||
161725770|NCT00051558|584039848|FG000|Overall Study|Lost to Follow-up|4|||
161725771|NCT00051558|584039849|FG001|Overall Study|Lost to Follow-up|13|||
161725772|NCT00051558|584039848|FG000|Overall Study|Protocol Violation|3|||
161725773|NCT00051558|584039849|FG001|Overall Study|Protocol Violation|4|||
161725774|NCT00051558|584039848|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
161725775|NCT00051558|584039849|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
161725776|NCT00051558|584039848|FG000|Overall Study|Sponsor Decision|6|||
161725777|NCT00051558|584039849|FG001|Overall Study|Sponsor Decision|1|||
161725778|NCT00051558|584039848|FG000|Overall Study|Other|2|||
161725779|NCT00051558|584039849|FG001|Overall Study|Other|1|||
161725780|NCT00051558|584039848|FG000|Overall Study|Significant Lab Value|2|||
161725781|NCT00051558|584039849|FG001|Overall Study|Significant Lab Value|0|||
161725782|NCT00051558|584039848|FG000|Overall Study|Physician Decision|5|||
161725783|NCT00051558|584039849|FG001|Overall Study|Physician Decision|0|||
161725784|NCT02163993|584039851|FG000|Treatment Period|Adverse Event|0|||
161725785|NCT02163993|584039852|FG001|Treatment Period|Adverse Event|1|||
161725786|NCT02163993|584039853|FG002|Treatment Period|Adverse Event|0|||
161725787|NCT02163993|584039854|FG003|Treatment Period|Adverse Event|0|||
161725788|NCT02163993|584039855|FG004|Treatment Period|Adverse Event|1|||
161725789|NCT02163993|584039851|FG000|Treatment Period|Lost to Follow-up|2|||
161725790|NCT02163993|584039852|FG001|Treatment Period|Lost to Follow-up|3|||
161725791|NCT02163993|584039853|FG002|Treatment Period|Lost to Follow-up|1|||
161725792|NCT02163993|584039854|FG003|Treatment Period|Lost to Follow-up|3|||
161725793|NCT02163993|584039855|FG004|Treatment Period|Lost to Follow-up|1|||
161725794|NCT02163993|584039851|FG000|Treatment Period|Physician Decision|1|||
161725795|NCT02163993|584039852|FG001|Treatment Period|Physician Decision|0|||
161725796|NCT02163993|584039853|FG002|Treatment Period|Physician Decision|0|||
161725797|NCT02163993|584039854|FG003|Treatment Period|Physician Decision|0|||
161965499|NCT00191724|584920342|FG002|Overall Study|Withdrawal by Subject|0|||
161965500|NCT00191724|584920343|FG003|Overall Study|Withdrawal by Subject|1|||
161725798|NCT02163993|584039855|FG004|Treatment Period|Physician Decision|0|||
161725799|NCT02163993|584039851|FG000|Treatment Period|Protocol Violation|2|||
161725800|NCT02163993|584039852|FG001|Treatment Period|Protocol Violation|1|||
161725801|NCT02163993|584039853|FG002|Treatment Period|Protocol Violation|0|||
161725802|NCT02163993|584039854|FG003|Treatment Period|Protocol Violation|1|||
161725803|NCT02163993|584039855|FG004|Treatment Period|Protocol Violation|2|||
161725804|NCT02163993|584039851|FG000|Treatment Period|Withdrawal by Subject|6|||
161725805|NCT02163993|584039852|FG001|Treatment Period|Withdrawal by Subject|4|||
161725806|NCT02163993|584039853|FG002|Treatment Period|Withdrawal by Subject|1|||
161725807|NCT02163993|584039854|FG003|Treatment Period|Withdrawal by Subject|4|||
161725808|NCT02163993|584039855|FG004|Treatment Period|Withdrawal by Subject|1|||
161725809|NCT02163993|584039851|FG000|Treatment Period|Not treated|1|||
161725810|NCT02163993|584039852|FG001|Treatment Period|Not treated|0|||
161725811|NCT02163993|584039853|FG002|Treatment Period|Not treated|0|||
161725812|NCT02163993|584039854|FG003|Treatment Period|Not treated|1|||
161725813|NCT02163993|584039855|FG004|Treatment Period|Not treated|2|||
161725814|NCT02163993|584039851|FG000|Post-treatment Period|Adverse Event|0|||
161965501|NCT00191724|584920344|FG004|Overall Study|Withdrawal by Subject|0|||
161965502|NCT00608023|584920345|FG000|Overall Study|Withdrawal by Subject|8|||
161965503|NCT00608023|584920346|FG001|Overall Study|Withdrawal by Subject|10|||
161725815|NCT02163993|584039852|FG001|Post-treatment Period|Adverse Event|0|||
161725816|NCT02163993|584039853|FG002|Post-treatment Period|Adverse Event|1|||
161725817|NCT02163993|584039854|FG003|Post-treatment Period|Adverse Event|0|||
161725818|NCT02163993|584039855|FG004|Post-treatment Period|Adverse Event|0|||
161725819|NCT02163993|584039851|FG000|Post-treatment Period|Lost to Follow-up|2|||
161725820|NCT02163993|584039852|FG001|Post-treatment Period|Lost to Follow-up|2|||
161725821|NCT02163993|584039853|FG002|Post-treatment Period|Lost to Follow-up|3|||
161725822|NCT02163993|584039854|FG003|Post-treatment Period|Lost to Follow-up|1|||
161725823|NCT02163993|584039855|FG004|Post-treatment Period|Lost to Follow-up|0|||
161725824|NCT02163993|584039851|FG000|Post-treatment Period|Protocol Violation|0|||
161725825|NCT02163993|584039852|FG001|Post-treatment Period|Protocol Violation|0|||
161725826|NCT02163993|584039853|FG002|Post-treatment Period|Protocol Violation|0|||
161725827|NCT02163993|584039854|FG003|Post-treatment Period|Protocol Violation|0|||
161725828|NCT02163993|584039855|FG004|Post-treatment Period|Protocol Violation|1|||
161725829|NCT02163993|584039851|FG000|Post-treatment Period|Withdrawal by Subject|2|||
161725830|NCT02163993|584039852|FG001|Post-treatment Period|Withdrawal by Subject|4|||
161725831|NCT02163993|584039853|FG002|Post-treatment Period|Withdrawal by Subject|0|||
161725832|NCT02163993|584039854|FG003|Post-treatment Period|Withdrawal by Subject|1|||
161725833|NCT02163993|584039855|FG004|Post-treatment Period|Withdrawal by Subject|2|||
161725834|NCT01808118|584039856|FG000|Period 1|Adverse Event|15|||
161725835|NCT01808118|584039857|FG001|Period 1|Adverse Event|0|||
161725836|NCT01808118|584039858|FG002|Period 1|Adverse Event|0|||
161725837|NCT01808118|584039856|FG000|Period 1|Withdrew consent|24|||
161725838|NCT01808118|584039857|FG001|Period 1|Withdrew consent|0|||
161725839|NCT01808118|584039858|FG002|Period 1|Withdrew consent|0|||
161725840|NCT01808118|584039856|FG000|Period 1|Lost to Follow-up|9|||
161725841|NCT01808118|584039857|FG001|Period 1|Lost to Follow-up|0|||
161725842|NCT01808118|584039858|FG002|Period 1|Lost to Follow-up|0|||
161725843|NCT01808118|584039856|FG000|Period 1|Did not meet criteria for remission|303|||
161725844|NCT01808118|584039857|FG001|Period 1|Did not meet criteria for remission|0|||
161725845|NCT01808118|584039858|FG002|Period 1|Did not meet criteria for remission|0|||
161725846|NCT01808118|584039856|FG000|Period 1|Enrolled in error|7|||
161725847|NCT01808118|584039857|FG001|Period 1|Enrolled in error|0|||
161725848|NCT01808118|584039858|FG002|Period 1|Enrolled in error|0|||
161725849|NCT01808118|584039856|FG000|Period 1|Did not meet inclusion criteria|3|||
161725850|NCT01808118|584039857|FG001|Period 1|Did not meet inclusion criteria|0|||
161725851|NCT01808118|584039858|FG002|Period 1|Did not meet inclusion criteria|0|||
161725852|NCT01808118|584039856|FG000|Period 1|Non-conformance with inclusion criteria|3|||
161725853|NCT01808118|584039857|FG001|Period 1|Non-conformance with inclusion criteria|0|||
161725854|NCT01808118|584039858|FG002|Period 1|Non-conformance with inclusion criteria|0|||
161725855|NCT01808118|584039856|FG000|Period 1|Investigator decision: site closure|2|||
161725856|NCT01808118|584039857|FG001|Period 1|Investigator decision: site closure|0|||
161725857|NCT01808118|584039858|FG002|Period 1|Investigator decision: site closure|0|||
161725858|NCT01808118|584039856|FG000|Period 1|Non-compliance per sponsor|1|||
161725859|NCT01808118|584039857|FG001|Period 1|Non-compliance per sponsor|0|||
161725860|NCT01808118|584039858|FG002|Period 1|Non-compliance per sponsor|0|||
161725861|NCT01808118|584039856|FG000|Period 1|Lack of Efficacy|1|||
161725862|NCT01808118|584039857|FG001|Period 1|Lack of Efficacy|0|||
161725863|NCT01808118|584039858|FG002|Period 1|Lack of Efficacy|0|||
161725864|NCT01808118|584039856|FG000|Period 2|Adverse Event|0|||
161725865|NCT01808118|584039857|FG001|Period 2|Adverse Event|4|||
161725866|NCT01808118|584039858|FG002|Period 2|Adverse Event|0|||
161725867|NCT01808118|584039856|FG000|Period 2|Withdrew consent|0|||
161725868|NCT01808118|584039857|FG001|Period 2|Withdrew consent|7|||
161725869|NCT01808118|584039858|FG002|Period 2|Withdrew consent|6|||
161725870|NCT01808118|584039856|FG000|Period 2|Lost to Follow-up|0|||
161725871|NCT01808118|584039857|FG001|Period 2|Lost to Follow-up|0|||
161725872|NCT01808118|584039858|FG002|Period 2|Lost to Follow-up|2|||
161725873|NCT01808118|584039856|FG000|Period 2|Investigator no longer conducting trials|0|||
161725874|NCT01808118|584039857|FG001|Period 2|Investigator no longer conducting trials|1|||
161725875|NCT01808118|584039858|FG002|Period 2|Investigator no longer conducting trials|0|||
161725876|NCT01808118|584039856|FG000|Period 2|Switched to other therapy|0|||
161725877|NCT01808118|584039857|FG001|Period 2|Switched to other therapy|1|||
161725878|NCT01808118|584039858|FG002|Period 2|Switched to other therapy|0|||
161725879|NCT03097328|584039864|FG000|Overall Study|Still on Therapy|2|||
161725880|NCT03097328|584039864|FG000|Overall Study|Progressive Disease|29|||
161725881|NCT03097328|584039864|FG000|Overall Study|Adverse Event|4|||
161725882|NCT03097328|584039864|FG000|Overall Study|Withdrawal by Subject|1|||
161725883|NCT03097328|584039864|FG000|Overall Study|Physician Decision|1|||
161965504|NCT00608023|584920347|FG002|Overall Study|Withdrawal by Subject|7|||
161725884|NCT03097328|584039864|FG000|Overall Study|Patient Decision|1|||
161725885|NCT03097328|584039864|FG000|Overall Study|Ineligible for Study Drug|1|||
161725886|NCT02023164|584039865|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
161725887|NCT02023164|584039866|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
161725888|NCT01984346|584039870|FG000|Overall Study|Physician Decision|4|||
161725889|NCT01984346|584039871|FG001|Overall Study|Physician Decision|2|||
161725890|NCT01984346|584039870|FG000|Overall Study|Withdrawal by Subject|2|||
161725891|NCT01984346|584039871|FG001|Overall Study|Withdrawal by Subject|2|||
161725892|NCT01984346|584039870|FG000|Overall Study|Enrollment Closed|8|||
161725893|NCT01984346|584039871|FG001|Overall Study|Enrollment Closed|1|||
161725894|NCT01984346|584039870|FG000|Overall Study|Insurance Coverage|1|||
161725895|NCT01984346|584039871|FG001|Overall Study|Insurance Coverage|0|||
161725896|NCT01984346|584039870|FG000|Overall Study|Intra-operative Exclusion|2|||
161725897|NCT01984346|584039871|FG001|Overall Study|Intra-operative Exclusion|0|||
161725898|NCT02042404|584039874|FG000|Overall Study|Death|1|||
161725899|NCT02042404|584039875|FG001|Overall Study|Death|0|||
161725900|NCT02042404|584039874|FG000|Overall Study|Unrelated Adverse Event|3|||
161725901|NCT02042404|584039875|FG001|Overall Study|Unrelated Adverse Event|0|||
161725902|NCT02042404|584039874|FG000|Overall Study|Inability to meet time requirements|1|||
161725903|NCT02042404|584039875|FG001|Overall Study|Inability to meet time requirements|0|||
161725904|NCT03100942|584039876|FG000|Randomized Treatment Period|Withdrew Consent|4|||
161725905|NCT03100942|584039877|FG001|Randomized Treatment Period|Withdrew Consent|5|||
161725906|NCT03100942|584039878|FG002|Randomized Treatment Period|Withdrew Consent|3|||
161725907|NCT03100942|584039879|FG003|Randomized Treatment Period|Withdrew Consent|3|||
161725908|NCT03100942|584039880|FG004|Randomized Treatment Period|Withdrew Consent|0|||
161725909|NCT03100942|584039881|FG005|Randomized Treatment Period|Withdrew Consent|0|||
161725910|NCT03100942|584039882|FG006|Randomized Treatment Period|Withdrew Consent|0|||
161725911|NCT03100942|584039876|FG000|Randomized Treatment Period|Adverse Event|5|||
161725912|NCT03100942|584039877|FG001|Randomized Treatment Period|Adverse Event|2|||
161725913|NCT03100942|584039878|FG002|Randomized Treatment Period|Adverse Event|1|||
161725914|NCT03100942|584039879|FG003|Randomized Treatment Period|Adverse Event|0|||
161725915|NCT03100942|584039880|FG004|Randomized Treatment Period|Adverse Event|0|||
161725916|NCT03100942|584039881|FG005|Randomized Treatment Period|Adverse Event|0|||
161725917|NCT03100942|584039882|FG006|Randomized Treatment Period|Adverse Event|0|||
161725918|NCT03100942|584039876|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
161725919|NCT03100942|584039877|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
161725920|NCT03100942|584039878|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
161725921|NCT03100942|584039879|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
161725922|NCT03100942|584039880|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
161725923|NCT03100942|584039881|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
161725924|NCT03100942|584039882|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
161725925|NCT03100942|584039876|FG000|Randomized Treatment Period|Protocol Violation|0|||
161725926|NCT03100942|584039877|FG001|Randomized Treatment Period|Protocol Violation|1|||
161725927|NCT03100942|584039878|FG002|Randomized Treatment Period|Protocol Violation|1|||
161725928|NCT03100942|584039879|FG003|Randomized Treatment Period|Protocol Violation|1|||
161725929|NCT03100942|584039880|FG004|Randomized Treatment Period|Protocol Violation|0|||
161725930|NCT03100942|584039881|FG005|Randomized Treatment Period|Protocol Violation|0|||
161725931|NCT03100942|584039882|FG006|Randomized Treatment Period|Protocol Violation|0|||
161725932|NCT03100942|584039876|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
161725933|NCT03100942|584039877|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
161725934|NCT03100942|584039878|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
161725935|NCT03100942|584039879|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
161725936|NCT03100942|584039880|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
161725937|NCT03100942|584039881|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
161725938|NCT03100942|584039882|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
161725939|NCT03100942|584039876|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
161725940|NCT03100942|584039877|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161725941|NCT03100942|584039878|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161725942|NCT03100942|584039879|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
161725943|NCT03100942|584039880|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161725944|NCT03100942|584039881|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161725945|NCT03100942|584039882|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161725946|NCT03100942|584039876|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161725947|NCT03100942|584039877|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161725948|NCT03100942|584039878|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161725949|NCT03100942|584039879|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161725950|NCT03100942|584039880|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161725951|NCT03100942|584039881|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161725952|NCT03100942|584039882|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
161725953|NCT01876732|584039887|FG000|Overall Study|MMA was not over 800mg/dL|75|||
161725954|NCT00536731|584039888|FG000|Overall Study|Adverse Event|3|||
161725955|NCT00536731|584039889|FG001|Overall Study|Adverse Event|2|||
161725956|NCT00536731|584039890|FG002|Overall Study|Adverse Event|3|||
161725957|NCT00536731|584039888|FG000|Overall Study|Withdrawal by Subject|0|||
161725958|NCT00536731|584039889|FG001|Overall Study|Withdrawal by Subject|2|||
161965505|NCT00608023|584920345|FG000|Overall Study|Adverse Event|1|||
161725959|NCT00536731|584039890|FG002|Overall Study|Withdrawal by Subject|0|||
161725960|NCT00536731|584039888|FG000|Overall Study|Intake of prohibited conc. medication|0|||
161725961|NCT00536731|584039889|FG001|Overall Study|Intake of prohibited conc. medication|0|||
161725962|NCT00536731|584039890|FG002|Overall Study|Intake of prohibited conc. medication|1|||
161725963|NCT00536731|584039888|FG000|Overall Study|Safety reasons|0|||
161725964|NCT00536731|584039889|FG001|Overall Study|Safety reasons|0|||
161725965|NCT00536731|584039890|FG002|Overall Study|Safety reasons|1|||
161725966|NCT00536731|584039888|FG000|Overall Study|Other|1|||
161725967|NCT00536731|584039889|FG001|Overall Study|Other|1|||
161725968|NCT00536731|584039890|FG002|Overall Study|Other|0|||
161725969|NCT00718419|584039891|FG000|Overall Study|Adverse Event|2|||
161725970|NCT00718419|584039892|FG001|Overall Study|Adverse Event|1|||
161725971|NCT00718419|584039891|FG000|Overall Study|Physician Decision|1|||
161725972|NCT00718419|584039892|FG001|Overall Study|Physician Decision|6|||
161725973|NCT00718419|584039891|FG000|Overall Study|Sponsor decision|0|||
161725974|NCT00718419|584039892|FG001|Overall Study|Sponsor decision|1|||
161725975|NCT00718419|584039891|FG000|Overall Study|Withdrawal by Subject|0|||
161725976|NCT00718419|584039892|FG001|Overall Study|Withdrawal by Subject|5|||
161725977|NCT00718419|584039891|FG000|Overall Study|Progressive Disease|7|||
161725978|NCT00718419|584039892|FG001|Overall Study|Progressive Disease|25|||
161725979|NCT00718419|584039891|FG000|Overall Study|Death Due to Progressive Disease|2|||
161725980|NCT00718419|584039892|FG001|Overall Study|Death Due to Progressive Disease|0|||
161725981|NCT00718419|584039891|FG000|Overall Study|Death Due to Study Drug Related|0|||
161725982|NCT00718419|584039892|FG001|Overall Study|Death Due to Study Drug Related|1|||
161725983|NCT00718419|584039891|FG000|Overall Study|Death Due to Adverse Events|1|||
161725984|NCT00718419|584039892|FG001|Overall Study|Death Due to Adverse Events|0|||
161725985|NCT04184622|584039895|FG000|Primary Treatment Period|Adverse Event|6|||
161725986|NCT04184622|584039896|FG001|Primary Treatment Period|Adverse Event|4|||
161725987|NCT04184622|584039897|FG002|Primary Treatment Period|Adverse Event|8|||
161725988|NCT04184622|584039898|FG003|Primary Treatment Period|Adverse Event|6|||
161725989|NCT04184622|584039895|FG000|Primary Treatment Period|Death|4|||
161725990|NCT04184622|584039896|FG001|Primary Treatment Period|Death|4|||
161725991|NCT04184622|584039897|FG002|Primary Treatment Period|Death|2|||
161725992|NCT04184622|584039898|FG003|Primary Treatment Period|Death|1|||
161725993|NCT04184622|584039895|FG000|Primary Treatment Period|Lost to Follow-up|41|||
161725994|NCT04184622|584039896|FG001|Primary Treatment Period|Lost to Follow-up|17|||
161725995|NCT04184622|584039897|FG002|Primary Treatment Period|Lost to Follow-up|15|||
161725996|NCT04184622|584039898|FG003|Primary Treatment Period|Lost to Follow-up|13|||
161725997|NCT04184622|584039895|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
161725998|NCT04184622|584039896|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
161725999|NCT04184622|584039897|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
161726000|NCT04184622|584039898|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
161726001|NCT04184622|584039895|FG000|Primary Treatment Period|Physician Decision|0|||
161726002|NCT04184622|584039896|FG001|Primary Treatment Period|Physician Decision|0|||
161726003|NCT04184622|584039897|FG002|Primary Treatment Period|Physician Decision|3|||
161726004|NCT04184622|584039898|FG003|Primary Treatment Period|Physician Decision|1|||
161726005|NCT04184622|584039895|FG000|Primary Treatment Period|Pregnancy|4|||
161726006|NCT04184622|584039896|FG001|Primary Treatment Period|Pregnancy|3|||
161726007|NCT04184622|584039897|FG002|Primary Treatment Period|Pregnancy|4|||
161726008|NCT04184622|584039898|FG003|Primary Treatment Period|Pregnancy|1|||
161726009|NCT04184622|584039895|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
161726010|NCT04184622|584039896|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
161726011|NCT04184622|584039897|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
161726012|NCT04184622|584039898|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
161726013|NCT04184622|584039895|FG000|Additional Treatment Period|Adverse Event|1|||
161726014|NCT04184622|584039896|FG001|Additional Treatment Period|Adverse Event|2|||
161726015|NCT04184622|584039897|FG002|Additional Treatment Period|Adverse Event|1|||
161726016|NCT04184622|584039898|FG003|Additional Treatment Period|Adverse Event|0|||
161726017|NCT04184622|584039895|FG000|Additional Treatment Period|Death|0|||
161726018|NCT04184622|584039896|FG001|Additional Treatment Period|Death|0|||
161726019|NCT04184622|584039897|FG002|Additional Treatment Period|Death|1|||
161726020|NCT04184622|584039898|FG003|Additional Treatment Period|Death|1|||
161726021|NCT04184622|584039895|FG000|Additional Treatment Period|Lost to Follow-up|6|||
161726022|NCT04184622|584039896|FG001|Additional Treatment Period|Lost to Follow-up|4|||
161726023|NCT04184622|584039897|FG002|Additional Treatment Period|Lost to Follow-up|8|||
161726024|NCT04184622|584039898|FG003|Additional Treatment Period|Lost to Follow-up|6|||
161726025|NCT04184622|584039895|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
161726026|NCT04184622|584039896|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
161726027|NCT04184622|584039897|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
161726028|NCT04184622|584039898|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
161726029|NCT04184622|584039895|FG000|Additional Treatment Period|Physician Decision|0|||
161965506|NCT00608023|584920346|FG001|Overall Study|Adverse Event|4|||
161726030|NCT04184622|584039896|FG001|Additional Treatment Period|Physician Decision|0|||
161726031|NCT04184622|584039897|FG002|Additional Treatment Period|Physician Decision|1|||
161726032|NCT04184622|584039898|FG003|Additional Treatment Period|Physician Decision|0|||
161726033|NCT04184622|584039895|FG000|Additional Treatment Period|Pregnancy|0|||
161726034|NCT04184622|584039896|FG001|Additional Treatment Period|Pregnancy|0|||
161726035|NCT04184622|584039897|FG002|Additional Treatment Period|Pregnancy|0|||
161726036|NCT04184622|584039898|FG003|Additional Treatment Period|Pregnancy|1|||
161726037|NCT04184622|584039895|FG000|Additional Treatment Period|Protocol deviation|0|||
161726038|NCT04184622|584039896|FG001|Additional Treatment Period|Protocol deviation|0|||
161726039|NCT04184622|584039897|FG002|Additional Treatment Period|Protocol deviation|1|||
161726040|NCT04184622|584039898|FG003|Additional Treatment Period|Protocol deviation|0|||
161726041|NCT04184622|584039895|FG000|Additional Treatment Period|Site closed|1|||
161726042|NCT04184622|584039896|FG001|Additional Treatment Period|Site closed|0|||
161726043|NCT04184622|584039897|FG002|Additional Treatment Period|Site closed|1|||
161726044|NCT04184622|584039898|FG003|Additional Treatment Period|Site closed|0|||
161726045|NCT04184622|584039895|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
161726046|NCT04184622|584039896|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
161726047|NCT04184622|584039897|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
161726048|NCT04184622|584039898|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
161726049|NCT04184622|584039895|FG000|Safety Follow-up Period|Adverse Event|6|||
161726050|NCT04184622|584039896|FG001|Safety Follow-up Period|Adverse Event|8|||
161726051|NCT04184622|584039897|FG002|Safety Follow-up Period|Adverse Event|9|||
161726052|NCT04184622|584039898|FG003|Safety Follow-up Period|Adverse Event|16|||
161726053|NCT04184622|584039895|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
161726054|NCT04184622|584039896|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
161726055|NCT04184622|584039897|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
161726056|NCT04184622|584039898|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
161726057|NCT04184622|584039895|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
161726058|NCT04184622|584039896|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
161726059|NCT04184622|584039897|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
161726060|NCT04184622|584039898|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
161726061|NCT04184622|584039895|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
161726062|NCT04184622|584039896|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
161726063|NCT04184622|584039897|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
161726064|NCT04184622|584039898|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
161726065|NCT04184622|584039895|FG000|Safety Follow-up Period|Physician Decision|1|||
161726066|NCT04184622|584039896|FG001|Safety Follow-up Period|Physician Decision|0|||
161726067|NCT04184622|584039897|FG002|Safety Follow-up Period|Physician Decision|0|||
161726068|NCT04184622|584039898|FG003|Safety Follow-up Period|Physician Decision|1|||
161726069|NCT04184622|584039895|FG000|Safety Follow-up Period|Pregnancy|1|||
161726070|NCT04184622|584039896|FG001|Safety Follow-up Period|Pregnancy|3|||
161726071|NCT04184622|584039897|FG002|Safety Follow-up Period|Pregnancy|0|||
161726072|NCT04184622|584039898|FG003|Safety Follow-up Period|Pregnancy|6|||
161726073|NCT04184622|584039895|FG000|Safety Follow-up Period|Protocol deviation|1|||
161726074|NCT04184622|584039896|FG001|Safety Follow-up Period|Protocol deviation|0|||
161726075|NCT04184622|584039897|FG002|Safety Follow-up Period|Protocol deviation|0|||
161726076|NCT04184622|584039898|FG003|Safety Follow-up Period|Protocol deviation|0|||
161726077|NCT04184622|584039895|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
161726078|NCT04184622|584039896|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
161726079|NCT04184622|584039897|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
161726080|NCT04184622|584039898|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
161726081|NCT02795988|584039899|FG000|Phase 1b|Withdrawal by Subject|0|||
161726082|NCT02795988|584039900|FG001|Phase 1b|Withdrawal by Subject|1|||
161726083|NCT02795988|584039901|FG002|Phase 1b|Withdrawal by Subject|0|||
161726084|NCT02795988|584039902|FG003|Phase 1b|Withdrawal by Subject|0|||
161726085|NCT02795988|584039903|FG004|Phase 1b|Withdrawal by Subject|0|||
161726086|NCT02795988|584039904|FG005|Phase 1b|Withdrawal by Subject|0|||
161726087|NCT02795988|584039905|FG006|Phase 1b|Withdrawal by Subject|0|||
161726088|NCT02795988|584039899|FG000|Phase 1b|Death|1|||
161726089|NCT02795988|584039900|FG001|Phase 1b|Death|2|||
161726090|NCT02795988|584039901|FG002|Phase 1b|Death|1|||
161726091|NCT02795988|584039902|FG003|Phase 1b|Death|0|||
161726092|NCT02795988|584039903|FG004|Phase 1b|Death|0|||
161726093|NCT02795988|584039904|FG005|Phase 1b|Death|0|||
161726094|NCT02795988|584039905|FG006|Phase 1b|Death|0|||
161726095|NCT02795988|584039899|FG000|Phase 1b|Physician Decision|0|||
161726096|NCT02795988|584039900|FG001|Phase 1b|Physician Decision|0|||
161726097|NCT02795988|584039901|FG002|Phase 1b|Physician Decision|1|||
161726098|NCT02795988|584039902|FG003|Phase 1b|Physician Decision|0|||
161726099|NCT02795988|584039903|FG004|Phase 1b|Physician Decision|0|||
161726100|NCT02795988|584039904|FG005|Phase 1b|Physician Decision|0|||
161726101|NCT02795988|584039905|FG006|Phase 1b|Physician Decision|0|||
161726102|NCT02795988|584039899|FG000|Phase 1b|Progressive Disease|2|||
161726103|NCT02795988|584039900|FG001|Phase 1b|Progressive Disease|2|||
161726104|NCT02795988|584039901|FG002|Phase 1b|Progressive Disease|0|||
161726105|NCT02795988|584039902|FG003|Phase 1b|Progressive Disease|0|||
161726106|NCT02795988|584039903|FG004|Phase 1b|Progressive Disease|0|||
161726107|NCT02795988|584039904|FG005|Phase 1b|Progressive Disease|0|||
161726108|NCT02795988|584039905|FG006|Phase 1b|Progressive Disease|0|||
161726109|NCT02795988|584039899|FG000|Phase 2|Withdrawal by Subject|0|||
161726110|NCT02795988|584039900|FG001|Phase 2|Withdrawal by Subject|0|||
161726111|NCT02795988|584039901|FG002|Phase 2|Withdrawal by Subject|0|||
161726112|NCT02795988|584039902|FG003|Phase 2|Withdrawal by Subject|1|||
161726113|NCT02795988|584039903|FG004|Phase 2|Withdrawal by Subject|0|||
161726114|NCT02795988|584039904|FG005|Phase 2|Withdrawal by Subject|0|||
161726115|NCT02795988|584039905|FG006|Phase 2|Withdrawal by Subject|0|||
161726116|NCT02795988|584039899|FG000|Phase 2|Death|0|||
161726117|NCT02795988|584039900|FG001|Phase 2|Death|0|||
161726118|NCT02795988|584039901|FG002|Phase 2|Death|0|||
161726119|NCT02795988|584039902|FG003|Phase 2|Death|17|||
161726120|NCT02795988|584039903|FG004|Phase 2|Death|17|||
161726121|NCT02795988|584039904|FG005|Phase 2|Death|0|||
161726122|NCT02795988|584039905|FG006|Phase 2|Death|0|||
161726123|NCT02795988|584039899|FG000|Phase 2|Other|0|||
161726124|NCT02795988|584039900|FG001|Phase 2|Other|0|||
161726125|NCT02795988|584039901|FG002|Phase 2|Other|0|||
161726126|NCT02795988|584039902|FG003|Phase 2|Other|1|||
161726127|NCT02795988|584039903|FG004|Phase 2|Other|0|||
161726128|NCT02795988|584039904|FG005|Phase 2|Other|0|||
161726129|NCT02795988|584039905|FG006|Phase 2|Other|0|||
161726130|NCT02795988|584039899|FG000|Phase 2 Extension|Death|0|||
161726131|NCT02795988|584039900|FG001|Phase 2 Extension|Death|0|||
161726132|NCT02795988|584039901|FG002|Phase 2 Extension|Death|0|||
161726133|NCT02795988|584039902|FG003|Phase 2 Extension|Death|0|||
161726134|NCT02795988|584039903|FG004|Phase 2 Extension|Death|0|||
161726135|NCT02795988|584039904|FG005|Phase 2 Extension|Death|5|||
161726136|NCT02795988|584039905|FG006|Phase 2 Extension|Death|6|||
161726137|NCT02795988|584039899|FG000|Phase 2 Extension|Other reasons|0|||
161726138|NCT02795988|584039900|FG001|Phase 2 Extension|Other reasons|0|||
161726139|NCT02795988|584039901|FG002|Phase 2 Extension|Other reasons|0|||
161726140|NCT02795988|584039902|FG003|Phase 2 Extension|Other reasons|0|||
161726141|NCT02795988|584039903|FG004|Phase 2 Extension|Other reasons|0|||
161726142|NCT02795988|584039904|FG005|Phase 2 Extension|Other reasons|2|||
161726143|NCT02795988|584039905|FG006|Phase 2 Extension|Other reasons|1|||
161726144|NCT02341014|584039906|FG000|Overall Study|Adverse Event|0|||
161726145|NCT02341014|584039907|FG001|Overall Study|Adverse Event|1|||
161726146|NCT02341014|584039908|FG002|Overall Study|Adverse Event|0|||
161726147|NCT02341014|584039909|FG003|Overall Study|Adverse Event|0|||
161726148|NCT02341014|584039910|FG004|Overall Study|Adverse Event|2|||
161726149|NCT00726323|584039911|FG000|Overall Study|Withdrawal by Subject|3|||
161726150|NCT00726323|584039912|FG001|Overall Study|Withdrawal by Subject|1|||
161726151|NCT00726323|584039911|FG000|Overall Study|Physician Decision|1|||
161726152|NCT00726323|584039912|FG001|Overall Study|Physician Decision|0|||
161726153|NCT00726323|584039911|FG000|Overall Study|Progressive disease|23|||
161726154|NCT00726323|584039912|FG001|Overall Study|Progressive disease|16|||
161965507|NCT00608023|584920347|FG002|Overall Study|Adverse Event|5|||
161965508|NCT00608023|584920345|FG000|Overall Study|Lost to Follow-up|2|||
161965509|NCT00608023|584920346|FG001|Overall Study|Lost to Follow-up|2|||
161965510|NCT00608023|584920347|FG002|Overall Study|Lost to Follow-up|1|||
161965511|NCT00608023|584920345|FG000|Overall Study|Protocol Violation|1|||
161965512|NCT00608023|584920346|FG001|Overall Study|Protocol Violation|3|||
161965513|NCT00608023|584920347|FG002|Overall Study|Protocol Violation|1|||
161965514|NCT00608023|584920345|FG000|Overall Study|Unknown reason|0|||
161965515|NCT00608023|584920346|FG001|Overall Study|Unknown reason|3|||
161965516|NCT00608023|584920347|FG002|Overall Study|Unknown reason|0|||
161965517|NCT01231321|584920350|FG000|Overall Study|Adverse Event|3|||
161965518|NCT01231321|584920350|FG000|Overall Study|Lack of Efficacy|2|||
161965519|NCT00489736|584920351|FG000|Overall Study|Lack of Efficacy|53|||
161965520|NCT00489736|584920352|FG001|Overall Study|Lack of Efficacy|14|||
161965521|NCT00489736|584920351|FG000|Overall Study|Adverse Event|32|||
161965522|NCT00489736|584920352|FG001|Overall Study|Adverse Event|45|||
161965523|NCT00489736|584920351|FG000|Overall Study|Poor compliance|6|||
161965524|NCT00489736|584920352|FG001|Overall Study|Poor compliance|2|||
161965525|NCT00489736|584920351|FG000|Overall Study|Not coded/ Not pre-specified|5|||
161726155|NCT00726323|584039911|FG000|Overall Study|Clinical progression|0|||
161726156|NCT00726323|584039912|FG001|Overall Study|Clinical progression|3|||
161726157|NCT00726323|584039911|FG000|Overall Study|Adverse Event|9|||
161965526|NCT00489736|584920352|FG001|Overall Study|Not coded/ Not pre-specified|8|||
161965527|NCT04021524|584920353|FG000|Overall Study|Change in surgical intervention|0|||
161726158|NCT00726323|584039912|FG001|Overall Study|Adverse Event|9|||
161726159|NCT00726323|584039911|FG000|Overall Study|Death|1|||
161726160|NCT00726323|584039912|FG001|Overall Study|Death|0|||
161726161|NCT00726323|584039911|FG000|Overall Study|Participant wished to discontinue|0|||
161726162|NCT00726323|584039912|FG001|Overall Study|Participant wished to discontinue|1|||
161726163|NCT00726323|584039911|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
161726164|NCT00726323|584039912|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
161726165|NCT05058664|584039913|FG000|Overall Study|No follow-up data provided|4|||
161726166|NCT05058664|584039914|FG001|Overall Study|No follow-up data provided|0|||
161726167|NCT05058664|584039915|FG002|Overall Study|No follow-up data provided|2|||
161726168|NCT05058664|584039913|FG000|Overall Study|Withdrawal by Subject|0|||
161726169|NCT05058664|584039914|FG001|Overall Study|Withdrawal by Subject|0|||
161726170|NCT05058664|584039915|FG002|Overall Study|Withdrawal by Subject|1|||
161726171|NCT01617681|584039916|FG000|Period 1 Double Blind|Adverse Event|2|||
161726172|NCT01617681|584039917|FG001|Period 1 Double Blind|Adverse Event|0|||
161726173|NCT01617681|584039918|FG002|Period 1 Double Blind|Adverse Event|0|||
161726174|NCT01617681|584039919|FG003|Period 1 Double Blind|Adverse Event|2|||
161726175|NCT01617681|584039920|FG004|Period 1 Double Blind|Adverse Event|0|||
161726176|NCT01617681|584039916|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
161726177|NCT01617681|584039917|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
161726178|NCT01617681|584039918|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
161726179|NCT01617681|584039919|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
161726180|NCT01617681|584039920|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
161726181|NCT01617681|584039916|FG000|Period 2 Open Label|Adverse Event|0|||
161726182|NCT01617681|584039917|FG001|Period 2 Open Label|Adverse Event|0|||
161726183|NCT01617681|584039918|FG002|Period 2 Open Label|Adverse Event|0|||
161726184|NCT01617681|584039919|FG003|Period 2 Open Label|Adverse Event|0|||
161726185|NCT01617681|584039920|FG004|Period 2 Open Label|Adverse Event|3|||
161726186|NCT01617681|584039916|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
161726187|NCT01617681|584039917|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
161726188|NCT01617681|584039918|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
161726189|NCT01617681|584039919|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
161726190|NCT01617681|584039920|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
161726191|NCT00109733|584039927|FG000|Overall Study|Protocol Violation|0|||
161726192|NCT00109733|584039928|FG001|Overall Study|Protocol Violation|1|||
161726193|NCT00109733|584039927|FG000|Overall Study|Stopped taking study drug|1|||
161726194|NCT00109733|584039928|FG001|Overall Study|Stopped taking study drug|1|||
161726195|NCT00109733|584039927|FG000|Overall Study|Non-compliant|0|||
161726196|NCT00109733|584039928|FG001|Overall Study|Non-compliant|1|||
161726197|NCT00109733|584039927|FG000|Overall Study|Could not commit time for study|1|||
161726198|NCT00109733|584039928|FG001|Overall Study|Could not commit time for study|1|||
161726199|NCT01234402|584039937|FG000|Overall Study|Lost to Follow-up|0|||
161726200|NCT01234402|584039938|FG001|Overall Study|Lost to Follow-up|1|||
161726201|NCT01234402|584039939|FG002|Overall Study|Lost to Follow-up|3|||
161726202|NCT01234402|584039937|FG000|Overall Study|Withdrawal by Subject|1|||
161726203|NCT01234402|584039938|FG001|Overall Study|Withdrawal by Subject|3|||
161726204|NCT01234402|584039939|FG002|Overall Study|Withdrawal by Subject|4|||
161726205|NCT01234402|584039937|FG000|Overall Study|Never treated: Death|0|||
161726206|NCT01234402|584039938|FG001|Overall Study|Never treated: Death|0|||
161726207|NCT01234402|584039939|FG002|Overall Study|Never treated: Death|1|||
161726208|NCT01234402|584039937|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
161726209|NCT01234402|584039938|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
161726210|NCT01234402|584039939|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
161726211|NCT01234402|584039937|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
161726212|NCT01234402|584039938|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
161726213|NCT01234402|584039939|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
161726214|NCT02280291|584039941|FG000|Overall Study|Lost to Follow-up|2|||
161726215|NCT02280291|584039942|FG001|Overall Study|Lost to Follow-up|1|||
161726216|NCT02280291|584039943|FG002|Overall Study|Lost to Follow-up|3|||
161726217|NCT02280291|584039944|FG003|Overall Study|Lost to Follow-up|8|||
161726218|NCT02280291|584039941|FG000|Overall Study|Protocol Violation|1|||
161726219|NCT02280291|584039942|FG001|Overall Study|Protocol Violation|0|||
161726220|NCT02280291|584039943|FG002|Overall Study|Protocol Violation|0|||
161726221|NCT02280291|584039944|FG003|Overall Study|Protocol Violation|0|||
161726222|NCT02280291|584039941|FG000|Overall Study|Other|1|||
161726223|NCT02280291|584039942|FG001|Overall Study|Other|1|||
161726224|NCT02280291|584039943|FG002|Overall Study|Other|0|||
161726225|NCT02280291|584039944|FG003|Overall Study|Other|0|||
161726226|NCT00316303|584039946|FG000|Overall Study|Lost to Follow-up|11|||
161726227|NCT00316303|584039947|FG001|Overall Study|Lost to Follow-up|16|||
161726228|NCT01106534|584039948|FG000|Overall Study|Withdrawal by Subject|18|||
161726229|NCT01106534|584039948|FG000|Overall Study|Lost to Follow-up|2|||
161726230|NCT01106534|584039948|FG000|Overall Study|Death|16|||
161726231|NCT01106534|584039948|FG000|Overall Study|Physician Decision|1|||
161726232|NCT00570739|584039949|FG000|Overall Study|Adverse Event|8|||
161726233|NCT00570739|584039950|FG001|Overall Study|Adverse Event|6|||
161726234|NCT00570739|584039951|FG002|Overall Study|Adverse Event|2|||
161726235|NCT00570739|584039952|FG003|Overall Study|Adverse Event|2|||
161726236|NCT00570739|584039949|FG000|Overall Study|Lost to Follow-up|4|||
161965528|NCT04021524|584920354|FG001|Overall Study|Change in surgical intervention|1|||
161726237|NCT00570739|584039950|FG001|Overall Study|Lost to Follow-up|5|||
161726238|NCT00570739|584039951|FG002|Overall Study|Lost to Follow-up|4|||
161726239|NCT00570739|584039952|FG003|Overall Study|Lost to Follow-up|1|||
161726240|NCT00570739|584039949|FG000|Overall Study|Physician Decision|1|||
161726241|NCT00570739|584039950|FG001|Overall Study|Physician Decision|1|||
161726242|NCT00570739|584039951|FG002|Overall Study|Physician Decision|0|||
161726243|NCT00570739|584039952|FG003|Overall Study|Physician Decision|0|||
161726244|NCT00570739|584039949|FG000|Overall Study|Withdrawal by Subject|7|||
161726245|NCT00570739|584039950|FG001|Overall Study|Withdrawal by Subject|7|||
161726246|NCT00570739|584039951|FG002|Overall Study|Withdrawal by Subject|3|||
161726247|NCT00570739|584039952|FG003|Overall Study|Withdrawal by Subject|5|||
161726248|NCT00570739|584039949|FG000|Overall Study|Required restricted medication|0|||
161726249|NCT00570739|584039950|FG001|Overall Study|Required restricted medication|0|||
161726250|NCT00570739|584039951|FG002|Overall Study|Required restricted medication|1|||
161726251|NCT00570739|584039952|FG003|Overall Study|Required restricted medication|0|||
161726252|NCT00570739|584039949|FG000|Overall Study|Met discontinuation criteria|1|||
161726253|NCT00570739|584039950|FG001|Overall Study|Met discontinuation criteria|0|||
161726254|NCT00570739|584039951|FG002|Overall Study|Met discontinuation criteria|1|||
161726255|NCT00570739|584039952|FG003|Overall Study|Met discontinuation criteria|1|||
161726256|NCT00570739|584039949|FG000|Overall Study|Other|0|||
161726257|NCT00570739|584039950|FG001|Overall Study|Other|2|||
161726258|NCT00570739|584039951|FG002|Overall Study|Other|5|||
161726259|NCT00570739|584039952|FG003|Overall Study|Other|3|||
161726260|NCT02086565|584039954|FG000|Overall Study|Lost to Follow-up|9|||
161726261|NCT02086565|584039955|FG001|Overall Study|Lost to Follow-up|7|||
161726262|NCT02086565|584039954|FG000|Overall Study|Withdrawal by Subject|2|||
161726263|NCT02086565|584039955|FG001|Overall Study|Withdrawal by Subject|1|||
161726264|NCT02086565|584039954|FG000|Overall Study|Death|3|||
161726265|NCT02086565|584039955|FG001|Overall Study|Death|2|||
161726266|NCT02086565|584039954|FG000|Overall Study|withdrawn by research team|2|||
161726267|NCT02086565|584039955|FG001|Overall Study|withdrawn by research team|2|||
161726268|NCT00739297|584039956|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
161726269|NCT00739297|584039957|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
161726270|NCT00739297|584039958|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
161726271|NCT00739297|584039959|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
161726272|NCT00739297|584039960|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
161726273|NCT00739297|584039961|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
161726274|NCT00739297|584039962|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
161726275|NCT00739297|584039956|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161726276|NCT00739297|584039957|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161726277|NCT00739297|584039958|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161726278|NCT00739297|584039959|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161726279|NCT00739297|584039960|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161726280|NCT00739297|584039961|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
161726281|NCT00739297|584039962|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
161726282|NCT01400971|584039963|FG000|Overall Study|Death|82|||
161726283|NCT01400971|584039963|FG000|Overall Study|Lost to Follow-up|196|||
161726284|NCT01400971|584039963|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
161726285|NCT01400971|584039963|FG000|Overall Study|Physician Decision|57|||
161726286|NCT01400971|584039963|FG000|Overall Study|Withdrawal by Subject|158|||
161726287|NCT01400971|584039963|FG000|Overall Study|Other|422|||
161726288|NCT01041573|584039973|FG000|Overall Study|Withdrawal by Subject|2|||
161726289|NCT01041573|584039974|FG001|Overall Study|Withdrawal by Subject|5|||
161726290|NCT01041573|584039975|FG002|Overall Study|Withdrawal by Subject|2|||
161726291|NCT01041573|584039976|FG003|Overall Study|Withdrawal by Subject|0|||
161726292|NCT01041573|584039973|FG000|Overall Study|Death|1|||
161726293|NCT01041573|584039974|FG001|Overall Study|Death|0|||
161726294|NCT01041573|584039975|FG002|Overall Study|Death|0|||
161726295|NCT01041573|584039976|FG003|Overall Study|Death|0|||
161726296|NCT01041573|584039973|FG000|Overall Study|Lost to Follow-up|0|||
161726297|NCT01041573|584039974|FG001|Overall Study|Lost to Follow-up|1|||
161726298|NCT01041573|584039975|FG002|Overall Study|Lost to Follow-up|2|||
161726299|NCT01041573|584039976|FG003|Overall Study|Lost to Follow-up|1|||
161726300|NCT01041573|584039973|FG000|Overall Study|Adverse Event|0|||
161726301|NCT01041573|584039974|FG001|Overall Study|Adverse Event|2|||
161726302|NCT01041573|584039975|FG002|Overall Study|Adverse Event|0|||
161726303|NCT01041573|584039976|FG003|Overall Study|Adverse Event|0|||
161726304|NCT01041573|584039973|FG000|Overall Study|relocation|1|||
161726305|NCT01041573|584039974|FG001|Overall Study|relocation|4|||
161726306|NCT01041573|584039975|FG002|Overall Study|relocation|3|||
161726307|NCT01041573|584039976|FG003|Overall Study|relocation|1|||
161726308|NCT01041573|584039973|FG000|Overall Study|further blood extraction|0|||
161726309|NCT01041573|584039974|FG001|Overall Study|further blood extraction|1|||
161726310|NCT01041573|584039975|FG002|Overall Study|further blood extraction|0|||
161726311|NCT01041573|584039976|FG003|Overall Study|further blood extraction|0|||
161726312|NCT01041573|584039973|FG000|Overall Study|positive to anti-HCV|1|||
161726313|NCT01041573|584039974|FG001|Overall Study|positive to anti-HCV|0|||
161726314|NCT01041573|584039975|FG002|Overall Study|positive to anti-HCV|0|||
161726315|NCT01041573|584039976|FG003|Overall Study|positive to anti-HCV|0|||
161726316|NCT03634072|584039977|FG000|Overall Study|Early termination of overall study|1|||
161726317|NCT03634072|584039978|FG001|Overall Study|Early termination of overall study|0|||
161726318|NCT00620321|584041278|FG000|Overall Study|Adverse Event|1|||
161726319|NCT00620321|584041279|FG001|Overall Study|Adverse Event|1|||
161726320|NCT00620321|584041278|FG000|Overall Study|Death|1|||
161726321|NCT00620321|584041279|FG001|Overall Study|Death|1|||
161726322|NCT00620321|584041278|FG000|Overall Study|Physician Decision|0|||
161726323|NCT00620321|584041279|FG001|Overall Study|Physician Decision|7|||
161726324|NCT00620321|584041278|FG000|Overall Study|Progressive Disease|5|||
161726325|NCT00620321|584041279|FG001|Overall Study|Progressive Disease|5|||
161726326|NCT00620321|584041278|FG000|Overall Study|Sponsor Decision|0|||
161726327|NCT00620321|584041279|FG001|Overall Study|Sponsor Decision|1|||
161726328|NCT00620321|584041278|FG000|Overall Study|Withdrawal by Subject|1|||
161726329|NCT00620321|584041279|FG001|Overall Study|Withdrawal by Subject|1|||
161726330|NCT00643487|584041283|FG000|Overall Study|Technical difficulty|3|||
161726331|NCT05628181|584041288|FG000|Overall Study|Death|2|||
161726332|NCT05628181|584041289|FG001|Overall Study|Death|4|||
161726333|NCT05628181|584041290|FG002|Overall Study|Death|0|||
161726334|NCT03508622|584041291|FG000|Overall Study|Protocol Violation|1|||
161726335|NCT03508622|584041292|FG001|Overall Study|Protocol Violation|0|||
161726336|NCT03508622|584041291|FG000|Overall Study|Withdrawal by Subject|1|||
161726337|NCT03508622|584041292|FG001|Overall Study|Withdrawal by Subject|0|||
161726338|NCT03508622|584041291|FG000|Overall Study|Lost to Follow-up|16|||
161726339|NCT03508622|584041292|FG001|Overall Study|Lost to Follow-up|0|||
161726340|NCT03508622|584041291|FG000|Overall Study|Incomplete data|0|||
161726341|NCT03508622|584041292|FG001|Overall Study|Incomplete data|24|||
161726342|NCT00506077|584041293|FG000|Treatment Period 1|Adverse Event|2|||
161726343|NCT00506077|584041294|FG001|Treatment Period 1|Adverse Event|1|||
161726344|NCT00506077|584041293|FG000|Treatment Period 1|Lost to Follow-up|0|||
161726345|NCT00506077|584041294|FG001|Treatment Period 1|Lost to Follow-up|2|||
161726346|NCT00506077|584041293|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161726347|NCT00506077|584041294|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161726348|NCT00506077|584041293|FG000|Treatment Period 2|Adverse Event|0|||
161726349|NCT00506077|584041294|FG001|Treatment Period 2|Adverse Event|1|||
161726350|NCT00506077|584041293|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161726351|NCT00506077|584041294|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161726352|NCT02985450|584041306|FG000|Overall Study|Lost to Follow-up|7|||
161726353|NCT00069576|584041307|FG000|Original Trial|Lost to Follow-up|25|||
161726354|NCT00069576|584041308|FG001|Original Trial|Lost to Follow-up|33|||
161726355|NCT00069576|584041307|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
161726356|NCT00069576|584041308|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
161726357|NCT00905307|584041309|FG000|Overall Study|Switched to Open Label Rescue|7|||
161726358|NCT00905307|584041310|FG001|Overall Study|Switched to Open Label Rescue|17|||
161726359|NCT00905307|584041311|FG002|Overall Study|Switched to Open Label Rescue|11|||
161726360|NCT00905307|584041312|FG003|Overall Study|Switched to Open Label Rescue|11|||
161726361|NCT00905307|584041313|FG004|Overall Study|Switched to Open Label Rescue|4|||
161726362|NCT00905307|584041314|FG005|Overall Study|Switched to Open Label Rescue|15|||
161726363|NCT00905307|584041309|FG000|Overall Study|Lost to Follow-up|0|||
161726364|NCT00905307|584041310|FG001|Overall Study|Lost to Follow-up|0|||
161726365|NCT00905307|584041311|FG002|Overall Study|Lost to Follow-up|0|||
161726366|NCT00905307|584041312|FG003|Overall Study|Lost to Follow-up|0|||
161726367|NCT00905307|584041313|FG004|Overall Study|Lost to Follow-up|1|||
161726368|NCT00905307|584041314|FG005|Overall Study|Lost to Follow-up|1|||
161726369|NCT00905307|584041309|FG000|Overall Study|Adverse Event|3|||
161726370|NCT00905307|584041310|FG001|Overall Study|Adverse Event|4|||
161726371|NCT00905307|584041311|FG002|Overall Study|Adverse Event|5|||
161726372|NCT00905307|584041312|FG003|Overall Study|Adverse Event|11|||
161726373|NCT00905307|584041313|FG004|Overall Study|Adverse Event|3|||
161726374|NCT00905307|584041314|FG005|Overall Study|Adverse Event|5|||
161726375|NCT00905307|584041309|FG000|Overall Study|Withdrawal by Subject|5|||
161726376|NCT00905307|584041310|FG001|Overall Study|Withdrawal by Subject|13|||
161726377|NCT00905307|584041311|FG002|Overall Study|Withdrawal by Subject|15|||
161726378|NCT00905307|584041312|FG003|Overall Study|Withdrawal by Subject|11|||
161726379|NCT00905307|584041313|FG004|Overall Study|Withdrawal by Subject|4|||
161726380|NCT00905307|584041314|FG005|Overall Study|Withdrawal by Subject|13|||
161965529|NCT06422364|584920355|FG000|Overall Study|Withdrawn due to study closure|0|||
161726381|NCT00905307|584041309|FG000|Overall Study|Protocol Violation|1|||
161726382|NCT00905307|584041310|FG001|Overall Study|Protocol Violation|0|||
161726383|NCT00905307|584041311|FG002|Overall Study|Protocol Violation|1|||
161726384|NCT00905307|584041312|FG003|Overall Study|Protocol Violation|0|||
161726385|NCT00905307|584041313|FG004|Overall Study|Protocol Violation|0|||
161726386|NCT00905307|584041314|FG005|Overall Study|Protocol Violation|0|||
161726387|NCT00905307|584041309|FG000|Overall Study|Lack of Efficacy|6|||
161726388|NCT00905307|584041310|FG001|Overall Study|Lack of Efficacy|3|||
161726389|NCT00905307|584041311|FG002|Overall Study|Lack of Efficacy|5|||
161726390|NCT00905307|584041312|FG003|Overall Study|Lack of Efficacy|4|||
161726391|NCT00905307|584041313|FG004|Overall Study|Lack of Efficacy|4|||
161726392|NCT00905307|584041314|FG005|Overall Study|Lack of Efficacy|8|||
161726393|NCT05590793|584041315|FG000|Overall Study|Withdrawal by Subject|6|||
161726394|NCT05590793|584041315|FG000|Overall Study|Physician Decision|1|||
161726395|NCT04060667|584041316|FG000|Overall Study|Lost to Follow-up|75|||
161726396|NCT04060667|584041317|FG001|Overall Study|Lost to Follow-up|10|||
161726397|NCT03015610|584041318|FG000|Overall Study|Lost to Follow-up|1|||
161726398|NCT03015610|584041319|FG001|Overall Study|Lost to Follow-up|5|||
161726399|NCT01603641|584041320|FG000|Overall Study|Did not Receive Treatment|3|||
161726400|NCT01603641|584041320|FG000|Overall Study|Adverse Event|1|||
161726401|NCT01603641|584041320|FG000|Overall Study|Lack of Efficacy|1|||
161726402|NCT01603641|584041320|FG000|Overall Study|Lost to Follow-up|6|||
161726403|NCT01603641|584041320|FG000|Overall Study|Personal Reasons|18|||
161726404|NCT01603641|584041320|FG000|Overall Study|Other Miscellaneous Reasons|6|||
161726405|NCT00358917|584041321|FG000|Overall Study|Adverse Event|14|||
161726406|NCT00358917|584041322|FG001|Overall Study|Adverse Event|21|||
161726407|NCT00358917|584041321|FG000|Overall Study|Withdrawal by Subject|5|||
161726408|NCT00358917|584041322|FG001|Overall Study|Withdrawal by Subject|7|||
161726409|NCT00358917|584041321|FG000|Overall Study|Lost to Follow-up|20|||
161726410|NCT00358917|584041322|FG001|Overall Study|Lost to Follow-up|17|||
161726411|NCT00358917|584041321|FG000|Overall Study|Noncompliance|12|||
161726412|NCT00358917|584041322|FG001|Overall Study|Noncompliance|11|||
161726413|NCT00358917|584041321|FG000|Overall Study|Death|2|||
161726414|NCT00358917|584041322|FG001|Overall Study|Death|3|||
161726415|NCT00358917|584041321|FG000|Overall Study|Virologic failure|11|||
161726416|NCT00358917|584041322|FG001|Overall Study|Virologic failure|8|||
161726417|NCT00358917|584041321|FG000|Overall Study|Unable to Continue Participation|2|||
161726418|NCT00358917|584041322|FG001|Overall Study|Unable to Continue Participation|2|||
161726419|NCT01757704|584041327|FG000|Overall Study|Protocol Violation|1|||
161726420|NCT01757704|584041328|FG001|Overall Study|Protocol Violation|3|||
161726421|NCT02890329|584041329|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161726422|NCT02890329|584041330|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
161726423|NCT02890329|584041331|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161726424|NCT02890329|584041332|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161726425|NCT02890329|584041333|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161726426|NCT02890329|584041334|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161726427|NCT02890329|584041329|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
161726428|NCT02890329|584041330|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
161726429|NCT02890329|584041331|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
161726430|NCT02890329|584041332|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
161726431|NCT02890329|584041333|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
161726432|NCT02890329|584041334|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
161726433|NCT02890329|584041329|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161726434|NCT02890329|584041330|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161726435|NCT02890329|584041331|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161726436|NCT02890329|584041332|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
161726437|NCT02890329|584041333|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161726438|NCT02890329|584041334|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161726439|NCT02890329|584041329|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161726440|NCT02890329|584041330|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161726441|NCT02890329|584041331|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
161726442|NCT02890329|584041332|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161726443|NCT02890329|584041333|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161726444|NCT02890329|584041334|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161726445|NCT01379534|584041335|FG000|Treatment Phase|Withdrawal by Subject|2|||
161726446|NCT01379534|584041336|FG001|Treatment Phase|Withdrawal by Subject|2|||
161726447|NCT01379534|584041335|FG000|Treatment Phase|Progressive disease|13|||
161726448|NCT01379534|584041336|FG001|Treatment Phase|Progressive disease|22|||
161726449|NCT01379534|584041335|FG000|Treatment Phase|Adverse Event|7|||
161726450|NCT01379534|584041336|FG001|Treatment Phase|Adverse Event|7|||
161726451|NCT01379534|584041335|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
161726452|NCT01379534|584041336|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
161726453|NCT01379534|584041335|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
161726454|NCT01379534|584041336|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
161726455|NCT01379534|584041335|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
161726456|NCT01379534|584041336|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
161726457|NCT01379534|584041335|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
161726458|NCT01379534|584041336|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
161726459|NCT00616239|584041338|FG000|Overall Study|Withdrawal by Subject|2|||
161726460|NCT01558089|584041341|FG000|Overall Study|Adverse Event|1|||
161726461|NCT01558089|584041341|FG000|Overall Study|Lack of Efficacy|1|||
161726462|NCT01558089|584041341|FG000|Overall Study|Lost to Follow-up|5|||
161726463|NCT01558089|584041341|FG000|Overall Study|Withdrawal by Subject|6|||
161726464|NCT01597193|584041342|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
161726465|NCT01597193|584041343|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
161726466|NCT01597193|584041344|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161726467|NCT01597193|584041345|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161726468|NCT01597193|584041346|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161726469|NCT01597193|584041347|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161726470|NCT01597193|584041348|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161726471|NCT01597193|584041342|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
161726472|NCT01597193|584041343|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
161726473|NCT01597193|584041344|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
161726474|NCT01597193|584041345|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
161726475|NCT01597193|584041346|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
161726476|NCT01597193|584041347|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
161726477|NCT01597193|584041348|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
161726478|NCT01597193|584041342|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
161726479|NCT01597193|584041343|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
161726480|NCT01597193|584041344|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
161726481|NCT01597193|584041345|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
161726482|NCT01597193|584041346|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
161726483|NCT01597193|584041347|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
161726484|NCT01597193|584041348|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
161726485|NCT01597193|584041342|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161726486|NCT01597193|584041343|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161726487|NCT01597193|584041344|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161726488|NCT01597193|584041345|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161726489|NCT01597193|584041346|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161726490|NCT01597193|584041347|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
161726491|NCT01597193|584041348|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161726492|NCT01597193|584041342|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161726493|NCT01597193|584041343|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161726494|NCT01597193|584041344|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161726495|NCT01597193|584041345|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
161726496|NCT01597193|584041346|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161726497|NCT01597193|584041347|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
161726498|NCT01597193|584041348|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161726499|NCT03184701|584041350|FG000|Overall Study|Death|3|||
161726500|NCT03184701|584041350|FG000|Overall Study|Physician Decision|3|||
161726501|NCT03184701|584041350|FG000|Overall Study|Withdrawal by Subject|6|||
161726502|NCT03184701|584041350|FG000|Overall Study|Lost to Follow-up|5|||
161726503|NCT00590681|584041353|FG000|Overall Study|Withdrawal by Subject|7|||
161726504|NCT00590681|584041353|FG000|Overall Study|Adverse Event|8|||
161726505|NCT00590681|584041353|FG000|Overall Study|Death|3|||
161726506|NCT00590681|584041353|FG000|Overall Study|Lost to Follow-up|1|||
161726507|NCT00590681|584041353|FG000|Overall Study|disease progression|1|||
161726508|NCT01259297|584041354|FG000|Double Blind Randomized Period|Death|1|||
161726509|NCT01259297|584041355|FG001|Double Blind Randomized Period|Death|1|||
161726510|NCT01259297|584041356|FG002|Double Blind Randomized Period|Death|1|||
161726511|NCT01259297|584041357|FG003|Double Blind Randomized Period|Death|2|||
161726512|NCT01259297|584041358|FG004|Double Blind Randomized Period|Death|1|||
161726513|NCT01259297|584041359|FG005|Double Blind Randomized Period|Death|5|||
161726514|NCT01259297|584041360|FG006|Double Blind Randomized Period|Death|2|||
161726515|NCT01259297|584041361|FG007|Double Blind Randomized Period|Death|1|||
161726516|NCT01259297|584041354|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161726517|NCT01259297|584041355|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161726518|NCT01259297|584041356|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
161726519|NCT01259297|584041357|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
161726520|NCT01259297|584041358|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
161726521|NCT01259297|584041359|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161965530|NCT06422364|584920356|FG001|Overall Study|Withdrawn due to study closure|2|||
161965531|NCT05260073|584920358|FG000|Overall Study|Physician Decision|1|||
161965532|NCT05260073|584920358|FG000|Overall Study|Withdrawal by Subject|6|||
161726522|NCT01259297|584041360|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161726523|NCT01259297|584041361|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161726524|NCT01259297|584041354|FG000|Double Blind Randomized Period|Other reasons|0|||
161726525|NCT01259297|584041355|FG001|Double Blind Randomized Period|Other reasons|1|||
161726526|NCT01259297|584041356|FG002|Double Blind Randomized Period|Other reasons|0|||
161726527|NCT01259297|584041357|FG003|Double Blind Randomized Period|Other reasons|0|||
161726528|NCT01259297|584041358|FG004|Double Blind Randomized Period|Other reasons|1|||
161726529|NCT01259297|584041359|FG005|Double Blind Randomized Period|Other reasons|2|||
161726530|NCT01259297|584041360|FG006|Double Blind Randomized Period|Other reasons|3|||
161726531|NCT01259297|584041361|FG007|Double Blind Randomized Period|Other reasons|1|||
161726532|NCT00933335|584041362|FG000|Overall Study|Lost to Follow-up|1|||
161726533|NCT00933335|584041363|FG001|Overall Study|Lost to Follow-up|3|||
161726534|NCT00933335|584041362|FG000|Overall Study|Withdrawal by Subject|0|||
161726535|NCT00933335|584041363|FG001|Overall Study|Withdrawal by Subject|1|||
161726536|NCT00933335|584041362|FG000|Overall Study|Progressive Disease|0|||
161726537|NCT00933335|584041363|FG001|Overall Study|Progressive Disease|11|||
161726538|NCT00933335|584041362|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
161726539|NCT00933335|584041363|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
161726540|NCT00933335|584041362|FG000|Overall Study|Co-morbid Illness|1|||
161726541|NCT00933335|584041363|FG001|Overall Study|Co-morbid Illness|0|||
161726542|NCT02229864|584041364|FG000|Overall Study|Death|2|||
161726543|NCT02229864|584041364|FG000|Overall Study|Lost to Follow-up|1|||
161726544|NCT02650284|584041367|FG000|Overall Study|Lost to Follow-up|3|||
161726545|NCT02650284|584041368|FG001|Overall Study|Lost to Follow-up|3|||
161726546|NCT02650284|584041367|FG000|Overall Study|Consent incorrectly taken|0|||
161726547|NCT02650284|584041368|FG001|Overall Study|Consent incorrectly taken|1|||
161726548|NCT00374907|584041373|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
161726549|NCT00374907|584041374|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
161726550|NCT00374907|584041373|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
161726551|NCT00374907|584041374|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
161726552|NCT00374907|584041373|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
161726553|NCT00374907|584041374|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
161726554|NCT00374907|584041373|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
161726555|NCT00374907|584041374|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
161726556|NCT00374907|584041373|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
161726557|NCT00374907|584041374|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
161726558|NCT02815397|584041378|FG000|Overall Study|Physician Decision|2|||
161726559|NCT00085540|584041381|FG000|Overall Study|Withdrawal by Subject|0|||
161726560|NCT00085540|584041382|FG001|Overall Study|Withdrawal by Subject|1|||
161726561|NCT00085540|584041381|FG000|Overall Study|Protocol Violation|0|||
161726562|NCT00085540|584041382|FG001|Overall Study|Protocol Violation|1|||
161726563|NCT01605396|584041383|FG000|Overall Study|Adverse Event|5|||
161726564|NCT01605396|584041384|FG001|Overall Study|Adverse Event|3|||
161726565|NCT01605396|584041383|FG000|Overall Study|Lost to Follow-up|1|||
161726566|NCT01605396|584041384|FG001|Overall Study|Lost to Follow-up|0|||
161726567|NCT01605396|584041383|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161726568|NCT01605396|584041384|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161726569|NCT01605396|584041383|FG000|Overall Study|Physician Decision|2|||
161726570|NCT01605396|584041384|FG001|Overall Study|Physician Decision|2|||
161726571|NCT01605396|584041383|FG000|Overall Study|Progressive Disease|23|||
161726572|NCT01605396|584041384|FG001|Overall Study|Progressive Disease|27|||
161726573|NCT01605396|584041383|FG000|Overall Study|Withdrawal by Subject|4|||
161726574|NCT01605396|584041384|FG001|Overall Study|Withdrawal by Subject|2|||
161726575|NCT01605396|584041383|FG000|Overall Study|Transfer Off Study|4|||
161726576|NCT01605396|584041384|FG001|Overall Study|Transfer Off Study|5|||
161726577|NCT04598165|584041385|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
161726578|NCT04598165|584041386|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
161726579|NCT04598165|584041385|FG000|Completed 6-week Follow-up|Death|2|||
161726580|NCT04598165|584041386|FG001|Completed 6-week Follow-up|Death|1|||
161726581|NCT04598165|584041385|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
161726582|NCT04598165|584041386|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
161726583|NCT04598165|584041385|FG000|Completed 6-week Follow-up|Ineligible|4|||
161726584|NCT04598165|584041386|FG001|Completed 6-week Follow-up|Ineligible|3|||
161726585|NCT04598165|584041385|FG000|Completed 6-week Follow-up|Partner refusal|0|||
161726586|NCT04598165|584041386|FG001|Completed 6-week Follow-up|Partner refusal|1|||
161726587|NCT04598165|584041385|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
161726588|NCT04598165|584041386|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
161726589|NCT00878072|584041387|FG000|Overall Study|Withdrew consent|2|||
161726590|NCT00426751|584041398|FG000|Overall Study|Adverse Event|8|||
161726591|NCT00426751|584041399|FG001|Overall Study|Adverse Event|1|||
161726592|NCT00426751|584041398|FG000|Overall Study|Lost to Follow-up|7|||
161726593|NCT00426751|584041399|FG001|Overall Study|Lost to Follow-up|6|||
161726594|NCT00426751|584041398|FG000|Overall Study|Consent Withdrawn|0|||
161726595|NCT00426751|584041399|FG001|Overall Study|Consent Withdrawn|1|||
161726596|NCT00426751|584041398|FG000|Overall Study|Other Reasons|7|||
161726597|NCT00426751|584041399|FG001|Overall Study|Other Reasons|12|||
161726598|NCT01200511|584041400|FG000|Overall Study|Lost to Follow-up|3|||
161726599|NCT01200511|584041400|FG000|Overall Study|Withdrawal by Subject|1|||
161726600|NCT01200511|584041400|FG000|Overall Study|Adverse Event|1|||
161726601|NCT00576693|584041401|FG000|Overall Study|Lost to Follow-up|7|||
161726602|NCT00576693|584041402|FG001|Overall Study|Lost to Follow-up|11|||
161726603|NCT00576693|584041401|FG000|Overall Study|Withdrawal by Subject|3|||
161726604|NCT00576693|584041402|FG001|Overall Study|Withdrawal by Subject|13|||
161726605|NCT00705224|584041403|FG000|Overall Study|Adverse Event|1|||
161726606|NCT00705224|584041403|FG000|Overall Study|Lack of Efficacy|2|||
161726607|NCT00705224|584041403|FG000|Overall Study|Withdrawal by Subject|3|||
161726608|NCT00705224|584041403|FG000|Overall Study|Lost to Follow-up|5|||
161726609|NCT01721408|584041404|FG000|Overall Study|Adverse Event|6|||
161726610|NCT01721408|584041405|FG001|Overall Study|Adverse Event|1|||
161726611|NCT01721408|584041404|FG000|Overall Study|Death|1|||
161726612|NCT01721408|584041405|FG001|Overall Study|Death|0|||
161726613|NCT01721408|584041404|FG000|Overall Study|Insufficient clinical response|15|||
161726614|NCT01721408|584041405|FG001|Overall Study|Insufficient clinical response|6|||
161726615|NCT01721408|584041404|FG000|Overall Study|No longer willing to participate study|9|||
161726616|NCT01721408|584041405|FG001|Overall Study|No longer willing to participate study|10|||
161726617|NCT01721408|584041404|FG000|Overall Study|Protocol Violation|0|||
161726618|NCT01721408|584041405|FG001|Overall Study|Protocol Violation|2|||
161726619|NCT01721408|584041404|FG000|Overall Study|Other|3|||
161726620|NCT01721408|584041405|FG001|Overall Study|Other|3|||
161726621|NCT01721408|584041404|FG000|Overall Study|Lost to Follow-up|1|||
161726622|NCT01721408|584041405|FG001|Overall Study|Lost to Follow-up|2|||
161726623|NCT01721408|584041404|FG000|Overall Study|Does not meet entrance criteria|1|||
161726624|NCT01721408|584041405|FG001|Overall Study|Does not meet entrance criteria|0|||
161726625|NCT01187901|584041406|FG000|Overall Study|Protocol Violation|1|||
161726626|NCT01187901|584041407|FG001|Overall Study|Protocol Violation|0|||
161726627|NCT01187901|584041406|FG000|Overall Study|Lost to Follow-up|1|||
161726628|NCT01187901|584041407|FG001|Overall Study|Lost to Follow-up|2|||
161726629|NCT01187901|584041406|FG000|Overall Study|Unrelated Health Reasons|1|||
161726630|NCT01187901|584041407|FG001|Overall Study|Unrelated Health Reasons|2|||
161726631|NCT01187901|584041406|FG000|Overall Study|Suspected Allergic Reaction|1|||
161726632|NCT01187901|584041407|FG001|Overall Study|Suspected Allergic Reaction|1|||
161726633|NCT01187901|584041406|FG000|Overall Study|Adverse Event|3|||
161726634|NCT01187901|584041407|FG001|Overall Study|Adverse Event|0|||
161726635|NCT01187901|584041406|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
161726636|NCT01187901|584041407|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
161726637|NCT01187901|584041406|FG000|Overall Study|Pregnancy|0|||
161726638|NCT01187901|584041407|FG001|Overall Study|Pregnancy|2|||
161726639|NCT04160468|584041408|FG000|Overall Study|Lost to Follow-up|19|||
161726640|NCT04160468|584041409|FG001|Overall Study|Lost to Follow-up|4|||
161726641|NCT04160468|584041408|FG000|Overall Study|Randomized but not dosed|6|||
161726642|NCT04160468|584041409|FG001|Overall Study|Randomized but not dosed|0|||
161726643|NCT04160468|584041408|FG000|Overall Study|Withdrawal by Subject|4|||
161726644|NCT04160468|584041409|FG001|Overall Study|Withdrawal by Subject|1|||
161726645|NCT04160468|584041408|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
161726646|NCT04160468|584041409|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
161726647|NCT04160468|584041408|FG000|Overall Study|Participant incarcerated|1|||
161726648|NCT04160468|584041409|FG001|Overall Study|Participant incarcerated|0|||
161726649|NCT03987620|584041412|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
161726650|NCT03987620|584041413|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
161726651|NCT03987620|584041412|FG000|Overall Study|Adverse Event|3|||
161726652|NCT03987620|584041413|FG001|Overall Study|Adverse Event|0|||
161726653|NCT03987620|584041412|FG000|Overall Study|Lost to Follow-up|1|||
161726654|NCT03987620|584041413|FG001|Overall Study|Lost to Follow-up|2|||
161726655|NCT03987620|584041412|FG000|Overall Study|Physician Decision|0|||
161726656|NCT03987620|584041413|FG001|Overall Study|Physician Decision|1|||
161726657|NCT03987620|584041412|FG000|Overall Study|Pregnancy|1|||
161726658|NCT03987620|584041413|FG001|Overall Study|Pregnancy|0|||
161726659|NCT03987620|584041412|FG000|Overall Study|Withdrawal by Subject|7|||
161726660|NCT03987620|584041413|FG001|Overall Study|Withdrawal by Subject|1|||
161726661|NCT03987620|584041412|FG000|Overall Study|Other|2|||
161726662|NCT03987620|584041413|FG001|Overall Study|Other|5|||
161726663|NCT02149836|584041414|FG000|Overall Study|Withdrawal by Subject|1|||
161726664|NCT00376688|584041415|FG000|Overall Study|Adverse Event|3|||
161726665|NCT00376688|584041415|FG000|Overall Study|Death|1|||
161726666|NCT01770353|584041416|FG000|Overall Study|Progressive disease|2|||
161726667|NCT01770353|584041417|FG001|Overall Study|Progressive disease|1|||
161726668|NCT01770353|584041416|FG000|Overall Study|Adverse Event|0|||
161726669|NCT01770353|584041417|FG001|Overall Study|Adverse Event|1|||
161726670|NCT01770353|584041416|FG000|Overall Study|Protocol Violation|1|||
161726671|NCT01770353|584041417|FG001|Overall Study|Protocol Violation|0|||
161726672|NCT01770353|584041416|FG000|Overall Study|Physician Decision|0|||
161726673|NCT01770353|584041417|FG001|Overall Study|Physician Decision|3|||
161726674|NCT01770353|584041416|FG000|Overall Study|Clinical deterioration|3|||
161726675|NCT01770353|584041417|FG001|Overall Study|Clinical deterioration|6|||
161726676|NCT01770353|584041416|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
161726677|NCT01770353|584041417|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
161726678|NCT05128162|584041418|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
161726679|NCT05128162|584041418|FG000|Overall Study|Physician Decision|1|||
161726680|NCT00370149|584041419|FG000|Overall Study|Physician Decision|16|||
161726681|NCT00370149|584041420|FG001|Overall Study|Physician Decision|16|||
161726682|NCT00370149|584041419|FG000|Overall Study|Protocol Violation|1|||
161726683|NCT00370149|584041420|FG001|Overall Study|Protocol Violation|0|||
161726684|NCT00370149|584041419|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
161726685|NCT00370149|584041420|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
161726686|NCT00370149|584041419|FG000|Overall Study|Pre-existing infection|0|||
161726687|NCT00370149|584041420|FG001|Overall Study|Pre-existing infection|1|||
161726688|NCT00370149|584041419|FG000|Overall Study|Antibiotic coated dressing placed|0|||
161726689|NCT00370149|584041420|FG001|Overall Study|Antibiotic coated dressing placed|1|||
161726690|NCT04920084|584042987|FG000|Overall Study|Adverse Event|1|||
161726691|NCT04920084|584042987|FG000|Overall Study|Lost to Follow-up|2|||
161726692|NCT04920084|584042987|FG000|Overall Study|Withdrawal by Subject|2|||
161726693|NCT01096446|584042988|FG000|Overall Study|Death|1|||
161726694|NCT01096446|584042989|FG001|Overall Study|Death|0|||
161726695|NCT01096446|584042988|FG000|Overall Study|Protocol Violation|2|||
161726696|NCT01096446|584042989|FG001|Overall Study|Protocol Violation|0|||
161726697|NCT02410902|584042990|FG000|Overall Study|Adverse Event|2|||
161726698|NCT02410902|584042991|FG001|Overall Study|Adverse Event|3|||
161726699|NCT02410902|584042990|FG000|Overall Study|Lost to Follow-up|4|||
161726700|NCT02410902|584042991|FG001|Overall Study|Lost to Follow-up|1|||
161726701|NCT02410902|584042990|FG000|Overall Study|Protocol Violation|1|||
161726702|NCT02410902|584042991|FG001|Overall Study|Protocol Violation|4|||
161726703|NCT02410902|584042990|FG000|Overall Study|Withdrawal by Subject|6|||
161726704|NCT02410902|584042991|FG001|Overall Study|Withdrawal by Subject|8|||
161726705|NCT02410902|584042990|FG000|Overall Study|Non-Compliance|8|||
161726706|NCT02410902|584042991|FG001|Overall Study|Non-Compliance|2|||
161726707|NCT02279524|584042993|FG000|Overall Study|Withdrawal by Subject|3|||
161726708|NCT02279524|584042994|FG001|Overall Study|Withdrawal by Subject|6|||
161726709|NCT02279524|584042995|FG002|Overall Study|Withdrawal by Subject|3|||
161726710|NCT02279524|584042993|FG000|Overall Study|Adverse Event|4|||
161726711|NCT02279524|584042994|FG001|Overall Study|Adverse Event|3|||
161726712|NCT02279524|584042995|FG002|Overall Study|Adverse Event|2|||
161726713|NCT02279524|584042993|FG000|Overall Study|Lost to Follow-up|1|||
161726714|NCT02279524|584042994|FG001|Overall Study|Lost to Follow-up|1|||
161726715|NCT02279524|584042995|FG002|Overall Study|Lost to Follow-up|0|||
161726716|NCT02279524|584042993|FG000|Overall Study|Disallowed medication|1|||
161726717|NCT02279524|584042994|FG001|Overall Study|Disallowed medication|1|||
161726718|NCT02279524|584042995|FG002|Overall Study|Disallowed medication|2|||
161726719|NCT02279524|584042993|FG000|Overall Study|Bariatric surgery|1|||
161726720|NCT02279524|584042994|FG001|Overall Study|Bariatric surgery|0|||
161726721|NCT02279524|584042995|FG002|Overall Study|Bariatric surgery|0|||
161726722|NCT00392171|584043000|FG000|Overall Study|Did not meet inclusion criteria|4|||
161726723|NCT00392171|584043000|FG000|Overall Study|Disease progression|101|||
161726724|NCT03488472|584043001|FG000|Overall Study|disease progression additional mets|1|||
161726725|NCT00028002|584043002|FG000|Overall Study|Withdrawal by Subject|3|||
161726726|NCT00028002|584043002|FG000|Overall Study|Ineligible|8|||
161726727|NCT00414310|584043006|FG000|Overall Study|Not treated|1|||
161726728|NCT00414310|584043007|FG001|Overall Study|Not treated|0|||
161726729|NCT01441440|584043011|FG000|Overall Study|Death|1|||
161726730|NCT01441440|584043012|FG001|Overall Study|Death|0|||
161726731|NCT01441440|584043013|FG002|Overall Study|Death|1|||
161726732|NCT01441440|584043011|FG000|Overall Study|Adverse Event|2|||
161726733|NCT01441440|584043012|FG001|Overall Study|Adverse Event|9|||
161726734|NCT01441440|584043013|FG002|Overall Study|Adverse Event|9|||
161726735|NCT01441440|584043011|FG000|Overall Study|Lost to Follow-up|0|||
161726736|NCT01441440|584043012|FG001|Overall Study|Lost to Follow-up|2|||
161726737|NCT01441440|584043013|FG002|Overall Study|Lost to Follow-up|1|||
161726738|NCT01441440|584043011|FG000|Overall Study|Withdrawal by Subject|11|||
161726739|NCT01441440|584043012|FG001|Overall Study|Withdrawal by Subject|9|||
161726740|NCT01441440|584043013|FG002|Overall Study|Withdrawal by Subject|9|||
161726741|NCT01441440|584043011|FG000|Overall Study|Pregnancy|1|||
161726742|NCT01441440|584043012|FG001|Overall Study|Pregnancy|0|||
161726743|NCT01441440|584043013|FG002|Overall Study|Pregnancy|0|||
161726744|NCT01441440|584043011|FG000|Overall Study|Lack of Efficacy|1|||
161726745|NCT01441440|584043012|FG001|Overall Study|Lack of Efficacy|0|||
161965533|NCT05260073|584920358|FG000|Overall Study|Lost to Follow-up|14|||
161726746|NCT01441440|584043013|FG002|Overall Study|Lack of Efficacy|1|||
161726747|NCT01441440|584043011|FG000|Overall Study|Moving|0|||
161726748|NCT01441440|584043012|FG001|Overall Study|Moving|1|||
161726749|NCT01441440|584043013|FG002|Overall Study|Moving|1|||
161726750|NCT01441440|584043011|FG000|Overall Study|Work-related matter|0|||
161726751|NCT01441440|584043012|FG001|Overall Study|Work-related matter|1|||
161726752|NCT01441440|584043013|FG002|Overall Study|Work-related matter|0|||
161726753|NCT01441440|584043011|FG000|Overall Study|Difficllty in keeping the schedule|1|||
161726754|NCT01441440|584043012|FG001|Overall Study|Difficllty in keeping the schedule|1|||
161726755|NCT01441440|584043013|FG002|Overall Study|Difficllty in keeping the schedule|0|||
161726756|NCT01993329|584043014|FG000|Period 2|Adverse Event|0|||
161965534|NCT03458910|584920359|FG000|Overall Study|Withdrawal by Subject|7|||
161726757|NCT01993329|584043015|FG001|Period 2|Adverse Event|0|||
161726758|NCT01993329|584043016|FG002|Period 2|Adverse Event|0|||
161965535|NCT03458910|584920360|FG001|Overall Study|Withdrawal by Subject|8|||
161726759|NCT01993329|584043017|FG003|Period 2|Adverse Event|0|||
161726760|NCT01993329|584043018|FG004|Period 2|Adverse Event|0|||
161726761|NCT01993329|584043019|FG005|Period 2|Adverse Event|1|||
161726762|NCT01993329|584043014|FG000|Wash-out|Personal reasons|0|||
161726763|NCT01993329|584043015|FG001|Wash-out|Personal reasons|1|||
161726764|NCT01993329|584043016|FG002|Wash-out|Personal reasons|0|||
161726765|NCT01993329|584043017|FG003|Wash-out|Personal reasons|0|||
161726766|NCT01993329|584043018|FG004|Wash-out|Personal reasons|0|||
161726767|NCT01993329|584043019|FG005|Wash-out|Personal reasons|0|||
161726768|NCT00883558|584043020|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
161726769|NCT00883558|584043021|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
161726770|NCT00883558|584043022|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
161726771|NCT00883558|584043020|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
161726772|NCT00883558|584043021|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
161726773|NCT00883558|584043022|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
161726774|NCT00883558|584043020|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
161726775|NCT00883558|584043021|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
161726776|NCT00883558|584043022|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
161726777|NCT00883558|584043020|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
161726778|NCT00883558|584043021|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
161726779|NCT00883558|584043022|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
161726780|NCT00883558|584043020|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
161726781|NCT00883558|584043021|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
161726782|NCT00883558|584043022|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
161726783|NCT03539458|584043023|FG000|Overall Study|Death|1|||
161726784|NCT02750800|584043026|FG000|Overall Study|Adverse Event|18|||
161726785|NCT02750800|584043026|FG000|Overall Study|Lost to Follow-up|12|||
161726786|NCT02750800|584043026|FG000|Overall Study|Investigator decision|53|||
161726787|NCT02750800|584043026|FG000|Overall Study|Patient request|12|||
161726788|NCT02750800|584043026|FG000|Overall Study|Other, not specified|3|||
161726789|NCT00879814|584043027|FG000|Overall Study|Adverse Event|0|||
161726790|NCT00879814|584043028|FG001|Overall Study|Adverse Event|1|||
161726791|NCT00879814|584043029|FG002|Overall Study|Adverse Event|0|||
161726792|NCT00879814|584043030|FG003|Overall Study|Adverse Event|0|||
161726793|NCT00879814|584043027|FG000|Overall Study|Lost to Follow-up|1|||
161726794|NCT00879814|584043028|FG001|Overall Study|Lost to Follow-up|0|||
161726795|NCT00879814|584043029|FG002|Overall Study|Lost to Follow-up|0|||
161726796|NCT00879814|584043030|FG003|Overall Study|Lost to Follow-up|2|||
161726797|NCT00879814|584043027|FG000|Overall Study|Participant Failed to Return|0|||
161726798|NCT00879814|584043028|FG001|Overall Study|Participant Failed to Return|0|||
161726799|NCT00879814|584043029|FG002|Overall Study|Participant Failed to Return|0|||
161726800|NCT00879814|584043030|FG003|Overall Study|Participant Failed to Return|1|||
161726801|NCT00879814|584043027|FG000|Overall Study|Withdrawal by Subject|3|||
161726802|NCT00879814|584043028|FG001|Overall Study|Withdrawal by Subject|1|||
161726803|NCT00879814|584043029|FG002|Overall Study|Withdrawal by Subject|1|||
161726804|NCT00879814|584043030|FG003|Overall Study|Withdrawal by Subject|2|||
161726805|NCT00879814|584043027|FG000|Overall Study|Physician Decision|0|||
161726806|NCT00879814|584043028|FG001|Overall Study|Physician Decision|0|||
161726807|NCT00879814|584043029|FG002|Overall Study|Physician Decision|1|||
161726808|NCT00879814|584043030|FG003|Overall Study|Physician Decision|0|||
161726809|NCT00879814|584043027|FG000|Overall Study|Other|0|||
161726810|NCT00879814|584043028|FG001|Overall Study|Other|0|||
161726811|NCT00879814|584043029|FG002|Overall Study|Other|1|||
161726812|NCT00879814|584043030|FG003|Overall Study|Other|0|||
161726813|NCT00972478|584043031|FG000|Overall Study|Adverse Event|3|||
161726814|NCT00972478|584043032|FG001|Overall Study|Adverse Event|16|||
161726815|NCT00972478|584043031|FG000|Overall Study|Withdrawal by Subject|1|||
161726816|NCT00972478|584043032|FG001|Overall Study|Withdrawal by Subject|8|||
161726817|NCT00972478|584043031|FG000|Overall Study|Progression/Relapse|0|||
161726818|NCT00972478|584043032|FG001|Overall Study|Progression/Relapse|2|||
161726819|NCT00972478|584043031|FG000|Overall Study|Death|0|||
161726820|NCT00972478|584043032|FG001|Overall Study|Death|2|||
161726821|NCT00972478|584043031|FG000|Overall Study|Not protocol specified|1|||
161726822|NCT00972478|584043032|FG001|Overall Study|Not protocol specified|1|||
161726823|NCT00972478|584043031|FG000|Overall Study|Ineligible|1|||
161726824|NCT00972478|584043032|FG001|Overall Study|Ineligible|7|||
161726825|NCT00972478|584043031|FG000|Overall Study|Not start protocol treatment|1|||
161726826|NCT00972478|584043032|FG001|Overall Study|Not start protocol treatment|2|||
161726827|NCT04742907|584043039|FG000|Overall Study|Adverse Event|1|||
161726828|NCT04742907|584043040|FG001|Overall Study|Adverse Event|0|||
161726829|NCT04742907|584043041|FG002|Overall Study|Adverse Event|1|||
161726830|NCT04742907|584043039|FG000|Overall Study|Lost to Follow-up|3|||
161726831|NCT04742907|584043040|FG001|Overall Study|Lost to Follow-up|3|||
161726832|NCT04742907|584043041|FG002|Overall Study|Lost to Follow-up|2|||
161726833|NCT04742907|584043039|FG000|Overall Study|Physician Decision|0|||
161726834|NCT04742907|584043040|FG001|Overall Study|Physician Decision|1|||
161726835|NCT04742907|584043041|FG002|Overall Study|Physician Decision|0|||
161726836|NCT04742907|584043039|FG000|Overall Study|Protocol Violation|1|||
161726837|NCT04742907|584043040|FG001|Overall Study|Protocol Violation|1|||
161726838|NCT04742907|584043041|FG002|Overall Study|Protocol Violation|1|||
161726839|NCT04742907|584043039|FG000|Overall Study|Withdrawal by Subject|5|||
161726840|NCT04742907|584043040|FG001|Overall Study|Withdrawal by Subject|6|||
161726841|NCT04742907|584043041|FG002|Overall Study|Withdrawal by Subject|4|||
161726842|NCT04742907|584043039|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
161726843|NCT04742907|584043040|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
161726844|NCT04742907|584043041|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
161726845|NCT04742907|584043039|FG000|Overall Study|Did Not Receive the Study Drug|2|||
161726846|NCT04742907|584043040|FG001|Overall Study|Did Not Receive the Study Drug|4|||
161726847|NCT04742907|584043041|FG002|Overall Study|Did Not Receive the Study Drug|4|||
161726848|NCT01428063|584043042|FG000|Overall Study|Lack of Efficacy|8|||
161726849|NCT01428063|584043043|FG001|Overall Study|Lack of Efficacy|4|||
161726850|NCT01428063|584043044|FG002|Overall Study|Lack of Efficacy|1|||
161726851|NCT01428063|584043042|FG000|Overall Study|Adverse Event|2|||
161726852|NCT01428063|584043043|FG001|Overall Study|Adverse Event|3|||
161726853|NCT01428063|584043044|FG002|Overall Study|Adverse Event|0|||
161726854|NCT01428063|584043042|FG000|Overall Study|Lost to Follow-up|0|||
161726855|NCT01428063|584043043|FG001|Overall Study|Lost to Follow-up|2|||
161726856|NCT01428063|584043044|FG002|Overall Study|Lost to Follow-up|0|||
161726857|NCT01428063|584043042|FG000|Overall Study|No longer meets study criteria|0|||
161726858|NCT01428063|584043043|FG001|Overall Study|No longer meets study criteria|1|||
161726859|NCT01428063|584043044|FG002|Overall Study|No longer meets study criteria|0|||
161726860|NCT01005719|584043045|FG000|Period 1|Adverse Event|0|||
161726861|NCT01005719|584043046|FG001|Period 1|Adverse Event|0|||
161726862|NCT01005719|584043047|FG002|Period 1|Adverse Event|0|||
161726863|NCT01005719|584043048|FG003|Period 1|Adverse Event|1|||
161726864|NCT01005719|584043049|FG004|Period 1|Adverse Event|0|||
161726865|NCT01005719|584043050|FG005|Period 1|Adverse Event|0|||
161726866|NCT01005719|584043045|FG000|Period 1|Delay in completing study procedures|0|||
161726867|NCT01005719|584043046|FG001|Period 1|Delay in completing study procedures|0|||
161726868|NCT01005719|584043047|FG002|Period 1|Delay in completing study procedures|0|||
161726869|NCT01005719|584043048|FG003|Period 1|Delay in completing study procedures|0|||
161726870|NCT01005719|584043049|FG004|Period 1|Delay in completing study procedures|0|||
161726871|NCT01005719|584043050|FG005|Period 1|Delay in completing study procedures|1|||
161726872|NCT01005719|584043045|FG000|Period 2|Adverse Event|0|||
161726873|NCT01005719|584043046|FG001|Period 2|Adverse Event|0|||
161726874|NCT01005719|584043047|FG002|Period 2|Adverse Event|0|||
161726875|NCT01005719|584043048|FG003|Period 2|Adverse Event|0|||
161726876|NCT01005719|584043049|FG004|Period 2|Adverse Event|1|||
161726877|NCT01005719|584043050|FG005|Period 2|Adverse Event|1|||
161726878|NCT01753076|584043051|FG000|Overall Study|Adverse Event|17|||
161726879|NCT01753076|584043052|FG001|Overall Study|Adverse Event|18|||
161726880|NCT01753076|584043051|FG000|Overall Study|Lack of Efficacy|3|||
161726881|NCT01753076|584043052|FG001|Overall Study|Lack of Efficacy|1|||
161726882|NCT01753076|584043051|FG000|Overall Study|Lost to Follow-up|2|||
161726883|NCT01753076|584043052|FG001|Overall Study|Lost to Follow-up|1|||
161726884|NCT01753076|584043051|FG000|Overall Study|Physician Decision|4|||
161726885|NCT01753076|584043052|FG001|Overall Study|Physician Decision|2|||
161726886|NCT01753076|584043051|FG000|Overall Study|Withdrawal by Subject|14|||
161726887|NCT01753076|584043052|FG001|Overall Study|Withdrawal by Subject|24|||
161726888|NCT01753076|584043051|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
161726889|NCT01753076|584043052|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
161726890|NCT01259856|584043053|FG000|Overall Study|Adverse Event|12|||
161726891|NCT01259856|584043054|FG001|Overall Study|Adverse Event|9|||
161726892|NCT01259856|584043053|FG000|Overall Study|Death|0|||
161726893|NCT01259856|584043054|FG001|Overall Study|Death|1|||
161726894|NCT01259856|584043053|FG000|Overall Study|Lack of Efficacy|3|||
161726895|NCT01259856|584043054|FG001|Overall Study|Lack of Efficacy|1|||
161726896|NCT01259856|584043053|FG000|Overall Study|Lost to Follow-up|1|||
161726897|NCT01259856|584043054|FG001|Overall Study|Lost to Follow-up|1|||
161726898|NCT01259856|584043053|FG000|Overall Study|Physician Decision|2|||
161965536|NCT03458910|584920361|FG002|Overall Study|Withdrawal by Subject|6|||
161965537|NCT03458910|584920362|FG003|Overall Study|Withdrawal by Subject|4|||
161726899|NCT01259856|584043054|FG001|Overall Study|Physician Decision|1|||
161726900|NCT01259856|584043053|FG000|Overall Study|Withdrawal by Subject|9|||
161965538|NCT03458910|584920359|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
161726901|NCT01259856|584043054|FG001|Overall Study|Withdrawal by Subject|10|||
161726902|NCT01259856|584043053|FG000|Overall Study|Treatment never started|0|||
161726903|NCT01259856|584043054|FG001|Overall Study|Treatment never started|6|||
161726904|NCT01259856|584043053|FG000|Overall Study|Study closure by sponsor|40|||
161726905|NCT01259856|584043054|FG001|Overall Study|Study closure by sponsor|41|||
161726906|NCT01259856|584043053|FG000|Overall Study|Patient developed other disease|0|||
161726907|NCT01259856|584043054|FG001|Overall Study|Patient developed other disease|1|||
161726908|NCT01259856|584043053|FG000|Overall Study|Transfer to another study|0|||
161965539|NCT03458910|584920360|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
161965540|NCT03458910|584920361|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
161965541|NCT03458910|584920362|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
161965542|NCT05275010|584920363|FG000|Overall Study|Reason Not Specified|4|||
161965543|NCT05275010|584920364|FG001|Overall Study|Reason Not Specified|1|||
161726909|NCT01259856|584043054|FG001|Overall Study|Transfer to another study|1|||
161726910|NCT01259856|584043053|FG000|Overall Study|Unknown/missing|2|||
161726911|NCT01259856|584043054|FG001|Overall Study|Unknown/missing|2|||
161726912|NCT00788775|584043055|FG000|Overall Study|Progressive Disease|8|||
161726913|NCT00788775|584043056|FG001|Overall Study|Progressive Disease|6|||
161726914|NCT00788775|584043055|FG000|Overall Study|Withdrawal by Subject|0|||
161726915|NCT00788775|584043056|FG001|Overall Study|Withdrawal by Subject|2|||
161726916|NCT00788775|584043055|FG000|Overall Study|Patient Non-Compliance|1|||
161726917|NCT00788775|584043056|FG001|Overall Study|Patient Non-Compliance|0|||
161726918|NCT00788775|584043055|FG000|Overall Study|Patient's measurable disease resected.|1|||
161726919|NCT00788775|584043056|FG001|Overall Study|Patient's measurable disease resected.|0|||
161726920|NCT04488822|584043059|FG000|Overall Study|Adverse Event|8|||
161726921|NCT04488822|584043059|FG000|Overall Study|Withdrawal by Subject|1|||
161726922|NCT03838367|584043060|FG000|Overall Study|Early termination of study|3|||
161726923|NCT03838367|584043061|FG001|Overall Study|Early termination of study|4|||
161726924|NCT03838367|584043062|FG002|Overall Study|Early termination of study|3|||
161726925|NCT03838367|584043063|FG003|Overall Study|Early termination of study|0|||
161726926|NCT03406104|584043064|FG000|Overall Study|Lost to Follow-up|2|||
161726927|NCT03406104|584043064|FG000|Overall Study|Withdrawal by Subject|2|||
161726928|NCT03406104|584043064|FG000|Overall Study|due to Covid patient did not want to travel|1|||
161726929|NCT03406104|584043064|FG000|Overall Study|Death|2|||
161726930|NCT00114972|584043069|FG000|Overall Study|Withdrawal by Subject|40|||
161726931|NCT00114972|584043070|FG001|Overall Study|Withdrawal by Subject|7|||
161726932|NCT00114972|584043069|FG000|Overall Study|Lost to Follow-up|8|||
161726933|NCT00114972|584043070|FG001|Overall Study|Lost to Follow-up|5|||
161726934|NCT01035255|584043079|FG000|Overall Study|Death|724|||
161726935|NCT01035255|584043080|FG001|Overall Study|Death|844|||
161726936|NCT01035255|584043079|FG000|Overall Study|Lost to Follow-up|2|||
161726937|NCT01035255|584043080|FG001|Overall Study|Lost to Follow-up|5|||
161726938|NCT01035255|584043079|FG000|Overall Study|patient's request|15|||
161726939|NCT01035255|584043080|FG001|Overall Study|patient's request|13|||
161726940|NCT00195260|584043086|FG000|Part 1: Dose Escalation|Adverse Event|0|||
161726941|NCT00195260|584043087|FG001|Part 1: Dose Escalation|Adverse Event|1|||
161726942|NCT00195260|584043088|FG002|Part 1: Dose Escalation|Adverse Event|0|||
161726943|NCT00195260|584043089|FG003|Part 1: Dose Escalation|Adverse Event|1|||
161726944|NCT00195260|584043090|FG004|Part 1: Dose Escalation|Adverse Event|1|||
161726945|NCT00195260|584043091|FG005|Part 1: Dose Escalation|Adverse Event|0|||
161726946|NCT00195260|584043092|FG006|Part 1: Dose Escalation|Adverse Event|3|||
161726947|NCT00195260|584043093|FG007|Part 1: Dose Escalation|Adverse Event|0|||
161726948|NCT00195260|584043094|FG008|Part 1: Dose Escalation|Adverse Event|0|||
161726949|NCT00195260|584043095|FG009|Part 1: Dose Escalation|Adverse Event|0|||
161726950|NCT00195260|584043096|FG010|Part 1: Dose Escalation|Adverse Event|0|||
161726951|NCT00195260|584043086|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726952|NCT00195260|584043087|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726953|NCT00195260|584043088|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726954|NCT00195260|584043089|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726955|NCT00195260|584043090|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161726956|NCT00195260|584043091|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726957|NCT00195260|584043092|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726958|NCT00195260|584043093|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
161726959|NCT00195260|584043094|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726960|NCT00195260|584043095|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726961|NCT00195260|584043096|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161726962|NCT00195260|584043086|FG000|Part 1: Dose Escalation|Death|0|||
161726963|NCT00195260|584043087|FG001|Part 1: Dose Escalation|Death|0|||
161726964|NCT00195260|584043088|FG002|Part 1: Dose Escalation|Death|0|||
161726965|NCT00195260|584043089|FG003|Part 1: Dose Escalation|Death|0|||
161726966|NCT00195260|584043090|FG004|Part 1: Dose Escalation|Death|0|||
161726967|NCT00195260|584043091|FG005|Part 1: Dose Escalation|Death|0|||
161965544|NCT05275010|584920363|FG000|Overall Study|Withdrawal by Subject|1|||
161726968|NCT00195260|584043092|FG006|Part 1: Dose Escalation|Death|0|||
161726969|NCT00195260|584043093|FG007|Part 1: Dose Escalation|Death|1|||
161726970|NCT00195260|584043094|FG008|Part 1: Dose Escalation|Death|0|||
161726971|NCT00195260|584043095|FG009|Part 1: Dose Escalation|Death|0|||
161726972|NCT00195260|584043096|FG010|Part 1: Dose Escalation|Death|0|||
161726973|NCT00195260|584043086|FG000|Part 1: Dose Escalation|Disease Progression|3|||
161965545|NCT05275010|584920364|FG001|Overall Study|Withdrawal by Subject|0|||
161965546|NCT05275010|584920363|FG000|Overall Study|Lost to Follow-up|0|||
161726974|NCT00195260|584043087|FG001|Part 1: Dose Escalation|Disease Progression|2|||
161726975|NCT00195260|584043088|FG002|Part 1: Dose Escalation|Disease Progression|5|||
161726976|NCT00195260|584043089|FG003|Part 1: Dose Escalation|Disease Progression|6|||
161726977|NCT00195260|584043090|FG004|Part 1: Dose Escalation|Disease Progression|4|||
161726978|NCT00195260|584043091|FG005|Part 1: Dose Escalation|Disease Progression|6|||
161726979|NCT00195260|584043092|FG006|Part 1: Dose Escalation|Disease Progression|7|||
161726980|NCT00195260|584043093|FG007|Part 1: Dose Escalation|Disease Progression|4|||
161726981|NCT00195260|584043094|FG008|Part 1: Dose Escalation|Disease Progression|0|||
161726982|NCT00195260|584043095|FG009|Part 1: Dose Escalation|Disease Progression|0|||
161726983|NCT00195260|584043096|FG010|Part 1: Dose Escalation|Disease Progression|0|||
161726984|NCT00195260|584043086|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
161726985|NCT00195260|584043087|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
161726986|NCT00195260|584043088|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
161726987|NCT00195260|584043089|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726988|NCT00195260|584043090|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726989|NCT00195260|584043091|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
161726990|NCT00195260|584043092|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726991|NCT00195260|584043093|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726992|NCT00195260|584043094|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726993|NCT00195260|584043095|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726994|NCT00195260|584043096|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161726995|NCT00195260|584043086|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161726996|NCT00195260|584043087|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161726997|NCT00195260|584043088|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161726998|NCT00195260|584043089|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161726999|NCT00195260|584043090|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161727000|NCT00195260|584043091|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161727001|NCT00195260|584043092|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161727002|NCT00195260|584043093|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161727003|NCT00195260|584043094|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
161727004|NCT00195260|584043095|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
161727005|NCT00195260|584043096|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
161727006|NCT00195260|584043086|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727007|NCT00195260|584043087|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727008|NCT00195260|584043088|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727009|NCT00195260|584043089|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727010|NCT00195260|584043090|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727011|NCT00195260|584043091|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727012|NCT00195260|584043092|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727013|NCT00195260|584043093|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161727014|NCT00195260|584043094|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
161727015|NCT00195260|584043095|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
161727016|NCT00195260|584043096|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
161727017|NCT00195260|584043086|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727018|NCT00195260|584043087|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727019|NCT00195260|584043088|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727020|NCT00195260|584043089|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727021|NCT00195260|584043090|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727022|NCT00195260|584043091|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727023|NCT00195260|584043092|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727024|NCT00195260|584043093|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161727025|NCT00195260|584043094|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
161727026|NCT00195260|584043095|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
161727027|NCT00195260|584043096|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
161727028|NCT00195260|584043086|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727029|NCT00195260|584043087|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727030|NCT00195260|584043088|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727031|NCT00195260|584043089|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727032|NCT00195260|584043090|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727033|NCT00195260|584043091|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727034|NCT00195260|584043092|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727035|NCT00195260|584043093|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161727036|NCT00195260|584043094|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
161727037|NCT00195260|584043095|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
161727038|NCT00195260|584043096|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
161727039|NCT02749721|584043097|FG000|Screening|Withdrawal by Subject|1|||
161727040|NCT02749721|584043097|FG000|Screening|Lost to Follow-up|2|||
161727041|NCT02749721|584043097|FG000|Screening|Protocol Violation|3|||
161727042|NCT02749721|584043097|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
161965547|NCT05275010|584920364|FG001|Overall Study|Lost to Follow-up|1|||
161727043|NCT02749721|584043097|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
161727044|NCT00772967|584043098|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
161727045|NCT00772967|584043099|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
161727046|NCT00772967|584043100|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
161727047|NCT00772967|584043101|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
161727048|NCT00772967|584043102|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
161727049|NCT00772967|584043103|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
161727050|NCT00772967|584043098|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161727051|NCT00772967|584043099|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
161727052|NCT00772967|584043100|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161727053|NCT00772967|584043101|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161727054|NCT00772967|584043102|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161727055|NCT00772967|584043103|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161727056|NCT00772967|584043098|FG000|Crossover Treatment 3|Adverse Event|0|||
161727057|NCT00772967|584043099|FG001|Crossover Treatment 3|Adverse Event|0|||
161727058|NCT00772967|584043100|FG002|Crossover Treatment 3|Adverse Event|0|||
161727059|NCT00772967|584043101|FG003|Crossover Treatment 3|Adverse Event|0|||
161727060|NCT00772967|584043102|FG004|Crossover Treatment 3|Adverse Event|1|||
161727061|NCT00772967|584043103|FG005|Crossover Treatment 3|Adverse Event|0|||
161727062|NCT00231062|584043104|FG000|Overall Study|Physician Decision|6|||
161727063|NCT00803244|584043105|FG000|Overall Study|Adverse Event|1|||
161727064|NCT00803244|584043106|FG001|Overall Study|Adverse Event|2|||
161727065|NCT00803244|584043105|FG000|Overall Study|Withdrawal by Subject|2|||
161727066|NCT00803244|584043106|FG001|Overall Study|Withdrawal by Subject|3|||
161727067|NCT00803244|584043105|FG000|Overall Study|Any other reason not above-mentioned|4|||
161727068|NCT00803244|584043106|FG001|Overall Study|Any other reason not above-mentioned|10|||
161727069|NCT03321929|584043107|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
161727070|NCT00443430|584043110|FG000|Overall Study|Lack of Efficacy|3|||
161727071|NCT00443430|584043111|FG001|Overall Study|Lack of Efficacy|3|||
161727072|NCT00443430|584043110|FG000|Overall Study|Adverse Event|1|||
161727073|NCT00443430|584043111|FG001|Overall Study|Adverse Event|1|||
161727074|NCT02379923|584043114|FG000|Overall Study|Death|5|||
161727075|NCT03288779|584043119|FG000|Overall Study|Withdrawal by Subject|3|||
161727076|NCT03382899|584043120|FG000|Overall Study|Ineligibility Determined|0|||
161727077|NCT03382899|584043121|FG001|Overall Study|Ineligibility Determined|1|||
161727078|NCT03382899|584043120|FG000|Overall Study|Lost to Follow-up|0|||
161727079|NCT03382899|584043121|FG001|Overall Study|Lost to Follow-up|1|||
161727080|NCT03382899|584043120|FG000|Overall Study|Sponsor's decision|31|||
161727081|NCT03382899|584043121|FG001|Overall Study|Sponsor's decision|28|||
161727082|NCT03382899|584043120|FG000|Overall Study|Withdrawal by Subject|0|||
161727083|NCT03382899|584043121|FG001|Overall Study|Withdrawal by Subject|5|||
161727084|NCT00524745|584043123|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
161727085|NCT00524745|584043124|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
161727086|NCT00524745|584043125|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
161727087|NCT00524745|584043126|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
161727088|NCT02504892|584043127|FG000|Overall Study|Adverse event-pneumonitis|2|||
161727089|NCT01413178|584043128|FG000|Overall Study|Toxicity|1|||
161727090|NCT01413178|584043129|FG001|Overall Study|Toxicity|0|||
161727091|NCT01413178|584043128|FG000|Overall Study|Ineligible|0|||
161727092|NCT01413178|584043129|FG001|Overall Study|Ineligible|2|||
161727093|NCT00540449|584043130|FG000|Overall Study|Adverse Event|12|||
161727094|NCT00540449|584043131|FG001|Overall Study|Adverse Event|32|||
161727095|NCT00540449|584043130|FG000|Overall Study|Sponsor's Decision|1|||
161727096|NCT00540449|584043131|FG001|Overall Study|Sponsor's Decision|1|||
161727097|NCT00540449|584043130|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
161727098|NCT00540449|584043131|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
161727099|NCT00540449|584043130|FG000|Overall Study|Lost to Follow-up|19|||
161727100|NCT00540449|584043131|FG001|Overall Study|Lost to Follow-up|17|||
161727101|NCT00540449|584043130|FG000|Overall Study|Subject Non-Compliant|7|||
161727102|NCT00540449|584043131|FG001|Overall Study|Subject Non-Compliant|5|||
161727103|NCT00540449|584043130|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
161727104|NCT00540449|584043131|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
161727105|NCT00540449|584043130|FG000|Overall Study|Withdrawal by Subject|10|||
161727106|NCT00540449|584043131|FG001|Overall Study|Withdrawal by Subject|10|||
161727107|NCT00540449|584043130|FG000|Overall Study|Other|1|||
161727108|NCT00540449|584043131|FG001|Overall Study|Other|4|||
161727109|NCT03283163|584043132|FG000|Overall Study|Lost to Follow-up|1|||
161727110|NCT03283163|584043132|FG000|Overall Study|other life commitments|6|||
161727111|NCT03283163|584043132|FG000|Overall Study|COVID-19 institution wide halting|1|||
161727112|NCT03283163|584043132|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
161727113|NCT03283163|584043132|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
161727114|NCT00237796|584043133|FG000|Overall Study|Baseline and one other ILSS required|10|||
161727115|NCT00237796|584043134|FG001|Overall Study|Baseline and one other ILSS required|5|||
161727116|NCT04238663|584043135|FG000|Overall Study|Lost to Follow-up|0|||
161727117|NCT04238663|584043136|FG001|Overall Study|Lost to Follow-up|1|||
161727118|NCT04238663|584043137|FG002|Overall Study|Lost to Follow-up|0|||
161727119|NCT02566525|584043138|FG000|Overall Study|Protocol Violation|3|||
161727120|NCT02566525|584043139|FG001|Overall Study|Protocol Violation|5|||
161727121|NCT00337467|584043140|FG000|Overall Study|Adverse Event|3|||
161727122|NCT00337467|584043140|FG000|Overall Study|Subject Withdrew Consent|2|||
161727123|NCT00337467|584043140|FG000|Overall Study|Pregnancy|1|||
161727124|NCT00337467|584043140|FG000|Overall Study|Lost to Follow-up|2|||
161727125|NCT00337467|584043140|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
161727126|NCT03141086|584043143|FG000|Overall Study|Study Terminated By Sponsor|1|||
161727127|NCT03141086|584043144|FG001|Overall Study|Study Terminated By Sponsor|1|||
161727128|NCT03141086|584043143|FG000|Overall Study|Withdrawal by Subject|0|||
161727129|NCT03141086|584043144|FG001|Overall Study|Withdrawal by Subject|1|||
161727130|NCT03141086|584043143|FG000|Overall Study|Protocol Violation|0|||
161727131|NCT03141086|584043144|FG001|Overall Study|Protocol Violation|1|||
161727132|NCT03141086|584043143|FG000|Overall Study|Adverse Event|0|||
161727133|NCT03141086|584043144|FG001|Overall Study|Adverse Event|2|||
161727134|NCT04430582|584043146|FG000|Overall Study|Found to meet exclusionary criteria|1|||
161727135|NCT04430582|584043147|FG001|Overall Study|Found to meet exclusionary criteria|0|||
161727136|NCT04430582|584043146|FG000|Overall Study|Withdrawal by Subject|0|||
161727137|NCT04430582|584043147|FG001|Overall Study|Withdrawal by Subject|1|||
161727138|NCT03607682|584043148|FG000|Overall Study|Withdrawal by Subject|1|||
161727139|NCT03607682|584043148|FG000|Overall Study|Disease progression|1|||
161727140|NCT00074412|584044121|FG000|Overall Study|Death|30|||
161727141|NCT00074412|584044122|FG001|Overall Study|Death|26|||
161727142|NCT00074412|584044121|FG000|Overall Study|Lost to Follow-up|52|||
161727143|NCT00074412|584044122|FG001|Overall Study|Lost to Follow-up|58|||
161727144|NCT01043185|584044123|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
161727145|NCT01043185|584044124|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
161727146|NCT01043185|584044125|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
161727147|NCT01043185|584044126|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
161727148|NCT01043185|584044127|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
161727149|NCT01043185|584044128|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
161727150|NCT01043185|584044129|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
161727151|NCT01043185|584044130|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
161727152|NCT01043185|584044131|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
161727153|NCT01043185|584044132|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
161727154|NCT01881620|584044135|FG000|Overall Study|Protocol Violation|4|||
161727155|NCT02561000|584044137|FG000|Overall Study|Withdrawal by Subject|2|||
161727156|NCT02561000|584044138|FG001|Overall Study|Withdrawal by Subject|3|||
161727157|NCT02561000|584044139|FG002|Overall Study|Withdrawal by Subject|0|||
161727158|NCT02561000|584044137|FG000|Overall Study|Adverse Event|0|||
161727159|NCT02561000|584044138|FG001|Overall Study|Adverse Event|1|||
161727160|NCT02561000|584044139|FG002|Overall Study|Adverse Event|0|||
161727161|NCT03430245|584044142|FG000|Overall Study|Withdrawal by Subject|6|||
161727162|NCT03430245|584044142|FG000|Overall Study|Lost to Follow-up|1|||
161727163|NCT03656926|584044143|FG000|Overall Study|Adverse Event|5|||
161727164|NCT03656926|584044144|FG001|Overall Study|Adverse Event|4|||
161727165|NCT03656926|584044143|FG000|Overall Study|Withdrawal by Subject|7|||
161727166|NCT03656926|584044144|FG001|Overall Study|Withdrawal by Subject|2|||
161727167|NCT03656926|584044143|FG000|Overall Study|Screen fail after randomization|1|||
161727168|NCT03656926|584044144|FG001|Overall Study|Screen fail after randomization|0|||
161727169|NCT03656926|584044143|FG000|Overall Study|PI decision due to patient condition|1|||
161838092|NCT00770692|584450334|FG001|Overall Study|Withdrawal by Subject|9|||
161838093|NCT00770692|584450335|FG002|Overall Study|Withdrawal by Subject|9|||
161838094|NCT00770692|584450336|FG003|Overall Study|Withdrawal by Subject|6|||
161838095|NCT00770692|584450333|FG000|Overall Study|Adverse Event|3|||
161838096|NCT00770692|584450334|FG001|Overall Study|Adverse Event|0|||
161838097|NCT00770692|584450335|FG002|Overall Study|Adverse Event|4|||
161838098|NCT00770692|584450336|FG003|Overall Study|Adverse Event|4|||
161838099|NCT00770692|584450333|FG000|Overall Study|Investigator judgment|2|||
161838100|NCT00770692|584450334|FG001|Overall Study|Investigator judgment|0|||
161838101|NCT00770692|584450335|FG002|Overall Study|Investigator judgment|1|||
161838102|NCT00770692|584450336|FG003|Overall Study|Investigator judgment|1|||
161838103|NCT01230892|584450337|FG000|Overall Study|Withdrawal by Subject|1|||
161838104|NCT01230892|584450338|FG001|Overall Study|Withdrawal by Subject|1|||
161838105|NCT01230892|584450337|FG000|Overall Study|Lost to Follow-up|2|||
161727170|NCT03656926|584044144|FG001|Overall Study|PI decision due to patient condition|0|||
161727171|NCT03656926|584044143|FG000|Overall Study|Patient unresponsiveness|1|||
161727172|NCT03656926|584044144|FG001|Overall Study|Patient unresponsiveness|0|||
161727173|NCT00850759|584044149|FG000|Overall Study|Lost to Follow-up|7|||
161727174|NCT00850759|584044150|FG001|Overall Study|Lost to Follow-up|5|||
161727175|NCT00850759|584044151|FG002|Overall Study|Lost to Follow-up|5|||
161727176|NCT00850759|584044152|FG003|Overall Study|Lost to Follow-up|3|||
161727177|NCT03196505|584044153|FG000|Overall Study|Physician Decision|26|||
161838106|NCT01230892|584450338|FG001|Overall Study|Lost to Follow-up|0|||
161727178|NCT03196505|584044154|FG001|Overall Study|Physician Decision|26|||
161727179|NCT02575079|584044156|FG000|Overall Study|Death|3|||
161727180|NCT02575079|584044157|FG001|Overall Study|Death|0|||
161727181|NCT02575079|584044156|FG000|Overall Study|Withdrawal by Subject|3|||
161727182|NCT02575079|584044157|FG001|Overall Study|Withdrawal by Subject|0|||
161727183|NCT02918266|584044158|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
161727184|NCT02918266|584044159|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727185|NCT02918266|584044160|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727186|NCT02918266|584044161|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727187|NCT02918266|584044162|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727188|NCT02918266|584044163|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727189|NCT02918266|584044164|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
161727190|NCT02918266|584044165|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727191|NCT02918266|584044166|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
161727192|NCT02918266|584044167|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727193|NCT02918266|584044168|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161727194|NCT00578864|584044171|FG000|Overall Study|Death|1|||
161727195|NCT00578864|584044172|FG001|Overall Study|Death|0|||
161727196|NCT01293032|584044176|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
161727197|NCT01293032|584044177|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
161727198|NCT01293032|584044178|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
161727199|NCT01293032|584044179|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
161727200|NCT01293032|584044176|FG000|Treatment|Adverse Event|0|||
161727201|NCT01293032|584044177|FG001|Treatment|Adverse Event|0|||
161727202|NCT01293032|584044178|FG002|Treatment|Adverse Event|1|||
161727203|NCT01293032|584044179|FG003|Treatment|Adverse Event|1|||
161727204|NCT01293032|584044176|FG000|Treatment|Withdrawal by Subject|2|||
161727205|NCT01293032|584044177|FG001|Treatment|Withdrawal by Subject|4|||
161727206|NCT01293032|584044178|FG002|Treatment|Withdrawal by Subject|0|||
161727207|NCT01293032|584044179|FG003|Treatment|Withdrawal by Subject|0|||
161727208|NCT01293032|584044176|FG000|Treatment|Disease Progression, relapse|0|||
161727209|NCT01293032|584044177|FG001|Treatment|Disease Progression, relapse|1|||
161727210|NCT01293032|584044178|FG002|Treatment|Disease Progression, relapse|0|||
161727211|NCT01293032|584044179|FG003|Treatment|Disease Progression, relapse|0|||
161727212|NCT01253044|584044180|FG000|Overall Study|Lost to Follow-up|38|||
161727213|NCT01253044|584044181|FG001|Overall Study|Lost to Follow-up|29|||
161727214|NCT01087528|584044184|FG000|Overall Study|Withdrawal by Subject|1|||
161727215|NCT01087528|584044184|FG000|Overall Study|Incomplete CE procedure|6|||
161727216|NCT03116399|584044185|FG000|Overall Study|Death|8|||
161727217|NCT03116399|584044186|FG001|Overall Study|Death|3|||
161727218|NCT03116399|584044185|FG000|Overall Study|Lost to Follow-up|7|||
161727219|NCT03116399|584044186|FG001|Overall Study|Lost to Follow-up|11|||
161727220|NCT03116399|584044185|FG000|Overall Study|Investigator Decision|1|||
161727221|NCT03116399|584044186|FG001|Overall Study|Investigator Decision|1|||
161727222|NCT03116399|584044185|FG000|Overall Study|Withdrawal by Subject|24|||
161727223|NCT03116399|584044186|FG001|Overall Study|Withdrawal by Subject|9|||
161727224|NCT00987623|584044188|FG000|Overall Study|Lost to Follow-up|2|||
161727225|NCT00987623|584044189|FG001|Overall Study|Lost to Follow-up|1|||
161727226|NCT00987623|584044188|FG000|Overall Study|Time/job conflict|2|||
161727227|NCT00987623|584044189|FG001|Overall Study|Time/job conflict|0|||
161727228|NCT00987623|584044188|FG000|Overall Study|Discomfort|1|||
161727229|NCT00987623|584044189|FG001|Overall Study|Discomfort|0|||
161727230|NCT00987623|584044188|FG000|Overall Study|Biomicroscopy|0|||
161727231|NCT00987623|584044189|FG001|Overall Study|Biomicroscopy|1|||
161727232|NCT00987623|584044188|FG000|Overall Study|Influenza|0|||
161727233|NCT00987623|584044189|FG001|Overall Study|Influenza|1|||
161727234|NCT02691247|584044192|FG000|Overall Study|Withdrawal by Subject|1|||
161727235|NCT02691247|584044193|FG001|Overall Study|Withdrawal by Subject|2|||
161727236|NCT02691247|584044194|FG002|Overall Study|Withdrawal by Subject|2|||
161727237|NCT02691247|584044192|FG000|Overall Study|Lost to Follow-up|2|||
161727238|NCT02691247|584044193|FG001|Overall Study|Lost to Follow-up|0|||
161727239|NCT02691247|584044194|FG002|Overall Study|Lost to Follow-up|1|||
161727240|NCT01519245|584044195|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
161727241|NCT01519245|584044196|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
161727242|NCT02873715|584044199|FG000|Overall Study|Lost to Follow-up|84|||
161727243|NCT02873715|584044200|FG001|Overall Study|Lost to Follow-up|94|||
161727244|NCT02873715|584044199|FG000|Overall Study|Withdrawal by Subject|7|||
161727245|NCT02873715|584044200|FG001|Overall Study|Withdrawal by Subject|26|||
161727246|NCT02144220|584044204|FG000|Overall Study|technology incompatibility|9|||
161727247|NCT02144220|584044204|FG000|Overall Study|Lack of Efficacy|4|||
161727248|NCT02144220|584044204|FG000|Overall Study|Physician Decision|3|||
161727249|NCT02144220|584044204|FG000|Overall Study|Withdrawal by Subject|2|||
161727250|NCT02144220|584044204|FG000|Overall Study|Protocol Violation|1|||
161727251|NCT00592501|584044207|FG000|Overall Study|Withdrawal by Subject|1|||
161727252|NCT00592501|584044207|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
161727253|NCT00053846|584044208|FG000|Overall Study|Changed mind|8|||
161727254|NCT00053846|584044209|FG001|Overall Study|Changed mind|13|||
161727255|NCT00053846|584044208|FG000|Overall Study|Became too ill|8|||
161727256|NCT00053846|584044209|FG001|Overall Study|Became too ill|7|||
161727257|NCT00053846|584044208|FG000|Overall Study|Expired|5|||
161727258|NCT00053846|584044209|FG001|Overall Study|Expired|0|||
161727259|NCT00053846|584044208|FG000|Overall Study|Became ineligible|3|||
161727260|NCT00053846|584044209|FG001|Overall Study|Became ineligible|1|||
161727261|NCT00053846|584044208|FG000|Overall Study|Did not return data|1|||
161727262|NCT00053846|584044209|FG001|Overall Study|Did not return data|2|||
161727263|NCT00053846|584044208|FG000|Overall Study|Quit due to side effects|1|||
161727264|NCT00053846|584044209|FG001|Overall Study|Quit due to side effects|3|||
161727265|NCT00053846|584044208|FG000|Overall Study|Pills too large|0|||
161727266|NCT00053846|584044209|FG001|Overall Study|Pills too large|1|||
161727267|NCT03880227|584044210|FG000|First Visit|Withdrawal by Subject|1|||
161727268|NCT03880227|584044211|FG001|First Visit|Withdrawal by Subject|0|||
161727269|NCT03880227|584044212|FG002|First Visit|Withdrawal by Subject|0|||
161727270|NCT03880227|584044213|FG003|First Visit|Withdrawal by Subject|0|||
161727271|NCT03880227|584044210|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
161727272|NCT03880227|584044211|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
161727273|NCT03880227|584044212|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
161727274|NCT03880227|584044213|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
161727275|NCT03880227|584044210|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
161727276|NCT03880227|584044211|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
161727277|NCT03880227|584044212|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
161727278|NCT03880227|584044213|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
161727279|NCT03880227|584044210|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
161727280|NCT03880227|584044211|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
161727281|NCT03880227|584044212|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
161727282|NCT03880227|584044213|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
161727283|NCT04590937|584044214|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
161727284|NCT01635933|584044215|FG000|Overall Study|Adverse Event|1|||
161727285|NCT01635933|584044216|FG001|Overall Study|Adverse Event|0|||
161727286|NCT01635933|584044215|FG000|Overall Study|Lost to Follow-up|0|||
161727287|NCT01635933|584044216|FG001|Overall Study|Lost to Follow-up|5|||
161727288|NCT01635933|584044215|FG000|Overall Study|Subject decision|1|||
161727289|NCT01635933|584044216|FG001|Overall Study|Subject decision|1|||
161727290|NCT01635933|584044215|FG000|Overall Study|Noncompliance|0|||
161727291|NCT01635933|584044216|FG001|Overall Study|Noncompliance|1|||
161727292|NCT01635933|584044215|FG000|Overall Study|No longer had transportation|0|||
161727293|NCT01635933|584044216|FG001|Overall Study|No longer had transportation|1|||
161727294|NCT01544595|584044217|FG000|Status at Week 68|Adverse Event|3|||
161727295|NCT01544595|584044218|FG001|Status at Week 68|Adverse Event|2|||
161727296|NCT01544595|584044219|FG002|Status at Week 68|Adverse Event|1|||
161727297|NCT01544595|584044220|FG003|Status at Week 68|Adverse Event|0|||
161727298|NCT01544595|584044221|FG004|Status at Week 68|Adverse Event|0|||
161727299|NCT01544595|584044222|FG005|Status at Week 68|Adverse Event|0|||
161727300|NCT01544595|584044217|FG000|Status at Week 68|Lack of Efficacy|1|||
161727301|NCT01544595|584044218|FG001|Status at Week 68|Lack of Efficacy|0|||
161727302|NCT01544595|584044219|FG002|Status at Week 68|Lack of Efficacy|0|||
161727303|NCT01544595|584044220|FG003|Status at Week 68|Lack of Efficacy|0|||
161727304|NCT01544595|584044221|FG004|Status at Week 68|Lack of Efficacy|0|||
161727305|NCT01544595|584044222|FG005|Status at Week 68|Lack of Efficacy|0|||
161727306|NCT01544595|584044217|FG000|Status at Week 68|Lost to Follow-up|1|||
161727307|NCT01544595|584044218|FG001|Status at Week 68|Lost to Follow-up|1|||
161727308|NCT01544595|584044219|FG002|Status at Week 68|Lost to Follow-up|0|||
161727309|NCT01544595|584044220|FG003|Status at Week 68|Lost to Follow-up|0|||
161727310|NCT01544595|584044221|FG004|Status at Week 68|Lost to Follow-up|0|||
161727311|NCT01544595|584044222|FG005|Status at Week 68|Lost to Follow-up|0|||
161727312|NCT01544595|584044217|FG000|Status at Week 68|Non-compliance with study treatment|1|||
161727313|NCT01544595|584044218|FG001|Status at Week 68|Non-compliance with study treatment|0|||
161727314|NCT01544595|584044219|FG002|Status at Week 68|Non-compliance with study treatment|0|||
161727315|NCT01544595|584044220|FG003|Status at Week 68|Non-compliance with study treatment|1|||
161727316|NCT01544595|584044221|FG004|Status at Week 68|Non-compliance with study treatment|0|||
161727317|NCT01544595|584044222|FG005|Status at Week 68|Non-compliance with study treatment|0|||
161727318|NCT01544595|584044217|FG000|Status at Week 68|Protocol Violation|2|||
161727319|NCT01544595|584044218|FG001|Status at Week 68|Protocol Violation|0|||
161727320|NCT01544595|584044219|FG002|Status at Week 68|Protocol Violation|1|||
161727321|NCT01544595|584044220|FG003|Status at Week 68|Protocol Violation|1|||
161727322|NCT01544595|584044221|FG004|Status at Week 68|Protocol Violation|0|||
161727323|NCT01544595|584044222|FG005|Status at Week 68|Protocol Violation|0|||
161727324|NCT01544595|584044217|FG000|Status at Week 68|Technical problems|1|||
161727325|NCT01544595|584044218|FG001|Status at Week 68|Technical problems|0|||
161727326|NCT01544595|584044219|FG002|Status at Week 68|Technical problems|0|||
161727327|NCT01544595|584044220|FG003|Status at Week 68|Technical problems|1|||
161727328|NCT01544595|584044221|FG004|Status at Week 68|Technical problems|0|||
161965548|NCT04484649|584920365|FG000|Overall Study|Lost to Follow-up|2|||
161965549|NCT04484649|584920366|FG001|Overall Study|Lost to Follow-up|1|||
161965550|NCT04484649|584920365|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
161727329|NCT01544595|584044222|FG005|Status at Week 68|Technical problems|0|||
161727330|NCT01544595|584044217|FG000|Status at Week 68|Withdrawal by Subject|0|||
161727331|NCT01544595|584044218|FG001|Status at Week 68|Withdrawal by Subject|1|||
161727332|NCT01544595|584044219|FG002|Status at Week 68|Withdrawal by Subject|1|||
161727333|NCT01544595|584044220|FG003|Status at Week 68|Withdrawal by Subject|2|||
161727334|NCT01544595|584044221|FG004|Status at Week 68|Withdrawal by Subject|0|||
161727335|NCT01544595|584044222|FG005|Status at Week 68|Withdrawal by Subject|0|||
161727336|NCT01544595|584044217|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
161727337|NCT01544595|584044218|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
161727338|NCT01544595|584044219|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
161727339|NCT01544595|584044220|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
161727340|NCT01544595|584044221|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
161727341|NCT01544595|584044222|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
161727342|NCT01544595|584044217|FG000|Status at Week 156|Withdrawal by Subject|9|||
161727343|NCT01544595|584044218|FG001|Status at Week 156|Withdrawal by Subject|10|||
161727344|NCT01544595|584044219|FG002|Status at Week 156|Withdrawal by Subject|4|||
161727345|NCT01544595|584044220|FG003|Status at Week 156|Withdrawal by Subject|9|||
161727346|NCT01544595|584044221|FG004|Status at Week 156|Withdrawal by Subject|20|||
161727347|NCT01544595|584044222|FG005|Status at Week 156|Withdrawal by Subject|6|||
161727348|NCT01544595|584044217|FG000|Status at Week 156|Adverse Event|9|||
161727349|NCT01544595|584044218|FG001|Status at Week 156|Adverse Event|11|||
161727350|NCT01544595|584044219|FG002|Status at Week 156|Adverse Event|1|||
161727351|NCT01544595|584044220|FG003|Status at Week 156|Adverse Event|3|||
161727352|NCT01544595|584044221|FG004|Status at Week 156|Adverse Event|4|||
161727353|NCT01544595|584044222|FG005|Status at Week 156|Adverse Event|2|||
161727354|NCT01544595|584044217|FG000|Status at Week 156|Lost to Follow-up|4|||
161727355|NCT01544595|584044218|FG001|Status at Week 156|Lost to Follow-up|4|||
161727356|NCT01544595|584044219|FG002|Status at Week 156|Lost to Follow-up|0|||
161727357|NCT01544595|584044220|FG003|Status at Week 156|Lost to Follow-up|1|||
161727358|NCT01544595|584044221|FG004|Status at Week 156|Lost to Follow-up|4|||
161727359|NCT01544595|584044222|FG005|Status at Week 156|Lost to Follow-up|1|||
161727360|NCT01544595|584044217|FG000|Status at Week 156|Non-compliance with study treatement|0|||
161727361|NCT01544595|584044218|FG001|Status at Week 156|Non-compliance with study treatement|1|||
161727362|NCT01544595|584044219|FG002|Status at Week 156|Non-compliance with study treatement|0|||
161727363|NCT01544595|584044220|FG003|Status at Week 156|Non-compliance with study treatement|1|||
161727364|NCT01544595|584044221|FG004|Status at Week 156|Non-compliance with study treatement|0|||
161727365|NCT01544595|584044222|FG005|Status at Week 156|Non-compliance with study treatement|1|||
161727366|NCT01544595|584044217|FG000|Status at Week 156|Physician Decision|0|||
161727367|NCT01544595|584044218|FG001|Status at Week 156|Physician Decision|3|||
161727368|NCT01544595|584044219|FG002|Status at Week 156|Physician Decision|1|||
161727369|NCT01544595|584044220|FG003|Status at Week 156|Physician Decision|0|||
161727370|NCT01544595|584044221|FG004|Status at Week 156|Physician Decision|0|||
161727371|NCT01544595|584044222|FG005|Status at Week 156|Physician Decision|0|||
161727372|NCT01544595|584044217|FG000|Status at Week 156|Pregnancy|2|||
161727373|NCT01544595|584044218|FG001|Status at Week 156|Pregnancy|3|||
161727374|NCT01544595|584044219|FG002|Status at Week 156|Pregnancy|0|||
161727375|NCT01544595|584044220|FG003|Status at Week 156|Pregnancy|0|||
161727376|NCT01544595|584044221|FG004|Status at Week 156|Pregnancy|0|||
161727377|NCT01544595|584044222|FG005|Status at Week 156|Pregnancy|0|||
161727378|NCT01544595|584044217|FG000|Status at Week 156|Protocol Violation|3|||
161727379|NCT01544595|584044218|FG001|Status at Week 156|Protocol Violation|1|||
161727380|NCT01544595|584044219|FG002|Status at Week 156|Protocol Violation|2|||
161727381|NCT01544595|584044220|FG003|Status at Week 156|Protocol Violation|2|||
161727382|NCT01544595|584044221|FG004|Status at Week 156|Protocol Violation|0|||
161727383|NCT01544595|584044222|FG005|Status at Week 156|Protocol Violation|0|||
161727384|NCT01544595|584044217|FG000|Status at Week 156|Technical problems|3|||
161727385|NCT01544595|584044218|FG001|Status at Week 156|Technical problems|1|||
161727386|NCT01544595|584044219|FG002|Status at Week 156|Technical problems|0|||
161965551|NCT04484649|584920366|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
161727387|NCT01544595|584044220|FG003|Status at Week 156|Technical problems|1|||
161727388|NCT01544595|584044221|FG004|Status at Week 156|Technical problems|0|||
161727389|NCT01544595|584044222|FG005|Status at Week 156|Technical problems|0|||
161727390|NCT01544595|584044217|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
161727391|NCT01544595|584044218|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
161727392|NCT01544595|584044219|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
161727393|NCT01544595|584044220|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
161727394|NCT01544595|584044221|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
161727395|NCT01544595|584044222|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
161727396|NCT01544595|584044217|FG000|Status at Week 156|Lack of Efficacy|1|||
161965552|NCT05059301|584920369|FG000|Overall Study|Adverse Event|0|||
161727397|NCT01544595|584044218|FG001|Status at Week 156|Lack of Efficacy|0|||
161727398|NCT01544595|584044219|FG002|Status at Week 156|Lack of Efficacy|1|||
161727399|NCT01544595|584044220|FG003|Status at Week 156|Lack of Efficacy|4|||
161727400|NCT01544595|584044221|FG004|Status at Week 156|Lack of Efficacy|10|||
161727401|NCT01544595|584044222|FG005|Status at Week 156|Lack of Efficacy|5|||
161727402|NCT01929044|584044223|FG000|Overall Study|Adverse Event|1|||
161727403|NCT01929044|584044224|FG001|Overall Study|Adverse Event|0|||
161727404|NCT01929044|584044223|FG000|Overall Study|Protocol Violation|9|||
161727405|NCT01929044|584044224|FG001|Overall Study|Protocol Violation|14|||
161727406|NCT01929044|584044223|FG000|Overall Study|Not Treated|1|||
161727407|NCT01929044|584044224|FG001|Overall Study|Not Treated|3|||
161727408|NCT02275026|584044229|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
161727409|NCT02275026|584044229|FG000|Overall Study|Withdrawal by Subject|4|||
161727410|NCT02275026|584044229|FG000|Overall Study|Ineligible due to medical history|13|||
161727411|NCT02275026|584044229|FG000|Overall Study|MRI malfunction precluded testing|1|||
161727412|NCT02275026|584044229|FG000|Overall Study|Ineligible after MRI findings|1|||
161727413|NCT02275026|584044229|FG000|Overall Study|Lost to Follow-up|2|||
161727414|NCT02275026|584044229|FG000|Overall Study|Scanner failure|1|||
161727415|NCT03643432|584044230|FG000|Overall Study|Lost to Follow-up|1|||
161727416|NCT03643432|584044231|FG001|Overall Study|Lost to Follow-up|0|||
161727417|NCT02574312|584044237|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
161727418|NCT02574312|584044238|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
161727419|NCT02326467|584045763|FG000|Overall Study|Withdrawal by Subject|1|||
161727420|NCT04467164|584045765|FG000|Washout (1 Week)|Lost to Follow-up|2|||
161727421|NCT04467164|584045766|FG001|Washout (1 Week)|Lost to Follow-up|0|||
161727422|NCT01998581|584045767|FG000|Overall Study|Refused repeat treatment|20|||
161727423|NCT01998581|584045768|FG001|Overall Study|Refused repeat treatment|4|||
161727424|NCT01998581|584045767|FG000|Overall Study|Protocol Violation|1|||
161727425|NCT01998581|584045768|FG001|Overall Study|Protocol Violation|0|||
161727426|NCT01998581|584045767|FG000|Overall Study|Withdrawal by Subject|8|||
161727427|NCT01998581|584045768|FG001|Overall Study|Withdrawal by Subject|1|||
161727428|NCT01998581|584045767|FG000|Overall Study|Lost to Follow-up|12|||
161727429|NCT01998581|584045768|FG001|Overall Study|Lost to Follow-up|4|||
161727430|NCT01998581|584045767|FG000|Overall Study|Adverse Event|1|||
161727431|NCT01998581|584045768|FG001|Overall Study|Adverse Event|1|||
161727432|NCT01998581|584045767|FG000|Overall Study|Other reasons|3|||
161727433|NCT01998581|584045768|FG001|Overall Study|Other reasons|2|||
161727434|NCT01998581|584045767|FG000|Overall Study|Randomized but withdrew before treatment|1|||
161727435|NCT01998581|584045768|FG001|Overall Study|Randomized but withdrew before treatment|0|||
161727436|NCT02273050|584045771|FG000|Overall Study|Adverse Event|4|||
161727437|NCT02273050|584045772|FG001|Overall Study|Adverse Event|3|||
161727438|NCT02273050|584045773|FG002|Overall Study|Adverse Event|3|||
161727439|NCT02273050|584045771|FG000|Overall Study|Death|0|||
161727440|NCT02273050|584045772|FG001|Overall Study|Death|0|||
161727441|NCT02273050|584045773|FG002|Overall Study|Death|1|||
161727442|NCT02273050|584045771|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
161727443|NCT02273050|584045772|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
161727444|NCT02273050|584045773|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
161727445|NCT02273050|584045771|FG000|Overall Study|Lack of Efficacy|0|||
161727446|NCT02273050|584045772|FG001|Overall Study|Lack of Efficacy|1|||
161727447|NCT02273050|584045773|FG002|Overall Study|Lack of Efficacy|1|||
161727448|NCT02273050|584045771|FG000|Overall Study|Withdrawal by Subject|17|||
161727449|NCT02273050|584045772|FG001|Overall Study|Withdrawal by Subject|14|||
161727450|NCT02273050|584045773|FG002|Overall Study|Withdrawal by Subject|16|||
161727451|NCT02273050|584045771|FG000|Overall Study|Lost to Follow-up|0|||
161727452|NCT02273050|584045772|FG001|Overall Study|Lost to Follow-up|2|||
161727453|NCT02273050|584045773|FG002|Overall Study|Lost to Follow-up|3|||
161727454|NCT02273050|584045771|FG000|Overall Study|Protocol Violation|3|||
161727455|NCT02273050|584045772|FG001|Overall Study|Protocol Violation|1|||
161727456|NCT02273050|584045773|FG002|Overall Study|Protocol Violation|4|||
161727457|NCT02273752|584045774|FG000|Overall Study|Trial was terminated early|2|||
161727458|NCT00903032|584045775|FG000|Overall Study|Withdrawal by Subject|5|||
161727459|NCT00903032|584045776|FG001|Overall Study|Withdrawal by Subject|3|||
161727460|NCT00903032|584045775|FG000|Overall Study|Lost to Follow-up|2|||
161727461|NCT00903032|584045776|FG001|Overall Study|Lost to Follow-up|2|||
161727462|NCT05619172|584045777|FG000|Safety Cohort 1|Death|7|||
161727463|NCT05619172|584045778|FG001|Safety Cohort 1|Death|0|||
161727464|NCT05619172|584045777|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
161727465|NCT05619172|584045778|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
161727466|NCT05619172|584045777|FG000|Safety Cohort 2|Death|0|||
161727467|NCT05619172|584045778|FG001|Safety Cohort 2|Death|1|||
161727468|NCT05619172|584045777|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
161727469|NCT05619172|584045778|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
161727470|NCT01429792|584045779|FG000|Overall Study|Other Reasons|67|||
161727471|NCT01429792|584045779|FG000|Overall Study|Unknown Disposition|94|||
161727472|NCT01429792|584045779|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
161727473|NCT01429792|584045779|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
161965553|NCT05059301|584920370|FG001|Overall Study|Adverse Event|2|||
161965554|NCT05059301|584920371|FG002|Overall Study|Adverse Event|2|||
161965555|NCT05059301|584920369|FG000|Overall Study|Lost to Follow-up|2|||
161727474|NCT01429792|584045779|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
161727475|NCT01429792|584045779|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
161727476|NCT01429792|584045779|FG000|Overall Study|Withdrawal by Subject|70|||
161727477|NCT01429792|584045779|FG000|Overall Study|Lost to Follow-up|88|||
161727478|NCT01763905|584045782|FG000|Overall Study|Withdrawal by Subject|1|||
161727479|NCT01763905|584045783|FG001|Overall Study|Withdrawal by Subject|1|||
161727480|NCT01763905|584045784|FG002|Overall Study|Withdrawal by Subject|0|||
161727481|NCT01763905|584045785|FG003|Overall Study|Withdrawal by Subject|1|||
161727482|NCT01763905|584045782|FG000|Overall Study|Decision by sponsor|5|||
161727483|NCT01763905|584045783|FG001|Overall Study|Decision by sponsor|0|||
161727484|NCT01763905|584045784|FG002|Overall Study|Decision by sponsor|8|||
161727485|NCT01763905|584045785|FG003|Overall Study|Decision by sponsor|0|||
161727486|NCT01763905|584045782|FG000|Overall Study|Lost to Follow-up|0|||
161727487|NCT01763905|584045783|FG001|Overall Study|Lost to Follow-up|0|||
161727488|NCT01763905|584045784|FG002|Overall Study|Lost to Follow-up|1|||
161727489|NCT01763905|584045785|FG003|Overall Study|Lost to Follow-up|0|||
161727490|NCT04346628|584045786|FG000|Overall Study|Lost to Follow-up|4|||
161727491|NCT04346628|584045787|FG001|Overall Study|Lost to Follow-up|4|||
161727492|NCT04346628|584045786|FG000|Overall Study|Withdrew (had personal reasons)|2|||
161727493|NCT04346628|584045787|FG001|Overall Study|Withdrew (had personal reasons)|5|||
161727494|NCT04346628|584045786|FG000|Overall Study|Withdrew (medication intolerant)|0|||
161727495|NCT04346628|584045787|FG001|Overall Study|Withdrew (medication intolerant)|3|||
161727496|NCT04346628|584045786|FG000|Overall Study|Withdrew (declined intervention)|0|||
161727497|NCT04346628|584045787|FG001|Overall Study|Withdrew (declined intervention)|1|||
161727498|NCT01457118|584045788|FG000|Overall Study|Adverse Event|1|||
161727499|NCT01457118|584045789|FG001|Overall Study|Adverse Event|0|||
161727500|NCT01457118|584045790|FG002|Overall Study|Adverse Event|0|||
161727501|NCT01457118|584045791|FG003|Overall Study|Adverse Event|1|||
161727502|NCT01457118|584045788|FG000|Overall Study|Clinical Progression|0|||
161727503|NCT01457118|584045789|FG001|Overall Study|Clinical Progression|1|||
161727504|NCT01457118|584045790|FG002|Overall Study|Clinical Progression|0|||
161727505|NCT01457118|584045791|FG003|Overall Study|Clinical Progression|1|||
161727506|NCT01457118|584045788|FG000|Overall Study|Physician Decision|2|||
161727507|NCT01457118|584045789|FG001|Overall Study|Physician Decision|0|||
161727508|NCT01457118|584045790|FG002|Overall Study|Physician Decision|0|||
161727509|NCT01457118|584045791|FG003|Overall Study|Physician Decision|0|||
161727510|NCT01457118|584045788|FG000|Overall Study|Progressive Disease by RECIST|12|||
161727511|NCT01457118|584045789|FG001|Overall Study|Progressive Disease by RECIST|3|||
161727512|NCT01457118|584045790|FG002|Overall Study|Progressive Disease by RECIST|1|||
161727513|NCT01457118|584045791|FG003|Overall Study|Progressive Disease by RECIST|0|||
161727514|NCT01457118|584045788|FG000|Overall Study|Withdrawal by Subject|5|||
161727515|NCT01457118|584045789|FG001|Overall Study|Withdrawal by Subject|0|||
161727516|NCT01457118|584045790|FG002|Overall Study|Withdrawal by Subject|0|||
161727517|NCT01457118|584045791|FG003|Overall Study|Withdrawal by Subject|0|||
161727518|NCT03456713|584045794|FG000|Overall Study|Lost to Follow-up|1|||
161727519|NCT03456713|584045795|FG001|Overall Study|Lost to Follow-up|0|||
161727520|NCT03456713|584045796|FG002|Overall Study|Lost to Follow-up|0|||
161727521|NCT03456713|584045797|FG003|Overall Study|Lost to Follow-up|0|||
161727522|NCT01263691|584045798|FG000|Overall Study|Lost to Follow-up|1|||
161727523|NCT01263691|584045799|FG001|Overall Study|Lost to Follow-up|0|||
161727524|NCT01263691|584045800|FG002|Overall Study|Lost to Follow-up|1|||
161727525|NCT01263691|584045801|FG003|Overall Study|Lost to Follow-up|1|||
161727526|NCT01263691|584045802|FG004|Overall Study|Lost to Follow-up|0|||
161727527|NCT01263691|584045803|FG005|Overall Study|Lost to Follow-up|0|||
161727528|NCT01263691|584045798|FG000|Overall Study|Withdrawal by Subject|1|||
161727529|NCT01263691|584045799|FG001|Overall Study|Withdrawal by Subject|0|||
161727530|NCT01263691|584045800|FG002|Overall Study|Withdrawal by Subject|0|||
161727531|NCT01263691|584045801|FG003|Overall Study|Withdrawal by Subject|0|||
161727532|NCT01263691|584045802|FG004|Overall Study|Withdrawal by Subject|0|||
161727533|NCT01263691|584045803|FG005|Overall Study|Withdrawal by Subject|0|||
161965556|NCT05059301|584920370|FG001|Overall Study|Lost to Follow-up|3|||
161727534|NCT01263691|584045798|FG000|Overall Study|Adverse Event|1|||
161727535|NCT01263691|584045799|FG001|Overall Study|Adverse Event|0|||
161727536|NCT01263691|584045800|FG002|Overall Study|Adverse Event|0|||
161727537|NCT01263691|584045801|FG003|Overall Study|Adverse Event|0|||
161965557|NCT05059301|584920371|FG002|Overall Study|Lost to Follow-up|3|||
161727538|NCT01263691|584045802|FG004|Overall Study|Adverse Event|0|||
161965558|NCT04952597|584920373|FG000|Overall Study|Death|12|||
161727539|NCT01263691|584045803|FG005|Overall Study|Adverse Event|0|||
161727540|NCT00630812|584045815|FG000|Randomisation to First Dose|Adverse Event|1|||
161727541|NCT00630812|584045816|FG001|Randomisation to First Dose|Adverse Event|1|||
161727542|NCT00630812|584045815|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
161727543|NCT00630812|584045816|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
161727544|NCT00630812|584045815|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
161727545|NCT00630812|584045816|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
161727546|NCT00630812|584045815|FG000|Randomisation to First Dose|Protocol Violation|4|||
161727547|NCT00630812|584045816|FG001|Randomisation to First Dose|Protocol Violation|1|||
161727548|NCT00630812|584045815|FG000|Double Blind Treatment Period|Adverse Event|13|||
161727549|NCT00630812|584045816|FG001|Double Blind Treatment Period|Adverse Event|5|||
161727550|NCT00630812|584045815|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
161727551|NCT00630812|584045816|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
161727552|NCT00630812|584045815|FG000|Double Blind Treatment Period|Physician Decision|2|||
161727553|NCT00630812|584045816|FG001|Double Blind Treatment Period|Physician Decision|1|||
161727554|NCT00630812|584045815|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161727555|NCT00630812|584045816|FG001|Double Blind Treatment Period|Protocol Violation|0|||
161727556|NCT00630812|584045815|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
161727557|NCT00630812|584045816|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
161727558|NCT00630812|584045815|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
161727559|NCT00630812|584045816|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
161727560|NCT00630812|584045815|FG000|Double Blind Treatment Period|Non-compliance|0|||
161727561|NCT00630812|584045816|FG001|Double Blind Treatment Period|Non-compliance|1|||
161727562|NCT05761444|584045817|FG000|Overall Study|Protocol Violation|2|||
161727563|NCT05761444|584045818|FG001|Overall Study|Protocol Violation|1|||
161727564|NCT05761444|584045817|FG000|Overall Study|Adverse Event|2|||
161727565|NCT05761444|584045818|FG001|Overall Study|Adverse Event|2|||
161727566|NCT05761444|584045817|FG000|Overall Study|Withdrawal by Subject|3|||
161727567|NCT05761444|584045818|FG001|Overall Study|Withdrawal by Subject|2|||
161727568|NCT05761444|584045817|FG000|Overall Study|Other|1|||
161727569|NCT05761444|584045818|FG001|Overall Study|Other|0|||
161727570|NCT01842308|584045820|FG000|Overall Study|Withdrawal by Subject|0|||
161727571|NCT01842308|584045821|FG001|Overall Study|Withdrawal by Subject|0|||
161727572|NCT01842308|584045822|FG002|Overall Study|Withdrawal by Subject|0|||
161727573|NCT01842308|584045823|FG003|Overall Study|Withdrawal by Subject|0|||
161727574|NCT01842308|584045824|FG004|Overall Study|Withdrawal by Subject|1|||
161727575|NCT02868216|584045825|FG000|Overall Study|Death|0|||
161727576|NCT02868216|584045826|FG001|Overall Study|Death|1|||
161727577|NCT02868216|584045825|FG000|Overall Study|coronary artery bypass|1|||
161727578|NCT02868216|584045826|FG001|Overall Study|coronary artery bypass|0|||
161727579|NCT02868216|584045825|FG000|Overall Study|Withdrawal by Subject|7|||
161727580|NCT02868216|584045826|FG001|Overall Study|Withdrawal by Subject|5|||
161727581|NCT03161678|584045827|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
161727582|NCT03161678|584045828|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
161727583|NCT03161678|584045829|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
161727584|NCT03161678|584045830|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
161727585|NCT03161678|584045831|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
161727586|NCT03161678|584045832|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
161727587|NCT03161678|584045827|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
161727588|NCT03161678|584045828|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
161727589|NCT03161678|584045829|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
161727590|NCT03161678|584045830|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
161727591|NCT03161678|584045831|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
161727592|NCT03161678|584045832|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
161727593|NCT03161678|584045827|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
161727594|NCT03161678|584045828|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
161727595|NCT03161678|584045829|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
161727596|NCT03161678|584045830|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
161727597|NCT03161678|584045831|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
161727598|NCT03161678|584045832|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
161727599|NCT03161678|584045827|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161727600|NCT03161678|584045828|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161727601|NCT03161678|584045829|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161727602|NCT03161678|584045830|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
161727603|NCT03161678|584045831|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161727604|NCT03161678|584045832|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161727605|NCT00752609|584045833|FG000|Overall Study|Adverse Event|2|||
161727606|NCT00752609|584045834|FG001|Overall Study|Adverse Event|2|||
161727607|NCT00752609|584045833|FG000|Overall Study|Withdrawal by Subject|3|||
161727608|NCT00752609|584045834|FG001|Overall Study|Withdrawal by Subject|0|||
161727609|NCT00752609|584045833|FG000|Overall Study|Physician Decision|1|||
161727610|NCT00752609|584045834|FG001|Overall Study|Physician Decision|0|||
161727611|NCT00752609|584045833|FG000|Overall Study|Death|1|||
161727612|NCT00752609|584045834|FG001|Overall Study|Death|0|||
161727613|NCT00752609|584045833|FG000|Overall Study|Met exclusion criteria|1|||
161727614|NCT00752609|584045834|FG001|Overall Study|Met exclusion criteria|0|||
161727615|NCT00752609|584045833|FG000|Overall Study|Received Aranesp in error|1|||
161727616|NCT00752609|584045834|FG001|Overall Study|Received Aranesp in error|0|||
161727617|NCT00938327|584045835|FG000|Overall Study|Adverse Event|2|||
161727618|NCT00938327|584045835|FG000|Overall Study|Protocol Violation|1|||
161727619|NCT00938327|584045835|FG000|Overall Study|Withdrawal by Subject|4|||
161838107|NCT02037165|584450339|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
161838108|NCT02037165|584450340|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
161838109|NCT02037165|584450341|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
161838110|NCT02037165|584450342|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
161838111|NCT02037165|584450343|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
161838112|NCT00673933|584450344|FG000|Overall Study|Withdrawal by Subject|2|||
161838113|NCT00673933|584450344|FG000|Overall Study|Lost to Follow-up|1|||
161838114|NCT02206620|584450345|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
161838115|NCT02206620|584450346|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
161838116|NCT02206620|584450345|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
161838117|NCT02206620|584450346|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
161838118|NCT05816200|584450347|FG000|Overall Study|Lost to Follow-up|2|||
161838119|NCT05816200|584450348|FG001|Overall Study|Lost to Follow-up|1|||
161838120|NCT02394730|584450349|FG000|Overall Study|Lost to Follow-up|1|||
161838121|NCT02394730|584450350|FG001|Overall Study|Lost to Follow-up|0|||
161838122|NCT02394730|584450349|FG000|Overall Study|Withdrawal by Subject|0|||
161838123|NCT02394730|584450350|FG001|Overall Study|Withdrawal by Subject|1|||
161838124|NCT00588640|584450351|FG000|Overall Study|Physician Decision|1|||
161838125|NCT00588640|584450351|FG000|Overall Study|Ineligible Patient|1|||
161838126|NCT01393730|584450352|FG000|Overall Study|Withdrawal by Subject|3|||
161838127|NCT01393730|584450352|FG000|Overall Study|Other|2|||
161838128|NCT01393730|584450352|FG000|Overall Study|Adverse Event|1|||
161838129|NCT00321828|584451783|FG000|Overall Study|Ineligible|3|||
161838130|NCT00321828|584451783|FG000|Overall Study|No follow up data|1|||
161838131|NCT00678041|584451795|FG000|Overall Study|Physician Decision|5|||
161838132|NCT00678041|584451796|FG001|Overall Study|Physician Decision|5|||
161838133|NCT00577395|584451799|FG000|Overall Study|Study was terminated early by Sponsor|7|||
161838134|NCT00577395|584451800|FG001|Overall Study|Study was terminated early by Sponsor|6|||
161838135|NCT03084367|584451803|FG000|Overall Study|Lost to Follow-up|32|||
161838136|NCT03084367|584451803|FG000|Overall Study|Withdrawal by Subject|4|||
161838137|NCT03084367|584451803|FG000|Overall Study|Other|1|||
161838138|NCT01206101|584451804|FG000|Overall Study|Adverse Event|1|||
161838139|NCT01206101|584451805|FG001|Overall Study|Adverse Event|0|||
161838140|NCT01206101|584451804|FG000|Overall Study|Physician Decision|0|||
161838141|NCT01206101|584451805|FG001|Overall Study|Physician Decision|1|||
161838142|NCT01206101|584451804|FG000|Overall Study|Unclassified|1|||
161838143|NCT01206101|584451805|FG001|Overall Study|Unclassified|0|||
161838144|NCT00368979|584451811|FG000|Overall Study|Adverse Event|9|||
161838145|NCT00368979|584451812|FG001|Overall Study|Adverse Event|16|||
161838146|NCT00368979|584451811|FG000|Overall Study|Lack of Efficacy|5|||
161838147|NCT00368979|584451812|FG001|Overall Study|Lack of Efficacy|3|||
161838148|NCT00368979|584451811|FG000|Overall Study|Other|3|||
161838149|NCT00368979|584451812|FG001|Overall Study|Other|1|||
161838150|NCT00368979|584451811|FG000|Overall Study|Lost to Follow-up|1|||
161838151|NCT00368979|584451812|FG001|Overall Study|Lost to Follow-up|0|||
161838152|NCT00368979|584451811|FG000|Overall Study|Protocol Violation|2|||
161838153|NCT00368979|584451812|FG001|Overall Study|Protocol Violation|1|||
161838154|NCT00368979|584451811|FG000|Overall Study|Withdrawal by Subject|5|||
161838155|NCT00368979|584451812|FG001|Overall Study|Withdrawal by Subject|9|||
161838156|NCT00103311|584451813|FG000|Overall Study|Lost to Follow-up|1|||
161838157|NCT00103311|584451814|FG001|Overall Study|Lost to Follow-up|0|||
161838158|NCT00103311|584451813|FG000|Overall Study|Withdrawal by Subject|2|||
161838159|NCT00103311|584451814|FG001|Overall Study|Withdrawal by Subject|1|||
161838160|NCT00103311|584451813|FG000|Overall Study|Adverse Event|1|||
161838161|NCT00103311|584451814|FG001|Overall Study|Adverse Event|0|||
161838162|NCT00912093|584451815|FG000|The Controlled Phase|Death|0|||
161838163|NCT00912093|584451816|FG001|The Controlled Phase|Death|1|||
161838164|NCT00912093|584451817|FG002|The Controlled Phase|Death|0|||
161838165|NCT00912093|584451818|FG003|The Controlled Phase|Death|0|||
161838166|NCT00912093|584451819|FG004|The Controlled Phase|Death|0|||
161838167|NCT00912093|584451815|FG000|The Controlled Phase|Medical Condition|0|||
161838168|NCT00912093|584451816|FG001|The Controlled Phase|Medical Condition|1|||
161838169|NCT00912093|584451817|FG002|The Controlled Phase|Medical Condition|0|||
161838170|NCT00912093|584451818|FG003|The Controlled Phase|Medical Condition|0|||
161838171|NCT00912093|584451819|FG004|The Controlled Phase|Medical Condition|0|||
161838172|NCT00912093|584451815|FG000|The Controlled Phase|Lost to Follow-up|0|||
161838173|NCT00912093|584451816|FG001|The Controlled Phase|Lost to Follow-up|0|||
161838174|NCT00912093|584451817|FG002|The Controlled Phase|Lost to Follow-up|0|||
161838175|NCT00912093|584451818|FG003|The Controlled Phase|Lost to Follow-up|0|||
161838176|NCT00912093|584451819|FG004|The Controlled Phase|Lost to Follow-up|1|||
161838177|NCT00394524|584451820|FG000|Overall Study|Protocol Violation|2|||
161838178|NCT00394524|584451821|FG001|Overall Study|Protocol Violation|3|||
161838179|NCT00394524|584451820|FG000|Overall Study|Death|1|||
161838180|NCT00394524|584451821|FG001|Overall Study|Death|0|||
161838181|NCT00394524|584451820|FG000|Overall Study|Withdrawal by Subject|0|||
161838182|NCT00394524|584451821|FG001|Overall Study|Withdrawal by Subject|1|||
161838183|NCT01462318|584451824|FG000|Main Study / TP-DI Study|Other|2|||
161838184|NCT01462318|584451825|FG001|Main Study / TP-DI Study|Other|0|||
161838185|NCT01462318|584451826|FG002|Main Study / TP-DI Study|Other|0|||
161838186|NCT01462318|584451824|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
161838187|NCT01462318|584451825|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
161838188|NCT01462318|584451826|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
161838189|NCT01462318|584451824|FG000|Main Study / TP-DI Study|Adverse Event|4|||
161838190|NCT01462318|584451825|FG001|Main Study / TP-DI Study|Adverse Event|0|||
161838191|NCT01462318|584451826|FG002|Main Study / TP-DI Study|Adverse Event|0|||
161838192|NCT01462318|584451824|FG000|Extension Phase|Lost to Follow-up|0|||
161838193|NCT01462318|584451825|FG001|Extension Phase|Lost to Follow-up|0|||
161838194|NCT01462318|584451826|FG002|Extension Phase|Lost to Follow-up|1|||
161838195|NCT01462318|584451824|FG000|Extension Phase|Other|0|||
161838196|NCT01462318|584451825|FG001|Extension Phase|Other|0|||
161838197|NCT01462318|584451826|FG002|Extension Phase|Other|1|||
161838198|NCT01462318|584451824|FG000|Extension Phase|Disease Progression|0|||
161838199|NCT01462318|584451825|FG001|Extension Phase|Disease Progression|0|||
161838200|NCT01462318|584451826|FG002|Extension Phase|Disease Progression|1|||
161838201|NCT01462318|584451824|FG000|Extension Phase|Withdrawal by Subject|0|||
161838202|NCT01462318|584451825|FG001|Extension Phase|Withdrawal by Subject|0|||
161838203|NCT01462318|584451826|FG002|Extension Phase|Withdrawal by Subject|15|||
161838204|NCT01462318|584451824|FG000|Extension Phase|Investigator Decision|0|||
161838205|NCT01462318|584451825|FG001|Extension Phase|Investigator Decision|0|||
161838206|NCT01462318|584451826|FG002|Extension Phase|Investigator Decision|5|||
161838207|NCT01462318|584451824|FG000|Extension Phase|Adverse Event|0|||
161838208|NCT01462318|584451825|FG001|Extension Phase|Adverse Event|0|||
161838209|NCT01462318|584451826|FG002|Extension Phase|Adverse Event|22|||
161838210|NCT03827564|584451827|FG000|Overall Study|Discontinued due to Study Termination|1|||
161838211|NCT03827564|584451828|FG001|Overall Study|Discontinued due to Study Termination|0|||
161838212|NCT02238626|584451829|FG000|Overall Study|Adverse Event|3|||
161838213|NCT02238626|584451830|FG001|Overall Study|Adverse Event|5|||
161838214|NCT02238626|584451831|FG002|Overall Study|Adverse Event|0|||
161838215|NCT02238626|584451832|FG003|Overall Study|Adverse Event|3|||
161838216|NCT02238626|584451829|FG000|Overall Study|Lost to Follow-up|2|||
161838217|NCT02238626|584451830|FG001|Overall Study|Lost to Follow-up|4|||
161838218|NCT02238626|584451831|FG002|Overall Study|Lost to Follow-up|2|||
161838219|NCT02238626|584451832|FG003|Overall Study|Lost to Follow-up|2|||
161838220|NCT02238626|584451829|FG000|Overall Study|Withdrawal by Subject|0|||
161838221|NCT02238626|584451830|FG001|Overall Study|Withdrawal by Subject|3|||
161838222|NCT02238626|584451831|FG002|Overall Study|Withdrawal by Subject|0|||
161838223|NCT02238626|584451832|FG003|Overall Study|Withdrawal by Subject|1|||
161838224|NCT02238626|584451829|FG000|Overall Study|Death|0|||
161838225|NCT02238626|584451830|FG001|Overall Study|Death|0|||
161838226|NCT02238626|584451831|FG002|Overall Study|Death|1|||
161838227|NCT02238626|584451832|FG003|Overall Study|Death|1|||
161838228|NCT02238626|584451829|FG000|Overall Study|Other|0|||
161838229|NCT02238626|584451830|FG001|Overall Study|Other|2|||
161838230|NCT02238626|584451831|FG002|Overall Study|Other|0|||
161838231|NCT02238626|584451832|FG003|Overall Study|Other|0|||
161838232|NCT00270257|584451833|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
161838233|NCT00270257|584451834|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
161838234|NCT01195103|584451837|FG000|Overall Study|Withdrawal by Subject|1|||
161838235|NCT01195103|584451838|FG001|Overall Study|Withdrawal by Subject|0|||
161838236|NCT01195103|584451839|FG002|Overall Study|Withdrawal by Subject|0|||
161838237|NCT00450619|584451846|FG000|Overall Study|refused treatment after randomization|2|||
161965559|NCT04952597|584920374|FG001|Overall Study|Death|13|||
161965560|NCT04952597|584920375|FG002|Overall Study|Death|14|||
161965561|NCT04952597|584920373|FG000|Overall Study|Withdrawal by Subject|1|||
161965562|NCT04952597|584920374|FG001|Overall Study|Withdrawal by Subject|0|||
161965563|NCT04952597|584920375|FG002|Overall Study|Withdrawal by Subject|3|||
161965564|NCT04952597|584920373|FG000|Overall Study|Lost to Follow-up|0|||
162032167|NCT01992159|585175417|FG000|Overall Study|Withdrawal by Subject|4|||
162032168|NCT01992159|585175418|FG001|Overall Study|Withdrawal by Subject|7|||
162032169|NCT01992159|585175419|FG002|Overall Study|Withdrawal by Subject|0|||
161838238|NCT00450619|584451847|FG001|Overall Study|refused treatment after randomization|0|||
161838239|NCT00450619|584451846|FG000|Overall Study|did not progress; refused further trmt|1|||
161838240|NCT00450619|584451847|FG001|Overall Study|did not progress; refused further trmt|1|||
161838241|NCT00450619|584451846|FG000|Overall Study|Adverse Event|1|||
161838242|NCT00450619|584451847|FG001|Overall Study|Adverse Event|0|||
161965565|NCT04952597|584920374|FG001|Overall Study|Lost to Follow-up|1|||
161965566|NCT04952597|584920375|FG002|Overall Study|Lost to Follow-up|1|||
161965567|NCT00923975|584920380|FG000|Overall Study|Did not meet inclusion criteria|1|||
161965568|NCT01005316|584920383|FG000|Overall Study|Adverse Event|0|||
161838243|NCT02963311|584451848|FG000|Overall Study|Withdrawal by Subject|1|||
161838244|NCT02963311|584451848|FG000|Overall Study|Screen Failure|4|||
162032170|NCT01992159|585175420|FG003|Overall Study|Withdrawal by Subject|3|||
161838245|NCT04442490|584451851|FG000|Overall Study|Withdrawal by Subject|18|||
161838246|NCT04442490|584451852|FG001|Overall Study|Withdrawal by Subject|10|||
161838247|NCT04442490|584451851|FG000|Overall Study|Lost to Follow-up|7|||
162032171|NCT01992159|585175417|FG000|Overall Study|Adverse Event|0|||
162032172|NCT01992159|585175418|FG001|Overall Study|Adverse Event|1|||
162032173|NCT01992159|585175419|FG002|Overall Study|Adverse Event|0|||
162032174|NCT01992159|585175420|FG003|Overall Study|Adverse Event|1|||
162032175|NCT01992159|585175417|FG000|Overall Study|Death|0|||
161727620|NCT00938327|584045835|FG000|Overall Study|Lost to Follow-up|37|||
161727621|NCT00938327|584045835|FG000|Overall Study|2nd dose received outside of the study|7|||
161727622|NCT00938327|584045835|FG000|Overall Study|Vaccine not received as out of stock|9|||
161727623|NCT01425190|584045836|FG000|Overall Study|Full dose not consumed.|1|||
161727624|NCT01425190|584045837|FG001|Overall Study|Full dose not consumed.|0|||
161727625|NCT01425190|584045838|FG002|Overall Study|Full dose not consumed.|0|||
161727626|NCT02552355|584045840|FG000|Overall Study|Adverse Event|0|||
161727627|NCT02552355|584045841|FG001|Overall Study|Adverse Event|2|||
161727628|NCT02552355|584045842|FG002|Overall Study|Adverse Event|2|||
161727629|NCT02552355|584045843|FG003|Overall Study|Adverse Event|0|||
161727630|NCT02552355|584045840|FG000|Overall Study|Withdrawal by Subject|0|||
161727631|NCT02552355|584045841|FG001|Overall Study|Withdrawal by Subject|0|||
161727632|NCT02552355|584045842|FG002|Overall Study|Withdrawal by Subject|0|||
161727633|NCT02552355|584045843|FG003|Overall Study|Withdrawal by Subject|1|||
161727634|NCT00850460|584045846|FG000|Overall Study|Lost to Follow-up|4|||
161727635|NCT00850460|584045847|FG001|Overall Study|Lost to Follow-up|4|||
161727636|NCT02084134|584045852|FG000|Overall Study|Protocol Violation|4|||
161727637|NCT02084134|584045853|FG001|Overall Study|Protocol Violation|2|||
161727638|NCT02084134|584045852|FG000|Overall Study|Death|0|||
161727639|NCT02084134|584045853|FG001|Overall Study|Death|1|||
161727640|NCT02026271|584045854|FG000|Overall Study|Adverse Event|2|||
161727641|NCT02026271|584045855|FG001|Overall Study|Adverse Event|3|||
161727642|NCT02026271|584045856|FG002|Overall Study|Adverse Event|2|||
161727643|NCT02026271|584045857|FG003|Overall Study|Adverse Event|3|||
161727644|NCT02026271|584045858|FG004|Overall Study|Adverse Event|0|||
161727645|NCT02026271|584045854|FG000|Overall Study|Withdrawal by Subject|0|||
161727646|NCT02026271|584045855|FG001|Overall Study|Withdrawal by Subject|0|||
161727647|NCT02026271|584045856|FG002|Overall Study|Withdrawal by Subject|0|||
161727648|NCT02026271|584045857|FG003|Overall Study|Withdrawal by Subject|0|||
161727649|NCT02026271|584045858|FG004|Overall Study|Withdrawal by Subject|1|||
161727650|NCT04333433|584045859|FG000|Overall Study|Withdrawal by Subject|6|||
161727651|NCT04333433|584045860|FG001|Overall Study|Withdrawal by Subject|3|||
161727652|NCT04333433|584045859|FG000|Overall Study|Death|3|||
161727653|NCT04333433|584045860|FG001|Overall Study|Death|0|||
161727654|NCT04333433|584045859|FG000|Overall Study|Lost to Follow-up|6|||
161727655|NCT04333433|584045860|FG001|Overall Study|Lost to Follow-up|1|||
161727656|NCT04333433|584045859|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
161727657|NCT04333433|584045860|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
161727658|NCT02807454|584045861|FG000|Overall Study|Adverse Event|1|||
161727659|NCT02807454|584045862|FG001|Overall Study|Adverse Event|0|||
161727660|NCT02807454|584045861|FG000|Overall Study|Withdrawal by Subject|0|||
161727661|NCT02807454|584045862|FG001|Overall Study|Withdrawal by Subject|1|||
161727662|NCT02807454|584045861|FG000|Overall Study|Progressive Disease|30|||
161727663|NCT02807454|584045862|FG001|Overall Study|Progressive Disease|3|||
161727664|NCT02807454|584045861|FG000|Overall Study|Other Reasons|1|||
161727665|NCT02807454|584045862|FG001|Overall Study|Other Reasons|1|||
161727666|NCT05468086|584045865|FG000|Overall Study|Withdrawal by Subject|3|||
161727667|NCT05468086|584045865|FG000|Overall Study|Subject was found ineligible after consent|1|||
161727668|NCT01108809|584045866|FG000|Overall Study|Adverse Event|3|||
161727669|NCT01108809|584045866|FG000|Overall Study|Lost to Follow-up|1|||
161727670|NCT00001262|584045872|FG000|Overall Study|Death|10|||
161727671|NCT00001262|584045873|FG001|Overall Study|Death|11|||
161727672|NCT00001262|584045874|FG002|Overall Study|Death|0|||
161727673|NCT00001262|584045872|FG000|Overall Study|Withdrawal by Subject|0|||
161727674|NCT00001262|584045873|FG001|Overall Study|Withdrawal by Subject|3|||
161727675|NCT00001262|584045874|FG002|Overall Study|Withdrawal by Subject|0|||
161838248|NCT04442490|584451852|FG001|Overall Study|Lost to Follow-up|7|||
162032176|NCT01992159|585175418|FG001|Overall Study|Death|0|||
161727676|NCT00783705|584045875|FG000|Overall Study|Adverse Event|2|||
161727677|NCT00783705|584045876|FG001|Overall Study|Adverse Event|0|||
161727678|NCT00783705|584045875|FG000|Overall Study|Withdrawal by Subject|3|||
161727679|NCT00783705|584045876|FG001|Overall Study|Withdrawal by Subject|2|||
161727680|NCT00783705|584045875|FG000|Overall Study|Lost to Follow-up|1|||
161727681|NCT00783705|584045876|FG001|Overall Study|Lost to Follow-up|3|||
162032177|NCT01992159|585175419|FG002|Overall Study|Death|1|||
161727682|NCT00748540|584045878|FG000|Overall Study|Physician Decision|1|||
161727683|NCT04743635|584045879|FG000|Overall Study|Lost to Follow-up|2|||
161727684|NCT04743635|584045880|FG001|Overall Study|Lost to Follow-up|0|||
161727685|NCT00804193|584045881|FG000|Overall Study|Lack of baseline fungus|32|||
161727686|NCT00804193|584045882|FG001|Overall Study|Lack of baseline fungus|31|||
162032178|NCT01992159|585175420|FG003|Overall Study|Death|0|||
161727687|NCT00804193|584045883|FG002|Overall Study|Lack of baseline fungus|19|||
162032179|NCT00095238|585175421|FG000|Overall Study|Lack of Efficacy|9|||
161727688|NCT00804193|584045881|FG000|Overall Study|Adverse Event|0|||
161727689|NCT00804193|584045882|FG001|Overall Study|Adverse Event|0|||
161727690|NCT00804193|584045883|FG002|Overall Study|Adverse Event|2|||
161727691|NCT00804193|584045881|FG000|Overall Study|Lack of Efficacy|1|||
161727692|NCT00804193|584045882|FG001|Overall Study|Lack of Efficacy|1|||
161727693|NCT00804193|584045883|FG002|Overall Study|Lack of Efficacy|3|||
161727694|NCT00804193|584045881|FG000|Overall Study|Protocol Violation|0|||
161727695|NCT00804193|584045882|FG001|Overall Study|Protocol Violation|8|||
161727696|NCT00804193|584045883|FG002|Overall Study|Protocol Violation|2|||
161727697|NCT00804193|584045881|FG000|Overall Study|Lost to Follow-up|3|||
161727698|NCT00804193|584045882|FG001|Overall Study|Lost to Follow-up|3|||
161727699|NCT00804193|584045883|FG002|Overall Study|Lost to Follow-up|4|||
161727700|NCT00804193|584045881|FG000|Overall Study|Withdrawal by Subject|3|||
161727701|NCT00804193|584045882|FG001|Overall Study|Withdrawal by Subject|1|||
161727702|NCT00804193|584045883|FG002|Overall Study|Withdrawal by Subject|2|||
161727703|NCT01193348|584045886|FG000|Screening Period|Screen Failure|5|||
161727704|NCT01193348|584045886|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
161727705|NCT01193348|584045886|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
161727706|NCT01193348|584045886|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
161727707|NCT01193348|584045886|FG000|Extension Treatment Period|Physician Decision|1|||
161727708|NCT01193348|584045886|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
161727709|NCT00968253|584045887|FG000|Overall Study|Death|0|||
161727710|NCT00968253|584045888|FG001|Overall Study|Death|0|||
161727711|NCT00968253|584045889|FG002|Overall Study|Death|2|||
161727712|NCT00968253|584045887|FG000|Overall Study|Withdrawal by Subject|0|||
161727713|NCT00968253|584045888|FG001|Overall Study|Withdrawal by Subject|0|||
161727714|NCT00968253|584045889|FG002|Overall Study|Withdrawal by Subject|1|||
161727715|NCT00968253|584045887|FG000|Overall Study|Disease Progression|0|||
161727716|NCT00968253|584045888|FG001|Overall Study|Disease Progression|3|||
161727717|NCT00968253|584045889|FG002|Overall Study|Disease Progression|3|||
161727718|NCT00968253|584045887|FG000|Overall Study|Adverse Event|0|||
161727719|NCT00968253|584045888|FG001|Overall Study|Adverse Event|0|||
161727720|NCT00968253|584045889|FG002|Overall Study|Adverse Event|1|||
161727721|NCT01402284|584045890|FG000|Overall Study|Withdrawal consent|2|||
161727722|NCT01402284|584045890|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
161727723|NCT01402284|584045890|FG000|Overall Study|Physician Decision|1|||
161727724|NCT01402284|584045890|FG000|Overall Study|Disease progression on study|10|||
161727725|NCT01745393|584045892|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
161727726|NCT01745393|584045893|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
161727727|NCT01745393|584045892|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
161727728|NCT01745393|584045893|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
161727729|NCT01745393|584045892|FG000|12-month Follow-up|Lost to Follow-up|6|||
161727730|NCT01745393|584045893|FG001|12-month Follow-up|Lost to Follow-up|5|||
161727731|NCT00905021|584045898|FG000|Overall Study|Adverse Event|2|||
161727732|NCT02488759|584045900|FG000|Overall Study|Disease progression|73|||
161727733|NCT02488759|584045901|FG001|Overall Study|Disease progression|111|||
161727734|NCT02488759|584045902|FG002|Overall Study|Disease progression|62|||
161727735|NCT02488759|584045903|FG003|Overall Study|Disease progression|7|||
161727736|NCT02488759|584045904|FG004|Overall Study|Disease progression|4|||
161727737|NCT02488759|584045905|FG005|Overall Study|Disease progression|2|||
161727738|NCT02488759|584045900|FG000|Overall Study|Study drug toxicity|11|||
161727739|NCT02488759|584045901|FG001|Overall Study|Study drug toxicity|33|||
161727740|NCT02488759|584045902|FG002|Overall Study|Study drug toxicity|31|||
161727741|NCT02488759|584045903|FG003|Overall Study|Study drug toxicity|0|||
161727742|NCT02488759|584045904|FG004|Overall Study|Study drug toxicity|0|||
161727743|NCT02488759|584045905|FG005|Overall Study|Study drug toxicity|2|||
161727744|NCT02488759|584045900|FG000|Overall Study|Adverse event unrelated to study drug|9|||
161727745|NCT02488759|584045901|FG001|Overall Study|Adverse event unrelated to study drug|11|||
161727746|NCT02488759|584045902|FG002|Overall Study|Adverse event unrelated to study drug|7|||
161727747|NCT02488759|584045903|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161727748|NCT02488759|584045904|FG004|Overall Study|Adverse event unrelated to study drug|1|||
161727749|NCT02488759|584045905|FG005|Overall Study|Adverse event unrelated to study drug|0|||
161727750|NCT02488759|584045900|FG000|Overall Study|Participant request to discontinue study treatment|6|||
161727751|NCT02488759|584045901|FG001|Overall Study|Participant request to discontinue study treatment|8|||
161727752|NCT02488759|584045902|FG002|Overall Study|Participant request to discontinue study treatment|4|||
161727753|NCT02488759|584045903|FG003|Overall Study|Participant request to discontinue study treatment|0|||
161838249|NCT04442490|584451851|FG000|Overall Study|Adverse Event|2|||
161727754|NCT02488759|584045904|FG004|Overall Study|Participant request to discontinue study treatment|0|||
161727755|NCT02488759|584045905|FG005|Overall Study|Participant request to discontinue study treatment|0|||
161727756|NCT02488759|584045900|FG000|Overall Study|Withdrawal by Subject|4|||
161727757|NCT02488759|584045901|FG001|Overall Study|Withdrawal by Subject|0|||
161727758|NCT02488759|584045902|FG002|Overall Study|Withdrawal by Subject|3|||
161727759|NCT02488759|584045903|FG003|Overall Study|Withdrawal by Subject|0|||
161727760|NCT02488759|584045904|FG004|Overall Study|Withdrawal by Subject|0|||
161727761|NCT02488759|584045905|FG005|Overall Study|Withdrawal by Subject|2|||
161727762|NCT02488759|584045900|FG000|Overall Study|Lost to Follow-up|0|||
161727763|NCT02488759|584045901|FG001|Overall Study|Lost to Follow-up|0|||
161727764|NCT02488759|584045902|FG002|Overall Study|Lost to Follow-up|2|||
161727765|NCT02488759|584045903|FG003|Overall Study|Lost to Follow-up|0|||
161727766|NCT02488759|584045904|FG004|Overall Study|Lost to Follow-up|0|||
161727767|NCT02488759|584045905|FG005|Overall Study|Lost to Follow-up|0|||
161727768|NCT02488759|584045900|FG000|Overall Study|Maximum clinical benefit|3|||
161727769|NCT02488759|584045901|FG001|Overall Study|Maximum clinical benefit|0|||
161727770|NCT02488759|584045902|FG002|Overall Study|Maximum clinical benefit|1|||
161727771|NCT02488759|584045903|FG003|Overall Study|Maximum clinical benefit|0|||
161727772|NCT02488759|584045904|FG004|Overall Study|Maximum clinical benefit|0|||
161727773|NCT02488759|584045905|FG005|Overall Study|Maximum clinical benefit|0|||
161727774|NCT02488759|584045900|FG000|Overall Study|Other reasons|7|||
161727775|NCT02488759|584045901|FG001|Overall Study|Other reasons|32|||
161727776|NCT02488759|584045902|FG002|Overall Study|Other reasons|23|||
161727777|NCT02488759|584045903|FG003|Overall Study|Other reasons|1|||
161727778|NCT02488759|584045904|FG004|Overall Study|Other reasons|1|||
161727779|NCT02488759|584045905|FG005|Overall Study|Other reasons|1|||
161727780|NCT03860844|584045906|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
161727781|NCT03860844|584045907|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
161727782|NCT03860844|584045908|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
161727783|NCT03860844|584045906|FG000|Overall Study|Progressive disease|5|||
161727784|NCT03860844|584045907|FG001|Overall Study|Progressive disease|3|||
161727785|NCT03860844|584045908|FG002|Overall Study|Progressive disease|4|||
161727786|NCT03860844|584045906|FG000|Overall Study|Other, Not related to COVID-19|0|||
161727787|NCT03860844|584045907|FG001|Overall Study|Other, Not related to COVID-19|1|||
161727788|NCT03860844|584045908|FG002|Overall Study|Other, Not related to COVID-19|0|||
161727789|NCT01678807|584045911|FG000|Overall Study|Adverse Event|4|||
161727790|NCT01678807|584045912|FG001|Overall Study|Adverse Event|4|||
161727791|NCT01678807|584045913|FG002|Overall Study|Adverse Event|0|||
161727792|NCT01678807|584045911|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
161727793|NCT01678807|584045912|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
161727794|NCT01678807|584045913|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
161727795|NCT05281523|584045914|FG000|Overall Study|Adverse Event|1|||
161727796|NCT05281523|584045915|FG001|Overall Study|Adverse Event|1|||
161727797|NCT05281523|584045914|FG000|Overall Study|Physician Decision|1|||
161727798|NCT05281523|584045915|FG001|Overall Study|Physician Decision|1|||
161727799|NCT05281523|584045914|FG000|Overall Study|Withdrawal by Subject|5|||
161727800|NCT05281523|584045915|FG001|Overall Study|Withdrawal by Subject|15|||
161727801|NCT05281523|584045914|FG000|Overall Study|GCP violations|3|||
161727802|NCT05281523|584045915|FG001|Overall Study|GCP violations|4|||
161727803|NCT04038255|584047773|FG000|Overall Study|Lost to Follow-up|0|||
161727804|NCT04038255|584047774|FG001|Overall Study|Lost to Follow-up|9|||
161727805|NCT04038255|584047775|FG002|Overall Study|Lost to Follow-up|5|||
161727806|NCT04038255|584047773|FG000|Overall Study|Withdrawal by Subject|0|||
161727807|NCT04038255|584047774|FG001|Overall Study|Withdrawal by Subject|0|||
161727808|NCT04038255|584047775|FG002|Overall Study|Withdrawal by Subject|1|||
161727809|NCT05183867|584047776|FG000|Overall Study|Withdrawal by Subject|3|||
161727810|NCT05183867|584047777|FG001|Overall Study|Withdrawal by Subject|2|||
161727811|NCT05183867|584047778|FG002|Overall Study|Withdrawal by Subject|0|||
161727812|NCT05306873|584047781|FG000|Stage 2|Study stopped|1|||
161727813|NCT05306873|584047782|FG001|Stage 2|Study stopped|1|||
161727814|NCT05306873|584047783|FG002|Stage 2|Study stopped|0|||
161727815|NCT05306873|584047784|FG003|Stage 2|Study stopped|0|||
161727816|NCT05306873|584047781|FG000|Stage 2|Stage 2 Treatment Failure|2|||
161727817|NCT05306873|584047782|FG001|Stage 2|Stage 2 Treatment Failure|3|||
161727818|NCT05306873|584047783|FG002|Stage 2|Stage 2 Treatment Failure|0|||
161727819|NCT05306873|584047784|FG003|Stage 2|Stage 2 Treatment Failure|0|||
161727820|NCT05306873|584047781|FG000|Stage 2|Logistical issues due to participant moving|1|||
161727821|NCT05306873|584047782|FG001|Stage 2|Logistical issues due to participant moving|0|||
161727822|NCT05306873|584047783|FG002|Stage 2|Logistical issues due to participant moving|0|||
161727823|NCT05306873|584047784|FG003|Stage 2|Logistical issues due to participant moving|0|||
161727824|NCT05306873|584047781|FG000|Stage 3|Stage 3 Treatment Failure|0|||
161727825|NCT05306873|584047782|FG001|Stage 3|Stage 3 Treatment Failure|0|||
161965569|NCT01005316|584920384|FG001|Overall Study|Adverse Event|0|||
161727826|NCT05306873|584047783|FG002|Stage 3|Stage 3 Treatment Failure|0|||
161727827|NCT05306873|584047784|FG003|Stage 3|Stage 3 Treatment Failure|1|||
161727828|NCT05306873|584047781|FG000|Stage 3|Study Stopped|0|||
161727829|NCT05306873|584047782|FG001|Stage 3|Study Stopped|0|||
161727830|NCT05306873|584047783|FG002|Stage 3|Study Stopped|1|||
161727831|NCT05306873|584047784|FG003|Stage 3|Study Stopped|0|||
161727832|NCT02614287|584047785|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
161727833|NCT02614287|584047786|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
161727834|NCT02614287|584047785|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
161727835|NCT02614287|584047786|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
161838250|NCT04442490|584451852|FG001|Overall Study|Adverse Event|6|||
161838251|NCT04442490|584451851|FG000|Overall Study|Noncompliance|3|||
161838252|NCT04442490|584451852|FG001|Overall Study|Noncompliance|1|||
161727836|NCT02614287|584047785|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
161727837|NCT02614287|584047786|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
161727838|NCT02614287|584047785|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
161727839|NCT02614287|584047786|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
161727840|NCT02614287|584047785|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
161727841|NCT02614287|584047786|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
161727842|NCT02614287|584047785|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
161727843|NCT02614287|584047786|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
161727844|NCT02614287|584047785|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
161727845|NCT02614287|584047786|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
161727846|NCT02614287|584047785|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
161727847|NCT02614287|584047786|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
161727848|NCT00418834|584047787|FG000|Overall Study|Adverse Event|16|||
161727849|NCT00418834|584047788|FG001|Overall Study|Adverse Event|9|||
161727850|NCT00418834|584047787|FG000|Overall Study|Lost to Follow-up|0|||
161727851|NCT00418834|584047788|FG001|Overall Study|Lost to Follow-up|1|||
161727852|NCT00418834|584047787|FG000|Overall Study|Protocol Violation|4|||
161727853|NCT00418834|584047788|FG001|Overall Study|Protocol Violation|3|||
161727854|NCT00418834|584047787|FG000|Overall Study|Withdrawal by Subject|3|||
161727855|NCT00418834|584047788|FG001|Overall Study|Withdrawal by Subject|7|||
161727856|NCT01953328|584047789|FG000|Overall Study|Withdrawal by Subject|0|||
161727857|NCT01953328|584047790|FG001|Overall Study|Withdrawal by Subject|0|||
161727858|NCT01953328|584047791|FG002|Overall Study|Withdrawal by Subject|0|||
161727859|NCT01953328|584047792|FG003|Overall Study|Withdrawal by Subject|0|||
161727860|NCT01953328|584047793|FG004|Overall Study|Withdrawal by Subject|1|||
161727861|NCT01953328|584047794|FG005|Overall Study|Withdrawal by Subject|0|||
161727862|NCT01953328|584047795|FG006|Overall Study|Withdrawal by Subject|0|||
161727863|NCT01953328|584047796|FG007|Overall Study|Withdrawal by Subject|0|||
161727864|NCT01953328|584047789|FG000|Overall Study|Lost to Follow-up|0|||
161727865|NCT01953328|584047790|FG001|Overall Study|Lost to Follow-up|0|||
161727866|NCT01953328|584047791|FG002|Overall Study|Lost to Follow-up|0|||
161727867|NCT01953328|584047792|FG003|Overall Study|Lost to Follow-up|0|||
161727868|NCT01953328|584047793|FG004|Overall Study|Lost to Follow-up|1|||
161727869|NCT01953328|584047794|FG005|Overall Study|Lost to Follow-up|0|||
161727870|NCT01953328|584047795|FG006|Overall Study|Lost to Follow-up|0|||
161727871|NCT01953328|584047796|FG007|Overall Study|Lost to Follow-up|0|||
161727872|NCT01755195|584047799|FG000|Overall Study|Participant noncompliance|2|||
161727873|NCT01755195|584047799|FG000|Overall Study|Switched to alternative treatment|4|||
161727874|NCT01755195|584047799|FG000|Overall Study|Withdrawal by Subject|1|||
161727875|NCT01755195|584047799|FG000|Overall Study|Participant refused to start treatment|1|||
161727876|NCT01755195|584047799|FG000|Overall Study|Participant has been consented for another trial|1|||
161727877|NCT01755195|584047799|FG000|Overall Study|Refused further treatment|3|||
161727878|NCT01755195|584047799|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
161838253|NCT04442490|584451851|FG000|Overall Study|Physician Decision|2|||
161838254|NCT04442490|584451852|FG001|Overall Study|Physician Decision|1|||
161838255|NCT04442490|584451851|FG000|Overall Study|Reason not Specified|2|||
161838256|NCT04442490|584451852|FG001|Overall Study|Reason not Specified|1|||
161838257|NCT04442490|584451851|FG000|Overall Study|Randomized but not Treated|3|||
161838258|NCT04442490|584451852|FG001|Overall Study|Randomized but not Treated|3|||
161838259|NCT00415194|584451857|FG000|Overall Study|Adverse Event|37|||
161838260|NCT00415194|584451858|FG001|Overall Study|Adverse Event|32|||
161838261|NCT00415194|584451857|FG000|Overall Study|Entry Criteria Not Met|4|||
161838262|NCT00415194|584451858|FG001|Overall Study|Entry Criteria Not Met|8|||
161838263|NCT00415194|584451857|FG000|Overall Study|Lost to Follow-up|1|||
161965570|NCT01005316|584920385|FG002|Overall Study|Adverse Event|0|||
161965571|NCT01005316|584920386|FG003|Overall Study|Adverse Event|1|||
161965572|NCT01005316|584920383|FG000|Overall Study|Death|20|||
161727879|NCT05113953|584047800|FG000|Overall Study|Adverse Event|5|||
161727880|NCT05113953|584047801|FG001|Overall Study|Adverse Event|0|||
161838264|NCT00415194|584451858|FG001|Overall Study|Lost to Follow-up|0|||
161838265|NCT00415194|584451857|FG000|Overall Study|Physician Decision|10|||
161965573|NCT01005316|584920384|FG001|Overall Study|Death|5|||
161965574|NCT01005316|584920385|FG002|Overall Study|Death|1|||
161965575|NCT01005316|584920386|FG003|Overall Study|Death|15|||
161727881|NCT05113953|584047802|FG002|Overall Study|Adverse Event|3|||
161727882|NCT05113953|584047800|FG000|Overall Study|Lost to Follow-up|3|||
161727883|NCT05113953|584047801|FG001|Overall Study|Lost to Follow-up|4|||
161727884|NCT05113953|584047802|FG002|Overall Study|Lost to Follow-up|2|||
161727885|NCT05113953|584047800|FG000|Overall Study|Non-compliance with Study Drug|1|||
161727886|NCT05113953|584047801|FG001|Overall Study|Non-compliance with Study Drug|0|||
161838266|NCT00415194|584451858|FG001|Overall Study|Physician Decision|16|||
161838267|NCT00415194|584451857|FG000|Overall Study|Progressive Disease|180|||
161838268|NCT00415194|584451858|FG001|Overall Study|Progressive Disease|217|||
161838269|NCT00415194|584451857|FG000|Overall Study|Protocol Violation|4|||
161727887|NCT05113953|584047802|FG002|Overall Study|Non-compliance with Study Drug|0|||
161727888|NCT05113953|584047800|FG000|Overall Study|Withdrawal by Subject|2|||
161727889|NCT05113953|584047801|FG001|Overall Study|Withdrawal by Subject|6|||
161727890|NCT05113953|584047802|FG002|Overall Study|Withdrawal by Subject|4|||
161727891|NCT05113953|584047800|FG000|Overall Study|Reason not Specified|2|||
161727892|NCT05113953|584047801|FG001|Overall Study|Reason not Specified|0|||
161727893|NCT05113953|584047802|FG002|Overall Study|Reason not Specified|0|||
161727894|NCT00492856|584047804|FG000|Induction|Adverse Event|2|||
161727895|NCT00492856|584047805|FG001|Induction|Adverse Event|0|||
161727896|NCT00492856|584047806|FG002|Induction|Adverse Event|0|||
161727897|NCT00492856|584047807|FG003|Induction|Adverse Event|0|||
161727898|NCT00492856|584047804|FG000|Induction|Withdrawal by Subject|1|||
161727899|NCT00492856|584047805|FG001|Induction|Withdrawal by Subject|0|||
161727900|NCT00492856|584047806|FG002|Induction|Withdrawal by Subject|0|||
161727901|NCT00492856|584047807|FG003|Induction|Withdrawal by Subject|0|||
161727902|NCT00492856|584047804|FG000|Induction|Death|3|||
161727903|NCT00492856|584047805|FG001|Induction|Death|0|||
161727904|NCT00492856|584047806|FG002|Induction|Death|0|||
161727905|NCT00492856|584047807|FG003|Induction|Death|0|||
161727906|NCT00492856|584047804|FG000|Consolidation|Adverse Event|6|||
161727907|NCT00492856|584047805|FG001|Consolidation|Adverse Event|0|||
161727908|NCT00492856|584047806|FG002|Consolidation|Adverse Event|0|||
161727909|NCT00492856|584047807|FG003|Consolidation|Adverse Event|0|||
161727910|NCT00492856|584047804|FG000|Consolidation|Not protocol specified|2|||
161727911|NCT00492856|584047805|FG001|Consolidation|Not protocol specified|0|||
161838270|NCT00415194|584451858|FG001|Overall Study|Protocol Violation|2|||
161838271|NCT00415194|584451857|FG000|Overall Study|Withdrawal by Subject|28|||
161838272|NCT00415194|584451858|FG001|Overall Study|Withdrawal by Subject|21|||
161838273|NCT00415194|584451857|FG000|Overall Study|Death Due to Study Disease|26|||
161838274|NCT00415194|584451858|FG001|Overall Study|Death Due to Study Disease|29|||
161838275|NCT00415194|584451857|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
161838276|NCT00415194|584451858|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
161838277|NCT00415194|584451857|FG000|Overall Study|Death Due to Procedural Related AE|0|||
161838278|NCT00415194|584451858|FG001|Overall Study|Death Due to Procedural Related AE|1|||
161838279|NCT00415194|584451857|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
161838280|NCT00415194|584451858|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
161838281|NCT01297465|584451859|FG000|Overall Study|Lack of Ovarian Response|1|||
161838282|NCT01297465|584451860|FG001|Overall Study|Lack of Ovarian Response|1|||
161838283|NCT01297465|584451859|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
161838284|NCT01297465|584451860|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161838285|NCT01297465|584451859|FG000|Overall Study|No Oocytes Retrieved|1|||
161838286|NCT01297465|584451860|FG001|Overall Study|No Oocytes Retrieved|1|||
161838287|NCT01297465|584451859|FG000|Overall Study|Poor oocyte quality|0|||
161838288|NCT01297465|584451860|FG001|Overall Study|Poor oocyte quality|1|||
161838289|NCT01297465|584451859|FG000|Overall Study|No Fertilization|6|||
161838290|NCT01297465|584451860|FG001|Overall Study|No Fertilization|4|||
161838291|NCT01297465|584451859|FG000|Overall Study|All Embryos Discarded|0|||
161838292|NCT01297465|584451860|FG001|Overall Study|All Embryos Discarded|1|||
161838293|NCT01297465|584451859|FG000|Overall Study|Intention to Freeze all Embryos|0|||
161838294|NCT01297465|584451860|FG001|Overall Study|Intention to Freeze all Embryos|1|||
161838295|NCT00969540|584451861|FG000|Overall Study|Lost to Follow-up|1|||
161838296|NCT00969540|584451862|FG001|Overall Study|Lost to Follow-up|1|||
161838297|NCT04078126|584451865|FG000|Washout|Study put on hold due to COVID-19|0|||
161838298|NCT04078126|584451866|FG001|Washout|Study put on hold due to COVID-19|2|||
161965576|NCT01005316|584920383|FG000|Overall Study|Study Termination|5|||
161965577|NCT01005316|584920384|FG001|Overall Study|Study Termination|63|||
161965578|NCT01005316|584920385|FG002|Overall Study|Study Termination|9|||
161727912|NCT00492856|584047806|FG002|Consolidation|Not protocol specified|0|||
161727913|NCT00492856|584047807|FG003|Consolidation|Not protocol specified|0|||
161727914|NCT00492856|584047804|FG000|Consolidation|Lost to Follow-up|1|||
161727915|NCT00492856|584047805|FG001|Consolidation|Lost to Follow-up|0|||
161727916|NCT00492856|584047806|FG002|Consolidation|Lost to Follow-up|0|||
161727917|NCT00492856|584047807|FG003|Consolidation|Lost to Follow-up|0|||
161727918|NCT00492856|584047804|FG000|Post-consolidation|Adverse Event|0|||
161727919|NCT00492856|584047805|FG001|Post-consolidation|Adverse Event|4|||
161727920|NCT00492856|584047806|FG002|Post-consolidation|Adverse Event|0|||
161727921|NCT00492856|584047807|FG003|Post-consolidation|Adverse Event|1|||
161965579|NCT01005316|584920386|FG003|Overall Study|Study Termination|85|||
161965580|NCT01005316|584920383|FG000|Overall Study|Lost to Follow-up|1|||
161965581|NCT01005316|584920384|FG001|Overall Study|Lost to Follow-up|3|||
161965582|NCT01005316|584920385|FG002|Overall Study|Lost to Follow-up|0|||
161727922|NCT00492856|584047804|FG000|Post-consolidation|Withdrawal by Subject|0|||
161727923|NCT00492856|584047805|FG001|Post-consolidation|Withdrawal by Subject|4|||
161838299|NCT04078126|584451865|FG000|Period 2|Study put on hold due to COVID-19|1|||
161727924|NCT00492856|584047806|FG002|Post-consolidation|Withdrawal by Subject|0|||
161727925|NCT00492856|584047807|FG003|Post-consolidation|Withdrawal by Subject|0|||
161727926|NCT00492856|584047804|FG000|Post-consolidation|Death|0|||
161727927|NCT00492856|584047805|FG001|Post-consolidation|Death|1|||
161965583|NCT01005316|584920386|FG003|Overall Study|Lost to Follow-up|2|||
161965584|NCT01005316|584920383|FG000|Overall Study|Physician Decision|6|||
161965585|NCT01005316|584920384|FG001|Overall Study|Physician Decision|0|||
161965586|NCT01005316|584920385|FG002|Overall Study|Physician Decision|0|||
161965587|NCT01005316|584920386|FG003|Overall Study|Physician Decision|0|||
161727928|NCT00492856|584047806|FG002|Post-consolidation|Death|0|||
161727929|NCT00492856|584047807|FG003|Post-consolidation|Death|0|||
161727930|NCT00492856|584047804|FG000|Post-consolidation|Not protocol specified|0|||
161727931|NCT00492856|584047805|FG001|Post-consolidation|Not protocol specified|1|||
161727932|NCT00492856|584047806|FG002|Post-consolidation|Not protocol specified|0|||
161727933|NCT00492856|584047807|FG003|Post-consolidation|Not protocol specified|0|||
161727934|NCT00492856|584047804|FG000|Post-consolidation|Lost to Follow-up|0|||
161727935|NCT00492856|584047805|FG001|Post-consolidation|Lost to Follow-up|2|||
161727936|NCT00492856|584047806|FG002|Post-consolidation|Lost to Follow-up|0|||
161727937|NCT00492856|584047807|FG003|Post-consolidation|Lost to Follow-up|0|||
161727938|NCT00492856|584047804|FG000|Post-consolidation|Observation Arm|0|||
161727939|NCT00492856|584047805|FG001|Post-consolidation|Observation Arm|0|||
161727940|NCT00492856|584047806|FG002|Post-consolidation|Observation Arm|27|||
161727941|NCT00492856|584047807|FG003|Post-consolidation|Observation Arm|0|||
161727942|NCT03987919|584047808|FG000|Overall Study|Adverse Event|1|||
161727943|NCT03987919|584047809|FG001|Overall Study|Adverse Event|4|||
161727944|NCT03987919|584047810|FG002|Overall Study|Adverse Event|1|||
161727945|NCT03987919|584047811|FG003|Overall Study|Adverse Event|3|||
161727946|NCT03987919|584047808|FG000|Overall Study|Death|4|||
161727947|NCT03987919|584047809|FG001|Overall Study|Death|4|||
161727948|NCT03987919|584047810|FG002|Overall Study|Death|4|||
161727949|NCT03987919|584047811|FG003|Overall Study|Death|1|||
161727950|NCT03987919|584047808|FG000|Overall Study|Lost to Follow-up|5|||
161727951|NCT03987919|584047809|FG001|Overall Study|Lost to Follow-up|6|||
161727952|NCT03987919|584047810|FG002|Overall Study|Lost to Follow-up|8|||
161727953|NCT03987919|584047811|FG003|Overall Study|Lost to Follow-up|12|||
161727954|NCT03987919|584047808|FG000|Overall Study|Physician Decision|0|||
161727955|NCT03987919|584047809|FG001|Overall Study|Physician Decision|2|||
161727956|NCT03987919|584047810|FG002|Overall Study|Physician Decision|0|||
161727957|NCT03987919|584047811|FG003|Overall Study|Physician Decision|4|||
161727958|NCT03987919|584047808|FG000|Overall Study|Pregnancy|1|||
161727959|NCT03987919|584047809|FG001|Overall Study|Pregnancy|0|||
161727960|NCT03987919|584047810|FG002|Overall Study|Pregnancy|1|||
161727961|NCT03987919|584047811|FG003|Overall Study|Pregnancy|1|||
161727962|NCT03987919|584047808|FG000|Overall Study|Protocol Violation|0|||
161727963|NCT03987919|584047809|FG001|Overall Study|Protocol Violation|1|||
161727964|NCT03987919|584047810|FG002|Overall Study|Protocol Violation|0|||
161727965|NCT03987919|584047811|FG003|Overall Study|Protocol Violation|0|||
161727966|NCT03987919|584047808|FG000|Overall Study|Site terminated by Sponsor|0|||
161727967|NCT03987919|584047809|FG001|Overall Study|Site terminated by Sponsor|0|||
161727968|NCT03987919|584047810|FG002|Overall Study|Site terminated by Sponsor|0|||
161727969|NCT03987919|584047811|FG003|Overall Study|Site terminated by Sponsor|1|||
161727970|NCT03987919|584047808|FG000|Overall Study|Withdrawal by Subject|7|||
161727971|NCT03987919|584047809|FG001|Overall Study|Withdrawal by Subject|7|||
161727972|NCT03987919|584047810|FG002|Overall Study|Withdrawal by Subject|8|||
161727973|NCT03987919|584047811|FG003|Overall Study|Withdrawal by Subject|4|||
161727974|NCT03987919|584047808|FG000|Overall Study|Other - as reported by the investigator|1|||
161727975|NCT03987919|584047809|FG001|Overall Study|Other - as reported by the investigator|3|||
161727976|NCT03987919|584047810|FG002|Overall Study|Other - as reported by the investigator|2|||
161727977|NCT03987919|584047811|FG003|Overall Study|Other - as reported by the investigator|0|||
161727978|NCT03470922|584047817|FG000|Overall Study|Death|107|||
161727979|NCT03470922|584047818|FG001|Overall Study|Death|118|||
161727980|NCT03470922|584047817|FG000|Overall Study|Lost to Follow-up|5|||
161727981|NCT03470922|584047818|FG001|Overall Study|Lost to Follow-up|5|||
161727982|NCT03470922|584047817|FG000|Overall Study|Participant Withdrew Consent|4|||
161727983|NCT03470922|584047818|FG001|Overall Study|Participant Withdrew Consent|9|||
161727984|NCT03470922|584047817|FG000|Overall Study|Other reasons|1|||
161727985|NCT03470922|584047818|FG001|Overall Study|Other reasons|0|||
161727986|NCT03470922|584047817|FG000|Overall Study|Not reported|1|||
161727987|NCT03470922|584047818|FG001|Overall Study|Not reported|0|||
161727988|NCT02340819|584047819|FG000|Overall Study|Adverse Event|1|||
161727989|NCT02340819|584047819|FG000|Overall Study|Withdrawal by Subject|2|||
161727990|NCT02340819|584047819|FG000|Overall Study|Discontinued with other reason|1|||
161727991|NCT02626819|584047820|FG000|Overall Study|Lost to Follow-up|3|||
161727992|NCT02626819|584047821|FG001|Overall Study|Lost to Follow-up|2|||
161727993|NCT02626819|584047820|FG000|Overall Study|Withdrawal by Subject|1|||
161727994|NCT02626819|584047821|FG001|Overall Study|Withdrawal by Subject|0|||
161965588|NCT01005316|584920383|FG000|Overall Study|Sponsor Decision|6|||
161965589|NCT01005316|584920384|FG001|Overall Study|Sponsor Decision|3|||
161727995|NCT02626819|584047820|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
161727996|NCT02626819|584047821|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
161727997|NCT02361762|584047822|FG000|Overall Study|Withdrawal by Subject|0|||
161727998|NCT02361762|584047823|FG001|Overall Study|Withdrawal by Subject|1|||
161838300|NCT04078126|584451866|FG001|Period 2|Study put on hold due to COVID-19|1|||
161838301|NCT02149108|584451869|FG000|Overall Study|Not treated|1|||
161838302|NCT02149108|584451870|FG001|Overall Study|Not treated|2|||
161838303|NCT02149108|584451869|FG000|Overall Study|Progressive Disease (PD)|324|||
161838304|NCT02149108|584451870|FG001|Overall Study|Progressive Disease (PD)|318|||
161838305|NCT02149108|584451869|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
161838306|NCT02149108|584451870|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
161838307|NCT02149108|584451869|FG000|Overall Study|Other Adverse Event (AE)|8|||
161838308|NCT02149108|584451870|FG001|Overall Study|Other Adverse Event (AE)|18|||
161838309|NCT02149108|584451869|FG000|Overall Study|Other not defined above|0|||
161838310|NCT02149108|584451870|FG001|Overall Study|Other not defined above|2|||
161838311|NCT02149108|584451869|FG000|Overall Study|Refusal to continue trial medication|15|||
161838312|NCT02149108|584451870|FG001|Overall Study|Refusal to continue trial medication|11|||
161838313|NCT02149108|584451869|FG000|Overall Study|Lost to Follow-up|1|||
161838314|NCT02149108|584451870|FG001|Overall Study|Lost to Follow-up|0|||
161838315|NCT00950963|584451871|FG000|Overall Study|Lost to Follow-up|29|||
161838316|NCT00950963|584451872|FG001|Overall Study|Lost to Follow-up|24|||
161838317|NCT01675661|584451873|FG000|Overall Study|Lost to Follow-up|22|||
161838318|NCT01675661|584451874|FG001|Overall Study|Lost to Follow-up|23|||
161838319|NCT01675661|584451873|FG000|Overall Study|Practical problems|9|||
161838320|NCT01675661|584451874|FG001|Overall Study|Practical problems|5|||
161838321|NCT01675661|584451873|FG000|Overall Study|Moved away|5|||
161838322|NCT01675661|584451874|FG001|Overall Study|Moved away|6|||
161838323|NCT01675661|584451873|FG000|Overall Study|Withdrawal by Subject|3|||
161838324|NCT01675661|584451874|FG001|Overall Study|Withdrawal by Subject|7|||
161838325|NCT01675661|584451873|FG000|Overall Study|Physician Decision|0|||
161838326|NCT01675661|584451874|FG001|Overall Study|Physician Decision|2|||
161838327|NCT01675661|584451873|FG000|Overall Study|Death|0|||
161838328|NCT01675661|584451874|FG001|Overall Study|Death|1|||
161838329|NCT01675661|584451873|FG000|Overall Study|Other reason|1|||
161838330|NCT01675661|584451874|FG001|Overall Study|Other reason|2|||
161838331|NCT00987389|584451875|FG000|Overall Study|Ineligible|0|||
161965590|NCT01005316|584920385|FG002|Overall Study|Sponsor Decision|0|||
161965591|NCT01005316|584920386|FG003|Overall Study|Sponsor Decision|0|||
161727999|NCT02361762|584047822|FG000|Overall Study|Lost to Follow-up|0|||
161728000|NCT02361762|584047823|FG001|Overall Study|Lost to Follow-up|1|||
161728001|NCT00502307|584047824|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
161728002|NCT00502307|584047825|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
161728003|NCT00502307|584047826|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
161728004|NCT00502307|584047824|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
161728005|NCT00502307|584047825|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
161728006|NCT00502307|584047826|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
161728007|NCT00502307|584047824|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
161728008|NCT00502307|584047825|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
161728009|NCT00502307|584047826|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
161728010|NCT00502307|584047824|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
161728011|NCT00502307|584047825|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
161728012|NCT00502307|584047826|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
161728013|NCT00502307|584047824|FG000|Maintenance Period|Progressive disease|80|||
161728014|NCT00502307|584047825|FG001|Maintenance Period|Progressive disease|0|||
161728015|NCT00502307|584047826|FG002|Maintenance Period|Progressive disease|0|||
161728016|NCT00502307|584047824|FG000|Maintenance Period|Discontinued due to other reasons|68|||
161728017|NCT00502307|584047825|FG001|Maintenance Period|Discontinued due to other reasons|0|||
161728018|NCT00502307|584047826|FG002|Maintenance Period|Discontinued due to other reasons|0|||
161728019|NCT00423085|584047827|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
161728020|NCT00423085|584047828|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
161728021|NCT00423085|584047829|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
161838332|NCT00987389|584451876|FG001|Overall Study|Ineligible|3|||
161838333|NCT00987389|584451877|FG002|Overall Study|Ineligible|0|||
161838334|NCT00987389|584451878|FG003|Overall Study|Ineligible|0|||
161838335|NCT00987389|584451875|FG000|Overall Study|Lost to Follow-up|4|||
161838336|NCT00987389|584451876|FG001|Overall Study|Lost to Follow-up|1|||
161838337|NCT00987389|584451877|FG002|Overall Study|Lost to Follow-up|3|||
161838338|NCT00987389|584451878|FG003|Overall Study|Lost to Follow-up|1|||
161965592|NCT01005316|584920383|FG000|Overall Study|Withdrawal by Subject|1|||
161728022|NCT00423085|584047830|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
161728023|NCT00423085|584047827|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
161728024|NCT00423085|584047828|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
161838339|NCT00987389|584451875|FG000|Overall Study|Withdrawal by Subject|4|||
161838340|NCT00987389|584451876|FG001|Overall Study|Withdrawal by Subject|3|||
161838341|NCT00987389|584451877|FG002|Overall Study|Withdrawal by Subject|2|||
161838342|NCT00987389|584451878|FG003|Overall Study|Withdrawal by Subject|1|||
161838343|NCT00987389|584451875|FG000|Overall Study|Withdrawn from Treatment|0|||
161838344|NCT00987389|584451876|FG001|Overall Study|Withdrawn from Treatment|1|||
161728025|NCT00423085|584047829|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
161728026|NCT00423085|584047830|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161728027|NCT00423085|584047827|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
161728028|NCT00423085|584047828|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
161728029|NCT00423085|584047829|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
161728030|NCT00423085|584047830|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
161728031|NCT00423085|584047827|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
161728032|NCT00423085|584047828|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
161728033|NCT00423085|584047829|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
161728034|NCT00423085|584047830|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
161728035|NCT00423085|584047827|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
161728036|NCT00423085|584047828|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
161728037|NCT00423085|584047829|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
161728038|NCT00423085|584047830|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
161728039|NCT00423085|584047827|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
161728040|NCT00423085|584047828|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
161728041|NCT00423085|584047829|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
161728042|NCT00423085|584047830|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
161728043|NCT00423085|584047827|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
161728044|NCT00423085|584047828|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
161728045|NCT00423085|584047829|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
161728046|NCT00423085|584047830|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
161728047|NCT00423085|584047827|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
161728048|NCT00423085|584047828|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
161728049|NCT00423085|584047829|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
161728050|NCT00423085|584047830|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
161728051|NCT00423085|584047827|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
161728052|NCT00423085|584047828|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
161728053|NCT00423085|584047829|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
161728054|NCT00423085|584047830|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
161728055|NCT00423085|584047827|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
161728056|NCT00423085|584047828|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
161728057|NCT00423085|584047829|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
161728058|NCT00423085|584047830|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
161728059|NCT00423085|584047827|FG000|52-Week Open-Label Extension Phase|Death|0|||
161728060|NCT00423085|584047828|FG001|52-Week Open-Label Extension Phase|Death|0|||
161728061|NCT00423085|584047829|FG002|52-Week Open-Label Extension Phase|Death|0|||
161728062|NCT00423085|584047830|FG003|52-Week Open-Label Extension Phase|Death|2|||
161728063|NCT03331666|584047831|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
161728064|NCT03331666|584047832|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
161728065|NCT00434512|584047833|FG000|Overall Study|Migrated/moved from study area|0|||
161728066|NCT00434512|584047834|FG001|Overall Study|Migrated/moved from study area|0|||
161728067|NCT00434512|584047835|FG002|Overall Study|Migrated/moved from study area|0|||
161728068|NCT00434512|584047836|FG003|Overall Study|Migrated/moved from study area|1|||
161728069|NCT00434512|584047837|FG004|Overall Study|Migrated/moved from study area|1|||
161728070|NCT00434512|584047838|FG005|Overall Study|Migrated/moved from study area|1|||
161728071|NCT00434512|584047833|FG000|Overall Study|Other|0|||
161728072|NCT00434512|584047834|FG001|Overall Study|Other|1|||
161728073|NCT00434512|584047835|FG002|Overall Study|Other|0|||
161728074|NCT00434512|584047836|FG003|Overall Study|Other|0|||
161728075|NCT00434512|584047837|FG004|Overall Study|Other|0|||
161728076|NCT00434512|584047838|FG005|Overall Study|Other|0|||
161728077|NCT02750813|584047841|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
161728078|NCT02750813|584047842|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
161728079|NCT02750813|584047841|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
161728080|NCT02750813|584047842|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
161728081|NCT00441441|584047843|FG000|Overall Study|Adverse Event|2|||
161728082|NCT00441441|584047844|FG001|Overall Study|Adverse Event|1|||
161728083|NCT00441441|584047843|FG000|Overall Study|Protocol Violation|4|||
161728084|NCT00441441|584047844|FG001|Overall Study|Protocol Violation|6|||
161728085|NCT00441441|584047843|FG000|Overall Study|Exacerbation of asthma|1|||
161728086|NCT00441441|584047844|FG001|Overall Study|Exacerbation of asthma|2|||
161728087|NCT00441441|584047843|FG000|Overall Study|Withdrawal by Subject|1|||
161728088|NCT00441441|584047844|FG001|Overall Study|Withdrawal by Subject|2|||
161728089|NCT00441441|584047843|FG000|Overall Study|Other|3|||
161728090|NCT00441441|584047844|FG001|Overall Study|Other|3|||
161728091|NCT03165721|584047855|FG000|Overall Study|Refused further treatment|3|||
161728092|NCT03165721|584047856|FG001|Overall Study|Refused further treatment|0|||
161728093|NCT03165721|584047857|FG002|Overall Study|Refused further treatment|0|||
161965593|NCT01005316|584920384|FG001|Overall Study|Withdrawal by Subject|1|||
161965594|NCT01005316|584920385|FG002|Overall Study|Withdrawal by Subject|0|||
161728094|NCT03165721|584047855|FG000|Overall Study|Physician Decision|1|||
161728095|NCT03165721|584047856|FG001|Overall Study|Physician Decision|0|||
161728096|NCT03165721|584047857|FG002|Overall Study|Physician Decision|0|||
161728097|NCT02324842|584047859|FG000|Overall Study|Lost to Follow-up|1|||
161728098|NCT02324842|584047860|FG001|Overall Study|Lost to Follow-up|1|||
161728099|NCT02324842|584047861|FG002|Overall Study|Lost to Follow-up|2|||
161728100|NCT03298412|584047862|FG000|Run-in Period|Other, Not Specified|1|||
161728101|NCT03298412|584047862|FG000|Run-in Period|Disease Progression|1|||
161728102|NCT03298412|584047862|FG000|Run-in Period|Ineligibility Determined|1|||
161728103|NCT03298412|584047862|FG000|Run-in Period|Decision by Sponsor|6|||
161728104|NCT01202227|584047865|FG000|Overall Study|Adverse Event|16|||
161728105|NCT01202227|584047865|FG000|Overall Study|Withdrawal by Subject|2|||
161728106|NCT01202227|584047865|FG000|Overall Study|Lack of Efficacy|1|||
161728107|NCT01894477|584047866|FG000|Overall Study|Protocol Violation|0|||
161728108|NCT01894477|584047867|FG001|Overall Study|Protocol Violation|1|||
161728109|NCT01894477|584047866|FG000|Overall Study|protocol changed due SC changed to cord|0|||
161728110|NCT01894477|584047867|FG001|Overall Study|protocol changed due SC changed to cord|1|||
161728111|NCT01533935|584047868|FG000|Overall Study|Adverse Event|5|||
161728112|NCT01533935|584047869|FG001|Overall Study|Adverse Event|7|||
161728113|NCT01533935|584047870|FG002|Overall Study|Adverse Event|1|||
161728114|NCT01533935|584047871|FG003|Overall Study|Adverse Event|5|||
161728115|NCT01533935|584047872|FG004|Overall Study|Adverse Event|3|||
161728116|NCT01533935|584047868|FG000|Overall Study|Protocol Violation|0|||
161728117|NCT01533935|584047869|FG001|Overall Study|Protocol Violation|2|||
161728118|NCT01533935|584047870|FG002|Overall Study|Protocol Violation|0|||
161728119|NCT01533935|584047871|FG003|Overall Study|Protocol Violation|0|||
161728120|NCT01533935|584047872|FG004|Overall Study|Protocol Violation|0|||
161728121|NCT01533935|584047868|FG000|Overall Study|Lost to Follow-up|0|||
161728122|NCT01533935|584047869|FG001|Overall Study|Lost to Follow-up|0|||
161728123|NCT01533935|584047870|FG002|Overall Study|Lost to Follow-up|1|||
161728124|NCT01533935|584047871|FG003|Overall Study|Lost to Follow-up|0|||
161728125|NCT01533935|584047872|FG004|Overall Study|Lost to Follow-up|0|||
161728126|NCT01533935|584047868|FG000|Overall Study|Withdrawal by Subject|0|||
161728127|NCT01533935|584047869|FG001|Overall Study|Withdrawal by Subject|4|||
161728128|NCT01533935|584047870|FG002|Overall Study|Withdrawal by Subject|5|||
161728129|NCT01533935|584047871|FG003|Overall Study|Withdrawal by Subject|2|||
161728130|NCT01533935|584047872|FG004|Overall Study|Withdrawal by Subject|4|||
161728131|NCT01533935|584047868|FG000|Overall Study|Other reason not defined above|1|||
161728132|NCT01533935|584047869|FG001|Overall Study|Other reason not defined above|0|||
161728133|NCT01533935|584047870|FG002|Overall Study|Other reason not defined above|1|||
161728134|NCT01533935|584047871|FG003|Overall Study|Other reason not defined above|0|||
161728135|NCT01533935|584047872|FG004|Overall Study|Other reason not defined above|1|||
161728136|NCT01554956|584047875|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
161728137|NCT01554956|584047876|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
161728138|NCT01554956|584047877|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
161728139|NCT01554956|584047875|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
161728140|NCT01554956|584047876|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
161728141|NCT01554956|584047877|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
161728142|NCT01554956|584047875|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
161728143|NCT01554956|584047876|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
161728144|NCT01554956|584047877|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
161728145|NCT00069095|584047878|FG000|Primary Treatment Phase|Ongoing|0|||
161728146|NCT00069095|584047879|FG001|Primary Treatment Phase|Ongoing|0|||
161728147|NCT00069095|584047880|FG002|Primary Treatment Phase|Ongoing|5|||
161728148|NCT00069095|584047881|FG003|Primary Treatment Phase|Ongoing|7|||
161728149|NCT00069095|584047882|FG004|Primary Treatment Phase|Ongoing|7|||
161728150|NCT00069095|584047883|FG005|Primary Treatment Phase|Ongoing|4|||
161728151|NCT00069095|584047878|FG000|Primary Treatment Phase|Admin/Other|29|||
161728152|NCT00069095|584047879|FG001|Primary Treatment Phase|Admin/Other|38|||
161965595|NCT01005316|584920386|FG003|Overall Study|Withdrawal by Subject|2|||
161965596|NCT01005316|584920383|FG000|Overall Study|Consented to Another Study|2|||
161965597|NCT01005316|584920384|FG001|Overall Study|Consented to Another Study|0|||
161965598|NCT01005316|584920385|FG002|Overall Study|Consented to Another Study|0|||
161965599|NCT01005316|584920386|FG003|Overall Study|Consented to Another Study|0|||
161728153|NCT00069095|584047880|FG002|Primary Treatment Phase|Admin/Other|31|||
161728154|NCT00069095|584047881|FG003|Primary Treatment Phase|Admin/Other|45|||
161965600|NCT01005316|584920383|FG000|Overall Study|Delisted|8|||
161965601|NCT01005316|584920384|FG001|Overall Study|Delisted|0|||
161728155|NCT00069095|584047882|FG004|Primary Treatment Phase|Admin/Other|48|||
161728156|NCT00069095|584047883|FG005|Primary Treatment Phase|Admin/Other|42|||
161965602|NCT01005316|584920385|FG002|Overall Study|Delisted|0|||
161965603|NCT01005316|584920386|FG003|Overall Study|Delisted|0|||
161965604|NCT01005316|584920383|FG000|Overall Study|Transferred Care|1|||
161728157|NCT00069095|584047878|FG000|Primary Treatment Phase|Adverse Event|99|||
161728158|NCT00069095|584047879|FG001|Primary Treatment Phase|Adverse Event|92|||
161728159|NCT00069095|584047880|FG002|Primary Treatment Phase|Adverse Event|71|||
161728160|NCT00069095|584047881|FG003|Primary Treatment Phase|Adverse Event|72|||
161728161|NCT00069095|584047882|FG004|Primary Treatment Phase|Adverse Event|109|||
161728162|NCT00069095|584047883|FG005|Primary Treatment Phase|Adverse Event|101|||
161728163|NCT00069095|584047878|FG000|Primary Treatment Phase|Death|14|||
161728164|NCT00069095|584047879|FG001|Primary Treatment Phase|Death|8|||
161728165|NCT00069095|584047880|FG002|Primary Treatment Phase|Death|2|||
161728166|NCT00069095|584047881|FG003|Primary Treatment Phase|Death|5|||
161728167|NCT00069095|584047882|FG004|Primary Treatment Phase|Death|8|||
161728168|NCT00069095|584047883|FG005|Primary Treatment Phase|Death|8|||
161728169|NCT00069095|584047878|FG000|Primary Treatment Phase|Failure to return|5|||
161728170|NCT00069095|584047879|FG001|Primary Treatment Phase|Failure to return|5|||
161728171|NCT00069095|584047880|FG002|Primary Treatment Phase|Failure to return|0|||
161728172|NCT00069095|584047881|FG003|Primary Treatment Phase|Failure to return|0|||
161728173|NCT00069095|584047882|FG004|Primary Treatment Phase|Failure to return|0|||
161728174|NCT00069095|584047883|FG005|Primary Treatment Phase|Failure to return|2|||
161728175|NCT00069095|584047878|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
161728176|NCT00069095|584047879|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
161728177|NCT00069095|584047880|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
161728178|NCT00069095|584047881|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
161728179|NCT00069095|584047882|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
161728180|NCT00069095|584047883|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
161728181|NCT00069095|584047878|FG000|Primary Treatment Phase|Refused treatment|15|||
161728182|NCT00069095|584047879|FG001|Primary Treatment Phase|Refused treatment|26|||
161728183|NCT00069095|584047880|FG002|Primary Treatment Phase|Refused treatment|17|||
161728184|NCT00069095|584047881|FG003|Primary Treatment Phase|Refused treatment|31|||
161728185|NCT00069095|584047882|FG004|Primary Treatment Phase|Refused treatment|24|||
161728186|NCT00069095|584047883|FG005|Primary Treatment Phase|Refused treatment|27|||
161728187|NCT00069095|584047878|FG000|Primary Treatment Phase|Withdrew|2|||
161728188|NCT00069095|584047879|FG001|Primary Treatment Phase|Withdrew|3|||
161728189|NCT00069095|584047880|FG002|Primary Treatment Phase|Withdrew|8|||
161728190|NCT00069095|584047881|FG003|Primary Treatment Phase|Withdrew|2|||
161728191|NCT00069095|584047882|FG004|Primary Treatment Phase|Withdrew|4|||
161728192|NCT00069095|584047883|FG005|Primary Treatment Phase|Withdrew|9|||
161728193|NCT00069095|584047878|FG000|Primary Treatment Phase|Other Violation|0|||
161728194|NCT00069095|584047879|FG001|Primary Treatment Phase|Other Violation|1|||
161728195|NCT00069095|584047880|FG002|Primary Treatment Phase|Other Violation|1|||
161728196|NCT00069095|584047881|FG003|Primary Treatment Phase|Other Violation|1|||
161728197|NCT00069095|584047882|FG004|Primary Treatment Phase|Other Violation|0|||
161728198|NCT00069095|584047883|FG005|Primary Treatment Phase|Other Violation|1|||
161728199|NCT00069095|584047878|FG000|Primary Treatment Phase|Violation criteria|0|||
161728200|NCT00069095|584047879|FG001|Primary Treatment Phase|Violation criteria|2|||
161728201|NCT00069095|584047880|FG002|Primary Treatment Phase|Violation criteria|4|||
161728202|NCT00069095|584047881|FG003|Primary Treatment Phase|Violation criteria|3|||
161728203|NCT00069095|584047882|FG004|Primary Treatment Phase|Violation criteria|1|||
161728204|NCT00069095|584047883|FG005|Primary Treatment Phase|Violation criteria|5|||
161728205|NCT00069095|584047878|FG000|Post-study Treatment Phase|Missing reason|1|||
161728206|NCT00069095|584047879|FG001|Post-study Treatment Phase|Missing reason|3|||
161728207|NCT00069095|584047880|FG002|Post-study Treatment Phase|Missing reason|12|||
161728208|NCT00069095|584047881|FG003|Post-study Treatment Phase|Missing reason|8|||
161728209|NCT00069095|584047882|FG004|Post-study Treatment Phase|Missing reason|18|||
161728210|NCT00069095|584047883|FG005|Post-study Treatment Phase|Missing reason|17|||
161728211|NCT00069095|584047878|FG000|Post-study Treatment Phase|Adverse Event|2|||
161728212|NCT00069095|584047879|FG001|Post-study Treatment Phase|Adverse Event|3|||
161728213|NCT00069095|584047880|FG002|Post-study Treatment Phase|Adverse Event|1|||
161728214|NCT00069095|584047881|FG003|Post-study Treatment Phase|Adverse Event|0|||
161728215|NCT00069095|584047882|FG004|Post-study Treatment Phase|Adverse Event|5|||
161728216|NCT00069095|584047883|FG005|Post-study Treatment Phase|Adverse Event|1|||
161728217|NCT00069095|584047878|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
161728218|NCT00069095|584047879|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
161728219|NCT00069095|584047880|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
161728220|NCT00069095|584047881|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
161728221|NCT00069095|584047882|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
161728222|NCT00069095|584047883|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
161728223|NCT00069095|584047878|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
161728224|NCT00069095|584047879|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
161728225|NCT00069095|584047880|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
161728226|NCT00069095|584047881|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
161728227|NCT00069095|584047882|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
161728228|NCT00069095|584047883|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
161728229|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
161838345|NCT00987389|584451877|FG002|Overall Study|Withdrawn from Treatment|0|||
161838346|NCT00987389|584451878|FG003|Overall Study|Withdrawn from Treatment|0|||
161838347|NCT00987389|584451875|FG000|Overall Study|Multiple different reasons|1|||
161838348|NCT00987389|584451876|FG001|Overall Study|Multiple different reasons|0|||
161838349|NCT00987389|584451877|FG002|Overall Study|Multiple different reasons|3|||
161838350|NCT00987389|584451878|FG003|Overall Study|Multiple different reasons|1|||
161838351|NCT02992418|584451881|FG000|Overall Study|Withdrawal by Subject|11|||
161838352|NCT02992418|584451882|FG001|Overall Study|Withdrawal by Subject|12|||
161838353|NCT02992418|584451881|FG000|Overall Study|Non-compliance with the protocol|308|||
161838354|NCT02992418|584451882|FG001|Overall Study|Non-compliance with the protocol|308|||
161838355|NCT02992418|584451881|FG000|Overall Study|Lost to Follow-up|27|||
161838356|NCT02992418|584451882|FG001|Overall Study|Lost to Follow-up|22|||
161838357|NCT00289536|584451883|FG000|Period 3|Lost to Follow-up|0|||
161838358|NCT00289536|584451884|FG001|Period 3|Lost to Follow-up|0|||
161838359|NCT00289536|584451885|FG002|Period 3|Lost to Follow-up|1|||
161838360|NCT01974440|584451886|FG000|Overall Study|Lost to Follow-up|7|||
161838361|NCT01974440|584451887|FG001|Overall Study|Lost to Follow-up|7|||
161838362|NCT01974440|584451886|FG000|Overall Study|Withdrawal by Subject|24|||
161838363|NCT01974440|584451887|FG001|Overall Study|Withdrawal by Subject|20|||
161838364|NCT01974440|584451886|FG000|Overall Study|Sponsor decision|109|||
161838365|NCT01974440|584451887|FG001|Overall Study|Sponsor decision|110|||
161838366|NCT02749292|584451890|FG000|Overall Study|Physician Decision|1|||
161838367|NCT02749292|584451891|FG001|Overall Study|Physician Decision|0|||
161838368|NCT02749292|584451890|FG000|Overall Study|Withdrawal by Subject|5|||
161838369|NCT02749292|584451891|FG001|Overall Study|Withdrawal by Subject|7|||
161838370|NCT02749292|584451890|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
161838371|NCT02749292|584451891|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
161838372|NCT02749292|584451890|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
161838373|NCT02749292|584451891|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
161838374|NCT02749292|584451890|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
161838375|NCT02749292|584451891|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
161838376|NCT02749292|584451890|FG000|Overall Study|Adverse Event|4|||
161838377|NCT02749292|584451891|FG001|Overall Study|Adverse Event|1|||
161838378|NCT02749292|584451890|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
161838379|NCT02749292|584451891|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
161838380|NCT02749292|584451890|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
161838381|NCT02749292|584451891|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
161838382|NCT02749292|584451890|FG000|Overall Study|Requiring glucocorticoids|0|||
161838383|NCT02749292|584451891|FG001|Overall Study|Requiring glucocorticoids|3|||
161838384|NCT02749292|584451890|FG000|Overall Study|Cancer|1|||
161838385|NCT02749292|584451891|FG001|Overall Study|Cancer|0|||
161838386|NCT00251641|584451892|FG000|Overall Study|Adverse Event|80|||
161838387|NCT00251641|584451893|FG001|Overall Study|Adverse Event|8|||
161838388|NCT00251641|584451892|FG000|Overall Study|Lack of Efficacy|2|||
161838389|NCT00251641|584451893|FG001|Overall Study|Lack of Efficacy|1|||
161838390|NCT00251641|584451892|FG000|Overall Study|Progression of Disease|0|||
162032180|NCT00095238|585175422|FG001|Overall Study|Lack of Efficacy|9|||
162032181|NCT00095238|585175421|FG000|Overall Study|Adverse Event|331|||
161838391|NCT00251641|584451893|FG001|Overall Study|Progression of Disease|2|||
161838392|NCT00251641|584451892|FG000|Overall Study|Lost to Follow-up|3|||
161838393|NCT00251641|584451893|FG001|Overall Study|Lost to Follow-up|3|||
161838394|NCT00251641|584451892|FG000|Overall Study|Withdrawal by Subject|6|||
161838395|NCT00251641|584451893|FG001|Overall Study|Withdrawal by Subject|8|||
161838396|NCT00251641|584451892|FG000|Overall Study|Protocol Violation|10|||
161838397|NCT00251641|584451893|FG001|Overall Study|Protocol Violation|2|||
161838398|NCT00251641|584451892|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
161838399|NCT00251641|584451893|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
161838400|NCT00251641|584451892|FG000|Overall Study|Switched Treatment|9|||
161838401|NCT00251641|584451893|FG001|Overall Study|Switched Treatment|63|||
161838402|NCT00876018|584451894|FG000|Overall Study|Lost to Follow-up|0|||
161838403|NCT00876018|584451895|FG001|Overall Study|Lost to Follow-up|1|||
162032182|NCT00095238|585175422|FG001|Overall Study|Adverse Event|287|||
162032183|NCT00095238|585175421|FG000|Overall Study|Subject Withdrew Consent|208|||
161838404|NCT00876018|584451896|FG002|Overall Study|Lost to Follow-up|1|||
161838405|NCT00876018|584451894|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
161838406|NCT00876018|584451895|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
161838407|NCT00876018|584451896|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
161838408|NCT01000493|584451899|FG000|Overall Study|Adverse Event|3|||
161838409|NCT01000493|584451900|FG001|Overall Study|Adverse Event|6|||
161838410|NCT01000493|584451899|FG000|Overall Study|Lack of Efficacy|1|||
161838411|NCT01000493|584451900|FG001|Overall Study|Lack of Efficacy|1|||
161838412|NCT01000493|584451899|FG000|Overall Study|Protocol Violation|1|||
161838413|NCT01000493|584451900|FG001|Overall Study|Protocol Violation|8|||
161838414|NCT01000493|584451899|FG000|Overall Study|Study closed/terminated|25|||
161838415|NCT01000493|584451900|FG001|Overall Study|Study closed/terminated|23|||
161838416|NCT01000493|584451899|FG000|Overall Study|Lost to Follow-up|5|||
161838417|NCT01000493|584451900|FG001|Overall Study|Lost to Follow-up|9|||
161838418|NCT01000493|584451899|FG000|Overall Study|Physician Decision|1|||
161838419|NCT01000493|584451900|FG001|Overall Study|Physician Decision|1|||
161838420|NCT01000493|584451899|FG000|Overall Study|Withdrawal by Subject|3|||
161838421|NCT01000493|584451900|FG001|Overall Study|Withdrawal by Subject|7|||
161838422|NCT03629028|584451901|FG000|Overall Study|Lost to Follow-up|26|||
161838423|NCT03629028|584451902|FG001|Overall Study|Lost to Follow-up|23|||
161838424|NCT03629028|584451901|FG000|Overall Study|Pregnancy|4|||
161838425|NCT03629028|584451902|FG001|Overall Study|Pregnancy|2|||
161838426|NCT03629028|584451901|FG000|Overall Study|intolerance to examination|2|||
161838427|NCT03629028|584451902|FG001|Overall Study|intolerance to examination|0|||
161838428|NCT03828448|584451904|FG000|Overall Study|Sponsor's Discretion|34|||
161838429|NCT02192164|584451910|FG000|Overall Study|Other|8|||
161838430|NCT02192164|584451910|FG000|Overall Study|Withdrawal by Subject|1|||
161838431|NCT02192164|584451910|FG000|Overall Study|Physician Decision|4|||
161838432|NCT02192164|584451910|FG000|Overall Study|Did not meet the exclusion criteria|1|||
161838433|NCT03123861|584451911|FG000|Overall Study|Protocol Violation|1|||
161838434|NCT03123861|584451912|FG001|Overall Study|Protocol Violation|1|||
161838435|NCT03123861|584451911|FG000|Overall Study|Withdrawal by Subject|2|||
161838436|NCT03123861|584451912|FG001|Overall Study|Withdrawal by Subject|2|||
161838437|NCT05069155|584451913|FG000|Overall Study|Withdrawal by Subject|1|||
161838438|NCT05069155|584451914|FG001|Overall Study|Withdrawal by Subject|3|||
161838439|NCT01929031|584451915|FG000|Overall Study|Adverse Event|3|||
161838440|NCT01929031|584451916|FG001|Overall Study|Adverse Event|1|||
161838441|NCT01929031|584451917|FG002|Overall Study|Adverse Event|1|||
161838442|NCT01929031|584451918|FG003|Overall Study|Adverse Event|0|||
161838443|NCT01929031|584451919|FG004|Overall Study|Adverse Event|0|||
161838444|NCT01929031|584451920|FG005|Overall Study|Adverse Event|0|||
161838445|NCT01929031|584451915|FG000|Overall Study|Protocol Violation|1|||
161838446|NCT01929031|584451916|FG001|Overall Study|Protocol Violation|0|||
161728230|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
161728231|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
161728232|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
161728233|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
161728234|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
161728235|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant had complete response|1|||
161728236|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant had complete response|1|||
161728237|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant had complete response|0|||
161728238|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant had complete response|0|||
161728239|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant had complete response|0|||
161728240|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant had complete response|0|||
161728241|NCT00069095|584047878|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161728242|NCT00069095|584047879|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
161728243|NCT00069095|584047880|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161728244|NCT00069095|584047881|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161728245|NCT00069095|584047882|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161728246|NCT00069095|584047883|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161728247|NCT00069095|584047878|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
161728248|NCT00069095|584047879|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
161728249|NCT00069095|584047880|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
161728250|NCT00069095|584047881|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
161728251|NCT00069095|584047882|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
161728252|NCT00069095|584047883|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
161728253|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
161728254|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
161838447|NCT01929031|584451917|FG002|Overall Study|Protocol Violation|0|||
161838448|NCT01929031|584451918|FG003|Overall Study|Protocol Violation|0|||
161838449|NCT01929031|584451919|FG004|Overall Study|Protocol Violation|0|||
161838450|NCT01929031|584451920|FG005|Overall Study|Protocol Violation|1|||
161838451|NCT01929031|584451915|FG000|Overall Study|Reason other than specified above|0|||
161838452|NCT01929031|584451916|FG001|Overall Study|Reason other than specified above|1|||
161838453|NCT01929031|584451917|FG002|Overall Study|Reason other than specified above|0|||
161838454|NCT01929031|584451918|FG003|Overall Study|Reason other than specified above|0|||
161838455|NCT01929031|584451919|FG004|Overall Study|Reason other than specified above|1|||
161838456|NCT01929031|584451920|FG005|Overall Study|Reason other than specified above|0|||
161838457|NCT01366443|584451921|FG000|Overall Study|Lost to Follow-up|2|||
161838458|NCT01366443|584451921|FG000|Overall Study|Under 18 yo|1|||
161838459|NCT00731549|584451922|FG000|Overall Study|Lost to Follow-up|19|||
161838460|NCT00731549|584451922|FG000|Overall Study|Met withdrawal criteria|24|||
161838461|NCT00731549|584451922|FG000|Overall Study|Physician Decision|16|||
161965605|NCT01005316|584920384|FG001|Overall Study|Transferred Care|0|||
161728255|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
161728256|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
161728257|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
161728258|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
161728259|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
161728260|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
161728261|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
161728262|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
161728263|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
161728264|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
161728265|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161728266|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161728267|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161728268|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
161728269|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161728270|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161728271|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
161728272|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
161728273|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
161728274|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
161728275|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
161728276|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
161728277|NCT00069095|584047878|FG000|Post-study Treatment Phase|Surgery|0|||
161728278|NCT00069095|584047879|FG001|Post-study Treatment Phase|Surgery|0|||
161728279|NCT00069095|584047880|FG002|Post-study Treatment Phase|Surgery|0|||
161728280|NCT00069095|584047881|FG003|Post-study Treatment Phase|Surgery|1|||
161728281|NCT00069095|584047882|FG004|Post-study Treatment Phase|Surgery|1|||
161728282|NCT00069095|584047883|FG005|Post-study Treatment Phase|Surgery|0|||
161728283|NCT00069095|584047878|FG000|Post-study Treatment Phase|Death|0|||
161728284|NCT00069095|584047879|FG001|Post-study Treatment Phase|Death|0|||
161728285|NCT00069095|584047880|FG002|Post-study Treatment Phase|Death|0|||
161728286|NCT00069095|584047881|FG003|Post-study Treatment Phase|Death|0|||
161728287|NCT00069095|584047882|FG004|Post-study Treatment Phase|Death|1|||
161728288|NCT00069095|584047883|FG005|Post-study Treatment Phase|Death|0|||
161728289|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
161728290|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
161728291|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
161728292|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
161728293|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
161728294|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
161728295|NCT00069095|584047878|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161728296|NCT00069095|584047879|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161728297|NCT00069095|584047880|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161728298|NCT00069095|584047881|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161728299|NCT00069095|584047882|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
161728300|NCT00069095|584047883|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161728301|NCT00069095|584047878|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161728302|NCT00069095|584047879|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161728303|NCT00069095|584047880|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161728304|NCT00069095|584047881|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161728305|NCT00069095|584047882|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
161728306|NCT00069095|584047883|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161728307|NCT00069095|584047878|FG000|Post-study Treatment Phase|Investigator decision|0|||
161728308|NCT00069095|584047879|FG001|Post-study Treatment Phase|Investigator decision|0|||
161728309|NCT00069095|584047880|FG002|Post-study Treatment Phase|Investigator decision|0|||
161728310|NCT00069095|584047881|FG003|Post-study Treatment Phase|Investigator decision|0|||
161728311|NCT00069095|584047882|FG004|Post-study Treatment Phase|Investigator decision|0|||
161728312|NCT00069095|584047883|FG005|Post-study Treatment Phase|Investigator decision|1|||
161728313|NCT00069095|584047878|FG000|Follow-up Phase|Death|174|||
161728314|NCT00069095|584047879|FG001|Follow-up Phase|Death|206|||
161728315|NCT00069095|584047880|FG002|Follow-up Phase|Death|120|||
161728316|NCT00069095|584047881|FG003|Follow-up Phase|Death|112|||
161728317|NCT00069095|584047882|FG004|Follow-up Phase|Death|92|||
161728318|NCT00069095|584047883|FG005|Follow-up Phase|Death|101|||
161728319|NCT05610176|584047884|FG000|Overall Study|Death|6|||
161728320|NCT01727713|584047889|FG000|Overall Study|Lost to Follow-up|5|||
161728321|NCT01727713|584047889|FG000|Overall Study|Adverse Event|10|||
161728322|NCT01727713|584047889|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
161728323|NCT01727713|584047889|FG000|Overall Study|Withdrawal by Subject|13|||
161728324|NCT01727713|584047889|FG000|Overall Study|Protocol Deviation|2|||
161728325|NCT02389816|584047890|FG000|Overall Study|Randomized but Not Treated|1|||
161728326|NCT02389816|584047891|FG001|Overall Study|Randomized but Not Treated|0|||
161728327|NCT02389816|584047892|FG002|Overall Study|Randomized but Not Treated|0|||
161728328|NCT02389816|584047890|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
161728329|NCT02389816|584047891|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
161728330|NCT02389816|584047892|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
161728331|NCT02389816|584047890|FG000|Overall Study|Major Protocol Deviation|1|||
161728332|NCT02389816|584047891|FG001|Overall Study|Major Protocol Deviation|0|||
161728333|NCT02389816|584047892|FG002|Overall Study|Major Protocol Deviation|0|||
161728334|NCT02389816|584047890|FG000|Overall Study|Lost to Follow-up|1|||
161728335|NCT02389816|584047891|FG001|Overall Study|Lost to Follow-up|0|||
161728336|NCT02389816|584047892|FG002|Overall Study|Lost to Follow-up|0|||
161728337|NCT02389816|584047890|FG000|Overall Study|Withdrawal of Consent|6|||
161728338|NCT02389816|584047891|FG001|Overall Study|Withdrawal of Consent|4|||
161728339|NCT02389816|584047892|FG002|Overall Study|Withdrawal of Consent|4|||
161728340|NCT02389816|584047890|FG000|Overall Study|Lack of Efficacy|1|||
161728341|NCT02389816|584047891|FG001|Overall Study|Lack of Efficacy|0|||
161965606|NCT01005316|584920385|FG002|Overall Study|Transferred Care|1|||
161965607|NCT01005316|584920386|FG003|Overall Study|Transferred Care|3|||
161965608|NCT01005316|584920383|FG000|Overall Study|Retransplanted|0|||
161965609|NCT01005316|584920384|FG001|Overall Study|Retransplanted|1|||
161965610|NCT01005316|584920385|FG002|Overall Study|Retransplanted|0|||
161965611|NCT01005316|584920386|FG003|Overall Study|Retransplanted|0|||
161965612|NCT00632827|584920387|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
161965613|NCT00632827|584920387|FG000|Overall Study|Death|2|||
161965614|NCT00632827|584920387|FG000|Overall Study|Adverse Event|5|||
161965615|NCT00632827|584920387|FG000|Overall Study|Lost to Follow-up|1|||
161965616|NCT03703817|584920388|FG000|Overall Study|Not meeting eligibility criteria|7|||
161965617|NCT03703817|584920389|FG001|Overall Study|Not meeting eligibility criteria|4|||
161965618|NCT05129449|584920390|FG000|Overall Study|Protocol Violation|1|||
161965619|NCT02470585|584920391|FG000|Overall Study|Death|224|||
161965620|NCT02470585|584920392|FG001|Overall Study|Death|227|||
162032184|NCT00095238|585175422|FG001|Overall Study|Subject Withdrew Consent|223|||
161728342|NCT02389816|584047892|FG002|Overall Study|Lack of Efficacy|0|||
161728343|NCT02389816|584047890|FG000|Overall Study|Non Compliance with Study Drug|1|||
161728344|NCT02389816|584047891|FG001|Overall Study|Non Compliance with Study Drug|1|||
161728345|NCT02389816|584047892|FG002|Overall Study|Non Compliance with Study Drug|1|||
161728346|NCT02389816|584047890|FG000|Overall Study|Reason not Specified|0|||
161728347|NCT02389816|584047891|FG001|Overall Study|Reason not Specified|2|||
161728348|NCT02389816|584047892|FG002|Overall Study|Reason not Specified|0|||
161728349|NCT01217190|584047899|FG000|Second Dosing|Withdrawal by Subject|0|||
161728350|NCT01217190|584047900|FG001|Second Dosing|Withdrawal by Subject|2|||
161728351|NCT01594476|584047901|FG000|Overall Study|Protocol Violation|1|||
161728352|NCT01594476|584047902|FG001|Overall Study|Protocol Violation|3|||
161728353|NCT05114590|584047903|FG000|Overall Study|Adverse Event|1|||
161728354|NCT05114590|584047903|FG000|Overall Study|Investigator decision|1|||
161728355|NCT05114590|584047903|FG000|Overall Study|Lost to Follow-up|5|||
161728356|NCT05114590|584047903|FG000|Overall Study|Withdrawal by Subject|5|||
161728357|NCT05114590|584047903|FG000|Overall Study|Other|2|||
161728358|NCT03007953|584047904|FG000|Overall Study|Withdrawal by Subject|5|||
161728359|NCT03007953|584047905|FG001|Overall Study|Withdrawal by Subject|2|||
161728360|NCT03007953|584047904|FG000|Overall Study|Death|5|||
161728361|NCT03007953|584047905|FG001|Overall Study|Death|7|||
161728362|NCT03007953|584047904|FG000|Overall Study|Lost to Follow-up|3|||
161728363|NCT03007953|584047905|FG001|Overall Study|Lost to Follow-up|2|||
161728364|NCT03007953|584047904|FG000|Overall Study|Enrolled in Hospice|3|||
161728365|NCT03007953|584047905|FG001|Overall Study|Enrolled in Hospice|2|||
161728366|NCT02224846|584047906|FG000|Period 1 (Month 3)|Adverse Event|2|||
161965621|NCT02470585|584920393|FG002|Overall Study|Death|199|||
162032185|NCT00095238|585175421|FG000|Overall Study|Death|154|||
161728367|NCT02224846|584047907|FG001|Period 1 (Month 3)|Adverse Event|1|||
161728368|NCT02224846|584047906|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
161728369|NCT02224846|584047907|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
161965622|NCT02470585|584920391|FG000|Overall Study|Withdrew consent|21|||
161728370|NCT02224846|584047906|FG000|Period 1 (Month 3)|Protocol Violation|4|||
161728371|NCT02224846|584047907|FG001|Period 1 (Month 3)|Protocol Violation|8|||
161728372|NCT02224846|584047906|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
162032186|NCT00095238|585175422|FG001|Overall Study|Death|170|||
161728373|NCT02224846|584047907|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
161728374|NCT02224846|584047906|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
161728375|NCT02224846|584047907|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
161965623|NCT02470585|584920392|FG001|Overall Study|Withdrew consent|22|||
161965624|NCT02470585|584920393|FG002|Overall Study|Withdrew consent|31|||
161965625|NCT02470585|584920391|FG000|Overall Study|Lost to Follow-up|8|||
161728376|NCT02224846|584047906|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
161728377|NCT02224846|584047907|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
161728378|NCT02224846|584047906|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
161728379|NCT02224846|584047907|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
161728380|NCT02224846|584047906|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
161728381|NCT02224846|584047907|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
161728382|NCT02224846|584047906|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
161728383|NCT02224846|584047907|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
161728384|NCT02224846|584047906|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
161728385|NCT02224846|584047907|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
161728386|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
161728387|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
161728388|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
161728389|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
161728390|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
161728391|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
161728392|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
161728393|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
161728394|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
161728395|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
161728396|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
161728397|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
161728398|NCT02224846|584047906|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
161728399|NCT02224846|584047907|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
161728400|NCT03196297|584047908|FG000|Main Period|Withdrawal by Subject|4|||
161728401|NCT03196297|584047908|FG000|Extension Period|Withdrawal by Subject|1|||
161728402|NCT03196297|584047908|FG000|Extension Period|Lack of Efficacy|2|||
161728403|NCT00320385|584047912|FG000|Overall Study|Lost to Follow-up|7|||
161728404|NCT00320385|584047913|FG001|Overall Study|Lost to Follow-up|10|||
161728405|NCT00320385|584047912|FG000|Overall Study|Withdrawal by Subject|6|||
161728406|NCT00320385|584047913|FG001|Overall Study|Withdrawal by Subject|7|||
161728407|NCT00320385|584047912|FG000|Overall Study|Sponsor Terminated Study|2|||
161728408|NCT00320385|584047913|FG001|Overall Study|Sponsor Terminated Study|1|||
161728409|NCT00320385|584047912|FG000|Overall Study|Investigator Decision|0|||
161728410|NCT00320385|584047913|FG001|Overall Study|Investigator Decision|1|||
161728411|NCT00320385|584047912|FG000|Overall Study|Death|1|||
161728412|NCT00320385|584047913|FG001|Overall Study|Death|2|||
161728413|NCT00320385|584047912|FG000|Overall Study|Serious Adverse Event|1|||
161728414|NCT00320385|584047913|FG001|Overall Study|Serious Adverse Event|0|||
161728415|NCT00320385|584047912|FG000|Overall Study|Withdrew Consent|1|||
161728416|NCT00320385|584047913|FG001|Overall Study|Withdrew Consent|0|||
161728417|NCT00320385|584047912|FG000|Overall Study|Adverse Event|0|||
161728418|NCT00320385|584047913|FG001|Overall Study|Adverse Event|1|||
161728419|NCT04370028|584047914|FG000|Overall Study|Withdrawal by Subject|695|||
161728420|NCT04370028|584047914|FG000|Overall Study|Protocol Violation|9|||
161728421|NCT04370028|584047914|FG000|Overall Study|Adverse Event|3|||
161728422|NCT00872170|584047915|FG000|Overall Study|Adverse Event|1|||
161728423|NCT00872170|584047916|FG001|Overall Study|Adverse Event|0|||
161728424|NCT02928406|584047917|FG000|Overall Study|Death|780|||
161728425|NCT02928406|584047917|FG000|Overall Study|Progressive disease|3|||
161728426|NCT02928406|584047917|FG000|Overall Study|Lost to Follow-up|49|||
161728427|NCT02928406|584047917|FG000|Overall Study|Non-compliance|2|||
161728428|NCT02928406|584047917|FG000|Overall Study|Withdrawal by Subject|40|||
161728429|NCT02928406|584047917|FG000|Overall Study|Study terminated by sponsor|57|||
161728430|NCT02928406|584047917|FG000|Overall Study|Physician Decision|1|||
161728431|NCT02928406|584047917|FG000|Overall Study|Various reasons|72|||
161728432|NCT00786838|584047918|FG000|Overall Study|Physician Decision|4|||
161728433|NCT00786838|584047918|FG000|Overall Study|Death|4|||
161728434|NCT00786838|584047918|FG000|Overall Study|Adverse Event|6|||
161728435|NCT00786838|584047918|FG000|Overall Study|Progressive disease|31|||
161728436|NCT00786838|584047918|FG000|Overall Study|Withdrawal by Subject|4|||
161728437|NCT04937816|584047919|FG000|Overall Study|Study drug stopped, reason missing|5|||
161728438|NCT04937816|584047920|FG001|Overall Study|Study drug stopped, reason missing|3|||
161728439|NCT04937816|584047921|FG002|Overall Study|Study drug stopped, reason missing|4|||
161728440|NCT04937816|584047922|FG003|Overall Study|Study drug stopped, reason missing|6|||
161728441|NCT04937816|584047923|FG004|Overall Study|Study drug stopped, reason missing|1|||
161728442|NCT04937816|584047924|FG005|Overall Study|Study drug stopped, reason missing|0|||
161728443|NCT04937816|584047925|FG006|Overall Study|Study drug stopped, reason missing|0|||
161728444|NCT04937816|584047919|FG000|Overall Study|Other than stated below|173|||
161728445|NCT04937816|584047920|FG001|Overall Study|Other than stated below|143|||
161728446|NCT04937816|584047921|FG002|Overall Study|Other than stated below|125|||
161728447|NCT04937816|584047922|FG003|Overall Study|Other than stated below|44|||
161728448|NCT04937816|584047923|FG004|Overall Study|Other than stated below|45|||
161728449|NCT04937816|584047924|FG005|Overall Study|Other than stated below|28|||
161965626|NCT02470585|584920392|FG001|Overall Study|Lost to Follow-up|15|||
161728450|NCT04937816|584047925|FG006|Overall Study|Other than stated below|31|||
161728451|NCT04937816|584047919|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
161728452|NCT04937816|584047920|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
161728453|NCT04937816|584047921|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
161728454|NCT04937816|584047922|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
161728455|NCT04937816|584047923|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
161728456|NCT04937816|584047924|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
161728457|NCT04937816|584047925|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
161728458|NCT04937816|584047919|FG000|Overall Study|Lost to Follow-up|15|||
161728459|NCT04937816|584047920|FG001|Overall Study|Lost to Follow-up|9|||
161728460|NCT04937816|584047921|FG002|Overall Study|Lost to Follow-up|6|||
161728461|NCT04937816|584047922|FG003|Overall Study|Lost to Follow-up|6|||
161728462|NCT04937816|584047923|FG004|Overall Study|Lost to Follow-up|16|||
161728463|NCT04937816|584047924|FG005|Overall Study|Lost to Follow-up|11|||
161728464|NCT04937816|584047925|FG006|Overall Study|Lost to Follow-up|17|||
161728465|NCT04937816|584047919|FG000|Overall Study|Protocol Violation|15|||
161728466|NCT04937816|584047920|FG001|Overall Study|Protocol Violation|15|||
161728467|NCT04937816|584047921|FG002|Overall Study|Protocol Violation|12|||
161728468|NCT04937816|584047922|FG003|Overall Study|Protocol Violation|30|||
161728469|NCT04937816|584047923|FG004|Overall Study|Protocol Violation|24|||
161728470|NCT04937816|584047924|FG005|Overall Study|Protocol Violation|5|||
161728471|NCT04937816|584047925|FG006|Overall Study|Protocol Violation|5|||
161728472|NCT04937816|584047919|FG000|Overall Study|Adverse Event|303|||
161728473|NCT04937816|584047920|FG001|Overall Study|Adverse Event|267|||
161728474|NCT04937816|584047921|FG002|Overall Study|Adverse Event|273|||
161728475|NCT04937816|584047922|FG003|Overall Study|Adverse Event|553|||
161728476|NCT04937816|584047923|FG004|Overall Study|Adverse Event|575|||
161728477|NCT04937816|584047924|FG005|Overall Study|Adverse Event|343|||
161728478|NCT04937816|584047925|FG006|Overall Study|Adverse Event|337|||
161728479|NCT04937816|584047919|FG000|Overall Study|Not treated|4|||
161728480|NCT04937816|584047920|FG001|Overall Study|Not treated|2|||
161728481|NCT04937816|584047921|FG002|Overall Study|Not treated|2|||
161728482|NCT04937816|584047922|FG003|Overall Study|Not treated|2|||
161728483|NCT04937816|584047923|FG004|Overall Study|Not treated|1|||
161728484|NCT04937816|584047924|FG005|Overall Study|Not treated|4|||
161728485|NCT04937816|584047925|FG006|Overall Study|Not treated|0|||
161728486|NCT00436215|584047926|FG000|Overall Study|Refused further treatment|3|||
161728487|NCT00436215|584047926|FG000|Overall Study|Small bowel obstruction|1|||
161728488|NCT05513053|584047927|FG000|Overall Study|Lost to Follow-up|9|||
161728489|NCT05513053|584047928|FG001|Overall Study|Lost to Follow-up|11|||
161728490|NCT05513053|584047927|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161965627|NCT02470585|584920393|FG002|Overall Study|Lost to Follow-up|13|||
161728491|NCT05513053|584047928|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161728492|NCT05513053|584047927|FG000|Overall Study|Withdrawal by Subject|2|||
161728493|NCT05513053|584047928|FG001|Overall Study|Withdrawal by Subject|9|||
161728494|NCT05513053|584047927|FG000|Overall Study|Protocol Violation|6|||
161728495|NCT05513053|584047928|FG001|Overall Study|Protocol Violation|3|||
161728496|NCT05513053|584047927|FG000|Overall Study|Adverse Event|0|||
161728497|NCT05513053|584047928|FG001|Overall Study|Adverse Event|2|||
161728498|NCT04491877|584049714|FG000|Overall Study|Protocol Deviation|1|||
161728499|NCT04491877|584049715|FG001|Overall Study|Protocol Deviation|0|||
161728500|NCT04491877|584049716|FG002|Overall Study|Protocol Deviation|2|||
161728501|NCT04491877|584049717|FG003|Overall Study|Protocol Deviation|0|||
161728502|NCT04491877|584049718|FG004|Overall Study|Protocol Deviation|0|||
161728503|NCT04491877|584049719|FG005|Overall Study|Protocol Deviation|0|||
161728504|NCT04491877|584049720|FG006|Overall Study|Protocol Deviation|1|||
161728505|NCT04491877|584049721|FG007|Overall Study|Protocol Deviation|1|||
161728506|NCT04491877|584049722|FG008|Overall Study|Protocol Deviation|0|||
161728507|NCT04491877|584049714|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161728508|NCT04491877|584049715|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161728509|NCT04491877|584049716|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161728510|NCT04491877|584049717|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
161728511|NCT04491877|584049718|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161728512|NCT04491877|584049719|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
161728513|NCT04491877|584049720|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
161728514|NCT04491877|584049721|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
161728515|NCT04491877|584049722|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
161728516|NCT04491877|584049714|FG000|Overall Study|Lost to Follow-up|0|||
161728517|NCT04491877|584049715|FG001|Overall Study|Lost to Follow-up|2|||
161728518|NCT04491877|584049716|FG002|Overall Study|Lost to Follow-up|0|||
161728519|NCT04491877|584049717|FG003|Overall Study|Lost to Follow-up|0|||
161728520|NCT04491877|584049718|FG004|Overall Study|Lost to Follow-up|0|||
161728521|NCT04491877|584049719|FG005|Overall Study|Lost to Follow-up|0|||
161728522|NCT04491877|584049720|FG006|Overall Study|Lost to Follow-up|2|||
161728523|NCT04491877|584049721|FG007|Overall Study|Lost to Follow-up|1|||
161728524|NCT04491877|584049722|FG008|Overall Study|Lost to Follow-up|1|||
161728525|NCT02429258|584049726|FG000|Overall Study|Withdrawal by Subject|2|||
161728526|NCT02429258|584049727|FG001|Overall Study|Withdrawal by Subject|0|||
161728527|NCT02429258|584049726|FG000|Overall Study|Protocol Violation|0|||
161728528|NCT02429258|584049727|FG001|Overall Study|Protocol Violation|1|||
161728529|NCT03364335|584049728|FG000|Overall Study|Adverse Event|3|||
161728530|NCT03364335|584049729|FG001|Overall Study|Adverse Event|4|||
161728531|NCT03364335|584049730|FG002|Overall Study|Adverse Event|1|||
161728532|NCT03364335|584049731|FG003|Overall Study|Adverse Event|2|||
161728533|NCT03364335|584049732|FG004|Overall Study|Adverse Event|0|||
161728534|NCT03364335|584049728|FG000|Overall Study|Lost to Follow-up|7|||
161728535|NCT03364335|584049729|FG001|Overall Study|Lost to Follow-up|7|||
161728536|NCT03364335|584049730|FG002|Overall Study|Lost to Follow-up|10|||
161728537|NCT03364335|584049731|FG003|Overall Study|Lost to Follow-up|11|||
161728538|NCT03364335|584049732|FG004|Overall Study|Lost to Follow-up|11|||
161728539|NCT03725202|584049735|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
161728540|NCT03725202|584049736|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
161728541|NCT03725202|584049737|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
161728542|NCT03725202|584049738|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161728543|NCT03725202|584049739|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161728544|NCT03725202|584049740|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161728545|NCT03725202|584049741|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161728546|NCT03725202|584049742|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161728547|NCT03725202|584049735|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
161728548|NCT03725202|584049736|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
161728549|NCT03725202|584049737|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
161728550|NCT03725202|584049738|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161728551|NCT03725202|584049739|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161728552|NCT03725202|584049740|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161728553|NCT03725202|584049741|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161728554|NCT03725202|584049742|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161728555|NCT03725202|584049735|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
161728556|NCT03725202|584049736|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728557|NCT03725202|584049737|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728558|NCT03725202|584049738|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728559|NCT03725202|584049739|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728560|NCT03725202|584049740|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728561|NCT03725202|584049741|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728562|NCT03725202|584049742|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161728563|NCT03725202|584049735|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
161728564|NCT03725202|584049736|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728565|NCT03725202|584049737|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728566|NCT03725202|584049738|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728567|NCT03725202|584049739|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728568|NCT03725202|584049740|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728569|NCT03725202|584049741|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728570|NCT03725202|584049742|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161728571|NCT03725202|584049735|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
161728572|NCT03725202|584049736|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
161728573|NCT03725202|584049737|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
161728574|NCT03725202|584049738|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161728575|NCT03725202|584049739|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161728576|NCT03725202|584049740|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161728577|NCT03725202|584049741|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161728578|NCT03725202|584049742|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161728579|NCT03725202|584049735|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728580|NCT03725202|584049736|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728581|NCT03725202|584049737|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
161728582|NCT03725202|584049738|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728583|NCT03725202|584049739|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728584|NCT03725202|584049740|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728585|NCT03725202|584049741|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728586|NCT03725202|584049742|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161728587|NCT03725202|584049735|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
161728588|NCT03725202|584049736|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
161728589|NCT03725202|584049737|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
161728590|NCT03725202|584049738|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
161728591|NCT03725202|584049739|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
161728592|NCT03725202|584049740|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
161728593|NCT03725202|584049741|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
161728594|NCT03725202|584049742|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
161728595|NCT03725202|584049735|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
161728596|NCT03725202|584049736|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
161728597|NCT03725202|584049737|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
161728598|NCT03725202|584049738|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
161728599|NCT03725202|584049739|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
161728600|NCT03725202|584049740|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
161728601|NCT03725202|584049741|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
161728602|NCT03725202|584049742|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
161728603|NCT03725202|584049735|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161728604|NCT03725202|584049736|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161728605|NCT03725202|584049737|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161728606|NCT03725202|584049738|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
161728607|NCT03725202|584049739|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161728608|NCT03725202|584049740|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161728609|NCT03725202|584049741|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
161728610|NCT03725202|584049742|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
161728611|NCT03725202|584049735|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728612|NCT03725202|584049736|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728613|NCT03725202|584049737|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728614|NCT03725202|584049738|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728615|NCT03725202|584049739|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728616|NCT03725202|584049740|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728617|NCT03725202|584049741|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
161728618|NCT03725202|584049742|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161728619|NCT03725202|584049735|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728620|NCT03725202|584049736|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728621|NCT03725202|584049737|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728622|NCT03725202|584049738|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728623|NCT03725202|584049739|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728624|NCT03725202|584049740|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
161728625|NCT03725202|584049741|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728626|NCT03725202|584049742|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161728627|NCT03725202|584049735|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161728628|NCT03725202|584049736|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161728629|NCT03725202|584049737|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161728630|NCT03725202|584049738|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
161728631|NCT03725202|584049739|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161728632|NCT03725202|584049740|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161728633|NCT03725202|584049741|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
161728634|NCT03725202|584049742|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
161728635|NCT01520324|584049743|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
161728636|NCT01328249|584049746|FG000|Overall Study|Adverse Event|3|||
161728637|NCT01328249|584049747|FG001|Overall Study|Adverse Event|0|||
161728638|NCT01328249|584049746|FG000|Overall Study|Disease progression|1|||
161728639|NCT01328249|584049747|FG001|Overall Study|Disease progression|0|||
161728640|NCT01328249|584049746|FG000|Overall Study|Withdrawal by Subject|1|||
161728641|NCT01328249|584049747|FG001|Overall Study|Withdrawal by Subject|1|||
161728642|NCT01328249|584049746|FG000|Overall Study|Moved before end of treatment visit|1|||
161728643|NCT01328249|584049747|FG001|Overall Study|Moved before end of treatment visit|0|||
161728644|NCT01328249|584049746|FG000|Overall Study|Subject choice|1|||
161728645|NCT01328249|584049747|FG001|Overall Study|Subject choice|1|||
161728646|NCT01328249|584049746|FG000|Overall Study|Protocol Violation|0|||
161728647|NCT01328249|584049747|FG001|Overall Study|Protocol Violation|1|||
161728648|NCT00748553|584049748|FG000|Overall Study|Adverse Event|0|||
161728649|NCT00748553|584049749|FG001|Overall Study|Adverse Event|1|||
161728650|NCT00748553|584049748|FG000|Overall Study|disease progression|2|||
161728651|NCT00748553|584049749|FG001|Overall Study|disease progression|0|||
161728652|NCT00748553|584049748|FG000|Overall Study|noncompliance|1|||
161728653|NCT00748553|584049749|FG001|Overall Study|noncompliance|0|||
161728654|NCT02330549|584049751|FG000|Overall Study|Adverse Event|1|||
161965628|NCT02470585|584920391|FG000|Overall Study|Sponsor discontinued study|117|||
161728655|NCT02330549|584049752|FG001|Overall Study|Adverse Event|0|||
161728656|NCT02330549|584049751|FG000|Overall Study|Subject withdrew consent|2|||
161728657|NCT02330549|584049752|FG001|Overall Study|Subject withdrew consent|1|||
161728658|NCT02330549|584049751|FG000|Overall Study|Failure to meet randomization criteria|1|||
161728659|NCT02330549|584049752|FG001|Overall Study|Failure to meet randomization criteria|0|||
161728660|NCT00745368|584049753|FG000|Overall Study|Unable to provide sample|3|||
161728661|NCT00495495|584049755|FG000|Overall Study|Protocol Violation|99|||
161728662|NCT02245568|584049756|FG000|Overall Study|Study terminated by Sponsor|346|||
161728663|NCT02245568|584049756|FG000|Overall Study|Adverse Event|144|||
161728664|NCT02245568|584049756|FG000|Overall Study|Lack of Efficacy|98|||
161728665|NCT02245568|584049756|FG000|Overall Study|Withdrawal by Caregiver|85|||
161728666|NCT02245568|584049756|FG000|Overall Study|Withdrawal by Subject|77|||
161728667|NCT02245568|584049756|FG000|Overall Study|Withdrawal by Legal Representative|31|||
161728668|NCT02245568|584049756|FG000|Overall Study|Missing (Site closure)|16|||
161728669|NCT02245568|584049756|FG000|Overall Study|Physician Decision|14|||
161728670|NCT02245568|584049756|FG000|Overall Study|Non-compliance with study drug|11|||
161728671|NCT02245568|584049756|FG000|Overall Study|Death|9|||
161728672|NCT02245568|584049756|FG000|Overall Study|Blue staining|6|||
161728673|NCT02245568|584049756|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
161728674|NCT02245568|584049756|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
161728675|NCT02245568|584049756|FG000|Overall Study|Lost to Follow-up|5|||
161728676|NCT04009096|584049760|FG000|Overall Study|Withdrawal by Subject|0|||
161728677|NCT04009096|584049761|FG001|Overall Study|Withdrawal by Subject|7|||
161728678|NCT04009096|584049762|FG002|Overall Study|Withdrawal by Subject|0|||
161728679|NCT04009096|584049760|FG000|Overall Study|Physician Decision|0|||
161728680|NCT04009096|584049761|FG001|Overall Study|Physician Decision|1|||
161728681|NCT04009096|584049762|FG002|Overall Study|Physician Decision|0|||
161728682|NCT04263142|584049763|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
161728683|NCT04263142|584049764|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
161728684|NCT04263142|584049765|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
161728685|NCT04263142|584049766|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
161728686|NCT04263142|584049767|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
161728687|NCT04263142|584049763|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
161728688|NCT04263142|584049764|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
161728689|NCT04263142|584049765|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
161728690|NCT04263142|584049766|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
161728691|NCT04263142|584049767|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
161728692|NCT00769704|584049768|FG000|Overall Study|Lost to Follow-up|3|||
161728693|NCT00769704|584049769|FG001|Overall Study|Lost to Follow-up|2|||
161728694|NCT00769704|584049768|FG000|Overall Study|Death|95|||
161728695|NCT00769704|584049769|FG001|Overall Study|Death|190|||
161728696|NCT00769704|584049768|FG000|Overall Study|Withdrawal by Subject|12|||
161728697|NCT00769704|584049769|FG001|Overall Study|Withdrawal by Subject|5|||
161728698|NCT00769704|584049768|FG000|Overall Study|Other|1|||
161728699|NCT00769704|584049769|FG001|Overall Study|Other|2|||
161728700|NCT00450372|584049770|FG000|Overall Study|Physician Decision|1|||
161728701|NCT03010423|584049771|FG000|Overall Study|Study termination|8|||
161728702|NCT00520676|584049772|FG000|Overall Study|Death|84|||
161728703|NCT00520676|584049773|FG001|Overall Study|Death|81|||
161728704|NCT00520676|584049772|FG000|Overall Study|Lost to Follow-up|6|||
161728705|NCT00520676|584049773|FG001|Overall Study|Lost to Follow-up|10|||
161728706|NCT00520676|584049772|FG000|Overall Study|Physician Decision|4|||
161728707|NCT00520676|584049773|FG001|Overall Study|Physician Decision|1|||
161728708|NCT00520676|584049772|FG000|Overall Study|Withdrawal by Subject|7|||
161728709|NCT00520676|584049773|FG001|Overall Study|Withdrawal by Subject|11|||
161728710|NCT03439748|584049774|FG000|Overall Study|Withdrawal by Subject|11|||
161728711|NCT03439748|584049775|FG001|Overall Study|Withdrawal by Subject|17|||
161728712|NCT05131451|584049776|FG000|Overall Study|Protocol Violation|1|||
161728713|NCT05131451|584049777|FG001|Overall Study|Protocol Violation|0|||
161728714|NCT01856595|584049784|FG000|Overall Study|Withdrawal by Subject|0|||
161728715|NCT01856595|584049785|FG001|Overall Study|Withdrawal by Subject|1|||
161728716|NCT01856595|584049786|FG002|Overall Study|Withdrawal by Subject|0|||
161728717|NCT01856595|584049787|FG003|Overall Study|Withdrawal by Subject|0|||
161728718|NCT01856595|584049788|FG004|Overall Study|Withdrawal by Subject|0|||
161728719|NCT01856595|584049789|FG005|Overall Study|Withdrawal by Subject|0|||
161728720|NCT01856595|584049790|FG006|Overall Study|Withdrawal by Subject|1|||
161728721|NCT01856595|584049791|FG007|Overall Study|Withdrawal by Subject|0|||
161728722|NCT01856595|584049792|FG008|Overall Study|Withdrawal by Subject|0|||
161728723|NCT04426825|584049794|FG000|Overall Study|Death|17|||
161728724|NCT04426825|584049794|FG000|Overall Study|Lost to Follow-up|1|||
161728725|NCT04426825|584049794|FG000|Overall Study|Study terminated by sponsor|5|||
161965629|NCT02470585|584920392|FG001|Overall Study|Sponsor discontinued study|110|||
161728726|NCT02582749|584049807|FG000|Overall Study|Study terminated by funder|5|||
161728727|NCT02582749|584049808|FG001|Overall Study|Study terminated by funder|10|||
161728728|NCT02582749|584049807|FG000|Overall Study|Withdrawal by Subject|0|||
161728729|NCT02582749|584049808|FG001|Overall Study|Withdrawal by Subject|1|||
161728730|NCT02213198|584049809|FG000|Baseline|No show for intake|7|||
161728731|NCT02213198|584049810|FG001|Baseline|No show for intake|9|||
161728732|NCT02213198|584049809|FG000|Baseline|Withdrawal by Subject|34|||
161728733|NCT02213198|584049810|FG001|Baseline|Withdrawal by Subject|11|||
161838462|NCT00731549|584451922|FG000|Overall Study|Withdrawal by Subject|89|||
161965630|NCT02470585|584920393|FG002|Overall Study|Sponsor discontinued study|122|||
161728734|NCT02213198|584049809|FG000|Baseline|transferred out of clinic|7|||
161728735|NCT02213198|584049810|FG001|Baseline|transferred out of clinic|9|||
161838463|NCT00731549|584451922|FG000|Overall Study|Protocol deviation|1|||
161728736|NCT02213198|584049809|FG000|Baseline|Lost to Follow-up|40|||
161728737|NCT02213198|584049810|FG001|Baseline|Lost to Follow-up|21|||
161728738|NCT02213198|584049809|FG000|Baseline|incarcerated,violent|0|||
161728739|NCT02213198|584049810|FG001|Baseline|incarcerated,violent|1|||
161728740|NCT02213198|584049809|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
161728741|NCT02213198|584049810|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
161728742|NCT02213198|584049809|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
161728743|NCT02213198|584049810|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
161728744|NCT02213198|584049809|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
161728745|NCT02213198|584049810|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
161728746|NCT02213198|584049809|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
161728747|NCT02213198|584049810|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
161728748|NCT02213198|584049809|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
161728749|NCT02213198|584049810|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
161728750|NCT02213198|584049809|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
161728751|NCT02213198|584049810|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
161728752|NCT01518192|584049811|FG000|Overall Study|Lost to Follow-up|29|||
161728753|NCT01518192|584049812|FG001|Overall Study|Lost to Follow-up|26|||
161728754|NCT01518192|584049813|FG002|Overall Study|Lost to Follow-up|35|||
161728755|NCT01954121|584049815|FG000|Overall Study|Lack of Efficacy|94|||
161728756|NCT01954121|584049816|FG001|Overall Study|Lack of Efficacy|41|||
161728757|NCT01954121|584049815|FG000|Overall Study|Protocol Violation|0|||
161728758|NCT01954121|584049816|FG001|Overall Study|Protocol Violation|2|||
161728759|NCT01954121|584049815|FG000|Overall Study|Lost to Follow-up|5|||
161728760|NCT01954121|584049816|FG001|Overall Study|Lost to Follow-up|6|||
161728761|NCT01954121|584049815|FG000|Overall Study|Withdrawal by Subject|18|||
161728762|NCT01954121|584049816|FG001|Overall Study|Withdrawal by Subject|12|||
161728763|NCT01954121|584049815|FG000|Overall Study|Pregnancy|1|||
161728764|NCT01954121|584049816|FG001|Overall Study|Pregnancy|1|||
161728765|NCT01954121|584049815|FG000|Overall Study|AE, serious fatal|1|||
161728766|NCT01954121|584049816|FG001|Overall Study|AE, serious fatal|0|||
161728767|NCT01954121|584049815|FG000|Overall Study|AE, non-serious non-fatal|5|||
161728768|NCT01954121|584049816|FG001|Overall Study|AE, non-serious non-fatal|22|||
161728769|NCT01954121|584049815|FG000|Overall Study|SAE, non-fatal|1|||
161728770|NCT01954121|584049816|FG001|Overall Study|SAE, non-fatal|4|||
161728771|NCT01954121|584049815|FG000|Overall Study|Non-compliant with study procedures|1|||
161728772|NCT01954121|584049816|FG001|Overall Study|Non-compliant with study procedures|0|||
161728773|NCT01954121|584049815|FG000|Overall Study|Non-compliant patient|1|||
161728774|NCT01954121|584049816|FG001|Overall Study|Non-compliant patient|1|||
161728775|NCT01954121|584049815|FG000|Overall Study|Subject did not follow instructions|0|||
161728776|NCT01954121|584049816|FG001|Overall Study|Subject did not follow instructions|2|||
161728777|NCT00601523|584049817|FG000|Overall Study|Adverse Event|42|||
161728778|NCT00601523|584049818|FG001|Overall Study|Adverse Event|14|||
161728779|NCT00601523|584049817|FG000|Overall Study|Lack of Efficacy|3|||
161728780|NCT00601523|584049818|FG001|Overall Study|Lack of Efficacy|0|||
161728781|NCT00601523|584049817|FG000|Overall Study|Protocol Violation|5|||
161728782|NCT00601523|584049818|FG001|Overall Study|Protocol Violation|1|||
161728783|NCT00601523|584049817|FG000|Overall Study|Lost to Follow-up|0|||
161728784|NCT00601523|584049818|FG001|Overall Study|Lost to Follow-up|1|||
161728785|NCT00601523|584049817|FG000|Overall Study|Withdrawal by Subject|18|||
161728786|NCT00601523|584049818|FG001|Overall Study|Withdrawal by Subject|9|||
161728787|NCT00601523|584049817|FG000|Overall Study|Other|9|||
161728788|NCT00601523|584049818|FG001|Overall Study|Other|1|||
161728789|NCT01987986|584049819|FG000|Overall Study|Lost to Follow-up|1|||
161728790|NCT01987986|584049820|FG001|Overall Study|Lost to Follow-up|0|||
161728791|NCT01987986|584049821|FG002|Overall Study|Lost to Follow-up|0|||
161838464|NCT00731549|584451922|FG000|Overall Study|Adverse Event|31|||
161838465|NCT00731549|584451922|FG000|Overall Study|Lack of efficacy with AE|37|||
161838466|NCT00731549|584451922|FG000|Overall Study|Lack of efficacy without AE|6|||
161728792|NCT01987986|584049822|FG003|Overall Study|Lost to Follow-up|0|||
161728793|NCT01987986|584049819|FG000|Overall Study|Adverse Event|1|||
161728794|NCT01987986|584049820|FG001|Overall Study|Adverse Event|0|||
161838467|NCT00448136|584451925|FG000|Overall Study|Death|3|||
161838468|NCT00448136|584451926|FG001|Overall Study|Death|8|||
161838469|NCT00448136|584451925|FG000|Overall Study|Investigator's decision (progression)|1|||
161728795|NCT01987986|584049821|FG002|Overall Study|Adverse Event|2|||
161728796|NCT01987986|584049822|FG003|Overall Study|Adverse Event|0|||
161728797|NCT01617434|584049823|FG000|Overall Study|Adverse Event|12|||
161728798|NCT01617434|584049824|FG001|Overall Study|Adverse Event|3|||
161728799|NCT01617434|584049823|FG000|Overall Study|Protocol Violation|8|||
161728800|NCT01617434|584049824|FG001|Overall Study|Protocol Violation|7|||
161728801|NCT01617434|584049823|FG000|Overall Study|Withdrawal Criteria|12|||
161728802|NCT01617434|584049824|FG001|Overall Study|Withdrawal Criteria|37|||
161838470|NCT00448136|584451926|FG001|Overall Study|Investigator's decision (progression)|0|||
161838471|NCT00609466|584451927|FG000|Overall Study|Withdrawal by Subject|0|||
162032187|NCT00095238|585175421|FG000|Overall Study|Lost to Follow-up|19|||
162032188|NCT00095238|585175422|FG001|Overall Study|Lost to Follow-up|24|||
162032189|NCT00095238|585175421|FG000|Overall Study|Noncompliance|44|||
162032190|NCT00095238|585175422|FG001|Overall Study|Noncompliance|45|||
161728803|NCT01617434|584049823|FG000|Overall Study|Unclassified|3|||
161728804|NCT01617434|584049824|FG001|Overall Study|Unclassified|4|||
161728805|NCT03342469|584049831|FG000|Overall Study|Withdrawal by Subject|0|||
161728806|NCT03342469|584049832|FG001|Overall Study|Withdrawal by Subject|1|||
161728807|NCT03342469|584049833|FG002|Overall Study|Withdrawal by Subject|0|||
161728808|NCT03342469|584049834|FG003|Overall Study|Withdrawal by Subject|0|||
161728809|NCT05515601|584049838|FG000|Overall Study|Withdrawal by Subject|1|||
161728810|NCT05515601|584049839|FG001|Overall Study|Withdrawal by Subject|3|||
161728811|NCT05515601|584049840|FG002|Overall Study|Withdrawal by Subject|2|||
161728812|NCT05515601|584049841|FG003|Overall Study|Withdrawal by Subject|1|||
161728813|NCT05515601|584049842|FG004|Overall Study|Withdrawal by Subject|1|||
161728814|NCT05515601|584049843|FG005|Overall Study|Withdrawal by Subject|1|||
161728815|NCT05515601|584049838|FG000|Overall Study|Lost to Follow-up|0|||
161728816|NCT05515601|584049839|FG001|Overall Study|Lost to Follow-up|0|||
161728817|NCT05515601|584049840|FG002|Overall Study|Lost to Follow-up|0|||
161728818|NCT05515601|584049841|FG003|Overall Study|Lost to Follow-up|0|||
161728819|NCT05515601|584049842|FG004|Overall Study|Lost to Follow-up|1|||
161728820|NCT05515601|584049843|FG005|Overall Study|Lost to Follow-up|0|||
161728821|NCT00540436|584049844|FG000|First 12-Week Treatment Period|Adverse Event|1|||
161728822|NCT00540436|584049844|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
161728823|NCT00540436|584049844|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
161728824|NCT00540436|584049844|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
161728825|NCT01515306|584049845|FG000|Overall Study|Adverse Event|3|||
161728826|NCT01515306|584049846|FG001|Overall Study|Adverse Event|2|||
161728827|NCT01515306|584049845|FG000|Overall Study|Progressive Disease|19|||
161728828|NCT01515306|584049846|FG001|Overall Study|Progressive Disease|9|||
161728829|NCT01515306|584049845|FG000|Overall Study|Withdrawal by Subject|1|||
161728830|NCT01515306|584049846|FG001|Overall Study|Withdrawal by Subject|2|||
161728831|NCT01515306|584049845|FG000|Overall Study|Physician Decision|1|||
161728832|NCT01515306|584049846|FG001|Overall Study|Physician Decision|1|||
161728833|NCT02678780|584049848|FG000|Overall Study|Adverse Event|11|||
161728834|NCT02678780|584049849|FG001|Overall Study|Adverse Event|14|||
161728835|NCT02678780|584049848|FG000|Overall Study|Withdrawal by Subject|2|||
161728836|NCT02678780|584049849|FG001|Overall Study|Withdrawal by Subject|1|||
161728837|NCT02678780|584049848|FG000|Overall Study|Sponsor discontinuation|7|||
161728838|NCT02678780|584049849|FG001|Overall Study|Sponsor discontinuation|4|||
161728839|NCT02678780|584049848|FG000|Overall Study|Death|1|||
161728840|NCT02678780|584049849|FG001|Overall Study|Death|1|||
161728841|NCT02678780|584049848|FG000|Overall Study|Other|6|||
161728842|NCT02678780|584049849|FG001|Overall Study|Other|8|||
161728843|NCT01064648|584049862|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
161728844|NCT01064648|584049863|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
161728845|NCT01064648|584049864|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
161728846|NCT01064648|584049865|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
161728847|NCT01064648|584049862|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
161728848|NCT01064648|584049863|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
161728849|NCT01064648|584049864|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
161728850|NCT01064648|584049865|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
161728851|NCT01064648|584049862|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
161728852|NCT01064648|584049863|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
161728853|NCT01064648|584049864|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
162032191|NCT00095238|585175421|FG000|Overall Study|No longer met study criteria|4|||
161728854|NCT01064648|584049865|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
161728855|NCT01064648|584049862|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
161728856|NCT01064648|584049863|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
161728857|NCT01064648|584049864|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
161728858|NCT01064648|584049865|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
161728859|NCT01064648|584049862|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
161728860|NCT01064648|584049863|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
161728861|NCT01064648|584049864|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
161728862|NCT01064648|584049865|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
161728863|NCT01064648|584049862|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
161728864|NCT01064648|584049863|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
161728865|NCT01064648|584049864|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
161728866|NCT01064648|584049865|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
162032192|NCT00095238|585175422|FG001|Overall Study|No longer met study criteria|5|||
161728867|NCT01064648|584049862|FG000|Phase II|Adverse Event|0|||
161728868|NCT01064648|584049863|FG001|Phase II|Adverse Event|0|||
161728869|NCT01064648|584049864|FG002|Phase II|Adverse Event|15|||
162032193|NCT00095238|585175421|FG000|Overall Study|Study terminated by sponsor|0|||
162032194|NCT00095238|585175422|FG001|Overall Study|Study terminated by sponsor|1|||
161965631|NCT02470585|584920391|FG000|Overall Study|Other, not specified|5|||
161965632|NCT02470585|584920392|FG001|Overall Study|Other, not specified|7|||
161965633|NCT02470585|584920393|FG002|Overall Study|Other, not specified|14|||
161965634|NCT02470585|584920391|FG000|Overall Study|Missing due to site non-compliance|0|||
161965635|NCT02470585|584920392|FG001|Overall Study|Missing due to site non-compliance|2|||
161965636|NCT02470585|584920393|FG002|Overall Study|Missing due to site non-compliance|3|||
161965637|NCT03028415|584920394|FG000|Overall Study|Lost to Follow-up|6|||
161728870|NCT01064648|584049865|FG003|Phase II|Adverse Event|8|||
161728871|NCT01064648|584049862|FG000|Phase II|Death|0|||
161728872|NCT01064648|584049863|FG001|Phase II|Death|0|||
161728873|NCT01064648|584049864|FG002|Phase II|Death|4|||
161728874|NCT01064648|584049865|FG003|Phase II|Death|5|||
161728875|NCT01064648|584049862|FG000|Phase II|Withdrawal by Subject|0|||
161728876|NCT01064648|584049863|FG001|Phase II|Withdrawal by Subject|0|||
161728877|NCT01064648|584049864|FG002|Phase II|Withdrawal by Subject|2|||
161728878|NCT01064648|584049865|FG003|Phase II|Withdrawal by Subject|5|||
161728879|NCT01064648|584049862|FG000|Phase II|Progression|0|||
161728880|NCT01064648|584049863|FG001|Phase II|Progression|0|||
161728881|NCT01064648|584049864|FG002|Phase II|Progression|21|||
161728882|NCT01064648|584049865|FG003|Phase II|Progression|27|||
161728883|NCT01064648|584049862|FG000|Phase II|Non-protocol specified|0|||
161728884|NCT01064648|584049863|FG001|Phase II|Non-protocol specified|0|||
161728885|NCT01064648|584049864|FG002|Phase II|Non-protocol specified|5|||
161728886|NCT01064648|584049865|FG003|Phase II|Non-protocol specified|3|||
161728887|NCT01064648|584049862|FG000|Phase II|Under Review|0|||
161728888|NCT01064648|584049863|FG001|Phase II|Under Review|0|||
161728889|NCT01064648|584049864|FG002|Phase II|Under Review|2|||
161728890|NCT01064648|584049865|FG003|Phase II|Under Review|0|||
161728891|NCT05513391|584049866|FG000|Overall Study|Adverse Event|1|||
161728892|NCT05513391|584049867|FG001|Overall Study|Adverse Event|0|||
161728893|NCT05513391|584049866|FG000|Overall Study|Protocol Deviation|0|||
161728894|NCT05513391|584049867|FG001|Overall Study|Protocol Deviation|1|||
161728895|NCT05513391|584049866|FG000|Overall Study|Withdrawal by Subject|3|||
161728896|NCT05513391|584049867|FG001|Overall Study|Withdrawal by Subject|1|||
161728897|NCT05513391|584049866|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161728898|NCT05513391|584049867|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161728899|NCT05513391|584049866|FG000|Overall Study|Lost to Follow-up|0|||
161728900|NCT05513391|584049867|FG001|Overall Study|Lost to Follow-up|2|||
161728901|NCT02429427|584049868|FG000|Overall Study|Adverse Event|220|||
161728902|NCT02429427|584049869|FG001|Overall Study|Adverse Event|92|||
161728903|NCT02429427|584049868|FG000|Overall Study|Protocol Violation|10|||
161728904|NCT02429427|584049869|FG001|Overall Study|Protocol Violation|6|||
161728905|NCT02429427|584049868|FG000|Overall Study|Lost to Follow-up|15|||
161728906|NCT02429427|584049869|FG001|Overall Study|Lost to Follow-up|6|||
161728907|NCT02429427|584049868|FG000|Overall Study|Withdrawal by Subject|64|||
161728908|NCT02429427|584049869|FG001|Overall Study|Withdrawal by Subject|34|||
161728909|NCT02429427|584049868|FG000|Overall Study|Other|62|||
161728910|NCT02429427|584049869|FG001|Overall Study|Other|41|||
161728911|NCT00719732|584049870|FG000|Overall Study|Lost to Follow-up|20|||
161728912|NCT00719732|584049870|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
161728913|NCT00719732|584049870|FG000|Overall Study|Illness not associated with device|1|||
161728914|NCT00309777|584049875|FG000|Overall Study|Adverse Event|13|||
161728915|NCT00309777|584049876|FG001|Overall Study|Adverse Event|2|||
161728916|NCT00309777|584049877|FG002|Overall Study|Adverse Event|8|||
161728917|NCT00309777|584049878|FG003|Overall Study|Adverse Event|1|||
161728918|NCT00309777|584049875|FG000|Overall Study|Protocol Violation|4|||
161728919|NCT00309777|584049876|FG001|Overall Study|Protocol Violation|1|||
161728920|NCT00309777|584049877|FG002|Overall Study|Protocol Violation|3|||
161728921|NCT00309777|584049878|FG003|Overall Study|Protocol Violation|1|||
161728922|NCT00309777|584049875|FG000|Overall Study|Withdrawal by Subject|6|||
161728923|NCT00309777|584049876|FG001|Overall Study|Withdrawal by Subject|5|||
161728924|NCT00309777|584049877|FG002|Overall Study|Withdrawal by Subject|7|||
161728925|NCT00309777|584049878|FG003|Overall Study|Withdrawal by Subject|2|||
161728926|NCT00309777|584049875|FG000|Overall Study|Lost to Follow-up|0|||
161965638|NCT03028415|584920395|FG001|Overall Study|Lost to Follow-up|3|||
161965639|NCT03028415|584920394|FG000|Overall Study|Withdrawal by Subject|1|||
162032195|NCT00095238|585175421|FG000|Overall Study|Missing|1|||
162032196|NCT00095238|585175422|FG001|Overall Study|Missing|0|||
162032197|NCT00095238|585175421|FG000|Overall Study|Other Reasons|87|||
162032198|NCT00095238|585175422|FG001|Overall Study|Other Reasons|88|||
161728927|NCT00309777|584049876|FG001|Overall Study|Lost to Follow-up|0|||
161728928|NCT00309777|584049877|FG002|Overall Study|Lost to Follow-up|1|||
162032199|NCT03754972|585175423|FG000|Overall Study|Protocol Violation|25|||
161728929|NCT00309777|584049878|FG003|Overall Study|Lost to Follow-up|0|||
161728930|NCT00309777|584049875|FG000|Overall Study|Death|0|||
161728931|NCT00309777|584049876|FG001|Overall Study|Death|1|||
161728932|NCT00309777|584049877|FG002|Overall Study|Death|0|||
161728933|NCT00309777|584049878|FG003|Overall Study|Death|0|||
161728934|NCT00683475|584051750|FG000|Overall Study|Withdrawal by Subject|1|||
161728935|NCT00683475|584051751|FG001|Overall Study|Withdrawal by Subject|0|||
161728936|NCT00683475|584051750|FG000|Overall Study|Never Treated: Adverse Event|2|||
161728937|NCT00683475|584051751|FG001|Overall Study|Never Treated: Adverse Event|3|||
161728938|NCT00683475|584051750|FG000|Overall Study|Never Treated: Progressive Disease|1|||
161728939|NCT00683475|584051751|FG001|Overall Study|Never Treated: Progressive Disease|0|||
161728940|NCT00948818|584051755|FG000|Overall Study|Adverse Event|10|||
161728941|NCT00948818|584051756|FG001|Overall Study|Adverse Event|32|||
161728942|NCT00948818|584051755|FG000|Overall Study|Protocol Violation|9|||
161728943|NCT00948818|584051756|FG001|Overall Study|Protocol Violation|10|||
161728944|NCT00948818|584051755|FG000|Overall Study|Withdrawal by Subject|25|||
161728945|NCT00948818|584051756|FG001|Overall Study|Withdrawal by Subject|25|||
161728946|NCT00948818|584051755|FG000|Overall Study|Lost to Follow-up|10|||
161728947|NCT00948818|584051756|FG001|Overall Study|Lost to Follow-up|17|||
161728948|NCT00948818|584051755|FG000|Overall Study|Lack of Efficacy|4|||
161728949|NCT00948818|584051756|FG001|Overall Study|Lack of Efficacy|5|||
161728950|NCT00948818|584051755|FG000|Overall Study|Other Reason|4|||
161728951|NCT00948818|584051756|FG001|Overall Study|Other Reason|5|||
161728952|NCT02364947|584051759|FG000|Overall Study|Withdrawal by Subject|10|||
161728953|NCT02364947|584051760|FG001|Overall Study|Withdrawal by Subject|8|||
161728954|NCT02364947|584051761|FG002|Overall Study|Withdrawal by Subject|9|||
161728955|NCT02364947|584051759|FG000|Overall Study|Adverse Event|45|||
161728956|NCT02364947|584051760|FG001|Overall Study|Adverse Event|33|||
161728957|NCT02364947|584051761|FG002|Overall Study|Adverse Event|11|||
161728958|NCT02364947|584051759|FG000|Overall Study|Protocol Violation|1|||
161728959|NCT02364947|584051760|FG001|Overall Study|Protocol Violation|1|||
161728960|NCT02364947|584051761|FG002|Overall Study|Protocol Violation|1|||
161728961|NCT02364947|584051759|FG000|Overall Study|Physician Decision|3|||
161728962|NCT02364947|584051760|FG001|Overall Study|Physician Decision|2|||
161728963|NCT02364947|584051761|FG002|Overall Study|Physician Decision|5|||
161728964|NCT02364947|584051759|FG000|Overall Study|Death|0|||
161728965|NCT02364947|584051760|FG001|Overall Study|Death|1|||
161728966|NCT02364947|584051761|FG002|Overall Study|Death|0|||
161728967|NCT02702518|584051765|FG000|Overall Study|Lost to Follow-up|3|||
161728968|NCT02702518|584051766|FG001|Overall Study|Lost to Follow-up|4|||
161728969|NCT00853489|584051767|FG000|Overall Study|Lost to Follow-up|5|||
161728970|NCT00853489|584051768|FG001|Overall Study|Lost to Follow-up|2|||
161728971|NCT01251276|584051770|FG000|Overall Study|Protocol Violation|1|||
161728972|NCT01251276|584051771|FG001|Overall Study|Protocol Violation|0|||
161728973|NCT01251276|584051770|FG000|Overall Study|Lost to Follow-up|0|||
161728974|NCT01251276|584051771|FG001|Overall Study|Lost to Follow-up|1|||
161728975|NCT00262080|584051777|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
161728976|NCT00262080|584051778|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
161728977|NCT00262080|584051779|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
161728978|NCT00262080|584051777|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
161728979|NCT00262080|584051778|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
161728980|NCT00262080|584051779|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
161728981|NCT00262080|584051777|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
161728982|NCT00262080|584051778|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
161728983|NCT00262080|584051779|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
161728984|NCT00262080|584051777|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
161728985|NCT00262080|584051778|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
161728986|NCT00262080|584051779|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
161728987|NCT00262080|584051777|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
161728988|NCT00262080|584051778|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
161728989|NCT00262080|584051779|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
161728990|NCT00262080|584051777|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
161728991|NCT00262080|584051778|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
161728992|NCT00262080|584051779|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
161728993|NCT01051986|584051780|FG000|Overall Study|Death|1|||
161728994|NCT01051986|584051781|FG001|Overall Study|Death|0|||
161728995|NCT01051986|584051780|FG000|Overall Study|Withdrawal by Subject|2|||
161728996|NCT01051986|584051781|FG001|Overall Study|Withdrawal by Subject|1|||
161728997|NCT01051986|584051780|FG000|Overall Study|Protocol Violation|2|||
161728998|NCT01051986|584051781|FG001|Overall Study|Protocol Violation|3|||
161728999|NCT01725152|584051783|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
161729000|NCT01725152|584051784|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
161729001|NCT01725152|584051783|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
161729002|NCT01725152|584051784|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
161729003|NCT01725152|584051783|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
161729004|NCT01725152|584051784|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
161729005|NCT01725152|584051783|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
161729006|NCT01725152|584051784|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
161838472|NCT00609466|584451928|FG001|Overall Study|Withdrawal by Subject|1|||
161838473|NCT00609466|584451929|FG002|Overall Study|Withdrawal by Subject|1|||
161965640|NCT03028415|584920395|FG001|Overall Study|Withdrawal by Subject|0|||
161965641|NCT03028415|584920394|FG000|Overall Study|Discontinued due to COVID-19|1|||
161838474|NCT00609466|584451927|FG000|Overall Study|Adverse Event|2|||
161729007|NCT02044159|584051785|FG000|Overall Study|Consent declined (deferred consent)|2|||
161729008|NCT02044159|584051786|FG001|Overall Study|Consent declined (deferred consent)|4|||
161729009|NCT02044159|584051785|FG000|Overall Study|No longer eligible, drug not given|1|||
161729010|NCT02044159|584051786|FG001|Overall Study|No longer eligible, drug not given|0|||
161729011|NCT02044159|584051785|FG000|Overall Study|Nurse declined to give study drug|1|||
161729012|NCT02044159|584051786|FG001|Overall Study|Nurse declined to give study drug|0|||
161729013|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
161729014|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161729015|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161729016|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161729017|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161729018|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
161729019|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161729020|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161729021|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161729022|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161729023|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
161729024|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161729025|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161729026|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161729027|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161729028|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
161729029|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
161729030|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
161729031|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
161729032|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
161729033|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
161729034|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
161729035|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
161729036|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
161729037|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
161729038|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
161729039|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161729040|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161729041|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161729042|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161729043|NCT01111539|584051789|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
161729044|NCT01111539|584051790|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
161729045|NCT01111539|584051791|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
161729046|NCT01111539|584051792|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
161729047|NCT01111539|584051793|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
161729048|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161729049|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161729050|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
161729051|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161729052|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
161729053|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161729054|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161729055|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
161729056|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161965642|NCT03028415|584920395|FG001|Overall Study|Discontinued due to COVID-19|0|||
161965643|NCT05005013|584920398|FG000|Overall Study|Withdrawal by Subject|5|||
161965644|NCT05005013|584920399|FG001|Overall Study|Withdrawal by Subject|1|||
161965645|NCT05005013|584920398|FG000|Overall Study|Lost to Follow-up|3|||
161965646|NCT05005013|584920399|FG001|Overall Study|Lost to Follow-up|1|||
161965647|NCT05005013|584920398|FG000|Overall Study|Ineligibility|1|||
161965648|NCT05005013|584920399|FG001|Overall Study|Ineligibility|1|||
161965649|NCT04283994|584920400|FG000|Overall Study|Death|11|||
161729057|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
161729058|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
161729059|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
161729060|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
161729061|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
161729062|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
161729063|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
161965650|NCT04283994|584920401|FG001|Overall Study|Death|20|||
161965651|NCT04283994|584920402|FG002|Overall Study|Death|11|||
161965652|NCT04283994|584920403|FG003|Overall Study|Death|0|||
161729064|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
161729065|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
161729066|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
161729067|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
161729068|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
161729069|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
161729070|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
161729071|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
161729072|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
161729073|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
161729074|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
161729075|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
161729076|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
161729077|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
161729078|NCT01111539|584051789|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161729079|NCT01111539|584051790|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161729080|NCT01111539|584051791|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161729081|NCT01111539|584051792|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161729082|NCT01111539|584051793|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
161729083|NCT03580382|584051798|FG000|Overall Study|Early Termination of Study|0|||
161729084|NCT03580382|584051799|FG001|Overall Study|Early Termination of Study|3|||
161729085|NCT02808312|584051800|FG000|Overall Study|Enrolled but Never Treated|0|||
161729086|NCT02808312|584051801|FG001|Overall Study|Enrolled but Never Treated|0|||
161729087|NCT02808312|584051802|FG002|Overall Study|Enrolled but Never Treated|1|||
161729088|NCT02808312|584051803|FG003|Overall Study|Enrolled but Never Treated|0|||
161729089|NCT02808312|584051804|FG004|Overall Study|Enrolled but Never Treated|0|||
161729090|NCT03628417|584051805|FG000|Overall Study|Death|1|||
161729091|NCT03628417|584051806|FG001|Overall Study|Death|1|||
161729092|NCT02420223|584051807|FG000|Overall Study|Adverse Event|1|||
161729093|NCT02420223|584051808|FG001|Overall Study|Adverse Event|0|||
161729094|NCT02420223|584051807|FG000|Overall Study|Physician Decision|0|||
161729095|NCT02420223|584051808|FG001|Overall Study|Physician Decision|2|||
161729096|NCT01361009|584051809|FG000|Overall Study|Protocol Violation|116|||
161729097|NCT01826422|584051810|FG000|Overall Study|Withdrawal by Subject|1|||
161729098|NCT01826422|584051811|FG001|Overall Study|Withdrawal by Subject|3|||
161729099|NCT03484923|584051817|FG000|Overall Study|Adverse Event|3|||
161729100|NCT03484923|584051818|FG001|Overall Study|Adverse Event|3|||
161729101|NCT03484923|584051819|FG002|Overall Study|Adverse Event|5|||
161729102|NCT03484923|584051820|FG003|Overall Study|Adverse Event|11|||
161729103|NCT03484923|584051821|FG004|Overall Study|Adverse Event|1|||
161729104|NCT03484923|584051817|FG000|Overall Study|Death|2|||
161729105|NCT03484923|584051818|FG001|Overall Study|Death|2|||
161729106|NCT03484923|584051819|FG002|Overall Study|Death|3|||
161729107|NCT03484923|584051820|FG003|Overall Study|Death|0|||
161729108|NCT03484923|584051821|FG004|Overall Study|Death|1|||
161729109|NCT03484923|584051817|FG000|Overall Study|Physician Decision|6|||
161729110|NCT03484923|584051818|FG001|Overall Study|Physician Decision|7|||
161729111|NCT03484923|584051819|FG002|Overall Study|Physician Decision|6|||
161729112|NCT03484923|584051820|FG003|Overall Study|Physician Decision|3|||
161729113|NCT03484923|584051821|FG004|Overall Study|Physician Decision|2|||
161729114|NCT03484923|584051817|FG000|Overall Study|Progressive disease|33|||
161729115|NCT03484923|584051818|FG001|Overall Study|Progressive disease|28|||
161729116|NCT03484923|584051819|FG002|Overall Study|Progressive disease|26|||
161729117|NCT03484923|584051820|FG003|Overall Study|Progressive disease|30|||
161729118|NCT03484923|584051821|FG004|Overall Study|Progressive disease|16|||
161729119|NCT03484923|584051817|FG000|Overall Study|Subject Decision|1|||
161729120|NCT03484923|584051818|FG001|Overall Study|Subject Decision|3|||
161729121|NCT03484923|584051819|FG002|Overall Study|Subject Decision|3|||
161729122|NCT03484923|584051820|FG003|Overall Study|Subject Decision|0|||
161729123|NCT03484923|584051821|FG004|Overall Study|Subject Decision|1|||
161729124|NCT01863849|584051822|FG000|Overall Study|Lost to Follow-up|1|||
161729125|NCT01863849|584051823|FG001|Overall Study|Lost to Follow-up|0|||
162032200|NCT02311582|585175424|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
161729126|NCT04402008|584051826|FG000|Overall Study|Adverse Event|0|||
161729127|NCT04402008|584051827|FG001|Overall Study|Adverse Event|0|||
161729128|NCT04402008|584051828|FG002|Overall Study|Adverse Event|0|||
161729129|NCT04402008|584051829|FG003|Overall Study|Adverse Event|1|||
161729130|NCT04402008|584051830|FG004|Overall Study|Adverse Event|0|||
161729131|NCT04402008|584051831|FG005|Overall Study|Adverse Event|0|||
161729132|NCT04402008|584051832|FG006|Overall Study|Adverse Event|0|||
161729133|NCT04402008|584051826|FG000|Overall Study|Disease Progression|3|||
161729134|NCT04402008|584051827|FG001|Overall Study|Disease Progression|2|||
161729135|NCT04402008|584051828|FG002|Overall Study|Disease Progression|3|||
161729136|NCT04402008|584051829|FG003|Overall Study|Disease Progression|3|||
161729137|NCT04402008|584051830|FG004|Overall Study|Disease Progression|4|||
161729138|NCT04402008|584051831|FG005|Overall Study|Disease Progression|3|||
161729139|NCT04402008|584051832|FG006|Overall Study|Disease Progression|10|||
161729140|NCT04402008|584051826|FG000|Overall Study|Withdrawal by Subject|0|||
161729141|NCT04402008|584051827|FG001|Overall Study|Withdrawal by Subject|1|||
161729142|NCT04402008|584051828|FG002|Overall Study|Withdrawal by Subject|0|||
161729143|NCT04402008|584051829|FG003|Overall Study|Withdrawal by Subject|0|||
161729144|NCT04402008|584051830|FG004|Overall Study|Withdrawal by Subject|1|||
161729145|NCT04402008|584051831|FG005|Overall Study|Withdrawal by Subject|0|||
161729146|NCT04402008|584051832|FG006|Overall Study|Withdrawal by Subject|0|||
161729147|NCT04402008|584051826|FG000|Overall Study|Sponsor Decision|0|||
161729148|NCT04402008|584051827|FG001|Overall Study|Sponsor Decision|0|||
161729149|NCT04402008|584051828|FG002|Overall Study|Sponsor Decision|0|||
161729150|NCT04402008|584051829|FG003|Overall Study|Sponsor Decision|0|||
161729151|NCT04402008|584051830|FG004|Overall Study|Sponsor Decision|0|||
161729152|NCT04402008|584051831|FG005|Overall Study|Sponsor Decision|0|||
161729153|NCT04402008|584051832|FG006|Overall Study|Sponsor Decision|3|||
161729154|NCT04402008|584051826|FG000|Overall Study|Death|0|||
161729155|NCT04402008|584051827|FG001|Overall Study|Death|0|||
161729156|NCT04402008|584051828|FG002|Overall Study|Death|0|||
161729157|NCT04402008|584051829|FG003|Overall Study|Death|0|||
161729158|NCT04402008|584051830|FG004|Overall Study|Death|1|||
161729159|NCT04402008|584051831|FG005|Overall Study|Death|0|||
161729160|NCT04402008|584051832|FG006|Overall Study|Death|2|||
161729161|NCT04402008|584051826|FG000|Overall Study|Other|0|||
161729162|NCT04402008|584051827|FG001|Overall Study|Other|0|||
161729163|NCT04402008|584051828|FG002|Overall Study|Other|0|||
161729164|NCT04402008|584051829|FG003|Overall Study|Other|0|||
161729165|NCT04402008|584051830|FG004|Overall Study|Other|0|||
161729166|NCT04402008|584051831|FG005|Overall Study|Other|0|||
161729167|NCT04402008|584051832|FG006|Overall Study|Other|5|||
161729168|NCT00913978|584051833|FG000|Overall Study|Surgeon choice|1|||
161729169|NCT00913978|584051834|FG001|Overall Study|Surgeon choice|3|||
161729170|NCT04716933|584051835|FG000|Overall Study|Sponsor Decision|36|||
161729171|NCT04716933|584051836|FG001|Overall Study|Sponsor Decision|33|||
161729172|NCT04716933|584051835|FG000|Overall Study|Death|65|||
161729173|NCT04716933|584051836|FG001|Overall Study|Death|67|||
161729174|NCT01327651|584051837|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
161729175|NCT01327651|584051838|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
161729176|NCT01327651|584051839|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
161729177|NCT01327651|584051840|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
161729178|NCT01327651|584051841|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
161729179|NCT01327651|584051842|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
161729180|NCT01327651|584051843|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
161729181|NCT01327651|584051844|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
161729182|NCT01327651|584051845|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
161729183|NCT01327651|584051837|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
161729184|NCT01327651|584051838|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729185|NCT01327651|584051839|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729186|NCT01327651|584051840|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729187|NCT01327651|584051841|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729188|NCT01327651|584051842|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729189|NCT01327651|584051843|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729190|NCT01327651|584051844|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729191|NCT01327651|584051845|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161729192|NCT01327651|584051837|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
161729193|NCT01327651|584051838|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
161729194|NCT01327651|584051839|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
161729195|NCT01327651|584051840|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
161729196|NCT01327651|584051841|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
161729197|NCT01327651|584051842|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
161729198|NCT01327651|584051843|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
161838475|NCT00609466|584451928|FG001|Overall Study|Adverse Event|3|||
161838476|NCT00609466|584451929|FG002|Overall Study|Adverse Event|1|||
162032201|NCT02311582|585175425|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
161729199|NCT01327651|584051844|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
161729200|NCT01327651|584051845|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
161838477|NCT00609466|584451927|FG000|Overall Study|Lack of Efficacy|0|||
161729201|NCT01327651|584051837|FG000|Post Study Follow-up|Lost to Follow-up|0|||
161729202|NCT01327651|584051838|FG001|Post Study Follow-up|Lost to Follow-up|1|||
161729203|NCT01327651|584051839|FG002|Post Study Follow-up|Lost to Follow-up|1|||
161729204|NCT01327651|584051840|FG003|Post Study Follow-up|Lost to Follow-up|0|||
161729205|NCT01327651|584051841|FG004|Post Study Follow-up|Lost to Follow-up|0|||
161838478|NCT00609466|584451928|FG001|Overall Study|Lack of Efficacy|2|||
161729206|NCT01327651|584051842|FG005|Post Study Follow-up|Lost to Follow-up|0|||
161729207|NCT01327651|584051843|FG006|Post Study Follow-up|Lost to Follow-up|4|||
161729208|NCT01327651|584051844|FG007|Post Study Follow-up|Lost to Follow-up|1|||
161729209|NCT01327651|584051845|FG008|Post Study Follow-up|Lost to Follow-up|2|||
161729210|NCT03249792|584051846|FG000|Arms 1, 2, and 4|Death|1|||
161729211|NCT03249792|584051847|FG001|Arms 1, 2, and 4|Death|1|||
161729212|NCT03249792|584051848|FG002|Arms 1, 2, and 4|Death|0|||
161729213|NCT03249792|584051849|FG003|Arms 1, 2, and 4|Death|2|||
161729214|NCT03249792|584051850|FG004|Arms 1, 2, and 4|Death|3|||
161729215|NCT03249792|584051851|FG005|Arms 1, 2, and 4|Death|2|||
161729216|NCT03249792|584051852|FG006|Arms 1, 2, and 4|Death|2|||
161729217|NCT03249792|584051853|FG007|Arms 1, 2, and 4|Death|4|||
161729218|NCT03249792|584051854|FG008|Arms 1, 2, and 4|Death|2|||
161729219|NCT03249792|584051855|FG009|Arms 1, 2, and 4|Death|1|||
161729220|NCT03249792|584051856|FG010|Arms 1, 2, and 4|Death|7|||
161729221|NCT03249792|584051857|FG011|Arms 1, 2, and 4|Death|7|||
161729222|NCT03249792|584051858|FG012|Arms 1, 2, and 4|Death|12|||
161729223|NCT03249792|584051859|FG013|Arms 1, 2, and 4|Death|7|||
161729224|NCT03249792|584051860|FG014|Arms 1, 2, and 4|Death|0|||
161729225|NCT03249792|584051861|FG015|Arms 1, 2, and 4|Death|4|||
161729226|NCT03249792|584051862|FG016|Arms 1, 2, and 4|Death|4|||
161729227|NCT03249792|584051863|FG017|Arms 1, 2, and 4|Death|12|||
161729228|NCT03249792|584051864|FG018|Arms 1, 2, and 4|Death|6|||
161729229|NCT03249792|584051865|FG019|Arms 1, 2, and 4|Death|4|||
161729230|NCT03249792|584051866|FG020|Arms 1, 2, and 4|Death|2|||
161729231|NCT03249792|584051867|FG021|Arms 1, 2, and 4|Death|3|||
161729232|NCT03249792|584051868|FG022|Arms 1, 2, and 4|Death|1|||
161729233|NCT03249792|584051869|FG023|Arms 1, 2, and 4|Death|1|||
161729234|NCT03249792|584051870|FG024|Arms 1, 2, and 4|Death|4|||
161729235|NCT03249792|584051871|FG025|Arms 1, 2, and 4|Death|0|||
161729236|NCT03249792|584051872|FG026|Arms 1, 2, and 4|Death|0|||
161729237|NCT03249792|584051873|FG027|Arms 1, 2, and 4|Death|0|||
161729238|NCT03249792|584051874|FG028|Arms 1, 2, and 4|Death|0|||
161729239|NCT03249792|584051875|FG029|Arms 1, 2, and 4|Death|0|||
161729240|NCT03249792|584051876|FG030|Arms 1, 2, and 4|Death|0|||
161729241|NCT03249792|584051877|FG031|Arms 1, 2, and 4|Death|0|||
161729242|NCT03249792|584051878|FG032|Arms 1, 2, and 4|Death|0|||
161729243|NCT03249792|584051846|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729244|NCT03249792|584051847|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729245|NCT03249792|584051848|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161729246|NCT03249792|584051849|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729247|NCT03249792|584051850|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729248|NCT03249792|584051851|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161729249|NCT03249792|584051852|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
161729250|NCT03249792|584051853|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729251|NCT03249792|584051854|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
161729252|NCT03249792|584051855|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161729253|NCT03249792|584051856|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
161729254|NCT03249792|584051857|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
161729255|NCT03249792|584051858|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
161729256|NCT03249792|584051859|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
161729257|NCT03249792|584051860|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729258|NCT03249792|584051861|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729259|NCT03249792|584051862|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
161729260|NCT03249792|584051863|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729261|NCT03249792|584051864|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161729262|NCT03249792|584051865|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729263|NCT03249792|584051866|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729264|NCT03249792|584051867|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729265|NCT03249792|584051868|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161729266|NCT03249792|584051869|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161729267|NCT03249792|584051870|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729268|NCT03249792|584051871|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729269|NCT03249792|584051872|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729270|NCT03249792|584051873|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729271|NCT03249792|584051874|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729272|NCT03249792|584051875|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729273|NCT03249792|584051876|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729274|NCT03249792|584051877|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729275|NCT03249792|584051878|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161729276|NCT03249792|584051846|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
161729277|NCT03249792|584051847|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
161729278|NCT03249792|584051848|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
161729279|NCT03249792|584051849|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
161729280|NCT03249792|584051850|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
161729281|NCT03249792|584051851|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
161729282|NCT03249792|584051852|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
161729283|NCT03249792|584051853|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
161729284|NCT03249792|584051854|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
161729285|NCT03249792|584051855|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
161729286|NCT03249792|584051856|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
161729287|NCT03249792|584051857|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
161729288|NCT03249792|584051858|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
161729289|NCT03249792|584051859|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
161729290|NCT03249792|584051860|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
161729291|NCT03249792|584051861|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
161729292|NCT03249792|584051862|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
161729293|NCT03249792|584051863|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
161729294|NCT03249792|584051864|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
161729295|NCT03249792|584051865|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
161729296|NCT03249792|584051866|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
161729297|NCT03249792|584051867|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
161729298|NCT03249792|584051868|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
161729299|NCT03249792|584051869|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
161729300|NCT03249792|584051870|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
161729301|NCT03249792|584051871|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
161729302|NCT03249792|584051872|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
161729303|NCT03249792|584051873|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
161729304|NCT03249792|584051874|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
161729305|NCT03249792|584051875|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
161729306|NCT03249792|584051876|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
161729307|NCT03249792|584051877|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
161729308|NCT03249792|584051878|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
161729309|NCT03249792|584051846|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729310|NCT03249792|584051847|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729311|NCT03249792|584051848|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729312|NCT03249792|584051849|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729313|NCT03249792|584051850|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729314|NCT03249792|584051851|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729315|NCT03249792|584051852|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729316|NCT03249792|584051853|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729317|NCT03249792|584051854|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
161729318|NCT03249792|584051855|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729319|NCT03249792|584051856|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729320|NCT03249792|584051857|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729321|NCT03249792|584051858|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729322|NCT03249792|584051859|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729323|NCT03249792|584051860|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729324|NCT03249792|584051861|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729325|NCT03249792|584051862|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
161729326|NCT03249792|584051863|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
161729327|NCT03249792|584051864|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729328|NCT03249792|584051865|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
161729329|NCT03249792|584051866|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729330|NCT03249792|584051867|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729331|NCT03249792|584051868|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729332|NCT03249792|584051869|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729333|NCT03249792|584051870|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729334|NCT03249792|584051871|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729335|NCT03249792|584051872|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729336|NCT03249792|584051873|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729337|NCT03249792|584051874|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729338|NCT03249792|584051875|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729339|NCT03249792|584051876|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729340|NCT03249792|584051877|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729341|NCT03249792|584051878|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
161729342|NCT03249792|584051846|FG000|Switch Over Period|Withdrawal by Subject|0|||
161729343|NCT03249792|584051847|FG001|Switch Over Period|Withdrawal by Subject|0|||
161729344|NCT03249792|584051848|FG002|Switch Over Period|Withdrawal by Subject|0|||
161729345|NCT03249792|584051849|FG003|Switch Over Period|Withdrawal by Subject|0|||
161729346|NCT03249792|584051850|FG004|Switch Over Period|Withdrawal by Subject|0|||
161729347|NCT03249792|584051851|FG005|Switch Over Period|Withdrawal by Subject|0|||
161838479|NCT00609466|584451929|FG002|Overall Study|Lack of Efficacy|2|||
161838480|NCT03407430|584451930|FG000|Washout|Protocol Violation|1|||
161729348|NCT03249792|584051852|FG006|Switch Over Period|Withdrawal by Subject|0|||
161729349|NCT03249792|584051853|FG007|Switch Over Period|Withdrawal by Subject|0|||
161729350|NCT03249792|584051854|FG008|Switch Over Period|Withdrawal by Subject|0|||
161729351|NCT03249792|584051855|FG009|Switch Over Period|Withdrawal by Subject|0|||
161729352|NCT03249792|584051856|FG010|Switch Over Period|Withdrawal by Subject|0|||
161729353|NCT03249792|584051857|FG011|Switch Over Period|Withdrawal by Subject|0|||
161729354|NCT03249792|584051858|FG012|Switch Over Period|Withdrawal by Subject|0|||
161729355|NCT03249792|584051859|FG013|Switch Over Period|Withdrawal by Subject|0|||
161729356|NCT03249792|584051860|FG014|Switch Over Period|Withdrawal by Subject|0|||
161729357|NCT03249792|584051861|FG015|Switch Over Period|Withdrawal by Subject|0|||
161729358|NCT03249792|584051862|FG016|Switch Over Period|Withdrawal by Subject|0|||
161729359|NCT03249792|584051863|FG017|Switch Over Period|Withdrawal by Subject|0|||
161729360|NCT03249792|584051864|FG018|Switch Over Period|Withdrawal by Subject|0|||
161729361|NCT03249792|584051865|FG019|Switch Over Period|Withdrawal by Subject|0|||
161838481|NCT03407430|584451931|FG001|Washout|Protocol Violation|0|||
161838482|NCT00922987|584451933|FG000|Overall Study|Insufficient clinical response|1|||
161838483|NCT00922987|584451933|FG000|Overall Study|Protocol Violation|2|||
161838484|NCT00922987|584451933|FG000|Overall Study|Adverse Event|1|||
161838485|NCT01334710|584451940|FG000|Overall Study|Trial was terminated|3|||
161838486|NCT05011123|584453434|FG000|Overall Study|Withdrawal by Subject|4|||
161838487|NCT05011123|584453435|FG001|Overall Study|Withdrawal by Subject|2|||
161838488|NCT05011123|584453434|FG000|Overall Study|Lost to Follow-up|7|||
162032202|NCT02311582|585175426|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
162032203|NCT02311582|585175427|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
161729362|NCT03249792|584051866|FG020|Switch Over Period|Withdrawal by Subject|0|||
161729363|NCT03249792|584051867|FG021|Switch Over Period|Withdrawal by Subject|0|||
161729364|NCT03249792|584051868|FG022|Switch Over Period|Withdrawal by Subject|0|||
161729365|NCT03249792|584051869|FG023|Switch Over Period|Withdrawal by Subject|0|||
161729366|NCT03249792|584051870|FG024|Switch Over Period|Withdrawal by Subject|0|||
161729367|NCT03249792|584051871|FG025|Switch Over Period|Withdrawal by Subject|0|||
161729368|NCT03249792|584051872|FG026|Switch Over Period|Withdrawal by Subject|0|||
161729369|NCT03249792|584051873|FG027|Switch Over Period|Withdrawal by Subject|0|||
161729370|NCT03249792|584051874|FG028|Switch Over Period|Withdrawal by Subject|0|||
161729371|NCT03249792|584051875|FG029|Switch Over Period|Withdrawal by Subject|0|||
161729372|NCT03249792|584051876|FG030|Switch Over Period|Withdrawal by Subject|0|||
161729373|NCT03249792|584051877|FG031|Switch Over Period|Withdrawal by Subject|1|||
161729374|NCT03249792|584051878|FG032|Switch Over Period|Withdrawal by Subject|0|||
161729375|NCT03249792|584051846|FG000|Switch Over Period|Progressive Disease|0|||
161729376|NCT03249792|584051847|FG001|Switch Over Period|Progressive Disease|0|||
161729377|NCT03249792|584051848|FG002|Switch Over Period|Progressive Disease|0|||
161729378|NCT03249792|584051849|FG003|Switch Over Period|Progressive Disease|0|||
161729379|NCT03249792|584051850|FG004|Switch Over Period|Progressive Disease|0|||
161729380|NCT03249792|584051851|FG005|Switch Over Period|Progressive Disease|0|||
161729381|NCT03249792|584051852|FG006|Switch Over Period|Progressive Disease|0|||
161729382|NCT03249792|584051853|FG007|Switch Over Period|Progressive Disease|0|||
161729383|NCT03249792|584051854|FG008|Switch Over Period|Progressive Disease|0|||
161729384|NCT03249792|584051855|FG009|Switch Over Period|Progressive Disease|0|||
161729385|NCT03249792|584051856|FG010|Switch Over Period|Progressive Disease|0|||
161729386|NCT03249792|584051857|FG011|Switch Over Period|Progressive Disease|0|||
161729387|NCT03249792|584051858|FG012|Switch Over Period|Progressive Disease|0|||
161729388|NCT03249792|584051859|FG013|Switch Over Period|Progressive Disease|0|||
161729389|NCT03249792|584051860|FG014|Switch Over Period|Progressive Disease|0|||
161729390|NCT03249792|584051861|FG015|Switch Over Period|Progressive Disease|0|||
161729391|NCT03249792|584051862|FG016|Switch Over Period|Progressive Disease|0|||
161729392|NCT03249792|584051863|FG017|Switch Over Period|Progressive Disease|0|||
161729393|NCT03249792|584051864|FG018|Switch Over Period|Progressive Disease|0|||
161729394|NCT03249792|584051865|FG019|Switch Over Period|Progressive Disease|0|||
161729395|NCT03249792|584051866|FG020|Switch Over Period|Progressive Disease|0|||
161729396|NCT03249792|584051867|FG021|Switch Over Period|Progressive Disease|0|||
161729397|NCT03249792|584051868|FG022|Switch Over Period|Progressive Disease|0|||
161729398|NCT03249792|584051869|FG023|Switch Over Period|Progressive Disease|0|||
161729399|NCT03249792|584051870|FG024|Switch Over Period|Progressive Disease|0|||
161729400|NCT03249792|584051871|FG025|Switch Over Period|Progressive Disease|0|||
161729401|NCT03249792|584051872|FG026|Switch Over Period|Progressive Disease|1|||
161729402|NCT03249792|584051873|FG027|Switch Over Period|Progressive Disease|0|||
161729403|NCT03249792|584051874|FG028|Switch Over Period|Progressive Disease|1|||
161729404|NCT03249792|584051875|FG029|Switch Over Period|Progressive Disease|2|||
161729405|NCT03249792|584051876|FG030|Switch Over Period|Progressive Disease|1|||
161729406|NCT03249792|584051877|FG031|Switch Over Period|Progressive Disease|0|||
161729407|NCT03249792|584051878|FG032|Switch Over Period|Progressive Disease|1|||
161729408|NCT03249792|584051846|FG000|Switch Over Period|Adverse Event|0|||
161729409|NCT03249792|584051847|FG001|Switch Over Period|Adverse Event|0|||
161729410|NCT03249792|584051848|FG002|Switch Over Period|Adverse Event|0|||
161729411|NCT03249792|584051849|FG003|Switch Over Period|Adverse Event|0|||
161729412|NCT03249792|584051850|FG004|Switch Over Period|Adverse Event|0|||
161729413|NCT03249792|584051851|FG005|Switch Over Period|Adverse Event|0|||
161729414|NCT03249792|584051852|FG006|Switch Over Period|Adverse Event|0|||
161729415|NCT03249792|584051853|FG007|Switch Over Period|Adverse Event|0|||
161838489|NCT05011123|584453435|FG001|Overall Study|Lost to Follow-up|6|||
161729416|NCT03249792|584051854|FG008|Switch Over Period|Adverse Event|0|||
161729417|NCT03249792|584051855|FG009|Switch Over Period|Adverse Event|0|||
161729418|NCT03249792|584051856|FG010|Switch Over Period|Adverse Event|0|||
161729419|NCT03249792|584051857|FG011|Switch Over Period|Adverse Event|0|||
161729420|NCT03249792|584051858|FG012|Switch Over Period|Adverse Event|0|||
161729421|NCT03249792|584051859|FG013|Switch Over Period|Adverse Event|0|||
161729422|NCT03249792|584051860|FG014|Switch Over Period|Adverse Event|0|||
161729423|NCT03249792|584051861|FG015|Switch Over Period|Adverse Event|0|||
161729424|NCT03249792|584051862|FG016|Switch Over Period|Adverse Event|0|||
161729425|NCT03249792|584051863|FG017|Switch Over Period|Adverse Event|0|||
161838490|NCT05011123|584453434|FG000|Overall Study|Ongoing at the time of DBL date|36|||
161838491|NCT05011123|584453435|FG001|Overall Study|Ongoing at the time of DBL date|10|||
162032204|NCT02311582|585175428|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
161729426|NCT03249792|584051864|FG018|Switch Over Period|Adverse Event|0|||
161729427|NCT03249792|584051865|FG019|Switch Over Period|Adverse Event|0|||
161729428|NCT03249792|584051866|FG020|Switch Over Period|Adverse Event|0|||
161729429|NCT03249792|584051867|FG021|Switch Over Period|Adverse Event|0|||
161729430|NCT03249792|584051868|FG022|Switch Over Period|Adverse Event|0|||
161729431|NCT03249792|584051869|FG023|Switch Over Period|Adverse Event|0|||
161729432|NCT03249792|584051870|FG024|Switch Over Period|Adverse Event|0|||
161729433|NCT03249792|584051871|FG025|Switch Over Period|Adverse Event|1|||
161729434|NCT03249792|584051872|FG026|Switch Over Period|Adverse Event|0|||
161729435|NCT03249792|584051873|FG027|Switch Over Period|Adverse Event|1|||
161729436|NCT03249792|584051874|FG028|Switch Over Period|Adverse Event|0|||
161729437|NCT03249792|584051875|FG029|Switch Over Period|Adverse Event|0|||
161729438|NCT03249792|584051876|FG030|Switch Over Period|Adverse Event|0|||
161729439|NCT03249792|584051877|FG031|Switch Over Period|Adverse Event|0|||
161729440|NCT03249792|584051878|FG032|Switch Over Period|Adverse Event|0|||
161729441|NCT00532948|584051882|FG000|Overall Study|Protocol Violation|1|||
161729442|NCT00532948|584051883|FG001|Overall Study|Protocol Violation|0|||
161729443|NCT00532948|584051884|FG002|Overall Study|Protocol Violation|0|||
161729444|NCT00532948|584051882|FG000|Overall Study|Death|3|||
161729445|NCT00532948|584051883|FG001|Overall Study|Death|3|||
161729446|NCT00532948|584051884|FG002|Overall Study|Death|4|||
161729447|NCT00532948|584051882|FG000|Overall Study|Violation of selection criteria at entry|0|||
161729448|NCT00532948|584051883|FG001|Overall Study|Violation of selection criteria at entry|1|||
161729449|NCT00532948|584051884|FG002|Overall Study|Violation of selection criteria at entry|0|||
161729450|NCT00532948|584051882|FG000|Overall Study|Failure to return|0|||
161729451|NCT00532948|584051883|FG001|Overall Study|Failure to return|1|||
161729452|NCT00532948|584051884|FG002|Overall Study|Failure to return|0|||
161729453|NCT01201798|584051893|FG000|Overall Study|Adverse Event|2|||
161729454|NCT01201798|584051894|FG001|Overall Study|Adverse Event|0|||
161729455|NCT01201798|584051893|FG000|Overall Study|Lost to Follow-up|3|||
161729456|NCT01201798|584051894|FG001|Overall Study|Lost to Follow-up|5|||
161729457|NCT01201798|584051893|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
161729458|NCT01201798|584051894|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
161729459|NCT01201798|584051893|FG000|Overall Study|Noncompliance|1|||
161729460|NCT01201798|584051894|FG001|Overall Study|Noncompliance|0|||
161729461|NCT01201798|584051893|FG000|Overall Study|Protocol Violation|1|||
161729462|NCT01201798|584051894|FG001|Overall Study|Protocol Violation|1|||
161729463|NCT01201798|584051893|FG000|Overall Study|Treatment Failure|1|||
161729464|NCT01201798|584051894|FG001|Overall Study|Treatment Failure|8|||
161729465|NCT02509598|584051895|FG000|Overall Study|Withdrawal by Subject|1|||
161729466|NCT05692154|584051896|FG000|Overall Study|Adverse Event|0|||
161729467|NCT05692154|584051897|FG001|Overall Study|Adverse Event|1|||
161729468|NCT03609359|584051900|FG000|Overall Study|Progression of primary disease (PD)|25|||
161729469|NCT03609359|584051900|FG000|Overall Study|Patient's refusal|1|||
161729470|NCT03609359|584051900|FG000|Overall Study|Physician Decision|1|||
161729471|NCT03609359|584051900|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
161729472|NCT01912729|584051901|FG000|Overall Study|Withdrawal by Subject|0|||
161729473|NCT01912729|584051902|FG001|Overall Study|Withdrawal by Subject|1|||
161729474|NCT01952834|584051909|FG000|Overall Study|Adverse Event|1|||
161729475|NCT01975272|584051912|FG000|Overall Study|Excluded after protocol amendment|1|||
161729476|NCT01975272|584051913|FG001|Overall Study|Excluded after protocol amendment|1|||
161729477|NCT01975272|584051914|FG002|Overall Study|Excluded after protocol amendment|2|||
161729478|NCT00740779|584051921|FG000|Overall Study|Adverse Event|4|||
161729479|NCT00740779|584051922|FG001|Overall Study|Adverse Event|6|||
161729480|NCT00740779|584051923|FG002|Overall Study|Adverse Event|3|||
161729481|NCT00740779|584051921|FG000|Overall Study|Protocol Violation|1|||
161729482|NCT00740779|584051922|FG001|Overall Study|Protocol Violation|1|||
161729483|NCT00740779|584051923|FG002|Overall Study|Protocol Violation|1|||
162032205|NCT03404960|585175430|FG000|Overall Study|Adverse Event|0|||
161729484|NCT00740779|584051921|FG000|Overall Study|Lack of Efficacy|0|||
161729485|NCT00740779|584051922|FG001|Overall Study|Lack of Efficacy|0|||
161729486|NCT00740779|584051923|FG002|Overall Study|Lack of Efficacy|2|||
161729487|NCT00740779|584051921|FG000|Overall Study|Withdrawal by Subject|2|||
161729488|NCT00740779|584051922|FG001|Overall Study|Withdrawal by Subject|4|||
161729489|NCT00740779|584051923|FG002|Overall Study|Withdrawal by Subject|2|||
161729490|NCT00740779|584051921|FG000|Overall Study|Lost to Follow-up|2|||
161729491|NCT00740779|584051922|FG001|Overall Study|Lost to Follow-up|3|||
161729492|NCT00740779|584051923|FG002|Overall Study|Lost to Follow-up|5|||
161729493|NCT00988559|584051929|FG000|Overall Study|Withdrawal by Subject|1|||
161729494|NCT00988559|584051930|FG001|Overall Study|Withdrawal by Subject|1|||
161729495|NCT00988559|584051931|FG002|Overall Study|Withdrawal by Subject|0|||
161729496|NCT00988559|584051932|FG003|Overall Study|Withdrawal by Subject|1|||
162032206|NCT03404960|585175431|FG001|Overall Study|Adverse Event|2|||
161729497|NCT00988559|584051929|FG000|Overall Study|Pregnancy|0|||
161729498|NCT00988559|584051930|FG001|Overall Study|Pregnancy|1|||
161729499|NCT00988559|584051931|FG002|Overall Study|Pregnancy|1|||
161729500|NCT00988559|584051932|FG003|Overall Study|Pregnancy|0|||
161729501|NCT00988559|584051929|FG000|Overall Study|Lost to Follow-up|0|||
161729502|NCT00988559|584051930|FG001|Overall Study|Lost to Follow-up|0|||
161729503|NCT00988559|584051931|FG002|Overall Study|Lost to Follow-up|1|||
161729504|NCT00988559|584051932|FG003|Overall Study|Lost to Follow-up|0|||
161729505|NCT01052012|584051933|FG000|Overall Study|Not treated|2|||
161729506|NCT01052012|584051934|FG001|Overall Study|Not treated|5|||
161729507|NCT01052012|584051935|FG002|Overall Study|Not treated|0|||
161729508|NCT01052012|584051936|FG003|Overall Study|Not treated|0|||
161729509|NCT01052012|584051937|FG004|Overall Study|Not treated|11|||
161729510|NCT01052012|584051938|FG005|Overall Study|Not treated|8|||
161729511|NCT01052012|584051933|FG000|Overall Study|Adverse Event|1|||
161729512|NCT01052012|584051934|FG001|Overall Study|Adverse Event|0|||
161729513|NCT01052012|584051935|FG002|Overall Study|Adverse Event|0|||
161729514|NCT01052012|584051936|FG003|Overall Study|Adverse Event|1|||
161729515|NCT01052012|584051937|FG004|Overall Study|Adverse Event|0|||
161729516|NCT01052012|584051938|FG005|Overall Study|Adverse Event|0|||
161729517|NCT01052012|584051933|FG000|Overall Study|Lost to Follow-up|0|||
161729518|NCT01052012|584051934|FG001|Overall Study|Lost to Follow-up|0|||
161729519|NCT01052012|584051935|FG002|Overall Study|Lost to Follow-up|0|||
161729520|NCT01052012|584051936|FG003|Overall Study|Lost to Follow-up|0|||
161729521|NCT01052012|584051937|FG004|Overall Study|Lost to Follow-up|1|||
161729522|NCT01052012|584051938|FG005|Overall Study|Lost to Follow-up|0|||
161729523|NCT01052012|584051933|FG000|Overall Study|Withdrawal by Subject|1|||
161729524|NCT01052012|584051934|FG001|Overall Study|Withdrawal by Subject|1|||
161729525|NCT01052012|584051935|FG002|Overall Study|Withdrawal by Subject|0|||
161729526|NCT01052012|584051936|FG003|Overall Study|Withdrawal by Subject|0|||
161729527|NCT01052012|584051937|FG004|Overall Study|Withdrawal by Subject|3|||
161729528|NCT01052012|584051938|FG005|Overall Study|Withdrawal by Subject|1|||
161729529|NCT01052012|584051933|FG000|Overall Study|Physician Decision|0|||
161729530|NCT01052012|584051934|FG001|Overall Study|Physician Decision|0|||
161729531|NCT01052012|584051935|FG002|Overall Study|Physician Decision|0|||
161729532|NCT01052012|584051936|FG003|Overall Study|Physician Decision|0|||
161729533|NCT01052012|584051937|FG004|Overall Study|Physician Decision|0|||
161729534|NCT01052012|584051938|FG005|Overall Study|Physician Decision|1|||
161729535|NCT01052012|584051933|FG000|Overall Study|Other|0|||
161729536|NCT01052012|584051934|FG001|Overall Study|Other|0|||
161729537|NCT01052012|584051935|FG002|Overall Study|Other|0|||
161729538|NCT01052012|584051936|FG003|Overall Study|Other|0|||
161729539|NCT01052012|584051937|FG004|Overall Study|Other|1|||
161729540|NCT01052012|584051938|FG005|Overall Study|Other|0|||
161729541|NCT00829166|584051942|FG000|Overall Study|Death|305|||
161729542|NCT00829166|584051943|FG001|Overall Study|Death|333|||
161729543|NCT00829166|584051942|FG000|Overall Study|Lost to Follow-up|5|||
161729544|NCT00829166|584051943|FG001|Overall Study|Lost to Follow-up|4|||
161729545|NCT00829166|584051942|FG000|Overall Study|Physician's Decision|4|||
161729546|NCT00829166|584051943|FG001|Overall Study|Physician's Decision|3|||
161729547|NCT00829166|584051942|FG000|Overall Study|Subject's Decision|41|||
161729548|NCT00829166|584051943|FG001|Overall Study|Subject's Decision|55|||
161729549|NCT00829166|584051942|FG000|Overall Study|Sponsor's Decision|137|||
161729550|NCT00829166|584051943|FG001|Overall Study|Sponsor's Decision|98|||
161729551|NCT00829166|584051942|FG000|Overall Study|Reason Not Specified|3|||
161729552|NCT00829166|584051943|FG001|Overall Study|Reason Not Specified|3|||
161729553|NCT02538666|584051944|FG000|Pre-Treatment|Disease progression|1|||
161729554|NCT02538666|584051945|FG001|Pre-Treatment|Disease progression|0|||
161729555|NCT02538666|584051946|FG002|Pre-Treatment|Disease progression|0|||
161729556|NCT02538666|584051944|FG000|Pre-Treatment|no longer meets study criteria|1|||
161729557|NCT02538666|584051945|FG001|Pre-Treatment|no longer meets study criteria|0|||
161729558|NCT02538666|584051946|FG002|Pre-Treatment|no longer meets study criteria|0|||
161729559|NCT02538666|584051944|FG000|Pre-Treatment|Withdrew Consent|0|||
161729560|NCT02538666|584051945|FG001|Pre-Treatment|Withdrew Consent|1|||
161729561|NCT02538666|584051946|FG002|Pre-Treatment|Withdrew Consent|1|||
161729562|NCT02538666|584051944|FG000|Treatment|Disease progression|270|||
161729563|NCT02538666|584051945|FG001|Treatment|Disease progression|227|||
161729564|NCT02538666|584051946|FG002|Treatment|Disease progression|165|||
161729565|NCT02538666|584051944|FG000|Treatment|Study drug toxicity|1|||
161729566|NCT02538666|584051945|FG001|Treatment|Study drug toxicity|29|||
161729567|NCT02538666|584051946|FG002|Treatment|Study drug toxicity|92|||
161729568|NCT02538666|584051944|FG000|Treatment|Death|0|||
161729569|NCT02538666|584051945|FG001|Treatment|Death|2|||
161729570|NCT02538666|584051946|FG002|Treatment|Death|3|||
161729571|NCT02538666|584051944|FG000|Treatment|Adverse event unrelated to study drug|8|||
161729572|NCT02538666|584051945|FG001|Treatment|Adverse event unrelated to study drug|10|||
161729573|NCT02538666|584051946|FG002|Treatment|Adverse event unrelated to study drug|15|||
161729574|NCT02538666|584051944|FG000|Treatment|Participant request to discontinue study treatment|3|||
161729575|NCT02538666|584051945|FG001|Treatment|Participant request to discontinue study treatment|6|||
161729576|NCT02538666|584051946|FG002|Treatment|Participant request to discontinue study treatment|11|||
161729577|NCT02538666|584051944|FG000|Treatment|Participant withdrew consent|2|||
161729578|NCT02538666|584051945|FG001|Treatment|Participant withdrew consent|5|||
161729579|NCT02538666|584051946|FG002|Treatment|Participant withdrew consent|3|||
161838492|NCT05011123|584453434|FG000|Overall Study|Randomized but did not receive vaccination|1|||
161838493|NCT05011123|584453435|FG001|Overall Study|Randomized but did not receive vaccination|0|||
161838494|NCT04221789|584453436|FG000|Overall Study|deviation from protoco|22|||
161838495|NCT04221789|584453437|FG001|Overall Study|deviation from protoco|8|||
161838496|NCT02068092|584453440|FG000|Overall Study|Physician Decision|2|||
161838497|NCT02068092|584453440|FG000|Overall Study|Adverse Event|2|||
161838498|NCT02068092|584453440|FG000|Overall Study|Lost to Follow-up|4|||
161838499|NCT02068092|584453440|FG000|Overall Study|Withdrawal by Subject|2|||
161838500|NCT03502707|584453441|FG000|Overall Study|Adverse Event|0|||
161838501|NCT03502707|584453442|FG001|Overall Study|Adverse Event|0|||
161838502|NCT03502707|584453443|FG002|Overall Study|Adverse Event|0|||
161838503|NCT03502707|584453444|FG003|Overall Study|Adverse Event|0|||
161838504|NCT03502707|584453445|FG004|Overall Study|Adverse Event|0|||
161838505|NCT03502707|584453446|FG005|Overall Study|Adverse Event|0|||
161838506|NCT03502707|584453447|FG006|Overall Study|Adverse Event|0|||
161838507|NCT03502707|584453448|FG007|Overall Study|Adverse Event|0|||
161838508|NCT03502707|584453449|FG008|Overall Study|Adverse Event|0|||
161838509|NCT03502707|584453450|FG009|Overall Study|Adverse Event|0|||
161838510|NCT03502707|584453451|FG010|Overall Study|Adverse Event|0|||
161838511|NCT03502707|584453452|FG011|Overall Study|Adverse Event|0|||
161838512|NCT03502707|584453453|FG012|Overall Study|Adverse Event|0|||
161838513|NCT03502707|584453454|FG013|Overall Study|Adverse Event|0|||
161838514|NCT03502707|584453455|FG014|Overall Study|Adverse Event|0|||
161838515|NCT03502707|584453456|FG015|Overall Study|Adverse Event|1|||
161838516|NCT03502707|584453457|FG016|Overall Study|Adverse Event|5|||
161838517|NCT03502707|584453458|FG017|Overall Study|Adverse Event|0|||
161838518|NCT03502707|584453441|FG000|Overall Study|Death|0|||
161838519|NCT03502707|584453442|FG001|Overall Study|Death|0|||
161838520|NCT03502707|584453443|FG002|Overall Study|Death|0|||
161838521|NCT03502707|584453444|FG003|Overall Study|Death|1|||
161838522|NCT03502707|584453445|FG004|Overall Study|Death|0|||
161838523|NCT03502707|584453446|FG005|Overall Study|Death|0|||
161838524|NCT03502707|584453447|FG006|Overall Study|Death|0|||
161838525|NCT03502707|584453448|FG007|Overall Study|Death|0|||
161838526|NCT03502707|584453449|FG008|Overall Study|Death|1|||
161729580|NCT02538666|584051944|FG000|Treatment|Lost to Follow-up|0|||
161729581|NCT02538666|584051945|FG001|Treatment|Lost to Follow-up|1|||
161729582|NCT02538666|584051946|FG002|Treatment|Lost to Follow-up|1|||
161729583|NCT02538666|584051944|FG000|Treatment|Maximum clinical benefit|4|||
161729584|NCT02538666|584051945|FG001|Treatment|Maximum clinical benefit|3|||
161729585|NCT02538666|584051946|FG002|Treatment|Maximum clinical benefit|4|||
161729586|NCT02538666|584051944|FG000|Treatment|Poor/non-compliance|0|||
161729587|NCT02538666|584051945|FG001|Treatment|Poor/non-compliance|1|||
161729588|NCT02538666|584051946|FG002|Treatment|Poor/non-compliance|0|||
161729589|NCT02538666|584051944|FG000|Treatment|Participant no longer meets study criteria|0|||
161729590|NCT02538666|584051945|FG001|Treatment|Participant no longer meets study criteria|2|||
161729591|NCT02538666|584051946|FG002|Treatment|Participant no longer meets study criteria|0|||
161729592|NCT02538666|584051944|FG000|Treatment|Administrative reason by sponsor|0|||
161729593|NCT02538666|584051945|FG001|Treatment|Administrative reason by sponsor|0|||
161729594|NCT02538666|584051946|FG002|Treatment|Administrative reason by sponsor|1|||
161729595|NCT02538666|584051944|FG000|Treatment|Other reasons|8|||
161729596|NCT02538666|584051945|FG001|Treatment|Other reasons|15|||
161729597|NCT02538666|584051946|FG002|Treatment|Other reasons|5|||
161838527|NCT03502707|584453450|FG009|Overall Study|Death|1|||
161838528|NCT03502707|584453451|FG010|Overall Study|Death|0|||
161838529|NCT03502707|584453452|FG011|Overall Study|Death|0|||
161838530|NCT03502707|584453453|FG012|Overall Study|Death|1|||
161838531|NCT03502707|584453454|FG013|Overall Study|Death|0|||
161729598|NCT02538666|584051944|FG000|Treatment|Not reported|2|||
161729599|NCT02538666|584051945|FG001|Treatment|Not reported|2|||
161838532|NCT03502707|584453455|FG014|Overall Study|Death|0|||
161838533|NCT03502707|584453456|FG015|Overall Study|Death|1|||
161838534|NCT03502707|584453457|FG016|Overall Study|Death|0|||
161838535|NCT03502707|584453458|FG017|Overall Study|Death|0|||
161729600|NCT02538666|584051946|FG002|Treatment|Not reported|2|||
161729601|NCT01465178|584051951|FG000|Overall Study|Withdrawal by Subject|1|||
161729602|NCT01465178|584051952|FG001|Overall Study|Withdrawal by Subject|0|||
161729603|NCT04072146|584051953|FG000|Overall Study|Adverse Event|0|||
161729604|NCT04072146|584051954|FG001|Overall Study|Adverse Event|1|||
161729605|NCT02993224|584051955|FG000|Core Phase - Period 1|Adverse Event|4|||
161838536|NCT03502707|584453441|FG000|Overall Study|Lost to Follow-up|0|||
161838537|NCT03502707|584453442|FG001|Overall Study|Lost to Follow-up|0|||
161838538|NCT03502707|584453443|FG002|Overall Study|Lost to Follow-up|0|||
161838539|NCT03502707|584453444|FG003|Overall Study|Lost to Follow-up|0|||
161838540|NCT03502707|584453445|FG004|Overall Study|Lost to Follow-up|0|||
161838541|NCT03502707|584453446|FG005|Overall Study|Lost to Follow-up|0|||
161838542|NCT03502707|584453447|FG006|Overall Study|Lost to Follow-up|0|||
161838543|NCT03502707|584453448|FG007|Overall Study|Lost to Follow-up|5|||
161838544|NCT03502707|584453449|FG008|Overall Study|Lost to Follow-up|0|||
161838545|NCT03502707|584453450|FG009|Overall Study|Lost to Follow-up|2|||
161838546|NCT03502707|584453451|FG010|Overall Study|Lost to Follow-up|1|||
161729606|NCT02993224|584051955|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
161729607|NCT02993224|584051955|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
161729608|NCT02993224|584051955|FG000|Core Phase- Period 2|Adverse Event|1|||
161729609|NCT02993224|584051955|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
161729610|NCT02993224|584051955|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
161729611|NCT02993224|584051955|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
161729612|NCT02993224|584051955|FG000|Extension Phase|Adverse Event|3|||
161729613|NCT02993224|584051955|FG000|Extension Phase|Withdrawal by Subject|3|||
161729614|NCT02993224|584051955|FG000|Extension Phase|Lost to Follow-up|2|||
161729615|NCT02993224|584051955|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
161729616|NCT00111475|584053556|FG000|Overall Study|Lost to Follow-up|0|||
161729617|NCT00111475|584053557|FG001|Overall Study|Lost to Follow-up|0|||
161729618|NCT00111475|584053558|FG002|Overall Study|Lost to Follow-up|0|||
161729619|NCT00111475|584053559|FG003|Overall Study|Lost to Follow-up|0|||
161729620|NCT00111475|584053560|FG004|Overall Study|Lost to Follow-up|0|||
161729621|NCT00111475|584053561|FG005|Overall Study|Lost to Follow-up|1|||
161729622|NCT00111475|584053562|FG006|Overall Study|Lost to Follow-up|0|||
161729623|NCT00111475|584053563|FG007|Overall Study|Lost to Follow-up|0|||
161729624|NCT00111475|584053564|FG008|Overall Study|Lost to Follow-up|0|||
161729625|NCT00111475|584053565|FG009|Overall Study|Lost to Follow-up|0|||
161729626|NCT01597557|584053569|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
161729627|NCT01597557|584053570|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
161729628|NCT00115349|584053573|FG000|Overall Study|Study closed due to low enrollment.|11|||
161729629|NCT00115349|584053574|FG001|Overall Study|Study closed due to low enrollment.|9|||
161729630|NCT02935634|584053578|FG000|Randomization|Participant withdrew consent|0|||
161729631|NCT02935634|584053579|FG001|Randomization|Participant withdrew consent|1|||
161729632|NCT02935634|584053580|FG002|Randomization|Participant withdrew consent|0|||
161729633|NCT02935634|584053581|FG003|Randomization|Participant withdrew consent|0|||
161729634|NCT02935634|584053582|FG004|Randomization|Participant withdrew consent|0|||
161729635|NCT02935634|584053583|FG005|Randomization|Participant withdrew consent|0|||
161729636|NCT02935634|584053578|FG000|Randomization|Death|2|||
161729637|NCT02935634|584053579|FG001|Randomization|Death|1|||
161729638|NCT02935634|584053580|FG002|Randomization|Death|1|||
161729639|NCT02935634|584053581|FG003|Randomization|Death|0|||
161729640|NCT02935634|584053582|FG004|Randomization|Death|0|||
161729641|NCT02935634|584053583|FG005|Randomization|Death|0|||
161729642|NCT02935634|584053578|FG000|Randomization|Other reasons|0|||
161729643|NCT02935634|584053579|FG001|Randomization|Other reasons|2|||
161729644|NCT02935634|584053580|FG002|Randomization|Other reasons|2|||
161729645|NCT02935634|584053581|FG003|Randomization|Other reasons|0|||
161729646|NCT02935634|584053582|FG004|Randomization|Other reasons|0|||
161729647|NCT02935634|584053583|FG005|Randomization|Other reasons|0|||
161729648|NCT02935634|584053578|FG000|Treatment: Track 1|Disease progression|15|||
161729649|NCT02935634|584053579|FG001|Treatment: Track 1|Disease progression|17|||
161729650|NCT02935634|584053580|FG002|Treatment: Track 1|Disease progression|28|||
161729651|NCT02935634|584053581|FG003|Treatment: Track 1|Disease progression|4|||
161729652|NCT02935634|584053582|FG004|Treatment: Track 1|Disease progression|6|||
161729653|NCT02935634|584053583|FG005|Treatment: Track 1|Disease progression|2|||
161729654|NCT02935634|584053578|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
161729655|NCT02935634|584053579|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
161729656|NCT02935634|584053580|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
161729657|NCT02935634|584053581|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
161729658|NCT02935634|584053582|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
161729659|NCT02935634|584053583|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
161729660|NCT02935634|584053578|FG000|Treatment: Track 1|Lost to Follow-up|1|||
161729661|NCT02935634|584053579|FG001|Treatment: Track 1|Lost to Follow-up|0|||
161729662|NCT02935634|584053580|FG002|Treatment: Track 1|Lost to Follow-up|0|||
161729663|NCT02935634|584053581|FG003|Treatment: Track 1|Lost to Follow-up|0|||
161729664|NCT02935634|584053582|FG004|Treatment: Track 1|Lost to Follow-up|0|||
161729665|NCT02935634|584053583|FG005|Treatment: Track 1|Lost to Follow-up|0|||
161729666|NCT02935634|584053578|FG000|Treatment: Track 1|Study drug toxicity|2|||
161729667|NCT02935634|584053579|FG001|Treatment: Track 1|Study drug toxicity|1|||
161729668|NCT02935634|584053580|FG002|Treatment: Track 1|Study drug toxicity|3|||
161729669|NCT02935634|584053581|FG003|Treatment: Track 1|Study drug toxicity|0|||
161729670|NCT02935634|584053582|FG004|Treatment: Track 1|Study drug toxicity|0|||
161729671|NCT02935634|584053583|FG005|Treatment: Track 1|Study drug toxicity|1|||
161729672|NCT02935634|584053578|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
161729673|NCT02935634|584053579|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
161729674|NCT02935634|584053580|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
161729675|NCT02935634|584053581|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
161729676|NCT02935634|584053582|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
161729677|NCT02935634|584053583|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
161729678|NCT02935634|584053578|FG000|Treatment: Track 1|Participant withdrew consent|2|||
161729679|NCT02935634|584053579|FG001|Treatment: Track 1|Participant withdrew consent|0|||
161729680|NCT02935634|584053580|FG002|Treatment: Track 1|Participant withdrew consent|1|||
161729681|NCT02935634|584053581|FG003|Treatment: Track 1|Participant withdrew consent|0|||
161729682|NCT02935634|584053582|FG004|Treatment: Track 1|Participant withdrew consent|1|||
161729683|NCT02935634|584053583|FG005|Treatment: Track 1|Participant withdrew consent|0|||
161729684|NCT02935634|584053578|FG000|Treatment: Track 1|Other reasons|0|||
161729685|NCT02935634|584053579|FG001|Treatment: Track 1|Other reasons|0|||
161729686|NCT02935634|584053580|FG002|Treatment: Track 1|Other reasons|2|||
161729687|NCT02935634|584053581|FG003|Treatment: Track 1|Other reasons|0|||
161729688|NCT02935634|584053582|FG004|Treatment: Track 1|Other reasons|0|||
161729689|NCT02935634|584053583|FG005|Treatment: Track 1|Other reasons|0|||
161729690|NCT02935634|584053578|FG000|Treatment: Track 2|Disease progression|13|||
161729691|NCT02935634|584053579|FG001|Treatment: Track 2|Disease progression|26|||
161729692|NCT02935634|584053580|FG002|Treatment: Track 2|Disease progression|20|||
161729693|NCT02935634|584053581|FG003|Treatment: Track 2|Disease progression|5|||
161729694|NCT02935634|584053582|FG004|Treatment: Track 2|Disease progression|1|||
161729695|NCT02935634|584053583|FG005|Treatment: Track 2|Disease progression|4|||
161729696|NCT02935634|584053578|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
161729697|NCT02935634|584053579|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
161729698|NCT02935634|584053580|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
161729699|NCT02935634|584053581|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
161729700|NCT02935634|584053582|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
161729701|NCT02935634|584053583|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
161729702|NCT02935634|584053578|FG000|Treatment: Track 2|Study drug toxicity|7|||
161729703|NCT02935634|584053579|FG001|Treatment: Track 2|Study drug toxicity|3|||
161729704|NCT02935634|584053580|FG002|Treatment: Track 2|Study drug toxicity|0|||
161729705|NCT02935634|584053581|FG003|Treatment: Track 2|Study drug toxicity|0|||
161729706|NCT02935634|584053582|FG004|Treatment: Track 2|Study drug toxicity|0|||
161729707|NCT02935634|584053583|FG005|Treatment: Track 2|Study drug toxicity|0|||
161729708|NCT02935634|584053578|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
161729709|NCT02935634|584053579|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
161729710|NCT02935634|584053580|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
161729711|NCT02935634|584053581|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
161729712|NCT02935634|584053582|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
161729713|NCT02935634|584053583|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
161729714|NCT02935634|584053578|FG000|Treatment: Track 2|Participant withdrew consent|0|||
161729715|NCT02935634|584053579|FG001|Treatment: Track 2|Participant withdrew consent|1|||
161729716|NCT02935634|584053580|FG002|Treatment: Track 2|Participant withdrew consent|1|||
161729717|NCT02935634|584053581|FG003|Treatment: Track 2|Participant withdrew consent|0|||
161729718|NCT02935634|584053582|FG004|Treatment: Track 2|Participant withdrew consent|1|||
161729719|NCT02935634|584053583|FG005|Treatment: Track 2|Participant withdrew consent|0|||
161729720|NCT06150573|584053586|FG000|Overall Study|Did not meet study criteria|1|||
161729721|NCT06150573|584053587|FG001|Overall Study|Did not meet study criteria|0|||
161729722|NCT06150573|584053586|FG000|Overall Study|Adverse Event|1|||
161729723|NCT06150573|584053587|FG001|Overall Study|Adverse Event|0|||
161729724|NCT06150573|584053586|FG000|Overall Study|Lost to Follow-up|0|||
161729725|NCT06150573|584053587|FG001|Overall Study|Lost to Follow-up|1|||
161729726|NCT06150573|584053586|FG000|Overall Study|Protocol Violation|0|||
161729727|NCT06150573|584053587|FG001|Overall Study|Protocol Violation|1|||
161729728|NCT06150573|584053586|FG000|Overall Study|Withdrawal by Subject|2|||
161729729|NCT06150573|584053587|FG001|Overall Study|Withdrawal by Subject|0|||
161729730|NCT00210158|584053588|FG000|Overall Study|Protocol Violation|0|||
161729731|NCT00210158|584053589|FG001|Overall Study|Protocol Violation|2|||
161729732|NCT02284906|584053594|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161729733|NCT02284906|584053595|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
161729734|NCT02284906|584053596|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161729735|NCT02284906|584053594|FG000|Overall Study|Major Protocol Deviation|0|||
161729736|NCT02284906|584053595|FG001|Overall Study|Major Protocol Deviation|1|||
161729737|NCT02284906|584053596|FG002|Overall Study|Major Protocol Deviation|0|||
161729738|NCT02284906|584053594|FG000|Overall Study|Voluntary Withdrawal|2|||
161729739|NCT02284906|584053595|FG001|Overall Study|Voluntary Withdrawal|4|||
161729740|NCT02284906|584053596|FG002|Overall Study|Voluntary Withdrawal|5|||
161729741|NCT02284906|584053594|FG000|Overall Study|Study Termination|0|||
161729742|NCT02284906|584053595|FG001|Overall Study|Study Termination|11|||
161729743|NCT02284906|584053596|FG002|Overall Study|Study Termination|14|||
161729744|NCT02284906|584053594|FG000|Overall Study|Reason not Specified|1|||
161729745|NCT02284906|584053595|FG001|Overall Study|Reason not Specified|1|||
161729746|NCT02284906|584053596|FG002|Overall Study|Reason not Specified|0|||
161729747|NCT01409031|584053597|FG000|Overall Study|transferred to other hosp|1|||
161729748|NCT01409031|584053598|FG001|Overall Study|transferred to other hosp|0|||
161729749|NCT00995345|584053599|FG000|Overall Study|Withdrawal by Subject|4|||
161729750|NCT00995345|584053600|FG001|Overall Study|Withdrawal by Subject|2|||
161729751|NCT00995345|584053601|FG002|Overall Study|Withdrawal by Subject|1|||
161729752|NCT00995345|584053602|FG003|Overall Study|Withdrawal by Subject|3|||
161729753|NCT00995345|584053603|FG004|Overall Study|Withdrawal by Subject|1|||
161729754|NCT00995345|584053599|FG000|Overall Study|Adverse Event|3|||
161729755|NCT00995345|584053600|FG001|Overall Study|Adverse Event|1|||
161729756|NCT00995345|584053601|FG002|Overall Study|Adverse Event|2|||
161729757|NCT00995345|584053602|FG003|Overall Study|Adverse Event|0|||
161729758|NCT00995345|584053603|FG004|Overall Study|Adverse Event|1|||
161729759|NCT00995345|584053599|FG000|Overall Study|Lost to Follow-up|2|||
161729760|NCT00995345|584053600|FG001|Overall Study|Lost to Follow-up|2|||
161729761|NCT00995345|584053601|FG002|Overall Study|Lost to Follow-up|2|||
161729762|NCT00995345|584053602|FG003|Overall Study|Lost to Follow-up|1|||
161729763|NCT00995345|584053603|FG004|Overall Study|Lost to Follow-up|0|||
161729764|NCT00995345|584053599|FG000|Overall Study|all other reasons combined|2|||
161729765|NCT00995345|584053600|FG001|Overall Study|all other reasons combined|2|||
161729766|NCT00995345|584053601|FG002|Overall Study|all other reasons combined|2|||
161729767|NCT00995345|584053602|FG003|Overall Study|all other reasons combined|1|||
161729768|NCT00995345|584053603|FG004|Overall Study|all other reasons combined|3|||
161729769|NCT03885726|584053605|FG000|Overall Study|Staffing issues/lost interest|1|||
161729770|NCT03885726|584053605|FG000|Overall Study|Early discharge from hospital|3|||
161729771|NCT02702193|584053606|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
161729772|NCT02702193|584053607|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
161729773|NCT02702193|584053606|FG000|4 Month Follow up|Withdrawal by Subject|1|||
161729774|NCT02702193|584053607|FG001|4 Month Follow up|Withdrawal by Subject|0|||
161729775|NCT02702193|584053606|FG000|4 Month Follow up|Lost to Follow-up|17|||
161729776|NCT02702193|584053607|FG001|4 Month Follow up|Lost to Follow-up|18|||
161729777|NCT02702193|584053606|FG000|8 Month Follow up|Withdrawal by Subject|1|||
161729778|NCT02702193|584053607|FG001|8 Month Follow up|Withdrawal by Subject|0|||
161729779|NCT02702193|584053606|FG000|8 Month Follow up|Lost to Follow-up|14|||
161729780|NCT02702193|584053607|FG001|8 Month Follow up|Lost to Follow-up|18|||
161729781|NCT02702193|584053606|FG000|12 Month Follow up|Withdrawal by Subject|1|||
161729782|NCT02702193|584053607|FG001|12 Month Follow up|Withdrawal by Subject|0|||
161729783|NCT02702193|584053606|FG000|12 Month Follow up|Lost to Follow-up|16|||
161729784|NCT02702193|584053607|FG001|12 Month Follow up|Lost to Follow-up|18|||
161729785|NCT04056455|584053609|FG000|Overall Study|Adverse Event|1|||
161729786|NCT04056455|584053610|FG001|Overall Study|Adverse Event|0|||
161729787|NCT02512068|584053611|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
161729788|NCT02512068|584053612|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
161729789|NCT02512068|584053611|FG000|Overall Study|Major Protocol Deviation|1|||
161729790|NCT02512068|584053612|FG001|Overall Study|Major Protocol Deviation|0|||
161729791|NCT02512068|584053611|FG000|Overall Study|Voluntary Withdrawal|0|||
161729792|NCT02512068|584053612|FG001|Overall Study|Voluntary Withdrawal|1|||
161729793|NCT02512068|584053611|FG000|Overall Study|Lack of Efficacy|0|||
161729794|NCT02512068|584053612|FG001|Overall Study|Lack of Efficacy|1|||
161729795|NCT02512068|584053611|FG000|Overall Study|Reason Not Specified|3|||
161729796|NCT02512068|584053612|FG001|Overall Study|Reason Not Specified|5|||
161729797|NCT03521687|584053614|FG000|Overall Study|Adverse Event|4|||
161729798|NCT03521687|584053614|FG000|Overall Study|Physician Decision|1|||
161729799|NCT01276457|584053620|FG000|Core Study|Adverse Event|6|||
161729800|NCT01276457|584053621|FG001|Core Study|Adverse Event|3|||
161729801|NCT01276457|584053620|FG000|Core Study|Lost to Follow-up|1|||
161729802|NCT01276457|584053621|FG001|Core Study|Lost to Follow-up|2|||
161729803|NCT01276457|584053620|FG000|Core Study|Administrative problems|1|||
161729804|NCT01276457|584053621|FG001|Core Study|Administrative problems|1|||
161729805|NCT01276457|584053620|FG000|Core Study|Death|2|||
161729806|NCT01276457|584053621|FG001|Core Study|Death|2|||
161729807|NCT01276457|584053620|FG000|Core Study|Lack of Efficacy|3|||
161729808|NCT01276457|584053621|FG001|Core Study|Lack of Efficacy|12|||
161729809|NCT01276457|584053620|FG000|Extension Study|Lost to Follow-up|3|||
161729810|NCT01276457|584053621|FG001|Extension Study|Lost to Follow-up|0|||
161729811|NCT01276457|584053620|FG000|Extension Study|Death|0|||
161729812|NCT01276457|584053621|FG001|Extension Study|Death|1|||
161729813|NCT01276457|584053620|FG000|Extension Study|Lack of Efficacy|3|||
161729814|NCT01276457|584053621|FG001|Extension Study|Lack of Efficacy|1|||
161729815|NCT04891770|584053626|FG000|Overall Study|Withdrew consent|1|||
161729816|NCT04891770|584053627|FG001|Overall Study|Withdrew consent|3|||
161729817|NCT04891770|584053628|FG002|Overall Study|Withdrew consent|0|||
161729818|NCT04891770|584053626|FG000|Overall Study|Enrolled but never treated|0|||
161729819|NCT04891770|584053627|FG001|Overall Study|Enrolled but never treated|0|||
161729820|NCT04891770|584053628|FG002|Overall Study|Enrolled but never treated|1|||
161729821|NCT04891770|584053626|FG000|Overall Study|Investigator's discretion|0|||
161729822|NCT04891770|584053627|FG001|Overall Study|Investigator's discretion|1|||
161729823|NCT04891770|584053628|FG002|Overall Study|Investigator's discretion|0|||
161729824|NCT05122650|584053629|FG000|Overall Study|Adverse Event|4|||
161729825|NCT05122650|584053630|FG001|Overall Study|Adverse Event|16|||
161729826|NCT05122650|584053631|FG002|Overall Study|Adverse Event|11|||
161729827|NCT05122650|584053632|FG003|Overall Study|Adverse Event|12|||
161729828|NCT05122650|584053629|FG000|Overall Study|Lack of Efficacy|0|||
161729829|NCT05122650|584053630|FG001|Overall Study|Lack of Efficacy|1|||
162032207|NCT03404960|585175430|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
162032208|NCT03404960|585175431|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
162032209|NCT03404960|585175430|FG000|Overall Study|Bowel obstruction|0|||
162032210|NCT03404960|585175431|FG001|Overall Study|Bowel obstruction|1|||
162032211|NCT03404960|585175430|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
162032212|NCT03404960|585175431|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
162032213|NCT06460493|585175434|FG000|Overall Study|Withdrawal by Subject|2|||
162032214|NCT00075270|585175439|FG000|Overall Study|Withdrawal by Subject|28|||
161729830|NCT05122650|584053631|FG002|Overall Study|Lack of Efficacy|1|||
161729831|NCT05122650|584053632|FG003|Overall Study|Lack of Efficacy|2|||
161729832|NCT05122650|584053629|FG000|Overall Study|Lost to Follow-up|1|||
161729833|NCT05122650|584053630|FG001|Overall Study|Lost to Follow-up|1|||
161729834|NCT05122650|584053631|FG002|Overall Study|Lost to Follow-up|3|||
161729835|NCT05122650|584053632|FG003|Overall Study|Lost to Follow-up|0|||
161729836|NCT05122650|584053629|FG000|Overall Study|Non-compliance with study intervention|0|||
161729837|NCT05122650|584053630|FG001|Overall Study|Non-compliance with study intervention|0|||
161729838|NCT05122650|584053631|FG002|Overall Study|Non-compliance with study intervention|0|||
161729839|NCT05122650|584053632|FG003|Overall Study|Non-compliance with study intervention|2|||
161729840|NCT05122650|584053629|FG000|Overall Study|Protocol Violation|0|||
161729841|NCT05122650|584053630|FG001|Overall Study|Protocol Violation|1|||
161729842|NCT05122650|584053631|FG002|Overall Study|Protocol Violation|0|||
161729843|NCT05122650|584053632|FG003|Overall Study|Protocol Violation|1|||
161729844|NCT05122650|584053629|FG000|Overall Study|Randomized by mistake|0|||
161729845|NCT05122650|584053630|FG001|Overall Study|Randomized by mistake|0|||
161729846|NCT05122650|584053631|FG002|Overall Study|Randomized by mistake|3|||
161729847|NCT05122650|584053632|FG003|Overall Study|Randomized by mistake|2|||
161729848|NCT05122650|584053629|FG000|Overall Study|Sponsor request|0|||
161729849|NCT05122650|584053630|FG001|Overall Study|Sponsor request|1|||
161729850|NCT05122650|584053631|FG002|Overall Study|Sponsor request|1|||
161729851|NCT05122650|584053632|FG003|Overall Study|Sponsor request|2|||
161729852|NCT05122650|584053629|FG000|Overall Study|Withdrawal by Subject|3|||
161729853|NCT05122650|584053630|FG001|Overall Study|Withdrawal by Subject|7|||
161729854|NCT05122650|584053631|FG002|Overall Study|Withdrawal by Subject|4|||
161729855|NCT05122650|584053632|FG003|Overall Study|Withdrawal by Subject|8|||
161729856|NCT05122650|584053629|FG000|Overall Study|Other|5|||
161729857|NCT05122650|584053630|FG001|Overall Study|Other|0|||
161729858|NCT05122650|584053631|FG002|Overall Study|Other|0|||
161729859|NCT05122650|584053632|FG003|Overall Study|Other|0|||
161729860|NCT03280550|584053636|FG000|Overall Study|Withdrawal by Subject|2|||
161729861|NCT03280550|584053637|FG001|Overall Study|Withdrawal by Subject|2|||
161729862|NCT03280550|584053636|FG000|Overall Study|Physician Decision|0|||
161729863|NCT03280550|584053637|FG001|Overall Study|Physician Decision|1|||
161729864|NCT01318083|584053638|FG000|Overall Study|Adverse Event|4|||
161729865|NCT01318083|584053639|FG001|Overall Study|Adverse Event|1|||
161729866|NCT01318083|584053640|FG002|Overall Study|Adverse Event|2|||
161729867|NCT01318083|584053638|FG000|Overall Study|Withdrawal by Subject|1|||
161729868|NCT01318083|584053639|FG001|Overall Study|Withdrawal by Subject|0|||
161729869|NCT01318083|584053640|FG002|Overall Study|Withdrawal by Subject|2|||
161729870|NCT01318083|584053638|FG000|Overall Study|Lack of Efficacy|0|||
161729871|NCT01318083|584053639|FG001|Overall Study|Lack of Efficacy|0|||
161729872|NCT01318083|584053640|FG002|Overall Study|Lack of Efficacy|1|||
161729873|NCT01318083|584053638|FG000|Overall Study|Treatment Complications|1|||
161729874|NCT01318083|584053639|FG001|Overall Study|Treatment Complications|0|||
161729875|NCT01318083|584053640|FG002|Overall Study|Treatment Complications|0|||
161729876|NCT01318083|584053638|FG000|Overall Study|Lack of Study Medication Compliance|0|||
161729877|NCT01318083|584053639|FG001|Overall Study|Lack of Study Medication Compliance|1|||
161729878|NCT01318083|584053640|FG002|Overall Study|Lack of Study Medication Compliance|0|||
161729879|NCT05896761|584053641|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
161729880|NCT05896761|584053642|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
161729881|NCT05896761|584053641|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
161729882|NCT05896761|584053642|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
161729883|NCT02028338|584053645|FG000|Overall Study|Withdrawal by Subject|3|||
161729884|NCT02028338|584053646|FG001|Overall Study|Withdrawal by Subject|1|||
161729885|NCT02028338|584053645|FG000|Overall Study|Unable to contact participant|1|||
161729886|NCT02028338|584053646|FG001|Overall Study|Unable to contact participant|0|||
161729887|NCT03552549|584053648|FG000|Overall Study|Disease progression|25|||
161729888|NCT03552549|584053649|FG001|Overall Study|Disease progression|17|||
161729889|NCT03552549|584053648|FG000|Overall Study|Adverse event in first 12 months|12|||
161729890|NCT03552549|584053649|FG001|Overall Study|Adverse event in first 12 months|8|||
161729891|NCT03552549|584053648|FG000|Overall Study|Withdrawal by Subject|7|||
161729892|NCT03552549|584053649|FG001|Overall Study|Withdrawal by Subject|7|||
162032215|NCT00075270|585175440|FG001|Overall Study|Withdrawal by Subject|21|||
161729893|NCT03552549|584053648|FG000|Overall Study|Unknown (no reason provided)|4|||
161729894|NCT03552549|584053649|FG001|Overall Study|Unknown (no reason provided)|2|||
161838547|NCT03502707|584453452|FG011|Overall Study|Lost to Follow-up|2|||
161838548|NCT03502707|584453453|FG012|Overall Study|Lost to Follow-up|1|||
161838549|NCT03502707|584453454|FG013|Overall Study|Lost to Follow-up|1|||
161838550|NCT03502707|584453455|FG014|Overall Study|Lost to Follow-up|0|||
161838551|NCT03502707|584453456|FG015|Overall Study|Lost to Follow-up|4|||
161838552|NCT03502707|584453457|FG016|Overall Study|Lost to Follow-up|9|||
161838553|NCT03502707|584453458|FG017|Overall Study|Lost to Follow-up|2|||
161838554|NCT03502707|584453441|FG000|Overall Study|Physician Decision|0|||
161838555|NCT03502707|584453442|FG001|Overall Study|Physician Decision|0|||
161838556|NCT03502707|584453443|FG002|Overall Study|Physician Decision|0|||
161838557|NCT03502707|584453444|FG003|Overall Study|Physician Decision|0|||
161838558|NCT03502707|584453445|FG004|Overall Study|Physician Decision|0|||
161838559|NCT03502707|584453446|FG005|Overall Study|Physician Decision|0|||
161838560|NCT03502707|584453447|FG006|Overall Study|Physician Decision|0|||
161838561|NCT03502707|584453448|FG007|Overall Study|Physician Decision|0|||
161838562|NCT03502707|584453449|FG008|Overall Study|Physician Decision|2|||
161838563|NCT03502707|584453450|FG009|Overall Study|Physician Decision|1|||
161838564|NCT03502707|584453451|FG010|Overall Study|Physician Decision|0|||
161838565|NCT03502707|584453452|FG011|Overall Study|Physician Decision|0|||
161838566|NCT03502707|584453453|FG012|Overall Study|Physician Decision|0|||
161838567|NCT03502707|584453454|FG013|Overall Study|Physician Decision|0|||
161838568|NCT03502707|584453455|FG014|Overall Study|Physician Decision|1|||
161838569|NCT03502707|584453456|FG015|Overall Study|Physician Decision|3|||
161838570|NCT03502707|584453457|FG016|Overall Study|Physician Decision|0|||
161838571|NCT03502707|584453458|FG017|Overall Study|Physician Decision|0|||
161838572|NCT03502707|584453441|FG000|Overall Study|Protocol Violation|0|||
161838573|NCT03502707|584453442|FG001|Overall Study|Protocol Violation|0|||
161838574|NCT03502707|584453443|FG002|Overall Study|Protocol Violation|0|||
161838575|NCT03502707|584453444|FG003|Overall Study|Protocol Violation|0|||
161838576|NCT03502707|584453445|FG004|Overall Study|Protocol Violation|0|||
161838577|NCT03502707|584453446|FG005|Overall Study|Protocol Violation|0|||
161838578|NCT03502707|584453447|FG006|Overall Study|Protocol Violation|0|||
161838579|NCT03502707|584453448|FG007|Overall Study|Protocol Violation|0|||
161838580|NCT03502707|584453449|FG008|Overall Study|Protocol Violation|0|||
161838581|NCT03502707|584453450|FG009|Overall Study|Protocol Violation|0|||
161838582|NCT03502707|584453451|FG010|Overall Study|Protocol Violation|0|||
161838583|NCT03502707|584453452|FG011|Overall Study|Protocol Violation|0|||
161838584|NCT03502707|584453453|FG012|Overall Study|Protocol Violation|0|||
161838585|NCT03502707|584453454|FG013|Overall Study|Protocol Violation|0|||
161729895|NCT03552549|584053648|FG000|Overall Study|Not in participant's best interest|2|||
161729896|NCT03552549|584053649|FG001|Overall Study|Not in participant's best interest|1|||
161729897|NCT03552549|584053648|FG000|Overall Study|Did not complete study treatment|2|||
161729898|NCT03552549|584053649|FG001|Overall Study|Did not complete study treatment|3|||
161729899|NCT03552549|584053648|FG000|Overall Study|Did not meet eligibility criteria|1|||
161729900|NCT03552549|584053649|FG001|Overall Study|Did not meet eligibility criteria|0|||
161729901|NCT03552549|584053648|FG000|Overall Study|Administrative|0|||
161729902|NCT03552549|584053649|FG001|Overall Study|Administrative|14|||
161729903|NCT02761993|584053658|FG000|Overall Study|Adverse Event|0|||
161729904|NCT02761993|584053659|FG001|Overall Study|Adverse Event|2|||
161729905|NCT02761993|584053660|FG002|Overall Study|Adverse Event|0|||
161729906|NCT02761993|584053658|FG000|Overall Study|Lost to Follow-up|1|||
161729907|NCT02761993|584053659|FG001|Overall Study|Lost to Follow-up|3|||
161729908|NCT02761993|584053660|FG002|Overall Study|Lost to Follow-up|2|||
161729909|NCT02761993|584053658|FG000|Overall Study|Withdrawal by Subject|1|||
161729910|NCT02761993|584053659|FG001|Overall Study|Withdrawal by Subject|1|||
161729911|NCT02761993|584053660|FG002|Overall Study|Withdrawal by Subject|2|||
161729912|NCT00256867|584053661|FG000|Overall Study|Adverse Event|0|||
161729913|NCT00256867|584053662|FG001|Overall Study|Adverse Event|1|||
161729914|NCT00256867|584053663|FG002|Overall Study|Adverse Event|1|||
161729915|NCT00256867|584053664|FG003|Overall Study|Adverse Event|1|||
161729916|NCT00256867|584053665|FG004|Overall Study|Adverse Event|2|||
161838586|NCT03502707|584453455|FG014|Overall Study|Protocol Violation|0|||
161838587|NCT03502707|584453456|FG015|Overall Study|Protocol Violation|1|||
161838588|NCT03502707|584453457|FG016|Overall Study|Protocol Violation|0|||
161838589|NCT03502707|584453458|FG017|Overall Study|Protocol Violation|0|||
161838590|NCT03502707|584453441|FG000|Overall Study|Withdrawal by Subject|1|||
161729917|NCT00256867|584053666|FG005|Overall Study|Adverse Event|2|||
161838591|NCT03502707|584453442|FG001|Overall Study|Withdrawal by Subject|1|||
161838592|NCT03502707|584453443|FG002|Overall Study|Withdrawal by Subject|0|||
161838593|NCT03502707|584453444|FG003|Overall Study|Withdrawal by Subject|0|||
161838594|NCT03502707|584453445|FG004|Overall Study|Withdrawal by Subject|0|||
161838595|NCT03502707|584453446|FG005|Overall Study|Withdrawal by Subject|2|||
161729918|NCT00256867|584053667|FG006|Overall Study|Adverse Event|1|||
161729919|NCT00256867|584053668|FG007|Overall Study|Adverse Event|4|||
162032216|NCT00075270|585175439|FG000|Overall Study|Lost to Follow-up|25|||
161729920|NCT00256867|584053661|FG000|Overall Study|Lost to Follow-up|2|||
161838596|NCT03502707|584453447|FG006|Overall Study|Withdrawal by Subject|0|||
161838597|NCT03502707|584453448|FG007|Overall Study|Withdrawal by Subject|3|||
161838598|NCT03502707|584453449|FG008|Overall Study|Withdrawal by Subject|1|||
161838599|NCT03502707|584453450|FG009|Overall Study|Withdrawal by Subject|2|||
161838600|NCT03502707|584453451|FG010|Overall Study|Withdrawal by Subject|12|||
161838601|NCT03502707|584453452|FG011|Overall Study|Withdrawal by Subject|23|||
161838602|NCT03502707|584453453|FG012|Overall Study|Withdrawal by Subject|5|||
161838603|NCT03502707|584453454|FG013|Overall Study|Withdrawal by Subject|3|||
161838604|NCT03502707|584453455|FG014|Overall Study|Withdrawal by Subject|3|||
161838605|NCT03502707|584453456|FG015|Overall Study|Withdrawal by Subject|43|||
161838606|NCT03502707|584453457|FG016|Overall Study|Withdrawal by Subject|44|||
161838607|NCT03502707|584453458|FG017|Overall Study|Withdrawal by Subject|18|||
161838608|NCT03502707|584453441|FG000|Overall Study|Sponsor's Decision|1|||
161838609|NCT03502707|584453442|FG001|Overall Study|Sponsor's Decision|0|||
161838610|NCT03502707|584453443|FG002|Overall Study|Sponsor's Decision|0|||
161838611|NCT03502707|584453444|FG003|Overall Study|Sponsor's Decision|0|||
161838612|NCT03502707|584453445|FG004|Overall Study|Sponsor's Decision|0|||
161838613|NCT03502707|584453446|FG005|Overall Study|Sponsor's Decision|0|||
161838614|NCT03502707|584453447|FG006|Overall Study|Sponsor's Decision|0|||
161838615|NCT03502707|584453448|FG007|Overall Study|Sponsor's Decision|0|||
161838616|NCT03502707|584453449|FG008|Overall Study|Sponsor's Decision|0|||
161838617|NCT03502707|584453450|FG009|Overall Study|Sponsor's Decision|1|||
161838618|NCT03502707|584453451|FG010|Overall Study|Sponsor's Decision|0|||
161838619|NCT03502707|584453452|FG011|Overall Study|Sponsor's Decision|0|||
161838620|NCT03502707|584453453|FG012|Overall Study|Sponsor's Decision|0|||
161838621|NCT03502707|584453454|FG013|Overall Study|Sponsor's Decision|0|||
161838622|NCT03502707|584453455|FG014|Overall Study|Sponsor's Decision|0|||
161838623|NCT03502707|584453456|FG015|Overall Study|Sponsor's Decision|2|||
161838624|NCT03502707|584453457|FG016|Overall Study|Sponsor's Decision|1|||
161838625|NCT03502707|584453458|FG017|Overall Study|Sponsor's Decision|0|||
161838626|NCT03502707|584453441|FG000|Overall Study|Initiated Prohibited Medication|0|||
161838627|NCT03502707|584453442|FG001|Overall Study|Initiated Prohibited Medication|0|||
161838628|NCT03502707|584453443|FG002|Overall Study|Initiated Prohibited Medication|0|||
161838629|NCT03502707|584453444|FG003|Overall Study|Initiated Prohibited Medication|0|||
161838630|NCT03502707|584453445|FG004|Overall Study|Initiated Prohibited Medication|0|||
161838631|NCT03502707|584453446|FG005|Overall Study|Initiated Prohibited Medication|0|||
161838632|NCT03502707|584453447|FG006|Overall Study|Initiated Prohibited Medication|0|||
161838633|NCT03502707|584453448|FG007|Overall Study|Initiated Prohibited Medication|0|||
161838634|NCT03502707|584453449|FG008|Overall Study|Initiated Prohibited Medication|0|||
161838635|NCT03502707|584453450|FG009|Overall Study|Initiated Prohibited Medication|0|||
161838636|NCT03502707|584453451|FG010|Overall Study|Initiated Prohibited Medication|0|||
161838637|NCT03502707|584453452|FG011|Overall Study|Initiated Prohibited Medication|0|||
161838638|NCT03502707|584453453|FG012|Overall Study|Initiated Prohibited Medication|0|||
161838639|NCT03502707|584453454|FG013|Overall Study|Initiated Prohibited Medication|0|||
161838640|NCT03502707|584453455|FG014|Overall Study|Initiated Prohibited Medication|0|||
161838641|NCT03502707|584453456|FG015|Overall Study|Initiated Prohibited Medication|0|||
161838642|NCT03502707|584453457|FG016|Overall Study|Initiated Prohibited Medication|1|||
161729921|NCT00256867|584053662|FG001|Overall Study|Lost to Follow-up|2|||
161729922|NCT00256867|584053663|FG002|Overall Study|Lost to Follow-up|2|||
161729923|NCT00256867|584053664|FG003|Overall Study|Lost to Follow-up|3|||
161729924|NCT00256867|584053665|FG004|Overall Study|Lost to Follow-up|2|||
161729925|NCT00256867|584053666|FG005|Overall Study|Lost to Follow-up|0|||
161729926|NCT00256867|584053667|FG006|Overall Study|Lost to Follow-up|1|||
161729927|NCT00256867|584053668|FG007|Overall Study|Lost to Follow-up|2|||
161729928|NCT00256867|584053661|FG000|Overall Study|Protocol Violation|0|||
161729929|NCT00256867|584053662|FG001|Overall Study|Protocol Violation|0|||
161729930|NCT00256867|584053663|FG002|Overall Study|Protocol Violation|0|||
161729931|NCT00256867|584053664|FG003|Overall Study|Protocol Violation|1|||
161729932|NCT00256867|584053665|FG004|Overall Study|Protocol Violation|0|||
161729933|NCT00256867|584053666|FG005|Overall Study|Protocol Violation|1|||
161729934|NCT00256867|584053667|FG006|Overall Study|Protocol Violation|0|||
161729935|NCT00256867|584053668|FG007|Overall Study|Protocol Violation|1|||
161729936|NCT00256867|584053661|FG000|Overall Study|Withdrawal by Subject|0|||
161729937|NCT00256867|584053662|FG001|Overall Study|Withdrawal by Subject|0|||
161838643|NCT03502707|584453458|FG017|Overall Study|Initiated Prohibited Medication|0|||
161838644|NCT03502707|584453441|FG000|Overall Study|Other|0|||
161838645|NCT03502707|584453442|FG001|Overall Study|Other|0|||
161838646|NCT03502707|584453443|FG002|Overall Study|Other|0|||
161838647|NCT03502707|584453444|FG003|Overall Study|Other|0|||
161838648|NCT03502707|584453445|FG004|Overall Study|Other|0|||
161838649|NCT03502707|584453446|FG005|Overall Study|Other|0|||
161729938|NCT00256867|584053663|FG002|Overall Study|Withdrawal by Subject|1|||
161838650|NCT03502707|584453447|FG006|Overall Study|Other|0|||
161838651|NCT03502707|584453448|FG007|Overall Study|Other|0|||
161838652|NCT03502707|584453449|FG008|Overall Study|Other|1|||
161838653|NCT03502707|584453450|FG009|Overall Study|Other|1|||
161838654|NCT03502707|584453451|FG010|Overall Study|Other|2|||
161729939|NCT00256867|584053664|FG003|Overall Study|Withdrawal by Subject|1|||
161729940|NCT00256867|584053665|FG004|Overall Study|Withdrawal by Subject|2|||
161729941|NCT00256867|584053666|FG005|Overall Study|Withdrawal by Subject|2|||
161729942|NCT00256867|584053667|FG006|Overall Study|Withdrawal by Subject|3|||
161729943|NCT00256867|584053668|FG007|Overall Study|Withdrawal by Subject|2|||
161729944|NCT00256867|584053661|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729945|NCT00256867|584053662|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
161729946|NCT00256867|584053663|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729947|NCT00256867|584053664|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729948|NCT00256867|584053665|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729949|NCT00256867|584053666|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729950|NCT00256867|584053667|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729951|NCT00256867|584053668|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161729952|NCT00256867|584053661|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729953|NCT00256867|584053662|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729954|NCT00256867|584053663|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729955|NCT00256867|584053664|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729956|NCT00256867|584053665|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729957|NCT00256867|584053666|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729958|NCT00256867|584053667|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161729959|NCT00256867|584053668|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
161729960|NCT00256867|584053661|FG000|Overall Study|Investigator's Decision|0|||
161729961|NCT00256867|584053662|FG001|Overall Study|Investigator's Decision|0|||
161729962|NCT00256867|584053663|FG002|Overall Study|Investigator's Decision|0|||
161729963|NCT00256867|584053664|FG003|Overall Study|Investigator's Decision|0|||
161729964|NCT00256867|584053665|FG004|Overall Study|Investigator's Decision|1|||
161729965|NCT00256867|584053666|FG005|Overall Study|Investigator's Decision|0|||
161729966|NCT00256867|584053667|FG006|Overall Study|Investigator's Decision|0|||
161729967|NCT00256867|584053668|FG007|Overall Study|Investigator's Decision|0|||
161729968|NCT00256867|584053661|FG000|Overall Study|Non-compliance with study medication|0|||
161729969|NCT00256867|584053662|FG001|Overall Study|Non-compliance with study medication|0|||
161729970|NCT00256867|584053663|FG002|Overall Study|Non-compliance with study medication|0|||
161729971|NCT00256867|584053664|FG003|Overall Study|Non-compliance with study medication|0|||
161729972|NCT00256867|584053665|FG004|Overall Study|Non-compliance with study medication|0|||
161729973|NCT00256867|584053666|FG005|Overall Study|Non-compliance with study medication|0|||
161729974|NCT00256867|584053667|FG006|Overall Study|Non-compliance with study medication|0|||
161729975|NCT00256867|584053668|FG007|Overall Study|Non-compliance with study medication|1|||
161729976|NCT00256867|584053661|FG000|Overall Study|Participant travelled Overseas|0|||
161729977|NCT00256867|584053662|FG001|Overall Study|Participant travelled Overseas|1|||
161729978|NCT00256867|584053663|FG002|Overall Study|Participant travelled Overseas|0|||
161729979|NCT00256867|584053664|FG003|Overall Study|Participant travelled Overseas|0|||
161729980|NCT00256867|584053665|FG004|Overall Study|Participant travelled Overseas|0|||
161729981|NCT00256867|584053666|FG005|Overall Study|Participant travelled Overseas|0|||
161729982|NCT00256867|584053667|FG006|Overall Study|Participant travelled Overseas|0|||
161729983|NCT00256867|584053668|FG007|Overall Study|Participant travelled Overseas|0|||
161729984|NCT00256867|584053661|FG000|Overall Study|Participant out of assessment window|0|||
161729985|NCT00256867|584053662|FG001|Overall Study|Participant out of assessment window|0|||
161729986|NCT00256867|584053663|FG002|Overall Study|Participant out of assessment window|1|||
161729987|NCT00256867|584053664|FG003|Overall Study|Participant out of assessment window|0|||
161729988|NCT00256867|584053665|FG004|Overall Study|Participant out of assessment window|0|||
161729989|NCT00256867|584053666|FG005|Overall Study|Participant out of assessment window|0|||
161729990|NCT00256867|584053667|FG006|Overall Study|Participant out of assessment window|0|||
161729991|NCT00256867|584053668|FG007|Overall Study|Participant out of assessment window|0|||
161729992|NCT00256867|584053661|FG000|Overall Study|Withdrawal by participant|0|||
161729993|NCT00256867|584053662|FG001|Overall Study|Withdrawal by participant|0|||
161729994|NCT00256867|584053663|FG002|Overall Study|Withdrawal by participant|0|||
161729995|NCT00256867|584053664|FG003|Overall Study|Withdrawal by participant|0|||
161729996|NCT00256867|584053665|FG004|Overall Study|Withdrawal by participant|0|||
161729997|NCT00256867|584053666|FG005|Overall Study|Withdrawal by participant|1|||
161729998|NCT00256867|584053667|FG006|Overall Study|Withdrawal by participant|0|||
161729999|NCT00256867|584053668|FG007|Overall Study|Withdrawal by participant|0|||
161730000|NCT00527111|584053673|FG000|Overall Study|Adverse Event|14|||
161730001|NCT00527111|584053674|FG001|Overall Study|Adverse Event|13|||
161730002|NCT00527111|584053673|FG000|Overall Study|Death|0|||
161730003|NCT00527111|584053674|FG001|Overall Study|Death|1|||
161730004|NCT00527111|584053673|FG000|Overall Study|Investigator Request|2|||
161730005|NCT00527111|584053674|FG001|Overall Study|Investigator Request|1|||
161730006|NCT00527111|584053673|FG000|Overall Study|Patient Request|2|||
161730007|NCT00527111|584053674|FG001|Overall Study|Patient Request|5|||
161730008|NCT00527111|584053673|FG000|Overall Study|Other|2|||
161730009|NCT00527111|584053674|FG001|Overall Study|Other|2|||
161730010|NCT01930799|584053678|FG000|Overall Study|Withdrawal by Subject|3|||
161730011|NCT01930799|584053678|FG000|Overall Study|Lost to Follow-up|5|||
161730012|NCT00875017|584053679|FG000|First Intervention|Withdrawal by Subject|1|||
161730013|NCT00875017|584053680|FG001|First Intervention|Withdrawal by Subject|0|||
161730014|NCT00875017|584053681|FG002|First Intervention|Withdrawal by Subject|1|||
161730015|NCT00875017|584053682|FG003|First Intervention|Withdrawal by Subject|0|||
161730016|NCT00875017|584053683|FG004|First Intervention|Withdrawal by Subject|0|||
161730017|NCT00875017|584053684|FG005|First Intervention|Withdrawal by Subject|0|||
161730018|NCT00875017|584053679|FG000|First Intervention|Adverse Event|0|||
161730019|NCT00875017|584053680|FG001|First Intervention|Adverse Event|0|||
161730020|NCT00875017|584053681|FG002|First Intervention|Adverse Event|0|||
161730021|NCT00875017|584053682|FG003|First Intervention|Adverse Event|1|||
161730022|NCT00875017|584053683|FG004|First Intervention|Adverse Event|0|||
161730023|NCT00875017|584053684|FG005|First Intervention|Adverse Event|0|||
161730024|NCT00875017|584053679|FG000|First Intervention|Problems collecting rectal effluent|1|||
161730025|NCT00875017|584053680|FG001|First Intervention|Problems collecting rectal effluent|0|||
161730026|NCT00875017|584053681|FG002|First Intervention|Problems collecting rectal effluent|0|||
161730027|NCT00875017|584053682|FG003|First Intervention|Problems collecting rectal effluent|0|||
161730028|NCT00875017|584053683|FG004|First Intervention|Problems collecting rectal effluent|0|||
161730029|NCT00875017|584053684|FG005|First Intervention|Problems collecting rectal effluent|0|||
161730030|NCT00875017|584053679|FG000|First Intervention|Intolerance to nasogastric tube|0|||
161730031|NCT00875017|584053680|FG001|First Intervention|Intolerance to nasogastric tube|0|||
161730032|NCT00875017|584053681|FG002|First Intervention|Intolerance to nasogastric tube|0|||
161730033|NCT00875017|584053682|FG003|First Intervention|Intolerance to nasogastric tube|0|||
161730034|NCT00875017|584053683|FG004|First Intervention|Intolerance to nasogastric tube|1|||
161730035|NCT00875017|584053684|FG005|First Intervention|Intolerance to nasogastric tube|0|||
161730036|NCT00875017|584053679|FG000|Washout|Problem collecting rectal effluent|0|||
161730037|NCT00875017|584053680|FG001|Washout|Problem collecting rectal effluent|0|||
161730038|NCT00875017|584053681|FG002|Washout|Problem collecting rectal effluent|1|||
161730039|NCT00875017|584053682|FG003|Washout|Problem collecting rectal effluent|0|||
161730040|NCT00875017|584053683|FG004|Washout|Problem collecting rectal effluent|0|||
161730041|NCT00875017|584053684|FG005|Washout|Problem collecting rectal effluent|0|||
161730042|NCT00875017|584053679|FG000|Second Intervention|Adverse Event|0|||
161730043|NCT00875017|584053680|FG001|Second Intervention|Adverse Event|0|||
161730044|NCT00875017|584053681|FG002|Second Intervention|Adverse Event|0|||
161730045|NCT00875017|584053682|FG003|Second Intervention|Adverse Event|1|||
161730046|NCT00875017|584053683|FG004|Second Intervention|Adverse Event|0|||
161730047|NCT00875017|584053684|FG005|Second Intervention|Adverse Event|0|||
161730048|NCT00875017|584053679|FG000|Washout|Problems collecting rectal effluent|0|||
161730049|NCT00875017|584053680|FG001|Washout|Problems collecting rectal effluent|1|||
161730050|NCT00875017|584053681|FG002|Washout|Problems collecting rectal effluent|0|||
161730051|NCT00875017|584053682|FG003|Washout|Problems collecting rectal effluent|0|||
161730052|NCT00875017|584053683|FG004|Washout|Problems collecting rectal effluent|0|||
161730053|NCT00875017|584053684|FG005|Washout|Problems collecting rectal effluent|0|||
161730054|NCT00875017|584053679|FG000|Third Intervention|Adverse Event|0|||
161730055|NCT00875017|584053680|FG001|Third Intervention|Adverse Event|1|||
161730056|NCT00875017|584053681|FG002|Third Intervention|Adverse Event|1|||
161730057|NCT00875017|584053682|FG003|Third Intervention|Adverse Event|0|||
161730058|NCT00875017|584053683|FG004|Third Intervention|Adverse Event|0|||
161730059|NCT00875017|584053684|FG005|Third Intervention|Adverse Event|0|||
161730060|NCT00875017|584053679|FG000|Washout|Withdrawal by Subject|0|||
161730061|NCT00875017|584053680|FG001|Washout|Withdrawal by Subject|0|||
161730062|NCT00875017|584053681|FG002|Washout|Withdrawal by Subject|0|||
161730063|NCT00875017|584053682|FG003|Washout|Withdrawal by Subject|0|||
161730064|NCT00875017|584053683|FG004|Washout|Withdrawal by Subject|1|||
161730065|NCT00875017|584053684|FG005|Washout|Withdrawal by Subject|0|||
161730066|NCT00875017|584053679|FG000|Fourth Intervention|Inability to comply with fasting|0|||
161730067|NCT00875017|584053680|FG001|Fourth Intervention|Inability to comply with fasting|0|||
161730068|NCT00875017|584053681|FG002|Fourth Intervention|Inability to comply with fasting|0|||
161730069|NCT00875017|584053682|FG003|Fourth Intervention|Inability to comply with fasting|0|||
161730070|NCT00875017|584053683|FG004|Fourth Intervention|Inability to comply with fasting|0|||
161730071|NCT00875017|584053684|FG005|Fourth Intervention|Inability to comply with fasting|1|||
161730072|NCT02689219|584053685|FG000|Overall Study|Death|1|||
161838655|NCT03502707|584453452|FG011|Overall Study|Other|0|||
161838656|NCT03502707|584453453|FG012|Overall Study|Other|0|||
161730073|NCT02689219|584053686|FG001|Overall Study|Death|1|||
161730074|NCT02689219|584053685|FG000|Overall Study|Disease Progression|10|||
161730075|NCT02689219|584053686|FG001|Overall Study|Disease Progression|6|||
161730076|NCT01477892|584053687|FG000|Overall Study|Withdrawal by Subject|0|||
161730077|NCT01477892|584053688|FG001|Overall Study|Withdrawal by Subject|2|||
161730078|NCT01921257|584053693|FG000|Overall Study|Adverse Event|1|||
161730079|NCT01921257|584053693|FG000|Overall Study|Protocol Violation|1|||
161730080|NCT01921257|584053693|FG000|Overall Study|Withdrawal by Subject|1|||
161730081|NCT00364845|584053694|FG000|Overall Study|Adverse Event|1|||
161730082|NCT00364845|584053695|FG001|Overall Study|Adverse Event|0|||
161730083|NCT00364845|584053694|FG000|Overall Study|Withdrawal by Subject|2|||
161730084|NCT00364845|584053695|FG001|Overall Study|Withdrawal by Subject|1|||
161838657|NCT03502707|584453454|FG013|Overall Study|Other|0|||
161838658|NCT03502707|584453455|FG014|Overall Study|Other|0|||
161730085|NCT00364845|584053694|FG000|Overall Study|Physician Decision|8|||
161730086|NCT00364845|584053695|FG001|Overall Study|Physician Decision|8|||
161730087|NCT00364845|584053694|FG000|Overall Study|Lost to Follow-up|0|||
161730088|NCT00364845|584053695|FG001|Overall Study|Lost to Follow-up|1|||
161730089|NCT00364845|584053694|FG000|Overall Study|Death|0|||
161730090|NCT00364845|584053695|FG001|Overall Study|Death|1|||
161730091|NCT02426658|584053696|FG000|Overall Study|Withdrawal by Subject|1|||
161730092|NCT02426658|584053696|FG000|Overall Study|Patient expired before treatment|2|||
161730093|NCT03255291|584053699|FG000|Overall Study|Determined to be ineligible|10|||
161730094|NCT03255291|584053700|FG001|Overall Study|Determined to be ineligible|12|||
161730095|NCT03255291|584053701|FG002|Overall Study|Determined to be ineligible|6|||
161730096|NCT03255291|584053702|FG003|Overall Study|Determined to be ineligible|6|||
161730097|NCT03255291|584053703|FG004|Overall Study|Determined to be ineligible|5|||
161730098|NCT03255291|584053704|FG005|Overall Study|Determined to be ineligible|10|||
161730099|NCT03255291|584053699|FG000|Overall Study|Baseline data collection issues|3|||
161730100|NCT03255291|584053700|FG001|Overall Study|Baseline data collection issues|0|||
161730101|NCT03255291|584053701|FG002|Overall Study|Baseline data collection issues|0|||
161730102|NCT03255291|584053702|FG003|Overall Study|Baseline data collection issues|0|||
161730103|NCT03255291|584053703|FG004|Overall Study|Baseline data collection issues|2|||
161730104|NCT03255291|584053704|FG005|Overall Study|Baseline data collection issues|0|||
161730105|NCT01423617|584053705|FG000|Overall Study|Lost to Follow-up|0|||
161730106|NCT01423617|584053706|FG001|Overall Study|Lost to Follow-up|1|||
161730107|NCT00634244|584053707|FG000|Overall Study|Never started treatment|0|||
161730108|NCT00634244|584053708|FG001|Overall Study|Never started treatment|1|||
161730109|NCT00634244|584053709|FG002|Overall Study|Never started treatment|0|||
161730110|NCT00634244|584053707|FG000|Overall Study|Death|1|||
161730111|NCT00634244|584053708|FG001|Overall Study|Death|6|||
161730112|NCT00634244|584053709|FG002|Overall Study|Death|0|||
161730113|NCT00634244|584053707|FG000|Overall Study|Adverse Event|0|||
161730114|NCT00634244|584053708|FG001|Overall Study|Adverse Event|2|||
161730115|NCT00634244|584053709|FG002|Overall Study|Adverse Event|0|||
161730116|NCT00634244|584053707|FG000|Overall Study|Withdrawal by Subject|0|||
161730117|NCT00634244|584053708|FG001|Overall Study|Withdrawal by Subject|1|||
161730118|NCT00634244|584053709|FG002|Overall Study|Withdrawal by Subject|0|||
161730119|NCT00634244|584053707|FG000|Overall Study|Physician Decision|0|||
161730120|NCT00634244|584053708|FG001|Overall Study|Physician Decision|1|||
161730121|NCT00634244|584053709|FG002|Overall Study|Physician Decision|0|||
161730122|NCT00634244|584053707|FG000|Overall Study|Disease progression/relapse|0|||
161730123|NCT00634244|584053708|FG001|Overall Study|Disease progression/relapse|1|||
161730124|NCT00634244|584053709|FG002|Overall Study|Disease progression/relapse|0|||
161730125|NCT00634244|584053707|FG000|Overall Study|Other complicating disease|0|||
161730126|NCT00634244|584053708|FG001|Overall Study|Other complicating disease|1|||
161730127|NCT00634244|584053709|FG002|Overall Study|Other complicating disease|0|||
161730128|NCT01204658|584053711|FG000|Primary Phase|Adverse Event|0|||
161730129|NCT01204658|584053712|FG001|Primary Phase|Adverse Event|0|||
161730130|NCT01204658|584053713|FG002|Primary Phase|Adverse Event|1|||
161730131|NCT01204658|584053714|FG003|Primary Phase|Adverse Event|0|||
161730132|NCT04594239|584053719|FG000|Overall Study|Withdrawal by Subject|3|||
161730133|NCT04594239|584053720|FG001|Overall Study|Withdrawal by Subject|4|||
161730134|NCT04594239|584053721|FG002|Overall Study|Withdrawal by Subject|2|||
161730135|NCT04594239|584053722|FG003|Overall Study|Withdrawal by Subject|4|||
161730136|NCT04594239|584053719|FG000|Overall Study|Lost to Follow-up|8|||
161730137|NCT04594239|584053720|FG001|Overall Study|Lost to Follow-up|5|||
161730138|NCT04594239|584053721|FG002|Overall Study|Lost to Follow-up|4|||
161730139|NCT04594239|584053722|FG003|Overall Study|Lost to Follow-up|6|||
161730140|NCT04594239|584053719|FG000|Overall Study|Subject relocated|0|||
161730141|NCT04594239|584053720|FG001|Overall Study|Subject relocated|0|||
161730142|NCT04594239|584053721|FG002|Overall Study|Subject relocated|0|||
161730143|NCT04594239|584053722|FG003|Overall Study|Subject relocated|1|||
161730144|NCT03050359|584055811|FG000|Overall Study|Randomized But Not Treated|2|||
161730145|NCT03050359|584055812|FG001|Overall Study|Randomized But Not Treated|0|||
161730146|NCT03050359|584055811|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
161730147|NCT03050359|584055812|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
161730148|NCT03050359|584055811|FG000|Overall Study|Significant Protocol Deviation|2|||
161730149|NCT03050359|584055812|FG001|Overall Study|Significant Protocol Deviation|3|||
161730150|NCT03050359|584055811|FG000|Overall Study|Lost to Follow-up|2|||
161730151|NCT03050359|584055812|FG001|Overall Study|Lost to Follow-up|1|||
161730152|NCT03050359|584055811|FG000|Overall Study|Voluntary Withdrawal|4|||
161838659|NCT03502707|584453456|FG015|Overall Study|Other|4|||
161730153|NCT03050359|584055812|FG001|Overall Study|Voluntary Withdrawal|6|||
161730154|NCT03050359|584055811|FG000|Overall Study|Pregnancy|1|||
161730155|NCT03050359|584055812|FG001|Overall Study|Pregnancy|0|||
161730156|NCT03050359|584055811|FG000|Overall Study|Reason Not Specified|1|||
161730157|NCT03050359|584055812|FG001|Overall Study|Reason Not Specified|0|||
161730158|NCT02020031|584055813|FG000|Overall Study|Physician Decision|1|||
161838660|NCT03502707|584453457|FG016|Overall Study|Other|1|||
161730159|NCT02020031|584055814|FG001|Overall Study|Physician Decision|1|||
161730160|NCT00755846|584055817|FG000|Overall Study|Adverse Event|0|||
161730161|NCT00755846|584055818|FG001|Overall Study|Adverse Event|0|||
161965653|NCT04283994|584920404|FG004|Overall Study|Death|0|||
161730162|NCT00755846|584055819|FG002|Overall Study|Adverse Event|0|||
161730163|NCT00755846|584055820|FG003|Overall Study|Adverse Event|1|||
161730164|NCT00755846|584055821|FG004|Overall Study|Adverse Event|3|||
161730165|NCT00755846|584055822|FG005|Overall Study|Adverse Event|2|||
161730166|NCT00755846|584055817|FG000|Overall Study|Protocol Violation|1|||
161730167|NCT00755846|584055818|FG001|Overall Study|Protocol Violation|1|||
161730168|NCT00755846|584055819|FG002|Overall Study|Protocol Violation|1|||
161730169|NCT00755846|584055820|FG003|Overall Study|Protocol Violation|1|||
161730170|NCT00755846|584055821|FG004|Overall Study|Protocol Violation|1|||
161730171|NCT00755846|584055822|FG005|Overall Study|Protocol Violation|1|||
161730172|NCT00755846|584055817|FG000|Overall Study|Lost to Follow-up|0|||
161730173|NCT00755846|584055818|FG001|Overall Study|Lost to Follow-up|2|||
161730174|NCT00755846|584055819|FG002|Overall Study|Lost to Follow-up|1|||
161730175|NCT00755846|584055820|FG003|Overall Study|Lost to Follow-up|0|||
161730176|NCT00755846|584055821|FG004|Overall Study|Lost to Follow-up|4|||
161730177|NCT00755846|584055822|FG005|Overall Study|Lost to Follow-up|2|||
161730178|NCT00755846|584055817|FG000|Overall Study|Withdrawal by Subject|2|||
161730179|NCT00755846|584055818|FG001|Overall Study|Withdrawal by Subject|3|||
161730180|NCT00755846|584055819|FG002|Overall Study|Withdrawal by Subject|5|||
161730181|NCT00755846|584055820|FG003|Overall Study|Withdrawal by Subject|2|||
161730182|NCT00755846|584055821|FG004|Overall Study|Withdrawal by Subject|0|||
161730183|NCT00755846|584055822|FG005|Overall Study|Withdrawal by Subject|1|||
161730184|NCT00755846|584055817|FG000|Overall Study|Hyperglycemic Rescue|21|||
161730185|NCT00755846|584055818|FG001|Overall Study|Hyperglycemic Rescue|7|||
161730186|NCT00755846|584055819|FG002|Overall Study|Hyperglycemic Rescue|5|||
161730187|NCT00755846|584055820|FG003|Overall Study|Hyperglycemic Rescue|8|||
161730188|NCT00755846|584055821|FG004|Overall Study|Hyperglycemic Rescue|8|||
161730189|NCT00755846|584055822|FG005|Overall Study|Hyperglycemic Rescue|7|||
161730190|NCT00755846|584055817|FG000|Overall Study|Physician Decision|1|||
161730191|NCT00755846|584055818|FG001|Overall Study|Physician Decision|3|||
161730192|NCT00755846|584055819|FG002|Overall Study|Physician Decision|0|||
161730193|NCT00755846|584055820|FG003|Overall Study|Physician Decision|1|||
161730194|NCT00755846|584055821|FG004|Overall Study|Physician Decision|0|||
161730195|NCT00755846|584055822|FG005|Overall Study|Physician Decision|1|||
161730196|NCT00755846|584055817|FG000|Overall Study|Administrative Error|0|||
161730197|NCT00755846|584055818|FG001|Overall Study|Administrative Error|1|||
161730198|NCT00755846|584055819|FG002|Overall Study|Administrative Error|0|||
161730199|NCT00755846|584055820|FG003|Overall Study|Administrative Error|0|||
161730200|NCT00755846|584055821|FG004|Overall Study|Administrative Error|0|||
161730201|NCT00755846|584055822|FG005|Overall Study|Administrative Error|0|||
161730202|NCT00755846|584055817|FG000|Overall Study|Participant Non-compliance|0|||
161730203|NCT00755846|584055818|FG001|Overall Study|Participant Non-compliance|0|||
161730204|NCT00755846|584055819|FG002|Overall Study|Participant Non-compliance|0|||
161730205|NCT00755846|584055820|FG003|Overall Study|Participant Non-compliance|0|||
161730206|NCT00755846|584055821|FG004|Overall Study|Participant Non-compliance|1|||
161730207|NCT00755846|584055822|FG005|Overall Study|Participant Non-compliance|0|||
161730208|NCT02723604|584055835|FG000|Overall Study|ineligible|1|||
161730209|NCT02723604|584055835|FG000|Overall Study|never received treatment|1|||
161730210|NCT00762372|584055836|FG000|Overall Study|Adverse Event|1|||
161730211|NCT00762372|584055837|FG001|Overall Study|Adverse Event|0|||
161730212|NCT00762372|584055838|FG002|Overall Study|Adverse Event|0|||
161730213|NCT02616185|584055839|FG000|Overall Study|Death|0|||
161730214|NCT02616185|584055840|FG001|Overall Study|Death|0|||
161730215|NCT02616185|584055841|FG002|Overall Study|Death|0|||
161730216|NCT02616185|584055842|FG003|Overall Study|Death|1|||
161730217|NCT02616185|584055843|FG004|Overall Study|Death|2|||
161730218|NCT02616185|584055844|FG005|Overall Study|Death|0|||
161730219|NCT02616185|584055845|FG006|Overall Study|Death|0|||
161838661|NCT03502707|584453458|FG017|Overall Study|Other|0|||
161838662|NCT03502707|584453441|FG000|Overall Study|Randomized but not vaccinated|0|||
161838663|NCT03502707|584453442|FG001|Overall Study|Randomized but not vaccinated|0|||
161965654|NCT04283994|584920405|FG005|Overall Study|Death|0|||
161965655|NCT04283994|584920406|FG006|Overall Study|Death|0|||
161730220|NCT02616185|584055846|FG007|Overall Study|Death|2|||
161730221|NCT02616185|584055847|FG008|Overall Study|Death|1|||
161730222|NCT02616185|584055839|FG000|Overall Study|Study terminated by sponsor|0|||
161730223|NCT02616185|584055840|FG001|Overall Study|Study terminated by sponsor|0|||
161730224|NCT02616185|584055841|FG002|Overall Study|Study terminated by sponsor|1|||
161730225|NCT02616185|584055842|FG003|Overall Study|Study terminated by sponsor|0|||
161730226|NCT02616185|584055843|FG004|Overall Study|Study terminated by sponsor|0|||
161730227|NCT02616185|584055844|FG005|Overall Study|Study terminated by sponsor|0|||
161730228|NCT02616185|584055845|FG006|Overall Study|Study terminated by sponsor|5|||
161730229|NCT02616185|584055846|FG007|Overall Study|Study terminated by sponsor|2|||
161730230|NCT02616185|584055847|FG008|Overall Study|Study terminated by sponsor|0|||
161730231|NCT02616185|584055839|FG000|Overall Study|Participant refused further follow-up|1|||
161730232|NCT02616185|584055840|FG001|Overall Study|Participant refused further follow-up|1|||
161730233|NCT02616185|584055841|FG002|Overall Study|Participant refused further follow-up|2|||
162032217|NCT00075270|585175440|FG001|Overall Study|Lost to Follow-up|28|||
161730234|NCT02616185|584055842|FG003|Overall Study|Participant refused further follow-up|3|||
161730235|NCT02616185|584055843|FG004|Overall Study|Participant refused further follow-up|4|||
161730236|NCT02616185|584055844|FG005|Overall Study|Participant refused further follow-up|0|||
161730237|NCT02616185|584055845|FG006|Overall Study|Participant refused further follow-up|3|||
161730238|NCT02616185|584055846|FG007|Overall Study|Participant refused further follow-up|4|||
161730239|NCT02616185|584055847|FG008|Overall Study|Participant refused further follow-up|3|||
161730240|NCT02616185|584055839|FG000|Overall Study|Not reported|0|||
161730241|NCT02616185|584055840|FG001|Overall Study|Not reported|0|||
161730242|NCT02616185|584055841|FG002|Overall Study|Not reported|0|||
161730243|NCT02616185|584055842|FG003|Overall Study|Not reported|1|||
161730244|NCT02616185|584055843|FG004|Overall Study|Not reported|3|||
161730245|NCT02616185|584055844|FG005|Overall Study|Not reported|1|||
161730246|NCT02616185|584055845|FG006|Overall Study|Not reported|0|||
161730247|NCT02616185|584055846|FG007|Overall Study|Not reported|5|||
161730248|NCT02616185|584055847|FG008|Overall Study|Not reported|2|||
161730249|NCT03303092|584055848|FG000|Overall Study|Adverse Event|1|||
161730250|NCT03303092|584055849|FG001|Overall Study|Adverse Event|0|||
161730251|NCT03303092|584055850|FG002|Overall Study|Adverse Event|1|||
161730252|NCT03303092|584055848|FG000|Overall Study|Protocol Violation|1|||
161730253|NCT03303092|584055849|FG001|Overall Study|Protocol Violation|5|||
161730254|NCT03303092|584055850|FG002|Overall Study|Protocol Violation|1|||
161730255|NCT03303092|584055848|FG000|Overall Study|Withdrawal by Subject|1|||
161730256|NCT03303092|584055849|FG001|Overall Study|Withdrawal by Subject|1|||
161730257|NCT03303092|584055850|FG002|Overall Study|Withdrawal by Subject|3|||
161730258|NCT01995136|584055856|FG000|Overall Study|Change in residence|1|||
161730259|NCT00833248|584055860|FG000|Overall Study|Adverse Event|3|||
161730260|NCT00833248|584055861|FG001|Overall Study|Adverse Event|0|||
161730261|NCT00833248|584055860|FG000|Overall Study|Protocol Violation|1|||
161730262|NCT00833248|584055861|FG001|Overall Study|Protocol Violation|2|||
161730263|NCT00833248|584055860|FG000|Overall Study|Withdrawal by Subject|0|||
161730264|NCT00833248|584055861|FG001|Overall Study|Withdrawal by Subject|1|||
161730265|NCT01830543|584055862|FG000|Overall Study|Subject Decision|19|||
161730266|NCT01830543|584055863|FG001|Overall Study|Subject Decision|21|||
161730267|NCT01830543|584055864|FG002|Overall Study|Subject Decision|57|||
161730268|NCT01830543|584055862|FG000|Overall Study|Adverse Event|91|||
161730269|NCT01830543|584055863|FG001|Overall Study|Adverse Event|77|||
161730270|NCT01830543|584055864|FG002|Overall Study|Adverse Event|76|||
161730271|NCT01830543|584055862|FG000|Overall Study|Death|20|||
161730272|NCT01830543|584055863|FG001|Overall Study|Death|22|||
161730273|NCT01830543|584055864|FG002|Overall Study|Death|22|||
161730274|NCT01830543|584055862|FG000|Overall Study|Protocol Violation|3|||
161730275|NCT01830543|584055863|FG001|Overall Study|Protocol Violation|7|||
161730276|NCT01830543|584055864|FG002|Overall Study|Protocol Violation|7|||
161730277|NCT01830543|584055862|FG000|Overall Study|Physician Decision|11|||
161730278|NCT01830543|584055863|FG001|Overall Study|Physician Decision|5|||
161730279|NCT01830543|584055864|FG002|Overall Study|Physician Decision|12|||
161730280|NCT01830543|584055862|FG000|Overall Study|Withdrawal by consent|3|||
161730281|NCT01830543|584055863|FG001|Overall Study|Withdrawal by consent|3|||
161730282|NCT01830543|584055864|FG002|Overall Study|Withdrawal by consent|3|||
161730283|NCT01830543|584055862|FG000|Overall Study|Other|12|||
161730284|NCT01830543|584055863|FG001|Overall Study|Other|17|||
161730285|NCT01830543|584055864|FG002|Overall Study|Other|37|||
161730286|NCT02585999|584055869|FG000|Overall Study|Lost to Follow-up|1|||
161730287|NCT02585999|584055869|FG000|Overall Study|Protocol Violation|1|||
161730288|NCT01028651|584055872|FG000|Overall Study|Death|2|||
161730289|NCT01028651|584055872|FG000|Overall Study|Adverse Event|1|||
161730290|NCT00390416|584055874|FG000|Overall Study|Withdrawal by Subject|1|||
161730291|NCT00390416|584055874|FG000|Overall Study|Not treated|3|||
161730292|NCT01592409|584055875|FG000|Overall Study|Withdrawal by Subject|0|||
161730293|NCT01592409|584055876|FG001|Overall Study|Withdrawal by Subject|1|||
161730294|NCT01728584|584055877|FG000|Overall Study|Adverse Event|1|||
161730295|NCT01728584|584055878|FG001|Overall Study|Adverse Event|0|||
161730296|NCT01728584|584055879|FG002|Overall Study|Adverse Event|0|||
161730297|NCT01728584|584055880|FG003|Overall Study|Adverse Event|0|||
161730298|NCT01728584|584055877|FG000|Overall Study|Physician Decision|4|||
161965656|NCT04283994|584920400|FG000|Overall Study|Withdrawal by Subject|16|||
161965657|NCT04283994|584920401|FG001|Overall Study|Withdrawal by Subject|4|||
161730299|NCT01728584|584055878|FG001|Overall Study|Physician Decision|0|||
161730300|NCT01728584|584055879|FG002|Overall Study|Physician Decision|1|||
161838664|NCT03502707|584453443|FG002|Overall Study|Randomized but not vaccinated|0|||
161965658|NCT04283994|584920402|FG002|Overall Study|Withdrawal by Subject|6|||
161730301|NCT01728584|584055880|FG003|Overall Study|Physician Decision|0|||
161965659|NCT04283994|584920403|FG003|Overall Study|Withdrawal by Subject|1|||
161730302|NCT01728584|584055877|FG000|Overall Study|Withdrawal by Subject|1|||
161730303|NCT01728584|584055878|FG001|Overall Study|Withdrawal by Subject|0|||
161730304|NCT01728584|584055879|FG002|Overall Study|Withdrawal by Subject|0|||
161730305|NCT01728584|584055880|FG003|Overall Study|Withdrawal by Subject|0|||
161730306|NCT01728584|584055877|FG000|Overall Study|Screen failure|1|||
161730307|NCT01728584|584055878|FG001|Overall Study|Screen failure|0|||
161838665|NCT03502707|584453444|FG003|Overall Study|Randomized but not vaccinated|0|||
161838666|NCT03502707|584453445|FG004|Overall Study|Randomized but not vaccinated|0|||
161838667|NCT03502707|584453446|FG005|Overall Study|Randomized but not vaccinated|0|||
161838668|NCT03502707|584453447|FG006|Overall Study|Randomized but not vaccinated|0|||
161838669|NCT03502707|584453448|FG007|Overall Study|Randomized but not vaccinated|0|||
161838670|NCT03502707|584453449|FG008|Overall Study|Randomized but not vaccinated|0|||
161838671|NCT03502707|584453450|FG009|Overall Study|Randomized but not vaccinated|0|||
161838672|NCT03502707|584453451|FG010|Overall Study|Randomized but not vaccinated|0|||
161838673|NCT03502707|584453452|FG011|Overall Study|Randomized but not vaccinated|1|||
161838674|NCT03502707|584453453|FG012|Overall Study|Randomized but not vaccinated|0|||
161838675|NCT03502707|584453454|FG013|Overall Study|Randomized but not vaccinated|0|||
161838676|NCT03502707|584453455|FG014|Overall Study|Randomized but not vaccinated|0|||
161838677|NCT03502707|584453456|FG015|Overall Study|Randomized but not vaccinated|0|||
161838678|NCT03502707|584453457|FG016|Overall Study|Randomized but not vaccinated|0|||
161838679|NCT03502707|584453458|FG017|Overall Study|Randomized but not vaccinated|1|||
161838680|NCT00461253|584453459|FG000|Overall Study|Death|985|||
161838681|NCT00461253|584453460|FG001|Overall Study|Death|0|||
161838682|NCT00461253|584453459|FG000|Overall Study|Protocol Violation|613|||
161838683|NCT00461253|584453460|FG001|Overall Study|Protocol Violation|236|||
161838684|NCT00461253|584453459|FG000|Overall Study|no response|2609|||
161838685|NCT00461253|584453460|FG001|Overall Study|no response|11789|||
161838686|NCT00461253|584453459|FG000|Overall Study|administrative|773|||
161838687|NCT00461253|584453460|FG001|Overall Study|administrative|7773|||
161838688|NCT01933113|584453461|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
161838689|NCT02297438|584453462|FG000|Overall Study|Death|79|||
161838690|NCT02297438|584453463|FG001|Overall Study|Death|86|||
161838691|NCT02297438|584453462|FG000|Overall Study|Lost to Follow-up|9|||
161838692|NCT02297438|584453463|FG001|Overall Study|Lost to Follow-up|7|||
161838693|NCT02297438|584453462|FG000|Overall Study|Withdrawal by Subject|7|||
161838694|NCT02297438|584453463|FG001|Overall Study|Withdrawal by Subject|0|||
161838695|NCT02297438|584453462|FG000|Overall Study|Other|9|||
161838696|NCT02297438|584453463|FG001|Overall Study|Other|5|||
161838697|NCT02297438|584453462|FG000|Overall Study|Ongoing|65|||
161838698|NCT02297438|584453463|FG001|Overall Study|Ongoing|73|||
161838699|NCT02358343|584453466|FG000|Screening Intervention|Death|0|||
161838700|NCT02358343|584453467|FG001|Screening Intervention|Death|2|||
161838701|NCT02358343|584453468|FG002|Screening Intervention|Death|0|||
161838702|NCT02358343|584453469|FG003|Screening Intervention|Death|0|||
161838703|NCT02358343|584453470|FG004|Screening Intervention|Death|0|||
161838704|NCT02358343|584453466|FG000|Screening Intervention|Withdrawal by Subject|1|||
161838705|NCT02358343|584453467|FG001|Screening Intervention|Withdrawal by Subject|0|||
161838706|NCT02358343|584453468|FG002|Screening Intervention|Withdrawal by Subject|0|||
161838707|NCT02358343|584453469|FG003|Screening Intervention|Withdrawal by Subject|0|||
161838708|NCT02358343|584453470|FG004|Screening Intervention|Withdrawal by Subject|0|||
161838709|NCT02358343|584453466|FG000|Screening Intervention|Determined Ineligible|5|||
161838710|NCT02358343|584453467|FG001|Screening Intervention|Determined Ineligible|6|||
161838711|NCT02358343|584453468|FG002|Screening Intervention|Determined Ineligible|0|||
161838712|NCT02358343|584453469|FG003|Screening Intervention|Determined Ineligible|0|||
161838713|NCT02358343|584453470|FG004|Screening Intervention|Determined Ineligible|0|||
161838714|NCT02358343|584453466|FG000|Comparative Efficacy Trial / Observation|Death|0|||
161838715|NCT02358343|584453467|FG001|Comparative Efficacy Trial / Observation|Death|0|||
161838716|NCT02358343|584453468|FG002|Comparative Efficacy Trial / Observation|Death|2|||
161838717|NCT02358343|584453469|FG003|Comparative Efficacy Trial / Observation|Death|0|||
161838718|NCT02358343|584453470|FG004|Comparative Efficacy Trial / Observation|Death|0|||
161838719|NCT02358343|584453466|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
161838720|NCT02358343|584453467|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
161838721|NCT02358343|584453468|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
161838722|NCT02358343|584453469|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
161838723|NCT02358343|584453470|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
161838724|NCT02358343|584453466|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
161838725|NCT02358343|584453467|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
161838726|NCT02358343|584453468|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
161838727|NCT02358343|584453469|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
161838728|NCT02358343|584453470|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
161838729|NCT01951885|584453472|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
161838730|NCT01951885|584453473|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
161838731|NCT01951885|584453472|FG000|Overall Study|Adverse Event|1|||
161838732|NCT01951885|584453473|FG001|Overall Study|Adverse Event|0|||
161838733|NCT01951885|584453472|FG000|Overall Study|Withdrawal by Subject|0|||
161838734|NCT01951885|584453473|FG001|Overall Study|Withdrawal by Subject|1|||
161838735|NCT01951885|584453472|FG000|Overall Study|ineligible due to a change in donor|0|||
161838736|NCT01951885|584453473|FG001|Overall Study|ineligible due to a change in donor|1|||
161730308|NCT01728584|584055879|FG002|Overall Study|Screen failure|0|||
161730309|NCT01728584|584055880|FG003|Overall Study|Screen failure|0|||
161730310|NCT01728584|584055877|FG000|Overall Study|Other reason (not specified)|1|||
161730311|NCT01728584|584055878|FG001|Overall Study|Other reason (not specified)|0|||
161730312|NCT01728584|584055879|FG002|Overall Study|Other reason (not specified)|0|||
161730313|NCT01728584|584055880|FG003|Overall Study|Other reason (not specified)|1|||
161730314|NCT05132569|584055882|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
161730315|NCT05132569|584055883|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
161730316|NCT05132569|584055882|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
161730317|NCT05132569|584055883|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
161730318|NCT05132569|584055882|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
161730319|NCT05132569|584055883|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
161730320|NCT02345252|584055898|FG000|Double-Blind Phase|Adverse Event|2|||
161730321|NCT02345252|584055899|FG001|Double-Blind Phase|Adverse Event|3|||
161730322|NCT02345252|584055898|FG000|Double-Blind Phase|Death|1|||
161730323|NCT02345252|584055899|FG001|Double-Blind Phase|Death|2|||
161730324|NCT02345252|584055898|FG000|Double-Blind Phase|Lack of Efficacy|1|||
161730325|NCT02345252|584055899|FG001|Double-Blind Phase|Lack of Efficacy|0|||
161730326|NCT02345252|584055898|FG000|Double-Blind Phase|Investigator's Discretion|4|||
161730327|NCT02345252|584055899|FG001|Double-Blind Phase|Investigator's Discretion|6|||
161730328|NCT02345252|584055898|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
161730329|NCT02345252|584055899|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
161730330|NCT02345252|584055898|FG000|Double-Blind Phase|Protocol Violation|2|||
161730331|NCT02345252|584055899|FG001|Double-Blind Phase|Protocol Violation|1|||
161730332|NCT02345252|584055898|FG000|Double-Blind Phase|Withdrew Consent|21|||
161730333|NCT02345252|584055899|FG001|Double-Blind Phase|Withdrew Consent|23|||
161730334|NCT02345252|584055898|FG000|Double-Blind Phase|Lost to Follow-up|8|||
161730335|NCT02345252|584055899|FG001|Double-Blind Phase|Lost to Follow-up|10|||
161730336|NCT02345252|584055898|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
161730337|NCT02345252|584055899|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
161730338|NCT00471536|584055910|FG000|Overall Study|Withdrawal by Subject|1|||
161730339|NCT01188564|584055913|FG000|Double-blind Phase|randomized not treated|1|||
161730340|NCT01188564|584055914|FG001|Double-blind Phase|randomized not treated|0|||
161730341|NCT01094730|584055917|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
161730342|NCT01094730|584055918|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
161730343|NCT01094730|584055917|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
161730344|NCT01094730|584055918|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
161730345|NCT01094730|584055917|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
161730346|NCT01094730|584055918|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
161730347|NCT01094730|584055917|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
161730348|NCT01094730|584055918|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
161730349|NCT01094730|584055917|FG000|Period 2 (14 Days)|Protocol Violation|2|||
161730350|NCT01094730|584055918|FG001|Period 2 (14 Days)|Protocol Violation|0|||
161730351|NCT01094730|584055917|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
161730352|NCT01094730|584055918|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
161730353|NCT01094730|584055917|FG000|Period 2 (14 Days)|Adverse Event|0|||
161730354|NCT01094730|584055918|FG001|Period 2 (14 Days)|Adverse Event|1|||
161730355|NCT01094730|584055917|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
161730356|NCT01094730|584055918|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
161730357|NCT04171037|584055919|FG000|Overall Study|Lost to Follow-up|1|||
161730358|NCT04171037|584055920|FG001|Overall Study|Lost to Follow-up|0|||
161730359|NCT04171037|584055919|FG000|Overall Study|Physician Decision|3|||
161730360|NCT04171037|584055920|FG001|Overall Study|Physician Decision|3|||
161730361|NCT01934894|584055921|FG000|Overall Study|Adverse Event|1|||
161730362|NCT01934894|584055922|FG001|Overall Study|Adverse Event|2|||
161730363|NCT01934894|584055921|FG000|Overall Study|Death|2|||
161730364|NCT01934894|584055922|FG001|Overall Study|Death|0|||
161730365|NCT01934894|584055921|FG000|Overall Study|Withdrawal by Subject|0|||
161730366|NCT01934894|584055922|FG001|Overall Study|Withdrawal by Subject|1|||
161730367|NCT01934894|584055921|FG000|Overall Study|Progressive Disease|3|||
161730368|NCT01934894|584055922|FG001|Overall Study|Progressive Disease|2|||
161730369|NCT01954251|584055923|FG000|Overall Study|Adverse Event|5|||
162032218|NCT00075270|585175439|FG000|Overall Study|Protocol Violation|0|||
161730370|NCT01954251|584055924|FG001|Overall Study|Adverse Event|7|||
161730371|NCT01954251|584055923|FG000|Overall Study|Lost to Follow-up|6|||
161730372|NCT01954251|584055924|FG001|Overall Study|Lost to Follow-up|6|||
161730373|NCT01954251|584055923|FG000|Overall Study|Withdrawal by Subject|2|||
161730374|NCT01954251|584055924|FG001|Overall Study|Withdrawal by Subject|6|||
162032219|NCT00075270|585175440|FG001|Overall Study|Protocol Violation|2|||
161730375|NCT02864940|584055925|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
161730376|NCT02864940|584055926|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
161730377|NCT02232087|584055927|FG000|Overall Study|Withdrawal by Subject|2|||
161730378|NCT02232087|584055928|FG001|Overall Study|Withdrawal by Subject|0|||
161730379|NCT02232087|584055929|FG002|Overall Study|Withdrawal by Subject|0|||
161730380|NCT02232087|584055930|FG003|Overall Study|Withdrawal by Subject|0|||
161730381|NCT02232087|584055931|FG004|Overall Study|Withdrawal by Subject|0|||
161730382|NCT02232087|584055932|FG005|Overall Study|Withdrawal by Subject|1|||
161730383|NCT02232087|584055927|FG000|Overall Study|poor inhalation technique|0|||
161730384|NCT02232087|584055928|FG001|Overall Study|poor inhalation technique|1|||
161730385|NCT02232087|584055929|FG002|Overall Study|poor inhalation technique|0|||
161730386|NCT02232087|584055930|FG003|Overall Study|poor inhalation technique|0|||
161730387|NCT02232087|584055931|FG004|Overall Study|poor inhalation technique|0|||
161730388|NCT02232087|584055932|FG005|Overall Study|poor inhalation technique|2|||
161730389|NCT02232087|584055927|FG000|Overall Study|protocol stop criteria|0|||
161730390|NCT02232087|584055928|FG001|Overall Study|protocol stop criteria|1|||
161730391|NCT02232087|584055929|FG002|Overall Study|protocol stop criteria|0|||
161730392|NCT02232087|584055930|FG003|Overall Study|protocol stop criteria|1|||
161730393|NCT02232087|584055931|FG004|Overall Study|protocol stop criteria|0|||
161730394|NCT02232087|584055932|FG005|Overall Study|protocol stop criteria|0|||
161730395|NCT02232087|584055927|FG000|Overall Study|Adverse Event|0|||
161730396|NCT02232087|584055928|FG001|Overall Study|Adverse Event|0|||
161730397|NCT02232087|584055929|FG002|Overall Study|Adverse Event|0|||
161730398|NCT02232087|584055930|FG003|Overall Study|Adverse Event|0|||
161730399|NCT02232087|584055931|FG004|Overall Study|Adverse Event|1|||
161730400|NCT02232087|584055932|FG005|Overall Study|Adverse Event|0|||
161730401|NCT01958125|584055933|FG000|Overall Study|Missing diary data|2|||
161730402|NCT01958125|584055934|FG001|Overall Study|Missing diary data|6|||
161730403|NCT01958125|584055933|FG000|Overall Study|No headache attacks|0|||
161730404|NCT01958125|584055934|FG001|Overall Study|No headache attacks|2|||
161730405|NCT04096326|584055935|FG000|Overall Study|Withdrawal by Subject|0|||
161730406|NCT04096326|584055936|FG001|Overall Study|Withdrawal by Subject|0|||
161730407|NCT04096326|584055937|FG002|Overall Study|Withdrawal by Subject|0|||
161730408|NCT04096326|584055938|FG003|Overall Study|Withdrawal by Subject|0|||
161730409|NCT04096326|584055939|FG004|Overall Study|Withdrawal by Subject|0|||
161730410|NCT04096326|584055940|FG005|Overall Study|Withdrawal by Subject|0|||
161730411|NCT04096326|584055941|FG006|Overall Study|Withdrawal by Subject|1|||
161730412|NCT04096326|584055942|FG007|Overall Study|Withdrawal by Subject|0|||
161730413|NCT04096326|584055943|FG008|Overall Study|Withdrawal by Subject|0|||
161730414|NCT04096326|584055944|FG009|Overall Study|Withdrawal by Subject|0|||
161730415|NCT04096326|584055935|FG000|Overall Study|Lost to Follow-up|0|||
161730416|NCT04096326|584055936|FG001|Overall Study|Lost to Follow-up|1|||
161730417|NCT04096326|584055937|FG002|Overall Study|Lost to Follow-up|0|||
161730418|NCT04096326|584055938|FG003|Overall Study|Lost to Follow-up|0|||
161730419|NCT04096326|584055939|FG004|Overall Study|Lost to Follow-up|0|||
161730420|NCT04096326|584055940|FG005|Overall Study|Lost to Follow-up|0|||
161730421|NCT04096326|584055941|FG006|Overall Study|Lost to Follow-up|0|||
161730422|NCT04096326|584055942|FG007|Overall Study|Lost to Follow-up|0|||
161730423|NCT04096326|584055943|FG008|Overall Study|Lost to Follow-up|0|||
161730424|NCT04096326|584055944|FG009|Overall Study|Lost to Follow-up|0|||
161730425|NCT04096326|584055935|FG000|Overall Study|COVID-19-related reasons|0|||
161730426|NCT04096326|584055936|FG001|Overall Study|COVID-19-related reasons|0|||
161730427|NCT04096326|584055937|FG002|Overall Study|COVID-19-related reasons|0|||
161730428|NCT04096326|584055938|FG003|Overall Study|COVID-19-related reasons|0|||
161730429|NCT04096326|584055939|FG004|Overall Study|COVID-19-related reasons|1|||
161730430|NCT04096326|584055940|FG005|Overall Study|COVID-19-related reasons|5|||
161730431|NCT04096326|584055941|FG006|Overall Study|COVID-19-related reasons|0|||
161730432|NCT04096326|584055942|FG007|Overall Study|COVID-19-related reasons|0|||
161730433|NCT04096326|584055943|FG008|Overall Study|COVID-19-related reasons|0|||
161730434|NCT04096326|584055944|FG009|Overall Study|COVID-19-related reasons|0|||
161730435|NCT04804033|584055945|FG000|Period 1: DBT Phase|Adverse Event|1|||
161730436|NCT04804033|584055946|FG001|Period 1: DBT Phase|Adverse Event|5|||
161730437|NCT04804033|584055947|FG002|Period 1: DBT Phase|Adverse Event|3|||
161730438|NCT04804033|584055948|FG003|Period 1: DBT Phase|Adverse Event|4|||
161730439|NCT04804033|584055945|FG000|Period 1: DBT Phase|Death|1|||
161838737|NCT01951885|584453472|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
161838738|NCT01951885|584453473|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
161730440|NCT04804033|584055946|FG001|Period 1: DBT Phase|Death|0|||
161730441|NCT04804033|584055947|FG002|Period 1: DBT Phase|Death|0|||
161730442|NCT04804033|584055948|FG003|Period 1: DBT Phase|Death|0|||
161730443|NCT04804033|584055945|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
161730444|NCT04804033|584055946|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
161838739|NCT01687478|584453474|FG000|Overall Study|Adverse Event|3|||
161730445|NCT04804033|584055947|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
161730446|NCT04804033|584055948|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
161838740|NCT01687478|584453475|FG001|Overall Study|Adverse Event|10|||
161730447|NCT04804033|584055945|FG000|Period 1: DBT Phase|Non-compliance|1|||
161730448|NCT04804033|584055946|FG001|Period 1: DBT Phase|Non-compliance|0|||
161730449|NCT04804033|584055947|FG002|Period 1: DBT Phase|Non-compliance|1|||
161730450|NCT04804033|584055948|FG003|Period 1: DBT Phase|Non-compliance|2|||
161730451|NCT04804033|584055945|FG000|Period 1: DBT Phase|Other|0|||
161730452|NCT04804033|584055946|FG001|Period 1: DBT Phase|Other|1|||
161730453|NCT04804033|584055947|FG002|Period 1: DBT Phase|Other|0|||
161838741|NCT01687478|584453474|FG000|Overall Study|Lost to Follow-up|1|||
161838742|NCT01687478|584453475|FG001|Overall Study|Lost to Follow-up|3|||
161838743|NCT01687478|584453474|FG000|Overall Study|Protocol Violation|0|||
161838744|NCT01687478|584453475|FG001|Overall Study|Protocol Violation|2|||
161838745|NCT01687478|584453474|FG000|Overall Study|Withdrawal by Subject|21|||
161838746|NCT01687478|584453475|FG001|Overall Study|Withdrawal by Subject|19|||
161838747|NCT01687478|584453474|FG000|Overall Study|Physician Decision|1|||
161838748|NCT01687478|584453475|FG001|Overall Study|Physician Decision|3|||
161838749|NCT01687478|584453474|FG000|Overall Study|Entry Criteria Not Met|6|||
161838750|NCT01687478|584453475|FG001|Overall Study|Entry Criteria Not Met|2|||
161838751|NCT03188718|584453476|FG000|Overall Study|Participant noncompliance|4|||
161838752|NCT03188718|584453476|FG000|Overall Study|Withdrawal by Subject|1|||
161838753|NCT03188718|584453476|FG000|Overall Study|Device failure|3|||
161838754|NCT04322149|584453477|FG000|Overall Study|Adverse Event|1|||
161838755|NCT04322149|584453478|FG001|Overall Study|Adverse Event|1|||
161838756|NCT04322149|584453479|FG002|Overall Study|Adverse Event|0|||
161838757|NCT04322149|584453480|FG003|Overall Study|Adverse Event|0|||
161838758|NCT04322149|584453477|FG000|Overall Study|Withdrawal by Subject|0|||
161838759|NCT04322149|584453478|FG001|Overall Study|Withdrawal by Subject|0|||
161838760|NCT04322149|584453479|FG002|Overall Study|Withdrawal by Subject|0|||
161838761|NCT04322149|584453480|FG003|Overall Study|Withdrawal by Subject|2|||
161838762|NCT04322149|584453477|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
161838763|NCT04322149|584453478|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
161838764|NCT04322149|584453479|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
161838765|NCT04322149|584453480|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
161838766|NCT01700049|584453487|FG000|Overall Study|Withdrawal by Subject|1|||
161730454|NCT04804033|584055948|FG003|Period 1: DBT Phase|Other|0|||
161730455|NCT04804033|584055945|FG000|Period 1: DBT Phase|Pregnancy|2|||
161730456|NCT04804033|584055946|FG001|Period 1: DBT Phase|Pregnancy|0|||
161730457|NCT04804033|584055947|FG002|Period 1: DBT Phase|Pregnancy|0|||
161730458|NCT04804033|584055948|FG003|Period 1: DBT Phase|Pregnancy|0|||
161730459|NCT04804033|584055945|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
161730460|NCT04804033|584055946|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
161730461|NCT04804033|584055947|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
161730462|NCT04804033|584055948|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
161730463|NCT04804033|584055945|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
161730464|NCT04804033|584055946|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
161730465|NCT04804033|584055947|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
161838767|NCT00792935|584453488|FG000|Overall Study|Adverse Event|2|||
161838768|NCT00792935|584453489|FG001|Overall Study|Adverse Event|1|||
161838769|NCT00792935|584453488|FG000|Overall Study|Lost to Follow-up|0|||
161838770|NCT00792935|584453489|FG001|Overall Study|Lost to Follow-up|1|||
161838771|NCT00792935|584453488|FG000|Overall Study|Protocol Violation|2|||
161838772|NCT00792935|584453489|FG001|Overall Study|Protocol Violation|0|||
161838773|NCT00792935|584453488|FG000|Overall Study|Withdrawal by Subject|0|||
161838774|NCT00792935|584453489|FG001|Overall Study|Withdrawal by Subject|1|||
161838775|NCT01155024|584453497|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
161838776|NCT01155024|584453498|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
161838777|NCT01155024|584453497|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
161838778|NCT01155024|584453498|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
161838779|NCT01155024|584453497|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
161838780|NCT01155024|584453498|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
161838781|NCT01593696|584453499|FG000|Dose Escalation|Progressive Disease|2|||
161838782|NCT01593696|584453500|FG001|Dose Escalation|Progressive Disease|0|||
161838783|NCT01593696|584453501|FG002|Dose Escalation|Progressive Disease|0|||
161838784|NCT01593696|584453502|FG003|Dose Escalation|Progressive Disease|0|||
161838785|NCT01593696|584453499|FG000|Dose Expansion|Fungal infection|0|||
161838786|NCT01593696|584453500|FG001|Dose Expansion|Fungal infection|0|||
161965660|NCT04283994|584920404|FG004|Overall Study|Withdrawal by Subject|0|||
161730466|NCT04804033|584055948|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
161730467|NCT04804033|584055945|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
161730468|NCT04804033|584055946|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
161730469|NCT04804033|584055947|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
161838787|NCT01593696|584453501|FG002|Dose Expansion|Fungal infection|1|||
161838788|NCT01593696|584453502|FG003|Dose Expansion|Fungal infection|0|||
161838789|NCT00369655|584453503|FG000|Overall Study|Refusal of further treatment|2|||
161838790|NCT03402750|584453504|FG000|Overall Study|Lost to Follow-up|2|||
161838791|NCT03402750|584453505|FG001|Overall Study|Lost to Follow-up|1|||
161965661|NCT04283994|584920405|FG005|Overall Study|Withdrawal by Subject|1|||
162032220|NCT00075270|585175439|FG000|Overall Study|Death|198|||
161730470|NCT04804033|584055948|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
161730471|NCT04804033|584055945|FG000|Period 2: OLE Phase|Adverse Event|3|||
161730472|NCT04804033|584055946|FG001|Period 2: OLE Phase|Adverse Event|4|||
161730473|NCT04804033|584055947|FG002|Period 2: OLE Phase|Adverse Event|2|||
161730474|NCT04804033|584055948|FG003|Period 2: OLE Phase|Adverse Event|0|||
161730475|NCT04804033|584055945|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
161730476|NCT04804033|584055946|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
161730477|NCT04804033|584055947|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
161730478|NCT04804033|584055948|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
161730479|NCT04804033|584055945|FG000|Period 2: OLE Phase|Non-compliance|2|||
161730480|NCT04804033|584055946|FG001|Period 2: OLE Phase|Non-compliance|2|||
161730481|NCT04804033|584055947|FG002|Period 2: OLE Phase|Non-compliance|0|||
161730482|NCT04804033|584055948|FG003|Period 2: OLE Phase|Non-compliance|1|||
161730483|NCT04804033|584055945|FG000|Period 2: OLE Phase|Other|0|||
161730484|NCT04804033|584055946|FG001|Period 2: OLE Phase|Other|2|||
161730485|NCT04804033|584055947|FG002|Period 2: OLE Phase|Other|0|||
161730486|NCT04804033|584055948|FG003|Period 2: OLE Phase|Other|0|||
161730487|NCT04804033|584055945|FG000|Period 2: OLE Phase|Physician Decision|1|||
161730488|NCT04804033|584055946|FG001|Period 2: OLE Phase|Physician Decision|1|||
161730489|NCT04804033|584055947|FG002|Period 2: OLE Phase|Physician Decision|0|||
161730490|NCT04804033|584055948|FG003|Period 2: OLE Phase|Physician Decision|0|||
161730491|NCT04804033|584055945|FG000|Period 2: OLE Phase|Pregnancy|0|||
161730492|NCT04804033|584055946|FG001|Period 2: OLE Phase|Pregnancy|0|||
161730493|NCT04804033|584055947|FG002|Period 2: OLE Phase|Pregnancy|2|||
161730494|NCT04804033|584055948|FG003|Period 2: OLE Phase|Pregnancy|0|||
161730495|NCT04804033|584055945|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
161730496|NCT04804033|584055946|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
161730497|NCT04804033|584055947|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
161730498|NCT04804033|584055948|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
161730499|NCT04804033|584055945|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
161730500|NCT04804033|584055946|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
161730501|NCT04804033|584055947|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
161730502|NCT04804033|584055948|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
161730503|NCT04804033|584055945|FG000|Period 2: OLE Phase|Not reported|0|||
161730504|NCT04804033|584055946|FG001|Period 2: OLE Phase|Not reported|2|||
161730505|NCT04804033|584055947|FG002|Period 2: OLE Phase|Not reported|0|||
161730506|NCT04804033|584055948|FG003|Period 2: OLE Phase|Not reported|0|||
161730507|NCT04804033|584055945|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
161730508|NCT04804033|584055946|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
161730509|NCT04804033|584055947|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
161730510|NCT04804033|584055948|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
161730511|NCT04804033|584055945|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
161730512|NCT04804033|584055946|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
161730513|NCT04804033|584055947|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
161730514|NCT04804033|584055948|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
161730515|NCT04804033|584055945|FG000|Period 3: Follow-up Phase|Other|0|||
161730516|NCT04804033|584055946|FG001|Period 3: Follow-up Phase|Other|1|||
161730517|NCT04804033|584055947|FG002|Period 3: Follow-up Phase|Other|2|||
161730518|NCT04804033|584055948|FG003|Period 3: Follow-up Phase|Other|1|||
161730519|NCT04804033|584055945|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
161730520|NCT04804033|584055946|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
161730521|NCT04804033|584055947|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
161730522|NCT04804033|584055948|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
161730523|NCT04804033|584055945|FG000|Period 3: Follow-up Phase|Not reported|18|||
161730524|NCT04804033|584055946|FG001|Period 3: Follow-up Phase|Not reported|15|||
161730525|NCT04804033|584055947|FG002|Period 3: Follow-up Phase|Not reported|1|||
161730526|NCT04804033|584055948|FG003|Period 3: Follow-up Phase|Not reported|4|||
161730527|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
161730528|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
161730529|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
161730530|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
161730531|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
161730532|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
161730533|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
161730534|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
161730535|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
161730536|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
161730537|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
161730538|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
161730539|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
161730540|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
161730541|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
161730542|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
161730543|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
161730544|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
162032221|NCT00075270|585175440|FG001|Overall Study|Death|215|||
161730545|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
161730546|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
161730547|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
161730548|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161730549|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161730550|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161730551|NCT01106625|584055951|FG000|Core Period: Baseline to Week 26|Other|8|||
161730552|NCT01106625|584055952|FG001|Core Period: Baseline to Week 26|Other|7|||
161730553|NCT01106625|584055953|FG002|Core Period: Baseline to Week 26|Other|4|||
161730554|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
161730555|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
161730556|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
161730557|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
161730558|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
161730559|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
161730560|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
161730561|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161730562|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
161730563|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161730564|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161730565|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161730566|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
161730567|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161730568|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161730569|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
161730570|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
161730571|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
161730572|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
161730573|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
161730574|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
161730575|NCT01106625|584055951|FG000|Extension Period: Week 26 to Week 52|Other|5|||
161730576|NCT01106625|584055952|FG001|Extension Period: Week 26 to Week 52|Other|5|||
161730577|NCT01106625|584055953|FG002|Extension Period: Week 26 to Week 52|Other|4|||
161730578|NCT02496585|584055954|FG000|Overall Study|Death|3|||
161730579|NCT02496585|584055955|FG001|Overall Study|Death|0|||
161730580|NCT02496585|584055954|FG000|Overall Study|Lost to Follow-up|2|||
161730581|NCT02496585|584055955|FG001|Overall Study|Lost to Follow-up|0|||
161730582|NCT02496585|584055954|FG000|Overall Study|Withdrawal by Subject|1|||
161730583|NCT02496585|584055955|FG001|Overall Study|Withdrawal by Subject|2|||
161730584|NCT02496585|584055954|FG000|Overall Study|Progression of Malignancy|4|||
161730585|NCT02496585|584055955|FG001|Overall Study|Progression of Malignancy|1|||
161730586|NCT01864018|584055959|FG000|Overall Study|Ineligible|3|||
161730587|NCT01864018|584055960|FG001|Overall Study|Ineligible|1|||
161730588|NCT05372575|584055964|FG000|Overall Study|Protocol Violation|7|||
161730589|NCT05372575|584055965|FG001|Overall Study|Protocol Violation|16|||
161730590|NCT03345836|584055966|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
161730591|NCT03345836|584055967|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
161730592|NCT03345836|584055968|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
161730593|NCT03345836|584055969|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
161730594|NCT03345836|584055970|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
161730595|NCT03345836|584055971|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
161730596|NCT03345836|584055966|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
161730597|NCT03345836|584055967|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
161730598|NCT03345836|584055968|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
161730599|NCT03345836|584055969|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
161730600|NCT03345836|584055970|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
161730601|NCT03345836|584055971|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
161730602|NCT03345836|584055966|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161730603|NCT03345836|584055967|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
161730604|NCT03345836|584055968|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161730605|NCT03345836|584055969|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161730606|NCT03345836|584055970|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161730607|NCT03345836|584055971|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161730608|NCT03345836|584055966|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
161730609|NCT03345836|584055967|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
161965662|NCT04283994|584920406|FG006|Overall Study|Withdrawal by Subject|0|||
161838792|NCT02981303|584453506|FG000|Overall Study|Progressive Disease|17|||
161838793|NCT02981303|584453507|FG001|Overall Study|Progressive Disease|37|||
161838794|NCT02981303|584453506|FG000|Overall Study|Adverse Event|1|||
161838795|NCT02981303|584453507|FG001|Overall Study|Adverse Event|4|||
161838796|NCT02981303|584453506|FG000|Overall Study|Withdrawal by Subject|0|||
161838797|NCT02981303|584453507|FG001|Overall Study|Withdrawal by Subject|1|||
161838798|NCT00848107|584453508|FG000|Overall Study|Lost to Follow-up|2|||
161838799|NCT00848107|584453508|FG000|Overall Study|Withdrawal by Subject|8|||
161838800|NCT00848107|584453508|FG000|Overall Study|Adverse Event|9|||
161838801|NCT00848107|584453508|FG000|Overall Study|Death|1|||
161838802|NCT00848107|584453508|FG000|Overall Study|Pregnancy|1|||
161838803|NCT02266134|584453512|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
161838804|NCT02266134|584453513|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
161838805|NCT02266134|584453514|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
161838806|NCT02266134|584453515|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
161838807|NCT02266134|584453512|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
161838808|NCT02266134|584453513|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
161838809|NCT02266134|584453514|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
161838810|NCT02266134|584453515|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
161838811|NCT02266134|584453512|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
161838812|NCT02266134|584453513|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
161838813|NCT02266134|584453514|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
161838814|NCT02266134|584453515|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
161838815|NCT02266134|584453512|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
161838816|NCT02266134|584453513|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
161838817|NCT02266134|584453514|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
161838818|NCT02266134|584453515|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
161838819|NCT02266134|584453512|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
161838820|NCT02266134|584453513|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
161838821|NCT02266134|584453514|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
161838822|NCT02266134|584453515|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
161838823|NCT02266134|584453512|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
161838824|NCT02266134|584453513|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
161838825|NCT02266134|584453514|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
161838826|NCT02266134|584453515|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
161838827|NCT00762437|584453516|FG000|Overall Study|Lost to Follow-up|7|||
161838828|NCT00762437|584453516|FG000|Overall Study|Missed final study visit|11|||
161838829|NCT00762437|584453516|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
161838830|NCT00302081|584453520|FG000|Overall Study|Adverse Event|6|||
161838831|NCT00302081|584453521|FG001|Overall Study|Adverse Event|5|||
161965663|NCT03315793|584920407|FG000|Overall Study|Adverse Event|4|||
161965664|NCT03315793|584920408|FG001|Overall Study|Adverse Event|2|||
161965665|NCT03315793|584920407|FG000|Overall Study|Protocol Deviation|1|||
161965666|NCT03315793|584920408|FG001|Overall Study|Protocol Deviation|0|||
161965667|NCT03315793|584920407|FG000|Overall Study|Difficult for regular visit|0|||
161965668|NCT03315793|584920408|FG001|Overall Study|Difficult for regular visit|1|||
161965669|NCT01448824|584921821|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161965670|NCT01448824|584921822|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161965671|NCT01448824|584921823|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161965672|NCT01448824|584921824|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161965673|NCT01448824|584921825|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161965674|NCT01448824|584921826|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161965675|NCT01448824|584921827|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
161965676|NCT01448824|584921828|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
161965677|NCT01448824|584921821|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
161965678|NCT01448824|584921822|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
161965679|NCT01448824|584921823|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
161965680|NCT01448824|584921824|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
161965681|NCT01448824|584921825|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
161965682|NCT01448824|584921826|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
161730610|NCT03345836|584055968|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
161730611|NCT03345836|584055969|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
161730612|NCT03345836|584055970|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
161730613|NCT03345836|584055971|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
161730614|NCT03345836|584055966|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
161730615|NCT03345836|584055967|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
161730616|NCT03345836|584055968|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
161730617|NCT03345836|584055969|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
161730618|NCT03345836|584055970|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
161730619|NCT03345836|584055971|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
161730620|NCT03345836|584055966|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
161730621|NCT03345836|584055967|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
161730622|NCT03345836|584055968|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
161730623|NCT03345836|584055969|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
161730624|NCT03345836|584055970|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
161730625|NCT03345836|584055971|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
161730626|NCT03345836|584055966|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
161730627|NCT03345836|584055967|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
161730628|NCT03345836|584055968|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
161730629|NCT03345836|584055969|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
161730630|NCT03345836|584055970|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
161730631|NCT03345836|584055971|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
161730632|NCT03345836|584055966|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161730633|NCT03345836|584055967|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161730634|NCT03345836|584055968|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161730635|NCT03345836|584055969|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161730636|NCT03345836|584055970|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161730637|NCT03345836|584055971|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
161730638|NCT03345836|584055966|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
161730639|NCT03345836|584055967|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
161730640|NCT03345836|584055968|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
161730641|NCT03345836|584055969|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
161730642|NCT03345836|584055970|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
161730643|NCT03345836|584055971|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
161730644|NCT03345836|584055966|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161730645|NCT03345836|584055967|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161730646|NCT03345836|584055968|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161730647|NCT03345836|584055969|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161730648|NCT03345836|584055970|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
161838832|NCT00302081|584453522|FG002|Overall Study|Adverse Event|4|||
161838833|NCT00302081|584453520|FG000|Overall Study|Lost to Follow-up|21|||
161838834|NCT00302081|584453521|FG001|Overall Study|Lost to Follow-up|18|||
161838835|NCT00302081|584453522|FG002|Overall Study|Lost to Follow-up|28|||
161838836|NCT00302081|584453520|FG000|Overall Study|Withdrawal by Subject|8|||
161838837|NCT00302081|584453521|FG001|Overall Study|Withdrawal by Subject|12|||
161838838|NCT00302081|584453522|FG002|Overall Study|Withdrawal by Subject|8|||
161838839|NCT00302081|584453520|FG000|Overall Study|Protocol Violation|5|||
161838840|NCT00302081|584453521|FG001|Overall Study|Protocol Violation|1|||
161838841|NCT00302081|584453522|FG002|Overall Study|Protocol Violation|2|||
161838842|NCT00302081|584453520|FG000|Overall Study|Lack of Efficacy|1|||
161838843|NCT00302081|584453521|FG001|Overall Study|Lack of Efficacy|0|||
161965683|NCT01448824|584921827|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
161965684|NCT01448824|584921828|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
161965685|NCT01448824|584921821|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161965686|NCT01448824|584921822|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161965687|NCT01448824|584921823|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161965688|NCT01448824|584921824|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161965689|NCT01448824|584921825|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161965690|NCT01448824|584921826|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
161965691|NCT01448824|584921827|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161965692|NCT01448824|584921828|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
161965693|NCT01448824|584921821|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
161965694|NCT01448824|584921822|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
161965695|NCT01448824|584921823|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
161965696|NCT01448824|584921824|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
161965697|NCT01448824|584921825|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
161965698|NCT01448824|584921826|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
161965699|NCT01448824|584921827|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
161965700|NCT01448824|584921828|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
161965701|NCT01448824|584921821|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161965702|NCT01448824|584921822|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161965703|NCT01448824|584921823|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161965704|NCT01448824|584921824|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161965705|NCT01448824|584921825|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161838844|NCT00302081|584453522|FG002|Overall Study|Lack of Efficacy|5|||
161838845|NCT00302081|584453520|FG000|Overall Study|Death|2|||
161838846|NCT00302081|584453521|FG001|Overall Study|Death|1|||
161838847|NCT00302081|584453522|FG002|Overall Study|Death|0|||
161838848|NCT00302081|584453520|FG000|Overall Study|Other|13|||
161838849|NCT00302081|584453521|FG001|Overall Study|Other|6|||
161838850|NCT00302081|584453522|FG002|Overall Study|Other|5|||
161838851|NCT04771403|584453523|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
161838852|NCT04771403|584453524|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
161838853|NCT04771403|584453523|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
161838854|NCT04771403|584453524|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
161838855|NCT04771403|584453523|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
161838856|NCT04771403|584453524|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
161838857|NCT04771403|584453523|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
161838858|NCT04771403|584453524|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
161838859|NCT04771403|584453523|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
161838860|NCT04771403|584453524|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
161838861|NCT04771403|584453523|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
161838862|NCT04771403|584453524|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
161838863|NCT04771403|584453523|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
161838864|NCT04771403|584453524|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
161838865|NCT04771403|584453523|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
161838866|NCT04771403|584453524|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
161838867|NCT00857259|584453525|FG000|Overall Study|Protocol Violation|1|||
161838868|NCT00857259|584453526|FG001|Overall Study|Protocol Violation|0|||
161838869|NCT00857259|584453527|FG002|Overall Study|Protocol Violation|1|||
161838870|NCT02701413|584453528|FG000|Overall Study|Withdrawal by Subject|7|||
161838871|NCT02701413|584453529|FG001|Overall Study|Withdrawal by Subject|11|||
161838872|NCT02138136|584453530|FG000|Overall Study|Protocol Violation|4|||
161838873|NCT02138136|584453530|FG000|Overall Study|Physician Decision|7|||
161838874|NCT02138136|584453530|FG000|Overall Study|Lack of Efficacy|35|||
161838875|NCT02138136|584453530|FG000|Overall Study|Pregnancy|2|||
161838876|NCT02138136|584453530|FG000|Overall Study|Adverse Event|18|||
161838877|NCT02138136|584453530|FG000|Overall Study|Withdrawal by Subject|36|||
161838878|NCT02138136|584453530|FG000|Overall Study|Lost to Follow-up|32|||
161838879|NCT02138136|584453530|FG000|Overall Study|Withdrawn by Sponsor|5|||
161838880|NCT01359644|584453535|FG000|Treatment Period|Lack of Efficacy|0|||
161838881|NCT01359644|584453536|FG001|Treatment Period|Lack of Efficacy|1|||
161838882|NCT01359644|584453537|FG002|Treatment Period|Lack of Efficacy|0|||
161838883|NCT01359644|584453538|FG003|Treatment Period|Lack of Efficacy|0|||
161838884|NCT01359644|584453539|FG004|Treatment Period|Lack of Efficacy|0|||
161838885|NCT01359644|584453540|FG005|Treatment Period|Lack of Efficacy|0|||
161838886|NCT01359644|584453541|FG006|Treatment Period|Lack of Efficacy|0|||
161838887|NCT01359644|584453542|FG007|Treatment Period|Lack of Efficacy|0|||
161838888|NCT01359644|584453543|FG008|Treatment Period|Lack of Efficacy|0|||
161838889|NCT01359644|584453544|FG009|Treatment Period|Lack of Efficacy|0|||
161838890|NCT01359644|584453535|FG000|Treatment Period|Adverse Event|0|||
161838891|NCT01359644|584453536|FG001|Treatment Period|Adverse Event|0|||
161838892|NCT01359644|584453537|FG002|Treatment Period|Adverse Event|1|||
161838893|NCT01359644|584453538|FG003|Treatment Period|Adverse Event|0|||
161838894|NCT01359644|584453539|FG004|Treatment Period|Adverse Event|0|||
161838895|NCT01359644|584453540|FG005|Treatment Period|Adverse Event|1|||
161838896|NCT01359644|584453541|FG006|Treatment Period|Adverse Event|0|||
161838897|NCT01359644|584453542|FG007|Treatment Period|Adverse Event|0|||
161838898|NCT01359644|584453543|FG008|Treatment Period|Adverse Event|0|||
161838899|NCT01359644|584453544|FG009|Treatment Period|Adverse Event|0|||
161838900|NCT01359644|584453535|FG000|Treatment Period|Lost to Follow-up|0|||
161838901|NCT01359644|584453536|FG001|Treatment Period|Lost to Follow-up|0|||
161838902|NCT01359644|584453537|FG002|Treatment Period|Lost to Follow-up|0|||
161838903|NCT01359644|584453538|FG003|Treatment Period|Lost to Follow-up|0|||
161838904|NCT01359644|584453539|FG004|Treatment Period|Lost to Follow-up|0|||
161838905|NCT01359644|584453540|FG005|Treatment Period|Lost to Follow-up|1|||
161838906|NCT01359644|584453541|FG006|Treatment Period|Lost to Follow-up|0|||
161838907|NCT01359644|584453542|FG007|Treatment Period|Lost to Follow-up|0|||
161838908|NCT01359644|584453543|FG008|Treatment Period|Lost to Follow-up|0|||
161838909|NCT01359644|584453544|FG009|Treatment Period|Lost to Follow-up|0|||
161965706|NCT01448824|584921826|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161730649|NCT03345836|584055971|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161730650|NCT03345836|584055966|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
161730651|NCT03345836|584055967|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
161730652|NCT03345836|584055968|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
161730653|NCT03345836|584055969|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
161730654|NCT03345836|584055970|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
161730655|NCT03345836|584055971|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
161730656|NCT03510663|584055972|FG000|Overall Study|Withdrawal by Subject|0|||
161730657|NCT03510663|584055973|FG001|Overall Study|Withdrawal by Subject|1|||
161730658|NCT03510663|584055974|FG002|Overall Study|Withdrawal by Subject|0|||
161730659|NCT03510663|584055975|FG003|Overall Study|Withdrawal by Subject|0|||
161730660|NCT03510663|584055976|FG004|Overall Study|Withdrawal by Subject|0|||
161730661|NCT03510663|584055977|FG005|Overall Study|Withdrawal by Subject|0|||
161730662|NCT03510663|584055978|FG006|Overall Study|Withdrawal by Subject|0|||
161730663|NCT03510663|584055979|FG007|Overall Study|Withdrawal by Subject|0|||
161730664|NCT00222729|584055982|FG000|Overall Study|Adverse Event|3|||
161730665|NCT01915849|584055985|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
161730666|NCT01915849|584055986|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
161730667|NCT01915849|584055987|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
161730668|NCT01915849|584055988|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
161730669|NCT01915849|584055985|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
161730670|NCT01915849|584055986|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161730671|NCT01915849|584055987|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161730672|NCT01915849|584055988|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161730673|NCT01798706|584055989|FG000|Overall Study|Adverse Event|15|||
161730674|NCT01798706|584055990|FG001|Overall Study|Adverse Event|10|||
161730675|NCT01798706|584055989|FG000|Overall Study|Lack of Efficacy|0|||
161730676|NCT01798706|584055990|FG001|Overall Study|Lack of Efficacy|2|||
161730677|NCT01798706|584055989|FG000|Overall Study|Poor compliance to protocol|1|||
161730678|NCT01798706|584055990|FG001|Overall Study|Poor compliance to protocol|0|||
161730679|NCT01798706|584055989|FG000|Overall Study|Other than specified above|5|||
161730680|NCT01798706|584055990|FG001|Overall Study|Other than specified above|9|||
161730681|NCT02775864|584055991|FG000|Overall Study|Data ended end of 2010|1764|||
161730682|NCT02775864|584055992|FG001|Overall Study|Data ended end of 2010|2880|||
161730683|NCT02775864|584055993|FG002|Overall Study|Data ended end of 2010|1140|||
161730684|NCT02775864|584055994|FG003|Overall Study|Data ended end of 2010|1194|||
161730685|NCT02775864|584055991|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
161730686|NCT02775864|584055992|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
161730687|NCT02775864|584055993|FG002|Overall Study|Medicaid eligibility discontinued|720|||
161730688|NCT02775864|584055994|FG003|Overall Study|Medicaid eligibility discontinued|890|||
161730689|NCT04369430|584056002|FG000|Overall Study|Adverse Event|2|||
161730690|NCT04369430|584056003|FG001|Overall Study|Adverse Event|3|||
161730691|NCT04369430|584056002|FG000|Overall Study|Death|1|||
161730692|NCT04369430|584056003|FG001|Overall Study|Death|0|||
161730693|NCT04369430|584056002|FG000|Overall Study|Withdrawal by Subject|4|||
161730694|NCT04369430|584056003|FG001|Overall Study|Withdrawal by Subject|3|||
161730695|NCT04369430|584056002|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
161730696|NCT04369430|584056003|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
161730697|NCT04369430|584056002|FG000|Overall Study|Lost to Follow-up|0|||
161730698|NCT04369430|584056003|FG001|Overall Study|Lost to Follow-up|1|||
161730699|NCT04737031|584056004|FG000|Overall Study|Patients who did not have a treatment visit|0|||
161730700|NCT04737031|584056005|FG001|Overall Study|Patients who did not have a treatment visit|31|||
161730701|NCT04737031|584056006|FG002|Overall Study|Patients who did not have a treatment visit|93|||
161730702|NCT04737031|584056007|FG003|Overall Study|Patients who did not have a treatment visit|227|||
161730703|NCT02669862|584057965|FG000|Overall Study|Lost to Follow-up|0|||
161730704|NCT02669862|584057966|FG001|Overall Study|Lost to Follow-up|2|||
161730705|NCT02669862|584057967|FG002|Overall Study|Lost to Follow-up|1|||
161730706|NCT02669862|584057965|FG000|Overall Study|Withdrawal by Subject|2|||
161730707|NCT02669862|584057966|FG001|Overall Study|Withdrawal by Subject|2|||
161730708|NCT02669862|584057967|FG002|Overall Study|Withdrawal by Subject|3|||
161730709|NCT02669862|584057965|FG000|Overall Study|moved|0|||
161730710|NCT02669862|584057966|FG001|Overall Study|moved|1|||
161730711|NCT02669862|584057967|FG002|Overall Study|moved|0|||
161730712|NCT02669862|584057965|FG000|Overall Study|Protocol Violation|0|||
161730713|NCT02669862|584057966|FG001|Overall Study|Protocol Violation|0|||
161730714|NCT02669862|584057967|FG002|Overall Study|Protocol Violation|1|||
161730715|NCT01194804|584057968|FG000|Overall Study|Withdrawal by Subject|1|||
161730716|NCT02670915|584057969|FG000|Overall Study|Withdrawal by Subject|0|||
161730717|NCT02670915|584057970|FG001|Overall Study|Withdrawal by Subject|1|||
161730718|NCT02670915|584057971|FG002|Overall Study|Withdrawal by Subject|4|||
161730719|NCT02670915|584057969|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161730720|NCT02670915|584057970|FG001|Overall Study|Withdrawal by parent/guardian|4|||
161730721|NCT02670915|584057971|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161730722|NCT02670915|584057969|FG000|Overall Study|Unclassified|0|||
161838910|NCT01359644|584453535|FG000|Follow-up Period|Withdrawal by Subject|0|||
161838911|NCT01359644|584453536|FG001|Follow-up Period|Withdrawal by Subject|0|||
161838912|NCT01359644|584453537|FG002|Follow-up Period|Withdrawal by Subject|0|||
161838913|NCT01359644|584453538|FG003|Follow-up Period|Withdrawal by Subject|0|||
161838914|NCT01359644|584453539|FG004|Follow-up Period|Withdrawal by Subject|0|||
161838915|NCT01359644|584453540|FG005|Follow-up Period|Withdrawal by Subject|1|||
161838916|NCT01359644|584453541|FG006|Follow-up Period|Withdrawal by Subject|0|||
161838917|NCT01359644|584453542|FG007|Follow-up Period|Withdrawal by Subject|0|||
161838918|NCT01359644|584453543|FG008|Follow-up Period|Withdrawal by Subject|0|||
161838919|NCT01359644|584453544|FG009|Follow-up Period|Withdrawal by Subject|0|||
161838920|NCT01359644|584453535|FG000|Follow-up Period|Lost to Follow-up|0|||
161730723|NCT02670915|584057970|FG001|Overall Study|Unclassified|3|||
161730724|NCT02670915|584057971|FG002|Overall Study|Unclassified|0|||
161730725|NCT00818207|584057972|FG000|Overall Study|Adverse Event|6|||
161730726|NCT00818207|584057973|FG001|Overall Study|Adverse Event|0|||
161730727|NCT00818207|584057972|FG000|Overall Study|Lost to Follow-up|160|||
161730728|NCT00818207|584057973|FG001|Overall Study|Lost to Follow-up|146|||
161730729|NCT00818207|584057972|FG000|Overall Study|Multiple reasons|11|||
161730730|NCT00818207|584057973|FG001|Overall Study|Multiple reasons|12|||
161730731|NCT00818207|584057972|FG000|Overall Study|Withdrawal by Subject|42|||
161730732|NCT00818207|584057973|FG001|Overall Study|Withdrawal by Subject|104|||
161730733|NCT00818207|584057972|FG000|Overall Study|Death|3|||
161730734|NCT00818207|584057973|FG001|Overall Study|Death|5|||
161730735|NCT01303380|584057974|FG000|Overall Study|Lack of compliance to study procedures|1|||
161730736|NCT01030458|584057975|FG000|Overall Study|Lost to Follow-up|9|||
161730737|NCT01030458|584057976|FG001|Overall Study|Lost to Follow-up|10|||
161730738|NCT01030458|584057975|FG000|Overall Study|Withdrawal by Subject|2|||
161730739|NCT01030458|584057976|FG001|Overall Study|Withdrawal by Subject|3|||
161730740|NCT01030458|584057975|FG000|Overall Study|Logistical reasons|9|||
161730741|NCT01030458|584057976|FG001|Overall Study|Logistical reasons|5|||
161730742|NCT01030458|584057975|FG000|Overall Study|Moved or changed job|6|||
161730743|NCT01030458|584057976|FG001|Overall Study|Moved or changed job|13|||
161730744|NCT01030458|584057975|FG000|Overall Study|Side effect of medication|1|||
161730745|NCT01030458|584057976|FG001|Overall Study|Side effect of medication|1|||
161730746|NCT00839423|584057979|FG000|Overall Study|Adverse Event|4|||
161730747|NCT00839423|584057980|FG001|Overall Study|Adverse Event|3|||
161730748|NCT00839423|584057981|FG002|Overall Study|Adverse Event|7|||
161730749|NCT00839423|584057982|FG003|Overall Study|Adverse Event|16|||
161730750|NCT00839423|584057979|FG000|Overall Study|Lack of Efficacy|6|||
161730751|NCT00839423|584057980|FG001|Overall Study|Lack of Efficacy|6|||
161730752|NCT00839423|584057981|FG002|Overall Study|Lack of Efficacy|3|||
161730753|NCT00839423|584057982|FG003|Overall Study|Lack of Efficacy|2|||
161730754|NCT00839423|584057979|FG000|Overall Study|Non-compliance|0|||
161730755|NCT00839423|584057980|FG001|Overall Study|Non-compliance|0|||
161730756|NCT00839423|584057981|FG002|Overall Study|Non-compliance|0|||
161730757|NCT00839423|584057982|FG003|Overall Study|Non-compliance|1|||
161730758|NCT00839423|584057979|FG000|Overall Study|Protocol Violation|0|||
161730759|NCT00839423|584057980|FG001|Overall Study|Protocol Violation|1|||
161730760|NCT00839423|584057981|FG002|Overall Study|Protocol Violation|2|||
161730761|NCT00839423|584057982|FG003|Overall Study|Protocol Violation|0|||
161730762|NCT00839423|584057979|FG000|Overall Study|Withdrawal of consent|4|||
161730763|NCT00839423|584057980|FG001|Overall Study|Withdrawal of consent|0|||
161730764|NCT00839423|584057981|FG002|Overall Study|Withdrawal of consent|4|||
161730765|NCT00839423|584057982|FG003|Overall Study|Withdrawal of consent|1|||
161730766|NCT00839423|584057979|FG000|Overall Study|Lost to Follow-up|1|||
161838921|NCT01359644|584453536|FG001|Follow-up Period|Lost to Follow-up|0|||
161838922|NCT01359644|584453537|FG002|Follow-up Period|Lost to Follow-up|0|||
161838923|NCT01359644|584453538|FG003|Follow-up Period|Lost to Follow-up|0|||
161838924|NCT01359644|584453539|FG004|Follow-up Period|Lost to Follow-up|0|||
161838925|NCT01359644|584453540|FG005|Follow-up Period|Lost to Follow-up|0|||
161838926|NCT01359644|584453541|FG006|Follow-up Period|Lost to Follow-up|1|||
161838927|NCT01359644|584453542|FG007|Follow-up Period|Lost to Follow-up|2|||
161838928|NCT01359644|584453543|FG008|Follow-up Period|Lost to Follow-up|0|||
161730767|NCT00839423|584057980|FG001|Overall Study|Lost to Follow-up|0|||
161838929|NCT01359644|584453544|FG009|Follow-up Period|Lost to Follow-up|0|||
161838930|NCT01660334|584453546|FG000|Overall Study|Lost to Follow-up|1|||
161730768|NCT00839423|584057981|FG002|Overall Study|Lost to Follow-up|1|||
161730769|NCT00839423|584057982|FG003|Overall Study|Lost to Follow-up|0|||
161838931|NCT00311311|584453547|FG000|Overall Study|Adverse Event|3|||
161730770|NCT00839423|584057979|FG000|Overall Study|Administrative or other reasons|3|||
161730771|NCT00839423|584057980|FG001|Overall Study|Administrative or other reasons|0|||
161730772|NCT00839423|584057981|FG002|Overall Study|Administrative or other reasons|1|||
161730773|NCT00839423|584057982|FG003|Overall Study|Administrative or other reasons|0|||
161730774|NCT01071096|584057983|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
161730775|NCT01071096|584057984|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
161730776|NCT01369849|584057985|FG000|Overall Study|Ineligible prior to treatment|0|||
161730777|NCT01369849|584057986|FG001|Overall Study|Ineligible prior to treatment|0|||
161730778|NCT01369849|584057987|FG002|Overall Study|Ineligible prior to treatment|1|||
161730779|NCT01369849|584057985|FG000|Overall Study|Ineligible after receiving treatment|0|||
161730780|NCT01369849|584057986|FG001|Overall Study|Ineligible after receiving treatment|1|||
161730781|NCT01369849|584057987|FG002|Overall Study|Ineligible after receiving treatment|0|||
161730782|NCT00756886|584057988|FG000|Overall Study|Lost to Follow-up|1|||
161730783|NCT00756886|584057989|FG001|Overall Study|Lost to Follow-up|0|||
161730784|NCT00756886|584057988|FG000|Overall Study|Adverse Event|0|||
161730785|NCT00756886|584057989|FG001|Overall Study|Adverse Event|3|||
161730786|NCT00756886|584057988|FG000|Overall Study|Lack of Efficacy|1|||
161730787|NCT00756886|584057989|FG001|Overall Study|Lack of Efficacy|0|||
161730788|NCT00756886|584057988|FG000|Overall Study|Ineligible|9|||
161730789|NCT00756886|584057989|FG001|Overall Study|Ineligible|4|||
161730790|NCT00871377|584057994|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161730791|NCT00871377|584057995|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161730792|NCT00871377|584057996|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
161730793|NCT00871377|584057997|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161730794|NCT00871377|584057998|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161730795|NCT00871377|584057999|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161730796|NCT00871377|584057994|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161730797|NCT00871377|584057995|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161730798|NCT00871377|584057996|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161730799|NCT00871377|584057997|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161730800|NCT00871377|584057998|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161730801|NCT00871377|584057999|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
161730802|NCT00871377|584057994|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
161730803|NCT00871377|584057995|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730804|NCT00871377|584057996|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730805|NCT00871377|584057997|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730806|NCT00871377|584057998|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730807|NCT00871377|584057999|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730808|NCT00871377|584057994|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730809|NCT00871377|584057995|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730810|NCT00871377|584057996|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730811|NCT00871377|584057997|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730812|NCT00871377|584057998|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
161730813|NCT00871377|584057999|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
161730814|NCT00871377|584057994|FG000|Third Intervention (10 Weeks)|Death|0|||
161730815|NCT00871377|584057995|FG001|Third Intervention (10 Weeks)|Death|0|||
161730816|NCT00871377|584057996|FG002|Third Intervention (10 Weeks)|Death|0|||
161730817|NCT00871377|584057997|FG003|Third Intervention (10 Weeks)|Death|1|||
161730818|NCT00871377|584057998|FG004|Third Intervention (10 Weeks)|Death|0|||
161730819|NCT00871377|584057999|FG005|Third Intervention (10 Weeks)|Death|0|||
161730820|NCT04348656|584058000|FG000|Overall Study|Withdrawal by Subject|2|||
161730821|NCT04348656|584058001|FG001|Overall Study|Withdrawal by Subject|0|||
161730822|NCT04348656|584058000|FG000|Overall Study|Lost to Follow-up|11|||
161730823|NCT04348656|584058001|FG001|Overall Study|Lost to Follow-up|6|||
161730824|NCT00288860|584058006|FG000|Overall Study|Did not complete intake|4|||
161730825|NCT00288860|584058007|FG001|Overall Study|Did not complete intake|8|||
161730826|NCT00288860|584058006|FG000|Overall Study|Death|4|||
161730827|NCT00288860|584058007|FG001|Overall Study|Death|3|||
161730828|NCT00288860|584058006|FG000|Overall Study|Withdrawal by Subject|20|||
161730829|NCT00288860|584058007|FG001|Overall Study|Withdrawal by Subject|15|||
161730830|NCT00288860|584058006|FG000|Overall Study|Lost to Follow-up|74|||
161730831|NCT00288860|584058007|FG001|Overall Study|Lost to Follow-up|71|||
161730832|NCT05142332|584058012|FG000|Overall Study|Withdrawal by Subject|0|||
161730833|NCT05142332|584058013|FG001|Overall Study|Withdrawal by Subject|1|||
161730834|NCT05142332|584058014|FG002|Overall Study|Withdrawal by Subject|2|||
161730835|NCT05142332|584058015|FG003|Overall Study|Withdrawal by Subject|0|||
161730836|NCT05142332|584058016|FG004|Overall Study|Withdrawal by Subject|0|||
161730837|NCT05142332|584058017|FG005|Overall Study|Withdrawal by Subject|2|||
161730838|NCT05142332|584058018|FG006|Overall Study|Withdrawal by Subject|6|||
161730839|NCT05142332|584058012|FG000|Overall Study|Left ED|3|||
161965707|NCT01448824|584921827|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
161965708|NCT01448824|584921828|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
161965709|NCT01448824|584921821|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161965710|NCT01448824|584921822|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161730840|NCT05142332|584058013|FG001|Overall Study|Left ED|0|||
161730841|NCT05142332|584058014|FG002|Overall Study|Left ED|4|||
161730842|NCT05142332|584058015|FG003|Overall Study|Left ED|6|||
161730843|NCT05142332|584058016|FG004|Overall Study|Left ED|1|||
161730844|NCT05142332|584058017|FG005|Overall Study|Left ED|2|||
161730845|NCT05142332|584058018|FG006|Overall Study|Left ED|6|||
161730846|NCT05142332|584058012|FG000|Overall Study|Physician Decision|0|||
161730847|NCT05142332|584058013|FG001|Overall Study|Physician Decision|0|||
161730848|NCT05142332|584058014|FG002|Overall Study|Physician Decision|2|||
161838932|NCT00311311|584453548|FG001|Overall Study|Adverse Event|2|||
161838933|NCT00311311|584453547|FG000|Overall Study|Withdrawal by Subject|1|||
161838934|NCT00311311|584453548|FG001|Overall Study|Withdrawal by Subject|1|||
161838935|NCT00311311|584453547|FG000|Overall Study|Noncompliance|0|||
161838936|NCT00311311|584453548|FG001|Overall Study|Noncompliance|1|||
161838937|NCT00311311|584453547|FG000|Overall Study|Study Termination by Sponsor|3|||
161838938|NCT00311311|584453548|FG001|Overall Study|Study Termination by Sponsor|4|||
161838939|NCT00311311|584453547|FG000|Overall Study|Death|1|||
161838940|NCT00311311|584453548|FG001|Overall Study|Death|0|||
161838941|NCT00311311|584453547|FG000|Overall Study|Lack of ancillary assistance|0|||
161838942|NCT00311311|584453548|FG001|Overall Study|Lack of ancillary assistance|1|||
161838943|NCT00536263|584453549|FG000|Overall Study|Adverse Event|5|||
161838944|NCT00536263|584453550|FG001|Overall Study|Adverse Event|5|||
161838945|NCT00536263|584453551|FG002|Overall Study|Adverse Event|7|||
161838946|NCT00536263|584453549|FG000|Overall Study|Lost to Follow-up|3|||
161838947|NCT00536263|584453550|FG001|Overall Study|Lost to Follow-up|4|||
161838948|NCT00536263|584453551|FG002|Overall Study|Lost to Follow-up|4|||
161838949|NCT00536263|584453549|FG000|Overall Study|Subject withdrew - not treatment related|2|||
161838950|NCT00536263|584453550|FG001|Overall Study|Subject withdrew - not treatment related|0|||
161838951|NCT00536263|584453551|FG002|Overall Study|Subject withdrew - not treatment related|5|||
161838952|NCT00536263|584453549|FG000|Overall Study|Subject withdrew - treatment related|0|||
161838953|NCT00536263|584453550|FG001|Overall Study|Subject withdrew - treatment related|3|||
161838954|NCT00536263|584453551|FG002|Overall Study|Subject withdrew - treatment related|2|||
161838955|NCT00536263|584453549|FG000|Overall Study|Noncompliance with protocol|0|||
161838956|NCT00536263|584453550|FG001|Overall Study|Noncompliance with protocol|0|||
161838957|NCT00536263|584453551|FG002|Overall Study|Noncompliance with protocol|1|||
161838958|NCT00536263|584453549|FG000|Overall Study|Did not meet protocol eligibility|1|||
161838959|NCT00536263|584453550|FG001|Overall Study|Did not meet protocol eligibility|2|||
161838960|NCT00536263|584453551|FG002|Overall Study|Did not meet protocol eligibility|2|||
161838961|NCT00826449|584453552|FG000|Overall Study|Disease Progression|4|||
161838962|NCT00826449|584453552|FG000|Overall Study|Withdrawal by Subject|1|||
161838963|NCT01640873|584453571|FG000|Overall Study|Protocol Violation|2|||
161838964|NCT01640873|584453572|FG001|Overall Study|Protocol Violation|1|||
161838965|NCT01875471|584453573|FG000|Overall Study|Adverse Event|0|||
161838966|NCT01875471|584453574|FG001|Overall Study|Adverse Event|1|||
161838967|NCT01875471|584453573|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
161838968|NCT01875471|584453574|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
161838969|NCT01321008|584453575|FG000|Overall Study|Early Study Termination|1|||
161838970|NCT02458092|584453576|FG000|Overall Study|Withdrawal by Subject|1|||
161838971|NCT02458092|584453577|FG001|Overall Study|Withdrawal by Subject|0|||
161838972|NCT00679913|584453578|FG000|Overall Study|Protocol Violation|18|||
162032222|NCT00075270|585175439|FG000|Overall Study|Other/Unknown|9|||
162032223|NCT00075270|585175440|FG001|Overall Study|Other/Unknown|5|||
162032224|NCT00075270|585175439|FG000|Overall Study|Missing|26|||
162032225|NCT00075270|585175440|FG001|Overall Study|Missing|13|||
162032226|NCT00246571|585175441|FG000|Overall Study|Adverse Event|7|||
162032227|NCT00246571|585175442|FG001|Overall Study|Adverse Event|0|||
162032228|NCT00246571|585175441|FG000|Overall Study|Protocol Violation|0|||
162032229|NCT00246571|585175442|FG001|Overall Study|Protocol Violation|1|||
162032230|NCT00246571|585175441|FG000|Overall Study|Withdrawal by Subject|2|||
162032231|NCT00246571|585175442|FG001|Overall Study|Withdrawal by Subject|3|||
161838973|NCT00679913|584453579|FG001|Overall Study|Protocol Violation|13|||
161838974|NCT00456495|584453588|FG000|Overall Study|Physician Decision|2|||
161838975|NCT01301508|584453589|FG000|Overall Study|Withdrawal by Subject|1|||
161838976|NCT01301508|584453590|FG001|Overall Study|Withdrawal by Subject|2|||
161838977|NCT01301508|584453589|FG000|Overall Study|Lost to Follow-up|0|||
161838978|NCT01301508|584453590|FG001|Overall Study|Lost to Follow-up|1|||
161838979|NCT01300923|584453591|FG000|Overall Study|Physician Decision|0|||
161838980|NCT01300923|584453592|FG001|Overall Study|Physician Decision|2|||
161838981|NCT02707861|584453595|FG000|Overall Study|Went onto commercial drug|30|||
161838982|NCT02707861|584453596|FG001|Overall Study|Went onto commercial drug|23|||
161838983|NCT02707861|584453595|FG000|Overall Study|Adverse Event|2|||
162032232|NCT00246571|585175441|FG000|Overall Study|Lack of Efficacy|84|||
161838984|NCT02707861|584453596|FG001|Overall Study|Adverse Event|3|||
161838985|NCT02707861|584453595|FG000|Overall Study|Death|5|||
161838986|NCT02707861|584453596|FG001|Overall Study|Death|2|||
162032233|NCT00246571|585175442|FG001|Overall Study|Lack of Efficacy|21|||
162032234|NCT00246571|585175441|FG000|Overall Study|Death|17|||
162032235|NCT00246571|585175442|FG001|Overall Study|Death|3|||
161838987|NCT02707861|584453595|FG000|Overall Study|Lack of Efficacy|0|||
161838988|NCT02707861|584453596|FG001|Overall Study|Lack of Efficacy|2|||
161838989|NCT02707861|584453595|FG000|Overall Study|Physician Decision|1|||
161838990|NCT02707861|584453596|FG001|Overall Study|Physician Decision|4|||
161838991|NCT02707861|584453595|FG000|Overall Study|Withdrawal by Subject|2|||
161838992|NCT02707861|584453596|FG001|Overall Study|Withdrawal by Subject|1|||
162032236|NCT00246571|585175441|FG000|Overall Study|Sponsor|0|||
162032237|NCT00246571|585175442|FG001|Overall Study|Sponsor|1|||
162032238|NCT00246571|585175441|FG000|Overall Study|Did not meet entrance criteria|2|||
161730849|NCT05142332|584058015|FG003|Overall Study|Physician Decision|1|||
161730850|NCT05142332|584058016|FG004|Overall Study|Physician Decision|0|||
161730851|NCT05142332|584058017|FG005|Overall Study|Physician Decision|0|||
161730852|NCT05142332|584058018|FG006|Overall Study|Physician Decision|3|||
161730853|NCT05142332|584058012|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
161730854|NCT05142332|584058013|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
161730855|NCT05142332|584058014|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
161730856|NCT05142332|584058015|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
161730857|NCT05142332|584058016|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
161730858|NCT05142332|584058017|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
161730859|NCT05142332|584058018|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
161730860|NCT02116660|584058019|FG000|Overall Study|Deteriorating renal function|0|||
161730861|NCT02116660|584058020|FG001|Overall Study|Deteriorating renal function|1|||
161730862|NCT02116660|584058019|FG000|Overall Study|Adverse Event|1|||
161730863|NCT02116660|584058020|FG001|Overall Study|Adverse Event|1|||
161730864|NCT02116660|584058019|FG000|Overall Study|Withdrawal by Subject|0|||
161730865|NCT02116660|584058020|FG001|Overall Study|Withdrawal by Subject|2|||
161730866|NCT02116660|584058019|FG000|Overall Study|Organization reason|1|||
161730867|NCT02116660|584058020|FG001|Overall Study|Organization reason|0|||
161730868|NCT00937560|584058026|FG000|Initial Treatment|Death|6|||
161730869|NCT00937560|584058026|FG000|Initial Treatment|Withdraw consent|3|||
161730870|NCT00937560|584058026|FG000|Initial Treatment|Adverse Event|1|||
161730871|NCT00937560|584058026|FG000|Initial Treatment|Lost to Follow-up|1|||
161730872|NCT00937560|584058026|FG000|Initial Treatment|No end of study page|10|||
161730873|NCT00937560|584058026|FG000|Maintenance Treatment|Death|12|||
161730874|NCT00937560|584058026|FG000|Maintenance Treatment|Withdraw consent|5|||
161730875|NCT00937560|584058026|FG000|Maintenance Treatment|According to protocol|1|||
161730876|NCT00411788|584058027|FG000|Overall Study|Protocol Violation|1|||
161730877|NCT00411788|584058027|FG000|Overall Study|Adverse Event|1|||
161730878|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
161730879|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
161730880|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
161730881|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
161730882|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
161730883|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
161730884|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
161730885|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
161730886|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
161730887|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
161730888|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
161730889|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
161730890|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
161730891|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
161730892|NCT00848549|584058028|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
161730893|NCT00848549|584058029|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
161730894|NCT00848549|584058028|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
161730895|NCT00848549|584058029|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
161730896|NCT00848549|584058028|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
161730897|NCT00848549|584058029|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
161730898|NCT00848549|584058028|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
161730899|NCT00848549|584058029|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
161730900|NCT00848549|584058028|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
161730901|NCT00848549|584058029|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
161730902|NCT00848549|584058028|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
161730903|NCT00848549|584058029|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
161730904|NCT00848549|584058028|FG000|E2090-E044-314 (Extension Study)|Other|5|||
161730905|NCT00848549|584058029|FG001|E2090-E044-314 (Extension Study)|Other|6|||
161730906|NCT02561299|584058030|FG000|Overall Study|Death|2|||
161730907|NCT02561299|584058031|FG001|Overall Study|Death|4|||
161730908|NCT02561299|584058030|FG000|Overall Study|Lost to Follow-up|1|||
161965711|NCT01448824|584921823|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161965712|NCT01448824|584921824|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161965713|NCT01448824|584921825|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161730909|NCT02561299|584058031|FG001|Overall Study|Lost to Follow-up|0|||
161965714|NCT01448824|584921826|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161730910|NCT02561299|584058030|FG000|Overall Study|Withdrawal by Subject|2|||
161730911|NCT02561299|584058031|FG001|Overall Study|Withdrawal by Subject|2|||
161730912|NCT05631548|584058032|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
161965715|NCT01448824|584921827|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
161838993|NCT02707861|584453595|FG000|Overall Study|Lost to Follow-up|1|||
161838994|NCT02707861|584453596|FG001|Overall Study|Lost to Follow-up|3|||
161838995|NCT01346774|584453599|FG000|Overall Study|Did not take a single dose|6|||
161838996|NCT01346774|584453600|FG001|Overall Study|Did not take a single dose|4|||
161838997|NCT01346774|584453599|FG000|Overall Study|Lost to Follow-up|3|||
161838998|NCT01346774|584453600|FG001|Overall Study|Lost to Follow-up|4|||
161838999|NCT01346774|584453599|FG000|Overall Study|Withdrawal by Subject|1|||
161839000|NCT01346774|584453600|FG001|Overall Study|Withdrawal by Subject|4|||
161839001|NCT01346774|584453599|FG000|Overall Study|Protocol Violation|2|||
161839002|NCT01346774|584453600|FG001|Overall Study|Protocol Violation|3|||
161839003|NCT01346774|584453599|FG000|Overall Study|Adverse Event|1|||
161839004|NCT01346774|584453600|FG001|Overall Study|Adverse Event|2|||
161839005|NCT00369382|584453608|FG000|Overall Study|Death|0|||
161839006|NCT00369382|584453609|FG001|Overall Study|Death|2|||
161839007|NCT00369382|584453608|FG000|Overall Study|Physician Decision|2|||
161839008|NCT00369382|584453609|FG001|Overall Study|Physician Decision|1|||
161839009|NCT00369382|584453608|FG000|Overall Study|Withdrawal by Subject|5|||
161839010|NCT00369382|584453609|FG001|Overall Study|Withdrawal by Subject|0|||
161839011|NCT00369382|584453608|FG000|Overall Study|Randomized, not treated|2|||
161839012|NCT00369382|584453609|FG001|Overall Study|Randomized, not treated|0|||
161839013|NCT00369382|584453608|FG000|Overall Study|Other|1|||
161839014|NCT00369382|584453609|FG001|Overall Study|Other|0|||
161839015|NCT00507546|584453610|FG000|Overall Study|Withdrawal by Subject|1|||
161839016|NCT00507546|584453611|FG001|Overall Study|Withdrawal by Subject|0|||
161839017|NCT00507546|584453610|FG000|Overall Study|Protocol Violation|1|||
161839018|NCT00507546|584453611|FG001|Overall Study|Protocol Violation|0|||
161839019|NCT00507546|584453610|FG000|Overall Study|Physician Decision|0|||
161839020|NCT00507546|584453611|FG001|Overall Study|Physician Decision|1|||
161839021|NCT03512262|584453615|FG000|Overall Study|Adverse Event|8|||
161839022|NCT03512262|584453616|FG001|Overall Study|Adverse Event|3|||
161839023|NCT03512262|584453615|FG000|Overall Study|Death (non-treatment emergent)|1|||
161839024|NCT03512262|584453616|FG001|Overall Study|Death (non-treatment emergent)|0|||
161839025|NCT03512262|584453615|FG000|Overall Study|Withdrawal by Subject|17|||
161839026|NCT03512262|584453616|FG001|Overall Study|Withdrawal by Subject|9|||
161839027|NCT03512262|584453615|FG000|Overall Study|Lost to Follow-up|7|||
161839028|NCT03512262|584453616|FG001|Overall Study|Lost to Follow-up|1|||
161839029|NCT03512262|584453615|FG000|Overall Study|Other than Specified|2|||
161839030|NCT03512262|584453616|FG001|Overall Study|Other than Specified|2|||
161839031|NCT01299805|584453619|FG000|Overall Study|Adverse Event|2|||
161839032|NCT01299805|584453620|FG001|Overall Study|Adverse Event|0|||
161839033|NCT04394351|584455262|FG000|Part A (16 Weeks)|Adverse Event|1|||
161839034|NCT04394351|584455263|FG001|Part A (16 Weeks)|Adverse Event|0|||
161839035|NCT04394351|584455264|FG002|Part A (16 Weeks)|Adverse Event|0|||
161839036|NCT04394351|584455265|FG003|Part A (16 Weeks)|Adverse Event|0|||
161839037|NCT04394351|584455266|FG004|Part A (16 Weeks)|Adverse Event|0|||
161839038|NCT04394351|584455267|FG005|Part A (16 Weeks)|Adverse Event|0|||
161839039|NCT04394351|584455268|FG006|Part A (16 Weeks)|Adverse Event|0|||
161839040|NCT04394351|584455269|FG007|Part A (16 Weeks)|Adverse Event|0|||
161839041|NCT04394351|584455262|FG000|Part A (16 Weeks)|Physician Decision|0|||
161839042|NCT04394351|584455263|FG001|Part A (16 Weeks)|Physician Decision|1|||
161839043|NCT04394351|584455264|FG002|Part A (16 Weeks)|Physician Decision|0|||
161839044|NCT04394351|584455265|FG003|Part A (16 Weeks)|Physician Decision|0|||
161839045|NCT04394351|584455266|FG004|Part A (16 Weeks)|Physician Decision|0|||
161839046|NCT04394351|584455267|FG005|Part A (16 Weeks)|Physician Decision|0|||
161839047|NCT04394351|584455268|FG006|Part A (16 Weeks)|Physician Decision|0|||
161839048|NCT04394351|584455269|FG007|Part A (16 Weeks)|Physician Decision|0|||
161839049|NCT04394351|584455262|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839050|NCT04394351|584455263|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
161839051|NCT04394351|584455264|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839052|NCT04394351|584455265|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839053|NCT04394351|584455266|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839054|NCT04394351|584455267|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839055|NCT04394351|584455268|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839056|NCT04394351|584455269|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
161839057|NCT04394351|584455262|FG000|Part B (36 Weeks)|Adverse Event|0|||
161839058|NCT04394351|584455263|FG001|Part B (36 Weeks)|Adverse Event|0|||
161839059|NCT04394351|584455264|FG002|Part B (36 Weeks)|Adverse Event|0|||
161839060|NCT04394351|584455265|FG003|Part B (36 Weeks)|Adverse Event|0|||
161839061|NCT04394351|584455266|FG004|Part B (36 Weeks)|Adverse Event|0|||
161839062|NCT04394351|584455267|FG005|Part B (36 Weeks)|Adverse Event|0|||
161839063|NCT04394351|584455268|FG006|Part B (36 Weeks)|Adverse Event|1|||
161839064|NCT04394351|584455269|FG007|Part B (36 Weeks)|Adverse Event|0|||
161839065|NCT04394351|584455262|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161839066|NCT04394351|584455263|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161839067|NCT04394351|584455264|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161839068|NCT04394351|584455265|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161839069|NCT04394351|584455266|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161730913|NCT05631548|584058033|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
161730914|NCT01219959|584058034|FG000|Overall Study|Adverse Event|6|||
161730915|NCT01219959|584058035|FG001|Overall Study|Adverse Event|14|||
161730916|NCT01219959|584058034|FG000|Overall Study|Physician Decision|0|||
161730917|NCT01219959|584058035|FG001|Overall Study|Physician Decision|4|||
161730918|NCT01219959|584058034|FG000|Overall Study|Withdrawal by Subject|0|||
161730919|NCT01219959|584058035|FG001|Overall Study|Withdrawal by Subject|2|||
161730920|NCT01219959|584058034|FG000|Overall Study|Renal Transplantation|0|||
161730921|NCT01219959|584058035|FG001|Overall Study|Renal Transplantation|3|||
161730922|NCT01219959|584058034|FG000|Overall Study|Other|1|||
161730923|NCT01219959|584058035|FG001|Overall Study|Other|0|||
161730924|NCT05906732|584058036|FG000|Overall Study|Withdrawal by Subject|1|||
161730925|NCT05906732|584058037|FG001|Overall Study|Withdrawal by Subject|0|||
161730926|NCT05906732|584058038|FG002|Overall Study|Withdrawal by Subject|0|||
161730927|NCT05906732|584058039|FG003|Overall Study|Withdrawal by Subject|0|||
161730928|NCT05906732|584058036|FG000|Overall Study|Physician Decision|2|||
161730929|NCT05906732|584058037|FG001|Overall Study|Physician Decision|4|||
161730930|NCT05906732|584058038|FG002|Overall Study|Physician Decision|0|||
161730931|NCT05906732|584058039|FG003|Overall Study|Physician Decision|0|||
161730932|NCT01248130|584058040|FG000|Overall Study|Protocol Violation|1|||
161730933|NCT01248130|584058041|FG001|Overall Study|Protocol Violation|0|||
161730934|NCT01248130|584058040|FG000|Overall Study|Ineligible|1|||
161730935|NCT01248130|584058041|FG001|Overall Study|Ineligible|0|||
161730936|NCT02052778|584058042|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
161730937|NCT02052778|584058043|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
161730938|NCT02052778|584058044|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
161730939|NCT02052778|584058045|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
161730940|NCT02052778|584058046|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
161730941|NCT02052778|584058047|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
161730942|NCT02052778|584058048|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730943|NCT02052778|584058049|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
161730944|NCT02052778|584058050|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
161730945|NCT02052778|584058051|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
161730946|NCT02052778|584058052|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
161730947|NCT02052778|584058053|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
161730948|NCT02052778|584058054|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
161730949|NCT02052778|584058055|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
161730950|NCT02052778|584058056|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730951|NCT02052778|584058057|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730952|NCT02052778|584058058|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730953|NCT02052778|584058059|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730954|NCT02052778|584058060|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730955|NCT02052778|584058061|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730956|NCT02052778|584058062|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730957|NCT02052778|584058063|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730958|NCT02052778|584058064|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161730959|NCT02052778|584058042|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161730960|NCT02052778|584058043|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161730961|NCT02052778|584058044|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161730962|NCT02052778|584058045|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161730963|NCT02052778|584058046|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161730964|NCT02052778|584058047|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161730965|NCT02052778|584058048|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
161730966|NCT02052778|584058049|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161730967|NCT02052778|584058050|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161730968|NCT02052778|584058051|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730969|NCT02052778|584058052|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730970|NCT02052778|584058053|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161730971|NCT02052778|584058054|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161730972|NCT02052778|584058055|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
161730973|NCT02052778|584058056|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730974|NCT02052778|584058057|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730975|NCT02052778|584058058|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730976|NCT02052778|584058059|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730977|NCT02052778|584058060|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730978|NCT02052778|584058061|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730979|NCT02052778|584058062|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730980|NCT02052778|584058063|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730981|NCT02052778|584058064|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161730982|NCT02052778|584058042|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730983|NCT02052778|584058043|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730984|NCT02052778|584058044|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730985|NCT02052778|584058045|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730986|NCT02052778|584058046|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730987|NCT02052778|584058047|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730988|NCT02052778|584058048|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730989|NCT02052778|584058049|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730990|NCT02052778|584058050|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730991|NCT02052778|584058051|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730992|NCT02052778|584058052|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730993|NCT02052778|584058053|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730994|NCT02052778|584058054|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730995|NCT02052778|584058055|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
161730996|NCT02052778|584058056|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730997|NCT02052778|584058057|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730998|NCT02052778|584058058|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161730999|NCT02052778|584058059|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161731000|NCT02052778|584058060|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161731001|NCT02052778|584058061|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161731002|NCT02052778|584058062|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161731003|NCT02052778|584058063|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161731004|NCT02052778|584058064|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161731005|NCT02052778|584058042|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
161731006|NCT02052778|584058043|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
161731007|NCT02052778|584058044|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
161731008|NCT02052778|584058045|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
161731009|NCT02052778|584058046|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
161731010|NCT02052778|584058047|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
161731011|NCT02052778|584058048|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
161731012|NCT02052778|584058049|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
161731013|NCT02052778|584058050|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
161731014|NCT02052778|584058051|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
161731015|NCT02052778|584058052|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
161731016|NCT02052778|584058053|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
161731017|NCT02052778|584058054|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
161731018|NCT02052778|584058055|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
161731019|NCT02052778|584058056|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
161731020|NCT02052778|584058057|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
161731021|NCT02052778|584058058|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
161731022|NCT02052778|584058059|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
161731023|NCT02052778|584058060|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
161731024|NCT02052778|584058061|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
161731025|NCT02052778|584058062|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
161731026|NCT02052778|584058063|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
161731027|NCT02052778|584058064|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
161731028|NCT02052778|584058042|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731029|NCT02052778|584058043|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731030|NCT02052778|584058044|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731031|NCT02052778|584058045|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731032|NCT02052778|584058046|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731033|NCT02052778|584058047|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731034|NCT02052778|584058048|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731035|NCT02052778|584058049|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731036|NCT02052778|584058050|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
161731037|NCT02052778|584058051|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731038|NCT02052778|584058052|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731039|NCT02052778|584058053|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731040|NCT02052778|584058054|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731041|NCT02052778|584058055|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
161731042|NCT02052778|584058056|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731043|NCT02052778|584058057|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731044|NCT02052778|584058058|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731045|NCT02052778|584058059|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731046|NCT02052778|584058060|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731047|NCT02052778|584058061|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731048|NCT02052778|584058062|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731049|NCT02052778|584058063|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731050|NCT02052778|584058064|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161731051|NCT02052778|584058042|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731052|NCT02052778|584058043|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731053|NCT02052778|584058044|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731054|NCT02052778|584058045|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731055|NCT02052778|584058046|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731056|NCT02052778|584058047|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
161731057|NCT02052778|584058048|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731058|NCT02052778|584058049|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731059|NCT02052778|584058050|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731060|NCT02052778|584058051|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731061|NCT02052778|584058052|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731062|NCT02052778|584058053|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731063|NCT02052778|584058054|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
161731064|NCT02052778|584058055|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731065|NCT02052778|584058056|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731066|NCT02052778|584058057|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731067|NCT02052778|584058058|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731068|NCT02052778|584058059|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731069|NCT02052778|584058060|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731070|NCT02052778|584058061|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731071|NCT02052778|584058062|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731072|NCT02052778|584058063|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731073|NCT02052778|584058064|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161731074|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731075|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731076|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731077|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731078|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731079|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731080|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731081|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731082|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731083|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731084|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731085|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731086|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731087|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731088|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
161731089|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
161731090|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
161731091|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
161731092|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
161731093|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
161731094|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
161731095|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
161731096|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161731097|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731098|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731099|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161965716|NCT01448824|584921828|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
161965717|NCT01448824|584921821|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161965718|NCT01448824|584921822|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161731100|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731101|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731102|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731103|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731104|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731105|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731106|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731107|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731108|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731109|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731110|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731111|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
161731112|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
161731113|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731114|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
161731115|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
161731116|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
161731117|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
161731118|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
161731119|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161731120|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731121|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731122|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731123|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731124|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731125|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731126|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731127|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731128|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731129|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731130|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731131|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731132|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731133|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731134|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
161731135|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
161731136|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
161731137|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731138|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
161731139|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
161731140|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731141|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731142|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161731143|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731144|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731145|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731146|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731147|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731148|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731149|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731150|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731151|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731152|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731153|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731154|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731155|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731156|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731157|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
161731158|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
161731159|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731160|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731161|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
162032239|NCT00246571|585175442|FG001|Overall Study|Did not meet entrance criteria|1|||
161731162|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731163|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731164|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731165|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161731166|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731167|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731168|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731169|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731170|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731171|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731172|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731173|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731174|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731175|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731176|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731177|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731178|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731179|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731180|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
161731181|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
161731182|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731183|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731184|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731185|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
161731186|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731187|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731188|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161731189|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
161731190|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
161731191|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
161731192|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
161731193|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
161731194|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
161731195|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
161731196|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
161731197|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
161731198|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
161731199|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
161731200|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
161731201|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
161731202|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
161731203|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
161731204|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
161731205|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
161731206|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
161731207|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
161731208|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
161731209|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
161731210|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
161731211|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
161731212|NCT02052778|584058042|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731213|NCT02052778|584058043|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731214|NCT02052778|584058044|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731215|NCT02052778|584058045|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731216|NCT02052778|584058046|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731217|NCT02052778|584058047|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731218|NCT02052778|584058048|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731219|NCT02052778|584058049|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731220|NCT02052778|584058050|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731221|NCT02052778|584058051|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731222|NCT02052778|584058052|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731223|NCT02052778|584058053|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731224|NCT02052778|584058054|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731225|NCT02052778|584058055|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161839070|NCT04394351|584455267|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161731226|NCT02052778|584058056|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161731227|NCT02052778|584058057|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161731228|NCT02052778|584058058|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161731229|NCT02052778|584058059|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731230|NCT02052778|584058060|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161731231|NCT02052778|584058061|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731232|NCT02052778|584058062|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731233|NCT02052778|584058063|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731234|NCT02052778|584058064|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161731235|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731236|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731237|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731238|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731239|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731240|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731241|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731242|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731243|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731244|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731245|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731246|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731247|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731248|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731249|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731250|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731251|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731252|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731253|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731254|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731255|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731256|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161731257|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
161731258|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731259|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731260|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731261|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731262|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731263|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731264|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731265|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731266|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731267|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731268|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731269|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731270|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731271|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731272|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731273|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731274|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731275|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731276|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731277|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731278|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731279|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161731280|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
161731281|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731282|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731283|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731284|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731285|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731286|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731287|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731288|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731289|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731290|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731291|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731292|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731293|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731294|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731295|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731296|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731297|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731298|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731299|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731300|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731301|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731302|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161731303|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
161731304|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731305|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731306|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731307|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731308|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731309|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731310|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731311|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731312|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731313|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731314|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731315|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731316|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731317|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731318|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731319|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731320|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731321|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731322|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731323|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731324|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731325|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161731326|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
161731327|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731328|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731329|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731330|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731331|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731332|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731333|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731334|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731335|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731336|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731337|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731338|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731339|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731340|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731341|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731342|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731343|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731344|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731345|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731346|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731347|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731348|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161731349|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
161731350|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
161731351|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
161731352|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
161731353|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
161731354|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
161839071|NCT04394351|584455268|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161839072|NCT04394351|584455269|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
161839073|NCT04394351|584455262|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839074|NCT04394351|584455263|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839075|NCT04394351|584455264|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839076|NCT04394351|584455265|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839077|NCT04394351|584455266|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839078|NCT04394351|584455267|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839079|NCT04394351|584455268|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161839080|NCT04394351|584455269|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
161839081|NCT04394351|584455262|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839082|NCT04394351|584455263|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839083|NCT04394351|584455264|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839084|NCT04394351|584455265|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839085|NCT04394351|584455266|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839086|NCT04394351|584455267|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839087|NCT04394351|584455268|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161839088|NCT04394351|584455269|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
161839089|NCT04394351|584455262|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839090|NCT04394351|584455263|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839091|NCT04394351|584455264|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839092|NCT04394351|584455265|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839093|NCT04394351|584455266|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839094|NCT04394351|584455267|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839095|NCT04394351|584455268|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161839096|NCT04394351|584455269|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
161839097|NCT03653507|584455270|FG000|Overall Study|Miscellaneous|28|||
161839098|NCT03653507|584455271|FG001|Overall Study|Miscellaneous|19|||
161839099|NCT03653507|584455270|FG000|Overall Study|Withdrawal by Subject|37|||
161839100|NCT03653507|584455271|FG001|Overall Study|Withdrawal by Subject|22|||
161839101|NCT03653507|584455270|FG000|Overall Study|Protocol Deviation|2|||
161839102|NCT03653507|584455271|FG001|Overall Study|Protocol Deviation|1|||
161839103|NCT03653507|584455270|FG000|Overall Study|Progressive disease|117|||
161839104|NCT03653507|584455271|FG001|Overall Study|Progressive disease|168|||
161839105|NCT03653507|584455270|FG000|Overall Study|Lost to Follow-up|1|||
161839106|NCT03653507|584455271|FG001|Overall Study|Lost to Follow-up|1|||
161839107|NCT03653507|584455270|FG000|Overall Study|Death|25|||
161839108|NCT03653507|584455271|FG001|Overall Study|Death|22|||
161839109|NCT03653507|584455270|FG000|Overall Study|Adverse Event|35|||
161839110|NCT03653507|584455271|FG001|Overall Study|Adverse Event|14|||
161839111|NCT01288053|584455278|FG000|Overall Study|Death|1|||
161839112|NCT03188666|584455279|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
161839113|NCT03188666|584455280|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
161839114|NCT03188666|584455281|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
161839115|NCT03188666|584455282|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
161839116|NCT03188666|584455279|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
161839117|NCT03188666|584455280|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
161839118|NCT03188666|584455281|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
161839119|NCT03188666|584455282|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
161839120|NCT03188666|584455279|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
161839121|NCT03188666|584455280|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
161839122|NCT03188666|584455281|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
161839123|NCT03188666|584455282|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
161839124|NCT03188666|584455279|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
161839125|NCT03188666|584455280|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
161839126|NCT03188666|584455281|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
161839127|NCT03188666|584455282|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
161839128|NCT00144781|584455283|FG000|Overall Study|Adverse Event|0|||
161839129|NCT00144781|584455284|FG001|Overall Study|Adverse Event|1|||
161839130|NCT00144781|584455285|FG002|Overall Study|Adverse Event|0|||
161839131|NCT00144781|584455286|FG003|Overall Study|Adverse Event|0|||
161839132|NCT00144781|584455283|FG000|Overall Study|Non-compliant|0|||
161839133|NCT00144781|584455284|FG001|Overall Study|Non-compliant|1|||
161839134|NCT00144781|584455285|FG002|Overall Study|Non-compliant|0|||
161731355|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
161731356|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
161731357|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
161731358|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
161731359|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
161731360|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
161731361|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
161731362|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
161839135|NCT00144781|584455286|FG003|Overall Study|Non-compliant|0|||
161839136|NCT03696953|584455287|FG000|Overall Study|Withdrawal by Subject|6|||
161839137|NCT03696953|584455288|FG001|Overall Study|Withdrawal by Subject|1|||
161839138|NCT03696953|584455287|FG000|Overall Study|missed GBS swabs|2|||
161839139|NCT03696953|584455288|FG001|Overall Study|missed GBS swabs|2|||
161839140|NCT03696953|584455287|FG000|Overall Study|lost study bottle containing capsules|2|||
161839141|NCT03696953|584455288|FG001|Overall Study|lost study bottle containing capsules|0|||
161839142|NCT03696953|584455287|FG000|Overall Study|Premature birth|1|||
161839143|NCT03696953|584455288|FG001|Overall Study|Premature birth|4|||
161839144|NCT03696953|584455287|FG000|Overall Study|Gestational hypertension|1|||
161839145|NCT03696953|584455288|FG001|Overall Study|Gestational hypertension|1|||
161839146|NCT03696953|584455287|FG000|Overall Study|Gestational diabetes|2|||
161839147|NCT03696953|584455288|FG001|Overall Study|Gestational diabetes|1|||
161839148|NCT03696953|584455287|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
161839149|NCT03696953|584455288|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
161839150|NCT03696953|584455287|FG000|Overall Study|Changed prenatal provider|1|||
161839151|NCT03696953|584455288|FG001|Overall Study|Changed prenatal provider|1|||
161839152|NCT04092894|584455289|FG000|Overall Study|Withdrawal by Subject|2|||
161839153|NCT04092894|584455290|FG001|Overall Study|Withdrawal by Subject|4|||
161839154|NCT04092894|584455289|FG000|Overall Study|Discontinued EEG after randomization|10|||
161839155|NCT04092894|584455290|FG001|Overall Study|Discontinued EEG after randomization|6|||
161839156|NCT01106014|584455291|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
161839157|NCT01106014|584455292|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
161839158|NCT01106014|584455291|FG000|Overall Study|Adverse Event|78|||
161839159|NCT01106014|584455292|FG001|Overall Study|Adverse Event|42|||
161839160|NCT01106014|584455291|FG000|Overall Study|Withdrawal by Subject|43|||
161839161|NCT01106014|584455292|FG001|Overall Study|Withdrawal by Subject|37|||
161839162|NCT01106014|584455291|FG000|Overall Study|Administrative reason|7|||
161839163|NCT01106014|584455292|FG001|Overall Study|Administrative reason|6|||
161839164|NCT01106014|584455291|FG000|Overall Study|Lost to Follow-up|2|||
161839165|NCT01106014|584455292|FG001|Overall Study|Lost to Follow-up|3|||
161839166|NCT02935686|584455293|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
161839167|NCT02935686|584455294|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
161839168|NCT02935686|584455295|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
161839169|NCT02935686|584455296|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
161839170|NCT02935686|584455297|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
161839171|NCT02935686|584455293|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
161839172|NCT02935686|584455294|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
161839173|NCT02935686|584455295|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
161839174|NCT02935686|584455296|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
161839175|NCT02935686|584455297|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
161839176|NCT02935686|584455293|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
161839177|NCT02935686|584455294|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
161839178|NCT02935686|584455295|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
161839179|NCT02935686|584455296|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
161839180|NCT02935686|584455297|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
161839181|NCT02935686|584455293|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
161839182|NCT02935686|584455294|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
161839183|NCT02935686|584455295|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
161839184|NCT02935686|584455296|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
161839185|NCT02935686|584455297|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
161839186|NCT02935686|584455293|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
161839187|NCT02935686|584455294|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
161839188|NCT02935686|584455295|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
161839189|NCT02935686|584455296|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
161839190|NCT02935686|584455297|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
161839191|NCT02935686|584455293|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
161839192|NCT02935686|584455294|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
161839193|NCT02935686|584455295|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
161839194|NCT02935686|584455296|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
161839195|NCT02935686|584455297|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
161839196|NCT02935686|584455293|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
161839197|NCT02935686|584455294|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
161839198|NCT02935686|584455295|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
161839199|NCT02935686|584455296|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
161965719|NCT01448824|584921823|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161965720|NCT01448824|584921824|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161965721|NCT01448824|584921825|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161965722|NCT01448824|584921826|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161965723|NCT01448824|584921827|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
161731363|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
161731364|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
161731365|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
161731366|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
161731367|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
161731368|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
161731369|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
161731370|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
161731371|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
161731372|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
161731373|NCT02052778|584058042|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731374|NCT02052778|584058043|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731375|NCT02052778|584058044|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731376|NCT02052778|584058045|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731377|NCT02052778|584058046|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731378|NCT02052778|584058047|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731379|NCT02052778|584058048|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731380|NCT02052778|584058049|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731381|NCT02052778|584058050|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731382|NCT02052778|584058051|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731383|NCT02052778|584058052|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731384|NCT02052778|584058053|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731385|NCT02052778|584058054|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731386|NCT02052778|584058055|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731387|NCT02052778|584058056|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731388|NCT02052778|584058057|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731389|NCT02052778|584058058|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731390|NCT02052778|584058059|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731391|NCT02052778|584058060|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731392|NCT02052778|584058061|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731393|NCT02052778|584058062|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731394|NCT02052778|584058063|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
161731395|NCT02052778|584058064|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
161731396|NCT02651194|584058069|FG000|Overall Study|Lost to Follow-up|3|||
161731397|NCT02651194|584058069|FG000|Overall Study|Other|2|||
161731398|NCT01980706|584058070|FG000|Overall Study|Withdrawal by Subject|9|||
161731399|NCT01980706|584058071|FG001|Overall Study|Withdrawal by Subject|6|||
161731400|NCT01980706|584058072|FG002|Overall Study|Withdrawal by Subject|2|||
161731401|NCT01980706|584058070|FG000|Overall Study|Adverse Event|1|||
161731402|NCT01980706|584058071|FG001|Overall Study|Adverse Event|2|||
161731403|NCT01980706|584058072|FG002|Overall Study|Adverse Event|5|||
161731404|NCT01980706|584058070|FG000|Overall Study|Lost to Follow-up|3|||
161731405|NCT01980706|584058071|FG001|Overall Study|Lost to Follow-up|4|||
161731406|NCT01980706|584058072|FG002|Overall Study|Lost to Follow-up|3|||
161731407|NCT01980706|584058070|FG000|Overall Study|miscellaneous|4|||
161731408|NCT01980706|584058071|FG001|Overall Study|miscellaneous|5|||
161731409|NCT01980706|584058072|FG002|Overall Study|miscellaneous|3|||
161731410|NCT02546674|584058073|FG000|Overall Study|Adverse Event|19|||
161731411|NCT02546674|584058073|FG000|Overall Study|Death|1|||
161731412|NCT02546674|584058073|FG000|Overall Study|Lost to Follow-up|1|||
161731413|NCT02546674|584058073|FG000|Overall Study|Physician Decision|13|||
161731414|NCT02546674|584058073|FG000|Overall Study|Pregnancy|1|||
161731415|NCT02546674|584058073|FG000|Overall Study|Progressive Disease|2|||
161731416|NCT02546674|584058073|FG000|Overall Study|Protocol Deviation|2|||
161731417|NCT02546674|584058073|FG000|Overall Study|Subject/Guardian Decision|6|||
161731418|NCT02546674|584058073|FG000|Overall Study|Withdrawal of Informed Consent|3|||
161731419|NCT02208024|584058074|FG000|Overall Study|Withdrawal by Subject|1|||
161731420|NCT00830037|584058078|FG000|Overall Study|Withdrawal by Subject|2|||
161731421|NCT00830037|584058079|FG001|Overall Study|Withdrawal by Subject|3|||
161731422|NCT00830037|584058078|FG000|Overall Study|Lost to Follow-up|1|||
161731423|NCT00830037|584058079|FG001|Overall Study|Lost to Follow-up|2|||
161731424|NCT00830037|584058078|FG000|Overall Study|Active when terminated by DSMB|15|||
161731425|NCT00830037|584058079|FG001|Overall Study|Active when terminated by DSMB|14|||
161731426|NCT01401010|584058080|FG000|Overall Study|Could not interpret assay results|1|||
161731427|NCT01401010|584058081|FG001|Overall Study|Could not interpret assay results|0|||
161731428|NCT04285346|584058084|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
161731429|NCT04285346|584058085|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
161731430|NCT04285346|584058084|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
161731431|NCT04285346|584058085|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161731432|NCT04285346|584058084|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
161731433|NCT04285346|584058085|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161731434|NCT00610935|584058086|FG000|Overall Study|Lost to Follow-up|0|||
161731435|NCT00610935|584058087|FG001|Overall Study|Lost to Follow-up|1|||
161731436|NCT00610935|584058086|FG000|Overall Study|Withdrawal by Subject|0|||
161731437|NCT00610935|584058087|FG001|Overall Study|Withdrawal by Subject|2|||
161731438|NCT00610935|584058086|FG000|Overall Study|Sponsor Discontinuation|1|||
161731439|NCT00610935|584058087|FG001|Overall Study|Sponsor Discontinuation|0|||
161731440|NCT04360187|584058090|FG000|Double-Blind Treatment|Adverse Event|9|||
161731441|NCT04360187|584058091|FG001|Double-Blind Treatment|Adverse Event|11|||
161731442|NCT04360187|584058090|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
161731443|NCT04360187|584058091|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
161731444|NCT04360187|584058090|FG000|Double-Blind Treatment|Physician Decision|1|||
161731445|NCT04360187|584058091|FG001|Double-Blind Treatment|Physician Decision|0|||
161731446|NCT04360187|584058090|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
161731447|NCT04360187|584058091|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
161731448|NCT04360187|584058090|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
161839200|NCT02935686|584455297|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
161839201|NCT02935686|584455293|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
161839202|NCT02935686|584455294|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
161839203|NCT02935686|584455295|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
161839204|NCT02935686|584455296|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
161839205|NCT02935686|584455297|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
161839206|NCT02935686|584455293|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
161839207|NCT02935686|584455294|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
161839208|NCT02935686|584455295|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
161839209|NCT02935686|584455296|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
161839210|NCT02935686|584455297|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
161839211|NCT02935686|584455293|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
161839212|NCT02935686|584455294|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
161839213|NCT02935686|584455295|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
161839214|NCT02935686|584455296|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
161839215|NCT02935686|584455297|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
161839216|NCT02935686|584455293|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
161839217|NCT02935686|584455294|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
161839218|NCT02935686|584455295|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
161839219|NCT02935686|584455296|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
161839220|NCT02935686|584455297|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
161839221|NCT00062010|584455300|FG000|Overall Study|Ineligible|3|||
161839222|NCT00852969|584455301|FG000|Overall Study|Adverse Event|0|||
161839223|NCT00852969|584455302|FG001|Overall Study|Adverse Event|1|||
161839224|NCT00852969|584455301|FG000|Overall Study|Lost to Follow-up|0|||
161839225|NCT00852969|584455302|FG001|Overall Study|Lost to Follow-up|1|||
161839226|NCT03986138|584455306|FG000|First MRI Examination|Physician Decision|0|||
161839227|NCT03986138|584455307|FG001|First MRI Examination|Physician Decision|1|||
161839228|NCT03986138|584455306|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
161839229|NCT03986138|584455307|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
161839230|NCT03986138|584455306|FG000|Washout|Withdrawal by Subject|4|||
161839231|NCT03986138|584455307|FG001|Washout|Withdrawal by Subject|5|||
161839232|NCT03986138|584455306|FG000|Washout|Lost to Follow-up|0|||
161839233|NCT03986138|584455307|FG001|Washout|Lost to Follow-up|2|||
161839234|NCT03986138|584455306|FG000|Washout|Adverse Event|1|||
161839235|NCT03986138|584455307|FG001|Washout|Adverse Event|1|||
161839236|NCT03986138|584455306|FG000|Washout|Other reason|5|||
161839237|NCT03986138|584455307|FG001|Washout|Other reason|5|||
161839238|NCT03986138|584455306|FG000|Second MRI Examination|Withdrawal by Subject|0|||
161839239|NCT03986138|584455307|FG001|Second MRI Examination|Withdrawal by Subject|2|||
161839240|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
161839241|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
161839242|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
161839243|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
161839244|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
162032240|NCT00246571|585175441|FG000|Overall Study|Laboratory abnormalities|1|||
162032241|NCT00246571|585175442|FG001|Overall Study|Laboratory abnormalities|0|||
162032242|NCT00246571|585175441|FG000|Overall Study|Crossover participants|0|||
161731449|NCT04360187|584058091|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
161731450|NCT04360187|584058090|FG000|Follow-Up|Lost to Follow-up|1|||
161731451|NCT04360187|584058091|FG001|Follow-Up|Lost to Follow-up|0|||
161839245|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
161839246|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
161839247|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
161839248|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
161839249|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
161839250|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
162032243|NCT00246571|585175442|FG001|Overall Study|Crossover participants|74|||
162032244|NCT00775203|585175443|FG000|Overall Study|Adverse Event|25|||
161731452|NCT02399813|584058092|FG000|Overall Study|Progressive Disease-Radiographic|2|||
161839251|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
161839252|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
161839253|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
161839254|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
161839255|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
161839256|NCT03182244|584455311|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
161839257|NCT03182244|584455312|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
161839258|NCT03182244|584455311|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
161839259|NCT03182244|584455312|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
161839260|NCT03182244|584455311|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
161839261|NCT03182244|584455312|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
161839262|NCT03182244|584455311|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
161839263|NCT03182244|584455312|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
161839264|NCT03182244|584455311|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
161839265|NCT03182244|584455312|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
161839266|NCT02049450|584455313|FG000|Overall Study|Adverse Event|2|||
161839267|NCT02049450|584455313|FG000|Overall Study|Withdrawal by Subject|1|||
161839268|NCT02049450|584455313|FG000|Overall Study|Patients/guardian decision|1|||
161839269|NCT03186781|584455314|FG000|Overall Study|Lost to Follow-up|0|||
161839270|NCT03186781|584455315|FG001|Overall Study|Lost to Follow-up|0|||
161839271|NCT03186781|584455316|FG002|Overall Study|Lost to Follow-up|1|||
161839272|NCT03186781|584455317|FG003|Overall Study|Lost to Follow-up|0|||
161839273|NCT03186781|584455318|FG004|Overall Study|Lost to Follow-up|1|||
161839274|NCT03186781|584455319|FG005|Overall Study|Lost to Follow-up|0|||
161839275|NCT03186781|584455314|FG000|Overall Study|Moved from Area|0|||
161839276|NCT03186781|584455315|FG001|Overall Study|Moved from Area|0|||
161839277|NCT03186781|584455316|FG002|Overall Study|Moved from Area|0|||
161839278|NCT03186781|584455317|FG003|Overall Study|Moved from Area|0|||
161839279|NCT03186781|584455318|FG004|Overall Study|Moved from Area|1|||
161839280|NCT03186781|584455319|FG005|Overall Study|Moved from Area|0|||
161839281|NCT03186781|584455314|FG000|Overall Study|Withdrawal by Subject|0|||
161839282|NCT03186781|584455315|FG001|Overall Study|Withdrawal by Subject|0|||
161839283|NCT03186781|584455316|FG002|Overall Study|Withdrawal by Subject|0|||
161839284|NCT03186781|584455317|FG003|Overall Study|Withdrawal by Subject|0|||
161839285|NCT03186781|584455318|FG004|Overall Study|Withdrawal by Subject|1|||
161839286|NCT03186781|584455319|FG005|Overall Study|Withdrawal by Subject|0|||
161839287|NCT04709835|584455320|FG000|Overall Study|Withdrawal by Subject|0|||
161839288|NCT04709835|584455321|FG001|Overall Study|Withdrawal by Subject|1|||
161839289|NCT04709835|584455322|FG002|Overall Study|Withdrawal by Subject|0|||
161839290|NCT01570686|584455323|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161839291|NCT01570686|584455324|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161839292|NCT01570686|584455323|FG000|Overall Study|Administrative problems|0|||
161839293|NCT01570686|584455324|FG001|Overall Study|Administrative problems|1|||
161839294|NCT01570686|584455323|FG000|Overall Study|Adverse Event|8|||
161839295|NCT01570686|584455324|FG001|Overall Study|Adverse Event|6|||
161839296|NCT01570686|584455323|FG000|Overall Study|Lost to Follow-up|4|||
161839297|NCT01570686|584455324|FG001|Overall Study|Lost to Follow-up|3|||
161965724|NCT01448824|584921828|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
161965725|NCT01448824|584921821|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161965726|NCT01448824|584921822|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161965727|NCT01448824|584921823|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161965728|NCT01448824|584921824|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161965729|NCT01448824|584921825|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161965730|NCT01448824|584921826|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161965731|NCT01448824|584921827|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
161965732|NCT01448824|584921828|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
161965733|NCT01537081|584921831|FG000|Overall Study|Adverse Event|5|||
161965734|NCT01537081|584921832|FG001|Overall Study|Adverse Event|2|||
161965735|NCT01537081|584921833|FG002|Overall Study|Adverse Event|2|||
161965736|NCT01537081|584921831|FG000|Overall Study|Lack of Efficacy|2|||
161965737|NCT01537081|584921832|FG001|Overall Study|Lack of Efficacy|1|||
161965738|NCT01537081|584921833|FG002|Overall Study|Lack of Efficacy|0|||
161965739|NCT01537081|584921831|FG000|Overall Study|Lost to Follow-up|17|||
161965740|NCT01537081|584921832|FG001|Overall Study|Lost to Follow-up|15|||
161839298|NCT01570686|584455323|FG000|Overall Study|Protocol Deviation|3|||
161965741|NCT01537081|584921833|FG002|Overall Study|Lost to Follow-up|9|||
161965742|NCT01537081|584921831|FG000|Overall Study|Protocol Violation|3|||
161839299|NCT01570686|584455324|FG001|Overall Study|Protocol Deviation|0|||
161839300|NCT01570686|584455323|FG000|Overall Study|Withdrawal by Subject|4|||
161839301|NCT01570686|584455324|FG001|Overall Study|Withdrawal by Subject|4|||
161839302|NCT01570686|584455323|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161839303|NCT01570686|584455324|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161839304|NCT02372071|584455325|FG000|Overall Study|Protocol Violation|18|||
161731453|NCT02399813|584058092|FG000|Overall Study|Death|20|||
161731454|NCT02399813|584058092|FG000|Overall Study|Withdrawal by Subject|3|||
161731455|NCT02399813|584058092|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
161731456|NCT02399813|584058092|FG000|Overall Study|Lost to Follow-up|2|||
161731457|NCT02399813|584058092|FG000|Overall Study|Other than specified|5|||
161731458|NCT02203838|584058095|FG000|Overall Study|Lack of Efficacy|7|||
161731459|NCT02203838|584058096|FG001|Overall Study|Lack of Efficacy|0|||
161731460|NCT02203838|584058097|FG002|Overall Study|Lack of Efficacy|1|||
161731461|NCT02203838|584058098|FG003|Overall Study|Lack of Efficacy|1|||
161731462|NCT02203838|584058095|FG000|Overall Study|Adverse Event|46|||
161731463|NCT02203838|584058096|FG001|Overall Study|Adverse Event|6|||
161731464|NCT02203838|584058097|FG002|Overall Study|Adverse Event|3|||
161731465|NCT02203838|584058098|FG003|Overall Study|Adverse Event|2|||
161731466|NCT02203838|584058095|FG000|Overall Study|Lost to Follow-up|39|||
161731467|NCT02203838|584058096|FG001|Overall Study|Lost to Follow-up|3|||
161731468|NCT02203838|584058097|FG002|Overall Study|Lost to Follow-up|2|||
161731469|NCT02203838|584058098|FG003|Overall Study|Lost to Follow-up|1|||
161731470|NCT02203838|584058095|FG000|Overall Study|Protocol Violation|7|||
161731471|NCT02203838|584058096|FG001|Overall Study|Protocol Violation|3|||
161731472|NCT02203838|584058097|FG002|Overall Study|Protocol Violation|0|||
161731473|NCT02203838|584058098|FG003|Overall Study|Protocol Violation|0|||
161731474|NCT02203838|584058095|FG000|Overall Study|Withdrawal by Subject|83|||
161731475|NCT02203838|584058096|FG001|Overall Study|Withdrawal by Subject|10|||
161731476|NCT02203838|584058097|FG002|Overall Study|Withdrawal by Subject|8|||
161731477|NCT02203838|584058098|FG003|Overall Study|Withdrawal by Subject|11|||
161731478|NCT02203838|584058095|FG000|Overall Study|Physician Decision|27|||
161731479|NCT02203838|584058096|FG001|Overall Study|Physician Decision|0|||
161731480|NCT02203838|584058097|FG002|Overall Study|Physician Decision|2|||
161731481|NCT02203838|584058098|FG003|Overall Study|Physician Decision|3|||
161731482|NCT02203838|584058095|FG000|Overall Study|Other|1|||
161731483|NCT02203838|584058096|FG001|Overall Study|Other|0|||
161731484|NCT02203838|584058097|FG002|Overall Study|Other|0|||
161731485|NCT02203838|584058098|FG003|Overall Study|Other|0|||
161731486|NCT05091060|584058101|FG000|Overall Study|Lost to Follow-up|1|||
161731487|NCT02739594|584058102|FG000|Overall Study|Undesired Event|3|||
161731488|NCT02739594|584058103|FG001|Overall Study|Undesired Event|4|||
161731489|NCT02739594|584058102|FG000|Overall Study|Violation of Eligibility Criteria|1|||
161731490|NCT02739594|584058103|FG001|Overall Study|Violation of Eligibility Criteria|2|||
161731491|NCT02739594|584058102|FG000|Overall Study|Protocol Violation|5|||
161731492|NCT02739594|584058103|FG001|Overall Study|Protocol Violation|6|||
161731493|NCT02739594|584058102|FG000|Overall Study|Death|4|||
161731494|NCT02739594|584058103|FG001|Overall Study|Death|2|||
161731495|NCT02739594|584058102|FG000|Overall Study|Renal Insufficiency|4|||
161731496|NCT02739594|584058103|FG001|Overall Study|Renal Insufficiency|6|||
161731497|NCT02739594|584058102|FG000|Overall Study|Administrative Reasons|1|||
161731498|NCT02739594|584058103|FG001|Overall Study|Administrative Reasons|3|||
161731499|NCT02739594|584058102|FG000|Overall Study|Withdrawal by Subject|1|||
161731500|NCT02739594|584058103|FG001|Overall Study|Withdrawal by Subject|1|||
161731501|NCT02739594|584058102|FG000|Overall Study|Lost to Follow-up|0|||
161731502|NCT02739594|584058103|FG001|Overall Study|Lost to Follow-up|1|||
161731503|NCT02739594|584058102|FG000|Overall Study|Elevated Serum Creatinine|0|||
161731504|NCT02739594|584058103|FG001|Overall Study|Elevated Serum Creatinine|1|||
161731505|NCT02739594|584058102|FG000|Overall Study|Other|6|||
161731506|NCT02739594|584058103|FG001|Overall Study|Other|2|||
161731507|NCT00952289|584058106|FG000|All Participants|Death|9|||
161731508|NCT00952289|584058107|FG001|All Participants|Death|9|||
161731509|NCT00952289|584058106|FG000|All Participants|Adverse Event|8|||
161731510|NCT00952289|584058107|FG001|All Participants|Adverse Event|8|||
161731511|NCT00952289|584058106|FG000|All Participants|Disease progression|3|||
161731512|NCT00952289|584058107|FG001|All Participants|Disease progression|12|||
161731513|NCT00952289|584058106|FG000|All Participants|Withdrawal by Subject|1|||
161731514|NCT00952289|584058107|FG001|All Participants|Withdrawal by Subject|10|||
161731515|NCT00952289|584058106|FG000|All Participants|Data lost during site relocation|0|||
161731516|NCT00952289|584058107|FG001|All Participants|Data lost during site relocation|1|||
161731517|NCT00952289|584058106|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
161731518|NCT00952289|584058107|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
161731519|NCT00952289|584058106|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
161731520|NCT00952289|584058107|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
161731521|NCT00952289|584058106|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
161731522|NCT00952289|584058107|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
161731523|NCT00952289|584058106|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
161731524|NCT00952289|584058107|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
161731525|NCT00952289|584058106|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
161731526|NCT00952289|584058107|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
161731527|NCT03259334|584058108|FG000|Overall Study|Adverse Event|3|||
161731528|NCT03259334|584058109|FG001|Overall Study|Adverse Event|8|||
161731529|NCT03259334|584058110|FG002|Overall Study|Adverse Event|5|||
161731530|NCT03259334|584058108|FG000|Overall Study|Withdrawal by Subject|4|||
161731531|NCT03259334|584058109|FG001|Overall Study|Withdrawal by Subject|2|||
161731532|NCT03259334|584058110|FG002|Overall Study|Withdrawal by Subject|4|||
161731533|NCT03259334|584058108|FG000|Overall Study|Physician Decision|1|||
161731534|NCT03259334|584058109|FG001|Overall Study|Physician Decision|0|||
161731535|NCT03259334|584058110|FG002|Overall Study|Physician Decision|0|||
161731536|NCT03259334|584058108|FG000|Overall Study|Lost to Follow-up|0|||
161731537|NCT03259334|584058109|FG001|Overall Study|Lost to Follow-up|2|||
161731538|NCT03259334|584058110|FG002|Overall Study|Lost to Follow-up|1|||
161731539|NCT03259334|584058108|FG000|Overall Study|Protocol Deviation|0|||
161731540|NCT03259334|584058109|FG001|Overall Study|Protocol Deviation|3|||
161731541|NCT03259334|584058110|FG002|Overall Study|Protocol Deviation|2|||
161731542|NCT03259334|584058108|FG000|Overall Study|Lack of Efficacy|2|||
161731543|NCT03259334|584058109|FG001|Overall Study|Lack of Efficacy|0|||
161731544|NCT03259334|584058110|FG002|Overall Study|Lack of Efficacy|1|||
161731545|NCT03259334|584058108|FG000|Overall Study|Randomized but never treated|0|||
161731546|NCT03259334|584058109|FG001|Overall Study|Randomized but never treated|2|||
161731547|NCT03259334|584058110|FG002|Overall Study|Randomized but never treated|0|||
161731548|NCT03375112|584058111|FG000|Overall Study|Withdrawal by Subject|3|||
161731549|NCT03375112|584058112|FG001|Overall Study|Withdrawal by Subject|0|||
161731550|NCT03599141|584058113|FG000|Overall Study|Lost to Follow-up|3|||
161731551|NCT03599141|584058114|FG001|Overall Study|Lost to Follow-up|1|||
161731552|NCT00777491|584058115|FG000|Overall Study|Protocol Violation|0|||
161731553|NCT00777491|584058116|FG001|Overall Study|Protocol Violation|2|||
161731554|NCT00777491|584058115|FG000|Overall Study|Did not receive any protocol treatment|2|||
161731555|NCT00777491|584058116|FG001|Overall Study|Did not receive any protocol treatment|0|||
161731556|NCT01689207|584058117|FG000|Overall Study|Adverse Event|0|||
161731557|NCT01689207|584058118|FG001|Overall Study|Adverse Event|1|||
161731558|NCT01689207|584058119|FG002|Overall Study|Adverse Event|0|||
161731559|NCT01689207|584058120|FG003|Overall Study|Adverse Event|0|||
161731560|NCT01689207|584058121|FG004|Overall Study|Adverse Event|2|||
161731561|NCT01689207|584058122|FG005|Overall Study|Adverse Event|1|||
161731562|NCT01689207|584058123|FG006|Overall Study|Adverse Event|0|||
161731563|NCT01689207|584058124|FG007|Overall Study|Adverse Event|0|||
161731564|NCT01689207|584058125|FG008|Overall Study|Adverse Event|1|||
161731565|NCT01689207|584058126|FG009|Overall Study|Adverse Event|0|||
161731566|NCT01689207|584058127|FG010|Overall Study|Adverse Event|0|||
161731567|NCT01912768|584058128|FG000|Overall Study|Adverse Event|2|||
161731568|NCT01912768|584058129|FG001|Overall Study|Adverse Event|0|||
161731569|NCT01912768|584058128|FG000|Overall Study|Lost to Follow-up|2|||
161731570|NCT01912768|584058129|FG001|Overall Study|Lost to Follow-up|1|||
161731571|NCT01912768|584058128|FG000|Overall Study|Withdrawal by Subject|5|||
161731572|NCT01912768|584058129|FG001|Overall Study|Withdrawal by Subject|3|||
161731573|NCT01912768|584058128|FG000|Overall Study|Randomized in error|1|||
161731574|NCT01912768|584058129|FG001|Overall Study|Randomized in error|0|||
161731575|NCT03591146|584058130|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
161731576|NCT03591146|584058131|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
161731577|NCT03591146|584058132|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
161731578|NCT03591146|584058133|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
161731579|NCT03591146|584058134|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
161731580|NCT03591146|584058130|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
161731581|NCT03591146|584058131|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
161731582|NCT03591146|584058132|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
161731583|NCT03591146|584058133|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
161731584|NCT03591146|584058134|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
161731585|NCT03591146|584058130|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161731586|NCT03591146|584058131|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161731587|NCT03591146|584058132|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161731588|NCT03591146|584058133|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161731589|NCT03591146|584058134|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
161731590|NCT03591146|584058130|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
161731591|NCT03591146|584058131|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
161731592|NCT03591146|584058132|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
161731593|NCT03591146|584058133|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
161731594|NCT03591146|584058134|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
161731595|NCT03453151|584058135|FG000|Overall Study|Withdrawal by Subject|1|||
161731596|NCT03453151|584058135|FG000|Overall Study|Physician Decision|3|||
161731597|NCT00142519|584058136|FG000|Overall Study|Not Treated|7|||
161731598|NCT00142519|584058137|FG001|Overall Study|Not Treated|9|||
161731599|NCT00142519|584058136|FG000|Overall Study|Protocol Violation|1|||
161731600|NCT00142519|584058137|FG001|Overall Study|Protocol Violation|0|||
161731601|NCT00142519|584058136|FG000|Overall Study|Withdrawal by Subject|10|||
161731602|NCT00142519|584058137|FG001|Overall Study|Withdrawal by Subject|7|||
161731603|NCT01468909|584058138|FG000|Overall Study|Never Treated|2|||
161731604|NCT01468909|584058139|FG001|Overall Study|Never Treated|2|||
161731605|NCT01511419|584058142|FG000|Dose 2|Physician Decision|1|||
161731606|NCT01511419|584058143|FG001|Dose 2|Physician Decision|0|||
161731607|NCT00937768|584058144|FG000|Overall Study|Refused Further Treatment|3|||
161731608|NCT00937768|584058145|FG001|Overall Study|Refused Further Treatment|2|||
161731609|NCT00937768|584058144|FG000|Overall Study|Disease Progression|1|||
161731610|NCT00937768|584058145|FG001|Overall Study|Disease Progression|1|||
161731611|NCT00937768|584058144|FG000|Overall Study|Alternate Treatment|0|||
161731612|NCT00937768|584058145|FG001|Overall Study|Alternate Treatment|1|||
161731613|NCT00937768|584058144|FG000|Overall Study|No Further Funding|4|||
161731614|NCT00937768|584058145|FG001|Overall Study|No Further Funding|4|||
161731615|NCT03229759|584058151|FG000|Overall Study|Screen Failure|30|||
161731616|NCT00311181|584059751|FG000|Overall Study|Final DFTs were not obtained|96|||
161731617|NCT02294318|584059752|FG000|Overall Study|Worsening of drinking|3|||
161731618|NCT02294318|584059753|FG001|Overall Study|Worsening of drinking|0|||
161731619|NCT02294318|584059752|FG000|Overall Study|Not exposed to intervention|0|||
161731620|NCT02294318|584059753|FG001|Overall Study|Not exposed to intervention|2|||
161731621|NCT01694420|584059757|FG000|Overall Study|Lost to Follow-up|3|||
161731622|NCT00506948|584059758|FG000|Overall Study|Death|4|||
161731623|NCT00506948|584059758|FG000|Overall Study|Adverse Event|5|||
161731624|NCT00506948|584059758|FG000|Overall Study|Physician Decision|1|||
161731625|NCT02395653|584059759|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
161731626|NCT02395653|584059759|FG000|Overall Study|Consent Withdrawn at Screening|1|||
161731627|NCT02395653|584059759|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
161731628|NCT02395653|584059759|FG000|Overall Study|Investigator Decision at Screening|1|||
161731629|NCT02395653|584059759|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
161731630|NCT02395653|584059759|FG000|Overall Study|Withdrawal by Subject|1|||
161731631|NCT02395653|584059759|FG000|Overall Study|Lost to Follow-up|1|||
161731632|NCT02494778|584059760|FG000|Overall Study|Death|3|||
161731633|NCT02494778|584059760|FG000|Overall Study|Other|173|||
161731634|NCT02494778|584059760|FG000|Overall Study|Lack of Efficacy|4|||
161731635|NCT02494778|584059760|FG000|Overall Study|Adverse Event|18|||
161731636|NCT02494778|584059760|FG000|Overall Study|Withdrawal by Subject|20|||
161731637|NCT02494778|584059760|FG000|Overall Study|Lost to Follow-up|2|||
161731638|NCT02494778|584059760|FG000|Overall Study|Noncompliant with study drug admin.|1|||
161731639|NCT03621943|584059761|FG000|First Randomized Intervention|Lost to Follow-up|51|||
161731640|NCT03621943|584059762|FG001|First Randomized Intervention|Lost to Follow-up|54|||
161731641|NCT03621943|584059761|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
161731642|NCT03621943|584059762|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
161731643|NCT03621943|584059761|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
161731644|NCT03621943|584059762|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
161731645|NCT03621943|584059761|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
161731646|NCT03621943|584059762|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
161731647|NCT00967226|584059763|FG000|Overall Study|Adverse Event|0|||
161731648|NCT00967226|584059764|FG001|Overall Study|Adverse Event|5|||
161731649|NCT00967226|584059763|FG000|Overall Study|Protocol Violation|2|||
161731650|NCT00967226|584059764|FG001|Overall Study|Protocol Violation|0|||
161731651|NCT00967226|584059763|FG000|Overall Study|Physician Decision|0|||
161731652|NCT00967226|584059764|FG001|Overall Study|Physician Decision|1|||
161731653|NCT02174861|584059765|FG000|Overall Study|Decision by sponsor|8|||
161731654|NCT02174861|584059765|FG000|Overall Study|Withdrawal by Subject|124|||
161731655|NCT02174861|584059765|FG000|Overall Study|Lost to Follow-up|26|||
161731656|NCT01670656|584059766|FG000|Overall Study|Non-compliance with study drug|0|||
161731657|NCT01670656|584059767|FG001|Overall Study|Non-compliance with study drug|0|||
161731658|NCT01670656|584059768|FG002|Overall Study|Non-compliance with study drug|3|||
161731659|NCT01670656|584059769|FG003|Overall Study|Non-compliance with study drug|0|||
161731660|NCT01670656|584059770|FG004|Overall Study|Non-compliance with study drug|1|||
161731661|NCT01670656|584059766|FG000|Overall Study|Pregnancy|0|||
161731662|NCT01670656|584059767|FG001|Overall Study|Pregnancy|0|||
161731663|NCT01670656|584059768|FG002|Overall Study|Pregnancy|0|||
161731664|NCT01670656|584059769|FG003|Overall Study|Pregnancy|0|||
161731665|NCT01670656|584059770|FG004|Overall Study|Pregnancy|1|||
161731666|NCT01670656|584059766|FG000|Overall Study|Withdrawal by Subject|1|||
161731667|NCT01670656|584059767|FG001|Overall Study|Withdrawal by Subject|1|||
161731668|NCT01670656|584059768|FG002|Overall Study|Withdrawal by Subject|0|||
161731669|NCT01670656|584059769|FG003|Overall Study|Withdrawal by Subject|0|||
161731670|NCT01670656|584059770|FG004|Overall Study|Withdrawal by Subject|0|||
161839305|NCT03347422|584455329|FG000|Part A (26 Weeks)|Adverse Event|3|||
161839306|NCT03347422|584455330|FG001|Part A (26 Weeks)|Adverse Event|0|||
161731671|NCT01670656|584059766|FG000|Overall Study|Non-compliance with protocol|0|||
161731672|NCT01670656|584059767|FG001|Overall Study|Non-compliance with protocol|3|||
161731673|NCT01670656|584059768|FG002|Overall Study|Non-compliance with protocol|1|||
161731674|NCT01670656|584059769|FG003|Overall Study|Non-compliance with protocol|1|||
161731675|NCT01670656|584059770|FG004|Overall Study|Non-compliance with protocol|2|||
161731676|NCT01670656|584059766|FG000|Overall Study|Adverse Event|2|||
161731677|NCT01670656|584059767|FG001|Overall Study|Adverse Event|2|||
161731678|NCT01670656|584059768|FG002|Overall Study|Adverse Event|2|||
161731679|NCT01670656|584059769|FG003|Overall Study|Adverse Event|3|||
161839307|NCT03347422|584455329|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
161839308|NCT03347422|584455330|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
161839309|NCT03347422|584455329|FG000|Part B (149 Weeks)|Adverse Event|0|||
161839310|NCT03347422|584455330|FG001|Part B (149 Weeks)|Adverse Event|1|||
161839311|NCT03347422|584455329|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
161839312|NCT03347422|584455330|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
161839313|NCT03347422|584455329|FG000|Part B (149 Weeks)|Other|1|||
161839314|NCT03347422|584455330|FG001|Part B (149 Weeks)|Other|0|||
161839315|NCT00622466|584455337|FG000|Overall Study|Death|1|||
161839316|NCT00622466|584455337|FG000|Overall Study|Adverse Event|1|||
161839317|NCT00622466|584455337|FG000|Overall Study|Withdrawal by Subject|2|||
161839318|NCT01936623|584455349|FG000|Overall Study|Lost to Follow-up|0|||
161839319|NCT01936623|584455350|FG001|Overall Study|Lost to Follow-up|5|||
161839320|NCT01383135|584455351|FG000|Overall Study|Not Scanned / Imaged|1|||
161839321|NCT01383135|584455352|FG001|Overall Study|Not Scanned / Imaged|0|||
161839322|NCT01383135|584455353|FG002|Overall Study|Not Scanned / Imaged|1|||
161839323|NCT01383135|584455354|FG003|Overall Study|Not Scanned / Imaged|0|||
161839324|NCT02534844|584455359|FG000|Part B|Withdrawal by Subject|0|||
161839325|NCT02534844|584455360|FG001|Part B|Withdrawal by Subject|0|||
161839326|NCT02534844|584455361|FG002|Part B|Withdrawal by Subject|0|||
161839327|NCT02534844|584455362|FG003|Part B|Withdrawal by Subject|0|||
161839328|NCT02534844|584455363|FG004|Part B|Withdrawal by Subject|2|||
161839329|NCT02534844|584455364|FG005|Part B|Withdrawal by Subject|1|||
161839330|NCT01971970|584455365|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
161839331|NCT01971970|584455366|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
161839332|NCT01971970|584455365|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
161839333|NCT01971970|584455366|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
161839334|NCT01971970|584455365|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
161839335|NCT01971970|584455366|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
161839336|NCT01971970|584455365|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
161839337|NCT01971970|584455366|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
161839338|NCT01971970|584455365|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
161839339|NCT01971970|584455366|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
161839340|NCT01971970|584455365|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
161839341|NCT01971970|584455366|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
161839342|NCT01971970|584455365|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
161839343|NCT01971970|584455366|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
161839344|NCT01831765|584455367|FG000|Overall Study|Lack of Efficacy|1|||
161839345|NCT01831765|584455368|FG001|Overall Study|Lack of Efficacy|0|||
161839346|NCT01831765|584455369|FG002|Overall Study|Lack of Efficacy|0|||
161839347|NCT01831765|584455367|FG000|Overall Study|Other, sponsor withdrew subject|0|||
161839348|NCT01831765|584455368|FG001|Overall Study|Other, sponsor withdrew subject|1|||
161839349|NCT01831765|584455369|FG002|Overall Study|Other, sponsor withdrew subject|0|||
161839350|NCT01831765|584455367|FG000|Overall Study|Pregnancy|1|||
161839351|NCT01831765|584455368|FG001|Overall Study|Pregnancy|1|||
161839352|NCT01831765|584455369|FG002|Overall Study|Pregnancy|2|||
161839353|NCT01831765|584455367|FG000|Overall Study|Death|0|||
161839354|NCT01831765|584455368|FG001|Overall Study|Death|1|||
161839355|NCT01831765|584455369|FG002|Overall Study|Death|1|||
161839356|NCT01831765|584455367|FG000|Overall Study|Other, site closed|1|||
161839357|NCT01831765|584455368|FG001|Overall Study|Other, site closed|1|||
161839358|NCT01831765|584455369|FG002|Overall Study|Other, site closed|0|||
161839359|NCT01831765|584455367|FG000|Overall Study|Adverse Event|5|||
161839360|NCT01831765|584455368|FG001|Overall Study|Adverse Event|3|||
161839361|NCT01831765|584455369|FG002|Overall Study|Adverse Event|3|||
161839362|NCT01831765|584455367|FG000|Overall Study|Withdrawal by Subject|22|||
161839363|NCT01831765|584455368|FG001|Overall Study|Withdrawal by Subject|7|||
161839364|NCT01831765|584455369|FG002|Overall Study|Withdrawal by Subject|17|||
161839365|NCT01831765|584455367|FG000|Overall Study|Withdrawal criteria|12|||
161839366|NCT01831765|584455368|FG001|Overall Study|Withdrawal criteria|10|||
161965743|NCT01537081|584921832|FG001|Overall Study|Protocol Violation|2|||
161965744|NCT01537081|584921833|FG002|Overall Study|Protocol Violation|2|||
161965745|NCT01537081|584921831|FG000|Overall Study|Withdrawal by Subject|6|||
161965746|NCT01537081|584921832|FG001|Overall Study|Withdrawal by Subject|11|||
161839367|NCT01831765|584455369|FG002|Overall Study|Withdrawal criteria|16|||
161839368|NCT01831765|584455367|FG000|Overall Study|Lost to Follow-up|2|||
161839369|NCT01831765|584455368|FG001|Overall Study|Lost to Follow-up|3|||
161965747|NCT01537081|584921833|FG002|Overall Study|Withdrawal by Subject|3|||
161839370|NCT01831765|584455369|FG002|Overall Study|Lost to Follow-up|3|||
161839371|NCT00859586|584455370|FG000|Overall Study|Donors|4|||
161839372|NCT00080938|584455371|FG000|Overall Study|Adverse Event|3|||
161839373|NCT00080938|584455371|FG000|Overall Study|Withdrawal by Subject|6|||
161839374|NCT00080938|584455371|FG000|Overall Study|Death|2|||
161839375|NCT00080938|584455371|FG000|Overall Study|Lack of Efficacy|7|||
161839376|NCT00080938|584455371|FG000|Overall Study|other disease|1|||
161839377|NCT00080938|584455371|FG000|Overall Study|Not started protocol therapy|1|||
161731680|NCT01670656|584059770|FG004|Overall Study|Adverse Event|3|||
161731681|NCT01670656|584059766|FG000|Overall Study|Subject withdrew consent|0|||
161731682|NCT01670656|584059767|FG001|Overall Study|Subject withdrew consent|1|||
161731683|NCT01670656|584059768|FG002|Overall Study|Subject withdrew consent|2|||
161731684|NCT01670656|584059769|FG003|Overall Study|Subject withdrew consent|1|||
161731685|NCT01670656|584059770|FG004|Overall Study|Subject withdrew consent|1|||
161731686|NCT01670656|584059766|FG000|Overall Study|Lost to Follow-up|0|||
161731687|NCT01670656|584059767|FG001|Overall Study|Lost to Follow-up|0|||
161731688|NCT01670656|584059768|FG002|Overall Study|Lost to Follow-up|0|||
161731689|NCT01670656|584059769|FG003|Overall Study|Lost to Follow-up|0|||
161731690|NCT01670656|584059770|FG004|Overall Study|Lost to Follow-up|3|||
161731691|NCT01670656|584059766|FG000|Overall Study|Subject moved|0|||
161731692|NCT01670656|584059767|FG001|Overall Study|Subject moved|0|||
161731693|NCT01670656|584059768|FG002|Overall Study|Subject moved|0|||
161731694|NCT01670656|584059769|FG003|Overall Study|Subject moved|1|||
161731695|NCT01670656|584059770|FG004|Overall Study|Subject moved|0|||
161731696|NCT00165841|584059771|FG000|Overall Study|Adverse Event|2|||
161731697|NCT00165841|584059772|FG001|Overall Study|Adverse Event|3|||
161731698|NCT00165841|584059771|FG000|Overall Study|Lack of Efficacy|6|||
161731699|NCT00165841|584059772|FG001|Overall Study|Lack of Efficacy|33|||
161731700|NCT00165841|584059771|FG000|Overall Study|Lost to Follow-up|4|||
161731701|NCT00165841|584059772|FG001|Overall Study|Lost to Follow-up|4|||
161731702|NCT00165841|584059771|FG000|Overall Study|Withdrawal by Subject|7|||
161731703|NCT00165841|584059772|FG001|Overall Study|Withdrawal by Subject|8|||
161731704|NCT00165841|584059771|FG000|Overall Study|Physician Decision|1|||
161731705|NCT00165841|584059772|FG001|Overall Study|Physician Decision|0|||
161731706|NCT00165841|584059771|FG000|Overall Study|Protocol Violation|6|||
161731707|NCT00165841|584059772|FG001|Overall Study|Protocol Violation|8|||
161731708|NCT00165841|584059771|FG000|Overall Study|Other|3|||
161731709|NCT00165841|584059772|FG001|Overall Study|Other|5|||
161731710|NCT00165841|584059771|FG000|Overall Study|Medication Noncompliance|1|||
161731711|NCT00165841|584059772|FG001|Overall Study|Medication Noncompliance|1|||
161731712|NCT00789958|584059773|FG000|Overall Study|Adverse Event|3|||
161731713|NCT00789958|584059773|FG000|Overall Study|Withdrawal by Subject|4|||
161731714|NCT00789958|584059773|FG000|Overall Study|Progression|3|||
161731715|NCT00789958|584059773|FG000|Overall Study|not protocol specified|1|||
161731716|NCT00789958|584059773|FG000|Overall Study|Not eligible/not analyzable|26|||
161731717|NCT00487084|584059774|FG000|Overall Study|Did not receive intervention|4|||
161731718|NCT00487084|584059775|FG001|Overall Study|Did not receive intervention|3|||
161731719|NCT00487084|584059776|FG002|Overall Study|Did not receive intervention|5|||
161731720|NCT01697267|584059777|FG000|Overall Study|Death|3|||
161731721|NCT01697267|584059778|FG001|Overall Study|Death|1|||
161731722|NCT01697267|584059777|FG000|Overall Study|Withdrawal by Subject|5|||
161731723|NCT01697267|584059778|FG001|Overall Study|Withdrawal by Subject|5|||
161731724|NCT01697267|584059777|FG000|Overall Study|Adverse Event|2|||
161731725|NCT01697267|584059778|FG001|Overall Study|Adverse Event|1|||
161731726|NCT01697267|584059777|FG000|Overall Study|Lost to Follow-up|2|||
161731727|NCT01697267|584059778|FG001|Overall Study|Lost to Follow-up|4|||
161731728|NCT01697267|584059777|FG000|Overall Study|Physician Decision|2|||
161731729|NCT01697267|584059778|FG001|Overall Study|Physician Decision|4|||
161731730|NCT02796391|584059781|FG000|Overall Study|Lost to Follow-up|2|||
161731731|NCT02796391|584059782|FG001|Overall Study|Lost to Follow-up|2|||
161731732|NCT02796391|584059783|FG002|Overall Study|Lost to Follow-up|13|||
161731733|NCT02796391|584059784|FG003|Overall Study|Lost to Follow-up|8|||
161731734|NCT02796391|584059785|FG004|Overall Study|Lost to Follow-up|14|||
161731735|NCT02796391|584059786|FG005|Overall Study|Lost to Follow-up|13|||
161731736|NCT02796391|584059781|FG000|Overall Study|COVID|0|||
161731737|NCT02796391|584059782|FG001|Overall Study|COVID|0|||
161731738|NCT02796391|584059783|FG002|Overall Study|COVID|5|||
161731739|NCT02796391|584059784|FG003|Overall Study|COVID|5|||
161731740|NCT02796391|584059785|FG004|Overall Study|COVID|2|||
161839378|NCT00080938|584455371|FG000|Overall Study|Ineligible|4|||
161839379|NCT00706511|584455374|FG000|Overall Study|Withdrawal by Subject|1|||
161731741|NCT02796391|584059786|FG005|Overall Study|COVID|4|||
161731742|NCT02796391|584059781|FG000|Overall Study|Participant did not like study cigarettes|0|||
161731743|NCT02796391|584059782|FG001|Overall Study|Participant did not like study cigarettes|0|||
161839380|NCT00706511|584455375|FG001|Overall Study|Withdrawal by Subject|0|||
162032245|NCT00775203|585175444|FG001|Overall Study|Adverse Event|6|||
161731744|NCT02796391|584059783|FG002|Overall Study|Participant did not like study cigarettes|3|||
161731745|NCT02796391|584059784|FG003|Overall Study|Participant did not like study cigarettes|0|||
161731746|NCT02796391|584059785|FG004|Overall Study|Participant did not like study cigarettes|0|||
161731747|NCT02796391|584059786|FG005|Overall Study|Participant did not like study cigarettes|0|||
161731748|NCT02796391|584059781|FG000|Overall Study|Withdrawal by Subject|1|||
161731749|NCT02796391|584059782|FG001|Overall Study|Withdrawal by Subject|1|||
161731750|NCT02796391|584059783|FG002|Overall Study|Withdrawal by Subject|4|||
161839381|NCT00706511|584455376|FG002|Overall Study|Withdrawal by Subject|0|||
161731751|NCT02796391|584059784|FG003|Overall Study|Withdrawal by Subject|3|||
161731752|NCT02796391|584059785|FG004|Overall Study|Withdrawal by Subject|4|||
161731753|NCT02796391|584059786|FG005|Overall Study|Withdrawal by Subject|3|||
161731754|NCT02796391|584059781|FG000|Overall Study|Adverse Event|0|||
161731755|NCT02796391|584059782|FG001|Overall Study|Adverse Event|0|||
161731756|NCT02796391|584059783|FG002|Overall Study|Adverse Event|0|||
161731757|NCT02796391|584059784|FG003|Overall Study|Adverse Event|1|||
161731758|NCT02796391|584059785|FG004|Overall Study|Adverse Event|0|||
161731759|NCT02796391|584059786|FG005|Overall Study|Adverse Event|0|||
161731760|NCT02796391|584059781|FG000|Overall Study|Protocol Violation|0|||
161731761|NCT02796391|584059782|FG001|Overall Study|Protocol Violation|0|||
161731762|NCT02796391|584059783|FG002|Overall Study|Protocol Violation|0|||
161731763|NCT02796391|584059784|FG003|Overall Study|Protocol Violation|1|||
161731764|NCT02796391|584059785|FG004|Overall Study|Protocol Violation|0|||
161731765|NCT02796391|584059786|FG005|Overall Study|Protocol Violation|0|||
161731766|NCT02681055|584059787|FG000|Weeks 5-12|Adverse Event|1|||
161731767|NCT00377611|584059790|FG000|Overall Study|Adverse Event|2|||
161731768|NCT00377611|584059791|FG001|Overall Study|Adverse Event|9|||
161731769|NCT00377611|584059790|FG000|Overall Study|Protocol Violation|2|||
161731770|NCT00377611|584059791|FG001|Overall Study|Protocol Violation|0|||
161731771|NCT00377611|584059790|FG000|Overall Study|Withdrawal by Subject|0|||
161731772|NCT00377611|584059791|FG001|Overall Study|Withdrawal by Subject|5|||
161731773|NCT00377611|584059790|FG000|Overall Study|Lost to Follow-up|18|||
161731774|NCT00377611|584059791|FG001|Overall Study|Lost to Follow-up|16|||
161731775|NCT00377611|584059790|FG000|Overall Study|Other|0|||
161731776|NCT00377611|584059791|FG001|Overall Study|Other|3|||
161731777|NCT03446651|584059797|FG000|Overall Study|Lost to Follow-up|4|||
161731778|NCT03446651|584059798|FG001|Overall Study|Lost to Follow-up|0|||
161731779|NCT03446651|584059797|FG000|Overall Study|Open Label Participants|5|||
161731780|NCT03446651|584059798|FG001|Overall Study|Open Label Participants|0|||
161731781|NCT00343291|584059799|FG000|Overall Study|Adverse Event|13|||
161731782|NCT00343291|584059800|FG001|Overall Study|Adverse Event|13|||
161731783|NCT00343291|584059799|FG000|Overall Study|Death|3|||
161731784|NCT00343291|584059800|FG001|Overall Study|Death|2|||
161731785|NCT00343291|584059799|FG000|Overall Study|Progressive disease|33|||
161731786|NCT00343291|584059800|FG001|Overall Study|Progressive disease|34|||
161731787|NCT00343291|584059799|FG000|Overall Study|Withdrawal by Subject|0|||
161731788|NCT00343291|584059800|FG001|Overall Study|Withdrawal by Subject|2|||
161731789|NCT00343291|584059799|FG000|Overall Study|Other|8|||
161731790|NCT00343291|584059800|FG001|Overall Study|Other|5|||
161731791|NCT04831515|584059801|FG000|First Intervention|Adverse Event|0|||
161731792|NCT04831515|584059802|FG001|First Intervention|Adverse Event|1|||
161731793|NCT03712345|584059805|FG000|Overall Study|Failure to meet randomization criteria|0|||
161731794|NCT03712345|584059806|FG001|Overall Study|Failure to meet randomization criteria|0|||
161731795|NCT03712345|584059807|FG002|Overall Study|Failure to meet randomization criteria|1|||
161731796|NCT00960934|584059808|FG000|Overall Study|Adverse Event|2|||
161731797|NCT00960934|584059809|FG001|Overall Study|Adverse Event|3|||
161731798|NCT00960934|584059810|FG002|Overall Study|Adverse Event|3|||
161731799|NCT00960934|584059811|FG003|Overall Study|Adverse Event|2|||
161731800|NCT00960934|584059812|FG004|Overall Study|Adverse Event|4|||
161731801|NCT00960934|584059813|FG005|Overall Study|Adverse Event|3|||
161731802|NCT00960934|584059808|FG000|Overall Study|Lack of Efficacy|1|||
161731803|NCT00960934|584059809|FG001|Overall Study|Lack of Efficacy|0|||
161731804|NCT00960934|584059810|FG002|Overall Study|Lack of Efficacy|0|||
161731805|NCT00960934|584059811|FG003|Overall Study|Lack of Efficacy|0|||
161731806|NCT00960934|584059812|FG004|Overall Study|Lack of Efficacy|0|||
161731807|NCT00960934|584059813|FG005|Overall Study|Lack of Efficacy|0|||
161731808|NCT00960934|584059808|FG000|Overall Study|Lost to Follow-up|0|||
161731809|NCT00960934|584059809|FG001|Overall Study|Lost to Follow-up|1|||
161731810|NCT00960934|584059810|FG002|Overall Study|Lost to Follow-up|0|||
161731811|NCT00960934|584059811|FG003|Overall Study|Lost to Follow-up|0|||
161731812|NCT00960934|584059812|FG004|Overall Study|Lost to Follow-up|0|||
161731813|NCT00960934|584059813|FG005|Overall Study|Lost to Follow-up|0|||
161731814|NCT00960934|584059808|FG000|Overall Study|Other|2|||
161731815|NCT00960934|584059809|FG001|Overall Study|Other|1|||
161731816|NCT00960934|584059810|FG002|Overall Study|Other|5|||
161731817|NCT00960934|584059811|FG003|Overall Study|Other|4|||
161731818|NCT00960934|584059812|FG004|Overall Study|Other|2|||
161731819|NCT00960934|584059813|FG005|Overall Study|Other|2|||
161731820|NCT00960934|584059808|FG000|Overall Study|Physician Decision|0|||
161731821|NCT00960934|584059809|FG001|Overall Study|Physician Decision|1|||
161731822|NCT00960934|584059810|FG002|Overall Study|Physician Decision|0|||
161731823|NCT00960934|584059811|FG003|Overall Study|Physician Decision|0|||
161839382|NCT00706511|584455377|FG003|Overall Study|Withdrawal by Subject|0|||
161965748|NCT01537081|584921831|FG000|Overall Study|Physician Decision|5|||
161731824|NCT00960934|584059812|FG004|Overall Study|Physician Decision|0|||
161731825|NCT00960934|584059813|FG005|Overall Study|Physician Decision|0|||
161731826|NCT00960934|584059808|FG000|Overall Study|Progressive Disease|1|||
161731827|NCT00960934|584059809|FG001|Overall Study|Progressive Disease|1|||
161731828|NCT00960934|584059810|FG002|Overall Study|Progressive Disease|0|||
161731829|NCT00960934|584059811|FG003|Overall Study|Progressive Disease|0|||
161731830|NCT00960934|584059812|FG004|Overall Study|Progressive Disease|1|||
161731831|NCT00960934|584059813|FG005|Overall Study|Progressive Disease|1|||
161731832|NCT00960934|584059808|FG000|Overall Study|Protocol Violation|3|||
161965749|NCT01537081|584921832|FG001|Overall Study|Physician Decision|6|||
161965750|NCT01537081|584921833|FG002|Overall Study|Physician Decision|0|||
161731833|NCT00960934|584059809|FG001|Overall Study|Protocol Violation|4|||
161731834|NCT00960934|584059810|FG002|Overall Study|Protocol Violation|0|||
161731835|NCT00960934|584059811|FG003|Overall Study|Protocol Violation|3|||
161731836|NCT00960934|584059812|FG004|Overall Study|Protocol Violation|3|||
161731837|NCT00960934|584059813|FG005|Overall Study|Protocol Violation|2|||
161731838|NCT00960934|584059808|FG000|Overall Study|Withdrawal by Subject|5|||
161731839|NCT00960934|584059809|FG001|Overall Study|Withdrawal by Subject|6|||
161731840|NCT00960934|584059810|FG002|Overall Study|Withdrawal by Subject|4|||
161731841|NCT00960934|584059811|FG003|Overall Study|Withdrawal by Subject|5|||
161731842|NCT00960934|584059812|FG004|Overall Study|Withdrawal by Subject|5|||
161731843|NCT00960934|584059813|FG005|Overall Study|Withdrawal by Subject|7|||
161731844|NCT00960934|584059808|FG000|Overall Study|Study Terminated by Sponsor|50|||
161731845|NCT00960934|584059809|FG001|Overall Study|Study Terminated by Sponsor|46|||
161731846|NCT00960934|584059810|FG002|Overall Study|Study Terminated by Sponsor|52|||
161731847|NCT00960934|584059811|FG003|Overall Study|Study Terminated by Sponsor|50|||
161731848|NCT00960934|584059812|FG004|Overall Study|Study Terminated by Sponsor|49|||
161731849|NCT00960934|584059813|FG005|Overall Study|Study Terminated by Sponsor|49|||
161731850|NCT02338492|584059825|FG000|Overall Study|Death|32|||
161731851|NCT02338492|584059825|FG000|Overall Study|Adverse Event|3|||
161731852|NCT02338492|584059825|FG000|Overall Study|Lost to Follow-up|4|||
161731853|NCT02338492|584059825|FG000|Overall Study|Reason not captured above|6|||
161731854|NCT01332019|584059826|FG000|Overall Study|Was Not Dosed|1|||
161731855|NCT01332019|584059827|FG001|Overall Study|Was Not Dosed|0|||
161731856|NCT01332019|584059826|FG000|Overall Study|Other|16|||
161731857|NCT01332019|584059827|FG001|Overall Study|Other|18|||
161731858|NCT01332019|584059826|FG000|Overall Study|Death|2|||
161731859|NCT01332019|584059827|FG001|Overall Study|Death|1|||
161731860|NCT01332019|584059826|FG000|Overall Study|Physician Decision|4|||
161731861|NCT01332019|584059827|FG001|Overall Study|Physician Decision|3|||
161731862|NCT01332019|584059826|FG000|Overall Study|Withdrawal by Subject|73|||
161731863|NCT01332019|584059827|FG001|Overall Study|Withdrawal by Subject|71|||
161731864|NCT01332019|584059826|FG000|Overall Study|Lost to Follow-up|4|||
161731865|NCT01332019|584059827|FG001|Overall Study|Lost to Follow-up|7|||
161731866|NCT01332019|584059826|FG000|Overall Study|Adverse Event|13|||
161731867|NCT01332019|584059827|FG001|Overall Study|Adverse Event|22|||
161731868|NCT04281030|584059830|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
161731869|NCT04281030|584059831|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
161731870|NCT04281030|584059830|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
161731871|NCT04281030|584059831|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
161731872|NCT01395368|584059832|FG000|Overall Study|Physician Decision|14|||
161731873|NCT01395368|584059832|FG000|Overall Study|Withdrawal by Subject|2|||
161731874|NCT00310388|584059833|FG000|Primary Reporting Phase|Adverse Event|101|||
161731875|NCT00310388|584059834|FG001|Primary Reporting Phase|Adverse Event|0|||
161731876|NCT00310388|584059833|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
161731877|NCT00310388|584059834|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
161731878|NCT00310388|584059833|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
161731879|NCT00310388|584059834|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
161731880|NCT00310388|584059833|FG000|Primary Reporting Phase|Protocol Violation|10|||
161731881|NCT00310388|584059834|FG001|Primary Reporting Phase|Protocol Violation|0|||
161731882|NCT00310388|584059833|FG000|Primary Reporting Phase|Pregnancy|3|||
161731883|NCT00310388|584059834|FG001|Primary Reporting Phase|Pregnancy|0|||
161731884|NCT00310388|584059833|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
161731885|NCT00310388|584059834|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
161731886|NCT00310388|584059833|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
161731887|NCT00310388|584059834|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
161731888|NCT00310388|584059833|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
161731889|NCT00310388|584059834|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
161731890|NCT00310388|584059833|FG000|Primary Reporting Phase|Physician Decision|2|||
161731891|NCT00310388|584059834|FG001|Primary Reporting Phase|Physician Decision|0|||
161731892|NCT00310388|584059833|FG000|Primary Reporting Phase|Request of the sponsor|19|||
161731893|NCT00310388|584059834|FG001|Primary Reporting Phase|Request of the sponsor|0|||
161731894|NCT00310388|584059833|FG000|Primary Reporting Phase|Failed to return|8|||
161731895|NCT00310388|584059834|FG001|Primary Reporting Phase|Failed to return|0|||
161731896|NCT00310388|584059833|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
161839383|NCT02605993|584455378|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
161965751|NCT01537081|584921831|FG000|Overall Study|Sponsor decision|0|||
161731897|NCT00310388|584059834|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
161965752|NCT01537081|584921832|FG001|Overall Study|Sponsor decision|1|||
161965753|NCT01537081|584921833|FG002|Overall Study|Sponsor decision|0|||
161965754|NCT01537081|584921831|FG000|Overall Study|Assigned but never dosed|1|||
161731898|NCT00310388|584059833|FG000|Primary Reporting Phase|Participant request|2|||
161731899|NCT00310388|584059834|FG001|Primary Reporting Phase|Participant request|0|||
161731900|NCT00310388|584059833|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
161731901|NCT00310388|584059834|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
161731902|NCT00310388|584059833|FG000|Primary Reporting Phase|Discontinuation of study|1|||
161731903|NCT00310388|584059834|FG001|Primary Reporting Phase|Discontinuation of study|0|||
161731904|NCT00310388|584059833|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
161731905|NCT00310388|584059834|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
161731906|NCT00310388|584059833|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
161731907|NCT00310388|584059834|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
161731908|NCT00310388|584059833|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
161731909|NCT00310388|584059834|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
161731910|NCT00310388|584059833|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
161731911|NCT00310388|584059834|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
161731912|NCT00310388|584059833|FG000|Primary Reporting Phase|Participant passed away|1|||
161731913|NCT00310388|584059834|FG001|Primary Reporting Phase|Participant passed away|0|||
161731914|NCT00310388|584059833|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
161731915|NCT00310388|584059834|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
161731916|NCT00310388|584059833|FG000|Primary Reporting Phase|Missing|1|||
161731917|NCT00310388|584059834|FG001|Primary Reporting Phase|Missing|0|||
161731918|NCT00310388|584059833|FG000|Primary Reporting Phase|Other|1|||
161731919|NCT00310388|584059834|FG001|Primary Reporting Phase|Other|0|||
161731920|NCT00310388|584059833|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
161731921|NCT00310388|584059834|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
161731922|NCT00310388|584059833|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
161731923|NCT00310388|584059834|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
161731924|NCT00310388|584059833|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
161731925|NCT00310388|584059834|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
161731926|NCT00310388|584059833|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
161731927|NCT00310388|584059834|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
161731928|NCT00882999|584059839|FG000|Overall Study|Adverse Event|0|||
161731929|NCT00882999|584059840|FG001|Overall Study|Adverse Event|0|||
161731930|NCT00882999|584059841|FG002|Overall Study|Adverse Event|0|||
161731931|NCT00882999|584059842|FG003|Overall Study|Adverse Event|0|||
161731932|NCT00882999|584059843|FG004|Overall Study|Adverse Event|1|||
161731933|NCT00882999|584059844|FG005|Overall Study|Adverse Event|0|||
161731934|NCT00882999|584059845|FG006|Overall Study|Adverse Event|0|||
161731935|NCT00882999|584059839|FG000|Overall Study|Death|0|||
161731936|NCT00882999|584059840|FG001|Overall Study|Death|1|||
161731937|NCT00882999|584059841|FG002|Overall Study|Death|0|||
161731938|NCT00882999|584059842|FG003|Overall Study|Death|0|||
161731939|NCT00882999|584059843|FG004|Overall Study|Death|0|||
161731940|NCT00882999|584059844|FG005|Overall Study|Death|0|||
161731941|NCT00882999|584059845|FG006|Overall Study|Death|0|||
161731942|NCT00882999|584059839|FG000|Overall Study|Withdrawal by Subject|7|||
161731943|NCT00882999|584059840|FG001|Overall Study|Withdrawal by Subject|6|||
161731944|NCT00882999|584059841|FG002|Overall Study|Withdrawal by Subject|3|||
161731945|NCT00882999|584059842|FG003|Overall Study|Withdrawal by Subject|3|||
161731946|NCT00882999|584059843|FG004|Overall Study|Withdrawal by Subject|6|||
161731947|NCT00882999|584059844|FG005|Overall Study|Withdrawal by Subject|5|||
161731948|NCT00882999|584059845|FG006|Overall Study|Withdrawal by Subject|5|||
161731949|NCT00882999|584059839|FG000|Overall Study|Lost to Follow-up|0|||
161731950|NCT00882999|584059840|FG001|Overall Study|Lost to Follow-up|1|||
161731951|NCT00882999|584059841|FG002|Overall Study|Lost to Follow-up|1|||
161731952|NCT00882999|584059842|FG003|Overall Study|Lost to Follow-up|2|||
161731953|NCT00882999|584059843|FG004|Overall Study|Lost to Follow-up|1|||
161731954|NCT00882999|584059844|FG005|Overall Study|Lost to Follow-up|1|||
161731955|NCT00882999|584059845|FG006|Overall Study|Lost to Follow-up|2|||
161731956|NCT00882999|584059839|FG000|Overall Study|Physician Decision|1|||
161731957|NCT00882999|584059840|FG001|Overall Study|Physician Decision|0|||
161731958|NCT00882999|584059841|FG002|Overall Study|Physician Decision|0|||
161731959|NCT00882999|584059842|FG003|Overall Study|Physician Decision|0|||
161731960|NCT00882999|584059843|FG004|Overall Study|Physician Decision|0|||
161731961|NCT00882999|584059844|FG005|Overall Study|Physician Decision|1|||
161731962|NCT00882999|584059845|FG006|Overall Study|Physician Decision|1|||
161731963|NCT01757405|584059848|FG000|Overall Study|Lost to Follow-up|1|||
161731964|NCT01757405|584059849|FG001|Overall Study|Lost to Follow-up|1|||
161731965|NCT01757405|584059848|FG000|Overall Study|Withdrawal by Subject|0|||
161731966|NCT01757405|584059849|FG001|Overall Study|Withdrawal by Subject|1|||
161731967|NCT00082758|584059850|FG000|Overall Study|Adverse Event|0|||
161731968|NCT00082758|584059851|FG001|Overall Study|Adverse Event|2|||
161731969|NCT00082758|584059852|FG002|Overall Study|Adverse Event|0|||
161731970|NCT00082758|584059850|FG000|Overall Study|Lack of Efficacy|12|||
161731971|NCT00082758|584059851|FG001|Overall Study|Lack of Efficacy|13|||
161731972|NCT00082758|584059852|FG002|Overall Study|Lack of Efficacy|0|||
161731973|NCT00082758|584059850|FG000|Overall Study|Physician Decision|0|||
161731974|NCT00082758|584059851|FG001|Overall Study|Physician Decision|1|||
161731975|NCT00082758|584059852|FG002|Overall Study|Physician Decision|0|||
161731976|NCT00082758|584059850|FG000|Overall Study|Withdrawal by Subject|3|||
161731977|NCT00082758|584059851|FG001|Overall Study|Withdrawal by Subject|0|||
161731978|NCT00082758|584059852|FG002|Overall Study|Withdrawal by Subject|0|||
161731979|NCT00082758|584059850|FG000|Overall Study|Protocol Violation|0|||
161731980|NCT00082758|584059851|FG001|Overall Study|Protocol Violation|1|||
161731981|NCT00082758|584059852|FG002|Overall Study|Protocol Violation|0|||
161731982|NCT01994226|584059855|FG000|Overall Study|Protocol Violation|13|||
161731983|NCT01994226|584059856|FG001|Overall Study|Protocol Violation|10|||
161731984|NCT01994226|584059855|FG000|Overall Study|Early Cessation of treatment|6|||
161731985|NCT01994226|584059856|FG001|Overall Study|Early Cessation of treatment|11|||
161731986|NCT02488551|584059857|FG000|Overall Study|Lost to Follow-up|4|||
161731987|NCT02488551|584059858|FG001|Overall Study|Lost to Follow-up|7|||
161731988|NCT02488551|584059859|FG002|Overall Study|Lost to Follow-up|0|||
161731989|NCT02488551|584059860|FG003|Overall Study|Lost to Follow-up|0|||
161731990|NCT02488551|584059857|FG000|Overall Study|Military Deployment|1|||
161731991|NCT02488551|584059858|FG001|Overall Study|Military Deployment|1|||
161731992|NCT02488551|584059859|FG002|Overall Study|Military Deployment|0|||
161731993|NCT02488551|584059860|FG003|Overall Study|Military Deployment|0|||
161731994|NCT00436566|584059861|FG000|Overall Study|Withdrawal by Subject|2|||
161731995|NCT00436566|584059861|FG000|Overall Study|Protocol Violation|1|||
161731996|NCT02841787|584059871|FG000|Overall Study|Lost to Follow-up|1|||
161731997|NCT02841787|584059872|FG001|Overall Study|Lost to Follow-up|0|||
161731998|NCT02841787|584059873|FG002|Overall Study|Lost to Follow-up|0|||
161731999|NCT02841787|584059871|FG000|Overall Study|Symptoms dropped below threshold|1|||
161732000|NCT02841787|584059872|FG001|Overall Study|Symptoms dropped below threshold|0|||
161732001|NCT02841787|584059873|FG002|Overall Study|Symptoms dropped below threshold|0|||
161732002|NCT02841787|584059871|FG000|Overall Study|Withdrawal by Subject|1|||
161732003|NCT02841787|584059872|FG001|Overall Study|Withdrawal by Subject|4|||
161732004|NCT02841787|584059873|FG002|Overall Study|Withdrawal by Subject|0|||
161732005|NCT01474746|584059874|FG000|Overall Study|Lost to Follow-up|1|||
161732006|NCT01474746|584059875|FG001|Overall Study|Lost to Follow-up|1|||
161732007|NCT01474746|584059874|FG000|Overall Study|Withdrawal by Subject|2|||
161732008|NCT01474746|584059875|FG001|Overall Study|Withdrawal by Subject|1|||
161732009|NCT00524316|584059876|FG000|Overall Study|Withdrawal by Subject|2|||
161732010|NCT00524316|584059876|FG000|Overall Study|Adverse Event|7|||
161732011|NCT00524316|584059876|FG000|Overall Study|Disease Progression|7|||
161732012|NCT01199263|584059877|FG000|Overall Study|Ineligible|0|||
161732013|NCT01199263|584059878|FG001|Overall Study|Ineligible|2|||
161732014|NCT01199263|584059877|FG000|Overall Study|Never Treated|6|||
161732015|NCT01199263|584059878|FG001|Overall Study|Never Treated|0|||
161732016|NCT01687413|584059883|FG000|Overall Study|Withdrawal by Subject|0|||
161732017|NCT01687413|584059884|FG001|Overall Study|Withdrawal by Subject|2|||
161732018|NCT01687413|584059883|FG000|Overall Study|Not eligible|0|||
161732019|NCT01687413|584059884|FG001|Overall Study|Not eligible|2|||
161732020|NCT01687413|584059883|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
161732021|NCT01687413|584059884|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
161732022|NCT04973228|584059887|FG000|Overall Study|Adverse Event|2|||
161732023|NCT04973228|584059888|FG001|Overall Study|Adverse Event|3|||
161732024|NCT04973228|584059887|FG000|Overall Study|Lack of Efficacy|1|||
161732025|NCT04973228|584059888|FG001|Overall Study|Lack of Efficacy|3|||
161732026|NCT04973228|584059887|FG000|Overall Study|Lost to Follow-up|12|||
161732027|NCT04973228|584059888|FG001|Overall Study|Lost to Follow-up|4|||
161732028|NCT04973228|584059887|FG000|Overall Study|Withdrawal by Subject|11|||
161732029|NCT04973228|584059888|FG001|Overall Study|Withdrawal by Subject|4|||
161732030|NCT04973228|584059887|FG000|Overall Study|Did not tolerate application|1|||
161732031|NCT04973228|584059888|FG001|Overall Study|Did not tolerate application|0|||
161732032|NCT04973228|584059887|FG000|Overall Study|Wanted to early terminate and use own product|0|||
161732033|NCT04973228|584059888|FG001|Overall Study|Wanted to early terminate and use own product|1|||
161732034|NCT04973228|584059887|FG000|Overall Study|Missed visits due to new work schedule|1|||
161732035|NCT04973228|584059888|FG001|Overall Study|Missed visits due to new work schedule|0|||
161732036|NCT00091390|584059894|FG000|Overall Study|Protocol Violation|1|||
161732037|NCT00091390|584059894|FG000|Overall Study|No protocol treatment|3|||
161732038|NCT00406640|584059899|FG000|Acute Phase|Adverse Event|18|||
161732039|NCT00406640|584059900|FG001|Acute Phase|Adverse Event|13|||
161732040|NCT00406640|584059899|FG000|Acute Phase|Failed to Return|5|||
161732041|NCT00406640|584059900|FG001|Acute Phase|Failed to Return|1|||
161732042|NCT00406640|584059899|FG000|Acute Phase|Physician Decision|0|||
161732043|NCT00406640|584059900|FG001|Acute Phase|Physician Decision|1|||
161732044|NCT00406640|584059899|FG000|Acute Phase|Lost to Follow-up|7|||
161732045|NCT00406640|584059900|FG001|Acute Phase|Lost to Follow-up|4|||
161732046|NCT00406640|584059899|FG000|Acute Phase|Protocol deviation|4|||
161732047|NCT00406640|584059900|FG001|Acute Phase|Protocol deviation|10|||
161732048|NCT00406640|584059899|FG000|Acute Phase|Protocol Violation|3|||
161839384|NCT02605993|584455379|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
161839385|NCT02605993|584455380|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
161839386|NCT02605993|584455381|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
161732049|NCT00406640|584059900|FG001|Acute Phase|Protocol Violation|2|||
161732050|NCT00406640|584059899|FG000|Acute Phase|Withdrawal by Subject|11|||
161839387|NCT02116608|584455389|FG000|Overall Study|Lost to Follow-up|0|||
161839388|NCT02116608|584455390|FG001|Overall Study|Lost to Follow-up|0|||
161839389|NCT02116608|584455391|FG002|Overall Study|Lost to Follow-up|1|||
161839390|NCT02116608|584455389|FG000|Overall Study|Physician Decision|0|||
161839391|NCT02116608|584455390|FG001|Overall Study|Physician Decision|1|||
161839392|NCT02116608|584455391|FG002|Overall Study|Physician Decision|0|||
161839393|NCT02116608|584455389|FG000|Overall Study|Death|0|||
161839394|NCT02116608|584455390|FG001|Overall Study|Death|1|||
161839395|NCT02116608|584455391|FG002|Overall Study|Death|0|||
161839396|NCT01169532|584455394|FG000|Overall Study|Withdrawal by Subject|1|||
161839397|NCT00117325|584455395|FG000|Overall Study|Adverse Event|3|||
161839398|NCT00117325|584455396|FG001|Overall Study|Adverse Event|3|||
161839399|NCT00117325|584455395|FG000|Overall Study|Lost to Follow-up|1|||
161839400|NCT00117325|584455396|FG001|Overall Study|Lost to Follow-up|1|||
161839401|NCT00117325|584455395|FG000|Overall Study|Protocol Violation|2|||
161839402|NCT00117325|584455396|FG001|Overall Study|Protocol Violation|3|||
161839403|NCT00117325|584455395|FG000|Overall Study|Withdrawal by Subject|3|||
161839404|NCT00117325|584455396|FG001|Overall Study|Withdrawal by Subject|2|||
161839405|NCT00117325|584455395|FG000|Overall Study|Lack of Efficacy|1|||
161839406|NCT00117325|584455396|FG001|Overall Study|Lack of Efficacy|0|||
161839407|NCT00117325|584455395|FG000|Overall Study|Use of prohibited medicine|1|||
161839408|NCT00117325|584455396|FG001|Overall Study|Use of prohibited medicine|2|||
161839409|NCT00117325|584455395|FG000|Overall Study|Early termination|1|||
161839410|NCT00117325|584455396|FG001|Overall Study|Early termination|1|||
161839411|NCT00117325|584455395|FG000|Overall Study|Admisnitrative|1|||
162032246|NCT00775203|585175443|FG000|Overall Study|Lack of Efficacy|8|||
162032247|NCT00775203|585175444|FG001|Overall Study|Lack of Efficacy|9|||
162032248|NCT00775203|585175443|FG000|Overall Study|Withdrawal by Subject|11|||
162032249|NCT00775203|585175444|FG001|Overall Study|Withdrawal by Subject|9|||
162032250|NCT00775203|585175443|FG000|Overall Study|Lost to Follow-up|11|||
162032251|NCT00775203|585175444|FG001|Overall Study|Lost to Follow-up|15|||
162032252|NCT00775203|585175443|FG000|Overall Study|Administrative reason|2|||
162032253|NCT00775203|585175444|FG001|Overall Study|Administrative reason|0|||
161732051|NCT00406640|584059900|FG001|Acute Phase|Withdrawal by Subject|9|||
161732052|NCT00406640|584059899|FG000|Acute Phase|Lack of Efficacy|3|||
161732053|NCT00406640|584059900|FG001|Acute Phase|Lack of Efficacy|3|||
161732054|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
161732055|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
161732056|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Death|1|||
161732057|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Death|0|||
161732058|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
161732059|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
161732060|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
161732061|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
161732062|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
161732063|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
161732064|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|non-compliance|7|||
161732065|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|non-compliance|5|||
161732066|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
162032254|NCT00775203|585175443|FG000|Overall Study|Noncompliance|4|||
162032255|NCT00775203|585175444|FG001|Overall Study|Noncompliance|2|||
162032256|NCT00775203|585175443|FG000|Overall Study|Protocol Violation|0|||
162032257|NCT00775203|585175444|FG001|Overall Study|Protocol Violation|1|||
162032258|NCT00775203|585175443|FG000|Overall Study|Entered other study|1|||
162032259|NCT00775203|585175444|FG001|Overall Study|Entered other study|0|||
162032260|NCT00775203|585175443|FG000|Overall Study|Physician Decision|0|||
162032261|NCT00775203|585175444|FG001|Overall Study|Physician Decision|1|||
161732067|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
161732068|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
161732069|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
161732070|NCT00406640|584059899|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
161839412|NCT00117325|584455396|FG001|Overall Study|Admisnitrative|0|||
161839413|NCT01468818|584455400|FG000|Overall Study|Death during treatment|2|||
161839414|NCT04620135|584455402|FG000|Study Completion|Adverse Event|2|||
161839415|NCT04620135|584455403|FG001|Study Completion|Adverse Event|3|||
161839416|NCT04620135|584455402|FG000|Study Completion|Withdrawal by Subject|2|||
161839417|NCT04620135|584455403|FG001|Study Completion|Withdrawal by Subject|0|||
161839418|NCT01442688|584455404|FG000|First Intervention|Withdrawal by Subject|1|||
162032262|NCT02987660|585175445|FG000|Overall Study|Study terminated by sponsor|10|||
162032263|NCT02987660|585175446|FG001|Overall Study|Study terminated by sponsor|10|||
162032264|NCT05247398|585175447|FG000|Overall Study|Withdrawal by Subject|1|||
162032265|NCT05171816|585175448|FG000|Overall Study|Death|18|||
162032266|NCT05171816|585175449|FG001|Overall Study|Death|16|||
162032267|NCT02937571|585175450|FG000|Overall Study|Adverse Event|0|||
162032268|NCT02937571|585175451|FG001|Overall Study|Adverse Event|0|||
162032269|NCT02937571|585175452|FG002|Overall Study|Adverse Event|4|||
162032270|NCT02937571|585175450|FG000|Overall Study|Withdrawal by Subject|0|||
162032271|NCT02937571|585175451|FG001|Overall Study|Withdrawal by Subject|0|||
162032272|NCT02937571|585175452|FG002|Overall Study|Withdrawal by Subject|3|||
162032273|NCT04902326|585175453|FG000|Overall Study|Withdrawal by Subject|1|||
162032274|NCT04902326|585175454|FG001|Overall Study|Withdrawal by Subject|3|||
162032275|NCT04902326|585175455|FG002|Overall Study|Withdrawal by Subject|0|||
161839419|NCT01442688|584455405|FG001|First Intervention|Withdrawal by Subject|0|||
161839420|NCT01442688|584455404|FG000|First Intervention|subject incarcerated|1|||
161839421|NCT01442688|584455405|FG001|First Intervention|subject incarcerated|0|||
161839422|NCT01442688|584455404|FG000|Second Intervention|Adverse Event|1|||
161839423|NCT01442688|584455405|FG001|Second Intervention|Adverse Event|0|||
161839424|NCT04480021|584455406|FG000|Overall Study|Lost to Follow-up|3|||
161839425|NCT04480021|584455407|FG001|Overall Study|Lost to Follow-up|4|||
161839426|NCT00546572|584455408|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
161839427|NCT00546572|584455409|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
161839428|NCT00546572|584455408|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
161839429|NCT00546572|584455409|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
161839430|NCT00546572|584455408|FG000|Vax 1 / Year 0|Protocol Violation|3|||
161839431|NCT00546572|584455409|FG001|Vax 1 / Year 0|Protocol Violation|4|||
161839432|NCT00546572|584455408|FG000|Vax 1 / Year 0|Death|2|||
161839433|NCT00546572|584455409|FG001|Vax 1 / Year 0|Death|2|||
161839434|NCT00546572|584455408|FG000|Vax 1 / Year 0|Adverse Event|0|||
161839435|NCT00546572|584455409|FG001|Vax 1 / Year 0|Adverse Event|1|||
161839436|NCT00546572|584455408|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
161839437|NCT00546572|584455409|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
161839438|NCT00546572|584455408|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
161839439|NCT00546572|584455409|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
161839440|NCT00546572|584455408|FG000|Vax 2 / Year 1|Other|1|||
161839441|NCT00546572|584455409|FG001|Vax 2 / Year 1|Other|1|||
161839442|NCT00546572|584455408|FG000|Vax 2 / Year 1|Adverse Event|1|||
161839443|NCT00546572|584455409|FG001|Vax 2 / Year 1|Adverse Event|0|||
161839444|NCT00546572|584455408|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
161839445|NCT00546572|584455409|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
161839446|NCT03979820|584455410|FG000|Overall Study|Protocol Violation|1|||
161839447|NCT03979820|584455411|FG001|Overall Study|Protocol Violation|0|||
161839448|NCT03979820|584455412|FG002|Overall Study|Protocol Violation|0|||
161839449|NCT03979820|584455413|FG003|Overall Study|Protocol Violation|0|||
161839450|NCT03979820|584455410|FG000|Overall Study|Withdrawal by Subject|0|||
161839451|NCT03979820|584455411|FG001|Overall Study|Withdrawal by Subject|0|||
161839452|NCT03979820|584455412|FG002|Overall Study|Withdrawal by Subject|1|||
161839453|NCT03979820|584455413|FG003|Overall Study|Withdrawal by Subject|0|||
161839454|NCT03979820|584455410|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
161839455|NCT03979820|584455411|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
161839456|NCT03979820|584455412|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
161839457|NCT03979820|584455413|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
161839458|NCT02685202|584455414|FG000|Overall Study|Lost to Follow-up|9|||
161839459|NCT01229735|584455415|FG000|Overall Study|Lack of Efficacy|8|||
161839460|NCT01229735|584455416|FG001|Overall Study|Lack of Efficacy|8|||
161839461|NCT01229735|584455415|FG000|Overall Study|Protocol Violation|13|||
161839462|NCT01229735|584455416|FG001|Overall Study|Protocol Violation|8|||
161839463|NCT01229735|584455415|FG000|Overall Study|Lost to Follow-up|0|||
161839464|NCT01229735|584455416|FG001|Overall Study|Lost to Follow-up|2|||
161839465|NCT01229735|584455415|FG000|Overall Study|Withdrawal by Subject|18|||
161839466|NCT01229735|584455416|FG001|Overall Study|Withdrawal by Subject|17|||
162032276|NCT04902326|585175456|FG003|Overall Study|Withdrawal by Subject|1|||
162032277|NCT04902326|585175453|FG000|Overall Study|Lost to Follow-up|14|||
162032278|NCT04902326|585175454|FG001|Overall Study|Lost to Follow-up|14|||
161839467|NCT01229735|584455415|FG000|Overall Study|Other Reason|13|||
161839468|NCT01229735|584455416|FG001|Overall Study|Other Reason|10|||
161839469|NCT01229735|584455415|FG000|Overall Study|SAE, non-fatal|0|||
161839470|NCT01229735|584455416|FG001|Overall Study|SAE, non-fatal|4|||
161839471|NCT01229735|584455415|FG000|Overall Study|AE, non-serious non-fatal|13|||
161839472|NCT01229735|584455416|FG001|Overall Study|AE, non-serious non-fatal|17|||
161839473|NCT01229735|584455415|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161839474|NCT01229735|584455416|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
161839475|NCT02130882|584455417|FG000|Overall Study|Withdrawal by Subject|0|||
161839476|NCT02130882|584455418|FG001|Overall Study|Withdrawal by Subject|1|||
161839477|NCT02331368|584455423|FG000|Overall Study|Withdrawal by Subject|3|||
162032279|NCT04902326|585175455|FG002|Overall Study|Lost to Follow-up|14|||
161732071|NCT00406640|584059900|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
161732072|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
161732073|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
161732074|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
161732075|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
161732076|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
161732077|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
161732078|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
161732079|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
161732080|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
161732081|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
161732082|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
161732083|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
161732084|NCT00406640|584059899|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
161732085|NCT00406640|584059900|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
161732086|NCT01116687|584061482|FG000|Overall Study|Withdrawal by Subject|4|||
161732087|NCT03497429|584061483|FG000|Overall Study|Progressive disease|3|||
161732088|NCT03497429|584061484|FG001|Overall Study|Progressive disease|4|||
161732089|NCT03497429|584061483|FG000|Overall Study|Adverse Event|0|||
161732090|NCT03497429|584061484|FG001|Overall Study|Adverse Event|2|||
161732091|NCT01215734|584061485|FG000|Overall Study|Death|0|||
161732092|NCT01215734|584061486|FG001|Overall Study|Death|1|||
161732093|NCT00315705|584061487|FG000|Phase 1|Refused further treatment|1|||
161732094|NCT00315705|584061487|FG000|Phase 1|Failure to achieve response|8|||
161732095|NCT00315705|584061487|FG000|Phase 1|Disease relapse|4|||
161732096|NCT00315705|584061487|FG000|Phase 1|Scheduled for transplant|9|||
161732097|NCT00315705|584061487|FG000|Phase 1|Death|3|||
161732098|NCT00315705|584061487|FG000|Phase 2|Physician Decision|4|||
161732099|NCT00315705|584061487|FG000|Phase 2|Adverse Event|1|||
161732100|NCT00315705|584061487|FG000|Phase 2|Failure to achieve response|3|||
161732101|NCT00315705|584061487|FG000|Phase 2|Disease relapse|1|||
161732102|NCT00315705|584061487|FG000|Phase 2|Scheduled for transplant|8|||
161732103|NCT00315705|584061487|FG000|Phase 2|Other|1|||
161732104|NCT00315705|584061487|FG000|Phase 2|Death|7|||
161732105|NCT01346371|584061488|FG000|Overall Study|Lost to Follow-up|2|||
161732106|NCT01346371|584061489|FG001|Overall Study|Lost to Follow-up|0|||
161732107|NCT01716533|584061490|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
161732108|NCT01716533|584061491|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
161732109|NCT01716533|584061492|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
161732110|NCT01716533|584061493|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
161732111|NCT01716533|584061490|FG000|Overall Study|Withdrawal by Subject|0|||
161732112|NCT01716533|584061491|FG001|Overall Study|Withdrawal by Subject|0|||
161732113|NCT01716533|584061492|FG002|Overall Study|Withdrawal by Subject|0|||
161732114|NCT01716533|584061493|FG003|Overall Study|Withdrawal by Subject|5|||
161732115|NCT01716533|584061490|FG000|Overall Study|Death|0|||
161732116|NCT01716533|584061491|FG001|Overall Study|Death|0|||
161732117|NCT01716533|584061492|FG002|Overall Study|Death|0|||
161732118|NCT01716533|584061493|FG003|Overall Study|Death|2|||
161732119|NCT01716533|584061490|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
161732120|NCT01716533|584061491|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
161732121|NCT01716533|584061492|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
161732122|NCT01716533|584061493|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
161732123|NCT02622724|584061503|FG000|Overall Study|Death|51|||
161732124|NCT02622724|584061504|FG001|Overall Study|Death|53|||
161732125|NCT02622724|584061503|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
161732126|NCT02622724|584061504|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
161732127|NCT02622724|584061503|FG000|Overall Study|Early termination of study|38|||
161732128|NCT02622724|584061504|FG001|Overall Study|Early termination of study|43|||
161732129|NCT00254293|584061505|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161732130|NCT00254293|584061506|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
161732131|NCT00254293|584061507|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161732132|NCT00254293|584061508|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
161732133|NCT00254293|584061509|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161732134|NCT00254293|584061510|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161732135|NCT00254293|584061511|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161732136|NCT00254293|584061505|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161732137|NCT00254293|584061506|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161732138|NCT00254293|584061507|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
161732139|NCT00254293|584061508|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161732140|NCT00254293|584061509|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161732141|NCT00254293|584061510|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161732142|NCT00254293|584061511|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161839478|NCT02302859|584455424|FG000|Overall Study|Lost Phone|1|||
161839479|NCT02302859|584455425|FG001|Overall Study|Lost Phone|1|||
161839480|NCT02302859|584455424|FG000|Overall Study|Withdrawal by Subject|0|||
161839481|NCT02302859|584455425|FG001|Overall Study|Withdrawal by Subject|1|||
161839482|NCT00424775|584455426|FG000|Overall Study|Adverse Event|2|||
161839483|NCT00424775|584455427|FG001|Overall Study|Adverse Event|0|||
161839484|NCT00424775|584455426|FG000|Overall Study|Lack of Efficacy|1|||
161839485|NCT00424775|584455427|FG001|Overall Study|Lack of Efficacy|0|||
161839486|NCT02384850|584455431|FG000|Overall Study|Withdrawal by Subject|2|||
161839487|NCT02384850|584455432|FG001|Overall Study|Withdrawal by Subject|2|||
161839488|NCT02312063|584455433|FG000|Overall Study|Withdrawal by Subject|0|||
161839489|NCT02312063|584455434|FG001|Overall Study|Withdrawal by Subject|1|||
161839490|NCT03548064|584458504|FG000|Overall Study|Withdrawal by Subject|0|||
161839491|NCT03548064|584458505|FG001|Overall Study|Withdrawal by Subject|0|||
161839492|NCT03548064|584458506|FG002|Overall Study|Withdrawal by Subject|0|||
161839493|NCT03548064|584458507|FG003|Overall Study|Withdrawal by Subject|1|||
161732143|NCT00254293|584061505|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161732144|NCT00254293|584061506|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161732145|NCT00254293|584061507|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
161732146|NCT00254293|584061508|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161732147|NCT00254293|584061509|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161732148|NCT00254293|584061510|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161732149|NCT00254293|584061511|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161732150|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Death|0|||
161732151|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Death|0|||
161732152|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Death|1|||
161732153|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Death|0|||
161732154|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Death|0|||
161732155|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Death|0|||
161732156|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Death|0|||
161732157|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
161732158|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
161732159|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
161732160|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
161732161|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
161732162|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
161732163|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
161732164|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
161732165|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
161732166|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
161732167|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
161732168|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
161732169|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
161732170|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
161732171|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161732172|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161732173|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
161732174|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161732175|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161732176|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161732177|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161732178|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161732179|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161732180|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
161732181|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161732182|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161732183|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161732184|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161732185|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161732186|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161839494|NCT03548064|584458508|FG004|Overall Study|Withdrawal by Subject|0|||
162032280|NCT04902326|585175456|FG003|Overall Study|Lost to Follow-up|6|||
162032281|NCT01120067|585175462|FG000|Overall Study|Lost to Follow-up|3|||
161732187|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
161839495|NCT03548064|584458509|FG005|Overall Study|Withdrawal by Subject|0|||
161839496|NCT03548064|584458510|FG006|Overall Study|Withdrawal by Subject|0|||
162032282|NCT01120067|585175463|FG001|Overall Study|Lost to Follow-up|1|||
161839497|NCT03548064|584458511|FG007|Overall Study|Withdrawal by Subject|0|||
161839498|NCT03548064|584458504|FG000|Overall Study|Lost to Follow-up|0|||
162032283|NCT01120067|585175462|FG000|Overall Study|fail to engage >3 sessions|2|||
161965755|NCT01537081|584921832|FG001|Overall Study|Assigned but never dosed|0|||
161732188|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161732189|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161732190|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161732191|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161732192|NCT00254293|584061505|FG000|LTE Open Label Variable SC Dosing|Other|0|||
161732193|NCT00254293|584061506|FG001|LTE Open Label Variable SC Dosing|Other|0|||
161732194|NCT00254293|584061507|FG002|LTE Open Label Variable SC Dosing|Other|2|||
161732195|NCT00254293|584061508|FG003|LTE Open Label Variable SC Dosing|Other|0|||
161732196|NCT00254293|584061509|FG004|LTE Open Label Variable SC Dosing|Other|0|||
161732197|NCT00254293|584061510|FG005|LTE Open Label Variable SC Dosing|Other|0|||
161732198|NCT00254293|584061511|FG006|LTE Open Label Variable SC Dosing|Other|0|||
161732199|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Death|0|||
161732200|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Death|0|||
161732201|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Death|0|||
161732202|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Death|0|||
161732203|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Death|0|||
161732204|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Death|0|||
161732205|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Death|3|||
161732206|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
161732207|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
161732208|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
161732209|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
161732210|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
161732211|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
161732212|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
161732213|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161732214|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161732215|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161732216|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161732217|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161732218|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161732219|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
161732220|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161732221|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161732222|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161732223|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161732224|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161732225|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161732226|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
161732227|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161732228|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161732229|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161732230|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161732231|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161732232|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161732233|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
161732234|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161732235|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161732236|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161732237|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161732238|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161732239|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161732240|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
161732241|NCT00254293|584061505|FG000|LTE Open Label Fixed Dosing|Other|0|||
161732242|NCT00254293|584061506|FG001|LTE Open Label Fixed Dosing|Other|0|||
161732243|NCT00254293|584061507|FG002|LTE Open Label Fixed Dosing|Other|0|||
161732244|NCT00254293|584061508|FG003|LTE Open Label Fixed Dosing|Other|0|||
161732245|NCT00254293|584061509|FG004|LTE Open Label Fixed Dosing|Other|0|||
161732246|NCT00254293|584061510|FG005|LTE Open Label Fixed Dosing|Other|0|||
161732247|NCT00254293|584061511|FG006|LTE Open Label Fixed Dosing|Other|1|||
161732248|NCT01575197|584061512|FG000|Overall Study|Migration out of study area|1|||
161732249|NCT01575197|584061513|FG001|Overall Study|Migration out of study area|5|||
161732250|NCT01575197|584061514|FG002|Overall Study|Migration out of study area|4|||
161732251|NCT01575197|584061512|FG000|Overall Study|SAE|0|||
161732252|NCT01575197|584061513|FG001|Overall Study|SAE|1|||
161732253|NCT01575197|584061514|FG002|Overall Study|SAE|0|||
161732254|NCT01575197|584061512|FG000|Overall Study|Lost to Follow-up|0|||
161732255|NCT01575197|584061513|FG001|Overall Study|Lost to Follow-up|1|||
161732256|NCT01575197|584061514|FG002|Overall Study|Lost to Follow-up|0|||
161732257|NCT01575197|584061512|FG000|Overall Study|Withdrawal by Subject|0|||
161839499|NCT03548064|584458505|FG001|Overall Study|Lost to Follow-up|0|||
161732258|NCT01575197|584061513|FG001|Overall Study|Withdrawal by Subject|1|||
161732259|NCT01575197|584061514|FG002|Overall Study|Withdrawal by Subject|1|||
161732260|NCT01575197|584061512|FG000|Overall Study|Protocol Violation|2|||
161732261|NCT01575197|584061513|FG001|Overall Study|Protocol Violation|1|||
161732262|NCT01575197|584061514|FG002|Overall Study|Protocol Violation|1|||
161732263|NCT01000727|584061515|FG000|Overall Study|Lost to Follow-up|41|||
161732264|NCT01000727|584061516|FG001|Overall Study|Lost to Follow-up|43|||
161732265|NCT01000727|584061515|FG000|Overall Study|Withdrawal by Subject|111|||
161732266|NCT01000727|584061516|FG001|Overall Study|Withdrawal by Subject|109|||
161732267|NCT01000727|584061515|FG000|Overall Study|Study closed/terminated|23|||
161732268|NCT01000727|584061516|FG001|Overall Study|Study closed/terminated|24|||
161732269|NCT03196193|584061517|FG000|Overall Study|Adverse Event|1|||
161732270|NCT03196193|584061518|FG001|Overall Study|Adverse Event|0|||
161732271|NCT03196193|584061517|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
161732272|NCT03196193|584061518|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
161732273|NCT02709083|584061519|FG000|Overall Study|Original PI left institution|7|||
161732274|NCT01026389|584061523|FG000|Overall Study|Withdrawal by Subject|1|||
161732275|NCT01026389|584061524|FG001|Overall Study|Withdrawal by Subject|3|||
161732276|NCT01026389|584061523|FG000|Overall Study|change of treatment, patient moved|4|||
161732277|NCT01026389|584061524|FG001|Overall Study|change of treatment, patient moved|2|||
161732278|NCT03544268|584061525|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
161732279|NCT03544268|584061526|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
161732280|NCT04410198|584061527|FG000|Overall Study|Death|10|||
161732281|NCT04410198|584061527|FG000|Overall Study|Withdrawal by Subject|7|||
161732282|NCT04410198|584061527|FG000|Overall Study|Transferred/Relocation|4|||
161732283|NCT04410198|584061527|FG000|Overall Study|Kidney Transplant|9|||
161732284|NCT04410198|584061527|FG000|Overall Study|Adverse Event|4|||
161732285|NCT04410198|584061527|FG000|Overall Study|Physician Decision|2|||
161732286|NCT04410198|584061527|FG000|Overall Study|Other than specified|1|||
161732287|NCT01626352|584061531|FG000|Overall Study|Disease Progression|3|||
161732288|NCT01626352|584061531|FG000|Overall Study|Intercurrent Illness|2|||
161732289|NCT01626352|584061531|FG000|Overall Study|Death|2|||
161732290|NCT01626352|584061531|FG000|Overall Study|Withdrawal by Subject|1|||
161732291|NCT01626352|584061531|FG000|Overall Study|Non-Compliance|1|||
161732292|NCT01626352|584061531|FG000|Overall Study|Never Treated|1|||
161732293|NCT03583372|584061534|FG000|Overall Study|Withdrawal by Subject|6|||
161732294|NCT03583372|584061535|FG001|Overall Study|Withdrawal by Subject|11|||
161732295|NCT03583372|584061536|FG002|Overall Study|Withdrawal by Subject|7|||
161732296|NCT03583372|584061537|FG003|Overall Study|Withdrawal by Subject|8|||
161732297|NCT03583372|584061534|FG000|Overall Study|Lost to Follow-up|4|||
161732298|NCT03583372|584061535|FG001|Overall Study|Lost to Follow-up|6|||
161732299|NCT03583372|584061536|FG002|Overall Study|Lost to Follow-up|3|||
161732300|NCT03583372|584061537|FG003|Overall Study|Lost to Follow-up|2|||
161732301|NCT03583372|584061534|FG000|Overall Study|Adverse Event|1|||
161732302|NCT03583372|584061535|FG001|Overall Study|Adverse Event|3|||
161732303|NCT03583372|584061536|FG002|Overall Study|Adverse Event|4|||
161732304|NCT03583372|584061537|FG003|Overall Study|Adverse Event|4|||
161732305|NCT03583372|584061534|FG000|Overall Study|Physician Decision|0|||
161732306|NCT03583372|584061535|FG001|Overall Study|Physician Decision|1|||
161732307|NCT03583372|584061536|FG002|Overall Study|Physician Decision|1|||
161732308|NCT03583372|584061537|FG003|Overall Study|Physician Decision|1|||
161732309|NCT03583372|584061534|FG000|Overall Study|Lack of Efficacy|0|||
161732310|NCT03583372|584061535|FG001|Overall Study|Lack of Efficacy|1|||
161732311|NCT03583372|584061536|FG002|Overall Study|Lack of Efficacy|0|||
161732312|NCT03583372|584061537|FG003|Overall Study|Lack of Efficacy|1|||
161732313|NCT03583372|584061534|FG000|Overall Study|Death|1|||
161732314|NCT03583372|584061535|FG001|Overall Study|Death|0|||
161732315|NCT03583372|584061536|FG002|Overall Study|Death|0|||
161732316|NCT03583372|584061537|FG003|Overall Study|Death|0|||
161732317|NCT03583372|584061534|FG000|Overall Study|Protocol Violation|0|||
161732318|NCT03583372|584061535|FG001|Overall Study|Protocol Violation|1|||
161732319|NCT03583372|584061536|FG002|Overall Study|Protocol Violation|0|||
161965756|NCT01537081|584921833|FG002|Overall Study|Assigned but never dosed|0|||
161732320|NCT03583372|584061537|FG003|Overall Study|Protocol Violation|0|||
161732321|NCT03583372|584061534|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
161839500|NCT03548064|584458506|FG002|Overall Study|Lost to Follow-up|0|||
161839501|NCT03548064|584458507|FG003|Overall Study|Lost to Follow-up|0|||
161965757|NCT01463111|584921834|FG000|Overall Study|Withdrawal by Subject|2|||
161965758|NCT01463111|584921834|FG000|Overall Study|Lost to Follow-up|5|||
161732322|NCT03583372|584061535|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
161965759|NCT01463111|584921834|FG000|Overall Study|Physician Decision|2|||
161732323|NCT03583372|584061536|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
161732324|NCT03583372|584061537|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
161732325|NCT03583372|584061534|FG000|Overall Study|Did Not Receive Study Drug|0|||
161732326|NCT03583372|584061535|FG001|Overall Study|Did Not Receive Study Drug|1|||
161732327|NCT03583372|584061536|FG002|Overall Study|Did Not Receive Study Drug|0|||
161732328|NCT03583372|584061537|FG003|Overall Study|Did Not Receive Study Drug|0|||
161839502|NCT03548064|584458508|FG004|Overall Study|Lost to Follow-up|2|||
161732329|NCT03583372|584061534|FG000|Overall Study|Captured as Other in the Database|1|||
161965760|NCT00882583|584921835|FG000|Overall Study|Physician Decision|1|||
161965761|NCT00882583|584921836|FG001|Overall Study|Physician Decision|0|||
161965762|NCT00882583|584921835|FG000|Overall Study|Adverse Event|0|||
161965763|NCT00882583|584921836|FG001|Overall Study|Adverse Event|1|||
161732330|NCT03583372|584061535|FG001|Overall Study|Captured as Other in the Database|2|||
161732331|NCT03583372|584061536|FG002|Overall Study|Captured as Other in the Database|4|||
161732332|NCT03583372|584061537|FG003|Overall Study|Captured as Other in the Database|1|||
161732333|NCT02695524|584061538|FG000|Overall Study|Lost to Follow-up|3|||
161732334|NCT02695524|584061539|FG001|Overall Study|Lost to Follow-up|2|||
161732335|NCT02695524|584061538|FG000|Overall Study|Death|0|||
161732336|NCT02695524|584061539|FG001|Overall Study|Death|1|||
161732337|NCT00798655|584061542|FG000|Overall Study|Did not receive at least one dose of pan|2|||
161732338|NCT00174785|584061549|FG000|Overall Study|Adverse Event|293|||
161732339|NCT00174785|584061550|FG001|Overall Study|Adverse Event|191|||
161732340|NCT00174785|584061549|FG000|Overall Study|Protocol Violation|14|||
161732341|NCT00174785|584061550|FG001|Overall Study|Protocol Violation|14|||
161732342|NCT00174785|584061549|FG000|Overall Study|Withdrawal by Subject|173|||
161732343|NCT00174785|584061550|FG001|Overall Study|Withdrawal by Subject|175|||
161732344|NCT00174785|584061549|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
161732345|NCT00174785|584061550|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
161732346|NCT00174785|584061549|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
161732347|NCT00174785|584061550|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
161732348|NCT00174785|584061549|FG000|Overall Study|Other prohibited medication|5|||
161732349|NCT00174785|584061550|FG001|Overall Study|Other prohibited medication|3|||
161732350|NCT00174785|584061549|FG000|Overall Study|Family request|6|||
161732351|NCT00174785|584061550|FG001|Overall Study|Family request|8|||
161732352|NCT00174785|584061549|FG000|Overall Study|Not pre-specified/Not coded|56|||
161732353|NCT00174785|584061550|FG001|Overall Study|Not pre-specified/Not coded|70|||
161732354|NCT00120289|584061551|FG000|Overall Study|Death|96|||
161732355|NCT00120289|584061552|FG001|Overall Study|Death|82|||
161732356|NCT00120289|584061551|FG000|Overall Study|Lost to Follow-up|11|||
161732357|NCT00120289|584061552|FG001|Overall Study|Lost to Follow-up|14|||
161732358|NCT00120289|584061551|FG000|Overall Study|Withdrawal by Subject|14|||
161732359|NCT00120289|584061552|FG001|Overall Study|Withdrawal by Subject|13|||
161732360|NCT02179515|584061556|FG000|Overall Study|switched to alternative treatment|0|||
161732361|NCT02179515|584061557|FG001|Overall Study|switched to alternative treatment|1|||
161732362|NCT02179515|584061558|FG002|Overall Study|switched to alternative treatment|1|||
161732363|NCT02179515|584061556|FG000|Overall Study|Death|0|||
161732364|NCT02179515|584061557|FG001|Overall Study|Death|1|||
161732365|NCT02179515|584061558|FG002|Overall Study|Death|1|||
161732366|NCT02179515|584061556|FG000|Overall Study|refused further treatment|0|||
161732367|NCT02179515|584061557|FG001|Overall Study|refused further treatment|3|||
161732368|NCT02179515|584061558|FG002|Overall Study|refused further treatment|4|||
161732369|NCT02179515|584061556|FG000|Overall Study|Disease progression on study|2|||
161732370|NCT02179515|584061557|FG001|Overall Study|Disease progression on study|11|||
161732371|NCT02179515|584061558|FG002|Overall Study|Disease progression on study|8|||
161732372|NCT00782418|584061559|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
161732373|NCT00782418|584061560|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161732374|NCT00782418|584061561|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161732375|NCT00782418|584061562|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161732376|NCT00782418|584061563|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161732377|NCT00782418|584061564|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161732378|NCT00782418|584061565|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161732379|NCT00782418|584061559|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
161732380|NCT00782418|584061560|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161732381|NCT00782418|584061561|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161732382|NCT00782418|584061562|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161732383|NCT00782418|584061563|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
161732384|NCT00782418|584061564|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
161732385|NCT00782418|584061565|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161732386|NCT01718509|584061566|FG000|Overall Study|Lost to Follow-up|18|||
161732387|NCT01718509|584061567|FG001|Overall Study|Lost to Follow-up|15|||
161732388|NCT01718509|584061566|FG000|Overall Study|Withdrawal by Subject|7|||
161732389|NCT01718509|584061567|FG001|Overall Study|Withdrawal by Subject|13|||
161732390|NCT01718509|584061566|FG000|Overall Study|Adverse Event|5|||
161732391|NCT01718509|584061567|FG001|Overall Study|Adverse Event|7|||
161732392|NCT01718509|584061566|FG000|Overall Study|Other|13|||
161732393|NCT01718509|584061567|FG001|Overall Study|Other|11|||
161732394|NCT01718509|584061566|FG000|Overall Study|Protocol Violation|4|||
161732395|NCT01718509|584061567|FG001|Overall Study|Protocol Violation|2|||
161732396|NCT01718509|584061566|FG000|Overall Study|Lack of Efficacy|1|||
161732397|NCT01718509|584061567|FG001|Overall Study|Lack of Efficacy|0|||
161965764|NCT00983515|584921837|FG000|Ritonavir Alone|liver panel out of range|6|||
161965765|NCT00983515|584921837|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
161839503|NCT03548064|584458509|FG005|Overall Study|Lost to Follow-up|0|||
161732398|NCT00238303|584061568|FG000|Overall Study|Withdrawal by Subject|11|||
161732399|NCT00238303|584061569|FG001|Overall Study|Withdrawal by Subject|1|||
161732400|NCT00238303|584061570|FG002|Overall Study|Withdrawal by Subject|2|||
161732401|NCT00238303|584061568|FG000|Overall Study|Death|1|||
161732402|NCT00238303|584061569|FG001|Overall Study|Death|0|||
161732403|NCT00238303|584061570|FG002|Overall Study|Death|1|||
161732404|NCT00238303|584061568|FG000|Overall Study|Other Medical Problems|2|||
161732405|NCT00238303|584061569|FG001|Overall Study|Other Medical Problems|0|||
161732406|NCT00238303|584061570|FG002|Overall Study|Other Medical Problems|2|||
161732407|NCT00238303|584061568|FG000|Overall Study|Poor tolerance of study treatment|1|||
161732408|NCT00238303|584061569|FG001|Overall Study|Poor tolerance of study treatment|0|||
161732409|NCT00238303|584061570|FG002|Overall Study|Poor tolerance of study treatment|1|||
161732410|NCT00238303|584061568|FG000|Overall Study|Adverse Event|0|||
161732411|NCT00238303|584061569|FG001|Overall Study|Adverse Event|1|||
161732412|NCT00238303|584061570|FG002|Overall Study|Adverse Event|3|||
161732413|NCT04507867|584061577|FG000|Overall Study|Death|7|||
161732414|NCT04507867|584061578|FG001|Overall Study|Death|1|||
161732415|NCT01860534|584061581|FG000|ROP #1|Needed treatment for ROP|0|||
161732416|NCT01860534|584061582|FG001|ROP #1|Needed treatment for ROP|1|||
161732417|NCT01860534|584061581|FG000|ROP #2|discharged prior to ROP #2|1|||
161732418|NCT01860534|584061582|FG001|ROP #2|discharged prior to ROP #2|0|||
161732419|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
161732420|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732421|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732422|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732423|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732424|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732425|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732426|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732427|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161732428|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
161732429|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732430|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732431|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732432|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732433|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732434|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732435|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732436|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161732437|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
161732438|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732439|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732440|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732441|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732442|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732443|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732444|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732445|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161732446|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
161732447|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732448|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732449|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732450|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732451|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732452|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
161839504|NCT03548064|584458510|FG006|Overall Study|Lost to Follow-up|0|||
161839505|NCT03548064|584458511|FG007|Overall Study|Lost to Follow-up|0|||
161839506|NCT03548064|584458504|FG000|Overall Study|Covid-19 Pandemic|0|||
161839507|NCT03548064|584458505|FG001|Overall Study|Covid-19 Pandemic|0|||
161839508|NCT03548064|584458506|FG002|Overall Study|Covid-19 Pandemic|0|||
161732453|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732454|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
161732455|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
161732456|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732457|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732458|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732459|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161839509|NCT03548064|584458507|FG003|Overall Study|Covid-19 Pandemic|0|||
161839510|NCT03548064|584458508|FG004|Overall Study|Covid-19 Pandemic|10|||
161839511|NCT03548064|584458509|FG005|Overall Study|Covid-19 Pandemic|3|||
162032284|NCT01120067|585175463|FG001|Overall Study|fail to engage >3 sessions|0|||
161732460|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732461|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732462|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732463|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161732464|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
161732465|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732466|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732467|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732468|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732469|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732470|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732471|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732472|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161732473|NCT02175771|584061588|FG000|Run-In Period (Pre-assignment)|Other|8|||
161732474|NCT02175771|584061589|FG001|Run-In Period (Pre-assignment)|Other|0|||
161732475|NCT02175771|584061590|FG002|Run-In Period (Pre-assignment)|Other|0|||
161732476|NCT02175771|584061591|FG003|Run-In Period (Pre-assignment)|Other|0|||
161732477|NCT02175771|584061592|FG004|Run-In Period (Pre-assignment)|Other|0|||
161732478|NCT02175771|584061593|FG005|Run-In Period (Pre-assignment)|Other|0|||
161732479|NCT02175771|584061594|FG006|Run-In Period (Pre-assignment)|Other|0|||
161732480|NCT02175771|584061595|FG007|Run-In Period (Pre-assignment)|Other|0|||
161732481|NCT02175771|584061596|FG008|Run-In Period (Pre-assignment)|Other|0|||
161732482|NCT02175771|584061588|FG000|Treatment Period|Adverse Event|0|||
161732483|NCT02175771|584061589|FG001|Treatment Period|Adverse Event|2|||
161732484|NCT02175771|584061590|FG002|Treatment Period|Adverse Event|1|||
161732485|NCT02175771|584061591|FG003|Treatment Period|Adverse Event|1|||
161732486|NCT02175771|584061592|FG004|Treatment Period|Adverse Event|1|||
161732487|NCT02175771|584061593|FG005|Treatment Period|Adverse Event|3|||
161732488|NCT02175771|584061594|FG006|Treatment Period|Adverse Event|2|||
161732489|NCT02175771|584061595|FG007|Treatment Period|Adverse Event|0|||
161732490|NCT02175771|584061596|FG008|Treatment Period|Adverse Event|1|||
161732491|NCT02175771|584061588|FG000|Treatment Period|Withdrawal by Subject|0|||
161732492|NCT02175771|584061589|FG001|Treatment Period|Withdrawal by Subject|9|||
161732493|NCT02175771|584061590|FG002|Treatment Period|Withdrawal by Subject|3|||
161732494|NCT02175771|584061591|FG003|Treatment Period|Withdrawal by Subject|6|||
161732495|NCT02175771|584061592|FG004|Treatment Period|Withdrawal by Subject|2|||
161732496|NCT02175771|584061593|FG005|Treatment Period|Withdrawal by Subject|4|||
161732497|NCT02175771|584061594|FG006|Treatment Period|Withdrawal by Subject|2|||
161732498|NCT02175771|584061595|FG007|Treatment Period|Withdrawal by Subject|9|||
161732499|NCT02175771|584061596|FG008|Treatment Period|Withdrawal by Subject|2|||
161732500|NCT02175771|584061588|FG000|Treatment Period|Noncompliance|0|||
161732501|NCT02175771|584061589|FG001|Treatment Period|Noncompliance|1|||
161732502|NCT02175771|584061590|FG002|Treatment Period|Noncompliance|2|||
161732503|NCT02175771|584061591|FG003|Treatment Period|Noncompliance|0|||
161732504|NCT02175771|584061592|FG004|Treatment Period|Noncompliance|0|||
161732505|NCT02175771|584061593|FG005|Treatment Period|Noncompliance|0|||
161732506|NCT02175771|584061594|FG006|Treatment Period|Noncompliance|0|||
162032285|NCT02216812|585175466|FG000|Overall Study|Lost to Follow-up|10|||
162032286|NCT02216812|585175467|FG001|Overall Study|Lost to Follow-up|5|||
162032287|NCT00527488|585175468|FG000|Overall Study|Withdrawn prior to dosing|0|||
162032288|NCT00527488|585175469|FG001|Overall Study|Withdrawn prior to dosing|1|||
162032289|NCT00527488|585175470|FG002|Overall Study|Withdrawn prior to dosing|1|||
162032290|NCT00527488|585175471|FG003|Overall Study|Withdrawn prior to dosing|0|||
162032291|NCT03036800|585175472|FG000|Overall Study|Protocol Violation|1|||
162032292|NCT03036800|585175473|FG001|Overall Study|Protocol Violation|0|||
162032293|NCT03036800|585175472|FG000|Overall Study|Non-compliance|1|||
162032294|NCT03036800|585175473|FG001|Overall Study|Non-compliance|0|||
162032295|NCT03036800|585175472|FG000|Overall Study|Lost to Follow-up|1|||
162032296|NCT03036800|585175473|FG001|Overall Study|Lost to Follow-up|0|||
162032297|NCT03036800|585175472|FG000|Overall Study|Death|1|||
162032298|NCT03036800|585175473|FG001|Overall Study|Death|0|||
162032299|NCT03036800|585175472|FG000|Overall Study|Tolerance|5|||
162032300|NCT03036800|585175473|FG001|Overall Study|Tolerance|0|||
161732507|NCT02175771|584061595|FG007|Treatment Period|Noncompliance|0|||
161732508|NCT02175771|584061596|FG008|Treatment Period|Noncompliance|1|||
161732509|NCT02175771|584061588|FG000|Treatment Period|Protocol Violation|0|||
162032301|NCT03036800|585175472|FG000|Overall Study|Unknown/no reason given|50|||
161732510|NCT02175771|584061589|FG001|Treatment Period|Protocol Violation|0|||
162032302|NCT03036800|585175473|FG001|Overall Study|Unknown/no reason given|39|||
162032303|NCT01986933|585175474|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
162032304|NCT01986933|585175475|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
162032305|NCT01986933|585175476|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
162032306|NCT01986933|585175477|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
161732511|NCT02175771|584061590|FG002|Treatment Period|Protocol Violation|0|||
161732512|NCT02175771|584061591|FG003|Treatment Period|Protocol Violation|0|||
161732513|NCT02175771|584061592|FG004|Treatment Period|Protocol Violation|0|||
161732514|NCT02175771|584061593|FG005|Treatment Period|Protocol Violation|0|||
161732515|NCT02175771|584061594|FG006|Treatment Period|Protocol Violation|0|||
161732516|NCT02175771|584061595|FG007|Treatment Period|Protocol Violation|1|||
161732517|NCT02175771|584061596|FG008|Treatment Period|Protocol Violation|0|||
161732518|NCT02175771|584061588|FG000|Treatment Period|Disease progression|0|||
161732519|NCT02175771|584061589|FG001|Treatment Period|Disease progression|0|||
161732520|NCT02175771|584061590|FG002|Treatment Period|Disease progression|0|||
161732521|NCT02175771|584061591|FG003|Treatment Period|Disease progression|0|||
161732522|NCT02175771|584061592|FG004|Treatment Period|Disease progression|0|||
161732523|NCT02175771|584061593|FG005|Treatment Period|Disease progression|0|||
161732524|NCT02175771|584061594|FG006|Treatment Period|Disease progression|0|||
161732525|NCT02175771|584061595|FG007|Treatment Period|Disease progression|2|||
161732526|NCT02175771|584061596|FG008|Treatment Period|Disease progression|0|||
161732527|NCT02175771|584061588|FG000|Treatment Period|Lost to Follow-up|0|||
161732528|NCT02175771|584061589|FG001|Treatment Period|Lost to Follow-up|3|||
161732529|NCT02175771|584061590|FG002|Treatment Period|Lost to Follow-up|1|||
161732530|NCT02175771|584061591|FG003|Treatment Period|Lost to Follow-up|3|||
161732531|NCT02175771|584061592|FG004|Treatment Period|Lost to Follow-up|1|||
161732532|NCT02175771|584061593|FG005|Treatment Period|Lost to Follow-up|2|||
161732533|NCT02175771|584061594|FG006|Treatment Period|Lost to Follow-up|1|||
161732534|NCT02175771|584061595|FG007|Treatment Period|Lost to Follow-up|2|||
161732535|NCT02175771|584061596|FG008|Treatment Period|Lost to Follow-up|2|||
161732536|NCT02175771|584061588|FG000|Treatment Period|Lack of Efficacy|0|||
161732537|NCT02175771|584061589|FG001|Treatment Period|Lack of Efficacy|0|||
161732538|NCT02175771|584061590|FG002|Treatment Period|Lack of Efficacy|0|||
161732539|NCT02175771|584061591|FG003|Treatment Period|Lack of Efficacy|0|||
161732540|NCT02175771|584061592|FG004|Treatment Period|Lack of Efficacy|0|||
161732541|NCT02175771|584061593|FG005|Treatment Period|Lack of Efficacy|1|||
161732542|NCT02175771|584061594|FG006|Treatment Period|Lack of Efficacy|0|||
161732543|NCT02175771|584061595|FG007|Treatment Period|Lack of Efficacy|1|||
161732544|NCT02175771|584061596|FG008|Treatment Period|Lack of Efficacy|0|||
161732545|NCT02175771|584061588|FG000|Treatment Period|Other|0|||
161732546|NCT02175771|584061589|FG001|Treatment Period|Other|1|||
161732547|NCT02175771|584061590|FG002|Treatment Period|Other|0|||
161732548|NCT02175771|584061591|FG003|Treatment Period|Other|3|||
161732549|NCT02175771|584061592|FG004|Treatment Period|Other|1|||
161732550|NCT02175771|584061593|FG005|Treatment Period|Other|0|||
161732551|NCT02175771|584061594|FG006|Treatment Period|Other|0|||
161732552|NCT02175771|584061595|FG007|Treatment Period|Other|2|||
161732553|NCT02175771|584061596|FG008|Treatment Period|Other|0|||
161732554|NCT03364673|584061597|FG000|Overall Study|Withdrawal by Subject|2|||
161732555|NCT03364673|584061597|FG000|Overall Study|Injury unrelated to study|3|||
161732556|NCT00779324|584061598|FG000|Overall Study|Lost to Follow-up|2|||
161732557|NCT00779324|584061599|FG001|Overall Study|Lost to Follow-up|1|||
161732558|NCT00779324|584061598|FG000|Overall Study|Withdrawal by Subject|4|||
161732559|NCT00779324|584061599|FG001|Overall Study|Withdrawal by Subject|2|||
161732560|NCT00779324|584061598|FG000|Overall Study|Missed visit|1|||
161732561|NCT00779324|584061599|FG001|Overall Study|Missed visit|1|||
161732562|NCT02207556|584061600|FG000|Overall Study|Physician Decision|1|||
161732563|NCT02207556|584061601|FG001|Overall Study|Physician Decision|0|||
161732564|NCT02207556|584061600|FG000|Overall Study|Withdrawal by Subject|1|||
161732565|NCT02207556|584061601|FG001|Overall Study|Withdrawal by Subject|0|||
161732566|NCT02207556|584061600|FG000|Overall Study|Death|0|||
161732567|NCT02207556|584061601|FG001|Overall Study|Death|5|||
161732568|NCT03558555|584061602|FG000|Overall Study|Lost to Follow-up|2|||
161732569|NCT03558555|584061603|FG001|Overall Study|Lost to Follow-up|1|||
161732570|NCT00194025|584061604|FG000|Overall Study|Adverse Event|1|||
161732571|NCT00194025|584061604|FG000|Overall Study|non-adherence with study medication|4|||
161732572|NCT01766336|584061605|FG000|Overall Study|Adverse Event|11|||
161732573|NCT01766336|584061606|FG001|Overall Study|Adverse Event|8|||
161839512|NCT03548064|584458510|FG006|Overall Study|Covid-19 Pandemic|0|||
161839513|NCT03548064|584458511|FG007|Overall Study|Covid-19 Pandemic|0|||
161732574|NCT01766336|584061605|FG000|Overall Study|Death|4|||
161732575|NCT01766336|584061606|FG001|Overall Study|Death|3|||
161732576|NCT01766336|584061605|FG000|Overall Study|Lost to Follow-up|1|||
161732577|NCT01766336|584061606|FG001|Overall Study|Lost to Follow-up|3|||
161732578|NCT01766336|584061605|FG000|Overall Study|Physician Decision|4|||
161732579|NCT01766336|584061606|FG001|Overall Study|Physician Decision|2|||
161732580|NCT01766336|584061605|FG000|Overall Study|Protocol Violation|0|||
161732581|NCT01766336|584061606|FG001|Overall Study|Protocol Violation|1|||
161732582|NCT01766336|584061605|FG000|Overall Study|Sponsor Decision|52|||
161732583|NCT01766336|584061606|FG001|Overall Study|Sponsor Decision|43|||
161732584|NCT01766336|584061605|FG000|Overall Study|Withdrawal by Subject|18|||
161839514|NCT06077487|584458514|FG000|Overall Study|Withdrawal by Subject|0|||
161732585|NCT01766336|584061606|FG001|Overall Study|Withdrawal by Subject|15|||
161732586|NCT03029650|584061607|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
161732587|NCT03029650|584061608|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
161732588|NCT03029650|584061607|FG000|Washout (1 Week)|Physician Decision|0|||
161732589|NCT03029650|584061608|FG001|Washout (1 Week)|Physician Decision|1|||
161732590|NCT01814800|584061611|FG000|Overall Study|Adverse Event|2|||
161732591|NCT01814800|584061611|FG000|Overall Study|Pregnancy|1|||
161732592|NCT01814800|584061611|FG000|Overall Study|Sponsor decision|1|||
161732593|NCT01814800|584061611|FG000|Overall Study|Subject relocation|1|||
161732594|NCT02402218|584061612|FG000|Overall Study|Did not pickup study medication|12|||
161732595|NCT02402218|584061613|FG001|Overall Study|Did not pickup study medication|9|||
161732596|NCT02402218|584061614|FG002|Overall Study|Did not pickup study medication|13|||
161732597|NCT02402218|584061612|FG000|Overall Study|Lack of Efficacy|0|||
161732598|NCT02402218|584061613|FG001|Overall Study|Lack of Efficacy|1|||
161732599|NCT02402218|584061614|FG002|Overall Study|Lack of Efficacy|1|||
161732600|NCT02402218|584061612|FG000|Overall Study|Death|1|||
161732601|NCT02402218|584061613|FG001|Overall Study|Death|0|||
161732602|NCT02402218|584061614|FG002|Overall Study|Death|0|||
161732603|NCT02402218|584061612|FG000|Overall Study|Reinfection|0|||
161732604|NCT02402218|584061613|FG001|Overall Study|Reinfection|0|||
161732605|NCT02402218|584061614|FG002|Overall Study|Reinfection|1|||
161732606|NCT02402218|584061612|FG000|Overall Study|Adverse Event|0|||
161732607|NCT02402218|584061613|FG001|Overall Study|Adverse Event|2|||
161732608|NCT02402218|584061614|FG002|Overall Study|Adverse Event|1|||
161732609|NCT02402218|584061612|FG000|Overall Study|Withdrawal by Subject|1|||
161732610|NCT02402218|584061613|FG001|Overall Study|Withdrawal by Subject|1|||
161732611|NCT02402218|584061614|FG002|Overall Study|Withdrawal by Subject|1|||
161732612|NCT03827473|584061615|FG000|Overall Study|Withdrawal by Subject|1|||
161732613|NCT03827473|584061616|FG001|Overall Study|Withdrawal by Subject|0|||
161732614|NCT04436822|584061617|FG000|Overall Study|Physician Decision|2|||
161732615|NCT04436822|584061618|FG001|Overall Study|Physician Decision|0|||
161732616|NCT04436822|584061617|FG000|Overall Study|Sponsor request|1|||
161732617|NCT04436822|584061618|FG001|Overall Study|Sponsor request|0|||
161732618|NCT04436822|584061617|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161732619|NCT04436822|584061618|FG001|Overall Study|Withdrawal by parent/guardian|3|||
161732620|NCT04436822|584061617|FG000|Overall Study|Unsuccessful procedure|0|||
161732621|NCT04436822|584061618|FG001|Overall Study|Unsuccessful procedure|1|||
161732622|NCT04436822|584061617|FG000|Overall Study|Withdrawal due to Covid-19|8|||
161732623|NCT04436822|584061618|FG001|Overall Study|Withdrawal due to Covid-19|1|||
161732624|NCT04436822|584061617|FG000|Overall Study|Withdrawal by Subject|1|||
161732625|NCT04436822|584061618|FG001|Overall Study|Withdrawal by Subject|0|||
161732626|NCT04436822|584061617|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
161732627|NCT04436822|584061618|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
161732628|NCT03807739|584061619|FG000|Overall Study|Adverse Event|1|||
161732629|NCT03807739|584061620|FG001|Overall Study|Adverse Event|0|||
161732630|NCT03807739|584061621|FG002|Overall Study|Adverse Event|0|||
161732631|NCT03807739|584061622|FG003|Overall Study|Adverse Event|0|||
161732632|NCT03807739|584061619|FG000|Overall Study|Withdrawal by Subject|1|||
161732633|NCT03807739|584061620|FG001|Overall Study|Withdrawal by Subject|0|||
161732634|NCT03807739|584061621|FG002|Overall Study|Withdrawal by Subject|0|||
161732635|NCT03807739|584061622|FG003|Overall Study|Withdrawal by Subject|0|||
161732636|NCT00488033|584061632|FG000|Overall Study|Withdrawal by Subject|1|||
161732637|NCT00488033|584061633|FG001|Overall Study|Withdrawal by Subject|0|||
161732638|NCT00369668|584061634|FG000|Overall Study|Lack of Efficacy|4|||
161732639|NCT00369668|584061635|FG001|Overall Study|Lack of Efficacy|5|||
161732640|NCT00369668|584061636|FG002|Overall Study|Lack of Efficacy|7|||
161732641|NCT00303108|584061639|FG000|Overall Study|Adverse Event|5|||
161732642|NCT00303108|584061640|FG001|Overall Study|Adverse Event|6|||
161732643|NCT00303108|584061641|FG002|Overall Study|Adverse Event|7|||
161732644|NCT00303108|584061639|FG000|Overall Study|Patient Request|4|||
161732645|NCT00303108|584061640|FG001|Overall Study|Patient Request|2|||
161732646|NCT00303108|584061641|FG002|Overall Study|Patient Request|8|||
161732647|NCT00303108|584061639|FG000|Overall Study|Failed Entry|1|||
161732648|NCT00303108|584061640|FG001|Overall Study|Failed Entry|0|||
161732649|NCT00303108|584061641|FG002|Overall Study|Failed Entry|1|||
161732650|NCT00303108|584061639|FG000|Overall Study|ineligible|2|||
161732651|NCT00303108|584061640|FG001|Overall Study|ineligible|1|||
161732652|NCT00303108|584061641|FG002|Overall Study|ineligible|0|||
161732653|NCT03855137|584061642|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
161732654|NCT03855137|584061643|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
161732655|NCT03855137|584061644|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
161732656|NCT03855137|584061642|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
161732657|NCT03855137|584061643|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
161732658|NCT03855137|584061644|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
161732659|NCT03855137|584061642|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
161732660|NCT03855137|584061643|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
161732661|NCT03855137|584061644|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
161732662|NCT03855137|584061642|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
161732663|NCT03855137|584061643|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
161732664|NCT03855137|584061644|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
162032307|NCT01986933|585175478|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
161732665|NCT03855137|584061642|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
161732666|NCT03855137|584061643|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
161732667|NCT03855137|584061644|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
161732668|NCT03855137|584061642|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
161732669|NCT03855137|584061643|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
161732670|NCT03855137|584061644|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
161732671|NCT03855137|584061642|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
161732672|NCT03855137|584061643|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
161732673|NCT03855137|584061644|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
161732674|NCT03855137|584061642|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
161732675|NCT03855137|584061643|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
161732676|NCT03855137|584061644|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
161732677|NCT03855137|584061642|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
161732678|NCT03855137|584061643|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
161732679|NCT03855137|584061644|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
161732680|NCT03855137|584061642|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
161732681|NCT03855137|584061643|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
161732682|NCT03855137|584061644|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
161732683|NCT02427477|584061645|FG000|Period 1|Adverse Event|1|||
161732684|NCT02427477|584061646|FG001|Period 1|Adverse Event|0|||
161732685|NCT02435277|584061647|FG000|Overall Study|Adverse Event|1|||
161732686|NCT02435277|584061648|FG001|Overall Study|Adverse Event|1|||
161732687|NCT02435277|584061649|FG002|Overall Study|Adverse Event|0|||
161732688|NCT02435277|584061650|FG003|Overall Study|Adverse Event|0|||
161732689|NCT02435277|584061647|FG000|Overall Study|Withdrawal by Subject|1|||
161732690|NCT02435277|584061648|FG001|Overall Study|Withdrawal by Subject|0|||
161732691|NCT02435277|584061649|FG002|Overall Study|Withdrawal by Subject|0|||
161732692|NCT02435277|584061650|FG003|Overall Study|Withdrawal by Subject|0|||
161732693|NCT00444626|584061653|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
161732694|NCT00444626|584061653|FG000|Initial Treatment Period|Adverse Event|1|||
161732695|NCT00444626|584061653|FG000|Initial Treatment Period|Lost to Follow-up|9|||
161732696|NCT00008138|584061654|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
161732697|NCT00008138|584061654|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
161732698|NCT00008138|584061654|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
161732699|NCT00008138|584061654|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
161732700|NCT00008138|584061654|FG000|Interval Debulking|Withdrawal by Subject|2|||
161732701|NCT00008138|584061654|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
161732702|NCT00008138|584061654|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
161732703|NCT00008138|584061654|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
161732704|NCT03213626|584061655|FG000|Overall Study|Adverse Event|1|||
161732705|NCT03213626|584061655|FG000|Overall Study|Progressive Disease|6|||
161732706|NCT02635737|584061656|FG000|Overall Study|Protocol Violation|1|||
161732707|NCT01005732|584061657|FG000|Overall Study|Lost to Follow-up|10|||
161732708|NCT01005732|584061657|FG000|Overall Study|Death|1|||
161732709|NCT01552928|584061658|FG000|Period 3|Adverse Event|0|||
161732710|NCT01552928|584061659|FG001|Period 3|Adverse Event|0|||
161732711|NCT01552928|584061660|FG002|Period 3|Adverse Event|1|||
161732712|NCT01552928|584061661|FG003|Period 3|Adverse Event|0|||
161732713|NCT02349789|584063597|FG000|Overall Study|Withdrawal by Subject|2|||
161732714|NCT00786032|584063600|FG000|Overall Study|Death|4|||
161732715|NCT00786032|584063600|FG000|Overall Study|Withdrawal by Subject|14|||
161732716|NCT00786032|584063600|FG000|Overall Study|Did not complete in the timeframe|6|||
161732717|NCT02457182|584063601|FG000|Overall Study|Lost to Follow-up|1|||
161732718|NCT02457182|584063602|FG001|Overall Study|Lost to Follow-up|0|||
161732719|NCT00424528|584063605|FG000|Overall Study|Adverse Event|2|||
161732720|NCT00424528|584063606|FG001|Overall Study|Adverse Event|1|||
161732721|NCT00424528|584063607|FG002|Overall Study|Adverse Event|2|||
161732722|NCT00424528|584063605|FG000|Overall Study|Protocol Violation|1|||
161732723|NCT00424528|584063606|FG001|Overall Study|Protocol Violation|1|||
161732724|NCT00424528|584063607|FG002|Overall Study|Protocol Violation|0|||
161732725|NCT00424528|584063605|FG000|Overall Study|Lost to Follow-up|0|||
161732726|NCT00424528|584063606|FG001|Overall Study|Lost to Follow-up|1|||
161732727|NCT00424528|584063607|FG002|Overall Study|Lost to Follow-up|0|||
161732728|NCT00424528|584063605|FG000|Overall Study|noncompliance with study requirements|2|||
161732729|NCT00424528|584063606|FG001|Overall Study|noncompliance with study requirements|1|||
161732730|NCT00424528|584063607|FG002|Overall Study|noncompliance with study requirements|2|||
161732731|NCT01009983|584063611|FG000|Overall Study|necessary scans not completed|1|||
161732732|NCT03137121|584063620|FG000|Overall Study|Withdrawal by Subject|0|||
161732733|NCT03137121|584063621|FG001|Overall Study|Withdrawal by Subject|1|||
161732734|NCT02871401|584063622|FG000|Overall Study|Adverse Event|1|||
161732735|NCT02871401|584063623|FG001|Overall Study|Adverse Event|0|||
161732736|NCT02282982|584063624|FG000|Overall Study|Lost to Follow-up|15|||
161732737|NCT02282982|584063624|FG000|Overall Study|Withdrew consent|2|||
161732738|NCT02282982|584063624|FG000|Overall Study|Death|4|||
161732739|NCT02282982|584063624|FG000|Overall Study|Lack of product|156|||
161732740|NCT02282982|584063624|FG000|Overall Study|Palivizumab is ended|11|||
161732741|NCT02282982|584063624|FG000|Overall Study|Other, not specified|18|||
161732742|NCT02006667|584063625|FG000|Overall Study|Adverse Event|3|||
161732743|NCT02006667|584063625|FG000|Overall Study|Death|2|||
161732744|NCT02006667|584063625|FG000|Overall Study|Withdrawal by Subject|1|||
161732745|NCT02939937|584063626|FG000|Overall Study|Adverse Event|5|||
161732746|NCT02939937|584063627|FG001|Overall Study|Adverse Event|0|||
161732747|NCT02939937|584063626|FG000|Overall Study|Lost to Follow-up|1|||
161732748|NCT02939937|584063627|FG001|Overall Study|Lost to Follow-up|3|||
161732749|NCT00568958|584063629|FG000|Allocation|Withdrawal by Subject|7|||
161732750|NCT00568958|584063630|FG001|Allocation|Withdrawal by Subject|3|||
161732751|NCT00568958|584063629|FG000|Allocation|Physician Decision|2|||
161732752|NCT00568958|584063630|FG001|Allocation|Physician Decision|0|||
161732753|NCT00568958|584063629|FG000|Follow-Up|Withdrawal by Subject|6|||
161732754|NCT00568958|584063630|FG001|Follow-Up|Withdrawal by Subject|6|||
161732755|NCT00568958|584063629|FG000|Follow-Up|Physician Decision|1|||
161732756|NCT00568958|584063630|FG001|Follow-Up|Physician Decision|1|||
161732757|NCT00568958|584063629|FG000|Follow-Up|Family Emergency|1|||
161732758|NCT00568958|584063630|FG001|Follow-Up|Family Emergency|0|||
161732759|NCT00568958|584063629|FG000|Follow-Up|Adverse Event|1|||
161732760|NCT00568958|584063630|FG001|Follow-Up|Adverse Event|0|||
161732761|NCT05254613|584063636|FG000|Overall Study|Lost to Follow-up|0|||
161732762|NCT05254613|584063637|FG001|Overall Study|Lost to Follow-up|0|||
161732763|NCT05254613|584063638|FG002|Overall Study|Lost to Follow-up|1|||
161732764|NCT02387372|584063639|FG000|Overall Study|Not Treated|1|||
161732765|NCT02387372|584063640|FG001|Overall Study|Not Treated|0|||
161732766|NCT01911845|584063642|FG000|Overall Study|Adverse Event|2|||
161732767|NCT01911845|584063642|FG000|Overall Study|Lost to Follow-up|1|||
161732768|NCT01911845|584063642|FG000|Overall Study|Other (not specified)|3|||
161732769|NCT01576016|584063643|FG000|Lead Safety|Death|132|||
161732770|NCT01576016|584063644|FG001|Lead Safety|Death|0|||
161732771|NCT01576016|584063643|FG000|Lead Safety|Withdrawal by Subject|81|||
161732772|NCT01576016|584063644|FG001|Lead Safety|Withdrawal by Subject|0|||
161732773|NCT01576016|584063643|FG000|Lead Safety|System Explanted without Replacement|24|||
161732774|NCT01576016|584063644|FG001|Lead Safety|System Explanted without Replacement|0|||
161732775|NCT01576016|584063643|FG000|Lead Safety|Physician Decision|14|||
161732776|NCT01576016|584063644|FG001|Lead Safety|Physician Decision|0|||
161732777|NCT01576016|584063643|FG000|Lead Safety|Lost to Follow-up|13|||
161732778|NCT01576016|584063644|FG001|Lead Safety|Lost to Follow-up|0|||
161732779|NCT01576016|584063643|FG000|Lead Safety|Unsuccessful implant|2|||
161732780|NCT01576016|584063644|FG001|Lead Safety|Unsuccessful implant|0|||
161732781|NCT01576016|584063643|FG000|Lead Safety|Sponsor request|1|||
161732782|NCT01576016|584063644|FG001|Lead Safety|Sponsor request|0|||
161732783|NCT01576016|584063643|FG000|Lead Safety|Device replaced with CRT-D|1|||
161732784|NCT01576016|584063644|FG001|Lead Safety|Device replaced with CRT-D|0|||
161732785|NCT01576016|584063643|FG000|Lead Safety|Patient on Palliative Care|1|||
161732786|NCT01576016|584063644|FG001|Lead Safety|Patient on Palliative Care|0|||
161732787|NCT01576016|584063643|FG000|Lead Safety|Patient noncompliance|1|||
161732788|NCT01576016|584063644|FG001|Lead Safety|Patient noncompliance|0|||
161839515|NCT06077487|584458515|FG001|Overall Study|Withdrawal by Subject|1|||
161839516|NCT02788045|584458516|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
161839517|NCT02788045|584458517|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
161839518|NCT02788045|584458518|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
161839519|NCT02788045|584458516|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
161839520|NCT02788045|584458517|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
162032308|NCT01986933|585175474|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
161732789|NCT01576016|584063643|FG000|Lead Safety|Too far from study site|1|||
161732790|NCT01576016|584063644|FG001|Lead Safety|Too far from study site|0|||
161732791|NCT01576016|584063643|FG000|Lead Safety|System deactivated|1|||
161732792|NCT01576016|584063644|FG001|Lead Safety|System deactivated|0|||
161732793|NCT01576016|584063643|FG000|Lead Safety|Patient no longer followed by study PI|1|||
161732794|NCT01576016|584063644|FG001|Lead Safety|Patient no longer followed by study PI|0|||
161732795|NCT01576016|584063643|FG000|MRI Safety|Withdrawal by Subject|0|||
161732796|NCT01576016|584063644|FG001|MRI Safety|Withdrawal by Subject|10|||
161732797|NCT01576016|584063643|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
161732798|NCT01576016|584063644|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
161732799|NCT01576016|584063643|FG000|MRI Safety|Has not yet completed MRI scan|0|||
162032309|NCT01986933|585175475|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
162032310|NCT01986933|585175476|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
161732800|NCT01576016|584063644|FG001|MRI Safety|Has not yet completed MRI scan|56|||
161732801|NCT01576016|584063643|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
161732802|NCT01576016|584063644|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
161732803|NCT01774344|584063645|FG000|Overall Study|Withdrawal by Subject|3|||
161732804|NCT01774344|584063646|FG001|Overall Study|Withdrawal by Subject|10|||
161732805|NCT01774344|584063645|FG000|Overall Study|Protocol Violation|0|||
161732806|NCT01774344|584063646|FG001|Overall Study|Protocol Violation|1|||
161732807|NCT01774344|584063645|FG000|Overall Study|Lost to Follow-up|4|||
161732808|NCT01774344|584063646|FG001|Overall Study|Lost to Follow-up|10|||
161732809|NCT01774344|584063645|FG000|Overall Study|End of survival follow-up not available|2|||
161732810|NCT01774344|584063646|FG001|Overall Study|End of survival follow-up not available|2|||
161732811|NCT01774344|584063645|FG000|Overall Study|Data collection finished|4|||
161732812|NCT01774344|584063646|FG001|Overall Study|Data collection finished|14|||
161732813|NCT01774344|584063645|FG000|Overall Study|Other|0|||
161732814|NCT01774344|584063646|FG001|Overall Study|Other|1|||
161732815|NCT01774344|584063645|FG000|Overall Study|Did not enter Survival Follow up|49|||
161732816|NCT01774344|584063646|FG001|Overall Study|Did not enter Survival Follow up|83|||
161732817|NCT00502320|584063655|FG000|Overall Study|Lost to Follow-up|1|||
161732818|NCT00502320|584063656|FG001|Overall Study|Lost to Follow-up|1|||
161732819|NCT00502320|584063655|FG000|Overall Study|Withdrew Consent|1|||
161732820|NCT00502320|584063656|FG001|Overall Study|Withdrew Consent|0|||
161732821|NCT00502320|584063655|FG000|Overall Study|No longer met criteria|1|||
161732822|NCT00502320|584063656|FG001|Overall Study|No longer met criteria|0|||
161732823|NCT00502320|584063655|FG000|Overall Study|Screen Failure|0|||
161732824|NCT00502320|584063656|FG001|Overall Study|Screen Failure|1|||
161732825|NCT00502320|584063655|FG000|Overall Study|Adverse Event|3|||
161732826|NCT00502320|584063656|FG001|Overall Study|Adverse Event|5|||
161732827|NCT00543569|584063660|FG000|Overall Study|Death|2|||
161732828|NCT00543569|584063661|FG001|Overall Study|Death|2|||
161732829|NCT00543569|584063662|FG002|Overall Study|Death|3|||
161732830|NCT00543569|584063663|FG003|Overall Study|Death|1|||
161732831|NCT00543569|584063660|FG000|Overall Study|Lost to Follow-up|0|||
161732832|NCT00543569|584063661|FG001|Overall Study|Lost to Follow-up|0|||
161732833|NCT00543569|584063662|FG002|Overall Study|Lost to Follow-up|1|||
161965766|NCT02526524|584921840|FG000|Overall Study|Withdrawal by Subject|3|||
161965767|NCT02526524|584921841|FG001|Overall Study|Withdrawal by Subject|3|||
161965768|NCT02526524|584921842|FG002|Overall Study|Withdrawal by Subject|6|||
161965769|NCT02526524|584921843|FG003|Overall Study|Withdrawal by Subject|1|||
161965770|NCT02526524|584921844|FG004|Overall Study|Withdrawal by Subject|9|||
161732834|NCT00543569|584063663|FG003|Overall Study|Lost to Follow-up|1|||
161732835|NCT00543569|584063660|FG000|Overall Study|Miscellaneous Reasons|7|||
161732836|NCT00543569|584063661|FG001|Overall Study|Miscellaneous Reasons|3|||
161732837|NCT00543569|584063662|FG002|Overall Study|Miscellaneous Reasons|11|||
161732838|NCT00543569|584063663|FG003|Overall Study|Miscellaneous Reasons|4|||
161732839|NCT00543569|584063660|FG000|Overall Study|Randomized but never received study drug|3|||
161732840|NCT00543569|584063661|FG001|Overall Study|Randomized but never received study drug|3|||
161732841|NCT00543569|584063662|FG002|Overall Study|Randomized but never received study drug|5|||
161732842|NCT00543569|584063663|FG003|Overall Study|Randomized but never received study drug|3|||
161732843|NCT00862849|584063665|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161732844|NCT00862849|584063666|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
161732845|NCT00862849|584063667|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161732846|NCT00862849|584063668|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161732847|NCT00862849|584063669|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161732848|NCT00862849|584063670|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161965771|NCT02526524|584921845|FG005|Overall Study|Withdrawal by Subject|5|||
161965772|NCT02526524|584921840|FG000|Overall Study|Adverse Event|3|||
161965773|NCT02526524|584921841|FG001|Overall Study|Adverse Event|2|||
161965774|NCT02526524|584921842|FG002|Overall Study|Adverse Event|4|||
161965775|NCT02526524|584921843|FG003|Overall Study|Adverse Event|2|||
161965776|NCT02526524|584921844|FG004|Overall Study|Adverse Event|6|||
161965777|NCT02526524|584921845|FG005|Overall Study|Adverse Event|8|||
161965778|NCT02526524|584921840|FG000|Overall Study|Lost to Follow-up|2|||
161965779|NCT02526524|584921841|FG001|Overall Study|Lost to Follow-up|3|||
161965780|NCT02526524|584921842|FG002|Overall Study|Lost to Follow-up|8|||
161965781|NCT02526524|584921843|FG003|Overall Study|Lost to Follow-up|1|||
161965782|NCT02526524|584921844|FG004|Overall Study|Lost to Follow-up|2|||
161965783|NCT02526524|584921845|FG005|Overall Study|Lost to Follow-up|5|||
161965784|NCT02526524|584921840|FG000|Overall Study|Protocol Violation|3|||
161965785|NCT02526524|584921841|FG001|Overall Study|Protocol Violation|1|||
161965786|NCT02526524|584921842|FG002|Overall Study|Protocol Violation|5|||
161732849|NCT00862849|584063665|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161732850|NCT00862849|584063666|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
161732851|NCT00862849|584063667|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161732852|NCT00862849|584063668|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161732853|NCT00862849|584063669|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161732854|NCT00862849|584063670|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161732855|NCT00617409|584063671|FG000|Overall Study|Withdrawal by Subject|4|||
161732856|NCT00617409|584063672|FG001|Overall Study|Withdrawal by Subject|1|||
161732857|NCT00617409|584063673|FG002|Overall Study|Withdrawal by Subject|2|||
161732858|NCT00617409|584063671|FG000|Overall Study|Adverse Event|0|||
161965787|NCT02526524|584921843|FG003|Overall Study|Protocol Violation|3|||
161965788|NCT02526524|584921844|FG004|Overall Study|Protocol Violation|4|||
161965789|NCT02526524|584921845|FG005|Overall Study|Protocol Violation|3|||
161965790|NCT02526524|584921840|FG000|Overall Study|Loss of Glucose Control|0|||
161965791|NCT02526524|584921841|FG001|Overall Study|Loss of Glucose Control|0|||
161965792|NCT02526524|584921842|FG002|Overall Study|Loss of Glucose Control|3|||
161965793|NCT02526524|584921843|FG003|Overall Study|Loss of Glucose Control|0|||
161732859|NCT00617409|584063672|FG001|Overall Study|Adverse Event|2|||
161732860|NCT00617409|584063673|FG002|Overall Study|Adverse Event|3|||
161732861|NCT00617409|584063671|FG000|Overall Study|Disease Progression|8|||
161732862|NCT00617409|584063672|FG001|Overall Study|Disease Progression|8|||
161732863|NCT00617409|584063673|FG002|Overall Study|Disease Progression|18|||
161732864|NCT00617409|584063671|FG000|Overall Study|Death|3|||
161732865|NCT00617409|584063672|FG001|Overall Study|Death|5|||
161732866|NCT00617409|584063673|FG002|Overall Study|Death|4|||
161732867|NCT00617409|584063671|FG000|Overall Study|Alternative Therapy|1|||
161732868|NCT00617409|584063672|FG001|Overall Study|Alternative Therapy|2|||
161732869|NCT00617409|584063673|FG002|Overall Study|Alternative Therapy|0|||
161732870|NCT02124707|584063682|FG000|Overall Study|Adverse Event|5|||
161732871|NCT02124707|584063682|FG000|Overall Study|Physician Decision|1|||
161732872|NCT02124707|584063682|FG000|Overall Study|Death|1|||
161732873|NCT01363713|584063693|FG000|Overall Study|Adverse Event|1|||
161732874|NCT01363713|584063693|FG000|Overall Study|Protocol Violation|3|||
161732875|NCT01363713|584063693|FG000|Overall Study|Withdrawal by Subject|2|||
161732876|NCT01199055|584063694|FG000|Overall Study|Death|0|||
161732877|NCT01199055|584063695|FG001|Overall Study|Death|1|||
161732878|NCT01199055|584063696|FG002|Overall Study|Death|0|||
161732879|NCT01199055|584063694|FG000|Overall Study|Physician Decision|0|||
161732880|NCT01199055|584063695|FG001|Overall Study|Physician Decision|1|||
161732881|NCT01199055|584063696|FG002|Overall Study|Physician Decision|1|||
161732882|NCT01199055|584063694|FG000|Overall Study|Progressive disease|2|||
161732883|NCT01199055|584063695|FG001|Overall Study|Progressive disease|1|||
161732884|NCT01199055|584063696|FG002|Overall Study|Progressive disease|2|||
161732885|NCT01199055|584063694|FG000|Overall Study|Withdrawal by Subject|0|||
161732886|NCT01199055|584063695|FG001|Overall Study|Withdrawal by Subject|0|||
161732887|NCT01199055|584063696|FG002|Overall Study|Withdrawal by Subject|1|||
161732888|NCT00511342|584063697|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
161732889|NCT00511342|584063698|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
161732890|NCT00511342|584063697|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
161732891|NCT00511342|584063698|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
161732892|NCT00511342|584063697|FG000|Overall Study|Pregnancy|0|||
161732893|NCT00511342|584063698|FG001|Overall Study|Pregnancy|1|||
161732894|NCT00511342|584063697|FG000|Overall Study|Pregnancy wish|0|||
161732895|NCT00511342|584063698|FG001|Overall Study|Pregnancy wish|1|||
161732896|NCT00511342|584063697|FG000|Overall Study|Lost to Follow-up|1|||
161732897|NCT00511342|584063698|FG001|Overall Study|Lost to Follow-up|5|||
161732898|NCT00511342|584063697|FG000|Overall Study|Other Reason|2|||
161732899|NCT00511342|584063698|FG001|Overall Study|Other Reason|2|||
161732900|NCT02432040|584063699|FG000|Overall Study|Lack of Efficacy|3|||
161732901|NCT02432040|584063700|FG001|Overall Study|Lack of Efficacy|0|||
161732902|NCT02432040|584063699|FG000|Overall Study|Lost to Follow-up|4|||
161732903|NCT02432040|584063700|FG001|Overall Study|Lost to Follow-up|5|||
161732904|NCT02432040|584063699|FG000|Overall Study|Physician Decision|1|||
161732905|NCT02432040|584063700|FG001|Overall Study|Physician Decision|1|||
161732906|NCT00718666|584063701|FG000|Booster Phase Year 5|No active participation request|0|||
161732907|NCT00718666|584063702|FG001|Booster Phase Year 5|No active participation request|0|||
161732908|NCT00718666|584063703|FG002|Booster Phase Year 5|No active participation request|1|||
161732909|NCT00718666|584063701|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
161732910|NCT00718666|584063702|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
161732911|NCT00718666|584063703|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
161732912|NCT00718666|584063701|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
161732913|NCT00718666|584063702|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
161732914|NCT00718666|584063703|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
161732915|NCT00718666|584063701|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
161732916|NCT00718666|584063702|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
161732917|NCT00718666|584063703|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
161732918|NCT02196038|584063704|FG000|Overall Study|Death|16|||
161732919|NCT02196038|584063705|FG001|Overall Study|Death|21|||
161732920|NCT02196038|584063704|FG000|Overall Study|Withdrawal by Subject|0|||
161732921|NCT02196038|584063705|FG001|Overall Study|Withdrawal by Subject|1|||
161732922|NCT02196038|584063704|FG000|Overall Study|Lost to Follow-up|1|||
161732923|NCT02196038|584063705|FG001|Overall Study|Lost to Follow-up|0|||
161732924|NCT04544709|584063718|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
161732925|NCT03135028|584063719|FG000|Overall Study|Death|6|||
161732926|NCT03135028|584063719|FG000|Overall Study|Study Terminated by Sponsor|2|||
161732927|NCT03135028|584063719|FG000|Overall Study|Withdrew Consent|1|||
161732928|NCT00496873|584063720|FG000|Overall Study|Ineligible|2|||
161732929|NCT00496873|584063720|FG000|Overall Study|Death|2|||
161732930|NCT00496873|584063720|FG000|Overall Study|Withdrawal by Subject|3|||
161732931|NCT02065869|584063721|FG000|Overall Study|Death|7|||
161732932|NCT02065869|584063721|FG000|Overall Study|Disease relapse|16|||
161732933|NCT02065869|584063721|FG000|Overall Study|Lost to Follow-up|4|||
161732934|NCT02065869|584063721|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
161732935|NCT02065869|584063721|FG000|Overall Study|Withdrawal by Subject|1|||
161732936|NCT01842620|584063722|FG000|Period 1|Withdrawal by Subject|1|||
161732937|NCT01842620|584063723|FG001|Period 1|Withdrawal by Subject|0|||
161732938|NCT02371759|584063724|FG000|Overall Study|Protocol Violation|3|||
161732939|NCT02371759|584063725|FG001|Overall Study|Protocol Violation|1|||
161732940|NCT02371759|584063726|FG002|Overall Study|Protocol Violation|1|||
161732941|NCT02371759|584063727|FG003|Overall Study|Protocol Violation|0|||
161732942|NCT02371759|584063728|FG004|Overall Study|Protocol Violation|3|||
161732943|NCT02371759|584063729|FG005|Overall Study|Protocol Violation|1|||
161732944|NCT02371759|584063730|FG006|Overall Study|Protocol Violation|0|||
161732945|NCT02371759|584063731|FG007|Overall Study|Protocol Violation|3|||
161732946|NCT02371759|584063724|FG000|Overall Study|Withdrawal by Subject|0|||
161732947|NCT02371759|584063725|FG001|Overall Study|Withdrawal by Subject|0|||
161732948|NCT02371759|584063726|FG002|Overall Study|Withdrawal by Subject|0|||
161732949|NCT02371759|584063727|FG003|Overall Study|Withdrawal by Subject|0|||
161732950|NCT02371759|584063728|FG004|Overall Study|Withdrawal by Subject|0|||
161732951|NCT02371759|584063729|FG005|Overall Study|Withdrawal by Subject|0|||
161732952|NCT02371759|584063730|FG006|Overall Study|Withdrawal by Subject|0|||
161732953|NCT02371759|584063731|FG007|Overall Study|Withdrawal by Subject|1|||
161732954|NCT03136185|584063735|FG000|Overall Study|Adverse Event|0|||
161732955|NCT03136185|584063736|FG001|Overall Study|Adverse Event|1|||
161732956|NCT03136185|584063737|FG002|Overall Study|Adverse Event|3|||
161732957|NCT03136185|584063738|FG003|Overall Study|Adverse Event|1|||
161732958|NCT03136185|584063739|FG004|Overall Study|Adverse Event|2|||
161732959|NCT03136185|584063740|FG005|Overall Study|Adverse Event|2|||
161732960|NCT03136185|584063741|FG006|Overall Study|Adverse Event|5|||
161732961|NCT03136185|584063742|FG007|Overall Study|Adverse Event|1|||
161732962|NCT03136185|584063743|FG008|Overall Study|Adverse Event|1|||
161732963|NCT03136185|584063735|FG000|Overall Study|Death|0|||
161732964|NCT03136185|584063736|FG001|Overall Study|Death|0|||
161732965|NCT03136185|584063737|FG002|Overall Study|Death|0|||
161732966|NCT03136185|584063738|FG003|Overall Study|Death|1|||
161732967|NCT03136185|584063739|FG004|Overall Study|Death|1|||
161732968|NCT03136185|584063740|FG005|Overall Study|Death|0|||
161732969|NCT03136185|584063741|FG006|Overall Study|Death|1|||
161732970|NCT03136185|584063742|FG007|Overall Study|Death|0|||
161732971|NCT03136185|584063743|FG008|Overall Study|Death|0|||
161732972|NCT03136185|584063735|FG000|Overall Study|Physician Decision|3|||
161732973|NCT03136185|584063736|FG001|Overall Study|Physician Decision|1|||
161732974|NCT03136185|584063737|FG002|Overall Study|Physician Decision|1|||
161732975|NCT03136185|584063738|FG003|Overall Study|Physician Decision|2|||
161732976|NCT03136185|584063739|FG004|Overall Study|Physician Decision|1|||
161732977|NCT03136185|584063740|FG005|Overall Study|Physician Decision|2|||
161732978|NCT03136185|584063741|FG006|Overall Study|Physician Decision|1|||
161732979|NCT03136185|584063742|FG007|Overall Study|Physician Decision|0|||
161732980|NCT03136185|584063743|FG008|Overall Study|Physician Decision|1|||
161732981|NCT03136185|584063735|FG000|Overall Study|Protocol Defined Disease Progression|0|||
161732982|NCT03136185|584063736|FG001|Overall Study|Protocol Defined Disease Progression|0|||
161732983|NCT03136185|584063737|FG002|Overall Study|Protocol Defined Disease Progression|1|||
161732984|NCT03136185|584063738|FG003|Overall Study|Protocol Defined Disease Progression|0|||
161732985|NCT03136185|584063739|FG004|Overall Study|Protocol Defined Disease Progression|0|||
161732986|NCT03136185|584063740|FG005|Overall Study|Protocol Defined Disease Progression|1|||
161732987|NCT03136185|584063741|FG006|Overall Study|Protocol Defined Disease Progression|0|||
161732988|NCT03136185|584063742|FG007|Overall Study|Protocol Defined Disease Progression|1|||
161732989|NCT03136185|584063743|FG008|Overall Study|Protocol Defined Disease Progression|1|||
161732990|NCT03136185|584063735|FG000|Overall Study|Withdrawal by Subject|1|||
161732991|NCT03136185|584063736|FG001|Overall Study|Withdrawal by Subject|0|||
161965794|NCT02526524|584921844|FG004|Overall Study|Loss of Glucose Control|2|||
161732992|NCT03136185|584063737|FG002|Overall Study|Withdrawal by Subject|1|||
161732993|NCT03136185|584063738|FG003|Overall Study|Withdrawal by Subject|1|||
161732994|NCT03136185|584063739|FG004|Overall Study|Withdrawal by Subject|1|||
161732995|NCT03136185|584063740|FG005|Overall Study|Withdrawal by Subject|1|||
161732996|NCT03136185|584063741|FG006|Overall Study|Withdrawal by Subject|2|||
161732997|NCT03136185|584063742|FG007|Overall Study|Withdrawal by Subject|3|||
161732998|NCT03136185|584063743|FG008|Overall Study|Withdrawal by Subject|3|||
161732999|NCT03136185|584063735|FG000|Overall Study|Not Reported|4|||
161733000|NCT03136185|584063736|FG001|Overall Study|Not Reported|1|||
161733001|NCT03136185|584063737|FG002|Overall Study|Not Reported|0|||
161733002|NCT03136185|584063738|FG003|Overall Study|Not Reported|1|||
161733003|NCT03136185|584063739|FG004|Overall Study|Not Reported|0|||
161733004|NCT03136185|584063740|FG005|Overall Study|Not Reported|2|||
161733005|NCT03136185|584063741|FG006|Overall Study|Not Reported|1|||
161733006|NCT03136185|584063742|FG007|Overall Study|Not Reported|1|||
161733007|NCT03136185|584063743|FG008|Overall Study|Not Reported|0|||
161733008|NCT05118386|584063747|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161965795|NCT02526524|584921845|FG005|Overall Study|Loss of Glucose Control|0|||
161965796|NCT02526524|584921840|FG000|Overall Study|Physician Decision|0|||
161733009|NCT05118386|584063748|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161733010|NCT05118386|584063749|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161733011|NCT05118386|584063750|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
161733012|NCT05118386|584063751|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161733013|NCT05118386|584063752|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161733014|NCT05118386|584063747|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161733015|NCT05118386|584063748|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161733016|NCT05118386|584063749|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161733017|NCT05118386|584063750|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161733018|NCT05118386|584063751|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
161733019|NCT05118386|584063752|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161733020|NCT00894413|584063753|FG000|Overall Study|Physician Decision|0|||
161733021|NCT00894413|584063754|FG001|Overall Study|Physician Decision|2|||
161733022|NCT00894413|584063753|FG000|Overall Study|Adverse Event|0|||
161733023|NCT00894413|584063754|FG001|Overall Study|Adverse Event|2|||
161733024|NCT00894413|584063753|FG000|Overall Study|Withdrawal by Subject|0|||
161733025|NCT00894413|584063754|FG001|Overall Study|Withdrawal by Subject|4|||
161733026|NCT01067508|584063761|FG000|Overall Study|Physician Decision|0|||
161733027|NCT01067508|584063762|FG001|Overall Study|Physician Decision|1|||
161733028|NCT01067508|584063761|FG000|Overall Study|Withdrawal by Subject|0|||
161733029|NCT01067508|584063762|FG001|Overall Study|Withdrawal by Subject|1|||
161733030|NCT00632463|584063767|FG000|Overall Study|Adverse Event|0|||
161733031|NCT00632463|584063768|FG001|Overall Study|Adverse Event|1|||
161733032|NCT00632463|584063769|FG002|Overall Study|Adverse Event|0|||
161733033|NCT02065622|584063770|FG000|Induction Study|Adverse Event|13|||
161733034|NCT02065622|584063771|FG001|Induction Study|Adverse Event|19|||
161733035|NCT02065622|584063772|FG002|Induction Study|Adverse Event|0|||
161733036|NCT02065622|584063773|FG003|Induction Study|Adverse Event|0|||
161733037|NCT02065622|584063774|FG004|Induction Study|Adverse Event|0|||
161733038|NCT02065622|584063770|FG000|Induction Study|Withdrawal by Subject|3|||
161733039|NCT02065622|584063771|FG001|Induction Study|Withdrawal by Subject|5|||
161733040|NCT02065622|584063772|FG002|Induction Study|Withdrawal by Subject|0|||
161733041|NCT02065622|584063773|FG003|Induction Study|Withdrawal by Subject|0|||
161733042|NCT02065622|584063774|FG004|Induction Study|Withdrawal by Subject|0|||
161733043|NCT02065622|584063770|FG000|Induction Study|Lost to Follow-up|1|||
161733044|NCT02065622|584063771|FG001|Induction Study|Lost to Follow-up|0|||
161733045|NCT02065622|584063772|FG002|Induction Study|Lost to Follow-up|0|||
161733046|NCT02065622|584063773|FG003|Induction Study|Lost to Follow-up|0|||
161733047|NCT02065622|584063774|FG004|Induction Study|Lost to Follow-up|0|||
161733048|NCT02065622|584063770|FG000|Induction Study|Lack of Efficacy|22|||
161733049|NCT02065622|584063771|FG001|Induction Study|Lack of Efficacy|27|||
161733050|NCT02065622|584063772|FG002|Induction Study|Lack of Efficacy|0|||
161733051|NCT02065622|584063773|FG003|Induction Study|Lack of Efficacy|0|||
161733052|NCT02065622|584063774|FG004|Induction Study|Lack of Efficacy|0|||
161733053|NCT02065622|584063770|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
161733054|NCT02065622|584063771|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
161733055|NCT02065622|584063772|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
161733056|NCT02065622|584063773|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
161733057|NCT02065622|584063774|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
161733058|NCT02065622|584063770|FG000|Induction Study|Subject Noncompliance|1|||
161733059|NCT02065622|584063771|FG001|Induction Study|Subject Noncompliance|1|||
161733060|NCT02065622|584063772|FG002|Induction Study|Subject Noncompliance|0|||
161733061|NCT02065622|584063773|FG003|Induction Study|Subject Noncompliance|0|||
161733062|NCT02065622|584063774|FG004|Induction Study|Subject Noncompliance|0|||
161733063|NCT02065622|584063770|FG000|Induction Study|Other, Not Specified|3|||
161733064|NCT02065622|584063771|FG001|Induction Study|Other, Not Specified|2|||
161733065|NCT02065622|584063772|FG002|Induction Study|Other, Not Specified|0|||
161733066|NCT02065622|584063773|FG003|Induction Study|Other, Not Specified|0|||
161733067|NCT02065622|584063774|FG004|Induction Study|Other, Not Specified|0|||
161965797|NCT02526524|584921841|FG001|Overall Study|Physician Decision|0|||
161965798|NCT02526524|584921842|FG002|Overall Study|Physician Decision|0|||
161965799|NCT02526524|584921843|FG003|Overall Study|Physician Decision|0|||
161965800|NCT02526524|584921844|FG004|Overall Study|Physician Decision|1|||
161965801|NCT02526524|584921845|FG005|Overall Study|Physician Decision|0|||
161733068|NCT02065622|584063770|FG000|Maintenance Study|Adverse Event|0|||
161733069|NCT02065622|584063771|FG001|Maintenance Study|Adverse Event|0|||
161733070|NCT02065622|584063772|FG002|Maintenance Study|Adverse Event|25|||
161733071|NCT02065622|584063773|FG003|Maintenance Study|Adverse Event|22|||
161733072|NCT02065622|584063774|FG004|Maintenance Study|Adverse Event|11|||
161733073|NCT02065622|584063770|FG000|Maintenance Study|Withdrawal by Subject|0|||
161733074|NCT02065622|584063771|FG001|Maintenance Study|Withdrawal by Subject|0|||
161733075|NCT02065622|584063772|FG002|Maintenance Study|Withdrawal by Subject|11|||
161965802|NCT02526524|584921840|FG000|Overall Study|Sponsor Decision|1|||
161965803|NCT02526524|584921841|FG001|Overall Study|Sponsor Decision|0|||
161733076|NCT02065622|584063773|FG003|Maintenance Study|Withdrawal by Subject|5|||
161733077|NCT02065622|584063774|FG004|Maintenance Study|Withdrawal by Subject|7|||
161733078|NCT02065622|584063770|FG000|Maintenance Study|Lost to Follow-up|0|||
161733079|NCT02065622|584063771|FG001|Maintenance Study|Lost to Follow-up|0|||
161733080|NCT02065622|584063772|FG002|Maintenance Study|Lost to Follow-up|4|||
161733081|NCT02065622|584063773|FG003|Maintenance Study|Lost to Follow-up|1|||
161733082|NCT02065622|584063774|FG004|Maintenance Study|Lost to Follow-up|1|||
161733083|NCT02065622|584063770|FG000|Maintenance Study|Lack of Efficacy|0|||
161733084|NCT02065622|584063771|FG001|Maintenance Study|Lack of Efficacy|0|||
161733085|NCT02065622|584063772|FG002|Maintenance Study|Lack of Efficacy|70|||
161733086|NCT02065622|584063773|FG003|Maintenance Study|Lack of Efficacy|55|||
161733087|NCT02065622|584063774|FG004|Maintenance Study|Lack of Efficacy|19|||
161733088|NCT02065622|584063770|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
161733089|NCT02065622|584063771|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
161733090|NCT02065622|584063772|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
161733091|NCT02065622|584063773|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
161733092|NCT02065622|584063774|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
161733093|NCT02065622|584063770|FG000|Maintenance Study|Subject Non-Compliance|0|||
161733094|NCT02065622|584063771|FG001|Maintenance Study|Subject Non-Compliance|0|||
161733095|NCT02065622|584063772|FG002|Maintenance Study|Subject Non-Compliance|1|||
161733096|NCT02065622|584063773|FG003|Maintenance Study|Subject Non-Compliance|3|||
161733097|NCT02065622|584063774|FG004|Maintenance Study|Subject Non-Compliance|2|||
161733098|NCT02065622|584063770|FG000|Maintenance Study|Other, Not Specified|0|||
161733099|NCT02065622|584063771|FG001|Maintenance Study|Other, Not Specified|0|||
161733100|NCT02065622|584063772|FG002|Maintenance Study|Other, Not Specified|6|||
161733101|NCT02065622|584063773|FG003|Maintenance Study|Other, Not Specified|14|||
161733102|NCT02065622|584063774|FG004|Maintenance Study|Other, Not Specified|2|||
161733103|NCT02065622|584063770|FG000|Maintenance Study|Unknown Reason|0|||
161733104|NCT02065622|584063771|FG001|Maintenance Study|Unknown Reason|0|||
161733105|NCT02065622|584063772|FG002|Maintenance Study|Unknown Reason|0|||
161733106|NCT02065622|584063773|FG003|Maintenance Study|Unknown Reason|1|||
161733107|NCT02065622|584063774|FG004|Maintenance Study|Unknown Reason|0|||
161733108|NCT00488618|584063785|FG000|Overall Study|Adverse Event|13|||
161733109|NCT00488618|584063786|FG001|Overall Study|Adverse Event|17|||
161733110|NCT00488618|584063785|FG000|Overall Study|Insufficient Therapeutic Response|18|||
161733111|NCT00488618|584063786|FG001|Overall Study|Insufficient Therapeutic Response|11|||
161733112|NCT00488618|584063785|FG000|Overall Study|Protocol Violation|0|||
161733113|NCT00488618|584063786|FG001|Overall Study|Protocol Violation|2|||
161733114|NCT00488618|584063785|FG000|Overall Study|Withdrawal of Consent|15|||
161733115|NCT00488618|584063786|FG001|Overall Study|Withdrawal of Consent|13|||
161733116|NCT00488618|584063785|FG000|Overall Study|Lost to Follow-up|1|||
161733117|NCT00488618|584063786|FG001|Overall Study|Lost to Follow-up|0|||
161733118|NCT02198651|584065643|FG000|Lead-in Period|Withdrew consent|13|||
161733119|NCT02198651|584065644|FG001|Lead-in Period|Withdrew consent|0|||
161733120|NCT02198651|584065645|FG002|Lead-in Period|Withdrew consent|0|||
161733121|NCT02198651|584065646|FG003|Lead-in Period|Withdrew consent|0|||
161733122|NCT02198651|584065647|FG004|Lead-in Period|Withdrew consent|0|||
161733123|NCT02198651|584065643|FG000|Lead-in Period|Adverse Event|2|||
161733124|NCT02198651|584065644|FG001|Lead-in Period|Adverse Event|0|||
161733125|NCT02198651|584065645|FG002|Lead-in Period|Adverse Event|0|||
161733126|NCT02198651|584065646|FG003|Lead-in Period|Adverse Event|0|||
161733127|NCT02198651|584065647|FG004|Lead-in Period|Adverse Event|0|||
161733128|NCT02198651|584065643|FG000|Lead-in Period|Other, not specified|22|||
161733129|NCT02198651|584065644|FG001|Lead-in Period|Other, not specified|0|||
161733130|NCT02198651|584065645|FG002|Lead-in Period|Other, not specified|0|||
161733131|NCT02198651|584065646|FG003|Lead-in Period|Other, not specified|0|||
161733132|NCT02198651|584065647|FG004|Lead-in Period|Other, not specified|0|||
161733133|NCT02198651|584065643|FG000|Double-blind Period|Withdrew consent|0|||
161733134|NCT02198651|584065644|FG001|Double-blind Period|Withdrew consent|4|||
161733135|NCT02198651|584065645|FG002|Double-blind Period|Withdrew consent|0|||
161733136|NCT02198651|584065646|FG003|Double-blind Period|Withdrew consent|0|||
161733137|NCT02198651|584065647|FG004|Double-blind Period|Withdrew consent|0|||
161733138|NCT02198651|584065643|FG000|Double-blind Period|Adverse Event|0|||
161733139|NCT02198651|584065644|FG001|Double-blind Period|Adverse Event|1|||
161733140|NCT02198651|584065645|FG002|Double-blind Period|Adverse Event|0|||
161733141|NCT02198651|584065646|FG003|Double-blind Period|Adverse Event|0|||
161733142|NCT02198651|584065647|FG004|Double-blind Period|Adverse Event|0|||
161733143|NCT02198651|584065643|FG000|Double-blind Period|Other, not specified|0|||
161733144|NCT02198651|584065644|FG001|Double-blind Period|Other, not specified|4|||
161733145|NCT02198651|584065645|FG002|Double-blind Period|Other, not specified|1|||
161733146|NCT02198651|584065646|FG003|Double-blind Period|Other, not specified|0|||
161733147|NCT02198651|584065647|FG004|Double-blind Period|Other, not specified|0|||
161733148|NCT02198651|584065643|FG000|Open-label Rescue Period|Withdrew consent|0|||
161733149|NCT02198651|584065644|FG001|Open-label Rescue Period|Withdrew consent|0|||
161733150|NCT02198651|584065645|FG002|Open-label Rescue Period|Withdrew consent|0|||
161733151|NCT02198651|584065646|FG003|Open-label Rescue Period|Withdrew consent|2|||
161733152|NCT02198651|584065647|FG004|Open-label Rescue Period|Withdrew consent|0|||
161733153|NCT02198651|584065643|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
161733154|NCT02198651|584065644|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
161733155|NCT02198651|584065645|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
161733156|NCT02198651|584065646|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
161733157|NCT02198651|584065647|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
161733158|NCT02922634|584065650|FG000|Overall Study|Withdrawal by Subject|5|||
161733159|NCT02922634|584065650|FG000|Overall Study|Did not have their surgery|5|||
161733160|NCT02625324|584065651|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
161733161|NCT02625324|584065651|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
161733162|NCT02625324|584065651|FG000|6-Month Follow-up Subject Accountability|Death|5|||
161733163|NCT02625324|584065651|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
161733164|NCT02625324|584065651|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
161733165|NCT02625324|584065651|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
161733166|NCT02625324|584065651|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
161733167|NCT02625324|584065651|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
161733168|NCT02625324|584065651|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
161733169|NCT02625324|584065651|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
161733170|NCT02625324|584065651|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
161733171|NCT02625324|584065651|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
161733172|NCT02625324|584065651|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
161733173|NCT02625324|584065651|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
161733174|NCT02625324|584065651|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
161733175|NCT02625324|584065651|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
161733176|NCT02625324|584065651|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
161733177|NCT00352755|584065652|FG000|Overall Study|Physician Decision|1|||
161733178|NCT00352755|584065652|FG000|Overall Study|Adverse Event|1|||
161733179|NCT02397694|584065655|FG000|Double-Blinded Phase|Adverse Event|1|||
161733180|NCT02397694|584065656|FG001|Double-Blinded Phase|Adverse Event|0|||
161733181|NCT02397694|584065655|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
161733182|NCT02397694|584065656|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
161733183|NCT02397694|584065655|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
161733184|NCT02397694|584065656|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
161733185|NCT02397694|584065655|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
161733186|NCT02397694|584065656|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
161733187|NCT02397694|584065655|FG000|Open Label Extension Phase|Protocol Violation|1|||
161733188|NCT02397694|584065656|FG001|Open Label Extension Phase|Protocol Violation|0|||
161733189|NCT02397694|584065655|FG000|Open Label Extension Phase|Withdrew Consent|3|||
161733190|NCT02397694|584065656|FG001|Open Label Extension Phase|Withdrew Consent|1|||
161733191|NCT02397694|584065655|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
161733192|NCT02397694|584065656|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
161733193|NCT02115113|584065657|FG000|Participants in Run-in Period|Death|0|||
161733194|NCT02115113|584065658|FG001|Participants in Run-in Period|Death|0|||
161733195|NCT02115113|584065659|FG002|Participants in Run-in Period|Death|1|||
161733196|NCT02115113|584065657|FG000|Participants in Run-in Period|Administrative problems|0|||
161733197|NCT02115113|584065658|FG001|Participants in Run-in Period|Administrative problems|0|||
161733198|NCT02115113|584065659|FG002|Participants in Run-in Period|Administrative problems|1|||
161733199|NCT02115113|584065657|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
161733200|NCT02115113|584065658|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
161733201|NCT02115113|584065659|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
161733202|NCT02115113|584065657|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
161733203|NCT02115113|584065658|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
161733204|NCT02115113|584065659|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
161733205|NCT02115113|584065657|FG000|Participants Randomized|Lost to Follow-up|1|||
161733206|NCT02115113|584065658|FG001|Participants Randomized|Lost to Follow-up|0|||
161733207|NCT02115113|584065659|FG002|Participants Randomized|Lost to Follow-up|0|||
161733208|NCT02115113|584065657|FG000|Participants Randomized|Death|1|||
161733209|NCT02115113|584065658|FG001|Participants Randomized|Death|0|||
161733210|NCT02115113|584065659|FG002|Participants Randomized|Death|0|||
161733211|NCT00789191|584065661|FG000|Overall Study|Adverse Event|2|||
161733212|NCT00789191|584065662|FG001|Overall Study|Adverse Event|4|||
161733213|NCT00789191|584065661|FG000|Overall Study|Lack of Efficacy|0|||
161733214|NCT00789191|584065662|FG001|Overall Study|Lack of Efficacy|5|||
161733215|NCT00789191|584065661|FG000|Overall Study|Protocol Violation|5|||
161733216|NCT00789191|584065662|FG001|Overall Study|Protocol Violation|3|||
161733217|NCT00789191|584065661|FG000|Overall Study|Withdrawal Criteria|2|||
161733218|NCT00789191|584065662|FG001|Overall Study|Withdrawal Criteria|4|||
161733219|NCT00789191|584065661|FG000|Overall Study|Unclassified|5|||
161733220|NCT00789191|584065662|FG001|Overall Study|Unclassified|3|||
161965804|NCT02526524|584921842|FG002|Overall Study|Sponsor Decision|0|||
161965805|NCT02526524|584921843|FG003|Overall Study|Sponsor Decision|0|||
161965806|NCT02526524|584921844|FG004|Overall Study|Sponsor Decision|0|||
161965807|NCT02526524|584921845|FG005|Overall Study|Sponsor Decision|0|||
161965808|NCT01681069|584921856|FG000|Overall Study|Withdrawal by Subject|4|||
161965809|NCT01681069|584921857|FG001|Overall Study|Withdrawal by Subject|5|||
161733221|NCT00296725|584065668|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
161733222|NCT00296725|584065668|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
161733223|NCT00296725|584065668|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
161733224|NCT00356863|584065669|FG000|Overall Study|Death|16|||
161733225|NCT00356863|584065670|FG001|Overall Study|Death|32|||
161733226|NCT00356863|584065669|FG000|Overall Study|Lost to Follow-up|76|||
161733227|NCT00356863|584065670|FG001|Overall Study|Lost to Follow-up|43|||
161733228|NCT00836277|584065678|FG000|Overall Study|Not evaluable for response|6|||
161733229|NCT00280150|584065679|FG000|Overall Study|Adverse Event|0|||
161733230|NCT00280150|584065680|FG001|Overall Study|Adverse Event|1|||
161733231|NCT00280150|584065681|FG002|Overall Study|Adverse Event|2|||
161733232|NCT00280150|584065682|FG003|Overall Study|Adverse Event|3|||
161733233|NCT00280150|584065679|FG000|Overall Study|Lack of Efficacy|0|||
161733234|NCT00280150|584065680|FG001|Overall Study|Lack of Efficacy|0|||
161733235|NCT00280150|584065681|FG002|Overall Study|Lack of Efficacy|0|||
161733236|NCT00280150|584065682|FG003|Overall Study|Lack of Efficacy|3|||
161733237|NCT00280150|584065679|FG000|Overall Study|Physician Decision|0|||
161733238|NCT00280150|584065680|FG001|Overall Study|Physician Decision|0|||
161733239|NCT00280150|584065681|FG002|Overall Study|Physician Decision|0|||
161733240|NCT00280150|584065682|FG003|Overall Study|Physician Decision|1|||
161733241|NCT00280150|584065679|FG000|Overall Study|Protocol Violation|0|||
161733242|NCT00280150|584065680|FG001|Overall Study|Protocol Violation|0|||
161733243|NCT00280150|584065681|FG002|Overall Study|Protocol Violation|0|||
161733244|NCT00280150|584065682|FG003|Overall Study|Protocol Violation|1|||
161733245|NCT00280150|584065679|FG000|Overall Study|Withdrawal by Subject|0|||
161733246|NCT00280150|584065680|FG001|Overall Study|Withdrawal by Subject|0|||
161733247|NCT00280150|584065681|FG002|Overall Study|Withdrawal by Subject|0|||
161733248|NCT00280150|584065682|FG003|Overall Study|Withdrawal by Subject|1|||
161733249|NCT00280150|584065679|FG000|Overall Study|Did not get consolidation therapy|3|||
161733250|NCT00280150|584065680|FG001|Overall Study|Did not get consolidation therapy|0|||
161733251|NCT00280150|584065681|FG002|Overall Study|Did not get consolidation therapy|3|||
161733252|NCT00280150|584065682|FG003|Overall Study|Did not get consolidation therapy|0|||
161733253|NCT00280150|584065679|FG000|Overall Study|Declining Performance Status|0|||
161733254|NCT00280150|584065680|FG001|Overall Study|Declining Performance Status|0|||
161733255|NCT00280150|584065681|FG002|Overall Study|Declining Performance Status|0|||
161733256|NCT00280150|584065682|FG003|Overall Study|Declining Performance Status|1|||
161733257|NCT01944969|584065692|FG000|Overall Study|Adverse Event|1|||
161733258|NCT01944969|584065692|FG000|Overall Study|Lack of Efficacy|1|||
161733259|NCT01944969|584065692|FG000|Overall Study|Non-compliance with IMP|1|||
161733260|NCT01944969|584065692|FG000|Overall Study|Administrative or other reasons|23|||
161733261|NCT03198754|584065696|FG000|Overall Study|Withdrawal by Subject|5|||
161733262|NCT03198754|584065697|FG001|Overall Study|Withdrawal by Subject|4|||
161733263|NCT03198754|584065696|FG000|Overall Study|Lost to Follow-up|4|||
161733264|NCT03198754|584065697|FG001|Overall Study|Lost to Follow-up|3|||
161733265|NCT03198754|584065696|FG000|Overall Study|Ineligible|2|||
161733266|NCT03198754|584065697|FG001|Overall Study|Ineligible|1|||
161733267|NCT03247413|584065703|FG000|Overall Study|Lost to Follow-up|28|||
161733268|NCT00668200|584065704|FG000|Overall Study|Withdrawal by Subject|2|||
161733269|NCT00668200|584065704|FG000|Overall Study|Lost to Follow-up|1|||
161733270|NCT00642746|584065705|FG000|Overall Study|Patient unevaluable|1|||
161733271|NCT00642746|584065706|FG001|Overall Study|Patient unevaluable|0|||
161733272|NCT00424294|584065710|FG000|Overall Study|Adverse Event|4|||
161733273|NCT00424294|584065711|FG001|Overall Study|Adverse Event|10|||
161733274|NCT00424294|584065710|FG000|Overall Study|Lack of Efficacy|2|||
161733275|NCT00424294|584065711|FG001|Overall Study|Lack of Efficacy|1|||
161733276|NCT00424294|584065710|FG000|Overall Study|Withdrawal by Subject|1|||
161733277|NCT00424294|584065711|FG001|Overall Study|Withdrawal by Subject|2|||
161733278|NCT00424294|584065710|FG000|Overall Study|Other|0|||
161965810|NCT01681069|584921856|FG000|Overall Study|Protocol Violation|1|||
161733279|NCT00424294|584065711|FG001|Overall Study|Other|2|||
161733280|NCT00424294|584065710|FG000|Overall Study|Randomized but not Treated|1|||
161733281|NCT00424294|584065711|FG001|Overall Study|Randomized but not Treated|0|||
161733282|NCT01100307|584065712|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
161733283|NCT01100307|584065713|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
161965811|NCT01681069|584921857|FG001|Overall Study|Protocol Violation|1|||
161965812|NCT01681069|584921856|FG000|Overall Study|Adverse Event|0|||
162032311|NCT01986933|585175477|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
161733284|NCT01100307|584065712|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
161965813|NCT01681069|584921857|FG001|Overall Study|Adverse Event|1|||
161965814|NCT01463696|584921858|FG000|Overall Study|Adverse Event|0|||
161733285|NCT01100307|584065713|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
161733286|NCT01100307|584065712|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
162032312|NCT01986933|585175478|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
162032313|NCT01986933|585175474|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
162032314|NCT01986933|585175475|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
161733287|NCT01100307|584065713|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
161733288|NCT01100307|584065712|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
161733289|NCT01100307|584065713|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
161733290|NCT01100307|584065712|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
161733291|NCT01100307|584065713|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
161733292|NCT01100307|584065712|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
161733293|NCT01100307|584065713|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
161733294|NCT01496430|584065714|FG000|Overall Study|Adverse Event|0|||
161733295|NCT01496430|584065715|FG001|Overall Study|Adverse Event|0|||
161733296|NCT01496430|584065716|FG002|Overall Study|Adverse Event|1|||
161733297|NCT01496430|584065714|FG000|Overall Study|Major Protocol Deviation|0|||
161733298|NCT01496430|584065715|FG001|Overall Study|Major Protocol Deviation|0|||
161733299|NCT01496430|584065716|FG002|Overall Study|Major Protocol Deviation|1|||
161733300|NCT01496430|584065714|FG000|Overall Study|Lost to Follow-up|2|||
161733301|NCT01496430|584065715|FG001|Overall Study|Lost to Follow-up|3|||
161733302|NCT01496430|584065716|FG002|Overall Study|Lost to Follow-up|1|||
161733303|NCT01496430|584065714|FG000|Overall Study|Voluntary Withdrawal|2|||
161733304|NCT01496430|584065715|FG001|Overall Study|Voluntary Withdrawal|1|||
161733305|NCT01496430|584065716|FG002|Overall Study|Voluntary Withdrawal|6|||
161733306|NCT01496430|584065714|FG000|Overall Study|Principal Investigator Discretion|0|||
161733307|NCT01496430|584065715|FG001|Overall Study|Principal Investigator Discretion|1|||
161733308|NCT01496430|584065716|FG002|Overall Study|Principal Investigator Discretion|1|||
161733309|NCT01496430|584065714|FG000|Overall Study|Other|2|||
161733310|NCT01496430|584065715|FG001|Overall Study|Other|0|||
161733311|NCT01496430|584065716|FG002|Overall Study|Other|0|||
161733312|NCT02108951|584065717|FG000|Overall Study|Lost to Follow-up|1|||
161733313|NCT02108951|584065717|FG000|Overall Study|Patient's/guardian's decision|1|||
161733314|NCT02108951|584065717|FG000|Overall Study|Study Terminated by Sponsor|14|||
161733315|NCT00997321|584065718|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
161733316|NCT00997321|584065719|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
161733317|NCT01151579|584065728|FG000|Overall Study|Physician Decision|3|||
161733318|NCT01151579|584065729|FG001|Overall Study|Physician Decision|1|||
161733319|NCT01151579|584065728|FG000|Overall Study|Withdrawal by Subject|3|||
161733320|NCT01151579|584065729|FG001|Overall Study|Withdrawal by Subject|2|||
161733321|NCT01151579|584065728|FG000|Overall Study|Not meet inclusion criteria|6|||
161733322|NCT01151579|584065729|FG001|Overall Study|Not meet inclusion criteria|4|||
161733323|NCT00608530|584065730|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
161733324|NCT00608530|584065731|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
161733325|NCT00608530|584065732|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
161733326|NCT00608530|584065733|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
161733327|NCT00608530|584065730|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
161733328|NCT00608530|584065731|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
161733329|NCT00608530|584065732|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
161733330|NCT00608530|584065733|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
161733331|NCT00608530|584065730|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
161733332|NCT00608530|584065731|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
161733333|NCT00608530|584065732|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
161733334|NCT00608530|584065733|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
161733335|NCT00608530|584065730|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
161733336|NCT00608530|584065731|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
161733337|NCT00608530|584065732|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
161733338|NCT00608530|584065733|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
161733339|NCT00608530|584065730|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
161733340|NCT00608530|584065731|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
161733341|NCT00608530|584065732|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
161733342|NCT00608530|584065733|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
161733343|NCT00608530|584065730|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
161733344|NCT00608530|584065731|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
161733345|NCT00608530|584065732|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
161839521|NCT02788045|584458518|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
161839522|NCT02788045|584458516|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
161733346|NCT00608530|584065733|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
161733347|NCT00077610|584065734|FG000|Overall Study|Adverse Event|9|||
161733348|NCT00077610|584065735|FG001|Overall Study|Adverse Event|7|||
161733349|NCT00077610|584065736|FG002|Overall Study|Adverse Event|1|||
161733350|NCT00077610|584065734|FG000|Overall Study|Lost to Follow-up|0|||
161733351|NCT00077610|584065735|FG001|Overall Study|Lost to Follow-up|1|||
161839523|NCT02788045|584458517|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
161733352|NCT00077610|584065736|FG002|Overall Study|Lost to Follow-up|2|||
161733353|NCT00077610|584065734|FG000|Overall Study|Withdrawal by Subject|4|||
161733354|NCT00077610|584065735|FG001|Overall Study|Withdrawal by Subject|10|||
161733355|NCT00077610|584065736|FG002|Overall Study|Withdrawal by Subject|6|||
161733356|NCT00077610|584065734|FG000|Overall Study|Death|17|||
161733357|NCT00077610|584065735|FG001|Overall Study|Death|13|||
161733358|NCT00077610|584065736|FG002|Overall Study|Death|13|||
161733359|NCT00077610|584065734|FG000|Overall Study|Renal transplant|12|||
161733360|NCT00077610|584065735|FG001|Overall Study|Renal transplant|15|||
161733361|NCT00077610|584065736|FG002|Overall Study|Renal transplant|11|||
161733362|NCT00077610|584065734|FG000|Overall Study|Withdrew from dialysis care|5|||
161733363|NCT00077610|584065735|FG001|Overall Study|Withdrew from dialysis care|0|||
161733364|NCT00077610|584065736|FG002|Overall Study|Withdrew from dialysis care|3|||
161733365|NCT00077610|584065734|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161733366|NCT00077610|584065735|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161733367|NCT00077610|584065736|FG002|Overall Study|Insufficient Therapeutic Response|0|||
161733368|NCT00077610|584065734|FG000|Overall Study|Multiple blood transfusions|0|||
161733369|NCT00077610|584065735|FG001|Overall Study|Multiple blood transfusions|0|||
161733370|NCT00077610|584065736|FG002|Overall Study|Multiple blood transfusions|1|||
161733371|NCT00077610|584065734|FG000|Overall Study|Principal Investigator's decision|1|||
161733372|NCT00077610|584065735|FG001|Overall Study|Principal Investigator's decision|0|||
161733373|NCT00077610|584065736|FG002|Overall Study|Principal Investigator's decision|1|||
161733374|NCT00077610|584065734|FG000|Overall Study|Worsening of health condition|1|||
161733375|NCT00077610|584065735|FG001|Overall Study|Worsening of health condition|1|||
161733376|NCT00077610|584065736|FG002|Overall Study|Worsening of health condition|0|||
161733377|NCT00077610|584065734|FG000|Overall Study|Given Epogen in hospital|1|||
161733378|NCT00077610|584065735|FG001|Overall Study|Given Epogen in hospital|0|||
161733379|NCT00077610|584065736|FG002|Overall Study|Given Epogen in hospital|0|||
161733380|NCT00077610|584065734|FG000|Overall Study|Transferred to other unit|0|||
161733381|NCT00077610|584065735|FG001|Overall Study|Transferred to other unit|0|||
161733382|NCT00077610|584065736|FG002|Overall Study|Transferred to other unit|1|||
161733383|NCT00077610|584065734|FG000|Overall Study|Transferred to nursing home|0|||
161733384|NCT00077610|584065735|FG001|Overall Study|Transferred to nursing home|0|||
161733385|NCT00077610|584065736|FG002|Overall Study|Transferred to nursing home|1|||
161733386|NCT00077610|584065734|FG000|Overall Study|Transfer to satellite unit|1|||
161733387|NCT00077610|584065735|FG001|Overall Study|Transfer to satellite unit|0|||
161733388|NCT00077610|584065736|FG002|Overall Study|Transfer to satellite unit|0|||
161733389|NCT00077610|584065734|FG000|Overall Study|Transfer to other center for surgery|1|||
161733390|NCT00077610|584065735|FG001|Overall Study|Transfer to other center for surgery|0|||
161733391|NCT00077610|584065736|FG002|Overall Study|Transfer to other center for surgery|0|||
161733392|NCT00077610|584065734|FG000|Overall Study|Change in dialysis modality|1|||
161733393|NCT00077610|584065735|FG001|Overall Study|Change in dialysis modality|0|||
161733394|NCT00077610|584065736|FG002|Overall Study|Change in dialysis modality|0|||
161733395|NCT00077610|584065734|FG000|Overall Study|Relocation|0|||
161733396|NCT00077610|584065735|FG001|Overall Study|Relocation|8|||
161733397|NCT00077610|584065736|FG002|Overall Study|Relocation|5|||
161733398|NCT00077610|584065734|FG000|Overall Study|Financial issues|0|||
161733399|NCT00077610|584065735|FG001|Overall Study|Financial issues|1|||
161733400|NCT00077610|584065736|FG002|Overall Study|Financial issues|0|||
161733401|NCT00077610|584065734|FG000|Overall Study|Sponsors decision to withdraw|0|||
161733402|NCT00077610|584065735|FG001|Overall Study|Sponsors decision to withdraw|0|||
161733403|NCT00077610|584065736|FG002|Overall Study|Sponsors decision to withdraw|1|||
161733404|NCT01357915|584065740|FG000|Overall Study|Lost to Follow-up|3|||
161733405|NCT01357915|584065741|FG001|Overall Study|Lost to Follow-up|0|||
161733406|NCT00305253|584065744|FG000|Overall Study|Withdrawal by Subject|0|||
161733407|NCT00305253|584065745|FG001|Overall Study|Withdrawal by Subject|1|||
161733408|NCT01098461|584065746|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
161733409|NCT01098461|584065747|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
161733410|NCT01098461|584065748|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
161733411|NCT01098461|584065749|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
161733412|NCT01098461|584065746|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
161733413|NCT01098461|584065747|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
161733414|NCT01098461|584065748|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
161733415|NCT01098461|584065749|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
161733416|NCT01098461|584065746|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
161733417|NCT01098461|584065747|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
161733418|NCT01098461|584065748|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
161733419|NCT01098461|584065749|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
161733420|NCT01098461|584065746|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
161733421|NCT01098461|584065747|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
161733422|NCT01098461|584065748|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
161733423|NCT01098461|584065749|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
161733424|NCT01098461|584065746|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
161839524|NCT02788045|584458518|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
161839525|NCT02788045|584458516|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
161839526|NCT02788045|584458517|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
161839527|NCT02788045|584458518|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
161839528|NCT02788045|584458516|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
161839529|NCT02788045|584458517|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
161839530|NCT02788045|584458518|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
161839531|NCT02788045|584458516|FG000|Main Study (Up to Week 72)|Other|3|||
161839532|NCT02788045|584458517|FG001|Main Study (Up to Week 72)|Other|0|||
161839533|NCT02788045|584458518|FG002|Main Study (Up to Week 72)|Other|0|||
161839534|NCT02788045|584458516|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
161839535|NCT02788045|584458517|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
161839536|NCT02788045|584458518|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
161839537|NCT02788045|584458516|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
161839538|NCT02788045|584458517|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
161839539|NCT02788045|584458518|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
161839540|NCT02788045|584458516|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
161839541|NCT02788045|584458517|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
161839542|NCT02788045|584458518|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
161839543|NCT02128217|584458525|FG000|Overall Study|Lost to Follow-up|0|||
161839544|NCT02128217|584458526|FG001|Overall Study|Lost to Follow-up|1|||
161839545|NCT05071313|584458529|FG000|Overall Study|Lost to Follow-up|17|||
161839546|NCT05071313|584458530|FG001|Overall Study|Lost to Follow-up|10|||
161839547|NCT05071313|584458529|FG000|Overall Study|Physician Decision|1|||
161839548|NCT05071313|584458530|FG001|Overall Study|Physician Decision|6|||
161839549|NCT05071313|584458529|FG000|Overall Study|Death|1|||
161839550|NCT05071313|584458530|FG001|Overall Study|Death|0|||
161839551|NCT05071313|584458529|FG000|Overall Study|Withdrawal by Subject|10|||
161733425|NCT01098461|584065747|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
161733426|NCT01098461|584065748|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
161733427|NCT01098461|584065749|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
161733428|NCT01098461|584065746|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
161733429|NCT01098461|584065747|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
161733430|NCT01098461|584065748|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
161733431|NCT01098461|584065749|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
161733432|NCT01098461|584065746|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
161733433|NCT01098461|584065747|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
161733434|NCT01098461|584065748|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
161733435|NCT01098461|584065749|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
161733436|NCT02662985|584065752|FG000|Treatment Period 1|Adverse Event|0|||
161733437|NCT02662985|584065753|FG001|Treatment Period 1|Adverse Event|2|||
161733438|NCT02662985|584065752|FG000|Treatment Period 1|Protocol Violation|0|||
161733439|NCT02662985|584065753|FG001|Treatment Period 1|Protocol Violation|1|||
161733440|NCT02662985|584065752|FG000|Treatment Period 1|Physician Decision|1|||
161733441|NCT02662985|584065753|FG001|Treatment Period 1|Physician Decision|0|||
161733442|NCT02662985|584065752|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161733443|NCT02662985|584065753|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161733444|NCT02662985|584065752|FG000|Treatment Period 2|Lack of Efficacy|0|||
161733445|NCT02662985|584065753|FG001|Treatment Period 2|Lack of Efficacy|1|||
161733446|NCT02662985|584065752|FG000|Treatment Period 2|Lost to Follow-up|1|||
161839552|NCT05071313|584458530|FG001|Overall Study|Withdrawal by Subject|15|||
161839553|NCT05071313|584458529|FG000|Overall Study|Other|1|||
161839554|NCT05071313|584458530|FG001|Overall Study|Other|0|||
161839555|NCT05071313|584458529|FG000|Overall Study|Randomized but not vaccinated|4|||
161839556|NCT05071313|584458530|FG001|Overall Study|Randomized but not vaccinated|2|||
161839557|NCT00541970|584458531|FG000|Month 7|Protocol Violation|9|||
161839558|NCT00541970|584458532|FG001|Month 7|Protocol Violation|13|||
161839559|NCT00541970|584458533|FG002|Month 7|Protocol Violation|11|||
161839560|NCT00541970|584458534|FG003|Month 7|Protocol Violation|5|||
161839561|NCT00541970|584458531|FG000|Month 12|Adverse Event|0|||
161965815|NCT01463696|584921859|FG001|Overall Study|Adverse Event|1|||
161965816|NCT01463696|584921860|FG002|Overall Study|Adverse Event|0|||
161965817|NCT01463696|584921861|FG003|Overall Study|Adverse Event|2|||
161965818|NCT01463696|584921862|FG004|Overall Study|Adverse Event|0|||
161965819|NCT01463696|584921863|FG005|Overall Study|Adverse Event|1|||
161965820|NCT01463696|584921864|FG006|Overall Study|Adverse Event|3|||
161965821|NCT01463696|584921865|FG007|Overall Study|Adverse Event|2|||
161965822|NCT01463696|584921858|FG000|Overall Study|Lost to Follow-up|0|||
161965823|NCT01463696|584921859|FG001|Overall Study|Lost to Follow-up|0|||
161965824|NCT01463696|584921860|FG002|Overall Study|Lost to Follow-up|1|||
161965825|NCT01463696|584921861|FG003|Overall Study|Lost to Follow-up|0|||
161965826|NCT01463696|584921862|FG004|Overall Study|Lost to Follow-up|0|||
161965827|NCT01463696|584921863|FG005|Overall Study|Lost to Follow-up|0|||
161965828|NCT01463696|584921864|FG006|Overall Study|Lost to Follow-up|0|||
161733447|NCT02662985|584065753|FG001|Treatment Period 2|Lost to Follow-up|0|||
161733448|NCT02662985|584065752|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
161733449|NCT02662985|584065753|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
161733450|NCT02662985|584065752|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
161733451|NCT02662985|584065753|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
161733452|NCT02662985|584065752|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
161733453|NCT02662985|584065753|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
161733454|NCT02662985|584065752|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
161733455|NCT02662985|584065753|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
161733456|NCT02662985|584065752|FG000|Treatment Period 3 (Extension Period)|Death|0|||
161733457|NCT02662985|584065753|FG001|Treatment Period 3 (Extension Period)|Death|1|||
161733458|NCT01153763|584065754|FG000|Overall Study|Study Closed|16|||
161733459|NCT01153763|584065754|FG000|Overall Study|Lost to Follow-up|1|||
161733460|NCT01153763|584065754|FG000|Overall Study|Physician Decision|2|||
161733461|NCT01153763|584065754|FG000|Overall Study|Withdrawal by Subject|2|||
161733462|NCT05373706|584065759|FG000|Overall Study|Lost to Follow-up|2|||
161733463|NCT05373706|584065760|FG001|Overall Study|Lost to Follow-up|2|||
161733464|NCT01486784|584065761|FG000|Overall Study|Withdrawal by Subject|0|||
161733465|NCT01486784|584065762|FG001|Overall Study|Withdrawal by Subject|0|||
161733466|NCT01486784|584065763|FG002|Overall Study|Withdrawal by Subject|1|||
161733467|NCT01486784|584065764|FG003|Overall Study|Withdrawal by Subject|0|||
161733468|NCT01486784|584065765|FG004|Overall Study|Withdrawal by Subject|1|||
161733469|NCT01486784|584065766|FG005|Overall Study|Withdrawal by Subject|2|||
161733470|NCT01486784|584065761|FG000|Overall Study|Subject did not meet entry criteria|0|||
161733471|NCT01486784|584065762|FG001|Overall Study|Subject did not meet entry criteria|0|||
161733472|NCT01486784|584065763|FG002|Overall Study|Subject did not meet entry criteria|0|||
161733473|NCT01486784|584065764|FG003|Overall Study|Subject did not meet entry criteria|0|||
161733474|NCT01486784|584065765|FG004|Overall Study|Subject did not meet entry criteria|1|||
161733475|NCT01486784|584065766|FG005|Overall Study|Subject did not meet entry criteria|0|||
161733476|NCT01486784|584065761|FG000|Overall Study|Death|0|||
161733477|NCT01486784|584065762|FG001|Overall Study|Death|0|||
161733478|NCT01486784|584065763|FG002|Overall Study|Death|0|||
161733479|NCT01486784|584065764|FG003|Overall Study|Death|0|||
161733480|NCT01486784|584065765|FG004|Overall Study|Death|0|||
161733481|NCT01486784|584065766|FG005|Overall Study|Death|1|||
161733482|NCT03491553|584065767|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
161733483|NCT03491553|584065768|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
161733484|NCT03491553|584065769|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
161733485|NCT03491553|584065770|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
161733486|NCT03491553|584065771|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
161733487|NCT03491553|584065772|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
161733488|NCT03491553|584065767|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
161733489|NCT03491553|584065768|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
161733490|NCT03491553|584065769|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
161733491|NCT03491553|584065770|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
161733492|NCT03491553|584065771|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
161733493|NCT03491553|584065772|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
161733494|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
161733495|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
161733496|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Death|2|||
161733497|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Death|1|||
161733498|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
161733499|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
161733500|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
161733501|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
161733502|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
161733503|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
161733504|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
161733505|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
161733506|NCT03633227|584065773|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
161733507|NCT03633227|584065774|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
161733508|NCT03633227|584065773|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
161733509|NCT03633227|584065774|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
161733510|NCT03633227|584065773|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
161733511|NCT03633227|584065774|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
161733512|NCT03633227|584065773|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
161733513|NCT03633227|584065774|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
161733514|NCT03633227|584065773|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
161733515|NCT03633227|584065774|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
161733516|NCT03633227|584065773|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
161733517|NCT03633227|584065774|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
161733518|NCT01479374|584065781|FG000|Overall Study|Adverse Event|2|||
161733519|NCT01479374|584065782|FG001|Overall Study|Adverse Event|1|||
161733520|NCT01479374|584065783|FG002|Overall Study|Adverse Event|0|||
161733521|NCT01479374|584065781|FG000|Overall Study|Lost to Follow-up|1|||
161733522|NCT01479374|584065782|FG001|Overall Study|Lost to Follow-up|2|||
161733523|NCT01479374|584065783|FG002|Overall Study|Lost to Follow-up|0|||
161733524|NCT01479374|584065781|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
161733525|NCT01479374|584065782|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
161733526|NCT01479374|584065783|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
161733527|NCT01479374|584065781|FG000|Overall Study|Other|0|||
161733528|NCT01479374|584065782|FG001|Overall Study|Other|4|||
161733529|NCT01479374|584065783|FG002|Overall Study|Other|5|||
161733530|NCT01606761|584065785|FG000|Prior to Week 24|Lost to Follow-up|0|||
161733531|NCT01606761|584065786|FG001|Prior to Week 24|Lost to Follow-up|3|||
161733532|NCT01606761|584065787|FG002|Prior to Week 24|Lost to Follow-up|2|||
161733533|NCT01606761|584065788|FG003|Prior to Week 24|Lost to Follow-up|0|||
161733534|NCT01606761|584065789|FG004|Prior to Week 24|Lost to Follow-up|0|||
161733535|NCT01606761|584065785|FG000|Prior to Week 24|Withdrawal by Subject|12|||
161733536|NCT01606761|584065786|FG001|Prior to Week 24|Withdrawal by Subject|10|||
161733537|NCT01606761|584065787|FG002|Prior to Week 24|Withdrawal by Subject|9|||
161733538|NCT01606761|584065788|FG003|Prior to Week 24|Withdrawal by Subject|0|||
161733539|NCT01606761|584065789|FG004|Prior to Week 24|Withdrawal by Subject|0|||
161733540|NCT01606761|584065785|FG000|Prior to Week 24|Adverse Event|11|||
161733541|NCT01606761|584065786|FG001|Prior to Week 24|Adverse Event|18|||
161733542|NCT01606761|584065787|FG002|Prior to Week 24|Adverse Event|22|||
161733543|NCT01606761|584065788|FG003|Prior to Week 24|Adverse Event|0|||
161733544|NCT01606761|584065789|FG004|Prior to Week 24|Adverse Event|0|||
161733545|NCT01606761|584065785|FG000|Prior to Week 24|Lack of Efficacy|15|||
161733546|NCT01606761|584065786|FG001|Prior to Week 24|Lack of Efficacy|14|||
161733547|NCT01606761|584065787|FG002|Prior to Week 24|Lack of Efficacy|8|||
161733548|NCT01606761|584065788|FG003|Prior to Week 24|Lack of Efficacy|0|||
161733549|NCT01606761|584065789|FG004|Prior to Week 24|Lack of Efficacy|0|||
161733550|NCT01606761|584065785|FG000|Prior to Week 24|Physician Decision|0|||
161733551|NCT01606761|584065786|FG001|Prior to Week 24|Physician Decision|3|||
161733552|NCT01606761|584065787|FG002|Prior to Week 24|Physician Decision|1|||
161733553|NCT01606761|584065788|FG003|Prior to Week 24|Physician Decision|0|||
161733554|NCT01606761|584065789|FG004|Prior to Week 24|Physician Decision|0|||
161733555|NCT01606761|584065785|FG000|Prior to Week 24|Other|4|||
161733556|NCT01606761|584065786|FG001|Prior to Week 24|Other|7|||
161733557|NCT01606761|584065787|FG002|Prior to Week 24|Other|5|||
161733558|NCT01606761|584065788|FG003|Prior to Week 24|Other|0|||
161733559|NCT01606761|584065789|FG004|Prior to Week 24|Other|0|||
161733560|NCT01606761|584065785|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
161733561|NCT01606761|584065786|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
161733562|NCT01606761|584065787|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
161733563|NCT01606761|584065788|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
161733564|NCT01606761|584065789|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
161733565|NCT01606761|584065785|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
161733566|NCT01606761|584065786|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
161733567|NCT01606761|584065787|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
161733568|NCT01606761|584065788|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
161733569|NCT01606761|584065789|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
161733570|NCT01606761|584065785|FG000|Week 24 to Week 52|Adverse Event|0|||
161733571|NCT01606761|584065786|FG001|Week 24 to Week 52|Adverse Event|11|||
161733572|NCT01606761|584065787|FG002|Week 24 to Week 52|Adverse Event|14|||
161733573|NCT01606761|584065788|FG003|Week 24 to Week 52|Adverse Event|3|||
161733574|NCT01606761|584065789|FG004|Week 24 to Week 52|Adverse Event|15|||
161733575|NCT01606761|584065785|FG000|Week 24 to Week 52|Death|0|||
161733576|NCT01606761|584065786|FG001|Week 24 to Week 52|Death|0|||
161733577|NCT01606761|584065787|FG002|Week 24 to Week 52|Death|2|||
161733578|NCT01606761|584065788|FG003|Week 24 to Week 52|Death|1|||
161733579|NCT01606761|584065789|FG004|Week 24 to Week 52|Death|0|||
161733580|NCT01606761|584065785|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
161733581|NCT01606761|584065786|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
161733582|NCT01606761|584065787|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
161733583|NCT01606761|584065788|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
161733584|NCT01606761|584065789|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
161733585|NCT01606761|584065785|FG000|Week 24 to Week 52|Physician Decision|0|||
161733586|NCT01606761|584065786|FG001|Week 24 to Week 52|Physician Decision|1|||
161733587|NCT01606761|584065787|FG002|Week 24 to Week 52|Physician Decision|1|||
161839562|NCT00541970|584458532|FG001|Month 12|Adverse Event|1|||
161839563|NCT00541970|584458533|FG002|Month 12|Adverse Event|1|||
161733588|NCT01606761|584065788|FG003|Week 24 to Week 52|Physician Decision|0|||
161733589|NCT01606761|584065789|FG004|Week 24 to Week 52|Physician Decision|0|||
161733590|NCT01606761|584065785|FG000|Week 24 to Week 52|Other|0|||
161733591|NCT01606761|584065786|FG001|Week 24 to Week 52|Other|1|||
161733592|NCT01606761|584065787|FG002|Week 24 to Week 52|Other|5|||
161839564|NCT00541970|584458534|FG003|Month 12|Adverse Event|1|||
161733593|NCT01606761|584065788|FG003|Week 24 to Week 52|Other|2|||
161733594|NCT01606761|584065789|FG004|Week 24 to Week 52|Other|2|||
161733595|NCT01606761|584065785|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
161733596|NCT01606761|584065786|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
161733597|NCT01606761|584065787|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
161733598|NCT01606761|584065788|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
161733599|NCT01606761|584065789|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
161733600|NCT01606761|584065785|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
161733601|NCT01606761|584065786|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
161733602|NCT01606761|584065787|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
161733603|NCT01606761|584065788|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
161733604|NCT01606761|584065789|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
161733605|NCT01606761|584065785|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
161733606|NCT01606761|584065786|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
161733607|NCT01606761|584065787|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
161733608|NCT01606761|584065788|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
161733609|NCT01606761|584065789|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
161733610|NCT01606761|584065785|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
161733611|NCT01606761|584065786|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
161733612|NCT01606761|584065787|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
161733613|NCT01606761|584065788|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
161733614|NCT01606761|584065789|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
161733615|NCT00992446|584065795|FG000|Overall Study|Disease Progression|1|||
161733616|NCT00992446|584065795|FG000|Overall Study|Withdrawal by Subject|2|||
161733617|NCT00992446|584065795|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
161733618|NCT00333619|584067644|FG000|Overall Study|Death|12|||
161733619|NCT00333619|584067645|FG001|Overall Study|Death|6|||
161733620|NCT00333619|584067644|FG000|Overall Study|Withdrawal by Subject|6|||
161733621|NCT00333619|584067645|FG001|Overall Study|Withdrawal by Subject|1|||
161733622|NCT00333619|584067644|FG000|Overall Study|Lost to Follow-up|3|||
161733623|NCT00333619|584067645|FG001|Overall Study|Lost to Follow-up|3|||
161733624|NCT01120379|584067654|FG000|One Year Timepoint|Withdrawal by Subject|41|||
161733625|NCT01120379|584067654|FG000|One Year Timepoint|Lost to Follow-up|115|||
161733626|NCT01120379|584067654|FG000|One Year Timepoint|Death|108|||
161733627|NCT01120379|584067654|FG000|One Year Timepoint|Physician Decision|9|||
161733628|NCT01120379|584067654|FG000|One Year Timepoint|Any other reason for early termination|5|||
161733629|NCT01120379|584067654|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
161733630|NCT01120379|584067654|FG000|Two Year Timepoint|Lost to Follow-up|87|||
161733631|NCT01120379|584067654|FG000|Two Year Timepoint|Death|123|||
161733632|NCT01120379|584067654|FG000|Two Year Timepoint|Physician Decision|12|||
161733633|NCT01120379|584067654|FG000|Two Year Timepoint|Any other reason for early termination|4|||
161733634|NCT01120379|584067654|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
161733635|NCT01120379|584067654|FG000|Three Year Timepoint|Lost to Follow-up|43|||
161733636|NCT01120379|584067654|FG000|Three Year Timepoint|Death|120|||
161733637|NCT01120379|584067654|FG000|Three Year Timepoint|Physician Decision|9|||
161733638|NCT01120379|584067654|FG000|Three Year Timepoint|Any other reason for early termination|17|||
161733639|NCT01120379|584067654|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
161733640|NCT01120379|584067654|FG000|Four Year Timepoint|Lost to Follow-up|10|||
161733641|NCT01120379|584067654|FG000|Four Year Timepoint|Death|131|||
161733642|NCT01120379|584067654|FG000|Four Year Timepoint|Physician Decision|5|||
161733643|NCT01120379|584067654|FG000|Four Year Timepoint|Any other reason for early termination|217|||
161733644|NCT03162055|584067655|FG000|Overall Study|Adverse Event|6|||
161733645|NCT03162055|584067656|FG001|Overall Study|Adverse Event|5|||
161733646|NCT03162055|584067655|FG000|Overall Study|Death|3|||
161733647|NCT03162055|584067656|FG001|Overall Study|Death|3|||
161733648|NCT03162055|584067655|FG000|Overall Study|Lost to Follow-up|0|||
161733649|NCT03162055|584067656|FG001|Overall Study|Lost to Follow-up|1|||
161733650|NCT03162055|584067655|FG000|Overall Study|Study-specific withdrawal criteria|22|||
161733651|NCT03162055|584067656|FG001|Overall Study|Study-specific withdrawal criteria|14|||
161733652|NCT03162055|584067655|FG000|Overall Study|Withdrawal by Subject|17|||
161733653|NCT03162055|584067656|FG001|Overall Study|Withdrawal by Subject|2|||
161733654|NCT03162055|584067655|FG000|Overall Study|Did not receive treatment|2|||
161839565|NCT00541970|584458531|FG000|Month 12|Protocol Violation|12|||
161965829|NCT01463696|584921865|FG007|Overall Study|Lost to Follow-up|0|||
161965830|NCT01463696|584921858|FG000|Overall Study|Progressive Disease|0|||
161965831|NCT01463696|584921859|FG001|Overall Study|Progressive Disease|1|||
161965832|NCT01463696|584921860|FG002|Overall Study|Progressive Disease|0|||
161965833|NCT01463696|584921861|FG003|Overall Study|Progressive Disease|1|||
161733655|NCT03162055|584067656|FG001|Overall Study|Did not receive treatment|0|||
161733656|NCT03162055|584067655|FG000|Overall Study|Incorrect randomization|4|||
161733657|NCT03162055|584067656|FG001|Overall Study|Incorrect randomization|3|||
161733658|NCT03162055|584067655|FG000|Overall Study|Other|8|||
161965834|NCT01463696|584921862|FG004|Overall Study|Progressive Disease|0|||
161965835|NCT01463696|584921863|FG005|Overall Study|Progressive Disease|1|||
161839566|NCT00541970|584458532|FG001|Month 12|Protocol Violation|21|||
161839567|NCT00541970|584458533|FG002|Month 12|Protocol Violation|20|||
161839568|NCT00541970|584458534|FG003|Month 12|Protocol Violation|15|||
161839569|NCT00541970|584458531|FG000|Month 18|Adverse Event|0|||
161839570|NCT00541970|584458532|FG001|Month 18|Adverse Event|1|||
161733659|NCT03162055|584067656|FG001|Overall Study|Other|15|||
161733660|NCT04031404|584067657|FG000|Baseline|Lost to Follow-up|0|||
161733661|NCT04031404|584067658|FG001|Baseline|Lost to Follow-up|1|||
161839571|NCT00541970|584458533|FG002|Month 18|Adverse Event|1|||
161839572|NCT00541970|584458534|FG003|Month 18|Adverse Event|1|||
161839573|NCT00541970|584458531|FG000|Month 18|Protocol Violation|14|||
161839574|NCT00541970|584458532|FG001|Month 18|Protocol Violation|23|||
161839575|NCT00541970|584458533|FG002|Month 18|Protocol Violation|24|||
161839576|NCT00541970|584458534|FG003|Month 18|Protocol Violation|16|||
161839577|NCT00541970|584458531|FG000|Month 24|Adverse Event|0|||
161839578|NCT00541970|584458532|FG001|Month 24|Adverse Event|1|||
161839579|NCT00541970|584458533|FG002|Month 24|Adverse Event|1|||
161839580|NCT00541970|584458534|FG003|Month 24|Adverse Event|1|||
161839581|NCT00541970|584458531|FG000|Month 24|Protocol Violation|29|||
161839582|NCT00541970|584458532|FG001|Month 24|Protocol Violation|31|||
161839583|NCT00541970|584458533|FG002|Month 24|Protocol Violation|31|||
161839584|NCT00541970|584458534|FG003|Month 24|Protocol Violation|21|||
161839585|NCT00541970|584458531|FG000|Month 36|Protocol Violation|61|||
161839586|NCT00541970|584458532|FG001|Month 36|Protocol Violation|66|||
161839587|NCT00541970|584458533|FG002|Month 36|Protocol Violation|66|||
161839588|NCT00541970|584458534|FG003|Month 36|Protocol Violation|60|||
161839589|NCT00541970|584458531|FG000|Month 48|Withdrawal by Subject|2|||
161839590|NCT00541970|584458532|FG001|Month 48|Withdrawal by Subject|4|||
161839591|NCT00541970|584458533|FG002|Month 48|Withdrawal by Subject|4|||
161839592|NCT00541970|584458534|FG003|Month 48|Withdrawal by Subject|2|||
161839593|NCT00541970|584458531|FG000|Month 48|Other|3|||
161839594|NCT00541970|584458532|FG001|Month 48|Other|1|||
161839595|NCT00541970|584458533|FG002|Month 48|Other|1|||
161839596|NCT00541970|584458534|FG003|Month 48|Other|0|||
161839597|NCT00541970|584458531|FG000|Month 48|Lost to Follow-up|66|||
161839598|NCT00541970|584458532|FG001|Month 48|Lost to Follow-up|68|||
161839599|NCT00541970|584458533|FG002|Month 48|Lost to Follow-up|68|||
161839600|NCT00541970|584458534|FG003|Month 48|Lost to Follow-up|73|||
161839601|NCT00541970|584458531|FG000|Month 60|Protocol Violation|78|||
161839602|NCT00541970|584458532|FG001|Month 60|Protocol Violation|77|||
161839603|NCT00541970|584458533|FG002|Month 60|Protocol Violation|82|||
161733662|NCT04031404|584067657|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
161733663|NCT04031404|584067658|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
161733664|NCT04031404|584067657|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
161733665|NCT04031404|584067658|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
161733666|NCT04031404|584067657|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
161733667|NCT04031404|584067658|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
161733668|NCT04031404|584067657|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
161733669|NCT04031404|584067658|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
161839604|NCT00541970|584458534|FG003|Month 60|Protocol Violation|72|||
161839605|NCT03107026|584458535|FG000|Overall Study|Adverse Event|2|||
161839606|NCT03107026|584458536|FG001|Overall Study|Adverse Event|14|||
161839607|NCT03107026|584458537|FG002|Overall Study|Adverse Event|23|||
161839608|NCT03107026|584458535|FG000|Overall Study|Lost to Follow-up|12|||
161839609|NCT03107026|584458536|FG001|Overall Study|Lost to Follow-up|12|||
161839610|NCT03107026|584458537|FG002|Overall Study|Lost to Follow-up|13|||
161839611|NCT03107026|584458535|FG000|Overall Study|Protocol Violation|1|||
161965836|NCT01463696|584921864|FG006|Overall Study|Progressive Disease|4|||
161965837|NCT01463696|584921865|FG007|Overall Study|Progressive Disease|2|||
161965838|NCT01463696|584921858|FG000|Overall Study|Withdrawal by Subject|0|||
161733670|NCT01104584|584067663|FG000|Overall Study|Study drug never administered|21|||
161839612|NCT03107026|584458536|FG001|Overall Study|Protocol Violation|2|||
161839613|NCT03107026|584458537|FG002|Overall Study|Protocol Violation|0|||
161839614|NCT03107026|584458535|FG000|Overall Study|Pregnancy|1|||
161839615|NCT03107026|584458536|FG001|Overall Study|Pregnancy|0|||
161839616|NCT03107026|584458537|FG002|Overall Study|Pregnancy|0|||
161839617|NCT03107026|584458535|FG000|Overall Study|Withdrawal by Subject|13|||
161839618|NCT03107026|584458536|FG001|Overall Study|Withdrawal by Subject|5|||
161839619|NCT03107026|584458537|FG002|Overall Study|Withdrawal by Subject|17|||
161839620|NCT03107026|584458535|FG000|Overall Study|non compliance with study visits|1|||
161839621|NCT03107026|584458536|FG001|Overall Study|non compliance with study visits|2|||
161839622|NCT03107026|584458537|FG002|Overall Study|non compliance with study visits|0|||
161839623|NCT03107026|584458535|FG000|Overall Study|non-compliance with study drug|2|||
161839624|NCT03107026|584458536|FG001|Overall Study|non-compliance with study drug|2|||
161839625|NCT03107026|584458537|FG002|Overall Study|non-compliance with study drug|3|||
161839626|NCT03107026|584458535|FG000|Overall Study|Physician Decision|0|||
161839627|NCT03107026|584458536|FG001|Overall Study|Physician Decision|1|||
161839628|NCT03107026|584458537|FG002|Overall Study|Physician Decision|0|||
161839629|NCT01183221|584458538|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
161965839|NCT01463696|584921859|FG001|Overall Study|Withdrawal by Subject|0|||
161733671|NCT01104584|584067663|FG000|Overall Study|Study prematurely discontinued|2|||
161733672|NCT02370498|584067664|FG000|Overall Study|Adverse Event|10|||
161733673|NCT02370498|584067665|FG001|Overall Study|Adverse Event|8|||
161733674|NCT02370498|584067664|FG000|Overall Study|Death|263|||
161733675|NCT02370498|584067665|FG001|Overall Study|Death|265|||
161733676|NCT02370498|584067664|FG000|Overall Study|Protocol Violation|1|||
161733677|NCT02370498|584067665|FG001|Overall Study|Protocol Violation|2|||
161733678|NCT02370498|584067664|FG000|Overall Study|Withdrawal by Subject|7|||
161733679|NCT02370498|584067665|FG001|Overall Study|Withdrawal by Subject|12|||
161733680|NCT02370498|584067664|FG000|Overall Study|Sponsor's decision|15|||
161733681|NCT02370498|584067665|FG001|Overall Study|Sponsor's decision|9|||
161733682|NCT04017442|584067666|FG000|Overall Study|Withdrawal by Subject|0|||
161733683|NCT04017442|584067667|FG001|Overall Study|Withdrawal by Subject|3|||
161733684|NCT04017442|584067666|FG000|Overall Study|Lost to Follow-up|21|||
161733685|NCT04017442|584067667|FG001|Overall Study|Lost to Follow-up|19|||
161733686|NCT03225716|584067671|FG000|Overall Study|Withdrawal by Subject|2|||
161733687|NCT03225716|584067672|FG001|Overall Study|Withdrawal by Subject|2|||
161733688|NCT03225716|584067673|FG002|Overall Study|Withdrawal by Subject|0|||
161733689|NCT03225716|584067671|FG000|Overall Study|Lack of Efficacy|1|||
161733690|NCT03225716|584067672|FG001|Overall Study|Lack of Efficacy|0|||
161733691|NCT03225716|584067673|FG002|Overall Study|Lack of Efficacy|0|||
161733692|NCT03225716|584067671|FG000|Overall Study|Adverse Event|2|||
161733693|NCT03225716|584067672|FG001|Overall Study|Adverse Event|0|||
161733694|NCT03225716|584067673|FG002|Overall Study|Adverse Event|1|||
161733695|NCT03225716|584067671|FG000|Overall Study|Study early termination by Sponsor|0|||
161733696|NCT03225716|584067672|FG001|Overall Study|Study early termination by Sponsor|0|||
161733697|NCT03225716|584067673|FG002|Overall Study|Study early termination by Sponsor|2|||
161733698|NCT00848250|584067674|FG000|Overall Study|surgery was completed without cardiopulm|0|||
161733699|NCT00848250|584067675|FG001|Overall Study|surgery was completed without cardiopulm|1|||
161733700|NCT02883049|584067683|FG000|Induction|Adverse Event|52|||
161733701|NCT02883049|584067684|FG001|Induction|Adverse Event|2|||
161733702|NCT02883049|584067685|FG002|Induction|Adverse Event|0|||
161733703|NCT02883049|584067686|FG003|Induction|Adverse Event|0|||
161733704|NCT02883049|584067687|FG004|Induction|Adverse Event|0|||
161733705|NCT02883049|584067688|FG005|Induction|Adverse Event|0|||
161733706|NCT02883049|584067689|FG006|Induction|Adverse Event|0|||
161733707|NCT02883049|584067690|FG007|Induction|Adverse Event|0|||
161733708|NCT02883049|584067691|FG008|Induction|Adverse Event|0|||
161733709|NCT02883049|584067692|FG009|Induction|Adverse Event|0|||
161733710|NCT02883049|584067693|FG010|Induction|Adverse Event|0|||
161733711|NCT02883049|584067694|FG011|Induction|Adverse Event|0|||
161733712|NCT02883049|584067695|FG012|Induction|Adverse Event|0|||
161733713|NCT02883049|584067696|FG013|Induction|Adverse Event|0|||
161733714|NCT02883049|584067697|FG014|Induction|Adverse Event|0|||
161733715|NCT02883049|584067698|FG015|Induction|Adverse Event|0|||
161733716|NCT02883049|584067683|FG000|Induction|Death|76|||
161733717|NCT02883049|584067684|FG001|Induction|Death|8|||
161733718|NCT02883049|584067685|FG002|Induction|Death|0|||
161733719|NCT02883049|584067686|FG003|Induction|Death|0|||
161733720|NCT02883049|584067687|FG004|Induction|Death|0|||
161733721|NCT02883049|584067688|FG005|Induction|Death|0|||
161733722|NCT02883049|584067689|FG006|Induction|Death|0|||
161733723|NCT02883049|584067690|FG007|Induction|Death|0|||
161733724|NCT02883049|584067691|FG008|Induction|Death|0|||
161733725|NCT02883049|584067692|FG009|Induction|Death|0|||
161733726|NCT02883049|584067693|FG010|Induction|Death|0|||
161733727|NCT02883049|584067694|FG011|Induction|Death|0|||
161733728|NCT02883049|584067695|FG012|Induction|Death|0|||
161733729|NCT02883049|584067696|FG013|Induction|Death|0|||
161733730|NCT02883049|584067697|FG014|Induction|Death|0|||
161733731|NCT02883049|584067698|FG015|Induction|Death|0|||
161733732|NCT02883049|584067683|FG000|Induction|Lost to Follow-up|2|||
161733733|NCT02883049|584067684|FG001|Induction|Lost to Follow-up|0|||
161733734|NCT02883049|584067685|FG002|Induction|Lost to Follow-up|0|||
161733735|NCT02883049|584067686|FG003|Induction|Lost to Follow-up|0|||
161733736|NCT02883049|584067687|FG004|Induction|Lost to Follow-up|0|||
161733737|NCT02883049|584067688|FG005|Induction|Lost to Follow-up|0|||
161733738|NCT02883049|584067689|FG006|Induction|Lost to Follow-up|0|||
161733739|NCT02883049|584067690|FG007|Induction|Lost to Follow-up|0|||
161733740|NCT02883049|584067691|FG008|Induction|Lost to Follow-up|0|||
161733741|NCT02883049|584067692|FG009|Induction|Lost to Follow-up|0|||
161733742|NCT02883049|584067693|FG010|Induction|Lost to Follow-up|0|||
161733743|NCT02883049|584067694|FG011|Induction|Lost to Follow-up|0|||
161733744|NCT02883049|584067695|FG012|Induction|Lost to Follow-up|0|||
161733745|NCT02883049|584067696|FG013|Induction|Lost to Follow-up|0|||
161733746|NCT02883049|584067697|FG014|Induction|Lost to Follow-up|0|||
161733747|NCT02883049|584067698|FG015|Induction|Lost to Follow-up|0|||
161733748|NCT02883049|584067683|FG000|Induction|Physician Decision|1407|||
161733749|NCT02883049|584067684|FG001|Induction|Physician Decision|8|||
161733750|NCT02883049|584067685|FG002|Induction|Physician Decision|0|||
161733751|NCT02883049|584067686|FG003|Induction|Physician Decision|0|||
161733752|NCT02883049|584067687|FG004|Induction|Physician Decision|0|||
161733753|NCT02883049|584067688|FG005|Induction|Physician Decision|0|||
161733754|NCT02883049|584067689|FG006|Induction|Physician Decision|0|||
161733755|NCT02883049|584067690|FG007|Induction|Physician Decision|0|||
161733756|NCT02883049|584067691|FG008|Induction|Physician Decision|0|||
161733757|NCT02883049|584067692|FG009|Induction|Physician Decision|0|||
161733758|NCT02883049|584067693|FG010|Induction|Physician Decision|0|||
161733759|NCT02883049|584067694|FG011|Induction|Physician Decision|0|||
161733760|NCT02883049|584067695|FG012|Induction|Physician Decision|0|||
161733761|NCT02883049|584067696|FG013|Induction|Physician Decision|0|||
161733762|NCT02883049|584067697|FG014|Induction|Physician Decision|0|||
161733763|NCT02883049|584067698|FG015|Induction|Physician Decision|0|||
161733764|NCT02883049|584067683|FG000|Induction|Protocol Violation|6|||
161733765|NCT02883049|584067684|FG001|Induction|Protocol Violation|0|||
161733766|NCT02883049|584067685|FG002|Induction|Protocol Violation|0|||
161733767|NCT02883049|584067686|FG003|Induction|Protocol Violation|0|||
161733768|NCT02883049|584067687|FG004|Induction|Protocol Violation|0|||
161733769|NCT02883049|584067688|FG005|Induction|Protocol Violation|0|||
161733770|NCT02883049|584067689|FG006|Induction|Protocol Violation|0|||
161733771|NCT02883049|584067690|FG007|Induction|Protocol Violation|0|||
161733772|NCT02883049|584067691|FG008|Induction|Protocol Violation|0|||
161733773|NCT02883049|584067692|FG009|Induction|Protocol Violation|0|||
161733774|NCT02883049|584067693|FG010|Induction|Protocol Violation|0|||
161733775|NCT02883049|584067694|FG011|Induction|Protocol Violation|0|||
161733776|NCT02883049|584067695|FG012|Induction|Protocol Violation|0|||
161733777|NCT02883049|584067696|FG013|Induction|Protocol Violation|0|||
161733778|NCT02883049|584067697|FG014|Induction|Protocol Violation|0|||
161733779|NCT02883049|584067698|FG015|Induction|Protocol Violation|0|||
161733780|NCT02883049|584067683|FG000|Induction|Withdrawal by Subject|6|||
161733781|NCT02883049|584067684|FG001|Induction|Withdrawal by Subject|0|||
161733782|NCT02883049|584067685|FG002|Induction|Withdrawal by Subject|0|||
161733783|NCT02883049|584067686|FG003|Induction|Withdrawal by Subject|0|||
161733784|NCT02883049|584067687|FG004|Induction|Withdrawal by Subject|0|||
161733785|NCT02883049|584067688|FG005|Induction|Withdrawal by Subject|0|||
161733786|NCT02883049|584067689|FG006|Induction|Withdrawal by Subject|0|||
161733787|NCT02883049|584067690|FG007|Induction|Withdrawal by Subject|0|||
161733788|NCT02883049|584067691|FG008|Induction|Withdrawal by Subject|0|||
161733789|NCT02883049|584067692|FG009|Induction|Withdrawal by Subject|0|||
161733790|NCT02883049|584067693|FG010|Induction|Withdrawal by Subject|0|||
161733791|NCT02883049|584067694|FG011|Induction|Withdrawal by Subject|0|||
161733792|NCT02883049|584067695|FG012|Induction|Withdrawal by Subject|0|||
161733793|NCT02883049|584067696|FG013|Induction|Withdrawal by Subject|0|||
161733794|NCT02883049|584067697|FG014|Induction|Withdrawal by Subject|0|||
161733795|NCT02883049|584067698|FG015|Induction|Withdrawal by Subject|0|||
161733796|NCT02883049|584067683|FG000|Induction|Ineligible|35|||
161733797|NCT02883049|584067684|FG001|Induction|Ineligible|1|||
161733798|NCT02883049|584067685|FG002|Induction|Ineligible|0|||
161733799|NCT02883049|584067686|FG003|Induction|Ineligible|0|||
161733800|NCT02883049|584067687|FG004|Induction|Ineligible|0|||
161733801|NCT02883049|584067688|FG005|Induction|Ineligible|0|||
161733802|NCT02883049|584067689|FG006|Induction|Ineligible|0|||
161733803|NCT02883049|584067690|FG007|Induction|Ineligible|0|||
161733804|NCT02883049|584067691|FG008|Induction|Ineligible|0|||
161733805|NCT02883049|584067692|FG009|Induction|Ineligible|0|||
161733806|NCT02883049|584067693|FG010|Induction|Ineligible|0|||
161733807|NCT02883049|584067694|FG011|Induction|Ineligible|0|||
161733808|NCT02883049|584067695|FG012|Induction|Ineligible|0|||
161733809|NCT02883049|584067696|FG013|Induction|Ineligible|0|||
161733810|NCT02883049|584067697|FG014|Induction|Ineligible|0|||
161733811|NCT02883049|584067698|FG015|Induction|Ineligible|0|||
161733812|NCT02883049|584067683|FG000|Induction|Refusal of further protocol therapy|466|||
161733813|NCT02883049|584067684|FG001|Induction|Refusal of further protocol therapy|2|||
161733814|NCT02883049|584067685|FG002|Induction|Refusal of further protocol therapy|0|||
161733815|NCT02883049|584067686|FG003|Induction|Refusal of further protocol therapy|0|||
161733816|NCT02883049|584067687|FG004|Induction|Refusal of further protocol therapy|0|||
161733817|NCT02883049|584067688|FG005|Induction|Refusal of further protocol therapy|0|||
161733818|NCT02883049|584067689|FG006|Induction|Refusal of further protocol therapy|0|||
161733819|NCT02883049|584067690|FG007|Induction|Refusal of further protocol therapy|0|||
161733820|NCT02883049|584067691|FG008|Induction|Refusal of further protocol therapy|0|||
161733821|NCT02883049|584067692|FG009|Induction|Refusal of further protocol therapy|0|||
161733822|NCT02883049|584067693|FG010|Induction|Refusal of further protocol therapy|0|||
161733823|NCT02883049|584067694|FG011|Induction|Refusal of further protocol therapy|0|||
161733824|NCT02883049|584067695|FG012|Induction|Refusal of further protocol therapy|0|||
161733825|NCT02883049|584067696|FG013|Induction|Refusal of further protocol therapy|0|||
161733826|NCT02883049|584067697|FG014|Induction|Refusal of further protocol therapy|0|||
161733827|NCT02883049|584067698|FG015|Induction|Refusal of further protocol therapy|0|||
161839630|NCT01183221|584458539|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
161733828|NCT02883049|584067683|FG000|Induction|Identified as Ph+ patients|279|||
161733829|NCT02883049|584067684|FG001|Induction|Identified as Ph+ patients|1|||
161733830|NCT02883049|584067685|FG002|Induction|Identified as Ph+ patients|0|||
161733831|NCT02883049|584067686|FG003|Induction|Identified as Ph+ patients|0|||
161733832|NCT02883049|584067687|FG004|Induction|Identified as Ph+ patients|0|||
161733833|NCT02883049|584067688|FG005|Induction|Identified as Ph+ patients|0|||
161733834|NCT02883049|584067689|FG006|Induction|Identified as Ph+ patients|0|||
161733835|NCT02883049|584067690|FG007|Induction|Identified as Ph+ patients|0|||
161733836|NCT02883049|584067691|FG008|Induction|Identified as Ph+ patients|0|||
161733837|NCT02883049|584067692|FG009|Induction|Identified as Ph+ patients|0|||
161733838|NCT02883049|584067693|FG010|Induction|Identified as Ph+ patients|0|||
161733839|NCT02883049|584067694|FG011|Induction|Identified as Ph+ patients|0|||
161733840|NCT02883049|584067695|FG012|Induction|Identified as Ph+ patients|0|||
161733841|NCT02883049|584067696|FG013|Induction|Identified as Ph+ patients|0|||
161733842|NCT02883049|584067697|FG014|Induction|Identified as Ph+ patients|0|||
161733843|NCT02883049|584067698|FG015|Induction|Identified as Ph+ patients|0|||
161733844|NCT02883049|584067683|FG000|Induction|M3 Marrow at Day29|8|||
161733845|NCT02883049|584067684|FG001|Induction|M3 Marrow at Day29|1|||
161733846|NCT02883049|584067685|FG002|Induction|M3 Marrow at Day29|0|||
161733847|NCT02883049|584067686|FG003|Induction|M3 Marrow at Day29|0|||
161733848|NCT02883049|584067687|FG004|Induction|M3 Marrow at Day29|0|||
161733849|NCT02883049|584067688|FG005|Induction|M3 Marrow at Day29|0|||
161733850|NCT02883049|584067689|FG006|Induction|M3 Marrow at Day29|0|||
161733851|NCT02883049|584067690|FG007|Induction|M3 Marrow at Day29|0|||
161733852|NCT02883049|584067691|FG008|Induction|M3 Marrow at Day29|0|||
161733853|NCT02883049|584067692|FG009|Induction|M3 Marrow at Day29|0|||
161733854|NCT02883049|584067693|FG010|Induction|M3 Marrow at Day29|0|||
161733855|NCT02883049|584067694|FG011|Induction|M3 Marrow at Day29|0|||
161733856|NCT02883049|584067695|FG012|Induction|M3 Marrow at Day29|0|||
161733857|NCT02883049|584067696|FG013|Induction|M3 Marrow at Day29|0|||
161733858|NCT02883049|584067697|FG014|Induction|M3 Marrow at Day29|0|||
161733859|NCT02883049|584067698|FG015|Induction|M3 Marrow at Day29|0|||
161733860|NCT02883049|584067683|FG000|Induction|Inevaluable|33|||
161733861|NCT02883049|584067684|FG001|Induction|Inevaluable|1|||
161733862|NCT02883049|584067685|FG002|Induction|Inevaluable|0|||
161733863|NCT02883049|584067686|FG003|Induction|Inevaluable|0|||
161733864|NCT02883049|584067687|FG004|Induction|Inevaluable|0|||
161733865|NCT02883049|584067688|FG005|Induction|Inevaluable|0|||
161733866|NCT02883049|584067689|FG006|Induction|Inevaluable|0|||
161733867|NCT02883049|584067690|FG007|Induction|Inevaluable|0|||
161733868|NCT02883049|584067691|FG008|Induction|Inevaluable|0|||
161733869|NCT02883049|584067692|FG009|Induction|Inevaluable|0|||
161733870|NCT02883049|584067693|FG010|Induction|Inevaluable|0|||
161733871|NCT02883049|584067694|FG011|Induction|Inevaluable|0|||
161733872|NCT02883049|584067695|FG012|Induction|Inevaluable|0|||
161733873|NCT02883049|584067696|FG013|Induction|Inevaluable|0|||
161733874|NCT02883049|584067697|FG014|Induction|Inevaluable|0|||
161733875|NCT02883049|584067698|FG015|Induction|Inevaluable|0|||
161733876|NCT02883049|584067683|FG000|Induction|Identified as VHR at end of Induction|244|||
161733877|NCT02883049|584067684|FG001|Induction|Identified as VHR at end of Induction|0|||
161733878|NCT02883049|584067685|FG002|Induction|Identified as VHR at end of Induction|0|||
161733879|NCT02883049|584067686|FG003|Induction|Identified as VHR at end of Induction|0|||
161733880|NCT02883049|584067687|FG004|Induction|Identified as VHR at end of Induction|0|||
161733881|NCT02883049|584067688|FG005|Induction|Identified as VHR at end of Induction|0|||
161733882|NCT02883049|584067689|FG006|Induction|Identified as VHR at end of Induction|0|||
161733883|NCT02883049|584067690|FG007|Induction|Identified as VHR at end of Induction|0|||
161733884|NCT02883049|584067691|FG008|Induction|Identified as VHR at end of Induction|0|||
161733885|NCT02883049|584067692|FG009|Induction|Identified as VHR at end of Induction|0|||
161733886|NCT02883049|584067693|FG010|Induction|Identified as VHR at end of Induction|0|||
161733887|NCT02883049|584067694|FG011|Induction|Identified as VHR at end of Induction|0|||
161733888|NCT02883049|584067695|FG012|Induction|Identified as VHR at end of Induction|0|||
161733889|NCT02883049|584067696|FG013|Induction|Identified as VHR at end of Induction|0|||
161733890|NCT02883049|584067697|FG014|Induction|Identified as VHR at end of Induction|0|||
161733891|NCT02883049|584067698|FG015|Induction|Identified as VHR at end of Induction|0|||
161733892|NCT02883049|584067683|FG000|Induction|Moved to another non-COG institution|3|||
161733893|NCT02883049|584067684|FG001|Induction|Moved to another non-COG institution|0|||
161733894|NCT02883049|584067685|FG002|Induction|Moved to another non-COG institution|0|||
161733895|NCT02883049|584067686|FG003|Induction|Moved to another non-COG institution|0|||
161733896|NCT02883049|584067687|FG004|Induction|Moved to another non-COG institution|0|||
161733897|NCT02883049|584067688|FG005|Induction|Moved to another non-COG institution|0|||
161733898|NCT02883049|584067689|FG006|Induction|Moved to another non-COG institution|0|||
161733899|NCT02883049|584067690|FG007|Induction|Moved to another non-COG institution|0|||
161733900|NCT02883049|584067691|FG008|Induction|Moved to another non-COG institution|0|||
161733901|NCT02883049|584067692|FG009|Induction|Moved to another non-COG institution|0|||
161733902|NCT02883049|584067693|FG010|Induction|Moved to another non-COG institution|0|||
161733903|NCT02883049|584067694|FG011|Induction|Moved to another non-COG institution|0|||
161733904|NCT02883049|584067695|FG012|Induction|Moved to another non-COG institution|0|||
161733905|NCT02883049|584067696|FG013|Induction|Moved to another non-COG institution|0|||
161733906|NCT02883049|584067697|FG014|Induction|Moved to another non-COG institution|0|||
161965840|NCT01463696|584921860|FG002|Overall Study|Withdrawal by Subject|0|||
161733907|NCT02883049|584067698|FG015|Induction|Moved to another non-COG institution|0|||
161733908|NCT02883049|584067683|FG000|Induction|Randomization closed|41|||
161733909|NCT02883049|584067684|FG001|Induction|Randomization closed|0|||
161733910|NCT02883049|584067685|FG002|Induction|Randomization closed|0|||
161733911|NCT02883049|584067686|FG003|Induction|Randomization closed|0|||
161733912|NCT02883049|584067687|FG004|Induction|Randomization closed|0|||
161733913|NCT02883049|584067688|FG005|Induction|Randomization closed|0|||
161733914|NCT02883049|584067689|FG006|Induction|Randomization closed|0|||
161733915|NCT02883049|584067690|FG007|Induction|Randomization closed|0|||
161733916|NCT02883049|584067691|FG008|Induction|Randomization closed|0|||
161733917|NCT02883049|584067692|FG009|Induction|Randomization closed|0|||
161733918|NCT02883049|584067693|FG010|Induction|Randomization closed|0|||
161733919|NCT02883049|584067694|FG011|Induction|Randomization closed|0|||
161733920|NCT02883049|584067695|FG012|Induction|Randomization closed|0|||
161733921|NCT02883049|584067696|FG013|Induction|Randomization closed|0|||
161733922|NCT02883049|584067697|FG014|Induction|Randomization closed|0|||
161733923|NCT02883049|584067698|FG015|Induction|Randomization closed|0|||
161733924|NCT02883049|584067683|FG000|Induction|MRD negative|36|||
161733925|NCT02883049|584067684|FG001|Induction|MRD negative|0|||
161733926|NCT02883049|584067685|FG002|Induction|MRD negative|0|||
161733927|NCT02883049|584067686|FG003|Induction|MRD negative|0|||
161733928|NCT02883049|584067687|FG004|Induction|MRD negative|0|||
161733929|NCT02883049|584067688|FG005|Induction|MRD negative|0|||
161733930|NCT02883049|584067689|FG006|Induction|MRD negative|0|||
161733931|NCT02883049|584067690|FG007|Induction|MRD negative|0|||
161733932|NCT02883049|584067691|FG008|Induction|MRD negative|0|||
161733933|NCT02883049|584067692|FG009|Induction|MRD negative|0|||
161733934|NCT02883049|584067693|FG010|Induction|MRD negative|0|||
161733935|NCT02883049|584067694|FG011|Induction|MRD negative|0|||
161733936|NCT02883049|584067695|FG012|Induction|MRD negative|0|||
161733937|NCT02883049|584067696|FG013|Induction|MRD negative|0|||
161733938|NCT02883049|584067697|FG014|Induction|MRD negative|0|||
161733939|NCT02883049|584067698|FG015|Induction|MRD negative|0|||
161733940|NCT02883049|584067683|FG000|Induction|Identified as HR patients|165|||
161733941|NCT02883049|584067684|FG001|Induction|Identified as HR patients|0|||
161733942|NCT02883049|584067685|FG002|Induction|Identified as HR patients|0|||
161733943|NCT02883049|584067686|FG003|Induction|Identified as HR patients|0|||
161733944|NCT02883049|584067687|FG004|Induction|Identified as HR patients|0|||
161733945|NCT02883049|584067688|FG005|Induction|Identified as HR patients|0|||
161733946|NCT02883049|584067689|FG006|Induction|Identified as HR patients|0|||
161733947|NCT02883049|584067690|FG007|Induction|Identified as HR patients|0|||
161733948|NCT02883049|584067691|FG008|Induction|Identified as HR patients|0|||
161733949|NCT02883049|584067692|FG009|Induction|Identified as HR patients|0|||
161733950|NCT02883049|584067693|FG010|Induction|Identified as HR patients|0|||
161733951|NCT02883049|584067694|FG011|Induction|Identified as HR patients|0|||
161733952|NCT02883049|584067695|FG012|Induction|Identified as HR patients|0|||
161965841|NCT01463696|584921861|FG003|Overall Study|Withdrawal by Subject|1|||
161965842|NCT01463696|584921862|FG004|Overall Study|Withdrawal by Subject|1|||
161965843|NCT01463696|584921863|FG005|Overall Study|Withdrawal by Subject|1|||
161965844|NCT01463696|584921864|FG006|Overall Study|Withdrawal by Subject|2|||
161965845|NCT01463696|584921865|FG007|Overall Study|Withdrawal by Subject|0|||
161965846|NCT01463696|584921858|FG000|Overall Study|Not Treated|0|||
161965847|NCT01463696|584921859|FG001|Overall Study|Not Treated|0|||
161965848|NCT01463696|584921860|FG002|Overall Study|Not Treated|0|||
162032315|NCT01986933|585175476|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
161733953|NCT02883049|584067696|FG013|Induction|Identified as HR patients|0|||
161733954|NCT02883049|584067697|FG014|Induction|Identified as HR patients|0|||
161733955|NCT02883049|584067698|FG015|Induction|Identified as HR patients|0|||
161733956|NCT02883049|584067683|FG000|Induction|Developed SMN|0|||
161733957|NCT02883049|584067684|FG001|Induction|Developed SMN|1|||
161733958|NCT02883049|584067685|FG002|Induction|Developed SMN|0|||
161733959|NCT02883049|584067686|FG003|Induction|Developed SMN|0|||
161733960|NCT02883049|584067687|FG004|Induction|Developed SMN|0|||
161733961|NCT02883049|584067688|FG005|Induction|Developed SMN|0|||
161733962|NCT02883049|584067689|FG006|Induction|Developed SMN|0|||
161839631|NCT03596151|584458544|FG000|Overall Study|Withdrawal by Subject|1|||
161965849|NCT01463696|584921861|FG003|Overall Study|Not Treated|0|||
161733963|NCT02883049|584067690|FG007|Induction|Developed SMN|0|||
161733964|NCT02883049|584067691|FG008|Induction|Developed SMN|0|||
161733965|NCT02883049|584067692|FG009|Induction|Developed SMN|0|||
161839632|NCT00807248|584458546|FG000|Overall Study|Adverse Event|1|||
161839633|NCT00807248|584458547|FG001|Overall Study|Adverse Event|2|||
161839634|NCT00807248|584458548|FG002|Overall Study|Adverse Event|2|||
161839635|NCT00807248|584458549|FG003|Overall Study|Adverse Event|6|||
161839636|NCT00807248|584458546|FG000|Overall Study|Lack of Efficacy|14|||
161839637|NCT00807248|584458547|FG001|Overall Study|Lack of Efficacy|4|||
161839638|NCT00807248|584458548|FG002|Overall Study|Lack of Efficacy|8|||
161839639|NCT00807248|584458549|FG003|Overall Study|Lack of Efficacy|3|||
161839640|NCT00807248|584458546|FG000|Overall Study|Protocol Violation|0|||
161839641|NCT00807248|584458547|FG001|Overall Study|Protocol Violation|1|||
161839642|NCT00807248|584458548|FG002|Overall Study|Protocol Violation|1|||
161733966|NCT02883049|584067693|FG010|Induction|Developed SMN|0|||
161733967|NCT02883049|584067694|FG011|Induction|Developed SMN|0|||
161733968|NCT02883049|584067695|FG012|Induction|Developed SMN|0|||
161733969|NCT02883049|584067696|FG013|Induction|Developed SMN|0|||
161733970|NCT02883049|584067697|FG014|Induction|Developed SMN|0|||
161733971|NCT02883049|584067698|FG015|Induction|Developed SMN|0|||
161733972|NCT02883049|584067683|FG000|Induction|Enrolled onto another COG study|72|||
161733973|NCT02883049|584067684|FG001|Induction|Enrolled onto another COG study|0|||
161733974|NCT02883049|584067685|FG002|Induction|Enrolled onto another COG study|0|||
161733975|NCT02883049|584067686|FG003|Induction|Enrolled onto another COG study|0|||
161733976|NCT02883049|584067687|FG004|Induction|Enrolled onto another COG study|0|||
161733977|NCT02883049|584067688|FG005|Induction|Enrolled onto another COG study|0|||
161733978|NCT02883049|584067689|FG006|Induction|Enrolled onto another COG study|0|||
161733979|NCT02883049|584067690|FG007|Induction|Enrolled onto another COG study|0|||
161733980|NCT02883049|584067691|FG008|Induction|Enrolled onto another COG study|0|||
161733981|NCT02883049|584067692|FG009|Induction|Enrolled onto another COG study|0|||
161733982|NCT02883049|584067693|FG010|Induction|Enrolled onto another COG study|0|||
161733983|NCT02883049|584067694|FG011|Induction|Enrolled onto another COG study|0|||
161733984|NCT02883049|584067695|FG012|Induction|Enrolled onto another COG study|0|||
161733985|NCT02883049|584067696|FG013|Induction|Enrolled onto another COG study|0|||
161733986|NCT02883049|584067697|FG014|Induction|Enrolled onto another COG study|0|||
161733987|NCT02883049|584067698|FG015|Induction|Enrolled onto another COG study|0|||
161733988|NCT02883049|584067683|FG000|Induction|Incomplete induction data|17|||
161733989|NCT02883049|584067684|FG001|Induction|Incomplete induction data|0|||
161733990|NCT02883049|584067685|FG002|Induction|Incomplete induction data|0|||
161733991|NCT02883049|584067686|FG003|Induction|Incomplete induction data|0|||
161733992|NCT02883049|584067687|FG004|Induction|Incomplete induction data|0|||
161733993|NCT02883049|584067688|FG005|Induction|Incomplete induction data|0|||
161733994|NCT02883049|584067689|FG006|Induction|Incomplete induction data|0|||
161733995|NCT02883049|584067690|FG007|Induction|Incomplete induction data|0|||
161733996|NCT02883049|584067691|FG008|Induction|Incomplete induction data|0|||
161733997|NCT02883049|584067692|FG009|Induction|Incomplete induction data|0|||
161733998|NCT02883049|584067693|FG010|Induction|Incomplete induction data|0|||
161733999|NCT02883049|584067694|FG011|Induction|Incomplete induction data|0|||
161734000|NCT02883049|584067695|FG012|Induction|Incomplete induction data|0|||
161734001|NCT02883049|584067696|FG013|Induction|Incomplete induction data|0|||
161734002|NCT02883049|584067697|FG014|Induction|Incomplete induction data|0|||
161734003|NCT02883049|584067698|FG015|Induction|Incomplete induction data|0|||
161734004|NCT02883049|584067683|FG000|Post Induction|Adverse Event|0|||
161734005|NCT02883049|584067684|FG001|Post Induction|Adverse Event|0|||
161734006|NCT02883049|584067685|FG002|Post Induction|Adverse Event|0|||
161734007|NCT02883049|584067686|FG003|Post Induction|Adverse Event|7|||
161734008|NCT02883049|584067687|FG004|Post Induction|Adverse Event|8|||
161734009|NCT02883049|584067688|FG005|Post Induction|Adverse Event|3|||
161734010|NCT02883049|584067689|FG006|Post Induction|Adverse Event|4|||
161734011|NCT02883049|584067690|FG007|Post Induction|Adverse Event|5|||
161734012|NCT02883049|584067691|FG008|Post Induction|Adverse Event|6|||
161734013|NCT02883049|584067692|FG009|Post Induction|Adverse Event|7|||
161734014|NCT02883049|584067693|FG010|Post Induction|Adverse Event|2|||
161734015|NCT02883049|584067694|FG011|Post Induction|Adverse Event|2|||
161734016|NCT02883049|584067695|FG012|Post Induction|Adverse Event|0|||
161734017|NCT02883049|584067696|FG013|Post Induction|Adverse Event|0|||
161734018|NCT02883049|584067697|FG014|Post Induction|Adverse Event|5|||
161734019|NCT02883049|584067698|FG015|Post Induction|Adverse Event|2|||
161839643|NCT00807248|584458549|FG003|Overall Study|Protocol Violation|0|||
161839644|NCT00807248|584458546|FG000|Overall Study|Withdrawal of Consent|5|||
161839645|NCT00807248|584458547|FG001|Overall Study|Withdrawal of Consent|5|||
161734020|NCT02883049|584067683|FG000|Post Induction|Death|0|||
161839646|NCT00807248|584458548|FG002|Overall Study|Withdrawal of Consent|5|||
161839647|NCT00807248|584458549|FG003|Overall Study|Withdrawal of Consent|5|||
161839648|NCT00807248|584458546|FG000|Overall Study|Lost to Follow-up|1|||
161839649|NCT00807248|584458547|FG001|Overall Study|Lost to Follow-up|0|||
161839650|NCT00807248|584458548|FG002|Overall Study|Lost to Follow-up|0|||
161965850|NCT01463696|584921862|FG004|Overall Study|Not Treated|0|||
161965851|NCT01463696|584921863|FG005|Overall Study|Not Treated|0|||
161965852|NCT01463696|584921864|FG006|Overall Study|Not Treated|1|||
161965853|NCT01463696|584921865|FG007|Overall Study|Not Treated|0|||
161965854|NCT03883165|584921867|FG000|Overall Study|Withdrawal by Subject|4|||
161965855|NCT03883165|584921868|FG001|Overall Study|Withdrawal by Subject|3|||
161734021|NCT02883049|584067684|FG001|Post Induction|Death|0|||
161734022|NCT02883049|584067685|FG002|Post Induction|Death|0|||
161734023|NCT02883049|584067686|FG003|Post Induction|Death|9|||
161734024|NCT02883049|584067687|FG004|Post Induction|Death|9|||
161734025|NCT02883049|584067688|FG005|Post Induction|Death|0|||
161734026|NCT02883049|584067689|FG006|Post Induction|Death|1|||
161734027|NCT02883049|584067690|FG007|Post Induction|Death|6|||
161734028|NCT02883049|584067691|FG008|Post Induction|Death|5|||
161734029|NCT02883049|584067692|FG009|Post Induction|Death|3|||
161839651|NCT00807248|584458549|FG003|Overall Study|Lost to Follow-up|0|||
161965856|NCT00967694|584921869|FG000|Overall Study|Withdrawal by Subject|6|||
161734030|NCT02883049|584067693|FG010|Post Induction|Death|1|||
161734031|NCT02883049|584067694|FG011|Post Induction|Death|0|||
161734032|NCT02883049|584067695|FG012|Post Induction|Death|1|||
161734033|NCT02883049|584067696|FG013|Post Induction|Death|1|||
161734034|NCT02883049|584067697|FG014|Post Induction|Death|10|||
161734035|NCT02883049|584067698|FG015|Post Induction|Death|2|||
161734036|NCT02883049|584067683|FG000|Post Induction|Lost to Follow-up|0|||
161734037|NCT02883049|584067684|FG001|Post Induction|Lost to Follow-up|0|||
161734038|NCT02883049|584067685|FG002|Post Induction|Lost to Follow-up|0|||
161734039|NCT02883049|584067686|FG003|Post Induction|Lost to Follow-up|0|||
161734040|NCT02883049|584067687|FG004|Post Induction|Lost to Follow-up|1|||
161734041|NCT02883049|584067688|FG005|Post Induction|Lost to Follow-up|1|||
161734042|NCT02883049|584067689|FG006|Post Induction|Lost to Follow-up|0|||
161734043|NCT02883049|584067690|FG007|Post Induction|Lost to Follow-up|0|||
161734044|NCT02883049|584067691|FG008|Post Induction|Lost to Follow-up|3|||
161734045|NCT02883049|584067692|FG009|Post Induction|Lost to Follow-up|0|||
161734046|NCT02883049|584067693|FG010|Post Induction|Lost to Follow-up|1|||
161734047|NCT02883049|584067694|FG011|Post Induction|Lost to Follow-up|0|||
161734048|NCT02883049|584067695|FG012|Post Induction|Lost to Follow-up|0|||
161734049|NCT02883049|584067696|FG013|Post Induction|Lost to Follow-up|0|||
161734050|NCT02883049|584067697|FG014|Post Induction|Lost to Follow-up|0|||
161734051|NCT02883049|584067698|FG015|Post Induction|Lost to Follow-up|0|||
161734052|NCT02883049|584067683|FG000|Post Induction|Physician Decision|0|||
161734053|NCT02883049|584067684|FG001|Post Induction|Physician Decision|0|||
161734054|NCT02883049|584067685|FG002|Post Induction|Physician Decision|0|||
161734055|NCT02883049|584067686|FG003|Post Induction|Physician Decision|27|||
161734056|NCT02883049|584067687|FG004|Post Induction|Physician Decision|27|||
161734057|NCT02883049|584067688|FG005|Post Induction|Physician Decision|23|||
161734058|NCT02883049|584067689|FG006|Post Induction|Physician Decision|30|||
161734059|NCT02883049|584067690|FG007|Post Induction|Physician Decision|56|||
161734060|NCT02883049|584067691|FG008|Post Induction|Physician Decision|85|||
161734061|NCT02883049|584067692|FG009|Post Induction|Physician Decision|12|||
161734062|NCT02883049|584067693|FG010|Post Induction|Physician Decision|5|||
161734063|NCT02883049|584067694|FG011|Post Induction|Physician Decision|14|||
161734064|NCT02883049|584067695|FG012|Post Induction|Physician Decision|1|||
161734065|NCT02883049|584067696|FG013|Post Induction|Physician Decision|11|||
161734066|NCT02883049|584067697|FG014|Post Induction|Physician Decision|19|||
161734067|NCT02883049|584067698|FG015|Post Induction|Physician Decision|5|||
161734068|NCT02883049|584067683|FG000|Post Induction|Protocol Violation|0|||
161734069|NCT02883049|584067684|FG001|Post Induction|Protocol Violation|0|||
161734070|NCT02883049|584067685|FG002|Post Induction|Protocol Violation|0|||
161734071|NCT02883049|584067686|FG003|Post Induction|Protocol Violation|0|||
161734072|NCT02883049|584067687|FG004|Post Induction|Protocol Violation|0|||
161734073|NCT02883049|584067688|FG005|Post Induction|Protocol Violation|0|||
161734074|NCT02883049|584067689|FG006|Post Induction|Protocol Violation|0|||
161734075|NCT02883049|584067690|FG007|Post Induction|Protocol Violation|1|||
161734076|NCT02883049|584067691|FG008|Post Induction|Protocol Violation|0|||
161734077|NCT02883049|584067692|FG009|Post Induction|Protocol Violation|0|||
161734078|NCT02883049|584067693|FG010|Post Induction|Protocol Violation|0|||
161734079|NCT02883049|584067694|FG011|Post Induction|Protocol Violation|0|||
161734080|NCT02883049|584067695|FG012|Post Induction|Protocol Violation|0|||
161734081|NCT02883049|584067696|FG013|Post Induction|Protocol Violation|0|||
161734082|NCT02883049|584067697|FG014|Post Induction|Protocol Violation|0|||
161734083|NCT02883049|584067698|FG015|Post Induction|Protocol Violation|0|||
161734084|NCT02883049|584067683|FG000|Post Induction|Withdrawal by Subject|0|||
161734085|NCT02883049|584067684|FG001|Post Induction|Withdrawal by Subject|0|||
161734086|NCT02883049|584067685|FG002|Post Induction|Withdrawal by Subject|0|||
161734087|NCT02883049|584067686|FG003|Post Induction|Withdrawal by Subject|5|||
161734088|NCT02883049|584067687|FG004|Post Induction|Withdrawal by Subject|2|||
161839652|NCT00807248|584458546|FG000|Overall Study|Other Reason|0|||
161839653|NCT00807248|584458547|FG001|Overall Study|Other Reason|0|||
161839654|NCT00807248|584458548|FG002|Overall Study|Other Reason|2|||
161839655|NCT00807248|584458549|FG003|Overall Study|Other Reason|0|||
161839656|NCT02444793|584458550|FG000|Overall Study|Lost to Follow-up|2|||
161839657|NCT02444793|584458551|FG001|Overall Study|Lost to Follow-up|2|||
161734089|NCT02883049|584067688|FG005|Post Induction|Withdrawal by Subject|1|||
161734090|NCT02883049|584067689|FG006|Post Induction|Withdrawal by Subject|0|||
161734091|NCT02883049|584067690|FG007|Post Induction|Withdrawal by Subject|0|||
161734092|NCT02883049|584067691|FG008|Post Induction|Withdrawal by Subject|2|||
161734093|NCT02883049|584067692|FG009|Post Induction|Withdrawal by Subject|0|||
161734094|NCT02883049|584067693|FG010|Post Induction|Withdrawal by Subject|1|||
161734095|NCT02883049|584067694|FG011|Post Induction|Withdrawal by Subject|1|||
161734096|NCT02883049|584067695|FG012|Post Induction|Withdrawal by Subject|0|||
161734097|NCT02883049|584067696|FG013|Post Induction|Withdrawal by Subject|0|||
161734098|NCT02883049|584067697|FG014|Post Induction|Withdrawal by Subject|1|||
161734099|NCT02883049|584067698|FG015|Post Induction|Withdrawal by Subject|0|||
161734100|NCT02883049|584067683|FG000|Post Induction|Ineligible|0|||
161734101|NCT02883049|584067684|FG001|Post Induction|Ineligible|0|||
161734102|NCT02883049|584067685|FG002|Post Induction|Ineligible|2|||
161734103|NCT02883049|584067686|FG003|Post Induction|Ineligible|0|||
161839658|NCT02444793|584458552|FG002|Overall Study|Lost to Follow-up|0|||
161734104|NCT02883049|584067687|FG004|Post Induction|Ineligible|0|||
161734105|NCT02883049|584067688|FG005|Post Induction|Ineligible|0|||
161734106|NCT02883049|584067689|FG006|Post Induction|Ineligible|1|||
161734107|NCT02883049|584067690|FG007|Post Induction|Ineligible|0|||
161734108|NCT02883049|584067691|FG008|Post Induction|Ineligible|0|||
161734109|NCT02883049|584067692|FG009|Post Induction|Ineligible|0|||
161734110|NCT02883049|584067693|FG010|Post Induction|Ineligible|1|||
161734111|NCT02883049|584067694|FG011|Post Induction|Ineligible|0|||
161734112|NCT02883049|584067695|FG012|Post Induction|Ineligible|0|||
161734113|NCT02883049|584067696|FG013|Post Induction|Ineligible|0|||
161734114|NCT02883049|584067697|FG014|Post Induction|Ineligible|0|||
161734115|NCT02883049|584067698|FG015|Post Induction|Ineligible|1|||
161734116|NCT02883049|584067683|FG000|Post Induction|Refusal of further protocol therapy|0|||
161734117|NCT02883049|584067684|FG001|Post Induction|Refusal of further protocol therapy|0|||
161734118|NCT02883049|584067685|FG002|Post Induction|Refusal of further protocol therapy|0|||
161734119|NCT02883049|584067686|FG003|Post Induction|Refusal of further protocol therapy|11|||
161734120|NCT02883049|584067687|FG004|Post Induction|Refusal of further protocol therapy|15|||
161734121|NCT02883049|584067688|FG005|Post Induction|Refusal of further protocol therapy|9|||
161734122|NCT02883049|584067689|FG006|Post Induction|Refusal of further protocol therapy|13|||
161734123|NCT02883049|584067690|FG007|Post Induction|Refusal of further protocol therapy|5|||
161734124|NCT02883049|584067691|FG008|Post Induction|Refusal of further protocol therapy|21|||
161734125|NCT02883049|584067692|FG009|Post Induction|Refusal of further protocol therapy|7|||
161734126|NCT02883049|584067693|FG010|Post Induction|Refusal of further protocol therapy|0|||
161734127|NCT02883049|584067694|FG011|Post Induction|Refusal of further protocol therapy|7|||
161734128|NCT02883049|584067695|FG012|Post Induction|Refusal of further protocol therapy|3|||
161734129|NCT02883049|584067696|FG013|Post Induction|Refusal of further protocol therapy|0|||
161734130|NCT02883049|584067697|FG014|Post Induction|Refusal of further protocol therapy|4|||
161734131|NCT02883049|584067698|FG015|Post Induction|Refusal of further protocol therapy|1|||
161734132|NCT02883049|584067683|FG000|Post Induction|Inevaluable|0|||
161734133|NCT02883049|584067684|FG001|Post Induction|Inevaluable|0|||
161734134|NCT02883049|584067685|FG002|Post Induction|Inevaluable|0|||
161734135|NCT02883049|584067686|FG003|Post Induction|Inevaluable|1|||
161734136|NCT02883049|584067687|FG004|Post Induction|Inevaluable|1|||
161734137|NCT02883049|584067688|FG005|Post Induction|Inevaluable|2|||
161734138|NCT02883049|584067689|FG006|Post Induction|Inevaluable|7|||
161734139|NCT02883049|584067690|FG007|Post Induction|Inevaluable|6|||
161734140|NCT02883049|584067691|FG008|Post Induction|Inevaluable|4|||
161734141|NCT02883049|584067692|FG009|Post Induction|Inevaluable|4|||
161734142|NCT02883049|584067693|FG010|Post Induction|Inevaluable|1|||
161734143|NCT02883049|584067694|FG011|Post Induction|Inevaluable|1|||
161734144|NCT02883049|584067695|FG012|Post Induction|Inevaluable|2|||
161734145|NCT02883049|584067696|FG013|Post Induction|Inevaluable|0|||
161734146|NCT02883049|584067697|FG014|Post Induction|Inevaluable|0|||
161734147|NCT02883049|584067698|FG015|Post Induction|Inevaluable|1|||
161734148|NCT02883049|584067683|FG000|Post Induction|Moved to another non-COG institution|0|||
161734149|NCT02883049|584067684|FG001|Post Induction|Moved to another non-COG institution|0|||
161734150|NCT02883049|584067685|FG002|Post Induction|Moved to another non-COG institution|0|||
161734151|NCT02883049|584067686|FG003|Post Induction|Moved to another non-COG institution|0|||
161734152|NCT02883049|584067687|FG004|Post Induction|Moved to another non-COG institution|0|||
161734153|NCT02883049|584067688|FG005|Post Induction|Moved to another non-COG institution|0|||
161734154|NCT02883049|584067689|FG006|Post Induction|Moved to another non-COG institution|0|||
161734155|NCT02883049|584067690|FG007|Post Induction|Moved to another non-COG institution|2|||
161734156|NCT02883049|584067691|FG008|Post Induction|Moved to another non-COG institution|2|||
161734157|NCT02883049|584067692|FG009|Post Induction|Moved to another non-COG institution|0|||
161734158|NCT02883049|584067693|FG010|Post Induction|Moved to another non-COG institution|0|||
161734159|NCT02883049|584067694|FG011|Post Induction|Moved to another non-COG institution|1|||
162032316|NCT01986933|585175477|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
162032317|NCT01986933|585175478|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
161734160|NCT02883049|584067695|FG012|Post Induction|Moved to another non-COG institution|0|||
161734161|NCT02883049|584067696|FG013|Post Induction|Moved to another non-COG institution|0|||
161734162|NCT02883049|584067697|FG014|Post Induction|Moved to another non-COG institution|0|||
161734163|NCT02883049|584067698|FG015|Post Induction|Moved to another non-COG institution|0|||
162032318|NCT01986933|585175474|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
162032319|NCT01986933|585175475|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
161734164|NCT02883049|584067683|FG000|Post Induction|Randomization closed|0|||
161734165|NCT02883049|584067684|FG001|Post Induction|Randomization closed|0|||
161734166|NCT02883049|584067685|FG002|Post Induction|Randomization closed|0|||
161734167|NCT02883049|584067686|FG003|Post Induction|Randomization closed|0|||
161734168|NCT02883049|584067687|FG004|Post Induction|Randomization closed|0|||
161734169|NCT02883049|584067688|FG005|Post Induction|Randomization closed|0|||
161734170|NCT02883049|584067689|FG006|Post Induction|Randomization closed|0|||
161734171|NCT02883049|584067690|FG007|Post Induction|Randomization closed|20|||
161734172|NCT02883049|584067691|FG008|Post Induction|Randomization closed|0|||
161734173|NCT02883049|584067692|FG009|Post Induction|Randomization closed|0|||
161734174|NCT02883049|584067693|FG010|Post Induction|Randomization closed|0|||
161734175|NCT02883049|584067694|FG011|Post Induction|Randomization closed|0|||
161734176|NCT02883049|584067695|FG012|Post Induction|Randomization closed|0|||
161734177|NCT02883049|584067696|FG013|Post Induction|Randomization closed|0|||
161734178|NCT02883049|584067697|FG014|Post Induction|Randomization closed|0|||
161734179|NCT02883049|584067698|FG015|Post Induction|Randomization closed|0|||
161734180|NCT02883049|584067683|FG000|Post Induction|MRD negative|0|||
161734181|NCT02883049|584067684|FG001|Post Induction|MRD negative|0|||
161965857|NCT05526781|584921871|FG000|Overall Study|Lost to Follow-up|1|||
161965858|NCT03905265|584921872|FG000|Overall Study|Withdrawal by Subject|1|||
161734182|NCT02883049|584067685|FG002|Post Induction|MRD negative|0|||
161734183|NCT02883049|584067686|FG003|Post Induction|MRD negative|0|||
161734184|NCT02883049|584067687|FG004|Post Induction|MRD negative|0|||
161734185|NCT02883049|584067688|FG005|Post Induction|MRD negative|0|||
161734186|NCT02883049|584067689|FG006|Post Induction|MRD negative|0|||
161734187|NCT02883049|584067690|FG007|Post Induction|MRD negative|11|||
161734188|NCT02883049|584067691|FG008|Post Induction|MRD negative|0|||
161734189|NCT02883049|584067692|FG009|Post Induction|MRD negative|0|||
161734190|NCT02883049|584067693|FG010|Post Induction|MRD negative|0|||
161734191|NCT02883049|584067694|FG011|Post Induction|MRD negative|0|||
161734192|NCT02883049|584067695|FG012|Post Induction|MRD negative|0|||
161734193|NCT02883049|584067696|FG013|Post Induction|MRD negative|0|||
161734194|NCT02883049|584067697|FG014|Post Induction|MRD negative|0|||
161734195|NCT02883049|584067698|FG015|Post Induction|MRD negative|0|||
161734196|NCT02883049|584067683|FG000|Post Induction|Developed SMN|0|||
161734197|NCT02883049|584067684|FG001|Post Induction|Developed SMN|0|||
161734198|NCT02883049|584067685|FG002|Post Induction|Developed SMN|0|||
161734199|NCT02883049|584067686|FG003|Post Induction|Developed SMN|0|||
161734200|NCT02883049|584067687|FG004|Post Induction|Developed SMN|1|||
161734201|NCT02883049|584067688|FG005|Post Induction|Developed SMN|0|||
161734202|NCT02883049|584067689|FG006|Post Induction|Developed SMN|1|||
161965859|NCT03905265|584921873|FG001|Overall Study|Withdrawal by Subject|1|||
161734203|NCT02883049|584067690|FG007|Post Induction|Developed SMN|0|||
161734204|NCT02883049|584067691|FG008|Post Induction|Developed SMN|0|||
161734205|NCT02883049|584067692|FG009|Post Induction|Developed SMN|0|||
161734206|NCT02883049|584067693|FG010|Post Induction|Developed SMN|1|||
161734207|NCT02883049|584067694|FG011|Post Induction|Developed SMN|1|||
161734208|NCT02883049|584067695|FG012|Post Induction|Developed SMN|0|||
161734209|NCT02883049|584067696|FG013|Post Induction|Developed SMN|0|||
161734210|NCT02883049|584067697|FG014|Post Induction|Developed SMN|1|||
161734211|NCT02883049|584067698|FG015|Post Induction|Developed SMN|0|||
161734212|NCT02883049|584067683|FG000|Post Induction|Enrolled onto another COG study|0|||
161734213|NCT02883049|584067684|FG001|Post Induction|Enrolled onto another COG study|0|||
161734214|NCT02883049|584067685|FG002|Post Induction|Enrolled onto another COG study|0|||
161734215|NCT02883049|584067686|FG003|Post Induction|Enrolled onto another COG study|1|||
161734216|NCT02883049|584067687|FG004|Post Induction|Enrolled onto another COG study|1|||
161734217|NCT02883049|584067688|FG005|Post Induction|Enrolled onto another COG study|0|||
161734218|NCT02883049|584067689|FG006|Post Induction|Enrolled onto another COG study|0|||
161734219|NCT02883049|584067690|FG007|Post Induction|Enrolled onto another COG study|4|||
161734220|NCT02883049|584067691|FG008|Post Induction|Enrolled onto another COG study|0|||
161734221|NCT02883049|584067692|FG009|Post Induction|Enrolled onto another COG study|0|||
161734222|NCT02883049|584067693|FG010|Post Induction|Enrolled onto another COG study|0|||
161965860|NCT03905265|584921874|FG002|Overall Study|Withdrawal by Subject|0|||
161965861|NCT03905265|584921875|FG003|Overall Study|Withdrawal by Subject|0|||
161965862|NCT04085458|584921878|FG000|Overall Study|Other|1|||
161965863|NCT04085458|584921878|FG000|Overall Study|Withdrawal by Subject|2|||
161734223|NCT02883049|584067694|FG011|Post Induction|Enrolled onto another COG study|2|||
161734224|NCT02883049|584067695|FG012|Post Induction|Enrolled onto another COG study|0|||
161965864|NCT04085458|584921878|FG000|Overall Study|Adverse Event|2|||
161965865|NCT03632993|584921879|FG000|Overall Study|Withdrawal by Subject|1|||
161965866|NCT03632993|584921880|FG001|Overall Study|Withdrawal by Subject|0|||
161734225|NCT02883049|584067696|FG013|Post Induction|Enrolled onto another COG study|1|||
161734226|NCT02883049|584067697|FG014|Post Induction|Enrolled onto another COG study|0|||
161734227|NCT02883049|584067698|FG015|Post Induction|Enrolled onto another COG study|0|||
161734228|NCT02883049|584067683|FG000|Post Induction|Recurrent leukemia|0|||
162032320|NCT01986933|585175476|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
162032321|NCT01986933|585175477|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
161734229|NCT02883049|584067684|FG001|Post Induction|Recurrent leukemia|0|||
161734230|NCT02883049|584067685|FG002|Post Induction|Recurrent leukemia|0|||
161734231|NCT02883049|584067686|FG003|Post Induction|Recurrent leukemia|17|||
161734232|NCT02883049|584067687|FG004|Post Induction|Recurrent leukemia|12|||
161734233|NCT02883049|584067688|FG005|Post Induction|Recurrent leukemia|4|||
161734234|NCT02883049|584067689|FG006|Post Induction|Recurrent leukemia|1|||
161734235|NCT02883049|584067690|FG007|Post Induction|Recurrent leukemia|13|||
161734236|NCT02883049|584067691|FG008|Post Induction|Recurrent leukemia|27|||
161965867|NCT03632993|584921881|FG002|Overall Study|Withdrawal by Subject|0|||
161734237|NCT02883049|584067692|FG009|Post Induction|Recurrent leukemia|5|||
161734238|NCT02883049|584067693|FG010|Post Induction|Recurrent leukemia|3|||
161734239|NCT02883049|584067694|FG011|Post Induction|Recurrent leukemia|12|||
161734240|NCT02883049|584067695|FG012|Post Induction|Recurrent leukemia|1|||
161734241|NCT02883049|584067696|FG013|Post Induction|Recurrent leukemia|1|||
161734242|NCT02883049|584067697|FG014|Post Induction|Recurrent leukemia|9|||
161734243|NCT02883049|584067698|FG015|Post Induction|Recurrent leukemia|3|||
161734244|NCT02883049|584067683|FG000|Post Induction|Induction Failure|0|||
161734245|NCT02883049|584067684|FG001|Post Induction|Induction Failure|0|||
161734246|NCT02883049|584067685|FG002|Post Induction|Induction Failure|0|||
161734247|NCT02883049|584067686|FG003|Post Induction|Induction Failure|0|||
161734248|NCT02883049|584067687|FG004|Post Induction|Induction Failure|0|||
161734249|NCT02883049|584067688|FG005|Post Induction|Induction Failure|0|||
161734250|NCT02883049|584067689|FG006|Post Induction|Induction Failure|0|||
161734251|NCT02883049|584067690|FG007|Post Induction|Induction Failure|2|||
161734252|NCT02883049|584067691|FG008|Post Induction|Induction Failure|2|||
161734253|NCT02883049|584067692|FG009|Post Induction|Induction Failure|0|||
161734254|NCT02883049|584067693|FG010|Post Induction|Induction Failure|0|||
161734255|NCT02883049|584067694|FG011|Post Induction|Induction Failure|0|||
161734256|NCT02883049|584067695|FG012|Post Induction|Induction Failure|0|||
161734257|NCT02883049|584067696|FG013|Post Induction|Induction Failure|2|||
161734258|NCT02883049|584067697|FG014|Post Induction|Induction Failure|0|||
161734259|NCT02883049|584067698|FG015|Post Induction|Induction Failure|0|||
161734260|NCT03421964|584067701|FG000|Overall Study|Lost to Follow-up|11|||
161734261|NCT03421964|584067702|FG001|Overall Study|Lost to Follow-up|21|||
161734262|NCT03421964|584067701|FG000|Overall Study|Withdrawal by Subject|9|||
161734263|NCT03421964|584067702|FG001|Overall Study|Withdrawal by Subject|3|||
161734264|NCT03421964|584067701|FG000|Overall Study|Incarcerated|1|||
161734265|NCT03421964|584067702|FG001|Overall Study|Incarcerated|0|||
161734266|NCT03421964|584067701|FG000|Overall Study|Inpt Treatment Facility|1|||
161734267|NCT03421964|584067702|FG001|Overall Study|Inpt Treatment Facility|1|||
161734268|NCT03421964|584067701|FG000|Overall Study|Virtual Platform Issues|1|||
161734269|NCT03421964|584067702|FG001|Overall Study|Virtual Platform Issues|1|||
161734270|NCT02106455|584067710|FG000|Overall Study|Case Report Form Uncollected|6|||
161734271|NCT02106455|584067710|FG000|Overall Study|Protocol Deviation|2|||
161734272|NCT03364608|584067711|FG000|Overall Study|Withdrawal by Subject|4|||
161734273|NCT03364608|584067711|FG000|Overall Study|Protocol Violation|2|||
161734274|NCT03364608|584067711|FG000|Overall Study|Lost to Follow-up|2|||
161734275|NCT03888391|584067712|FG000|Overall Study|Lost to Follow-up|15|||
161734276|NCT02504268|584067715|FG000|Overall Study|Adverse Event|18|||
161734277|NCT02504268|584067716|FG001|Overall Study|Adverse Event|8|||
161734278|NCT02504268|584067717|FG002|Overall Study|Adverse Event|14|||
161734279|NCT02504268|584067718|FG003|Overall Study|Adverse Event|0|||
161734280|NCT02504268|584067719|FG004|Overall Study|Adverse Event|0|||
161734281|NCT02504268|584067720|FG005|Overall Study|Adverse Event|0|||
161734282|NCT02504268|584067721|FG006|Overall Study|Adverse Event|0|||
161734283|NCT02504268|584067722|FG007|Overall Study|Adverse Event|0|||
161734284|NCT02504268|584067723|FG008|Overall Study|Adverse Event|0|||
161734285|NCT02504268|584067715|FG000|Overall Study|Withdrawal of Consent|11|||
161734286|NCT02504268|584067716|FG001|Overall Study|Withdrawal of Consent|10|||
161734287|NCT02504268|584067717|FG002|Overall Study|Withdrawal of Consent|3|||
161734288|NCT02504268|584067718|FG003|Overall Study|Withdrawal of Consent|0|||
161734289|NCT02504268|584067719|FG004|Overall Study|Withdrawal of Consent|0|||
161734290|NCT02504268|584067720|FG005|Overall Study|Withdrawal of Consent|0|||
161734291|NCT02504268|584067721|FG006|Overall Study|Withdrawal of Consent|0|||
161734292|NCT02504268|584067722|FG007|Overall Study|Withdrawal of Consent|0|||
161734293|NCT02504268|584067723|FG008|Overall Study|Withdrawal of Consent|0|||
161734294|NCT02504268|584067715|FG000|Overall Study|Pregnancy|2|||
161734295|NCT02504268|584067716|FG001|Overall Study|Pregnancy|0|||
161734296|NCT02504268|584067717|FG002|Overall Study|Pregnancy|0|||
161734297|NCT02504268|584067718|FG003|Overall Study|Pregnancy|0|||
161734298|NCT02504268|584067719|FG004|Overall Study|Pregnancy|0|||
161734299|NCT02504268|584067720|FG005|Overall Study|Pregnancy|0|||
161734300|NCT02504268|584067721|FG006|Overall Study|Pregnancy|0|||
161734301|NCT02504268|584067722|FG007|Overall Study|Pregnancy|0|||
161734302|NCT02504268|584067723|FG008|Overall Study|Pregnancy|0|||
161734303|NCT02504268|584067715|FG000|Overall Study|Lost to Follow-up|3|||
161734304|NCT02504268|584067716|FG001|Overall Study|Lost to Follow-up|6|||
161734305|NCT02504268|584067717|FG002|Overall Study|Lost to Follow-up|4|||
161734306|NCT02504268|584067718|FG003|Overall Study|Lost to Follow-up|0|||
161734307|NCT02504268|584067719|FG004|Overall Study|Lost to Follow-up|0|||
161734308|NCT02504268|584067720|FG005|Overall Study|Lost to Follow-up|0|||
161734309|NCT02504268|584067721|FG006|Overall Study|Lost to Follow-up|0|||
161734310|NCT02504268|584067722|FG007|Overall Study|Lost to Follow-up|0|||
161734311|NCT02504268|584067723|FG008|Overall Study|Lost to Follow-up|0|||
161734312|NCT02504268|584067715|FG000|Overall Study|Death|1|||
161734313|NCT02504268|584067716|FG001|Overall Study|Death|1|||
161734314|NCT02504268|584067717|FG002|Overall Study|Death|0|||
161734315|NCT02504268|584067718|FG003|Overall Study|Death|0|||
161734316|NCT02504268|584067719|FG004|Overall Study|Death|0|||
161734317|NCT02504268|584067720|FG005|Overall Study|Death|0|||
161839659|NCT02444793|584458553|FG003|Overall Study|Lost to Follow-up|0|||
161839660|NCT02444793|584458550|FG000|Overall Study|Death|0|||
161839661|NCT02444793|584458551|FG001|Overall Study|Death|3|||
161839662|NCT02444793|584458552|FG002|Overall Study|Death|0|||
161839663|NCT02444793|584458553|FG003|Overall Study|Death|0|||
161839664|NCT02444793|584458550|FG000|Overall Study|Other|0|||
161839665|NCT02444793|584458551|FG001|Overall Study|Other|0|||
161839666|NCT02444793|584458552|FG002|Overall Study|Other|2|||
161839667|NCT02444793|584458553|FG003|Overall Study|Other|0|||
161839668|NCT02444793|584458550|FG000|Overall Study|Objective progression or relapse|9|||
161839669|NCT02444793|584458551|FG001|Overall Study|Objective progression or relapse|1|||
161839670|NCT02444793|584458552|FG002|Overall Study|Objective progression or relapse|2|||
161839671|NCT02444793|584458553|FG003|Overall Study|Objective progression or relapse|3|||
161839672|NCT02504671|584458555|FG000|Overall Study|Withdrawal by Subject|1|||
161839673|NCT02504671|584458556|FG001|Overall Study|Withdrawal by Subject|5|||
161839674|NCT02504671|584458557|FG002|Overall Study|Withdrawal by Subject|4|||
161839675|NCT02504671|584458558|FG003|Overall Study|Withdrawal by Subject|4|||
161839676|NCT02504671|584458559|FG004|Overall Study|Withdrawal by Subject|5|||
161839677|NCT02504671|584458560|FG005|Overall Study|Withdrawal by Subject|3|||
161839678|NCT02504671|584458555|FG000|Overall Study|Lack of Efficacy|1|||
161839679|NCT02504671|584458556|FG001|Overall Study|Lack of Efficacy|3|||
161839680|NCT02504671|584458557|FG002|Overall Study|Lack of Efficacy|1|||
161839681|NCT02504671|584458558|FG003|Overall Study|Lack of Efficacy|0|||
161839682|NCT02504671|584458559|FG004|Overall Study|Lack of Efficacy|4|||
161839683|NCT02504671|584458560|FG005|Overall Study|Lack of Efficacy|4|||
161839684|NCT02504671|584458555|FG000|Overall Study|Adverse Event|1|||
161839685|NCT02504671|584458556|FG001|Overall Study|Adverse Event|1|||
161839686|NCT02504671|584458557|FG002|Overall Study|Adverse Event|0|||
161839687|NCT02504671|584458558|FG003|Overall Study|Adverse Event|1|||
161839688|NCT02504671|584458559|FG004|Overall Study|Adverse Event|0|||
161839689|NCT02504671|584458560|FG005|Overall Study|Adverse Event|2|||
161839690|NCT02504671|584458555|FG000|Overall Study|Protocol Violation|2|||
161839691|NCT02504671|584458556|FG001|Overall Study|Protocol Violation|1|||
161839692|NCT02504671|584458557|FG002|Overall Study|Protocol Violation|0|||
161839693|NCT02504671|584458558|FG003|Overall Study|Protocol Violation|0|||
161839694|NCT02504671|584458559|FG004|Overall Study|Protocol Violation|0|||
161839695|NCT02504671|584458560|FG005|Overall Study|Protocol Violation|1|||
161839696|NCT02504671|584458555|FG000|Overall Study|Lost to Follow-up|0|||
161839697|NCT02504671|584458556|FG001|Overall Study|Lost to Follow-up|0|||
161839698|NCT02504671|584458557|FG002|Overall Study|Lost to Follow-up|2|||
161839699|NCT02504671|584458558|FG003|Overall Study|Lost to Follow-up|0|||
161839700|NCT02504671|584458559|FG004|Overall Study|Lost to Follow-up|0|||
161839701|NCT02504671|584458560|FG005|Overall Study|Lost to Follow-up|1|||
161839702|NCT02504671|584458555|FG000|Overall Study|Protocol defined stopping criteria|7|||
161839703|NCT02504671|584458556|FG001|Overall Study|Protocol defined stopping criteria|4|||
161839704|NCT02504671|584458557|FG002|Overall Study|Protocol defined stopping criteria|3|||
161839705|NCT02504671|584458558|FG003|Overall Study|Protocol defined stopping criteria|5|||
161839706|NCT02504671|584458559|FG004|Overall Study|Protocol defined stopping criteria|3|||
161839707|NCT02504671|584458560|FG005|Overall Study|Protocol defined stopping criteria|3|||
161839708|NCT00210249|584458561|FG000|Overall Study|Lost to Follow-up|5|||
161839709|NCT00210249|584458561|FG000|Overall Study|Protocol Violation|11|||
161839710|NCT03222583|584458562|FG000|Overall Study|Withdrawal by Subject|3|||
161839711|NCT03222583|584458563|FG001|Overall Study|Withdrawal by Subject|3|||
161839712|NCT03222583|584458562|FG000|Overall Study|Lost to Follow-up|1|||
161839713|NCT03222583|584458563|FG001|Overall Study|Lost to Follow-up|0|||
161839714|NCT03222583|584458562|FG000|Overall Study|Other|1|||
161839715|NCT03222583|584458563|FG001|Overall Study|Other|3|||
161839716|NCT04280705|584458564|FG000|Overall Study|Enrolled but not treated|4|||
161839717|NCT04280705|584458565|FG001|Overall Study|Enrolled but not treated|10|||
161839718|NCT04280705|584458564|FG000|Overall Study|Physician Decision|1|||
161839719|NCT04280705|584458565|FG001|Overall Study|Physician Decision|0|||
161839720|NCT04280705|584458564|FG000|Overall Study|Withdrawal by Subject|7|||
161839721|NCT04280705|584458565|FG001|Overall Study|Withdrawal by Subject|9|||
161839722|NCT04280705|584458564|FG000|Overall Study|Adverse Event|0|||
161839723|NCT04280705|584458565|FG001|Overall Study|Adverse Event|4|||
161839724|NCT04280705|584458564|FG000|Overall Study|Transferred to another hospital|1|||
161839725|NCT04280705|584458565|FG001|Overall Study|Transferred to another hospital|1|||
161839726|NCT02518919|584458568|FG000|Overall Study|Protocol Violation|1|||
161839727|NCT02518919|584458569|FG001|Overall Study|Protocol Violation|1|||
161839728|NCT02518919|584458570|FG002|Overall Study|Protocol Violation|2|||
161839729|NCT04498403|584458571|FG000|Overall Study|Adverse Event|1|||
161839730|NCT04498403|584458572|FG001|Overall Study|Adverse Event|0|||
161839731|NCT04498403|584458571|FG000|Overall Study|Study Terminated By Sponsor|29|||
161839732|NCT04498403|584458572|FG001|Overall Study|Study Terminated By Sponsor|10|||
161839733|NCT02492880|584458573|FG000|Overall Study|Lost to Follow-up|1|||
161839734|NCT02492880|584458573|FG000|Overall Study|Protocol Violation|1|||
161839735|NCT01200992|584458574|FG000|Overall Study|Study terminated early|35|||
161839736|NCT01200992|584458575|FG001|Overall Study|Study terminated early|41|||
161839737|NCT01200992|584458574|FG000|Overall Study|Randomized but not treated|2|||
161839738|NCT01200992|584458575|FG001|Overall Study|Randomized but not treated|0|||
161839739|NCT00667810|584458576|FG000|Overall Study|Adverse Event|13|||
161839740|NCT00667810|584458577|FG001|Overall Study|Adverse Event|14|||
161839741|NCT00667810|584458578|FG002|Overall Study|Adverse Event|19|||
161839742|NCT00667810|584458579|FG003|Overall Study|Adverse Event|1|||
161839743|NCT00667810|584458576|FG000|Overall Study|Death|1|||
161839744|NCT00667810|584458577|FG001|Overall Study|Death|1|||
161839745|NCT00667810|584458578|FG002|Overall Study|Death|3|||
161839746|NCT00667810|584458579|FG003|Overall Study|Death|0|||
161839747|NCT00667810|584458576|FG000|Overall Study|Lack of Efficacy|1|||
161839748|NCT00667810|584458577|FG001|Overall Study|Lack of Efficacy|0|||
161839749|NCT00667810|584458578|FG002|Overall Study|Lack of Efficacy|2|||
161839750|NCT00667810|584458579|FG003|Overall Study|Lack of Efficacy|0|||
161839751|NCT00667810|584458576|FG000|Overall Study|Lost to Follow-up|1|||
161839752|NCT00667810|584458577|FG001|Overall Study|Lost to Follow-up|4|||
161839753|NCT00667810|584458578|FG002|Overall Study|Lost to Follow-up|2|||
161839754|NCT00667810|584458579|FG003|Overall Study|Lost to Follow-up|0|||
161839755|NCT00667810|584458576|FG000|Overall Study|Physician Decision|1|||
161839756|NCT00667810|584458577|FG001|Overall Study|Physician Decision|1|||
161839757|NCT00667810|584458578|FG002|Overall Study|Physician Decision|2|||
161839758|NCT00667810|584458579|FG003|Overall Study|Physician Decision|0|||
161839759|NCT00667810|584458576|FG000|Overall Study|Protocol Violation|0|||
161839760|NCT00667810|584458577|FG001|Overall Study|Protocol Violation|2|||
161839761|NCT00667810|584458578|FG002|Overall Study|Protocol Violation|0|||
161839762|NCT00667810|584458579|FG003|Overall Study|Protocol Violation|0|||
161839763|NCT00667810|584458576|FG000|Overall Study|Withdrawal by Subject|14|||
161839764|NCT00667810|584458577|FG001|Overall Study|Withdrawal by Subject|20|||
161839765|NCT00667810|584458578|FG002|Overall Study|Withdrawal by Subject|29|||
161839766|NCT00667810|584458579|FG003|Overall Study|Withdrawal by Subject|1|||
161839767|NCT00667810|584458576|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
161839768|NCT00667810|584458577|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
161839769|NCT00667810|584458578|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
161839770|NCT00667810|584458579|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
161839771|NCT00667810|584458576|FG000|Overall Study|Failed to Return|0|||
161839772|NCT00667810|584458577|FG001|Overall Study|Failed to Return|0|||
161839773|NCT00667810|584458578|FG002|Overall Study|Failed to Return|2|||
161839774|NCT00667810|584458579|FG003|Overall Study|Failed to Return|0|||
161839775|NCT00667810|584458576|FG000|Overall Study|Loss of Caregiver|0|||
161839776|NCT00667810|584458577|FG001|Overall Study|Loss of Caregiver|1|||
161839777|NCT00667810|584458578|FG002|Overall Study|Loss of Caregiver|3|||
161839778|NCT00667810|584458579|FG003|Overall Study|Loss of Caregiver|0|||
161839779|NCT00667810|584458576|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
161839780|NCT00667810|584458577|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
161839781|NCT00667810|584458578|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
161839782|NCT00667810|584458579|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
161839783|NCT00667810|584458576|FG000|Overall Study|Other|6|||
161839784|NCT00667810|584458577|FG001|Overall Study|Other|6|||
161839785|NCT00667810|584458578|FG002|Overall Study|Other|5|||
161839786|NCT00667810|584458579|FG003|Overall Study|Other|0|||
161839787|NCT00754650|584458582|FG000|Overall Study|Disease Progression|2|||
161839788|NCT00158600|584458592|FG000|Overall Study|unable to commit time to study|0|||
161839789|NCT00158600|584458593|FG001|Overall Study|unable to commit time to study|1|||
161839790|NCT00158600|584458592|FG000|Overall Study|Adverse Event|2|||
161839791|NCT00158600|584458593|FG001|Overall Study|Adverse Event|1|||
161839792|NCT00158600|584458592|FG000|Overall Study|Death|1|||
161839793|NCT00158600|584458593|FG001|Overall Study|Death|0|||
161839794|NCT00158600|584458592|FG000|Overall Study|Withdrawal by Subject|2|||
161839795|NCT00158600|584458593|FG001|Overall Study|Withdrawal by Subject|2|||
161839796|NCT02570113|584458594|FG000|Overall Study|Withdrawal by Subject|3|||
161839797|NCT02038907|584458595|FG000|Overall Study|Protocol Violation|0|||
161965868|NCT03632993|584921882|FG003|Overall Study|Withdrawal by Subject|0|||
161839798|NCT02038907|584458596|FG001|Overall Study|Protocol Violation|0|||
161839799|NCT02038907|584458597|FG002|Overall Study|Protocol Violation|0|||
161839800|NCT02038907|584458598|FG003|Overall Study|Protocol Violation|0|||
161839801|NCT02038907|584458599|FG004|Overall Study|Protocol Violation|0|||
161839802|NCT02038907|584458600|FG005|Overall Study|Protocol Violation|0|||
161839803|NCT02038907|584458601|FG006|Overall Study|Protocol Violation|0|||
161839804|NCT02038907|584458602|FG007|Overall Study|Protocol Violation|0|||
161839805|NCT02038907|584458603|FG008|Overall Study|Protocol Violation|0|||
161839806|NCT02038907|584458604|FG009|Overall Study|Protocol Violation|0|||
161839807|NCT02038907|584458605|FG010|Overall Study|Protocol Violation|1|||
161839808|NCT02038907|584458606|FG011|Overall Study|Protocol Violation|0|||
161839809|NCT02038907|584458607|FG012|Overall Study|Protocol Violation|0|||
161839810|NCT02038907|584458608|FG013|Overall Study|Protocol Violation|0|||
161839811|NCT02038907|584458595|FG000|Overall Study|Withdrawal by Subject|0|||
161839812|NCT02038907|584458596|FG001|Overall Study|Withdrawal by Subject|0|||
161839813|NCT02038907|584458597|FG002|Overall Study|Withdrawal by Subject|0|||
161839814|NCT02038907|584458598|FG003|Overall Study|Withdrawal by Subject|0|||
161965869|NCT03632993|584921883|FG004|Overall Study|Withdrawal by Subject|0|||
161734318|NCT02504268|584067721|FG006|Overall Study|Death|0|||
161734319|NCT02504268|584067722|FG007|Overall Study|Death|0|||
161734320|NCT02504268|584067723|FG008|Overall Study|Death|0|||
161734321|NCT02504268|584067715|FG000|Overall Study|Subject Request to Discontinue|11|||
161734322|NCT02504268|584067716|FG001|Overall Study|Subject Request to Discontinue|3|||
161734323|NCT02504268|584067717|FG002|Overall Study|Subject Request to Discontinue|6|||
161734324|NCT02504268|584067718|FG003|Overall Study|Subject Request to Discontinue|0|||
161734325|NCT02504268|584067719|FG004|Overall Study|Subject Request to Discontinue|0|||
161734326|NCT02504268|584067720|FG005|Overall Study|Subject Request to Discontinue|0|||
161734327|NCT02504268|584067721|FG006|Overall Study|Subject Request to Discontinue|0|||
161734328|NCT02504268|584067722|FG007|Overall Study|Subject Request to Discontinue|0|||
161734329|NCT02504268|584067723|FG008|Overall Study|Subject Request to Discontinue|0|||
161734330|NCT02504268|584067715|FG000|Overall Study|No Longer Meets Study Criteria|2|||
161734331|NCT02504268|584067716|FG001|Overall Study|No Longer Meets Study Criteria|3|||
161734332|NCT02504268|584067717|FG002|Overall Study|No Longer Meets Study Criteria|0|||
161734333|NCT02504268|584067718|FG003|Overall Study|No Longer Meets Study Criteria|0|||
161734334|NCT02504268|584067719|FG004|Overall Study|No Longer Meets Study Criteria|0|||
161734335|NCT02504268|584067720|FG005|Overall Study|No Longer Meets Study Criteria|0|||
161734336|NCT02504268|584067721|FG006|Overall Study|No Longer Meets Study Criteria|0|||
161734337|NCT02504268|584067722|FG007|Overall Study|No Longer Meets Study Criteria|0|||
161734338|NCT02504268|584067723|FG008|Overall Study|No Longer Meets Study Criteria|0|||
161734339|NCT02504268|584067715|FG000|Overall Study|Lack of Efficacy|11|||
161734340|NCT02504268|584067716|FG001|Overall Study|Lack of Efficacy|35|||
161734341|NCT02504268|584067717|FG002|Overall Study|Lack of Efficacy|9|||
161734342|NCT02504268|584067718|FG003|Overall Study|Lack of Efficacy|0|||
161734343|NCT02504268|584067719|FG004|Overall Study|Lack of Efficacy|0|||
161734344|NCT02504268|584067720|FG005|Overall Study|Lack of Efficacy|0|||
161734345|NCT02504268|584067721|FG006|Overall Study|Lack of Efficacy|0|||
161734346|NCT02504268|584067722|FG007|Overall Study|Lack of Efficacy|0|||
161734347|NCT02504268|584067723|FG008|Overall Study|Lack of Efficacy|0|||
161734348|NCT02504268|584067715|FG000|Overall Study|Poor/Non-Compliance|3|||
161734349|NCT02504268|584067716|FG001|Overall Study|Poor/Non-Compliance|2|||
161734350|NCT02504268|584067717|FG002|Overall Study|Poor/Non-Compliance|3|||
161734351|NCT02504268|584067718|FG003|Overall Study|Poor/Non-Compliance|0|||
161734352|NCT02504268|584067719|FG004|Overall Study|Poor/Non-Compliance|0|||
161734353|NCT02504268|584067720|FG005|Overall Study|Poor/Non-Compliance|0|||
161734354|NCT02504268|584067721|FG006|Overall Study|Poor/Non-Compliance|0|||
161734355|NCT02504268|584067722|FG007|Overall Study|Poor/Non-Compliance|0|||
161734356|NCT02504268|584067723|FG008|Overall Study|Poor/Non-Compliance|0|||
161734357|NCT02504268|584067715|FG000|Overall Study|Not Disclosed|1|||
161734358|NCT02504268|584067716|FG001|Overall Study|Not Disclosed|0|||
161734359|NCT02504268|584067717|FG002|Overall Study|Not Disclosed|2|||
161734360|NCT02504268|584067718|FG003|Overall Study|Not Disclosed|0|||
161734361|NCT02504268|584067719|FG004|Overall Study|Not Disclosed|0|||
161734362|NCT02504268|584067720|FG005|Overall Study|Not Disclosed|0|||
161734363|NCT02504268|584067721|FG006|Overall Study|Not Disclosed|0|||
161734364|NCT02504268|584067722|FG007|Overall Study|Not Disclosed|0|||
161734365|NCT02504268|584067723|FG008|Overall Study|Not Disclosed|0|||
161734366|NCT03654755|584067727|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
161734367|NCT03654755|584067728|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
161734368|NCT03654755|584067729|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
161734369|NCT03654755|584067727|FG000|Overall Study|Withdrawal by Subject|2|||
161734370|NCT03654755|584067728|FG001|Overall Study|Withdrawal by Subject|4|||
161734371|NCT03654755|584067729|FG002|Overall Study|Withdrawal by Subject|8|||
161734372|NCT03654755|584067727|FG000|Overall Study|Lost to Follow-up|1|||
161734373|NCT03654755|584067728|FG001|Overall Study|Lost to Follow-up|3|||
161839815|NCT02038907|584458599|FG004|Overall Study|Withdrawal by Subject|0|||
161839816|NCT02038907|584458600|FG005|Overall Study|Withdrawal by Subject|0|||
161965870|NCT03632993|584921884|FG005|Overall Study|Withdrawal by Subject|0|||
161965871|NCT03632993|584921885|FG006|Overall Study|Withdrawal by Subject|0|||
161965872|NCT03632993|584921886|FG007|Overall Study|Withdrawal by Subject|0|||
161965873|NCT03632993|584921887|FG008|Overall Study|Withdrawal by Subject|0|||
161965874|NCT03632993|584921888|FG009|Overall Study|Withdrawal by Subject|1|||
161965875|NCT03632993|584921879|FG000|Overall Study|Protocol Non-compliance|0|||
161734374|NCT03654755|584067729|FG002|Overall Study|Lost to Follow-up|7|||
161734375|NCT03654755|584067727|FG000|Overall Study|Physician Decision|0|||
161734376|NCT03654755|584067728|FG001|Overall Study|Physician Decision|1|||
161734377|NCT03654755|584067729|FG002|Overall Study|Physician Decision|0|||
161734378|NCT03654755|584067727|FG000|Overall Study|Adverse Event|0|||
161734379|NCT03654755|584067728|FG001|Overall Study|Adverse Event|0|||
161734380|NCT03654755|584067729|FG002|Overall Study|Adverse Event|4|||
161734381|NCT03654755|584067727|FG000|Overall Study|Lack of Efficacy|0|||
161965876|NCT03632993|584921880|FG001|Overall Study|Protocol Non-compliance|1|||
161734382|NCT03654755|584067728|FG001|Overall Study|Lack of Efficacy|0|||
161734383|NCT03654755|584067729|FG002|Overall Study|Lack of Efficacy|1|||
161965877|NCT03632993|584921881|FG002|Overall Study|Protocol Non-compliance|0|||
161734384|NCT00992784|584067731|FG000|Overall Study|Adverse Event|2|||
161734385|NCT00992784|584067732|FG001|Overall Study|Adverse Event|1|||
161734386|NCT00992784|584067733|FG002|Overall Study|Adverse Event|0|||
161734387|NCT00992784|584067731|FG000|Overall Study|Withdrawal by Subject|1|||
161734388|NCT00992784|584067732|FG001|Overall Study|Withdrawal by Subject|1|||
161734389|NCT00992784|584067733|FG002|Overall Study|Withdrawal by Subject|1|||
161734390|NCT03442829|584067736|FG000|Overall Study|Scheduling clash|3|||
161734391|NCT03442829|584067737|FG001|Overall Study|Scheduling clash|1|||
161734392|NCT03442829|584067736|FG000|Overall Study|Illness unrelated to study|1|||
161734393|NCT03442829|584067737|FG001|Overall Study|Illness unrelated to study|1|||
161734394|NCT05086289|584067738|FG000|Overall Study|Adverse Event|4|||
161734395|NCT05086289|584067739|FG001|Overall Study|Adverse Event|2|||
161734396|NCT05086289|584067738|FG000|Overall Study|Lost to Follow-up|2|||
161734397|NCT05086289|584067739|FG001|Overall Study|Lost to Follow-up|0|||
161734398|NCT05086289|584067738|FG000|Overall Study|Non-compliance with study drug|2|||
161734399|NCT05086289|584067739|FG001|Overall Study|Non-compliance with study drug|1|||
161734400|NCT05086289|584067738|FG000|Overall Study|Physician Decision|2|||
161734401|NCT05086289|584067739|FG001|Overall Study|Physician Decision|0|||
161734402|NCT05086289|584067738|FG000|Overall Study|Withdrawal by Subject|5|||
161734403|NCT05086289|584067739|FG001|Overall Study|Withdrawal by Subject|2|||
161734404|NCT01996748|584067745|FG000|Overall Study|Personal reason|1|||
161734405|NCT01996748|584067746|FG001|Overall Study|Personal reason|0|||
161734406|NCT01996748|584067745|FG000|Overall Study|Physician Decision|2|||
161734407|NCT01996748|584067746|FG001|Overall Study|Physician Decision|0|||
161734408|NCT01996748|584067745|FG000|Overall Study|Adverse Event|1|||
161734409|NCT01996748|584067746|FG001|Overall Study|Adverse Event|4|||
161734410|NCT01996748|584067745|FG000|Overall Study|Withdrawal by Subject|0|||
161734411|NCT01996748|584067746|FG001|Overall Study|Withdrawal by Subject|1|||
161734412|NCT01996748|584067745|FG000|Overall Study|Lost to Follow-up|4|||
161734413|NCT01996748|584067746|FG001|Overall Study|Lost to Follow-up|1|||
161734414|NCT03628508|584067747|FG000|Overall Study|Lost to Follow-up|1|||
161734415|NCT03238235|584067748|FG000|Overall Study|Adverse Event|2|||
161734416|NCT03238235|584067749|FG001|Overall Study|Adverse Event|0|||
161734417|NCT03238235|584067748|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
161734418|NCT03238235|584067749|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
161734419|NCT00243230|584067755|FG000|Double-Blind Period|Adverse Event|0|||
161734420|NCT00243230|584067756|FG001|Double-Blind Period|Adverse Event|2|||
161734421|NCT00243230|584067757|FG002|Double-Blind Period|Adverse Event|2|||
161734422|NCT00243230|584067758|FG003|Double-Blind Period|Adverse Event|0|||
161734423|NCT00243230|584067755|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161734424|NCT00243230|584067756|FG001|Double-Blind Period|Withdrawal by Subject|0|||
161734425|NCT00243230|584067757|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161734426|NCT00243230|584067758|FG003|Double-Blind Period|Withdrawal by Subject|0|||
161734427|NCT00243230|584067755|FG000|Double-Blind Period|Protocol Violation|0|||
161734428|NCT00243230|584067756|FG001|Double-Blind Period|Protocol Violation|0|||
161734429|NCT00243230|584067757|FG002|Double-Blind Period|Protocol Violation|1|||
161734430|NCT00243230|584067758|FG003|Double-Blind Period|Protocol Violation|0|||
161734431|NCT00243230|584067755|FG000|Double-Blind Period|Randomized but Not Treated|0|||
161734432|NCT00243230|584067756|FG001|Double-Blind Period|Randomized but Not Treated|0|||
161734433|NCT00243230|584067757|FG002|Double-Blind Period|Randomized but Not Treated|2|||
161734434|NCT00243230|584067758|FG003|Double-Blind Period|Randomized but Not Treated|0|||
161839817|NCT02038907|584458601|FG006|Overall Study|Withdrawal by Subject|0|||
161839818|NCT02038907|584458602|FG007|Overall Study|Withdrawal by Subject|0|||
161734435|NCT00243230|584067755|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
161734436|NCT00243230|584067756|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
161734437|NCT00243230|584067757|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
161734438|NCT00243230|584067758|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
161734439|NCT00243230|584067755|FG000|Open Label Period|Adverse Event|0|||
161734440|NCT00243230|584067756|FG001|Open Label Period|Adverse Event|0|||
161734441|NCT00243230|584067757|FG002|Open Label Period|Adverse Event|0|||
161734442|NCT00243230|584067758|FG003|Open Label Period|Adverse Event|2|||
161734443|NCT00243230|584067755|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
161734444|NCT00243230|584067756|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
161734445|NCT00243230|584067757|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
161839819|NCT02038907|584458603|FG008|Overall Study|Withdrawal by Subject|0|||
161734446|NCT00243230|584067758|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
161734447|NCT00243230|584067755|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
161734448|NCT00243230|584067756|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
161734449|NCT00243230|584067757|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
161734450|NCT00243230|584067758|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
161734451|NCT00243230|584067755|FG000|Open Label Period|Lost to Follow-up|0|||
161734452|NCT00243230|584067756|FG001|Open Label Period|Lost to Follow-up|0|||
161734453|NCT00243230|584067757|FG002|Open Label Period|Lost to Follow-up|0|||
162032322|NCT01986933|585175478|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
162032323|NCT01986933|585175474|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
161734454|NCT00243230|584067758|FG003|Open Label Period|Lost to Follow-up|2|||
161734455|NCT00243230|584067755|FG000|Open Label Period|Withdrawal by Subject|0|||
161734456|NCT00243230|584067756|FG001|Open Label Period|Withdrawal by Subject|0|||
161734457|NCT00243230|584067757|FG002|Open Label Period|Withdrawal by Subject|0|||
161734458|NCT00243230|584067758|FG003|Open Label Period|Withdrawal by Subject|2|||
161734459|NCT00243230|584067755|FG000|Open Label Period|Protocol Violation|0|||
161734460|NCT00243230|584067756|FG001|Open Label Period|Protocol Violation|0|||
161734461|NCT00243230|584067757|FG002|Open Label Period|Protocol Violation|0|||
161734462|NCT00243230|584067758|FG003|Open Label Period|Protocol Violation|2|||
161734463|NCT00243230|584067755|FG000|Open Label Period|Administrative Reason|0|||
161734464|NCT00243230|584067756|FG001|Open Label Period|Administrative Reason|0|||
161734465|NCT00243230|584067757|FG002|Open Label Period|Administrative Reason|0|||
161734466|NCT00243230|584067758|FG003|Open Label Period|Administrative Reason|63|||
161734467|NCT03011840|584067759|FG000|Overall Study|Not received PIL in post PIL phase|0|||
161734468|NCT03011840|584067760|FG001|Overall Study|Not received PIL in post PIL phase|21|||
161734469|NCT03201198|584067766|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
161734470|NCT03201198|584067767|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
161734471|NCT03201198|584067766|FG000|Overall Study|Withdrawal by Subject|2|||
161734472|NCT03201198|584067767|FG001|Overall Study|Withdrawal by Subject|3|||
161734473|NCT00471445|584067768|FG000|Overall Study|Withdrawal by Subject|1|||
161734474|NCT00471445|584067769|FG001|Overall Study|Withdrawal by Subject|1|||
161734475|NCT00471445|584067768|FG000|Overall Study|Ineligible|1|||
161734476|NCT00471445|584067769|FG001|Overall Study|Ineligible|0|||
161734477|NCT00471445|584067768|FG000|Overall Study|Protocol Violation|0|||
161734478|NCT00471445|584067769|FG001|Overall Study|Protocol Violation|1|||
161734479|NCT04715230|584067770|FG000|Overall Study|Withdrawal by Subject|1|||
161734480|NCT04715230|584067771|FG001|Overall Study|Withdrawal by Subject|0|||
161734481|NCT04715230|584067772|FG002|Overall Study|Withdrawal by Subject|0|||
161734482|NCT04715230|584067770|FG000|Overall Study|Lost to Follow-up|0|||
161734483|NCT04715230|584067771|FG001|Overall Study|Lost to Follow-up|5|||
161734484|NCT04715230|584067772|FG002|Overall Study|Lost to Follow-up|1|||
161734485|NCT02596711|584067779|FG000|Overall Study|Lost to Follow-up|1|||
161734486|NCT02596711|584067780|FG001|Overall Study|Lost to Follow-up|2|||
161734487|NCT02596711|584067781|FG002|Overall Study|Lost to Follow-up|3|||
161734488|NCT00586924|584067782|FG000|Overall Study|Adverse event/serious adverse event|0|||
161734489|NCT00586924|584067783|FG001|Overall Study|Adverse event/serious adverse event|0|||
161734490|NCT00586924|584067784|FG002|Overall Study|Adverse event/serious adverse event|0|||
161734491|NCT00586924|584067785|FG003|Overall Study|Adverse event/serious adverse event|1|||
161734492|NCT00586924|584067786|FG004|Overall Study|Adverse event/serious adverse event|0|||
161734493|NCT00586924|584067787|FG005|Overall Study|Adverse event/serious adverse event|2|||
161734494|NCT00586924|584067782|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
161734495|NCT00586924|584067783|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
161734496|NCT00586924|584067784|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
161734497|NCT00586924|584067785|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
161734498|NCT00586924|584067786|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
161734499|NCT00586924|584067787|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
161734500|NCT00586924|584067782|FG000|Overall Study|Disease progression|0|||
161734501|NCT00586924|584067783|FG001|Overall Study|Disease progression|0|||
161734502|NCT00586924|584067784|FG002|Overall Study|Disease progression|0|||
161734503|NCT00586924|584067785|FG003|Overall Study|Disease progression|1|||
161734504|NCT00586924|584067786|FG004|Overall Study|Disease progression|1|||
161734505|NCT00586924|584067787|FG005|Overall Study|Disease progression|0|||
161734506|NCT00586924|584067782|FG000|Overall Study|Development of neutralizing antibodies|2|||
161734507|NCT00586924|584067783|FG001|Overall Study|Development of neutralizing antibodies|2|||
161734508|NCT00586924|584067784|FG002|Overall Study|Development of neutralizing antibodies|2|||
161734509|NCT00586924|584067785|FG003|Overall Study|Development of neutralizing antibodies|0|||
161734510|NCT00586924|584067786|FG004|Overall Study|Development of neutralizing antibodies|0|||
161734511|NCT00586924|584067787|FG005|Overall Study|Development of neutralizing antibodies|22|||
161734512|NCT00586924|584067782|FG000|Overall Study|Complete response|0|||
161734513|NCT00586924|584067783|FG001|Overall Study|Complete response|1|||
162032324|NCT01986933|585175475|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
161734514|NCT00586924|584067784|FG002|Overall Study|Complete response|0|||
161734515|NCT00586924|584067785|FG003|Overall Study|Complete response|0|||
161734516|NCT00586924|584067786|FG004|Overall Study|Complete response|2|||
161734517|NCT00586924|584067787|FG005|Overall Study|Complete response|2|||
161734518|NCT00586924|584067782|FG000|Overall Study|Other|1|||
161734519|NCT00586924|584067783|FG001|Overall Study|Other|0|||
161734520|NCT00586924|584067784|FG002|Overall Study|Other|1|||
161734521|NCT00586924|584067785|FG003|Overall Study|Other|1|||
161734522|NCT00586924|584067786|FG004|Overall Study|Other|1|||
161839820|NCT02038907|584458604|FG009|Overall Study|Withdrawal by Subject|0|||
161734523|NCT00586924|584067787|FG005|Overall Study|Other|6|||
161734524|NCT01767194|584067791|FG000|Overall Study|Adverse Event|1|||
161734525|NCT01767194|584067792|FG001|Overall Study|Adverse Event|1|||
161734526|NCT01767194|584067791|FG000|Overall Study|Death|0|||
161734527|NCT01767194|584067792|FG001|Overall Study|Death|1|||
161734528|NCT01767194|584067791|FG000|Overall Study|Lack of Efficacy|12|||
161734529|NCT01767194|584067792|FG001|Overall Study|Lack of Efficacy|11|||
161734530|NCT01767194|584067791|FG000|Overall Study|Physician Decision|2|||
161734531|NCT01767194|584067792|FG001|Overall Study|Physician Decision|23|||
161734532|NCT01767194|584067791|FG000|Overall Study|Withdrawal by Subject|0|||
161734533|NCT01767194|584067792|FG001|Overall Study|Withdrawal by Subject|1|||
161734534|NCT01767194|584067791|FG000|Overall Study|Ineligible|1|||
161734535|NCT01767194|584067792|FG001|Overall Study|Ineligible|1|||
161734536|NCT01767194|584067791|FG000|Overall Study|Refusal by patient/parent|2|||
161734537|NCT01767194|584067792|FG001|Overall Study|Refusal by patient/parent|4|||
161734538|NCT01767194|584067791|FG000|Overall Study|Criteria not met on time for next cycle|0|||
161734539|NCT01767194|584067792|FG001|Overall Study|Criteria not met on time for next cycle|1|||
161734540|NCT02112994|584067793|FG000|Overall Study|Progressive Disease|0|||
161734541|NCT02112994|584067794|FG001|Overall Study|Progressive Disease|0|||
161734542|NCT02112994|584067795|FG002|Overall Study|Progressive Disease|1|||
161734543|NCT02112994|584067793|FG000|Overall Study|Pregnancy|0|||
161734544|NCT02112994|584067794|FG001|Overall Study|Pregnancy|1|||
161734545|NCT02112994|584067795|FG002|Overall Study|Pregnancy|1|||
161734546|NCT02112994|584067793|FG000|Overall Study|Liver Transplant|0|||
161734547|NCT02112994|584067794|FG001|Overall Study|Liver Transplant|1|||
161734548|NCT02112994|584067795|FG002|Overall Study|Liver Transplant|0|||
161734549|NCT02112994|584067793|FG000|Overall Study|Withdrawal by Subject|0|||
161734550|NCT02112994|584067794|FG001|Overall Study|Withdrawal by Subject|0|||
161734551|NCT02112994|584067795|FG002|Overall Study|Withdrawal by Subject|1|||
161734552|NCT04191577|584067799|FG000|Overall Study|Withdrawal by Subject|2|||
161734553|NCT04191577|584067800|FG001|Overall Study|Withdrawal by Subject|2|||
161734554|NCT04191577|584067801|FG002|Overall Study|Withdrawal by Subject|1|||
161734555|NCT04191577|584067799|FG000|Overall Study|Physician Decision|1|||
161734556|NCT04191577|584067800|FG001|Overall Study|Physician Decision|1|||
161734557|NCT04191577|584067801|FG002|Overall Study|Physician Decision|0|||
161734558|NCT04191577|584067799|FG000|Overall Study|Adverse Event|0|||
161734559|NCT04191577|584067800|FG001|Overall Study|Adverse Event|0|||
161734560|NCT04191577|584067801|FG002|Overall Study|Adverse Event|1|||
161734561|NCT04191577|584067799|FG000|Overall Study|Death|0|||
161734562|NCT04191577|584067800|FG001|Overall Study|Death|0|||
161734563|NCT04191577|584067801|FG002|Overall Study|Death|1|||
161734564|NCT01927744|584069247|FG000|Overall Study|Death|2|||
161734565|NCT01927744|584069248|FG001|Overall Study|Death|9|||
161734566|NCT00369967|584069249|FG000|Overall Study|Lost to Follow-up|23|||
161734567|NCT00369967|584069250|FG001|Overall Study|Lost to Follow-up|12|||
161734568|NCT00605722|584069255|FG000|Overall Study|Adverse Event|6|||
161734569|NCT00605722|584069255|FG000|Overall Study|Insufficient therapeutic response|44|||
161734570|NCT00605722|584069255|FG000|Overall Study|Failure to return|1|||
161734571|NCT03073213|584069256|FG000|Multiple Dose Period|Protocol Violation|0|||
161734572|NCT03073213|584069257|FG001|Multiple Dose Period|Protocol Violation|0|||
161734573|NCT03073213|584069258|FG002|Multiple Dose Period|Protocol Violation|1|||
161734574|NCT01993615|584069264|FG000|Overall Study|Death|1|||
161734575|NCT01993615|584069265|FG001|Overall Study|Death|0|||
161734576|NCT02064205|584069271|FG000|Overall Study|Withdrawal by Subject|1|||
161734577|NCT01354353|584069275|FG000|Overall Study|Adverse Event|1|||
161734578|NCT01354353|584069276|FG001|Overall Study|Adverse Event|0|||
161734579|NCT01354353|584069277|FG002|Overall Study|Adverse Event|0|||
161734580|NCT01354353|584069278|FG003|Overall Study|Adverse Event|4|||
161734581|NCT01354353|584069279|FG004|Overall Study|Adverse Event|0|||
161734582|NCT01354353|584069280|FG005|Overall Study|Adverse Event|5|||
161734583|NCT01354353|584069275|FG000|Overall Study|Entry Criteria Not Met|0|||
161734584|NCT01354353|584069276|FG001|Overall Study|Entry Criteria Not Met|0|||
161734585|NCT01354353|584069277|FG002|Overall Study|Entry Criteria Not Met|0|||
161734586|NCT01354353|584069278|FG003|Overall Study|Entry Criteria Not Met|1|||
161734587|NCT01354353|584069279|FG004|Overall Study|Entry Criteria Not Met|1|||
161734588|NCT01354353|584069280|FG005|Overall Study|Entry Criteria Not Met|0|||
161734589|NCT01354353|584069275|FG000|Overall Study|Physician Decision|0|||
161734590|NCT01354353|584069276|FG001|Overall Study|Physician Decision|1|||
161734591|NCT01354353|584069277|FG002|Overall Study|Physician Decision|1|||
161734592|NCT01354353|584069278|FG003|Overall Study|Physician Decision|0|||
161734593|NCT01354353|584069279|FG004|Overall Study|Physician Decision|0|||
161734594|NCT01354353|584069280|FG005|Overall Study|Physician Decision|0|||
161734595|NCT01354353|584069275|FG000|Overall Study|Withdrawal by Subject|2|||
161734596|NCT01354353|584069276|FG001|Overall Study|Withdrawal by Subject|0|||
161734597|NCT01354353|584069277|FG002|Overall Study|Withdrawal by Subject|1|||
161734598|NCT01354353|584069278|FG003|Overall Study|Withdrawal by Subject|0|||
161734599|NCT01354353|584069279|FG004|Overall Study|Withdrawal by Subject|0|||
161734600|NCT01354353|584069280|FG005|Overall Study|Withdrawal by Subject|1|||
161734601|NCT00831441|584069281|FG000|Randomized|Death|82|||
161734602|NCT00831441|584069282|FG001|Randomized|Death|81|||
161839821|NCT02038907|584458605|FG010|Overall Study|Withdrawal by Subject|1|||
161839822|NCT02038907|584458606|FG011|Overall Study|Withdrawal by Subject|0|||
161839823|NCT02038907|584458607|FG012|Overall Study|Withdrawal by Subject|0|||
161839824|NCT02038907|584458608|FG013|Overall Study|Withdrawal by Subject|0|||
161839825|NCT02746471|584458609|FG000|Overall Study|Death|43|||
161839826|NCT02746471|584458609|FG000|Overall Study|Exited before 36 months|1119|||
161839827|NCT02564211|584458610|FG000|Overall Study|Adverse Event|4|||
161839828|NCT02618408|584458612|FG000|Overall Study|Withdrawal by Subject|1|||
161839829|NCT02618408|584458613|FG001|Overall Study|Withdrawal by Subject|0|||
161839830|NCT02618408|584458614|FG002|Overall Study|Withdrawal by Subject|4|||
161839831|NCT02618408|584458612|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
161839832|NCT02618408|584458613|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
161839833|NCT02618408|584458614|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
161839834|NCT02618408|584458612|FG000|Overall Study|Lost to Follow-up|4|||
161839835|NCT02618408|584458613|FG001|Overall Study|Lost to Follow-up|2|||
161839836|NCT02618408|584458614|FG002|Overall Study|Lost to Follow-up|6|||
161839837|NCT02618408|584458612|FG000|Overall Study|Adverse Event|4|||
161839838|NCT02618408|584458613|FG001|Overall Study|Adverse Event|0|||
161839839|NCT02618408|584458614|FG002|Overall Study|Adverse Event|10|||
161839840|NCT02618408|584458612|FG000|Overall Study|Physician Decision|1|||
161839841|NCT02618408|584458613|FG001|Overall Study|Physician Decision|1|||
161839842|NCT02618408|584458614|FG002|Overall Study|Physician Decision|2|||
161839843|NCT02618408|584458612|FG000|Overall Study|Protocol Violation|1|||
161839844|NCT02618408|584458613|FG001|Overall Study|Protocol Violation|1|||
161839845|NCT02618408|584458614|FG002|Overall Study|Protocol Violation|2|||
161839846|NCT02618408|584458612|FG000|Overall Study|Other, Multiple Categories|0|||
161839847|NCT02618408|584458613|FG001|Overall Study|Other, Multiple Categories|0|||
161839848|NCT02618408|584458614|FG002|Overall Study|Other, Multiple Categories|4|||
161839849|NCT03914950|584458619|FG000|Overall Study|Physician Decision|54|||
161839850|NCT03167723|584458625|FG000|Overall Study|Protocol Violation|4|||
161839851|NCT03167723|584458626|FG001|Overall Study|Protocol Violation|6|||
161839852|NCT03397771|584458627|FG000|Overall Study|2 erroneously randomized, never treated|3|||
161839853|NCT03397771|584458628|FG001|Overall Study|2 erroneously randomized, never treated|1|||
161839854|NCT03397771|584458627|FG000|Overall Study|Withdrawal by Subject|1|||
161734603|NCT00831441|584069281|FG000|Randomized|Adverse Event|248|||
161734604|NCT00831441|584069282|FG001|Randomized|Adverse Event|321|||
161734605|NCT00831441|584069281|FG000|Randomized|Emergency procedure|2|||
161734606|NCT00831441|584069282|FG001|Randomized|Emergency procedure|2|||
161734607|NCT00831441|584069281|FG000|Randomized|Elective procedure|26|||
161734608|NCT00831441|584069282|FG001|Randomized|Elective procedure|25|||
161734609|NCT00831441|584069281|FG000|Randomized|Physician Decision|26|||
161734610|NCT00831441|584069282|FG001|Randomized|Physician Decision|35|||
161734611|NCT00831441|584069281|FG000|Randomized|No longer met criteria|13|||
161734612|NCT00831441|584069282|FG001|Randomized|No longer met criteria|19|||
161734613|NCT00831441|584069281|FG000|Randomized|Withdrawal by Subject|178|||
161734614|NCT00831441|584069282|FG001|Randomized|Withdrawal by Subject|212|||
161734615|NCT00831441|584069281|FG000|Randomized|Lost to Follow-up|26|||
161734616|NCT00831441|584069282|FG001|Randomized|Lost to Follow-up|35|||
161734617|NCT00831441|584069281|FG000|Randomized|Administrative reason by sponsor|2780|||
161734618|NCT00831441|584069282|FG001|Randomized|Administrative reason by sponsor|2671|||
161734619|NCT00831441|584069281|FG000|Randomized|poor/non-compliance|30|||
161734620|NCT00831441|584069282|FG001|Randomized|poor/non-compliance|38|||
161734621|NCT00831441|584069281|FG000|Randomized|non-specified|276|||
161734622|NCT00831441|584069282|FG001|Randomized|non-specified|266|||
161734623|NCT00831441|584069281|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
161734624|NCT00831441|584069282|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
161734625|NCT00831441|584069281|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
161839855|NCT03397771|584458628|FG001|Overall Study|Withdrawal by Subject|3|||
161839856|NCT03397771|584458627|FG000|Overall Study|Protocol Violation|2|||
161839857|NCT03397771|584458628|FG001|Overall Study|Protocol Violation|2|||
161839858|NCT03397771|584458627|FG000|Overall Study|Adverse Event|2|||
161839859|NCT03397771|584458628|FG001|Overall Study|Adverse Event|1|||
161965878|NCT03632993|584921882|FG003|Overall Study|Protocol Non-compliance|0|||
161734626|NCT00831441|584069282|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
161734627|NCT00831441|584069281|FG000|Follow Up (30 Days)|Death|63|||
161734628|NCT00831441|584069282|FG001|Follow Up (30 Days)|Death|86|||
161734629|NCT00831441|584069281|FG000|Follow Up (30 Days)|non-specified|16|||
161734630|NCT00831441|584069282|FG001|Follow Up (30 Days)|non-specified|26|||
161734631|NCT00831441|584069281|FG000|Follow Up (30 Days)|missing end of study status|0|||
161734632|NCT00831441|584069282|FG001|Follow Up (30 Days)|missing end of study status|1|||
161839860|NCT02669758|584458631|FG000|Overall Study|Withdrawal by Subject|43|||
161839861|NCT02669758|584458631|FG000|Overall Study|Lost to Follow-up|19|||
161839862|NCT02669758|584458631|FG000|Overall Study|Adverse Event|16|||
161839863|NCT02669758|584458631|FG000|Overall Study|Non-Compliance with Study Drug|8|||
161734633|NCT05674344|584069283|FG000|Overall Study|Screen Fail|21|||
161734634|NCT05674344|584069283|FG000|Overall Study|Incomplete study procedures|3|||
161734635|NCT00111917|584069284|FG000|Overall Study|Withdrawal by Subject|1|||
161734636|NCT00111917|584069285|FG001|Overall Study|Withdrawal by Subject|1|||
161734637|NCT01640925|584069286|FG000|Overall Study|Withdrawal by Subject|1|||
161734638|NCT01640925|584069287|FG001|Overall Study|Withdrawal by Subject|0|||
161734639|NCT01640925|584069286|FG000|Overall Study|Previously enrolled in this trial|13|||
161734640|NCT01640925|584069287|FG001|Overall Study|Previously enrolled in this trial|11|||
161734641|NCT02156492|584069288|FG000|Period 1|No Reason Given|0|||
161734642|NCT02156492|584069289|FG001|Period 1|No Reason Given|1|||
161734643|NCT02156492|584069290|FG002|Period 1|No Reason Given|0|||
161734644|NCT02156492|584069288|FG000|Period 3|Adverse Event|0|||
161734645|NCT02156492|584069289|FG001|Period 3|Adverse Event|1|||
161734646|NCT02156492|584069290|FG002|Period 3|Adverse Event|0|||
161734647|NCT00485589|584069299|FG000|Overall Study|Death|2|||
161734648|NCT00485589|584069300|FG001|Overall Study|Death|2|||
161734649|NCT00485589|584069301|FG002|Overall Study|Death|0|||
161734650|NCT00485589|584069299|FG000|Overall Study|Failure to return|6|||
161734651|NCT00485589|584069300|FG001|Overall Study|Failure to return|5|||
161734652|NCT00485589|584069301|FG002|Overall Study|Failure to return|1|||
161734653|NCT00485589|584069299|FG000|Overall Study|Protocol Violation|1|||
161734654|NCT00485589|584069300|FG001|Overall Study|Protocol Violation|0|||
161734655|NCT00485589|584069301|FG002|Overall Study|Protocol Violation|0|||
161734656|NCT00485589|584069299|FG000|Overall Study|Violation of selection criteria at entry|0|||
161734657|NCT00485589|584069300|FG001|Overall Study|Violation of selection criteria at entry|3|||
161734658|NCT00485589|584069301|FG002|Overall Study|Violation of selection criteria at entry|1|||
161734659|NCT00485589|584069299|FG000|Overall Study|Administrative/Other|1|||
161734660|NCT00485589|584069300|FG001|Overall Study|Administrative/Other|2|||
161734661|NCT00485589|584069301|FG002|Overall Study|Administrative/Other|1|||
161734662|NCT00485589|584069299|FG000|Overall Study|Insufficient therapeutic response|10|||
161734663|NCT00485589|584069300|FG001|Overall Study|Insufficient therapeutic response|3|||
161734664|NCT00485589|584069301|FG002|Overall Study|Insufficient therapeutic response|1|||
161734665|NCT00485589|584069299|FG000|Overall Study|Refused treatment/did not cooperate|1|||
161734666|NCT00485589|584069300|FG001|Overall Study|Refused treatment/did not cooperate|0|||
161734667|NCT00485589|584069301|FG002|Overall Study|Refused treatment/did not cooperate|2|||
161734668|NCT00485589|584069299|FG000|Overall Study|Withdrawal by Subject|3|||
161734669|NCT00485589|584069300|FG001|Overall Study|Withdrawal by Subject|2|||
161734670|NCT00485589|584069301|FG002|Overall Study|Withdrawal by Subject|2|||
161734671|NCT00485589|584069299|FG000|Overall Study|Adverse Event|3|||
161734672|NCT00485589|584069300|FG001|Overall Study|Adverse Event|3|||
161734673|NCT00485589|584069301|FG002|Overall Study|Adverse Event|10|||
161734674|NCT02924688|584069304|FG000|Overall Study|Adverse Event|9|||
161734675|NCT02924688|584069305|FG001|Overall Study|Adverse Event|3|||
161734676|NCT02924688|584069306|FG002|Overall Study|Adverse Event|2|||
161734677|NCT02924688|584069307|FG003|Overall Study|Adverse Event|2|||
161734678|NCT02924688|584069308|FG004|Overall Study|Adverse Event|3|||
161734679|NCT02924688|584069309|FG005|Overall Study|Adverse Event|2|||
161734680|NCT02924688|584069304|FG000|Overall Study|Lack of Efficacy|2|||
161734681|NCT02924688|584069305|FG001|Overall Study|Lack of Efficacy|3|||
161734682|NCT02924688|584069306|FG002|Overall Study|Lack of Efficacy|4|||
161734683|NCT02924688|584069307|FG003|Overall Study|Lack of Efficacy|2|||
161734684|NCT02924688|584069308|FG004|Overall Study|Lack of Efficacy|1|||
161734685|NCT02924688|584069309|FG005|Overall Study|Lack of Efficacy|1|||
161734686|NCT02924688|584069304|FG000|Overall Study|Protocol Violation|3|||
161734687|NCT02924688|584069305|FG001|Overall Study|Protocol Violation|7|||
161734688|NCT02924688|584069306|FG002|Overall Study|Protocol Violation|5|||
161734689|NCT02924688|584069307|FG003|Overall Study|Protocol Violation|6|||
161734690|NCT02924688|584069308|FG004|Overall Study|Protocol Violation|2|||
161734691|NCT02924688|584069309|FG005|Overall Study|Protocol Violation|2|||
161734692|NCT02924688|584069304|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
161734693|NCT02924688|584069305|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
161734694|NCT02924688|584069306|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
161734695|NCT02924688|584069307|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
161734696|NCT02924688|584069308|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
161734697|NCT02924688|584069309|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
161734698|NCT02924688|584069304|FG000|Overall Study|Lost to Follow-up|2|||
161734699|NCT02924688|584069305|FG001|Overall Study|Lost to Follow-up|4|||
161734700|NCT02924688|584069306|FG002|Overall Study|Lost to Follow-up|2|||
161734701|NCT02924688|584069307|FG003|Overall Study|Lost to Follow-up|4|||
161734702|NCT02924688|584069308|FG004|Overall Study|Lost to Follow-up|2|||
161734703|NCT02924688|584069309|FG005|Overall Study|Lost to Follow-up|4|||
161734704|NCT02924688|584069304|FG000|Overall Study|Physician Decision|2|||
161734705|NCT02924688|584069305|FG001|Overall Study|Physician Decision|1|||
161734706|NCT02924688|584069306|FG002|Overall Study|Physician Decision|0|||
161734707|NCT02924688|584069307|FG003|Overall Study|Physician Decision|1|||
161734708|NCT02924688|584069308|FG004|Overall Study|Physician Decision|1|||
161734709|NCT02924688|584069309|FG005|Overall Study|Physician Decision|1|||
161734710|NCT02924688|584069304|FG000|Overall Study|Withdrawal by Subject|14|||
161734711|NCT02924688|584069305|FG001|Overall Study|Withdrawal by Subject|13|||
161734712|NCT02924688|584069306|FG002|Overall Study|Withdrawal by Subject|9|||
161734713|NCT02924688|584069307|FG003|Overall Study|Withdrawal by Subject|12|||
161839864|NCT02669758|584458631|FG000|Overall Study|Lack of Efficacy|5|||
161734714|NCT02924688|584069308|FG004|Overall Study|Withdrawal by Subject|13|||
161734715|NCT02924688|584069309|FG005|Overall Study|Withdrawal by Subject|14|||
161734716|NCT03072719|584069311|FG000|Overall Study|Adverse Event|1|||
161734717|NCT03072719|584069312|FG001|Overall Study|Adverse Event|1|||
161734718|NCT02586233|584069314|FG000|Overall Study|Randomized but did not receive treatment|0|||
161734719|NCT02586233|584069315|FG001|Overall Study|Randomized but did not receive treatment|1|||
161734720|NCT02586233|584069316|FG002|Overall Study|Randomized but did not receive treatment|0|||
161734721|NCT02586233|584069317|FG003|Overall Study|Randomized but did not receive treatment|0|||
161734722|NCT02586233|584069318|FG004|Overall Study|Randomized but did not receive treatment|0|||
161734723|NCT02586233|584069319|FG005|Overall Study|Randomized but did not receive treatment|2|||
161734724|NCT02586233|584069320|FG006|Overall Study|Randomized but did not receive treatment|2|||
161734725|NCT02586233|584069314|FG000|Overall Study|Death|0|||
161734726|NCT02586233|584069315|FG001|Overall Study|Death|1|||
161734727|NCT02586233|584069316|FG002|Overall Study|Death|0|||
161734728|NCT02586233|584069317|FG003|Overall Study|Death|0|||
161734729|NCT02586233|584069318|FG004|Overall Study|Death|2|||
161734730|NCT02586233|584069319|FG005|Overall Study|Death|0|||
161734731|NCT02586233|584069320|FG006|Overall Study|Death|0|||
161734732|NCT01205451|584069321|FG000|Overall Study|Lost to Follow-up|1|||
161734733|NCT01205451|584069322|FG001|Overall Study|Lost to Follow-up|1|||
161734734|NCT01205451|584069321|FG000|Overall Study|Withdrawal by Subject|5|||
161734735|NCT01205451|584069322|FG001|Overall Study|Withdrawal by Subject|9|||
161734736|NCT02226146|584069326|FG000|Overall Study|Received rescue therapy|1|||
161734737|NCT02226146|584069326|FG000|Overall Study|Withdrawal by Subject|2|||
161734738|NCT05464836|584069327|FG000|Overall Study|Progression of Disease|1|||
161734739|NCT05464836|584069327|FG000|Overall Study|Physician Decision|1|||
161734740|NCT01522976|584069328|FG000|Overall Study|Ineligible|4|||
161734741|NCT01522976|584069329|FG001|Overall Study|Ineligible|0|||
161734742|NCT01522976|584069330|FG002|Overall Study|Ineligible|1|||
161734743|NCT01522976|584069328|FG000|Overall Study|Death|7|||
161734744|NCT01522976|584069329|FG001|Overall Study|Death|6|||
161734745|NCT01522976|584069330|FG002|Overall Study|Death|2|||
161734746|NCT01522976|584069328|FG000|Overall Study|Still on treatment|9|||
161734747|NCT01522976|584069329|FG001|Overall Study|Still on treatment|9|||
161734748|NCT01522976|584069330|FG002|Overall Study|Still on treatment|6|||
161734749|NCT01522976|584069328|FG000|Overall Study|Disease progression|28|||
161734750|NCT01522976|584069329|FG001|Overall Study|Disease progression|30|||
161734751|NCT01522976|584069330|FG002|Overall Study|Disease progression|25|||
161734752|NCT01522976|584069328|FG000|Overall Study|Adverse Event|17|||
161734753|NCT01522976|584069329|FG001|Overall Study|Adverse Event|7|||
161734754|NCT01522976|584069330|FG002|Overall Study|Adverse Event|18|||
161734755|NCT01522976|584069328|FG000|Overall Study|Refusal unrelated to adverse event|10|||
161734756|NCT01522976|584069329|FG001|Overall Study|Refusal unrelated to adverse event|13|||
161734757|NCT01522976|584069330|FG002|Overall Study|Refusal unrelated to adverse event|14|||
161734758|NCT01522976|584069328|FG000|Overall Study|Not protocol specified|22|||
161734759|NCT01522976|584069329|FG001|Overall Study|Not protocol specified|27|||
161734760|NCT01522976|584069330|FG002|Overall Study|Not protocol specified|27|||
161734761|NCT02938585|584069331|FG000|Overall Study|Withdrawal by parent or guardian|0|||
161734762|NCT02938585|584069332|FG001|Overall Study|Withdrawal by parent or guardian|1|||
161734763|NCT02938585|584069333|FG002|Overall Study|Withdrawal by parent or guardian|0|||
161734764|NCT02938585|584069334|FG003|Overall Study|Withdrawal by parent or guardian|0|||
161734765|NCT02938585|584069331|FG000|Overall Study|Withdrawal by Subject|0|||
161734766|NCT02938585|584069332|FG001|Overall Study|Withdrawal by Subject|0|||
161734767|NCT02938585|584069333|FG002|Overall Study|Withdrawal by Subject|0|||
161734768|NCT02938585|584069334|FG003|Overall Study|Withdrawal by Subject|5|||
161734769|NCT00213980|584069335|FG000|Overall Study|Withdrawal by Subject|3|||
161734770|NCT00213980|584069336|FG001|Overall Study|Withdrawal by Subject|1|||
161734771|NCT00213980|584069335|FG000|Overall Study|Adverse Event|1|||
161965879|NCT03632993|584921883|FG004|Overall Study|Protocol Non-compliance|0|||
161965880|NCT03632993|584921884|FG005|Overall Study|Protocol Non-compliance|0|||
161965881|NCT03632993|584921885|FG006|Overall Study|Protocol Non-compliance|0|||
161734772|NCT00213980|584069336|FG001|Overall Study|Adverse Event|1|||
161734773|NCT00213980|584069335|FG000|Overall Study|Disease progression|0|||
161965882|NCT03632993|584921886|FG007|Overall Study|Protocol Non-compliance|0|||
161734774|NCT00213980|584069336|FG001|Overall Study|Disease progression|2|||
161734775|NCT00213980|584069335|FG000|Overall Study|Developed ovarian cancer|1|||
161734776|NCT00213980|584069336|FG001|Overall Study|Developed ovarian cancer|0|||
161734777|NCT00213980|584069335|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
161734778|NCT00213980|584069336|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
161734779|NCT03607838|584069337|FG000|Overall Study|Lack of Efficacy|14|||
161734780|NCT03607838|584069338|FG001|Overall Study|Lack of Efficacy|20|||
161734781|NCT03607838|584069337|FG000|Overall Study|Withdrawal by Subject|13|||
161734782|NCT03607838|584069338|FG001|Overall Study|Withdrawal by Subject|8|||
161734783|NCT03607838|584069337|FG000|Overall Study|Lost to Follow-up|6|||
161734784|NCT03607838|584069338|FG001|Overall Study|Lost to Follow-up|11|||
161734785|NCT03607838|584069337|FG000|Overall Study|Adverse Event|2|||
161734786|NCT03607838|584069338|FG001|Overall Study|Adverse Event|2|||
161734787|NCT03607838|584069337|FG000|Overall Study|Physician Decision|2|||
161734788|NCT03607838|584069338|FG001|Overall Study|Physician Decision|0|||
161734789|NCT03607838|584069337|FG000|Overall Study|Failure to meet randomization criteria|1|||
161734790|NCT03607838|584069338|FG001|Overall Study|Failure to meet randomization criteria|2|||
161734791|NCT03607838|584069337|FG000|Overall Study|Pregnancy|1|||
161734792|NCT03607838|584069338|FG001|Overall Study|Pregnancy|0|||
161734793|NCT03607838|584069337|FG000|Overall Study|Protocol Violation|1|||
161734794|NCT03607838|584069338|FG001|Overall Study|Protocol Violation|0|||
161734795|NCT03607838|584069337|FG000|Overall Study|Due to work|1|||
161734796|NCT03607838|584069338|FG001|Overall Study|Due to work|0|||
161734797|NCT03607838|584069337|FG000|Overall Study|Litigation|0|||
161734798|NCT03607838|584069338|FG001|Overall Study|Litigation|1|||
161734799|NCT03607838|584069337|FG000|Overall Study|Temperature excursion for study drug|0|||
161734800|NCT03607838|584069338|FG001|Overall Study|Temperature excursion for study drug|1|||
161734801|NCT03607838|584069337|FG000|Overall Study|Change of mind|0|||
161734802|NCT03607838|584069338|FG001|Overall Study|Change of mind|1|||
161734803|NCT02411201|584069339|FG000|Overall Study|Adverse Event|2|||
161734804|NCT02411201|584069339|FG000|Overall Study|Withdrawal by Subject|2|||
161734805|NCT02411201|584069339|FG000|Overall Study|Age group completed|2|||
161734806|NCT01260467|584069340|FG000|Overall Study|Withdrawal by Subject|2|||
161734807|NCT00798694|584069341|FG000|Overall Study|Lost to Follow-up|1|||
161734808|NCT00798694|584069342|FG001|Overall Study|Lost to Follow-up|1|||
161734809|NCT00798694|584069341|FG000|Overall Study|Physician Decision|1|||
161734810|NCT00798694|584069342|FG001|Overall Study|Physician Decision|0|||
161734811|NCT01163253|584069348|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
161734812|NCT01163253|584069349|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
161734813|NCT01163253|584069348|FG000|Overall Study|Study Terminated by Sponsor|978|||
161734814|NCT01163253|584069349|FG001|Overall Study|Study Terminated by Sponsor|349|||
161734815|NCT01163253|584069348|FG000|Overall Study|Protocol Violation|43|||
161734816|NCT01163253|584069349|FG001|Overall Study|Protocol Violation|12|||
161734817|NCT01163253|584069348|FG000|Overall Study|Withdrawal by Subject|199|||
161734818|NCT01163253|584069349|FG001|Overall Study|Withdrawal by Subject|50|||
161734819|NCT01163253|584069348|FG000|Overall Study|Medication Error|1|||
161734820|NCT01163253|584069349|FG001|Overall Study|Medication Error|0|||
161734821|NCT01163253|584069348|FG000|Overall Study|Lost to Follow-up|125|||
161734822|NCT01163253|584069349|FG001|Overall Study|Lost to Follow-up|23|||
161734823|NCT01163253|584069348|FG000|Overall Study|Insufficient Clinical Response|423|||
161734824|NCT01163253|584069349|FG001|Overall Study|Insufficient Clinical Response|29|||
161734825|NCT01163253|584069348|FG000|Overall Study|Adverse Event|300|||
161734826|NCT01163253|584069349|FG001|Overall Study|Adverse Event|78|||
161734827|NCT01163253|584069348|FG000|Overall Study|Death|17|||
161734828|NCT01163253|584069349|FG001|Overall Study|Death|5|||
161734829|NCT01163253|584069348|FG000|Overall Study|Ongoing|13|||
161734830|NCT01163253|584069349|FG001|Overall Study|Ongoing|4|||
161734831|NCT01163253|584069348|FG000|Overall Study|Other Unspecified|170|||
161734832|NCT01163253|584069349|FG001|Overall Study|Other Unspecified|34|||
161734833|NCT03025217|584069355|FG000|Overall Study|Pregnancy|1|||
161734834|NCT03025217|584069355|FG000|Overall Study|Lost to Follow-up|1|||
161734835|NCT03025217|584069355|FG000|Overall Study|Not eligible, poor English|2|||
161734836|NCT00781599|584069358|FG000|Overall Study|Lost to Follow-up|7|||
161734837|NCT00781599|584069359|FG001|Overall Study|Lost to Follow-up|4|||
161734838|NCT01088438|584069360|FG000|Overall Study|Withdrawal by Subject|11|||
161734839|NCT01088438|584069361|FG001|Overall Study|Withdrawal by Subject|6|||
161734840|NCT01088438|584069360|FG000|Overall Study|Lost to Follow-up|18|||
161734841|NCT01088438|584069361|FG001|Overall Study|Lost to Follow-up|30|||
161734842|NCT02605447|584069367|FG000|Overall Study|Death|66|||
161734843|NCT02605447|584069367|FG000|Overall Study|Physician Decision|1|||
161734844|NCT02605447|584069367|FG000|Overall Study|Lost to Follow-up|24|||
161734845|NCT02605447|584069367|FG000|Overall Study|Withdrawal by Subject|10|||
161965883|NCT03632993|584921887|FG008|Overall Study|Protocol Non-compliance|0|||
161965884|NCT03632993|584921888|FG009|Overall Study|Protocol Non-compliance|0|||
161965885|NCT03632993|584921879|FG000|Overall Study|Lost to Follow-up|0|||
161965886|NCT03632993|584921880|FG001|Overall Study|Lost to Follow-up|0|||
161965887|NCT03632993|584921881|FG002|Overall Study|Lost to Follow-up|0|||
161734846|NCT02605447|584069367|FG000|Overall Study|Not disclosed|1|||
161734847|NCT02237157|584069368|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
161734848|NCT02237157|584069369|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
161734849|NCT02237157|584069370|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
161734850|NCT02237157|584069371|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
161734851|NCT02237157|584069368|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
161734852|NCT02237157|584069369|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
161734853|NCT02237157|584069370|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
161734854|NCT02237157|584069371|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
161734855|NCT04533815|584069376|FG000|Overall Study|Adverse Event|2|||
161734856|NCT04533815|584069376|FG000|Overall Study|Site withdrew|5|||
161734857|NCT02045212|584069377|FG000|Overall Study|Adverse Event|0|||
161734858|NCT02045212|584069378|FG001|Overall Study|Adverse Event|1|||
161965888|NCT03632993|584921882|FG003|Overall Study|Lost to Follow-up|0|||
161839865|NCT02669758|584458631|FG000|Overall Study|Pregnancy|1|||
161839866|NCT02669758|584458631|FG000|Overall Study|Study noncompliance|1|||
161734859|NCT02045212|584069377|FG000|Overall Study|Withdrawal by Subject|1|||
161734860|NCT02045212|584069378|FG001|Overall Study|Withdrawal by Subject|0|||
161734861|NCT02045212|584069377|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
161734862|NCT02045212|584069378|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
161734863|NCT00488592|584069379|FG000|Overall Study|Withdrawal by Subject|1|||
161734864|NCT00488592|584069379|FG000|Overall Study|Disease progression|1|||
161839867|NCT02669758|584458631|FG000|Overall Study|Protocol Violation|1|||
161839868|NCT02455050|584458632|FG000|Treatment Period 1|Lost to Follow-up|1|||
161839869|NCT02455050|584458633|FG001|Treatment Period 1|Lost to Follow-up|1|||
161839870|NCT02455050|584458634|FG002|Treatment Period 1|Lost to Follow-up|1|||
161839871|NCT02455050|584458635|FG003|Treatment Period 1|Lost to Follow-up|2|||
161839872|NCT02455050|584458632|FG000|Treatment Period 2|Lost to Follow-up|1|||
161839873|NCT02455050|584458633|FG001|Treatment Period 2|Lost to Follow-up|0|||
161839874|NCT02455050|584458634|FG002|Treatment Period 2|Lost to Follow-up|2|||
161839875|NCT02455050|584458635|FG003|Treatment Period 2|Lost to Follow-up|1|||
161839876|NCT03393806|584458638|FG000|Overall Study|Physician Decision|1|||
161839877|NCT03393806|584458639|FG001|Overall Study|Physician Decision|0|||
161839878|NCT01259115|584458640|FG000|Period 1|Adverse Event|1|||
161839879|NCT01259115|584458641|FG001|Period 1|Adverse Event|0|||
161839880|NCT01259115|584458640|FG000|Period 1|Protocol Violation|2|||
161839881|NCT01259115|584458641|FG001|Period 1|Protocol Violation|0|||
161839882|NCT01259115|584458640|FG000|Period 1|Lost to Follow-up|0|||
161839883|NCT01259115|584458641|FG001|Period 1|Lost to Follow-up|1|||
161839884|NCT01259115|584458640|FG000|Period 2|Adverse Event|1|||
161839885|NCT01259115|584458641|FG001|Period 2|Adverse Event|0|||
161839886|NCT03493386|584458642|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161839887|NCT03493386|584458643|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
161839888|NCT03493386|584458644|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161839889|NCT03493386|584458645|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161839890|NCT00988442|584458647|FG000|Overall Study|Death|1|||
161839891|NCT00988442|584458648|FG001|Overall Study|Death|2|||
161839892|NCT00988442|584458647|FG000|Overall Study|Lost to Follow-up|0|||
161839893|NCT00988442|584458648|FG001|Overall Study|Lost to Follow-up|1|||
161839894|NCT00988442|584458647|FG000|Overall Study|Early Study Closure|29|||
161839895|NCT00988442|584458648|FG001|Overall Study|Early Study Closure|25|||
161839896|NCT02731326|584458651|FG000|Overall Study|Withdrawal by Subject|4|||
161839897|NCT02731326|584458652|FG001|Overall Study|Withdrawal by Subject|1|||
161839898|NCT02731326|584458651|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
161839899|NCT02731326|584458652|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
161839900|NCT02731326|584458651|FG000|Overall Study|Discharged without AliveCor|10|||
161839901|NCT02731326|584458652|FG001|Overall Study|Discharged without AliveCor|0|||
161839902|NCT02731326|584458651|FG000|Overall Study|Duplicate Participant|1|||
161839903|NCT02731326|584458652|FG001|Overall Study|Duplicate Participant|1|||
161839904|NCT04453202|584458657|FG000|Overall Study|Adverse Event|0|||
161839905|NCT04453202|584458658|FG001|Overall Study|Adverse Event|0|||
161839906|NCT04453202|584458659|FG002|Overall Study|Adverse Event|0|||
161839907|NCT04453202|584458660|FG003|Overall Study|Adverse Event|0|||
161839908|NCT04453202|584458661|FG004|Overall Study|Adverse Event|0|||
161839909|NCT04453202|584458662|FG005|Overall Study|Adverse Event|0|||
161839910|NCT04453202|584458663|FG006|Overall Study|Adverse Event|1|||
161965889|NCT03632993|584921883|FG004|Overall Study|Lost to Follow-up|0|||
161965890|NCT03632993|584921884|FG005|Overall Study|Lost to Follow-up|1|||
161734865|NCT00488592|584069379|FG000|Overall Study|Enrolled but not treated|1|||
161734866|NCT00441103|584069380|FG000|Overall Study|Adverse Event|2|||
161965891|NCT03632993|584921885|FG006|Overall Study|Lost to Follow-up|0|||
161965892|NCT03632993|584921886|FG007|Overall Study|Lost to Follow-up|1|||
161965893|NCT03632993|584921887|FG008|Overall Study|Lost to Follow-up|0|||
161734867|NCT00441103|584069381|FG001|Overall Study|Adverse Event|1|||
161734868|NCT00441103|584069380|FG000|Overall Study|Death|1|||
161839911|NCT04453202|584458664|FG007|Overall Study|Adverse Event|0|||
161839912|NCT04453202|584458665|FG008|Overall Study|Adverse Event|0|||
161839913|NCT04453202|584458666|FG009|Overall Study|Adverse Event|0|||
161839914|NCT04453202|584458667|FG010|Overall Study|Adverse Event|0|||
161965894|NCT03632993|584921888|FG009|Overall Study|Lost to Follow-up|0|||
161965895|NCT03632993|584921879|FG000|Overall Study|Adverse Event|0|||
161734869|NCT00441103|584069381|FG001|Overall Study|Death|0|||
161734870|NCT00441103|584069380|FG000|Overall Study|Disease Progression|2|||
161839915|NCT04453202|584458657|FG000|Overall Study|Death|0|||
161839916|NCT04453202|584458658|FG001|Overall Study|Death|0|||
161839917|NCT04453202|584458659|FG002|Overall Study|Death|0|||
161839918|NCT04453202|584458660|FG003|Overall Study|Death|0|||
161839919|NCT04453202|584458661|FG004|Overall Study|Death|0|||
161839920|NCT04453202|584458662|FG005|Overall Study|Death|0|||
161839921|NCT04453202|584458663|FG006|Overall Study|Death|0|||
161839922|NCT04453202|584458664|FG007|Overall Study|Death|0|||
161839923|NCT04453202|584458665|FG008|Overall Study|Death|0|||
161965896|NCT03632993|584921880|FG001|Overall Study|Adverse Event|0|||
161839924|NCT04453202|584458666|FG009|Overall Study|Death|1|||
161839925|NCT04453202|584458667|FG010|Overall Study|Death|0|||
161839926|NCT04453202|584458657|FG000|Overall Study|Lost to Follow-up|0|||
161839927|NCT04453202|584458658|FG001|Overall Study|Lost to Follow-up|1|||
161839928|NCT04453202|584458659|FG002|Overall Study|Lost to Follow-up|0|||
161839929|NCT04453202|584458660|FG003|Overall Study|Lost to Follow-up|1|||
161839930|NCT04453202|584458661|FG004|Overall Study|Lost to Follow-up|0|||
161839931|NCT04453202|584458662|FG005|Overall Study|Lost to Follow-up|0|||
161839932|NCT04453202|584458663|FG006|Overall Study|Lost to Follow-up|0|||
161839933|NCT04453202|584458664|FG007|Overall Study|Lost to Follow-up|0|||
161839934|NCT04453202|584458665|FG008|Overall Study|Lost to Follow-up|0|||
161839935|NCT04453202|584458666|FG009|Overall Study|Lost to Follow-up|1|||
161839936|NCT04453202|584458667|FG010|Overall Study|Lost to Follow-up|1|||
161839937|NCT04453202|584458657|FG000|Overall Study|Withdrawal by Subject|1|||
161839938|NCT04453202|584458658|FG001|Overall Study|Withdrawal by Subject|2|||
161839939|NCT04453202|584458659|FG002|Overall Study|Withdrawal by Subject|1|||
161839940|NCT04453202|584458660|FG003|Overall Study|Withdrawal by Subject|2|||
161839941|NCT04453202|584458661|FG004|Overall Study|Withdrawal by Subject|1|||
161839942|NCT04453202|584458662|FG005|Overall Study|Withdrawal by Subject|1|||
161839943|NCT04453202|584458663|FG006|Overall Study|Withdrawal by Subject|0|||
161839944|NCT04453202|584458664|FG007|Overall Study|Withdrawal by Subject|0|||
161839945|NCT04453202|584458665|FG008|Overall Study|Withdrawal by Subject|0|||
161839946|NCT04453202|584458666|FG009|Overall Study|Withdrawal by Subject|1|||
161839947|NCT04453202|584458667|FG010|Overall Study|Withdrawal by Subject|0|||
161839948|NCT04453202|584458657|FG000|Overall Study|Adverse Event|0|||
161839949|NCT04453202|584458658|FG001|Overall Study|Adverse Event|0|||
161839950|NCT04453202|584458659|FG002|Overall Study|Adverse Event|0|||
161839951|NCT04453202|584458660|FG003|Overall Study|Adverse Event|0|||
161839952|NCT04453202|584458661|FG004|Overall Study|Adverse Event|0|||
161839953|NCT04453202|584458662|FG005|Overall Study|Adverse Event|1|||
161839954|NCT04453202|584458663|FG006|Overall Study|Adverse Event|0|||
161839955|NCT04453202|584458664|FG007|Overall Study|Adverse Event|0|||
161839956|NCT04453202|584458665|FG008|Overall Study|Adverse Event|0|||
161839957|NCT04453202|584458666|FG009|Overall Study|Adverse Event|0|||
161839958|NCT04453202|584458667|FG010|Overall Study|Adverse Event|0|||
161839959|NCT01355159|584458672|FG000|Overall Study|Withdrew consent|39|||
161839960|NCT01355159|584458673|FG001|Overall Study|Withdrew consent|47|||
161839961|NCT01355159|584458672|FG000|Overall Study|No primary outcome data|17|||
161839962|NCT01355159|584458673|FG001|Overall Study|No primary outcome data|11|||
161839963|NCT01355159|584458672|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
161839964|NCT01355159|584458673|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
161839965|NCT01355159|584458672|FG000|Overall Study|Early intrauterine fetal death|6|||
161839966|NCT01355159|584458673|FG001|Overall Study|Early intrauterine fetal death|6|||
161839967|NCT03276221|584458674|FG000|Overall Study|Lost to Follow-up|6|||
161839968|NCT03276221|584458675|FG001|Overall Study|Lost to Follow-up|2|||
161839969|NCT03276221|584458676|FG002|Overall Study|Lost to Follow-up|0|||
161839970|NCT03276221|584458674|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
161839971|NCT03276221|584458675|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
161839972|NCT03276221|584458676|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
161839973|NCT02615171|584458677|FG000|Overall Study|Lost to Follow-up|2|||
161839974|NCT02615171|584458678|FG001|Overall Study|Lost to Follow-up|1|||
161734871|NCT00441103|584069381|FG001|Overall Study|Disease Progression|0|||
161734872|NCT00441103|584069380|FG000|Overall Study|Lost to Follow-up|1|||
161734873|NCT00441103|584069381|FG001|Overall Study|Lost to Follow-up|0|||
161734874|NCT00441103|584069380|FG000|Overall Study|Protocol Violation|1|||
161734875|NCT00441103|584069381|FG001|Overall Study|Protocol Violation|0|||
161734876|NCT00441103|584069380|FG000|Overall Study|Participant unable to use Rebiject II|1|||
161734877|NCT00441103|584069381|FG001|Overall Study|Participant unable to use Rebiject II|0|||
161734878|NCT00441103|584069380|FG000|Overall Study|Participant refused MRI|1|||
161734879|NCT00441103|584069381|FG001|Overall Study|Participant refused MRI|0|||
161734880|NCT00441103|584069380|FG000|Overall Study|Inclusion criteria absent|1|||
161734881|NCT00441103|584069381|FG001|Overall Study|Inclusion criteria absent|0|||
161734882|NCT00441103|584069380|FG000|Overall Study|Non-compliant|0|||
161734883|NCT00441103|584069381|FG001|Overall Study|Non-compliant|1|||
161734884|NCT00441103|584069380|FG000|Overall Study|Participant decided to withdraw|1|||
161734885|NCT00441103|584069381|FG001|Overall Study|Participant decided to withdraw|0|||
161839975|NCT00975286|584458683|FG000|Overall Study|Adverse Event|9|||
161839976|NCT00975286|584458684|FG001|Overall Study|Adverse Event|19|||
161839977|NCT00975286|584458683|FG000|Overall Study|Protocol Violation|1|||
161839978|NCT00975286|584458684|FG001|Overall Study|Protocol Violation|2|||
161839979|NCT00975286|584458683|FG000|Overall Study|Withdrawal by Subject|0|||
161839980|NCT00975286|584458684|FG001|Overall Study|Withdrawal by Subject|2|||
161839981|NCT00975286|584458683|FG000|Overall Study|Familial and Personal Reasons|2|||
161839982|NCT00975286|584458684|FG001|Overall Study|Familial and Personal Reasons|2|||
161734886|NCT00441103|584069380|FG000|Overall Study|Participant's reason|0|||
161734887|NCT00441103|584069381|FG001|Overall Study|Participant's reason|1|||
161734888|NCT00441103|584069380|FG000|Overall Study|Participant decided to stop|0|||
161734889|NCT00441103|584069381|FG001|Overall Study|Participant decided to stop|1|||
161734890|NCT00515008|584069382|FG000|Overall Study|Lost to Follow-up|1|||
161734891|NCT00515008|584069383|FG001|Overall Study|Lost to Follow-up|0|||
161734892|NCT00515008|584069382|FG000|Overall Study|Declined|0|||
161734893|NCT00515008|584069383|FG001|Overall Study|Declined|3|||
161734894|NCT00515008|584069382|FG000|Overall Study|Left the Boston Area|1|||
161734895|NCT00515008|584069383|FG001|Overall Study|Left the Boston Area|1|||
161734896|NCT00515008|584069382|FG000|Overall Study|Scheduling conflict|1|||
161734897|NCT00515008|584069383|FG001|Overall Study|Scheduling conflict|0|||
161734898|NCT05836818|584069384|FG000|Overall Study|Physician Decision|1|||
161734899|NCT05836818|584069385|FG001|Overall Study|Physician Decision|1|||
161734900|NCT05836818|584069386|FG002|Overall Study|Physician Decision|0|||
161734901|NCT05836818|584069384|FG000|Overall Study|Withdrawal by Subject|0|||
161734902|NCT05836818|584069385|FG001|Overall Study|Withdrawal by Subject|0|||
161734903|NCT05836818|584069386|FG002|Overall Study|Withdrawal by Subject|1|||
161734904|NCT05836818|584069384|FG000|Overall Study|Later found to be previously vaccinated|0|||
161734905|NCT05836818|584069385|FG001|Overall Study|Later found to be previously vaccinated|1|||
161734906|NCT05836818|584069386|FG002|Overall Study|Later found to be previously vaccinated|3|||
161734907|NCT05836818|584069384|FG000|Overall Study|Pregnancy|0|||
161734908|NCT05836818|584069385|FG001|Overall Study|Pregnancy|1|||
161734909|NCT05836818|584069386|FG002|Overall Study|Pregnancy|0|||
161734910|NCT05836818|584069384|FG000|Overall Study|Allergic to vaccines|0|||
161734911|NCT05836818|584069385|FG001|Overall Study|Allergic to vaccines|1|||
161734912|NCT05836818|584069386|FG002|Overall Study|Allergic to vaccines|0|||
161734913|NCT03738566|584069387|FG000|Initial Study Phase|Withdrawal by Subject|1|||
161734914|NCT03738566|584069388|FG001|Initial Study Phase|Withdrawal by Subject|1|||
161734915|NCT03738566|584069389|FG002|Initial Study Phase|Withdrawal by Subject|2|||
161734916|NCT03738566|584069390|FG003|Initial Study Phase|Withdrawal by Subject|0|||
161734917|NCT03738566|584069387|FG000|Initial Study Phase|Death|0|||
161734918|NCT03738566|584069388|FG001|Initial Study Phase|Death|1|||
161734919|NCT03738566|584069389|FG002|Initial Study Phase|Death|0|||
161734920|NCT03738566|584069390|FG003|Initial Study Phase|Death|0|||
161734921|NCT03738566|584069387|FG000|Initial Study Phase|Treatment failure|5|||
161734922|NCT03738566|584069388|FG001|Initial Study Phase|Treatment failure|0|||
161734923|NCT03738566|584069389|FG002|Initial Study Phase|Treatment failure|0|||
161734924|NCT03738566|584069390|FG003|Initial Study Phase|Treatment failure|0|||
161734925|NCT03738566|584069387|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
161734926|NCT03738566|584069388|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
161734927|NCT03738566|584069389|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
161734928|NCT03738566|584069390|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
161734929|NCT03126539|584069399|FG000|Overall Study|Lost to Follow-up|1|||
161734930|NCT03126539|584069400|FG001|Overall Study|Lost to Follow-up|1|||
161734931|NCT03126539|584069401|FG002|Overall Study|Lost to Follow-up|1|||
161734932|NCT03126539|584069402|FG003|Overall Study|Lost to Follow-up|0|||
161734933|NCT03126539|584069403|FG004|Overall Study|Lost to Follow-up|0|||
161734934|NCT01627067|584069404|FG000|Overall Study|Screen Failure|1|||
161734935|NCT00926796|584069405|FG000|Overall Study|Did not receive randomized treatment|4|||
161734936|NCT00926796|584069406|FG001|Overall Study|Did not receive randomized treatment|7|||
161734937|NCT00926796|584069405|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
161734938|NCT00926796|584069406|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
161734939|NCT00926796|584069405|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
161734940|NCT00926796|584069406|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
161734941|NCT00926796|584069405|FG000|Overall Study|Adverse Event|7|||
161734942|NCT00926796|584069406|FG001|Overall Study|Adverse Event|14|||
161734943|NCT00926796|584069405|FG000|Overall Study|Lost to Follow-up|22|||
161734944|NCT00926796|584069406|FG001|Overall Study|Lost to Follow-up|13|||
161734945|NCT00926796|584069405|FG000|Overall Study|Protocol Violation|15|||
161734946|NCT00926796|584069406|FG001|Overall Study|Protocol Violation|11|||
161734947|NCT00926796|584069405|FG000|Overall Study|Withdrawal by Subject|1|||
161734948|NCT00926796|584069406|FG001|Overall Study|Withdrawal by Subject|0|||
161734949|NCT01683071|584069408|FG000|Part 1|Lack of Efficacy|1|||
161734950|NCT01683071|584069409|FG001|Part 1|Lack of Efficacy|0|||
161734951|NCT01683071|584069410|FG002|Part 1|Lack of Efficacy|0|||
161734952|NCT01683071|584069411|FG003|Part 1|Lack of Efficacy|3|||
161734953|NCT01683071|584069412|FG004|Part 1|Lack of Efficacy|0|||
161734954|NCT01683071|584069413|FG005|Part 1|Lack of Efficacy|0|||
161734955|NCT01683071|584069408|FG000|Part 1|Withdrawal by Subject|1|||
161734956|NCT01683071|584069409|FG001|Part 1|Withdrawal by Subject|2|||
161734957|NCT01683071|584069410|FG002|Part 1|Withdrawal by Subject|2|||
161734958|NCT01683071|584069411|FG003|Part 1|Withdrawal by Subject|1|||
161734959|NCT01683071|584069412|FG004|Part 1|Withdrawal by Subject|0|||
161734960|NCT01683071|584069413|FG005|Part 1|Withdrawal by Subject|0|||
161734961|NCT01683071|584069408|FG000|Part 1|Surgery Cancelled|1|||
161734962|NCT01683071|584069409|FG001|Part 1|Surgery Cancelled|0|||
161734963|NCT01683071|584069410|FG002|Part 1|Surgery Cancelled|0|||
161734964|NCT01683071|584069411|FG003|Part 1|Surgery Cancelled|0|||
161734965|NCT01683071|584069412|FG004|Part 1|Surgery Cancelled|0|||
161734966|NCT01683071|584069413|FG005|Part 1|Surgery Cancelled|0|||
161965897|NCT03632993|584921881|FG002|Overall Study|Adverse Event|0|||
161965898|NCT03632993|584921882|FG003|Overall Study|Adverse Event|0|||
161965899|NCT03632993|584921883|FG004|Overall Study|Adverse Event|0|||
161965900|NCT03632993|584921884|FG005|Overall Study|Adverse Event|1|||
161965901|NCT03632993|584921885|FG006|Overall Study|Adverse Event|0|||
161965902|NCT03632993|584921886|FG007|Overall Study|Adverse Event|1|||
161965903|NCT03632993|584921887|FG008|Overall Study|Adverse Event|0|||
161965904|NCT03632993|584921888|FG009|Overall Study|Adverse Event|0|||
161965905|NCT02449889|584921889|FG000|Overall Study|Adverse Event|1|||
162032325|NCT01986933|585175476|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
161734967|NCT01683071|584069408|FG000|Part 1|Did not receive study drug|1|||
161734968|NCT01683071|584069409|FG001|Part 1|Did not receive study drug|0|||
161734969|NCT01683071|584069410|FG002|Part 1|Did not receive study drug|0|||
161734970|NCT01683071|584069411|FG003|Part 1|Did not receive study drug|1|||
161734971|NCT01683071|584069412|FG004|Part 1|Did not receive study drug|0|||
161734972|NCT01683071|584069413|FG005|Part 1|Did not receive study drug|0|||
161734973|NCT01683071|584069408|FG000|Part 1|Early termination; met exclusion criteria|0|||
161734974|NCT01683071|584069409|FG001|Part 1|Early termination; met exclusion criteria|2|||
161734975|NCT01683071|584069410|FG002|Part 1|Early termination; met exclusion criteria|1|||
161734976|NCT01683071|584069411|FG003|Part 1|Early termination; met exclusion criteria|0|||
161734977|NCT01683071|584069412|FG004|Part 1|Early termination; met exclusion criteria|0|||
161734978|NCT01683071|584069413|FG005|Part 1|Early termination; met exclusion criteria|0|||
161734979|NCT01683071|584069408|FG000|Part 2|Lack of Efficacy|0|||
161734980|NCT01683071|584069409|FG001|Part 2|Lack of Efficacy|0|||
161734981|NCT01683071|584069410|FG002|Part 2|Lack of Efficacy|0|||
161734982|NCT01683071|584069411|FG003|Part 2|Lack of Efficacy|0|||
161734983|NCT01683071|584069412|FG004|Part 2|Lack of Efficacy|3|||
161734984|NCT01683071|584069413|FG005|Part 2|Lack of Efficacy|4|||
161734985|NCT01683071|584069408|FG000|Part 2|Lost to Follow-up|0|||
161734986|NCT01683071|584069409|FG001|Part 2|Lost to Follow-up|0|||
161734987|NCT01683071|584069410|FG002|Part 2|Lost to Follow-up|0|||
161734988|NCT01683071|584069411|FG003|Part 2|Lost to Follow-up|0|||
161734989|NCT01683071|584069412|FG004|Part 2|Lost to Follow-up|2|||
161734990|NCT01683071|584069413|FG005|Part 2|Lost to Follow-up|0|||
161734991|NCT01683071|584069408|FG000|Part 2|Withdrawal by Subject|0|||
161734992|NCT01683071|584069409|FG001|Part 2|Withdrawal by Subject|0|||
161734993|NCT01683071|584069410|FG002|Part 2|Withdrawal by Subject|0|||
161734994|NCT01683071|584069411|FG003|Part 2|Withdrawal by Subject|0|||
161734995|NCT01683071|584069412|FG004|Part 2|Withdrawal by Subject|3|||
161734996|NCT01683071|584069413|FG005|Part 2|Withdrawal by Subject|3|||
161734997|NCT01683071|584069408|FG000|Part 2|Surgery cancelled|0|||
161734998|NCT01683071|584069409|FG001|Part 2|Surgery cancelled|0|||
161734999|NCT01683071|584069410|FG002|Part 2|Surgery cancelled|0|||
161735000|NCT01683071|584069411|FG003|Part 2|Surgery cancelled|0|||
161735001|NCT01683071|584069412|FG004|Part 2|Surgery cancelled|4|||
161735002|NCT01683071|584069413|FG005|Part 2|Surgery cancelled|2|||
161735003|NCT01683071|584069408|FG000|Part 2|Did not receive study drug|0|||
161735004|NCT01683071|584069409|FG001|Part 2|Did not receive study drug|0|||
161735005|NCT01683071|584069410|FG002|Part 2|Did not receive study drug|0|||
161735006|NCT01683071|584069411|FG003|Part 2|Did not receive study drug|0|||
161735007|NCT01683071|584069412|FG004|Part 2|Did not receive study drug|2|||
161735008|NCT01683071|584069413|FG005|Part 2|Did not receive study drug|1|||
161735009|NCT01683071|584069408|FG000|Part 2|Met exclusion criterion|0|||
161735010|NCT01683071|584069409|FG001|Part 2|Met exclusion criterion|0|||
161965906|NCT02449889|584921890|FG001|Overall Study|Adverse Event|2|||
161965907|NCT02449889|584921891|FG002|Overall Study|Adverse Event|0|||
161965908|NCT02449889|584921889|FG000|Overall Study|Protocol Violation|0|||
161965909|NCT02449889|584921890|FG001|Overall Study|Protocol Violation|4|||
161965910|NCT02449889|584921891|FG002|Overall Study|Protocol Violation|1|||
161735011|NCT01683071|584069410|FG002|Part 2|Met exclusion criterion|0|||
161735012|NCT01683071|584069411|FG003|Part 2|Met exclusion criterion|0|||
161735013|NCT01683071|584069412|FG004|Part 2|Met exclusion criterion|1|||
161735014|NCT01683071|584069413|FG005|Part 2|Met exclusion criterion|1|||
161735015|NCT01683071|584069408|FG000|Part 2|Protocol deviation|0|||
161735016|NCT01683071|584069409|FG001|Part 2|Protocol deviation|0|||
161735017|NCT01683071|584069410|FG002|Part 2|Protocol deviation|0|||
161735018|NCT01683071|584069411|FG003|Part 2|Protocol deviation|0|||
161735019|NCT01683071|584069412|FG004|Part 2|Protocol deviation|1|||
161735020|NCT01683071|584069413|FG005|Part 2|Protocol deviation|2|||
161735021|NCT01683071|584069408|FG000|Part 2|Withdrawal by investigator decision|0|||
161735022|NCT01683071|584069409|FG001|Part 2|Withdrawal by investigator decision|0|||
161735023|NCT01683071|584069410|FG002|Part 2|Withdrawal by investigator decision|0|||
161735024|NCT01683071|584069411|FG003|Part 2|Withdrawal by investigator decision|0|||
161735025|NCT01683071|584069412|FG004|Part 2|Withdrawal by investigator decision|1|||
161735026|NCT01683071|584069413|FG005|Part 2|Withdrawal by investigator decision|2|||
161735027|NCT01708941|584070886|FG000|Overall Study|Adverse Event|4|||
161735028|NCT01708941|584070887|FG001|Overall Study|Adverse Event|6|||
161735029|NCT01708941|584070888|FG002|Overall Study|Adverse Event|1|||
161965911|NCT00758264|584921892|FG000|Active Phase|Withdrawal by Subject|0|||
161965912|NCT00758264|584921893|FG001|Active Phase|Withdrawal by Subject|0|||
161735030|NCT01708941|584070889|FG003|Overall Study|Adverse Event|0|||
161735031|NCT01708941|584070886|FG000|Overall Study|Death|1|||
161735032|NCT01708941|584070887|FG001|Overall Study|Death|1|||
161735033|NCT01708941|584070888|FG002|Overall Study|Death|2|||
161735034|NCT01708941|584070889|FG003|Overall Study|Death|14|||
161735035|NCT01708941|584070886|FG000|Overall Study|Withdrawal by Subject|1|||
161735036|NCT01708941|584070887|FG001|Overall Study|Withdrawal by Subject|0|||
161735037|NCT01708941|584070888|FG002|Overall Study|Withdrawal by Subject|3|||
161735038|NCT01708941|584070889|FG003|Overall Study|Withdrawal by Subject|4|||
161735039|NCT01708941|584070886|FG000|Overall Study|Disease progression|9|||
161735040|NCT01708941|584070887|FG001|Overall Study|Disease progression|10|||
161735041|NCT01708941|584070888|FG002|Overall Study|Disease progression|8|||
161735042|NCT01708941|584070889|FG003|Overall Study|Disease progression|0|||
161735043|NCT01708941|584070886|FG000|Overall Study|Alternative therapy|0|||
161735044|NCT01708941|584070887|FG001|Overall Study|Alternative therapy|0|||
161735045|NCT01708941|584070888|FG002|Overall Study|Alternative therapy|2|||
161735046|NCT01708941|584070889|FG003|Overall Study|Alternative therapy|0|||
161735047|NCT01708941|584070886|FG000|Overall Study|Ineligible and never started treatment|1|||
161735048|NCT01708941|584070887|FG001|Overall Study|Ineligible and never started treatment|0|||
161735049|NCT01708941|584070888|FG002|Overall Study|Ineligible and never started treatment|1|||
161735050|NCT01708941|584070889|FG003|Overall Study|Ineligible and never started treatment|0|||
161735051|NCT01708941|584070886|FG000|Overall Study|Never started treatment|2|||
161735052|NCT01708941|584070887|FG001|Overall Study|Never started treatment|1|||
161735053|NCT01708941|584070888|FG002|Overall Study|Never started treatment|0|||
161735054|NCT01708941|584070889|FG003|Overall Study|Never started treatment|0|||
161735055|NCT01708941|584070886|FG000|Overall Study|Ineligible|0|||
161735056|NCT01708941|584070887|FG001|Overall Study|Ineligible|0|||
161735057|NCT01708941|584070888|FG002|Overall Study|Ineligible|2|||
161735058|NCT01708941|584070889|FG003|Overall Study|Ineligible|0|||
161735059|NCT00229203|584070890|FG000|Overall Study|Progressive disease|18|||
161735060|NCT00229203|584070891|FG001|Overall Study|Progressive disease|9|||
161735061|NCT00229203|584070890|FG000|Overall Study|Toxicity|6|||
161735062|NCT00229203|584070891|FG001|Overall Study|Toxicity|1|||
161735063|NCT00229203|584070890|FG000|Overall Study|Death|4|||
161735064|NCT00229203|584070891|FG001|Overall Study|Death|2|||
161735065|NCT00229203|584070890|FG000|Overall Study|Other|3|||
161735066|NCT00229203|584070891|FG001|Overall Study|Other|3|||
161735067|NCT00229203|584070890|FG000|Overall Study|Withdrawal by Subject|1|||
161735068|NCT00229203|584070891|FG001|Overall Study|Withdrawal by Subject|4|||
161735069|NCT03457103|584070892|FG000|Overall Study|illness/hospitalization|4|||
161735070|NCT03457103|584070893|FG001|Overall Study|illness/hospitalization|2|||
161735071|NCT03457103|584070892|FG000|Overall Study|Lost to Follow-up|2|||
161735072|NCT03457103|584070893|FG001|Overall Study|Lost to Follow-up|1|||
161735073|NCT03457103|584070892|FG000|Overall Study|Withdrawal by Subject|1|||
161735074|NCT03457103|584070893|FG001|Overall Study|Withdrawal by Subject|2|||
161735075|NCT03457103|584070892|FG000|Overall Study|financial/ insurance issues|1|||
161735076|NCT03457103|584070893|FG001|Overall Study|financial/ insurance issues|1|||
161735077|NCT00423735|584070894|FG000|Overall Study|Ineligible / No protocol treatment|8|||
161735078|NCT00423735|584070895|FG001|Overall Study|Ineligible / No protocol treatment|6|||
161735079|NCT00423735|584070896|FG002|Overall Study|Ineligible / No protocol treatment|0|||
161735080|NCT02394808|584070897|FG000|Period 1|Unsatisfactory lens fitting|0|||
161965913|NCT00758264|584921894|FG002|Active Phase|Withdrawal by Subject|1|||
161965914|NCT00758264|584921892|FG000|Active Phase|Lost to Follow-up|1|||
161965915|NCT00758264|584921893|FG001|Active Phase|Lost to Follow-up|0|||
161965916|NCT00758264|584921894|FG002|Active Phase|Lost to Follow-up|0|||
161965917|NCT00758264|584921892|FG000|Active Phase|Other|0|||
161965918|NCT00758264|584921893|FG001|Active Phase|Other|0|||
161965919|NCT00758264|584921894|FG002|Active Phase|Other|4|||
161735081|NCT02394808|584070898|FG001|Period 1|Unsatisfactory lens fitting|1|||
161735082|NCT02394808|584070897|FG000|Period 2|Lost to Follow-up|1|||
161735083|NCT02394808|584070898|FG001|Period 2|Lost to Follow-up|0|||
161735084|NCT03150095|584070899|FG000|Overall Study|Death|0|||
161735085|NCT03150095|584070900|FG001|Overall Study|Death|1|||
161735086|NCT03150095|584070899|FG000|Overall Study|Lost to Follow-up|1|||
161735087|NCT03150095|584070900|FG001|Overall Study|Lost to Follow-up|1|||
161735088|NCT03150095|584070899|FG000|Overall Study|Withdrawal by Subject|4|||
161735089|NCT03150095|584070900|FG001|Overall Study|Withdrawal by Subject|0|||
161735090|NCT03150095|584070899|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
161735091|NCT03150095|584070900|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
161735092|NCT04032171|584070902|FG000|Overall Study|Study Termination|1|||
161735093|NCT04032171|584070903|FG001|Overall Study|Study Termination|0|||
161735094|NCT00089479|584070913|FG000|Overall Study|Death|108|||
161735095|NCT00089479|584070914|FG001|Overall Study|Death|75|||
161735096|NCT00089479|584070913|FG000|Overall Study|Withdrawal by Subject|86|||
161735097|NCT00089479|584070914|FG001|Overall Study|Withdrawal by Subject|107|||
161735098|NCT00089479|584070913|FG000|Overall Study|Lost to Follow-up|137|||
161735099|NCT00089479|584070914|FG001|Overall Study|Lost to Follow-up|107|||
161965920|NCT00368836|584921896|FG000|Phase II|Screen Failure|1|||
161965921|NCT00368836|584921896|FG000|Phase II|Withdrawal by Subject|1|||
161839983|NCT00975286|584458683|FG000|Overall Study|Poor Compliance to Protocol|0|||
161839984|NCT00975286|584458684|FG001|Overall Study|Poor Compliance to Protocol|2|||
162032326|NCT01986933|585175477|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
162032327|NCT01986933|585175478|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
162032328|NCT01986933|585175474|FG000|Active-to-active (Part B)|Adverse Event|0|||
162032329|NCT01986933|585175475|FG001|Active-to-active (Part B)|Adverse Event|2|||
162032330|NCT01986933|585175476|FG002|Active-to-active (Part B)|Adverse Event|0|||
162032331|NCT01986933|585175477|FG003|Active-to-active (Part B)|Adverse Event|1|||
162032332|NCT01986933|585175478|FG004|Active-to-active (Part B)|Adverse Event|3|||
162032333|NCT01986933|585175474|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
162032334|NCT01986933|585175475|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
162032335|NCT01986933|585175476|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
162032336|NCT01986933|585175477|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
162032337|NCT01986933|585175478|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
162032338|NCT01986933|585175474|FG000|Active-to-active (Part B)|Pregnancy|0|||
162032339|NCT01986933|585175475|FG001|Active-to-active (Part B)|Pregnancy|0|||
162032340|NCT01986933|585175476|FG002|Active-to-active (Part B)|Pregnancy|0|||
162032341|NCT01986933|585175477|FG003|Active-to-active (Part B)|Pregnancy|0|||
162032342|NCT01986933|585175478|FG004|Active-to-active (Part B)|Pregnancy|1|||
162032343|NCT01986933|585175474|FG000|Active-to-active (Part B)|Physician Decision|0|||
161735100|NCT03943953|584070915|FG000|Trial of ITG 1|Lost to Follow-up|19|||
162032344|NCT01986933|585175475|FG001|Active-to-active (Part B)|Physician Decision|0|||
162032345|NCT01986933|585175476|FG002|Active-to-active (Part B)|Physician Decision|1|||
162032346|NCT01986933|585175477|FG003|Active-to-active (Part B)|Physician Decision|1|||
162032347|NCT01986933|585175478|FG004|Active-to-active (Part B)|Physician Decision|0|||
162032348|NCT01986933|585175474|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
162032349|NCT01986933|585175475|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
162032350|NCT01986933|585175476|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
162032351|NCT01986933|585175477|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
162032352|NCT01986933|585175478|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
162032353|NCT01986933|585175474|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
162032354|NCT01986933|585175475|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
161735101|NCT03943953|584070916|FG001|Trial of ITG 1|Lost to Follow-up|1|||
161735102|NCT03943953|584070915|FG000|Trial of ITG 2|Lost to Follow-up|8|||
161735103|NCT03943953|584070916|FG001|Trial of ITG 2|Lost to Follow-up|0|||
161735104|NCT03943953|584070915|FG000|Trial of ITG 3|Lost to Follow-up|2|||
161735105|NCT03943953|584070916|FG001|Trial of ITG 3|Lost to Follow-up|0|||
161735106|NCT03943953|584070915|FG000|Trial of ITG 4|Lost to Follow-up|2|||
161735107|NCT03943953|584070916|FG001|Trial of ITG 4|Lost to Follow-up|0|||
161735108|NCT00289185|584070919|FG000|Overall Study|Withdrawal by Subject|4|||
161735109|NCT00289185|584070920|FG001|Overall Study|Withdrawal by Subject|8|||
161735110|NCT00289185|584070919|FG000|Overall Study|Lost to Follow-up|23|||
161735111|NCT00289185|584070920|FG001|Overall Study|Lost to Follow-up|17|||
161735112|NCT00289185|584070919|FG000|Overall Study|Death|1|||
161735113|NCT00289185|584070920|FG001|Overall Study|Death|1|||
161735114|NCT01124448|584070921|FG000|Overall Study|Lost to Follow-up|0|||
161735115|NCT01124448|584070922|FG001|Overall Study|Lost to Follow-up|3|||
161735116|NCT01124448|584070921|FG000|Overall Study|Protocol Violation|2|||
161735117|NCT01124448|584070922|FG001|Overall Study|Protocol Violation|0|||
161735118|NCT03337152|584070927|FG000|Overall Study|Physician Decision|1|||
161735119|NCT03337152|584070928|FG001|Overall Study|Physician Decision|0|||
161735120|NCT03337152|584070927|FG000|Overall Study|Lost to Follow-up|1|||
161735121|NCT03337152|584070928|FG001|Overall Study|Lost to Follow-up|3|||
161735122|NCT03337152|584070927|FG000|Overall Study|Adverse Event|3|||
161735123|NCT03337152|584070928|FG001|Overall Study|Adverse Event|1|||
161735124|NCT03337152|584070927|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
161735125|NCT03337152|584070928|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
161735126|NCT00421343|584070929|FG000|Overall Study|Death|1|||
161839985|NCT00975286|584458683|FG000|Overall Study|Sponsor Decision|0|||
161839986|NCT00975286|584458684|FG001|Overall Study|Sponsor Decision|2|||
162032355|NCT01986933|585175476|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
162032356|NCT01986933|585175477|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
162032357|NCT01986933|585175478|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
162032358|NCT01986933|585175474|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
161735127|NCT00421343|584070929|FG000|Overall Study|Withdrawal by Subject|2|||
161735128|NCT00421343|584070929|FG000|Overall Study|Lost to Follow-up|3|||
161735129|NCT03471767|584070930|FG000|Overall Study|Withdrawal by Subject|3|||
161735130|NCT03471767|584070931|FG001|Overall Study|Withdrawal by Subject|1|||
161735131|NCT03471767|584070930|FG000|Overall Study|Adverse Event|1|||
161735132|NCT03471767|584070931|FG001|Overall Study|Adverse Event|0|||
161735133|NCT03471767|584070930|FG000|Overall Study|Lost to Follow-up|1|||
161735134|NCT03471767|584070931|FG001|Overall Study|Lost to Follow-up|0|||
161735135|NCT03471767|584070930|FG000|Overall Study|PI Withdrawal|1|||
161735136|NCT03471767|584070931|FG001|Overall Study|PI Withdrawal|3|||
161735137|NCT00678587|584070932|FG000|Overall Study|Adverse Event|3|||
161735138|NCT00678587|584070933|FG001|Overall Study|Adverse Event|3|||
161735139|NCT00678587|584070932|FG000|Overall Study|Lack of Efficacy|1|||
161735140|NCT00678587|584070933|FG001|Overall Study|Lack of Efficacy|0|||
161735141|NCT00678587|584070932|FG000|Overall Study|Protocol Violation|2|||
161735142|NCT00678587|584070933|FG001|Overall Study|Protocol Violation|1|||
161735143|NCT00678587|584070932|FG000|Overall Study|Study Closed/Terminated|1|||
161735144|NCT00678587|584070933|FG001|Overall Study|Study Closed/Terminated|0|||
161735145|NCT00678587|584070932|FG000|Overall Study|Lost to Follow-up|3|||
161735146|NCT00678587|584070933|FG001|Overall Study|Lost to Follow-up|5|||
161735147|NCT00678587|584070932|FG000|Overall Study|Investigator Discretion|2|||
161735148|NCT00678587|584070933|FG001|Overall Study|Investigator Discretion|6|||
161735149|NCT00678587|584070932|FG000|Overall Study|Withdrew Consent|8|||
161735150|NCT00678587|584070933|FG001|Overall Study|Withdrew Consent|3|||
161735151|NCT01952730|584070936|FG000|Overall Study|FDA shut down core lab used by study|1|||
161735152|NCT00976950|584070940|FG000|Overall Study|Adverse Event|3|||
161735153|NCT00976950|584070940|FG000|Overall Study|Events with no relationship to Aptivus|3|||
161735154|NCT01514188|584070943|FG000|Overall Study|Adverse Event|3|||
161735155|NCT01514188|584070944|FG001|Overall Study|Adverse Event|5|||
161735156|NCT01514188|584070943|FG000|Overall Study|Withdrawal by Subject|2|||
161735157|NCT01514188|584070944|FG001|Overall Study|Withdrawal by Subject|4|||
161735158|NCT01514188|584070943|FG000|Overall Study|Protocol Violation|2|||
161735159|NCT01514188|584070944|FG001|Overall Study|Protocol Violation|4|||
161735160|NCT01514188|584070943|FG000|Overall Study|Physician Decision|0|||
161735161|NCT01514188|584070944|FG001|Overall Study|Physician Decision|2|||
161735162|NCT01514188|584070943|FG000|Overall Study|Disease Progression|13|||
161735163|NCT01514188|584070944|FG001|Overall Study|Disease Progression|14|||
161735164|NCT01514188|584070943|FG000|Overall Study|Death|1|||
161735165|NCT01514188|584070944|FG001|Overall Study|Death|3|||
161735166|NCT01514188|584070943|FG000|Overall Study|Other|2|||
161735167|NCT01514188|584070944|FG001|Overall Study|Other|1|||
161735168|NCT01019486|584070945|FG000|Overall Study|Withdrawal by Subject|1|||
161735169|NCT01019486|584070946|FG001|Overall Study|Withdrawal by Subject|1|||
161735170|NCT01019486|584070947|FG002|Overall Study|Withdrawal by Subject|1|||
161735171|NCT02932332|584070948|FG000|Overall Study|Withdrawal by Subject|1|||
161735172|NCT02932332|584070949|FG001|Overall Study|Withdrawal by Subject|1|||
161735173|NCT02932332|584070950|FG002|Overall Study|Withdrawal by Subject|0|||
161735174|NCT02932332|584070951|FG003|Overall Study|Withdrawal by Subject|1|||
161735175|NCT02932332|584070948|FG000|Overall Study|Chest pain|0|||
161735176|NCT02932332|584070949|FG001|Overall Study|Chest pain|0|||
161735177|NCT02932332|584070950|FG002|Overall Study|Chest pain|0|||
161735178|NCT02932332|584070951|FG003|Overall Study|Chest pain|1|||
161735179|NCT02932332|584070948|FG000|Overall Study|Not Dyspneic cough|1|||
161735180|NCT02932332|584070949|FG001|Overall Study|Not Dyspneic cough|2|||
161735181|NCT02932332|584070950|FG002|Overall Study|Not Dyspneic cough|1|||
161735182|NCT02932332|584070951|FG003|Overall Study|Not Dyspneic cough|0|||
161735183|NCT01069523|584070953|FG000|Overall Study|Withdrawal by Subject|4|||
161735184|NCT01069523|584070954|FG001|Overall Study|Withdrawal by Subject|7|||
161735185|NCT01875367|584070955|FG000|Overall Study|Not complete at least 2 questionaries|4|||
161735186|NCT01875367|584070956|FG001|Overall Study|Not complete at least 2 questionaries|2|||
161735187|NCT01875367|584070955|FG000|Overall Study|Not receive study treatment|1|||
161735188|NCT01875367|584070956|FG001|Overall Study|Not receive study treatment|0|||
161735189|NCT02951988|584070957|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
161735190|NCT02951988|584070958|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
161735191|NCT02951988|584070959|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
161735192|NCT02951988|584070960|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
161735193|NCT02951988|584070957|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
161735194|NCT02951988|584070958|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
161735195|NCT02951988|584070959|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
161735196|NCT02951988|584070960|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
161839987|NCT03456960|584458689|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161735197|NCT02951988|584070957|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
161735198|NCT02951988|584070958|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
161735199|NCT02951988|584070959|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
161735200|NCT02951988|584070960|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
161735201|NCT02951988|584070957|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
161735202|NCT02951988|584070958|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
161735203|NCT02951988|584070959|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
161735204|NCT02951988|584070960|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
161735205|NCT02951988|584070957|FG000|Open-Label Treatment Period|Protocol Violation|22|||
161735206|NCT02951988|584070958|FG001|Open-Label Treatment Period|Protocol Violation|0|||
161735207|NCT02951988|584070959|FG002|Open-Label Treatment Period|Protocol Violation|0|||
161735208|NCT02951988|584070960|FG003|Open-Label Treatment Period|Protocol Violation|0|||
161735209|NCT02951988|584070957|FG000|Open-Label Treatment Period|Pregnancy|2|||
161735210|NCT02951988|584070958|FG001|Open-Label Treatment Period|Pregnancy|0|||
161735211|NCT02951988|584070959|FG002|Open-Label Treatment Period|Pregnancy|0|||
161735212|NCT02951988|584070960|FG003|Open-Label Treatment Period|Pregnancy|0|||
161735213|NCT02951988|584070957|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
161735214|NCT02951988|584070958|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
161735215|NCT02951988|584070959|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
161735216|NCT02951988|584070960|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
161735217|NCT02951988|584070957|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
161735218|NCT02951988|584070958|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
161735219|NCT02951988|584070959|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
161735220|NCT02951988|584070960|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
161735221|NCT02951988|584070957|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
161735222|NCT02951988|584070958|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
161735223|NCT02951988|584070959|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
161735224|NCT02951988|584070960|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
161735225|NCT02951988|584070957|FG000|Open-Label Treatment Period|Adverse Event|45|||
161735226|NCT02951988|584070958|FG001|Open-Label Treatment Period|Adverse Event|0|||
161735227|NCT02951988|584070959|FG002|Open-Label Treatment Period|Adverse Event|0|||
161735228|NCT02951988|584070960|FG003|Open-Label Treatment Period|Adverse Event|0|||
161735229|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
161735230|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
161735231|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
161735232|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
161735233|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
161735234|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
161735235|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
161735236|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
161735237|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
161735238|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
161735239|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
161735240|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
161735241|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
161735242|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
161735243|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
161735244|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
161735245|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Pregnancy|0|||
161735246|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Pregnancy|1|||
161735247|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Pregnancy|1|||
161735248|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Pregnancy|0|||
161735249|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161735250|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
161735251|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
161735252|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
161735253|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161735254|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
161735255|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
161735256|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
161735257|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161735258|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Adverse Event|8|||
161735259|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Adverse Event|3|||
161735260|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Adverse Event|6|||
161735261|NCT02951988|584070957|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
161735262|NCT02951988|584070958|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
161735263|NCT02951988|584070959|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
161735264|NCT02951988|584070960|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
161735265|NCT03352414|584070964|FG000|Overall Study|Ineligible by operative criteria|12|||
161735266|NCT03352414|584070965|FG001|Overall Study|Ineligible by operative criteria|10|||
161735267|NCT00516269|584070966|FG000|Overall Study|Adverse Event|2|||
161735268|NCT00516269|584070967|FG001|Overall Study|Adverse Event|1|||
161735269|NCT00516269|584070966|FG000|Overall Study|Lost to Follow-up|0|||
161735270|NCT00516269|584070967|FG001|Overall Study|Lost to Follow-up|1|||
161735271|NCT00516269|584070966|FG000|Overall Study|Protocol Violation|0|||
161735272|NCT00516269|584070967|FG001|Overall Study|Protocol Violation|1|||
161735273|NCT04570657|584070970|FG000|Overall Study|Adverse Event|0|||
161735274|NCT04570657|584070971|FG001|Overall Study|Adverse Event|0|||
161735275|NCT04570657|584070972|FG002|Overall Study|Adverse Event|1|||
161735276|NCT04570657|584070970|FG000|Overall Study|Lost to Follow-up|0|||
161735277|NCT04570657|584070971|FG001|Overall Study|Lost to Follow-up|0|||
161735278|NCT04570657|584070972|FG002|Overall Study|Lost to Follow-up|1|||
161735279|NCT04570657|584070970|FG000|Overall Study|Physician Decision|0|||
161735280|NCT04570657|584070971|FG001|Overall Study|Physician Decision|1|||
161735281|NCT04570657|584070972|FG002|Overall Study|Physician Decision|0|||
162032359|NCT01986933|585175475|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
162032360|NCT01986933|585175476|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
162032361|NCT01986933|585175477|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
162032362|NCT01986933|585175478|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
162032363|NCT01986933|585175474|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
162032364|NCT01986933|585175475|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
162032365|NCT01986933|585175476|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
162032366|NCT01986933|585175477|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
162032367|NCT01986933|585175478|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
162032368|NCT01986933|585175474|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
162032369|NCT01986933|585175475|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
162032370|NCT01986933|585175476|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
162032371|NCT01986933|585175477|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
162032372|NCT01986933|585175478|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
162032373|NCT01986933|585175474|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
162032374|NCT01986933|585175475|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
162032375|NCT01986933|585175476|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
162032376|NCT01986933|585175477|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
162032377|NCT01986933|585175478|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
162032378|NCT01986933|585175474|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
162032379|NCT01986933|585175475|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
162032380|NCT01986933|585175476|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
162032381|NCT01986933|585175477|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
162032382|NCT01986933|585175478|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
162032383|NCT01986933|585175474|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
162032384|NCT01986933|585175475|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
161735282|NCT04570657|584070970|FG000|Overall Study|Withdrawal by Subject|1|||
161735283|NCT04570657|584070971|FG001|Overall Study|Withdrawal by Subject|2|||
161735284|NCT04570657|584070972|FG002|Overall Study|Withdrawal by Subject|2|||
161735285|NCT01079962|584070973|FG000|Overall Study|Adverse Event|2|||
161735286|NCT01079962|584070974|FG001|Overall Study|Adverse Event|2|||
161735287|NCT01079962|584070973|FG000|Overall Study|Withdrawal by Subject|5|||
161735288|NCT01079962|584070974|FG001|Overall Study|Withdrawal by Subject|7|||
161735289|NCT01079962|584070973|FG000|Overall Study|Protocol Violation|2|||
161735290|NCT01079962|584070974|FG001|Overall Study|Protocol Violation|2|||
161735291|NCT01079962|584070973|FG000|Overall Study|No blood pressure (BP) control|3|||
161735292|NCT01079962|584070974|FG001|Overall Study|No blood pressure (BP) control|0|||
161735293|NCT01079962|584070973|FG000|Overall Study|Inclusion/exclusion criteria|1|||
161735294|NCT01079962|584070974|FG001|Overall Study|Inclusion/exclusion criteria|3|||
161735295|NCT01079962|584070973|FG000|Overall Study|Participant not returning for next visit|1|||
161735296|NCT01079962|584070974|FG001|Overall Study|Participant not returning for next visit|0|||
161735297|NCT01079962|584070973|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
161735298|NCT01079962|584070974|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
161735299|NCT01331239|584070975|FG000|Part II: Core Study|Adverse Event|0|||
161735300|NCT01331239|584070976|FG001|Part II: Core Study|Adverse Event|3|||
161735301|NCT01331239|584070977|FG002|Part II: Core Study|Adverse Event|0|||
161735302|NCT01331239|584070975|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
161735303|NCT01331239|584070976|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
161735304|NCT01331239|584070977|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
161735305|NCT01331239|584070975|FG000|Part II: Core Study|Withdrawal by Subject|0|||
161735306|NCT01331239|584070976|FG001|Part II: Core Study|Withdrawal by Subject|2|||
162032385|NCT01986933|585175476|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
162032386|NCT01986933|585175477|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
162032387|NCT01986933|585175478|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
162032388|NCT01077154|585175479|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
162032389|NCT01077154|585175480|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
162032390|NCT01077154|585175479|FG000|Overall Study|Withdrawal by Subject|369|||
162032391|NCT01077154|585175480|FG001|Overall Study|Withdrawal by Subject|385|||
162032392|NCT01077154|585175479|FG000|Overall Study|Death|215|||
162032393|NCT01077154|585175480|FG001|Overall Study|Death|214|||
162032394|NCT01077154|585175479|FG000|Overall Study|Lost to Follow-up|43|||
162032395|NCT01077154|585175480|FG001|Overall Study|Lost to Follow-up|35|||
162032396|NCT01077154|585175479|FG000|Overall Study|Noncompliance|22|||
162032397|NCT01077154|585175480|FG001|Overall Study|Noncompliance|20|||
161735307|NCT01331239|584070977|FG002|Part II: Core Study|Withdrawal by Subject|0|||
161735308|NCT01331239|584070975|FG000|Part II: Core Study|Administrative problems|0|||
161735309|NCT01331239|584070976|FG001|Part II: Core Study|Administrative problems|1|||
161839988|NCT03456960|584458690|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161735310|NCT01331239|584070977|FG002|Part II: Core Study|Administrative problems|0|||
161735311|NCT01072539|584070978|FG000|Overall Study|Treated prior to the Site Initiation|1|||
161735312|NCT01072539|584070978|FG000|Overall Study|Protocol Violation|2|||
161735313|NCT00946530|584070979|FG000|Overall Study|Withdrawal by Subject|0|||
161735314|NCT00946530|584070980|FG001|Overall Study|Withdrawal by Subject|3|||
161735315|NCT00946530|584070981|FG002|Overall Study|Withdrawal by Subject|0|||
161735316|NCT00946530|584070982|FG003|Overall Study|Withdrawal by Subject|3|||
161735317|NCT00946530|584070979|FG000|Overall Study|Physician Decision|1|||
161735318|NCT00946530|584070980|FG001|Overall Study|Physician Decision|1|||
161735319|NCT00946530|584070981|FG002|Overall Study|Physician Decision|1|||
161735320|NCT00946530|584070982|FG003|Overall Study|Physician Decision|1|||
161735321|NCT04167306|584070983|FG000|Overall Study|Lost to Follow-up|2|||
161735322|NCT04167306|584070984|FG001|Overall Study|Lost to Follow-up|2|||
161735323|NCT04167306|584070985|FG002|Overall Study|Lost to Follow-up|5|||
161735324|NCT04167306|584070986|FG003|Overall Study|Lost to Follow-up|5|||
161735325|NCT04167306|584070983|FG000|Overall Study|Adverse Event|13|||
161735326|NCT04167306|584070984|FG001|Overall Study|Adverse Event|14|||
161735327|NCT04167306|584070985|FG002|Overall Study|Adverse Event|5|||
161735328|NCT04167306|584070986|FG003|Overall Study|Adverse Event|4|||
161735329|NCT04167306|584070983|FG000|Overall Study|Withdrawal by Subject|4|||
161735330|NCT04167306|584070984|FG001|Overall Study|Withdrawal by Subject|6|||
161735331|NCT04167306|584070985|FG002|Overall Study|Withdrawal by Subject|8|||
161735332|NCT04167306|584070986|FG003|Overall Study|Withdrawal by Subject|3|||
161735333|NCT04167306|584070983|FG000|Overall Study|covid|1|||
161735334|NCT04167306|584070984|FG001|Overall Study|covid|1|||
161735335|NCT04167306|584070985|FG002|Overall Study|covid|2|||
161735336|NCT04167306|584070986|FG003|Overall Study|covid|1|||
161735337|NCT04167306|584070983|FG000|Overall Study|concomitant medication|0|||
161735338|NCT04167306|584070984|FG001|Overall Study|concomitant medication|0|||
161735339|NCT04167306|584070985|FG002|Overall Study|concomitant medication|0|||
161735340|NCT04167306|584070986|FG003|Overall Study|concomitant medication|1|||
161735341|NCT04167306|584070983|FG000|Overall Study|Alcohol treatment|0|||
161735342|NCT04167306|584070984|FG001|Overall Study|Alcohol treatment|4|||
161735343|NCT04167306|584070985|FG002|Overall Study|Alcohol treatment|3|||
161735344|NCT04167306|584070986|FG003|Overall Study|Alcohol treatment|2|||
161735345|NCT04167306|584070983|FG000|Overall Study|non-compliance|0|||
161735346|NCT04167306|584070984|FG001|Overall Study|non-compliance|0|||
161735347|NCT04167306|584070985|FG002|Overall Study|non-compliance|1|||
161735348|NCT04167306|584070986|FG003|Overall Study|non-compliance|0|||
161735349|NCT04167306|584070983|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
161735350|NCT04167306|584070984|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
161735351|NCT04167306|584070985|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
161735352|NCT04167306|584070986|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
161735353|NCT00621855|584070987|FG000|Overall Study|Adverse Event|32|||
161735354|NCT00621855|584070988|FG001|Overall Study|Adverse Event|31|||
161735355|NCT00621855|584070989|FG002|Overall Study|Adverse Event|48|||
161735356|NCT00621855|584070990|FG003|Overall Study|Adverse Event|34|||
161735357|NCT00621855|584070991|FG004|Overall Study|Adverse Event|31|||
161735358|NCT00621855|584070987|FG000|Overall Study|Lost to Follow-up|0|||
161735359|NCT00621855|584070988|FG001|Overall Study|Lost to Follow-up|1|||
161735360|NCT00621855|584070989|FG002|Overall Study|Lost to Follow-up|3|||
161735361|NCT00621855|584070990|FG003|Overall Study|Lost to Follow-up|4|||
161735362|NCT00621855|584070991|FG004|Overall Study|Lost to Follow-up|1|||
161735363|NCT00621855|584070987|FG000|Overall Study|Protocol Violation|16|||
161735364|NCT00621855|584070988|FG001|Overall Study|Protocol Violation|8|||
161735365|NCT00621855|584070989|FG002|Overall Study|Protocol Violation|6|||
161735366|NCT00621855|584070990|FG003|Overall Study|Protocol Violation|7|||
161735367|NCT00621855|584070991|FG004|Overall Study|Protocol Violation|8|||
161839989|NCT03456960|584458691|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
161839990|NCT03456960|584458692|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
161965922|NCT00368836|584921896|FG000|Phase II|unable to collect blood and/or breath|17|||
161735368|NCT00621855|584070987|FG000|Overall Study|Withdrawal by Subject|16|||
161735369|NCT00621855|584070988|FG001|Overall Study|Withdrawal by Subject|11|||
161839991|NCT03456960|584458693|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161839992|NCT03456960|584458694|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161839993|NCT03456960|584458689|FG000|Period 2 (1 Day)|Adverse Event|1|||
161965923|NCT00368836|584921896|FG000|Phase II|Protocol Violation|2|||
161735370|NCT00621855|584070989|FG002|Overall Study|Withdrawal by Subject|13|||
161735371|NCT00621855|584070990|FG003|Overall Study|Withdrawal by Subject|13|||
161735372|NCT00621855|584070991|FG004|Overall Study|Withdrawal by Subject|9|||
161735373|NCT00621855|584070987|FG000|Overall Study|Other|9|||
161735374|NCT00621855|584070988|FG001|Overall Study|Other|7|||
161735375|NCT00621855|584070989|FG002|Overall Study|Other|6|||
161735376|NCT00621855|584070990|FG003|Overall Study|Other|5|||
161735377|NCT00621855|584070991|FG004|Overall Study|Other|4|||
161735378|NCT00621855|584070987|FG000|Overall Study|Patients did not receive study drug|3|||
161735379|NCT00621855|584070988|FG001|Overall Study|Patients did not receive study drug|3|||
161735380|NCT00621855|584070989|FG002|Overall Study|Patients did not receive study drug|5|||
161735381|NCT00621855|584070990|FG003|Overall Study|Patients did not receive study drug|4|||
161735382|NCT00621855|584070991|FG004|Overall Study|Patients did not receive study drug|2|||
161735383|NCT03731364|584070992|FG000|Overall Study|Adverse Event|0|||
161735384|NCT03731364|584070993|FG001|Overall Study|Adverse Event|0|||
161735385|NCT03731364|584070994|FG002|Overall Study|Adverse Event|1|||
161735386|NCT03731364|584070995|FG003|Overall Study|Adverse Event|2|||
161735387|NCT03731364|584070996|FG004|Overall Study|Adverse Event|1|||
161735388|NCT04387136|584070997|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
161735389|NCT04387136|584070998|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
161735390|NCT00417976|584070999|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
161735391|NCT00417976|584070999|FG000|Overall Study|Treatment -related toxicity|2|||
161735392|NCT02358369|584071000|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
161735393|NCT02358369|584071001|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
161735394|NCT02358369|584071002|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
161735395|NCT02358369|584071003|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
161735396|NCT02358369|584071004|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
161735397|NCT02358369|584071000|FG000|Treatment Period A/B|Adverse Event|0|||
161735398|NCT02358369|584071001|FG001|Treatment Period A/B|Adverse Event|0|||
161735399|NCT02358369|584071002|FG002|Treatment Period A/B|Adverse Event|1|||
161735400|NCT02358369|584071003|FG003|Treatment Period A/B|Adverse Event|2|||
161735401|NCT02358369|584071004|FG004|Treatment Period A/B|Adverse Event|0|||
161735402|NCT02358369|584071000|FG000|Treatment Period A/B|Death|0|||
161735403|NCT02358369|584071001|FG001|Treatment Period A/B|Death|0|||
161735404|NCT02358369|584071002|FG002|Treatment Period A/B|Death|1|||
161735405|NCT02358369|584071003|FG003|Treatment Period A/B|Death|0|||
161735406|NCT02358369|584071004|FG004|Treatment Period A/B|Death|0|||
161735407|NCT02358369|584071000|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
161735408|NCT02358369|584071001|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
161735409|NCT02358369|584071002|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
161735410|NCT02358369|584071003|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
161735411|NCT02358369|584071004|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
161735412|NCT02358369|584071000|FG000|Treatment Period C|Adverse Event|0|||
161735413|NCT02358369|584071001|FG001|Treatment Period C|Adverse Event|0|||
161735414|NCT02358369|584071002|FG002|Treatment Period C|Adverse Event|0|||
161735415|NCT02358369|584071003|FG003|Treatment Period C|Adverse Event|0|||
161735416|NCT02358369|584071004|FG004|Treatment Period C|Adverse Event|7|||
161735417|NCT03655717|584071005|FG000|Overall Study|Withdrawal by Subject|4|||
161735418|NCT03655717|584071006|FG001|Overall Study|Withdrawal by Subject|8|||
161735419|NCT03655717|584071007|FG002|Overall Study|Withdrawal by Subject|1|||
161735420|NCT03655717|584071008|FG003|Overall Study|Withdrawal by Subject|0|||
161735421|NCT03655717|584071009|FG004|Overall Study|Withdrawal by Subject|0|||
161735422|NCT03655717|584071010|FG005|Overall Study|Withdrawal by Subject|1|||
161735423|NCT03655717|584071011|FG006|Overall Study|Withdrawal by Subject|3|||
161735424|NCT03655717|584071012|FG007|Overall Study|Withdrawal by Subject|1|||
161735425|NCT03655717|584071013|FG008|Overall Study|Withdrawal by Subject|2|||
161735426|NCT03655717|584071014|FG009|Overall Study|Withdrawal by Subject|0|||
161735427|NCT03655717|584071015|FG010|Overall Study|Withdrawal by Subject|0|||
161735428|NCT03655717|584071016|FG011|Overall Study|Withdrawal by Subject|1|||
161735429|NCT03655717|584071017|FG012|Overall Study|Withdrawal by Subject|0|||
161735430|NCT03655717|584071018|FG013|Overall Study|Withdrawal by Subject|3|||
161735431|NCT03655717|584071019|FG014|Overall Study|Withdrawal by Subject|0|||
161735432|NCT03655717|584071020|FG015|Overall Study|Withdrawal by Subject|1|||
161735433|NCT03655717|584071021|FG016|Overall Study|Withdrawal by Subject|0|||
161735434|NCT03655717|584071022|FG017|Overall Study|Withdrawal by Subject|0|||
161735435|NCT03655717|584071023|FG018|Overall Study|Withdrawal by Subject|1|||
161735436|NCT03655717|584071024|FG019|Overall Study|Withdrawal by Subject|0|||
161735437|NCT03655717|584071025|FG020|Overall Study|Withdrawal by Subject|0|||
161735438|NCT03655717|584071026|FG021|Overall Study|Withdrawal by Subject|1|||
161735439|NCT03655717|584071027|FG022|Overall Study|Withdrawal by Subject|2|||
161735440|NCT03655717|584071028|FG023|Overall Study|Withdrawal by Subject|1|||
161735441|NCT03655717|584071029|FG024|Overall Study|Withdrawal by Subject|1|||
161735442|NCT03655717|584071030|FG025|Overall Study|Withdrawal by Subject|0|||
161735443|NCT03655717|584071005|FG000|Overall Study|Physician Decision|3|||
161735444|NCT03655717|584071006|FG001|Overall Study|Physician Decision|3|||
161735445|NCT03655717|584071007|FG002|Overall Study|Physician Decision|0|||
161735446|NCT03655717|584071008|FG003|Overall Study|Physician Decision|0|||
161735447|NCT03655717|584071009|FG004|Overall Study|Physician Decision|0|||
161735448|NCT03655717|584071010|FG005|Overall Study|Physician Decision|0|||
161735449|NCT03655717|584071011|FG006|Overall Study|Physician Decision|0|||
161735450|NCT03655717|584071012|FG007|Overall Study|Physician Decision|0|||
161735451|NCT03655717|584071013|FG008|Overall Study|Physician Decision|0|||
161735452|NCT03655717|584071014|FG009|Overall Study|Physician Decision|1|||
161735453|NCT03655717|584071015|FG010|Overall Study|Physician Decision|0|||
161735454|NCT03655717|584071016|FG011|Overall Study|Physician Decision|0|||
161735455|NCT03655717|584071017|FG012|Overall Study|Physician Decision|0|||
161735456|NCT03655717|584071018|FG013|Overall Study|Physician Decision|0|||
161735457|NCT03655717|584071019|FG014|Overall Study|Physician Decision|0|||
161735458|NCT03655717|584071020|FG015|Overall Study|Physician Decision|0|||
161735459|NCT03655717|584071021|FG016|Overall Study|Physician Decision|0|||
161735460|NCT03655717|584071022|FG017|Overall Study|Physician Decision|0|||
161735461|NCT03655717|584071023|FG018|Overall Study|Physician Decision|0|||
161735462|NCT03655717|584071024|FG019|Overall Study|Physician Decision|1|||
161735463|NCT03655717|584071025|FG020|Overall Study|Physician Decision|0|||
161735464|NCT03655717|584071026|FG021|Overall Study|Physician Decision|0|||
161735465|NCT03655717|584071027|FG022|Overall Study|Physician Decision|0|||
161735466|NCT03655717|584071028|FG023|Overall Study|Physician Decision|1|||
161735467|NCT03655717|584071029|FG024|Overall Study|Physician Decision|0|||
161735468|NCT03655717|584071030|FG025|Overall Study|Physician Decision|0|||
161735469|NCT03655717|584071005|FG000|Overall Study|Lost to Follow-up|3|||
161735470|NCT03655717|584071006|FG001|Overall Study|Lost to Follow-up|1|||
161735471|NCT03655717|584071007|FG002|Overall Study|Lost to Follow-up|0|||
161735472|NCT03655717|584071008|FG003|Overall Study|Lost to Follow-up|1|||
161735473|NCT03655717|584071009|FG004|Overall Study|Lost to Follow-up|0|||
161735474|NCT03655717|584071010|FG005|Overall Study|Lost to Follow-up|1|||
161735475|NCT03655717|584071011|FG006|Overall Study|Lost to Follow-up|0|||
161735476|NCT03655717|584071012|FG007|Overall Study|Lost to Follow-up|0|||
161735477|NCT03655717|584071013|FG008|Overall Study|Lost to Follow-up|0|||
161735478|NCT03655717|584071014|FG009|Overall Study|Lost to Follow-up|0|||
161735479|NCT03655717|584071015|FG010|Overall Study|Lost to Follow-up|0|||
161735480|NCT03655717|584071016|FG011|Overall Study|Lost to Follow-up|1|||
161735481|NCT03655717|584071017|FG012|Overall Study|Lost to Follow-up|0|||
161735482|NCT03655717|584071018|FG013|Overall Study|Lost to Follow-up|0|||
161735483|NCT03655717|584071019|FG014|Overall Study|Lost to Follow-up|0|||
161735484|NCT03655717|584071020|FG015|Overall Study|Lost to Follow-up|0|||
161735485|NCT03655717|584071021|FG016|Overall Study|Lost to Follow-up|0|||
161735486|NCT03655717|584071022|FG017|Overall Study|Lost to Follow-up|0|||
161735487|NCT03655717|584071023|FG018|Overall Study|Lost to Follow-up|0|||
161735488|NCT03655717|584071024|FG019|Overall Study|Lost to Follow-up|0|||
161735489|NCT03655717|584071025|FG020|Overall Study|Lost to Follow-up|0|||
161735490|NCT03655717|584071026|FG021|Overall Study|Lost to Follow-up|0|||
161735491|NCT03655717|584071027|FG022|Overall Study|Lost to Follow-up|0|||
161735492|NCT03655717|584071028|FG023|Overall Study|Lost to Follow-up|0|||
161735493|NCT03655717|584071029|FG024|Overall Study|Lost to Follow-up|0|||
161735494|NCT03655717|584071030|FG025|Overall Study|Lost to Follow-up|0|||
161735495|NCT01185249|584071031|FG000|Overall Study|Patients discharged or change in status|42|||
161735496|NCT01973452|584071032|FG000|Overall Study|Lack of Efficacy|0|||
161735497|NCT01973452|584071033|FG001|Overall Study|Lack of Efficacy|1|||
161735498|NCT01973452|584071032|FG000|Overall Study|Lost to Follow-up|1|||
161735499|NCT01973452|584071033|FG001|Overall Study|Lost to Follow-up|0|||
161839994|NCT03456960|584458690|FG001|Period 2 (1 Day)|Adverse Event|0|||
161839995|NCT03456960|584458691|FG002|Period 2 (1 Day)|Adverse Event|0|||
161839996|NCT03456960|584458692|FG003|Period 2 (1 Day)|Adverse Event|1|||
161839997|NCT03456960|584458693|FG004|Period 2 (1 Day)|Adverse Event|0|||
161839998|NCT03456960|584458694|FG005|Period 2 (1 Day)|Adverse Event|0|||
161839999|NCT02989168|584458695|FG000|Overall Study|Withdrawal by Subject|2|||
161840000|NCT02989168|584458696|FG001|Overall Study|Withdrawal by Subject|0|||
161840001|NCT02989168|584458695|FG000|Overall Study|Physician Decision|0|||
161840002|NCT02989168|584458696|FG001|Overall Study|Physician Decision|1|||
161840003|NCT02989168|584458695|FG000|Overall Study|Adverse Event|1|||
161840004|NCT02989168|584458696|FG001|Overall Study|Adverse Event|2|||
161840005|NCT02989168|584458695|FG000|Overall Study|Sponsor stopped study.|1|||
161840006|NCT02989168|584458696|FG001|Overall Study|Sponsor stopped study.|0|||
161840007|NCT01940497|584458697|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
161840008|NCT01940497|584458698|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
161840009|NCT01940497|584458697|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
161840010|NCT01940497|584458698|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
161840011|NCT01940497|584458697|FG000|Overall Study|Violation of Entry Criteria|1|||
161840012|NCT01940497|584458698|FG001|Overall Study|Violation of Entry Criteria|1|||
161735500|NCT01973452|584071032|FG000|Overall Study|Withdrawal by Subject|10|||
161735501|NCT01973452|584071033|FG001|Overall Study|Withdrawal by Subject|9|||
161735502|NCT01973452|584071032|FG000|Overall Study|Ineligible|1|||
161735503|NCT01973452|584071033|FG001|Overall Study|Ineligible|1|||
161735504|NCT01973452|584071032|FG000|Overall Study|Surgery canceled by participant|5|||
161840013|NCT01940497|584458697|FG000|Overall Study|Refused Treatment|1|||
161735505|NCT01973452|584071033|FG001|Overall Study|Surgery canceled by participant|3|||
161735506|NCT00064350|584071035|FG000|Induction Treatment|Disease Progression|5|||
161735507|NCT00064350|584071036|FG001|Induction Treatment|Disease Progression|1|||
161840014|NCT01940497|584458698|FG001|Overall Study|Refused Treatment|3|||
161735508|NCT00064350|584071037|FG002|Induction Treatment|Disease Progression|110|||
161735509|NCT00064350|584071035|FG000|Induction Treatment|Adverse Event|0|||
161735510|NCT00064350|584071036|FG001|Induction Treatment|Adverse Event|2|||
161735511|NCT00064350|584071037|FG002|Induction Treatment|Adverse Event|49|||
161735512|NCT00064350|584071035|FG000|Induction Treatment|Death|0|||
161735513|NCT00064350|584071036|FG001|Induction Treatment|Death|0|||
161735514|NCT00064350|584071037|FG002|Induction Treatment|Death|9|||
161735515|NCT00064350|584071035|FG000|Induction Treatment|Withdrawal by Subject|0|||
161840015|NCT01940497|584458697|FG000|Overall Study|Withdrew Consent|6|||
161840016|NCT01940497|584458698|FG001|Overall Study|Withdrew Consent|2|||
161735516|NCT00064350|584071036|FG001|Induction Treatment|Withdrawal by Subject|0|||
161735517|NCT00064350|584071037|FG002|Induction Treatment|Withdrawal by Subject|21|||
161735518|NCT00064350|584071035|FG000|Induction Treatment|Ineligible or never started treatment|3|||
161735519|NCT00064350|584071036|FG001|Induction Treatment|Ineligible or never started treatment|6|||
161735520|NCT00064350|584071037|FG002|Induction Treatment|Ineligible or never started treatment|34|||
161735521|NCT00064350|584071035|FG000|Induction Treatment|Other|0|||
161735522|NCT00064350|584071036|FG001|Induction Treatment|Other|0|||
161735523|NCT00064350|584071037|FG002|Induction Treatment|Other|13|||
161735524|NCT00064350|584071035|FG000|Randomization|Adverse Event|8|||
161735525|NCT00064350|584071036|FG001|Randomization|Adverse Event|3|||
161735526|NCT00064350|584071037|FG002|Randomization|Adverse Event|0|||
161735527|NCT00064350|584071035|FG000|Randomization|Death|3|||
161735528|NCT00064350|584071036|FG001|Randomization|Death|0|||
161735529|NCT00064350|584071037|FG002|Randomization|Death|0|||
161735530|NCT00064350|584071035|FG000|Randomization|Withdrawal by Subject|1|||
161735531|NCT00064350|584071036|FG001|Randomization|Withdrawal by Subject|0|||
161735532|NCT00064350|584071037|FG002|Randomization|Withdrawal by Subject|0|||
161735533|NCT00064350|584071035|FG000|Randomization|Ineligible or never started treatment|9|||
161735534|NCT00064350|584071036|FG001|Randomization|Ineligible or never started treatment|15|||
161735535|NCT00064350|584071037|FG002|Randomization|Ineligible or never started treatment|0|||
161735536|NCT00064350|584071035|FG000|Randomization|Other|5|||
161735537|NCT00064350|584071036|FG001|Randomization|Other|0|||
161735538|NCT00064350|584071037|FG002|Randomization|Other|0|||
161735539|NCT00064350|584071035|FG000|Cross-Over|Adverse Event|0|||
161735540|NCT00064350|584071036|FG001|Cross-Over|Adverse Event|1|||
161735541|NCT00064350|584071037|FG002|Cross-Over|Adverse Event|0|||
161735542|NCT00064350|584071035|FG000|Cross-Over|Death|1|||
161735543|NCT00064350|584071036|FG001|Cross-Over|Death|3|||
161735544|NCT00064350|584071037|FG002|Cross-Over|Death|0|||
161735545|NCT00064350|584071035|FG000|Cross-Over|Withdrawal by Subject|2|||
161735546|NCT00064350|584071036|FG001|Cross-Over|Withdrawal by Subject|2|||
161735547|NCT00064350|584071037|FG002|Cross-Over|Withdrawal by Subject|0|||
161735548|NCT00064350|584071035|FG000|Cross-Over|Ineligible or never started treatment|3|||
161735549|NCT00064350|584071036|FG001|Cross-Over|Ineligible or never started treatment|6|||
161735550|NCT00064350|584071037|FG002|Cross-Over|Ineligible or never started treatment|0|||
161735551|NCT00064350|584071035|FG000|Cross-Over|Other|0|||
161735552|NCT00064350|584071036|FG001|Cross-Over|Other|2|||
161735553|NCT00064350|584071037|FG002|Cross-Over|Other|0|||
161735554|NCT00115765|584071038|FG000|Overall Study|Withdrawal by Subject|22|||
161735555|NCT00115765|584071039|FG001|Overall Study|Withdrawal by Subject|53|||
161735556|NCT00115765|584071040|FG002|Overall Study|Withdrawal by Subject|76|||
161735557|NCT00115765|584071041|FG003|Overall Study|Withdrawal by Subject|15|||
161735558|NCT00115765|584071038|FG000|Overall Study|Physician Decision|4|||
161735559|NCT00115765|584071039|FG001|Overall Study|Physician Decision|15|||
161735560|NCT00115765|584071040|FG002|Overall Study|Physician Decision|18|||
161735561|NCT00115765|584071041|FG003|Overall Study|Physician Decision|13|||
161735562|NCT00115765|584071038|FG000|Overall Study|Lost to Follow-up|3|||
161735563|NCT00115765|584071039|FG001|Overall Study|Lost to Follow-up|20|||
161735564|NCT00115765|584071040|FG002|Overall Study|Lost to Follow-up|18|||
161735565|NCT00115765|584071041|FG003|Overall Study|Lost to Follow-up|1|||
161735566|NCT00115765|584071038|FG000|Overall Study|Other|6|||
161735567|NCT00115765|584071039|FG001|Overall Study|Other|12|||
161735568|NCT00115765|584071040|FG002|Overall Study|Other|9|||
161735569|NCT00115765|584071041|FG003|Overall Study|Other|2|||
161735570|NCT03707158|584071044|FG000|Midtreatment|Lost to Follow-up|16|||
161735571|NCT03707158|584071045|FG001|Midtreatment|Lost to Follow-up|7|||
161735572|NCT03707158|584071044|FG000|Midtreatment|Withdrawal by Subject|28|||
161735573|NCT03707158|584071045|FG001|Midtreatment|Withdrawal by Subject|19|||
161735574|NCT03707158|584071044|FG000|Posttreatment|Lost to Follow-up|0|||
161735575|NCT03707158|584071045|FG001|Posttreatment|Lost to Follow-up|5|||
161840017|NCT01940497|584458697|FG000|Overall Study|Administrative/Other|1|||
161965924|NCT01082874|584921901|FG000|Overall Study|Lost to Follow-up|10|||
161735576|NCT03707158|584071044|FG000|Follow-up|Lost to Follow-up|19|||
161735577|NCT03707158|584071045|FG001|Follow-up|Lost to Follow-up|18|||
161735578|NCT03707158|584071044|FG000|Follow-up|Withdrawal by Subject|13|||
161735579|NCT03707158|584071045|FG001|Follow-up|Withdrawal by Subject|6|||
161735580|NCT01454401|584071046|FG000|Overall Study|Death|1|||
161840018|NCT01940497|584458698|FG001|Overall Study|Administrative/Other|1|||
161840019|NCT00502801|584458699|FG000|Treatment Period|Withdrawal by Subject|3|||
161965925|NCT01082874|584921902|FG001|Overall Study|Lost to Follow-up|10|||
161965926|NCT01082874|584921903|FG002|Overall Study|Lost to Follow-up|6|||
161735581|NCT01454401|584071046|FG000|Overall Study|hospitalised|1|||
161735582|NCT01454401|584071046|FG000|Overall Study|osteomyelitis|2|||
161735583|NCT01454401|584071046|FG000|Overall Study|non-adherence|1|||
161735584|NCT01968187|584071049|FG000|Overall Study|Adverse Event|0|||
161735585|NCT01968187|584071050|FG001|Overall Study|Adverse Event|1|||
161735586|NCT01968187|584071049|FG000|Overall Study|Randomized but not treated|1|||
161735587|NCT01968187|584071050|FG001|Overall Study|Randomized but not treated|0|||
161735588|NCT00430521|584071051|FG000|Overall Study|Adverse Event|0|||
161735589|NCT00430521|584071052|FG001|Overall Study|Adverse Event|0|||
161735590|NCT00430521|584071053|FG002|Overall Study|Adverse Event|0|||
161735591|NCT00430521|584071054|FG003|Overall Study|Adverse Event|0|||
161735592|NCT00430521|584071055|FG004|Overall Study|Adverse Event|0|||
161735593|NCT00430521|584071056|FG005|Overall Study|Adverse Event|2|||
161735594|NCT00430521|584071057|FG006|Overall Study|Adverse Event|1|||
161735595|NCT00430521|584071058|FG007|Overall Study|Adverse Event|0|||
161735596|NCT00430521|584071051|FG000|Overall Study|Lost to Follow-up|7|||
161735597|NCT00430521|584071052|FG001|Overall Study|Lost to Follow-up|8|||
161735598|NCT00430521|584071053|FG002|Overall Study|Lost to Follow-up|3|||
161735599|NCT00430521|584071054|FG003|Overall Study|Lost to Follow-up|5|||
161735600|NCT00430521|584071055|FG004|Overall Study|Lost to Follow-up|5|||
161735601|NCT00430521|584071056|FG005|Overall Study|Lost to Follow-up|2|||
161735602|NCT00430521|584071057|FG006|Overall Study|Lost to Follow-up|8|||
161735603|NCT00430521|584071058|FG007|Overall Study|Lost to Follow-up|10|||
161735604|NCT00430521|584071051|FG000|Overall Study|Pregnancy|0|||
161735605|NCT00430521|584071052|FG001|Overall Study|Pregnancy|0|||
161735606|NCT00430521|584071053|FG002|Overall Study|Pregnancy|0|||
161735607|NCT00430521|584071054|FG003|Overall Study|Pregnancy|0|||
161735608|NCT00430521|584071055|FG004|Overall Study|Pregnancy|0|||
161735609|NCT00430521|584071056|FG005|Overall Study|Pregnancy|0|||
161735610|NCT00430521|584071057|FG006|Overall Study|Pregnancy|1|||
161735611|NCT00430521|584071058|FG007|Overall Study|Pregnancy|0|||
161735612|NCT00430521|584071051|FG000|Overall Study|Vaccine Expired|0|||
161735613|NCT00430521|584071052|FG001|Overall Study|Vaccine Expired|0|||
161735614|NCT00430521|584071053|FG002|Overall Study|Vaccine Expired|0|||
161735615|NCT00430521|584071054|FG003|Overall Study|Vaccine Expired|0|||
161965927|NCT01082874|584921904|FG003|Overall Study|Lost to Follow-up|10|||
161965928|NCT01082874|584921901|FG000|Overall Study|Withdrawal by Subject|1|||
161965929|NCT01082874|584921902|FG001|Overall Study|Withdrawal by Subject|2|||
161965930|NCT01082874|584921903|FG002|Overall Study|Withdrawal by Subject|5|||
161965931|NCT01082874|584921904|FG003|Overall Study|Withdrawal by Subject|3|||
161965932|NCT03176472|584921913|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
161965933|NCT03176472|584921914|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
161965934|NCT03176472|584921913|FG000|Double Blind Treatment Period|Adverse Event|0|||
161965935|NCT03176472|584921914|FG001|Double Blind Treatment Period|Adverse Event|5|||
161965936|NCT03176472|584921913|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
161965937|NCT03176472|584921914|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
161965938|NCT03176472|584921913|FG000|Double Blind Treatment Period|Physician Decision|0|||
161965939|NCT03176472|584921914|FG001|Double Blind Treatment Period|Physician Decision|1|||
161965940|NCT03176472|584921913|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161965941|NCT03176472|584921914|FG001|Double Blind Treatment Period|Protocol Violation|0|||
161965942|NCT03176472|584921913|FG000|Double Blind Treatment Period|Not Provided|1|||
161965943|NCT03176472|584921914|FG001|Double Blind Treatment Period|Not Provided|0|||
161965944|NCT03176472|584921913|FG000|Open Label Extension|Withdrawal by Subject|3|||
161965945|NCT03176472|584921914|FG001|Open Label Extension|Withdrawal by Subject|4|||
161965946|NCT03176472|584921913|FG000|Open Label Extension|Adverse Event|2|||
161965947|NCT03176472|584921914|FG001|Open Label Extension|Adverse Event|4|||
161965948|NCT03176472|584921913|FG000|Open Label Extension|Lost to Follow-up|1|||
161965949|NCT03176472|584921914|FG001|Open Label Extension|Lost to Follow-up|2|||
161965950|NCT03176472|584921913|FG000|Open Label Extension|Protocol Violation|0|||
161965951|NCT03176472|584921914|FG001|Open Label Extension|Protocol Violation|1|||
161965952|NCT03176472|584921913|FG000|Open Label Extension|Not Provided|2|||
161965953|NCT03176472|584921914|FG001|Open Label Extension|Not Provided|1|||
161965954|NCT03272828|584921915|FG000|Overall Study|Lost to Follow-up|7|||
161965955|NCT03272828|584921916|FG001|Overall Study|Lost to Follow-up|7|||
161965956|NCT03272828|584921915|FG000|Overall Study|Withdrawal by Subject|2|||
161965957|NCT03272828|584921916|FG001|Overall Study|Withdrawal by Subject|0|||
161735616|NCT00430521|584071055|FG004|Overall Study|Vaccine Expired|0|||
161735617|NCT00430521|584071056|FG005|Overall Study|Vaccine Expired|1|||
161735618|NCT00430521|584071057|FG006|Overall Study|Vaccine Expired|0|||
161735619|NCT00430521|584071058|FG007|Overall Study|Vaccine Expired|0|||
161735620|NCT00430521|584071051|FG000|Overall Study|Protocol Violation|1|||
161735621|NCT00430521|584071052|FG001|Overall Study|Protocol Violation|0|||
161735622|NCT00430521|584071053|FG002|Overall Study|Protocol Violation|0|||
161965958|NCT03272828|584921915|FG000|Overall Study|Deceased|1|||
161965959|NCT03272828|584921916|FG001|Overall Study|Deceased|1|||
161965960|NCT03272828|584921915|FG000|Overall Study|Failed implant|1|||
161965961|NCT03272828|584921916|FG001|Overall Study|Failed implant|2|||
161735623|NCT00430521|584071054|FG003|Overall Study|Protocol Violation|0|||
161735624|NCT00430521|584071055|FG004|Overall Study|Protocol Violation|0|||
161735625|NCT00430521|584071056|FG005|Overall Study|Protocol Violation|0|||
161735626|NCT00430521|584071057|FG006|Overall Study|Protocol Violation|0|||
161965962|NCT01846663|584921917|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
161965963|NCT01846663|584921918|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
161735627|NCT00430521|584071058|FG007|Overall Study|Protocol Violation|0|||
161735628|NCT00430521|584071051|FG000|Overall Study|Withdrawal by Subject|3|||
161735629|NCT00430521|584071052|FG001|Overall Study|Withdrawal by Subject|1|||
161735630|NCT00430521|584071053|FG002|Overall Study|Withdrawal by Subject|0|||
161965964|NCT01846663|584921917|FG000|Overall Study|Withdrawal by Subject|1|||
161735631|NCT00430521|584071054|FG003|Overall Study|Withdrawal by Subject|3|||
161735632|NCT00430521|584071055|FG004|Overall Study|Withdrawal by Subject|0|||
161735633|NCT00430521|584071056|FG005|Overall Study|Withdrawal by Subject|0|||
161735634|NCT00430521|584071057|FG006|Overall Study|Withdrawal by Subject|0|||
161735635|NCT00430521|584071058|FG007|Overall Study|Withdrawal by Subject|2|||
161735636|NCT03675737|584071059|FG000|Overall Study|Death|593|||
161735637|NCT03675737|584071060|FG001|Overall Study|Death|660|||
161735638|NCT03675737|584071059|FG000|Overall Study|Lost to Follow-up|1|||
161735639|NCT03675737|584071060|FG001|Overall Study|Lost to Follow-up|5|||
161735640|NCT03675737|584071059|FG000|Overall Study|Physician Decision|1|||
161735641|NCT03675737|584071060|FG001|Overall Study|Physician Decision|0|||
161735642|NCT03675737|584071059|FG000|Overall Study|Withdrawal by Subject|14|||
161735643|NCT03675737|584071060|FG001|Overall Study|Withdrawal by Subject|12|||
161735644|NCT03675737|584071059|FG000|Overall Study|Ongoing in Study|181|||
161735645|NCT03675737|584071060|FG001|Overall Study|Ongoing in Study|112|||
161735646|NCT03422133|584071061|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
161735647|NCT03422133|584071062|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
161735648|NCT01274338|584073219|FG000|Overall Study|Lack of Efficacy|72|||
161735649|NCT01274338|584073220|FG001|Overall Study|Lack of Efficacy|108|||
161735650|NCT01274338|584073221|FG002|Overall Study|Lack of Efficacy|116|||
161735651|NCT01274338|584073222|FG003|Overall Study|Lack of Efficacy|0|||
161735652|NCT01274338|584073223|FG004|Overall Study|Lack of Efficacy|0|||
161735653|NCT01274338|584073224|FG005|Overall Study|Lack of Efficacy|0|||
161735654|NCT01274338|584073219|FG000|Overall Study|Adverse Event|272|||
161735655|NCT01274338|584073220|FG001|Overall Study|Adverse Event|105|||
161735656|NCT01274338|584073221|FG002|Overall Study|Adverse Event|180|||
161735657|NCT01274338|584073222|FG003|Overall Study|Adverse Event|1|||
161735658|NCT01274338|584073223|FG004|Overall Study|Adverse Event|0|||
161735659|NCT01274338|584073224|FG005|Overall Study|Adverse Event|0|||
161735660|NCT01274338|584073219|FG000|Overall Study|Death|8|||
161735661|NCT01274338|584073220|FG001|Overall Study|Death|1|||
161735662|NCT01274338|584073221|FG002|Overall Study|Death|0|||
161735663|NCT01274338|584073222|FG003|Overall Study|Death|0|||
161735664|NCT01274338|584073223|FG004|Overall Study|Death|0|||
161735665|NCT01274338|584073224|FG005|Overall Study|Death|0|||
161735666|NCT01274338|584073219|FG000|Overall Study|Withdrawal by Subject|27|||
161735667|NCT01274338|584073220|FG001|Overall Study|Withdrawal by Subject|99|||
161735668|NCT01274338|584073221|FG002|Overall Study|Withdrawal by Subject|17|||
161735669|NCT01274338|584073222|FG003|Overall Study|Withdrawal by Subject|0|||
161735670|NCT01274338|584073223|FG004|Overall Study|Withdrawal by Subject|0|||
161735671|NCT01274338|584073224|FG005|Overall Study|Withdrawal by Subject|0|||
161735672|NCT01274338|584073219|FG000|Overall Study|Did not start treatment|8|||
161735673|NCT01274338|584073220|FG001|Overall Study|Did not start treatment|116|||
161735674|NCT01274338|584073221|FG002|Overall Study|Did not start treatment|7|||
161735675|NCT01274338|584073222|FG003|Overall Study|Did not start treatment|0|||
161735676|NCT01274338|584073223|FG004|Overall Study|Did not start treatment|0|||
161735677|NCT01274338|584073224|FG005|Overall Study|Did not start treatment|0|||
161735678|NCT01274338|584073219|FG000|Overall Study|Alternative therapy|0|||
161735679|NCT01274338|584073220|FG001|Overall Study|Alternative therapy|1|||
161735680|NCT01274338|584073221|FG002|Overall Study|Alternative therapy|0|||
161735681|NCT01274338|584073222|FG003|Overall Study|Alternative therapy|0|||
161735682|NCT01274338|584073223|FG004|Overall Study|Alternative therapy|0|||
161965965|NCT01846663|584921918|FG001|Overall Study|Withdrawal by Subject|0|||
161965966|NCT01846663|584921917|FG000|Overall Study|Adverse Event|1|||
161735683|NCT01274338|584073224|FG005|Overall Study|Alternative therapy|0|||
161735684|NCT01274338|584073219|FG000|Overall Study|Other complicating diseases|0|||
161735685|NCT01274338|584073220|FG001|Overall Study|Other complicating diseases|3|||
161735686|NCT01274338|584073221|FG002|Overall Study|Other complicating diseases|1|||
161735687|NCT01274338|584073222|FG003|Overall Study|Other complicating diseases|0|||
161735688|NCT01274338|584073223|FG004|Overall Study|Other complicating diseases|0|||
161735689|NCT01274338|584073224|FG005|Overall Study|Other complicating diseases|0|||
161735690|NCT01274338|584073219|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
161735691|NCT01274338|584073220|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
161735692|NCT01274338|584073221|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
161735693|NCT01274338|584073222|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
161735694|NCT01274338|584073223|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
161735695|NCT01274338|584073224|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
161735696|NCT01274338|584073219|FG000|Overall Study|Pregnancy|0|||
161735697|NCT01274338|584073220|FG001|Overall Study|Pregnancy|0|||
161735698|NCT01274338|584073221|FG002|Overall Study|Pregnancy|1|||
161735699|NCT01274338|584073222|FG003|Overall Study|Pregnancy|0|||
161735700|NCT01274338|584073223|FG004|Overall Study|Pregnancy|0|||
161735701|NCT01274338|584073224|FG005|Overall Study|Pregnancy|0|||
161735702|NCT01274338|584073219|FG000|Overall Study|Reason not reported|12|||
161735703|NCT01274338|584073220|FG001|Overall Study|Reason not reported|21|||
161735704|NCT01274338|584073221|FG002|Overall Study|Reason not reported|3|||
162032398|NCT01077154|585175479|FG000|Overall Study|Disease Progression|18|||
162032399|NCT01077154|585175480|FG001|Overall Study|Disease Progression|20|||
162032400|NCT01077154|585175479|FG000|Overall Study|Ineligibility Determined|10|||
162032401|NCT01077154|585175480|FG001|Overall Study|Ineligibility Determined|14|||
162032402|NCT01077154|585175479|FG000|Overall Study|Other|14|||
162032403|NCT01077154|585175480|FG001|Overall Study|Other|11|||
162032404|NCT01077154|585175479|FG000|Overall Study|Adverse Event|9|||
162032405|NCT01077154|585175480|FG001|Overall Study|Adverse Event|9|||
162032406|NCT01077154|585175479|FG000|Overall Study|Administrative Decision|1|||
162032407|NCT01077154|585175480|FG001|Overall Study|Administrative Decision|6|||
162032408|NCT01077154|585175479|FG000|Overall Study|Protocol Deviation|1|||
162032409|NCT01077154|585175480|FG001|Overall Study|Protocol Deviation|0|||
161735705|NCT01274338|584073222|FG003|Overall Study|Reason not reported|0|||
161735706|NCT01274338|584073223|FG004|Overall Study|Reason not reported|1|||
161735707|NCT01274338|584073224|FG005|Overall Study|Reason not reported|0|||
161735708|NCT03004469|584073225|FG000|Overall Study|Adverse Event|6|||
161735709|NCT03004469|584073226|FG001|Overall Study|Adverse Event|4|||
161735710|NCT03004469|584073227|FG002|Overall Study|Adverse Event|6|||
161735711|NCT03004469|584073225|FG000|Overall Study|Lack of Efficacy|1|||
161735712|NCT03004469|584073226|FG001|Overall Study|Lack of Efficacy|0|||
161735713|NCT03004469|584073227|FG002|Overall Study|Lack of Efficacy|1|||
161735714|NCT03004469|584073225|FG000|Overall Study|Lost to Follow-up|23|||
161735715|NCT03004469|584073226|FG001|Overall Study|Lost to Follow-up|14|||
161735716|NCT03004469|584073227|FG002|Overall Study|Lost to Follow-up|6|||
161735717|NCT03004469|584073225|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161735718|NCT03004469|584073226|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161735719|NCT03004469|584073227|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161735720|NCT03004469|584073225|FG000|Overall Study|Protocol Violation|0|||
161735721|NCT03004469|584073226|FG001|Overall Study|Protocol Violation|0|||
161735722|NCT03004469|584073227|FG002|Overall Study|Protocol Violation|1|||
161735723|NCT03004469|584073225|FG000|Overall Study|Withdrawal by Subject|29|||
161735724|NCT03004469|584073226|FG001|Overall Study|Withdrawal by Subject|27|||
161735725|NCT03004469|584073227|FG002|Overall Study|Withdrawal by Subject|10|||
161735726|NCT03004469|584073225|FG000|Overall Study|Other unspecified reason|0|||
161735727|NCT03004469|584073226|FG001|Overall Study|Other unspecified reason|4|||
161735728|NCT03004469|584073227|FG002|Overall Study|Other unspecified reason|1|||
161735729|NCT01397552|584073228|FG000|Overall Study|Adverse Event|1|||
161735730|NCT01397552|584073229|FG001|Overall Study|Adverse Event|0|||
161735731|NCT01397552|584073228|FG000|Overall Study|Withdrawal by Subject|2|||
161735732|NCT01397552|584073229|FG001|Overall Study|Withdrawal by Subject|1|||
161735733|NCT00579501|584073232|FG000|Overall Study|Death|1|||
161735734|NCT00579501|584073232|FG000|Overall Study|End of neoadjuvant therapy|25|||
161735735|NCT00579501|584073232|FG000|Overall Study|toxicity|1|||
161735736|NCT00579501|584073232|FG000|Overall Study|Secondary lesion|1|||
161735737|NCT00579501|584073232|FG000|Overall Study|Radiation therapy before surgery|1|||
161735738|NCT00190983|584073233|FG000|Overall Study|Inevaluable (never treated)|2|||
161735739|NCT02287402|584073234|FG000|Treatment Period|Adverse Event|17|||
161735740|NCT02287402|584073234|FG000|Treatment Period|Voluntary Withdrawal|10|||
161735741|NCT02287402|584073234|FG000|Follow-up|Lost to Follow-up|1|||
161735742|NCT02287402|584073234|FG000|Follow-up|Voluntary Withdrawal|2|||
161735743|NCT04247815|584073235|FG000|Overall Study|Adverse Event|1|||
161735744|NCT04247815|584073236|FG001|Overall Study|Adverse Event|0|||
161735745|NCT04247815|584073235|FG000|Overall Study|Withdrawal by Subject|1|||
161735746|NCT04247815|584073236|FG001|Overall Study|Withdrawal by Subject|0|||
161735747|NCT04247815|584073235|FG000|Overall Study|Protocol Violation|0|||
161735748|NCT04247815|584073236|FG001|Overall Study|Protocol Violation|1|||
161735749|NCT02130427|584073240|FG000|Overall Study|Imaging results not interpretable|30|||
162032410|NCT04030026|585175481|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
162032411|NCT04030026|585175482|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
162032412|NCT04030026|585175481|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
161735750|NCT02108600|584073241|FG000|Overall Study|Withdrawal by Subject|2|||
161840020|NCT00502801|584458699|FG000|Treatment Period|Adverse Event|7|||
161840021|NCT00502801|584458699|FG000|Treatment Period|Death|14|||
161840022|NCT00502801|584458699|FG000|Treatment Period|OTHER|30|||
162032413|NCT04030026|585175482|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
161735751|NCT02108600|584073242|FG001|Overall Study|Withdrawal by Subject|0|||
161735752|NCT02108600|584073241|FG000|Overall Study|Lost to Follow-up|1|||
161735753|NCT02108600|584073242|FG001|Overall Study|Lost to Follow-up|1|||
161735754|NCT01295580|584073245|FG000|Overall Study|Protocol Violation|4|||
161735755|NCT01295580|584073246|FG001|Overall Study|Protocol Violation|2|||
161735756|NCT01295580|584073245|FG000|Overall Study|Withdrawal by Subject|1|||
161735757|NCT01295580|584073246|FG001|Overall Study|Withdrawal by Subject|4|||
161735758|NCT01295580|584073245|FG000|Overall Study|Adverse Event|2|||
162032414|NCT04030026|585175481|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
161735759|NCT01295580|584073246|FG001|Overall Study|Adverse Event|1|||
161735760|NCT01295580|584073245|FG000|Overall Study|Lost to Follow-up|1|||
161735761|NCT01295580|584073246|FG001|Overall Study|Lost to Follow-up|0|||
161735762|NCT01295580|584073245|FG000|Overall Study|Lack of Efficacy|1|||
161840023|NCT00502801|584458699|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
161840024|NCT00502801|584458699|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
161840025|NCT00502801|584458699|FG000|End of Therapy to Test of Cure|Death|3|||
161840026|NCT00502801|584458699|FG000|End of Therapy to Test of Cure|OTHER|2|||
161840027|NCT03071094|584458703|FG000|Overall Study|Death|1|||
161840028|NCT03071094|584458704|FG001|Overall Study|Death|1|||
161840029|NCT03071094|584458703|FG000|Overall Study|Adverse Event|1|||
161840030|NCT03071094|584458704|FG001|Overall Study|Adverse Event|0|||
161840031|NCT01195272|584458708|FG000|Overall Study|Adverse Event|1|||
161840032|NCT01195272|584458708|FG000|Overall Study|Lack of Efficacy|3|||
161840033|NCT01769339|584458711|FG000|Overall Study|Lost to Follow-up|42|||
161840034|NCT01769339|584458711|FG000|Overall Study|Adverse Event|1|||
161840035|NCT04969861|584458712|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
161840036|NCT04969861|584458713|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
161840037|NCT06218823|584460409|FG000|Overall Study|Death|3|||
161840038|NCT06218823|584460410|FG001|Overall Study|Death|0|||
161840039|NCT06218823|584460409|FG000|Overall Study|Lost to Follow-up|0|||
161840040|NCT06218823|584460410|FG001|Overall Study|Lost to Follow-up|2|||
161840041|NCT05101486|584460411|FG000|Overall Study|Death|1|||
161840042|NCT05101486|584460412|FG001|Overall Study|Death|0|||
161840043|NCT05101486|584460413|FG002|Overall Study|Death|1|||
161840044|NCT05101486|584460411|FG000|Overall Study|Lost to Follow-up|12|||
161840045|NCT05101486|584460412|FG001|Overall Study|Lost to Follow-up|8|||
161840046|NCT05101486|584460413|FG002|Overall Study|Lost to Follow-up|17|||
161840047|NCT05101486|584460411|FG000|Overall Study|Physician Decision|1|||
161840048|NCT05101486|584460412|FG001|Overall Study|Physician Decision|0|||
161840049|NCT05101486|584460413|FG002|Overall Study|Physician Decision|0|||
161840050|NCT05101486|584460411|FG000|Overall Study|Protocol Violation|0|||
161840051|NCT05101486|584460412|FG001|Overall Study|Protocol Violation|0|||
161840052|NCT05101486|584460413|FG002|Overall Study|Protocol Violation|1|||
161840053|NCT05101486|584460411|FG000|Overall Study|Withdrawal by Subject|5|||
161840054|NCT05101486|584460412|FG001|Overall Study|Withdrawal by Subject|2|||
161840055|NCT05101486|584460413|FG002|Overall Study|Withdrawal by Subject|4|||
161840056|NCT05101486|584460411|FG000|Overall Study|Randomized but not vaccinated|1|||
161840057|NCT05101486|584460412|FG001|Overall Study|Randomized but not vaccinated|1|||
161840058|NCT05101486|584460413|FG002|Overall Study|Randomized but not vaccinated|1|||
161840059|NCT00292188|584460419|FG000|Single-Blind|Adverse Event|14|||
161840060|NCT00292188|584460420|FG001|Single-Blind|Adverse Event|0|||
161840061|NCT00292188|584460421|FG002|Single-Blind|Adverse Event|0|||
161840062|NCT00292188|584460419|FG000|Single-Blind|Lack of Efficacy|2|||
161840063|NCT00292188|584460420|FG001|Single-Blind|Lack of Efficacy|0|||
161840064|NCT00292188|584460421|FG002|Single-Blind|Lack of Efficacy|0|||
161840065|NCT00292188|584460419|FG000|Single-Blind|Laboratory Abnormality|5|||
161840066|NCT00292188|584460420|FG001|Single-Blind|Laboratory Abnormality|0|||
161840067|NCT00292188|584460421|FG002|Single-Blind|Laboratory Abnormality|0|||
161965967|NCT01846663|584921918|FG001|Overall Study|Adverse Event|2|||
161965968|NCT03888235|584921924|FG000|Overall Study|Lost to Follow-up|1|||
161965969|NCT03888235|584921925|FG001|Overall Study|Lost to Follow-up|1|||
161965970|NCT03888235|584921926|FG002|Overall Study|Lost to Follow-up|0|||
161965971|NCT01054560|584921927|FG000|Overall Study|Death|10|||
161965972|NCT01054560|584921928|FG001|Overall Study|Death|21|||
161965973|NCT01054560|584921927|FG000|Overall Study|Lost to Follow-up|2|||
161965974|NCT01054560|584921928|FG001|Overall Study|Lost to Follow-up|5|||
161965975|NCT01054560|584921927|FG000|Overall Study|Withdrawal by Subject|0|||
161965976|NCT01054560|584921928|FG001|Overall Study|Withdrawal by Subject|2|||
161965977|NCT01054560|584921927|FG000|Overall Study|Physician Decision|1|||
161965978|NCT01054560|584921928|FG001|Overall Study|Physician Decision|0|||
161965979|NCT00244933|584921936|FG000|Overall Study|Not response evaluable|2|||
162032415|NCT04030026|585175482|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
161840068|NCT00292188|584460419|FG000|Single-Blind|Lost to Follow-up|3|||
161840069|NCT00292188|584460420|FG001|Single-Blind|Lost to Follow-up|0|||
161840070|NCT00292188|584460421|FG002|Single-Blind|Lost to Follow-up|0|||
161840071|NCT00292188|584460419|FG000|Single-Blind|Other|77|||
161840072|NCT00292188|584460420|FG001|Single-Blind|Other|0|||
161965980|NCT02901054|584921942|FG000|Overall Study|Physician Decision|1|||
161965981|NCT02901054|584921942|FG000|Overall Study|Withdrawal by Subject|3|||
162032416|NCT04030026|585175481|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
161965982|NCT06359028|584921946|FG000|Overall Study|Adverse Event|1|||
161965983|NCT06359028|584921947|FG001|Overall Study|Adverse Event|0|||
161965984|NCT06359028|584921946|FG000|Overall Study|Withdrawal by Subject|1|||
162032417|NCT04030026|585175482|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
161840073|NCT00292188|584460421|FG002|Single-Blind|Other|0|||
161840074|NCT00292188|584460419|FG000|Single-Blind|Withdrawal by Subject|12|||
161840075|NCT00292188|584460420|FG001|Single-Blind|Withdrawal by Subject|0|||
161840076|NCT00292188|584460421|FG002|Single-Blind|Withdrawal by Subject|0|||
161840077|NCT00292188|584460419|FG000|Single-Blind|Did not receive treatment|1|||
161840078|NCT00292188|584460420|FG001|Single-Blind|Did not receive treatment|0|||
161965985|NCT06359028|584921947|FG001|Overall Study|Withdrawal by Subject|0|||
161840079|NCT00292188|584460421|FG002|Single-Blind|Did not receive treatment|0|||
161840080|NCT00292188|584460419|FG000|Double-Blind|Adverse Event|0|||
161840081|NCT00292188|584460420|FG001|Double-Blind|Adverse Event|25|||
161840082|NCT00292188|584460421|FG002|Double-Blind|Adverse Event|9|||
161840083|NCT00292188|584460419|FG000|Double-Blind|Lack of Efficacy|0|||
161840084|NCT00292188|584460420|FG001|Double-Blind|Lack of Efficacy|2|||
161840085|NCT00292188|584460421|FG002|Double-Blind|Lack of Efficacy|12|||
161840086|NCT00292188|584460419|FG000|Double-Blind|Lost to Follow-up|0|||
161840087|NCT00292188|584460420|FG001|Double-Blind|Lost to Follow-up|1|||
161840088|NCT00292188|584460421|FG002|Double-Blind|Lost to Follow-up|0|||
161840089|NCT00292188|584460419|FG000|Double-Blind|Other|0|||
161840090|NCT00292188|584460420|FG001|Double-Blind|Other|3|||
161840091|NCT00292188|584460421|FG002|Double-Blind|Other|4|||
161840092|NCT00292188|584460419|FG000|Double-Blind|Withdrawal by Subject|0|||
161840093|NCT00292188|584460420|FG001|Double-Blind|Withdrawal by Subject|0|||
161840094|NCT00292188|584460421|FG002|Double-Blind|Withdrawal by Subject|3|||
161840095|NCT00292188|584460419|FG000|Double-Blind|Laboratory Abnormality|0|||
161840096|NCT00292188|584460420|FG001|Double-Blind|Laboratory Abnormality|0|||
161840097|NCT00292188|584460421|FG002|Double-Blind|Laboratory Abnormality|1|||
161840098|NCT00824616|584460422|FG000|Overall Study|Adverse Event|2|||
161735763|NCT01295580|584073246|FG001|Overall Study|Lack of Efficacy|0|||
161735764|NCT01295580|584073245|FG000|Overall Study|Other: inconvenience|1|||
161735765|NCT01295580|584073246|FG001|Overall Study|Other: inconvenience|0|||
161735766|NCT01295580|584073245|FG000|Overall Study|Other: family objection|0|||
161840099|NCT00824616|584460423|FG001|Overall Study|Adverse Event|1|||
161840100|NCT00824616|584460422|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
161840101|NCT00824616|584460423|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
161735767|NCT01295580|584073246|FG001|Overall Study|Other: family objection|1|||
161735768|NCT01742078|584073247|FG000|Overall Study|Withdrawal by Subject|0|||
161735769|NCT01742078|584073248|FG001|Overall Study|Withdrawal by Subject|0|||
161735770|NCT01742078|584073249|FG002|Overall Study|Withdrawal by Subject|0|||
161735771|NCT01742078|584073250|FG003|Overall Study|Withdrawal by Subject|1|||
161735772|NCT01742078|584073251|FG004|Overall Study|Withdrawal by Subject|0|||
161735773|NCT01742078|584073252|FG005|Overall Study|Withdrawal by Subject|0|||
161735774|NCT01742078|584073253|FG006|Overall Study|Withdrawal by Subject|0|||
161735775|NCT01742078|584073254|FG007|Overall Study|Withdrawal by Subject|0|||
161735776|NCT01742078|584073255|FG008|Overall Study|Withdrawal by Subject|0|||
161735777|NCT05025787|584073258|FG000|Overall Study|Lack of Efficacy|0|||
161735778|NCT05025787|584073259|FG001|Overall Study|Lack of Efficacy|1|||
161735779|NCT05025787|584073258|FG000|Overall Study|Adverse Event|2|||
161735780|NCT05025787|584073259|FG001|Overall Study|Adverse Event|4|||
161735781|NCT05025787|584073258|FG000|Overall Study|Non compliance|0|||
161735782|NCT05025787|584073259|FG001|Overall Study|Non compliance|1|||
161735783|NCT05025787|584073258|FG000|Overall Study|Protocol Violation|3|||
161735784|NCT05025787|584073259|FG001|Overall Study|Protocol Violation|1|||
161735785|NCT05025787|584073258|FG000|Overall Study|Stopping criteria met|1|||
161735786|NCT05025787|584073259|FG001|Overall Study|Stopping criteria met|1|||
161735787|NCT05025787|584073258|FG000|Overall Study|Withdrawal by Subject|3|||
161735788|NCT05025787|584073259|FG001|Overall Study|Withdrawal by Subject|1|||
161735789|NCT03806179|584073260|FG000|Overall Study|Progressive disease|0|||
161735790|NCT03806179|584073261|FG001|Overall Study|Progressive disease|2|||
161735791|NCT05600309|584073262|FG000|Overall Study|Death|41|||
161735792|NCT05600309|584073263|FG001|Overall Study|Death|38|||
161735793|NCT05600309|584073262|FG000|Overall Study|Sponsor Decision|9|||
161735794|NCT05600309|584073263|FG001|Overall Study|Sponsor Decision|6|||
161840102|NCT00824616|584460422|FG000|Overall Study|Hyperglycemia|1|||
161840103|NCT00824616|584460423|FG001|Overall Study|Hyperglycemia|1|||
161840104|NCT00824616|584460422|FG000|Overall Study|Lack of Efficacy|2|||
161840105|NCT00824616|584460423|FG001|Overall Study|Lack of Efficacy|1|||
161965986|NCT05248997|584921948|FG000|Overall Study|Lost to Follow-up|1|||
161965987|NCT05248997|584921949|FG001|Overall Study|Lost to Follow-up|1|||
161965988|NCT05248997|584921948|FG000|Overall Study|Randomized but not treated|32|||
161965989|NCT05248997|584921949|FG001|Overall Study|Randomized but not treated|25|||
161965990|NCT03515551|584921950|FG000|Overall Study|Death|4|||
161965991|NCT03515551|584921951|FG001|Overall Study|Death|1|||
161965992|NCT03515551|584921952|FG002|Overall Study|Death|2|||
161965993|NCT03515551|584921953|FG003|Overall Study|Death|2|||
161735795|NCT05822830|584073264|FG000|Overall Study|Adverse Event|6|||
161840106|NCT00824616|584460422|FG000|Overall Study|Lost to Follow-up|0|||
161840107|NCT00824616|584460423|FG001|Overall Study|Lost to Follow-up|1|||
161840108|NCT00824616|584460422|FG000|Overall Study|Withdrawal by Subject|1|||
161840109|NCT00824616|584460423|FG001|Overall Study|Withdrawal by Subject|1|||
161840110|NCT00721630|584460424|FG000|Overall Study|Participant found to be ineligible|1|||
161840111|NCT04711902|584460428|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
161840112|NCT04711902|584460429|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
161965994|NCT03515551|584921954|FG004|Overall Study|Death|2|||
161735796|NCT05822830|584073265|FG001|Overall Study|Adverse Event|6|||
161735797|NCT05822830|584073264|FG000|Overall Study|Assigned Treatment by Mistake|5|||
161965995|NCT03515551|584921955|FG005|Overall Study|Death|4|||
161735798|NCT05822830|584073265|FG001|Overall Study|Assigned Treatment by Mistake|3|||
161735799|NCT05822830|584073264|FG000|Overall Study|Lost to Follow-up|16|||
161735800|NCT05822830|584073265|FG001|Overall Study|Lost to Follow-up|18|||
161735801|NCT05822830|584073264|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161735802|NCT05822830|584073265|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161735803|NCT05822830|584073264|FG000|Overall Study|Participant was Out of the Country|0|||
161735804|NCT05822830|584073265|FG001|Overall Study|Participant was Out of the Country|1|||
161735805|NCT05822830|584073264|FG000|Overall Study|Pregnancy|1|||
161735806|NCT05822830|584073265|FG001|Overall Study|Pregnancy|2|||
161735807|NCT05822830|584073264|FG000|Overall Study|Withdrawal by Subject|27|||
161735808|NCT05822830|584073265|FG001|Overall Study|Withdrawal by Subject|26|||
161735809|NCT00807846|584073266|FG000|Overall Study|Adverse Event|5|||
161735810|NCT00807846|584073267|FG001|Overall Study|Adverse Event|0|||
161735811|NCT00807846|584073266|FG000|Overall Study|Lack of Efficacy|2|||
161735812|NCT00807846|584073267|FG001|Overall Study|Lack of Efficacy|0|||
161735813|NCT00807846|584073266|FG000|Overall Study|Protocol Violation|2|||
161735814|NCT00807846|584073267|FG001|Overall Study|Protocol Violation|1|||
161735815|NCT00807846|584073266|FG000|Overall Study|Withdrawal by Subject|2|||
161735816|NCT00807846|584073267|FG001|Overall Study|Withdrawal by Subject|1|||
161735817|NCT00807846|584073266|FG000|Overall Study|Other|1|||
161735818|NCT00807846|584073267|FG001|Overall Study|Other|2|||
161735819|NCT01081873|584073268|FG000|Overall Study|Death|86|||
161735820|NCT01081873|584073268|FG000|Overall Study|Withdrawal by Subject|10|||
161735821|NCT01081873|584073268|FG000|Overall Study|Lost to Follow-up|142|||
161735822|NCT01081873|584073268|FG000|Overall Study|Progression of prostate cancer|13|||
161735823|NCT01081873|584073268|FG000|Overall Study|Other|47|||
161735824|NCT01165021|584073270|FG000|Overall Study|Death|1|||
161735825|NCT02491073|584073271|FG000|Overall Study|screen failure|1|||
161735826|NCT02491073|584073272|FG001|Overall Study|screen failure|0|||
161735827|NCT01419665|584073273|FG000|Combination Treatment|Adverse Event|7|||
161735828|NCT01419665|584073274|FG001|Combination Treatment|Adverse Event|10|||
161735829|NCT01419665|584073273|FG000|Combination Treatment|Physician Decision|5|||
161735830|NCT01419665|584073274|FG001|Combination Treatment|Physician Decision|8|||
161735831|NCT01419665|584073273|FG000|Combination Treatment|Protocol Violation|6|||
161735832|NCT01419665|584073274|FG001|Combination Treatment|Protocol Violation|2|||
161735833|NCT01419665|584073273|FG000|Combination Treatment|disease progression|10|||
161735834|NCT01419665|584073274|FG001|Combination Treatment|disease progression|9|||
161735835|NCT01419665|584073273|FG000|Combination Treatment|Death|5|||
161735836|NCT01419665|584073274|FG001|Combination Treatment|Death|7|||
161735837|NCT01419665|584073273|FG000|Combination Treatment|administrative problems|0|||
161735838|NCT01419665|584073274|FG001|Combination Treatment|administrative problems|1|||
161735839|NCT01419665|584073273|FG000|Combination Treatment|Withdrawal by Subject|5|||
161735840|NCT01419665|584073274|FG001|Combination Treatment|Withdrawal by Subject|4|||
161735841|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
161735842|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
161735843|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
161735844|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
161735845|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
161735846|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
161735847|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
161735848|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
161735849|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
161735850|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
161735851|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
161735852|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
161735853|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|Death|1|||
161735854|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|Death|2|||
161735855|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
161735856|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
161735857|NCT01419665|584073273|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
161735858|NCT01419665|584073274|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
162032418|NCT04030026|585175481|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
162032419|NCT04030026|585175482|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
161735859|NCT01419665|584073273|FG000|Open Label Phase|Death|1|||
161735860|NCT01419665|584073274|FG001|Open Label Phase|Death|0|||
161735861|NCT01419665|584073273|FG000|Open Label Phase|disease progression|0|||
161735862|NCT01419665|584073274|FG001|Open Label Phase|disease progression|1|||
161735863|NCT03977727|584073275|FG000|Second Treatment|Lost to Follow-up|0|||
161735864|NCT03977727|584073276|FG001|Second Treatment|Lost to Follow-up|3|||
161735865|NCT01655823|584073278|FG000|Overall Study|Lost to Follow-up|0|||
161735866|NCT01655823|584073279|FG001|Overall Study|Lost to Follow-up|1|||
161735867|NCT01655823|584073280|FG002|Overall Study|Lost to Follow-up|0|||
161735868|NCT01655823|584073281|FG003|Overall Study|Lost to Follow-up|0|||
161840113|NCT04711902|584460430|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
161840114|NCT04711902|584460431|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
161840115|NCT04711902|584460432|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
161840116|NCT04711902|584460433|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
161840117|NCT03786718|584460434|FG000|Overall Study|Lost to Follow-up|3|||
161840118|NCT03786718|584460434|FG000|Overall Study|Withdrawal by Subject|1|||
161840119|NCT03786718|584460434|FG000|Overall Study|Did not use the intervention|2|||
161840120|NCT03786718|584460434|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
161840121|NCT00372411|584460441|FG000|Overall Study|Withdrawal by Subject|3|||
161840122|NCT00372411|584460442|FG001|Overall Study|Withdrawal by Subject|4|||
161840123|NCT00372411|584460443|FG002|Overall Study|Withdrawal by Subject|1|||
161840124|NCT00372411|584460441|FG000|Overall Study|Death|0|||
161840125|NCT00372411|584460442|FG001|Overall Study|Death|2|||
161840126|NCT00372411|584460443|FG002|Overall Study|Death|1|||
161840127|NCT00372411|584460441|FG000|Overall Study|Lost to Follow-up|1|||
161840128|NCT00372411|584460442|FG001|Overall Study|Lost to Follow-up|1|||
161840129|NCT00372411|584460443|FG002|Overall Study|Lost to Follow-up|1|||
161840130|NCT00372411|584460441|FG000|Overall Study|Adverse Event|1|||
161840131|NCT00372411|584460442|FG001|Overall Study|Adverse Event|1|||
161840132|NCT00372411|584460443|FG002|Overall Study|Adverse Event|0|||
161735869|NCT01655823|584073282|FG004|Overall Study|Lost to Follow-up|1|||
161735870|NCT01655823|584073278|FG000|Overall Study|Withdrawal by Subject|0|||
161735871|NCT01655823|584073279|FG001|Overall Study|Withdrawal by Subject|1|||
161735872|NCT01655823|584073280|FG002|Overall Study|Withdrawal by Subject|0|||
161735873|NCT01655823|584073281|FG003|Overall Study|Withdrawal by Subject|1|||
161735874|NCT01655823|584073282|FG004|Overall Study|Withdrawal by Subject|0|||
161735875|NCT02683525|584073283|FG000|Overall Study|Lost to Follow-up|1|||
161735876|NCT02683525|584073283|FG000|Overall Study|Physician Decision|1|||
161735877|NCT02683525|584073283|FG000|Overall Study|Disease Progression|6|||
161735878|NCT02632110|584073288|FG000|Overall Study|Withdrawal by Subject|1|||
161735879|NCT02632110|584073289|FG001|Overall Study|Withdrawal by Subject|1|||
161735880|NCT02632110|584073290|FG002|Overall Study|Withdrawal by Subject|0|||
161735881|NCT02632110|584073291|FG003|Overall Study|Withdrawal by Subject|0|||
161735882|NCT02632110|584073292|FG004|Overall Study|Withdrawal by Subject|1|||
161735883|NCT02632110|584073293|FG005|Overall Study|Withdrawal by Subject|1|||
161735884|NCT02632110|584073294|FG006|Overall Study|Withdrawal by Subject|3|||
161735885|NCT02632110|584073295|FG007|Overall Study|Withdrawal by Subject|3|||
161735886|NCT02632110|584073296|FG008|Overall Study|Withdrawal by Subject|1|||
161735887|NCT02632110|584073297|FG009|Overall Study|Withdrawal by Subject|1|||
161735888|NCT01008995|584073302|FG000|Controlled Period|Adverse Event|1|||
161735889|NCT01008995|584073303|FG001|Controlled Period|Adverse Event|2|||
161735890|NCT01008995|584073304|FG002|Controlled Period|Adverse Event|0|||
161735891|NCT01008995|584073305|FG003|Controlled Period|Adverse Event|0|||
161735892|NCT01008995|584073302|FG000|Controlled Period|Other|2|||
161735893|NCT01008995|584073303|FG001|Controlled Period|Other|1|||
161735894|NCT01008995|584073304|FG002|Controlled Period|Other|0|||
161735895|NCT01008995|584073305|FG003|Controlled Period|Other|0|||
161735896|NCT01008995|584073302|FG000|After Controlled Period|Adverse Event|0|||
161735897|NCT01008995|584073303|FG001|After Controlled Period|Adverse Event|0|||
161735898|NCT01008995|584073304|FG002|After Controlled Period|Adverse Event|1|||
161735899|NCT01008995|584073305|FG003|After Controlled Period|Adverse Event|1|||
161735900|NCT01008995|584073302|FG000|After Controlled Period|Other|0|||
161735901|NCT01008995|584073303|FG001|After Controlled Period|Other|0|||
161735902|NCT01008995|584073304|FG002|After Controlled Period|Other|1|||
161735903|NCT01008995|584073305|FG003|After Controlled Period|Other|0|||
161735904|NCT00115804|584073308|FG000|Overall Study|Adverse Event|2|||
161735905|NCT00403559|584073309|FG000|Overall Study|Adverse Event|0|||
161840133|NCT01398514|584460444|FG000|Overall Study|Adverse Event|1|||
161840134|NCT01398514|584460445|FG001|Overall Study|Adverse Event|0|||
161840135|NCT01398514|584460444|FG000|Overall Study|Non-compliance with study procedures|2|||
161840136|NCT01398514|584460445|FG001|Overall Study|Non-compliance with study procedures|0|||
161840137|NCT01398514|584460444|FG000|Overall Study|Physiologic non-responsiveness|1|||
161840138|NCT01398514|584460445|FG001|Overall Study|Physiologic non-responsiveness|3|||
161840139|NCT01398514|584460444|FG000|Overall Study|Failure to show a conditioned response|4|||
161735906|NCT00403559|584073310|FG001|Overall Study|Adverse Event|1|||
161735907|NCT00403559|584073309|FG000|Overall Study|Lost to Follow-up|3|||
161840140|NCT01398514|584460445|FG001|Overall Study|Failure to show a conditioned response|3|||
161840141|NCT02227147|584460455|FG000|Controlled Treatment Period|Adverse Event|4|||
161735908|NCT00403559|584073310|FG001|Overall Study|Lost to Follow-up|3|||
161735909|NCT00403559|584073309|FG000|Overall Study|Withdrawal by Subject|1|||
161735910|NCT00403559|584073310|FG001|Overall Study|Withdrawal by Subject|0|||
161735911|NCT00547378|584073311|FG000|Randomized Cohort|Withdrawal by Subject|7|||
161735912|NCT00547378|584073312|FG001|Randomized Cohort|Withdrawal by Subject|5|||
161735913|NCT00547378|584073313|FG002|Randomized Cohort|Withdrawal by Subject|0|||
161735914|NCT00547378|584073311|FG000|Randomized Cohort|Death|0|||
161735915|NCT00547378|584073312|FG001|Randomized Cohort|Death|1|||
161735916|NCT00547378|584073313|FG002|Randomized Cohort|Death|0|||
161735917|NCT00547378|584073311|FG000|Randomized Cohort|Lost to Follow-up|1|||
161735918|NCT00547378|584073312|FG001|Randomized Cohort|Lost to Follow-up|0|||
161735919|NCT00547378|584073313|FG002|Randomized Cohort|Lost to Follow-up|0|||
161735920|NCT00547378|584073311|FG000|Randomized Cohort|Adverse Event|1|||
161735921|NCT00547378|584073312|FG001|Randomized Cohort|Adverse Event|0|||
161735922|NCT00547378|584073313|FG002|Randomized Cohort|Adverse Event|0|||
161735923|NCT00547378|584073311|FG000|Randomized Cohort|Other reasons|2|||
161735924|NCT00547378|584073312|FG001|Randomized Cohort|Other reasons|0|||
161735925|NCT00547378|584073313|FG002|Randomized Cohort|Other reasons|0|||
161735926|NCT00547378|584073311|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
161735927|NCT00547378|584073312|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
161735928|NCT00547378|584073313|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
161735929|NCT00547378|584073311|FG000|All Implanted Cohort|Adverse Event|4|||
161735930|NCT00547378|584073312|FG001|All Implanted Cohort|Adverse Event|10|||
161735931|NCT00547378|584073313|FG002|All Implanted Cohort|Adverse Event|17|||
161735932|NCT00547378|584073311|FG000|All Implanted Cohort|Lost to Follow-up|0|||
161735933|NCT00547378|584073312|FG001|All Implanted Cohort|Lost to Follow-up|1|||
161735934|NCT00547378|584073313|FG002|All Implanted Cohort|Lost to Follow-up|14|||
161735935|NCT00547378|584073311|FG000|All Implanted Cohort|Death|3|||
161735936|NCT00547378|584073312|FG001|All Implanted Cohort|Death|1|||
161735937|NCT00547378|584073313|FG002|All Implanted Cohort|Death|4|||
161735938|NCT00547378|584073311|FG000|All Implanted Cohort|Physician Decision|0|||
161735939|NCT00547378|584073312|FG001|All Implanted Cohort|Physician Decision|2|||
161735940|NCT00547378|584073313|FG002|All Implanted Cohort|Physician Decision|6|||
161735941|NCT00547378|584073311|FG000|All Implanted Cohort|Site closure|2|||
161735942|NCT00547378|584073312|FG001|All Implanted Cohort|Site closure|0|||
161735943|NCT00547378|584073313|FG002|All Implanted Cohort|Site closure|1|||
161735944|NCT00547378|584073311|FG000|All Implanted Cohort|Other reasons|1|||
161735945|NCT00547378|584073312|FG001|All Implanted Cohort|Other reasons|0|||
161735946|NCT00547378|584073313|FG002|All Implanted Cohort|Other reasons|1|||
161735947|NCT01982773|584073316|FG000|Overall Study|Withdrawal by Subject|1|||
161735948|NCT01982773|584073317|FG001|Overall Study|Withdrawal by Subject|3|||
161735949|NCT01982773|584073316|FG000|Overall Study|Lost to Follow-up|7|||
161735950|NCT01982773|584073317|FG001|Overall Study|Lost to Follow-up|1|||
161735951|NCT01029886|584073318|FG000|Overall Study|Adverse Event|12|||
161735952|NCT01029886|584073319|FG001|Overall Study|Adverse Event|25|||
161735953|NCT01029886|584073318|FG000|Overall Study|Lost to Follow-up|1|||
161735954|NCT01029886|584073319|FG001|Overall Study|Lost to Follow-up|0|||
161735955|NCT01029886|584073318|FG000|Overall Study|Physician Decision|2|||
161735956|NCT01029886|584073319|FG001|Overall Study|Physician Decision|6|||
161735957|NCT01029886|584073318|FG000|Overall Study|Protocol Violation|17|||
161735958|NCT01029886|584073319|FG001|Overall Study|Protocol Violation|5|||
161735959|NCT01029886|584073318|FG000|Overall Study|Withdrawal by Subject|8|||
161735960|NCT01029886|584073319|FG001|Overall Study|Withdrawal by Subject|18|||
161735961|NCT01029886|584073318|FG000|Overall Study|Entry Criteria Not Met|13|||
161735962|NCT01029886|584073319|FG001|Overall Study|Entry Criteria Not Met|5|||
161735963|NCT01029886|584073318|FG000|Overall Study|Sponsor Decision|1|||
161735964|NCT01029886|584073319|FG001|Overall Study|Sponsor Decision|0|||
161735965|NCT01029886|584073318|FG000|Overall Study|Loss Glucose Control|7|||
161735966|NCT01029886|584073319|FG001|Overall Study|Loss Glucose Control|1|||
161735967|NCT03294681|584073320|FG000|Overall Study|Withdrawal by Subject|1|||
161735968|NCT02720016|584073323|FG000|Overall Study|Separation of couple|6|||
161735969|NCT02720016|584073324|FG001|Overall Study|Separation of couple|8|||
161735970|NCT02720016|584073325|FG002|Overall Study|Separation of couple|2|||
161735971|NCT02720016|584073323|FG000|Overall Study|Withdrawal by Subject|6|||
161735972|NCT02720016|584073324|FG001|Overall Study|Withdrawal by Subject|6|||
161735973|NCT02720016|584073325|FG002|Overall Study|Withdrawal by Subject|4|||
161735974|NCT02720016|584073323|FG000|Overall Study|Scheduling issues|2|||
161735975|NCT02720016|584073324|FG001|Overall Study|Scheduling issues|4|||
161735976|NCT02720016|584073325|FG002|Overall Study|Scheduling issues|7|||
161735977|NCT02720016|584073323|FG000|Overall Study|Childcare|2|||
161735978|NCT02720016|584073324|FG001|Overall Study|Childcare|0|||
161735979|NCT02720016|584073325|FG002|Overall Study|Childcare|2|||
161735980|NCT02720016|584073323|FG000|Overall Study|Withdrawal by PI|2|||
161735981|NCT02720016|584073324|FG001|Overall Study|Withdrawal by PI|2|||
161735982|NCT02720016|584073325|FG002|Overall Study|Withdrawal by PI|0|||
161735983|NCT02720016|584073323|FG000|Overall Study|Moved away|2|||
161735984|NCT02720016|584073324|FG001|Overall Study|Moved away|0|||
161735985|NCT02720016|584073325|FG002|Overall Study|Moved away|0|||
161735986|NCT02720016|584073323|FG000|Overall Study|Not Primary Health Concern|0|||
161735987|NCT02720016|584073324|FG001|Overall Study|Not Primary Health Concern|0|||
161735988|NCT02720016|584073325|FG002|Overall Study|Not Primary Health Concern|2|||
161735989|NCT02720016|584073323|FG000|Overall Study|Transportation issues|0|||
161735990|NCT02720016|584073324|FG001|Overall Study|Transportation issues|0|||
161735991|NCT02720016|584073325|FG002|Overall Study|Transportation issues|1|||
161735992|NCT02720016|584073323|FG000|Overall Study|Other|0|||
161735993|NCT02720016|584073324|FG001|Overall Study|Other|0|||
161735994|NCT02720016|584073325|FG002|Overall Study|Other|2|||
161735995|NCT04501679|584073326|FG000|Overall Study|Pregnancy|0|||
161735996|NCT04501679|584073327|FG001|Overall Study|Pregnancy|1|||
161735997|NCT04501679|584073326|FG000|Overall Study|Adverse Event|4|||
161735998|NCT04501679|584073327|FG001|Overall Study|Adverse Event|2|||
161735999|NCT04501679|584073326|FG000|Overall Study|Withdrawal by Subject|2|||
161736000|NCT04501679|584073327|FG001|Overall Study|Withdrawal by Subject|0|||
161736001|NCT04501679|584073326|FG000|Overall Study|Physician Decision|1|||
161736002|NCT04501679|584073327|FG001|Overall Study|Physician Decision|0|||
161736003|NCT04501679|584073326|FG000|Overall Study|Lost to Follow-up|2|||
161736004|NCT04501679|584073327|FG001|Overall Study|Lost to Follow-up|0|||
161736005|NCT02121756|584073331|FG000|Overall Study|Adverse Event|3|||
161736006|NCT02121756|584073332|FG001|Overall Study|Adverse Event|0|||
161736007|NCT02121756|584073331|FG000|Overall Study|Protocol Violation|1|||
161736008|NCT02121756|584073332|FG001|Overall Study|Protocol Violation|1|||
161736009|NCT02121756|584073331|FG000|Overall Study|Physician Decision|2|||
161736010|NCT02121756|584073332|FG001|Overall Study|Physician Decision|1|||
161736011|NCT05319080|584073333|FG000|Overall Study|Withdrawal by Subject|2|||
161736012|NCT05319080|584073333|FG000|Overall Study|Physician Decision|4|||
161736013|NCT00751114|584073334|FG000|Overall Study|Adverse Event|2|||
161736014|NCT00751114|584073335|FG001|Overall Study|Adverse Event|4|||
161736015|NCT00751114|584073334|FG000|Overall Study|Protocol Violation|8|||
161736016|NCT00751114|584073335|FG001|Overall Study|Protocol Violation|9|||
161736017|NCT00751114|584073334|FG000|Overall Study|Withdrawal by Subject|9|||
161736018|NCT00751114|584073335|FG001|Overall Study|Withdrawal by Subject|4|||
161736019|NCT00751114|584073334|FG000|Overall Study|Lost to Follow-up|4|||
161736020|NCT00751114|584073335|FG001|Overall Study|Lost to Follow-up|7|||
161736021|NCT00751114|584073334|FG000|Overall Study|Lack of Efficacy|0|||
161736022|NCT00751114|584073335|FG001|Overall Study|Lack of Efficacy|7|||
161736023|NCT00751114|584073334|FG000|Overall Study|Not Treated|13|||
161736024|NCT00751114|584073335|FG001|Overall Study|Not Treated|1|||
161736025|NCT00751114|584073334|FG000|Overall Study|Out of country for 2 months|1|||
161736026|NCT00751114|584073335|FG001|Overall Study|Out of country for 2 months|0|||
161736027|NCT00751114|584073334|FG000|Overall Study|Move to another city|1|||
161736028|NCT00751114|584073335|FG001|Overall Study|Move to another city|0|||
161736029|NCT03095521|584073336|FG000|Overall Study|Withdrawal by Subject|0|||
161736030|NCT03095521|584073337|FG001|Overall Study|Withdrawal by Subject|1|||
161736031|NCT03095521|584073336|FG000|Overall Study|Lost to Follow-up|0|||
161736032|NCT03095521|584073337|FG001|Overall Study|Lost to Follow-up|1|||
161736033|NCT01536119|584073340|FG000|Overall Study|Lost to Follow-up|17|||
161736034|NCT01536119|584073341|FG001|Overall Study|Lost to Follow-up|14|||
161736035|NCT00448916|584073342|FG000|Overall Study|Adverse Event|2|||
161736036|NCT00448916|584073343|FG001|Overall Study|Adverse Event|2|||
161736037|NCT00448916|584073344|FG002|Overall Study|Adverse Event|3|||
161736038|NCT00448916|584073345|FG003|Overall Study|Adverse Event|2|||
161736039|NCT00448916|584073342|FG000|Overall Study|Lack of Efficacy|1|||
161736040|NCT00448916|584073343|FG001|Overall Study|Lack of Efficacy|0|||
161736041|NCT00448916|584073344|FG002|Overall Study|Lack of Efficacy|2|||
161736042|NCT00448916|584073345|FG003|Overall Study|Lack of Efficacy|1|||
161736043|NCT00448916|584073342|FG000|Overall Study|Withdrawal by Subject|3|||
161736044|NCT00448916|584073343|FG001|Overall Study|Withdrawal by Subject|3|||
161736045|NCT00448916|584073344|FG002|Overall Study|Withdrawal by Subject|1|||
161736046|NCT00448916|584073345|FG003|Overall Study|Withdrawal by Subject|1|||
161736047|NCT00448916|584073342|FG000|Overall Study|Other|1|||
161736048|NCT00448916|584073343|FG001|Overall Study|Other|0|||
161736049|NCT00448916|584073344|FG002|Overall Study|Other|0|||
161736050|NCT00448916|584073345|FG003|Overall Study|Other|0|||
161736051|NCT00448916|584073342|FG000|Overall Study|Lost to Follow-up|0|||
161736052|NCT00448916|584073343|FG001|Overall Study|Lost to Follow-up|1|||
161736053|NCT00448916|584073344|FG002|Overall Study|Lost to Follow-up|0|||
161736054|NCT00448916|584073345|FG003|Overall Study|Lost to Follow-up|1|||
161736055|NCT00448916|584073342|FG000|Overall Study|Protocol Violation|0|||
161736056|NCT00448916|584073343|FG001|Overall Study|Protocol Violation|0|||
161736057|NCT00448916|584073344|FG002|Overall Study|Protocol Violation|0|||
161736058|NCT00448916|584073345|FG003|Overall Study|Protocol Violation|1|||
161736059|NCT02365584|584073346|FG000|Overall Study|Adverse Event|2|||
161736060|NCT02365584|584073347|FG001|Overall Study|Adverse Event|2|||
161736061|NCT02365584|584073346|FG000|Overall Study|Withdrawal by Subject|1|||
161736062|NCT02365584|584073347|FG001|Overall Study|Withdrawal by Subject|0|||
161736063|NCT02365584|584073346|FG000|Overall Study|Disease Progression|9|||
161736064|NCT02365584|584073347|FG001|Overall Study|Disease Progression|12|||
161736065|NCT03521193|584073348|FG000|Overall Study|Withdrawal by Subject|8|||
161736066|NCT03521193|584073349|FG001|Overall Study|Withdrawal by Subject|0|||
161736067|NCT03521193|584073348|FG000|Overall Study|non compliant to ASA treatment|8|||
161736068|NCT03521193|584073349|FG001|Overall Study|non compliant to ASA treatment|0|||
161736069|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
161736070|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
161736071|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
161736072|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
161736073|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
161736074|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
161965996|NCT03515551|584921956|FG006|Overall Study|Death|1|||
161736075|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
161736076|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
161736077|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
161736078|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
161736079|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
161736080|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
161736081|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
161736082|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
161736083|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
161736084|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
161736085|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Missing|3|||
161736086|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Missing|1|||
161736087|NCT00838916|584073350|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
161736088|NCT00838916|584073351|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
161736089|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
161736090|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
161736091|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
161736092|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
161736093|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
161736094|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
161736095|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
161736096|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
161736097|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
161736098|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
161736099|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
161736100|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
161736101|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
161736102|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
161736103|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
161736104|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
161736105|NCT00838916|584073350|FG000|Follow-up Period (8 Weeks)|Missing|3|||
161736106|NCT00838916|584073351|FG001|Follow-up Period (8 Weeks)|Missing|0|||
161736107|NCT01927419|584073352|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161736108|NCT01927419|584073353|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
161736109|NCT01927419|584073352|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
161736110|NCT01927419|584073353|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
161736111|NCT01927419|584073352|FG000|Treatment Period|Disease progression|17|||
161736112|NCT01927419|584073353|FG001|Treatment Period|Disease progression|20|||
161736113|NCT01927419|584073352|FG000|Treatment Period|Study drug toxicity|48|||
161736114|NCT01927419|584073353|FG001|Treatment Period|Study drug toxicity|10|||
161736115|NCT01927419|584073352|FG000|Treatment Period|Death|0|||
161736116|NCT01927419|584073353|FG001|Treatment Period|Death|1|||
161736117|NCT01927419|584073352|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
161736118|NCT01927419|584073353|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
161736119|NCT01927419|584073352|FG000|Treatment Period|Participant request to discontinue|12|||
161736120|NCT01927419|584073353|FG001|Treatment Period|Participant request to discontinue|4|||
161736121|NCT01927419|584073352|FG000|Treatment Period|Withdrawal by Subject|1|||
161736122|NCT01927419|584073353|FG001|Treatment Period|Withdrawal by Subject|1|||
161736123|NCT01927419|584073352|FG000|Treatment Period|Maximum Clinical Benefit|6|||
161736124|NCT01927419|584073353|FG001|Treatment Period|Maximum Clinical Benefit|2|||
161736125|NCT01927419|584073352|FG000|Treatment Period|Other reasons|3|||
161736126|NCT01927419|584073353|FG001|Treatment Period|Other reasons|4|||
161736127|NCT01927419|584073352|FG000|Treatment Period|Not Reported|1|||
161736128|NCT01927419|584073353|FG001|Treatment Period|Not Reported|1|||
161736129|NCT01935336|584073356|FG000|Overall Study|Adverse Event|1|||
161736130|NCT01935336|584073357|FG001|Overall Study|Adverse Event|0|||
161736131|NCT01935336|584073358|FG002|Overall Study|Adverse Event|0|||
161736132|NCT01935336|584073359|FG003|Overall Study|Adverse Event|0|||
161736133|NCT01935336|584073356|FG000|Overall Study|Progressive disease|5|||
161965997|NCT03515551|584921950|FG000|Overall Study|Lost to Follow-up|0|||
161736134|NCT01935336|584073357|FG001|Overall Study|Progressive disease|3|||
161736135|NCT01935336|584073358|FG002|Overall Study|Progressive disease|47|||
161736136|NCT01935336|584073359|FG003|Overall Study|Progressive disease|66|||
161736137|NCT02773238|584073361|FG000|Overall Study|Lack of Efficacy|4|||
161736138|NCT03260205|584073362|FG000|Overall Study|Adverse Event|2|||
161736139|NCT03260205|584073363|FG001|Overall Study|Adverse Event|0|||
161736140|NCT03260205|584073364|FG002|Overall Study|Adverse Event|2|||
161965998|NCT03515551|584921951|FG001|Overall Study|Lost to Follow-up|0|||
161965999|NCT03515551|584921952|FG002|Overall Study|Lost to Follow-up|1|||
161736141|NCT03260205|584073365|FG003|Overall Study|Adverse Event|2|||
161736142|NCT03260205|584073366|FG004|Overall Study|Adverse Event|4|||
161736143|NCT03260205|584073362|FG000|Overall Study|Lost to Follow-up|2|||
161736144|NCT03260205|584073363|FG001|Overall Study|Lost to Follow-up|2|||
161736145|NCT03260205|584073364|FG002|Overall Study|Lost to Follow-up|1|||
161736146|NCT03260205|584073365|FG003|Overall Study|Lost to Follow-up|1|||
161736147|NCT03260205|584073366|FG004|Overall Study|Lost to Follow-up|5|||
161736148|NCT03260205|584073362|FG000|Overall Study|Protocol Violation|0|||
161736149|NCT03260205|584073363|FG001|Overall Study|Protocol Violation|0|||
161736150|NCT03260205|584073364|FG002|Overall Study|Protocol Violation|2|||
161736151|NCT03260205|584073365|FG003|Overall Study|Protocol Violation|0|||
161736152|NCT03260205|584073366|FG004|Overall Study|Protocol Violation|1|||
161736153|NCT03260205|584073362|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
161736154|NCT03260205|584073363|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
161736155|NCT03260205|584073364|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
161736156|NCT03260205|584073365|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
161736157|NCT03260205|584073366|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
161736158|NCT03260205|584073362|FG000|Overall Study|Other: Unspecified|0|||
161736159|NCT03260205|584073363|FG001|Overall Study|Other: Unspecified|0|||
161736160|NCT03260205|584073364|FG002|Overall Study|Other: Unspecified|3|||
161736161|NCT03260205|584073365|FG003|Overall Study|Other: Unspecified|1|||
161736162|NCT03260205|584073366|FG004|Overall Study|Other: Unspecified|1|||
161736163|NCT03260205|584073362|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
161736164|NCT03260205|584073363|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
161736165|NCT03260205|584073364|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
161736166|NCT03260205|584073365|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
161736167|NCT03260205|584073366|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
161736168|NCT00479557|584073369|FG000|Overall Study|Death|0|||
161736169|NCT00479557|584073370|FG001|Overall Study|Death|0|||
161736170|NCT00479557|584073371|FG002|Overall Study|Death|0|||
161736171|NCT00479557|584073372|FG003|Overall Study|Death|0|||
161736172|NCT00479557|584073373|FG004|Overall Study|Death|0|||
161736173|NCT00479557|584073374|FG005|Overall Study|Death|1|||
161736174|NCT00479557|584073375|FG006|Overall Study|Death|0|||
161736175|NCT00479557|584073369|FG000|Overall Study|Lack of Efficacy|1|||
161736176|NCT00479557|584073370|FG001|Overall Study|Lack of Efficacy|0|||
161736177|NCT00479557|584073371|FG002|Overall Study|Lack of Efficacy|0|||
161736178|NCT00479557|584073372|FG003|Overall Study|Lack of Efficacy|0|||
161736179|NCT00479557|584073373|FG004|Overall Study|Lack of Efficacy|0|||
161736180|NCT00479557|584073374|FG005|Overall Study|Lack of Efficacy|0|||
161736181|NCT00479557|584073375|FG006|Overall Study|Lack of Efficacy|0|||
161736182|NCT00479557|584073369|FG000|Overall Study|Lost to Follow-up|0|||
161736183|NCT00479557|584073370|FG001|Overall Study|Lost to Follow-up|2|||
161736184|NCT00479557|584073371|FG002|Overall Study|Lost to Follow-up|0|||
161736185|NCT00479557|584073372|FG003|Overall Study|Lost to Follow-up|2|||
161736186|NCT00479557|584073373|FG004|Overall Study|Lost to Follow-up|0|||
161736187|NCT00479557|584073374|FG005|Overall Study|Lost to Follow-up|0|||
161736188|NCT00479557|584073375|FG006|Overall Study|Lost to Follow-up|0|||
161736189|NCT00479557|584073369|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
161736190|NCT00479557|584073370|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
161736191|NCT00479557|584073371|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
161736192|NCT00479557|584073372|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
161736193|NCT00479557|584073373|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
161736194|NCT00479557|584073374|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
161736195|NCT00479557|584073375|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
161736196|NCT00479557|584073369|FG000|Overall Study|AE not related to Study Drug|1|||
161736197|NCT00479557|584073370|FG001|Overall Study|AE not related to Study Drug|3|||
161736198|NCT00479557|584073371|FG002|Overall Study|AE not related to Study Drug|0|||
161736199|NCT00479557|584073372|FG003|Overall Study|AE not related to Study Drug|0|||
161736200|NCT00479557|584073373|FG004|Overall Study|AE not related to Study Drug|2|||
161736201|NCT00479557|584073374|FG005|Overall Study|AE not related to Study Drug|2|||
161840142|NCT02227147|584460456|FG001|Controlled Treatment Period|Adverse Event|3|||
161840143|NCT02227147|584460455|FG000|Controlled Treatment Period|Other|2|||
161736202|NCT00479557|584073375|FG006|Overall Study|AE not related to Study Drug|1|||
161736203|NCT00479557|584073369|FG000|Overall Study|Caregiver Request|2|||
161736204|NCT00479557|584073370|FG001|Overall Study|Caregiver Request|2|||
161736205|NCT00479557|584073371|FG002|Overall Study|Caregiver Request|2|||
161736206|NCT00479557|584073372|FG003|Overall Study|Caregiver Request|0|||
161736207|NCT00479557|584073373|FG004|Overall Study|Caregiver Request|1|||
161736208|NCT00479557|584073374|FG005|Overall Study|Caregiver Request|2|||
161736209|NCT00479557|584073375|FG006|Overall Study|Caregiver Request|0|||
161736210|NCT00479557|584073369|FG000|Overall Study|Investigator Request|0|||
161736211|NCT00479557|584073370|FG001|Overall Study|Investigator Request|0|||
161736212|NCT00479557|584073371|FG002|Overall Study|Investigator Request|1|||
161736213|NCT00479557|584073372|FG003|Overall Study|Investigator Request|0|||
161736214|NCT00479557|584073373|FG004|Overall Study|Investigator Request|0|||
162032420|NCT04030026|585175481|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
161736215|NCT00479557|584073374|FG005|Overall Study|Investigator Request|0|||
161736216|NCT00479557|584073375|FG006|Overall Study|Investigator Request|0|||
161736217|NCT00479557|584073369|FG000|Overall Study|Subject Request|3|||
161736218|NCT00479557|584073370|FG001|Overall Study|Subject Request|0|||
161736219|NCT00479557|584073371|FG002|Overall Study|Subject Request|1|||
161736220|NCT00479557|584073372|FG003|Overall Study|Subject Request|1|||
161736221|NCT00479557|584073373|FG004|Overall Study|Subject Request|1|||
161736222|NCT00479557|584073374|FG005|Overall Study|Subject Request|4|||
161736223|NCT00479557|584073375|FG006|Overall Study|Subject Request|1|||
161736224|NCT00479557|584073369|FG000|Overall Study|Other|2|||
161736225|NCT00479557|584073370|FG001|Overall Study|Other|3|||
161736226|NCT00479557|584073371|FG002|Overall Study|Other|1|||
161736227|NCT00479557|584073372|FG003|Overall Study|Other|0|||
161736228|NCT00479557|584073373|FG004|Overall Study|Other|0|||
161736229|NCT00479557|584073374|FG005|Overall Study|Other|3|||
161736230|NCT00479557|584073375|FG006|Overall Study|Other|0|||
161736231|NCT01511107|584073378|FG000|Overall Study|Ineligible|3|||
161736232|NCT01511107|584073379|FG001|Overall Study|Ineligible|2|||
161736233|NCT01511107|584073378|FG000|Overall Study|Lost to Follow-up|10|||
161736234|NCT01511107|584073379|FG001|Overall Study|Lost to Follow-up|19|||
161736235|NCT01511107|584073378|FG000|Overall Study|Withdrawal by Subject|9|||
161736236|NCT01511107|584073379|FG001|Overall Study|Withdrawal by Subject|20|||
161736237|NCT05371912|584073380|FG000|Overall Study|Lost to Follow-up|3|||
161736238|NCT05371912|584073381|FG001|Overall Study|Lost to Follow-up|2|||
161736239|NCT04752189|584073382|FG000|Overall Study|Withdrawal by Subject|0|||
161736240|NCT04752189|584073383|FG001|Overall Study|Withdrawal by Subject|150|||
161736241|NCT04752189|584073382|FG000|Overall Study|Lost to Follow-up|261|||
161736242|NCT04752189|584073383|FG001|Overall Study|Lost to Follow-up|126|||
161736243|NCT00975195|584073384|FG000|Overall Study|Adverse Event|108|||
161736244|NCT00975195|584073385|FG001|Overall Study|Adverse Event|101|||
161736245|NCT00975195|584073384|FG000|Overall Study|Lack of Efficacy|6|||
161736246|NCT00975195|584073385|FG001|Overall Study|Lack of Efficacy|6|||
161736247|NCT00975195|584073384|FG000|Overall Study|Protocol Violation|27|||
161736248|NCT00975195|584073385|FG001|Overall Study|Protocol Violation|23|||
161736249|NCT00975195|584073384|FG000|Overall Study|Lost to Follow-up|9|||
161736250|NCT00975195|584073385|FG001|Overall Study|Lost to Follow-up|7|||
161736251|NCT00975195|584073384|FG000|Overall Study|Withdrawal by Subject|48|||
161736252|NCT00975195|584073385|FG001|Overall Study|Withdrawal by Subject|61|||
161736253|NCT00975195|584073384|FG000|Overall Study|Other reason not defined above|29|||
161736254|NCT00975195|584073385|FG001|Overall Study|Other reason not defined above|33|||
161736255|NCT00975195|584073384|FG000|Overall Study|Not treated|1|||
161736256|NCT00975195|584073385|FG001|Overall Study|Not treated|2|||
161736257|NCT02180724|584074692|FG000|Overall Study|Death|26|||
161736258|NCT02180724|584074693|FG001|Overall Study|Death|1|||
161736259|NCT02180724|584074692|FG000|Overall Study|Lost to Follow-up|3|||
161736260|NCT02180724|584074693|FG001|Overall Study|Lost to Follow-up|1|||
161736261|NCT02180724|584074692|FG000|Overall Study|Withdrawal by Subject|4|||
161736262|NCT02180724|584074693|FG001|Overall Study|Withdrawal by Subject|2|||
161736263|NCT02180724|584074692|FG000|Overall Study|PI Decision|5|||
161736264|NCT02180724|584074693|FG001|Overall Study|PI Decision|2|||
161736265|NCT02180724|584074692|FG000|Overall Study|Study terminated by sponsor|54|||
161736266|NCT02180724|584074693|FG001|Overall Study|Study terminated by sponsor|8|||
161736267|NCT05195359|584074694|FG000|Overall Study|Lost to Follow-up|124|||
161736268|NCT05195359|584074695|FG001|Overall Study|Lost to Follow-up|34|||
161736269|NCT01146951|584074696|FG000|Overall Study|Adverse Event|4|||
161736270|NCT01146951|584074697|FG001|Overall Study|Adverse Event|1|||
161736271|NCT01747811|584074701|FG000|Overall Study|Lack of Efficacy|2|||
161736272|NCT01747811|584074702|FG001|Overall Study|Lack of Efficacy|4|||
161736273|NCT02492997|584074704|FG000|Overall Study|Withdrawal by Subject|1|||
161736274|NCT02492997|584074705|FG001|Overall Study|Withdrawal by Subject|0|||
161736275|NCT02492997|584074704|FG000|Overall Study|Gained Weight|1|||
161736276|NCT02492997|584074705|FG001|Overall Study|Gained Weight|0|||
161736277|NCT02492997|584074704|FG000|Overall Study|Lost to Follow-up|0|||
161736278|NCT02492997|584074705|FG001|Overall Study|Lost to Follow-up|1|||
161736279|NCT01089582|584074706|FG000|Overall Study|Death|2|||
161736280|NCT01089582|584074706|FG000|Overall Study|Adverse Event|15|||
162032421|NCT04030026|585175482|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
161736281|NCT01089582|584074706|FG000|Overall Study|Lost to Follow-up|8|||
161736282|NCT01089582|584074706|FG000|Overall Study|Other|4|||
161736283|NCT01089582|584074706|FG000|Overall Study|Withdrawal by Subject|1|||
161736284|NCT04069156|584074707|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
161736285|NCT04069156|584074708|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
161736286|NCT04069156|584074707|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
161736287|NCT04069156|584074708|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
161736288|NCT04069156|584074707|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
161736289|NCT04069156|584074708|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
161736290|NCT04069156|584074707|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
161736291|NCT04069156|584074708|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
161736292|NCT03368664|584074723|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
161840144|NCT02227147|584460456|FG001|Controlled Treatment Period|Other|0|||
161840145|NCT02227147|584460455|FG000|Follow-up Period|Other|3|||
161840146|NCT02227147|584460456|FG001|Follow-up Period|Other|5|||
161840147|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
161840148|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
161840149|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
161840150|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
161840151|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
161840152|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
161840153|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
161840154|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
161840155|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
161840156|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
161840157|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
161840158|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
161840159|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
161840160|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
161840161|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
161840162|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
161840163|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
161840164|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
161840165|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
161840166|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
161840167|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
161840168|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
161840169|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
161840170|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
161840171|NCT03514641|584460460|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
161840172|NCT03514641|584460461|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
161840173|NCT03514641|584460462|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
161840174|NCT03514641|584460463|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
161840175|NCT03514641|584460460|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
161840176|NCT03514641|584460461|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
161840177|NCT03514641|584460462|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
161840178|NCT03514641|584460463|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
161840179|NCT03514641|584460460|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
161840180|NCT03514641|584460461|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
161840181|NCT03514641|584460462|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
161840182|NCT03514641|584460463|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
161840183|NCT03514641|584460460|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
161840184|NCT03514641|584460461|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
161840185|NCT03514641|584460462|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
161840186|NCT03514641|584460463|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
161840187|NCT03514641|584460460|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
161840188|NCT03514641|584460461|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
161840189|NCT03514641|584460462|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
161840190|NCT03514641|584460463|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
161840191|NCT03514641|584460460|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
161840192|NCT03514641|584460461|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
161966000|NCT03515551|584921953|FG003|Overall Study|Lost to Follow-up|0|||
161966001|NCT03515551|584921954|FG004|Overall Study|Lost to Follow-up|0|||
161966002|NCT03515551|584921955|FG005|Overall Study|Lost to Follow-up|0|||
161966003|NCT03515551|584921956|FG006|Overall Study|Lost to Follow-up|0|||
161966004|NCT03515551|584921950|FG000|Overall Study|Withdrawal by Subject|0|||
161966005|NCT03515551|584921951|FG001|Overall Study|Withdrawal by Subject|1|||
161966006|NCT03515551|584921952|FG002|Overall Study|Withdrawal by Subject|0|||
161966007|NCT03515551|584921953|FG003|Overall Study|Withdrawal by Subject|0|||
161966008|NCT03515551|584921954|FG004|Overall Study|Withdrawal by Subject|0|||
161966009|NCT03515551|584921955|FG005|Overall Study|Withdrawal by Subject|0|||
161966010|NCT03515551|584921956|FG006|Overall Study|Withdrawal by Subject|1|||
161840193|NCT03514641|584460462|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
161966011|NCT03515551|584921950|FG000|Overall Study|Study ended by sponsor|0|||
161840194|NCT03514641|584460463|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
161840195|NCT01345175|584460464|FG000|Overall Study|Physician Decision|0|||
161840196|NCT01345175|584460465|FG001|Overall Study|Physician Decision|1|||
161840197|NCT01345175|584460464|FG000|Overall Study|Withdrawal by Subject|1|||
161840198|NCT01345175|584460465|FG001|Overall Study|Withdrawal by Subject|1|||
161840199|NCT01345175|584460464|FG000|Overall Study|Failed to complete BFI|3|||
161966012|NCT03515551|584921951|FG001|Overall Study|Study ended by sponsor|0|||
161966013|NCT03515551|584921952|FG002|Overall Study|Study ended by sponsor|2|||
161966014|NCT03515551|584921953|FG003|Overall Study|Study ended by sponsor|1|||
161966015|NCT03515551|584921954|FG004|Overall Study|Study ended by sponsor|3|||
161736293|NCT03368664|584074723|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
161736294|NCT03368664|584074723|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
161736295|NCT03368664|584074723|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
161736296|NCT05441592|584074724|FG000|Overall Study|Lost to Follow-up|1|||
161736297|NCT05441592|584074725|FG001|Overall Study|Lost to Follow-up|5|||
161736298|NCT01021852|584074726|FG000|Treatment Period 1|Adverse Event|3|||
161736299|NCT01021852|584074727|FG001|Treatment Period 1|Adverse Event|1|||
161736300|NCT01021852|584074728|FG002|Treatment Period 1|Adverse Event|1|||
161736301|NCT01021852|584074729|FG003|Treatment Period 1|Adverse Event|0|||
161736302|NCT01021852|584074730|FG004|Treatment Period 1|Adverse Event|2|||
161736303|NCT01021852|584074731|FG005|Treatment Period 1|Adverse Event|2|||
161736304|NCT01021852|584074732|FG006|Treatment Period 1|Adverse Event|0|||
161736305|NCT01021852|584074733|FG007|Treatment Period 1|Adverse Event|0|||
161736306|NCT01021852|584074726|FG000|Treatment Period 1|Pregnancy|0|||
161736307|NCT01021852|584074727|FG001|Treatment Period 1|Pregnancy|0|||
161736308|NCT01021852|584074728|FG002|Treatment Period 1|Pregnancy|1|||
161736309|NCT01021852|584074729|FG003|Treatment Period 1|Pregnancy|0|||
161736310|NCT01021852|584074730|FG004|Treatment Period 1|Pregnancy|0|||
161736311|NCT01021852|584074731|FG005|Treatment Period 1|Pregnancy|0|||
161736312|NCT01021852|584074732|FG006|Treatment Period 1|Pregnancy|0|||
161736313|NCT01021852|584074733|FG007|Treatment Period 1|Pregnancy|0|||
161736314|NCT01021852|584074726|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161736315|NCT01021852|584074727|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161736316|NCT01021852|584074728|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161736317|NCT01021852|584074729|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161736318|NCT01021852|584074730|FG004|Treatment Period 1|Withdrawal by Subject|1|||
161736319|NCT01021852|584074731|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161736320|NCT01021852|584074732|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161736321|NCT01021852|584074733|FG007|Treatment Period 1|Withdrawal by Subject|1|||
161736322|NCT01021852|584074726|FG000|Treatment Period 1|Not Treated|0|||
161736323|NCT01021852|584074727|FG001|Treatment Period 1|Not Treated|0|||
161736324|NCT01021852|584074728|FG002|Treatment Period 1|Not Treated|0|||
161736325|NCT01021852|584074729|FG003|Treatment Period 1|Not Treated|2|||
161736326|NCT01021852|584074730|FG004|Treatment Period 1|Not Treated|0|||
161736327|NCT01021852|584074731|FG005|Treatment Period 1|Not Treated|0|||
161736328|NCT01021852|584074732|FG006|Treatment Period 1|Not Treated|0|||
161736329|NCT01021852|584074733|FG007|Treatment Period 1|Not Treated|0|||
161736330|NCT01021852|584074726|FG000|Washout Period-Placebo|Adverse Event|0|||
161736331|NCT01021852|584074727|FG001|Washout Period-Placebo|Adverse Event|0|||
161736332|NCT01021852|584074728|FG002|Washout Period-Placebo|Adverse Event|0|||
161736333|NCT01021852|584074729|FG003|Washout Period-Placebo|Adverse Event|1|||
161736334|NCT01021852|584074730|FG004|Washout Period-Placebo|Adverse Event|0|||
161736335|NCT01021852|584074731|FG005|Washout Period-Placebo|Adverse Event|1|||
161736336|NCT01021852|584074732|FG006|Washout Period-Placebo|Adverse Event|0|||
161736337|NCT01021852|584074733|FG007|Washout Period-Placebo|Adverse Event|0|||
161736338|NCT01021852|584074726|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
161736339|NCT01021852|584074727|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
161736340|NCT01021852|584074728|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
161736341|NCT01021852|584074729|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
161736342|NCT01021852|584074730|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
161736343|NCT01021852|584074731|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
161736344|NCT01021852|584074732|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
161736345|NCT01021852|584074733|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
161736346|NCT01021852|584074726|FG000|Washout Period-Placebo|Protocol Violation|0|||
161736347|NCT01021852|584074727|FG001|Washout Period-Placebo|Protocol Violation|0|||
161736348|NCT01021852|584074728|FG002|Washout Period-Placebo|Protocol Violation|0|||
161736349|NCT01021852|584074729|FG003|Washout Period-Placebo|Protocol Violation|0|||
161736350|NCT01021852|584074730|FG004|Washout Period-Placebo|Protocol Violation|0|||
161736351|NCT01021852|584074731|FG005|Washout Period-Placebo|Protocol Violation|0|||
161736352|NCT01021852|584074732|FG006|Washout Period-Placebo|Protocol Violation|1|||
161736353|NCT01021852|584074733|FG007|Washout Period-Placebo|Protocol Violation|0|||
161736354|NCT01021852|584074726|FG000|Washout Period-No Drug|Adverse Event|1|||
161736355|NCT01021852|584074727|FG001|Washout Period-No Drug|Adverse Event|0|||
161736356|NCT01021852|584074728|FG002|Washout Period-No Drug|Adverse Event|0|||
161736357|NCT01021852|584074729|FG003|Washout Period-No Drug|Adverse Event|0|||
161736358|NCT01021852|584074730|FG004|Washout Period-No Drug|Adverse Event|0|||
161736359|NCT01021852|584074731|FG005|Washout Period-No Drug|Adverse Event|1|||
161736360|NCT01021852|584074732|FG006|Washout Period-No Drug|Adverse Event|0|||
161736361|NCT01021852|584074733|FG007|Washout Period-No Drug|Adverse Event|0|||
161736362|NCT01021852|584074726|FG000|Treatment Period 2|Adverse Event|0|||
161736363|NCT01021852|584074727|FG001|Treatment Period 2|Adverse Event|1|||
161736364|NCT01021852|584074728|FG002|Treatment Period 2|Adverse Event|0|||
161736365|NCT01021852|584074729|FG003|Treatment Period 2|Adverse Event|0|||
161736366|NCT01021852|584074730|FG004|Treatment Period 2|Adverse Event|1|||
161736367|NCT01021852|584074731|FG005|Treatment Period 2|Adverse Event|0|||
162032422|NCT04030026|585175481|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
161736368|NCT01021852|584074732|FG006|Treatment Period 2|Adverse Event|1|||
161736369|NCT01021852|584074733|FG007|Treatment Period 2|Adverse Event|0|||
161736370|NCT01021852|584074726|FG000|Treatment Period 2|Lack of Efficacy|0|||
161736371|NCT01021852|584074727|FG001|Treatment Period 2|Lack of Efficacy|0|||
161736372|NCT01021852|584074728|FG002|Treatment Period 2|Lack of Efficacy|0|||
161736373|NCT01021852|584074729|FG003|Treatment Period 2|Lack of Efficacy|0|||
161736374|NCT01021852|584074730|FG004|Treatment Period 2|Lack of Efficacy|0|||
161736375|NCT01021852|584074731|FG005|Treatment Period 2|Lack of Efficacy|1|||
161736376|NCT01021852|584074732|FG006|Treatment Period 2|Lack of Efficacy|0|||
161736377|NCT01021852|584074733|FG007|Treatment Period 2|Lack of Efficacy|0|||
161736378|NCT01021852|584074726|FG000|Treatment Period 2|Physician Decision|0|||
161736379|NCT01021852|584074727|FG001|Treatment Period 2|Physician Decision|0|||
161736380|NCT01021852|584074728|FG002|Treatment Period 2|Physician Decision|1|||
161736381|NCT01021852|584074729|FG003|Treatment Period 2|Physician Decision|0|||
161736382|NCT01021852|584074730|FG004|Treatment Period 2|Physician Decision|0|||
161736383|NCT01021852|584074731|FG005|Treatment Period 2|Physician Decision|0|||
161736384|NCT01021852|584074732|FG006|Treatment Period 2|Physician Decision|0|||
161736385|NCT01021852|584074733|FG007|Treatment Period 2|Physician Decision|0|||
161736386|NCT01021852|584074726|FG000|Treatment Period 2|Protocol Violation|0|||
161736387|NCT01021852|584074727|FG001|Treatment Period 2|Protocol Violation|0|||
161736388|NCT01021852|584074728|FG002|Treatment Period 2|Protocol Violation|0|||
161736389|NCT01021852|584074729|FG003|Treatment Period 2|Protocol Violation|0|||
161736390|NCT01021852|584074730|FG004|Treatment Period 2|Protocol Violation|1|||
161736391|NCT01021852|584074731|FG005|Treatment Period 2|Protocol Violation|0|||
161736392|NCT01021852|584074732|FG006|Treatment Period 2|Protocol Violation|1|||
161736393|NCT01021852|584074733|FG007|Treatment Period 2|Protocol Violation|0|||
161736394|NCT01021852|584074726|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161736395|NCT01021852|584074727|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161736396|NCT01021852|584074728|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161736397|NCT01021852|584074729|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161736398|NCT01021852|584074730|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161736399|NCT01021852|584074731|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161736400|NCT01021852|584074732|FG006|Treatment Period 2|Withdrawal by Subject|1|||
161736401|NCT01021852|584074733|FG007|Treatment Period 2|Withdrawal by Subject|2|||
161736402|NCT01371981|584074734|FG000|Overall Study|Adverse Event|12|||
161736403|NCT01371981|584074735|FG001|Overall Study|Adverse Event|17|||
161736404|NCT01371981|584074736|FG002|Overall Study|Adverse Event|0|||
161736405|NCT01371981|584074737|FG003|Overall Study|Adverse Event|4|||
161966016|NCT03515551|584921955|FG005|Overall Study|Study ended by sponsor|0|||
161966017|NCT03515551|584921956|FG006|Overall Study|Study ended by sponsor|3|||
161966018|NCT03515551|584921950|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
161966019|NCT03515551|584921951|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
161966020|NCT03515551|584921952|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
161966021|NCT03515551|584921953|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
161736406|NCT01371981|584074738|FG004|Overall Study|Adverse Event|1|||
161736407|NCT01371981|584074739|FG005|Overall Study|Adverse Event|0|||
161736408|NCT01371981|584074734|FG000|Overall Study|Death|22|||
161736409|NCT01371981|584074735|FG001|Overall Study|Death|16|||
161736410|NCT01371981|584074736|FG002|Overall Study|Death|0|||
161736411|NCT01371981|584074737|FG003|Overall Study|Death|0|||
161736412|NCT01371981|584074738|FG004|Overall Study|Death|2|||
161736413|NCT01371981|584074739|FG005|Overall Study|Death|2|||
161736414|NCT01371981|584074734|FG000|Overall Study|Lack of Efficacy|69|||
161736415|NCT01371981|584074735|FG001|Overall Study|Lack of Efficacy|61|||
161736416|NCT01371981|584074736|FG002|Overall Study|Lack of Efficacy|4|||
161736417|NCT01371981|584074737|FG003|Overall Study|Lack of Efficacy|8|||
161736418|NCT01371981|584074738|FG004|Overall Study|Lack of Efficacy|5|||
161736419|NCT01371981|584074739|FG005|Overall Study|Lack of Efficacy|0|||
161736420|NCT01371981|584074734|FG000|Overall Study|Physician Decision|48|||
161736421|NCT01371981|584074735|FG001|Overall Study|Physician Decision|63|||
161736422|NCT01371981|584074736|FG002|Overall Study|Physician Decision|1|||
161736423|NCT01371981|584074737|FG003|Overall Study|Physician Decision|7|||
161736424|NCT01371981|584074738|FG004|Overall Study|Physician Decision|14|||
161736425|NCT01371981|584074739|FG005|Overall Study|Physician Decision|3|||
161736426|NCT01371981|584074734|FG000|Overall Study|Withdrawal by Subject|12|||
161736427|NCT01371981|584074735|FG001|Overall Study|Withdrawal by Subject|19|||
161736428|NCT01371981|584074736|FG002|Overall Study|Withdrawal by Subject|1|||
161736429|NCT01371981|584074737|FG003|Overall Study|Withdrawal by Subject|2|||
161966022|NCT03515551|584921954|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
161736430|NCT01371981|584074738|FG004|Overall Study|Withdrawal by Subject|10|||
161736431|NCT01371981|584074739|FG005|Overall Study|Withdrawal by Subject|3|||
161736432|NCT01371981|584074734|FG000|Overall Study|Ineligible|19|||
161736433|NCT01371981|584074735|FG001|Overall Study|Ineligible|13|||
161736434|NCT01371981|584074736|FG002|Overall Study|Ineligible|0|||
161736435|NCT01371981|584074737|FG003|Overall Study|Ineligible|0|||
161736436|NCT01371981|584074738|FG004|Overall Study|Ineligible|0|||
161736437|NCT01371981|584074739|FG005|Overall Study|Ineligible|4|||
161736438|NCT01371981|584074734|FG000|Overall Study|Did not start treatment|2|||
161736439|NCT01371981|584074735|FG001|Overall Study|Did not start treatment|3|||
161736440|NCT01371981|584074736|FG002|Overall Study|Did not start treatment|0|||
161736441|NCT01371981|584074737|FG003|Overall Study|Did not start treatment|0|||
161736442|NCT01371981|584074738|FG004|Overall Study|Did not start treatment|0|||
161736443|NCT01371981|584074739|FG005|Overall Study|Did not start treatment|2|||
161736444|NCT02493426|584074740|FG000|Overall Study|Withdrawal by Subject|0|||
161736445|NCT02493426|584074741|FG001|Overall Study|Withdrawal by Subject|1|||
161736446|NCT01025817|584074743|FG000|Completed Study Medication|Adverse Event|66|||
161736447|NCT01025817|584074744|FG001|Completed Study Medication|Adverse Event|39|||
161736448|NCT01025817|584074743|FG000|Completed Study Medication|Protocol Deviation|9|||
161736449|NCT01025817|584074744|FG001|Completed Study Medication|Protocol Deviation|8|||
161736450|NCT01025817|584074743|FG000|Completed Study Medication|Withdrawal by Subject|8|||
161736451|NCT01025817|584074744|FG001|Completed Study Medication|Withdrawal by Subject|9|||
161736452|NCT01025817|584074743|FG000|Completed Study Medication|Administrative problems|7|||
161736453|NCT01025817|584074744|FG001|Completed Study Medication|Administrative problems|5|||
161736454|NCT01025817|584074743|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
161736455|NCT01025817|584074744|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
161736456|NCT01025817|584074743|FG000|Completed Study Medication|Abnormal test procedure|4|||
161736457|NCT01025817|584074744|FG001|Completed Study Medication|Abnormal test procedure|0|||
161736458|NCT01025817|584074743|FG000|Completed Study Medication|Graft loss|2|||
161736459|NCT01025817|584074744|FG001|Completed Study Medication|Graft loss|5|||
161736460|NCT01025817|584074743|FG000|Completed Study Medication|Death|2|||
161736461|NCT01025817|584074744|FG001|Completed Study Medication|Death|2|||
161736462|NCT01025817|584074743|FG000|Completed Study Medication|Abnormal lab values|0|||
161736463|NCT01025817|584074744|FG001|Completed Study Medication|Abnormal lab values|2|||
161736464|NCT01025817|584074743|FG000|Completed Study Medication|Subject no longer required study drug|0|||
161736465|NCT01025817|584074744|FG001|Completed Study Medication|Subject no longer required study drug|1|||
161736466|NCT01025817|584074743|FG000|Completed Study Medication|Lost to Follow-up|0|||
161736467|NCT01025817|584074744|FG001|Completed Study Medication|Lost to Follow-up|1|||
161736468|NCT01025817|584074743|FG000|Completed Study|Withdrawal by Subject|8|||
161736469|NCT01025817|584074744|FG001|Completed Study|Withdrawal by Subject|16|||
161736470|NCT01025817|584074743|FG000|Completed Study|Death|6|||
161736471|NCT01025817|584074744|FG001|Completed Study|Death|5|||
161736472|NCT01025817|584074743|FG000|Completed Study|Missing|2|||
161736473|NCT01025817|584074744|FG001|Completed Study|Missing|0|||
161736474|NCT01025817|584074743|FG000|Completed Study|Lost to Follow-up|0|||
161736475|NCT01025817|584074744|FG001|Completed Study|Lost to Follow-up|1|||
161736476|NCT01153893|584074747|FG000|Overall Study|Adverse Event|1|||
161736477|NCT01153893|584074748|FG001|Overall Study|Adverse Event|0|||
161736478|NCT04799405|584074749|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
161736479|NCT01029002|584074750|FG000|Overall Study|Lost to Follow-up|2|||
161736480|NCT01029002|584074751|FG001|Overall Study|Lost to Follow-up|4|||
161736481|NCT00118482|584074752|FG000|Overall Study|Lost to Follow-up|7|||
161736482|NCT00118482|584074753|FG001|Overall Study|Lost to Follow-up|7|||
161736483|NCT00118482|584074752|FG000|Overall Study|Withdrawal by Subject|23|||
161736484|NCT00118482|584074753|FG001|Overall Study|Withdrawal by Subject|22|||
161736485|NCT01934192|584074758|FG000|Overall Study|Protocol Violation|0|||
161736486|NCT01934192|584074759|FG001|Overall Study|Protocol Violation|0|||
161736487|NCT01934192|584074760|FG002|Overall Study|Protocol Violation|0|||
161736488|NCT01934192|584074761|FG003|Overall Study|Protocol Violation|1|||
161736489|NCT01934192|584074758|FG000|Overall Study|Other: reached stopping criteria|6|||
161736490|NCT01934192|584074759|FG001|Overall Study|Other: reached stopping criteria|5|||
161736491|NCT01934192|584074760|FG002|Overall Study|Other: reached stopping criteria|1|||
161736492|NCT01934192|584074761|FG003|Overall Study|Other: reached stopping criteria|0|||
161736493|NCT01934192|584074758|FG000|Overall Study|Physician Decision|3|||
161736494|NCT01934192|584074759|FG001|Overall Study|Physician Decision|2|||
161736495|NCT01934192|584074760|FG002|Overall Study|Physician Decision|0|||
161736496|NCT01934192|584074761|FG003|Overall Study|Physician Decision|0|||
161736497|NCT01737840|584074762|FG000|Overall Study|Diagnosed with an other pathology|2|||
161736498|NCT01737840|584074763|FG001|Overall Study|Diagnosed with an other pathology|2|||
161736499|NCT01189435|584074764|FG000|Overall Study|Withdrawal by Subject|1|||
161736500|NCT01189435|584074764|FG000|Overall Study|Physician Decision|1|||
161966023|NCT03515551|584921955|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
161966024|NCT03515551|584921956|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
161966025|NCT00673231|584921957|FG000|Overall Study|Withdrawal by Subject|14|||
161736501|NCT04105244|584074767|FG000|Overall Study|Withdrawal by Subject|10|||
161736502|NCT04105244|584074768|FG001|Overall Study|Withdrawal by Subject|12|||
161736503|NCT04105244|584074767|FG000|Overall Study|Lost to Follow-up|20|||
161736504|NCT04105244|584074768|FG001|Overall Study|Lost to Follow-up|15|||
161736505|NCT04105244|584074767|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
161736506|NCT04105244|584074768|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
161736507|NCT04105244|584074767|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
161736508|NCT04105244|584074768|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
161736509|NCT01449682|584074769|FG000|Overall Study|Death|0|||
161736510|NCT01449682|584074770|FG001|Overall Study|Death|1|||
161736511|NCT01449682|584074769|FG000|Overall Study|Adverse Event|1|||
161736512|NCT01449682|584074770|FG001|Overall Study|Adverse Event|0|||
161736513|NCT02768194|584074771|FG000|Period 1|Adverse Event|0|||
161736514|NCT02768194|584074772|FG001|Period 1|Adverse Event|0|||
161736515|NCT02768194|584074773|FG002|Period 1|Adverse Event|0|||
161736516|NCT02768194|584074774|FG003|Period 1|Adverse Event|1|||
161736517|NCT02768194|584074775|FG004|Period 1|Adverse Event|0|||
161736518|NCT02768194|584074776|FG005|Period 1|Adverse Event|0|||
161736519|NCT02768194|584074771|FG000|Period 2|Other (Reason not specified)|1|||
161736520|NCT02768194|584074772|FG001|Period 2|Other (Reason not specified)|0|||
161736521|NCT02768194|584074773|FG002|Period 2|Other (Reason not specified)|0|||
161736522|NCT02768194|584074774|FG003|Period 2|Other (Reason not specified)|0|||
161736523|NCT02768194|584074775|FG004|Period 2|Other (Reason not specified)|0|||
161736524|NCT02768194|584074776|FG005|Period 2|Other (Reason not specified)|0|||
161736525|NCT02768194|584074771|FG000|Period 3|Other (Reason not specified)|0|||
161736526|NCT02768194|584074772|FG001|Period 3|Other (Reason not specified)|1|||
161736527|NCT02768194|584074773|FG002|Period 3|Other (Reason not specified)|0|||
161736528|NCT02768194|584074774|FG003|Period 3|Other (Reason not specified)|0|||
161736529|NCT02768194|584074775|FG004|Period 3|Other (Reason not specified)|0|||
161736530|NCT02768194|584074776|FG005|Period 3|Other (Reason not specified)|0|||
161736531|NCT04863014|584074777|FG000|Overall Study|Lost to Follow-up|3|||
161736532|NCT04863014|584074778|FG001|Overall Study|Lost to Follow-up|2|||
161736533|NCT04863014|584074777|FG000|Overall Study|Subject Decision|0|||
161736534|NCT04863014|584074778|FG001|Overall Study|Subject Decision|4|||
161736535|NCT04633473|584074779|FG000|Overall Study|Withdrawal by Subject|6|||
161736536|NCT01822691|584074785|FG000|Overall Study|Withdrawal by Subject|2|||
161736537|NCT01553916|584074786|FG000|Overall Study|Withdrawal by Subject|2|||
161736538|NCT01553916|584074786|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
161736539|NCT03089216|584074787|FG000|Overall Study|Adverse Event|0|||
161736540|NCT03089216|584074788|FG001|Overall Study|Adverse Event|0|||
161736541|NCT03089216|584074789|FG002|Overall Study|Adverse Event|0|||
161736542|NCT03089216|584074790|FG003|Overall Study|Adverse Event|1|||
161736543|NCT03259490|584074791|FG000|Period 1|Withdrawal by Subject|0|||
161736544|NCT03259490|584074792|FG001|Period 1|Withdrawal by Subject|1|||
161736545|NCT03259490|584074791|FG000|Period 2|Protocol Violation|1|||
161736546|NCT03259490|584074792|FG001|Period 2|Protocol Violation|0|||
161736547|NCT00819585|584074795|FG000|Core Study|Adverse Event|2|||
161736548|NCT00819585|584074796|FG001|Core Study|Adverse Event|1|||
161736549|NCT00819585|584074797|FG002|Core Study|Adverse Event|1|||
161736550|NCT00819585|584074798|FG003|Core Study|Adverse Event|4|||
161736551|NCT00819585|584074799|FG004|Core Study|Adverse Event|1|||
161736552|NCT00819585|584074800|FG005|Core Study|Adverse Event|0|||
161736553|NCT00819585|584074801|FG006|Core Study|Adverse Event|2|||
161736554|NCT00819585|584074802|FG007|Core Study|Adverse Event|0|||
161736555|NCT00819585|584074803|FG008|Core Study|Adverse Event|0|||
161736556|NCT00819585|584074804|FG009|Core Study|Adverse Event|0|||
161736557|NCT00819585|584074805|FG010|Core Study|Adverse Event|0|||
161736558|NCT00819585|584074795|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
161736559|NCT00819585|584074796|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
161736560|NCT00819585|584074797|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
161840200|NCT01345175|584460465|FG001|Overall Study|Failed to complete BFI|2|||
161736561|NCT00819585|584074798|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
161736562|NCT00819585|584074799|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
161736563|NCT00819585|584074800|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
161736564|NCT00819585|584074801|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
161736565|NCT00819585|584074802|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
161736566|NCT00819585|584074803|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
161736567|NCT00819585|584074804|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
161736568|NCT00819585|584074805|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
161736569|NCT00819585|584074795|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
161840201|NCT01345175|584460464|FG000|Overall Study|Stopped taking medication|2|||
161840202|NCT01345175|584460465|FG001|Overall Study|Stopped taking medication|2|||
161736570|NCT00819585|584074796|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
161736571|NCT00819585|584074797|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736572|NCT00819585|584074798|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736573|NCT00819585|584074799|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736574|NCT00819585|584074800|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736575|NCT00819585|584074801|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
161736576|NCT00819585|584074802|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736577|NCT00819585|584074803|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736578|NCT00819585|584074804|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736579|NCT00819585|584074805|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
161736580|NCT00819585|584074795|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
161736581|NCT00819585|584074796|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
161736582|NCT00819585|584074797|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
161736583|NCT00819585|584074798|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
161966026|NCT00673231|584921958|FG001|Overall Study|Withdrawal by Subject|10|||
161966027|NCT00673231|584921959|FG002|Overall Study|Withdrawal by Subject|8|||
161736584|NCT00819585|584074799|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
161736585|NCT00819585|584074800|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
161736586|NCT00819585|584074801|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
161736587|NCT00819585|584074802|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
161736588|NCT00819585|584074803|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
161736589|NCT00819585|584074804|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
161736590|NCT00819585|584074805|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
161736591|NCT00819585|584074795|FG000|Core Study|Subject Withdrew Consent|0|||
161736592|NCT00819585|584074796|FG001|Core Study|Subject Withdrew Consent|3|||
161736593|NCT00819585|584074797|FG002|Core Study|Subject Withdrew Consent|2|||
161736594|NCT00819585|584074798|FG003|Core Study|Subject Withdrew Consent|1|||
161736595|NCT00819585|584074799|FG004|Core Study|Subject Withdrew Consent|0|||
161736596|NCT00819585|584074800|FG005|Core Study|Subject Withdrew Consent|0|||
161736597|NCT00819585|584074801|FG006|Core Study|Subject Withdrew Consent|3|||
161736598|NCT00819585|584074802|FG007|Core Study|Subject Withdrew Consent|0|||
161736599|NCT00819585|584074803|FG008|Core Study|Subject Withdrew Consent|0|||
161736600|NCT00819585|584074804|FG009|Core Study|Subject Withdrew Consent|0|||
161736601|NCT00819585|584074805|FG010|Core Study|Subject Withdrew Consent|0|||
161736602|NCT00819585|584074795|FG000|Core Study|Lost to Follow-up|2|||
161736603|NCT00819585|584074796|FG001|Core Study|Lost to Follow-up|1|||
161736604|NCT00819585|584074797|FG002|Core Study|Lost to Follow-up|2|||
161736605|NCT00819585|584074798|FG003|Core Study|Lost to Follow-up|0|||
161736606|NCT00819585|584074799|FG004|Core Study|Lost to Follow-up|1|||
161736607|NCT00819585|584074800|FG005|Core Study|Lost to Follow-up|1|||
161736608|NCT00819585|584074801|FG006|Core Study|Lost to Follow-up|1|||
161736609|NCT00819585|584074802|FG007|Core Study|Lost to Follow-up|0|||
161736610|NCT00819585|584074803|FG008|Core Study|Lost to Follow-up|0|||
161736611|NCT00819585|584074804|FG009|Core Study|Lost to Follow-up|0|||
161736612|NCT00819585|584074805|FG010|Core Study|Lost to Follow-up|0|||
161736613|NCT00819585|584074795|FG000|Core Study|Administrative Problems|0|||
161736614|NCT00819585|584074796|FG001|Core Study|Administrative Problems|0|||
161736615|NCT00819585|584074797|FG002|Core Study|Administrative Problems|0|||
161736616|NCT00819585|584074798|FG003|Core Study|Administrative Problems|0|||
161736617|NCT00819585|584074799|FG004|Core Study|Administrative Problems|0|||
161736618|NCT00819585|584074800|FG005|Core Study|Administrative Problems|0|||
161736619|NCT00819585|584074801|FG006|Core Study|Administrative Problems|2|||
161736620|NCT00819585|584074802|FG007|Core Study|Administrative Problems|0|||
161736621|NCT00819585|584074803|FG008|Core Study|Administrative Problems|0|||
161736622|NCT00819585|584074804|FG009|Core Study|Administrative Problems|0|||
161736623|NCT00819585|584074805|FG010|Core Study|Administrative Problems|0|||
161736624|NCT00819585|584074795|FG000|Core Study|Death|0|||
161736625|NCT00819585|584074796|FG001|Core Study|Death|0|||
161736626|NCT00819585|584074797|FG002|Core Study|Death|0|||
161736627|NCT00819585|584074798|FG003|Core Study|Death|0|||
161736628|NCT00819585|584074799|FG004|Core Study|Death|0|||
161736629|NCT00819585|584074800|FG005|Core Study|Death|0|||
161736630|NCT00819585|584074801|FG006|Core Study|Death|1|||
161736631|NCT00819585|584074802|FG007|Core Study|Death|0|||
161736632|NCT00819585|584074803|FG008|Core Study|Death|0|||
161736633|NCT00819585|584074804|FG009|Core Study|Death|0|||
161736634|NCT00819585|584074805|FG010|Core Study|Death|0|||
161736635|NCT00819585|584074795|FG000|Core Study|Protocol Violation|0|||
161736636|NCT00819585|584074796|FG001|Core Study|Protocol Violation|0|||
161966028|NCT00673231|584921960|FG003|Overall Study|Withdrawal by Subject|6|||
161966029|NCT00673231|584921957|FG000|Overall Study|Adverse Event|6|||
161966030|NCT00673231|584921958|FG001|Overall Study|Adverse Event|5|||
161966031|NCT00673231|584921959|FG002|Overall Study|Adverse Event|9|||
161966032|NCT00673231|584921960|FG003|Overall Study|Adverse Event|6|||
161966033|NCT00673231|584921957|FG000|Overall Study|Lost to Follow-up|1|||
161736637|NCT00819585|584074797|FG002|Core Study|Protocol Violation|1|||
161736638|NCT00819585|584074798|FG003|Core Study|Protocol Violation|0|||
161736639|NCT00819585|584074799|FG004|Core Study|Protocol Violation|0|||
161736640|NCT00819585|584074800|FG005|Core Study|Protocol Violation|1|||
161736641|NCT00819585|584074801|FG006|Core Study|Protocol Violation|3|||
161736642|NCT00819585|584074802|FG007|Core Study|Protocol Violation|0|||
161736643|NCT00819585|584074803|FG008|Core Study|Protocol Violation|0|||
161736644|NCT00819585|584074804|FG009|Core Study|Protocol Violation|0|||
161736645|NCT00819585|584074805|FG010|Core Study|Protocol Violation|0|||
161736646|NCT00819585|584074795|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
161736647|NCT00819585|584074796|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
161736648|NCT00819585|584074797|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
161966034|NCT00673231|584921958|FG001|Overall Study|Lost to Follow-up|2|||
161966035|NCT00673231|584921959|FG002|Overall Study|Lost to Follow-up|1|||
161966036|NCT00673231|584921960|FG003|Overall Study|Lost to Follow-up|2|||
161736649|NCT00819585|584074798|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
161736650|NCT00819585|584074799|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
161966037|NCT00673231|584921957|FG000|Overall Study|Death|0|||
161736651|NCT00819585|584074800|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
161736652|NCT00819585|584074801|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
161736653|NCT00819585|584074802|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
161736654|NCT00819585|584074803|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
161736655|NCT00819585|584074804|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
161736656|NCT00819585|584074805|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
161736657|NCT00819585|584074795|FG000|Extension Study|Subject Withdrew Consent|0|||
161736658|NCT00819585|584074796|FG001|Extension Study|Subject Withdrew Consent|0|||
161736659|NCT00819585|584074797|FG002|Extension Study|Subject Withdrew Consent|0|||
161736660|NCT00819585|584074798|FG003|Extension Study|Subject Withdrew Consent|0|||
161736661|NCT00819585|584074799|FG004|Extension Study|Subject Withdrew Consent|0|||
161736662|NCT00819585|584074800|FG005|Extension Study|Subject Withdrew Consent|0|||
161736663|NCT00819585|584074801|FG006|Extension Study|Subject Withdrew Consent|0|||
161736664|NCT00819585|584074802|FG007|Extension Study|Subject Withdrew Consent|0|||
161736665|NCT00819585|584074803|FG008|Extension Study|Subject Withdrew Consent|3|||
161736666|NCT00819585|584074804|FG009|Extension Study|Subject Withdrew Consent|0|||
161736667|NCT00819585|584074805|FG010|Extension Study|Subject Withdrew Consent|1|||
161736668|NCT00819585|584074795|FG000|Extension Study|Lost to Follow-up|0|||
161736669|NCT00819585|584074796|FG001|Extension Study|Lost to Follow-up|0|||
161736670|NCT00819585|584074797|FG002|Extension Study|Lost to Follow-up|0|||
161736671|NCT00819585|584074798|FG003|Extension Study|Lost to Follow-up|0|||
161736672|NCT00819585|584074799|FG004|Extension Study|Lost to Follow-up|0|||
161736673|NCT00819585|584074800|FG005|Extension Study|Lost to Follow-up|0|||
161736674|NCT00819585|584074801|FG006|Extension Study|Lost to Follow-up|0|||
161736675|NCT00819585|584074802|FG007|Extension Study|Lost to Follow-up|0|||
161736676|NCT00819585|584074803|FG008|Extension Study|Lost to Follow-up|2|||
161736677|NCT00819585|584074804|FG009|Extension Study|Lost to Follow-up|1|||
161736678|NCT00819585|584074805|FG010|Extension Study|Lost to Follow-up|1|||
161736679|NCT00819585|584074795|FG000|Extension Study|Death|0|||
161736680|NCT00819585|584074796|FG001|Extension Study|Death|0|||
161736681|NCT00819585|584074797|FG002|Extension Study|Death|0|||
161736682|NCT00819585|584074798|FG003|Extension Study|Death|0|||
161736683|NCT00819585|584074799|FG004|Extension Study|Death|0|||
161736684|NCT00819585|584074800|FG005|Extension Study|Death|0|||
161736685|NCT00819585|584074801|FG006|Extension Study|Death|0|||
161736686|NCT00819585|584074802|FG007|Extension Study|Death|0|||
161736687|NCT00819585|584074803|FG008|Extension Study|Death|2|||
161736688|NCT00819585|584074804|FG009|Extension Study|Death|0|||
161736689|NCT00819585|584074805|FG010|Extension Study|Death|0|||
161840203|NCT04112173|584460467|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
161840204|NCT01561430|584460468|FG000|Overall Study|Adverse Event|0|||
161840205|NCT01561430|584460469|FG001|Overall Study|Adverse Event|0|||
161840206|NCT01561430|584460470|FG002|Overall Study|Adverse Event|3|||
161840207|NCT01561430|584460471|FG003|Overall Study|Adverse Event|1|||
161840208|NCT01561430|584460468|FG000|Overall Study|Withdrawal by Subject|0|||
161840209|NCT01561430|584460469|FG001|Overall Study|Withdrawal by Subject|0|||
161840210|NCT01561430|584460470|FG002|Overall Study|Withdrawal by Subject|1|||
161840211|NCT01561430|584460471|FG003|Overall Study|Withdrawal by Subject|0|||
161840212|NCT01561430|584460468|FG000|Overall Study|Physician Decision|0|||
161840213|NCT01561430|584460469|FG001|Overall Study|Physician Decision|1|||
161840214|NCT01561430|584460470|FG002|Overall Study|Physician Decision|0|||
161840215|NCT01561430|584460471|FG003|Overall Study|Physician Decision|0|||
161840216|NCT01561430|584460468|FG000|Overall Study|Sponsor Decision|1|||
161840217|NCT01561430|584460469|FG001|Overall Study|Sponsor Decision|14|||
161840218|NCT01561430|584460470|FG002|Overall Study|Sponsor Decision|13|||
161840219|NCT01561430|584460471|FG003|Overall Study|Sponsor Decision|12|||
161840220|NCT04234984|584460472|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
161840221|NCT04234984|584460472|FG000|Follow-up at the Second Time Point|Death|1|||
161736690|NCT01877382|584074806|FG000|Dose Escalation|Progressive disease|2|||
161736691|NCT01877382|584074807|FG001|Dose Escalation|Progressive disease|0|||
161736692|NCT01877382|584074808|FG002|Dose Escalation|Progressive disease|1|||
161840222|NCT04234984|584460472|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
161840223|NCT01055132|584460473|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
161840224|NCT01055132|584460474|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
161840225|NCT01055132|584460473|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
161840226|NCT01055132|584460474|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
161840227|NCT00910091|584460475|FG000|Pre-assignment|Withdrawal by Subject|0|||
161840228|NCT00910091|584460476|FG001|Pre-assignment|Withdrawal by Subject|2|||
161840229|NCT00910091|584460475|FG000|Treatment and Survival|Withdrawal by Subject|3|||
161840230|NCT00910091|584460476|FG001|Treatment and Survival|Withdrawal by Subject|4|||
161966038|NCT00673231|584921958|FG001|Overall Study|Death|0|||
161736693|NCT01877382|584074809|FG003|Dose Escalation|Progressive disease|6|||
161736694|NCT01877382|584074810|FG004|Dose Escalation|Progressive disease|1|||
161736695|NCT01877382|584074811|FG005|Dose Escalation|Progressive disease|0|||
161736696|NCT01877382|584074812|FG006|Dose Escalation|Progressive disease|3|||
161736697|NCT01877382|584074813|FG007|Dose Escalation|Progressive disease|10|||
161966039|NCT00673231|584921959|FG002|Overall Study|Death|1|||
161736698|NCT01877382|584074814|FG008|Dose Escalation|Progressive disease|4|||
161736699|NCT01877382|584074815|FG009|Dose Escalation|Progressive disease|2|||
161736700|NCT01877382|584074816|FG010|Dose Escalation|Progressive disease|3|||
161736701|NCT01877382|584074817|FG011|Dose Escalation|Progressive disease|3|||
161736702|NCT01877382|584074818|FG012|Dose Escalation|Progressive disease|13|||
161736703|NCT01877382|584074819|FG013|Dose Escalation|Progressive disease|1|||
161736704|NCT01877382|584074820|FG014|Dose Escalation|Progressive disease|0|||
161736705|NCT01877382|584074806|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
161736706|NCT01877382|584074807|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736707|NCT01877382|584074808|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736708|NCT01877382|584074809|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
161736709|NCT01877382|584074810|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736710|NCT01877382|584074811|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736711|NCT01877382|584074812|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
161736712|NCT01877382|584074813|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736713|NCT01877382|584074814|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736714|NCT01877382|584074815|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736715|NCT01877382|584074816|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736716|NCT01877382|584074817|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736717|NCT01877382|584074818|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736718|NCT01877382|584074819|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736719|NCT01877382|584074820|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736720|NCT01877382|584074806|FG000|Dose Escalation|Clinical progression|0|||
161736721|NCT01877382|584074807|FG001|Dose Escalation|Clinical progression|1|||
161736722|NCT01877382|584074808|FG002|Dose Escalation|Clinical progression|0|||
161736723|NCT01877382|584074809|FG003|Dose Escalation|Clinical progression|2|||
161736724|NCT01877382|584074810|FG004|Dose Escalation|Clinical progression|0|||
161736725|NCT01877382|584074811|FG005|Dose Escalation|Clinical progression|0|||
161736726|NCT01877382|584074812|FG006|Dose Escalation|Clinical progression|1|||
161736727|NCT01877382|584074813|FG007|Dose Escalation|Clinical progression|0|||
161736728|NCT01877382|584074814|FG008|Dose Escalation|Clinical progression|0|||
161736729|NCT01877382|584074815|FG009|Dose Escalation|Clinical progression|1|||
161736730|NCT01877382|584074816|FG010|Dose Escalation|Clinical progression|0|||
161736731|NCT01877382|584074817|FG011|Dose Escalation|Clinical progression|0|||
161736732|NCT01877382|584074818|FG012|Dose Escalation|Clinical progression|2|||
161736733|NCT01877382|584074819|FG013|Dose Escalation|Clinical progression|1|||
161736734|NCT01877382|584074820|FG014|Dose Escalation|Clinical progression|0|||
161736735|NCT01877382|584074806|FG000|Dose Escalation|Adverse Event|0|||
161736736|NCT01877382|584074807|FG001|Dose Escalation|Adverse Event|0|||
161736737|NCT01877382|584074808|FG002|Dose Escalation|Adverse Event|0|||
161736738|NCT01877382|584074809|FG003|Dose Escalation|Adverse Event|4|||
161736739|NCT01877382|584074810|FG004|Dose Escalation|Adverse Event|1|||
161736740|NCT01877382|584074811|FG005|Dose Escalation|Adverse Event|2|||
161736741|NCT01877382|584074812|FG006|Dose Escalation|Adverse Event|1|||
161736742|NCT01877382|584074813|FG007|Dose Escalation|Adverse Event|2|||
161736743|NCT01877382|584074814|FG008|Dose Escalation|Adverse Event|0|||
161736744|NCT01877382|584074815|FG009|Dose Escalation|Adverse Event|0|||
161736745|NCT01877382|584074816|FG010|Dose Escalation|Adverse Event|0|||
161736746|NCT01877382|584074817|FG011|Dose Escalation|Adverse Event|0|||
161736747|NCT01877382|584074818|FG012|Dose Escalation|Adverse Event|1|||
161736748|NCT01877382|584074819|FG013|Dose Escalation|Adverse Event|0|||
161736749|NCT01877382|584074820|FG014|Dose Escalation|Adverse Event|0|||
161736750|NCT01877382|584074806|FG000|Dose Escalation|Withdrawal by Subject|0|||
161736751|NCT01877382|584074807|FG001|Dose Escalation|Withdrawal by Subject|0|||
161736752|NCT01877382|584074808|FG002|Dose Escalation|Withdrawal by Subject|0|||
161736753|NCT01877382|584074809|FG003|Dose Escalation|Withdrawal by Subject|0|||
161736754|NCT01877382|584074810|FG004|Dose Escalation|Withdrawal by Subject|0|||
161736755|NCT01877382|584074811|FG005|Dose Escalation|Withdrawal by Subject|3|||
161736756|NCT01877382|584074812|FG006|Dose Escalation|Withdrawal by Subject|2|||
161736757|NCT01877382|584074813|FG007|Dose Escalation|Withdrawal by Subject|1|||
161736758|NCT01877382|584074814|FG008|Dose Escalation|Withdrawal by Subject|1|||
161736759|NCT01877382|584074815|FG009|Dose Escalation|Withdrawal by Subject|0|||
161736760|NCT01877382|584074816|FG010|Dose Escalation|Withdrawal by Subject|0|||
161736761|NCT01877382|584074817|FG011|Dose Escalation|Withdrawal by Subject|0|||
161736762|NCT01877382|584074818|FG012|Dose Escalation|Withdrawal by Subject|0|||
161736763|NCT01877382|584074819|FG013|Dose Escalation|Withdrawal by Subject|0|||
161736764|NCT01877382|584074820|FG014|Dose Escalation|Withdrawal by Subject|0|||
161736765|NCT01877382|584074806|FG000|Dose Escalation|Protocol Violation|0|||
161736766|NCT01877382|584074807|FG001|Dose Escalation|Protocol Violation|0|||
161736767|NCT01877382|584074808|FG002|Dose Escalation|Protocol Violation|0|||
161736768|NCT01877382|584074809|FG003|Dose Escalation|Protocol Violation|0|||
161840231|NCT00910091|584460475|FG000|Treatment and Survival|Adverse Event|1|||
161840232|NCT00910091|584460476|FG001|Treatment and Survival|Adverse Event|0|||
161840233|NCT01908816|584460479|FG000|Overall Study|Subject's no longer requires study drug|0|||
161840234|NCT01908816|584460480|FG001|Overall Study|Subject's no longer requires study drug|0|||
161840235|NCT01908816|584460481|FG002|Overall Study|Subject's no longer requires study drug|0|||
161840236|NCT01908816|584460482|FG003|Overall Study|Subject's no longer requires study drug|1|||
161840237|NCT01908816|584460479|FG000|Overall Study|Protocol deviation|1|||
161840238|NCT01908816|584460480|FG001|Overall Study|Protocol deviation|2|||
161840239|NCT01908816|584460481|FG002|Overall Study|Protocol deviation|1|||
161840240|NCT01908816|584460482|FG003|Overall Study|Protocol deviation|1|||
161840241|NCT01908816|584460479|FG000|Overall Study|Withdrawal by Subject|0|||
161840242|NCT01908816|584460480|FG001|Overall Study|Withdrawal by Subject|4|||
161840243|NCT01908816|584460481|FG002|Overall Study|Withdrawal by Subject|2|||
161840244|NCT01908816|584460482|FG003|Overall Study|Withdrawal by Subject|2|||
161840245|NCT01908816|584460479|FG000|Overall Study|Lost to Follow-up|3|||
161840246|NCT01908816|584460480|FG001|Overall Study|Lost to Follow-up|5|||
161840247|NCT01908816|584460481|FG002|Overall Study|Lost to Follow-up|4|||
161840248|NCT01908816|584460482|FG003|Overall Study|Lost to Follow-up|2|||
161840249|NCT01908816|584460479|FG000|Overall Study|Death|1|||
161840250|NCT01908816|584460480|FG001|Overall Study|Death|0|||
161840251|NCT01908816|584460481|FG002|Overall Study|Death|7|||
161840252|NCT01908816|584460482|FG003|Overall Study|Death|1|||
161840253|NCT01908816|584460479|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161840254|NCT01908816|584460480|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
161840255|NCT01908816|584460481|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
161840256|NCT01908816|584460482|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161840257|NCT01908816|584460479|FG000|Overall Study|Early termination|87|||
161840258|NCT01908816|584460480|FG001|Overall Study|Early termination|60|||
161840259|NCT01908816|584460481|FG002|Overall Study|Early termination|43|||
161840260|NCT01908816|584460482|FG003|Overall Study|Early termination|28|||
161840261|NCT05183217|584460483|FG000|Overall Study|Withdrawal by Subject|1|||
161840262|NCT05183217|584460484|FG001|Overall Study|Withdrawal by Subject|1|||
161840263|NCT00507130|584460485|FG000|Overall Study|Lost to Follow-up|0|||
161840264|NCT00507130|584460486|FG001|Overall Study|Lost to Follow-up|0|||
161840265|NCT00507130|584460487|FG002|Overall Study|Lost to Follow-up|1|||
161840266|NCT00507130|584460488|FG003|Overall Study|Lost to Follow-up|1|||
161840267|NCT00507130|584460485|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
161840268|NCT00507130|584460486|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
161840269|NCT00507130|584460487|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
161840270|NCT00507130|584460488|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
161840271|NCT02524730|584460489|FG000|Overall Study|Lost to Follow-up|5|||
161840272|NCT02524730|584460489|FG000|Overall Study|Withdrawal by Subject|18|||
161840273|NCT02524730|584460489|FG000|Overall Study|Death|10|||
161840274|NCT02524730|584460489|FG000|Overall Study|Adverse Event|8|||
161840275|NCT02524730|584460489|FG000|Overall Study|Protocol Violation|1|||
161840276|NCT02524730|584460489|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
161840277|NCT03678285|584460501|FG000|Overall Study|Adverse Event|2|||
161840278|NCT03678285|584460501|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
161840279|NCT03678285|584460501|FG000|Overall Study|Dehydrated prior to start of workout|1|||
161840280|NCT01447420|584460504|FG000|Overall Study|Adverse Event|2|||
161840281|NCT01447420|584460505|FG001|Overall Study|Adverse Event|4|||
161840282|NCT01447420|584460506|FG002|Overall Study|Adverse Event|2|||
161840283|NCT01447420|584460504|FG000|Overall Study|Protocol Violation|3|||
161840284|NCT01447420|584460505|FG001|Overall Study|Protocol Violation|3|||
161840285|NCT01447420|584460506|FG002|Overall Study|Protocol Violation|0|||
161840286|NCT01447420|584460504|FG000|Overall Study|Withdrawal by Subject|4|||
161840287|NCT01447420|584460505|FG001|Overall Study|Withdrawal by Subject|1|||
161840288|NCT01447420|584460506|FG002|Overall Study|Withdrawal by Subject|0|||
161840289|NCT01447420|584460504|FG000|Overall Study|Lack of Efficacy|1|||
161840290|NCT01447420|584460505|FG001|Overall Study|Lack of Efficacy|19|||
161840291|NCT01447420|584460506|FG002|Overall Study|Lack of Efficacy|8|||
161840292|NCT04480710|584460510|FG000|Overall Study|Adverse Event|0|||
161840293|NCT04480710|584460511|FG001|Overall Study|Adverse Event|2|||
161840294|NCT04480710|584460512|FG002|Overall Study|Adverse Event|0|||
161840295|NCT04480710|584460513|FG003|Overall Study|Adverse Event|0|||
162032423|NCT04030026|585175482|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
161840296|NCT04480710|584460510|FG000|Overall Study|Withdrawal by Subject|0|||
161840297|NCT04480710|584460511|FG001|Overall Study|Withdrawal by Subject|1|||
161840298|NCT04480710|584460512|FG002|Overall Study|Withdrawal by Subject|0|||
161840299|NCT04480710|584460513|FG003|Overall Study|Withdrawal by Subject|0|||
161840300|NCT04480710|584460510|FG000|Overall Study|Physician Decision|0|||
161840301|NCT04480710|584460511|FG001|Overall Study|Physician Decision|0|||
161840302|NCT04480710|584460512|FG002|Overall Study|Physician Decision|1|||
161840303|NCT04480710|584460513|FG003|Overall Study|Physician Decision|0|||
161840304|NCT01103466|584460521|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
161840305|NCT01103466|584460522|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
161736769|NCT01877382|584074810|FG004|Dose Escalation|Protocol Violation|0|||
161736770|NCT01877382|584074811|FG005|Dose Escalation|Protocol Violation|0|||
161736771|NCT01877382|584074812|FG006|Dose Escalation|Protocol Violation|1|||
161736772|NCT01877382|584074813|FG007|Dose Escalation|Protocol Violation|0|||
161736773|NCT01877382|584074814|FG008|Dose Escalation|Protocol Violation|0|||
161736774|NCT01877382|584074815|FG009|Dose Escalation|Protocol Violation|0|||
161736775|NCT01877382|584074816|FG010|Dose Escalation|Protocol Violation|0|||
161736776|NCT01877382|584074817|FG011|Dose Escalation|Protocol Violation|0|||
161736777|NCT01877382|584074818|FG012|Dose Escalation|Protocol Violation|0|||
161736778|NCT01877382|584074819|FG013|Dose Escalation|Protocol Violation|0|||
161736779|NCT01877382|584074820|FG014|Dose Escalation|Protocol Violation|0|||
161736780|NCT01877382|584074806|FG000|Dose Escalation|Study terminated by sponsor|0|||
161736781|NCT01877382|584074807|FG001|Dose Escalation|Study terminated by sponsor|0|||
161736782|NCT01877382|584074808|FG002|Dose Escalation|Study terminated by sponsor|0|||
161736783|NCT01877382|584074809|FG003|Dose Escalation|Study terminated by sponsor|0|||
161736784|NCT01877382|584074810|FG004|Dose Escalation|Study terminated by sponsor|0|||
161736785|NCT01877382|584074811|FG005|Dose Escalation|Study terminated by sponsor|0|||
161736786|NCT01877382|584074812|FG006|Dose Escalation|Study terminated by sponsor|0|||
161736787|NCT01877382|584074813|FG007|Dose Escalation|Study terminated by sponsor|1|||
161736788|NCT01877382|584074814|FG008|Dose Escalation|Study terminated by sponsor|1|||
161736789|NCT01877382|584074815|FG009|Dose Escalation|Study terminated by sponsor|0|||
161736790|NCT01877382|584074816|FG010|Dose Escalation|Study terminated by sponsor|0|||
161736791|NCT01877382|584074817|FG011|Dose Escalation|Study terminated by sponsor|0|||
161736792|NCT01877382|584074818|FG012|Dose Escalation|Study terminated by sponsor|3|||
161736793|NCT01877382|584074819|FG013|Dose Escalation|Study terminated by sponsor|0|||
161736794|NCT01877382|584074820|FG014|Dose Escalation|Study terminated by sponsor|0|||
161736795|NCT01877382|584074806|FG000|Dose Escalation|Death|0|||
161736796|NCT01877382|584074807|FG001|Dose Escalation|Death|0|||
161736797|NCT01877382|584074808|FG002|Dose Escalation|Death|0|||
161736798|NCT01877382|584074809|FG003|Dose Escalation|Death|0|||
161736799|NCT01877382|584074810|FG004|Dose Escalation|Death|0|||
161736800|NCT01877382|584074811|FG005|Dose Escalation|Death|0|||
161736801|NCT01877382|584074812|FG006|Dose Escalation|Death|0|||
161736802|NCT01877382|584074813|FG007|Dose Escalation|Death|1|||
161736803|NCT01877382|584074814|FG008|Dose Escalation|Death|0|||
161736804|NCT01877382|584074815|FG009|Dose Escalation|Death|0|||
161736805|NCT01877382|584074816|FG010|Dose Escalation|Death|0|||
161736806|NCT01877382|584074817|FG011|Dose Escalation|Death|0|||
161736807|NCT01877382|584074818|FG012|Dose Escalation|Death|1|||
161736808|NCT01877382|584074819|FG013|Dose Escalation|Death|1|||
161736809|NCT01877382|584074820|FG014|Dose Escalation|Death|0|||
161736810|NCT01877382|584074806|FG000|Dose Expansion|Progressive disease|0|||
161736811|NCT01877382|584074807|FG001|Dose Expansion|Progressive disease|0|||
161736812|NCT01877382|584074808|FG002|Dose Expansion|Progressive disease|0|||
161736813|NCT01877382|584074809|FG003|Dose Expansion|Progressive disease|0|||
161736814|NCT01877382|584074810|FG004|Dose Expansion|Progressive disease|0|||
161736815|NCT01877382|584074811|FG005|Dose Expansion|Progressive disease|0|||
161736816|NCT01877382|584074812|FG006|Dose Expansion|Progressive disease|0|||
161736817|NCT01877382|584074813|FG007|Dose Expansion|Progressive disease|0|||
161736818|NCT01877382|584074814|FG008|Dose Expansion|Progressive disease|0|||
161736819|NCT01877382|584074815|FG009|Dose Expansion|Progressive disease|0|||
161736820|NCT01877382|584074816|FG010|Dose Expansion|Progressive disease|0|||
161736821|NCT01877382|584074817|FG011|Dose Expansion|Progressive disease|0|||
161736822|NCT01877382|584074818|FG012|Dose Expansion|Progressive disease|0|||
161736823|NCT01877382|584074819|FG013|Dose Expansion|Progressive disease|0|||
161736824|NCT01877382|584074820|FG014|Dose Expansion|Progressive disease|11|||
161736825|NCT01877382|584074806|FG000|Dose Expansion|Clinical progression|0|||
161736826|NCT01877382|584074807|FG001|Dose Expansion|Clinical progression|0|||
161736827|NCT01877382|584074808|FG002|Dose Expansion|Clinical progression|0|||
161736828|NCT01877382|584074809|FG003|Dose Expansion|Clinical progression|0|||
161736829|NCT01877382|584074810|FG004|Dose Expansion|Clinical progression|0|||
161736830|NCT01877382|584074811|FG005|Dose Expansion|Clinical progression|0|||
161966040|NCT00673231|584921960|FG003|Overall Study|Death|0|||
161966041|NCT00673231|584921957|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
161736831|NCT01877382|584074812|FG006|Dose Expansion|Clinical progression|0|||
161736832|NCT01877382|584074813|FG007|Dose Expansion|Clinical progression|0|||
161736833|NCT01877382|584074814|FG008|Dose Expansion|Clinical progression|0|||
161966042|NCT00673231|584921958|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
161966043|NCT00673231|584921959|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
161736834|NCT01877382|584074815|FG009|Dose Expansion|Clinical progression|0|||
161736835|NCT01877382|584074816|FG010|Dose Expansion|Clinical progression|0|||
161736836|NCT01877382|584074817|FG011|Dose Expansion|Clinical progression|0|||
161736837|NCT01877382|584074818|FG012|Dose Expansion|Clinical progression|0|||
161736838|NCT01877382|584074819|FG013|Dose Expansion|Clinical progression|0|||
161736839|NCT01877382|584074820|FG014|Dose Expansion|Clinical progression|6|||
161736840|NCT01877382|584074806|FG000|Dose Expansion|Adverse Event|0|||
161736841|NCT01877382|584074807|FG001|Dose Expansion|Adverse Event|0|||
161736842|NCT01877382|584074808|FG002|Dose Expansion|Adverse Event|0|||
161736843|NCT01877382|584074809|FG003|Dose Expansion|Adverse Event|0|||
161736844|NCT01877382|584074810|FG004|Dose Expansion|Adverse Event|0|||
161736845|NCT01877382|584074811|FG005|Dose Expansion|Adverse Event|0|||
161736846|NCT01877382|584074812|FG006|Dose Expansion|Adverse Event|0|||
161736847|NCT01877382|584074813|FG007|Dose Expansion|Adverse Event|0|||
161736848|NCT01877382|584074814|FG008|Dose Expansion|Adverse Event|0|||
161736849|NCT01877382|584074815|FG009|Dose Expansion|Adverse Event|0|||
161736850|NCT01877382|584074816|FG010|Dose Expansion|Adverse Event|0|||
161736851|NCT01877382|584074817|FG011|Dose Expansion|Adverse Event|0|||
161736852|NCT01877382|584074818|FG012|Dose Expansion|Adverse Event|0|||
161736853|NCT01877382|584074819|FG013|Dose Expansion|Adverse Event|0|||
161736854|NCT01877382|584074820|FG014|Dose Expansion|Adverse Event|1|||
161736855|NCT01877382|584074806|FG000|Dose Expansion|Death|0|||
161736856|NCT01877382|584074807|FG001|Dose Expansion|Death|0|||
161736857|NCT01877382|584074808|FG002|Dose Expansion|Death|0|||
161736858|NCT01877382|584074809|FG003|Dose Expansion|Death|0|||
161736859|NCT01877382|584074810|FG004|Dose Expansion|Death|0|||
161736860|NCT01877382|584074811|FG005|Dose Expansion|Death|0|||
161736861|NCT01877382|584074812|FG006|Dose Expansion|Death|0|||
161736862|NCT01877382|584074813|FG007|Dose Expansion|Death|0|||
161736863|NCT01877382|584074814|FG008|Dose Expansion|Death|0|||
161736864|NCT01877382|584074815|FG009|Dose Expansion|Death|0|||
161736865|NCT01877382|584074816|FG010|Dose Expansion|Death|0|||
161736866|NCT01877382|584074817|FG011|Dose Expansion|Death|0|||
161736867|NCT01877382|584074818|FG012|Dose Expansion|Death|0|||
161736868|NCT01877382|584074819|FG013|Dose Expansion|Death|0|||
161736869|NCT01877382|584074820|FG014|Dose Expansion|Death|1|||
161736870|NCT01877382|584074806|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736871|NCT01877382|584074807|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736872|NCT01877382|584074808|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736873|NCT01877382|584074809|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736874|NCT01877382|584074810|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736875|NCT01877382|584074811|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736876|NCT01877382|584074812|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736877|NCT01877382|584074813|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736878|NCT01877382|584074814|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736879|NCT01877382|584074815|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736880|NCT01877382|584074816|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736881|NCT01877382|584074817|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736882|NCT01877382|584074818|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736883|NCT01877382|584074819|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161736884|NCT01877382|584074820|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
161736885|NCT03423979|584074821|FG000|Overall Study|Death|5|||
161736886|NCT03423979|584074821|FG000|Overall Study|Adverse Event|4|||
161736887|NCT03423979|584074821|FG000|Overall Study|Withdrawal by Subject|3|||
161736888|NCT03423979|584074821|FG000|Overall Study|Lost to Follow-up|16|||
161840306|NCT01103466|584460523|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
161840307|NCT01103466|584460521|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
161840308|NCT01103466|584460522|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
161736889|NCT00808249|584074824|FG000|Overall Study|Adverse Event|4|||
161736890|NCT00808249|584074825|FG001|Overall Study|Adverse Event|7|||
161736891|NCT00808249|584074826|FG002|Overall Study|Adverse Event|10|||
161736892|NCT00808249|584074827|FG003|Overall Study|Adverse Event|6|||
161736893|NCT00808249|584074824|FG000|Overall Study|Lost to Follow-up|2|||
161736894|NCT00808249|584074825|FG001|Overall Study|Lost to Follow-up|3|||
161736895|NCT00808249|584074826|FG002|Overall Study|Lost to Follow-up|3|||
161736896|NCT00808249|584074827|FG003|Overall Study|Lost to Follow-up|5|||
161736897|NCT00808249|584074824|FG000|Overall Study|Withdrawal by Subject|4|||
161736898|NCT00808249|584074825|FG001|Overall Study|Withdrawal by Subject|0|||
161736899|NCT00808249|584074826|FG002|Overall Study|Withdrawal by Subject|2|||
161736900|NCT00808249|584074827|FG003|Overall Study|Withdrawal by Subject|4|||
161736901|NCT00808249|584074824|FG000|Overall Study|Protocol Violation|3|||
161736902|NCT00808249|584074825|FG001|Overall Study|Protocol Violation|3|||
161736903|NCT00808249|584074826|FG002|Overall Study|Protocol Violation|3|||
161736904|NCT00808249|584074827|FG003|Overall Study|Protocol Violation|0|||
161840309|NCT01103466|584460523|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
161736905|NCT00808249|584074824|FG000|Overall Study|Lack of Efficacy|1|||
161736906|NCT00808249|584074825|FG001|Overall Study|Lack of Efficacy|1|||
161736907|NCT00808249|584074826|FG002|Overall Study|Lack of Efficacy|0|||
161736908|NCT00808249|584074827|FG003|Overall Study|Lack of Efficacy|0|||
161840310|NCT01103466|584460521|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
161736909|NCT00808249|584074824|FG000|Overall Study|study specific discontinuation criteria|1|||
161736910|NCT00808249|584074825|FG001|Overall Study|study specific discontinuation criteria|0|||
161736911|NCT00808249|584074826|FG002|Overall Study|study specific discontinuation criteria|1|||
161736912|NCT00808249|584074827|FG003|Overall Study|study specific discontinuation criteria|0|||
161736913|NCT00808249|584074824|FG000|Overall Study|All other reasons|2|||
161736914|NCT00808249|584074825|FG001|Overall Study|All other reasons|1|||
161736915|NCT00808249|584074826|FG002|Overall Study|All other reasons|3|||
161736916|NCT00808249|584074827|FG003|Overall Study|All other reasons|1|||
161736917|NCT05108805|584074831|FG000|Overall Study|T-cell expansion was not successful.|5|||
161736918|NCT04095286|584074832|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736919|NCT04095286|584074833|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
161736920|NCT04095286|584074834|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736921|NCT04095286|584074835|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736922|NCT04095286|584074836|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736923|NCT04095286|584074837|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736924|NCT04095286|584074832|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
161736925|NCT04095286|584074833|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161736926|NCT04095286|584074834|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161736927|NCT04095286|584074835|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161736928|NCT04095286|584074836|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161736929|NCT04095286|584074837|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161736930|NCT04095286|584074832|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161736931|NCT04095286|584074833|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161736932|NCT04095286|584074834|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
161736933|NCT04095286|584074835|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161736934|NCT04095286|584074836|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161736935|NCT04095286|584074837|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161736936|NCT04095286|584074832|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736937|NCT04095286|584074833|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736938|NCT04095286|584074834|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
161736939|NCT04095286|584074835|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736940|NCT04095286|584074836|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736941|NCT04095286|584074837|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161736942|NCT04095286|584074832|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161736943|NCT04095286|584074833|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161736944|NCT04095286|584074834|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161736945|NCT04095286|584074835|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161736946|NCT04095286|584074836|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
161736947|NCT04095286|584074837|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161736948|NCT03003403|584074838|FG000|Overall Study|Ineligible|8|||
161736949|NCT03003403|584074839|FG001|Overall Study|Ineligible|7|||
161736950|NCT03003403|584074838|FG000|Overall Study|Withdrawal by Subject|3|||
161736951|NCT03003403|584074839|FG001|Overall Study|Withdrawal by Subject|1|||
161736952|NCT01255306|584076628|FG000|Overall Study|Physician Decision|1|||
161736953|NCT01255306|584076629|FG001|Overall Study|Physician Decision|1|||
161736954|NCT01617655|584076635|FG000|Overall Study|Adverse Event|2|||
161736955|NCT01617655|584076636|FG001|Overall Study|Adverse Event|3|||
161736956|NCT01617655|584076635|FG000|Overall Study|Poor compliance to protocol|1|||
161736957|NCT01617655|584076636|FG001|Overall Study|Poor compliance to protocol|4|||
161736958|NCT01617655|584076635|FG000|Overall Study|Participants moved|0|||
161736959|NCT01617655|584076636|FG001|Overall Study|Participants moved|4|||
161736960|NCT01617655|584076635|FG000|Overall Study|Consent withdrawn by participant|1|||
161736961|NCT01617655|584076636|FG001|Overall Study|Consent withdrawn by participant|1|||
161736962|NCT01617655|584076635|FG000|Overall Study|Last visit outside protocol visit window|1|||
161840311|NCT01103466|584460522|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
161966044|NCT00673231|584921960|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
161966045|NCT02952313|584921961|FG000|Primary Endpoint|Lost to Follow-up|4|||
161736963|NCT01617655|584076636|FG001|Overall Study|Last visit outside protocol visit window|10|||
161736964|NCT01617655|584076635|FG000|Overall Study|Site closure|3|||
161736965|NCT01617655|584076636|FG001|Overall Study|Site closure|5|||
161736966|NCT01617655|584076635|FG000|Overall Study|Other than specified above|1|||
161736967|NCT01617655|584076636|FG001|Overall Study|Other than specified above|2|||
161736968|NCT01175213|584076639|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
161736969|NCT01175213|584076640|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
161736970|NCT01175213|584076639|FG000|IGSC, 10%/rHuPH20|Death|1|||
161736971|NCT01175213|584076640|FG001|IGSC, 10%/rHuPH20|Death|0|||
161736972|NCT01175213|584076639|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
161736973|NCT01175213|584076640|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
161736974|NCT01175213|584076639|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
161840312|NCT01103466|584460523|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
161840313|NCT01103466|584460521|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
161840314|NCT01103466|584460522|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
161840315|NCT01103466|584460523|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
161840316|NCT01103466|584460521|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
161840317|NCT01103466|584460522|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
161840318|NCT01103466|584460523|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
161840319|NCT01103466|584460521|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
161840320|NCT01103466|584460522|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
161840321|NCT01103466|584460523|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
161840322|NCT02994940|584460524|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
161840323|NCT02994940|584460525|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
161840324|NCT02994940|584460524|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
161840325|NCT02994940|584460525|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
161736975|NCT01175213|584076640|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
161736976|NCT01175213|584076639|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
161736977|NCT01175213|584076640|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
161736978|NCT01175213|584076639|FG000|Safety Follow-up|Adverse Event|1|||
161736979|NCT01175213|584076640|FG001|Safety Follow-up|Adverse Event|0|||
161736980|NCT01517412|584076646|FG000|Overall Study|Adverse Event|10|||
161736981|NCT01517412|584076647|FG001|Overall Study|Adverse Event|11|||
161736982|NCT01517412|584076646|FG000|Overall Study|Lack of Efficacy|10|||
161736983|NCT01517412|584076647|FG001|Overall Study|Lack of Efficacy|5|||
161736984|NCT01517412|584076646|FG000|Overall Study|Poor compliance to protocol|8|||
161736985|NCT01517412|584076647|FG001|Overall Study|Poor compliance to protocol|3|||
161736986|NCT01517412|584076646|FG000|Overall Study|Other than specified above|8|||
161736987|NCT01517412|584076647|FG001|Overall Study|Other than specified above|5|||
161736988|NCT01253187|584076648|FG000|Period 2|Withdrawal by Subject|0|||
161736989|NCT01253187|584076649|FG001|Period 2|Withdrawal by Subject|0|||
161736990|NCT01253187|584076650|FG002|Period 2|Withdrawal by Subject|0|||
161736991|NCT01253187|584076651|FG003|Period 2|Withdrawal by Subject|0|||
161736992|NCT01253187|584076652|FG004|Period 2|Withdrawal by Subject|1|||
161736993|NCT01253187|584076653|FG005|Period 2|Withdrawal by Subject|0|||
161736994|NCT01253187|584076648|FG000|Period 3|Pregnancy|1|||
161736995|NCT01253187|584076649|FG001|Period 3|Pregnancy|0|||
161736996|NCT01253187|584076650|FG002|Period 3|Pregnancy|0|||
161736997|NCT01253187|584076651|FG003|Period 3|Pregnancy|0|||
161736998|NCT01253187|584076652|FG004|Period 3|Pregnancy|0|||
161736999|NCT01253187|584076653|FG005|Period 3|Pregnancy|0|||
161737000|NCT01253187|584076648|FG000|Period 3|difficulty with blood sampling|0|||
161737001|NCT01253187|584076649|FG001|Period 3|difficulty with blood sampling|1|||
161737002|NCT01253187|584076650|FG002|Period 3|difficulty with blood sampling|0|||
161737003|NCT01253187|584076651|FG003|Period 3|difficulty with blood sampling|0|||
161737004|NCT01253187|584076652|FG004|Period 3|difficulty with blood sampling|0|||
161737005|NCT01253187|584076653|FG005|Period 3|difficulty with blood sampling|0|||
161737006|NCT01253187|584076648|FG000|Period 3|non-compliance|0|||
161737007|NCT01253187|584076649|FG001|Period 3|non-compliance|0|||
161737008|NCT01253187|584076650|FG002|Period 3|non-compliance|0|||
161737009|NCT01253187|584076651|FG003|Period 3|non-compliance|0|||
161737010|NCT01253187|584076652|FG004|Period 3|non-compliance|1|||
161737011|NCT01253187|584076653|FG005|Period 3|non-compliance|0|||
161737012|NCT03569449|584076654|FG000|Overall Study|Lost to Follow-up|0|||
161737013|NCT03569449|584076655|FG001|Overall Study|Lost to Follow-up|1|||
161737014|NCT03569449|584076656|FG002|Overall Study|Lost to Follow-up|0|||
161737015|NCT03569449|584076657|FG003|Overall Study|Lost to Follow-up|2|||
161737016|NCT03569449|584076658|FG004|Overall Study|Lost to Follow-up|0|||
161840326|NCT02994940|584460524|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
161966046|NCT02952313|584921961|FG000|Primary Endpoint|Withdrawal by Subject|1|||
161840327|NCT02994940|584460525|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
161840328|NCT02987959|584460530|FG000|Overall Study|Grantor stopped supply of drugs|6|||
161840329|NCT04126213|584460533|FG000|Overall Study|Lost to Follow-up|9|||
161840330|NCT04126213|584460534|FG001|Overall Study|Lost to Follow-up|1|||
161840331|NCT04126213|584460535|FG002|Overall Study|Lost to Follow-up|5|||
161966047|NCT02952313|584921961|FG000|Primary Endpoint|Lack of Efficacy|1|||
161966048|NCT02952313|584921961|FG000|Primary Endpoint|Missed visit|1|||
161966049|NCT02952313|584921961|FG000|Long-term Follow-up|Lost to Follow-up|12|||
161966050|NCT02952313|584921961|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
161737017|NCT03569449|584076659|FG005|Overall Study|Lost to Follow-up|0|||
161737018|NCT03569449|584076660|FG006|Overall Study|Lost to Follow-up|0|||
161737019|NCT03569449|584076661|FG007|Overall Study|Lost to Follow-up|0|||
161737020|NCT03569449|584076662|FG008|Overall Study|Lost to Follow-up|0|||
161737021|NCT03569449|584076663|FG009|Overall Study|Lost to Follow-up|0|||
161737022|NCT03569449|584076664|FG010|Overall Study|Lost to Follow-up|0|||
161737023|NCT03569449|584076665|FG011|Overall Study|Lost to Follow-up|0|||
161737024|NCT03569449|584076666|FG012|Overall Study|Lost to Follow-up|0|||
161737025|NCT03569449|584076667|FG013|Overall Study|Lost to Follow-up|0|||
161737026|NCT03569449|584076668|FG014|Overall Study|Lost to Follow-up|1|||
161840332|NCT04126213|584460536|FG003|Overall Study|Lost to Follow-up|10|||
161840333|NCT04126213|584460537|FG004|Overall Study|Lost to Follow-up|4|||
161840334|NCT04126213|584460538|FG005|Overall Study|Lost to Follow-up|7|||
161840335|NCT04126213|584460533|FG000|Overall Study|Withdrawal by Subject|3|||
161840336|NCT04126213|584460534|FG001|Overall Study|Withdrawal by Subject|2|||
161840337|NCT04126213|584460535|FG002|Overall Study|Withdrawal by Subject|1|||
161840338|NCT04126213|584460536|FG003|Overall Study|Withdrawal by Subject|1|||
161840339|NCT04126213|584460537|FG004|Overall Study|Withdrawal by Subject|1|||
161840340|NCT04126213|584460538|FG005|Overall Study|Withdrawal by Subject|1|||
161840341|NCT04126213|584460533|FG000|Overall Study|Other|0|||
161840342|NCT04126213|584460534|FG001|Overall Study|Other|0|||
161840343|NCT04126213|584460535|FG002|Overall Study|Other|2|||
161840344|NCT04126213|584460536|FG003|Overall Study|Other|2|||
161840345|NCT04126213|584460537|FG004|Overall Study|Other|0|||
161840346|NCT04126213|584460538|FG005|Overall Study|Other|1|||
161840347|NCT04126213|584460533|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161840348|NCT04126213|584460534|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161840349|NCT04126213|584460535|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161840350|NCT04126213|584460536|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161840351|NCT04126213|584460537|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161840352|NCT04126213|584460538|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161840353|NCT02853370|584460539|FG000|Overall Study|Physician Decision|1|||
161840354|NCT02853370|584460539|FG000|Overall Study|Lack of Efficacy|2|||
161840355|NCT02853370|584460539|FG000|Overall Study|Death|1|||
161840356|NCT02853370|584460539|FG000|Overall Study|Adverse Event|4|||
161840357|NCT02853370|584460539|FG000|Overall Study|Withdrawal by Subject|3|||
161840358|NCT03283761|584460543|FG000|Study Treatment|Patient Non-Compliance|1|||
161840359|NCT03283761|584460543|FG000|Study Treatment|Alternative Cancer Therapy|7|||
161840360|NCT03283761|584460543|FG000|Study Treatment|Disease progression|21|||
161840361|NCT03283761|584460543|FG000|Study Treatment|Adverse Event|3|||
161840362|NCT03283761|584460543|FG000|Study Treatment|Withdrawal by Subject|4|||
161840363|NCT03283761|584460543|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
161840364|NCT03283761|584460543|FG000|Study Treatment|Symptomatic Deterioration|1|||
161840365|NCT03283761|584460543|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
161840366|NCT03283761|584460543|FG000|Follow up|Lost to Follow-up|1|||
161840367|NCT03283761|584460543|FG000|Follow up|Symptomatic Deterioration|1|||
161840368|NCT03283761|584460543|FG000|Follow up|Death|29|||
161840369|NCT03283761|584460543|FG000|Follow up|study terminated|4|||
161840370|NCT03283761|584460543|FG000|Follow up|Primary Investigator Withdrawal|1|||
161840371|NCT03283761|584460543|FG000|Follow up|Switched to alternative therapy|1|||
161840372|NCT03283761|584460543|FG000|Follow up|Subject is now in Hospice|1|||
161840373|NCT00741936|584460546|FG000|Overall Study|Lost to Follow-up|1|||
161840374|NCT00741936|584460547|FG001|Overall Study|Lost to Follow-up|1|||
161737027|NCT03569449|584076669|FG015|Overall Study|Lost to Follow-up|0|||
161737028|NCT03569449|584076654|FG000|Overall Study|Withdrawal by Subject|0|||
161737029|NCT03569449|584076655|FG001|Overall Study|Withdrawal by Subject|1|||
161737030|NCT03569449|584076656|FG002|Overall Study|Withdrawal by Subject|0|||
161737031|NCT03569449|584076657|FG003|Overall Study|Withdrawal by Subject|0|||
161737032|NCT03569449|584076658|FG004|Overall Study|Withdrawal by Subject|1|||
161737033|NCT03569449|584076659|FG005|Overall Study|Withdrawal by Subject|0|||
161737034|NCT03569449|584076660|FG006|Overall Study|Withdrawal by Subject|0|||
161737035|NCT03569449|584076661|FG007|Overall Study|Withdrawal by Subject|0|||
161737036|NCT03569449|584076662|FG008|Overall Study|Withdrawal by Subject|0|||
161737037|NCT03569449|584076663|FG009|Overall Study|Withdrawal by Subject|0|||
161737038|NCT03569449|584076664|FG010|Overall Study|Withdrawal by Subject|0|||
161737039|NCT03569449|584076665|FG011|Overall Study|Withdrawal by Subject|0|||
161840375|NCT00741936|584460546|FG000|Overall Study|Adverse Event|3|||
161840376|NCT00741936|584460547|FG001|Overall Study|Adverse Event|4|||
161840377|NCT00741936|584460546|FG000|Overall Study|Pregnancy|0|||
161840378|NCT00741936|584460547|FG001|Overall Study|Pregnancy|1|||
161737040|NCT03569449|584076666|FG012|Overall Study|Withdrawal by Subject|0|||
161737041|NCT03569449|584076667|FG013|Overall Study|Withdrawal by Subject|0|||
161840379|NCT00741936|584460546|FG000|Overall Study|Protocol Violation|2|||
161840380|NCT00741936|584460547|FG001|Overall Study|Protocol Violation|0|||
161840381|NCT00741936|584460546|FG000|Overall Study|Lack of Efficacy|0|||
161840382|NCT00741936|584460547|FG001|Overall Study|Lack of Efficacy|2|||
161840383|NCT00741936|584460546|FG000|Overall Study|Low compliance|3|||
161840384|NCT00741936|584460547|FG001|Overall Study|Low compliance|0|||
161840385|NCT01941940|584460548|FG000|Overall Study|Adverse Event|11|||
161840386|NCT01941940|584460548|FG000|Overall Study|Lost to Follow-up|2|||
161840387|NCT01941940|584460548|FG000|Overall Study|Physician Decision|2|||
161966051|NCT02952313|584921961|FG000|Long-term Follow-up|Lack of Efficacy|6|||
161966052|NCT02952313|584921961|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
161840388|NCT01941940|584460548|FG000|Overall Study|Withdrawal by Subject|15|||
161840389|NCT01941940|584460548|FG000|Overall Study|Death|1|||
161966053|NCT02952313|584921961|FG000|Long-term Follow-up|Physician Decision|1|||
161737042|NCT03569449|584076668|FG014|Overall Study|Withdrawal by Subject|0|||
161737043|NCT03569449|584076669|FG015|Overall Study|Withdrawal by Subject|0|||
161737044|NCT04124692|584076670|FG000|Overall Study|Medical reason|0|||
161737045|NCT04124692|584076671|FG001|Overall Study|Medical reason|1|||
161737046|NCT04124692|584076670|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
161737047|NCT04124692|584076671|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
161737048|NCT04124692|584076670|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
161737049|NCT04124692|584076671|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
161737050|NCT04124692|584076670|FG000|Overall Study|Lost to Follow-up|2|||
161737051|NCT04124692|584076671|FG001|Overall Study|Lost to Follow-up|4|||
161737052|NCT04124692|584076670|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
161737053|NCT04124692|584076671|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
161737054|NCT05279898|584076683|FG000|Overall Study|Withdrawal by Subject|1|||
161737055|NCT05279898|584076684|FG001|Overall Study|Withdrawal by Subject|0|||
161737056|NCT05279898|584076683|FG000|Overall Study|Physician Decision|1|||
161737057|NCT05279898|584076684|FG001|Overall Study|Physician Decision|1|||
161737058|NCT05136170|584076685|FG000|Overall Study|Withdrawal by Subject|2|||
161737059|NCT05136170|584076686|FG001|Overall Study|Withdrawal by Subject|2|||
161737060|NCT05136170|584076685|FG000|Overall Study|Can no longer make office visits|1|||
161737061|NCT05136170|584076686|FG001|Overall Study|Can no longer make office visits|0|||
161737062|NCT04393038|584076687|FG000|Overall Study|Adverse Event|11|||
161737063|NCT04393038|584076688|FG001|Overall Study|Adverse Event|2|||
161737064|NCT04393038|584076687|FG000|Overall Study|Protocol Violation|1|||
161737065|NCT04393038|584076688|FG001|Overall Study|Protocol Violation|0|||
161737066|NCT04393038|584076687|FG000|Overall Study|Death|6|||
161737067|NCT04393038|584076688|FG001|Overall Study|Death|4|||
161737068|NCT04393038|584076687|FG000|Overall Study|Withdrawal by Subject|24|||
161737069|NCT04393038|584076688|FG001|Overall Study|Withdrawal by Subject|8|||
161737070|NCT04393038|584076687|FG000|Overall Study|Lost to Follow-up|5|||
161737071|NCT04393038|584076688|FG001|Overall Study|Lost to Follow-up|4|||
161737072|NCT04393038|584076687|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
161737073|NCT04393038|584076688|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
161737074|NCT04393038|584076687|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
161737075|NCT04393038|584076688|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
161737076|NCT05168813|584076689|FG000|Part A (Open-label)|Lost to Follow-up|21|||
161737077|NCT05168813|584076690|FG001|Part A (Open-label)|Lost to Follow-up|39|||
161737078|NCT05168813|584076691|FG002|Part A (Open-label)|Lost to Follow-up|8|||
161737079|NCT05168813|584076692|FG003|Part A (Open-label)|Lost to Follow-up|26|||
161737080|NCT05168813|584076693|FG004|Part A (Open-label)|Lost to Follow-up|0|||
161737081|NCT05168813|584076694|FG005|Part A (Open-label)|Lost to Follow-up|0|||
161737082|NCT05168813|584076689|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
161737083|NCT05168813|584076690|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
161737084|NCT05168813|584076691|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
161737085|NCT05168813|584076692|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
161737086|NCT05168813|584076693|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
161737087|NCT05168813|584076694|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
161737088|NCT05168813|584076689|FG000|Part A (Open-label)|Death|23|||
161737089|NCT05168813|584076690|FG001|Part A (Open-label)|Death|28|||
161737090|NCT05168813|584076691|FG002|Part A (Open-label)|Death|1|||
161737091|NCT05168813|584076692|FG003|Part A (Open-label)|Death|9|||
161737092|NCT05168813|584076693|FG004|Part A (Open-label)|Death|0|||
161737093|NCT05168813|584076694|FG005|Part A (Open-label)|Death|0|||
161737094|NCT05168813|584076689|FG000|Part A (Open-label)|Physician Decision|0|||
161737095|NCT05168813|584076690|FG001|Part A (Open-label)|Physician Decision|1|||
161737096|NCT05168813|584076691|FG002|Part A (Open-label)|Physician Decision|0|||
161737097|NCT05168813|584076692|FG003|Part A (Open-label)|Physician Decision|2|||
161737098|NCT05168813|584076693|FG004|Part A (Open-label)|Physician Decision|0|||
161840390|NCT01941940|584460548|FG000|Overall Study|Other|1|||
161840391|NCT01941940|584460548|FG000|Overall Study|Other|1|||
161840392|NCT00532935|584460549|FG000|Overall Study|Adverse Event|11|||
161840393|NCT00532935|584460550|FG001|Overall Study|Adverse Event|12|||
161840394|NCT00532935|584460549|FG000|Overall Study|Lack of Efficacy|0|||
161840395|NCT00532935|584460550|FG001|Overall Study|Lack of Efficacy|3|||
161840396|NCT00532935|584460549|FG000|Overall Study|Lost to Follow-up|10|||
161840397|NCT00532935|584460550|FG001|Overall Study|Lost to Follow-up|6|||
161737099|NCT05168813|584076694|FG005|Part A (Open-label)|Physician Decision|0|||
161737100|NCT05168813|584076689|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
161737101|NCT05168813|584076690|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
161737102|NCT05168813|584076691|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
161737103|NCT05168813|584076692|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
161737104|NCT05168813|584076693|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
161737105|NCT05168813|584076694|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
161737106|NCT05168813|584076689|FG000|Part A (Open-label)|Protocol Violation|0|||
161840398|NCT00532935|584460549|FG000|Overall Study|Physician Decision|4|||
161737107|NCT05168813|584076690|FG001|Part A (Open-label)|Protocol Violation|1|||
161737108|NCT05168813|584076691|FG002|Part A (Open-label)|Protocol Violation|0|||
161737109|NCT05168813|584076692|FG003|Part A (Open-label)|Protocol Violation|0|||
161737110|NCT05168813|584076693|FG004|Part A (Open-label)|Protocol Violation|0|||
161737111|NCT05168813|584076694|FG005|Part A (Open-label)|Protocol Violation|0|||
161737112|NCT05168813|584076689|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
161737113|NCT05168813|584076690|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
161737114|NCT05168813|584076691|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
161737115|NCT05168813|584076692|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
161737116|NCT05168813|584076693|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
161737117|NCT05168813|584076694|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
161737118|NCT05168813|584076689|FG000|Part A (Open-label)|Other|0|||
161737119|NCT05168813|584076690|FG001|Part A (Open-label)|Other|1|||
161737120|NCT05168813|584076691|FG002|Part A (Open-label)|Other|0|||
161737121|NCT05168813|584076692|FG003|Part A (Open-label)|Other|0|||
161737122|NCT05168813|584076693|FG004|Part A (Open-label)|Other|0|||
161737123|NCT05168813|584076694|FG005|Part A (Open-label)|Other|0|||
161737124|NCT05168813|584076689|FG000|Part B (Blinded)|Lost to Follow-up|0|||
161737125|NCT05168813|584076690|FG001|Part B (Blinded)|Lost to Follow-up|0|||
161737126|NCT05168813|584076691|FG002|Part B (Blinded)|Lost to Follow-up|0|||
161737127|NCT05168813|584076692|FG003|Part B (Blinded)|Lost to Follow-up|0|||
161737128|NCT05168813|584076693|FG004|Part B (Blinded)|Lost to Follow-up|219|||
161737129|NCT05168813|584076694|FG005|Part B (Blinded)|Lost to Follow-up|88|||
161737130|NCT05168813|584076689|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
161737131|NCT05168813|584076690|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
161737132|NCT05168813|584076691|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
161737133|NCT05168813|584076692|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
161737134|NCT05168813|584076693|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
161737135|NCT05168813|584076694|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
161737136|NCT05168813|584076689|FG000|Part B (Blinded)|Death|0|||
161737137|NCT05168813|584076690|FG001|Part B (Blinded)|Death|0|||
161737138|NCT05168813|584076691|FG002|Part B (Blinded)|Death|0|||
161737139|NCT05168813|584076692|FG003|Part B (Blinded)|Death|0|||
161737140|NCT05168813|584076693|FG004|Part B (Blinded)|Death|63|||
161737141|NCT05168813|584076694|FG005|Part B (Blinded)|Death|19|||
161737142|NCT05168813|584076689|FG000|Part B (Blinded)|Physician Decision|0|||
161737143|NCT05168813|584076690|FG001|Part B (Blinded)|Physician Decision|0|||
161737144|NCT05168813|584076691|FG002|Part B (Blinded)|Physician Decision|0|||
161737145|NCT05168813|584076692|FG003|Part B (Blinded)|Physician Decision|0|||
161737146|NCT05168813|584076693|FG004|Part B (Blinded)|Physician Decision|6|||
161737147|NCT05168813|584076694|FG005|Part B (Blinded)|Physician Decision|1|||
161737148|NCT05168813|584076689|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
161737149|NCT05168813|584076690|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
161737150|NCT05168813|584076691|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
161737151|NCT05168813|584076692|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
161737152|NCT05168813|584076693|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
161737153|NCT05168813|584076694|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
161737154|NCT05168813|584076689|FG000|Part B (Blinded)|Pregnancy|0|||
161737155|NCT05168813|584076690|FG001|Part B (Blinded)|Pregnancy|0|||
161737156|NCT05168813|584076691|FG002|Part B (Blinded)|Pregnancy|0|||
161737157|NCT05168813|584076692|FG003|Part B (Blinded)|Pregnancy|0|||
161737158|NCT05168813|584076693|FG004|Part B (Blinded)|Pregnancy|1|||
161737159|NCT05168813|584076694|FG005|Part B (Blinded)|Pregnancy|0|||
161737160|NCT05168813|584076689|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
161737161|NCT05168813|584076690|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
161737162|NCT05168813|584076691|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
161737163|NCT05168813|584076692|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
161737164|NCT05168813|584076693|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
161737165|NCT05168813|584076694|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
161737166|NCT05168813|584076689|FG000|Part B (Blinded)|Other|0|||
161737167|NCT05168813|584076690|FG001|Part B (Blinded)|Other|0|||
161737168|NCT05168813|584076691|FG002|Part B (Blinded)|Other|0|||
161737169|NCT05168813|584076692|FG003|Part B (Blinded)|Other|0|||
161737170|NCT05168813|584076693|FG004|Part B (Blinded)|Other|41|||
161737171|NCT05168813|584076694|FG005|Part B (Blinded)|Other|27|||
161737172|NCT04580394|584076695|FG000|First Intervention|Incorrectly Randomized|1|||
161737173|NCT04580394|584076695|FG000|First Intervention|Physician Decision|1|||
161737174|NCT04580394|584076695|FG000|First Intervention|Lost to Follow-up|1|||
161737175|NCT04580394|584076695|FG000|Washout (One Week)|Withdrawal by Subject|1|||
161737176|NCT04580394|584076695|FG000|Washout (One Week)|Adverse Event|1|||
161737177|NCT04580394|584076695|FG000|Washout (One Week)|Withdrawal by Subject|2|||
161737178|NCT04580394|584076695|FG000|Third Intervention|Adverse Event|1|||
161737179|NCT04580394|584076695|FG000|Third Intervention|Withdrawal by Subject|1|||
161737180|NCT04580394|584076695|FG000|Washout (One Week)|Withdrawal by Subject|2|||
161737181|NCT03201965|584076698|FG000|Overall Study|Death|5|||
161737182|NCT03201965|584076699|FG001|Overall Study|Death|65|||
161737183|NCT03201965|584076700|FG002|Overall Study|Death|47|||
161840399|NCT00532935|584460550|FG001|Overall Study|Physician Decision|5|||
161840400|NCT00532935|584460549|FG000|Overall Study|Pregnancy|1|||
161840401|NCT00532935|584460550|FG001|Overall Study|Pregnancy|0|||
161840402|NCT00532935|584460549|FG000|Overall Study|Protocol Violation|4|||
161840403|NCT00532935|584460550|FG001|Overall Study|Protocol Violation|2|||
161840404|NCT00532935|584460549|FG000|Overall Study|Withdrawal by Subject|10|||
161840405|NCT00532935|584460550|FG001|Overall Study|Withdrawal by Subject|9|||
161840406|NCT00532935|584460549|FG000|Overall Study|Protocol Specific Criteria|11|||
161840407|NCT00532935|584460550|FG001|Overall Study|Protocol Specific Criteria|15|||
161840408|NCT03212521|584460553|FG000|Overall Study|Adverse Event|1|||
161840409|NCT03212521|584460553|FG000|Overall Study|Lost to Follow-up|4|||
161840410|NCT03212521|584460553|FG000|Overall Study|Withdrawal by Subject|1|||
161840411|NCT03212521|584460553|FG000|Overall Study|Other|1|||
161840412|NCT02435836|584460556|FG000|Overall Study|Lost to Follow-up|21|||
161840413|NCT02435836|584460556|FG000|Overall Study|Lack of Efficacy|1|||
161840414|NCT02435836|584460556|FG000|Overall Study|Withdrawal by Subject|236|||
161840415|NCT02435836|584460556|FG000|Overall Study|Insufficient Clinical Response|26|||
161840416|NCT02435836|584460556|FG000|Overall Study|Adverse Event|44|||
161840417|NCT02435836|584460556|FG000|Overall Study|Sponsor discontinued trial|167|||
161840418|NCT02435836|584460556|FG000|Overall Study|Noncompliance|27|||
161840419|NCT02435836|584460556|FG000|Overall Study|Protocol Violation|6|||
161840420|NCT02435836|584460556|FG000|Overall Study|Met Withdrawal Criteria|7|||
161840421|NCT02435836|584460556|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
161840422|NCT00914459|584460557|FG000|Overall Study|Protocol Violation|0|||
161840423|NCT00914459|584460558|FG001|Overall Study|Protocol Violation|1|||
161840424|NCT00914459|584460557|FG000|Overall Study|Parent/Legal guardian request|1|||
161840425|NCT00914459|584460558|FG001|Overall Study|Parent/Legal guardian request|0|||
161840426|NCT03176459|584460559|FG000|Overall Study|Lost to Follow-up|5|||
161840427|NCT03176459|584460560|FG001|Overall Study|Lost to Follow-up|7|||
161840428|NCT01661179|584460561|FG000|Overall Study|Death|1|||
161840429|NCT01661179|584460561|FG000|Overall Study|Withdrawal by Subject|1|||
161840430|NCT01661179|584460561|FG000|Overall Study|Other Eligibility criteria|4|||
161840431|NCT01083810|584460562|FG000|Overall Study|Lost to Follow-up|23|||
161840432|NCT01083810|584460563|FG001|Overall Study|Lost to Follow-up|11|||
161840433|NCT01083810|584460564|FG002|Overall Study|Lost to Follow-up|4|||
161840434|NCT01083810|584460562|FG000|Overall Study|Adverse Event|15|||
161840435|NCT01083810|584460563|FG001|Overall Study|Adverse Event|11|||
161840436|NCT01083810|584460564|FG002|Overall Study|Adverse Event|4|||
161840437|NCT01083810|584460562|FG000|Overall Study|Withdrawal by Subject|7|||
161840438|NCT01083810|584460563|FG001|Overall Study|Withdrawal by Subject|2|||
161840439|NCT01083810|584460564|FG002|Overall Study|Withdrawal by Subject|4|||
161840440|NCT01083810|584460562|FG000|Overall Study|Reason not reported|6|||
161840441|NCT01083810|584460563|FG001|Overall Study|Reason not reported|1|||
161840442|NCT01083810|584460564|FG002|Overall Study|Reason not reported|1|||
161840443|NCT01083810|584460562|FG000|Overall Study|Non-compliance|4|||
161840444|NCT01083810|584460563|FG001|Overall Study|Non-compliance|7|||
161840445|NCT01083810|584460564|FG002|Overall Study|Non-compliance|2|||
161840446|NCT01083810|584460562|FG000|Overall Study|Simplification|4|||
161840447|NCT01083810|584460563|FG001|Overall Study|Simplification|1|||
161840448|NCT01083810|584460564|FG002|Overall Study|Simplification|0|||
161840449|NCT01083810|584460562|FG000|Overall Study|Death|2|||
161840450|NCT01083810|584460563|FG001|Overall Study|Death|2|||
161840451|NCT01083810|584460564|FG002|Overall Study|Death|3|||
161840452|NCT01083810|584460562|FG000|Overall Study|Co-morbidities|1|||
161840453|NCT01083810|584460563|FG001|Overall Study|Co-morbidities|0|||
161840454|NCT01083810|584460564|FG002|Overall Study|Co-morbidities|0|||
161840455|NCT01083810|584460562|FG000|Overall Study|Participation in study|1|||
161840456|NCT01083810|584460563|FG001|Overall Study|Participation in study|0|||
161840457|NCT01083810|584460564|FG002|Overall Study|Participation in study|0|||
161840458|NCT01083810|584460562|FG000|Overall Study|Therapy break|1|||
161840459|NCT01083810|584460563|FG001|Overall Study|Therapy break|2|||
161840460|NCT01083810|584460564|FG002|Overall Study|Therapy break|2|||
161840461|NCT01083810|584460562|FG000|Overall Study|Virologic failure|1|||
161840462|NCT01083810|584460563|FG001|Overall Study|Virologic failure|8|||
161840463|NCT01083810|584460564|FG002|Overall Study|Virologic failure|0|||
161840464|NCT01602965|584460565|FG000|Overall Study|Lost to Follow-up|4|||
161840465|NCT01602965|584460566|FG001|Overall Study|Lost to Follow-up|2|||
161840466|NCT00446199|584460569|FG000|Overall Study|Adverse Event|7|||
161840467|NCT00446199|584460570|FG001|Overall Study|Adverse Event|4|||
161840468|NCT00446199|584460571|FG002|Overall Study|Adverse Event|6|||
161840469|NCT00446199|584460572|FG003|Overall Study|Adverse Event|4|||
161840470|NCT00446199|584460569|FG000|Overall Study|Lost to Follow-up|4|||
161840471|NCT00446199|584460570|FG001|Overall Study|Lost to Follow-up|5|||
161840472|NCT00446199|584460571|FG002|Overall Study|Lost to Follow-up|2|||
161840473|NCT00446199|584460572|FG003|Overall Study|Lost to Follow-up|6|||
161840474|NCT00446199|584460569|FG000|Overall Study|Protocol Violation|1|||
161840475|NCT00446199|584460570|FG001|Overall Study|Protocol Violation|2|||
161840476|NCT00446199|584460571|FG002|Overall Study|Protocol Violation|1|||
161840477|NCT00446199|584460572|FG003|Overall Study|Protocol Violation|3|||
161840478|NCT00446199|584460569|FG000|Overall Study|Withdrawal by Subject|2|||
161966054|NCT02952313|584921961|FG000|Long-term Follow-up|Death|1|||
161737184|NCT03201965|584076698|FG000|Overall Study|Lost to Follow-up|0|||
161737185|NCT03201965|584076699|FG001|Overall Study|Lost to Follow-up|6|||
161737186|NCT03201965|584076700|FG002|Overall Study|Lost to Follow-up|0|||
161737187|NCT03201965|584076698|FG000|Overall Study|Withdrawal by Subject|3|||
161737188|NCT03201965|584076699|FG001|Overall Study|Withdrawal by Subject|23|||
161737189|NCT03201965|584076700|FG002|Overall Study|Withdrawal by Subject|8|||
161737190|NCT03201965|584076698|FG000|Overall Study|Sponsor's Decision|20|||
161737191|NCT03201965|584076699|FG001|Overall Study|Sponsor's Decision|99|||
161737192|NCT03201965|584076700|FG002|Overall Study|Sponsor's Decision|140|||
161737193|NCT03589326|584076701|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
161737194|NCT03589326|584076702|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
161737195|NCT03589326|584076701|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
161737196|NCT03589326|584076702|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
161737197|NCT03589326|584076701|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
161737198|NCT03589326|584076702|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
161737199|NCT03589326|584076701|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
161737200|NCT03589326|584076702|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
161737201|NCT03589326|584076701|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
161737202|NCT03589326|584076702|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
161737203|NCT00603980|584076705|FG000|Study Qualification|Protocol Violation|3|||
161737204|NCT00603980|584076705|FG000|Study Qualification|Inconsistent data reporting|13|||
161737205|NCT00603980|584076705|FG000|Main Study|14th subject completed trial|1|||
161737206|NCT01577160|584076706|FG000|Overall Study|Adverse Event|9|||
161737207|NCT01577160|584076706|FG000|Overall Study|Lack of Efficacy|15|||
161737208|NCT01577160|584076706|FG000|Overall Study|Lost to Follow-up|40|||
161737209|NCT01577160|584076706|FG000|Overall Study|Withdrawal by Subject|18|||
161737210|NCT01577160|584076706|FG000|Overall Study|Subject Uncooperative|7|||
161737211|NCT01577160|584076706|FG000|Overall Study|Other|9|||
161737212|NCT01341652|584076707|FG000|Overall Study|Incorrect Random Assignment|0|||
161737213|NCT01341652|584076708|FG001|Overall Study|Incorrect Random Assignment|1|||
161737214|NCT01341652|584076707|FG000|Overall Study|ineligible; presence metastatic disease|0|||
161737215|NCT01341652|584076708|FG001|Overall Study|ineligible; presence metastatic disease|1|||
161737216|NCT02618928|584076711|FG000|Overall Study|Failure to Return|28|||
161737217|NCT02618928|584076711|FG000|Overall Study|Insufficient Virological Response|1|||
161737218|NCT02618928|584076711|FG000|Overall Study|Withdrawal by Subject|2|||
161737219|NCT02618928|584076711|FG000|Overall Study|Death|3|||
161737220|NCT02618928|584076711|FG000|Overall Study|Other|11|||
161737221|NCT02618928|584076711|FG000|Overall Study|Missing|6|||
161737222|NCT02618928|584076711|FG000|Overall Study|Treatment Never Started|7|||
161737223|NCT01096849|584076716|FG000|Overall Study|Consent Withdrawn|1|||
161737224|NCT01096849|584076717|FG001|Overall Study|Consent Withdrawn|4|||
161737225|NCT01096849|584076718|FG002|Overall Study|Consent Withdrawn|2|||
161737226|NCT01096849|584076716|FG000|Overall Study|Lack of Efficacy|0|||
161737227|NCT01096849|584076717|FG001|Overall Study|Lack of Efficacy|2|||
161737228|NCT01096849|584076718|FG002|Overall Study|Lack of Efficacy|0|||
161737229|NCT01096849|584076716|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
161737230|NCT01096849|584076717|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
161737231|NCT01096849|584076718|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
161737232|NCT01096849|584076716|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
161737233|NCT01096849|584076717|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
161737234|NCT01096849|584076718|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
161737235|NCT01096849|584076716|FG000|Overall Study|Administrative Reasons|0|||
161737236|NCT01096849|584076717|FG001|Overall Study|Administrative Reasons|1|||
161737237|NCT01096849|584076718|FG002|Overall Study|Administrative Reasons|2|||
161737238|NCT01096849|584076716|FG000|Overall Study|Lost to Follow-up|1|||
161737239|NCT01096849|584076717|FG001|Overall Study|Lost to Follow-up|3|||
161737240|NCT01096849|584076718|FG002|Overall Study|Lost to Follow-up|1|||
161737241|NCT02998554|584076719|FG000|Overall Study|Adverse Event|8|||
161737242|NCT02998554|584076720|FG001|Overall Study|Adverse Event|3|||
161737243|NCT02998554|584076719|FG000|Overall Study|Protocol deviation|1|||
161737244|NCT02998554|584076720|FG001|Overall Study|Protocol deviation|0|||
161737245|NCT02998554|584076719|FG000|Overall Study|Withdrawal by Subject|2|||
161737246|NCT02998554|584076720|FG001|Overall Study|Withdrawal by Subject|6|||
161737247|NCT02998554|584076719|FG000|Overall Study|Lost to Follow-up|0|||
161737248|NCT02998554|584076720|FG001|Overall Study|Lost to Follow-up|1|||
161737249|NCT02998554|584076719|FG000|Overall Study|Lack of Efficacy|0|||
161737250|NCT02998554|584076720|FG001|Overall Study|Lack of Efficacy|1|||
161737251|NCT04146467|584076721|FG000|Overall Study|Adverse Event|0|||
161737252|NCT04146467|584076722|FG001|Overall Study|Adverse Event|1|||
161737253|NCT04146467|584076721|FG000|Overall Study|Lost to Follow-up|0|||
161737254|NCT04146467|584076722|FG001|Overall Study|Lost to Follow-up|2|||
161737255|NCT02953782|584076725|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
161737256|NCT02953782|584076726|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
161737257|NCT02953782|584076727|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
162032424|NCT02545543|585175483|FG000|Overall Study|Lost to Follow-up|67|||
162032425|NCT02545543|585175484|FG001|Overall Study|Lost to Follow-up|25|||
162032426|NCT02545543|585175483|FG000|Overall Study|Physician Decision|3|||
162032427|NCT02545543|585175484|FG001|Overall Study|Physician Decision|0|||
161737258|NCT02953782|584076728|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
161737259|NCT02953782|584076729|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
161737260|NCT02953782|584076730|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
161737261|NCT02953782|584076731|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
161737262|NCT02953782|584076732|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
161737263|NCT02953782|584076725|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
161737264|NCT02953782|584076726|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161737265|NCT02953782|584076727|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
161737266|NCT02953782|584076728|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161737267|NCT02953782|584076729|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
161737268|NCT02953782|584076730|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161737269|NCT02953782|584076731|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161737270|NCT02953782|584076732|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161737271|NCT02953782|584076725|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161737272|NCT02953782|584076726|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
161737273|NCT02953782|584076727|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161737274|NCT02953782|584076728|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
161737275|NCT02953782|584076729|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
161737276|NCT02953782|584076730|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161737277|NCT02953782|584076731|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161737278|NCT02953782|584076732|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161737279|NCT02953782|584076725|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161737280|NCT02953782|584076726|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161737281|NCT02953782|584076727|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
161737282|NCT02953782|584076728|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
161737283|NCT02953782|584076729|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161737284|NCT02953782|584076730|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161737285|NCT02953782|584076731|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161737286|NCT02953782|584076732|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161737287|NCT02953782|584076725|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161737288|NCT02953782|584076726|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161737289|NCT02953782|584076727|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161737290|NCT02953782|584076728|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161737291|NCT02953782|584076729|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161737292|NCT02953782|584076730|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
161737293|NCT02953782|584076731|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
161737294|NCT02953782|584076732|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
161737295|NCT02953782|584076725|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161737296|NCT02953782|584076726|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161737297|NCT02953782|584076727|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161737298|NCT02953782|584076728|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161737299|NCT02953782|584076729|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161737300|NCT02953782|584076730|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
161737301|NCT02953782|584076731|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
161737302|NCT02953782|584076732|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
161737303|NCT02953782|584076725|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161840479|NCT00446199|584460570|FG001|Overall Study|Withdrawal by Subject|5|||
161840480|NCT00446199|584460571|FG002|Overall Study|Withdrawal by Subject|9|||
161840481|NCT00446199|584460572|FG003|Overall Study|Withdrawal by Subject|10|||
161840482|NCT00446199|584460569|FG000|Overall Study|Site termination|2|||
161840483|NCT00446199|584460570|FG001|Overall Study|Site termination|0|||
161840484|NCT00446199|584460571|FG002|Overall Study|Site termination|0|||
161840485|NCT00446199|584460572|FG003|Overall Study|Site termination|1|||
161840486|NCT00446199|584460569|FG000|Overall Study|Randomization in Error|2|||
161840487|NCT00446199|584460570|FG001|Overall Study|Randomization in Error|0|||
161840488|NCT00446199|584460571|FG002|Overall Study|Randomization in Error|1|||
161840489|NCT00446199|584460572|FG003|Overall Study|Randomization in Error|1|||
161840490|NCT00446199|584460569|FG000|Overall Study|Lack of Efficacy|1|||
161840491|NCT00446199|584460570|FG001|Overall Study|Lack of Efficacy|0|||
161840492|NCT00446199|584460571|FG002|Overall Study|Lack of Efficacy|0|||
162032428|NCT02545543|585175483|FG000|Overall Study|Withdrawal by Subject|9|||
162032429|NCT02545543|585175484|FG001|Overall Study|Withdrawal by Subject|8|||
162032430|NCT02545543|585175483|FG000|Overall Study|Noncomplaince|1|||
161737304|NCT02953782|584076726|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161737305|NCT02953782|584076727|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161737306|NCT02953782|584076728|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161737307|NCT02953782|584076729|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161737308|NCT02953782|584076730|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
161737309|NCT02953782|584076731|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
161737310|NCT02953782|584076732|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
161737311|NCT02953782|584076725|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737312|NCT02953782|584076726|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737313|NCT02953782|584076727|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737314|NCT02953782|584076728|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737315|NCT02953782|584076729|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737316|NCT02953782|584076730|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737317|NCT02953782|584076731|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
161737318|NCT02953782|584076732|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161737319|NCT02128763|584076733|FG000|Overall Study|Death|1|||
161737320|NCT02128763|584076734|FG001|Overall Study|Death|0|||
161737321|NCT02128763|584076733|FG000|Overall Study|Lost to Follow-up|19|||
161737322|NCT02128763|584076734|FG001|Overall Study|Lost to Follow-up|16|||
161737323|NCT02357849|584076737|FG000|Overall Study|Withdrawal by Subject|2|||
161737324|NCT02357849|584076738|FG001|Overall Study|Withdrawal by Subject|3|||
161737325|NCT03105700|584076741|FG000|Overall Study|screen fail|3|||
161737326|NCT03105700|584076741|FG000|Overall Study|Lost to Follow-up|4|||
161737327|NCT01253421|584076742|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
161737328|NCT01253421|584076743|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
161737329|NCT01253421|584076744|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
161737330|NCT01253421|584076745|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
161737331|NCT01253421|584076746|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
161737332|NCT01253421|584076742|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
161737333|NCT01253421|584076743|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
161737334|NCT01253421|584076744|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
161737335|NCT01253421|584076745|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
161737336|NCT01253421|584076746|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
161737337|NCT01253421|584076742|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
161737338|NCT01253421|584076743|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
161737339|NCT01253421|584076744|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
161737340|NCT01253421|584076745|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
161737341|NCT01253421|584076746|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
161737342|NCT01253421|584076742|FG000|Assessment and Scheduling|Physician Decision|1|||
161737343|NCT01253421|584076743|FG001|Assessment and Scheduling|Physician Decision|0|||
161737344|NCT01253421|584076744|FG002|Assessment and Scheduling|Physician Decision|0|||
161737345|NCT01253421|584076745|FG003|Assessment and Scheduling|Physician Decision|0|||
161737346|NCT01253421|584076746|FG004|Assessment and Scheduling|Physician Decision|0|||
161737347|NCT01253421|584076742|FG000|Drug+Scanning Visit|Physician Decision|0|||
161737348|NCT01253421|584076743|FG001|Drug+Scanning Visit|Physician Decision|0|||
161737349|NCT01253421|584076744|FG002|Drug+Scanning Visit|Physician Decision|0|||
161737350|NCT01253421|584076745|FG003|Drug+Scanning Visit|Physician Decision|0|||
161737351|NCT01253421|584076746|FG004|Drug+Scanning Visit|Physician Decision|1|||
161737352|NCT01608724|584076748|FG000|Overall Study|Withdrawal by Subject|131|||
161737353|NCT01608724|584076748|FG000|Overall Study|Lost to Follow-up|41|||
161737354|NCT01608724|584076748|FG000|Overall Study|Study-specific discontinuation criteria|32|||
161737355|NCT01608724|584076748|FG000|Overall Study|Adverse Event|29|||
161737356|NCT01608724|584076748|FG000|Overall Study|Protocol Violation|6|||
161737357|NCT01608724|584076748|FG000|Overall Study|bood sugar too high, etc.|3|||
161737358|NCT01608724|584076748|FG000|Overall Study|Safety reasons|1|||
161737359|NCT00099359|584076749|FG000|Overall Study|Death|11|||
161737360|NCT00099359|584076750|FG001|Overall Study|Death|15|||
161737361|NCT00099359|584076751|FG002|Overall Study|Death|17|||
161737362|NCT00099359|584076749|FG000|Overall Study|Withdrawal by Subject|19|||
161737363|NCT00099359|584076750|FG001|Overall Study|Withdrawal by Subject|19|||
161737364|NCT00099359|584076751|FG002|Overall Study|Withdrawal by Subject|23|||
161737365|NCT00099359|584076749|FG000|Overall Study|Lost to Follow-up|15|||
161737366|NCT00099359|584076750|FG001|Overall Study|Lost to Follow-up|24|||
161737367|NCT00099359|584076751|FG002|Overall Study|Lost to Follow-up|24|||
161737368|NCT00099359|584076749|FG000|Overall Study|moved out of area|9|||
161737369|NCT00099359|584076750|FG001|Overall Study|moved out of area|7|||
161737370|NCT00099359|584076751|FG002|Overall Study|moved out of area|4|||
161737371|NCT00717366|584076752|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
161737372|NCT00717366|584076753|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
161737373|NCT00717366|584076752|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
161737374|NCT00717366|584076753|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
161840493|NCT00446199|584460572|FG003|Overall Study|Lack of Efficacy|1|||
161737375|NCT00717366|584076752|FG000|Core Study Period (20 Weeks)|Death|0|||
161737376|NCT00717366|584076753|FG001|Core Study Period (20 Weeks)|Death|1|||
161737377|NCT00717366|584076752|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
161737378|NCT00717366|584076753|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
161737379|NCT00717366|584076752|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
161737380|NCT00717366|584076753|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
161737381|NCT00717366|584076752|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
161737382|NCT00717366|584076753|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
161737383|NCT00717366|584076752|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
161737384|NCT00717366|584076753|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
161737385|NCT02104804|584076756|FG000|Overall Study|Did not take study medication|0|||
161737386|NCT02104804|584076757|FG001|Overall Study|Did not take study medication|1|||
161737387|NCT02104804|584076756|FG000|Overall Study|Study specific discontinuation criteria|6|||
161737388|NCT02104804|584076757|FG001|Overall Study|Study specific discontinuation criteria|1|||
161737389|NCT02104804|584076756|FG000|Overall Study|Other listed|2|||
161737390|NCT02104804|584076757|FG001|Overall Study|Other listed|1|||
161737391|NCT02104804|584076756|FG000|Overall Study|Protocol Violation|0|||
161737392|NCT02104804|584076757|FG001|Overall Study|Protocol Violation|1|||
161737393|NCT02104804|584076756|FG000|Overall Study|Adverse Event|4|||
161737394|NCT02104804|584076757|FG001|Overall Study|Adverse Event|3|||
161737395|NCT02104804|584076756|FG000|Overall Study|Withdrawal by Subject|4|||
161737396|NCT02104804|584076757|FG001|Overall Study|Withdrawal by Subject|12|||
161737397|NCT01364233|584076758|FG000|Overall Study|Lost to Follow-up|1|||
161737398|NCT00406783|584076759|FG000|Overall Study|Adverse Event|4|||
161737399|NCT00406783|584076760|FG001|Overall Study|Adverse Event|4|||
161737400|NCT00406783|584076759|FG000|Overall Study|Treatment Failure|2|||
161737401|NCT00406783|584076760|FG001|Overall Study|Treatment Failure|3|||
161737402|NCT00406783|584076759|FG000|Overall Study|Lost to Follow-up|3|||
161737403|NCT00406783|584076760|FG001|Overall Study|Lost to Follow-up|0|||
161737404|NCT00406783|584076759|FG000|Overall Study|Withdrawal by Subject|1|||
161737405|NCT00406783|584076760|FG001|Overall Study|Withdrawal by Subject|4|||
161737406|NCT00406783|584076759|FG000|Overall Study|Protocol Violation|4|||
161737407|NCT00406783|584076760|FG001|Overall Study|Protocol Violation|4|||
161737408|NCT02034474|584076761|FG000|Overall Study|Adverse Event|3|||
161737409|NCT02034474|584076762|FG001|Overall Study|Adverse Event|2|||
161737410|NCT02034474|584076761|FG000|Overall Study|Withdrawal by Subject|1|||
161737411|NCT02034474|584076762|FG001|Overall Study|Withdrawal by Subject|2|||
161737412|NCT01391819|584076763|FG000|Overall Study|Withdrawal by Subject|56|||
161737413|NCT01391819|584076763|FG000|Overall Study|Migrated/moved from study area|82|||
161737414|NCT01391819|584076763|FG000|Overall Study|Lost to Follow-up|252|||
161737415|NCT01391819|584076763|FG000|Overall Study|Death|3|||
161737416|NCT01391819|584076763|FG000|Overall Study|Other|9|||
161737417|NCT00995670|584076764|FG000|Overall Study|Failed arterial cannulation|1|||
161737418|NCT00995670|584076765|FG001|Overall Study|Failed arterial cannulation|0|||
161737419|NCT00995670|584076766|FG002|Overall Study|Failed arterial cannulation|3|||
161737420|NCT00675103|584076767|FG000|Overall Study|Lack of Efficacy|2|||
161737421|NCT00675103|584076767|FG000|Overall Study|Adverse Event|1|||
161737422|NCT01810042|584076770|FG000|Overall Study|Lost to Follow-up|10|||
161737423|NCT01208038|584076773|FG000|Overall Study|Withdrawal by Subject|1|||
161737424|NCT02509494|584076776|FG000|Overall Study|Lost to Follow-up|8|||
161737425|NCT02509494|584076777|FG001|Overall Study|Lost to Follow-up|47|||
161737426|NCT02509494|584076778|FG002|Overall Study|Lost to Follow-up|19|||
161737427|NCT02509494|584076779|FG003|Overall Study|Lost to Follow-up|6|||
161737428|NCT02509494|584076780|FG004|Overall Study|Lost to Follow-up|3|||
161737429|NCT02509494|584076781|FG005|Overall Study|Lost to Follow-up|3|||
161737430|NCT02509494|584076782|FG006|Overall Study|Lost to Follow-up|1|||
161737431|NCT02509494|584076783|FG007|Overall Study|Lost to Follow-up|3|||
161737432|NCT02509494|584076784|FG008|Overall Study|Lost to Follow-up|1|||
161737433|NCT02509494|584076776|FG000|Overall Study|Physician Decision|2|||
161737434|NCT02509494|584076777|FG001|Overall Study|Physician Decision|1|||
161737435|NCT02509494|584076778|FG002|Overall Study|Physician Decision|0|||
161737436|NCT02509494|584076779|FG003|Overall Study|Physician Decision|0|||
161737437|NCT02509494|584076780|FG004|Overall Study|Physician Decision|0|||
161737438|NCT02509494|584076781|FG005|Overall Study|Physician Decision|0|||
161966055|NCT00920387|584921964|FG000|Stage 1|Adverse Event|1|||
161966056|NCT00920387|584921965|FG001|Stage 1|Adverse Event|0|||
161966057|NCT00920387|584921966|FG002|Stage 1|Adverse Event|0|||
161966058|NCT04470908|584921967|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
161966059|NCT02602275|584921978|FG000|Day 1|Physician Decision|0|||
161737439|NCT02509494|584076782|FG006|Overall Study|Physician Decision|0|||
161737440|NCT02509494|584076783|FG007|Overall Study|Physician Decision|0|||
161737441|NCT02509494|584076784|FG008|Overall Study|Physician Decision|0|||
161737442|NCT02509494|584076776|FG000|Overall Study|Withdrawal by Subject|4|||
161737443|NCT02509494|584076777|FG001|Overall Study|Withdrawal by Subject|17|||
161737444|NCT02509494|584076778|FG002|Overall Study|Withdrawal by Subject|7|||
161737445|NCT02509494|584076779|FG003|Overall Study|Withdrawal by Subject|5|||
161737446|NCT02509494|584076780|FG004|Overall Study|Withdrawal by Subject|0|||
161737447|NCT02509494|584076781|FG005|Overall Study|Withdrawal by Subject|6|||
161737448|NCT02509494|584076782|FG006|Overall Study|Withdrawal by Subject|1|||
161737449|NCT02509494|584076783|FG007|Overall Study|Withdrawal by Subject|2|||
161737450|NCT02509494|584076784|FG008|Overall Study|Withdrawal by Subject|1|||
161737451|NCT02509494|584076776|FG000|Overall Study|Death|0|||
161737452|NCT02509494|584076777|FG001|Overall Study|Death|1|||
161737453|NCT02509494|584076778|FG002|Overall Study|Death|0|||
161737454|NCT02509494|584076779|FG003|Overall Study|Death|0|||
161737455|NCT02509494|584076780|FG004|Overall Study|Death|1|||
161737456|NCT02509494|584076781|FG005|Overall Study|Death|0|||
161737457|NCT02509494|584076782|FG006|Overall Study|Death|0|||
161737458|NCT02509494|584076783|FG007|Overall Study|Death|1|||
161737459|NCT02509494|584076784|FG008|Overall Study|Death|0|||
161737460|NCT02509494|584076776|FG000|Overall Study|Other|0|||
161737461|NCT02509494|584076777|FG001|Overall Study|Other|4|||
161737462|NCT02509494|584076778|FG002|Overall Study|Other|5|||
161737463|NCT02509494|584076779|FG003|Overall Study|Other|0|||
161737464|NCT02509494|584076780|FG004|Overall Study|Other|0|||
161737465|NCT02509494|584076781|FG005|Overall Study|Other|0|||
161737466|NCT02509494|584076782|FG006|Overall Study|Other|0|||
161737467|NCT02509494|584076783|FG007|Overall Study|Other|0|||
161737468|NCT02509494|584076784|FG008|Overall Study|Other|0|||
161737469|NCT02509494|584076776|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161737470|NCT02509494|584076777|FG001|Overall Study|Non-Compliance With Study Drug|11|||
161737471|NCT02509494|584076778|FG002|Overall Study|Non-Compliance With Study Drug|7|||
161737472|NCT02509494|584076779|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161737473|NCT02509494|584076780|FG004|Overall Study|Non-Compliance With Study Drug|1|||
161737474|NCT02509494|584076781|FG005|Overall Study|Non-Compliance With Study Drug|2|||
161737475|NCT02509494|584076782|FG006|Overall Study|Non-Compliance With Study Drug|1|||
161737476|NCT02509494|584076783|FG007|Overall Study|Non-Compliance With Study Drug|1|||
161737477|NCT02509494|584076784|FG008|Overall Study|Non-Compliance With Study Drug|0|||
161737478|NCT05084053|584079050|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
161737479|NCT05084053|584079051|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
161737480|NCT05084053|584079052|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
161737481|NCT05084053|584079053|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
161737482|NCT05084053|584079050|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
161737483|NCT05084053|584079051|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
161737484|NCT05084053|584079052|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
161737485|NCT05084053|584079053|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
161737486|NCT05084053|584079050|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
161737487|NCT05084053|584079051|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
161737488|NCT05084053|584079052|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
161737489|NCT05084053|584079053|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
161737490|NCT01179347|584079057|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
161737491|NCT01179347|584079058|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
161737492|NCT01179347|584079057|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
161737493|NCT01179347|584079058|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
161737494|NCT01179347|584079057|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
161737495|NCT01179347|584079058|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
161737496|NCT01179347|584079057|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
161737497|NCT01179347|584079058|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
161737498|NCT01179347|584079057|FG000|Double-blind Period (12 Weeks)|Other|2|||
161737499|NCT01179347|584079058|FG001|Double-blind Period (12 Weeks)|Other|4|||
161737500|NCT01179347|584079057|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
161737501|NCT01179347|584079058|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
161737502|NCT01179347|584079057|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
161737503|NCT01179347|584079058|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
161737504|NCT01179347|584079057|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
161737505|NCT01179347|584079058|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
161737506|NCT01179347|584079057|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
161737507|NCT01179347|584079058|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
161737508|NCT01179347|584079057|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
161737509|NCT01179347|584079058|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
161737510|NCT01179347|584079057|FG000|Open-label Period (12 Weeks)|Other|7|||
161737511|NCT01179347|584079058|FG001|Open-label Period (12 Weeks)|Other|4|||
161737512|NCT04092816|584079059|FG000|Overall Study|Lost to Follow-up|1|||
161737513|NCT04092816|584079060|FG001|Overall Study|Lost to Follow-up|2|||
161737514|NCT01677624|584079061|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
161840494|NCT00446199|584460569|FG000|Overall Study|Non-compliant with study drug|1|||
161737515|NCT01337167|584079065|FG000|Infant Series|Adverse Event|1|||
161737516|NCT01337167|584079066|FG001|Infant Series|Adverse Event|1|||
161840495|NCT00446199|584460570|FG001|Overall Study|Non-compliant with study drug|0|||
161737517|NCT01337167|584079065|FG000|Infant Series|Death|1|||
161737518|NCT01337167|584079066|FG001|Infant Series|Death|1|||
161737519|NCT01337167|584079065|FG000|Infant Series|Lost to Follow-up|13|||
161737520|NCT01337167|584079066|FG001|Infant Series|Lost to Follow-up|7|||
161737521|NCT01337167|584079065|FG000|Infant Series|Non-compliance with study drug|2|||
161737522|NCT01337167|584079066|FG001|Infant Series|Non-compliance with study drug|1|||
161737523|NCT01337167|584079065|FG000|Infant Series|Physician Decision|3|||
161737524|NCT01337167|584079066|FG001|Infant Series|Physician Decision|1|||
161737525|NCT01337167|584079065|FG000|Infant Series|Protocol Violation|22|||
161737526|NCT01337167|584079066|FG001|Infant Series|Protocol Violation|9|||
161737527|NCT01337167|584079065|FG000|Infant Series|Withdrawal by Subject|15|||
161737528|NCT01337167|584079066|FG001|Infant Series|Withdrawal by Subject|4|||
161737529|NCT01337167|584079065|FG000|Infant Series|Randomized but not vaccinated|5|||
161737530|NCT01337167|584079066|FG001|Infant Series|Randomized but not vaccinated|3|||
161737531|NCT01337167|584079065|FG000|Interim Period|Lost to Follow-up|51|||
161737532|NCT01337167|584079066|FG001|Interim Period|Lost to Follow-up|23|||
161737533|NCT01337167|584079065|FG000|Interim Period|Non-compliance with study drug|1|||
161737534|NCT01337167|584079066|FG001|Interim Period|Non-compliance with study drug|0|||
161737535|NCT01337167|584079065|FG000|Interim Period|Physician Decision|6|||
161737536|NCT01337167|584079066|FG001|Interim Period|Physician Decision|3|||
161737537|NCT01337167|584079065|FG000|Interim Period|Protocol Violation|5|||
161737538|NCT01337167|584079066|FG001|Interim Period|Protocol Violation|3|||
161737539|NCT01337167|584079065|FG000|Interim Period|Withdrawal by Subject|18|||
161737540|NCT01337167|584079066|FG001|Interim Period|Withdrawal by Subject|10|||
161737541|NCT01337167|584079065|FG000|Interim Period|Other protocol criterion not met|0|||
161737542|NCT01337167|584079066|FG001|Interim Period|Other protocol criterion not met|1|||
161737543|NCT01337167|584079065|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
161737544|NCT01337167|584079066|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
161737545|NCT01337167|584079065|FG000|Toddler Vaccinations|Protocol Violation|0|||
161737546|NCT01337167|584079066|FG001|Toddler Vaccinations|Protocol Violation|1|||
161737547|NCT01337167|584079065|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
161737548|NCT01337167|584079066|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
161737549|NCT03833817|584079067|FG000|Overall Study|Withdrawal by Subject|3|||
161737550|NCT03833817|584079068|FG001|Overall Study|Withdrawal by Subject|3|||
161737551|NCT03833817|584079067|FG000|Overall Study|Lost to Follow-up|3|||
161737552|NCT03833817|584079068|FG001|Overall Study|Lost to Follow-up|3|||
161737553|NCT02126670|584079073|FG000|Overall Study|Withdrawal by Subject|1|||
161737554|NCT02126670|584079074|FG001|Overall Study|Withdrawal by Subject|0|||
161737555|NCT02126670|584079075|FG002|Overall Study|Withdrawal by Subject|0|||
161737556|NCT02126670|584079076|FG003|Overall Study|Withdrawal by Subject|1|||
161737557|NCT03363919|584079079|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
161737558|NCT03363919|584079080|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
161737559|NCT03363919|584079079|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
161737560|NCT03363919|584079080|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
161737561|NCT01975246|584079081|FG000|Overall Study|Adverse Event|2|||
161737562|NCT01975246|584079082|FG001|Overall Study|Adverse Event|1|||
161737563|NCT01975246|584079081|FG000|Overall Study|Lack of Efficacy|1|||
161737564|NCT01975246|584079082|FG001|Overall Study|Lack of Efficacy|0|||
161737565|NCT01975246|584079081|FG000|Overall Study|Protocol Violation|1|||
161737566|NCT01975246|584079082|FG001|Overall Study|Protocol Violation|0|||
161737567|NCT01975246|584079081|FG000|Overall Study|Other than stated|0|||
161737568|NCT01975246|584079082|FG001|Overall Study|Other than stated|1|||
161737569|NCT01646398|584079083|FG000|Overall Study|Withdrawal by Subject|1|||
161737570|NCT01646398|584079084|FG001|Overall Study|Withdrawal by Subject|0|||
161737571|NCT01263093|584079085|FG000|Washout|Physician Decision|1|||
161737572|NCT01263093|584079086|FG001|Washout|Physician Decision|0|||
161737573|NCT01263093|584079085|FG000|Period 2|Adverse Event|1|||
161737574|NCT01263093|584079086|FG001|Period 2|Adverse Event|0|||
161737575|NCT01827319|584079087|FG000|Overall Study|Lost to Follow-up|3|||
161737576|NCT00574119|584079089|FG000|Overall Study|Adverse Event|1|||
161737577|NCT00574119|584079089|FG000|Overall Study|Protocol Violation|1|||
161737578|NCT00574119|584079089|FG000|Overall Study|Withdrawal by Subject|1|||
161737579|NCT00574119|584079089|FG000|Overall Study|Physician Decision|1|||
161737580|NCT03287245|584079090|FG000|Overall Study|Study terminated by sponsor|3|||
161737581|NCT03287245|584079091|FG001|Overall Study|Study terminated by sponsor|0|||
161737582|NCT03287245|584079092|FG002|Overall Study|Study terminated by sponsor|3|||
161737583|NCT03287245|584079093|FG003|Overall Study|Study terminated by sponsor|1|||
161737584|NCT03287245|584079090|FG000|Overall Study|Adverse Event|1|||
161737585|NCT03287245|584079091|FG001|Overall Study|Adverse Event|0|||
161737586|NCT03287245|584079092|FG002|Overall Study|Adverse Event|0|||
161737587|NCT03287245|584079093|FG003|Overall Study|Adverse Event|0|||
161737588|NCT03287245|584079090|FG000|Overall Study|Withdrawal by Subject|8|||
161737589|NCT03287245|584079091|FG001|Overall Study|Withdrawal by Subject|3|||
161737590|NCT03287245|584079092|FG002|Overall Study|Withdrawal by Subject|3|||
161737591|NCT03287245|584079093|FG003|Overall Study|Withdrawal by Subject|0|||
161737592|NCT03287245|584079090|FG000|Overall Study|Physician Decision|3|||
161737593|NCT03287245|584079091|FG001|Overall Study|Physician Decision|2|||
161737594|NCT03287245|584079092|FG002|Overall Study|Physician Decision|0|||
161737595|NCT03287245|584079093|FG003|Overall Study|Physician Decision|0|||
161737596|NCT02862548|584079094|FG000|Randomized Phase (Up to Week 48)|Death|0|||
161737597|NCT02862548|584079095|FG001|Randomized Phase (Up to Week 48)|Death|1|||
161737598|NCT02862548|584079094|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
161737599|NCT02862548|584079095|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
161737600|NCT02862548|584079094|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
161737601|NCT02862548|584079095|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
161737602|NCT02862548|584079094|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
161737603|NCT02862548|584079095|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
161737604|NCT00880763|584079096|FG000|Extension Period (Part 2)|Adverse Event|0|||
161737605|NCT00880763|584079097|FG001|Extension Period (Part 2)|Adverse Event|0|||
161737606|NCT00880763|584079098|FG002|Extension Period (Part 2)|Adverse Event|1|||
161737607|NCT00880763|584079099|FG003|Extension Period (Part 2)|Adverse Event|1|||
161737608|NCT00880763|584079096|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
161737609|NCT00880763|584079097|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
161737610|NCT00880763|584079098|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
161737611|NCT00880763|584079099|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
161737612|NCT00880763|584079096|FG000|Extension Period (Part 2)|Physician Decision|0|||
161737613|NCT00880763|584079097|FG001|Extension Period (Part 2)|Physician Decision|1|||
161737614|NCT00880763|584079098|FG002|Extension Period (Part 2)|Physician Decision|1|||
161737615|NCT00880763|584079099|FG003|Extension Period (Part 2)|Physician Decision|0|||
161737616|NCT00880763|584079096|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
161737617|NCT00880763|584079097|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
161737618|NCT00880763|584079098|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
161737619|NCT00880763|584079099|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
161737620|NCT00205699|584079107|FG000|Overall Study|Lost to Follow-up|1|||
161737621|NCT00205699|584079108|FG001|Overall Study|Lost to Follow-up|3|||
161737622|NCT00205699|584079109|FG002|Overall Study|Lost to Follow-up|5|||
161737623|NCT00205699|584079107|FG000|Overall Study|Adverse Event|1|||
161737624|NCT00205699|584079108|FG001|Overall Study|Adverse Event|0|||
161737625|NCT00205699|584079109|FG002|Overall Study|Adverse Event|0|||
161737626|NCT00205699|584079107|FG000|Overall Study|Withdrawal by Subject|1|||
161737627|NCT00205699|584079108|FG001|Overall Study|Withdrawal by Subject|2|||
161737628|NCT00205699|584079109|FG002|Overall Study|Withdrawal by Subject|1|||
161737629|NCT00205699|584079107|FG000|Overall Study|Lack of Efficacy|0|||
161737630|NCT00205699|584079108|FG001|Overall Study|Lack of Efficacy|1|||
161737631|NCT00205699|584079109|FG002|Overall Study|Lack of Efficacy|0|||
161737632|NCT01754922|584079111|FG000|Overall Study|Adverse Event|0|||
161737633|NCT01754922|584079112|FG001|Overall Study|Adverse Event|1|||
161737634|NCT01207388|584079115|FG000|Overall Study|Death|67|||
161737635|NCT01207388|584079115|FG000|Overall Study|Withdrawal by Subject|1|||
161737636|NCT01885078|584079116|FG000|Treatment Period|Adverse Event|52|||
161737637|NCT01885078|584079117|FG001|Treatment Period|Adverse Event|136|||
161737638|NCT01885078|584079118|FG002|Treatment Period|Adverse Event|30|||
161737639|NCT01885078|584079119|FG003|Treatment Period|Adverse Event|73|||
161737640|NCT01885078|584079120|FG004|Treatment Period|Adverse Event|17|||
161737641|NCT01885078|584079121|FG005|Treatment Period|Adverse Event|72|||
161737642|NCT01885078|584079122|FG006|Treatment Period|Adverse Event|24|||
161737643|NCT01885078|584079123|FG007|Treatment Period|Adverse Event|5|||
161737644|NCT01885078|584079124|FG008|Treatment Period|Adverse Event|0|||
161737645|NCT01885078|584079125|FG009|Treatment Period|Adverse Event|0|||
161737646|NCT01885078|584079116|FG000|Treatment Period|Death|13|||
161737647|NCT01885078|584079117|FG001|Treatment Period|Death|33|||
161737648|NCT01885078|584079118|FG002|Treatment Period|Death|5|||
161737649|NCT01885078|584079119|FG003|Treatment Period|Death|9|||
161737650|NCT01885078|584079120|FG004|Treatment Period|Death|2|||
161737651|NCT01885078|584079121|FG005|Treatment Period|Death|10|||
161737652|NCT01885078|584079122|FG006|Treatment Period|Death|3|||
161737653|NCT01885078|584079123|FG007|Treatment Period|Death|2|||
161737654|NCT01885078|584079124|FG008|Treatment Period|Death|0|||
161737655|NCT01885078|584079125|FG009|Treatment Period|Death|0|||
161737656|NCT01885078|584079116|FG000|Treatment Period|Lack of Efficacy|12|||
161737657|NCT01885078|584079117|FG001|Treatment Period|Lack of Efficacy|33|||
161737658|NCT01885078|584079118|FG002|Treatment Period|Lack of Efficacy|10|||
161737659|NCT01885078|584079119|FG003|Treatment Period|Lack of Efficacy|23|||
161737660|NCT01885078|584079120|FG004|Treatment Period|Lack of Efficacy|24|||
161737661|NCT01885078|584079121|FG005|Treatment Period|Lack of Efficacy|58|||
161737662|NCT01885078|584079122|FG006|Treatment Period|Lack of Efficacy|9|||
161737663|NCT01885078|584079123|FG007|Treatment Period|Lack of Efficacy|5|||
161737664|NCT01885078|584079124|FG008|Treatment Period|Lack of Efficacy|0|||
161737665|NCT01885078|584079125|FG009|Treatment Period|Lack of Efficacy|0|||
161737666|NCT01885078|584079116|FG000|Treatment Period|Lost to Follow-up|16|||
161737667|NCT01885078|584079117|FG001|Treatment Period|Lost to Follow-up|19|||
161737668|NCT01885078|584079118|FG002|Treatment Period|Lost to Follow-up|7|||
161737669|NCT01885078|584079119|FG003|Treatment Period|Lost to Follow-up|9|||
161737670|NCT01885078|584079120|FG004|Treatment Period|Lost to Follow-up|2|||
161737671|NCT01885078|584079121|FG005|Treatment Period|Lost to Follow-up|8|||
161737672|NCT01885078|584079122|FG006|Treatment Period|Lost to Follow-up|2|||
161737673|NCT01885078|584079123|FG007|Treatment Period|Lost to Follow-up|0|||
161737674|NCT01885078|584079124|FG008|Treatment Period|Lost to Follow-up|0|||
161737675|NCT01885078|584079125|FG009|Treatment Period|Lost to Follow-up|0|||
161737676|NCT01885078|584079116|FG000|Treatment Period|Physician Decision|19|||
161737677|NCT01885078|584079117|FG001|Treatment Period|Physician Decision|21|||
161737678|NCT01885078|584079118|FG002|Treatment Period|Physician Decision|5|||
161737679|NCT01885078|584079119|FG003|Treatment Period|Physician Decision|12|||
161737680|NCT01885078|584079120|FG004|Treatment Period|Physician Decision|9|||
161737681|NCT01885078|584079121|FG005|Treatment Period|Physician Decision|24|||
161737682|NCT01885078|584079122|FG006|Treatment Period|Physician Decision|4|||
161737683|NCT01885078|584079123|FG007|Treatment Period|Physician Decision|3|||
161737684|NCT01885078|584079124|FG008|Treatment Period|Physician Decision|0|||
161737685|NCT01885078|584079125|FG009|Treatment Period|Physician Decision|0|||
161737686|NCT01885078|584079116|FG000|Treatment Period|Protocol Violation|3|||
161737687|NCT01885078|584079117|FG001|Treatment Period|Protocol Violation|5|||
161737688|NCT01885078|584079118|FG002|Treatment Period|Protocol Violation|0|||
161737689|NCT01885078|584079119|FG003|Treatment Period|Protocol Violation|3|||
161737690|NCT01885078|584079120|FG004|Treatment Period|Protocol Violation|1|||
161737691|NCT01885078|584079121|FG005|Treatment Period|Protocol Violation|6|||
161737692|NCT01885078|584079122|FG006|Treatment Period|Protocol Violation|0|||
161737693|NCT01885078|584079123|FG007|Treatment Period|Protocol Violation|0|||
161737694|NCT01885078|584079124|FG008|Treatment Period|Protocol Violation|0|||
161737695|NCT01885078|584079125|FG009|Treatment Period|Protocol Violation|0|||
161737696|NCT01885078|584079116|FG000|Treatment Period|Sponsor Decision|245|||
161737697|NCT01885078|584079117|FG001|Treatment Period|Sponsor Decision|648|||
161737698|NCT01885078|584079118|FG002|Treatment Period|Sponsor Decision|49|||
161737699|NCT01885078|584079119|FG003|Treatment Period|Sponsor Decision|90|||
161737700|NCT01885078|584079120|FG004|Treatment Period|Sponsor Decision|20|||
161737701|NCT01885078|584079121|FG005|Treatment Period|Sponsor Decision|38|||
161737702|NCT01885078|584079122|FG006|Treatment Period|Sponsor Decision|162|||
161737703|NCT01885078|584079123|FG007|Treatment Period|Sponsor Decision|3|||
161737704|NCT01885078|584079124|FG008|Treatment Period|Sponsor Decision|0|||
161737705|NCT01885078|584079125|FG009|Treatment Period|Sponsor Decision|0|||
161737706|NCT01885078|584079116|FG000|Treatment Period|Withdrawal by Subject|72|||
161737707|NCT01885078|584079117|FG001|Treatment Period|Withdrawal by Subject|132|||
161737708|NCT01885078|584079118|FG002|Treatment Period|Withdrawal by Subject|25|||
161737709|NCT01885078|584079119|FG003|Treatment Period|Withdrawal by Subject|63|||
161737710|NCT01885078|584079120|FG004|Treatment Period|Withdrawal by Subject|15|||
161737711|NCT01885078|584079121|FG005|Treatment Period|Withdrawal by Subject|34|||
161737712|NCT01885078|584079122|FG006|Treatment Period|Withdrawal by Subject|17|||
161737713|NCT01885078|584079123|FG007|Treatment Period|Withdrawal by Subject|10|||
161737714|NCT01885078|584079124|FG008|Treatment Period|Withdrawal by Subject|0|||
161737715|NCT01885078|584079125|FG009|Treatment Period|Withdrawal by Subject|0|||
161737716|NCT01885078|584079116|FG000|Treatment Period|Other|0|||
161737717|NCT01885078|584079117|FG001|Treatment Period|Other|0|||
161737718|NCT01885078|584079118|FG002|Treatment Period|Other|0|||
161737719|NCT01885078|584079119|FG003|Treatment Period|Other|1|||
161737720|NCT01885078|584079120|FG004|Treatment Period|Other|0|||
161737721|NCT01885078|584079121|FG005|Treatment Period|Other|0|||
162032431|NCT02545543|585175484|FG001|Overall Study|Noncomplaince|0|||
162032432|NCT02545543|585175483|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
161737722|NCT01885078|584079122|FG006|Treatment Period|Other|0|||
161737723|NCT01885078|584079123|FG007|Treatment Period|Other|0|||
161737724|NCT01885078|584079124|FG008|Treatment Period|Other|0|||
161737725|NCT01885078|584079125|FG009|Treatment Period|Other|0|||
161737726|NCT01885078|584079116|FG000|Step-down Period|Sponsor Decision|0|||
161737727|NCT01885078|584079117|FG001|Step-down Period|Sponsor Decision|0|||
161737728|NCT01885078|584079118|FG002|Step-down Period|Sponsor Decision|0|||
161737729|NCT01885078|584079119|FG003|Step-down Period|Sponsor Decision|0|||
161737730|NCT01885078|584079120|FG004|Step-down Period|Sponsor Decision|0|||
161737731|NCT01885078|584079121|FG005|Step-down Period|Sponsor Decision|0|||
161737732|NCT01885078|584079122|FG006|Step-down Period|Sponsor Decision|0|||
161737733|NCT01885078|584079123|FG007|Step-down Period|Sponsor Decision|0|||
161737734|NCT01885078|584079124|FG008|Step-down Period|Sponsor Decision|1|||
161737735|NCT01885078|584079125|FG009|Step-down Period|Sponsor Decision|1|||
161737736|NCT01885078|584079116|FG000|Step-down Period|Adverse Event|0|||
161737737|NCT01885078|584079117|FG001|Step-down Period|Adverse Event|0|||
161737738|NCT01885078|584079118|FG002|Step-down Period|Adverse Event|0|||
161737739|NCT01885078|584079119|FG003|Step-down Period|Adverse Event|0|||
161737740|NCT01885078|584079120|FG004|Step-down Period|Adverse Event|0|||
161737741|NCT01885078|584079121|FG005|Step-down Period|Adverse Event|0|||
161737742|NCT01885078|584079122|FG006|Step-down Period|Adverse Event|0|||
161737743|NCT01885078|584079123|FG007|Step-down Period|Adverse Event|0|||
161737744|NCT01885078|584079124|FG008|Step-down Period|Adverse Event|29|||
161737745|NCT01885078|584079125|FG009|Step-down Period|Adverse Event|38|||
161737746|NCT01885078|584079116|FG000|Step-down Period|Withdrawal by Subject|0|||
162032433|NCT02545543|585175484|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
161737747|NCT01885078|584079117|FG001|Step-down Period|Withdrawal by Subject|0|||
161737748|NCT01885078|584079118|FG002|Step-down Period|Withdrawal by Subject|0|||
161737749|NCT01885078|584079119|FG003|Step-down Period|Withdrawal by Subject|0|||
161737750|NCT01885078|584079120|FG004|Step-down Period|Withdrawal by Subject|0|||
161737751|NCT01885078|584079121|FG005|Step-down Period|Withdrawal by Subject|0|||
161966060|NCT02602275|584921979|FG001|Day 1|Physician Decision|1|||
161966061|NCT02241733|584921980|FG000|Overall Study|Lost to Follow-up|9|||
161966062|NCT02241733|584921981|FG001|Overall Study|Lost to Follow-up|4|||
161966063|NCT02241733|584921980|FG000|Overall Study|Physician Decision|6|||
161737752|NCT01885078|584079122|FG006|Step-down Period|Withdrawal by Subject|0|||
161737753|NCT01885078|584079123|FG007|Step-down Period|Withdrawal by Subject|0|||
161737754|NCT01885078|584079124|FG008|Step-down Period|Withdrawal by Subject|25|||
161737755|NCT01885078|584079125|FG009|Step-down Period|Withdrawal by Subject|15|||
161737756|NCT01885078|584079116|FG000|Step-down Period|Physician Decision|0|||
161737757|NCT01885078|584079117|FG001|Step-down Period|Physician Decision|0|||
161737758|NCT01885078|584079118|FG002|Step-down Period|Physician Decision|0|||
161737759|NCT01885078|584079119|FG003|Step-down Period|Physician Decision|0|||
161737760|NCT01885078|584079120|FG004|Step-down Period|Physician Decision|0|||
161737761|NCT01885078|584079121|FG005|Step-down Period|Physician Decision|0|||
161737762|NCT01885078|584079122|FG006|Step-down Period|Physician Decision|0|||
161737763|NCT01885078|584079123|FG007|Step-down Period|Physician Decision|0|||
161737764|NCT01885078|584079124|FG008|Step-down Period|Physician Decision|7|||
161737765|NCT01885078|584079125|FG009|Step-down Period|Physician Decision|2|||
161737766|NCT01885078|584079116|FG000|Step-down Period|Death|0|||
161737767|NCT01885078|584079117|FG001|Step-down Period|Death|0|||
161737768|NCT01885078|584079118|FG002|Step-down Period|Death|0|||
161737769|NCT01885078|584079119|FG003|Step-down Period|Death|0|||
161737770|NCT01885078|584079120|FG004|Step-down Period|Death|0|||
161737771|NCT01885078|584079121|FG005|Step-down Period|Death|0|||
161737772|NCT01885078|584079122|FG006|Step-down Period|Death|0|||
161737773|NCT01885078|584079123|FG007|Step-down Period|Death|0|||
161737774|NCT01885078|584079124|FG008|Step-down Period|Death|4|||
161737775|NCT01885078|584079125|FG009|Step-down Period|Death|3|||
161737776|NCT01885078|584079116|FG000|Step-down Period|Lost to Follow-up|0|||
161737777|NCT01885078|584079117|FG001|Step-down Period|Lost to Follow-up|0|||
161737778|NCT01885078|584079118|FG002|Step-down Period|Lost to Follow-up|0|||
161737779|NCT01885078|584079119|FG003|Step-down Period|Lost to Follow-up|0|||
161737780|NCT01885078|584079120|FG004|Step-down Period|Lost to Follow-up|0|||
161737781|NCT01885078|584079121|FG005|Step-down Period|Lost to Follow-up|0|||
161737782|NCT01885078|584079122|FG006|Step-down Period|Lost to Follow-up|0|||
161737783|NCT01885078|584079123|FG007|Step-down Period|Lost to Follow-up|0|||
161737784|NCT01885078|584079124|FG008|Step-down Period|Lost to Follow-up|1|||
161737785|NCT01885078|584079125|FG009|Step-down Period|Lost to Follow-up|1|||
161737786|NCT01885078|584079116|FG000|Step-down Period|Lack of Efficacy|0|||
161737787|NCT01885078|584079117|FG001|Step-down Period|Lack of Efficacy|0|||
161737788|NCT01885078|584079118|FG002|Step-down Period|Lack of Efficacy|0|||
161737789|NCT01885078|584079119|FG003|Step-down Period|Lack of Efficacy|0|||
161737790|NCT01885078|584079120|FG004|Step-down Period|Lack of Efficacy|0|||
161737791|NCT01885078|584079121|FG005|Step-down Period|Lack of Efficacy|0|||
161737792|NCT01885078|584079122|FG006|Step-down Period|Lack of Efficacy|0|||
161737793|NCT01885078|584079123|FG007|Step-down Period|Lack of Efficacy|0|||
161737794|NCT01885078|584079124|FG008|Step-down Period|Lack of Efficacy|1|||
161737795|NCT01885078|584079125|FG009|Step-down Period|Lack of Efficacy|0|||
161737796|NCT01885078|584079116|FG000|Step-down Period|Protocol Violation|0|||
161966064|NCT02241733|584921981|FG001|Overall Study|Physician Decision|2|||
161966065|NCT02241733|584921980|FG000|Overall Study|Withdrawal by Subject|0|||
161966066|NCT02241733|584921981|FG001|Overall Study|Withdrawal by Subject|2|||
161966067|NCT02241733|584921980|FG000|Overall Study|Death|0|||
161966068|NCT02241733|584921981|FG001|Overall Study|Death|2|||
161737797|NCT01885078|584079117|FG001|Step-down Period|Protocol Violation|0|||
161737798|NCT01885078|584079118|FG002|Step-down Period|Protocol Violation|0|||
161737799|NCT01885078|584079119|FG003|Step-down Period|Protocol Violation|0|||
161737800|NCT01885078|584079120|FG004|Step-down Period|Protocol Violation|0|||
161737801|NCT01885078|584079121|FG005|Step-down Period|Protocol Violation|0|||
161737802|NCT01885078|584079122|FG006|Step-down Period|Protocol Violation|0|||
161737803|NCT01885078|584079123|FG007|Step-down Period|Protocol Violation|0|||
161737804|NCT01885078|584079124|FG008|Step-down Period|Protocol Violation|1|||
161737805|NCT01885078|584079125|FG009|Step-down Period|Protocol Violation|1|||
161737806|NCT02680587|584079126|FG000|Overall Study|Withdrawal by Subject|1|||
161737807|NCT02680587|584079127|FG001|Overall Study|Withdrawal by Subject|0|||
161737808|NCT00571688|584079131|FG000|Overall Study|Lost to Follow-up|3|||
161737809|NCT00571688|584079132|FG001|Overall Study|Lost to Follow-up|6|||
161737810|NCT00571688|584079131|FG000|Overall Study|subject did not tolerate Consta|1|||
161737811|NCT00571688|584079132|FG001|Overall Study|subject did not tolerate Consta|0|||
161737812|NCT00571688|584079131|FG000|Overall Study|subject moved out of the area|1|||
161737813|NCT00571688|584079132|FG001|Overall Study|subject moved out of the area|0|||
161737814|NCT01194869|584079133|FG000|Overall Study|Disease Progression|2|||
161737815|NCT01194869|584079133|FG000|Overall Study|Toxicity|2|||
161966069|NCT01866111|584921984|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
161737816|NCT00259740|584079137|FG000|Overall Study|Physician Decision|1|||
161737817|NCT00259740|584079138|FG001|Overall Study|Physician Decision|1|||
161737818|NCT00259740|584079137|FG000|Overall Study|Adverse Event|0|||
161737819|NCT00259740|584079138|FG001|Overall Study|Adverse Event|2|||
161737820|NCT00259740|584079137|FG000|Overall Study|Withdrawal by Subject|2|||
161737821|NCT00259740|584079138|FG001|Overall Study|Withdrawal by Subject|6|||
161737822|NCT00259740|584079137|FG000|Overall Study|Death|1|||
161737823|NCT00259740|584079138|FG001|Overall Study|Death|1|||
161737824|NCT00259740|584079137|FG000|Overall Study|Disease progression|19|||
161737825|NCT00259740|584079138|FG001|Overall Study|Disease progression|36|||
161737826|NCT00259740|584079137|FG000|Overall Study|Ongoing|17|||
161737827|NCT00259740|584079138|FG001|Overall Study|Ongoing|3|||
161737828|NCT00259740|584079137|FG000|Overall Study|Other|3|||
161737829|NCT00259740|584079138|FG001|Overall Study|Other|0|||
161737830|NCT00259740|584079137|FG000|Overall Study|Requirement for alternative therapy|0|||
161737831|NCT00259740|584079138|FG001|Overall Study|Requirement for alternative therapy|4|||
161737832|NCT01844830|584079143|FG000|Overall Study|Withdrawal by Subject|1|||
161737833|NCT01844830|584079144|FG001|Overall Study|Withdrawal by Subject|0|||
161737834|NCT04735393|584079148|FG000|Overall Study|Lost to Follow-up|46|||
161737835|NCT04735393|584079149|FG001|Overall Study|Lost to Follow-up|24|||
161737836|NCT04735393|584079148|FG000|Overall Study|Physician Decision|2|||
161737837|NCT04735393|584079149|FG001|Overall Study|Physician Decision|1|||
161737838|NCT04735393|584079148|FG000|Overall Study|Not Detailed|1|||
161737839|NCT04735393|584079149|FG001|Overall Study|Not Detailed|2|||
161737840|NCT04735393|584079148|FG000|Overall Study|Withdrawal by Subject|71|||
161737841|NCT04735393|584079149|FG001|Overall Study|Withdrawal by Subject|28|||
161737842|NCT04735393|584079148|FG000|Overall Study|Adverse Event|56|||
161737843|NCT04735393|584079149|FG001|Overall Study|Adverse Event|7|||
161737844|NCT04735393|584079148|FG000|Overall Study|Protocol Violation|6|||
161737845|NCT04735393|584079149|FG001|Overall Study|Protocol Violation|1|||
161737846|NCT04735393|584079148|FG000|Overall Study|Trial terminated by Sponsor|49|||
161737847|NCT04735393|584079149|FG001|Overall Study|Trial terminated by Sponsor|29|||
161737848|NCT00209170|584079150|FG000|Overall Study|Adverse Event|0|||
161737849|NCT00209170|584079151|FG001|Overall Study|Adverse Event|1|||
161737850|NCT00209170|584079150|FG000|Overall Study|Withdrawal by Subject|2|||
161737851|NCT00209170|584079151|FG001|Overall Study|Withdrawal by Subject|1|||
161737852|NCT00209170|584079150|FG000|Overall Study|Lack of Efficacy|0|||
161737853|NCT00209170|584079151|FG001|Overall Study|Lack of Efficacy|1|||
161737854|NCT03224104|584079155|FG000|Overall Study|Lack of Efficacy|2|||
161737855|NCT03224104|584079156|FG001|Overall Study|Lack of Efficacy|6|||
161737856|NCT03224104|584079157|FG002|Overall Study|Lack of Efficacy|3|||
161737857|NCT03224104|584079158|FG003|Overall Study|Lack of Efficacy|4|||
161737858|NCT03224104|584079159|FG004|Overall Study|Lack of Efficacy|42|||
161737859|NCT03224104|584079155|FG000|Overall Study|Withdrawal by Subject|0|||
161737860|NCT03224104|584079156|FG001|Overall Study|Withdrawal by Subject|2|||
161737861|NCT03224104|584079157|FG002|Overall Study|Withdrawal by Subject|0|||
161737862|NCT03224104|584079158|FG003|Overall Study|Withdrawal by Subject|1|||
161737863|NCT03224104|584079159|FG004|Overall Study|Withdrawal by Subject|3|||
161737864|NCT03224104|584079155|FG000|Overall Study|Death|0|||
161737865|NCT03224104|584079156|FG001|Overall Study|Death|1|||
161737866|NCT03224104|584079157|FG002|Overall Study|Death|0|||
161737867|NCT03224104|584079158|FG003|Overall Study|Death|0|||
161737868|NCT03224104|584079159|FG004|Overall Study|Death|0|||
161737869|NCT03224104|584079155|FG000|Overall Study|Adverse Event|1|||
161737870|NCT03224104|584079156|FG001|Overall Study|Adverse Event|0|||
161737871|NCT03224104|584079157|FG002|Overall Study|Adverse Event|0|||
161737872|NCT03224104|584079158|FG003|Overall Study|Adverse Event|1|||
161737873|NCT03224104|584079159|FG004|Overall Study|Adverse Event|3|||
161737874|NCT03224104|584079155|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
161737875|NCT03224104|584079156|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
161737876|NCT03224104|584079157|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
161737877|NCT03224104|584079158|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
161737878|NCT03224104|584079159|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
161737879|NCT03224104|584079155|FG000|Overall Study|Treatment ongoing|0|||
161737880|NCT03224104|584079156|FG001|Overall Study|Treatment ongoing|0|||
161737881|NCT03224104|584079157|FG002|Overall Study|Treatment ongoing|0|||
161737882|NCT03224104|584079158|FG003|Overall Study|Treatment ongoing|0|||
161737883|NCT03224104|584079159|FG004|Overall Study|Treatment ongoing|1|||
161737884|NCT04397718|584079160|FG000|Overall Study|Death|7|||
161737885|NCT04397718|584079161|FG001|Overall Study|Death|11|||
161737886|NCT04397718|584079160|FG000|Overall Study|Lost to Follow-up|0|||
161737887|NCT04397718|584079161|FG001|Overall Study|Lost to Follow-up|4|||
161840496|NCT00446199|584460571|FG002|Overall Study|Non-compliant with study drug|5|||
161737888|NCT06087328|584079162|FG000|28-Day Treatment|Lost to Follow-up|7|||
161737889|NCT06087328|584079163|FG001|28-Day Treatment|Lost to Follow-up|3|||
161737890|NCT06087328|584079164|FG002|28-Day Treatment|Lost to Follow-up|4|||
161737891|NCT06087328|584079162|FG000|1-month Follow-up|Lost to Follow-up|0|||
161737892|NCT06087328|584079163|FG001|1-month Follow-up|Lost to Follow-up|1|||
161737893|NCT06087328|584079164|FG002|1-month Follow-up|Lost to Follow-up|1|||
161737894|NCT01778127|584079167|FG000|Overall Study|Lost to Follow-up|5|||
161737895|NCT01778127|584079168|FG001|Overall Study|Lost to Follow-up|1|||
161737896|NCT01778127|584079169|FG002|Overall Study|Lost to Follow-up|2|||
161737897|NCT01778127|584079167|FG000|Overall Study|Withdrawal by Subject|3|||
161737898|NCT01778127|584079168|FG001|Overall Study|Withdrawal by Subject|1|||
161737899|NCT01778127|584079169|FG002|Overall Study|Withdrawal by Subject|4|||
161737900|NCT01348425|584079170|FG000|Overall Study|Imaging was not taken.|1|||
161737901|NCT01348425|584079171|FG001|Overall Study|Imaging was not taken.|1|||
161737902|NCT01968954|584079181|FG000|Overall Study|Adverse Event|6|||
161737903|NCT01968954|584079182|FG001|Overall Study|Adverse Event|3|||
161737904|NCT01968954|584079181|FG000|Overall Study|Death|1|||
161737905|NCT01968954|584079182|FG001|Overall Study|Death|2|||
161737906|NCT01968954|584079181|FG000|Overall Study|Lost to Follow-up|6|||
161737907|NCT01968954|584079182|FG001|Overall Study|Lost to Follow-up|4|||
161737908|NCT01968954|584079181|FG000|Overall Study|Withdrawal by Subject|20|||
161737909|NCT01968954|584079182|FG001|Overall Study|Withdrawal by Subject|23|||
161737910|NCT01968954|584079181|FG000|Overall Study|Other|7|||
161737911|NCT01968954|584079182|FG001|Overall Study|Other|8|||
161737912|NCT01968954|584079181|FG000|Overall Study|Protocol Violation|0|||
161737913|NCT01968954|584079182|FG001|Overall Study|Protocol Violation|1|||
161737914|NCT01968954|584079181|FG000|Overall Study|Did not met inclusion criteria|0|||
161737915|NCT01968954|584079182|FG001|Overall Study|Did not met inclusion criteria|2|||
161737916|NCT00645567|584079185|FG000|Overall Study|Adverse Event|1|||
161737917|NCT00255086|584079189|FG000|Overall Study|Adverse Event|1|||
161737918|NCT00255086|584079190|FG001|Overall Study|Adverse Event|1|||
161737919|NCT00255086|584079189|FG000|Overall Study|Protocol Violation|1|||
161737920|NCT00255086|584079190|FG001|Overall Study|Protocol Violation|1|||
161737921|NCT00434122|584079191|FG000|Overall Study|Non-compliance with protocol|0|||
161737922|NCT00434122|584079192|FG001|Overall Study|Non-compliance with protocol|1|||
161737923|NCT00434122|584079191|FG000|Overall Study|loss of subject contact|1|||
161737924|NCT00434122|584079192|FG001|Overall Study|loss of subject contact|1|||
161737925|NCT00434122|584079191|FG000|Overall Study|Personal reasons|1|||
161737926|NCT00434122|584079192|FG001|Overall Study|Personal reasons|1|||
161737927|NCT00434122|584079191|FG000|Overall Study|Large follicle size|2|||
161737928|NCT00434122|584079192|FG001|Overall Study|Large follicle size|2|||
161737929|NCT00434122|584079191|FG000|Overall Study|Low follicular response.|1|||
161737930|NCT00434122|584079192|FG001|Overall Study|Low follicular response.|2|||
161737931|NCT00434122|584079191|FG000|Overall Study|Travelling of subject.|1|||
161737932|NCT00434122|584079192|FG001|Overall Study|Travelling of subject.|0|||
161737933|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
161737934|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
161737935|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
161737936|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
161737937|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
161737938|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
161737939|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
161737940|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
161737941|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
161737942|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
161737943|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
161737944|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
161737945|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161737946|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161737947|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
161737948|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161737949|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161840497|NCT00446199|584460572|FG003|Overall Study|Non-compliant with study drug|0|||
161966070|NCT01866111|584921985|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
161737950|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161737951|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
161737952|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
161737953|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
161737954|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
161737955|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
161737956|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
161737957|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
161737958|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
161737959|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
161737960|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
161737961|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
161737962|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
161737963|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161737964|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161737965|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161737966|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
161737967|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161737968|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161737969|NCT01963208|584079193|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161737970|NCT01963208|584079194|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161737971|NCT01963208|584079195|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161737972|NCT01963208|584079196|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
161737973|NCT01963208|584079197|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161737974|NCT01963208|584079198|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161737975|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
161737976|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
161737977|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
161737978|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
161737979|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
161737980|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
161737981|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
161737982|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
161737983|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
161737984|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
161737985|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
161737986|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
161737987|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161737988|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161737989|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161737990|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161737991|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161737992|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
161737993|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161737994|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161737995|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161737996|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161737997|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161737998|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
161737999|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
161738000|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
161738001|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
161738002|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
161738003|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
161738004|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
161738005|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
161738006|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
161738007|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
161738008|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
161738009|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
161738010|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
161738011|NCT01963208|584079193|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
161738012|NCT01963208|584079194|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
161738013|NCT01963208|584079195|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
161738014|NCT01963208|584079196|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
161738015|NCT01963208|584079197|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
161738016|NCT01963208|584079198|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
161738017|NCT00438399|584079199|FG000|Overall Study|Lost to Follow-up|2|||
161738018|NCT00438399|584079200|FG001|Overall Study|Lost to Follow-up|2|||
161738019|NCT00438399|584079201|FG002|Overall Study|Lost to Follow-up|1|||
161738020|NCT00438399|584079202|FG003|Overall Study|Lost to Follow-up|1|||
161840498|NCT00446199|584460569|FG000|Overall Study|Non-compliant with visit schedule|1|||
161840499|NCT00446199|584460570|FG001|Overall Study|Non-compliant with visit schedule|1|||
161840500|NCT00446199|584460571|FG002|Overall Study|Non-compliant with visit schedule|1|||
162032434|NCT00811642|585175489|FG000|Overall Study|Adverse Event|3|||
161738021|NCT00438399|584079203|FG004|Overall Study|Lost to Follow-up|1|||
161738022|NCT00438399|584079204|FG005|Overall Study|Lost to Follow-up|1|||
161738023|NCT00438399|584079199|FG000|Overall Study|Adverse Event|0|||
161738024|NCT00438399|584079200|FG001|Overall Study|Adverse Event|0|||
161738025|NCT00438399|584079201|FG002|Overall Study|Adverse Event|1|||
161738026|NCT00438399|584079202|FG003|Overall Study|Adverse Event|1|||
161738027|NCT00438399|584079203|FG004|Overall Study|Adverse Event|0|||
161738028|NCT00438399|584079204|FG005|Overall Study|Adverse Event|1|||
161738029|NCT00438399|584079199|FG000|Overall Study|Withdrawal by Subject|5|||
161738030|NCT00438399|584079200|FG001|Overall Study|Withdrawal by Subject|6|||
161738031|NCT00438399|584079201|FG002|Overall Study|Withdrawal by Subject|3|||
161738032|NCT00438399|584079202|FG003|Overall Study|Withdrawal by Subject|2|||
161738033|NCT00438399|584079203|FG004|Overall Study|Withdrawal by Subject|2|||
161738034|NCT00438399|584079204|FG005|Overall Study|Withdrawal by Subject|2|||
161738035|NCT00438399|584079199|FG000|Overall Study|Protocol Violation|0|||
161738036|NCT00438399|584079200|FG001|Overall Study|Protocol Violation|0|||
161738037|NCT00438399|584079201|FG002|Overall Study|Protocol Violation|1|||
161738038|NCT00438399|584079202|FG003|Overall Study|Protocol Violation|0|||
161738039|NCT00438399|584079203|FG004|Overall Study|Protocol Violation|0|||
161738040|NCT00438399|584079204|FG005|Overall Study|Protocol Violation|1|||
161738041|NCT00438399|584079199|FG000|Overall Study|Subje stopped study|0|||
161738042|NCT00438399|584079200|FG001|Overall Study|Subje stopped study|0|||
161738043|NCT00438399|584079201|FG002|Overall Study|Subje stopped study|1|||
161738044|NCT00438399|584079202|FG003|Overall Study|Subje stopped study|0|||
161738045|NCT00438399|584079203|FG004|Overall Study|Subje stopped study|0|||
161738046|NCT00438399|584079204|FG005|Overall Study|Subje stopped study|0|||
161738047|NCT00438399|584079199|FG000|Overall Study|Pregnancy|0|||
161738048|NCT00438399|584079200|FG001|Overall Study|Pregnancy|0|||
161738049|NCT00438399|584079201|FG002|Overall Study|Pregnancy|0|||
161738050|NCT00438399|584079202|FG003|Overall Study|Pregnancy|0|||
161738051|NCT00438399|584079203|FG004|Overall Study|Pregnancy|0|||
161738052|NCT00438399|584079204|FG005|Overall Study|Pregnancy|1|||
161738053|NCT00438399|584079199|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
161738054|NCT00438399|584079200|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
161738055|NCT00438399|584079201|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
161738056|NCT00438399|584079202|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
161738057|NCT00438399|584079203|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
161738058|NCT00438399|584079204|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
161738059|NCT03334396|584079206|FG000|Overall Study|Adverse Event|1|||
161738060|NCT03334396|584079207|FG001|Overall Study|Adverse Event|0|||
161738061|NCT03334396|584079208|FG002|Overall Study|Adverse Event|1|||
161738062|NCT03334396|584079209|FG003|Overall Study|Adverse Event|0|||
161738063|NCT03334396|584079210|FG004|Overall Study|Adverse Event|0|||
161738064|NCT03334396|584079211|FG005|Overall Study|Adverse Event|0|||
161738065|NCT03334396|584079212|FG006|Overall Study|Adverse Event|0|||
161738066|NCT03334396|584079213|FG007|Overall Study|Adverse Event|0|||
161738067|NCT03334396|584079206|FG000|Overall Study|Lack of Efficacy|10|||
161738068|NCT03334396|584079207|FG001|Overall Study|Lack of Efficacy|4|||
161738069|NCT03334396|584079208|FG002|Overall Study|Lack of Efficacy|1|||
161738070|NCT03334396|584079209|FG003|Overall Study|Lack of Efficacy|3|||
161738071|NCT03334396|584079210|FG004|Overall Study|Lack of Efficacy|1|||
161738072|NCT03334396|584079211|FG005|Overall Study|Lack of Efficacy|0|||
161738073|NCT03334396|584079212|FG006|Overall Study|Lack of Efficacy|0|||
161738074|NCT03334396|584079213|FG007|Overall Study|Lack of Efficacy|1|||
161738075|NCT03334396|584079206|FG000|Overall Study|Lost to Follow-up|0|||
161738076|NCT03334396|584079207|FG001|Overall Study|Lost to Follow-up|0|||
161738077|NCT03334396|584079208|FG002|Overall Study|Lost to Follow-up|1|||
161738078|NCT03334396|584079209|FG003|Overall Study|Lost to Follow-up|0|||
161738079|NCT03334396|584079210|FG004|Overall Study|Lost to Follow-up|0|||
161738080|NCT03334396|584079211|FG005|Overall Study|Lost to Follow-up|0|||
161738081|NCT03334396|584079212|FG006|Overall Study|Lost to Follow-up|1|||
161738082|NCT03334396|584079213|FG007|Overall Study|Lost to Follow-up|0|||
161738083|NCT03334396|584079206|FG000|Overall Study|Physician Decision|1|||
161738084|NCT03334396|584079207|FG001|Overall Study|Physician Decision|0|||
161738085|NCT03334396|584079208|FG002|Overall Study|Physician Decision|0|||
161738086|NCT03334396|584079209|FG003|Overall Study|Physician Decision|0|||
161738087|NCT03334396|584079210|FG004|Overall Study|Physician Decision|0|||
161738088|NCT03334396|584079211|FG005|Overall Study|Physician Decision|0|||
161738089|NCT03334396|584079212|FG006|Overall Study|Physician Decision|0|||
161738090|NCT03334396|584079213|FG007|Overall Study|Physician Decision|0|||
161738091|NCT03334396|584079206|FG000|Overall Study|Withdrawal by Subject|10|||
161738092|NCT03334396|584079207|FG001|Overall Study|Withdrawal by Subject|5|||
161738093|NCT03334396|584079208|FG002|Overall Study|Withdrawal by Subject|7|||
161738094|NCT03334396|584079209|FG003|Overall Study|Withdrawal by Subject|2|||
161738095|NCT03334396|584079210|FG004|Overall Study|Withdrawal by Subject|2|||
161738096|NCT03334396|584079211|FG005|Overall Study|Withdrawal by Subject|1|||
161738097|NCT03334396|584079212|FG006|Overall Study|Withdrawal by Subject|2|||
161738098|NCT03334396|584079213|FG007|Overall Study|Withdrawal by Subject|0|||
161738099|NCT03334396|584079206|FG000|Overall Study|Pregnancy|0|||
161738100|NCT03334396|584079207|FG001|Overall Study|Pregnancy|1|||
161738101|NCT03334396|584079208|FG002|Overall Study|Pregnancy|0|||
161738102|NCT03334396|584079209|FG003|Overall Study|Pregnancy|0|||
161738103|NCT03334396|584079210|FG004|Overall Study|Pregnancy|0|||
161966071|NCT01866111|584921986|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
161966072|NCT01866111|584921987|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
161738104|NCT03334396|584079211|FG005|Overall Study|Pregnancy|0|||
161738105|NCT03334396|584079212|FG006|Overall Study|Pregnancy|0|||
161738106|NCT03334396|584079213|FG007|Overall Study|Pregnancy|0|||
161738107|NCT03334396|584079206|FG000|Overall Study|Ineligible|0|||
161738108|NCT03334396|584079207|FG001|Overall Study|Ineligible|1|||
161738109|NCT03334396|584079208|FG002|Overall Study|Ineligible|0|||
161738110|NCT03334396|584079209|FG003|Overall Study|Ineligible|0|||
161738111|NCT03334396|584079210|FG004|Overall Study|Ineligible|0|||
161738112|NCT03334396|584079211|FG005|Overall Study|Ineligible|0|||
161738113|NCT03334396|584079212|FG006|Overall Study|Ineligible|0|||
161738114|NCT03334396|584079213|FG007|Overall Study|Ineligible|0|||
161738115|NCT03334396|584079206|FG000|Overall Study|Started New Job|1|||
161738116|NCT03334396|584079207|FG001|Overall Study|Started New Job|0|||
161738117|NCT03334396|584079208|FG002|Overall Study|Started New Job|0|||
161738118|NCT03334396|584079209|FG003|Overall Study|Started New Job|0|||
161738119|NCT03334396|584079210|FG004|Overall Study|Started New Job|0|||
161738120|NCT03334396|584079211|FG005|Overall Study|Started New Job|0|||
161738121|NCT03334396|584079212|FG006|Overall Study|Started New Job|0|||
161738122|NCT03334396|584079213|FG007|Overall Study|Started New Job|0|||
161738123|NCT03488251|584079215|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
161738124|NCT03488251|584079216|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
161738125|NCT03488251|584079217|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
161738126|NCT03488251|584079218|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
161738127|NCT03488251|584079215|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
161738128|NCT03488251|584079216|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
161738129|NCT03488251|584079217|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
161738130|NCT03488251|584079218|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
161738131|NCT03488251|584079215|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
161738132|NCT03488251|584079216|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
161738133|NCT03488251|584079217|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
161738134|NCT03488251|584079218|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
161738135|NCT03488251|584079215|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
161738136|NCT03488251|584079216|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
161738137|NCT03488251|584079217|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
161738138|NCT03488251|584079218|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
161738139|NCT03488251|584079215|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
161738140|NCT03488251|584079216|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
161738141|NCT03488251|584079217|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
161738142|NCT03488251|584079218|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
161738143|NCT03600714|584079219|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
161738144|NCT00592553|584079221|FG000|Overall Study|Protocol Noncompliance|1|||
161738145|NCT00592553|584079222|FG001|Overall Study|Protocol Noncompliance|0|||
161738146|NCT00592553|584079223|FG002|Overall Study|Protocol Noncompliance|0|||
161738147|NCT03829332|584079224|FG000|Overall Study|Death|225|||
161738148|NCT03829332|584079225|FG001|Overall Study|Death|230|||
161738149|NCT03829332|584079224|FG000|Overall Study|Lost to Follow-up|1|||
161738150|NCT03829332|584079225|FG001|Overall Study|Lost to Follow-up|3|||
161738151|NCT03829332|584079224|FG000|Overall Study|Physician Decision|1|||
161738152|NCT03829332|584079225|FG001|Overall Study|Physician Decision|0|||
161738153|NCT03829332|584079224|FG000|Overall Study|Sponsor Decision|71|||
161738154|NCT03829332|584079225|FG001|Overall Study|Sponsor Decision|72|||
161738155|NCT03829332|584079224|FG000|Overall Study|Withdrawal by Subject|11|||
161738156|NCT03829332|584079225|FG001|Overall Study|Withdrawal by Subject|9|||
161738157|NCT01283997|584081329|FG000|Overall Study|Physician Decision|8|||
161738158|NCT01283997|584081330|FG001|Overall Study|Physician Decision|10|||
161738159|NCT01283997|584081329|FG000|Overall Study|Withdrawal by Subject|3|||
161738160|NCT01283997|584081330|FG001|Overall Study|Withdrawal by Subject|2|||
161738161|NCT01283997|584081329|FG000|Overall Study|Physically unable to continue|0|||
161738162|NCT01283997|584081330|FG001|Overall Study|Physically unable to continue|1|||
161738163|NCT01283997|584081329|FG000|Overall Study|Progressive disease|1|||
161738164|NCT01283997|584081330|FG001|Overall Study|Progressive disease|0|||
161738165|NCT01283997|584081329|FG000|Overall Study|Other|4|||
161738166|NCT01283997|584081330|FG001|Overall Study|Other|4|||
161738167|NCT02109744|584081331|FG000|Overall Study|Death|1|||
161738168|NCT02109744|584081332|FG001|Overall Study|Death|1|||
161738169|NCT02109744|584081331|FG000|Overall Study|no marrow exam|1|||
161738170|NCT02109744|584081332|FG001|Overall Study|no marrow exam|0|||
161738171|NCT04095442|584081336|FG000|Overall Study|Lost to Follow-up|0|||
161738172|NCT04095442|584081337|FG001|Overall Study|Lost to Follow-up|1|||
161738173|NCT04095442|584081336|FG000|Overall Study|Screen failure|1|||
161738174|NCT04095442|584081337|FG001|Overall Study|Screen failure|0|||
161738175|NCT00884221|584081342|FG000|Overall Study|Withdrawal by Subject|0|||
161738176|NCT00884221|584081343|FG001|Overall Study|Withdrawal by Subject|3|||
161738177|NCT00884221|584081342|FG000|Overall Study|Adverse Event|6|||
161738178|NCT00884221|584081343|FG001|Overall Study|Adverse Event|3|||
161738179|NCT00884221|584081342|FG000|Overall Study|Protocol Violation|16|||
161738180|NCT00884221|584081343|FG001|Overall Study|Protocol Violation|13|||
161738181|NCT00884221|584081342|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
161738182|NCT00884221|584081343|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
161738183|NCT00255034|584081344|FG000|Overall Study|Withdrawal by Subject|15|||
161738184|NCT00255034|584081345|FG001|Overall Study|Withdrawal by Subject|38|||
161738185|NCT00424346|584081346|FG000|Core Study|Adverse Event|5|||
161738186|NCT00424346|584081347|FG001|Core Study|Adverse Event|3|||
161738187|NCT00424346|584081348|FG002|Core Study|Adverse Event|1|||
161738188|NCT00424346|584081349|FG003|Core Study|Adverse Event|1|||
161738189|NCT00424346|584081346|FG000|Core Study|Abnormal Laboratory Values|0|||
161738190|NCT00424346|584081347|FG001|Core Study|Abnormal Laboratory Values|1|||
161738191|NCT00424346|584081348|FG002|Core Study|Abnormal Laboratory Values|0|||
161738192|NCT00424346|584081349|FG003|Core Study|Abnormal Laboratory Values|0|||
161738193|NCT00424346|584081346|FG000|Core Study|Lack of Efficacy|1|||
161738194|NCT00424346|584081347|FG001|Core Study|Lack of Efficacy|3|||
161738195|NCT00424346|584081348|FG002|Core Study|Lack of Efficacy|0|||
161738196|NCT00424346|584081349|FG003|Core Study|Lack of Efficacy|4|||
161738197|NCT00424346|584081346|FG000|Core Study|Withdrawal by Subject|1|||
161738198|NCT00424346|584081347|FG001|Core Study|Withdrawal by Subject|0|||
161738199|NCT00424346|584081348|FG002|Core Study|Withdrawal by Subject|0|||
161738200|NCT00424346|584081349|FG003|Core Study|Withdrawal by Subject|2|||
161738201|NCT00424346|584081346|FG000|Core Study|Lost to Follow-up|1|||
161738202|NCT00424346|584081347|FG001|Core Study|Lost to Follow-up|1|||
161738203|NCT00424346|584081348|FG002|Core Study|Lost to Follow-up|0|||
161738204|NCT00424346|584081349|FG003|Core Study|Lost to Follow-up|0|||
161738205|NCT00424346|584081346|FG000|Core Study|Administrative Problems|1|||
161738206|NCT00424346|584081347|FG001|Core Study|Administrative Problems|0|||
161738207|NCT00424346|584081348|FG002|Core Study|Administrative Problems|1|||
161738208|NCT00424346|584081349|FG003|Core Study|Administrative Problems|0|||
161738209|NCT00424346|584081346|FG000|Core Study|Protocol Violation|0|||
161738210|NCT00424346|584081347|FG001|Core Study|Protocol Violation|0|||
161738211|NCT00424346|584081348|FG002|Core Study|Protocol Violation|2|||
161738212|NCT00424346|584081349|FG003|Core Study|Protocol Violation|0|||
161738213|NCT00424346|584081346|FG000|Extension Phase|Adverse Event|0|||
161738214|NCT00424346|584081347|FG001|Extension Phase|Adverse Event|9|||
161738215|NCT00424346|584081348|FG002|Extension Phase|Adverse Event|5|||
161738216|NCT00424346|584081349|FG003|Extension Phase|Adverse Event|4|||
161738217|NCT00424346|584081346|FG000|Extension Phase|Lack of Efficacy|0|||
161738218|NCT00424346|584081347|FG001|Extension Phase|Lack of Efficacy|16|||
161738219|NCT00424346|584081348|FG002|Extension Phase|Lack of Efficacy|14|||
161738220|NCT00424346|584081349|FG003|Extension Phase|Lack of Efficacy|11|||
161738221|NCT00424346|584081346|FG000|Extension Phase|Withdrawal by Subject|0|||
161738222|NCT00424346|584081347|FG001|Extension Phase|Withdrawal by Subject|5|||
161738223|NCT00424346|584081348|FG002|Extension Phase|Withdrawal by Subject|3|||
161738224|NCT00424346|584081349|FG003|Extension Phase|Withdrawal by Subject|4|||
161738225|NCT00424346|584081346|FG000|Extension Phase|Lost to Follow-up|0|||
161738226|NCT00424346|584081347|FG001|Extension Phase|Lost to Follow-up|2|||
161738227|NCT00424346|584081348|FG002|Extension Phase|Lost to Follow-up|0|||
161738228|NCT00424346|584081349|FG003|Extension Phase|Lost to Follow-up|0|||
161738229|NCT00424346|584081346|FG000|Extension Phase|Administrative Problems|0|||
161738230|NCT00424346|584081347|FG001|Extension Phase|Administrative Problems|69|||
161738231|NCT00424346|584081348|FG002|Extension Phase|Administrative Problems|32|||
161738232|NCT00424346|584081349|FG003|Extension Phase|Administrative Problems|35|||
161738233|NCT00424346|584081346|FG000|Extension Phase|Death|0|||
161738234|NCT00424346|584081347|FG001|Extension Phase|Death|0|||
161738235|NCT00424346|584081348|FG002|Extension Phase|Death|0|||
161738236|NCT00424346|584081349|FG003|Extension Phase|Death|1|||
161738237|NCT00424346|584081346|FG000|Extension Phase|Protocol Violation|0|||
161738238|NCT00424346|584081347|FG001|Extension Phase|Protocol Violation|1|||
161738239|NCT00424346|584081348|FG002|Extension Phase|Protocol Violation|1|||
161738240|NCT00424346|584081349|FG003|Extension Phase|Protocol Violation|0|||
161738241|NCT00571519|584081350|FG000|Overall Study|Subject withdrew consent|0|||
161738242|NCT00571519|584081351|FG001|Overall Study|Subject withdrew consent|1|||
161738243|NCT00571519|584081352|FG002|Overall Study|Subject withdrew consent|0|||
161738244|NCT00571519|584081353|FG003|Overall Study|Subject withdrew consent|2|||
161738245|NCT00571519|584081354|FG004|Overall Study|Subject withdrew consent|1|||
161840501|NCT00446199|584460572|FG003|Overall Study|Non-compliant with visit schedule|2|||
161840502|NCT00446199|584460569|FG000|Overall Study|Hormone fear|0|||
162032435|NCT00811642|585175489|FG000|Overall Study|Protocol Violation|1|||
162032436|NCT00811642|585175489|FG000|Overall Study|Death|2|||
161738246|NCT00571519|584081355|FG005|Overall Study|Subject withdrew consent|1|||
161738247|NCT00571519|584081356|FG006|Overall Study|Subject withdrew consent|2|||
161738248|NCT00571519|584081350|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
161840503|NCT00446199|584460570|FG001|Overall Study|Hormone fear|0|||
161738249|NCT00571519|584081351|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
161738250|NCT00571519|584081352|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
161738251|NCT00571519|584081353|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
161738252|NCT00571519|584081354|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
161738253|NCT00571519|584081355|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
161738254|NCT00571519|584081356|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
161738255|NCT00571519|584081350|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
161738256|NCT00571519|584081351|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
161738257|NCT00571519|584081352|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
161738258|NCT00571519|584081353|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
161738259|NCT00571519|584081354|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
161738260|NCT00571519|584081355|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
161738261|NCT00571519|584081356|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
161738262|NCT00571519|584081350|FG000|Overall Study|Termination of study by Sponsor|2|||
161738263|NCT00571519|584081351|FG001|Overall Study|Termination of study by Sponsor|7|||
161738264|NCT00571519|584081352|FG002|Overall Study|Termination of study by Sponsor|10|||
161738265|NCT00571519|584081353|FG003|Overall Study|Termination of study by Sponsor|24|||
161738266|NCT00571519|584081354|FG004|Overall Study|Termination of study by Sponsor|8|||
161738267|NCT00571519|584081355|FG005|Overall Study|Termination of study by Sponsor|9|||
161738268|NCT00571519|584081356|FG006|Overall Study|Termination of study by Sponsor|22|||
161738269|NCT00571519|584081350|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161738270|NCT00571519|584081351|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161738271|NCT00571519|584081352|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
161738272|NCT00571519|584081353|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161738273|NCT00571519|584081354|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161738274|NCT00571519|584081355|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161738275|NCT00571519|584081356|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161738276|NCT03947255|584081358|FG000|Overall Study|Study Closure by Sponsor|2|||
161738277|NCT03947255|584081359|FG001|Overall Study|Study Closure by Sponsor|2|||
161738278|NCT03947255|584081358|FG000|Overall Study|Withdrawal by Subject|2|||
161738279|NCT03947255|584081359|FG001|Overall Study|Withdrawal by Subject|2|||
161738280|NCT03947255|584081358|FG000|Overall Study|Lost to Follow-up|2|||
161738281|NCT03947255|584081359|FG001|Overall Study|Lost to Follow-up|0|||
161738282|NCT03947255|584081358|FG000|Overall Study|Death|0|||
161738283|NCT03947255|584081359|FG001|Overall Study|Death|2|||
161738284|NCT02499575|584081360|FG000|Overall Study|Protocol Violation|0|||
161738285|NCT02499575|584081361|FG001|Overall Study|Protocol Violation|1|||
161738286|NCT05458011|584081362|FG000|DB Period (12 Weeks)|Adverse Event|2|||
161738287|NCT05458011|584081363|FG001|DB Period (12 Weeks)|Adverse Event|1|||
161738288|NCT05458011|584081364|FG002|DB Period (12 Weeks)|Adverse Event|1|||
161738289|NCT05458011|584081362|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
161738290|NCT05458011|584081363|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
161738291|NCT05458011|584081364|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
161738292|NCT05458011|584081362|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
161738293|NCT05458011|584081363|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
161738294|NCT05458011|584081364|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
161738295|NCT05458011|584081362|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
161738296|NCT05458011|584081363|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
161738297|NCT05458011|584081364|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
161738298|NCT05458011|584081362|FG000|OL Period (12 Weeks)|Adverse Event|1|||
161738299|NCT05458011|584081363|FG001|OL Period (12 Weeks)|Adverse Event|2|||
161738300|NCT05458011|584081364|FG002|OL Period (12 Weeks)|Adverse Event|1|||
161738301|NCT05458011|584081362|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
161738302|NCT05458011|584081363|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
161738303|NCT05458011|584081364|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
161738304|NCT02690207|584081372|FG000|Overall Study|Lost to Follow-up|48|||
161738305|NCT02690207|584081372|FG000|Overall Study|Withdrawal by Subject|46|||
161738306|NCT02690207|584081372|FG000|Overall Study|Protocol Violation|2|||
161738307|NCT02690207|584081372|FG000|Overall Study|Serious adverse event|110|||
161738308|NCT02690207|584081372|FG000|Overall Study|Non-serious Adverse Event|18|||
161738309|NCT02690207|584081372|FG000|Overall Study|Migrated/moved from study area|5|||
161738310|NCT02690207|584081372|FG000|Overall Study|Suspected HZ Episode|1|||
161738311|NCT02690207|584081372|FG000|Overall Study|Other reasons for withdrawal|23|||
161738312|NCT04656418|584081375|FG000|Overall Study|Withdrawal by Subject|1|||
161738313|NCT04656418|584081376|FG001|Overall Study|Withdrawal by Subject|3|||
161738314|NCT02586077|584081377|FG000|Overall Study|Withdrawal by Subject|1|||
161738315|NCT02586077|584081377|FG000|Overall Study|Physician Decision|4|||
161840504|NCT00446199|584460571|FG002|Overall Study|Hormone fear|0|||
161840505|NCT00446199|584460572|FG003|Overall Study|Hormone fear|1|||
161840506|NCT00446199|584460569|FG000|Overall Study|Lost interest in study participation|0|||
161840507|NCT00446199|584460570|FG001|Overall Study|Lost interest in study participation|1|||
161840508|NCT00446199|584460571|FG002|Overall Study|Lost interest in study participation|0|||
161966073|NCT01866111|584921984|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
161738316|NCT02586077|584081377|FG000|Overall Study|Lost to Follow-up|3|||
161738317|NCT02701192|584081378|FG000|Overall Study|Protocol Violation|2|||
161738318|NCT02701192|584081378|FG000|Overall Study|Lost to Follow-up|4|||
161738319|NCT01245764|584081380|FG000|Study Phase A|Other|3|||
161738320|NCT01245764|584081381|FG001|Study Phase A|Other|2|||
161840509|NCT00446199|584460572|FG003|Overall Study|Lost interest in study participation|0|||
161738321|NCT01245764|584081382|FG002|Study Phase A|Other|3|||
161738322|NCT01245764|584081383|FG003|Study Phase A|Other|1|||
161738323|NCT01245764|584081380|FG000|Study Phase A|Protocol Violation|6|||
161738324|NCT01245764|584081381|FG001|Study Phase A|Protocol Violation|3|||
161738325|NCT01245764|584081382|FG002|Study Phase A|Protocol Violation|2|||
161738326|NCT01245764|584081383|FG003|Study Phase A|Protocol Violation|2|||
161738327|NCT01245764|584081380|FG000|Study Phase A|Lost to Follow-up|0|||
161738328|NCT01245764|584081381|FG001|Study Phase A|Lost to Follow-up|0|||
161738329|NCT01245764|584081382|FG002|Study Phase A|Lost to Follow-up|5|||
161738330|NCT01245764|584081383|FG003|Study Phase A|Lost to Follow-up|0|||
161738331|NCT00003476|584081384|FG000|Overall Study|Not evaluable|1|||
161738332|NCT02667457|584081387|FG000|Overall Study|Withdrawal by Subject|1|||
161738333|NCT02667457|584081388|FG001|Overall Study|Withdrawal by Subject|0|||
161738334|NCT02667457|584081387|FG000|Overall Study|Other Reason|0|||
161738335|NCT02667457|584081388|FG001|Overall Study|Other Reason|2|||
161738336|NCT02475850|584081389|FG000|Overall Study|Death|155|||
161738337|NCT02475850|584081390|FG001|Overall Study|Death|141|||
161738338|NCT02475850|584081389|FG000|Overall Study|Lost to Follow-up|217|||
161738339|NCT02475850|584081390|FG001|Overall Study|Lost to Follow-up|188|||
161738340|NCT02475850|584081389|FG000|Overall Study|Withdrawal by Subject|221|||
161738341|NCT02475850|584081390|FG001|Overall Study|Withdrawal by Subject|155|||
161738342|NCT03097614|584081392|FG000|Overall Study|Adverse Event|3|||
161738343|NCT03057951|584081398|FG000|Overall Study|Adverse Event|553|||
161738344|NCT03057951|584081399|FG001|Overall Study|Adverse Event|575|||
161738345|NCT03057951|584081398|FG000|Overall Study|Protocol Violation|30|||
161738346|NCT03057951|584081399|FG001|Overall Study|Protocol Violation|24|||
161738347|NCT03057951|584081398|FG000|Overall Study|Lost to Follow-up|6|||
161738348|NCT03057951|584081399|FG001|Overall Study|Lost to Follow-up|16|||
161738349|NCT03057951|584081398|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
161738350|NCT03057951|584081399|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
161738351|NCT03057951|584081398|FG000|Overall Study|Study drug stopped, reason missing|6|||
161738352|NCT03057951|584081399|FG001|Overall Study|Study drug stopped, reason missing|1|||
161738353|NCT03057951|584081398|FG000|Overall Study|Medical advice|6|||
161738354|NCT03057951|584081399|FG001|Overall Study|Medical advice|2|||
161738355|NCT03057951|584081398|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
161738356|NCT03057951|584081399|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
161738357|NCT03057951|584081398|FG000|Overall Study|Investigator decision|2|||
161738358|NCT03057951|584081399|FG001|Overall Study|Investigator decision|0|||
161738359|NCT03057951|584081398|FG000|Overall Study|Patient decision|5|||
161738360|NCT03057951|584081399|FG001|Overall Study|Patient decision|2|||
161738361|NCT03057951|584081398|FG000|Overall Study|Not attending study visits|3|||
161738362|NCT03057951|584081399|FG001|Overall Study|Not attending study visits|0|||
161738363|NCT03057951|584081398|FG000|Overall Study|Patient moved away|3|||
161738364|NCT03057951|584081399|FG001|Overall Study|Patient moved away|4|||
161738365|NCT03057951|584081398|FG000|Overall Study|Other reason than stated above|23|||
161738366|NCT03057951|584081399|FG001|Overall Study|Other reason than stated above|29|||
161738367|NCT03057951|584081398|FG000|Overall Study|Not treated|2|||
161738368|NCT03057951|584081399|FG001|Overall Study|Not treated|1|||
161738369|NCT02700919|584081400|FG000|Overall Study|Physician Decision|1|||
161738370|NCT02700919|584081401|FG001|Overall Study|Physician Decision|0|||
161738371|NCT02700919|584081402|FG002|Overall Study|Physician Decision|0|||
161738372|NCT02700919|584081400|FG000|Overall Study|Protocol Violation|1|||
161738373|NCT02700919|584081401|FG001|Overall Study|Protocol Violation|0|||
161738374|NCT02700919|584081402|FG002|Overall Study|Protocol Violation|0|||
161738375|NCT02700919|584081400|FG000|Overall Study|Adverse Event|1|||
161738376|NCT02700919|584081401|FG001|Overall Study|Adverse Event|3|||
161738377|NCT02700919|584081402|FG002|Overall Study|Adverse Event|1|||
161738378|NCT02700919|584081400|FG000|Overall Study|Withdrawal by Subject|5|||
161738379|NCT02700919|584081401|FG001|Overall Study|Withdrawal by Subject|8|||
161738380|NCT02700919|584081402|FG002|Overall Study|Withdrawal by Subject|2|||
161738381|NCT02700919|584081400|FG000|Overall Study|Lost to Follow-up|2|||
161738382|NCT02700919|584081401|FG001|Overall Study|Lost to Follow-up|0|||
161738383|NCT02700919|584081402|FG002|Overall Study|Lost to Follow-up|0|||
161738384|NCT02700919|584081400|FG000|Overall Study|Other|2|||
161738385|NCT02700919|584081401|FG001|Overall Study|Other|1|||
161738386|NCT02700919|584081402|FG002|Overall Study|Other|1|||
161738387|NCT03434418|584081403|FG000|Overall Study|Disease Progression|11|||
161738388|NCT03434418|584081403|FG000|Overall Study|Adverse Event|2|||
161738389|NCT03434418|584081403|FG000|Overall Study|Physician Decision|1|||
161738390|NCT03434418|584081403|FG000|Overall Study|Decline in Performance Status (PS)|1|||
161738391|NCT00696436|584081405|FG000|Overall Study|Adverse Event|7|||
161840510|NCT00446199|584460569|FG000|Overall Study|In-/Exclusion criterion violated|2|||
161840511|NCT00446199|584460570|FG001|Overall Study|In-/Exclusion criterion violated|1|||
161738392|NCT00696436|584081406|FG001|Overall Study|Adverse Event|9|||
161738393|NCT00696436|584081407|FG002|Overall Study|Adverse Event|8|||
161738394|NCT00696436|584081408|FG003|Overall Study|Adverse Event|6|||
161738395|NCT00696436|584081409|FG004|Overall Study|Adverse Event|4|||
161738396|NCT00696436|584081405|FG000|Overall Study|Protocol Violation|3|||
161738397|NCT00696436|584081406|FG001|Overall Study|Protocol Violation|2|||
161738398|NCT00696436|584081407|FG002|Overall Study|Protocol Violation|2|||
161738399|NCT00696436|584081408|FG003|Overall Study|Protocol Violation|0|||
161738400|NCT00696436|584081409|FG004|Overall Study|Protocol Violation|1|||
161738401|NCT00696436|584081405|FG000|Overall Study|Lost to Follow-up|1|||
161738402|NCT00696436|584081406|FG001|Overall Study|Lost to Follow-up|6|||
161738403|NCT00696436|584081407|FG002|Overall Study|Lost to Follow-up|2|||
161738404|NCT00696436|584081408|FG003|Overall Study|Lost to Follow-up|4|||
161738405|NCT00696436|584081409|FG004|Overall Study|Lost to Follow-up|3|||
161738406|NCT00696436|584081405|FG000|Overall Study|Withdrawal by Subject|4|||
161738407|NCT00696436|584081406|FG001|Overall Study|Withdrawal by Subject|11|||
161738408|NCT00696436|584081407|FG002|Overall Study|Withdrawal by Subject|5|||
161738409|NCT00696436|584081408|FG003|Overall Study|Withdrawal by Subject|7|||
161738410|NCT00696436|584081409|FG004|Overall Study|Withdrawal by Subject|1|||
161738411|NCT00696436|584081405|FG000|Overall Study|Lack of Efficacy|3|||
161738412|NCT00696436|584081406|FG001|Overall Study|Lack of Efficacy|1|||
161738413|NCT00696436|584081407|FG002|Overall Study|Lack of Efficacy|5|||
161738414|NCT00696436|584081408|FG003|Overall Study|Lack of Efficacy|2|||
161738415|NCT00696436|584081409|FG004|Overall Study|Lack of Efficacy|4|||
161738416|NCT00696436|584081405|FG000|Overall Study|Participant Unavailability|2|||
161738417|NCT00696436|584081406|FG001|Overall Study|Participant Unavailability|0|||
161738418|NCT00696436|584081407|FG002|Overall Study|Participant Unavailability|2|||
161738419|NCT00696436|584081408|FG003|Overall Study|Participant Unavailability|1|||
161738420|NCT00696436|584081409|FG004|Overall Study|Participant Unavailability|0|||
161738421|NCT00696436|584081405|FG000|Overall Study|Administrative Error|2|||
161738422|NCT00696436|584081406|FG001|Overall Study|Administrative Error|0|||
161738423|NCT00696436|584081407|FG002|Overall Study|Administrative Error|2|||
161738424|NCT00696436|584081408|FG003|Overall Study|Administrative Error|0|||
161738425|NCT00696436|584081409|FG004|Overall Study|Administrative Error|0|||
161738426|NCT00696436|584081405|FG000|Overall Study|Participant Non-compliance|0|||
161738427|NCT00696436|584081406|FG001|Overall Study|Participant Non-compliance|0|||
161738428|NCT00696436|584081407|FG002|Overall Study|Participant Non-compliance|1|||
161738429|NCT00696436|584081408|FG003|Overall Study|Participant Non-compliance|2|||
161738430|NCT00696436|584081409|FG004|Overall Study|Participant Non-compliance|0|||
161738431|NCT00696436|584081405|FG000|Overall Study|Administrative Decision|1|||
161738432|NCT00696436|584081406|FG001|Overall Study|Administrative Decision|0|||
161738433|NCT00696436|584081407|FG002|Overall Study|Administrative Decision|0|||
161738434|NCT00696436|584081408|FG003|Overall Study|Administrative Decision|0|||
161738435|NCT00696436|584081409|FG004|Overall Study|Administrative Decision|0|||
161738436|NCT00696436|584081405|FG000|Overall Study|Missing|0|||
161738437|NCT00696436|584081406|FG001|Overall Study|Missing|1|||
161738438|NCT00696436|584081407|FG002|Overall Study|Missing|1|||
161738439|NCT00696436|584081408|FG003|Overall Study|Missing|0|||
161738440|NCT00696436|584081409|FG004|Overall Study|Missing|0|||
161738441|NCT03039738|584081411|FG000|Overall Study|Incomplete data sets|54|||
161738442|NCT03039738|584081412|FG001|Overall Study|Incomplete data sets|0|||
161738443|NCT01293006|584081414|FG000|Period 2|Lost to Follow-up|1|||
161738444|NCT01293006|584081415|FG001|Period 2|Lost to Follow-up|0|||
161738445|NCT01293006|584081416|FG002|Period 2|Lost to Follow-up|0|||
161738446|NCT01293006|584081417|FG003|Period 2|Lost to Follow-up|0|||
161738447|NCT01494987|584081418|FG000|Overall Study|Adverse Event|6|||
161738448|NCT01494987|584081419|FG001|Overall Study|Adverse Event|5|||
161738449|NCT01494987|584081418|FG000|Overall Study|Hyperglycemia|6|||
161738450|NCT01494987|584081419|FG001|Overall Study|Hyperglycemia|4|||
161738451|NCT01494987|584081418|FG000|Overall Study|Investigator's Discretion|1|||
161738452|NCT01494987|584081419|FG001|Overall Study|Investigator's Discretion|2|||
161738453|NCT01494987|584081418|FG000|Overall Study|Lost to Follow-up|1|||
161738454|NCT01494987|584081419|FG001|Overall Study|Lost to Follow-up|1|||
161738455|NCT01494987|584081418|FG000|Overall Study|Protocol Violation|3|||
161738456|NCT01494987|584081419|FG001|Overall Study|Protocol Violation|3|||
161738457|NCT01494987|584081418|FG000|Overall Study|Subject Non-Compliance|9|||
161738458|NCT01494987|584081419|FG001|Overall Study|Subject Non-Compliance|10|||
161738459|NCT01494987|584081418|FG000|Overall Study|Subject Withdrew Consent|2|||
161738460|NCT01494987|584081419|FG001|Overall Study|Subject Withdrew Consent|3|||
161738461|NCT00600028|584081422|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161738462|NCT00600028|584081423|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
161738463|NCT00600028|584081422|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
161738464|NCT00600028|584081423|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
161738465|NCT00600028|584081422|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
161738466|NCT00600028|584081423|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
161738467|NCT01830816|584081424|FG000|Overall Study|Progressive Disease|12|||
161738468|NCT01830816|584081425|FG001|Overall Study|Progressive Disease|7|||
161738469|NCT01830816|584081426|FG002|Overall Study|Progressive Disease|7|||
161738470|NCT01830816|584081424|FG000|Overall Study|Adverse Event|3|||
161738471|NCT01830816|584081425|FG001|Overall Study|Adverse Event|4|||
161738472|NCT01830816|584081426|FG002|Overall Study|Adverse Event|0|||
161738473|NCT01830816|584081424|FG000|Overall Study|Study Terminated by Sponsor|1|||
161738474|NCT01830816|584081425|FG001|Overall Study|Study Terminated by Sponsor|1|||
161966074|NCT01866111|584921985|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
161966075|NCT01866111|584921986|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
161966076|NCT01866111|584921987|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
161966077|NCT01866111|584921984|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
161966078|NCT01866111|584921985|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
161966079|NCT01866111|584921986|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
161738475|NCT01830816|584081426|FG002|Overall Study|Study Terminated by Sponsor|0|||
161738476|NCT01830816|584081424|FG000|Overall Study|Withdrawal by Subject|1|||
161738477|NCT01830816|584081425|FG001|Overall Study|Withdrawal by Subject|1|||
161738478|NCT01830816|584081426|FG002|Overall Study|Withdrawal by Subject|0|||
161738479|NCT01830816|584081424|FG000|Overall Study|Lost to Follow-up|0|||
161738480|NCT01830816|584081425|FG001|Overall Study|Lost to Follow-up|1|||
161738481|NCT01830816|584081426|FG002|Overall Study|Lost to Follow-up|0|||
161738482|NCT01830816|584081424|FG000|Overall Study|Symptomatic Deterioration|1|||
161738483|NCT01830816|584081425|FG001|Overall Study|Symptomatic Deterioration|0|||
161738484|NCT01830816|584081426|FG002|Overall Study|Symptomatic Deterioration|0|||
161738485|NCT01830816|584081424|FG000|Overall Study|Reason not Specified|2|||
161738486|NCT01830816|584081425|FG001|Overall Study|Reason not Specified|0|||
161738487|NCT01830816|584081426|FG002|Overall Study|Reason not Specified|0|||
161738488|NCT01586156|584081429|FG000|Overall Study|Pregnancy|0|||
161738489|NCT01586156|584081430|FG001|Overall Study|Pregnancy|1|||
161738490|NCT01586156|584081431|FG002|Overall Study|Pregnancy|0|||
161738491|NCT04465396|584081432|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
161738492|NCT04465396|584081433|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
161738493|NCT04465396|584081434|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
161738494|NCT04465396|584081435|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
161738495|NCT00349752|584081437|FG000|Overall Study|Adverse Event|8|||
161738496|NCT00349752|584081438|FG001|Overall Study|Adverse Event|12|||
161738497|NCT00349752|584081437|FG000|Overall Study|Lack of Efficacy|37|||
161738498|NCT00349752|584081438|FG001|Overall Study|Lack of Efficacy|42|||
161738499|NCT00349752|584081437|FG000|Overall Study|Lost to Follow-up|4|||
161738500|NCT00349752|584081438|FG001|Overall Study|Lost to Follow-up|2|||
161738501|NCT00349752|584081437|FG000|Overall Study|Personal reasons|6|||
161738502|NCT00349752|584081438|FG001|Overall Study|Personal reasons|5|||
161738503|NCT00349752|584081437|FG000|Overall Study|Other: Required exclusionary medication|0|||
161738504|NCT00349752|584081438|FG001|Overall Study|Other: Required exclusionary medication|1|||
161738505|NCT00349752|584081437|FG000|Overall Study|Other: Non compliance|0|||
161738506|NCT00349752|584081438|FG001|Overall Study|Other: Non compliance|1|||
161738507|NCT00349752|584081437|FG000|Overall Study|Other: Patient stopped steroids|0|||
161738508|NCT00349752|584081438|FG001|Overall Study|Other: Patient stopped steroids|1|||
161738509|NCT00349752|584081437|FG000|Overall Study|Other: Patient's steroid use|1|||
161738510|NCT00349752|584081438|FG001|Overall Study|Other: Patient's steroid use|0|||
161738511|NCT00349752|584081437|FG000|Overall Study|Other: Ineligible|1|||
161738512|NCT00349752|584081438|FG001|Overall Study|Other: Ineligible|0|||
161738513|NCT00349752|584081437|FG000|Overall Study|Other: Inadvertently unblinded|1|||
161738514|NCT00349752|584081438|FG001|Overall Study|Other: Inadvertently unblinded|0|||
161738515|NCT00349752|584081437|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
161738516|NCT00349752|584081438|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
161738517|NCT05294211|584081441|FG000|Overall Study|Withdrawal by Subject|3|||
161738518|NCT05294211|584081441|FG000|Overall Study|Physician Decision|2|||
161738519|NCT05294211|584081441|FG000|Overall Study|Progressed to active labor|1|||
161738520|NCT05294211|584081441|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
161738521|NCT05294211|584081441|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
161738522|NCT01842607|584081443|FG000|Overall Study|Adverse Event|11|||
161738523|NCT01842607|584081443|FG000|Overall Study|Lack of Efficacy|19|||
161738524|NCT01842607|584081443|FG000|Overall Study|Protocol Violation|8|||
161738525|NCT01842607|584081443|FG000|Overall Study|Protocol defined stopping criteria|2|||
161738526|NCT01842607|584081443|FG000|Overall Study|Lost to Follow-up|3|||
161738527|NCT01842607|584081443|FG000|Overall Study|Physician Decision|9|||
161966080|NCT01866111|584921987|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
161966081|NCT01866111|584921984|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
161738528|NCT01842607|584081443|FG000|Overall Study|Withdrawal by Subject|14|||
161738529|NCT00012012|584081444|FG000|Overall Study|Protocol Violation|1|||
161738530|NCT00012012|584081445|FG001|Overall Study|Protocol Violation|1|||
161738531|NCT00012012|584081444|FG000|Overall Study|Withdrawal by Subject|0|||
161738532|NCT00012012|584081445|FG001|Overall Study|Withdrawal by Subject|2|||
161738533|NCT02159469|584081446|FG000|Overall Study|Missing Completion status|1|||
161738534|NCT02159469|584081446|FG000|Overall Study|Adverse Event|5|||
161738535|NCT02159469|584081446|FG000|Overall Study|Non-compliance|2|||
161738536|NCT02159469|584081446|FG000|Overall Study|Withdrawal by Subject|9|||
161738537|NCT02159469|584081446|FG000|Overall Study|Lost to Follow-up|1|||
161738538|NCT02159469|584081446|FG000|Overall Study|Sponsor's request|2|||
161738539|NCT02159469|584081446|FG000|Overall Study|Met Stopping Criteria|3|||
161738540|NCT02159469|584081446|FG000|Overall Study|Other|1|||
161738541|NCT02159469|584081446|FG000|Overall Study|Multiple|29|||
161738542|NCT03629041|584081447|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
161738543|NCT03629041|584081448|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
161738544|NCT03629041|584081449|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
161738545|NCT03629041|584081450|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
161738546|NCT03730194|584081456|FG000|First Stage Treatment|Withdrawal by Subject|1|||
161738547|NCT03730194|584081457|FG001|First Stage Treatment|Withdrawal by Subject|1|||
161738548|NCT03730194|584081458|FG002|First Stage Treatment|Withdrawal by Subject|0|||
161738549|NCT03730194|584081459|FG003|First Stage Treatment|Withdrawal by Subject|0|||
161738550|NCT03730194|584081460|FG004|First Stage Treatment|Withdrawal by Subject|0|||
161738551|NCT03730194|584081461|FG005|First Stage Treatment|Withdrawal by Subject|0|||
161738552|NCT03730194|584081456|FG000|First Stage Treatment|Protocol Violation|3|||
161738553|NCT03730194|584081457|FG001|First Stage Treatment|Protocol Violation|3|||
161738554|NCT03730194|584081458|FG002|First Stage Treatment|Protocol Violation|0|||
161738555|NCT03730194|584081459|FG003|First Stage Treatment|Protocol Violation|0|||
161738556|NCT03730194|584081460|FG004|First Stage Treatment|Protocol Violation|0|||
161738557|NCT03730194|584081461|FG005|First Stage Treatment|Protocol Violation|0|||
161738558|NCT01766817|584081464|FG000|Overall Study|Drug-related adverse event|1|||
161738559|NCT01766817|584081465|FG001|Overall Study|Drug-related adverse event|2|||
161738560|NCT01766817|584081466|FG002|Overall Study|Drug-related adverse event|1|||
161738561|NCT01766817|584081464|FG000|Overall Study|Drug-unrelated adverse event|3|||
161738562|NCT01766817|584081465|FG001|Overall Study|Drug-unrelated adverse event|3|||
161738563|NCT01766817|584081466|FG002|Overall Study|Drug-unrelated adverse event|3|||
161738564|NCT01766817|584081464|FG000|Overall Study|Death|1|||
161738565|NCT01766817|584081465|FG001|Overall Study|Death|1|||
161738566|NCT01766817|584081466|FG002|Overall Study|Death|0|||
161738567|NCT01766817|584081464|FG000|Overall Study|Unable to take study drug|0|||
161738568|NCT01766817|584081465|FG001|Overall Study|Unable to take study drug|1|||
161738569|NCT01766817|584081466|FG002|Overall Study|Unable to take study drug|0|||
161738570|NCT01766817|584081464|FG000|Overall Study|Withdrawal by Subject|2|||
161738571|NCT01766817|584081465|FG001|Overall Study|Withdrawal by Subject|0|||
161738572|NCT01766817|584081466|FG002|Overall Study|Withdrawal by Subject|3|||
161738573|NCT01766817|584081464|FG000|Overall Study|Subject non-compliance|0|||
161738574|NCT01766817|584081465|FG001|Overall Study|Subject non-compliance|1|||
161738575|NCT01766817|584081466|FG002|Overall Study|Subject non-compliance|2|||
161738576|NCT01766817|584081464|FG000|Overall Study|Physician Decision|3|||
161738577|NCT01766817|584081465|FG001|Overall Study|Physician Decision|3|||
161738578|NCT01766817|584081466|FG002|Overall Study|Physician Decision|4|||
161738579|NCT01766817|584081464|FG000|Overall Study|Other|1|||
161738580|NCT01766817|584081465|FG001|Overall Study|Other|0|||
161738581|NCT01766817|584081466|FG002|Overall Study|Other|0|||
161738582|NCT03814590|584081467|FG000|Overall Study|Adverse Event|0|||
161738583|NCT03814590|584081468|FG001|Overall Study|Adverse Event|0|||
161738584|NCT03814590|584081469|FG002|Overall Study|Adverse Event|0|||
161738585|NCT03814590|584081470|FG003|Overall Study|Adverse Event|0|||
161738586|NCT03814590|584081471|FG004|Overall Study|Adverse Event|0|||
161738587|NCT03814590|584081472|FG005|Overall Study|Adverse Event|1|||
161738588|NCT03814590|584081473|FG006|Overall Study|Adverse Event|1|||
161738589|NCT03814590|584081474|FG007|Overall Study|Adverse Event|1|||
161738590|NCT03814590|584081475|FG008|Overall Study|Adverse Event|0|||
161738591|NCT03814590|584081476|FG009|Overall Study|Adverse Event|0|||
161738592|NCT03814590|584081477|FG010|Overall Study|Adverse Event|1|||
161738593|NCT03814590|584081478|FG011|Overall Study|Adverse Event|0|||
161738594|NCT03814590|584081479|FG012|Overall Study|Adverse Event|3|||
161738595|NCT03814590|584081480|FG013|Overall Study|Adverse Event|0|||
161738596|NCT03814590|584081467|FG000|Overall Study|Lost to Follow-up|0|||
161738597|NCT03814590|584081468|FG001|Overall Study|Lost to Follow-up|2|||
161738598|NCT03814590|584081469|FG002|Overall Study|Lost to Follow-up|1|||
161738599|NCT03814590|584081470|FG003|Overall Study|Lost to Follow-up|0|||
161738600|NCT03814590|584081471|FG004|Overall Study|Lost to Follow-up|1|||
161738601|NCT03814590|584081472|FG005|Overall Study|Lost to Follow-up|1|||
161738602|NCT03814590|584081473|FG006|Overall Study|Lost to Follow-up|1|||
161738603|NCT03814590|584081474|FG007|Overall Study|Lost to Follow-up|1|||
161738604|NCT03814590|584081475|FG008|Overall Study|Lost to Follow-up|0|||
161738605|NCT03814590|584081476|FG009|Overall Study|Lost to Follow-up|0|||
161738606|NCT03814590|584081477|FG010|Overall Study|Lost to Follow-up|1|||
161738607|NCT03814590|584081478|FG011|Overall Study|Lost to Follow-up|0|||
161738608|NCT03814590|584081479|FG012|Overall Study|Lost to Follow-up|0|||
161738609|NCT03814590|584081480|FG013|Overall Study|Lost to Follow-up|1|||
161738610|NCT03814590|584081467|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738611|NCT03814590|584081468|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738612|NCT03814590|584081469|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738613|NCT03814590|584081470|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738614|NCT03814590|584081471|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738615|NCT03814590|584081472|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738616|NCT03814590|584081473|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738617|NCT03814590|584081474|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738618|NCT03814590|584081475|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738619|NCT03814590|584081476|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
161738620|NCT03814590|584081477|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738621|NCT03814590|584081478|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738622|NCT03814590|584081479|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738623|NCT03814590|584081480|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161738624|NCT03814590|584081467|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738625|NCT03814590|584081468|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738626|NCT03814590|584081469|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738627|NCT03814590|584081470|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738628|NCT03814590|584081471|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738629|NCT03814590|584081472|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
161738630|NCT03814590|584081473|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
161738631|NCT03814590|584081474|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
161738632|NCT03814590|584081475|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738633|NCT03814590|584081476|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
161738634|NCT03814590|584081477|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
161738635|NCT03814590|584081478|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161738636|NCT03814590|584081479|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
161738637|NCT03814590|584081480|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
161738638|NCT03814590|584081467|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738639|NCT03814590|584081468|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738640|NCT03814590|584081469|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738641|NCT03814590|584081470|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738642|NCT03814590|584081471|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738643|NCT03814590|584081472|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738644|NCT03814590|584081473|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738645|NCT03814590|584081474|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161738646|NCT03814590|584081475|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738647|NCT03814590|584081476|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161738648|NCT03814590|584081477|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738649|NCT03814590|584081478|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738650|NCT03814590|584081479|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738651|NCT03814590|584081480|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161738652|NCT03814590|584081467|FG000|Overall Study|UNKNOWN REASON|0|||
161738653|NCT03814590|584081468|FG001|Overall Study|UNKNOWN REASON|0|||
161738654|NCT03814590|584081469|FG002|Overall Study|UNKNOWN REASON|0|||
161738655|NCT03814590|584081470|FG003|Overall Study|UNKNOWN REASON|0|||
161738656|NCT03814590|584081471|FG004|Overall Study|UNKNOWN REASON|0|||
161738657|NCT03814590|584081472|FG005|Overall Study|UNKNOWN REASON|0|||
161738658|NCT03814590|584081473|FG006|Overall Study|UNKNOWN REASON|0|||
161738659|NCT03814590|584081474|FG007|Overall Study|UNKNOWN REASON|1|||
161738660|NCT03814590|584081475|FG008|Overall Study|UNKNOWN REASON|0|||
161738661|NCT03814590|584081476|FG009|Overall Study|UNKNOWN REASON|0|||
161738662|NCT03814590|584081477|FG010|Overall Study|UNKNOWN REASON|0|||
161738663|NCT03814590|584081478|FG011|Overall Study|UNKNOWN REASON|0|||
161738664|NCT03814590|584081479|FG012|Overall Study|UNKNOWN REASON|0|||
161738665|NCT03814590|584081480|FG013|Overall Study|UNKNOWN REASON|0|||
161738666|NCT03519516|584081483|FG000|Overall Study|Adverse Event|0|||
161738667|NCT03519516|584081484|FG001|Overall Study|Adverse Event|1|||
161738668|NCT01244191|584081487|FG000|Overall Study|Progressive disease|295|||
161738669|NCT01244191|584081488|FG001|Overall Study|Progressive disease|350|||
161738670|NCT01244191|584081487|FG000|Overall Study|Clinical disease progression|54|||
161738671|NCT01244191|584081488|FG001|Overall Study|Clinical disease progression|36|||
161738672|NCT01244191|584081487|FG000|Overall Study|Adverse Event|65|||
161738673|NCT01244191|584081488|FG001|Overall Study|Adverse Event|48|||
161738674|NCT01244191|584081487|FG000|Overall Study|Death|22|||
161738675|NCT01244191|584081488|FG001|Overall Study|Death|29|||
161738676|NCT01244191|584081487|FG000|Overall Study|Lost to Follow-up|0|||
161738677|NCT01244191|584081488|FG001|Overall Study|Lost to Follow-up|2|||
161738678|NCT01244191|584081487|FG000|Overall Study|Protocol Violation|1|||
161738679|NCT01244191|584081488|FG001|Overall Study|Protocol Violation|2|||
161738680|NCT01244191|584081487|FG000|Overall Study|Withdrawal by Subject|31|||
161738681|NCT01244191|584081488|FG001|Overall Study|Withdrawal by Subject|23|||
161738682|NCT01244191|584081487|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
161738683|NCT01244191|584081488|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
161738684|NCT01752842|584081489|FG000|Overall Study|Adverse Event|3|||
161738685|NCT01752842|584081490|FG001|Overall Study|Adverse Event|0|||
161738686|NCT01752842|584081489|FG000|Overall Study|Withdrawal by Subject|0|||
161738687|NCT01752842|584081490|FG001|Overall Study|Withdrawal by Subject|2|||
161738688|NCT02164513|584081491|FG000|Overall Study|Adverse Event|162|||
161738689|NCT02164513|584081492|FG001|Overall Study|Adverse Event|180|||
161738690|NCT02164513|584081493|FG002|Overall Study|Adverse Event|111|||
161738691|NCT02164513|584081491|FG000|Overall Study|Other: Study Closed or terminated|5|||
161738692|NCT02164513|584081492|FG001|Overall Study|Other: Study Closed or terminated|2|||
161738693|NCT02164513|584081493|FG002|Overall Study|Other: Study Closed or terminated|4|||
161738694|NCT02164513|584081491|FG000|Overall Study|Lost to Follow-up|30|||
161738695|NCT02164513|584081492|FG001|Overall Study|Lost to Follow-up|36|||
161738696|NCT02164513|584081493|FG002|Overall Study|Lost to Follow-up|22|||
161738697|NCT02164513|584081491|FG000|Overall Study|Physician Decision|47|||
161738698|NCT02164513|584081492|FG001|Overall Study|Physician Decision|57|||
161738699|NCT02164513|584081493|FG002|Overall Study|Physician Decision|28|||
161738700|NCT02164513|584081491|FG000|Overall Study|Withdrawal by Subject|192|||
161738701|NCT02164513|584081492|FG001|Overall Study|Withdrawal by Subject|261|||
161738702|NCT02164513|584081493|FG002|Overall Study|Withdrawal by Subject|130|||
161738703|NCT02164513|584081491|FG000|Overall Study|Other: Reason not provided by site|1|||
161738704|NCT02164513|584081492|FG001|Overall Study|Other: Reason not provided by site|0|||
161738705|NCT02164513|584081493|FG002|Overall Study|Other: Reason not provided by site|0|||
161738706|NCT05301322|584081494|FG000|Overall Study|Adverse Event|7|||
161738707|NCT05301322|584081495|FG001|Overall Study|Adverse Event|3|||
161738708|NCT05301322|584081494|FG000|Overall Study|Death|0|||
161738709|NCT05301322|584081495|FG001|Overall Study|Death|1|||
161738710|NCT05301322|584081494|FG000|Overall Study|Lost to Follow-up|2|||
161738711|NCT05301322|584081495|FG001|Overall Study|Lost to Follow-up|1|||
161738712|NCT05301322|584081494|FG000|Overall Study|Protocol Violation|3|||
161738713|NCT05301322|584081495|FG001|Overall Study|Protocol Violation|1|||
161738714|NCT05301322|584081494|FG000|Overall Study|Withdrawal by Subject|3|||
161738715|NCT05301322|584081495|FG001|Overall Study|Withdrawal by Subject|0|||
161738716|NCT05301322|584081494|FG000|Overall Study|Other|4|||
161738717|NCT05301322|584081495|FG001|Overall Study|Other|0|||
161738718|NCT04971785|584081496|FG000|Overall Study|Withdrew Consent|5|||
161738719|NCT04971785|584081497|FG001|Overall Study|Withdrew Consent|5|||
161738720|NCT04971785|584081498|FG002|Overall Study|Withdrew Consent|17|||
161738721|NCT04971785|584081499|FG003|Overall Study|Withdrew Consent|7|||
161738722|NCT04971785|584081496|FG000|Overall Study|Adverse Event|7|||
161738723|NCT04971785|584081497|FG001|Overall Study|Adverse Event|8|||
161738724|NCT04971785|584081498|FG002|Overall Study|Adverse Event|6|||
161738725|NCT04971785|584081499|FG003|Overall Study|Adverse Event|3|||
161738726|NCT04971785|584081496|FG000|Overall Study|Lost to Follow-up|2|||
161738727|NCT04971785|584081497|FG001|Overall Study|Lost to Follow-up|1|||
161738728|NCT04971785|584081498|FG002|Overall Study|Lost to Follow-up|6|||
161738729|NCT04971785|584081499|FG003|Overall Study|Lost to Follow-up|7|||
161738730|NCT04971785|584081496|FG000|Overall Study|Protocol Violation|3|||
161738731|NCT04971785|584081497|FG001|Overall Study|Protocol Violation|1|||
161738732|NCT04971785|584081498|FG002|Overall Study|Protocol Violation|1|||
161738733|NCT04971785|584081499|FG003|Overall Study|Protocol Violation|2|||
161738734|NCT04971785|584081496|FG000|Overall Study|Investigator's Discretion|3|||
161738735|NCT04971785|584081497|FG001|Overall Study|Investigator's Discretion|1|||
161738736|NCT04971785|584081498|FG002|Overall Study|Investigator's Discretion|1|||
161738737|NCT04971785|584081499|FG003|Overall Study|Investigator's Discretion|0|||
161738738|NCT04971785|584081496|FG000|Overall Study|Randomized but Never Treated|1|||
161738739|NCT04971785|584081497|FG001|Overall Study|Randomized but Never Treated|2|||
161738740|NCT04971785|584081498|FG002|Overall Study|Randomized but Never Treated|0|||
161738741|NCT04971785|584081499|FG003|Overall Study|Randomized but Never Treated|1|||
161738742|NCT04971785|584081496|FG000|Overall Study|Death|0|||
161738743|NCT04971785|584081497|FG001|Overall Study|Death|1|||
161738744|NCT04971785|584081498|FG002|Overall Study|Death|1|||
161738745|NCT04971785|584081499|FG003|Overall Study|Death|0|||
161738746|NCT04971785|584081496|FG000|Overall Study|Site Terminated by Sponsor|1|||
161738747|NCT04971785|584081497|FG001|Overall Study|Site Terminated by Sponsor|1|||
161738748|NCT04971785|584081498|FG002|Overall Study|Site Terminated by Sponsor|0|||
161738749|NCT04971785|584081499|FG003|Overall Study|Site Terminated by Sponsor|0|||
161738750|NCT00781963|584083139|FG000|Overall Study|Death|3|||
161738751|NCT00781963|584083140|FG001|Overall Study|Death|0|||
161738752|NCT00781963|584083139|FG000|Overall Study|Lost to Follow-up|2|||
161738753|NCT00781963|584083140|FG001|Overall Study|Lost to Follow-up|1|||
161738754|NCT00781963|584083139|FG000|Overall Study|Withdrawal by Subject|3|||
161738755|NCT00781963|584083140|FG001|Overall Study|Withdrawal by Subject|1|||
161738756|NCT00781963|584083139|FG000|Overall Study|Refused follow-up|9|||
161738757|NCT00781963|584083140|FG001|Overall Study|Refused follow-up|0|||
161738758|NCT03297216|584083141|FG000|Overall Study|Death|0|||
161738759|NCT03297216|584083142|FG001|Overall Study|Death|1|||
161738760|NCT03297216|584083141|FG000|Overall Study|Miscarriage|0|||
161738761|NCT03297216|584083142|FG001|Overall Study|Miscarriage|2|||
161738762|NCT03297216|584083141|FG000|Overall Study|Lost to Follow-up|3|||
161738763|NCT03297216|584083142|FG001|Overall Study|Lost to Follow-up|2|||
161738764|NCT00912340|584083151|FG000|Overall Study|Adverse Event|2|||
161738765|NCT00912340|584083152|FG001|Overall Study|Adverse Event|4|||
161738766|NCT00912340|584083153|FG002|Overall Study|Adverse Event|0|||
161738767|NCT00912340|584083151|FG000|Overall Study|Protocol revised to remove arm|0|||
161738768|NCT00912340|584083152|FG001|Overall Study|Protocol revised to remove arm|0|||
161738769|NCT00912340|584083153|FG002|Overall Study|Protocol revised to remove arm|4|||
161738770|NCT00436982|584083158|FG000|Overall Study|Withdrawal by Subject|3|||
161738771|NCT00436982|584083159|FG001|Overall Study|Withdrawal by Subject|1|||
161738772|NCT00436982|584083158|FG000|Overall Study|Did not receive allocated intervention|0|||
161738773|NCT00436982|584083159|FG001|Overall Study|Did not receive allocated intervention|1|||
161738774|NCT00436982|584083158|FG000|Overall Study|no RSA data|1|||
161738775|NCT00436982|584083159|FG001|Overall Study|no RSA data|2|||
161738776|NCT00953225|584083163|FG000|Overall Study|Withdrawal by Subject|2|||
161738777|NCT00953225|584083164|FG001|Overall Study|Withdrawal by Subject|0|||
161738778|NCT02254551|584083165|FG000|Dose Escalation|Physician Decision|1|||
161738779|NCT02254551|584083165|FG000|Dose Escalation|Dose-limiting toxicity|2|||
161738780|NCT04058158|584083166|FG000|Period 1|Death|1|||
161738781|NCT04058158|584083167|FG001|Period 1|Death|0|||
161738782|NCT04058158|584083166|FG000|Period 1|Adverse Event|1|||
161738783|NCT04058158|584083167|FG001|Period 1|Adverse Event|1|||
161738784|NCT04058158|584083166|FG000|Period 1|Pregnancy|0|||
161738785|NCT04058158|584083167|FG001|Period 1|Pregnancy|1|||
161738786|NCT02215616|584083168|FG000|Overall Study|Sponsor requested to stop study drug|0|||
161738787|NCT02215616|584083169|FG001|Overall Study|Sponsor requested to stop study drug|0|||
161738788|NCT02215616|584083170|FG002|Overall Study|Sponsor requested to stop study drug|1|||
161738789|NCT02215616|584083171|FG003|Overall Study|Sponsor requested to stop study drug|4|||
161738790|NCT02215616|584083168|FG000|Overall Study|Death|1|||
161738791|NCT02215616|584083169|FG001|Overall Study|Death|0|||
161738792|NCT02215616|584083170|FG002|Overall Study|Death|0|||
161738793|NCT02215616|584083171|FG003|Overall Study|Death|0|||
161738794|NCT02215616|584083168|FG000|Overall Study|Adverse Event|7|||
161738795|NCT02215616|584083169|FG001|Overall Study|Adverse Event|4|||
161738796|NCT02215616|584083170|FG002|Overall Study|Adverse Event|9|||
161738797|NCT02215616|584083171|FG003|Overall Study|Adverse Event|2|||
161738798|NCT02215616|584083168|FG000|Overall Study|Withdrawal by Subject|1|||
161738799|NCT02215616|584083169|FG001|Overall Study|Withdrawal by Subject|8|||
161738800|NCT02215616|584083170|FG002|Overall Study|Withdrawal by Subject|2|||
161738801|NCT02215616|584083171|FG003|Overall Study|Withdrawal by Subject|5|||
161738802|NCT02215616|584083168|FG000|Overall Study|Non-compliance|0|||
161738803|NCT02215616|584083169|FG001|Overall Study|Non-compliance|2|||
161738804|NCT02215616|584083170|FG002|Overall Study|Non-compliance|1|||
161738805|NCT02215616|584083171|FG003|Overall Study|Non-compliance|0|||
161738806|NCT02215616|584083168|FG000|Overall Study|Protocol Violation|0|||
161738807|NCT02215616|584083169|FG001|Overall Study|Protocol Violation|2|||
161738808|NCT02215616|584083170|FG002|Overall Study|Protocol Violation|0|||
161738809|NCT02215616|584083171|FG003|Overall Study|Protocol Violation|0|||
161738810|NCT02215616|584083168|FG000|Overall Study|Lost to Follow-up|1|||
161738811|NCT02215616|584083169|FG001|Overall Study|Lost to Follow-up|1|||
161738812|NCT02215616|584083170|FG002|Overall Study|Lost to Follow-up|0|||
161738813|NCT02215616|584083171|FG003|Overall Study|Lost to Follow-up|1|||
161738814|NCT02215616|584083168|FG000|Overall Study|Other than specified|1|||
161738815|NCT02215616|584083169|FG001|Overall Study|Other than specified|0|||
161738816|NCT02215616|584083170|FG002|Overall Study|Other than specified|1|||
161738817|NCT02215616|584083171|FG003|Overall Study|Other than specified|1|||
161738818|NCT01634113|584083172|FG000|Overall Study|Not treated|0|||
161738819|NCT01634113|584083173|FG001|Overall Study|Not treated|0|||
161738820|NCT01634113|584083174|FG002|Overall Study|Not treated|1|||
161840512|NCT00446199|584460571|FG002|Overall Study|In-/Exclusion criterion violated|2|||
162032437|NCT00811642|585175489|FG000|Overall Study|Withdrawal by Subject|7|||
161738821|NCT00520299|584083177|FG000|Overall Study|Withdrawal by Subject|0|||
161738822|NCT00520299|584083178|FG001|Overall Study|Withdrawal by Subject|0|||
161738823|NCT00520299|584083179|FG002|Overall Study|Withdrawal by Subject|2|||
161738824|NCT00520299|584083177|FG000|Overall Study|Progressive disease|0|||
161738825|NCT00520299|584083178|FG001|Overall Study|Progressive disease|3|||
161738826|NCT00520299|584083179|FG002|Overall Study|Progressive disease|4|||
161738827|NCT01352845|584083180|FG000|Overall Study|Lost to Follow-up|313|||
161840513|NCT00446199|584460572|FG003|Overall Study|In-/Exclusion criterion violated|1|||
161738828|NCT01352845|584083181|FG001|Overall Study|Lost to Follow-up|92|||
161840514|NCT00446199|584460569|FG000|Overall Study|Move|0|||
161840515|NCT00446199|584460570|FG001|Overall Study|Move|1|||
161840516|NCT00446199|584460571|FG002|Overall Study|Move|0|||
161738829|NCT01352845|584083180|FG000|Overall Study|No Longer Willing to Participate|205|||
161738830|NCT01352845|584083181|FG001|Overall Study|No Longer Willing to Participate|58|||
161738831|NCT01352845|584083180|FG000|Overall Study|Withdrawal by Subject|48|||
161738832|NCT01352845|584083181|FG001|Overall Study|Withdrawal by Subject|16|||
161840517|NCT00446199|584460572|FG003|Overall Study|Move|0|||
161738833|NCT01352845|584083180|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
161738834|NCT01352845|584083181|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
161738835|NCT01352845|584083180|FG000|Overall Study|Pregnancy|27|||
161738836|NCT01352845|584083181|FG001|Overall Study|Pregnancy|7|||
161738837|NCT01352845|584083180|FG000|Overall Study|Adverse Event|22|||
161738838|NCT01352845|584083181|FG001|Overall Study|Adverse Event|6|||
161738839|NCT01352845|584083180|FG000|Overall Study|Other|17|||
161738840|NCT01352845|584083181|FG001|Overall Study|Other|7|||
161738841|NCT01352845|584083180|FG000|Overall Study|Protocol Violation|12|||
161738842|NCT01352845|584083181|FG001|Overall Study|Protocol Violation|6|||
161738843|NCT01352845|584083180|FG000|Overall Study|Death|3|||
161738844|NCT01352845|584083181|FG001|Overall Study|Death|0|||
161738845|NCT02062463|584083182|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
161738846|NCT02062463|584083183|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
161738847|NCT02062463|584083184|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
161738848|NCT02062463|584083185|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
161738849|NCT02062463|584083182|FG000|Stage 2|Adverse Event|0|||
161738850|NCT02062463|584083183|FG001|Stage 2|Adverse Event|0|||
161738851|NCT02062463|584083184|FG002|Stage 2|Adverse Event|12|||
161738852|NCT02062463|584083185|FG003|Stage 2|Adverse Event|20|||
161738853|NCT02062463|584083182|FG000|Stage 2|Lack of Efficacy|0|||
161738854|NCT02062463|584083183|FG001|Stage 2|Lack of Efficacy|0|||
161738855|NCT02062463|584083184|FG002|Stage 2|Lack of Efficacy|3|||
161738856|NCT02062463|584083185|FG003|Stage 2|Lack of Efficacy|4|||
161738857|NCT02062463|584083182|FG000|Stage 2|Lost to Follow-up|0|||
161738858|NCT02062463|584083183|FG001|Stage 2|Lost to Follow-up|0|||
161738859|NCT02062463|584083184|FG002|Stage 2|Lost to Follow-up|20|||
161738860|NCT02062463|584083185|FG003|Stage 2|Lost to Follow-up|20|||
161738861|NCT02062463|584083182|FG000|Stage 2|Non-Compliance|0|||
161738862|NCT02062463|584083183|FG001|Stage 2|Non-Compliance|0|||
161738863|NCT02062463|584083184|FG002|Stage 2|Non-Compliance|0|||
161738864|NCT02062463|584083185|FG003|Stage 2|Non-Compliance|1|||
161738865|NCT02062463|584083182|FG000|Stage 2|Other than specified|0|||
161738866|NCT02062463|584083183|FG001|Stage 2|Other than specified|0|||
161738867|NCT02062463|584083184|FG002|Stage 2|Other than specified|3|||
161738868|NCT02062463|584083185|FG003|Stage 2|Other than specified|1|||
161738869|NCT02062463|584083182|FG000|Stage 2|Withdrawal by Subject|0|||
161738870|NCT02062463|584083183|FG001|Stage 2|Withdrawal by Subject|0|||
161738871|NCT02062463|584083184|FG002|Stage 2|Withdrawal by Subject|15|||
161738872|NCT02062463|584083185|FG003|Stage 2|Withdrawal by Subject|10|||
161738873|NCT01956240|584083194|FG000|Overall Study|Lost to Follow-up|6|||
161738874|NCT01956240|584083195|FG001|Overall Study|Lost to Follow-up|20|||
161738875|NCT01956240|584083194|FG000|Overall Study|Adverse Event|17|||
161738876|NCT01956240|584083195|FG001|Overall Study|Adverse Event|4|||
161738877|NCT03172481|584083199|FG000|Double-blind|Withdrawal by Subject|1|||
161738878|NCT03172481|584083200|FG001|Double-blind|Withdrawal by Subject|0|||
161738879|NCT02716194|584083201|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
161738880|NCT02716194|584083202|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
161738881|NCT02716194|584083203|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
161738882|NCT00363051|584083207|FG000|Overall Study|Adminstrative problems|1|||
161738883|NCT00363051|584083208|FG001|Overall Study|Adminstrative problems|1|||
161738884|NCT00363051|584083207|FG000|Overall Study|Adverse Event|21|||
161738885|NCT00363051|584083208|FG001|Overall Study|Adverse Event|12|||
161738886|NCT00363051|584083207|FG000|Overall Study|New Cancer Therapy|2|||
161738887|NCT00363051|584083208|FG001|Overall Study|New Cancer Therapy|1|||
161738888|NCT00363051|584083207|FG000|Overall Study|Withdrawal by Subject|11|||
161738889|NCT00363051|584083208|FG001|Overall Study|Withdrawal by Subject|3|||
161738890|NCT00363051|584083207|FG000|Overall Study|Lost to Follow-up|0|||
161738891|NCT00363051|584083208|FG001|Overall Study|Lost to Follow-up|1|||
161966082|NCT01866111|584921985|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
161966083|NCT01866111|584921986|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
161966084|NCT01866111|584921987|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
161966085|NCT01866111|584921984|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
161738892|NCT00363051|584083207|FG000|Overall Study|Protocol Violation|0|||
161738893|NCT00363051|584083208|FG001|Overall Study|Protocol Violation|2|||
161966086|NCT01866111|584921985|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
161738894|NCT00363051|584083207|FG000|Overall Study|Death|3|||
161738895|NCT00363051|584083208|FG001|Overall Study|Death|2|||
161738896|NCT02759562|584083209|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
161738897|NCT02759562|584083210|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
161738898|NCT02759562|584083209|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
161738899|NCT02759562|584083210|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
161738900|NCT02293993|584083211|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
161738901|NCT02293993|584083212|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
161738902|NCT02293993|584083213|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
161738903|NCT02293993|584083214|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
161738904|NCT02293993|584083211|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
161738905|NCT02293993|584083212|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
161738906|NCT02293993|584083213|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
161738907|NCT02293993|584083214|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
161738908|NCT02293993|584083211|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
161738909|NCT02293993|584083212|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
161738910|NCT02293993|584083213|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
161738911|NCT02293993|584083214|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
161738912|NCT02293993|584083211|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
161738913|NCT02293993|584083212|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
161738914|NCT02293993|584083213|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
161738915|NCT02293993|584083214|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
161738916|NCT02293993|584083211|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
161738917|NCT02293993|584083212|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
161738918|NCT02293993|584083213|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
161738919|NCT02293993|584083214|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
161738920|NCT01957709|584083215|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
161738921|NCT03587584|584083216|FG000|Overall Study|SOC deviations|4|||
161738922|NCT03587584|584083217|FG001|Overall Study|SOC deviations|6|||
161738923|NCT03587584|584083216|FG000|Overall Study|Incomplete data|0|||
161738924|NCT03587584|584083217|FG001|Overall Study|Incomplete data|3|||
161738925|NCT00830115|584083218|FG000|Overall Study|Adverse Event|2|||
161738926|NCT00830115|584083218|FG000|Overall Study|Improvement/recovery|1|||
161738927|NCT01061736|584083226|FG000|Overall Study|Dose regimen not selected|0|||
161738928|NCT01061736|584083227|FG001|Overall Study|Dose regimen not selected|0|||
161738929|NCT01061736|584083228|FG002|Overall Study|Dose regimen not selected|0|||
161738930|NCT01061736|584083229|FG003|Overall Study|Dose regimen not selected|0|||
161738931|NCT01061736|584083230|FG004|Overall Study|Dose regimen not selected|0|||
161738932|NCT01061736|584083231|FG005|Overall Study|Dose regimen not selected|0|||
161738933|NCT01061736|584083232|FG006|Overall Study|Dose regimen not selected|79|||
161738934|NCT01061736|584083233|FG007|Overall Study|Dose regimen not selected|0|||
161738935|NCT01061736|584083234|FG008|Overall Study|Dose regimen not selected|0|||
161738936|NCT01061736|584083235|FG009|Overall Study|Dose regimen not selected|0|||
161738937|NCT01061736|584083226|FG000|Overall Study|Adverse Event|13|||
161738938|NCT01061736|584083227|FG001|Overall Study|Adverse Event|1|||
161738939|NCT01061736|584083228|FG002|Overall Study|Adverse Event|3|||
161738940|NCT01061736|584083229|FG003|Overall Study|Adverse Event|2|||
161738941|NCT01061736|584083230|FG004|Overall Study|Adverse Event|4|||
161738942|NCT01061736|584083231|FG005|Overall Study|Adverse Event|1|||
161738943|NCT01061736|584083232|FG006|Overall Study|Adverse Event|4|||
161738944|NCT01061736|584083233|FG007|Overall Study|Adverse Event|63|||
161738945|NCT01061736|584083234|FG008|Overall Study|Adverse Event|67|||
161738946|NCT01061736|584083235|FG009|Overall Study|Adverse Event|34|||
161738947|NCT01061736|584083226|FG000|Overall Study|Lack of Efficacy|0|||
161738948|NCT01061736|584083227|FG001|Overall Study|Lack of Efficacy|2|||
161738949|NCT01061736|584083228|FG002|Overall Study|Lack of Efficacy|1|||
161738950|NCT01061736|584083229|FG003|Overall Study|Lack of Efficacy|1|||
161738951|NCT01061736|584083230|FG004|Overall Study|Lack of Efficacy|1|||
161738952|NCT01061736|584083231|FG005|Overall Study|Lack of Efficacy|2|||
161738953|NCT01061736|584083232|FG006|Overall Study|Lack of Efficacy|1|||
161738954|NCT01061736|584083233|FG007|Overall Study|Lack of Efficacy|9|||
161738955|NCT01061736|584083234|FG008|Overall Study|Lack of Efficacy|9|||
161738956|NCT01061736|584083235|FG009|Overall Study|Lack of Efficacy|10|||
161738957|NCT01061736|584083226|FG000|Overall Study|Poor compliance to protocol|0|||
161738958|NCT01061736|584083227|FG001|Overall Study|Poor compliance to protocol|0|||
161738959|NCT01061736|584083228|FG002|Overall Study|Poor compliance to protocol|0|||
161738960|NCT01061736|584083229|FG003|Overall Study|Poor compliance to protocol|0|||
161738961|NCT01061736|584083230|FG004|Overall Study|Poor compliance to protocol|0|||
161738962|NCT01061736|584083231|FG005|Overall Study|Poor compliance to protocol|0|||
161738963|NCT01061736|584083232|FG006|Overall Study|Poor compliance to protocol|0|||
161738964|NCT01061736|584083233|FG007|Overall Study|Poor compliance to protocol|2|||
161738965|NCT01061736|584083234|FG008|Overall Study|Poor compliance to protocol|5|||
161738966|NCT01061736|584083235|FG009|Overall Study|Poor compliance to protocol|9|||
161738967|NCT01061736|584083226|FG000|Overall Study|Not treated|0|||
161738968|NCT01061736|584083227|FG001|Overall Study|Not treated|0|||
161738969|NCT01061736|584083228|FG002|Overall Study|Not treated|0|||
161738970|NCT01061736|584083229|FG003|Overall Study|Not treated|0|||
161738971|NCT01061736|584083230|FG004|Overall Study|Not treated|1|||
161966087|NCT01866111|584921986|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
161966088|NCT01866111|584921987|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
161738972|NCT01061736|584083231|FG005|Overall Study|Not treated|0|||
161738973|NCT01061736|584083232|FG006|Overall Study|Not treated|0|||
161738974|NCT01061736|584083233|FG007|Overall Study|Not treated|2|||
161738975|NCT01061736|584083234|FG008|Overall Study|Not treated|1|||
161738976|NCT01061736|584083235|FG009|Overall Study|Not treated|0|||
161738977|NCT01061736|584083226|FG000|Overall Study|Other than specified above|0|||
161738978|NCT01061736|584083227|FG001|Overall Study|Other than specified above|1|||
161738979|NCT01061736|584083228|FG002|Overall Study|Other than specified above|2|||
161738980|NCT01061736|584083229|FG003|Overall Study|Other than specified above|0|||
161738981|NCT01061736|584083230|FG004|Overall Study|Other than specified above|1|||
161738982|NCT01061736|584083231|FG005|Overall Study|Other than specified above|0|||
161738983|NCT01061736|584083232|FG006|Overall Study|Other than specified above|0|||
161738984|NCT01061736|584083233|FG007|Overall Study|Other than specified above|18|||
161738985|NCT01061736|584083234|FG008|Overall Study|Other than specified above|15|||
161738986|NCT01061736|584083235|FG009|Overall Study|Other than specified above|21|||
161738987|NCT01925612|584083236|FG000|Overall Study|Progressive Disease|1|||
161738988|NCT01925612|584083237|FG001|Overall Study|Progressive Disease|1|||
161738989|NCT01925612|584083238|FG002|Overall Study|Progressive Disease|1|||
161738990|NCT01925612|584083239|FG003|Overall Study|Progressive Disease|0|||
161738991|NCT01925612|584083240|FG004|Overall Study|Progressive Disease|0|||
161738992|NCT01925612|584083236|FG000|Overall Study|Adverse Event|3|||
161738993|NCT01925612|584083237|FG001|Overall Study|Adverse Event|3|||
161738994|NCT01925612|584083238|FG002|Overall Study|Adverse Event|0|||
161738995|NCT01925612|584083239|FG003|Overall Study|Adverse Event|1|||
161738996|NCT01925612|584083240|FG004|Overall Study|Adverse Event|2|||
161738997|NCT01107405|584083245|FG000|Overall Study|Adverse Event|1|||
161738998|NCT01107405|584083246|FG001|Overall Study|Adverse Event|1|||
161738999|NCT01107405|584083247|FG002|Overall Study|Adverse Event|0|||
161739000|NCT01107405|584083248|FG003|Overall Study|Adverse Event|0|||
161739001|NCT01107405|584083249|FG004|Overall Study|Adverse Event|2|||
161739002|NCT01107405|584083245|FG000|Overall Study|Withdrawal by Subject|1|||
161739003|NCT01107405|584083246|FG001|Overall Study|Withdrawal by Subject|0|||
161739004|NCT01107405|584083247|FG002|Overall Study|Withdrawal by Subject|1|||
161739005|NCT01107405|584083248|FG003|Overall Study|Withdrawal by Subject|2|||
161739006|NCT01107405|584083249|FG004|Overall Study|Withdrawal by Subject|1|||
161739007|NCT01107405|584083245|FG000|Overall Study|Protocol Violation|0|||
161739008|NCT01107405|584083246|FG001|Overall Study|Protocol Violation|0|||
161739009|NCT01107405|584083247|FG002|Overall Study|Protocol Violation|1|||
161739010|NCT01107405|584083248|FG003|Overall Study|Protocol Violation|1|||
161739011|NCT01107405|584083249|FG004|Overall Study|Protocol Violation|0|||
161739012|NCT01895452|584083256|FG000|Overall Study|Adverse Event|1|||
161739013|NCT01895452|584083257|FG001|Overall Study|Adverse Event|4|||
161739014|NCT01895452|584083256|FG000|Overall Study|Lost to Follow-up|1|||
161739015|NCT01895452|584083257|FG001|Overall Study|Lost to Follow-up|5|||
161739016|NCT01895452|584083256|FG000|Overall Study|Pregnancy|0|||
161739017|NCT01895452|584083257|FG001|Overall Study|Pregnancy|1|||
161739018|NCT01895452|584083256|FG000|Overall Study|Withdrawal by Subject|2|||
161739019|NCT01895452|584083257|FG001|Overall Study|Withdrawal by Subject|14|||
161739020|NCT01895452|584083256|FG000|Overall Study|Underlying disease|0|||
161739021|NCT01895452|584083257|FG001|Overall Study|Underlying disease|3|||
161739022|NCT01895452|584083256|FG000|Overall Study|Noncompliance with study drug|0|||
161739023|NCT01895452|584083257|FG001|Overall Study|Noncompliance with study drug|1|||
161739024|NCT01653158|584083258|FG000|Overall Study|Death|0|||
161739025|NCT01653158|584083259|FG001|Overall Study|Death|0|||
161739026|NCT01653158|584083260|FG002|Overall Study|Death|0|||
161739027|NCT01653158|584083261|FG003|Overall Study|Death|1|||
161739028|NCT01653158|584083262|FG004|Overall Study|Death|0|||
161739029|NCT01653158|584083263|FG005|Overall Study|Death|0|||
161739030|NCT01653158|584083264|FG006|Overall Study|Death|0|||
161739031|NCT01653158|584083265|FG007|Overall Study|Death|2|||
161739032|NCT01653158|584083258|FG000|Overall Study|Adverse Event|0|||
161739033|NCT01653158|584083259|FG001|Overall Study|Adverse Event|0|||
161739034|NCT01653158|584083260|FG002|Overall Study|Adverse Event|0|||
161739035|NCT01653158|584083261|FG003|Overall Study|Adverse Event|1|||
161739036|NCT01653158|584083262|FG004|Overall Study|Adverse Event|0|||
161739037|NCT01653158|584083263|FG005|Overall Study|Adverse Event|0|||
161739038|NCT01653158|584083264|FG006|Overall Study|Adverse Event|0|||
161739039|NCT01653158|584083265|FG007|Overall Study|Adverse Event|3|||
161739040|NCT01653158|584083258|FG000|Overall Study|Other|0|||
161739041|NCT01653158|584083259|FG001|Overall Study|Other|0|||
161739042|NCT01653158|584083260|FG002|Overall Study|Other|0|||
161739043|NCT01653158|584083261|FG003|Overall Study|Other|0|||
161739044|NCT01653158|584083262|FG004|Overall Study|Other|0|||
161739045|NCT01653158|584083263|FG005|Overall Study|Other|0|||
161739046|NCT01653158|584083264|FG006|Overall Study|Other|0|||
161739047|NCT01653158|584083265|FG007|Overall Study|Other|1|||
161739048|NCT01653158|584083258|FG000|Overall Study|Progressive disease|0|||
161739049|NCT01653158|584083259|FG001|Overall Study|Progressive disease|0|||
161739050|NCT01653158|584083260|FG002|Overall Study|Progressive disease|0|||
161739051|NCT01653158|584083261|FG003|Overall Study|Progressive disease|0|||
161739052|NCT01653158|584083262|FG004|Overall Study|Progressive disease|1|||
161739053|NCT01653158|584083263|FG005|Overall Study|Progressive disease|1|||
161739054|NCT01653158|584083264|FG006|Overall Study|Progressive disease|2|||
161739055|NCT01653158|584083265|FG007|Overall Study|Progressive disease|9|||
161739056|NCT01653158|584083258|FG000|Overall Study|Withdrawal by Subject|1|||
161739057|NCT01653158|584083259|FG001|Overall Study|Withdrawal by Subject|0|||
161739058|NCT01653158|584083260|FG002|Overall Study|Withdrawal by Subject|0|||
161739059|NCT01653158|584083261|FG003|Overall Study|Withdrawal by Subject|0|||
161739060|NCT01653158|584083262|FG004|Overall Study|Withdrawal by Subject|0|||
161739061|NCT01653158|584083263|FG005|Overall Study|Withdrawal by Subject|0|||
161739062|NCT01653158|584083264|FG006|Overall Study|Withdrawal by Subject|0|||
161739063|NCT01653158|584083265|FG007|Overall Study|Withdrawal by Subject|0|||
161739064|NCT00980343|584083266|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
161739065|NCT00980343|584083267|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
161739066|NCT01188538|584083274|FG000|Overall Study|Lost to Follow-up|0|||
161739067|NCT01188538|584083275|FG001|Overall Study|Lost to Follow-up|1|||
161739068|NCT01170702|584083278|FG000|Overall Study|Exclusion criteria met after consent|1|||
161739069|NCT01170702|584083279|FG001|Overall Study|Exclusion criteria met after consent|2|||
161739070|NCT01170702|584083280|FG002|Overall Study|Exclusion criteria met after consent|0|||
161739071|NCT01170702|584083281|FG003|Overall Study|Exclusion criteria met after consent|2|||
161739072|NCT01677507|584083282|FG000|Initial Assignment|Adverse Event|0|||
161739073|NCT01677507|584083283|FG001|Initial Assignment|Adverse Event|1|||
161739074|NCT01677507|584083282|FG000|Initial Assignment|Protocol Violation|0|||
161739075|NCT01677507|584083283|FG001|Initial Assignment|Protocol Violation|1|||
161739076|NCT01677507|584083282|FG000|Second Assigment|Withdrawal by Subject|2|||
161739077|NCT01677507|584083283|FG001|Second Assigment|Withdrawal by Subject|2|||
161739078|NCT01677507|584083282|FG000|Second Assigment|Adverse Event|1|||
161739079|NCT01677507|584083283|FG001|Second Assigment|Adverse Event|3|||
161739080|NCT00469209|584083284|FG000|Overall Study|Adverse Event|1|||
161739081|NCT00469209|584083285|FG001|Overall Study|Adverse Event|0|||
161739082|NCT00469209|584083286|FG002|Overall Study|Adverse Event|1|||
161739083|NCT04999969|584083289|FG000|Overall Study|Death|76|||
161739084|NCT04999969|584083289|FG000|Overall Study|Progressive Disease|1|||
161739085|NCT04999969|584083289|FG000|Overall Study|Withdrawal by Subject|8|||
161739086|NCT06964165|584083291|FG000|Overall Study|Death|4|||
161739087|NCT06964165|584083292|FG001|Overall Study|Death|4|||
161739088|NCT06964165|584083291|FG000|Overall Study|Physician Decision|1|||
161739089|NCT06964165|584083292|FG001|Overall Study|Physician Decision|1|||
161739090|NCT06964165|584083291|FG000|Overall Study|Withdrawal by Subject|0|||
161739091|NCT06964165|584083292|FG001|Overall Study|Withdrawal by Subject|2|||
161739092|NCT06964165|584083291|FG000|Overall Study|Study terminated by sponsor|12|||
161739093|NCT06964165|584083292|FG001|Overall Study|Study terminated by sponsor|10|||
161739094|NCT06964165|584083291|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
161739095|NCT06964165|584083292|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
161739096|NCT06964165|584083291|FG000|Overall Study|Participant removed due to non-compliance|0|||
161739097|NCT06964165|584083292|FG001|Overall Study|Participant removed due to non-compliance|1|||
161739098|NCT00085917|584083293|FG000|Overall Study|Adverse Event|4|||
161739099|NCT00085917|584083294|FG001|Overall Study|Adverse Event|3|||
161739100|NCT01464788|584083295|FG000|Overall Study|Lost to Follow-up|0|||
161739101|NCT01464788|584083296|FG001|Overall Study|Lost to Follow-up|1|||
161739102|NCT01464788|584083297|FG002|Overall Study|Lost to Follow-up|0|||
161739103|NCT01464788|584083295|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
161739104|NCT01464788|584083296|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
161739105|NCT01464788|584083297|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
161739106|NCT01551758|584083298|FG000|Overall Study|Adverse Event|29|||
161739107|NCT01551758|584083299|FG001|Overall Study|Adverse Event|43|||
161739108|NCT01551758|584083298|FG000|Overall Study|Lack of Efficacy|0|||
161739109|NCT01551758|584083299|FG001|Overall Study|Lack of Efficacy|1|||
161739110|NCT01551758|584083298|FG000|Overall Study|Protocol Violation|5|||
161739111|NCT01551758|584083299|FG001|Overall Study|Protocol Violation|6|||
161739112|NCT01551758|584083298|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
161739113|NCT01551758|584083299|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
161739114|NCT01551758|584083298|FG000|Overall Study|Lost to Follow-up|29|||
161739115|NCT01551758|584083299|FG001|Overall Study|Lost to Follow-up|25|||
161739116|NCT01551758|584083298|FG000|Overall Study|Physician Decision|9|||
161739117|NCT01551758|584083299|FG001|Overall Study|Physician Decision|3|||
161739118|NCT01551758|584083298|FG000|Overall Study|Withdrawal by Subject|14|||
161739119|NCT01551758|584083299|FG001|Overall Study|Withdrawal by Subject|17|||
161739120|NCT00125190|584083301|FG000|Overall Study|Subject/Parent Decision|7|||
161739121|NCT00125190|584083301|FG000|Overall Study|Non-compliance|2|||
161739122|NCT00125190|584083301|FG000|Overall Study|Adverse Event|1|||
161739123|NCT00125190|584083301|FG000|Overall Study|Other|1|||
161739124|NCT00125190|584083301|FG000|Overall Study|Lost to Follow-up|4|||
161739125|NCT05584202|584083305|FG000|Overall Study|Withdrawal of Consent|3|||
161739126|NCT05584202|584083306|FG001|Overall Study|Withdrawal of Consent|2|||
161739127|NCT05584202|584083305|FG000|Overall Study|Lost to Follow-up|2|||
161739128|NCT05584202|584083306|FG001|Overall Study|Lost to Follow-up|1|||
161739129|NCT05584202|584083305|FG000|Overall Study|Death|0|||
161739130|NCT05584202|584083306|FG001|Overall Study|Death|1|||
161739131|NCT00646113|584084643|FG000|Overall Study|Lost to Follow-up|5|||
161739132|NCT00646113|584084643|FG000|Overall Study|Adverse Event|3|||
161739133|NCT00603733|584084646|FG000|Active Phase ITT|Adverse Event|8|||
161739134|NCT00603733|584084647|FG001|Active Phase ITT|Adverse Event|7|||
161739135|NCT00603733|584084646|FG000|Active Phase ITT|Withdrawal by Subject|0|||
161739136|NCT00603733|584084647|FG001|Active Phase ITT|Withdrawal by Subject|3|||
161739137|NCT00603733|584084646|FG000|Active Phase ITT|Lost to Follow-up|0|||
161739138|NCT00603733|584084647|FG001|Active Phase ITT|Lost to Follow-up|1|||
161739139|NCT00603733|584084646|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
161739140|NCT00603733|584084647|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
161739141|NCT00603733|584084646|FG000|Active Phase ITT|Lack of Efficacy|1|||
161739142|NCT00603733|584084647|FG001|Active Phase ITT|Lack of Efficacy|2|||
161739143|NCT00603733|584084646|FG000|Active Phase ITT|Subject moved, site closed|1|||
161739144|NCT00603733|584084647|FG001|Active Phase ITT|Subject moved, site closed|1|||
161739145|NCT00603733|584084646|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
161739146|NCT00603733|584084647|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
161739147|NCT00603733|584084646|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
161739148|NCT00603733|584084647|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
161739149|NCT00603733|584084646|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
161739150|NCT00603733|584084647|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
161739151|NCT00603733|584084646|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
161739152|NCT00603733|584084647|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
161739153|NCT00603733|584084646|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
161739154|NCT00603733|584084647|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
161739155|NCT00603733|584084646|FG000|Maintenance Phase ITT|Adverse Event|3|||
161739156|NCT00603733|584084647|FG001|Maintenance Phase ITT|Adverse Event|6|||
161739157|NCT00603733|584084646|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
161739158|NCT00603733|584084647|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
161739159|NCT00603733|584084646|FG000|Maintenance Phase ITT|Protocol Violation|1|||
161739160|NCT00603733|584084647|FG001|Maintenance Phase ITT|Protocol Violation|1|||
161739161|NCT00603733|584084646|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
161739162|NCT00603733|584084647|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
161739163|NCT00603733|584084646|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
161739164|NCT00603733|584084647|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
161739165|NCT00603733|584084646|FG000|Maintenance Phase ITT|Physician Decision|0|||
161739166|NCT00603733|584084647|FG001|Maintenance Phase ITT|Physician Decision|1|||
161739167|NCT00603733|584084646|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
161739168|NCT00603733|584084647|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
161739169|NCT01093755|584084648|FG000|Overall Study|Withdrawal by Subject|3|||
161739170|NCT01093755|584084649|FG001|Overall Study|Withdrawal by Subject|4|||
161739171|NCT03115112|584084650|FG000|Overall Study|Adverse Event|5|||
161739172|NCT03115112|584084651|FG001|Overall Study|Adverse Event|1|||
161739173|NCT03115112|584084650|FG000|Overall Study|Withdrawal by Subject|4|||
161739174|NCT03115112|584084651|FG001|Overall Study|Withdrawal by Subject|2|||
161739175|NCT03115112|584084650|FG000|Overall Study|Lost to Follow-up|0|||
161739176|NCT03115112|584084651|FG001|Overall Study|Lost to Follow-up|1|||
161739177|NCT03115112|584084650|FG000|Overall Study|Death|1|||
161739178|NCT03115112|584084651|FG001|Overall Study|Death|0|||
161739179|NCT03115112|584084650|FG000|Overall Study|Pregnancy|1|||
161739180|NCT03115112|584084651|FG001|Overall Study|Pregnancy|0|||
161739181|NCT03115112|584084650|FG000|Overall Study|Site closure|1|||
161739182|NCT03115112|584084651|FG001|Overall Study|Site closure|1|||
161739183|NCT01610076|584084652|FG000|Overall Study|Technical issue with video|0|||
161739184|NCT01610076|584084653|FG001|Overall Study|Technical issue with video|1|||
161739185|NCT01610076|584084652|FG000|Overall Study|Lost to Follow-up|3|||
161739186|NCT01610076|584084653|FG001|Overall Study|Lost to Follow-up|4|||
161739187|NCT02168803|584084654|FG000|Overall Study|Lost to Follow-up|1|||
161739188|NCT02168803|584084655|FG001|Overall Study|Lost to Follow-up|0|||
161739189|NCT02168803|584084656|FG002|Overall Study|Lost to Follow-up|1|||
161840518|NCT01079832|584460573|FG000|Overall Study|Withdrawal by Subject|1|||
161840519|NCT00290251|584460574|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161840520|NCT00290251|584460575|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161739190|NCT02168803|584084654|FG000|Overall Study|Withdrawal by Subject|1|||
161739191|NCT02168803|584084655|FG001|Overall Study|Withdrawal by Subject|1|||
161840521|NCT00290251|584460576|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161739192|NCT02168803|584084656|FG002|Overall Study|Withdrawal by Subject|2|||
161739193|NCT02168803|584084654|FG000|Overall Study|Physician Decision|0|||
161739194|NCT02168803|584084655|FG001|Overall Study|Physician Decision|1|||
161840522|NCT00290251|584460577|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161739195|NCT02168803|584084656|FG002|Overall Study|Physician Decision|0|||
161739196|NCT02168803|584084654|FG000|Overall Study|Adverse Event|0|||
161840523|NCT00290251|584460578|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161966089|NCT01866111|584921984|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
161739197|NCT02168803|584084655|FG001|Overall Study|Adverse Event|1|||
161739198|NCT02168803|584084656|FG002|Overall Study|Adverse Event|1|||
161739199|NCT02168803|584084654|FG000|Overall Study|Death|0|||
161739200|NCT02168803|584084655|FG001|Overall Study|Death|0|||
161739201|NCT02168803|584084656|FG002|Overall Study|Death|1|||
161739202|NCT02168803|584084654|FG000|Overall Study|Sponsor Decision|0|||
161739203|NCT02168803|584084655|FG001|Overall Study|Sponsor Decision|0|||
161739204|NCT02168803|584084656|FG002|Overall Study|Sponsor Decision|1|||
161739205|NCT02310906|584084667|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
161739206|NCT02310906|584084668|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
161739207|NCT02310906|584084669|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
161739208|NCT02310906|584084670|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
161739209|NCT02310906|584084667|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
161739210|NCT02310906|584084668|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
161739211|NCT02310906|584084669|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
161739212|NCT02310906|584084670|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
161739213|NCT02310906|584084667|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
161739214|NCT02310906|584084668|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
161739215|NCT02310906|584084669|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
161739216|NCT02310906|584084670|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
161739217|NCT02310906|584084667|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
161739218|NCT02310906|584084668|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
161739219|NCT02310906|584084669|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
161739220|NCT02310906|584084670|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
161739221|NCT00433446|584084671|FG000|Overall Study|Adverse Event|4|||
161739222|NCT00433446|584084671|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
161739223|NCT00433446|584084671|FG000|Overall Study|Progression|44|||
161739224|NCT00433446|584084671|FG000|Overall Study|Other - Not Protocol specified|3|||
161739225|NCT00433446|584084671|FG000|Overall Study|Ineligible|9|||
161739226|NCT02899377|584084672|FG000|Overall Study|Adverse Event|1|||
161739227|NCT02899377|584084673|FG001|Overall Study|Adverse Event|0|||
161739228|NCT01231607|584084677|FG000|Overall Study|Adverse Event|0|||
161739229|NCT01231607|584084678|FG001|Overall Study|Adverse Event|8|||
161739230|NCT01231607|584084679|FG002|Overall Study|Adverse Event|4|||
161739231|NCT01231607|584084680|FG003|Overall Study|Adverse Event|4|||
161739232|NCT01231607|584084681|FG004|Overall Study|Adverse Event|5|||
161739233|NCT01231607|584084677|FG000|Overall Study|Lost to Follow-up|13|||
161739234|NCT01231607|584084678|FG001|Overall Study|Lost to Follow-up|11|||
161739235|NCT01231607|584084679|FG002|Overall Study|Lost to Follow-up|10|||
161739236|NCT01231607|584084680|FG003|Overall Study|Lost to Follow-up|10|||
161739237|NCT01231607|584084681|FG004|Overall Study|Lost to Follow-up|4|||
161739238|NCT01231607|584084677|FG000|Overall Study|Physician Decision|4|||
161739239|NCT01231607|584084678|FG001|Overall Study|Physician Decision|4|||
161739240|NCT01231607|584084679|FG002|Overall Study|Physician Decision|3|||
161739241|NCT01231607|584084680|FG003|Overall Study|Physician Decision|5|||
161739242|NCT01231607|584084681|FG004|Overall Study|Physician Decision|4|||
161739243|NCT01231607|584084677|FG000|Overall Study|Protocol Violation|3|||
161739244|NCT01231607|584084678|FG001|Overall Study|Protocol Violation|2|||
161739245|NCT01231607|584084679|FG002|Overall Study|Protocol Violation|0|||
161739246|NCT01231607|584084680|FG003|Overall Study|Protocol Violation|2|||
161739247|NCT01231607|584084681|FG004|Overall Study|Protocol Violation|2|||
161739248|NCT01231607|584084677|FG000|Overall Study|Withdrawal by Subject|9|||
161739249|NCT01231607|584084678|FG001|Overall Study|Withdrawal by Subject|9|||
161739250|NCT01231607|584084679|FG002|Overall Study|Withdrawal by Subject|14|||
161739251|NCT01231607|584084680|FG003|Overall Study|Withdrawal by Subject|17|||
161739252|NCT01231607|584084681|FG004|Overall Study|Withdrawal by Subject|9|||
161739253|NCT03779334|584084685|FG000|Overall Study|Withdrawal by Subject|3|||
161739254|NCT03779334|584084686|FG001|Overall Study|Withdrawal by Subject|0|||
161739255|NCT03779334|584084687|FG002|Overall Study|Withdrawal by Subject|0|||
161739256|NCT03779334|584084685|FG000|Overall Study|Ongoing in Study|5|||
161739257|NCT03779334|584084686|FG001|Overall Study|Ongoing in Study|13|||
161739258|NCT03779334|584084687|FG002|Overall Study|Ongoing in Study|5|||
161739259|NCT04321252|584084694|FG000|Overall Study|Withdrawal by Subject|0|||
161739260|NCT04321252|584084695|FG001|Overall Study|Withdrawal by Subject|0|||
161739261|NCT04321252|584084696|FG002|Overall Study|Withdrawal by Subject|0|||
161739262|NCT04321252|584084697|FG003|Overall Study|Withdrawal by Subject|0|||
161739263|NCT04321252|584084698|FG004|Overall Study|Withdrawal by Subject|0|||
161739264|NCT04321252|584084699|FG005|Overall Study|Withdrawal by Subject|1|||
161739265|NCT04321252|584084700|FG006|Overall Study|Withdrawal by Subject|0|||
161739266|NCT04321252|584084701|FG007|Overall Study|Withdrawal by Subject|0|||
161739267|NCT04321252|584084702|FG008|Overall Study|Withdrawal by Subject|0|||
161739268|NCT06245044|584084703|FG000|No MI help|Technical issues|18|||
161739269|NCT01082367|584084706|FG000|Double-blind Period|Administrative problems|0|||
161739270|NCT01082367|584084707|FG001|Double-blind Period|Administrative problems|1|||
161739271|NCT01082367|584084706|FG000|Double-blind Period|Lack of Efficacy|5|||
161739272|NCT01082367|584084707|FG001|Double-blind Period|Lack of Efficacy|11|||
161739273|NCT01082367|584084706|FG000|Double-blind Period|Adverse Event|0|||
161739274|NCT01082367|584084707|FG001|Double-blind Period|Adverse Event|1|||
161739275|NCT01082367|584084706|FG000|Follow-up (F-U) Period|Administrative problems|1|||
161739276|NCT01082367|584084707|FG001|Follow-up (F-U) Period|Administrative problems|0|||
161739277|NCT01082367|584084706|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
161739278|NCT01082367|584084707|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
161739279|NCT01082367|584084706|FG000|Follow-up (F-U) Period|Adverse Event|0|||
161739280|NCT01082367|584084707|FG001|Follow-up (F-U) Period|Adverse Event|1|||
161739281|NCT00098020|584084710|FG000|Overall Study|Adverse Event|2|||
161739282|NCT00098020|584084710|FG000|Overall Study|Lost to Follow-up|1|||
161739283|NCT00098020|584084710|FG000|Overall Study|elevated liver enzymes|1|||
161739284|NCT00098020|584084710|FG000|Overall Study|Low urine PCR|1|||
161739285|NCT00098020|584084710|FG000|Overall Study|Low epidermal growth factor receptor|1|||
161739286|NCT00865189|584084717|FG000|Overall Study|Other|1|||
161739287|NCT00865189|584084718|FG001|Overall Study|Other|2|||
161739288|NCT00865189|584084717|FG000|Overall Study|Death|4|||
161739289|NCT00865189|584084718|FG001|Overall Study|Death|11|||
161739290|NCT00865189|584084717|FG000|Overall Study|Lost to Follow-up|6|||
161739291|NCT00865189|584084718|FG001|Overall Study|Lost to Follow-up|6|||
161739292|NCT00865189|584084717|FG000|Overall Study|Withdrawal by Subject|1|||
161739293|NCT00865189|584084718|FG001|Overall Study|Withdrawal by Subject|0|||
161739294|NCT01658579|584084720|FG000|Treatment Period A|Other|0|||
161739295|NCT01658579|584084721|FG001|Treatment Period A|Other|0|||
161739296|NCT01658579|584084722|FG002|Treatment Period A|Other|1|||
161739297|NCT01658579|584084723|FG003|Treatment Period A|Other|1|||
161739298|NCT01658579|584084720|FG000|Treatment Period A|Adverse Event|1|||
161739299|NCT01658579|584084721|FG001|Treatment Period A|Adverse Event|0|||
161739300|NCT01658579|584084722|FG002|Treatment Period A|Adverse Event|0|||
161739301|NCT01658579|584084723|FG003|Treatment Period A|Adverse Event|0|||
161739302|NCT01658579|584084720|FG000|Treatment Period B|Other|0|||
161739303|NCT01658579|584084721|FG001|Treatment Period B|Other|0|||
161739304|NCT01658579|584084722|FG002|Treatment Period B|Other|0|||
161739305|NCT01658579|584084723|FG003|Treatment Period B|Other|1|||
161739306|NCT05590767|584084724|FG000|Overall Study|Protocol Violation|1|||
161739307|NCT05590767|584084724|FG000|Overall Study|surgery canceled|1|||
161739308|NCT05590767|584084724|FG000|Overall Study|interscalene brachial block not performed|1|||
161739309|NCT00084929|584084725|FG000|Overall Study|ineligible - medical contraindication|1|||
161739310|NCT00084929|584084725|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
161739311|NCT00084929|584084725|FG000|Overall Study|Ineligible - Medical history|6|||
161739312|NCT00084929|584084725|FG000|Overall Study|Withdrawal by Subject|10|||
161739313|NCT00084929|584084725|FG000|Overall Study|Missing/incomplete CTC exam|9|||
161739314|NCT00084929|584084725|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
161739315|NCT00664209|584084726|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
161739316|NCT00664209|584084726|FG000|Study Treatment Period|Physician Decision|4|||
161739317|NCT00664209|584084726|FG000|Study Treatment Period|Withdrawal by Subject|2|||
161739318|NCT02767856|584084737|FG000|Overall Study|Lost to Follow-up|9|||
161739319|NCT02767856|584084738|FG001|Overall Study|Lost to Follow-up|1|||
161739320|NCT02767856|584084737|FG000|Overall Study|Withdrawal by Subject|2|||
161739321|NCT02767856|584084738|FG001|Overall Study|Withdrawal by Subject|1|||
161739322|NCT00091026|584084741|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
161739323|NCT00091026|584084742|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
161966090|NCT01866111|584921985|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
161966091|NCT01866111|584921986|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
161966092|NCT01866111|584921987|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
161966093|NCT01866111|584921984|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
161739324|NCT00091026|584084741|FG000|Overall Study|Patient withdrew and never received trea|0|||
161739325|NCT00091026|584084742|FG001|Overall Study|Patient withdrew and never received trea|2|||
161966094|NCT01866111|584921985|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
161739326|NCT00091026|584084741|FG000|Overall Study|Unknown-never received treatment|0|||
161739327|NCT00091026|584084742|FG001|Overall Study|Unknown-never received treatment|1|||
161739328|NCT00418379|584084745|FG000|Year 1|Adverse Event|9|||
161966095|NCT01866111|584921986|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
161739329|NCT00418379|584084746|FG001|Year 1|Adverse Event|15|||
161739330|NCT00418379|584084747|FG002|Year 1|Adverse Event|3|||
161966096|NCT01866111|584921987|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
161966097|NCT01866111|584921984|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
161966098|NCT01866111|584921985|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
161739331|NCT00418379|584084745|FG000|Year 1|Withdrawal by Subject|7|||
161739332|NCT00418379|584084746|FG001|Year 1|Withdrawal by Subject|8|||
161739333|NCT00418379|584084747|FG002|Year 1|Withdrawal by Subject|5|||
161739334|NCT00418379|584084745|FG000|Year 1|Any other reason not above-mentioned|2|||
161739335|NCT00418379|584084746|FG001|Year 1|Any other reason not above-mentioned|5|||
161739336|NCT00418379|584084747|FG002|Year 1|Any other reason not above-mentioned|7|||
161739337|NCT00418379|584084745|FG000|Year 2|Adverse Event|5|||
161739338|NCT00418379|584084746|FG001|Year 2|Adverse Event|2|||
161739339|NCT00418379|584084747|FG002|Year 2|Adverse Event|1|||
161739340|NCT00418379|584084745|FG000|Year 2|Withdrawal by Subject|1|||
161739341|NCT00418379|584084746|FG001|Year 2|Withdrawal by Subject|1|||
161739342|NCT00418379|584084747|FG002|Year 2|Withdrawal by Subject|3|||
161739343|NCT00418379|584084745|FG000|Year 2|Any other reason not above-mentioned|2|||
161739344|NCT00418379|584084746|FG001|Year 2|Any other reason not above-mentioned|1|||
161739345|NCT00418379|584084747|FG002|Year 2|Any other reason not above-mentioned|6|||
161739346|NCT00418379|584084745|FG000|Year 3|Withdrawal by Subject|1|||
161739347|NCT00418379|584084746|FG001|Year 3|Withdrawal by Subject|1|||
161739348|NCT00418379|584084747|FG002|Year 3|Withdrawal by Subject|2|||
161739349|NCT00418379|584084745|FG000|Year 3|Any other reason not above-mentioned|2|||
161739350|NCT00418379|584084746|FG001|Year 3|Any other reason not above-mentioned|1|||
161739351|NCT00418379|584084747|FG002|Year 3|Any other reason not above-mentioned|1|||
161739352|NCT00418379|584084745|FG000|Year 4|Adverse Event|0|||
161739353|NCT00418379|584084746|FG001|Year 4|Adverse Event|1|||
161739354|NCT00418379|584084747|FG002|Year 4|Adverse Event|0|||
161739355|NCT00418379|584084745|FG000|Year 4|Withdrawal by Subject|2|||
161739356|NCT00418379|584084746|FG001|Year 4|Withdrawal by Subject|3|||
161739357|NCT00418379|584084747|FG002|Year 4|Withdrawal by Subject|2|||
161739358|NCT00418379|584084745|FG000|Year 4|Any other reason not above-mentioned|1|||
161739359|NCT00418379|584084746|FG001|Year 4|Any other reason not above-mentioned|1|||
161739360|NCT00418379|584084747|FG002|Year 4|Any other reason not above-mentioned|0|||
161739361|NCT00418379|584084745|FG000|Year 5|Adverse Event|0|||
161739362|NCT00418379|584084746|FG001|Year 5|Adverse Event|1|||
161739363|NCT00418379|584084747|FG002|Year 5|Adverse Event|0|||
161739364|NCT00418379|584084745|FG000|Year 5|Any other reason not above-mentioned|2|||
161739365|NCT00418379|584084746|FG001|Year 5|Any other reason not above-mentioned|4|||
161739366|NCT00418379|584084747|FG002|Year 5|Any other reason not above-mentioned|3|||
161739367|NCT00843843|584084748|FG000|Overall Study|Physician Decision|1|||
161739368|NCT00843843|584084749|FG001|Overall Study|Physician Decision|1|||
161739369|NCT00843843|584084748|FG000|Overall Study|Protocol Violation|1|||
161739370|NCT00843843|584084749|FG001|Overall Study|Protocol Violation|1|||
161739371|NCT01797965|584084750|FG000|Overall Study|Adverse Event|104|||
161739372|NCT01797965|584084751|FG001|Overall Study|Adverse Event|129|||
161739373|NCT01797965|584084752|FG002|Overall Study|Adverse Event|4|||
161739374|NCT01797965|584084753|FG003|Overall Study|Adverse Event|21|||
161739375|NCT01797965|584084750|FG000|Overall Study|Lost to Follow-up|9|||
161739376|NCT01797965|584084751|FG001|Overall Study|Lost to Follow-up|8|||
161739377|NCT01797965|584084752|FG002|Overall Study|Lost to Follow-up|1|||
161739378|NCT01797965|584084753|FG003|Overall Study|Lost to Follow-up|2|||
161739379|NCT01797965|584084750|FG000|Overall Study|Consent withdrawn|130|||
161739380|NCT01797965|584084751|FG001|Overall Study|Consent withdrawn|117|||
161739381|NCT01797965|584084752|FG002|Overall Study|Consent withdrawn|3|||
161739382|NCT01797965|584084753|FG003|Overall Study|Consent withdrawn|35|||
161739383|NCT01797965|584084750|FG000|Overall Study|Investigator decision|21|||
161739384|NCT01797965|584084751|FG001|Overall Study|Investigator decision|15|||
161739385|NCT01797965|584084752|FG002|Overall Study|Investigator decision|0|||
161739386|NCT01797965|584084753|FG003|Overall Study|Investigator decision|0|||
161739387|NCT01797965|584084750|FG000|Overall Study|Death|2|||
161739388|NCT01797965|584084751|FG001|Overall Study|Death|4|||
161739389|NCT01797965|584084752|FG002|Overall Study|Death|0|||
161739390|NCT01797965|584084753|FG003|Overall Study|Death|0|||
161739391|NCT01797965|584084750|FG000|Overall Study|Disease progression, defined by protocol|3|||
161739392|NCT01797965|584084751|FG001|Overall Study|Disease progression, defined by protocol|1|||
161739393|NCT01797965|584084752|FG002|Overall Study|Disease progression, defined by protocol|0|||
161739394|NCT01797965|584084753|FG003|Overall Study|Disease progression, defined by protocol|0|||
161739395|NCT01797965|584084750|FG000|Overall Study|Reason Not Specified|280|||
161739396|NCT01797965|584084751|FG001|Overall Study|Reason Not Specified|295|||
161739397|NCT01797965|584084752|FG002|Overall Study|Reason Not Specified|0|||
161739398|NCT01797965|584084753|FG003|Overall Study|Reason Not Specified|15|||
161739399|NCT01764256|584084754|FG000|Received All Vaccinations|Adverse Event|1|||
161739400|NCT01764256|584084755|FG001|Received All Vaccinations|Adverse Event|1|||
161739401|NCT01764256|584084756|FG002|Received All Vaccinations|Adverse Event|0|||
161739402|NCT01764256|584084757|FG003|Received All Vaccinations|Adverse Event|0|||
161739403|NCT01764256|584084754|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
161739404|NCT01764256|584084755|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
161739405|NCT01764256|584084756|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
161739406|NCT01764256|584084757|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
161739407|NCT01764256|584084754|FG000|Received All Vaccinations|Lost to Follow-up|1|||
161739408|NCT01764256|584084755|FG001|Received All Vaccinations|Lost to Follow-up|0|||
161739409|NCT01764256|584084756|FG002|Received All Vaccinations|Lost to Follow-up|0|||
161739410|NCT01764256|584084757|FG003|Received All Vaccinations|Lost to Follow-up|0|||
161739411|NCT01764256|584084754|FG000|Completed Study|Lost to Follow-up|0|||
161739412|NCT01764256|584084755|FG001|Completed Study|Lost to Follow-up|0|||
161739413|NCT01764256|584084756|FG002|Completed Study|Lost to Follow-up|0|||
161739414|NCT01764256|584084757|FG003|Completed Study|Lost to Follow-up|1|||
161739415|NCT00304915|584084758|FG000|Overall Study|Lost to Follow-up|11|||
161739416|NCT00304915|584084759|FG001|Overall Study|Lost to Follow-up|11|||
161739417|NCT00304915|584084758|FG000|Overall Study|Death|4|||
161739418|NCT00304915|584084759|FG001|Overall Study|Death|5|||
161739419|NCT00304915|584084758|FG000|Overall Study|Withdrawal by Subject|3|||
161739420|NCT00304915|584084759|FG001|Overall Study|Withdrawal by Subject|0|||
161739421|NCT00565058|584084760|FG000|Overall Study|Adverse Event|1|||
161739422|NCT00565058|584084761|FG001|Overall Study|Adverse Event|0|||
161739423|NCT02029638|584084762|FG000|Overall Study|Death|0|||
161739424|NCT02029638|584084763|FG001|Overall Study|Death|0|||
161739425|NCT02029638|584084764|FG002|Overall Study|Death|1|||
161739426|NCT02029638|584084762|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
161739427|NCT02029638|584084763|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
161739428|NCT02029638|584084764|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
161739429|NCT00363246|584084774|FG000|Overall Study|Death|40|||
161739430|NCT00363246|584084774|FG000|Overall Study|Withdrawal by Subject|19|||
161739431|NCT00363246|584084774|FG000|Overall Study|Lost to Follow-up|14|||
161739432|NCT00363246|584084774|FG000|Overall Study|Bad health|6|||
161739433|NCT00363246|584084774|FG000|Overall Study|Stopped using wheelchair|11|||
161739434|NCT00363246|584084774|FG000|Overall Study|Subject expressed security concerns|2|||
161739435|NCT00363246|584084774|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
161739436|NCT00264849|584084775|FG000|Overall Study|Adverse Event|7|||
161739437|NCT00264849|584084776|FG001|Overall Study|Adverse Event|2|||
161739438|NCT00264849|584084775|FG000|Overall Study|Withdrawal by Subject|7|||
161739439|NCT00264849|584084776|FG001|Overall Study|Withdrawal by Subject|11|||
161739440|NCT00264849|584084775|FG000|Overall Study|Protocol Violation|5|||
161739441|NCT00264849|584084776|FG001|Overall Study|Protocol Violation|3|||
161739442|NCT00264849|584084775|FG000|Overall Study|Lack of Efficacy|1|||
161739443|NCT00264849|584084776|FG001|Overall Study|Lack of Efficacy|6|||
161739444|NCT00264849|584084775|FG000|Overall Study|Lost to Follow-up|0|||
161739445|NCT00264849|584084776|FG001|Overall Study|Lost to Follow-up|2|||
161739446|NCT00264849|584084775|FG000|Overall Study|Death|0|||
161739447|NCT00264849|584084776|FG001|Overall Study|Death|1|||
161739448|NCT00264849|584084775|FG000|Overall Study|Administrative Problems|2|||
161739449|NCT00264849|584084776|FG001|Overall Study|Administrative Problems|0|||
161739450|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
161739451|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
161739452|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
161739453|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
161739454|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
161739455|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
161739456|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
161739457|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
161739458|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
161739459|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
161739460|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
161739461|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
161739462|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
161739463|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
161739464|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
161739465|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
161739466|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
161739467|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
161739468|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
161739469|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
161739470|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
161739471|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
161739472|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
161739473|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
161739474|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
161739475|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
161739476|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
161739477|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
161739478|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
161739479|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
161739480|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
161739481|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
161739482|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
161739483|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
161739484|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
161739485|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
161739486|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
161739487|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
161739488|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
161739489|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
161739490|NCT00383721|584084777|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
161739491|NCT00383721|584084778|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
161739492|NCT00383721|584084779|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
161739493|NCT00383721|584084780|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
161739494|NCT00383721|584084781|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
161739495|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
161739496|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
161739497|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
161739498|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
161739499|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
161739500|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
161739501|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
161739502|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
161739503|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
161739504|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
161739505|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
161739506|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
161739507|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
161739508|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
161739509|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
161739510|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
161739511|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
161739512|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
161739513|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
161739514|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
161739515|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161739516|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161739517|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161739518|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161739519|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
161739520|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
161739521|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
161739522|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
161739523|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
161739524|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
161739525|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
161739526|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
161739527|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
161739528|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
161739529|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
161739530|NCT00383721|584084777|FG000|26-Week Treatment Safety Extension|Administrative|1|||
161739531|NCT00383721|584084778|FG001|26-Week Treatment Safety Extension|Administrative|2|||
161840524|NCT00290251|584460579|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
161840525|NCT00290251|584460574|FG000|Treatment 1 (Months 2-4)|headache|0|||
161840526|NCT00290251|584460575|FG001|Treatment 1 (Months 2-4)|headache|0|||
161840527|NCT00290251|584460576|FG002|Treatment 1 (Months 2-4)|headache|0|||
161840528|NCT00290251|584460577|FG003|Treatment 1 (Months 2-4)|headache|0|||
161840529|NCT00290251|584460578|FG004|Treatment 1 (Months 2-4)|headache|1|||
161840530|NCT00290251|584460579|FG005|Treatment 1 (Months 2-4)|headache|0|||
161840531|NCT00290251|584460574|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
161840532|NCT00290251|584460575|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
161840533|NCT00290251|584460576|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
161966099|NCT01866111|584921986|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
161966100|NCT01866111|584921987|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
161966101|NCT01866111|584921984|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
161966102|NCT01866111|584921985|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
161966103|NCT01866111|584921986|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
161966104|NCT01866111|584921987|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
161966105|NCT01866111|584921984|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
161966106|NCT01866111|584921985|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
161966107|NCT01866111|584921986|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
161966108|NCT01866111|584921987|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
161966109|NCT01866111|584921984|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
161966110|NCT01866111|584921985|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
161966111|NCT01866111|584921986|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
161739532|NCT00383721|584084779|FG002|26-Week Treatment Safety Extension|Administrative|3|||
161739533|NCT00383721|584084780|FG003|26-Week Treatment Safety Extension|Administrative|1|||
161739534|NCT00383721|584084781|FG004|26-Week Treatment Safety Extension|Administrative|0|||
161739535|NCT00949910|584086521|FG000|Overall Study|Progressive Disease|3750|||
161739536|NCT00949910|584086521|FG000|Overall Study|Symptomatic Deterioration|1088|||
161739537|NCT00949910|584086521|FG000|Overall Study|Lost to Follow-up|100|||
161739538|NCT00949910|584086521|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
161739539|NCT00949910|584086521|FG000|Overall Study|Participant Refusal|390|||
161739540|NCT00949910|584086521|FG000|Overall Study|Death Due to Malignant Disease|456|||
161739541|NCT00949910|584086521|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
161739542|NCT00949910|584086521|FG000|Overall Study|Death Due to Adverse Event|115|||
161739543|NCT00949910|584086521|FG000|Overall Study|Death Due to Toxicity|3|||
161739544|NCT00949910|584086521|FG000|Overall Study|Death from Unknown Cause|5|||
161739545|NCT00949910|584086521|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
161739546|NCT00949910|584086521|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
161739547|NCT00949910|584086521|FG000|Overall Study|Switched to Commercial Treatment|4|||
161739548|NCT00949910|584086521|FG000|Overall Study|Violation of Eligibility|23|||
161739549|NCT00949910|584086521|FG000|Overall Study|Logistical Reasons|13|||
161739550|NCT00949910|584086521|FG000|Overall Study|Non-Compliance|10|||
161739551|NCT00949910|584086521|FG000|Overall Study|Prolonged Dosing Interruption|4|||
161739552|NCT00949910|584086521|FG000|Overall Study|Adverse Event|83|||
161739553|NCT00949910|584086521|FG000|Overall Study|Serious Adverse Event|6|||
161739554|NCT00949910|584086521|FG000|Overall Study|Physician/Participant Decision|7|||
161739555|NCT00949910|584086521|FG000|Overall Study|Other|4|||
161739556|NCT00949910|584086521|FG000|Overall Study|No Data|9|||
161739557|NCT00971425|584086522|FG000|Overall Study|Adverse Event|1|||
161739558|NCT00971425|584086523|FG001|Overall Study|Adverse Event|1|||
161739559|NCT00971425|584086522|FG000|Overall Study|Withdrawal by Subject|0|||
161739560|NCT00971425|584086523|FG001|Overall Study|Withdrawal by Subject|1|||
161739561|NCT00132314|584086524|FG000|Overall Study|Lost to Follow-up|70|||
161739562|NCT00132314|584086525|FG001|Overall Study|Lost to Follow-up|62|||
161739563|NCT00132314|584086524|FG000|Overall Study|Lacked SSN|1|||
161739564|NCT00132314|584086525|FG001|Overall Study|Lacked SSN|3|||
161739565|NCT00132314|584086524|FG000|Overall Study|Refused intervention at baseline|2|||
161739566|NCT00132314|584086525|FG001|Overall Study|Refused intervention at baseline|7|||
161739567|NCT01453998|584086542|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
161739568|NCT01453998|584086543|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
161739569|NCT01453998|584086544|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
161739570|NCT01840228|584086551|FG000|Overall Study|Lost to Follow-up|1|||
161739571|NCT01840228|584086552|FG001|Overall Study|Lost to Follow-up|1|||
161739572|NCT00712933|584086553|FG000|Overall Study|Adverse Event|69|||
161739573|NCT00712933|584086553|FG000|Overall Study|Lack of Efficacy|6|||
161739574|NCT00712933|584086553|FG000|Overall Study|Lost to Follow-up|22|||
161739575|NCT00712933|584086553|FG000|Overall Study|Non-compliance with study drug|13|||
161739576|NCT00712933|584086553|FG000|Overall Study|Other Pregnancy|37|||
161739577|NCT00712933|584086553|FG000|Overall Study|Sponsor decision|14|||
161739578|NCT00712933|584086553|FG000|Overall Study|Withdrew consent|4|||
161739579|NCT00712933|584086553|FG000|Overall Study|Hip replacement surgery|1|||
161739580|NCT00712933|584086553|FG000|Overall Study|Involved in Clinical research|3|||
161739581|NCT00712933|584086553|FG000|Overall Study|Participant hospitalized|1|||
161739582|NCT00712933|584086553|FG000|Overall Study|Participant travelled overseas|2|||
161739583|NCT00712933|584086553|FG000|Overall Study|Death of patient|1|||
161739584|NCT00712933|584086553|FG000|Overall Study|Other Physician decision|1|||
161739585|NCT00712933|584086553|FG000|Overall Study|Not committed to contraception|1|||
161739586|NCT00712933|584086553|FG000|Overall Study|Participant received medication|1|||
161739587|NCT00712933|584086553|FG000|Overall Study|Physician Decision|36|||
161739588|NCT00712933|584086553|FG000|Overall Study|Protocol Violation|4|||
161739589|NCT00712933|584086553|FG000|Overall Study|Withdrawal by Subject|151|||
161739590|NCT02022033|584086559|FG000|Overall Study|Physician Decision|1|||
161739591|NCT01429077|584086560|FG000|Overall Study|Lost to Follow-up|0|||
161739592|NCT01429077|584086561|FG001|Overall Study|Lost to Follow-up|3|||
161739593|NCT01413542|584086563|FG000|Overall Study|Physician Decision|1|||
161739594|NCT01413542|584086564|FG001|Overall Study|Physician Decision|0|||
161739595|NCT01413542|584086565|FG002|Overall Study|Physician Decision|3|||
161739596|NCT01413542|584086566|FG003|Overall Study|Physician Decision|0|||
161739597|NCT01413542|584086563|FG000|Overall Study|Adverse Event|0|||
161739598|NCT01413542|584086564|FG001|Overall Study|Adverse Event|0|||
161739599|NCT01413542|584086565|FG002|Overall Study|Adverse Event|0|||
161739600|NCT01413542|584086566|FG003|Overall Study|Adverse Event|1|||
161739601|NCT00065442|584086568|FG000|Overall Study|Lost to Follow-up|1|||
161739602|NCT00065442|584086569|FG001|Overall Study|Lost to Follow-up|1|||
161739603|NCT00065442|584086568|FG000|Overall Study|Death|121|||
161739604|NCT00065442|584086569|FG001|Overall Study|Death|210|||
161739605|NCT00065442|584086568|FG000|Overall Study|Withdrawal by Subject|3|||
161739606|NCT00065442|584086569|FG001|Overall Study|Withdrawal by Subject|9|||
161739607|NCT05489081|584086573|FG000|Overall Study|student left classroom|0|||
161739608|NCT05489081|584086574|FG001|Overall Study|student left classroom|1|||
161739609|NCT05489081|584086573|FG000|Overall Study|teacher left school|0|||
161739610|NCT05489081|584086574|FG001|Overall Study|teacher left school|2|||
161739611|NCT00712322|584086578|FG000|Overall Study|Protocol deviation|0|||
161739612|NCT00712322|584086579|FG001|Overall Study|Protocol deviation|1|||
161739613|NCT00712322|584086580|FG002|Overall Study|Protocol deviation|0|||
161739614|NCT00973921|584086582|FG000|Overall Study|IVUS results were not available|9|||
161739615|NCT00400712|584086593|FG000|Overall Study|Death|1|||
161739616|NCT00400712|584086594|FG001|Overall Study|Death|0|||
161739617|NCT00400712|584086593|FG000|Overall Study|Withdrawal by Subject|11|||
161739618|NCT00400712|584086594|FG001|Overall Study|Withdrawal by Subject|12|||
161739619|NCT00400712|584086593|FG000|Overall Study|Physician Decision|5|||
161739620|NCT00400712|584086594|FG001|Overall Study|Physician Decision|4|||
161739621|NCT02670330|584086595|FG000|Overall Study|Protocol Deviation|1|||
161739622|NCT02670330|584086596|FG001|Overall Study|Protocol Deviation|0|||
161739623|NCT02670330|584086595|FG000|Overall Study|Study Terminated By Sponsor|36|||
161739624|NCT02670330|584086596|FG001|Overall Study|Study Terminated By Sponsor|43|||
161739625|NCT02670330|584086595|FG000|Overall Study|Adverse Event|1|||
161739626|NCT02670330|584086596|FG001|Overall Study|Adverse Event|3|||
161739627|NCT02670330|584086595|FG000|Overall Study|Withdrawal by Subject|34|||
161739628|NCT02670330|584086596|FG001|Overall Study|Withdrawal by Subject|29|||
161739629|NCT02670330|584086595|FG000|Overall Study|Lost to Follow-up|3|||
161739630|NCT02670330|584086596|FG001|Overall Study|Lost to Follow-up|2|||
161739631|NCT04404010|584086597|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
161739632|NCT04404010|584086598|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
161739633|NCT02120157|584086599|FG000|Overall Study|Death|8|||
161739634|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
161739635|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
161739636|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
161739637|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
161739638|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
161739639|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
161739640|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Death|1|||
161739641|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Death|3|||
161739642|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
161739643|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
161739644|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
161739645|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
161739646|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
161739647|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
161739648|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
161739649|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
161739650|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
161739651|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
161739652|NCT02553317|584086600|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
161739653|NCT02553317|584086601|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
161966112|NCT01866111|584921987|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
161966113|NCT01866111|584921984|FG000|Open-label Extension Study YKP3089C017|Death|1|||
161966114|NCT01866111|584921985|FG001|Open-label Extension Study YKP3089C017|Death|1|||
161966115|NCT01866111|584921986|FG002|Open-label Extension Study YKP3089C017|Death|3|||
161966116|NCT01866111|584921987|FG003|Open-label Extension Study YKP3089C017|Death|2|||
161966117|NCT01866111|584921984|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
161966118|NCT01866111|584921985|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
161966119|NCT01866111|584921986|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
161966120|NCT01866111|584921987|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
161966121|NCT01866111|584921984|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
161966122|NCT01866111|584921985|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
161739654|NCT00634114|584086605|FG000|Overall Study|Adverse Event|6|||
161739655|NCT00634114|584086606|FG001|Overall Study|Adverse Event|8|||
161739656|NCT00634114|584086607|FG002|Overall Study|Adverse Event|3|||
161739657|NCT00634114|584086605|FG000|Overall Study|Withdrawal by Subject|9|||
161739658|NCT00634114|584086606|FG001|Overall Study|Withdrawal by Subject|6|||
161739659|NCT00634114|584086607|FG002|Overall Study|Withdrawal by Subject|11|||
161739660|NCT00634114|584086605|FG000|Overall Study|Lost to Follow-up|0|||
161739661|NCT00634114|584086606|FG001|Overall Study|Lost to Follow-up|0|||
161739662|NCT00634114|584086607|FG002|Overall Study|Lost to Follow-up|1|||
161739663|NCT00634114|584086605|FG000|Overall Study|Protocol Violation|3|||
161739664|NCT00634114|584086606|FG001|Overall Study|Protocol Violation|3|||
161739665|NCT00634114|584086607|FG002|Overall Study|Protocol Violation|1|||
161739666|NCT00634114|584086605|FG000|Overall Study|Pregnancy|1|||
161739667|NCT00634114|584086606|FG001|Overall Study|Pregnancy|0|||
161739668|NCT00634114|584086607|FG002|Overall Study|Pregnancy|0|||
161739669|NCT00634114|584086605|FG000|Overall Study|Incorrect enrolment|0|||
161739670|NCT00634114|584086606|FG001|Overall Study|Incorrect enrolment|1|||
161739671|NCT00634114|584086607|FG002|Overall Study|Incorrect enrolment|0|||
161739672|NCT00634114|584086605|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
161739673|NCT00634114|584086606|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
161739674|NCT00634114|584086607|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
161739675|NCT00634114|584086605|FG000|Overall Study|Difficult to continue|3|||
161739676|NCT00634114|584086606|FG001|Overall Study|Difficult to continue|1|||
161739677|NCT00634114|584086607|FG002|Overall Study|Difficult to continue|1|||
161739678|NCT00634114|584086605|FG000|Overall Study|Other reason|1|||
161739679|NCT00634114|584086606|FG001|Overall Study|Other reason|1|||
161739680|NCT00634114|584086607|FG002|Overall Study|Other reason|1|||
161739681|NCT01599754|584086608|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
161739682|NCT01599754|584086609|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
161739683|NCT01599754|584086608|FG000|Overall Study|Participant noncompliance|4|||
161739684|NCT01599754|584086609|FG001|Overall Study|Participant noncompliance|4|||
161739685|NCT01599754|584086608|FG000|Overall Study|Lost to Follow-up|13|||
161739686|NCT01599754|584086609|FG001|Overall Study|Lost to Follow-up|6|||
161739687|NCT01599754|584086608|FG000|Overall Study|Death|31|||
161739688|NCT01599754|584086609|FG001|Overall Study|Death|33|||
161739689|NCT01599754|584086608|FG000|Overall Study|Adverse Event|3|||
161739690|NCT01599754|584086609|FG001|Overall Study|Adverse Event|2|||
161739691|NCT01599754|584086608|FG000|Overall Study|Investigator decision|1|||
161739692|NCT01599754|584086609|FG001|Overall Study|Investigator decision|3|||
161739693|NCT01599754|584086608|FG000|Overall Study|Withdrawal by Subject|24|||
161739694|NCT01599754|584086609|FG001|Overall Study|Withdrawal by Subject|25|||
161739695|NCT01599754|584086608|FG000|Overall Study|Study terminated by sponsor|282|||
161739696|NCT01599754|584086609|FG001|Overall Study|Study terminated by sponsor|285|||
161739697|NCT03670641|584086614|FG000|Overall Study|Lost to Follow-up|3|||
161739698|NCT00916370|584086620|FG000|Overall Study|Death|3|||
161739699|NCT00916370|584086621|FG001|Overall Study|Death|1|||
161739700|NCT00916370|584086620|FG000|Overall Study|Withdrawal by Subject|2|||
161739701|NCT00916370|584086621|FG001|Overall Study|Withdrawal by Subject|0|||
161739702|NCT00916370|584086620|FG000|Overall Study|Physician Decision|0|||
161739703|NCT00916370|584086621|FG001|Overall Study|Physician Decision|1|||
161739704|NCT03550131|584086622|FG000|Overall Study|Lost to Follow-up|16|||
161739705|NCT03550131|584086623|FG001|Overall Study|Lost to Follow-up|24|||
161739706|NCT03550131|584086622|FG000|Overall Study|Withdrawal by Subject|36|||
161739707|NCT03550131|584086623|FG001|Overall Study|Withdrawal by Subject|28|||
161739708|NCT03550131|584086622|FG000|Overall Study|Illness of dyad member|10|||
161739709|NCT03550131|584086623|FG001|Overall Study|Illness of dyad member|2|||
161739710|NCT03550131|584086622|FG000|Overall Study|Death of person with dementia|4|||
161739711|NCT03550131|584086623|FG001|Overall Study|Death of person with dementia|8|||
161739712|NCT00414960|584086624|FG000|Overall Study|Adverse Event|4|||
161739713|NCT00414960|584086625|FG001|Overall Study|Adverse Event|0|||
161739714|NCT00414960|584086624|FG000|Overall Study|Withdrawal by Subject|3|||
161739715|NCT00414960|584086625|FG001|Overall Study|Withdrawal by Subject|0|||
161739716|NCT00414960|584086624|FG000|Overall Study|Physician Decision|0|||
161739717|NCT00414960|584086625|FG001|Overall Study|Physician Decision|1|||
161739718|NCT01318512|584086626|FG000|Maintenance Period (6 Months)|Death|2|||
161739719|NCT01318512|584086626|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
161739720|NCT02756650|584086629|FG000|Overall Study|Physician Decision|1|||
161739721|NCT02756650|584086629|FG000|Overall Study|Adverse Event|1|||
161739722|NCT00622869|584086634|FG000|Overall Study|Subject Withdrew Consent|13|||
161739723|NCT00622869|584086635|FG001|Overall Study|Subject Withdrew Consent|17|||
161739724|NCT00622869|584086636|FG002|Overall Study|Subject Withdrew Consent|11|||
161739725|NCT00622869|584086634|FG000|Overall Study|Administrative Problems|11|||
161966123|NCT01866111|584921986|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
161966124|NCT01866111|584921987|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
161739726|NCT00622869|584086635|FG001|Overall Study|Administrative Problems|17|||
161739727|NCT00622869|584086636|FG002|Overall Study|Administrative Problems|13|||
161739728|NCT00622869|584086634|FG000|Overall Study|Death|12|||
161739729|NCT00622869|584086635|FG001|Overall Study|Death|15|||
161840534|NCT00290251|584460577|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
161739730|NCT00622869|584086636|FG002|Overall Study|Death|10|||
161739731|NCT00622869|584086634|FG000|Overall Study|Lost to Follow-up|2|||
161739732|NCT00622869|584086635|FG001|Overall Study|Lost to Follow-up|4|||
161739733|NCT00622869|584086636|FG002|Overall Study|Lost to Follow-up|2|||
161739734|NCT00622869|584086634|FG000|Overall Study|Graft Loss|5|||
161739735|NCT00622869|584086635|FG001|Overall Study|Graft Loss|3|||
161739736|NCT00622869|584086636|FG002|Overall Study|Graft Loss|2|||
161739737|NCT00622869|584086634|FG000|Overall Study|Missing|0|||
161739738|NCT00622869|584086635|FG001|Overall Study|Missing|1|||
161739739|NCT00622869|584086636|FG002|Overall Study|Missing|1|||
161739740|NCT04348591|584086637|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
161739741|NCT04348591|584086638|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
161739742|NCT04348591|584086637|FG000|Imaging Session (120 Min)|Physician Decision|0|||
161739743|NCT04348591|584086638|FG001|Imaging Session (120 Min)|Physician Decision|1|||
161739744|NCT04348591|584086637|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
161739745|NCT04348591|584086638|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
161739746|NCT03722784|584086642|FG000|Overall Study|Withdrawal by Subject|1|||
161739747|NCT03722784|584086643|FG001|Overall Study|Withdrawal by Subject|0|||
161739748|NCT03722784|584086642|FG000|Overall Study|Physician Decision|1|||
161739749|NCT03722784|584086643|FG001|Overall Study|Physician Decision|1|||
161739750|NCT03722784|584086642|FG000|Overall Study|Protocol Violation|0|||
161739751|NCT03722784|584086643|FG001|Overall Study|Protocol Violation|1|||
161739752|NCT00910429|584086646|FG000|Overall Study|Death|18|||
161739753|NCT00910429|584086647|FG001|Overall Study|Death|12|||
161739754|NCT00910429|584086646|FG000|Overall Study|Withdrawal by Subject|3|||
161739755|NCT00910429|584086647|FG001|Overall Study|Withdrawal by Subject|2|||
161739756|NCT00910429|584086646|FG000|Overall Study|Protocol Violation|1|||
161739757|NCT00910429|584086647|FG001|Overall Study|Protocol Violation|0|||
161739758|NCT00910429|584086646|FG000|Overall Study|Lost to Follow-up|2|||
161739759|NCT00910429|584086647|FG001|Overall Study|Lost to Follow-up|1|||
161739760|NCT00910429|584086646|FG000|Overall Study|Adverse Event|10|||
161739761|NCT00910429|584086647|FG001|Overall Study|Adverse Event|5|||
161739762|NCT00910429|584086646|FG000|Overall Study|Drug non-compliance|1|||
161739763|NCT00910429|584086647|FG001|Overall Study|Drug non-compliance|0|||
161739764|NCT00910429|584086646|FG000|Overall Study|Lack of Efficacy|4|||
161739765|NCT00910429|584086647|FG001|Overall Study|Lack of Efficacy|1|||
161739766|NCT01317615|584086648|FG000|Overall Study|Disease progression|25|||
161739767|NCT01317615|584086648|FG000|Overall Study|New cancer therapy|5|||
161739768|NCT01317615|584086648|FG000|Overall Study|Death|6|||
161739769|NCT01317615|584086648|FG000|Overall Study|Withdrawal by Subject|5|||
161739770|NCT01317615|584086648|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161739771|NCT01317615|584086648|FG000|Overall Study|Adverse Event|7|||
161739772|NCT02648724|584086651|FG000|Overall Study|Withdrawal by Subject|0|||
161739773|NCT02648724|584086652|FG001|Overall Study|Withdrawal by Subject|1|||
161739774|NCT02648724|584086653|FG002|Overall Study|Withdrawal by Subject|1|||
161739775|NCT02648724|584086654|FG003|Overall Study|Withdrawal by Subject|0|||
161739776|NCT02648724|584086655|FG004|Overall Study|Withdrawal by Subject|1|||
161739777|NCT02648724|584086656|FG005|Overall Study|Withdrawal by Subject|0|||
161739778|NCT02648724|584086657|FG006|Overall Study|Withdrawal by Subject|0|||
161739779|NCT02648724|584086651|FG000|Overall Study|Progressive disease|2|||
161739780|NCT02648724|584086652|FG001|Overall Study|Progressive disease|2|||
161739781|NCT02648724|584086653|FG002|Overall Study|Progressive disease|2|||
161840535|NCT00290251|584460578|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
161739782|NCT02648724|584086654|FG003|Overall Study|Progressive disease|3|||
161739783|NCT02648724|584086655|FG004|Overall Study|Progressive disease|22|||
161739784|NCT02648724|584086656|FG005|Overall Study|Progressive disease|7|||
161739785|NCT02648724|584086657|FG006|Overall Study|Progressive disease|8|||
161739786|NCT02648724|584086651|FG000|Overall Study|Other reason (unknown)|1|||
161840536|NCT00290251|584460579|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
161840537|NCT04941729|584462787|FG000|Overall Study|Death|0|||
161840538|NCT04941729|584462788|FG001|Overall Study|Death|1|||
161966125|NCT01866111|584921984|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
161966126|NCT01866111|584921985|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
161966127|NCT01866111|584921986|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
161966128|NCT01866111|584921987|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
161966129|NCT04113018|584921988|FG000|Overall Study|Death|2|||
161739787|NCT02648724|584086652|FG001|Overall Study|Other reason (unknown)|0|||
161739788|NCT02648724|584086653|FG002|Overall Study|Other reason (unknown)|0|||
161840539|NCT04941729|584462787|FG000|Overall Study|Study terminated by sponsor|11|||
161840540|NCT04941729|584462788|FG001|Overall Study|Study terminated by sponsor|10|||
161966130|NCT04113018|584921988|FG000|Overall Study|Lost to Follow-up|1|||
161966131|NCT04113018|584921988|FG000|Overall Study|Still On Study (on study treatment)|24|||
161966132|NCT04113018|584921988|FG000|Overall Study|Still On Study (in follow up)|12|||
161739789|NCT02648724|584086654|FG003|Overall Study|Other reason (unknown)|0|||
161739790|NCT02648724|584086655|FG004|Overall Study|Other reason (unknown)|0|||
161739791|NCT02648724|584086656|FG005|Overall Study|Other reason (unknown)|0|||
161739792|NCT02648724|584086657|FG006|Overall Study|Other reason (unknown)|0|||
161739793|NCT02648724|584086651|FG000|Overall Study|Protocol Violation|0|||
161739794|NCT02648724|584086652|FG001|Overall Study|Protocol Violation|0|||
161739795|NCT02648724|584086653|FG002|Overall Study|Protocol Violation|0|||
161739796|NCT02648724|584086654|FG003|Overall Study|Protocol Violation|0|||
161739797|NCT02648724|584086655|FG004|Overall Study|Protocol Violation|1|||
161840541|NCT00006721|584462789|FG000|Overall Study|Adverse Event|0|||
161840542|NCT00006721|584462790|FG001|Overall Study|Adverse Event|4|||
161840543|NCT00006721|584462791|FG002|Overall Study|Adverse Event|4|||
161840544|NCT00006721|584462789|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
161840545|NCT00006721|584462790|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
161840546|NCT00006721|584462791|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
161840547|NCT00006721|584462789|FG000|Overall Study|Progression/Relapse|0|||
161840548|NCT00006721|584462790|FG001|Overall Study|Progression/Relapse|1|||
161840549|NCT00006721|584462791|FG002|Overall Study|Progression/Relapse|2|||
161840550|NCT00006721|584462789|FG000|Overall Study|Death|0|||
161840551|NCT00006721|584462790|FG001|Overall Study|Death|1|||
161840552|NCT00006721|584462791|FG002|Overall Study|Death|2|||
161840553|NCT00006721|584462789|FG000|Overall Study|Other - Not Protocol Specified|0|||
161840554|NCT00006721|584462790|FG001|Overall Study|Other - Not Protocol Specified|7|||
161840555|NCT00006721|584462791|FG002|Overall Study|Other - Not Protocol Specified|7|||
161840556|NCT00006721|584462789|FG000|Overall Study|Ineligible|2|||
161840557|NCT00006721|584462790|FG001|Overall Study|Ineligible|12|||
161840558|NCT00006721|584462791|FG002|Overall Study|Ineligible|10|||
161840559|NCT00006721|584462789|FG000|Overall Study|Eligible but no Treatment Received|1|||
161840560|NCT00006721|584462790|FG001|Overall Study|Eligible but no Treatment Received|0|||
161840561|NCT00006721|584462791|FG002|Overall Study|Eligible but no Treatment Received|0|||
161739798|NCT02648724|584086656|FG005|Overall Study|Protocol Violation|0|||
161739799|NCT02648724|584086657|FG006|Overall Study|Protocol Violation|0|||
161739800|NCT02648724|584086651|FG000|Overall Study|Death|0|||
161739801|NCT02648724|584086652|FG001|Overall Study|Death|0|||
161739802|NCT02648724|584086653|FG002|Overall Study|Death|0|||
161739803|NCT02648724|584086654|FG003|Overall Study|Death|0|||
161739804|NCT02648724|584086655|FG004|Overall Study|Death|0|||
161739805|NCT02648724|584086656|FG005|Overall Study|Death|0|||
161739806|NCT02648724|584086657|FG006|Overall Study|Death|3|||
161739807|NCT02648724|584086651|FG000|Overall Study|Physician Decision|0|||
161739808|NCT02648724|584086652|FG001|Overall Study|Physician Decision|0|||
161739809|NCT02648724|584086653|FG002|Overall Study|Physician Decision|0|||
161739810|NCT02648724|584086654|FG003|Overall Study|Physician Decision|0|||
161739811|NCT02648724|584086655|FG004|Overall Study|Physician Decision|1|||
161739812|NCT02648724|584086656|FG005|Overall Study|Physician Decision|0|||
161739813|NCT02648724|584086657|FG006|Overall Study|Physician Decision|1|||
161739814|NCT02648724|584086651|FG000|Overall Study|Transferred to named patient program|0|||
161739815|NCT02648724|584086652|FG001|Overall Study|Transferred to named patient program|0|||
161739816|NCT02648724|584086653|FG002|Overall Study|Transferred to named patient program|0|||
161739817|NCT02648724|584086654|FG003|Overall Study|Transferred to named patient program|0|||
161739818|NCT02648724|584086655|FG004|Overall Study|Transferred to named patient program|0|||
161739819|NCT02648724|584086656|FG005|Overall Study|Transferred to named patient program|1|||
161739820|NCT02648724|584086657|FG006|Overall Study|Transferred to named patient program|0|||
161739821|NCT00302718|584086659|FG000|Overall Study|Participant left the hospital|1|||
161739822|NCT00302718|584086660|FG001|Overall Study|Participant left the hospital|0|||
161739823|NCT00302718|584086661|FG002|Overall Study|Participant left the hospital|0|||
161739824|NCT00302718|584086662|FG003|Overall Study|Participant left the hospital|1|||
161739825|NCT00302718|584086659|FG000|Overall Study|Withdrawal by Subject|0|||
161739826|NCT00302718|584086660|FG001|Overall Study|Withdrawal by Subject|1|||
161739827|NCT00302718|584086661|FG002|Overall Study|Withdrawal by Subject|0|||
161739828|NCT00302718|584086662|FG003|Overall Study|Withdrawal by Subject|0|||
161739829|NCT00302718|584086659|FG000|Overall Study|Participant left primary care setting|0|||
161739830|NCT00302718|584086660|FG001|Overall Study|Participant left primary care setting|0|||
161739831|NCT00302718|584086661|FG002|Overall Study|Participant left primary care setting|2|||
161739832|NCT00302718|584086662|FG003|Overall Study|Participant left primary care setting|1|||
161739833|NCT00738374|584086663|FG000|Induction Treatment Phase|Adverse Event|14|||
161739834|NCT00738374|584086664|FG001|Induction Treatment Phase|Adverse Event|0|||
161739835|NCT00738374|584086665|FG002|Induction Treatment Phase|Adverse Event|0|||
161739836|NCT00738374|584086666|FG003|Induction Treatment Phase|Adverse Event|0|||
161739837|NCT00738374|584086663|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
161739838|NCT00738374|584086664|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
161739839|NCT00738374|584086665|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
161739840|NCT00738374|584086666|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
161739841|NCT00738374|584086663|FG000|Induction Treatment Phase|Physician Decision|2|||
161966133|NCT00157196|584921989|FG000|Overall Study|Ongoing at data cut-off|9|||
161966134|NCT00583752|584921990|FG000|Overall Study|Lost to Follow-up|5|||
161966135|NCT00583752|584921991|FG001|Overall Study|Lost to Follow-up|5|||
161739842|NCT00738374|584086664|FG001|Induction Treatment Phase|Physician Decision|0|||
161840562|NCT03845296|584462792|FG000|Overall Study|On Treatment|2|||
161966136|NCT00526656|584921992|FG000|Overall Study|Death|1|||
161840563|NCT03845296|584462793|FG001|Overall Study|On Treatment|1|||
161966137|NCT00526656|584921992|FG000|Overall Study|Refused surgery|1|||
161840564|NCT03845296|584462792|FG000|Overall Study|Adverse Event|4|||
161840565|NCT03845296|584462793|FG001|Overall Study|Adverse Event|11|||
161739843|NCT00738374|584086665|FG002|Induction Treatment Phase|Physician Decision|0|||
161739844|NCT00738374|584086666|FG003|Induction Treatment Phase|Physician Decision|0|||
161739845|NCT00738374|584086663|FG000|Induction Treatment Phase|Protocol Violation|2|||
161739846|NCT00738374|584086664|FG001|Induction Treatment Phase|Protocol Violation|0|||
161739847|NCT00738374|584086665|FG002|Induction Treatment Phase|Protocol Violation|0|||
161739848|NCT00738374|584086666|FG003|Induction Treatment Phase|Protocol Violation|0|||
161739849|NCT00738374|584086663|FG000|Induction Treatment Phase|Non-compliance|1|||
161739850|NCT00738374|584086664|FG001|Induction Treatment Phase|Non-compliance|0|||
161739851|NCT00738374|584086665|FG002|Induction Treatment Phase|Non-compliance|0|||
161739852|NCT00738374|584086666|FG003|Induction Treatment Phase|Non-compliance|0|||
161739853|NCT00738374|584086663|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
161739854|NCT00738374|584086664|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
161739855|NCT00738374|584086665|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
161739856|NCT00738374|584086666|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
161739857|NCT00738374|584086663|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
161739858|NCT00738374|584086664|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
161739859|NCT00738374|584086665|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
161739860|NCT00738374|584086666|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
161739861|NCT00738374|584086663|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
161739862|NCT00738374|584086664|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
161739863|NCT00738374|584086665|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
161739864|NCT00738374|584086666|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
161739865|NCT00738374|584086663|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
161739866|NCT00738374|584086664|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
161739867|NCT00738374|584086665|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
161739868|NCT00738374|584086666|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
161739869|NCT00738374|584086663|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
161739870|NCT00738374|584086664|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
161739871|NCT00738374|584086665|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
161739872|NCT00738374|584086666|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
161739873|NCT00738374|584086663|FG000|Maintenance Treatment/Observation Phase|Other|0|||
161739874|NCT00738374|584086664|FG001|Maintenance Treatment/Observation Phase|Other|1|||
161739875|NCT00738374|584086665|FG002|Maintenance Treatment/Observation Phase|Other|0|||
161739876|NCT00738374|584086666|FG003|Maintenance Treatment/Observation Phase|Other|0|||
161739877|NCT00632541|584086667|FG000|Overall Study|Adverse Event|7|||
161739878|NCT02927873|584086668|FG000|Overall Study|Lost to Follow-up|0|||
161739879|NCT02927873|584086669|FG001|Overall Study|Lost to Follow-up|1|||
161739880|NCT02927873|584086670|FG002|Overall Study|Lost to Follow-up|0|||
161739881|NCT02927873|584086671|FG003|Overall Study|Lost to Follow-up|0|||
161739882|NCT02927873|584086672|FG004|Overall Study|Lost to Follow-up|0|||
161739883|NCT02927873|584086673|FG005|Overall Study|Lost to Follow-up|0|||
161739884|NCT02927873|584086668|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161739885|NCT02927873|584086669|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
161739886|NCT02927873|584086670|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161739887|NCT02927873|584086671|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161739888|NCT02927873|584086672|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161739889|NCT02927873|584086673|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161739890|NCT02927873|584086668|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161739891|NCT02927873|584086669|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161739892|NCT02927873|584086670|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161739893|NCT02927873|584086671|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161739894|NCT02927873|584086672|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161739895|NCT02927873|584086673|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161739896|NCT02927873|584086668|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161739897|NCT02927873|584086669|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
161739898|NCT02927873|584086670|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161739899|NCT02927873|584086671|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161739900|NCT02927873|584086672|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161739901|NCT02927873|584086673|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161739902|NCT02927873|584086668|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
161739903|NCT02927873|584086669|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161739904|NCT02927873|584086670|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161739905|NCT02927873|584086671|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
162032438|NCT00811642|585175489|FG000|Overall Study|Cumulative use of antifungal agent|2|||
162032439|NCT01395784|585175501|FG000|Overall Study|Lost to Follow-up|7|||
162032440|NCT01395784|585175501|FG000|Overall Study|Withdrawal by Subject|3|||
161840566|NCT03845296|584462792|FG000|Overall Study|Refusal unrelated to adverse event|0|||
161840567|NCT03845296|584462793|FG001|Overall Study|Refusal unrelated to adverse event|1|||
161840568|NCT03845296|584462792|FG000|Overall Study|Progression/relapse|14|||
161840569|NCT03845296|584462793|FG001|Overall Study|Progression/relapse|18|||
161840570|NCT03845296|584462792|FG000|Overall Study|Death|4|||
161840571|NCT03845296|584462793|FG001|Overall Study|Death|0|||
161840572|NCT03845296|584462792|FG000|Overall Study|Other - not protocol specified|1|||
161840573|NCT03845296|584462793|FG001|Overall Study|Other - not protocol specified|3|||
161840574|NCT05424042|584462794|FG000|Overall Study|Withdrawal by Subject|2|||
161840575|NCT05424042|584462795|FG001|Overall Study|Withdrawal by Subject|0|||
161840576|NCT05424042|584462796|FG002|Overall Study|Withdrawal by Subject|4|||
161840577|NCT05424042|584462794|FG000|Overall Study|Lost to Follow-up|0|||
161840578|NCT05424042|584462795|FG001|Overall Study|Lost to Follow-up|0|||
161840579|NCT05424042|584462796|FG002|Overall Study|Lost to Follow-up|1|||
161840580|NCT05091307|584462797|FG000|Overall Study|Death|0|||
161840581|NCT05091307|584462798|FG001|Overall Study|Death|0|||
161840582|NCT05091307|584462799|FG002|Overall Study|Death|1|||
161840583|NCT05091307|584462800|FG003|Overall Study|Death|0|||
161840584|NCT05091307|584462797|FG000|Overall Study|Lost to Follow-up|33|||
161840585|NCT05091307|584462798|FG001|Overall Study|Lost to Follow-up|33|||
161840586|NCT05091307|584462799|FG002|Overall Study|Lost to Follow-up|2|||
161840587|NCT05091307|584462800|FG003|Overall Study|Lost to Follow-up|0|||
161840588|NCT05091307|584462797|FG000|Overall Study|Physician Decision|1|||
161840589|NCT05091307|584462798|FG001|Overall Study|Physician Decision|0|||
161840590|NCT05091307|584462799|FG002|Overall Study|Physician Decision|0|||
161840591|NCT05091307|584462800|FG003|Overall Study|Physician Decision|0|||
161840592|NCT05091307|584462797|FG000|Overall Study|Protocol Violation|1|||
161840593|NCT05091307|584462798|FG001|Overall Study|Protocol Violation|0|||
161840594|NCT05091307|584462799|FG002|Overall Study|Protocol Violation|0|||
161840595|NCT05091307|584462800|FG003|Overall Study|Protocol Violation|0|||
161840596|NCT05091307|584462797|FG000|Overall Study|Withdrawal by Subject|16|||
161840597|NCT05091307|584462798|FG001|Overall Study|Withdrawal by Subject|16|||
161840598|NCT05091307|584462799|FG002|Overall Study|Withdrawal by Subject|0|||
161840599|NCT05091307|584462800|FG003|Overall Study|Withdrawal by Subject|1|||
161840600|NCT05091307|584462797|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
161840601|NCT05091307|584462798|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
161840602|NCT05091307|584462799|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
161840603|NCT05091307|584462800|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
161840604|NCT05091307|584462797|FG000|Overall Study|Initiated Prohibited Medication|1|||
161840605|NCT05091307|584462798|FG001|Overall Study|Initiated Prohibited Medication|0|||
161840606|NCT05091307|584462799|FG002|Overall Study|Initiated Prohibited Medication|0|||
161840607|NCT05091307|584462800|FG003|Overall Study|Initiated Prohibited Medication|0|||
161840608|NCT05091307|584462797|FG000|Overall Study|Other|4|||
161840609|NCT05091307|584462798|FG001|Overall Study|Other|4|||
161840610|NCT05091307|584462799|FG002|Overall Study|Other|0|||
161840611|NCT05091307|584462800|FG003|Overall Study|Other|0|||
161840612|NCT05091307|584462797|FG000|Overall Study|Randomized but not vaccinated|0|||
161840613|NCT05091307|584462798|FG001|Overall Study|Randomized but not vaccinated|2|||
161840614|NCT05091307|584462799|FG002|Overall Study|Randomized but not vaccinated|0|||
161840615|NCT05091307|584462800|FG003|Overall Study|Randomized but not vaccinated|0|||
161966138|NCT04091581|584921993|FG000|Overall Study|Lost to Follow-up|0|||
161966139|NCT04091581|584921994|FG001|Overall Study|Lost to Follow-up|1|||
161966140|NCT01795495|584921995|FG000|Overall Study|Protocol Violation|1|||
161966141|NCT01795495|584921996|FG001|Overall Study|Protocol Violation|0|||
161966142|NCT01795495|584921997|FG002|Overall Study|Protocol Violation|1|||
161966143|NCT01795495|584921995|FG000|Overall Study|Physician Decision|0|||
161966144|NCT01795495|584921996|FG001|Overall Study|Physician Decision|0|||
161966145|NCT01795495|584921997|FG002|Overall Study|Physician Decision|1|||
161966146|NCT01331837|584921998|FG000|Overall Study|Death|30|||
161966147|NCT01331837|584921999|FG001|Overall Study|Death|34|||
161966148|NCT01331837|584921998|FG000|Overall Study|Lost to Follow-up|3|||
161966149|NCT01331837|584921999|FG001|Overall Study|Lost to Follow-up|1|||
161840616|NCT04732221|584462803|FG000|Base Period|Death|2|||
161840617|NCT04732221|584462804|FG001|Base Period|Death|0|||
161840618|NCT04732221|584462805|FG002|Base Period|Death|0|||
161840619|NCT04732221|584462806|FG003|Base Period|Death|0|||
161840620|NCT04732221|584462807|FG004|Base Period|Death|0|||
161840621|NCT04732221|584462808|FG005|Base Period|Death|0|||
161840622|NCT04732221|584462809|FG006|Base Period|Death|0|||
161840623|NCT04732221|584462803|FG000|Base Period|Withdrawal by Subject|0|||
161840624|NCT04732221|584462804|FG001|Base Period|Withdrawal by Subject|1|||
161966150|NCT01331837|584921998|FG000|Overall Study|Info not recorded|10|||
161966151|NCT01331837|584921999|FG001|Overall Study|Info not recorded|16|||
161840625|NCT04732221|584462805|FG002|Base Period|Withdrawal by Subject|1|||
161840626|NCT04732221|584462806|FG003|Base Period|Withdrawal by Subject|0|||
161840627|NCT04732221|584462807|FG004|Base Period|Withdrawal by Subject|0|||
161840628|NCT04732221|584462808|FG005|Base Period|Withdrawal by Subject|0|||
161840629|NCT04732221|584462809|FG006|Base Period|Withdrawal by Subject|0|||
161840630|NCT04732221|584462803|FG000|Extension Period|Adverse Event|0|||
161840631|NCT04732221|584462804|FG001|Extension Period|Adverse Event|0|||
161739906|NCT02927873|584086672|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161739907|NCT02927873|584086673|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161739908|NCT02927873|584086668|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
161739909|NCT02927873|584086669|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161739910|NCT02927873|584086670|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161739911|NCT02927873|584086671|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161739912|NCT02927873|584086672|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161739913|NCT02927873|584086673|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161739914|NCT05757427|584086677|FG000|Overall Study|Adverse Event|1|||
161739915|NCT05757427|584086677|FG000|Overall Study|Device deficiency|1|||
161739916|NCT05757427|584086677|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
161739917|NCT05757427|584086677|FG000|Overall Study|MWBI scan of only 1 breast|3|||
161739918|NCT05757427|584086677|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
161739919|NCT02017899|584088727|FG000|Overall Study|Withdrawal by Subject|0|||
161739920|NCT02017899|584088728|FG001|Overall Study|Withdrawal by Subject|0|||
161739921|NCT02017899|584088729|FG002|Overall Study|Withdrawal by Subject|0|||
161739922|NCT02017899|584088730|FG003|Overall Study|Withdrawal by Subject|1|||
161739923|NCT02017899|584088731|FG004|Overall Study|Withdrawal by Subject|1|||
161739924|NCT02017899|584088732|FG005|Overall Study|Withdrawal by Subject|0|||
161739925|NCT02843178|584088733|FG000|Overall Study|Lost to Follow-up|8|||
161739926|NCT02843178|584088734|FG001|Overall Study|Lost to Follow-up|8|||
161739927|NCT02843178|584088735|FG002|Overall Study|Lost to Follow-up|6|||
161739928|NCT02843178|584088736|FG003|Overall Study|Lost to Follow-up|3|||
161739929|NCT02843178|584088733|FG000|Overall Study|Withdrawal by Subject|0|||
161739930|NCT02843178|584088734|FG001|Overall Study|Withdrawal by Subject|0|||
161739931|NCT02843178|584088735|FG002|Overall Study|Withdrawal by Subject|1|||
161739932|NCT02843178|584088736|FG003|Overall Study|Withdrawal by Subject|1|||
161739933|NCT02420795|584088744|FG000|Overall Study|Withdrawal by Subject|1|||
161739934|NCT02420795|584088745|FG001|Overall Study|Withdrawal by Subject|0|||
161739935|NCT02420795|584088746|FG002|Overall Study|Withdrawal by Subject|0|||
161739936|NCT02420795|584088744|FG000|Overall Study|Adverse Event|1|||
161739937|NCT02420795|584088745|FG001|Overall Study|Adverse Event|0|||
161739938|NCT02420795|584088746|FG002|Overall Study|Adverse Event|0|||
161739939|NCT02420795|584088744|FG000|Overall Study|Progressive disease|2|||
161739940|NCT02420795|584088745|FG001|Overall Study|Progressive disease|2|||
161739941|NCT02420795|584088746|FG002|Overall Study|Progressive disease|4|||
161739942|NCT02420795|584088744|FG000|Overall Study|Death|0|||
161739943|NCT02420795|584088745|FG001|Overall Study|Death|0|||
161739944|NCT02420795|584088746|FG002|Overall Study|Death|1|||
161739945|NCT02528253|584088749|FG000|Overall Study|Adverse Event|3|||
161739946|NCT02528253|584088750|FG001|Overall Study|Adverse Event|4|||
161739947|NCT02528253|584088751|FG002|Overall Study|Adverse Event|4|||
161739948|NCT02528253|584088752|FG003|Overall Study|Adverse Event|8|||
161739949|NCT02528253|584088753|FG004|Overall Study|Adverse Event|18|||
161739950|NCT02528253|584088749|FG000|Overall Study|Death|2|||
161739951|NCT02528253|584088750|FG001|Overall Study|Death|2|||
161739952|NCT02528253|584088751|FG002|Overall Study|Death|1|||
161739953|NCT02528253|584088752|FG003|Overall Study|Death|0|||
161739954|NCT02528253|584088753|FG004|Overall Study|Death|1|||
161739955|NCT02528253|584088749|FG000|Overall Study|Insufficient clinical response|7|||
161739956|NCT02528253|584088750|FG001|Overall Study|Insufficient clinical response|10|||
161739957|NCT02528253|584088751|FG002|Overall Study|Insufficient clinical response|13|||
161739958|NCT02528253|584088752|FG003|Overall Study|Insufficient clinical response|12|||
161739959|NCT02528253|584088753|FG004|Overall Study|Insufficient clinical response|16|||
161739960|NCT02528253|584088749|FG000|Overall Study|Lost to Follow-up|16|||
161739961|NCT02528253|584088750|FG001|Overall Study|Lost to Follow-up|9|||
161739962|NCT02528253|584088751|FG002|Overall Study|Lost to Follow-up|31|||
161739963|NCT02528253|584088752|FG003|Overall Study|Lost to Follow-up|16|||
161739964|NCT02528253|584088753|FG004|Overall Study|Lost to Follow-up|34|||
161739965|NCT02528253|584088749|FG000|Overall Study|Other|21|||
161739966|NCT02528253|584088750|FG001|Overall Study|Other|22|||
161739967|NCT02528253|584088751|FG002|Overall Study|Other|58|||
161739968|NCT02528253|584088752|FG003|Overall Study|Other|52|||
161739969|NCT02528253|584088753|FG004|Overall Study|Other|76|||
161739970|NCT02528253|584088749|FG000|Overall Study|Withdrawal by Subject|25|||
161739971|NCT02528253|584088750|FG001|Overall Study|Withdrawal by Subject|20|||
161739972|NCT02528253|584088751|FG002|Overall Study|Withdrawal by Subject|29|||
161739973|NCT02528253|584088752|FG003|Overall Study|Withdrawal by Subject|48|||
161739974|NCT02528253|584088753|FG004|Overall Study|Withdrawal by Subject|73|||
161739975|NCT02528253|584088749|FG000|Overall Study|Protocol Violation|1|||
161840632|NCT04732221|584462805|FG002|Extension Period|Adverse Event|0|||
161739976|NCT02528253|584088750|FG001|Overall Study|Protocol Violation|2|||
161739977|NCT02528253|584088751|FG002|Overall Study|Protocol Violation|4|||
161739978|NCT02528253|584088752|FG003|Overall Study|Protocol Violation|0|||
161739979|NCT02528253|584088753|FG004|Overall Study|Protocol Violation|4|||
161739980|NCT02528253|584088749|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
161739981|NCT02528253|584088750|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
161739982|NCT02528253|584088751|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
161739983|NCT02528253|584088752|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
161739984|NCT02528253|584088753|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
161739985|NCT00505752|584088754|FG000|Overall Study|Adverse Event|1|||
161739986|NCT00505752|584088755|FG001|Overall Study|Adverse Event|0|||
161739987|NCT00505752|584088756|FG002|Overall Study|Adverse Event|1|||
161739988|NCT00505752|584088757|FG003|Overall Study|Adverse Event|0|||
161739989|NCT00505752|584088754|FG000|Overall Study|Lost to Follow-up|1|||
161739990|NCT00505752|584088755|FG001|Overall Study|Lost to Follow-up|0|||
161739991|NCT00505752|584088756|FG002|Overall Study|Lost to Follow-up|0|||
161739992|NCT00505752|584088757|FG003|Overall Study|Lost to Follow-up|0|||
161739993|NCT00505752|584088754|FG000|Overall Study|Lack of ovarian response|1|||
161739994|NCT00505752|584088755|FG001|Overall Study|Lack of ovarian response|3|||
161739995|NCT00505752|584088756|FG002|Overall Study|Lack of ovarian response|0|||
161739996|NCT00505752|584088757|FG003|Overall Study|Lack of ovarian response|0|||
161739997|NCT00505752|584088754|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161739998|NCT00505752|584088755|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161739999|NCT00505752|584088756|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
161740000|NCT00505752|584088757|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161740001|NCT00505752|584088754|FG000|Overall Study|No oocytes retrieved|0|||
161740002|NCT00505752|584088755|FG001|Overall Study|No oocytes retrieved|2|||
161740003|NCT00505752|584088756|FG002|Overall Study|No oocytes retrieved|0|||
161740004|NCT00505752|584088757|FG003|Overall Study|No oocytes retrieved|1|||
161740005|NCT00505752|584088754|FG000|Overall Study|No Fertilization|1|||
161740006|NCT00505752|584088755|FG001|Overall Study|No Fertilization|1|||
161740007|NCT00505752|584088756|FG002|Overall Study|No Fertilization|2|||
161740008|NCT00505752|584088757|FG003|Overall Study|No Fertilization|1|||
161740009|NCT00505752|584088754|FG000|Overall Study|All embryos/blastocysts discarded|0|||
161740010|NCT00505752|584088755|FG001|Overall Study|All embryos/blastocysts discarded|0|||
161740011|NCT00505752|584088756|FG002|Overall Study|All embryos/blastocysts discarded|1|||
161740012|NCT00505752|584088757|FG003|Overall Study|All embryos/blastocysts discarded|1|||
161740013|NCT00505752|584088754|FG000|Overall Study|Other|1|||
161740014|NCT00505752|584088755|FG001|Overall Study|Other|2|||
161740015|NCT00505752|584088756|FG002|Overall Study|Other|1|||
161740016|NCT00505752|584088757|FG003|Overall Study|Other|2|||
161740017|NCT01624506|584088758|FG000|Overall Study|Lost to Follow-up|29|||
161740018|NCT01624506|584088759|FG001|Overall Study|Lost to Follow-up|15|||
161740019|NCT01624506|584088758|FG000|Overall Study|Withdrawal by Subject|9|||
161740020|NCT01624506|584088759|FG001|Overall Study|Withdrawal by Subject|2|||
161740021|NCT01624506|584088758|FG000|Overall Study|Death|1|||
161740022|NCT01624506|584088759|FG001|Overall Study|Death|0|||
161740023|NCT01624506|584088758|FG000|Overall Study|LINX explants|23|||
161740024|NCT01624506|584088759|FG001|Overall Study|LINX explants|0|||
161740025|NCT01624506|584088758|FG000|Overall Study|Adverse Event|3|||
161740026|NCT01624506|584088759|FG001|Overall Study|Adverse Event|0|||
161740027|NCT00225147|584088761|FG000|Open-label Phase|Lost to Follow-up|0|||
161740028|NCT00225147|584088762|FG001|Open-label Phase|Lost to Follow-up|0|||
161740029|NCT00225147|584088763|FG002|Open-label Phase|Lost to Follow-up|0|||
161740030|NCT00225147|584088764|FG003|Open-label Phase|Lost to Follow-up|4|||
161740031|NCT00225147|584088761|FG000|Open-label Phase|Withdrawal by Subject|0|||
161740032|NCT00225147|584088762|FG001|Open-label Phase|Withdrawal by Subject|0|||
161740033|NCT00225147|584088763|FG002|Open-label Phase|Withdrawal by Subject|0|||
161740034|NCT00225147|584088764|FG003|Open-label Phase|Withdrawal by Subject|6|||
161740035|NCT04019795|584088765|FG000|Overall Study|Withdrawal by Subject|1|||
161740036|NCT04019795|584088766|FG001|Overall Study|Withdrawal by Subject|2|||
161740037|NCT04019795|584088767|FG002|Overall Study|Withdrawal by Subject|2|||
161966152|NCT01331837|584921998|FG000|Overall Study|Withdrawal by Subject|13|||
161966153|NCT01331837|584921999|FG001|Overall Study|Withdrawal by Subject|16|||
161966154|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Adverse Event|76|||
161966155|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Adverse Event|0|||
161966156|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Adverse Event|0|||
161740038|NCT04019795|584088768|FG003|Overall Study|Withdrawal by Subject|1|||
161740039|NCT04019795|584088765|FG000|Overall Study|Lost to Follow-up|0|||
161740040|NCT04019795|584088766|FG001|Overall Study|Lost to Follow-up|1|||
161740041|NCT04019795|584088767|FG002|Overall Study|Lost to Follow-up|1|||
161740042|NCT04019795|584088768|FG003|Overall Study|Lost to Follow-up|2|||
161740043|NCT04019795|584088765|FG000|Overall Study|Treatment non-compliance|3|||
161740044|NCT04019795|584088766|FG001|Overall Study|Treatment non-compliance|1|||
161740045|NCT04019795|584088767|FG002|Overall Study|Treatment non-compliance|2|||
161740046|NCT04019795|584088768|FG003|Overall Study|Treatment non-compliance|0|||
161740047|NCT04019795|584088765|FG000|Overall Study|Physician Decision|0|||
161740048|NCT04019795|584088766|FG001|Overall Study|Physician Decision|0|||
161740049|NCT04019795|584088767|FG002|Overall Study|Physician Decision|1|||
161740050|NCT04019795|584088768|FG003|Overall Study|Physician Decision|0|||
161740051|NCT04019795|584088765|FG000|Overall Study|Adverse Event|1|||
161740052|NCT04019795|584088766|FG001|Overall Study|Adverse Event|0|||
161740053|NCT04019795|584088767|FG002|Overall Study|Adverse Event|0|||
161740054|NCT04019795|584088768|FG003|Overall Study|Adverse Event|0|||
161740055|NCT03625141|584088769|FG000|Overall Study|Adverse Event|0|||
161740056|NCT03625141|584088770|FG001|Overall Study|Adverse Event|2|||
161740057|NCT03625141|584088769|FG000|Overall Study|Study Terminated By Sponsor|1|||
161740058|NCT03625141|584088770|FG001|Overall Study|Study Terminated By Sponsor|13|||
161740059|NCT03625141|584088769|FG000|Overall Study|Withdrawal by Subject|3|||
161740060|NCT03625141|584088770|FG001|Overall Study|Withdrawal by Subject|0|||
161740061|NCT03625141|584088769|FG000|Overall Study|Withdrawal Of Consent|0|||
161740062|NCT03625141|584088770|FG001|Overall Study|Withdrawal Of Consent|1|||
161740063|NCT03625141|584088769|FG000|Overall Study|Death|11|||
161740064|NCT03625141|584088770|FG001|Overall Study|Death|47|||
161740065|NCT03625141|584088769|FG000|Overall Study|Progressive Disease|0|||
161740066|NCT03625141|584088770|FG001|Overall Study|Progressive Disease|2|||
161740067|NCT03250377|584088771|FG000|Overall Study|Adverse Event|2|||
161740068|NCT03250377|584088772|FG001|Overall Study|Adverse Event|4|||
161740069|NCT03250377|584088773|FG002|Overall Study|Adverse Event|0|||
161740070|NCT03250377|584088774|FG003|Overall Study|Adverse Event|4|||
161740071|NCT03250377|584088771|FG000|Overall Study|Lack of Efficacy|5|||
161740072|NCT03250377|584088772|FG001|Overall Study|Lack of Efficacy|14|||
161740073|NCT03250377|584088773|FG002|Overall Study|Lack of Efficacy|1|||
161740074|NCT03250377|584088774|FG003|Overall Study|Lack of Efficacy|3|||
161740075|NCT03250377|584088771|FG000|Overall Study|Protocol Violation|0|||
161740076|NCT03250377|584088772|FG001|Overall Study|Protocol Violation|2|||
161740077|NCT03250377|584088773|FG002|Overall Study|Protocol Violation|0|||
161740078|NCT03250377|584088774|FG003|Overall Study|Protocol Violation|1|||
161740079|NCT03250377|584088771|FG000|Overall Study|Lost to Follow-up|0|||
161740080|NCT03250377|584088772|FG001|Overall Study|Lost to Follow-up|1|||
161740081|NCT03250377|584088773|FG002|Overall Study|Lost to Follow-up|0|||
161740082|NCT03250377|584088774|FG003|Overall Study|Lost to Follow-up|0|||
161740083|NCT03250377|584088771|FG000|Overall Study|Withdrawal by Subject|7|||
161740084|NCT03250377|584088772|FG001|Overall Study|Withdrawal by Subject|7|||
161740085|NCT03250377|584088773|FG002|Overall Study|Withdrawal by Subject|0|||
161740086|NCT03250377|584088774|FG003|Overall Study|Withdrawal by Subject|4|||
161740087|NCT03250377|584088771|FG000|Overall Study|Investigator's Judgment|1|||
161740088|NCT03250377|584088772|FG001|Overall Study|Investigator's Judgment|0|||
161740089|NCT03250377|584088773|FG002|Overall Study|Investigator's Judgment|0|||
161740090|NCT03250377|584088774|FG003|Overall Study|Investigator's Judgment|0|||
161740091|NCT03250377|584088771|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
161740092|NCT03250377|584088772|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
161740093|NCT03250377|584088773|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
161740094|NCT03250377|584088774|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
161740095|NCT03250377|584088771|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
161740096|NCT03250377|584088772|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
161740097|NCT03250377|584088773|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
161740098|NCT03250377|584088774|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
161740099|NCT03250377|584088771|FG000|Overall Study|Epilepsy Surgery|0|||
161740100|NCT03250377|584088772|FG001|Overall Study|Epilepsy Surgery|1|||
161740101|NCT03250377|584088773|FG002|Overall Study|Epilepsy Surgery|2|||
161740102|NCT03250377|584088774|FG003|Overall Study|Epilepsy Surgery|0|||
161740103|NCT03250377|584088771|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
161740104|NCT03250377|584088772|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
161740105|NCT03250377|584088773|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
161740106|NCT03250377|584088774|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
161740107|NCT03250377|584088771|FG000|Overall Study|Request From The Sponsor|0|||
161740108|NCT03250377|584088772|FG001|Overall Study|Request From The Sponsor|1|||
161740109|NCT03250377|584088773|FG002|Overall Study|Request From The Sponsor|0|||
161740110|NCT03250377|584088774|FG003|Overall Study|Request From The Sponsor|0|||
161740111|NCT03250377|584088771|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
161740112|NCT03250377|584088772|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
161740113|NCT03250377|584088773|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
161740114|NCT03250377|584088774|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
161740115|NCT03250377|584088771|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
161740116|NCT03250377|584088772|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
161740117|NCT03250377|584088773|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
161740118|NCT03250377|584088774|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
161740119|NCT03250377|584088771|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
161740120|NCT03250377|584088772|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
161740121|NCT03250377|584088773|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
161740122|NCT03250377|584088774|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
161740123|NCT03250377|584088771|FG000|Overall Study|Pregnancy Event|0|||
161740124|NCT03250377|584088772|FG001|Overall Study|Pregnancy Event|1|||
161840633|NCT04732221|584462806|FG003|Extension Period|Adverse Event|0|||
161740125|NCT03250377|584088773|FG002|Overall Study|Pregnancy Event|0|||
161740126|NCT03250377|584088774|FG003|Overall Study|Pregnancy Event|0|||
161740127|NCT03250377|584088771|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
161740128|NCT03250377|584088772|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
161966157|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Death|3|||
161966158|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Death|0|||
161966159|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Death|0|||
161966160|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
161740129|NCT03250377|584088773|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
161740130|NCT03250377|584088774|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
161740131|NCT03250377|584088771|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
161740132|NCT03250377|584088772|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
161740133|NCT03250377|584088773|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
161740134|NCT03250377|584088774|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
161740135|NCT03250377|584088771|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
161740136|NCT03250377|584088772|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
161740137|NCT03250377|584088773|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
161740138|NCT03250377|584088774|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
161740139|NCT03250377|584088771|FG000|Overall Study|Patient requested to change hospital|0|||
161740140|NCT03250377|584088772|FG001|Overall Study|Patient requested to change hospital|0|||
161740141|NCT03250377|584088773|FG002|Overall Study|Patient requested to change hospital|0|||
161740142|NCT03250377|584088774|FG003|Overall Study|Patient requested to change hospital|1|||
161740143|NCT03250377|584088771|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
161740144|NCT03250377|584088772|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
161740145|NCT03250377|584088773|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
161740146|NCT03250377|584088774|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
161740147|NCT01114373|584088775|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
161740148|NCT01114373|584088776|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
161740149|NCT01114373|584088775|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
161740150|NCT01114373|584088776|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
161740151|NCT01114373|584088775|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
161740152|NCT01114373|584088776|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
161740153|NCT01114373|584088775|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
161740154|NCT01114373|584088776|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
161740155|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
161840634|NCT04732221|584462807|FG004|Extension Period|Adverse Event|0|||
161840635|NCT04732221|584462808|FG005|Extension Period|Adverse Event|1|||
161840636|NCT04732221|584462809|FG006|Extension Period|Adverse Event|0|||
161840637|NCT04732221|584462803|FG000|Extension Period|Death|0|||
161840638|NCT04732221|584462804|FG001|Extension Period|Death|0|||
161840639|NCT04732221|584462805|FG002|Extension Period|Death|0|||
161840640|NCT04732221|584462806|FG003|Extension Period|Death|0|||
161840641|NCT04732221|584462807|FG004|Extension Period|Death|1|||
161840642|NCT04732221|584462808|FG005|Extension Period|Death|0|||
161840643|NCT04732221|584462809|FG006|Extension Period|Death|2|||
161840644|NCT04732221|584462803|FG000|Extension Period|Pregnancy|0|||
161840645|NCT04732221|584462804|FG001|Extension Period|Pregnancy|0|||
161840646|NCT04732221|584462805|FG002|Extension Period|Pregnancy|0|||
161840647|NCT04732221|584462806|FG003|Extension Period|Pregnancy|0|||
161840648|NCT04732221|584462807|FG004|Extension Period|Pregnancy|1|||
161840649|NCT04732221|584462808|FG005|Extension Period|Pregnancy|0|||
161840650|NCT04732221|584462809|FG006|Extension Period|Pregnancy|0|||
161840651|NCT04732221|584462803|FG000|Extension Period|Sponsors Decision|0|||
161840652|NCT04732221|584462804|FG001|Extension Period|Sponsors Decision|0|||
161840653|NCT04732221|584462805|FG002|Extension Period|Sponsors Decision|0|||
161966161|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
161966162|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
161966163|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Physician Decision|9|||
161966164|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Physician Decision|0|||
161966165|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Physician Decision|0|||
161840654|NCT04732221|584462806|FG003|Extension Period|Sponsors Decision|0|||
161840655|NCT04732221|584462807|FG004|Extension Period|Sponsors Decision|41|||
161840656|NCT04732221|584462808|FG005|Extension Period|Sponsors Decision|40|||
161840657|NCT04732221|584462809|FG006|Extension Period|Sponsors Decision|40|||
161840658|NCT04732221|584462803|FG000|Extension Period|Withdrawal by Subject|0|||
161840659|NCT04732221|584462804|FG001|Extension Period|Withdrawal by Subject|0|||
161840660|NCT04732221|584462805|FG002|Extension Period|Withdrawal by Subject|0|||
161840661|NCT04732221|584462806|FG003|Extension Period|Withdrawal by Subject|0|||
161966166|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
161966167|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
161966168|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
161966169|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Disease progression|45|||
161966170|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Disease progression|0|||
161966171|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Disease progression|0|||
161966172|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
161966173|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
161740156|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
161740157|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
161740158|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
161740159|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
161740160|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
161740161|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
161740162|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
161740163|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
161740164|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
161740165|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
161740166|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
161740167|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
161740168|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
161740169|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
161740170|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161740171|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161740172|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161740173|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
161740174|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
161740175|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
161740176|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
161740177|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
161740178|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
161740179|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
161740180|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
161740181|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
161740182|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
161740183|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
161740184|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
161740185|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
161740186|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161740187|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161740188|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161740189|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161740190|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161740191|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
161740192|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
161740193|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
161740194|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
161740195|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
161740196|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
161740197|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
161740198|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
161740199|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
161740200|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
161740201|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
161740202|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
161740203|NCT03444870|584088777|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
161740204|NCT03444870|584088778|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161740205|NCT03444870|584088779|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161740206|NCT03444870|584088780|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161740207|NCT03444870|584088781|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161740208|NCT03444870|584088782|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161740209|NCT03444870|584088777|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161740210|NCT03444870|584088778|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161740211|NCT03444870|584088779|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161740212|NCT03444870|584088780|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161740213|NCT03444870|584088781|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
161966174|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
161966175|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
161966176|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
161966177|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
161740214|NCT03444870|584088782|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
161740215|NCT03444870|584088777|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
161740216|NCT03444870|584088778|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
161740217|NCT03444870|584088779|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
161740218|NCT03444870|584088780|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
161740219|NCT03444870|584088781|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
161740220|NCT03444870|584088782|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
161740221|NCT03444870|584088777|FG000|Open-Label Extension (OLE) Period|Death|0|||
161740222|NCT03444870|584088778|FG001|Open-Label Extension (OLE) Period|Death|0|||
161740223|NCT03444870|584088779|FG002|Open-Label Extension (OLE) Period|Death|0|||
161740224|NCT03444870|584088780|FG003|Open-Label Extension (OLE) Period|Death|0|||
161740225|NCT03444870|584088781|FG004|Open-Label Extension (OLE) Period|Death|1|||
161740226|NCT03444870|584088782|FG005|Open-Label Extension (OLE) Period|Death|0|||
161740227|NCT02034552|584088783|FG000|Overall Study|Never treated|3|||
161740228|NCT02034552|584088784|FG001|Overall Study|Never treated|2|||
161740229|NCT02034552|584088785|FG002|Overall Study|Never treated|0|||
161740230|NCT02034552|584088783|FG000|Overall Study|Radiological progression|3|||
161740231|NCT02034552|584088784|FG001|Overall Study|Radiological progression|5|||
161740232|NCT02034552|584088785|FG002|Overall Study|Radiological progression|4|||
161740233|NCT02034552|584088783|FG000|Overall Study|AE not assoc. with disease progression|1|||
161740234|NCT02034552|584088784|FG001|Overall Study|AE not assoc. with disease progression|4|||
161740235|NCT02034552|584088785|FG002|Overall Study|AE not assoc. with disease progression|2|||
161740236|NCT02034552|584088783|FG000|Overall Study|AE associated with disease progression|0|||
161740237|NCT02034552|584088784|FG001|Overall Study|AE associated with disease progression|1|||
161740238|NCT02034552|584088785|FG002|Overall Study|AE associated with disease progression|0|||
161740239|NCT02034552|584088783|FG000|Overall Study|Withdrawal by Subject|2|||
161740240|NCT02034552|584088784|FG001|Overall Study|Withdrawal by Subject|1|||
161740241|NCT02034552|584088785|FG002|Overall Study|Withdrawal by Subject|1|||
161740242|NCT02034552|584088783|FG000|Overall Study|Non-compliance with study drug|0|||
161740243|NCT02034552|584088784|FG001|Overall Study|Non-compliance with study drug|0|||
161740244|NCT02034552|584088785|FG002|Overall Study|Non-compliance with study drug|1|||
161740245|NCT02034552|584088783|FG000|Overall Study|Clinical progression|5|||
161740246|NCT02034552|584088784|FG001|Overall Study|Clinical progression|7|||
161740247|NCT02034552|584088785|FG002|Overall Study|Clinical progression|9|||
161740248|NCT03819218|584088788|FG000|Overall Study|Protocol Violation|1|||
161740249|NCT02501902|584088789|FG000|Overall Study|Subject Refused Further Follow-up|0|||
161740250|NCT02501902|584088790|FG001|Overall Study|Subject Refused Further Follow-up|0|||
161740251|NCT02501902|584088791|FG002|Overall Study|Subject Refused Further Follow-up|0|||
161740252|NCT02501902|584088792|FG003|Overall Study|Subject Refused Further Follow-up|0|||
161740253|NCT02501902|584088793|FG004|Overall Study|Subject Refused Further Follow-up|0|||
161740254|NCT02501902|584088794|FG005|Overall Study|Subject Refused Further Follow-up|0|||
161740255|NCT02501902|584088795|FG006|Overall Study|Subject Refused Further Follow-up|0|||
161740256|NCT02501902|584088796|FG007|Overall Study|Subject Refused Further Follow-up|1|||
161740257|NCT02501902|584088789|FG000|Overall Study|Study Terminated by Sponsor|0|||
161740258|NCT02501902|584088790|FG001|Overall Study|Study Terminated by Sponsor|3|||
161740259|NCT02501902|584088791|FG002|Overall Study|Study Terminated by Sponsor|0|||
161740260|NCT02501902|584088792|FG003|Overall Study|Study Terminated by Sponsor|1|||
161740261|NCT02501902|584088793|FG004|Overall Study|Study Terminated by Sponsor|1|||
161740262|NCT02501902|584088794|FG005|Overall Study|Study Terminated by Sponsor|0|||
161740263|NCT02501902|584088795|FG006|Overall Study|Study Terminated by Sponsor|2|||
161740264|NCT02501902|584088796|FG007|Overall Study|Study Terminated by Sponsor|4|||
161740265|NCT02501902|584088789|FG000|Overall Study|Death|3|||
161740266|NCT02501902|584088790|FG001|Overall Study|Death|4|||
161740267|NCT02501902|584088791|FG002|Overall Study|Death|4|||
161740268|NCT02501902|584088792|FG003|Overall Study|Death|10|||
161740269|NCT02501902|584088793|FG004|Overall Study|Death|10|||
161740270|NCT02501902|584088794|FG005|Overall Study|Death|11|||
161740271|NCT02501902|584088795|FG006|Overall Study|Death|7|||
161740272|NCT02501902|584088796|FG007|Overall Study|Death|15|||
161740273|NCT02267278|584088797|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
161740274|NCT02267278|584088797|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
161740275|NCT02267278|584088797|FG000|Overall Study|Developed new cancer diagnoses|2|||
161740276|NCT02267278|584088797|FG000|Overall Study|prescribed prohibited medication|1|||
161740277|NCT02513771|584088798|FG000|Overall Study|Lost to Follow-up|1|||
161740278|NCT02513771|584088799|FG001|Overall Study|Lost to Follow-up|1|||
161740279|NCT02513771|584088798|FG000|Overall Study|Not being able to get to clinic|1|||
161740280|NCT02513771|584088799|FG001|Overall Study|Not being able to get to clinic|0|||
161740281|NCT04295356|584088800|FG000|Overall Study|Physician Decision|1|||
161740282|NCT04295356|584088801|FG001|Overall Study|Physician Decision|0|||
161740283|NCT04295356|584088800|FG000|Overall Study|Lost to Follow-up|0|||
161740284|NCT04295356|584088801|FG001|Overall Study|Lost to Follow-up|3|||
161740285|NCT04295356|584088800|FG000|Overall Study|Protocol Violation|0|||
161740286|NCT04295356|584088801|FG001|Overall Study|Protocol Violation|1|||
161740287|NCT01280266|584088802|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
161840662|NCT04732221|584462807|FG004|Extension Period|Withdrawal by Subject|1|||
161840663|NCT04732221|584462808|FG005|Extension Period|Withdrawal by Subject|5|||
161840664|NCT04732221|584462809|FG006|Extension Period|Withdrawal by Subject|2|||
161840665|NCT03611543|584462810|FG000|Overall Study|Withdrawal by Subject|4|||
161840666|NCT03611543|584462811|FG001|Overall Study|Withdrawal by Subject|4|||
161840667|NCT03611543|584462810|FG000|Overall Study|Physician Decision|1|||
161840668|NCT03611543|584462811|FG001|Overall Study|Physician Decision|1|||
161840669|NCT03611543|584462810|FG000|Overall Study|Protocol Violation|2|||
161840670|NCT03611543|584462811|FG001|Overall Study|Protocol Violation|2|||
161840671|NCT03611543|584462810|FG000|Overall Study|Device failure|2|||
161840672|NCT03611543|584462811|FG001|Overall Study|Device failure|2|||
161840673|NCT03611543|584462810|FG000|Overall Study|Missing information|5|||
161840674|NCT03611543|584462811|FG001|Overall Study|Missing information|5|||
161840675|NCT00379340|584462812|FG000|Overall Study|Death|0|||
161840676|NCT00379340|584462813|FG001|Overall Study|Death|0|||
161840677|NCT00379340|584462814|FG002|Overall Study|Death|0|||
161840678|NCT00379340|584462815|FG003|Overall Study|Death|2|||
161840679|NCT00379340|584462816|FG004|Overall Study|Death|0|||
161840680|NCT00379340|584462812|FG000|Overall Study|Lack of Efficacy|6|||
161840681|NCT00379340|584462813|FG001|Overall Study|Lack of Efficacy|1|||
161840682|NCT00379340|584462814|FG002|Overall Study|Lack of Efficacy|0|||
161840683|NCT00379340|584462815|FG003|Overall Study|Lack of Efficacy|4|||
161840684|NCT00379340|584462816|FG004|Overall Study|Lack of Efficacy|3|||
161840685|NCT00379340|584462812|FG000|Overall Study|Physician Decision|6|||
161840686|NCT00379340|584462813|FG001|Overall Study|Physician Decision|2|||
161840687|NCT00379340|584462814|FG002|Overall Study|Physician Decision|1|||
161840688|NCT00379340|584462815|FG003|Overall Study|Physician Decision|2|||
161840689|NCT00379340|584462816|FG004|Overall Study|Physician Decision|3|||
161840690|NCT00379340|584462812|FG000|Overall Study|Withdrawal by Subject|0|||
161840691|NCT00379340|584462813|FG001|Overall Study|Withdrawal by Subject|0|||
161840692|NCT00379340|584462814|FG002|Overall Study|Withdrawal by Subject|0|||
161840693|NCT00379340|584462815|FG003|Overall Study|Withdrawal by Subject|1|||
161840694|NCT00379340|584462816|FG004|Overall Study|Withdrawal by Subject|0|||
161840695|NCT00379340|584462812|FG000|Overall Study|Refusal of further protocol therapy|1|||
161840696|NCT00379340|584462813|FG001|Overall Study|Refusal of further protocol therapy|0|||
161740288|NCT01280266|584088803|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
161740289|NCT01280266|584088802|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
161740290|NCT01280266|584088803|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
161740291|NCT04116073|584088806|FG000|Overall Study|Withdrawal by Subject|2|||
161740292|NCT04116073|584088806|FG000|Overall Study|failed to maintained eligibility|1|||
161740293|NCT04268004|584088807|FG000|Overall Study|Excluded from analyses|0|||
161740294|NCT04268004|584088808|FG001|Overall Study|Excluded from analyses|1|||
161740295|NCT03495453|584088809|FG000|Overall Study|Withdrawal by Subject|0|||
161740296|NCT03495453|584088810|FG001|Overall Study|Withdrawal by Subject|1|||
161740297|NCT01879319|584088815|FG000|Overall Study|Withdrawal by Subject|1|||
161740298|NCT01879319|584088816|FG001|Overall Study|Withdrawal by Subject|0|||
161740299|NCT01879319|584088815|FG000|Overall Study|Lost to Follow-up|1|||
161740300|NCT01879319|584088816|FG001|Overall Study|Lost to Follow-up|5|||
161740301|NCT01360762|584088817|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
161740302|NCT01360762|584088817|FG000|Main Study Period (12-month Treatment)|Death|5|||
161740303|NCT01360762|584088817|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
161740304|NCT01360762|584088817|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
161840697|NCT00379340|584462814|FG002|Overall Study|Refusal of further protocol therapy|1|||
161840698|NCT00379340|584462815|FG003|Overall Study|Refusal of further protocol therapy|1|||
161840699|NCT00379340|584462816|FG004|Overall Study|Refusal of further protocol therapy|7|||
161840700|NCT00379340|584462812|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
161840701|NCT00379340|584462813|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
161840702|NCT00379340|584462814|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
161840703|NCT00379340|584462815|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
161840704|NCT00379340|584462816|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
161740305|NCT01360762|584088817|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
161740306|NCT01360762|584088817|FG000|Whole Study Period|Lost to Follow-up|10|||
161740307|NCT01360762|584088817|FG000|Whole Study Period|Death|7|||
161840705|NCT00379340|584462812|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
161840706|NCT00379340|584462813|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
161840707|NCT00379340|584462814|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
161840708|NCT00379340|584462815|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
161840709|NCT00379340|584462816|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
161840710|NCT03047473|584462820|FG000|Overall Study|Lost to Follow-up|2|||
161840711|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Death|89|||
161840712|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Death|193|||
161840713|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Death|198|||
161840714|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
162032441|NCT01395784|585175501|FG000|Overall Study|Physician Decision|5|||
161740308|NCT01360762|584088817|FG000|Whole Study Period|Patient relapsed|18|||
161740309|NCT01360762|584088817|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
161740310|NCT01103778|584088818|FG000|Overall Study|Lost to Follow-up|1|||
161740311|NCT01103778|584088818|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
161740312|NCT01103778|584088818|FG000|Overall Study|Screen failure|1|||
161740313|NCT03067129|584088819|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
161740314|NCT03067129|584088820|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
161740315|NCT03067129|584088821|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
161740316|NCT03067129|584088822|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
161740317|NCT03067129|584088819|FG000|Overall Study|Withdrawal by Subject|0|||
161740318|NCT03067129|584088820|FG001|Overall Study|Withdrawal by Subject|0|||
161740319|NCT03067129|584088821|FG002|Overall Study|Withdrawal by Subject|1|||
161740320|NCT03067129|584088822|FG003|Overall Study|Withdrawal by Subject|2|||
161740321|NCT03067129|584088819|FG000|Overall Study|Lost to Follow-up|5|||
161740322|NCT03067129|584088820|FG001|Overall Study|Lost to Follow-up|5|||
161740323|NCT03067129|584088821|FG002|Overall Study|Lost to Follow-up|4|||
161740324|NCT03067129|584088822|FG003|Overall Study|Lost to Follow-up|3|||
161740325|NCT03372603|584088823|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
161740326|NCT03372603|584088824|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
161740327|NCT03372603|584088823|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
161740328|NCT03372603|584088824|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
161740329|NCT03084718|584088825|FG000|Overall Study|Withdrawal by Subject|4|||
161740330|NCT03084718|584088826|FG001|Overall Study|Withdrawal by Subject|3|||
161740331|NCT03084718|584088827|FG002|Overall Study|Withdrawal by Subject|4|||
161740332|NCT03084718|584088828|FG003|Overall Study|Withdrawal by Subject|0|||
161740333|NCT03084718|584088829|FG004|Overall Study|Withdrawal by Subject|0|||
161740334|NCT03084718|584088825|FG000|Overall Study|Physician Decision|1|||
161740335|NCT03084718|584088826|FG001|Overall Study|Physician Decision|0|||
161740336|NCT03084718|584088827|FG002|Overall Study|Physician Decision|0|||
161740337|NCT03084718|584088828|FG003|Overall Study|Physician Decision|0|||
161740338|NCT03084718|584088829|FG004|Overall Study|Physician Decision|0|||
161740339|NCT03084718|584088825|FG000|Overall Study|Adverse Event|3|||
161740340|NCT03084718|584088826|FG001|Overall Study|Adverse Event|5|||
161740341|NCT03084718|584088827|FG002|Overall Study|Adverse Event|5|||
161740342|NCT03084718|584088828|FG003|Overall Study|Adverse Event|8|||
161740343|NCT03084718|584088829|FG004|Overall Study|Adverse Event|2|||
161740344|NCT03084718|584088825|FG000|Overall Study|Lack of Efficacy|2|||
161740345|NCT03084718|584088826|FG001|Overall Study|Lack of Efficacy|0|||
161740346|NCT03084718|584088827|FG002|Overall Study|Lack of Efficacy|1|||
161740347|NCT03084718|584088828|FG003|Overall Study|Lack of Efficacy|4|||
161740348|NCT03084718|584088829|FG004|Overall Study|Lack of Efficacy|0|||
161740349|NCT03084718|584088825|FG000|Overall Study|Lost to Follow-up|0|||
161740350|NCT03084718|584088826|FG001|Overall Study|Lost to Follow-up|1|||
161740351|NCT03084718|584088827|FG002|Overall Study|Lost to Follow-up|0|||
161740352|NCT03084718|584088828|FG003|Overall Study|Lost to Follow-up|0|||
161740353|NCT03084718|584088829|FG004|Overall Study|Lost to Follow-up|2|||
161740354|NCT03084718|584088825|FG000|Overall Study|Protocol Violation|0|||
161740355|NCT03084718|584088826|FG001|Overall Study|Protocol Violation|0|||
161740356|NCT03084718|584088827|FG002|Overall Study|Protocol Violation|1|||
161740357|NCT03084718|584088828|FG003|Overall Study|Protocol Violation|0|||
161740358|NCT03084718|584088829|FG004|Overall Study|Protocol Violation|0|||
161740359|NCT03084718|584088825|FG000|Overall Study|Death|0|||
161740360|NCT03084718|584088826|FG001|Overall Study|Death|1|||
161740361|NCT03084718|584088827|FG002|Overall Study|Death|0|||
161740362|NCT03084718|584088828|FG003|Overall Study|Death|0|||
161740363|NCT03084718|584088829|FG004|Overall Study|Death|0|||
161740364|NCT03084718|584088825|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
161740365|NCT03084718|584088826|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
161740366|NCT03084718|584088827|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
161740367|NCT03084718|584088828|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
161740368|NCT03084718|584088829|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
161740369|NCT03986190|584088830|FG000|Overall Study|Withdrawal by Subject|12|||
161740370|NCT03986190|584088831|FG001|Overall Study|Withdrawal by Subject|0|||
161740371|NCT02806947|584088832|FG000|Overall Study|Withdrawal by Subject|5|||
161740372|NCT02806947|584088833|FG001|Overall Study|Withdrawal by Subject|1|||
161840715|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
161966178|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
161740373|NCT04929613|584088834|FG000|Overall Study|Withdrawal by Subject|12|||
161740374|NCT00844649|584088841|FG000|Overall Study|Progressive Disease|196|||
161740375|NCT00844649|584088842|FG001|Overall Study|Progressive Disease|245|||
161740376|NCT00844649|584088841|FG000|Overall Study|Adverse Event|128|||
161740377|NCT00844649|584088842|FG001|Overall Study|Adverse Event|73|||
161740378|NCT00844649|584088841|FG000|Overall Study|Physician Decision|25|||
161740379|NCT00844649|584088842|FG001|Overall Study|Physician Decision|18|||
161966179|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
161740380|NCT00844649|584088841|FG000|Overall Study|Protocol Violation|10|||
161740381|NCT00844649|584088842|FG001|Overall Study|Protocol Violation|6|||
161740382|NCT00844649|584088841|FG000|Overall Study|Withdrawal by Subject|28|||
161740383|NCT00844649|584088842|FG001|Overall Study|Withdrawal by Subject|39|||
161740384|NCT00844649|584088841|FG000|Overall Study|Other|7|||
161740385|NCT00844649|584088842|FG001|Overall Study|Other|10|||
161740386|NCT00844649|584088841|FG000|Overall Study|Withdrew prior to starting treatment|11|||
161740387|NCT00844649|584088842|FG001|Overall Study|Withdrew prior to starting treatment|27|||
161740388|NCT01594333|584088843|FG000|Overall Study|Death|96|||
161740389|NCT01594333|584088844|FG001|Overall Study|Death|83|||
161740390|NCT01594333|584088843|FG000|Overall Study|Lost to Follow-up|5|||
161740391|NCT01594333|584088844|FG001|Overall Study|Lost to Follow-up|5|||
161740392|NCT01594333|584088843|FG000|Overall Study|Withdrawal by Subject|60|||
161740393|NCT01594333|584088844|FG001|Overall Study|Withdrawal by Subject|63|||
161740394|NCT00242580|584088848|FG000|Overall Study|Adverse Event|3|||
161740395|NCT00242580|584088849|FG001|Overall Study|Adverse Event|0|||
161740396|NCT00242580|584088850|FG002|Overall Study|Adverse Event|2|||
161740397|NCT00242580|584088848|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161740398|NCT00242580|584088849|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
161740399|NCT00242580|584088850|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
161740400|NCT00242580|584088848|FG000|Overall Study|Protocol Violation|0|||
161740401|NCT00242580|584088849|FG001|Overall Study|Protocol Violation|0|||
161740402|NCT00242580|584088850|FG002|Overall Study|Protocol Violation|1|||
161740403|NCT00242580|584088848|FG000|Overall Study|Subject withdrew consent|2|||
161740404|NCT00242580|584088849|FG001|Overall Study|Subject withdrew consent|2|||
161740405|NCT00242580|584088850|FG002|Overall Study|Subject withdrew consent|5|||
161740406|NCT00242580|584088848|FG000|Overall Study|Lost to Follow-up|0|||
161740407|NCT00242580|584088849|FG001|Overall Study|Lost to Follow-up|3|||
161740408|NCT00242580|584088850|FG002|Overall Study|Lost to Follow-up|0|||
161740409|NCT00242580|584088848|FG000|Overall Study|Death|1|||
161740410|NCT00242580|584088849|FG001|Overall Study|Death|2|||
161740411|NCT00242580|584088850|FG002|Overall Study|Death|1|||
161740412|NCT03666858|584088853|FG000|Cohort 1|Adverse Event|1|||
161740413|NCT03666858|584088854|FG001|Cohort 1|Adverse Event|0|||
161740414|NCT03666858|584088853|FG000|Cohort 2|Adverse Event|0|||
161740415|NCT03666858|584088854|FG001|Cohort 2|Adverse Event|1|||
161740416|NCT03282357|584088855|FG000|Overall Study|Lost to Follow-up|3|||
161740417|NCT03282357|584088855|FG000|Overall Study|Withdrawal by Subject|4|||
161740418|NCT03282357|584088855|FG000|Overall Study|Adverse Event|1|||
161740419|NCT03282357|584088855|FG000|Overall Study|Other|9|||
161740420|NCT00393913|584088857|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
161740421|NCT00393913|584088857|FG000|Initial Assessment|Withdrawal by Subject|16|||
161740422|NCT00393913|584088857|FG000|CPAP|Withdrawal by Subject|3|||
161740423|NCT00393913|584088857|FG000|CPAP|Physician Decision|1|||
161740424|NCT00393913|584088857|FG000|CPAP|TEchnical problem with CPAP|3|||
161740425|NCT01518244|584088858|FG000|Overall Study|Adverse Event|3|||
161740426|NCT04900038|584088860|FG000|Overall Study|Adverse Event|1|||
161740427|NCT04900038|584088861|FG001|Overall Study|Adverse Event|0|||
161740428|NCT04900038|584088862|FG002|Overall Study|Adverse Event|1|||
161740429|NCT04900038|584088863|FG003|Overall Study|Adverse Event|1|||
161740430|NCT04900038|584088860|FG000|Overall Study|Withdrawal by Subject|0|||
161740431|NCT04900038|584088861|FG001|Overall Study|Withdrawal by Subject|1|||
161740432|NCT04900038|584088862|FG002|Overall Study|Withdrawal by Subject|0|||
161740433|NCT04900038|584088863|FG003|Overall Study|Withdrawal by Subject|0|||
161740434|NCT04900038|584088860|FG000|Overall Study|Study terminated by sponsor|18|||
161740435|NCT04900038|584088861|FG001|Overall Study|Study terminated by sponsor|15|||
161740436|NCT04900038|584088862|FG002|Overall Study|Study terminated by sponsor|17|||
161740437|NCT04900038|584088863|FG003|Overall Study|Study terminated by sponsor|14|||
161740438|NCT04900038|584088860|FG000|Overall Study|Protocol Deviation|1|||
161740439|NCT04900038|584088861|FG001|Overall Study|Protocol Deviation|1|||
161740440|NCT04900038|584088862|FG002|Overall Study|Protocol Deviation|0|||
161740441|NCT04900038|584088863|FG003|Overall Study|Protocol Deviation|0|||
161740442|NCT04900038|584088860|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
161740443|NCT04900038|584088861|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
161740444|NCT04900038|584088862|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
161740445|NCT04900038|584088863|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
161740446|NCT04900038|584088860|FG000|Overall Study|Lost to Follow-up|0|||
161740447|NCT04900038|584088861|FG001|Overall Study|Lost to Follow-up|0|||
161740448|NCT04900038|584088862|FG002|Overall Study|Lost to Follow-up|0|||
161740449|NCT04900038|584088863|FG003|Overall Study|Lost to Follow-up|1|||
161740450|NCT00594204|584088865|FG000|Overall Study|Adverse Event|15|||
161740451|NCT00594204|584088866|FG001|Overall Study|Adverse Event|3|||
161740452|NCT00594204|584088865|FG000|Overall Study|Lost to Follow-up|9|||
161740453|NCT00594204|584088866|FG001|Overall Study|Lost to Follow-up|5|||
161740454|NCT00594204|584088865|FG000|Overall Study|Withdrawal by Subject|23|||
161740455|NCT00594204|584088866|FG001|Overall Study|Withdrawal by Subject|29|||
161740456|NCT00594204|584088865|FG000|Overall Study|Other|4|||
161740457|NCT00594204|584088866|FG001|Overall Study|Other|3|||
161840716|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
161840717|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
161840718|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
161840719|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
161840720|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
161840721|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
161840722|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
161840723|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
161840724|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
161840725|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
161840726|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
161840727|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
161840728|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
161840729|NCT02031458|584462821|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
161840730|NCT02031458|584462822|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
161840731|NCT02031458|584462823|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
161840732|NCT02031458|584462821|FG000|Baseline to May 8, 2015|Death|36|||
161840733|NCT02031458|584462822|FG001|Baseline to May 8, 2015|Death|87|||
161840734|NCT02031458|584462823|FG002|Baseline to May 8, 2015|Death|100|||
161840735|NCT02031458|584462821|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
161966180|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
161966181|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
161966182|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
161966183|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
161966184|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
161966185|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
162032442|NCT05772702|585175502|FG000|Overall Study|Adverse Event|1|||
161740458|NCT00594204|584088865|FG000|Overall Study|Lack of Efficacy|3|||
161740459|NCT00594204|584088866|FG001|Overall Study|Lack of Efficacy|4|||
161740460|NCT00594204|584088865|FG000|Overall Study|Randomized but not treated|4|||
161740461|NCT00594204|584088866|FG001|Overall Study|Randomized but not treated|1|||
161740462|NCT01740388|584088867|FG000|Overall Study|Withdrawal by Subject|1|||
161740463|NCT01740388|584088868|FG001|Overall Study|Withdrawal by Subject|2|||
161740464|NCT01740388|584088867|FG000|Overall Study|Lost to Follow-up|2|||
161740465|NCT01740388|584088868|FG001|Overall Study|Lost to Follow-up|0|||
161740466|NCT01740388|584088867|FG000|Overall Study|Physician Decision|2|||
161740467|NCT01740388|584088868|FG001|Overall Study|Physician Decision|6|||
161740468|NCT01740388|584088867|FG000|Overall Study|Subjects missing data, completed|41|||
161740469|NCT01740388|584088868|FG001|Overall Study|Subjects missing data, completed|36|||
161740470|NCT01582971|584088871|FG000|Overall Study|Death|2|||
161740471|NCT01582971|584088872|FG001|Overall Study|Death|1|||
161740472|NCT01582971|584088871|FG000|Overall Study|Lost to Follow-up|18|||
161740473|NCT01582971|584088872|FG001|Overall Study|Lost to Follow-up|21|||
161740474|NCT01582971|584088871|FG000|Overall Study|Withdrawal by Subject|4|||
161740475|NCT01582971|584088872|FG001|Overall Study|Withdrawal by Subject|2|||
161740476|NCT01582971|584088871|FG000|Overall Study|Other|15|||
161740477|NCT01582971|584088872|FG001|Overall Study|Other|13|||
161740478|NCT01641991|584088873|FG000|Overall Study|Physician Decision|0|||
161740479|NCT01641991|584088874|FG001|Overall Study|Physician Decision|1|||
161740480|NCT01641991|584088875|FG002|Overall Study|Physician Decision|7|||
161740481|NCT01641991|584088876|FG003|Overall Study|Physician Decision|5|||
161740482|NCT01641991|584088873|FG000|Overall Study|Withdrawal by Subject|4|||
161740483|NCT01641991|584088874|FG001|Overall Study|Withdrawal by Subject|2|||
161740484|NCT01641991|584088875|FG002|Overall Study|Withdrawal by Subject|1|||
161740485|NCT01641991|584088876|FG003|Overall Study|Withdrawal by Subject|5|||
161740486|NCT01641991|584088873|FG000|Overall Study|Adverse Event|2|||
161740487|NCT01641991|584088874|FG001|Overall Study|Adverse Event|1|||
161740488|NCT01641991|584088875|FG002|Overall Study|Adverse Event|2|||
161740489|NCT01641991|584088876|FG003|Overall Study|Adverse Event|1|||
161740490|NCT01641991|584088873|FG000|Overall Study|Lost to Follow-up|0|||
161740491|NCT01641991|584088874|FG001|Overall Study|Lost to Follow-up|2|||
161740492|NCT01641991|584088875|FG002|Overall Study|Lost to Follow-up|3|||
161740493|NCT01641991|584088876|FG003|Overall Study|Lost to Follow-up|1|||
161840736|NCT02031458|584462822|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
161840737|NCT02031458|584462823|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
161966186|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
162032443|NCT04285580|585177384|FG000|Overall Study|Protocol Violation|0|||
161740494|NCT01641991|584088873|FG000|Overall Study|Protocol Violation|1|||
161740495|NCT01641991|584088874|FG001|Overall Study|Protocol Violation|1|||
161740496|NCT01641991|584088875|FG002|Overall Study|Protocol Violation|3|||
161740497|NCT01641991|584088876|FG003|Overall Study|Protocol Violation|0|||
161740498|NCT01641991|584088873|FG000|Overall Study|Pregnancy|0|||
161740499|NCT01641991|584088874|FG001|Overall Study|Pregnancy|0|||
161840738|NCT02031458|584462821|FG000|Baseline to May 8, 2015|Physician Decision|0|||
161840739|NCT02031458|584462822|FG001|Baseline to May 8, 2015|Physician Decision|1|||
161840740|NCT02031458|584462823|FG002|Baseline to May 8, 2015|Physician Decision|0|||
161840741|NCT02031458|584462821|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
161840742|NCT02031458|584462822|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
161840743|NCT02031458|584462823|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
161840744|NCT02031458|584462821|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
161840745|NCT02031458|584462822|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
161840746|NCT02031458|584462823|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
161840747|NCT02031458|584462821|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
161840748|NCT02031458|584462822|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
161840749|NCT02031458|584462823|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
161840750|NCT02031458|584462821|FG000|Baseline to May 8, 2015|On Treatment|43|||
161840751|NCT02031458|584462822|FG001|Baseline to May 8, 2015|On Treatment|81|||
161840752|NCT02031458|584462823|FG002|Baseline to May 8, 2015|On Treatment|73|||
161840753|NCT02031458|584462821|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
161840754|NCT02031458|584462822|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
161840755|NCT02031458|584462823|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
161840756|NCT04305587|584462824|FG000|Overall Study|Withdrawal by Subject|0|||
161840757|NCT04305587|584462825|FG001|Overall Study|Withdrawal by Subject|0|||
161840758|NCT04305587|584462826|FG002|Overall Study|Withdrawal by Subject|0|||
161840759|NCT04305587|584462827|FG003|Overall Study|Withdrawal by Subject|1|||
161840760|NCT04305587|584462828|FG004|Overall Study|Withdrawal by Subject|0|||
161840761|NCT04305587|584462829|FG005|Overall Study|Withdrawal by Subject|0|||
161840762|NCT04305587|584462830|FG006|Overall Study|Withdrawal by Subject|0|||
161840763|NCT04305587|584462831|FG007|Overall Study|Withdrawal by Subject|0|||
161840764|NCT04305587|584462832|FG008|Overall Study|Withdrawal by Subject|0|||
161840765|NCT02752906|584462833|FG000|Overall Study|Protocol Violation|2|||
161840766|NCT02752906|584462834|FG001|Overall Study|Protocol Violation|1|||
161840767|NCT02752906|584462833|FG000|Overall Study|Withdrawal by Subject|2|||
161840768|NCT02752906|584462834|FG001|Overall Study|Withdrawal by Subject|2|||
161840769|NCT02752906|584462833|FG000|Overall Study|Lost to Follow-up|3|||
161840770|NCT02752906|584462834|FG001|Overall Study|Lost to Follow-up|2|||
161840771|NCT01007942|584462836|FG000|Overall Study|Adverse Event|29|||
161840772|NCT01007942|584462837|FG001|Overall Study|Adverse Event|14|||
161840773|NCT01007942|584462836|FG000|Overall Study|Abnormal test procedure|0|||
161840774|NCT01007942|584462837|FG001|Overall Study|Abnormal test procedure|1|||
161840775|NCT01007942|584462836|FG000|Overall Study|Disease progression|217|||
161840776|NCT01007942|584462837|FG001|Overall Study|Disease progression|242|||
161840777|NCT01007942|584462836|FG000|Overall Study|New cancer therapy|5|||
161840778|NCT01007942|584462837|FG001|Overall Study|New cancer therapy|1|||
161840779|NCT01007942|584462836|FG000|Overall Study|Protocol Violation|1|||
161840780|NCT01007942|584462837|FG001|Overall Study|Protocol Violation|1|||
161840781|NCT01007942|584462836|FG000|Overall Study|Withdrawal by Subject|19|||
161840782|NCT01007942|584462837|FG001|Overall Study|Withdrawal by Subject|14|||
161840783|NCT01007942|584462836|FG000|Overall Study|Lost to Follow-up|1|||
161840784|NCT01007942|584462837|FG001|Overall Study|Lost to Follow-up|0|||
161840785|NCT01007942|584462836|FG000|Overall Study|Administrative problems|2|||
161840786|NCT01007942|584462837|FG001|Overall Study|Administrative problems|0|||
161840787|NCT01007942|584462836|FG000|Overall Study|Death|3|||
161840788|NCT01007942|584462837|FG001|Overall Study|Death|2|||
161840789|NCT01007942|584462836|FG000|Overall Study|Patients untreated|4|||
161840790|NCT01007942|584462837|FG001|Overall Study|Patients untreated|3|||
161840791|NCT03412396|584462838|FG000|Overall Study|Withdrawal by Subject|2|||
161966187|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
161966188|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
161966189|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
161966190|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
161966191|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
161966192|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
161966193|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
161966194|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
161966195|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
161966196|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
161966197|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
161966198|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
161966199|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Promotor request|1|||
161966200|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Promotor request|0|||
161966201|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Promotor request|0|||
161966202|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
161966203|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
161966204|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
161966205|NCT01461928|584923554|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
161740500|NCT01641991|584088875|FG002|Overall Study|Pregnancy|1|||
161740501|NCT01641991|584088876|FG003|Overall Study|Pregnancy|0|||
161740502|NCT01641991|584088873|FG000|Overall Study|no longer eligible|2|||
161740503|NCT01641991|584088874|FG001|Overall Study|no longer eligible|1|||
161740504|NCT01641991|584088875|FG002|Overall Study|no longer eligible|0|||
161740505|NCT01641991|584088876|FG003|Overall Study|no longer eligible|4|||
161740506|NCT03245723|584088877|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
161740507|NCT03245723|584088878|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
161740508|NCT03245723|584088877|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
161740509|NCT03245723|584088878|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
161740510|NCT03245723|584088877|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
161740511|NCT03245723|584088878|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
161740512|NCT03245723|584088877|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
161740513|NCT03245723|584088878|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
161740514|NCT00077376|584088879|FG000|Overall Study|Adverse Event|8|||
161740515|NCT00077376|584088879|FG000|Overall Study|Withdrawal by Subject|2|||
161740516|NCT00077376|584088879|FG000|Overall Study|Death|1|||
161740517|NCT00077376|584088879|FG000|Overall Study|Physician Decision|1|||
161740518|NCT00077376|584088879|FG000|Overall Study|Alternative therapy|5|||
161740519|NCT00077376|584088879|FG000|Overall Study|Complicating disease|1|||
161740520|NCT00077376|584088879|FG000|Overall Study|Still on treatment|1|||
161740521|NCT00077376|584088879|FG000|Overall Study|Symptomatic deterioration|1|||
161740522|NCT00077376|584088879|FG000|Overall Study|Surgery|1|||
161740523|NCT00077376|584088879|FG000|Overall Study|Insurance ran out|1|||
161740524|NCT03927911|584090433|FG000|Overall Study|problems with eDiary|0|||
161740525|NCT03927911|584090434|FG001|Overall Study|problems with eDiary|1|||
161740526|NCT03927911|584090435|FG002|Overall Study|problems with eDiary|0|||
161740527|NCT03927911|584090436|FG003|Overall Study|problems with eDiary|1|||
161740528|NCT03927911|584090437|FG004|Overall Study|problems with eDiary|0|||
161740529|NCT03927911|584090438|FG005|Overall Study|problems with eDiary|4|||
161740530|NCT03927911|584090433|FG000|Overall Study|Adverse Event|0|||
161740531|NCT03927911|584090434|FG001|Overall Study|Adverse Event|0|||
161740532|NCT03927911|584090435|FG002|Overall Study|Adverse Event|0|||
161740533|NCT03927911|584090436|FG003|Overall Study|Adverse Event|0|||
161740534|NCT03927911|584090437|FG004|Overall Study|Adverse Event|0|||
161740535|NCT03927911|584090438|FG005|Overall Study|Adverse Event|1|||
161740536|NCT03927911|584090433|FG000|Overall Study|not treated -study terminated by sponsor|0|||
161740537|NCT03927911|584090434|FG001|Overall Study|not treated -study terminated by sponsor|1|||
161740538|NCT03927911|584090435|FG002|Overall Study|not treated -study terminated by sponsor|0|||
161740539|NCT03927911|584090436|FG003|Overall Study|not treated -study terminated by sponsor|0|||
161740540|NCT03927911|584090437|FG004|Overall Study|not treated -study terminated by sponsor|0|||
161740541|NCT03927911|584090438|FG005|Overall Study|not treated -study terminated by sponsor|0|||
161740542|NCT03927911|584090433|FG000|Overall Study|Surgery cancelled|0|||
161740543|NCT03927911|584090434|FG001|Overall Study|Surgery cancelled|0|||
161740544|NCT03927911|584090435|FG002|Overall Study|Surgery cancelled|0|||
161740545|NCT03927911|584090436|FG003|Overall Study|Surgery cancelled|1|||
161740546|NCT03927911|584090437|FG004|Overall Study|Surgery cancelled|0|||
161740547|NCT03927911|584090438|FG005|Overall Study|Surgery cancelled|1|||
161740548|NCT03927911|584090433|FG000|Overall Study|Protocol Violation|0|||
161740549|NCT03927911|584090434|FG001|Overall Study|Protocol Violation|0|||
161740550|NCT03927911|584090435|FG002|Overall Study|Protocol Violation|0|||
161740551|NCT03927911|584090436|FG003|Overall Study|Protocol Violation|0|||
161740552|NCT03927911|584090437|FG004|Overall Study|Protocol Violation|0|||
161740553|NCT03927911|584090438|FG005|Overall Study|Protocol Violation|1|||
161740554|NCT02658968|584090439|FG000|Received Rituximab|Adverse Event|0|||
161740555|NCT02658968|584090440|FG001|Received Rituximab|Adverse Event|0|||
161740556|NCT02658968|584090441|FG002|Received Rituximab|Adverse Event|0|||
161740557|NCT02658968|584090442|FG003|Received Rituximab|Adverse Event|0|||
161740558|NCT02658968|584090443|FG004|Received Rituximab|Adverse Event|1|||
161740559|NCT02658968|584090439|FG000|Received Rituximab|Progressive disease|0|||
161740560|NCT02658968|584090440|FG001|Received Rituximab|Progressive disease|0|||
161740561|NCT02658968|584090441|FG002|Received Rituximab|Progressive disease|0|||
161740562|NCT02658968|584090442|FG003|Received Rituximab|Progressive disease|0|||
161740563|NCT02658968|584090443|FG004|Received Rituximab|Progressive disease|1|||
161740564|NCT02658968|584090439|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
161740565|NCT02658968|584090440|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
161740566|NCT02658968|584090441|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
161740567|NCT02658968|584090442|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
161740568|NCT02658968|584090443|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
161740569|NCT02658968|584090439|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
161740570|NCT02658968|584090440|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
161740571|NCT02658968|584090441|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
161740572|NCT02658968|584090442|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
161740573|NCT02658968|584090443|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
161740574|NCT02658968|584090439|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
161740575|NCT02658968|584090440|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
161740576|NCT02658968|584090441|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
161740577|NCT02658968|584090442|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
161740578|NCT02658968|584090443|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
161740579|NCT02658968|584090439|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
161740580|NCT02658968|584090440|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
161740581|NCT02658968|584090441|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
161740582|NCT02658968|584090442|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
161740583|NCT02658968|584090443|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
161740584|NCT02658968|584090439|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
161740585|NCT02658968|584090440|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
161740586|NCT02658968|584090441|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
161740587|NCT02658968|584090442|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
161740588|NCT02658968|584090443|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
161740589|NCT01149343|584090444|FG000|Overall Study|Withdrawal by Subject|1|||
161740590|NCT01149343|584090445|FG001|Overall Study|Withdrawal by Subject|1|||
161740591|NCT01149343|584090446|FG002|Overall Study|Withdrawal by Subject|1|||
161740592|NCT01149343|584090447|FG003|Overall Study|Withdrawal by Subject|5|||
161740593|NCT01149343|584090444|FG000|Overall Study|Death|10|||
161740594|NCT01149343|584090445|FG001|Overall Study|Death|13|||
161740595|NCT01149343|584090446|FG002|Overall Study|Death|18|||
161740596|NCT01149343|584090447|FG003|Overall Study|Death|18|||
161740597|NCT01149343|584090444|FG000|Overall Study|Lost to Follow-up|1|||
161740598|NCT01149343|584090445|FG001|Overall Study|Lost to Follow-up|0|||
161740599|NCT01149343|584090446|FG002|Overall Study|Lost to Follow-up|0|||
161740600|NCT01149343|584090447|FG003|Overall Study|Lost to Follow-up|1|||
161740601|NCT01149343|584090444|FG000|Overall Study|Other|8|||
161740602|NCT01149343|584090445|FG001|Overall Study|Other|10|||
161740603|NCT01149343|584090446|FG002|Overall Study|Other|2|||
161740604|NCT01149343|584090447|FG003|Overall Study|Other|14|||
161740605|NCT01149343|584090444|FG000|Overall Study|Sponsor study termination|0|||
161740606|NCT01149343|584090445|FG001|Overall Study|Sponsor study termination|0|||
161740607|NCT01149343|584090446|FG002|Overall Study|Sponsor study termination|0|||
161740608|NCT01149343|584090447|FG003|Overall Study|Sponsor study termination|2|||
161740609|NCT01149343|584090444|FG000|Overall Study|Recurrence / Progressive disease|0|||
161740610|NCT01149343|584090445|FG001|Overall Study|Recurrence / Progressive disease|0|||
161740611|NCT01149343|584090446|FG002|Overall Study|Recurrence / Progressive disease|1|||
161740612|NCT01149343|584090447|FG003|Overall Study|Recurrence / Progressive disease|0|||
161740613|NCT03472040|584090464|FG000|Overall Study|Physician Decision|0|||
161740614|NCT03472040|584090465|FG001|Overall Study|Physician Decision|3|||
161740615|NCT03472040|584090464|FG000|Overall Study|Withdrawal by Subject|10|||
161740616|NCT03472040|584090465|FG001|Overall Study|Withdrawal by Subject|23|||
161740617|NCT03472040|584090464|FG000|Overall Study|Perceived Lack of Efficacy|29|||
161740618|NCT03472040|584090465|FG001|Overall Study|Perceived Lack of Efficacy|30|||
161740619|NCT03472040|584090464|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
161740620|NCT03472040|584090465|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
161740621|NCT03472040|584090464|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
161740622|NCT03472040|584090465|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
161740623|NCT03472040|584090464|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
161740624|NCT03472040|584090465|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
161740625|NCT03472040|584090464|FG000|Overall Study|Subject Non-compliance|2|||
161740626|NCT03472040|584090465|FG001|Overall Study|Subject Non-compliance|5|||
161740627|NCT03472040|584090464|FG000|Overall Study|Discontinuation due to Rash|0|||
161740628|NCT03472040|584090465|FG001|Overall Study|Discontinuation due to Rash|1|||
161740629|NCT03472040|584090464|FG000|Overall Study|Subsequent Ineligibility|0|||
161740630|NCT03472040|584090465|FG001|Overall Study|Subsequent Ineligibility|2|||
161840792|NCT03412396|584462838|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
161840793|NCT03412396|584462838|FG000|Overall Study|Did not undergo RP|2|||
161840794|NCT00655876|584462840|FG000|Overall Study|Protocol Violation|9|||
161740631|NCT03472040|584090464|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
161740632|NCT03472040|584090465|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
161840795|NCT00655876|584462841|FG001|Overall Study|Protocol Violation|7|||
161840796|NCT00470067|584462844|FG000|Overall Study|Death|1|||
161966206|NCT01461928|584923555|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
161966207|NCT01461928|584923556|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
161740633|NCT02769832|584090466|FG000|Overall Study|Death|30|||
161740634|NCT02197897|584090467|FG000|Overall Study|not eligible|1|||
161840797|NCT00470067|584462844|FG000|Overall Study|Disease Progression|6|||
161966208|NCT01461928|584923554|FG000|Maintenance I (24 Months)|Death|3|||
161966209|NCT01461928|584923555|FG001|Maintenance I (24 Months)|Death|0|||
161840798|NCT01460901|584462845|FG000|Overall Study|Withdrawal by Subject|2|||
161840799|NCT01059539|584462848|FG000|Overall Study|Adverse Event|66|||
161840800|NCT01059539|584462848|FG000|Overall Study|Insufficient Therapeutic Response|26|||
161840801|NCT01059539|584462848|FG000|Overall Study|Protocol Violation|55|||
161840802|NCT01059539|584462848|FG000|Overall Study|Withdrawal of Consent|80|||
161840803|NCT01059539|584462848|FG000|Overall Study|Lost to Follow-up|42|||
161840804|NCT01059539|584462848|FG000|Overall Study|Reason Not Specified|2|||
161840805|NCT04091659|584462852|FG000|Overall Study|Protocol Violation|3|||
161840806|NCT04091659|584462853|FG001|Overall Study|Protocol Violation|0|||
161840807|NCT04091659|584462852|FG000|Overall Study|Lost to Follow-up|0|||
161840808|NCT04091659|584462853|FG001|Overall Study|Lost to Follow-up|1|||
161840809|NCT00895947|584462854|FG000|Overall Study|Adverse Event|3|||
161840810|NCT00895947|584462855|FG001|Overall Study|Adverse Event|4|||
161740635|NCT00650091|584090469|FG000|Amended Study Design|Withdrawal by Subject|12|||
161740636|NCT00650091|584090470|FG001|Amended Study Design|Withdrawal by Subject|11|||
161740637|NCT00650091|584090471|FG002|Amended Study Design|Withdrawal by Subject|0|||
161740638|NCT00650091|584090469|FG000|Amended Study Design|Physician Decision|5|||
161740639|NCT00650091|584090470|FG001|Amended Study Design|Physician Decision|0|||
161740640|NCT00650091|584090471|FG002|Amended Study Design|Physician Decision|0|||
161740641|NCT00650091|584090469|FG000|Amended Study Design|Adverse Event|1|||
161740642|NCT00650091|584090470|FG001|Amended Study Design|Adverse Event|4|||
161740643|NCT00650091|584090471|FG002|Amended Study Design|Adverse Event|0|||
161740644|NCT00650091|584090469|FG000|Amended Study Design|Lung transplantation|4|||
161740645|NCT00650091|584090470|FG001|Amended Study Design|Lung transplantation|2|||
161740646|NCT00650091|584090471|FG002|Amended Study Design|Lung transplantation|0|||
161740647|NCT00650091|584090469|FG000|Amended Study Design|Other|1|||
161740648|NCT00650091|584090470|FG001|Amended Study Design|Other|3|||
161740649|NCT00650091|584090471|FG002|Amended Study Design|Other|0|||
161740650|NCT04724733|584090491|FG000|Overall Study|Lost to Follow-up|1|||
161740651|NCT04724733|584090492|FG001|Overall Study|Lost to Follow-up|1|||
161740652|NCT04724733|584090493|FG002|Overall Study|Lost to Follow-up|1|||
161740653|NCT03341923|584090494|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
161740654|NCT03341923|584090495|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
161740655|NCT04511819|584090496|FG000|Overall Study|Non-compliance with study drug|5|||
161740656|NCT04511819|584090497|FG001|Overall Study|Non-compliance with study drug|1|||
161740657|NCT04511819|584090496|FG000|Overall Study|Withdrawal by Subject|0|||
161740658|NCT04511819|584090497|FG001|Overall Study|Withdrawal by Subject|3|||
161740659|NCT04511819|584090496|FG000|Overall Study|Adverse Event|0|||
161740660|NCT04511819|584090497|FG001|Overall Study|Adverse Event|1|||
161740661|NCT04511819|584090496|FG000|Overall Study|Protocol deviation|1|||
161740662|NCT04511819|584090497|FG001|Overall Study|Protocol deviation|0|||
161740663|NCT00168064|584090500|FG000|Overall Study|Adverse Event|26|||
161740664|NCT00168064|584090501|FG001|Overall Study|Adverse Event|22|||
161740665|NCT00168064|584090500|FG000|Overall Study|Withdrawal by Subject|3|||
161740666|NCT00168064|584090501|FG001|Overall Study|Withdrawal by Subject|4|||
161740667|NCT00168064|584090500|FG000|Overall Study|Lack of Efficacy|4|||
161740668|NCT00168064|584090501|FG001|Overall Study|Lack of Efficacy|4|||
161740669|NCT00168064|584090500|FG000|Overall Study|Lost to Follow-up|4|||
161740670|NCT00168064|584090501|FG001|Overall Study|Lost to Follow-up|3|||
161740671|NCT00168064|584090500|FG000|Overall Study|Non-compliance|2|||
161740672|NCT00168064|584090501|FG001|Overall Study|Non-compliance|3|||
161740673|NCT00168064|584090500|FG000|Overall Study|Concurrent Illness|4|||
161740674|NCT00168064|584090501|FG001|Overall Study|Concurrent Illness|3|||
161740675|NCT00168064|584090500|FG000|Overall Study|Subject's Best interest|2|||
161740676|NCT00168064|584090501|FG001|Overall Study|Subject's Best interest|2|||
161740677|NCT00168064|584090500|FG000|Overall Study|Various|4|||
161740678|NCT00168064|584090501|FG001|Overall Study|Various|3|||
161740679|NCT00589979|584090503|FG000|Run-In Period|Adverse Event|5|||
161740680|NCT00589979|584090504|FG001|Run-In Period|Adverse Event|0|||
161740681|NCT00589979|584090505|FG002|Run-In Period|Adverse Event|0|||
161740682|NCT00589979|584090503|FG000|Run-In Period|Protocol Violation|3|||
161740683|NCT00589979|584090504|FG001|Run-In Period|Protocol Violation|0|||
161740684|NCT00589979|584090505|FG002|Run-In Period|Protocol Violation|0|||
161740685|NCT00589979|584090503|FG000|Run-In Period|Did not qualify for randomization|54|||
161740686|NCT00589979|584090504|FG001|Run-In Period|Did not qualify for randomization|0|||
161740687|NCT00589979|584090505|FG002|Run-In Period|Did not qualify for randomization|0|||
161740688|NCT00589979|584090503|FG000|Run-In Period|Withdrawal by Subject|10|||
161740689|NCT00589979|584090504|FG001|Run-In Period|Withdrawal by Subject|0|||
161740690|NCT00589979|584090505|FG002|Run-In Period|Withdrawal by Subject|0|||
161740691|NCT00589979|584090503|FG000|Run-In Period|Informed Consent Withdrawn|4|||
161740692|NCT00589979|584090504|FG001|Run-In Period|Informed Consent Withdrawn|0|||
161740693|NCT00589979|584090505|FG002|Run-In Period|Informed Consent Withdrawn|0|||
161740694|NCT00589979|584090503|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
161740695|NCT00589979|584090504|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
161740696|NCT00589979|584090505|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
161740697|NCT00589979|584090503|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
161740698|NCT00589979|584090504|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
161740699|NCT00589979|584090505|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
161740700|NCT00589979|584090503|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
161740701|NCT00589979|584090504|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
161740702|NCT00589979|584090505|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
161740703|NCT00589979|584090503|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
161740704|NCT00589979|584090504|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
161740705|NCT00589979|584090505|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
161740706|NCT00589979|584090503|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
161740707|NCT00589979|584090504|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
161740708|NCT00589979|584090505|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
161740709|NCT00589979|584090503|FG000|Double-Blind Treatment Period 2|Other|0|||
161740710|NCT00589979|584090504|FG001|Double-Blind Treatment Period 2|Other|0|||
161740711|NCT00589979|584090505|FG002|Double-Blind Treatment Period 2|Other|1|||
161740712|NCT00589979|584090503|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
161740713|NCT00589979|584090504|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
161740714|NCT00589979|584090505|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
161740715|NCT00589979|584090503|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
161740716|NCT00589979|584090504|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
161740717|NCT00589979|584090505|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
161740718|NCT01153841|584090506|FG000|Overall Study|Adverse Event|1|||
161740719|NCT01153841|584090507|FG001|Overall Study|Adverse Event|0|||
161740720|NCT01153841|584090506|FG000|Overall Study|Withdrawal by Subject|1|||
161740721|NCT01153841|584090507|FG001|Overall Study|Withdrawal by Subject|0|||
161740722|NCT01153841|584090506|FG000|Overall Study|Protocol Violation|2|||
161740723|NCT01153841|584090507|FG001|Overall Study|Protocol Violation|0|||
161740724|NCT01153841|584090506|FG000|Overall Study|Lost to Follow-up|2|||
161740725|NCT01153841|584090507|FG001|Overall Study|Lost to Follow-up|0|||
161740726|NCT03428997|584090513|FG000|Overall Study|Sponsor decision.|1|||
161740727|NCT03428997|584090513|FG000|Overall Study|Withdrawal by Subject|3|||
161740728|NCT03428997|584090513|FG000|Overall Study|Lost to Follow-up|4|||
161740729|NCT00510068|584090517|FG000|Double-blind Period|Disease progression|98|||
161740730|NCT00510068|584090518|FG001|Double-blind Period|Disease progression|169|||
161740731|NCT00510068|584090517|FG000|Double-blind Period|Final primary analysis|52|||
161740732|NCT00510068|584090518|FG001|Double-blind Period|Final primary analysis|18|||
161740733|NCT00510068|584090517|FG000|Double-blind Period|Adverse Event|37|||
161740734|NCT00510068|584090518|FG001|Double-blind Period|Adverse Event|7|||
161740735|NCT00510068|584090517|FG000|Double-blind Period|Withdrawal by Subject|8|||
161740736|NCT00510068|584090518|FG001|Double-blind Period|Withdrawal by Subject|6|||
161740737|NCT00510068|584090517|FG000|Double-blind Period|Death|4|||
161740738|NCT00510068|584090518|FG001|Double-blind Period|Death|3|||
161740739|NCT00510068|584090517|FG000|Double-blind Period|Abnormal test result (s)|1|||
161740740|NCT00510068|584090518|FG001|Double-blind Period|Abnormal test result (s)|0|||
161740741|NCT00510068|584090517|FG000|Double-blind Period|Lost to Follow-up|1|||
161740742|NCT00510068|584090518|FG001|Double-blind Period|Lost to Follow-up|0|||
161740743|NCT00510068|584090517|FG000|Double-blind Period|Protocol Violation|6|||
161740744|NCT00510068|584090518|FG001|Double-blind Period|Protocol Violation|0|||
161740745|NCT00510068|584090517|FG000|Open-label Period|Disease Progression|124|||
161740746|NCT00510068|584090518|FG001|Open-label Period|Disease Progression|0|||
161740747|NCT00510068|584090517|FG000|Open-label Period|Adverse Event|46|||
161740748|NCT00510068|584090518|FG001|Open-label Period|Adverse Event|0|||
161740749|NCT00510068|584090517|FG000|Open-label Period|Withdrawal by Subject|21|||
161740750|NCT00510068|584090518|FG001|Open-label Period|Withdrawal by Subject|0|||
161740751|NCT00510068|584090517|FG000|Open-label Period|Administrative problems|17|||
161740752|NCT00510068|584090518|FG001|Open-label Period|Administrative problems|0|||
161740753|NCT00510068|584090517|FG000|Open-label Period|Death|7|||
161740754|NCT00510068|584090518|FG001|Open-label Period|Death|0|||
161740755|NCT00510068|584090517|FG000|Open-label Period|New cancer therapy|7|||
161740756|NCT00510068|584090518|FG001|Open-label Period|New cancer therapy|0|||
161740757|NCT00510068|584090517|FG000|Open-label Period|Protocol Violation|2|||
161740758|NCT00510068|584090518|FG001|Open-label Period|Protocol Violation|0|||
161740759|NCT00510068|584090517|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
161740760|NCT00510068|584090518|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
161966210|NCT01461928|584923556|FG002|Maintenance I (24 Months)|Death|0|||
161740761|NCT01354431|584090520|FG000|Pre-Treatment Period|Not reported|1|||
161740762|NCT01354431|584090521|FG001|Pre-Treatment Period|Not reported|0|||
161740763|NCT01354431|584090522|FG002|Pre-Treatment Period|Not reported|0|||
161740764|NCT01354431|584090520|FG000|Treatment Period|Disease Progression|50|||
161740765|NCT01354431|584090521|FG001|Treatment Period|Disease Progression|40|||
161740766|NCT01354431|584090522|FG002|Treatment Period|Disease Progression|44|||
161740767|NCT01354431|584090520|FG000|Treatment Period|Study Drug Toxicity|5|||
161740768|NCT01354431|584090521|FG001|Treatment Period|Study Drug Toxicity|8|||
161740769|NCT01354431|584090522|FG002|Treatment Period|Study Drug Toxicity|4|||
161740770|NCT01354431|584090520|FG000|Treatment Period|Death|0|||
161740771|NCT01354431|584090521|FG001|Treatment Period|Death|1|||
161740772|NCT01354431|584090522|FG002|Treatment Period|Death|0|||
161740773|NCT01354431|584090520|FG000|Treatment Period|AE unrelated to study drug|1|||
161740774|NCT01354431|584090521|FG001|Treatment Period|AE unrelated to study drug|2|||
161740775|NCT01354431|584090522|FG002|Treatment Period|AE unrelated to study drug|5|||
161740776|NCT01354431|584090520|FG000|Treatment Period|Participant request to discontinue|2|||
161740777|NCT01354431|584090521|FG001|Treatment Period|Participant request to discontinue|2|||
161740778|NCT01354431|584090522|FG002|Treatment Period|Participant request to discontinue|1|||
161740779|NCT01354431|584090520|FG000|Treatment Period|Participant withdrew consent|0|||
161740780|NCT01354431|584090521|FG001|Treatment Period|Participant withdrew consent|1|||
161740781|NCT01354431|584090522|FG002|Treatment Period|Participant withdrew consent|0|||
161740782|NCT01354431|584090520|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
161740783|NCT01354431|584090521|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
161740784|NCT01354431|584090522|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
161740785|NCT03176277|584090523|FG000|Part A Dose Escalation Study|Adverse Event|1|||
161740786|NCT03176277|584090524|FG001|Part A Dose Escalation Study|Adverse Event|0|||
161740787|NCT03176277|584090525|FG002|Part A Dose Escalation Study|Adverse Event|1|||
161740788|NCT03176277|584090526|FG003|Part A Dose Escalation Study|Adverse Event|0|||
161740789|NCT03176277|584090523|FG000|Part A Dose Escalation Study|Physician Decision|1|||
161740790|NCT03176277|584090524|FG001|Part A Dose Escalation Study|Physician Decision|1|||
161740791|NCT03176277|584090525|FG002|Part A Dose Escalation Study|Physician Decision|2|||
161740792|NCT03176277|584090526|FG003|Part A Dose Escalation Study|Physician Decision|0|||
161740793|NCT03176277|584090523|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
161740794|NCT03176277|584090524|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
161740795|NCT03176277|584090525|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
161740796|NCT03176277|584090526|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
161740797|NCT03176277|584090523|FG000|Part A Dose Escalation Study|Progressive disease|3|||
161740798|NCT03176277|584090524|FG001|Part A Dose Escalation Study|Progressive disease|1|||
161740799|NCT03176277|584090525|FG002|Part A Dose Escalation Study|Progressive disease|3|||
161740800|NCT03176277|584090526|FG003|Part A Dose Escalation Study|Progressive disease|0|||
161740801|NCT02802878|584090527|FG000|Overall Study|Withdrawal by Subject|3|||
161740802|NCT02802878|584090528|FG001|Overall Study|Withdrawal by Subject|3|||
161740803|NCT02802878|584090527|FG000|Overall Study|Protocol Violation|1|||
161740804|NCT02802878|584090528|FG001|Overall Study|Protocol Violation|0|||
161740805|NCT00702052|584090529|FG000|Overall Study|Adverse Event|23|||
161740806|NCT00702052|584090529|FG000|Overall Study|Disease Progression|30|||
161740807|NCT00702052|584090529|FG000|Overall Study|Withdrawal by Subject|5|||
161740808|NCT00101192|584090530|FG000|Overall Study|Ineligible|6|||
161740809|NCT00101192|584090530|FG000|Overall Study|Inevaluable|1|||
161740810|NCT03691610|584090531|FG000|Overall Study|Adverse Event|0|||
161740811|NCT03691610|584090532|FG001|Overall Study|Adverse Event|1|||
161740812|NCT03691610|584090533|FG002|Overall Study|Adverse Event|0|||
161740813|NCT03691610|584090534|FG003|Overall Study|Adverse Event|0|||
161740814|NCT03691610|584090531|FG000|Overall Study|Protocol Deviation|15|||
161740815|NCT03691610|584090532|FG001|Overall Study|Protocol Deviation|8|||
161740816|NCT03691610|584090533|FG002|Overall Study|Protocol Deviation|1|||
161740817|NCT03691610|584090534|FG003|Overall Study|Protocol Deviation|2|||
161740818|NCT03691610|584090531|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
161740819|NCT03691610|584090532|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
161740820|NCT03691610|584090533|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
161740821|NCT03691610|584090534|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
161740822|NCT03691610|584090531|FG000|Overall Study|Lost to Follow-up|20|||
161740823|NCT03691610|584090532|FG001|Overall Study|Lost to Follow-up|11|||
161740824|NCT03691610|584090533|FG002|Overall Study|Lost to Follow-up|5|||
161740825|NCT03691610|584090534|FG003|Overall Study|Lost to Follow-up|2|||
161740826|NCT00536978|584090535|FG000|Overall Study|Not eligible for Adback Infusion|22|||
161740827|NCT01232894|584090536|FG000|Overall Study|Lost to Follow-up|0|||
161740828|NCT01232894|584090537|FG001|Overall Study|Lost to Follow-up|1|||
161740829|NCT01232894|584090536|FG000|Overall Study|Death|1|||
161740830|NCT01232894|584090537|FG001|Overall Study|Death|0|||
161740831|NCT01232894|584090536|FG000|Overall Study|Protocol Violation|1|||
161740832|NCT01232894|584090537|FG001|Overall Study|Protocol Violation|1|||
161740833|NCT01232894|584090536|FG000|Overall Study|Withdrawal by Subject|8|||
161740834|NCT01232894|584090537|FG001|Overall Study|Withdrawal by Subject|5|||
161740835|NCT01232894|584090536|FG000|Overall Study|Physician Decision|2|||
161740836|NCT01232894|584090537|FG001|Overall Study|Physician Decision|1|||
161740837|NCT03970395|584090538|FG000|Overall Study|Withdrawal by Subject|3|||
161740838|NCT03970395|584090539|FG001|Overall Study|Withdrawal by Subject|4|||
161740839|NCT03970395|584090538|FG000|Overall Study|Lost to Follow-up|4|||
161740840|NCT03970395|584090539|FG001|Overall Study|Lost to Follow-up|8|||
162032444|NCT04285580|585177385|FG001|Overall Study|Protocol Violation|1|||
162032445|NCT00562627|585177386|FG000|Overall Study|Protocol Violation|1|||
161740841|NCT02921919|584090540|FG000|Overall Study|Other|5|||
161740842|NCT02921919|584090541|FG001|Overall Study|Other|6|||
161740843|NCT02921919|584090540|FG000|Overall Study|Lost to Follow-up|0|||
161740844|NCT02921919|584090541|FG001|Overall Study|Lost to Follow-up|1|||
161740845|NCT02921919|584090540|FG000|Overall Study|Withdrawal by Subject|5|||
161740846|NCT02921919|584090541|FG001|Overall Study|Withdrawal by Subject|1|||
161740847|NCT02921919|584090540|FG000|Overall Study|Disease Progression|47|||
161740848|NCT02921919|584090541|FG001|Overall Study|Disease Progression|38|||
161740849|NCT02921919|584090540|FG000|Overall Study|Physician Decision|3|||
161740850|NCT02921919|584090541|FG001|Overall Study|Physician Decision|2|||
161740851|NCT02921919|584090540|FG000|Overall Study|Adverse Event|6|||
161740852|NCT02921919|584090541|FG001|Overall Study|Adverse Event|4|||
161740853|NCT04664855|584090542|FG000|Overall Study|Withdrawal by Subject|0|||
161740854|NCT04664855|584090543|FG001|Overall Study|Withdrawal by Subject|2|||
161740855|NCT01086150|584090551|FG000|Overall Study|Withdrawal by Subject|0|||
161740856|NCT01086150|584090552|FG001|Overall Study|Withdrawal by Subject|4|||
161740857|NCT01086150|584090553|FG002|Overall Study|Withdrawal by Subject|1|||
161740858|NCT01086150|584090551|FG000|Overall Study|Lost to Follow-up|0|||
161740859|NCT01086150|584090552|FG001|Overall Study|Lost to Follow-up|1|||
161740860|NCT01086150|584090553|FG002|Overall Study|Lost to Follow-up|0|||
161740861|NCT01086150|584090551|FG000|Overall Study|Screen Failure|0|||
161740862|NCT01086150|584090552|FG001|Overall Study|Screen Failure|1|||
161740863|NCT01086150|584090553|FG002|Overall Study|Screen Failure|0|||
161740864|NCT00178464|584090555|FG000|Overall Study|Withdrawal by Subject|1|||
161740865|NCT00178464|584090555|FG000|Overall Study|Physician Decision|1|||
161740866|NCT00870818|584090556|FG000|Overall Study|Lost to Follow-up|3|||
161740867|NCT00870818|584090557|FG001|Overall Study|Lost to Follow-up|2|||
161740868|NCT00870818|584090558|FG002|Overall Study|Lost to Follow-up|1|||
161740869|NCT00870818|584090559|FG003|Overall Study|Lost to Follow-up|0|||
161740870|NCT00870818|584090560|FG004|Overall Study|Lost to Follow-up|0|||
161740871|NCT00870818|584090556|FG000|Overall Study|Withdrawal by Subject|0|||
161740872|NCT00870818|584090557|FG001|Overall Study|Withdrawal by Subject|0|||
161740873|NCT00870818|584090558|FG002|Overall Study|Withdrawal by Subject|1|||
161740874|NCT00870818|584090559|FG003|Overall Study|Withdrawal by Subject|2|||
161740875|NCT00870818|584090560|FG004|Overall Study|Withdrawal by Subject|0|||
161740876|NCT00870818|584090556|FG000|Overall Study|Terminated by sponsor|29|||
161740877|NCT00870818|584090557|FG001|Overall Study|Terminated by sponsor|70|||
161740878|NCT00870818|584090558|FG002|Overall Study|Terminated by sponsor|36|||
161740879|NCT00870818|584090559|FG003|Overall Study|Terminated by sponsor|36|||
161740880|NCT00870818|584090560|FG004|Overall Study|Terminated by sponsor|38|||
161740881|NCT00870818|584090556|FG000|Overall Study|Other|0|||
161740882|NCT00870818|584090557|FG001|Overall Study|Other|1|||
161740883|NCT00870818|584090558|FG002|Overall Study|Other|0|||
161740884|NCT00870818|584090559|FG003|Overall Study|Other|0|||
161740885|NCT00870818|584090560|FG004|Overall Study|Other|0|||
161740886|NCT02260648|584090563|FG000|Overall Study|Adverse Event|3|||
161740887|NCT02260648|584090564|FG001|Overall Study|Adverse Event|0|||
161740888|NCT02260648|584090565|FG002|Overall Study|Adverse Event|1|||
161740889|NCT02260648|584090563|FG000|Overall Study|Withdrawal by Subject|1|||
161740890|NCT02260648|584090564|FG001|Overall Study|Withdrawal by Subject|1|||
161740891|NCT02260648|584090565|FG002|Overall Study|Withdrawal by Subject|0|||
161740892|NCT02260648|584090563|FG000|Overall Study|Protocol Violation|1|||
161740893|NCT02260648|584090564|FG001|Overall Study|Protocol Violation|0|||
161740894|NCT02260648|584090565|FG002|Overall Study|Protocol Violation|0|||
161740895|NCT02260648|584090563|FG000|Overall Study|Discontinue Due to Study Termination|13|||
161740896|NCT02260648|584090564|FG001|Overall Study|Discontinue Due to Study Termination|12|||
161740897|NCT02260648|584090565|FG002|Overall Study|Discontinue Due to Study Termination|7|||
161966211|NCT01461928|584923554|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
161966212|NCT01461928|584923555|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
161966213|NCT01461928|584923556|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
161966214|NCT01461928|584923554|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
161966215|NCT01461928|584923555|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
161966216|NCT01461928|584923556|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
161966217|NCT01461928|584923554|FG000|Maintenance I (24 Months)|Diseases progression|91|||
161966218|NCT01461928|584923555|FG001|Maintenance I (24 Months)|Diseases progression|0|||
161966219|NCT01461928|584923556|FG002|Maintenance I (24 Months)|Diseases progression|0|||
161966220|NCT01461928|584923554|FG000|Maintenance I (24 Months)|Adverse Event|70|||
161740898|NCT04093258|584090566|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
161740899|NCT04093258|584090567|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
161740900|NCT01890512|584090568|FG000|Overall Study|Physician Decision|1|||
161740901|NCT01890512|584090568|FG000|Overall Study|Withdrawal by Subject|1|||
161740902|NCT01890512|584090568|FG000|Overall Study|Protocol Violation|1|||
161740903|NCT01529385|584090569|FG000|Overall Study|Lost to Follow-up|2|||
161740904|NCT01529385|584090570|FG001|Overall Study|Lost to Follow-up|1|||
161740905|NCT00805545|584090571|FG000|Overall Study|Protocol Violation|3|||
161740906|NCT00805545|584090572|FG001|Overall Study|Protocol Violation|2|||
161740907|NCT00805545|584090571|FG000|Overall Study|Protocol Violation|3|||
161740908|NCT00805545|584090572|FG001|Overall Study|Protocol Violation|1|||
161740909|NCT03543358|584090573|FG000|Overall Study|Death|1|||
161740910|NCT03543358|584090574|FG001|Overall Study|Death|0|||
161740911|NCT03543358|584090573|FG000|Overall Study|Disease Progression|1|||
161740912|NCT03543358|584090574|FG001|Overall Study|Disease Progression|0|||
162032446|NCT00562627|585177387|FG001|Overall Study|Protocol Violation|1|||
162032447|NCT00562627|585177388|FG002|Overall Study|Protocol Violation|1|||
162032448|NCT02316548|585177392|FG000|Overall Study|Protocol Violation|0|||
162032449|NCT02316548|585177393|FG001|Overall Study|Protocol Violation|1|||
162032450|NCT04972630|585177394|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
162032451|NCT04972630|585177395|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
162032452|NCT04972630|585177396|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
162032453|NCT03422627|585177399|FG000|Overall Study|Protocol-specified Criteria|1|||
162032454|NCT03422627|585177400|FG001|Overall Study|Protocol-specified Criteria|1|||
162032455|NCT03422627|585177401|FG002|Overall Study|Protocol-specified Criteria|0|||
162032456|NCT03422627|585177402|FG003|Overall Study|Protocol-specified Criteria|0|||
162032457|NCT03422627|585177403|FG004|Overall Study|Protocol-specified Criteria|2|||
162032458|NCT03422627|585177399|FG000|Overall Study|Requirement for Alternative Therapy|1|||
162032459|NCT03422627|585177400|FG001|Overall Study|Requirement for Alternative Therapy|1|||
161740913|NCT03543358|584090573|FG000|Overall Study|Parent Study Closure|1|||
161740914|NCT03543358|584090574|FG001|Overall Study|Parent Study Closure|0|||
161740915|NCT00986427|584090575|FG000|Overall Study|Lost to Follow-up|2|||
161740916|NCT00986427|584090576|FG001|Overall Study|Lost to Follow-up|0|||
161740917|NCT00986427|584090575|FG000|Overall Study|Lack of Efficacy|1|||
161740918|NCT00986427|584090576|FG001|Overall Study|Lack of Efficacy|0|||
161740919|NCT00986427|584090575|FG000|Overall Study|Withdrawal by Subject|1|||
161740920|NCT00986427|584090576|FG001|Overall Study|Withdrawal by Subject|0|||
161740921|NCT01401465|584090577|FG000|Treatment Period 1|Adverse Event|4|||
161740922|NCT01401465|584090578|FG001|Treatment Period 1|Adverse Event|1|||
161740923|NCT01401465|584090577|FG000|Treatment Period 1|Pregnancy|0|||
161740924|NCT01401465|584090578|FG001|Treatment Period 1|Pregnancy|1|||
161740925|NCT01401465|584090577|FG000|Treatment Period 1|Protocol Violation|5|||
161740926|NCT01401465|584090578|FG001|Treatment Period 1|Protocol Violation|0|||
161740927|NCT01401465|584090577|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161740928|NCT01401465|584090578|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161740929|NCT01401465|584090577|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
161740930|NCT01401465|584090578|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
161740931|NCT01401465|584090577|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
161740932|NCT01401465|584090578|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
161740933|NCT01401465|584090577|FG000|Treatment Period 1|Scheduling Difficulties|1|||
161740934|NCT01401465|584090578|FG001|Treatment Period 1|Scheduling Difficulties|1|||
161740935|NCT01401465|584090577|FG000|Treatment Period 2|Lost to Follow-up|0|||
161740936|NCT01401465|584090578|FG001|Treatment Period 2|Lost to Follow-up|1|||
161740937|NCT01401465|584090577|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161740938|NCT01401465|584090578|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161740939|NCT01115738|584090579|FG000|Overall Study|Death|1|||
161740940|NCT01115738|584090580|FG001|Overall Study|Death|0|||
161740941|NCT01115738|584090581|FG002|Overall Study|Death|0|||
161740942|NCT01115738|584090579|FG000|Overall Study|Lost to Follow-up|0|||
161740943|NCT01115738|584090580|FG001|Overall Study|Lost to Follow-up|0|||
161740944|NCT01115738|584090581|FG002|Overall Study|Lost to Follow-up|1|||
161740945|NCT01115738|584090579|FG000|Overall Study|Physician Decision|18|||
161740946|NCT01115738|584090580|FG001|Overall Study|Physician Decision|15|||
161740947|NCT01115738|584090581|FG002|Overall Study|Physician Decision|17|||
161740948|NCT01115738|584090579|FG000|Overall Study|Withdrawal by Subject|6|||
161740949|NCT01115738|584090580|FG001|Overall Study|Withdrawal by Subject|6|||
161740950|NCT01115738|584090581|FG002|Overall Study|Withdrawal by Subject|9|||
161740951|NCT02379390|584090586|FG000|Overall Study|Adverse Event|1|||
161740952|NCT02379390|584090587|FG001|Overall Study|Adverse Event|1|||
161740953|NCT02379390|584090586|FG000|Overall Study|Investigator's decision|1|||
161740954|NCT02379390|584090587|FG001|Overall Study|Investigator's decision|0|||
161740955|NCT02379390|584090586|FG000|Overall Study|Study Termination|0|||
161740956|NCT02379390|584090587|FG001|Overall Study|Study Termination|1|||
161740957|NCT00575094|584090588|FG000|Overall Study|Adverse Event|2|||
161740958|NCT00575094|584090588|FG000|Overall Study|Withdrawal by Subject|1|||
161740959|NCT00643604|584090592|FG000|Overall Study|Death|1|||
161740960|NCT02702011|584090593|FG000|Overall Study|Withdrawal by Subject|0|||
161740961|NCT02702011|584090594|FG001|Overall Study|Withdrawal by Subject|1|||
161740962|NCT02702011|584090595|FG002|Overall Study|Withdrawal by Subject|0|||
161740963|NCT02702011|584090596|FG003|Overall Study|Withdrawal by Subject|0|||
161740964|NCT02721251|584090598|FG000|Overall Study|Withdrawal by Subject|8|||
161740965|NCT02721251|584090599|FG001|Overall Study|Withdrawal by Subject|7|||
161740966|NCT02721251|584090600|FG002|Overall Study|Withdrawal by Subject|9|||
162032460|NCT03422627|585177401|FG002|Overall Study|Requirement for Alternative Therapy|2|||
161740967|NCT02721251|584090598|FG000|Overall Study|poor adherence|2|||
161740968|NCT02721251|584090599|FG001|Overall Study|poor adherence|2|||
161740969|NCT02721251|584090600|FG002|Overall Study|poor adherence|2|||
161740970|NCT02921763|584090603|FG000|Overall Study|Adverse Event|4|||
161740971|NCT02921763|584090603|FG000|Overall Study|Lost to Follow-up|4|||
161740972|NCT02921763|584090603|FG000|Overall Study|Lack of Efficacy|3|||
162032461|NCT03422627|585177402|FG003|Overall Study|Requirement for Alternative Therapy|0|||
161740973|NCT02921763|584090603|FG000|Overall Study|Protocol Violation|2|||
161740974|NCT02921763|584090603|FG000|Overall Study|Withdrawal by Subject|2|||
161740975|NCT02921763|584090603|FG000|Overall Study|Physician Decision|1|||
161740976|NCT02921763|584090603|FG000|Overall Study|No data obtained|2|||
161740977|NCT03784027|584090618|FG000|Period 1|Withdrawal by Subject|0|||
161740978|NCT03784027|584090619|FG001|Period 1|Withdrawal by Subject|1|||
161740979|NCT06025396|584091856|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
161740980|NCT06025396|584091857|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
161740981|NCT06025396|584091858|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
161740982|NCT06025396|584091859|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
161740983|NCT06025396|584091860|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
161740984|NCT06025396|584091856|FG000|Overall Study|Withdrawal by Subject|0|||
161740985|NCT06025396|584091857|FG001|Overall Study|Withdrawal by Subject|1|||
161740986|NCT06025396|584091858|FG002|Overall Study|Withdrawal by Subject|1|||
161740987|NCT06025396|584091859|FG003|Overall Study|Withdrawal by Subject|0|||
161740988|NCT06025396|584091860|FG004|Overall Study|Withdrawal by Subject|0|||
161740989|NCT05691829|584091861|FG000|Overall Study|Physician Decision|2|||
161740990|NCT05691829|584091861|FG000|Overall Study|Eligibility criteria not met|3|||
161740991|NCT01512108|584091862|FG000|Overall Study|Adverse Event|9|||
161740992|NCT01512108|584091863|FG001|Overall Study|Adverse Event|4|||
161740993|NCT01512108|584091862|FG000|Overall Study|Protocol Violation|1|||
161740994|NCT01512108|584091863|FG001|Overall Study|Protocol Violation|2|||
161740995|NCT01512108|584091862|FG000|Overall Study|Withdrawal Criteria|1|||
161740996|NCT01512108|584091863|FG001|Overall Study|Withdrawal Criteria|0|||
161740997|NCT01512108|584091862|FG000|Overall Study|Unclassified|11|||
161740998|NCT01512108|584091863|FG001|Overall Study|Unclassified|3|||
161740999|NCT06422377|584091868|FG000|Overall Study|Study Terminated by Sponsor|1|||
161741000|NCT03287869|584091869|FG000|Overall Study|Adverse Event|14|||
161741001|NCT03287869|584091870|FG001|Overall Study|Adverse Event|12|||
161741002|NCT03287869|584091869|FG000|Overall Study|Lack of Efficacy|1|||
161741003|NCT03287869|584091870|FG001|Overall Study|Lack of Efficacy|0|||
161741004|NCT03287869|584091869|FG000|Overall Study|Lost to Follow-up|13|||
161741005|NCT03287869|584091870|FG001|Overall Study|Lost to Follow-up|19|||
161741006|NCT03287869|584091869|FG000|Overall Study|Non-Compliance With Study Drug|5|||
161741007|NCT03287869|584091870|FG001|Overall Study|Non-Compliance With Study Drug|9|||
161741008|NCT03287869|584091869|FG000|Overall Study|Progressive Disease|1|||
161741009|NCT03287869|584091870|FG001|Overall Study|Progressive Disease|0|||
161741010|NCT03287869|584091869|FG000|Overall Study|Protocol Deviation|2|||
161741011|NCT03287869|584091870|FG001|Overall Study|Protocol Deviation|1|||
161741012|NCT03287869|584091869|FG000|Overall Study|Withdrawal by Subject|36|||
161741013|NCT03287869|584091870|FG001|Overall Study|Withdrawal by Subject|43|||
161741014|NCT03287869|584091869|FG000|Overall Study|Early Closure of the Site|0|||
161741015|NCT03287869|584091870|FG001|Overall Study|Early Closure of the Site|1|||
161741016|NCT03287869|584091869|FG000|Overall Study|Physician Decision|5|||
161741017|NCT03287869|584091870|FG001|Overall Study|Physician Decision|5|||
161741018|NCT03287869|584091869|FG000|Overall Study|Reason not Specified|6|||
161741019|NCT03287869|584091870|FG001|Overall Study|Reason not Specified|3|||
161741020|NCT04847141|584091871|FG000|Overall Study|Adverse Event|1|||
161741021|NCT04847141|584091872|FG001|Overall Study|Adverse Event|0|||
161741022|NCT04847141|584091873|FG002|Overall Study|Adverse Event|1|||
161741023|NCT04847141|584091871|FG000|Overall Study|Withdrawal by Subject|2|||
161741024|NCT04847141|584091872|FG001|Overall Study|Withdrawal by Subject|4|||
161741025|NCT04847141|584091873|FG002|Overall Study|Withdrawal by Subject|3|||
161741026|NCT04847141|584091871|FG000|Overall Study|Lost to Follow-up|7|||
161741027|NCT04847141|584091872|FG001|Overall Study|Lost to Follow-up|5|||
161741028|NCT04847141|584091873|FG002|Overall Study|Lost to Follow-up|7|||
161741029|NCT04847141|584091871|FG000|Overall Study|Reason not Specified|0|||
161741030|NCT04847141|584091872|FG001|Overall Study|Reason not Specified|1|||
161741031|NCT04847141|584091873|FG002|Overall Study|Reason not Specified|0|||
161741032|NCT00324740|584091874|FG000|Overall Study|Withdrawal by Subject|1|||
161741033|NCT00324740|584091875|FG001|Overall Study|Withdrawal by Subject|0|||
161741034|NCT00324740|584091876|FG002|Overall Study|Withdrawal by Subject|1|||
161840811|NCT00895947|584462854|FG000|Overall Study|Lost to Follow-up|3|||
161840812|NCT00895947|584462855|FG001|Overall Study|Lost to Follow-up|4|||
161741035|NCT01357980|584091881|FG000|Overall Study|Lack of Efficacy|0|||
161741036|NCT01357980|584091882|FG001|Overall Study|Lack of Efficacy|1|||
161741037|NCT01357980|584091883|FG002|Overall Study|Lack of Efficacy|0|||
161741038|NCT01357980|584091884|FG003|Overall Study|Lack of Efficacy|0|||
161741039|NCT01357980|584091881|FG000|Overall Study|Consent withdrawn|0|||
161741040|NCT01357980|584091882|FG001|Overall Study|Consent withdrawn|0|||
161741041|NCT01357980|584091883|FG002|Overall Study|Consent withdrawn|1|||
162032462|NCT03422627|585177403|FG004|Overall Study|Requirement for Alternative Therapy|0|||
161741042|NCT01357980|584091884|FG003|Overall Study|Consent withdrawn|0|||
161741043|NCT00094835|584091888|FG000|Overall Study|Physician Decision|1|||
161741044|NCT00094835|584091889|FG001|Overall Study|Physician Decision|0|||
161741045|NCT00094835|584091890|FG002|Overall Study|Physician Decision|0|||
161741046|NCT00094835|584091891|FG003|Overall Study|Physician Decision|0|||
161741047|NCT00094835|584091892|FG004|Overall Study|Physician Decision|0|||
161840813|NCT00895947|584462854|FG000|Overall Study|Protocol Violation|4|||
161840814|NCT00895947|584462855|FG001|Overall Study|Protocol Violation|2|||
161840815|NCT00895947|584462854|FG000|Overall Study|Withdrawal by Subject|2|||
161840816|NCT00895947|584462855|FG001|Overall Study|Withdrawal by Subject|0|||
161840817|NCT00123474|584462864|FG000|Randomized to Treatment|Randomized, never treated|1|||
161840818|NCT00123474|584462865|FG001|Randomized to Treatment|Randomized, never treated|4|||
161840819|NCT00123474|584462866|FG002|Randomized to Treatment|Randomized, never treated|2|||
161840820|NCT00123474|584462867|FG003|Randomized to Treatment|Randomized, never treated|1|||
161840821|NCT00123474|584462864|FG000|As Treated at Study Closure|not reported when site closed|1|||
161840822|NCT00123474|584462865|FG001|As Treated at Study Closure|not reported when site closed|0|||
161840823|NCT00123474|584462866|FG002|As Treated at Study Closure|not reported when site closed|1|||
161840824|NCT00123474|584462867|FG003|As Treated at Study Closure|not reported when site closed|0|||
161840825|NCT00123474|584462864|FG000|As Treated at Study Closure|Adverse Event|10|||
161840826|NCT00123474|584462865|FG001|As Treated at Study Closure|Adverse Event|4|||
161840827|NCT00123474|584462866|FG002|As Treated at Study Closure|Adverse Event|10|||
161840828|NCT00123474|584462867|FG003|As Treated at Study Closure|Adverse Event|8|||
161840829|NCT00123474|584462864|FG000|As Treated at Study Closure|Disease Progression|35|||
161840830|NCT00123474|584462865|FG001|As Treated at Study Closure|Disease Progression|42|||
161840831|NCT00123474|584462866|FG002|As Treated at Study Closure|Disease Progression|29|||
161840832|NCT00123474|584462867|FG003|As Treated at Study Closure|Disease Progression|27|||
161840833|NCT00123474|584462864|FG000|As Treated at Study Closure|Investigator Request|12|||
161840834|NCT00123474|584462865|FG001|As Treated at Study Closure|Investigator Request|6|||
161840835|NCT00123474|584462866|FG002|As Treated at Study Closure|Investigator Request|7|||
161840836|NCT00123474|584462867|FG003|As Treated at Study Closure|Investigator Request|5|||
161840837|NCT00123474|584462864|FG000|As Treated at Study Closure|non-specified|54|||
161840838|NCT00123474|584462865|FG001|As Treated at Study Closure|non-specified|47|||
161840839|NCT00123474|584462866|FG002|As Treated at Study Closure|non-specified|57|||
161840840|NCT00123474|584462867|FG003|As Treated at Study Closure|non-specified|60|||
161840841|NCT00123474|584462864|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
161840842|NCT00123474|584462865|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
161840843|NCT00123474|584462866|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
161840844|NCT00123474|584462867|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
161840845|NCT00123474|584462864|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
161840846|NCT00123474|584462865|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
161840847|NCT00123474|584462866|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
161840848|NCT00123474|584462867|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
161840849|NCT01059344|584462868|FG000|Overall Study|Adverse Event|12|||
161840850|NCT01059344|584462869|FG001|Overall Study|Adverse Event|30|||
161840851|NCT01059344|584462868|FG000|Overall Study|Withdrawal by Subject|6|||
161840852|NCT01059344|584462869|FG001|Overall Study|Withdrawal by Subject|9|||
161840853|NCT01059344|584462868|FG000|Overall Study|Lost to Follow-up|1|||
161840854|NCT01059344|584462869|FG001|Overall Study|Lost to Follow-up|1|||
161840855|NCT01059344|584462868|FG000|Overall Study|Other|3|||
161840856|NCT01059344|584462869|FG001|Overall Study|Other|6|||
161840857|NCT00616629|584462870|FG000|Overall Study|Protocol Violation|1|||
161840858|NCT00616629|584462871|FG001|Overall Study|Protocol Violation|2|||
161840859|NCT00616629|584462872|FG002|Overall Study|Protocol Violation|1|||
161840860|NCT00616629|584462873|FG003|Overall Study|Protocol Violation|0|||
161840861|NCT00616629|584462874|FG004|Overall Study|Protocol Violation|0|||
161840862|NCT00616629|584462870|FG000|Overall Study|AV-block|1|||
161840863|NCT00616629|584462871|FG001|Overall Study|AV-block|0|||
161840864|NCT00616629|584462872|FG002|Overall Study|AV-block|0|||
161840865|NCT00616629|584462873|FG003|Overall Study|AV-block|0|||
161840866|NCT00616629|584462874|FG004|Overall Study|AV-block|0|||
161840867|NCT01739348|584462875|FG000|Part I (Base Study)|Adverse Event|41|||
161840868|NCT01739348|584462876|FG001|Part I (Base Study)|Adverse Event|52|||
161840869|NCT01739348|584462877|FG002|Part I (Base Study)|Adverse Event|8|||
161840870|NCT01739348|584462878|FG003|Part I (Base Study)|Adverse Event|33|||
161741048|NCT00094835|584091893|FG005|Overall Study|Physician Decision|1|||
161741049|NCT00094835|584091894|FG006|Overall Study|Physician Decision|0|||
161741050|NCT00094835|584091888|FG000|Overall Study|Withdrawal by Subject|0|||
161741051|NCT00094835|584091889|FG001|Overall Study|Withdrawal by Subject|0|||
161741052|NCT00094835|584091890|FG002|Overall Study|Withdrawal by Subject|0|||
161741053|NCT00094835|584091891|FG003|Overall Study|Withdrawal by Subject|0|||
161741054|NCT00094835|584091892|FG004|Overall Study|Withdrawal by Subject|0|||
161741055|NCT00094835|584091893|FG005|Overall Study|Withdrawal by Subject|0|||
161840871|NCT01739348|584462875|FG000|Part I (Base Study)|Death|10|||
162032463|NCT03422627|585177399|FG000|Overall Study|Disease Progression|1|||
161741056|NCT00094835|584091894|FG006|Overall Study|Withdrawal by Subject|1|||
161741057|NCT00094835|584091888|FG000|Overall Study|Lost to Follow-up|0|||
161840872|NCT01739348|584462876|FG001|Part I (Base Study)|Death|7|||
161840873|NCT01739348|584462877|FG002|Part I (Base Study)|Death|2|||
161840874|NCT01739348|584462878|FG003|Part I (Base Study)|Death|8|||
161840875|NCT01739348|584462875|FG000|Part I (Base Study)|Lack of Efficacy|3|||
161840876|NCT01739348|584462876|FG001|Part I (Base Study)|Lack of Efficacy|8|||
162032464|NCT03422627|585177400|FG001|Overall Study|Disease Progression|0|||
161741058|NCT00094835|584091889|FG001|Overall Study|Lost to Follow-up|0|||
161741059|NCT00094835|584091890|FG002|Overall Study|Lost to Follow-up|0|||
161741060|NCT00094835|584091891|FG003|Overall Study|Lost to Follow-up|0|||
161741061|NCT00094835|584091892|FG004|Overall Study|Lost to Follow-up|1|||
161741062|NCT00094835|584091893|FG005|Overall Study|Lost to Follow-up|0|||
161741063|NCT00094835|584091894|FG006|Overall Study|Lost to Follow-up|0|||
161741064|NCT00094835|584091888|FG000|Overall Study|Death|1|||
161741065|NCT00094835|584091889|FG001|Overall Study|Death|0|||
161741066|NCT00094835|584091890|FG002|Overall Study|Death|0|||
161741067|NCT00094835|584091891|FG003|Overall Study|Death|0|||
161741068|NCT00094835|584091892|FG004|Overall Study|Death|1|||
161741069|NCT00094835|584091893|FG005|Overall Study|Death|0|||
161741070|NCT00094835|584091894|FG006|Overall Study|Death|0|||
161741071|NCT00094835|584091888|FG000|Overall Study|Non-compliance|1|||
161741072|NCT00094835|584091889|FG001|Overall Study|Non-compliance|2|||
161741073|NCT00094835|584091890|FG002|Overall Study|Non-compliance|2|||
161741074|NCT00094835|584091891|FG003|Overall Study|Non-compliance|0|||
161741075|NCT00094835|584091892|FG004|Overall Study|Non-compliance|2|||
161741076|NCT00094835|584091893|FG005|Overall Study|Non-compliance|2|||
161741077|NCT00094835|584091894|FG006|Overall Study|Non-compliance|1|||
161741078|NCT00094835|584091888|FG000|Overall Study|Other|1|||
161741079|NCT00094835|584091889|FG001|Overall Study|Other|1|||
161741080|NCT00094835|584091890|FG002|Overall Study|Other|1|||
161741081|NCT00094835|584091891|FG003|Overall Study|Other|1|||
161741082|NCT00094835|584091892|FG004|Overall Study|Other|0|||
161741083|NCT00094835|584091893|FG005|Overall Study|Other|0|||
161741084|NCT00094835|584091894|FG006|Overall Study|Other|0|||
161741085|NCT00387348|584091895|FG000|Overall Study|Death|1|||
161741086|NCT00387348|584091896|FG001|Overall Study|Death|1|||
161741087|NCT00387348|584091897|FG002|Overall Study|Death|0|||
161741088|NCT00387348|584091895|FG000|Overall Study|Physician Decision|1|||
161741089|NCT00387348|584091896|FG001|Overall Study|Physician Decision|0|||
161741090|NCT00387348|584091897|FG002|Overall Study|Physician Decision|1|||
161741091|NCT00387348|584091895|FG000|Overall Study|Withdrawal by Subject|0|||
161741092|NCT00387348|584091896|FG001|Overall Study|Withdrawal by Subject|2|||
161741093|NCT00387348|584091897|FG002|Overall Study|Withdrawal by Subject|2|||
161741094|NCT00387348|584091895|FG000|Overall Study|Adverse Event|1|||
161741095|NCT00387348|584091896|FG001|Overall Study|Adverse Event|0|||
161741096|NCT00387348|584091897|FG002|Overall Study|Adverse Event|1|||
161741097|NCT03628599|584091898|FG000|Overall Study|Adverse Event|0|||
161741098|NCT03628599|584091899|FG001|Overall Study|Adverse Event|1|||
161741099|NCT00868166|584091903|FG000|Overall Study|Death|58|||
161741100|NCT00868166|584091904|FG001|Overall Study|Death|65|||
161741101|NCT00868166|584091903|FG000|Overall Study|Withdrawal by Subject|33|||
161741102|NCT00868166|584091904|FG001|Overall Study|Withdrawal by Subject|25|||
161741103|NCT00868166|584091903|FG000|Overall Study|Protocol Violation|1|||
161741104|NCT00868166|584091904|FG001|Overall Study|Protocol Violation|0|||
161741105|NCT00868166|584091903|FG000|Overall Study|Lost to Follow-up|1|||
161741106|NCT00868166|584091904|FG001|Overall Study|Lost to Follow-up|3|||
161741107|NCT00868166|584091903|FG000|Overall Study|Adverse Event|9|||
161741108|NCT00868166|584091904|FG001|Overall Study|Adverse Event|10|||
161741109|NCT00868166|584091903|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
161741110|NCT00868166|584091904|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
161741111|NCT00868166|584091903|FG000|Overall Study|Non-compliance with IMP|1|||
161741112|NCT00868166|584091904|FG001|Overall Study|Non-compliance with IMP|1|||
161741113|NCT01204697|584091912|FG000|Overall Study|Death|26|||
161741114|NCT01204697|584091913|FG001|Overall Study|Death|27|||
161741115|NCT01204697|584091912|FG000|Overall Study|Lost to Follow-up|3|||
161741116|NCT01204697|584091913|FG001|Overall Study|Lost to Follow-up|4|||
161741117|NCT01204697|584091912|FG000|Overall Study|Withdrawal by Subject|2|||
161741118|NCT01204697|584091913|FG001|Overall Study|Withdrawal by Subject|4|||
161741119|NCT01204697|584091912|FG000|Overall Study|Randomized, but not treated|0|||
161741120|NCT01204697|584091913|FG001|Overall Study|Randomized, but not treated|1|||
161741121|NCT03939637|584091914|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
161741122|NCT03939637|584091915|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
161741123|NCT03939637|584091914|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
161741124|NCT03939637|584091915|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
161741125|NCT00830804|584091916|FG000|Overall Study|Lost to Follow-up|4|||
161741126|NCT00830804|584091916|FG000|Overall Study|Death|1|||
161741127|NCT00830804|584091916|FG000|Overall Study|Unable to get to clinic|7|||
161741128|NCT00830804|584091916|FG000|Overall Study|Consent withdrawn|2|||
161741129|NCT00830804|584091916|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
161741130|NCT01397448|584091918|FG000|Overall Study|Adverse Event|4|||
161741131|NCT01397448|584091919|FG001|Overall Study|Adverse Event|4|||
161741132|NCT01397448|584091920|FG002|Overall Study|Adverse Event|6|||
161741133|NCT01397448|584091918|FG000|Overall Study|Withdrawal by Subject|4|||
161741134|NCT01397448|584091919|FG001|Overall Study|Withdrawal by Subject|4|||
161741135|NCT01397448|584091920|FG002|Overall Study|Withdrawal by Subject|3|||
161741136|NCT01397448|584091918|FG000|Overall Study|Lack of Efficacy|2|||
161741137|NCT01397448|584091919|FG001|Overall Study|Lack of Efficacy|0|||
161741138|NCT01397448|584091920|FG002|Overall Study|Lack of Efficacy|5|||
161741139|NCT01397448|584091918|FG000|Overall Study|Other|8|||
161741140|NCT01397448|584091919|FG001|Overall Study|Other|7|||
161741141|NCT01397448|584091920|FG002|Overall Study|Other|4|||
161741142|NCT02180217|584091927|FG000|Overall Study|Adverse Event|3|||
161741143|NCT02180217|584091928|FG001|Overall Study|Adverse Event|2|||
161741144|NCT02180217|584091929|FG002|Overall Study|Adverse Event|22|||
161741145|NCT02180217|584091927|FG000|Overall Study|Death|1|||
161741146|NCT02180217|584091928|FG001|Overall Study|Death|1|||
161741147|NCT02180217|584091929|FG002|Overall Study|Death|0|||
161741148|NCT02180217|584091927|FG000|Overall Study|Withdrawal by Subject|1|||
161741149|NCT02180217|584091928|FG001|Overall Study|Withdrawal by Subject|1|||
161741150|NCT02180217|584091929|FG002|Overall Study|Withdrawal by Subject|4|||
161741151|NCT02180217|584091927|FG000|Overall Study|Subject/Guardian decision|5|||
161741152|NCT02180217|584091928|FG001|Overall Study|Subject/Guardian decision|3|||
161741153|NCT02180217|584091929|FG002|Overall Study|Subject/Guardian decision|6|||
161741154|NCT02180217|584091927|FG000|Overall Study|Physician Decision|1|||
161741155|NCT02180217|584091928|FG001|Overall Study|Physician Decision|1|||
161741156|NCT02180217|584091929|FG002|Overall Study|Physician Decision|6|||
161741157|NCT02180217|584091927|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161741158|NCT02180217|584091928|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161741159|NCT02180217|584091929|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161741160|NCT00776555|584091932|FG000|Overall Study|Study terminated|3|||
161741161|NCT00776555|584091933|FG001|Overall Study|Study terminated|0|||
161741162|NCT03483116|584091935|FG000|Overall Study|Adverse Event|0|||
161741163|NCT03483116|584091936|FG001|Overall Study|Adverse Event|1|||
161741164|NCT03483116|584091937|FG002|Overall Study|Adverse Event|0|||
161741165|NCT03483116|584091938|FG003|Overall Study|Adverse Event|1|||
161741166|NCT03483116|584091935|FG000|Overall Study|Protocol Violation|1|||
161741167|NCT03483116|584091936|FG001|Overall Study|Protocol Violation|0|||
161741168|NCT03483116|584091937|FG002|Overall Study|Protocol Violation|0|||
161741169|NCT03483116|584091938|FG003|Overall Study|Protocol Violation|7|||
161741170|NCT03483116|584091935|FG000|Overall Study|Lost to Follow-up|9|||
161741171|NCT03483116|584091936|FG001|Overall Study|Lost to Follow-up|4|||
161741172|NCT03483116|584091937|FG002|Overall Study|Lost to Follow-up|9|||
161741173|NCT03483116|584091938|FG003|Overall Study|Lost to Follow-up|5|||
161741174|NCT03483116|584091935|FG000|Overall Study|Death|1|||
161741175|NCT03483116|584091936|FG001|Overall Study|Death|0|||
161741176|NCT03483116|584091937|FG002|Overall Study|Death|2|||
161741177|NCT03483116|584091938|FG003|Overall Study|Death|1|||
161741178|NCT03483116|584091935|FG000|Overall Study|Withdrawal by Subject|14|||
161741179|NCT03483116|584091936|FG001|Overall Study|Withdrawal by Subject|16|||
161741180|NCT03483116|584091937|FG002|Overall Study|Withdrawal by Subject|14|||
161741181|NCT03483116|584091938|FG003|Overall Study|Withdrawal by Subject|16|||
161741182|NCT03483116|584091935|FG000|Overall Study|Unknown other reason|3|||
161741183|NCT03483116|584091936|FG001|Overall Study|Unknown other reason|2|||
161741184|NCT03483116|584091937|FG002|Overall Study|Unknown other reason|1|||
161741185|NCT03483116|584091938|FG003|Overall Study|Unknown other reason|1|||
161741186|NCT01181102|584091939|FG000|Overall Study|Adverse Event|28|||
161741187|NCT01181102|584091940|FG001|Overall Study|Adverse Event|26|||
161741188|NCT01181102|584091939|FG000|Overall Study|Lack of Efficacy|3|||
161741189|NCT01181102|584091940|FG001|Overall Study|Lack of Efficacy|1|||
161741190|NCT01181102|584091939|FG000|Overall Study|Lost to Follow-up|2|||
161741191|NCT01181102|584091940|FG001|Overall Study|Lost to Follow-up|0|||
161741192|NCT01181102|584091939|FG000|Overall Study|Physician Decision|3|||
161741193|NCT01181102|584091940|FG001|Overall Study|Physician Decision|1|||
161741194|NCT01181102|584091939|FG000|Overall Study|Protocol Violation|5|||
161741195|NCT01181102|584091940|FG001|Overall Study|Protocol Violation|6|||
161741196|NCT01181102|584091939|FG000|Overall Study|Withdrawal by Subject|10|||
161741197|NCT01181102|584091940|FG001|Overall Study|Withdrawal by Subject|12|||
161741198|NCT00239837|584091945|FG000|Overall Study|Lost to Follow-up|3|||
161741199|NCT00239837|584091946|FG001|Overall Study|Lost to Follow-up|7|||
161741200|NCT01838590|584091947|FG000|Overall Study|Lack of Efficacy|12|||
161741201|NCT01838590|584091948|FG001|Overall Study|Lack of Efficacy|4|||
161741202|NCT01838590|584091947|FG000|Overall Study|Lost to Follow-up|0|||
161741203|NCT01838590|584091948|FG001|Overall Study|Lost to Follow-up|1|||
161741204|NCT04685499|584091949|FG000|Overall Study|Study Terminated Early|1|||
161741205|NCT01996904|584091950|FG000|Overall Study|Lost to Follow-up|38|||
161741206|NCT01996904|584091951|FG001|Overall Study|Lost to Follow-up|27|||
161741207|NCT00929734|584091955|FG000|Overall Study|Lost to Follow-up|2|||
161741208|NCT00929734|584091956|FG001|Overall Study|Lost to Follow-up|1|||
161741209|NCT00929734|584091955|FG000|Overall Study|Withdrawal by Subject|0|||
161741210|NCT00929734|584091956|FG001|Overall Study|Withdrawal by Subject|2|||
161741211|NCT00980980|584091957|FG000|Overall Study|Withdrawal by Hospital|0|||
161741212|NCT00980980|584091958|FG001|Overall Study|Withdrawal by Hospital|1|||
161741213|NCT00980980|584091959|FG002|Overall Study|Withdrawal by Hospital|0|||
161741214|NCT00121992|584091960|FG000|Overall Study|Treatment not received|2|||
161741215|NCT00121992|584091961|FG001|Overall Study|Treatment not received|11|||
161741216|NCT03076190|584091962|FG000|Overall Study|Lost to Follow-up|9|||
161741217|NCT03076190|584091963|FG001|Overall Study|Lost to Follow-up|34|||
161741218|NCT03076190|584091962|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
161741219|NCT03076190|584091963|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
161741220|NCT01441115|584091964|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
161741221|NCT02475395|584091965|FG000|Overall Study|Protocol Violation|30|||
161741222|NCT02475395|584091966|FG001|Overall Study|Protocol Violation|3|||
161741223|NCT01681576|584091967|FG000|Period 1|Adverse Event|1|||
161741224|NCT01681576|584091968|FG001|Period 1|Adverse Event|0|||
161741225|NCT01681576|584091967|FG000|Period 1|Protocol Deviation|1|||
161741226|NCT01681576|584091968|FG001|Period 1|Protocol Deviation|0|||
161741227|NCT01681576|584091967|FG000|Period 2|subject/guardian decision|3|||
161741228|NCT01681576|584091968|FG001|Period 2|subject/guardian decision|1|||
161741229|NCT01681576|584091967|FG000|Period 2|Non-compliance with study treatment|1|||
161741230|NCT01681576|584091968|FG001|Period 2|Non-compliance with study treatment|0|||
161741231|NCT00764478|584091969|FG000|Overall Study|Adverse Event|1|||
161741232|NCT00764478|584091970|FG001|Overall Study|Adverse Event|1|||
161741233|NCT00764478|584091971|FG002|Overall Study|Adverse Event|1|||
161741234|NCT00764478|584091969|FG000|Overall Study|Withdrawal by Subject|7|||
161741235|NCT00764478|584091970|FG001|Overall Study|Withdrawal by Subject|12|||
161741236|NCT00764478|584091971|FG002|Overall Study|Withdrawal by Subject|1|||
161741237|NCT00764478|584091969|FG000|Overall Study|Lost to Follow-up|7|||
161741238|NCT00764478|584091970|FG001|Overall Study|Lost to Follow-up|8|||
161741239|NCT00764478|584091971|FG002|Overall Study|Lost to Follow-up|5|||
161741240|NCT00764478|584091969|FG000|Overall Study|Protocol Violation|0|||
161741241|NCT00764478|584091970|FG001|Overall Study|Protocol Violation|1|||
161741242|NCT00764478|584091971|FG002|Overall Study|Protocol Violation|1|||
161741243|NCT04142216|584091972|FG000|Overall Study|Hospitalization|0|||
161741244|NCT04142216|584091973|FG001|Overall Study|Hospitalization|2|||
161741245|NCT04142216|584091972|FG000|Overall Study|Death|3|||
161741246|NCT04142216|584091973|FG001|Overall Study|Death|1|||
161741247|NCT04142216|584091972|FG000|Overall Study|Referral to another hemodialysis unit|3|||
161741248|NCT04142216|584091973|FG001|Overall Study|Referral to another hemodialysis unit|2|||
161741249|NCT04142216|584091972|FG000|Overall Study|Use of clove|0|||
161741250|NCT04142216|584091973|FG001|Overall Study|Use of clove|1|||
161741251|NCT00862121|584091974|FG000|Overall Study|Adverse Event|1|||
161741252|NCT00862121|584091975|FG001|Overall Study|Adverse Event|2|||
161741253|NCT00862121|584091974|FG000|Overall Study|Lack of Efficacy|0|||
161741254|NCT00862121|584091975|FG001|Overall Study|Lack of Efficacy|3|||
161741255|NCT00862121|584091974|FG000|Overall Study|Protocol Violation|0|||
161741256|NCT00862121|584091975|FG001|Overall Study|Protocol Violation|1|||
161741257|NCT00862121|584091974|FG000|Overall Study|Exclusion criterion violation|0|||
161741258|NCT00862121|584091975|FG001|Overall Study|Exclusion criterion violation|1|||
161741259|NCT00862121|584091974|FG000|Overall Study|Incorrect randomisation|0|||
161741260|NCT00862121|584091975|FG001|Overall Study|Incorrect randomisation|1|||
161741261|NCT02007954|584091976|FG000|Overall Study|Received liver transplant|3|||
161741262|NCT02007954|584091976|FG000|Overall Study|Switch in treatment modality|2|||
161741263|NCT02007954|584091976|FG000|Overall Study|Disease progression and unrelated AE|1|||
161741264|NCT02007954|584091976|FG000|Overall Study|Death|1|||
161741265|NCT01054976|584091981|FG000|Overall Study|Adverse Event|16|||
161741266|NCT01054976|584091981|FG000|Overall Study|Uncooperative participations to study|7|||
161741267|NCT01054976|584091981|FG000|Overall Study|Withdrawal by Subject|4|||
161741268|NCT01054976|584091981|FG000|Overall Study|Other|8|||
161741269|NCT01195363|584091983|FG000|Overall Study|Lost to Follow-up|7|||
161741270|NCT01195363|584091984|FG001|Overall Study|Lost to Follow-up|4|||
161741271|NCT01195363|584091983|FG000|Overall Study|Adverse Event|3|||
161741272|NCT01195363|584091984|FG001|Overall Study|Adverse Event|1|||
161741273|NCT01195363|584091983|FG000|Overall Study|Lack of Efficacy|0|||
161741274|NCT01195363|584091984|FG001|Overall Study|Lack of Efficacy|4|||
161741275|NCT01195363|584091983|FG000|Overall Study|incarceration|1|||
161741276|NCT01195363|584091984|FG001|Overall Study|incarceration|0|||
161741277|NCT01164865|584091986|FG000|Overall Study|Lost to Follow-up|2|||
161741278|NCT01164865|584091987|FG001|Overall Study|Lost to Follow-up|1|||
161741279|NCT00475540|584091989|FG000|36 Months|Lost to Follow-up|4|||
161741280|NCT00475540|584091990|FG001|36 Months|Lost to Follow-up|4|||
161741281|NCT00475540|584091989|FG000|36 Months|Death|1|||
161741282|NCT00475540|584091990|FG001|36 Months|Death|2|||
161741283|NCT00475540|584091989|FG000|36 Months|Censored due to reoperation|3|||
161966221|NCT01461928|584923555|FG001|Maintenance I (24 Months)|Adverse Event|0|||
161741284|NCT00475540|584091990|FG001|36 Months|Censored due to reoperation|0|||
161741285|NCT00377429|584091991|FG000|Overall Study|Withdrawal by Subject|5|||
161741286|NCT00377429|584091991|FG000|Overall Study|Adverse Event|8|||
161741287|NCT00377429|584091991|FG000|Overall Study|Physician Decision|1|||
161741288|NCT00377429|584091991|FG000|Overall Study|Patient non-compliance|1|||
161741289|NCT02394795|584091994|FG000|Overall Study|Adverse Event|92|||
161741290|NCT02394795|584091995|FG001|Overall Study|Adverse Event|70|||
161741291|NCT02394795|584091994|FG000|Overall Study|Lost to Follow-up|0|||
161741292|NCT02394795|584091995|FG001|Overall Study|Lost to Follow-up|1|||
161741293|NCT02394795|584091994|FG000|Overall Study|Withdrawal by Subject|17|||
161741294|NCT02394795|584091995|FG001|Overall Study|Withdrawal by Subject|26|||
161741295|NCT02394795|584091994|FG000|Overall Study|Lack of Efficacy|181|||
161741296|NCT02394795|584091995|FG001|Overall Study|Lack of Efficacy|211|||
161741297|NCT02394795|584091994|FG000|Overall Study|Death|4|||
161741298|NCT02394795|584091995|FG001|Overall Study|Death|5|||
161741299|NCT02394795|584091994|FG000|Overall Study|Physician Decision|109|||
161741300|NCT02394795|584091995|FG001|Overall Study|Physician Decision|93|||
161741301|NCT00453180|584093261|FG000|Overall Study|Lost to Follow-up|2|||
161741302|NCT00453180|584093262|FG001|Overall Study|Lost to Follow-up|1|||
161741303|NCT00453180|584093261|FG000|Overall Study|Adverse Event|1|||
161741304|NCT00453180|584093262|FG001|Overall Study|Adverse Event|2|||
161741305|NCT00804843|584093263|FG000|Overall Study|Protocol Violation|1|||
161741306|NCT00804843|584093264|FG001|Overall Study|Protocol Violation|0|||
161741307|NCT00804843|584093263|FG000|Overall Study|Adverse Event|8|||
161741308|NCT00804843|584093264|FG001|Overall Study|Adverse Event|5|||
161741309|NCT00804843|584093263|FG000|Overall Study|Withdrawal by Subject|1|||
161741310|NCT00804843|584093264|FG001|Overall Study|Withdrawal by Subject|2|||
161741311|NCT03326869|584093270|FG000|Overall Study|Study data has been lost to natural disa|1|||
161741312|NCT03326869|584093271|FG001|Overall Study|Study data has been lost to natural disa|1|||
161741313|NCT01002742|584093274|FG000|Overall Study|Determined to be ineligible|0|||
161741314|NCT01002742|584093275|FG001|Overall Study|Determined to be ineligible|1|||
161741315|NCT00562640|584093276|FG000|Overall Study|Death|0|||
161741316|NCT00562640|584093277|FG001|Overall Study|Death|1|||
161741317|NCT00562640|584093278|FG002|Overall Study|Death|1|||
161741318|NCT00562640|584093279|FG003|Overall Study|Death|0|||
161741319|NCT05263921|584093280|FG000|Overall Study|Other: family emergency.|0|||
161741320|NCT05263921|584093281|FG001|Overall Study|Other: family emergency.|0|||
161741321|NCT05263921|584093282|FG002|Overall Study|Other: family emergency.|1|||
161741322|NCT05263921|584093283|FG003|Overall Study|Other: family emergency.|0|||
161741323|NCT01297309|584093288|FG000|Overall Study|Eligibility failure|2|||
161741324|NCT01297309|584093288|FG000|Overall Study|Screen failure|2|||
161741325|NCT01297309|584093288|FG000|Overall Study|Withdrawal by Subject|5|||
161741326|NCT01297309|584093288|FG000|Overall Study|Adverse Event|1|||
161741327|NCT01297309|584093288|FG000|Overall Study|Investigator Decision|2|||
161741328|NCT01297309|584093288|FG000|Overall Study|Death|1|||
161741329|NCT01297309|584093288|FG000|Overall Study|Participant not entering extensionperiod|1|||
161741330|NCT02670928|584093289|FG000|Overall Study|Adverse Event|3|||
161741331|NCT02670928|584093290|FG001|Overall Study|Adverse Event|1|||
161741332|NCT02670928|584093289|FG000|Overall Study|Withdrawal by Subject|4|||
161741333|NCT02670928|584093290|FG001|Overall Study|Withdrawal by Subject|0|||
161741334|NCT02670928|584093289|FG000|Overall Study|Lost to Follow-up|1|||
161741335|NCT02670928|584093290|FG001|Overall Study|Lost to Follow-up|0|||
161741336|NCT02670928|584093289|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
161741337|NCT02670928|584093290|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
161741338|NCT02678312|584093291|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
161741339|NCT02678312|584093292|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
161741340|NCT02678312|584093293|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
161741341|NCT02678312|584093294|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
161741342|NCT02678312|584093295|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
161741343|NCT02678312|584093291|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
161741344|NCT02678312|584093292|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
161741345|NCT02678312|584093293|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
161741346|NCT02678312|584093294|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
161741347|NCT02678312|584093295|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
161741348|NCT02678312|584093291|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
161741349|NCT02678312|584093292|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
161741350|NCT02678312|584093293|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
161741351|NCT02678312|584093294|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
161741352|NCT02678312|584093295|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
162032465|NCT03422627|585177401|FG002|Overall Study|Disease Progression|1|||
161741353|NCT02678312|584093291|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
161741354|NCT02678312|584093292|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
161741355|NCT02678312|584093293|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
161741356|NCT02678312|584093294|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
161741357|NCT02678312|584093295|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
161741358|NCT02678312|584093291|FG000|Part 2 Double Blind Epoch|Death|0|||
161741359|NCT02678312|584093292|FG001|Part 2 Double Blind Epoch|Death|0|||
161741360|NCT02678312|584093293|FG002|Part 2 Double Blind Epoch|Death|0|||
161741361|NCT02678312|584093294|FG003|Part 2 Double Blind Epoch|Death|8|||
161741362|NCT02678312|584093295|FG004|Part 2 Double Blind Epoch|Death|12|||
161840877|NCT01739348|584462877|FG002|Part I (Base Study)|Lack of Efficacy|0|||
161741363|NCT02678312|584093291|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
161741364|NCT02678312|584093292|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
161741365|NCT02678312|584093293|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
162032466|NCT03422627|585177402|FG003|Overall Study|Disease Progression|2|||
161741366|NCT02678312|584093294|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
161741367|NCT02678312|584093295|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
161741368|NCT02678312|584093291|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
161741369|NCT02678312|584093292|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
161741370|NCT02678312|584093293|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
161741371|NCT02678312|584093294|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
161741372|NCT02678312|584093295|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
161741373|NCT02678312|584093291|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
161741374|NCT02678312|584093292|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
161741375|NCT02678312|584093293|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
161741376|NCT02678312|584093294|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
161741377|NCT02678312|584093295|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
161741378|NCT02591238|584093296|FG000|Overall Study|Pregnancy|1|||
161741379|NCT02591238|584093297|FG001|Overall Study|Pregnancy|0|||
161741380|NCT02591238|584093298|FG002|Overall Study|Pregnancy|0|||
161741381|NCT02591238|584093299|FG003|Overall Study|Pregnancy|0|||
161741382|NCT02591238|584093296|FG000|Overall Study|Withdrawal by Subject|0|||
161741383|NCT02591238|584093297|FG001|Overall Study|Withdrawal by Subject|0|||
161741384|NCT02591238|584093298|FG002|Overall Study|Withdrawal by Subject|0|||
161741385|NCT02591238|584093299|FG003|Overall Study|Withdrawal by Subject|1|||
161741386|NCT02591238|584093296|FG000|Overall Study|influenza|0|||
161741387|NCT02591238|584093297|FG001|Overall Study|influenza|0|||
161741388|NCT02591238|584093298|FG002|Overall Study|influenza|0|||
161741389|NCT02591238|584093299|FG003|Overall Study|influenza|1|||
161741390|NCT02591238|584093296|FG000|Overall Study|personal circumstances|0|||
161741391|NCT02591238|584093297|FG001|Overall Study|personal circumstances|0|||
161741392|NCT02591238|584093298|FG002|Overall Study|personal circumstances|0|||
161741393|NCT02591238|584093299|FG003|Overall Study|personal circumstances|1|||
161741394|NCT02591238|584093296|FG000|Overall Study|personal circumstances|0|||
161741395|NCT02591238|584093297|FG001|Overall Study|personal circumstances|1|||
161741396|NCT02591238|584093298|FG002|Overall Study|personal circumstances|0|||
161741397|NCT02591238|584093299|FG003|Overall Study|personal circumstances|0|||
161741398|NCT00656084|584093300|FG000|Overall Study|Adverse Event|4|||
161741399|NCT00656084|584093300|FG000|Overall Study|Withdrawal by Subject|1|||
161741400|NCT00656084|584093300|FG000|Overall Study|Patient Request|1|||
161741401|NCT00656084|584093300|FG000|Overall Study|Investigator Request|1|||
161741402|NCT00640146|584093304|FG000|Overall Study|Adverse Event|2|||
161741403|NCT00640146|584093305|FG001|Overall Study|Adverse Event|0|||
161741404|NCT00640146|584093304|FG000|Overall Study|Lost to Follow-up|0|||
161741405|NCT00640146|584093305|FG001|Overall Study|Lost to Follow-up|1|||
161741406|NCT00640146|584093304|FG000|Overall Study|Lack of Efficacy|0|||
161741407|NCT00640146|584093305|FG001|Overall Study|Lack of Efficacy|1|||
161741408|NCT00640146|584093304|FG000|Overall Study|Withdrawal by Subject|1|||
161741409|NCT00640146|584093305|FG001|Overall Study|Withdrawal by Subject|1|||
161741410|NCT00640146|584093304|FG000|Overall Study|Randomized but not treated|1|||
161741411|NCT00640146|584093305|FG001|Overall Study|Randomized but not treated|3|||
161741412|NCT00525785|584093309|FG000|Overall Study|Withdrawal by Subject|1|||
161741413|NCT00525785|584093309|FG000|Overall Study|Lack of Efficacy|1|||
161741414|NCT00525785|584093309|FG000|Overall Study|Physician Decision|1|||
161741415|NCT02455388|584093310|FG000|Overall Study|Protocol Violation|1|||
161741416|NCT02455388|584093311|FG001|Overall Study|Protocol Violation|0|||
161741417|NCT02455388|584093312|FG002|Overall Study|Protocol Violation|4|||
161741418|NCT02455388|584093310|FG000|Overall Study|Withdrawal by Subject|0|||
161741419|NCT02455388|584093311|FG001|Overall Study|Withdrawal by Subject|0|||
161741420|NCT02455388|584093312|FG002|Overall Study|Withdrawal by Subject|7|||
161741421|NCT04507776|584093314|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
161741422|NCT04624672|584093317|FG000|Overall Study|Early Study Closure|2|||
161741423|NCT04624672|584093318|FG001|Overall Study|Early Study Closure|1|||
161741424|NCT05905601|584093325|FG000|Overall Study|Lost to Follow-up|1|||
161741425|NCT05905601|584093326|FG001|Overall Study|Lost to Follow-up|3|||
161741426|NCT03024255|584093327|FG000|Overall Study|Adverse Event|1|||
161741427|NCT03024255|584093328|FG001|Overall Study|Adverse Event|4|||
161741428|NCT03024255|584093329|FG002|Overall Study|Adverse Event|8|||
161741429|NCT03024255|584093330|FG003|Overall Study|Adverse Event|0|||
161741430|NCT03024255|584093327|FG000|Overall Study|Withdrawal by Subject|3|||
161741431|NCT03024255|584093328|FG001|Overall Study|Withdrawal by Subject|1|||
161741432|NCT03024255|584093329|FG002|Overall Study|Withdrawal by Subject|0|||
161741433|NCT03024255|584093330|FG003|Overall Study|Withdrawal by Subject|3|||
161741434|NCT03024255|584093327|FG000|Overall Study|Protocol Violation|0|||
161741435|NCT03024255|584093328|FG001|Overall Study|Protocol Violation|0|||
161741436|NCT03024255|584093329|FG002|Overall Study|Protocol Violation|2|||
161741437|NCT03024255|584093330|FG003|Overall Study|Protocol Violation|0|||
161741438|NCT03024255|584093327|FG000|Overall Study|Lost to Follow-up|1|||
161741439|NCT03024255|584093328|FG001|Overall Study|Lost to Follow-up|2|||
161741440|NCT03024255|584093329|FG002|Overall Study|Lost to Follow-up|1|||
161741441|NCT03024255|584093330|FG003|Overall Study|Lost to Follow-up|1|||
161741442|NCT03024255|584093327|FG000|Overall Study|Lack of Efficacy|1|||
161966222|NCT01461928|584923556|FG002|Maintenance I (24 Months)|Adverse Event|0|||
161741443|NCT03024255|584093328|FG001|Overall Study|Lack of Efficacy|0|||
161741444|NCT03024255|584093329|FG002|Overall Study|Lack of Efficacy|0|||
161741445|NCT03024255|584093330|FG003|Overall Study|Lack of Efficacy|0|||
161741446|NCT03024255|584093327|FG000|Overall Study|Protocol Noncompliance|1|||
161741447|NCT03024255|584093328|FG001|Overall Study|Protocol Noncompliance|1|||
161741448|NCT03024255|584093329|FG002|Overall Study|Protocol Noncompliance|0|||
161741449|NCT03024255|584093330|FG003|Overall Study|Protocol Noncompliance|1|||
161741450|NCT01779648|584093335|FG000|Overall Study|Protocol Violation|1|||
161741451|NCT01779648|584093336|FG001|Overall Study|Protocol Violation|0|||
161741452|NCT01797445|584093337|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
161741453|NCT01797445|584093338|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
161741454|NCT01797445|584093337|FG000|Double-Blind Phase|Adverse Event|3|||
161741455|NCT01797445|584093338|FG001|Double-Blind Phase|Adverse Event|0|||
161741456|NCT01797445|584093337|FG000|Double-Blind Phase|Death|5|||
161741457|NCT01797445|584093338|FG001|Double-Blind Phase|Death|4|||
161741458|NCT01797445|584093337|FG000|Double-Blind Phase|Pregnancy|0|||
161741459|NCT01797445|584093338|FG001|Double-Blind Phase|Pregnancy|1|||
161741460|NCT01797445|584093337|FG000|Double-Blind Phase|Lack of Efficacy|1|||
161741461|NCT01797445|584093338|FG001|Double-Blind Phase|Lack of Efficacy|2|||
161741462|NCT01797445|584093337|FG000|Double-Blind Phase|Investigator's Discretion|15|||
161741463|NCT01797445|584093338|FG001|Double-Blind Phase|Investigator's Discretion|17|||
161741464|NCT01797445|584093337|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
161741465|NCT01797445|584093338|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
161741466|NCT01797445|584093337|FG000|Double-Blind Phase|Protocol Violation|0|||
161741467|NCT01797445|584093338|FG001|Double-Blind Phase|Protocol Violation|1|||
161741468|NCT01797445|584093337|FG000|Double-Blind Phase|Withdrew Consent|20|||
161741469|NCT01797445|584093338|FG001|Double-Blind Phase|Withdrew Consent|35|||
161741470|NCT01797445|584093337|FG000|Double-Blind Phase|Lost to Follow-up|34|||
161741471|NCT01797445|584093338|FG001|Double-Blind Phase|Lost to Follow-up|26|||
161741472|NCT01797445|584093337|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
161741473|NCT01797445|584093338|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
161741474|NCT02119026|584093341|FG000|1st-line Treatment|Adverse Event|9|||
161741475|NCT02119026|584093342|FG001|1st-line Treatment|Adverse Event|14|||
161741476|NCT02119026|584093341|FG000|1st-line Treatment|Physician Decision|3|||
161741477|NCT02119026|584093342|FG001|1st-line Treatment|Physician Decision|8|||
161741478|NCT02119026|584093341|FG000|1st-line Treatment|Withdrawal by Subject|4|||
161741479|NCT02119026|584093342|FG001|1st-line Treatment|Withdrawal by Subject|10|||
161741480|NCT02119026|584093341|FG000|1st-line Treatment|Patient condition or compliance|6|||
161741481|NCT02119026|584093342|FG001|1st-line Treatment|Patient condition or compliance|4|||
161741482|NCT02119026|584093341|FG000|1st-line Treatment|Surgery of metastases|2|||
161741483|NCT02119026|584093342|FG001|1st-line Treatment|Surgery of metastases|1|||
161741484|NCT02119026|584093341|FG000|1st-line Treatment|Death|2|||
161741485|NCT02119026|584093342|FG001|1st-line Treatment|Death|1|||
161741486|NCT02119026|584093341|FG000|2nd-line Treatment|Lost to Follow-up|2|||
161741487|NCT02119026|584093342|FG001|2nd-line Treatment|Lost to Follow-up|0|||
161741488|NCT02119026|584093341|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
161741489|NCT02119026|584093342|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
161741490|NCT02119026|584093341|FG000|2nd-line Treatment|Adverse Event|4|||
161741491|NCT02119026|584093342|FG001|2nd-line Treatment|Adverse Event|1|||
161741492|NCT01143714|584093343|FG000|Overall Study|Adverse Event|4|||
161741493|NCT01143714|584093344|FG001|Overall Study|Adverse Event|2|||
161741494|NCT01143714|584093343|FG000|Overall Study|Withdrawal by Subject|1|||
161741495|NCT01143714|584093344|FG001|Overall Study|Withdrawal by Subject|0|||
161741496|NCT01143714|584093343|FG000|Overall Study|Subject non-compliance|0|||
161741497|NCT01143714|584093344|FG001|Overall Study|Subject non-compliance|1|||
161741498|NCT01143714|584093343|FG000|Overall Study|wound closed = deemed healed|1|||
161741499|NCT01143714|584093344|FG001|Overall Study|wound closed = deemed healed|0|||
161741500|NCT01143714|584093343|FG000|Overall Study|wound size increased|1|||
161741501|NCT01143714|584093344|FG001|Overall Study|wound size increased|0|||
161741502|NCT04190186|584093345|FG000|Overall Study|ILR is no longer functioning|0|||
161741503|NCT04190186|584093346|FG001|Overall Study|ILR is no longer functioning|1|||
161741504|NCT04190186|584093345|FG000|Overall Study|Lost to Follow-up|0|||
161741505|NCT04190186|584093346|FG001|Overall Study|Lost to Follow-up|1|||
161741506|NCT04190186|584093345|FG000|Overall Study|Withdrawal by Subject|2|||
161741507|NCT04190186|584093346|FG001|Overall Study|Withdrawal by Subject|0|||
161741508|NCT04190186|584093345|FG000|Overall Study|Subject choice to explant|1|||
161741509|NCT04190186|584093346|FG001|Overall Study|Subject choice to explant|0|||
161741510|NCT04190186|584093345|FG000|Overall Study|Physician Decision|0|||
161741511|NCT04190186|584093346|FG001|Overall Study|Physician Decision|1|||
161741512|NCT04190186|584093345|FG000|Overall Study|Study was stopped|4|||
161741513|NCT04190186|584093346|FG001|Overall Study|Study was stopped|5|||
161741514|NCT02016898|584093347|FG000|Overall Study|Death|1|||
161741515|NCT02016898|584093348|FG001|Overall Study|Death|1|||
161741516|NCT02016898|584093347|FG000|Overall Study|Lost to Follow-up|4|||
161741517|NCT02016898|584093348|FG001|Overall Study|Lost to Follow-up|4|||
161840878|NCT01739348|584462878|FG003|Part I (Base Study)|Lack of Efficacy|7|||
161840879|NCT01739348|584462875|FG000|Part I (Base Study)|Lost to Follow-up|4|||
161741518|NCT01381718|584093349|FG000|Overall Study|Withdrawal by Subject|2|||
161741519|NCT01381718|584093350|FG001|Overall Study|Withdrawal by Subject|5|||
161741520|NCT01381718|584093349|FG000|Overall Study|Lost to Follow-up|3|||
161741521|NCT01381718|584093350|FG001|Overall Study|Lost to Follow-up|5|||
161741522|NCT01381718|584093349|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
161741523|NCT01381718|584093350|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
161741524|NCT03017846|584093351|FG000|Overall Study|Lost to Follow-up|3|||
161741525|NCT03017846|584093351|FG000|Overall Study|Adverse Event|2|||
161741526|NCT00992186|584093354|FG000|Overall Study|Withdrawal by Subject|2|||
161741527|NCT00992186|584093354|FG000|Overall Study|Protocol Violation|1|||
161741528|NCT00992186|584093354|FG000|Overall Study|Physician Decision|1|||
161741529|NCT00992186|584093354|FG000|Overall Study|Adverse Event|9|||
161741530|NCT00992186|584093354|FG000|Overall Study|Progressive Disease|30|||
161741531|NCT00992186|584093354|FG000|Overall Study|Refusal To Receive Study Agent|3|||
161741532|NCT00171314|584093358|FG000|Overall Study|Adverse Event|44|||
161741533|NCT00171314|584093359|FG001|Overall Study|Adverse Event|41|||
161741534|NCT00171314|584093358|FG000|Overall Study|Lack of Efficacy|19|||
161741535|NCT00171314|584093359|FG001|Overall Study|Lack of Efficacy|14|||
161741536|NCT00171314|584093358|FG000|Overall Study|Withdrawal by Subject|9|||
161741537|NCT00171314|584093359|FG001|Overall Study|Withdrawal by Subject|6|||
161741538|NCT00171314|584093358|FG000|Overall Study|Abnormal Test Procedure Results|9|||
161741539|NCT00171314|584093359|FG001|Overall Study|Abnormal Test Procedure Results|3|||
161741540|NCT00171314|584093358|FG000|Overall Study|Protocol Violation|3|||
161741541|NCT00171314|584093359|FG001|Overall Study|Protocol Violation|7|||
161741542|NCT00171314|584093358|FG000|Overall Study|Administrative Problems|4|||
161741543|NCT00171314|584093359|FG001|Overall Study|Administrative Problems|3|||
161741544|NCT00171314|584093358|FG000|Overall Study|Lost to Follow-up|1|||
161741545|NCT00171314|584093359|FG001|Overall Study|Lost to Follow-up|3|||
161741546|NCT00171314|584093358|FG000|Overall Study|Death|2|||
161741547|NCT00171314|584093359|FG001|Overall Study|Death|1|||
161741548|NCT00318565|584093360|FG000|Overall Study|Excluded per protocol|24|||
161741549|NCT00493467|584093361|FG000|Overall Study|Death|1|||
161741550|NCT01409993|584093364|FG000|Overall Study|Adverse Event|4|||
161741551|NCT01409993|584093365|FG001|Overall Study|Adverse Event|4|||
161741552|NCT01409993|584093366|FG002|Overall Study|Adverse Event|3|||
161741553|NCT01409993|584093367|FG003|Overall Study|Adverse Event|1|||
161741554|NCT01409993|584093364|FG000|Overall Study|Withdrawal by Subject|0|||
161741555|NCT01409993|584093365|FG001|Overall Study|Withdrawal by Subject|0|||
161741556|NCT01409993|584093366|FG002|Overall Study|Withdrawal by Subject|0|||
161741557|NCT01409993|584093367|FG003|Overall Study|Withdrawal by Subject|4|||
161741558|NCT01409993|584093364|FG000|Overall Study|Lost to Follow-up|0|||
161741559|NCT01409993|584093365|FG001|Overall Study|Lost to Follow-up|1|||
161741560|NCT01409993|584093366|FG002|Overall Study|Lost to Follow-up|0|||
161741561|NCT01409993|584093367|FG003|Overall Study|Lost to Follow-up|0|||
161741562|NCT03074149|584093370|FG000|Overall Study|Reason unknown|22|||
161741563|NCT03074149|584093371|FG001|Overall Study|Reason unknown|35|||
161741564|NCT03074149|584093370|FG000|Overall Study|Death|10|||
161741565|NCT03074149|584093371|FG001|Overall Study|Death|45|||
161741566|NCT00830960|584093372|FG000|Overall Study|Death|5|||
161741567|NCT00830960|584093373|FG001|Overall Study|Death|4|||
161741568|NCT00830960|584093374|FG002|Overall Study|Death|3|||
161741569|NCT00830960|584093375|FG003|Overall Study|Death|2|||
161741570|NCT00830960|584093376|FG004|Overall Study|Death|6|||
161741571|NCT00830960|584093377|FG005|Overall Study|Death|1|||
161741572|NCT00830960|584093372|FG000|Overall Study|Lost to Follow-up|1|||
161741573|NCT00830960|584093373|FG001|Overall Study|Lost to Follow-up|1|||
161741574|NCT00830960|584093374|FG002|Overall Study|Lost to Follow-up|1|||
161741575|NCT00830960|584093375|FG003|Overall Study|Lost to Follow-up|0|||
161741576|NCT00830960|584093376|FG004|Overall Study|Lost to Follow-up|0|||
161741577|NCT00830960|584093377|FG005|Overall Study|Lost to Follow-up|1|||
161840880|NCT01739348|584462876|FG001|Part I (Base Study)|Lost to Follow-up|2|||
161966223|NCT01461928|584923554|FG000|Maintenance I (24 Months)|Physician Decision|9|||
161966224|NCT01461928|584923555|FG001|Maintenance I (24 Months)|Physician Decision|0|||
161741578|NCT00830960|584093372|FG000|Overall Study|Withdrawal by Subject|19|||
161741579|NCT00830960|584093373|FG001|Overall Study|Withdrawal by Subject|19|||
161741580|NCT00830960|584093374|FG002|Overall Study|Withdrawal by Subject|18|||
161966225|NCT01461928|584923556|FG002|Maintenance I (24 Months)|Physician Decision|0|||
161741581|NCT00830960|584093375|FG003|Overall Study|Withdrawal by Subject|23|||
161741582|NCT00830960|584093376|FG004|Overall Study|Withdrawal by Subject|16|||
161741583|NCT00830960|584093377|FG005|Overall Study|Withdrawal by Subject|21|||
161741584|NCT00830960|584093372|FG000|Overall Study|Sponsor Decision|1|||
161741585|NCT00830960|584093373|FG001|Overall Study|Sponsor Decision|2|||
161741586|NCT00830960|584093374|FG002|Overall Study|Sponsor Decision|3|||
161741587|NCT00830960|584093375|FG003|Overall Study|Sponsor Decision|4|||
161741588|NCT00830960|584093376|FG004|Overall Study|Sponsor Decision|5|||
161741589|NCT00830960|584093377|FG005|Overall Study|Sponsor Decision|7|||
161840881|NCT01739348|584462877|FG002|Part I (Base Study)|Lost to Follow-up|4|||
161741590|NCT00830960|584093372|FG000|Overall Study|No study drug received|7|||
161741591|NCT00830960|584093373|FG001|Overall Study|No study drug received|2|||
161741592|NCT00830960|584093374|FG002|Overall Study|No study drug received|4|||
161741593|NCT00830960|584093375|FG003|Overall Study|No study drug received|3|||
161741594|NCT00830960|584093376|FG004|Overall Study|No study drug received|5|||
161741595|NCT00830960|584093377|FG005|Overall Study|No study drug received|7|||
161741596|NCT01309841|584093380|FG000|Overall Study|Other|0|||
161741597|NCT01309841|584093381|FG001|Overall Study|Other|1|||
161741598|NCT01309841|584093382|FG002|Overall Study|Other|1|||
161741599|NCT01309841|584093380|FG000|Overall Study|Lost to Follow-up|7|||
161741600|NCT01309841|584093381|FG001|Overall Study|Lost to Follow-up|6|||
161741601|NCT01309841|584093382|FG002|Overall Study|Lost to Follow-up|4|||
161741602|NCT01309841|584093380|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
161741603|NCT01309841|584093381|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
161741604|NCT01309841|584093382|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
161741605|NCT01309841|584093380|FG000|Overall Study|Lack of Efficacy|0|||
161741606|NCT01309841|584093381|FG001|Overall Study|Lack of Efficacy|0|||
161741607|NCT01309841|584093382|FG002|Overall Study|Lack of Efficacy|2|||
161741608|NCT01309841|584093380|FG000|Overall Study|Adverse Event|9|||
161741609|NCT01309841|584093381|FG001|Overall Study|Adverse Event|22|||
161741610|NCT01309841|584093382|FG002|Overall Study|Adverse Event|11|||
161741611|NCT01309841|584093380|FG000|Overall Study|Death|1|||
161741612|NCT01309841|584093381|FG001|Overall Study|Death|0|||
161741613|NCT01309841|584093382|FG002|Overall Study|Death|0|||
161741614|NCT01309841|584093380|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161741615|NCT01309841|584093381|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161741616|NCT01309841|584093382|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
161741617|NCT01309841|584093380|FG000|Overall Study|Withdrawal by Subject|17|||
161741618|NCT01309841|584093381|FG001|Overall Study|Withdrawal by Subject|6|||
161741619|NCT01309841|584093382|FG002|Overall Study|Withdrawal by Subject|13|||
161741620|NCT01309841|584093380|FG000|Overall Study|Did Not Receive Treatment|2|||
161741621|NCT01309841|584093381|FG001|Overall Study|Did Not Receive Treatment|0|||
161741622|NCT01309841|584093382|FG002|Overall Study|Did Not Receive Treatment|1|||
161741623|NCT01309841|584093380|FG000|Overall Study|Severe non-compliance with protocol|0|||
161741624|NCT01309841|584093381|FG001|Overall Study|Severe non-compliance with protocol|5|||
161741625|NCT01309841|584093382|FG002|Overall Study|Severe non-compliance with protocol|2|||
161741626|NCT03448224|584093386|FG000|Overall Study|Provided same answer to every question|1|||
161741627|NCT03448224|584093387|FG001|Overall Study|Provided same answer to every question|0|||
161741628|NCT03103906|584093388|FG000|Overall Study|Adverse Event|2|||
161741629|NCT03103906|584093389|FG001|Overall Study|Adverse Event|3|||
161741630|NCT03103906|584093388|FG000|Overall Study|Other|2|||
161741631|NCT03103906|584093389|FG001|Overall Study|Other|0|||
161741632|NCT03498287|584093393|FG000|Overall Study|Withdrawal by Subject|3|||
161741633|NCT03498287|584093394|FG001|Overall Study|Withdrawal by Subject|0|||
161741634|NCT03498287|584093393|FG000|Overall Study|Protocol Violation|0|||
161741635|NCT03498287|584093394|FG001|Overall Study|Protocol Violation|4|||
161741636|NCT03498287|584093393|FG000|Overall Study|Adverse Event|0|||
161741637|NCT03498287|584093394|FG001|Overall Study|Adverse Event|1|||
161741638|NCT02939599|584093395|FG000|Overall Study|Adverse Event|1|||
161741639|NCT02939599|584093396|FG001|Overall Study|Adverse Event|0|||
161741640|NCT02939599|584093395|FG000|Overall Study|Study Terminated By Sponsor|2|||
161741641|NCT02939599|584093396|FG001|Overall Study|Study Terminated By Sponsor|2|||
161741642|NCT01669811|584093397|FG000|Overall Study|Investigator decision|0|||
161741643|NCT01669811|584093398|FG001|Overall Study|Investigator decision|1|||
161741644|NCT01669811|584093397|FG000|Overall Study|Withdrawal by Subject|1|||
161741645|NCT01669811|584093398|FG001|Overall Study|Withdrawal by Subject|2|||
161741646|NCT01669811|584093397|FG000|Overall Study|Adverse Event|2|||
161741647|NCT01669811|584093398|FG001|Overall Study|Adverse Event|6|||
161741648|NCT01669811|584093397|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161966226|NCT01461928|584923554|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
161966227|NCT01461928|584923555|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
161966228|NCT01461928|584923556|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
161966229|NCT01461928|584923554|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
161966230|NCT01461928|584923555|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
161966231|NCT01461928|584923556|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
162032467|NCT03422627|585177403|FG004|Overall Study|Disease Progression|0|||
161741649|NCT01669811|584093398|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
161741650|NCT03288493|584093403|FG000|Overall Study|Withdrawal by Subject|4|||
161741651|NCT03288493|584093404|FG001|Overall Study|Withdrawal by Subject|0|||
161741652|NCT03288493|584093405|FG002|Overall Study|Withdrawal by Subject|0|||
161741653|NCT03288493|584093406|FG003|Overall Study|Withdrawal by Subject|0|||
161741654|NCT03288493|584093407|FG004|Overall Study|Withdrawal by Subject|0|||
161741655|NCT03288493|584093408|FG005|Overall Study|Withdrawal by Subject|2|||
161741656|NCT03288493|584093409|FG006|Overall Study|Withdrawal by Subject|0|||
161741657|NCT03288493|584093403|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
161840882|NCT01739348|584462878|FG003|Part I (Base Study)|Lost to Follow-up|4|||
161840883|NCT01739348|584462875|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
161840884|NCT01739348|584462876|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
161840885|NCT01739348|584462877|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
161840886|NCT01739348|584462878|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
161840887|NCT01739348|584462875|FG000|Part I (Base Study)|Physician Decision|10|||
161840888|NCT01739348|584462876|FG001|Part I (Base Study)|Physician Decision|7|||
161840889|NCT01739348|584462877|FG002|Part I (Base Study)|Physician Decision|1|||
161840890|NCT01739348|584462878|FG003|Part I (Base Study)|Physician Decision|4|||
161840891|NCT01739348|584462875|FG000|Part I (Base Study)|Protocol Violation|2|||
161840892|NCT01739348|584462876|FG001|Part I (Base Study)|Protocol Violation|0|||
161840893|NCT01739348|584462877|FG002|Part I (Base Study)|Protocol Violation|1|||
161840894|NCT01739348|584462878|FG003|Part I (Base Study)|Protocol Violation|2|||
161840895|NCT01739348|584462875|FG000|Part I (Base Study)|Screen Failure|2|||
161840896|NCT01739348|584462876|FG001|Part I (Base Study)|Screen Failure|0|||
161840897|NCT01739348|584462877|FG002|Part I (Base Study)|Screen Failure|0|||
161840898|NCT01739348|584462878|FG003|Part I (Base Study)|Screen Failure|0|||
161840899|NCT01739348|584462875|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
161840900|NCT01739348|584462876|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
161840901|NCT01739348|584462877|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
161840902|NCT01739348|584462878|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
161840903|NCT01739348|584462875|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
161840904|NCT01739348|584462876|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
161840905|NCT01739348|584462877|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
161840906|NCT01739348|584462878|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
161840907|NCT01739348|584462875|FG000|Part I (Base Study)|Participant Moved|4|||
161840908|NCT01739348|584462876|FG001|Part I (Base Study)|Participant Moved|3|||
161840909|NCT01739348|584462877|FG002|Part I (Base Study)|Participant Moved|1|||
161840910|NCT01739348|584462878|FG003|Part I (Base Study)|Participant Moved|7|||
161840911|NCT01739348|584462875|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
161840912|NCT01739348|584462876|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
161840913|NCT01739348|584462877|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
161840914|NCT01739348|584462878|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
161840915|NCT01739348|584462875|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
161840916|NCT01739348|584462876|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
161840917|NCT01739348|584462877|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
161840918|NCT01739348|584462878|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
161840919|NCT01739348|584462875|FG000|Part II (Extension Study)|Adverse Event|10|||
161840920|NCT01739348|584462876|FG001|Part II (Extension Study)|Adverse Event|11|||
161840921|NCT01739348|584462877|FG002|Part II (Extension Study)|Adverse Event|7|||
161840922|NCT01739348|584462878|FG003|Part II (Extension Study)|Adverse Event|26|||
161840923|NCT01739348|584462875|FG000|Part II (Extension Study)|Death|3|||
161840924|NCT01739348|584462876|FG001|Part II (Extension Study)|Death|3|||
161840925|NCT01739348|584462877|FG002|Part II (Extension Study)|Death|2|||
161840926|NCT01739348|584462878|FG003|Part II (Extension Study)|Death|6|||
161840927|NCT01739348|584462875|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
161840928|NCT01739348|584462876|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
161741658|NCT03288493|584093404|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
161741659|NCT03288493|584093405|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
161741660|NCT03288493|584093406|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
161741661|NCT03288493|584093407|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
161741662|NCT03288493|584093408|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
161741663|NCT03288493|584093409|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
161741664|NCT03288493|584093403|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
161741665|NCT03288493|584093404|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
161840929|NCT01739348|584462877|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
161840930|NCT01739348|584462878|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
161840931|NCT01739348|584462875|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
161840932|NCT01739348|584462876|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
161840933|NCT01739348|584462877|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
161840934|NCT01739348|584462878|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
161840935|NCT01739348|584462875|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
161840936|NCT01739348|584462876|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
161840937|NCT01739348|584462877|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
161840938|NCT01739348|584462878|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
161840939|NCT01739348|584462875|FG000|Part II (Extension Study)|Physician Decision|7|||
161741666|NCT03288493|584093405|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
161840940|NCT01739348|584462876|FG001|Part II (Extension Study)|Physician Decision|11|||
161840941|NCT01739348|584462877|FG002|Part II (Extension Study)|Physician Decision|6|||
161840942|NCT01739348|584462878|FG003|Part II (Extension Study)|Physician Decision|12|||
161840943|NCT01739348|584462875|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
161840944|NCT01739348|584462876|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
161840945|NCT01739348|584462877|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
161840946|NCT01739348|584462878|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
161840947|NCT01739348|584462875|FG000|Part II (Extension Study)|Participant Moved|3|||
161840948|NCT01739348|584462876|FG001|Part II (Extension Study)|Participant Moved|3|||
161840949|NCT01739348|584462877|FG002|Part II (Extension Study)|Participant Moved|0|||
161840950|NCT01739348|584462878|FG003|Part II (Extension Study)|Participant Moved|3|||
161840951|NCT01739348|584462875|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
161840952|NCT01739348|584462876|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
161840953|NCT01739348|584462877|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
161840954|NCT01739348|584462878|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
161840955|NCT01739348|584462875|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
161840956|NCT01739348|584462876|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
161840957|NCT01739348|584462877|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
161840958|NCT01739348|584462878|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
161840959|NCT01085201|584462888|FG000|Overall Study|Scheduling conflict|1|||
161840960|NCT01085201|584462889|FG001|Overall Study|Scheduling conflict|0|||
161741667|NCT03288493|584093406|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
161741668|NCT03288493|584093407|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
161741669|NCT03288493|584093408|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
161741670|NCT03288493|584093409|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
161741671|NCT03288493|584093403|FG000|Overall Study|Death|2|||
161741672|NCT03288493|584093404|FG001|Overall Study|Death|0|||
161741673|NCT03288493|584093405|FG002|Overall Study|Death|0|||
161741674|NCT03288493|584093406|FG003|Overall Study|Death|0|||
161741675|NCT03288493|584093407|FG004|Overall Study|Death|0|||
161741676|NCT03288493|584093408|FG005|Overall Study|Death|0|||
161741677|NCT03288493|584093409|FG006|Overall Study|Death|0|||
161741678|NCT03288493|584093403|FG000|Overall Study|other reason not listed above|2|||
161741679|NCT03288493|584093404|FG001|Overall Study|other reason not listed above|0|||
161741680|NCT03288493|584093405|FG002|Overall Study|other reason not listed above|0|||
161741681|NCT03288493|584093406|FG003|Overall Study|other reason not listed above|0|||
161741682|NCT03288493|584093407|FG004|Overall Study|other reason not listed above|0|||
161741683|NCT03288493|584093408|FG005|Overall Study|other reason not listed above|0|||
161741684|NCT03288493|584093409|FG006|Overall Study|other reason not listed above|0|||
161741685|NCT01136746|584095894|FG000|Overall Study|Lost to Follow-up|0|||
161741686|NCT01136746|584095895|FG001|Overall Study|Lost to Follow-up|2|||
161741687|NCT01136746|584095894|FG000|Overall Study|Protocol Violation|2|||
161741688|NCT01136746|584095895|FG001|Overall Study|Protocol Violation|1|||
161741689|NCT01136746|584095894|FG000|Overall Study|Death|1|||
161741690|NCT01136746|584095895|FG001|Overall Study|Death|0|||
161741691|NCT00092677|584095901|FG000|Overall Study|Lost to Follow-up|0|||
161741692|NCT00092677|584095902|FG001|Overall Study|Lost to Follow-up|2|||
161741693|NCT00092677|584095901|FG000|Overall Study|Adminstrative|5|||
161741694|NCT00092677|584095902|FG001|Overall Study|Adminstrative|9|||
161741695|NCT00010803|584095907|FG000|Overall Study|Withdrawal by Subject|97|||
161741696|NCT00010803|584095908|FG001|Overall Study|Withdrawal by Subject|98|||
161741697|NCT01415908|584095909|FG000|Overall Study|Withdrawal by Subject|1|||
161741698|NCT01415908|584095910|FG001|Overall Study|Withdrawal by Subject|0|||
161741699|NCT02685995|584095911|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
161741700|NCT02685995|584095912|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
161741701|NCT01188096|584095913|FG000|Overall Study|progression of disease|4|||
161741702|NCT01188096|584095913|FG000|Overall Study|Withdrawal by Subject|2|||
161741703|NCT02384395|584095914|FG000|Overall Study|Physician Decision|4|||
161741704|NCT02384395|584095914|FG000|Overall Study|Withdrawal by Subject|3|||
161741705|NCT02384395|584095914|FG000|Overall Study|Lost to Follow-up|3|||
161741706|NCT03485222|584095915|FG000|Overall Study|Death|0|||
161741707|NCT03485222|584095916|FG001|Overall Study|Death|1|||
161741708|NCT03485222|584095915|FG000|Overall Study|Lost to Follow-up|2|||
161741709|NCT03485222|584095916|FG001|Overall Study|Lost to Follow-up|1|||
161741710|NCT00688545|584095917|FG000|Overall Study|Lost to Follow-up|1|||
161741711|NCT00688545|584095918|FG001|Overall Study|Lost to Follow-up|4|||
161741712|NCT00688545|584095917|FG000|Overall Study|Insurance/cost of drug|0|||
161741713|NCT00688545|584095918|FG001|Overall Study|Insurance/cost of drug|1|||
161741714|NCT00688545|584095917|FG000|Overall Study|Withdrawal by Subject|2|||
161741715|NCT00688545|584095918|FG001|Overall Study|Withdrawal by Subject|3|||
161840961|NCT01085201|584462890|FG002|Overall Study|Scheduling conflict|1|||
161741716|NCT00688545|584095917|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
161741717|NCT00688545|584095918|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
161741718|NCT01878097|584095921|FG000|Baseline|Surveys not fully completed|2497|||
161741719|NCT01878097|584095922|FG001|Baseline|Surveys not fully completed|1800|||
161741720|NCT01878097|584095921|FG000|Implementation Year 1|Surveys not fully completed|3202|||
161741721|NCT01878097|584095922|FG001|Implementation Year 1|Surveys not fully completed|2549|||
161741722|NCT01878097|584095921|FG000|Implementation Year 2|Surveys not fully completed|3281|||
161741723|NCT01878097|584095922|FG001|Implementation Year 2|Surveys not fully completed|2841|||
161741724|NCT01878097|584095921|FG000|Implementation Year 3|Surveys not fully completed|3494|||
161741725|NCT01878097|584095922|FG001|Implementation Year 3|Surveys not fully completed|2980|||
161741726|NCT01878097|584095921|FG000|Implementation Year 4|Surveys not fully completed|3604|||
161741727|NCT01878097|584095922|FG001|Implementation Year 4|Surveys not fully completed|3007|||
161741728|NCT01595438|584095923|FG000|Overall Study|Lost to Follow-up|20|||
161741729|NCT01595438|584095924|FG001|Overall Study|Lost to Follow-up|20|||
161741730|NCT01595438|584095923|FG000|Overall Study|Withdrawal by Subject|12|||
161741731|NCT01595438|584095924|FG001|Overall Study|Withdrawal by Subject|12|||
161741732|NCT01595438|584095923|FG000|Overall Study|Other Eligibility criteria|11|||
161741733|NCT01595438|584095924|FG001|Overall Study|Other Eligibility criteria|9|||
161741734|NCT00985738|584095926|FG000|Overall Study|Study closed prematurely|8|||
161741735|NCT00985738|584095927|FG001|Overall Study|Study closed prematurely|8|||
161741736|NCT01373918|584095932|FG000|Overall Study|Physician Decision|0|||
161741737|NCT01373918|584095933|FG001|Overall Study|Physician Decision|1|||
161741738|NCT00340834|584095937|FG000|Core Phase of Study|Adverse Event|26|||
161741739|NCT00340834|584095938|FG001|Core Phase of Study|Adverse Event|9|||
161741740|NCT00340834|584095939|FG002|Core Phase of Study|Adverse Event|9|||
161741741|NCT00340834|584095940|FG003|Core Phase of Study|Adverse Event|0|||
161741742|NCT00340834|584095941|FG004|Core Phase of Study|Adverse Event|0|||
161741743|NCT00340834|584095937|FG000|Core Phase of Study|Withdrawal by Subject|11|||
161741744|NCT00340834|584095938|FG001|Core Phase of Study|Withdrawal by Subject|9|||
161741745|NCT00340834|584095939|FG002|Core Phase of Study|Withdrawal by Subject|16|||
161741746|NCT00340834|584095940|FG003|Core Phase of Study|Withdrawal by Subject|0|||
161741747|NCT00340834|584095941|FG004|Core Phase of Study|Withdrawal by Subject|0|||
161741748|NCT00340834|584095937|FG000|Core Phase of Study|Administrative Problems|6|||
161741749|NCT00340834|584095938|FG001|Core Phase of Study|Administrative Problems|2|||
161741750|NCT00340834|584095939|FG002|Core Phase of Study|Administrative Problems|7|||
161741751|NCT00340834|584095940|FG003|Core Phase of Study|Administrative Problems|0|||
161741752|NCT00340834|584095941|FG004|Core Phase of Study|Administrative Problems|0|||
161741753|NCT00340834|584095937|FG000|Core Phase of Study|Lack of Efficacy|3|||
161741754|NCT00340834|584095938|FG001|Core Phase of Study|Lack of Efficacy|3|||
161741755|NCT00340834|584095939|FG002|Core Phase of Study|Lack of Efficacy|7|||
161741756|NCT00340834|584095940|FG003|Core Phase of Study|Lack of Efficacy|0|||
161741757|NCT00340834|584095941|FG004|Core Phase of Study|Lack of Efficacy|0|||
161741758|NCT00340834|584095937|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
161741759|NCT00340834|584095938|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
161741760|NCT00340834|584095939|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
161741761|NCT00340834|584095940|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
161741762|NCT00340834|584095941|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
161741763|NCT00340834|584095937|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
161741764|NCT00340834|584095938|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
161741765|NCT00340834|584095939|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
161741766|NCT00340834|584095940|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
161741767|NCT00340834|584095941|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
161741768|NCT00340834|584095937|FG000|Core Phase of Study|Lost to Follow-up|1|||
161741769|NCT00340834|584095938|FG001|Core Phase of Study|Lost to Follow-up|1|||
161741770|NCT00340834|584095939|FG002|Core Phase of Study|Lost to Follow-up|4|||
161741771|NCT00340834|584095940|FG003|Core Phase of Study|Lost to Follow-up|0|||
161741772|NCT00340834|584095941|FG004|Core Phase of Study|Lost to Follow-up|0|||
161741773|NCT00340834|584095937|FG000|Core Phase of Study|Death|2|||
161741774|NCT00340834|584095938|FG001|Core Phase of Study|Death|0|||
161741775|NCT00340834|584095939|FG002|Core Phase of Study|Death|0|||
161741776|NCT00340834|584095940|FG003|Core Phase of Study|Death|0|||
161741777|NCT00340834|584095941|FG004|Core Phase of Study|Death|0|||
161741778|NCT00340834|584095937|FG000|Core Phase of Study|Protocol Violation|0|||
161741779|NCT00340834|584095938|FG001|Core Phase of Study|Protocol Violation|0|||
161741780|NCT00340834|584095939|FG002|Core Phase of Study|Protocol Violation|2|||
161741781|NCT00340834|584095940|FG003|Core Phase of Study|Protocol Violation|0|||
161741782|NCT00340834|584095941|FG004|Core Phase of Study|Protocol Violation|0|||
161741783|NCT00340834|584095937|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
161741784|NCT00340834|584095938|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
161741785|NCT00340834|584095939|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
161741786|NCT00340834|584095940|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
161741787|NCT00340834|584095941|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
161741788|NCT00340834|584095937|FG000|Extension Phase of Study|Subject withdrew consent|26|||
161840962|NCT01085201|584462891|FG003|Overall Study|Scheduling conflict|0|||
161840963|NCT01085201|584462892|FG004|Overall Study|Scheduling conflict|0|||
161840964|NCT01085201|584462888|FG000|Overall Study|Unknown- no study drug|2|||
161840965|NCT01085201|584462889|FG001|Overall Study|Unknown- no study drug|0|||
161840966|NCT01085201|584462890|FG002|Overall Study|Unknown- no study drug|0|||
161840967|NCT01085201|584462891|FG003|Overall Study|Unknown- no study drug|0|||
161840968|NCT01085201|584462892|FG004|Overall Study|Unknown- no study drug|0|||
161840969|NCT01085201|584462888|FG000|Overall Study|Fond ineligible after consent|0|||
161840970|NCT01085201|584462889|FG001|Overall Study|Fond ineligible after consent|1|||
161840971|NCT01085201|584462890|FG002|Overall Study|Fond ineligible after consent|1|||
161840972|NCT01085201|584462891|FG003|Overall Study|Fond ineligible after consent|0|||
161840973|NCT01085201|584462892|FG004|Overall Study|Fond ineligible after consent|0|||
161840974|NCT00528411|584462893|FG000|Overall Study|Adverse Event|4|||
161840975|NCT00528411|584462894|FG001|Overall Study|Adverse Event|0|||
161840976|NCT00528411|584462895|FG002|Overall Study|Adverse Event|1|||
161840977|NCT00528411|584462893|FG000|Overall Study|Incorrect Enrolment|1|||
161840978|NCT00528411|584462894|FG001|Overall Study|Incorrect Enrolment|1|||
161840979|NCT00528411|584462895|FG002|Overall Study|Incorrect Enrolment|0|||
161840980|NCT00528411|584462893|FG000|Overall Study|Severe non-compliance to protocol|0|||
161840981|NCT00528411|584462894|FG001|Overall Study|Severe non-compliance to protocol|1|||
161840982|NCT00528411|584462895|FG002|Overall Study|Severe non-compliance to protocol|0|||
161840983|NCT00528411|584462893|FG000|Overall Study|Prior commitment medication|0|||
161840984|NCT00528411|584462894|FG001|Overall Study|Prior commitment medication|1|||
161840985|NCT00528411|584462895|FG002|Overall Study|Prior commitment medication|0|||
161840986|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
161840987|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
161840988|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
161840989|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
161840990|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
161840991|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
161840992|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
161840993|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
161840994|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
161840995|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161840996|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
161840997|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161840998|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161840999|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161841000|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161841001|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161841002|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161966232|NCT01461928|584923554|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
161966233|NCT01461928|584923555|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
161966234|NCT01461928|584923556|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
161741789|NCT00340834|584095938|FG001|Extension Phase of Study|Subject withdrew consent|31|||
161741790|NCT00340834|584095939|FG002|Extension Phase of Study|Subject withdrew consent|0|||
161741791|NCT00340834|584095940|FG003|Extension Phase of Study|Subject withdrew consent|12|||
161741792|NCT00340834|584095941|FG004|Extension Phase of Study|Subject withdrew consent|15|||
161741793|NCT00340834|584095937|FG000|Extension Phase of Study|Adverse Event|21|||
161741794|NCT00340834|584095938|FG001|Extension Phase of Study|Adverse Event|22|||
161741795|NCT00340834|584095939|FG002|Extension Phase of Study|Adverse Event|0|||
161741796|NCT00340834|584095940|FG003|Extension Phase of Study|Adverse Event|19|||
161741797|NCT00340834|584095941|FG004|Extension Phase of Study|Adverse Event|7|||
161741798|NCT00340834|584095937|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
161741799|NCT00340834|584095938|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
161741800|NCT00340834|584095939|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
161741801|NCT00340834|584095940|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
161741802|NCT00340834|584095941|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
161841003|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161841004|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841005|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
161841006|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841007|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
161966235|NCT01461928|584923554|FG000|Maintenance I (24 Months)|Not compliant|1|||
161841008|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841009|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841010|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841011|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161966236|NCT01461928|584923555|FG001|Maintenance I (24 Months)|Not compliant|0|||
161841012|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841013|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841014|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
161841015|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841016|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
161841017|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841018|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841019|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841020|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841021|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161841022|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
161841023|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
161841024|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
161841025|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841026|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
161841027|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841028|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841029|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841030|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841031|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841032|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
161841033|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841034|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841035|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841036|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841037|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841038|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841039|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161841040|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841041|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841042|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841043|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
161841044|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841045|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841046|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841047|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841048|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841049|NCT03893565|584462896|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161841050|NCT03893565|584462897|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
161841051|NCT03893565|584462898|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
161841052|NCT03893565|584462899|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
161841053|NCT03893565|584462900|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161841054|NCT03893565|584462901|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161966237|NCT01461928|584923556|FG002|Maintenance I (24 Months)|Not compliant|0|||
161741803|NCT00340834|584095937|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
161741804|NCT00340834|584095938|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
161741805|NCT00340834|584095939|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
161741806|NCT00340834|584095940|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
161741807|NCT00340834|584095941|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
161741808|NCT00340834|584095937|FG000|Extension Phase of Study|Lost to Follow-up|1|||
161741809|NCT00340834|584095938|FG001|Extension Phase of Study|Lost to Follow-up|1|||
161741810|NCT00340834|584095939|FG002|Extension Phase of Study|Lost to Follow-up|0|||
161741811|NCT00340834|584095940|FG003|Extension Phase of Study|Lost to Follow-up|2|||
161741812|NCT00340834|584095941|FG004|Extension Phase of Study|Lost to Follow-up|3|||
161741813|NCT00340834|584095937|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
161741814|NCT00340834|584095938|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
161741815|NCT00340834|584095939|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
161741816|NCT00340834|584095940|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
161741817|NCT00340834|584095941|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
161741818|NCT00340834|584095937|FG000|Extension Phase of Study|Administrative problems|3|||
161741819|NCT00340834|584095938|FG001|Extension Phase of Study|Administrative problems|0|||
161741820|NCT00340834|584095939|FG002|Extension Phase of Study|Administrative problems|0|||
161741821|NCT00340834|584095940|FG003|Extension Phase of Study|Administrative problems|1|||
161741822|NCT00340834|584095941|FG004|Extension Phase of Study|Administrative problems|1|||
161741823|NCT00340834|584095937|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
161741824|NCT00340834|584095938|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
161741825|NCT00340834|584095939|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
161741826|NCT00340834|584095940|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
161741827|NCT00340834|584095941|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
161741828|NCT00340834|584095937|FG000|Extension Phase of Study|Protocol Violation|3|||
161741829|NCT00340834|584095938|FG001|Extension Phase of Study|Protocol Violation|0|||
161741830|NCT00340834|584095939|FG002|Extension Phase of Study|Protocol Violation|0|||
161741831|NCT00340834|584095940|FG003|Extension Phase of Study|Protocol Violation|0|||
161741832|NCT00340834|584095941|FG004|Extension Phase of Study|Protocol Violation|0|||
161741833|NCT00340834|584095937|FG000|Extension Phase of Study|Death|0|||
161741834|NCT00340834|584095938|FG001|Extension Phase of Study|Death|0|||
161741835|NCT00340834|584095939|FG002|Extension Phase of Study|Death|0|||
161741836|NCT00340834|584095940|FG003|Extension Phase of Study|Death|0|||
161741837|NCT00340834|584095941|FG004|Extension Phase of Study|Death|1|||
161741838|NCT00291499|584095942|FG000|Overall Study|Adverse Event|3|||
161741839|NCT00291499|584095943|FG001|Overall Study|Adverse Event|8|||
161741840|NCT00291499|584095942|FG000|Overall Study|Change to other therapy|2|||
161741841|NCT00291499|584095943|FG001|Overall Study|Change to other therapy|1|||
161741842|NCT00291499|584095942|FG000|Overall Study|Intercurrent illness|1|||
161741843|NCT00291499|584095943|FG001|Overall Study|Intercurrent illness|0|||
161741844|NCT00291499|584095942|FG000|Overall Study|Protocol Violation|2|||
161741845|NCT00291499|584095943|FG001|Overall Study|Protocol Violation|2|||
161741846|NCT00291499|584095942|FG000|Overall Study|Other reasons|1|||
161741847|NCT00291499|584095943|FG001|Overall Study|Other reasons|4|||
161741848|NCT02786836|584095944|FG000|Overall Study|Death|1|||
161741849|NCT02786836|584095944|FG000|Overall Study|Lack of Efficacy|2|||
161741850|NCT02786836|584095944|FG000|Overall Study|Protocol Violation|3|||
161741851|NCT02786836|584095944|FG000|Overall Study|Withdrawal by Subject|3|||
161741852|NCT02786836|584095944|FG000|Overall Study|Liver Transplantation|2|||
161741853|NCT02786836|584095944|FG000|Overall Study|Device or Pharmacy Issues|3|||
161741854|NCT03783442|584095955|FG000|Overall Study|Death|252|||
161741855|NCT03783442|584095956|FG001|Overall Study|Death|268|||
161741856|NCT03783442|584095955|FG000|Overall Study|Withdrawal by Subject|19|||
161741857|NCT03783442|584095956|FG001|Overall Study|Withdrawal by Subject|21|||
161741858|NCT03783442|584095955|FG000|Overall Study|Lost to Follow-up|7|||
161741859|NCT03783442|584095956|FG001|Overall Study|Lost to Follow-up|6|||
161741860|NCT03783442|584095955|FG000|Overall Study|Sponsor Ended Study|48|||
161741861|NCT03783442|584095956|FG001|Overall Study|Sponsor Ended Study|28|||
161741862|NCT01457924|584095957|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
161741863|NCT01457924|584095958|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
161741864|NCT01457924|584095959|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
161741865|NCT01457924|584095960|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
161741866|NCT01457924|584095961|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
161741867|NCT01457924|584095957|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
161741868|NCT01457924|584095958|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
161741869|NCT01457924|584095959|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
161741870|NCT01457924|584095960|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
161741871|NCT01457924|584095961|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
161741872|NCT01457924|584095957|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
161741873|NCT01457924|584095958|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
161741874|NCT01457924|584095959|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
161741875|NCT01457924|584095960|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
161741876|NCT01457924|584095961|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
161741877|NCT01457924|584095957|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
161741878|NCT01457924|584095958|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
161741879|NCT01457924|584095959|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
161741880|NCT01457924|584095960|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
161741881|NCT01457924|584095961|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
161741882|NCT01457924|584095957|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
161741883|NCT01457924|584095958|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
161741884|NCT01457924|584095959|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
161741885|NCT01457924|584095960|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
161741886|NCT01457924|584095961|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
161741887|NCT01457924|584095957|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
161741888|NCT01457924|584095958|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
161741889|NCT01457924|584095959|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
161741890|NCT01457924|584095960|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
162032468|NCT03422627|585177399|FG000|Overall Study|Adverse Event|2|||
162032469|NCT03422627|585177400|FG001|Overall Study|Adverse Event|1|||
161741891|NCT01457924|584095961|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
161741892|NCT01457924|584095957|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
161741893|NCT01457924|584095958|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
161741894|NCT01457924|584095959|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
161741895|NCT01457924|584095960|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
161741896|NCT01457924|584095961|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
161741897|NCT01457924|584095957|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
161741898|NCT01457924|584095958|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
161741899|NCT01457924|584095959|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
161741900|NCT01457924|584095960|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
161741901|NCT01457924|584095961|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
161741902|NCT01457924|584095957|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
161741903|NCT01457924|584095958|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
161741904|NCT01457924|584095959|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
161741905|NCT01457924|584095960|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
161741906|NCT01457924|584095961|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
161741907|NCT01457924|584095957|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
161741908|NCT01457924|584095958|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
161741909|NCT01457924|584095959|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
161741910|NCT01457924|584095960|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
161741911|NCT01457924|584095961|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
161741912|NCT01457924|584095957|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
161741913|NCT01457924|584095958|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
161741914|NCT01457924|584095959|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
161741915|NCT01457924|584095960|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
161741916|NCT01457924|584095961|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
161741917|NCT01457924|584095957|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
161741918|NCT01457924|584095958|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
161741919|NCT01457924|584095959|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
161741920|NCT01457924|584095960|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
161741921|NCT01457924|584095961|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
161741922|NCT01457924|584095957|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
161741923|NCT01457924|584095958|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
161741924|NCT01457924|584095959|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
161741925|NCT01457924|584095960|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
161741926|NCT01457924|584095961|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
161741927|NCT02505542|584095964|FG000|Part A: Open-Label Period|Adverse Event|31|||
161741928|NCT02505542|584095965|FG001|Part A: Open-Label Period|Adverse Event|0|||
161741929|NCT02505542|584095966|FG002|Part A: Open-Label Period|Adverse Event|0|||
161741930|NCT02505542|584095967|FG003|Part A: Open-Label Period|Adverse Event|0|||
161741931|NCT02505542|584095964|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
161741932|NCT02505542|584095965|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
161741933|NCT02505542|584095966|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
161741934|NCT02505542|584095967|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
161741935|NCT02505542|584095964|FG000|Part A: Open-Label Period|Protocol Violation|1|||
161741936|NCT02505542|584095965|FG001|Part A: Open-Label Period|Protocol Violation|0|||
161741937|NCT02505542|584095966|FG002|Part A: Open-Label Period|Protocol Violation|0|||
161741938|NCT02505542|584095967|FG003|Part A: Open-Label Period|Protocol Violation|0|||
161741939|NCT02505542|584095964|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
161741940|NCT02505542|584095965|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
161741941|NCT02505542|584095966|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
161841055|NCT03893565|584462902|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161841056|NCT03893565|584462903|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161841057|NCT03893565|584462904|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161841058|NCT03893565|584462896|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
161841059|NCT03893565|584462897|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
161841060|NCT03893565|584462898|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
161841061|NCT03893565|584462899|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
161841062|NCT03893565|584462900|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
161841063|NCT03893565|584462901|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
161841064|NCT03893565|584462902|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
161841065|NCT03893565|584462903|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
161841066|NCT03893565|584462904|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
161741942|NCT02505542|584095967|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
161741943|NCT02505542|584095964|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
161741944|NCT02505542|584095965|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
161741945|NCT02505542|584095966|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
161741946|NCT02505542|584095967|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
161741947|NCT02505542|584095964|FG000|Part A: Open-Label Period|New medical history available|1|||
161741948|NCT02505542|584095965|FG001|Part A: Open-Label Period|New medical history available|0|||
161741949|NCT02505542|584095966|FG002|Part A: Open-Label Period|New medical history available|0|||
161741950|NCT02505542|584095967|FG003|Part A: Open-Label Period|New medical history available|0|||
161741951|NCT02505542|584095964|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
161741952|NCT02505542|584095965|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
161741953|NCT02505542|584095966|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
161741954|NCT02505542|584095967|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
161741955|NCT02505542|584095964|FG000|Part A: Open-Label Period|Pregnancy|2|||
161741956|NCT02505542|584095965|FG001|Part A: Open-Label Period|Pregnancy|0|||
161741957|NCT02505542|584095966|FG002|Part A: Open-Label Period|Pregnancy|0|||
161741958|NCT02505542|584095967|FG003|Part A: Open-Label Period|Pregnancy|0|||
161741959|NCT02505542|584095964|FG000|Part A: Open-Label Period|Sponsor directive|1|||
161741960|NCT02505542|584095965|FG001|Part A: Open-Label Period|Sponsor directive|0|||
161741961|NCT02505542|584095966|FG002|Part A: Open-Label Period|Sponsor directive|0|||
161741962|NCT02505542|584095967|FG003|Part A: Open-Label Period|Sponsor directive|0|||
161741963|NCT02505542|584095964|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
161741964|NCT02505542|584095965|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
161741965|NCT02505542|584095966|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
161741966|NCT02505542|584095967|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
161741967|NCT02505542|584095964|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
161741968|NCT02505542|584095965|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
161741969|NCT02505542|584095966|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
161741970|NCT02505542|584095967|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
161741971|NCT02505542|584095964|FG000|Part A: Open-Label Period|Non-compliance|1|||
161741972|NCT02505542|584095965|FG001|Part A: Open-Label Period|Non-compliance|0|||
161741973|NCT02505542|584095966|FG002|Part A: Open-Label Period|Non-compliance|0|||
161741974|NCT02505542|584095967|FG003|Part A: Open-Label Period|Non-compliance|0|||
161741975|NCT02505542|584095964|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
161741976|NCT02505542|584095965|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
161741977|NCT02505542|584095966|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
161741978|NCT02505542|584095967|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
161741979|NCT02505542|584095964|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
161741980|NCT02505542|584095965|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
161741981|NCT02505542|584095966|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
161741982|NCT02505542|584095967|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
161741983|NCT02505542|584095964|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
161741984|NCT02505542|584095965|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
161741985|NCT02505542|584095966|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
161741986|NCT02505542|584095967|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
161741987|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Adverse Event|0|||
161741988|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Adverse Event|0|||
161741989|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Adverse Event|1|||
161741990|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Adverse Event|3|||
161741991|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
161741992|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
161741993|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
161741994|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
161741995|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
161741996|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
161741997|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
161741998|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
161741999|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
161742000|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
161742001|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
161742002|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
161742003|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
161742004|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
161742005|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
161742006|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
161742007|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
161742008|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
161742009|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
161742010|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
161742011|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
161742012|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
161742013|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
161742014|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
162032470|NCT03422627|585177401|FG002|Overall Study|Adverse Event|0|||
161841067|NCT03893565|584462896|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841068|NCT03893565|584462897|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841069|NCT03893565|584462898|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841070|NCT03893565|584462899|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841071|NCT03893565|584462900|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841072|NCT03893565|584462901|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841073|NCT03893565|584462902|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
161841074|NCT03893565|584462903|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841075|NCT03893565|584462904|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161841076|NCT03893565|584462896|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841077|NCT03893565|584462897|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841078|NCT03893565|584462898|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841079|NCT03893565|584462899|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841080|NCT03893565|584462900|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841081|NCT03893565|584462901|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
161841082|NCT03893565|584462902|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
161841083|NCT03893565|584462903|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841084|NCT03893565|584462904|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161841085|NCT03893565|584462896|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
161841086|NCT03893565|584462897|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
161841087|NCT03893565|584462898|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
161841088|NCT03893565|584462899|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
161742015|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Miscalculation|0|||
161841089|NCT03893565|584462900|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
161841090|NCT03893565|584462901|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
161742016|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Miscalculation|1|||
161742017|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Miscalculation|0|||
161742018|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Miscalculation|0|||
161742019|NCT02505542|584095964|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
161742020|NCT02505542|584095965|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
161742021|NCT02505542|584095966|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
161742022|NCT02505542|584095967|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
161742023|NCT01438307|584095970|FG000|Overall Study|Death|1|||
161742024|NCT01438307|584095971|FG001|Overall Study|Death|1|||
161742025|NCT02378883|584095972|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
161742026|NCT02378883|584095972|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
161742027|NCT02378883|584095972|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
161742028|NCT02378883|584095972|FG000|30 Day Follow-Up|Physician Decision|2|||
161742029|NCT02378883|584095972|FG000|30 Day Follow-Up|Missed Visit|2|||
161742030|NCT02378883|584095972|FG000|30 Day Follow-Up|Death|1|||
161742031|NCT02378883|584095972|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
161742032|NCT02378883|584095972|FG000|12 Months Follow-Up|Death|2|||
161742033|NCT01588353|584095973|FG000|Step2|Withdrawal by Subject|0|||
161742034|NCT01588353|584095974|FG001|Step2|Withdrawal by Subject|1|||
161742035|NCT01588353|584095975|FG002|Step2|Withdrawal by Subject|0|||
161742036|NCT01588353|584095973|FG000|Step3|Adverse Event|0|||
161742037|NCT01588353|584095974|FG001|Step3|Adverse Event|0|||
161742038|NCT01588353|584095975|FG002|Step3|Adverse Event|2|||
161742039|NCT02855450|584095979|FG000|Overall Study|Adverse Event|1|||
161742040|NCT02855450|584095980|FG001|Overall Study|Adverse Event|0|||
161742041|NCT02855450|584095979|FG000|Overall Study|Lost to Follow-up|4|||
161742042|NCT02855450|584095980|FG001|Overall Study|Lost to Follow-up|0|||
161742043|NCT01504971|584095982|FG000|Overall Study|Physician Decision|13|||
161742044|NCT00936117|584095985|FG000|Overall Study|Adverse Event|7|||
161742045|NCT00936117|584095985|FG000|Overall Study|Unable to continue oral medication|3|||
161742046|NCT04581863|584095986|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
161742047|NCT04581863|584095987|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
161742048|NCT01803711|584095996|FG000|Overall Study|Adverse Event|1|||
161742049|NCT01803711|584095997|FG001|Overall Study|Adverse Event|1|||
161742050|NCT00225212|584095998|FG000|Overall Study|Disease progression|2|||
161742051|NCT00225212|584095998|FG000|Overall Study|Death|1|||
161841091|NCT03893565|584462902|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
161841092|NCT03893565|584462903|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
161841093|NCT03893565|584462904|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
162032471|NCT03422627|585177402|FG003|Overall Study|Adverse Event|0|||
162032472|NCT03422627|585177403|FG004|Overall Study|Adverse Event|2|||
161742052|NCT00225212|584095998|FG000|Overall Study|Adverse Event|2|||
162032473|NCT03422627|585177399|FG000|Overall Study|Ineligibility Determined|0|||
161742053|NCT00225212|584095998|FG000|Overall Study|Intercurrent illness|1|||
161742054|NCT05159362|584096001|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
161742055|NCT05159362|584096002|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
161742056|NCT05159362|584096003|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
161742057|NCT01376245|584096004|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
161742058|NCT01376245|584096005|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
161742059|NCT01376245|584096006|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
161742060|NCT01376245|584096007|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
161742061|NCT01376245|584096008|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
161742062|NCT01376245|584096004|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
161742063|NCT01376245|584096005|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
161742064|NCT01376245|584096006|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
161742065|NCT01376245|584096007|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
161742066|NCT01376245|584096008|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
161742067|NCT01376245|584096004|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
161742068|NCT01376245|584096005|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
161742069|NCT01376245|584096006|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
161742070|NCT01376245|584096007|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
161742071|NCT01376245|584096008|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
161742072|NCT01376245|584096004|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
161742073|NCT01376245|584096005|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
161742074|NCT01376245|584096006|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
161742075|NCT01376245|584096007|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
161742076|NCT01376245|584096008|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
161742077|NCT01376245|584096004|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
161742078|NCT01376245|584096005|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
161742079|NCT01376245|584096006|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
161742080|NCT01376245|584096007|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
161742081|NCT01376245|584096008|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
161742082|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
161742083|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
161742084|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
161742085|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
161742086|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
161742087|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
161742088|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
161742089|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
161742090|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
161742091|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
161742092|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
161742093|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
161742094|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
161742095|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
161742096|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
161742097|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161742098|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
161742099|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
161742100|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
161742101|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161742102|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161742103|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
161742104|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161742105|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
161742106|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
161742107|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
161742108|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
161742109|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
161742110|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
161742111|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
161742112|NCT01376245|584096004|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161742113|NCT01376245|584096005|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
161742114|NCT01376245|584096006|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
161742115|NCT01376245|584096007|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
161742116|NCT01376245|584096008|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
161742117|NCT01357889|584096009|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
161742118|NCT01357889|584096010|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
161742119|NCT01357889|584096009|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
161742120|NCT01357889|584096010|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
161742121|NCT01357889|584096009|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
161742122|NCT01357889|584096010|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
161742123|NCT01357889|584096009|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
161742124|NCT01357889|584096010|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
161742125|NCT01357889|584096009|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
161742126|NCT01357889|584096010|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
161742127|NCT01357889|584096009|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
161742128|NCT01357889|584096010|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
161742129|NCT01357889|584096009|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
161742130|NCT01357889|584096010|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
161742131|NCT01357889|584096009|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
161742132|NCT01357889|584096010|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
161742133|NCT01357889|584096009|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
161742134|NCT01357889|584096010|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
161742135|NCT01357889|584096009|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
161742136|NCT01357889|584096010|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
161742137|NCT01357889|584096009|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
161742138|NCT01357889|584096010|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
161742139|NCT01357889|584096009|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
161742140|NCT01357889|584096010|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
161742141|NCT01357889|584096009|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
161742142|NCT01357889|584096010|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
161742143|NCT01335698|584096011|FG000|Treatment Stage 1|Lack of Efficacy|3|||
161742144|NCT01335698|584096012|FG001|Treatment Stage 1|Lack of Efficacy|1|||
161742145|NCT01335698|584096013|FG002|Treatment Stage 1|Lack of Efficacy|3|||
161742146|NCT01335698|584096014|FG003|Treatment Stage 1|Lack of Efficacy|3|||
161742147|NCT01335698|584096015|FG004|Treatment Stage 1|Lack of Efficacy|1|||
161742148|NCT01335698|584096011|FG000|Treatment Stage 1|Adverse Event|1|||
161742149|NCT01335698|584096012|FG001|Treatment Stage 1|Adverse Event|2|||
161742150|NCT01335698|584096013|FG002|Treatment Stage 1|Adverse Event|2|||
161742151|NCT01335698|584096014|FG003|Treatment Stage 1|Adverse Event|1|||
161742152|NCT01335698|584096015|FG004|Treatment Stage 1|Adverse Event|1|||
161742153|NCT01335698|584096011|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
161742154|NCT01335698|584096012|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
161742155|NCT01335698|584096013|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
161742156|NCT01335698|584096014|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
161742157|NCT01335698|584096015|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
161742158|NCT01335698|584096011|FG000|Treatment Stage 1|Lost to Follow-up|1|||
161742159|NCT01335698|584096012|FG001|Treatment Stage 1|Lost to Follow-up|1|||
161742160|NCT01335698|584096013|FG002|Treatment Stage 1|Lost to Follow-up|0|||
161742161|NCT01335698|584096014|FG003|Treatment Stage 1|Lost to Follow-up|0|||
161742162|NCT01335698|584096015|FG004|Treatment Stage 1|Lost to Follow-up|0|||
161742163|NCT01335698|584096011|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
161742164|NCT01335698|584096012|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
161742165|NCT01335698|584096013|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
161742166|NCT01335698|584096014|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
161742167|NCT01335698|584096015|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
161742168|NCT01335698|584096011|FG000|Treatment Stage 1|No longer meets study criteria|1|||
161742169|NCT01335698|584096012|FG001|Treatment Stage 1|No longer meets study criteria|1|||
161742170|NCT01335698|584096013|FG002|Treatment Stage 1|No longer meets study criteria|0|||
161742171|NCT01335698|584096014|FG003|Treatment Stage 1|No longer meets study criteria|1|||
161742172|NCT01335698|584096015|FG004|Treatment Stage 1|No longer meets study criteria|0|||
161742173|NCT01335698|584096011|FG000|Treatment Stage 1|Other|1|||
161742174|NCT01335698|584096012|FG001|Treatment Stage 1|Other|0|||
161742175|NCT01335698|584096013|FG002|Treatment Stage 1|Other|0|||
161742176|NCT01335698|584096014|FG003|Treatment Stage 1|Other|1|||
161742177|NCT01335698|584096015|FG004|Treatment Stage 1|Other|0|||
161742178|NCT01335698|584096011|FG000|Treatment Stage 2|Lack of Efficacy|2|||
161742179|NCT01335698|584096012|FG001|Treatment Stage 2|Lack of Efficacy|1|||
161742180|NCT01335698|584096013|FG002|Treatment Stage 2|Lack of Efficacy|3|||
161742181|NCT01335698|584096014|FG003|Treatment Stage 2|Lack of Efficacy|1|||
161742182|NCT01335698|584096015|FG004|Treatment Stage 2|Lack of Efficacy|0|||
161742183|NCT01335698|584096011|FG000|Treatment Stage 2|Adverse Event|2|||
161742184|NCT01335698|584096012|FG001|Treatment Stage 2|Adverse Event|0|||
161841094|NCT03893565|584462896|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841095|NCT03893565|584462897|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161742185|NCT01335698|584096013|FG002|Treatment Stage 2|Adverse Event|0|||
161841096|NCT03893565|584462898|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841097|NCT03893565|584462899|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841098|NCT03893565|584462900|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841099|NCT03893565|584462901|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841100|NCT03893565|584462902|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841101|NCT03893565|584462903|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
161841102|NCT03893565|584462904|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161841103|NCT03893565|584462896|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841104|NCT03893565|584462897|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841105|NCT03893565|584462898|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841106|NCT03893565|584462899|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841107|NCT03893565|584462900|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841108|NCT03893565|584462901|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841109|NCT03893565|584462902|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841110|NCT03893565|584462903|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
161841111|NCT03893565|584462904|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161841112|NCT03893565|584462896|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841113|NCT03893565|584462897|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841114|NCT03893565|584462898|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841115|NCT03893565|584462899|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841116|NCT03893565|584462900|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841117|NCT03893565|584462901|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841118|NCT03893565|584462902|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841119|NCT03893565|584462903|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
161841120|NCT03893565|584462904|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161841121|NCT03893565|584462896|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841122|NCT03893565|584462897|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841123|NCT03893565|584462898|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841124|NCT03893565|584462899|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841125|NCT03893565|584462900|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841126|NCT03893565|584462901|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841127|NCT03893565|584462902|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841128|NCT03893565|584462903|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161841129|NCT03893565|584462904|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
161841130|NCT03870477|584462909|FG000|Overall Study|Early Study Termination|1|||
161841131|NCT02256436|584462916|FG000|Overall Study|Adverse Event|9|||
161841132|NCT02256436|584462917|FG001|Overall Study|Adverse Event|14|||
161841133|NCT02256436|584462916|FG000|Overall Study|Death|216|||
161841134|NCT02256436|584462917|FG001|Overall Study|Death|208|||
161841135|NCT02256436|584462916|FG000|Overall Study|Lost to Follow-up|1|||
161841136|NCT02256436|584462917|FG001|Overall Study|Lost to Follow-up|2|||
161841137|NCT02256436|584462916|FG000|Overall Study|Physician Decision|1|||
161841138|NCT02256436|584462917|FG001|Overall Study|Physician Decision|0|||
161841139|NCT02256436|584462916|FG000|Overall Study|Protocol Violation|0|||
161841140|NCT02256436|584462917|FG001|Overall Study|Protocol Violation|1|||
161841141|NCT02256436|584462916|FG000|Overall Study|Withdrawal by Subject|26|||
161841142|NCT02256436|584462917|FG001|Overall Study|Withdrawal by Subject|10|||
161841143|NCT02256436|584462916|FG000|Overall Study|Transferred to Extension Study|11|||
161841144|NCT02256436|584462917|FG001|Overall Study|Transferred to Extension Study|23|||
161966238|NCT01461928|584923554|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
161966239|NCT01461928|584923555|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
161966240|NCT01461928|584923556|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
161966241|NCT01461928|584923554|FG000|Maintenance II (15 Months)|Adverse Event|0|||
161966242|NCT01461928|584923555|FG001|Maintenance II (15 Months)|Adverse Event|2|||
161742186|NCT01335698|584096014|FG003|Treatment Stage 2|Adverse Event|3|||
161742187|NCT01335698|584096015|FG004|Treatment Stage 2|Adverse Event|0|||
161742188|NCT01335698|584096011|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
161742189|NCT01335698|584096012|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
161742190|NCT01335698|584096013|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
161742191|NCT01335698|584096014|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
161742192|NCT01335698|584096015|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
161742193|NCT01335698|584096011|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
161841145|NCT02256436|584462916|FG000|Overall Study|Did Not Continue on Extension Study|8|||
161966243|NCT01461928|584923556|FG002|Maintenance II (15 Months)|Adverse Event|0|||
161966244|NCT01461928|584923554|FG000|Maintenance II (15 Months)|Death|0|||
161966245|NCT01461928|584923555|FG001|Maintenance II (15 Months)|Death|10|||
161742194|NCT01335698|584096012|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
161742195|NCT01335698|584096013|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
161966246|NCT01461928|584923556|FG002|Maintenance II (15 Months)|Death|8|||
161966247|NCT01461928|584923554|FG000|Maintenance II (15 Months)|Physician Decision|0|||
161966248|NCT01461928|584923555|FG001|Maintenance II (15 Months)|Physician Decision|0|||
161966249|NCT01461928|584923556|FG002|Maintenance II (15 Months)|Physician Decision|4|||
161966250|NCT01461928|584923554|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
161966251|NCT01461928|584923555|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
161966252|NCT01461928|584923556|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
161966253|NCT01461928|584923554|FG000|Maintenance II (15 Months)|Moved to another town|0|||
161966254|NCT01461928|584923555|FG001|Maintenance II (15 Months)|Moved to another town|1|||
161742196|NCT01335698|584096014|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
161742197|NCT01335698|584096015|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
161742198|NCT01335698|584096011|FG000|Treatment Stage 2|Lost to Follow-up|1|||
161742199|NCT01335698|584096012|FG001|Treatment Stage 2|Lost to Follow-up|0|||
161742200|NCT01335698|584096013|FG002|Treatment Stage 2|Lost to Follow-up|0|||
161742201|NCT01335698|584096014|FG003|Treatment Stage 2|Lost to Follow-up|0|||
161742202|NCT01335698|584096015|FG004|Treatment Stage 2|Lost to Follow-up|0|||
161742203|NCT01335698|584096011|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
161742204|NCT01335698|584096012|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
161742205|NCT01335698|584096013|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
161742206|NCT01335698|584096014|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
161742207|NCT01335698|584096015|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
161742208|NCT01335698|584096011|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
161742209|NCT01335698|584096012|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
161742210|NCT01335698|584096013|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
161742211|NCT01335698|584096014|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
161742212|NCT01335698|584096015|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
161742213|NCT01335698|584096011|FG000|Treatment Stage 2|Switched to another formulation|1|||
161742214|NCT01335698|584096012|FG001|Treatment Stage 2|Switched to another formulation|1|||
161742215|NCT01335698|584096013|FG002|Treatment Stage 2|Switched to another formulation|0|||
161742216|NCT01335698|584096014|FG003|Treatment Stage 2|Switched to another formulation|0|||
161742217|NCT01335698|584096015|FG004|Treatment Stage 2|Switched to another formulation|0|||
161742218|NCT01170221|584096016|FG000|Overall Study|Lost to Follow-up|22|||
161742219|NCT01170221|584096017|FG001|Overall Study|Lost to Follow-up|21|||
161742220|NCT01170221|584096016|FG000|Overall Study|Withdrawal by Subject|9|||
161742221|NCT01170221|584096017|FG001|Overall Study|Withdrawal by Subject|7|||
161742222|NCT01170221|584096016|FG000|Overall Study|Subject completed only screening and LFU|1|||
161742223|NCT01170221|584096017|FG001|Overall Study|Subject completed only screening and LFU|0|||
161742224|NCT01170221|584096016|FG000|Overall Study|Randomized but not treated|1|||
161742225|NCT01170221|584096017|FG001|Overall Study|Randomized but not treated|0|||
161742226|NCT02693691|584096018|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
161742227|NCT02693691|584096018|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
161742228|NCT02693691|584096018|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
161742229|NCT02693691|584096018|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
161742230|NCT02693691|584096018|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
161742231|NCT02693691|584096018|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
161742232|NCT02693691|584096018|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
161742233|NCT00416312|584096019|FG000|Overall Study|tumors not visible on imaging|2|||
161742234|NCT00050960|584096020|FG000|Overall Study|Progressive Disease|137|||
161742235|NCT00050960|584096021|FG001|Overall Study|Progressive Disease|93|||
161742236|NCT00050960|584096020|FG000|Overall Study|Stable Disease|19|||
161742237|NCT00050960|584096021|FG001|Overall Study|Stable Disease|48|||
161742238|NCT00050960|584096020|FG000|Overall Study|Partial Response|14|||
161742239|NCT00050960|584096021|FG001|Overall Study|Partial Response|19|||
161742240|NCT00050960|584096020|FG000|Overall Study|Complete Response|0|||
161742241|NCT00050960|584096021|FG001|Overall Study|Complete Response|2|||
161742242|NCT00050960|584096020|FG000|Overall Study|Adverse Event|62|||
161742243|NCT00050960|584096021|FG001|Overall Study|Adverse Event|61|||
161742244|NCT00050960|584096020|FG000|Overall Study|Lost to Follow-up|0|||
161742245|NCT00050960|584096021|FG001|Overall Study|Lost to Follow-up|1|||
161742246|NCT00050960|584096020|FG000|Overall Study|Withdrawal by Subject|23|||
161742247|NCT00050960|584096021|FG001|Overall Study|Withdrawal by Subject|18|||
161742248|NCT00050960|584096020|FG000|Overall Study|Administrative|31|||
161742249|NCT00050960|584096021|FG001|Overall Study|Administrative|46|||
161742250|NCT00050960|584096020|FG000|Overall Study|Non-compliance|3|||
161742251|NCT00050960|584096021|FG001|Overall Study|Non-compliance|1|||
161742252|NCT00050960|584096020|FG000|Overall Study|Death|13|||
161742253|NCT00050960|584096021|FG001|Overall Study|Death|15|||
161742254|NCT02727660|584096022|FG000|Overall Study|Lack of Efficacy|40|||
161742255|NCT02727660|584096023|FG001|Overall Study|Lack of Efficacy|40|||
161742256|NCT02727660|584096024|FG002|Overall Study|Lack of Efficacy|70|||
161742257|NCT02727660|584096022|FG000|Overall Study|Adverse Event|28|||
161742258|NCT02727660|584096023|FG001|Overall Study|Adverse Event|21|||
161841146|NCT02256436|584462917|FG001|Overall Study|Did Not Continue on Extension Study|12|||
161966255|NCT01461928|584923556|FG002|Maintenance II (15 Months)|Moved to another town|0|||
161966256|NCT01461928|584923554|FG000|Maintenance II (15 Months)|Disease progression|0|||
161966257|NCT01461928|584923555|FG001|Maintenance II (15 Months)|Disease progression|0|||
161966258|NCT01461928|584923556|FG002|Maintenance II (15 Months)|Disease progression|3|||
161966259|NCT01461928|584923554|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
161966260|NCT01461928|584923555|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
161742259|NCT02727660|584096024|FG002|Overall Study|Adverse Event|32|||
161742260|NCT02727660|584096022|FG000|Overall Study|Withdrawal by Subject|26|||
161742261|NCT02727660|584096023|FG001|Overall Study|Withdrawal by Subject|25|||
161742262|NCT02727660|584096024|FG002|Overall Study|Withdrawal by Subject|30|||
161742263|NCT02727660|584096022|FG000|Overall Study|Physician Decision|3|||
161742264|NCT02727660|584096023|FG001|Overall Study|Physician Decision|8|||
161742265|NCT02727660|584096024|FG002|Overall Study|Physician Decision|14|||
161742266|NCT02727660|584096022|FG000|Overall Study|Lost to Follow-up|5|||
161742267|NCT02727660|584096023|FG001|Overall Study|Lost to Follow-up|9|||
161742268|NCT02727660|584096024|FG002|Overall Study|Lost to Follow-up|8|||
161742269|NCT02727660|584096022|FG000|Overall Study|Protocol Violation|7|||
161742270|NCT02727660|584096023|FG001|Overall Study|Protocol Violation|5|||
161742271|NCT02727660|584096024|FG002|Overall Study|Protocol Violation|5|||
161742272|NCT02727660|584096022|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
161742273|NCT02727660|584096023|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
161742274|NCT02727660|584096024|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
161742275|NCT02727660|584096022|FG000|Overall Study|Administrative Reasons|2|||
161742276|NCT02727660|584096023|FG001|Overall Study|Administrative Reasons|3|||
161742277|NCT02727660|584096024|FG002|Overall Study|Administrative Reasons|4|||
161742278|NCT00764946|584096029|FG000|Overall Study|Lack of Efficacy|1|||
161742279|NCT00764946|584096030|FG001|Overall Study|Lack of Efficacy|0|||
161742280|NCT00764946|584096031|FG002|Overall Study|Lack of Efficacy|0|||
161742281|NCT00764946|584096029|FG000|Overall Study|Lost to Follow-up|3|||
161742282|NCT00764946|584096030|FG001|Overall Study|Lost to Follow-up|4|||
161742283|NCT00764946|584096031|FG002|Overall Study|Lost to Follow-up|0|||
161742284|NCT00764946|584096029|FG000|Overall Study|Physician Decision|2|||
161742285|NCT00764946|584096030|FG001|Overall Study|Physician Decision|4|||
161742286|NCT00764946|584096031|FG002|Overall Study|Physician Decision|0|||
161742287|NCT00764946|584096029|FG000|Overall Study|Adverse Event|3|||
161742288|NCT00764946|584096030|FG001|Overall Study|Adverse Event|2|||
161742289|NCT00764946|584096031|FG002|Overall Study|Adverse Event|1|||
161742290|NCT00764946|584096029|FG000|Overall Study|Withdrawal by Subject|3|||
161742291|NCT00764946|584096030|FG001|Overall Study|Withdrawal by Subject|6|||
161742292|NCT00764946|584096031|FG002|Overall Study|Withdrawal by Subject|2|||
161742293|NCT00764946|584096029|FG000|Overall Study|Never Treated|1|||
161742294|NCT00764946|584096030|FG001|Overall Study|Never Treated|1|||
161742295|NCT00764946|584096031|FG002|Overall Study|Never Treated|1|||
161742296|NCT01162304|584096032|FG000|Overall Study|Beck scale to high|11|||
161742297|NCT01315847|584096033|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
161742298|NCT01315847|584096034|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
161742299|NCT01315847|584096033|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
161742300|NCT01315847|584096034|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
161742301|NCT02940626|584096035|FG000|Overall Study|Death|40|||
161742302|NCT02940626|584096036|FG001|Overall Study|Death|32|||
161742303|NCT02940626|584096035|FG000|Overall Study|Lost to Follow-up|5|||
161742304|NCT02940626|584096036|FG001|Overall Study|Lost to Follow-up|2|||
161742305|NCT02940626|584096035|FG000|Overall Study|Withdrawal by Subject|1|||
161742306|NCT02940626|584096036|FG001|Overall Study|Withdrawal by Subject|0|||
161742307|NCT02940626|584096035|FG000|Overall Study|Transfer to Hospice Care|1|||
161742308|NCT02940626|584096036|FG001|Overall Study|Transfer to Hospice Care|0|||
161742309|NCT02940626|584096035|FG000|Overall Study|Prohibited Concomitant Medication|0|||
161742310|NCT02940626|584096036|FG001|Overall Study|Prohibited Concomitant Medication|1|||
161742311|NCT00585923|584096038|FG000|Overall Study|Physician decided not to continue|31|||
161742312|NCT00585923|584096039|FG001|Overall Study|Physician decided not to continue|33|||
161742313|NCT01324622|584096040|FG000|Overall Study|Lost to Follow-up|7|||
161742314|NCT01324622|584096041|FG001|Overall Study|Lost to Follow-up|7|||
161742315|NCT01324622|584096040|FG000|Overall Study|Death|1|||
161742316|NCT01324622|584096041|FG001|Overall Study|Death|0|||
161742317|NCT01324622|584096040|FG000|Overall Study|Lack of Efficacy|1|||
161742318|NCT01324622|584096041|FG001|Overall Study|Lack of Efficacy|0|||
161742319|NCT00878215|584096042|FG000|Overall Study|Determined to be ineligible|0|||
161966261|NCT01461928|584923556|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
161966262|NCT01461928|584923554|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
161966263|NCT01461928|584923555|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
161966264|NCT01461928|584923556|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
161966265|NCT01461928|584923554|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
161742320|NCT00878215|584096043|FG001|Overall Study|Determined to be ineligible|10|||
161742321|NCT00878215|584096044|FG002|Overall Study|Determined to be ineligible|0|||
161742322|NCT00878215|584096045|FG003|Overall Study|Determined to be ineligible|0|||
161742323|NCT00138424|584096046|FG000|Overall Study|Physician Decision|0|||
161841147|NCT05961215|584462918|FG000|Overall Study|Withdrawal by Subject|1|||
161841148|NCT01394952|584462919|FG000|Overall Study|Lost to Follow-up|0|||
161841149|NCT01394952|584462920|FG001|Overall Study|Lost to Follow-up|5|||
161841150|NCT01394952|584462919|FG000|Overall Study|Withdrawal by Subject|10|||
161841151|NCT01394952|584462920|FG001|Overall Study|Withdrawal by Subject|5|||
161841152|NCT01394952|584462919|FG000|Overall Study|Physician Decision|2|||
161841153|NCT01394952|584462920|FG001|Overall Study|Physician Decision|0|||
161841154|NCT01394952|584462919|FG000|Overall Study|Sponsor Decision|5|||
161841155|NCT01394952|584462920|FG001|Overall Study|Sponsor Decision|7|||
161841156|NCT01986010|584462921|FG000|Overall Study|Adverse Event|0|||
161841157|NCT01986010|584462922|FG001|Overall Study|Adverse Event|1|||
161841158|NCT01986010|584462923|FG002|Overall Study|Adverse Event|0|||
161841159|NCT01986010|584462924|FG003|Overall Study|Adverse Event|0|||
161841160|NCT01986010|584462925|FG004|Overall Study|Adverse Event|0|||
161841161|NCT01986010|584462926|FG005|Overall Study|Adverse Event|0|||
161841162|NCT01986010|584462927|FG006|Overall Study|Adverse Event|0|||
161841163|NCT01986010|584462928|FG007|Overall Study|Adverse Event|0|||
161841164|NCT01986010|584462929|FG008|Overall Study|Adverse Event|0|||
161841165|NCT01986010|584462930|FG009|Overall Study|Adverse Event|0|||
161841166|NCT01986010|584462931|FG010|Overall Study|Adverse Event|0|||
161841167|NCT01986010|584462932|FG011|Overall Study|Adverse Event|0|||
161841168|NCT01986010|584462933|FG012|Overall Study|Adverse Event|0|||
161841169|NCT01986010|584462934|FG013|Overall Study|Adverse Event|0|||
161841170|NCT01986010|584462935|FG014|Overall Study|Adverse Event|0|||
161841171|NCT01986010|584462936|FG015|Overall Study|Adverse Event|1|||
161841172|NCT01986010|584462937|FG016|Overall Study|Adverse Event|0|||
161841173|NCT01986010|584462921|FG000|Overall Study|Lost to Follow-up|2|||
161841174|NCT01986010|584462922|FG001|Overall Study|Lost to Follow-up|1|||
161841175|NCT01986010|584462923|FG002|Overall Study|Lost to Follow-up|2|||
161841176|NCT01986010|584462924|FG003|Overall Study|Lost to Follow-up|2|||
161841177|NCT01986010|584462925|FG004|Overall Study|Lost to Follow-up|2|||
161841178|NCT01986010|584462926|FG005|Overall Study|Lost to Follow-up|2|||
161841179|NCT01986010|584462927|FG006|Overall Study|Lost to Follow-up|0|||
161841180|NCT01986010|584462928|FG007|Overall Study|Lost to Follow-up|0|||
161841181|NCT01986010|584462929|FG008|Overall Study|Lost to Follow-up|4|||
161841182|NCT01986010|584462930|FG009|Overall Study|Lost to Follow-up|2|||
161841183|NCT01986010|584462931|FG010|Overall Study|Lost to Follow-up|0|||
161841184|NCT01986010|584462932|FG011|Overall Study|Lost to Follow-up|1|||
161841185|NCT01986010|584462933|FG012|Overall Study|Lost to Follow-up|1|||
161841186|NCT01986010|584462934|FG013|Overall Study|Lost to Follow-up|1|||
161841187|NCT01986010|584462935|FG014|Overall Study|Lost to Follow-up|2|||
161841188|NCT01986010|584462936|FG015|Overall Study|Lost to Follow-up|0|||
161841189|NCT01986010|584462937|FG016|Overall Study|Lost to Follow-up|0|||
161841190|NCT01986010|584462921|FG000|Overall Study|Physician Decision|0|||
161841191|NCT01986010|584462922|FG001|Overall Study|Physician Decision|0|||
161841192|NCT01986010|584462923|FG002|Overall Study|Physician Decision|0|||
161966266|NCT01461928|584923555|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
161966267|NCT01461928|584923556|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
161966268|NCT01461928|584923554|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
161966269|NCT01461928|584923555|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
161841193|NCT01986010|584462924|FG003|Overall Study|Physician Decision|0|||
161841194|NCT01986010|584462925|FG004|Overall Study|Physician Decision|0|||
161841195|NCT01986010|584462926|FG005|Overall Study|Physician Decision|0|||
161841196|NCT01986010|584462927|FG006|Overall Study|Physician Decision|0|||
161841197|NCT01986010|584462928|FG007|Overall Study|Physician Decision|0|||
161841198|NCT01986010|584462929|FG008|Overall Study|Physician Decision|0|||
161841199|NCT01986010|584462930|FG009|Overall Study|Physician Decision|0|||
161841200|NCT01986010|584462931|FG010|Overall Study|Physician Decision|0|||
161841201|NCT01986010|584462932|FG011|Overall Study|Physician Decision|0|||
161966270|NCT01461928|584923556|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
161966271|NCT01461928|584923554|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
161966272|NCT01461928|584923555|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
161966273|NCT01461928|584923556|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
161966274|NCT00539513|584923561|FG000|Overall Study|Withdrawal by Subject|2|||
161966275|NCT00539513|584923562|FG001|Overall Study|Withdrawal by Subject|1|||
161966276|NCT00539513|584923561|FG000|Overall Study|Lost to Follow-up|0|||
161841202|NCT01986010|584462933|FG012|Overall Study|Physician Decision|0|||
161841203|NCT01986010|584462934|FG013|Overall Study|Physician Decision|0|||
161841204|NCT01986010|584462935|FG014|Overall Study|Physician Decision|1|||
161841205|NCT01986010|584462936|FG015|Overall Study|Physician Decision|0|||
161841206|NCT01986010|584462937|FG016|Overall Study|Physician Decision|0|||
161841207|NCT01986010|584462921|FG000|Overall Study|Withdrawal by Subject|2|||
161841208|NCT01986010|584462922|FG001|Overall Study|Withdrawal by Subject|2|||
161841209|NCT01986010|584462923|FG002|Overall Study|Withdrawal by Subject|3|||
161841210|NCT01986010|584462924|FG003|Overall Study|Withdrawal by Subject|0|||
161841211|NCT01986010|584462925|FG004|Overall Study|Withdrawal by Subject|2|||
161841212|NCT01986010|584462926|FG005|Overall Study|Withdrawal by Subject|4|||
161841213|NCT01986010|584462927|FG006|Overall Study|Withdrawal by Subject|0|||
161966277|NCT00539513|584923562|FG001|Overall Study|Lost to Follow-up|1|||
161742324|NCT00138424|584096047|FG001|Overall Study|Physician Decision|1|||
161742325|NCT00138424|584096048|FG002|Overall Study|Physician Decision|0|||
161742326|NCT00138424|584096049|FG003|Overall Study|Physician Decision|0|||
161742327|NCT00413062|584096056|FG000|Overall Study|Adverse event/serious adverse event|289|||
161742328|NCT00413062|584096057|FG001|Overall Study|Adverse event/serious adverse event|56|||
161742329|NCT00413062|584096056|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
161742330|NCT00413062|584096057|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
161742331|NCT00413062|584096056|FG000|Overall Study|Withdrawal of informed consent|111|||
161742332|NCT00413062|584096057|FG001|Overall Study|Withdrawal of informed consent|36|||
161742333|NCT00413062|584096056|FG000|Overall Study|Pregnancy|15|||
161742334|NCT00413062|584096057|FG001|Overall Study|Pregnancy|5|||
161742335|NCT00413062|584096056|FG000|Overall Study|Pregnancy wish|17|||
161742336|NCT00413062|584096057|FG001|Overall Study|Pregnancy wish|6|||
161742337|NCT00413062|584096056|FG000|Overall Study|Lost to Follow-up|175|||
161742338|NCT00413062|584096057|FG001|Overall Study|Lost to Follow-up|73|||
161742339|NCT00413062|584096056|FG000|Overall Study|Other reason|70|||
161742340|NCT00413062|584096057|FG001|Overall Study|Other reason|34|||
161742341|NCT02176291|584096058|FG000|Overall Study|Death|1|||
161742342|NCT02176291|584096059|FG001|Overall Study|Death|0|||
161742343|NCT02176291|584096058|FG000|Overall Study|non compliance with protocol|2|||
161742344|NCT02176291|584096059|FG001|Overall Study|non compliance with protocol|0|||
161742345|NCT02176291|584096058|FG000|Overall Study|Withdrawal by Subject|2|||
161742346|NCT02176291|584096059|FG001|Overall Study|Withdrawal by Subject|0|||
161742347|NCT02815293|584096060|FG000|Overall Study|Study termination by sponsor|10|||
161742348|NCT02815293|584096061|FG001|Overall Study|Study termination by sponsor|7|||
161742349|NCT02815293|584096062|FG002|Overall Study|Study termination by sponsor|0|||
161742350|NCT02815293|584096060|FG000|Overall Study|Participants not randomized|0|||
161742351|NCT02815293|584096061|FG001|Overall Study|Participants not randomized|0|||
161742352|NCT02815293|584096062|FG002|Overall Study|Participants not randomized|18|||
161742353|NCT02815293|584096060|FG000|Overall Study|Adverse Event|0|||
161742354|NCT02815293|584096061|FG001|Overall Study|Adverse Event|1|||
161742355|NCT02815293|584096062|FG002|Overall Study|Adverse Event|0|||
161742356|NCT02431468|584096063|FG000|Overall Study|Adverse Event|2|||
161742357|NCT02431468|584096064|FG001|Overall Study|Adverse Event|4|||
161742358|NCT02431468|584096065|FG002|Overall Study|Adverse Event|5|||
161742359|NCT02431468|584096063|FG000|Overall Study|Withdrawal by Subject|4|||
161742360|NCT02431468|584096064|FG001|Overall Study|Withdrawal by Subject|12|||
161742361|NCT02431468|584096065|FG002|Overall Study|Withdrawal by Subject|2|||
161742362|NCT02431468|584096063|FG000|Overall Study|noncompliance, investigator termination,|2|||
161742363|NCT02431468|584096064|FG001|Overall Study|noncompliance, investigator termination,|2|||
161742364|NCT02431468|584096065|FG002|Overall Study|noncompliance, investigator termination,|2|||
161742365|NCT00006604|584096066|FG000|Overall Study|Met study objective - no further FU|1|||
161742366|NCT00006604|584096067|FG001|Overall Study|Met study objective - no further FU|0|||
161742367|NCT00006604|584096068|FG002|Overall Study|Met study objective - no further FU|0|||
161742368|NCT00006604|584096069|FG003|Overall Study|Met study objective - no further FU|0|||
161742369|NCT00006604|584096070|FG004|Overall Study|Met study objective - no further FU|0|||
161742370|NCT00006604|584096071|FG005|Overall Study|Met study objective - no further FU|0|||
161742371|NCT00006604|584096072|FG006|Overall Study|Met study objective - no further FU|0|||
161742372|NCT00006604|584096073|FG007|Overall Study|Met study objective - no further FU|0|||
161742373|NCT00006604|584096074|FG008|Overall Study|Met study objective - no further FU|0|||
161742374|NCT00006604|584096075|FG009|Overall Study|Met study objective - no further FU|0|||
161742375|NCT00006604|584096076|FG010|Overall Study|Met study objective - no further FU|0|||
161742376|NCT00006604|584096077|FG011|Overall Study|Met study objective - no further FU|0|||
161742377|NCT00006604|584096078|FG012|Overall Study|Met study objective - no further FU|0|||
161742378|NCT00006604|584096079|FG013|Overall Study|Met study objective - no further FU|0|||
161742379|NCT00006604|584096080|FG014|Overall Study|Met study objective - no further FU|1|||
161742380|NCT00006604|584096081|FG015|Overall Study|Met study objective - no further FU|1|||
161742381|NCT00006604|584096082|FG016|Overall Study|Met study objective - no further FU|0|||
161742382|NCT00006604|584096066|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
161742383|NCT00006604|584096067|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
161742384|NCT00006604|584096068|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
161742385|NCT00006604|584096069|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
161742386|NCT00006604|584096070|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
161742387|NCT00006604|584096071|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
161742388|NCT00006604|584096072|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
161742389|NCT00006604|584096073|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
161742390|NCT00006604|584096074|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
161742391|NCT00006604|584096075|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
161742392|NCT00006604|584096076|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
161742393|NCT00006604|584096077|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
161966278|NCT02456636|584923563|FG000|Overall Study|Death|0|||
161966279|NCT02456636|584923564|FG001|Overall Study|Death|3|||
161742394|NCT00006604|584096078|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
161742395|NCT00006604|584096079|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
161742396|NCT00006604|584096080|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
161742397|NCT00006604|584096081|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
161742398|NCT00006604|584096082|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
161742399|NCT00006604|584096066|FG000|Overall Study|Death|0|||
161742400|NCT00006604|584096067|FG001|Overall Study|Death|0|||
161742401|NCT00006604|584096068|FG002|Overall Study|Death|0|||
161742402|NCT00006604|584096069|FG003|Overall Study|Death|0|||
161742403|NCT00006604|584096070|FG004|Overall Study|Death|0|||
161742404|NCT00006604|584096071|FG005|Overall Study|Death|0|||
161742405|NCT00006604|584096072|FG006|Overall Study|Death|0|||
161742406|NCT00006604|584096073|FG007|Overall Study|Death|0|||
161742407|NCT00006604|584096074|FG008|Overall Study|Death|0|||
161742408|NCT00006604|584096075|FG009|Overall Study|Death|1|||
161742409|NCT00006604|584096076|FG010|Overall Study|Death|1|||
161742410|NCT00006604|584096077|FG011|Overall Study|Death|1|||
161742411|NCT00006604|584096078|FG012|Overall Study|Death|0|||
161742412|NCT00006604|584096079|FG013|Overall Study|Death|0|||
161742413|NCT00006604|584096080|FG014|Overall Study|Death|0|||
161742414|NCT00006604|584096081|FG015|Overall Study|Death|0|||
161742415|NCT00006604|584096082|FG016|Overall Study|Death|0|||
161742416|NCT00006604|584096066|FG000|Overall Study|Severe debilitation, unable to continue|0|||
161742417|NCT00006604|584096067|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161742418|NCT00006604|584096068|FG002|Overall Study|Severe debilitation, unable to continue|0|||
161742419|NCT00006604|584096069|FG003|Overall Study|Severe debilitation, unable to continue|0|||
161742420|NCT00006604|584096070|FG004|Overall Study|Severe debilitation, unable to continue|0|||
161742421|NCT00006604|584096071|FG005|Overall Study|Severe debilitation, unable to continue|0|||
161742422|NCT00006604|584096072|FG006|Overall Study|Severe debilitation, unable to continue|3|||
161742423|NCT00006604|584096073|FG007|Overall Study|Severe debilitation, unable to continue|0|||
161742424|NCT00006604|584096074|FG008|Overall Study|Severe debilitation, unable to continue|0|||
161742425|NCT00006604|584096075|FG009|Overall Study|Severe debilitation, unable to continue|5|||
161742426|NCT00006604|584096076|FG010|Overall Study|Severe debilitation, unable to continue|0|||
161742427|NCT00006604|584096077|FG011|Overall Study|Severe debilitation, unable to continue|2|||
161742428|NCT00006604|584096078|FG012|Overall Study|Severe debilitation, unable to continue|1|||
161742429|NCT00006604|584096079|FG013|Overall Study|Severe debilitation, unable to continue|0|||
161742430|NCT00006604|584096080|FG014|Overall Study|Severe debilitation, unable to continue|2|||
161742431|NCT00006604|584096081|FG015|Overall Study|Severe debilitation, unable to continue|0|||
161742432|NCT00006604|584096082|FG016|Overall Study|Severe debilitation, unable to continue|0|||
161742433|NCT00006604|584096066|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
161742434|NCT00006604|584096067|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
161742435|NCT00006604|584096068|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
161742436|NCT00006604|584096069|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
161742437|NCT00006604|584096070|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
161742438|NCT00006604|584096071|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
161742439|NCT00006604|584096072|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
161742440|NCT00006604|584096073|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
161742441|NCT00006604|584096074|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
161742442|NCT00006604|584096075|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
161742443|NCT00006604|584096076|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
161742444|NCT00006604|584096077|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
161742445|NCT00006604|584096078|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
161742446|NCT00006604|584096079|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
161742447|NCT00006604|584096080|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
161742448|NCT00006604|584096081|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
161742449|NCT00006604|584096082|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
161742450|NCT00006604|584096066|FG000|Overall Study|Site closing|0|||
161742451|NCT00006604|584096067|FG001|Overall Study|Site closing|0|||
161742452|NCT00006604|584096068|FG002|Overall Study|Site closing|1|||
161742453|NCT00006604|584096069|FG003|Overall Study|Site closing|1|||
161742454|NCT00006604|584096070|FG004|Overall Study|Site closing|0|||
161742455|NCT00006604|584096071|FG005|Overall Study|Site closing|0|||
161742456|NCT00006604|584096072|FG006|Overall Study|Site closing|0|||
161742457|NCT00006604|584096073|FG007|Overall Study|Site closing|1|||
161742458|NCT00006604|584096074|FG008|Overall Study|Site closing|0|||
161742459|NCT00006604|584096075|FG009|Overall Study|Site closing|0|||
161742460|NCT00006604|584096076|FG010|Overall Study|Site closing|0|||
161742461|NCT00006604|584096077|FG011|Overall Study|Site closing|1|||
161742462|NCT00006604|584096078|FG012|Overall Study|Site closing|1|||
161742463|NCT00006604|584096079|FG013|Overall Study|Site closing|1|||
161742464|NCT00006604|584096080|FG014|Overall Study|Site closing|0|||
161742465|NCT00006604|584096081|FG015|Overall Study|Site closing|0|||
161742466|NCT00006604|584096082|FG016|Overall Study|Site closing|1|||
161966280|NCT02456636|584923565|FG002|Overall Study|Death|0|||
161966281|NCT02456636|584923563|FG000|Overall Study|Pregnancy|1|||
161966282|NCT02456636|584923564|FG001|Overall Study|Pregnancy|3|||
161966283|NCT02456636|584923565|FG002|Overall Study|Pregnancy|5|||
161742467|NCT00006604|584096066|FG000|Overall Study|Withdrawal by Subject|1|||
161742468|NCT00006604|584096067|FG001|Overall Study|Withdrawal by Subject|0|||
161742469|NCT00006604|584096068|FG002|Overall Study|Withdrawal by Subject|2|||
161742470|NCT00006604|584096069|FG003|Overall Study|Withdrawal by Subject|0|||
161742471|NCT00006604|584096070|FG004|Overall Study|Withdrawal by Subject|1|||
161742472|NCT00006604|584096071|FG005|Overall Study|Withdrawal by Subject|2|||
161742473|NCT00006604|584096072|FG006|Overall Study|Withdrawal by Subject|2|||
161742474|NCT00006604|584096073|FG007|Overall Study|Withdrawal by Subject|0|||
161742475|NCT00006604|584096074|FG008|Overall Study|Withdrawal by Subject|1|||
161742476|NCT00006604|584096075|FG009|Overall Study|Withdrawal by Subject|3|||
161742477|NCT00006604|584096076|FG010|Overall Study|Withdrawal by Subject|2|||
161742478|NCT00006604|584096077|FG011|Overall Study|Withdrawal by Subject|0|||
161742479|NCT00006604|584096078|FG012|Overall Study|Withdrawal by Subject|1|||
161742480|NCT00006604|584096079|FG013|Overall Study|Withdrawal by Subject|2|||
161742481|NCT00006604|584096080|FG014|Overall Study|Withdrawal by Subject|1|||
161742482|NCT00006604|584096081|FG015|Overall Study|Withdrawal by Subject|0|||
161742483|NCT00006604|584096082|FG016|Overall Study|Withdrawal by Subject|1|||
161742484|NCT00006604|584096066|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
161742485|NCT00006604|584096067|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
161742486|NCT00006604|584096068|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
161742487|NCT00006604|584096069|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
161742488|NCT00006604|584096070|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
161742489|NCT00006604|584096071|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
161742490|NCT00006604|584096072|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
161742491|NCT00006604|584096073|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
161742492|NCT00006604|584096074|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
161742493|NCT00006604|584096075|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
161742494|NCT00006604|584096076|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
161742495|NCT00006604|584096077|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
161742496|NCT00006604|584096078|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
161742497|NCT00006604|584096079|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
161742498|NCT00006604|584096080|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
161742499|NCT00006604|584096081|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
161742500|NCT00006604|584096082|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
161742501|NCT00006604|584096066|FG000|Overall Study|Lost to Follow-up|0|||
161742502|NCT00006604|584096067|FG001|Overall Study|Lost to Follow-up|0|||
161742503|NCT00006604|584096068|FG002|Overall Study|Lost to Follow-up|0|||
161742504|NCT00006604|584096069|FG003|Overall Study|Lost to Follow-up|0|||
161742505|NCT00006604|584096070|FG004|Overall Study|Lost to Follow-up|0|||
161742506|NCT00006604|584096071|FG005|Overall Study|Lost to Follow-up|0|||
161742507|NCT00006604|584096072|FG006|Overall Study|Lost to Follow-up|0|||
161742508|NCT00006604|584096073|FG007|Overall Study|Lost to Follow-up|1|||
161742509|NCT00006604|584096074|FG008|Overall Study|Lost to Follow-up|0|||
161742510|NCT00006604|584096075|FG009|Overall Study|Lost to Follow-up|2|||
161742511|NCT00006604|584096076|FG010|Overall Study|Lost to Follow-up|0|||
161742512|NCT00006604|584096077|FG011|Overall Study|Lost to Follow-up|0|||
161742513|NCT00006604|584096078|FG012|Overall Study|Lost to Follow-up|0|||
161742514|NCT00006604|584096079|FG013|Overall Study|Lost to Follow-up|0|||
161742515|NCT00006604|584096080|FG014|Overall Study|Lost to Follow-up|0|||
161742516|NCT00006604|584096081|FG015|Overall Study|Lost to Follow-up|1|||
161742517|NCT00006604|584096082|FG016|Overall Study|Lost to Follow-up|3|||
161742518|NCT00006604|584096066|FG000|Overall Study|Other Reason|0|||
161742519|NCT00006604|584096067|FG001|Overall Study|Other Reason|0|||
161742520|NCT00006604|584096068|FG002|Overall Study|Other Reason|0|||
161742521|NCT00006604|584096069|FG003|Overall Study|Other Reason|0|||
161742522|NCT00006604|584096070|FG004|Overall Study|Other Reason|0|||
161966284|NCT02456636|584923563|FG000|Overall Study|Physician Decision|4|||
161966285|NCT02456636|584923564|FG001|Overall Study|Physician Decision|5|||
161966286|NCT02456636|584923565|FG002|Overall Study|Physician Decision|4|||
161966287|NCT02456636|584923563|FG000|Overall Study|Withdrawal by Subject|13|||
161742523|NCT00006604|584096071|FG005|Overall Study|Other Reason|1|||
161742524|NCT00006604|584096072|FG006|Overall Study|Other Reason|0|||
161742525|NCT00006604|584096073|FG007|Overall Study|Other Reason|0|||
161742526|NCT00006604|584096074|FG008|Overall Study|Other Reason|0|||
161742527|NCT00006604|584096075|FG009|Overall Study|Other Reason|1|||
161742528|NCT00006604|584096076|FG010|Overall Study|Other Reason|0|||
161742529|NCT00006604|584096077|FG011|Overall Study|Other Reason|0|||
161742530|NCT00006604|584096078|FG012|Overall Study|Other Reason|0|||
161742531|NCT00006604|584096079|FG013|Overall Study|Other Reason|0|||
161742532|NCT00006604|584096080|FG014|Overall Study|Other Reason|0|||
161742533|NCT00006604|584096081|FG015|Overall Study|Other Reason|0|||
161966288|NCT02456636|584923564|FG001|Overall Study|Withdrawal by Subject|14|||
161742534|NCT00006604|584096082|FG016|Overall Study|Other Reason|0|||
161742535|NCT01361919|584096083|FG000|Overall Study|technical issues|10|||
161742536|NCT01361919|584096084|FG001|Overall Study|technical issues|12|||
161742537|NCT01361919|584096085|FG002|Overall Study|technical issues|10|||
161742538|NCT01056341|584096086|FG000|Overall Study|Treatment Intolerance|0|||
161742539|NCT01056341|584096087|FG001|Overall Study|Treatment Intolerance|2|||
161742540|NCT01056341|584096088|FG002|Overall Study|Treatment Intolerance|0|||
161742541|NCT01056341|584096089|FG003|Overall Study|Treatment Intolerance|2|||
161742542|NCT01056341|584096090|FG004|Overall Study|Treatment Intolerance|0|||
161742543|NCT01056341|584096086|FG000|Overall Study|Lack of Efficacy|32|||
161742544|NCT01056341|584096087|FG001|Overall Study|Lack of Efficacy|30|||
161742545|NCT01056341|584096088|FG002|Overall Study|Lack of Efficacy|7|||
161742546|NCT01056341|584096089|FG003|Overall Study|Lack of Efficacy|25|||
161742547|NCT01056341|584096090|FG004|Overall Study|Lack of Efficacy|9|||
161742548|NCT01056341|584096086|FG000|Overall Study|Other reasons|4|||
161742549|NCT01056341|584096087|FG001|Overall Study|Other reasons|4|||
161742550|NCT01056341|584096088|FG002|Overall Study|Other reasons|8|||
161742551|NCT01056341|584096089|FG003|Overall Study|Other reasons|9|||
161742552|NCT01056341|584096090|FG004|Overall Study|Other reasons|5|||
161742553|NCT03454412|584096091|FG000|Baseline Assesment|Physician Decision|12|||
161742554|NCT01167582|584096094|FG000|Overall Study|Lost to Follow-up|0|||
161742555|NCT01167582|584096095|FG001|Overall Study|Lost to Follow-up|1|||
161742556|NCT03956225|584096096|FG000|Overall Study|Lack of Efficacy|1|||
161742557|NCT03956225|584096097|FG001|Overall Study|Lack of Efficacy|1|||
161742558|NCT03956225|584096096|FG000|Overall Study|Lost to Follow-up|0|||
161742559|NCT03956225|584096097|FG001|Overall Study|Lost to Follow-up|1|||
161742560|NCT03956225|584096096|FG000|Overall Study|Withdrawal by Subject|2|||
161742561|NCT03956225|584096097|FG001|Overall Study|Withdrawal by Subject|1|||
161742562|NCT03956225|584096096|FG000|Overall Study|Other Reasons|2|||
161742563|NCT03956225|584096097|FG001|Overall Study|Other Reasons|1|||
161742564|NCT00567541|584096098|FG000|Overall Study|Adverse Event|0|||
161742565|NCT00567541|584096099|FG001|Overall Study|Adverse Event|1|||
161742566|NCT02157506|584096100|FG000|Overall Study|Adverse Event|0|||
161742567|NCT02157506|584096101|FG001|Overall Study|Adverse Event|1|||
161742568|NCT02157506|584096102|FG002|Overall Study|Adverse Event|0|||
161742569|NCT02157506|584096103|FG003|Overall Study|Adverse Event|0|||
161841214|NCT01986010|584462928|FG007|Overall Study|Withdrawal by Subject|0|||
161841215|NCT01986010|584462929|FG008|Overall Study|Withdrawal by Subject|0|||
161841216|NCT01986010|584462930|FG009|Overall Study|Withdrawal by Subject|0|||
161841217|NCT01986010|584462931|FG010|Overall Study|Withdrawal by Subject|0|||
161841218|NCT01986010|584462932|FG011|Overall Study|Withdrawal by Subject|2|||
161841219|NCT01986010|584462933|FG012|Overall Study|Withdrawal by Subject|0|||
161841220|NCT01986010|584462934|FG013|Overall Study|Withdrawal by Subject|1|||
161841221|NCT01986010|584462935|FG014|Overall Study|Withdrawal by Subject|2|||
161841222|NCT01986010|584462936|FG015|Overall Study|Withdrawal by Subject|0|||
161841223|NCT01986010|584462937|FG016|Overall Study|Withdrawal by Subject|0|||
161841224|NCT01986010|584462921|FG000|Overall Study|Status Not Recorded|2|||
161841225|NCT01986010|584462922|FG001|Overall Study|Status Not Recorded|4|||
161841226|NCT01986010|584462923|FG002|Overall Study|Status Not Recorded|2|||
161841227|NCT01986010|584462924|FG003|Overall Study|Status Not Recorded|0|||
161841228|NCT01986010|584462925|FG004|Overall Study|Status Not Recorded|1|||
161841229|NCT01986010|584462926|FG005|Overall Study|Status Not Recorded|2|||
161841230|NCT01986010|584462927|FG006|Overall Study|Status Not Recorded|0|||
161841231|NCT01986010|584462928|FG007|Overall Study|Status Not Recorded|0|||
161841232|NCT01986010|584462929|FG008|Overall Study|Status Not Recorded|2|||
161841233|NCT01986010|584462930|FG009|Overall Study|Status Not Recorded|1|||
161841234|NCT01986010|584462931|FG010|Overall Study|Status Not Recorded|7|||
161841235|NCT01986010|584462932|FG011|Overall Study|Status Not Recorded|7|||
161841236|NCT01986010|584462933|FG012|Overall Study|Status Not Recorded|9|||
161841237|NCT01986010|584462934|FG013|Overall Study|Status Not Recorded|9|||
161841238|NCT01986010|584462935|FG014|Overall Study|Status Not Recorded|5|||
161841239|NCT01986010|584462936|FG015|Overall Study|Status Not Recorded|10|||
161841240|NCT01986010|584462937|FG016|Overall Study|Status Not Recorded|4|||
161841241|NCT01335997|584462938|FG000|Period I and II|Adverse Event|63|||
161841242|NCT01335997|584462939|FG001|Period I and II|Adverse Event|43|||
161841243|NCT01335997|584462938|FG000|Period I and II|Noncompliance with Study Drug|1|||
161841244|NCT01335997|584462939|FG001|Period I and II|Noncompliance with Study Drug|1|||
161841245|NCT01335997|584462938|FG000|Period I and II|Lost to Follow-up|3|||
161841246|NCT01335997|584462939|FG001|Period I and II|Lost to Follow-up|5|||
161841247|NCT01335997|584462938|FG000|Period I and II|Withdrawal by Subject|9|||
161841248|NCT01335997|584462939|FG001|Period I and II|Withdrawal by Subject|4|||
161742570|NCT02157506|584096104|FG004|Overall Study|Adverse Event|0|||
161841249|NCT01335997|584462938|FG000|Period I and II|Study Terminated by Sponsor|406|||
161742571|NCT02157506|584096100|FG000|Overall Study|Lost to Follow-up|0|||
161742572|NCT02157506|584096101|FG001|Overall Study|Lost to Follow-up|0|||
161742573|NCT02157506|584096102|FG002|Overall Study|Lost to Follow-up|1|||
161742574|NCT02157506|584096103|FG003|Overall Study|Lost to Follow-up|0|||
161742575|NCT02157506|584096104|FG004|Overall Study|Lost to Follow-up|0|||
161742576|NCT01763866|584096105|FG000|Overall Study|Withdrawal by Subject|2|||
161966289|NCT02456636|584923565|FG002|Overall Study|Withdrawal by Subject|16|||
161966290|NCT02456636|584923563|FG000|Overall Study|Lost to Follow-up|50|||
161966291|NCT02456636|584923564|FG001|Overall Study|Lost to Follow-up|44|||
161966292|NCT02456636|584923565|FG002|Overall Study|Lost to Follow-up|50|||
161966293|NCT01801436|584923579|FG000|Overall Study|Withdrawal by Subject|3|||
161966294|NCT01801436|584923579|FG000|Overall Study|Adverse Event|2|||
161966295|NCT01801436|584923579|FG000|Overall Study|Progressive disease|4|||
161742577|NCT01763866|584096106|FG001|Overall Study|Withdrawal by Subject|1|||
161742578|NCT01763866|584096107|FG002|Overall Study|Withdrawal by Subject|4|||
161841250|NCT01335997|584462939|FG001|Period I and II|Study Terminated by Sponsor|415|||
161841251|NCT01335997|584462938|FG000|Period I and II|Protocol Violation|9|||
161841252|NCT01335997|584462939|FG001|Period I and II|Protocol Violation|10|||
161841253|NCT01335997|584462938|FG000|Period I and II|Physician Decision|2|||
161841254|NCT01335997|584462939|FG001|Period I and II|Physician Decision|1|||
161841255|NCT01335997|584462938|FG000|Period III|Adverse Event|0|||
161841256|NCT01335997|584462939|FG001|Period III|Adverse Event|2|||
161841257|NCT01335997|584462938|FG000|Period III|Study Terminated by Sponsor|77|||
161841258|NCT01335997|584462939|FG001|Period III|Study Terminated by Sponsor|76|||
161841259|NCT01335997|584462938|FG000|Period III|Protocol Violation|0|||
161841260|NCT01335997|584462939|FG001|Period III|Protocol Violation|1|||
161841261|NCT01335997|584462938|FG000|Period III|Lost to Follow-up|1|||
161841262|NCT01335997|584462939|FG001|Period III|Lost to Follow-up|0|||
161841263|NCT04740814|584462942|FG000|Overall Study|Adverse Event|3|||
161841264|NCT04740814|584462942|FG000|Overall Study|Protocol Violation|2|||
161841265|NCT04740814|584462942|FG000|Overall Study|Lost to Follow-up|2|||
161742579|NCT01763866|584096108|FG003|Overall Study|Withdrawal by Subject|0|||
161742580|NCT01763866|584096109|FG004|Overall Study|Withdrawal by Subject|0|||
161742581|NCT01763866|584096110|FG005|Overall Study|Withdrawal by Subject|3|||
161742582|NCT01763866|584096111|FG006|Overall Study|Withdrawal by Subject|4|||
161742583|NCT01763866|584096112|FG007|Overall Study|Withdrawal by Subject|0|||
161742584|NCT01763866|584096113|FG008|Overall Study|Withdrawal by Subject|1|||
161742585|NCT01763866|584096114|FG009|Overall Study|Withdrawal by Subject|1|||
161742586|NCT01763866|584096115|FG010|Overall Study|Withdrawal by Subject|2|||
161742587|NCT01763866|584096116|FG011|Overall Study|Withdrawal by Subject|2|||
161742588|NCT01763866|584096117|FG012|Overall Study|Withdrawal by Subject|2|||
161742589|NCT01763866|584096118|FG013|Overall Study|Withdrawal by Subject|0|||
161742590|NCT01763866|584096119|FG014|Overall Study|Withdrawal by Subject|6|||
161742591|NCT01763866|584096120|FG015|Overall Study|Withdrawal by Subject|3|||
161742592|NCT01763866|584096121|FG016|Overall Study|Withdrawal by Subject|0|||
161742593|NCT01763866|584096122|FG017|Overall Study|Withdrawal by Subject|1|||
161742594|NCT01763866|584096123|FG018|Overall Study|Withdrawal by Subject|1|||
161742595|NCT01763866|584096124|FG019|Overall Study|Withdrawal by Subject|1|||
161742596|NCT01763866|584096125|FG020|Overall Study|Withdrawal by Subject|2|||
161742597|NCT01763866|584096126|FG021|Overall Study|Withdrawal by Subject|1|||
161742598|NCT01763866|584096127|FG022|Overall Study|Withdrawal by Subject|2|||
161742599|NCT01763866|584096128|FG023|Overall Study|Withdrawal by Subject|1|||
161742600|NCT01763866|584096105|FG000|Overall Study|Decision by sponsor|0|||
161742601|NCT01763866|584096106|FG001|Overall Study|Decision by sponsor|0|||
161742602|NCT01763866|584096107|FG002|Overall Study|Decision by sponsor|1|||
161742603|NCT01763866|584096108|FG003|Overall Study|Decision by sponsor|0|||
161742604|NCT01763866|584096109|FG004|Overall Study|Decision by sponsor|2|||
161742605|NCT01763866|584096110|FG005|Overall Study|Decision by sponsor|0|||
161742606|NCT01763866|584096111|FG006|Overall Study|Decision by sponsor|2|||
161742607|NCT01763866|584096112|FG007|Overall Study|Decision by sponsor|0|||
161742608|NCT01763866|584096113|FG008|Overall Study|Decision by sponsor|2|||
161742609|NCT01763866|584096114|FG009|Overall Study|Decision by sponsor|0|||
161742610|NCT01763866|584096115|FG010|Overall Study|Decision by sponsor|6|||
161742611|NCT01763866|584096116|FG011|Overall Study|Decision by sponsor|0|||
161841266|NCT04740814|584462942|FG000|Overall Study|Withdrawal by Subject|3|||
161841267|NCT00085423|584462943|FG000|Overall Study|Withdrawal by Subject|1|||
161841268|NCT00085423|584462943|FG000|Overall Study|screen failure|1|||
161841269|NCT02317614|584462949|FG000|Overall Study|Lost to Follow-up|1|||
161841270|NCT02317614|584462950|FG001|Overall Study|Lost to Follow-up|1|||
161966296|NCT02447250|584923582|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
161742612|NCT01763866|584096117|FG012|Overall Study|Decision by sponsor|1|||
161742613|NCT01763866|584096118|FG013|Overall Study|Decision by sponsor|0|||
161742614|NCT01763866|584096119|FG014|Overall Study|Decision by sponsor|5|||
161742615|NCT01763866|584096120|FG015|Overall Study|Decision by sponsor|0|||
161742616|NCT01763866|584096121|FG016|Overall Study|Decision by sponsor|0|||
161841271|NCT02317614|584462949|FG000|Overall Study|Withdrawal by Subject|1|||
161841272|NCT02317614|584462950|FG001|Overall Study|Withdrawal by Subject|0|||
161966297|NCT02447250|584923582|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
161966298|NCT02447250|584923582|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
161742617|NCT01763866|584096122|FG017|Overall Study|Decision by sponsor|0|||
161742618|NCT01763866|584096123|FG018|Overall Study|Decision by sponsor|4|||
161742619|NCT01763866|584096124|FG019|Overall Study|Decision by sponsor|0|||
161742620|NCT01763866|584096125|FG020|Overall Study|Decision by sponsor|2|||
161841273|NCT02317614|584462949|FG000|Overall Study|Death|1|||
161841274|NCT02317614|584462950|FG001|Overall Study|Death|1|||
161841275|NCT03285308|584462951|FG000|Overall Study|Adverse Event|3|||
161841276|NCT03285308|584462952|FG001|Overall Study|Adverse Event|7|||
161841277|NCT03285308|584462951|FG000|Overall Study|Withdrawal by Subject|8|||
161841278|NCT03285308|584462952|FG001|Overall Study|Withdrawal by Subject|9|||
161841279|NCT03285308|584462951|FG000|Overall Study|Lost to Follow-up|3|||
161841280|NCT03285308|584462952|FG001|Overall Study|Lost to Follow-up|1|||
161841281|NCT03285308|584462951|FG000|Overall Study|Protocol Deviation|6|||
161841282|NCT03285308|584462952|FG001|Overall Study|Protocol Deviation|5|||
161841283|NCT03285308|584462951|FG000|Overall Study|Reason not Specified|0|||
161841284|NCT03285308|584462952|FG001|Overall Study|Reason not Specified|1|||
161841285|NCT01910389|584462953|FG000|Overall Study|Withdrawal by Subject|2|||
161841286|NCT01910389|584462954|FG001|Overall Study|Withdrawal by Subject|0|||
161841287|NCT01910389|584462953|FG000|Overall Study|Study Closed|13|||
161841288|NCT01910389|584462954|FG001|Overall Study|Study Closed|8|||
161841289|NCT01898650|584462955|FG000|Overall Study|the subject would not lie still for imaging|1|||
161841290|NCT02912650|584462957|FG000|Overall Study|Withdrawal by Subject|1|||
161841291|NCT02912650|584462958|FG001|Overall Study|Withdrawal by Subject|0|||
161841292|NCT02912650|584462959|FG002|Overall Study|Withdrawal by Subject|1|||
161841293|NCT02912650|584462960|FG003|Overall Study|Withdrawal by Subject|5|||
161841294|NCT02912650|584462957|FG000|Overall Study|Adverse Event|0|||
161841295|NCT02912650|584462958|FG001|Overall Study|Adverse Event|0|||
161841296|NCT02912650|584462959|FG002|Overall Study|Adverse Event|1|||
161841297|NCT02912650|584462960|FG003|Overall Study|Adverse Event|0|||
161841298|NCT02357342|584462961|FG000|First 6 Months|Death|2|||
161841299|NCT02357342|584462962|FG001|First 6 Months|Death|0|||
161841300|NCT01674647|584462963|FG000|Treatment Period|Death|4|||
161841301|NCT01674647|584462964|FG001|Treatment Period|Death|1|||
161841302|NCT01674647|584462963|FG000|Treatment Period|Efficacy outcome reached|0|||
161841303|NCT01674647|584462964|FG001|Treatment Period|Efficacy outcome reached|1|||
161841304|NCT01674647|584462963|FG000|Treatment Period|Physician Decision|3|||
161841305|NCT01674647|584462964|FG001|Treatment Period|Physician Decision|1|||
161841306|NCT01674647|584462963|FG000|Treatment Period|Adverse Event|60|||
161841307|NCT01674647|584462964|FG001|Treatment Period|Adverse Event|22|||
161841308|NCT01674647|584462963|FG000|Treatment Period|Non-compliance with study drug|3|||
161841309|NCT01674647|584462964|FG001|Treatment Period|Non-compliance with study drug|0|||
161841310|NCT01674647|584462963|FG000|Treatment Period|Lost to Follow-up|1|||
161841311|NCT01674647|584462964|FG001|Treatment Period|Lost to Follow-up|1|||
161841312|NCT01674647|584462963|FG000|Treatment Period|Withdrawal by Subject|19|||
161841313|NCT01674647|584462964|FG001|Treatment Period|Withdrawal by Subject|16|||
161841314|NCT01674647|584462963|FG000|Treatment Period|Switching to other therapy|5|||
161841315|NCT01674647|584462964|FG001|Treatment Period|Switching to other therapy|2|||
161841316|NCT01674647|584462963|FG000|Treatment Period|Logistical difficulties|5|||
161841317|NCT01674647|584462964|FG001|Treatment Period|Logistical difficulties|8|||
161841318|NCT01674647|584462963|FG000|Treatment Period|Treatment failure|0|||
161841319|NCT01674647|584462964|FG001|Treatment Period|Treatment failure|14|||
161841320|NCT01674647|584462963|FG000|Treatment Period|Protocol Violation|56|||
161742621|NCT01763866|584096126|FG021|Overall Study|Decision by sponsor|0|||
161742622|NCT01763866|584096127|FG022|Overall Study|Decision by sponsor|1|||
161742623|NCT01763866|584096128|FG023|Overall Study|Decision by sponsor|0|||
161742624|NCT01763866|584096105|FG000|Overall Study|Lost to Follow-up|0|||
161742625|NCT01763866|584096106|FG001|Overall Study|Lost to Follow-up|0|||
161742626|NCT01763866|584096107|FG002|Overall Study|Lost to Follow-up|0|||
161742627|NCT01763866|584096108|FG003|Overall Study|Lost to Follow-up|0|||
161742628|NCT01763866|584096109|FG004|Overall Study|Lost to Follow-up|0|||
161742629|NCT01763866|584096110|FG005|Overall Study|Lost to Follow-up|0|||
161742630|NCT01763866|584096111|FG006|Overall Study|Lost to Follow-up|1|||
161742631|NCT01763866|584096112|FG007|Overall Study|Lost to Follow-up|0|||
161841321|NCT01674647|584462964|FG001|Treatment Period|Protocol Violation|36|||
161742632|NCT01763866|584096113|FG008|Overall Study|Lost to Follow-up|0|||
161742633|NCT01763866|584096114|FG009|Overall Study|Lost to Follow-up|0|||
161841322|NCT01674647|584462963|FG000|30-day Safety Follow-up Period|Death|3|||
161841323|NCT01674647|584462964|FG001|30-day Safety Follow-up Period|Death|2|||
161841324|NCT01674647|584462963|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
161841325|NCT01674647|584462964|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
161841326|NCT01674647|584462963|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
161841327|NCT01674647|584462964|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
161841328|NCT01674647|584462963|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
161841329|NCT01674647|584462964|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
161966299|NCT02743949|584923583|FG000|Overall Study|Adverse Event|0|||
161841330|NCT01674647|584462963|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
161841331|NCT01674647|584462964|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
161966300|NCT02743949|584923584|FG001|Overall Study|Adverse Event|0|||
161966301|NCT02743949|584923585|FG002|Overall Study|Adverse Event|2|||
161742634|NCT01763866|584096115|FG010|Overall Study|Lost to Follow-up|0|||
161841332|NCT01674647|584462963|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
161841333|NCT01674647|584462964|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
161841334|NCT01490866|584462965|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
161841335|NCT01490866|584462965|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
161841336|NCT01490866|584462965|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
161841337|NCT01490866|584462965|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
161841338|NCT01490866|584462965|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
161841339|NCT01490866|584462965|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
161841340|NCT01490866|584462965|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
161841341|NCT01490866|584462965|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
161841342|NCT01490866|584462965|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
161841343|NCT01490866|584462965|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
161841344|NCT01490866|584462965|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
161841345|NCT03923530|584462966|FG000|Overall Study|Withdrawal by Subject|1|||
161841346|NCT03923530|584462966|FG000|Overall Study|screen failure|3|||
161841347|NCT04135196|584462967|FG000|Overall Study|Lost to Follow-up|8|||
161841348|NCT04135196|584462968|FG001|Overall Study|Lost to Follow-up|7|||
161841349|NCT04135196|584462969|FG002|Overall Study|Lost to Follow-up|8|||
161841350|NCT04135196|584462970|FG003|Overall Study|Lost to Follow-up|9|||
161841351|NCT04135196|584462971|FG004|Overall Study|Lost to Follow-up|1|||
161841352|NCT04135196|584462967|FG000|Overall Study|Pregnancy|0|||
161841353|NCT04135196|584462968|FG001|Overall Study|Pregnancy|0|||
161841354|NCT04135196|584462969|FG002|Overall Study|Pregnancy|1|||
161841355|NCT04135196|584462970|FG003|Overall Study|Pregnancy|0|||
161841356|NCT04135196|584462971|FG004|Overall Study|Pregnancy|0|||
161841357|NCT04135196|584462967|FG000|Overall Study|Withdrawal by Subject|0|||
161841358|NCT04135196|584462968|FG001|Overall Study|Withdrawal by Subject|0|||
161841359|NCT04135196|584462969|FG002|Overall Study|Withdrawal by Subject|0|||
161841360|NCT04135196|584462970|FG003|Overall Study|Withdrawal by Subject|0|||
161841361|NCT04135196|584462971|FG004|Overall Study|Withdrawal by Subject|1|||
161841362|NCT00444457|584462973|FG000|Infant Series|Other|0|||
161841363|NCT00444457|584462974|FG001|Infant Series|Other|1|||
161841364|NCT00444457|584462975|FG002|Infant Series|Other|0|||
161841365|NCT00444457|584462976|FG003|Infant Series|Other|0|||
161841366|NCT00444457|584462973|FG000|Infant Series|Parent or legal guardian request|18|||
161841367|NCT00444457|584462974|FG001|Infant Series|Parent or legal guardian request|29|||
161841368|NCT00444457|584462975|FG002|Infant Series|Parent or legal guardian request|34|||
161841369|NCT00444457|584462976|FG003|Infant Series|Parent or legal guardian request|14|||
161841370|NCT00444457|584462973|FG000|Infant Series|Lost to Follow-up|10|||
161841371|NCT00444457|584462974|FG001|Infant Series|Lost to Follow-up|11|||
161841372|NCT00444457|584462975|FG002|Infant Series|Lost to Follow-up|7|||
161841373|NCT00444457|584462976|FG003|Infant Series|Lost to Follow-up|6|||
161841374|NCT00444457|584462973|FG000|Infant Series|Protocol Violation|16|||
161841375|NCT00444457|584462974|FG001|Infant Series|Protocol Violation|8|||
161841376|NCT00444457|584462975|FG002|Infant Series|Protocol Violation|6|||
161841377|NCT00444457|584462976|FG003|Infant Series|Protocol Violation|3|||
161841378|NCT00444457|584462973|FG000|Infant Series|Failed to return|5|||
161841379|NCT00444457|584462974|FG001|Infant Series|Failed to return|4|||
161841380|NCT00444457|584462975|FG002|Infant Series|Failed to return|4|||
161841381|NCT00444457|584462976|FG003|Infant Series|Failed to return|2|||
161841382|NCT00444457|584462973|FG000|Infant Series|Investigator request|4|||
161841383|NCT00444457|584462974|FG001|Infant Series|Investigator request|3|||
161841384|NCT00444457|584462975|FG002|Infant Series|Investigator request|3|||
161841385|NCT00444457|584462976|FG003|Infant Series|Investigator request|2|||
161841386|NCT00444457|584462973|FG000|Infant Series|Other|0|||
161841387|NCT00444457|584462974|FG001|Infant Series|Other|2|||
161841388|NCT00444457|584462975|FG002|Infant Series|Other|4|||
161841389|NCT00444457|584462976|FG003|Infant Series|Other|0|||
161841390|NCT00444457|584462973|FG000|Infant Series|Adverse Event|1|||
161841391|NCT00444457|584462974|FG001|Infant Series|Adverse Event|2|||
161841392|NCT00444457|584462975|FG002|Infant Series|Adverse Event|2|||
161841393|NCT00444457|584462976|FG003|Infant Series|Adverse Event|0|||
161841394|NCT00444457|584462973|FG000|Infant Series|Death|0|||
161841395|NCT00444457|584462974|FG001|Infant Series|Death|1|||
161841396|NCT00444457|584462975|FG002|Infant Series|Death|1|||
161841397|NCT00444457|584462976|FG003|Infant Series|Death|1|||
161841398|NCT00444457|584462973|FG000|After Infant Series|Other|0|||
161841399|NCT00444457|584462974|FG001|After Infant Series|Other|1|||
161841400|NCT00444457|584462975|FG002|After Infant Series|Other|1|||
161841401|NCT00444457|584462976|FG003|After Infant Series|Other|1|||
161841402|NCT00444457|584462973|FG000|After Infant Series|Parent or legal guardian request|4|||
161841403|NCT00444457|584462974|FG001|After Infant Series|Parent or legal guardian request|11|||
161841404|NCT00444457|584462975|FG002|After Infant Series|Parent or legal guardian request|6|||
161841405|NCT00444457|584462976|FG003|After Infant Series|Parent or legal guardian request|3|||
161841406|NCT00444457|584462973|FG000|After Infant Series|Failed to return|7|||
161841407|NCT00444457|584462974|FG001|After Infant Series|Failed to return|6|||
161841408|NCT00444457|584462975|FG002|After Infant Series|Failed to return|5|||
161841409|NCT00444457|584462976|FG003|After Infant Series|Failed to return|1|||
161841410|NCT00444457|584462973|FG000|After Infant Series|Lost to Follow-up|5|||
161841411|NCT00444457|584462974|FG001|After Infant Series|Lost to Follow-up|5|||
161841412|NCT00444457|584462975|FG002|After Infant Series|Lost to Follow-up|5|||
161841413|NCT00444457|584462976|FG003|After Infant Series|Lost to Follow-up|2|||
161841414|NCT00444457|584462973|FG000|After Infant Series|Protocol Violation|2|||
161841415|NCT00444457|584462974|FG001|After Infant Series|Protocol Violation|4|||
161841416|NCT00444457|584462975|FG002|After Infant Series|Protocol Violation|2|||
161841417|NCT00444457|584462976|FG003|After Infant Series|Protocol Violation|2|||
161841418|NCT00444457|584462973|FG000|After Infant Series|Adverse Event|2|||
161841419|NCT00444457|584462974|FG001|After Infant Series|Adverse Event|2|||
161841420|NCT00444457|584462975|FG002|After Infant Series|Adverse Event|0|||
161841421|NCT00444457|584462976|FG003|After Infant Series|Adverse Event|0|||
161841422|NCT00444457|584462973|FG000|After Infant Series|Investigator request|0|||
161841423|NCT00444457|584462974|FG001|After Infant Series|Investigator request|0|||
161841424|NCT00444457|584462975|FG002|After Infant Series|Investigator request|0|||
161841425|NCT00444457|584462976|FG003|After Infant Series|Investigator request|1|||
161841426|NCT00444457|584462973|FG000|After Infant Series|Other|0|||
161841427|NCT00444457|584462974|FG001|After Infant Series|Other|1|||
161841428|NCT00444457|584462975|FG002|After Infant Series|Other|0|||
161841429|NCT00444457|584462976|FG003|After Infant Series|Other|0|||
161841430|NCT00444457|584462973|FG000|Toddler Dose|Lost to Follow-up|4|||
161841431|NCT00444457|584462974|FG001|Toddler Dose|Lost to Follow-up|1|||
161841432|NCT00444457|584462975|FG002|Toddler Dose|Lost to Follow-up|1|||
161841433|NCT00444457|584462976|FG003|Toddler Dose|Lost to Follow-up|3|||
161841434|NCT00444457|584462973|FG000|Toddler Dose|Failed to return|2|||
161841435|NCT00444457|584462974|FG001|Toddler Dose|Failed to return|2|||
161841436|NCT00444457|584462975|FG002|Toddler Dose|Failed to return|1|||
161841437|NCT00444457|584462976|FG003|Toddler Dose|Failed to return|3|||
161841438|NCT00444457|584462973|FG000|Toddler Dose|Parent or legal guardian request|0|||
161841439|NCT00444457|584462974|FG001|Toddler Dose|Parent or legal guardian request|3|||
161841440|NCT00444457|584462975|FG002|Toddler Dose|Parent or legal guardian request|2|||
161841441|NCT00444457|584462976|FG003|Toddler Dose|Parent or legal guardian request|1|||
161841442|NCT00444457|584462973|FG000|Toddler Dose|Protocol Violation|1|||
161841443|NCT00444457|584462974|FG001|Toddler Dose|Protocol Violation|0|||
161841444|NCT00444457|584462975|FG002|Toddler Dose|Protocol Violation|0|||
161841445|NCT00444457|584462976|FG003|Toddler Dose|Protocol Violation|1|||
161841446|NCT01946191|584462977|FG000|Allocation|Did not complete orientation|1|||
161841447|NCT01946191|584462978|FG001|Allocation|Did not complete orientation|1|||
161841448|NCT01946191|584462977|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
161841449|NCT01946191|584462978|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
161841450|NCT01946191|584462977|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
161841451|NCT01946191|584462978|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
161841452|NCT01946191|584462977|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
161841453|NCT01946191|584462978|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
161841454|NCT02799095|584466179|FG000|Part A|Adverse Event|1|||
161841455|NCT02799095|584466180|FG001|Part A|Adverse Event|0|||
161841456|NCT02799095|584466181|FG002|Part A|Adverse Event|1|||
161742635|NCT01763866|584096116|FG011|Overall Study|Lost to Follow-up|0|||
161742636|NCT01763866|584096117|FG012|Overall Study|Lost to Follow-up|1|||
161742637|NCT01763866|584096118|FG013|Overall Study|Lost to Follow-up|0|||
161742638|NCT01763866|584096119|FG014|Overall Study|Lost to Follow-up|1|||
161742639|NCT01763866|584096120|FG015|Overall Study|Lost to Follow-up|0|||
161742640|NCT01763866|584096121|FG016|Overall Study|Lost to Follow-up|0|||
161742641|NCT01763866|584096122|FG017|Overall Study|Lost to Follow-up|0|||
161742642|NCT01763866|584096123|FG018|Overall Study|Lost to Follow-up|1|||
161742643|NCT01763866|584096124|FG019|Overall Study|Lost to Follow-up|1|||
161841457|NCT02799095|584466182|FG003|Part A|Adverse Event|4|||
161841458|NCT02799095|584466183|FG004|Part A|Adverse Event|1|||
161841459|NCT02799095|584466184|FG005|Part A|Adverse Event|0|||
161841460|NCT02799095|584466185|FG006|Part A|Adverse Event|0|||
161841461|NCT02799095|584466186|FG007|Part A|Adverse Event|0|||
161841462|NCT02799095|584466187|FG008|Part A|Adverse Event|0|||
161841463|NCT02799095|584466188|FG009|Part A|Adverse Event|0|||
161841464|NCT02799095|584466189|FG010|Part A|Adverse Event|0|||
161841465|NCT02799095|584466190|FG011|Part A|Adverse Event|0|||
161841466|NCT02799095|584466191|FG012|Part A|Adverse Event|0|||
161841467|NCT02799095|584466192|FG013|Part A|Adverse Event|0|||
161742644|NCT01763866|584096125|FG020|Overall Study|Lost to Follow-up|0|||
161742645|NCT01763866|584096126|FG021|Overall Study|Lost to Follow-up|0|||
161742646|NCT01763866|584096127|FG022|Overall Study|Lost to Follow-up|0|||
161841468|NCT02799095|584466193|FG014|Part A|Adverse Event|0|||
161841469|NCT02799095|584466194|FG015|Part A|Adverse Event|0|||
161841470|NCT02799095|584466195|FG016|Part A|Adverse Event|0|||
161742647|NCT01763866|584096128|FG023|Overall Study|Lost to Follow-up|1|||
161841471|NCT02799095|584466179|FG000|Part A|Death|0|||
161841472|NCT02799095|584466180|FG001|Part A|Death|0|||
161841473|NCT02799095|584466181|FG002|Part A|Death|0|||
161841474|NCT02799095|584466182|FG003|Part A|Death|0|||
161841475|NCT02799095|584466183|FG004|Part A|Death|0|||
161841476|NCT02799095|584466184|FG005|Part A|Death|0|||
161841477|NCT02799095|584466185|FG006|Part A|Death|3|||
161742648|NCT01763866|584096105|FG000|Overall Study|Death|0|||
161742649|NCT01763866|584096106|FG001|Overall Study|Death|0|||
161742650|NCT01763866|584096107|FG002|Overall Study|Death|0|||
161742651|NCT01763866|584096108|FG003|Overall Study|Death|0|||
161742652|NCT01763866|584096109|FG004|Overall Study|Death|0|||
161742653|NCT01763866|584096110|FG005|Overall Study|Death|0|||
161742654|NCT01763866|584096111|FG006|Overall Study|Death|0|||
161742655|NCT01763866|584096112|FG007|Overall Study|Death|0|||
161742656|NCT01763866|584096113|FG008|Overall Study|Death|0|||
161742657|NCT01763866|584096114|FG009|Overall Study|Death|0|||
161742658|NCT01763866|584096115|FG010|Overall Study|Death|0|||
161742659|NCT01763866|584096116|FG011|Overall Study|Death|0|||
161742660|NCT01763866|584096117|FG012|Overall Study|Death|0|||
161742661|NCT01763866|584096118|FG013|Overall Study|Death|0|||
161742662|NCT01763866|584096119|FG014|Overall Study|Death|0|||
161742663|NCT01763866|584096120|FG015|Overall Study|Death|0|||
161742664|NCT01763866|584096121|FG016|Overall Study|Death|1|||
161742665|NCT01763866|584096122|FG017|Overall Study|Death|0|||
161742666|NCT01763866|584096123|FG018|Overall Study|Death|0|||
161742667|NCT01763866|584096124|FG019|Overall Study|Death|0|||
161742668|NCT01763866|584096125|FG020|Overall Study|Death|0|||
161742669|NCT01763866|584096126|FG021|Overall Study|Death|0|||
161742670|NCT01763866|584096127|FG022|Overall Study|Death|0|||
161742671|NCT01763866|584096128|FG023|Overall Study|Death|0|||
161742672|NCT00093470|584097860|FG000|Overall Study|Disease progression|39|||
161742673|NCT00093470|584097861|FG001|Overall Study|Disease progression|0|||
161742674|NCT00093470|584097860|FG000|Overall Study|Adverse Event|15|||
161742675|NCT00093470|584097861|FG001|Overall Study|Adverse Event|0|||
161742676|NCT00093470|584097860|FG000|Overall Study|Death|2|||
161742677|NCT00093470|584097861|FG001|Overall Study|Death|0|||
161742678|NCT00093470|584097860|FG000|Overall Study|Withdrawal by Subject|8|||
161742679|NCT00093470|584097861|FG001|Overall Study|Withdrawal by Subject|0|||
161742680|NCT00093470|584097860|FG000|Overall Study|Alternative therapy|2|||
161742681|NCT00093470|584097861|FG001|Overall Study|Alternative therapy|0|||
161742682|NCT00093470|584097860|FG000|Overall Study|Other complicating disease|3|||
161742683|NCT00093470|584097861|FG001|Overall Study|Other complicating disease|0|||
161742684|NCT00093470|584097860|FG000|Overall Study|Physician Decision|2|||
161742685|NCT00093470|584097861|FG001|Overall Study|Physician Decision|0|||
161742686|NCT00093470|584097860|FG000|Overall Study|Never started treatment|1|||
161742687|NCT00093470|584097861|FG001|Overall Study|Never started treatment|0|||
161742688|NCT00093470|584097860|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
161742689|NCT00093470|584097861|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
161742690|NCT01019252|584097862|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
161742691|NCT01019252|584097863|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
161742692|NCT01019252|584097862|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
161742693|NCT01019252|584097863|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
161742694|NCT01019252|584097862|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
161742695|NCT01019252|584097863|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
161742696|NCT01019252|584097862|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
161742697|NCT01019252|584097863|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
161742698|NCT02514772|584097864|FG000|Overall Study|Adverse Event|1|||
161742699|NCT02514772|584097865|FG001|Overall Study|Adverse Event|0|||
161742700|NCT02514772|584097864|FG000|Overall Study|Death|0|||
161742701|NCT02514772|584097865|FG001|Overall Study|Death|1|||
161742702|NCT02514772|584097864|FG000|Overall Study|Withdrawal by Subject|2|||
161742703|NCT02514772|584097865|FG001|Overall Study|Withdrawal by Subject|1|||
161742704|NCT00877006|584097866|FG000|Treatment Period|Death|2|||
161742705|NCT00877006|584097867|FG001|Treatment Period|Death|1|||
161742706|NCT00877006|584097866|FG000|Treatment Period|Adverse Event|10|||
161742707|NCT00877006|584097867|FG001|Treatment Period|Adverse Event|3|||
161742708|NCT00877006|584097866|FG000|Treatment Period|Withdrawal by Subject|2|||
161742709|NCT00877006|584097867|FG001|Treatment Period|Withdrawal by Subject|3|||
161742710|NCT00877006|584097866|FG000|Treatment Period|Protocol Violation|1|||
161742711|NCT00877006|584097867|FG001|Treatment Period|Protocol Violation|0|||
161742712|NCT00877006|584097866|FG000|Treatment Period|Lost to Follow-up|0|||
161742713|NCT00877006|584097867|FG001|Treatment Period|Lost to Follow-up|1|||
161742714|NCT00877006|584097866|FG000|Treatment Period|Disease Progression|1|||
161742715|NCT00877006|584097867|FG001|Treatment Period|Disease Progression|2|||
161742716|NCT00877006|584097866|FG000|Treatment Period|Started New Treatment Regimen|2|||
161742717|NCT00877006|584097867|FG001|Treatment Period|Started New Treatment Regimen|5|||
161742718|NCT00877006|584097866|FG000|Treatment Period|Other|4|||
161742719|NCT00877006|584097867|FG001|Treatment Period|Other|4|||
161742720|NCT00877006|584097866|FG000|Treatment Period|Randomized but Not Treated|3|||
161742721|NCT00877006|584097867|FG001|Treatment Period|Randomized but Not Treated|8|||
161742722|NCT00877006|584097866|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
161742723|NCT00877006|584097867|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
161742724|NCT00877006|584097866|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
161742725|NCT00877006|584097867|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
161742726|NCT00877006|584097866|FG000|Long-Term Follow-up Period|Death|26|||
161841478|NCT02799095|584466186|FG007|Part A|Death|0|||
161841479|NCT02799095|584466187|FG008|Part A|Death|0|||
161841480|NCT02799095|584466188|FG009|Part A|Death|0|||
161841481|NCT02799095|584466189|FG010|Part A|Death|0|||
161841482|NCT02799095|584466190|FG011|Part A|Death|0|||
161841483|NCT02799095|584466191|FG012|Part A|Death|0|||
161841484|NCT02799095|584466192|FG013|Part A|Death|0|||
161841485|NCT02799095|584466193|FG014|Part A|Death|0|||
161841486|NCT02799095|584466194|FG015|Part A|Death|0|||
161841487|NCT02799095|584466195|FG016|Part A|Death|0|||
161841488|NCT02799095|584466179|FG000|Part A|Lost to Follow-up|0|||
161841489|NCT02799095|584466180|FG001|Part A|Lost to Follow-up|1|||
161841490|NCT02799095|584466181|FG002|Part A|Lost to Follow-up|0|||
161841491|NCT02799095|584466182|FG003|Part A|Lost to Follow-up|0|||
161841492|NCT02799095|584466183|FG004|Part A|Lost to Follow-up|0|||
161841493|NCT02799095|584466184|FG005|Part A|Lost to Follow-up|0|||
161841494|NCT02799095|584466185|FG006|Part A|Lost to Follow-up|1|||
161841495|NCT02799095|584466186|FG007|Part A|Lost to Follow-up|0|||
161742727|NCT00877006|584097867|FG001|Long-Term Follow-up Period|Death|18|||
161742728|NCT00877006|584097866|FG000|Long-Term Follow-up Period|Other|7|||
161742729|NCT00877006|584097867|FG001|Long-Term Follow-up Period|Other|9|||
161742730|NCT04671342|584097868|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
161742731|NCT04671342|584097868|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
161742732|NCT04671342|584097868|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
161742733|NCT04671342|584097868|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
161742734|NCT04671342|584097868|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
161742735|NCT04671342|584097868|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
161742736|NCT03583606|584097869|FG000|Overall Study|Lost to Follow-up|0|||
161742737|NCT03583606|584097870|FG001|Overall Study|Lost to Follow-up|1|||
161742738|NCT03583606|584097871|FG002|Overall Study|Lost to Follow-up|0|||
161742739|NCT03583606|584097869|FG000|Overall Study|Ineligible at baseline|1|||
161742740|NCT03583606|584097870|FG001|Overall Study|Ineligible at baseline|0|||
161742741|NCT03583606|584097871|FG002|Overall Study|Ineligible at baseline|0|||
161742742|NCT00817206|584097872|FG000|Overall Study|Adverse Event|10|||
161742743|NCT00817206|584097873|FG001|Overall Study|Adverse Event|3|||
161742744|NCT00817206|584097872|FG000|Overall Study|Protocol Violation|0|||
161742745|NCT00817206|584097873|FG001|Overall Study|Protocol Violation|2|||
161742746|NCT00817206|584097872|FG000|Overall Study|Lost to Follow-up|0|||
161742747|NCT00817206|584097873|FG001|Overall Study|Lost to Follow-up|1|||
161742748|NCT00817206|584097872|FG000|Overall Study|Death|2|||
161742749|NCT00817206|584097873|FG001|Overall Study|Death|0|||
161742750|NCT00817206|584097872|FG000|Overall Study|Withdrawal by Subject|7|||
161742751|NCT00817206|584097873|FG001|Overall Study|Withdrawal by Subject|3|||
161742752|NCT00817206|584097872|FG000|Overall Study|Physician Decision|2|||
161742753|NCT00817206|584097873|FG001|Overall Study|Physician Decision|0|||
161742754|NCT00126581|584097874|FG000|Overall Study|Adverse Event|3|||
161742755|NCT00126581|584097875|FG001|Overall Study|Adverse Event|7|||
161742756|NCT00126581|584097874|FG000|Overall Study|Death|3|||
161742757|NCT00126581|584097875|FG001|Overall Study|Death|2|||
161742758|NCT00126581|584097874|FG000|Overall Study|Withdrawal by Subject|1|||
161742759|NCT00126581|584097875|FG001|Overall Study|Withdrawal by Subject|4|||
161742760|NCT00126581|584097874|FG000|Overall Study|Alternative therapy|3|||
161742761|NCT00126581|584097875|FG001|Overall Study|Alternative therapy|3|||
161742762|NCT00126581|584097874|FG000|Overall Study|Other illness/MD discretion|3|||
161742763|NCT00126581|584097875|FG001|Overall Study|Other illness/MD discretion|4|||
161742764|NCT00793182|584097876|FG000|Overall Study|Adverse Event|0|||
161742765|NCT00793182|584097877|FG001|Overall Study|Adverse Event|1|||
161742766|NCT03728140|584097878|FG000|Overall Study|Abnormal embryo transfer operation|10|||
161742767|NCT03728140|584097879|FG001|Overall Study|Abnormal embryo transfer operation|7|||
161742768|NCT02273037|584097881|FG000|Overall Study|Lost to Follow-up|1|||
161742769|NCT02273037|584097882|FG001|Overall Study|Lost to Follow-up|0|||
161742770|NCT02273037|584097881|FG000|Overall Study|Delivered before monitoring initiated|1|||
161742771|NCT02273037|584097882|FG001|Overall Study|Delivered before monitoring initiated|3|||
161742772|NCT02273037|584097881|FG000|Overall Study|Breech delivery|2|||
161742773|NCT02273037|584097882|FG001|Overall Study|Breech delivery|3|||
161742774|NCT02273037|584097881|FG000|Overall Study|Multiple delivery|2|||
161742775|NCT02273037|584097882|FG001|Overall Study|Multiple delivery|2|||
161742776|NCT02273037|584097881|FG000|Overall Study|Other complication|2|||
161742777|NCT02273037|584097882|FG001|Overall Study|Other complication|0|||
161742778|NCT00851253|584097883|FG000|Overall Study|Disease Progression|1|||
161742779|NCT00851253|584097884|FG001|Overall Study|Disease Progression|0|||
161841496|NCT02799095|584466187|FG008|Part A|Lost to Follow-up|0|||
161841497|NCT02799095|584466188|FG009|Part A|Lost to Follow-up|0|||
161841498|NCT02799095|584466189|FG010|Part A|Lost to Follow-up|0|||
161841499|NCT02799095|584466190|FG011|Part A|Lost to Follow-up|0|||
161841500|NCT02799095|584466191|FG012|Part A|Lost to Follow-up|0|||
161841501|NCT02799095|584466192|FG013|Part A|Lost to Follow-up|0|||
161841502|NCT02799095|584466193|FG014|Part A|Lost to Follow-up|0|||
161841503|NCT02799095|584466194|FG015|Part A|Lost to Follow-up|0|||
161841504|NCT02799095|584466195|FG016|Part A|Lost to Follow-up|0|||
161841505|NCT02799095|584466179|FG000|Part A|Progressive Disease|3|||
161841506|NCT02799095|584466180|FG001|Part A|Progressive Disease|3|||
161841507|NCT02799095|584466181|FG002|Part A|Progressive Disease|3|||
161841508|NCT02799095|584466182|FG003|Part A|Progressive Disease|2|||
161841509|NCT02799095|584466183|FG004|Part A|Progressive Disease|2|||
161841510|NCT02799095|584466184|FG005|Part A|Progressive Disease|0|||
161841511|NCT02799095|584466185|FG006|Part A|Progressive Disease|0|||
161841512|NCT02799095|584466186|FG007|Part A|Progressive Disease|0|||
161841513|NCT02799095|584466187|FG008|Part A|Progressive Disease|0|||
161841514|NCT02799095|584466188|FG009|Part A|Progressive Disease|0|||
161841515|NCT02799095|584466189|FG010|Part A|Progressive Disease|0|||
161841516|NCT02799095|584466190|FG011|Part A|Progressive Disease|0|||
161841517|NCT02799095|584466191|FG012|Part A|Progressive Disease|0|||
161841518|NCT02799095|584466192|FG013|Part A|Progressive Disease|0|||
161841519|NCT02799095|584466193|FG014|Part A|Progressive Disease|0|||
161841520|NCT02799095|584466194|FG015|Part A|Progressive Disease|0|||
161841521|NCT02799095|584466195|FG016|Part A|Progressive Disease|0|||
161841522|NCT02799095|584466179|FG000|Part A|Clinical Progression|1|||
161841523|NCT02799095|584466180|FG001|Part A|Clinical Progression|0|||
161841524|NCT02799095|584466181|FG002|Part A|Clinical Progression|2|||
161841525|NCT02799095|584466182|FG003|Part A|Clinical Progression|1|||
161841526|NCT02799095|584466183|FG004|Part A|Clinical Progression|5|||
161841527|NCT02799095|584466184|FG005|Part A|Clinical Progression|0|||
161841528|NCT02799095|584466185|FG006|Part A|Clinical Progression|0|||
161841529|NCT02799095|584466186|FG007|Part A|Clinical Progression|0|||
161841530|NCT02799095|584466187|FG008|Part A|Clinical Progression|0|||
161841531|NCT02799095|584466188|FG009|Part A|Clinical Progression|0|||
161841532|NCT02799095|584466189|FG010|Part A|Clinical Progression|0|||
161841533|NCT02799095|584466190|FG011|Part A|Clinical Progression|0|||
161841534|NCT02799095|584466191|FG012|Part A|Clinical Progression|0|||
161841535|NCT02799095|584466192|FG013|Part A|Clinical Progression|0|||
161841536|NCT02799095|584466193|FG014|Part A|Clinical Progression|0|||
161841537|NCT02799095|584466194|FG015|Part A|Clinical Progression|0|||
161841538|NCT02799095|584466195|FG016|Part A|Clinical Progression|0|||
161841539|NCT02799095|584466179|FG000|Part A|Protocol Deviation|0|||
161841540|NCT02799095|584466180|FG001|Part A|Protocol Deviation|0|||
161841541|NCT02799095|584466181|FG002|Part A|Protocol Deviation|1|||
161841542|NCT02799095|584466182|FG003|Part A|Protocol Deviation|0|||
161841543|NCT02799095|584466183|FG004|Part A|Protocol Deviation|0|||
161841544|NCT02799095|584466184|FG005|Part A|Protocol Deviation|0|||
161841545|NCT02799095|584466185|FG006|Part A|Protocol Deviation|0|||
161841546|NCT02799095|584466186|FG007|Part A|Protocol Deviation|0|||
161841547|NCT02799095|584466187|FG008|Part A|Protocol Deviation|0|||
161841548|NCT02799095|584466188|FG009|Part A|Protocol Deviation|0|||
161841549|NCT02799095|584466189|FG010|Part A|Protocol Deviation|0|||
161841550|NCT02799095|584466190|FG011|Part A|Protocol Deviation|0|||
161841551|NCT02799095|584466191|FG012|Part A|Protocol Deviation|0|||
161841552|NCT02799095|584466192|FG013|Part A|Protocol Deviation|0|||
161841553|NCT02799095|584466193|FG014|Part A|Protocol Deviation|0|||
161841554|NCT02799095|584466194|FG015|Part A|Protocol Deviation|0|||
161841555|NCT02799095|584466195|FG016|Part A|Protocol Deviation|0|||
161841556|NCT02799095|584466179|FG000|Part A|Withdrawal by Subject|0|||
162032474|NCT03422627|585177400|FG001|Overall Study|Ineligibility Determined|1|||
162032475|NCT03422627|585177401|FG002|Overall Study|Ineligibility Determined|0|||
161841557|NCT02799095|584466180|FG001|Part A|Withdrawal by Subject|0|||
161841558|NCT02799095|584466181|FG002|Part A|Withdrawal by Subject|0|||
161841559|NCT02799095|584466182|FG003|Part A|Withdrawal by Subject|1|||
161841560|NCT02799095|584466183|FG004|Part A|Withdrawal by Subject|3|||
161841561|NCT02799095|584466184|FG005|Part A|Withdrawal by Subject|1|||
161841562|NCT02799095|584466185|FG006|Part A|Withdrawal by Subject|1|||
161841563|NCT02799095|584466186|FG007|Part A|Withdrawal by Subject|0|||
161841564|NCT02799095|584466187|FG008|Part A|Withdrawal by Subject|0|||
161841565|NCT02799095|584466188|FG009|Part A|Withdrawal by Subject|0|||
161841566|NCT02799095|584466189|FG010|Part A|Withdrawal by Subject|0|||
161841567|NCT02799095|584466190|FG011|Part A|Withdrawal by Subject|0|||
161841568|NCT02799095|584466191|FG012|Part A|Withdrawal by Subject|0|||
161841569|NCT02799095|584466192|FG013|Part A|Withdrawal by Subject|0|||
161841570|NCT02799095|584466193|FG014|Part A|Withdrawal by Subject|0|||
161841571|NCT02799095|584466194|FG015|Part A|Withdrawal by Subject|0|||
161841572|NCT02799095|584466195|FG016|Part A|Withdrawal by Subject|0|||
161841573|NCT02799095|584466179|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
161841574|NCT02799095|584466180|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
161841575|NCT02799095|584466181|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
161841576|NCT02799095|584466182|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
161841577|NCT02799095|584466183|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
162032476|NCT03422627|585177402|FG003|Overall Study|Ineligibility Determined|0|||
161841578|NCT02799095|584466184|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
161841579|NCT02799095|584466185|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
161841580|NCT02799095|584466186|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
161841581|NCT02799095|584466187|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
161841582|NCT02799095|584466188|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
161841583|NCT02799095|584466189|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
161841584|NCT02799095|584466190|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
161841585|NCT02799095|584466191|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
161841586|NCT02799095|584466192|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
161841587|NCT02799095|584466193|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
161841588|NCT02799095|584466194|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
161841589|NCT02799095|584466195|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
161841590|NCT02799095|584466179|FG000|Part B|Death|0|||
161841591|NCT02799095|584466180|FG001|Part B|Death|0|||
161841592|NCT02799095|584466181|FG002|Part B|Death|0|||
161841593|NCT02799095|584466182|FG003|Part B|Death|0|||
161841594|NCT02799095|584466183|FG004|Part B|Death|0|||
161841595|NCT02799095|584466184|FG005|Part B|Death|0|||
161841596|NCT02799095|584466185|FG006|Part B|Death|0|||
161841597|NCT02799095|584466186|FG007|Part B|Death|7|||
161841598|NCT02799095|584466187|FG008|Part B|Death|7|||
161841599|NCT02799095|584466188|FG009|Part B|Death|0|||
161841600|NCT02799095|584466189|FG010|Part B|Death|0|||
161841601|NCT02799095|584466190|FG011|Part B|Death|0|||
161841602|NCT02799095|584466191|FG012|Part B|Death|0|||
161841603|NCT02799095|584466192|FG013|Part B|Death|0|||
161841604|NCT02799095|584466193|FG014|Part B|Death|0|||
161841605|NCT02799095|584466194|FG015|Part B|Death|0|||
161841606|NCT02799095|584466195|FG016|Part B|Death|0|||
161841607|NCT02799095|584466179|FG000|Part B|Progressive Disease|0|||
161841608|NCT02799095|584466180|FG001|Part B|Progressive Disease|0|||
161841609|NCT02799095|584466181|FG002|Part B|Progressive Disease|0|||
161841610|NCT02799095|584466182|FG003|Part B|Progressive Disease|0|||
161841611|NCT02799095|584466183|FG004|Part B|Progressive Disease|0|||
161841612|NCT02799095|584466184|FG005|Part B|Progressive Disease|0|||
161841613|NCT02799095|584466185|FG006|Part B|Progressive Disease|0|||
161841614|NCT02799095|584466186|FG007|Part B|Progressive Disease|1|||
161841615|NCT02799095|584466187|FG008|Part B|Progressive Disease|0|||
161841616|NCT02799095|584466188|FG009|Part B|Progressive Disease|0|||
161841617|NCT02799095|584466189|FG010|Part B|Progressive Disease|0|||
161841618|NCT02799095|584466190|FG011|Part B|Progressive Disease|0|||
161841619|NCT02799095|584466191|FG012|Part B|Progressive Disease|0|||
161841620|NCT02799095|584466192|FG013|Part B|Progressive Disease|0|||
161841621|NCT02799095|584466193|FG014|Part B|Progressive Disease|0|||
161841622|NCT02799095|584466194|FG015|Part B|Progressive Disease|0|||
161841623|NCT02799095|584466195|FG016|Part B|Progressive Disease|0|||
161841624|NCT02799095|584466179|FG000|Part B|Withdrawal by Subject|0|||
161841625|NCT02799095|584466180|FG001|Part B|Withdrawal by Subject|0|||
161841626|NCT02799095|584466181|FG002|Part B|Withdrawal by Subject|0|||
161841627|NCT02799095|584466182|FG003|Part B|Withdrawal by Subject|0|||
161841628|NCT02799095|584466183|FG004|Part B|Withdrawal by Subject|0|||
161841629|NCT02799095|584466184|FG005|Part B|Withdrawal by Subject|0|||
161841630|NCT02799095|584466185|FG006|Part B|Withdrawal by Subject|0|||
161841631|NCT02799095|584466186|FG007|Part B|Withdrawal by Subject|10|||
161841632|NCT02799095|584466187|FG008|Part B|Withdrawal by Subject|7|||
161841633|NCT02799095|584466188|FG009|Part B|Withdrawal by Subject|0|||
161841634|NCT02799095|584466189|FG010|Part B|Withdrawal by Subject|0|||
161841635|NCT02799095|584466190|FG011|Part B|Withdrawal by Subject|0|||
161841636|NCT02799095|584466191|FG012|Part B|Withdrawal by Subject|0|||
161841637|NCT02799095|584466192|FG013|Part B|Withdrawal by Subject|0|||
161841638|NCT02799095|584466193|FG014|Part B|Withdrawal by Subject|0|||
161841639|NCT02799095|584466194|FG015|Part B|Withdrawal by Subject|0|||
161841640|NCT02799095|584466195|FG016|Part B|Withdrawal by Subject|0|||
161841641|NCT02799095|584466179|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
161841642|NCT02799095|584466180|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
161841643|NCT02799095|584466181|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
161841644|NCT02799095|584466182|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
161841645|NCT02799095|584466183|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
161841646|NCT02799095|584466184|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
161841647|NCT02799095|584466185|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
161841648|NCT02799095|584466186|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
162032477|NCT03422627|585177403|FG004|Overall Study|Ineligibility Determined|0|||
161841649|NCT02799095|584466187|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
161841650|NCT02799095|584466188|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
161841651|NCT02799095|584466189|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
161841652|NCT02799095|584466190|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
161841653|NCT02799095|584466191|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
162032478|NCT03422627|585177399|FG000|Overall Study|Death|0|||
161841654|NCT02799095|584466192|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
161841655|NCT02799095|584466193|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
161841656|NCT02799095|584466194|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
161841657|NCT02799095|584466195|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
161841658|NCT02799095|584466179|FG000|Part C|Adverse Event|0|||
161841659|NCT02799095|584466180|FG001|Part C|Adverse Event|0|||
161841660|NCT02799095|584466181|FG002|Part C|Adverse Event|0|||
161841661|NCT02799095|584466182|FG003|Part C|Adverse Event|0|||
161841662|NCT02799095|584466183|FG004|Part C|Adverse Event|0|||
161841663|NCT02799095|584466184|FG005|Part C|Adverse Event|0|||
161841664|NCT02799095|584466185|FG006|Part C|Adverse Event|0|||
161742780|NCT03657810|584097889|FG000|Overall Study|Adverse Event|0|||
161742781|NCT03657810|584097890|FG001|Overall Study|Adverse Event|1|||
161742782|NCT03657810|584097891|FG002|Overall Study|Adverse Event|0|||
161742783|NCT03657810|584097889|FG000|Overall Study|Lack of Efficacy|4|||
161742784|NCT03657810|584097890|FG001|Overall Study|Lack of Efficacy|1|||
161742785|NCT03657810|584097891|FG002|Overall Study|Lack of Efficacy|3|||
161742786|NCT03657810|584097889|FG000|Overall Study|Protocol Violation|1|||
161742787|NCT03657810|584097890|FG001|Overall Study|Protocol Violation|0|||
161742788|NCT03657810|584097891|FG002|Overall Study|Protocol Violation|0|||
161742789|NCT03657810|584097889|FG000|Overall Study|Lost to Follow-up|0|||
161742790|NCT03657810|584097890|FG001|Overall Study|Lost to Follow-up|1|||
161742791|NCT03657810|584097891|FG002|Overall Study|Lost to Follow-up|0|||
161742792|NCT03657810|584097889|FG000|Overall Study|Not provided|0|||
161742793|NCT03657810|584097890|FG001|Overall Study|Not provided|1|||
161742794|NCT03657810|584097891|FG002|Overall Study|Not provided|0|||
161742795|NCT00574496|584097895|FG000|Overall Study|Withdrawal by Subject|1|||
161742796|NCT01969799|584097896|FG000|Overall Study|Adverse Event|0|||
161742797|NCT01969799|584097897|FG001|Overall Study|Adverse Event|1|||
161742798|NCT01969799|584097896|FG000|Overall Study|Death|16|||
161742799|NCT01969799|584097897|FG001|Overall Study|Death|11|||
161742800|NCT01969799|584097896|FG000|Overall Study|Lost to Follow-up|0|||
161742801|NCT01969799|584097897|FG001|Overall Study|Lost to Follow-up|2|||
161742802|NCT01969799|584097896|FG000|Overall Study|Physician Decision|1|||
161742803|NCT01969799|584097897|FG001|Overall Study|Physician Decision|0|||
161742804|NCT02227108|584097900|FG000|Overall Study|Did not receive treatment|2|||
161742805|NCT02227108|584097900|FG000|Overall Study|Other|3|||
161742806|NCT02227108|584097900|FG000|Overall Study|Progressive disease|17|||
161742807|NCT02227108|584097900|FG000|Overall Study|Initiation of alternative therapy|2|||
161742808|NCT02227108|584097900|FG000|Overall Study|Investigator discretion|1|||
161742809|NCT02227108|584097900|FG000|Overall Study|Adverse Event|6|||
161742810|NCT02486952|584097901|FG000|Overall Study|Not Started Induction Therapy|3|||
161742811|NCT02486952|584097901|FG000|Overall Study|Adverse Event|1|||
161742812|NCT02486952|584097901|FG000|Overall Study|Death|15|||
161742813|NCT02486952|584097901|FG000|Overall Study|Lack of Efficacy|3|||
161742814|NCT02486952|584097901|FG000|Overall Study|Lost to Follow-up|26|||
161742815|NCT02486952|584097901|FG000|Overall Study|Other|2|||
161742816|NCT04111107|584097902|FG000|Overall Study|Withdrawal by Subject|6|||
161742817|NCT04111107|584097902|FG000|Overall Study|Declining Health|5|||
161742818|NCT01928485|584097903|FG000|Overall Study|Physician Decision|0|||
161742819|NCT01928485|584097904|FG001|Overall Study|Physician Decision|1|||
161742820|NCT03589885|584097905|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
161742821|NCT03589885|584097906|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
161742822|NCT03589885|584097907|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
161742823|NCT03589885|584097908|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
161742824|NCT03589885|584097909|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
161742825|NCT03589885|584097905|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
161742826|NCT03589885|584097906|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
161742827|NCT03589885|584097907|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
161742828|NCT03589885|584097908|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
161742829|NCT03589885|584097909|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
161742830|NCT03589885|584097905|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
161742831|NCT03589885|584097906|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
161742832|NCT03589885|584097907|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
161742833|NCT03589885|584097908|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
161742834|NCT03589885|584097909|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
161742835|NCT03589885|584097905|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
161742836|NCT03589885|584097906|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
161742837|NCT03589885|584097907|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
161966302|NCT02743949|584923583|FG000|Overall Study|Significant Protocol Deviation|2|||
161966303|NCT02743949|584923584|FG001|Overall Study|Significant Protocol Deviation|0|||
161966304|NCT02743949|584923585|FG002|Overall Study|Significant Protocol Deviation|1|||
161742838|NCT03589885|584097908|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
161742839|NCT03589885|584097909|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
161742840|NCT03589885|584097905|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
161742841|NCT03589885|584097906|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
161742842|NCT03589885|584097907|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
161742843|NCT03589885|584097908|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
161742844|NCT03589885|584097909|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
161742845|NCT03589885|584097905|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
161742846|NCT03589885|584097906|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
161742847|NCT03589885|584097907|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
161966305|NCT02743949|584923583|FG000|Overall Study|Voluntary Withdrawal|2|||
161966306|NCT02743949|584923584|FG001|Overall Study|Voluntary Withdrawal|1|||
161841665|NCT02799095|584466186|FG007|Part C|Adverse Event|0|||
161966307|NCT02743949|584923585|FG002|Overall Study|Voluntary Withdrawal|0|||
161841666|NCT02799095|584466187|FG008|Part C|Adverse Event|0|||
161841667|NCT02799095|584466188|FG009|Part C|Adverse Event|0|||
161742848|NCT03589885|584097908|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
161742849|NCT03589885|584097909|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
161742850|NCT03589885|584097905|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
161742851|NCT03589885|584097906|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
161742852|NCT03589885|584097907|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
161742853|NCT03589885|584097908|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
161742854|NCT03589885|584097909|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
161742855|NCT03589885|584097905|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
161742856|NCT03589885|584097906|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
161742857|NCT03589885|584097907|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
161742858|NCT03589885|584097908|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
161742859|NCT03589885|584097909|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
161742860|NCT00039741|584097912|FG000|Overall Study|Death|0|||
161742861|NCT00039741|584097913|FG001|Overall Study|Death|1|||
161742862|NCT00039741|584097914|FG002|Overall Study|Death|0|||
161742863|NCT00039741|584097915|FG003|Overall Study|Death|0|||
161742864|NCT00039741|584097912|FG000|Overall Study|Lost to Follow-up|3|||
161742865|NCT00039741|584097913|FG001|Overall Study|Lost to Follow-up|1|||
161742866|NCT00039741|584097914|FG002|Overall Study|Lost to Follow-up|5|||
161742867|NCT00039741|584097915|FG003|Overall Study|Lost to Follow-up|2|||
161742868|NCT00039741|584097912|FG000|Overall Study|Confounding medical condition|1|||
161742869|NCT00039741|584097913|FG001|Overall Study|Confounding medical condition|0|||
161742870|NCT00039741|584097914|FG002|Overall Study|Confounding medical condition|0|||
161742871|NCT00039741|584097915|FG003|Overall Study|Confounding medical condition|0|||
161742872|NCT00039741|584097912|FG000|Overall Study|Not able to get to clinic|5|||
161742873|NCT00039741|584097913|FG001|Overall Study|Not able to get to clinic|2|||
161742874|NCT00039741|584097914|FG002|Overall Study|Not able to get to clinic|0|||
161742875|NCT00039741|584097915|FG003|Overall Study|Not able to get to clinic|3|||
161742876|NCT00039741|584097912|FG000|Overall Study|Moved|3|||
161742877|NCT00039741|584097913|FG001|Overall Study|Moved|2|||
161742878|NCT00039741|584097914|FG002|Overall Study|Moved|3|||
161742879|NCT00039741|584097915|FG003|Overall Study|Moved|6|||
161742880|NCT00039741|584097912|FG000|Overall Study|Non-compliance with protocol|1|||
161742881|NCT00039741|584097913|FG001|Overall Study|Non-compliance with protocol|0|||
161742882|NCT00039741|584097914|FG002|Overall Study|Non-compliance with protocol|1|||
161742883|NCT00039741|584097915|FG003|Overall Study|Non-compliance with protocol|0|||
161742884|NCT00039741|584097912|FG000|Overall Study|Withdrew consent|0|||
161742885|NCT00039741|584097913|FG001|Overall Study|Withdrew consent|5|||
161742886|NCT00039741|584097914|FG002|Overall Study|Withdrew consent|0|||
161742887|NCT00039741|584097915|FG003|Overall Study|Withdrew consent|1|||
161742888|NCT00039741|584097912|FG000|Overall Study|Missed final visit|2|||
161742889|NCT00039741|584097913|FG001|Overall Study|Missed final visit|1|||
161742890|NCT00039741|584097914|FG002|Overall Study|Missed final visit|2|||
161742891|NCT00039741|584097915|FG003|Overall Study|Missed final visit|2|||
161742892|NCT00946881|584097916|FG000|First Treatment|Withdrawal by Subject|1|||
161742893|NCT00946881|584097916|FG000|First Treatment|Patient relocated to another state|1|||
161742894|NCT00946881|584097916|FG000|Retreatment|Withdrawal by Subject|1|||
161742895|NCT00293423|584097917|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
161742896|NCT00293423|584097918|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
161742897|NCT00293423|584097917|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
161742898|NCT00293423|584097918|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
161742899|NCT00293423|584097917|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
161742900|NCT00293423|584097918|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
161742901|NCT00293423|584097917|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
161742902|NCT00293423|584097918|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
161742903|NCT00293423|584097917|FG000|Surgical Resection|processing error during surgical resection|1|||
161742904|NCT00293423|584097918|FG001|Surgical Resection|processing error during surgical resection|0|||
161742905|NCT00293423|584097917|FG000|Surgical Resection|Withdrawal by Subject|4|||
161742906|NCT00293423|584097918|FG001|Surgical Resection|Withdrawal by Subject|0|||
161742907|NCT00293423|584097917|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
161742908|NCT00293423|584097918|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
161742909|NCT01182337|584097925|FG000|Overall Study|Withdrawal by Subject|3|||
161742910|NCT01182337|584097926|FG001|Overall Study|Withdrawal by Subject|1|||
161742911|NCT01182337|584097925|FG000|Overall Study|Lost to Follow-up|0|||
161841668|NCT02799095|584466189|FG010|Part C|Adverse Event|3|||
161841669|NCT02799095|584466190|FG011|Part C|Adverse Event|1|||
161841670|NCT02799095|584466191|FG012|Part C|Adverse Event|0|||
161841671|NCT02799095|584466192|FG013|Part C|Adverse Event|1|||
161841672|NCT02799095|584466193|FG014|Part C|Adverse Event|0|||
161841673|NCT02799095|584466194|FG015|Part C|Adverse Event|0|||
161841674|NCT02799095|584466195|FG016|Part C|Adverse Event|0|||
161841675|NCT02799095|584466179|FG000|Part C|Death|0|||
161841676|NCT02799095|584466180|FG001|Part C|Death|0|||
161841677|NCT02799095|584466181|FG002|Part C|Death|0|||
161966308|NCT01921218|584923586|FG000|Overall Study|Death|2|||
161966309|NCT01921218|584923587|FG001|Overall Study|Death|1|||
161966310|NCT01921218|584923586|FG000|Overall Study|Withdrawal by Subject|0|||
161966311|NCT01921218|584923587|FG001|Overall Study|Withdrawal by Subject|2|||
161742912|NCT01182337|584097926|FG001|Overall Study|Lost to Follow-up|1|||
161742913|NCT03571256|584097927|FG000|Overall Study|Adverse Event|3|||
161742914|NCT03571256|584097928|FG001|Overall Study|Adverse Event|0|||
161742915|NCT03571256|584097929|FG002|Overall Study|Adverse Event|1|||
161742916|NCT03571256|584097927|FG000|Overall Study|Withdrawal by Subject|3|||
161742917|NCT03571256|584097928|FG001|Overall Study|Withdrawal by Subject|1|||
161742918|NCT03571256|584097929|FG002|Overall Study|Withdrawal by Subject|1|||
161742919|NCT03571256|584097927|FG000|Overall Study|Other than specified|0|||
161742920|NCT03571256|584097928|FG001|Overall Study|Other than specified|1|||
161742921|NCT03571256|584097929|FG002|Overall Study|Other than specified|1|||
161742922|NCT03571256|584097927|FG000|Overall Study|Protocol Violation|0|||
161742923|NCT03571256|584097928|FG001|Overall Study|Protocol Violation|1|||
161742924|NCT03571256|584097929|FG002|Overall Study|Protocol Violation|1|||
161742925|NCT02270684|584097930|FG000|Overall Study|Lost to Follow-up|0|||
161742926|NCT02270684|584097931|FG001|Overall Study|Lost to Follow-up|3|||
161742927|NCT02270684|584097930|FG000|Overall Study|Study terminated|1|||
161742928|NCT02270684|584097931|FG001|Overall Study|Study terminated|0|||
161742929|NCT02247401|584097934|FG000|Overall Study|Adverse Event|1|||
161742930|NCT02247401|584097935|FG001|Overall Study|Adverse Event|0|||
161742931|NCT02247401|584097936|FG002|Overall Study|Adverse Event|0|||
161742932|NCT02247401|584097934|FG000|Overall Study|Withdrawal by Subject|4|||
161742933|NCT02247401|584097935|FG001|Overall Study|Withdrawal by Subject|1|||
161742934|NCT02247401|584097936|FG002|Overall Study|Withdrawal by Subject|1|||
161742935|NCT02247401|584097934|FG000|Overall Study|Lost to Follow-up|1|||
161742936|NCT02247401|584097935|FG001|Overall Study|Lost to Follow-up|1|||
161742937|NCT02247401|584097936|FG002|Overall Study|Lost to Follow-up|1|||
161742938|NCT01714817|584097937|FG000|Year 1 Period|Lack of Efficacy|11|||
161742939|NCT01714817|584097938|FG001|Year 1 Period|Lack of Efficacy|9|||
161742940|NCT01714817|584097937|FG000|Year 1 Period|Adverse Event|20|||
161742941|NCT01714817|584097938|FG001|Year 1 Period|Adverse Event|17|||
161742942|NCT01714817|584097937|FG000|Year 1 Period|Withdrawal by Subject|6|||
161742943|NCT01714817|584097938|FG001|Year 1 Period|Withdrawal by Subject|7|||
161742944|NCT01714817|584097937|FG000|Year 1 Period|Death|1|||
161742945|NCT01714817|584097938|FG001|Year 1 Period|Death|1|||
161742946|NCT01714817|584097937|FG000|Year 1 Period|Lost to Follow-up|0|||
161742947|NCT01714817|584097938|FG001|Year 1 Period|Lost to Follow-up|2|||
161742948|NCT01714817|584097937|FG000|Year 1 Period|Poor / non-compliance|0|||
161742949|NCT01714817|584097938|FG001|Year 1 Period|Poor / non-compliance|1|||
161742950|NCT01714817|584097937|FG000|Year 1 Period|Pregnancy|2|||
161742951|NCT01714817|584097938|FG001|Year 1 Period|Pregnancy|0|||
161742952|NCT01714817|584097937|FG000|Year 1 Period|Participant no longer meets criteria|6|||
161742953|NCT01714817|584097938|FG001|Year 1 Period|Participant no longer meets criteria|2|||
161742954|NCT01714817|584097937|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
161742955|NCT01714817|584097938|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
161742956|NCT01714817|584097937|FG000|Year 1 Period|Change in Concomitant Medication|0|||
161742957|NCT01714817|584097938|FG001|Year 1 Period|Change in Concomitant Medication|1|||
161742958|NCT01714817|584097937|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
161742959|NCT01714817|584097938|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
161742960|NCT01714817|584097937|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
161742961|NCT01714817|584097938|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
161742962|NCT01714817|584097937|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
161742963|NCT01714817|584097938|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
161966312|NCT01921218|584923586|FG000|Overall Study|Kidney transplant|1|||
161966313|NCT01921218|584923587|FG001|Overall Study|Kidney transplant|1|||
161966314|NCT03389555|584923588|FG000|Overall Study|Protocol Violation|1|||
161742964|NCT01714817|584097937|FG000|Year 2 Period|Lack of Efficacy|4|||
161742965|NCT01714817|584097938|FG001|Year 2 Period|Lack of Efficacy|12|||
161742966|NCT01714817|584097937|FG000|Year 2 Period|Adverse Event|7|||
161742967|NCT01714817|584097938|FG001|Year 2 Period|Adverse Event|6|||
161742968|NCT01714817|584097937|FG000|Year 2 Period|Participant request to stop treatment|4|||
161742969|NCT01714817|584097938|FG001|Year 2 Period|Participant request to stop treatment|4|||
161742970|NCT01714817|584097937|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
161742971|NCT01714817|584097938|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
161742972|NCT01714817|584097937|FG000|Year 2 Period|Participant withdrew consent|1|||
161742973|NCT01714817|584097938|FG001|Year 2 Period|Participant withdrew consent|5|||
161742974|NCT01714817|584097937|FG000|Year 2 Period|Participant no longer meets criteria|1|||
161742975|NCT01714817|584097938|FG001|Year 2 Period|Participant no longer meets criteria|4|||
161742976|NCT01714817|584097937|FG000|Year 2 Period|Lost to Follow-up|2|||
161742977|NCT01714817|584097938|FG001|Year 2 Period|Lost to Follow-up|0|||
161841678|NCT02799095|584466182|FG003|Part C|Death|0|||
161966315|NCT03389555|584923589|FG001|Overall Study|Protocol Violation|3|||
161966316|NCT03389555|584923588|FG000|Overall Study|Death|1|||
161966317|NCT03389555|584923589|FG001|Overall Study|Death|0|||
161966318|NCT01885208|584923590|FG000|Overall Study|Unclassified|32|||
161966319|NCT01885208|584923591|FG001|Overall Study|Unclassified|38|||
161966320|NCT00920218|584923592|FG000|Overall Study|Serious Adverse Event|2|||
161966321|NCT00920218|584923593|FG001|Overall Study|Serious Adverse Event|0|||
161966322|NCT00920218|584923594|FG002|Overall Study|Serious Adverse Event|2|||
161966323|NCT00920218|584923595|FG003|Overall Study|Serious Adverse Event|1|||
161966324|NCT00920218|584923592|FG000|Overall Study|Withdrawal by Subject|0|||
161966325|NCT00920218|584923593|FG001|Overall Study|Withdrawal by Subject|3|||
161966326|NCT00920218|584923594|FG002|Overall Study|Withdrawal by Subject|2|||
161966327|NCT00920218|584923595|FG003|Overall Study|Withdrawal by Subject|0|||
161742978|NCT01714817|584097937|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
161742979|NCT01714817|584097938|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
161742980|NCT01714817|584097937|FG000|Year 2 Period|Pregnancy|1|||
161742981|NCT01714817|584097938|FG001|Year 2 Period|Pregnancy|1|||
161742982|NCT01714817|584097937|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
161742983|NCT01714817|584097938|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
161742984|NCT01714817|584097937|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
161742985|NCT01714817|584097938|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
161742986|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
161742987|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
161742988|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
161742989|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
161742990|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
161742991|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
161742992|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
161742993|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
161742994|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
161742995|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
161742996|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
161742997|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
161742998|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161742999|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
161743000|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
161743001|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
161743002|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
161743003|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
161743004|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
161743005|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
161743006|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
161743007|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
161743008|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
161743009|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
161743010|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
161743011|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
161743012|NCT01714817|584097937|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
161743013|NCT01714817|584097938|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
161743014|NCT01374217|584097939|FG000|Overall Study|Lack of Efficacy|13|||
161743015|NCT04169061|584097940|FG000|Overall Study|Adverse Event|2|||
161743016|NCT04169061|584097940|FG000|Overall Study|Death|1|||
161743017|NCT04169061|584097940|FG000|Overall Study|Withdrawal by Subject|1|||
161743018|NCT04169061|584097940|FG000|Overall Study|Protocol Violation|1|||
161743019|NCT02555657|584097943|FG000|Overall Study|Death|274|||
161743020|NCT02555657|584097944|FG001|Overall Study|Death|262|||
161743021|NCT02555657|584097943|FG000|Overall Study|Physician Decision|0|||
161841679|NCT02799095|584466183|FG004|Part C|Death|0|||
161966328|NCT00920218|584923592|FG000|Overall Study|Migrated/moved from study area|0|||
161966329|NCT00920218|584923593|FG001|Overall Study|Migrated/moved from study area|0|||
161966330|NCT00920218|584923594|FG002|Overall Study|Migrated/moved from study area|1|||
161966331|NCT00920218|584923595|FG003|Overall Study|Migrated/moved from study area|0|||
161966332|NCT00920218|584923592|FG000|Overall Study|Lost to Follow-up|0|||
161966333|NCT00920218|584923593|FG001|Overall Study|Lost to Follow-up|1|||
161966334|NCT00920218|584923594|FG002|Overall Study|Lost to Follow-up|0|||
161743022|NCT02555657|584097944|FG001|Overall Study|Physician Decision|1|||
161743023|NCT02555657|584097943|FG000|Overall Study|Sponsor Decision|27|||
161966335|NCT00920218|584923595|FG003|Overall Study|Lost to Follow-up|3|||
161966336|NCT00920218|584923592|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
161966337|NCT00920218|584923593|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
161966338|NCT00920218|584923594|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
161841680|NCT02799095|584466184|FG005|Part C|Death|0|||
161841681|NCT02799095|584466185|FG006|Part C|Death|0|||
161841682|NCT02799095|584466186|FG007|Part C|Death|0|||
161841683|NCT02799095|584466187|FG008|Part C|Death|0|||
161841684|NCT02799095|584466188|FG009|Part C|Death|0|||
161841685|NCT02799095|584466189|FG010|Part C|Death|7|||
161841686|NCT02799095|584466190|FG011|Part C|Death|5|||
161841687|NCT02799095|584466191|FG012|Part C|Death|6|||
161841688|NCT02799095|584466192|FG013|Part C|Death|8|||
161841689|NCT02799095|584466193|FG014|Part C|Death|1|||
161841690|NCT02799095|584466194|FG015|Part C|Death|8|||
161841691|NCT02799095|584466195|FG016|Part C|Death|1|||
161841692|NCT02799095|584466179|FG000|Part C|Lost to Follow-up|0|||
161841693|NCT02799095|584466180|FG001|Part C|Lost to Follow-up|0|||
161841694|NCT02799095|584466181|FG002|Part C|Lost to Follow-up|0|||
161841695|NCT02799095|584466182|FG003|Part C|Lost to Follow-up|0|||
161841696|NCT02799095|584466183|FG004|Part C|Lost to Follow-up|0|||
161841697|NCT02799095|584466184|FG005|Part C|Lost to Follow-up|0|||
161841698|NCT02799095|584466185|FG006|Part C|Lost to Follow-up|0|||
161841699|NCT02799095|584466186|FG007|Part C|Lost to Follow-up|0|||
161841700|NCT02799095|584466187|FG008|Part C|Lost to Follow-up|0|||
161841701|NCT02799095|584466188|FG009|Part C|Lost to Follow-up|0|||
161841702|NCT02799095|584466189|FG010|Part C|Lost to Follow-up|1|||
161841703|NCT02799095|584466190|FG011|Part C|Lost to Follow-up|1|||
161841704|NCT02799095|584466191|FG012|Part C|Lost to Follow-up|1|||
161841705|NCT02799095|584466192|FG013|Part C|Lost to Follow-up|3|||
161841706|NCT02799095|584466193|FG014|Part C|Lost to Follow-up|0|||
161841707|NCT02799095|584466194|FG015|Part C|Lost to Follow-up|0|||
161841708|NCT02799095|584466195|FG016|Part C|Lost to Follow-up|0|||
161841709|NCT02799095|584466179|FG000|Part C|Progressive Disease|0|||
161841710|NCT02799095|584466180|FG001|Part C|Progressive Disease|0|||
161966339|NCT00920218|584923595|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
161966340|NCT00920218|584923592|FG000|Overall Study|Other|0|||
161841711|NCT02799095|584466181|FG002|Part C|Progressive Disease|0|||
161841712|NCT02799095|584466182|FG003|Part C|Progressive Disease|0|||
161841713|NCT02799095|584466183|FG004|Part C|Progressive Disease|0|||
161841714|NCT02799095|584466184|FG005|Part C|Progressive Disease|0|||
161841715|NCT02799095|584466185|FG006|Part C|Progressive Disease|0|||
161841716|NCT02799095|584466186|FG007|Part C|Progressive Disease|0|||
161841717|NCT02799095|584466187|FG008|Part C|Progressive Disease|0|||
161841718|NCT02799095|584466188|FG009|Part C|Progressive Disease|2|||
161841719|NCT02799095|584466189|FG010|Part C|Progressive Disease|13|||
161841720|NCT02799095|584466190|FG011|Part C|Progressive Disease|2|||
161841721|NCT02799095|584466191|FG012|Part C|Progressive Disease|0|||
161841722|NCT02799095|584466192|FG013|Part C|Progressive Disease|1|||
161841723|NCT02799095|584466193|FG014|Part C|Progressive Disease|0|||
161841724|NCT02799095|584466194|FG015|Part C|Progressive Disease|0|||
161841725|NCT02799095|584466195|FG016|Part C|Progressive Disease|0|||
161841726|NCT02799095|584466179|FG000|Part C|Clinical Progression|0|||
161841727|NCT02799095|584466180|FG001|Part C|Clinical Progression|0|||
161841728|NCT02799095|584466181|FG002|Part C|Clinical Progression|0|||
161966341|NCT00920218|584923593|FG001|Overall Study|Other|0|||
161966342|NCT00920218|584923594|FG002|Overall Study|Other|1|||
161966343|NCT00920218|584923595|FG003|Overall Study|Other|0|||
161966344|NCT00960011|584923599|FG000|Overall Study|Death|5|||
161966345|NCT00960011|584923600|FG001|Overall Study|Death|0|||
161966346|NCT00960011|584923599|FG000|Overall Study|Lost to Follow-up|6|||
161841729|NCT02799095|584466182|FG003|Part C|Clinical Progression|0|||
161841730|NCT02799095|584466183|FG004|Part C|Clinical Progression|0|||
161841731|NCT02799095|584466184|FG005|Part C|Clinical Progression|0|||
161841732|NCT02799095|584466185|FG006|Part C|Clinical Progression|0|||
161841733|NCT02799095|584466186|FG007|Part C|Clinical Progression|0|||
161841734|NCT02799095|584466187|FG008|Part C|Clinical Progression|0|||
161841735|NCT02799095|584466188|FG009|Part C|Clinical Progression|1|||
161841736|NCT02799095|584466189|FG010|Part C|Clinical Progression|3|||
161841737|NCT02799095|584466190|FG011|Part C|Clinical Progression|0|||
161841738|NCT02799095|584466191|FG012|Part C|Clinical Progression|0|||
161841739|NCT02799095|584466192|FG013|Part C|Clinical Progression|1|||
161841740|NCT02799095|584466193|FG014|Part C|Clinical Progression|0|||
161841741|NCT02799095|584466194|FG015|Part C|Clinical Progression|0|||
161841742|NCT02799095|584466195|FG016|Part C|Clinical Progression|0|||
161841743|NCT02799095|584466179|FG000|Part C|Withdrawal by Subject|0|||
161841744|NCT02799095|584466180|FG001|Part C|Withdrawal by Subject|0|||
161966347|NCT00960011|584923600|FG001|Overall Study|Lost to Follow-up|2|||
161966348|NCT04417218|584923601|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
161841745|NCT02799095|584466181|FG002|Part C|Withdrawal by Subject|0|||
161841746|NCT02799095|584466182|FG003|Part C|Withdrawal by Subject|0|||
161841747|NCT02799095|584466183|FG004|Part C|Withdrawal by Subject|0|||
161841748|NCT02799095|584466184|FG005|Part C|Withdrawal by Subject|0|||
161841749|NCT02799095|584466185|FG006|Part C|Withdrawal by Subject|0|||
161841750|NCT02799095|584466186|FG007|Part C|Withdrawal by Subject|0|||
161841751|NCT02799095|584466187|FG008|Part C|Withdrawal by Subject|0|||
161841752|NCT02799095|584466188|FG009|Part C|Withdrawal by Subject|0|||
161841753|NCT02799095|584466189|FG010|Part C|Withdrawal by Subject|13|||
162032479|NCT03422627|585177400|FG001|Overall Study|Death|1|||
162032480|NCT03422627|585177401|FG002|Overall Study|Death|1|||
162032481|NCT03422627|585177402|FG003|Overall Study|Death|0|||
162032482|NCT03422627|585177403|FG004|Overall Study|Death|0|||
161743024|NCT02555657|584097944|FG001|Overall Study|Sponsor Decision|15|||
161743025|NCT02555657|584097943|FG000|Overall Study|Withdrawal by Subject|11|||
161743026|NCT02555657|584097944|FG001|Overall Study|Withdrawal by Subject|32|||
161743027|NCT02807363|584097945|FG000|Dosing Period|Adverse Event|0|||
161743028|NCT02807363|584097946|FG001|Dosing Period|Adverse Event|1|||
161743029|NCT02807363|584097947|FG002|Dosing Period|Adverse Event|0|||
161743030|NCT02807363|584097948|FG003|Dosing Period|Adverse Event|0|||
161743031|NCT02188719|584097949|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
161743032|NCT02188719|584097950|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
161743033|NCT02188719|584097951|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
161743034|NCT02188719|584097952|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
161743035|NCT00192036|584097956|FG000|Overall Study|Protocol Violation|3|||
161743036|NCT00192036|584097956|FG000|Overall Study|Adverse Event|6|||
161743037|NCT00192036|584097956|FG000|Overall Study|Patient/Physician Perception|1|||
161743038|NCT00192036|584097956|FG000|Overall Study|Objective Tumor Progression|4|||
161743039|NCT00192036|584097956|FG000|Overall Study|Clinical Disease Progression|1|||
161743040|NCT00192036|584097956|FG000|Overall Study|Death|1|||
161743041|NCT00192036|584097956|FG000|Overall Study|Unknown or Not Specified|5|||
161743042|NCT03371732|584097957|FG000|Overall Study|Withdrawal by Subject|9|||
161743043|NCT03371732|584097958|FG001|Overall Study|Withdrawal by Subject|3|||
161743044|NCT03371732|584097957|FG000|Overall Study|Refusal to continue|3|||
161743045|NCT03371732|584097958|FG001|Overall Study|Refusal to continue|4|||
161743046|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
161743047|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
161743048|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
161743049|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
161743050|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
161743051|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
161743052|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
161743053|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
161743054|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
161743055|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
161743056|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
161743057|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
161743058|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
161743059|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
161743060|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
161743061|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
161743062|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
161743063|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
161743064|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
161743065|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
161743066|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
161743067|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
161743068|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
161743069|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
161743070|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
161743071|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
161743072|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
161743073|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
161743074|NCT00476996|584097959|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
161743075|NCT00476996|584097960|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
161743076|NCT00476996|584097961|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
161743077|NCT00476996|584097962|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
161743078|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
161743079|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
161743080|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
161743081|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
161743082|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
161743083|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
161743084|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
161743085|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
161743086|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Death|0|||
161743087|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Death|0|||
162032483|NCT03422627|585177399|FG000|Overall Study|Withdrawal by Subject|0|||
161841754|NCT02799095|584466190|FG011|Part C|Withdrawal by Subject|15|||
161841755|NCT02799095|584466191|FG012|Part C|Withdrawal by Subject|13|||
161841756|NCT02799095|584466192|FG013|Part C|Withdrawal by Subject|21|||
161841757|NCT02799095|584466193|FG014|Part C|Withdrawal by Subject|0|||
161841758|NCT02799095|584466194|FG015|Part C|Withdrawal by Subject|12|||
161841759|NCT02799095|584466195|FG016|Part C|Withdrawal by Subject|1|||
161841760|NCT02799095|584466179|FG000|Part C|Physician Decision|0|||
161841761|NCT02799095|584466180|FG001|Part C|Physician Decision|0|||
161841762|NCT02799095|584466181|FG002|Part C|Physician Decision|0|||
161841763|NCT02799095|584466182|FG003|Part C|Physician Decision|0|||
161841764|NCT02799095|584466183|FG004|Part C|Physician Decision|0|||
161841765|NCT02799095|584466184|FG005|Part C|Physician Decision|0|||
161841766|NCT02799095|584466185|FG006|Part C|Physician Decision|0|||
161841767|NCT02799095|584466186|FG007|Part C|Physician Decision|0|||
161841768|NCT02799095|584466187|FG008|Part C|Physician Decision|0|||
161841769|NCT02799095|584466188|FG009|Part C|Physician Decision|0|||
161841770|NCT02799095|584466189|FG010|Part C|Physician Decision|1|||
161841771|NCT02799095|584466190|FG011|Part C|Physician Decision|0|||
161841772|NCT02799095|584466191|FG012|Part C|Physician Decision|0|||
161966349|NCT04417218|584923602|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
161966350|NCT00873041|584923603|FG000|Core Study|Adverse Event|2|||
161966351|NCT00873041|584923604|FG001|Core Study|Adverse Event|3|||
161966352|NCT00873041|584923605|FG002|Core Study|Adverse Event|1|||
161966353|NCT00873041|584923603|FG000|Core Study|Withdrawal by Subject|1|||
161966354|NCT00873041|584923604|FG001|Core Study|Withdrawal by Subject|2|||
161966355|NCT00873041|584923605|FG002|Core Study|Withdrawal by Subject|2|||
161966356|NCT00873041|584923603|FG000|Core Study|Lost to Follow-up|3|||
161966357|NCT00873041|584923604|FG001|Core Study|Lost to Follow-up|1|||
161743088|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Death|0|||
161743089|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Death|7|||
161743090|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
161743091|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
161743092|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
161743093|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
161743094|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
161743095|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
161743096|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
161743097|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
161743098|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
161743099|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
161743100|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
161743101|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
161743102|NCT00476996|584097959|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
161743103|NCT00476996|584097960|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
161743104|NCT00476996|584097961|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
161743105|NCT00476996|584097962|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
161743106|NCT02133742|584097976|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
161743107|NCT02133742|584097976|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
161743108|NCT02133742|584097976|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
161743109|NCT02133742|584097976|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
161743110|NCT02133742|584097976|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
161743111|NCT03479216|584097979|FG000|Overall Study|Withdrawal by Subject|3|||
161743112|NCT03479216|584097980|FG001|Overall Study|Withdrawal by Subject|2|||
161743113|NCT03479216|584097979|FG000|Overall Study|Physician Decision|2|||
161743114|NCT03479216|584097980|FG001|Overall Study|Physician Decision|3|||
161743115|NCT02031432|584097983|FG000|Overall Study|Protocol Violation|1|||
161743116|NCT02031432|584097983|FG000|Overall Study|Lack of Efficacy|5|||
161743117|NCT02031432|584097983|FG000|Overall Study|Cancer Progression|2|||
161743118|NCT02031432|584097983|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
161743119|NCT02031432|584097983|FG000|Overall Study|Adverse Event|8|||
161743120|NCT02031432|584097983|FG000|Overall Study|Withdrawal by Subject|5|||
161743121|NCT02031432|584097983|FG000|Overall Study|Lost to Follow-up|1|||
161743122|NCT02031432|584097983|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
161743123|NCT02031432|584097983|FG000|Overall Study|Death|10|||
161743124|NCT02148211|584097984|FG000|Overall Study|Lost to Follow-up|352|||
161743125|NCT01617187|584097986|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
161743126|NCT01617187|584097987|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
161743127|NCT01617187|584097988|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
161743128|NCT01617187|584097989|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
161743129|NCT01617187|584097986|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
161743130|NCT01617187|584097987|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
161841773|NCT02799095|584466192|FG013|Part C|Physician Decision|0|||
161841774|NCT02799095|584466193|FG014|Part C|Physician Decision|0|||
161841775|NCT02799095|584466194|FG015|Part C|Physician Decision|0|||
161841776|NCT02799095|584466195|FG016|Part C|Physician Decision|0|||
161841777|NCT02799095|584466179|FG000|Part C|Other|0|||
161841778|NCT02799095|584466180|FG001|Part C|Other|0|||
161841779|NCT02799095|584466181|FG002|Part C|Other|0|||
161841780|NCT02799095|584466182|FG003|Part C|Other|0|||
161841781|NCT02799095|584466183|FG004|Part C|Other|0|||
161841782|NCT02799095|584466184|FG005|Part C|Other|0|||
161841783|NCT02799095|584466185|FG006|Part C|Other|0|||
161841784|NCT02799095|584466186|FG007|Part C|Other|0|||
161841785|NCT02799095|584466187|FG008|Part C|Other|0|||
161841786|NCT02799095|584466188|FG009|Part C|Other|0|||
161841787|NCT02799095|584466189|FG010|Part C|Other|0|||
161841788|NCT02799095|584466190|FG011|Part C|Other|2|||
161841789|NCT02799095|584466191|FG012|Part C|Other|2|||
161841790|NCT02799095|584466192|FG013|Part C|Other|0|||
161841791|NCT02799095|584466193|FG014|Part C|Other|0|||
161841792|NCT02799095|584466194|FG015|Part C|Other|0|||
161841793|NCT02799095|584466195|FG016|Part C|Other|0|||
161841794|NCT05327816|584466197|FG000|Overall Study|Lost to Follow-up|1|||
161841795|NCT05327816|584466198|FG001|Overall Study|Lost to Follow-up|0|||
161841796|NCT05327816|584466199|FG002|Overall Study|Lost to Follow-up|0|||
161841797|NCT05327816|584466200|FG003|Overall Study|Lost to Follow-up|0|||
161841798|NCT05327816|584466201|FG004|Overall Study|Lost to Follow-up|0|||
161841799|NCT05327816|584466202|FG005|Overall Study|Lost to Follow-up|0|||
161841800|NCT05327816|584466203|FG006|Overall Study|Lost to Follow-up|0|||
161841801|NCT05327816|584466204|FG007|Overall Study|Lost to Follow-up|0|||
161841802|NCT05327816|584466205|FG008|Overall Study|Lost to Follow-up|0|||
161841803|NCT05327816|584466206|FG009|Overall Study|Lost to Follow-up|1|||
161841804|NCT05327816|584466207|FG010|Overall Study|Lost to Follow-up|0|||
161841805|NCT05327816|584466197|FG000|Overall Study|Withdrawal by Subject|0|||
161841806|NCT05327816|584466198|FG001|Overall Study|Withdrawal by Subject|0|||
161841807|NCT05327816|584466199|FG002|Overall Study|Withdrawal by Subject|0|||
161841808|NCT05327816|584466200|FG003|Overall Study|Withdrawal by Subject|0|||
161841809|NCT05327816|584466201|FG004|Overall Study|Withdrawal by Subject|1|||
161841810|NCT05327816|584466202|FG005|Overall Study|Withdrawal by Subject|1|||
161841811|NCT05327816|584466203|FG006|Overall Study|Withdrawal by Subject|0|||
161841812|NCT05327816|584466204|FG007|Overall Study|Withdrawal by Subject|0|||
161841813|NCT05327816|584466205|FG008|Overall Study|Withdrawal by Subject|0|||
161841814|NCT05327816|584466206|FG009|Overall Study|Withdrawal by Subject|0|||
161841815|NCT05327816|584466207|FG010|Overall Study|Withdrawal by Subject|0|||
161841816|NCT05327816|584466197|FG000|Overall Study|Study Terminated by Sponsor|11|||
161841817|NCT05327816|584466198|FG001|Overall Study|Study Terminated by Sponsor|12|||
161841818|NCT05327816|584466199|FG002|Overall Study|Study Terminated by Sponsor|12|||
161841819|NCT05327816|584466200|FG003|Overall Study|Study Terminated by Sponsor|12|||
161841820|NCT05327816|584466201|FG004|Overall Study|Study Terminated by Sponsor|11|||
161841821|NCT05327816|584466202|FG005|Overall Study|Study Terminated by Sponsor|11|||
161841822|NCT05327816|584466203|FG006|Overall Study|Study Terminated by Sponsor|11|||
161841823|NCT05327816|584466204|FG007|Overall Study|Study Terminated by Sponsor|11|||
161841824|NCT05327816|584466205|FG008|Overall Study|Study Terminated by Sponsor|11|||
161841825|NCT05327816|584466206|FG009|Overall Study|Study Terminated by Sponsor|11|||
161841826|NCT05327816|584466207|FG010|Overall Study|Study Terminated by Sponsor|12|||
161841827|NCT05327816|584466197|FG000|Overall Study|Randomized but not treated|0|||
161841828|NCT05327816|584466198|FG001|Overall Study|Randomized but not treated|0|||
161841829|NCT05327816|584466199|FG002|Overall Study|Randomized but not treated|0|||
161841830|NCT05327816|584466200|FG003|Overall Study|Randomized but not treated|0|||
161841831|NCT05327816|584466201|FG004|Overall Study|Randomized but not treated|0|||
161841832|NCT05327816|584466202|FG005|Overall Study|Randomized but not treated|0|||
161841833|NCT05327816|584466203|FG006|Overall Study|Randomized but not treated|1|||
161841834|NCT05327816|584466204|FG007|Overall Study|Randomized but not treated|1|||
161841835|NCT05327816|584466205|FG008|Overall Study|Randomized but not treated|1|||
161966358|NCT00873041|584923605|FG002|Core Study|Lost to Follow-up|0|||
161966359|NCT00873041|584923603|FG000|Core Study|Abnormal laboratory value|0|||
161966360|NCT00873041|584923604|FG001|Core Study|Abnormal laboratory value|0|||
161841836|NCT05327816|584466206|FG009|Overall Study|Randomized but not treated|0|||
161841837|NCT05327816|584466207|FG010|Overall Study|Randomized but not treated|0|||
161841838|NCT00759902|584466208|FG000|Overall Study|Adverse Event|0|||
161841839|NCT00759902|584466209|FG001|Overall Study|Adverse Event|1|||
161841840|NCT00658658|584466214|FG000|Overall Study|Withdrawal by Subject|0|||
161841841|NCT00658658|584466215|FG001|Overall Study|Withdrawal by Subject|1|||
161841842|NCT00658658|584466216|FG002|Overall Study|Withdrawal by Subject|0|||
161841843|NCT00658658|584466217|FG003|Overall Study|Withdrawal by Subject|0|||
161841844|NCT00658658|584466218|FG004|Overall Study|Withdrawal by Subject|0|||
161841845|NCT00658658|584466214|FG000|Overall Study|Death|4|||
161841846|NCT00658658|584466215|FG001|Overall Study|Death|0|||
161966361|NCT00873041|584923605|FG002|Core Study|Abnormal laboratory value|1|||
161966362|NCT00873041|584923603|FG000|Core Study|Protocol deviation|1|||
161841847|NCT00658658|584466216|FG002|Overall Study|Death|0|||
161841848|NCT00658658|584466217|FG003|Overall Study|Death|1|||
161841849|NCT00658658|584466218|FG004|Overall Study|Death|1|||
161841850|NCT00658658|584466214|FG000|Overall Study|Disease Progression|0|||
161841851|NCT00658658|584466215|FG001|Overall Study|Disease Progression|1|||
161841852|NCT00658658|584466216|FG002|Overall Study|Disease Progression|0|||
161966363|NCT00873041|584923604|FG001|Core Study|Protocol deviation|0|||
161966364|NCT00873041|584923605|FG002|Core Study|Protocol deviation|1|||
161966365|NCT00873041|584923603|FG000|Extension Study|Adverse Event|1|||
161966366|NCT00873041|584923604|FG001|Extension Study|Adverse Event|0|||
161966367|NCT00873041|584923605|FG002|Extension Study|Adverse Event|1|||
161966368|NCT00873041|584923603|FG000|Extension Study|Administrative reasons|0|||
161966369|NCT00873041|584923604|FG001|Extension Study|Administrative reasons|0|||
161966370|NCT00873041|584923605|FG002|Extension Study|Administrative reasons|1|||
161743131|NCT01617187|584097988|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
161743132|NCT01617187|584097989|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
161743133|NCT01617187|584097986|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
161743134|NCT01617187|584097987|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
161743135|NCT01617187|584097988|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
161743136|NCT01617187|584097989|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
161743137|NCT01617187|584097986|FG000|Treatment Through Study Completion|Adverse Event|1|||
161743138|NCT01617187|584097987|FG001|Treatment Through Study Completion|Adverse Event|1|||
161743139|NCT01617187|584097988|FG002|Treatment Through Study Completion|Adverse Event|0|||
161743140|NCT01617187|584097989|FG003|Treatment Through Study Completion|Adverse Event|1|||
161743141|NCT01617187|584097986|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
161743142|NCT01617187|584097987|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
161743143|NCT01617187|584097988|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
161743144|NCT01617187|584097989|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
161743145|NCT01617187|584097986|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
161743146|NCT01617187|584097987|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
161743147|NCT01617187|584097988|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
161743148|NCT01617187|584097989|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
161743149|NCT01617187|584097986|FG000|Treatment Through Study Completion|Protocol Violation|1|||
161743150|NCT01617187|584097987|FG001|Treatment Through Study Completion|Protocol Violation|0|||
161743151|NCT01617187|584097988|FG002|Treatment Through Study Completion|Protocol Violation|0|||
161743152|NCT01617187|584097989|FG003|Treatment Through Study Completion|Protocol Violation|1|||
161743153|NCT01265420|584097990|FG000|Overall Study|Lost to Follow-up|1|||
161743154|NCT03337139|584097994|FG000|Phase I|Withdrawal by Subject|10|||
161743155|NCT03337139|584097995|FG001|Phase I|Withdrawal by Subject|0|||
161743156|NCT01561560|584098000|FG000|First Two Weeks of Wear|Time/job conflict|0|||
161743157|NCT01561560|584098001|FG001|First Two Weeks of Wear|Time/job conflict|1|||
161743158|NCT01561560|584098000|FG000|First Two Weeks of Wear|Adverse Event|0|||
161743159|NCT01561560|584098001|FG001|First Two Weeks of Wear|Adverse Event|1|||
161743160|NCT01561560|584098000|FG000|Second Two Weeks of Wear|Adverse Event|0|||
161743161|NCT01561560|584098001|FG001|Second Two Weeks of Wear|Adverse Event|1|||
161743162|NCT03862131|584098002|FG000|Overall Study|Lost to Follow-up|1|||
161743163|NCT03862131|584098003|FG001|Overall Study|Lost to Follow-up|0|||
161743164|NCT03862131|584098004|FG002|Overall Study|Lost to Follow-up|1|||
161743165|NCT03862131|584098002|FG000|Overall Study|Determined to be ineligible|0|||
161743166|NCT03862131|584098003|FG001|Overall Study|Determined to be ineligible|0|||
161743167|NCT03862131|584098004|FG002|Overall Study|Determined to be ineligible|5|||
161743168|NCT03862131|584098002|FG000|Overall Study|Death|4|||
161743169|NCT03862131|584098003|FG001|Overall Study|Death|4|||
161743170|NCT03862131|584098004|FG002|Overall Study|Death|0|||
161743171|NCT03862131|584098002|FG000|Overall Study|Withdrawal by Subject|5|||
161743172|NCT03862131|584098003|FG001|Overall Study|Withdrawal by Subject|3|||
161743173|NCT03862131|584098004|FG002|Overall Study|Withdrawal by Subject|0|||
161743174|NCT03862131|584098002|FG000|Overall Study|Physician Decision|0|||
161743175|NCT03862131|584098003|FG001|Overall Study|Physician Decision|1|||
161743176|NCT03862131|584098004|FG002|Overall Study|Physician Decision|0|||
161743177|NCT01871896|584098007|FG000|Overall Study|Lost to Follow-up|1|||
161743178|NCT05406440|584099688|FG000|Overall Study|Lost to Follow-up|0|||
161743179|NCT05406440|584099689|FG001|Overall Study|Lost to Follow-up|0|||
161743180|NCT05406440|584099690|FG002|Overall Study|Lost to Follow-up|0|||
161743181|NCT05406440|584099691|FG003|Overall Study|Lost to Follow-up|0|||
161743182|NCT05406440|584099692|FG004|Overall Study|Lost to Follow-up|2|||
161743183|NCT05406440|584099693|FG005|Overall Study|Lost to Follow-up|0|||
161743184|NCT05406440|584099694|FG006|Overall Study|Lost to Follow-up|0|||
161743185|NCT05406440|584099688|FG000|Overall Study|Physician Decision|0|||
161743186|NCT05406440|584099689|FG001|Overall Study|Physician Decision|0|||
161743187|NCT05406440|584099690|FG002|Overall Study|Physician Decision|0|||
161743188|NCT05406440|584099691|FG003|Overall Study|Physician Decision|0|||
161743189|NCT05406440|584099692|FG004|Overall Study|Physician Decision|1|||
161743190|NCT05406440|584099693|FG005|Overall Study|Physician Decision|0|||
161743191|NCT05406440|584099694|FG006|Overall Study|Physician Decision|0|||
161743192|NCT05406440|584099688|FG000|Overall Study|Withdrawal by Subject|0|||
161743193|NCT05406440|584099689|FG001|Overall Study|Withdrawal by Subject|0|||
161743194|NCT05406440|584099690|FG002|Overall Study|Withdrawal by Subject|0|||
161743195|NCT05406440|584099691|FG003|Overall Study|Withdrawal by Subject|0|||
161966371|NCT04295681|584923619|FG000|Overall Study|Eligibility error|1|||
161966372|NCT04295681|584923620|FG001|Overall Study|Eligibility error|3|||
161966373|NCT02210689|584923627|FG000|Overall Study|Withdrawal by Subject|7|||
161966374|NCT02210689|584923628|FG001|Overall Study|Withdrawal by Subject|4|||
161966375|NCT02210689|584923629|FG002|Overall Study|Withdrawal by Subject|2|||
161966376|NCT02210689|584923627|FG000|Overall Study|Adverse Event|0|||
161966377|NCT02210689|584923628|FG001|Overall Study|Adverse Event|1|||
161841853|NCT00658658|584466217|FG003|Overall Study|Disease Progression|1|||
161841854|NCT00658658|584466218|FG004|Overall Study|Disease Progression|3|||
161841855|NCT00658658|584466214|FG000|Overall Study|Protocol-specified Criteria|1|||
161841856|NCT00658658|584466215|FG001|Overall Study|Protocol-specified Criteria|0|||
161841857|NCT00658658|584466216|FG002|Overall Study|Protocol-specified Criteria|0|||
161841858|NCT00658658|584466217|FG003|Overall Study|Protocol-specified Criteria|0|||
161841859|NCT00658658|584466218|FG004|Overall Study|Protocol-specified Criteria|0|||
161841860|NCT00658658|584466214|FG000|Overall Study|Other|0|||
161841861|NCT00658658|584466215|FG001|Overall Study|Other|0|||
161841862|NCT00658658|584466216|FG002|Overall Study|Other|0|||
161841863|NCT00658658|584466217|FG003|Overall Study|Other|0|||
161841864|NCT00658658|584466218|FG004|Overall Study|Other|1|||
161841865|NCT01167257|584466219|FG000|Overall Study|Lost to Follow-up|2|||
161841866|NCT01167257|584466220|FG001|Overall Study|Lost to Follow-up|2|||
161841867|NCT01167257|584466219|FG000|Overall Study|Withdrew consent|1|||
161841868|NCT01167257|584466220|FG001|Overall Study|Withdrew consent|1|||
161841869|NCT01523457|584466221|FG000|Overall Study|Withdrawal by Subject|7|||
161841870|NCT01523457|584466222|FG001|Overall Study|Withdrawal by Subject|2|||
161841871|NCT01367665|584466223|FG000|Overall Study|Death|102|||
161966378|NCT02210689|584923629|FG002|Overall Study|Adverse Event|0|||
161966379|NCT02210689|584923627|FG000|Overall Study|Protocol Violation|1|||
161966380|NCT02210689|584923628|FG001|Overall Study|Protocol Violation|0|||
161966381|NCT02210689|584923629|FG002|Overall Study|Protocol Violation|0|||
161743196|NCT05406440|584099692|FG004|Overall Study|Withdrawal by Subject|0|||
161743197|NCT05406440|584099693|FG005|Overall Study|Withdrawal by Subject|2|||
161743198|NCT05406440|584099694|FG006|Overall Study|Withdrawal by Subject|0|||
161743199|NCT01412151|584099695|FG000|Week 0 - 306 - Treatment Period|Death|1|||
161743200|NCT01412151|584099695|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
161743201|NCT01412151|584099695|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
161743202|NCT01412151|584099695|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
161743203|NCT03127852|584099696|FG000|Overall Study|Withdrawal by Subject|4|||
161743204|NCT03127852|584099697|FG001|Overall Study|Withdrawal by Subject|1|||
161743205|NCT03127852|584099696|FG000|Overall Study|Death|1|||
161743206|NCT03127852|584099697|FG001|Overall Study|Death|1|||
161743207|NCT03621189|584099698|FG000|Overall Study|Withdrawal by Subject|0|||
161743208|NCT03621189|584099699|FG001|Overall Study|Withdrawal by Subject|3|||
161743209|NCT03621189|584099698|FG000|Overall Study|Physician Decision|0|||
161743210|NCT03621189|584099699|FG001|Overall Study|Physician Decision|2|||
161743211|NCT01824693|584099700|FG000|Overall Study|Death|0|||
161743212|NCT01824693|584099701|FG001|Overall Study|Death|1|||
161743213|NCT01824693|584099702|FG002|Overall Study|Death|0|||
161743214|NCT01824693|584099700|FG000|Overall Study|Physician Decision|1|||
161743215|NCT01824693|584099701|FG001|Overall Study|Physician Decision|1|||
161743216|NCT01824693|584099702|FG002|Overall Study|Physician Decision|1|||
161743217|NCT01824693|584099700|FG000|Overall Study|Withdrawal by Subject|0|||
161743218|NCT01824693|584099701|FG001|Overall Study|Withdrawal by Subject|0|||
161743219|NCT01824693|584099702|FG002|Overall Study|Withdrawal by Subject|1|||
161743220|NCT01824693|584099700|FG000|Overall Study|Progressive Disease|0|||
161743221|NCT01824693|584099701|FG001|Overall Study|Progressive Disease|5|||
161743222|NCT01824693|584099702|FG002|Overall Study|Progressive Disease|0|||
161743223|NCT01824693|584099700|FG000|Overall Study|Ineligible|0|||
161743224|NCT01824693|584099701|FG001|Overall Study|Ineligible|0|||
161743225|NCT01824693|584099702|FG002|Overall Study|Ineligible|3|||
161743226|NCT01824693|584099700|FG000|Overall Study|No Transplant Planned|0|||
161743227|NCT01824693|584099701|FG001|Overall Study|No Transplant Planned|0|||
161743228|NCT01824693|584099702|FG002|Overall Study|No Transplant Planned|10|||
161966382|NCT02210689|584923627|FG000|Overall Study|Lost to Follow-up|11|||
161966383|NCT02210689|584923628|FG001|Overall Study|Lost to Follow-up|9|||
161743229|NCT02150213|584099703|FG000|Overall Study|Lost to Follow-up|1|||
161743230|NCT02150213|584099703|FG000|Overall Study|Withdrawal by Subject|1|||
161743231|NCT03488238|584099704|FG000|Overall Study|Equipment malfunction|1|||
161841872|NCT01367665|584466224|FG001|Overall Study|Death|19|||
161743232|NCT03488238|584099704|FG000|Overall Study|Adverse Event|1|||
161743233|NCT01432457|584099705|FG000|Overall Study|Adverse Event|7|||
161743234|NCT01432457|584099706|FG001|Overall Study|Adverse Event|10|||
161743235|NCT01432457|584099707|FG002|Overall Study|Adverse Event|16|||
161743236|NCT01432457|584099705|FG000|Overall Study|Lack of Efficacy|2|||
161841873|NCT01367665|584466223|FG000|Overall Study|Lost to Follow-up|222|||
161841874|NCT01367665|584466224|FG001|Overall Study|Lost to Follow-up|22|||
161841875|NCT01367665|584466223|FG000|Overall Study|Not Done|118|||
161841876|NCT01367665|584466224|FG001|Overall Study|Not Done|14|||
161841877|NCT03283319|584466225|FG000|Overall Study|Lost to Follow-up|5|||
161966384|NCT02210689|584923629|FG002|Overall Study|Lost to Follow-up|5|||
161966385|NCT02210689|584923627|FG000|Overall Study|Pregnancy|0|||
161966386|NCT02210689|584923628|FG001|Overall Study|Pregnancy|1|||
161966387|NCT02210689|584923629|FG002|Overall Study|Pregnancy|0|||
161966388|NCT02210689|584923627|FG000|Overall Study|Lack of Efficacy|0|||
161966389|NCT02210689|584923628|FG001|Overall Study|Lack of Efficacy|1|||
161966390|NCT02210689|584923629|FG002|Overall Study|Lack of Efficacy|5|||
161966391|NCT02210689|584923627|FG000|Overall Study|Prohibited medication|2|||
161966392|NCT02210689|584923628|FG001|Overall Study|Prohibited medication|8|||
161966393|NCT02210689|584923629|FG002|Overall Study|Prohibited medication|1|||
161966394|NCT02210689|584923627|FG000|Overall Study|Negative Nugent score at baseline|6|||
161966395|NCT02210689|584923628|FG001|Overall Study|Negative Nugent score at baseline|2|||
161966396|NCT02210689|584923629|FG002|Overall Study|Negative Nugent score at baseline|2|||
161966397|NCT02210689|584923627|FG000|Overall Study|Other|25|||
161966398|NCT02210689|584923628|FG001|Overall Study|Other|21|||
161966399|NCT02210689|584923629|FG002|Overall Study|Other|8|||
161966400|NCT00675441|584923630|FG000|Overall Study|Withdrawal by Subject|2|||
161966401|NCT00675441|584923630|FG000|Overall Study|Death|1|||
161966402|NCT01923363|584923631|FG000|Overall Study|Protocol Violation|1|||
161966403|NCT00866047|584923633|FG000|Treatment Period|Progressive disease|13|||
161966404|NCT00866047|584923633|FG000|Treatment Period|Adverse Event|16|||
161966405|NCT00866047|584923633|FG000|Treatment Period|Physician Decision|14|||
161966406|NCT00866047|584923633|FG000|Treatment Period|Withdrawal by Subject|5|||
161966407|NCT00866047|584923633|FG000|Follow-up Period|Lost to Follow-up|5|||
161966408|NCT02928029|584923634|FG000|Overall Study|Withdrawal by Subject|0|||
161966409|NCT02928029|584923635|FG001|Overall Study|Withdrawal by Subject|1|||
161966410|NCT02928029|584923634|FG000|Overall Study|Radiological progression|1|||
161966411|NCT02928029|584923635|FG001|Overall Study|Radiological progression|0|||
161966412|NCT02928029|584923634|FG000|Overall Study|Clinical progression|1|||
161966413|NCT02928029|584923635|FG001|Overall Study|Clinical progression|2|||
161966414|NCT02928029|584923634|FG000|Overall Study|AE not related to clinical progression|1|||
161966415|NCT02928029|584923635|FG001|Overall Study|AE not related to clinical progression|1|||
161966416|NCT05427539|584923637|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
161966417|NCT05427539|584923638|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
161966418|NCT05427539|584923637|FG000|Period 1|Withdrawal by Subject|1|||
161966419|NCT05427539|584923638|FG001|Period 1|Withdrawal by Subject|0|||
161966420|NCT03718884|584923639|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
161966421|NCT03718884|584923640|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
161966422|NCT03718884|584923639|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
161966423|NCT03718884|584923640|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
161966424|NCT02099344|584923643|FG000|Overall Study|Physician Decision|1|||
161966425|NCT02099344|584923644|FG001|Overall Study|Physician Decision|0|||
161966426|NCT00404755|584923647|FG000|Phase I (Bupropion)|Adverse Event|3|||
161966427|NCT00404755|584923647|FG000|Phase I (Bupropion)|Other|1|||
161966428|NCT00404755|584923647|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
161966429|NCT04376684|584923650|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
161966430|NCT04376684|584923651|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
161966431|NCT04376684|584923652|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
161966432|NCT04376684|584923653|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
161966433|NCT04376684|584923650|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
161966434|NCT04376684|584923651|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
161743237|NCT01432457|584099706|FG001|Overall Study|Lack of Efficacy|1|||
161743238|NCT01432457|584099707|FG002|Overall Study|Lack of Efficacy|1|||
161743239|NCT01432457|584099705|FG000|Overall Study|Lost to Follow-up|11|||
161743240|NCT01432457|584099706|FG001|Overall Study|Lost to Follow-up|15|||
161743241|NCT01432457|584099707|FG002|Overall Study|Lost to Follow-up|20|||
161743242|NCT01432457|584099705|FG000|Overall Study|Protocol Violation|3|||
161743243|NCT01432457|584099706|FG001|Overall Study|Protocol Violation|2|||
161743244|NCT01432457|584099707|FG002|Overall Study|Protocol Violation|6|||
161743245|NCT01432457|584099705|FG000|Overall Study|Withdrawal by Subject|6|||
161743246|NCT01432457|584099706|FG001|Overall Study|Withdrawal by Subject|11|||
161743247|NCT01432457|584099707|FG002|Overall Study|Withdrawal by Subject|9|||
161743248|NCT01432457|584099705|FG000|Overall Study|Reasons not defined|2|||
161743249|NCT01432457|584099706|FG001|Overall Study|Reasons not defined|3|||
161743250|NCT01432457|584099707|FG002|Overall Study|Reasons not defined|4|||
161966435|NCT04376684|584923652|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
161966436|NCT04376684|584923653|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
161966437|NCT04376684|584923650|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
161966438|NCT04376684|584923651|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
161966439|NCT04376684|584923652|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
161966440|NCT04376684|584923653|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
161966441|NCT04376684|584923650|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
161966442|NCT04376684|584923651|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
161743251|NCT01432457|584099705|FG000|Overall Study|Did not take study drug|6|||
161743252|NCT01432457|584099706|FG001|Overall Study|Did not take study drug|6|||
161966443|NCT04376684|584923652|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
161966444|NCT04376684|584923653|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
161966445|NCT04376684|584923650|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
161841878|NCT03283319|584466226|FG001|Overall Study|Lost to Follow-up|4|||
161841879|NCT03283319|584466227|FG002|Overall Study|Lost to Follow-up|5|||
161841880|NCT03283319|584466228|FG003|Overall Study|Lost to Follow-up|5|||
161841881|NCT03283319|584466229|FG004|Overall Study|Lost to Follow-up|4|||
161841882|NCT03283319|584466230|FG005|Overall Study|Lost to Follow-up|3|||
161841883|NCT03283319|584466225|FG000|Overall Study|Withdrawal by Subject|2|||
161841884|NCT03283319|584466226|FG001|Overall Study|Withdrawal by Subject|2|||
161841885|NCT03283319|584466227|FG002|Overall Study|Withdrawal by Subject|2|||
161841886|NCT03283319|584466228|FG003|Overall Study|Withdrawal by Subject|1|||
161841887|NCT03283319|584466229|FG004|Overall Study|Withdrawal by Subject|0|||
161841888|NCT03283319|584466230|FG005|Overall Study|Withdrawal by Subject|1|||
161841889|NCT03283319|584466225|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
161841890|NCT03283319|584466226|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
161841891|NCT03283319|584466227|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
161841892|NCT03283319|584466228|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
161841893|NCT03283319|584466229|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
161841894|NCT03283319|584466230|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
161841895|NCT03954834|584466233|FG000|Overall Study|Adverse Event|1|||
161841896|NCT03954834|584466234|FG001|Overall Study|Adverse Event|3|||
161841897|NCT03954834|584466235|FG002|Overall Study|Adverse Event|1|||
161841898|NCT03954834|584466236|FG003|Overall Study|Adverse Event|1|||
161841899|NCT03954834|584466233|FG000|Overall Study|Death|0|||
161841900|NCT03954834|584466234|FG001|Overall Study|Death|0|||
161841901|NCT03954834|584466235|FG002|Overall Study|Death|0|||
161841902|NCT03954834|584466236|FG003|Overall Study|Death|1|||
161841903|NCT03954834|584466233|FG000|Overall Study|Physician Decision|0|||
161841904|NCT03954834|584466234|FG001|Overall Study|Physician Decision|1|||
161841905|NCT03954834|584466235|FG002|Overall Study|Physician Decision|0|||
161841906|NCT03954834|584466236|FG003|Overall Study|Physician Decision|2|||
161841907|NCT03954834|584466233|FG000|Overall Study|Protocol Violation|1|||
161841908|NCT03954834|584466234|FG001|Overall Study|Protocol Violation|0|||
161841909|NCT03954834|584466235|FG002|Overall Study|Protocol Violation|0|||
161841910|NCT03954834|584466236|FG003|Overall Study|Protocol Violation|1|||
161841911|NCT03954834|584466233|FG000|Overall Study|Withdrawal by Subject|2|||
161841912|NCT03954834|584466234|FG001|Overall Study|Withdrawal by Subject|3|||
161841913|NCT03954834|584466235|FG002|Overall Study|Withdrawal by Subject|13|||
161841914|NCT03954834|584466236|FG003|Overall Study|Withdrawal by Subject|6|||
161841915|NCT03954834|584466233|FG000|Overall Study|Participant left the country|0|||
161841916|NCT03954834|584466234|FG001|Overall Study|Participant left the country|0|||
161841917|NCT03954834|584466235|FG002|Overall Study|Participant left the country|1|||
161841918|NCT03954834|584466236|FG003|Overall Study|Participant left the country|0|||
161841919|NCT03954834|584466233|FG000|Overall Study|Lost to Follow-up|3|||
161841920|NCT03954834|584466234|FG001|Overall Study|Lost to Follow-up|2|||
161841921|NCT03954834|584466235|FG002|Overall Study|Lost to Follow-up|3|||
161841922|NCT03954834|584466236|FG003|Overall Study|Lost to Follow-up|5|||
161841923|NCT00540293|584466242|FG000|Overall Study|Adverse event related to study drug|10|||
161841924|NCT00540293|584466242|FG000|Overall Study|Adverse event not related to study drug|7|||
161841925|NCT00540293|584466242|FG000|Overall Study|Withdrawal by Subject|6|||
161841926|NCT00540293|584466242|FG000|Overall Study|Protocol violation, & subject schedule|12|||
161841927|NCT04492020|584466245|FG000|Overall Study|Adverse Event|1|||
161841928|NCT04492020|584466246|FG001|Overall Study|Adverse Event|3|||
161841929|NCT04492020|584466245|FG000|Overall Study|Withdrawal by Subject|4|||
161841930|NCT04492020|584466246|FG001|Overall Study|Withdrawal by Subject|3|||
161841931|NCT04492020|584466245|FG000|Overall Study|Lost to Follow-up|4|||
161966446|NCT04376684|584923651|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
161966447|NCT04376684|584923652|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
161966448|NCT04376684|584923653|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
161966449|NCT04376684|584923650|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
161966450|NCT04376684|584923651|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
161841932|NCT04492020|584466246|FG001|Overall Study|Lost to Follow-up|3|||
161841933|NCT04492020|584466245|FG000|Overall Study|Protocol Violation|5|||
161841934|NCT04492020|584466246|FG001|Overall Study|Protocol Violation|2|||
161966451|NCT04376684|584923652|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
161966452|NCT04376684|584923653|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
161966453|NCT04376684|584923650|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
161841935|NCT04492020|584466245|FG000|Overall Study|Lack of Qualifying Event|25|||
161841936|NCT04492020|584466246|FG001|Overall Study|Lack of Qualifying Event|27|||
161841937|NCT04492020|584466245|FG000|Overall Study|Non-compliance with Study Drug|2|||
161841938|NCT04492020|584466246|FG001|Overall Study|Non-compliance with Study Drug|1|||
161966454|NCT04376684|584923651|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
161841939|NCT00325195|584466247|FG000|Randomized|Not dosed|5|||
161841940|NCT00325195|584466248|FG001|Randomized|Not dosed|5|||
161841941|NCT00325195|584466249|FG002|Randomized|Not dosed|3|||
161841942|NCT00325195|584466247|FG000|Received Intervention: ITT Population|Adverse Event|15|||
161841943|NCT00325195|584466248|FG001|Received Intervention: ITT Population|Adverse Event|17|||
161841944|NCT00325195|584466249|FG002|Received Intervention: ITT Population|Adverse Event|1|||
161743253|NCT01432457|584099707|FG002|Overall Study|Did not take study drug|3|||
161743254|NCT03382262|584099708|FG000|Overall Study|Physician Decision|0|||
161743255|NCT03382262|584099709|FG001|Overall Study|Physician Decision|0|||
161743256|NCT03382262|584099710|FG002|Overall Study|Physician Decision|1|||
161743257|NCT03382262|584099711|FG003|Overall Study|Physician Decision|0|||
161743258|NCT03382262|584099708|FG000|Overall Study|Withdrawal by Subject|0|||
161743259|NCT03382262|584099709|FG001|Overall Study|Withdrawal by Subject|0|||
161743260|NCT03382262|584099710|FG002|Overall Study|Withdrawal by Subject|0|||
161743261|NCT03382262|584099711|FG003|Overall Study|Withdrawal by Subject|1|||
161743262|NCT02966353|584099712|FG000|Overall Study|Withdrawal by Subject|7|||
161743263|NCT02966353|584099712|FG000|Overall Study|Adverse Event|4|||
161743264|NCT02966353|584099712|FG000|Overall Study|Death|4|||
161743265|NCT02966353|584099712|FG000|Overall Study|Physician Decision|3|||
161743266|NCT02966353|584099712|FG000|Overall Study|Progressive disease|2|||
161743267|NCT02966353|584099712|FG000|Overall Study|Protocol deviation|2|||
161743268|NCT01090102|584099713|FG000|First 12 Weeks|Withdrawal by Subject|1|||
161743269|NCT01090102|584099714|FG001|First 12 Weeks|Withdrawal by Subject|1|||
161743270|NCT01090102|584099713|FG000|First 12 Weeks|Adverse Event|2|||
161743271|NCT01090102|584099714|FG001|First 12 Weeks|Adverse Event|0|||
161743272|NCT01090102|584099713|FG000|First 12 Weeks|Death|1|||
161743273|NCT01090102|584099714|FG001|First 12 Weeks|Death|1|||
161743274|NCT01090102|584099713|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
161743275|NCT01090102|584099714|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
161743276|NCT03518034|584099717|FG000|Overall Study|Not Treated|5|||
161743277|NCT03518034|584099718|FG001|Overall Study|Not Treated|1|||
161743278|NCT03518034|584099717|FG000|Overall Study|Withdrawal by Subject|309|||
161743279|NCT03518034|584099718|FG001|Overall Study|Withdrawal by Subject|351|||
161743280|NCT03518034|584099717|FG000|Overall Study|Lost to Follow-up|446|||
161743281|NCT03518034|584099718|FG001|Overall Study|Lost to Follow-up|458|||
161743282|NCT03518034|584099717|FG000|Overall Study|Adverse Event|138|||
161743283|NCT03518034|584099718|FG001|Overall Study|Adverse Event|130|||
161743284|NCT03518034|584099717|FG000|Overall Study|Lack of Efficacy|11|||
161743285|NCT03518034|584099718|FG001|Overall Study|Lack of Efficacy|23|||
161743286|NCT03518034|584099717|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
161743287|NCT03518034|584099718|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
161743288|NCT03518034|584099717|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
161743289|NCT03518034|584099718|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
161743290|NCT03518034|584099717|FG000|Overall Study|Other, Not Specified|84|||
161743291|NCT03518034|584099718|FG001|Overall Study|Other, Not Specified|53|||
161743292|NCT03518034|584099717|FG000|Overall Study|Reason Missing|2|||
161743293|NCT03518034|584099718|FG001|Overall Study|Reason Missing|3|||
161743294|NCT01527110|584099719|FG000|Overall Study|Adverse Event|1|||
161743295|NCT02007252|584099720|FG000|Overall Study|Administrative problems|3|||
161743296|NCT02007252|584099721|FG001|Overall Study|Administrative problems|7|||
161743297|NCT02007252|584099720|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161743298|NCT02007252|584099721|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161743299|NCT02007252|584099720|FG000|Overall Study|Adverse Event|7|||
161743300|NCT02007252|584099721|FG001|Overall Study|Adverse Event|4|||
161743301|NCT00367341|584099722|FG000|Overall Study|Physician Decision|1|||
161743302|NCT00367341|584099723|FG001|Overall Study|Physician Decision|0|||
161743303|NCT00367341|584099722|FG000|Overall Study|Protocol Violation|1|||
161743304|NCT00367341|584099723|FG001|Overall Study|Protocol Violation|0|||
161743305|NCT03325556|584099724|FG000|Open-label Period|Lack of Response in OL period|70|||
161743306|NCT03325556|584099725|FG001|Open-label Period|Lack of Response in OL period|0|||
161743307|NCT03325556|584099726|FG002|Open-label Period|Lack of Response in OL period|0|||
161743308|NCT03325556|584099724|FG000|Open-label Period|Adverse Event|27|||
161743309|NCT03325556|584099725|FG001|Open-label Period|Adverse Event|0|||
161743310|NCT03325556|584099726|FG002|Open-label Period|Adverse Event|0|||
161743311|NCT03325556|584099724|FG000|Open-label Period|Death|1|||
161743312|NCT03325556|584099725|FG001|Open-label Period|Death|0|||
161743313|NCT03325556|584099726|FG002|Open-label Period|Death|0|||
161966455|NCT04376684|584923652|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
161743314|NCT03325556|584099724|FG000|Open-label Period|Lost to Follow-up|1|||
161743315|NCT03325556|584099725|FG001|Open-label Period|Lost to Follow-up|0|||
161743316|NCT03325556|584099726|FG002|Open-label Period|Lost to Follow-up|0|||
161743317|NCT03325556|584099724|FG000|Open-label Period|Non-compliance with study drug|5|||
161743318|NCT03325556|584099725|FG001|Open-label Period|Non-compliance with study drug|0|||
161743319|NCT03325556|584099726|FG002|Open-label Period|Non-compliance with study drug|0|||
161743320|NCT03325556|584099724|FG000|Open-label Period|Use of prohibited medication|1|||
161743321|NCT03325556|584099725|FG001|Open-label Period|Use of prohibited medication|0|||
161743322|NCT03325556|584099726|FG002|Open-label Period|Use of prohibited medication|0|||
161966456|NCT04376684|584923653|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
161743323|NCT03325556|584099724|FG000|Open-label Period|Protocol Violation|4|||
161743324|NCT03325556|584099725|FG001|Open-label Period|Protocol Violation|0|||
161743325|NCT03325556|584099726|FG002|Open-label Period|Protocol Violation|0|||
161966457|NCT01666119|584923654|FG000|Overall Study|Adverse Event|6|||
161743326|NCT03325556|584099724|FG000|Open-label Period|Withdrawal by Subject|17|||
161743327|NCT03325556|584099725|FG001|Open-label Period|Withdrawal by Subject|0|||
161743328|NCT03325556|584099726|FG002|Open-label Period|Withdrawal by Subject|0|||
161743329|NCT03325556|584099724|FG000|Open-label Period|Not otherwise specified|8|||
161743330|NCT03325556|584099725|FG001|Open-label Period|Not otherwise specified|0|||
161743331|NCT03325556|584099726|FG002|Open-label Period|Not otherwise specified|0|||
161743332|NCT03325556|584099724|FG000|Open-label Period|Administrative discont. at study termination|41|||
161743333|NCT03325556|584099725|FG001|Open-label Period|Administrative discont. at study termination|0|||
161743334|NCT03325556|584099726|FG002|Open-label Period|Administrative discont. at study termination|0|||
161743335|NCT03325556|584099724|FG000|Double-blind Period|Relapse|0|||
161743336|NCT03325556|584099725|FG001|Double-blind Period|Relapse|15|||
161743337|NCT03325556|584099726|FG002|Double-blind Period|Relapse|34|||
161743338|NCT03325556|584099724|FG000|Double-blind Period|Adverse Event|0|||
161743339|NCT03325556|584099725|FG001|Double-blind Period|Adverse Event|3|||
161743340|NCT03325556|584099726|FG002|Double-blind Period|Adverse Event|1|||
161743341|NCT03325556|584099724|FG000|Double-blind Period|Noncompliance with study drug|0|||
161743342|NCT03325556|584099725|FG001|Double-blind Period|Noncompliance with study drug|0|||
161743343|NCT03325556|584099726|FG002|Double-blind Period|Noncompliance with study drug|1|||
161743344|NCT03325556|584099724|FG000|Double-blind Period|Use of prohibited medication|0|||
161743345|NCT03325556|584099725|FG001|Double-blind Period|Use of prohibited medication|1|||
161743346|NCT03325556|584099726|FG002|Double-blind Period|Use of prohibited medication|0|||
161743347|NCT03325556|584099724|FG000|Double-blind Period|Physician Decision|0|||
161743348|NCT03325556|584099725|FG001|Double-blind Period|Physician Decision|0|||
161743349|NCT03325556|584099726|FG002|Double-blind Period|Physician Decision|1|||
161743350|NCT03325556|584099724|FG000|Double-blind Period|Withdrawal by Subject|0|||
161743351|NCT03325556|584099725|FG001|Double-blind Period|Withdrawal by Subject|6|||
161743352|NCT03325556|584099726|FG002|Double-blind Period|Withdrawal by Subject|4|||
161743353|NCT03325556|584099724|FG000|Double-blind Period|Not otherwise specified|0|||
161743354|NCT03325556|584099725|FG001|Double-blind Period|Not otherwise specified|1|||
161743355|NCT03325556|584099726|FG002|Double-blind Period|Not otherwise specified|5|||
161743356|NCT03325556|584099724|FG000|Double-blind Period|Administrative discont. at study termination|0|||
161743357|NCT03325556|584099725|FG001|Double-blind Period|Administrative discont. at study termination|35|||
161743358|NCT03325556|584099726|FG002|Double-blind Period|Administrative discont. at study termination|31|||
161743359|NCT01705587|584099727|FG000|Overall Study|Withdrawal by Subject|0|||
161743360|NCT01705587|584099728|FG001|Overall Study|Withdrawal by Subject|1|||
161743361|NCT00762268|584099729|FG000|Overall Study|Withdrawal by Subject|3|||
161743362|NCT00762268|584099730|FG001|Overall Study|Withdrawal by Subject|3|||
161743363|NCT03892707|584099737|FG000|Overall Study|Screen failure|6|||
161743364|NCT03892707|584099738|FG001|Overall Study|Screen failure|0|||
161743365|NCT03892707|584099737|FG000|Overall Study|Pain resolution|0|||
161743366|NCT03892707|584099738|FG001|Overall Study|Pain resolution|4|||
161743367|NCT03892707|584099737|FG000|Overall Study|Withdrawal by Subject|0|||
161743368|NCT03892707|584099738|FG001|Overall Study|Withdrawal by Subject|1|||
161743369|NCT03892707|584099737|FG000|Overall Study|Other (long business trip)|0|||
161743370|NCT03892707|584099738|FG001|Overall Study|Other (long business trip)|1|||
161743371|NCT05224076|584099741|FG000|Overall Study|Lost to Follow-up|24|||
161743372|NCT01807949|584099743|FG000|Overall Study|Adverse Event|1|||
161743373|NCT01807949|584099744|FG001|Overall Study|Adverse Event|2|||
161743374|NCT01807949|584099745|FG002|Overall Study|Adverse Event|2|||
161743375|NCT01807949|584099743|FG000|Overall Study|Withdrawal by Subject|1|||
161743376|NCT01807949|584099744|FG001|Overall Study|Withdrawal by Subject|2|||
161743377|NCT01807949|584099745|FG002|Overall Study|Withdrawal by Subject|2|||
161743378|NCT01807949|584099743|FG000|Overall Study|Non-Compliance|0|||
161743379|NCT01807949|584099744|FG001|Overall Study|Non-Compliance|0|||
161743380|NCT01807949|584099745|FG002|Overall Study|Non-Compliance|1|||
161743381|NCT01807949|584099743|FG000|Overall Study|Undefined|0|||
161743382|NCT01807949|584099744|FG001|Overall Study|Undefined|1|||
161743383|NCT01807949|584099745|FG002|Overall Study|Undefined|2|||
161743384|NCT01807949|584099743|FG000|Overall Study|Randomized But Not Treated|0|||
161743385|NCT01807949|584099744|FG001|Overall Study|Randomized But Not Treated|2|||
161743386|NCT01807949|584099745|FG002|Overall Study|Randomized But Not Treated|2|||
161743387|NCT04325906|584099748|FG000|Overall Study|Withdrawal by Subject|2|||
161743388|NCT04325906|584099749|FG001|Overall Study|Withdrawal by Subject|0|||
161743389|NCT00881361|584099750|FG000|Overall Study|Terminated prior to surgery|27|||
161743390|NCT00881361|584099751|FG001|Overall Study|Terminated prior to surgery|7|||
161743391|NCT00881361|584099752|FG002|Overall Study|Terminated prior to surgery|0|||
161743392|NCT00881361|584099750|FG000|Overall Study|Ineligible|17|||
161743393|NCT00881361|584099751|FG001|Overall Study|Ineligible|2|||
161743394|NCT00881361|584099752|FG002|Overall Study|Ineligible|2|||
161743395|NCT02141217|584099753|FG000|Overall Study|Adverse Event|1|||
161743396|NCT02141217|584099754|FG001|Overall Study|Adverse Event|2|||
161743397|NCT02141217|584099753|FG000|Overall Study|Protocol Violation|1|||
161743398|NCT02141217|584099754|FG001|Overall Study|Protocol Violation|4|||
161743399|NCT02141217|584099753|FG000|Overall Study|Withdrawal by Subject|6|||
161743400|NCT02141217|584099754|FG001|Overall Study|Withdrawal by Subject|0|||
161743401|NCT02141217|584099753|FG000|Overall Study|Lost to Follow-up|1|||
161841945|NCT00325195|584466247|FG000|Received Intervention: ITT Population|Death|3|||
161841946|NCT00325195|584466248|FG001|Received Intervention: ITT Population|Death|1|||
161841947|NCT00325195|584466249|FG002|Received Intervention: ITT Population|Death|0|||
161841948|NCT00325195|584466247|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
161841949|NCT00325195|584466248|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
161841950|NCT00325195|584466249|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
161841951|NCT00325195|584466247|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
161841952|NCT00325195|584466248|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
161841953|NCT00325195|584466249|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
161841954|NCT00325195|584466247|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
161841955|NCT00325195|584466248|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
161841956|NCT00325195|584466249|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
161841957|NCT04594707|584466250|FG000|Overall Study|Adverse Event|0|||
161841958|NCT04594707|584466251|FG001|Overall Study|Adverse Event|0|||
161841959|NCT04594707|584466252|FG002|Overall Study|Adverse Event|1|||
161841960|NCT04594707|584466250|FG000|Overall Study|Death|0|||
161841961|NCT04594707|584466251|FG001|Overall Study|Death|2|||
161841962|NCT04594707|584466252|FG002|Overall Study|Death|2|||
161841963|NCT04594707|584466250|FG000|Overall Study|Lung Transplant|0|||
161841964|NCT04594707|584466251|FG001|Overall Study|Lung Transplant|0|||
161841965|NCT04594707|584466252|FG002|Overall Study|Lung Transplant|1|||
161841966|NCT04594707|584466250|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
161841967|NCT04594707|584466251|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
161841968|NCT04594707|584466252|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
161841969|NCT04594707|584466250|FG000|Overall Study|Study Terminated By Sponsor|19|||
161841970|NCT04594707|584466251|FG001|Overall Study|Study Terminated By Sponsor|47|||
161841971|NCT04594707|584466252|FG002|Overall Study|Study Terminated By Sponsor|41|||
161841972|NCT04594707|584466250|FG000|Overall Study|Withdrawal by Subject|1|||
161841973|NCT04594707|584466251|FG001|Overall Study|Withdrawal by Subject|0|||
161841974|NCT04594707|584466252|FG002|Overall Study|Withdrawal by Subject|2|||
161966458|NCT01666119|584923654|FG000|Overall Study|Withdrawal by Subject|16|||
161743402|NCT02141217|584099754|FG001|Overall Study|Lost to Follow-up|1|||
161743403|NCT02141217|584099753|FG000|Overall Study|Physician Decision|1|||
161743404|NCT02141217|584099754|FG001|Overall Study|Physician Decision|0|||
161743405|NCT02141217|584099753|FG000|Overall Study|Surgical Intervention|1|||
161743406|NCT02141217|584099754|FG001|Overall Study|Surgical Intervention|1|||
161743407|NCT04603391|584099759|FG000|First Intervention (4 Days)|Adverse Event|1|||
161743408|NCT04603391|584099760|FG001|First Intervention (4 Days)|Adverse Event|0|||
161743409|NCT04603391|584099759|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
161743410|NCT04603391|584099760|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
161743411|NCT02759861|584099763|FG000|Overall Study|Death|1|||
161743412|NCT02151682|584099764|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161743413|NCT02151682|584099765|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
161743414|NCT02151682|584099766|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161743415|NCT02151682|584099767|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161743416|NCT02151682|584099768|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161743417|NCT02151682|584099769|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161743418|NCT02151682|584099764|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161743419|NCT02151682|584099765|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
161743420|NCT02151682|584099766|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161743421|NCT02151682|584099767|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161743422|NCT02151682|584099768|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161743423|NCT02151682|584099769|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161743424|NCT02151682|584099764|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161743425|NCT02151682|584099765|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
161743426|NCT02151682|584099766|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161743427|NCT02151682|584099767|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161743428|NCT02151682|584099768|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161743429|NCT02151682|584099769|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161743430|NCT02151682|584099764|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
161743431|NCT02151682|584099765|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
161743432|NCT02151682|584099766|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
161743433|NCT02151682|584099767|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
161743434|NCT02151682|584099768|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
161743435|NCT02151682|584099769|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
161743436|NCT02151682|584099764|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
161743437|NCT02151682|584099765|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161743438|NCT02151682|584099766|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161743439|NCT02151682|584099767|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161743440|NCT02151682|584099768|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161743441|NCT02151682|584099769|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161743442|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161743443|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161966459|NCT01666119|584923654|FG000|Overall Study|Lost to Follow-up|7|||
161966460|NCT01666119|584923654|FG000|Overall Study|non compliance with study medication, pa|18|||
161966461|NCT01666119|584923654|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
161966462|NCT00516906|584923667|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
161966463|NCT00516906|584923668|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
161966464|NCT01974206|584923669|FG000|Overall Study|Did Not Take Study Drug|0|||
161966465|NCT01974206|584923670|FG001|Overall Study|Did Not Take Study Drug|1|||
161966466|NCT01974206|584923669|FG000|Overall Study|Physician Decision|1|||
161966467|NCT01974206|584923670|FG001|Overall Study|Physician Decision|0|||
161966468|NCT01974206|584923669|FG000|Overall Study|Withdrawal by Subject|3|||
161966469|NCT01974206|584923670|FG001|Overall Study|Withdrawal by Subject|0|||
161966470|NCT01974206|584923669|FG000|Overall Study|Lost to Follow-up|1|||
161966471|NCT01974206|584923670|FG001|Overall Study|Lost to Follow-up|0|||
161966472|NCT01974206|584923669|FG000|Overall Study|Death|1|||
161966473|NCT01974206|584923670|FG001|Overall Study|Death|0|||
161966474|NCT03802630|584923671|FG000|Overall Study|Study terminated by sponsor|130|||
161966475|NCT03802630|584923672|FG001|Overall Study|Study terminated by sponsor|134|||
161966476|NCT03802630|584923671|FG000|Overall Study|Subject decision|16|||
161966477|NCT03802630|584923672|FG001|Overall Study|Subject decision|9|||
161966478|NCT03802630|584923671|FG000|Overall Study|Adverse Event|3|||
161966479|NCT03802630|584923672|FG001|Overall Study|Adverse Event|1|||
161966480|NCT03802630|584923671|FG000|Overall Study|Lost to Follow-up|2|||
161966481|NCT03802630|584923672|FG001|Overall Study|Lost to Follow-up|2|||
161966482|NCT03802630|584923671|FG000|Overall Study|Physician Decision|2|||
161966483|NCT03802630|584923672|FG001|Overall Study|Physician Decision|0|||
161966484|NCT03802630|584923671|FG000|Overall Study|Death|0|||
161966485|NCT03802630|584923672|FG001|Overall Study|Death|2|||
161966486|NCT06099223|584923673|FG000|Overall Study|Preoperative surveys missed|0|||
161966487|NCT06099223|584923674|FG001|Overall Study|Preoperative surveys missed|1|||
161966488|NCT01221623|584923677|FG000|Overall Study|Withdrawal by Subject|19|||
161966489|NCT01221623|584923678|FG001|Overall Study|Withdrawal by Subject|8|||
161966490|NCT01221623|584923677|FG000|Overall Study|Lost to Follow-up|7|||
161966491|NCT01221623|584923678|FG001|Overall Study|Lost to Follow-up|1|||
161743444|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
161743445|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161743446|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161743447|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161743448|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
161743449|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
161743450|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
161743451|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
161743452|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
161743453|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
161743454|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
161743455|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
161743456|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
161743457|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
161743458|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
161743459|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
161743460|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161743461|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161743462|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
161743463|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161743464|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161743465|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161743466|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161743467|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161743468|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
161743469|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161743470|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161743471|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161743472|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161743473|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161743474|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
161743475|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161841975|NCT01175811|584466253|FG000|Overall Study|Adverse Event|1|||
161743476|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161743477|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161743478|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
161743479|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
161743480|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
161743481|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
161743482|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
161743483|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
161743484|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
161743485|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
161743486|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
161743487|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
161743488|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
161743489|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
161743490|NCT02151682|584099764|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161743491|NCT02151682|584099765|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161743492|NCT02151682|584099766|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
161743493|NCT02151682|584099767|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161743494|NCT02151682|584099768|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161743495|NCT02151682|584099769|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161743496|NCT02151682|584099764|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161743497|NCT02151682|584099765|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161743498|NCT02151682|584099766|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161743499|NCT02151682|584099767|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161743500|NCT02151682|584099768|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161743501|NCT02151682|584099769|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
161743502|NCT02151682|584099764|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161743503|NCT02151682|584099765|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161743504|NCT02151682|584099766|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161743505|NCT02151682|584099767|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161743506|NCT02151682|584099768|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161743507|NCT02151682|584099769|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
161743508|NCT02151682|584099764|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161743509|NCT02151682|584099765|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161743510|NCT02151682|584099766|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161743511|NCT02151682|584099767|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161743512|NCT02151682|584099768|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161743513|NCT02151682|584099769|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
161743514|NCT02151682|584099764|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161743515|NCT02151682|584099765|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161743516|NCT02151682|584099766|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161743517|NCT02151682|584099767|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161743518|NCT02151682|584099768|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161743519|NCT02151682|584099769|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
161743520|NCT02988219|584099770|FG000|Overall Study|Lack of Efficacy|1|||
161743521|NCT02988219|584099771|FG001|Overall Study|Lack of Efficacy|1|||
161743522|NCT02988219|584099770|FG000|Overall Study|Withdrawal by Subject|0|||
161743523|NCT02988219|584099771|FG001|Overall Study|Withdrawal by Subject|2|||
161743524|NCT01522443|584099772|FG000|Overall Study|No longer receiving clinical benefit|36|||
161743525|NCT01522443|584099773|FG001|Overall Study|No longer receiving clinical benefit|28|||
161743526|NCT01522443|584099772|FG000|Overall Study|Adverse Event|10|||
161743527|NCT01522443|584099773|FG001|Overall Study|Adverse Event|15|||
161743528|NCT01522443|584099772|FG000|Overall Study|Withdrawal by Subject|5|||
161743529|NCT01522443|584099773|FG001|Overall Study|Withdrawal by Subject|8|||
161743530|NCT01522443|584099772|FG000|Overall Study|No study treatment given|1|||
161743531|NCT01522443|584099773|FG001|Overall Study|No study treatment given|1|||
161743532|NCT01522443|584099772|FG000|Overall Study|Other|1|||
161743533|NCT01522443|584099773|FG001|Overall Study|Other|3|||
161966492|NCT01221623|584923677|FG000|Overall Study|Adverse Event|6|||
161966493|NCT01221623|584923678|FG001|Overall Study|Adverse Event|3|||
161966494|NCT01221623|584923677|FG000|Overall Study|Death|1|||
161966495|NCT01221623|584923678|FG001|Overall Study|Death|0|||
161966496|NCT01221623|584923677|FG000|Overall Study|Other|5|||
161743534|NCT03260894|584099774|FG000|Overall Study|Death|6|||
161743535|NCT03260894|584099775|FG001|Overall Study|Death|8|||
161743536|NCT03260894|584099774|FG000|Overall Study|Withdrawal by Subject|4|||
161966497|NCT01221623|584923678|FG001|Overall Study|Other|2|||
161743537|NCT03260894|584099775|FG001|Overall Study|Withdrawal by Subject|11|||
161743538|NCT03260894|584099774|FG000|Overall Study|On-going at clinical cut off date|36|||
161743539|NCT03260894|584099775|FG001|Overall Study|On-going at clinical cut off date|31|||
161743540|NCT00973622|584099776|FG000|Overall Study|did not attend MRI|14|||
161743541|NCT00973622|584099777|FG001|Overall Study|did not attend MRI|3|||
161743542|NCT00973622|584099776|FG000|Overall Study|did not pass MRI screen|6|||
161743543|NCT00973622|584099777|FG001|Overall Study|did not pass MRI screen|0|||
161743544|NCT00973622|584099776|FG000|Overall Study|did not complete rTMS sessions|11|||
161743545|NCT00973622|584099777|FG001|Overall Study|did not complete rTMS sessions|2|||
161743546|NCT00555568|584099778|FG000|Overall Study|Lost to Follow-up|26|||
161743547|NCT00555568|584099779|FG001|Overall Study|Lost to Follow-up|16|||
161743548|NCT00555568|584099780|FG002|Overall Study|Lost to Follow-up|16|||
161743549|NCT06000501|584099781|FG000|Overall Study|Screen failure|3|||
161743550|NCT06000501|584099781|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
161743551|NCT06000501|584099781|FG000|Overall Study|Physician Decision|4|||
161743552|NCT06000501|584099781|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
161743553|NCT06000501|584099781|FG000|Overall Study|Scheduling issues|2|||
161743554|NCT02677220|584099782|FG000|Overall Study|Adverse Event|1|||
161743555|NCT00067470|584099783|FG000|Overall Study|Withdrawal by Subject|0|||
161743556|NCT00067470|584099784|FG001|Overall Study|Withdrawal by Subject|1|||
161743557|NCT01074658|584099785|FG000|Overall Study|No implant attempted|19|||
161743558|NCT00050622|584099786|FG000|Overall Study|Adverse Event|1|||
161743559|NCT01342952|584099787|FG000|Overall Study|Adverse Event|0|||
161966498|NCT00661726|584923679|FG000|Overall Study|Adverse Event|1|||
161966499|NCT02147197|584923680|FG000|Overall Study|Adverse Event|1|||
161743560|NCT01342952|584099788|FG001|Overall Study|Adverse Event|5|||
161743561|NCT01342952|584099789|FG002|Overall Study|Adverse Event|1|||
161743562|NCT01342952|584099790|FG003|Overall Study|Adverse Event|0|||
161743563|NCT01342952|584099787|FG000|Overall Study|Lost to Follow-up|0|||
161743564|NCT01342952|584099788|FG001|Overall Study|Lost to Follow-up|2|||
161743565|NCT01342952|584099789|FG002|Overall Study|Lost to Follow-up|0|||
161743566|NCT01342952|584099790|FG003|Overall Study|Lost to Follow-up|0|||
161743567|NCT01342952|584099787|FG000|Overall Study|Withdrawal by Subject|1|||
161743568|NCT01342952|584099788|FG001|Overall Study|Withdrawal by Subject|1|||
161743569|NCT01342952|584099789|FG002|Overall Study|Withdrawal by Subject|0|||
161743570|NCT01342952|584099790|FG003|Overall Study|Withdrawal by Subject|0|||
161743571|NCT01342952|584099787|FG000|Overall Study|Physician Decision|3|||
161743572|NCT01342952|584099788|FG001|Overall Study|Physician Decision|3|||
161743573|NCT01342952|584099789|FG002|Overall Study|Physician Decision|1|||
161743574|NCT01342952|584099790|FG003|Overall Study|Physician Decision|0|||
161743575|NCT00426556|584099791|FG000|Phase I - Core Phase|Disease Progression|0|||
161743576|NCT00426556|584099792|FG001|Phase I - Core Phase|Disease Progression|6|||
161743577|NCT00426556|584099793|FG002|Phase I - Core Phase|Disease Progression|2|||
161743578|NCT00426556|584099794|FG003|Phase I - Core Phase|Disease Progression|0|||
161743579|NCT00426556|584099791|FG000|Phase I - Core Phase|Adverse Event|1|||
161743580|NCT00426556|584099792|FG001|Phase I - Core Phase|Adverse Event|3|||
161743581|NCT00426556|584099793|FG002|Phase I - Core Phase|Adverse Event|1|||
161743582|NCT00426556|584099794|FG003|Phase I - Core Phase|Adverse Event|0|||
161743583|NCT00426556|584099791|FG000|Phase I - Core Phase|Death|0|||
161743584|NCT00426556|584099792|FG001|Phase I - Core Phase|Death|1|||
161743585|NCT00426556|584099793|FG002|Phase I - Core Phase|Death|0|||
161743586|NCT00426556|584099794|FG003|Phase I - Core Phase|Death|0|||
161743587|NCT00426556|584099791|FG000|Phase I - Extension Phase|Adverse Event|0|||
161743588|NCT00426556|584099792|FG001|Phase I - Extension Phase|Adverse Event|1|||
161743589|NCT00426556|584099793|FG002|Phase I - Extension Phase|Adverse Event|1|||
161743590|NCT00426556|584099794|FG003|Phase I - Extension Phase|Adverse Event|0|||
161743591|NCT00426556|584099791|FG000|Phase I - Extension Phase|Disease Progression|5|||
161743592|NCT00426556|584099792|FG001|Phase I - Extension Phase|Disease Progression|5|||
161743593|NCT00426556|584099793|FG002|Phase I - Extension Phase|Disease Progression|6|||
161743594|NCT00426556|584099794|FG003|Phase I - Extension Phase|Disease Progression|0|||
161743595|NCT00426556|584099791|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
161743596|NCT00426556|584099792|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
161743597|NCT00426556|584099793|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
161743598|NCT00426556|584099794|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
161743599|NCT00426556|584099791|FG000|Phase II - Core Phase|Disease Progression|0|||
161743600|NCT00426556|584099792|FG001|Phase II - Core Phase|Disease Progression|0|||
161743601|NCT00426556|584099793|FG002|Phase II - Core Phase|Disease Progression|0|||
161743602|NCT00426556|584099794|FG003|Phase II - Core Phase|Disease Progression|16|||
161743603|NCT00426556|584099791|FG000|Phase II - Core Phase|Adverse Event|0|||
161743604|NCT00426556|584099792|FG001|Phase II - Core Phase|Adverse Event|0|||
161743605|NCT00426556|584099793|FG002|Phase II - Core Phase|Adverse Event|0|||
161743606|NCT00426556|584099794|FG003|Phase II - Core Phase|Adverse Event|8|||
161743607|NCT00426556|584099791|FG000|Phase II - Extension Phase|Disease Progression|0|||
161743608|NCT00426556|584099792|FG001|Phase II - Extension Phase|Disease Progression|0|||
161743609|NCT00426556|584099793|FG002|Phase II - Extension Phase|Disease Progression|0|||
161743610|NCT00426556|584099794|FG003|Phase II - Extension Phase|Disease Progression|21|||
161743611|NCT00426556|584099791|FG000|Phase II - Extension Phase|Adverse Event|0|||
161966500|NCT02147197|584923681|FG001|Overall Study|Adverse Event|0|||
161966501|NCT02147197|584923682|FG002|Overall Study|Adverse Event|0|||
161966502|NCT02147197|584923680|FG000|Overall Study|Withdrawal of Consent|4|||
161966503|NCT02147197|584923681|FG001|Overall Study|Withdrawal of Consent|3|||
161966504|NCT02147197|584923682|FG002|Overall Study|Withdrawal of Consent|2|||
161966505|NCT02147197|584923680|FG000|Overall Study|Lost to Follow-up|2|||
161966506|NCT02147197|584923681|FG001|Overall Study|Lost to Follow-up|3|||
161966507|NCT02147197|584923682|FG002|Overall Study|Lost to Follow-up|1|||
161966508|NCT02147197|584923680|FG000|Overall Study|Protocol Violation|1|||
161966509|NCT02147197|584923681|FG001|Overall Study|Protocol Violation|0|||
161966510|NCT02147197|584923682|FG002|Overall Study|Protocol Violation|3|||
161966511|NCT02147197|584923680|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161966512|NCT02147197|584923681|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161966513|NCT02147197|584923682|FG002|Overall Study|Other Miscellaneous Reasons|3|||
161966514|NCT02644096|584923683|FG000|Overall Study|Withdrawal by Subject|28|||
161966515|NCT02644096|584923684|FG001|Overall Study|Withdrawal by Subject|25|||
161966516|NCT00830375|584923685|FG000|Overall Study|Lost to Follow-up|1|||
161966517|NCT01700959|584923686|FG000|Overall Study|Adverse Event|0|||
161966518|NCT01700959|584923687|FG001|Overall Study|Adverse Event|1|||
161966519|NCT01700959|584923688|FG002|Overall Study|Adverse Event|1|||
161966520|NCT01700959|584923689|FG003|Overall Study|Adverse Event|2|||
161966521|NCT01700959|584923690|FG004|Overall Study|Adverse Event|0|||
161966522|NCT01700959|584923691|FG005|Overall Study|Adverse Event|2|||
161966523|NCT01700959|584923686|FG000|Overall Study|Withdrawal by Subject|15|||
161966524|NCT01700959|584923687|FG001|Overall Study|Withdrawal by Subject|9|||
161966525|NCT01700959|584923688|FG002|Overall Study|Withdrawal by Subject|12|||
161966526|NCT01700959|584923689|FG003|Overall Study|Withdrawal by Subject|11|||
161966527|NCT01700959|584923690|FG004|Overall Study|Withdrawal by Subject|8|||
161966528|NCT01700959|584923691|FG005|Overall Study|Withdrawal by Subject|12|||
161966529|NCT01700959|584923686|FG000|Overall Study|Ineligible|2|||
161966530|NCT01700959|584923687|FG001|Overall Study|Ineligible|1|||
161966531|NCT01700959|584923688|FG002|Overall Study|Ineligible|2|||
161966532|NCT01700959|584923689|FG003|Overall Study|Ineligible|0|||
161966533|NCT01700959|584923690|FG004|Overall Study|Ineligible|0|||
161966534|NCT01700959|584923691|FG005|Overall Study|Ineligible|1|||
161966535|NCT01700959|584923686|FG000|Overall Study|Noncompliant|9|||
161966536|NCT01700959|584923687|FG001|Overall Study|Noncompliant|9|||
161966537|NCT01700959|584923688|FG002|Overall Study|Noncompliant|17|||
161966538|NCT01700959|584923689|FG003|Overall Study|Noncompliant|18|||
161966539|NCT01700959|584923690|FG004|Overall Study|Noncompliant|15|||
161966540|NCT01700959|584923691|FG005|Overall Study|Noncompliant|9|||
161966541|NCT01700959|584923686|FG000|Overall Study|Side effects|1|||
161966542|NCT01700959|584923687|FG001|Overall Study|Side effects|4|||
161966543|NCT01700959|584923688|FG002|Overall Study|Side effects|8|||
161743612|NCT00426556|584099792|FG001|Phase II - Extension Phase|Adverse Event|0|||
161743613|NCT00426556|584099793|FG002|Phase II - Extension Phase|Adverse Event|0|||
161743614|NCT00426556|584099794|FG003|Phase II - Extension Phase|Adverse Event|2|||
161743615|NCT01192204|584099800|FG000|Overall Study|could not keep recall appointments|1|||
161743616|NCT01192204|584099801|FG001|Overall Study|could not keep recall appointments|0|||
161966544|NCT01700959|584923689|FG003|Overall Study|Side effects|4|||
161966545|NCT01700959|584923690|FG004|Overall Study|Side effects|4|||
161966546|NCT01700959|584923691|FG005|Overall Study|Side effects|1|||
161966547|NCT00322452|584923692|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161966548|NCT00322452|584923693|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161966549|NCT00322452|584923692|FG000|Overall Study|Lost to Follow-up|5|||
161966550|NCT00322452|584923693|FG001|Overall Study|Lost to Follow-up|2|||
161966551|NCT00322452|584923692|FG000|Overall Study|Withdrawal by Subject|19|||
161966552|NCT00322452|584923693|FG001|Overall Study|Withdrawal by Subject|46|||
161966553|NCT00322452|584923692|FG000|Overall Study|Death|223|||
161966554|NCT00322452|584923693|FG001|Overall Study|Death|227|||
161966555|NCT02438384|584923694|FG000|Overall Study|Lost to Follow-up|8|||
161966556|NCT02438384|584923695|FG001|Overall Study|Lost to Follow-up|6|||
161966557|NCT02438384|584923696|FG002|Overall Study|Lost to Follow-up|4|||
161966558|NCT02650128|584923697|FG000|Overall Study|Death|2|||
161966559|NCT00711113|584925636|FG000|Overall Study|Lost to Follow-up|9|||
161966560|NCT00711113|584925636|FG000|Overall Study|Implant lost|2|||
161966561|NCT05312632|584925639|FG000|Overall Study|Adverse Event|12|||
161966562|NCT05312632|584925639|FG000|Overall Study|Withdrawal by Subject|10|||
161966563|NCT05312632|584925639|FG000|Overall Study|Lack of Efficacy|4|||
161966564|NCT05312632|584925639|FG000|Overall Study|Non-compliance with study procedures|9|||
161966565|NCT05312632|584925639|FG000|Overall Study|Other|4|||
161966566|NCT02379221|584925640|FG000|Overall Study|Lost to Follow-up|1|||
161966567|NCT00519376|584925641|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161966568|NCT00519376|584925642|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161966569|NCT00519376|584925643|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161966570|NCT00519376|584925644|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161966571|NCT00519376|584925645|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161966572|NCT00519376|584925646|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161743617|NCT02146248|584099802|FG000|Overall Study|Withdrawal by Subject|2|||
161743618|NCT00425100|584099803|FG000|Overall Study|Adverse Event|36|||
161743619|NCT00425100|584099803|FG000|Overall Study|Lack of Efficacy|4|||
161743620|NCT00425100|584099803|FG000|Overall Study|Lost to Follow-up|2|||
161743621|NCT00425100|584099803|FG000|Overall Study|Protocol Violation|4|||
161743622|NCT00425100|584099803|FG000|Overall Study|Withdrawal by Subject|7|||
161743623|NCT03699631|584099807|FG000|Overall Study|Adverse Event|3|||
161743624|NCT02219087|584099808|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
161743625|NCT02219087|584099809|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
161743626|NCT05127421|584099810|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
161743627|NCT05127421|584099811|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
161743628|NCT05127421|584099812|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
161743629|NCT05127421|584099813|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
161743630|NCT05127421|584099810|FG000|4-Week Double-Blind Period|Physician Decision|1|||
161743631|NCT05127421|584099811|FG001|4-Week Double-Blind Period|Physician Decision|0|||
161743632|NCT05127421|584099812|FG002|4-Week Double-Blind Period|Physician Decision|0|||
161743633|NCT05127421|584099813|FG003|4-Week Double-Blind Period|Physician Decision|0|||
161743634|NCT05127421|584099810|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
161743635|NCT05127421|584099811|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
161743636|NCT05127421|584099812|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
161743637|NCT05127421|584099813|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
161743638|NCT05127421|584099810|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
161743639|NCT05127421|584099811|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
161743640|NCT05127421|584099812|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
161743641|NCT05127421|584099813|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
161743642|NCT05127421|584099810|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
161743643|NCT05127421|584099811|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
161743644|NCT05127421|584099812|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
161743645|NCT05127421|584099813|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
161743646|NCT05127421|584099810|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
161743647|NCT05127421|584099811|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
161743648|NCT05127421|584099812|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
161743649|NCT05127421|584099813|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
161743650|NCT05127421|584099810|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
161743651|NCT05127421|584099811|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
161743652|NCT05127421|584099812|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
161743653|NCT05127421|584099813|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
161743654|NCT05127421|584099810|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
161743655|NCT05127421|584099811|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
161743656|NCT05127421|584099812|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
161743657|NCT05127421|584099813|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
161743658|NCT00618449|584099814|FG000|Overall Study|Lost to Follow-up|98|||
161743659|NCT00618449|584099815|FG001|Overall Study|Lost to Follow-up|110|||
161743660|NCT04311177|584099816|FG000|Overall Study|Adverse Event|3|||
161743661|NCT04311177|584099817|FG001|Overall Study|Adverse Event|1|||
161743662|NCT04311177|584099816|FG000|Overall Study|Physician Decision|4|||
161743663|NCT04311177|584099817|FG001|Overall Study|Physician Decision|3|||
161743664|NCT04311177|584099816|FG000|Overall Study|Withdrawal by Subject|1|||
161743665|NCT04311177|584099817|FG001|Overall Study|Withdrawal by Subject|0|||
161743666|NCT00599027|584099820|FG000|Overall Study|Withdrawal by Subject|1|||
161743667|NCT00599027|584099821|FG001|Overall Study|Withdrawal by Subject|1|||
161743668|NCT00599027|584099820|FG000|Overall Study|Adverse Event|0|||
161743669|NCT00599027|584099821|FG001|Overall Study|Adverse Event|1|||
161743670|NCT00599027|584099820|FG000|Overall Study|Treatment Failure|0|||
161743671|NCT00599027|584099821|FG001|Overall Study|Treatment Failure|1|||
161743672|NCT02581982|584099822|FG000|Overall Study|Lack of Efficacy|12|||
161743673|NCT02581982|584099822|FG000|Overall Study|Adverse Event|3|||
161743674|NCT02581982|584099822|FG000|Overall Study|Physician Decision|1|||
161743675|NCT00405821|584099823|FG000|Overall Study|Death|5|||
161743676|NCT00405821|584099824|FG001|Overall Study|Death|7|||
161743677|NCT00405821|584099823|FG000|Overall Study|Lost to Follow-up|7|||
161743678|NCT00405821|584099824|FG001|Overall Study|Lost to Follow-up|7|||
161743679|NCT00405821|584099823|FG000|Overall Study|Protocol Violation|1|||
161743680|NCT00405821|584099824|FG001|Overall Study|Protocol Violation|0|||
161743681|NCT00405821|584099823|FG000|Overall Study|initiated ART|9|||
161743682|NCT00405821|584099824|FG001|Overall Study|initiated ART|8|||
161743683|NCT02554253|584099835|FG000|Overall Study|ineligible after enrollment|1|||
161743684|NCT02554253|584099836|FG001|Overall Study|ineligible after enrollment|0|||
161743685|NCT02554253|584099835|FG000|Overall Study|converted to transcatheter procedure|0|||
161743686|NCT02554253|584099836|FG001|Overall Study|converted to transcatheter procedure|1|||
161743687|NCT02554253|584099835|FG000|Overall Study|received both drugs|0|||
161743688|NCT02554253|584099836|FG001|Overall Study|received both drugs|1|||
161743689|NCT02559206|584099839|FG000|Overall Study|Adverse Event|0|||
161743690|NCT02559206|584099840|FG001|Overall Study|Adverse Event|4|||
161743691|NCT02559206|584099841|FG002|Overall Study|Adverse Event|1|||
161743692|NCT02559206|584099842|FG003|Overall Study|Adverse Event|5|||
161743693|NCT02559206|584099843|FG004|Overall Study|Adverse Event|3|||
161743694|NCT02559206|584099844|FG005|Overall Study|Adverse Event|0|||
161743695|NCT02559206|584099845|FG006|Overall Study|Adverse Event|1|||
161743696|NCT02559206|584099846|FG007|Overall Study|Adverse Event|0|||
161743697|NCT02559206|584099839|FG000|Overall Study|Protocol Violation|1|||
161743698|NCT02559206|584099840|FG001|Overall Study|Protocol Violation|0|||
161743699|NCT02559206|584099841|FG002|Overall Study|Protocol Violation|1|||
161743700|NCT02559206|584099842|FG003|Overall Study|Protocol Violation|0|||
161743701|NCT02559206|584099843|FG004|Overall Study|Protocol Violation|0|||
161743702|NCT02559206|584099844|FG005|Overall Study|Protocol Violation|2|||
161743703|NCT02559206|584099845|FG006|Overall Study|Protocol Violation|0|||
161743704|NCT02559206|584099846|FG007|Overall Study|Protocol Violation|0|||
161743705|NCT02559206|584099839|FG000|Overall Study|Withdrawal by Subject|3|||
161743706|NCT02559206|584099840|FG001|Overall Study|Withdrawal by Subject|3|||
161743707|NCT02559206|584099841|FG002|Overall Study|Withdrawal by Subject|1|||
161743708|NCT02559206|584099842|FG003|Overall Study|Withdrawal by Subject|3|||
161743709|NCT02559206|584099843|FG004|Overall Study|Withdrawal by Subject|5|||
161743710|NCT02559206|584099844|FG005|Overall Study|Withdrawal by Subject|4|||
161743711|NCT02559206|584099845|FG006|Overall Study|Withdrawal by Subject|1|||
161743712|NCT02559206|584099846|FG007|Overall Study|Withdrawal by Subject|2|||
161743713|NCT02559206|584099839|FG000|Overall Study|Lost to Follow-up|3|||
161743714|NCT02559206|584099840|FG001|Overall Study|Lost to Follow-up|5|||
161743715|NCT02559206|584099841|FG002|Overall Study|Lost to Follow-up|3|||
161743716|NCT02559206|584099842|FG003|Overall Study|Lost to Follow-up|3|||
161743717|NCT02559206|584099843|FG004|Overall Study|Lost to Follow-up|2|||
161743718|NCT02559206|584099844|FG005|Overall Study|Lost to Follow-up|5|||
161743719|NCT02559206|584099845|FG006|Overall Study|Lost to Follow-up|1|||
161743720|NCT02559206|584099846|FG007|Overall Study|Lost to Follow-up|4|||
161743721|NCT02559206|584099839|FG000|Overall Study|Lack of Efficacy|1|||
161743722|NCT02559206|584099840|FG001|Overall Study|Lack of Efficacy|0|||
161743723|NCT02559206|584099841|FG002|Overall Study|Lack of Efficacy|3|||
161743724|NCT02559206|584099842|FG003|Overall Study|Lack of Efficacy|2|||
161743725|NCT02559206|584099843|FG004|Overall Study|Lack of Efficacy|2|||
161743726|NCT02559206|584099844|FG005|Overall Study|Lack of Efficacy|3|||
161743727|NCT02559206|584099845|FG006|Overall Study|Lack of Efficacy|3|||
161743728|NCT02559206|584099846|FG007|Overall Study|Lack of Efficacy|3|||
161743729|NCT02559206|584099839|FG000|Overall Study|Other Not Specified|0|||
161743730|NCT02559206|584099840|FG001|Overall Study|Other Not Specified|0|||
161743731|NCT02559206|584099841|FG002|Overall Study|Other Not Specified|0|||
161743732|NCT02559206|584099842|FG003|Overall Study|Other Not Specified|1|||
161743733|NCT02559206|584099843|FG004|Overall Study|Other Not Specified|0|||
161743734|NCT02559206|584099844|FG005|Overall Study|Other Not Specified|0|||
161743735|NCT02559206|584099845|FG006|Overall Study|Other Not Specified|0|||
161743736|NCT02559206|584099846|FG007|Overall Study|Other Not Specified|0|||
161743737|NCT01770145|584101997|FG000|Baseline|Adverse Event|20|||
161743738|NCT01770145|584101997|FG000|Baseline|Withdrawal by Subject|1|||
161743739|NCT01770145|584101997|FG000|Baseline|Lost to Follow-up|1|||
161743740|NCT01770145|584101997|FG000|Baseline|Unable to define optimal dose|4|||
161743741|NCT01770145|584101997|FG000|Treatment|Adverse Event|3|||
161743742|NCT01770145|584101997|FG000|Treatment|Withdrawal by Subject|1|||
161743743|NCT01102140|584101998|FG000|Overall Study|Lost to Follow-up|1|||
161743744|NCT01102140|584101999|FG001|Overall Study|Lost to Follow-up|0|||
161743745|NCT01102140|584101998|FG000|Overall Study|Investigator terminated study|2|||
161743746|NCT01102140|584101999|FG001|Overall Study|Investigator terminated study|2|||
161743747|NCT04134728|584102005|FG000|Overall Study|Adverse Event|3|||
161743748|NCT04134728|584102006|FG001|Overall Study|Adverse Event|2|||
161743749|NCT04134728|584102007|FG002|Overall Study|Adverse Event|9|||
161966573|NCT00519376|584925647|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161966574|NCT00519376|584925648|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161966575|NCT00519376|584925649|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161966576|NCT00519376|584925650|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161743750|NCT04134728|584102008|FG003|Overall Study|Adverse Event|0|||
161743751|NCT04134728|584102009|FG004|Overall Study|Adverse Event|0|||
161743752|NCT04134728|584102010|FG005|Overall Study|Adverse Event|0|||
161743753|NCT04134728|584102005|FG000|Overall Study|Lack of Efficacy|3|||
161743754|NCT04134728|584102006|FG001|Overall Study|Lack of Efficacy|3|||
161743755|NCT04134728|584102007|FG002|Overall Study|Lack of Efficacy|1|||
161743756|NCT04134728|584102008|FG003|Overall Study|Lack of Efficacy|2|||
161743757|NCT04134728|584102009|FG004|Overall Study|Lack of Efficacy|0|||
161743758|NCT04134728|584102010|FG005|Overall Study|Lack of Efficacy|0|||
161743759|NCT04134728|584102005|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161743760|NCT04134728|584102006|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161743761|NCT04134728|584102007|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
161743762|NCT04134728|584102008|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161743763|NCT04134728|584102009|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161743764|NCT04134728|584102010|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161743765|NCT04134728|584102005|FG000|Overall Study|Protocol Deviation|0|||
161743766|NCT04134728|584102006|FG001|Overall Study|Protocol Deviation|0|||
161743767|NCT04134728|584102007|FG002|Overall Study|Protocol Deviation|1|||
161743768|NCT04134728|584102008|FG003|Overall Study|Protocol Deviation|0|||
161743769|NCT04134728|584102009|FG004|Overall Study|Protocol Deviation|0|||
161743770|NCT04134728|584102010|FG005|Overall Study|Protocol Deviation|0|||
161743771|NCT04134728|584102005|FG000|Overall Study|Informed Consent Withdrawn|3|||
161743772|NCT04134728|584102006|FG001|Overall Study|Informed Consent Withdrawn|6|||
161743773|NCT04134728|584102007|FG002|Overall Study|Informed Consent Withdrawn|8|||
161743774|NCT04134728|584102008|FG003|Overall Study|Informed Consent Withdrawn|1|||
161743775|NCT04134728|584102009|FG004|Overall Study|Informed Consent Withdrawn|1|||
161743776|NCT04134728|584102010|FG005|Overall Study|Informed Consent Withdrawn|0|||
161743777|NCT04134728|584102005|FG000|Overall Study|Physician Decision|2|||
161743778|NCT04134728|584102006|FG001|Overall Study|Physician Decision|0|||
161743779|NCT04134728|584102007|FG002|Overall Study|Physician Decision|0|||
161743780|NCT04134728|584102008|FG003|Overall Study|Physician Decision|0|||
161743781|NCT04134728|584102009|FG004|Overall Study|Physician Decision|0|||
161743782|NCT04134728|584102010|FG005|Overall Study|Physician Decision|0|||
161743783|NCT04134728|584102005|FG000|Overall Study|Lost to Follow-up|1|||
161743784|NCT04134728|584102006|FG001|Overall Study|Lost to Follow-up|2|||
161743785|NCT04134728|584102007|FG002|Overall Study|Lost to Follow-up|1|||
161743786|NCT04134728|584102008|FG003|Overall Study|Lost to Follow-up|0|||
161743787|NCT04134728|584102009|FG004|Overall Study|Lost to Follow-up|0|||
161743788|NCT04134728|584102010|FG005|Overall Study|Lost to Follow-up|1|||
161743789|NCT04134728|584102005|FG000|Overall Study|Investigator Site Closed|0|||
161743790|NCT04134728|584102006|FG001|Overall Study|Investigator Site Closed|1|||
161743791|NCT04134728|584102007|FG002|Overall Study|Investigator Site Closed|1|||
161743792|NCT04134728|584102008|FG003|Overall Study|Investigator Site Closed|0|||
161743793|NCT04134728|584102009|FG004|Overall Study|Investigator Site Closed|0|||
161743794|NCT04134728|584102010|FG005|Overall Study|Investigator Site Closed|0|||
161743795|NCT00801892|584102011|FG000|Main Study Period|Withdrawal by Subject|0|||
161743796|NCT00801892|584102012|FG001|Main Study Period|Withdrawal by Subject|1|||
161743797|NCT00801892|584102011|FG000|Sham Crossover Period|Lost to Follow-up|0|||
161743798|NCT00801892|584102012|FG001|Sham Crossover Period|Lost to Follow-up|2|||
161743799|NCT01175590|584102018|FG000|Overall Study|Lost to Follow-up|1|||
161743800|NCT01175590|584102019|FG001|Overall Study|Lost to Follow-up|0|||
161743801|NCT01175590|584102018|FG000|Overall Study|Withdrawal by Subject|0|||
161743802|NCT01175590|584102019|FG001|Overall Study|Withdrawal by Subject|2|||
161743803|NCT01175590|584102018|FG000|Overall Study|Adverse Event|4|||
161743804|NCT01175590|584102019|FG001|Overall Study|Adverse Event|0|||
161743805|NCT01175590|584102018|FG000|Overall Study|Physician Decision|1|||
161743806|NCT01175590|584102019|FG001|Overall Study|Physician Decision|4|||
161743807|NCT01175590|584102018|FG000|Overall Study|Lack of Efficacy|1|||
161743808|NCT01175590|584102019|FG001|Overall Study|Lack of Efficacy|1|||
161743809|NCT01175590|584102018|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
161743810|NCT01175590|584102019|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
161743811|NCT01175590|584102018|FG000|Overall Study|Treated not as randomized|3|||
161743812|NCT01175590|584102019|FG001|Overall Study|Treated not as randomized|2|||
161743813|NCT01175590|584102018|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
161743814|NCT01175590|584102019|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
161743815|NCT01175590|584102018|FG000|Overall Study|Protocol Violation|0|||
161743816|NCT01175590|584102019|FG001|Overall Study|Protocol Violation|1|||
161743817|NCT02062398|584102020|FG000|Overall Study|Implant removal|1|||
161743818|NCT03351478|584102021|FG000|Overall Study|At the subject's own request|11|||
161743819|NCT03351478|584102022|FG001|Overall Study|At the subject's own request|12|||
161743820|NCT03351478|584102023|FG002|Overall Study|At the subject's own request|5|||
161743821|NCT03351478|584102021|FG000|Overall Study|Adverse Event|1|||
161743822|NCT03351478|584102022|FG001|Overall Study|Adverse Event|2|||
161743823|NCT03351478|584102023|FG002|Overall Study|Adverse Event|1|||
161743824|NCT03351478|584102021|FG000|Overall Study|Poor compliance to protocol|1|||
161743825|NCT03351478|584102022|FG001|Overall Study|Poor compliance to protocol|0|||
161743826|NCT03351478|584102023|FG002|Overall Study|Poor compliance to protocol|0|||
161743827|NCT03351478|584102021|FG000|Overall Study|Reason not Specified|1|||
161743828|NCT03351478|584102022|FG001|Overall Study|Reason not Specified|3|||
161743829|NCT03351478|584102023|FG002|Overall Study|Reason not Specified|0|||
161743830|NCT03351478|584102021|FG000|Overall Study|Lost to Follow-up|0|||
161743831|NCT03351478|584102022|FG001|Overall Study|Lost to Follow-up|0|||
161743832|NCT03351478|584102023|FG002|Overall Study|Lost to Follow-up|1|||
161743833|NCT03911869|584102024|FG000|Safety Lead-in Phase|Death|7|||
161743834|NCT03911869|584102025|FG001|Safety Lead-in Phase|Death|0|||
161743835|NCT03911869|584102026|FG002|Safety Lead-in Phase|Death|0|||
161743836|NCT03911869|584102024|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
161743837|NCT03911869|584102025|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
161743838|NCT03911869|584102026|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
161743839|NCT03911869|584102024|FG000|Safety Lead-in Phase|Other|1|||
161743840|NCT03911869|584102025|FG001|Safety Lead-in Phase|Other|0|||
161743841|NCT03911869|584102026|FG002|Safety Lead-in Phase|Other|0|||
161743842|NCT03911869|584102024|FG000|Phase 2|Death|0|||
161743843|NCT03911869|584102025|FG001|Phase 2|Death|3|||
161743844|NCT03911869|584102026|FG002|Phase 2|Death|0|||
161743845|NCT01106391|584102028|FG000|Overall Study|Death|12|||
161743846|NCT01106391|584102028|FG000|Overall Study|Withdrawal by Subject|7|||
161743847|NCT01387074|584102029|FG000|Overall Study|Lost to Follow-up|7|||
161743848|NCT01387074|584102029|FG000|Overall Study|Lack of Efficacy|1|||
161743849|NCT00150345|584102030|FG000|Overall Study|Death|5|||
161743850|NCT00150345|584102031|FG001|Overall Study|Death|2|||
161743851|NCT00150345|584102030|FG000|Overall Study|Adverse Event|8|||
161743852|NCT00150345|584102031|FG001|Overall Study|Adverse Event|6|||
161743853|NCT00150345|584102030|FG000|Overall Study|Lack of Efficacy|5|||
161743854|NCT00150345|584102031|FG001|Overall Study|Lack of Efficacy|4|||
161743855|NCT00150345|584102030|FG000|Overall Study|Withdrawal by Subject|3|||
161743856|NCT00150345|584102031|FG001|Overall Study|Withdrawal by Subject|4|||
161743857|NCT00150345|584102030|FG000|Overall Study|Laboratory abnormality|1|||
161743858|NCT00150345|584102031|FG001|Overall Study|Laboratory abnormality|2|||
161743859|NCT00150345|584102030|FG000|Overall Study|Other|12|||
161743860|NCT00150345|584102031|FG001|Overall Study|Other|14|||
161743861|NCT01392742|584102032|FG000|Overall Study|Premature study termination|42|||
161743862|NCT01392742|584102032|FG000|Overall Study|Failure to return|35|||
161743863|NCT01392742|584102032|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
161743864|NCT01392742|584102032|FG000|Overall Study|Lost to Follow-up|34|||
161743865|NCT01392742|584102032|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
161743866|NCT01392742|584102032|FG000|Overall Study|ITR and Protocol deviation|1|||
161743867|NCT01392742|584102032|FG000|Overall Study|Adverse event/intercurrent illness|17|||
161743868|NCT01392742|584102032|FG000|Overall Study|Protocol Violation|14|||
161743869|NCT01392742|584102032|FG000|Overall Study|Other|3|||
161743870|NCT01392742|584102032|FG000|Overall Study|Missing information|13|||
161743871|NCT01998958|584102033|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743872|NCT01998958|584102034|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
161743873|NCT01998958|584102035|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743874|NCT01998958|584102036|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743875|NCT01998958|584102037|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743876|NCT01998958|584102038|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743877|NCT01998958|584102039|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743878|NCT01998958|584102040|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743879|NCT01998958|584102041|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743880|NCT01998958|584102042|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743881|NCT01998958|584102043|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743882|NCT01998958|584102044|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743883|NCT01998958|584102045|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743884|NCT01998958|584102046|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743885|NCT01998958|584102047|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743886|NCT01998958|584102048|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743887|NCT01998958|584102049|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743888|NCT01998958|584102050|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743889|NCT01998958|584102051|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743890|NCT01998958|584102052|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743891|NCT01998958|584102053|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743892|NCT01998958|584102054|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743893|NCT01998958|584102055|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743894|NCT01998958|584102056|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743895|NCT01998958|584102057|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743896|NCT01998958|584102058|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743897|NCT01998958|584102059|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161966577|NCT00519376|584925651|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161966578|NCT00519376|584925652|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161966579|NCT00519376|584925653|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
161966580|NCT00519376|584925654|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161743898|NCT01998958|584102060|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743899|NCT01998958|584102061|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743900|NCT01998958|584102062|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743901|NCT01998958|584102063|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743902|NCT01998958|584102064|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161743903|NCT01998958|584102033|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743904|NCT01998958|584102034|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
161743905|NCT01998958|584102035|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743906|NCT01998958|584102036|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743907|NCT01998958|584102037|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743908|NCT01998958|584102038|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743909|NCT01998958|584102039|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743910|NCT01998958|584102040|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743911|NCT01998958|584102041|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743912|NCT01998958|584102042|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743913|NCT01998958|584102043|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743914|NCT01998958|584102044|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743915|NCT01998958|584102045|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743916|NCT01998958|584102046|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743917|NCT01998958|584102047|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743918|NCT01998958|584102048|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743919|NCT01998958|584102049|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743920|NCT01998958|584102050|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743921|NCT01998958|584102051|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743922|NCT01998958|584102052|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743923|NCT01998958|584102053|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743924|NCT01998958|584102054|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743925|NCT01998958|584102055|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743926|NCT01998958|584102056|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743927|NCT01998958|584102057|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743928|NCT01998958|584102058|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743929|NCT01998958|584102059|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743930|NCT01998958|584102060|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743931|NCT01998958|584102061|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743932|NCT01998958|584102062|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743933|NCT01998958|584102063|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743934|NCT01998958|584102064|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161743935|NCT01998958|584102033|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
161743936|NCT01998958|584102034|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
161743937|NCT01998958|584102035|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
161743938|NCT01998958|584102036|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
161743939|NCT01998958|584102037|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
161743940|NCT01998958|584102038|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
161743941|NCT01998958|584102039|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
161743942|NCT01998958|584102040|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
161743943|NCT01998958|584102041|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
161743944|NCT01998958|584102042|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
161743945|NCT01998958|584102043|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
161743946|NCT01998958|584102044|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
161743947|NCT01998958|584102045|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
161743948|NCT01998958|584102046|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
161743949|NCT01998958|584102047|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
161743950|NCT01998958|584102048|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
161743951|NCT01998958|584102049|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
161743952|NCT01998958|584102050|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
161743953|NCT01998958|584102051|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
161743954|NCT01998958|584102052|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
161743955|NCT01998958|584102053|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
161743956|NCT01998958|584102054|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
161743957|NCT01998958|584102055|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
161743958|NCT01998958|584102056|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
161743959|NCT01998958|584102057|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
161743960|NCT01998958|584102058|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
161743961|NCT01998958|584102059|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
161743962|NCT01998958|584102060|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
161743963|NCT01998958|584102061|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
161743964|NCT01998958|584102062|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
161743965|NCT01998958|584102063|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
161743966|NCT01998958|584102064|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
161743967|NCT01998958|584102033|FG000|Period 1 (Panel A and B)|Other|1|||
161743968|NCT01998958|584102034|FG001|Period 1 (Panel A and B)|Other|0|||
161743969|NCT01998958|584102035|FG002|Period 1 (Panel A and B)|Other|0|||
161743970|NCT01998958|584102036|FG003|Period 1 (Panel A and B)|Other|0|||
161743971|NCT01998958|584102037|FG004|Period 1 (Panel A and B)|Other|0|||
161743972|NCT01998958|584102038|FG005|Period 1 (Panel A and B)|Other|0|||
161743973|NCT01998958|584102039|FG006|Period 1 (Panel A and B)|Other|0|||
161743974|NCT01998958|584102040|FG007|Period 1 (Panel A and B)|Other|0|||
161743975|NCT01998958|584102041|FG008|Period 1 (Panel A and B)|Other|0|||
161966581|NCT00519376|584925655|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161966582|NCT00519376|584925656|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
161966583|NCT00519376|584925641|FG000|Treatment Period 4|Lost to Follow-up|0|||
161966584|NCT00519376|584925642|FG001|Treatment Period 4|Lost to Follow-up|0|||
161743976|NCT01998958|584102042|FG009|Period 1 (Panel A and B)|Other|0|||
161743977|NCT01998958|584102043|FG010|Period 1 (Panel A and B)|Other|0|||
161743978|NCT01998958|584102044|FG011|Period 1 (Panel A and B)|Other|0|||
161743979|NCT01998958|584102045|FG012|Period 1 (Panel A and B)|Other|0|||
161743980|NCT01998958|584102046|FG013|Period 1 (Panel A and B)|Other|0|||
161743981|NCT01998958|584102047|FG014|Period 1 (Panel A and B)|Other|0|||
161966585|NCT00519376|584925643|FG002|Treatment Period 4|Lost to Follow-up|1|||
161743982|NCT01998958|584102048|FG015|Period 1 (Panel A and B)|Other|0|||
161743983|NCT01998958|584102049|FG016|Period 1 (Panel A and B)|Other|0|||
161743984|NCT01998958|584102050|FG017|Period 1 (Panel A and B)|Other|0|||
161743985|NCT01998958|584102051|FG018|Period 1 (Panel A and B)|Other|0|||
161743986|NCT01998958|584102052|FG019|Period 1 (Panel A and B)|Other|0|||
161743987|NCT01998958|584102053|FG020|Period 1 (Panel A and B)|Other|0|||
161743988|NCT01998958|584102054|FG021|Period 1 (Panel A and B)|Other|0|||
161743989|NCT01998958|584102055|FG022|Period 1 (Panel A and B)|Other|0|||
161743990|NCT01998958|584102056|FG023|Period 1 (Panel A and B)|Other|0|||
161743991|NCT01998958|584102057|FG024|Period 1 (Panel A and B)|Other|0|||
161743992|NCT01998958|584102058|FG025|Period 1 (Panel A and B)|Other|0|||
161743993|NCT01998958|584102059|FG026|Period 1 (Panel A and B)|Other|0|||
161743994|NCT01998958|584102060|FG027|Period 1 (Panel A and B)|Other|0|||
161743995|NCT01998958|584102061|FG028|Period 1 (Panel A and B)|Other|0|||
161743996|NCT01998958|584102062|FG029|Period 1 (Panel A and B)|Other|0|||
161743997|NCT01998958|584102063|FG030|Period 1 (Panel A and B)|Other|0|||
161743998|NCT01998958|584102064|FG031|Period 1 (Panel A and B)|Other|0|||
161743999|NCT01998958|584102033|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
161744000|NCT01998958|584102034|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
161744001|NCT01998958|584102035|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
161744002|NCT01998958|584102036|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
161744003|NCT01998958|584102037|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
161744004|NCT01998958|584102038|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
161744005|NCT01998958|584102039|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
161744006|NCT01998958|584102040|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
161744007|NCT01998958|584102041|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
161744008|NCT01998958|584102042|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
161744009|NCT01998958|584102043|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
161744010|NCT01998958|584102044|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
161744011|NCT01998958|584102045|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
161744012|NCT01998958|584102046|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
161744013|NCT01998958|584102047|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
161744014|NCT01998958|584102048|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
161744015|NCT01998958|584102049|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
161744016|NCT01998958|584102050|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
161744017|NCT01998958|584102051|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
161744018|NCT01998958|584102052|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
161744019|NCT01998958|584102053|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
161744020|NCT01998958|584102054|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
161744021|NCT01998958|584102055|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
161744022|NCT01998958|584102056|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
161744023|NCT01998958|584102057|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
161744024|NCT01998958|584102058|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
161744025|NCT01998958|584102059|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
161744026|NCT01998958|584102060|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
161744027|NCT01998958|584102061|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
161744028|NCT01998958|584102062|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
161744029|NCT01998958|584102063|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
161744030|NCT01998958|584102064|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
161744031|NCT01998958|584102033|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744032|NCT01998958|584102034|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744033|NCT01998958|584102035|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744034|NCT01998958|584102036|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744035|NCT01998958|584102037|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744036|NCT01998958|584102038|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744037|NCT01998958|584102039|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744038|NCT01998958|584102040|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744039|NCT01998958|584102041|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744040|NCT01998958|584102042|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744041|NCT01998958|584102043|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744042|NCT01998958|584102044|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744043|NCT01998958|584102045|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744044|NCT01998958|584102046|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744045|NCT01998958|584102047|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
161744046|NCT01998958|584102048|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744047|NCT01998958|584102049|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744048|NCT01998958|584102050|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744049|NCT01998958|584102051|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
161744050|NCT01998958|584102052|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744051|NCT01998958|584102053|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744052|NCT01998958|584102054|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744053|NCT01998958|584102055|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744054|NCT01998958|584102056|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744055|NCT01998958|584102057|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161841976|NCT01175811|584466254|FG001|Overall Study|Adverse Event|1|||
161744056|NCT01998958|584102058|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744057|NCT01998958|584102059|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744058|NCT01998958|584102060|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744059|NCT01998958|584102061|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744060|NCT01998958|584102062|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744061|NCT01998958|584102063|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744062|NCT01998958|584102064|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161744063|NCT01998958|584102033|FG000|Open Label Phase (Optional)|Adverse Event|0|||
161744064|NCT01998958|584102034|FG001|Open Label Phase (Optional)|Adverse Event|0|||
161744065|NCT01998958|584102035|FG002|Open Label Phase (Optional)|Adverse Event|0|||
161744066|NCT01998958|584102036|FG003|Open Label Phase (Optional)|Adverse Event|0|||
161744067|NCT01998958|584102037|FG004|Open Label Phase (Optional)|Adverse Event|0|||
161744068|NCT01998958|584102038|FG005|Open Label Phase (Optional)|Adverse Event|0|||
161744069|NCT01998958|584102039|FG006|Open Label Phase (Optional)|Adverse Event|0|||
161744070|NCT01998958|584102040|FG007|Open Label Phase (Optional)|Adverse Event|0|||
161744071|NCT01998958|584102041|FG008|Open Label Phase (Optional)|Adverse Event|0|||
161744072|NCT01998958|584102042|FG009|Open Label Phase (Optional)|Adverse Event|0|||
161744073|NCT01998958|584102043|FG010|Open Label Phase (Optional)|Adverse Event|0|||
161744074|NCT01998958|584102044|FG011|Open Label Phase (Optional)|Adverse Event|0|||
161744075|NCT01998958|584102045|FG012|Open Label Phase (Optional)|Adverse Event|0|||
161744076|NCT01998958|584102046|FG013|Open Label Phase (Optional)|Adverse Event|0|||
161744077|NCT01998958|584102047|FG014|Open Label Phase (Optional)|Adverse Event|0|||
161744078|NCT01998958|584102048|FG015|Open Label Phase (Optional)|Adverse Event|0|||
161744079|NCT01998958|584102049|FG016|Open Label Phase (Optional)|Adverse Event|0|||
161744080|NCT01998958|584102050|FG017|Open Label Phase (Optional)|Adverse Event|0|||
161744081|NCT01998958|584102051|FG018|Open Label Phase (Optional)|Adverse Event|0|||
161744082|NCT01998958|584102052|FG019|Open Label Phase (Optional)|Adverse Event|0|||
161744083|NCT01998958|584102053|FG020|Open Label Phase (Optional)|Adverse Event|0|||
161744084|NCT01998958|584102054|FG021|Open Label Phase (Optional)|Adverse Event|0|||
161744085|NCT01998958|584102055|FG022|Open Label Phase (Optional)|Adverse Event|0|||
161744086|NCT01998958|584102056|FG023|Open Label Phase (Optional)|Adverse Event|1|||
161744087|NCT01998958|584102057|FG024|Open Label Phase (Optional)|Adverse Event|0|||
161744088|NCT01998958|584102058|FG025|Open Label Phase (Optional)|Adverse Event|0|||
161744089|NCT01998958|584102059|FG026|Open Label Phase (Optional)|Adverse Event|0|||
161744090|NCT01998958|584102060|FG027|Open Label Phase (Optional)|Adverse Event|0|||
161744091|NCT01998958|584102061|FG028|Open Label Phase (Optional)|Adverse Event|0|||
161744092|NCT01998958|584102062|FG029|Open Label Phase (Optional)|Adverse Event|0|||
161744093|NCT01998958|584102063|FG030|Open Label Phase (Optional)|Adverse Event|0|||
161744094|NCT01998958|584102064|FG031|Open Label Phase (Optional)|Adverse Event|0|||
161744095|NCT01998958|584102033|FG000|Open Label Phase (Optional)|Other|0|||
161744096|NCT01998958|584102034|FG001|Open Label Phase (Optional)|Other|0|||
161744097|NCT01998958|584102035|FG002|Open Label Phase (Optional)|Other|0|||
161744098|NCT01998958|584102036|FG003|Open Label Phase (Optional)|Other|0|||
161744099|NCT01998958|584102037|FG004|Open Label Phase (Optional)|Other|0|||
161744100|NCT01998958|584102038|FG005|Open Label Phase (Optional)|Other|0|||
161744101|NCT01998958|584102039|FG006|Open Label Phase (Optional)|Other|0|||
161744102|NCT01998958|584102040|FG007|Open Label Phase (Optional)|Other|0|||
161744103|NCT01998958|584102041|FG008|Open Label Phase (Optional)|Other|0|||
161744104|NCT01998958|584102042|FG009|Open Label Phase (Optional)|Other|0|||
161744105|NCT01998958|584102043|FG010|Open Label Phase (Optional)|Other|0|||
161744106|NCT01998958|584102044|FG011|Open Label Phase (Optional)|Other|0|||
161744107|NCT01998958|584102045|FG012|Open Label Phase (Optional)|Other|0|||
161744108|NCT01998958|584102046|FG013|Open Label Phase (Optional)|Other|0|||
161744109|NCT01998958|584102047|FG014|Open Label Phase (Optional)|Other|0|||
161744110|NCT01998958|584102048|FG015|Open Label Phase (Optional)|Other|0|||
161744111|NCT01998958|584102049|FG016|Open Label Phase (Optional)|Other|0|||
161744112|NCT01998958|584102050|FG017|Open Label Phase (Optional)|Other|0|||
161744113|NCT01998958|584102051|FG018|Open Label Phase (Optional)|Other|0|||
161744114|NCT01998958|584102052|FG019|Open Label Phase (Optional)|Other|0|||
161744115|NCT01998958|584102053|FG020|Open Label Phase (Optional)|Other|0|||
161744116|NCT01998958|584102054|FG021|Open Label Phase (Optional)|Other|0|||
161744117|NCT01998958|584102055|FG022|Open Label Phase (Optional)|Other|5|||
161744118|NCT01998958|584102056|FG023|Open Label Phase (Optional)|Other|1|||
161744119|NCT01998958|584102057|FG024|Open Label Phase (Optional)|Other|0|||
161744120|NCT01998958|584102058|FG025|Open Label Phase (Optional)|Other|0|||
161744121|NCT01998958|584102059|FG026|Open Label Phase (Optional)|Other|0|||
161744122|NCT01998958|584102060|FG027|Open Label Phase (Optional)|Other|0|||
161744123|NCT01998958|584102061|FG028|Open Label Phase (Optional)|Other|0|||
161744124|NCT01998958|584102062|FG029|Open Label Phase (Optional)|Other|0|||
161744125|NCT01998958|584102063|FG030|Open Label Phase (Optional)|Other|0|||
161744126|NCT01998958|584102064|FG031|Open Label Phase (Optional)|Other|0|||
161744127|NCT01998958|584102033|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744128|NCT01998958|584102034|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744129|NCT01998958|584102035|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744130|NCT01998958|584102036|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744131|NCT01998958|584102037|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744132|NCT01998958|584102038|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744133|NCT01998958|584102039|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744134|NCT01998958|584102040|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744135|NCT01998958|584102041|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744136|NCT01998958|584102042|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744137|NCT01998958|584102043|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744138|NCT01998958|584102044|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744139|NCT01998958|584102045|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744140|NCT01998958|584102046|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744141|NCT01998958|584102047|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744142|NCT01998958|584102048|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744143|NCT01998958|584102049|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744144|NCT01998958|584102050|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744145|NCT01998958|584102051|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744146|NCT01998958|584102052|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744147|NCT01998958|584102053|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744148|NCT01998958|584102054|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744149|NCT01998958|584102055|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
161744150|NCT01998958|584102056|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744151|NCT01998958|584102057|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744152|NCT01998958|584102058|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744153|NCT01998958|584102059|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744154|NCT01998958|584102060|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744155|NCT01998958|584102061|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744156|NCT01998958|584102062|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744157|NCT01998958|584102063|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744158|NCT01998958|584102064|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
161744159|NCT01998958|584102033|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744160|NCT01998958|584102034|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744161|NCT01998958|584102035|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744162|NCT01998958|584102036|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744163|NCT01998958|584102037|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744164|NCT01998958|584102038|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744165|NCT01998958|584102039|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744166|NCT01998958|584102040|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744167|NCT01998958|584102041|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744168|NCT01998958|584102042|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744169|NCT01998958|584102043|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744170|NCT01998958|584102044|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744171|NCT01998958|584102045|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744172|NCT01998958|584102046|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744173|NCT01998958|584102047|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744174|NCT01998958|584102048|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744175|NCT01998958|584102049|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744176|NCT01998958|584102050|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744177|NCT01998958|584102051|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744178|NCT01998958|584102052|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744179|NCT01998958|584102053|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744180|NCT01998958|584102054|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
161744181|NCT01998958|584102055|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
161744182|NCT01998958|584102056|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744183|NCT01998958|584102057|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744184|NCT01998958|584102058|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744185|NCT01998958|584102059|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744186|NCT01998958|584102060|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744187|NCT01998958|584102061|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744188|NCT01998958|584102062|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744189|NCT01998958|584102063|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744190|NCT01998958|584102064|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
161744191|NCT01998958|584102033|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744192|NCT01998958|584102034|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161966586|NCT00519376|584925644|FG003|Treatment Period 4|Lost to Follow-up|0|||
161744193|NCT01998958|584102035|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744194|NCT01998958|584102036|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744195|NCT01998958|584102037|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744196|NCT01998958|584102038|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744197|NCT01998958|584102039|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744198|NCT01998958|584102040|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744199|NCT01998958|584102041|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744200|NCT01998958|584102042|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744201|NCT01998958|584102043|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744202|NCT01998958|584102044|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744203|NCT01998958|584102045|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161966587|NCT00519376|584925645|FG004|Treatment Period 4|Lost to Follow-up|0|||
161966588|NCT00519376|584925646|FG005|Treatment Period 4|Lost to Follow-up|0|||
161966589|NCT00519376|584925647|FG006|Treatment Period 4|Lost to Follow-up|0|||
161966590|NCT00519376|584925648|FG007|Treatment Period 4|Lost to Follow-up|0|||
161966591|NCT00519376|584925649|FG008|Treatment Period 4|Lost to Follow-up|0|||
161966592|NCT00519376|584925650|FG009|Treatment Period 4|Lost to Follow-up|0|||
161966593|NCT00519376|584925651|FG010|Treatment Period 4|Lost to Follow-up|0|||
161966594|NCT00519376|584925652|FG011|Treatment Period 4|Lost to Follow-up|0|||
161966595|NCT00519376|584925653|FG012|Treatment Period 4|Lost to Follow-up|0|||
161966596|NCT00519376|584925654|FG013|Treatment Period 4|Lost to Follow-up|0|||
161966597|NCT00519376|584925655|FG014|Treatment Period 4|Lost to Follow-up|0|||
161966598|NCT00519376|584925656|FG015|Treatment Period 4|Lost to Follow-up|0|||
161966599|NCT02688088|584925660|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
161966600|NCT02688088|584925661|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
161966601|NCT02688088|584925662|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
161966602|NCT02688088|584925663|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
161966603|NCT02688088|584925664|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
161966604|NCT02688088|584925660|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
161966605|NCT02688088|584925661|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
161966606|NCT02688088|584925662|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
161966607|NCT02688088|584925663|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
161966608|NCT02688088|584925664|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
161966609|NCT02688088|584925660|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
161966610|NCT02688088|584925661|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
161966611|NCT02688088|584925662|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
161966612|NCT02688088|584925663|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
161966613|NCT02688088|584925664|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
161966614|NCT02688088|584925660|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
161966615|NCT02688088|584925661|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
161966616|NCT02688088|584925662|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
161966617|NCT02688088|584925663|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
161966618|NCT02688088|584925664|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
161966619|NCT02688088|584925660|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
161966620|NCT02688088|584925661|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
161966621|NCT02688088|584925662|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
161966622|NCT02688088|584925663|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
161966623|NCT02688088|584925664|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
161966624|NCT02688088|584925660|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
161966625|NCT02688088|584925661|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
161966626|NCT02688088|584925662|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
161966627|NCT02688088|584925663|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
161966628|NCT02688088|584925664|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
161966629|NCT02688088|584925660|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
161966630|NCT02688088|584925661|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
161966631|NCT02688088|584925662|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
161966632|NCT02688088|584925663|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
161966633|NCT02688088|584925664|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
161966634|NCT02688088|584925660|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
161966635|NCT02688088|584925661|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
161966636|NCT02688088|584925662|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
161966637|NCT02688088|584925663|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
161966638|NCT02688088|584925664|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
161966639|NCT02688088|584925660|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
161966640|NCT02688088|584925661|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
161966641|NCT02688088|584925662|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
162032484|NCT03422627|585177400|FG001|Overall Study|Withdrawal by Subject|0|||
161744204|NCT01998958|584102046|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162032485|NCT03422627|585177401|FG002|Overall Study|Withdrawal by Subject|0|||
162032486|NCT03422627|585177402|FG003|Overall Study|Withdrawal by Subject|1|||
162032487|NCT03422627|585177403|FG004|Overall Study|Withdrawal by Subject|0|||
162032488|NCT04251156|585177404|FG000|Overall Study|Lost to Follow-up|1|||
161744205|NCT01998958|584102047|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744206|NCT01998958|584102048|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744207|NCT01998958|584102049|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744208|NCT01998958|584102050|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
162032489|NCT04251156|585177405|FG001|Overall Study|Lost to Follow-up|1|||
162032490|NCT04251156|585177404|FG000|Overall Study|Withdrawal by Subject|4|||
162032491|NCT04251156|585177405|FG001|Overall Study|Withdrawal by Subject|4|||
162032492|NCT04214288|585177406|FG000|Overall Study|Ongoing in the study|41|||
162032493|NCT04214288|585177407|FG001|Overall Study|Ongoing in the study|51|||
162032494|NCT04214288|585177408|FG002|Overall Study|Ongoing in the study|12|||
162032495|NCT04214288|585177409|FG003|Overall Study|Ongoing in the study|39|||
162032496|NCT04214288|585177406|FG000|Overall Study|Adverse Event|1|||
162032497|NCT04214288|585177407|FG001|Overall Study|Adverse Event|0|||
162032498|NCT04214288|585177408|FG002|Overall Study|Adverse Event|0|||
162032499|NCT04214288|585177409|FG003|Overall Study|Adverse Event|0|||
162032500|NCT04214288|585177406|FG000|Overall Study|Death|22|||
162032501|NCT04214288|585177407|FG001|Overall Study|Death|13|||
162032502|NCT04214288|585177408|FG002|Overall Study|Death|7|||
162032503|NCT04214288|585177409|FG003|Overall Study|Death|19|||
162032504|NCT04214288|585177406|FG000|Overall Study|Lost to Follow-up|1|||
162032505|NCT04214288|585177407|FG001|Overall Study|Lost to Follow-up|2|||
162032506|NCT04214288|585177408|FG002|Overall Study|Lost to Follow-up|1|||
162032507|NCT04214288|585177409|FG003|Overall Study|Lost to Follow-up|0|||
162032508|NCT04214288|585177406|FG000|Overall Study|Other|1|||
162032509|NCT04214288|585177407|FG001|Overall Study|Other|2|||
162032510|NCT04214288|585177408|FG002|Overall Study|Other|0|||
162032511|NCT04214288|585177409|FG003|Overall Study|Other|6|||
162032512|NCT04214288|585177406|FG000|Overall Study|Protocol Violation|0|||
162032513|NCT04214288|585177407|FG001|Overall Study|Protocol Violation|1|||
162032514|NCT04214288|585177408|FG002|Overall Study|Protocol Violation|0|||
162032515|NCT04214288|585177409|FG003|Overall Study|Protocol Violation|0|||
162032516|NCT04214288|585177406|FG000|Overall Study|Withdrawal by Subject|8|||
162032517|NCT04214288|585177407|FG001|Overall Study|Withdrawal by Subject|4|||
162032518|NCT04214288|585177408|FG002|Overall Study|Withdrawal by Subject|0|||
162032519|NCT04214288|585177409|FG003|Overall Study|Withdrawal by Subject|9|||
162032520|NCT03675321|585177410|FG000|Overall Study|Lack of Efficacy|2|||
162032521|NCT03675321|585177411|FG001|Overall Study|Lack of Efficacy|2|||
162032522|NCT03675321|585177410|FG000|Overall Study|Withdrawal by Subject|1|||
162032523|NCT03675321|585177411|FG001|Overall Study|Withdrawal by Subject|3|||
162032524|NCT02455557|585177412|FG000|Overall Study|Withdrawal by Subject|2|||
162032525|NCT02278341|585177413|FG000|Overall Study|Randomized but never received study drug|1|||
162032526|NCT02278341|585177414|FG001|Overall Study|Randomized but never received study drug|1|||
162032527|NCT02278341|585177413|FG000|Overall Study|Adverse Event|3|||
162032528|NCT02278341|585177414|FG001|Overall Study|Adverse Event|0|||
162032529|NCT02278341|585177413|FG000|Overall Study|Death|68|||
162032530|NCT02278341|585177414|FG001|Overall Study|Death|56|||
162032531|NCT02278341|585177413|FG000|Overall Study|Withdrawal by Subject|30|||
162032532|NCT02278341|585177414|FG001|Overall Study|Withdrawal by Subject|19|||
162032533|NCT02278341|585177413|FG000|Overall Study|Lost to Follow-up|0|||
162032534|NCT02278341|585177414|FG001|Overall Study|Lost to Follow-up|1|||
162032535|NCT02278341|585177413|FG000|Overall Study|Physician Decision|1|||
162032536|NCT02278341|585177414|FG001|Overall Study|Physician Decision|1|||
162032537|NCT02278341|585177413|FG000|Overall Study|Miscellaneous|15|||
162032538|NCT02278341|585177414|FG001|Overall Study|Miscellaneous|14|||
162032539|NCT01129024|585177415|FG000|Overall Study|Physician Decision|5|||
162032540|NCT01129024|585177415|FG000|Overall Study|Study Terminated by Sponsor|8|||
162032541|NCT01129024|585177415|FG000|Overall Study|Withdrawal by Subject|2|||
162032542|NCT01129024|585177415|FG000|Overall Study|Lack of Efficacy|3|||
162032543|NCT01129024|585177415|FG000|Overall Study|Needed a Platelet Transfusion|1|||
162032544|NCT00934648|585177421|FG000|Overall Study|Failure to return|8|||
162032545|NCT00934648|585177421|FG000|Overall Study|Withdrawal by Subject|1|||
162032546|NCT02361580|585177425|FG000|Overall Study|Lost to Follow-up|6|||
162032547|NCT02361580|585177426|FG001|Overall Study|Lost to Follow-up|3|||
162032548|NCT02047318|585177427|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
162032549|NCT02047318|585177427|FG000|Core Study Period|Adverse Event|1|||
162032550|NCT02047318|585177427|FG000|Core Study Period|Withdrawal by caregiver|3|||
162032551|NCT02047318|585177427|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
162032552|NCT01487577|585177428|FG000|Overall Study|Became ineligible after signing consent|1|||
162032553|NCT01479985|585177429|FG000|Overall Study|Tablet malfunction, no data saved|1|||
162032554|NCT01479985|585177430|FG001|Overall Study|Tablet malfunction, no data saved|1|||
162032555|NCT01479985|585177429|FG000|Overall Study|No decisional conflict scale responses|0|||
162032556|NCT01479985|585177430|FG001|Overall Study|No decisional conflict scale responses|2|||
162032557|NCT01479985|585177429|FG000|Overall Study|No post-visit survey|5|||
162032558|NCT01479985|585177430|FG001|Overall Study|No post-visit survey|3|||
162032559|NCT00708201|585177431|FG000|Overall Study|Adverse Event|4|||
162032560|NCT00708201|585177432|FG001|Overall Study|Adverse Event|4|||
162032561|NCT00708201|585177431|FG000|Overall Study|Withdrawal by Subject|1|||
162032562|NCT00708201|585177432|FG001|Overall Study|Withdrawal by Subject|1|||
162032563|NCT00708201|585177431|FG000|Overall Study|Lost to Follow-up|2|||
162032564|NCT00708201|585177432|FG001|Overall Study|Lost to Follow-up|0|||
162032565|NCT00708201|585177431|FG000|Overall Study|Protocol Violation|0|||
162032566|NCT00708201|585177432|FG001|Overall Study|Protocol Violation|1|||
161966642|NCT02688088|584925663|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
161966643|NCT02688088|584925664|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
161966644|NCT03812185|584925668|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
161966645|NCT00313313|584925670|FG000|Overall Study|Lack of Efficacy|14|||
161744209|NCT01998958|584102051|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744210|NCT01998958|584102052|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744211|NCT01998958|584102053|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744212|NCT01998958|584102054|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
161744213|NCT01998958|584102055|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
161744214|NCT01998958|584102056|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
161744215|NCT01998958|584102057|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744216|NCT01998958|584102058|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744217|NCT01998958|584102059|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744218|NCT01998958|584102060|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744219|NCT01998958|584102061|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744220|NCT01998958|584102062|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744221|NCT01998958|584102063|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744222|NCT01998958|584102064|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161744223|NCT02432703|584102065|FG000|Overall Study|Adverse Event|1|||
161744224|NCT02432703|584102066|FG001|Overall Study|Adverse Event|4|||
161744225|NCT02432703|584102065|FG000|Overall Study|Lack of Efficacy|1|||
161744226|NCT02432703|584102066|FG001|Overall Study|Lack of Efficacy|0|||
161744227|NCT02432703|584102065|FG000|Overall Study|Lost to Follow-up|5|||
161744228|NCT02432703|584102066|FG001|Overall Study|Lost to Follow-up|3|||
161744229|NCT02432703|584102065|FG000|Overall Study|Withdrawal by Subject|9|||
161744230|NCT02432703|584102066|FG001|Overall Study|Withdrawal by Subject|6|||
161744231|NCT02432703|584102065|FG000|Overall Study|Other|6|||
161744232|NCT02432703|584102066|FG001|Overall Study|Other|5|||
161744233|NCT02137837|584102072|FG000|Overall Study|Adverse Event|0|||
161744234|NCT02137837|584102073|FG001|Overall Study|Adverse Event|2|||
161744235|NCT02137837|584102074|FG002|Overall Study|Adverse Event|1|||
161744236|NCT02137837|584102072|FG000|Overall Study|Refusal unrelated to adverse event|2|||
161744237|NCT02137837|584102073|FG001|Overall Study|Refusal unrelated to adverse event|2|||
161744238|NCT02137837|584102074|FG002|Overall Study|Refusal unrelated to adverse event|1|||
161744239|NCT02137837|584102072|FG000|Overall Study|Progression/relapse|9|||
161744240|NCT02137837|584102073|FG001|Overall Study|Progression/relapse|7|||
161744241|NCT02137837|584102074|FG002|Overall Study|Progression/relapse|7|||
161744242|NCT02137837|584102072|FG000|Overall Study|Not protocol specified|2|||
161744243|NCT02137837|584102073|FG001|Overall Study|Not protocol specified|1|||
161744244|NCT02137837|584102074|FG002|Overall Study|Not protocol specified|3|||
161744245|NCT01628393|584102075|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
161744246|NCT01628393|584102076|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161744247|NCT01628393|584102077|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161744248|NCT01628393|584102078|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161744249|NCT01628393|584102079|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161744250|NCT01628393|584102075|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
161744251|NCT01628393|584102076|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
161744252|NCT01628393|584102077|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
161744253|NCT01628393|584102078|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
161744254|NCT01628393|584102079|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
161744255|NCT01628393|584102075|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
161744256|NCT01628393|584102076|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
161744257|NCT01628393|584102077|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
161744258|NCT01628393|584102078|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
161744259|NCT01628393|584102079|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
161744260|NCT01628393|584102075|FG000|Blinded Active Extension Period|Adverse Event|0|||
161744261|NCT01628393|584102076|FG001|Blinded Active Extension Period|Adverse Event|1|||
161744262|NCT01628393|584102077|FG002|Blinded Active Extension Period|Adverse Event|0|||
161744263|NCT01628393|584102078|FG003|Blinded Active Extension Period|Adverse Event|2|||
161744264|NCT01628393|584102079|FG004|Blinded Active Extension Period|Adverse Event|2|||
161744265|NCT01628393|584102075|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
161744266|NCT01628393|584102076|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
161744267|NCT01628393|584102077|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
161744268|NCT01628393|584102078|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
161744269|NCT01628393|584102079|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
161744270|NCT01628393|584102075|FG000|Blinded Active Extension Period|Physician Decision|0|||
161744271|NCT01628393|584102076|FG001|Blinded Active Extension Period|Physician Decision|3|||
161744272|NCT01628393|584102077|FG002|Blinded Active Extension Period|Physician Decision|0|||
161744273|NCT01628393|584102078|FG003|Blinded Active Extension Period|Physician Decision|1|||
161744274|NCT01628393|584102079|FG004|Blinded Active Extension Period|Physician Decision|0|||
161744275|NCT01628393|584102075|FG000|Blinded Active Extension Period|Protocol Violation|0|||
161966646|NCT00313313|584925671|FG001|Overall Study|Lack of Efficacy|9|||
161966647|NCT00313313|584925672|FG002|Overall Study|Lack of Efficacy|20|||
161966648|NCT00313313|584925670|FG000|Overall Study|Withdrawal of consent by subject|18|||
161966649|NCT00313313|584925671|FG001|Overall Study|Withdrawal of consent by subject|17|||
161966650|NCT00313313|584925672|FG002|Overall Study|Withdrawal of consent by subject|31|||
161966651|NCT00313313|584925670|FG000|Overall Study|Lost to Follow-up|10|||
161744276|NCT01628393|584102076|FG001|Blinded Active Extension Period|Protocol Violation|0|||
161744277|NCT01628393|584102077|FG002|Blinded Active Extension Period|Protocol Violation|2|||
161744278|NCT01628393|584102078|FG003|Blinded Active Extension Period|Protocol Violation|1|||
161744279|NCT01628393|584102079|FG004|Blinded Active Extension Period|Protocol Violation|0|||
161744280|NCT01628393|584102075|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
161744281|NCT01628393|584102076|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
161744282|NCT01628393|584102077|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
161744283|NCT01628393|584102078|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
161744284|NCT01628393|584102079|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
161744285|NCT01329341|584102080|FG000|Overall Study|Withdrawal by Subject|44|||
161744286|NCT00448760|584102081|FG000|Overall Study|Death|3|||
161744287|NCT00561340|584102082|FG000|Overall Study|refused to drink pediasure|6|||
161744288|NCT00561340|584102083|FG001|Overall Study|refused to drink pediasure|0|||
161744289|NCT00618995|584102089|FG000|Period 1|Adverse Event|0|||
161744290|NCT00618995|584102090|FG001|Period 1|Adverse Event|0|||
161744291|NCT00618995|584102091|FG002|Period 1|Adverse Event|1|||
161744292|NCT00618995|584102092|FG003|Period 1|Adverse Event|0|||
161744293|NCT00618995|584102089|FG000|Period 1|Protocol Violation|0|||
161744294|NCT00618995|584102090|FG001|Period 1|Protocol Violation|1|||
161744295|NCT00618995|584102091|FG002|Period 1|Protocol Violation|1|||
161744296|NCT00618995|584102092|FG003|Period 1|Protocol Violation|0|||
161744297|NCT00618995|584102089|FG000|Period 2|Protocol Violation|0|||
161744298|NCT00618995|584102090|FG001|Period 2|Protocol Violation|0|||
161744299|NCT00618995|584102091|FG002|Period 2|Protocol Violation|1|||
161744300|NCT00618995|584102092|FG003|Period 2|Protocol Violation|0|||
161744301|NCT00618995|584102089|FG000|Period 4|Adverse Event|1|||
161744302|NCT00618995|584102090|FG001|Period 4|Adverse Event|0|||
161744303|NCT00618995|584102091|FG002|Period 4|Adverse Event|0|||
161744304|NCT00618995|584102092|FG003|Period 4|Adverse Event|0|||
161744305|NCT01306032|584102093|FG000|First Intervention|Adverse Event|1|||
161744306|NCT01306032|584102094|FG001|First Intervention|Adverse Event|0|||
161744307|NCT01306032|584102095|FG002|First Intervention|Adverse Event|1|||
161744308|NCT01306032|584102096|FG003|First Intervention|Adverse Event|0|||
161744309|NCT01306032|584102097|FG004|First Intervention|Adverse Event|0|||
161744310|NCT01306032|584102098|FG005|First Intervention|Adverse Event|1|||
161744311|NCT01306032|584102093|FG000|First Intervention|Withdrawal by Subject|0|||
161744312|NCT01306032|584102094|FG001|First Intervention|Withdrawal by Subject|2|||
161744313|NCT01306032|584102095|FG002|First Intervention|Withdrawal by Subject|0|||
161744314|NCT01306032|584102096|FG003|First Intervention|Withdrawal by Subject|1|||
161744315|NCT01306032|584102097|FG004|First Intervention|Withdrawal by Subject|0|||
161744316|NCT01306032|584102098|FG005|First Intervention|Withdrawal by Subject|0|||
161744317|NCT01306032|584102093|FG000|First Intervention|Death|0|||
161744318|NCT01306032|584102094|FG001|First Intervention|Death|0|||
161744319|NCT01306032|584102095|FG002|First Intervention|Death|1|||
161744320|NCT01306032|584102096|FG003|First Intervention|Death|0|||
161744321|NCT01306032|584102097|FG004|First Intervention|Death|0|||
161744322|NCT01306032|584102098|FG005|First Intervention|Death|0|||
161744323|NCT01306032|584102093|FG000|First Intervention|Ineligible|0|||
161744324|NCT01306032|584102094|FG001|First Intervention|Ineligible|0|||
161744325|NCT01306032|584102095|FG002|First Intervention|Ineligible|0|||
161744326|NCT01306032|584102096|FG003|First Intervention|Ineligible|0|||
161744327|NCT01306032|584102097|FG004|First Intervention|Ineligible|0|||
161744328|NCT01306032|584102098|FG005|First Intervention|Ineligible|1|||
161744329|NCT01306032|584102093|FG000|First Intervention|Progressive disease|0|||
161744330|NCT01306032|584102094|FG001|First Intervention|Progressive disease|0|||
161744331|NCT01306032|584102095|FG002|First Intervention|Progressive disease|0|||
161744332|NCT01306032|584102096|FG003|First Intervention|Progressive disease|0|||
161744333|NCT01306032|584102097|FG004|First Intervention|Progressive disease|2|||
161966652|NCT00313313|584925671|FG001|Overall Study|Lost to Follow-up|7|||
161744334|NCT01306032|584102098|FG005|First Intervention|Progressive disease|0|||
161744335|NCT01306032|584102093|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
161744336|NCT01306032|584102094|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
161744337|NCT01306032|584102095|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
161966653|NCT00313313|584925672|FG002|Overall Study|Lost to Follow-up|9|||
161744338|NCT01306032|584102096|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
161744339|NCT01306032|584102097|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
161744340|NCT01306032|584102098|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
161744341|NCT01306032|584102093|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
161744342|NCT01306032|584102094|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
161744343|NCT01306032|584102095|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
161966654|NCT00313313|584925670|FG000|Overall Study|Adverse Event|15|||
161966655|NCT00313313|584925671|FG001|Overall Study|Adverse Event|16|||
161966656|NCT00313313|584925672|FG002|Overall Study|Adverse Event|12|||
161966657|NCT00313313|584925670|FG000|Overall Study|Physician Decision|2|||
161966658|NCT00313313|584925671|FG001|Overall Study|Physician Decision|6|||
161966659|NCT00313313|584925672|FG002|Overall Study|Physician Decision|4|||
161966660|NCT00313313|584925670|FG000|Overall Study|Poor/Noncompliance|3|||
161966661|NCT00313313|584925671|FG001|Overall Study|Poor/Noncompliance|6|||
161966662|NCT00313313|584925672|FG002|Overall Study|Poor/Noncompliance|2|||
161966663|NCT00313313|584925670|FG000|Overall Study|Pregnancy|1|||
161966664|NCT00313313|584925671|FG001|Overall Study|Pregnancy|2|||
161966665|NCT00313313|584925672|FG002|Overall Study|Pregnancy|0|||
161966666|NCT00313313|584925670|FG000|Overall Study|Death|0|||
161966667|NCT00313313|584925671|FG001|Overall Study|Death|0|||
161966668|NCT00313313|584925672|FG002|Overall Study|Death|2|||
161966669|NCT00313313|584925670|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
161966670|NCT00313313|584925671|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
161966671|NCT00313313|584925672|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
161966672|NCT01973387|584925673|FG000|Overall Study|Adverse Event|14|||
161966673|NCT01973387|584925674|FG001|Overall Study|Adverse Event|4|||
161966674|NCT01973387|584925673|FG000|Overall Study|Withdrawal by Subject|7|||
161966675|NCT01973387|584925674|FG001|Overall Study|Withdrawal by Subject|4|||
161966676|NCT01973387|584925673|FG000|Overall Study|Study terminated by sponsor|63|||
161966677|NCT01973387|584925674|FG001|Overall Study|Study terminated by sponsor|0|||
161966678|NCT01973387|584925673|FG000|Overall Study|Progressive disease or relapse|16|||
161966679|NCT01973387|584925674|FG001|Overall Study|Progressive disease or relapse|5|||
161966680|NCT01973387|584925673|FG000|Overall Study|Death|4|||
161966681|NCT01973387|584925674|FG001|Overall Study|Death|3|||
161966682|NCT01973387|584925673|FG000|Overall Study|Randomized, not treated|2|||
161966683|NCT01973387|584925674|FG001|Overall Study|Randomized, not treated|2|||
161966684|NCT01498575|584925675|FG000|Overall Sample|Withdrawal by Subject|60|||
161966685|NCT01498575|584925676|FG001|Overall Sample|Withdrawal by Subject|14|||
161966686|NCT01498575|584925675|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
161966687|NCT01498575|584925676|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
161966688|NCT01498575|584925675|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
161966689|NCT01498575|584925676|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
161966690|NCT01345591|584925680|FG000|Overall Study|Lost to Follow-up|1|||
161966691|NCT00090142|584925681|FG000|Treatment Period I|Lost to Follow-up|1|||
161966692|NCT00090142|584925682|FG001|Treatment Period I|Lost to Follow-up|2|||
161966693|NCT00090142|584925681|FG000|Treatment Period I|Protocol Violation|2|||
161966694|NCT00090142|584925682|FG001|Treatment Period I|Protocol Violation|0|||
161966695|NCT00090142|584925681|FG000|Treatment Period I|Withdrawal by Subject|2|||
161966696|NCT00090142|584925682|FG001|Treatment Period I|Withdrawal by Subject|0|||
161966697|NCT00090142|584925681|FG000|Treatment Period I|Other|0|||
161966698|NCT00090142|584925682|FG001|Treatment Period I|Other|1|||
161966699|NCT00090142|584925681|FG000|Treatment Period II|Other|1|||
161966700|NCT00090142|584925682|FG001|Treatment Period II|Other|0|||
161966701|NCT01126437|584925683|FG000|Overall Study|Not treated|11|||
161966702|NCT01126437|584925684|FG001|Overall Study|Not treated|18|||
161966703|NCT01126437|584925685|FG002|Overall Study|Not treated|19|||
161966704|NCT01126437|584925683|FG000|Overall Study|Sites with data irregularities/fraud|6|||
161966705|NCT01126437|584925684|FG001|Overall Study|Sites with data irregularities/fraud|6|||
161744344|NCT01306032|584102096|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
161966706|NCT01126437|584925685|FG002|Overall Study|Sites with data irregularities/fraud|7|||
161966707|NCT01126437|584925683|FG000|Overall Study|Adverse Event|602|||
161966708|NCT01126437|584925684|FG001|Overall Study|Adverse Event|606|||
161966709|NCT01126437|584925685|FG002|Overall Study|Adverse Event|635|||
161966710|NCT01126437|584925683|FG000|Overall Study|Lack of Efficacy|65|||
161966711|NCT01126437|584925684|FG001|Overall Study|Lack of Efficacy|60|||
161966712|NCT01126437|584925685|FG002|Overall Study|Lack of Efficacy|59|||
161966713|NCT01126437|584925683|FG000|Overall Study|Protocol Violation|64|||
161966714|NCT01126437|584925684|FG001|Overall Study|Protocol Violation|66|||
161966715|NCT01126437|584925685|FG002|Overall Study|Protocol Violation|41|||
161966716|NCT01126437|584925683|FG000|Overall Study|Lost to Follow-up|52|||
161966717|NCT01126437|584925684|FG001|Overall Study|Lost to Follow-up|63|||
161966718|NCT01126437|584925685|FG002|Overall Study|Lost to Follow-up|55|||
161966719|NCT01126437|584925683|FG000|Overall Study|Withdrawal by Subject|331|||
161744345|NCT01306032|584102097|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
161966720|NCT01126437|584925684|FG001|Overall Study|Withdrawal by Subject|335|||
161966721|NCT01126437|584925685|FG002|Overall Study|Withdrawal by Subject|319|||
161966722|NCT01126437|584925683|FG000|Overall Study|Other reason not specified|210|||
161966723|NCT01126437|584925684|FG001|Overall Study|Other reason not specified|176|||
161966724|NCT01126437|584925685|FG002|Overall Study|Other reason not specified|178|||
161966725|NCT00006046|584925691|FG000|Overall Study|Adverse Event|3|||
161966726|NCT00006046|584925692|FG001|Overall Study|Adverse Event|0|||
161966727|NCT00006046|584925693|FG002|Overall Study|Adverse Event|0|||
161966728|NCT00006046|584925694|FG003|Overall Study|Adverse Event|0|||
161744346|NCT01306032|584102098|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
161744347|NCT01213264|584102099|FG000|Overall Study|Adverse Event|1|||
161744348|NCT01213264|584102100|FG001|Overall Study|Adverse Event|0|||
161744349|NCT01213264|584102101|FG002|Overall Study|Adverse Event|0|||
161744350|NCT01213264|584102099|FG000|Overall Study|Lost to Follow-up|1|||
161744351|NCT01213264|584102100|FG001|Overall Study|Lost to Follow-up|2|||
161744352|NCT01213264|584102101|FG002|Overall Study|Lost to Follow-up|6|||
161744353|NCT00290589|584102105|FG000|Overall Study|Lost to Follow-up|2|||
161744354|NCT00290589|584102106|FG001|Overall Study|Lost to Follow-up|2|||
161744355|NCT03814005|584102108|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
161744356|NCT03814005|584102109|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
161744357|NCT03814005|584102110|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
161744358|NCT03814005|584102108|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
161744359|NCT03814005|584102109|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
161744360|NCT03814005|584102110|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
161744361|NCT03814005|584102108|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
161744362|NCT03814005|584102109|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
161744363|NCT03814005|584102110|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
161744364|NCT03814005|584102108|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
161744365|NCT03814005|584102109|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
161841977|NCT01175811|584466253|FG000|Overall Study|Entry criteria not met|3|||
161841978|NCT01175811|584466254|FG001|Overall Study|Entry criteria not met|1|||
161841979|NCT01175811|584466253|FG000|Overall Study|Lack of Efficacy|1|||
161841980|NCT01175811|584466254|FG001|Overall Study|Lack of Efficacy|0|||
161841981|NCT01175811|584466253|FG000|Overall Study|Lost to Follow-up|3|||
161841982|NCT01175811|584466254|FG001|Overall Study|Lost to Follow-up|2|||
161841983|NCT01175811|584466253|FG000|Overall Study|Physician Decision|1|||
161841984|NCT01175811|584466254|FG001|Overall Study|Physician Decision|1|||
161841985|NCT01175811|584466253|FG000|Overall Study|Protocol Violation|1|||
161841986|NCT01175811|584466254|FG001|Overall Study|Protocol Violation|2|||
161841987|NCT01175811|584466253|FG000|Overall Study|Withdrawal by Subject|6|||
161841988|NCT01175811|584466254|FG001|Overall Study|Withdrawal by Subject|7|||
161841989|NCT02628743|584466256|FG000|Overall Study|Other|3|||
161841990|NCT02628743|584466256|FG000|Overall Study|Withdrawal by Subject|50|||
161841991|NCT02628743|584466256|FG000|Overall Study|Study Terminated by Sponsor|76|||
161841992|NCT02628743|584466256|FG000|Overall Study|Physician Decision|2|||
161841993|NCT04715932|584466257|FG000|Overall Study|Lost to Follow-up|1|||
161841994|NCT04715932|584466258|FG001|Overall Study|Lost to Follow-up|0|||
161841995|NCT03560986|584466259|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
161841996|NCT03560986|584466260|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
161841997|NCT03560986|584466259|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
161841998|NCT03560986|584466260|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
161841999|NCT03560986|584466259|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
161842000|NCT03560986|584466260|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
161842001|NCT03560986|584466259|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
161842002|NCT03560986|584466260|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
161842003|NCT03560986|584466259|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
161842004|NCT03560986|584466260|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
161842005|NCT03560986|584466259|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
161842006|NCT03560986|584466260|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
161842007|NCT03560986|584466259|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
161842008|NCT03560986|584466260|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
161842009|NCT00326963|584466261|FG000|Overall Study|Adverse Event|2|||
161842010|NCT00326963|584466261|FG000|Overall Study|Injection site reaction|1|||
161842011|NCT00326963|584466261|FG000|Overall Study|Death|1|||
161842012|NCT00326963|584466261|FG000|Overall Study|Failure to return|10|||
161842013|NCT00326963|584466261|FG000|Overall Study|Withdrawal by Subject|10|||
161842014|NCT00326963|584466261|FG000|Overall Study|Refused treatment / did not cooperate|5|||
161842015|NCT00326963|584466261|FG000|Overall Study|Violation of selection criteria at entry|2|||
161842016|NCT00326963|584466261|FG000|Overall Study|Other protocol violation|1|||
161842017|NCT00326963|584466261|FG000|Overall Study|Administrative / other|1|||
161842018|NCT00699374|584466262|FG000|Overall Study|Death|93|||
161842019|NCT00699374|584466263|FG001|Overall Study|Death|83|||
161842020|NCT00699374|584466262|FG000|Overall Study|Adverse Event|70|||
161842021|NCT00699374|584466263|FG001|Overall Study|Adverse Event|67|||
161842022|NCT00699374|584466262|FG000|Overall Study|Global deterioration of health status|7|||
161842023|NCT00699374|584466263|FG001|Overall Study|Global deterioration of health status|8|||
161842024|NCT00699374|584466262|FG000|Overall Study|Lost to Follow-up|3|||
161842025|NCT00699374|584466263|FG001|Overall Study|Lost to Follow-up|5|||
161842026|NCT00699374|584466262|FG000|Overall Study|Withdrawal by Subject|34|||
161842027|NCT00699374|584466263|FG001|Overall Study|Withdrawal by Subject|44|||
161842028|NCT00699374|584466262|FG000|Overall Study|Objective progression or relapse|281|||
161966729|NCT00006046|584925695|FG004|Overall Study|Adverse Event|0|||
161842029|NCT00699374|584466263|FG001|Overall Study|Objective progression or relapse|277|||
161842030|NCT00699374|584466262|FG000|Overall Study|Other|18|||
161842031|NCT00699374|584466263|FG001|Overall Study|Other|15|||
161842032|NCT00699374|584466262|FG000|Overall Study|Protocol Violation|2|||
161842033|NCT00699374|584466263|FG001|Overall Study|Protocol Violation|6|||
161842034|NCT00699374|584466262|FG000|Overall Study|Study terminated by sponsor|13|||
161842035|NCT00699374|584466263|FG001|Overall Study|Study terminated by sponsor|28|||
161842036|NCT00699374|584466262|FG000|Overall Study|Randomized but not treated|4|||
161842037|NCT00699374|584466263|FG001|Overall Study|Randomized but not treated|2|||
161842038|NCT00699374|584466262|FG000|Overall Study|Died 28 days after last dose|5|||
161842039|NCT00699374|584466263|FG001|Overall Study|Died 28 days after last dose|9|||
161842040|NCT01783548|584466267|FG000|Overall Study|Adverse Event|8|||
161842041|NCT01783548|584466268|FG001|Overall Study|Adverse Event|4|||
161842042|NCT01783548|584466267|FG000|Overall Study|Withdrawal by Subject|11|||
161842043|NCT01783548|584466268|FG001|Overall Study|Withdrawal by Subject|8|||
161842044|NCT01783548|584466267|FG000|Overall Study|Non-compliance|4|||
161842045|NCT01783548|584466268|FG001|Overall Study|Non-compliance|0|||
161842046|NCT01783548|584466267|FG000|Overall Study|Protocol Violation|2|||
161842047|NCT01783548|584466268|FG001|Overall Study|Protocol Violation|2|||
161842048|NCT01783548|584466267|FG000|Overall Study|Lost to Follow-up|8|||
161842049|NCT01783548|584466268|FG001|Overall Study|Lost to Follow-up|3|||
161842050|NCT01783548|584466267|FG000|Overall Study|Lack of Efficacy|1|||
161842051|NCT01783548|584466268|FG001|Overall Study|Lack of Efficacy|1|||
161842052|NCT04645966|584466269|FG000|Vaccination Phase|Adverse Event|1|||
161842053|NCT04645966|584466270|FG001|Vaccination Phase|Adverse Event|0|||
161842054|NCT04645966|584466271|FG002|Vaccination Phase|Adverse Event|0|||
161842055|NCT04645966|584466272|FG003|Vaccination Phase|Adverse Event|0|||
161842056|NCT04645966|584466273|FG004|Vaccination Phase|Adverse Event|0|||
161842057|NCT04645966|584466274|FG005|Vaccination Phase|Adverse Event|0|||
161842058|NCT04645966|584466275|FG006|Vaccination Phase|Adverse Event|1|||
161842059|NCT04645966|584466276|FG007|Vaccination Phase|Adverse Event|0|||
161842060|NCT04645966|584466277|FG008|Vaccination Phase|Adverse Event|0|||
161842061|NCT04645966|584466269|FG000|Vaccination Phase|Death|0|||
161842062|NCT04645966|584466270|FG001|Vaccination Phase|Death|0|||
161842063|NCT04645966|584466271|FG002|Vaccination Phase|Death|0|||
161842064|NCT04645966|584466272|FG003|Vaccination Phase|Death|0|||
161842065|NCT04645966|584466273|FG004|Vaccination Phase|Death|0|||
161842066|NCT04645966|584466274|FG005|Vaccination Phase|Death|1|||
161842067|NCT04645966|584466275|FG006|Vaccination Phase|Death|0|||
161842068|NCT04645966|584466276|FG007|Vaccination Phase|Death|0|||
161842069|NCT04645966|584466277|FG008|Vaccination Phase|Death|0|||
161842070|NCT04645966|584466269|FG000|Vaccination Phase|Protocol Violation|0|||
161842071|NCT04645966|584466270|FG001|Vaccination Phase|Protocol Violation|0|||
161842072|NCT04645966|584466271|FG002|Vaccination Phase|Protocol Violation|0|||
161842073|NCT04645966|584466272|FG003|Vaccination Phase|Protocol Violation|0|||
161842074|NCT04645966|584466273|FG004|Vaccination Phase|Protocol Violation|1|||
161842075|NCT04645966|584466274|FG005|Vaccination Phase|Protocol Violation|0|||
161842076|NCT04645966|584466275|FG006|Vaccination Phase|Protocol Violation|0|||
161842077|NCT04645966|584466276|FG007|Vaccination Phase|Protocol Violation|0|||
161842078|NCT04645966|584466277|FG008|Vaccination Phase|Protocol Violation|0|||
161842079|NCT04645966|584466269|FG000|Vaccination Phase|Study terminated by sponsor|0|||
161842080|NCT04645966|584466270|FG001|Vaccination Phase|Study terminated by sponsor|0|||
161842081|NCT04645966|584466271|FG002|Vaccination Phase|Study terminated by sponsor|14|||
161842082|NCT04645966|584466272|FG003|Vaccination Phase|Study terminated by sponsor|15|||
161842083|NCT04645966|584466273|FG004|Vaccination Phase|Study terminated by sponsor|47|||
161842084|NCT04645966|584466274|FG005|Vaccination Phase|Study terminated by sponsor|43|||
161842085|NCT04645966|584466275|FG006|Vaccination Phase|Study terminated by sponsor|29|||
161842086|NCT04645966|584466276|FG007|Vaccination Phase|Study terminated by sponsor|29|||
161842087|NCT04645966|584466277|FG008|Vaccination Phase|Study terminated by sponsor|12|||
161842088|NCT04645966|584466269|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
161842089|NCT04645966|584466270|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
161842090|NCT04645966|584466271|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
161842091|NCT04645966|584466272|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
161842092|NCT04645966|584466273|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
161842093|NCT04645966|584466274|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
161842094|NCT04645966|584466275|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
161842095|NCT04645966|584466276|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
161842096|NCT04645966|584466277|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
161842097|NCT04645966|584466269|FG000|Vaccination Phase|Other|0|||
161842098|NCT04645966|584466270|FG001|Vaccination Phase|Other|0|||
161842099|NCT04645966|584466271|FG002|Vaccination Phase|Other|0|||
161842100|NCT04645966|584466272|FG003|Vaccination Phase|Other|0|||
161842101|NCT04645966|584466273|FG004|Vaccination Phase|Other|0|||
161842102|NCT04645966|584466274|FG005|Vaccination Phase|Other|2|||
161842103|NCT04645966|584466275|FG006|Vaccination Phase|Other|0|||
161842104|NCT04645966|584466276|FG007|Vaccination Phase|Other|0|||
161842105|NCT04645966|584466277|FG008|Vaccination Phase|Other|0|||
161842106|NCT04645966|584466269|FG000|Vaccination Phase|Lost to Follow-up|0|||
161744366|NCT03814005|584102110|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
161744367|NCT03814005|584102108|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
161744368|NCT03814005|584102109|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
161744369|NCT03814005|584102110|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
161744370|NCT03814005|584102108|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
161744371|NCT03814005|584102109|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
161744372|NCT03814005|584102110|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
161744373|NCT01700985|584102111|FG000|Overall Study|Incarcerated|0|||
161744374|NCT01700985|584102112|FG001|Overall Study|Incarcerated|1|||
161744375|NCT00965146|584102113|FG000|Overall Study|Death|7|||
161744376|NCT00965146|584102113|FG000|Overall Study|Lost to Follow-up|22|||
161744377|NCT00965146|584102113|FG000|Overall Study|Withdrawal by Subject|17|||
161744378|NCT00965146|584102113|FG000|Overall Study|Unable to return|1|||
161744379|NCT00965146|584102113|FG000|Overall Study|Unwilling to return|11|||
161744380|NCT00965146|584102113|FG000|Overall Study|Intercurrent illness|1|||
161744381|NCT00965146|584102113|FG000|Overall Study|Revision / Removal of Study Implant|6|||
161744382|NCT00965146|584102113|FG000|Overall Study|Overall Study Termination|145|||
161744383|NCT05067452|584102114|FG000|Overall Study|Lost to Follow-up|0|||
161744384|NCT05067452|584102115|FG001|Overall Study|Lost to Follow-up|4|||
161744385|NCT01135017|584102116|FG000|Overall Study|Adverse Event|3|||
161744386|NCT01135017|584102117|FG001|Overall Study|Adverse Event|8|||
161744387|NCT01135017|584102116|FG000|Overall Study|Other than above|3|||
161744388|NCT01135017|584102117|FG001|Overall Study|Other than above|4|||
161744389|NCT01148693|584102118|FG000|Overall Study|Attempts for cannulation were failed|13|||
161744390|NCT01148693|584102119|FG001|Overall Study|Attempts for cannulation were failed|10|||
161744391|NCT00432562|584102120|FG000|Overall Study|Death|3|||
161744392|NCT00432562|584102121|FG001|Overall Study|Death|0|||
161744393|NCT03970824|584102122|FG000|Overall Study|Withdrawal by Subject|1|||
161744394|NCT03970824|584102123|FG001|Overall Study|Withdrawal by Subject|1|||
161744395|NCT03970824|584102124|FG002|Overall Study|Withdrawal by Subject|3|||
161744396|NCT03970824|584102122|FG000|Overall Study|Lost to Follow-up|0|||
161744397|NCT03970824|584102123|FG001|Overall Study|Lost to Follow-up|2|||
161744398|NCT03970824|584102124|FG002|Overall Study|Lost to Follow-up|1|||
161744399|NCT03970824|584102122|FG000|Overall Study|Adverse Event|1|||
161744400|NCT03970824|584102123|FG001|Overall Study|Adverse Event|0|||
161744401|NCT03970824|584102124|FG002|Overall Study|Adverse Event|0|||
161744402|NCT00507416|584102127|FG000|Overall Study|Adverse Event|58|||
161744403|NCT00507416|584102128|FG001|Overall Study|Adverse Event|67|||
161744404|NCT00507416|584102129|FG002|Overall Study|Adverse Event|65|||
161744405|NCT00507416|584102127|FG000|Overall Study|Protocol Violation|1|||
161744406|NCT00507416|584102128|FG001|Overall Study|Protocol Violation|2|||
161744407|NCT00507416|584102129|FG002|Overall Study|Protocol Violation|0|||
161744408|NCT00507416|584102127|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
161744409|NCT00507416|584102128|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
161744410|NCT00507416|584102129|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
161744411|NCT00507416|584102127|FG000|Overall Study|Progressive Disease|20|||
161744412|NCT00507416|584102128|FG001|Overall Study|Progressive Disease|10|||
161744413|NCT00507416|584102129|FG002|Overall Study|Progressive Disease|13|||
161744414|NCT00507416|584102127|FG000|Overall Study|Patient declined further treatment|18|||
161744415|NCT00507416|584102128|FG001|Overall Study|Patient declined further treatment|14|||
161744416|NCT00507416|584102129|FG002|Overall Study|Patient declined further treatment|11|||
161744417|NCT00507416|584102127|FG000|Overall Study|Other|11|||
161744418|NCT00507416|584102128|FG001|Overall Study|Other|16|||
161744419|NCT00507416|584102129|FG002|Overall Study|Other|13|||
161744420|NCT00507416|584102127|FG000|Overall Study|Did not Receive Study Treatment|3|||
161744421|NCT00507416|584102128|FG001|Overall Study|Did not Receive Study Treatment|9|||
161744422|NCT00507416|584102129|FG002|Overall Study|Did not Receive Study Treatment|4|||
161744423|NCT00964158|584102130|FG000|Overall Study|Lost to Follow-up|0|||
161744424|NCT00964158|584102131|FG001|Overall Study|Lost to Follow-up|1|||
161744425|NCT00964158|584102132|FG002|Overall Study|Lost to Follow-up|2|||
161744426|NCT00964158|584102130|FG000|Overall Study|Withdrawal by Subject|0|||
161842107|NCT04645966|584466270|FG001|Vaccination Phase|Lost to Follow-up|0|||
161744427|NCT00964158|584102131|FG001|Overall Study|Withdrawal by Subject|0|||
161744428|NCT00964158|584102132|FG002|Overall Study|Withdrawal by Subject|6|||
161744429|NCT03101514|584102133|FG000|Overall Study|Withdrawal by Subject|4|||
161744430|NCT03101514|584102133|FG000|Overall Study|Protocol Violation|2|||
161744431|NCT03101514|584102133|FG000|Overall Study|patient's information was incomplete|1|||
161744432|NCT03695393|584102142|FG000|Overall Study|Death|3|||
161744433|NCT03695393|584102143|FG001|Overall Study|Death|1|||
161744434|NCT03695393|584102142|FG000|Overall Study|Lost to Follow-up|0|||
161744435|NCT03695393|584102143|FG001|Overall Study|Lost to Follow-up|1|||
161744436|NCT04585451|584102144|FG000|Overall Study|Withdrawal by Subject|26|||
161744437|NCT04585451|584102145|FG001|Overall Study|Withdrawal by Subject|0|||
161744438|NCT01578785|584102146|FG000|Overall Study|Withdrawal by Subject|0|||
161744439|NCT01578785|584102147|FG001|Overall Study|Withdrawal by Subject|1|||
161842108|NCT04645966|584466271|FG002|Vaccination Phase|Lost to Follow-up|0|||
161744440|NCT01578785|584102146|FG000|Overall Study|Study terminated by sponsor|59|||
161744441|NCT01578785|584102147|FG001|Overall Study|Study terminated by sponsor|118|||
161744442|NCT00966693|584102148|FG000|Overall Study|Adverse Event|0|||
161744443|NCT00966693|584102149|FG001|Overall Study|Adverse Event|0|||
161744444|NCT00966693|584102150|FG002|Overall Study|Adverse Event|1|||
161744445|NCT00966693|584102151|FG003|Overall Study|Adverse Event|2|||
161744446|NCT00966693|584102148|FG000|Overall Study|Death|0|||
161744447|NCT00966693|584102149|FG001|Overall Study|Death|0|||
161744448|NCT00966693|584102150|FG002|Overall Study|Death|1|||
161744449|NCT00966693|584102151|FG003|Overall Study|Death|0|||
161744450|NCT00966693|584102148|FG000|Overall Study|Withdrawal by Subject|1|||
161744451|NCT00966693|584102149|FG001|Overall Study|Withdrawal by Subject|0|||
161744452|NCT00966693|584102150|FG002|Overall Study|Withdrawal by Subject|0|||
161744453|NCT00966693|584102151|FG003|Overall Study|Withdrawal by Subject|5|||
161744454|NCT00966693|584102148|FG000|Overall Study|Disease Progression|0|||
161744455|NCT00966693|584102149|FG001|Overall Study|Disease Progression|0|||
161744456|NCT00966693|584102150|FG002|Overall Study|Disease Progression|1|||
161744457|NCT00966693|584102151|FG003|Overall Study|Disease Progression|16|||
161744458|NCT01769469|584102152|FG000|Overall Study|Consent Withdrawn|5|||
161744459|NCT01769469|584102152|FG000|Overall Study|Moved Out Of Area|3|||
161744460|NCT01769469|584102152|FG000|Overall Study|Lost to Follow-up|17|||
161744461|NCT01769469|584102152|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
161744462|NCT01769469|584102152|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
161744463|NCT02713789|584102164|FG000|Overall Study|Lost to Follow-up|0|||
161744464|NCT02713789|584102165|FG001|Overall Study|Lost to Follow-up|1|||
161744465|NCT02713789|584102166|FG002|Overall Study|Lost to Follow-up|1|||
161744466|NCT04186663|584102175|FG000|Overall Study|Lost to Follow-up|1|||
161744467|NCT04186663|584102175|FG000|Overall Study|Unable to complete blood draw|3|||
161744468|NCT01736254|584102177|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
161744469|NCT01736254|584102177|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
161744470|NCT01375647|584103611|FG000|Overall Study|Lost to Follow-up|3|||
161744471|NCT01375647|584103612|FG001|Overall Study|Lost to Follow-up|3|||
161744472|NCT01375647|584103613|FG002|Overall Study|Lost to Follow-up|7|||
161744473|NCT01375647|584103614|FG003|Overall Study|Lost to Follow-up|10|||
161744474|NCT01375647|584103611|FG000|Overall Study|Death|1|||
161744475|NCT01375647|584103612|FG001|Overall Study|Death|2|||
161744476|NCT01375647|584103613|FG002|Overall Study|Death|1|||
161744477|NCT01375647|584103614|FG003|Overall Study|Death|0|||
161744478|NCT01375647|584103611|FG000|Overall Study|Withdrawal by Subject|17|||
161744479|NCT01375647|584103612|FG001|Overall Study|Withdrawal by Subject|20|||
161744480|NCT01375647|584103613|FG002|Overall Study|Withdrawal by Subject|26|||
161744481|NCT01375647|584103614|FG003|Overall Study|Withdrawal by Subject|14|||
161744482|NCT01375647|584103611|FG000|Overall Study|Physician Decision|1|||
161744483|NCT01375647|584103612|FG001|Overall Study|Physician Decision|0|||
161744484|NCT01375647|584103613|FG002|Overall Study|Physician Decision|0|||
161744485|NCT01375647|584103614|FG003|Overall Study|Physician Decision|0|||
161744486|NCT03788967|584103617|FG000|Overall Study|Lost to Follow-up|14|||
161744487|NCT03788967|584103618|FG001|Overall Study|Lost to Follow-up|10|||
161744488|NCT03788967|584103617|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
161744489|NCT03788967|584103618|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
161744490|NCT03788967|584103617|FG000|Overall Study|Participant Withdrawal of Consent|13|||
161744491|NCT03788967|584103618|FG001|Overall Study|Participant Withdrawal of Consent|5|||
161744492|NCT03788967|584103617|FG000|Overall Study|Adverse Event|1|||
161744493|NCT03788967|584103618|FG001|Overall Study|Adverse Event|1|||
161744494|NCT03788967|584103617|FG000|Overall Study|COVID-19|1|||
161744495|NCT03788967|584103618|FG001|Overall Study|COVID-19|2|||
161744496|NCT04268303|584103619|FG000|Overall Study|Lost to Follow-up|1|||
161744497|NCT04268303|584103620|FG001|Overall Study|Lost to Follow-up|1|||
161744498|NCT04268303|584103621|FG002|Overall Study|Lost to Follow-up|2|||
161744499|NCT04268303|584103619|FG000|Overall Study|Withdrawal by Subject|0|||
161744500|NCT04268303|584103620|FG001|Overall Study|Withdrawal by Subject|1|||
161744501|NCT04268303|584103621|FG002|Overall Study|Withdrawal by Subject|1|||
161744502|NCT04268303|584103619|FG000|Overall Study|Adverse Event|2|||
161744503|NCT04268303|584103620|FG001|Overall Study|Adverse Event|0|||
161744504|NCT04268303|584103621|FG002|Overall Study|Adverse Event|0|||
161744505|NCT00355134|584103622|FG000|Core Phase|Withdrawal by Subject|35|||
161744506|NCT00355134|584103623|FG001|Core Phase|Withdrawal by Subject|24|||
161744507|NCT00355134|584103624|FG002|Core Phase|Withdrawal by Subject|35|||
161744508|NCT00355134|584103625|FG003|Core Phase|Withdrawal by Subject|0|||
161744509|NCT00355134|584103626|FG004|Core Phase|Withdrawal by Subject|0|||
161744510|NCT00355134|584103622|FG000|Core Phase|Adverse Event|28|||
161744511|NCT00355134|584103623|FG001|Core Phase|Adverse Event|22|||
161744512|NCT00355134|584103624|FG002|Core Phase|Adverse Event|16|||
161744513|NCT00355134|584103625|FG003|Core Phase|Adverse Event|0|||
161744514|NCT00355134|584103626|FG004|Core Phase|Adverse Event|0|||
161744515|NCT00355134|584103622|FG000|Core Phase|Lost to Follow-up|17|||
161744516|NCT00355134|584103623|FG001|Core Phase|Lost to Follow-up|13|||
161744517|NCT00355134|584103624|FG002|Core Phase|Lost to Follow-up|21|||
161744518|NCT00355134|584103625|FG003|Core Phase|Lost to Follow-up|0|||
161744519|NCT00355134|584103626|FG004|Core Phase|Lost to Follow-up|0|||
161966730|NCT00006046|584925691|FG000|Overall Study|Disease Progression|2|||
161966731|NCT00006046|584925692|FG001|Overall Study|Disease Progression|0|||
161966732|NCT00006046|584925693|FG002|Overall Study|Disease Progression|0|||
161966733|NCT00006046|584925694|FG003|Overall Study|Disease Progression|0|||
161966734|NCT00006046|584925695|FG004|Overall Study|Disease Progression|0|||
161966735|NCT00596154|584925696|FG000|Overall Study|Not Evaluable|2|||
161966736|NCT00642369|584925706|FG000|Overall Study|Adverse Event|2|||
161966737|NCT00642369|584925707|FG001|Overall Study|Adverse Event|3|||
161966738|NCT00642369|584925706|FG000|Overall Study|Withdrawal by Subject|1|||
161966739|NCT00642369|584925707|FG001|Overall Study|Withdrawal by Subject|0|||
161966740|NCT00642369|584925706|FG000|Overall Study|misdiagnosis|0|||
161966741|NCT00642369|584925707|FG001|Overall Study|misdiagnosis|1|||
161966742|NCT00642369|584925706|FG000|Overall Study|Lack of Efficacy|2|||
161966743|NCT00642369|584925707|FG001|Overall Study|Lack of Efficacy|2|||
161966744|NCT00996281|584925715|FG000|Overall Study|Adverse Event|75|||
161966745|NCT00996281|584925716|FG001|Overall Study|Adverse Event|37|||
161966746|NCT00996281|584925715|FG000|Overall Study|Major Protocol Deviation|6|||
161966747|NCT00996281|584925716|FG001|Overall Study|Major Protocol Deviation|7|||
161966748|NCT00996281|584925715|FG000|Overall Study|Lost to Follow-up|14|||
161744520|NCT00355134|584103622|FG000|Core Phase|Abnormal laboratory value(s)|19|||
161744521|NCT00355134|584103623|FG001|Core Phase|Abnormal laboratory value(s)|14|||
161744522|NCT00355134|584103624|FG002|Core Phase|Abnormal laboratory value(s)|2|||
161744523|NCT00355134|584103625|FG003|Core Phase|Abnormal laboratory value(s)|0|||
161744524|NCT00355134|584103626|FG004|Core Phase|Abnormal laboratory value(s)|0|||
161744525|NCT00355134|584103622|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
161966749|NCT00996281|584925716|FG001|Overall Study|Lost to Follow-up|16|||
161744526|NCT00355134|584103623|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
161744527|NCT00355134|584103624|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
161744528|NCT00355134|584103625|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
161744529|NCT00355134|584103626|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
161744530|NCT00355134|584103622|FG000|Core Phase|Administrative problems|5|||
161744531|NCT00355134|584103623|FG001|Core Phase|Administrative problems|3|||
161744532|NCT00355134|584103624|FG002|Core Phase|Administrative problems|5|||
161744533|NCT00355134|584103625|FG003|Core Phase|Administrative problems|0|||
161744534|NCT00355134|584103626|FG004|Core Phase|Administrative problems|0|||
161744535|NCT00355134|584103622|FG000|Core Phase|Protocol Violation|3|||
161744536|NCT00355134|584103623|FG001|Core Phase|Protocol Violation|2|||
161744537|NCT00355134|584103624|FG002|Core Phase|Protocol Violation|2|||
161744538|NCT00355134|584103625|FG003|Core Phase|Protocol Violation|0|||
161744539|NCT00355134|584103626|FG004|Core Phase|Protocol Violation|0|||
161744540|NCT00355134|584103622|FG000|Core Phase|Abnormal test procedure result(s)|1|||
161744541|NCT00355134|584103623|FG001|Core Phase|Abnormal test procedure result(s)|2|||
161744542|NCT00355134|584103624|FG002|Core Phase|Abnormal test procedure result(s)|1|||
161744543|NCT00355134|584103625|FG003|Core Phase|Abnormal test procedure result(s)|0|||
161744544|NCT00355134|584103626|FG004|Core Phase|Abnormal test procedure result(s)|0|||
161744545|NCT00355134|584103622|FG000|Core Phase|Condition no longer requires study drug|1|||
161744546|NCT00355134|584103623|FG001|Core Phase|Condition no longer requires study drug|0|||
161744547|NCT00355134|584103624|FG002|Core Phase|Condition no longer requires study drug|1|||
161744548|NCT00355134|584103625|FG003|Core Phase|Condition no longer requires study drug|0|||
161744549|NCT00355134|584103626|FG004|Core Phase|Condition no longer requires study drug|0|||
161744550|NCT00355134|584103622|FG000|Extension Phase|Withdrawal by Subject|7|||
161744551|NCT00355134|584103623|FG001|Extension Phase|Withdrawal by Subject|11|||
161744552|NCT00355134|584103624|FG002|Extension Phase|Withdrawal by Subject|0|||
161744553|NCT00355134|584103625|FG003|Extension Phase|Withdrawal by Subject|7|||
161744554|NCT00355134|584103626|FG004|Extension Phase|Withdrawal by Subject|5|||
161744555|NCT00355134|584103622|FG000|Extension Phase|Adverse Event|13|||
161744556|NCT00355134|584103623|FG001|Extension Phase|Adverse Event|9|||
161744557|NCT00355134|584103624|FG002|Extension Phase|Adverse Event|0|||
161744558|NCT00355134|584103625|FG003|Extension Phase|Adverse Event|3|||
161744559|NCT00355134|584103626|FG004|Extension Phase|Adverse Event|5|||
161744560|NCT00355134|584103622|FG000|Extension Phase|Lost to Follow-up|2|||
161744561|NCT00355134|584103623|FG001|Extension Phase|Lost to Follow-up|6|||
161744562|NCT00355134|584103624|FG002|Extension Phase|Lost to Follow-up|0|||
161842109|NCT04645966|584466272|FG003|Vaccination Phase|Lost to Follow-up|0|||
161966750|NCT00996281|584925715|FG000|Overall Study|Withdrawal by Subject|31|||
161966751|NCT00996281|584925716|FG001|Overall Study|Withdrawal by Subject|20|||
161966752|NCT00996281|584925715|FG000|Overall Study|Lack of Efficacy|0|||
161966753|NCT00996281|584925716|FG001|Overall Study|Lack of Efficacy|2|||
161744563|NCT00355134|584103625|FG003|Extension Phase|Lost to Follow-up|2|||
161744564|NCT00355134|584103626|FG004|Extension Phase|Lost to Follow-up|4|||
161744565|NCT00355134|584103622|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
161744566|NCT00355134|584103623|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
161744567|NCT00355134|584103624|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
161744568|NCT00355134|584103625|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
161842110|NCT04645966|584466273|FG004|Vaccination Phase|Lost to Follow-up|0|||
161966754|NCT00996281|584925715|FG000|Overall Study|Other|5|||
161744569|NCT00355134|584103626|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
161744570|NCT00355134|584103622|FG000|Extension Phase|Administrative problems|2|||
161744571|NCT00355134|584103623|FG001|Extension Phase|Administrative problems|4|||
161744572|NCT00355134|584103624|FG002|Extension Phase|Administrative problems|0|||
161744573|NCT00355134|584103625|FG003|Extension Phase|Administrative problems|1|||
161744574|NCT00355134|584103626|FG004|Extension Phase|Administrative problems|1|||
161744575|NCT00355134|584103622|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
161744576|NCT00355134|584103623|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
161744577|NCT00355134|584103624|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
161744578|NCT00355134|584103625|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
161744579|NCT00355134|584103626|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
161744580|NCT00355134|584103622|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
161744581|NCT00355134|584103623|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
161744582|NCT00355134|584103624|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
161744583|NCT00355134|584103625|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
161744584|NCT00355134|584103626|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
161744585|NCT00355134|584103622|FG000|Extension Phase|Protocol Violation|0|||
161744586|NCT00355134|584103623|FG001|Extension Phase|Protocol Violation|0|||
161744587|NCT00355134|584103624|FG002|Extension Phase|Protocol Violation|0|||
161744588|NCT00355134|584103625|FG003|Extension Phase|Protocol Violation|1|||
161744589|NCT00355134|584103626|FG004|Extension Phase|Protocol Violation|0|||
161744590|NCT01316939|584103629|FG000|Overall Study|Study closed/terminated|26|||
161744591|NCT01316939|584103630|FG001|Overall Study|Study closed/terminated|25|||
161744592|NCT01316939|584103631|FG002|Overall Study|Study closed/terminated|23|||
161744593|NCT01316939|584103629|FG000|Overall Study|Lack of Efficacy|24|||
161744594|NCT01316939|584103630|FG001|Overall Study|Lack of Efficacy|25|||
161744595|NCT01316939|584103631|FG002|Overall Study|Lack of Efficacy|25|||
161744596|NCT01316939|584103629|FG000|Overall Study|Adverse Event|9|||
161744597|NCT01316939|584103630|FG001|Overall Study|Adverse Event|12|||
161744598|NCT01316939|584103631|FG002|Overall Study|Adverse Event|11|||
161744599|NCT01316939|584103629|FG000|Overall Study|Withdrawal by Subject|1|||
161744600|NCT01316939|584103630|FG001|Overall Study|Withdrawal by Subject|3|||
161744601|NCT01316939|584103631|FG002|Overall Study|Withdrawal by Subject|6|||
161744602|NCT01316939|584103629|FG000|Overall Study|Physician Decision|2|||
161744603|NCT01316939|584103630|FG001|Overall Study|Physician Decision|2|||
161744604|NCT01316939|584103631|FG002|Overall Study|Physician Decision|1|||
161744605|NCT01316939|584103629|FG000|Overall Study|Lost to Follow-up|0|||
161744606|NCT01316939|584103630|FG001|Overall Study|Lost to Follow-up|0|||
161744607|NCT01316939|584103631|FG002|Overall Study|Lost to Follow-up|2|||
161744608|NCT01316939|584103629|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
161744609|NCT01316939|584103630|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
161744610|NCT01316939|584103631|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
161744611|NCT01316939|584103629|FG000|Overall Study|Protocol Violation|0|||
161744612|NCT01316939|584103630|FG001|Overall Study|Protocol Violation|1|||
161744613|NCT01316939|584103631|FG002|Overall Study|Protocol Violation|0|||
161744614|NCT02715804|584103632|FG000|Overall Study|Death|222|||
161744615|NCT02715804|584103633|FG001|Overall Study|Death|106|||
161744616|NCT02715804|584103632|FG000|Overall Study|Withdrawal by Subject|5|||
161744617|NCT02715804|584103633|FG001|Overall Study|Withdrawal by Subject|4|||
161744618|NCT02715804|584103632|FG000|Overall Study|Other than specified|2|||
161744619|NCT02715804|584103633|FG001|Overall Study|Other than specified|3|||
161744620|NCT01625611|584103636|FG000|Overall Study|No adlib drinks Lab 1|3|||
161744621|NCT01625611|584103637|FG001|Overall Study|No adlib drinks Lab 1|0|||
161744622|NCT01625611|584103636|FG000|Overall Study|Technical issues with PET|1|||
161744623|NCT01625611|584103637|FG001|Overall Study|Technical issues with PET|0|||
161744624|NCT01625611|584103636|FG000|Overall Study|Unable to complete study procedures|1|||
161744625|NCT01625611|584103637|FG001|Overall Study|Unable to complete study procedures|0|||
161744626|NCT01625611|584103636|FG000|Overall Study|Withdrawal by Subject|3|||
161744627|NCT01625611|584103637|FG001|Overall Study|Withdrawal by Subject|0|||
161842111|NCT04645966|584466274|FG005|Vaccination Phase|Lost to Follow-up|0|||
161842112|NCT04645966|584466275|FG006|Vaccination Phase|Lost to Follow-up|0|||
161842113|NCT04645966|584466276|FG007|Vaccination Phase|Lost to Follow-up|1|||
162032567|NCT00761748|585177433|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
161744628|NCT00948194|584103638|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
161744629|NCT00948194|584103639|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
161744630|NCT00233324|584103640|FG000|Main Study|Death|68|||
161744631|NCT00233324|584103641|FG001|Main Study|Death|60|||
161744632|NCT00233324|584103642|FG002|Main Study|Death|62|||
161744633|NCT00233324|584103643|FG003|Main Study|Death|47|||
161744634|NCT00233324|584103640|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
161744635|NCT00233324|584103641|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
161842114|NCT04645966|584466277|FG008|Vaccination Phase|Lost to Follow-up|0|||
161744636|NCT00233324|584103642|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
161744637|NCT00233324|584103643|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
161744638|NCT00233324|584103640|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
161966755|NCT00996281|584925716|FG001|Overall Study|Other|7|||
161966756|NCT01453205|584925719|FG000|Overall Study|Lost to Follow-up|3|||
161966757|NCT01453205|584925720|FG001|Overall Study|Lost to Follow-up|0|||
161966758|NCT01453205|584925721|FG002|Overall Study|Lost to Follow-up|1|||
161966759|NCT01453205|584925719|FG000|Overall Study|Withdrawal by Subject|8|||
161966760|NCT01453205|584925720|FG001|Overall Study|Withdrawal by Subject|3|||
161966761|NCT01453205|584925721|FG002|Overall Study|Withdrawal by Subject|0|||
161966762|NCT01453205|584925719|FG000|Overall Study|Death|24|||
161966763|NCT01453205|584925720|FG001|Overall Study|Death|22|||
161966764|NCT01453205|584925721|FG002|Overall Study|Death|18|||
161966765|NCT01453205|584925719|FG000|Overall Study|Other|45|||
161966766|NCT01453205|584925720|FG001|Overall Study|Other|27|||
161966767|NCT01453205|584925721|FG002|Overall Study|Other|35|||
161966768|NCT05593913|584925722|FG000|Overall Study|Insufficient image quality|39|||
161966769|NCT04934800|584925723|FG000|Overall Study|Other|1|||
161966770|NCT04934800|584925723|FG000|Overall Study|Withdrawal by Subject|5|||
161966771|NCT04934800|584925723|FG000|Overall Study|Lack of Efficacy|1|||
161966772|NCT04934800|584925723|FG000|Overall Study|Adverse Event|9|||
161966773|NCT04934800|584925723|FG000|Overall Study|Lost to Follow-up|5|||
161966774|NCT04934800|584925723|FG000|Overall Study|Enrolled but not treated|1|||
161966775|NCT05596734|584925724|FG000|Substudy A|Withdrawal by Subject|1|||
161744639|NCT00233324|584103641|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
161744640|NCT00233324|584103642|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
161744641|NCT00233324|584103643|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
161744642|NCT01281189|584103650|FG000|Overall Study|Adverse Event|7|||
161744643|NCT01281189|584103651|FG001|Overall Study|Adverse Event|9|||
161744644|NCT01281189|584103650|FG000|Overall Study|Lost to Follow-up|6|||
161744645|NCT01281189|584103651|FG001|Overall Study|Lost to Follow-up|4|||
161744646|NCT01281189|584103650|FG000|Overall Study|Withdrawal by Subject|21|||
161744647|NCT01281189|584103651|FG001|Overall Study|Withdrawal by Subject|24|||
161744648|NCT01281189|584103650|FG000|Overall Study|Physician Decision|2|||
161744649|NCT01281189|584103651|FG001|Overall Study|Physician Decision|3|||
161744650|NCT01281189|584103650|FG000|Overall Study|Death|103|||
161744651|NCT01281189|584103651|FG001|Overall Study|Death|91|||
161744652|NCT01281189|584103650|FG000|Overall Study|Other|8|||
161744653|NCT01281189|584103651|FG001|Overall Study|Other|12|||
161744654|NCT00527072|584103658|FG000|Overall Study|Adverse Event|13|||
161744655|NCT00527072|584103658|FG000|Overall Study|Lack of Efficacy|11|||
161744656|NCT00527072|584103658|FG000|Overall Study|Lost to Follow-up|3|||
161744657|NCT00527072|584103658|FG000|Overall Study|Protocol Violation|2|||
161744658|NCT00527072|584103658|FG000|Overall Study|Withdrawal by Subject|7|||
161744659|NCT02657434|584103659|FG000|Overall Study|Study Terminated By Sponsor|64|||
161744660|NCT02657434|584103660|FG001|Overall Study|Study Terminated By Sponsor|82|||
161744661|NCT02657434|584103659|FG000|Overall Study|Death|189|||
161744662|NCT02657434|584103660|FG001|Overall Study|Death|190|||
161744663|NCT02657434|584103659|FG000|Overall Study|Lost to Follow-up|2|||
161744664|NCT02657434|584103660|FG001|Overall Study|Lost to Follow-up|2|||
161744665|NCT02657434|584103659|FG000|Overall Study|Randomization by Error|2|||
161744666|NCT02657434|584103660|FG001|Overall Study|Randomization by Error|0|||
161744667|NCT02657434|584103659|FG000|Overall Study|Withdrawal by Subject|28|||
161744668|NCT02657434|584103660|FG001|Overall Study|Withdrawal by Subject|17|||
161744669|NCT02657434|584103659|FG000|Overall Study|Protocol Violation|1|||
161744670|NCT02657434|584103660|FG001|Overall Study|Protocol Violation|0|||
161744671|NCT02657434|584103659|FG000|Overall Study|Physician Decision|0|||
161744672|NCT02657434|584103660|FG001|Overall Study|Physician Decision|1|||
161744673|NCT00608881|584103661|FG000|Overall Study|Death|22|||
161744674|NCT00608881|584103662|FG001|Overall Study|Death|13|||
161744675|NCT00608881|584103661|FG000|Overall Study|Adverse Event|5|||
161744676|NCT00608881|584103662|FG001|Overall Study|Adverse Event|3|||
161744677|NCT00608881|584103661|FG000|Overall Study|Lost to Follow-up|28|||
161744678|NCT00608881|584103662|FG001|Overall Study|Lost to Follow-up|14|||
161744679|NCT00608881|584103661|FG000|Overall Study|Withdrawal by Subject|18|||
161744680|NCT00608881|584103662|FG001|Overall Study|Withdrawal by Subject|29|||
161744681|NCT00608881|584103661|FG000|Overall Study|Physician Decision|5|||
161744682|NCT00608881|584103662|FG001|Overall Study|Physician Decision|5|||
161744683|NCT00608881|584103661|FG000|Overall Study|Institutionalized|1|||
161966776|NCT05596734|584925725|FG001|Substudy A|Withdrawal by Subject|0|||
161966777|NCT05596734|584925726|FG002|Substudy A|Withdrawal by Subject|0|||
161744684|NCT00608881|584103662|FG001|Overall Study|Institutionalized|2|||
161966778|NCT05596734|584925727|FG003|Substudy A|Withdrawal by Subject|0|||
161966779|NCT05596734|584925728|FG004|Substudy A|Withdrawal by Subject|0|||
161744685|NCT00510484|584103663|FG000|Wash-out Period|Adverse Event|0|||
161966780|NCT05596734|584925729|FG005|Substudy A|Withdrawal by Subject|0|||
161744686|NCT00510484|584103664|FG001|Wash-out Period|Adverse Event|1|||
161744687|NCT01590212|584103665|FG000|Overall Study|Withdrawal by Subject|2|||
161744688|NCT01590212|584103666|FG001|Overall Study|Withdrawal by Subject|2|||
161744689|NCT01590212|584103667|FG002|Overall Study|Withdrawal by Subject|2|||
161744690|NCT01590212|584103665|FG000|Overall Study|Lost to Follow-up|1|||
161744691|NCT01590212|584103666|FG001|Overall Study|Lost to Follow-up|2|||
161966781|NCT05596734|584925730|FG006|Substudy A|Withdrawal by Subject|1|||
161744692|NCT01590212|584103667|FG002|Overall Study|Lost to Follow-up|3|||
161744693|NCT03004976|584103668|FG000|Overall Study|Lost to Follow-up|7|||
161744694|NCT03004976|584103669|FG001|Overall Study|Lost to Follow-up|5|||
161744695|NCT03004976|584103668|FG000|Overall Study|Physician Decision|1|||
161744696|NCT03004976|584103669|FG001|Overall Study|Physician Decision|0|||
161744697|NCT03004976|584103668|FG000|Overall Study|Withdrawal by Subject|1|||
161744698|NCT03004976|584103669|FG001|Overall Study|Withdrawal by Subject|0|||
161744699|NCT03004976|584103668|FG000|Overall Study|Death|4|||
161744700|NCT03004976|584103669|FG001|Overall Study|Death|1|||
161744701|NCT02533401|584103670|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
161744702|NCT02533401|584103670|FG000|Overall Study|Death|5|||
161842115|NCT04645966|584466269|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
161842116|NCT04645966|584466270|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
161842117|NCT04645966|584466271|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
161842118|NCT04645966|584466272|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
161842119|NCT04645966|584466273|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
161842120|NCT04645966|584466274|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
161842121|NCT04645966|584466275|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
161842122|NCT04645966|584466276|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
161842123|NCT04645966|584466277|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
161842124|NCT04645966|584466269|FG000|Follow-up Phase|Lost to Follow-up|0|||
161842125|NCT04645966|584466270|FG001|Follow-up Phase|Lost to Follow-up|0|||
161842126|NCT04645966|584466271|FG002|Follow-up Phase|Lost to Follow-up|0|||
161842127|NCT04645966|584466272|FG003|Follow-up Phase|Lost to Follow-up|0|||
161842128|NCT04645966|584466273|FG004|Follow-up Phase|Lost to Follow-up|0|||
161842129|NCT04645966|584466274|FG005|Follow-up Phase|Lost to Follow-up|0|||
161842130|NCT04645966|584466275|FG006|Follow-up Phase|Lost to Follow-up|0|||
161842131|NCT04645966|584466276|FG007|Follow-up Phase|Lost to Follow-up|1|||
161842132|NCT04645966|584466277|FG008|Follow-up Phase|Lost to Follow-up|0|||
161842133|NCT00552578|584466281|FG000|Overall Study|Lost to Follow-up|1|||
161842134|NCT00552578|584466282|FG001|Overall Study|Lost to Follow-up|1|||
161842135|NCT04729309|584466283|FG000|Period 1|Subject unable to return for Period 2|3|||
161842136|NCT04729309|584466284|FG001|Period 1|Subject unable to return for Period 2|0|||
161842137|NCT04729309|584466283|FG000|Period 1|Lost to Follow-up|1|||
161842138|NCT04729309|584466284|FG001|Period 1|Lost to Follow-up|0|||
161842139|NCT02695537|584466294|FG000|Overall Study|Adverse Event|3|||
161842140|NCT02695537|584466294|FG000|Overall Study|Lack of Efficacy|28|||
161842141|NCT02695537|584466294|FG000|Overall Study|Withdrawal by Subject|4|||
161842142|NCT02695537|584466294|FG000|Overall Study|Protocol Violation|3|||
161842143|NCT04015908|584466295|FG000|Overall Study|Lost to Follow-up|0|||
161842144|NCT04015908|584466296|FG001|Overall Study|Lost to Follow-up|1|||
161842145|NCT02792699|584466297|FG000|Overall Study|Adverse Event|1|||
161842146|NCT02792699|584466298|FG001|Overall Study|Adverse Event|2|||
161842147|NCT02792699|584466299|FG002|Overall Study|Adverse Event|4|||
161842148|NCT02792699|584466297|FG000|Overall Study|Withdrawal by Subject|4|||
161842149|NCT02792699|584466298|FG001|Overall Study|Withdrawal by Subject|4|||
161842150|NCT02792699|584466299|FG002|Overall Study|Withdrawal by Subject|3|||
161842151|NCT02792699|584466297|FG000|Overall Study|Lost to Follow-up|0|||
161842152|NCT02792699|584466298|FG001|Overall Study|Lost to Follow-up|1|||
161842153|NCT02792699|584466299|FG002|Overall Study|Lost to Follow-up|2|||
161842154|NCT02792699|584466297|FG000|Overall Study|Physician Decision|2|||
161842155|NCT02792699|584466298|FG001|Overall Study|Physician Decision|0|||
161842156|NCT02792699|584466299|FG002|Overall Study|Physician Decision|0|||
161842157|NCT02792699|584466297|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
161842158|NCT02792699|584466298|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
161842159|NCT02792699|584466299|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
161842160|NCT02792699|584466297|FG000|Overall Study|Other|1|||
161842161|NCT02792699|584466298|FG001|Overall Study|Other|0|||
161842162|NCT02792699|584466299|FG002|Overall Study|Other|0|||
161842163|NCT01715571|584466302|FG000|Overall Study|Lost to Follow-up|8|||
161842164|NCT00077857|584466305|FG000|Overall Study|Adverse Event|30|||
161842165|NCT00077857|584466306|FG001|Overall Study|Adverse Event|32|||
161842166|NCT00077857|584466305|FG000|Overall Study|Death|7|||
161842167|NCT00077857|584466306|FG001|Overall Study|Death|3|||
161842168|NCT00077857|584466305|FG000|Overall Study|Insufficient therapeutic response|112|||
161842169|NCT00077857|584466306|FG001|Overall Study|Insufficient therapeutic response|128|||
161842170|NCT00077857|584466305|FG000|Overall Study|Violation of selection criteria at entry|3|||
161842171|NCT00077857|584466306|FG001|Overall Study|Violation of selection criteria at entry|1|||
161842172|NCT00077857|584466305|FG000|Overall Study|Other protocol violation|0|||
161842173|NCT00077857|584466306|FG001|Overall Study|Other protocol violation|1|||
161842174|NCT00077857|584466305|FG000|Overall Study|Refused treatment|29|||
161744703|NCT02533401|584103670|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
161744704|NCT02533401|584103670|FG000|Overall Study|Lost to Follow-up|1|||
161744705|NCT02533401|584103670|FG000|Overall Study|Violation of Selection Criteria|1|||
161842175|NCT00077857|584466306|FG001|Overall Study|Refused treatment|21|||
161842176|NCT00077857|584466305|FG000|Overall Study|Failure to return|5|||
161842177|NCT00077857|584466306|FG001|Overall Study|Failure to return|5|||
161966782|NCT05596734|584925731|FG007|Substudy A|Withdrawal by Subject|0|||
161966783|NCT05596734|584925732|FG008|Substudy A|Withdrawal by Subject|0|||
161966784|NCT05596734|584925733|FG009|Substudy A|Withdrawal by Subject|0|||
161966785|NCT05596734|584925734|FG010|Substudy A|Withdrawal by Subject|0|||
161966786|NCT05596734|584925735|FG011|Substudy A|Withdrawal by Subject|0|||
161966787|NCT05596734|584925736|FG012|Substudy A|Withdrawal by Subject|0|||
161966788|NCT05596734|584925737|FG013|Substudy A|Withdrawal by Subject|0|||
161744706|NCT04897594|584103675|FG000|Overall Study|Lost to Follow-up|0|||
161744707|NCT04897594|584103676|FG001|Overall Study|Lost to Follow-up|1|||
161744708|NCT04897594|584103677|FG002|Overall Study|Lost to Follow-up|1|||
161744709|NCT04897594|584103675|FG000|Overall Study|Sponsor Decision|0|||
161744710|NCT04897594|584103676|FG001|Overall Study|Sponsor Decision|0|||
161744711|NCT04897594|584103677|FG002|Overall Study|Sponsor Decision|1|||
161744712|NCT04897594|584103675|FG000|Overall Study|Withdrawal by Subject|1|||
161744713|NCT04897594|584103676|FG001|Overall Study|Withdrawal by Subject|0|||
161744714|NCT04897594|584103677|FG002|Overall Study|Withdrawal by Subject|1|||
161744715|NCT02147691|584103680|FG000|Overall Study|Withdrawal by Subject|2|||
161744716|NCT02147691|584103681|FG001|Overall Study|Withdrawal by Subject|0|||
161744717|NCT02147691|584103680|FG000|Overall Study|Adverse Event|2|||
161744718|NCT02147691|584103681|FG001|Overall Study|Adverse Event|0|||
161744719|NCT02147691|584103680|FG000|Overall Study|Lost to Follow-up|0|||
161744720|NCT02147691|584103681|FG001|Overall Study|Lost to Follow-up|1|||
161744721|NCT01181141|584103684|FG000|Overall Study|Adverse Event|2|||
161744722|NCT01181141|584103685|FG001|Overall Study|Adverse Event|1|||
161744723|NCT01181141|584103684|FG000|Overall Study|Lack of Efficacy|1|||
161744724|NCT01181141|584103685|FG001|Overall Study|Lack of Efficacy|0|||
161744725|NCT01181141|584103684|FG000|Overall Study|Lost to Follow-up|1|||
161744726|NCT01181141|584103685|FG001|Overall Study|Lost to Follow-up|1|||
161744727|NCT01181141|584103684|FG000|Overall Study|Physician Decision|2|||
161744728|NCT01181141|584103685|FG001|Overall Study|Physician Decision|0|||
161744729|NCT01181141|584103684|FG000|Overall Study|Protocol Violation|3|||
161744730|NCT01181141|584103685|FG001|Overall Study|Protocol Violation|1|||
161744731|NCT01181141|584103684|FG000|Overall Study|Withdrawal by Subject|3|||
161744732|NCT01181141|584103685|FG001|Overall Study|Withdrawal by Subject|1|||
161744733|NCT01665768|584103686|FG000|Overall Study|Adverse Event|3|||
161744734|NCT01665768|584103686|FG000|Overall Study|Lack of Efficacy|19|||
161744735|NCT01665768|584103686|FG000|Overall Study|Withdrawal by Subject|1|||
161744736|NCT00118911|584103687|FG000|Overall Study|Withdrawal by Subject|2|||
161744737|NCT00118911|584103688|FG001|Overall Study|Withdrawal by Subject|5|||
161744738|NCT05014542|584103689|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
161744739|NCT05014542|584103690|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
161744740|NCT05014542|584103689|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
161744741|NCT05014542|584103690|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
161744742|NCT05014542|584103689|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
161744743|NCT05014542|584103690|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
161744744|NCT05014542|584103689|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
161744745|NCT05014542|584103690|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
161744746|NCT03496662|584103691|FG000|Overall Study|Adverse Event|0|||
161744747|NCT03496662|584103692|FG001|Overall Study|Adverse Event|0|||
161744748|NCT03496662|584103693|FG002|Overall Study|Adverse Event|4|||
161744749|NCT03496662|584103691|FG000|Overall Study|Withdrawal by Subject|1|||
161744750|NCT03496662|584103692|FG001|Overall Study|Withdrawal by Subject|0|||
161744751|NCT03496662|584103693|FG002|Overall Study|Withdrawal by Subject|2|||
161744752|NCT03496662|584103691|FG000|Overall Study|Death|0|||
161744753|NCT03496662|584103692|FG001|Overall Study|Death|0|||
161744754|NCT03496662|584103693|FG002|Overall Study|Death|2|||
161744755|NCT03496662|584103691|FG000|Overall Study|Noncompliance|0|||
161966789|NCT05596734|584925738|FG014|Substudy A|Withdrawal by Subject|0|||
161966790|NCT05596734|584925739|FG015|Substudy A|Withdrawal by Subject|0|||
161744756|NCT03496662|584103692|FG001|Overall Study|Noncompliance|0|||
161744757|NCT03496662|584103693|FG002|Overall Study|Noncompliance|1|||
161744758|NCT01467661|584103694|FG000|Overall Study|Adverse Event|16|||
161744759|NCT01467661|584103694|FG000|Overall Study|Withdrawal by Subject|1|||
161744760|NCT01467661|584103694|FG000|Overall Study|Lack of Efficacy|3|||
161744761|NCT01467661|584103694|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
161744762|NCT00691093|584103696|FG000|Overall Study|Adverse Event|1|||
161744763|NCT00691093|584103696|FG000|Overall Study|Lost to Follow-up|1|||
161744764|NCT00691093|584103696|FG000|Overall Study|Lack of Efficacy|1|||
161744765|NCT00691093|584103696|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
161744766|NCT03395223|584103698|FG000|Overall Study|Lost to Follow-up|3|||
161744767|NCT03395223|584103698|FG000|Overall Study|Other|1|||
161744768|NCT00810810|584103699|FG000|Overall Study|Withdrawal by Subject|0|||
161744769|NCT00810810|584103700|FG001|Overall Study|Withdrawal by Subject|8|||
161744770|NCT00810810|584103701|FG002|Overall Study|Withdrawal by Subject|10|||
161744771|NCT00810810|584103702|FG003|Overall Study|Withdrawal by Subject|8|||
161744772|NCT00810810|584103699|FG000|Overall Study|Physician Decision|0|||
161842178|NCT00077857|584466305|FG000|Overall Study|Other|15|||
161744773|NCT00810810|584103700|FG001|Overall Study|Physician Decision|3|||
161744774|NCT00810810|584103701|FG002|Overall Study|Physician Decision|1|||
161842179|NCT00077857|584466306|FG001|Overall Study|Other|13|||
161842180|NCT05084963|584466310|FG000|Overall Study|Withdrawal by Subject|0|||
161842181|NCT05084963|584466311|FG001|Overall Study|Withdrawal by Subject|0|||
161842182|NCT05084963|584466312|FG002|Overall Study|Withdrawal by Subject|1|||
161842183|NCT06187909|584466313|FG000|Overall Study|Withdrawal by Subject|2|||
161842184|NCT06187909|584466314|FG001|Overall Study|Withdrawal by Subject|2|||
161842185|NCT03569228|584466315|FG000|Overall Study|Withdrawal by PI|0|||
161842186|NCT03569228|584466316|FG001|Overall Study|Withdrawal by PI|0|||
161842187|NCT03569228|584466317|FG002|Overall Study|Withdrawal by PI|2|||
161842188|NCT03569228|584466318|FG003|Overall Study|Withdrawal by PI|2|||
161842189|NCT03569228|584466319|FG004|Overall Study|Withdrawal by PI|1|||
161744775|NCT00810810|584103702|FG003|Overall Study|Physician Decision|5|||
161744776|NCT01896856|584103703|FG000|Overall Study|Transportation issues / Non-compliance|0|||
161744777|NCT01896856|584103704|FG001|Overall Study|Transportation issues / Non-compliance|0|||
161744778|NCT01896856|584103705|FG002|Overall Study|Transportation issues / Non-compliance|1|||
161744779|NCT01896856|584103706|FG003|Overall Study|Transportation issues / Non-compliance|0|||
161744780|NCT01896856|584103707|FG004|Overall Study|Transportation issues / Non-compliance|0|||
161744781|NCT01896856|584103708|FG005|Overall Study|Transportation issues / Non-compliance|0|||
161744782|NCT01156532|584103709|FG000|Overall Study|Family Reasons|1|||
161744783|NCT01156532|584103709|FG000|Overall Study|Lost to Follow-up|1|||
161744784|NCT02563925|584103712|FG000|Overall Study|Withdrawal by Subject|2|||
161744785|NCT00282867|584103716|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
161744786|NCT00282867|584103717|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
161744787|NCT00282867|584103718|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
161744788|NCT00673894|584103731|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
161744789|NCT00673894|584103732|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
161744790|NCT00673894|584103731|FG000|First Intervention 4 Weeks|Adverse Event|1|||
161744791|NCT00673894|584103732|FG001|First Intervention 4 Weeks|Adverse Event|0|||
161744792|NCT01688635|584103740|FG000|Washout 1|Withdrawal by Subject|1|||
161744793|NCT01688635|584103741|FG001|Washout 1|Withdrawal by Subject|0|||
161744794|NCT01688635|584103740|FG000|Washout 1|Adverse Event|0|||
161744795|NCT01688635|584103741|FG001|Washout 1|Adverse Event|1|||
161744796|NCT01688635|584103740|FG000|Washout 1|Physician Decision|0|||
161744797|NCT01688635|584103741|FG001|Washout 1|Physician Decision|1|||
161744798|NCT01688635|584103740|FG000|Washout 2|Physician Decision|1|||
161744799|NCT01688635|584103741|FG001|Washout 2|Physician Decision|0|||
161744800|NCT01688635|584103740|FG000|Washout 2|Withdrawal by Subject|1|||
161744801|NCT01688635|584103741|FG001|Washout 2|Withdrawal by Subject|0|||
161744802|NCT01688635|584103740|FG000|Washout 2|Sponsor Decision|1|||
161744803|NCT01688635|584103741|FG001|Washout 2|Sponsor Decision|2|||
161744804|NCT01688635|584103740|FG000|Washout 3|Withdrawal by Subject|1|||
161744805|NCT01688635|584103741|FG001|Washout 3|Withdrawal by Subject|0|||
161744806|NCT03820726|584103742|FG000|Overall Study|Other than listed|23|||
161744807|NCT03820726|584103742|FG000|Overall Study|Withdrawal by Subject|37|||
161744808|NCT03820726|584103742|FG000|Overall Study|Lost to Follow-up|3|||
161744809|NCT03820726|584103742|FG000|Overall Study|Protocol deviation|1|||
161744810|NCT03820726|584103742|FG000|Overall Study|Adverse Event|146|||
161744811|NCT03820726|584103742|FG000|Overall Study|Not treated|1|||
161744812|NCT00141037|584103746|FG000|Overall Study|Physician Decision|1|||
161744813|NCT00141037|584103747|FG001|Overall Study|Physician Decision|2|||
161744814|NCT00141037|584103746|FG000|Overall Study|Lost to Follow-up|3|||
161744815|NCT00141037|584103747|FG001|Overall Study|Lost to Follow-up|1|||
161744816|NCT00141037|584103746|FG000|Overall Study|Protocol Violation|0|||
161744817|NCT00141037|584103747|FG001|Overall Study|Protocol Violation|2|||
161744818|NCT00141037|584103746|FG000|Overall Study|Withdrawal by Subject|2|||
161744819|NCT00141037|584103747|FG001|Overall Study|Withdrawal by Subject|1|||
161744820|NCT00141037|584103746|FG000|Overall Study|Other|0|||
161744821|NCT00141037|584103747|FG001|Overall Study|Other|1|||
161744822|NCT00141037|584103746|FG000|Overall Study|Moved from area|1|||
161744823|NCT00141037|584103747|FG001|Overall Study|Moved from area|7|||
161744824|NCT00141037|584103746|FG000|Overall Study|Graft Failure|3|||
161744825|NCT00141037|584103747|FG001|Overall Study|Graft Failure|4|||
161744826|NCT00888615|584103748|FG000|Overall Study|No treatment|2|||
161842190|NCT03569228|584466320|FG005|Overall Study|Withdrawal by PI|0|||
161842191|NCT03569228|584466321|FG006|Overall Study|Withdrawal by PI|0|||
161842192|NCT03569228|584466322|FG007|Overall Study|Withdrawal by PI|0|||
161744827|NCT00861380|584103749|FG000|Overall Study|Withdrawal Information not recorded|8427|||
161744828|NCT00861380|584103750|FG001|Overall Study|Withdrawal Information not recorded|9112|||
161744829|NCT00861380|584103751|FG002|Overall Study|Withdrawal Information not recorded|8872|||
161744830|NCT00861380|584103752|FG003|Overall Study|Withdrawal Information not recorded|3689|||
161744831|NCT00861380|584103753|FG004|Overall Study|Withdrawal Information not recorded|1812|||
161842193|NCT03569228|584466323|FG008|Overall Study|Withdrawal by PI|0|||
161842194|NCT03569228|584466315|FG000|Overall Study|Lost to Follow-up|0|||
161744832|NCT00861380|584103754|FG005|Overall Study|Withdrawal Information not recorded|6249|||
161744833|NCT00861380|584103755|FG006|Overall Study|Withdrawal Information not recorded|3020|||
161744834|NCT00637377|584103756|FG000|Overall Study|Adverse Event|2|||
161842195|NCT03569228|584466316|FG001|Overall Study|Lost to Follow-up|0|||
161842196|NCT03569228|584466317|FG002|Overall Study|Lost to Follow-up|0|||
161842197|NCT03569228|584466318|FG003|Overall Study|Lost to Follow-up|0|||
161842198|NCT03569228|584466319|FG004|Overall Study|Lost to Follow-up|0|||
161842199|NCT03569228|584466320|FG005|Overall Study|Lost to Follow-up|0|||
161842200|NCT03569228|584466321|FG006|Overall Study|Lost to Follow-up|0|||
161842201|NCT03569228|584466322|FG007|Overall Study|Lost to Follow-up|0|||
161842202|NCT03569228|584466323|FG008|Overall Study|Lost to Follow-up|1|||
161842203|NCT03569228|584466315|FG000|Overall Study|Screen Fail|2|||
161842204|NCT03569228|584466316|FG001|Overall Study|Screen Fail|2|||
161842205|NCT03569228|584466317|FG002|Overall Study|Screen Fail|1|||
161842206|NCT03569228|584466318|FG003|Overall Study|Screen Fail|1|||
161842207|NCT03569228|584466319|FG004|Overall Study|Screen Fail|1|||
161842208|NCT03569228|584466320|FG005|Overall Study|Screen Fail|3|||
161842209|NCT03569228|584466321|FG006|Overall Study|Screen Fail|1|||
161842210|NCT03569228|584466322|FG007|Overall Study|Screen Fail|5|||
161842211|NCT03569228|584466323|FG008|Overall Study|Screen Fail|2|||
161842212|NCT06354998|584466324|FG000|Overall Study|Withdrawal by Subject|3|||
161842213|NCT06354998|584466325|FG001|Overall Study|Withdrawal by Subject|0|||
161842214|NCT05442866|584466326|FG000|Overall Study|Death|1|||
161842215|NCT05442866|584466326|FG000|Overall Study|Lost to Follow-up|9|||
161842216|NCT05442866|584466326|FG000|Overall Study|Protocol Violation|1|||
161842217|NCT03819049|584466327|FG000|Overall Study|Lost to Follow-up|1|||
161842218|NCT03819049|584466328|FG001|Overall Study|Lost to Follow-up|2|||
161842219|NCT03819049|584466329|FG002|Overall Study|Lost to Follow-up|9|||
161842220|NCT03819049|584466330|FG003|Overall Study|Lost to Follow-up|0|||
161842221|NCT03819049|584466331|FG004|Overall Study|Lost to Follow-up|3|||
161842222|NCT03819049|584466332|FG005|Overall Study|Lost to Follow-up|1|||
161842223|NCT03819049|584466333|FG006|Overall Study|Lost to Follow-up|0|||
161842224|NCT03819049|584466327|FG000|Overall Study|Withdrawal by Subject|0|||
161842225|NCT03819049|584466328|FG001|Overall Study|Withdrawal by Subject|0|||
161842226|NCT03819049|584466329|FG002|Overall Study|Withdrawal by Subject|18|||
161842227|NCT03819049|584466330|FG003|Overall Study|Withdrawal by Subject|0|||
161842228|NCT03819049|584466331|FG004|Overall Study|Withdrawal by Subject|10|||
161842229|NCT03819049|584466332|FG005|Overall Study|Withdrawal by Subject|9|||
161842230|NCT03819049|584466333|FG006|Overall Study|Withdrawal by Subject|1|||
161842231|NCT03819049|584466327|FG000|Overall Study|Ongoing|0|||
161842232|NCT03819049|584466328|FG001|Overall Study|Ongoing|0|||
161842233|NCT03819049|584466329|FG002|Overall Study|Ongoing|75|||
161842234|NCT03819049|584466330|FG003|Overall Study|Ongoing|0|||
161842235|NCT03819049|584466331|FG004|Overall Study|Ongoing|41|||
161842236|NCT03819049|584466332|FG005|Overall Study|Ongoing|0|||
161842237|NCT03819049|584466333|FG006|Overall Study|Ongoing|0|||
161842238|NCT03819049|584466327|FG000|Overall Study|Other|0|||
161842239|NCT03819049|584466328|FG001|Overall Study|Other|0|||
161842240|NCT03819049|584466329|FG002|Overall Study|Other|2|||
161842241|NCT03819049|584466330|FG003|Overall Study|Other|0|||
161842242|NCT03819049|584466331|FG004|Overall Study|Other|0|||
161842243|NCT03819049|584466332|FG005|Overall Study|Other|0|||
161842244|NCT03819049|584466333|FG006|Overall Study|Other|0|||
161842245|NCT03819049|584466327|FG000|Overall Study|Randomized but not vaccinated|0|||
161842246|NCT03819049|584466328|FG001|Overall Study|Randomized but not vaccinated|0|||
161842247|NCT03819049|584466329|FG002|Overall Study|Randomized but not vaccinated|0|||
161842248|NCT03819049|584466330|FG003|Overall Study|Randomized but not vaccinated|1|||
161842249|NCT03819049|584466331|FG004|Overall Study|Randomized but not vaccinated|0|||
161842250|NCT03819049|584466332|FG005|Overall Study|Randomized but not vaccinated|2|||
161842251|NCT03819049|584466333|FG006|Overall Study|Randomized but not vaccinated|1|||
161842252|NCT03819049|584466327|FG000|Overall Study|Physician Decision|0|||
161842253|NCT03819049|584466328|FG001|Overall Study|Physician Decision|0|||
161842254|NCT03819049|584466329|FG002|Overall Study|Physician Decision|0|||
161842255|NCT03819049|584466330|FG003|Overall Study|Physician Decision|0|||
161842256|NCT03819049|584466331|FG004|Overall Study|Physician Decision|0|||
161966791|NCT05596734|584925740|FG016|Substudy A|Withdrawal by Subject|0|||
161966792|NCT05596734|584925741|FG017|Substudy A|Withdrawal by Subject|0|||
161966793|NCT05596734|584925742|FG018|Substudy A|Withdrawal by Subject|0|||
161966794|NCT05596734|584925743|FG019|Substudy A|Withdrawal by Subject|0|||
161966795|NCT05596734|584925744|FG020|Substudy A|Withdrawal by Subject|0|||
161966796|NCT05596734|584925745|FG021|Substudy A|Withdrawal by Subject|0|||
161842257|NCT03819049|584466332|FG005|Overall Study|Physician Decision|0|||
161966797|NCT05596734|584925746|FG022|Substudy A|Withdrawal by Subject|0|||
161842258|NCT03819049|584466333|FG006|Overall Study|Physician Decision|1|||
161842259|NCT02440568|584466334|FG000|Overall Study|Death|1|||
161842260|NCT02440568|584466335|FG001|Overall Study|Death|3|||
161842261|NCT02440568|584466336|FG002|Overall Study|Death|4|||
161842262|NCT02440568|584466337|FG003|Overall Study|Death|2|||
161842263|NCT02440568|584466334|FG000|Overall Study|Lack of Efficacy|2|||
161842264|NCT02440568|584466335|FG001|Overall Study|Lack of Efficacy|0|||
161842265|NCT02440568|584466336|FG002|Overall Study|Lack of Efficacy|1|||
161842266|NCT02440568|584466337|FG003|Overall Study|Lack of Efficacy|0|||
161842267|NCT02440568|584466334|FG000|Overall Study|Lost to Follow-up|1|||
161842268|NCT02440568|584466335|FG001|Overall Study|Lost to Follow-up|0|||
161966798|NCT05596734|584925747|FG023|Substudy A|Withdrawal by Subject|0|||
161744835|NCT00637377|584103757|FG001|Overall Study|Adverse Event|6|||
161744836|NCT00637377|584103758|FG002|Overall Study|Adverse Event|8|||
161744837|NCT00637377|584103759|FG003|Overall Study|Adverse Event|9|||
161744838|NCT00637377|584103756|FG000|Overall Study|Death|1|||
161744839|NCT00637377|584103757|FG001|Overall Study|Death|3|||
161744840|NCT00637377|584103758|FG002|Overall Study|Death|2|||
161744841|NCT00637377|584103759|FG003|Overall Study|Death|1|||
161744842|NCT00637377|584103756|FG000|Overall Study|Lack of Efficacy|0|||
161744843|NCT00637377|584103757|FG001|Overall Study|Lack of Efficacy|0|||
161744844|NCT00637377|584103758|FG002|Overall Study|Lack of Efficacy|1|||
161744845|NCT00637377|584103759|FG003|Overall Study|Lack of Efficacy|1|||
161744846|NCT00637377|584103756|FG000|Overall Study|Lost to Follow-up|4|||
161744847|NCT00637377|584103757|FG001|Overall Study|Lost to Follow-up|1|||
161744848|NCT00637377|584103758|FG002|Overall Study|Lost to Follow-up|2|||
161744849|NCT00637377|584103759|FG003|Overall Study|Lost to Follow-up|2|||
161744850|NCT00637377|584103756|FG000|Overall Study|Protocol Violation|2|||
161744851|NCT00637377|584103757|FG001|Overall Study|Protocol Violation|1|||
161744852|NCT00637377|584103758|FG002|Overall Study|Protocol Violation|1|||
161744853|NCT00637377|584103759|FG003|Overall Study|Protocol Violation|0|||
161744854|NCT00637377|584103756|FG000|Overall Study|Withdrawal by Subject|11|||
161744855|NCT00637377|584103757|FG001|Overall Study|Withdrawal by Subject|15|||
161744856|NCT00637377|584103758|FG002|Overall Study|Withdrawal by Subject|13|||
161744857|NCT00637377|584103759|FG003|Overall Study|Withdrawal by Subject|11|||
161744858|NCT00637377|584103756|FG000|Overall Study|Other (no further information available)|7|||
161744859|NCT00637377|584103757|FG001|Overall Study|Other (no further information available)|6|||
161744860|NCT00637377|584103758|FG002|Overall Study|Other (no further information available)|10|||
161744861|NCT00637377|584103759|FG003|Overall Study|Other (no further information available)|5|||
161744862|NCT01293084|584103760|FG000|Overall Study|Physician Decision|3|||
161744863|NCT01293084|584103760|FG000|Overall Study|Withdrawal by Subject|2|||
161744864|NCT00107172|584105976|FG000|Overall Study|Withdrawal by Subject|1|||
161744865|NCT00107172|584105977|FG001|Overall Study|Withdrawal by Subject|0|||
161744866|NCT00107172|584105976|FG000|Overall Study|Death|0|||
161744867|NCT00107172|584105977|FG001|Overall Study|Death|2|||
161744868|NCT00107172|584105976|FG000|Overall Study|Other Reason|4|||
161744869|NCT00107172|584105977|FG001|Overall Study|Other Reason|3|||
161744870|NCT04432376|584105978|FG000|Double-blind Treatment Period|Adverse Event|2|||
161744871|NCT04432376|584105979|FG001|Double-blind Treatment Period|Adverse Event|6|||
161744872|NCT04432376|584105980|FG002|Double-blind Treatment Period|Adverse Event|0|||
161744873|NCT04432376|584105978|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
161744874|NCT04432376|584105979|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
161744875|NCT04432376|584105980|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
161744876|NCT04432376|584105978|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161744877|NCT04432376|584105979|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161744878|NCT04432376|584105980|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161744879|NCT04432376|584105978|FG000|Double-blind Treatment Period|Protocol Violation|0|||
161744880|NCT04432376|584105979|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161744881|NCT04432376|584105980|FG002|Double-blind Treatment Period|Protocol Violation|0|||
161744882|NCT04432376|584105978|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
161744883|NCT04432376|584105979|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
161744884|NCT04432376|584105980|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
161744885|NCT03706040|584105981|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
161744886|NCT03706040|584105982|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
161744887|NCT03706040|584105983|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
161744888|NCT03706040|584105984|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
161744889|NCT03706040|584105985|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
161744890|NCT03706040|584105986|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
161744891|NCT03706040|584105987|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
161744892|NCT03706040|584105981|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
161744893|NCT03706040|584105982|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
161744894|NCT03706040|584105983|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
161744895|NCT03706040|584105984|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
161744896|NCT03706040|584105985|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
161744897|NCT03706040|584105986|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
161744898|NCT03706040|584105987|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
161744899|NCT03706040|584105981|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
161744900|NCT03706040|584105982|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
161744901|NCT03706040|584105983|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
161744902|NCT03706040|584105984|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
161744903|NCT03706040|584105985|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
161744904|NCT03706040|584105986|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
161744905|NCT03706040|584105987|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
161744906|NCT03706040|584105981|FG000|Period A (Week 0 to Week 16)|Other|2|||
161966799|NCT05596734|584925724|FG000|Substudy A|Lost to Follow-up|1|||
161842269|NCT02440568|584466336|FG002|Overall Study|Lost to Follow-up|0|||
161842270|NCT02440568|584466337|FG003|Overall Study|Lost to Follow-up|0|||
161842271|NCT01584843|584466341|FG000|First Treatment Period|Adverse Event|0|||
161842272|NCT01584843|584466342|FG001|First Treatment Period|Adverse Event|0|||
161842273|NCT01584843|584466343|FG002|First Treatment Period|Adverse Event|1|||
161842274|NCT01584843|584466344|FG003|First Treatment Period|Adverse Event|0|||
161842275|NCT01584843|584466345|FG004|First Treatment Period|Adverse Event|0|||
161842276|NCT01584843|584466346|FG005|First Treatment Period|Adverse Event|0|||
161842277|NCT01584843|584466341|FG000|First Treatment Period|Protocol Violation|0|||
161842278|NCT01584843|584466342|FG001|First Treatment Period|Protocol Violation|0|||
161842279|NCT01584843|584466343|FG002|First Treatment Period|Protocol Violation|0|||
161842280|NCT01584843|584466344|FG003|First Treatment Period|Protocol Violation|0|||
161842281|NCT01584843|584466345|FG004|First Treatment Period|Protocol Violation|0|||
161744907|NCT03706040|584105982|FG001|Period A (Week 0 to Week 16)|Other|0|||
161744908|NCT03706040|584105983|FG002|Period A (Week 0 to Week 16)|Other|2|||
161744909|NCT03706040|584105984|FG003|Period A (Week 0 to Week 16)|Other|0|||
161744910|NCT03706040|584105985|FG004|Period A (Week 0 to Week 16)|Other|0|||
161744911|NCT03706040|584105986|FG005|Period A (Week 0 to Week 16)|Other|0|||
161744912|NCT03706040|584105987|FG006|Period A (Week 0 to Week 16)|Other|0|||
161744913|NCT03706040|584105981|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
161744914|NCT03706040|584105982|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
161744915|NCT03706040|584105983|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
161744916|NCT03706040|584105984|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
161744917|NCT03706040|584105985|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
161744918|NCT03706040|584105986|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
161744919|NCT03706040|584105987|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
161744920|NCT03706040|584105981|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
161744921|NCT03706040|584105982|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
161744922|NCT03706040|584105983|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
161744923|NCT03706040|584105984|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
161744924|NCT03706040|584105985|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
161744925|NCT03706040|584105986|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
161744926|NCT03706040|584105987|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
161744927|NCT03706040|584105981|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161744928|NCT03706040|584105982|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161744929|NCT03706040|584105983|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161744930|NCT03706040|584105984|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161744931|NCT03706040|584105985|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161744932|NCT03706040|584105986|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
161744933|NCT03706040|584105987|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
161744934|NCT03706040|584105981|FG000|Period B (Week 16 to Week 52)|Other|0|||
161744935|NCT03706040|584105982|FG001|Period B (Week 16 to Week 52)|Other|0|||
161744936|NCT03706040|584105983|FG002|Period B (Week 16 to Week 52)|Other|0|||
161744937|NCT03706040|584105984|FG003|Period B (Week 16 to Week 52)|Other|4|||
161744938|NCT03706040|584105985|FG004|Period B (Week 16 to Week 52)|Other|5|||
161744939|NCT03706040|584105986|FG005|Period B (Week 16 to Week 52)|Other|23|||
161744940|NCT03706040|584105987|FG006|Period B (Week 16 to Week 52)|Other|17|||
161744941|NCT00927758|584105988|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
161744942|NCT00927758|584105989|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
161744943|NCT00927758|584105990|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
161744944|NCT00927758|584105991|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
161744945|NCT00927758|584105992|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
161744946|NCT00927758|584105993|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
161744947|NCT00927758|584105988|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
161744948|NCT00927758|584105989|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
161842282|NCT01584843|584466346|FG005|First Treatment Period|Protocol Violation|1|||
161842283|NCT01584843|584466341|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161842284|NCT01584843|584466342|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161842285|NCT01584843|584466343|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161842286|NCT01584843|584466344|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161842287|NCT01584843|584466345|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161842288|NCT01584843|584466346|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
161842289|NCT01584843|584466341|FG000|Second Treatment Period|Withdrawal by Subject|0|||
161842290|NCT01584843|584466342|FG001|Second Treatment Period|Withdrawal by Subject|0|||
161842291|NCT01584843|584466343|FG002|Second Treatment Period|Withdrawal by Subject|0|||
161842292|NCT01584843|584466344|FG003|Second Treatment Period|Withdrawal by Subject|0|||
161744949|NCT00927758|584105990|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
161744950|NCT00927758|584105991|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
161744951|NCT00927758|584105992|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
161842293|NCT01584843|584466345|FG004|Second Treatment Period|Withdrawal by Subject|0|||
161744952|NCT00927758|584105993|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
161744953|NCT00439725|584105994|FG000|Treatment Period|Withdrawal by Subject|22|||
161744954|NCT00439725|584105995|FG001|Treatment Period|Withdrawal by Subject|19|||
161744955|NCT00439725|584105994|FG000|Treatment Period|Study terminated by sponsor|156|||
161744956|NCT00439725|584105995|FG001|Treatment Period|Study terminated by sponsor|148|||
161744957|NCT00439725|584105994|FG000|Treatment Period|Site closed by investigator|1|||
161744958|NCT00439725|584105995|FG001|Treatment Period|Site closed by investigator|2|||
161744959|NCT00439725|584105994|FG000|Treatment Period|Adverse Event|39|||
161744960|NCT00439725|584105995|FG001|Treatment Period|Adverse Event|18|||
161744961|NCT00439725|584105994|FG000|Treatment Period|Physician Decision|1|||
161744962|NCT00439725|584105995|FG001|Treatment Period|Physician Decision|1|||
161744963|NCT00439725|584105994|FG000|Treatment Period|Protocol Violation|2|||
161744964|NCT00439725|584105995|FG001|Treatment Period|Protocol Violation|1|||
161744965|NCT00439725|584105994|FG000|Treatment Period|Clinical endpoint reached|6|||
161744966|NCT00439725|584105995|FG001|Treatment Period|Clinical endpoint reached|50|||
161744967|NCT00439725|584105994|FG000|Treatment Period|Technical problems|1|||
161744968|NCT00439725|584105995|FG001|Treatment Period|Technical problems|0|||
161744969|NCT00439725|584105994|FG000|Treatment Period|Lost to Follow-up|1|||
161744970|NCT00439725|584105995|FG001|Treatment Period|Lost to Follow-up|1|||
161744971|NCT00439725|584105994|FG000|Treatment Period|Participant convenience|1|||
161744972|NCT00439725|584105995|FG001|Treatment Period|Participant convenience|0|||
161744973|NCT00439725|584105994|FG000|Treatment Period|Protocol driven decision point|1|||
161744974|NCT00439725|584105995|FG001|Treatment Period|Protocol driven decision point|1|||
161744975|NCT00439725|584105994|FG000|Treatment Period|Death|1|||
161744976|NCT00439725|584105995|FG001|Treatment Period|Death|1|||
161744977|NCT00439725|584105994|FG000|Treatment Period|Participant did not receive treatment|4|||
161744978|NCT00439725|584105995|FG001|Treatment Period|Participant did not receive treatment|4|||
161744979|NCT00439725|584105994|FG000|Observational Period|Withdrawal by Subject|2|||
161744980|NCT00439725|584105995|FG001|Observational Period|Withdrawal by Subject|2|||
161744981|NCT00439725|584105994|FG000|Observational Period|Lost to Follow-up|0|||
161744982|NCT00439725|584105995|FG001|Observational Period|Lost to Follow-up|1|||
161744983|NCT00439725|584105994|FG000|Observational Period|Death|0|||
161744984|NCT00439725|584105995|FG001|Observational Period|Death|2|||
161744985|NCT00439725|584105994|FG000|Observational Period|Study termination by sponsor|1|||
161744986|NCT00439725|584105995|FG001|Observational Period|Study termination by sponsor|1|||
161744987|NCT00439725|584105994|FG000|Observational Period|Clinical endpoint reached|3|||
161744988|NCT00439725|584105995|FG001|Observational Period|Clinical endpoint reached|1|||
161744989|NCT00439725|584105994|FG000|Observational Period|Technical problems|1|||
161744990|NCT00439725|584105995|FG001|Observational Period|Technical problems|0|||
161744991|NCT00439725|584105994|FG000|Observational Period|Participant convenience|1|||
161744992|NCT00439725|584105995|FG001|Observational Period|Participant convenience|0|||
161744993|NCT02848313|584105996|FG000|Overall Study|Adverse Event|1|||
161744994|NCT02848313|584105997|FG001|Overall Study|Adverse Event|2|||
161744995|NCT02848313|584105996|FG000|Overall Study|Lack of Efficacy|0|||
161744996|NCT02848313|584105997|FG001|Overall Study|Lack of Efficacy|1|||
161744997|NCT02848313|584105996|FG000|Overall Study|Withdrawal by Subject|1|||
161744998|NCT02848313|584105997|FG001|Overall Study|Withdrawal by Subject|1|||
161744999|NCT02848313|584105996|FG000|Overall Study|Lost to follow up|1|||
161745000|NCT02848313|584105997|FG001|Overall Study|Lost to follow up|0|||
161745001|NCT03984812|584105998|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745002|NCT03984812|584105999|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745003|NCT03984812|584106000|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
161745004|NCT03984812|584106001|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745005|NCT03984812|584106002|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745006|NCT03984812|584106003|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745007|NCT03984812|584106004|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161966800|NCT05596734|584925725|FG001|Substudy A|Lost to Follow-up|0|||
161966801|NCT05596734|584925726|FG002|Substudy A|Lost to Follow-up|1|||
161966802|NCT05596734|584925727|FG003|Substudy A|Lost to Follow-up|0|||
161966803|NCT05596734|584925728|FG004|Substudy A|Lost to Follow-up|0|||
161966804|NCT05596734|584925729|FG005|Substudy A|Lost to Follow-up|0|||
161966805|NCT05596734|584925730|FG006|Substudy A|Lost to Follow-up|0|||
161745008|NCT03984812|584106005|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745009|NCT03984812|584106006|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745010|NCT03984812|584106007|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745011|NCT03984812|584106008|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161745012|NCT03510910|584106009|FG000|Overall Study|Incomplete Survey|2|||
161745013|NCT03510910|584106010|FG001|Overall Study|Incomplete Survey|3|||
161745014|NCT01673490|584106011|FG000|Overall Study|Lost to Follow-up|1|||
161745015|NCT01673490|584106011|FG000|Overall Study|Adverse Event|3|||
161842294|NCT01584843|584466346|FG005|Second Treatment Period|Withdrawal by Subject|1|||
161745016|NCT01673490|584106011|FG000|Overall Study|Withdrawal by Subject|3|||
161745017|NCT00379236|584106012|FG000|Double-blind|Adverse Event|11|||
161745018|NCT00379236|584106013|FG001|Double-blind|Adverse Event|6|||
161966806|NCT05596734|584925731|FG007|Substudy A|Lost to Follow-up|0|||
161745019|NCT00379236|584106014|FG002|Double-blind|Adverse Event|0|||
161745020|NCT00379236|584106012|FG000|Double-blind|Protocol Violation|3|||
161745021|NCT00379236|584106013|FG001|Double-blind|Protocol Violation|3|||
161745022|NCT00379236|584106014|FG002|Double-blind|Protocol Violation|0|||
161745023|NCT00379236|584106012|FG000|Double-blind|Withdrawal by Subject|12|||
161745024|NCT00379236|584106013|FG001|Double-blind|Withdrawal by Subject|13|||
161745025|NCT00379236|584106014|FG002|Double-blind|Withdrawal by Subject|0|||
161745026|NCT00379236|584106012|FG000|Double-blind|Lost to Follow-up|4|||
161745027|NCT00379236|584106013|FG001|Double-blind|Lost to Follow-up|3|||
161745028|NCT00379236|584106014|FG002|Double-blind|Lost to Follow-up|0|||
161745029|NCT00379236|584106012|FG000|Double-blind|Use of exclusionary medication|1|||
161745030|NCT00379236|584106013|FG001|Double-blind|Use of exclusionary medication|2|||
161745031|NCT00379236|584106014|FG002|Double-blind|Use of exclusionary medication|0|||
161745032|NCT00379236|584106012|FG000|Double-blind|Other|3|||
161745033|NCT00379236|584106013|FG001|Double-blind|Other|7|||
161745034|NCT00379236|584106014|FG002|Double-blind|Other|0|||
161745035|NCT00379236|584106012|FG000|Double-blind|Data could not be retrieved|2|||
161745036|NCT00379236|584106013|FG001|Double-blind|Data could not be retrieved|2|||
161745037|NCT00379236|584106014|FG002|Double-blind|Data could not be retrieved|0|||
161745038|NCT00379236|584106012|FG000|Open-label Extension|Adverse Event|0|||
161745039|NCT00379236|584106013|FG001|Open-label Extension|Adverse Event|0|||
161745040|NCT00379236|584106014|FG002|Open-label Extension|Adverse Event|13|||
161745041|NCT00379236|584106012|FG000|Open-label Extension|Protocol Violation|0|||
161745042|NCT00379236|584106013|FG001|Open-label Extension|Protocol Violation|0|||
161745043|NCT00379236|584106014|FG002|Open-label Extension|Protocol Violation|7|||
161745044|NCT00379236|584106012|FG000|Open-label Extension|Withdrawal by Subject|0|||
161745045|NCT00379236|584106013|FG001|Open-label Extension|Withdrawal by Subject|0|||
161745046|NCT00379236|584106014|FG002|Open-label Extension|Withdrawal by Subject|13|||
161745047|NCT00379236|584106012|FG000|Open-label Extension|Lost to Follow-up|0|||
161745048|NCT00379236|584106013|FG001|Open-label Extension|Lost to Follow-up|0|||
161745049|NCT00379236|584106014|FG002|Open-label Extension|Lost to Follow-up|12|||
161745050|NCT00379236|584106012|FG000|Open-label Extension|Use of exclusionary medication|0|||
161745051|NCT00379236|584106013|FG001|Open-label Extension|Use of exclusionary medication|0|||
161745052|NCT00379236|584106014|FG002|Open-label Extension|Use of exclusionary medication|3|||
161745053|NCT00379236|584106012|FG000|Open-label Extension|Other|0|||
161745054|NCT00379236|584106013|FG001|Open-label Extension|Other|0|||
161745055|NCT00379236|584106014|FG002|Open-label Extension|Other|7|||
161745056|NCT02940860|584106022|FG000|Overall Study|Non-serious AE|1|||
161745057|NCT02940860|584106023|FG001|Overall Study|Non-serious AE|2|||
161745058|NCT02940860|584106022|FG000|Overall Study|Serious AE|7|||
161745059|NCT02940860|584106023|FG001|Overall Study|Serious AE|3|||
161745060|NCT02940860|584106022|FG000|Overall Study|Withdrawal by Subject|19|||
161745061|NCT02940860|584106023|FG001|Overall Study|Withdrawal by Subject|9|||
161745062|NCT02940860|584106022|FG000|Overall Study|Lost to Follow-up|13|||
161745063|NCT02940860|584106023|FG001|Overall Study|Lost to Follow-up|7|||
161745064|NCT02940860|584106022|FG000|Overall Study|Physician Decision|5|||
161745065|NCT02940860|584106023|FG001|Overall Study|Physician Decision|3|||
161745066|NCT02940860|584106022|FG000|Overall Study|Sponsor Decision|0|||
161745067|NCT02940860|584106023|FG001|Overall Study|Sponsor Decision|1|||
161745068|NCT02940860|584106022|FG000|Overall Study|Protocol Violation|0|||
161745069|NCT02940860|584106023|FG001|Overall Study|Protocol Violation|2|||
161745070|NCT02940860|584106022|FG000|Overall Study|Death|3|||
161745071|NCT02940860|584106023|FG001|Overall Study|Death|2|||
161745072|NCT02940860|584106022|FG000|Overall Study|Moved, poor venous access, transport|6|||
161745073|NCT02940860|584106023|FG001|Overall Study|Moved, poor venous access, transport|4|||
161745074|NCT02940860|584106022|FG000|Overall Study|Not treated|2|||
161745075|NCT02940860|584106023|FG001|Overall Study|Not treated|2|||
161745076|NCT04914819|584106024|FG000|Overall Study|Pregnancy|3|||
161745077|NCT04914819|584106025|FG001|Overall Study|Pregnancy|1|||
161745078|NCT04914819|584106024|FG000|Overall Study|Discontinued study|4|||
161842295|NCT00643565|584466347|FG000|Overall Study|Death|12|||
161842296|NCT00643565|584466348|FG001|Overall Study|Death|11|||
161842297|NCT00643565|584466347|FG000|Overall Study|Withdrawal by Subject|4|||
161842298|NCT00643565|584466348|FG001|Overall Study|Withdrawal by Subject|1|||
161745079|NCT04914819|584106025|FG001|Overall Study|Discontinued study|1|||
161842299|NCT00643565|584466347|FG000|Overall Study|Lost to Follow-up|0|||
161745080|NCT04914819|584106024|FG000|Overall Study|Lost to Follow-up|7|||
161745081|NCT04914819|584106025|FG001|Overall Study|Lost to Follow-up|0|||
161745082|NCT02431793|584106027|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
161745083|NCT02431793|584106028|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
161745084|NCT02431793|584106029|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
161745085|NCT02431793|584106027|FG000|Overall Study|Withdrawal by Subject|7|||
161745086|NCT02431793|584106028|FG001|Overall Study|Withdrawal by Subject|5|||
161745087|NCT02431793|584106029|FG002|Overall Study|Withdrawal by Subject|5|||
161745088|NCT02431793|584106027|FG000|Overall Study|Lost to Follow-up|101|||
161745089|NCT02431793|584106028|FG001|Overall Study|Lost to Follow-up|122|||
161745090|NCT02431793|584106029|FG002|Overall Study|Lost to Follow-up|104|||
161745091|NCT01711541|584106036|FG000|Overall Study|Cancel prior to treatment|0|||
161966807|NCT05596734|584925732|FG008|Substudy A|Lost to Follow-up|0|||
161966808|NCT05596734|584925733|FG009|Substudy A|Lost to Follow-up|0|||
161966809|NCT05596734|584925734|FG010|Substudy A|Lost to Follow-up|0|||
161966810|NCT05596734|584925735|FG011|Substudy A|Lost to Follow-up|0|||
161966811|NCT05596734|584925736|FG012|Substudy A|Lost to Follow-up|0|||
161966812|NCT05596734|584925737|FG013|Substudy A|Lost to Follow-up|0|||
161745092|NCT01711541|584106037|FG001|Overall Study|Cancel prior to treatment|0|||
161745093|NCT01711541|584106038|FG002|Overall Study|Cancel prior to treatment|0|||
161745094|NCT01711541|584106039|FG003|Overall Study|Cancel prior to treatment|1|||
161745095|NCT01711541|584106040|FG004|Overall Study|Cancel prior to treatment|0|||
161745096|NCT01711541|584106036|FG000|Overall Study|Ineligible|0|||
161745097|NCT01711541|584106037|FG001|Overall Study|Ineligible|1|||
161745098|NCT01711541|584106038|FG002|Overall Study|Ineligible|0|||
161745099|NCT01711541|584106039|FG003|Overall Study|Ineligible|0|||
161745100|NCT01711541|584106040|FG004|Overall Study|Ineligible|0|||
161745101|NCT00438464|584106041|FG000|Overall Study|Terminated Early|14|||
161745102|NCT00438464|584106042|FG001|Overall Study|Terminated Early|5|||
161745103|NCT00438464|584106041|FG000|Overall Study|Incomplete data submission|0|||
161745104|NCT00438464|584106042|FG001|Overall Study|Incomplete data submission|2|||
161745105|NCT00728936|584106043|FG000|Overall Study|Withdrawal by Subject|0|||
161745106|NCT00728936|584106044|FG001|Overall Study|Withdrawal by Subject|0|||
161745107|NCT00728936|584106045|FG002|Overall Study|Withdrawal by Subject|0|||
161745108|NCT00728936|584106046|FG003|Overall Study|Withdrawal by Subject|0|||
161745109|NCT00728936|584106047|FG004|Overall Study|Withdrawal by Subject|0|||
161745110|NCT00728936|584106048|FG005|Overall Study|Withdrawal by Subject|1|||
161745111|NCT00728936|584106049|FG006|Overall Study|Withdrawal by Subject|0|||
161745112|NCT03943446|584106050|FG000|Overall Study|Lost to Follow-up|0|||
161745113|NCT03943446|584106051|FG001|Overall Study|Lost to Follow-up|0|||
161745114|NCT03943446|584106052|FG002|Overall Study|Lost to Follow-up|1|||
161745115|NCT03943446|584106050|FG000|Overall Study|Withdrawal by Subject|1|||
161745116|NCT03943446|584106051|FG001|Overall Study|Withdrawal by Subject|1|||
161745117|NCT03943446|584106052|FG002|Overall Study|Withdrawal by Subject|2|||
161745118|NCT03943446|584106050|FG000|Overall Study|Study Terminated by Sponsor|1|||
161745119|NCT03943446|584106051|FG001|Overall Study|Study Terminated by Sponsor|2|||
161745120|NCT03943446|584106052|FG002|Overall Study|Study Terminated by Sponsor|1|||
161745121|NCT03943446|584106050|FG000|Overall Study|Reason not Specified|5|||
161745122|NCT03943446|584106051|FG001|Overall Study|Reason not Specified|1|||
161745123|NCT03943446|584106052|FG002|Overall Study|Reason not Specified|3|||
161745124|NCT02905825|584106060|FG000|Overall Study|Protocol Violation|11|||
161745125|NCT02905825|584106060|FG000|Overall Study|Device Malfunction|1|||
161745126|NCT01563107|584106061|FG000|Overall Study|Physician Decision|0|||
161745127|NCT01563107|584106062|FG001|Overall Study|Physician Decision|1|||
161745128|NCT01563107|584106063|FG002|Overall Study|Physician Decision|1|||
161745129|NCT01563107|584106064|FG003|Overall Study|Physician Decision|3|||
161745130|NCT01563107|584106061|FG000|Overall Study|Withdrawal by Subject|1|||
161745131|NCT01563107|584106062|FG001|Overall Study|Withdrawal by Subject|2|||
161745132|NCT01563107|584106063|FG002|Overall Study|Withdrawal by Subject|1|||
161745133|NCT01563107|584106064|FG003|Overall Study|Withdrawal by Subject|2|||
161745134|NCT05355818|584106065|FG000|Overall Study|Adverse Event|1|||
161745135|NCT05355818|584106066|FG001|Overall Study|Adverse Event|1|||
161745136|NCT05355818|584106065|FG000|Overall Study|Lack of Efficacy|2|||
161745137|NCT05355818|584106066|FG001|Overall Study|Lack of Efficacy|1|||
161745138|NCT05355818|584106065|FG000|Overall Study|Lost to Follow-up|0|||
161745139|NCT05355818|584106066|FG001|Overall Study|Lost to Follow-up|1|||
161745140|NCT02707601|584106067|FG000|Overall Study|Death|0|||
161745141|NCT02707601|584106068|FG001|Overall Study|Death|1|||
161745142|NCT02707601|584106067|FG000|Overall Study|Lack of Efficacy|0|||
161745143|NCT02707601|584106068|FG001|Overall Study|Lack of Efficacy|1|||
161745144|NCT02707601|584106067|FG000|Overall Study|Investigator's Discretion|1|||
161745145|NCT02707601|584106068|FG001|Overall Study|Investigator's Discretion|0|||
161966813|NCT05596734|584925738|FG014|Substudy A|Lost to Follow-up|0|||
161966814|NCT05596734|584925739|FG015|Substudy A|Lost to Follow-up|0|||
161966815|NCT05596734|584925740|FG016|Substudy A|Lost to Follow-up|0|||
161966816|NCT05596734|584925741|FG017|Substudy A|Lost to Follow-up|0|||
161966817|NCT05596734|584925742|FG018|Substudy A|Lost to Follow-up|0|||
161966818|NCT05596734|584925743|FG019|Substudy A|Lost to Follow-up|0|||
161745146|NCT02707601|584106067|FG000|Overall Study|Withdrew Consent|0|||
161745147|NCT02707601|584106068|FG001|Overall Study|Withdrew Consent|1|||
161745148|NCT02707601|584106067|FG000|Overall Study|Lost to Follow-up|1|||
161745149|NCT02707601|584106068|FG001|Overall Study|Lost to Follow-up|1|||
161745150|NCT02707601|584106067|FG000|Overall Study|Participants Randomized but Not Treated|2|||
161745151|NCT02707601|584106068|FG001|Overall Study|Participants Randomized but Not Treated|0|||
161745152|NCT00063986|584106070|FG000|Overall Study|Withdrawal by Subject|1|||
161745153|NCT00063986|584106070|FG000|Overall Study|Ineligible|1|||
161745154|NCT00063986|584106070|FG000|Overall Study|Intra-operatively ineligible|4|||
161745155|NCT01601704|584106071|FG000|Overall Study|Randomized but not dispensed study med|1|||
161745156|NCT01601704|584106072|FG001|Overall Study|Randomized but not dispensed study med|4|||
161745157|NCT01021813|584106075|FG000|DB Treatment Phase|Adverse Event|60|||
161745158|NCT01021813|584106076|FG001|DB Treatment Phase|Adverse Event|22|||
161745159|NCT01021813|584106077|FG002|DB Treatment Phase|Adverse Event|0|||
161745160|NCT01021813|584106078|FG003|DB Treatment Phase|Adverse Event|0|||
161745161|NCT01021813|584106079|FG004|DB Treatment Phase|Adverse Event|0|||
161745162|NCT01021813|584106075|FG000|DB Treatment Phase|Lack of Efficacy|44|||
161745163|NCT01021813|584106076|FG001|DB Treatment Phase|Lack of Efficacy|28|||
161745164|NCT01021813|584106077|FG002|DB Treatment Phase|Lack of Efficacy|0|||
161745165|NCT01021813|584106078|FG003|DB Treatment Phase|Lack of Efficacy|0|||
161745166|NCT01021813|584106079|FG004|DB Treatment Phase|Lack of Efficacy|0|||
161745167|NCT01021813|584106075|FG000|DB Treatment Phase|Lost to Follow-up|14|||
161745168|NCT01021813|584106076|FG001|DB Treatment Phase|Lost to Follow-up|12|||
161745169|NCT01021813|584106077|FG002|DB Treatment Phase|Lost to Follow-up|0|||
161745170|NCT01021813|584106078|FG003|DB Treatment Phase|Lost to Follow-up|0|||
161745171|NCT01021813|584106079|FG004|DB Treatment Phase|Lost to Follow-up|0|||
161745172|NCT01021813|584106075|FG000|DB Treatment Phase|Physician Decision|17|||
161745173|NCT01021813|584106076|FG001|DB Treatment Phase|Physician Decision|8|||
161745174|NCT01021813|584106077|FG002|DB Treatment Phase|Physician Decision|0|||
161745175|NCT01021813|584106078|FG003|DB Treatment Phase|Physician Decision|0|||
161745176|NCT01021813|584106079|FG004|DB Treatment Phase|Physician Decision|0|||
161745177|NCT01021813|584106075|FG000|DB Treatment Phase|Pregnancy|1|||
161745178|NCT01021813|584106076|FG001|DB Treatment Phase|Pregnancy|0|||
161745179|NCT01021813|584106077|FG002|DB Treatment Phase|Pregnancy|0|||
161745180|NCT01021813|584106078|FG003|DB Treatment Phase|Pregnancy|0|||
161745181|NCT01021813|584106079|FG004|DB Treatment Phase|Pregnancy|0|||
161745182|NCT01021813|584106075|FG000|DB Treatment Phase|Protocol Violation|4|||
161745183|NCT01021813|584106076|FG001|DB Treatment Phase|Protocol Violation|3|||
161745184|NCT01021813|584106077|FG002|DB Treatment Phase|Protocol Violation|0|||
161745185|NCT01021813|584106078|FG003|DB Treatment Phase|Protocol Violation|0|||
161745186|NCT01021813|584106079|FG004|DB Treatment Phase|Protocol Violation|0|||
161745187|NCT01021813|584106075|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
161745188|NCT01021813|584106076|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
161745189|NCT01021813|584106077|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
161745190|NCT01021813|584106078|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
161745191|NCT01021813|584106079|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
161745192|NCT01021813|584106075|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
161745193|NCT01021813|584106076|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
161745194|NCT01021813|584106077|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
161745195|NCT01021813|584106078|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
161745196|NCT01021813|584106079|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
161745197|NCT01021813|584106075|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
161745198|NCT01021813|584106076|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
161745199|NCT01021813|584106077|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
161745200|NCT01021813|584106078|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
161745201|NCT01021813|584106079|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
161745202|NCT01021813|584106075|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
161745203|NCT01021813|584106076|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
161745204|NCT01021813|584106077|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
161745205|NCT01021813|584106078|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
161745206|NCT01021813|584106079|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
161745207|NCT01021813|584106075|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
161745208|NCT01021813|584106076|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
161745209|NCT01021813|584106077|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
161745210|NCT01021813|584106078|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
161745211|NCT01021813|584106079|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
161745212|NCT01021813|584106075|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
161745213|NCT01021813|584106076|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
161745214|NCT01021813|584106077|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
161745215|NCT01021813|584106078|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
161745216|NCT01021813|584106079|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
161745217|NCT00493974|584106081|FG000|Overall Study|Death|1|||
161745218|NCT00493974|584106082|FG001|Overall Study|Death|2|||
161745219|NCT00493974|584106081|FG000|Overall Study|Withdrawal by Subject|8|||
161745220|NCT00493974|584106082|FG001|Overall Study|Withdrawal by Subject|6|||
161745221|NCT00493974|584106081|FG000|Overall Study|Lost to Follow-up|4|||
161745222|NCT00493974|584106082|FG001|Overall Study|Lost to Follow-up|6|||
161745223|NCT00326417|584106083|FG000|Overall Study|Withdrawal by Subject|0|||
161745224|NCT00326417|584106084|FG001|Overall Study|Withdrawal by Subject|0|||
161745225|NCT00326417|584106085|FG002|Overall Study|Withdrawal by Subject|1|||
161745226|NCT00326417|584106086|FG003|Overall Study|Withdrawal by Subject|0|||
161745227|NCT00326417|584106083|FG000|Overall Study|Arm Closed|7|||
161745228|NCT00326417|584106084|FG001|Overall Study|Arm Closed|0|||
161745229|NCT00326417|584106085|FG002|Overall Study|Arm Closed|0|||
161842300|NCT00643565|584466348|FG001|Overall Study|Lost to Follow-up|6|||
161842301|NCT00643565|584466347|FG000|Overall Study|Other|7|||
161745230|NCT00326417|584106086|FG003|Overall Study|Arm Closed|3|||
161745231|NCT00326417|584106083|FG000|Overall Study|Death|7|||
161745232|NCT00326417|584106084|FG001|Overall Study|Death|0|||
161745233|NCT00326417|584106085|FG002|Overall Study|Death|0|||
161745234|NCT00326417|584106086|FG003|Overall Study|Death|0|||
161745235|NCT00844285|584106087|FG000|Overall Study|Other|0|||
161745236|NCT00844285|584106088|FG001|Overall Study|Other|1|||
161745237|NCT00844285|584106089|FG002|Overall Study|Other|0|||
161745238|NCT00844285|584106087|FG000|Overall Study|Other than specified|95|||
161745239|NCT00844285|584106088|FG001|Overall Study|Other than specified|129|||
161745240|NCT00844285|584106089|FG002|Overall Study|Other than specified|12|||
161745241|NCT00844285|584106087|FG000|Overall Study|Site closure|256|||
161745242|NCT00844285|584106088|FG001|Overall Study|Site closure|450|||
161745243|NCT00844285|584106089|FG002|Overall Study|Site closure|50|||
161745244|NCT00844285|584106087|FG000|Overall Study|Follow-up < 8 years|16|||
161745245|NCT00844285|584106088|FG001|Overall Study|Follow-up < 8 years|23|||
161745246|NCT00844285|584106089|FG002|Overall Study|Follow-up < 8 years|4|||
161745247|NCT00844285|584106087|FG000|Overall Study|Protocol Violation|26|||
161745248|NCT00844285|584106088|FG001|Overall Study|Protocol Violation|28|||
161745249|NCT00844285|584106089|FG002|Overall Study|Protocol Violation|54|||
161745250|NCT00844285|584106087|FG000|Overall Study|Death|22|||
161745251|NCT00844285|584106088|FG001|Overall Study|Death|21|||
161745252|NCT00844285|584106089|FG002|Overall Study|Death|8|||
161745253|NCT00844285|584106087|FG000|Overall Study|Withdrew Consent|344|||
161745254|NCT00844285|584106088|FG001|Overall Study|Withdrew Consent|466|||
161745255|NCT00844285|584106089|FG002|Overall Study|Withdrew Consent|70|||
161745256|NCT00844285|584106087|FG000|Overall Study|Lost to Follow-up|330|||
161745257|NCT00844285|584106088|FG001|Overall Study|Lost to Follow-up|486|||
161745258|NCT00844285|584106089|FG002|Overall Study|Lost to Follow-up|74|||
161745259|NCT04682353|584106090|FG000|Overall Study|Lost to Follow-up|0|||
161745260|NCT04682353|584106091|FG001|Overall Study|Lost to Follow-up|1|||
161745261|NCT04682353|584106092|FG002|Overall Study|Lost to Follow-up|0|||
161745262|NCT04682353|584106093|FG003|Overall Study|Lost to Follow-up|1|||
161745263|NCT04682353|584106090|FG000|Overall Study|Personal reasons|0|||
161745264|NCT04682353|584106091|FG001|Overall Study|Personal reasons|1|||
161745265|NCT04682353|584106092|FG002|Overall Study|Personal reasons|0|||
161745266|NCT04682353|584106093|FG003|Overall Study|Personal reasons|0|||
161745267|NCT00862654|584106094|FG000|Overall Study|Lack of Efficacy|1|||
161745268|NCT00862654|584106095|FG001|Overall Study|Lack of Efficacy|0|||
161745269|NCT00862654|584106096|FG002|Overall Study|Lack of Efficacy|1|||
161745270|NCT00862654|584106097|FG003|Overall Study|Lack of Efficacy|0|||
161745271|NCT00862654|584106094|FG000|Overall Study|Lost to Follow-up|1|||
161745272|NCT00862654|584106095|FG001|Overall Study|Lost to Follow-up|2|||
161745273|NCT00862654|584106096|FG002|Overall Study|Lost to Follow-up|1|||
161745274|NCT00862654|584106097|FG003|Overall Study|Lost to Follow-up|3|||
161745275|NCT00862654|584106094|FG000|Overall Study|Adverse Event|0|||
161745276|NCT00862654|584106095|FG001|Overall Study|Adverse Event|1|||
161745277|NCT00862654|584106096|FG002|Overall Study|Adverse Event|1|||
161745278|NCT00862654|584106097|FG003|Overall Study|Adverse Event|0|||
161745279|NCT00862654|584106094|FG000|Overall Study|Pregnancy|1|||
161745280|NCT00862654|584106095|FG001|Overall Study|Pregnancy|1|||
161745281|NCT00862654|584106096|FG002|Overall Study|Pregnancy|0|||
161745282|NCT00862654|584106097|FG003|Overall Study|Pregnancy|0|||
161745283|NCT00862654|584106094|FG000|Overall Study|Withdrawal by Subject|2|||
161745284|NCT00862654|584106095|FG001|Overall Study|Withdrawal by Subject|2|||
161745285|NCT00862654|584106096|FG002|Overall Study|Withdrawal by Subject|2|||
161745286|NCT00862654|584106097|FG003|Overall Study|Withdrawal by Subject|3|||
161745287|NCT00862654|584106094|FG000|Overall Study|Subject mistake|0|||
161745288|NCT00862654|584106095|FG001|Overall Study|Subject mistake|1|||
161745289|NCT00862654|584106096|FG002|Overall Study|Subject mistake|0|||
161745290|NCT00862654|584106097|FG003|Overall Study|Subject mistake|0|||
161745291|NCT00862654|584106094|FG000|Overall Study|Familly constraint|0|||
161842302|NCT00643565|584466348|FG001|Overall Study|Other|8|||
161842303|NCT00643565|584466347|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
161842304|NCT00643565|584466348|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
161842305|NCT00643565|584466347|FG000|Overall Study|Recurrence of Disease|2|||
161745292|NCT00862654|584106095|FG001|Overall Study|Familly constraint|1|||
161745293|NCT00862654|584106096|FG002|Overall Study|Familly constraint|0|||
161745294|NCT00862654|584106097|FG003|Overall Study|Familly constraint|0|||
161745295|NCT00862654|584106094|FG000|Overall Study|Never used study drugs|1|||
161745296|NCT00862654|584106095|FG001|Overall Study|Never used study drugs|0|||
161745297|NCT00862654|584106096|FG002|Overall Study|Never used study drugs|0|||
161745298|NCT00862654|584106097|FG003|Overall Study|Never used study drugs|0|||
161745299|NCT00862654|584106094|FG000|Overall Study|Included after end of inclusions|0|||
161745300|NCT00862654|584106095|FG001|Overall Study|Included after end of inclusions|0|||
161745301|NCT00862654|584106096|FG002|Overall Study|Included after end of inclusions|1|||
161745302|NCT00862654|584106097|FG003|Overall Study|Included after end of inclusions|0|||
161745303|NCT03219567|584106098|FG000|Overall Study|Withdrawal by Subject|0|||
161745304|NCT03219567|584106099|FG001|Overall Study|Withdrawal by Subject|1|||
161745305|NCT01313208|584106100|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
161745306|NCT01313208|584106101|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
161745307|NCT01313208|584106100|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
161745308|NCT01313208|584106101|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
161745309|NCT01313208|584106100|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
161745310|NCT01313208|584106101|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
161745311|NCT01313208|584106100|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
161745312|NCT01313208|584106101|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
161745313|NCT01313208|584106100|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
161745314|NCT01313208|584106101|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
161745315|NCT01313208|584106100|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
161745316|NCT01313208|584106101|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
161745317|NCT01313208|584106100|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
161745318|NCT01313208|584106101|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
161745319|NCT01313208|584106100|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
161745320|NCT01313208|584106101|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
161745321|NCT01313208|584106100|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
161745322|NCT01313208|584106101|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
161745323|NCT01151540|584106103|FG000|Overall Study|Other|2|||
161745324|NCT01151540|584106103|FG000|Overall Study|Adverse event, non-fatal|4|||
161745325|NCT01151540|584106103|FG000|Overall Study|Withdrawal by Subject|7|||
161745326|NCT01412060|584106107|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
161745327|NCT01412060|584106108|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
161745328|NCT01412060|584106109|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
161745329|NCT01412060|584106107|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
161745330|NCT01412060|584106108|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
161745331|NCT01412060|584106109|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
161745332|NCT01412060|584106107|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
161745333|NCT01412060|584106108|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
161745334|NCT01412060|584106109|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
161745335|NCT01412060|584106107|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
161745336|NCT01412060|584106108|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
161745337|NCT01412060|584106109|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
161745338|NCT01412060|584106107|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
161745339|NCT01412060|584106108|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
161745340|NCT01412060|584106109|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
161745341|NCT01412060|584106107|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
161745342|NCT01412060|584106108|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
161745343|NCT01412060|584106109|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
161745344|NCT01412060|584106107|FG000|Period Between RIP and SP|Adverse Event|4|||
161745345|NCT01412060|584106108|FG001|Period Between RIP and SP|Adverse Event|0|||
161745346|NCT01412060|584106109|FG002|Period Between RIP and SP|Adverse Event|0|||
161745347|NCT01412060|584106107|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
161745348|NCT01412060|584106108|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
161745349|NCT01412060|584106109|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
161745350|NCT01412060|584106107|FG000|Period Between RIP and SP|Protocol Violation|2|||
161745351|NCT01412060|584106108|FG001|Period Between RIP and SP|Protocol Violation|0|||
161745352|NCT01412060|584106109|FG002|Period Between RIP and SP|Protocol Violation|0|||
161745353|NCT01412060|584106107|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
161745354|NCT01412060|584106108|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
161745355|NCT01412060|584106109|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
161745356|NCT01412060|584106107|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
161745357|NCT01412060|584106108|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
161745358|NCT01412060|584106109|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
161745359|NCT01412060|584106107|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
161745360|NCT01412060|584106108|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
161745361|NCT01412060|584106109|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
161745362|NCT01412060|584106107|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
161745363|NCT01412060|584106108|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
161745364|NCT01412060|584106109|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
161745365|NCT01412060|584106107|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
161745366|NCT01412060|584106108|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
161745367|NCT01412060|584106109|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
161745368|NCT01412060|584106107|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
161745369|NCT01412060|584106108|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
161745370|NCT01412060|584106109|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
161745371|NCT01412060|584106107|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
161745372|NCT01412060|584106108|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
161842306|NCT00643565|584466348|FG001|Overall Study|Recurrence of Disease|1|||
161842307|NCT00643565|584466347|FG000|Overall Study|Progression of Disease|18|||
161842308|NCT00643565|584466348|FG001|Overall Study|Progression of Disease|14|||
161842309|NCT00643565|584466347|FG000|Overall Study|Protocol Violation|3|||
161842310|NCT00643565|584466348|FG001|Overall Study|Protocol Violation|0|||
161842311|NCT00643565|584466347|FG000|Overall Study|Did Not Cooperate|0|||
161842312|NCT00643565|584466348|FG001|Overall Study|Did Not Cooperate|1|||
161842313|NCT00643565|584466347|FG000|Overall Study|Administrative|22|||
161842314|NCT00643565|584466348|FG001|Overall Study|Administrative|16|||
161842315|NCT00643565|584466347|FG000|Overall Study|Adverse Event|5|||
161842316|NCT00643565|584466348|FG001|Overall Study|Adverse Event|8|||
161842317|NCT02283983|584466349|FG000|Overall Study|Inclusion criteria not met|0|||
161842318|NCT02283983|584466350|FG001|Overall Study|Inclusion criteria not met|1|||
161842319|NCT02283983|584466349|FG000|Overall Study|Withdrawal by Subject|4|||
161842320|NCT02283983|584466350|FG001|Overall Study|Withdrawal by Subject|2|||
161842321|NCT02283983|584466349|FG000|Overall Study|Protocol Violation|0|||
161842322|NCT02283983|584466350|FG001|Overall Study|Protocol Violation|4|||
161842323|NCT02283983|584466349|FG000|Overall Study|Physician Decision|2|||
161842324|NCT02283983|584466350|FG001|Overall Study|Physician Decision|4|||
161842325|NCT02283983|584466349|FG000|Overall Study|Death|1|||
161842326|NCT02283983|584466350|FG001|Overall Study|Death|0|||
161842327|NCT02283983|584466349|FG000|Overall Study|Adverse Event|1|||
161842328|NCT02283983|584466350|FG001|Overall Study|Adverse Event|0|||
161842329|NCT02283983|584466349|FG000|Overall Study|Lost to Follow-up|9|||
161842330|NCT02283983|584466350|FG001|Overall Study|Lost to Follow-up|8|||
161842331|NCT02283983|584466349|FG000|Overall Study|Relapse|1|||
161842332|NCT02283983|584466350|FG001|Overall Study|Relapse|0|||
161842333|NCT03275064|584466351|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
161842334|NCT03275064|584466352|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
161842335|NCT03275064|584466353|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
161842336|NCT03275064|584466354|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
161842337|NCT03275064|584466355|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
161842338|NCT03275064|584466351|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
161842339|NCT03275064|584466352|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
161842340|NCT03275064|584466353|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
161842341|NCT03275064|584466354|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
161842342|NCT03275064|584466355|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
161842343|NCT03275064|584466351|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
161842344|NCT03275064|584466352|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
161842345|NCT03275064|584466353|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
161842346|NCT03275064|584466354|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
161842347|NCT03275064|584466355|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
161842348|NCT03275064|584466351|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
161842349|NCT03275064|584466352|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
161842350|NCT03275064|584466353|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
161842351|NCT03275064|584466354|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
161842352|NCT03275064|584466355|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
161842353|NCT03275064|584466351|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
161842354|NCT03275064|584466352|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
161842355|NCT03275064|584466353|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
161842356|NCT03275064|584466354|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
161842357|NCT03275064|584466355|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
161842358|NCT00620555|584466358|FG000|Overall Study|Adverse Event|4|||
161842359|NCT00620555|584466358|FG000|Overall Study|Protocol Violation|2|||
161842360|NCT00620555|584466358|FG000|Overall Study|Lack of Efficacy|12|||
161842361|NCT00620555|584466358|FG000|Overall Study|Withdrawal by Subject|1|||
161842362|NCT00620555|584466358|FG000|Overall Study|Choice of other treatment|1|||
161842363|NCT00620555|584466358|FG000|Overall Study|Visit failure against planned|1|||
161842364|NCT03796039|584466359|FG000|Overall Study|Death|2|||
161842365|NCT03796039|584466360|FG001|Overall Study|Death|1|||
161842366|NCT03796039|584466359|FG000|Overall Study|Withdrawal by Subject|7|||
161842367|NCT03796039|584466360|FG001|Overall Study|Withdrawal by Subject|4|||
161966819|NCT05596734|584925744|FG020|Substudy A|Lost to Follow-up|0|||
161966820|NCT05596734|584925745|FG021|Substudy A|Lost to Follow-up|0|||
161966821|NCT05596734|584925746|FG022|Substudy A|Lost to Follow-up|0|||
161966822|NCT05596734|584925747|FG023|Substudy A|Lost to Follow-up|0|||
161842368|NCT01140503|584466361|FG000|Overall Study|Withdrawal by Subject|1|||
161842369|NCT00669071|584466363|FG000|Overall Study|Lost to Follow-up|3|||
161842370|NCT00669071|584466363|FG000|Overall Study|Final visit 40 days out of window|1|||
161842371|NCT04305496|584466364|FG000|Global Cohort|Withdrawal by Subject|13|||
161842372|NCT04305496|584466365|FG001|Global Cohort|Withdrawal by Subject|6|||
161842373|NCT04305496|584466364|FG000|Global Cohort|Physician Decision|1|||
161842374|NCT04305496|584466365|FG001|Global Cohort|Physician Decision|1|||
161842375|NCT04305496|584466364|FG000|Global Cohort|Subjective disease progression|16|||
161842376|NCT04305496|584466365|FG001|Global Cohort|Subjective disease progression|17|||
161842377|NCT04305496|584466364|FG000|Global Cohort|Condition under investigation worsened|209|||
161842378|NCT04305496|584466365|FG001|Global Cohort|Condition under investigation worsened|273|||
161842379|NCT04305496|584466364|FG000|Global Cohort|Protocol Violation|2|||
161842380|NCT04305496|584466365|FG001|Global Cohort|Protocol Violation|0|||
161842381|NCT04305496|584466364|FG000|Global Cohort|Adverse Event|44|||
162032568|NCT00761748|585177434|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
162032569|NCT00761748|585177433|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
162032570|NCT00761748|585177434|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
161745373|NCT01412060|584106109|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
161745374|NCT01412060|584106107|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
161745375|NCT01412060|584106108|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
161842382|NCT04305496|584466365|FG001|Global Cohort|Adverse Event|6|||
161842383|NCT04305496|584466364|FG000|Global Cohort|Death|3|||
161842384|NCT04305496|584466365|FG001|Global Cohort|Death|2|||
161842385|NCT04305496|584466364|FG000|Global Cohort|Any reason not specifically recorded|4|||
161842386|NCT04305496|584466365|FG001|Global Cohort|Any reason not specifically recorded|5|||
161842387|NCT04305496|584466364|FG000|China Cohort|Any reason not specifically recorded|1|||
161842388|NCT04305496|584466365|FG001|China Cohort|Any reason not specifically recorded|1|||
161842389|NCT04305496|584466364|FG000|China Cohort|Adverse Event|8|||
161842390|NCT04305496|584466365|FG001|China Cohort|Adverse Event|2|||
161745376|NCT01412060|584106109|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
161745377|NCT01412060|584106107|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
161745378|NCT01412060|584106108|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
161745379|NCT01412060|584106109|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
161745380|NCT01412060|584106107|FG000|Period Between SP and DBP|Protocol Violation|2|||
161745381|NCT01412060|584106108|FG001|Period Between SP and DBP|Protocol Violation|0|||
161745382|NCT01412060|584106109|FG002|Period Between SP and DBP|Protocol Violation|0|||
161745383|NCT01412060|584106107|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
161745384|NCT01412060|584106108|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
161745385|NCT01412060|584106109|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
161745386|NCT01412060|584106107|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
161745387|NCT01412060|584106108|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
161745388|NCT01412060|584106109|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
161745389|NCT01412060|584106107|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
161745390|NCT01412060|584106108|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
161745391|NCT01412060|584106109|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
161745392|NCT01412060|584106107|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
161745393|NCT01412060|584106108|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
161745394|NCT01412060|584106109|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
161745395|NCT01412060|584106107|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
161745396|NCT01412060|584106108|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
161745397|NCT01412060|584106109|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
161745398|NCT01412060|584106107|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
161745399|NCT01412060|584106108|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
161745400|NCT01412060|584106109|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
161745401|NCT01412060|584106107|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
161745402|NCT01412060|584106108|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
161745403|NCT01412060|584106109|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
161745404|NCT01412060|584106107|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
161745405|NCT01412060|584106108|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
161745406|NCT01412060|584106109|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
161842391|NCT04305496|584466364|FG000|China Cohort|Condition under investigation worsened|40|||
161842392|NCT04305496|584466365|FG001|China Cohort|Condition under investigation worsened|47|||
161842393|NCT04305496|584466364|FG000|China Cohort|Subjective disease progression|2|||
161842394|NCT04305496|584466365|FG001|China Cohort|Subjective disease progression|2|||
161842395|NCT04305496|584466364|FG000|China Cohort|Withdrawal by Subject|2|||
161842396|NCT04305496|584466365|FG001|China Cohort|Withdrawal by Subject|1|||
161842397|NCT01157897|584466367|FG000|Overall Study|Lost to Follow-up|2|||
161842398|NCT01157897|584466368|FG001|Overall Study|Lost to Follow-up|0|||
161842399|NCT01157897|584466369|FG002|Overall Study|Lost to Follow-up|0|||
161842400|NCT01157897|584466370|FG003|Overall Study|Lost to Follow-up|1|||
161842401|NCT01157897|584466367|FG000|Overall Study|Relocated|0|||
161842402|NCT01157897|584466368|FG001|Overall Study|Relocated|2|||
161842403|NCT01157897|584466369|FG002|Overall Study|Relocated|0|||
161842404|NCT01157897|584466370|FG003|Overall Study|Relocated|0|||
161842405|NCT00681590|584466372|FG000|Overall Study|Withdrawal by Subject|2|||
161842406|NCT00681590|584466373|FG001|Overall Study|Withdrawal by Subject|12|||
161842407|NCT01791153|584466376|FG000|Part 1: Blinded Period|Adverse Event|7|||
161745407|NCT01412060|584106107|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
161842408|NCT01791153|584466377|FG001|Part 1: Blinded Period|Adverse Event|3|||
161842409|NCT01791153|584466378|FG002|Part 1: Blinded Period|Adverse Event|2|||
161842410|NCT01791153|584466379|FG003|Part 1: Blinded Period|Adverse Event|0|||
161842411|NCT01791153|584466380|FG004|Part 1: Blinded Period|Adverse Event|0|||
161842412|NCT01791153|584466381|FG005|Part 1: Blinded Period|Adverse Event|0|||
161842413|NCT01791153|584466382|FG006|Part 1: Blinded Period|Adverse Event|0|||
161842414|NCT01791153|584466383|FG007|Part 1: Blinded Period|Adverse Event|0|||
161842415|NCT01791153|584466376|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
161842416|NCT01791153|584466377|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
161842417|NCT01791153|584466378|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
161842418|NCT01791153|584466379|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
161842419|NCT01791153|584466380|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
161842420|NCT01791153|584466381|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
161842421|NCT01791153|584466382|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
161842422|NCT01791153|584466383|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
161842423|NCT01791153|584466376|FG000|Part 1: Blinded Period|Non-Compliance|1|||
161745408|NCT01412060|584106108|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
161745409|NCT01412060|584106109|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
161745410|NCT01412060|584106107|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
161745411|NCT01412060|584106108|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
161745412|NCT01412060|584106109|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
161745413|NCT00004732|584106110|FG000|Overall Study|Withdrawal by Subject|36|||
161745414|NCT00004732|584106111|FG001|Overall Study|Withdrawal by Subject|64|||
161745415|NCT00004732|584106110|FG000|Overall Study|Lost to Follow-up|33|||
161745416|NCT00004732|584106111|FG001|Overall Study|Lost to Follow-up|47|||
161745417|NCT02674685|584106112|FG000|Overall Study|Withdrawal by Subject|4|||
161745418|NCT01181778|584106113|FG000|Overall Study|Physician Decision|48|||
161745419|NCT02726113|584106116|FG000|Total Enrollment|Physician Decision|0|||
161745420|NCT02726113|584106117|FG001|Total Enrollment|Physician Decision|1|||
161745421|NCT02726113|584106116|FG000|Total Enrollment|Protocol Violation|1|||
161745422|NCT02726113|584106117|FG001|Total Enrollment|Protocol Violation|0|||
161745423|NCT02726113|584106116|FG000|Total Enrollment|Withdrawal by Subject|2|||
161745424|NCT02726113|584106117|FG001|Total Enrollment|Withdrawal by Subject|1|||
161745425|NCT02726113|584106116|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
161745426|NCT02726113|584106117|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
161745427|NCT02726113|584106116|FG000|Genomic Analysis|Protocol Violation|1|||
161745428|NCT02726113|584106117|FG001|Genomic Analysis|Protocol Violation|0|||
161745429|NCT02726113|584106116|FG000|Genomic Analysis|Withdrawal by Subject|2|||
161745430|NCT02726113|584106117|FG001|Genomic Analysis|Withdrawal by Subject|1|||
161745431|NCT02726113|584106116|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
161745432|NCT02726113|584106117|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
161745433|NCT03549117|584106121|FG000|Overall Study|Withdrawal by Subject|1|||
161745434|NCT03549117|584106122|FG001|Overall Study|Withdrawal by Subject|0|||
161745435|NCT02661464|584106123|FG000|Overall Study|Lost to Follow-up|28|||
161745436|NCT02661464|584106124|FG001|Overall Study|Lost to Follow-up|0|||
161745437|NCT02661464|584106125|FG002|Overall Study|Lost to Follow-up|0|||
161842424|NCT01791153|584466377|FG001|Part 1: Blinded Period|Non-Compliance|0|||
161842425|NCT01791153|584466378|FG002|Part 1: Blinded Period|Non-Compliance|0|||
161842426|NCT01791153|584466379|FG003|Part 1: Blinded Period|Non-Compliance|0|||
161842427|NCT01791153|584466380|FG004|Part 1: Blinded Period|Non-Compliance|0|||
161842428|NCT01791153|584466381|FG005|Part 1: Blinded Period|Non-Compliance|0|||
161842429|NCT01791153|584466382|FG006|Part 1: Blinded Period|Non-Compliance|0|||
161842430|NCT01791153|584466383|FG007|Part 1: Blinded Period|Non-Compliance|0|||
161842431|NCT01791153|584466376|FG000|Part 1: Blinded Period|Physician Decision|0|||
161842432|NCT01791153|584466377|FG001|Part 1: Blinded Period|Physician Decision|0|||
161842433|NCT01791153|584466378|FG002|Part 1: Blinded Period|Physician Decision|0|||
161842434|NCT01791153|584466379|FG003|Part 1: Blinded Period|Physician Decision|1|||
161842435|NCT01791153|584466380|FG004|Part 1: Blinded Period|Physician Decision|0|||
161842436|NCT01791153|584466381|FG005|Part 1: Blinded Period|Physician Decision|0|||
161745438|NCT02661464|584106126|FG003|Overall Study|Lost to Follow-up|0|||
161745439|NCT02661464|584106123|FG000|Overall Study|Withdrawal by Subject|3|||
161745440|NCT02661464|584106124|FG001|Overall Study|Withdrawal by Subject|1|||
161745441|NCT02661464|584106125|FG002|Overall Study|Withdrawal by Subject|0|||
161745442|NCT02661464|584106126|FG003|Overall Study|Withdrawal by Subject|0|||
161745443|NCT02661464|584106123|FG000|Overall Study|Participants terminated prematurely|288|||
161745444|NCT02661464|584106124|FG001|Overall Study|Participants terminated prematurely|52|||
161745445|NCT02661464|584106125|FG002|Overall Study|Participants terminated prematurely|1|||
161842437|NCT01791153|584466382|FG006|Part 1: Blinded Period|Physician Decision|0|||
161842438|NCT01791153|584466383|FG007|Part 1: Blinded Period|Physician Decision|0|||
161842439|NCT01791153|584466376|FG000|Part 1: Blinded Period|Protocol Violation|0|||
161745446|NCT02661464|584106126|FG003|Overall Study|Participants terminated prematurely|1|||
161745447|NCT02661464|584106123|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
161745448|NCT02661464|584106124|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
161745449|NCT02661464|584106125|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
161745450|NCT02661464|584106126|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
161745451|NCT03148756|584106128|FG000|Overall Study|Study Terminated|0|||
161745452|NCT03148756|584106129|FG001|Overall Study|Study Terminated|1|||
161745453|NCT05567393|584106130|FG000|Overall Study|Voluntary Withdrawal|0|||
161745454|NCT05567393|584106131|FG001|Overall Study|Voluntary Withdrawal|0|||
161966823|NCT05596734|584925724|FG000|Substudy B|Withdrawal by Subject|0|||
161966824|NCT05596734|584925725|FG001|Substudy B|Withdrawal by Subject|0|||
161745455|NCT05567393|584106132|FG002|Overall Study|Voluntary Withdrawal|0|||
161745456|NCT05567393|584106133|FG003|Overall Study|Voluntary Withdrawal|0|||
161745457|NCT05567393|584106134|FG004|Overall Study|Voluntary Withdrawal|0|||
161745458|NCT05567393|584106135|FG005|Overall Study|Voluntary Withdrawal|0|||
161745459|NCT05567393|584106136|FG006|Overall Study|Voluntary Withdrawal|0|||
161745460|NCT05567393|584106137|FG007|Overall Study|Voluntary Withdrawal|0|||
161745461|NCT05567393|584106138|FG008|Overall Study|Voluntary Withdrawal|0|||
161745462|NCT05567393|584106139|FG009|Overall Study|Voluntary Withdrawal|0|||
161745463|NCT05567393|584106140|FG010|Overall Study|Voluntary Withdrawal|0|||
161745464|NCT05567393|584106141|FG011|Overall Study|Voluntary Withdrawal|0|||
161745465|NCT05567393|584106142|FG012|Overall Study|Voluntary Withdrawal|0|||
161745466|NCT05567393|584106143|FG013|Overall Study|Voluntary Withdrawal|1|||
161745467|NCT05567393|584106144|FG014|Overall Study|Voluntary Withdrawal|0|||
161745468|NCT05567393|584106145|FG015|Overall Study|Voluntary Withdrawal|0|||
161745469|NCT05567393|584106146|FG016|Overall Study|Voluntary Withdrawal|0|||
161745470|NCT05567393|584106147|FG017|Overall Study|Voluntary Withdrawal|0|||
161745471|NCT01924299|584106151|FG000|Period 2|Withdrawal by Subject|1|||
161745472|NCT01924299|584106152|FG001|Period 2|Withdrawal by Subject|0|||
161745473|NCT01924299|584106151|FG000|Period 2|Adverse Event|0|||
161745474|NCT01924299|584106152|FG001|Period 2|Adverse Event|1|||
161745475|NCT02177175|584106153|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
161745476|NCT02177175|584106154|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
161745477|NCT04199793|584106155|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
161745478|NCT04199793|584106156|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
161745479|NCT04199793|584106155|FG000|Overall Study|Withdrawal by Subject|1|||
161745480|NCT04199793|584106156|FG001|Overall Study|Withdrawal by Subject|1|||
161745481|NCT00628758|584106157|FG000|Overall Study|Adverse Event|2|||
161745482|NCT00628758|584106158|FG001|Overall Study|Adverse Event|3|||
161745483|NCT00628758|584106157|FG000|Overall Study|Withdrawal by Subject|6|||
161745484|NCT00628758|584106158|FG001|Overall Study|Withdrawal by Subject|3|||
161745485|NCT00628758|584106157|FG000|Overall Study|Death|1|||
161745486|NCT00628758|584106158|FG001|Overall Study|Death|0|||
161745487|NCT00628758|584106157|FG000|Overall Study|Protocol Violation|5|||
161745488|NCT00628758|584106158|FG001|Overall Study|Protocol Violation|1|||
161745489|NCT00628758|584106157|FG000|Overall Study|Lost to Follow-up|25|||
161745490|NCT00628758|584106158|FG001|Overall Study|Lost to Follow-up|31|||
161745491|NCT00628758|584106157|FG000|Overall Study|Pregnancy|2|||
161745492|NCT00628758|584106158|FG001|Overall Study|Pregnancy|2|||
161745493|NCT00628758|584106157|FG000|Overall Study|Investigator Moved|3|||
161745494|NCT00628758|584106158|FG001|Overall Study|Investigator Moved|0|||
161745495|NCT00628758|584106157|FG000|Overall Study|Treatment Failure|0|||
161745496|NCT00628758|584106158|FG001|Overall Study|Treatment Failure|2|||
161745497|NCT00719862|584106170|FG000|Overall Study|Adverse Event|1|||
161745498|NCT00719862|584106171|FG001|Overall Study|Adverse Event|2|||
161745499|NCT00719862|584106170|FG000|Overall Study|Lack of Efficacy|3|||
161745500|NCT00719862|584106171|FG001|Overall Study|Lack of Efficacy|0|||
161745501|NCT00719862|584106170|FG000|Overall Study|Non-Compliance|1|||
161745502|NCT00719862|584106171|FG001|Overall Study|Non-Compliance|0|||
161745503|NCT00719862|584106170|FG000|Overall Study|Withdrawal by Subject|1|||
161745504|NCT00719862|584106171|FG001|Overall Study|Withdrawal by Subject|0|||
161966825|NCT05596734|584925726|FG002|Substudy B|Withdrawal by Subject|0|||
161966826|NCT05596734|584925727|FG003|Substudy B|Withdrawal by Subject|0|||
161966827|NCT05596734|584925728|FG004|Substudy B|Withdrawal by Subject|0|||
161745505|NCT00719862|584106170|FG000|Overall Study|Lost to Follow-up|0|||
161745506|NCT00719862|584106171|FG001|Overall Study|Lost to Follow-up|1|||
161745507|NCT00719862|584106170|FG000|Overall Study|Other|2|||
161745508|NCT00719862|584106171|FG001|Overall Study|Other|3|||
161745509|NCT01184846|584106172|FG000|Overall Study|Adverse Event|2|||
161745510|NCT01184846|584106172|FG000|Overall Study|Insufficient response|1|||
161745511|NCT04021706|584108096|FG000|Overall Study|Adverse Event|2|||
161745512|NCT04021706|584108097|FG001|Overall Study|Adverse Event|0|||
161745513|NCT04021706|584108096|FG000|Overall Study|Withdrawal by Subject|1|||
161745514|NCT04021706|584108097|FG001|Overall Study|Withdrawal by Subject|2|||
161745515|NCT04021706|584108096|FG000|Overall Study|Physician Decision|1|||
161745516|NCT04021706|584108097|FG001|Overall Study|Physician Decision|0|||
161966828|NCT05596734|584925729|FG005|Substudy B|Withdrawal by Subject|0|||
161966829|NCT05596734|584925730|FG006|Substudy B|Withdrawal by Subject|0|||
161966830|NCT05596734|584925731|FG007|Substudy B|Withdrawal by Subject|0|||
161966831|NCT05596734|584925732|FG008|Substudy B|Withdrawal by Subject|0|||
161966832|NCT05596734|584925733|FG009|Substudy B|Withdrawal by Subject|0|||
161966833|NCT05596734|584925734|FG010|Substudy B|Withdrawal by Subject|0|||
161745517|NCT02332798|584108098|FG000|Overall Study|Unwilling to Participate in Study|0|||
161745518|NCT02332798|584108099|FG001|Overall Study|Unwilling to Participate in Study|1|||
161966834|NCT05596734|584925735|FG011|Substudy B|Withdrawal by Subject|0|||
161966835|NCT05596734|584925736|FG012|Substudy B|Withdrawal by Subject|1|||
161745519|NCT02332798|584108100|FG002|Overall Study|Unwilling to Participate in Study|1|||
161745520|NCT02332798|584108098|FG000|Overall Study|Positive Urine Drug Test|0|||
161745521|NCT02332798|584108099|FG001|Overall Study|Positive Urine Drug Test|1|||
161745522|NCT02332798|584108100|FG002|Overall Study|Positive Urine Drug Test|0|||
161745523|NCT02332798|584108098|FG000|Overall Study|Abnormal Laboratory Findings|1|||
161745524|NCT02332798|584108099|FG001|Overall Study|Abnormal Laboratory Findings|0|||
161745525|NCT02332798|584108100|FG002|Overall Study|Abnormal Laboratory Findings|0|||
161745526|NCT00595868|584108101|FG000|Overall Study|Lost to Follow-up|45|||
161745527|NCT00595868|584108102|FG001|Overall Study|Lost to Follow-up|50|||
161745528|NCT02688153|584108103|FG000|Overall Study|Death|7|||
161745529|NCT02688153|584108104|FG001|Overall Study|Death|5|||
161745530|NCT02688153|584108103|FG000|Overall Study|Withdrawal by Subject|4|||
161745531|NCT02688153|584108104|FG001|Overall Study|Withdrawal by Subject|2|||
161745532|NCT02688153|584108103|FG000|Overall Study|Valve Explant|1|||
161745533|NCT02688153|584108104|FG001|Overall Study|Valve Explant|0|||
161745534|NCT02688153|584108103|FG000|Overall Study|Conversion to Commercial Valve|3|||
161745535|NCT02688153|584108104|FG001|Overall Study|Conversion to Commercial Valve|0|||
161745536|NCT00859573|584108105|FG000|Overall Study|Withdrawal by Subject|4|||
161745537|NCT00859573|584108106|FG001|Overall Study|Withdrawal by Subject|1|||
161745538|NCT00859573|584108105|FG000|Overall Study|Physician Decision|1|||
161745539|NCT00859573|584108106|FG001|Overall Study|Physician Decision|1|||
161745540|NCT01135394|584108118|FG000|Screening|Lost to Follow-up|2|||
161745541|NCT01135394|584108118|FG000|Screening|Withdrawal by Subject|10|||
161745542|NCT01135394|584108118|FG000|Screening|Screening failure|16|||
161745543|NCT01135394|584108118|FG000|Screening|Physician Decision|5|||
161745544|NCT01135394|584108118|FG000|Baseline Assessment|Withdrawal by Subject|9|||
161745545|NCT01135394|584108118|FG000|Baseline Assessment|Physician Decision|3|||
161745546|NCT01135394|584108118|FG000|Baseline Assessment|Lost to Follow-up|2|||
161745547|NCT01135394|584108118|FG000|Baseline Assessment|Adverse Event|1|||
161745548|NCT01135394|584108118|FG000|Study Treatment|Withdrawal by Subject|1|||
161745549|NCT01135394|584108118|FG000|Study Treatment|Physician Decision|1|||
161745550|NCT01135394|584108118|FG000|Study Treatment|Adverse Event|2|||
161745551|NCT00462488|584108119|FG000|Overall Study|Protocol Violation|1|||
161745552|NCT00462488|584108120|FG001|Overall Study|Protocol Violation|0|||
161745553|NCT00462488|584108119|FG000|Overall Study|Lack of Efficacy|19|||
161745554|NCT00462488|584108120|FG001|Overall Study|Lack of Efficacy|17|||
161745555|NCT01742091|584108125|FG000|Overall Study|Adverse Event|0|||
161745556|NCT01742091|584108126|FG001|Overall Study|Adverse Event|0|||
161745557|NCT01742091|584108127|FG002|Overall Study|Adverse Event|0|||
161745558|NCT01742091|584108128|FG003|Overall Study|Adverse Event|0|||
161745559|NCT01742091|584108129|FG004|Overall Study|Adverse Event|1|||
161745560|NCT01742091|584108130|FG005|Overall Study|Adverse Event|0|||
161745561|NCT01742091|584108125|FG000|Overall Study|Physician Decision|0|||
161745562|NCT01742091|584108126|FG001|Overall Study|Physician Decision|0|||
161745563|NCT01742091|584108127|FG002|Overall Study|Physician Decision|0|||
161745564|NCT01742091|584108128|FG003|Overall Study|Physician Decision|0|||
161745565|NCT01742091|584108129|FG004|Overall Study|Physician Decision|0|||
161745566|NCT01742091|584108130|FG005|Overall Study|Physician Decision|1|||
161745567|NCT01742091|584108125|FG000|Overall Study|Withdrawal by Subject|0|||
161745568|NCT01742091|584108126|FG001|Overall Study|Withdrawal by Subject|0|||
161966836|NCT05596734|584925737|FG013|Substudy B|Withdrawal by Subject|0|||
161966837|NCT05596734|584925738|FG014|Substudy B|Withdrawal by Subject|1|||
161966838|NCT05596734|584925739|FG015|Substudy B|Withdrawal by Subject|2|||
161966839|NCT05596734|584925740|FG016|Substudy B|Withdrawal by Subject|2|||
161966840|NCT05596734|584925741|FG017|Substudy B|Withdrawal by Subject|1|||
161966841|NCT05596734|584925742|FG018|Substudy B|Withdrawal by Subject|2|||
161966842|NCT05596734|584925743|FG019|Substudy B|Withdrawal by Subject|0|||
161745569|NCT01742091|584108127|FG002|Overall Study|Withdrawal by Subject|0|||
161745570|NCT01742091|584108128|FG003|Overall Study|Withdrawal by Subject|1|||
161745571|NCT01742091|584108129|FG004|Overall Study|Withdrawal by Subject|0|||
161745572|NCT01742091|584108130|FG005|Overall Study|Withdrawal by Subject|0|||
161745573|NCT01742091|584108125|FG000|Overall Study|Lost to Follow-up|0|||
161745574|NCT01742091|584108126|FG001|Overall Study|Lost to Follow-up|0|||
161966843|NCT05596734|584925744|FG020|Substudy B|Withdrawal by Subject|0|||
161966844|NCT05596734|584925745|FG021|Substudy B|Withdrawal by Subject|0|||
161745575|NCT01742091|584108127|FG002|Overall Study|Lost to Follow-up|0|||
161745576|NCT01742091|584108128|FG003|Overall Study|Lost to Follow-up|0|||
161745577|NCT01742091|584108129|FG004|Overall Study|Lost to Follow-up|0|||
161966845|NCT05596734|584925746|FG022|Substudy B|Withdrawal by Subject|0|||
161966846|NCT05596734|584925747|FG023|Substudy B|Withdrawal by Subject|1|||
162032571|NCT02554279|585177435|FG000|Overall Study|Adverse Event|2|||
162032572|NCT02554279|585177436|FG001|Overall Study|Adverse Event|5|||
161745578|NCT01742091|584108130|FG005|Overall Study|Lost to Follow-up|1|||
161745579|NCT02088541|584108131|FG000|Overall Study|Adverse Event|3|||
161745580|NCT02088541|584108132|FG001|Overall Study|Adverse Event|0|||
161745581|NCT02088541|584108133|FG002|Overall Study|Adverse Event|3|||
161745582|NCT02088541|584108134|FG003|Overall Study|Adverse Event|3|||
161745583|NCT02088541|584108135|FG004|Overall Study|Adverse Event|0|||
161745584|NCT02088541|584108131|FG000|Overall Study|Death|51|||
161745585|NCT02088541|584108132|FG001|Overall Study|Death|21|||
161745586|NCT02088541|584108133|FG002|Overall Study|Death|85|||
161745587|NCT02088541|584108134|FG003|Overall Study|Death|28|||
161745588|NCT02088541|584108135|FG004|Overall Study|Death|38|||
161745589|NCT02088541|584108131|FG000|Overall Study|Lost to Follow-up|2|||
161745590|NCT02088541|584108132|FG001|Overall Study|Lost to Follow-up|0|||
161745591|NCT02088541|584108133|FG002|Overall Study|Lost to Follow-up|1|||
161745592|NCT02088541|584108134|FG003|Overall Study|Lost to Follow-up|0|||
161745593|NCT02088541|584108135|FG004|Overall Study|Lost to Follow-up|0|||
161745594|NCT02088541|584108131|FG000|Overall Study|Physician Decision|2|||
161745595|NCT02088541|584108132|FG001|Overall Study|Physician Decision|1|||
161745596|NCT02088541|584108133|FG002|Overall Study|Physician Decision|2|||
161745597|NCT02088541|584108134|FG003|Overall Study|Physician Decision|0|||
161745598|NCT02088541|584108135|FG004|Overall Study|Physician Decision|2|||
161745599|NCT02088541|584108131|FG000|Overall Study|Disease progression|7|||
161745600|NCT02088541|584108132|FG001|Overall Study|Disease progression|1|||
161745601|NCT02088541|584108133|FG002|Overall Study|Disease progression|2|||
161745602|NCT02088541|584108134|FG003|Overall Study|Disease progression|3|||
161745603|NCT02088541|584108135|FG004|Overall Study|Disease progression|1|||
161745604|NCT02088541|584108131|FG000|Overall Study|Study terminated by sponsor|1|||
161842440|NCT01791153|584466377|FG001|Part 1: Blinded Period|Protocol Violation|0|||
161842441|NCT01791153|584466378|FG002|Part 1: Blinded Period|Protocol Violation|0|||
161842442|NCT01791153|584466379|FG003|Part 1: Blinded Period|Protocol Violation|1|||
161842443|NCT01791153|584466380|FG004|Part 1: Blinded Period|Protocol Violation|0|||
161842444|NCT01791153|584466381|FG005|Part 1: Blinded Period|Protocol Violation|0|||
161842445|NCT01791153|584466382|FG006|Part 1: Blinded Period|Protocol Violation|0|||
161842446|NCT01791153|584466383|FG007|Part 1: Blinded Period|Protocol Violation|0|||
161842447|NCT01791153|584466376|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
161842448|NCT01791153|584466377|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
161842449|NCT01791153|584466378|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
161842450|NCT01791153|584466379|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
161842451|NCT01791153|584466380|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
161842452|NCT01791153|584466381|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
161842453|NCT01791153|584466382|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
161842454|NCT01791153|584466383|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
161842455|NCT01791153|584466376|FG000|Part 2: Open-label Period|Adverse Event|0|||
161842456|NCT01791153|584466377|FG001|Part 2: Open-label Period|Adverse Event|0|||
161842457|NCT01791153|584466378|FG002|Part 2: Open-label Period|Adverse Event|0|||
161842458|NCT01791153|584466379|FG003|Part 2: Open-label Period|Adverse Event|0|||
161842459|NCT01791153|584466380|FG004|Part 2: Open-label Period|Adverse Event|0|||
161842460|NCT01791153|584466381|FG005|Part 2: Open-label Period|Adverse Event|1|||
161842461|NCT01791153|584466382|FG006|Part 2: Open-label Period|Adverse Event|1|||
161842462|NCT01791153|584466383|FG007|Part 2: Open-label Period|Adverse Event|2|||
161842463|NCT01791153|584466376|FG000|Part 2: Open-label Period|Death|0|||
161842464|NCT01791153|584466377|FG001|Part 2: Open-label Period|Death|0|||
161842465|NCT01791153|584466378|FG002|Part 2: Open-label Period|Death|0|||
161842466|NCT01791153|584466379|FG003|Part 2: Open-label Period|Death|0|||
161842467|NCT01791153|584466380|FG004|Part 2: Open-label Period|Death|0|||
161842468|NCT01791153|584466381|FG005|Part 2: Open-label Period|Death|1|||
161842469|NCT01791153|584466382|FG006|Part 2: Open-label Period|Death|1|||
161842470|NCT01791153|584466383|FG007|Part 2: Open-label Period|Death|1|||
161842471|NCT01791153|584466376|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
161842472|NCT01791153|584466377|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
161842473|NCT01791153|584466378|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
161842474|NCT01791153|584466379|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
161842475|NCT01791153|584466380|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
161842476|NCT01791153|584466381|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
162032573|NCT02554279|585177435|FG000|Overall Study|Lost to Follow-up|3|||
161745605|NCT02088541|584108132|FG001|Overall Study|Study terminated by sponsor|1|||
161745606|NCT02088541|584108133|FG002|Overall Study|Study terminated by sponsor|12|||
161745607|NCT02088541|584108134|FG003|Overall Study|Study terminated by sponsor|2|||
161745608|NCT02088541|584108135|FG004|Overall Study|Study terminated by sponsor|6|||
161745609|NCT02088541|584108131|FG000|Overall Study|Withdrawal by Subject|3|||
161842477|NCT01791153|584466382|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
161842478|NCT01791153|584466383|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
161745610|NCT02088541|584108132|FG001|Overall Study|Withdrawal by Subject|2|||
161745611|NCT02088541|584108133|FG002|Overall Study|Withdrawal by Subject|9|||
161745612|NCT02088541|584108134|FG003|Overall Study|Withdrawal by Subject|7|||
161966847|NCT05596734|584925724|FG000|Substudy B|Physician Decision|0|||
161966848|NCT05596734|584925725|FG001|Substudy B|Physician Decision|0|||
161966849|NCT05596734|584925726|FG002|Substudy B|Physician Decision|0|||
161966850|NCT05596734|584925727|FG003|Substudy B|Physician Decision|0|||
161966851|NCT05596734|584925728|FG004|Substudy B|Physician Decision|0|||
161966852|NCT05596734|584925729|FG005|Substudy B|Physician Decision|0|||
161966853|NCT05596734|584925730|FG006|Substudy B|Physician Decision|0|||
161966854|NCT05596734|584925731|FG007|Substudy B|Physician Decision|0|||
161966855|NCT05596734|584925732|FG008|Substudy B|Physician Decision|0|||
161966856|NCT05596734|584925733|FG009|Substudy B|Physician Decision|0|||
161966857|NCT05596734|584925734|FG010|Substudy B|Physician Decision|0|||
161966858|NCT05596734|584925735|FG011|Substudy B|Physician Decision|0|||
161966859|NCT05596734|584925736|FG012|Substudy B|Physician Decision|0|||
161966860|NCT05596734|584925737|FG013|Substudy B|Physician Decision|0|||
161966861|NCT05596734|584925738|FG014|Substudy B|Physician Decision|0|||
161966862|NCT05596734|584925739|FG015|Substudy B|Physician Decision|1|||
161966863|NCT05596734|584925740|FG016|Substudy B|Physician Decision|0|||
161966864|NCT05596734|584925741|FG017|Substudy B|Physician Decision|0|||
161966865|NCT05596734|584925742|FG018|Substudy B|Physician Decision|0|||
161966866|NCT05596734|584925743|FG019|Substudy B|Physician Decision|0|||
161966867|NCT05596734|584925744|FG020|Substudy B|Physician Decision|0|||
161966868|NCT05596734|584925745|FG021|Substudy B|Physician Decision|0|||
161966869|NCT05596734|584925746|FG022|Substudy B|Physician Decision|0|||
161966870|NCT05596734|584925747|FG023|Substudy B|Physician Decision|0|||
161966871|NCT05596734|584925724|FG000|Substudy B|Lost to Follow-up|0|||
161966872|NCT05596734|584925725|FG001|Substudy B|Lost to Follow-up|0|||
161966873|NCT05596734|584925726|FG002|Substudy B|Lost to Follow-up|0|||
161966874|NCT05596734|584925727|FG003|Substudy B|Lost to Follow-up|0|||
161966875|NCT05596734|584925728|FG004|Substudy B|Lost to Follow-up|0|||
161966876|NCT05596734|584925729|FG005|Substudy B|Lost to Follow-up|0|||
161966877|NCT05596734|584925730|FG006|Substudy B|Lost to Follow-up|0|||
161966878|NCT05596734|584925731|FG007|Substudy B|Lost to Follow-up|0|||
161966879|NCT05596734|584925732|FG008|Substudy B|Lost to Follow-up|0|||
161966880|NCT05596734|584925733|FG009|Substudy B|Lost to Follow-up|0|||
161966881|NCT05596734|584925734|FG010|Substudy B|Lost to Follow-up|0|||
161966882|NCT05596734|584925735|FG011|Substudy B|Lost to Follow-up|0|||
161966883|NCT05596734|584925736|FG012|Substudy B|Lost to Follow-up|1|||
161966884|NCT05596734|584925737|FG013|Substudy B|Lost to Follow-up|0|||
161966885|NCT05596734|584925738|FG014|Substudy B|Lost to Follow-up|1|||
161966886|NCT05596734|584925739|FG015|Substudy B|Lost to Follow-up|1|||
161966887|NCT05596734|584925740|FG016|Substudy B|Lost to Follow-up|0|||
161966888|NCT05596734|584925741|FG017|Substudy B|Lost to Follow-up|0|||
161745613|NCT02088541|584108135|FG004|Overall Study|Withdrawal by Subject|10|||
161745614|NCT02088541|584108131|FG000|Overall Study|Other|2|||
161745615|NCT02088541|584108132|FG001|Overall Study|Other|1|||
161745616|NCT02088541|584108133|FG002|Overall Study|Other|3|||
161745617|NCT02088541|584108134|FG003|Overall Study|Other|1|||
161745618|NCT02088541|584108135|FG004|Overall Study|Other|1|||
161745619|NCT05742841|584108136|FG000|Overall Study|Withdrawal by Subject|1|||
161745620|NCT05742841|584108136|FG000|Overall Study|Lost to Follow-up|1|||
161745621|NCT03750240|584108138|FG000|Overall Study|Technical Difficulties|2|||
161745622|NCT00247273|584108142|FG000|Overall Study|Adverse Event|85|||
161745623|NCT00247273|584108143|FG001|Overall Study|Adverse Event|80|||
161842479|NCT01791153|584466376|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
161966889|NCT05596734|584925742|FG018|Substudy B|Lost to Follow-up|0|||
161966890|NCT05596734|584925743|FG019|Substudy B|Lost to Follow-up|0|||
161966891|NCT05596734|584925744|FG020|Substudy B|Lost to Follow-up|0|||
161966892|NCT05596734|584925745|FG021|Substudy B|Lost to Follow-up|0|||
161966893|NCT05596734|584925746|FG022|Substudy B|Lost to Follow-up|0|||
161745624|NCT00247273|584108142|FG000|Overall Study|Physician Decision|6|||
161842480|NCT01791153|584466377|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
161842481|NCT01791153|584466378|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
161966894|NCT05596734|584925747|FG023|Substudy B|Lost to Follow-up|0|||
161966895|NCT02059499|584925753|FG000|Upto Week 20|Lost to Follow-up|2|||
161966896|NCT02059499|584925754|FG001|Upto Week 20|Lost to Follow-up|6|||
161966897|NCT02059499|584925755|FG002|Upto Week 20|Lost to Follow-up|0|||
161966898|NCT02059499|584925753|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
161966899|NCT02059499|584925754|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
161966900|NCT02059499|584925755|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
161966901|NCT02059499|584925753|FG000|Upto Week 20|Withdrawal by Subject|1|||
161745625|NCT00247273|584108143|FG001|Overall Study|Physician Decision|3|||
161745626|NCT00247273|584108142|FG000|Overall Study|Lost to Follow-up|7|||
161745627|NCT00247273|584108143|FG001|Overall Study|Lost to Follow-up|7|||
161842482|NCT01791153|584466379|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
161966902|NCT02059499|584925754|FG001|Upto Week 20|Withdrawal by Subject|1|||
161966903|NCT02059499|584925755|FG002|Upto Week 20|Withdrawal by Subject|0|||
161966904|NCT02059499|584925753|FG000|Upto Week 20|No treatment per protocol criteria|0|||
161966905|NCT02059499|584925754|FG001|Upto Week 20|No treatment per protocol criteria|0|||
161966906|NCT02059499|584925755|FG002|Upto Week 20|No treatment per protocol criteria|5|||
161842483|NCT01791153|584466380|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
161842484|NCT01791153|584466381|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
161842485|NCT01791153|584466382|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
161842486|NCT01791153|584466383|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
161842487|NCT01791153|584466376|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
161842488|NCT01791153|584466377|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
161842489|NCT01791153|584466378|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
161842490|NCT01791153|584466379|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
161842491|NCT01791153|584466380|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
161842492|NCT01791153|584466381|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
161842493|NCT01791153|584466382|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
161842494|NCT01791153|584466383|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
161842495|NCT01791153|584466376|FG000|Part 2: Open-label Period|Physician Decision|0|||
161842496|NCT01791153|584466377|FG001|Part 2: Open-label Period|Physician Decision|0|||
161842497|NCT01791153|584466378|FG002|Part 2: Open-label Period|Physician Decision|0|||
161842498|NCT01791153|584466379|FG003|Part 2: Open-label Period|Physician Decision|0|||
161842499|NCT01791153|584466380|FG004|Part 2: Open-label Period|Physician Decision|1|||
161842500|NCT01791153|584466381|FG005|Part 2: Open-label Period|Physician Decision|1|||
161842501|NCT01791153|584466382|FG006|Part 2: Open-label Period|Physician Decision|0|||
161842502|NCT01791153|584466383|FG007|Part 2: Open-label Period|Physician Decision|0|||
161842503|NCT02562482|584466384|FG000|Overall Study|Enrolled, but did not receive product|4|||
161842504|NCT02562482|584466385|FG001|Overall Study|Enrolled, but did not receive product|0|||
161842505|NCT02562482|584466384|FG000|Overall Study|Lost to Follow-up|9|||
161842506|NCT02562482|584466385|FG001|Overall Study|Lost to Follow-up|6|||
161842507|NCT02562482|584466384|FG000|Overall Study|Moved from area|2|||
161842508|NCT02562482|584466385|FG001|Overall Study|Moved from area|3|||
161842509|NCT02562482|584466384|FG000|Overall Study|Withdrawal by Subject|5|||
161842510|NCT02562482|584466385|FG001|Overall Study|Withdrawal by Subject|3|||
161842511|NCT02562482|584466384|FG000|Overall Study|Physician Decision|1|||
161842512|NCT02562482|584466385|FG001|Overall Study|Physician Decision|3|||
161842513|NCT02562482|584466384|FG000|Overall Study|Illness/Injury unrelated to product|0|||
161842514|NCT02562482|584466385|FG001|Overall Study|Illness/Injury unrelated to product|1|||
161842515|NCT05896202|584466388|FG000|Overall Study|Lost to Follow-up|2|||
161842516|NCT05896202|584466389|FG001|Overall Study|Lost to Follow-up|2|||
161842517|NCT01181271|584466392|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
161842518|NCT01181271|584466392|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
161842519|NCT01181271|584466392|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
161966907|NCT02059499|584925753|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
161966908|NCT02059499|584925754|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
161966909|NCT02059499|584925755|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
161966910|NCT02059499|584925753|FG000|Post-week 20|Lost to Follow-up|0|||
161966911|NCT02059499|584925754|FG001|Post-week 20|Lost to Follow-up|2|||
161966912|NCT02059499|584925755|FG002|Post-week 20|Lost to Follow-up|0|||
161966913|NCT02059499|584925753|FG000|Post-week 20|Withdrawal by Subject|0|||
161966914|NCT02059499|584925754|FG001|Post-week 20|Withdrawal by Subject|1|||
161966915|NCT02059499|584925755|FG002|Post-week 20|Withdrawal by Subject|0|||
161966916|NCT02059499|584925753|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
161966917|NCT02059499|584925754|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
161966918|NCT02059499|584925755|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
161842520|NCT01181271|584466392|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
161842521|NCT02041091|584466393|FG000|Treatment|Adverse Event|3|||
161842522|NCT02041091|584466394|FG001|Treatment|Adverse Event|3|||
161842523|NCT02041091|584466393|FG000|Treatment|Withdrawal by Subject|2|||
161842524|NCT02041091|584466394|FG001|Treatment|Withdrawal by Subject|4|||
161842525|NCT02041091|584466393|FG000|Treatment|Physician Decision|1|||
161842526|NCT02041091|584466394|FG001|Treatment|Physician Decision|0|||
161842527|NCT02041091|584466393|FG000|Treatment|Sponsor Decision|15|||
161842528|NCT02041091|584466394|FG001|Treatment|Sponsor Decision|16|||
161842529|NCT02041091|584466393|FG000|Treatment|Lost to Follow-up|1|||
161842530|NCT02041091|584466394|FG001|Treatment|Lost to Follow-up|0|||
161842531|NCT02041091|584466393|FG000|Optional Safety Extension Period|Adverse Event|4|||
161842532|NCT02041091|584466394|FG001|Optional Safety Extension Period|Adverse Event|2|||
161842533|NCT02041091|584466393|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
161966919|NCT04210245|584925756|FG000|Overall Study|Adverse Event|0|||
161966920|NCT04210245|584925757|FG001|Overall Study|Adverse Event|3|||
161966921|NCT04210245|584925758|FG002|Overall Study|Adverse Event|6|||
161966922|NCT04210245|584925759|FG003|Overall Study|Adverse Event|0|||
161966923|NCT04210245|584925756|FG000|Overall Study|Withdrawal by Subject|0|||
161966924|NCT04210245|584925757|FG001|Overall Study|Withdrawal by Subject|1|||
161966925|NCT04210245|584925758|FG002|Overall Study|Withdrawal by Subject|4|||
161966926|NCT04210245|584925759|FG003|Overall Study|Withdrawal by Subject|4|||
161966927|NCT04210245|584925756|FG000|Overall Study|Lost to Follow-up|0|||
161966928|NCT04210245|584925757|FG001|Overall Study|Lost to Follow-up|1|||
161842534|NCT02041091|584466394|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
161842535|NCT02041091|584466393|FG000|Optional Safety Extension Period|Protocol Violation|2|||
161842536|NCT02041091|584466394|FG001|Optional Safety Extension Period|Protocol Violation|0|||
161842537|NCT02041091|584466393|FG000|Optional Safety Extension Period|Physician Decision|2|||
161842538|NCT02041091|584466394|FG001|Optional Safety Extension Period|Physician Decision|1|||
161842539|NCT02041091|584466393|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
161842540|NCT02041091|584466394|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
161842541|NCT02041091|584466393|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
161842542|NCT02041091|584466394|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
161842543|NCT03970837|584466395|FG000|Overall Study|Adverse Event|23|||
161842544|NCT03970837|584466396|FG001|Overall Study|Adverse Event|20|||
161842545|NCT03970837|584466397|FG002|Overall Study|Adverse Event|16|||
161842546|NCT03970837|584466398|FG003|Overall Study|Adverse Event|6|||
161842547|NCT03970837|584466399|FG004|Overall Study|Adverse Event|4|||
161842548|NCT03970837|584466400|FG005|Overall Study|Adverse Event|5|||
161842549|NCT03970837|584466401|FG006|Overall Study|Adverse Event|1|||
161842550|NCT03970837|584466402|FG007|Overall Study|Adverse Event|5|||
161842551|NCT03970837|584466403|FG008|Overall Study|Adverse Event|0|||
161842552|NCT03970837|584466404|FG009|Overall Study|Adverse Event|0|||
161842553|NCT03970837|584466405|FG010|Overall Study|Adverse Event|1|||
161842554|NCT03970837|584466406|FG011|Overall Study|Adverse Event|1|||
161842555|NCT03970837|584466395|FG000|Overall Study|Lack of Efficacy|14|||
161842556|NCT03970837|584466396|FG001|Overall Study|Lack of Efficacy|12|||
161842557|NCT03970837|584466397|FG002|Overall Study|Lack of Efficacy|1|||
161842558|NCT03970837|584466398|FG003|Overall Study|Lack of Efficacy|2|||
161842559|NCT03970837|584466399|FG004|Overall Study|Lack of Efficacy|3|||
161842560|NCT03970837|584466400|FG005|Overall Study|Lack of Efficacy|4|||
161842561|NCT03970837|584466401|FG006|Overall Study|Lack of Efficacy|6|||
161842562|NCT03970837|584466402|FG007|Overall Study|Lack of Efficacy|1|||
161842563|NCT03970837|584466403|FG008|Overall Study|Lack of Efficacy|1|||
161842564|NCT03970837|584466404|FG009|Overall Study|Lack of Efficacy|0|||
161842565|NCT03970837|584466405|FG010|Overall Study|Lack of Efficacy|0|||
161842566|NCT03970837|584466406|FG011|Overall Study|Lack of Efficacy|0|||
161842567|NCT03970837|584466395|FG000|Overall Study|Lost to Follow-up|6|||
161842568|NCT03970837|584466396|FG001|Overall Study|Lost to Follow-up|5|||
161842569|NCT03970837|584466397|FG002|Overall Study|Lost to Follow-up|5|||
161842570|NCT03970837|584466398|FG003|Overall Study|Lost to Follow-up|1|||
161842571|NCT03970837|584466399|FG004|Overall Study|Lost to Follow-up|0|||
161842572|NCT03970837|584466400|FG005|Overall Study|Lost to Follow-up|2|||
161842573|NCT03970837|584466401|FG006|Overall Study|Lost to Follow-up|0|||
161842574|NCT03970837|584466402|FG007|Overall Study|Lost to Follow-up|0|||
161842575|NCT03970837|584466403|FG008|Overall Study|Lost to Follow-up|0|||
161842576|NCT03970837|584466404|FG009|Overall Study|Lost to Follow-up|0|||
161842577|NCT03970837|584466405|FG010|Overall Study|Lost to Follow-up|0|||
161842578|NCT03970837|584466406|FG011|Overall Study|Lost to Follow-up|0|||
161842579|NCT03970837|584466395|FG000|Overall Study|Protocol Violation|1|||
161842580|NCT03970837|584466396|FG001|Overall Study|Protocol Violation|0|||
161842581|NCT03970837|584466397|FG002|Overall Study|Protocol Violation|0|||
161842582|NCT03970837|584466398|FG003|Overall Study|Protocol Violation|0|||
161842583|NCT03970837|584466399|FG004|Overall Study|Protocol Violation|0|||
161842584|NCT03970837|584466400|FG005|Overall Study|Protocol Violation|0|||
161842585|NCT03970837|584466401|FG006|Overall Study|Protocol Violation|0|||
161842586|NCT03970837|584466402|FG007|Overall Study|Protocol Violation|0|||
161842587|NCT03970837|584466403|FG008|Overall Study|Protocol Violation|0|||
161842588|NCT03970837|584466404|FG009|Overall Study|Protocol Violation|0|||
161842589|NCT03970837|584466405|FG010|Overall Study|Protocol Violation|0|||
161842590|NCT03970837|584466406|FG011|Overall Study|Protocol Violation|0|||
161842591|NCT03970837|584466395|FG000|Overall Study|Physician Decision|5|||
161842592|NCT03970837|584466396|FG001|Overall Study|Physician Decision|8|||
161842593|NCT03970837|584466397|FG002|Overall Study|Physician Decision|4|||
161842594|NCT03970837|584466398|FG003|Overall Study|Physician Decision|1|||
161842595|NCT03970837|584466399|FG004|Overall Study|Physician Decision|5|||
161842596|NCT03970837|584466400|FG005|Overall Study|Physician Decision|2|||
161842597|NCT03970837|584466401|FG006|Overall Study|Physician Decision|4|||
161842598|NCT03970837|584466402|FG007|Overall Study|Physician Decision|5|||
161842599|NCT03970837|584466403|FG008|Overall Study|Physician Decision|0|||
161842600|NCT03970837|584466404|FG009|Overall Study|Physician Decision|1|||
161842601|NCT03970837|584466405|FG010|Overall Study|Physician Decision|0|||
161842602|NCT03970837|584466406|FG011|Overall Study|Physician Decision|0|||
161842603|NCT03970837|584466395|FG000|Overall Study|Withdrawal by Subject|32|||
161842604|NCT03970837|584466396|FG001|Overall Study|Withdrawal by Subject|35|||
161842605|NCT03970837|584466397|FG002|Overall Study|Withdrawal by Subject|12|||
161842606|NCT03970837|584466398|FG003|Overall Study|Withdrawal by Subject|8|||
161842607|NCT03970837|584466399|FG004|Overall Study|Withdrawal by Subject|6|||
161842608|NCT03970837|584466400|FG005|Overall Study|Withdrawal by Subject|8|||
161842609|NCT03970837|584466401|FG006|Overall Study|Withdrawal by Subject|2|||
161842610|NCT03970837|584466402|FG007|Overall Study|Withdrawal by Subject|3|||
161842611|NCT03970837|584466403|FG008|Overall Study|Withdrawal by Subject|0|||
161842612|NCT03970837|584466404|FG009|Overall Study|Withdrawal by Subject|0|||
161842613|NCT03970837|584466405|FG010|Overall Study|Withdrawal by Subject|0|||
161842614|NCT03970837|584466406|FG011|Overall Study|Withdrawal by Subject|1|||
161842615|NCT03970837|584466395|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
161842616|NCT03970837|584466396|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
161842617|NCT03970837|584466397|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
161842618|NCT03970837|584466398|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161842619|NCT03970837|584466399|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
161842620|NCT03970837|584466400|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161842621|NCT03970837|584466401|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161842622|NCT03970837|584466402|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161842623|NCT03970837|584466403|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161842624|NCT03970837|584466404|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161842625|NCT03970837|584466405|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161842626|NCT03970837|584466406|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161842627|NCT03970837|584466395|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161842628|NCT03970837|584466396|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161842629|NCT03970837|584466397|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161842630|NCT03970837|584466398|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161842631|NCT03970837|584466399|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161842632|NCT03970837|584466400|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161842633|NCT03970837|584466401|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
161842634|NCT03970837|584466402|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
161842635|NCT03970837|584466403|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
161842636|NCT03970837|584466404|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
161842637|NCT03970837|584466405|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
161842638|NCT03970837|584466406|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
161842639|NCT03190330|584469930|FG000|Overall Study|Adverse Event|2|||
161842640|NCT03190330|584469930|FG000|Overall Study|Death|10|||
161842641|NCT03190330|584469930|FG000|Overall Study|Lost to Follow-up|1|||
161842642|NCT03190330|584469930|FG000|Overall Study|Withdrawal by Subject|6|||
161842643|NCT03190330|584469930|FG000|Overall Study|Progressive Disease|1|||
161842644|NCT02081209|584469931|FG000|Overall Study|Withdrawal by Subject|1|||
161842645|NCT02370329|584469932|FG000|Overall Study|Alternate treatment|1|||
161842646|NCT02370329|584469932|FG000|Overall Study|Adverse Event|1|||
161842647|NCT02370329|584469932|FG000|Overall Study|Disease progression|3|||
161842648|NCT02370329|584469932|FG000|Overall Study|Physician Decision|2|||
161842649|NCT02370329|584469932|FG000|Overall Study|Study closure|4|||
161842650|NCT02022748|584469933|FG000|Overall Study|Adverse Event|1|||
161842651|NCT02022748|584469934|FG001|Overall Study|Adverse Event|1|||
161842652|NCT02022748|584469935|FG002|Overall Study|Adverse Event|0|||
161842653|NCT02022748|584469933|FG000|Overall Study|Withdrawal by Subject|0|||
161842654|NCT02022748|584469934|FG001|Overall Study|Withdrawal by Subject|1|||
161842655|NCT02022748|584469935|FG002|Overall Study|Withdrawal by Subject|0|||
161842656|NCT04347122|584469936|FG000|Overall Study|Physician Decision|0|||
161842657|NCT04347122|584469937|FG001|Overall Study|Physician Decision|3|||
161842658|NCT04347122|584469938|FG002|Overall Study|Physician Decision|3|||
161842659|NCT04347122|584469939|FG003|Overall Study|Physician Decision|6|||
161842660|NCT03510598|584469940|FG000|Overall Study|Withdrawal by Subject|1|||
161842661|NCT00112866|584469941|FG000|Overall Study|Protocol Violation|1|||
161842662|NCT00112866|584469942|FG001|Overall Study|Protocol Violation|0|||
161842663|NCT00112866|584469941|FG000|Overall Study|did not start treatment post-op|1|||
161842664|NCT00112866|584469942|FG001|Overall Study|did not start treatment post-op|2|||
161842665|NCT04663295|584469943|FG000|Run-in Period|Withdrawal by Subject|3|||
161842666|NCT04663295|584469943|FG000|Overall Study Period|Pregnancy|1|||
161842667|NCT04663295|584469943|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
161842668|NCT00554190|584469944|FG000|Overall Study|Termination forms not completed|10|||
161842669|NCT01502410|584469945|FG000|Overall Study|Adverse Event|1|||
161842670|NCT01502410|584469946|FG001|Overall Study|Adverse Event|2|||
161842671|NCT01502410|584469947|FG002|Overall Study|Adverse Event|0|||
161842672|NCT01502410|584469948|FG003|Overall Study|Adverse Event|0|||
161842673|NCT01502410|584469945|FG000|Overall Study|Lack of Efficacy|7|||
161842674|NCT01502410|584469946|FG001|Overall Study|Lack of Efficacy|7|||
161842675|NCT01502410|584469947|FG002|Overall Study|Lack of Efficacy|0|||
161842676|NCT01502410|584469948|FG003|Overall Study|Lack of Efficacy|0|||
161842677|NCT01502410|584469945|FG000|Overall Study|Physician Decision|0|||
161842678|NCT01502410|584469946|FG001|Overall Study|Physician Decision|1|||
161842679|NCT01502410|584469947|FG002|Overall Study|Physician Decision|0|||
161842680|NCT01502410|584469948|FG003|Overall Study|Physician Decision|0|||
161842681|NCT01502410|584469945|FG000|Overall Study|Withdrawal by Subject|2|||
161842682|NCT01502410|584469946|FG001|Overall Study|Withdrawal by Subject|0|||
161842683|NCT01502410|584469947|FG002|Overall Study|Withdrawal by Subject|0|||
161842684|NCT01502410|584469948|FG003|Overall Study|Withdrawal by Subject|0|||
161842685|NCT03700385|584469952|FG000|Overall Study|Lost to Follow-up|1|||
161842686|NCT00699283|584469953|FG000|Overall Study|Lack of Efficacy|15|||
161842687|NCT00699283|584469954|FG001|Overall Study|Lack of Efficacy|5|||
161745628|NCT00247273|584108142|FG000|Overall Study|Withdrawal by Subject|46|||
161745629|NCT00247273|584108143|FG001|Overall Study|Withdrawal by Subject|47|||
161745630|NCT00247273|584108142|FG000|Overall Study|Did not take any study drug|2|||
161745631|NCT00247273|584108143|FG001|Overall Study|Did not take any study drug|0|||
161745632|NCT03276572|584108144|FG000|Overall Study|In follow-up|0|||
161745633|NCT03276572|584108145|FG001|Overall Study|In follow-up|0|||
161745634|NCT03276572|584108146|FG002|Overall Study|In follow-up|0|||
161745635|NCT03276572|584108147|FG003|Overall Study|In follow-up|0|||
161745636|NCT03276572|584108148|FG004|Overall Study|In follow-up|0|||
161745637|NCT03276572|584108149|FG005|Overall Study|In follow-up|1|||
161745638|NCT03276572|584108150|FG006|Overall Study|In follow-up|1|||
161745639|NCT03276572|584108144|FG000|Overall Study|Lost to Follow-up|0|||
161745640|NCT03276572|584108145|FG001|Overall Study|Lost to Follow-up|0|||
161745641|NCT03276572|584108146|FG002|Overall Study|Lost to Follow-up|0|||
161745642|NCT03276572|584108147|FG003|Overall Study|Lost to Follow-up|0|||
161745643|NCT03276572|584108148|FG004|Overall Study|Lost to Follow-up|0|||
161745644|NCT03276572|584108149|FG005|Overall Study|Lost to Follow-up|0|||
161745645|NCT03276572|584108150|FG006|Overall Study|Lost to Follow-up|1|||
161745646|NCT02580240|584108151|FG000|Overall Study|Physician Decision|2|||
161745647|NCT02580240|584108152|FG001|Overall Study|Physician Decision|0|||
161745648|NCT01709708|584108165|FG000|Overall Study|Protocol Violation|1|||
161745649|NCT01709708|584108166|FG001|Overall Study|Protocol Violation|2|||
161745650|NCT00511108|584108169|FG000|Overall Study|Adverse Event|2|||
161745651|NCT00511108|584108170|FG001|Overall Study|Adverse Event|0|||
161745652|NCT00511108|584108171|FG002|Overall Study|Adverse Event|1|||
161745653|NCT00511108|584108172|FG003|Overall Study|Adverse Event|2|||
161745654|NCT00511108|584108169|FG000|Overall Study|Lost to Follow-up|0|||
161745655|NCT00511108|584108170|FG001|Overall Study|Lost to Follow-up|2|||
161745656|NCT00511108|584108171|FG002|Overall Study|Lost to Follow-up|1|||
161745657|NCT00511108|584108172|FG003|Overall Study|Lost to Follow-up|0|||
161745658|NCT00511108|584108169|FG000|Overall Study|Physician Decision|0|||
161745659|NCT00511108|584108170|FG001|Overall Study|Physician Decision|0|||
161745660|NCT00511108|584108171|FG002|Overall Study|Physician Decision|0|||
161745661|NCT00511108|584108172|FG003|Overall Study|Physician Decision|1|||
161745662|NCT00511108|584108169|FG000|Overall Study|Withdrawal by Subject|4|||
161745663|NCT00511108|584108170|FG001|Overall Study|Withdrawal by Subject|0|||
161745664|NCT00511108|584108171|FG002|Overall Study|Withdrawal by Subject|3|||
161745665|NCT00511108|584108172|FG003|Overall Study|Withdrawal by Subject|2|||
161745666|NCT02954952|584108173|FG000|Overall Study|Withdrawal by Subject|1|||
161745667|NCT02954952|584108174|FG001|Overall Study|Withdrawal by Subject|0|||
161745668|NCT02954952|584108175|FG002|Overall Study|Withdrawal by Subject|0|||
161745669|NCT02954952|584108173|FG000|Overall Study|No data collected|0|||
161745670|NCT02954952|584108174|FG001|Overall Study|No data collected|1|||
161745671|NCT02954952|584108175|FG002|Overall Study|No data collected|0|||
161745672|NCT02911519|584108176|FG000|Overall Study|Lost to Follow-up|2|||
161745673|NCT02911519|584108177|FG001|Overall Study|Lost to Follow-up|2|||
161745674|NCT02911519|584108176|FG000|Overall Study|Death|0|||
161745675|NCT02911519|584108177|FG001|Overall Study|Death|2|||
161745676|NCT00810043|584108178|FG000|Overall Study|Withdrawal by Subject|1|||
161745677|NCT00810043|584108179|FG001|Overall Study|Withdrawal by Subject|0|||
161745678|NCT00810043|584108180|FG002|Overall Study|Withdrawal by Subject|2|||
161745679|NCT00810043|584108178|FG000|Overall Study|Lost to Follow-up|1|||
161745680|NCT00810043|584108179|FG001|Overall Study|Lost to Follow-up|0|||
161745681|NCT00810043|584108180|FG002|Overall Study|Lost to Follow-up|0|||
161745682|NCT00810043|584108178|FG000|Overall Study|Physician Decision|0|||
161745683|NCT00810043|584108179|FG001|Overall Study|Physician Decision|0|||
161745684|NCT00810043|584108180|FG002|Overall Study|Physician Decision|2|||
161745685|NCT00810043|584108178|FG000|Overall Study|Death|2|||
161745686|NCT00810043|584108179|FG001|Overall Study|Death|0|||
161745687|NCT00810043|584108180|FG002|Overall Study|Death|0|||
161745688|NCT00810043|584108178|FG000|Overall Study|Unrelated medical problem|0|||
161745689|NCT00810043|584108179|FG001|Overall Study|Unrelated medical problem|1|||
161745690|NCT00810043|584108180|FG002|Overall Study|Unrelated medical problem|0|||
161745691|NCT00810043|584108178|FG000|Overall Study|Non-medical problem|0|||
161745692|NCT00810043|584108179|FG001|Overall Study|Non-medical problem|0|||
161745693|NCT00810043|584108180|FG002|Overall Study|Non-medical problem|1|||
161745694|NCT00810043|584108178|FG000|Overall Study|No longer met enrollment criteria|0|||
161745695|NCT00810043|584108179|FG001|Overall Study|No longer met enrollment criteria|0|||
161745696|NCT00810043|584108180|FG002|Overall Study|No longer met enrollment criteria|3|||
161745697|NCT02001688|584108181|FG000|Overall Study|Withdrawal by Subject|0|||
161745698|NCT02001688|584108182|FG001|Overall Study|Withdrawal by Subject|0|||
161745699|NCT02001688|584108183|FG002|Overall Study|Withdrawal by Subject|1|||
161745700|NCT02001688|584108181|FG000|Overall Study|Adverse Event|0|||
161745701|NCT02001688|584108182|FG001|Overall Study|Adverse Event|1|||
161745702|NCT02001688|584108183|FG002|Overall Study|Adverse Event|0|||
161745703|NCT01675141|584108187|FG000|Overall Study|Lenalidomide outside NIH|3|||
161745704|NCT01675141|584108187|FG000|Overall Study|Withdrawal by Subject|3|||
161745705|NCT01675141|584108187|FG000|Overall Study|Physician Decision|4|||
161745706|NCT01675141|584108187|FG000|Overall Study|No treatment, per protocol|1|||
161966929|NCT04210245|584925758|FG002|Overall Study|Lost to Follow-up|1|||
161966930|NCT04210245|584925759|FG003|Overall Study|Lost to Follow-up|1|||
161966931|NCT04210245|584925756|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
161966932|NCT04210245|584925757|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
161966933|NCT04210245|584925758|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
161966934|NCT04210245|584925759|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
161966935|NCT03989349|584925762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
161966936|NCT03989349|584925763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161966937|NCT03989349|584925764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161966938|NCT03989349|584925765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161966939|NCT03989349|584925766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161745707|NCT00105183|584108191|FG000|Overall Study|Death|19|||
161745708|NCT00105183|584108192|FG001|Overall Study|Death|13|||
161745709|NCT00105183|584108193|FG002|Overall Study|Death|15|||
161745710|NCT00105183|584108191|FG000|Overall Study|Withdrawal by Subject|1|||
161745711|NCT00105183|584108192|FG001|Overall Study|Withdrawal by Subject|1|||
161745712|NCT00105183|584108193|FG002|Overall Study|Withdrawal by Subject|4|||
161745713|NCT00105183|584108191|FG000|Overall Study|Physician Decision|1|||
161745714|NCT00105183|584108192|FG001|Overall Study|Physician Decision|2|||
161745715|NCT00105183|584108193|FG002|Overall Study|Physician Decision|3|||
161966940|NCT03989349|584925767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
161966941|NCT03989349|584925762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
161745716|NCT00105183|584108191|FG000|Overall Study|Lost to Follow-up|0|||
161745717|NCT00105183|584108192|FG001|Overall Study|Lost to Follow-up|1|||
161745718|NCT00105183|584108193|FG002|Overall Study|Lost to Follow-up|1|||
161745719|NCT00105183|584108191|FG000|Overall Study|Other reason|1|||
161745720|NCT00105183|584108192|FG001|Overall Study|Other reason|2|||
161745721|NCT00105183|584108193|FG002|Overall Study|Other reason|0|||
161745722|NCT00270998|584108198|FG000|3 Month Follow-up|Adverse Event|1|||
161745723|NCT00270998|584108199|FG001|3 Month Follow-up|Adverse Event|0|||
161745724|NCT00270998|584108200|FG002|3 Month Follow-up|Adverse Event|0|||
161745725|NCT00270998|584108198|FG000|3 Month Follow-up|Lack of Efficacy|1|||
161745726|NCT00270998|584108199|FG001|3 Month Follow-up|Lack of Efficacy|2|||
161745727|NCT00270998|584108200|FG002|3 Month Follow-up|Lack of Efficacy|1|||
161745728|NCT00270998|584108198|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
161745729|NCT00270998|584108199|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
161745730|NCT00270998|584108200|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
161745731|NCT00270998|584108198|FG000|3 Month Follow-up|Pessary did not fit|12|||
161745732|NCT00270998|584108199|FG001|3 Month Follow-up|Pessary did not fit|0|||
161745733|NCT00270998|584108200|FG002|3 Month Follow-up|Pessary did not fit|0|||
161745734|NCT00270998|584108198|FG000|3 Month Follow-up|Personal/family health|1|||
161745735|NCT00270998|584108199|FG001|3 Month Follow-up|Personal/family health|1|||
161745736|NCT00270998|584108200|FG002|3 Month Follow-up|Personal/family health|0|||
161745737|NCT00270998|584108198|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
161745738|NCT00270998|584108199|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
161745739|NCT00270998|584108200|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
161745740|NCT00270998|584108198|FG000|12 Month Follow-up|Lack of Efficacy|5|||
161745741|NCT00270998|584108199|FG001|12 Month Follow-up|Lack of Efficacy|4|||
161745742|NCT00270998|584108200|FG002|12 Month Follow-up|Lack of Efficacy|3|||
161745743|NCT00270998|584108198|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
161745744|NCT00270998|584108199|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
161745745|NCT00270998|584108200|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
161745746|NCT00270998|584108198|FG000|12 Month Follow-up|Pessary did not fit|1|||
161745747|NCT00270998|584108199|FG001|12 Month Follow-up|Pessary did not fit|0|||
161745748|NCT00270998|584108200|FG002|12 Month Follow-up|Pessary did not fit|0|||
162032574|NCT02554279|585177436|FG001|Overall Study|Lost to Follow-up|2|||
162032575|NCT02554279|585177435|FG000|Overall Study|Withdrawal by Subject|6|||
161745749|NCT00270998|584108198|FG000|12 Month Follow-up|Personal/family health|0|||
161745750|NCT00270998|584108199|FG001|12 Month Follow-up|Personal/family health|5|||
161745751|NCT00270998|584108200|FG002|12 Month Follow-up|Personal/family health|1|||
161745752|NCT00270998|584108198|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
161745753|NCT00270998|584108199|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
161745754|NCT00270998|584108200|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
161745755|NCT04075396|584108203|FG000|Overall Study|Death|11|||
161745756|NCT04075396|584108204|FG001|Overall Study|Death|9|||
161745757|NCT04075396|584108203|FG000|Overall Study|Withdrawal by Subject|1|||
161745758|NCT04075396|584108204|FG001|Overall Study|Withdrawal by Subject|2|||
161745759|NCT04075396|584108203|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
161745760|NCT04075396|584108204|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
161745761|NCT04075396|584108203|FG000|Overall Study|Enrolled but not-treated|0|||
161745762|NCT04075396|584108204|FG001|Overall Study|Enrolled but not-treated|1|||
161842688|NCT00699283|584469953|FG000|Overall Study|Lost to Follow-up|2|||
161842689|NCT00699283|584469954|FG001|Overall Study|Lost to Follow-up|0|||
161842690|NCT00699283|584469953|FG000|Overall Study|Withdrawal by Subject|1|||
161842691|NCT00699283|584469954|FG001|Overall Study|Withdrawal by Subject|0|||
161842692|NCT00699283|584469953|FG000|Overall Study|Other Reason|5|||
161842693|NCT00699283|584469954|FG001|Overall Study|Other Reason|1|||
161842694|NCT00699283|584469953|FG000|Overall Study|SAE, non-fatal|1|||
161842695|NCT00699283|584469954|FG001|Overall Study|SAE, non-fatal|1|||
161842696|NCT00699283|584469953|FG000|Overall Study|AE, non-serious non-fatal|8|||
162032576|NCT02554279|585177436|FG001|Overall Study|Withdrawal by Subject|4|||
162032577|NCT02554279|585177435|FG000|Overall Study|Protocol Violation|2|||
162032578|NCT02554279|585177436|FG001|Overall Study|Protocol Violation|1|||
162032579|NCT02554279|585177435|FG000|Overall Study|Other reason|19|||
162032580|NCT02554279|585177436|FG001|Overall Study|Other reason|6|||
162032581|NCT00812487|585177437|FG000|Overall Study|Lost to Follow-up|2|||
162032582|NCT00812487|585177438|FG001|Overall Study|Lost to Follow-up|0|||
162032583|NCT00812487|585177437|FG000|Overall Study|Withdrawal by Subject|3|||
162032584|NCT00812487|585177438|FG001|Overall Study|Withdrawal by Subject|2|||
162032585|NCT00812487|585177437|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
162032586|NCT00812487|585177438|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
162032587|NCT00812487|585177437|FG000|Overall Study|Protocol Violation|0|||
162032588|NCT00812487|585177438|FG001|Overall Study|Protocol Violation|1|||
162032589|NCT00998764|585177439|FG000|Overall Study|Lack of Efficacy|3|||
162032590|NCT00998764|585177440|FG001|Overall Study|Lack of Efficacy|6|||
162032591|NCT00998764|585177439|FG000|Overall Study|Adverse Event|17|||
162032592|NCT00998764|585177440|FG001|Overall Study|Adverse Event|12|||
162032593|NCT00998764|585177439|FG000|Overall Study|Withdrawal by Subject|19|||
162032594|NCT00998764|585177440|FG001|Overall Study|Withdrawal by Subject|25|||
162032595|NCT00998764|585177439|FG000|Overall Study|Physician Decision|3|||
162032596|NCT00998764|585177440|FG001|Overall Study|Physician Decision|3|||
162032597|NCT00998764|585177439|FG000|Overall Study|Death|3|||
162032598|NCT00998764|585177440|FG001|Overall Study|Death|1|||
162032599|NCT00998764|585177439|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
162032600|NCT00998764|585177440|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
162032601|NCT00998764|585177439|FG000|Overall Study|Protocol Violation|0|||
161745763|NCT02443805|584108209|FG000|Overall Study|Adverse Event|100|||
161745764|NCT02443805|584108210|FG001|Overall Study|Adverse Event|18|||
161745765|NCT02443805|584108209|FG000|Overall Study|Withdrawal by Subject|73|||
161745766|NCT02443805|584108210|FG001|Overall Study|Withdrawal by Subject|74|||
161745767|NCT02443805|584108209|FG000|Overall Study|Lost to Follow-up|19|||
161745768|NCT02443805|584108210|FG001|Overall Study|Lost to Follow-up|14|||
161745769|NCT02443805|584108209|FG000|Overall Study|Pregnancy|6|||
161745770|NCT02443805|584108210|FG001|Overall Study|Pregnancy|5|||
161745771|NCT02443805|584108209|FG000|Overall Study|Protocol Violation|2|||
161745772|NCT02443805|584108210|FG001|Overall Study|Protocol Violation|4|||
161745773|NCT02443805|584108209|FG000|Overall Study|Lack of Efficacy|1|||
161745774|NCT02443805|584108210|FG001|Overall Study|Lack of Efficacy|1|||
161745775|NCT02443805|584108209|FG000|Overall Study|Non-compliance with study drug|6|||
161745776|NCT02443805|584108210|FG001|Overall Study|Non-compliance with study drug|4|||
161745777|NCT02443805|584108209|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161745778|NCT02443805|584108210|FG001|Overall Study|Withdrawal by parent/guardian|5|||
161745779|NCT02443805|584108209|FG000|Overall Study|Any other reason not above-mentioned|3|||
161745780|NCT02443805|584108210|FG001|Overall Study|Any other reason not above-mentioned|2|||
161745781|NCT00961116|584108211|FG000|Washout Period of 7 Days|Adverse Event|1|||
161745782|NCT00961116|584108212|FG001|Washout Period of 7 Days|Adverse Event|1|||
161745783|NCT00961116|584108211|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
161745784|NCT00961116|584108212|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161745785|NCT00961116|584108211|FG000|Washout Period of 7 Days|Protocol Violation|0|||
161745786|NCT00961116|584108212|FG001|Washout Period of 7 Days|Protocol Violation|1|||
161745787|NCT00968708|584108213|FG000|Overall Study|Adverse Event|169|||
161745788|NCT00968708|584108214|FG001|Overall Study|Adverse Event|150|||
161745789|NCT00968708|584108213|FG000|Overall Study|Major Protocol Deviation|0|||
161842697|NCT00699283|584469954|FG001|Overall Study|AE, non-serious non-fatal|1|||
162032602|NCT00998764|585177440|FG001|Overall Study|Protocol Violation|1|||
162032603|NCT00998764|585177439|FG000|Overall Study|Failed to Return|1|||
162032604|NCT00998764|585177440|FG001|Overall Study|Failed to Return|1|||
162032605|NCT00998764|585177439|FG000|Overall Study|Lost to Follow-up|1|||
162032606|NCT00998764|585177440|FG001|Overall Study|Lost to Follow-up|1|||
162032607|NCT00998764|585177439|FG000|Overall Study|Loss of Caregiver|0|||
162032608|NCT00998764|585177440|FG001|Overall Study|Loss of Caregiver|3|||
161842698|NCT00699283|584469953|FG000|Overall Study|AE of unknown type|1|||
161842699|NCT00699283|584469954|FG001|Overall Study|AE of unknown type|0|||
161842700|NCT04590040|584469960|FG000|Treatment Period|Lost to Follow-up|2|||
161842701|NCT04590040|584469961|FG001|Treatment Period|Lost to Follow-up|5|||
162032609|NCT00998764|585177439|FG000|Overall Study|Other|4|||
162032610|NCT00998764|585177440|FG001|Overall Study|Other|4|||
162032611|NCT00998764|585177439|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
161966942|NCT03989349|584925763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
161966943|NCT03989349|584925764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161966944|NCT03989349|584925765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161966945|NCT03989349|584925766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161966946|NCT03989349|584925767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
161966947|NCT03989349|584925762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
161966948|NCT03989349|584925763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
161966949|NCT03989349|584925764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
161966950|NCT03989349|584925765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
161966951|NCT03989349|584925766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
161966952|NCT03989349|584925767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
161966953|NCT03989349|584925762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
161966954|NCT03989349|584925763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
161966955|NCT03989349|584925764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161966956|NCT03989349|584925765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161745790|NCT00968708|584108214|FG001|Overall Study|Major Protocol Deviation|1|||
161745791|NCT00968708|584108213|FG000|Overall Study|Lost to Follow-up|19|||
161745792|NCT00968708|584108214|FG001|Overall Study|Lost to Follow-up|11|||
161745793|NCT00968708|584108213|FG000|Overall Study|Voluntary Withdrawal|104|||
161745794|NCT00968708|584108214|FG001|Overall Study|Voluntary Withdrawal|101|||
161745795|NCT00968708|584108213|FG000|Overall Study|Investigator Discretion|0|||
161745796|NCT00968708|584108214|FG001|Overall Study|Investigator Discretion|1|||
161745797|NCT00968708|584108213|FG000|Overall Study|Other|26|||
161745798|NCT00968708|584108214|FG001|Overall Study|Other|34|||
161745799|NCT02708966|584108215|FG000|Overall Study|Lost to Follow-up|2|||
161745800|NCT02708966|584108216|FG001|Overall Study|Lost to Follow-up|2|||
161745801|NCT00389441|584108217|FG000|Overall Study|Adverse Event|7|||
161745802|NCT00389441|584108217|FG000|Overall Study|Death|4|||
161745803|NCT00389441|584108217|FG000|Overall Study|Lost to Follow-up|2|||
161745804|NCT00389441|584108217|FG000|Overall Study|Withdrawal by Subject|4|||
161745805|NCT00389441|584108217|FG000|Overall Study|Physician Decision|1|||
161745806|NCT00389441|584108217|FG000|Overall Study|Protocol Violation|1|||
161745807|NCT00389441|584108217|FG000|Overall Study|Global deterioration of health status|4|||
161745808|NCT00389441|584108217|FG000|Overall Study|Objective progression or relapse|26|||
161745809|NCT00389441|584108217|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
161745810|NCT00389441|584108217|FG000|Overall Study|Clinical progression|1|||
161745811|NCT01981109|584108218|FG000|Overall Study|Death|36|||
161745812|NCT01981109|584108218|FG000|Overall Study|Withdrawal by Subject|40|||
161745813|NCT01981109|584108218|FG000|Overall Study|Lost to Follow-up|9|||
161745814|NCT01981109|584108218|FG000|Overall Study|No Discontinuation Documentation|37|||
161745815|NCT01981109|584108218|FG000|Overall Study|Study Termination|100|||
161745816|NCT01981109|584108218|FG000|Overall Study|No data available|2|||
161745817|NCT03407170|584108219|FG000|Overall Study|Adverse Event|1|||
161745818|NCT00105560|584108221|FG000|Overall Study|Lost to Follow-up|1|||
161745819|NCT00636441|584108222|FG000|Overall Study|Adverse Event|0|||
161745820|NCT00636441|584108223|FG001|Overall Study|Adverse Event|1|||
161745821|NCT00636441|584108224|FG002|Overall Study|Adverse Event|1|||
161745822|NCT00636441|584108225|FG003|Overall Study|Adverse Event|0|||
161745823|NCT00636441|584108226|FG004|Overall Study|Adverse Event|0|||
161745824|NCT00636441|584108227|FG005|Overall Study|Adverse Event|1|||
161745825|NCT00636441|584108228|FG006|Overall Study|Adverse Event|0|||
161745826|NCT00636441|584108222|FG000|Overall Study|Late, ineligible|0|||
161745827|NCT00636441|584108223|FG001|Overall Study|Late, ineligible|0|||
161745828|NCT00636441|584108224|FG002|Overall Study|Late, ineligible|0|||
161745829|NCT00636441|584108225|FG003|Overall Study|Late, ineligible|0|||
161745830|NCT00636441|584108226|FG004|Overall Study|Late, ineligible|0|||
161745831|NCT00636441|584108227|FG005|Overall Study|Late, ineligible|0|||
161745832|NCT00636441|584108228|FG006|Overall Study|Late, ineligible|1|||
161745833|NCT00636441|584108222|FG000|Overall Study|Screen Failure|0|||
161745834|NCT00636441|584108223|FG001|Overall Study|Screen Failure|0|||
161745835|NCT00636441|584108224|FG002|Overall Study|Screen Failure|0|||
161745836|NCT00636441|584108225|FG003|Overall Study|Screen Failure|0|||
161745837|NCT00636441|584108226|FG004|Overall Study|Screen Failure|0|||
161745838|NCT00636441|584108227|FG005|Overall Study|Screen Failure|0|||
161966957|NCT03989349|584925766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161966958|NCT03989349|584925767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
161966959|NCT03989349|584925762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
161745839|NCT00636441|584108228|FG006|Overall Study|Screen Failure|17|||
161745840|NCT00305604|584108230|FG000|Overall Study|Adverse Event|6|||
161745841|NCT00305604|584108231|FG001|Overall Study|Adverse Event|3|||
161745842|NCT00305604|584108230|FG000|Overall Study|Lack of Efficacy|11|||
161745843|NCT00305604|584108231|FG001|Overall Study|Lack of Efficacy|18|||
161745844|NCT00305604|584108230|FG000|Overall Study|Lost to Follow-up|0|||
161745845|NCT00305604|584108231|FG001|Overall Study|Lost to Follow-up|4|||
161745846|NCT00305604|584108230|FG000|Overall Study|Protocol Violation|2|||
161745847|NCT00305604|584108231|FG001|Overall Study|Protocol Violation|1|||
161745848|NCT00305604|584108230|FG000|Overall Study|Withdrawal by Subject|12|||
161745849|NCT00305604|584108231|FG001|Overall Study|Withdrawal by Subject|21|||
161745850|NCT00305604|584108230|FG000|Overall Study|Patient moved|1|||
161745851|NCT00305604|584108231|FG001|Overall Study|Patient moved|0|||
161745852|NCT01248364|584108233|FG000|Overall Study|Adverse Event|0|||
161745853|NCT01248364|584108234|FG001|Overall Study|Adverse Event|1|||
161745854|NCT01248364|584108235|FG002|Overall Study|Adverse Event|0|||
161745855|NCT01248364|584108236|FG003|Overall Study|Adverse Event|0|||
161745856|NCT02559713|584108239|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
161745857|NCT01767519|584108241|FG000|Overall Study|Other Reasons|4|||
161745858|NCT01767519|584108242|FG001|Overall Study|Other Reasons|4|||
161745859|NCT01767519|584108243|FG002|Overall Study|Other Reasons|2|||
161745860|NCT01767519|584108241|FG000|Overall Study|Protocol Violation|0|||
161745861|NCT01767519|584108242|FG001|Overall Study|Protocol Violation|3|||
161745862|NCT01767519|584108243|FG002|Overall Study|Protocol Violation|0|||
161745863|NCT01767519|584108241|FG000|Overall Study|Personal Reasons|1|||
161745864|NCT01767519|584108242|FG001|Overall Study|Personal Reasons|0|||
161745865|NCT01767519|584108243|FG002|Overall Study|Personal Reasons|0|||
161745866|NCT01767519|584108241|FG000|Overall Study|Lost to Follow-up|3|||
161745867|NCT01767519|584108242|FG001|Overall Study|Lost to Follow-up|1|||
161745868|NCT01767519|584108243|FG002|Overall Study|Lost to Follow-up|2|||
161745869|NCT01767519|584108241|FG000|Overall Study|Lack of Efficacy|1|||
161745870|NCT01767519|584108242|FG001|Overall Study|Lack of Efficacy|0|||
161745871|NCT01767519|584108243|FG002|Overall Study|Lack of Efficacy|0|||
161745872|NCT01767519|584108241|FG000|Overall Study|Adverse Event|5|||
161745873|NCT01767519|584108242|FG001|Overall Study|Adverse Event|5|||
161745874|NCT01767519|584108243|FG002|Overall Study|Adverse Event|1|||
161745875|NCT01117012|584108245|FG000|Overall Study|Adverse Event|0|||
161745876|NCT01117012|584108246|FG001|Overall Study|Adverse Event|1|||
161745877|NCT01117012|584108245|FG000|Overall Study|Death|1|||
161745878|NCT01117012|584108246|FG001|Overall Study|Death|1|||
161745879|NCT01117012|584108245|FG000|Overall Study|Withdrawal by Subject|3|||
161745880|NCT01117012|584108246|FG001|Overall Study|Withdrawal by Subject|0|||
161745881|NCT01117012|584108245|FG000|Overall Study|Undefined|4|||
161745882|NCT01117012|584108246|FG001|Overall Study|Undefined|3|||
161745883|NCT01586806|584108254|FG000|Overall Study|Protocol Violation|0|||
161745884|NCT01586806|584108255|FG001|Overall Study|Protocol Violation|1|||
161745885|NCT01586806|584108256|FG002|Overall Study|Protocol Violation|0|||
161745886|NCT01586806|584108254|FG000|Overall Study|Withdrawal by Subject|1|||
161745887|NCT01586806|584108255|FG001|Overall Study|Withdrawal by Subject|0|||
161745888|NCT01586806|584108256|FG002|Overall Study|Withdrawal by Subject|0|||
161745889|NCT01586806|584108254|FG000|Overall Study|Lost to Follow-up|2|||
161745890|NCT01586806|584108255|FG001|Overall Study|Lost to Follow-up|3|||
161745891|NCT01586806|584108256|FG002|Overall Study|Lost to Follow-up|2|||
161745892|NCT00555906|584108257|FG000|Phase 1|Objective Progression or Relapse|3|||
161745893|NCT00555906|584108258|FG001|Phase 1|Objective Progression or Relapse|5|||
161966960|NCT03989349|584925763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
161745894|NCT00555906|584108259|FG002|Phase 1|Objective Progression or Relapse|3|||
161745895|NCT00555906|584108260|FG003|Phase 1|Objective Progression or Relapse|1|||
161745896|NCT00555906|584108261|FG004|Phase 1|Objective Progression or Relapse|0|||
161745897|NCT00555906|584108257|FG000|Phase 1|Global Deterioration of Health Status|0|||
161745898|NCT00555906|584108258|FG001|Phase 1|Global Deterioration of Health Status|1|||
161745899|NCT00555906|584108259|FG002|Phase 1|Global Deterioration of Health Status|1|||
161745900|NCT00555906|584108260|FG003|Phase 1|Global Deterioration of Health Status|1|||
161745901|NCT00555906|584108261|FG004|Phase 1|Global Deterioration of Health Status|0|||
161745902|NCT00555906|584108257|FG000|Phase 1|Adverse Event|0|||
161745903|NCT00555906|584108258|FG001|Phase 1|Adverse Event|0|||
161745904|NCT00555906|584108259|FG002|Phase 1|Adverse Event|3|||
161745905|NCT00555906|584108260|FG003|Phase 1|Adverse Event|2|||
161745906|NCT00555906|584108261|FG004|Phase 1|Adverse Event|0|||
161745907|NCT00555906|584108257|FG000|Phase 1|Withdrawal by Subject|0|||
161745908|NCT00555906|584108258|FG001|Phase 1|Withdrawal by Subject|0|||
161745909|NCT00555906|584108259|FG002|Phase 1|Withdrawal by Subject|0|||
161745910|NCT00555906|584108260|FG003|Phase 1|Withdrawal by Subject|1|||
161745911|NCT00555906|584108261|FG004|Phase 1|Withdrawal by Subject|0|||
161745912|NCT00555906|584108257|FG000|Phase 2|Adverse Event|0|||
161745913|NCT00555906|584108258|FG001|Phase 2|Adverse Event|0|||
161745914|NCT00555906|584108259|FG002|Phase 2|Adverse Event|0|||
161745915|NCT00555906|584108260|FG003|Phase 2|Adverse Event|0|||
161745916|NCT00555906|584108261|FG004|Phase 2|Adverse Event|4|||
161745917|NCT00555906|584108257|FG000|Phase 2|Global Deterioration of Health Status|0|||
161745918|NCT00555906|584108258|FG001|Phase 2|Global Deterioration of Health Status|0|||
161745919|NCT00555906|584108259|FG002|Phase 2|Global Deterioration of Health Status|0|||
161745920|NCT00555906|584108260|FG003|Phase 2|Global Deterioration of Health Status|0|||
161745921|NCT00555906|584108261|FG004|Phase 2|Global Deterioration of Health Status|2|||
161745922|NCT00555906|584108257|FG000|Phase 2|Objective Progression or Relapse|0|||
161745923|NCT00555906|584108258|FG001|Phase 2|Objective Progression or Relapse|0|||
161745924|NCT00555906|584108259|FG002|Phase 2|Objective Progression or Relapse|0|||
161745925|NCT00555906|584108260|FG003|Phase 2|Objective Progression or Relapse|0|||
161745926|NCT00555906|584108261|FG004|Phase 2|Objective Progression or Relapse|16|||
161745927|NCT00555906|584108257|FG000|Phase 2|Withdrawal by Subject|0|||
161745928|NCT00555906|584108258|FG001|Phase 2|Withdrawal by Subject|0|||
161745929|NCT00555906|584108259|FG002|Phase 2|Withdrawal by Subject|0|||
161745930|NCT00555906|584108260|FG003|Phase 2|Withdrawal by Subject|0|||
161745931|NCT00555906|584108261|FG004|Phase 2|Withdrawal by Subject|2|||
161745932|NCT00555906|584108257|FG000|Phase 2|Other|0|||
161745933|NCT00555906|584108258|FG001|Phase 2|Other|0|||
161745934|NCT00555906|584108259|FG002|Phase 2|Other|0|||
161745935|NCT00555906|584108260|FG003|Phase 2|Other|0|||
161745936|NCT00555906|584108261|FG004|Phase 2|Other|6|||
161745937|NCT00555906|584108257|FG000|Phase 2|Randomized but not Treated|0|||
161745938|NCT00555906|584108258|FG001|Phase 2|Randomized but not Treated|0|||
161745939|NCT00555906|584108259|FG002|Phase 2|Randomized but not Treated|0|||
161745940|NCT00555906|584108260|FG003|Phase 2|Randomized but not Treated|0|||
161745941|NCT00555906|584108261|FG004|Phase 2|Randomized but not Treated|2|||
161745942|NCT02193828|584108262|FG000|Overall Study|Withdrawal by Subject|0|||
161745943|NCT02193828|584108263|FG001|Overall Study|Withdrawal by Subject|0|||
161745944|NCT02193828|584108264|FG002|Overall Study|Withdrawal by Subject|1|||
161745945|NCT02193828|584108265|FG003|Overall Study|Withdrawal by Subject|1|||
161745946|NCT02983799|584108268|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
161745947|NCT02983799|584108269|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
161745948|NCT02983799|584108270|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
161745949|NCT02983799|584108271|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
161745950|NCT02983799|584108272|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
161745951|NCT02983799|584108268|FG000|Overall Study|Death|20|||
161745952|NCT02983799|584108269|FG001|Overall Study|Death|5|||
161745953|NCT02983799|584108270|FG002|Overall Study|Death|23|||
161745954|NCT02983799|584108271|FG003|Overall Study|Death|47|||
161745955|NCT02983799|584108272|FG004|Overall Study|Death|7|||
161745956|NCT02983799|584108268|FG000|Overall Study|Withdrawal by Subject|1|||
161745957|NCT02983799|584108269|FG001|Overall Study|Withdrawal by Subject|0|||
161745958|NCT02983799|584108270|FG002|Overall Study|Withdrawal by Subject|3|||
161745959|NCT02983799|584108271|FG003|Overall Study|Withdrawal by Subject|4|||
161745960|NCT02983799|584108272|FG004|Overall Study|Withdrawal by Subject|1|||
161745961|NCT02983799|584108268|FG000|Overall Study|Protocol Violation|0|||
161745962|NCT02983799|584108269|FG001|Overall Study|Protocol Violation|1|||
161745963|NCT02983799|584108270|FG002|Overall Study|Protocol Violation|0|||
161745964|NCT02983799|584108271|FG003|Overall Study|Protocol Violation|0|||
161745965|NCT02983799|584108272|FG004|Overall Study|Protocol Violation|1|||
161745966|NCT02983799|584108268|FG000|Overall Study|Lost to Follow-up|1|||
161745967|NCT02983799|584108269|FG001|Overall Study|Lost to Follow-up|0|||
161745968|NCT02983799|584108270|FG002|Overall Study|Lost to Follow-up|1|||
161745969|NCT02983799|584108271|FG003|Overall Study|Lost to Follow-up|0|||
161745970|NCT02983799|584108272|FG004|Overall Study|Lost to Follow-up|0|||
161745971|NCT01626989|584108273|FG000|Screening Period|Screen Failure|15|||
161745972|NCT01626989|584108274|FG001|Screening Period|Screen Failure|0|||
161745973|NCT01626989|584108275|FG002|Screening Period|Screen Failure|0|||
161745974|NCT01626989|584108273|FG000|Screening Period|Withdrawal by Subject|2|||
161745975|NCT01626989|584108274|FG001|Screening Period|Withdrawal by Subject|0|||
161745976|NCT01626989|584108275|FG002|Screening Period|Withdrawal by Subject|0|||
161745977|NCT02293902|584108284|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
161745978|NCT02293902|584108285|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
161745979|NCT02293902|584108286|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
161745980|NCT02293902|584108287|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
161745981|NCT02293902|584108288|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
161745982|NCT02293902|584108284|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
161745983|NCT02293902|584108285|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
161745984|NCT02293902|584108286|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
161745985|NCT02293902|584108287|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
161745986|NCT02293902|584108288|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
161745987|NCT02293902|584108284|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
161745988|NCT02293902|584108285|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
161745989|NCT02293902|584108286|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
161745990|NCT02293902|584108287|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
161745991|NCT02293902|584108288|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
161745992|NCT02293902|584108284|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
161745993|NCT02293902|584108285|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
161745994|NCT02293902|584108286|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
161745995|NCT02293902|584108287|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
161745996|NCT02293902|584108288|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
161745997|NCT02293902|584108284|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
161745998|NCT02293902|584108285|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
161745999|NCT02293902|584108286|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
161746000|NCT02293902|584108287|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
161746001|NCT02293902|584108288|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
161746002|NCT03366844|584110322|FG000|Overall Study|Physician Decision|1|||
161746003|NCT03366844|584110322|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
161746004|NCT02687711|584110325|FG000|Overall Study|Adverse Event|89|||
161746005|NCT02687711|584110325|FG000|Overall Study|Lack of Efficacy|70|||
161746006|NCT02687711|584110325|FG000|Overall Study|Lost to Follow-up|20|||
161746007|NCT02687711|584110325|FG000|Overall Study|Consent withdrawn|15|||
161746008|NCT02687711|584110325|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
161746009|NCT02687711|584110325|FG000|Overall Study|Too expensive|4|||
161746010|NCT02687711|584110325|FG000|Overall Study|Participant moved abroad|1|||
161746011|NCT02687711|584110325|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
161746012|NCT02687711|584110325|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
161746013|NCT02687711|584110325|FG000|Overall Study|Disliked taste|1|||
161746014|NCT02687711|584110325|FG000|Overall Study|Low mood|1|||
161746015|NCT02687711|584110325|FG000|Overall Study|Side effects|1|||
161746016|NCT02687711|584110325|FG000|Overall Study|Change of Hospital|1|||
161746017|NCT02687711|584110325|FG000|Overall Study|Liver Encephalopathy|1|||
161842702|NCT04590040|584469962|FG002|Treatment Period|Lost to Follow-up|0|||
161842703|NCT04590040|584469960|FG000|Treatment Period|Physician Decision|0|||
161842704|NCT04590040|584469961|FG001|Treatment Period|Physician Decision|0|||
161842705|NCT04590040|584469962|FG002|Treatment Period|Physician Decision|2|||
161842706|NCT00000378|584469965|FG000|Overall Study|Lack of Efficacy|16|||
161842707|NCT00000378|584469966|FG001|Overall Study|Lack of Efficacy|14|||
161842708|NCT01284361|584469969|FG000|Overall Study|Withdrawal by Subject|1|||
161842709|NCT01284361|584469969|FG000|Overall Study|Protocol Violation|5|||
161842710|NCT01284361|584469969|FG000|Overall Study|Adverse Event|1|||
162032612|NCT00998764|585177440|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
161842711|NCT01284361|584469969|FG000|Overall Study|Lost to Follow-up|2|||
161842712|NCT00805675|584469970|FG000|Overall Study|Adverse Event|0|||
161842713|NCT00805675|584469971|FG001|Overall Study|Adverse Event|0|||
161842714|NCT00805675|584469972|FG002|Overall Study|Adverse Event|1|||
161842715|NCT02771795|584469976|FG000|Overall Study|Withdrawal by Subject|47|||
161842716|NCT02771795|584469977|FG001|Overall Study|Withdrawal by Subject|37|||
161842717|NCT02771795|584469976|FG000|Overall Study|Termination by premature discontinuation of study|168|||
161842718|NCT02771795|584469977|FG001|Overall Study|Termination by premature discontinuation of study|185|||
161842719|NCT01957397|584469979|FG000|Test Period 1|sudden leakage/small bag|1|||
161842720|NCT01957397|584469980|FG001|Test Period 1|sudden leakage/small bag|1|||
161842721|NCT01957397|584469979|FG000|Test Period 1|Withdrawal by Subject|1|||
161842722|NCT01957397|584469980|FG001|Test Period 1|Withdrawal by Subject|0|||
161842723|NCT01957397|584469979|FG000|Test Period 2|Adverse Event|0|||
161842724|NCT01957397|584469980|FG001|Test Period 2|Adverse Event|1|||
161842725|NCT01957397|584469979|FG000|Test Period 3|Adverse Event|1|||
161842726|NCT01957397|584469980|FG001|Test Period 3|Adverse Event|2|||
161842727|NCT01957397|584469979|FG000|Test Period 3|the adhesive did not work|1|||
161842728|NCT01957397|584469980|FG001|Test Period 3|the adhesive did not work|0|||
161842729|NCT00505375|584469981|FG000|Overall Study|Death|1|||
161842730|NCT00505375|584469982|FG001|Overall Study|Death|0|||
161842731|NCT00505375|584469981|FG000|Overall Study|Withdrawal by Subject|2|||
161842732|NCT00505375|584469982|FG001|Overall Study|Withdrawal by Subject|2|||
161842733|NCT00505375|584469981|FG000|Overall Study|Lost to Follow-up|0|||
161842734|NCT00505375|584469982|FG001|Overall Study|Lost to Follow-up|2|||
161842735|NCT00505375|584469981|FG000|Overall Study|Pregnancy|1|||
161842736|NCT00505375|584469982|FG001|Overall Study|Pregnancy|0|||
161842737|NCT00505375|584469981|FG000|Overall Study|Travel issues|0|||
161842738|NCT00505375|584469982|FG001|Overall Study|Travel issues|1|||
161842739|NCT02906930|584469983|FG000|Overall Study|Withdrawal by Subject|0|||
161842740|NCT02906930|584469984|FG001|Overall Study|Withdrawal by Subject|5|||
161842741|NCT02906930|584469985|FG002|Overall Study|Withdrawal by Subject|5|||
161842742|NCT02906930|584469986|FG003|Overall Study|Withdrawal by Subject|4|||
161746018|NCT02687711|584110325|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
161746019|NCT02687711|584110325|FG000|Overall Study|Withdrawn due to intake interruption|1|||
161746020|NCT02687711|584110325|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
161746021|NCT02687711|584110325|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
161746022|NCT02687711|584110325|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
161746023|NCT02971007|584110327|FG000|Overall Study|Adverse Event|1|||
161746024|NCT02971007|584110328|FG001|Overall Study|Adverse Event|0|||
161842743|NCT02906930|584469983|FG000|Overall Study|Lost to Follow-up|5|||
161842744|NCT02906930|584469984|FG001|Overall Study|Lost to Follow-up|7|||
161842745|NCT02906930|584469985|FG002|Overall Study|Lost to Follow-up|5|||
161842746|NCT02906930|584469986|FG003|Overall Study|Lost to Follow-up|2|||
161966961|NCT03989349|584925764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
161966962|NCT03989349|584925765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
161966963|NCT03989349|584925766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
161966964|NCT03989349|584925767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
161966965|NCT03989349|584925762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
161966966|NCT03989349|584925763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
161966967|NCT03989349|584925764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
161746025|NCT02971007|584110329|FG002|Overall Study|Adverse Event|0|||
161746026|NCT02971007|584110327|FG000|Overall Study|Lost to Follow-up|0|||
161746027|NCT02971007|584110328|FG001|Overall Study|Lost to Follow-up|1|||
161746028|NCT02971007|584110329|FG002|Overall Study|Lost to Follow-up|1|||
161746029|NCT02971007|584110327|FG000|Overall Study|Withdrawal by Subject|0|||
161746030|NCT02971007|584110328|FG001|Overall Study|Withdrawal by Subject|1|||
161746031|NCT02971007|584110329|FG002|Overall Study|Withdrawal by Subject|0|||
161746032|NCT02971007|584110327|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
161746033|NCT02971007|584110328|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
161746034|NCT02971007|584110329|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
161746035|NCT02971007|584110327|FG000|Overall Study|Patient discontinued study drug|0|||
161746036|NCT02971007|584110328|FG001|Overall Study|Patient discontinued study drug|1|||
161746037|NCT02971007|584110329|FG002|Overall Study|Patient discontinued study drug|0|||
161746038|NCT00607919|584110330|FG000|Acute Phase|Adverse Event|9|||
161746039|NCT00607919|584110331|FG001|Acute Phase|Adverse Event|2|||
161746040|NCT00607919|584110330|FG000|Acute Phase|Entry Criteria Not Met|1|||
161746041|NCT00607919|584110331|FG001|Acute Phase|Entry Criteria Not Met|1|||
161746042|NCT00607919|584110330|FG000|Acute Phase|Lack of Efficacy|1|||
161746043|NCT00607919|584110331|FG001|Acute Phase|Lack of Efficacy|2|||
161746044|NCT00607919|584110330|FG000|Acute Phase|Lost to Follow-up|9|||
161746045|NCT00607919|584110331|FG001|Acute Phase|Lost to Follow-up|3|||
161746046|NCT00607919|584110330|FG000|Acute Phase|Parent/Caregiver Decision|6|||
161746047|NCT00607919|584110331|FG001|Acute Phase|Parent/Caregiver Decision|4|||
161746048|NCT00607919|584110330|FG000|Acute Phase|Protocol Violation|5|||
161746049|NCT00607919|584110331|FG001|Acute Phase|Protocol Violation|1|||
161746050|NCT00607919|584110330|FG000|Acute Phase|Withdrawal by Subject|3|||
161746051|NCT00607919|584110331|FG001|Acute Phase|Withdrawal by Subject|3|||
161746052|NCT00607919|584110330|FG000|Open-Label Phase|Adverse Event|1|||
161746053|NCT00607919|584110331|FG001|Open-Label Phase|Adverse Event|5|||
161746054|NCT00607919|584110330|FG000|Open-Label Phase|Lost to Follow-up|4|||
161746055|NCT00607919|584110331|FG001|Open-Label Phase|Lost to Follow-up|1|||
161746056|NCT00607919|584110330|FG000|Open-Label Phase|Protocol Violation|2|||
161746057|NCT00607919|584110331|FG001|Open-Label Phase|Protocol Violation|2|||
161746058|NCT00607919|584110330|FG000|Open-Label Phase|Withdrawal by Subject|2|||
161746059|NCT00607919|584110331|FG001|Open-Label Phase|Withdrawal by Subject|2|||
161746060|NCT00607919|584110330|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
161746061|NCT00607919|584110331|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
161746062|NCT00724815|584110336|FG000|Overall Study|Randomized, not treated|31|||
161746063|NCT00724815|584110337|FG001|Overall Study|Randomized, not treated|30|||
161746064|NCT00724815|584110336|FG000|Overall Study|Adverse Event|5|||
161746065|NCT00724815|584110337|FG001|Overall Study|Adverse Event|3|||
161746066|NCT00724815|584110336|FG000|Overall Study|Lost to Follow-up|4|||
161746067|NCT00724815|584110337|FG001|Overall Study|Lost to Follow-up|1|||
161746068|NCT00724815|584110336|FG000|Overall Study|Other Various|3|||
161746069|NCT00724815|584110337|FG001|Overall Study|Other Various|5|||
161746070|NCT03862495|584110340|FG000|Overall Study|Lost to Follow-up|37|||
161746071|NCT03862495|584110341|FG001|Overall Study|Lost to Follow-up|35|||
161966968|NCT03989349|584925765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
161966969|NCT03989349|584925766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
161746072|NCT00064077|584110342|FG000|Overall Study|Improper prior treatment|1|||
161746073|NCT00064077|584110343|FG001|Overall Study|Improper prior treatment|0|||
161746074|NCT00064077|584110344|FG002|Overall Study|Improper prior treatment|0|||
161746075|NCT00064077|584110345|FG003|Overall Study|Improper prior treatment|0|||
161746076|NCT00064077|584110342|FG000|Overall Study|Poor risk|2|||
161746077|NCT00064077|584110343|FG001|Overall Study|Poor risk|0|||
161746078|NCT00064077|584110344|FG002|Overall Study|Poor risk|1|||
161746079|NCT00064077|584110345|FG003|Overall Study|Poor risk|1|||
161746080|NCT00064077|584110342|FG000|Overall Study|Pathology|10|||
161746081|NCT00064077|584110343|FG001|Overall Study|Pathology|7|||
161746082|NCT00064077|584110344|FG002|Overall Study|Pathology|3|||
161842747|NCT02906930|584469983|FG000|Overall Study|Death|0|||
161966970|NCT03989349|584925767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
161966971|NCT03989349|584925762|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
161746083|NCT00064077|584110345|FG003|Overall Study|Pathology|4|||
161746084|NCT00064077|584110342|FG000|Overall Study|No surgery|0|||
161746085|NCT00064077|584110343|FG001|Overall Study|No surgery|0|||
161746086|NCT00064077|584110344|FG002|Overall Study|No surgery|1|||
161842748|NCT02906930|584469984|FG001|Overall Study|Death|0|||
161842749|NCT02906930|584469985|FG002|Overall Study|Death|1|||
161842750|NCT02906930|584469986|FG003|Overall Study|Death|0|||
161842751|NCT02906930|584469983|FG000|Overall Study|Other|1|||
161842752|NCT02906930|584469984|FG001|Overall Study|Other|2|||
161842753|NCT02906930|584469985|FG002|Overall Study|Other|1|||
161842754|NCT02906930|584469986|FG003|Overall Study|Other|2|||
161842755|NCT03537599|584469987|FG000|Overall Study|Disease Progression|2|||
161842756|NCT03537599|584469988|FG001|Overall Study|Disease Progression|1|||
161842757|NCT03537599|584469987|FG000|Overall Study|Death|0|||
161842758|NCT03537599|584469988|FG001|Overall Study|Death|1|||
161842759|NCT04585789|584469989|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
161842760|NCT04585789|584469990|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
161842761|NCT04585789|584469991|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
161842762|NCT04585789|584469989|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
161842763|NCT04585789|584469990|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
161842764|NCT04585789|584469991|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
161842765|NCT05083585|584469992|FG000|Overall Study|Death|1|||
161842766|NCT05083585|584469993|FG001|Overall Study|Death|1|||
161842767|NCT05083585|584469992|FG000|Overall Study|Lost to Follow-up|1|||
161842768|NCT05083585|584469993|FG001|Overall Study|Lost to Follow-up|1|||
161842769|NCT05083585|584469992|FG000|Overall Study|Withdrawal by Subject|2|||
161842770|NCT05083585|584469993|FG001|Overall Study|Withdrawal by Subject|0|||
161842771|NCT05083585|584469992|FG000|Overall Study|Randomized but not vaccinated|2|||
161842772|NCT05083585|584469993|FG001|Overall Study|Randomized but not vaccinated|0|||
161842773|NCT00114166|584469994|FG000|Overall Study|Wrong primary|0|||
161842774|NCT00114166|584469995|FG001|Overall Study|Wrong primary|1|||
161842775|NCT03469336|584469996|FG000|Overall Study|Adverse Event|1|||
161842776|NCT02740699|584469999|FG000|Overall Study|Lost to Follow-up|5|||
161842777|NCT02740699|584469999|FG000|Overall Study|Withdrawal by Subject|14|||
161842778|NCT02740699|584469999|FG000|Overall Study|Physician Decision|5|||
161842779|NCT02393248|584470000|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842780|NCT02393248|584470001|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
161842781|NCT02393248|584470002|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842782|NCT02393248|584470003|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842783|NCT02393248|584470004|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842784|NCT02393248|584470005|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
161842785|NCT02393248|584470006|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
161842786|NCT02393248|584470007|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842787|NCT02393248|584470008|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842788|NCT02393248|584470009|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842789|NCT02393248|584470010|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842790|NCT02393248|584470011|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842791|NCT02393248|584470012|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842792|NCT02393248|584470013|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842793|NCT02393248|584470014|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842794|NCT02393248|584470015|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842795|NCT02393248|584470016|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842796|NCT02393248|584470017|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842797|NCT02393248|584470018|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842798|NCT02393248|584470019|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842799|NCT02393248|584470020|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842800|NCT02393248|584470021|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842801|NCT02393248|584470022|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842802|NCT02393248|584470023|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842803|NCT02393248|584470024|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161842804|NCT02393248|584470000|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842805|NCT02393248|584470001|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
161842806|NCT02393248|584470002|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842807|NCT02393248|584470003|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842808|NCT02393248|584470004|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842809|NCT02393248|584470005|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161746087|NCT00064077|584110345|FG003|Overall Study|No surgery|0|||
161746088|NCT00064077|584110342|FG000|Overall Study|No tumor|0|||
161746089|NCT00064077|584110343|FG001|Overall Study|No tumor|0|||
161746090|NCT00064077|584110344|FG002|Overall Study|No tumor|1|||
161746091|NCT00064077|584110345|FG003|Overall Study|No tumor|0|||
161746092|NCT00064077|584110342|FG000|Overall Study|Other reasons|2|||
161746093|NCT00064077|584110343|FG001|Overall Study|Other reasons|2|||
161746094|NCT00064077|584110344|FG002|Overall Study|Other reasons|1|||
161746095|NCT00064077|584110345|FG003|Overall Study|Other reasons|2|||
161746096|NCT00615914|584110346|FG000|Overall Study|Adverse Event|274|||
161746097|NCT00615914|584110346|FG000|Overall Study|Death|20|||
161746098|NCT00615914|584110346|FG000|Overall Study|Lack of Efficacy|59|||
161746099|NCT00615914|584110346|FG000|Overall Study|Lost to Follow-up|187|||
161746100|NCT00615914|584110346|FG000|Overall Study|Withdrawal by Subject|16|||
161746101|NCT00615914|584110346|FG000|Overall Study|Physician Decision|4|||
161746102|NCT00615914|584110346|FG000|Overall Study|No data was collected.|65|||
161746103|NCT00615914|584110346|FG000|Overall Study|No treatment|2|||
161746104|NCT00615914|584110346|FG000|Overall Study|Irregularly enrolled patients|10|||
161746105|NCT03673956|584110347|FG000|Overall Study|Lost to Follow-up|1|||
161746106|NCT03673956|584110348|FG001|Overall Study|Lost to Follow-up|0|||
161746107|NCT03673956|584110349|FG002|Overall Study|Lost to Follow-up|0|||
161746108|NCT03673956|584110350|FG003|Overall Study|Lost to Follow-up|0|||
161746109|NCT03673956|584110347|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
161746110|NCT03673956|584110348|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
161746111|NCT03673956|584110349|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
161746112|NCT03673956|584110350|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
161746113|NCT03037307|584110353|FG000|Period 1|Did Not Meet Study Criteria|0|||
161746114|NCT03037307|584110354|FG001|Period 1|Did Not Meet Study Criteria|0|||
161746115|NCT03037307|584110355|FG002|Period 1|Did Not Meet Study Criteria|0|||
161746116|NCT03037307|584110356|FG003|Period 1|Did Not Meet Study Criteria|1|||
161746117|NCT03037307|584110357|FG004|Period 1|Did Not Meet Study Criteria|0|||
161746118|NCT03037307|584110358|FG005|Period 1|Did Not Meet Study Criteria|0|||
161746119|NCT04397796|584110359|FG000|Overall Study|Death|3|||
161746120|NCT04397796|584110360|FG001|Overall Study|Death|1|||
161746121|NCT00802867|584110363|FG000|Overall Study|Lost to Follow-up|6|||
161746122|NCT00802867|584110363|FG000|Overall Study|Protocol Violation|6|||
161746123|NCT00802867|584110363|FG000|Overall Study|Withdrawal by Subject|1|||
161746124|NCT00770224|584110366|FG000|Step 1: Induction|Adverse Event|3|||
161746125|NCT00770224|584110367|FG001|Step 1: Induction|Adverse Event|0|||
161746126|NCT00770224|584110366|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
161746127|NCT00770224|584110367|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
161746128|NCT00770224|584110366|FG000|Step 1: Induction|Other reason not protocol specified|2|||
161746129|NCT00770224|584110367|FG001|Step 1: Induction|Other reason not protocol specified|0|||
161746130|NCT00770224|584110366|FG000|Step 1: Induction|Ineligible|2|||
161746131|NCT00770224|584110367|FG001|Step 1: Induction|Ineligible|0|||
161746132|NCT00770224|584110366|FG000|Step 1: Induction|No protocol treatment given|1|||
161746133|NCT00770224|584110367|FG001|Step 1: Induction|No protocol treatment given|0|||
161746134|NCT00770224|584110366|FG000|Step 2: Maintenance|Adverse Event|0|||
161746135|NCT00770224|584110367|FG001|Step 2: Maintenance|Adverse Event|10|||
161746136|NCT00770224|584110366|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
161746137|NCT00770224|584110367|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
161746138|NCT00770224|584110366|FG000|Step 2: Maintenance|Progression/relapse|0|||
161746139|NCT00770224|584110367|FG001|Step 2: Maintenance|Progression/relapse|1|||
161746140|NCT00770224|584110366|FG000|Step 2: Maintenance|Death|0|||
161746141|NCT00770224|584110367|FG001|Step 2: Maintenance|Death|2|||
161746142|NCT00770224|584110366|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
161746143|NCT00770224|584110367|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
161746144|NCT00770224|584110366|FG000|Step 2: Maintenance|Ineligible|0|||
161746145|NCT00770224|584110367|FG001|Step 2: Maintenance|Ineligible|2|||
161746146|NCT04737759|584110368|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
161746147|NCT04737759|584110369|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
161746148|NCT04737759|584110368|FG000|Overall Study|Death|2|||
161746149|NCT04737759|584110369|FG001|Overall Study|Death|0|||
161746150|NCT04737759|584110368|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
161746151|NCT04737759|584110369|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
161746152|NCT04737759|584110368|FG000|Overall Study|Lost to Follow-up|4|||
161746153|NCT04737759|584110369|FG001|Overall Study|Lost to Follow-up|12|||
161746154|NCT01484561|584110370|FG000|Overall Study|Lack of Efficacy|3|||
161746155|NCT01484561|584110371|FG001|Overall Study|Lack of Efficacy|1|||
161746156|NCT01484561|584110370|FG000|Overall Study|Lost to Follow-up|1|||
161746157|NCT01484561|584110371|FG001|Overall Study|Lost to Follow-up|0|||
161746158|NCT01484561|584110370|FG000|Overall Study|Withdrawal by Subject|3|||
161746159|NCT01484561|584110371|FG001|Overall Study|Withdrawal by Subject|0|||
161746160|NCT01484561|584110370|FG000|Overall Study|Other|1|||
161746161|NCT01484561|584110371|FG001|Overall Study|Other|1|||
161746162|NCT01484561|584110370|FG000|Overall Study|Adverse Event|1|||
161746163|NCT01484561|584110371|FG001|Overall Study|Adverse Event|4|||
161746164|NCT01112982|584110372|FG000|Overall Study|Withdrawal by Subject|1|||
161746165|NCT01112982|584110372|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
161746166|NCT03371251|584110373|FG000|Overall Study|Withdrawal by Subject|1|||
161746167|NCT03371251|584110374|FG001|Overall Study|Withdrawal by Subject|0|||
161746168|NCT03371251|584110375|FG002|Overall Study|Withdrawal by Subject|1|||
161746169|NCT03371251|584110376|FG003|Overall Study|Withdrawal by Subject|0|||
161746170|NCT03371251|584110377|FG004|Overall Study|Withdrawal by Subject|2|||
161746171|NCT03371251|584110378|FG005|Overall Study|Withdrawal by Subject|2|||
161746172|NCT03371251|584110373|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
161746173|NCT03371251|584110374|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
161746174|NCT03371251|584110375|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
161746175|NCT03371251|584110376|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
161746176|NCT03371251|584110377|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
161746177|NCT03371251|584110378|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
161746178|NCT03371251|584110373|FG000|Overall Study|Adverse Event|0|||
161746179|NCT03371251|584110374|FG001|Overall Study|Adverse Event|0|||
161746180|NCT03371251|584110375|FG002|Overall Study|Adverse Event|0|||
161746181|NCT03371251|584110376|FG003|Overall Study|Adverse Event|0|||
161746182|NCT03371251|584110377|FG004|Overall Study|Adverse Event|1|||
161746183|NCT03371251|584110378|FG005|Overall Study|Adverse Event|0|||
161746184|NCT03371251|584110373|FG000|Overall Study|Decision by Sponsor|0|||
161746185|NCT03371251|584110374|FG001|Overall Study|Decision by Sponsor|0|||
161746186|NCT03371251|584110375|FG002|Overall Study|Decision by Sponsor|0|||
161746187|NCT03371251|584110376|FG003|Overall Study|Decision by Sponsor|0|||
161746188|NCT03371251|584110377|FG004|Overall Study|Decision by Sponsor|2|||
161746189|NCT03371251|584110378|FG005|Overall Study|Decision by Sponsor|0|||
161746190|NCT00294684|584110381|FG000|Overall Study|Lost to Follow-up|5|||
161746191|NCT00294684|584110382|FG001|Overall Study|Lost to Follow-up|8|||
161746192|NCT02260388|584110385|FG000|Overall Study|Lost to Follow-up|2|||
161746193|NCT02260388|584110386|FG001|Overall Study|Lost to Follow-up|8|||
161746194|NCT02260388|584110387|FG002|Overall Study|Lost to Follow-up|3|||
161746195|NCT02260388|584110388|FG003|Overall Study|Lost to Follow-up|4|||
161746196|NCT05425719|584110389|FG000|Overall Study|Lost to Follow-up|4|||
161746197|NCT05425719|584110390|FG001|Overall Study|Lost to Follow-up|0|||
161746198|NCT05425719|584110389|FG000|Overall Study|Withdrew consent|1|||
161746199|NCT05425719|584110390|FG001|Overall Study|Withdrew consent|1|||
161746200|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
161746201|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
161746202|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
161746203|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
161746204|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
161746205|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
161746206|NCT00996593|584110391|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
161746207|NCT00996593|584110391|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
161746208|NCT00996593|584110391|FG000|Long-Term Follow-Up|Site Closed|1|||
161746209|NCT01033487|584110392|FG000|Fourth Intervention Period|Adverse Event|0|||
161746210|NCT01033487|584110393|FG001|Fourth Intervention Period|Adverse Event|0|||
161746211|NCT01033487|584110394|FG002|Fourth Intervention Period|Adverse Event|0|||
161746212|NCT01033487|584110395|FG003|Fourth Intervention Period|Adverse Event|0|||
161746213|NCT01033487|584110396|FG004|Fourth Intervention Period|Adverse Event|0|||
161746214|NCT01033487|584110397|FG005|Fourth Intervention Period|Adverse Event|0|||
161746215|NCT01033487|584110398|FG006|Fourth Intervention Period|Adverse Event|0|||
161746216|NCT01033487|584110399|FG007|Fourth Intervention Period|Adverse Event|0|||
161746217|NCT01033487|584110400|FG008|Fourth Intervention Period|Adverse Event|1|||
161746218|NCT01033487|584110401|FG009|Fourth Intervention Period|Adverse Event|0|||
161746219|NCT02849626|584110402|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
161746220|NCT02849626|584110403|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
161746221|NCT02849626|584110404|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
161746222|NCT02849626|584110405|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
161746223|NCT02849626|584110402|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
161746224|NCT02849626|584110403|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
161746225|NCT02849626|584110404|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
161746226|NCT02849626|584110405|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
161746227|NCT02849626|584110402|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
161746228|NCT02849626|584110403|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
161746229|NCT02849626|584110404|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
161746230|NCT02849626|584110405|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
161746231|NCT02849626|584110402|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
161746232|NCT02849626|584110403|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
161746233|NCT02849626|584110404|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
161746234|NCT02849626|584110405|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
161746235|NCT02849626|584110402|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
161746236|NCT02849626|584110403|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
161746237|NCT02849626|584110404|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
161746238|NCT02849626|584110405|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
161746239|NCT02849626|584110402|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
161746240|NCT02849626|584110403|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
161746241|NCT02849626|584110404|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
161746242|NCT02849626|584110405|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
161746243|NCT02849626|584110402|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
161746244|NCT02849626|584110403|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
161746245|NCT02849626|584110404|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
161746246|NCT02849626|584110405|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
161746247|NCT02849626|584110402|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
161746248|NCT02849626|584110403|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
161746249|NCT02849626|584110404|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
161746250|NCT02849626|584110405|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
161746251|NCT02849626|584110402|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
161746252|NCT02849626|584110403|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
161746253|NCT02849626|584110404|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
161746254|NCT02849626|584110405|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
161746255|NCT02849626|584110402|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
161746256|NCT02849626|584110403|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
161746257|NCT02849626|584110404|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
161746258|NCT02849626|584110405|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
161746259|NCT02849626|584110402|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
161746260|NCT02849626|584110403|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
161746261|NCT02849626|584110404|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
161746262|NCT02849626|584110405|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
161746263|NCT00889681|584110406|FG000|Overall Study|Not meeting qualification Criteria|2|||
161746264|NCT00889681|584110406|FG000|Overall Study|Insurance disapproval|1|||
161746265|NCT01185704|584110407|FG000|Overall Study|Randomized but not treated|3|||
161746266|NCT01185704|584110408|FG001|Overall Study|Randomized but not treated|3|||
161746267|NCT01185704|584110407|FG000|Overall Study|Lack of ovarian response|5|||
161746268|NCT01185704|584110408|FG001|Overall Study|Lack of ovarian response|1|||
161746269|NCT01185704|584110407|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
161746270|NCT01185704|584110408|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
161746271|NCT01185704|584110407|FG000|Overall Study|Ectopic pregnancy|0|||
161746272|NCT01185704|584110408|FG001|Overall Study|Ectopic pregnancy|1|||
161746273|NCT00871572|584110409|FG000|Overall Study|Adverse Event|0|||
161746274|NCT00871572|584110410|FG001|Overall Study|Adverse Event|2|||
161746275|NCT00871572|584110411|FG002|Overall Study|Adverse Event|0|||
161746276|NCT00871572|584110412|FG003|Overall Study|Adverse Event|3|||
161746277|NCT00871572|584110409|FG000|Overall Study|Investigator Decision|0|||
161746278|NCT00871572|584110410|FG001|Overall Study|Investigator Decision|1|||
161746279|NCT00871572|584110411|FG002|Overall Study|Investigator Decision|0|||
161746280|NCT00871572|584110412|FG003|Overall Study|Investigator Decision|1|||
161746281|NCT00871572|584110409|FG000|Overall Study|Lost to Follow-up|0|||
161746282|NCT00871572|584110410|FG001|Overall Study|Lost to Follow-up|1|||
161746283|NCT00871572|584110411|FG002|Overall Study|Lost to Follow-up|0|||
161746284|NCT00871572|584110412|FG003|Overall Study|Lost to Follow-up|1|||
161746285|NCT00871572|584110409|FG000|Overall Study|Protocol Violation|0|||
161746286|NCT00871572|584110410|FG001|Overall Study|Protocol Violation|0|||
161746287|NCT00871572|584110411|FG002|Overall Study|Protocol Violation|1|||
161746288|NCT00871572|584110412|FG003|Overall Study|Protocol Violation|1|||
161746289|NCT00871572|584110409|FG000|Overall Study|Sponsor Decision|1|||
161746290|NCT00871572|584110410|FG001|Overall Study|Sponsor Decision|0|||
161746291|NCT00871572|584110411|FG002|Overall Study|Sponsor Decision|0|||
161746292|NCT00871572|584110412|FG003|Overall Study|Sponsor Decision|0|||
161746293|NCT00871572|584110409|FG000|Overall Study|Withdrawal by Subject|1|||
161746294|NCT00871572|584110410|FG001|Overall Study|Withdrawal by Subject|2|||
161746295|NCT00871572|584110411|FG002|Overall Study|Withdrawal by Subject|3|||
161746296|NCT00871572|584110412|FG003|Overall Study|Withdrawal by Subject|1|||
161746297|NCT04176445|584110417|FG000|Overall Study|Adverse Event|0|||
161746298|NCT04176445|584110418|FG001|Overall Study|Adverse Event|1|||
161746299|NCT04176445|584110417|FG000|Overall Study|change plans weaning after first intervention|0|||
161746300|NCT04176445|584110418|FG001|Overall Study|change plans weaning after first intervention|1|||
161746301|NCT00187889|584110419|FG000|Overall Study|Withdrawal by Subject|6|||
161746302|NCT00187889|584110420|FG001|Overall Study|Withdrawal by Subject|4|||
161746303|NCT04046341|584110421|FG000|Overall Study|Lost to Follow-up|2|||
161746304|NCT04046341|584110421|FG000|Overall Study|Withdrawal by Subject|1|||
161966972|NCT03989349|584925763|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
161746305|NCT04377672|584110422|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
161746306|NCT03954444|584110423|FG000|Overall Study|Withdrawal by Subject|5|||
161746307|NCT03954444|584110424|FG001|Overall Study|Withdrawal by Subject|5|||
161746308|NCT03954444|584110425|FG002|Overall Study|Withdrawal by Subject|5|||
161746309|NCT03954444|584110423|FG000|Overall Study|Adverse Event|1|||
161746310|NCT03954444|584110424|FG001|Overall Study|Adverse Event|3|||
161746311|NCT03954444|584110425|FG002|Overall Study|Adverse Event|2|||
161746312|NCT03954444|584110423|FG000|Overall Study|Protocol Violation|0|||
161746313|NCT03954444|584110424|FG001|Overall Study|Protocol Violation|3|||
161746314|NCT03954444|584110425|FG002|Overall Study|Protocol Violation|5|||
161842810|NCT02393248|584470006|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842811|NCT02393248|584470007|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842812|NCT02393248|584470008|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842813|NCT02393248|584470009|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842814|NCT02393248|584470010|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842815|NCT02393248|584470011|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842816|NCT02393248|584470012|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842817|NCT02393248|584470013|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842818|NCT02393248|584470014|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842819|NCT02393248|584470015|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842820|NCT02393248|584470016|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842821|NCT02393248|584470017|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842822|NCT02393248|584470018|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842823|NCT02393248|584470019|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842824|NCT02393248|584470020|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842825|NCT02393248|584470021|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842826|NCT02393248|584470022|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842827|NCT02393248|584470023|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842828|NCT02393248|584470024|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161842829|NCT02393248|584470000|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
161842830|NCT02393248|584470001|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
161842831|NCT02393248|584470002|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
161842832|NCT02393248|584470003|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
161842833|NCT02393248|584470004|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
161842834|NCT02393248|584470005|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
161842835|NCT02393248|584470006|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
162032613|NCT04761627|585177443|FG000|Run-in Period|Death|1|||
161746315|NCT03954444|584110423|FG000|Overall Study|Use of prohibited therapy|1|||
161746316|NCT03954444|584110424|FG001|Overall Study|Use of prohibited therapy|1|||
161746317|NCT03954444|584110425|FG002|Overall Study|Use of prohibited therapy|2|||
161746318|NCT03954444|584110423|FG000|Overall Study|Lost to Follow-up|1|||
161746319|NCT03954444|584110424|FG001|Overall Study|Lost to Follow-up|0|||
161746320|NCT03954444|584110425|FG002|Overall Study|Lost to Follow-up|1|||
161746321|NCT03954444|584110423|FG000|Overall Study|Non-compliant with study drug application|2|||
161746322|NCT03954444|584110424|FG001|Overall Study|Non-compliant with study drug application|2|||
161746323|NCT03954444|584110425|FG002|Overall Study|Non-compliant with study drug application|0|||
161746324|NCT03954444|584110423|FG000|Overall Study|Administrative reasons|0|||
161746325|NCT03954444|584110424|FG001|Overall Study|Administrative reasons|0|||
161746326|NCT03954444|584110425|FG002|Overall Study|Administrative reasons|1|||
161746327|NCT03954444|584110423|FG000|Overall Study|Miscellaneous|3|||
161746328|NCT03954444|584110424|FG001|Overall Study|Miscellaneous|2|||
161746329|NCT03954444|584110425|FG002|Overall Study|Miscellaneous|1|||
161746330|NCT02447458|584110426|FG000|Overall Study|Other|0|||
161746331|NCT02447458|584110427|FG001|Overall Study|Other|0|||
161746332|NCT02447458|584110428|FG002|Overall Study|Other|1|||
161746333|NCT02447458|584110429|FG003|Overall Study|Other|0|||
161746334|NCT02447458|584110430|FG004|Overall Study|Other|0|||
161746335|NCT02447458|584110431|FG005|Overall Study|Other|0|||
161746336|NCT00405652|584110432|FG000|Overall Study|Adverse Event|4|||
161746337|NCT00435994|584110435|FG000|Overall Study|Lost to Follow-up|7|||
161746338|NCT00435994|584110436|FG001|Overall Study|Lost to Follow-up|0|||
161746339|NCT00435994|584110437|FG002|Overall Study|Lost to Follow-up|0|||
161746340|NCT03505749|584110438|FG000|Overall Study|Lost to Follow-up|7|||
161746341|NCT03505749|584110439|FG001|Overall Study|Lost to Follow-up|11|||
161746342|NCT03505749|584110438|FG000|Overall Study|Withdrawal by Subject|6|||
161746343|NCT03505749|584110439|FG001|Overall Study|Withdrawal by Subject|0|||
161746344|NCT03505749|584110438|FG000|Overall Study|Discharged from treatment|3|||
161746345|NCT03505749|584110439|FG001|Overall Study|Discharged from treatment|6|||
161746346|NCT03846219|584110441|FG000|Overall Study|Withdrawal by Subject|3|||
161746347|NCT03846219|584110442|FG001|Overall Study|Withdrawal by Subject|2|||
161746348|NCT03846219|584110443|FG002|Overall Study|Withdrawal by Subject|2|||
161746349|NCT03846219|584110441|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
161746350|NCT03846219|584110442|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
161746351|NCT03846219|584110443|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
161842836|NCT02393248|584470007|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
161842837|NCT02393248|584470008|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
161842838|NCT02393248|584470009|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
162032614|NCT04761627|585177444|FG001|Run-in Period|Death|0|||
161746352|NCT03846219|584110441|FG000|Overall Study|Physician Decision|0|||
161746353|NCT03846219|584110442|FG001|Overall Study|Physician Decision|0|||
161746354|NCT03846219|584110443|FG002|Overall Study|Physician Decision|2|||
161746355|NCT05109702|584110444|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
161746356|NCT05109702|584110445|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
162032615|NCT04761627|585177445|FG002|Run-in Period|Death|0|||
161746357|NCT05109702|584110446|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
161746358|NCT05109702|584110444|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
161746359|NCT05109702|584110445|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
161746360|NCT05109702|584110446|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
161746361|NCT05109702|584110444|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
161746362|NCT05109702|584110445|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
161746363|NCT05109702|584110446|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
161746364|NCT05109702|584110444|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
161746365|NCT05109702|584110445|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
161746366|NCT05109702|584110446|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
161746367|NCT05109702|584110444|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
161746368|NCT05109702|584110445|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
161746369|NCT05109702|584110446|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
161746370|NCT03094832|584110451|FG000|Overall Study|Lost to Follow-up|0|||
161746371|NCT03094832|584110452|FG001|Overall Study|Lost to Follow-up|0|||
161746372|NCT03094832|584110453|FG002|Overall Study|Lost to Follow-up|0|||
161746373|NCT03094832|584110454|FG003|Overall Study|Lost to Follow-up|1|||
161746374|NCT03094832|584110455|FG004|Overall Study|Lost to Follow-up|1|||
161746375|NCT03094832|584110451|FG000|Overall Study|Death|1|||
161746376|NCT03094832|584110452|FG001|Overall Study|Death|0|||
161746377|NCT03094832|584110453|FG002|Overall Study|Death|0|||
161746378|NCT03094832|584110454|FG003|Overall Study|Death|0|||
161746379|NCT03094832|584110455|FG004|Overall Study|Death|0|||
161746380|NCT03094832|584110451|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161746381|NCT03094832|584110452|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161746382|NCT03094832|584110453|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161746383|NCT03094832|584110454|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161746384|NCT03094832|584110455|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161746385|NCT03094832|584110451|FG000|Overall Study|Other|13|||
161746386|NCT03094832|584110452|FG001|Overall Study|Other|20|||
161746387|NCT03094832|584110453|FG002|Overall Study|Other|1|||
161746388|NCT03094832|584110454|FG003|Overall Study|Other|7|||
161746389|NCT03094832|584110455|FG004|Overall Study|Other|1|||
161746390|NCT01392378|584110458|FG000|Infant Series|Adverse Event|0|||
161746391|NCT01392378|584110459|FG001|Infant Series|Adverse Event|0|||
161746392|NCT01392378|584110460|FG002|Infant Series|Adverse Event|0|||
161746393|NCT01392378|584110461|FG003|Infant Series|Adverse Event|1|||
161746394|NCT01392378|584110462|FG004|Infant Series|Adverse Event|0|||
161746395|NCT01392378|584110458|FG000|Infant Series|Lost to Follow-up|0|||
161746396|NCT01392378|584110459|FG001|Infant Series|Lost to Follow-up|0|||
161746397|NCT01392378|584110460|FG002|Infant Series|Lost to Follow-up|0|||
161746398|NCT01392378|584110461|FG003|Infant Series|Lost to Follow-up|1|||
161746399|NCT01392378|584110462|FG004|Infant Series|Lost to Follow-up|0|||
161746400|NCT01392378|584110458|FG000|Infant Series|Protocol Violation|0|||
161746401|NCT01392378|584110459|FG001|Infant Series|Protocol Violation|1|||
161746402|NCT01392378|584110460|FG002|Infant Series|Protocol Violation|0|||
161746403|NCT01392378|584110461|FG003|Infant Series|Protocol Violation|0|||
161746404|NCT01392378|584110462|FG004|Infant Series|Protocol Violation|0|||
161746405|NCT01392378|584110458|FG000|Infant Series|Withdrawal by Parent|4|||
161746406|NCT01392378|584110459|FG001|Infant Series|Withdrawal by Parent|1|||
161746407|NCT01392378|584110460|FG002|Infant Series|Withdrawal by Parent|0|||
161746408|NCT01392378|584110461|FG003|Infant Series|Withdrawal by Parent|0|||
161746409|NCT01392378|584110462|FG004|Infant Series|Withdrawal by Parent|0|||
161746410|NCT01392378|584110458|FG000|After Infant Series|Lost to Follow-up|0|||
161746411|NCT01392378|584110459|FG001|After Infant Series|Lost to Follow-up|0|||
161746412|NCT01392378|584110460|FG002|After Infant Series|Lost to Follow-up|1|||
161746413|NCT01392378|584110461|FG003|After Infant Series|Lost to Follow-up|0|||
161746414|NCT01392378|584110462|FG004|After Infant Series|Lost to Follow-up|0|||
161746415|NCT01392378|584110458|FG000|After Infant Series|Withdrawal by Parent|0|||
161746416|NCT01392378|584110459|FG001|After Infant Series|Withdrawal by Parent|1|||
161746417|NCT01392378|584110460|FG002|After Infant Series|Withdrawal by Parent|1|||
161746418|NCT01392378|584110461|FG003|After Infant Series|Withdrawal by Parent|0|||
161746419|NCT01392378|584110462|FG004|After Infant Series|Withdrawal by Parent|1|||
161746420|NCT01392378|584110458|FG000|Toddler Dose|Lost to Follow-up|0|||
161746421|NCT01392378|584110459|FG001|Toddler Dose|Lost to Follow-up|0|||
161746422|NCT01392378|584110460|FG002|Toddler Dose|Lost to Follow-up|0|||
161746423|NCT01392378|584110461|FG003|Toddler Dose|Lost to Follow-up|1|||
161746424|NCT01392378|584110462|FG004|Toddler Dose|Lost to Follow-up|0|||
161746425|NCT01392378|584110458|FG000|Toddler Dose|Withdrawal by Parent|0|||
161746426|NCT01392378|584110459|FG001|Toddler Dose|Withdrawal by Parent|1|||
161746427|NCT01392378|584110460|FG002|Toddler Dose|Withdrawal by Parent|0|||
161746428|NCT01392378|584110461|FG003|Toddler Dose|Withdrawal by Parent|1|||
161746429|NCT01392378|584110462|FG004|Toddler Dose|Withdrawal by Parent|1|||
161746430|NCT02322411|584110465|FG000|Overall Study|Lost to Follow-up|4|||
161746431|NCT02322411|584110466|FG001|Overall Study|Lost to Follow-up|7|||
161746432|NCT02322411|584110465|FG000|Overall Study|Withdrawal by Subject|1|||
161746433|NCT02322411|584110466|FG001|Overall Study|Withdrawal by Subject|0|||
161746434|NCT00788697|584110467|FG000|Overall Study|No study drug administered|12|||
161746435|NCT00788697|584110467|FG000|Overall Study|Training Patients|74|||
161746436|NCT00788697|584110467|FG000|Overall Study|no truth standard procedure available|5|||
161746437|NCT00788697|584110467|FG000|Overall Study|Technically inadequate truth standard|1|||
161746438|NCT00788697|584110467|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
161746439|NCT01998880|584110469|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
161746440|NCT01998880|584110470|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
161746441|NCT01998880|584110469|FG000|Overall Study|Disease Progression|1|||
161746442|NCT01998880|584110470|FG001|Overall Study|Disease Progression|8|||
161746443|NCT01998880|584110469|FG000|Overall Study|Withdrew Consent|2|||
161746444|NCT01998880|584110470|FG001|Overall Study|Withdrew Consent|1|||
161746445|NCT01998880|584110469|FG000|Overall Study|Death|3|||
161966973|NCT03989349|584925764|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
161746446|NCT01998880|584110470|FG001|Overall Study|Death|6|||
161746447|NCT01998880|584110469|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161746448|NCT01998880|584110470|FG001|Overall Study|Insufficient Therapeutic Response|5|||
161746449|NCT01998880|584110469|FG000|Overall Study|Administrative/Other|1|||
161746450|NCT01998880|584110470|FG001|Overall Study|Administrative/Other|1|||
161746451|NCT01998880|584110469|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
161746452|NCT01998880|584110470|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
161746453|NCT01998880|584110469|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
161746454|NCT01998880|584110470|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
161746455|NCT01998880|584110469|FG000|Overall Study|Did Not Receive Treatment|3|||
161746456|NCT01998880|584110470|FG001|Overall Study|Did Not Receive Treatment|2|||
161746457|NCT02248857|584110471|FG000|3 Month|Withdrawal by Subject|9|||
161746458|NCT02248857|584110472|FG001|3 Month|Withdrawal by Subject|3|||
161746459|NCT02248857|584110473|FG002|3 Month|Withdrawal by Subject|4|||
161746460|NCT02248857|584110471|FG000|3 Month|Unable to reach for 3 month|35|||
161746461|NCT02248857|584110472|FG001|3 Month|Unable to reach for 3 month|29|||
161746462|NCT02248857|584110473|FG002|3 Month|Unable to reach for 3 month|26|||
161746463|NCT02248857|584110471|FG000|3 Month|Partially completed, unable to finish|2|||
161746464|NCT02248857|584110472|FG001|3 Month|Partially completed, unable to finish|2|||
161746465|NCT02248857|584110473|FG002|3 Month|Partially completed, unable to finish|1|||
161746466|NCT02248857|584110471|FG000|6 Month|Lost to Follow-up|27|||
161746467|NCT02248857|584110472|FG001|6 Month|Lost to Follow-up|26|||
161746468|NCT02248857|584110473|FG002|6 Month|Lost to Follow-up|15|||
161746469|NCT02248857|584110471|FG000|6 Month|Partially completed, unable to finish|0|||
161746470|NCT02248857|584110472|FG001|6 Month|Partially completed, unable to finish|1|||
161746471|NCT02248857|584110473|FG002|6 Month|Partially completed, unable to finish|0|||
161746472|NCT02248857|584110471|FG000|6 Month|Withdrawal by Subject|0|||
161746473|NCT02248857|584110472|FG001|6 Month|Withdrawal by Subject|2|||
161746474|NCT02248857|584110473|FG002|6 Month|Withdrawal by Subject|2|||
161746475|NCT02248857|584110471|FG000|6 Month|Death|1|||
161746476|NCT02248857|584110472|FG001|6 Month|Death|0|||
161746477|NCT02248857|584110473|FG002|6 Month|Death|0|||
161746478|NCT02671461|584110474|FG000|Treatment|Adverse Event|0|||
161746479|NCT02671461|584110475|FG001|Treatment|Adverse Event|0|||
161746480|NCT02671461|584110476|FG002|Treatment|Adverse Event|1|||
161746481|NCT02671461|584110474|FG000|Treatment|Administrative Reason by Sponsor|1|||
161746482|NCT02671461|584110475|FG001|Treatment|Administrative Reason by Sponsor|3|||
161746483|NCT02671461|584110476|FG002|Treatment|Administrative Reason by Sponsor|4|||
161746484|NCT02671461|584110474|FG000|Treatment|Randomized, not treated|1|||
161746485|NCT02671461|584110475|FG001|Treatment|Randomized, not treated|0|||
161746486|NCT02671461|584110476|FG002|Treatment|Randomized, not treated|0|||
161746487|NCT02671461|584110474|FG000|Follow-up|Withdrawal by Subject|1|||
161842839|NCT02393248|584470010|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
161966974|NCT03989349|584925765|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
162032616|NCT04761627|585177443|FG000|Run-in Period|Required alternative therapy|2|||
161746488|NCT02671461|584110475|FG001|Follow-up|Withdrawal by Subject|0|||
161746489|NCT02671461|584110476|FG002|Follow-up|Withdrawal by Subject|0|||
161746490|NCT02671461|584110474|FG000|Follow-up|Lost to Follow-up|0|||
161746491|NCT02671461|584110475|FG001|Follow-up|Lost to Follow-up|0|||
161746492|NCT02671461|584110476|FG002|Follow-up|Lost to Follow-up|1|||
161746493|NCT02671461|584110474|FG000|Follow-up|Administrative Reason by Sponsor|0|||
161746494|NCT02671461|584110475|FG001|Follow-up|Administrative Reason by Sponsor|1|||
161746495|NCT02671461|584110476|FG002|Follow-up|Administrative Reason by Sponsor|0|||
161746496|NCT02261883|584110477|FG000|Overall Study|Death|3|||
161746497|NCT02261883|584110478|FG001|Overall Study|Death|2|||
161746498|NCT02261883|584110477|FG000|Overall Study|Physician Decision|1|||
161746499|NCT02261883|584110478|FG001|Overall Study|Physician Decision|0|||
161746500|NCT02261883|584110477|FG000|Overall Study|Protocol Violation|1|||
161746501|NCT02261883|584110478|FG001|Overall Study|Protocol Violation|0|||
161746502|NCT02261883|584110477|FG000|Overall Study|Withdrawal by Subject|0|||
161746503|NCT02261883|584110478|FG001|Overall Study|Withdrawal by Subject|1|||
161746504|NCT02261883|584110477|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
161746505|NCT02261883|584110478|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
161746506|NCT00367432|584110480|FG000|First Period (16 Weeks)|Adverse Event|6|||
161746507|NCT00367432|584110481|FG001|First Period (16 Weeks)|Adverse Event|0|||
161746508|NCT00367432|584110480|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
161746509|NCT00367432|584110481|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
161746510|NCT00367432|584110480|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
161746511|NCT00367432|584110481|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
161746512|NCT00367432|584110480|FG000|First Period (16 Weeks)|Other Reason|2|||
161746513|NCT00367432|584110481|FG001|First Period (16 Weeks)|Other Reason|0|||
161746514|NCT00367432|584110480|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
161746515|NCT00367432|584110481|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
161746516|NCT00367432|584110480|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
161746517|NCT00367432|584110481|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
161746518|NCT00367432|584110480|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
161746519|NCT00367432|584110481|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
161746520|NCT00367432|584110480|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
161746521|NCT00367432|584110481|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
161746522|NCT00367432|584110480|FG000|Second Period (up to 54 Months)|Other Reason|6|||
161746523|NCT00367432|584110481|FG001|Second Period (up to 54 Months)|Other Reason|2|||
161746524|NCT00903370|584110482|FG000|Overall Study|Death|13|||
161746525|NCT00903370|584110483|FG001|Overall Study|Death|10|||
161746526|NCT00903370|584110482|FG000|Overall Study|Withdrawal by Subject|9|||
161746527|NCT00903370|584110483|FG001|Overall Study|Withdrawal by Subject|6|||
161746528|NCT00903370|584110482|FG000|Overall Study|Lost to Follow-up|6|||
161746529|NCT00903370|584110483|FG001|Overall Study|Lost to Follow-up|8|||
161746530|NCT00014911|584110484|FG000|Overall Study|Adverse Event|1|||
161746531|NCT00014911|584110484|FG000|Overall Study|Lost to Follow-up|1|||
161746532|NCT00014911|584110484|FG000|Overall Study|Withdrawal by Subject|6|||
161746533|NCT00014911|584110484|FG000|Overall Study|Unknown Reasons|2|||
161746534|NCT00014911|584110484|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
161746535|NCT01105936|584112564|FG000|Period 1|Adverse Event|0|||
161746536|NCT01105936|584112565|FG001|Period 1|Adverse Event|0|||
161746537|NCT01105936|584112566|FG002|Period 1|Adverse Event|0|||
161746538|NCT01105936|584112567|FG003|Period 1|Adverse Event|1|||
161746539|NCT01105936|584112564|FG000|Period 2|Adverse Event|1|||
161746540|NCT01105936|584112565|FG001|Period 2|Adverse Event|0|||
161746541|NCT01105936|584112566|FG002|Period 2|Adverse Event|0|||
161746542|NCT01105936|584112567|FG003|Period 2|Adverse Event|0|||
161746543|NCT01105936|584112564|FG000|Period 3|Protocol Violation|0|||
161746544|NCT01105936|584112565|FG001|Period 3|Protocol Violation|2|||
161746545|NCT01105936|584112566|FG002|Period 3|Protocol Violation|0|||
161746546|NCT01105936|584112567|FG003|Period 3|Protocol Violation|0|||
161746547|NCT03170258|584112570|FG000|Overall Study|Physician Decision|4|||
161746548|NCT03170258|584112571|FG001|Overall Study|Physician Decision|0|||
161746549|NCT03170258|584112570|FG000|Overall Study|Equipment issues|1|||
161746550|NCT03170258|584112571|FG001|Overall Study|Equipment issues|0|||
161746551|NCT03170258|584112570|FG000|Overall Study|Medication|1|||
161746552|NCT03170258|584112571|FG001|Overall Study|Medication|0|||
161966975|NCT03989349|584925766|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
161966976|NCT03989349|584925767|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
161966977|NCT03989349|584925762|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161966978|NCT03989349|584925763|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161966979|NCT03989349|584925764|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
161966980|NCT03989349|584925765|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
161966981|NCT03989349|584925766|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
161966982|NCT03989349|584925767|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
161966983|NCT03989349|584925762|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161966984|NCT03989349|584925763|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161746553|NCT03170258|584112570|FG000|Overall Study|Sleep issues|1|||
161746554|NCT03170258|584112571|FG001|Overall Study|Sleep issues|0|||
161746555|NCT02471586|584112572|FG000|Overall Study|Lost to Follow-up|3|||
161746556|NCT02471586|584112573|FG001|Overall Study|Lost to Follow-up|8|||
161746557|NCT02471586|584112574|FG002|Overall Study|Lost to Follow-up|4|||
161746558|NCT02471586|584112572|FG000|Overall Study|Death|2|||
161746559|NCT02471586|584112573|FG001|Overall Study|Death|2|||
161746560|NCT02471586|584112574|FG002|Overall Study|Death|0|||
161746561|NCT01510028|584112577|FG000|Overall Study|Lack of Efficacy|1|||
161746562|NCT01510028|584112578|FG001|Overall Study|Lack of Efficacy|0|||
161746563|NCT01510028|584112579|FG002|Overall Study|Lack of Efficacy|0|||
161746564|NCT01510028|584112580|FG003|Overall Study|Lack of Efficacy|0|||
161746565|NCT05091918|584112581|FG000|Overall Study|Adverse Event|1|||
161746566|NCT05091918|584112581|FG000|Overall Study|Withdrawal by Subject|81|||
161746567|NCT01100658|584112586|FG000|Overall Study|Withdrawal by Subject|1|||
161746568|NCT00239356|584112587|FG000|Overall Study|Lack of Efficacy|1|||
161746569|NCT00239356|584112588|FG001|Overall Study|Lack of Efficacy|0|||
161746570|NCT00239356|584112587|FG000|Overall Study|Adverse Event|6|||
161746571|NCT00239356|584112588|FG001|Overall Study|Adverse Event|0|||
161746572|NCT00239356|584112587|FG000|Overall Study|Withdrawal by Subject|15|||
161746573|NCT00239356|584112588|FG001|Overall Study|Withdrawal by Subject|6|||
161746574|NCT00239356|584112587|FG000|Overall Study|Lost to Follow-up|3|||
161746575|NCT00239356|584112588|FG001|Overall Study|Lost to Follow-up|0|||
161746576|NCT00239356|584112587|FG000|Overall Study|poor/non-compliance|2|||
161746577|NCT00239356|584112588|FG001|Overall Study|poor/non-compliance|0|||
161746578|NCT00239356|584112587|FG000|Overall Study|Pregnancy|1|||
161746579|NCT00239356|584112588|FG001|Overall Study|Pregnancy|0|||
161746580|NCT00239356|584112587|FG000|Overall Study|Administrative reason|0|||
161746581|NCT00239356|584112588|FG001|Overall Study|Administrative reason|1|||
161746582|NCT00239356|584112587|FG000|Overall Study|Drug available on market|11|||
161746583|NCT00239356|584112588|FG001|Overall Study|Drug available on market|2|||
161746584|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
161746585|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
161746586|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
161746587|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
161746588|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
161746589|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
161746590|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
161746591|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
161746592|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
161746593|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
161746594|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
161746595|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
161746596|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
161746597|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
161746598|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
161746599|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
161746600|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
161746601|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
161746602|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
161746603|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
161842840|NCT02393248|584470011|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
161842841|NCT02393248|584470012|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
161842842|NCT02393248|584470013|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
161842843|NCT02393248|584470014|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
161842844|NCT02393248|584470015|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
161842845|NCT02393248|584470016|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
161842846|NCT02393248|584470017|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
161842847|NCT02393248|584470018|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
161842848|NCT02393248|584470019|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
161842849|NCT02393248|584470020|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
161842850|NCT02393248|584470021|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
161842851|NCT02393248|584470022|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
161842852|NCT02393248|584470023|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
161842853|NCT02393248|584470024|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
161842854|NCT02393248|584470000|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
161842855|NCT02393248|584470001|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842856|NCT02393248|584470002|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842857|NCT02393248|584470003|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842858|NCT02393248|584470004|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842859|NCT02393248|584470005|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842860|NCT02393248|584470006|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842861|NCT02393248|584470007|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842862|NCT02393248|584470008|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842863|NCT02393248|584470009|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842864|NCT02393248|584470010|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842865|NCT02393248|584470011|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842866|NCT02393248|584470012|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842867|NCT02393248|584470013|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
162032617|NCT04761627|585177444|FG001|Run-in Period|Required alternative therapy|0|||
161746604|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
161746605|NCT01001572|584112589|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
161746606|NCT01001572|584112590|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
161746607|NCT01001572|584112591|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
161746608|NCT01001572|584112589|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161746609|NCT01001572|584112590|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
161746610|NCT01001572|584112591|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
161746611|NCT01001572|584112589|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161746612|NCT01001572|584112590|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
161746613|NCT01001572|584112591|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
161746614|NCT01001572|584112589|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
161746615|NCT01001572|584112590|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
161746616|NCT01001572|584112591|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
161746617|NCT01001572|584112589|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
161746618|NCT01001572|584112590|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
161746619|NCT01001572|584112591|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
161746620|NCT01001572|584112589|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
161746621|NCT01001572|584112590|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
161746622|NCT01001572|584112591|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
161746623|NCT01001572|584112589|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161746624|NCT01001572|584112590|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161746625|NCT01001572|584112591|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161746626|NCT01094808|584112592|FG000|Overall Study|Withdrawal by Subject|1|||
161842868|NCT02393248|584470014|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842869|NCT02393248|584470015|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842870|NCT02393248|584470016|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842871|NCT02393248|584470017|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842872|NCT02393248|584470018|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842873|NCT02393248|584470019|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842874|NCT02393248|584470020|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842875|NCT02393248|584470021|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842876|NCT02393248|584470022|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842877|NCT02393248|584470023|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161746627|NCT01094808|584112593|FG001|Overall Study|Withdrawal by Subject|1|||
161746628|NCT01094808|584112594|FG002|Overall Study|Withdrawal by Subject|0|||
161746629|NCT02044822|584112595|FG000|Overall Study|Study Terminated by Sponsor|77|||
161746630|NCT02044822|584112595|FG000|Overall Study|Investigator's Discretion|10|||
161746631|NCT02044822|584112595|FG000|Overall Study|Withdrew Consent|3|||
161746632|NCT02044822|584112595|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
161746633|NCT02044822|584112595|FG000|Overall Study|Lost to Follow-up|1|||
161746634|NCT02025530|584112598|FG000|Overall Study|No longer met elligibility criteria|5|||
161746635|NCT02025530|584112599|FG001|Overall Study|No longer met elligibility criteria|1|||
161746636|NCT03551626|584112600|FG000|Overall Study|Adverse Event|88|||
161746637|NCT03551626|584112600|FG000|Overall Study|Disease relapse|18|||
161746638|NCT03551626|584112600|FG000|Overall Study|Withdrawal of informed consent|6|||
161746639|NCT03551626|584112600|FG000|Overall Study|Patient decision|5|||
161746640|NCT03551626|584112600|FG000|Overall Study|Physician Decision|4|||
161746641|NCT03551626|584112600|FG000|Overall Study|Lost to Follow-up|3|||
161746642|NCT03551626|584112600|FG000|Overall Study|Pregnancy|1|||
161746643|NCT03551626|584112600|FG000|Overall Study|Protocol deviation|1|||
161746644|NCT03551626|584112600|FG000|Overall Study|Technical problems|1|||
161746645|NCT00653328|584112601|FG000|Overall Study|Withdrawal by Subject|1|||
161746646|NCT00653328|584112601|FG000|Overall Study|Adverse Event|2|||
161746647|NCT00653328|584112601|FG000|Overall Study|Disease progression|10|||
161746648|NCT00653328|584112601|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
161746649|NCT01237223|584112608|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
161746650|NCT01237223|584112609|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161746651|NCT01237223|584112610|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161746652|NCT01237223|584112611|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161746653|NCT01237223|584112612|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161746654|NCT01237223|584112613|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161746655|NCT01237223|584112608|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
161746656|NCT01237223|584112609|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161746657|NCT01237223|584112610|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161746658|NCT01237223|584112611|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161746659|NCT01237223|584112612|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161842878|NCT02393248|584470024|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161842879|NCT02393248|584470000|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842880|NCT02393248|584470001|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842881|NCT02393248|584470002|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842882|NCT02393248|584470003|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161966985|NCT03989349|584925764|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
161746660|NCT01237223|584112613|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161746661|NCT01237223|584112608|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
161966986|NCT03989349|584925765|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
161966987|NCT03989349|584925766|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
161746662|NCT01237223|584112609|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161746663|NCT01237223|584112610|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161746664|NCT01237223|584112611|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161746665|NCT01237223|584112612|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161746666|NCT01237223|584112613|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161746667|NCT01237223|584112608|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
161746668|NCT01237223|584112609|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161746669|NCT01237223|584112610|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161746670|NCT01237223|584112611|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161746671|NCT01237223|584112612|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161746672|NCT01237223|584112613|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161746673|NCT01237223|584112608|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
161746674|NCT01237223|584112609|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161746675|NCT01237223|584112610|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161746676|NCT01237223|584112611|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161746677|NCT01237223|584112612|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161746678|NCT01237223|584112613|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161746679|NCT01237223|584112608|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
161746680|NCT01237223|584112609|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
161746681|NCT01237223|584112610|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
161746682|NCT01237223|584112611|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
161746683|NCT01237223|584112612|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
161746684|NCT01237223|584112613|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
161746685|NCT01237223|584112608|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
161746686|NCT01237223|584112609|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
161746687|NCT01237223|584112610|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
161746688|NCT01237223|584112611|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
161746689|NCT01237223|584112612|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
161746690|NCT01237223|584112613|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
161746691|NCT01237223|584112608|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
161746692|NCT01237223|584112609|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
161746693|NCT01237223|584112610|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
161746694|NCT01237223|584112611|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
161746695|NCT01237223|584112612|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
161746696|NCT01237223|584112613|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
161746697|NCT01237223|584112608|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161746698|NCT01237223|584112609|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161746699|NCT01237223|584112610|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161746700|NCT01237223|584112611|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161746701|NCT01237223|584112612|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161746702|NCT01237223|584112613|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
161746703|NCT01237223|584112608|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
161746704|NCT01237223|584112609|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
161746705|NCT01237223|584112610|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
161746706|NCT01237223|584112611|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
161746707|NCT01237223|584112612|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
161746708|NCT01237223|584112613|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
161746709|NCT00443846|584112617|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
161746710|NCT00443846|584112618|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
161746711|NCT00443846|584112617|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
161746712|NCT00443846|584112618|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
161746713|NCT00443846|584112617|FG000|Overall Study|Adverse Event|0|||
161746714|NCT00443846|584112618|FG001|Overall Study|Adverse Event|1|||
161746715|NCT00443846|584112617|FG000|Overall Study|Personal reason|8|||
161746716|NCT00443846|584112618|FG001|Overall Study|Personal reason|3|||
161746717|NCT00443846|584112617|FG000|Overall Study|Lost to Follow-up|1|||
161746718|NCT00443846|584112618|FG001|Overall Study|Lost to Follow-up|2|||
161746719|NCT00445341|584112625|FG000|Overall Study|refused further treatment|1|||
161746720|NCT00445341|584112625|FG000|Overall Study|taken off treatment too early|1|||
161746721|NCT03051217|584112626|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
161746722|NCT03051217|584112627|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161746723|NCT03051217|584112628|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
161746724|NCT03051217|584112629|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161746725|NCT03051217|584112630|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161746726|NCT03051217|584112631|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161746727|NCT03051217|584112632|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161746728|NCT03051217|584112626|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161746729|NCT03051217|584112627|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
161746730|NCT03051217|584112628|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161746731|NCT03051217|584112629|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161746732|NCT03051217|584112630|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161746733|NCT03051217|584112631|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161746734|NCT03051217|584112632|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161746735|NCT03051217|584112626|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
161746736|NCT03051217|584112627|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
161746737|NCT03051217|584112628|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
161746738|NCT03051217|584112629|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161746739|NCT03051217|584112630|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161746740|NCT03051217|584112631|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161746741|NCT03051217|584112632|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161746742|NCT03051217|584112626|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
161746743|NCT03051217|584112627|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
161746744|NCT03051217|584112628|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
161746745|NCT03051217|584112629|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
161746746|NCT03051217|584112630|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
161746747|NCT03051217|584112631|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
161746748|NCT03051217|584112632|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
161746749|NCT03051217|584112626|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161746750|NCT03051217|584112627|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161746751|NCT03051217|584112628|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161746752|NCT03051217|584112629|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
161746753|NCT03051217|584112630|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161746754|NCT03051217|584112631|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161746755|NCT03051217|584112632|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161746756|NCT03051217|584112626|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161746757|NCT03051217|584112627|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161746758|NCT03051217|584112628|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161746759|NCT03051217|584112629|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
161746760|NCT03051217|584112630|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161746761|NCT03051217|584112631|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161746762|NCT03051217|584112632|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161746763|NCT03051217|584112626|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161746764|NCT03051217|584112627|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161746765|NCT03051217|584112628|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161746766|NCT03051217|584112629|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161746767|NCT03051217|584112630|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
161746768|NCT03051217|584112631|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161746769|NCT03051217|584112632|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161746770|NCT03051217|584112626|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161746771|NCT03051217|584112627|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161746772|NCT03051217|584112628|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161746773|NCT03051217|584112629|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161746774|NCT03051217|584112630|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161746775|NCT03051217|584112631|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
161746776|NCT03051217|584112632|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161746777|NCT00641706|584112633|FG000|Overall Study|Adverse Event|2|||
161746778|NCT00641706|584112634|FG001|Overall Study|Adverse Event|1|||
161746779|NCT00641706|584112633|FG000|Overall Study|Withdrawal by Subject|6|||
161746780|NCT00641706|584112634|FG001|Overall Study|Withdrawal by Subject|1|||
161746781|NCT00641706|584112633|FG000|Overall Study|Clinical Decline|1|||
161746782|NCT00641706|584112634|FG001|Overall Study|Clinical Decline|0|||
161746783|NCT00641706|584112633|FG000|Overall Study|Lead Investigator Decision|0|||
161746784|NCT00641706|584112634|FG001|Overall Study|Lead Investigator Decision|1|||
161746785|NCT00109772|584112635|FG000|Double-blind Treatment|Adverse Event|14|||
161746786|NCT00109772|584112636|FG001|Double-blind Treatment|Adverse Event|5|||
161746787|NCT00109772|584112635|FG000|Double-blind Treatment|Lack of Efficacy|1|||
161746788|NCT00109772|584112636|FG001|Double-blind Treatment|Lack of Efficacy|0|||
161746789|NCT00109772|584112635|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
161746790|NCT00109772|584112636|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
161966988|NCT03989349|584925767|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
161966989|NCT03989349|584925762|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161966990|NCT03989349|584925763|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161746791|NCT00109772|584112635|FG000|Double-blind Treatment|Lost to Follow-up|2|||
161746792|NCT00109772|584112636|FG001|Double-blind Treatment|Lost to Follow-up|3|||
161746793|NCT00109772|584112635|FG000|Double-blind Treatment|Protocol Violation|0|||
161746794|NCT00109772|584112636|FG001|Double-blind Treatment|Protocol Violation|1|||
161746795|NCT00109772|584112635|FG000|Double-blind Treatment|Other|0|||
161746796|NCT00109772|584112636|FG001|Double-blind Treatment|Other|4|||
161746797|NCT00109772|584112635|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
161746798|NCT00109772|584112636|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
161746799|NCT00109772|584112635|FG000|Open-label Extension|Adverse Event|10|||
161746800|NCT00109772|584112636|FG001|Open-label Extension|Adverse Event|19|||
161746801|NCT00109772|584112635|FG000|Open-label Extension|Lack of Efficacy|19|||
161746802|NCT00109772|584112636|FG001|Open-label Extension|Lack of Efficacy|11|||
161746803|NCT00109772|584112635|FG000|Open-label Extension|Withdrawal by Subject|9|||
161746804|NCT00109772|584112636|FG001|Open-label Extension|Withdrawal by Subject|6|||
161746805|NCT00109772|584112635|FG000|Open-label Extension|Lost to Follow-up|1|||
161746806|NCT00109772|584112636|FG001|Open-label Extension|Lost to Follow-up|0|||
161746807|NCT00109772|584112635|FG000|Open-label Extension|Death|0|||
161746808|NCT00109772|584112636|FG001|Open-label Extension|Death|1|||
161746809|NCT00109772|584112635|FG000|Open-label Extension|Protocol Violation|2|||
161746810|NCT00109772|584112636|FG001|Open-label Extension|Protocol Violation|2|||
161746811|NCT00109772|584112635|FG000|Open-label Extension|Other|4|||
161746812|NCT00109772|584112636|FG001|Open-label Extension|Other|10|||
161746813|NCT00391807|584112640|FG000|Overall Study|Did not receive study medication|23|||
161746814|NCT00391807|584112640|FG000|Overall Study|Adverse Event|177|||
161746815|NCT00391807|584112640|FG000|Overall Study|Pregnancy|25|||
161746816|NCT00391807|584112640|FG000|Overall Study|Lost to Follow-up|227|||
161746817|NCT00391807|584112640|FG000|Overall Study|Withdrawal by Subject|147|||
161746818|NCT00391807|584112640|FG000|Overall Study|Protocol Violation|20|||
161746819|NCT00391807|584112640|FG000|Overall Study|Various|96|||
161746820|NCT05441540|584112643|FG000|Overall Study|Withdrawal by Subject|2|||
161746821|NCT00813917|584112644|FG000|Overall Study|Adverse Event|0|||
161746822|NCT00813917|584112645|FG001|Overall Study|Adverse Event|1|||
161746823|NCT00813917|584112644|FG000|Overall Study|Withdrawal by Subject|3|||
161746824|NCT00813917|584112645|FG001|Overall Study|Withdrawal by Subject|4|||
161746825|NCT00813917|584112644|FG000|Overall Study|Lost to Follow-up|3|||
161746826|NCT00813917|584112645|FG001|Overall Study|Lost to Follow-up|1|||
161746827|NCT01359046|584112646|FG000|Overall Study|Did not receive allocated intervention|6|||
161746828|NCT01359046|584112647|FG001|Overall Study|Did not receive allocated intervention|6|||
161746829|NCT01359046|584112646|FG000|Overall Study|Physician Decision|1|||
161746830|NCT01359046|584112647|FG001|Overall Study|Physician Decision|11|||
161746831|NCT01369225|584112652|FG000|Overall Study|Withdrawal by Subject|1|||
161746832|NCT01369225|584112653|FG001|Overall Study|Withdrawal by Subject|0|||
161746833|NCT01369225|584112654|FG002|Overall Study|Withdrawal by Subject|2|||
161746834|NCT01369225|584112655|FG003|Overall Study|Withdrawal by Subject|1|||
161746835|NCT01369225|584112656|FG004|Overall Study|Withdrawal by Subject|0|||
161746836|NCT01369225|584112657|FG005|Overall Study|Withdrawal by Subject|0|||
161746837|NCT01369225|584112652|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
161746838|NCT01369225|584112653|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
161746839|NCT01369225|584112654|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
161746840|NCT01369225|584112655|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
161746841|NCT01369225|584112656|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
161746842|NCT01369225|584112657|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
161746843|NCT01369225|584112652|FG000|Overall Study|Other|1|||
161746844|NCT01369225|584112653|FG001|Overall Study|Other|0|||
161746845|NCT01369225|584112654|FG002|Overall Study|Other|0|||
161746846|NCT01369225|584112655|FG003|Overall Study|Other|0|||
161746847|NCT01369225|584112656|FG004|Overall Study|Other|1|||
161746848|NCT01369225|584112657|FG005|Overall Study|Other|0|||
161746849|NCT01369225|584112652|FG000|Overall Study|Adverse Event|0|||
161746850|NCT01369225|584112653|FG001|Overall Study|Adverse Event|0|||
161746851|NCT01369225|584112654|FG002|Overall Study|Adverse Event|0|||
161746852|NCT01369225|584112655|FG003|Overall Study|Adverse Event|1|||
161746853|NCT01369225|584112656|FG004|Overall Study|Adverse Event|1|||
161746854|NCT01369225|584112657|FG005|Overall Study|Adverse Event|0|||
161746855|NCT04539262|584112659|FG000|Overall Study|Adverse Event|0|||
161746856|NCT04539262|584112660|FG001|Overall Study|Adverse Event|0|||
161966991|NCT03989349|584925764|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
161746857|NCT04539262|584112661|FG002|Overall Study|Adverse Event|1|||
161746858|NCT04539262|584112662|FG003|Overall Study|Adverse Event|0|||
161746859|NCT04539262|584112663|FG004|Overall Study|Adverse Event|0|||
161746860|NCT04539262|584112664|FG005|Overall Study|Adverse Event|0|||
161746861|NCT04539262|584112665|FG006|Overall Study|Adverse Event|0|||
161746862|NCT04539262|584112666|FG007|Overall Study|Adverse Event|0|||
161966992|NCT03989349|584925765|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
161746863|NCT04539262|584112659|FG000|Overall Study|Withdrew Consent|0|||
161746864|NCT04539262|584112660|FG001|Overall Study|Withdrew Consent|0|||
161746865|NCT04539262|584112661|FG002|Overall Study|Withdrew Consent|0|||
161746866|NCT04539262|584112662|FG003|Overall Study|Withdrew Consent|1|||
161746867|NCT04539262|584112663|FG004|Overall Study|Withdrew Consent|0|||
161746868|NCT04539262|584112664|FG005|Overall Study|Withdrew Consent|0|||
161746869|NCT04539262|584112665|FG006|Overall Study|Withdrew Consent|0|||
161746870|NCT04539262|584112666|FG007|Overall Study|Withdrew Consent|0|||
161746871|NCT04539262|584112659|FG000|Overall Study|Randomized, Not treated|0|||
161746872|NCT04539262|584112660|FG001|Overall Study|Randomized, Not treated|1|||
161746873|NCT04539262|584112661|FG002|Overall Study|Randomized, Not treated|0|||
161746874|NCT04539262|584112662|FG003|Overall Study|Randomized, Not treated|0|||
161746875|NCT04539262|584112663|FG004|Overall Study|Randomized, Not treated|0|||
161746876|NCT04539262|584112664|FG005|Overall Study|Randomized, Not treated|0|||
161746877|NCT04539262|584112665|FG006|Overall Study|Randomized, Not treated|1|||
161746878|NCT04539262|584112666|FG007|Overall Study|Randomized, Not treated|0|||
161746879|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
161746880|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
161746881|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
161746882|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
161746883|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
161746884|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
161746885|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
161746886|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
161746887|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
161746888|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
161746889|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
161746890|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
161746891|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
161746892|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
161746893|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
161746894|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
161746895|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
161746896|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
161746897|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
161746898|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
161746899|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
161746900|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
161746901|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
161746902|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
161746903|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
161746904|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Other|1|||
161746905|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Other|0|||
161746906|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Other|0|||
161746907|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Other|0|||
161746908|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Other|1|||
161746909|NCT02980692|584112669|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
161746910|NCT02980692|584112670|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
161746911|NCT02980692|584112671|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
161746912|NCT02980692|584112672|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
161746913|NCT02980692|584112673|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
161746914|NCT02980692|584112669|FG000|Double-blind Follow-up Period|Adverse Event|0|||
161746915|NCT02980692|584112670|FG001|Double-blind Follow-up Period|Adverse Event|0|||
161746916|NCT02980692|584112671|FG002|Double-blind Follow-up Period|Adverse Event|0|||
161746917|NCT02980692|584112672|FG003|Double-blind Follow-up Period|Adverse Event|1|||
161746918|NCT02980692|584112673|FG004|Double-blind Follow-up Period|Adverse Event|1|||
161746919|NCT02980692|584112669|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
161746920|NCT02980692|584112670|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
161746921|NCT02980692|584112671|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
161966993|NCT03989349|584925766|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
161966994|NCT03989349|584925767|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
161966995|NCT03989349|584925762|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161966996|NCT03989349|584925763|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161966997|NCT03989349|584925764|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
161966998|NCT03989349|584925765|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161966999|NCT03989349|584925766|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
161746922|NCT02980692|584112672|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
161746923|NCT02980692|584112673|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
161746924|NCT02980692|584112669|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
161746925|NCT02980692|584112670|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
161746926|NCT02980692|584112671|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
161746927|NCT02980692|584112672|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
161746928|NCT02980692|584112673|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
161746929|NCT02980692|584112669|FG000|Double-blind Follow-up Period|Pregnancy|0|||
161746930|NCT02980692|584112670|FG001|Double-blind Follow-up Period|Pregnancy|0|||
161746931|NCT02980692|584112671|FG002|Double-blind Follow-up Period|Pregnancy|1|||
161746932|NCT02980692|584112672|FG003|Double-blind Follow-up Period|Pregnancy|1|||
161746933|NCT02980692|584112673|FG004|Double-blind Follow-up Period|Pregnancy|0|||
161746934|NCT02980692|584112669|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
161746935|NCT02980692|584112670|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
161746936|NCT02980692|584112671|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
161746937|NCT02980692|584112672|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
161746938|NCT02980692|584112673|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
161746939|NCT02980692|584112669|FG000|Double-blind Follow-up Period|Other|0|||
161746940|NCT02980692|584112670|FG001|Double-blind Follow-up Period|Other|0|||
161746941|NCT02980692|584112671|FG002|Double-blind Follow-up Period|Other|1|||
161746942|NCT02980692|584112672|FG003|Double-blind Follow-up Period|Other|1|||
161746943|NCT02980692|584112673|FG004|Double-blind Follow-up Period|Other|3|||
161746944|NCT00792701|584112674|FG000|Overall Study|Adverse Event|0|||
161746945|NCT00792701|584112675|FG001|Overall Study|Adverse Event|22|||
161746946|NCT00792701|584112674|FG000|Overall Study|Ineligible|1|||
161746947|NCT00792701|584112675|FG001|Overall Study|Ineligible|3|||
161746948|NCT00792701|584112674|FG000|Overall Study|Withdrawal by Subject|1|||
161746949|NCT00792701|584112675|FG001|Overall Study|Withdrawal by Subject|19|||
161746950|NCT00792701|584112674|FG000|Overall Study|Not protocol specified|17|||
161746951|NCT00792701|584112675|FG001|Overall Study|Not protocol specified|0|||
161746952|NCT05507580|584112678|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161746953|NCT05507580|584112679|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
161746954|NCT05507580|584112680|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
161746955|NCT05507580|584112681|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
161746956|NCT05507580|584112682|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
161746957|NCT05507580|584112683|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
161746958|NCT05507580|584112678|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
161746959|NCT05507580|584112679|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161746960|NCT05507580|584112680|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161746961|NCT05507580|584112681|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161746962|NCT05507580|584112682|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161746963|NCT05507580|584112683|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161746964|NCT05507580|584112678|FG000|Double-Blind Treatment Period|Other, not specified|5|||
161746965|NCT05507580|584112679|FG001|Double-Blind Treatment Period|Other, not specified|4|||
161746966|NCT05507580|584112680|FG002|Double-Blind Treatment Period|Other, not specified|0|||
161746967|NCT05507580|584112681|FG003|Double-Blind Treatment Period|Other, not specified|0|||
161746968|NCT05507580|584112682|FG004|Double-Blind Treatment Period|Other, not specified|0|||
161746969|NCT05507580|584112683|FG005|Double-Blind Treatment Period|Other, not specified|0|||
161746970|NCT05507580|584112678|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
161746971|NCT05507580|584112679|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
161746972|NCT05507580|584112680|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
161842883|NCT02393248|584470004|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161967000|NCT03989349|584925767|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161967001|NCT03989349|584925762|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161967002|NCT03989349|584925763|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161746973|NCT05507580|584112681|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
161746974|NCT05507580|584112682|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
161746975|NCT05507580|584112683|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
161746976|NCT05507580|584112678|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
161746977|NCT05507580|584112679|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
161746978|NCT05507580|584112680|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
161842884|NCT02393248|584470005|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
161967003|NCT03989349|584925764|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
161967004|NCT03989349|584925765|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
161746979|NCT05507580|584112681|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
161746980|NCT05507580|584112682|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
161746981|NCT05507580|584112683|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
161746982|NCT05507580|584112678|FG000|Single-Blind Treatment Period|Other, not specified|0|||
161746983|NCT05507580|584112679|FG001|Single-Blind Treatment Period|Other, not specified|0|||
161746984|NCT05507580|584112680|FG002|Single-Blind Treatment Period|Other, not specified|2|||
161967005|NCT03989349|584925766|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161967006|NCT03989349|584925767|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
161967007|NCT03989349|584925762|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
161967008|NCT03989349|584925763|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
161967009|NCT03989349|584925764|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
161967010|NCT03989349|584925765|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
161967011|NCT03989349|584925766|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
161967012|NCT03989349|584925767|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
161967013|NCT03989349|584925762|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
161967014|NCT03989349|584925763|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
161967015|NCT03989349|584925764|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
161967016|NCT03989349|584925765|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
161967017|NCT03989349|584925766|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
161967018|NCT03989349|584925767|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
161967019|NCT02684058|584925768|FG000|Treatment Period|Progressive disease|4|||
161967020|NCT02684058|584925769|FG001|Treatment Period|Progressive disease|10|||
161967021|NCT02684058|584925770|FG002|Treatment Period|Progressive disease|19|||
161967022|NCT02684058|584925768|FG000|Treatment Period|Adverse Event|3|||
161967023|NCT02684058|584925769|FG001|Treatment Period|Adverse Event|8|||
161967024|NCT02684058|584925770|FG002|Treatment Period|Adverse Event|1|||
161967025|NCT02684058|584925768|FG000|Treatment Period|Physician Decision|5|||
161967026|NCT02684058|584925769|FG001|Treatment Period|Physician Decision|1|||
161967027|NCT02684058|584925770|FG002|Treatment Period|Physician Decision|2|||
161967028|NCT02684058|584925768|FG000|Treatment Period|New therapy for study indication|1|||
161967029|NCT02684058|584925769|FG001|Treatment Period|New therapy for study indication|0|||
161967030|NCT02684058|584925770|FG002|Treatment Period|New therapy for study indication|0|||
161967031|NCT02684058|584925768|FG000|Treatment Period|Protocol deviation|0|||
161967032|NCT02684058|584925769|FG001|Treatment Period|Protocol deviation|1|||
161967033|NCT02684058|584925770|FG002|Treatment Period|Protocol deviation|0|||
161967034|NCT02684058|584925768|FG000|Treatment Period|Subject/guardian decision|4|||
161967035|NCT02684058|584925769|FG001|Treatment Period|Subject/guardian decision|3|||
161967036|NCT02684058|584925770|FG002|Treatment Period|Subject/guardian decision|0|||
161967037|NCT02684058|584925768|FG000|Treatment Period|Death|0|||
161967038|NCT02684058|584925769|FG001|Treatment Period|Death|0|||
161967039|NCT02684058|584925770|FG002|Treatment Period|Death|2|||
161967040|NCT02684058|584925768|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161967041|NCT02684058|584925769|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
161967042|NCT02684058|584925770|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
161967043|NCT02684058|584925768|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
161967044|NCT02684058|584925769|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
161967045|NCT02684058|584925770|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
161967046|NCT02684058|584925768|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
161967047|NCT02684058|584925769|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
161967048|NCT02684058|584925770|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
161967049|NCT02684058|584925768|FG000|Post-treatment Efficacy Follow-up|Death|0|||
161967050|NCT02684058|584925769|FG001|Post-treatment Efficacy Follow-up|Death|0|||
161967051|NCT02684058|584925770|FG002|Post-treatment Efficacy Follow-up|Death|3|||
161967052|NCT02684058|584925768|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
161967053|NCT02684058|584925769|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
161967054|NCT02684058|584925770|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
161967055|NCT02684058|584925768|FG000|Post-treatment Survival Follow-up|Death|0|||
161967056|NCT02684058|584925769|FG001|Post-treatment Survival Follow-up|Death|0|||
161967057|NCT02684058|584925770|FG002|Post-treatment Survival Follow-up|Death|7|||
161967058|NCT02684058|584925768|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
161967059|NCT02684058|584925769|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
161967060|NCT02684058|584925770|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
161967061|NCT02684058|584925768|FG000|Crossover Treatment Period|Progressive disease|0|||
161967062|NCT02684058|584925769|FG001|Crossover Treatment Period|Progressive disease|1|||
161967063|NCT02684058|584925770|FG002|Crossover Treatment Period|Progressive disease|0|||
161967064|NCT01802580|584925771|FG000|Overall Study|Physician Decision|1|||
161967065|NCT01802580|584925772|FG001|Overall Study|Physician Decision|0|||
161967066|NCT01802580|584925771|FG000|Overall Study|Protocol Violation|2|||
161967067|NCT01802580|584925772|FG001|Overall Study|Protocol Violation|0|||
162032618|NCT04761627|585177445|FG002|Run-in Period|Required alternative therapy|0|||
162032619|NCT04761627|585177443|FG000|Run-in Period|Lost to Follow-up|2|||
162032620|NCT04761627|585177444|FG001|Run-in Period|Lost to Follow-up|0|||
161967068|NCT01802580|584925771|FG000|Overall Study|Withdrawal by Subject|5|||
161746985|NCT05507580|584112681|FG003|Single-Blind Treatment Period|Other, not specified|7|||
161746986|NCT05507580|584112682|FG004|Single-Blind Treatment Period|Other, not specified|3|||
161967069|NCT01802580|584925772|FG001|Overall Study|Withdrawal by Subject|6|||
161967070|NCT01802580|584925771|FG000|Overall Study|Other|1|||
161967071|NCT01802580|584925772|FG001|Overall Study|Other|3|||
161967072|NCT01802580|584925771|FG000|Overall Study|Lack of Efficacy|0|||
161967073|NCT01802580|584925772|FG001|Overall Study|Lack of Efficacy|2|||
161967074|NCT03255967|584925773|FG000|Overall Study|Adverse Event|26|||
161967075|NCT03255967|584925774|FG001|Overall Study|Adverse Event|30|||
161967076|NCT03255967|584925773|FG000|Overall Study|Withdrawal by Subject|6|||
161967077|NCT03255967|584925774|FG001|Overall Study|Withdrawal by Subject|6|||
161967078|NCT03255967|584925773|FG000|Overall Study|Schedule conflict|6|||
161967079|NCT03255967|584925774|FG001|Overall Study|Schedule conflict|4|||
161967080|NCT03255967|584925773|FG000|Overall Study|POA did not sign consent form|2|||
161967081|NCT03255967|584925774|FG001|Overall Study|POA did not sign consent form|0|||
161967082|NCT01252186|584925775|FG000|Overall Study|Adverse Event|9|||
161967083|NCT01252186|584925776|FG001|Overall Study|Adverse Event|6|||
161967084|NCT01252186|584925777|FG002|Overall Study|Adverse Event|8|||
161967085|NCT01252186|584925775|FG000|Overall Study|Withdrawal by Subject|2|||
161967086|NCT01252186|584925776|FG001|Overall Study|Withdrawal by Subject|5|||
161967087|NCT01252186|584925777|FG002|Overall Study|Withdrawal by Subject|2|||
161967088|NCT01252186|584925775|FG000|Overall Study|Physician Decision|0|||
161967089|NCT01252186|584925776|FG001|Overall Study|Physician Decision|0|||
161967090|NCT01252186|584925777|FG002|Overall Study|Physician Decision|1|||
161967091|NCT01252186|584925775|FG000|Overall Study|Non-compliance|0|||
161967092|NCT01252186|584925776|FG001|Overall Study|Non-compliance|3|||
161967093|NCT01252186|584925777|FG002|Overall Study|Non-compliance|4|||
161967094|NCT01252186|584925775|FG000|Overall Study|Protocol Violation|0|||
161967095|NCT01252186|584925776|FG001|Overall Study|Protocol Violation|0|||
161967096|NCT01252186|584925777|FG002|Overall Study|Protocol Violation|1|||
161967097|NCT01252186|584925775|FG000|Overall Study|Pregnancy|2|||
161967098|NCT01252186|584925776|FG001|Overall Study|Pregnancy|2|||
161967099|NCT01252186|584925777|FG002|Overall Study|Pregnancy|0|||
161967100|NCT01252186|584925775|FG000|Overall Study|Sponsor Request|2|||
161967101|NCT01252186|584925776|FG001|Overall Study|Sponsor Request|1|||
161967102|NCT01252186|584925777|FG002|Overall Study|Sponsor Request|0|||
161967103|NCT01252186|584925775|FG000|Overall Study|Lost to Follow-up|10|||
161967104|NCT01252186|584925776|FG001|Overall Study|Lost to Follow-up|10|||
161967105|NCT01252186|584925777|FG002|Overall Study|Lost to Follow-up|11|||
161967106|NCT01252186|584925775|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
161967107|NCT01252186|584925776|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
161967108|NCT01252186|584925777|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
161967109|NCT01327053|584925786|FG000|Overall Study|Adverse Event|23|||
161967110|NCT01327053|584925787|FG001|Overall Study|Adverse Event|57|||
161967111|NCT01327053|584925786|FG000|Overall Study|Patient/guardian decision|11|||
161967112|NCT01327053|584925787|FG001|Overall Study|Patient/guardian decision|35|||
161967113|NCT01327053|584925786|FG000|Overall Study|Physician Decision|10|||
161967114|NCT01327053|584925787|FG001|Overall Study|Physician Decision|14|||
161967115|NCT01327053|584925786|FG000|Overall Study|Death|1|||
161967116|NCT01327053|584925787|FG001|Overall Study|Death|5|||
161967117|NCT01327053|584925786|FG000|Overall Study|Lost to Follow-up|2|||
161967118|NCT01327053|584925787|FG001|Overall Study|Lost to Follow-up|4|||
161967119|NCT01327053|584925786|FG000|Overall Study|Non-compliance with study treatment|0|||
161967120|NCT01327053|584925787|FG001|Overall Study|Non-compliance with study treatment|5|||
161967121|NCT01327053|584925786|FG000|Overall Study|Study terminated by Sponsor|1|||
161967122|NCT01327053|584925787|FG001|Overall Study|Study terminated by Sponsor|3|||
161967123|NCT01327053|584925786|FG000|Overall Study|Progressive disease|31|||
161967124|NCT01327053|584925787|FG001|Overall Study|Progressive disease|26|||
161967125|NCT01327053|584925786|FG000|Overall Study|Protocol Violation|0|||
161746987|NCT05507580|584112683|FG005|Single-Blind Treatment Period|Other, not specified|5|||
161746988|NCT04702984|584112689|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
161746989|NCT00618813|584112690|FG000|Overall Study|Lack of Efficacy|1|||
161746990|NCT00618813|584112690|FG000|Overall Study|Physician Decision|2|||
161746991|NCT00618813|584112690|FG000|Overall Study|Withdrawal by Subject|1|||
161746992|NCT01809197|584112691|FG000|Overall Study|Lost to Follow-up|4|||
161746993|NCT01809197|584112692|FG001|Overall Study|Lost to Follow-up|2|||
161746994|NCT01809197|584112691|FG000|Overall Study|Adverse Event|2|||
161746995|NCT01809197|584112692|FG001|Overall Study|Adverse Event|3|||
161746996|NCT01809197|584112691|FG000|Overall Study|Failed slit lamp exam|1|||
161842885|NCT02393248|584470006|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
161967126|NCT01327053|584925787|FG001|Overall Study|Protocol Violation|1|||
161967127|NCT01327053|584925786|FG000|Overall Study|Untreated|0|||
161967128|NCT01327053|584925787|FG001|Overall Study|Untreated|1|||
161967129|NCT00778258|584925788|FG000|Overall Study|Adverse Event|1|||
161967130|NCT00778258|584925789|FG001|Overall Study|Adverse Event|0|||
161967131|NCT00778258|584925790|FG002|Overall Study|Adverse Event|0|||
161967132|NCT00778258|584925791|FG003|Overall Study|Adverse Event|0|||
161967133|NCT00778258|584925792|FG004|Overall Study|Adverse Event|0|||
161967134|NCT00778258|584925793|FG005|Overall Study|Adverse Event|1|||
161967135|NCT00778258|584925794|FG006|Overall Study|Adverse Event|0|||
161967136|NCT00778258|584925795|FG007|Overall Study|Adverse Event|0|||
161967137|NCT00778258|584925796|FG008|Overall Study|Adverse Event|0|||
161967138|NCT00778258|584925788|FG000|Overall Study|Lost to Follow-up|0|||
161967139|NCT00778258|584925789|FG001|Overall Study|Lost to Follow-up|0|||
161967140|NCT00778258|584925790|FG002|Overall Study|Lost to Follow-up|2|||
161967141|NCT00778258|584925791|FG003|Overall Study|Lost to Follow-up|0|||
161967142|NCT00778258|584925792|FG004|Overall Study|Lost to Follow-up|0|||
161967143|NCT00778258|584925793|FG005|Overall Study|Lost to Follow-up|3|||
161967144|NCT00778258|584925794|FG006|Overall Study|Lost to Follow-up|2|||
161967145|NCT00778258|584925795|FG007|Overall Study|Lost to Follow-up|2|||
161967146|NCT00778258|584925796|FG008|Overall Study|Lost to Follow-up|0|||
161967147|NCT00778258|584925788|FG000|Overall Study|Withdrawal by Subject|6|||
161967148|NCT00778258|584925789|FG001|Overall Study|Withdrawal by Subject|2|||
161967149|NCT00778258|584925790|FG002|Overall Study|Withdrawal by Subject|8|||
161967150|NCT00778258|584925791|FG003|Overall Study|Withdrawal by Subject|2|||
161967151|NCT00778258|584925792|FG004|Overall Study|Withdrawal by Subject|0|||
161967152|NCT00778258|584925793|FG005|Overall Study|Withdrawal by Subject|6|||
161967153|NCT00778258|584925794|FG006|Overall Study|Withdrawal by Subject|12|||
161967154|NCT00778258|584925795|FG007|Overall Study|Withdrawal by Subject|12|||
161967155|NCT00778258|584925796|FG008|Overall Study|Withdrawal by Subject|4|||
161967156|NCT00778258|584925788|FG000|Overall Study|New Contraindication|0|||
161967157|NCT00778258|584925789|FG001|Overall Study|New Contraindication|0|||
161967158|NCT00778258|584925790|FG002|Overall Study|New Contraindication|0|||
161967159|NCT00778258|584925791|FG003|Overall Study|New Contraindication|0|||
161967160|NCT00778258|584925792|FG004|Overall Study|New Contraindication|0|||
161967161|NCT00778258|584925793|FG005|Overall Study|New Contraindication|0|||
161967162|NCT00778258|584925794|FG006|Overall Study|New Contraindication|0|||
161967163|NCT00778258|584925795|FG007|Overall Study|New Contraindication|1|||
161967164|NCT00778258|584925796|FG008|Overall Study|New Contraindication|0|||
161967165|NCT00778258|584925788|FG000|Overall Study|Non-compliance|0|||
161967166|NCT00778258|584925789|FG001|Overall Study|Non-compliance|0|||
161967167|NCT00778258|584925790|FG002|Overall Study|Non-compliance|0|||
161967168|NCT00778258|584925791|FG003|Overall Study|Non-compliance|1|||
161967169|NCT00778258|584925792|FG004|Overall Study|Non-compliance|0|||
161967170|NCT00778258|584925793|FG005|Overall Study|Non-compliance|0|||
161967171|NCT00778258|584925794|FG006|Overall Study|Non-compliance|0|||
161967172|NCT00778258|584925795|FG007|Overall Study|Non-compliance|0|||
161967173|NCT00778258|584925796|FG008|Overall Study|Non-compliance|0|||
161967174|NCT00778258|584925788|FG000|Overall Study|Other|0|||
161967175|NCT00778258|584925789|FG001|Overall Study|Other|0|||
161967176|NCT00778258|584925790|FG002|Overall Study|Other|0|||
161967177|NCT00778258|584925791|FG003|Overall Study|Other|0|||
161967178|NCT00778258|584925792|FG004|Overall Study|Other|0|||
161967179|NCT00778258|584925793|FG005|Overall Study|Other|0|||
161967180|NCT00778258|584925794|FG006|Overall Study|Other|1|||
161967181|NCT00778258|584925795|FG007|Overall Study|Other|0|||
161967182|NCT00778258|584925796|FG008|Overall Study|Other|0|||
161967183|NCT00780143|584925797|FG000|Overall Study|Progressive disease|1|||
161967184|NCT00780143|584925797|FG000|Overall Study|Toxicity|1|||
161967185|NCT00780143|584925797|FG000|Overall Study|Adverse Event|1|||
161967186|NCT01457014|584925802|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
161967187|NCT01457014|584925803|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
161967188|NCT01457014|584925804|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
161967189|NCT01457014|584925805|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
161967190|NCT01457014|584925802|FG000|First Night|Withdrawal by Subject|3|||
161967191|NCT01457014|584925803|FG001|First Night|Withdrawal by Subject|0|||
161967192|NCT01457014|584925804|FG002|First Night|Withdrawal by Subject|0|||
161967193|NCT01457014|584925805|FG003|First Night|Withdrawal by Subject|0|||
161967194|NCT02461290|584925806|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
161967195|NCT02461290|584925806|FG000|Overall Study|Lost to Follow-up|3|||
161967196|NCT03319953|584925811|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
161967197|NCT03319953|584925812|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
161967198|NCT03319953|584925813|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
161967199|NCT03319953|584925814|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
161967200|NCT03319953|584925811|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
161967201|NCT03319953|584925812|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
161967202|NCT03319953|584925813|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
161967203|NCT03319953|584925814|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
161967204|NCT04027049|584925818|FG000|Overall Study|Withdrawn by family|1|||
161967205|NCT04027049|584925819|FG001|Overall Study|Withdrawn by family|0|||
161967206|NCT04027049|584925818|FG000|Overall Study|Participant safety|1|||
161967207|NCT04027049|584925819|FG001|Overall Study|Participant safety|0|||
161967208|NCT01263015|584927633|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
161967209|NCT01263015|584927634|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
162032621|NCT04761627|585177445|FG002|Run-in Period|Lost to Follow-up|0|||
161967210|NCT01263015|584927633|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
161967211|NCT01263015|584927634|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
161967212|NCT01263015|584927633|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
161967213|NCT01263015|584927634|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
161967214|NCT01263015|584927633|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
161967215|NCT01263015|584927634|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
161967216|NCT01263015|584927633|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
161967217|NCT01263015|584927634|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
161967218|NCT01263015|584927633|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
161967219|NCT01263015|584927634|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
161967220|NCT01263015|584927633|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
161967221|NCT01263015|584927634|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
161967222|NCT01263015|584927633|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
161967223|NCT01263015|584927634|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
161967224|NCT01263015|584927633|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
161967225|NCT01263015|584927634|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
161967226|NCT01263015|584927633|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
161967227|NCT01263015|584927634|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
161967228|NCT01263015|584927633|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
161967229|NCT01263015|584927634|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
161967230|NCT01263015|584927633|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
161967231|NCT01263015|584927634|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
161967232|NCT05599451|584927635|FG000|Overall Study|Not randomized|11|||
161967233|NCT05599451|584927636|FG001|Overall Study|Not randomized|0|||
161967234|NCT05599451|584927637|FG002|Overall Study|Not randomized|0|||
161967235|NCT05599451|584927638|FG003|Overall Study|Not randomized|0|||
161967236|NCT05599451|584927639|FG004|Overall Study|Not randomized|0|||
161967237|NCT05599451|584927635|FG000|Overall Study|Physician Decision|0|||
161967238|NCT05599451|584927636|FG001|Overall Study|Physician Decision|0|||
161967239|NCT05599451|584927637|FG002|Overall Study|Physician Decision|0|||
161967240|NCT05599451|584927638|FG003|Overall Study|Physician Decision|1|||
161967241|NCT05599451|584927639|FG004|Overall Study|Physician Decision|0|||
161967242|NCT02723006|584927640|FG000|Overall Study|Withdrawal by Subject|0|||
161967243|NCT02723006|584927641|FG001|Overall Study|Withdrawal by Subject|1|||
161967244|NCT02723006|584927642|FG002|Overall Study|Withdrawal by Subject|1|||
161967245|NCT02723006|584927640|FG000|Overall Study|Study Terminated by Sponsor|1|||
161967246|NCT02723006|584927641|FG001|Overall Study|Study Terminated by Sponsor|6|||
161967247|NCT02723006|584927642|FG002|Overall Study|Study Terminated by Sponsor|6|||
161967248|NCT00303446|584927643|FG000|Overall Study|Withdrawal by Subject|2|||
161967249|NCT00303446|584927644|FG001|Overall Study|Withdrawal by Subject|2|||
161967250|NCT00303446|584927643|FG000|Overall Study|Death|0|||
161967251|NCT00303446|584927644|FG001|Overall Study|Death|1|||
161967252|NCT00303446|584927643|FG000|Overall Study|Physician Decision|0|||
161967253|NCT00303446|584927644|FG001|Overall Study|Physician Decision|1|||
161967254|NCT03285958|584927645|FG000|Overall Study|Lost to Follow-up|1|||
161967255|NCT03285958|584927646|FG001|Overall Study|Lost to Follow-up|1|||
161967256|NCT03285958|584927645|FG000|Overall Study|Withdrawal by Subject|1|||
161967257|NCT03285958|584927646|FG001|Overall Study|Withdrawal by Subject|0|||
161967258|NCT03285958|584927645|FG000|Overall Study|Not able to attend required orientation|3|||
161967259|NCT03285958|584927646|FG001|Overall Study|Not able to attend required orientation|0|||
161967260|NCT03116828|584927648|FG000|Overall Study|Adverse Event|1|||
161967261|NCT03116828|584927649|FG001|Overall Study|Adverse Event|10|||
161967262|NCT03116828|584927648|FG000|Overall Study|Withdrawal by Subject|4|||
161967263|NCT03116828|584927649|FG001|Overall Study|Withdrawal by Subject|8|||
161967264|NCT03116828|584927648|FG000|Overall Study|OTHER|3|||
161967265|NCT03116828|584927649|FG001|Overall Study|OTHER|3|||
161967266|NCT05243745|584927652|FG000|Overall Study|Withdrawal by Subject|0|||
161967267|NCT05243745|584927653|FG001|Overall Study|Withdrawal by Subject|0|||
161967268|NCT05243745|584927654|FG002|Overall Study|Withdrawal by Subject|0|||
161967269|NCT05243745|584927655|FG003|Overall Study|Withdrawal by Subject|1|||
161967270|NCT05243745|584927652|FG000|Overall Study|Unable to Attend Visit 6|0|||
161967271|NCT05243745|584927653|FG001|Overall Study|Unable to Attend Visit 6|0|||
161967272|NCT05243745|584927654|FG002|Overall Study|Unable to Attend Visit 6|1|||
161967273|NCT05243745|584927655|FG003|Overall Study|Unable to Attend Visit 6|0|||
161967274|NCT02998203|584927656|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
161967275|NCT02998203|584927657|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
161967276|NCT02998203|584927656|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
161967277|NCT02998203|584927657|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
161967278|NCT03842969|584927670|FG000|Overall Study|Participant declined follow-up visit|0|||
161967279|NCT03842969|584927671|FG001|Overall Study|Participant declined follow-up visit|1|||
161967280|NCT03842969|584927672|FG002|Overall Study|Participant declined follow-up visit|0|||
161842886|NCT02393248|584470007|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161746997|NCT01809197|584112692|FG001|Overall Study|Failed slit lamp exam|0|||
161746998|NCT01809197|584112691|FG000|Overall Study|Non-Compliance|1|||
161746999|NCT01809197|584112692|FG001|Overall Study|Non-Compliance|1|||
161747000|NCT01809197|584112691|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
161747001|NCT01809197|584112692|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
161747002|NCT01809197|584112691|FG000|Overall Study|Withdrawal by Subject|1|||
161747003|NCT01809197|584112692|FG001|Overall Study|Withdrawal by Subject|1|||
161747004|NCT01809197|584112691|FG000|Overall Study|Product not available|0|||
161747005|NCT01809197|584112692|FG001|Overall Study|Product not available|1|||
161747006|NCT01855945|584112693|FG000|Overall Study|Adverse Event|0|||
161747007|NCT01855945|584112694|FG001|Overall Study|Adverse Event|0|||
161842887|NCT02393248|584470008|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842888|NCT02393248|584470009|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
161842889|NCT02393248|584470010|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842890|NCT02393248|584470011|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842891|NCT02393248|584470012|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842892|NCT02393248|584470013|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842893|NCT02393248|584470014|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842894|NCT02393248|584470015|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842895|NCT02393248|584470016|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842896|NCT02393248|584470017|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842897|NCT02393248|584470018|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842898|NCT02393248|584470019|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842899|NCT02393248|584470020|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842900|NCT02393248|584470021|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842901|NCT02393248|584470022|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842902|NCT02393248|584470023|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842903|NCT02393248|584470024|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161842904|NCT02393248|584470000|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842905|NCT02393248|584470001|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842906|NCT02393248|584470002|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842907|NCT02393248|584470003|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842908|NCT02393248|584470004|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842909|NCT02393248|584470005|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842910|NCT02393248|584470006|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
161842911|NCT02393248|584470007|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842912|NCT02393248|584470008|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842913|NCT02393248|584470009|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842914|NCT02393248|584470010|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842915|NCT02393248|584470011|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842916|NCT02393248|584470012|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842917|NCT02393248|584470013|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842918|NCT02393248|584470014|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842919|NCT02393248|584470015|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842920|NCT02393248|584470016|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842921|NCT02393248|584470017|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842922|NCT02393248|584470018|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842923|NCT02393248|584470019|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842924|NCT02393248|584470020|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842925|NCT02393248|584470021|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842926|NCT02393248|584470022|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842927|NCT02393248|584470023|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842928|NCT02393248|584470024|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161842929|NCT02393248|584470000|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842930|NCT02393248|584470001|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842931|NCT02393248|584470002|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842932|NCT02393248|584470003|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842933|NCT02393248|584470004|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842934|NCT02393248|584470005|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161747008|NCT01855945|584112695|FG002|Overall Study|Adverse Event|0|||
161747009|NCT01855945|584112696|FG003|Overall Study|Adverse Event|0|||
161842935|NCT02393248|584470006|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842936|NCT02393248|584470007|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842937|NCT02393248|584470008|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842938|NCT02393248|584470009|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842939|NCT02393248|584470010|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842940|NCT02393248|584470011|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
161842941|NCT02393248|584470012|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
161842942|NCT02393248|584470013|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
161842943|NCT02393248|584470014|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
161842944|NCT02393248|584470015|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842945|NCT02393248|584470016|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842946|NCT02393248|584470017|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842947|NCT02393248|584470018|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842948|NCT02393248|584470019|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842949|NCT02393248|584470020|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842950|NCT02393248|584470021|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842951|NCT02393248|584470022|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842952|NCT02393248|584470023|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842953|NCT02393248|584470024|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161842954|NCT02393248|584470000|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842955|NCT02393248|584470001|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842956|NCT02393248|584470002|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842957|NCT02393248|584470003|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842958|NCT02393248|584470004|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842959|NCT02393248|584470005|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842960|NCT02393248|584470006|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842961|NCT02393248|584470007|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842962|NCT02393248|584470008|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842963|NCT02393248|584470009|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842964|NCT02393248|584470010|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
161842965|NCT02393248|584470011|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
161842966|NCT02393248|584470012|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842967|NCT02393248|584470013|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842968|NCT02393248|584470014|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842969|NCT02393248|584470015|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842970|NCT02393248|584470016|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842971|NCT02393248|584470017|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842972|NCT02393248|584470018|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842973|NCT02393248|584470019|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842974|NCT02393248|584470020|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842975|NCT02393248|584470021|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842976|NCT02393248|584470022|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842977|NCT02393248|584470023|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161842978|NCT02393248|584470024|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161967281|NCT03842969|584927670|FG000|Overall Study|Sponsor's decision|12|||
161967282|NCT03842969|584927671|FG001|Overall Study|Sponsor's decision|99|||
161967283|NCT03842969|584927672|FG002|Overall Study|Sponsor's decision|61|||
161967284|NCT03842969|584927670|FG000|Overall Study|Pregnancy|0|||
161967285|NCT03842969|584927671|FG001|Overall Study|Pregnancy|0|||
161967286|NCT03842969|584927672|FG002|Overall Study|Pregnancy|1|||
161967287|NCT03842969|584927670|FG000|Overall Study|Death|1|||
161967288|NCT03842969|584927671|FG001|Overall Study|Death|0|||
161967289|NCT03842969|584927672|FG002|Overall Study|Death|1|||
161967290|NCT03842969|584927670|FG000|Overall Study|Withdrawal by Subject|3|||
161967291|NCT03842969|584927671|FG001|Overall Study|Withdrawal by Subject|30|||
161967292|NCT03842969|584927672|FG002|Overall Study|Withdrawal by Subject|18|||
161967293|NCT03842969|584927670|FG000|Overall Study|Protocol Violation|1|||
161967294|NCT03842969|584927671|FG001|Overall Study|Protocol Violation|1|||
161842979|NCT02393248|584470000|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
161967295|NCT03842969|584927672|FG002|Overall Study|Protocol Violation|0|||
161967296|NCT03842969|584927670|FG000|Overall Study|Physician Decision|0|||
161967297|NCT03842969|584927671|FG001|Overall Study|Physician Decision|3|||
161967298|NCT03842969|584927672|FG002|Overall Study|Physician Decision|0|||
161967299|NCT03842969|584927670|FG000|Overall Study|Lost to Follow-up|0|||
161967300|NCT03842969|584927671|FG001|Overall Study|Lost to Follow-up|2|||
161967301|NCT03842969|584927672|FG002|Overall Study|Lost to Follow-up|0|||
161967302|NCT03842969|584927670|FG000|Overall Study|Adverse Event|0|||
161967303|NCT03842969|584927671|FG001|Overall Study|Adverse Event|2|||
161967304|NCT03842969|584927672|FG002|Overall Study|Adverse Event|0|||
161967305|NCT04187144|584927673|FG000|Overall Study|Lost to Follow-up|12|||
161967306|NCT04187144|584927674|FG001|Overall Study|Lost to Follow-up|11|||
162032622|NCT04761627|585177443|FG000|Run-in Period|Protocol Violation|3|||
162032623|NCT04761627|585177444|FG001|Run-in Period|Protocol Violation|0|||
162032624|NCT04761627|585177445|FG002|Run-in Period|Protocol Violation|0|||
162032625|NCT04761627|585177443|FG000|Run-in Period|Abnormal liver function|1|||
162032626|NCT04761627|585177444|FG001|Run-in Period|Abnormal liver function|0|||
162032627|NCT04761627|585177445|FG002|Run-in Period|Abnormal liver function|0|||
162032628|NCT04761627|585177443|FG000|Run-in Period|Adverse Event|6|||
162032629|NCT04761627|585177444|FG001|Run-in Period|Adverse Event|0|||
162032630|NCT04761627|585177445|FG002|Run-in Period|Adverse Event|0|||
162032631|NCT04761627|585177443|FG000|Run-in Period|Withdrawal by Subject|7|||
162032632|NCT04761627|585177444|FG001|Run-in Period|Withdrawal by Subject|0|||
162032633|NCT04761627|585177445|FG002|Run-in Period|Withdrawal by Subject|0|||
162032634|NCT04761627|585177443|FG000|Run-in Period|Did not meet PASI 50|15|||
162032635|NCT04761627|585177444|FG001|Run-in Period|Did not meet PASI 50|0|||
162032636|NCT04761627|585177445|FG002|Run-in Period|Did not meet PASI 50|0|||
162032637|NCT04761627|585177443|FG000|Run-in Period|Study site closure|2|||
162032638|NCT04761627|585177444|FG001|Run-in Period|Study site closure|0|||
162032639|NCT04761627|585177445|FG002|Run-in Period|Study site closure|0|||
162032640|NCT04761627|585177443|FG000|Run-in Period|Pregnancy|2|||
162032641|NCT04761627|585177444|FG001|Run-in Period|Pregnancy|0|||
162032642|NCT04761627|585177445|FG002|Run-in Period|Pregnancy|0|||
162032643|NCT04761627|585177443|FG000|Post-randomization Period|Military service|0|||
162032644|NCT04761627|585177444|FG001|Post-randomization Period|Military service|1|||
161747010|NCT01855945|584112697|FG004|Overall Study|Adverse Event|0|||
161747011|NCT01855945|584112698|FG005|Overall Study|Adverse Event|0|||
161747012|NCT01855945|584112699|FG006|Overall Study|Adverse Event|1|||
161747013|NCT01855945|584112700|FG007|Overall Study|Adverse Event|0|||
161747014|NCT01855945|584112701|FG008|Overall Study|Adverse Event|0|||
161747015|NCT01855945|584112702|FG009|Overall Study|Adverse Event|0|||
161747016|NCT01855945|584112703|FG010|Overall Study|Adverse Event|0|||
161747017|NCT01855945|584112704|FG011|Overall Study|Adverse Event|0|||
161747018|NCT01855945|584112693|FG000|Overall Study|Death|0|||
161747019|NCT01855945|584112694|FG001|Overall Study|Death|0|||
161747020|NCT01855945|584112695|FG002|Overall Study|Death|0|||
161747021|NCT01855945|584112696|FG003|Overall Study|Death|0|||
161747022|NCT01855945|584112697|FG004|Overall Study|Death|0|||
161747023|NCT01855945|584112698|FG005|Overall Study|Death|0|||
161747024|NCT01855945|584112699|FG006|Overall Study|Death|2|||
161747025|NCT01855945|584112700|FG007|Overall Study|Death|0|||
161747026|NCT01855945|584112701|FG008|Overall Study|Death|0|||
161747027|NCT01855945|584112702|FG009|Overall Study|Death|0|||
161747028|NCT01855945|584112703|FG010|Overall Study|Death|0|||
161747029|NCT01855945|584112704|FG011|Overall Study|Death|0|||
161747030|NCT01855945|584112693|FG000|Overall Study|Lost to Follow-up|11|||
161747031|NCT01855945|584112694|FG001|Overall Study|Lost to Follow-up|10|||
161747032|NCT01855945|584112695|FG002|Overall Study|Lost to Follow-up|7|||
161747033|NCT01855945|584112696|FG003|Overall Study|Lost to Follow-up|3|||
161747034|NCT01855945|584112697|FG004|Overall Study|Lost to Follow-up|0|||
161747035|NCT01855945|584112698|FG005|Overall Study|Lost to Follow-up|3|||
161747036|NCT01855945|584112699|FG006|Overall Study|Lost to Follow-up|4|||
161747037|NCT01855945|584112700|FG007|Overall Study|Lost to Follow-up|7|||
161747038|NCT01855945|584112701|FG008|Overall Study|Lost to Follow-up|2|||
161747039|NCT01855945|584112702|FG009|Overall Study|Lost to Follow-up|0|||
161747040|NCT01855945|584112703|FG010|Overall Study|Lost to Follow-up|0|||
161747041|NCT01855945|584112704|FG011|Overall Study|Lost to Follow-up|2|||
161747042|NCT01855945|584112693|FG000|Overall Study|Other - Unclassified|1|||
161747043|NCT01855945|584112694|FG001|Overall Study|Other - Unclassified|1|||
161747044|NCT01855945|584112695|FG002|Overall Study|Other - Unclassified|1|||
161747045|NCT01855945|584112696|FG003|Overall Study|Other - Unclassified|0|||
161747046|NCT01855945|584112697|FG004|Overall Study|Other - Unclassified|0|||
161747047|NCT01855945|584112698|FG005|Overall Study|Other - Unclassified|0|||
161747048|NCT01855945|584112699|FG006|Overall Study|Other - Unclassified|2|||
161747049|NCT01855945|584112700|FG007|Overall Study|Other - Unclassified|1|||
161747050|NCT01855945|584112701|FG008|Overall Study|Other - Unclassified|0|||
161747051|NCT01855945|584112702|FG009|Overall Study|Other - Unclassified|0|||
161747052|NCT01855945|584112703|FG010|Overall Study|Other - Unclassified|1|||
161747053|NCT01855945|584112704|FG011|Overall Study|Other - Unclassified|0|||
162032645|NCT04761627|585177445|FG002|Post-randomization Period|Military service|0|||
161747054|NCT01855945|584112693|FG000|Overall Study|Withdrawal by Subject|4|||
161747055|NCT01855945|584112694|FG001|Overall Study|Withdrawal by Subject|0|||
161747056|NCT01855945|584112695|FG002|Overall Study|Withdrawal by Subject|4|||
161747057|NCT01855945|584112696|FG003|Overall Study|Withdrawal by Subject|1|||
161747058|NCT01855945|584112697|FG004|Overall Study|Withdrawal by Subject|1|||
161747059|NCT01855945|584112698|FG005|Overall Study|Withdrawal by Subject|0|||
161747060|NCT01855945|584112699|FG006|Overall Study|Withdrawal by Subject|1|||
161842980|NCT02393248|584470001|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
162032646|NCT04761627|585177443|FG000|Post-randomization Period|Adverse Event|0|||
162032647|NCT04761627|585177444|FG001|Post-randomization Period|Adverse Event|4|||
162032648|NCT04761627|585177445|FG002|Post-randomization Period|Adverse Event|2|||
161842981|NCT02393248|584470002|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
161842982|NCT02393248|584470003|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
161842983|NCT02393248|584470004|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
161842984|NCT02393248|584470005|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
161842985|NCT02393248|584470006|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
161842986|NCT02393248|584470007|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
161842987|NCT02393248|584470008|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
161842988|NCT02393248|584470009|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
161842989|NCT02393248|584470010|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
161842990|NCT02393248|584470011|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
161842991|NCT02393248|584470012|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
161842992|NCT02393248|584470013|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
161842993|NCT02393248|584470014|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
161842994|NCT02393248|584470015|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
161842995|NCT02393248|584470016|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
161842996|NCT02393248|584470017|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
161967307|NCT04187144|584927673|FG000|Overall Study|Withdrawal by Subject|20|||
161967308|NCT04187144|584927674|FG001|Overall Study|Withdrawal by Subject|18|||
161747061|NCT01855945|584112700|FG007|Overall Study|Withdrawal by Subject|0|||
161747062|NCT01855945|584112701|FG008|Overall Study|Withdrawal by Subject|0|||
161747063|NCT01855945|584112702|FG009|Overall Study|Withdrawal by Subject|2|||
161747064|NCT01855945|584112703|FG010|Overall Study|Withdrawal by Subject|4|||
161747065|NCT01855945|584112704|FG011|Overall Study|Withdrawal by Subject|1|||
161747066|NCT02156804|584112709|FG000|Overall Study|Withdrawal by Subject|1|||
161747067|NCT03228394|584112710|FG000|Overall Study|Lost to Follow-up|0|||
161747068|NCT03228394|584112711|FG001|Overall Study|Lost to Follow-up|0|||
161747069|NCT03228394|584112712|FG002|Overall Study|Lost to Follow-up|1|||
161747070|NCT03228394|584112713|FG003|Overall Study|Lost to Follow-up|1|||
161747071|NCT03228394|584112714|FG004|Overall Study|Lost to Follow-up|0|||
161747072|NCT03228394|584112715|FG005|Overall Study|Lost to Follow-up|0|||
161747073|NCT03228394|584112716|FG006|Overall Study|Lost to Follow-up|2|||
161747074|NCT03228394|584112717|FG007|Overall Study|Lost to Follow-up|0|||
161747075|NCT03228394|584112710|FG000|Overall Study|Withdrawal by Subject|0|||
161747076|NCT03228394|584112711|FG001|Overall Study|Withdrawal by Subject|0|||
161747077|NCT03228394|584112712|FG002|Overall Study|Withdrawal by Subject|1|||
161747078|NCT03228394|584112713|FG003|Overall Study|Withdrawal by Subject|0|||
161747079|NCT03228394|584112714|FG004|Overall Study|Withdrawal by Subject|0|||
161747080|NCT03228394|584112715|FG005|Overall Study|Withdrawal by Subject|0|||
161747081|NCT03228394|584112716|FG006|Overall Study|Withdrawal by Subject|1|||
161747082|NCT03228394|584112717|FG007|Overall Study|Withdrawal by Subject|3|||
161747083|NCT03228394|584112710|FG000|Overall Study|Protocol Violation|0|||
161747084|NCT03228394|584112711|FG001|Overall Study|Protocol Violation|0|||
161747085|NCT03228394|584112712|FG002|Overall Study|Protocol Violation|0|||
161747086|NCT03228394|584112713|FG003|Overall Study|Protocol Violation|1|||
161747087|NCT03228394|584112714|FG004|Overall Study|Protocol Violation|0|||
161747088|NCT03228394|584112715|FG005|Overall Study|Protocol Violation|0|||
161747089|NCT03228394|584112716|FG006|Overall Study|Protocol Violation|0|||
161747090|NCT03228394|584112717|FG007|Overall Study|Protocol Violation|0|||
161747091|NCT03228394|584112710|FG000|Overall Study|Physician Decision|0|||
161747092|NCT03228394|584112711|FG001|Overall Study|Physician Decision|0|||
161747093|NCT03228394|584112712|FG002|Overall Study|Physician Decision|0|||
161747094|NCT03228394|584112713|FG003|Overall Study|Physician Decision|0|||
161747095|NCT03228394|584112714|FG004|Overall Study|Physician Decision|0|||
161747096|NCT03228394|584112715|FG005|Overall Study|Physician Decision|0|||
161842997|NCT02393248|584470018|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
161842998|NCT02393248|584470019|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
161842999|NCT02393248|584470020|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
161843000|NCT02393248|584470021|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
161843001|NCT02393248|584470022|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
161843002|NCT02393248|584470023|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
161843003|NCT02393248|584470024|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
161843004|NCT02393248|584470000|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161967309|NCT04187144|584927673|FG000|Overall Study|Adverse Event|19|||
161967310|NCT04187144|584927674|FG001|Overall Study|Adverse Event|4|||
161967311|NCT04187144|584927673|FG000|Overall Study|Physician Decision|5|||
161967312|NCT04187144|584927674|FG001|Overall Study|Physician Decision|3|||
161967313|NCT04187144|584927673|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
161747097|NCT03228394|584112716|FG006|Overall Study|Physician Decision|1|||
161843005|NCT02393248|584470001|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843006|NCT02393248|584470002|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161747098|NCT03228394|584112717|FG007|Overall Study|Physician Decision|0|||
161747099|NCT03228394|584112710|FG000|Overall Study|Noncompliance|0|||
161747100|NCT03228394|584112711|FG001|Overall Study|Noncompliance|0|||
161747101|NCT03228394|584112712|FG002|Overall Study|Noncompliance|0|||
161843007|NCT02393248|584470003|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161747102|NCT03228394|584112713|FG003|Overall Study|Noncompliance|0|||
161747103|NCT03228394|584112714|FG004|Overall Study|Noncompliance|0|||
161747104|NCT03228394|584112715|FG005|Overall Study|Noncompliance|0|||
161747105|NCT03228394|584112716|FG006|Overall Study|Noncompliance|1|||
161747106|NCT03228394|584112717|FG007|Overall Study|Noncompliance|0|||
161747107|NCT03000686|584112718|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
161747108|NCT03000686|584112719|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
161747109|NCT03000686|584112720|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
161747110|NCT03000686|584112721|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
161747111|NCT01851863|584112726|FG000|Overall Study|Did not receive study medication|2|||
161747112|NCT01851863|584112727|FG001|Overall Study|Did not receive study medication|5|||
161747113|NCT01851863|584112728|FG002|Overall Study|Did not receive study medication|3|||
161747114|NCT01851863|584112729|FG003|Overall Study|Did not receive study medication|0|||
161747115|NCT01851863|584112726|FG000|Overall Study|Lost to Follow-up|3|||
161747116|NCT01851863|584112727|FG001|Overall Study|Lost to Follow-up|4|||
161747117|NCT01851863|584112728|FG002|Overall Study|Lost to Follow-up|2|||
161747118|NCT01851863|584112729|FG003|Overall Study|Lost to Follow-up|3|||
161747119|NCT00753623|584112730|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
161747120|NCT00753623|584112731|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
161747121|NCT00753623|584112730|FG000|Phase I (14 Days)|Physician Decision|1|||
161747122|NCT00753623|584112731|FG001|Phase I (14 Days)|Physician Decision|2|||
161747123|NCT00753623|584112730|FG000|Phase I (14 Days)|Adverse Event|0|||
161747124|NCT00753623|584112731|FG001|Phase I (14 Days)|Adverse Event|1|||
161747125|NCT00753623|584112730|FG000|Washout (7 Days)|Physician Decision|1|||
161747126|NCT00753623|584112731|FG001|Washout (7 Days)|Physician Decision|0|||
161747127|NCT00753623|584112730|FG000|Phase II (14 Days)|Physician Decision|0|||
161747128|NCT00753623|584112731|FG001|Phase II (14 Days)|Physician Decision|1|||
161747129|NCT03332303|584112732|FG000|Overall Study|Participant did not dose|1|||
161747130|NCT03332303|584112733|FG001|Overall Study|Participant did not dose|2|||
161747131|NCT03332303|584112734|FG002|Overall Study|Participant did not dose|0|||
161747132|NCT03332303|584112732|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
161747133|NCT03332303|584112733|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
161747134|NCT03332303|584112734|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
161747135|NCT03332303|584112732|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
161747136|NCT03332303|584112733|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
161747137|NCT03332303|584112734|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
161747138|NCT03332303|584112732|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
161747139|NCT03332303|584112733|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
161747140|NCT03332303|584112734|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
161747141|NCT03332303|584112732|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
161967314|NCT04187144|584927674|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
161967315|NCT04187144|584927673|FG000|Overall Study|Protocol Deviation|1|||
161967316|NCT04187144|584927674|FG001|Overall Study|Protocol Deviation|4|||
161967317|NCT01044745|584927675|FG000|Overall Study|Ineiligible|2|||
161967318|NCT01159171|584927678|FG000|Overall Study|Adverse Event|11|||
161967319|NCT01159171|584927678|FG000|Overall Study|Progression of Disease|28|||
161747142|NCT03332303|584112733|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
161747143|NCT03332303|584112734|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
161747144|NCT03332303|584112732|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
161747145|NCT03332303|584112733|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
161747146|NCT03332303|584112734|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
161747147|NCT03332303|584112732|FG000|Overall Study|Participant had a significant protocol deviation|0|||
161747148|NCT03332303|584112733|FG001|Overall Study|Participant had a significant protocol deviation|1|||
161747149|NCT03332303|584112734|FG002|Overall Study|Participant had a significant protocol deviation|0|||
161747150|NCT00345540|584112735|FG000|Overall Study|Withdrawal by Subject|1|||
161747151|NCT04179786|584112736|FG000|Overall Study|Withdrawal by Subject|8|||
161747152|NCT01938001|584112737|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
161747153|NCT01938001|584112738|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
161747154|NCT01938001|584112737|FG000|Pre-Treatment|Death|1|||
161747155|NCT01938001|584112738|FG001|Pre-Treatment|Death|0|||
161747156|NCT01938001|584112737|FG000|Treatment|Death|2|||
161747157|NCT01938001|584112738|FG001|Treatment|Death|0|||
161747158|NCT01938001|584112737|FG000|Treatment|Adverse Event|14|||
161747159|NCT01938001|584112738|FG001|Treatment|Adverse Event|8|||
161967320|NCT01159171|584927678|FG000|Overall Study|Protocol Violation|1|||
161967321|NCT01159171|584927678|FG000|Overall Study|Need for Surgery|5|||
161967322|NCT01159171|584927678|FG000|Overall Study|Medical Decision|4|||
161747160|NCT01938001|584112737|FG000|Treatment|Progressive Disease|21|||
161747161|NCT01938001|584112738|FG001|Treatment|Progressive Disease|54|||
161967323|NCT01159171|584927678|FG000|Overall Study|Death|1|||
161967324|NCT01962987|584927679|FG000|Overall Study|Adverse Event|4|||
161967325|NCT01962987|584927680|FG001|Overall Study|Adverse Event|4|||
161843008|NCT02393248|584470004|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843009|NCT02393248|584470005|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843010|NCT02393248|584470006|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843011|NCT02393248|584470007|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843012|NCT02393248|584470008|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843013|NCT02393248|584470009|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161747162|NCT01938001|584112737|FG000|Treatment|Withdrawal by Subject|13|||
161747163|NCT01938001|584112738|FG001|Treatment|Withdrawal by Subject|7|||
161747164|NCT01938001|584112737|FG000|Treatment|Other reasons|2|||
161747165|NCT01938001|584112738|FG001|Treatment|Other reasons|1|||
161747166|NCT03310580|584112739|FG000|Overall Study|Adverse Event|0|||
161747167|NCT03310580|584112740|FG001|Overall Study|Adverse Event|1|||
161747168|NCT03310580|584112741|FG002|Overall Study|Adverse Event|0|||
161747169|NCT03205982|584112742|FG000|Overall Study|Lost to Follow-up|20|||
161747170|NCT03205982|584112743|FG001|Overall Study|Lost to Follow-up|19|||
161747171|NCT03205982|584112742|FG000|Overall Study|Withdrawal by Subject|4|||
161747172|NCT03205982|584112743|FG001|Overall Study|Withdrawal by Subject|3|||
161747173|NCT03205982|584112742|FG000|Overall Study|Withdrawal by PI|0|||
161747174|NCT03205982|584112743|FG001|Overall Study|Withdrawal by PI|1|||
161747175|NCT00418717|584112744|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
161747176|NCT00418717|584112744|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
161747177|NCT02762708|584112749|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
161747178|NCT02762708|584112750|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
161747179|NCT02762708|584112751|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
161747180|NCT02762708|584112752|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
161747181|NCT01468701|584112753|FG000|Overall Study|Not eligible|91|||
161747182|NCT01468701|584112754|FG001|Overall Study|Not eligible|140|||
161747183|NCT01468701|584112755|FG002|Overall Study|Not eligible|29|||
161747184|NCT01468701|584112756|FG003|Overall Study|Not eligible|12|||
161747185|NCT01468701|584112757|FG004|Overall Study|Not eligible|22|||
161747186|NCT01468701|584112758|FG005|Overall Study|Not eligible|2|||
161747187|NCT01468701|584112759|FG006|Overall Study|Not eligible|39|||
161747188|NCT01468701|584112760|FG007|Overall Study|Not eligible|1|||
161747189|NCT01468701|584112761|FG008|Overall Study|Not eligible|40|||
161747190|NCT01468701|584112762|FG009|Overall Study|Not eligible|126|||
161747191|NCT01468701|584112763|FG010|Overall Study|Not eligible|39|||
161747192|NCT01468701|584112764|FG011|Overall Study|Not eligible|33|||
161747193|NCT01468701|584112765|FG012|Overall Study|Not eligible|1|||
161747194|NCT01468701|584112766|FG013|Overall Study|Not eligible|19|||
161747195|NCT01468701|584112767|FG014|Overall Study|Not eligible|1|||
161747196|NCT01468701|584112768|FG015|Overall Study|Not eligible|32|||
161747197|NCT01468701|584112769|FG016|Overall Study|Not eligible|0|||
161747198|NCT01468701|584112753|FG000|Overall Study|Lost to Follow-up|306|||
161747199|NCT01468701|584112754|FG001|Overall Study|Lost to Follow-up|0|||
161747200|NCT01468701|584112755|FG002|Overall Study|Lost to Follow-up|0|||
161747201|NCT01468701|584112756|FG003|Overall Study|Lost to Follow-up|0|||
161747202|NCT01468701|584112757|FG004|Overall Study|Lost to Follow-up|0|||
161747203|NCT01468701|584112758|FG005|Overall Study|Lost to Follow-up|0|||
161747204|NCT01468701|584112759|FG006|Overall Study|Lost to Follow-up|0|||
161747205|NCT01468701|584112760|FG007|Overall Study|Lost to Follow-up|0|||
161747206|NCT01468701|584112761|FG008|Overall Study|Lost to Follow-up|215|||
161747207|NCT01468701|584112762|FG009|Overall Study|Lost to Follow-up|309|||
161747208|NCT01468701|584112763|FG010|Overall Study|Lost to Follow-up|224|||
161747209|NCT01468701|584112764|FG011|Overall Study|Lost to Follow-up|212|||
161747210|NCT01468701|584112765|FG012|Overall Study|Lost to Follow-up|11|||
161747211|NCT01468701|584112766|FG013|Overall Study|Lost to Follow-up|164|||
161843014|NCT02393248|584470010|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843015|NCT02393248|584470011|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
161747212|NCT01468701|584112767|FG014|Overall Study|Lost to Follow-up|17|||
161747213|NCT01468701|584112768|FG015|Overall Study|Lost to Follow-up|127|||
161747214|NCT01468701|584112769|FG016|Overall Study|Lost to Follow-up|1|||
161747215|NCT01468701|584112753|FG000|Overall Study|Withdrawal by Subject|165|||
161747216|NCT01468701|584112754|FG001|Overall Study|Withdrawal by Subject|0|||
161747217|NCT01468701|584112755|FG002|Overall Study|Withdrawal by Subject|0|||
161747218|NCT01468701|584112756|FG003|Overall Study|Withdrawal by Subject|0|||
161967326|NCT01962987|584927681|FG002|Overall Study|Adverse Event|0|||
161747219|NCT01468701|584112757|FG004|Overall Study|Withdrawal by Subject|0|||
161747220|NCT01468701|584112758|FG005|Overall Study|Withdrawal by Subject|0|||
161747221|NCT01468701|584112759|FG006|Overall Study|Withdrawal by Subject|0|||
161747222|NCT01468701|584112760|FG007|Overall Study|Withdrawal by Subject|0|||
161747223|NCT01468701|584112761|FG008|Overall Study|Withdrawal by Subject|83|||
161967327|NCT01962987|584927679|FG000|Overall Study|Lost to Follow-up|0|||
161747224|NCT01468701|584112762|FG009|Overall Study|Withdrawal by Subject|88|||
161747225|NCT01468701|584112763|FG010|Overall Study|Withdrawal by Subject|100|||
161967328|NCT01962987|584927680|FG001|Overall Study|Lost to Follow-up|0|||
161967329|NCT01962987|584927681|FG002|Overall Study|Lost to Follow-up|1|||
161747226|NCT01468701|584112764|FG011|Overall Study|Withdrawal by Subject|114|||
161747227|NCT01468701|584112765|FG012|Overall Study|Withdrawal by Subject|9|||
161747228|NCT01468701|584112766|FG013|Overall Study|Withdrawal by Subject|47|||
161747229|NCT01468701|584112767|FG014|Overall Study|Withdrawal by Subject|6|||
161747230|NCT01468701|584112768|FG015|Overall Study|Withdrawal by Subject|31|||
161747231|NCT01468701|584112769|FG016|Overall Study|Withdrawal by Subject|0|||
161747232|NCT01468701|584112753|FG000|Overall Study|Other reasons than listed|437|||
161747233|NCT01468701|584112754|FG001|Overall Study|Other reasons than listed|0|||
161747234|NCT01468701|584112755|FG002|Overall Study|Other reasons than listed|0|||
161747235|NCT01468701|584112756|FG003|Overall Study|Other reasons than listed|0|||
161747236|NCT01468701|584112757|FG004|Overall Study|Other reasons than listed|0|||
161747237|NCT01468701|584112758|FG005|Overall Study|Other reasons than listed|0|||
161747238|NCT01468701|584112759|FG006|Overall Study|Other reasons than listed|0|||
161747239|NCT01468701|584112760|FG007|Overall Study|Other reasons than listed|0|||
161747240|NCT01468701|584112761|FG008|Overall Study|Other reasons than listed|318|||
161747241|NCT01468701|584112762|FG009|Overall Study|Other reasons than listed|658|||
161747242|NCT01468701|584112763|FG010|Overall Study|Other reasons than listed|433|||
161747243|NCT01468701|584112764|FG011|Overall Study|Other reasons than listed|504|||
161747244|NCT01468701|584112765|FG012|Overall Study|Other reasons than listed|28|||
161747245|NCT01468701|584112766|FG013|Overall Study|Other reasons than listed|239|||
161747246|NCT01468701|584112767|FG014|Overall Study|Other reasons than listed|39|||
161747247|NCT01468701|584112768|FG015|Overall Study|Other reasons than listed|172|||
161747248|NCT01468701|584112769|FG016|Overall Study|Other reasons than listed|0|||
161747249|NCT01468701|584112753|FG000|Overall Study|No end of study case report form|0|||
161747250|NCT01468701|584112754|FG001|Overall Study|No end of study case report form|0|||
161747251|NCT01468701|584112755|FG002|Overall Study|No end of study case report form|0|||
161747252|NCT01468701|584112756|FG003|Overall Study|No end of study case report form|0|||
161747253|NCT01468701|584112757|FG004|Overall Study|No end of study case report form|0|||
161747254|NCT01468701|584112758|FG005|Overall Study|No end of study case report form|0|||
161747255|NCT01468701|584112759|FG006|Overall Study|No end of study case report form|0|||
161747256|NCT01468701|584112760|FG007|Overall Study|No end of study case report form|0|||
161747257|NCT01468701|584112761|FG008|Overall Study|No end of study case report form|4|||
161747258|NCT01468701|584112762|FG009|Overall Study|No end of study case report form|1|||
161747259|NCT01468701|584112763|FG010|Overall Study|No end of study case report form|2|||
161747260|NCT01468701|584112764|FG011|Overall Study|No end of study case report form|3|||
161747261|NCT01468701|584112765|FG012|Overall Study|No end of study case report form|0|||
161747262|NCT01468701|584112766|FG013|Overall Study|No end of study case report form|1|||
161747263|NCT01468701|584112767|FG014|Overall Study|No end of study case report form|0|||
161747264|NCT01468701|584112768|FG015|Overall Study|No end of study case report form|0|||
161747265|NCT01468701|584112769|FG016|Overall Study|No end of study case report form|0|||
161747266|NCT01468701|584112753|FG000|Overall Study|Not being followed up|0|||
161747267|NCT01468701|584112754|FG001|Overall Study|Not being followed up|4963|||
161747268|NCT01468701|584112755|FG002|Overall Study|Not being followed up|1755|||
161747269|NCT01468701|584112756|FG003|Overall Study|Not being followed up|703|||
161747270|NCT01468701|584112757|FG004|Overall Study|Not being followed up|1714|||
161747271|NCT01468701|584112758|FG005|Overall Study|Not being followed up|126|||
161747272|NCT01468701|584112759|FG006|Overall Study|Not being followed up|1170|||
161747273|NCT01468701|584112760|FG007|Overall Study|Not being followed up|4|||
161747274|NCT01468701|584112761|FG008|Overall Study|Not being followed up|0|||
161747275|NCT01468701|584112762|FG009|Overall Study|Not being followed up|0|||
161747276|NCT01468701|584112763|FG010|Overall Study|Not being followed up|0|||
161747277|NCT01468701|584112764|FG011|Overall Study|Not being followed up|0|||
161747278|NCT01468701|584112765|FG012|Overall Study|Not being followed up|0|||
161747279|NCT01468701|584112766|FG013|Overall Study|Not being followed up|0|||
161747280|NCT01468701|584112767|FG014|Overall Study|Not being followed up|0|||
161747281|NCT01468701|584112768|FG015|Overall Study|Not being followed up|0|||
161747282|NCT01468701|584112769|FG016|Overall Study|Not being followed up|0|||
161747283|NCT00970268|584112774|FG000|Overall Study|Withdrawal by Subject|12|||
161747284|NCT00970268|584112775|FG001|Overall Study|Withdrawal by Subject|19|||
161747285|NCT00970268|584112774|FG000|Overall Study|Adverse Event|15|||
161747286|NCT00970268|584112775|FG001|Overall Study|Adverse Event|12|||
161843016|NCT02393248|584470012|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843017|NCT02393248|584470013|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
161747287|NCT00970268|584112774|FG000|Overall Study|Lack of Efficacy|3|||
161747288|NCT00970268|584112775|FG001|Overall Study|Lack of Efficacy|6|||
161747289|NCT00970268|584112774|FG000|Overall Study|Protocol Violation|4|||
161747290|NCT00970268|584112775|FG001|Overall Study|Protocol Violation|7|||
161747291|NCT00970268|584112774|FG000|Overall Study|Other Reason|3|||
161747292|NCT00970268|584112775|FG001|Overall Study|Other Reason|1|||
161747293|NCT00970268|584112774|FG000|Overall Study|COPD Exacerbation|4|||
161747294|NCT00970268|584112775|FG001|Overall Study|COPD Exacerbation|2|||
161747295|NCT00970268|584112774|FG000|Overall Study|Lost to Follow-up|1|||
161747296|NCT00970268|584112775|FG001|Overall Study|Lost to Follow-up|2|||
161747297|NCT00970268|584112774|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
161843018|NCT02393248|584470014|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161747298|NCT00970268|584112775|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
161747299|NCT01079195|584112779|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
161747300|NCT01079195|584112779|FG000|Overall Study|No Documentation Available|437|||
161747301|NCT01079195|584112779|FG000|Overall Study|Adverse Event|157|||
161747302|NCT01079195|584112779|FG000|Overall Study|Reason Unknown|39|||
161747303|NCT01079195|584112779|FG000|Overall Study|Withdrawal by Subject|18|||
161747304|NCT01079195|584112779|FG000|Overall Study|Financial Reasons|15|||
161843019|NCT02393248|584470015|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843020|NCT02393248|584470016|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843021|NCT02393248|584470017|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843022|NCT02393248|584470018|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161747305|NCT01079195|584112779|FG000|Overall Study|Lack of Effectiveness|12|||
161747306|NCT01079195|584112779|FG000|Overall Study|Physician Decision|4|||
161747307|NCT01079195|584112779|FG000|Overall Study|Improved Status of Participant|4|||
161747308|NCT01079195|584112779|FG000|Overall Study|No Follow-up Documentation Available|4|||
161747309|NCT01079195|584112779|FG000|Overall Study|Non-compliance|2|||
161747310|NCT01999946|584112780|FG000|Overall Study|Participant not released from jail|2|||
161747311|NCT01999946|584112781|FG001|Overall Study|Participant not released from jail|2|||
161747312|NCT01999946|584112782|FG002|Overall Study|Participant not released from jail|0|||
161747313|NCT01999946|584112780|FG000|Overall Study|Not included in primary outcome analysis|0|||
161747314|NCT01999946|584112781|FG001|Overall Study|Not included in primary outcome analysis|0|||
161747315|NCT01999946|584112782|FG002|Overall Study|Not included in primary outcome analysis|79|||
161747316|NCT03906136|584114192|FG000|Overall Study|Adverse Event|1|||
161747317|NCT03906136|584114193|FG001|Overall Study|Adverse Event|0|||
161747318|NCT03906136|584114192|FG000|Overall Study|Lost to Follow-up|7|||
161747319|NCT03906136|584114193|FG001|Overall Study|Lost to Follow-up|4|||
161747320|NCT03906136|584114192|FG000|Overall Study|Physician Decision|1|||
161747321|NCT03906136|584114193|FG001|Overall Study|Physician Decision|0|||
161747322|NCT03906136|584114192|FG000|Overall Study|Withdrawal by Subject|3|||
161747323|NCT03906136|584114193|FG001|Overall Study|Withdrawal by Subject|7|||
161747324|NCT01696396|584114198|FG000|Overall Study|Withdrawal by Subject|19|||
161747325|NCT01696396|584114199|FG001|Overall Study|Withdrawal by Subject|5|||
161747326|NCT01696396|584114200|FG002|Overall Study|Withdrawal by Subject|19|||
161747327|NCT01696396|584114201|FG003|Overall Study|Withdrawal by Subject|11|||
161747328|NCT01696396|584114198|FG000|Overall Study|Decision by Sponsor|3|||
161747329|NCT01696396|584114199|FG001|Overall Study|Decision by Sponsor|1|||
161747330|NCT01696396|584114200|FG002|Overall Study|Decision by Sponsor|2|||
161747331|NCT01696396|584114201|FG003|Overall Study|Decision by Sponsor|2|||
161747332|NCT01696396|584114198|FG000|Overall Study|Lost to Follow-up|9|||
161747333|NCT01696396|584114199|FG001|Overall Study|Lost to Follow-up|1|||
161747334|NCT01696396|584114200|FG002|Overall Study|Lost to Follow-up|4|||
161747335|NCT01696396|584114201|FG003|Overall Study|Lost to Follow-up|1|||
161747336|NCT01696396|584114198|FG000|Overall Study|Death|0|||
161747337|NCT01696396|584114199|FG001|Overall Study|Death|0|||
161747338|NCT01696396|584114200|FG002|Overall Study|Death|1|||
161747339|NCT01696396|584114201|FG003|Overall Study|Death|0|||
161747340|NCT02371980|584114207|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
161747341|NCT02371980|584114208|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
161747342|NCT02371980|584114209|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
161747343|NCT02371980|584114210|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
161747344|NCT02371980|584114211|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
161747345|NCT02371980|584114207|FG000|Open-label Period|Significant Protocol Deviation|19|||
161747346|NCT02371980|584114208|FG001|Open-label Period|Significant Protocol Deviation|0|||
161843023|NCT02393248|584470019|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843024|NCT02393248|584470020|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843025|NCT02393248|584470021|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843026|NCT02393248|584470022|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843027|NCT02393248|584470023|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843028|NCT02393248|584470024|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161843029|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
162032649|NCT04761627|585177443|FG000|Post-randomization Period|Lost to Follow-up|0|||
162032650|NCT04761627|585177444|FG001|Post-randomization Period|Lost to Follow-up|6|||
162032651|NCT04761627|585177445|FG002|Post-randomization Period|Lost to Follow-up|6|||
161747347|NCT02371980|584114209|FG002|Open-label Period|Significant Protocol Deviation|0|||
161747348|NCT02371980|584114210|FG003|Open-label Period|Significant Protocol Deviation|0|||
161747349|NCT02371980|584114211|FG004|Open-label Period|Significant Protocol Deviation|0|||
161747350|NCT02371980|584114207|FG000|Open-label Period|Noncompliance with Study Drug|10|||
161747351|NCT02371980|584114208|FG001|Open-label Period|Noncompliance with Study Drug|0|||
161747352|NCT02371980|584114209|FG002|Open-label Period|Noncompliance with Study Drug|0|||
161747353|NCT02371980|584114210|FG003|Open-label Period|Noncompliance with Study Drug|0|||
161843030|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161967330|NCT01962987|584927679|FG000|Overall Study|Non compliance with dosing requirements|4|||
161967331|NCT01962987|584927680|FG001|Overall Study|Non compliance with dosing requirements|2|||
161967332|NCT01962987|584927681|FG002|Overall Study|Non compliance with dosing requirements|0|||
161747354|NCT02371980|584114211|FG004|Open-label Period|Noncompliance with Study Drug|0|||
161967333|NCT01962987|584927679|FG000|Overall Study|Miscellaneous|1|||
161967334|NCT01962987|584927680|FG001|Overall Study|Miscellaneous|9|||
161967335|NCT01962987|584927681|FG002|Overall Study|Miscellaneous|2|||
161967336|NCT01962987|584927679|FG000|Overall Study|Restricted medication|5|||
161967337|NCT01962987|584927680|FG001|Overall Study|Restricted medication|1|||
161967338|NCT01962987|584927681|FG002|Overall Study|Restricted medication|1|||
161967339|NCT01962987|584927679|FG000|Overall Study|Serious Adverse Event|1|||
161967340|NCT01962987|584927680|FG001|Overall Study|Serious Adverse Event|0|||
161967341|NCT01962987|584927681|FG002|Overall Study|Serious Adverse Event|0|||
161967342|NCT01962987|584927679|FG000|Overall Study|Withdrawal by Subject|11|||
161967343|NCT01962987|584927680|FG001|Overall Study|Withdrawal by Subject|10|||
161967344|NCT01962987|584927681|FG002|Overall Study|Withdrawal by Subject|6|||
161967345|NCT01962987|584927679|FG000|Overall Study|Randomized in Error|4|||
161967346|NCT01962987|584927680|FG001|Overall Study|Randomized in Error|2|||
161967347|NCT01962987|584927681|FG002|Overall Study|Randomized in Error|2|||
161967348|NCT02264665|584927682|FG000|Overall Study|Other|0|||
161967349|NCT02264665|584927683|FG001|Overall Study|Other|0|||
161967350|NCT02264665|584927684|FG002|Overall Study|Other|3|||
161967351|NCT02264665|584927685|FG003|Overall Study|Other|0|||
161967352|NCT02264665|584927686|FG004|Overall Study|Other|0|||
161967353|NCT02264665|584927687|FG005|Overall Study|Other|0|||
161967354|NCT02264665|584927688|FG006|Overall Study|Other|0|||
161967355|NCT02264665|584927682|FG000|Overall Study|Death|9|||
161967356|NCT02264665|584927683|FG001|Overall Study|Death|8|||
161967357|NCT02264665|584927684|FG002|Overall Study|Death|13|||
161967358|NCT02264665|584927685|FG003|Overall Study|Death|5|||
161967359|NCT02264665|584927686|FG004|Overall Study|Death|0|||
161967360|NCT02264665|584927687|FG005|Overall Study|Death|0|||
161967361|NCT02264665|584927688|FG006|Overall Study|Death|1|||
161967362|NCT02264665|584927682|FG000|Overall Study|Lost to Follow-up|1|||
161967363|NCT02264665|584927683|FG001|Overall Study|Lost to Follow-up|0|||
161967364|NCT02264665|584927684|FG002|Overall Study|Lost to Follow-up|2|||
161967365|NCT02264665|584927685|FG003|Overall Study|Lost to Follow-up|1|||
161967366|NCT02264665|584927686|FG004|Overall Study|Lost to Follow-up|0|||
161967367|NCT02264665|584927687|FG005|Overall Study|Lost to Follow-up|0|||
161747355|NCT02371980|584114207|FG000|Open-label Period|Lost to Follow-up|55|||
161747356|NCT02371980|584114208|FG001|Open-label Period|Lost to Follow-up|0|||
161747357|NCT02371980|584114209|FG002|Open-label Period|Lost to Follow-up|0|||
161747358|NCT02371980|584114210|FG003|Open-label Period|Lost to Follow-up|0|||
161747359|NCT02371980|584114211|FG004|Open-label Period|Lost to Follow-up|0|||
161747360|NCT02371980|584114207|FG000|Open-label Period|Voluntary Withdrawal|91|||
161747361|NCT02371980|584114208|FG001|Open-label Period|Voluntary Withdrawal|0|||
161747362|NCT02371980|584114209|FG002|Open-label Period|Voluntary Withdrawal|0|||
161747363|NCT02371980|584114210|FG003|Open-label Period|Voluntary Withdrawal|0|||
161747364|NCT02371980|584114211|FG004|Open-label Period|Voluntary Withdrawal|0|||
161747365|NCT02371980|584114207|FG000|Open-label Period|Pregnancy|1|||
161747366|NCT02371980|584114208|FG001|Open-label Period|Pregnancy|0|||
161747367|NCT02371980|584114209|FG002|Open-label Period|Pregnancy|0|||
161747368|NCT02371980|584114210|FG003|Open-label Period|Pregnancy|0|||
161747369|NCT02371980|584114211|FG004|Open-label Period|Pregnancy|0|||
161967368|NCT02264665|584927688|FG006|Overall Study|Lost to Follow-up|0|||
161967369|NCT02264665|584927682|FG000|Overall Study|Participant decision|0|||
161967370|NCT02264665|584927683|FG001|Overall Study|Participant decision|0|||
161967371|NCT02264665|584927684|FG002|Overall Study|Participant decision|0|||
161967372|NCT02264665|584927685|FG003|Overall Study|Participant decision|1|||
161967373|NCT02264665|584927686|FG004|Overall Study|Participant decision|0|||
161967374|NCT02264665|584927687|FG005|Overall Study|Participant decision|0|||
161967375|NCT02264665|584927688|FG006|Overall Study|Participant decision|0|||
161967376|NCT02264665|584927682|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
161967377|NCT02264665|584927683|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
162032652|NCT04761627|585177443|FG000|Post-randomization Period|Withdrawal by Subject|0|||
162032653|NCT04761627|585177444|FG001|Post-randomization Period|Withdrawal by Subject|7|||
161747370|NCT02371980|584114207|FG000|Open-label Period|Lack of Efficacy|116|||
161747371|NCT02371980|584114208|FG001|Open-label Period|Lack of Efficacy|0|||
161747372|NCT02371980|584114209|FG002|Open-label Period|Lack of Efficacy|0|||
161967378|NCT02264665|584927684|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
161967379|NCT02264665|584927685|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
161967380|NCT02264665|584927686|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
161967381|NCT02264665|584927687|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
161967382|NCT02264665|584927688|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
161967383|NCT02264665|584927682|FG000|Overall Study|Data Missing|0|||
161967384|NCT02264665|584927683|FG001|Overall Study|Data Missing|0|||
161967385|NCT02264665|584927684|FG002|Overall Study|Data Missing|1|||
161843031|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843032|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843033|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843034|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161747373|NCT02371980|584114210|FG003|Open-label Period|Lack of Efficacy|0|||
161747374|NCT02371980|584114211|FG004|Open-label Period|Lack of Efficacy|0|||
161843035|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843036|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843037|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843038|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843039|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843040|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843041|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843042|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843043|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843044|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843045|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843046|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843047|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
161843048|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843049|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
161843050|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
161843051|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843052|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
161843053|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161843054|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Death|0|||
161843055|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Death|0|||
161747375|NCT02371980|584114207|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
161747376|NCT02371980|584114208|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
161747377|NCT02371980|584114209|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
161747378|NCT02371980|584114210|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
161747379|NCT02371980|584114211|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
161747380|NCT02371980|584114207|FG000|Open-label Period|Reason not Specified|9|||
161747381|NCT02371980|584114208|FG001|Open-label Period|Reason not Specified|0|||
161747382|NCT02371980|584114209|FG002|Open-label Period|Reason not Specified|0|||
161747383|NCT02371980|584114210|FG003|Open-label Period|Reason not Specified|0|||
161747384|NCT02371980|584114211|FG004|Open-label Period|Reason not Specified|0|||
161747385|NCT02371980|584114207|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
161747386|NCT02371980|584114208|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
161747387|NCT02371980|584114209|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
161747388|NCT02371980|584114210|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
161747389|NCT02371980|584114211|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
161747390|NCT02371980|584114207|FG000|Double-blind Period|Significant Protocol Deviation|0|||
161747391|NCT02371980|584114208|FG001|Double-blind Period|Significant Protocol Deviation|2|||
161747392|NCT02371980|584114209|FG002|Double-blind Period|Significant Protocol Deviation|7|||
161747393|NCT02371980|584114210|FG003|Double-blind Period|Significant Protocol Deviation|3|||
161747394|NCT02371980|584114211|FG004|Double-blind Period|Significant Protocol Deviation|3|||
161747395|NCT02371980|584114207|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
161747396|NCT02371980|584114208|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
161747397|NCT02371980|584114209|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
161747398|NCT02371980|584114210|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
161747399|NCT02371980|584114211|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
161747400|NCT02371980|584114207|FG000|Double-blind Period|Lost to Follow-up|0|||
161747401|NCT02371980|584114208|FG001|Double-blind Period|Lost to Follow-up|8|||
161747402|NCT02371980|584114209|FG002|Double-blind Period|Lost to Follow-up|8|||
161747403|NCT02371980|584114210|FG003|Double-blind Period|Lost to Follow-up|6|||
161747404|NCT02371980|584114211|FG004|Double-blind Period|Lost to Follow-up|5|||
161747405|NCT02371980|584114207|FG000|Double-blind Period|Voluntary Withdrawal|0|||
161747406|NCT02371980|584114208|FG001|Double-blind Period|Voluntary Withdrawal|12|||
161747407|NCT02371980|584114209|FG002|Double-blind Period|Voluntary Withdrawal|8|||
161747408|NCT02371980|584114210|FG003|Double-blind Period|Voluntary Withdrawal|9|||
161747409|NCT02371980|584114211|FG004|Double-blind Period|Voluntary Withdrawal|11|||
161843056|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Death|0|||
161967386|NCT02264665|584927685|FG003|Overall Study|Data Missing|0|||
161747410|NCT02371980|584114207|FG000|Double-blind Period|Relapse|0|||
161747411|NCT02371980|584114208|FG001|Double-blind Period|Relapse|50|||
161747412|NCT02371980|584114209|FG002|Double-blind Period|Relapse|25|||
161843057|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Death|0|||
161843058|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Death|0|||
161843059|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Death|0|||
161843060|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Death|0|||
161843061|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Death|0|||
161747413|NCT02371980|584114210|FG003|Double-blind Period|Relapse|25|||
161747414|NCT02371980|584114211|FG004|Double-blind Period|Relapse|26|||
161747415|NCT02371980|584114207|FG000|Double-blind Period|Reason not Specified|0|||
161747416|NCT02371980|584114208|FG001|Double-blind Period|Reason not Specified|3|||
161747417|NCT02371980|584114209|FG002|Double-blind Period|Reason not Specified|3|||
161747418|NCT02371980|584114210|FG003|Double-blind Period|Reason not Specified|2|||
161747419|NCT02371980|584114211|FG004|Double-blind Period|Reason not Specified|1|||
161747420|NCT02371980|584114207|FG000|Double-blind Period|Missing|0|||
161747421|NCT02371980|584114208|FG001|Double-blind Period|Missing|1|||
161747422|NCT02371980|584114209|FG002|Double-blind Period|Missing|0|||
161747423|NCT02371980|584114210|FG003|Double-blind Period|Missing|0|||
161747424|NCT02371980|584114211|FG004|Double-blind Period|Missing|0|||
161747425|NCT01280812|584114213|FG000|Overall Study|Withdrawal by Subject|2|||
161747426|NCT01280812|584114214|FG001|Overall Study|Withdrawal by Subject|1|||
161747427|NCT01280812|584114215|FG002|Overall Study|Withdrawal by Subject|0|||
161747428|NCT01280812|584114213|FG000|Overall Study|Lost to Follow-up|1|||
161747429|NCT01280812|584114214|FG001|Overall Study|Lost to Follow-up|1|||
161747430|NCT01280812|584114215|FG002|Overall Study|Lost to Follow-up|1|||
161747431|NCT03907969|584114219|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
161747432|NCT03907969|584114220|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
161747433|NCT03907969|584114221|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
161747434|NCT03907969|584114222|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
161747435|NCT03907969|584114223|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
161747436|NCT03907969|584114224|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
161747437|NCT03907969|584114225|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
161747438|NCT03907969|584114226|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
161747439|NCT03907969|584114227|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
161747440|NCT03907969|584114228|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
161747441|NCT03907969|584114229|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
161747442|NCT03907969|584114219|FG000|Monotherapy Part A|Progressive Disease|0|||
161747443|NCT03907969|584114220|FG001|Monotherapy Part A|Progressive Disease|1|||
161747444|NCT03907969|584114221|FG002|Monotherapy Part A|Progressive Disease|0|||
161747445|NCT03907969|584114222|FG003|Monotherapy Part A|Progressive Disease|0|||
161747446|NCT03907969|584114223|FG004|Monotherapy Part A|Progressive Disease|0|||
161747447|NCT03907969|584114224|FG005|Monotherapy Part A|Progressive Disease|1|||
161747448|NCT03907969|584114225|FG006|Monotherapy Part A|Progressive Disease|2|||
161747449|NCT03907969|584114226|FG007|Monotherapy Part A|Progressive Disease|0|||
161747450|NCT03907969|584114227|FG008|Monotherapy Part A|Progressive Disease|0|||
161747451|NCT03907969|584114228|FG009|Monotherapy Part A|Progressive Disease|0|||
161747452|NCT03907969|584114229|FG010|Monotherapy Part A|Progressive Disease|0|||
161747453|NCT03907969|584114219|FG000|Monotherapy Part A|Death|0|||
161747454|NCT03907969|584114220|FG001|Monotherapy Part A|Death|0|||
161747455|NCT03907969|584114221|FG002|Monotherapy Part A|Death|1|||
161747456|NCT03907969|584114222|FG003|Monotherapy Part A|Death|1|||
161747457|NCT03907969|584114223|FG004|Monotherapy Part A|Death|0|||
161747458|NCT03907969|584114224|FG005|Monotherapy Part A|Death|1|||
161967387|NCT02264665|584927686|FG004|Overall Study|Data Missing|0|||
161967388|NCT02264665|584927687|FG005|Overall Study|Data Missing|0|||
161967389|NCT02264665|584927688|FG006|Overall Study|Data Missing|0|||
161967390|NCT00789581|584927689|FG000|AC Therapy|Adverse Event|2|||
161967391|NCT00789581|584927690|FG001|AC Therapy|Adverse Event|3|||
161967392|NCT00789581|584927689|FG000|AC Therapy|Withdrawal by Subject|4|||
161967393|NCT00789581|584927690|FG001|AC Therapy|Withdrawal by Subject|7|||
161967394|NCT00789581|584927689|FG000|AC Therapy|Disease recurrence|3|||
161967395|NCT00789581|584927690|FG001|AC Therapy|Disease recurrence|1|||
161967396|NCT00789581|584927689|FG000|AC Therapy|Intercurrent Illness|1|||
161967397|NCT00789581|584927690|FG001|AC Therapy|Intercurrent Illness|0|||
161967398|NCT00789581|584927689|FG000|AC Therapy|Never Treated|1|||
161967399|NCT00789581|584927690|FG001|AC Therapy|Never Treated|4|||
161967400|NCT00789581|584927689|FG000|AC Therapy|Other|0|||
161967401|NCT00789581|584927690|FG001|AC Therapy|Other|2|||
161747459|NCT03907969|584114225|FG006|Monotherapy Part A|Death|0|||
161967402|NCT00789581|584927689|FG000|Adjuvant Therapy|Never treated|2|||
161747460|NCT03907969|584114226|FG007|Monotherapy Part A|Death|0|||
161747461|NCT03907969|584114227|FG008|Monotherapy Part A|Death|0|||
161747462|NCT03907969|584114228|FG009|Monotherapy Part A|Death|0|||
161747463|NCT03907969|584114229|FG010|Monotherapy Part A|Death|0|||
161747464|NCT03907969|584114219|FG000|Combination Therapy Part A|Adverse Event|0|||
161747465|NCT03907969|584114220|FG001|Combination Therapy Part A|Adverse Event|0|||
161747466|NCT03907969|584114221|FG002|Combination Therapy Part A|Adverse Event|0|||
161747467|NCT03907969|584114222|FG003|Combination Therapy Part A|Adverse Event|0|||
161747468|NCT03907969|584114223|FG004|Combination Therapy Part A|Adverse Event|0|||
161967403|NCT00789581|584927690|FG001|Adjuvant Therapy|Never treated|2|||
161747469|NCT03907969|584114224|FG005|Combination Therapy Part A|Adverse Event|0|||
161747470|NCT03907969|584114225|FG006|Combination Therapy Part A|Adverse Event|0|||
161747471|NCT03907969|584114226|FG007|Combination Therapy Part A|Adverse Event|0|||
161967404|NCT00789581|584927689|FG000|Adjuvant Therapy|Adverse Event|20|||
161967405|NCT00789581|584927690|FG001|Adjuvant Therapy|Adverse Event|44|||
161967406|NCT00789581|584927689|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
161967407|NCT00789581|584927690|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
161747472|NCT03907969|584114227|FG008|Combination Therapy Part A|Adverse Event|0|||
161747473|NCT03907969|584114228|FG009|Combination Therapy Part A|Adverse Event|1|||
161747474|NCT03907969|584114229|FG010|Combination Therapy Part A|Adverse Event|1|||
161747475|NCT03907969|584114219|FG000|Combination Therapy Part A|Progressive disease|0|||
161747476|NCT03907969|584114220|FG001|Combination Therapy Part A|Progressive disease|0|||
161747477|NCT03907969|584114221|FG002|Combination Therapy Part A|Progressive disease|0|||
161747478|NCT03907969|584114222|FG003|Combination Therapy Part A|Progressive disease|0|||
161747479|NCT03907969|584114223|FG004|Combination Therapy Part A|Progressive disease|0|||
161747480|NCT03907969|584114224|FG005|Combination Therapy Part A|Progressive disease|0|||
161747481|NCT03907969|584114225|FG006|Combination Therapy Part A|Progressive disease|0|||
161747482|NCT03907969|584114226|FG007|Combination Therapy Part A|Progressive disease|1|||
161747483|NCT03907969|584114227|FG008|Combination Therapy Part A|Progressive disease|0|||
161747484|NCT03907969|584114228|FG009|Combination Therapy Part A|Progressive disease|2|||
161747485|NCT03907969|584114229|FG010|Combination Therapy Part A|Progressive disease|3|||
161747486|NCT03907969|584114219|FG000|Combination Therapy Part A|Death|0|||
161747487|NCT03907969|584114220|FG001|Combination Therapy Part A|Death|0|||
161747488|NCT03907969|584114221|FG002|Combination Therapy Part A|Death|0|||
161747489|NCT03907969|584114222|FG003|Combination Therapy Part A|Death|0|||
161747490|NCT03907969|584114223|FG004|Combination Therapy Part A|Death|0|||
161747491|NCT03907969|584114224|FG005|Combination Therapy Part A|Death|0|||
161747492|NCT03907969|584114225|FG006|Combination Therapy Part A|Death|0|||
161747493|NCT03907969|584114226|FG007|Combination Therapy Part A|Death|0|||
161747494|NCT03907969|584114227|FG008|Combination Therapy Part A|Death|1|||
161747495|NCT03907969|584114228|FG009|Combination Therapy Part A|Death|0|||
161747496|NCT03907969|584114229|FG010|Combination Therapy Part A|Death|1|||
161747497|NCT03907969|584114219|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
161747498|NCT03907969|584114220|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
161747499|NCT03907969|584114221|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
161747500|NCT03907969|584114222|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
161747501|NCT03907969|584114223|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
161747502|NCT03907969|584114224|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
161747503|NCT03907969|584114225|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
161747504|NCT03907969|584114226|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
161747505|NCT03907969|584114227|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
161747506|NCT03907969|584114228|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
161747507|NCT03907969|584114229|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
161747508|NCT03907969|584114219|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
161747509|NCT03907969|584114220|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
161747510|NCT03907969|584114221|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
161747511|NCT03907969|584114222|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
161747512|NCT03907969|584114223|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
161747513|NCT03907969|584114224|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
161747514|NCT03907969|584114225|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
161747515|NCT03907969|584114226|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
161747516|NCT03907969|584114227|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
161747517|NCT03907969|584114228|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
161747518|NCT03907969|584114229|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
161747519|NCT03907969|584114219|FG000|Combination Therapy Part A|Physician Decision|0|||
161747520|NCT03907969|584114220|FG001|Combination Therapy Part A|Physician Decision|0|||
161747521|NCT03907969|584114221|FG002|Combination Therapy Part A|Physician Decision|0|||
161747522|NCT03907969|584114222|FG003|Combination Therapy Part A|Physician Decision|0|||
161747523|NCT03907969|584114223|FG004|Combination Therapy Part A|Physician Decision|0|||
161747524|NCT03907969|584114224|FG005|Combination Therapy Part A|Physician Decision|0|||
161747525|NCT03907969|584114225|FG006|Combination Therapy Part A|Physician Decision|0|||
161747526|NCT03907969|584114226|FG007|Combination Therapy Part A|Physician Decision|1|||
161747527|NCT03907969|584114227|FG008|Combination Therapy Part A|Physician Decision|0|||
161747528|NCT03907969|584114228|FG009|Combination Therapy Part A|Physician Decision|0|||
161747529|NCT03907969|584114229|FG010|Combination Therapy Part A|Physician Decision|1|||
161747530|NCT00666536|584114230|FG000|Overall Study|Adverse Event|9|||
161747531|NCT00666536|584114231|FG001|Overall Study|Adverse Event|19|||
161747532|NCT00666536|584114230|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161747533|NCT00666536|584114231|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161747534|NCT00666536|584114230|FG000|Overall Study|Protocol deviation(s)|8|||
161747535|NCT00666536|584114231|FG001|Overall Study|Protocol deviation(s)|6|||
161747536|NCT00666536|584114230|FG000|Overall Study|Withdrawal by Subject|10|||
161967408|NCT00789581|584927689|FG000|Adjuvant Therapy|Disease recurrence|2|||
161967409|NCT00789581|584927690|FG001|Adjuvant Therapy|Disease recurrence|1|||
161747537|NCT00666536|584114231|FG001|Overall Study|Withdrawal by Subject|9|||
161747538|NCT00666536|584114230|FG000|Overall Study|Lost to Follow-up|4|||
161747539|NCT00666536|584114231|FG001|Overall Study|Lost to Follow-up|3|||
161747540|NCT02853123|584114235|FG000|Treatment Period 1|Adverse Event|0|||
161967410|NCT00789581|584927689|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
161967411|NCT00789581|584927690|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
161967412|NCT00789581|584927689|FG000|Adjuvant Therapy|Protocol Violation|1|||
161967413|NCT00789581|584927690|FG001|Adjuvant Therapy|Protocol Violation|1|||
161747541|NCT02853123|584114236|FG001|Treatment Period 1|Adverse Event|3|||
161747542|NCT02853123|584114235|FG000|Washout Period|Worsening of COPD|0|||
161747543|NCT02853123|584114236|FG001|Washout Period|Worsening of COPD|3|||
161747544|NCT02853123|584114235|FG000|Washout Period|Adverse Event|1|||
161747545|NCT02853123|584114236|FG001|Washout Period|Adverse Event|0|||
161747546|NCT01419015|584114247|FG000|Overall Study|Death|2|||
161747547|NCT04209530|584114248|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
161747548|NCT04209530|584114249|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
161747549|NCT04209530|584114248|FG000|Overall Study|Withdrawal by Subject|0|||
161747550|NCT04209530|584114249|FG001|Overall Study|Withdrawal by Subject|1|||
161747551|NCT04839393|584114250|FG000|Overall Study|Adverse Event|0|||
161747552|NCT04839393|584114251|FG001|Overall Study|Adverse Event|0|||
161747553|NCT04839393|584114252|FG002|Overall Study|Adverse Event|2|||
161747554|NCT04839393|584114250|FG000|Overall Study|Withdrawal by participant|0|||
161747555|NCT04839393|584114251|FG001|Overall Study|Withdrawal by participant|0|||
161747556|NCT04839393|584114252|FG002|Overall Study|Withdrawal by participant|1|||
161747557|NCT00633893|584114255|FG000|Overall Study|Death|1|||
161747558|NCT00633893|584114256|FG001|Overall Study|Death|3|||
161747559|NCT00633893|584114257|FG002|Overall Study|Death|9|||
161747560|NCT00633893|584114255|FG000|Overall Study|Adverse Event|65|||
161747561|NCT00633893|584114256|FG001|Overall Study|Adverse Event|58|||
161747562|NCT00633893|584114257|FG002|Overall Study|Adverse Event|126|||
161747563|NCT00633893|584114255|FG000|Overall Study|Withdrawal by Subject|7|||
161747564|NCT00633893|584114256|FG001|Overall Study|Withdrawal by Subject|12|||
161747565|NCT00633893|584114257|FG002|Overall Study|Withdrawal by Subject|6|||
161747566|NCT00633893|584114255|FG000|Overall Study|Lost to Follow-up|2|||
161747567|NCT00633893|584114256|FG001|Overall Study|Lost to Follow-up|4|||
161747568|NCT00633893|584114257|FG002|Overall Study|Lost to Follow-up|8|||
161747569|NCT00633893|584114255|FG000|Overall Study|Poor/non-compliance|5|||
161747570|NCT00633893|584114256|FG001|Overall Study|Poor/non-compliance|12|||
161747571|NCT00633893|584114257|FG002|Overall Study|Poor/non-compliance|3|||
161747572|NCT00633893|584114255|FG000|Overall Study|Pregnancy|2|||
161747573|NCT00633893|584114256|FG001|Overall Study|Pregnancy|1|||
161747574|NCT00633893|584114257|FG002|Overall Study|Pregnancy|1|||
161747575|NCT00633893|584114255|FG000|Overall Study|Not meet/no longer meets criteria|4|||
161747576|NCT00633893|584114256|FG001|Overall Study|Not meet/no longer meets criteria|6|||
161747577|NCT00633893|584114257|FG002|Overall Study|Not meet/no longer meets criteria|4|||
161747578|NCT00633893|584114255|FG000|Overall Study|Other|28|||
161747579|NCT00633893|584114256|FG001|Overall Study|Other|33|||
161747580|NCT00633893|584114257|FG002|Overall Study|Other|31|||
161747581|NCT02741310|584114258|FG000|Overall Study|Sponsor Decision|2|||
161747582|NCT02741310|584114259|FG001|Overall Study|Sponsor Decision|2|||
161747583|NCT01784211|584114260|FG000|Part A (Days 1-15)|Adverse Event|1|||
161747584|NCT01784211|584114261|FG001|Part A (Days 1-15)|Adverse Event|1|||
161747585|NCT01784211|584114262|FG002|Part A (Days 1-15)|Adverse Event|0|||
161747586|NCT01784211|584114263|FG003|Part A (Days 1-15)|Adverse Event|0|||
161843062|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Death|0|||
161967414|NCT00789581|584927689|FG000|Adjuvant Therapy|Other|0|||
161967415|NCT00789581|584927690|FG001|Adjuvant Therapy|Other|1|||
161967416|NCT01468207|584927691|FG000|Treatment Period 1|Adverse Event|1|||
161967417|NCT01468207|584927692|FG001|Treatment Period 1|Adverse Event|0|||
161967418|NCT01468207|584927693|FG002|Treatment Period 1|Adverse Event|0|||
161967419|NCT01468207|584927694|FG003|Treatment Period 1|Adverse Event|0|||
161967420|NCT01468207|584927695|FG004|Treatment Period 1|Adverse Event|0|||
161967421|NCT01468207|584927696|FG005|Treatment Period 1|Adverse Event|0|||
161967422|NCT01468207|584927691|FG000|Treatment Period 1|Protocol Violation|1|||
161967423|NCT01468207|584927692|FG001|Treatment Period 1|Protocol Violation|1|||
161967424|NCT01468207|584927693|FG002|Treatment Period 1|Protocol Violation|0|||
161967425|NCT01468207|584927694|FG003|Treatment Period 1|Protocol Violation|0|||
161967426|NCT01468207|584927695|FG004|Treatment Period 1|Protocol Violation|0|||
161967427|NCT01468207|584927696|FG005|Treatment Period 1|Protocol Violation|0|||
161747587|NCT01784211|584114264|FG004|Part A (Days 1-15)|Adverse Event|0|||
161747588|NCT01784211|584114265|FG005|Part A (Days 1-15)|Adverse Event|0|||
161747589|NCT01784211|584114260|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
161747590|NCT01784211|584114261|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
161747591|NCT01784211|584114262|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
161843063|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Death|0|||
161747592|NCT01784211|584114263|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
161747593|NCT01784211|584114264|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
161843064|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Death|0|||
161967428|NCT01468207|584927691|FG000|Treatment Period 1|Withdrawal by Subject|5|||
161967429|NCT01468207|584927692|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161967430|NCT01468207|584927693|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161967431|NCT01468207|584927694|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161967432|NCT01468207|584927695|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161967433|NCT01468207|584927696|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161967434|NCT01468207|584927691|FG000|Treatment Period 1|Lost to Follow-up|2|||
161967435|NCT01468207|584927692|FG001|Treatment Period 1|Lost to Follow-up|1|||
161967436|NCT01468207|584927693|FG002|Treatment Period 1|Lost to Follow-up|0|||
161967437|NCT01468207|584927694|FG003|Treatment Period 1|Lost to Follow-up|0|||
161967438|NCT01468207|584927695|FG004|Treatment Period 1|Lost to Follow-up|0|||
161967439|NCT01468207|584927696|FG005|Treatment Period 1|Lost to Follow-up|0|||
161747594|NCT01784211|584114265|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
161747595|NCT00369278|584114268|FG000|Overall Study|Adverse Event|14|||
161747596|NCT00369278|584114269|FG001|Overall Study|Adverse Event|11|||
161747597|NCT00369278|584114268|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161747598|NCT00369278|584114269|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
161747599|NCT00369278|584114268|FG000|Overall Study|Protocol Violation|2|||
161747600|NCT00369278|584114269|FG001|Overall Study|Protocol Violation|1|||
161747601|NCT00369278|584114268|FG000|Overall Study|Withdrawal by Subject|2|||
161747602|NCT00369278|584114269|FG001|Overall Study|Withdrawal by Subject|2|||
161747603|NCT00369278|584114268|FG000|Overall Study|Lost to Follow-up|1|||
161747604|NCT00369278|584114269|FG001|Overall Study|Lost to Follow-up|0|||
161747605|NCT00369278|584114268|FG000|Overall Study|Graft loss|1|||
161747606|NCT00369278|584114269|FG001|Overall Study|Graft loss|2|||
161747607|NCT01017549|584114274|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
161747608|NCT01017549|584114274|FG000|One-year Follow-up|Lost to Follow-up|2|||
161747609|NCT01017549|584114274|FG000|One-year Follow-up|Withdrawal by Subject|5|||
161747610|NCT01017549|584114274|FG000|5 Year Follow-up|Lost to Follow-up|9|||
161747611|NCT01017549|584114274|FG000|5 Year Follow-up|Mastectomy|3|||
161747612|NCT01989754|584114277|FG000|Overall Study|Withdrawal by Subject|10|||
161747613|NCT01989754|584114278|FG001|Overall Study|Withdrawal by Subject|14|||
161747614|NCT01989754|584114277|FG000|Overall Study|Lost to Follow-up|28|||
161747615|NCT01989754|584114278|FG001|Overall Study|Lost to Follow-up|20|||
161747616|NCT01989754|584114277|FG000|Overall Study|Closed Site|1|||
161747617|NCT01989754|584114278|FG001|Overall Study|Closed Site|1|||
161747618|NCT03725293|584114285|FG000|Overall Study|Physician Decision|9|||
161747619|NCT03725293|584114286|FG001|Overall Study|Physician Decision|6|||
161747620|NCT03725293|584114285|FG000|Overall Study|alternative vascular access needs|1|||
161747621|NCT03725293|584114286|FG001|Overall Study|alternative vascular access needs|2|||
161747622|NCT03725293|584114285|FG000|Overall Study|venous anatomy screen failures|2|||
161747623|NCT03725293|584114286|FG001|Overall Study|venous anatomy screen failures|1|||
161747624|NCT02143141|584114287|FG000|Overall Study|pain scores at 24 hours not collected|1|||
161747625|NCT02143141|584114288|FG001|Overall Study|pain scores at 24 hours not collected|0|||
161747626|NCT01057862|584114289|FG000|Overall Study|Withdrawal by Subject|1|||
161747627|NCT01057862|584114290|FG001|Overall Study|Withdrawal by Subject|2|||
161747628|NCT03363165|584114291|FG000|3-month Follow-up|Death|0|||
161747629|NCT03363165|584114292|FG001|3-month Follow-up|Death|1|||
161747630|NCT03363165|584114291|FG000|6-month Follow-up|Death|0|||
161747631|NCT03363165|584114292|FG001|6-month Follow-up|Death|1|||
161747632|NCT03363165|584114291|FG000|6-month Follow-up|Withdrawal by Subject|1|||
161747633|NCT03363165|584114292|FG001|6-month Follow-up|Withdrawal by Subject|1|||
161747634|NCT03363165|584114291|FG000|12-month Follow-up|Death|1|||
161747635|NCT03363165|584114292|FG001|12-month Follow-up|Death|1|||
161747636|NCT03363165|584114291|FG000|12-month Follow-up|Withdrawal by Subject|1|||
161967440|NCT01468207|584927691|FG000|Treatment Period 1|Other|0|||
161967441|NCT01468207|584927692|FG001|Treatment Period 1|Other|2|||
161967442|NCT01468207|584927693|FG002|Treatment Period 1|Other|0|||
161967443|NCT01468207|584927694|FG003|Treatment Period 1|Other|0|||
161967444|NCT01468207|584927695|FG004|Treatment Period 1|Other|0|||
161967445|NCT01468207|584927696|FG005|Treatment Period 1|Other|0|||
161967446|NCT01468207|584927691|FG000|Treatment Period 2|Adverse Event|0|||
161747637|NCT03363165|584114292|FG001|12-month Follow-up|Withdrawal by Subject|1|||
161747638|NCT02255760|584114293|FG000|Overall Study|Lost to Follow-up|0|||
161747639|NCT02255760|584114294|FG001|Overall Study|Lost to Follow-up|1|||
161747640|NCT02255760|584114295|FG002|Overall Study|Lost to Follow-up|0|||
161747641|NCT02255760|584114296|FG003|Overall Study|Lost to Follow-up|0|||
161747642|NCT02255760|584114297|FG004|Overall Study|Lost to Follow-up|0|||
161747643|NCT00003838|584114298|FG000|Overall Study|Death|0|||
161747644|NCT00003838|584114299|FG001|Overall Study|Death|12|||
161747645|NCT00003838|584114300|FG002|Overall Study|Death|7|||
161747646|NCT00003838|584114298|FG000|Overall Study|Lost to Follow-up|0|||
161747647|NCT00003838|584114299|FG001|Overall Study|Lost to Follow-up|1|||
161747648|NCT00003838|584114300|FG002|Overall Study|Lost to Follow-up|1|||
161747649|NCT00003838|584114298|FG000|Overall Study|Disease Progression|0|||
161747650|NCT00003838|584114299|FG001|Overall Study|Disease Progression|12|||
161967447|NCT01468207|584927692|FG001|Treatment Period 2|Adverse Event|0|||
161967448|NCT01468207|584927693|FG002|Treatment Period 2|Adverse Event|6|||
161747651|NCT00003838|584114300|FG002|Overall Study|Disease Progression|0|||
161747652|NCT01296698|584114301|FG000|Overall Study|Adverse Event|1|||
161747653|NCT01296698|584114302|FG001|Overall Study|Adverse Event|0|||
161747654|NCT01296698|584114301|FG000|Overall Study|Death|1|||
161967449|NCT01468207|584927694|FG003|Treatment Period 2|Adverse Event|1|||
161967450|NCT01468207|584927695|FG004|Treatment Period 2|Adverse Event|2|||
161747655|NCT01296698|584114302|FG001|Overall Study|Death|0|||
161747656|NCT01296698|584114301|FG000|Overall Study|Lost to Follow-up|19|||
161747657|NCT01296698|584114302|FG001|Overall Study|Lost to Follow-up|1|||
161747658|NCT01296698|584114301|FG000|Overall Study|Withdrawal by Subject|12|||
161747659|NCT01296698|584114302|FG001|Overall Study|Withdrawal by Subject|0|||
161747660|NCT01296698|584114301|FG000|Overall Study|Difficulty Contacting Subject|2|||
161747661|NCT01296698|584114302|FG001|Overall Study|Difficulty Contacting Subject|0|||
161747662|NCT01296698|584114301|FG000|Overall Study|Study Terminated by Sponsor|209|||
161747663|NCT01296698|584114302|FG001|Overall Study|Study Terminated by Sponsor|12|||
161747664|NCT03495817|584114306|FG000|26 Week Open Label|Adverse Event|3|||
161747665|NCT03495817|584114306|FG000|26 Week Open Label|Withdrawal by Subject|4|||
161747666|NCT03495817|584114306|FG000|26 Week Open Label|Lost to Follow-up|1|||
161747667|NCT03495817|584114306|FG000|26 Week Extension|Lost to Follow-up|2|||
161747668|NCT01957787|584114307|FG000|Overall Study|Death|18|||
161747669|NCT01957787|584114307|FG000|Overall Study|Lost to Follow-up|3|||
161747670|NCT01957787|584114307|FG000|Overall Study|Withdrawal by Subject|3|||
161747671|NCT01957787|584114307|FG000|Overall Study|Entered Hospice or Similar Program|2|||
161747672|NCT01957787|584114307|FG000|Overall Study|Index Tumor(s) Resected|2|||
161747673|NCT01957787|584114307|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
161747674|NCT01957787|584114307|FG000|Overall Study|Local therapy, not cryoablation|6|||
161747675|NCT01686958|584114308|FG000|Overall Study|Withdrawal by Subject|1|||
161747676|NCT04294095|584114317|FG000|Overall Study|Adverse Event|1|||
161747677|NCT04294095|584114318|FG001|Overall Study|Adverse Event|0|||
161747678|NCT02224638|584114322|FG000|Overall Study|Adverse Event|1|||
161747679|NCT02224638|584114323|FG001|Overall Study|Adverse Event|1|||
161747680|NCT01400139|584114329|FG000|HYD Core Study|Adverse Event|210|||
161747681|NCT01400139|584114329|FG000|HYD Core Study|Lack of Efficacy|59|||
161747682|NCT01400139|584114329|FG000|HYD Core Study|Withdrawal by Subject|114|||
161747683|NCT01400139|584114329|FG000|HYD Core Study|Lost to Follow-up|39|||
161747684|NCT01400139|584114329|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
161747685|NCT01400139|584114329|FG000|HYD Core Study|Administrative|56|||
161747686|NCT01400139|584114329|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
161747687|NCT01400139|584114329|FG000|HYD Extension Period|Adverse Event|8|||
161747688|NCT01400139|584114329|FG000|HYD Extension Period|Withdrawal by Subject|5|||
161747689|NCT01400139|584114329|FG000|HYD Extension Period|Administrative|10|||
161747690|NCT00631540|584114330|FG000|Overall Study|Withdrawal by Subject|5|||
161747691|NCT00631540|584114330|FG000|Overall Study|Death|4|||
161747692|NCT00631540|584114330|FG000|Overall Study|Lost to Follow-up|2|||
161747693|NCT00631540|584114330|FG000|Overall Study|Core Lab Data Unavailable|3|||
161747694|NCT00795509|584114331|FG000|Overall Study|Protocol Violation|31|||
161747695|NCT00719953|584114334|FG000|Overall Study|Adverse Event|4|||
161747696|NCT03726333|584114338|FG000|Overall Study|Progressive Disease|0|||
161747697|NCT03726333|584114339|FG001|Overall Study|Progressive Disease|0|||
161747698|NCT03726333|584114340|FG002|Overall Study|Progressive Disease|1|||
161747699|NCT03726333|584114341|FG003|Overall Study|Progressive Disease|0|||
161747700|NCT03726333|584114342|FG004|Overall Study|Progressive Disease|0|||
161747701|NCT02947022|584114343|FG000|Overall Study|Study Stopped|1|||
161747702|NCT01230749|584114344|FG000|Overall Study|Adverse Event|0|||
161747703|NCT01230749|584114345|FG001|Overall Study|Adverse Event|0|||
161747704|NCT01230749|584114346|FG002|Overall Study|Adverse Event|0|||
161747705|NCT01230749|584114347|FG003|Overall Study|Adverse Event|1|||
161747706|NCT01230749|584114344|FG000|Overall Study|Physician Decision|0|||
161747707|NCT01230749|584114345|FG001|Overall Study|Physician Decision|0|||
161967451|NCT01468207|584927696|FG005|Treatment Period 2|Adverse Event|1|||
161967452|NCT01468207|584927691|FG000|Treatment Period 2|Lack of Efficacy|0|||
161967453|NCT01468207|584927692|FG001|Treatment Period 2|Lack of Efficacy|0|||
161967454|NCT01468207|584927693|FG002|Treatment Period 2|Lack of Efficacy|1|||
161967455|NCT01468207|584927694|FG003|Treatment Period 2|Lack of Efficacy|1|||
161967456|NCT01468207|584927695|FG004|Treatment Period 2|Lack of Efficacy|0|||
161967457|NCT01468207|584927696|FG005|Treatment Period 2|Lack of Efficacy|2|||
161747708|NCT01230749|584114346|FG002|Overall Study|Physician Decision|1|||
161747709|NCT01230749|584114347|FG003|Overall Study|Physician Decision|0|||
161747710|NCT01230749|584114344|FG000|Overall Study|Withdrawal by Subject|0|||
161747711|NCT01230749|584114345|FG001|Overall Study|Withdrawal by Subject|1|||
161747712|NCT01230749|584114346|FG002|Overall Study|Withdrawal by Subject|0|||
161747713|NCT01230749|584114347|FG003|Overall Study|Withdrawal by Subject|0|||
161747714|NCT01230749|584114344|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
161747715|NCT01230749|584114345|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
161747716|NCT01230749|584114346|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
161747717|NCT01230749|584114347|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
161967458|NCT01468207|584927691|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161747718|NCT00959894|584116153|FG000|Overall Study|Lost to Follow-up|10|||
161747719|NCT00959894|584116153|FG000|Overall Study|Adverse Event|3|||
161747720|NCT00959894|584116153|FG000|Overall Study|Withdrawal by Subject|1|||
161747721|NCT00959894|584116153|FG000|Overall Study|Need for contraindicated medication|1|||
161747722|NCT00959894|584116153|FG000|Overall Study|Subject moved out of town|1|||
161747723|NCT00922974|584116154|FG000|Phase II Component|Protocol Violation|2|||
161747724|NCT00922974|584116155|FG001|Phase II Component|Protocol Violation|0|||
161747725|NCT00922974|584116154|FG000|Phase II Component|Not evaluable for treatment review|5|||
161747726|NCT00922974|584116155|FG001|Phase II Component|Not evaluable for treatment review|0|||
161747727|NCT00922974|584116154|FG000|Phase III Component|Protocol Violation|8|||
161747728|NCT00922974|584116155|FG001|Phase III Component|Protocol Violation|6|||
161747729|NCT03682055|584116156|FG000|Overall Study|Lack of Efficacy|1|||
161747730|NCT03682055|584116157|FG001|Overall Study|Lack of Efficacy|2|||
161747731|NCT03682055|584116158|FG002|Overall Study|Lack of Efficacy|1|||
161747732|NCT03682055|584116159|FG003|Overall Study|Lack of Efficacy|2|||
161747733|NCT03682055|584116160|FG004|Overall Study|Lack of Efficacy|1|||
161747734|NCT03682055|584116161|FG005|Overall Study|Lack of Efficacy|3|||
161747735|NCT03682055|584116156|FG000|Overall Study|Withdrawal by Subject|0|||
161747736|NCT03682055|584116157|FG001|Overall Study|Withdrawal by Subject|0|||
161747737|NCT03682055|584116158|FG002|Overall Study|Withdrawal by Subject|0|||
161747738|NCT03682055|584116159|FG003|Overall Study|Withdrawal by Subject|0|||
161747739|NCT03682055|584116160|FG004|Overall Study|Withdrawal by Subject|0|||
161747740|NCT03682055|584116161|FG005|Overall Study|Withdrawal by Subject|1|||
161747741|NCT03682055|584116156|FG000|Overall Study|Termination of Study by Sponsor|0|||
161747742|NCT03682055|584116157|FG001|Overall Study|Termination of Study by Sponsor|0|||
161747743|NCT03682055|584116158|FG002|Overall Study|Termination of Study by Sponsor|0|||
161747744|NCT03682055|584116159|FG003|Overall Study|Termination of Study by Sponsor|0|||
161747745|NCT03682055|584116160|FG004|Overall Study|Termination of Study by Sponsor|0|||
161747746|NCT03682055|584116161|FG005|Overall Study|Termination of Study by Sponsor|3|||
161747747|NCT00191386|584116162|FG000|Overall Study|Adverse Event|16|||
161747748|NCT00191386|584116162|FG000|Overall Study|Lost to Follow-up|1|||
161747749|NCT00191386|584116162|FG000|Overall Study|Entry Criteria Exclusion|3|||
161747750|NCT00191386|584116162|FG000|Overall Study|Protocol Violation|18|||
161747751|NCT00191386|584116162|FG000|Overall Study|Withdrawal by Subject|96|||
161747752|NCT00191386|584116162|FG000|Overall Study|Physician Decision|11|||
161747753|NCT00191386|584116162|FG000|Overall Study|Lack of Efficacy|15|||
161747754|NCT03077243|584116164|FG000|Overall Study|Death|1|||
161747755|NCT03077243|584116165|FG001|Overall Study|Death|2|||
161747756|NCT03077243|584116166|FG002|Overall Study|Death|0|||
161747757|NCT03077243|584116167|FG003|Overall Study|Death|0|||
161747758|NCT03077243|584116164|FG000|Overall Study|Withdrawal by Subject|1|||
161747759|NCT03077243|584116165|FG001|Overall Study|Withdrawal by Subject|3|||
161747760|NCT03077243|584116166|FG002|Overall Study|Withdrawal by Subject|0|||
161747761|NCT03077243|584116167|FG003|Overall Study|Withdrawal by Subject|0|||
161747762|NCT03077243|584116164|FG000|Overall Study|Physician Decision|1|||
161747763|NCT03077243|584116165|FG001|Overall Study|Physician Decision|0|||
161747764|NCT03077243|584116166|FG002|Overall Study|Physician Decision|0|||
161747765|NCT03077243|584116167|FG003|Overall Study|Physician Decision|0|||
161747766|NCT03077243|584116164|FG000|Overall Study|Research at two study sites terminated early|0|||
161747767|NCT03077243|584116165|FG001|Overall Study|Research at two study sites terminated early|0|||
161747768|NCT03077243|584116166|FG002|Overall Study|Research at two study sites terminated early|0|||
161747769|NCT03077243|584116167|FG003|Overall Study|Research at two study sites terminated early|69|||
161747770|NCT01544478|584116168|FG000|Overall Study|Adverse Event|1|||
161747771|NCT01544478|584116168|FG000|Overall Study|Death|1|||
161747772|NCT01544478|584116168|FG000|Overall Study|Lost to Follow-up|48|||
161747773|NCT01544478|584116168|FG000|Overall Study|Physician Decision|15|||
161747774|NCT01544478|584116168|FG000|Overall Study|Pregnancy|1|||
161747775|NCT01544478|584116168|FG000|Overall Study|Withdrawal by Subject|52|||
161747776|NCT00212758|584116169|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
161747777|NCT00212758|584116170|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
161747778|NCT00212758|584116169|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
161747779|NCT00212758|584116170|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
161747780|NCT02574481|584116171|FG000|Overall Study|Withdrawal by Subject|29|||
161747781|NCT02574481|584116172|FG001|Overall Study|Withdrawal by Subject|15|||
161747782|NCT02574481|584116173|FG002|Overall Study|Withdrawal by Subject|4|||
161747783|NCT02574481|584116174|FG003|Overall Study|Withdrawal by Subject|1|||
161747784|NCT02574481|584116171|FG000|Overall Study|Adverse Event|5|||
161747785|NCT02574481|584116172|FG001|Overall Study|Adverse Event|1|||
161747786|NCT02574481|584116173|FG002|Overall Study|Adverse Event|1|||
161747787|NCT02574481|584116174|FG003|Overall Study|Adverse Event|0|||
161747788|NCT02574481|584116171|FG000|Overall Study|Visit Missed|15|||
161747789|NCT02574481|584116172|FG001|Overall Study|Visit Missed|7|||
161747790|NCT02574481|584116173|FG002|Overall Study|Visit Missed|5|||
161747791|NCT02574481|584116174|FG003|Overall Study|Visit Missed|0|||
161747792|NCT02574481|584116171|FG000|Overall Study|Other|7|||
161747793|NCT02574481|584116172|FG001|Overall Study|Other|2|||
161747794|NCT02574481|584116173|FG002|Overall Study|Other|0|||
161747795|NCT02574481|584116174|FG003|Overall Study|Other|0|||
161747796|NCT02574481|584116171|FG000|Overall Study|Death|48|||
161747797|NCT02574481|584116172|FG001|Overall Study|Death|26|||
161747798|NCT02574481|584116173|FG002|Overall Study|Death|12|||
161747799|NCT02574481|584116174|FG003|Overall Study|Death|4|||
161843065|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Death|0|||
161843066|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Death|0|||
161843067|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Death|0|||
161843068|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Death|0|||
161843069|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Death|1|||
161843070|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Death|7|||
161843071|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Death|5|||
161843072|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Death|5|||
161843073|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Death|3|||
161843074|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Death|7|||
161843075|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Death|5|||
161843076|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Death|6|||
161843077|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Death|3|||
161843078|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Death|0|||
161843079|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843080|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843081|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843082|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843083|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843084|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843085|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843086|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843087|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843088|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843089|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843090|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843091|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843092|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843093|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843094|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843095|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843096|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161843097|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161843098|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161843099|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161843100|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161843101|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161843102|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
161843103|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161843104|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Disease Progression|0|||
161843105|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Disease Progression|0|||
161843106|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Disease Progression|0|||
161843107|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Disease Progression|0|||
161843108|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Disease Progression|0|||
161843109|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Disease Progression|0|||
161843110|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Disease Progression|0|||
161843111|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Disease Progression|0|||
161843112|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Disease Progression|0|||
161843113|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Disease Progression|0|||
161843114|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Disease Progression|0|||
161843115|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Disease Progression|0|||
162032654|NCT04761627|585177445|FG002|Post-randomization Period|Withdrawal by Subject|6|||
161747800|NCT02574481|584116171|FG000|Overall Study|Physician Decision|5|||
161747801|NCT02574481|584116172|FG001|Overall Study|Physician Decision|2|||
161747802|NCT02574481|584116173|FG002|Overall Study|Physician Decision|0|||
161747803|NCT02574481|584116174|FG003|Overall Study|Physician Decision|0|||
161747804|NCT02574481|584116171|FG000|Overall Study|Lost to Follow-up|5|||
161747805|NCT02574481|584116172|FG001|Overall Study|Lost to Follow-up|1|||
161747806|NCT02574481|584116173|FG002|Overall Study|Lost to Follow-up|3|||
161747807|NCT02574481|584116174|FG003|Overall Study|Lost to Follow-up|0|||
161747808|NCT00446641|584116178|FG000|Overall Study|Withdrawal by Subject|8|||
161747809|NCT00446641|584116179|FG001|Overall Study|Withdrawal by Subject|3|||
161747810|NCT00446641|584116178|FG000|Overall Study|poor compliance|8|||
161747811|NCT00446641|584116179|FG001|Overall Study|poor compliance|6|||
161747812|NCT00446641|584116178|FG000|Overall Study|Lost to Follow-up|1|||
161747813|NCT00446641|584116179|FG001|Overall Study|Lost to Follow-up|1|||
161843116|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Disease Progression|0|||
161843117|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Disease Progression|0|||
161843118|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Disease Progression|0|||
161843119|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Disease Progression|0|||
161843120|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Disease Progression|0|||
161747814|NCT01826448|584116181|FG000|Overall Study|Adverse Event|1|||
161967459|NCT01468207|584927692|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161967460|NCT01468207|584927693|FG002|Treatment Period 2|Withdrawal by Subject|5|||
161967461|NCT01468207|584927694|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161967462|NCT01468207|584927695|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161747815|NCT01826448|584116182|FG001|Overall Study|Adverse Event|3|||
161747816|NCT01826448|584116181|FG000|Overall Study|Disease progression|2|||
161747817|NCT01826448|584116182|FG001|Overall Study|Disease progression|4|||
161747818|NCT01826448|584116181|FG000|Overall Study|Withdrawal by Subject|1|||
161747819|NCT01826448|584116182|FG001|Overall Study|Withdrawal by Subject|0|||
161747820|NCT01826448|584116181|FG000|Overall Study|Physician Decision|0|||
161747821|NCT01826448|584116182|FG001|Overall Study|Physician Decision|1|||
161747822|NCT01826448|584116181|FG000|Overall Study|2 active cancers|0|||
161747823|NCT01826448|584116182|FG001|Overall Study|2 active cancers|1|||
161747824|NCT02038790|584116187|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
161747825|NCT02038790|584116188|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
161747826|NCT00784459|584116190|FG000|Overall Study|Adverse Event|0|||
161747827|NCT00784459|584116191|FG001|Overall Study|Adverse Event|2|||
161747828|NCT02431702|584116192|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
161747829|NCT02431702|584116193|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161747830|NCT02431702|584116194|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161747831|NCT02431702|584116195|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161747832|NCT02431702|584116196|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161747833|NCT02431702|584116197|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161747834|NCT02431702|584116198|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161747835|NCT02431702|584116192|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
161747836|NCT02431702|584116193|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161747837|NCT02431702|584116194|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161747838|NCT02431702|584116195|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161747839|NCT02431702|584116196|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161747840|NCT02431702|584116197|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161747841|NCT02431702|584116198|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
161747842|NCT02431702|584116192|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
161747843|NCT02431702|584116193|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161747844|NCT02431702|584116194|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161747845|NCT02431702|584116195|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161747846|NCT02431702|584116196|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161747847|NCT02431702|584116197|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161747848|NCT02431702|584116198|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
161747849|NCT02431702|584116192|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
161747850|NCT02431702|584116193|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161747851|NCT02431702|584116194|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161747852|NCT02431702|584116195|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161747853|NCT02431702|584116196|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161747854|NCT02431702|584116197|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161747855|NCT02431702|584116198|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
161747856|NCT02431702|584116192|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
161747857|NCT02431702|584116193|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161747858|NCT02431702|584116194|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161747859|NCT02431702|584116195|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161747860|NCT02431702|584116196|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161747861|NCT02431702|584116197|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161747862|NCT02431702|584116198|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161747863|NCT02431702|584116192|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161747864|NCT02431702|584116193|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
161747865|NCT02431702|584116194|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
161747866|NCT02431702|584116195|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161747867|NCT02431702|584116196|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161747868|NCT02431702|584116197|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161747869|NCT02431702|584116198|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161747870|NCT02431702|584116192|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161747871|NCT02431702|584116193|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
161747872|NCT02431702|584116194|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
161747873|NCT02431702|584116195|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161747874|NCT02431702|584116196|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161967463|NCT01468207|584927696|FG005|Treatment Period 2|Withdrawal by Subject|2|||
161967464|NCT01468207|584927691|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
161747875|NCT02431702|584116197|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161747876|NCT02431702|584116198|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161747877|NCT02431702|584116192|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161747878|NCT02431702|584116193|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
161747879|NCT02431702|584116194|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
161747880|NCT02431702|584116195|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161747881|NCT02431702|584116196|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161747882|NCT02431702|584116197|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161747883|NCT02431702|584116198|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161747884|NCT02431702|584116192|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161747885|NCT02431702|584116193|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
161747886|NCT02431702|584116194|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161747887|NCT02431702|584116195|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161747888|NCT02431702|584116196|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161747889|NCT02431702|584116197|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161747890|NCT02431702|584116198|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161747891|NCT02431702|584116192|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
161747892|NCT02431702|584116193|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
161747893|NCT02431702|584116194|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
161747894|NCT02431702|584116195|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
161747895|NCT02431702|584116196|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
161747896|NCT02431702|584116197|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
161747897|NCT02431702|584116198|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
161747898|NCT02431702|584116192|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161747899|NCT02431702|584116193|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161747900|NCT02431702|584116194|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
161747901|NCT02431702|584116195|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161747902|NCT02431702|584116196|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161747903|NCT02431702|584116197|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161747904|NCT02431702|584116198|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161747905|NCT02431702|584116192|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161747906|NCT02431702|584116193|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161747907|NCT02431702|584116194|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161747908|NCT02431702|584116195|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
161747909|NCT02431702|584116196|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
161747910|NCT02431702|584116197|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161747911|NCT02431702|584116198|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161747912|NCT02431702|584116192|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161747913|NCT02431702|584116193|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161747914|NCT02431702|584116194|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161747915|NCT02431702|584116195|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
161747916|NCT02431702|584116196|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161747917|NCT02431702|584116197|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
161747918|NCT02431702|584116198|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161747919|NCT02431702|584116192|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
161747920|NCT02431702|584116193|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
161747921|NCT02431702|584116194|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
161747922|NCT02431702|584116195|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
161747923|NCT02431702|584116196|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
161747924|NCT02431702|584116197|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
161747925|NCT02431702|584116198|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
161747926|NCT02431702|584116192|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
161747927|NCT02431702|584116193|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
161747928|NCT02431702|584116194|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
161747929|NCT02431702|584116195|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
161747930|NCT02431702|584116196|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
161747931|NCT02431702|584116197|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
161747932|NCT02431702|584116198|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
161747933|NCT01376388|584116213|FG000|Overall Study|Adverse Event|13|||
161747934|NCT01376388|584116213|FG000|Overall Study|Lack of Efficacy|2|||
161747935|NCT01376388|584116213|FG000|Overall Study|Withdrawal by Subject|3|||
161747936|NCT02009930|584116214|FG000|Overall Study|withdrawn|5|||
161747937|NCT00425113|584116226|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
162032655|NCT04761627|585177443|FG000|Post-randomization Period|Pregnancy|0|||
162032656|NCT04761627|585177444|FG001|Post-randomization Period|Pregnancy|0|||
162032657|NCT04761627|585177445|FG002|Post-randomization Period|Pregnancy|1|||
162032658|NCT04761627|585177443|FG000|Post-randomization Period|Study site closure|0|||
161747938|NCT00425113|584116227|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
161747939|NCT00425113|584116226|FG000|Overall Study|diagnosis of abdominal TB|0|||
161747940|NCT00425113|584116227|FG001|Overall Study|diagnosis of abdominal TB|1|||
161747941|NCT00425113|584116226|FG000|Overall Study|missing study drug more than 14 days|0|||
161747942|NCT00425113|584116227|FG001|Overall Study|missing study drug more than 14 days|1|||
161747943|NCT00425113|584116226|FG000|Overall Study|Withdrawal by Subject|1|||
161747944|NCT00425113|584116227|FG001|Overall Study|Withdrawal by Subject|0|||
161747945|NCT00879437|584116228|FG000|Overall Study|Protocol Violation|0|||
161747946|NCT00879437|584116229|FG001|Overall Study|Protocol Violation|1|||
161747947|NCT00879437|584116228|FG000|Overall Study|Death|1|||
161747948|NCT00879437|584116229|FG001|Overall Study|Death|0|||
161747949|NCT02920450|584116230|FG000|Overall Study|Death|1|||
161747950|NCT02920450|584116231|FG001|Overall Study|Death|0|||
161747951|NCT02920450|584116232|FG002|Overall Study|Death|0|||
161747952|NCT02920450|584116233|FG003|Overall Study|Death|0|||
161747953|NCT02920450|584116230|FG000|Overall Study|Withdrawal by Subject|1|||
161747954|NCT02920450|584116231|FG001|Overall Study|Withdrawal by Subject|0|||
161747955|NCT02920450|584116232|FG002|Overall Study|Withdrawal by Subject|0|||
161747956|NCT02920450|584116233|FG003|Overall Study|Withdrawal by Subject|0|||
161747957|NCT00291187|584116234|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
161747958|NCT00291187|584116235|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
161747959|NCT00291187|584116236|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
161747960|NCT00291187|584116237|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
161747961|NCT02023268|584116238|FG000|Overall Study|Lack of Efficacy|0|||
161747962|NCT02023268|584116239|FG001|Overall Study|Lack of Efficacy|1|||
161747963|NCT02023268|584116238|FG000|Overall Study|Adverse Event|0|||
161747964|NCT02023268|584116239|FG001|Overall Study|Adverse Event|2|||
161747965|NCT02023268|584116238|FG000|Overall Study|Withdrawal by Subject|0|||
161747966|NCT02023268|584116239|FG001|Overall Study|Withdrawal by Subject|1|||
161747967|NCT00126672|584116241|FG000|Overall Study|Adverse Event|4|||
161747968|NCT00126672|584116241|FG000|Overall Study|Lost to Follow-up|4|||
161747969|NCT01001234|584116243|FG000|Overall Study|Withdrawal by Subject|2|||
161747970|NCT01001234|584116244|FG001|Overall Study|Withdrawal by Subject|0|||
161747971|NCT01001234|584116245|FG002|Overall Study|Withdrawal by Subject|3|||
161747972|NCT01001234|584116246|FG003|Overall Study|Withdrawal by Subject|0|||
161747973|NCT01001234|584116247|FG004|Overall Study|Withdrawal by Subject|0|||
161747974|NCT01001234|584116243|FG000|Overall Study|Protocol Violation|34|||
161747975|NCT01001234|584116244|FG001|Overall Study|Protocol Violation|3|||
161747976|NCT01001234|584116245|FG002|Overall Study|Protocol Violation|19|||
161747977|NCT01001234|584116246|FG003|Overall Study|Protocol Violation|18|||
161747978|NCT01001234|584116247|FG004|Overall Study|Protocol Violation|0|||
161747979|NCT01001234|584116243|FG000|Overall Study|Lost to Follow-up|0|||
161747980|NCT01001234|584116244|FG001|Overall Study|Lost to Follow-up|0|||
161747981|NCT01001234|584116245|FG002|Overall Study|Lost to Follow-up|1|||
161747982|NCT01001234|584116246|FG003|Overall Study|Lost to Follow-up|2|||
161747983|NCT01001234|584116247|FG004|Overall Study|Lost to Follow-up|0|||
161747984|NCT01001234|584116243|FG000|Overall Study|Physician Decision|1|||
161747985|NCT01001234|584116244|FG001|Overall Study|Physician Decision|0|||
161747986|NCT01001234|584116245|FG002|Overall Study|Physician Decision|0|||
161747987|NCT01001234|584116246|FG003|Overall Study|Physician Decision|0|||
161747988|NCT01001234|584116247|FG004|Overall Study|Physician Decision|0|||
161747989|NCT01001234|584116243|FG000|Overall Study|Not Treated: Adverse Event|1|||
161747990|NCT01001234|584116244|FG001|Overall Study|Not Treated: Adverse Event|0|||
161747991|NCT01001234|584116245|FG002|Overall Study|Not Treated: Adverse Event|0|||
161747992|NCT01001234|584116246|FG003|Overall Study|Not Treated: Adverse Event|0|||
161747993|NCT01001234|584116247|FG004|Overall Study|Not Treated: Adverse Event|0|||
161747994|NCT01001234|584116243|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
161747995|NCT01001234|584116244|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
161747996|NCT01001234|584116245|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
161747997|NCT01001234|584116246|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
161843121|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Disease Progression|0|||
161747998|NCT01001234|584116247|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
161747999|NCT01001234|584116243|FG000|Overall Study|Not Treated: Protocol Violation|3|||
161748000|NCT01001234|584116244|FG001|Overall Study|Not Treated: Protocol Violation|0|||
161748001|NCT01001234|584116245|FG002|Overall Study|Not Treated: Protocol Violation|0|||
161748002|NCT01001234|584116246|FG003|Overall Study|Not Treated: Protocol Violation|0|||
161748003|NCT01001234|584116247|FG004|Overall Study|Not Treated: Protocol Violation|0|||
161748004|NCT01001234|584116243|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
161748005|NCT01001234|584116244|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
161748006|NCT01001234|584116245|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
161748007|NCT01001234|584116246|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
161748008|NCT01001234|584116247|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
161748009|NCT01001234|584116243|FG000|Overall Study|Not Treated: Pregnancy|3|||
161748010|NCT01001234|584116244|FG001|Overall Study|Not Treated: Pregnancy|0|||
161748011|NCT01001234|584116245|FG002|Overall Study|Not Treated: Pregnancy|0|||
161748012|NCT01001234|584116246|FG003|Overall Study|Not Treated: Pregnancy|0|||
161748013|NCT01001234|584116247|FG004|Overall Study|Not Treated: Pregnancy|0|||
161748014|NCT01001234|584116243|FG000|Overall Study|Not Treated: Physician Decision|37|||
161748015|NCT01001234|584116244|FG001|Overall Study|Not Treated: Physician Decision|4|||
161748016|NCT01001234|584116245|FG002|Overall Study|Not Treated: Physician Decision|0|||
161748017|NCT01001234|584116246|FG003|Overall Study|Not Treated: Physician Decision|0|||
161748018|NCT01001234|584116247|FG004|Overall Study|Not Treated: Physician Decision|0|||
161748019|NCT01001234|584116243|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
161748020|NCT01001234|584116244|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
161748021|NCT01001234|584116245|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
161748022|NCT01001234|584116246|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
161748023|NCT01001234|584116247|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
161748024|NCT02475629|584116253|FG000|Overall Study|Adverse Event|1|||
161748025|NCT02475629|584116253|FG000|Overall Study|Death|4|||
161748026|NCT02475629|584116253|FG000|Overall Study|Physician Decision|1|||
161748027|NCT02475629|584116253|FG000|Overall Study|Withdrawal by Subject|1|||
161748028|NCT02475629|584116253|FG000|Overall Study|Lost to Follow-up|1|||
161748029|NCT02475629|584116253|FG000|Overall Study|Subject non-compliance|1|||
161748030|NCT03379376|584116254|FG000|Overall Study|Lost to Follow-up|2|||
161748031|NCT03379376|584116254|FG000|Overall Study|Did not wish to complete follow up|1|||
161748032|NCT03379376|584116254|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
161748033|NCT03379376|584116254|FG000|Overall Study|Death|1|||
161748034|NCT01611298|584116255|FG000|Overall Study|Relapsed|2|||
161748035|NCT03238352|584116256|FG000|Overall Study|Lost to Follow-up|0|||
161748036|NCT03238352|584116257|FG001|Overall Study|Lost to Follow-up|2|||
161748037|NCT03238352|584116258|FG002|Overall Study|Lost to Follow-up|1|||
161748038|NCT03238352|584116256|FG000|Overall Study|Withdrawal by Subject|0|||
161748039|NCT03238352|584116257|FG001|Overall Study|Withdrawal by Subject|1|||
161748040|NCT03238352|584116258|FG002|Overall Study|Withdrawal by Subject|0|||
161748041|NCT00928512|584116259|FG000|Overall Study|Adverse Event|4|||
161748042|NCT00928512|584116260|FG001|Overall Study|Adverse Event|3|||
161748043|NCT00928512|584116261|FG002|Overall Study|Adverse Event|2|||
161748044|NCT00928512|584116262|FG003|Overall Study|Adverse Event|8|||
161748045|NCT00928512|584116263|FG004|Overall Study|Adverse Event|6|||
161748046|NCT00928512|584116259|FG000|Overall Study|Lack of Efficacy|2|||
161748047|NCT00928512|584116260|FG001|Overall Study|Lack of Efficacy|0|||
161748048|NCT00928512|584116261|FG002|Overall Study|Lack of Efficacy|4|||
161748049|NCT00928512|584116262|FG003|Overall Study|Lack of Efficacy|7|||
161748050|NCT00928512|584116263|FG004|Overall Study|Lack of Efficacy|3|||
161748051|NCT00928512|584116259|FG000|Overall Study|Protocol Violation|0|||
161748052|NCT00928512|584116260|FG001|Overall Study|Protocol Violation|1|||
161748053|NCT00928512|584116261|FG002|Overall Study|Protocol Violation|0|||
161748054|NCT00928512|584116262|FG003|Overall Study|Protocol Violation|1|||
161748055|NCT00928512|584116263|FG004|Overall Study|Protocol Violation|3|||
161748056|NCT00928512|584116259|FG000|Overall Study|Withdrawal by Subject|3|||
161748057|NCT00928512|584116260|FG001|Overall Study|Withdrawal by Subject|0|||
161748058|NCT00928512|584116261|FG002|Overall Study|Withdrawal by Subject|3|||
161748059|NCT00928512|584116262|FG003|Overall Study|Withdrawal by Subject|4|||
161748060|NCT00928512|584116263|FG004|Overall Study|Withdrawal by Subject|0|||
161748061|NCT00928512|584116259|FG000|Overall Study|Lost to Follow-up|1|||
161748062|NCT00928512|584116260|FG001|Overall Study|Lost to Follow-up|1|||
161748063|NCT00928512|584116261|FG002|Overall Study|Lost to Follow-up|2|||
161748064|NCT00928512|584116262|FG003|Overall Study|Lost to Follow-up|1|||
161748065|NCT00928512|584116263|FG004|Overall Study|Lost to Follow-up|3|||
161748066|NCT00928512|584116259|FG000|Overall Study|Administrative Problems|0|||
161748067|NCT00928512|584116260|FG001|Overall Study|Administrative Problems|1|||
161748068|NCT00928512|584116261|FG002|Overall Study|Administrative Problems|0|||
161748069|NCT00928512|584116262|FG003|Overall Study|Administrative Problems|0|||
161748070|NCT00928512|584116263|FG004|Overall Study|Administrative Problems|0|||
161748071|NCT01963780|584116264|FG000|Overall Study|Death|7|||
161748072|NCT04153929|584116265|FG000|Overall Study|Other than listed|2|||
161748073|NCT04153929|584116266|FG001|Overall Study|Other than listed|2|||
161748074|NCT04153929|584116267|FG002|Overall Study|Other than listed|0|||
162032659|NCT04761627|585177444|FG001|Post-randomization Period|Study site closure|0|||
161748075|NCT04153929|584116268|FG003|Overall Study|Other than listed|1|||
161748076|NCT04153929|584116269|FG004|Overall Study|Other than listed|0|||
161748077|NCT04153929|584116270|FG005|Overall Study|Other than listed|2|||
161748078|NCT04153929|584116271|FG006|Overall Study|Other than listed|2|||
161748079|NCT04153929|584116272|FG007|Overall Study|Other than listed|1|||
161748080|NCT04153929|584116265|FG000|Overall Study|Lost to Follow-up|2|||
161748081|NCT04153929|584116266|FG001|Overall Study|Lost to Follow-up|1|||
161748082|NCT04153929|584116267|FG002|Overall Study|Lost to Follow-up|0|||
161748083|NCT04153929|584116268|FG003|Overall Study|Lost to Follow-up|1|||
161748084|NCT04153929|584116269|FG004|Overall Study|Lost to Follow-up|1|||
161748085|NCT04153929|584116270|FG005|Overall Study|Lost to Follow-up|0|||
161748086|NCT04153929|584116271|FG006|Overall Study|Lost to Follow-up|0|||
161748087|NCT04153929|584116272|FG007|Overall Study|Lost to Follow-up|0|||
161748088|NCT04153929|584116265|FG000|Overall Study|Withdrawal by Subject|3|||
161748089|NCT04153929|584116266|FG001|Overall Study|Withdrawal by Subject|1|||
161748090|NCT04153929|584116267|FG002|Overall Study|Withdrawal by Subject|0|||
161748091|NCT04153929|584116268|FG003|Overall Study|Withdrawal by Subject|3|||
161748092|NCT04153929|584116269|FG004|Overall Study|Withdrawal by Subject|1|||
161748093|NCT04153929|584116270|FG005|Overall Study|Withdrawal by Subject|0|||
161748094|NCT04153929|584116271|FG006|Overall Study|Withdrawal by Subject|1|||
161748095|NCT04153929|584116272|FG007|Overall Study|Withdrawal by Subject|0|||
161748096|NCT04153929|584116265|FG000|Overall Study|Protocol Violation|0|||
161748097|NCT04153929|584116266|FG001|Overall Study|Protocol Violation|0|||
161748098|NCT04153929|584116267|FG002|Overall Study|Protocol Violation|0|||
161748099|NCT04153929|584116268|FG003|Overall Study|Protocol Violation|0|||
161748100|NCT04153929|584116269|FG004|Overall Study|Protocol Violation|0|||
161748101|NCT04153929|584116270|FG005|Overall Study|Protocol Violation|0|||
161748102|NCT04153929|584116271|FG006|Overall Study|Protocol Violation|1|||
161748103|NCT04153929|584116272|FG007|Overall Study|Protocol Violation|2|||
161748104|NCT04153929|584116265|FG000|Overall Study|Adverse Event|3|||
161748105|NCT04153929|584116266|FG001|Overall Study|Adverse Event|5|||
161748106|NCT04153929|584116267|FG002|Overall Study|Adverse Event|5|||
161748107|NCT04153929|584116268|FG003|Overall Study|Adverse Event|11|||
161748108|NCT04153929|584116269|FG004|Overall Study|Adverse Event|15|||
161748109|NCT04153929|584116270|FG005|Overall Study|Adverse Event|4|||
161748110|NCT04153929|584116271|FG006|Overall Study|Adverse Event|8|||
161748111|NCT04153929|584116272|FG007|Overall Study|Adverse Event|2|||
161748112|NCT04153929|584116265|FG000|Overall Study|Not treated|1|||
161748113|NCT04153929|584116266|FG001|Overall Study|Not treated|0|||
161748114|NCT04153929|584116267|FG002|Overall Study|Not treated|0|||
161748115|NCT04153929|584116268|FG003|Overall Study|Not treated|0|||
161748116|NCT04153929|584116269|FG004|Overall Study|Not treated|0|||
161748117|NCT04153929|584116270|FG005|Overall Study|Not treated|0|||
161748118|NCT04153929|584116271|FG006|Overall Study|Not treated|1|||
161748119|NCT04153929|584116272|FG007|Overall Study|Not treated|0|||
161748120|NCT04083794|584116273|FG000|Overall Study|Lost to Follow-up|9|||
161748121|NCT03383614|584116274|FG000|Overall Study|Withdrawal by Subject|0|||
161748122|NCT03383614|584116275|FG001|Overall Study|Withdrawal by Subject|1|||
161748123|NCT03383614|584116276|FG002|Overall Study|Withdrawal by Subject|0|||
161748124|NCT03383614|584116277|FG003|Overall Study|Withdrawal by Subject|0|||
161748125|NCT03595384|584116280|FG000|Overall Study|Other time commitments|8|||
161748126|NCT03595384|584116280|FG000|Overall Study|Changes to session time|7|||
161748127|NCT03595384|584116280|FG000|Overall Study|Relocation out of country|1|||
161748128|NCT03803202|584116281|FG000|Overall Study|Other|0|||
161748129|NCT03803202|584116282|FG001|Overall Study|Other|1|||
161748130|NCT03803202|584116283|FG002|Overall Study|Other|0|||
161748131|NCT03803202|584116284|FG003|Overall Study|Other|0|||
161748132|NCT03803202|584116285|FG004|Overall Study|Other|0|||
161748133|NCT03803202|584116286|FG005|Overall Study|Other|0|||
161748134|NCT03803202|584116287|FG006|Overall Study|Other|0|||
161748135|NCT03803202|584116288|FG007|Overall Study|Other|0|||
161748136|NCT03803202|584116289|FG008|Overall Study|Other|0|||
161748137|NCT03803202|584116281|FG000|Overall Study|Death|0|||
161748138|NCT03803202|584116282|FG001|Overall Study|Death|0|||
161748139|NCT03803202|584116283|FG002|Overall Study|Death|0|||
161748140|NCT03803202|584116284|FG003|Overall Study|Death|0|||
161748141|NCT03803202|584116285|FG004|Overall Study|Death|0|||
161748142|NCT03803202|584116286|FG005|Overall Study|Death|1|||
161748143|NCT03803202|584116287|FG006|Overall Study|Death|0|||
161967465|NCT01468207|584927692|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
161967466|NCT01468207|584927693|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
161748144|NCT03803202|584116288|FG007|Overall Study|Death|0|||
161748145|NCT03803202|584116289|FG008|Overall Study|Death|0|||
161748146|NCT03803202|584116281|FG000|Overall Study|Withdrawal by Subject|0|||
161748147|NCT03803202|584116282|FG001|Overall Study|Withdrawal by Subject|0|||
161748148|NCT03803202|584116283|FG002|Overall Study|Withdrawal by Subject|1|||
161748149|NCT03803202|584116284|FG003|Overall Study|Withdrawal by Subject|0|||
161748150|NCT03803202|584116285|FG004|Overall Study|Withdrawal by Subject|0|||
161748151|NCT03803202|584116286|FG005|Overall Study|Withdrawal by Subject|0|||
161748152|NCT03803202|584116287|FG006|Overall Study|Withdrawal by Subject|0|||
161748153|NCT03803202|584116288|FG007|Overall Study|Withdrawal by Subject|1|||
161748154|NCT03803202|584116289|FG008|Overall Study|Withdrawal by Subject|0|||
161748155|NCT03803202|584116281|FG000|Overall Study|Lost to Follow-up|0|||
161748156|NCT03803202|584116282|FG001|Overall Study|Lost to Follow-up|0|||
161748157|NCT03803202|584116283|FG002|Overall Study|Lost to Follow-up|0|||
161748158|NCT03803202|584116284|FG003|Overall Study|Lost to Follow-up|1|||
161748159|NCT03803202|584116285|FG004|Overall Study|Lost to Follow-up|1|||
161748160|NCT03803202|584116286|FG005|Overall Study|Lost to Follow-up|0|||
161748161|NCT03803202|584116287|FG006|Overall Study|Lost to Follow-up|1|||
161748162|NCT03803202|584116288|FG007|Overall Study|Lost to Follow-up|0|||
161748163|NCT03803202|584116289|FG008|Overall Study|Lost to Follow-up|0|||
161748164|NCT00293241|584116290|FG000|Overall Study|Lost to Follow-up|9|||
161748165|NCT00293241|584116291|FG001|Overall Study|Lost to Follow-up|16|||
161748166|NCT00293241|584116290|FG000|Overall Study|Physician Decision|23|||
161748167|NCT00293241|584116291|FG001|Overall Study|Physician Decision|17|||
161748168|NCT00293241|584116290|FG000|Overall Study|Withdrawal by Subject|4|||
161748169|NCT00293241|584116291|FG001|Overall Study|Withdrawal by Subject|8|||
161748170|NCT01125293|584116292|FG000|Overall Study|Disease Progression|1|||
161748171|NCT01125293|584116293|FG001|Overall Study|Disease Progression|3|||
161748172|NCT01125293|584116294|FG002|Overall Study|Disease Progression|4|||
161748173|NCT01125293|584116295|FG003|Overall Study|Disease Progression|3|||
161748174|NCT01125293|584116296|FG004|Overall Study|Disease Progression|5|||
161748175|NCT01125293|584116297|FG005|Overall Study|Disease Progression|12|||
161748176|NCT01125293|584116292|FG000|Overall Study|Adverse Event|1|||
161748177|NCT01125293|584116293|FG001|Overall Study|Adverse Event|0|||
161748178|NCT01125293|584116294|FG002|Overall Study|Adverse Event|0|||
161748179|NCT01125293|584116295|FG003|Overall Study|Adverse Event|0|||
161748180|NCT01125293|584116296|FG004|Overall Study|Adverse Event|2|||
161748181|NCT01125293|584116297|FG005|Overall Study|Adverse Event|8|||
161748182|NCT01125293|584116292|FG000|Overall Study|Symptomatic Deterioration|1|||
161748183|NCT01125293|584116293|FG001|Overall Study|Symptomatic Deterioration|0|||
161748184|NCT01125293|584116294|FG002|Overall Study|Symptomatic Deterioration|0|||
161748185|NCT01125293|584116295|FG003|Overall Study|Symptomatic Deterioration|0|||
161748186|NCT01125293|584116296|FG004|Overall Study|Symptomatic Deterioration|0|||
161748187|NCT01125293|584116297|FG005|Overall Study|Symptomatic Deterioration|0|||
161748188|NCT01125293|584116292|FG000|Overall Study|Death|0|||
161748189|NCT01125293|584116293|FG001|Overall Study|Death|0|||
161748190|NCT01125293|584116294|FG002|Overall Study|Death|0|||
161748191|NCT01125293|584116295|FG003|Overall Study|Death|0|||
161748192|NCT01125293|584116296|FG004|Overall Study|Death|1|||
161748193|NCT01125293|584116297|FG005|Overall Study|Death|0|||
161748194|NCT01125293|584116292|FG000|Overall Study|Withdrawal by Subject|0|||
161748195|NCT01125293|584116293|FG001|Overall Study|Withdrawal by Subject|0|||
161748196|NCT01125293|584116294|FG002|Overall Study|Withdrawal by Subject|0|||
161748197|NCT01125293|584116295|FG003|Overall Study|Withdrawal by Subject|0|||
161748198|NCT01125293|584116296|FG004|Overall Study|Withdrawal by Subject|2|||
161748199|NCT01125293|584116297|FG005|Overall Study|Withdrawal by Subject|1|||
161748200|NCT01125293|584116292|FG000|Overall Study|Physician Decision|0|||
161748201|NCT01125293|584116293|FG001|Overall Study|Physician Decision|0|||
161748202|NCT01125293|584116294|FG002|Overall Study|Physician Decision|0|||
161748203|NCT01125293|584116295|FG003|Overall Study|Physician Decision|0|||
161748204|NCT01125293|584116296|FG004|Overall Study|Physician Decision|0|||
161748205|NCT01125293|584116297|FG005|Overall Study|Physician Decision|2|||
161748206|NCT01270958|584116298|FG000|Overall Study|Lost to Follow-up|2|||
161748207|NCT01270958|584116298|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
161748208|NCT01406652|584116301|FG000|Overall Study|Lost-to-follow-up|3|||
161748209|NCT01406652|584116302|FG001|Overall Study|Lost-to-follow-up|4|||
161748210|NCT01406652|584116301|FG000|Overall Study|Withdrawal by Subject|2|||
161748211|NCT01406652|584116302|FG001|Overall Study|Withdrawal by Subject|2|||
161748212|NCT01406652|584116301|FG000|Overall Study|Insufficient follow-up|5|||
161748213|NCT01406652|584116302|FG001|Overall Study|Insufficient follow-up|4|||
161748214|NCT01406652|584116301|FG000|Overall Study|Infection not sure|10|||
161748215|NCT01406652|584116302|FG001|Overall Study|Infection not sure|10|||
161748216|NCT00260429|584116305|FG000|Overall Study|failure to follow appointments|1|||
161748217|NCT00260429|584116306|FG001|Overall Study|failure to follow appointments|0|||
161748218|NCT00260429|584116305|FG000|Overall Study|scheduled hand surgery|1|||
161748219|NCT00260429|584116306|FG001|Overall Study|scheduled hand surgery|0|||
161748220|NCT00659126|584116307|FG000|Overall Study|Adverse Event|2|||
161748221|NCT00659126|584116308|FG001|Overall Study|Adverse Event|2|||
161748222|NCT00659126|584116307|FG000|Overall Study|Screen failure|1|||
161748223|NCT00659126|584116308|FG001|Overall Study|Screen failure|1|||
161748224|NCT00659126|584116307|FG000|Overall Study|Technical problems with MRI|0|||
161748225|NCT00659126|584116308|FG001|Overall Study|Technical problems with MRI|1|||
161748226|NCT02228564|584116312|FG000|Overall Study|Withdrawal by Subject|10|||
161748227|NCT02228564|584116312|FG000|Overall Study|Death|11|||
161748228|NCT02228564|584116312|FG000|Overall Study|Physician Decision|5|||
161748229|NCT02228564|584116312|FG000|Overall Study|Lost to Follow-up|17|||
161748230|NCT02228564|584116312|FG000|Overall Study|Other|6|||
161748231|NCT02633046|584116313|FG000|Overall Study|Adverse Event|8|||
161748232|NCT02633046|584116313|FG000|Overall Study|Physician Decision|7|||
161748233|NCT02633046|584116313|FG000|Overall Study|Withdrawal by Subject|8|||
161748234|NCT02633046|584116313|FG000|Overall Study|Increased proteinuria|2|||
161748235|NCT02633046|584116313|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
161748236|NCT02633046|584116313|FG000|Overall Study|Mutual decision patient and physician|1|||
161748237|NCT03136367|584116321|FG000|T1 Consultation|discontinued mistakenly included|2|||
161748238|NCT03136367|584116322|FG001|T1 Consultation|discontinued mistakenly included|6|||
161748239|NCT03136367|584116323|FG002|T1 Consultation|discontinued mistakenly included|1|||
161748240|NCT03136367|584116321|FG000|T1 Consultation|Discontinued other|0|||
161748241|NCT03136367|584116322|FG001|T1 Consultation|Discontinued other|1|||
161748242|NCT03136367|584116323|FG002|T1 Consultation|Discontinued other|0|||
161748243|NCT03136367|584116321|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
161748244|NCT03136367|584116322|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
161748245|NCT03136367|584116323|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
161748246|NCT03136367|584116321|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
161748247|NCT03136367|584116322|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
161748248|NCT03136367|584116323|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
161748249|NCT03136367|584116321|FG000|T2 Post-consultation|Discontinued other|0|||
161748250|NCT03136367|584116322|FG001|T2 Post-consultation|Discontinued other|2|||
161748251|NCT03136367|584116323|FG002|T2 Post-consultation|Discontinued other|6|||
161748252|NCT03136367|584116321|FG000|T2 Post-consultation|Discontinued transferred care|0|||
161748253|NCT03136367|584116322|FG001|T2 Post-consultation|Discontinued transferred care|0|||
161748254|NCT03136367|584116323|FG002|T2 Post-consultation|Discontinued transferred care|3|||
161748255|NCT03136367|584116321|FG000|T2 Post-consultation|Discontinued lost contact|0|||
161748256|NCT03136367|584116322|FG001|T2 Post-consultation|Discontinued lost contact|1|||
161748257|NCT03136367|584116323|FG002|T2 Post-consultation|Discontinued lost contact|0|||
161748258|NCT03136367|584116321|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
161748259|NCT03136367|584116322|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
161748260|NCT03136367|584116323|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
161748261|NCT03136367|584116321|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
161748262|NCT03136367|584116322|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
161748263|NCT03136367|584116323|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
161748264|NCT03136367|584116321|FG000|T3 1 Week After Surgery|other discontinued|2|||
161748265|NCT03136367|584116322|FG001|T3 1 Week After Surgery|other discontinued|4|||
161748266|NCT03136367|584116323|FG002|T3 1 Week After Surgery|other discontinued|3|||
161748267|NCT03136367|584116321|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
161748268|NCT03136367|584116322|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
161748269|NCT03136367|584116323|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
161748270|NCT03136367|584116321|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
161748271|NCT03136367|584116322|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
161748272|NCT03136367|584116323|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
161748273|NCT03136367|584116321|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
161748274|NCT03136367|584116322|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
161748275|NCT03136367|584116323|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
161748276|NCT03136367|584116321|FG000|T4 12 Weeks After Surgery|Death|0|||
161748277|NCT03136367|584116322|FG001|T4 12 Weeks After Surgery|Death|1|||
161748278|NCT03136367|584116323|FG002|T4 12 Weeks After Surgery|Death|3|||
161748279|NCT03136367|584116321|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
161748280|NCT03136367|584116322|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
161748281|NCT03136367|584116323|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
161748282|NCT03136367|584116321|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
161748283|NCT03136367|584116322|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
161748284|NCT03136367|584116323|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
161748285|NCT03136367|584116321|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
161748286|NCT03136367|584116322|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
161748287|NCT03136367|584116323|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
161748288|NCT03136367|584116321|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
161748289|NCT03136367|584116322|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
161748290|NCT03136367|584116323|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
161748291|NCT03136367|584116321|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
161748292|NCT03136367|584116322|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
161748293|NCT03136367|584116323|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
161748294|NCT03136367|584116321|FG000|T5 1 Year After Surgery|Death|0|||
161748295|NCT03136367|584116322|FG001|T5 1 Year After Surgery|Death|0|||
161748296|NCT03136367|584116323|FG002|T5 1 Year After Surgery|Death|1|||
161748297|NCT03136367|584116321|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
161748298|NCT03136367|584116322|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
161748299|NCT03136367|584116323|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
161748300|NCT03136367|584116321|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
161748301|NCT03136367|584116322|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
161748302|NCT03136367|584116323|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
161748303|NCT03136367|584116321|FG000|T5 1 Year After Surgery|study ended before due|31|||
161748304|NCT03136367|584116322|FG001|T5 1 Year After Surgery|study ended before due|103|||
161748305|NCT03136367|584116323|FG002|T5 1 Year After Surgery|study ended before due|110|||
161748306|NCT03136367|584116321|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
161748307|NCT03136367|584116322|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
161748308|NCT03136367|584116323|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
161748309|NCT01594749|584118575|FG000|Overall Study|Adverse Event|2|||
161748310|NCT01594749|584118576|FG001|Overall Study|Adverse Event|1|||
161748311|NCT01594749|584118575|FG000|Overall Study|Withdrawal by Subject|2|||
161748312|NCT01594749|584118576|FG001|Overall Study|Withdrawal by Subject|2|||
161748313|NCT01594749|584118575|FG000|Overall Study|Protocol Violation|2|||
161748314|NCT01594749|584118576|FG001|Overall Study|Protocol Violation|0|||
161748315|NCT01594749|584118575|FG000|Overall Study|Physician Decision|1|||
161748316|NCT01594749|584118576|FG001|Overall Study|Physician Decision|1|||
161748317|NCT01594749|584118575|FG000|Overall Study|Non-compliance with Protocol|0|||
161748318|NCT01594749|584118576|FG001|Overall Study|Non-compliance with Protocol|1|||
161748319|NCT01594749|584118575|FG000|Overall Study|Lost to Follow-up|1|||
161748320|NCT01594749|584118576|FG001|Overall Study|Lost to Follow-up|0|||
161748321|NCT01594749|584118575|FG000|Overall Study|Death|9|||
161748322|NCT01594749|584118576|FG001|Overall Study|Death|3|||
161748323|NCT01594749|584118575|FG000|Overall Study|Not Treated|4|||
161748324|NCT01594749|584118576|FG001|Overall Study|Not Treated|10|||
161748325|NCT01594749|584118575|FG000|Overall Study|Lost Source Documentation|1|||
161748326|NCT01594749|584118576|FG001|Overall Study|Lost Source Documentation|0|||
161748327|NCT02578992|584118578|FG000|Overall Study|equipment not available or malfunction|3|||
161748328|NCT02578992|584118579|FG001|Overall Study|equipment not available or malfunction|3|||
161748329|NCT00086385|584118580|FG000|Overall Study|Death|2|||
161748330|NCT00086385|584118581|FG001|Overall Study|Death|2|||
161748331|NCT00086385|584118582|FG002|Overall Study|Death|1|||
161748332|NCT00086385|584118583|FG003|Overall Study|Death|1|||
161748333|NCT00880100|584118584|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
161748334|NCT00880100|584118584|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
161748335|NCT00880100|584118584|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
161748336|NCT04038385|584118586|FG000|Overall Study|Completed baseline assessment only|7|||
161748337|NCT04038385|584118587|FG001|Overall Study|Completed baseline assessment only|4|||
161748338|NCT04038385|584118586|FG000|Overall Study|Moved out of area|4|||
161748339|NCT04038385|584118587|FG001|Overall Study|Moved out of area|2|||
161748340|NCT04038385|584118586|FG000|Overall Study|Discontinued study involvement|6|||
161748341|NCT04038385|584118587|FG001|Overall Study|Discontinued study involvement|1|||
161748342|NCT03424044|584118588|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748343|NCT03424044|584118589|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748344|NCT03424044|584118590|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
161748345|NCT03424044|584118591|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748346|NCT03424044|584118592|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748347|NCT03424044|584118593|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748348|NCT03424044|584118594|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748349|NCT03424044|584118595|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748350|NCT03424044|584118596|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161748351|NCT03424044|584118588|FG000|First Intervention (76 Hours)|Adverse Event|0|||
161748352|NCT03424044|584118589|FG001|First Intervention (76 Hours)|Adverse Event|0|||
161748353|NCT03424044|584118590|FG002|First Intervention (76 Hours)|Adverse Event|0|||
161748354|NCT03424044|584118591|FG003|First Intervention (76 Hours)|Adverse Event|0|||
161748355|NCT03424044|584118592|FG004|First Intervention (76 Hours)|Adverse Event|1|||
161748356|NCT03424044|584118593|FG005|First Intervention (76 Hours)|Adverse Event|0|||
161748357|NCT03424044|584118594|FG006|First Intervention (76 Hours)|Adverse Event|0|||
161748358|NCT03424044|584118595|FG007|First Intervention (76 Hours)|Adverse Event|0|||
161748359|NCT03424044|584118596|FG008|First Intervention (76 Hours)|Adverse Event|0|||
161748360|NCT03424044|584118588|FG000|First Intervention (76 Hours)|device issues|0|||
161748361|NCT03424044|584118589|FG001|First Intervention (76 Hours)|device issues|0|||
161748362|NCT03424044|584118590|FG002|First Intervention (76 Hours)|device issues|0|||
161748363|NCT03424044|584118591|FG003|First Intervention (76 Hours)|device issues|0|||
161748364|NCT03424044|584118592|FG004|First Intervention (76 Hours)|device issues|0|||
161748365|NCT03424044|584118593|FG005|First Intervention (76 Hours)|device issues|0|||
161748366|NCT03424044|584118594|FG006|First Intervention (76 Hours)|device issues|1|||
161748367|NCT03424044|584118595|FG007|First Intervention (76 Hours)|device issues|1|||
161748368|NCT03424044|584118596|FG008|First Intervention (76 Hours)|device issues|1|||
161748369|NCT03424044|584118588|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
161748370|NCT03424044|584118589|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
161748371|NCT03424044|584118590|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
161748372|NCT03424044|584118591|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
161748373|NCT03424044|584118592|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
161748374|NCT03424044|584118593|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
161748375|NCT03424044|584118594|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
161748376|NCT03424044|584118595|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
161748377|NCT03424044|584118596|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
161748378|NCT03424044|584118588|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748379|NCT03424044|584118589|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748380|NCT03424044|584118590|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748381|NCT03424044|584118591|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
161748382|NCT03424044|584118592|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748383|NCT03424044|584118593|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748384|NCT03424044|584118594|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748385|NCT03424044|584118595|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748386|NCT03424044|584118596|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161748387|NCT00402285|584118603|FG000|Overall Study|insufficient RNA quality|7|||
161748388|NCT00402285|584118604|FG001|Overall Study|insufficient RNA quality|6|||
161748389|NCT00402285|584118605|FG002|Overall Study|insufficient RNA quality|2|||
161748390|NCT00405275|584118608|FG000|Overall Study|Death|1|||
161748391|NCT00405275|584118609|FG001|Overall Study|Death|0|||
161748392|NCT00405275|584118608|FG000|Overall Study|Lost to Follow-up|5|||
161748393|NCT00405275|584118609|FG001|Overall Study|Lost to Follow-up|1|||
161748394|NCT00405275|584118608|FG000|Overall Study|Withdrawal by Subject|7|||
161748395|NCT00405275|584118609|FG001|Overall Study|Withdrawal by Subject|9|||
161748396|NCT00405275|584118608|FG000|Overall Study|Unwilling to continue|10|||
161748397|NCT00405275|584118609|FG001|Overall Study|Unwilling to continue|9|||
161748398|NCT00088595|584118610|FG000|Overall Study|Adverse Event|11|||
161748399|NCT00088595|584118610|FG000|Overall Study|Withdrawal by Subject|8|||
161748400|NCT00088595|584118610|FG000|Overall Study|Ongoing (After Core)|7|||
161748401|NCT00088595|584118610|FG000|Overall Study|New Cancer Therapy|2|||
161748402|NCT02959970|584118620|FG000|Overall Study|Adverse Event|1|||
161748403|NCT02959970|584118621|FG001|Overall Study|Adverse Event|0|||
161748404|NCT02959970|584118620|FG000|Overall Study|Withdrawal by Subject|0|||
161748405|NCT02959970|584118621|FG001|Overall Study|Withdrawal by Subject|2|||
161748406|NCT02959970|584118620|FG000|Overall Study|Lost to Follow-up|1|||
161748407|NCT02959970|584118621|FG001|Overall Study|Lost to Follow-up|5|||
161748408|NCT03235726|584118622|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748409|NCT03235726|584118623|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748410|NCT03235726|584118624|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748411|NCT03235726|584118625|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748412|NCT03235726|584118626|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
161748413|NCT03235726|584118627|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748414|NCT03235726|584118628|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748415|NCT03235726|584118629|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748416|NCT03235726|584118630|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748417|NCT03235726|584118631|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161748418|NCT03235726|584118622|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748419|NCT03235726|584118623|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748420|NCT03235726|584118624|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748421|NCT03235726|584118625|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748422|NCT03235726|584118626|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
161748423|NCT03235726|584118627|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748424|NCT03235726|584118628|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748425|NCT03235726|584118629|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748426|NCT03235726|584118630|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748427|NCT03235726|584118631|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161748428|NCT00268463|584118632|FG000|Overall Study|study terminated due to low accrual|10|||
161748429|NCT00268463|584118633|FG001|Overall Study|study terminated due to low accrual|12|||
161748430|NCT04685538|584118634|FG000|Overall Study|Adverse Event|0|||
161748431|NCT04685538|584118635|FG001|Overall Study|Adverse Event|1|||
161748432|NCT04685538|584118634|FG000|Overall Study|Lost to Follow-up|0|||
161748433|NCT04685538|584118635|FG001|Overall Study|Lost to Follow-up|2|||
161748434|NCT01040845|584118636|FG000|Overall Study|Withdrawal by Subject|1|||
161748435|NCT01040845|584118637|FG001|Overall Study|Withdrawal by Subject|1|||
161748436|NCT01040845|584118636|FG000|Overall Study|Physician Decision|1|||
161748437|NCT01040845|584118637|FG001|Overall Study|Physician Decision|0|||
161748438|NCT04362813|584118638|FG000|Overall Study|Death|12|||
161748439|NCT04362813|584118639|FG001|Overall Study|Death|16|||
161748440|NCT04362813|584118638|FG000|Overall Study|Withdrawal by Subject|3|||
161748441|NCT04362813|584118639|FG001|Overall Study|Withdrawal by Subject|1|||
161748442|NCT04362813|584118638|FG000|Overall Study|Protocol Violation|0|||
161748443|NCT04362813|584118639|FG001|Overall Study|Protocol Violation|3|||
161748444|NCT04362813|584118638|FG000|Overall Study|Lost to Follow-up|1|||
161748445|NCT04362813|584118639|FG001|Overall Study|Lost to Follow-up|1|||
161748446|NCT04362813|584118638|FG000|Overall Study|Enrolled but did not receive treatment|2|||
161748447|NCT04362813|584118639|FG001|Overall Study|Enrolled but did not receive treatment|4|||
161748448|NCT01732107|584118643|FG000|Overall Study|Adverse Event|2|||
161748449|NCT01732107|584118643|FG000|Overall Study|Disease Progression|8|||
161967467|NCT01468207|584927694|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
161748450|NCT01732107|584118643|FG000|Overall Study|Physician Decision|1|||
161748451|NCT01732107|584118643|FG000|Overall Study|Withdrawal by Subject|2|||
161748452|NCT04445688|584118645|FG000|Washout (One Week)|Adverse Event|2|||
161748453|NCT04445688|584118645|FG000|Washout (One Week)|Withdrawal by Subject|1|||
161748454|NCT00918346|584118647|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
161967468|NCT01468207|584927695|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
161748455|NCT00918346|584118648|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
161748456|NCT01749800|584118649|FG000|Overall Study|not meeting inclusion criteria|3|||
161748457|NCT01749800|584118650|FG001|Overall Study|not meeting inclusion criteria|0|||
161748458|NCT01749800|584118651|FG002|Overall Study|not meeting inclusion criteria|0|||
161748459|NCT01749800|584118649|FG000|Overall Study|Withdrawal by Subject|0|||
161748460|NCT01749800|584118650|FG001|Overall Study|Withdrawal by Subject|1|||
161748461|NCT01749800|584118651|FG002|Overall Study|Withdrawal by Subject|0|||
161748462|NCT00224003|584118656|FG000|Overall Study|Adverse Event|1|||
161748463|NCT00224003|584118656|FG000|Overall Study|Protocol Violation|2|||
161748464|NCT00224003|584118656|FG000|Overall Study|Withdrawal by Subject|1|||
161748465|NCT00224003|584118656|FG000|Overall Study|unk|3|||
161748466|NCT03549429|584118657|FG000|Overall Study|Protocol Violation|5|||
161748467|NCT03549429|584118658|FG001|Overall Study|Protocol Violation|3|||
161748468|NCT00729326|584118668|FG000|Overall Study|Lost to Follow-up|2|||
161748469|NCT00729326|584118669|FG001|Overall Study|Lost to Follow-up|0|||
161748470|NCT00729326|584118668|FG000|Overall Study|Physician Decision|0|||
161748471|NCT00729326|584118669|FG001|Overall Study|Physician Decision|1|||
161748472|NCT00729326|584118668|FG000|Overall Study|Protocol Violation|3|||
161748473|NCT00729326|584118669|FG001|Overall Study|Protocol Violation|2|||
161748474|NCT00729326|584118668|FG000|Overall Study|Subject Decision|4|||
161748475|NCT00729326|584118669|FG001|Overall Study|Subject Decision|4|||
161748476|NCT00729326|584118668|FG000|Overall Study|Sponsor Decision|1|||
161748477|NCT00729326|584118669|FG001|Overall Study|Sponsor Decision|2|||
161748478|NCT01235728|584118670|FG000|Overall Study|Protocol Violation|0|||
161748479|NCT01235728|584118671|FG001|Overall Study|Protocol Violation|0|||
161748480|NCT01235728|584118672|FG002|Overall Study|Protocol Violation|0|||
161748481|NCT01235728|584118673|FG003|Overall Study|Protocol Violation|1|||
161748482|NCT01235728|584118674|FG004|Overall Study|Protocol Violation|0|||
161748483|NCT01235728|584118675|FG005|Overall Study|Protocol Violation|0|||
161748484|NCT01235728|584118676|FG006|Overall Study|Protocol Violation|0|||
161748485|NCT01235728|584118677|FG007|Overall Study|Protocol Violation|0|||
161748486|NCT01000025|584118678|FG000|Overall Study|Adverse Event|43|||
161748487|NCT01000025|584118679|FG001|Overall Study|Adverse Event|2|||
161748488|NCT01000025|584118678|FG000|Overall Study|Withdrawal by Subject|13|||
161748489|NCT01000025|584118679|FG001|Overall Study|Withdrawal by Subject|8|||
161748490|NCT01000025|584118678|FG000|Overall Study|Death|23|||
161748491|NCT01000025|584118679|FG001|Overall Study|Death|13|||
161748492|NCT01000025|584118678|FG000|Overall Study|Lack of Efficacy|363|||
161748493|NCT01000025|584118679|FG001|Overall Study|Lack of Efficacy|208|||
161748494|NCT01000025|584118678|FG000|Overall Study|Intercurrent Illness|26|||
161748495|NCT01000025|584118679|FG001|Overall Study|Intercurrent Illness|7|||
161748496|NCT04423757|584118680|FG000|Overall Study|Adverse Event|2|||
161748497|NCT04423757|584118681|FG001|Overall Study|Adverse Event|0|||
161748498|NCT04423757|584118680|FG000|Overall Study|Not treated|1|||
161748499|NCT04423757|584118681|FG001|Overall Study|Not treated|1|||
161748500|NCT01202760|584118682|FG000|Overall Study|Entry Criteria Not Met|0|||
161748501|NCT01202760|584118683|FG001|Overall Study|Entry Criteria Not Met|3|||
161748502|NCT01202760|584118684|FG002|Overall Study|Entry Criteria Not Met|1|||
161748503|NCT01202760|584118682|FG000|Overall Study|Adverse Event|11|||
161748504|NCT01202760|584118683|FG001|Overall Study|Adverse Event|9|||
161748505|NCT01202760|584118684|FG002|Overall Study|Adverse Event|10|||
161748506|NCT01202760|584118682|FG000|Overall Study|Death|2|||
161748507|NCT01202760|584118683|FG001|Overall Study|Death|1|||
161748508|NCT01202760|584118684|FG002|Overall Study|Death|0|||
161748509|NCT01202760|584118682|FG000|Overall Study|Lack of Efficacy|6|||
161748510|NCT01202760|584118683|FG001|Overall Study|Lack of Efficacy|8|||
161748511|NCT01202760|584118684|FG002|Overall Study|Lack of Efficacy|7|||
161748512|NCT01202760|584118682|FG000|Overall Study|Lost to Follow-up|0|||
161748513|NCT01202760|584118683|FG001|Overall Study|Lost to Follow-up|2|||
161748514|NCT01202760|584118684|FG002|Overall Study|Lost to Follow-up|1|||
161843122|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Disease Progression|0|||
161843123|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Disease Progression|0|||
161748515|NCT01202760|584118682|FG000|Overall Study|Parent / Caregiver Decision|0|||
161748516|NCT01202760|584118683|FG001|Overall Study|Parent / Caregiver Decision|1|||
161748517|NCT01202760|584118684|FG002|Overall Study|Parent / Caregiver Decision|0|||
161748518|NCT01202760|584118682|FG000|Overall Study|Withdrawal by Subject|17|||
161748519|NCT01202760|584118683|FG001|Overall Study|Withdrawal by Subject|18|||
161748520|NCT01202760|584118684|FG002|Overall Study|Withdrawal by Subject|14|||
161748521|NCT01202760|584118682|FG000|Overall Study|Physician Decision|0|||
161748522|NCT01202760|584118683|FG001|Overall Study|Physician Decision|1|||
161748523|NCT01202760|584118684|FG002|Overall Study|Physician Decision|0|||
161748524|NCT01202760|584118682|FG000|Overall Study|Protocol Violation|7|||
161748525|NCT01202760|584118683|FG001|Overall Study|Protocol Violation|5|||
161748526|NCT01202760|584118684|FG002|Overall Study|Protocol Violation|2|||
161748527|NCT01202760|584118682|FG000|Overall Study|Sponsor Decision|4|||
161748528|NCT01202760|584118683|FG001|Overall Study|Sponsor Decision|4|||
161843124|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Disease Progression|2|||
161748529|NCT01202760|584118684|FG002|Overall Study|Sponsor Decision|0|||
161748530|NCT01654523|584118685|FG000|Overall Study|Withdrawal by Subject|1|||
161748531|NCT02810951|584118686|FG000|Overall Study|Adverse Event|1|||
161748532|NCT03199638|584118687|FG000|Overall Study|inability to drink glutamine during regularly|0|||
161748533|NCT03199638|584118688|FG001|Overall Study|inability to drink glutamine during regularly|2|||
161748534|NCT01575899|584118691|FG000|Overall Study|Lost to Follow-up|3|||
161748535|NCT01575899|584118692|FG001|Overall Study|Lost to Follow-up|4|||
161748536|NCT01575899|584118693|FG002|Overall Study|Lost to Follow-up|2|||
161748537|NCT01575899|584118691|FG000|Overall Study|Protocol Violation|2|||
161748538|NCT01575899|584118692|FG001|Overall Study|Protocol Violation|1|||
161748539|NCT01575899|584118693|FG002|Overall Study|Protocol Violation|0|||
161748540|NCT02807844|584118694|FG000|Overall Study|Physician Decision|0|||
161748541|NCT02807844|584118695|FG001|Overall Study|Physician Decision|0|||
161748542|NCT02807844|584118696|FG002|Overall Study|Physician Decision|0|||
161748543|NCT02807844|584118697|FG003|Overall Study|Physician Decision|0|||
161748544|NCT02807844|584118698|FG004|Overall Study|Physician Decision|0|||
161748545|NCT02807844|584118699|FG005|Overall Study|Physician Decision|0|||
161748546|NCT02807844|584118700|FG006|Overall Study|Physician Decision|3|||
161748547|NCT02807844|584118701|FG007|Overall Study|Physician Decision|0|||
161748548|NCT02807844|584118702|FG008|Overall Study|Physician Decision|1|||
161748549|NCT02807844|584118703|FG009|Overall Study|Physician Decision|2|||
161748550|NCT02807844|584118694|FG000|Overall Study|Death|0|||
161748551|NCT02807844|584118695|FG001|Overall Study|Death|0|||
161748552|NCT02807844|584118696|FG002|Overall Study|Death|2|||
161748553|NCT02807844|584118697|FG003|Overall Study|Death|4|||
161748554|NCT02807844|584118698|FG004|Overall Study|Death|1|||
161748555|NCT02807844|584118699|FG005|Overall Study|Death|2|||
161748556|NCT02807844|584118700|FG006|Overall Study|Death|1|||
161748557|NCT02807844|584118701|FG007|Overall Study|Death|2|||
161748558|NCT02807844|584118702|FG008|Overall Study|Death|0|||
161748559|NCT02807844|584118703|FG009|Overall Study|Death|1|||
161748560|NCT02807844|584118694|FG000|Overall Study|Withdrawal by Subject|0|||
161748561|NCT02807844|584118695|FG001|Overall Study|Withdrawal by Subject|0|||
161748562|NCT02807844|584118696|FG002|Overall Study|Withdrawal by Subject|2|||
161748563|NCT02807844|584118697|FG003|Overall Study|Withdrawal by Subject|1|||
161748564|NCT02807844|584118698|FG004|Overall Study|Withdrawal by Subject|1|||
161748565|NCT02807844|584118699|FG005|Overall Study|Withdrawal by Subject|0|||
161748566|NCT02807844|584118700|FG006|Overall Study|Withdrawal by Subject|1|||
161748567|NCT02807844|584118701|FG007|Overall Study|Withdrawal by Subject|0|||
161748568|NCT02807844|584118702|FG008|Overall Study|Withdrawal by Subject|0|||
161748569|NCT02807844|584118703|FG009|Overall Study|Withdrawal by Subject|0|||
161748570|NCT02807844|584118694|FG000|Overall Study|Progressive disease|5|||
161748571|NCT02807844|584118695|FG001|Overall Study|Progressive disease|12|||
161748572|NCT02807844|584118696|FG002|Overall Study|Progressive disease|8|||
161748573|NCT02807844|584118697|FG003|Overall Study|Progressive disease|8|||
161748574|NCT02807844|584118698|FG004|Overall Study|Progressive disease|3|||
161748575|NCT02807844|584118699|FG005|Overall Study|Progressive disease|8|||
161748576|NCT02807844|584118700|FG006|Overall Study|Progressive disease|14|||
161748577|NCT02807844|584118701|FG007|Overall Study|Progressive disease|17|||
161748578|NCT02807844|584118702|FG008|Overall Study|Progressive disease|19|||
161748579|NCT02807844|584118703|FG009|Overall Study|Progressive disease|15|||
161748580|NCT02807844|584118694|FG000|Overall Study|Adverse Event|1|||
161748581|NCT02807844|584118695|FG001|Overall Study|Adverse Event|0|||
161748582|NCT02807844|584118696|FG002|Overall Study|Adverse Event|0|||
161748583|NCT02807844|584118697|FG003|Overall Study|Adverse Event|0|||
161748584|NCT02807844|584118698|FG004|Overall Study|Adverse Event|1|||
161748585|NCT02807844|584118699|FG005|Overall Study|Adverse Event|1|||
161748586|NCT02807844|584118700|FG006|Overall Study|Adverse Event|1|||
161748587|NCT02807844|584118701|FG007|Overall Study|Adverse Event|1|||
161748588|NCT02807844|584118702|FG008|Overall Study|Adverse Event|1|||
161748589|NCT02807844|584118703|FG009|Overall Study|Adverse Event|2|||
161748590|NCT03097029|584118704|FG000|Overall Study|Withdrawal by Subject|1|||
161748591|NCT00709124|584118705|FG000|Overall Study|Death|3|||
161748592|NCT00709124|584118706|FG001|Overall Study|Death|1|||
161967469|NCT01468207|584927696|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
161967470|NCT01468207|584927691|FG000|Treatment Period 2|Lost to Follow-up|0|||
161748593|NCT00709124|584118705|FG000|Overall Study|encephalopathy; can't do assessment|1|||
161748594|NCT00709124|584118706|FG001|Overall Study|encephalopathy; can't do assessment|0|||
161748595|NCT00373490|584118707|FG000|Overall Study|Adverse Event|0|||
161748596|NCT00373490|584118708|FG001|Overall Study|Adverse Event|1|||
161748597|NCT00373490|584118707|FG000|Overall Study|Lack of Efficacy|9|||
161748598|NCT00373490|584118708|FG001|Overall Study|Lack of Efficacy|4|||
161748599|NCT00373490|584118707|FG000|Overall Study|Withdrawal by Subject|0|||
161748600|NCT00373490|584118708|FG001|Overall Study|Withdrawal by Subject|1|||
161748601|NCT00753688|584118715|FG000|Overall Study|Death|102|||
161967471|NCT01468207|584927692|FG001|Treatment Period 2|Lost to Follow-up|0|||
161967472|NCT01468207|584927693|FG002|Treatment Period 2|Lost to Follow-up|5|||
161748602|NCT00753688|584118716|FG001|Overall Study|Death|203|||
161748603|NCT00753688|584118715|FG000|Overall Study|Missing|4|||
161748604|NCT00753688|584118716|FG001|Overall Study|Missing|9|||
161748605|NCT00753688|584118715|FG000|Overall Study|Participant Withdrew Consent|2|||
161748606|NCT00753688|584118716|FG001|Overall Study|Participant Withdrew Consent|2|||
161843125|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Disease Progression|1|||
161843126|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Disease Progression|0|||
161843127|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Disease Progression|0|||
161843128|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Disease Progression|0|||
161843129|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843130|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843131|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843132|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843133|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843134|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843135|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843136|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843137|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843138|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843139|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843140|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843141|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843142|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843143|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843144|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843145|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843146|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843147|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843148|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843149|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
161843150|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
161843151|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843152|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843153|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
161843154|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843155|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843156|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843157|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843158|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843159|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843160|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843161|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843162|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843163|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843164|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843165|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843166|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843167|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843168|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843169|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843170|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843171|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843172|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843173|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843174|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
161843175|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843176|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843177|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843178|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161843179|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Adverse Event|0|||
161843180|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Adverse Event|0|||
161843181|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Adverse Event|0|||
161843182|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Adverse Event|0|||
161843183|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Adverse Event|0|||
161843184|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Adverse Event|0|||
161748607|NCT00753688|584118715|FG000|Overall Study|Ongoing - in Follow-up|15|||
161748608|NCT00753688|584118716|FG001|Overall Study|Ongoing - in Follow-up|31|||
161748609|NCT00753688|584118715|FG000|Overall Study|Adverse Event|0|||
161748610|NCT00753688|584118716|FG001|Overall Study|Adverse Event|1|||
161748611|NCT01250756|584118717|FG000|Infant Series|Withdrawal by Subject|4|||
161748612|NCT01250756|584118718|FG001|Infant Series|Withdrawal by Subject|5|||
161748613|NCT01250756|584118717|FG000|Infant Series|Randomized, Not Vaccinated|2|||
161748614|NCT01250756|584118718|FG001|Infant Series|Randomized, Not Vaccinated|2|||
161748615|NCT01250756|584118717|FG000|Infant Series|Other|22|||
161748616|NCT01250756|584118718|FG001|Infant Series|Other|0|||
161748617|NCT01250756|584118717|FG000|After Infant Series|Adverse Event|5|||
161748618|NCT01250756|584118718|FG001|After Infant Series|Adverse Event|2|||
161748619|NCT01250756|584118717|FG000|After Infant Series|Withdrawal by Subject|4|||
161748620|NCT01250756|584118718|FG001|After Infant Series|Withdrawal by Subject|1|||
161748621|NCT01250756|584118717|FG000|After Infant Series|Other|2|||
161748622|NCT01250756|584118718|FG001|After Infant Series|Other|1|||
161748623|NCT01250756|584118717|FG000|Toddler Dose|Adverse Event|0|||
161748624|NCT01250756|584118718|FG001|Toddler Dose|Adverse Event|1|||
161748625|NCT01250756|584118717|FG000|After Toddler Dose|Adverse Event|0|||
161748626|NCT01250756|584118718|FG001|After Toddler Dose|Adverse Event|1|||
161748627|NCT00108953|584118719|FG000|Follow-up|Death|18|||
161748628|NCT00108953|584118720|FG001|Follow-up|Death|26|||
161748629|NCT00108953|584118719|FG000|Follow-up|Lost to Follow-up|1|||
161748630|NCT00108953|584118720|FG001|Follow-up|Lost to Follow-up|1|||
161748631|NCT00108953|584118719|FG000|Follow-up|Study terminated by sponsor|10|||
161748632|NCT00108953|584118720|FG001|Follow-up|Study terminated by sponsor|6|||
161748633|NCT02999100|584118723|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
161748634|NCT02999100|584118724|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
161748635|NCT02999100|584118725|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
161748636|NCT02999100|584118726|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
161748637|NCT02999100|584118727|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
161748638|NCT02999100|584118728|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
161748639|NCT02999100|584118723|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161748640|NCT02999100|584118724|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161748641|NCT02999100|584118725|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161748642|NCT02999100|584118726|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161748643|NCT02999100|584118727|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161748644|NCT02999100|584118728|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
161748645|NCT02999100|584118723|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161748646|NCT02999100|584118724|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161748647|NCT02999100|584118725|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
161748648|NCT02999100|584118726|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161748649|NCT02999100|584118727|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161748650|NCT02999100|584118728|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161748651|NCT02925312|584118732|FG000|Overall Study|Lost to Follow-up|25|||
161748652|NCT02925312|584118733|FG001|Overall Study|Lost to Follow-up|0|||
161748653|NCT02925312|584118732|FG000|Overall Study|Adverse Event|2|||
161748654|NCT02925312|584118733|FG001|Overall Study|Adverse Event|0|||
161748655|NCT02142504|584118734|FG000|Overall Study|Protocol Violation|2|||
161748656|NCT02142504|584118735|FG001|Overall Study|Protocol Violation|1|||
161748657|NCT02142504|584118736|FG002|Overall Study|Protocol Violation|2|||
161748658|NCT02142504|584118734|FG000|Overall Study|Adverse Event|2|||
161748659|NCT02142504|584118735|FG001|Overall Study|Adverse Event|3|||
161748660|NCT02142504|584118736|FG002|Overall Study|Adverse Event|4|||
161967473|NCT01468207|584927694|FG003|Treatment Period 2|Lost to Follow-up|1|||
161748661|NCT02142504|584118734|FG000|Overall Study|Lost to Follow-up|12|||
161748662|NCT02142504|584118735|FG001|Overall Study|Lost to Follow-up|19|||
161748663|NCT02142504|584118736|FG002|Overall Study|Lost to Follow-up|17|||
161748664|NCT02142504|584118734|FG000|Overall Study|Withdrawal by Subject|7|||
161748665|NCT02142504|584118735|FG001|Overall Study|Withdrawal by Subject|9|||
161748666|NCT02142504|584118736|FG002|Overall Study|Withdrawal by Subject|11|||
161748667|NCT02142504|584118734|FG000|Overall Study|Pregnancy|4|||
161748668|NCT02142504|584118735|FG001|Overall Study|Pregnancy|4|||
161967474|NCT01468207|584927695|FG004|Treatment Period 2|Lost to Follow-up|0|||
161748669|NCT02142504|584118736|FG002|Overall Study|Pregnancy|2|||
161748670|NCT02142504|584118734|FG000|Overall Study|Physician Decision|0|||
161748671|NCT02142504|584118735|FG001|Overall Study|Physician Decision|1|||
161748672|NCT02142504|584118736|FG002|Overall Study|Physician Decision|3|||
161748673|NCT02142504|584118734|FG000|Overall Study|Reason Not Specified|4|||
161748674|NCT02142504|584118735|FG001|Overall Study|Reason Not Specified|5|||
161748675|NCT02142504|584118736|FG002|Overall Study|Reason Not Specified|4|||
161748676|NCT04114539|584118744|FG000|Overall Study|Adverse Event|14|||
161748677|NCT04114539|584118744|FG000|Overall Study|Lost to Follow-up|2|||
161748678|NCT04114539|584118744|FG000|Overall Study|Non-compliance with Protocol|2|||
161748679|NCT04114539|584118744|FG000|Overall Study|Non-compliance with Study Drug|1|||
161748680|NCT04114539|584118744|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
161748681|NCT04114539|584118744|FG000|Overall Study|Withdrew consent|10|||
161843185|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Adverse Event|0|||
161843186|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Adverse Event|0|||
161843187|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Adverse Event|0|||
161843188|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Adverse Event|0|||
161843189|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Adverse Event|0|||
161843190|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Adverse Event|0|||
161843191|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Adverse Event|0|||
161843192|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Adverse Event|0|||
161843193|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Adverse Event|0|||
161843194|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Adverse Event|0|||
161843195|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Adverse Event|0|||
161843196|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Adverse Event|0|||
161843197|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Adverse Event|0|||
161843198|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Adverse Event|0|||
161843199|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Adverse Event|0|||
161843200|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Adverse Event|0|||
161843201|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Adverse Event|0|||
161843202|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Adverse Event|1|||
161843203|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Adverse Event|0|||
161843204|NCT02393248|584470000|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843205|NCT02393248|584470001|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843206|NCT02393248|584470002|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843207|NCT02393248|584470003|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843208|NCT02393248|584470004|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843209|NCT02393248|584470005|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843210|NCT02393248|584470006|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843211|NCT02393248|584470007|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843212|NCT02393248|584470008|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843213|NCT02393248|584470009|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843214|NCT02393248|584470010|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843215|NCT02393248|584470011|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843216|NCT02393248|584470012|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843217|NCT02393248|584470013|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843218|NCT02393248|584470014|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843219|NCT02393248|584470015|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843220|NCT02393248|584470016|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843221|NCT02393248|584470017|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843222|NCT02393248|584470018|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843223|NCT02393248|584470019|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843224|NCT02393248|584470020|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843225|NCT02393248|584470021|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843226|NCT02393248|584470022|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843227|NCT02393248|584470023|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
161843228|NCT02393248|584470024|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161843229|NCT02585934|584470025|FG000|Overall Study|Lost to Follow-up|2|||
161843230|NCT02585934|584470026|FG001|Overall Study|Lost to Follow-up|2|||
161843231|NCT02585934|584470025|FG000|Overall Study|Protocol Violation|14|||
161843232|NCT02585934|584470026|FG001|Overall Study|Protocol Violation|11|||
161843233|NCT02585934|584470025|FG000|Overall Study|Adverse Event|21|||
161843234|NCT02585934|584470026|FG001|Overall Study|Adverse Event|22|||
161843235|NCT02585934|584470025|FG000|Overall Study|Physician Decision|3|||
161843236|NCT02585934|584470026|FG001|Overall Study|Physician Decision|2|||
161843237|NCT02585934|584470025|FG000|Overall Study|Withdrawal by Subject|7|||
161843238|NCT02585934|584470026|FG001|Overall Study|Withdrawal by Subject|21|||
161843239|NCT02585934|584470025|FG000|Overall Study|Lack of Efficacy|2|||
161843240|NCT02585934|584470026|FG001|Overall Study|Lack of Efficacy|1|||
161843241|NCT02585934|584470025|FG000|Overall Study|Death|2|||
161843242|NCT02585934|584470026|FG001|Overall Study|Death|0|||
161843243|NCT02585934|584470025|FG000|Overall Study|Caregiver Withdrew Consent|7|||
161843244|NCT02585934|584470026|FG001|Overall Study|Caregiver Withdrew Consent|7|||
161843245|NCT02585934|584470025|FG000|Overall Study|Sponsor Termination|1|||
161843246|NCT02585934|584470026|FG001|Overall Study|Sponsor Termination|2|||
161843247|NCT02585934|584470025|FG000|Overall Study|Another Reason|10|||
161843248|NCT02585934|584470026|FG001|Overall Study|Another Reason|5|||
161843249|NCT01359969|584470039|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
161843250|NCT00593736|584470043|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
161843251|NCT00593736|584470044|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
161843252|NCT00593736|584470045|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
161748682|NCT04114539|584118744|FG000|Overall Study|Others not specified|5|||
161748683|NCT04114539|584118744|FG000|Overall Study|Investigator Decision|2|||
161748684|NCT01455415|584118747|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
161748685|NCT01455415|584118748|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
161748686|NCT01455415|584118747|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
161748687|NCT01455415|584118748|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
161748688|NCT01455415|584118747|FG000|Period 1|Drug Error not Associated to AE|0|||
161748689|NCT01455415|584118748|FG001|Period 1|Drug Error not Associated to AE|1|||
161748690|NCT01455415|584118747|FG000|Period 1|AE Not Related to Study Drug|2|||
161748691|NCT01455415|584118748|FG001|Period 1|AE Not Related to Study Drug|6|||
161748692|NCT01455415|584118747|FG000|Period 1|Withdrawal by Subject|4|||
161748693|NCT01455415|584118748|FG001|Period 1|Withdrawal by Subject|5|||
161748694|NCT01455415|584118747|FG000|Period 1|Unspecified Reason|1|||
161748695|NCT01455415|584118748|FG001|Period 1|Unspecified Reason|1|||
161748696|NCT01455415|584118747|FG000|Period 1|Protocol Violation|0|||
161748697|NCT01455415|584118748|FG001|Period 1|Protocol Violation|2|||
161748698|NCT01455415|584118747|FG000|Washout|AE Related to Study Drug|2|||
161748699|NCT01455415|584118748|FG001|Washout|AE Related to Study Drug|0|||
161748700|NCT01455415|584118747|FG000|Washout|Lost to Follow-up|1|||
161748701|NCT01455415|584118748|FG001|Washout|Lost to Follow-up|0|||
161748702|NCT01455415|584118747|FG000|Washout|Drug Error not Associated to AE|2|||
161748703|NCT01455415|584118748|FG001|Washout|Drug Error not Associated to AE|1|||
161748704|NCT01455415|584118747|FG000|Washout|AE Not Related to Study Drug|2|||
161748705|NCT01455415|584118748|FG001|Washout|AE Not Related to Study Drug|3|||
161748706|NCT01455415|584118747|FG000|Washout|Unspecified Reason|1|||
161748707|NCT01455415|584118748|FG001|Washout|Unspecified Reason|2|||
161748708|NCT01455415|584118747|FG000|Washout|Protocol Violation|0|||
161748709|NCT01455415|584118748|FG001|Washout|Protocol Violation|1|||
161748710|NCT01455415|584118747|FG000|Period 2|AE Related to Study Drug|1|||
161748711|NCT01455415|584118748|FG001|Period 2|AE Related to Study Drug|2|||
161748712|NCT01455415|584118747|FG000|Period 2|Lost to Follow-up|2|||
161748713|NCT01455415|584118748|FG001|Period 2|Lost to Follow-up|1|||
161748714|NCT01455415|584118747|FG000|Period 2|AE Not Related to Study Drug|2|||
161748715|NCT01455415|584118748|FG001|Period 2|AE Not Related to Study Drug|1|||
161748716|NCT01455415|584118747|FG000|Period 2|Lack of Efficacy|2|||
161748717|NCT01455415|584118748|FG001|Period 2|Lack of Efficacy|0|||
161748718|NCT01455415|584118747|FG000|Period 2|Withdrawal by Subject|2|||
161748719|NCT01455415|584118748|FG001|Period 2|Withdrawal by Subject|3|||
161748720|NCT01455415|584118747|FG000|Period 2|Unspecified Reason|2|||
161748721|NCT01455415|584118748|FG001|Period 2|Unspecified Reason|3|||
161748722|NCT01455415|584118747|FG000|Period 2|Protocol Violation|2|||
161748723|NCT01455415|584118748|FG001|Period 2|Protocol Violation|0|||
161748724|NCT01455415|584118747|FG000|Follow-up|AE Related to Study Drug|0|||
161748725|NCT01455415|584118748|FG001|Follow-up|AE Related to Study Drug|1|||
161748726|NCT01455415|584118747|FG000|Follow-up|Lack of Efficacy|0|||
161748727|NCT01455415|584118748|FG001|Follow-up|Lack of Efficacy|1|||
161748728|NCT01455415|584118747|FG000|Follow-up|Withdrawal by Subject|2|||
161748729|NCT01455415|584118748|FG001|Follow-up|Withdrawal by Subject|0|||
161748730|NCT01455415|584118747|FG000|Follow-up|Unspecified Reason|1|||
161748731|NCT01455415|584118748|FG001|Follow-up|Unspecified Reason|0|||
161748732|NCT00587301|584118749|FG000|Overall Study|Screen Failure|9|||
161748733|NCT00587301|584118749|FG000|Overall Study|Lost to Follow-up|22|||
161748734|NCT00587301|584118749|FG000|Overall Study|Withdrawal by Subject|7|||
161748735|NCT00587301|584118749|FG000|Overall Study|Protocol Violation|7|||
161748736|NCT02460978|584118751|FG000|Overall Study|Adverse Event|17|||
161748737|NCT02460978|584118752|FG001|Overall Study|Adverse Event|11|||
161748738|NCT02460978|584118753|FG002|Overall Study|Adverse Event|11|||
161748739|NCT02460978|584118751|FG000|Overall Study|Withdrawal by Subject|5|||
161748740|NCT02460978|584118752|FG001|Overall Study|Withdrawal by Subject|5|||
161748741|NCT02460978|584118753|FG002|Overall Study|Withdrawal by Subject|14|||
161843253|NCT00593736|584470046|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
161843254|NCT00593736|584470043|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
161843255|NCT00593736|584470044|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
161843256|NCT00593736|584470045|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
161843257|NCT00593736|584470046|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
161843258|NCT00593736|584470043|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
161748742|NCT02460978|584118751|FG000|Overall Study|Lost to Follow-up|2|||
161748743|NCT02460978|584118752|FG001|Overall Study|Lost to Follow-up|3|||
161748744|NCT02460978|584118753|FG002|Overall Study|Lost to Follow-up|1|||
161748745|NCT02460978|584118751|FG000|Overall Study|Protocol Violation|1|||
161748746|NCT02460978|584118752|FG001|Overall Study|Protocol Violation|1|||
161748747|NCT02460978|584118753|FG002|Overall Study|Protocol Violation|1|||
161748748|NCT02460978|584118751|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
161748749|NCT02460978|584118752|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
161748750|NCT02460978|584118753|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
161748751|NCT02460978|584118751|FG000|Overall Study|Pregnancy|0|||
161748752|NCT02460978|584118752|FG001|Overall Study|Pregnancy|0|||
161748753|NCT02460978|584118753|FG002|Overall Study|Pregnancy|2|||
161748754|NCT00719537|584118754|FG000|Overall Study|Withdrawal by Subject|1|||
161748755|NCT00719537|584118755|FG001|Overall Study|Withdrawal by Subject|0|||
161748756|NCT00719537|584118754|FG000|Overall Study|Lost to Follow-up|0|||
161748757|NCT00719537|584118755|FG001|Overall Study|Lost to Follow-up|1|||
161748758|NCT01142193|584118756|FG000|Overall Study|Adverse Event|12|||
161748759|NCT01142193|584118757|FG001|Overall Study|Adverse Event|4|||
161748760|NCT01142193|584118756|FG000|Overall Study|Lack of Efficacy|2|||
161748761|NCT01142193|584118757|FG001|Overall Study|Lack of Efficacy|1|||
161748762|NCT01142193|584118756|FG000|Overall Study|Physician Decision|1|||
161748763|NCT01142193|584118757|FG001|Overall Study|Physician Decision|1|||
161748764|NCT01142193|584118756|FG000|Overall Study|Withdrawal by Subject|4|||
161748765|NCT01142193|584118757|FG001|Overall Study|Withdrawal by Subject|3|||
161748766|NCT01142193|584118756|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
161748767|NCT01142193|584118757|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
161748768|NCT01142193|584118756|FG000|Overall Study|Other|1|||
161748769|NCT01142193|584118757|FG001|Overall Study|Other|2|||
161748770|NCT00994162|584118758|FG000|Overall Study|Withdrawal by Subject|1|||
161748771|NCT00994162|584118758|FG000|Overall Study|Lost to Follow-up|2|||
161748772|NCT00994162|584118758|FG000|Overall Study|Product Complaint|1|||
161748773|NCT00994162|584118758|FG000|Overall Study|Poor Compliance|5|||
161748774|NCT00994162|584118758|FG000|Overall Study|Lack of Response|3|||
161748775|NCT00994162|584118758|FG000|Overall Study|Discharged from Hospital|4|||
161748776|NCT00994162|584118758|FG000|Overall Study|Death|2|||
161748777|NCT00994162|584118758|FG000|Overall Study|Care Transferred to Another Physician|2|||
161748778|NCT00994162|584118758|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
161748779|NCT00994162|584118758|FG000|Overall Study|Physician Decision|2|||
161748780|NCT00994162|584118758|FG000|Overall Study|Surrounding Wound Erythematous|1|||
161748781|NCT00994162|584118758|FG000|Overall Study|Machine Losing Vaccum|1|||
161748782|NCT00994162|584118758|FG000|Overall Study|Patient Lived Too Far Away|1|||
161748783|NCT00994162|584118758|FG000|Overall Study|Above Knee Amputation|1|||
161748784|NCT00994162|584118758|FG000|Overall Study|Reason Not Reported By Site|1|||
161748785|NCT01225172|584118762|FG000|Overall Study|Subject decision to stop|1|||
161748786|NCT01225172|584118763|FG001|Overall Study|Subject decision to stop|0|||
161748787|NCT01225172|584118762|FG000|Overall Study|Subject request to discontinue treatment|3|||
161748788|NCT01225172|584118763|FG001|Overall Study|Subject request to discontinue treatment|1|||
161748789|NCT01225172|584118762|FG000|Overall Study|Subject no longer meets study criteria|1|||
161748790|NCT01225172|584118763|FG001|Overall Study|Subject no longer meets study criteria|0|||
161748791|NCT01225172|584118762|FG000|Overall Study|Withdrawal by Subject|1|||
161748792|NCT01225172|584118763|FG001|Overall Study|Withdrawal by Subject|0|||
161748793|NCT03175562|584118772|FG000|Overall Study|Adverse Event|1|||
161748794|NCT03175562|584118772|FG000|Overall Study|Lost to Follow-up|3|||
161748795|NCT03175562|584118772|FG000|Overall Study|Withdrawal by Subject|7|||
161748796|NCT03175562|584118772|FG000|Overall Study|Other (Not Specified)|5|||
161748797|NCT02146833|584118773|FG000|Overall Study|Death|10|||
161748798|NCT02146833|584118773|FG000|Overall Study|No longer consented to study treatment|1|||
161748799|NCT01946412|584118774|FG000|Overall Study|Adverse Event|1|||
161748800|NCT01946412|584118774|FG000|Overall Study|Non-Compliance|1|||
161748801|NCT01946412|584118774|FG000|Overall Study|Continued with commercial Kalydeco|2|||
161748802|NCT01946412|584118774|FG000|Overall Study|Difficulty in swallowing|1|||
161748803|NCT00323310|584120633|FG000|Overall Study|Withdrawal by Subject|1|||
161748804|NCT00323310|584120633|FG000|Overall Study|a parent refused blood draw|1|||
161748805|NCT00323310|584120633|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
161748806|NCT03565991|584120634|FG000|Overall Study|Other|11|||
161748807|NCT03565991|584120635|FG001|Overall Study|Other|0|||
161748808|NCT03565991|584120634|FG000|Overall Study|Global deterioration of health status|14|||
161748809|NCT03565991|584120635|FG001|Overall Study|Global deterioration of health status|4|||
161748810|NCT03565991|584120634|FG000|Overall Study|Withdrawal by Subject|2|||
161748811|NCT03565991|584120635|FG001|Overall Study|Withdrawal by Subject|6|||
161748812|NCT03565991|584120634|FG000|Overall Study|Progressive disease|121|||
161748813|NCT03565991|584120635|FG001|Overall Study|Progressive disease|29|||
161748814|NCT03565991|584120634|FG000|Overall Study|Death|3|||
161748815|NCT03565991|584120635|FG001|Overall Study|Death|0|||
161748816|NCT03565991|584120634|FG000|Overall Study|Adverse Event|7|||
161748817|NCT03565991|584120635|FG001|Overall Study|Adverse Event|2|||
161748818|NCT02944513|584120636|FG000|Overall Study|Withdrawal by Subject|4|||
161748819|NCT02944513|584120637|FG001|Overall Study|Withdrawal by Subject|1|||
161748820|NCT00937326|584120638|FG000|Overall Study|Adverse Event|0|||
161748821|NCT00937326|584120639|FG001|Overall Study|Adverse Event|3|||
161748822|NCT00937326|584120640|FG002|Overall Study|Adverse Event|1|||
161748823|NCT00937326|584120641|FG003|Overall Study|Adverse Event|1|||
161748824|NCT00937326|584120642|FG004|Overall Study|Adverse Event|2|||
161748825|NCT00937326|584120638|FG000|Overall Study|Death|0|||
161748826|NCT00937326|584120639|FG001|Overall Study|Death|0|||
161748827|NCT00937326|584120640|FG002|Overall Study|Death|1|||
161748828|NCT00937326|584120641|FG003|Overall Study|Death|0|||
161748829|NCT00937326|584120642|FG004|Overall Study|Death|0|||
161748830|NCT00937326|584120638|FG000|Overall Study|Withdrawal by Subject|3|||
161748831|NCT00937326|584120639|FG001|Overall Study|Withdrawal by Subject|4|||
161748832|NCT00937326|584120640|FG002|Overall Study|Withdrawal by Subject|1|||
161748833|NCT00937326|584120641|FG003|Overall Study|Withdrawal by Subject|4|||
161748834|NCT00937326|584120642|FG004|Overall Study|Withdrawal by Subject|3|||
161748835|NCT00937326|584120638|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
161748836|NCT00937326|584120639|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
161748837|NCT00937326|584120640|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
161748838|NCT00937326|584120641|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
161748839|NCT00937326|584120642|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
161748840|NCT01308853|584120643|FG000|Overall Study|Adverse Event|1|||
161748841|NCT01308853|584120643|FG000|Overall Study|Lost to Follow-up|2|||
161748842|NCT01308853|584120643|FG000|Overall Study|Insertion of permanent implants|1|||
161748843|NCT01473355|584120648|FG000|Overall Study|Protocol Violation|2|||
161748844|NCT01473355|584120648|FG000|Overall Study|Adverse Event|2|||
161748845|NCT01473355|584120648|FG000|Overall Study|Lost to Follow-up|2|||
161748846|NCT00106249|584120649|FG000|Overall Study|Lost to Follow-up|3|||
161748847|NCT00106249|584120650|FG001|Overall Study|Lost to Follow-up|2|||
161748848|NCT01843205|584120653|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
161748849|NCT01843205|584120654|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
161748850|NCT00606177|584120655|FG000|Overall Study|Adverse Event|9|||
161748851|NCT00606177|584120656|FG001|Overall Study|Adverse Event|5|||
161748852|NCT00606177|584120655|FG000|Overall Study|Lack of Efficacy|3|||
161748853|NCT00606177|584120656|FG001|Overall Study|Lack of Efficacy|7|||
161748854|NCT00606177|584120655|FG000|Overall Study|Physician Decision|1|||
161748855|NCT00606177|584120656|FG001|Overall Study|Physician Decision|0|||
161748856|NCT00606177|584120655|FG000|Overall Study|Protocol Violation|1|||
161748857|NCT00606177|584120656|FG001|Overall Study|Protocol Violation|4|||
161748858|NCT00606177|584120655|FG000|Overall Study|Withdrawal by Subject|5|||
161748859|NCT00606177|584120656|FG001|Overall Study|Withdrawal by Subject|6|||
161748860|NCT00606177|584120655|FG000|Overall Study|Progression to depressive phase|6|||
161748861|NCT00606177|584120656|FG001|Overall Study|Progression to depressive phase|1|||
161748862|NCT00606177|584120655|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
161748863|NCT00606177|584120656|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
161748864|NCT00606177|584120655|FG000|Overall Study|Change of residence or other commitments|1|||
161748865|NCT00606177|584120656|FG001|Overall Study|Change of residence or other commitments|1|||
161748866|NCT00136357|584120657|FG000|Overall Study|Withdrawal by Subject|3|||
161748867|NCT00136357|584120658|FG001|Overall Study|Withdrawal by Subject|2|||
161748868|NCT01518309|584120663|FG000|Overall Study|Adverse Event|6|||
161748869|NCT01518309|584120663|FG000|Overall Study|Death|6|||
161748870|NCT01518309|584120663|FG000|Overall Study|Lack of Efficacy|7|||
161748871|NCT01518309|584120663|FG000|Overall Study|Withdrawal by Subject|6|||
161748872|NCT01518309|584120663|FG000|Overall Study|Physician Decision|3|||
161748873|NCT01518309|584120663|FG000|Overall Study|Sponsor Decision|2|||
161748874|NCT01518309|584120663|FG000|Overall Study|Not in Predefined Categories|9|||
161748875|NCT02603172|584120664|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748876|NCT02603172|584120665|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748877|NCT02603172|584120666|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
161748878|NCT02603172|584120667|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748879|NCT02603172|584120668|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748880|NCT02603172|584120669|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748881|NCT02603172|584120670|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748882|NCT02603172|584120671|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161748883|NCT00863317|584120672|FG000|Overall Study|Lost to Follow-up|8|||
161748884|NCT00863317|584120673|FG001|Overall Study|Lost to Follow-up|9|||
161748885|NCT00038142|584120676|FG000|Overall Study|Ineligible|1|||
161748886|NCT00038142|584120677|FG001|Overall Study|Ineligible|0|||
161748887|NCT00038142|584120676|FG000|Overall Study|Progressive Disease|11|||
161748888|NCT00038142|584120677|FG001|Overall Study|Progressive Disease|7|||
161748889|NCT00038142|584120676|FG000|Overall Study|Death|1|||
161748890|NCT00038142|584120677|FG001|Overall Study|Death|0|||
161748891|NCT00038142|584120676|FG000|Overall Study|Adverse Event|1|||
161748892|NCT00038142|584120677|FG001|Overall Study|Adverse Event|0|||
161748893|NCT00038142|584120676|FG000|Overall Study|Unknown Reason|8|||
161748894|NCT00038142|584120677|FG001|Overall Study|Unknown Reason|0|||
161748895|NCT00441727|584120678|FG000|Overall Study|Protocol Violation|19|||
161748896|NCT00441727|584120679|FG001|Overall Study|Protocol Violation|28|||
161748897|NCT00441727|584120680|FG002|Overall Study|Protocol Violation|32|||
161748898|NCT00441727|584120678|FG000|Overall Study|Adverse Event|26|||
161748899|NCT00441727|584120679|FG001|Overall Study|Adverse Event|33|||
161748900|NCT00441727|584120680|FG002|Overall Study|Adverse Event|28|||
161748901|NCT00441727|584120678|FG000|Overall Study|Lack of Efficacy|7|||
161748902|NCT00441727|584120679|FG001|Overall Study|Lack of Efficacy|8|||
161748903|NCT00441727|584120680|FG002|Overall Study|Lack of Efficacy|48|||
161748904|NCT00441727|584120678|FG000|Overall Study|Withdrawal by Subject|40|||
161748905|NCT00441727|584120679|FG001|Overall Study|Withdrawal by Subject|34|||
161748906|NCT00441727|584120680|FG002|Overall Study|Withdrawal by Subject|47|||
161748907|NCT00441727|584120678|FG000|Overall Study|Lost to Follow-up|5|||
161748908|NCT00441727|584120679|FG001|Overall Study|Lost to Follow-up|6|||
161748909|NCT00441727|584120680|FG002|Overall Study|Lost to Follow-up|5|||
161748910|NCT00441727|584120678|FG000|Overall Study|Safety Reasons|3|||
161748911|NCT00441727|584120679|FG001|Overall Study|Safety Reasons|1|||
161748912|NCT00441727|584120680|FG002|Overall Study|Safety Reasons|3|||
161748913|NCT00441727|584120678|FG000|Overall Study|Various reason specified|6|||
161748914|NCT00441727|584120679|FG001|Overall Study|Various reason specified|8|||
161748915|NCT00441727|584120680|FG002|Overall Study|Various reason specified|5|||
161748916|NCT03417505|584120683|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
161748917|NCT03417505|584120684|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
161748918|NCT02133001|584120687|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
161748919|NCT02133001|584120688|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
161748920|NCT02133001|584120687|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
161748921|NCT02133001|584120688|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
161748922|NCT02133001|584120687|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
161748923|NCT02133001|584120688|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
161748924|NCT02133001|584120687|FG000|Double Blind (Day 1-25)|Other|2|||
161748925|NCT02133001|584120688|FG001|Double Blind (Day 1-25)|Other|2|||
161748926|NCT02133001|584120687|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
161748927|NCT02133001|584120688|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
161748928|NCT02133001|584120687|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
161748929|NCT02133001|584120688|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
161748930|NCT02133001|584120687|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
161748931|NCT02133001|584120688|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
161748932|NCT02133001|584120687|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
161748933|NCT02133001|584120688|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
161748934|NCT04211961|584120689|FG000|Overall Study|Death|0|||
161748935|NCT04211961|584120690|FG001|Overall Study|Death|1|||
161748936|NCT04211961|584120689|FG000|Overall Study|Lost to Follow-up|0|||
161748937|NCT04211961|584120690|FG001|Overall Study|Lost to Follow-up|1|||
161748938|NCT04211961|584120689|FG000|Overall Study|Withdrawal by Subject|0|||
161748939|NCT04211961|584120690|FG001|Overall Study|Withdrawal by Subject|1|||
161748940|NCT01831804|584120693|FG000|Overall Study|Adverse Event|0|||
161748941|NCT01831804|584120694|FG001|Overall Study|Adverse Event|0|||
161748942|NCT01831804|584120695|FG002|Overall Study|Adverse Event|0|||
161748943|NCT01831804|584120696|FG003|Overall Study|Adverse Event|0|||
161748944|NCT01831804|584120697|FG004|Overall Study|Adverse Event|0|||
161748945|NCT01831804|584120698|FG005|Overall Study|Adverse Event|0|||
161748946|NCT01831804|584120699|FG006|Overall Study|Adverse Event|1|||
161748947|NCT01831804|584120700|FG007|Overall Study|Adverse Event|0|||
161748948|NCT01831804|584120701|FG008|Overall Study|Adverse Event|1|||
161748949|NCT01831804|584120693|FG000|Overall Study|Protocol Violation|0|||
161748950|NCT01831804|584120694|FG001|Overall Study|Protocol Violation|0|||
161748951|NCT01831804|584120695|FG002|Overall Study|Protocol Violation|2|||
161748952|NCT01831804|584120696|FG003|Overall Study|Protocol Violation|0|||
161748953|NCT01831804|584120697|FG004|Overall Study|Protocol Violation|0|||
161748954|NCT01831804|584120698|FG005|Overall Study|Protocol Violation|0|||
161748955|NCT01831804|584120699|FG006|Overall Study|Protocol Violation|0|||
161748956|NCT01831804|584120700|FG007|Overall Study|Protocol Violation|0|||
161748957|NCT01831804|584120701|FG008|Overall Study|Protocol Violation|0|||
161748958|NCT01831804|584120693|FG000|Overall Study|Protocol defined stopping criteria|1|||
161748959|NCT01831804|584120694|FG001|Overall Study|Protocol defined stopping criteria|1|||
161748960|NCT01831804|584120695|FG002|Overall Study|Protocol defined stopping criteria|3|||
161748961|NCT01831804|584120696|FG003|Overall Study|Protocol defined stopping criteria|0|||
161748962|NCT01831804|584120697|FG004|Overall Study|Protocol defined stopping criteria|1|||
161748963|NCT01831804|584120698|FG005|Overall Study|Protocol defined stopping criteria|0|||
161748964|NCT01831804|584120699|FG006|Overall Study|Protocol defined stopping criteria|0|||
161748965|NCT01831804|584120700|FG007|Overall Study|Protocol defined stopping criteria|0|||
161748966|NCT01831804|584120701|FG008|Overall Study|Protocol defined stopping criteria|0|||
161748967|NCT01831804|584120693|FG000|Overall Study|Lost to Follow-up|0|||
161748968|NCT01831804|584120694|FG001|Overall Study|Lost to Follow-up|0|||
161748969|NCT01831804|584120695|FG002|Overall Study|Lost to Follow-up|1|||
161748970|NCT01831804|584120696|FG003|Overall Study|Lost to Follow-up|0|||
161748971|NCT01831804|584120697|FG004|Overall Study|Lost to Follow-up|0|||
161748972|NCT01831804|584120698|FG005|Overall Study|Lost to Follow-up|0|||
161843259|NCT00593736|584470044|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
161843260|NCT00593736|584470045|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
161843261|NCT00593736|584470046|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
161748973|NCT01831804|584120699|FG006|Overall Study|Lost to Follow-up|0|||
161748974|NCT01831804|584120700|FG007|Overall Study|Lost to Follow-up|0|||
161748975|NCT01831804|584120701|FG008|Overall Study|Lost to Follow-up|1|||
161748976|NCT01831804|584120693|FG000|Overall Study|Investigator discretion|0|||
161748977|NCT01831804|584120694|FG001|Overall Study|Investigator discretion|0|||
161748978|NCT01831804|584120695|FG002|Overall Study|Investigator discretion|0|||
161748979|NCT01831804|584120696|FG003|Overall Study|Investigator discretion|0|||
161748980|NCT01831804|584120697|FG004|Overall Study|Investigator discretion|1|||
161748981|NCT01831804|584120698|FG005|Overall Study|Investigator discretion|0|||
161748982|NCT01831804|584120699|FG006|Overall Study|Investigator discretion|0|||
161748983|NCT01831804|584120700|FG007|Overall Study|Investigator discretion|1|||
161748984|NCT01831804|584120701|FG008|Overall Study|Investigator discretion|0|||
161748985|NCT01831804|584120693|FG000|Overall Study|Withdrew Consent|0|||
161748986|NCT01831804|584120694|FG001|Overall Study|Withdrew Consent|1|||
161748987|NCT01831804|584120695|FG002|Overall Study|Withdrew Consent|0|||
161748988|NCT01831804|584120696|FG003|Overall Study|Withdrew Consent|0|||
161748989|NCT01831804|584120697|FG004|Overall Study|Withdrew Consent|0|||
161748990|NCT01831804|584120698|FG005|Overall Study|Withdrew Consent|0|||
161748991|NCT01831804|584120699|FG006|Overall Study|Withdrew Consent|0|||
161748992|NCT01831804|584120700|FG007|Overall Study|Withdrew Consent|2|||
161748993|NCT01831804|584120701|FG008|Overall Study|Withdrew Consent|0|||
161748994|NCT01819506|584120702|FG000|Overall Study|Physician Decision|5|||
161748995|NCT01819506|584120703|FG001|Overall Study|Physician Decision|2|||
161748996|NCT01819506|584120702|FG000|Overall Study|Withdrawal by Subject|3|||
161748997|NCT01819506|584120703|FG001|Overall Study|Withdrawal by Subject|3|||
161748998|NCT01505114|584120706|FG000|Overall Study|Withdrawal by Subject|5|||
161748999|NCT01505114|584120707|FG001|Overall Study|Withdrawal by Subject|4|||
161749000|NCT01505114|584120708|FG002|Overall Study|Withdrawal by Subject|4|||
161749001|NCT01505114|584120709|FG003|Overall Study|Withdrawal by Subject|7|||
161749002|NCT01505114|584120706|FG000|Overall Study|Death|1|||
161749003|NCT01505114|584120707|FG001|Overall Study|Death|0|||
161749004|NCT01505114|584120708|FG002|Overall Study|Death|0|||
161749005|NCT01505114|584120709|FG003|Overall Study|Death|1|||
161749006|NCT01505114|584120706|FG000|Overall Study|unable to adhere to visit schedule|3|||
161749007|NCT01505114|584120707|FG001|Overall Study|unable to adhere to visit schedule|2|||
161749008|NCT01505114|584120708|FG002|Overall Study|unable to adhere to visit schedule|3|||
161749009|NCT01505114|584120709|FG003|Overall Study|unable to adhere to visit schedule|3|||
161749010|NCT01505114|584120706|FG000|Overall Study|Lost to Follow-up|11|||
161749011|NCT01505114|584120707|FG001|Overall Study|Lost to Follow-up|5|||
161749012|NCT01505114|584120708|FG002|Overall Study|Lost to Follow-up|8|||
161749013|NCT01505114|584120709|FG003|Overall Study|Lost to Follow-up|7|||
161749014|NCT01505114|584120706|FG000|Overall Study|relocated|4|||
161749015|NCT01505114|584120707|FG001|Overall Study|relocated|2|||
161749016|NCT01505114|584120708|FG002|Overall Study|relocated|2|||
161749017|NCT01505114|584120709|FG003|Overall Study|relocated|3|||
161749018|NCT01505114|584120706|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
161749019|NCT01505114|584120707|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
161749020|NCT01505114|584120708|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
161749021|NCT01505114|584120709|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
161749022|NCT01505114|584120706|FG000|Overall Study|staff safety concerns|0|||
161749023|NCT01505114|584120707|FG001|Overall Study|staff safety concerns|0|||
161749024|NCT01505114|584120708|FG002|Overall Study|staff safety concerns|0|||
161749025|NCT01505114|584120709|FG003|Overall Study|staff safety concerns|1|||
161749026|NCT01505114|584120706|FG000|Overall Study|investigator decision|1|||
161749027|NCT01505114|584120707|FG001|Overall Study|investigator decision|0|||
161749028|NCT01505114|584120708|FG002|Overall Study|investigator decision|1|||
161749029|NCT01505114|584120709|FG003|Overall Study|investigator decision|0|||
161749030|NCT00615459|584120710|FG000|Period I|Adverse Event|2|||
161749031|NCT00615459|584120711|FG001|Period I|Adverse Event|0|||
161749032|NCT00615459|584120712|FG002|Period I|Adverse Event|1|||
161749033|NCT00615459|584120713|FG003|Period I|Adverse Event|0|||
161749034|NCT00615459|584120710|FG000|Period I|Subject withdrew consent|1|||
161749035|NCT00615459|584120711|FG001|Period I|Subject withdrew consent|0|||
161749036|NCT00615459|584120712|FG002|Period I|Subject withdrew consent|0|||
161749037|NCT00615459|584120713|FG003|Period I|Subject withdrew consent|1|||
161749038|NCT00615459|584120710|FG000|Period I|Abnormal test procedure results|1|||
161749039|NCT00615459|584120711|FG001|Period I|Abnormal test procedure results|1|||
161749040|NCT00615459|584120712|FG002|Period I|Abnormal test procedure results|1|||
161749041|NCT00615459|584120713|FG003|Period I|Abnormal test procedure results|0|||
161749042|NCT00615459|584120710|FG000|Period II|Adverse Event|1|||
161749043|NCT00615459|584120711|FG001|Period II|Adverse Event|0|||
161749044|NCT00615459|584120712|FG002|Period II|Adverse Event|0|||
161749045|NCT00615459|584120713|FG003|Period II|Adverse Event|0|||
161749046|NCT00615459|584120710|FG000|Period II|Lost to Follow-up|0|||
161749047|NCT00615459|584120711|FG001|Period II|Lost to Follow-up|0|||
161749048|NCT00615459|584120712|FG002|Period II|Lost to Follow-up|0|||
161749049|NCT00615459|584120713|FG003|Period II|Lost to Follow-up|1|||
161749050|NCT00615459|584120710|FG000|Period III|Adverse Event|0|||
161749051|NCT00615459|584120711|FG001|Period III|Adverse Event|1|||
161749052|NCT00615459|584120712|FG002|Period III|Adverse Event|0|||
161749053|NCT00615459|584120713|FG003|Period III|Adverse Event|0|||
161749054|NCT00615459|584120710|FG000|Period III|Administrative problems|0|||
161749055|NCT00615459|584120711|FG001|Period III|Administrative problems|1|||
161749056|NCT00615459|584120712|FG002|Period III|Administrative problems|1|||
161749057|NCT00615459|584120713|FG003|Period III|Administrative problems|0|||
161749058|NCT00615459|584120710|FG000|Period III|Unsatisfactory therapeutic effect|0|||
161749059|NCT00615459|584120711|FG001|Period III|Unsatisfactory therapeutic effect|1|||
161749060|NCT00615459|584120712|FG002|Period III|Unsatisfactory therapeutic effect|0|||
161749061|NCT00615459|584120713|FG003|Period III|Unsatisfactory therapeutic effect|0|||
161749062|NCT02017704|584120720|FG000|Overall Study|Withdrawal by Subject|2|||
161749063|NCT02017704|584120721|FG001|Overall Study|Withdrawal by Subject|0|||
161749064|NCT02076334|584120722|FG000|Overall Study|Protocol Violation|1|||
161749065|NCT02076334|584120723|FG001|Overall Study|Protocol Violation|0|||
161749066|NCT02076334|584120724|FG002|Overall Study|Protocol Violation|0|||
161749067|NCT02076334|584120725|FG003|Overall Study|Protocol Violation|0|||
161749068|NCT02076334|584120722|FG000|Overall Study|Lost to Follow-up|0|||
161749069|NCT02076334|584120723|FG001|Overall Study|Lost to Follow-up|1|||
161749070|NCT02076334|584120724|FG002|Overall Study|Lost to Follow-up|1|||
161749071|NCT02076334|584120725|FG003|Overall Study|Lost to Follow-up|0|||
161749072|NCT02076334|584120722|FG000|Overall Study|muscle soreness|0|||
161749073|NCT02076334|584120723|FG001|Overall Study|muscle soreness|0|||
161749074|NCT02076334|584120724|FG002|Overall Study|muscle soreness|0|||
161749075|NCT02076334|584120725|FG003|Overall Study|muscle soreness|1|||
161749076|NCT01975675|584120726|FG000|Overall Study|Death|0|||
161749077|NCT01975675|584120727|FG001|Overall Study|Death|1|||
161749078|NCT01975675|584120728|FG002|Overall Study|Death|0|||
161749079|NCT01975675|584120729|FG003|Overall Study|Death|0|||
161749080|NCT03639987|584120730|FG000|Overall Study|Study terminated by sponsor|26|||
161749081|NCT03639987|584120731|FG001|Overall Study|Study terminated by sponsor|25|||
161749082|NCT03639987|584120730|FG000|Overall Study|Lost to Follow-up|0|||
161967475|NCT01468207|584927696|FG005|Treatment Period 2|Lost to Follow-up|0|||
161967476|NCT01468207|584927691|FG000|Treatment Period 2|Other|0|||
161967477|NCT01468207|584927692|FG001|Treatment Period 2|Other|0|||
161967478|NCT01468207|584927693|FG002|Treatment Period 2|Other|5|||
161967479|NCT01468207|584927694|FG003|Treatment Period 2|Other|1|||
161967480|NCT01468207|584927695|FG004|Treatment Period 2|Other|1|||
161967481|NCT01468207|584927696|FG005|Treatment Period 2|Other|2|||
161967482|NCT00470093|584927697|FG000|Overall Study|Adverse Event|2|||
161967483|NCT00664560|584927698|FG000|Overall Study|Adverse Event|19|||
161967484|NCT00664560|584927699|FG001|Overall Study|Adverse Event|16|||
161967485|NCT00664560|584927700|FG002|Overall Study|Adverse Event|7|||
161967486|NCT00664560|584927698|FG000|Overall Study|Withdrawal by Subject|9|||
161967487|NCT00664560|584927699|FG001|Overall Study|Withdrawal by Subject|13|||
161967488|NCT00664560|584927700|FG002|Overall Study|Withdrawal by Subject|7|||
161967489|NCT00664560|584927698|FG000|Overall Study|Lost to Follow-up|0|||
161967490|NCT00664560|584927699|FG001|Overall Study|Lost to Follow-up|2|||
161967491|NCT00664560|584927700|FG002|Overall Study|Lost to Follow-up|0|||
161967492|NCT00664560|584927698|FG000|Overall Study|Other|11|||
161967493|NCT00664560|584927699|FG001|Overall Study|Other|4|||
162032660|NCT04761627|585177445|FG002|Post-randomization Period|Study site closure|1|||
162032661|NCT04761627|585177443|FG000|Post-randomization Period|Family planning|0|||
161749083|NCT03639987|584120731|FG001|Overall Study|Lost to Follow-up|1|||
161749084|NCT02738580|584120732|FG000|Overall Study|Adverse Event|1|||
161749085|NCT02738580|584120733|FG001|Overall Study|Adverse Event|0|||
161749086|NCT02738580|584120732|FG000|Overall Study|Lack of Efficacy|3|||
161749087|NCT02738580|584120733|FG001|Overall Study|Lack of Efficacy|2|||
161749088|NCT02738580|584120732|FG000|Overall Study|Withdrawal by Subject|0|||
161749089|NCT02738580|584120733|FG001|Overall Study|Withdrawal by Subject|1|||
161749090|NCT02738580|584120732|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
161749091|NCT02738580|584120733|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
161967494|NCT00664560|584927700|FG002|Overall Study|Other|5|||
162032662|NCT04761627|585177444|FG001|Post-randomization Period|Family planning|1|||
162032663|NCT04761627|585177445|FG002|Post-randomization Period|Family planning|0|||
162032664|NCT01634178|585177448|FG000|Treatment Period 1|Adverse Event|0|||
162032665|NCT01634178|585177449|FG001|Treatment Period 1|Adverse Event|1|||
161749092|NCT04354155|584120734|FG000|Overall Study|Withdrawal by Subject|1|||
161749093|NCT04354155|584120734|FG000|Overall Study|Did not meet criteria for study intervention|1|||
161749094|NCT01015820|584120737|FG000|Overall Study|Suboptimal measurements|1|||
161749095|NCT01015820|584120738|FG001|Overall Study|Suboptimal measurements|0|||
161749096|NCT01998399|584120742|FG000|Overall Study|Lost to Follow-up|1|||
161967495|NCT01328041|584927701|FG000|Overall Study|Adverse Event|7|||
161967496|NCT01328041|584927701|FG000|Overall Study|Lack of Efficacy|27|||
161967497|NCT01328041|584927701|FG000|Overall Study|Protocol Violation|7|||
161967498|NCT01328041|584927701|FG000|Overall Study|Lost to Follow-up|7|||
161967499|NCT01328041|584927701|FG000|Overall Study|Physician Decision|2|||
161967500|NCT01328041|584927701|FG000|Overall Study|Withdrawal by Subject|7|||
161967501|NCT03392883|584927706|FG000|Overall Study|Lost to Follow-up|122|||
162032666|NCT01634178|585177448|FG000|Treatment Period 2|Adverse Event|1|||
161749097|NCT01998399|584120743|FG001|Overall Study|Lost to Follow-up|3|||
161749098|NCT01998399|584120742|FG000|Overall Study|Death|4|||
161749099|NCT01998399|584120743|FG001|Overall Study|Death|2|||
161749100|NCT01998399|584120742|FG000|Overall Study|Study stopped before dosing completed|3|||
161749101|NCT01998399|584120743|FG001|Overall Study|Study stopped before dosing completed|3|||
161967502|NCT03392883|584927707|FG001|Overall Study|Lost to Follow-up|13|||
161967503|NCT03392883|584927708|FG002|Overall Study|Lost to Follow-up|9|||
161967504|NCT03392883|584927706|FG000|Overall Study|Death|4|||
161749102|NCT01998399|584120742|FG000|Overall Study|Withdrawal by Subject|0|||
161749103|NCT01998399|584120743|FG001|Overall Study|Withdrawal by Subject|1|||
161749104|NCT00617591|584120744|FG000|Overall Study|Withdrew consent during Induction|4|||
161749105|NCT00617591|584120744|FG000|Overall Study|Withdrew consent during Maintenance|6|||
161749106|NCT00376246|584120745|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
161749107|NCT00376246|584120746|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
161749108|NCT00376246|584120745|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161749109|NCT00376246|584120746|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
161749110|NCT00376246|584120745|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
161749111|NCT00376246|584120746|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161749112|NCT00351819|584120749|FG000|Overall Study|Lost to Follow-up|4|||
161749113|NCT00351819|584120750|FG001|Overall Study|Lost to Follow-up|4|||
161749114|NCT00351819|584120749|FG000|Overall Study|Withdrawal by Subject|0|||
161749115|NCT00351819|584120750|FG001|Overall Study|Withdrawal by Subject|4|||
161749116|NCT00351819|584120749|FG000|Overall Study|Elevated PSA|1|||
161749117|NCT00351819|584120750|FG001|Overall Study|Elevated PSA|1|||
161749118|NCT00351819|584120749|FG000|Overall Study|Traumatic ankle fracture|1|||
161749119|NCT00351819|584120750|FG001|Overall Study|Traumatic ankle fracture|0|||
161749120|NCT00351819|584120749|FG000|Overall Study|Unprofessional behavior|1|||
161749121|NCT00351819|584120750|FG001|Overall Study|Unprofessional behavior|0|||
161749122|NCT00351819|584120749|FG000|Overall Study|Non-compliance|0|||
161749123|NCT00351819|584120750|FG001|Overall Study|Non-compliance|1|||
161749124|NCT00351819|584120749|FG000|Overall Study|Incarcerated|0|||
161749125|NCT00351819|584120750|FG001|Overall Study|Incarcerated|1|||
161749126|NCT00351819|584120749|FG000|Overall Study|Enrolled in another trial|0|||
161749127|NCT00351819|584120750|FG001|Overall Study|Enrolled in another trial|1|||
161843262|NCT00593736|584470043|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
161843263|NCT00593736|584470044|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
161843264|NCT00593736|584470045|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
161843265|NCT00593736|584470046|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
161843266|NCT00593736|584470043|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
161843267|NCT00593736|584470044|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
161843268|NCT00593736|584470045|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
161967505|NCT03392883|584927707|FG001|Overall Study|Death|0|||
161967506|NCT03392883|584927708|FG002|Overall Study|Death|0|||
161749128|NCT01459068|584120752|FG000|Overall Study|Withdrawal by Subject|8|||
161749129|NCT01459068|584120753|FG001|Overall Study|Withdrawal by Subject|18|||
161749130|NCT01459068|584120752|FG000|Overall Study|Lost to Follow-up|31|||
161967507|NCT03392883|584927706|FG000|Overall Study|Lack of Efficacy|29|||
161967508|NCT03392883|584927707|FG001|Overall Study|Lack of Efficacy|0|||
161967509|NCT03392883|584927708|FG002|Overall Study|Lack of Efficacy|0|||
161967510|NCT03392883|584927706|FG000|Overall Study|Withdrawal by Subject|180|||
161967511|NCT03392883|584927707|FG001|Overall Study|Withdrawal by Subject|0|||
161967512|NCT03392883|584927708|FG002|Overall Study|Withdrawal by Subject|0|||
161967513|NCT03392883|584927706|FG000|Overall Study|Adverse Event|1|||
161967514|NCT03392883|584927707|FG001|Overall Study|Adverse Event|0|||
161967515|NCT03392883|584927708|FG002|Overall Study|Adverse Event|0|||
161967516|NCT00908115|584927715|FG000|Overall Study|Other|14|||
161967517|NCT03622112|584927726|FG000|Overall Study|Withdrawal by Subject|6|||
161967518|NCT03622112|584927727|FG001|Overall Study|Withdrawal by Subject|2|||
161967519|NCT03622112|584927728|FG002|Overall Study|Withdrawal by Subject|4|||
161967520|NCT03622112|584927729|FG003|Overall Study|Withdrawal by Subject|2|||
161967521|NCT03622112|584927730|FG004|Overall Study|Withdrawal by Subject|1|||
161967522|NCT03622112|584927731|FG005|Overall Study|Withdrawal by Subject|2|||
161967523|NCT03622112|584927732|FG006|Overall Study|Withdrawal by Subject|2|||
161967524|NCT03622112|584927726|FG000|Overall Study|Death|0|||
161967525|NCT03622112|584927727|FG001|Overall Study|Death|0|||
161967526|NCT03622112|584927728|FG002|Overall Study|Death|0|||
161967527|NCT03622112|584927729|FG003|Overall Study|Death|1|||
161967528|NCT03622112|584927730|FG004|Overall Study|Death|0|||
161967529|NCT03622112|584927731|FG005|Overall Study|Death|0|||
161967530|NCT03622112|584927732|FG006|Overall Study|Death|0|||
161967531|NCT03622112|584927726|FG000|Overall Study|Lost to Follow-up|1|||
161967532|NCT03622112|584927727|FG001|Overall Study|Lost to Follow-up|1|||
161967533|NCT03622112|584927728|FG002|Overall Study|Lost to Follow-up|0|||
161967534|NCT03622112|584927729|FG003|Overall Study|Lost to Follow-up|0|||
161967535|NCT03622112|584927730|FG004|Overall Study|Lost to Follow-up|0|||
161967536|NCT03622112|584927731|FG005|Overall Study|Lost to Follow-up|0|||
161967537|NCT03622112|584927732|FG006|Overall Study|Lost to Follow-up|0|||
161967538|NCT03622112|584927726|FG000|Overall Study|Study-specific withdrawal criteria|10|||
161967539|NCT03622112|584927727|FG001|Overall Study|Study-specific withdrawal criteria|8|||
161967540|NCT03622112|584927728|FG002|Overall Study|Study-specific withdrawal criteria|7|||
161967541|NCT03622112|584927729|FG003|Overall Study|Study-specific withdrawal criteria|6|||
161967542|NCT03622112|584927730|FG004|Overall Study|Study-specific withdrawal criteria|4|||
161967543|NCT03622112|584927731|FG005|Overall Study|Study-specific withdrawal criteria|18|||
161749131|NCT01459068|584120753|FG001|Overall Study|Lost to Follow-up|15|||
161749132|NCT01459068|584120752|FG000|Overall Study|Death|0|||
161749133|NCT01459068|584120753|FG001|Overall Study|Death|1|||
161749134|NCT02023112|584120756|FG000|Overall Study|Withdrawal by Subject|2|||
161749135|NCT02023112|584120757|FG001|Overall Study|Withdrawal by Subject|1|||
161749136|NCT01425749|584120758|FG000|Overall Study|progression of melanoma|0|||
161749137|NCT01425749|584120759|FG001|Overall Study|progression of melanoma|1|||
161749138|NCT02910219|584120760|FG000|Overall Study|Withdrawal by Subject|1|||
161749139|NCT02910219|584120761|FG001|Overall Study|Withdrawal by Subject|1|||
161749140|NCT02096042|584120764|FG000|Overall Study|Disease Progression|1|||
161749141|NCT02096042|584120765|FG001|Overall Study|Disease Progression|0|||
161749142|NCT02096042|584120766|FG002|Overall Study|Disease Progression|0|||
161749143|NCT00701441|584120770|FG000|Overall Study|failure in cpap compliance|0|||
161749144|NCT00701441|584120771|FG001|Overall Study|failure in cpap compliance|4|||
161749145|NCT03034057|584120772|FG000|Overall Study|Withdrawal by Subject|10|||
161749146|NCT03034057|584120772|FG000|Overall Study|Protocol Violation|1|||
161749147|NCT03034057|584120772|FG000|Overall Study|Not defined|2|||
161749148|NCT03034057|584120772|FG000|Overall Study|Lost to Follow-up|19|||
161749149|NCT03034057|584120772|FG000|Overall Study|Adverse Event|22|||
161749150|NCT03034057|584120772|FG000|Overall Study|Medication error without associated AE|1|||
161749151|NCT03339401|584120774|FG000|Overall Study|Death|2|||
161749152|NCT03339401|584120775|FG001|Overall Study|Death|1|||
161749153|NCT03339401|584120774|FG000|Overall Study|Withdrawal by Subject|2|||
161749154|NCT03339401|584120775|FG001|Overall Study|Withdrawal by Subject|0|||
161749155|NCT03339401|584120774|FG000|Overall Study|Study terminated|4|||
161749156|NCT03339401|584120775|FG001|Overall Study|Study terminated|3|||
161749157|NCT03339401|584120774|FG000|Overall Study|Investigator Decision|1|||
161749158|NCT03339401|584120775|FG001|Overall Study|Investigator Decision|0|||
161749159|NCT00718523|584120776|FG000|Overall Study|Withdrawal by Subject|5|||
161749160|NCT00718523|584120777|FG001|Overall Study|Withdrawal by Subject|7|||
161749161|NCT00718523|584120776|FG000|Overall Study|Death|13|||
161749162|NCT00718523|584120777|FG001|Overall Study|Death|17|||
161749163|NCT01313078|584120778|FG000|Overall Study|Death|1|||
161749164|NCT01313078|584120778|FG000|Overall Study|Discontinued study drug|1|||
161749165|NCT01313078|584120778|FG000|Overall Study|Withdrawal by Subject|1|||
161749166|NCT00910728|584120779|FG000|Overall Study|Lack of Efficacy|2|||
161749167|NCT00910728|584120780|FG001|Overall Study|Lack of Efficacy|3|||
161749168|NCT00910728|584120781|FG002|Overall Study|Lack of Efficacy|1|||
161749169|NCT00910728|584120782|FG003|Overall Study|Lack of Efficacy|2|||
161749170|NCT00910728|584120783|FG004|Overall Study|Lack of Efficacy|1|||
161749171|NCT00910728|584120784|FG005|Overall Study|Lack of Efficacy|0|||
161749172|NCT00910728|584120785|FG006|Overall Study|Lack of Efficacy|2|||
161749173|NCT00910728|584120786|FG007|Overall Study|Lack of Efficacy|2|||
161749174|NCT00910728|584120787|FG008|Overall Study|Lack of Efficacy|2|||
161749175|NCT00910728|584120779|FG000|Overall Study|Withdrawal by Subject|0|||
161749176|NCT00910728|584120780|FG001|Overall Study|Withdrawal by Subject|0|||
161749177|NCT00910728|584120781|FG002|Overall Study|Withdrawal by Subject|0|||
161749178|NCT00910728|584120782|FG003|Overall Study|Withdrawal by Subject|0|||
161749179|NCT00910728|584120783|FG004|Overall Study|Withdrawal by Subject|3|||
161749180|NCT00910728|584120784|FG005|Overall Study|Withdrawal by Subject|1|||
161749181|NCT00910728|584120785|FG006|Overall Study|Withdrawal by Subject|2|||
161749182|NCT00910728|584120786|FG007|Overall Study|Withdrawal by Subject|0|||
161749183|NCT00910728|584120787|FG008|Overall Study|Withdrawal by Subject|0|||
161749184|NCT00910728|584120779|FG000|Overall Study|(not specified)|2|||
161749185|NCT00910728|584120780|FG001|Overall Study|(not specified)|0|||
161749186|NCT00910728|584120781|FG002|Overall Study|(not specified)|1|||
161749187|NCT00910728|584120782|FG003|Overall Study|(not specified)|0|||
161749188|NCT00910728|584120783|FG004|Overall Study|(not specified)|1|||
161749189|NCT00910728|584120784|FG005|Overall Study|(not specified)|0|||
161749190|NCT00910728|584120785|FG006|Overall Study|(not specified)|0|||
161749191|NCT00910728|584120786|FG007|Overall Study|(not specified)|0|||
161749192|NCT00910728|584120787|FG008|Overall Study|(not specified)|0|||
161749193|NCT00910728|584120779|FG000|Overall Study|Adverse Event|2|||
161749194|NCT00910728|584120780|FG001|Overall Study|Adverse Event|0|||
161843269|NCT00593736|584470046|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
161843270|NCT00593736|584470043|FG000|Screening Period and Placebo Run-in|Various|0|||
161843271|NCT00593736|584470044|FG001|Screening Period and Placebo Run-in|Various|0|||
161843272|NCT00593736|584470045|FG002|Screening Period and Placebo Run-in|Various|0|||
161749195|NCT00910728|584120781|FG002|Overall Study|Adverse Event|1|||
161749196|NCT00910728|584120782|FG003|Overall Study|Adverse Event|1|||
161749197|NCT00910728|584120783|FG004|Overall Study|Adverse Event|0|||
161749198|NCT00910728|584120784|FG005|Overall Study|Adverse Event|0|||
161749199|NCT00910728|584120785|FG006|Overall Study|Adverse Event|2|||
161749200|NCT00910728|584120786|FG007|Overall Study|Adverse Event|1|||
161749201|NCT00910728|584120787|FG008|Overall Study|Adverse Event|1|||
161749202|NCT01068717|584120791|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
161843273|NCT00593736|584470046|FG003|Screening Period and Placebo Run-in|Various|25|||
161843274|NCT00593736|584470043|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
161967544|NCT03622112|584927732|FG006|Overall Study|Study-specific withdrawal criteria|4|||
161967545|NCT03622112|584927726|FG000|Overall Study|Protocol Violation|2|||
161967546|NCT03622112|584927727|FG001|Overall Study|Protocol Violation|0|||
161967547|NCT03622112|584927728|FG002|Overall Study|Protocol Violation|1|||
161967548|NCT03622112|584927729|FG003|Overall Study|Protocol Violation|1|||
161749203|NCT01068717|584120792|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
161749204|NCT01068717|584120793|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
161749205|NCT01068717|584120794|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
161749206|NCT01822223|584120795|FG000|Overall Study|Death|0|||
161749207|NCT01822223|584120796|FG001|Overall Study|Death|1|||
161749208|NCT01449955|584120799|FG000|Overall Study|Withdrawal by Subject|1|||
161749209|NCT01449955|584120800|FG001|Overall Study|Withdrawal by Subject|2|||
161749210|NCT03404518|584120805|FG000|Overall Study|Lost to Follow-up|28|||
161749211|NCT03404518|584120806|FG001|Overall Study|Lost to Follow-up|30|||
161749212|NCT03404518|584120805|FG000|Overall Study|Protocol Violation|13|||
161749213|NCT03404518|584120806|FG001|Overall Study|Protocol Violation|6|||
161749214|NCT03693404|584120809|FG000|Overall Study|Withdrawal by Subject|1|||
161749215|NCT03693404|584120810|FG001|Overall Study|Withdrawal by Subject|0|||
161749216|NCT03693404|584120809|FG000|Overall Study|Lost to Follow-up|0|||
161749217|NCT03693404|584120810|FG001|Overall Study|Lost to Follow-up|5|||
161749218|NCT03693404|584120809|FG000|Overall Study|Excluded from Analysis|0|||
161749219|NCT03693404|584120810|FG001|Overall Study|Excluded from Analysis|1|||
161749220|NCT01176240|584120811|FG000|Study 306A|Lack of Efficacy|2|||
161749221|NCT01176240|584120812|FG001|Study 306A|Lack of Efficacy|1|||
161749222|NCT01176240|584120811|FG000|Study 306A|Protocol Violation|0|||
161749223|NCT01176240|584120812|FG001|Study 306A|Protocol Violation|1|||
161749224|NCT01176240|584120811|FG000|Study 306A|Withdrawal by Subject|0|||
161749225|NCT01176240|584120812|FG001|Study 306A|Withdrawal by Subject|1|||
161749226|NCT01176240|584120811|FG000|Study 306A|Stop due to diverse problems|1|||
161749227|NCT01176240|584120812|FG001|Study 306A|Stop due to diverse problems|0|||
161749228|NCT01176240|584120811|FG000|Study 306B|Lack of Efficacy|5|||
161749229|NCT01176240|584120812|FG001|Study 306B|Lack of Efficacy|3|||
161749230|NCT01176240|584120811|FG000|Study 306B|Adverse Event|10|||
161749231|NCT01176240|584120812|FG001|Study 306B|Adverse Event|5|||
161749232|NCT01176240|584120811|FG000|Study 306B|Protocol Violation|2|||
161749233|NCT01176240|584120812|FG001|Study 306B|Protocol Violation|3|||
161749234|NCT01176240|584120811|FG000|Study 306B|Withdrawal by Subject|4|||
161749235|NCT01176240|584120812|FG001|Study 306B|Withdrawal by Subject|1|||
161749236|NCT01176240|584120811|FG000|Study 306B|Physician Decision|2|||
161749237|NCT01176240|584120812|FG001|Study 306B|Physician Decision|1|||
161749238|NCT01176240|584120811|FG000|Study 306B|Supine Hypertension|1|||
161749239|NCT01176240|584120812|FG001|Study 306B|Supine Hypertension|2|||
161749240|NCT01176240|584120811|FG000|Study 306B|Lost to Follow-up|0|||
161749241|NCT01176240|584120812|FG001|Study 306B|Lost to Follow-up|1|||
161749242|NCT01176240|584120811|FG000|Study 306B|withdrew prior to dosing|2|||
161749243|NCT01176240|584120812|FG001|Study 306B|withdrew prior to dosing|1|||
161749244|NCT05200455|584120815|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
161749245|NCT00807014|584120816|FG000|Overall Study|Participant Considered Disease Cured|13|||
161749246|NCT00807014|584120817|FG001|Overall Study|Participant Considered Disease Cured|2|||
161749247|NCT00807014|584120816|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
161749248|NCT00807014|584120817|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
161749249|NCT00807014|584120816|FG000|Overall Study|Protocol Violation|2|||
161749250|NCT00807014|584120817|FG001|Overall Study|Protocol Violation|8|||
161749251|NCT00807014|584120816|FG000|Overall Study|Adverse Event|0|||
161749252|NCT00807014|584120817|FG001|Overall Study|Adverse Event|2|||
161749253|NCT00807014|584120816|FG000|Overall Study|Lost to Follow-up|9|||
161749254|NCT00807014|584120817|FG001|Overall Study|Lost to Follow-up|7|||
161749255|NCT00807014|584120816|FG000|Overall Study|Recovery|1|||
161749256|NCT00807014|584120817|FG001|Overall Study|Recovery|0|||
161749257|NCT00807014|584120816|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
161749258|NCT00807014|584120817|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
161967549|NCT03622112|584927730|FG004|Overall Study|Protocol Violation|0|||
161749259|NCT00651313|584120818|FG000|Overall Study|Adverse Event|0|||
161749260|NCT00651313|584120819|FG001|Overall Study|Adverse Event|1|||
161749261|NCT00651313|584120818|FG000|Overall Study|Withdrawal by Subject|3|||
161749262|NCT00651313|584120819|FG001|Overall Study|Withdrawal by Subject|1|||
161749263|NCT00651313|584120818|FG000|Overall Study|Lost to Follow-up|1|||
161749264|NCT00651313|584120819|FG001|Overall Study|Lost to Follow-up|1|||
161749265|NCT00651313|584120818|FG000|Overall Study|Adminstrative Discontinuation|2|||
161749266|NCT00651313|584120819|FG001|Overall Study|Adminstrative Discontinuation|3|||
161749267|NCT01731990|584122972|FG000|Overall Study|Adverse Event|1|||
161749268|NCT01731990|584122973|FG001|Overall Study|Adverse Event|5|||
161749269|NCT01731990|584122972|FG000|Overall Study|Withdrawal by Subject|1|||
161749270|NCT01731990|584122973|FG001|Overall Study|Withdrawal by Subject|1|||
161749271|NCT01731990|584122972|FG000|Overall Study|Protocol deviation|1|||
161749272|NCT01731990|584122973|FG001|Overall Study|Protocol deviation|2|||
161749273|NCT01731990|584122972|FG000|Overall Study|Death|1|||
161749274|NCT01731990|584122973|FG001|Overall Study|Death|0|||
161749275|NCT01183104|584122976|FG000|Overall Study|Adverse Event|8|||
161749276|NCT01183104|584122977|FG001|Overall Study|Adverse Event|6|||
161749277|NCT01183104|584122976|FG000|Overall Study|Death|0|||
161749278|NCT01183104|584122977|FG001|Overall Study|Death|1|||
161749279|NCT01183104|584122976|FG000|Overall Study|Lost to Follow-up|14|||
161749280|NCT01183104|584122977|FG001|Overall Study|Lost to Follow-up|7|||
161749281|NCT01183104|584122976|FG000|Overall Study|Physician Decision|5|||
161749282|NCT01183104|584122977|FG001|Overall Study|Physician Decision|8|||
161749283|NCT01183104|584122976|FG000|Overall Study|Withdrawal by Subject|6|||
161749284|NCT01183104|584122977|FG001|Overall Study|Withdrawal by Subject|11|||
161749285|NCT01183104|584122976|FG000|Overall Study|Nonparticipation in Extension Study|39|||
161749286|NCT01183104|584122977|FG001|Overall Study|Nonparticipation in Extension Study|50|||
161749287|NCT01183104|584122976|FG000|Overall Study|Did not receive study drug|5|||
161749288|NCT01183104|584122977|FG001|Overall Study|Did not receive study drug|9|||
161749289|NCT00790218|584122978|FG000|Overall Study|Death|1|||
161749290|NCT00790218|584122979|FG001|Overall Study|Death|0|||
161749291|NCT00790218|584122980|FG002|Overall Study|Death|0|||
161749292|NCT04402385|584122986|FG000|Overall Study|Withdrawal by Subject|4|||
161749293|NCT04402385|584122987|FG001|Overall Study|Withdrawal by Subject|4|||
161749294|NCT04402385|584122986|FG000|Overall Study|Lost to Follow-up|1|||
161749295|NCT04402385|584122987|FG001|Overall Study|Lost to Follow-up|1|||
161749296|NCT04402385|584122986|FG000|Overall Study|Physician Decision|0|||
161749297|NCT04402385|584122987|FG001|Overall Study|Physician Decision|1|||
161749298|NCT00731666|584122988|FG000|Overall Study|Adverse Event|2|||
161749299|NCT00731666|584122988|FG000|Overall Study|Lost to Follow-up|8|||
161749300|NCT00731666|584122988|FG000|Overall Study|Withdrawal by Subject|2|||
161749301|NCT03250624|584122990|FG000|Overall Study|Lack of Efficacy|1|||
161749302|NCT03250624|584122991|FG001|Overall Study|Lack of Efficacy|4|||
161749303|NCT03250624|584122990|FG000|Overall Study|Adverse Event|0|||
161749304|NCT03250624|584122991|FG001|Overall Study|Adverse Event|1|||
161749305|NCT03250624|584122990|FG000|Overall Study|Other|1|||
161749306|NCT03250624|584122991|FG001|Overall Study|Other|2|||
161749307|NCT00948428|584122992|FG000|Overall Study|Withdrawal by Subject|6|||
161749308|NCT00948428|584122993|FG001|Overall Study|Withdrawal by Subject|12|||
161749309|NCT00948428|584122994|FG002|Overall Study|Withdrawal by Subject|7|||
161749310|NCT00948428|584122992|FG000|Overall Study|Adverse Event|6|||
161749311|NCT00948428|584122993|FG001|Overall Study|Adverse Event|3|||
161749312|NCT00948428|584122994|FG002|Overall Study|Adverse Event|0|||
161749313|NCT00948428|584122992|FG000|Overall Study|Lost to Follow-up|2|||
161749314|NCT00948428|584122993|FG001|Overall Study|Lost to Follow-up|1|||
161749315|NCT00948428|584122994|FG002|Overall Study|Lost to Follow-up|1|||
161749316|NCT00948428|584122992|FG000|Overall Study|Death|2|||
161749317|NCT00948428|584122993|FG001|Overall Study|Death|0|||
161749318|NCT00948428|584122994|FG002|Overall Study|Death|0|||
161749319|NCT00948428|584122992|FG000|Overall Study|Intercurrent Illness|1|||
161749320|NCT00948428|584122993|FG001|Overall Study|Intercurrent Illness|0|||
161749321|NCT00948428|584122994|FG002|Overall Study|Intercurrent Illness|0|||
161749322|NCT00948428|584122992|FG000|Overall Study|Non-compliance|1|||
161749323|NCT00948428|584122993|FG001|Overall Study|Non-compliance|2|||
161749324|NCT00948428|584122994|FG002|Overall Study|Non-compliance|0|||
161749325|NCT05516134|584123003|FG000|Overall Study|Lost to Follow-up|1|||
161749326|NCT05516134|584123004|FG001|Overall Study|Lost to Follow-up|0|||
161749327|NCT05516134|584123005|FG002|Overall Study|Lost to Follow-up|0|||
161749328|NCT01355497|584123016|FG000|Overall Study|Death|19|||
161749329|NCT01355497|584123017|FG001|Overall Study|Death|18|||
161749330|NCT01355497|584123016|FG000|Overall Study|Lost to Follow-up|3|||
161749331|NCT01355497|584123017|FG001|Overall Study|Lost to Follow-up|0|||
161749332|NCT01355497|584123016|FG000|Overall Study|Protocol Violation|0|||
161749333|NCT01355497|584123017|FG001|Overall Study|Protocol Violation|1|||
161749334|NCT01355497|584123016|FG000|Overall Study|other-not provided|9|||
161749335|NCT01355497|584123017|FG001|Overall Study|other-not provided|4|||
161749336|NCT01355497|584123016|FG000|Overall Study|Withdrawal by Subject|12|||
161749337|NCT01355497|584123017|FG001|Overall Study|Withdrawal by Subject|20|||
161967550|NCT03622112|584927731|FG005|Overall Study|Protocol Violation|0|||
161749338|NCT01355497|584123016|FG000|Overall Study|noncompliance|1|||
161749339|NCT01355497|584123017|FG001|Overall Study|noncompliance|2|||
161749340|NCT01355497|584123016|FG000|Overall Study|progressive disease|11|||
161749341|NCT01355497|584123017|FG001|Overall Study|progressive disease|8|||
161749342|NCT01355497|584123016|FG000|Overall Study|Adverse Event|11|||
161749343|NCT01355497|584123017|FG001|Overall Study|Adverse Event|10|||
161749344|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Death|3|||
161749345|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Death|0|||
161749346|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Death|0|||
161749347|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Death|0|||
161749348|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Death|0|||
161749349|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
161749350|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
161749351|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
161749352|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
161749353|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
161749354|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161749355|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
161749356|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
161749357|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161749358|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
161749359|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Other|0|||
161749360|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Other|0|||
161749361|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Other|1|||
161749362|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Other|0|||
161749363|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Other|0|||
161749364|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
161749365|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
161749366|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
161749367|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
161749368|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
161749369|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
161749370|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
161749371|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
161749372|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
161749373|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
161749374|NCT01224106|584123019|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161749375|NCT01224106|584123020|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161749376|NCT01224106|584123021|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161749377|NCT01224106|584123022|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161749378|NCT01224106|584123023|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161749379|NCT01224106|584123019|FG000|Open-Label Extension (OLE) Phase|Death|0|||
161749380|NCT01224106|584123020|FG001|Open-Label Extension (OLE) Phase|Death|0|||
161749381|NCT01224106|584123021|FG002|Open-Label Extension (OLE) Phase|Death|0|||
161749382|NCT01224106|584123022|FG003|Open-Label Extension (OLE) Phase|Death|1|||
161749383|NCT01224106|584123023|FG004|Open-Label Extension (OLE) Phase|Death|3|||
161749384|NCT01224106|584123019|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
161749385|NCT01224106|584123020|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
161749386|NCT01224106|584123021|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
161749387|NCT01224106|584123022|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
161749388|NCT01224106|584123023|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
161749389|NCT01224106|584123019|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
161749390|NCT01224106|584123020|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
161749391|NCT01224106|584123021|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
161749392|NCT01224106|584123022|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
161749393|NCT01224106|584123023|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
161749394|NCT01224106|584123019|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
161749395|NCT01224106|584123020|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
161749396|NCT01224106|584123021|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
161749397|NCT01224106|584123022|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
161749398|NCT01224106|584123023|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
161749399|NCT01224106|584123019|FG000|Open-Label Extension (OLE) Phase|Other|0|||
161749400|NCT01224106|584123020|FG001|Open-Label Extension (OLE) Phase|Other|0|||
161749401|NCT01224106|584123021|FG002|Open-Label Extension (OLE) Phase|Other|0|||
161749402|NCT01224106|584123022|FG003|Open-Label Extension (OLE) Phase|Other|5|||
161749403|NCT01224106|584123023|FG004|Open-Label Extension (OLE) Phase|Other|3|||
161749404|NCT00420342|584123026|FG000|Overall Study|Lost to Follow-up|1|||
161749405|NCT00420342|584123027|FG001|Overall Study|Lost to Follow-up|0|||
161749406|NCT00420342|584123028|FG002|Overall Study|Lost to Follow-up|1|||
161749407|NCT00420342|584123026|FG000|Overall Study|Withdrawal by Subject|0|||
161749408|NCT00420342|584123027|FG001|Overall Study|Withdrawal by Subject|2|||
161749409|NCT00420342|584123028|FG002|Overall Study|Withdrawal by Subject|0|||
161749410|NCT00839436|584123031|FG000|Overall Study|Developed exclusionary condition|1|||
161749411|NCT00839436|584123032|FG001|Overall Study|Developed exclusionary condition|0|||
161749412|NCT00839436|584123033|FG002|Overall Study|Developed exclusionary condition|0|||
161749413|NCT00839436|584123031|FG000|Overall Study|Withdrawal by Subject|0|||
161749414|NCT00839436|584123032|FG001|Overall Study|Withdrawal by Subject|1|||
161749415|NCT00839436|584123033|FG002|Overall Study|Withdrawal by Subject|0|||
161749416|NCT00839436|584123031|FG000|Overall Study|Study drug no longer available|0|||
161749417|NCT00839436|584123032|FG001|Overall Study|Study drug no longer available|0|||
161749418|NCT00839436|584123033|FG002|Overall Study|Study drug no longer available|1|||
161749419|NCT01440972|584123034|FG000|Overall Study|Withdrawal by Subject|3|||
161749420|NCT01440972|584123035|FG001|Overall Study|Withdrawal by Subject|2|||
161749421|NCT03933215|584123036|FG000|Overall Study|Other|6|||
161749422|NCT03933215|584123036|FG000|Overall Study|Sponsor decision|5|||
161967551|NCT03622112|584927732|FG006|Overall Study|Protocol Violation|0|||
161967552|NCT03622112|584927726|FG000|Overall Study|Adverse Event|6|||
161967553|NCT03622112|584927727|FG001|Overall Study|Adverse Event|8|||
161967554|NCT03622112|584927728|FG002|Overall Study|Adverse Event|4|||
161967555|NCT03622112|584927729|FG003|Overall Study|Adverse Event|11|||
161967556|NCT03622112|584927730|FG004|Overall Study|Adverse Event|4|||
161967557|NCT03622112|584927731|FG005|Overall Study|Adverse Event|20|||
161967558|NCT03622112|584927732|FG006|Overall Study|Adverse Event|2|||
161967559|NCT03622112|584927726|FG000|Overall Study|Reason not specified|0|||
161967560|NCT03622112|584927727|FG001|Overall Study|Reason not specified|1|||
161967561|NCT03622112|584927728|FG002|Overall Study|Reason not specified|0|||
161967562|NCT03622112|584927729|FG003|Overall Study|Reason not specified|1|||
161967563|NCT03622112|584927730|FG004|Overall Study|Reason not specified|1|||
161967564|NCT03622112|584927731|FG005|Overall Study|Reason not specified|2|||
161967565|NCT03622112|584927732|FG006|Overall Study|Reason not specified|1|||
161967566|NCT01155466|584927733|FG000|Overall Study|Adverse Event|13|||
161967567|NCT01155466|584927734|FG001|Overall Study|Adverse Event|15|||
161967568|NCT01155466|584927735|FG002|Overall Study|Adverse Event|6|||
161967569|NCT01155466|584927736|FG003|Overall Study|Adverse Event|17|||
161967570|NCT01155466|584927737|FG004|Overall Study|Adverse Event|18|||
161967571|NCT01155466|584927733|FG000|Overall Study|Lost to Follow-up|0|||
161967572|NCT01155466|584927734|FG001|Overall Study|Lost to Follow-up|0|||
161967573|NCT01155466|584927735|FG002|Overall Study|Lost to Follow-up|0|||
161967574|NCT01155466|584927736|FG003|Overall Study|Lost to Follow-up|0|||
161749423|NCT03933215|584123036|FG000|Overall Study|Protocol Violation|5|||
161749424|NCT03933215|584123036|FG000|Overall Study|Withdrawal by Subject|6|||
161749425|NCT03933215|584123036|FG000|Overall Study|Lost to Follow-up|6|||
161749426|NCT03933215|584123036|FG000|Overall Study|Enrolled but not treated|38|||
161749427|NCT04072575|584123039|FG000|Overall Study|Physician Decision|1|||
161749428|NCT04072575|584123039|FG000|Overall Study|Adverse Event|7|||
161749429|NCT04072575|584123039|FG000|Overall Study|Withdrawal by Subject|14|||
161749430|NCT04072575|584123039|FG000|Overall Study|Other|2|||
161749431|NCT05784129|584123040|FG000|Overall Study|Study terminated by sponsor|2|||
161749432|NCT05784129|584123041|FG001|Overall Study|Study terminated by sponsor|2|||
161749433|NCT01444898|584123042|FG000|Overall Study|Withdrawal by Subject|1|||
161749434|NCT02580591|584123043|FG000|Overall Study|Adverse Event|0|||
161749435|NCT02580591|584123044|FG001|Overall Study|Adverse Event|1|||
161749436|NCT02580591|584123045|FG002|Overall Study|Adverse Event|2|||
161749437|NCT02580591|584123046|FG003|Overall Study|Adverse Event|5|||
161749438|NCT02580591|584123043|FG000|Overall Study|Protocol Violation|3|||
161749439|NCT02580591|584123044|FG001|Overall Study|Protocol Violation|2|||
161749440|NCT02580591|584123045|FG002|Overall Study|Protocol Violation|1|||
161749441|NCT02580591|584123046|FG003|Overall Study|Protocol Violation|1|||
161749442|NCT02580591|584123043|FG000|Overall Study|Lost to Follow-up|5|||
161749443|NCT02580591|584123044|FG001|Overall Study|Lost to Follow-up|3|||
161749444|NCT02580591|584123045|FG002|Overall Study|Lost to Follow-up|3|||
161749445|NCT02580591|584123046|FG003|Overall Study|Lost to Follow-up|1|||
161749446|NCT02580591|584123043|FG000|Overall Study|Withdrawal by Subject|6|||
161749447|NCT02580591|584123044|FG001|Overall Study|Withdrawal by Subject|1|||
161749448|NCT02580591|584123045|FG002|Overall Study|Withdrawal by Subject|2|||
161749449|NCT02580591|584123046|FG003|Overall Study|Withdrawal by Subject|3|||
161749450|NCT02580591|584123043|FG000|Overall Study|Not treated|1|||
161749451|NCT02580591|584123044|FG001|Overall Study|Not treated|1|||
161749452|NCT02580591|584123045|FG002|Overall Study|Not treated|0|||
161749453|NCT02580591|584123046|FG003|Overall Study|Not treated|0|||
161749454|NCT02580591|584123043|FG000|Overall Study|Other than specified|3|||
161749455|NCT02580591|584123044|FG001|Overall Study|Other than specified|2|||
161749456|NCT02580591|584123045|FG002|Overall Study|Other than specified|5|||
161749457|NCT02580591|584123046|FG003|Overall Study|Other than specified|2|||
161749458|NCT01599806|584123048|FG000|Overall Study|Lost to Follow-up|20|||
161967575|NCT01155466|584927737|FG004|Overall Study|Lost to Follow-up|2|||
161967576|NCT01155466|584927733|FG000|Overall Study|Withdrawal by Subject|7|||
161967577|NCT01155466|584927734|FG001|Overall Study|Withdrawal by Subject|5|||
161967578|NCT01155466|584927735|FG002|Overall Study|Withdrawal by Subject|9|||
161967579|NCT01155466|584927736|FG003|Overall Study|Withdrawal by Subject|4|||
161967580|NCT01155466|584927737|FG004|Overall Study|Withdrawal by Subject|4|||
161967581|NCT01155466|584927733|FG000|Overall Study|Protocol Violation|0|||
161967582|NCT01155466|584927734|FG001|Overall Study|Protocol Violation|0|||
161967583|NCT01155466|584927735|FG002|Overall Study|Protocol Violation|2|||
161749459|NCT01599806|584123049|FG001|Overall Study|Lost to Follow-up|20|||
161749460|NCT01599806|584123048|FG000|Overall Study|Withdrawal by Subject|12|||
161749461|NCT01599806|584123049|FG001|Overall Study|Withdrawal by Subject|12|||
161967584|NCT01155466|584927736|FG003|Overall Study|Protocol Violation|0|||
161967585|NCT01155466|584927737|FG004|Overall Study|Protocol Violation|1|||
161749462|NCT01599806|584123048|FG000|Overall Study|Other Eligibility criteria|11|||
161749463|NCT01599806|584123049|FG001|Overall Study|Other Eligibility criteria|9|||
161749464|NCT04583969|584123050|FG000|Overall Study|Death|31|||
161749465|NCT04583969|584123051|FG001|Overall Study|Death|38|||
161749466|NCT04583969|584123050|FG000|Overall Study|Lost to Follow-up|16|||
161843275|NCT00593736|584470044|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
161843276|NCT00593736|584470045|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
161843277|NCT00593736|584470046|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
161843278|NCT00593736|584470043|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
161843279|NCT00593736|584470044|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
161843280|NCT00593736|584470045|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
161843281|NCT00593736|584470046|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
161843282|NCT00593736|584470043|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
161843283|NCT00593736|584470044|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
161843284|NCT00593736|584470045|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
161843285|NCT00593736|584470046|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
161843286|NCT00593736|584470043|FG000|Treatment Period and Placebo Run-out|Various|1|||
161843287|NCT00593736|584470044|FG001|Treatment Period and Placebo Run-out|Various|1|||
161843288|NCT00593736|584470045|FG002|Treatment Period and Placebo Run-out|Various|1|||
161843289|NCT00593736|584470046|FG003|Treatment Period and Placebo Run-out|Various|0|||
161843290|NCT01868893|584470047|FG000|Overall Study|Adverse Event|2|||
161843291|NCT01868893|584470047|FG000|Overall Study|Commercial availability of study drug|17|||
161843292|NCT01868893|584470047|FG000|Overall Study|Neutropenia|1|||
161843293|NCT01857271|584470048|FG000|Overall Study|Lost to Follow-up|1|||
161843294|NCT03825341|584470051|FG000|Overall Study|Withdrawal by Subject|0|||
161843295|NCT03825341|584470052|FG001|Overall Study|Withdrawal by Subject|1|||
161843296|NCT04283500|584470055|FG000|Overall Study|Lost to Follow-up|8|||
161843297|NCT04283500|584470055|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
161843298|NCT00338455|584470065|FG000|Overall Study|Death|2|||
161843299|NCT00338455|584470066|FG001|Overall Study|Death|1|||
161843300|NCT00338455|584470065|FG000|Overall Study|Physician Decision|1|||
161843301|NCT00338455|584470066|FG001|Overall Study|Physician Decision|0|||
161843302|NCT01517373|584470067|FG000|Run-in Period|Death|1|||
161843303|NCT01517373|584470068|FG001|Run-in Period|Death|0|||
161843304|NCT01517373|584470069|FG002|Run-in Period|Death|0|||
161843305|NCT01517373|584470070|FG003|Run-in Period|Death|0|||
161843306|NCT01517373|584470071|FG004|Run-in Period|Death|0|||
161843307|NCT01517373|584470072|FG005|Run-in Period|Death|0|||
161843308|NCT01517373|584470067|FG000|Run-in Period|Adverse Event|5|||
161843309|NCT01517373|584470068|FG001|Run-in Period|Adverse Event|0|||
161843310|NCT01517373|584470069|FG002|Run-in Period|Adverse Event|0|||
161843311|NCT01517373|584470070|FG003|Run-in Period|Adverse Event|0|||
161843312|NCT01517373|584470071|FG004|Run-in Period|Adverse Event|0|||
161843313|NCT01517373|584470072|FG005|Run-in Period|Adverse Event|0|||
161843314|NCT01517373|584470067|FG000|Run-in Period|Did not meet eligibility criteria|34|||
161843315|NCT01517373|584470068|FG001|Run-in Period|Did not meet eligibility criteria|0|||
161843316|NCT01517373|584470069|FG002|Run-in Period|Did not meet eligibility criteria|0|||
161843317|NCT01517373|584470070|FG003|Run-in Period|Did not meet eligibility criteria|0|||
161843318|NCT01517373|584470071|FG004|Run-in Period|Did not meet eligibility criteria|0|||
161843319|NCT01517373|584470072|FG005|Run-in Period|Did not meet eligibility criteria|0|||
161843320|NCT01517373|584470067|FG000|Run-in Period|Lost to Follow-up|1|||
161843321|NCT01517373|584470068|FG001|Run-in Period|Lost to Follow-up|0|||
161843322|NCT01517373|584470069|FG002|Run-in Period|Lost to Follow-up|0|||
161843323|NCT01517373|584470070|FG003|Run-in Period|Lost to Follow-up|0|||
161843324|NCT01517373|584470071|FG004|Run-in Period|Lost to Follow-up|0|||
161843325|NCT01517373|584470072|FG005|Run-in Period|Lost to Follow-up|0|||
161843326|NCT01517373|584470067|FG000|Run-in Period|Withdrawal by Subject|12|||
161843327|NCT01517373|584470068|FG001|Run-in Period|Withdrawal by Subject|0|||
161967586|NCT01155466|584927733|FG000|Overall Study|Administrative|0|||
161967587|NCT01155466|584927734|FG001|Overall Study|Administrative|3|||
161967588|NCT01155466|584927735|FG002|Overall Study|Administrative|0|||
161843328|NCT01517373|584470069|FG002|Run-in Period|Withdrawal by Subject|0|||
161843329|NCT01517373|584470070|FG003|Run-in Period|Withdrawal by Subject|0|||
161843330|NCT01517373|584470071|FG004|Run-in Period|Withdrawal by Subject|0|||
161843331|NCT01517373|584470072|FG005|Run-in Period|Withdrawal by Subject|0|||
161843332|NCT01517373|584470067|FG000|Run-in Period|Sponsor Decision|3|||
161843333|NCT01517373|584470068|FG001|Run-in Period|Sponsor Decision|0|||
161843334|NCT01517373|584470069|FG002|Run-in Period|Sponsor Decision|0|||
161843335|NCT01517373|584470070|FG003|Run-in Period|Sponsor Decision|0|||
161843336|NCT01517373|584470071|FG004|Run-in Period|Sponsor Decision|0|||
161843337|NCT01517373|584470072|FG005|Run-in Period|Sponsor Decision|0|||
161967589|NCT01155466|584927736|FG003|Overall Study|Administrative|0|||
161843338|NCT01517373|584470067|FG000|Run-in Period|Other|1|||
161843339|NCT01517373|584470068|FG001|Run-in Period|Other|0|||
161967590|NCT01155466|584927737|FG004|Overall Study|Administrative|0|||
161843340|NCT01517373|584470069|FG002|Run-in Period|Other|0|||
161843341|NCT01517373|584470070|FG003|Run-in Period|Other|0|||
161843342|NCT01517373|584470071|FG004|Run-in Period|Other|0|||
161843343|NCT01517373|584470072|FG005|Run-in Period|Other|0|||
161843344|NCT01517373|584470067|FG000|Treatment Period|Adverse Event|0|||
161843345|NCT01517373|584470068|FG001|Treatment Period|Adverse Event|0|||
161967591|NCT01155466|584927733|FG000|Overall Study|Randomized not treated|2|||
161749467|NCT04583969|584123051|FG001|Overall Study|Lost to Follow-up|13|||
161749468|NCT04583969|584123050|FG000|Overall Study|Protocol Violation|1|||
161749469|NCT04583969|584123051|FG001|Overall Study|Protocol Violation|0|||
161749470|NCT04583969|584123050|FG000|Overall Study|Withdrawal by Subject|3|||
161749471|NCT04583969|584123051|FG001|Overall Study|Withdrawal by Subject|3|||
161749472|NCT04583969|584123050|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
161749473|NCT04583969|584123051|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
161749474|NCT04583969|584123050|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
161749475|NCT04583969|584123051|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
161749476|NCT04583969|584123050|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
161749477|NCT04583969|584123051|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
161749478|NCT04583969|584123050|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
161749479|NCT04583969|584123051|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
161749480|NCT04583969|584123050|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
161749481|NCT04583969|584123051|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
161749482|NCT02873208|584123052|FG000|Overall Study|Withdrawal by Subject|36|||
161749483|NCT02873208|584123052|FG000|Overall Study|Lost to Follow-up|22|||
161749484|NCT02873208|584123052|FG000|Overall Study|Adverse Event|15|||
161749485|NCT02873208|584123052|FG000|Overall Study|Non-compliance with study drug|12|||
161749486|NCT02873208|584123052|FG000|Overall Study|Protocol Violation|8|||
161749487|NCT02873208|584123052|FG000|Overall Study|Pregnancy|2|||
161749488|NCT02873208|584123052|FG000|Overall Study|Incarceration|1|||
161749489|NCT02873208|584123052|FG000|Overall Study|Lack of Efficacy|1|||
161749490|NCT02873208|584123052|FG000|Overall Study|Physician Decision|1|||
161749491|NCT00415584|584123053|FG000|Overall Study|Withdrawal by Subject|1|||
161749492|NCT01061567|584123054|FG000|Overall Study|Adverse Event|32|||
161749493|NCT01061567|584123054|FG000|Overall Study|Death|2|||
161749494|NCT01061567|584123054|FG000|Overall Study|Lack of Efficacy|3|||
161749495|NCT01061567|584123054|FG000|Overall Study|Lost to Follow-up|24|||
161749496|NCT01061567|584123054|FG000|Overall Study|Protocol Violation|1|||
161749497|NCT01061567|584123054|FG000|Overall Study|Withdrawal by Subject|11|||
161749498|NCT01061567|584123054|FG000|Overall Study|Other reason than stated above|3|||
161749499|NCT00563368|584123055|FG000|Overall Study|Lost to Follow-up|14|||
161749500|NCT00563368|584123056|FG001|Overall Study|Lost to Follow-up|14|||
161749501|NCT00563368|584123057|FG002|Overall Study|Lost to Follow-up|12|||
161749502|NCT00563368|584123058|FG003|Overall Study|Lost to Follow-up|6|||
161749503|NCT00563368|584123059|FG004|Overall Study|Lost to Follow-up|9|||
161749504|NCT00563368|584123060|FG005|Overall Study|Lost to Follow-up|8|||
161749505|NCT00563368|584123061|FG006|Overall Study|Lost to Follow-up|9|||
161749506|NCT00563368|584123055|FG000|Overall Study|Adverse Event|3|||
161749507|NCT00563368|584123056|FG001|Overall Study|Adverse Event|4|||
161749508|NCT00563368|584123057|FG002|Overall Study|Adverse Event|5|||
161749509|NCT00563368|584123058|FG003|Overall Study|Adverse Event|9|||
161749510|NCT00563368|584123059|FG004|Overall Study|Adverse Event|6|||
161749511|NCT00563368|584123060|FG005|Overall Study|Adverse Event|10|||
161749512|NCT00563368|584123061|FG006|Overall Study|Adverse Event|17|||
161749513|NCT00563368|584123055|FG000|Overall Study|Withdrawal by Subject|11|||
161749514|NCT00563368|584123056|FG001|Overall Study|Withdrawal by Subject|6|||
161749515|NCT00563368|584123057|FG002|Overall Study|Withdrawal by Subject|5|||
161749516|NCT00563368|584123058|FG003|Overall Study|Withdrawal by Subject|7|||
161749517|NCT00563368|584123059|FG004|Overall Study|Withdrawal by Subject|8|||
161749518|NCT00563368|584123060|FG005|Overall Study|Withdrawal by Subject|5|||
161749519|NCT00563368|584123061|FG006|Overall Study|Withdrawal by Subject|4|||
161749520|NCT00563368|584123055|FG000|Overall Study|protocol non-compliance|1|||
161749521|NCT00563368|584123056|FG001|Overall Study|protocol non-compliance|1|||
161749522|NCT00563368|584123057|FG002|Overall Study|protocol non-compliance|2|||
161749523|NCT00563368|584123058|FG003|Overall Study|protocol non-compliance|1|||
161749524|NCT00563368|584123059|FG004|Overall Study|protocol non-compliance|0|||
161749525|NCT00563368|584123060|FG005|Overall Study|protocol non-compliance|1|||
161749526|NCT00563368|584123061|FG006|Overall Study|protocol non-compliance|3|||
161749527|NCT00563368|584123055|FG000|Overall Study|Pregnancy|1|||
161967592|NCT01155466|584927734|FG001|Overall Study|Randomized not treated|2|||
161967593|NCT01155466|584927735|FG002|Overall Study|Randomized not treated|3|||
161749528|NCT00563368|584123056|FG001|Overall Study|Pregnancy|0|||
161749529|NCT00563368|584123057|FG002|Overall Study|Pregnancy|1|||
161749530|NCT00563368|584123058|FG003|Overall Study|Pregnancy|2|||
161749531|NCT00563368|584123059|FG004|Overall Study|Pregnancy|1|||
161749532|NCT00563368|584123060|FG005|Overall Study|Pregnancy|2|||
161749533|NCT00563368|584123061|FG006|Overall Study|Pregnancy|0|||
161749534|NCT00563368|584123055|FG000|Overall Study|requirement for restricted medication|0|||
161749535|NCT00563368|584123056|FG001|Overall Study|requirement for restricted medication|0|||
161749536|NCT00563368|584123057|FG002|Overall Study|requirement for restricted medication|2|||
161967594|NCT01155466|584927736|FG003|Overall Study|Randomized not treated|0|||
161749537|NCT00563368|584123058|FG003|Overall Study|requirement for restricted medication|0|||
161749538|NCT00563368|584123059|FG004|Overall Study|requirement for restricted medication|0|||
161749539|NCT00563368|584123060|FG005|Overall Study|requirement for restricted medication|0|||
161749540|NCT00563368|584123061|FG006|Overall Study|requirement for restricted medication|0|||
161749541|NCT00563368|584123055|FG000|Overall Study|Other|5|||
161749542|NCT00563368|584123056|FG001|Overall Study|Other|5|||
161749543|NCT00563368|584123057|FG002|Overall Study|Other|3|||
161749544|NCT00563368|584123058|FG003|Overall Study|Other|4|||
161749545|NCT00563368|584123059|FG004|Overall Study|Other|4|||
161749546|NCT00563368|584123060|FG005|Overall Study|Other|4|||
161749547|NCT00563368|584123061|FG006|Overall Study|Other|0|||
161749548|NCT00114218|584123073|FG000|Overall Study|Wrong Cell Type|2|||
161749549|NCT00114218|584123073|FG000|Overall Study|Wrong Primary|1|||
161749550|NCT00114218|584123073|FG000|Overall Study|Never Treated|1|||
161749551|NCT03168555|584123074|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
161749552|NCT03168555|584123074|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
161749553|NCT03168555|584123074|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
161749554|NCT03168555|584123074|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
161749555|NCT02959190|584123076|FG000|Open Label|Adverse Event|5|||
161749556|NCT02959190|584123077|FG001|Open Label|Adverse Event|7|||
161749557|NCT02959190|584123078|FG002|Open Label|Adverse Event|3|||
161749558|NCT02959190|584123079|FG003|Open Label|Adverse Event|4|||
161749559|NCT02959190|584123076|FG000|Open Label|Pregnancy|0|||
161749560|NCT02959190|584123077|FG001|Open Label|Pregnancy|1|||
161749561|NCT02959190|584123078|FG002|Open Label|Pregnancy|0|||
161749562|NCT02959190|584123079|FG003|Open Label|Pregnancy|0|||
161749563|NCT02959190|584123076|FG000|Open Label|Withdrawal by Subject|2|||
161749564|NCT02959190|584123077|FG001|Open Label|Withdrawal by Subject|8|||
161749565|NCT02959190|584123078|FG002|Open Label|Withdrawal by Subject|0|||
161749566|NCT02959190|584123079|FG003|Open Label|Withdrawal by Subject|0|||
161749567|NCT02959190|584123076|FG000|Open Label|Physician Decision|0|||
161749568|NCT02959190|584123077|FG001|Open Label|Physician Decision|0|||
161749569|NCT02959190|584123078|FG002|Open Label|Physician Decision|1|||
161749570|NCT02959190|584123079|FG003|Open Label|Physician Decision|0|||
161749571|NCT02959190|584123076|FG000|Open Label|Protocol Violation|0|||
161749572|NCT02959190|584123077|FG001|Open Label|Protocol Violation|0|||
161749573|NCT02959190|584123078|FG002|Open Label|Protocol Violation|0|||
161749574|NCT02959190|584123079|FG003|Open Label|Protocol Violation|2|||
161749575|NCT02959190|584123076|FG000|Post Treatment Follow Up|Adverse Event|1|||
161749576|NCT02959190|584123077|FG001|Post Treatment Follow Up|Adverse Event|1|||
161749577|NCT02959190|584123078|FG002|Post Treatment Follow Up|Adverse Event|0|||
161749578|NCT02959190|584123079|FG003|Post Treatment Follow Up|Adverse Event|0|||
161749579|NCT02959190|584123076|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
161749580|NCT02959190|584123077|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
161749581|NCT02959190|584123078|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
161749582|NCT02959190|584123079|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
161749583|NCT01235507|584123081|FG000|Overall Study|Adverse Event|1|||
161749584|NCT01235507|584123081|FG000|Overall Study|Withdrawal by Subject|1|||
161749585|NCT00588523|584123086|FG000|Overall Study|Not treated|3|||
161749586|NCT02679781|584123087|FG000|Overall Study|Lost to Follow-up|1|||
161749587|NCT02679781|584123088|FG001|Overall Study|Lost to Follow-up|2|||
161749588|NCT02679781|584123087|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
161749589|NCT02679781|584123088|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
161749590|NCT04209400|584123091|FG000|Overall Study|Withdrawal by Subject|0|||
161843346|NCT01517373|584470069|FG002|Treatment Period|Adverse Event|0|||
161843347|NCT01517373|584470070|FG003|Treatment Period|Adverse Event|0|||
161843348|NCT01517373|584470071|FG004|Treatment Period|Adverse Event|0|||
161843349|NCT01517373|584470072|FG005|Treatment Period|Adverse Event|2|||
161843350|NCT01517373|584470067|FG000|Treatment Period|Lost to Follow-up|0|||
161843351|NCT01517373|584470068|FG001|Treatment Period|Lost to Follow-up|0|||
161843352|NCT01517373|584470069|FG002|Treatment Period|Lost to Follow-up|1|||
161843353|NCT01517373|584470070|FG003|Treatment Period|Lost to Follow-up|1|||
161843354|NCT01517373|584470071|FG004|Treatment Period|Lost to Follow-up|0|||
161843355|NCT01517373|584470072|FG005|Treatment Period|Lost to Follow-up|0|||
161843356|NCT01517373|584470067|FG000|Treatment Period|Withdrawal by Subject|0|||
161843357|NCT01517373|584470068|FG001|Treatment Period|Withdrawal by Subject|3|||
161843358|NCT01517373|584470069|FG002|Treatment Period|Withdrawal by Subject|2|||
161843359|NCT01517373|584470070|FG003|Treatment Period|Withdrawal by Subject|2|||
161843360|NCT01517373|584470071|FG004|Treatment Period|Withdrawal by Subject|2|||
161843361|NCT01517373|584470072|FG005|Treatment Period|Withdrawal by Subject|3|||
161749591|NCT04209400|584123092|FG001|Overall Study|Withdrawal by Subject|1|||
161749592|NCT01496274|584123093|FG000|Overall Study|Protocol Violation|0|||
161749593|NCT01496274|584123094|FG001|Overall Study|Protocol Violation|1|||
161749594|NCT01496274|584123093|FG000|Overall Study|Adverse Event|1|||
161749595|NCT01496274|584123094|FG001|Overall Study|Adverse Event|1|||
161749596|NCT01496274|584123093|FG000|Overall Study|Withdrawal by Subject|2|||
161749597|NCT01496274|584123094|FG001|Overall Study|Withdrawal by Subject|0|||
161749598|NCT01496274|584123093|FG000|Overall Study|Lost to Follow-up|0|||
161843362|NCT01517373|584470067|FG000|Treatment Period|Other|0|||
161749599|NCT01496274|584123094|FG001|Overall Study|Lost to Follow-up|3|||
161967595|NCT01155466|584927737|FG004|Overall Study|Randomized not treated|2|||
161967596|NCT03305419|584927738|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161967597|NCT03305419|584927739|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
161967598|NCT03305419|584927740|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161967599|NCT03305419|584927741|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161967600|NCT03305419|584927742|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161967601|NCT03305419|584927743|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161967602|NCT03305419|584927744|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161967603|NCT03305419|584927745|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
161967604|NCT03305419|584927738|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
161967605|NCT03305419|584927739|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161967606|NCT03305419|584927740|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161967607|NCT03305419|584927741|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161967608|NCT03305419|584927742|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161967609|NCT03305419|584927743|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161967610|NCT03305419|584927744|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161967611|NCT03305419|584927745|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
161967612|NCT03305419|584927738|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
161967613|NCT03305419|584927739|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161967614|NCT03305419|584927740|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161967615|NCT03305419|584927741|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161967616|NCT03305419|584927742|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161967617|NCT03305419|584927743|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161967618|NCT03305419|584927744|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161967619|NCT03305419|584927745|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
161967620|NCT03305419|584927738|FG000|Part B (14 Days)|Adverse Event|0|||
161967621|NCT03305419|584927739|FG001|Part B (14 Days)|Adverse Event|0|||
161967622|NCT03305419|584927740|FG002|Part B (14 Days)|Adverse Event|0|||
161967623|NCT03305419|584927741|FG003|Part B (14 Days)|Adverse Event|0|||
161967624|NCT03305419|584927742|FG004|Part B (14 Days)|Adverse Event|1|||
161967625|NCT03305419|584927743|FG005|Part B (14 Days)|Adverse Event|2|||
161967626|NCT03305419|584927744|FG006|Part B (14 Days)|Adverse Event|4|||
161967627|NCT03305419|584927745|FG007|Part B (14 Days)|Adverse Event|0|||
161967628|NCT03305419|584927738|FG000|Part B (14 Days)|Physician Decision|0|||
161967629|NCT03305419|584927739|FG001|Part B (14 Days)|Physician Decision|0|||
161967630|NCT03305419|584927740|FG002|Part B (14 Days)|Physician Decision|0|||
161967631|NCT03305419|584927741|FG003|Part B (14 Days)|Physician Decision|0|||
161967632|NCT03305419|584927742|FG004|Part B (14 Days)|Physician Decision|2|||
161967633|NCT03305419|584927743|FG005|Part B (14 Days)|Physician Decision|8|||
161967634|NCT03305419|584927744|FG006|Part B (14 Days)|Physician Decision|1|||
161967635|NCT03305419|584927745|FG007|Part B (14 Days)|Physician Decision|0|||
161967636|NCT00075946|584927746|FG000|Overall Study|Path ineligible: undetermined histology|0|||
161967637|NCT00075946|584927747|FG001|Overall Study|Path ineligible: undetermined histology|0|||
161967638|NCT00075946|584927748|FG002|Overall Study|Path ineligible: undetermined histology|0|||
161967639|NCT00075946|584927749|FG003|Overall Study|Path ineligible: undetermined histology|0|||
161749600|NCT05041062|584123096|FG000|Overall Study|Adverse Event|2|||
161749601|NCT04968353|584123100|FG000|Overall Study|Non-compliance|1|||
161749602|NCT04968353|584123101|FG001|Overall Study|Non-compliance|0|||
161749603|NCT04968353|584123102|FG002|Overall Study|Non-compliance|2|||
161749604|NCT04968353|584123103|FG003|Overall Study|Non-compliance|0|||
161749605|NCT00318370|584123104|FG000|Period 1|Lack of Efficacy|5|||
161749606|NCT00318370|584123105|FG001|Period 1|Lack of Efficacy|0|||
161749607|NCT00318370|584123106|FG002|Period 1|Lack of Efficacy|0|||
161749608|NCT00318370|584123104|FG000|Period 1|Physician Decision|1|||
161749609|NCT00318370|584123105|FG001|Period 1|Physician Decision|0|||
161749610|NCT00318370|584123106|FG002|Period 1|Physician Decision|0|||
161749611|NCT00318370|584123104|FG000|Period 1|Withdrawal by Subject|1|||
161749612|NCT00318370|584123105|FG001|Period 1|Withdrawal by Subject|0|||
161749613|NCT00318370|584123106|FG002|Period 1|Withdrawal by Subject|0|||
161749614|NCT00318370|584123104|FG000|Period 2|Adverse Event|0|||
161843363|NCT01517373|584470068|FG001|Treatment Period|Other|0|||
161967640|NCT00075946|584927750|FG004|Overall Study|Path ineligible: undetermined histology|6|||
161967641|NCT00075946|584927746|FG000|Overall Study|Did not achieve response after induction|0|||
161967642|NCT00075946|584927747|FG001|Overall Study|Did not achieve response after induction|0|||
161967643|NCT00075946|584927748|FG002|Overall Study|Did not achieve response after induction|0|||
161843364|NCT01517373|584470069|FG002|Treatment Period|Other|0|||
161749615|NCT00318370|584123105|FG001|Period 2|Adverse Event|3|||
161843365|NCT01517373|584470070|FG003|Treatment Period|Other|0|||
161749616|NCT00318370|584123106|FG002|Period 2|Adverse Event|0|||
161749617|NCT00318370|584123104|FG000|Period 2|Lack of Efficacy|0|||
161843366|NCT01517373|584470071|FG004|Treatment Period|Other|1|||
161749618|NCT00318370|584123105|FG001|Period 2|Lack of Efficacy|5|||
161749619|NCT00318370|584123106|FG002|Period 2|Lack of Efficacy|0|||
161749620|NCT00318370|584123104|FG000|Period 2|Physician Decision|0|||
161967644|NCT00075946|584927749|FG003|Overall Study|Did not achieve response after induction|0|||
161967645|NCT00075946|584927750|FG004|Overall Study|Did not achieve response after induction|182|||
161967646|NCT00075946|584927746|FG000|Overall Study|Incorrectly randomized (no response)|5|||
161967647|NCT00075946|584927747|FG001|Overall Study|Incorrectly randomized (no response)|5|||
161749621|NCT00318370|584123105|FG001|Period 2|Physician Decision|1|||
161749622|NCT00318370|584123106|FG002|Period 2|Physician Decision|0|||
161749623|NCT00318370|584123104|FG000|Period 2|Withdrawal by Subject|0|||
161749624|NCT00318370|584123105|FG001|Period 2|Withdrawal by Subject|1|||
161749625|NCT00318370|584123106|FG002|Period 2|Withdrawal by Subject|0|||
161749626|NCT00318370|584123104|FG000|Period 2|Other|0|||
161749627|NCT00318370|584123105|FG001|Period 2|Other|1|||
161749628|NCT00318370|584123106|FG002|Period 2|Other|0|||
161749629|NCT00318370|584123104|FG000|Period 3|Adverse Event|0|||
161749630|NCT00318370|584123105|FG001|Period 3|Adverse Event|0|||
161749631|NCT00318370|584123106|FG002|Period 3|Adverse Event|1|||
161749632|NCT00318370|584123104|FG000|Period 3|Lack of Efficacy|0|||
161749633|NCT00318370|584123105|FG001|Period 3|Lack of Efficacy|0|||
161749634|NCT00318370|584123106|FG002|Period 3|Lack of Efficacy|24|||
161749635|NCT00318370|584123104|FG000|Period 3|Death|0|||
161749636|NCT00318370|584123105|FG001|Period 3|Death|0|||
161749637|NCT00318370|584123106|FG002|Period 3|Death|1|||
161749638|NCT00318370|584123104|FG000|Period 3|Physician Decision|0|||
161749639|NCT00318370|584123105|FG001|Period 3|Physician Decision|0|||
161749640|NCT00318370|584123106|FG002|Period 3|Physician Decision|1|||
161749641|NCT00318370|584123104|FG000|Period 3|Withdrawal by Subject|0|||
161749642|NCT00318370|584123105|FG001|Period 3|Withdrawal by Subject|0|||
161749643|NCT00318370|584123106|FG002|Period 3|Withdrawal by Subject|3|||
161749644|NCT00318370|584123104|FG000|Period 3|Other|0|||
161749645|NCT00318370|584123105|FG001|Period 3|Other|0|||
161749646|NCT00318370|584123106|FG002|Period 3|Other|3|||
161749647|NCT00892957|584123112|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
161749648|NCT00892957|584123113|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
161749649|NCT00892957|584123112|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
161749650|NCT00892957|584123113|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
161749651|NCT03307629|584123119|FG000|Overall Study|Withdrawal by Subject|0|||
161749652|NCT03307629|584123120|FG001|Overall Study|Withdrawal by Subject|0|||
161749653|NCT03307629|584123121|FG002|Overall Study|Withdrawal by Subject|0|||
161749654|NCT03307629|584123122|FG003|Overall Study|Withdrawal by Subject|2|||
161749655|NCT03307629|584123119|FG000|Overall Study|Disease Progression|0|||
161749656|NCT03307629|584123120|FG001|Overall Study|Disease Progression|0|||
161749657|NCT03307629|584123121|FG002|Overall Study|Disease Progression|0|||
161749658|NCT03307629|584123122|FG003|Overall Study|Disease Progression|3|||
161749659|NCT03307629|584123119|FG000|Overall Study|Death|0|||
161749660|NCT03307629|584123120|FG001|Overall Study|Death|3|||
161749661|NCT03307629|584123121|FG002|Overall Study|Death|0|||
161749662|NCT03307629|584123122|FG003|Overall Study|Death|1|||
161749663|NCT02853032|584123127|FG000|Overall Study|Adverse Event|4|||
161749664|NCT02853032|584123128|FG001|Overall Study|Adverse Event|0|||
161749665|NCT02853032|584123127|FG000|Overall Study|Withdrawal by Subject|3|||
161749666|NCT02853032|584123128|FG001|Overall Study|Withdrawal by Subject|1|||
161749667|NCT02853032|584123127|FG000|Overall Study|Requested to withdraw from all treatment|2|||
161749668|NCT02853032|584123128|FG001|Overall Study|Requested to withdraw from all treatment|2|||
161749669|NCT03700736|584123129|FG000|Overall Study|Pregnancy|1|||
161749670|NCT03700736|584123130|FG001|Overall Study|Pregnancy|1|||
161749671|NCT03700736|584123129|FG000|Overall Study|Withdrawal by Subject|2|||
161749672|NCT03700736|584123130|FG001|Overall Study|Withdrawal by Subject|6|||
161749673|NCT04126031|584123132|FG000|Part A|Withdrawal by Subject|0|||
161749674|NCT04126031|584123133|FG001|Part A|Withdrawal by Subject|0|||
161749675|NCT04126031|584123134|FG002|Part A|Withdrawal by Subject|1|||
161749676|NCT04126031|584123135|FG003|Part A|Withdrawal by Subject|0|||
161967648|NCT00075946|584927748|FG002|Overall Study|Incorrectly randomized (no response)|5|||
161967649|NCT00075946|584927749|FG003|Overall Study|Incorrectly randomized (no response)|1|||
161749677|NCT04126031|584123136|FG004|Part A|Withdrawal by Subject|0|||
161749678|NCT04126031|584123137|FG005|Part A|Withdrawal by Subject|0|||
161749679|NCT04126031|584123132|FG000|Part A|Other|1|||
161749680|NCT04126031|584123133|FG001|Part A|Other|0|||
161749681|NCT04126031|584123134|FG002|Part A|Other|0|||
161749682|NCT04126031|584123135|FG003|Part A|Other|0|||
161749683|NCT04126031|584123136|FG004|Part A|Other|0|||
161749684|NCT04126031|584123137|FG005|Part A|Other|0|||
161749685|NCT04126031|584123132|FG000|Part B|Adverse Event|0|||
161749686|NCT04126031|584123133|FG001|Part B|Adverse Event|0|||
161749687|NCT04126031|584123134|FG002|Part B|Adverse Event|0|||
161749688|NCT04126031|584123135|FG003|Part B|Adverse Event|0|||
161749689|NCT04126031|584123136|FG004|Part B|Adverse Event|0|||
161749690|NCT04126031|584123137|FG005|Part B|Adverse Event|2|||
161749691|NCT04126031|584123132|FG000|Part B|Pre-existing hypertransaminasemia|0|||
161749692|NCT04126031|584123133|FG001|Part B|Pre-existing hypertransaminasemia|0|||
161749693|NCT04126031|584123134|FG002|Part B|Pre-existing hypertransaminasemia|0|||
161749694|NCT04126031|584123135|FG003|Part B|Pre-existing hypertransaminasemia|0|||
161749695|NCT04126031|584123136|FG004|Part B|Pre-existing hypertransaminasemia|1|||
161749696|NCT04126031|584123137|FG005|Part B|Pre-existing hypertransaminasemia|0|||
161749697|NCT00131664|584123138|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
161749698|NCT00131664|584123139|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
161749699|NCT00131664|584123140|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
161749700|NCT00131664|584123141|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
161749701|NCT00131664|584123142|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
161749702|NCT00131664|584123143|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
161749703|NCT00131664|584123138|FG000|First Period (First 6 Months)|Death|0|||
161749704|NCT00131664|584123139|FG001|First Period (First 6 Months)|Death|1|||
161749705|NCT00131664|584123140|FG002|First Period (First 6 Months)|Death|0|||
161749706|NCT00131664|584123141|FG003|First Period (First 6 Months)|Death|0|||
161749707|NCT00131664|584123142|FG004|First Period (First 6 Months)|Death|0|||
161749708|NCT00131664|584123143|FG005|First Period (First 6 Months)|Death|0|||
161749709|NCT00131664|584123138|FG000|First Period (First 6 Months)|Protocol Violation|2|||
161749710|NCT00131664|584123139|FG001|First Period (First 6 Months)|Protocol Violation|2|||
161749711|NCT00131664|584123140|FG002|First Period (First 6 Months)|Protocol Violation|1|||
161749712|NCT00131664|584123141|FG003|First Period (First 6 Months)|Protocol Violation|0|||
161749713|NCT00131664|584123142|FG004|First Period (First 6 Months)|Protocol Violation|0|||
161749714|NCT00131664|584123143|FG005|First Period (First 6 Months)|Protocol Violation|0|||
161749715|NCT00131664|584123138|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
161749716|NCT00131664|584123139|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
161749717|NCT00131664|584123140|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
161749718|NCT00131664|584123141|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
161749719|NCT00131664|584123142|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
161749720|NCT00131664|584123143|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
161749721|NCT00131664|584123138|FG000|First Period (First 6 Months)|Adverse Event|9|||
161749722|NCT00131664|584123139|FG001|First Period (First 6 Months)|Adverse Event|4|||
161749723|NCT00131664|584123140|FG002|First Period (First 6 Months)|Adverse Event|5|||
161749724|NCT00131664|584123141|FG003|First Period (First 6 Months)|Adverse Event|0|||
161749725|NCT00131664|584123142|FG004|First Period (First 6 Months)|Adverse Event|0|||
161749726|NCT00131664|584123143|FG005|First Period (First 6 Months)|Adverse Event|0|||
161749727|NCT00131664|584123138|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
161749728|NCT00131664|584123139|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
161749729|NCT00131664|584123140|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
161749730|NCT00131664|584123141|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
161749731|NCT00131664|584123142|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
161749732|NCT00131664|584123143|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
161749733|NCT00131664|584123138|FG000|First Period (First 6 Months)|Administrative reasons|2|||
161749734|NCT00131664|584123139|FG001|First Period (First 6 Months)|Administrative reasons|0|||
161749735|NCT00131664|584123140|FG002|First Period (First 6 Months)|Administrative reasons|5|||
161749736|NCT00131664|584123141|FG003|First Period (First 6 Months)|Administrative reasons|0|||
161749737|NCT00131664|584123142|FG004|First Period (First 6 Months)|Administrative reasons|0|||
161749738|NCT00131664|584123143|FG005|First Period (First 6 Months)|Administrative reasons|0|||
161749739|NCT00131664|584123138|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
161749740|NCT00131664|584123139|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
161749741|NCT00131664|584123140|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
161749742|NCT00131664|584123141|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
161749743|NCT00131664|584123142|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
161749744|NCT00131664|584123143|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
161749745|NCT00131664|584123138|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
161749746|NCT00131664|584123139|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
161749747|NCT00131664|584123140|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
161749748|NCT00131664|584123141|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
161749749|NCT00131664|584123142|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
161749750|NCT00131664|584123143|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
161749751|NCT00131664|584123138|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
161749752|NCT00131664|584123139|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161749753|NCT00131664|584123140|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161749754|NCT00131664|584123141|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161749755|NCT00131664|584123142|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161749756|NCT00131664|584123143|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161843367|NCT01517373|584470072|FG005|Treatment Period|Other|0|||
161843368|NCT01517373|584470067|FG000|Treatment Period|Protocol Violation|0|||
161749757|NCT00131664|584123138|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
161749758|NCT00131664|584123139|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
161749759|NCT00131664|584123140|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
161967650|NCT00075946|584927750|FG004|Overall Study|Incorrectly randomized (no response)|0|||
161749760|NCT00131664|584123141|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
161749761|NCT00131664|584123142|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
161749762|NCT00131664|584123143|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
161749763|NCT00131664|584123138|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161749764|NCT00131664|584123139|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161749765|NCT00131664|584123140|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161749766|NCT00131664|584123141|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
161749767|NCT00131664|584123142|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161749768|NCT00131664|584123143|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161749769|NCT00131664|584123138|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
161749770|NCT00131664|584123139|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
161749771|NCT00131664|584123140|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
161749772|NCT00131664|584123141|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
161749773|NCT00131664|584123142|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
161749774|NCT00131664|584123143|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
161749775|NCT01495689|584124515|FG000|Overall Study|Death|0|||
161749776|NCT01495689|584124516|FG001|Overall Study|Death|1|||
161749777|NCT01495689|584124515|FG000|Overall Study|Withdrawal by Subject|3|||
161749778|NCT01495689|584124516|FG001|Overall Study|Withdrawal by Subject|0|||
161749779|NCT01495689|584124515|FG000|Overall Study|Lost to Follow-up|7|||
161749780|NCT01495689|584124516|FG001|Overall Study|Lost to Follow-up|6|||
161749781|NCT01119963|584124517|FG000|Overall Study|Lost to Follow-up|1|||
161749782|NCT01119963|584124518|FG001|Overall Study|Lost to Follow-up|1|||
161749783|NCT00254163|584124519|FG000|Overall Study|Adverse Event|29|||
161749784|NCT00254163|584124520|FG001|Overall Study|Adverse Event|26|||
161749785|NCT00254163|584124519|FG000|Overall Study|Patient request/withdrew consent|6|||
161749786|NCT00254163|584124520|FG001|Overall Study|Patient request/withdrew consent|4|||
161749787|NCT00254163|584124519|FG000|Overall Study|Investigator request|1|||
161749788|NCT00254163|584124520|FG001|Overall Study|Investigator request|3|||
161749789|NCT00254163|584124519|FG000|Overall Study|Failed entry|1|||
161749790|NCT00254163|584124520|FG001|Overall Study|Failed entry|3|||
161749791|NCT00254163|584124519|FG000|Overall Study|Progressive disease|0|||
161749792|NCT00254163|584124520|FG001|Overall Study|Progressive disease|1|||
161749793|NCT00254163|584124519|FG000|Overall Study|Death|0|||
161749794|NCT00254163|584124520|FG001|Overall Study|Death|1|||
161749795|NCT00254163|584124519|FG000|Overall Study|Other|8|||
161749796|NCT00254163|584124520|FG001|Overall Study|Other|8|||
161749797|NCT02579863|584124521|FG000|Overall Study|Final Disposition Unknown|2|||
161749798|NCT02579863|584124522|FG001|Overall Study|Final Disposition Unknown|1|||
161749799|NCT02579863|584124521|FG000|Overall Study|Adverse Event|18|||
161749800|NCT02579863|584124522|FG001|Overall Study|Adverse Event|11|||
161749801|NCT02579863|584124521|FG000|Overall Study|Death|31|||
161749802|NCT02579863|584124522|FG001|Overall Study|Death|29|||
161749803|NCT02579863|584124521|FG000|Overall Study|Lost to Follow-up|2|||
161749804|NCT02579863|584124522|FG001|Overall Study|Lost to Follow-up|1|||
161749805|NCT02579863|584124521|FG000|Overall Study|Physician Decision|1|||
161749806|NCT02579863|584124522|FG001|Overall Study|Physician Decision|2|||
161749807|NCT02579863|584124521|FG000|Overall Study|Screen Failure|0|||
161749808|NCT02579863|584124522|FG001|Overall Study|Screen Failure|2|||
161749809|NCT02579863|584124521|FG000|Overall Study|Study Terminated at Selected Sites|82|||
161749810|NCT02579863|584124522|FG001|Overall Study|Study Terminated at Selected Sites|88|||
161749811|NCT02579863|584124521|FG000|Overall Study|Withdrawal by Subject|20|||
161749812|NCT02579863|584124522|FG001|Overall Study|Withdrawal by Subject|20|||
161749813|NCT00809614|584124527|FG000|Overall Study|Lack of Efficacy|2|||
161749814|NCT00809614|584124528|FG001|Overall Study|Lack of Efficacy|3|||
161749815|NCT00809614|584124527|FG000|Overall Study|Withdrawal by Subject|1|||
161749816|NCT00809614|584124528|FG001|Overall Study|Withdrawal by Subject|1|||
161749817|NCT00446797|584124529|FG000|Overall Study|Lack of Efficacy|0|||
161749818|NCT00446797|584124530|FG001|Overall Study|Lack of Efficacy|2|||
161967651|NCT00075946|584927746|FG000|Overall Study|Adverse Event|2|||
161967652|NCT00075946|584927747|FG001|Overall Study|Adverse Event|10|||
161967653|NCT00075946|584927748|FG002|Overall Study|Adverse Event|0|||
161967654|NCT00075946|584927749|FG003|Overall Study|Adverse Event|2|||
161749819|NCT00446797|584124529|FG000|Overall Study|Lost to Follow-up|5|||
161749820|NCT00446797|584124530|FG001|Overall Study|Lost to Follow-up|3|||
161749821|NCT00446797|584124529|FG000|Overall Study|Withdrawal by Subject|2|||
161749822|NCT00446797|584124530|FG001|Overall Study|Withdrawal by Subject|2|||
161749823|NCT00446797|584124529|FG000|Overall Study|Protocol Violation|1|||
161749824|NCT00446797|584124530|FG001|Overall Study|Protocol Violation|3|||
161749825|NCT00446797|584124529|FG000|Overall Study|subject entered at another site|0|||
161749826|NCT00446797|584124530|FG001|Overall Study|subject entered at another site|1|||
161749827|NCT00446797|584124529|FG000|Overall Study|did not meet entrance criteria|0|||
161967655|NCT00075946|584927750|FG004|Overall Study|Adverse Event|0|||
161967656|NCT00075946|584927746|FG000|Overall Study|Death|0|||
161967657|NCT00075946|584927747|FG001|Overall Study|Death|1|||
161967658|NCT00075946|584927748|FG002|Overall Study|Death|0|||
161749828|NCT00446797|584124530|FG001|Overall Study|did not meet entrance criteria|1|||
161749829|NCT00364832|584124531|FG000|Core Period|Early Withdrawals|2|||
161749830|NCT00364832|584124532|FG001|Core Period|Early Withdrawals|2|||
161749831|NCT00364832|584124533|FG002|Core Period|Early Withdrawals|1|||
161749832|NCT00364832|584124534|FG003|Core Period|Early Withdrawals|1|||
161749833|NCT00364832|584124535|FG004|Core Period|Early Withdrawals|0|||
161749834|NCT00364832|584124536|FG005|Core Period|Early Withdrawals|0|||
161749835|NCT00364832|584124537|FG006|Core Period|Early Withdrawals|4|||
161749836|NCT00364832|584124538|FG007|Core Period|Early Withdrawals|1|||
161749837|NCT00364832|584124539|FG008|Core Period|Early Withdrawals|0|||
161749838|NCT00364832|584124540|FG009|Core Period|Early Withdrawals|0|||
161749839|NCT00364832|584124541|FG010|Core Period|Early Withdrawals|0|||
161749840|NCT00364832|584124542|FG011|Core Period|Early Withdrawals|0|||
161749841|NCT00364832|584124531|FG000|Extension Year 1|Early Withdrawals|0|||
161749842|NCT00364832|584124532|FG001|Extension Year 1|Early Withdrawals|0|||
161749843|NCT00364832|584124533|FG002|Extension Year 1|Early Withdrawals|0|||
161749844|NCT00364832|584124534|FG003|Extension Year 1|Early Withdrawals|0|||
161749845|NCT00364832|584124535|FG004|Extension Year 1|Early Withdrawals|0|||
161749846|NCT00364832|584124536|FG005|Extension Year 1|Early Withdrawals|0|||
161749847|NCT00364832|584124537|FG006|Extension Year 1|Early Withdrawals|0|||
161749848|NCT00364832|584124538|FG007|Extension Year 1|Early Withdrawals|0|||
161749849|NCT00364832|584124539|FG008|Extension Year 1|Early Withdrawals|0|||
161749850|NCT00364832|584124540|FG009|Extension Year 1|Early Withdrawals|4|||
161749851|NCT00364832|584124541|FG010|Extension Year 1|Early Withdrawals|2|||
161749852|NCT00364832|584124542|FG011|Extension Year 1|Early Withdrawals|10|||
161749853|NCT00364832|584124531|FG000|Extension Year 2|Early Withdrawals|0|||
161749854|NCT00364832|584124532|FG001|Extension Year 2|Early Withdrawals|0|||
161749855|NCT00364832|584124533|FG002|Extension Year 2|Early Withdrawals|0|||
161749856|NCT00364832|584124534|FG003|Extension Year 2|Early Withdrawals|0|||
161749857|NCT00364832|584124535|FG004|Extension Year 2|Early Withdrawals|0|||
161749858|NCT00364832|584124536|FG005|Extension Year 2|Early Withdrawals|0|||
161749859|NCT00364832|584124537|FG006|Extension Year 2|Early Withdrawals|0|||
161749860|NCT00364832|584124538|FG007|Extension Year 2|Early Withdrawals|0|||
161749861|NCT00364832|584124539|FG008|Extension Year 2|Early Withdrawals|0|||
161749862|NCT00364832|584124540|FG009|Extension Year 2|Early Withdrawals|5|||
161749863|NCT00364832|584124541|FG010|Extension Year 2|Early Withdrawals|5|||
161749864|NCT00364832|584124542|FG011|Extension Year 2|Early Withdrawals|3|||
161749865|NCT03210220|584124543|FG000|Overall Study|Physician Decision|1|||
161749866|NCT03210220|584124544|FG001|Overall Study|Physician Decision|0|||
161749867|NCT00407550|584124545|FG000|Overall Study|Adverse Event|0|||
161749868|NCT00407550|584124546|FG001|Overall Study|Adverse Event|1|||
161749869|NCT00407550|584124545|FG000|Overall Study|Withdrawal by Subject|0|||
161749870|NCT00407550|584124546|FG001|Overall Study|Withdrawal by Subject|2|||
161749871|NCT00407550|584124545|FG000|Overall Study|Death|1|||
161749872|NCT00407550|584124546|FG001|Overall Study|Death|0|||
161749873|NCT00407550|584124545|FG000|Overall Study|Insurance or Other medical condition|2|||
161749874|NCT00407550|584124546|FG001|Overall Study|Insurance or Other medical condition|1|||
161749875|NCT03006926|584124548|FG000|Overall Study|Adverse Event|0|||
161749876|NCT03006926|584124549|FG001|Overall Study|Adverse Event|27|||
161749877|NCT03006926|584124548|FG000|Overall Study|Withdrawal by Subject|0|||
161749878|NCT03006926|584124549|FG001|Overall Study|Withdrawal by Subject|1|||
161749879|NCT03006926|584124548|FG000|Overall Study|Radiological Disease Progression|0|||
161749880|NCT03006926|584124549|FG001|Overall Study|Radiological Disease Progression|52|||
161749881|NCT03006926|584124548|FG000|Overall Study|Clinical Disease Progression|0|||
161749882|NCT03006926|584124549|FG001|Overall Study|Clinical Disease Progression|10|||
161749883|NCT03006926|584124548|FG000|Overall Study|Other|0|||
161749884|NCT03006926|584124549|FG001|Overall Study|Other|8|||
161749885|NCT01838213|584124550|FG000|Overall Study|Ineligible|166|||
161749886|NCT01838213|584124551|FG001|Overall Study|Ineligible|191|||
161749887|NCT04882072|584124556|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
161749888|NCT04882072|584124557|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
161749889|NCT04882072|584124556|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
161749890|NCT04882072|584124557|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
161749891|NCT04882072|584124556|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
161749892|NCT04882072|584124557|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
161749893|NCT02918318|584124558|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
161749894|NCT02918318|584124559|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
161749895|NCT02918318|584124560|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
161749896|NCT02918318|584124561|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
161749897|NCT02918318|584124562|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
161749898|NCT02918318|584124558|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
161967659|NCT00075946|584927749|FG003|Overall Study|Death|0|||
161749899|NCT02918318|584124559|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
161749900|NCT02918318|584124560|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
161749901|NCT02918318|584124561|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
161749902|NCT02918318|584124562|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
161749903|NCT02918318|584124558|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
161749904|NCT02918318|584124559|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
161749905|NCT02918318|584124560|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
161749906|NCT02918318|584124561|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
161749907|NCT02918318|584124562|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
161749908|NCT02918318|584124558|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
161749909|NCT02918318|584124559|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
161749910|NCT02918318|584124560|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
161749911|NCT02918318|584124561|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
161749912|NCT02918318|584124562|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
161749913|NCT02918318|584124558|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
161749914|NCT02918318|584124559|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
161749915|NCT02918318|584124560|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
161749916|NCT02918318|584124561|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
161749917|NCT02918318|584124562|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
161749918|NCT02918318|584124558|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
161749919|NCT02918318|584124559|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
161749920|NCT02918318|584124560|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
161749921|NCT02918318|584124561|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
161749922|NCT02918318|584124562|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
161749923|NCT02918318|584124558|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
161749924|NCT02918318|584124559|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
161749925|NCT02918318|584124560|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
161749926|NCT02918318|584124561|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
161749927|NCT02918318|584124562|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
161749928|NCT02918318|584124558|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
161749929|NCT02918318|584124559|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
161749930|NCT02918318|584124560|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
161749931|NCT02918318|584124561|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
161749932|NCT02918318|584124562|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
161749933|NCT02918318|584124558|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
161749934|NCT02918318|584124559|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
161749935|NCT02918318|584124560|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
161749936|NCT02918318|584124561|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
161749937|NCT02918318|584124562|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
161749938|NCT02918318|584124558|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
161749939|NCT02918318|584124559|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
161749940|NCT02918318|584124560|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
161749941|NCT02918318|584124561|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
161749942|NCT02918318|584124562|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
161749943|NCT02918318|584124558|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
161749944|NCT02918318|584124559|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
161749945|NCT02918318|584124560|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
161749946|NCT02918318|584124561|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
161749947|NCT02918318|584124562|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
161749948|NCT02918318|584124558|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
161749949|NCT02918318|584124559|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
161967660|NCT00075946|584927750|FG004|Overall Study|Death|0|||
161967661|NCT00075946|584927746|FG000|Overall Study|Withdrawal by Subject|23|||
161967662|NCT00075946|584927747|FG001|Overall Study|Withdrawal by Subject|58|||
161967663|NCT00075946|584927748|FG002|Overall Study|Withdrawal by Subject|4|||
161749950|NCT02918318|584124560|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
161749951|NCT02918318|584124561|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
161749952|NCT02918318|584124562|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
161749953|NCT00990249|584124563|FG000|Overall Study|Disease Progression|8|||
161749954|NCT00990249|584124563|FG000|Overall Study|Non-Compliance|1|||
161749955|NCT00990249|584124563|FG000|Overall Study|Death|2|||
161749956|NCT00990249|584124563|FG000|Overall Study|Not treated|2|||
161749957|NCT01548417|584124564|FG000|Overall Study|Withdrawal by Subject|0|||
161749958|NCT01548417|584124565|FG001|Overall Study|Withdrawal by Subject|2|||
161749959|NCT01098032|584124570|FG000|Overall Study|Withdrawal by Subject|1|||
161749960|NCT01098032|584124571|FG001|Overall Study|Withdrawal by Subject|1|||
161749961|NCT01421069|584124572|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
161749962|NCT01421069|584124572|FG000|Parent Study|Failed to return|3|||
161967664|NCT00075946|584927749|FG003|Overall Study|Withdrawal by Subject|9|||
161967665|NCT00075946|584927750|FG004|Overall Study|Withdrawal by Subject|0|||
161967666|NCT00075946|584927746|FG000|Overall Study|Alternative therapy|16|||
161967667|NCT00075946|584927747|FG001|Overall Study|Alternative therapy|2|||
161967668|NCT00075946|584927748|FG002|Overall Study|Alternative therapy|5|||
161967669|NCT00075946|584927749|FG003|Overall Study|Alternative therapy|0|||
161967670|NCT00075946|584927750|FG004|Overall Study|Alternative therapy|0|||
161967671|NCT00075946|584927746|FG000|Overall Study|Other complicating disease|7|||
161967672|NCT00075946|584927747|FG001|Overall Study|Other complicating disease|13|||
161749963|NCT01421069|584124572|FG000|Parent Study|Withdrawal by Subject|1|||
161749964|NCT01421069|584124572|FG000|Parent Study|Lost to Follow-up|2|||
161749965|NCT01421069|584124572|FG000|Parent Study|Lack of Efficacy|1|||
161749966|NCT01421069|584124572|FG000|Overall Period for Extension Study|Other|2|||
161749967|NCT01421069|584124572|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
161749968|NCT01421069|584124572|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
161749969|NCT01421069|584124572|FG000|Overall Period for Extension Study|Pregnancy|1|||
161749970|NCT01421069|584124572|FG000|Overall Period for Extension Study|Adverse Event|1|||
161749971|NCT01421069|584124572|FG000|Overall Period for Extension Study|Protocol Violation|1|||
161749972|NCT01421069|584124572|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
161749973|NCT01421069|584124572|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
161749974|NCT01421069|584124572|FG000|Active Treatment Period|Other|1|||
161749975|NCT01421069|584124572|FG000|Active Treatment Period|No longer willing to participate in study|8|||
161749976|NCT01421069|584124572|FG000|Active Treatment Period|Insufficient clinical response|1|||
161749977|NCT01421069|584124572|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
161749978|NCT01421069|584124572|FG000|Active Treatment Period|Pregnancy|1|||
161749979|NCT01421069|584124572|FG000|Active Treatment Period|Adverse Event|1|||
161749980|NCT01421069|584124572|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
161749981|NCT01421069|584124572|FG000|Active Treatment Period|Enrolled in observational period|29|||
161749982|NCT01421069|584124572|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
161749983|NCT01421069|584124572|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
161749984|NCT01421069|584124572|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
161749985|NCT01421069|584124572|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
161749986|NCT01421069|584124572|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
161749987|NCT01421069|584124572|FG000|2b. Retreatment Period|Protocol Violation|1|||
161749988|NCT01421069|584124572|FG000|Observational Period|Other|1|||
161749989|NCT01421069|584124572|FG000|Observational Period|No longer willing to participate in study|4|||
161749990|NCT01421069|584124572|FG000|Observational Period|Lost to Follow-up|3|||
161749991|NCT01641081|584124573|FG000|Period 1|Sponsor request (potential unblinding)|0|||
161749992|NCT01641081|584124574|FG001|Period 1|Sponsor request (potential unblinding)|0|||
161749993|NCT01641081|584124575|FG002|Period 1|Sponsor request (potential unblinding)|0|||
161749994|NCT01641081|584124576|FG003|Period 1|Sponsor request (potential unblinding)|0|||
161749995|NCT01641081|584124577|FG004|Period 1|Sponsor request (potential unblinding)|0|||
161749996|NCT01641081|584124578|FG005|Period 1|Sponsor request (potential unblinding)|0|||
161749997|NCT01641081|584124579|FG006|Period 1|Sponsor request (potential unblinding)|1|||
161749998|NCT01641081|584124580|FG007|Period 1|Sponsor request (potential unblinding)|0|||
161749999|NCT01641081|584124581|FG008|Period 1|Sponsor request (potential unblinding)|0|||
161750000|NCT01641081|584124582|FG009|Period 1|Sponsor request (potential unblinding)|0|||
161750001|NCT01641081|584124573|FG000|Period 1|Protocol Violation|0|||
161750002|NCT01641081|584124574|FG001|Period 1|Protocol Violation|0|||
161750003|NCT01641081|584124575|FG002|Period 1|Protocol Violation|0|||
161750004|NCT01641081|584124576|FG003|Period 1|Protocol Violation|0|||
161750005|NCT01641081|584124577|FG004|Period 1|Protocol Violation|1|||
161750006|NCT01641081|584124578|FG005|Period 1|Protocol Violation|0|||
161750007|NCT01641081|584124579|FG006|Period 1|Protocol Violation|0|||
161750008|NCT01641081|584124580|FG007|Period 1|Protocol Violation|1|||
161750009|NCT01641081|584124581|FG008|Period 1|Protocol Violation|0|||
161750010|NCT01641081|584124582|FG009|Period 1|Protocol Violation|0|||
161750011|NCT01641081|584124573|FG000|Period 1|Adverse Event|1|||
161750012|NCT01641081|584124574|FG001|Period 1|Adverse Event|0|||
161750013|NCT01641081|584124575|FG002|Period 1|Adverse Event|0|||
161750014|NCT01641081|584124576|FG003|Period 1|Adverse Event|0|||
161750015|NCT01641081|584124577|FG004|Period 1|Adverse Event|0|||
161750016|NCT01641081|584124578|FG005|Period 1|Adverse Event|0|||
161750017|NCT01641081|584124579|FG006|Period 1|Adverse Event|0|||
161750018|NCT01641081|584124580|FG007|Period 1|Adverse Event|2|||
161750019|NCT01641081|584124581|FG008|Period 1|Adverse Event|0|||
161750020|NCT01641081|584124582|FG009|Period 1|Adverse Event|0|||
161750021|NCT01641081|584124573|FG000|Period 2|Adverse Event|0|||
161750022|NCT01641081|584124574|FG001|Period 2|Adverse Event|0|||
161750023|NCT01641081|584124575|FG002|Period 2|Adverse Event|0|||
161750024|NCT01641081|584124576|FG003|Period 2|Adverse Event|0|||
161750025|NCT01641081|584124577|FG004|Period 2|Adverse Event|0|||
161750026|NCT01641081|584124578|FG005|Period 2|Adverse Event|1|||
161750027|NCT01641081|584124579|FG006|Period 2|Adverse Event|0|||
161750028|NCT01641081|584124580|FG007|Period 2|Adverse Event|0|||
161750029|NCT01641081|584124581|FG008|Period 2|Adverse Event|0|||
161967673|NCT00075946|584927748|FG002|Overall Study|Other complicating disease|1|||
161750030|NCT01641081|584124582|FG009|Period 2|Adverse Event|0|||
161750031|NCT01641081|584124573|FG000|Period 2|Withdrawal by Subject|0|||
161750032|NCT01641081|584124574|FG001|Period 2|Withdrawal by Subject|0|||
161750033|NCT01641081|584124575|FG002|Period 2|Withdrawal by Subject|0|||
161750034|NCT01641081|584124576|FG003|Period 2|Withdrawal by Subject|1|||
161750035|NCT01641081|584124577|FG004|Period 2|Withdrawal by Subject|0|||
161750036|NCT01641081|584124578|FG005|Period 2|Withdrawal by Subject|0|||
161750037|NCT01641081|584124579|FG006|Period 2|Withdrawal by Subject|2|||
161750038|NCT01641081|584124580|FG007|Period 2|Withdrawal by Subject|0|||
161750039|NCT01641081|584124581|FG008|Period 2|Withdrawal by Subject|0|||
161750040|NCT01641081|584124582|FG009|Period 2|Withdrawal by Subject|0|||
161750041|NCT01641081|584124573|FG000|Period 2|Protocol Violation|1|||
161750042|NCT01641081|584124574|FG001|Period 2|Protocol Violation|0|||
161750043|NCT01641081|584124575|FG002|Period 2|Protocol Violation|0|||
161750044|NCT01641081|584124576|FG003|Period 2|Protocol Violation|0|||
161750045|NCT01641081|584124577|FG004|Period 2|Protocol Violation|0|||
161750046|NCT01641081|584124578|FG005|Period 2|Protocol Violation|0|||
161750047|NCT01641081|584124579|FG006|Period 2|Protocol Violation|0|||
161750048|NCT01641081|584124580|FG007|Period 2|Protocol Violation|0|||
161750049|NCT01641081|584124581|FG008|Period 2|Protocol Violation|0|||
161750050|NCT01641081|584124582|FG009|Period 2|Protocol Violation|0|||
161750051|NCT01641081|584124573|FG000|Period 3|Adverse Event|0|||
161750052|NCT01641081|584124574|FG001|Period 3|Adverse Event|0|||
161750053|NCT01641081|584124575|FG002|Period 3|Adverse Event|1|||
161750054|NCT01641081|584124576|FG003|Period 3|Adverse Event|0|||
161750055|NCT01641081|584124577|FG004|Period 3|Adverse Event|0|||
161750056|NCT01641081|584124578|FG005|Period 3|Adverse Event|0|||
161750057|NCT01641081|584124579|FG006|Period 3|Adverse Event|0|||
161750058|NCT01641081|584124580|FG007|Period 3|Adverse Event|0|||
161750059|NCT01641081|584124581|FG008|Period 3|Adverse Event|0|||
161750060|NCT01641081|584124582|FG009|Period 3|Adverse Event|0|||
161750061|NCT01641081|584124573|FG000|Period 3|Withdrawal by Subject|0|||
161750062|NCT01641081|584124574|FG001|Period 3|Withdrawal by Subject|0|||
161750063|NCT01641081|584124575|FG002|Period 3|Withdrawal by Subject|0|||
161750064|NCT01641081|584124576|FG003|Period 3|Withdrawal by Subject|0|||
161750065|NCT01641081|584124577|FG004|Period 3|Withdrawal by Subject|0|||
161750066|NCT01641081|584124578|FG005|Period 3|Withdrawal by Subject|0|||
161750067|NCT01641081|584124579|FG006|Period 3|Withdrawal by Subject|0|||
161750068|NCT01641081|584124580|FG007|Period 3|Withdrawal by Subject|0|||
161750069|NCT01641081|584124581|FG008|Period 3|Withdrawal by Subject|1|||
161750070|NCT01641081|584124582|FG009|Period 3|Withdrawal by Subject|0|||
161750071|NCT01641081|584124573|FG000|Period 4|Adverse Event|0|||
161750072|NCT01641081|584124574|FG001|Period 4|Adverse Event|1|||
161750073|NCT01641081|584124575|FG002|Period 4|Adverse Event|0|||
161750074|NCT01641081|584124576|FG003|Period 4|Adverse Event|1|||
161750075|NCT01641081|584124577|FG004|Period 4|Adverse Event|0|||
161750076|NCT01641081|584124578|FG005|Period 4|Adverse Event|0|||
161750077|NCT01641081|584124579|FG006|Period 4|Adverse Event|0|||
161750078|NCT01641081|584124580|FG007|Period 4|Adverse Event|0|||
161750079|NCT01641081|584124581|FG008|Period 4|Adverse Event|0|||
161750080|NCT01641081|584124582|FG009|Period 4|Adverse Event|0|||
161750081|NCT01641081|584124573|FG000|Period 5|Adverse Event|0|||
161750082|NCT01641081|584124574|FG001|Period 5|Adverse Event|0|||
161750083|NCT01641081|584124575|FG002|Period 5|Adverse Event|2|||
161750084|NCT01641081|584124576|FG003|Period 5|Adverse Event|0|||
161750085|NCT01641081|584124577|FG004|Period 5|Adverse Event|0|||
161750086|NCT01641081|584124578|FG005|Period 5|Adverse Event|0|||
161750087|NCT01641081|584124579|FG006|Period 5|Adverse Event|0|||
161750088|NCT01641081|584124580|FG007|Period 5|Adverse Event|0|||
161750089|NCT01641081|584124581|FG008|Period 5|Adverse Event|0|||
161750090|NCT01641081|584124582|FG009|Period 5|Adverse Event|0|||
161750091|NCT01095666|584124586|FG000|Overall Study|Lack of Efficacy|0|||
161750092|NCT01095666|584124587|FG001|Overall Study|Lack of Efficacy|0|||
161843369|NCT01517373|584470068|FG001|Treatment Period|Protocol Violation|0|||
161843370|NCT01517373|584470069|FG002|Treatment Period|Protocol Violation|0|||
162032667|NCT01634178|585177449|FG001|Treatment Period 2|Adverse Event|0|||
161750093|NCT01095666|584124588|FG002|Overall Study|Lack of Efficacy|1|||
161750094|NCT01095666|584124586|FG000|Overall Study|Adverse Event|2|||
161750095|NCT01095666|584124587|FG001|Overall Study|Adverse Event|1|||
161750096|NCT01095666|584124588|FG002|Overall Study|Adverse Event|3|||
161750097|NCT01095666|584124586|FG000|Overall Study|Lost to Follow-up|2|||
161750098|NCT01095666|584124587|FG001|Overall Study|Lost to Follow-up|2|||
161750099|NCT01095666|584124588|FG002|Overall Study|Lost to Follow-up|0|||
161750100|NCT01095666|584124586|FG000|Overall Study|Withdrawal by Subject|6|||
161750101|NCT01095666|584124587|FG001|Overall Study|Withdrawal by Subject|6|||
161750102|NCT01095666|584124588|FG002|Overall Study|Withdrawal by Subject|1|||
161750103|NCT01095666|584124586|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
161750104|NCT01095666|584124587|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
161750105|NCT01095666|584124588|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
161750106|NCT00841672|584124595|FG000|Overall Study|Adverse Event|7|||
161750107|NCT00841672|584124596|FG001|Overall Study|Adverse Event|16|||
161750108|NCT00841672|584124595|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161967674|NCT00075946|584927749|FG003|Overall Study|Other complicating disease|4|||
161967675|NCT00075946|584927750|FG004|Overall Study|Other complicating disease|0|||
161967676|NCT00075946|584927746|FG000|Overall Study|No response to retreatment|23|||
161967677|NCT00075946|584927747|FG001|Overall Study|No response to retreatment|0|||
161967678|NCT00075946|584927748|FG002|Overall Study|No response to retreatment|2|||
161967679|NCT00075946|584927749|FG003|Overall Study|No response to retreatment|0|||
161967680|NCT00075946|584927750|FG004|Overall Study|No response to retreatment|0|||
161967681|NCT00075946|584927746|FG000|Overall Study|Time to progression less than 6 months|15|||
161967682|NCT00075946|584927747|FG001|Overall Study|Time to progression less than 6 months|30|||
161967683|NCT00075946|584927748|FG002|Overall Study|Time to progression less than 6 months|8|||
161967684|NCT00075946|584927749|FG003|Overall Study|Time to progression less than 6 months|3|||
161967685|NCT00075946|584927750|FG004|Overall Study|Time to progression less than 6 months|0|||
161967686|NCT00075946|584927746|FG000|Overall Study|Other|57|||
161967687|NCT00075946|584927747|FG001|Overall Study|Other|32|||
161967688|NCT00075946|584927748|FG002|Overall Study|Other|3|||
161967689|NCT00075946|584927749|FG003|Overall Study|Other|11|||
161967690|NCT00075946|584927750|FG004|Overall Study|Other|0|||
161967691|NCT04154605|584927755|FG000|Overall Study|Procedure Canceled|1|||
161967692|NCT04154605|584927756|FG001|Overall Study|Procedure Canceled|1|||
161967693|NCT04154605|584927755|FG000|Overall Study|Missed follow up|1|||
161967694|NCT04154605|584927756|FG001|Overall Study|Missed follow up|1|||
161967695|NCT04154605|584927755|FG000|Overall Study|Withdrawal by Subject|1|||
161967696|NCT04154605|584927756|FG001|Overall Study|Withdrawal by Subject|0|||
161967697|NCT01229254|584927759|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
161967698|NCT01229254|584927760|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
161967699|NCT01229254|584927761|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
161967700|NCT01229254|584927759|FG000|Overall Study|Adverse Event|4|||
161967701|NCT01229254|584927760|FG001|Overall Study|Adverse Event|5|||
161967702|NCT01229254|584927761|FG002|Overall Study|Adverse Event|3|||
161967703|NCT01229254|584927759|FG000|Overall Study|Lost to Follow-up|3|||
161967704|NCT01229254|584927760|FG001|Overall Study|Lost to Follow-up|0|||
161967705|NCT01229254|584927761|FG002|Overall Study|Lost to Follow-up|1|||
161967706|NCT01229254|584927759|FG000|Overall Study|Physician Decision|0|||
161750109|NCT00841672|584124596|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161750110|NCT00841672|584124595|FG000|Overall Study|Subject withdrew consent|2|||
161750111|NCT00841672|584124596|FG001|Overall Study|Subject withdrew consent|4|||
161750112|NCT00841672|584124595|FG000|Overall Study|Lost to Follow-up|1|||
161750113|NCT00841672|584124596|FG001|Overall Study|Lost to Follow-up|1|||
161750114|NCT00841672|584124595|FG000|Overall Study|Administrative problems|9|||
161750115|NCT00841672|584124596|FG001|Overall Study|Administrative problems|9|||
161750116|NCT00841672|584124595|FG000|Overall Study|Misrandomized|1|||
161750117|NCT00841672|584124596|FG001|Overall Study|Misrandomized|0|||
161750118|NCT00841672|584124595|FG000|Overall Study|Protocol Deviation|0|||
161750119|NCT00841672|584124596|FG001|Overall Study|Protocol Deviation|1|||
161750120|NCT00166517|584124597|FG000|Overall Study|Lost to Follow-up|1|||
161750121|NCT00166517|584124598|FG001|Overall Study|Lost to Follow-up|0|||
161750122|NCT00166517|584124597|FG000|Overall Study|Protocol Violation|4|||
161750123|NCT00166517|584124598|FG001|Overall Study|Protocol Violation|1|||
161750124|NCT00166517|584124597|FG000|Overall Study|Withdrawal by Subject|0|||
161750125|NCT00166517|584124598|FG001|Overall Study|Withdrawal by Subject|1|||
161750126|NCT03094611|584124602|FG000|Overall Study|Lack of Efficacy|1|||
161750127|NCT03094611|584124602|FG000|Overall Study|Stem Cell Transplant|1|||
161750128|NCT04285853|584124603|FG000|Overall Study|Withdrawal by Subject|1|||
161750129|NCT04285853|584124604|FG001|Overall Study|Withdrawal by Subject|0|||
161750130|NCT04285853|584124603|FG000|Overall Study|Lost to Follow-up|9|||
161750131|NCT04285853|584124604|FG001|Overall Study|Lost to Follow-up|5|||
161750132|NCT02758613|584124607|FG000|Treatment|Physician and Sponsor Decision|1|||
161750133|NCT02758613|584124608|FG001|Treatment|Physician and Sponsor Decision|0|||
161750134|NCT02758613|584124609|FG002|Treatment|Physician and Sponsor Decision|0|||
161750135|NCT02758613|584124610|FG003|Treatment|Physician and Sponsor Decision|0|||
161750136|NCT02758613|584124607|FG000|Treatment|Withdrawal by Subject|1|||
161750137|NCT02758613|584124608|FG001|Treatment|Withdrawal by Subject|0|||
161750138|NCT02758613|584124609|FG002|Treatment|Withdrawal by Subject|1|||
161750139|NCT02758613|584124610|FG003|Treatment|Withdrawal by Subject|0|||
161750140|NCT00196196|584124616|FG000|Overall Study|Withdrawal by Subject|2|||
161750141|NCT00196196|584124616|FG000|Overall Study|Did not have required condition (hydroce|5|||
161750142|NCT02343952|584124617|FG000|Study Treatment|Disease Progression|23|||
161967707|NCT01229254|584927760|FG001|Overall Study|Physician Decision|3|||
161967708|NCT01229254|584927761|FG002|Overall Study|Physician Decision|0|||
161750143|NCT02343952|584124617|FG000|Study Treatment|Death|3|||
161750144|NCT02343952|584124617|FG000|Study Treatment|Adverse Event|19|||
161750145|NCT02343952|584124617|FG000|Study Treatment|Withdrawal by Subject|7|||
161750146|NCT02343952|584124617|FG000|Study Treatment|other complicating Diseases|1|||
161750147|NCT02343952|584124617|FG000|Follow up|Withdrawal by Subject|3|||
161967709|NCT01229254|584927759|FG000|Overall Study|Protocol Violation|4|||
161967710|NCT01229254|584927760|FG001|Overall Study|Protocol Violation|6|||
161750148|NCT02343952|584124617|FG000|Follow up|Death|33|||
161750149|NCT02343952|584124617|FG000|Follow up|Patient does not meet eligibility for study.|1|||
161750150|NCT02343952|584124617|FG000|Follow up|Research department closed by the practice.|5|||
161750151|NCT02343952|584124617|FG000|Follow up|Patient went home to Russia|1|||
161750152|NCT02343952|584124617|FG000|Follow up|Disease Progression|1|||
161750153|NCT02343952|584124617|FG000|Follow up|study terminated|1|||
161750154|NCT04018612|584124618|FG000|Overall Study|Withdrawal by Subject|1|||
161750155|NCT04018612|584124619|FG001|Overall Study|Withdrawal by Subject|0|||
161750156|NCT04018612|584124620|FG002|Overall Study|Withdrawal by Subject|1|||
161750157|NCT00361218|584124621|FG000|Overall Study|Lost to Follow-up|11|||
161750158|NCT00361218|584124621|FG000|Overall Study|Personal Reasons|7|||
161750159|NCT00361218|584124621|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
161750160|NCT02671760|584124622|FG000|Overall Study|Lost to Follow-up|0|||
161750161|NCT02671760|584124623|FG001|Overall Study|Lost to Follow-up|1|||
161750162|NCT02671760|584124624|FG002|Overall Study|Lost to Follow-up|0|||
161750163|NCT02079519|584124634|FG000|Overall Study|Disease Progression|9|||
161750164|NCT02079519|584124634|FG000|Overall Study|Adverse Event|1|||
161750165|NCT01802515|584124635|FG000|Overall Study|Withdrawal by Subject|3|||
161750166|NCT01802515|584124636|FG001|Overall Study|Withdrawal by Subject|0|||
161750167|NCT01802515|584124637|FG002|Overall Study|Withdrawal by Subject|0|||
161750168|NCT02566109|584124638|FG000|Overall Study|Withdrawal by Subject|1|||
161750169|NCT01041404|584124641|FG000|Overall Study|Adverse Event|45|||
161750170|NCT01041404|584124642|FG001|Overall Study|Adverse Event|35|||
161750171|NCT01041404|584124641|FG000|Overall Study|Lack of Efficacy|200|||
161750172|NCT01041404|584124642|FG001|Overall Study|Lack of Efficacy|210|||
161750173|NCT01041404|584124641|FG000|Overall Study|Violation of Selection Criteria|0|||
161750174|NCT01041404|584124642|FG001|Overall Study|Violation of Selection Criteria|1|||
161750175|NCT01041404|584124641|FG000|Overall Study|Protocol Violation|4|||
161750176|NCT01041404|584124642|FG001|Overall Study|Protocol Violation|0|||
161750177|NCT01041404|584124641|FG000|Overall Study|Withdrawal by Subject|29|||
161750178|NCT01041404|584124642|FG001|Overall Study|Withdrawal by Subject|23|||
161750179|NCT01041404|584124641|FG000|Overall Study|Failure to Return|1|||
161750180|NCT01041404|584124642|FG001|Overall Study|Failure to Return|2|||
161750181|NCT01041404|584124641|FG000|Overall Study|Other|11|||
161750182|NCT01041404|584124642|FG001|Overall Study|Other|23|||
161750183|NCT01750840|584124643|FG000|Overall Study|Lost to Follow-up|4|||
161750184|NCT02091921|584124644|FG000|Overall Study|Adverse Event|3|||
161843371|NCT01517373|584470070|FG003|Treatment Period|Protocol Violation|0|||
161843372|NCT01517373|584470071|FG004|Treatment Period|Protocol Violation|1|||
161843373|NCT01517373|584470072|FG005|Treatment Period|Protocol Violation|0|||
161843374|NCT01517373|584470067|FG000|Treatment Period|Lack of Efficacy|0|||
161843375|NCT01517373|584470068|FG001|Treatment Period|Lack of Efficacy|1|||
161843376|NCT01517373|584470069|FG002|Treatment Period|Lack of Efficacy|1|||
161843377|NCT01517373|584470070|FG003|Treatment Period|Lack of Efficacy|3|||
161843378|NCT01517373|584470071|FG004|Treatment Period|Lack of Efficacy|2|||
161843379|NCT01517373|584470072|FG005|Treatment Period|Lack of Efficacy|0|||
161843380|NCT01517373|584470067|FG000|Treatment Period|Medication error without AEs|0|||
161843381|NCT01517373|584470068|FG001|Treatment Period|Medication error without AEs|0|||
161843382|NCT01517373|584470069|FG002|Treatment Period|Medication error without AEs|2|||
161843383|NCT01517373|584470070|FG003|Treatment Period|Medication error without AEs|1|||
161843384|NCT01517373|584470071|FG004|Treatment Period|Medication error without AEs|0|||
161843385|NCT01517373|584470072|FG005|Treatment Period|Medication error without AEs|2|||
161843386|NCT05005312|584470079|FG000|Overall Study|Enrolled, but not treated|0|||
161843387|NCT05005312|584470080|FG001|Overall Study|Enrolled, but not treated|1|||
161843388|NCT00851318|584470081|FG000|Overall Study|Withdrawal by Subject|7|||
161843389|NCT00851318|584470082|FG001|Overall Study|Withdrawal by Subject|1|||
161843390|NCT00851318|584470083|FG002|Overall Study|Withdrawal by Subject|5|||
161843391|NCT00851318|584470084|FG003|Overall Study|Withdrawal by Subject|3|||
161843392|NCT00851318|584470081|FG000|Overall Study|Adverse Event|13|||
161843393|NCT00851318|584470082|FG001|Overall Study|Adverse Event|2|||
161843394|NCT00851318|584470083|FG002|Overall Study|Adverse Event|9|||
161843395|NCT00851318|584470084|FG003|Overall Study|Adverse Event|12|||
161843396|NCT00851318|584470081|FG000|Overall Study|Pregnancy|0|||
161967711|NCT01229254|584927761|FG002|Overall Study|Protocol Violation|5|||
161967712|NCT01229254|584927759|FG000|Overall Study|Withdrawal by Subject|1|||
161843397|NCT00851318|584470082|FG001|Overall Study|Pregnancy|0|||
161843398|NCT00851318|584470083|FG002|Overall Study|Pregnancy|1|||
161843399|NCT00851318|584470084|FG003|Overall Study|Pregnancy|1|||
161843400|NCT00851318|584470081|FG000|Overall Study|Lack of Efficacy|8|||
161843401|NCT00851318|584470082|FG001|Overall Study|Lack of Efficacy|2|||
161967713|NCT01229254|584927760|FG001|Overall Study|Withdrawal by Subject|0|||
161967714|NCT01229254|584927761|FG002|Overall Study|Withdrawal by Subject|1|||
161750185|NCT02483078|584124645|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
161750186|NCT02483078|584124646|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
161750187|NCT02483078|584124645|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
161750188|NCT02483078|584124646|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
161750189|NCT02483078|584124645|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
161843402|NCT00851318|584470083|FG002|Overall Study|Lack of Efficacy|4|||
161750190|NCT02483078|584124646|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
161967715|NCT01229254|584927759|FG000|Overall Study|Non-compliance with Study Drug|0|||
161967716|NCT01229254|584927760|FG001|Overall Study|Non-compliance with Study Drug|1|||
161967717|NCT01229254|584927761|FG002|Overall Study|Non-compliance with Study Drug|1|||
161967718|NCT02231892|584927762|FG000|Overall Study|Lost to Follow-up|1|||
161967719|NCT02231892|584927763|FG001|Overall Study|Lost to Follow-up|0|||
161967720|NCT02231892|584927764|FG002|Overall Study|Lost to Follow-up|3|||
161967721|NCT02231892|584927762|FG000|Overall Study|Withdrawal by Subject|4|||
161967722|NCT02231892|584927763|FG001|Overall Study|Withdrawal by Subject|3|||
161967723|NCT02231892|584927764|FG002|Overall Study|Withdrawal by Subject|15|||
161967724|NCT02231892|584927762|FG000|Overall Study|Physician Decision|0|||
161967725|NCT02231892|584927763|FG001|Overall Study|Physician Decision|2|||
161967726|NCT02231892|584927764|FG002|Overall Study|Physician Decision|4|||
161967727|NCT02231892|584927762|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
161967728|NCT02231892|584927763|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
161750191|NCT02483078|584124645|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
161750192|NCT02483078|584124646|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
161750193|NCT02483078|584124645|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
161750194|NCT02483078|584124646|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
161750195|NCT02483078|584124645|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
161750196|NCT02483078|584124646|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
161750197|NCT04876599|584124647|FG000|Overall Study|Missed|2|||
161750198|NCT04876599|584124648|FG001|Overall Study|Missed|0|||
161750199|NCT04876599|584124647|FG000|Overall Study|Declined|2|||
161750200|NCT04876599|584124648|FG001|Overall Study|Declined|3|||
161750201|NCT00676208|584124655|FG000|Overall Study|Lost to Follow-up|0|||
161750202|NCT00676208|584124656|FG001|Overall Study|Lost to Follow-up|2|||
161750203|NCT00676208|584124655|FG000|Overall Study|Incomplete data|2|||
161750204|NCT00676208|584124656|FG001|Overall Study|Incomplete data|4|||
161750205|NCT00669032|584124657|FG000|Overall Study|Lost to Follow-up|6|||
161750206|NCT00669032|584124658|FG001|Overall Study|Lost to Follow-up|5|||
161750207|NCT00669032|584124657|FG000|Overall Study|Lack of Efficacy|8|||
161750208|NCT00669032|584124658|FG001|Overall Study|Lack of Efficacy|19|||
161750209|NCT00669032|584124657|FG000|Overall Study|Withdrawal by Subject|12|||
161750210|NCT00669032|584124658|FG001|Overall Study|Withdrawal by Subject|13|||
161750211|NCT00669032|584124657|FG000|Overall Study|Adverse Event|12|||
161750212|NCT00669032|584124658|FG001|Overall Study|Adverse Event|16|||
161750213|NCT00669032|584124657|FG000|Overall Study|Physician Decision|1|||
161750214|NCT00669032|584124658|FG001|Overall Study|Physician Decision|1|||
161750215|NCT00669032|584124657|FG000|Overall Study|No fulfilment of the selection criteria|5|||
161750216|NCT00669032|584124658|FG001|Overall Study|No fulfilment of the selection criteria|5|||
161750217|NCT01607073|584124661|FG000|Overall Study|Adverse Event|1|||
161750218|NCT00642018|584124662|FG000|Overall Study|Adverse Event|11|||
161750219|NCT00642018|584124663|FG001|Overall Study|Adverse Event|36|||
161750220|NCT00642018|584124662|FG000|Overall Study|Withdrawal by Subject|4|||
161750221|NCT00642018|584124663|FG001|Overall Study|Withdrawal by Subject|10|||
161750222|NCT00642018|584124662|FG000|Overall Study|Progressive Disease|13|||
161750223|NCT00642018|584124663|FG001|Overall Study|Progressive Disease|18|||
161750224|NCT00642018|584124662|FG000|Overall Study|Physician Decision|0|||
161750225|NCT00642018|584124663|FG001|Overall Study|Physician Decision|10|||
161750226|NCT00642018|584124662|FG000|Overall Study|Protocol Violation|0|||
161750227|NCT00642018|584124663|FG001|Overall Study|Protocol Violation|1|||
161750228|NCT00642018|584124662|FG000|Overall Study|Death|0|||
161750229|NCT00642018|584124663|FG001|Overall Study|Death|3|||
161750230|NCT00642018|584124662|FG000|Overall Study|Entry Criteria Not Met|0|||
161750231|NCT00642018|584124663|FG001|Overall Study|Entry Criteria Not Met|1|||
161750232|NCT01410799|584124664|FG000|Overall Study|PI decision|13|||
161750233|NCT00617656|584124665|FG000|Overall Study|Inclusion error|4|||
161750234|NCT00617656|584124666|FG001|Overall Study|Inclusion error|4|||
161750235|NCT00617656|584124667|FG002|Overall Study|Inclusion error|0|||
161750236|NCT00617656|584124668|FG003|Overall Study|Inclusion error|0|||
161750237|NCT00617656|584124665|FG000|Overall Study|Missing data|44|||
161750238|NCT00617656|584124666|FG001|Overall Study|Missing data|30|||
161967729|NCT02231892|584927764|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
161967730|NCT02231892|584927762|FG000|Overall Study|Participant motor threshold was >83%|0|||
161750239|NCT00617656|584124667|FG002|Overall Study|Missing data|13|||
161750240|NCT00617656|584124668|FG003|Overall Study|Missing data|6|||
161750241|NCT00617656|584124665|FG000|Overall Study|Withdrawal by Subject|0|||
161750242|NCT00617656|584124666|FG001|Overall Study|Withdrawal by Subject|2|||
161967731|NCT02231892|584927763|FG001|Overall Study|Participant motor threshold was >83%|0|||
161967732|NCT02231892|584927764|FG002|Overall Study|Participant motor threshold was >83%|9|||
161750243|NCT00617656|584124667|FG002|Overall Study|Withdrawal by Subject|0|||
161750244|NCT00617656|584124668|FG003|Overall Study|Withdrawal by Subject|0|||
161750245|NCT00509028|584126602|FG000|Overall Study|Adverse Event|2|||
161750246|NCT00509028|584126603|FG001|Overall Study|Adverse Event|0|||
161750247|NCT00509028|584126602|FG000|Overall Study|Withdrawal by Subject|4|||
161750248|NCT00509028|584126603|FG001|Overall Study|Withdrawal by Subject|3|||
161967733|NCT02231892|584927762|FG000|Overall Study|Could not find motor threshold|2|||
161967734|NCT02231892|584927763|FG001|Overall Study|Could not find motor threshold|0|||
161967735|NCT02231892|584927764|FG002|Overall Study|Could not find motor threshold|1|||
161967736|NCT02231892|584927762|FG000|Overall Study|Could not find reliable motor hotspot|0|||
161967737|NCT02231892|584927763|FG001|Overall Study|Could not find reliable motor hotspot|0|||
161967738|NCT02231892|584927764|FG002|Overall Study|Could not find reliable motor hotspot|1|||
161967739|NCT00223977|584927773|FG000|Overall Study|Adverse Event|7|||
161967740|NCT00223977|584927774|FG001|Overall Study|Adverse Event|10|||
161967741|NCT00223977|584927775|FG002|Overall Study|Adverse Event|0|||
161967742|NCT00223977|584927773|FG000|Overall Study|Protocol Violation|0|||
161967743|NCT00223977|584927774|FG001|Overall Study|Protocol Violation|0|||
161967744|NCT00223977|584927775|FG002|Overall Study|Protocol Violation|1|||
161967745|NCT00223977|584927773|FG000|Overall Study|Withdrawal by Subject|1|||
161967746|NCT00223977|584927774|FG001|Overall Study|Withdrawal by Subject|1|||
161967747|NCT00223977|584927775|FG002|Overall Study|Withdrawal by Subject|2|||
161967748|NCT00223977|584927773|FG000|Overall Study|Other|1|||
161967749|NCT00223977|584927774|FG001|Overall Study|Other|0|||
161967750|NCT00223977|584927775|FG002|Overall Study|Other|0|||
161967751|NCT02359045|584927776|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
161967752|NCT02359045|584927777|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161967753|NCT02359045|584927776|FG000|Overall Study|Lost to Follow-up|1|||
161967754|NCT02359045|584927777|FG001|Overall Study|Lost to Follow-up|1|||
161967755|NCT02359045|584927776|FG000|Overall Study|Adverse Event|0|||
161967756|NCT02359045|584927777|FG001|Overall Study|Adverse Event|1|||
161967757|NCT02118766|584927783|FG000|Overall Study|Adverse Event|7|||
161967758|NCT02118766|584927784|FG001|Overall Study|Adverse Event|2|||
161967759|NCT02118766|584927783|FG000|Overall Study|Withdrawal by Subject|3|||
161967760|NCT02118766|584927784|FG001|Overall Study|Withdrawal by Subject|6|||
161967761|NCT02118766|584927783|FG000|Overall Study|Lost to Follow-up|5|||
161967762|NCT02118766|584927784|FG001|Overall Study|Lost to Follow-up|4|||
161967763|NCT02118766|584927783|FG000|Overall Study|Withdrawal by parent/guardian|12|||
161967764|NCT02118766|584927784|FG001|Overall Study|Withdrawal by parent/guardian|18|||
161967765|NCT02118766|584927783|FG000|Overall Study|Other|3|||
161967766|NCT02118766|584927784|FG001|Overall Study|Other|1|||
161967767|NCT02248649|584927787|FG000|Overall Study|Death|7|||
161967768|NCT02248649|584927788|FG001|Overall Study|Death|11|||
161967769|NCT02248649|584927787|FG000|Overall Study|Lost to Follow-up|14|||
161967770|NCT02248649|584927788|FG001|Overall Study|Lost to Follow-up|10|||
161967771|NCT04621240|584927790|FG000|Overall Study|Withdrawal by Subject|36|||
161967772|NCT02226198|584929150|FG000|Lead-in Phase|Protocol Violation|1|||
161967773|NCT02226198|584929151|FG001|Lead-in Phase|Protocol Violation|0|||
161967774|NCT02226198|584929152|FG002|Lead-in Phase|Protocol Violation|0|||
161967775|NCT02226198|584929150|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
161967776|NCT02226198|584929151|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
161967777|NCT02226198|584929152|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
161967778|NCT01440517|584929156|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
161967779|NCT01288612|584929157|FG000|Overall Study|Unable to contact|11|||
161967780|NCT01288612|584929158|FG001|Overall Study|Unable to contact|16|||
161750249|NCT00509028|584126602|FG000|Overall Study|Lost to Follow-up|0|||
161750250|NCT00509028|584126603|FG001|Overall Study|Lost to Follow-up|1|||
161750251|NCT00509028|584126602|FG000|Overall Study|Protocol Violation|4|||
161750252|NCT00509028|584126603|FG001|Overall Study|Protocol Violation|2|||
161750253|NCT00509028|584126602|FG000|Overall Study|Non-compliance|2|||
161750254|NCT00509028|584126603|FG001|Overall Study|Non-compliance|1|||
161750255|NCT02996110|584126604|FG000|Pre-Treatment|Other Reasons|0|||
161750256|NCT02996110|584126605|FG001|Pre-Treatment|Other Reasons|1|||
161750257|NCT02996110|584126606|FG002|Pre-Treatment|Other Reasons|0|||
161750258|NCT02996110|584126607|FG003|Pre-Treatment|Other Reasons|0|||
161750259|NCT02996110|584126608|FG004|Pre-Treatment|Other Reasons|1|||
161750260|NCT02996110|584126604|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
161750261|NCT02996110|584126605|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
161750262|NCT02996110|584126606|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
161750263|NCT02996110|584126607|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
161750264|NCT02996110|584126608|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
161750265|NCT02996110|584126604|FG000|Track 1|Disease Progression|15|||
161750266|NCT02996110|584126605|FG001|Track 1|Disease Progression|17|||
161750267|NCT02996110|584126606|FG002|Track 1|Disease Progression|0|||
161750268|NCT02996110|584126607|FG003|Track 1|Disease Progression|0|||
161750269|NCT02996110|584126608|FG004|Track 1|Disease Progression|0|||
161843403|NCT00851318|584470084|FG003|Overall Study|Lack of Efficacy|2|||
161967781|NCT01288612|584929159|FG002|Overall Study|Unable to contact|20|||
161967782|NCT01288612|584929157|FG000|Overall Study|Declined|78|||
161967783|NCT01288612|584929158|FG001|Overall Study|Declined|63|||
161967784|NCT01288612|584929159|FG002|Overall Study|Declined|62|||
161967785|NCT01288612|584929157|FG000|Overall Study|Unable to intubate|0|||
161750270|NCT02996110|584126604|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
161750271|NCT02996110|584126605|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
161750272|NCT02996110|584126606|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
161750273|NCT02996110|584126607|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
161750274|NCT02996110|584126608|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
161750275|NCT02996110|584126604|FG000|Track 1|Study Drug Toxicity|5|||
161750276|NCT02996110|584126605|FG001|Track 1|Study Drug Toxicity|3|||
161750277|NCT02996110|584126606|FG002|Track 1|Study Drug Toxicity|0|||
161750278|NCT02996110|584126607|FG003|Track 1|Study Drug Toxicity|0|||
161750279|NCT02996110|584126608|FG004|Track 1|Study Drug Toxicity|0|||
161750280|NCT02996110|584126604|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
161750281|NCT02996110|584126605|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
161750282|NCT02996110|584126606|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
161750283|NCT02996110|584126607|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
161750284|NCT02996110|584126608|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
161750285|NCT02996110|584126604|FG000|Track 1|Administrative Reason by Sponsor|0|||
161967786|NCT01288612|584929158|FG001|Overall Study|Unable to intubate|3|||
161967787|NCT01288612|584929159|FG002|Overall Study|Unable to intubate|0|||
161967788|NCT00871923|584929160|FG000|Overall Study|Death|1|||
161967789|NCT00871923|584929160|FG000|Overall Study|Withdrawal by Subject|1|||
161967790|NCT00496483|584929166|FG000|Overall Study|Not dosed|9|||
161967791|NCT00496483|584929166|FG000|Overall Study|Adverse Event|2|||
161967792|NCT00496483|584929166|FG000|Overall Study|Lack of Efficacy|1|||
161967793|NCT04258995|584929168|FG000|Overall Study|Lost to Follow-up|1|||
161967794|NCT04258995|584929169|FG001|Overall Study|Lost to Follow-up|1|||
161967795|NCT00316693|584929173|FG000|Overall Study|Adverse Event|6|||
161967796|NCT00316693|584929174|FG001|Overall Study|Adverse Event|1|||
161967797|NCT00316693|584929173|FG000|Overall Study|Protocol Violation|1|||
161967798|NCT00316693|584929174|FG001|Overall Study|Protocol Violation|0|||
161967799|NCT00316693|584929173|FG000|Overall Study|Withdrawal by Subject|6|||
161967800|NCT00316693|584929174|FG001|Overall Study|Withdrawal by Subject|6|||
161967801|NCT00316693|584929173|FG000|Overall Study|Lost to Follow-up|26|||
161967802|NCT00316693|584929174|FG001|Overall Study|Lost to Follow-up|34|||
161967803|NCT00316693|584929173|FG000|Overall Study|Other|38|||
161967804|NCT00316693|584929174|FG001|Overall Study|Other|44|||
161967805|NCT01967823|584929175|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
161967806|NCT00413894|584929182|FG000|Overall Study|Withdrawal by Subject|10|||
161967807|NCT00413894|584929182|FG000|Overall Study|Administrative Reasons|1|||
161967808|NCT00413894|584929182|FG000|Overall Study|Hb <10 grams/deciliter|12|||
161967809|NCT00413894|584929182|FG000|Overall Study|Adverse Event|28|||
161967810|NCT00413894|584929182|FG000|Overall Study|Protocol Violation|11|||
161967811|NCT00413894|584929182|FG000|Overall Study|Other|18|||
161967812|NCT04225676|584929183|FG000|Overall Study|Physician Decision|1|||
161967813|NCT04225676|584929183|FG000|Overall Study|Lack of Efficacy|1|||
161967814|NCT04225676|584929183|FG000|Overall Study|Study terminated by sponsor|3|||
161967815|NCT05289271|584929186|FG000|Overall Study|Mistakenly allocated, untreated|1|||
161967816|NCT05289271|584929187|FG001|Overall Study|Mistakenly allocated, untreated|0|||
161967817|NCT02019108|584929188|FG000|Overall Study|Lost to Follow-up|5|||
161967818|NCT02019108|584929189|FG001|Overall Study|Lost to Follow-up|7|||
161967819|NCT02442310|584929191|FG000|Overall Study|Adverse Event|2|||
161967820|NCT02442310|584929191|FG000|Overall Study|Withdrawal by Subject|1|||
161750286|NCT02996110|584126605|FG001|Track 1|Administrative Reason by Sponsor|1|||
161750287|NCT02996110|584126606|FG002|Track 1|Administrative Reason by Sponsor|0|||
161750288|NCT02996110|584126607|FG003|Track 1|Administrative Reason by Sponsor|0|||
161750289|NCT02996110|584126608|FG004|Track 1|Administrative Reason by Sponsor|0|||
161750290|NCT02996110|584126604|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
161750291|NCT02996110|584126605|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
161750292|NCT02996110|584126606|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
161750293|NCT02996110|584126607|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
161750294|NCT02996110|584126608|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
161750295|NCT02996110|584126604|FG000|Track 2|Disease Progression|33|||
161750296|NCT02996110|584126605|FG001|Track 2|Disease Progression|26|||
161750297|NCT02996110|584126606|FG002|Track 2|Disease Progression|19|||
161750298|NCT02996110|584126607|FG003|Track 2|Disease Progression|16|||
161967821|NCT02851797|584929192|FG000|Overall Study|Withdrawal by Subject|4|||
161750299|NCT02996110|584126608|FG004|Track 2|Disease Progression|15|||
161750300|NCT02996110|584126604|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
161750301|NCT02996110|584126605|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
161750302|NCT02996110|584126606|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
161750303|NCT02996110|584126607|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
161967822|NCT02851797|584929193|FG001|Overall Study|Withdrawal by Subject|2|||
161967823|NCT02851797|584929192|FG000|Overall Study|Adverse Event|3|||
161967824|NCT02851797|584929193|FG001|Overall Study|Adverse Event|0|||
161967825|NCT03077438|584929194|FG000|Overall Study|Protocol Violation|3|||
161967826|NCT03077438|584929195|FG001|Overall Study|Protocol Violation|5|||
161967827|NCT03077438|584929194|FG000|Overall Study|Withdrawal by Subject|3|||
161967828|NCT03077438|584929195|FG001|Overall Study|Withdrawal by Subject|6|||
161967829|NCT03077438|584929194|FG000|Overall Study|Lost to Follow-up|6|||
161750304|NCT02996110|584126608|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
161750305|NCT02996110|584126604|FG000|Track 2|Death|0|||
161750306|NCT02996110|584126605|FG001|Track 2|Death|0|||
161750307|NCT02996110|584126606|FG002|Track 2|Death|1|||
161750308|NCT02996110|584126607|FG003|Track 2|Death|0|||
161750309|NCT02996110|584126608|FG004|Track 2|Death|1|||
161750310|NCT02996110|584126604|FG000|Track 2|Study Drug Toxicity|4|||
161750311|NCT02996110|584126605|FG001|Track 2|Study Drug Toxicity|1|||
161750312|NCT02996110|584126606|FG002|Track 2|Study Drug Toxicity|4|||
161750313|NCT02996110|584126607|FG003|Track 2|Study Drug Toxicity|1|||
161750314|NCT02996110|584126608|FG004|Track 2|Study Drug Toxicity|0|||
161750315|NCT02996110|584126604|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
161750316|NCT02996110|584126605|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
161750317|NCT02996110|584126606|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
161750318|NCT02996110|584126607|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
161750319|NCT02996110|584126608|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
161750320|NCT02996110|584126604|FG000|Track 2|Participant Withdrew Consent|1|||
161750321|NCT02996110|584126605|FG001|Track 2|Participant Withdrew Consent|2|||
161750322|NCT02996110|584126606|FG002|Track 2|Participant Withdrew Consent|3|||
161750323|NCT02996110|584126607|FG003|Track 2|Participant Withdrew Consent|1|||
161750324|NCT02996110|584126608|FG004|Track 2|Participant Withdrew Consent|1|||
161750325|NCT02996110|584126604|FG000|Track 2|Other Reasons|0|||
161750326|NCT02996110|584126605|FG001|Track 2|Other Reasons|0|||
161750327|NCT02996110|584126606|FG002|Track 2|Other Reasons|1|||
161750328|NCT02996110|584126607|FG003|Track 2|Other Reasons|0|||
161750329|NCT02996110|584126608|FG004|Track 2|Other Reasons|1|||
161750330|NCT02436915|584126609|FG000|Overall Study|Withdrawal by Subject|0|||
161750331|NCT02436915|584126610|FG001|Overall Study|Withdrawal by Subject|1|||
161750332|NCT03805971|584126611|FG000|Overall Study|Withdrawal by Subject|1|||
161750333|NCT03805971|584126611|FG000|Overall Study|Protocol Violation|2|||
161750334|NCT01366534|584126631|FG000|Overall Study|Lost to Follow-up|1|||
161750335|NCT01366534|584126632|FG001|Overall Study|Lost to Follow-up|0|||
161750336|NCT01366534|584126633|FG002|Overall Study|Lost to Follow-up|0|||
161750337|NCT01366534|584126631|FG000|Overall Study|Migrated|1|||
161750338|NCT01366534|584126632|FG001|Overall Study|Migrated|1|||
161750339|NCT01366534|584126633|FG002|Overall Study|Migrated|0|||
161750340|NCT01366534|584126631|FG000|Overall Study|Declined challenged|0|||
161750341|NCT01366534|584126632|FG001|Overall Study|Declined challenged|1|||
161750342|NCT01366534|584126633|FG002|Overall Study|Declined challenged|0|||
161750343|NCT02939976|584126634|FG000|Overall Study|Lost to Follow-up|7|||
161750344|NCT02939976|584126635|FG001|Overall Study|Lost to Follow-up|1|||
161750345|NCT02939976|584126636|FG002|Overall Study|Lost to Follow-up|1|||
161750346|NCT02939976|584126637|FG003|Overall Study|Lost to Follow-up|2|||
161750347|NCT02939976|584126634|FG000|Overall Study|Withdrawal by Subject|4|||
161750348|NCT02939976|584126635|FG001|Overall Study|Withdrawal by Subject|0|||
161750349|NCT02939976|584126636|FG002|Overall Study|Withdrawal by Subject|2|||
161750350|NCT02939976|584126637|FG003|Overall Study|Withdrawal by Subject|4|||
161750351|NCT02939976|584126634|FG000|Overall Study|Due to early study closure|4|||
161750352|NCT02939976|584126635|FG001|Overall Study|Due to early study closure|3|||
161750353|NCT02939976|584126636|FG002|Overall Study|Due to early study closure|2|||
161750354|NCT02939976|584126637|FG003|Overall Study|Due to early study closure|3|||
161750355|NCT02640755|584126638|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
161750356|NCT02640755|584126639|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
161750357|NCT02640755|584126638|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
161750358|NCT02640755|584126639|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
161750359|NCT02640755|584126638|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
161750360|NCT02640755|584126639|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
161750361|NCT04080752|584126640|FG000|Overall Study|Adverse Event|2|||
161750362|NCT04080752|584126641|FG001|Overall Study|Adverse Event|3|||
161750363|NCT04080752|584126640|FG000|Overall Study|Lack of Efficacy|1|||
161750364|NCT04080752|584126641|FG001|Overall Study|Lack of Efficacy|0|||
161750365|NCT04080752|584126640|FG000|Overall Study|Lost to Follow-up|1|||
161750366|NCT04080752|584126641|FG001|Overall Study|Lost to Follow-up|0|||
161750367|NCT04080752|584126640|FG000|Overall Study|Pregnancy|0|||
161750368|NCT04080752|584126641|FG001|Overall Study|Pregnancy|1|||
161750369|NCT04080752|584126640|FG000|Overall Study|Withdrawal by Subject|7|||
161843404|NCT00851318|584470081|FG000|Overall Study|Non-compliance with Study Procedures|2|||
161750370|NCT04080752|584126641|FG001|Overall Study|Withdrawal by Subject|0|||
161750371|NCT04080752|584126640|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161843405|NCT00851318|584470082|FG001|Overall Study|Non-compliance with Study Procedures|0|||
161843406|NCT00851318|584470083|FG002|Overall Study|Non-compliance with Study Procedures|1|||
161843407|NCT00851318|584470084|FG003|Overall Study|Non-compliance with Study Procedures|0|||
161843408|NCT00851318|584470081|FG000|Overall Study|Physician Decision|0|||
161843409|NCT00851318|584470082|FG001|Overall Study|Physician Decision|0|||
161750372|NCT04080752|584126641|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161843410|NCT00851318|584470083|FG002|Overall Study|Physician Decision|1|||
161843411|NCT00851318|584470084|FG003|Overall Study|Physician Decision|1|||
161967830|NCT03077438|584929195|FG001|Overall Study|Lost to Follow-up|3|||
161967831|NCT00813865|584929196|FG000|Overall Study|Failure to Respond|3|||
161750373|NCT04080752|584126640|FG000|Overall Study|Other|2|||
161750374|NCT04080752|584126641|FG001|Overall Study|Other|1|||
161750375|NCT01585168|584126646|FG000|Overall Study|Lost to Follow-up|3|||
161750376|NCT01585168|584126647|FG001|Overall Study|Lost to Follow-up|1|||
161750377|NCT01585168|584126648|FG002|Overall Study|Lost to Follow-up|1|||
161750378|NCT01585168|584126649|FG003|Overall Study|Lost to Follow-up|1|||
161750379|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
161750380|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
161750381|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
161750382|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
161750383|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
161750384|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
161750385|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
161750386|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
161750387|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
161750388|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
161750389|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
161750390|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
161750391|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
161750392|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
161750393|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
161750394|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
161750395|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
161750396|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
161750397|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
161750398|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
161750399|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
161750400|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
161750401|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
161750402|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
161750403|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Other|0|||
161750404|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Other|1|||
161750405|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Other|0|||
161750406|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Other|0|||
161750407|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
161750408|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
161750409|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
161750410|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
161750411|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
161750412|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
161750413|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
161750414|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
161750415|NCT01194414|584126650|FG000|24 Weeks Double Blind Period|Death|0|||
161750416|NCT01194414|584126651|FG001|24 Weeks Double Blind Period|Death|1|||
161750417|NCT01194414|584126652|FG002|24 Weeks Double Blind Period|Death|0|||
161750418|NCT01194414|584126653|FG003|24 Weeks Double Blind Period|Death|0|||
161750419|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
161750420|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
161750421|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
161750422|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
161750423|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
161750424|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
161750425|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
161750426|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
161750427|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
161750428|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
161750429|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
161750430|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
161750431|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
161843412|NCT00171951|584470085|FG000|Overall Study|Adverse Event|1|||
161967832|NCT00813865|584929196|FG000|Overall Study|Lost to Follow-up|3|||
161750432|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
161750433|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
161843413|NCT00171951|584470085|FG000|Overall Study|Abnormal Laboratory Values|2|||
161843414|NCT00171951|584470085|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161750434|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
161750435|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
161750436|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
161967833|NCT00813865|584929196|FG000|Overall Study|Withdrawal by Subject|1|||
161967834|NCT00624585|584929200|FG000|Overall Study|Death|3|||
161967835|NCT00624585|584929200|FG000|Overall Study|Disease Progression|6|||
161967836|NCT00624585|584929200|FG000|Overall Study|Adverse Event|3|||
161967837|NCT03466099|584929203|FG000|Overall Study|Adverse Event|1|||
161750437|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
161750438|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
161750439|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
161750440|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
161750441|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
161750442|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
161750443|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Other|2|||
161750444|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Other|1|||
161750445|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Other|0|||
161750446|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Other|0|||
161750447|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
161750448|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
161750449|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
161750450|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
161750451|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
161750452|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
161750453|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
161750454|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
161750455|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
161750456|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
161750457|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
161750458|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
161750459|NCT01194414|584126650|FG000|72 Weeks Open Label Extension|Death|1|||
161750460|NCT01194414|584126651|FG001|72 Weeks Open Label Extension|Death|2|||
161750461|NCT01194414|584126652|FG002|72 Weeks Open Label Extension|Death|0|||
161750462|NCT01194414|584126653|FG003|72 Weeks Open Label Extension|Death|2|||
161750463|NCT01192100|584126654|FG000|Overall Study|Withdrawal by Subject|0|||
161750464|NCT01192100|584126655|FG001|Overall Study|Withdrawal by Subject|0|||
161750465|NCT01192100|584126656|FG002|Overall Study|Withdrawal by Subject|0|||
161750466|NCT01192100|584126657|FG003|Overall Study|Withdrawal by Subject|0|||
161750467|NCT01192100|584126658|FG004|Overall Study|Withdrawal by Subject|1|||
161750468|NCT01192100|584126659|FG005|Overall Study|Withdrawal by Subject|0|||
161750469|NCT01192100|584126654|FG000|Overall Study|Protocol Violation|0|||
161750470|NCT01192100|584126655|FG001|Overall Study|Protocol Violation|0|||
161750471|NCT01192100|584126656|FG002|Overall Study|Protocol Violation|0|||
161750472|NCT01192100|584126657|FG003|Overall Study|Protocol Violation|1|||
161750473|NCT01192100|584126658|FG004|Overall Study|Protocol Violation|0|||
161750474|NCT01192100|584126659|FG005|Overall Study|Protocol Violation|0|||
161750475|NCT02057068|584126660|FG000|Overall Study|Withdrawal by Subject|2|||
161750476|NCT02057068|584126661|FG001|Overall Study|Withdrawal by Subject|2|||
161750477|NCT02057068|584126660|FG000|Overall Study|Caregiver (CG) Health|0|||
161750478|NCT02057068|584126661|FG001|Overall Study|Caregiver (CG) Health|2|||
161750479|NCT02057068|584126660|FG000|Overall Study|Carepartner (CP) Health|4|||
161750480|NCT02057068|584126661|FG001|Overall Study|Carepartner (CP) Health|2|||
161750481|NCT02057068|584126660|FG000|Overall Study|Lost to Follow-up|2|||
161750482|NCT02057068|584126661|FG001|Overall Study|Lost to Follow-up|2|||
161750483|NCT00865046|584126663|FG000|Overall Study|Lost to Follow-up|1|||
161750484|NCT00865046|584126664|FG001|Overall Study|Lost to Follow-up|4|||
161750485|NCT00865046|584126665|FG002|Overall Study|Lost to Follow-up|0|||
161750486|NCT00865046|584126663|FG000|Overall Study|Death|0|||
161750487|NCT00865046|584126664|FG001|Overall Study|Death|1|||
161967838|NCT03466099|584929204|FG001|Overall Study|Adverse Event|1|||
161967839|NCT03466099|584929205|FG002|Overall Study|Adverse Event|1|||
161967840|NCT03466099|584929203|FG000|Overall Study|Withdrawal by Subject|2|||
161750488|NCT00865046|584126665|FG002|Overall Study|Death|1|||
161750489|NCT00865046|584126663|FG000|Overall Study|Withdrawal by Subject|5|||
161750490|NCT00865046|584126664|FG001|Overall Study|Withdrawal by Subject|0|||
161750491|NCT00865046|584126665|FG002|Overall Study|Withdrawal by Subject|0|||
161967841|NCT03466099|584929204|FG001|Overall Study|Withdrawal by Subject|3|||
161750492|NCT00329784|584126671|FG000|Overall Study|Lost to Follow-up|0|||
161750493|NCT00329784|584126672|FG001|Overall Study|Lost to Follow-up|1|||
161750494|NCT00329784|584126673|FG002|Overall Study|Lost to Follow-up|0|||
161750495|NCT00329784|584126674|FG003|Overall Study|Lost to Follow-up|0|||
161750496|NCT00329784|584126671|FG000|Overall Study|Withdrawal by Subject|4|||
161967842|NCT03466099|584929205|FG002|Overall Study|Withdrawal by Subject|1|||
161967843|NCT03466099|584929203|FG000|Overall Study|Use of rescue medication|8|||
162032668|NCT01933789|585177450|FG000|Overall Study|Death|0|||
162032669|NCT01933789|585177451|FG001|Overall Study|Death|0|||
161750497|NCT00329784|584126672|FG001|Overall Study|Withdrawal by Subject|2|||
161750498|NCT00329784|584126673|FG002|Overall Study|Withdrawal by Subject|0|||
161750499|NCT00329784|584126674|FG003|Overall Study|Withdrawal by Subject|0|||
161750500|NCT00329784|584126671|FG000|Overall Study|Other|1|||
161750501|NCT00329784|584126672|FG001|Overall Study|Other|2|||
161750502|NCT00329784|584126673|FG002|Overall Study|Other|0|||
161750503|NCT00329784|584126674|FG003|Overall Study|Other|0|||
161750504|NCT01928082|584126679|FG000|Overall Study|Study terminated.|1|||
161750505|NCT05563714|584126680|FG000|Overall Study|Death|2|||
161750506|NCT05563714|584126681|FG001|Overall Study|Death|2|||
161750507|NCT05563714|584126682|FG002|Overall Study|Death|0|||
161750508|NCT05563714|584126683|FG003|Overall Study|Death|0|||
161750509|NCT05563714|584126680|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
161750510|NCT05563714|584126681|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
161750511|NCT05563714|584126682|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
161750512|NCT05563714|584126683|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
161750513|NCT05563714|584126680|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
161750514|NCT05563714|584126681|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
161750515|NCT05563714|584126682|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
161750516|NCT05563714|584126683|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
161750517|NCT05563714|584126680|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
161750518|NCT05563714|584126681|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
161750519|NCT05563714|584126682|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
161750520|NCT05563714|584126683|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
161750521|NCT05563714|584126680|FG000|Overall Study|Lost to Follow-up|22|||
161750522|NCT05563714|584126681|FG001|Overall Study|Lost to Follow-up|19|||
161750523|NCT05563714|584126682|FG002|Overall Study|Lost to Follow-up|0|||
161750524|NCT05563714|584126683|FG003|Overall Study|Lost to Follow-up|0|||
161750525|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
161750526|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
161750527|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
161750528|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
161750529|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
161750530|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
161750531|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
161750532|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
161750533|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161750534|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161750535|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161750536|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161750537|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161750538|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161750539|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
161750540|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
161750541|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
161750542|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
161750543|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
161750544|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
161750545|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
161750546|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
161750547|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161750548|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161750549|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161750550|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161750551|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161750552|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161750553|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
161750554|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161750555|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161750556|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161750557|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161750558|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161750559|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161750560|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
162032670|NCT01933789|585177452|FG002|Overall Study|Death|0|||
161843415|NCT00171951|584470085|FG000|Overall Study|Participants Withdrew Consent|3|||
161843416|NCT00171951|584470085|FG000|Overall Study|New Cancer Therapy|5|||
161843417|NCT00171951|584470085|FG000|Overall Study|Reason not Specified|2|||
161843418|NCT02970318|584470086|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
161843419|NCT02970318|584470087|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
161843420|NCT02970318|584470088|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
161843421|NCT02970318|584470089|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
161843422|NCT02970318|584470086|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
161843423|NCT02970318|584470087|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
161843424|NCT02970318|584470088|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
161843425|NCT02970318|584470089|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
161843426|NCT02970318|584470086|FG000|Overall for Arm A & Main for Arm B|Death|41|||
161843427|NCT02970318|584470087|FG001|Overall for Arm A & Main for Arm B|Death|33|||
161843428|NCT02970318|584470088|FG002|Overall for Arm A & Main for Arm B|Death|0|||
161843429|NCT02970318|584470089|FG003|Overall for Arm A & Main for Arm B|Death|0|||
161843430|NCT02970318|584470086|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
161843431|NCT02970318|584470087|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
161843432|NCT02970318|584470088|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
161843433|NCT02970318|584470089|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
161843434|NCT02970318|584470086|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
161843435|NCT02970318|584470087|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
161843436|NCT02970318|584470088|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
161843437|NCT02970318|584470089|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
161843438|NCT02970318|584470086|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
161843439|NCT02970318|584470087|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
161843440|NCT02970318|584470088|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
161843441|NCT02970318|584470089|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
161843442|NCT02970318|584470086|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
161843443|NCT02970318|584470087|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
161843444|NCT02970318|584470088|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
161843445|NCT02970318|584470089|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
161843446|NCT03384654|584470090|FG000|Overall Study|Withdrawal by Subject|0|||
161843447|NCT03384654|584470091|FG001|Overall Study|Withdrawal by Subject|0|||
161843448|NCT03384654|584470092|FG002|Overall Study|Withdrawal by Subject|1|||
161843449|NCT03384654|584470093|FG003|Overall Study|Withdrawal by Subject|0|||
161843450|NCT01616953|584470094|FG000|Overall Study|Lost to Follow-up|1|||
161843451|NCT01616953|584470095|FG001|Overall Study|Lost to Follow-up|0|||
161843452|NCT01616953|584470094|FG000|Overall Study|lack of bone and soft tissue|1|||
161843453|NCT01616953|584470095|FG001|Overall Study|lack of bone and soft tissue|0|||
161843454|NCT00816361|584470097|FG000|Overall Study|Withdrawal by Subject|0|||
161843455|NCT00816361|584470098|FG001|Overall Study|Withdrawal by Subject|0|||
161843456|NCT00816361|584470099|FG002|Overall Study|Withdrawal by Subject|0|||
161843457|NCT00816361|584470100|FG003|Overall Study|Withdrawal by Subject|0|||
161843458|NCT00816361|584470101|FG004|Overall Study|Withdrawal by Subject|1|||
161843459|NCT00816361|584470102|FG005|Overall Study|Withdrawal by Subject|2|||
161843460|NCT00816361|584470103|FG006|Overall Study|Withdrawal by Subject|0|||
161843461|NCT00816361|584470104|FG007|Overall Study|Withdrawal by Subject|2|||
161843462|NCT00816361|584470105|FG008|Overall Study|Withdrawal by Subject|1|||
161843463|NCT00816361|584470097|FG000|Overall Study|Death|4|||
161843464|NCT00816361|584470098|FG001|Overall Study|Death|3|||
161843465|NCT00816361|584470099|FG002|Overall Study|Death|3|||
161843466|NCT00816361|584470100|FG003|Overall Study|Death|3|||
161843467|NCT00816361|584470101|FG004|Overall Study|Death|1|||
161843468|NCT00816361|584470102|FG005|Overall Study|Death|1|||
161843469|NCT00816361|584470103|FG006|Overall Study|Death|3|||
161843470|NCT00816361|584470104|FG007|Overall Study|Death|7|||
161843471|NCT00816361|584470105|FG008|Overall Study|Death|8|||
161843472|NCT00816361|584470097|FG000|Overall Study|Other|0|||
161843473|NCT00816361|584470098|FG001|Overall Study|Other|0|||
161843474|NCT00816361|584470099|FG002|Overall Study|Other|0|||
161843475|NCT00816361|584470100|FG003|Overall Study|Other|0|||
161843476|NCT00816361|584470101|FG004|Overall Study|Other|0|||
161843477|NCT00816361|584470102|FG005|Overall Study|Other|0|||
161843478|NCT00816361|584470103|FG006|Overall Study|Other|0|||
161843479|NCT00816361|584470104|FG007|Overall Study|Other|0|||
161843480|NCT00816361|584470105|FG008|Overall Study|Other|1|||
161843481|NCT02500641|584470106|FG000|Overall Study|Adverse Event|0|||
161843482|NCT02500641|584470107|FG001|Overall Study|Adverse Event|2|||
161843483|NCT02500641|584470106|FG000|Overall Study|Withdrawal by Subject|4|||
161843484|NCT02500641|584470107|FG001|Overall Study|Withdrawal by Subject|5|||
161843485|NCT02500641|584470106|FG000|Overall Study|Unable to follow study procedures|3|||
161843486|NCT02500641|584470107|FG001|Overall Study|Unable to follow study procedures|2|||
161843487|NCT02500641|584470106|FG000|Overall Study|Protocol Violation|1|||
161967844|NCT03466099|584929204|FG001|Overall Study|Use of rescue medication|9|||
161967845|NCT03466099|584929205|FG002|Overall Study|Use of rescue medication|13|||
161967846|NCT03466099|584929203|FG000|Overall Study|Rescued without meeting criteria|4|||
161967847|NCT03466099|584929204|FG001|Overall Study|Rescued without meeting criteria|1|||
161967848|NCT03466099|584929205|FG002|Overall Study|Rescued without meeting criteria|1|||
161967849|NCT03466099|584929203|FG000|Overall Study|Subject compliance|2|||
161967850|NCT03466099|584929204|FG001|Overall Study|Subject compliance|0|||
161967851|NCT03466099|584929205|FG002|Overall Study|Subject compliance|0|||
161967852|NCT03466099|584929203|FG000|Overall Study|Worsening disease|0|||
161967853|NCT03466099|584929204|FG001|Overall Study|Worsening disease|0|||
161967854|NCT03466099|584929205|FG002|Overall Study|Worsening disease|1|||
161750561|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161750562|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161750563|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161750564|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161750565|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161750566|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161750567|NCT02120352|584126689|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
161750568|NCT02120352|584126690|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
161750569|NCT02120352|584126691|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
161750570|NCT02120352|584126692|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
161750571|NCT02120352|584126693|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
161750572|NCT02120352|584126694|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
161750573|NCT02120352|584126695|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
161750574|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
161750575|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
161750576|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
161750577|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
161750578|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
161750579|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
161750580|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
161750581|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161750582|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
161750583|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161750584|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
161750585|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161750586|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161750587|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161750588|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161750589|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
161750590|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
161750591|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161750592|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161750593|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161750594|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161750595|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161750596|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161750597|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
161750598|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
161750599|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161750600|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161750601|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161750602|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161750603|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161750604|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161750605|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
161750606|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161750607|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161750608|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161750609|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
161750610|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
161750611|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
161750612|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
161967855|NCT01165320|584929206|FG000|Overall Study|Clinical adverse experience|2|||
161750613|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
161967856|NCT01165320|584929207|FG001|Overall Study|Clinical adverse experience|1|||
161967857|NCT01165320|584929208|FG002|Overall Study|Clinical adverse experience|0|||
161967858|NCT01165320|584929206|FG000|Overall Study|Laboratory adverse experience|1|||
161750614|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
161750615|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
161750616|NCT02120352|584126689|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161750617|NCT02120352|584126690|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
161750618|NCT02120352|584126691|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161750619|NCT02120352|584126692|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161750620|NCT02120352|584126693|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161750621|NCT02120352|584126694|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161750622|NCT02120352|584126695|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161750623|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
161750624|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
161750625|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
161750626|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
161750627|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
161750628|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
161750629|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
161750630|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161750631|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161750632|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161750633|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161750634|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
161750635|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161750636|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161750637|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
161750638|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
161750639|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
161750640|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
161750641|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
161750642|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
161750643|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
161750644|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
161750645|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
161750646|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
161750647|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
161750648|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
161750649|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
161750650|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
161750651|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
161750652|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
161750653|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
161750654|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
161750655|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
161750656|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
161750657|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
161750658|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161750659|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
161750660|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
161750661|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161750662|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161750663|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161750664|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161750665|NCT02120352|584126689|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
161750666|NCT02120352|584126690|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
161750667|NCT02120352|584126691|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
161750668|NCT02120352|584126692|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
161750669|NCT02120352|584126693|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
161750670|NCT02120352|584126694|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
161750671|NCT02120352|584126695|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
161750672|NCT02120352|584126689|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161750673|NCT02120352|584126690|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161750674|NCT02120352|584126691|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161750675|NCT02120352|584126692|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161750676|NCT02120352|584126693|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161843488|NCT02500641|584470107|FG001|Overall Study|Protocol Violation|2|||
162032671|NCT01933789|585177453|FG003|Overall Study|Death|0|||
161843489|NCT02500641|584470106|FG000|Overall Study|Lost to Follow-up|1|||
161843490|NCT02500641|584470107|FG001|Overall Study|Lost to Follow-up|0|||
161843491|NCT02500641|584470106|FG000|Overall Study|Sponsor decision|1|||
161843492|NCT02500641|584470107|FG001|Overall Study|Sponsor decision|0|||
161843493|NCT02500641|584470106|FG000|Overall Study|Non compliance to study drug|0|||
161843494|NCT02500641|584470107|FG001|Overall Study|Non compliance to study drug|1|||
161843495|NCT01763684|584470108|FG000|Overall Study|Study terminated early due to low enrollment|126|||
161843496|NCT01763684|584470109|FG001|Overall Study|Study terminated early due to low enrollment|127|||
161843497|NCT01763684|584470108|FG000|Overall Study|Study surgery not performed|7|||
161843498|NCT01763684|584470109|FG001|Overall Study|Study surgery not performed|6|||
161843499|NCT02196701|584470110|FG000|Overall Study|Adverse Event|1|||
161843500|NCT02196701|584470110|FG000|Overall Study|Lost to Follow-up|1|||
161843501|NCT02196701|584470110|FG000|Overall Study|Non-adherence to Protocol|1|||
161843502|NCT01408628|584470116|FG000|Consented|Withdrawal by Subject|12|||
161843503|NCT01408628|584470116|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
161843504|NCT01408628|584470116|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
161843505|NCT01408628|584470116|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
161843506|NCT04156620|584470117|FG000|Overall Study|Adverse event - TP 1|5|||
161843507|NCT04156620|584470118|FG001|Overall Study|Adverse event - TP 1|2|||
161843508|NCT04156620|584470117|FG000|Overall Study|Lost to follow-up TP 1|1|||
161843509|NCT04156620|584470118|FG001|Overall Study|Lost to follow-up TP 1|1|||
161843510|NCT04156620|584470117|FG000|Overall Study|Progressive disease - TP 1|0|||
161843511|NCT04156620|584470118|FG001|Overall Study|Progressive disease - TP 1|1|||
161843512|NCT04156620|584470117|FG000|Overall Study|Subject decision - TP 1|3|||
161843513|NCT04156620|584470118|FG001|Overall Study|Subject decision - TP 1|5|||
161843514|NCT04156620|584470117|FG000|Overall Study|Adverse event - TP 2|5|||
161843515|NCT04156620|584470118|FG001|Overall Study|Adverse event - TP 2|6|||
161843516|NCT04156620|584470117|FG000|Overall Study|Death - TP 2|1|||
161843517|NCT04156620|584470118|FG001|Overall Study|Death - TP 2|0|||
161843518|NCT04156620|584470117|FG000|Overall Study|Lost to follow-up - TP 2|5|||
161843519|NCT04156620|584470118|FG001|Overall Study|Lost to follow-up - TP 2|2|||
161843520|NCT04156620|584470117|FG000|Overall Study|Physician decision - TP 2|4|||
161843521|NCT04156620|584470118|FG001|Overall Study|Physician decision - TP 2|2|||
161843522|NCT04156620|584470117|FG000|Overall Study|Pregnancy - TP 2|1|||
161843523|NCT04156620|584470118|FG001|Overall Study|Pregnancy - TP 2|1|||
161843524|NCT04156620|584470117|FG000|Overall Study|Subject decision - TP 2|11|||
161843525|NCT04156620|584470118|FG001|Overall Study|Subject decision - TP 2|9|||
161843526|NCT04156620|584470117|FG000|Overall Study|New therapy for study indication - TP 2|1|||
161843527|NCT04156620|584470118|FG001|Overall Study|New therapy for study indication - TP 2|0|||
161843528|NCT01855074|584470119|FG000|Overall Study|Adverse Event|1|||
161843529|NCT01855074|584470119|FG000|Overall Study|Lost to Follow-up|4|||
161843530|NCT01855074|584470119|FG000|Overall Study|Withdrawal by Subject|8|||
161843531|NCT01855074|584470119|FG000|Overall Study|Started but not treated|1|||
161843532|NCT02991430|584470120|FG000|Treatment Period 1|Adverse Event|1|||
161843533|NCT02991430|584470121|FG001|Treatment Period 1|Adverse Event|0|||
161843534|NCT02991430|584470122|FG002|Treatment Period 1|Adverse Event|2|||
161843535|NCT02991430|584470120|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161843536|NCT02991430|584470121|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161843537|NCT02991430|584470122|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161843538|NCT02991430|584470120|FG000|Treatment Period 2|Study Termination|6|||
161843539|NCT02991430|584470121|FG001|Treatment Period 2|Study Termination|3|||
161843540|NCT02991430|584470122|FG002|Treatment Period 2|Study Termination|3|||
161843541|NCT02991430|584470120|FG000|Treatment Period 2|Lost to Follow-up|0|||
161843542|NCT02991430|584470121|FG001|Treatment Period 2|Lost to Follow-up|0|||
161843543|NCT02991430|584470122|FG002|Treatment Period 2|Lost to Follow-up|1|||
161843544|NCT02991430|584470120|FG000|Post-treatment Observation Period|Study Termination|3|||
161843545|NCT02991430|584470121|FG001|Post-treatment Observation Period|Study Termination|6|||
161843546|NCT02991430|584470122|FG002|Post-treatment Observation Period|Study Termination|5|||
161843547|NCT01150890|584470123|FG000|Overall Study|Other|0|||
161843548|NCT01150890|584470124|FG001|Overall Study|Other|1|||
161967859|NCT01165320|584929207|FG001|Overall Study|Laboratory adverse experience|0|||
161967860|NCT01165320|584929208|FG002|Overall Study|Laboratory adverse experience|0|||
161967861|NCT01165320|584929206|FG000|Overall Study|Lack of Efficacy|0|||
161843549|NCT01150890|584470125|FG002|Overall Study|Other|0|||
161843550|NCT01150890|584470126|FG003|Overall Study|Other|2|||
161843551|NCT01150890|584470123|FG000|Overall Study|Pregnancy|0|||
161843552|NCT01150890|584470124|FG001|Overall Study|Pregnancy|0|||
161843553|NCT01150890|584470125|FG002|Overall Study|Pregnancy|0|||
161843554|NCT01150890|584470126|FG003|Overall Study|Pregnancy|1|||
161843555|NCT01150890|584470123|FG000|Overall Study|Administrative Decision|4|||
161843556|NCT01150890|584470124|FG001|Overall Study|Administrative Decision|4|||
161843557|NCT01150890|584470125|FG002|Overall Study|Administrative Decision|5|||
161843558|NCT01150890|584470126|FG003|Overall Study|Administrative Decision|6|||
161843559|NCT01150890|584470123|FG000|Overall Study|Ineligibility determined|0|||
161843560|NCT01150890|584470124|FG001|Overall Study|Ineligibility determined|1|||
161967862|NCT01165320|584929207|FG001|Overall Study|Lack of Efficacy|2|||
161750677|NCT02120352|584126694|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161750678|NCT02120352|584126695|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
161750679|NCT02427100|584126696|FG000|Overall Study|Lost to Follow-up|0|||
161750680|NCT02427100|584126697|FG001|Overall Study|Lost to Follow-up|2|||
161750681|NCT02186561|584126701|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
161750682|NCT02186561|584126701|FG000|Enrollment|Enrollment Cap Reached|5|||
161750683|NCT02186561|584126701|FG000|Enrollment|Insurance Denial|2|||
161750684|NCT02186561|584126701|FG000|Enrollment|Withdrawal by Subject|2|||
161750685|NCT02186561|584126701|FG000|Enrollment|Investigator Withdrew Consent|1|||
161750686|NCT02186561|584126701|FG000|30-Day Post Index Procedure Visit|Death|1|||
161750687|NCT02186561|584126701|FG000|1- Year Post Index Procedure Visit|Death|1|||
161750688|NCT02186561|584126701|FG000|1- Year Post Index Procedure Visit|Missed|1|||
161750689|NCT00842361|584126702|FG000|Overall Study|Protocol Violation|1|||
161750690|NCT00842361|584126703|FG001|Overall Study|Protocol Violation|0|||
161750691|NCT00842361|584126702|FG000|Overall Study|Unclassified|0|||
161750692|NCT00842361|584126703|FG001|Overall Study|Unclassified|2|||
161750693|NCT01072448|584126706|FG000|Overall Study|Adverse Event|9|||
161750694|NCT01072448|584126707|FG001|Overall Study|Adverse Event|10|||
161750695|NCT01072448|584126706|FG000|Overall Study|Subject withdrew consent|4|||
161750696|NCT01072448|584126707|FG001|Overall Study|Subject withdrew consent|9|||
161750697|NCT01072448|584126706|FG000|Overall Study|Protocol deviation|3|||
161750698|NCT01072448|584126707|FG001|Overall Study|Protocol deviation|4|||
161750699|NCT01072448|584126706|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161750700|NCT01072448|584126707|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161750701|NCT01072448|584126706|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161750702|NCT01072448|584126707|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161750703|NCT01072448|584126706|FG000|Overall Study|Lost to Follow-up|1|||
161750704|NCT01072448|584126707|FG001|Overall Study|Lost to Follow-up|1|||
161750705|NCT01072448|584126706|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161750706|NCT01072448|584126707|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161750707|NCT01072448|584126706|FG000|Overall Study|Death|0|||
161750708|NCT01072448|584126707|FG001|Overall Study|Death|2|||
161750709|NCT00249795|584126708|FG000|Overall Study|Not treated|16|||
161750710|NCT00249795|584126709|FG001|Overall Study|Not treated|14|||
161750711|NCT00249795|584126708|FG000|Overall Study|Symptomatic hypotension|127|||
161750712|NCT00249795|584126709|FG001|Overall Study|Symptomatic hypotension|64|||
161750713|NCT00249795|584126708|FG000|Overall Study|Other Serious Adverse Event|84|||
161750714|NCT00249795|584126709|FG001|Overall Study|Other Serious Adverse Event|93|||
161750715|NCT00249795|584126708|FG000|Overall Study|Qualifying condition not present|26|||
161750716|NCT00249795|584126709|FG001|Overall Study|Qualifying condition not present|29|||
161750717|NCT00249795|584126708|FG000|Overall Study|Withdrawal by Subject|678|||
161750718|NCT00249795|584126709|FG001|Overall Study|Withdrawal by Subject|742|||
161750719|NCT00249795|584126708|FG000|Overall Study|Thromboembolic / outcome event|39|||
161750720|NCT00249795|584126709|FG001|Overall Study|Thromboembolic / outcome event|45|||
161750721|NCT00249795|584126708|FG000|Overall Study|Oral anticoagulant required|2|||
161750722|NCT00249795|584126709|FG001|Overall Study|Oral anticoagulant required|0|||
161750723|NCT00249795|584126708|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
161750724|NCT00249795|584126709|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
161750725|NCT00249795|584126708|FG000|Overall Study|Non-compliance|71|||
161750726|NCT00249795|584126709|FG001|Overall Study|Non-compliance|69|||
161750727|NCT00249795|584126708|FG000|Overall Study|Study drug intolerance|3|||
161750728|NCT00249795|584126709|FG001|Overall Study|Study drug intolerance|3|||
161750729|NCT00249795|584126708|FG000|Overall Study|Other adverse events (non-serious)|188|||
161750730|NCT00249795|584126709|FG001|Overall Study|Other adverse events (non-serious)|159|||
161750731|NCT00249795|584126708|FG000|Overall Study|Physician withdrew consent|71|||
161750732|NCT00249795|584126709|FG001|Overall Study|Physician withdrew consent|63|||
161750733|NCT00249795|584126708|FG000|Overall Study|Surgery / procedure|4|||
161750734|NCT00249795|584126709|FG001|Overall Study|Surgery / procedure|5|||
161750735|NCT00249795|584126708|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
161750736|NCT00249795|584126709|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
161750737|NCT00249795|584126708|FG000|Overall Study|Lightheadedness / dizziness|15|||
161750738|NCT00249795|584126709|FG001|Overall Study|Lightheadedness / dizziness|11|||
161750739|NCT00249795|584126708|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
161750740|NCT00249795|584126709|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
161750741|NCT00249795|584126708|FG000|Overall Study|Other contraindicated medication|1|||
161750742|NCT00249795|584126709|FG001|Overall Study|Other contraindicated medication|1|||
161750743|NCT00249795|584126708|FG000|Overall Study|Event related to cardiac condition|17|||
161750744|NCT00249795|584126709|FG001|Overall Study|Event related to cardiac condition|16|||
161750745|NCT00249795|584126708|FG000|Overall Study|Patient not wish to continue after May08|4|||
161750746|NCT00249795|584126709|FG001|Overall Study|Patient not wish to continue after May08|6|||
161750747|NCT00249795|584126708|FG000|Overall Study|Site not agree to continue after May08|1|||
161750748|NCT00249795|584126709|FG001|Overall Study|Site not agree to continue after May08|1|||
161750749|NCT00249795|584126708|FG000|Overall Study|Lost to Follow-up|0|||
161750750|NCT00249795|584126709|FG001|Overall Study|Lost to Follow-up|2|||
161750751|NCT00249795|584126708|FG000|Overall Study|Missing|0|||
161967863|NCT01165320|584929208|FG002|Overall Study|Lack of Efficacy|0|||
161750752|NCT00249795|584126709|FG001|Overall Study|Missing|1|||
161750753|NCT01814826|584126714|FG000|Overall Study|Other|3|||
161750754|NCT01814826|584126715|FG001|Overall Study|Other|5|||
161750755|NCT01814826|584126716|FG002|Overall Study|Other|0|||
161750756|NCT01814826|584126714|FG000|Overall Study|Death|29|||
161750757|NCT01814826|584126715|FG001|Overall Study|Death|24|||
161750758|NCT01814826|584126716|FG002|Overall Study|Death|3|||
161750759|NCT02917629|584126717|FG000|Overall Study|Withdrawal by Subject|0|||
161750760|NCT02917629|584126718|FG001|Overall Study|Withdrawal by Subject|1|||
161750761|NCT03271307|584126719|FG000|Overall Study|Lost to Follow-up|0|||
161750762|NCT03271307|584126720|FG001|Overall Study|Lost to Follow-up|0|||
161750763|NCT03271307|584126721|FG002|Overall Study|Lost to Follow-up|0|||
161750764|NCT03271307|584126722|FG003|Overall Study|Lost to Follow-up|28|||
161750765|NCT03271307|584126723|FG004|Overall Study|Lost to Follow-up|91|||
161750766|NCT01042938|584126724|FG000|Overall Study|Withdrawal by Subject|1|||
161750767|NCT01042938|584126725|FG001|Overall Study|Withdrawal by Subject|1|||
161750768|NCT01042938|584126724|FG000|Overall Study|Protocol Violation|1|||
161750769|NCT01042938|584126725|FG001|Overall Study|Protocol Violation|1|||
161750770|NCT01042938|584126724|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
161750771|NCT01042938|584126725|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
161750772|NCT03136484|584126726|FG000|Overall Study|Withdrawal by Subject|19|||
161750773|NCT03136484|584126727|FG001|Overall Study|Withdrawal by Subject|14|||
161750774|NCT03136484|584126726|FG000|Overall Study|Lost to Follow-up|7|||
161750775|NCT03136484|584126727|FG001|Overall Study|Lost to Follow-up|8|||
161750776|NCT03136484|584126726|FG000|Overall Study|Death|1|||
161750777|NCT03136484|584126727|FG001|Overall Study|Death|0|||
161750778|NCT01601470|584126730|FG000|Period 2 - LCZ696|Physician Decision|1|||
161750779|NCT03032510|584126731|FG000|Overall Study|Adverse Event|5|||
161750780|NCT03032510|584126732|FG001|Overall Study|Adverse Event|2|||
161750781|NCT03032510|584126731|FG000|Overall Study|Lost to Follow-up|8|||
161750782|NCT03032510|584126732|FG001|Overall Study|Lost to Follow-up|7|||
161750783|NCT03032510|584126731|FG000|Overall Study|Withdrawal by Subject|8|||
161750784|NCT03032510|584126732|FG001|Overall Study|Withdrawal by Subject|7|||
161750785|NCT03032510|584126731|FG000|Overall Study|Subject noncompliance|4|||
161750786|NCT03032510|584126732|FG001|Overall Study|Subject noncompliance|2|||
161750787|NCT03032510|584126731|FG000|Overall Study|Physician Decision|2|||
161750788|NCT03032510|584126732|FG001|Overall Study|Physician Decision|0|||
161750789|NCT01203787|584126733|FG000|Overall Study|Death|12|||
161750790|NCT01203787|584126734|FG001|Overall Study|Death|10|||
161750791|NCT01203787|584126733|FG000|Overall Study|Withdrawal by Subject|6|||
161750792|NCT01203787|584126734|FG001|Overall Study|Withdrawal by Subject|2|||
161750793|NCT01203787|584126733|FG000|Overall Study|Lost to Follow-up|2|||
161750794|NCT01203787|584126734|FG001|Overall Study|Lost to Follow-up|0|||
161750795|NCT01203787|584126733|FG000|Overall Study|Adverse Event|11|||
161750796|NCT01203787|584126734|FG001|Overall Study|Adverse Event|15|||
161750797|NCT00431496|584126737|FG000|Overall Study|Adverse Event|3|||
161750798|NCT00431496|584126737|FG000|Overall Study|Lost to Follow-up|1|||
161750799|NCT00431496|584126737|FG000|Overall Study|Withdrawal by Subject|2|||
161750800|NCT00431496|584126737|FG000|Overall Study|Protocol-specified criteria|5|||
161750801|NCT02999191|584126738|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
161750802|NCT02999191|584126739|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
161750803|NCT02999191|584126740|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
161750804|NCT01570309|584126741|FG000|Overall Study|Withdrawal by Subject|3|||
161750805|NCT01570309|584126742|FG001|Overall Study|Withdrawal by Subject|3|||
161750806|NCT04095793|584126743|FG000|Overall Study|Adverse Event|3|||
161750807|NCT04095793|584126743|FG000|Overall Study|Study Terminated by Sponsor|103|||
161750808|NCT04095793|584126743|FG000|Overall Study|Withdrawal by Subject|4|||
161750809|NCT03619837|584126744|FG000|Screening|received organs from HCV-negative donors|47|||
161750810|NCT03619837|584126744|FG000|Screening|died on the wait-list|2|||
161750811|NCT03619837|584126744|FG000|Screening|remained on the wait list|40|||
161750812|NCT03619837|584126744|FG000|Screening|didn't meet eligibility criteria|3|||
161750813|NCT03619837|584126744|FG000|Screening|withdrew consent|2|||
161750814|NCT03619837|584126744|FG000|Screening|never listed for HCV-viremic donor|1|||
161750815|NCT03619837|584126744|FG000|Screening|developed exclusion criteria|2|||
161750816|NCT03619837|584126744|FG000|Screening|excluded by the investigator due to non-compliance|1|||
161750817|NCT01602549|584126745|FG000|Overall Study|Protocol Violation|0|||
161750818|NCT01602549|584126746|FG001|Overall Study|Protocol Violation|1|||
161750819|NCT01602549|584126745|FG000|Overall Study|Withdrawal by Subject|1|||
161750820|NCT01602549|584126746|FG001|Overall Study|Withdrawal by Subject|0|||
161750821|NCT03627494|584126749|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
161750822|NCT03627494|584126750|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750823|NCT03627494|584126751|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
161750824|NCT03627494|584126752|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750825|NCT03627494|584126753|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750826|NCT03627494|584126754|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750827|NCT03627494|584126755|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750828|NCT03627494|584126756|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750829|NCT03627494|584126757|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750830|NCT03627494|584126758|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750831|NCT03627494|584126759|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750832|NCT03627494|584126760|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
161750833|NCT03627494|584126749|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750834|NCT03627494|584126750|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750835|NCT03627494|584126751|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750836|NCT03627494|584126752|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750837|NCT03627494|584126753|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750838|NCT03627494|584126754|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750839|NCT03627494|584126755|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750840|NCT03627494|584126756|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750841|NCT03627494|584126757|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
161750842|NCT03627494|584126758|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750843|NCT03627494|584126759|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750844|NCT03627494|584126760|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
161750845|NCT03627494|584126749|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750846|NCT03627494|584126750|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750847|NCT03627494|584126751|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750848|NCT03627494|584126752|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750849|NCT03627494|584126753|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750850|NCT03627494|584126754|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750851|NCT03627494|584126755|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750852|NCT03627494|584126756|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750853|NCT03627494|584126757|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750854|NCT03627494|584126758|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
161750855|NCT03627494|584126759|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
161750856|NCT03627494|584126760|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
161843561|NCT01150890|584470125|FG002|Overall Study|Ineligibility determined|0|||
161843562|NCT01150890|584470126|FG003|Overall Study|Ineligibility determined|0|||
161843563|NCT01150890|584470123|FG000|Overall Study|Adverse Event|0|||
161843564|NCT01150890|584470124|FG001|Overall Study|Adverse Event|0|||
161843565|NCT01150890|584470125|FG002|Overall Study|Adverse Event|2|||
161843566|NCT01150890|584470126|FG003|Overall Study|Adverse Event|0|||
161843567|NCT01150890|584470123|FG000|Overall Study|Withdrawal by Subject|0|||
161843568|NCT01150890|584470124|FG001|Overall Study|Withdrawal by Subject|0|||
161843569|NCT01150890|584470125|FG002|Overall Study|Withdrawal by Subject|2|||
161843570|NCT01150890|584470126|FG003|Overall Study|Withdrawal by Subject|1|||
161843571|NCT01150890|584470123|FG000|Overall Study|Disease progression|0|||
161843572|NCT01150890|584470124|FG001|Overall Study|Disease progression|7|||
161843573|NCT01150890|584470125|FG002|Overall Study|Disease progression|3|||
161843574|NCT01150890|584470126|FG003|Overall Study|Disease progression|7|||
161843575|NCT01672970|584470127|FG000|Overall Study|Lack of Efficacy|12|||
161843576|NCT01672970|584470127|FG000|Overall Study|Adverse Event|18|||
161843577|NCT01672970|584470127|FG000|Overall Study|Withdrawal by Subject|2|||
161843578|NCT01672970|584470127|FG000|Overall Study|Lost to Follow-up|5|||
161843579|NCT01672970|584470127|FG000|Overall Study|Other|9|||
161843580|NCT01672970|584470127|FG000|Overall Study|Enrolled but not treated|1|||
161843581|NCT03118570|584470128|FG000|Overall Study|Adverse Event|2|||
161843582|NCT03118570|584470129|FG001|Overall Study|Adverse Event|0|||
161843583|NCT03118570|584470130|FG002|Overall Study|Adverse Event|0|||
161843584|NCT03118570|584470131|FG003|Overall Study|Adverse Event|0|||
161843585|NCT03118570|584470132|FG004|Overall Study|Adverse Event|3|||
161843586|NCT03118570|584470128|FG000|Overall Study|Withdrawal by Subject|0|||
161843587|NCT03118570|584470129|FG001|Overall Study|Withdrawal by Subject|1|||
161843588|NCT03118570|584470130|FG002|Overall Study|Withdrawal by Subject|4|||
161843589|NCT03118570|584470131|FG003|Overall Study|Withdrawal by Subject|0|||
161843590|NCT03118570|584470132|FG004|Overall Study|Withdrawal by Subject|1|||
161843591|NCT03118570|584470128|FG000|Overall Study|Lost to Follow-up|2|||
161843592|NCT03118570|584470129|FG001|Overall Study|Lost to Follow-up|3|||
161843593|NCT03118570|584470130|FG002|Overall Study|Lost to Follow-up|1|||
161843594|NCT03118570|584470131|FG003|Overall Study|Lost to Follow-up|0|||
161843595|NCT03118570|584470132|FG004|Overall Study|Lost to Follow-up|1|||
161843596|NCT03118570|584470128|FG000|Overall Study|Other, Not Specified|1|||
161843597|NCT03118570|584470129|FG001|Overall Study|Other, Not Specified|3|||
161843598|NCT03118570|584470130|FG002|Overall Study|Other, Not Specified|0|||
161843599|NCT03118570|584470131|FG003|Overall Study|Other, Not Specified|0|||
161843600|NCT03118570|584470132|FG004|Overall Study|Other, Not Specified|0|||
161843601|NCT02132754|584470133|FG000|Overall Study|Adverse Event|0|||
161843602|NCT02132754|584470134|FG001|Overall Study|Adverse Event|0|||
161843603|NCT02132754|584470135|FG002|Overall Study|Adverse Event|0|||
161843604|NCT02132754|584470136|FG003|Overall Study|Adverse Event|0|||
161843605|NCT02132754|584470137|FG004|Overall Study|Adverse Event|0|||
161843606|NCT02132754|584470138|FG005|Overall Study|Adverse Event|0|||
161843607|NCT02132754|584470139|FG006|Overall Study|Adverse Event|0|||
161843608|NCT02132754|584470140|FG007|Overall Study|Adverse Event|0|||
161843609|NCT02132754|584470141|FG008|Overall Study|Adverse Event|0|||
161843610|NCT02132754|584470142|FG009|Overall Study|Adverse Event|0|||
161750857|NCT01432756|584128355|FG000|Overall Study|Lost to Follow-up|1|||
161750858|NCT01432756|584128356|FG001|Overall Study|Lost to Follow-up|0|||
161750859|NCT01432756|584128357|FG002|Overall Study|Lost to Follow-up|2|||
161750860|NCT01432756|584128358|FG003|Overall Study|Lost to Follow-up|1|||
161750861|NCT02712008|584128359|FG000|Baseline (Day 1) up to Week 12|Death|3|||
161750862|NCT02712008|584128360|FG001|Baseline (Day 1) up to Week 12|Death|0|||
161750863|NCT02712008|584128361|FG002|Baseline (Day 1) up to Week 12|Death|0|||
161750864|NCT02712008|584128362|FG003|Baseline (Day 1) up to Week 12|Death|0|||
161750865|NCT02712008|584128363|FG004|Baseline (Day 1) up to Week 12|Death|0|||
161750866|NCT02712008|584128364|FG005|Baseline (Day 1) up to Week 12|Death|0|||
161750867|NCT02712008|584128365|FG006|Baseline (Day 1) up to Week 12|Death|0|||
161750868|NCT02712008|584128366|FG007|Baseline (Day 1) up to Week 12|Death|0|||
161750869|NCT02712008|584128359|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161750870|NCT02712008|584128360|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
161750871|NCT02712008|584128361|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
161750872|NCT02712008|584128362|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161750873|NCT02712008|584128363|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161750874|NCT02712008|584128364|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161750875|NCT02712008|584128365|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161750876|NCT02712008|584128366|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161750877|NCT02712008|584128359|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
161750878|NCT02712008|584128360|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161750879|NCT02712008|584128361|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
161750880|NCT02712008|584128362|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161750881|NCT02712008|584128363|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161750882|NCT02712008|584128364|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161750883|NCT02712008|584128365|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161750884|NCT02712008|584128366|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161750885|NCT02712008|584128359|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750886|NCT02712008|584128360|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750887|NCT02712008|584128361|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
161750888|NCT02712008|584128362|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750889|NCT02712008|584128363|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750890|NCT02712008|584128364|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750891|NCT02712008|584128365|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750892|NCT02712008|584128366|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161750893|NCT02712008|584128359|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750894|NCT02712008|584128360|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
161750895|NCT02712008|584128361|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750896|NCT02712008|584128362|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750897|NCT02712008|584128363|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750898|NCT02712008|584128364|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750899|NCT02712008|584128365|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750900|NCT02712008|584128366|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161750901|NCT02712008|584128359|FG000|From Week 12 up to Week 36|Adverse Event|0|||
161750902|NCT02712008|584128360|FG001|From Week 12 up to Week 36|Adverse Event|0|||
161750903|NCT02712008|584128361|FG002|From Week 12 up to Week 36|Adverse Event|0|||
161750904|NCT02712008|584128362|FG003|From Week 12 up to Week 36|Adverse Event|0|||
161750905|NCT02712008|584128363|FG004|From Week 12 up to Week 36|Adverse Event|1|||
161750906|NCT02712008|584128364|FG005|From Week 12 up to Week 36|Adverse Event|0|||
161750907|NCT02712008|584128365|FG006|From Week 12 up to Week 36|Adverse Event|0|||
161750908|NCT02712008|584128366|FG007|From Week 12 up to Week 36|Adverse Event|2|||
161750909|NCT02712008|584128359|FG000|From Week 12 up to Week 36|Death|1|||
161750910|NCT02712008|584128360|FG001|From Week 12 up to Week 36|Death|0|||
161750911|NCT02712008|584128361|FG002|From Week 12 up to Week 36|Death|0|||
161750912|NCT02712008|584128362|FG003|From Week 12 up to Week 36|Death|0|||
161750913|NCT02712008|584128363|FG004|From Week 12 up to Week 36|Death|0|||
161750914|NCT02712008|584128364|FG005|From Week 12 up to Week 36|Death|0|||
161750915|NCT02712008|584128365|FG006|From Week 12 up to Week 36|Death|1|||
161750916|NCT02712008|584128366|FG007|From Week 12 up to Week 36|Death|0|||
161750917|NCT02712008|584128359|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
161750918|NCT02712008|584128360|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
161750919|NCT02712008|584128361|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
161843611|NCT02132754|584470143|FG010|Overall Study|Adverse Event|0|||
161843612|NCT02132754|584470144|FG011|Overall Study|Adverse Event|0|||
161843613|NCT02132754|584470145|FG012|Overall Study|Adverse Event|0|||
161843614|NCT02132754|584470146|FG013|Overall Study|Adverse Event|0|||
161843615|NCT02132754|584470147|FG014|Overall Study|Adverse Event|0|||
161843616|NCT02132754|584470148|FG015|Overall Study|Adverse Event|0|||
161843617|NCT02132754|584470149|FG016|Overall Study|Adverse Event|0|||
161750920|NCT02712008|584128362|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
161750921|NCT02712008|584128363|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
161750922|NCT02712008|584128364|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
161967864|NCT01165320|584929206|FG000|Overall Study|Reason unknown|0|||
161967865|NCT01165320|584929207|FG001|Overall Study|Reason unknown|1|||
161967866|NCT01165320|584929208|FG002|Overall Study|Reason unknown|0|||
161967867|NCT02075047|584929214|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
161967868|NCT02075047|584929215|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
161967869|NCT02075047|584929214|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
161967870|NCT02075047|584929215|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
162032672|NCT01933789|585177454|FG004|Overall Study|Death|21|||
162032673|NCT01933789|585177455|FG005|Overall Study|Death|32|||
161750923|NCT02712008|584128365|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
161750924|NCT02712008|584128366|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
161750925|NCT02712008|584128359|FG000|From Week 12 up to Week 36|Physician Decision|0|||
161750926|NCT02712008|584128360|FG001|From Week 12 up to Week 36|Physician Decision|0|||
161750927|NCT02712008|584128361|FG002|From Week 12 up to Week 36|Physician Decision|0|||
161750928|NCT02712008|584128362|FG003|From Week 12 up to Week 36|Physician Decision|1|||
161750929|NCT02712008|584128363|FG004|From Week 12 up to Week 36|Physician Decision|1|||
161750930|NCT02712008|584128364|FG005|From Week 12 up to Week 36|Physician Decision|0|||
161750931|NCT02712008|584128365|FG006|From Week 12 up to Week 36|Physician Decision|0|||
161750932|NCT02712008|584128366|FG007|From Week 12 up to Week 36|Physician Decision|0|||
161750933|NCT02712008|584128359|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161750934|NCT02712008|584128360|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161750935|NCT02712008|584128361|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161750936|NCT02712008|584128362|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161750937|NCT02712008|584128363|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161750938|NCT02712008|584128364|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161750939|NCT02712008|584128365|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
161750940|NCT02712008|584128366|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
161750941|NCT04483544|584128367|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
161750942|NCT04483544|584128367|FG000|Post-Treatment|Admitted to hospice|2|||
161750943|NCT04483544|584128367|FG000|Post-Treatment|Study terminated|3|||
161750944|NCT01131078|584128368|FG000|Overall Study|Adverse Event|22|||
161750945|NCT01131078|584128369|FG001|Overall Study|Adverse Event|12|||
161750946|NCT01131078|584128370|FG002|Overall Study|Adverse Event|17|||
161750947|NCT01131078|584128368|FG000|Overall Study|Progressive Disease|58|||
161750948|NCT01131078|584128369|FG001|Overall Study|Progressive Disease|77|||
161750949|NCT01131078|584128370|FG002|Overall Study|Progressive Disease|71|||
161750950|NCT01131078|584128368|FG000|Overall Study|Protocol Violation|1|||
161750951|NCT01131078|584128369|FG001|Overall Study|Protocol Violation|0|||
161750952|NCT01131078|584128370|FG002|Overall Study|Protocol Violation|0|||
161750953|NCT01131078|584128368|FG000|Overall Study|Lost to Follow-up|1|||
161750954|NCT01131078|584128369|FG001|Overall Study|Lost to Follow-up|1|||
161750955|NCT01131078|584128370|FG002|Overall Study|Lost to Follow-up|1|||
161750956|NCT01131078|584128368|FG000|Overall Study|Withdrawal by Subject|2|||
161750957|NCT01131078|584128369|FG001|Overall Study|Withdrawal by Subject|4|||
161750958|NCT01131078|584128370|FG002|Overall Study|Withdrawal by Subject|3|||
161750959|NCT01131078|584128368|FG000|Overall Study|Non-compliance|3|||
161750960|NCT01131078|584128369|FG001|Overall Study|Non-compliance|0|||
161750961|NCT01131078|584128370|FG002|Overall Study|Non-compliance|0|||
161750962|NCT01131078|584128368|FG000|Overall Study|Physician Decision|10|||
161750963|NCT01131078|584128369|FG001|Overall Study|Physician Decision|6|||
161750964|NCT01131078|584128370|FG002|Overall Study|Physician Decision|8|||
161750965|NCT01131078|584128368|FG000|Overall Study|Death|4|||
161750966|NCT01131078|584128369|FG001|Overall Study|Death|0|||
161750967|NCT01131078|584128370|FG002|Overall Study|Death|2|||
161750968|NCT01131078|584128368|FG000|Overall Study|Other|0|||
161750969|NCT01131078|584128369|FG001|Overall Study|Other|1|||
161750970|NCT01131078|584128370|FG002|Overall Study|Other|0|||
161750971|NCT00364351|584128371|FG000|Overall Study|Adverse Event|90|||
161750972|NCT00364351|584128372|FG001|Overall Study|Adverse Event|44|||
161750973|NCT00364351|584128371|FG000|Overall Study|Condition under investigation worsened|469|||
161750974|NCT00364351|584128372|FG001|Overall Study|Condition under investigation worsened|497|||
161750975|NCT00364351|584128371|FG000|Overall Study|Prohibited concomitant medication|0|||
161750976|NCT00364351|584128372|FG001|Overall Study|Prohibited concomitant medication|2|||
161750977|NCT00364351|584128371|FG000|Overall Study|Lost to Follow-up|1|||
161750978|NCT00364351|584128372|FG001|Overall Study|Lost to Follow-up|1|||
161750979|NCT00364351|584128371|FG000|Overall Study|Withdrawal by Subject|30|||
161750980|NCT00364351|584128372|FG001|Overall Study|Withdrawal by Subject|29|||
161843618|NCT02132754|584470150|FG017|Overall Study|Adverse Event|1|||
162032674|NCT01933789|585177456|FG006|Overall Study|Death|0|||
161750981|NCT00364351|584128371|FG000|Overall Study|Incorrect enrollment|1|||
161750982|NCT00364351|584128372|FG001|Overall Study|Incorrect enrollment|1|||
161750983|NCT00364351|584128371|FG000|Overall Study|Sponsor decision|1|||
161750984|NCT00364351|584128372|FG001|Overall Study|Sponsor decision|0|||
161750985|NCT00364351|584128371|FG000|Overall Study|Poor treatment compliance|0|||
161750986|NCT00364351|584128372|FG001|Overall Study|Poor treatment compliance|3|||
161967871|NCT02075047|584929214|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
162032675|NCT01933789|585177457|FG007|Overall Study|Death|0|||
161843619|NCT02132754|584470151|FG018|Overall Study|Adverse Event|0|||
161843620|NCT02132754|584470152|FG019|Overall Study|Adverse Event|0|||
161843621|NCT02132754|584470153|FG020|Overall Study|Adverse Event|0|||
161843622|NCT02132754|584470154|FG021|Overall Study|Adverse Event|0|||
161843623|NCT02132754|584470155|FG022|Overall Study|Adverse Event|0|||
161843624|NCT02132754|584470156|FG023|Overall Study|Adverse Event|0|||
161843625|NCT02132754|584470157|FG024|Overall Study|Adverse Event|0|||
161843626|NCT02132754|584470158|FG025|Overall Study|Adverse Event|1|||
161843627|NCT02132754|584470159|FG026|Overall Study|Adverse Event|1|||
161843628|NCT02132754|584470160|FG027|Overall Study|Adverse Event|0|||
161843629|NCT02132754|584470161|FG028|Overall Study|Adverse Event|0|||
161843630|NCT02132754|584470162|FG029|Overall Study|Adverse Event|0|||
161843631|NCT02132754|584470163|FG030|Overall Study|Adverse Event|1|||
161967872|NCT02075047|584929215|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
161967873|NCT02075047|584929214|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
161967874|NCT02075047|584929215|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
161967875|NCT02075047|584929214|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
161967876|NCT02075047|584929215|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
161967877|NCT02075047|584929214|FG000|Treatment Phase (4 Weeks)|Other|1|||
161843632|NCT02132754|584470164|FG031|Overall Study|Adverse Event|0|||
161843633|NCT02132754|584470165|FG032|Overall Study|Adverse Event|1|||
161843634|NCT02132754|584470166|FG033|Overall Study|Adverse Event|1|||
161843635|NCT02132754|584470133|FG000|Overall Study|Clinical Progression|0|||
161843636|NCT02132754|584470134|FG001|Overall Study|Clinical Progression|0|||
161843637|NCT02132754|584470135|FG002|Overall Study|Clinical Progression|0|||
161843638|NCT02132754|584470136|FG003|Overall Study|Clinical Progression|0|||
161843639|NCT02132754|584470137|FG004|Overall Study|Clinical Progression|0|||
161843640|NCT02132754|584470138|FG005|Overall Study|Clinical Progression|0|||
161843641|NCT02132754|584470139|FG006|Overall Study|Clinical Progression|0|||
161843642|NCT02132754|584470140|FG007|Overall Study|Clinical Progression|0|||
161843643|NCT02132754|584470141|FG008|Overall Study|Clinical Progression|0|||
161843644|NCT02132754|584470142|FG009|Overall Study|Clinical Progression|1|||
161843645|NCT02132754|584470143|FG010|Overall Study|Clinical Progression|0|||
161843646|NCT02132754|584470144|FG011|Overall Study|Clinical Progression|0|||
161843647|NCT02132754|584470145|FG012|Overall Study|Clinical Progression|0|||
161843648|NCT02132754|584470146|FG013|Overall Study|Clinical Progression|0|||
161843649|NCT02132754|584470147|FG014|Overall Study|Clinical Progression|0|||
161843650|NCT02132754|584470148|FG015|Overall Study|Clinical Progression|0|||
161843651|NCT02132754|584470149|FG016|Overall Study|Clinical Progression|1|||
161843652|NCT02132754|584470150|FG017|Overall Study|Clinical Progression|1|||
161843653|NCT02132754|584470151|FG018|Overall Study|Clinical Progression|0|||
161843654|NCT02132754|584470152|FG019|Overall Study|Clinical Progression|1|||
161843655|NCT02132754|584470153|FG020|Overall Study|Clinical Progression|0|||
161843656|NCT02132754|584470154|FG021|Overall Study|Clinical Progression|0|||
161843657|NCT02132754|584470155|FG022|Overall Study|Clinical Progression|1|||
161843658|NCT02132754|584470156|FG023|Overall Study|Clinical Progression|0|||
161843659|NCT02132754|584470157|FG024|Overall Study|Clinical Progression|1|||
161843660|NCT02132754|584470158|FG025|Overall Study|Clinical Progression|1|||
161843661|NCT02132754|584470159|FG026|Overall Study|Clinical Progression|0|||
161843662|NCT02132754|584470160|FG027|Overall Study|Clinical Progression|1|||
161843663|NCT02132754|584470161|FG028|Overall Study|Clinical Progression|1|||
161843664|NCT02132754|584470162|FG029|Overall Study|Clinical Progression|0|||
161843665|NCT02132754|584470163|FG030|Overall Study|Clinical Progression|1|||
161843666|NCT02132754|584470164|FG031|Overall Study|Clinical Progression|0|||
161843667|NCT02132754|584470165|FG032|Overall Study|Clinical Progression|0|||
161843668|NCT02132754|584470166|FG033|Overall Study|Clinical Progression|2|||
161843669|NCT02132754|584470133|FG000|Overall Study|Death|0|||
161843670|NCT02132754|584470134|FG001|Overall Study|Death|0|||
161843671|NCT02132754|584470135|FG002|Overall Study|Death|0|||
161843672|NCT02132754|584470136|FG003|Overall Study|Death|0|||
161843673|NCT02132754|584470137|FG004|Overall Study|Death|0|||
161843674|NCT02132754|584470138|FG005|Overall Study|Death|0|||
161843675|NCT02132754|584470139|FG006|Overall Study|Death|0|||
161967878|NCT02075047|584929215|FG001|Treatment Phase (4 Weeks)|Other|1|||
161967879|NCT02075047|584929214|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
162032676|NCT01933789|585177458|FG008|Overall Study|Death|0|||
161967880|NCT02075047|584929215|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
161843676|NCT02132754|584470140|FG007|Overall Study|Death|0|||
161843677|NCT02132754|584470141|FG008|Overall Study|Death|0|||
161843678|NCT02132754|584470142|FG009|Overall Study|Death|0|||
161843679|NCT02132754|584470143|FG010|Overall Study|Death|0|||
161843680|NCT02132754|584470144|FG011|Overall Study|Death|0|||
161843681|NCT02132754|584470145|FG012|Overall Study|Death|0|||
161843682|NCT02132754|584470146|FG013|Overall Study|Death|0|||
161843683|NCT02132754|584470147|FG014|Overall Study|Death|0|||
161843684|NCT02132754|584470148|FG015|Overall Study|Death|1|||
161843685|NCT02132754|584470149|FG016|Overall Study|Death|0|||
161843686|NCT02132754|584470150|FG017|Overall Study|Death|0|||
161843687|NCT02132754|584470151|FG018|Overall Study|Death|0|||
161843688|NCT02132754|584470152|FG019|Overall Study|Death|1|||
161843689|NCT02132754|584470153|FG020|Overall Study|Death|0|||
161843690|NCT02132754|584470154|FG021|Overall Study|Death|1|||
161843691|NCT02132754|584470155|FG022|Overall Study|Death|0|||
161843692|NCT02132754|584470156|FG023|Overall Study|Death|0|||
161843693|NCT02132754|584470157|FG024|Overall Study|Death|0|||
161843694|NCT02132754|584470158|FG025|Overall Study|Death|0|||
161843695|NCT02132754|584470159|FG026|Overall Study|Death|1|||
161843696|NCT02132754|584470160|FG027|Overall Study|Death|0|||
161843697|NCT02132754|584470161|FG028|Overall Study|Death|0|||
161843698|NCT02132754|584470162|FG029|Overall Study|Death|0|||
161843699|NCT02132754|584470163|FG030|Overall Study|Death|0|||
161843700|NCT02132754|584470164|FG031|Overall Study|Death|0|||
161967881|NCT02075047|584929214|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
161967882|NCT02075047|584929215|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
161967883|NCT02075047|584929214|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
161967884|NCT02075047|584929215|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
161967885|NCT02075047|584929214|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
161967886|NCT02075047|584929215|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
161967887|NCT02075047|584929214|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
161843701|NCT02132754|584470165|FG032|Overall Study|Death|0|||
161843702|NCT02132754|584470166|FG033|Overall Study|Death|2|||
161843703|NCT02132754|584470133|FG000|Overall Study|Excluded Medication|0|||
161843704|NCT02132754|584470134|FG001|Overall Study|Excluded Medication|0|||
161843705|NCT02132754|584470135|FG002|Overall Study|Excluded Medication|0|||
161843706|NCT02132754|584470136|FG003|Overall Study|Excluded Medication|0|||
161843707|NCT02132754|584470137|FG004|Overall Study|Excluded Medication|0|||
161843708|NCT02132754|584470138|FG005|Overall Study|Excluded Medication|0|||
161843709|NCT02132754|584470139|FG006|Overall Study|Excluded Medication|0|||
161843710|NCT02132754|584470140|FG007|Overall Study|Excluded Medication|0|||
161843711|NCT02132754|584470141|FG008|Overall Study|Excluded Medication|0|||
161843712|NCT02132754|584470142|FG009|Overall Study|Excluded Medication|0|||
161843713|NCT02132754|584470143|FG010|Overall Study|Excluded Medication|0|||
161843714|NCT02132754|584470144|FG011|Overall Study|Excluded Medication|0|||
161843715|NCT02132754|584470145|FG012|Overall Study|Excluded Medication|0|||
161843716|NCT02132754|584470146|FG013|Overall Study|Excluded Medication|0|||
161843717|NCT02132754|584470147|FG014|Overall Study|Excluded Medication|0|||
161843718|NCT02132754|584470148|FG015|Overall Study|Excluded Medication|0|||
161843719|NCT02132754|584470149|FG016|Overall Study|Excluded Medication|0|||
161843720|NCT02132754|584470150|FG017|Overall Study|Excluded Medication|0|||
161843721|NCT02132754|584470151|FG018|Overall Study|Excluded Medication|0|||
161843722|NCT02132754|584470152|FG019|Overall Study|Excluded Medication|0|||
161843723|NCT02132754|584470153|FG020|Overall Study|Excluded Medication|1|||
161843724|NCT02132754|584470154|FG021|Overall Study|Excluded Medication|0|||
161843725|NCT02132754|584470155|FG022|Overall Study|Excluded Medication|0|||
161843726|NCT02132754|584470156|FG023|Overall Study|Excluded Medication|0|||
161843727|NCT02132754|584470157|FG024|Overall Study|Excluded Medication|0|||
161843728|NCT02132754|584470158|FG025|Overall Study|Excluded Medication|0|||
161843729|NCT02132754|584470159|FG026|Overall Study|Excluded Medication|0|||
161843730|NCT02132754|584470160|FG027|Overall Study|Excluded Medication|0|||
161843731|NCT02132754|584470161|FG028|Overall Study|Excluded Medication|0|||
161843732|NCT02132754|584470162|FG029|Overall Study|Excluded Medication|0|||
161843733|NCT02132754|584470163|FG030|Overall Study|Excluded Medication|0|||
161843734|NCT02132754|584470164|FG031|Overall Study|Excluded Medication|0|||
161843735|NCT02132754|584470165|FG032|Overall Study|Excluded Medication|0|||
161843736|NCT02132754|584470166|FG033|Overall Study|Excluded Medication|1|||
161843737|NCT02132754|584470133|FG000|Overall Study|Physician Decision|0|||
161843738|NCT02132754|584470134|FG001|Overall Study|Physician Decision|0|||
161843739|NCT02132754|584470135|FG002|Overall Study|Physician Decision|0|||
161843740|NCT02132754|584470136|FG003|Overall Study|Physician Decision|0|||
161843741|NCT02132754|584470137|FG004|Overall Study|Physician Decision|0|||
161843742|NCT02132754|584470138|FG005|Overall Study|Physician Decision|0|||
161967888|NCT02075047|584929215|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
161967889|NCT02075047|584929214|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
161967890|NCT02075047|584929215|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
162032677|NCT01933789|585177450|FG000|Overall Study|Lost to Follow-up|0|||
161843743|NCT02132754|584470139|FG006|Overall Study|Physician Decision|0|||
161843744|NCT02132754|584470140|FG007|Overall Study|Physician Decision|0|||
161967891|NCT02075047|584929214|FG000|Follow up Phase (5 Weeks)|Other|1|||
161967892|NCT02075047|584929215|FG001|Follow up Phase (5 Weeks)|Other|2|||
161843745|NCT02132754|584470141|FG008|Overall Study|Physician Decision|0|||
161843746|NCT02132754|584470142|FG009|Overall Study|Physician Decision|1|||
161843747|NCT02132754|584470143|FG010|Overall Study|Physician Decision|0|||
161843748|NCT02132754|584470144|FG011|Overall Study|Physician Decision|1|||
161843749|NCT02132754|584470145|FG012|Overall Study|Physician Decision|1|||
161843750|NCT02132754|584470146|FG013|Overall Study|Physician Decision|0|||
161843751|NCT02132754|584470147|FG014|Overall Study|Physician Decision|0|||
161843752|NCT02132754|584470148|FG015|Overall Study|Physician Decision|1|||
161843753|NCT02132754|584470149|FG016|Overall Study|Physician Decision|0|||
161750987|NCT00364351|584128371|FG000|Overall Study|Investigator error|0|||
161750988|NCT00364351|584128372|FG001|Overall Study|Investigator error|2|||
161750989|NCT00364351|584128371|FG000|Overall Study|Patient could not travel to site|0|||
161750990|NCT00364351|584128372|FG001|Overall Study|Patient could not travel to site|1|||
161750991|NCT00364351|584128371|FG000|Overall Study|Randomised treatment not started|0|||
161750992|NCT00364351|584128372|FG001|Overall Study|Randomised treatment not started|3|||
161750993|NCT02177786|584128373|FG000|Overall Study|Withdrew Consent|2|||
161750994|NCT02177786|584128374|FG001|Overall Study|Withdrew Consent|6|||
161750995|NCT02177786|584128375|FG002|Overall Study|Withdrew Consent|9|||
161750996|NCT02177786|584128376|FG003|Overall Study|Withdrew Consent|5|||
161750997|NCT02177786|584128373|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
161750998|NCT02177786|584128374|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
161750999|NCT02177786|584128375|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
161751000|NCT02177786|584128376|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
161751001|NCT02177786|584128373|FG000|Overall Study|Adverse Event|1|||
161751002|NCT02177786|584128374|FG001|Overall Study|Adverse Event|1|||
161751003|NCT02177786|584128375|FG002|Overall Study|Adverse Event|2|||
161751004|NCT02177786|584128376|FG003|Overall Study|Adverse Event|3|||
161751005|NCT02177786|584128373|FG000|Overall Study|Death|1|||
161751006|NCT02177786|584128374|FG001|Overall Study|Death|1|||
161751007|NCT02177786|584128375|FG002|Overall Study|Death|1|||
161751008|NCT02177786|584128376|FG003|Overall Study|Death|1|||
161751009|NCT02177786|584128373|FG000|Overall Study|Lost to Follow-up|0|||
161751010|NCT02177786|584128374|FG001|Overall Study|Lost to Follow-up|0|||
161751011|NCT02177786|584128375|FG002|Overall Study|Lost to Follow-up|2|||
161751012|NCT02177786|584128376|FG003|Overall Study|Lost to Follow-up|2|||
161751013|NCT02177786|584128373|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161751014|NCT02177786|584128374|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161751015|NCT02177786|584128375|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161751016|NCT02177786|584128376|FG003|Overall Study|Non-Compliance with Study Drug|1|||
161751017|NCT02177786|584128373|FG000|Overall Study|Protocol Violation|0|||
161751018|NCT02177786|584128374|FG001|Overall Study|Protocol Violation|0|||
161751019|NCT02177786|584128375|FG002|Overall Study|Protocol Violation|2|||
161751020|NCT02177786|584128376|FG003|Overall Study|Protocol Violation|0|||
161751021|NCT02177786|584128373|FG000|Overall Study|Progressive Disease|0|||
161751022|NCT02177786|584128374|FG001|Overall Study|Progressive Disease|1|||
161751023|NCT02177786|584128375|FG002|Overall Study|Progressive Disease|0|||
161751024|NCT02177786|584128376|FG003|Overall Study|Progressive Disease|0|||
161751025|NCT02177786|584128373|FG000|Overall Study|Missing study completion status|0|||
161751026|NCT02177786|584128374|FG001|Overall Study|Missing study completion status|1|||
161751027|NCT02177786|584128375|FG002|Overall Study|Missing study completion status|0|||
161751028|NCT02177786|584128376|FG003|Overall Study|Missing study completion status|0|||
161751029|NCT01305941|584128377|FG000|Overall Study|Adverse Event|6|||
161751030|NCT01305941|584128377|FG000|Overall Study|Clinical decline|2|||
161751031|NCT01305941|584128377|FG000|Overall Study|Withdrawal by Subject|1|||
161751032|NCT01305941|584128377|FG000|Overall Study|Death|1|||
161751033|NCT01957215|584128379|FG000|Overall Study|Adverse Event|2|||
161751034|NCT01957215|584128380|FG001|Overall Study|Adverse Event|2|||
161751035|NCT01957215|584128379|FG000|Overall Study|Lost to Follow-up|3|||
161751036|NCT01957215|584128380|FG001|Overall Study|Lost to Follow-up|3|||
161751037|NCT01957215|584128379|FG000|Overall Study|Protocol Violation|1|||
161751038|NCT01957215|584128380|FG001|Overall Study|Protocol Violation|2|||
161751039|NCT01957215|584128379|FG000|Overall Study|Withdrawal by Subject|7|||
161751040|NCT01957215|584128380|FG001|Overall Study|Withdrawal by Subject|5|||
161751041|NCT03597503|584128384|FG000|Overall Study|Withdrawal by Subject|0|||
161751042|NCT03597503|584128385|FG001|Overall Study|Withdrawal by Subject|2|||
161751043|NCT03597503|584128384|FG000|Overall Study|Lost to Follow-up|1|||
161751044|NCT03597503|584128385|FG001|Overall Study|Lost to Follow-up|2|||
161751045|NCT03597503|584128384|FG000|Overall Study|Protocol Violation|1|||
161751046|NCT03597503|584128385|FG001|Overall Study|Protocol Violation|0|||
161751047|NCT02667236|584128388|FG000|Overall Study|Adverse Event|1|||
161751048|NCT02667236|584128389|FG001|Overall Study|Adverse Event|1|||
161751049|NCT02667236|584128388|FG000|Overall Study|Withdrawal by Subject|2|||
161751050|NCT02667236|584128389|FG001|Overall Study|Withdrawal by Subject|0|||
161751051|NCT00634751|584128390|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
161751052|NCT00634751|584128391|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
161751053|NCT00634751|584128392|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
161751054|NCT00634751|584128393|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
161751055|NCT00634751|584128390|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
161751056|NCT00634751|584128391|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
161751057|NCT00634751|584128392|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
161751058|NCT00634751|584128393|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
161751059|NCT00634751|584128390|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
161751060|NCT00634751|584128391|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
161751061|NCT00634751|584128392|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
161751062|NCT00634751|584128393|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
161751063|NCT00608894|584128394|FG000|Overall Study|Withdrawal by Subject|0|||
161843754|NCT02132754|584470150|FG017|Overall Study|Physician Decision|0|||
161843755|NCT02132754|584470151|FG018|Overall Study|Physician Decision|0|||
161843756|NCT02132754|584470152|FG019|Overall Study|Physician Decision|0|||
161843757|NCT02132754|584470153|FG020|Overall Study|Physician Decision|0|||
161843758|NCT02132754|584470154|FG021|Overall Study|Physician Decision|0|||
161843759|NCT02132754|584470155|FG022|Overall Study|Physician Decision|0|||
161843760|NCT02132754|584470156|FG023|Overall Study|Physician Decision|0|||
161843761|NCT02132754|584470157|FG024|Overall Study|Physician Decision|1|||
161843762|NCT02132754|584470158|FG025|Overall Study|Physician Decision|0|||
161843763|NCT02132754|584470159|FG026|Overall Study|Physician Decision|0|||
161843764|NCT02132754|584470160|FG027|Overall Study|Physician Decision|0|||
161843765|NCT02132754|584470161|FG028|Overall Study|Physician Decision|0|||
161843766|NCT02132754|584470162|FG029|Overall Study|Physician Decision|0|||
161843767|NCT02132754|584470163|FG030|Overall Study|Physician Decision|0|||
161843768|NCT02132754|584470164|FG031|Overall Study|Physician Decision|1|||
161843769|NCT02132754|584470165|FG032|Overall Study|Physician Decision|0|||
161843770|NCT02132754|584470166|FG033|Overall Study|Physician Decision|3|||
161843771|NCT02132754|584470133|FG000|Overall Study|Progressive Disease|1|||
161843772|NCT02132754|584470134|FG001|Overall Study|Progressive Disease|1|||
161843773|NCT02132754|584470135|FG002|Overall Study|Progressive Disease|1|||
161843774|NCT02132754|584470136|FG003|Overall Study|Progressive Disease|1|||
161843775|NCT02132754|584470137|FG004|Overall Study|Progressive Disease|1|||
161843776|NCT02132754|584470138|FG005|Overall Study|Progressive Disease|1|||
161843777|NCT02132754|584470139|FG006|Overall Study|Progressive Disease|1|||
161843778|NCT02132754|584470140|FG007|Overall Study|Progressive Disease|1|||
161843779|NCT02132754|584470141|FG008|Overall Study|Progressive Disease|1|||
161843780|NCT02132754|584470142|FG009|Overall Study|Progressive Disease|3|||
161843781|NCT02132754|584470143|FG010|Overall Study|Progressive Disease|3|||
161843782|NCT02132754|584470144|FG011|Overall Study|Progressive Disease|2|||
161843783|NCT02132754|584470145|FG012|Overall Study|Progressive Disease|2|||
161843784|NCT02132754|584470146|FG013|Overall Study|Progressive Disease|3|||
161843785|NCT02132754|584470147|FG014|Overall Study|Progressive Disease|2|||
161843786|NCT02132754|584470148|FG015|Overall Study|Progressive Disease|1|||
161843787|NCT02132754|584470149|FG016|Overall Study|Progressive Disease|2|||
161843788|NCT02132754|584470150|FG017|Overall Study|Progressive Disease|1|||
161843789|NCT02132754|584470151|FG018|Overall Study|Progressive Disease|3|||
161843790|NCT02132754|584470152|FG019|Overall Study|Progressive Disease|1|||
161843791|NCT02132754|584470153|FG020|Overall Study|Progressive Disease|1|||
161843792|NCT02132754|584470154|FG021|Overall Study|Progressive Disease|3|||
161843793|NCT02132754|584470155|FG022|Overall Study|Progressive Disease|2|||
161843794|NCT02132754|584470156|FG023|Overall Study|Progressive Disease|3|||
161843795|NCT02132754|584470157|FG024|Overall Study|Progressive Disease|0|||
161843796|NCT02132754|584470158|FG025|Overall Study|Progressive Disease|1|||
161843797|NCT02132754|584470159|FG026|Overall Study|Progressive Disease|2|||
161843798|NCT02132754|584470160|FG027|Overall Study|Progressive Disease|1|||
161843799|NCT02132754|584470161|FG028|Overall Study|Progressive Disease|2|||
161843800|NCT02132754|584470162|FG029|Overall Study|Progressive Disease|3|||
161843801|NCT02132754|584470163|FG030|Overall Study|Progressive Disease|1|||
161843802|NCT02132754|584470164|FG031|Overall Study|Progressive Disease|1|||
161843803|NCT02132754|584470165|FG032|Overall Study|Progressive Disease|3|||
161843804|NCT02132754|584470166|FG033|Overall Study|Progressive Disease|6|||
161843805|NCT02132754|584470133|FG000|Overall Study|Screen Failure|0|||
161843806|NCT02132754|584470134|FG001|Overall Study|Screen Failure|0|||
161843807|NCT02132754|584470135|FG002|Overall Study|Screen Failure|0|||
161843808|NCT02132754|584470136|FG003|Overall Study|Screen Failure|0|||
161843809|NCT02132754|584470137|FG004|Overall Study|Screen Failure|0|||
161843810|NCT02132754|584470138|FG005|Overall Study|Screen Failure|0|||
161843811|NCT02132754|584470139|FG006|Overall Study|Screen Failure|0|||
161843812|NCT02132754|584470140|FG007|Overall Study|Screen Failure|0|||
161843813|NCT02132754|584470141|FG008|Overall Study|Screen Failure|0|||
161843814|NCT02132754|584470142|FG009|Overall Study|Screen Failure|0|||
161843815|NCT02132754|584470143|FG010|Overall Study|Screen Failure|0|||
162032678|NCT01933789|585177451|FG001|Overall Study|Lost to Follow-up|0|||
161843816|NCT02132754|584470144|FG011|Overall Study|Screen Failure|0|||
161843817|NCT02132754|584470145|FG012|Overall Study|Screen Failure|0|||
161843818|NCT02132754|584470146|FG013|Overall Study|Screen Failure|0|||
161843819|NCT02132754|584470147|FG014|Overall Study|Screen Failure|0|||
161843820|NCT02132754|584470148|FG015|Overall Study|Screen Failure|0|||
161843821|NCT02132754|584470149|FG016|Overall Study|Screen Failure|0|||
161843822|NCT02132754|584470150|FG017|Overall Study|Screen Failure|0|||
161843823|NCT02132754|584470151|FG018|Overall Study|Screen Failure|0|||
162032679|NCT01933789|585177452|FG002|Overall Study|Lost to Follow-up|0|||
162032680|NCT01933789|585177453|FG003|Overall Study|Lost to Follow-up|1|||
161843824|NCT02132754|584470152|FG019|Overall Study|Screen Failure|1|||
161843825|NCT02132754|584470153|FG020|Overall Study|Screen Failure|0|||
162032681|NCT01933789|585177454|FG004|Overall Study|Lost to Follow-up|8|||
161843826|NCT02132754|584470154|FG021|Overall Study|Screen Failure|1|||
161843827|NCT02132754|584470155|FG022|Overall Study|Screen Failure|0|||
161843828|NCT02132754|584470156|FG023|Overall Study|Screen Failure|0|||
161843829|NCT02132754|584470157|FG024|Overall Study|Screen Failure|0|||
161843830|NCT02132754|584470158|FG025|Overall Study|Screen Failure|0|||
161843831|NCT02132754|584470159|FG026|Overall Study|Screen Failure|0|||
161843832|NCT02132754|584470160|FG027|Overall Study|Screen Failure|0|||
161843833|NCT02132754|584470161|FG028|Overall Study|Screen Failure|0|||
161843834|NCT02132754|584470162|FG029|Overall Study|Screen Failure|0|||
161843835|NCT02132754|584470163|FG030|Overall Study|Screen Failure|0|||
161843836|NCT02132754|584470164|FG031|Overall Study|Screen Failure|0|||
161843837|NCT02132754|584470165|FG032|Overall Study|Screen Failure|0|||
161843838|NCT02132754|584470166|FG033|Overall Study|Screen Failure|0|||
161843839|NCT02132754|584470133|FG000|Overall Study|Transferred to Extension Study|0|||
161843840|NCT02132754|584470134|FG001|Overall Study|Transferred to Extension Study|0|||
161843841|NCT02132754|584470135|FG002|Overall Study|Transferred to Extension Study|0|||
161843842|NCT02132754|584470136|FG003|Overall Study|Transferred to Extension Study|0|||
161843843|NCT02132754|584470137|FG004|Overall Study|Transferred to Extension Study|0|||
161843844|NCT02132754|584470138|FG005|Overall Study|Transferred to Extension Study|0|||
161843845|NCT02132754|584470139|FG006|Overall Study|Transferred to Extension Study|0|||
161843846|NCT02132754|584470140|FG007|Overall Study|Transferred to Extension Study|0|||
161843847|NCT02132754|584470141|FG008|Overall Study|Transferred to Extension Study|0|||
161843848|NCT02132754|584470142|FG009|Overall Study|Transferred to Extension Study|0|||
161843849|NCT02132754|584470143|FG010|Overall Study|Transferred to Extension Study|0|||
161843850|NCT02132754|584470144|FG011|Overall Study|Transferred to Extension Study|0|||
161843851|NCT02132754|584470145|FG012|Overall Study|Transferred to Extension Study|0|||
161843852|NCT02132754|584470146|FG013|Overall Study|Transferred to Extension Study|0|||
161843853|NCT02132754|584470147|FG014|Overall Study|Transferred to Extension Study|0|||
161843854|NCT02132754|584470148|FG015|Overall Study|Transferred to Extension Study|0|||
161843855|NCT02132754|584470149|FG016|Overall Study|Transferred to Extension Study|0|||
161843856|NCT02132754|584470150|FG017|Overall Study|Transferred to Extension Study|0|||
161843857|NCT02132754|584470151|FG018|Overall Study|Transferred to Extension Study|0|||
161843858|NCT02132754|584470152|FG019|Overall Study|Transferred to Extension Study|0|||
161843859|NCT02132754|584470153|FG020|Overall Study|Transferred to Extension Study|0|||
161843860|NCT02132754|584470154|FG021|Overall Study|Transferred to Extension Study|0|||
161843861|NCT02132754|584470155|FG022|Overall Study|Transferred to Extension Study|0|||
161843862|NCT02132754|584470156|FG023|Overall Study|Transferred to Extension Study|0|||
161843863|NCT02132754|584470157|FG024|Overall Study|Transferred to Extension Study|0|||
161843864|NCT02132754|584470158|FG025|Overall Study|Transferred to Extension Study|0|||
161843865|NCT02132754|584470159|FG026|Overall Study|Transferred to Extension Study|0|||
161843866|NCT02132754|584470160|FG027|Overall Study|Transferred to Extension Study|0|||
161843867|NCT02132754|584470161|FG028|Overall Study|Transferred to Extension Study|0|||
161843868|NCT02132754|584470162|FG029|Overall Study|Transferred to Extension Study|0|||
161843869|NCT02132754|584470163|FG030|Overall Study|Transferred to Extension Study|0|||
161843870|NCT02132754|584470164|FG031|Overall Study|Transferred to Extension Study|0|||
161843871|NCT02132754|584470165|FG032|Overall Study|Transferred to Extension Study|0|||
161843872|NCT02132754|584470166|FG033|Overall Study|Transferred to Extension Study|6|||
161843873|NCT02132754|584470133|FG000|Overall Study|Withdrawal by Subject|0|||
161843874|NCT02132754|584470134|FG001|Overall Study|Withdrawal by Subject|0|||
161843875|NCT02132754|584470135|FG002|Overall Study|Withdrawal by Subject|0|||
161843876|NCT02132754|584470136|FG003|Overall Study|Withdrawal by Subject|0|||
161843877|NCT02132754|584470137|FG004|Overall Study|Withdrawal by Subject|0|||
161843878|NCT02132754|584470138|FG005|Overall Study|Withdrawal by Subject|0|||
161843879|NCT02132754|584470139|FG006|Overall Study|Withdrawal by Subject|0|||
161843880|NCT02132754|584470140|FG007|Overall Study|Withdrawal by Subject|0|||
161843881|NCT02132754|584470141|FG008|Overall Study|Withdrawal by Subject|0|||
161843882|NCT02132754|584470142|FG009|Overall Study|Withdrawal by Subject|1|||
161843883|NCT02132754|584470143|FG010|Overall Study|Withdrawal by Subject|0|||
161843884|NCT02132754|584470144|FG011|Overall Study|Withdrawal by Subject|0|||
161843885|NCT02132754|584470145|FG012|Overall Study|Withdrawal by Subject|1|||
161843886|NCT02132754|584470146|FG013|Overall Study|Withdrawal by Subject|0|||
161843887|NCT02132754|584470147|FG014|Overall Study|Withdrawal by Subject|1|||
161843888|NCT02132754|584470148|FG015|Overall Study|Withdrawal by Subject|2|||
161843889|NCT02132754|584470149|FG016|Overall Study|Withdrawal by Subject|1|||
161843890|NCT02132754|584470150|FG017|Overall Study|Withdrawal by Subject|0|||
161843891|NCT02132754|584470151|FG018|Overall Study|Withdrawal by Subject|0|||
161843892|NCT02132754|584470152|FG019|Overall Study|Withdrawal by Subject|0|||
161843893|NCT02132754|584470153|FG020|Overall Study|Withdrawal by Subject|1|||
161843894|NCT02132754|584470154|FG021|Overall Study|Withdrawal by Subject|0|||
161843895|NCT02132754|584470155|FG022|Overall Study|Withdrawal by Subject|0|||
161967893|NCT02075047|584929214|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
161843896|NCT02132754|584470156|FG023|Overall Study|Withdrawal by Subject|0|||
161843897|NCT02132754|584470157|FG024|Overall Study|Withdrawal by Subject|1|||
161843898|NCT02132754|584470158|FG025|Overall Study|Withdrawal by Subject|0|||
161843899|NCT02132754|584470159|FG026|Overall Study|Withdrawal by Subject|0|||
161843900|NCT02132754|584470160|FG027|Overall Study|Withdrawal by Subject|1|||
161843901|NCT02132754|584470161|FG028|Overall Study|Withdrawal by Subject|0|||
161843902|NCT02132754|584470162|FG029|Overall Study|Withdrawal by Subject|0|||
161843903|NCT02132754|584470163|FG030|Overall Study|Withdrawal by Subject|0|||
161843904|NCT02132754|584470164|FG031|Overall Study|Withdrawal by Subject|1|||
161843905|NCT02132754|584470165|FG032|Overall Study|Withdrawal by Subject|0|||
161843906|NCT02132754|584470166|FG033|Overall Study|Withdrawal by Subject|2|||
161843907|NCT02011386|584470173|FG000|Overall Study|Non-compliance|2|||
161843908|NCT02011386|584470173|FG000|Overall Study|Lack of Efficacy|3|||
161843909|NCT01193127|584470174|FG000|Randomized|Surgery Cancelled|0|||
161843910|NCT01193127|584470175|FG001|Randomized|Surgery Cancelled|0|||
161843911|NCT01193127|584470176|FG002|Randomized|Surgery Cancelled|0|||
161843912|NCT01193127|584470177|FG003|Randomized|Surgery Cancelled|1|||
161843913|NCT01193127|584470174|FG000|Treated|Withdrawal by Subject|0|||
161843914|NCT01193127|584470175|FG001|Treated|Withdrawal by Subject|0|||
161843915|NCT01193127|584470176|FG002|Treated|Withdrawal by Subject|0|||
161843916|NCT01193127|584470177|FG003|Treated|Withdrawal by Subject|1|||
161843917|NCT00761865|584470181|FG000|Overall Study|Lost to Follow-up|8|||
161843918|NCT00761865|584470182|FG001|Overall Study|Lost to Follow-up|7|||
161843919|NCT04555720|584470183|FG000|Overall Study|Lost to Follow-up|2|||
161843920|NCT04555720|584470184|FG001|Overall Study|Lost to Follow-up|0|||
161843921|NCT04555720|584470185|FG002|Overall Study|Lost to Follow-up|0|||
161843922|NCT04555720|584470186|FG003|Overall Study|Lost to Follow-up|0|||
161843923|NCT04555720|584470183|FG000|Overall Study|Withdrawal by Subject|4|||
161843924|NCT04555720|584470184|FG001|Overall Study|Withdrawal by Subject|6|||
161843925|NCT04555720|584470185|FG002|Overall Study|Withdrawal by Subject|0|||
161843926|NCT04555720|584470186|FG003|Overall Study|Withdrawal by Subject|0|||
161843927|NCT00321737|584470187|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
161843928|NCT00321737|584470188|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
161843929|NCT00321737|584470189|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
161843930|NCT00321737|584470187|FG000|Overall Study|Adverse Event|11|||
161843931|NCT00321737|584470188|FG001|Overall Study|Adverse Event|3|||
161843932|NCT00321737|584470189|FG002|Overall Study|Adverse Event|6|||
161843933|NCT00321737|584470187|FG000|Overall Study|Lost to Follow-up|5|||
161843934|NCT00321737|584470188|FG001|Overall Study|Lost to Follow-up|5|||
161843935|NCT00321737|584470189|FG002|Overall Study|Lost to Follow-up|6|||
161843936|NCT00321737|584470187|FG000|Overall Study|Withdrawal by Subject|19|||
161843937|NCT00321737|584470188|FG001|Overall Study|Withdrawal by Subject|12|||
161843938|NCT00321737|584470189|FG002|Overall Study|Withdrawal by Subject|17|||
161843939|NCT00321737|584470187|FG000|Overall Study|Protocol Violation|0|||
161843940|NCT00321737|584470188|FG001|Overall Study|Protocol Violation|0|||
161843941|NCT00321737|584470189|FG002|Overall Study|Protocol Violation|1|||
161843942|NCT00321737|584470187|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
161843943|NCT00321737|584470188|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
161843944|NCT00321737|584470189|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
161843945|NCT00321737|584470187|FG000|Overall Study|Possible Barrett's Esophagus|2|||
161843946|NCT00321737|584470188|FG001|Overall Study|Possible Barrett's Esophagus|1|||
161843947|NCT00321737|584470189|FG002|Overall Study|Possible Barrett's Esophagus|1|||
161843948|NCT00321737|584470187|FG000|Overall Study|Therapeutic Failure|6|||
161843949|NCT00321737|584470188|FG001|Overall Study|Therapeutic Failure|0|||
161843950|NCT00321737|584470189|FG002|Overall Study|Therapeutic Failure|2|||
161843951|NCT00321737|584470187|FG000|Overall Study|Pregnancy|0|||
161843952|NCT00321737|584470188|FG001|Overall Study|Pregnancy|2|||
161843953|NCT00321737|584470189|FG002|Overall Study|Pregnancy|0|||
161843954|NCT00321737|584470187|FG000|Overall Study|Noncompliance|2|||
161843955|NCT00321737|584470188|FG001|Overall Study|Noncompliance|0|||
161843956|NCT00321737|584470189|FG002|Overall Study|Noncompliance|0|||
161843957|NCT00321737|584470187|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
161843958|NCT00321737|584470188|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
161843959|NCT00321737|584470189|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
161843960|NCT02283294|584470190|FG000|Overall Study|Lost to Follow-up|1|||
161843961|NCT02283294|584470191|FG001|Overall Study|Lost to Follow-up|1|||
161843962|NCT02283294|584470190|FG000|Overall Study|Withdrawal by Subject|1|||
161967894|NCT02075047|584929215|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
161967895|NCT00515294|584929216|FG000|Overall Study|Lost to Follow-up|3|||
161967896|NCT00515294|584929217|FG001|Overall Study|Lost to Follow-up|2|||
161843963|NCT02283294|584470191|FG001|Overall Study|Withdrawal by Subject|6|||
161843964|NCT02283294|584470190|FG000|Overall Study|Protocol Violation|1|||
161843965|NCT02283294|584470191|FG001|Overall Study|Protocol Violation|0|||
161843966|NCT02283294|584470190|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
161843967|NCT02283294|584470191|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
161843968|NCT04994483|584472280|FG000|Overall Study|Adverse Event|26|||
161843969|NCT04994483|584472281|FG001|Overall Study|Adverse Event|17|||
161843970|NCT04994483|584472280|FG000|Overall Study|Lost to Follow-up|6|||
161843971|NCT04994483|584472281|FG001|Overall Study|Lost to Follow-up|10|||
161843972|NCT04994483|584472280|FG000|Overall Study|Noncompliance with study drug|8|||
161843973|NCT04994483|584472281|FG001|Overall Study|Noncompliance with study drug|5|||
161843974|NCT04994483|584472280|FG000|Overall Study|Physician Decision|5|||
161843975|NCT04994483|584472281|FG001|Overall Study|Physician Decision|0|||
161967897|NCT00515294|584929218|FG002|Overall Study|Lost to Follow-up|3|||
161843976|NCT04994483|584472280|FG000|Overall Study|Withdrawal by Subject|41|||
161843977|NCT04994483|584472281|FG001|Overall Study|Withdrawal by Subject|38|||
161843978|NCT04994483|584472280|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
161843979|NCT04994483|584472281|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
161843980|NCT04994483|584472280|FG000|Overall Study|Met stopping criteria|1|||
161843981|NCT04994483|584472281|FG001|Overall Study|Met stopping criteria|0|||
161843982|NCT04994483|584472280|FG000|Overall Study|Randomized in error, not treated|4|||
161843983|NCT04994483|584472281|FG001|Overall Study|Randomized in error, not treated|3|||
161843984|NCT04994483|584472280|FG000|Overall Study|Lack of a reliable study partner|0|||
161843985|NCT04994483|584472281|FG001|Overall Study|Lack of a reliable study partner|1|||
161843986|NCT04994483|584472280|FG000|Overall Study|Met MRI exclusion criteria|0|||
161843987|NCT04994483|584472281|FG001|Overall Study|Met MRI exclusion criteria|1|||
161843988|NCT02213510|584472282|FG000|Overall Study|Death|0|||
161843989|NCT02213510|584472283|FG001|Overall Study|Death|1|||
161843990|NCT02213510|584472282|FG000|Overall Study|Lost to Follow-up|1|||
161843991|NCT02213510|584472283|FG001|Overall Study|Lost to Follow-up|0|||
161843992|NCT02903030|584472284|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
161843993|NCT02903030|584472285|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
161843994|NCT02603393|584472291|FG000|Overall Study|Patient/guardian decision|32|||
161843995|NCT02603393|584472292|FG001|Overall Study|Patient/guardian decision|18|||
161843996|NCT02603393|584472291|FG000|Overall Study|Adverse Event|17|||
161843997|NCT02603393|584472292|FG001|Overall Study|Adverse Event|15|||
161843998|NCT02603393|584472291|FG000|Overall Study|Technical problems|4|||
161843999|NCT02603393|584472292|FG001|Overall Study|Technical problems|7|||
161844000|NCT02603393|584472291|FG000|Overall Study|Lack of Efficacy|7|||
161844001|NCT02603393|584472292|FG001|Overall Study|Lack of Efficacy|2|||
161844002|NCT02603393|584472291|FG000|Overall Study|Death|3|||
161844003|NCT02603393|584472292|FG001|Overall Study|Death|4|||
161844004|NCT02603393|584472291|FG000|Overall Study|Physician Decision|3|||
161844005|NCT02603393|584472292|FG001|Overall Study|Physician Decision|3|||
161844006|NCT02603393|584472291|FG000|Overall Study|Protocol deviation|2|||
161844007|NCT02603393|584472292|FG001|Overall Study|Protocol deviation|3|||
161844008|NCT02603393|584472291|FG000|Overall Study|Lost to Follow-up|1|||
161844009|NCT02603393|584472292|FG001|Overall Study|Lost to Follow-up|2|||
161844010|NCT02603393|584472291|FG000|Overall Study|Non-compliance with study treatment|1|||
161844011|NCT02603393|584472292|FG001|Overall Study|Non-compliance with study treatment|0|||
161844012|NCT02603393|584472291|FG000|Overall Study|Sponsor decision|1|||
161844013|NCT02603393|584472292|FG001|Overall Study|Sponsor decision|0|||
161844014|NCT04053465|584472294|FG000|Overall Study|Withdrawal by Subject|4|||
161844015|NCT04053465|584472295|FG001|Overall Study|Withdrawal by Subject|4|||
161844016|NCT02085135|584472296|FG000|Overall Study|Adverse Event|4|||
161844017|NCT02085135|584472297|FG001|Overall Study|Adverse Event|7|||
161844018|NCT02085135|584472296|FG000|Overall Study|Lost to Follow-up|2|||
161844019|NCT02085135|584472297|FG001|Overall Study|Lost to Follow-up|2|||
161844020|NCT02085135|584472296|FG000|Overall Study|Withdrawal by Subject|3|||
161844021|NCT02085135|584472297|FG001|Overall Study|Withdrawal by Subject|0|||
161844022|NCT02085135|584472296|FG000|Overall Study|Lack of Efficacy|2|||
161844023|NCT02085135|584472297|FG001|Overall Study|Lack of Efficacy|0|||
161844024|NCT01085734|584472298|FG000|Overall Study|Adverse Event|0|||
161844025|NCT01085734|584472299|FG001|Overall Study|Adverse Event|2|||
161844026|NCT01085734|584472298|FG000|Overall Study|Death|1|||
161844027|NCT01085734|584472299|FG001|Overall Study|Death|0|||
161844028|NCT01085734|584472298|FG000|Overall Study|Lost to Follow-up|0|||
161844029|NCT01085734|584472299|FG001|Overall Study|Lost to Follow-up|1|||
161844030|NCT01085734|584472298|FG000|Overall Study|Withdrawal by Subject|0|||
161844031|NCT01085734|584472299|FG001|Overall Study|Withdrawal by Subject|1|||
161844032|NCT00742924|584472302|FG000|Overall Study|Adverse Event|0|||
161844033|NCT00742924|584472303|FG001|Overall Study|Adverse Event|0|||
161844034|NCT00742924|584472304|FG002|Overall Study|Adverse Event|1|||
161844035|NCT00742924|584472305|FG003|Overall Study|Adverse Event|1|||
161844036|NCT00742924|584472302|FG000|Overall Study|Lack of Efficacy|5|||
161844037|NCT00742924|584472303|FG001|Overall Study|Lack of Efficacy|1|||
161844038|NCT00742924|584472304|FG002|Overall Study|Lack of Efficacy|2|||
161844039|NCT00742924|584472305|FG003|Overall Study|Lack of Efficacy|4|||
161844040|NCT00742924|584472302|FG000|Overall Study|Physician Decision|0|||
161844041|NCT00742924|584472303|FG001|Overall Study|Physician Decision|0|||
161844042|NCT00742924|584472304|FG002|Overall Study|Physician Decision|0|||
161844043|NCT00742924|584472305|FG003|Overall Study|Physician Decision|1|||
161844044|NCT00742924|584472302|FG000|Overall Study|Withdrawal by Subject|0|||
161844045|NCT00742924|584472303|FG001|Overall Study|Withdrawal by Subject|1|||
161844046|NCT00742924|584472304|FG002|Overall Study|Withdrawal by Subject|1|||
161844047|NCT00742924|584472305|FG003|Overall Study|Withdrawal by Subject|0|||
161844048|NCT00660400|584472306|FG000|Overall Study|Lack of insurance approval|1|||
161844049|NCT00660400|584472306|FG000|Overall Study|Suboptimal organ function|1|||
161844050|NCT00660400|584472306|FG000|Overall Study|Intracranial hemorrhage|1|||
161844051|NCT00660400|584472306|FG000|Overall Study|Withdrawal by Subject|1|||
161844052|NCT01161407|584472307|FG000|Overall Study|Protocol Violation|3|||
161844053|NCT01161407|584472308|FG001|Overall Study|Protocol Violation|1|||
161967898|NCT00515294|584929219|FG003|Overall Study|Lost to Follow-up|1|||
161967899|NCT00515294|584929216|FG000|Overall Study|Driver simulator problems|1|||
161967900|NCT00515294|584929217|FG001|Overall Study|Driver simulator problems|1|||
161751064|NCT00608894|584128395|FG001|Overall Study|Withdrawal by Subject|2|||
161751065|NCT03654560|584128402|FG000|Overall Study|Death|3|||
161751066|NCT03654560|584128403|FG001|Overall Study|Death|1|||
161751067|NCT03654560|584128402|FG000|Overall Study|Lost to Follow-up|1|||
161751068|NCT03654560|584128403|FG001|Overall Study|Lost to Follow-up|0|||
161751069|NCT00209092|584128404|FG000|Overall Study|Progression of disease|7|||
161751070|NCT00209092|584128405|FG001|Overall Study|Progression of disease|1|||
161751071|NCT00209092|584128404|FG000|Overall Study|Adverse Event|0|||
161751072|NCT00209092|584128405|FG001|Overall Study|Adverse Event|1|||
161751073|NCT00209092|584128404|FG000|Overall Study|Withdrawal by Subject|1|||
161751074|NCT00209092|584128405|FG001|Overall Study|Withdrawal by Subject|0|||
161751075|NCT00693420|584128406|FG000|Overall Study|Adverse Event|4|||
161751076|NCT00693420|584128407|FG001|Overall Study|Adverse Event|4|||
161751077|NCT00693420|584128406|FG000|Overall Study|Lost to Follow-up|0|||
161751078|NCT00693420|584128407|FG001|Overall Study|Lost to Follow-up|3|||
161751079|NCT00693420|584128406|FG000|Overall Study|Withdrawal by Subject|1|||
161751080|NCT00693420|584128407|FG001|Overall Study|Withdrawal by Subject|0|||
161751081|NCT00693420|584128406|FG000|Overall Study|Protocol Violation|0|||
161751082|NCT00693420|584128407|FG001|Overall Study|Protocol Violation|2|||
161751083|NCT00693420|584128406|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
161751084|NCT00693420|584128407|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
161751085|NCT00693420|584128406|FG000|Overall Study|Personal Reasons|1|||
161751086|NCT00693420|584128407|FG001|Overall Study|Personal Reasons|4|||
161751087|NCT01235338|584128409|FG000|Overall Study|Adverse Event|3|||
161751088|NCT01235338|584128410|FG001|Overall Study|Adverse Event|2|||
161751089|NCT01235338|584128409|FG000|Overall Study|Protocol Violation|1|||
161751090|NCT01235338|584128410|FG001|Overall Study|Protocol Violation|1|||
161751091|NCT01235338|584128409|FG000|Overall Study|Withdrawal by Subject|5|||
161751092|NCT01235338|584128410|FG001|Overall Study|Withdrawal by Subject|0|||
161751093|NCT01235338|584128409|FG000|Overall Study|Exclusion criteria violations|1|||
161751094|NCT01235338|584128410|FG001|Overall Study|Exclusion criteria violations|1|||
161751095|NCT01235338|584128409|FG000|Overall Study|Positive drug screen|0|||
161751096|NCT01235338|584128410|FG001|Overall Study|Positive drug screen|1|||
161751097|NCT01235338|584128409|FG000|Overall Study|Prohibited meds|1|||
161751098|NCT01235338|584128410|FG001|Overall Study|Prohibited meds|0|||
161751099|NCT05283499|584128412|FG000|Overall Study|Did not receive intervention|1|||
161751100|NCT05283499|584128413|FG001|Overall Study|Did not receive intervention|2|||
161751101|NCT02828644|584128414|FG000|Overall Study|Lost to Follow-up|23|||
161751102|NCT02828644|584128415|FG001|Overall Study|Lost to Follow-up|22|||
161751103|NCT02408484|584128416|FG000|Overall Study|Withdrawal by Subject|3|||
161751104|NCT02408484|584128416|FG000|Overall Study|Not treated during study period|1|||
161751105|NCT01117181|584128420|FG000|Overall Study|Lost to Follow-up|1|||
161751106|NCT01117181|584128421|FG001|Overall Study|Lost to Follow-up|0|||
161751107|NCT01117181|584128420|FG000|Overall Study|Withdrawal by Subject|0|||
161751108|NCT01117181|584128421|FG001|Overall Study|Withdrawal by Subject|2|||
161751109|NCT00524043|584128428|FG000|Overall Study|Lack of Efficacy|15|||
161751110|NCT00524043|584128429|FG001|Overall Study|Lack of Efficacy|13|||
161751111|NCT00524043|584128430|FG002|Overall Study|Lack of Efficacy|14|||
161751112|NCT00524043|584128428|FG000|Overall Study|Withdrawal by Subject|5|||
161751113|NCT00524043|584128429|FG001|Overall Study|Withdrawal by Subject|7|||
161751114|NCT00524043|584128430|FG002|Overall Study|Withdrawal by Subject|7|||
161751115|NCT00524043|584128428|FG000|Overall Study|Adverse Event|5|||
161751116|NCT00524043|584128429|FG001|Overall Study|Adverse Event|2|||
161751117|NCT00524043|584128430|FG002|Overall Study|Adverse Event|7|||
161751118|NCT00524043|584128428|FG000|Overall Study|Lost to Follow-up|3|||
161751119|NCT00524043|584128429|FG001|Overall Study|Lost to Follow-up|5|||
161751120|NCT00524043|584128430|FG002|Overall Study|Lost to Follow-up|3|||
161751121|NCT00524043|584128428|FG000|Overall Study|Various (eg, incarceration)|2|||
161751122|NCT00524043|584128429|FG001|Overall Study|Various (eg, incarceration)|1|||
161751123|NCT00524043|584128430|FG002|Overall Study|Various (eg, incarceration)|0|||
161751124|NCT00517413|584128431|FG000|Overall Study|Adverse Event|7|||
161751125|NCT00517413|584128431|FG000|Overall Study|Death|13|||
161751126|NCT00517413|584128431|FG000|Overall Study|Protocol Violation|15|||
161751127|NCT00517413|584128431|FG000|Overall Study|Withdrawal by Subject|2|||
161751128|NCT00517413|584128431|FG000|Overall Study|Failure to return|1|||
161751129|NCT00517413|584128431|FG000|Overall Study|Other-Reasons|23|||
161751130|NCT03938636|584128432|FG000|Overall Study|Protocol Violation|0|||
161751131|NCT03938636|584128433|FG001|Overall Study|Protocol Violation|1|||
161967901|NCT00515294|584929218|FG002|Overall Study|Driver simulator problems|1|||
161751132|NCT03938636|584128434|FG002|Overall Study|Protocol Violation|1|||
161751133|NCT03938636|584128432|FG000|Overall Study|Subject withdrew due to death in family|0|||
161751134|NCT03938636|584128433|FG001|Overall Study|Subject withdrew due to death in family|1|||
161751135|NCT03938636|584128434|FG002|Overall Study|Subject withdrew due to death in family|0|||
161751136|NCT03938636|584128432|FG000|Overall Study|Missed visit|0|||
162032682|NCT01933789|585177455|FG005|Overall Study|Lost to Follow-up|9|||
161844054|NCT01777620|584472309|FG000|Overall Study|Subject Withdrawal|1|||
161844055|NCT01777620|584472310|FG001|Overall Study|Subject Withdrawal|0|||
161844056|NCT04562155|584472313|FG000|Overall Study|COVID-19 pandemic|0|||
161844057|NCT04562155|584472314|FG001|Overall Study|COVID-19 pandemic|0|||
161844058|NCT04562155|584472315|FG002|Overall Study|COVID-19 pandemic|0|||
161844059|NCT04562155|584472316|FG003|Overall Study|COVID-19 pandemic|1|||
161844060|NCT04562155|584472313|FG000|Overall Study|Adverse Event|7|||
161844061|NCT04562155|584472314|FG001|Overall Study|Adverse Event|3|||
161844062|NCT04562155|584472315|FG002|Overall Study|Adverse Event|8|||
161844063|NCT04562155|584472316|FG003|Overall Study|Adverse Event|1|||
161844064|NCT04562155|584472313|FG000|Overall Study|Withdrawal by Subject|3|||
161844065|NCT04562155|584472314|FG001|Overall Study|Withdrawal by Subject|6|||
161844066|NCT04562155|584472315|FG002|Overall Study|Withdrawal by Subject|3|||
161844067|NCT04562155|584472316|FG003|Overall Study|Withdrawal by Subject|3|||
161844068|NCT04562155|584472313|FG000|Overall Study|Participant personal reason|1|||
161844069|NCT04562155|584472314|FG001|Overall Study|Participant personal reason|0|||
161844070|NCT04562155|584472315|FG002|Overall Study|Participant personal reason|2|||
161844071|NCT04562155|584472316|FG003|Overall Study|Participant personal reason|1|||
161844072|NCT01755767|584472333|FG000|Overall Study|Progressive Disease|8|||
161844073|NCT01755767|584472334|FG001|Overall Study|Progressive Disease|7|||
161844074|NCT01755767|584472335|FG002|Overall Study|Progressive Disease|91|||
161844075|NCT01755767|584472336|FG003|Overall Study|Progressive Disease|43|||
161844076|NCT01755767|584472333|FG000|Overall Study|Clinical Disease Progression|4|||
161844077|NCT01755767|584472334|FG001|Overall Study|Clinical Disease Progression|2|||
161844078|NCT01755767|584472335|FG002|Overall Study|Clinical Disease Progression|29|||
161844079|NCT01755767|584472336|FG003|Overall Study|Clinical Disease Progression|20|||
161844080|NCT01755767|584472333|FG000|Overall Study|Radiographic Disease Progression|9|||
161844081|NCT01755767|584472334|FG001|Overall Study|Radiographic Disease Progression|4|||
161844082|NCT01755767|584472335|FG002|Overall Study|Radiographic Disease Progression|44|||
161844083|NCT01755767|584472336|FG003|Overall Study|Radiographic Disease Progression|27|||
161844084|NCT01755767|584472333|FG000|Overall Study|Adverse Event|6|||
161844085|NCT01755767|584472334|FG001|Overall Study|Adverse Event|0|||
161844086|NCT01755767|584472335|FG002|Overall Study|Adverse Event|28|||
161844087|NCT01755767|584472336|FG003|Overall Study|Adverse Event|11|||
161844088|NCT01755767|584472333|FG000|Overall Study|Death|1|||
161844089|NCT01755767|584472334|FG001|Overall Study|Death|2|||
161844090|NCT01755767|584472335|FG002|Overall Study|Death|15|||
161844091|NCT01755767|584472336|FG003|Overall Study|Death|4|||
161844092|NCT01755767|584472333|FG000|Overall Study|Subject Decision|0|||
161844093|NCT01755767|584472334|FG001|Overall Study|Subject Decision|0|||
161844094|NCT01755767|584472335|FG002|Overall Study|Subject Decision|10|||
161844095|NCT01755767|584472336|FG003|Overall Study|Subject Decision|3|||
161844096|NCT01755767|584472333|FG000|Overall Study|Withdrawal by Subject|0|||
161844097|NCT01755767|584472334|FG001|Overall Study|Withdrawal by Subject|0|||
161844098|NCT01755767|584472335|FG002|Overall Study|Withdrawal by Subject|2|||
161844099|NCT01755767|584472336|FG003|Overall Study|Withdrawal by Subject|1|||
161844100|NCT01755767|584472333|FG000|Overall Study|Other|0|||
161844101|NCT01755767|584472334|FG001|Overall Study|Other|0|||
161844102|NCT01755767|584472335|FG002|Overall Study|Other|2|||
161844103|NCT01755767|584472336|FG003|Overall Study|Other|3|||
161844104|NCT01755767|584472333|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
161844105|NCT01755767|584472334|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
161844106|NCT01755767|584472335|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
161844107|NCT01755767|584472336|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
161844108|NCT02865460|584472337|FG000|Overall Study|Adverse Event|1|||
161844109|NCT02865460|584472338|FG001|Overall Study|Adverse Event|0|||
161844110|NCT02865460|584472337|FG000|Overall Study|Withdrawal by Subject|1|||
161844111|NCT02865460|584472338|FG001|Overall Study|Withdrawal by Subject|1|||
161844112|NCT02865460|584472337|FG000|Overall Study|Lost to Follow-up|7|||
161844113|NCT02865460|584472338|FG001|Overall Study|Lost to Follow-up|4|||
161844114|NCT02865460|584472337|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
161844115|NCT02865460|584472338|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
161844116|NCT00901576|584472339|FG000|Second Intervention|Withdrawal by Subject|0|||
162032683|NCT01933789|585177456|FG006|Overall Study|Lost to Follow-up|1|||
162032684|NCT01933789|585177457|FG007|Overall Study|Lost to Follow-up|4|||
162032685|NCT01933789|585177458|FG008|Overall Study|Lost to Follow-up|0|||
161844117|NCT00901576|584472340|FG001|Second Intervention|Withdrawal by Subject|0|||
161844118|NCT00901576|584472341|FG002|Second Intervention|Withdrawal by Subject|0|||
161844119|NCT00901576|584472342|FG003|Second Intervention|Withdrawal by Subject|1|||
161844120|NCT00901576|584472343|FG004|Second Intervention|Withdrawal by Subject|0|||
161844121|NCT00901576|584472344|FG005|Second Intervention|Withdrawal by Subject|1|||
161844122|NCT00901576|584472339|FG000|Second Intervention|Physician Decision|1|||
161844123|NCT00901576|584472340|FG001|Second Intervention|Physician Decision|0|||
161844124|NCT00901576|584472341|FG002|Second Intervention|Physician Decision|0|||
161844125|NCT00901576|584472342|FG003|Second Intervention|Physician Decision|0|||
161844126|NCT00901576|584472343|FG004|Second Intervention|Physician Decision|0|||
162032686|NCT01933789|585177450|FG000|Overall Study|Withdrawal by Subject|2|||
161844127|NCT00901576|584472344|FG005|Second Intervention|Physician Decision|0|||
161844128|NCT01696279|584472345|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
161844129|NCT01696279|584472346|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
161844130|NCT01696279|584472347|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
161844131|NCT01696279|584472348|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
161844132|NCT01696279|584472345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
161844133|NCT01696279|584472346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
161844134|NCT01696279|584472347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
161844135|NCT01696279|584472348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
161844136|NCT01696279|584472345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
161844137|NCT01696279|584472346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
161844138|NCT01696279|584472347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
161844139|NCT01696279|584472348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
161844140|NCT01696279|584472345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
161844141|NCT01696279|584472346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
161844142|NCT01696279|584472347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
161844143|NCT01696279|584472348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
161844144|NCT01696279|584472345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
161844145|NCT01696279|584472346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
161844146|NCT01696279|584472347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
161844147|NCT01696279|584472348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
161844148|NCT01696279|584472345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
161844149|NCT01696279|584472346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
161844150|NCT01696279|584472347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
161844151|NCT01696279|584472348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
161844152|NCT01696279|584472345|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
161844153|NCT01696279|584472346|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
161844154|NCT01696279|584472347|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
161844155|NCT01696279|584472348|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
161844156|NCT01696279|584472345|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
161967902|NCT00515294|584929219|FG003|Overall Study|Driver simulator problems|3|||
161967903|NCT00515294|584929216|FG000|Overall Study|Caffeine amount inaccurate|5|||
161967904|NCT00515294|584929217|FG001|Overall Study|Caffeine amount inaccurate|0|||
161967905|NCT00515294|584929218|FG002|Overall Study|Caffeine amount inaccurate|7|||
161967906|NCT00515294|584929219|FG003|Overall Study|Caffeine amount inaccurate|0|||
161967907|NCT01534260|584929224|FG000|Overall Study|Adverse Event|1|||
161967908|NCT01534260|584929225|FG001|Overall Study|Adverse Event|8|||
161967909|NCT01534260|584929224|FG000|Overall Study|Death|2|||
161967910|NCT01534260|584929225|FG001|Overall Study|Death|0|||
161967911|NCT01534260|584929224|FG000|Overall Study|Lack of Efficacy|1|||
161967912|NCT01534260|584929225|FG001|Overall Study|Lack of Efficacy|1|||
161967913|NCT01534260|584929224|FG000|Overall Study|Withdrawal by Subject|1|||
161967914|NCT01534260|584929225|FG001|Overall Study|Withdrawal by Subject|3|||
161967915|NCT01534260|584929224|FG000|Overall Study|Disease Progression|8|||
161967916|NCT01534260|584929225|FG001|Overall Study|Disease Progression|6|||
161967917|NCT01534260|584929224|FG000|Overall Study|Physician Decision|3|||
161967918|NCT01534260|584929225|FG001|Overall Study|Physician Decision|1|||
161967919|NCT01534260|584929224|FG000|Overall Study|No treatment, per protocol|0|||
161967920|NCT01534260|584929225|FG001|Overall Study|No treatment, per protocol|1|||
161967921|NCT01342965|584929227|FG000|Overall Study|Death|58|||
161967922|NCT01342965|584929228|FG001|Overall Study|Death|57|||
161967923|NCT01342965|584929227|FG000|Overall Study|Lost to Follow-up|5|||
161967924|NCT01342965|584929228|FG001|Overall Study|Lost to Follow-up|3|||
161967925|NCT01342965|584929227|FG000|Overall Study|Other Reasons- Unspecified|44|||
161967926|NCT01342965|584929228|FG001|Overall Study|Other Reasons- Unspecified|38|||
161967927|NCT01342965|584929227|FG000|Overall Study|Withdrawal by Subject|2|||
161967928|NCT01342965|584929228|FG001|Overall Study|Withdrawal by Subject|9|||
161967929|NCT00856206|584929233|FG000|Overall Study|Protocol Violation|6|||
161967930|NCT00856206|584929234|FG001|Overall Study|Protocol Violation|18|||
161967931|NCT00856206|584929233|FG000|Overall Study|Adverse Event|10|||
161967932|NCT00856206|584929234|FG001|Overall Study|Adverse Event|46|||
161967933|NCT00856206|584929233|FG000|Overall Study|Lack of Efficacy|1|||
161967934|NCT00856206|584929234|FG001|Overall Study|Lack of Efficacy|2|||
161967935|NCT00856206|584929233|FG000|Overall Study|Withdrawal by Subject|15|||
161967936|NCT00856206|584929234|FG001|Overall Study|Withdrawal by Subject|36|||
161967937|NCT00856206|584929233|FG000|Overall Study|Lost to Follow-up|13|||
161967938|NCT00856206|584929234|FG001|Overall Study|Lost to Follow-up|39|||
161967939|NCT00856206|584929233|FG000|Overall Study|Death|2|||
161967940|NCT00856206|584929234|FG001|Overall Study|Death|2|||
161967941|NCT00856206|584929233|FG000|Overall Study|Decision by the Sponsor|4|||
161967942|NCT00856206|584929234|FG001|Overall Study|Decision by the Sponsor|8|||
161967943|NCT00856206|584929233|FG000|Overall Study|Other than specified above|3|||
161844157|NCT01696279|584472346|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
161844158|NCT01696279|584472347|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
161844159|NCT01696279|584472348|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
161844160|NCT01696279|584472345|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
161844161|NCT01696279|584472346|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
161844162|NCT01696279|584472347|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
161844163|NCT01696279|584472348|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
161844164|NCT01696279|584472345|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
161844165|NCT01696279|584472346|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
161844166|NCT01696279|584472347|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
161844167|NCT01696279|584472348|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
161844168|NCT01696279|584472345|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
161844169|NCT01696279|584472346|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
161844170|NCT01696279|584472347|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
161844171|NCT01696279|584472348|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
161844172|NCT06077149|584472349|FG000|Overall Study|Death|1|||
161844173|NCT06077149|584472350|FG001|Overall Study|Death|0|||
161844174|NCT06077149|584472349|FG000|Overall Study|Withdrawal by Subject|2|||
161844175|NCT06077149|584472350|FG001|Overall Study|Withdrawal by Subject|0|||
161844176|NCT06077149|584472349|FG000|Overall Study|RSV infection before vaccination|3|||
161844177|NCT06077149|584472350|FG001|Overall Study|RSV infection before vaccination|0|||
161844178|NCT04658095|584472351|FG000|Overall Study|Study terminated|5|||
161844179|NCT04658095|584472352|FG001|Overall Study|Study terminated|1|||
161844180|NCT04658095|584472353|FG002|Overall Study|Study terminated|4|||
161844181|NCT04154631|584472354|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
161844182|NCT04154631|584472355|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
161844183|NCT01441947|584472356|FG000|Overall Study|Withdrawal by Subject|3|||
161844184|NCT01441947|584472357|FG001|Overall Study|Withdrawal by Subject|0|||
161844185|NCT01341782|584472359|FG000|Overall Study|Adverse Event|1|||
161844186|NCT01341782|584472360|FG001|Overall Study|Adverse Event|1|||
161844187|NCT01341782|584472359|FG000|Overall Study|Withdrawal by Subject|6|||
161844188|NCT01341782|584472360|FG001|Overall Study|Withdrawal by Subject|5|||
161844189|NCT01341782|584472359|FG000|Overall Study|Missed 3 consecutive doses|0|||
161844190|NCT01341782|584472360|FG001|Overall Study|Missed 3 consecutive doses|4|||
161844191|NCT01341782|584472359|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
161844192|NCT01341782|584472360|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
161844193|NCT01341782|584472359|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
161844194|NCT01341782|584472360|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
161844195|NCT01341782|584472359|FG000|Overall Study|Other|5|||
161844196|NCT01341782|584472360|FG001|Overall Study|Other|0|||
161844197|NCT02036775|584472361|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161844198|NCT02036775|584472362|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161844199|NCT02036775|584472363|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161844200|NCT02036775|584472364|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161844201|NCT02036775|584472365|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161844202|NCT02036775|584472366|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
161844203|NCT02927366|584472368|FG000|Overall Study|Adverse Event|1|||
161844204|NCT02927366|584472369|FG001|Overall Study|Adverse Event|0|||
161844205|NCT02927366|584472368|FG000|Overall Study|Patient schedule|1|||
161844206|NCT02927366|584472369|FG001|Overall Study|Patient schedule|0|||
161844207|NCT03496610|584472372|FG000|Overall Study|Lost to Follow-up|3|||
161844208|NCT03496610|584472373|FG001|Overall Study|Lost to Follow-up|2|||
161844209|NCT03496610|584472372|FG000|Overall Study|Physician Decision|1|||
161844210|NCT03496610|584472373|FG001|Overall Study|Physician Decision|0|||
161844211|NCT03496610|584472372|FG000|Overall Study|Withdrawal by Subject|1|||
161844212|NCT03496610|584472373|FG001|Overall Study|Withdrawal by Subject|0|||
161844213|NCT00426361|584472374|FG000|Overall Study|Lost to Follow-up|3|||
161967944|NCT00856206|584929234|FG001|Overall Study|Other than specified above|10|||
161967945|NCT00503581|584929237|FG000|Overall Study|Study closed|3|||
161844214|NCT00426361|584472375|FG001|Overall Study|Lost to Follow-up|2|||
161844215|NCT00426361|584472376|FG002|Overall Study|Lost to Follow-up|5|||
161844216|NCT00426361|584472374|FG000|Overall Study|Withdrawal by Subject|1|||
161844217|NCT00426361|584472375|FG001|Overall Study|Withdrawal by Subject|3|||
161967946|NCT00503581|584929238|FG001|Overall Study|Study closed|4|||
161967947|NCT00503581|584929239|FG002|Overall Study|Study closed|2|||
161844218|NCT00426361|584472376|FG002|Overall Study|Withdrawal by Subject|0|||
161844219|NCT04669691|584472377|FG000|Overall Study|Death|0|||
161844220|NCT04669691|584472378|FG001|Overall Study|Death|1|||
161844221|NCT04669691|584472379|FG002|Overall Study|Death|0|||
161844222|NCT04669691|584472380|FG003|Overall Study|Death|0|||
161967948|NCT02780856|584929240|FG000|Overall Study|Lost to Follow-up|1|||
161844223|NCT04669691|584472381|FG004|Overall Study|Death|0|||
161844224|NCT04669691|584472382|FG005|Overall Study|Death|0|||
161967949|NCT01301066|584929244|FG000|Overall Study|Lost to Follow-up|5|||
161967950|NCT01301066|584929245|FG001|Overall Study|Lost to Follow-up|11|||
161844225|NCT01753336|584472383|FG000|Overall Study|Patient decision|12|||
161844226|NCT01753336|584472383|FG000|Overall Study|Lost to Follow-up|3|||
161844227|NCT01753336|584472383|FG000|Overall Study|Physician Decision|2|||
161844228|NCT01753336|584472383|FG000|Overall Study|Sponsor's decision|2|||
161844229|NCT01753336|584472383|FG000|Overall Study|Withdrawal by Subject|1|||
161844230|NCT01121666|584472384|FG000|Overall Study|Protocol Violation|29|||
161844231|NCT01121666|584472385|FG001|Overall Study|Protocol Violation|10|||
161844232|NCT03201211|584472388|FG000|Overall Study|Adverse Event|1|||
161844233|NCT03201211|584472389|FG001|Overall Study|Adverse Event|0|||
161844234|NCT03201211|584472390|FG002|Overall Study|Adverse Event|0|||
161844235|NCT03201211|584472388|FG000|Overall Study|Protocol Violation|1|||
161844236|NCT03201211|584472389|FG001|Overall Study|Protocol Violation|0|||
161844237|NCT03201211|584472390|FG002|Overall Study|Protocol Violation|0|||
161844238|NCT03201211|584472388|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161844239|NCT03201211|584472389|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161844240|NCT03201211|584472390|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
161844241|NCT03201211|584472388|FG000|Overall Study|OTHER unknown reasons|0|||
161844242|NCT03201211|584472389|FG001|Overall Study|OTHER unknown reasons|1|||
161844243|NCT03201211|584472390|FG002|Overall Study|OTHER unknown reasons|0|||
161844244|NCT01970865|584472391|FG000|Overall Study|Death|3|||
161844245|NCT01970865|584472392|FG001|Overall Study|Death|2|||
161844246|NCT01970865|584472393|FG002|Overall Study|Death|3|||
161844247|NCT01970865|584472394|FG003|Overall Study|Death|6|||
161844248|NCT01970865|584472395|FG004|Overall Study|Death|9|||
161844249|NCT01970865|584472396|FG005|Overall Study|Death|3|||
161844250|NCT01970865|584472397|FG006|Overall Study|Death|2|||
161844251|NCT01970865|584472398|FG007|Overall Study|Death|3|||
161844252|NCT01970865|584472399|FG008|Overall Study|Death|2|||
161844253|NCT01970865|584472400|FG009|Overall Study|Death|2|||
161844254|NCT01970865|584472401|FG010|Overall Study|Death|8|||
161844255|NCT01970865|584472402|FG011|Overall Study|Death|13|||
161844256|NCT01970865|584472403|FG012|Overall Study|Death|25|||
161844257|NCT01970865|584472404|FG013|Overall Study|Death|46|||
161844258|NCT01970865|584472405|FG014|Overall Study|Death|37|||
161844259|NCT01970865|584472406|FG015|Overall Study|Death|22|||
161844260|NCT01970865|584472407|FG016|Overall Study|Death|1|||
161844261|NCT01970865|584472408|FG017|Overall Study|Death|17|||
161844262|NCT01970865|584472391|FG000|Overall Study|Lost to Follow-up|0|||
161844263|NCT01970865|584472392|FG001|Overall Study|Lost to Follow-up|0|||
161844264|NCT01970865|584472393|FG002|Overall Study|Lost to Follow-up|0|||
161844265|NCT01970865|584472394|FG003|Overall Study|Lost to Follow-up|1|||
161844266|NCT01970865|584472395|FG004|Overall Study|Lost to Follow-up|1|||
161844267|NCT01970865|584472396|FG005|Overall Study|Lost to Follow-up|0|||
161844268|NCT01970865|584472397|FG006|Overall Study|Lost to Follow-up|0|||
161844269|NCT01970865|584472398|FG007|Overall Study|Lost to Follow-up|0|||
161844270|NCT01970865|584472399|FG008|Overall Study|Lost to Follow-up|0|||
161844271|NCT01970865|584472400|FG009|Overall Study|Lost to Follow-up|0|||
161844272|NCT01970865|584472401|FG010|Overall Study|Lost to Follow-up|1|||
161844273|NCT01970865|584472402|FG011|Overall Study|Lost to Follow-up|0|||
161844274|NCT01970865|584472403|FG012|Overall Study|Lost to Follow-up|2|||
161844275|NCT01970865|584472404|FG013|Overall Study|Lost to Follow-up|0|||
161844276|NCT01970865|584472405|FG014|Overall Study|Lost to Follow-up|1|||
161844277|NCT01970865|584472406|FG015|Overall Study|Lost to Follow-up|4|||
161844278|NCT01970865|584472407|FG016|Overall Study|Lost to Follow-up|0|||
161844279|NCT01970865|584472408|FG017|Overall Study|Lost to Follow-up|1|||
161844280|NCT01970865|584472391|FG000|Overall Study|Other|0|||
161844281|NCT01970865|584472392|FG001|Overall Study|Other|1|||
161844282|NCT01970865|584472393|FG002|Overall Study|Other|0|||
161844283|NCT01970865|584472394|FG003|Overall Study|Other|1|||
161844284|NCT01970865|584472395|FG004|Overall Study|Other|1|||
161844285|NCT01970865|584472396|FG005|Overall Study|Other|0|||
161844286|NCT01970865|584472397|FG006|Overall Study|Other|1|||
161844287|NCT01970865|584472398|FG007|Overall Study|Other|0|||
161844288|NCT01970865|584472399|FG008|Overall Study|Other|0|||
161844289|NCT01970865|584472400|FG009|Overall Study|Other|0|||
161844290|NCT01970865|584472401|FG010|Overall Study|Other|2|||
161844291|NCT01970865|584472402|FG011|Overall Study|Other|3|||
161844292|NCT01970865|584472403|FG012|Overall Study|Other|8|||
161844293|NCT01970865|584472404|FG013|Overall Study|Other|3|||
161844294|NCT01970865|584472405|FG014|Overall Study|Other|2|||
161844295|NCT01970865|584472406|FG015|Overall Study|Other|3|||
161844296|NCT01970865|584472407|FG016|Overall Study|Other|0|||
161844297|NCT01970865|584472408|FG017|Overall Study|Other|2|||
161844298|NCT01970865|584472391|FG000|Overall Study|Participant refused further follow-up|0|||
161844299|NCT01970865|584472392|FG001|Overall Study|Participant refused further follow-up|0|||
161844300|NCT01970865|584472393|FG002|Overall Study|Participant refused further follow-up|0|||
161844301|NCT01970865|584472394|FG003|Overall Study|Participant refused further follow-up|2|||
161844302|NCT01970865|584472395|FG004|Overall Study|Participant refused further follow-up|3|||
161844303|NCT01970865|584472396|FG005|Overall Study|Participant refused further follow-up|0|||
161844304|NCT01970865|584472397|FG006|Overall Study|Participant refused further follow-up|0|||
161844305|NCT01970865|584472398|FG007|Overall Study|Participant refused further follow-up|0|||
161844306|NCT01970865|584472399|FG008|Overall Study|Participant refused further follow-up|0|||
161844307|NCT01970865|584472400|FG009|Overall Study|Participant refused further follow-up|0|||
161844308|NCT01970865|584472401|FG010|Overall Study|Participant refused further follow-up|1|||
161844309|NCT01970865|584472402|FG011|Overall Study|Participant refused further follow-up|4|||
161844310|NCT01970865|584472403|FG012|Overall Study|Participant refused further follow-up|7|||
161844311|NCT01970865|584472404|FG013|Overall Study|Participant refused further follow-up|8|||
161844312|NCT01970865|584472405|FG014|Overall Study|Participant refused further follow-up|3|||
161844313|NCT01970865|584472406|FG015|Overall Study|Participant refused further follow-up|11|||
161844314|NCT01970865|584472407|FG016|Overall Study|Participant refused further follow-up|0|||
161844315|NCT01970865|584472408|FG017|Overall Study|Participant refused further follow-up|6|||
161844316|NCT01629966|584472409|FG000|Overall Study|Pregnancy|0|||
161844317|NCT01629966|584472410|FG001|Overall Study|Pregnancy|1|||
161844318|NCT01629966|584472411|FG002|Overall Study|Pregnancy|0|||
161844319|NCT01629966|584472409|FG000|Overall Study|Lost to Follow-up|10|||
161844320|NCT01629966|584472410|FG001|Overall Study|Lost to Follow-up|13|||
161844321|NCT01629966|584472411|FG002|Overall Study|Lost to Follow-up|9|||
161844322|NCT01629966|584472409|FG000|Overall Study|Withdrawal by Subject|8|||
161844323|NCT01629966|584472410|FG001|Overall Study|Withdrawal by Subject|9|||
161844324|NCT01629966|584472411|FG002|Overall Study|Withdrawal by Subject|16|||
161844325|NCT01629966|584472409|FG000|Overall Study|Protocol Violation|7|||
161844326|NCT01629966|584472410|FG001|Overall Study|Protocol Violation|9|||
161844327|NCT01629966|584472411|FG002|Overall Study|Protocol Violation|7|||
161844328|NCT01629966|584472409|FG000|Overall Study|Lack of Efficacy|5|||
161844329|NCT01629966|584472410|FG001|Overall Study|Lack of Efficacy|2|||
161844330|NCT01629966|584472411|FG002|Overall Study|Lack of Efficacy|4|||
161844331|NCT01629966|584472409|FG000|Overall Study|Adverse Event|11|||
161844332|NCT01629966|584472410|FG001|Overall Study|Adverse Event|18|||
161844333|NCT01629966|584472411|FG002|Overall Study|Adverse Event|30|||
161844334|NCT04430855|584472412|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
161844335|NCT04430855|584472413|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
161844336|NCT04430855|584472412|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
161844337|NCT04430855|584472413|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
161844338|NCT04430855|584472412|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
161844339|NCT04430855|584472413|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
161844340|NCT04430855|584472412|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
161844341|NCT04430855|584472413|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
161844342|NCT04430855|584472412|FG000|Period 1 (Weeks 1-12)|Other|0|||
161844343|NCT04430855|584472413|FG001|Period 1 (Weeks 1-12)|Other|1|||
161844344|NCT04430855|584472412|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
161844345|NCT04430855|584472413|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
161844346|NCT04430855|584472412|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
161844347|NCT04430855|584472413|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
161844348|NCT04430855|584472412|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
161844349|NCT04430855|584472413|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
161844350|NCT01770392|584472419|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
161844351|NCT03401450|584472420|FG000|Overall Study|Lost to Follow-up|4|||
161844352|NCT03401450|584472421|FG001|Overall Study|Lost to Follow-up|6|||
161844353|NCT03401450|584472420|FG000|Overall Study|Anesthesia plan changed|2|||
161844354|NCT03401450|584472421|FG001|Overall Study|Anesthesia plan changed|2|||
161844355|NCT03401450|584472420|FG000|Overall Study|Did not complete medication diary|4|||
161844356|NCT03401450|584472421|FG001|Overall Study|Did not complete medication diary|2|||
161844357|NCT03401450|584472420|FG000|Overall Study|post surgery medication change|2|||
161844358|NCT03401450|584472421|FG001|Overall Study|post surgery medication change|1|||
161844359|NCT03401450|584472420|FG000|Overall Study|Cancelled surgery|0|||
161844360|NCT03401450|584472421|FG001|Overall Study|Cancelled surgery|2|||
161844361|NCT00228423|584472422|FG000|Overall Study|Adverse Event|2|||
161844362|NCT00228423|584472423|FG001|Overall Study|Adverse Event|5|||
161844363|NCT00228423|584472422|FG000|Overall Study|Withdrawal by Subject|7|||
161844364|NCT00228423|584472423|FG001|Overall Study|Withdrawal by Subject|3|||
161844365|NCT00228423|584472422|FG000|Overall Study|Protocol Violation|1|||
161844366|NCT00228423|584472423|FG001|Overall Study|Protocol Violation|3|||
161844367|NCT00228423|584472422|FG000|Overall Study|Physician Decision|0|||
161967951|NCT01301066|584929244|FG000|Overall Study|Protocol Violation|8|||
161967952|NCT01301066|584929245|FG001|Overall Study|Protocol Violation|7|||
161967953|NCT01301066|584929244|FG000|Overall Study|Withdrawal by Subject|4|||
161967954|NCT01301066|584929245|FG001|Overall Study|Withdrawal by Subject|9|||
161844368|NCT00228423|584472423|FG001|Overall Study|Physician Decision|1|||
161844369|NCT00390221|584472424|FG000|Overall Study|Lost to Follow-up|0|||
161844370|NCT00390221|584472425|FG001|Overall Study|Lost to Follow-up|3|||
161844371|NCT00390221|584472426|FG002|Overall Study|Lost to Follow-up|0|||
161844372|NCT00390221|584472424|FG000|Overall Study|Adverse Event|1|||
161844373|NCT00390221|584472425|FG001|Overall Study|Adverse Event|4|||
161844374|NCT00390221|584472426|FG002|Overall Study|Adverse Event|3|||
161844375|NCT00390221|584472424|FG000|Overall Study|Investigator Decision|0|||
161844376|NCT00390221|584472425|FG001|Overall Study|Investigator Decision|0|||
161844377|NCT00390221|584472426|FG002|Overall Study|Investigator Decision|1|||
161967955|NCT01301066|584929244|FG000|Overall Study|Adverse Event|6|||
161967956|NCT01301066|584929245|FG001|Overall Study|Adverse Event|6|||
161967957|NCT01301066|584929244|FG000|Overall Study|Sponsor Decision|2|||
161967958|NCT01301066|584929245|FG001|Overall Study|Sponsor Decision|1|||
161967959|NCT01301066|584929244|FG000|Overall Study|Physician Decision|0|||
161967960|NCT01301066|584929245|FG001|Overall Study|Physician Decision|1|||
161967961|NCT01301066|584929244|FG000|Overall Study|Other|2|||
161967962|NCT01301066|584929245|FG001|Overall Study|Other|0|||
161967963|NCT04003207|584929250|FG000|Overall Study|Protocol Violation|1|||
161967964|NCT03894969|584929253|FG000|Overall Study|Adverse Event|0|||
161967965|NCT03894969|584929254|FG001|Overall Study|Adverse Event|2|||
161967966|NCT03894969|584929255|FG002|Overall Study|Adverse Event|0|||
161751137|NCT03938636|584128433|FG001|Overall Study|Missed visit|1|||
161751138|NCT03938636|584128434|FG002|Overall Study|Missed visit|0|||
161844378|NCT00390221|584472424|FG000|Overall Study|Withdrawal by Subject|13|||
161844379|NCT00390221|584472425|FG001|Overall Study|Withdrawal by Subject|9|||
161844380|NCT00390221|584472426|FG002|Overall Study|Withdrawal by Subject|7|||
161844381|NCT00390221|584472424|FG000|Overall Study|Subject Non-compliance|1|||
161844382|NCT00390221|584472425|FG001|Overall Study|Subject Non-compliance|0|||
161844383|NCT00390221|584472426|FG002|Overall Study|Subject Non-compliance|2|||
161844384|NCT00390221|584472424|FG000|Overall Study|Other|3|||
161844385|NCT00390221|584472425|FG001|Overall Study|Other|4|||
161844386|NCT00390221|584472426|FG002|Overall Study|Other|2|||
161844387|NCT01709838|584472443|FG000|Overall Study|Withdrawal by Subject|21|||
161844388|NCT01709838|584472443|FG000|Overall Study|Lost to Follow-up|16|||
161844389|NCT01709838|584472443|FG000|Overall Study|Pregnancy|10|||
161844390|NCT01709838|584472443|FG000|Overall Study|Subject/guardian decision|8|||
161844391|NCT01709838|584472443|FG000|Overall Study|Adverse Event|4|||
161967967|NCT03894969|584929256|FG003|Overall Study|Adverse Event|1|||
161751139|NCT03938636|584128432|FG000|Overall Study|Adverse Event|0|||
161751140|NCT03938636|584128433|FG001|Overall Study|Adverse Event|0|||
161751141|NCT03938636|584128434|FG002|Overall Study|Adverse Event|1|||
161751142|NCT03938636|584128432|FG000|Overall Study|Lost to Follow-up|0|||
161751143|NCT03938636|584128433|FG001|Overall Study|Lost to Follow-up|0|||
161751144|NCT03938636|584128434|FG002|Overall Study|Lost to Follow-up|1|||
161751145|NCT00216086|584128435|FG000|Overall Study|Protocol Violation|1|||
161751146|NCT00216086|584128435|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
161751147|NCT00216086|584128435|FG000|Overall Study|Social Reasons|2|||
161751148|NCT01080625|584128442|FG000|Overall Study|Physician Decision|0|||
161751149|NCT01080625|584128443|FG001|Overall Study|Physician Decision|2|||
161751150|NCT01080625|584128444|FG002|Overall Study|Physician Decision|1|||
161751151|NCT01587274|584128447|FG000|Overall Study|Lost to Follow-up|4|||
161751152|NCT01587274|584128448|FG001|Overall Study|Lost to Follow-up|5|||
161751153|NCT01587274|584128449|FG002|Overall Study|Lost to Follow-up|3|||
161751154|NCT03236506|584128457|FG000|Overall Study|Death|1|||
161751155|NCT03236506|584128458|FG001|Overall Study|Death|1|||
161751156|NCT03236506|584128459|FG002|Overall Study|Death|1|||
161751157|NCT03236506|584128457|FG000|Overall Study|Withdrawal by Subject|3|||
161751158|NCT03236506|584128458|FG001|Overall Study|Withdrawal by Subject|3|||
161751159|NCT03236506|584128459|FG002|Overall Study|Withdrawal by Subject|4|||
161751160|NCT03236506|584128457|FG000|Overall Study|Did not initiate treatment|2|||
161751161|NCT03236506|584128458|FG001|Overall Study|Did not initiate treatment|1|||
161751162|NCT03236506|584128459|FG002|Overall Study|Did not initiate treatment|2|||
161751163|NCT00422669|584128468|FG000|Overall Study|The study was terminated early.|98|||
161751164|NCT00422669|584128469|FG001|Overall Study|The study was terminated early.|100|||
161751165|NCT00422669|584128470|FG002|Overall Study|The study was terminated early.|7|||
161751166|NCT02709109|584128471|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
161751167|NCT02709109|584128472|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
161751168|NCT02709109|584128473|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
161751169|NCT02709109|584128474|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
161751170|NCT02709109|584128471|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
161751171|NCT02709109|584128472|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
161751172|NCT02709109|584128473|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
161751173|NCT02709109|584128474|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
161844392|NCT01709838|584472443|FG000|Overall Study|Physician Decision|4|||
161844393|NCT01709838|584472443|FG000|Overall Study|Death|3|||
161844394|NCT01709838|584472443|FG000|Overall Study|Protocol Violation|1|||
161967968|NCT03894969|584929257|FG004|Overall Study|Adverse Event|2|||
161967969|NCT03894969|584929253|FG000|Overall Study|Lost to Follow-up|3|||
161967970|NCT03894969|584929254|FG001|Overall Study|Lost to Follow-up|1|||
161751174|NCT02709109|584128471|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
161751175|NCT02709109|584128472|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
161844395|NCT00620659|584472444|FG000|Treatment Period 1|Adverse Event|1|||
161844396|NCT00620659|584472445|FG001|Treatment Period 1|Adverse Event|0|||
161844397|NCT00620659|584472446|FG002|Treatment Period 1|Adverse Event|0|||
161844398|NCT00620659|584472447|FG003|Treatment Period 1|Adverse Event|3|||
161967971|NCT03894969|584929255|FG002|Overall Study|Lost to Follow-up|1|||
161967972|NCT03894969|584929256|FG003|Overall Study|Lost to Follow-up|0|||
161844399|NCT00620659|584472448|FG004|Treatment Period 1|Adverse Event|0|||
161844400|NCT00620659|584472449|FG005|Treatment Period 1|Adverse Event|0|||
161844401|NCT00620659|584472444|FG000|Treatment Period 1|Protocol Violation|1|||
161844402|NCT00620659|584472445|FG001|Treatment Period 1|Protocol Violation|0|||
161844403|NCT00620659|584472446|FG002|Treatment Period 1|Protocol Violation|0|||
161844404|NCT00620659|584472447|FG003|Treatment Period 1|Protocol Violation|0|||
161844405|NCT00620659|584472448|FG004|Treatment Period 1|Protocol Violation|0|||
161844406|NCT00620659|584472449|FG005|Treatment Period 1|Protocol Violation|0|||
161844407|NCT00620659|584472444|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161844408|NCT00620659|584472445|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161844409|NCT00620659|584472446|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161844410|NCT00620659|584472447|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161844411|NCT00620659|584472448|FG004|Treatment Period 1|Withdrawal by Subject|1|||
161844412|NCT00620659|584472449|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161967973|NCT03894969|584929257|FG004|Overall Study|Lost to Follow-up|0|||
161967974|NCT03894969|584929253|FG000|Overall Study|Withdrawal by Subject|2|||
161967975|NCT03894969|584929254|FG001|Overall Study|Withdrawal by Subject|1|||
161967976|NCT03894969|584929255|FG002|Overall Study|Withdrawal by Subject|3|||
161967977|NCT03894969|584929256|FG003|Overall Study|Withdrawal by Subject|4|||
161967978|NCT03894969|584929257|FG004|Overall Study|Withdrawal by Subject|8|||
161967979|NCT03894969|584929253|FG000|Overall Study|Other|0|||
161967980|NCT03894969|584929254|FG001|Overall Study|Other|0|||
161967981|NCT03894969|584929255|FG002|Overall Study|Other|0|||
161967982|NCT03894969|584929256|FG003|Overall Study|Other|0|||
161967983|NCT03894969|584929257|FG004|Overall Study|Other|3|||
161967984|NCT03894969|584929253|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
161967985|NCT03894969|584929254|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
161967986|NCT03894969|584929255|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
161967987|NCT03894969|584929256|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
161967988|NCT03894969|584929257|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
161967989|NCT03894969|584929253|FG000|Overall Study|Solicited Adverse Event|0|||
161967990|NCT03894969|584929254|FG001|Overall Study|Solicited Adverse Event|1|||
161967991|NCT03894969|584929255|FG002|Overall Study|Solicited Adverse Event|0|||
161967992|NCT03894969|584929256|FG003|Overall Study|Solicited Adverse Event|0|||
161967993|NCT03894969|584929257|FG004|Overall Study|Solicited Adverse Event|0|||
161967994|NCT00468676|584929258|FG000|Overall Study|Lost to Follow-up|14|||
161967995|NCT00468676|584929259|FG001|Overall Study|Lost to Follow-up|11|||
161967996|NCT00468676|584929258|FG000|Overall Study|Death|2|||
161967997|NCT00468676|584929259|FG001|Overall Study|Death|1|||
161967998|NCT03099174|584929262|FG000|Overall Study|Withdrawal by Subject|0|||
161967999|NCT03099174|584929263|FG001|Overall Study|Withdrawal by Subject|0|||
161968000|NCT03099174|584929264|FG002|Overall Study|Withdrawal by Subject|1|||
161844413|NCT00620659|584472444|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
161844414|NCT00620659|584472445|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
161968001|NCT03099174|584929265|FG003|Overall Study|Withdrawal by Subject|0|||
161968002|NCT03099174|584929266|FG004|Overall Study|Withdrawal by Subject|2|||
161751176|NCT02709109|584128473|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
161751177|NCT02709109|584128474|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
161751178|NCT02709109|584128471|FG000|Washout Period (28 Days)|Other|2|||
161751179|NCT02709109|584128472|FG001|Washout Period (28 Days)|Other|2|||
161751180|NCT02709109|584128473|FG002|Washout Period (28 Days)|Other|3|||
161751181|NCT02709109|584128474|FG003|Washout Period (28 Days)|Other|0|||
161751182|NCT02709109|584128471|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
161751183|NCT02709109|584128472|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
161751184|NCT02709109|584128473|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
161751185|NCT02709109|584128474|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
161751186|NCT02709109|584128471|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
161751187|NCT02709109|584128472|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
161751188|NCT02709109|584128473|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
161751189|NCT02709109|584128474|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
161751190|NCT02709109|584128471|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
161751191|NCT02709109|584128472|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
161751192|NCT02709109|584128473|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
161751193|NCT02709109|584128474|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
161844415|NCT00620659|584472446|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
161844416|NCT00620659|584472447|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
161968003|NCT03099174|584929267|FG005|Overall Study|Withdrawal by Subject|2|||
161968004|NCT03099174|584929268|FG006|Overall Study|Withdrawal by Subject|1|||
161968005|NCT03099174|584929269|FG007|Overall Study|Withdrawal by Subject|4|||
161968006|NCT03099174|584929262|FG000|Overall Study|Adverse Event|0|||
161968007|NCT03099174|584929263|FG001|Overall Study|Adverse Event|1|||
161968008|NCT03099174|584929264|FG002|Overall Study|Adverse Event|1|||
161968009|NCT03099174|584929265|FG003|Overall Study|Adverse Event|2|||
161968010|NCT03099174|584929266|FG004|Overall Study|Adverse Event|5|||
161968011|NCT03099174|584929267|FG005|Overall Study|Adverse Event|3|||
161968012|NCT03099174|584929268|FG006|Overall Study|Adverse Event|6|||
161968013|NCT03099174|584929269|FG007|Overall Study|Adverse Event|4|||
161968014|NCT03099174|584929262|FG000|Overall Study|Other than listed|6|||
161968015|NCT03099174|584929263|FG001|Overall Study|Other than listed|6|||
161968016|NCT03099174|584929264|FG002|Overall Study|Other than listed|5|||
161968017|NCT03099174|584929265|FG003|Overall Study|Other than listed|6|||
161968018|NCT03099174|584929266|FG004|Overall Study|Other than listed|19|||
161968019|NCT03099174|584929267|FG005|Overall Study|Other than listed|10|||
161968020|NCT03099174|584929268|FG006|Overall Study|Other than listed|26|||
161968021|NCT03099174|584929269|FG007|Overall Study|Other than listed|23|||
161751194|NCT02709109|584128471|FG000|Treatment Period 2 (28 Days)|Other|0|||
161751195|NCT02709109|584128472|FG001|Treatment Period 2 (28 Days)|Other|0|||
161751196|NCT02709109|584128473|FG002|Treatment Period 2 (28 Days)|Other|1|||
161751197|NCT02709109|584128474|FG003|Treatment Period 2 (28 Days)|Other|0|||
161751198|NCT02565615|584128476|FG000|Overall Study|Death|0|||
161751199|NCT02565615|584128477|FG001|Overall Study|Death|1|||
161751200|NCT02565615|584128478|FG002|Overall Study|Death|0|||
161751201|NCT02565615|584128479|FG003|Overall Study|Death|0|||
161751202|NCT02565615|584128480|FG004|Overall Study|Death|4|||
161751203|NCT02565615|584128476|FG000|Overall Study|Not willing to participate in study|2|||
161751204|NCT02565615|584128477|FG001|Overall Study|Not willing to participate in study|21|||
161751205|NCT02565615|584128478|FG002|Overall Study|Not willing to participate in study|0|||
162032687|NCT01933789|585177451|FG001|Overall Study|Withdrawal by Subject|1|||
161751206|NCT02565615|584128479|FG003|Overall Study|Not willing to participate in study|1|||
161751207|NCT02565615|584128480|FG004|Overall Study|Not willing to participate in study|169|||
161751208|NCT02565615|584128476|FG000|Overall Study|Lost to Follow-up|0|||
161751209|NCT02565615|584128477|FG001|Overall Study|Lost to Follow-up|4|||
161751210|NCT02565615|584128478|FG002|Overall Study|Lost to Follow-up|0|||
161751211|NCT02565615|584128479|FG003|Overall Study|Lost to Follow-up|1|||
161751212|NCT02565615|584128480|FG004|Overall Study|Lost to Follow-up|765|||
161751213|NCT02565615|584128476|FG000|Overall Study|Not meeting eligibility criteria|0|||
161751214|NCT02565615|584128477|FG001|Overall Study|Not meeting eligibility criteria|7|||
161751215|NCT02565615|584128478|FG002|Overall Study|Not meeting eligibility criteria|0|||
161751216|NCT02565615|584128479|FG003|Overall Study|Not meeting eligibility criteria|0|||
161751217|NCT02565615|584128480|FG004|Overall Study|Not meeting eligibility criteria|25|||
161751218|NCT02565615|584128476|FG000|Overall Study|Reason not defined|0|||
161751219|NCT02565615|584128477|FG001|Overall Study|Reason not defined|2|||
161751220|NCT02565615|584128478|FG002|Overall Study|Reason not defined|0|||
161751221|NCT02565615|584128479|FG003|Overall Study|Reason not defined|1|||
161751222|NCT02565615|584128480|FG004|Overall Study|Reason not defined|62|||
161751223|NCT02565615|584128476|FG000|Overall Study|Adverse Event|1|||
161751224|NCT02565615|584128477|FG001|Overall Study|Adverse Event|1|||
161751225|NCT02565615|584128478|FG002|Overall Study|Adverse Event|0|||
161751226|NCT02565615|584128479|FG003|Overall Study|Adverse Event|0|||
161751227|NCT02565615|584128480|FG004|Overall Study|Adverse Event|9|||
161751228|NCT02565615|584128476|FG000|Overall Study|Untreated|0|||
161751229|NCT02565615|584128477|FG001|Overall Study|Untreated|0|||
161751230|NCT02565615|584128478|FG002|Overall Study|Untreated|0|||
161751231|NCT02565615|584128479|FG003|Overall Study|Untreated|0|||
161751232|NCT02565615|584128480|FG004|Overall Study|Untreated|567|||
161751233|NCT01815580|584128484|FG000|Overall Study|Lost to Follow-up|4|||
161751234|NCT01815580|584128485|FG001|Overall Study|Lost to Follow-up|7|||
161751235|NCT01815580|584128484|FG000|Overall Study|Withdrawal by Subject|3|||
161751236|NCT01815580|584128485|FG001|Overall Study|Withdrawal by Subject|4|||
161751237|NCT01815580|584128484|FG000|Overall Study|Excluded from analysis|5|||
161751238|NCT01815580|584128485|FG001|Overall Study|Excluded from analysis|4|||
161751239|NCT00023712|584128488|FG000|Overall Study|Not platinum sensitive|1|||
162032688|NCT01933789|585177452|FG002|Overall Study|Withdrawal by Subject|0|||
162032689|NCT01933789|585177453|FG003|Overall Study|Withdrawal by Subject|0|||
162032690|NCT01933789|585177454|FG004|Overall Study|Withdrawal by Subject|17|||
161751240|NCT00023712|584128489|FG001|Overall Study|Not platinum sensitive|0|||
161751241|NCT00023712|584128488|FG000|Overall Study|Never treated|1|||
161751242|NCT00023712|584128489|FG001|Overall Study|Never treated|1|||
161751243|NCT00437203|584128490|FG000|Overall Study|Death|0|||
162032691|NCT01933789|585177455|FG005|Overall Study|Withdrawal by Subject|16|||
161751244|NCT00437203|584128491|FG001|Overall Study|Death|0|||
161751245|NCT00437203|584128492|FG002|Overall Study|Death|1|||
161751246|NCT00437203|584128493|FG003|Overall Study|Death|0|||
161968022|NCT03219034|584929270|FG000|Overall Study|Lost to Follow-up|9|||
162032692|NCT01933789|585177456|FG006|Overall Study|Withdrawal by Subject|1|||
162032693|NCT01933789|585177457|FG007|Overall Study|Withdrawal by Subject|4|||
161751247|NCT00437203|584128494|FG004|Overall Study|Death|0|||
161751248|NCT00437203|584128495|FG005|Overall Study|Death|0|||
161968023|NCT03219034|584929271|FG001|Overall Study|Lost to Follow-up|13|||
161968024|NCT03219034|584929270|FG000|Overall Study|Additional dental work needed|1|||
161751249|NCT00437203|584128496|FG006|Overall Study|Death|0|||
161751250|NCT00437203|584128497|FG007|Overall Study|Death|1|||
162032694|NCT01933789|585177458|FG008|Overall Study|Withdrawal by Subject|0|||
161751251|NCT00437203|584128498|FG008|Overall Study|Death|0|||
161751252|NCT00437203|584128499|FG009|Overall Study|Death|1|||
161968025|NCT03219034|584929271|FG001|Overall Study|Additional dental work needed|0|||
161968026|NCT03219034|584929270|FG000|Overall Study|UPPP Surgery|1|||
161968027|NCT03219034|584929271|FG001|Overall Study|UPPP Surgery|0|||
161968028|NCT03219034|584929270|FG000|Overall Study|Dental sensitivity|0|||
161968029|NCT03219034|584929271|FG001|Overall Study|Dental sensitivity|1|||
161968030|NCT03219034|584929270|FG000|Overall Study|Death in family|0|||
161968031|NCT03219034|584929271|FG001|Overall Study|Death in family|1|||
161968032|NCT02438683|584929275|FG000|Overall Study|Adverse Event|1|||
161968033|NCT02438683|584929276|FG001|Overall Study|Adverse Event|0|||
161968034|NCT02438683|584929277|FG002|Overall Study|Adverse Event|0|||
161968035|NCT02438683|584929278|FG003|Overall Study|Adverse Event|0|||
161968036|NCT02438683|584929279|FG004|Overall Study|Adverse Event|0|||
161968037|NCT02438683|584929280|FG005|Overall Study|Adverse Event|0|||
161968038|NCT00721578|584929281|FG000|Overall Study|Death|1|||
161968039|NCT00721578|584929282|FG001|Overall Study|Death|1|||
161968040|NCT00721578|584929281|FG000|Overall Study|Withdrawal by Subject|1|||
161968041|NCT00721578|584929282|FG001|Overall Study|Withdrawal by Subject|1|||
161968042|NCT00082368|584929293|FG000|Overall Study|Not treated-pt had poor IV access|1|||
161968043|NCT02825420|584929295|FG000|Overall Study|Death|30|||
161968044|NCT02825420|584929296|FG001|Overall Study|Death|12|||
161968045|NCT02825420|584929295|FG000|Overall Study|Progressive disease|6|||
161968046|NCT02825420|584929296|FG001|Overall Study|Progressive disease|1|||
161968047|NCT02825420|584929295|FG000|Overall Study|Lost to Follow-up|2|||
161968048|NCT02825420|584929296|FG001|Overall Study|Lost to Follow-up|2|||
161968049|NCT02825420|584929295|FG000|Overall Study|Withdrawal by Subject|1|||
161968050|NCT02825420|584929296|FG001|Overall Study|Withdrawal by Subject|1|||
161968051|NCT02825420|584929295|FG000|Overall Study|Protocol amendment not signed|1|||
161968052|NCT02825420|584929296|FG001|Overall Study|Protocol amendment not signed|1|||
161968053|NCT02825420|584929295|FG000|Overall Study|Physician Decision|1|||
161968054|NCT02825420|584929296|FG001|Overall Study|Physician Decision|0|||
161968055|NCT02825420|584929295|FG000|Overall Study|Did not receive PLD|2|||
161968056|NCT02825420|584929296|FG001|Overall Study|Did not receive PLD|0|||
161968057|NCT01145352|584931355|FG000|Overall Study|Found to have been registered twice|6|||
161968058|NCT01145352|584931355|FG000|Overall Study|Treated before marketing approval|4|||
161968059|NCT01145352|584931355|FG000|Overall Study|Syringe formulation was used|1|||
161968060|NCT01739933|584931356|FG000|Overall Study|Death|89|||
161968061|NCT01739933|584931357|FG001|Overall Study|Death|86|||
161968062|NCT01739933|584931356|FG000|Overall Study|Withdrawal by Subject|10|||
161968063|NCT01739933|584931357|FG001|Overall Study|Withdrawal by Subject|8|||
161968064|NCT01739933|584931356|FG000|Overall Study|Lost to Follow-up|3|||
161968065|NCT01739933|584931357|FG001|Overall Study|Lost to Follow-up|10|||
161968066|NCT01739933|584931356|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
161968067|NCT01739933|584931357|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
161968068|NCT03356977|584931358|FG000|Overall Study|Lost to Follow-up|3|||
161968069|NCT03356977|584931358|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161968070|NCT01728077|584931359|FG000|Overall Study|Lack of Efficacy|3|||
161968071|NCT01728077|584931360|FG001|Overall Study|Lack of Efficacy|1|||
161968072|NCT01728077|584931359|FG000|Overall Study|Lost to Follow-up|1|||
161968073|NCT01728077|584931360|FG001|Overall Study|Lost to Follow-up|0|||
161968074|NCT01728077|584931359|FG000|Overall Study|Subject choice|2|||
161968075|NCT01728077|584931360|FG001|Overall Study|Subject choice|3|||
161968076|NCT01728077|584931359|FG000|Overall Study|Death|0|||
161751253|NCT00437203|584128490|FG000|Overall Study|Adverse Event|1|||
161751254|NCT00437203|584128491|FG001|Overall Study|Adverse Event|1|||
161751255|NCT00437203|584128492|FG002|Overall Study|Adverse Event|0|||
161751256|NCT00437203|584128493|FG003|Overall Study|Adverse Event|0|||
161751257|NCT00437203|584128494|FG004|Overall Study|Adverse Event|0|||
161751258|NCT00437203|584128495|FG005|Overall Study|Adverse Event|0|||
161751259|NCT00437203|584128496|FG006|Overall Study|Adverse Event|0|||
161751260|NCT00437203|584128497|FG007|Overall Study|Adverse Event|1|||
161751261|NCT00437203|584128498|FG008|Overall Study|Adverse Event|0|||
161751262|NCT00437203|584128499|FG009|Overall Study|Adverse Event|1|||
161751263|NCT00437203|584128490|FG000|Overall Study|Study terminated by sponsor|0|||
161751264|NCT00437203|584128491|FG001|Overall Study|Study terminated by sponsor|0|||
161968077|NCT01728077|584931360|FG001|Overall Study|Death|1|||
161968078|NCT01728077|584931359|FG000|Overall Study|Patient moving|1|||
161968079|NCT01728077|584931360|FG001|Overall Study|Patient moving|0|||
161968080|NCT01728077|584931359|FG000|Overall Study|Non compliance|1|||
161968081|NCT01728077|584931360|FG001|Overall Study|Non compliance|0|||
161968082|NCT00378599|584931361|FG000|Overall Study|Adverse Event|38|||
161968083|NCT00378599|584931361|FG000|Overall Study|Protocol Violation|2|||
161968084|NCT00378599|584931361|FG000|Overall Study|Treatment failure|7|||
161968085|NCT00378599|584931361|FG000|Overall Study|Withdrawal by Subject|5|||
161751265|NCT00437203|584128492|FG002|Overall Study|Study terminated by sponsor|0|||
161751266|NCT00437203|584128493|FG003|Overall Study|Study terminated by sponsor|0|||
161968086|NCT03224507|584931364|FG000|Overall Study|Death|3|||
161968087|NCT03224507|584931365|FG001|Overall Study|Death|0|||
161844417|NCT00620659|584472448|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
161844418|NCT00620659|584472449|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
161844419|NCT00620659|584472444|FG000|Treatment Period 2|Adverse Event|0|||
161844420|NCT00620659|584472445|FG001|Treatment Period 2|Adverse Event|3|||
161844421|NCT00620659|584472446|FG002|Treatment Period 2|Adverse Event|0|||
161844422|NCT00620659|584472447|FG003|Treatment Period 2|Adverse Event|0|||
161844423|NCT00620659|584472448|FG004|Treatment Period 2|Adverse Event|2|||
161844424|NCT00620659|584472449|FG005|Treatment Period 2|Adverse Event|0|||
161844425|NCT00620659|584472444|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161844426|NCT00620659|584472445|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161844427|NCT00620659|584472446|FG002|Treatment Period 2|Withdrawal by Subject|1|||
161844428|NCT00620659|584472447|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161844429|NCT00620659|584472448|FG004|Treatment Period 2|Withdrawal by Subject|3|||
161844430|NCT00620659|584472449|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161844431|NCT00620659|584472444|FG000|Placebo Washout Period 2|Adverse Event|2|||
161844432|NCT00620659|584472445|FG001|Placebo Washout Period 2|Adverse Event|0|||
161844433|NCT00620659|584472446|FG002|Placebo Washout Period 2|Adverse Event|0|||
161844434|NCT00620659|584472447|FG003|Placebo Washout Period 2|Adverse Event|0|||
161844435|NCT00620659|584472448|FG004|Placebo Washout Period 2|Adverse Event|0|||
161844436|NCT00620659|584472449|FG005|Placebo Washout Period 2|Adverse Event|0|||
161844437|NCT00620659|584472444|FG000|Treatment Period 3|Adverse Event|0|||
161844438|NCT00620659|584472445|FG001|Treatment Period 3|Adverse Event|2|||
161844439|NCT00620659|584472446|FG002|Treatment Period 3|Adverse Event|0|||
161844440|NCT00620659|584472447|FG003|Treatment Period 3|Adverse Event|0|||
161844441|NCT00620659|584472448|FG004|Treatment Period 3|Adverse Event|0|||
161844442|NCT00620659|584472449|FG005|Treatment Period 3|Adverse Event|0|||
161844443|NCT00620659|584472444|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161844444|NCT00620659|584472445|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161844445|NCT00620659|584472446|FG002|Treatment Period 3|Withdrawal by Subject|0|||
161844446|NCT00620659|584472447|FG003|Treatment Period 3|Withdrawal by Subject|1|||
161844447|NCT00620659|584472448|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161844448|NCT00620659|584472449|FG005|Treatment Period 3|Withdrawal by Subject|0|||
161844449|NCT02352779|584472450|FG000|Overall Study|Personal Issues|1|||
161844450|NCT02352779|584472451|FG001|Overall Study|Personal Issues|1|||
161844451|NCT02352779|584472452|FG002|Overall Study|Personal Issues|0|||
161844452|NCT02352779|584472450|FG000|Overall Study|Too Many Forms|2|||
161844453|NCT02352779|584472451|FG001|Overall Study|Too Many Forms|0|||
161844454|NCT02352779|584472452|FG002|Overall Study|Too Many Forms|0|||
161844455|NCT02352779|584472450|FG000|Overall Study|Feeling Overwhelmed|1|||
161844456|NCT02352779|584472451|FG001|Overall Study|Feeling Overwhelmed|0|||
161844457|NCT02352779|584472452|FG002|Overall Study|Feeling Overwhelmed|0|||
161844458|NCT02352779|584472450|FG000|Overall Study|Disliked Intervention|1|||
161844459|NCT02352779|584472451|FG001|Overall Study|Disliked Intervention|0|||
161844460|NCT02352779|584472452|FG002|Overall Study|Disliked Intervention|0|||
161844461|NCT02352779|584472450|FG000|Overall Study|Changed Mind|1|||
161844462|NCT02352779|584472451|FG001|Overall Study|Changed Mind|0|||
161844463|NCT02352779|584472452|FG002|Overall Study|Changed Mind|0|||
161844464|NCT02352779|584472450|FG000|Overall Study|Study Related Symptoms|1|||
161844465|NCT02352779|584472451|FG001|Overall Study|Study Related Symptoms|0|||
161844466|NCT02352779|584472452|FG002|Overall Study|Study Related Symptoms|0|||
161844467|NCT02352779|584472450|FG000|Overall Study|Absence of Symptoms|1|||
161844468|NCT02352779|584472451|FG001|Overall Study|Absence of Symptoms|0|||
161844469|NCT02352779|584472452|FG002|Overall Study|Absence of Symptoms|0|||
161844470|NCT02352779|584472450|FG000|Overall Study|Other Medical Reason|0|||
161844471|NCT02352779|584472451|FG001|Overall Study|Other Medical Reason|0|||
161844472|NCT02352779|584472452|FG002|Overall Study|Other Medical Reason|1|||
161844473|NCT02352779|584472450|FG000|Overall Study|No Reason|0|||
161844474|NCT02352779|584472451|FG001|Overall Study|No Reason|0|||
161968088|NCT03224507|584931364|FG000|Overall Study|Lack of Efficacy|6|||
161968089|NCT03224507|584931365|FG001|Overall Study|Lack of Efficacy|0|||
161968090|NCT03224507|584931364|FG000|Overall Study|Withdrawal by Subject|6|||
161968091|NCT03224507|584931365|FG001|Overall Study|Withdrawal by Subject|0|||
161968092|NCT01032291|584931366|FG000|Safety Lead-in|Adverse Event|1|||
161968093|NCT01032291|584931367|FG001|Safety Lead-in|Adverse Event|0|||
161968094|NCT01032291|584931368|FG002|Safety Lead-in|Adverse Event|0|||
161844475|NCT02352779|584472452|FG002|Overall Study|No Reason|1|||
161844476|NCT00968799|584472455|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
161844477|NCT00719849|584472458|FG000|Overall Study|Death|0|||
161844478|NCT00719849|584472459|FG001|Overall Study|Death|1|||
161968095|NCT01032291|584931366|FG000|Safety Lead-in|Death|1|||
161844479|NCT00389831|584472463|FG000|Overall Study|Lack of Efficacy|0|||
161844480|NCT00389831|584472464|FG001|Overall Study|Lack of Efficacy|2|||
161968096|NCT01032291|584931367|FG001|Safety Lead-in|Death|0|||
161968097|NCT01032291|584931368|FG002|Safety Lead-in|Death|0|||
161968098|NCT01032291|584931366|FG000|Proof of Concept|Adverse Event|0|||
161844481|NCT00389831|584472463|FG000|Overall Study|Did not receive treatment.|0|||
161844482|NCT00389831|584472464|FG001|Overall Study|Did not receive treatment.|2|||
161844483|NCT00389831|584472463|FG000|Overall Study|Other reasons|0|||
161844484|NCT00389831|584472464|FG001|Overall Study|Other reasons|2|||
161968099|NCT01032291|584931367|FG001|Proof of Concept|Adverse Event|5|||
161968100|NCT01032291|584931368|FG002|Proof of Concept|Adverse Event|1|||
161968101|NCT01032291|584931366|FG000|Proof of Concept|Death|0|||
161968102|NCT01032291|584931367|FG001|Proof of Concept|Death|1|||
161968103|NCT01032291|584931368|FG002|Proof of Concept|Death|2|||
161968104|NCT01032291|584931366|FG000|Proof of Concept|Lack of Efficacy|0|||
161968105|NCT01032291|584931367|FG001|Proof of Concept|Lack of Efficacy|1|||
161968106|NCT01032291|584931368|FG002|Proof of Concept|Lack of Efficacy|0|||
161751267|NCT00437203|584128494|FG004|Overall Study|Study terminated by sponsor|0|||
161751268|NCT00437203|584128495|FG005|Overall Study|Study terminated by sponsor|0|||
161751269|NCT00437203|584128496|FG006|Overall Study|Study terminated by sponsor|0|||
161751270|NCT00437203|584128497|FG007|Overall Study|Study terminated by sponsor|0|||
161751271|NCT00437203|584128498|FG008|Overall Study|Study terminated by sponsor|1|||
161751272|NCT00437203|584128499|FG009|Overall Study|Study terminated by sponsor|0|||
161751273|NCT00437203|584128490|FG000|Overall Study|Objective progression or relapse|5|||
161751274|NCT00437203|584128491|FG001|Overall Study|Objective progression or relapse|6|||
161751275|NCT00437203|584128492|FG002|Overall Study|Objective progression or relapse|2|||
161751276|NCT00437203|584128493|FG003|Overall Study|Objective progression or relapse|3|||
161751277|NCT00437203|584128494|FG004|Overall Study|Objective progression or relapse|3|||
161751278|NCT00437203|584128495|FG005|Overall Study|Objective progression or relapse|3|||
161751279|NCT00437203|584128496|FG006|Overall Study|Objective progression or relapse|6|||
161751280|NCT00437203|584128497|FG007|Overall Study|Objective progression or relapse|1|||
161751281|NCT00437203|584128498|FG008|Overall Study|Objective progression or relapse|2|||
161751282|NCT00437203|584128499|FG009|Overall Study|Objective progression or relapse|2|||
161751283|NCT00437203|584128490|FG000|Overall Study|Other|0|||
161751284|NCT00437203|584128491|FG001|Overall Study|Other|1|||
161751285|NCT00437203|584128492|FG002|Overall Study|Other|0|||
161751286|NCT00437203|584128493|FG003|Overall Study|Other|0|||
161751287|NCT00437203|584128494|FG004|Overall Study|Other|0|||
161751288|NCT00437203|584128495|FG005|Overall Study|Other|0|||
161751289|NCT00437203|584128496|FG006|Overall Study|Other|1|||
161751290|NCT00437203|584128497|FG007|Overall Study|Other|0|||
161751291|NCT00437203|584128498|FG008|Overall Study|Other|0|||
161751292|NCT00437203|584128499|FG009|Overall Study|Other|0|||
161751293|NCT03997760|584128500|FG000|Overall Study|Protocol Deviation|0|||
161751294|NCT03997760|584128501|FG001|Overall Study|Protocol Deviation|1|||
161751295|NCT03997760|584128502|FG002|Overall Study|Protocol Deviation|0|||
161751296|NCT03997760|584128503|FG003|Overall Study|Protocol Deviation|0|||
161751297|NCT00856986|584128504|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
161751298|NCT00856986|584128505|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
161751299|NCT00856986|584128506|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
161751300|NCT00856986|584128507|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
161751301|NCT00856986|584128508|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
161751302|NCT00856986|584128504|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
161751303|NCT00856986|584128505|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
161751304|NCT00856986|584128506|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
161751305|NCT00856986|584128507|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
161751306|NCT00856986|584128508|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
161751307|NCT00856986|584128504|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
161751308|NCT00856986|584128505|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
161751309|NCT00856986|584128506|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
161751310|NCT00856986|584128507|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
161751311|NCT00856986|584128508|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
161751312|NCT00856986|584128504|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
161751313|NCT00856986|584128505|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
161751314|NCT00856986|584128506|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
161751315|NCT00856986|584128507|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
161751316|NCT00856986|584128508|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
161751317|NCT00856986|584128504|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
161751318|NCT00856986|584128505|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
161751319|NCT00856986|584128506|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
161751320|NCT00856986|584128507|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
161751321|NCT00856986|584128508|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
161751322|NCT00856986|584128504|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
161968107|NCT01032291|584931366|FG000|Proof of Concept|Never Received Study Drug|0|||
161968108|NCT01032291|584931367|FG001|Proof of Concept|Never Received Study Drug|1|||
161968109|NCT01032291|584931368|FG002|Proof of Concept|Never Received Study Drug|0|||
161968110|NCT00347438|584931369|FG000|Overall Study|Withdrawal by Subject|1|||
161751323|NCT00856986|584128505|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
161751324|NCT00856986|584128506|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
161751325|NCT00856986|584128507|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
161751326|NCT00856986|584128508|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
161751327|NCT00856986|584128504|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
161751328|NCT00856986|584128505|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
161751329|NCT00856986|584128506|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
161968111|NCT00347438|584931369|FG000|Overall Study|Physician Decision|1|||
161968112|NCT01529515|584931372|FG000|TRANSITION PHASE|Adverse Event|16|||
161968113|NCT01529515|584931373|FG001|TRANSITION PHASE|Adverse Event|0|||
161968114|NCT01529515|584931374|FG002|TRANSITION PHASE|Adverse Event|0|||
161968115|NCT01529515|584931375|FG003|TRANSITION PHASE|Adverse Event|0|||
161968116|NCT01529515|584931372|FG000|TRANSITION PHASE|Death|1|||
161968117|NCT01529515|584931373|FG001|TRANSITION PHASE|Death|0|||
161968118|NCT01529515|584931374|FG002|TRANSITION PHASE|Death|0|||
161968119|NCT01529515|584931375|FG003|TRANSITION PHASE|Death|0|||
161968120|NCT01529515|584931372|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
161968121|NCT01529515|584931373|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
162032695|NCT01933789|585177450|FG000|Overall Study|Became Ineligible|4|||
162032696|NCT01933789|585177451|FG001|Overall Study|Became Ineligible|0|||
161751330|NCT00856986|584128507|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
161751331|NCT00856986|584128508|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
161751332|NCT00856986|584128504|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
161751333|NCT00856986|584128505|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
161751334|NCT00856986|584128506|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
161751335|NCT00856986|584128507|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
161751336|NCT00856986|584128508|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
161751337|NCT00856986|584128504|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
161751338|NCT00856986|584128505|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
161751339|NCT00856986|584128506|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
161751340|NCT00856986|584128507|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
161751341|NCT00856986|584128508|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
161751342|NCT00856986|584128504|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
161751343|NCT00856986|584128505|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
161751344|NCT00856986|584128506|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
161751345|NCT00856986|584128507|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
161751346|NCT00856986|584128508|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
161751347|NCT00856986|584128504|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
161751348|NCT00856986|584128505|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
161751349|NCT00856986|584128506|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
161751350|NCT00856986|584128507|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
161751351|NCT00856986|584128508|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
161751352|NCT00856986|584128504|FG000|Main Period, Weeks 0-26|Unclassified|7|||
161751353|NCT00856986|584128505|FG001|Main Period, Weeks 0-26|Unclassified|6|||
161751354|NCT00856986|584128506|FG002|Main Period, Weeks 0-26|Unclassified|7|||
161751355|NCT00856986|584128507|FG003|Main Period, Weeks 0-26|Unclassified|0|||
161751356|NCT00856986|584128508|FG004|Main Period, Weeks 0-26|Unclassified|0|||
161751357|NCT00856986|584128504|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
161751358|NCT00856986|584128505|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
161751359|NCT00856986|584128506|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
161751360|NCT00856986|584128507|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
161751361|NCT00856986|584128508|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
161751362|NCT00856986|584128504|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
161751363|NCT00856986|584128505|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
161751364|NCT00856986|584128506|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
161751365|NCT00856986|584128507|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
161751366|NCT00856986|584128508|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
161751367|NCT00856986|584128504|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
161751368|NCT00856986|584128505|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
161751369|NCT00856986|584128506|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
161751370|NCT00856986|584128507|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
161751371|NCT00856986|584128508|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
161751372|NCT00856986|584128504|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
161751373|NCT00856986|584128505|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
161751374|NCT00856986|584128506|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
161751375|NCT00856986|584128507|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
161751376|NCT00856986|584128508|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
161751377|NCT00856986|584128504|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
161751378|NCT00856986|584128505|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
161751379|NCT00856986|584128506|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
161751380|NCT00856986|584128507|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
161751381|NCT00856986|584128508|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
161751382|NCT00856986|584128504|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
161751383|NCT00856986|584128505|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
161751384|NCT00856986|584128506|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
161751385|NCT00856986|584128507|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
161751386|NCT00856986|584128508|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
161751387|NCT01906476|584128510|FG000|Overall Study|Lost to Follow-up|17|||
161751388|NCT01906476|584128511|FG001|Overall Study|Lost to Follow-up|16|||
161751389|NCT01993667|584128515|FG000|Overall Study|Insufficient data to analyze|16|||
162032697|NCT01933789|585177452|FG002|Overall Study|Became Ineligible|0|||
161968122|NCT01529515|584931374|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
161968123|NCT01529515|584931375|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
161968124|NCT01529515|584931372|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
161968125|NCT01529515|584931373|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
161968126|NCT01529515|584931374|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
161968127|NCT01529515|584931375|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
161968128|NCT01529515|584931372|FG000|TRANSITION PHASE|Protocol Violation|4|||
161751390|NCT01993667|584128516|FG001|Overall Study|Insufficient data to analyze|16|||
161751391|NCT01993667|584128515|FG000|Overall Study|Insufficient altitude reached|3|||
161751392|NCT01993667|584128516|FG001|Overall Study|Insufficient altitude reached|1|||
161751393|NCT01993667|584128515|FG000|Overall Study|Lost to Follow-up|2|||
161751394|NCT01993667|584128516|FG001|Overall Study|Lost to Follow-up|2|||
161751395|NCT01931150|584128517|FG000|Overall Study|Withdrawal by Subject|1|||
161751396|NCT01931150|584128518|FG001|Overall Study|Withdrawal by Subject|2|||
161751397|NCT00845845|584128521|FG000|Overall Study|Lost to Follow-up|0|||
161751398|NCT00845845|584128522|FG001|Overall Study|Lost to Follow-up|4|||
161751399|NCT01685203|584128523|FG000|Overall Study|Lost to Follow-up|3|||
161751400|NCT01685203|584128524|FG001|Overall Study|Lost to Follow-up|3|||
161751401|NCT01685203|584128525|FG002|Overall Study|Lost to Follow-up|0|||
161751402|NCT01685203|584128526|FG003|Overall Study|Lost to Follow-up|1|||
161751403|NCT01685203|584128527|FG004|Overall Study|Lost to Follow-up|0|||
161751404|NCT01685203|584128528|FG005|Overall Study|Lost to Follow-up|0|||
161751405|NCT01685203|584128529|FG006|Overall Study|Lost to Follow-up|0|||
161751406|NCT01685203|584128523|FG000|Overall Study|Adverse Event|0|||
161751407|NCT01685203|584128524|FG001|Overall Study|Adverse Event|0|||
161751408|NCT01685203|584128525|FG002|Overall Study|Adverse Event|0|||
161751409|NCT01685203|584128526|FG003|Overall Study|Adverse Event|0|||
161751410|NCT01685203|584128527|FG004|Overall Study|Adverse Event|0|||
161751411|NCT01685203|584128528|FG005|Overall Study|Adverse Event|2|||
161751412|NCT01685203|584128529|FG006|Overall Study|Adverse Event|0|||
161751413|NCT01685203|584128523|FG000|Overall Study|Adverse event and withdrew consent|1|||
161751414|NCT01685203|584128524|FG001|Overall Study|Adverse event and withdrew consent|0|||
161751415|NCT01685203|584128525|FG002|Overall Study|Adverse event and withdrew consent|0|||
161751416|NCT01685203|584128526|FG003|Overall Study|Adverse event and withdrew consent|0|||
161751417|NCT01685203|584128527|FG004|Overall Study|Adverse event and withdrew consent|0|||
161751418|NCT01685203|584128528|FG005|Overall Study|Adverse event and withdrew consent|0|||
161751419|NCT01685203|584128529|FG006|Overall Study|Adverse event and withdrew consent|0|||
161751420|NCT01685203|584128523|FG000|Overall Study|Patient's decision|0|||
161751421|NCT01685203|584128524|FG001|Overall Study|Patient's decision|0|||
161751422|NCT01685203|584128525|FG002|Overall Study|Patient's decision|0|||
161751423|NCT01685203|584128526|FG003|Overall Study|Patient's decision|0|||
161751424|NCT01685203|584128527|FG004|Overall Study|Patient's decision|0|||
161751425|NCT01685203|584128528|FG005|Overall Study|Patient's decision|1|||
161751426|NCT01685203|584128529|FG006|Overall Study|Patient's decision|0|||
161751427|NCT00479167|584128530|FG000|Overall Study|Withdrawal by Subject|1|||
161751428|NCT02384993|584128531|FG000|Overall Study|Adverse Event|0|||
161751429|NCT02384993|584128532|FG001|Overall Study|Adverse Event|1|||
161751430|NCT03695471|584130867|FG000|Overall Study|Cancellation|1|||
161751431|NCT02859558|584130868|FG000|Step 1|Not Eligible|0|||
161751432|NCT02859558|584130869|FG001|Step 1|Not Eligible|0|||
161751433|NCT02859558|584130870|FG002|Step 1|Not Eligible|0|||
161751434|NCT02859558|584130871|FG003|Step 1|Not Eligible|0|||
161751435|NCT02859558|584130872|FG004|Step 1|Not Eligible|3|||
161751436|NCT02859558|584130868|FG000|Step 1|Lost to Follow-up|1|||
161751437|NCT02859558|584130869|FG001|Step 1|Lost to Follow-up|3|||
161751438|NCT02859558|584130870|FG002|Step 1|Lost to Follow-up|3|||
161751439|NCT02859558|584130871|FG003|Step 1|Lost to Follow-up|0|||
161751440|NCT02859558|584130872|FG004|Step 1|Lost to Follow-up|0|||
161751441|NCT02859558|584130868|FG000|Step 1|Did Not Return to Clinic|2|||
161751442|NCT02859558|584130869|FG001|Step 1|Did Not Return to Clinic|3|||
161751443|NCT02859558|584130870|FG002|Step 1|Did Not Return to Clinic|4|||
161751444|NCT02859558|584130871|FG003|Step 1|Did Not Return to Clinic|0|||
161751445|NCT02859558|584130872|FG004|Step 1|Did Not Return to Clinic|0|||
161751446|NCT02859558|584130868|FG000|Step 1|Moved|0|||
161751447|NCT02859558|584130869|FG001|Step 1|Moved|1|||
161751448|NCT02859558|584130870|FG002|Step 1|Moved|1|||
161751449|NCT02859558|584130871|FG003|Step 1|Moved|0|||
161751450|NCT02859558|584130872|FG004|Step 1|Moved|0|||
161751451|NCT02859558|584130868|FG000|Step 1|Withdrawal By Participant|1|||
161751452|NCT02859558|584130869|FG001|Step 1|Withdrawal By Participant|2|||
161751453|NCT02859558|584130870|FG002|Step 1|Withdrawal By Participant|1|||
161751454|NCT02859558|584130871|FG003|Step 1|Withdrawal By Participant|0|||
161751455|NCT02859558|584130872|FG004|Step 1|Withdrawal By Participant|0|||
161751456|NCT02859558|584130868|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
161751457|NCT02859558|584130869|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
161751458|NCT02859558|584130870|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
161968129|NCT01529515|584931373|FG001|TRANSITION PHASE|Protocol Violation|0|||
161968130|NCT01529515|584931374|FG002|TRANSITION PHASE|Protocol Violation|0|||
161751459|NCT02859558|584130871|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
161751460|NCT02859558|584130872|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
161968131|NCT01529515|584931375|FG003|TRANSITION PHASE|Protocol Violation|0|||
161968132|NCT01529515|584931372|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
161968133|NCT01529515|584931373|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
161968134|NCT01529515|584931374|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
161968135|NCT01529515|584931375|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
161968136|NCT01529515|584931372|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
161968137|NCT01529515|584931373|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
161968138|NCT01529515|584931374|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
161968139|NCT01529515|584931375|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
161968140|NCT01529515|584931372|FG000|TRANSITION PHASE|Other|9|||
161968141|NCT01529515|584931373|FG001|TRANSITION PHASE|Other|0|||
161968142|NCT01529515|584931374|FG002|TRANSITION PHASE|Other|0|||
161968143|NCT01529515|584931375|FG003|TRANSITION PHASE|Other|0|||
161968144|NCT01529515|584931372|FG000|MAINTENANCE PHASE|Adverse Event|0|||
161968145|NCT01529515|584931373|FG001|MAINTENANCE PHASE|Adverse Event|10|||
161968146|NCT01529515|584931374|FG002|MAINTENANCE PHASE|Adverse Event|0|||
161968147|NCT01529515|584931375|FG003|MAINTENANCE PHASE|Adverse Event|0|||
161968148|NCT01529515|584931372|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
161968149|NCT01529515|584931373|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
161968150|NCT01529515|584931374|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
161968151|NCT01529515|584931375|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
161968152|NCT01529515|584931372|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
161968153|NCT01529515|584931373|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
161968154|NCT01529515|584931374|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
161968155|NCT01529515|584931375|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
161968156|NCT01529515|584931372|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
161968157|NCT01529515|584931373|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
161968158|NCT01529515|584931374|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
161968159|NCT01529515|584931375|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
161968160|NCT01529515|584931372|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
161968161|NCT01529515|584931373|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
161968162|NCT01529515|584931374|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
161844485|NCT00389831|584472463|FG000|Overall Study|Lost to Follow-up|0|||
161844486|NCT00389831|584472464|FG001|Overall Study|Lost to Follow-up|1|||
161844487|NCT00594646|584472469|FG000|Overall Study|Withdrawal by Subject|1|||
161844488|NCT00594646|584472469|FG000|Overall Study|Lost to Follow-up|15|||
161844489|NCT03907462|584472470|FG000|Overall Study|Physician Decision|1|||
161844490|NCT03907462|584472471|FG001|Overall Study|Physician Decision|3|||
161844491|NCT03907462|584472472|FG002|Overall Study|Physician Decision|1|||
161844492|NCT03907462|584472470|FG000|Overall Study|Withdrawal by Subject|6|||
161844493|NCT03907462|584472471|FG001|Overall Study|Withdrawal by Subject|3|||
161844494|NCT03907462|584472472|FG002|Overall Study|Withdrawal by Subject|3|||
161844495|NCT03907462|584472470|FG000|Overall Study|Pregnancy|4|||
161844496|NCT03907462|584472471|FG001|Overall Study|Pregnancy|2|||
161844497|NCT03907462|584472472|FG002|Overall Study|Pregnancy|6|||
161844498|NCT03907462|584472470|FG000|Overall Study|Lost to Follow-up|16|||
161844499|NCT03907462|584472471|FG001|Overall Study|Lost to Follow-up|18|||
161844500|NCT03907462|584472472|FG002|Overall Study|Lost to Follow-up|22|||
161844501|NCT00633243|584474540|FG000|Overall Study|Withdrawal by Subject|0|||
161844502|NCT00633243|584474541|FG001|Overall Study|Withdrawal by Subject|1|||
161844503|NCT00633243|584474540|FG000|Overall Study|incarceration|0|||
161844504|NCT00633243|584474541|FG001|Overall Study|incarceration|2|||
161844505|NCT00633243|584474540|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
161844506|NCT00633243|584474541|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
161844507|NCT00633243|584474540|FG000|Overall Study|Not comfortable with self-injecting|0|||
161844508|NCT00633243|584474541|FG001|Overall Study|Not comfortable with self-injecting|1|||
161844509|NCT00633243|584474540|FG000|Overall Study|Mental Health--Depression|0|||
161844510|NCT00633243|584474541|FG001|Overall Study|Mental Health--Depression|1|||
161844511|NCT00633243|584474540|FG000|Overall Study|Couldn't tolerate side-effects|1|||
161844512|NCT00633243|584474541|FG001|Overall Study|Couldn't tolerate side-effects|1|||
161844513|NCT01682863|584474542|FG000|Overall Study|Subject/guardian decision|19|||
161844514|NCT01682863|584474543|FG001|Overall Study|Subject/guardian decision|12|||
161844515|NCT01682863|584474544|FG002|Overall Study|Subject/guardian decision|10|||
161844516|NCT01682863|584474542|FG000|Overall Study|Lost to Follow-up|5|||
161844517|NCT01682863|584474543|FG001|Overall Study|Lost to Follow-up|1|||
161844518|NCT01682863|584474544|FG002|Overall Study|Lost to Follow-up|6|||
161844519|NCT01682863|584474542|FG000|Overall Study|Death|1|||
161844520|NCT01682863|584474543|FG001|Overall Study|Death|3|||
161844521|NCT01682863|584474544|FG002|Overall Study|Death|4|||
161844522|NCT01682863|584474542|FG000|Overall Study|Protocol deviation|1|||
161968163|NCT01529515|584931375|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
161968164|NCT01529515|584931372|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
161968165|NCT01529515|584931373|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
161968166|NCT01529515|584931374|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
161968167|NCT01529515|584931375|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
161968168|NCT01529515|584931372|FG000|MAINTENANCE PHASE|Other|0|||
161844523|NCT01682863|584474543|FG001|Overall Study|Protocol deviation|0|||
161844524|NCT01682863|584474544|FG002|Overall Study|Protocol deviation|1|||
161844525|NCT01682863|584474542|FG000|Overall Study|Technical problems|1|||
161844526|NCT01682863|584474543|FG001|Overall Study|Technical problems|0|||
161844527|NCT01682863|584474544|FG002|Overall Study|Technical problems|0|||
161844528|NCT01682863|584474542|FG000|Overall Study|Adverse Event|0|||
161844529|NCT01682863|584474543|FG001|Overall Study|Adverse Event|1|||
161844530|NCT01682863|584474544|FG002|Overall Study|Adverse Event|2|||
161844531|NCT01682863|584474542|FG000|Overall Study|Physician Decision|0|||
161844532|NCT01682863|584474543|FG001|Overall Study|Physician Decision|0|||
161844533|NCT01682863|584474544|FG002|Overall Study|Physician Decision|1|||
161844534|NCT00918138|584474545|FG000|Overall Study|Subject withdrew consent|1|||
161844535|NCT00918138|584474546|FG001|Overall Study|Subject withdrew consent|1|||
161844536|NCT00918138|584474545|FG000|Overall Study|Death|1|||
161844537|NCT00918138|584474546|FG001|Overall Study|Death|0|||
161844538|NCT00977379|584474547|FG000|Overall Study|Withdrawal by Subject|1|||
161844539|NCT00977379|584474548|FG001|Overall Study|Withdrawal by Subject|1|||
161844540|NCT00977379|584474547|FG000|Overall Study|Death|7|||
161844541|NCT00977379|584474548|FG001|Overall Study|Death|9|||
161844542|NCT00977379|584474547|FG000|Overall Study|Premature Study Termination|4|||
161844543|NCT00977379|584474548|FG001|Overall Study|Premature Study Termination|0|||
161844544|NCT00977379|584474547|FG000|Overall Study|Participant Moving House|0|||
161844545|NCT00977379|584474548|FG001|Overall Study|Participant Moving House|1|||
161844546|NCT00977379|584474547|FG000|Overall Study|Randomization Error|0|||
161844547|NCT00977379|584474548|FG001|Overall Study|Randomization Error|1|||
161844548|NCT03972163|584474549|FG000|Overall Study|Death|0|||
161844549|NCT03972163|584474550|FG001|Overall Study|Death|1|||
161844550|NCT01212588|584474553|FG000|Overall Study|Physician Decision|0|||
161844551|NCT01212588|584474554|FG001|Overall Study|Physician Decision|1|||
161844552|NCT01212588|584474553|FG000|Overall Study|Protocol Violation|1|||
161844553|NCT01212588|584474554|FG001|Overall Study|Protocol Violation|1|||
161844554|NCT02885181|584474555|FG000|Overall Study|Investigator's Discretion|0|||
161844555|NCT02885181|584474556|FG001|Overall Study|Investigator's Discretion|1|||
161844556|NCT02885181|584474557|FG002|Overall Study|Investigator's Discretion|0|||
161844557|NCT02885181|584474558|FG003|Overall Study|Investigator's Discretion|1|||
161844558|NCT02885181|584474555|FG000|Overall Study|Adverse Event|0|||
161844559|NCT02885181|584474556|FG001|Overall Study|Adverse Event|0|||
161844560|NCT02885181|584474557|FG002|Overall Study|Adverse Event|0|||
161844561|NCT02885181|584474558|FG003|Overall Study|Adverse Event|1|||
161844562|NCT02885181|584474555|FG000|Overall Study|Withdrawal by Subject|0|||
161844563|NCT02885181|584474556|FG001|Overall Study|Withdrawal by Subject|0|||
161844564|NCT02885181|584474557|FG002|Overall Study|Withdrawal by Subject|0|||
161844565|NCT02885181|584474558|FG003|Overall Study|Withdrawal by Subject|1|||
161844566|NCT04005352|584474567|FG000|Overall Study|Adverse Event|4|||
161844567|NCT04005352|584474568|FG001|Overall Study|Adverse Event|5|||
161844568|NCT04005352|584474567|FG000|Overall Study|Death|4|||
161844569|NCT04005352|584474568|FG001|Overall Study|Death|2|||
161844570|NCT04005352|584474567|FG000|Overall Study|Lost to Follow-up|6|||
161844571|NCT04005352|584474568|FG001|Overall Study|Lost to Follow-up|2|||
161844572|NCT04005352|584474567|FG000|Overall Study|Physician Decision|7|||
161844573|NCT04005352|584474568|FG001|Overall Study|Physician Decision|13|||
161844574|NCT04005352|584474567|FG000|Overall Study|Protocol Violation|0|||
161844575|NCT04005352|584474568|FG001|Overall Study|Protocol Violation|1|||
161844576|NCT04005352|584474567|FG000|Overall Study|Withdrawal by Subject|28|||
161844577|NCT04005352|584474568|FG001|Overall Study|Withdrawal by Subject|38|||
161844578|NCT01283035|584474569|FG000|Overall Study|Subject later found ineligible|1|||
161844579|NCT03597529|584474572|FG000|Overall Study|Lost to Follow-up|10|||
161844580|NCT03597529|584474573|FG001|Overall Study|Lost to Follow-up|12|||
161844581|NCT03597529|584474572|FG000|Overall Study|Physician Decision|3|||
161844582|NCT03597529|584474573|FG001|Overall Study|Physician Decision|1|||
161844583|NCT03597529|584474572|FG000|Overall Study|Withdrawal by Subject|6|||
161844584|NCT03597529|584474573|FG001|Overall Study|Withdrawal by Subject|3|||
161844585|NCT03597529|584474572|FG000|Overall Study|Non-compliant with study activities|1|||
161844586|NCT03597529|584474573|FG001|Overall Study|Non-compliant with study activities|2|||
161844587|NCT00191165|584474574|FG000|Overall Study|Adverse Event|2|||
161844588|NCT00191165|584474575|FG001|Overall Study|Adverse Event|0|||
161968169|NCT01529515|584931373|FG001|MAINTENANCE PHASE|Other|10|||
161844589|NCT00191165|584474574|FG000|Overall Study|Protocol Violation|0|||
161844590|NCT00191165|584474575|FG001|Overall Study|Protocol Violation|1|||
161844591|NCT00191165|584474574|FG000|Overall Study|Participant Moved Away|0|||
161844592|NCT00191165|584474575|FG001|Overall Study|Participant Moved Away|1|||
161844593|NCT03200912|584474576|FG000|Overall Study|Adverse Event|3|||
161968170|NCT01529515|584931374|FG002|MAINTENANCE PHASE|Other|0|||
161844594|NCT03200912|584474577|FG001|Overall Study|Adverse Event|0|||
161844595|NCT03200912|584474578|FG002|Overall Study|Adverse Event|0|||
161844596|NCT03200912|584474576|FG000|Overall Study|Withdrawal by Subject|1|||
161844597|NCT03200912|584474577|FG001|Overall Study|Withdrawal by Subject|2|||
161968171|NCT01529515|584931375|FG003|MAINTENANCE PHASE|Other|0|||
161844598|NCT03200912|584474578|FG002|Overall Study|Withdrawal by Subject|4|||
161844599|NCT03200912|584474576|FG000|Overall Study|Non-compliance with study drug|0|||
161968172|NCT01529515|584931372|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
161751461|NCT02859558|584130868|FG000|Step 1|Incarceration|0|||
161751462|NCT02859558|584130869|FG001|Step 1|Incarceration|1|||
161751463|NCT02859558|584130870|FG002|Step 1|Incarceration|0|||
161751464|NCT02859558|584130871|FG003|Step 1|Incarceration|0|||
161751465|NCT02859558|584130872|FG004|Step 1|Incarceration|0|||
161751466|NCT02859558|584130868|FG000|Step 1|Non-Adherence to Study Drug|2|||
161751467|NCT02859558|584130869|FG001|Step 1|Non-Adherence to Study Drug|0|||
161751468|NCT02859558|584130870|FG002|Step 1|Non-Adherence to Study Drug|1|||
161751469|NCT02859558|584130871|FG003|Step 1|Non-Adherence to Study Drug|0|||
161751470|NCT02859558|584130872|FG004|Step 1|Non-Adherence to Study Drug|0|||
161751471|NCT02859558|584130868|FG000|Step 1|Non-Adherence to Study Requirements|3|||
161751472|NCT02859558|584130869|FG001|Step 1|Non-Adherence to Study Requirements|1|||
161751473|NCT02859558|584130870|FG002|Step 1|Non-Adherence to Study Requirements|0|||
161751474|NCT02859558|584130871|FG003|Step 1|Non-Adherence to Study Requirements|0|||
161751475|NCT02859558|584130872|FG004|Step 1|Non-Adherence to Study Requirements|0|||
161751476|NCT02859558|584130868|FG000|Step 1|Virologic Failure|2|||
161751477|NCT02859558|584130869|FG001|Step 1|Virologic Failure|1|||
161751478|NCT02859558|584130870|FG002|Step 1|Virologic Failure|1|||
161751479|NCT02859558|584130871|FG003|Step 1|Virologic Failure|0|||
161751480|NCT02859558|584130872|FG004|Step 1|Virologic Failure|0|||
161751481|NCT02859558|584130868|FG000|Step 2|Lost to Follow-up|3|||
161751482|NCT02859558|584130869|FG001|Step 2|Lost to Follow-up|3|||
161751483|NCT02859558|584130870|FG002|Step 2|Lost to Follow-up|1|||
161751484|NCT02859558|584130871|FG003|Step 2|Lost to Follow-up|0|||
161751485|NCT02859558|584130872|FG004|Step 2|Lost to Follow-up|0|||
161751486|NCT02859558|584130868|FG000|Step 2|Withdrawal by Subject|0|||
161751487|NCT02859558|584130869|FG001|Step 2|Withdrawal by Subject|1|||
161751488|NCT02859558|584130870|FG002|Step 2|Withdrawal by Subject|1|||
161751489|NCT02859558|584130871|FG003|Step 2|Withdrawal by Subject|0|||
161751490|NCT02859558|584130872|FG004|Step 2|Withdrawal by Subject|0|||
161751491|NCT02859558|584130868|FG000|Step 2|Unexpected Closure of Site|0|||
161751492|NCT02859558|584130869|FG001|Step 2|Unexpected Closure of Site|1|||
161751493|NCT02859558|584130870|FG002|Step 2|Unexpected Closure of Site|1|||
161751494|NCT02859558|584130871|FG003|Step 2|Unexpected Closure of Site|0|||
161751495|NCT02859558|584130872|FG004|Step 2|Unexpected Closure of Site|0|||
161751496|NCT02859558|584130868|FG000|Step 2|Death|1|||
161751497|NCT02859558|584130869|FG001|Step 2|Death|0|||
161751498|NCT02859558|584130870|FG002|Step 2|Death|0|||
161751499|NCT02859558|584130871|FG003|Step 2|Death|0|||
161751500|NCT02859558|584130872|FG004|Step 2|Death|0|||
161751501|NCT02859558|584130868|FG000|Step 2|Incarceration|0|||
161751502|NCT02859558|584130869|FG001|Step 2|Incarceration|0|||
161751503|NCT02859558|584130870|FG002|Step 2|Incarceration|1|||
161751504|NCT02859558|584130871|FG003|Step 2|Incarceration|0|||
161751505|NCT02859558|584130872|FG004|Step 2|Incarceration|0|||
161751506|NCT04507360|584130873|FG000|Week 1|Lost to Follow-up|0|||
161751507|NCT04507360|584130874|FG001|Week 1|Lost to Follow-up|0|||
161751508|NCT04507360|584130875|FG002|Week 1|Lost to Follow-up|0|||
161751509|NCT04507360|584130876|FG003|Week 1|Lost to Follow-up|0|||
161751510|NCT04507360|584130877|FG004|Week 1|Lost to Follow-up|0|||
161751511|NCT04507360|584130878|FG005|Week 1|Lost to Follow-up|0|||
161751512|NCT04507360|584130879|FG006|Week 1|Lost to Follow-up|0|||
161751513|NCT04507360|584130880|FG007|Week 1|Lost to Follow-up|0|||
161751514|NCT04507360|584130881|FG008|Week 1|Lost to Follow-up|72|||
161751515|NCT04507360|584130882|FG009|Week 1|Lost to Follow-up|22|||
161751516|NCT04507360|584130883|FG010|Week 1|Lost to Follow-up|10|||
161751517|NCT04507360|584130873|FG000|Week 2|Lost to Follow-up|0|||
161751518|NCT04507360|584130874|FG001|Week 2|Lost to Follow-up|0|||
161751519|NCT04507360|584130875|FG002|Week 2|Lost to Follow-up|0|||
161751520|NCT04507360|584130876|FG003|Week 2|Lost to Follow-up|0|||
161751521|NCT04507360|584130877|FG004|Week 2|Lost to Follow-up|0|||
161751522|NCT04507360|584130878|FG005|Week 2|Lost to Follow-up|0|||
161751523|NCT04507360|584130879|FG006|Week 2|Lost to Follow-up|0|||
161751524|NCT04507360|584130880|FG007|Week 2|Lost to Follow-up|0|||
161751525|NCT04507360|584130881|FG008|Week 2|Lost to Follow-up|121|||
161751526|NCT04507360|584130882|FG009|Week 2|Lost to Follow-up|85|||
161751527|NCT04507360|584130883|FG010|Week 2|Lost to Follow-up|82|||
161751528|NCT04507360|584130873|FG000|Week 3|Lost to Follow-up|0|||
161751529|NCT04507360|584130874|FG001|Week 3|Lost to Follow-up|0|||
161751530|NCT04507360|584130875|FG002|Week 3|Lost to Follow-up|0|||
161968173|NCT01529515|584931373|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
161968174|NCT01529515|584931374|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
161751531|NCT04507360|584130876|FG003|Week 3|Lost to Follow-up|0|||
161751532|NCT04507360|584130877|FG004|Week 3|Lost to Follow-up|0|||
161751533|NCT04507360|584130878|FG005|Week 3|Lost to Follow-up|0|||
161751534|NCT04507360|584130879|FG006|Week 3|Lost to Follow-up|0|||
161751535|NCT04507360|584130880|FG007|Week 3|Lost to Follow-up|0|||
161751536|NCT04507360|584130881|FG008|Week 3|Lost to Follow-up|123|||
161751537|NCT04507360|584130882|FG009|Week 3|Lost to Follow-up|92|||
161751538|NCT04507360|584130883|FG010|Week 3|Lost to Follow-up|84|||
161751539|NCT04507360|584130873|FG000|Week 4|Lost to Follow-up|0|||
161751540|NCT04507360|584130874|FG001|Week 4|Lost to Follow-up|0|||
161751541|NCT04507360|584130875|FG002|Week 4|Lost to Follow-up|0|||
161751542|NCT04507360|584130876|FG003|Week 4|Lost to Follow-up|0|||
161844600|NCT03200912|584474577|FG001|Overall Study|Non-compliance with study drug|1|||
161844601|NCT03200912|584474578|FG002|Overall Study|Non-compliance with study drug|0|||
161844602|NCT03196635|584474579|FG000|Overall Study|Withdrawal by Subject|1|||
161844603|NCT00998309|584474580|FG000|Overall Study|Protocol Violation|4|||
161844604|NCT05788289|584474583|FG000|Overall Study|Death|3|||
161844605|NCT02238795|584474585|FG000|Overall Study|Patient without purpura fulminans|1|||
161844606|NCT05187013|584474586|FG000|Overall Study|Withdrawal by Subject|1|||
161844607|NCT05187013|584474587|FG001|Overall Study|Withdrawal by Subject|1|||
161844608|NCT05187013|584474588|FG002|Overall Study|Withdrawal by Subject|0|||
161844609|NCT05187013|584474586|FG000|Overall Study|Death|0|||
161844610|NCT05187013|584474587|FG001|Overall Study|Death|1|||
161844611|NCT05187013|584474588|FG002|Overall Study|Death|0|||
161844612|NCT05187013|584474586|FG000|Overall Study|Lost to Follow-up|20|||
161844613|NCT05187013|584474587|FG001|Overall Study|Lost to Follow-up|17|||
161844614|NCT05187013|584474588|FG002|Overall Study|Lost to Follow-up|0|||
161844615|NCT05187013|584474586|FG000|Overall Study|Ongoing Participants|3|||
161844616|NCT05187013|584474587|FG001|Overall Study|Ongoing Participants|5|||
161844617|NCT05187013|584474588|FG002|Overall Study|Ongoing Participants|0|||
161844618|NCT01096368|584474590|FG000|Overall Study|Death|0|||
161844619|NCT01096368|584474591|FG001|Overall Study|Death|1|||
161844620|NCT01096368|584474592|FG002|Overall Study|Death|0|||
161844621|NCT01096368|584474593|FG003|Overall Study|Death|0|||
161844622|NCT01096368|584474594|FG004|Overall Study|Death|0|||
161844623|NCT01096368|584474590|FG000|Overall Study|Physician Decision|0|||
161844624|NCT01096368|584474591|FG001|Overall Study|Physician Decision|13|||
161844625|NCT01096368|584474592|FG002|Overall Study|Physician Decision|2|||
161844626|NCT01096368|584474593|FG003|Overall Study|Physician Decision|4|||
161844627|NCT01096368|584474594|FG004|Overall Study|Physician Decision|6|||
161844628|NCT01096368|584474590|FG000|Overall Study|Withdrawal by Subject|0|||
161844629|NCT01096368|584474591|FG001|Overall Study|Withdrawal by Subject|52|||
161844630|NCT01096368|584474592|FG002|Overall Study|Withdrawal by Subject|0|||
161844631|NCT01096368|584474593|FG003|Overall Study|Withdrawal by Subject|10|||
161844632|NCT01096368|584474594|FG004|Overall Study|Withdrawal by Subject|14|||
161844633|NCT01096368|584474590|FG000|Overall Study|Ineligible|0|||
161844634|NCT01096368|584474591|FG001|Overall Study|Ineligible|3|||
161844635|NCT01096368|584474592|FG002|Overall Study|Ineligible|2|||
161844636|NCT01096368|584474593|FG003|Overall Study|Ineligible|0|||
161844637|NCT01096368|584474594|FG004|Overall Study|Ineligible|25|||
161844638|NCT01096368|584474590|FG000|Overall Study|Did not start treatment|0|||
161844639|NCT01096368|584474591|FG001|Overall Study|Did not start treatment|4|||
161844640|NCT01096368|584474592|FG002|Overall Study|Did not start treatment|4|||
161844641|NCT01096368|584474593|FG003|Overall Study|Did not start treatment|0|||
161844642|NCT01096368|584474594|FG004|Overall Study|Did not start treatment|0|||
161844643|NCT01096368|584474590|FG000|Overall Study|Progressive disease|0|||
161844644|NCT01096368|584474591|FG001|Overall Study|Progressive disease|6|||
161844645|NCT01096368|584474592|FG002|Overall Study|Progressive disease|0|||
161844646|NCT01096368|584474593|FG003|Overall Study|Progressive disease|10|||
161844647|NCT01096368|584474594|FG004|Overall Study|Progressive disease|3|||
161844648|NCT01096368|584474590|FG000|Overall Study|Other|0|||
161844649|NCT01096368|584474591|FG001|Overall Study|Other|0|||
161844650|NCT01096368|584474592|FG002|Overall Study|Other|1|||
161844651|NCT01096368|584474593|FG003|Overall Study|Other|0|||
161844652|NCT01096368|584474594|FG004|Overall Study|Other|0|||
161844653|NCT01096368|584474590|FG000|Overall Study|Treated with institutional review|0|||
161968175|NCT01529515|584931375|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
161968176|NCT01529515|584931372|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
161968177|NCT01529515|584931373|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
161968178|NCT01529515|584931374|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
161968179|NCT01529515|584931375|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
161844654|NCT01096368|584474591|FG001|Overall Study|Treated with institutional review|0|||
161844655|NCT01096368|584474592|FG002|Overall Study|Treated with institutional review|0|||
161844656|NCT01096368|584474593|FG003|Overall Study|Treated with institutional review|0|||
161844657|NCT01096368|584474594|FG004|Overall Study|Treated with institutional review|1|||
161844658|NCT01568320|584474596|FG000|Overall Study|Death|20|||
161844659|NCT01568320|584474596|FG000|Overall Study|Lost to Follow-up|9|||
161844660|NCT01568320|584474596|FG000|Overall Study|Withdrawal by Subject|10|||
161844661|NCT01568320|584474596|FG000|Overall Study|Conversion to open repair|1|||
161844662|NCT01568320|584474596|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
161844663|NCT03233230|584474597|FG000|Overall Study|Adverse Event|6|||
161844664|NCT03233230|584474598|FG001|Overall Study|Adverse Event|3|||
161844665|NCT03233230|584474599|FG002|Overall Study|Adverse Event|6|||
161844666|NCT03233230|584474600|FG003|Overall Study|Adverse Event|3|||
161844667|NCT03233230|584474597|FG000|Overall Study|Protocol Violation|1|||
161844668|NCT03233230|584474598|FG001|Overall Study|Protocol Violation|2|||
161844669|NCT03233230|584474599|FG002|Overall Study|Protocol Violation|1|||
161844670|NCT03233230|584474600|FG003|Overall Study|Protocol Violation|1|||
161968180|NCT01529515|584931372|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
161968181|NCT01529515|584931373|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
161844671|NCT03233230|584474597|FG000|Overall Study|Lack of Efficacy|1|||
161844672|NCT03233230|584474598|FG001|Overall Study|Lack of Efficacy|0|||
161844673|NCT03233230|584474599|FG002|Overall Study|Lack of Efficacy|0|||
161844674|NCT03233230|584474600|FG003|Overall Study|Lack of Efficacy|0|||
161844675|NCT03233230|584474597|FG000|Overall Study|Other|5|||
161844676|NCT03233230|584474598|FG001|Overall Study|Other|5|||
161844677|NCT03233230|584474599|FG002|Overall Study|Other|5|||
161844678|NCT03233230|584474600|FG003|Overall Study|Other|3|||
161844679|NCT03233230|584474597|FG000|Overall Study|Withdrawal by Subject|2|||
161844680|NCT03233230|584474598|FG001|Overall Study|Withdrawal by Subject|2|||
161844681|NCT03233230|584474599|FG002|Overall Study|Withdrawal by Subject|0|||
161844682|NCT03233230|584474600|FG003|Overall Study|Withdrawal by Subject|1|||
161844683|NCT03233230|584474597|FG000|Overall Study|Lost to Follow-up|0|||
161844684|NCT03233230|584474598|FG001|Overall Study|Lost to Follow-up|3|||
161844685|NCT03233230|584474599|FG002|Overall Study|Lost to Follow-up|0|||
161844686|NCT03233230|584474600|FG003|Overall Study|Lost to Follow-up|0|||
161844687|NCT04159935|584474601|FG000|Overall Study|Study terminated due to COVID-19|1|||
161844688|NCT04159935|584474602|FG001|Overall Study|Study terminated due to COVID-19|3|||
161844689|NCT00587990|584474607|FG000|Overall Study|Death|0|||
161844690|NCT00587990|584474608|FG001|Overall Study|Death|0|||
161844691|NCT00587990|584474609|FG002|Overall Study|Death|1|||
161844692|NCT00206323|584474610|FG000|Overall Study|Lack of Efficacy|4|||
161844693|NCT00206323|584474611|FG001|Overall Study|Lack of Efficacy|1|||
161844694|NCT00206323|584474610|FG000|Overall Study|Adverse Event|1|||
161844695|NCT00206323|584474611|FG001|Overall Study|Adverse Event|1|||
161844696|NCT00206323|584474610|FG000|Overall Study|Lost to Follow-up|1|||
161844697|NCT00206323|584474611|FG001|Overall Study|Lost to Follow-up|1|||
161844698|NCT02910063|584474612|FG000|Phase 2|Withdrawal by Subject|3|||
161844699|NCT02910063|584474613|FG001|Phase 2|Withdrawal by Subject|0|||
161844700|NCT02910063|584474614|FG002|Phase 2|Withdrawal by Subject|0|||
161844701|NCT02910063|584474612|FG000|Phase 2|Lost to Follow-up|1|||
161844702|NCT02910063|584474613|FG001|Phase 2|Lost to Follow-up|0|||
161844703|NCT02910063|584474614|FG002|Phase 2|Lost to Follow-up|0|||
161844704|NCT02910063|584474612|FG000|Phase 2|Death|24|||
161844705|NCT02910063|584474613|FG001|Phase 2|Death|0|||
161844706|NCT02910063|584474614|FG002|Phase 2|Death|0|||
161844707|NCT03334617|584474617|FG000|Overall Study|Adverse Event|0|||
161844708|NCT03334617|584474618|FG001|Overall Study|Adverse Event|0|||
161844709|NCT03334617|584474619|FG002|Overall Study|Adverse Event|0|||
161844710|NCT03334617|584474620|FG003|Overall Study|Adverse Event|0|||
161844711|NCT03334617|584474621|FG004|Overall Study|Adverse Event|0|||
161844712|NCT03334617|584474622|FG005|Overall Study|Adverse Event|0|||
161844713|NCT03334617|584474623|FG006|Overall Study|Adverse Event|0|||
161844714|NCT03334617|584474624|FG007|Overall Study|Adverse Event|0|||
161844715|NCT03334617|584474625|FG008|Overall Study|Adverse Event|1|||
161751543|NCT04507360|584130877|FG004|Week 4|Lost to Follow-up|0|||
161751544|NCT04507360|584130878|FG005|Week 4|Lost to Follow-up|0|||
161751545|NCT04507360|584130879|FG006|Week 4|Lost to Follow-up|0|||
161751546|NCT04507360|584130880|FG007|Week 4|Lost to Follow-up|0|||
161751547|NCT04507360|584130881|FG008|Week 4|Lost to Follow-up|131|||
161751548|NCT04507360|584130882|FG009|Week 4|Lost to Follow-up|115|||
161844716|NCT03334617|584474626|FG009|Overall Study|Adverse Event|0|||
161844717|NCT03334617|584474627|FG010|Overall Study|Adverse Event|0|||
161844718|NCT03334617|584474628|FG011|Overall Study|Adverse Event|0|||
161844719|NCT03334617|584474629|FG012|Overall Study|Adverse Event|1|||
161844720|NCT03334617|584474630|FG013|Overall Study|Adverse Event|0|||
161844721|NCT03334617|584474631|FG014|Overall Study|Adverse Event|0|||
161751549|NCT04507360|584130883|FG010|Week 4|Lost to Follow-up|102|||
161751550|NCT04507360|584130873|FG000|Week 5|Lost to Follow-up|0|||
161751551|NCT04507360|584130874|FG001|Week 5|Lost to Follow-up|0|||
161751552|NCT04507360|584130875|FG002|Week 5|Lost to Follow-up|0|||
161751553|NCT04507360|584130876|FG003|Week 5|Lost to Follow-up|0|||
161751554|NCT04507360|584130877|FG004|Week 5|Lost to Follow-up|0|||
161751555|NCT04507360|584130878|FG005|Week 5|Lost to Follow-up|0|||
161751556|NCT04507360|584130879|FG006|Week 5|Lost to Follow-up|0|||
161751557|NCT04507360|584130880|FG007|Week 5|Lost to Follow-up|0|||
161751558|NCT04507360|584130881|FG008|Week 5|Lost to Follow-up|103|||
161751559|NCT04507360|584130882|FG009|Week 5|Lost to Follow-up|135|||
161751560|NCT04507360|584130883|FG010|Week 5|Lost to Follow-up|143|||
161751561|NCT04507360|584130873|FG000|Week 8|Lost to Follow-up|0|||
161844722|NCT03334617|584474632|FG015|Overall Study|Adverse Event|0|||
161844723|NCT03334617|584474633|FG016|Overall Study|Adverse Event|0|||
161844724|NCT03334617|584474634|FG017|Overall Study|Adverse Event|0|||
161844725|NCT03334617|584474635|FG018|Overall Study|Adverse Event|0|||
161844726|NCT03334617|584474636|FG019|Overall Study|Adverse Event|0|||
161844727|NCT03334617|584474637|FG020|Overall Study|Adverse Event|0|||
161844728|NCT03334617|584474638|FG021|Overall Study|Adverse Event|0|||
161751562|NCT04507360|584130874|FG001|Week 8|Lost to Follow-up|0|||
161751563|NCT04507360|584130875|FG002|Week 8|Lost to Follow-up|0|||
161751564|NCT04507360|584130876|FG003|Week 8|Lost to Follow-up|0|||
161751565|NCT04507360|584130877|FG004|Week 8|Lost to Follow-up|0|||
161844729|NCT03334617|584474617|FG000|Overall Study|Death|18|||
161844730|NCT03334617|584474618|FG001|Overall Study|Death|18|||
161844731|NCT03334617|584474619|FG002|Overall Study|Death|20|||
161844732|NCT03334617|584474620|FG003|Overall Study|Death|21|||
161844733|NCT03334617|584474621|FG004|Overall Study|Death|20|||
161844734|NCT03334617|584474622|FG005|Overall Study|Death|16|||
161844735|NCT03334617|584474623|FG006|Overall Study|Death|28|||
161844736|NCT03334617|584474624|FG007|Overall Study|Death|35|||
161844737|NCT03334617|584474625|FG008|Overall Study|Death|47|||
161844738|NCT03334617|584474626|FG009|Overall Study|Death|0|||
161844739|NCT03334617|584474627|FG010|Overall Study|Death|19|||
161844740|NCT03334617|584474628|FG011|Overall Study|Death|6|||
161844741|NCT03334617|584474629|FG012|Overall Study|Death|20|||
161844742|NCT03334617|584474630|FG013|Overall Study|Death|22|||
161844743|NCT03334617|584474631|FG014|Overall Study|Death|17|||
161844744|NCT03334617|584474632|FG015|Overall Study|Death|18|||
161844745|NCT03334617|584474633|FG016|Overall Study|Death|12|||
161844746|NCT03334617|584474634|FG017|Overall Study|Death|15|||
161844747|NCT03334617|584474635|FG018|Overall Study|Death|16|||
161844748|NCT03334617|584474636|FG019|Overall Study|Death|27|||
161844749|NCT03334617|584474637|FG020|Overall Study|Death|14|||
161844750|NCT03334617|584474638|FG021|Overall Study|Death|27|||
161844751|NCT03334617|584474617|FG000|Overall Study|Lost to Follow-up|0|||
161844752|NCT03334617|584474618|FG001|Overall Study|Lost to Follow-up|0|||
161844753|NCT03334617|584474619|FG002|Overall Study|Lost to Follow-up|0|||
161844754|NCT03334617|584474620|FG003|Overall Study|Lost to Follow-up|1|||
161844755|NCT03334617|584474621|FG004|Overall Study|Lost to Follow-up|0|||
161844756|NCT03334617|584474622|FG005|Overall Study|Lost to Follow-up|1|||
161844757|NCT03334617|584474623|FG006|Overall Study|Lost to Follow-up|0|||
161844758|NCT03334617|584474624|FG007|Overall Study|Lost to Follow-up|0|||
161844759|NCT03334617|584474625|FG008|Overall Study|Lost to Follow-up|1|||
161844760|NCT03334617|584474626|FG009|Overall Study|Lost to Follow-up|0|||
161844761|NCT03334617|584474627|FG010|Overall Study|Lost to Follow-up|0|||
161844762|NCT03334617|584474628|FG011|Overall Study|Lost to Follow-up|0|||
161844763|NCT03334617|584474629|FG012|Overall Study|Lost to Follow-up|0|||
161844764|NCT03334617|584474630|FG013|Overall Study|Lost to Follow-up|0|||
161844765|NCT03334617|584474631|FG014|Overall Study|Lost to Follow-up|0|||
161844766|NCT03334617|584474632|FG015|Overall Study|Lost to Follow-up|0|||
161844767|NCT03334617|584474633|FG016|Overall Study|Lost to Follow-up|0|||
161844768|NCT03334617|584474634|FG017|Overall Study|Lost to Follow-up|0|||
161844769|NCT03334617|584474635|FG018|Overall Study|Lost to Follow-up|0|||
161844770|NCT03334617|584474636|FG019|Overall Study|Lost to Follow-up|0|||
161844771|NCT03334617|584474637|FG020|Overall Study|Lost to Follow-up|0|||
161844772|NCT03334617|584474638|FG021|Overall Study|Lost to Follow-up|0|||
161844773|NCT03334617|584474617|FG000|Overall Study|Withdrawal by Subject|0|||
161844774|NCT03334617|584474618|FG001|Overall Study|Withdrawal by Subject|1|||
161844775|NCT03334617|584474619|FG002|Overall Study|Withdrawal by Subject|0|||
161844776|NCT03334617|584474620|FG003|Overall Study|Withdrawal by Subject|0|||
161844777|NCT03334617|584474621|FG004|Overall Study|Withdrawal by Subject|1|||
161844778|NCT03334617|584474622|FG005|Overall Study|Withdrawal by Subject|1|||
161844779|NCT03334617|584474623|FG006|Overall Study|Withdrawal by Subject|1|||
161844780|NCT03334617|584474624|FG007|Overall Study|Withdrawal by Subject|2|||
161844781|NCT03334617|584474625|FG008|Overall Study|Withdrawal by Subject|0|||
161844782|NCT03334617|584474626|FG009|Overall Study|Withdrawal by Subject|0|||
161844783|NCT03334617|584474627|FG010|Overall Study|Withdrawal by Subject|0|||
161844784|NCT03334617|584474628|FG011|Overall Study|Withdrawal by Subject|1|||
161844785|NCT03334617|584474629|FG012|Overall Study|Withdrawal by Subject|1|||
161844786|NCT03334617|584474630|FG013|Overall Study|Withdrawal by Subject|0|||
161844787|NCT03334617|584474631|FG014|Overall Study|Withdrawal by Subject|2|||
161844788|NCT03334617|584474632|FG015|Overall Study|Withdrawal by Subject|1|||
161844789|NCT03334617|584474633|FG016|Overall Study|Withdrawal by Subject|0|||
161844790|NCT03334617|584474634|FG017|Overall Study|Withdrawal by Subject|1|||
161844791|NCT03334617|584474635|FG018|Overall Study|Withdrawal by Subject|1|||
161968182|NCT01529515|584931374|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
161968183|NCT01529515|584931375|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
161844792|NCT03334617|584474636|FG019|Overall Study|Withdrawal by Subject|1|||
161844793|NCT03334617|584474637|FG020|Overall Study|Withdrawal by Subject|0|||
161968184|NCT01529515|584931372|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
161968185|NCT01529515|584931373|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
161844794|NCT03334617|584474638|FG021|Overall Study|Withdrawal by Subject|1|||
161844795|NCT03334617|584474617|FG000|Overall Study|Other|1|||
161844796|NCT03334617|584474618|FG001|Overall Study|Other|2|||
161844797|NCT03334617|584474619|FG002|Overall Study|Other|0|||
161844798|NCT03334617|584474620|FG003|Overall Study|Other|1|||
161844799|NCT03334617|584474621|FG004|Overall Study|Other|1|||
161844800|NCT03334617|584474622|FG005|Overall Study|Other|0|||
161844801|NCT03334617|584474623|FG006|Overall Study|Other|2|||
161844802|NCT03334617|584474624|FG007|Overall Study|Other|1|||
161844803|NCT03334617|584474625|FG008|Overall Study|Other|8|||
161844804|NCT03334617|584474626|FG009|Overall Study|Other|0|||
161844805|NCT03334617|584474627|FG010|Overall Study|Other|3|||
161968186|NCT01529515|584931374|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
161844806|NCT03334617|584474628|FG011|Overall Study|Other|1|||
161844807|NCT03334617|584474629|FG012|Overall Study|Other|3|||
161844808|NCT03334617|584474630|FG013|Overall Study|Other|1|||
161844809|NCT03334617|584474631|FG014|Overall Study|Other|1|||
162032698|NCT01933789|585177453|FG003|Overall Study|Became Ineligible|0|||
161751566|NCT04507360|584130878|FG005|Week 8|Lost to Follow-up|0|||
161751567|NCT04507360|584130879|FG006|Week 8|Lost to Follow-up|0|||
161751568|NCT04507360|584130880|FG007|Week 8|Lost to Follow-up|0|||
161751569|NCT04507360|584130881|FG008|Week 8|Lost to Follow-up|139|||
161751570|NCT04507360|584130882|FG009|Week 8|Lost to Follow-up|145|||
161751571|NCT04507360|584130883|FG010|Week 8|Lost to Follow-up|152|||
161751572|NCT00400946|584130884|FG000|Overall Study|Ineligible|0|||
161751573|NCT00400946|584130885|FG001|Overall Study|Ineligible|0|||
161751574|NCT00400946|584130886|FG002|Overall Study|Ineligible|0|||
161751575|NCT00400946|584130887|FG003|Overall Study|Ineligible|5|||
161751576|NCT00400946|584130888|FG004|Overall Study|Ineligible|1|||
161751577|NCT00400946|584130884|FG000|Overall Study|Induction Failure|0|||
161751578|NCT00400946|584130885|FG001|Overall Study|Induction Failure|0|||
161751579|NCT00400946|584130886|FG002|Overall Study|Induction Failure|0|||
161751580|NCT00400946|584130887|FG003|Overall Study|Induction Failure|11|||
161751581|NCT00400946|584130888|FG004|Overall Study|Induction Failure|8|||
161751582|NCT00400946|584130884|FG000|Overall Study|Induction Death|0|||
161751583|NCT00400946|584130885|FG001|Overall Study|Induction Death|0|||
161751584|NCT00400946|584130886|FG002|Overall Study|Induction Death|0|||
161751585|NCT00400946|584130887|FG003|Overall Study|Induction Death|13|||
161751586|NCT00400946|584130888|FG004|Overall Study|Induction Death|3|||
161751587|NCT00400946|584130884|FG000|Overall Study|Lost to Follow-up|1|||
161751588|NCT00400946|584130885|FG001|Overall Study|Lost to Follow-up|1|||
161751589|NCT00400946|584130886|FG002|Overall Study|Lost to Follow-up|0|||
161751590|NCT00400946|584130887|FG003|Overall Study|Lost to Follow-up|0|||
161751591|NCT00400946|584130888|FG004|Overall Study|Lost to Follow-up|1|||
161751592|NCT00400946|584130884|FG000|Overall Study|Remission Death|1|||
161751593|NCT00400946|584130885|FG001|Overall Study|Remission Death|1|||
161751594|NCT00400946|584130886|FG002|Overall Study|Remission Death|0|||
161751595|NCT00400946|584130887|FG003|Overall Study|Remission Death|0|||
161751596|NCT00400946|584130888|FG004|Overall Study|Remission Death|1|||
161751597|NCT00400946|584130884|FG000|Overall Study|Relapse|9|||
161751598|NCT00400946|584130885|FG001|Overall Study|Relapse|2|||
161751599|NCT00400946|584130886|FG002|Overall Study|Relapse|1|||
161751600|NCT00400946|584130887|FG003|Overall Study|Relapse|1|||
161751601|NCT00400946|584130888|FG004|Overall Study|Relapse|5|||
161751602|NCT00400946|584130884|FG000|Overall Study|Transplant in CR1|0|||
161751603|NCT00400946|584130885|FG001|Overall Study|Transplant in CR1|0|||
161751604|NCT00400946|584130886|FG002|Overall Study|Transplant in CR1|0|||
161751605|NCT00400946|584130887|FG003|Overall Study|Transplant in CR1|10|||
161751606|NCT00400946|584130888|FG004|Overall Study|Transplant in CR1|1|||
161751607|NCT00400946|584130884|FG000|Overall Study|Withdrawal by Subject|2|||
161751608|NCT00400946|584130885|FG001|Overall Study|Withdrawal by Subject|5|||
161751609|NCT00400946|584130886|FG002|Overall Study|Withdrawal by Subject|1|||
161751610|NCT00400946|584130887|FG003|Overall Study|Withdrawal by Subject|5|||
161751611|NCT00400946|584130888|FG004|Overall Study|Withdrawal by Subject|8|||
161751612|NCT00400946|584130884|FG000|Overall Study|Clinical|1|||
161751613|NCT00400946|584130885|FG001|Overall Study|Clinical|2|||
161751614|NCT00400946|584130886|FG002|Overall Study|Clinical|0|||
161751615|NCT00400946|584130887|FG003|Overall Study|Clinical|2|||
161751616|NCT00400946|584130888|FG004|Overall Study|Clinical|9|||
161751617|NCT00400946|584130884|FG000|Overall Study|Other|0|||
161751618|NCT00400946|584130885|FG001|Overall Study|Other|0|||
161751619|NCT00400946|584130886|FG002|Overall Study|Other|0|||
161751620|NCT00400946|584130887|FG003|Overall Study|Other|0|||
161751621|NCT00400946|584130888|FG004|Overall Study|Other|1|||
161751622|NCT03950440|584130891|FG000|Overall Study|Death|8|||
161751623|NCT03950440|584130892|FG001|Overall Study|Death|2|||
161751624|NCT03950440|584130893|FG002|Overall Study|Death|1|||
161751625|NCT02892734|584130894|FG000|Treatment on Study|Progressive Disease|2|||
161751626|NCT02892734|584130894|FG000|Follow up for 2 Years|Death|2|||
161751627|NCT02892734|584130894|FG000|Follow up for 2 Years|Study closed early|1|||
161751628|NCT00439309|584130895|FG000|Follow-Up|Death|1|||
161751629|NCT00439309|584130896|FG001|Follow-Up|Death|0|||
161751630|NCT00439309|584130895|FG000|Follow-Up|Lost to Follow-up|2|||
161751631|NCT00439309|584130896|FG001|Follow-Up|Lost to Follow-up|0|||
161751632|NCT00439309|584130895|FG000|Follow-Up|Withdrawal by Subject|0|||
161751633|NCT00439309|584130896|FG001|Follow-Up|Withdrawal by Subject|1|||
161751634|NCT00439309|584130895|FG000|Follow-Up|Late response by subject|0|||
161751635|NCT00439309|584130896|FG001|Follow-Up|Late response by subject|1|||
161751636|NCT02043509|584130897|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
161751637|NCT02043509|584130898|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
161751638|NCT02043509|584130897|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
161751639|NCT02043509|584130898|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
161751640|NCT02043509|584130897|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
161751641|NCT02043509|584130898|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
161751642|NCT02043509|584130897|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
161751643|NCT02043509|584130898|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
161751644|NCT00608244|584130903|FG000|Overall Study|Adverse Event|1|||
161751645|NCT00608244|584130903|FG000|Overall Study|Low trough levels|1|||
161751646|NCT00430027|584130904|FG000|Overall Study|Study terminated|8|||
161844810|NCT03334617|584474632|FG015|Overall Study|Other|3|||
161844811|NCT03334617|584474633|FG016|Overall Study|Other|3|||
161844812|NCT03334617|584474634|FG017|Overall Study|Other|3|||
161844813|NCT03334617|584474635|FG018|Overall Study|Other|7|||
161844814|NCT03334617|584474636|FG019|Overall Study|Other|4|||
161844815|NCT03334617|584474637|FG020|Overall Study|Other|1|||
161844816|NCT03334617|584474638|FG021|Overall Study|Other|4|||
161844817|NCT03334617|584474617|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
161844818|NCT03334617|584474618|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
161844819|NCT03334617|584474619|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
161844820|NCT03334617|584474620|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
161844821|NCT03334617|584474621|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
161844822|NCT03334617|584474622|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
161844823|NCT03334617|584474623|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
161844824|NCT03334617|584474624|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
161844825|NCT03334617|584474625|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
161844826|NCT03334617|584474626|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
161844827|NCT03334617|584474627|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
161844828|NCT03334617|584474628|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
161844829|NCT03334617|584474629|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
161844830|NCT03334617|584474630|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
161844831|NCT03334617|584474631|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
161751647|NCT01977040|584130909|FG000|Overall Study|Vasa previa not confirmed|2|||
161751648|NCT01685060|584130910|FG000|Overall Study|Rollover patients|16|||
161751649|NCT01685060|584130910|FG000|Overall Study|Adverse Event|12|||
161751650|NCT01685060|584130910|FG000|Overall Study|Progressive disease|69|||
161751651|NCT01685060|584130910|FG000|Overall Study|Physician Decision|14|||
161751652|NCT01685060|584130910|FG000|Overall Study|Subject/guardian decision|20|||
161751653|NCT01685060|584130910|FG000|Overall Study|Lost to Follow-up|1|||
161751654|NCT01685060|584130910|FG000|Overall Study|Death|8|||
161844832|NCT03334617|584474632|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
161844833|NCT03334617|584474633|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
161844834|NCT03334617|584474634|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
161844835|NCT03334617|584474635|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
161844836|NCT03334617|584474636|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
161844837|NCT03334617|584474637|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
161844838|NCT03334617|584474638|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
161844839|NCT03657342|584474640|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
161844840|NCT03657342|584474641|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
161844841|NCT03657342|584474640|FG000|Overall Study|Withdrawal by Subject|4|||
161844842|NCT03657342|584474641|FG001|Overall Study|Withdrawal by Subject|4|||
161844843|NCT03657342|584474640|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
161844844|NCT03657342|584474641|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
161844845|NCT03657342|584474640|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
161844846|NCT03657342|584474641|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
161844847|NCT00827632|584474642|FG000|Overall Study|Lost to Follow-up|8|||
161844848|NCT00827632|584474643|FG001|Overall Study|Lost to Follow-up|12|||
161844849|NCT00827632|584474642|FG000|Overall Study|Early withdrawal|14|||
161844850|NCT00827632|584474643|FG001|Overall Study|Early withdrawal|11|||
161844851|NCT00407758|584474658|FG000|Overall Study|ineligible -improper prior treatment|1|||
161844852|NCT00750308|584474671|FG000|First Treatment|Adverse Event|0|||
161844853|NCT00750308|584474672|FG001|First Treatment|Adverse Event|1|||
161844854|NCT00750308|584474673|FG002|First Treatment|Adverse Event|0|||
161844855|NCT00750308|584474674|FG003|First Treatment|Adverse Event|0|||
161844856|NCT00750308|584474675|FG004|First Treatment|Adverse Event|0|||
161844857|NCT00750308|584474676|FG005|First Treatment|Adverse Event|0|||
161844858|NCT00750308|584474677|FG006|First Treatment|Adverse Event|0|||
161751655|NCT02443155|584130913|FG000|Overall Study|Adverse Event|3|||
161751656|NCT02443155|584130914|FG001|Overall Study|Adverse Event|4|||
161751657|NCT02443155|584130915|FG002|Overall Study|Adverse Event|1|||
161844859|NCT00750308|584474678|FG007|First Treatment|Adverse Event|0|||
161751658|NCT02443155|584130916|FG003|Overall Study|Adverse Event|2|||
161751659|NCT02443155|584130913|FG000|Overall Study|Unclassified|0|||
161751660|NCT02443155|584130914|FG001|Overall Study|Unclassified|0|||
161751661|NCT02443155|584130915|FG002|Overall Study|Unclassified|2|||
161844860|NCT00750308|584474679|FG008|First Treatment|Adverse Event|0|||
161844861|NCT00750308|584474680|FG009|First Treatment|Adverse Event|0|||
161844862|NCT00750308|584474681|FG010|First Treatment|Adverse Event|1|||
161844863|NCT00750308|584474682|FG011|First Treatment|Adverse Event|1|||
161844864|NCT00750308|584474671|FG000|First Treatment|Withdrawal by Subject|0|||
161844865|NCT00750308|584474672|FG001|First Treatment|Withdrawal by Subject|0|||
162032699|NCT01933789|585177454|FG004|Overall Study|Became Ineligible|13|||
162032700|NCT01933789|585177455|FG005|Overall Study|Became Ineligible|10|||
162032701|NCT01933789|585177456|FG006|Overall Study|Became Ineligible|13|||
162032702|NCT01933789|585177457|FG007|Overall Study|Became Ineligible|6|||
162032703|NCT01933789|585177458|FG008|Overall Study|Became Ineligible|0|||
162032704|NCT02915874|585177462|FG000|Overall Study|Lost to Follow-up|5|||
162032705|NCT02915874|585177463|FG001|Overall Study|Lost to Follow-up|4|||
162032706|NCT02915874|585177462|FG000|Overall Study|Withdrawal by Subject|1|||
162032707|NCT02915874|585177463|FG001|Overall Study|Withdrawal by Subject|1|||
162032708|NCT02915874|585177462|FG000|Overall Study|Started New Anxiety Medication|0|||
162032709|NCT02915874|585177463|FG001|Overall Study|Started New Anxiety Medication|1|||
162032710|NCT01903252|585177465|FG000|Double-Blind Induction|Adverse Event|20|||
162032711|NCT01903252|585177466|FG001|Double-Blind Induction|Adverse Event|18|||
162032712|NCT01903252|585177467|FG002|Double-Blind Induction|Adverse Event|0|||
162032713|NCT01903252|585177468|FG003|Double-Blind Induction|Adverse Event|0|||
162032714|NCT01903252|585177469|FG004|Double-Blind Induction|Adverse Event|0|||
162032715|NCT01903252|585177470|FG005|Double-Blind Induction|Adverse Event|0|||
162032716|NCT01903252|585177465|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
162032717|NCT01903252|585177466|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
162032718|NCT01903252|585177467|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
162032719|NCT01903252|585177468|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
162032720|NCT01903252|585177469|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
162032721|NCT01903252|585177470|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
162032722|NCT01903252|585177465|FG000|Double-Blind Induction|Physician Decision|2|||
161751662|NCT02443155|584130916|FG003|Overall Study|Unclassified|1|||
161751663|NCT02443155|584130913|FG000|Overall Study|Withdrawal by Subject|4|||
161751664|NCT02443155|584130914|FG001|Overall Study|Withdrawal by Subject|7|||
161751665|NCT02443155|584130915|FG002|Overall Study|Withdrawal by Subject|3|||
161751666|NCT02443155|584130916|FG003|Overall Study|Withdrawal by Subject|9|||
161751667|NCT02443155|584130913|FG000|Overall Study|Pregnancy|3|||
161751668|NCT02443155|584130914|FG001|Overall Study|Pregnancy|1|||
161751669|NCT02443155|584130915|FG002|Overall Study|Pregnancy|1|||
161751670|NCT02443155|584130916|FG003|Overall Study|Pregnancy|2|||
161751671|NCT02443155|584130913|FG000|Overall Study|Lost to Follow-up|1|||
161751672|NCT02443155|584130914|FG001|Overall Study|Lost to Follow-up|2|||
161751673|NCT02443155|584130915|FG002|Overall Study|Lost to Follow-up|0|||
161751674|NCT02443155|584130916|FG003|Overall Study|Lost to Follow-up|1|||
161751675|NCT02443155|584130913|FG000|Overall Study|Protocol Violation|1|||
161751676|NCT02443155|584130914|FG001|Overall Study|Protocol Violation|0|||
161751677|NCT02443155|584130915|FG002|Overall Study|Protocol Violation|1|||
161751678|NCT02443155|584130916|FG003|Overall Study|Protocol Violation|1|||
161751679|NCT02443155|584130913|FG000|Overall Study|Death|0|||
161751680|NCT02443155|584130914|FG001|Overall Study|Death|0|||
161751681|NCT02443155|584130915|FG002|Overall Study|Death|1|||
161751682|NCT02443155|584130916|FG003|Overall Study|Death|0|||
161751683|NCT00688623|584130917|FG000|Overall Study|Adverse Event|22|||
161751684|NCT00688623|584130917|FG000|Overall Study|abnormal lab value|1|||
161751685|NCT00688623|584130917|FG000|Overall Study|Withdrawal by Subject|4|||
161751686|NCT00688623|584130917|FG000|Overall Study|Death|3|||
161751687|NCT00688623|584130917|FG000|Overall Study|disease progression|23|||
161751688|NCT00688623|584130917|FG000|Overall Study|Protocol Violation|2|||
161751689|NCT02000219|584130918|FG000|14-Week Study Period|Physician Decision|1|||
161751690|NCT02000219|584130918|FG000|14-Week Study Period|Adverse Event|1|||
161751691|NCT02000219|584130918|FG000|14-Week Study Period|Underwent transplantation|1|||
161751692|NCT02000219|584130918|FG000|Continuation Period|Withdrawal by Subject|1|||
161751693|NCT02000219|584130918|FG000|Continuation Period|Had liver transplant|2|||
161751694|NCT02000219|584130918|FG000|Continuation Period|Non-compliance with study drug|2|||
161751695|NCT00464620|584130919|FG000|Overall Study|Physician Decision|1|||
161751696|NCT00464620|584130920|FG001|Overall Study|Physician Decision|0|||
161751697|NCT00464620|584130921|FG002|Overall Study|Physician Decision|0|||
161751698|NCT00464620|584130919|FG000|Overall Study|Withdrawal by Subject|1|||
161751699|NCT00464620|584130920|FG001|Overall Study|Withdrawal by Subject|0|||
161751700|NCT00464620|584130921|FG002|Overall Study|Withdrawal by Subject|3|||
161751701|NCT00464620|584130919|FG000|Overall Study|Ineligible sarcoma subtype|0|||
161751702|NCT00464620|584130920|FG001|Overall Study|Ineligible sarcoma subtype|2|||
161751703|NCT00464620|584130921|FG002|Overall Study|Ineligible sarcoma subtype|2|||
161751704|NCT00464620|584130919|FG000|Overall Study|Use of prohibited concomitant medication|0|||
161751705|NCT00464620|584130920|FG001|Overall Study|Use of prohibited concomitant medication|0|||
161751706|NCT00464620|584130921|FG002|Overall Study|Use of prohibited concomitant medication|2|||
161751707|NCT01998906|584130922|FG000|Overall Study|Participants ongoing in follow-up|77|||
161751708|NCT01998906|584130923|FG001|Overall Study|Participants ongoing in follow-up|60|||
161751709|NCT01998906|584130924|FG002|Overall Study|Participants ongoing in follow-up|58|||
161751710|NCT01998906|584130922|FG000|Overall Study|Death|21|||
161751711|NCT01998906|584130923|FG001|Overall Study|Death|30|||
161751712|NCT01998906|584130924|FG002|Overall Study|Death|17|||
161751713|NCT01998906|584130922|FG000|Overall Study|Lack of Efficacy|10|||
162032723|NCT01903252|585177466|FG001|Double-Blind Induction|Physician Decision|3|||
161844866|NCT00750308|584474673|FG002|First Treatment|Withdrawal by Subject|0|||
161844867|NCT00750308|584474674|FG003|First Treatment|Withdrawal by Subject|1|||
161844868|NCT00750308|584474675|FG004|First Treatment|Withdrawal by Subject|0|||
161844869|NCT00750308|584474676|FG005|First Treatment|Withdrawal by Subject|0|||
161844870|NCT00750308|584474677|FG006|First Treatment|Withdrawal by Subject|0|||
161844871|NCT00750308|584474678|FG007|First Treatment|Withdrawal by Subject|1|||
161844872|NCT00750308|584474679|FG008|First Treatment|Withdrawal by Subject|0|||
161844873|NCT00750308|584474680|FG009|First Treatment|Withdrawal by Subject|0|||
161844874|NCT00750308|584474681|FG010|First Treatment|Withdrawal by Subject|0|||
161844875|NCT00750308|584474682|FG011|First Treatment|Withdrawal by Subject|0|||
161844876|NCT00750308|584474671|FG000|Second Treatment|Adverse Event|0|||
161844877|NCT00750308|584474672|FG001|Second Treatment|Adverse Event|0|||
161844878|NCT00750308|584474673|FG002|Second Treatment|Adverse Event|0|||
161844879|NCT00750308|584474674|FG003|Second Treatment|Adverse Event|0|||
161844880|NCT00750308|584474675|FG004|Second Treatment|Adverse Event|0|||
161844881|NCT00750308|584474676|FG005|Second Treatment|Adverse Event|1|||
161844882|NCT00750308|584474677|FG006|Second Treatment|Adverse Event|0|||
161844883|NCT00750308|584474678|FG007|Second Treatment|Adverse Event|0|||
161844884|NCT00750308|584474679|FG008|Second Treatment|Adverse Event|1|||
161844885|NCT00750308|584474680|FG009|Second Treatment|Adverse Event|0|||
161844886|NCT00750308|584474681|FG010|Second Treatment|Adverse Event|0|||
161844887|NCT00750308|584474682|FG011|Second Treatment|Adverse Event|0|||
161844888|NCT00750308|584474671|FG000|Second Treatment|Withdrawal by Subject|0|||
161844889|NCT00750308|584474672|FG001|Second Treatment|Withdrawal by Subject|0|||
161844890|NCT00750308|584474673|FG002|Second Treatment|Withdrawal by Subject|0|||
161844891|NCT00750308|584474674|FG003|Second Treatment|Withdrawal by Subject|0|||
161844892|NCT00750308|584474675|FG004|Second Treatment|Withdrawal by Subject|1|||
161844893|NCT00750308|584474676|FG005|Second Treatment|Withdrawal by Subject|0|||
161844894|NCT00750308|584474677|FG006|Second Treatment|Withdrawal by Subject|0|||
161844895|NCT00750308|584474678|FG007|Second Treatment|Withdrawal by Subject|0|||
161844896|NCT00750308|584474679|FG008|Second Treatment|Withdrawal by Subject|0|||
161844897|NCT00750308|584474680|FG009|Second Treatment|Withdrawal by Subject|0|||
161844898|NCT00750308|584474681|FG010|Second Treatment|Withdrawal by Subject|0|||
161844899|NCT00750308|584474682|FG011|Second Treatment|Withdrawal by Subject|0|||
161844900|NCT00750308|584474671|FG000|Third Treatment|Withdrawal by Subject|0|||
161844901|NCT00750308|584474672|FG001|Third Treatment|Withdrawal by Subject|1|||
161968187|NCT01529515|584931375|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
161968188|NCT01529515|584931372|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
161968189|NCT01529515|584931373|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
161968190|NCT01529515|584931374|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
161968191|NCT01529515|584931375|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
161968192|NCT01529515|584931372|FG000|DOUBLE BLIND PHASE|Other|0|||
161968193|NCT01529515|584931373|FG001|DOUBLE BLIND PHASE|Other|0|||
161968194|NCT01529515|584931374|FG002|DOUBLE BLIND PHASE|Other|9|||
161968195|NCT01529515|584931375|FG003|DOUBLE BLIND PHASE|Other|2|||
161968196|NCT00322023|584931377|FG000|Overall Study|various|0|||
161968197|NCT00322023|584931378|FG001|Overall Study|various|2|||
161968198|NCT00322023|584931379|FG002|Overall Study|various|6|||
161968199|NCT03327220|584931380|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
161968200|NCT03327220|584931381|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
161968201|NCT03327220|584931380|FG000|Overall Study|Investigator Decision|2|||
161968202|NCT03327220|584931381|FG001|Overall Study|Investigator Decision|0|||
161968203|NCT03327220|584931380|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
161968204|NCT03327220|584931381|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
161968205|NCT03327220|584931380|FG000|Overall Study|Fungal infection|1|||
161968206|NCT03327220|584931381|FG001|Overall Study|Fungal infection|0|||
161968207|NCT03327220|584931380|FG000|Overall Study|Discharged to Rehabilitation|0|||
161968208|NCT03327220|584931381|FG001|Overall Study|Discharged to Rehabilitation|1|||
161968209|NCT03327220|584931380|FG000|Overall Study|Missing|1|||
161968210|NCT03327220|584931381|FG001|Overall Study|Missing|0|||
161968211|NCT03920293|584931382|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
161968212|NCT03920293|584931383|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
161968213|NCT03920293|584931382|FG000|Randomized-Controlled Period|Physician Decision|1|||
161968214|NCT03920293|584931383|FG001|Randomized-Controlled Period|Physician Decision|2|||
161968215|NCT03920293|584931382|FG000|Randomized-Controlled Period|Adverse Event|0|||
161968216|NCT03920293|584931383|FG001|Randomized-Controlled Period|Adverse Event|2|||
161968217|NCT03920293|584931382|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
161968218|NCT03920293|584931383|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
161968219|NCT03920293|584931382|FG000|Randomized-Controlled Period|Death|2|||
161844902|NCT00750308|584474673|FG002|Third Treatment|Withdrawal by Subject|0|||
161844903|NCT00750308|584474674|FG003|Third Treatment|Withdrawal by Subject|0|||
161844904|NCT00750308|584474675|FG004|Third Treatment|Withdrawal by Subject|0|||
161844905|NCT00750308|584474676|FG005|Third Treatment|Withdrawal by Subject|0|||
161844906|NCT00750308|584474677|FG006|Third Treatment|Withdrawal by Subject|0|||
161844907|NCT00750308|584474678|FG007|Third Treatment|Withdrawal by Subject|0|||
161844908|NCT00750308|584474679|FG008|Third Treatment|Withdrawal by Subject|0|||
161968220|NCT03920293|584931383|FG001|Randomized-Controlled Period|Death|0|||
161968221|NCT03920293|584931382|FG000|Randomized-Controlled Period|Protocol Violation|1|||
161968222|NCT03920293|584931383|FG001|Randomized-Controlled Period|Protocol Violation|0|||
161751714|NCT01998906|584130923|FG001|Overall Study|Lack of Efficacy|9|||
161751715|NCT01998906|584130924|FG002|Overall Study|Lack of Efficacy|8|||
161751716|NCT01998906|584130922|FG000|Overall Study|Failure to return|0|||
161751717|NCT01998906|584130923|FG001|Overall Study|Failure to return|2|||
161751718|NCT01998906|584130924|FG002|Overall Study|Failure to return|4|||
161751719|NCT01998906|584130922|FG000|Overall Study|Violation of Selection Criteria|0|||
161751720|NCT01998906|584130923|FG001|Overall Study|Violation of Selection Criteria|0|||
161751721|NCT01998906|584130924|FG002|Overall Study|Violation of Selection Criteria|1|||
161751722|NCT01998906|584130922|FG000|Overall Study|Withdrawal by Subject|1|||
161751723|NCT01998906|584130923|FG001|Overall Study|Withdrawal by Subject|4|||
161751724|NCT01998906|584130924|FG002|Overall Study|Withdrawal by Subject|3|||
161751725|NCT01998906|584130922|FG000|Overall Study|Administrative/Other|2|||
161751726|NCT01998906|584130923|FG001|Overall Study|Administrative/Other|1|||
161751727|NCT01998906|584130924|FG002|Overall Study|Administrative/Other|3|||
161751728|NCT01998906|584130922|FG000|Overall Study|Other|3|||
161751729|NCT01998906|584130923|FG001|Overall Study|Other|8|||
161751730|NCT01998906|584130924|FG002|Overall Study|Other|4|||
161751731|NCT01572844|584130925|FG000|Overall Study|Physician Decision|1|||
161751732|NCT01572844|584130926|FG001|Overall Study|Physician Decision|1|||
161751733|NCT02809118|584130929|FG000|Overall Study|Withdrawal by Subject|0|||
161751734|NCT02809118|584130930|FG001|Overall Study|Withdrawal by Subject|1|||
161751735|NCT02809118|584130931|FG002|Overall Study|Withdrawal by Subject|1|||
161751736|NCT06048809|584130940|FG000|Overall Study|Adverse Event|2|||
161751737|NCT06048809|584130941|FG001|Overall Study|Adverse Event|0|||
161751738|NCT06048809|584130940|FG000|Overall Study|Withdrawal by Subject|1|||
161751739|NCT06048809|584130941|FG001|Overall Study|Withdrawal by Subject|1|||
161751740|NCT02158728|584130942|FG000|Overall Study|no procedure according to CIP done|3|||
161751741|NCT02158728|584130942|FG000|Overall Study|no qualified dataset|24|||
161751742|NCT01156363|584130946|FG000|Overall Study|Adverse Event|6|||
161751743|NCT01156363|584130946|FG000|Overall Study|Insufficient Therapeutic Response|5|||
161751744|NCT01156363|584130946|FG000|Overall Study|Failure to Return|1|||
161751745|NCT01156363|584130946|FG000|Overall Study|Refused Treatment|4|||
161751746|NCT01156363|584130946|FG000|Overall Study|Other|6|||
161751747|NCT03135262|584130947|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
161751748|NCT03135262|584130948|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
161751749|NCT03135262|584130949|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
161751750|NCT03135262|584130950|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
161751751|NCT03135262|584130951|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
161751752|NCT03135262|584130947|FG000|Overall Study|Progression of disease|0|||
161751753|NCT03135262|584130948|FG001|Overall Study|Progression of disease|0|||
161751754|NCT03135262|584130949|FG002|Overall Study|Progression of disease|0|||
161751755|NCT03135262|584130950|FG003|Overall Study|Progression of disease|1|||
161751756|NCT03135262|584130951|FG004|Overall Study|Progression of disease|0|||
161751757|NCT03135262|584130947|FG000|Overall Study|Death|6|||
161751758|NCT03135262|584130948|FG001|Overall Study|Death|2|||
161751759|NCT03135262|584130949|FG002|Overall Study|Death|2|||
161751760|NCT03135262|584130950|FG003|Overall Study|Death|2|||
161751761|NCT03135262|584130951|FG004|Overall Study|Death|0|||
161751762|NCT03135262|584130947|FG000|Overall Study|Withdrawal by Subject|0|||
161751763|NCT03135262|584130948|FG001|Overall Study|Withdrawal by Subject|0|||
161751764|NCT03135262|584130949|FG002|Overall Study|Withdrawal by Subject|1|||
161751765|NCT03135262|584130950|FG003|Overall Study|Withdrawal by Subject|0|||
161751766|NCT03135262|584130951|FG004|Overall Study|Withdrawal by Subject|1|||
161751767|NCT03135262|584130947|FG000|Overall Study|Study terminated by sponsor|2|||
161751768|NCT03135262|584130948|FG001|Overall Study|Study terminated by sponsor|4|||
161751769|NCT03135262|584130949|FG002|Overall Study|Study terminated by sponsor|4|||
161751770|NCT03135262|584130950|FG003|Overall Study|Study terminated by sponsor|3|||
161751771|NCT03135262|584130951|FG004|Overall Study|Study terminated by sponsor|0|||
161751772|NCT03745989|584130953|FG000|Overall Study|Death|3|||
161751773|NCT03745989|584130954|FG001|Overall Study|Death|7|||
161751774|NCT03745989|584130955|FG002|Overall Study|Death|4|||
161751775|NCT03745989|584130953|FG000|Overall Study|Lost to Follow-up|0|||
161751776|NCT03745989|584130954|FG001|Overall Study|Lost to Follow-up|2|||
161751777|NCT03745989|584130955|FG002|Overall Study|Lost to Follow-up|0|||
161751778|NCT03745989|584130953|FG000|Overall Study|Sponsor Decision|0|||
161751779|NCT03745989|584130954|FG001|Overall Study|Sponsor Decision|2|||
161751780|NCT03745989|584130955|FG002|Overall Study|Sponsor Decision|8|||
161751781|NCT03745989|584130953|FG000|Overall Study|Withdrawal by Subject|0|||
161968223|NCT03920293|584931382|FG000|Randomized-Controlled Period|Noncompliance|1|||
161968224|NCT03920293|584931383|FG001|Randomized-Controlled Period|Noncompliance|0|||
161751782|NCT03745989|584130954|FG001|Overall Study|Withdrawal by Subject|1|||
161751783|NCT03745989|584130955|FG002|Overall Study|Withdrawal by Subject|3|||
161751784|NCT02728206|584130957|FG000|Overall Study|Death|1|||
161968225|NCT03920293|584931382|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
161968226|NCT03920293|584931383|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
161968227|NCT03920293|584931382|FG000|Open- Label Extension Period|Death|3|||
161968228|NCT03920293|584931383|FG001|Open- Label Extension Period|Death|3|||
161968229|NCT03920293|584931382|FG000|Open- Label Extension Period|Physician Decision|5|||
161968230|NCT03920293|584931383|FG001|Open- Label Extension Period|Physician Decision|3|||
161968231|NCT03920293|584931382|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
161968232|NCT03920293|584931383|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
161968233|NCT00523705|584931384|FG000|Overall Study|No time for study.|0|||
161968234|NCT00523705|584931385|FG001|Overall Study|No time for study.|1|||
161968235|NCT00693017|584931386|FG000|Overall Study|Sponsor Decision|2|||
161968236|NCT00693017|584931387|FG001|Overall Study|Sponsor Decision|1|||
161968237|NCT00693017|584931386|FG000|Overall Study|Death|0|||
161968238|NCT00693017|584931387|FG001|Overall Study|Death|1|||
161968239|NCT01691885|584931391|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
161968240|NCT01691885|584931392|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
161968241|NCT01691885|584931391|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
161968242|NCT01691885|584931392|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
161968243|NCT03555981|584931393|FG000|Overall Study|Lost to Follow-up|0|||
161968244|NCT03555981|584931394|FG001|Overall Study|Lost to Follow-up|2|||
161968245|NCT00688324|584931396|FG000|Overall Study|Withdrawal by Subject|2|||
161968246|NCT00688324|584931396|FG000|Overall Study|Physician Decision|5|||
161968247|NCT00688324|584931396|FG000|Overall Study|Lost to Follow-up|1|||
161968248|NCT01972308|584931397|FG000|Overall Study|Withdrawal by Subject|0|||
161968249|NCT01972308|584931398|FG001|Overall Study|Withdrawal by Subject|1|||
161968250|NCT01972308|584931397|FG000|Overall Study|Lost to Follow-up|4|||
161968251|NCT01972308|584931398|FG001|Overall Study|Lost to Follow-up|6|||
161968252|NCT01972308|584931397|FG000|Overall Study|Death|4|||
161968253|NCT01972308|584931398|FG001|Overall Study|Death|1|||
161968254|NCT00847665|584931400|FG000|Overall Study|Withdrawal by Subject|1|||
161968255|NCT00847665|584931401|FG001|Overall Study|Withdrawal by Subject|0|||
161968256|NCT04035564|584931402|FG000|Overall Study|Protocol Violation|1|||
161968257|NCT04035564|584931403|FG001|Overall Study|Protocol Violation|2|||
161968258|NCT04035564|584931402|FG000|Overall Study|No laboratory available|2|||
161968259|NCT04035564|584931403|FG001|Overall Study|No laboratory available|2|||
161968260|NCT04035564|584931402|FG000|Overall Study|Guardian declined consent|1|||
161968261|NCT04035564|584931403|FG001|Overall Study|Guardian declined consent|2|||
161968262|NCT01562314|584931404|FG000|Overall Study|Adverse Event|10|||
161968263|NCT01562314|584931405|FG001|Overall Study|Adverse Event|5|||
161968264|NCT01562314|584931404|FG000|Overall Study|Met Withdrawal Criteria|3|||
161968265|NCT01562314|584931405|FG001|Overall Study|Met Withdrawal Criteria|2|||
161968266|NCT01562314|584931404|FG000|Overall Study|Withdrawal by Subject|0|||
161968267|NCT01562314|584931405|FG001|Overall Study|Withdrawal by Subject|1|||
161968268|NCT00585546|584931406|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
161968269|NCT00585546|584931406|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
161968270|NCT01190475|584931413|FG000|Overall Study|Withdrawal by Subject|0|||
161968271|NCT01190475|584931414|FG001|Overall Study|Withdrawal by Subject|0|||
161968272|NCT01190475|584931415|FG002|Overall Study|Withdrawal by Subject|1|||
161968273|NCT00543803|584931416|FG000|Overall Study|Adverse Event|14|||
161968274|NCT00543803|584931416|FG000|Overall Study|Lack of Efficacy|22|||
161968275|NCT00543803|584931416|FG000|Overall Study|Lost to Follow-up|20|||
161968276|NCT00543803|584931416|FG000|Overall Study|Other|86|||
161968277|NCT04154345|584931419|FG000|Overall Study|Covid-19 pandemic|4|||
161968278|NCT03505788|584931420|FG000|Overall Study|Lost to Follow-up|2|||
161968279|NCT03505788|584931421|FG001|Overall Study|Lost to Follow-up|1|||
161968280|NCT03505788|584931420|FG000|Overall Study|Withdrawal by Subject|1|||
161968281|NCT03505788|584931421|FG001|Overall Study|Withdrawal by Subject|3|||
161968282|NCT03505788|584931420|FG000|Overall Study|Physician Decision|0|||
161968283|NCT03505788|584931421|FG001|Overall Study|Physician Decision|1|||
161968284|NCT03333252|584931425|FG000|Overall Study|Adverse Event|10|||
161751785|NCT00735072|584130962|FG000|Overall Study|interrupted study med during ARV change|1|||
161751786|NCT00735072|584130963|FG001|Overall Study|interrupted study med during ARV change|0|||
161751787|NCT00735072|584130962|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
161751788|NCT00735072|584130963|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
161751789|NCT00911144|584130964|FG000|Overall Study|Withdrawal by Subject|16|||
161751790|NCT00911144|584130965|FG001|Overall Study|Withdrawal by Subject|5|||
161968285|NCT03333252|584931426|FG001|Overall Study|Adverse Event|6|||
161968286|NCT03333252|584931427|FG002|Overall Study|Adverse Event|5|||
161968287|NCT03333252|584931428|FG003|Overall Study|Adverse Event|2|||
161968288|NCT03333252|584931425|FG000|Overall Study|Death|1|||
161968289|NCT03333252|584931426|FG001|Overall Study|Death|3|||
161968290|NCT03333252|584931427|FG002|Overall Study|Death|0|||
161968291|NCT03333252|584931428|FG003|Overall Study|Death|0|||
161968292|NCT03333252|584931425|FG000|Overall Study|Lack of Efficacy|8|||
161968293|NCT03333252|584931426|FG001|Overall Study|Lack of Efficacy|4|||
161968294|NCT03333252|584931427|FG002|Overall Study|Lack of Efficacy|0|||
161968295|NCT03333252|584931428|FG003|Overall Study|Lack of Efficacy|7|||
161968296|NCT03333252|584931425|FG000|Overall Study|Lost to Follow-up|0|||
161968297|NCT03333252|584931426|FG001|Overall Study|Lost to Follow-up|5|||
161968298|NCT03333252|584931427|FG002|Overall Study|Lost to Follow-up|9|||
161968299|NCT03333252|584931428|FG003|Overall Study|Lost to Follow-up|3|||
161968300|NCT03333252|584931425|FG000|Overall Study|Withdrawal by Subject|14|||
161968301|NCT03333252|584931426|FG001|Overall Study|Withdrawal by Subject|24|||
161968302|NCT03333252|584931427|FG002|Overall Study|Withdrawal by Subject|11|||
161968303|NCT03333252|584931428|FG003|Overall Study|Withdrawal by Subject|17|||
161968304|NCT00396136|584931429|FG000|Overall Study|Death|43|||
161968305|NCT00396136|584931429|FG000|Overall Study|Withdrawal by Subject|59|||
161968306|NCT00396136|584931429|FG000|Overall Study|Lost to Follow-up|15|||
161968307|NCT00396136|584931429|FG000|Overall Study|Study device explanted|8|||
161968308|NCT04686084|584931431|FG000|Overall Study|Lost to Follow-up|1|||
161968309|NCT01535599|584931432|FG000|Overall Study|Adverse Event|6|||
161968310|NCT01535599|584931433|FG001|Overall Study|Adverse Event|15|||
161968311|NCT01535599|584931432|FG000|Overall Study|Lost to Follow-up|3|||
161751791|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
161751792|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
161751793|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
161751794|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
161751795|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
161751796|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
161751797|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
161751798|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
161751799|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
161968312|NCT01535599|584931433|FG001|Overall Study|Lost to Follow-up|4|||
161968313|NCT01535599|584931432|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
161968314|NCT01535599|584931433|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
161968315|NCT01535599|584931432|FG000|Overall Study|Treatment Failure|33|||
161968316|NCT01535599|584931433|FG001|Overall Study|Treatment Failure|66|||
161751800|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
161751801|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
161751802|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
161751803|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
161751804|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
161751805|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
161751806|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
161751807|NCT01291511|584130966|FG000|Cross-Titration and Stabilization Phase|Death|1|||
161751808|NCT01291511|584130967|FG001|Cross-Titration and Stabilization Phase|Death|0|||
161751809|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
161751810|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
161751811|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
161751812|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
161751813|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
161751814|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
161968317|NCT01535599|584931432|FG000|Overall Study|BL Culture + for Group A Strep|0|||
161968318|NCT01535599|584931433|FG001|Overall Study|BL Culture + for Group A Strep|1|||
161968319|NCT01535599|584931432|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
161968320|NCT01535599|584931433|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
161751815|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
161751816|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
161751817|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
161751818|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
161751819|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
161751820|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
161968321|NCT01535599|584931432|FG000|Overall Study|Randomized in Error|2|||
161751821|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
161751822|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
161751823|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
161751824|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
161751825|NCT01291511|584130966|FG000|Double-blind Relapse Prevention Phase|Death|1|||
161751826|NCT01291511|584130967|FG001|Double-blind Relapse Prevention Phase|Death|0|||
161844909|NCT00750308|584474680|FG009|Third Treatment|Withdrawal by Subject|0|||
161844910|NCT00750308|584474681|FG010|Third Treatment|Withdrawal by Subject|0|||
161844911|NCT00750308|584474682|FG011|Third Treatment|Withdrawal by Subject|0|||
161968322|NCT01535599|584931433|FG001|Overall Study|Randomized in Error|4|||
161968323|NCT01535599|584931432|FG000|Overall Study|Did not use product|1|||
161968324|NCT01535599|584931433|FG001|Overall Study|Did not use product|0|||
161968325|NCT01535599|584931432|FG000|Overall Study|Other|1|||
161751827|NCT00047008|584130970|FG000|Overall Study|Withdrawn consent|2|||
161751828|NCT00047008|584130971|FG001|Overall Study|Withdrawn consent|3|||
161751829|NCT00047008|584130970|FG000|Overall Study|Ineligible|9|||
161751830|NCT00047008|584130971|FG001|Overall Study|Ineligible|8|||
161751831|NCT00429572|584130972|FG000|Overall Study|Disease progression|1|||
161751832|NCT02773368|584130973|FG000|Overall Study|Lost to Follow-up|4|||
161751833|NCT02773368|584130974|FG001|Overall Study|Lost to Follow-up|1|||
161751834|NCT02773368|584130973|FG000|Overall Study|Withdrawal by Subject|5|||
161751835|NCT02773368|584130974|FG001|Overall Study|Withdrawal by Subject|1|||
161751836|NCT02773368|584130973|FG000|Overall Study|Unclassified|1|||
161751837|NCT02773368|584130974|FG001|Overall Study|Unclassified|1|||
161751838|NCT02773368|584130973|FG000|Overall Study|Missing|0|||
161751839|NCT02773368|584130974|FG001|Overall Study|Missing|1|||
161751840|NCT01929018|584130979|FG000|Overall Study|Lost to Follow-up|1|||
161751841|NCT01929018|584130980|FG001|Overall Study|Lost to Follow-up|0|||
161751842|NCT01929018|584130979|FG000|Overall Study|Hospitalization|0|||
161751843|NCT01929018|584130980|FG001|Overall Study|Hospitalization|1|||
161751844|NCT01047436|584130984|FG000|Overall Study|Protocol Violation|1|||
161751845|NCT01047436|584130985|FG001|Overall Study|Protocol Violation|0|||
161751846|NCT02635867|584130988|FG000|Overall Study|Lost to Follow-up|4|||
161751847|NCT02635867|584130989|FG001|Overall Study|Lost to Follow-up|3|||
161751848|NCT02635867|584130990|FG002|Overall Study|Lost to Follow-up|3|||
161751849|NCT02635867|584130991|FG003|Overall Study|Lost to Follow-up|4|||
161751850|NCT02635867|584130992|FG004|Overall Study|Lost to Follow-up|1|||
161751851|NCT02565576|584130995|FG000|Overall Study|abnormal lab value|2|||
161751852|NCT02565576|584130996|FG001|Overall Study|abnormal lab value|0|||
161751853|NCT02565576|584130995|FG000|Overall Study|subject / guardian decision|1|||
161751854|NCT02565576|584130996|FG001|Overall Study|subject / guardian decision|3|||
161751855|NCT02565576|584130995|FG000|Overall Study|Lost to Follow-up|1|||
161751856|NCT02565576|584130996|FG001|Overall Study|Lost to Follow-up|0|||
161751857|NCT02565576|584130995|FG000|Overall Study|Death|0|||
161751858|NCT02565576|584130996|FG001|Overall Study|Death|2|||
161751859|NCT02565576|584130995|FG000|Overall Study|Adverse Event|1|||
161751860|NCT02565576|584130996|FG001|Overall Study|Adverse Event|0|||
161751861|NCT00282568|584130997|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
161751862|NCT00282568|584130997|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
161751863|NCT00282568|584130997|FG000|Extended Treatment Period|Adverse Event|17|||
161751864|NCT00282568|584130997|FG000|Extended Treatment Period|Non-compliance|4|||
161751865|NCT00282568|584130997|FG000|Extended Treatment Period|Physician Decision|1|||
161751866|NCT00282568|584130997|FG000|Extended Treatment Period|Lost to Follow-up|2|||
161751867|NCT01266070|584130998|FG000|Overall Study|Adverse Event|3|||
161751868|NCT01266070|584130998|FG000|Overall Study|Protocol Violation|1|||
161751869|NCT00939341|584130999|FG000|Overall Study|Adverse Event|15|||
161751870|NCT00939341|584130999|FG000|Overall Study|Pregnancy|1|||
161751871|NCT00939341|584130999|FG000|Overall Study|Lost to Follow-up|23|||
161751872|NCT00939341|584130999|FG000|Overall Study|Withdrawal by Subject|13|||
161751873|NCT00939341|584130999|FG000|Overall Study|Protocol Violation|6|||
161751874|NCT00939341|584130999|FG000|Overall Study|Incorrect enrolment|8|||
161751875|NCT01408732|584131000|FG000|Overall Study|Withdrawal by Subject|2|||
161751876|NCT01408732|584131001|FG001|Overall Study|Withdrawal by Subject|2|||
161751877|NCT00764322|584131003|FG000|Overall Study|Withdrawal by Subject|11|||
161751878|NCT00764322|584131003|FG000|Overall Study|No CYP2D6 genotyping|9|||
161751879|NCT00796003|584131004|FG000|Overall Study|Disease Progression|2|||
161751880|NCT00796003|584131005|FG001|Overall Study|Disease Progression|13|||
161751881|NCT00796003|584131004|FG000|Overall Study|Adverse Event|1|||
161751882|NCT00796003|584131005|FG001|Overall Study|Adverse Event|7|||
161751883|NCT00796003|584131004|FG000|Overall Study|Specified organ function not met|0|||
161751884|NCT00796003|584131005|FG001|Overall Study|Specified organ function not met|1|||
161751885|NCT00796003|584131004|FG000|Overall Study|Physician Decision|0|||
161751886|NCT00796003|584131005|FG001|Overall Study|Physician Decision|4|||
161751887|NCT00796003|584131004|FG000|Overall Study|Withdrawal by Subject|0|||
161751888|NCT00796003|584131005|FG001|Overall Study|Withdrawal by Subject|1|||
161751889|NCT00796003|584131004|FG000|Overall Study|Other|0|||
161751890|NCT00796003|584131005|FG001|Overall Study|Other|1|||
161751891|NCT00796003|584131004|FG000|Overall Study|Participants Not treated|0|||
161751892|NCT00796003|584131005|FG001|Overall Study|Participants Not treated|2|||
161751893|NCT03185819|584131006|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
161751894|NCT03185819|584131007|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
161751895|NCT03185819|584131008|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
161751896|NCT03185819|584131009|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
161751897|NCT03185819|584131006|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
161751898|NCT03185819|584131007|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
161751899|NCT03185819|584131008|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
161751900|NCT03185819|584131009|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
161751901|NCT03185819|584131006|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
161751902|NCT03185819|584131007|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
161751903|NCT03185819|584131008|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
161751904|NCT03185819|584131009|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
161751905|NCT03185819|584131006|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
161751906|NCT03185819|584131007|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
161751907|NCT03185819|584131008|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
161751908|NCT03185819|584131009|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
161751909|NCT03185819|584131006|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
161751910|NCT03185819|584131007|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
161751911|NCT03185819|584131008|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
161751912|NCT03185819|584131009|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
161751913|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
161751914|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
161751915|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
161751916|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
161751917|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
161751918|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
161751919|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
161751920|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
161751921|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
161751922|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
161751923|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
161751924|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
161751925|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
161751926|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
161751927|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
161751928|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
161751929|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
161751930|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
161751931|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
161751932|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
161751933|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
161751934|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
161751935|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
161751936|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
161751937|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
161751938|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
161751939|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
161751940|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
161751941|NCT03185819|584131006|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
161751942|NCT03185819|584131007|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
161751943|NCT03185819|584131008|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
161751944|NCT03185819|584131009|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
161751945|NCT03447821|584131011|FG000|Overall Study|Withdrawal by Subject|1|||
161751946|NCT03447821|584131012|FG001|Overall Study|Withdrawal by Subject|1|||
161751947|NCT03447821|584131013|FG002|Overall Study|Withdrawal by Subject|0|||
161751948|NCT03447821|584131011|FG000|Overall Study|Lost to Follow-up|0|||
161751949|NCT03447821|584131012|FG001|Overall Study|Lost to Follow-up|0|||
161751950|NCT03447821|584131013|FG002|Overall Study|Lost to Follow-up|1|||
161751951|NCT02977507|584131014|FG000|Overall Study|Protocol Deviation|1|||
161751952|NCT02977507|584131015|FG001|Overall Study|Protocol Deviation|0|||
161751953|NCT02977507|584131014|FG000|Overall Study|Lost to Follow-up|1|||
161751954|NCT02977507|584131015|FG001|Overall Study|Lost to Follow-up|0|||
161751955|NCT00654420|584131016|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
161751956|NCT00654420|584131017|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
161751957|NCT00654420|584131018|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
161751958|NCT00654420|584131019|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
161751959|NCT00654420|584131016|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
161751960|NCT00654420|584131017|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
161751961|NCT00654420|584131018|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
161751962|NCT00654420|584131019|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
161751963|NCT00654420|584131016|FG000|Phase II|Adverse Event|0|||
161751964|NCT00654420|584131017|FG001|Phase II|Adverse Event|0|||
161751965|NCT00654420|584131018|FG002|Phase II|Adverse Event|3|||
161751966|NCT00654420|584131019|FG003|Phase II|Adverse Event|3|||
161751967|NCT00654420|584131016|FG000|Phase II|Lost to Follow-up|0|||
161844912|NCT02980874|584474683|FG000|Overall Study|Adverse Event|2|||
161751968|NCT00654420|584131017|FG001|Phase II|Lost to Follow-up|0|||
161751969|NCT00654420|584131018|FG002|Phase II|Lost to Follow-up|0|||
161751970|NCT00654420|584131019|FG003|Phase II|Lost to Follow-up|1|||
161751971|NCT00654420|584131016|FG000|Phase II|Physician Decision|0|||
161751972|NCT00654420|584131017|FG001|Phase II|Physician Decision|0|||
161751973|NCT00654420|584131018|FG002|Phase II|Physician Decision|0|||
161751974|NCT00654420|584131019|FG003|Phase II|Physician Decision|4|||
161751975|NCT00654420|584131016|FG000|Phase II|Progressive Disease|0|||
161751976|NCT00654420|584131017|FG001|Phase II|Progressive Disease|0|||
161751977|NCT00654420|584131018|FG002|Phase II|Progressive Disease|29|||
161751978|NCT00654420|584131019|FG003|Phase II|Progressive Disease|29|||
161751979|NCT00654420|584131016|FG000|Phase II|Withdrawal by Subject|0|||
161751980|NCT00654420|584131017|FG001|Phase II|Withdrawal by Subject|0|||
161751981|NCT00654420|584131018|FG002|Phase II|Withdrawal by Subject|4|||
161751982|NCT00654420|584131019|FG003|Phase II|Withdrawal by Subject|1|||
161751983|NCT00654420|584131016|FG000|Phase II|Missing Disposition Record|0|||
161751984|NCT00654420|584131017|FG001|Phase II|Missing Disposition Record|0|||
161751985|NCT00654420|584131018|FG002|Phase II|Missing Disposition Record|1|||
161751986|NCT00654420|584131019|FG003|Phase II|Missing Disposition Record|0|||
161751987|NCT00610207|584131024|FG000|Overall Study|Lost to Follow-up|3|||
161751988|NCT00741260|584131029|FG000|Overall Study|Disease Progression|3|||
161751989|NCT00741260|584131030|FG001|Overall Study|Disease Progression|5|||
161751990|NCT00741260|584131031|FG002|Overall Study|Disease Progression|3|||
161751991|NCT00741260|584131032|FG003|Overall Study|Disease Progression|3|||
161751992|NCT00741260|584131033|FG004|Overall Study|Disease Progression|5|||
161751993|NCT00741260|584131034|FG005|Overall Study|Disease Progression|37|||
161751994|NCT00741260|584131035|FG006|Overall Study|Disease Progression|4|||
161751995|NCT00741260|584131029|FG000|Overall Study|Death|0|||
161751996|NCT00741260|584131030|FG001|Overall Study|Death|1|||
161751997|NCT00741260|584131031|FG002|Overall Study|Death|0|||
161751998|NCT00741260|584131032|FG003|Overall Study|Death|1|||
161751999|NCT00741260|584131033|FG004|Overall Study|Death|2|||
161752000|NCT00741260|584131034|FG005|Overall Study|Death|2|||
161752001|NCT00741260|584131035|FG006|Overall Study|Death|1|||
161752002|NCT00741260|584131029|FG000|Overall Study|Withdrawal by Subject|0|||
161752003|NCT00741260|584131030|FG001|Overall Study|Withdrawal by Subject|0|||
161752004|NCT00741260|584131031|FG002|Overall Study|Withdrawal by Subject|0|||
161752005|NCT00741260|584131032|FG003|Overall Study|Withdrawal by Subject|0|||
161752006|NCT00741260|584131033|FG004|Overall Study|Withdrawal by Subject|1|||
161752007|NCT00741260|584131034|FG005|Overall Study|Withdrawal by Subject|3|||
161752008|NCT00741260|584131035|FG006|Overall Study|Withdrawal by Subject|1|||
161752009|NCT00741260|584131029|FG000|Overall Study|Physician Decision|1|||
161752010|NCT00741260|584131030|FG001|Overall Study|Physician Decision|1|||
161752011|NCT00741260|584131031|FG002|Overall Study|Physician Decision|0|||
161752012|NCT00741260|584131032|FG003|Overall Study|Physician Decision|0|||
161752013|NCT00741260|584131033|FG004|Overall Study|Physician Decision|0|||
161752014|NCT00741260|584131034|FG005|Overall Study|Physician Decision|0|||
161752015|NCT00741260|584131035|FG006|Overall Study|Physician Decision|0|||
161752016|NCT00741260|584131029|FG000|Overall Study|Other|2|||
161752017|NCT00741260|584131030|FG001|Overall Study|Other|1|||
161752018|NCT00741260|584131031|FG002|Overall Study|Other|1|||
161752019|NCT00741260|584131032|FG003|Overall Study|Other|2|||
161752020|NCT00741260|584131033|FG004|Overall Study|Other|1|||
161752021|NCT00741260|584131034|FG005|Overall Study|Other|3|||
161752022|NCT00741260|584131035|FG006|Overall Study|Other|1|||
161968326|NCT01535599|584931433|FG001|Overall Study|Other|0|||
161968327|NCT01535599|584931432|FG000|Overall Study|Stopped medication|0|||
161752023|NCT01610206|584131036|FG000|Overall Study|Adverse Event|10|||
161968328|NCT01535599|584931433|FG001|Overall Study|Stopped medication|1|||
161968329|NCT01535599|584931432|FG000|Overall Study|Noncompliance|0|||
161968330|NCT01535599|584931433|FG001|Overall Study|Noncompliance|1|||
161968331|NCT00676520|584931434|FG000|Overall Study|Withdrawal by Subject|163|||
161968332|NCT00676520|584931434|FG000|Overall Study|Lost to Follow-up|162|||
161968333|NCT00676520|584931434|FG000|Overall Study|Death|159|||
161968334|NCT00676520|584931434|FG000|Overall Study|Physician Decision|20|||
161752024|NCT01610206|584131037|FG001|Overall Study|Adverse Event|30|||
161752025|NCT00924729|584131038|FG000|Overall Study|insufficient volume for analysis|1|||
161752026|NCT00924729|584131039|FG001|Overall Study|insufficient volume for analysis|0|||
161752027|NCT00924729|584131038|FG000|Overall Study|Protocol Violation|1|||
161752028|NCT00924729|584131039|FG001|Overall Study|Protocol Violation|0|||
161752029|NCT01576406|584131043|FG000|Overall Study|Lost to Follow-up|1|||
161752030|NCT01576406|584131044|FG001|Overall Study|Lost to Follow-up|2|||
161752031|NCT01576406|584131045|FG002|Overall Study|Lost to Follow-up|0|||
161752032|NCT01576406|584131046|FG003|Overall Study|Lost to Follow-up|0|||
161752033|NCT01576406|584131047|FG004|Overall Study|Lost to Follow-up|0|||
161752034|NCT01576406|584131048|FG005|Overall Study|Lost to Follow-up|0|||
161844913|NCT02980874|584474684|FG001|Overall Study|Adverse Event|7|||
161968335|NCT00676520|584931434|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
161752035|NCT01576406|584131043|FG000|Overall Study|Death|3|||
161752036|NCT01576406|584131044|FG001|Overall Study|Death|4|||
161752037|NCT01576406|584131045|FG002|Overall Study|Death|8|||
161752038|NCT01576406|584131046|FG003|Overall Study|Death|5|||
161752039|NCT01576406|584131047|FG004|Overall Study|Death|7|||
161752040|NCT01576406|584131048|FG005|Overall Study|Death|9|||
161752041|NCT01576406|584131043|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
161752042|NCT01576406|584131044|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
161752043|NCT01576406|584131045|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
161752044|NCT01576406|584131046|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
161752045|NCT01576406|584131047|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
161752046|NCT01576406|584131048|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
161752047|NCT01576406|584131043|FG000|Overall Study|Withdrawal the consent|2|||
161752048|NCT01576406|584131044|FG001|Overall Study|Withdrawal the consent|2|||
161752049|NCT01576406|584131045|FG002|Overall Study|Withdrawal the consent|5|||
161752050|NCT01576406|584131046|FG003|Overall Study|Withdrawal the consent|1|||
161752051|NCT01576406|584131047|FG004|Overall Study|Withdrawal the consent|1|||
161752052|NCT01576406|584131048|FG005|Overall Study|Withdrawal the consent|3|||
161752053|NCT01576406|584131043|FG000|Overall Study|Other|0|||
161752054|NCT01576406|584131044|FG001|Overall Study|Other|0|||
161752055|NCT01576406|584131045|FG002|Overall Study|Other|2|||
161752056|NCT01576406|584131046|FG003|Overall Study|Other|2|||
161752057|NCT01576406|584131047|FG004|Overall Study|Other|0|||
161752058|NCT01576406|584131048|FG005|Overall Study|Other|0|||
161752059|NCT01627782|584131049|FG000|Overall Study|Adverse Event|1|||
161752060|NCT01627782|584131050|FG001|Overall Study|Adverse Event|2|||
161752061|NCT01627782|584131051|FG002|Overall Study|Adverse Event|0|||
161752062|NCT01627782|584131052|FG003|Overall Study|Adverse Event|1|||
161752063|NCT01627782|584131049|FG000|Overall Study|Lack of Efficacy|11|||
161752064|NCT01627782|584131050|FG001|Overall Study|Lack of Efficacy|1|||
161752065|NCT01627782|584131051|FG002|Overall Study|Lack of Efficacy|15|||
161752066|NCT01627782|584131052|FG003|Overall Study|Lack of Efficacy|2|||
161752067|NCT01627782|584131049|FG000|Overall Study|Protocol Violation|1|||
161752068|NCT01627782|584131050|FG001|Overall Study|Protocol Violation|0|||
161752069|NCT01627782|584131051|FG002|Overall Study|Protocol Violation|0|||
161752070|NCT01627782|584131052|FG003|Overall Study|Protocol Violation|0|||
161752071|NCT01627782|584131049|FG000|Overall Study|Withdrawal by Subject|2|||
161752072|NCT01627782|584131050|FG001|Overall Study|Withdrawal by Subject|1|||
161752073|NCT01627782|584131051|FG002|Overall Study|Withdrawal by Subject|0|||
161752074|NCT01627782|584131052|FG003|Overall Study|Withdrawal by Subject|0|||
161752075|NCT01627782|584131049|FG000|Overall Study|Other|0|||
161752076|NCT01627782|584131050|FG001|Overall Study|Other|2|||
161752077|NCT01627782|584131051|FG002|Overall Study|Other|0|||
161752078|NCT01627782|584131052|FG003|Overall Study|Other|3|||
161752079|NCT01627782|584131049|FG000|Overall Study|Randomized But Not Treated|1|||
161752080|NCT01627782|584131050|FG001|Overall Study|Randomized But Not Treated|0|||
161752081|NCT01627782|584131051|FG002|Overall Study|Randomized But Not Treated|0|||
161752082|NCT01627782|584131052|FG003|Overall Study|Randomized But Not Treated|0|||
161752083|NCT01004159|584133129|FG000|Overall Study|Adverse Event|2|||
161752084|NCT01004159|584133129|FG000|Overall Study|Disease Progression|18|||
161752085|NCT01199198|584133135|FG000|Overall Study|Adverse Event|3|||
161752086|NCT01199198|584133136|FG001|Overall Study|Adverse Event|0|||
161752087|NCT01199198|584133135|FG000|Overall Study|Lost to Follow-up|1|||
161752088|NCT01199198|584133136|FG001|Overall Study|Lost to Follow-up|5|||
161752089|NCT01199198|584133135|FG000|Overall Study|Withdrawal by Subject|1|||
161752090|NCT01199198|584133136|FG001|Overall Study|Withdrawal by Subject|2|||
161752091|NCT01199198|584133135|FG000|Overall Study|ICU Transfer|1|||
161752092|NCT01199198|584133136|FG001|Overall Study|ICU Transfer|2|||
161752093|NCT01199198|584133135|FG000|Overall Study|Hospice-care transfer|1|||
161752094|NCT01199198|584133136|FG001|Overall Study|Hospice-care transfer|2|||
161752095|NCT04315298|584133137|FG000|Overall Study|Withdrawal by Subject|0|||
161752096|NCT04315298|584133138|FG001|Overall Study|Withdrawal by Subject|0|||
161752097|NCT04315298|584133139|FG002|Overall Study|Withdrawal by Subject|0|||
161752098|NCT04315298|584133140|FG003|Overall Study|Withdrawal by Subject|2|||
161968336|NCT00676520|584931434|FG000|Overall Study|Other Reason|18|||
161968337|NCT01425359|584931435|FG000|Overall Study|Randomized but Not Treated|2|||
161752099|NCT04315298|584133141|FG004|Overall Study|Withdrawal by Subject|2|||
161752100|NCT04315298|584133142|FG005|Overall Study|Withdrawal by Subject|2|||
161752101|NCT04315298|584133143|FG006|Overall Study|Withdrawal by Subject|0|||
161752102|NCT04315298|584133144|FG007|Overall Study|Withdrawal by Subject|1|||
161752103|NCT04315298|584133145|FG008|Overall Study|Withdrawal by Subject|1|||
161752104|NCT04315298|584133146|FG009|Overall Study|Withdrawal by Subject|1|||
161752105|NCT04315298|584133147|FG010|Overall Study|Withdrawal by Subject|0|||
161752106|NCT04315298|584133148|FG011|Overall Study|Withdrawal by Subject|0|||
161752107|NCT04315298|584133149|FG012|Overall Study|Withdrawal by Subject|0|||
161752108|NCT04315298|584133150|FG013|Overall Study|Withdrawal by Subject|0|||
161752109|NCT04315298|584133151|FG014|Overall Study|Withdrawal by Subject|0|||
161752110|NCT04315298|584133152|FG015|Overall Study|Withdrawal by Subject|0|||
161752111|NCT04315298|584133153|FG016|Overall Study|Withdrawal by Subject|0|||
161752112|NCT04315298|584133154|FG017|Overall Study|Withdrawal by Subject|0|||
161752113|NCT04315298|584133155|FG018|Overall Study|Withdrawal by Subject|0|||
161968338|NCT01425359|584931436|FG001|Overall Study|Randomized but Not Treated|3|||
161968339|NCT01425359|584931435|FG000|Overall Study|Adverse Event|9|||
161968340|NCT01425359|584931436|FG001|Overall Study|Adverse Event|8|||
161968341|NCT01425359|584931435|FG000|Overall Study|Revascularization|0|||
161968342|NCT01425359|584931436|FG001|Overall Study|Revascularization|1|||
161968343|NCT01425359|584931435|FG000|Overall Study|Death|0|||
161968344|NCT01425359|584931436|FG001|Overall Study|Death|1|||
161968345|NCT01425359|584931435|FG000|Overall Study|Unsatisfactory Response|1|||
161968346|NCT01425359|584931436|FG001|Overall Study|Unsatisfactory Response|0|||
161968347|NCT01425359|584931435|FG000|Overall Study|Protocol Violation|1|||
161968348|NCT01425359|584931436|FG001|Overall Study|Protocol Violation|2|||
161968349|NCT01425359|584931435|FG000|Overall Study|Subject Withdrew Consent|1|||
161968350|NCT01425359|584931436|FG001|Overall Study|Subject Withdrew Consent|2|||
161968351|NCT01425359|584931435|FG000|Overall Study|Investigator's Discretion|2|||
161968352|NCT01425359|584931436|FG001|Overall Study|Investigator's Discretion|0|||
161968353|NCT01425359|584931435|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
161968354|NCT01425359|584931436|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
161968355|NCT04043234|584931450|FG000|Overall Study|Lost to Follow-up|1|||
161968356|NCT04043234|584931450|FG000|Overall Study|Withdrawal by Subject|1|||
161968357|NCT02135029|584931451|FG000|Overall Study|Adverse Event|2|||
161968358|NCT02135029|584931452|FG001|Overall Study|Adverse Event|2|||
161752114|NCT04315298|584133137|FG000|Overall Study|Physician Decision|0|||
161752115|NCT04315298|584133138|FG001|Overall Study|Physician Decision|0|||
161752116|NCT04315298|584133139|FG002|Overall Study|Physician Decision|0|||
161752117|NCT04315298|584133140|FG003|Overall Study|Physician Decision|0|||
161752118|NCT04315298|584133141|FG004|Overall Study|Physician Decision|1|||
161752119|NCT04315298|584133142|FG005|Overall Study|Physician Decision|0|||
161752120|NCT04315298|584133143|FG006|Overall Study|Physician Decision|0|||
161752121|NCT04315298|584133144|FG007|Overall Study|Physician Decision|0|||
161752122|NCT04315298|584133145|FG008|Overall Study|Physician Decision|0|||
161752123|NCT04315298|584133146|FG009|Overall Study|Physician Decision|0|||
161752124|NCT04315298|584133147|FG010|Overall Study|Physician Decision|0|||
161752125|NCT04315298|584133148|FG011|Overall Study|Physician Decision|0|||
161752126|NCT04315298|584133149|FG012|Overall Study|Physician Decision|0|||
161752127|NCT04315298|584133150|FG013|Overall Study|Physician Decision|0|||
161752128|NCT04315298|584133151|FG014|Overall Study|Physician Decision|0|||
161752129|NCT04315298|584133152|FG015|Overall Study|Physician Decision|0|||
161752130|NCT04315298|584133153|FG016|Overall Study|Physician Decision|0|||
161752131|NCT04315298|584133154|FG017|Overall Study|Physician Decision|0|||
161752132|NCT04315298|584133155|FG018|Overall Study|Physician Decision|0|||
161752133|NCT04315298|584133137|FG000|Overall Study|Lost to Follow-up|5|||
161752134|NCT04315298|584133138|FG001|Overall Study|Lost to Follow-up|10|||
161752135|NCT04315298|584133139|FG002|Overall Study|Lost to Follow-up|6|||
161752136|NCT04315298|584133140|FG003|Overall Study|Lost to Follow-up|8|||
161752137|NCT04315298|584133141|FG004|Overall Study|Lost to Follow-up|12|||
161752138|NCT04315298|584133142|FG005|Overall Study|Lost to Follow-up|13|||
161752139|NCT04315298|584133143|FG006|Overall Study|Lost to Follow-up|9|||
161752140|NCT04315298|584133144|FG007|Overall Study|Lost to Follow-up|16|||
161752141|NCT04315298|584133145|FG008|Overall Study|Lost to Follow-up|14|||
161752142|NCT04315298|584133146|FG009|Overall Study|Lost to Follow-up|0|||
161752143|NCT04315298|584133147|FG010|Overall Study|Lost to Follow-up|2|||
161752144|NCT04315298|584133148|FG011|Overall Study|Lost to Follow-up|1|||
161752145|NCT04315298|584133149|FG012|Overall Study|Lost to Follow-up|0|||
161752146|NCT04315298|584133150|FG013|Overall Study|Lost to Follow-up|0|||
161752147|NCT04315298|584133151|FG014|Overall Study|Lost to Follow-up|0|||
161752148|NCT04315298|584133152|FG015|Overall Study|Lost to Follow-up|2|||
161752149|NCT04315298|584133153|FG016|Overall Study|Lost to Follow-up|0|||
161752150|NCT04315298|584133154|FG017|Overall Study|Lost to Follow-up|0|||
161968359|NCT02135029|584931453|FG002|Overall Study|Adverse Event|2|||
161968360|NCT02135029|584931451|FG000|Overall Study|Lost to Follow-up|0|||
161752151|NCT04315298|584133155|FG018|Overall Study|Lost to Follow-up|0|||
161752152|NCT04315298|584133137|FG000|Overall Study|Death|24|||
161752153|NCT04315298|584133138|FG001|Overall Study|Death|60|||
161752154|NCT04315298|584133139|FG002|Overall Study|Death|49|||
161752155|NCT04315298|584133140|FG003|Overall Study|Death|59|||
161752156|NCT04315298|584133141|FG004|Overall Study|Death|70|||
161752157|NCT04315298|584133142|FG005|Overall Study|Death|114|||
161968361|NCT02135029|584931452|FG001|Overall Study|Lost to Follow-up|1|||
161968362|NCT02135029|584931453|FG002|Overall Study|Lost to Follow-up|0|||
161968363|NCT02135029|584931451|FG000|Overall Study|Withdrawal by Subject|2|||
161968364|NCT02135029|584931452|FG001|Overall Study|Withdrawal by Subject|0|||
161968365|NCT02135029|584931453|FG002|Overall Study|Withdrawal by Subject|1|||
161968366|NCT02135029|584931451|FG000|Overall Study|Other|0|||
161752158|NCT04315298|584133143|FG006|Overall Study|Death|9|||
161752159|NCT04315298|584133144|FG007|Overall Study|Death|12|||
161752160|NCT04315298|584133145|FG008|Overall Study|Death|21|||
161752161|NCT04315298|584133146|FG009|Overall Study|Death|16|||
161752162|NCT04315298|584133147|FG010|Overall Study|Death|40|||
161752163|NCT04315298|584133148|FG011|Overall Study|Death|40|||
161752164|NCT04315298|584133149|FG012|Overall Study|Death|3|||
161752165|NCT04315298|584133150|FG013|Overall Study|Death|4|||
161752166|NCT04315298|584133151|FG014|Overall Study|Death|6|||
161752167|NCT04315298|584133152|FG015|Overall Study|Death|4|||
161752168|NCT04315298|584133153|FG016|Overall Study|Death|3|||
161752169|NCT04315298|584133154|FG017|Overall Study|Death|1|||
161752170|NCT04315298|584133155|FG018|Overall Study|Death|0|||
161752171|NCT00736385|584133156|FG000|Overall Study|Withdrawal by Subject|2|||
161752172|NCT00736385|584133157|FG001|Overall Study|Withdrawal by Subject|2|||
161752173|NCT00736385|584133156|FG000|Overall Study|Adverse Event|0|||
161752174|NCT00736385|584133157|FG001|Overall Study|Adverse Event|1|||
161752175|NCT00098865|584133158|FG000|Overall Study|Progressive Disease|6|||
161752176|NCT00098865|584133158|FG000|Overall Study|Adverse Event|2|||
161752177|NCT00098865|584133158|FG000|Overall Study|Alternative Therapy|1|||
161752178|NCT03267511|584133159|FG000|Overall Study|Lost to Follow-up|0|||
161752179|NCT03267511|584133160|FG001|Overall Study|Lost to Follow-up|0|||
161752180|NCT03267511|584133161|FG002|Overall Study|Lost to Follow-up|0|||
161752181|NCT03267511|584133162|FG003|Overall Study|Lost to Follow-up|1|||
161752182|NCT03050307|584133165|FG000|Overall Study|Adverse Event|4|||
161752183|NCT03050307|584133166|FG001|Overall Study|Adverse Event|2|||
161752184|NCT03050307|584133165|FG000|Overall Study|Significant Protocol Deviation|0|||
161752185|NCT03050307|584133166|FG001|Overall Study|Significant Protocol Deviation|1|||
161752186|NCT03050307|584133165|FG000|Overall Study|Lost to Follow-up|0|||
161752187|NCT03050307|584133166|FG001|Overall Study|Lost to Follow-up|1|||
161752188|NCT03050307|584133165|FG000|Overall Study|Voluntary Withdrawal|3|||
161752189|NCT03050307|584133166|FG001|Overall Study|Voluntary Withdrawal|4|||
161752190|NCT03050307|584133165|FG000|Overall Study|Reason not Specified|1|||
161752191|NCT03050307|584133166|FG001|Overall Study|Reason not Specified|1|||
161752192|NCT00653068|584133167|FG000|Overall Study|Death|9|||
161752193|NCT00653068|584133167|FG000|Overall Study|Lack of Efficacy|34|||
161752194|NCT00653068|584133167|FG000|Overall Study|Physician Decision|4|||
161752195|NCT00653068|584133167|FG000|Overall Study|Withdrawal by Subject|1|||
161752196|NCT00653068|584133167|FG000|Overall Study|Ineligible|2|||
161752197|NCT02658149|584133186|FG000|Overall Study|Physician Decision|1|||
161752198|NCT02658149|584133187|FG001|Overall Study|Physician Decision|0|||
161752199|NCT01680991|584133190|FG000|Overall Study|Adverse Event|1|||
161752200|NCT01680991|584133191|FG001|Overall Study|Adverse Event|0|||
161752201|NCT01680991|584133192|FG002|Overall Study|Adverse Event|0|||
161752202|NCT01680991|584133190|FG000|Overall Study|Death|1|||
161752203|NCT01680991|584133191|FG001|Overall Study|Death|0|||
161752204|NCT01680991|584133192|FG002|Overall Study|Death|1|||
161752205|NCT01680991|584133190|FG000|Overall Study|Protocol Violation|0|||
161752206|NCT01680991|584133191|FG001|Overall Study|Protocol Violation|1|||
161752207|NCT01680991|584133192|FG002|Overall Study|Protocol Violation|0|||
161752208|NCT01680991|584133190|FG000|Overall Study|Withdrawal by Subject|5|||
161752209|NCT01680991|584133191|FG001|Overall Study|Withdrawal by Subject|1|||
161752210|NCT01680991|584133192|FG002|Overall Study|Withdrawal by Subject|0|||
161752211|NCT01680991|584133190|FG000|Overall Study|Progressive disease (PD)|0|||
161752212|NCT01680991|584133191|FG001|Overall Study|Progressive disease (PD)|10|||
161752213|NCT01680991|584133192|FG002|Overall Study|Progressive disease (PD)|0|||
161752214|NCT01680991|584133190|FG000|Overall Study|Physician Decision|0|||
161752215|NCT01680991|584133191|FG001|Overall Study|Physician Decision|7|||
161752216|NCT01680991|584133192|FG002|Overall Study|Physician Decision|2|||
161752217|NCT01680991|584133190|FG000|Overall Study|Bad physical condition|0|||
161752218|NCT01680991|584133191|FG001|Overall Study|Bad physical condition|0|||
161752219|NCT01680991|584133192|FG002|Overall Study|Bad physical condition|1|||
161752220|NCT01680991|584133190|FG000|Overall Study|PD confirmed in other hospital|1|||
161752221|NCT01680991|584133191|FG001|Overall Study|PD confirmed in other hospital|0|||
161752222|NCT01680991|584133192|FG002|Overall Study|PD confirmed in other hospital|0|||
161752223|NCT04097028|584133193|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
161752224|NCT04097028|584133193|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
161752225|NCT04097028|584133193|FG000|Overall Study|Disease Progression prior to Surgery|2|||
161752226|NCT04097028|584133193|FG000|Overall Study|Adverse Event prior to Surgery|1|||
161752227|NCT02473289|584133194|FG000|Overall Study|Adverse Event|2|||
161752228|NCT02473289|584133195|FG001|Overall Study|Adverse Event|3|||
161752229|NCT02473289|584133194|FG000|Overall Study|Lost to Follow-up|1|||
161752230|NCT02473289|584133195|FG001|Overall Study|Lost to Follow-up|1|||
161752231|NCT02473289|584133194|FG000|Overall Study|Protocol Violation|0|||
161752232|NCT02473289|584133195|FG001|Overall Study|Protocol Violation|1|||
161752233|NCT02473289|584133194|FG000|Overall Study|Withdrawal of consent|6|||
161752234|NCT02473289|584133195|FG001|Overall Study|Withdrawal of consent|7|||
161752235|NCT02473289|584133194|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
161752236|NCT02473289|584133195|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
161752237|NCT02473289|584133194|FG000|Overall Study|Other|2|||
161752238|NCT02473289|584133195|FG001|Overall Study|Other|0|||
161752239|NCT02244619|584133196|FG000|Overall Study|Did not receive study intervention|8|||
161752240|NCT02244619|584133197|FG001|Overall Study|Did not receive study intervention|21|||
161752241|NCT03285490|584133198|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
161752242|NCT03285490|584133199|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
161844914|NCT02980874|584474683|FG000|Overall Study|Withdrawal by Subject|7|||
161752243|NCT03285490|584133198|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
161752244|NCT03285490|584133199|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
161752245|NCT00068822|584133200|FG000|First Randomized Intervention|Lost to Follow-up|1|||
161752246|NCT00068822|584133201|FG001|First Randomized Intervention|Lost to Follow-up|2|||
161752247|NCT00424099|584133202|FG000|Overall Study|Adverse Event|0|||
161752248|NCT00424099|584133203|FG001|Overall Study|Adverse Event|1|||
161752249|NCT00424099|584133204|FG002|Overall Study|Adverse Event|1|||
161752250|NCT00424099|584133205|FG003|Overall Study|Adverse Event|0|||
161752251|NCT00424099|584133202|FG000|Overall Study|Death|0|||
161752252|NCT00424099|584133203|FG001|Overall Study|Death|1|||
161752253|NCT00424099|584133204|FG002|Overall Study|Death|0|||
161752254|NCT00424099|584133205|FG003|Overall Study|Death|0|||
161752255|NCT00424099|584133202|FG000|Overall Study|Illness|2|||
161752256|NCT00424099|584133203|FG001|Overall Study|Illness|0|||
161752257|NCT00424099|584133204|FG002|Overall Study|Illness|1|||
161752258|NCT00424099|584133205|FG003|Overall Study|Illness|4|||
161752259|NCT00424099|584133202|FG000|Overall Study|Lost to Follow-up|0|||
161752260|NCT00424099|584133203|FG001|Overall Study|Lost to Follow-up|0|||
161752261|NCT00424099|584133204|FG002|Overall Study|Lost to Follow-up|3|||
161752262|NCT00424099|584133205|FG003|Overall Study|Lost to Follow-up|0|||
161752263|NCT00424099|584133202|FG000|Overall Study|Hospitalized|1|||
161752264|NCT00424099|584133203|FG001|Overall Study|Hospitalized|2|||
161752265|NCT00424099|584133204|FG002|Overall Study|Hospitalized|1|||
161752266|NCT00424099|584133205|FG003|Overall Study|Hospitalized|3|||
161752267|NCT00424099|584133202|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
161752268|NCT00424099|584133203|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
161752269|NCT00424099|584133204|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
161752270|NCT00424099|584133205|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
161752271|NCT00424099|584133202|FG000|Overall Study|Withdrawal by Subject|1|||
161752272|NCT00424099|584133203|FG001|Overall Study|Withdrawal by Subject|9|||
161752273|NCT00424099|584133204|FG002|Overall Study|Withdrawal by Subject|4|||
161752274|NCT00424099|584133205|FG003|Overall Study|Withdrawal by Subject|6|||
161752275|NCT00424099|584133202|FG000|Overall Study|Physician Decision|0|||
161752276|NCT00424099|584133203|FG001|Overall Study|Physician Decision|0|||
161752277|NCT00424099|584133204|FG002|Overall Study|Physician Decision|1|||
161752278|NCT00424099|584133205|FG003|Overall Study|Physician Decision|0|||
161752279|NCT00424099|584133202|FG000|Overall Study|Missing|0|||
161752280|NCT00424099|584133203|FG001|Overall Study|Missing|0|||
161752281|NCT00424099|584133204|FG002|Overall Study|Missing|1|||
161752282|NCT00424099|584133205|FG003|Overall Study|Missing|0|||
161752283|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
161752284|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
161752285|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
161752286|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
161752287|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
161752288|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
161752289|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
161752290|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
161752291|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
161752292|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
161752293|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
161752294|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
161752295|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
161752296|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
161752297|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
161752298|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
161752299|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
161752300|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
161752301|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
161968367|NCT02135029|584931452|FG001|Overall Study|Other|1|||
161968368|NCT02135029|584931453|FG002|Overall Study|Other|0|||
161968369|NCT02135029|584931451|FG000|Overall Study|Death|0|||
161968370|NCT02135029|584931452|FG001|Overall Study|Death|1|||
161968371|NCT02135029|584931453|FG002|Overall Study|Death|0|||
161968372|NCT00590824|584931457|FG000|Overall Study|Disease could not be resected|0|||
161752302|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
161844915|NCT02980874|584474684|FG001|Overall Study|Withdrawal by Subject|2|||
161752303|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
161752304|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
161844916|NCT02980874|584474683|FG000|Overall Study|Lost to Follow-up|5|||
161752305|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
161752306|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
161968373|NCT00590824|584931458|FG001|Overall Study|Disease could not be resected|2|||
161968374|NCT00590824|584931459|FG002|Overall Study|Disease could not be resected|1|||
161968375|NCT00590824|584931460|FG003|Overall Study|Disease could not be resected|0|||
161968376|NCT00590824|584931457|FG000|Overall Study|Adverse Event|0|||
161968377|NCT00590824|584931458|FG001|Overall Study|Adverse Event|0|||
161968378|NCT00590824|584931459|FG002|Overall Study|Adverse Event|0|||
161968379|NCT00590824|584931460|FG003|Overall Study|Adverse Event|1|||
161968380|NCT00744978|584931463|FG000|Period 1|Lost to Follow-up|1|||
161968381|NCT00744978|584931464|FG001|Period 1|Lost to Follow-up|0|||
161968382|NCT00744978|584931463|FG000|Period 1|Withdrawal by Subject|0|||
161968383|NCT00744978|584931464|FG001|Period 1|Withdrawal by Subject|2|||
161968384|NCT00744978|584931463|FG000|Period 1|Other|0|||
161968385|NCT00744978|584931464|FG001|Period 1|Other|2|||
161968386|NCT00744978|584931463|FG000|Period 1|Adverse Event|4|||
161968387|NCT00744978|584931464|FG001|Period 1|Adverse Event|0|||
161968388|NCT00744978|584931463|FG000|Period 1|Randomized but not Treated|1|||
161968389|NCT00744978|584931464|FG001|Period 1|Randomized but not Treated|1|||
161968390|NCT00744978|584931463|FG000|Period 2|Adverse Event|0|||
161968391|NCT00744978|584931464|FG001|Period 2|Adverse Event|1|||
161968392|NCT03773133|584931465|FG000|Overall Study|Screen Failure|8|||
161968393|NCT03770728|584931466|FG000|Overall Study|Adverse Event|1|||
161968394|NCT03770728|584931467|FG001|Overall Study|Adverse Event|0|||
161968395|NCT03770728|584931468|FG002|Overall Study|Adverse Event|1|||
161968396|NCT03770728|584931469|FG003|Overall Study|Adverse Event|0|||
161968397|NCT03770728|584931466|FG000|Overall Study|Poor compliance to protocol|0|||
161968398|NCT03770728|584931467|FG001|Overall Study|Poor compliance to protocol|0|||
161968399|NCT03770728|584931468|FG002|Overall Study|Poor compliance to protocol|1|||
161968400|NCT03770728|584931469|FG003|Overall Study|Poor compliance to protocol|0|||
161968401|NCT03770728|584931466|FG000|Overall Study|Withdrawal by Subject|13|||
161968402|NCT03770728|584931467|FG001|Overall Study|Withdrawal by Subject|8|||
161968403|NCT03770728|584931468|FG002|Overall Study|Withdrawal by Subject|9|||
161968404|NCT03770728|584931469|FG003|Overall Study|Withdrawal by Subject|13|||
161968405|NCT03770728|584931466|FG000|Overall Study|Other than specified|24|||
161968406|NCT03770728|584931467|FG001|Overall Study|Other than specified|23|||
161968407|NCT03770728|584931468|FG002|Overall Study|Other than specified|21|||
161968408|NCT03770728|584931469|FG003|Overall Study|Other than specified|22|||
161968409|NCT02778555|584931470|FG000|Overall Study|Withdrawal by Subject|55|||
161968410|NCT02778555|584931471|FG001|Overall Study|Withdrawal by Subject|32|||
161968411|NCT02778555|584931472|FG002|Overall Study|Withdrawal by Subject|107|||
161968412|NCT02379988|584931473|FG000|Overall Study|Not eligible|1|||
161968413|NCT01895543|584931480|FG000|Overall Study|Withdrawal by Subject|43|||
161968414|NCT01895543|584931480|FG000|Overall Study|Lost to Follow-up|25|||
161968415|NCT01895543|584931480|FG000|Overall Study|Adverse Event|28|||
161968416|NCT01895543|584931480|FG000|Overall Study|Subject's substantial non-compliance|6|||
161968417|NCT01895543|584931480|FG000|Overall Study|Protocol Violation|1|||
161968418|NCT01895543|584931480|FG000|Overall Study|Physician Decision|2|||
161968419|NCT01895543|584931480|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
161968420|NCT03276026|584931481|FG000|Overall Study|Protocol Violation|1|||
161968421|NCT03276026|584931482|FG001|Overall Study|Protocol Violation|0|||
161968422|NCT04262882|584931483|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
161968423|NCT04262882|584931484|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
161968424|NCT04262882|584931483|FG000|Overall Study|Lost to Follow-up|1|||
161968425|NCT04262882|584931484|FG001|Overall Study|Lost to Follow-up|0|||
161968426|NCT02979093|584931485|FG000|First Scan Session|Scanning data problems|1|||
161968427|NCT02979093|584931486|FG001|First Scan Session|Scanning data problems|2|||
161968428|NCT02979093|584931487|FG002|First Scan Session|Scanning data problems|2|||
161752307|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
161752308|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
161752309|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
161752310|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
161968429|NCT02979093|584931488|FG003|First Scan Session|Scanning data problems|0|||
161968430|NCT02979093|584931485|FG000|Second Scan Session|Scanning data problems|3|||
161968431|NCT02979093|584931486|FG001|Second Scan Session|Scanning data problems|0|||
161968432|NCT02979093|584931487|FG002|Second Scan Session|Scanning data problems|1|||
161968433|NCT02979093|584931488|FG003|Second Scan Session|Scanning data problems|3|||
161968434|NCT04730635|584931489|FG000|Overall Study|Lost to Follow-up|1|||
161968435|NCT04730635|584931490|FG001|Overall Study|Lost to Follow-up|0|||
161968436|NCT04730635|584931489|FG000|Overall Study|Withdrawal by Subject|0|||
161968437|NCT04730635|584931490|FG001|Overall Study|Withdrawal by Subject|1|||
161968438|NCT00522418|584931491|FG000|Overall Study|Local IRB Consent Violation|5|||
161752311|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
161968439|NCT00522418|584931492|FG001|Overall Study|Local IRB Consent Violation|5|||
161968440|NCT00522418|584931491|FG000|Overall Study|Early Study Termination|46|||
161968441|NCT00522418|584931492|FG001|Overall Study|Early Study Termination|47|||
161752312|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
161968442|NCT00522418|584931491|FG000|Overall Study|Noncompliance|2|||
161752313|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
161752314|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
161752315|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
161752316|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
161752317|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
161752318|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
161752319|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
161752320|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
161752321|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
161752322|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
161752323|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
161752324|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
161752325|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
161752326|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
161752327|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
161752328|NCT03689972|584133206|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
161752329|NCT03689972|584133207|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
161752330|NCT03689972|584133208|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
161752331|NCT03689972|584133209|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
161752332|NCT03689972|584133210|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
161752333|NCT03689972|584133206|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
161752334|NCT03689972|584133207|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
161752335|NCT03689972|584133208|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
161752336|NCT03689972|584133209|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
161752337|NCT03689972|584133210|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
161752338|NCT03689972|584133206|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
161752339|NCT03689972|584133207|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
161752340|NCT03689972|584133208|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
161752341|NCT03689972|584133209|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
161752342|NCT03689972|584133210|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
161752343|NCT03689972|584133206|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
161752344|NCT03689972|584133207|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
161752345|NCT03689972|584133208|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
161752346|NCT03689972|584133209|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
161752347|NCT03689972|584133210|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
161752348|NCT03689972|584133206|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
161752349|NCT03689972|584133207|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
161752350|NCT03689972|584133208|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
161752351|NCT03689972|584133209|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
161752352|NCT03689972|584133210|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
161752353|NCT03689972|584133206|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
161752354|NCT03689972|584133207|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
161752355|NCT03689972|584133208|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
161752356|NCT03689972|584133209|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
161752357|NCT03689972|584133210|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
161752358|NCT03689972|584133206|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
161752359|NCT03689972|584133207|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
161752360|NCT03689972|584133208|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
161752361|NCT03689972|584133209|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
161752362|NCT03689972|584133210|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
161752363|NCT03689972|584133206|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
161752364|NCT03689972|584133207|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
161752365|NCT03689972|584133208|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
161752366|NCT03689972|584133209|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
161752367|NCT03689972|584133210|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
161752368|NCT03689972|584133206|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
161752369|NCT03689972|584133207|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
161752370|NCT03689972|584133208|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
161752371|NCT03689972|584133209|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
161752372|NCT03689972|584133210|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
161752373|NCT03689972|584133206|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
161752374|NCT03689972|584133207|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
161752375|NCT03689972|584133208|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
161752376|NCT03689972|584133209|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
161968443|NCT00522418|584931492|FG001|Overall Study|Noncompliance|2|||
161968444|NCT00522418|584931491|FG000|Overall Study|Reason Not Specified|3|||
161968445|NCT00522418|584931492|FG001|Overall Study|Reason Not Specified|1|||
161968446|NCT00522418|584931491|FG000|Overall Study|Consent Withdraw|1|||
161968447|NCT00522418|584931492|FG001|Overall Study|Consent Withdraw|2|||
161968448|NCT00522418|584931491|FG000|Overall Study|Lack of Efficacy|0|||
161968449|NCT00522418|584931492|FG001|Overall Study|Lack of Efficacy|1|||
161752377|NCT03689972|584133210|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
161752378|NCT01131130|584133212|FG000|Period 1 - Baseline|Pregnancy|1|||
161752379|NCT01131130|584133212|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
161752380|NCT02417064|584133213|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
161752381|NCT02417064|584133214|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
161752382|NCT02417064|584133215|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
161752383|NCT02417064|584133213|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
161752384|NCT02417064|584133214|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
161752385|NCT02417064|584133215|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
161752386|NCT02417064|584133213|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
161752387|NCT02417064|584133214|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
161968450|NCT02256384|584931498|FG000|Overall Study|Withdrawal by Subject|12|||
161968451|NCT02256384|584931498|FG000|Overall Study|Equipment not capturing data|2|||
161752388|NCT02417064|584133215|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
161752389|NCT02417064|584133213|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
161752390|NCT02417064|584133214|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
161752391|NCT02417064|584133215|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
161752392|NCT02417064|584133213|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
161752393|NCT02417064|584133214|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
161752394|NCT02417064|584133215|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
161752395|NCT02417064|584133213|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
161752396|NCT02417064|584133214|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
161752397|NCT02417064|584133215|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
161752398|NCT02417064|584133213|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
161752399|NCT02417064|584133214|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
161752400|NCT02417064|584133215|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
161752401|NCT02417064|584133213|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
161752402|NCT02417064|584133214|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
161752403|NCT02417064|584133215|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
161752404|NCT02417064|584133213|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
161752405|NCT02417064|584133214|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
161752406|NCT02417064|584133215|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
161752407|NCT02417064|584133213|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
161752408|NCT02417064|584133214|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
161752409|NCT02417064|584133215|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
161752410|NCT02417064|584133213|FG000|Follow-up Phase (24 Weeks)|Other|2|||
161752411|NCT02417064|584133214|FG001|Follow-up Phase (24 Weeks)|Other|2|||
161752412|NCT02417064|584133215|FG002|Follow-up Phase (24 Weeks)|Other|3|||
161752413|NCT02437162|584133220|FG000|Overall Study|Protocol Violation|0|||
161752414|NCT02437162|584133221|FG001|Overall Study|Protocol Violation|1|||
161752415|NCT02437162|584133222|FG002|Overall Study|Protocol Violation|0|||
161752416|NCT02437162|584133220|FG000|Overall Study|Randomized but not treated|0|||
161752417|NCT02437162|584133221|FG001|Overall Study|Randomized but not treated|0|||
161752418|NCT02437162|584133222|FG002|Overall Study|Randomized but not treated|1|||
161752419|NCT02437162|584133220|FG000|Overall Study|Study discontinued by Sponsor|93|||
161752420|NCT02437162|584133221|FG001|Overall Study|Study discontinued by Sponsor|98|||
161752421|NCT02437162|584133222|FG002|Overall Study|Study discontinued by Sponsor|97|||
161752422|NCT02437162|584133220|FG000|Overall Study|Withdrawal by Subject|13|||
161752423|NCT02437162|584133221|FG001|Overall Study|Withdrawal by Subject|7|||
161752424|NCT02437162|584133222|FG002|Overall Study|Withdrawal by Subject|9|||
161752425|NCT02437162|584133220|FG000|Overall Study|Adverse Event|0|||
161752426|NCT02437162|584133221|FG001|Overall Study|Adverse Event|1|||
161752427|NCT02437162|584133222|FG002|Overall Study|Adverse Event|0|||
161752428|NCT02437162|584133220|FG000|Overall Study|Lost to Follow-up|1|||
161752429|NCT02437162|584133221|FG001|Overall Study|Lost to Follow-up|0|||
161968452|NCT05032690|584931499|FG000|Period 1|Adverse Event|0|||
161968453|NCT05032690|584931500|FG001|Period 1|Adverse Event|1|||
161752430|NCT02437162|584133222|FG002|Overall Study|Lost to Follow-up|1|||
161752431|NCT02437162|584133220|FG000|Overall Study|Death|0|||
161752432|NCT02437162|584133221|FG001|Overall Study|Death|1|||
161752433|NCT02437162|584133222|FG002|Overall Study|Death|0|||
161968454|NCT05032690|584931501|FG002|Period 1|Adverse Event|0|||
161752434|NCT02437162|584133220|FG000|Overall Study|Other|0|||
161752435|NCT02437162|584133221|FG001|Overall Study|Other|0|||
161968455|NCT05032690|584931502|FG003|Period 1|Adverse Event|0|||
161968456|NCT05032690|584931499|FG000|Period 1|Withdrawal by Subject|1|||
161968457|NCT05032690|584931500|FG001|Period 1|Withdrawal by Subject|0|||
161752436|NCT02437162|584133222|FG002|Overall Study|Other|1|||
161752437|NCT03981744|584133223|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
161752438|NCT03981744|584133224|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
161752439|NCT03981744|584133225|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
161752440|NCT03981744|584133226|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
161752441|NCT03981744|584133223|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
161752442|NCT03981744|584133224|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
161752443|NCT03981744|584133225|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
161752444|NCT03981744|584133226|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
161752445|NCT03981744|584133223|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
161752446|NCT03981744|584133224|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
161752447|NCT03981744|584133225|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
161752448|NCT03981744|584133226|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
161752449|NCT04338321|584133227|FG000|Overall Study|Adverse Event|4|||
161752450|NCT04338321|584133228|FG001|Overall Study|Adverse Event|10|||
161752451|NCT04338321|584133227|FG000|Overall Study|Death|1|||
161752452|NCT04338321|584133228|FG001|Overall Study|Death|1|||
161752453|NCT04338321|584133227|FG000|Overall Study|Lost to Follow-up|4|||
161752454|NCT04338321|584133228|FG001|Overall Study|Lost to Follow-up|9|||
161752455|NCT04338321|584133227|FG000|Overall Study|Withdrawal by Subject|45|||
161752456|NCT04338321|584133228|FG001|Overall Study|Withdrawal by Subject|69|||
161752457|NCT04338321|584133227|FG000|Overall Study|Physician Decision|5|||
161752458|NCT04338321|584133228|FG001|Overall Study|Physician Decision|9|||
161752459|NCT04338321|584133227|FG000|Overall Study|Other|3|||
161752460|NCT04338321|584133228|FG001|Overall Study|Other|10|||
161752461|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
161752462|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
161752463|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
161752464|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
161752465|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
161752466|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
161752467|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
161752468|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
161752469|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
161752470|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
161752471|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
161752472|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
161752473|NCT03321526|584133229|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
161752474|NCT03321526|584133230|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
161752475|NCT03321526|584133229|FG000|Follow-up Phase (2 Weeks)|Other|24|||
161752476|NCT03321526|584133230|FG001|Follow-up Phase (2 Weeks)|Other|24|||
161752477|NCT03097133|584133231|FG000|Overall Study|Lost to Follow-up|3|||
161752478|NCT03097133|584133232|FG001|Overall Study|Lost to Follow-up|2|||
161752479|NCT03097133|584133231|FG000|Overall Study|Withdrawal by Subject|2|||
161752480|NCT03097133|584133232|FG001|Overall Study|Withdrawal by Subject|5|||
161752481|NCT03097133|584133231|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
161752482|NCT03097133|584133232|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
161752483|NCT03097133|584133231|FG000|Overall Study|Other|3|||
161752484|NCT03097133|584133232|FG001|Overall Study|Other|2|||
161752485|NCT03097133|584133231|FG000|Overall Study|Adverse Event|1|||
161752486|NCT03097133|584133232|FG001|Overall Study|Adverse Event|0|||
161752487|NCT01989572|584133235|FG000|Overall Study|Lack of Efficacy|35|||
161752488|NCT01989572|584133236|FG001|Overall Study|Lack of Efficacy|48|||
161752489|NCT01989572|584133237|FG002|Overall Study|Lack of Efficacy|48|||
161752490|NCT01989572|584133238|FG003|Overall Study|Lack of Efficacy|43|||
161752491|NCT01989572|584133239|FG004|Overall Study|Lack of Efficacy|71|||
161752492|NCT01989572|584133240|FG005|Overall Study|Lack of Efficacy|79|||
161752493|NCT01989572|584133235|FG000|Overall Study|Adverse Event|2|||
161752494|NCT01989572|584133236|FG001|Overall Study|Adverse Event|1|||
161752495|NCT01989572|584133237|FG002|Overall Study|Adverse Event|3|||
161752496|NCT01989572|584133238|FG003|Overall Study|Adverse Event|0|||
161752497|NCT01989572|584133239|FG004|Overall Study|Adverse Event|3|||
161968458|NCT05032690|584931501|FG002|Period 1|Withdrawal by Subject|0|||
161752498|NCT01989572|584133240|FG005|Overall Study|Adverse Event|0|||
161752499|NCT01989572|584133235|FG000|Overall Study|Death|0|||
161752500|NCT01989572|584133236|FG001|Overall Study|Death|0|||
161752501|NCT01989572|584133237|FG002|Overall Study|Death|0|||
161752502|NCT01989572|584133238|FG003|Overall Study|Death|0|||
161968459|NCT05032690|584931502|FG003|Period 1|Withdrawal by Subject|0|||
161968460|NCT05032690|584931499|FG000|Period 1|No longer meets eligibility criteria|0|||
161968461|NCT05032690|584931500|FG001|Period 1|No longer meets eligibility criteria|1|||
161752503|NCT01989572|584133239|FG004|Overall Study|Death|1|||
161752504|NCT01989572|584133240|FG005|Overall Study|Death|0|||
161752505|NCT01989572|584133235|FG000|Overall Study|Withdrawal by Subject|4|||
161752506|NCT01989572|584133236|FG001|Overall Study|Withdrawal by Subject|1|||
161752507|NCT01989572|584133237|FG002|Overall Study|Withdrawal by Subject|5|||
161752508|NCT01989572|584133238|FG003|Overall Study|Withdrawal by Subject|1|||
161752509|NCT01989572|584133239|FG004|Overall Study|Withdrawal by Subject|12|||
161752510|NCT01989572|584133240|FG005|Overall Study|Withdrawal by Subject|4|||
161752511|NCT01989572|584133235|FG000|Overall Study|complicating disease|1|||
161752512|NCT01989572|584133236|FG001|Overall Study|complicating disease|1|||
161752513|NCT01989572|584133237|FG002|Overall Study|complicating disease|2|||
161752514|NCT01989572|584133238|FG003|Overall Study|complicating disease|0|||
161752515|NCT01989572|584133239|FG004|Overall Study|complicating disease|1|||
161752516|NCT01989572|584133240|FG005|Overall Study|complicating disease|0|||
161752517|NCT01989572|584133235|FG000|Overall Study|error|2|||
161752518|NCT01989572|584133236|FG001|Overall Study|error|1|||
161752519|NCT01989572|584133237|FG002|Overall Study|error|1|||
161752520|NCT01989572|584133238|FG003|Overall Study|error|1|||
161752521|NCT01989572|584133239|FG004|Overall Study|error|1|||
161752522|NCT01989572|584133240|FG005|Overall Study|error|1|||
161752523|NCT01989572|584133235|FG000|Overall Study|maximum dose reached|0|||
161752524|NCT01989572|584133236|FG001|Overall Study|maximum dose reached|1|||
161752525|NCT01989572|584133237|FG002|Overall Study|maximum dose reached|0|||
161752526|NCT01989572|584133238|FG003|Overall Study|maximum dose reached|0|||
161752527|NCT01989572|584133239|FG004|Overall Study|maximum dose reached|1|||
161752528|NCT01989572|584133240|FG005|Overall Study|maximum dose reached|0|||
161752529|NCT01989572|584133235|FG000|Overall Study|unknown/not specify|3|||
161752530|NCT01989572|584133236|FG001|Overall Study|unknown/not specify|4|||
161752531|NCT01989572|584133237|FG002|Overall Study|unknown/not specify|1|||
161752532|NCT01989572|584133238|FG003|Overall Study|unknown/not specify|3|||
161752533|NCT01989572|584133239|FG004|Overall Study|unknown/not specify|3|||
161752534|NCT01989572|584133240|FG005|Overall Study|unknown/not specify|5|||
161752535|NCT01989572|584133235|FG000|Overall Study|not start protocol therapy|5|||
161752536|NCT01989572|584133236|FG001|Overall Study|not start protocol therapy|1|||
161752537|NCT01989572|584133237|FG002|Overall Study|not start protocol therapy|2|||
161752538|NCT01989572|584133238|FG003|Overall Study|not start protocol therapy|3|||
161752539|NCT01989572|584133239|FG004|Overall Study|not start protocol therapy|4|||
161752540|NCT01989572|584133240|FG005|Overall Study|not start protocol therapy|18|||
161752541|NCT01989572|584133235|FG000|Overall Study|alternative therapy|3|||
161752542|NCT01989572|584133236|FG001|Overall Study|alternative therapy|0|||
161752543|NCT01989572|584133237|FG002|Overall Study|alternative therapy|0|||
161752544|NCT01989572|584133238|FG003|Overall Study|alternative therapy|0|||
161752545|NCT01989572|584133239|FG004|Overall Study|alternative therapy|1|||
161752546|NCT01989572|584133240|FG005|Overall Study|alternative therapy|3|||
161752547|NCT00732641|584133245|FG000|Overall Study|Relapse or Progressive Disease|65|||
161752548|NCT00732641|584133246|FG001|Overall Study|Relapse or Progressive Disease|101|||
161752549|NCT00732641|584133245|FG000|Overall Study|Serious Adverse Events|12|||
161752550|NCT00732641|584133246|FG001|Overall Study|Serious Adverse Events|3|||
161752551|NCT00732641|584133245|FG000|Overall Study|Physician Decision|6|||
161752552|NCT00732641|584133246|FG001|Overall Study|Physician Decision|0|||
161752553|NCT00732641|584133245|FG000|Overall Study|Withdrawal by Subject|4|||
161752554|NCT00732641|584133246|FG001|Overall Study|Withdrawal by Subject|2|||
161752555|NCT00732641|584133245|FG000|Overall Study|Unable to Complete|1|||
161752556|NCT00732641|584133246|FG001|Overall Study|Unable to Complete|1|||
161752557|NCT00732641|584133245|FG000|Overall Study|Other|18|||
161752558|NCT00732641|584133246|FG001|Overall Study|Other|5|||
161752559|NCT00732238|584133247|FG000|Overall Study|Bacteremia|4|||
161752560|NCT00732238|584133248|FG001|Overall Study|Bacteremia|1|||
161752561|NCT00732238|584133247|FG000|Overall Study|Asymptomatic bacteriuria|1|||
161752562|NCT00732238|584133248|FG001|Overall Study|Asymptomatic bacteriuria|0|||
161752563|NCT02910089|584133249|FG000|Overall Study|Lost insurance eligibility|22|||
161752564|NCT02910089|584133250|FG001|Overall Study|Lost insurance eligibility|16|||
161752565|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
161752566|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
161752567|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
161752568|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
161752569|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
161752570|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
161752571|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
161752572|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
161752573|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
161752574|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
161752575|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
161752576|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
161752577|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
161752578|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
162032724|NCT01903252|585177467|FG002|Double-Blind Induction|Physician Decision|0|||
162032725|NCT01903252|585177468|FG003|Double-Blind Induction|Physician Decision|0|||
161968462|NCT05032690|584931501|FG002|Period 1|No longer meets eligibility criteria|0|||
161968463|NCT05032690|584931502|FG003|Period 1|No longer meets eligibility criteria|0|||
161968464|NCT05032690|584931499|FG000|Period 2|Adverse Event|1|||
161968465|NCT05032690|584931500|FG001|Period 2|Adverse Event|0|||
161968466|NCT05032690|584931501|FG002|Period 2|Adverse Event|0|||
161968467|NCT05032690|584931502|FG003|Period 2|Adverse Event|0|||
161968468|NCT05032690|584931499|FG000|Period 2|Withdrawal by Subject|0|||
161968469|NCT05032690|584931500|FG001|Period 2|Withdrawal by Subject|1|||
161968470|NCT05032690|584931501|FG002|Period 2|Withdrawal by Subject|0|||
161752579|NCT03434041|584133253|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
161752580|NCT03434041|584133254|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
161752581|NCT03434041|584133253|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
161752582|NCT03434041|584133254|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
161752583|NCT03434041|584133253|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
161752584|NCT03434041|584133254|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
161752585|NCT03434041|584133253|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
161752586|NCT03434041|584133254|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
161752587|NCT04159701|584133255|FG000|Period 1: Treatment Period|Pregnancy|1|||
161752588|NCT04159701|584133256|FG001|Period 1: Treatment Period|Pregnancy|0|||
161752589|NCT04159701|584133255|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
161752590|NCT04159701|584133256|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
161752591|NCT04159701|584133255|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
161752592|NCT04159701|584133256|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
161752593|NCT04159701|584133255|FG000|Washout Period|site terminated by sponsor|0|||
161752594|NCT04159701|584133256|FG001|Washout Period|site terminated by sponsor|1|||
161752595|NCT04159701|584133255|FG000|Washout Period|study terminated by sponsor|10|||
161752596|NCT04159701|584133256|FG001|Washout Period|study terminated by sponsor|3|||
161752597|NCT04159701|584133255|FG000|Washout Period|Withdrawal by Subject|1|||
161752598|NCT04159701|584133256|FG001|Washout Period|Withdrawal by Subject|0|||
161752599|NCT04159701|584133255|FG000|Washout Period|Inadvertent Enrollment|1|||
161752600|NCT04159701|584133256|FG001|Washout Period|Inadvertent Enrollment|0|||
161752601|NCT04159701|584133255|FG000|Washout Period|Miscellaneous|1|||
161752602|NCT04159701|584133256|FG001|Washout Period|Miscellaneous|0|||
161752603|NCT04159701|584133255|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
161752604|NCT04159701|584133256|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
161752605|NCT04159701|584133255|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
161752606|NCT04159701|584133256|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
161752607|NCT04159701|584133255|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
161752608|NCT04159701|584133256|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
161752609|NCT04159701|584133255|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
161752610|NCT04159701|584133256|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
161752611|NCT04159701|584133255|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
161752612|NCT04159701|584133256|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
161752613|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
161752614|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
161752615|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
161752616|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
161752617|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
161752618|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
161752619|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
161752620|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
161752621|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
161752622|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
161752623|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
161752624|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
161752625|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
161752626|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
161752627|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
161752628|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
161752629|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
161752630|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
161968471|NCT05032690|584931502|FG003|Period 2|Withdrawal by Subject|0|||
161752631|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
161752632|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
161968472|NCT05032690|584931499|FG000|Period 2|No longer meets eligibility criteria|0|||
161968473|NCT05032690|584931500|FG001|Period 2|No longer meets eligibility criteria|1|||
161968474|NCT05032690|584931501|FG002|Period 2|No longer meets eligibility criteria|0|||
161968475|NCT05032690|584931502|FG003|Period 2|No longer meets eligibility criteria|0|||
161968476|NCT05032690|584931499|FG000|Period 3|Adverse Event|0|||
161752633|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
161752634|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
161752635|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
161752636|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
161752637|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
161752638|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
161752639|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
161752640|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
161752641|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
161752642|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
161752643|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
161752644|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
161752645|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
161752646|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
161752647|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
161752648|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
161752649|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
161752650|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
161752651|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
161752652|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
161752653|NCT03605836|584133257|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
161752654|NCT03605836|584133258|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
161752655|NCT03605836|584133259|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
161752656|NCT03605836|584133260|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
161752657|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
161752658|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
161752659|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
161752660|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
161752661|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
161752662|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
161752663|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
161752664|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
161752665|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
161752666|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
161752667|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
161752668|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
161752669|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
161752670|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
161752671|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
161752672|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
161752673|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
161752674|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
161752675|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
161752676|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
161752677|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
161752678|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
161752679|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
161752680|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
161752681|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
161752682|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
161752683|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
161752684|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
161752685|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
161752686|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
161968477|NCT05032690|584931500|FG001|Period 3|Adverse Event|1|||
161968478|NCT05032690|584931501|FG002|Period 3|Adverse Event|0|||
161752687|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
161752688|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
161752689|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
161844917|NCT02980874|584474684|FG001|Overall Study|Lost to Follow-up|5|||
161844918|NCT02980874|584474683|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
161968479|NCT05032690|584931502|FG003|Period 3|Adverse Event|0|||
161968480|NCT00487942|584931503|FG000|Overall Study|Adverse Event|1|||
161968481|NCT00487942|584931504|FG001|Overall Study|Adverse Event|1|||
161968482|NCT00487942|584931505|FG002|Overall Study|Adverse Event|1|||
161968483|NCT00487942|584931506|FG003|Overall Study|Adverse Event|1|||
161968484|NCT00487942|584931503|FG000|Overall Study|Lost to Follow-up|1|||
161968485|NCT00487942|584931504|FG001|Overall Study|Lost to Follow-up|0|||
161968486|NCT00487942|584931505|FG002|Overall Study|Lost to Follow-up|0|||
162032726|NCT01903252|585177469|FG004|Double-Blind Induction|Physician Decision|0|||
162032727|NCT01903252|585177470|FG005|Double-Blind Induction|Physician Decision|0|||
162032728|NCT01903252|585177465|FG000|Double-Blind Induction|non-compliance,|7|||
162032729|NCT01903252|585177466|FG001|Double-Blind Induction|non-compliance,|7|||
162032730|NCT01903252|585177467|FG002|Double-Blind Induction|non-compliance,|0|||
162032731|NCT01903252|585177468|FG003|Double-Blind Induction|non-compliance,|0|||
162032732|NCT01903252|585177469|FG004|Double-Blind Induction|non-compliance,|0|||
162032733|NCT01903252|585177470|FG005|Double-Blind Induction|non-compliance,|0|||
162032734|NCT01903252|585177465|FG000|Extended Induction, Open-Label|Adverse Event|0|||
162032735|NCT01903252|585177466|FG001|Extended Induction, Open-Label|Adverse Event|0|||
162032736|NCT01903252|585177467|FG002|Extended Induction, Open-Label|Adverse Event|17|||
162032737|NCT01903252|585177468|FG003|Extended Induction, Open-Label|Adverse Event|0|||
162032738|NCT01903252|585177469|FG004|Extended Induction, Open-Label|Adverse Event|0|||
162032739|NCT01903252|585177470|FG005|Extended Induction, Open-Label|Adverse Event|0|||
162032740|NCT01903252|585177465|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
162032741|NCT01903252|585177466|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
162032742|NCT01903252|585177467|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
162032743|NCT01903252|585177468|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
162032744|NCT01903252|585177469|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
162032745|NCT01903252|585177470|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
162032746|NCT01903252|585177465|FG000|Extended Induction, Open-Label|Physician Decision|0|||
162032747|NCT01903252|585177466|FG001|Extended Induction, Open-Label|Physician Decision|0|||
162032748|NCT01903252|585177467|FG002|Extended Induction, Open-Label|Physician Decision|1|||
162032749|NCT01903252|585177468|FG003|Extended Induction, Open-Label|Physician Decision|0|||
162032750|NCT01903252|585177469|FG004|Extended Induction, Open-Label|Physician Decision|0|||
162032751|NCT01903252|585177470|FG005|Extended Induction, Open-Label|Physician Decision|0|||
162032752|NCT01903252|585177465|FG000|Maintenance, Open-Label|Adverse Event|0|||
162032753|NCT01903252|585177466|FG001|Maintenance, Open-Label|Adverse Event|0|||
162032754|NCT01903252|585177467|FG002|Maintenance, Open-Label|Adverse Event|0|||
162032755|NCT01903252|585177468|FG003|Maintenance, Open-Label|Adverse Event|3|||
162032756|NCT01903252|585177469|FG004|Maintenance, Open-Label|Adverse Event|9|||
162032757|NCT01903252|585177470|FG005|Maintenance, Open-Label|Adverse Event|14|||
162032758|NCT01903252|585177465|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
162032759|NCT01903252|585177466|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
162032760|NCT01903252|585177467|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
162032761|NCT01903252|585177468|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
162032762|NCT01903252|585177469|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
162032763|NCT01903252|585177470|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
162032764|NCT01903252|585177465|FG000|Maintenance, Open-Label|Other|0|||
162032765|NCT01903252|585177466|FG001|Maintenance, Open-Label|Other|0|||
162032766|NCT01903252|585177467|FG002|Maintenance, Open-Label|Other|0|||
162032767|NCT01903252|585177468|FG003|Maintenance, Open-Label|Other|2|||
162032768|NCT01903252|585177469|FG004|Maintenance, Open-Label|Other|6|||
162032769|NCT01903252|585177470|FG005|Maintenance, Open-Label|Other|2|||
162032770|NCT03562767|585177471|FG000|Overall Study|Physician Decision|2|||
162032771|NCT03562767|585177472|FG001|Overall Study|Physician Decision|0|||
162032772|NCT03562767|585177473|FG002|Overall Study|Physician Decision|0|||
162032773|NCT03562767|585177471|FG000|Overall Study|Logistic Reason|1|||
162032774|NCT03562767|585177472|FG001|Overall Study|Logistic Reason|3|||
162032775|NCT03562767|585177473|FG002|Overall Study|Logistic Reason|0|||
162032776|NCT02518464|585177476|FG000|Overall Study|Adverse Event|2|||
162032777|NCT03761797|585177477|FG000|Overall Study|Changing hospital|11|||
162032778|NCT03761797|585177477|FG000|Overall Study|Improvement/remission|6|||
162032779|NCT03761797|585177477|FG000|Overall Study|Withdrawal by Subject|19|||
162032780|NCT03761797|585177477|FG000|Overall Study|Lost to Follow-up|33|||
162032781|NCT03761797|585177477|FG000|Overall Study|Adverse Event|37|||
162032782|NCT03761797|585177477|FG000|Overall Study|Case report form (CRF) not collected|5|||
161752690|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
161752691|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
161968487|NCT00487942|584931506|FG003|Overall Study|Lost to Follow-up|1|||
161968488|NCT00487942|584931503|FG000|Overall Study|Protocol Violation|1|||
162032783|NCT03761797|585177477|FG000|Overall Study|No patient visit after entry|13|||
162032784|NCT03761797|585177477|FG000|Overall Study|Switch to other diabetes medication|10|||
162032785|NCT03761797|585177477|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
162032786|NCT03761797|585177477|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
161968489|NCT00487942|584931504|FG001|Overall Study|Protocol Violation|1|||
161968490|NCT00487942|584931505|FG002|Overall Study|Protocol Violation|0|||
161752692|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
161752693|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
161752694|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
161752695|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
161752696|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
161752697|NCT03605836|584133257|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
161752698|NCT03605836|584133258|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
161752699|NCT03605836|584133259|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
161752700|NCT03605836|584133260|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
161752701|NCT01782885|584133265|FG000|Overall Study|Lost to Follow-up|4|||
161752702|NCT01782885|584133266|FG001|Overall Study|Lost to Follow-up|6|||
161752703|NCT00633360|584133267|FG000|Overall Study|Lost to Follow-up|1|||
161752704|NCT00633360|584133268|FG001|Overall Study|Lost to Follow-up|1|||
161752705|NCT00633360|584133267|FG000|Overall Study|Adverse Event|3|||
161752706|NCT00633360|584133268|FG001|Overall Study|Adverse Event|1|||
161752707|NCT00633360|584133267|FG000|Overall Study|Protocol Violation|0|||
161752708|NCT00633360|584133268|FG001|Overall Study|Protocol Violation|1|||
161752709|NCT02348840|584133274|FG000|Overall Study|Withdrawal by Subject|2|||
161752710|NCT02348840|584133275|FG001|Overall Study|Withdrawal by Subject|1|||
161752711|NCT02348840|584133276|FG002|Overall Study|Withdrawal by Subject|0|||
161752712|NCT02348840|584133277|FG003|Overall Study|Withdrawal by Subject|0|||
161752713|NCT00621244|584133278|FG000|Overall Study|Withdrawal by Subject|7|||
161752714|NCT00621244|584133279|FG001|Overall Study|Withdrawal by Subject|3|||
161752715|NCT00621244|584133280|FG002|Overall Study|Withdrawal by Subject|3|||
161752716|NCT00621244|584133281|FG003|Overall Study|Withdrawal by Subject|3|||
161752717|NCT00621244|584133278|FG000|Overall Study|Disease progression|44|||
161752718|NCT00621244|584133279|FG001|Overall Study|Disease progression|20|||
161752719|NCT00621244|584133280|FG002|Overall Study|Disease progression|20|||
161752720|NCT00621244|584133281|FG003|Overall Study|Disease progression|15|||
161752721|NCT00621244|584133278|FG000|Overall Study|Death|3|||
161752722|NCT00621244|584133279|FG001|Overall Study|Death|3|||
161752723|NCT00621244|584133280|FG002|Overall Study|Death|1|||
161752724|NCT00621244|584133281|FG003|Overall Study|Death|1|||
161752725|NCT00621244|584133278|FG000|Overall Study|Adverse Event|27|||
161752726|NCT00621244|584133279|FG001|Overall Study|Adverse Event|7|||
161752727|NCT00621244|584133280|FG002|Overall Study|Adverse Event|9|||
161752728|NCT00621244|584133281|FG003|Overall Study|Adverse Event|2|||
161752729|NCT00621244|584133278|FG000|Overall Study|Administrative problems|5|||
161752730|NCT00621244|584133279|FG001|Overall Study|Administrative problems|1|||
161752731|NCT00621244|584133280|FG002|Overall Study|Administrative problems|0|||
161752732|NCT00621244|584133281|FG003|Overall Study|Administrative problems|2|||
161752733|NCT01690988|584133282|FG000|Overall Study|Withdrawal by Subject|2|||
161752734|NCT01690988|584133283|FG001|Overall Study|Withdrawal by Subject|2|||
161752735|NCT01690988|584133284|FG002|Overall Study|Withdrawal by Subject|3|||
161752736|NCT01690988|584133282|FG000|Overall Study|Physician Decision|0|||
161752737|NCT01690988|584133283|FG001|Overall Study|Physician Decision|0|||
161752738|NCT01690988|584133284|FG002|Overall Study|Physician Decision|1|||
161752739|NCT01690988|584133282|FG000|Overall Study|Operation Cancelled|1|||
161752740|NCT01690988|584133283|FG001|Overall Study|Operation Cancelled|1|||
161752741|NCT01690988|584133284|FG002|Overall Study|Operation Cancelled|0|||
161752742|NCT01690988|584133282|FG000|Overall Study|Determined ineligible|1|||
161752743|NCT01690988|584133283|FG001|Overall Study|Determined ineligible|0|||
161752744|NCT01690988|584133284|FG002|Overall Study|Determined ineligible|0|||
161752745|NCT01690988|584133282|FG000|Overall Study|Death|1|||
161752746|NCT01690988|584133283|FG001|Overall Study|Death|1|||
161752747|NCT01690988|584133284|FG002|Overall Study|Death|1|||
161752748|NCT01690988|584133282|FG000|Overall Study|Sedated|1|||
161752749|NCT01690988|584133283|FG001|Overall Study|Sedated|1|||
161752750|NCT01690988|584133284|FG002|Overall Study|Sedated|2|||
161752751|NCT00312728|584133289|FG000|Overall Study|Progressive disease|53|||
161752752|NCT00312728|584133289|FG000|Overall Study|Adverse Event|32|||
161752753|NCT00312728|584133289|FG000|Overall Study|Withdrawal by Subject|10|||
161752754|NCT00312728|584133289|FG000|Overall Study|Required non-protocol cancer treatment|2|||
161752755|NCT00312728|584133289|FG000|Overall Study|Protocol Violation|2|||
161752756|NCT00312728|584133289|FG000|Overall Study|Other|10|||
161752757|NCT00312728|584133289|FG000|Overall Study|Other|1|||
161752758|NCT03696576|584133290|FG000|Overall Study|Soreness of throat after therapy|1|||
161752759|NCT03696576|584133291|FG001|Overall Study|Soreness of throat after therapy|1|||
161752760|NCT03696576|584133290|FG000|Overall Study|Lost to Follow-up|2|||
161752761|NCT03696576|584133291|FG001|Overall Study|Lost to Follow-up|4|||
161752762|NCT00744991|584133292|FG000|Overall Study|Progressive Disease|11|||
161752763|NCT00744991|584133292|FG000|Overall Study|Withdrawal by Subject|8|||
161752764|NCT00744991|584133292|FG000|Overall Study|Physician Decision|3|||
161752765|NCT00744991|584133292|FG000|Overall Study|Adverse Event|2|||
161752766|NCT00744991|584133292|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
161752767|NCT01662986|584133293|FG000|Overall Study|Adverse Event|5|||
161752768|NCT01662986|584133294|FG001|Overall Study|Adverse Event|4|||
161968491|NCT00487942|584931506|FG003|Overall Study|Protocol Violation|0|||
161968492|NCT00487942|584931503|FG000|Overall Study|Withdrawal by Subject|0|||
161968493|NCT00487942|584931504|FG001|Overall Study|Withdrawal by Subject|1|||
161968494|NCT00487942|584931505|FG002|Overall Study|Withdrawal by Subject|2|||
161968495|NCT00487942|584931506|FG003|Overall Study|Withdrawal by Subject|0|||
161968496|NCT00211757|584931507|FG000|Overall Study|Withdrawal by Subject|1|||
161968497|NCT00211757|584931508|FG001|Overall Study|Withdrawal by Subject|1|||
161968498|NCT00211757|584931507|FG000|Overall Study|Lack of Efficacy|0|||
161968499|NCT00211757|584931508|FG001|Overall Study|Lack of Efficacy|1|||
161968500|NCT05151445|584931509|FG000|Overall Study|Withdrawal by Subject|3|||
161968501|NCT02298179|584931510|FG000|Overall Study|Lost to Follow-up|0|||
161968502|NCT02298179|584931511|FG001|Overall Study|Lost to Follow-up|0|||
161968503|NCT02298179|584931512|FG002|Overall Study|Lost to Follow-up|1|||
161968504|NCT02298179|584931513|FG003|Overall Study|Lost to Follow-up|0|||
161968505|NCT02298179|584931514|FG004|Overall Study|Lost to Follow-up|0|||
161968506|NCT02298179|584931515|FG005|Overall Study|Lost to Follow-up|0|||
161968507|NCT02298179|584931516|FG006|Overall Study|Lost to Follow-up|0|||
161968508|NCT02298179|584931517|FG007|Overall Study|Lost to Follow-up|1|||
161968509|NCT02298179|584931518|FG008|Overall Study|Lost to Follow-up|0|||
161968510|NCT02298179|584931519|FG009|Overall Study|Lost to Follow-up|0|||
161968511|NCT02298179|584931520|FG010|Overall Study|Lost to Follow-up|0|||
161968512|NCT02298179|584931521|FG011|Overall Study|Lost to Follow-up|0|||
161968513|NCT00642174|584933683|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
161968514|NCT00642174|584933684|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
161968515|NCT00896363|584933685|FG000|Overall Study|Adverse Event|3|||
161968516|NCT00896363|584933686|FG001|Overall Study|Adverse Event|4|||
161968517|NCT00896363|584933687|FG002|Overall Study|Adverse Event|2|||
161968518|NCT00896363|584933685|FG000|Overall Study|Lack of Efficacy|0|||
161968519|NCT00896363|584933686|FG001|Overall Study|Lack of Efficacy|2|||
161968520|NCT00896363|584933687|FG002|Overall Study|Lack of Efficacy|1|||
161968521|NCT00896363|584933685|FG000|Overall Study|Withdrawal by Subject|3|||
161968522|NCT00896363|584933686|FG001|Overall Study|Withdrawal by Subject|5|||
161968523|NCT00896363|584933687|FG002|Overall Study|Withdrawal by Subject|5|||
161968524|NCT01730339|584933688|FG000|Overall Study|Withdrawal by Subject|3|||
161968525|NCT01730339|584933689|FG001|Overall Study|Withdrawal by Subject|2|||
161968526|NCT01730339|584933688|FG000|Overall Study|Lost to Follow-up|1|||
161968527|NCT01730339|584933689|FG001|Overall Study|Lost to Follow-up|1|||
161968528|NCT01730339|584933688|FG000|Overall Study|Un-specified|1|||
161968529|NCT01730339|584933689|FG001|Overall Study|Un-specified|0|||
161968530|NCT03575065|584933692|FG000|Overall Study|Death|31|||
161968531|NCT03575065|584933693|FG001|Overall Study|Death|12|||
161968532|NCT03575065|584933692|FG000|Overall Study|Sponsor's Decision|28|||
161968533|NCT03575065|584933693|FG001|Overall Study|Sponsor's Decision|13|||
161968534|NCT03575065|584933692|FG000|Overall Study|Withdrawal by Subject|2|||
161968535|NCT03575065|584933693|FG001|Overall Study|Withdrawal by Subject|1|||
161968536|NCT03575065|584933692|FG000|Overall Study|Lost to Follow-up|1|||
161968537|NCT03575065|584933693|FG001|Overall Study|Lost to Follow-up|0|||
161968538|NCT02323126|584933698|FG000|Overall Study|Patient / guardian decision|0|||
161968539|NCT02323126|584933699|FG001|Overall Study|Patient / guardian decision|1|||
161968540|NCT02323126|584933700|FG002|Overall Study|Patient / guardian decision|2|||
161968541|NCT02323126|584933698|FG000|Overall Study|Progressive disease|14|||
161968542|NCT02323126|584933699|FG001|Overall Study|Progressive disease|8|||
161968543|NCT02323126|584933700|FG002|Overall Study|Progressive disease|14|||
161968544|NCT02323126|584933698|FG000|Overall Study|Physician Decision|0|||
161968545|NCT02323126|584933699|FG001|Overall Study|Physician Decision|1|||
161968546|NCT02323126|584933700|FG002|Overall Study|Physician Decision|3|||
161968547|NCT02323126|584933698|FG000|Overall Study|Death|1|||
161752769|NCT01662986|584133293|FG000|Overall Study|Protocol Violation|2|||
161752770|NCT01662986|584133294|FG001|Overall Study|Protocol Violation|3|||
161752771|NCT01662986|584133293|FG000|Overall Study|Lost to Follow-up|5|||
161968548|NCT02323126|584933699|FG001|Overall Study|Death|1|||
161968549|NCT02323126|584933700|FG002|Overall Study|Death|4|||
161968550|NCT02323126|584933698|FG000|Overall Study|Adverse Event|3|||
161968551|NCT02323126|584933699|FG001|Overall Study|Adverse Event|5|||
161968552|NCT02323126|584933700|FG002|Overall Study|Adverse Event|7|||
161968553|NCT00939029|584933701|FG000|Overall Study|Withdrawal by Subject|3|||
161968554|NCT00939029|584933702|FG001|Overall Study|Withdrawal by Subject|7|||
161968555|NCT00939029|584933701|FG000|Overall Study|Lost to Follow-up|3|||
161968556|NCT00939029|584933702|FG001|Overall Study|Lost to Follow-up|4|||
161968557|NCT00939029|584933701|FG000|Overall Study|Adverse Event|0|||
161968558|NCT00939029|584933702|FG001|Overall Study|Adverse Event|1|||
161968559|NCT01779856|584933703|FG000|Overall Study|Withdrawal by Subject|15|||
161968560|NCT01779856|584933703|FG000|Overall Study|Death|3|||
161968561|NCT01779856|584933703|FG000|Overall Study|Physician Decision|1|||
161968562|NCT01779856|584933703|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
161968563|NCT01779856|584933703|FG000|Overall Study|Delays in scheduling implant|1|||
161968564|NCT01779856|584933703|FG000|Overall Study|Subject ineligible for Implant|2|||
161968565|NCT03960580|584933708|FG000|Overall Study|Adverse Event|2|||
161968566|NCT03960580|584933709|FG001|Overall Study|Adverse Event|1|||
161968567|NCT03960580|584933710|FG002|Overall Study|Adverse Event|1|||
161968568|NCT03960580|584933708|FG000|Overall Study|Lost to Follow-up|1|||
161968569|NCT03960580|584933709|FG001|Overall Study|Lost to Follow-up|0|||
161968570|NCT03960580|584933710|FG002|Overall Study|Lost to Follow-up|0|||
161968571|NCT03960580|584933708|FG000|Overall Study|Lack of Efficacy|2|||
161968572|NCT03960580|584933709|FG001|Overall Study|Lack of Efficacy|1|||
161968573|NCT03960580|584933710|FG002|Overall Study|Lack of Efficacy|0|||
161968574|NCT03960580|584933708|FG000|Overall Study|Protocol Violation|0|||
161968575|NCT03960580|584933709|FG001|Overall Study|Protocol Violation|0|||
161968576|NCT03960580|584933710|FG002|Overall Study|Protocol Violation|1|||
161968577|NCT03960580|584933708|FG000|Overall Study|Withdrawal by Subject|1|||
161968578|NCT03960580|584933709|FG001|Overall Study|Withdrawal by Subject|1|||
161968579|NCT03960580|584933710|FG002|Overall Study|Withdrawal by Subject|1|||
161968580|NCT03960580|584933708|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
161968581|NCT03960580|584933709|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
161968582|NCT03960580|584933710|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
161752772|NCT01662986|584133294|FG001|Overall Study|Lost to Follow-up|4|||
161752773|NCT01662986|584133293|FG000|Overall Study|Withdrawal by Subject|2|||
161752774|NCT01662986|584133294|FG001|Overall Study|Withdrawal by Subject|2|||
161752775|NCT01662986|584133293|FG000|Overall Study|Not Treated|1|||
161752776|NCT01662986|584133294|FG001|Overall Study|Not Treated|0|||
161752777|NCT01662986|584133293|FG000|Overall Study|Other than stated above|3|||
161752778|NCT01662986|584133294|FG001|Overall Study|Other than stated above|0|||
161752779|NCT01594411|584133297|FG000|Overall Study|Lost to Follow-up|2|||
161752780|NCT01929707|584133298|FG000|Intervention Period 1|Lost to Follow-up|0|||
161752781|NCT01929707|584133299|FG001|Intervention Period 1|Lost to Follow-up|0|||
161752782|NCT01929707|584133300|FG002|Intervention Period 1|Lost to Follow-up|0|||
161752783|NCT01929707|584133301|FG003|Intervention Period 1|Lost to Follow-up|1|||
161752784|NCT01929707|584133302|FG004|Intervention Period 1|Lost to Follow-up|0|||
161752785|NCT01929707|584133303|FG005|Intervention Period 1|Lost to Follow-up|0|||
161752786|NCT01929707|584133304|FG006|Intervention Period 1|Lost to Follow-up|0|||
161752787|NCT01929707|584133305|FG007|Intervention Period 1|Lost to Follow-up|0|||
161752788|NCT01929707|584133298|FG000|Intervention Period 1|Withdrawal by Subject|0|||
161752789|NCT01929707|584133299|FG001|Intervention Period 1|Withdrawal by Subject|0|||
161752790|NCT01929707|584133300|FG002|Intervention Period 1|Withdrawal by Subject|0|||
161752791|NCT01929707|584133301|FG003|Intervention Period 1|Withdrawal by Subject|2|||
161752792|NCT01929707|584133302|FG004|Intervention Period 1|Withdrawal by Subject|0|||
161752793|NCT01929707|584133303|FG005|Intervention Period 1|Withdrawal by Subject|0|||
161752794|NCT01929707|584133304|FG006|Intervention Period 1|Withdrawal by Subject|0|||
161752795|NCT01929707|584133305|FG007|Intervention Period 1|Withdrawal by Subject|0|||
161752796|NCT01929707|584133298|FG000|Intervention Period 2|Withdrawal by Subject|0|||
161752797|NCT01929707|584133299|FG001|Intervention Period 2|Withdrawal by Subject|0|||
161752798|NCT01929707|584133300|FG002|Intervention Period 2|Withdrawal by Subject|0|||
161752799|NCT01929707|584133301|FG003|Intervention Period 2|Withdrawal by Subject|0|||
161752800|NCT01929707|584133302|FG004|Intervention Period 2|Withdrawal by Subject|0|||
161752801|NCT01929707|584133303|FG005|Intervention Period 2|Withdrawal by Subject|2|||
161752802|NCT01929707|584133304|FG006|Intervention Period 2|Withdrawal by Subject|0|||
161752803|NCT01929707|584133305|FG007|Intervention Period 2|Withdrawal by Subject|0|||
161752804|NCT02067533|584133312|FG000|Overall Study|Lost to Follow-up|4|||
161752805|NCT02067533|584133313|FG001|Overall Study|Lost to Follow-up|2|||
161752806|NCT02896192|584133317|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
161752807|NCT02896192|584133317|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
161752808|NCT02896192|584133317|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
161752809|NCT01997281|584133318|FG000|Overall Study|Withdrawal by Subject|1|||
161752810|NCT01997281|584133319|FG001|Overall Study|Withdrawal by Subject|0|||
161752811|NCT00368472|584133321|FG000|Overall Study|Adverse Event|22|||
161752812|NCT00368472|584133321|FG000|Overall Study|Medication non-compliance|4|||
161752813|NCT00368472|584133321|FG000|Overall Study|Protocol Violation|2|||
161752814|NCT00368472|584133321|FG000|Overall Study|Request of Investigator or Sponsor|3|||
161752815|NCT00368472|584133321|FG000|Overall Study|Withdrawal by Subject|40|||
161752816|NCT00368472|584133321|FG000|Overall Study|Diary non-compliance|1|||
161968583|NCT03172325|584933715|FG000|Overall Study|Adverse Event|2|||
161968584|NCT03172325|584933716|FG001|Overall Study|Adverse Event|3|||
161968585|NCT03172325|584933715|FG000|Overall Study|Positive PPD|1|||
161968586|NCT03172325|584933716|FG001|Overall Study|Positive PPD|0|||
161968587|NCT03172325|584933715|FG000|Overall Study|Poor Compliance|1|||
161968588|NCT03172325|584933716|FG001|Overall Study|Poor Compliance|1|||
161968589|NCT00385944|584933720|FG000|1st Maintenance Dose Period|Physician Decision|1|||
161968590|NCT00385944|584933721|FG001|1st Maintenance Dose Period|Physician Decision|0|||
161752817|NCT00368472|584133321|FG000|Overall Study|Other|32|||
161752818|NCT00368472|584133321|FG000|Overall Study|Missing Final Disposition Date|1|||
161752819|NCT02650895|584133323|FG000|Overall Study|Withdrawal by Subject|0|||
161752820|NCT02650895|584133324|FG001|Overall Study|Withdrawal by Subject|1|||
161752821|NCT02650895|584133325|FG002|Overall Study|Withdrawal by Subject|0|||
161968591|NCT00385944|584933722|FG002|1st Maintenance Dose Period|Physician Decision|0|||
161968592|NCT00385944|584933720|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
161968593|NCT00385944|584933721|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
161968594|NCT00385944|584933722|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
161968595|NCT00385944|584933720|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
161968596|NCT00385944|584933721|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
161968597|NCT00385944|584933722|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
161968598|NCT00385944|584933720|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
161968599|NCT00385944|584933721|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
161968600|NCT00385944|584933722|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
161968601|NCT03832322|584933724|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
161968602|NCT03832322|584933725|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
161968603|NCT01694121|584933727|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
161752822|NCT02650895|584133326|FG003|Overall Study|Withdrawal by Subject|0|||
161752823|NCT02650895|584133327|FG004|Overall Study|Withdrawal by Subject|0|||
161752824|NCT02650895|584133328|FG005|Overall Study|Withdrawal by Subject|0|||
161752825|NCT03209362|584133329|FG000|Overall Study|Adverse Event|0|||
161752826|NCT03209362|584133330|FG001|Overall Study|Adverse Event|1|||
161752827|NCT03209362|584133329|FG000|Overall Study|Lost to Follow-up|0|||
161752828|NCT03209362|584133330|FG001|Overall Study|Lost to Follow-up|1|||
161752829|NCT03209362|584133329|FG000|Overall Study|Withdrawal by Subject|2|||
161752830|NCT03209362|584133330|FG001|Overall Study|Withdrawal by Subject|0|||
161752831|NCT03209362|584133329|FG000|Overall Study|Other|0|||
161752832|NCT03209362|584133330|FG001|Overall Study|Other|1|||
161752833|NCT00643448|584133335|FG000|Overall Study|Lack of Efficacy|2|||
161752834|NCT00643448|584133336|FG001|Overall Study|Lack of Efficacy|0|||
161752835|NCT00643448|584133337|FG002|Overall Study|Lack of Efficacy|4|||
161752836|NCT00643448|584133335|FG000|Overall Study|Adverse Event|2|||
161752837|NCT00643448|584133336|FG001|Overall Study|Adverse Event|2|||
161752838|NCT00643448|584133337|FG002|Overall Study|Adverse Event|2|||
161752839|NCT00643448|584133335|FG000|Overall Study|QTcF>550 ms|0|||
161752840|NCT00643448|584133336|FG001|Overall Study|QTcF>550 ms|3|||
161752841|NCT00643448|584133337|FG002|Overall Study|QTcF>550 ms|0|||
161752842|NCT00981682|584133338|FG000|Overall Study|Adverse Event|48|||
161752843|NCT00981682|584133338|FG000|Overall Study|Withdrawal by Subject|52|||
161752844|NCT00981682|584133338|FG000|Overall Study|Lost to Follow-up|14|||
161752845|NCT00981682|584133338|FG000|Overall Study|Lack of Efficacy|13|||
161752846|NCT00981682|584133338|FG000|Overall Study|Protocol Violation|6|||
161752847|NCT00981682|584133338|FG000|Overall Study|administrative|9|||
161752848|NCT02358863|584135565|FG000|Overall Study|Physician Decision|3|||
161752849|NCT05426460|584135570|FG000|Overall Study|Protocol Violation|1|||
161752850|NCT05426460|584135571|FG001|Overall Study|Protocol Violation|1|||
161752851|NCT05426460|584135572|FG002|Overall Study|Protocol Violation|1|||
161752852|NCT05426460|584135573|FG003|Overall Study|Protocol Violation|0|||
161752853|NCT02204410|584135574|FG000|Overall Study|Lost to Follow-up|5|||
161752854|NCT02204410|584135574|FG000|Overall Study|Physician Decision|2|||
161752855|NCT02204410|584135574|FG000|Overall Study|Protocol Violation|1|||
161752856|NCT02204410|584135574|FG000|Overall Study|Withdrawal by Subject|3|||
161752857|NCT01405027|584135577|FG000|Overall Study|Withdrawn consent|3|||
161752858|NCT01405027|584135578|FG001|Overall Study|Withdrawn consent|0|||
161752859|NCT01405027|584135577|FG000|Overall Study|Lost to Follow-up|16|||
161752860|NCT01405027|584135578|FG001|Overall Study|Lost to Follow-up|24|||
161752861|NCT01405027|584135577|FG000|Overall Study|Investigator judgement|0|||
161752862|NCT01405027|584135578|FG001|Overall Study|Investigator judgement|2|||
161752863|NCT01405027|584135577|FG000|Overall Study|Death|1|||
161752864|NCT01405027|584135578|FG001|Overall Study|Death|0|||
161752865|NCT01405027|584135577|FG000|Overall Study|Other or Unknown|12|||
161752866|NCT01405027|584135578|FG001|Overall Study|Other or Unknown|25|||
161752867|NCT01536418|584135585|FG000|Overall Study|Protocol Violation|2|||
161752868|NCT01536418|584135586|FG001|Overall Study|Protocol Violation|3|||
161752869|NCT01536418|584135585|FG000|Overall Study|Physician Decision|1|||
161752870|NCT01536418|584135586|FG001|Overall Study|Physician Decision|3|||
161752871|NCT01536418|584135585|FG000|Overall Study|Study closed/terminated|41|||
161752872|NCT01536418|584135586|FG001|Overall Study|Study closed/terminated|37|||
161968604|NCT01694121|584933728|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
161968605|NCT00521599|584933729|FG000|Overall Study|Adverse Event|5|||
161968606|NCT00521599|584933730|FG001|Overall Study|Adverse Event|7|||
161968607|NCT00521599|584933731|FG002|Overall Study|Adverse Event|6|||
161752873|NCT01536418|584135585|FG000|Overall Study|Lack of Efficacy|10|||
161752874|NCT01536418|584135586|FG001|Overall Study|Lack of Efficacy|16|||
161752875|NCT01536418|584135585|FG000|Overall Study|Adverse Event|9|||
161752876|NCT01536418|584135586|FG001|Overall Study|Adverse Event|4|||
161752877|NCT01536418|584135585|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
161752878|NCT01536418|584135586|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
161752879|NCT01536418|584135585|FG000|Overall Study|Withdrawal by Subject|5|||
161752880|NCT01536418|584135586|FG001|Overall Study|Withdrawal by Subject|3|||
161752881|NCT00711412|584135591|FG000|Induction Treatment|Death|2|||
161968608|NCT00521599|584933729|FG000|Overall Study|Treatment Failure|8|||
161968609|NCT00521599|584933730|FG001|Overall Study|Treatment Failure|9|||
161968610|NCT00521599|584933731|FG002|Overall Study|Treatment Failure|22|||
161968611|NCT00521599|584933729|FG000|Overall Study|Lost to Follow-up|2|||
161968612|NCT00521599|584933730|FG001|Overall Study|Lost to Follow-up|1|||
161968613|NCT00521599|584933731|FG002|Overall Study|Lost to Follow-up|2|||
161968614|NCT00521599|584933729|FG000|Overall Study|Withdrawal by Subject|3|||
161968615|NCT00521599|584933730|FG001|Overall Study|Withdrawal by Subject|5|||
161968616|NCT00521599|584933731|FG002|Overall Study|Withdrawal by Subject|1|||
161968617|NCT00521599|584933729|FG000|Overall Study|Withdrawal by subject treatment related|3|||
161968618|NCT00521599|584933730|FG001|Overall Study|Withdrawal by subject treatment related|1|||
161968619|NCT00521599|584933731|FG002|Overall Study|Withdrawal by subject treatment related|2|||
161968620|NCT00521599|584933729|FG000|Overall Study|Protocol Violation|2|||
161968621|NCT00521599|584933730|FG001|Overall Study|Protocol Violation|4|||
161968622|NCT00521599|584933731|FG002|Overall Study|Protocol Violation|2|||
161968623|NCT00521599|584933729|FG000|Overall Study|Did not meet protocol eligibility|2|||
161968624|NCT00521599|584933730|FG001|Overall Study|Did not meet protocol eligibility|2|||
161968625|NCT00521599|584933731|FG002|Overall Study|Did not meet protocol eligibility|1|||
161968626|NCT01778049|584933735|FG000|Open Label Treatment Period|Adverse Event|5|||
161968627|NCT01778049|584933736|FG001|Open Label Treatment Period|Adverse Event|15|||
161968628|NCT01778049|584933737|FG002|Open Label Treatment Period|Adverse Event|0|||
161968629|NCT01778049|584933738|FG003|Open Label Treatment Period|Adverse Event|0|||
161968630|NCT01778049|584933739|FG004|Open Label Treatment Period|Adverse Event|0|||
161968631|NCT01778049|584933740|FG005|Open Label Treatment Period|Adverse Event|0|||
161968632|NCT01778049|584933735|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
161968633|NCT01778049|584933736|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
161968634|NCT01778049|584933737|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
161968635|NCT01778049|584933738|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
161968636|NCT01778049|584933739|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
161968637|NCT01778049|584933740|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
161968638|NCT01778049|584933735|FG000|Open Label Treatment Period|Protocol Violation|5|||
161968639|NCT01778049|584933736|FG001|Open Label Treatment Period|Protocol Violation|5|||
161968640|NCT01778049|584933737|FG002|Open Label Treatment Period|Protocol Violation|0|||
161968641|NCT01778049|584933738|FG003|Open Label Treatment Period|Protocol Violation|0|||
161968642|NCT01778049|584933739|FG004|Open Label Treatment Period|Protocol Violation|0|||
161968643|NCT01778049|584933740|FG005|Open Label Treatment Period|Protocol Violation|0|||
161968644|NCT01778049|584933735|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
161968645|NCT01778049|584933736|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
161968646|NCT01778049|584933737|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
161968647|NCT01778049|584933738|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
161968648|NCT01778049|584933739|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
161968649|NCT01778049|584933740|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
161968650|NCT01778049|584933735|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
161968651|NCT01778049|584933736|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
161968652|NCT01778049|584933737|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
161968653|NCT01778049|584933738|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
161968654|NCT01778049|584933739|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
161968655|NCT01778049|584933740|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
161752882|NCT00711412|584135591|FG000|Induction Treatment|Adverse Event|1|||
161752883|NCT00711412|584135591|FG000|Induction Treatment|Other|1|||
161752884|NCT00711412|584135591|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
161752885|NCT00711412|584135591|FG000|Evaluated for Combination Treatment|Death|1|||
161752886|NCT00711412|584135591|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
161752887|NCT00711412|584135591|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
161752888|NCT00711412|584135591|FG000|Combination Treatment|Progressive Disease|1|||
161752889|NCT00711412|584135591|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
161752890|NCT00711412|584135591|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
161968656|NCT01778049|584933735|FG000|Open Label Treatment Period|Not treated|2|||
161968657|NCT01778049|584933736|FG001|Open Label Treatment Period|Not treated|1|||
161968658|NCT01778049|584933737|FG002|Open Label Treatment Period|Not treated|0|||
161968659|NCT01778049|584933738|FG003|Open Label Treatment Period|Not treated|0|||
161968660|NCT01778049|584933739|FG004|Open Label Treatment Period|Not treated|0|||
161968661|NCT01778049|584933740|FG005|Open Label Treatment Period|Not treated|0|||
161968662|NCT01778049|584933735|FG000|Open Label Treatment Period|Other reason not defined above|77|||
161968663|NCT01778049|584933736|FG001|Open Label Treatment Period|Other reason not defined above|94|||
161968664|NCT01778049|584933737|FG002|Open Label Treatment Period|Other reason not defined above|0|||
161968665|NCT01778049|584933738|FG003|Open Label Treatment Period|Other reason not defined above|0|||
161968666|NCT01778049|584933739|FG004|Open Label Treatment Period|Other reason not defined above|0|||
161968667|NCT01778049|584933740|FG005|Open Label Treatment Period|Other reason not defined above|0|||
161968668|NCT01778049|584933735|FG000|Double Blind Treatment Period|Adverse Event|0|||
161968669|NCT01778049|584933736|FG001|Double Blind Treatment Period|Adverse Event|0|||
161968670|NCT01778049|584933737|FG002|Double Blind Treatment Period|Adverse Event|4|||
161968671|NCT01778049|584933738|FG003|Double Blind Treatment Period|Adverse Event|5|||
161968672|NCT01778049|584933739|FG004|Double Blind Treatment Period|Adverse Event|3|||
161968673|NCT01778049|584933740|FG005|Double Blind Treatment Period|Adverse Event|2|||
161968674|NCT01778049|584933735|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
161968675|NCT01778049|584933736|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
161968676|NCT01778049|584933737|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
161968677|NCT01778049|584933738|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
161968678|NCT01778049|584933739|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
161968679|NCT01778049|584933740|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
161752891|NCT00711412|584135591|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
161752892|NCT00711412|584135591|FG000|Evaluation for Response and Surgery|Death|1|||
161752893|NCT00711412|584135591|FG000|Survival Follow up Until Death|Other|12|||
161752894|NCT02234050|584135596|FG000|Overall Study|Lack of Efficacy|38|||
161752895|NCT02234050|584135597|FG001|Overall Study|Lack of Efficacy|22|||
161752896|NCT02234050|584135596|FG000|Overall Study|Adverse Event|13|||
161752897|NCT02234050|584135597|FG001|Overall Study|Adverse Event|1|||
161752898|NCT02234050|584135596|FG000|Overall Study|Withdrawal by Subject|4|||
161752899|NCT02234050|584135597|FG001|Overall Study|Withdrawal by Subject|2|||
161752900|NCT02234050|584135596|FG000|Overall Study|Sponsor's decision|6|||
161752901|NCT02234050|584135597|FG001|Overall Study|Sponsor's decision|0|||
161752902|NCT02498392|584135599|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
161752903|NCT02498392|584135600|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
161752904|NCT02498392|584135599|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
161752905|NCT02498392|584135600|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
161752906|NCT02498392|584135599|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
161752907|NCT02498392|584135600|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
161752908|NCT02498392|584135599|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
161752909|NCT02498392|584135600|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
161752910|NCT02498392|584135599|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
161752911|NCT02498392|584135600|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
161752912|NCT02498392|584135599|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
161752913|NCT02498392|584135600|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
161752914|NCT06073054|584135601|FG000|Overall Study|Withdrawal by Subject|2|||
161752915|NCT00981292|584135604|FG000|Day 1|Protocol Violation|1|||
161752916|NCT00981292|584135605|FG001|Day 1|Protocol Violation|0|||
161752917|NCT00981292|584135606|FG002|Day 1|Protocol Violation|0|||
161752918|NCT00981292|584135607|FG003|Day 1|Protocol Violation|0|||
161752919|NCT00981292|584135608|FG004|Day 1|Protocol Violation|0|||
161752920|NCT00981292|584135609|FG005|Day 1|Protocol Violation|2|||
161752921|NCT00981292|584135604|FG000|Day 2|Protocol Violation|2|||
161752922|NCT00981292|584135605|FG001|Day 2|Protocol Violation|0|||
161752923|NCT00981292|584135606|FG002|Day 2|Protocol Violation|0|||
161752924|NCT00981292|584135607|FG003|Day 2|Protocol Violation|0|||
161752925|NCT00981292|584135608|FG004|Day 2|Protocol Violation|0|||
161752926|NCT00981292|584135609|FG005|Day 2|Protocol Violation|0|||
161752927|NCT00981292|584135604|FG000|Day 3|Protocol Violation|0|||
161752928|NCT00981292|584135605|FG001|Day 3|Protocol Violation|0|||
161752929|NCT00981292|584135606|FG002|Day 3|Protocol Violation|0|||
161752930|NCT00981292|584135607|FG003|Day 3|Protocol Violation|0|||
161752931|NCT00981292|584135608|FG004|Day 3|Protocol Violation|0|||
161752932|NCT00981292|584135609|FG005|Day 3|Protocol Violation|1|||
161752933|NCT02782104|584135612|FG000|Overall Study|Other|215|||
161752934|NCT02782104|584135612|FG000|Overall Study|Induction Day 28 Non Responder|9|||
161752935|NCT02782104|584135612|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161752936|NCT02782104|584135612|FG000|Overall Study|Death|8|||
161752937|NCT02782104|584135612|FG000|Overall Study|Pregnancy|6|||
161752938|NCT02782104|584135612|FG000|Overall Study|Withdrawal by Subject|63|||
161752939|NCT02782104|584135612|FG000|Overall Study|Protocol Violation|7|||
161752940|NCT02782104|584135612|FG000|Overall Study|Lack of Efficacy|61|||
161752941|NCT02782104|584135612|FG000|Overall Study|Lost to Follow-up|23|||
161752942|NCT02782104|584135612|FG000|Overall Study|Adverse Event|74|||
161752943|NCT02438787|584135613|FG000|Overall Study|Adverse Event|1|||
161752944|NCT02438787|584135614|FG001|Overall Study|Adverse Event|0|||
161752945|NCT02438787|584135615|FG002|Overall Study|Adverse Event|2|||
161752946|NCT02438787|584135613|FG000|Overall Study|Lack of Efficacy|1|||
161752947|NCT02438787|584135614|FG001|Overall Study|Lack of Efficacy|2|||
161752948|NCT02438787|584135615|FG002|Overall Study|Lack of Efficacy|0|||
161752949|NCT02438787|584135613|FG000|Overall Study|Lost to Follow-up|0|||
161752950|NCT02438787|584135614|FG001|Overall Study|Lost to Follow-up|1|||
161752951|NCT02438787|584135615|FG002|Overall Study|Lost to Follow-up|0|||
161752952|NCT02438787|584135613|FG000|Overall Study|Protocol Violation|0|||
161752953|NCT02438787|584135614|FG001|Overall Study|Protocol Violation|0|||
161752954|NCT02438787|584135615|FG002|Overall Study|Protocol Violation|1|||
161968680|NCT01778049|584933735|FG000|Double Blind Treatment Period|Protocol Violation|0|||
161968681|NCT01778049|584933736|FG001|Double Blind Treatment Period|Protocol Violation|0|||
161968682|NCT01778049|584933737|FG002|Double Blind Treatment Period|Protocol Violation|2|||
161968683|NCT01778049|584933738|FG003|Double Blind Treatment Period|Protocol Violation|0|||
161968684|NCT01778049|584933739|FG004|Double Blind Treatment Period|Protocol Violation|0|||
161968685|NCT01778049|584933740|FG005|Double Blind Treatment Period|Protocol Violation|0|||
161968686|NCT01778049|584933735|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
161968687|NCT01778049|584933736|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
161968688|NCT01778049|584933737|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
161968689|NCT01778049|584933738|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
161968690|NCT01778049|584933739|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
161968691|NCT01778049|584933740|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
161968692|NCT01778049|584933735|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
161968693|NCT01778049|584933736|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
161968694|NCT01778049|584933737|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
161968695|NCT01778049|584933738|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
161968696|NCT01778049|584933739|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
161968697|NCT01778049|584933740|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
161968698|NCT01778049|584933735|FG000|Double Blind Treatment Period|Not treated|0|||
161752955|NCT02438787|584135613|FG000|Overall Study|Withdrawal by Subject|15|||
161752956|NCT02438787|584135614|FG001|Overall Study|Withdrawal by Subject|7|||
161752957|NCT02438787|584135615|FG002|Overall Study|Withdrawal by Subject|10|||
161752958|NCT02438787|584135613|FG000|Overall Study|Study discontinued by sponsor|64|||
161752959|NCT02438787|584135614|FG001|Overall Study|Study discontinued by sponsor|72|||
161752960|NCT02438787|584135615|FG002|Overall Study|Study discontinued by sponsor|69|||
161752961|NCT02438787|584135613|FG000|Overall Study|Other|0|||
161752962|NCT02438787|584135614|FG001|Overall Study|Other|1|||
161752963|NCT02438787|584135615|FG002|Overall Study|Other|0|||
161752964|NCT02438787|584135613|FG000|Overall Study|Site terminated by sponsor|0|||
161752965|NCT02438787|584135614|FG001|Overall Study|Site terminated by sponsor|0|||
161752966|NCT02438787|584135615|FG002|Overall Study|Site terminated by sponsor|1|||
161752967|NCT03412565|584135616|FG000|Overall Study|Lost to Follow-up|0|||
161752968|NCT03412565|584135617|FG001|Overall Study|Lost to Follow-up|0|||
161752969|NCT03412565|584135618|FG002|Overall Study|Lost to Follow-up|1|||
161752970|NCT03412565|584135619|FG003|Overall Study|Lost to Follow-up|0|||
161752971|NCT03412565|584135616|FG000|Overall Study|Physician Decision|0|||
161752972|NCT03412565|584135617|FG001|Overall Study|Physician Decision|0|||
161752973|NCT03412565|584135618|FG002|Overall Study|Physician Decision|0|||
161752974|NCT03412565|584135619|FG003|Overall Study|Physician Decision|1|||
161752975|NCT03412565|584135616|FG000|Overall Study|Withdrawal by Subject|0|||
161752976|NCT03412565|584135617|FG001|Overall Study|Withdrawal by Subject|4|||
161752977|NCT03412565|584135618|FG002|Overall Study|Withdrawal by Subject|5|||
161752978|NCT03412565|584135619|FG003|Overall Study|Withdrawal by Subject|5|||
161752979|NCT03412565|584135616|FG000|Overall Study|Death|1|||
161752980|NCT03412565|584135617|FG001|Overall Study|Death|3|||
161752981|NCT03412565|584135618|FG002|Overall Study|Death|4|||
161752982|NCT03412565|584135619|FG003|Overall Study|Death|5|||
161752983|NCT03412565|584135616|FG000|Overall Study|Data collection ended|0|||
161752984|NCT03412565|584135617|FG001|Overall Study|Data collection ended|41|||
161752985|NCT03412565|584135618|FG002|Overall Study|Data collection ended|41|||
161752986|NCT03412565|584135619|FG003|Overall Study|Data collection ended|40|||
161752987|NCT02280096|584135620|FG000|Overall Study|Pregnancy|1|||
161752988|NCT02280096|584135621|FG001|Overall Study|Pregnancy|0|||
161752989|NCT02280096|584135620|FG000|Overall Study|Functional neurological disorder|1|||
161752990|NCT02280096|584135621|FG001|Overall Study|Functional neurological disorder|0|||
161752991|NCT02280096|584135620|FG000|Overall Study|Lack of attachment|0|||
161752992|NCT02280096|584135621|FG001|Overall Study|Lack of attachment|1|||
161752993|NCT00246376|584135626|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
161752994|NCT00246376|584135627|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
161752995|NCT00246376|584135628|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
161752996|NCT00246376|584135629|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
161752997|NCT00246376|584135630|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
161752998|NCT00246376|584135626|FG000|Overall Study|Adverse Event|2|||
161968699|NCT01778049|584933736|FG001|Double Blind Treatment Period|Not treated|0|||
161968700|NCT01778049|584933737|FG002|Double Blind Treatment Period|Not treated|0|||
161752999|NCT00246376|584135627|FG001|Overall Study|Adverse Event|3|||
161753000|NCT00246376|584135628|FG002|Overall Study|Adverse Event|1|||
161753001|NCT00246376|584135629|FG003|Overall Study|Adverse Event|3|||
161753002|NCT00246376|584135630|FG004|Overall Study|Adverse Event|1|||
161753003|NCT00246376|584135626|FG000|Overall Study|Lost to Follow-up|2|||
161753004|NCT00246376|584135627|FG001|Overall Study|Lost to Follow-up|11|||
161968701|NCT01778049|584933738|FG003|Double Blind Treatment Period|Not treated|2|||
161753005|NCT00246376|584135628|FG002|Overall Study|Lost to Follow-up|11|||
161753006|NCT00246376|584135629|FG003|Overall Study|Lost to Follow-up|16|||
161753007|NCT00246376|584135630|FG004|Overall Study|Lost to Follow-up|13|||
161753008|NCT01872897|584135635|FG000|Overall Study|Withdrawal by Subject|1|||
161968702|NCT01778049|584933739|FG004|Double Blind Treatment Period|Not treated|2|||
161753009|NCT01872897|584135636|FG001|Overall Study|Withdrawal by Subject|0|||
161753010|NCT01849562|584135644|FG000|Overall Study|Lost to Follow-up|1|||
161753011|NCT01849562|584135645|FG001|Overall Study|Lost to Follow-up|0|||
161753012|NCT01849562|584135646|FG002|Overall Study|Lost to Follow-up|0|||
161753013|NCT01849562|584135644|FG000|Overall Study|Non-compliance with Study Drug|1|||
161753014|NCT01849562|584135645|FG001|Overall Study|Non-compliance with Study Drug|0|||
161753015|NCT01849562|584135646|FG002|Overall Study|Non-compliance with Study Drug|0|||
161753016|NCT00693693|584135650|FG000|Overall Study|Lost to Follow-up|1|||
161753017|NCT00693693|584135651|FG001|Overall Study|Lost to Follow-up|1|||
161753018|NCT00693693|584135652|FG002|Overall Study|Lost to Follow-up|2|||
161753019|NCT04599972|584135653|FG000|Overall Study|Withdrawal by Subject|6|||
161753020|NCT04599972|584135654|FG001|Overall Study|Withdrawal by Subject|1|||
161753021|NCT04599972|584135653|FG000|Overall Study|Adverse Event|1|||
161753022|NCT04599972|584135654|FG001|Overall Study|Adverse Event|1|||
161753023|NCT04599972|584135653|FG000|Overall Study|Lost to Follow-up|1|||
161753024|NCT04599972|584135654|FG001|Overall Study|Lost to Follow-up|6|||
161753025|NCT04599972|584135653|FG000|Overall Study|Protocol Violation|1|||
161753026|NCT04599972|584135654|FG001|Overall Study|Protocol Violation|0|||
161753027|NCT04599972|584135653|FG000|Overall Study|Other reason|1|||
161753028|NCT04599972|584135654|FG001|Overall Study|Other reason|0|||
161753029|NCT01025232|584135662|FG000|Overall Study|Study drug no longer available|3|||
161753030|NCT01025232|584135663|FG001|Overall Study|Study drug no longer available|6|||
161753031|NCT00373880|584135664|FG000|Overall Study|Physician Decision|3|||
161753032|NCT00373880|584135664|FG000|Overall Study|Arrested|1|||
161753033|NCT00373880|584135664|FG000|Overall Study|Protocol Violation|14|||
161753034|NCT03748420|584135665|FG000|Overall Study|No 12 month medication adherence data available|0|||
161753035|NCT03748420|584135666|FG001|Overall Study|No 12 month medication adherence data available|1|||
161753036|NCT03748420|584135665|FG000|Overall Study|Death|24|||
161753037|NCT03748420|584135666|FG001|Overall Study|Death|28|||
161753038|NCT03748420|584135665|FG000|Overall Study|Lost to Follow-up|231|||
161753039|NCT03748420|584135666|FG001|Overall Study|Lost to Follow-up|230|||
161753040|NCT01347073|584135668|FG000|Overall Study|Adverse Event|1|||
161753041|NCT01347073|584135668|FG000|Overall Study|Liver Transplant|1|||
161753042|NCT01634100|584135671|FG000|Overall Study|Withdrawal by Subject|1|||
161753043|NCT01634100|584135672|FG001|Overall Study|Withdrawal by Subject|0|||
161753044|NCT01634100|584135673|FG002|Overall Study|Withdrawal by Subject|1|||
161753045|NCT01634100|584135674|FG003|Overall Study|Withdrawal by Subject|0|||
161753046|NCT01634100|584135675|FG004|Overall Study|Withdrawal by Subject|0|||
161753047|NCT01634100|584135676|FG005|Overall Study|Withdrawal by Subject|0|||
161753048|NCT00338806|584135677|FG000|Acute Phase|Withdrawal by Subject|0|||
161753049|NCT00338806|584135678|FG001|Acute Phase|Withdrawal by Subject|1|||
161753050|NCT00338806|584135677|FG000|Follow-up|Lost to Follow-up|1|||
161753051|NCT00338806|584135678|FG001|Follow-up|Lost to Follow-up|3|||
161753052|NCT01975376|584135679|FG000|Overall Study|Adverse Event|5|||
161753053|NCT01975376|584135680|FG001|Overall Study|Adverse Event|5|||
161753054|NCT01975376|584135679|FG000|Overall Study|Death|65|||
161753055|NCT01975376|584135680|FG001|Overall Study|Death|72|||
161753056|NCT01975376|584135679|FG000|Overall Study|Lost to Follow-up|70|||
161753057|NCT01975376|584135680|FG001|Overall Study|Lost to Follow-up|66|||
161753058|NCT01975376|584135679|FG000|Overall Study|Withdrew consent|68|||
161753059|NCT01975376|584135680|FG001|Overall Study|Withdrew consent|62|||
161753060|NCT01975376|584135679|FG000|Overall Study|Other|2|||
161753061|NCT01975376|584135680|FG001|Overall Study|Other|4|||
161753062|NCT01975376|584135679|FG000|Overall Study|Randomized, Not Treated|16|||
161753063|NCT01975376|584135680|FG001|Overall Study|Randomized, Not Treated|8|||
161753064|NCT01451398|584135684|FG000|Overall Study|Adverse Event|7|||
161753065|NCT01451398|584135685|FG001|Overall Study|Adverse Event|9|||
161753066|NCT01451398|584135684|FG000|Overall Study|Protocol Violation|1|||
161753067|NCT01451398|584135685|FG001|Overall Study|Protocol Violation|2|||
161753068|NCT01451398|584135684|FG000|Overall Study|Physician Decision|1|||
161753069|NCT01451398|584135685|FG001|Overall Study|Physician Decision|1|||
161753070|NCT01451398|584135684|FG000|Overall Study|Withdrawal by Subject|10|||
161753071|NCT01451398|584135685|FG001|Overall Study|Withdrawal by Subject|14|||
161753072|NCT01451398|584135684|FG000|Overall Study|Lost to Follow-up|6|||
161753073|NCT01451398|584135685|FG001|Overall Study|Lost to Follow-up|4|||
161753074|NCT01451398|584135684|FG000|Overall Study|Non-compliance with study drug|1|||
161968703|NCT01778049|584933740|FG005|Double Blind Treatment Period|Not treated|0|||
161753075|NCT01451398|584135685|FG001|Overall Study|Non-compliance with study drug|3|||
161753076|NCT01451398|584135684|FG000|Overall Study|Non-compliance with protocol|1|||
161753077|NCT01451398|584135685|FG001|Overall Study|Non-compliance with protocol|1|||
161753078|NCT01451398|584135684|FG000|Overall Study|Moved out of country|0|||
161753079|NCT01451398|584135685|FG001|Overall Study|Moved out of country|1|||
161753080|NCT01451398|584135684|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
161753081|NCT01451398|584135685|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
161753082|NCT01451398|584135684|FG000|Overall Study|Lack of Efficacy|0|||
161753083|NCT01451398|584135685|FG001|Overall Study|Lack of Efficacy|1|||
161968704|NCT01778049|584933735|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
161968705|NCT01778049|584933736|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
161968706|NCT01778049|584933737|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
161968707|NCT01778049|584933738|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
161968708|NCT01778049|584933739|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
161968709|NCT01778049|584933740|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
161968710|NCT02186652|584933741|FG000|Overall Study|Lost to Follow-up|2|||
161753084|NCT04449276|584135686|FG000|Overall Study|Adverse Event|1|||
161753085|NCT04449276|584135687|FG001|Overall Study|Adverse Event|2|||
161753086|NCT04449276|584135688|FG002|Overall Study|Adverse Event|0|||
161753087|NCT04449276|584135689|FG003|Overall Study|Adverse Event|0|||
161753088|NCT04449276|584135690|FG004|Overall Study|Adverse Event|2|||
161753089|NCT04449276|584135691|FG005|Overall Study|Adverse Event|0|||
161753090|NCT04449276|584135692|FG006|Overall Study|Adverse Event|0|||
161968711|NCT02186652|584933742|FG001|Overall Study|Lost to Follow-up|0|||
161968712|NCT00149994|584933746|FG000|Overall Study|Administrative problems:|1|||
161968713|NCT00149994|584933747|FG001|Overall Study|Administrative problems:|0|||
161968714|NCT00149994|584933746|FG000|Overall Study|Protocol Violation|0|||
161968715|NCT00149994|584933747|FG001|Overall Study|Protocol Violation|1|||
161968716|NCT00503776|584933752|FG000|Overall Study|Withdrawal by Subject|1|||
161968717|NCT00503776|584933753|FG001|Overall Study|Withdrawal by Subject|0|||
161968718|NCT00503776|584933754|FG002|Overall Study|Withdrawal by Subject|1|||
161968719|NCT00503776|584933755|FG003|Overall Study|Withdrawal by Subject|1|||
162032787|NCT03761797|585177477|FG000|Overall Study|Insufficient effectives|2|||
161753091|NCT04449276|584135693|FG007|Overall Study|Adverse Event|1|||
161753092|NCT04449276|584135686|FG000|Overall Study|Withdrawal by Subject|2|||
161753093|NCT04449276|584135687|FG001|Overall Study|Withdrawal by Subject|0|||
161753094|NCT04449276|584135688|FG002|Overall Study|Withdrawal by Subject|0|||
161753095|NCT04449276|584135689|FG003|Overall Study|Withdrawal by Subject|1|||
161753096|NCT04449276|584135690|FG004|Overall Study|Withdrawal by Subject|0|||
161753097|NCT04449276|584135691|FG005|Overall Study|Withdrawal by Subject|0|||
161753098|NCT04449276|584135692|FG006|Overall Study|Withdrawal by Subject|0|||
161753099|NCT04449276|584135693|FG007|Overall Study|Withdrawal by Subject|0|||
161753100|NCT04449276|584135686|FG000|Overall Study|Other|0|||
161753101|NCT04449276|584135687|FG001|Overall Study|Other|2|||
161753102|NCT04449276|584135688|FG002|Overall Study|Other|3|||
161753103|NCT04449276|584135689|FG003|Overall Study|Other|2|||
161753104|NCT04449276|584135690|FG004|Overall Study|Other|0|||
161753105|NCT04449276|584135691|FG005|Overall Study|Other|0|||
161753106|NCT04449276|584135692|FG006|Overall Study|Other|0|||
161753107|NCT04449276|584135693|FG007|Overall Study|Other|1|||
161753108|NCT01614795|584135694|FG000|Overall Study|Adverse Event|0|||
161753109|NCT01614795|584135695|FG001|Overall Study|Adverse Event|0|||
161753110|NCT01614795|584135696|FG002|Overall Study|Adverse Event|1|||
161753111|NCT01614795|584135697|FG003|Overall Study|Adverse Event|1|||
161753112|NCT01614795|584135694|FG000|Overall Study|Lack of Efficacy|10|||
161753113|NCT01614795|584135695|FG001|Overall Study|Lack of Efficacy|10|||
161753114|NCT01614795|584135696|FG002|Overall Study|Lack of Efficacy|9|||
161753115|NCT01614795|584135697|FG003|Overall Study|Lack of Efficacy|8|||
161753116|NCT01614795|584135694|FG000|Overall Study|Physician Decision|1|||
161753117|NCT01614795|584135695|FG001|Overall Study|Physician Decision|0|||
161753118|NCT01614795|584135696|FG002|Overall Study|Physician Decision|1|||
161753119|NCT01614795|584135697|FG003|Overall Study|Physician Decision|1|||
161753120|NCT01614795|584135694|FG000|Overall Study|Withdrawal by Subject|0|||
161753121|NCT01614795|584135695|FG001|Overall Study|Withdrawal by Subject|1|||
161753122|NCT01614795|584135696|FG002|Overall Study|Withdrawal by Subject|0|||
161753123|NCT01614795|584135697|FG003|Overall Study|Withdrawal by Subject|2|||
161753124|NCT01614795|584135694|FG000|Overall Study|Ineligible|0|||
161753125|NCT01614795|584135695|FG001|Overall Study|Ineligible|1|||
161753126|NCT01614795|584135696|FG002|Overall Study|Ineligible|0|||
161753127|NCT01614795|584135697|FG003|Overall Study|Ineligible|0|||
161753128|NCT00701103|584135698|FG000|Overall Study|Adverse Event|0|||
161753129|NCT00701103|584135699|FG001|Overall Study|Adverse Event|0|||
161753130|NCT00701103|584135700|FG002|Overall Study|Adverse Event|1|||
161753131|NCT00701103|584135701|FG003|Overall Study|Adverse Event|1|||
161753132|NCT00701103|584135702|FG004|Overall Study|Adverse Event|0|||
161753133|NCT00701103|584135703|FG005|Overall Study|Adverse Event|1|||
161753134|NCT00701103|584135704|FG006|Overall Study|Adverse Event|1|||
161968720|NCT00503776|584933752|FG000|Overall Study|Physician Decision|0|||
162032788|NCT03761797|585177477|FG000|Overall Study|Excessive alcohol intake|1|||
162032789|NCT00266877|585177478|FG000|Overall Study|Death|1|||
161753135|NCT00701103|584135705|FG007|Overall Study|Adverse Event|0|||
161753136|NCT00701103|584135706|FG008|Overall Study|Adverse Event|0|||
161753137|NCT00701103|584135707|FG009|Overall Study|Adverse Event|2|||
161753138|NCT00701103|584135708|FG010|Overall Study|Adverse Event|0|||
161753139|NCT00701103|584135698|FG000|Overall Study|Progressive Disease|5|||
161753140|NCT00701103|584135699|FG001|Overall Study|Progressive Disease|2|||
161968721|NCT00503776|584933753|FG001|Overall Study|Physician Decision|0|||
161968722|NCT00503776|584933754|FG002|Overall Study|Physician Decision|1|||
161968723|NCT00503776|584933755|FG003|Overall Study|Physician Decision|1|||
161968724|NCT00107315|584933756|FG000|Overall Study|Disease Progression|9|||
161753141|NCT00701103|584135700|FG002|Overall Study|Progressive Disease|6|||
161753142|NCT00701103|584135701|FG003|Overall Study|Progressive Disease|5|||
161753143|NCT00701103|584135702|FG004|Overall Study|Progressive Disease|6|||
161753144|NCT00701103|584135703|FG005|Overall Study|Progressive Disease|5|||
161753145|NCT00701103|584135704|FG006|Overall Study|Progressive Disease|7|||
161753146|NCT00701103|584135705|FG007|Overall Study|Progressive Disease|7|||
161753147|NCT00701103|584135706|FG008|Overall Study|Progressive Disease|8|||
161753148|NCT00701103|584135707|FG009|Overall Study|Progressive Disease|8|||
161753149|NCT00701103|584135708|FG010|Overall Study|Progressive Disease|11|||
161753150|NCT00701103|584135698|FG000|Overall Study|Withdrawal by Subject|0|||
161753151|NCT00701103|584135699|FG001|Overall Study|Withdrawal by Subject|1|||
161753152|NCT00701103|584135700|FG002|Overall Study|Withdrawal by Subject|1|||
161753153|NCT00701103|584135701|FG003|Overall Study|Withdrawal by Subject|0|||
161753154|NCT00701103|584135702|FG004|Overall Study|Withdrawal by Subject|0|||
161753155|NCT00701103|584135703|FG005|Overall Study|Withdrawal by Subject|0|||
161753156|NCT00701103|584135704|FG006|Overall Study|Withdrawal by Subject|0|||
161753157|NCT00701103|584135705|FG007|Overall Study|Withdrawal by Subject|0|||
161753158|NCT00701103|584135706|FG008|Overall Study|Withdrawal by Subject|0|||
161753159|NCT00701103|584135707|FG009|Overall Study|Withdrawal by Subject|0|||
161753160|NCT00701103|584135708|FG010|Overall Study|Withdrawal by Subject|0|||
161753161|NCT00701103|584135698|FG000|Overall Study|Other|0|||
161753162|NCT00701103|584135699|FG001|Overall Study|Other|0|||
161753163|NCT00701103|584135700|FG002|Overall Study|Other|0|||
161753164|NCT00701103|584135701|FG003|Overall Study|Other|0|||
161753165|NCT00701103|584135702|FG004|Overall Study|Other|0|||
161753166|NCT00701103|584135703|FG005|Overall Study|Other|0|||
161753167|NCT00701103|584135704|FG006|Overall Study|Other|0|||
161753168|NCT00701103|584135705|FG007|Overall Study|Other|0|||
161753169|NCT00701103|584135706|FG008|Overall Study|Other|1|||
161753170|NCT00701103|584135707|FG009|Overall Study|Other|1|||
161753171|NCT00701103|584135708|FG010|Overall Study|Other|0|||
161753172|NCT00179517|584135709|FG000|Overall Study|Withdrawal by Subject|2|||
161753173|NCT00179517|584135710|FG001|Overall Study|Withdrawal by Subject|1|||
161753174|NCT01915095|584135711|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
161753175|NCT01915095|584135712|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
161753176|NCT01915095|584135713|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
161753177|NCT01915095|584135714|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
161753178|NCT01915095|584135715|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
161753179|NCT00565812|584135716|FG000|Overall Study|Death|2|||
161753180|NCT00565812|584135717|FG001|Overall Study|Death|1|||
161753181|NCT00565812|584135718|FG002|Overall Study|Death|3|||
161753182|NCT00565812|584135716|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
161753183|NCT00565812|584135717|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
161753184|NCT00565812|584135718|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
161753185|NCT00565812|584135716|FG000|Overall Study|Lost to Follow-up|10|||
161753186|NCT00565812|584135717|FG001|Overall Study|Lost to Follow-up|8|||
161753187|NCT00565812|584135718|FG002|Overall Study|Lost to Follow-up|8|||
161753188|NCT00565812|584135716|FG000|Overall Study|Withdrawal by Subject|58|||
161753189|NCT00565812|584135717|FG001|Overall Study|Withdrawal by Subject|47|||
161753190|NCT00565812|584135718|FG002|Overall Study|Withdrawal by Subject|48|||
161753191|NCT00565812|584135716|FG000|Overall Study|Work Schedule|5|||
161753192|NCT00565812|584135717|FG001|Overall Study|Work Schedule|3|||
161753193|NCT00565812|584135718|FG002|Overall Study|Work Schedule|1|||
161753194|NCT00565812|584135716|FG000|Overall Study|Protocol Violation|2|||
161753195|NCT00565812|584135717|FG001|Overall Study|Protocol Violation|6|||
161753196|NCT00565812|584135718|FG002|Overall Study|Protocol Violation|4|||
161753197|NCT00565812|584135716|FG000|Overall Study|Adverse Event|41|||
161753198|NCT00565812|584135717|FG001|Overall Study|Adverse Event|54|||
161753199|NCT00565812|584135718|FG002|Overall Study|Adverse Event|40|||
161753200|NCT00565812|584135716|FG000|Overall Study|Jury Duty|1|||
161968725|NCT00107315|584933756|FG000|Overall Study|Adverse Event|4|||
161968726|NCT00107315|584933756|FG000|Overall Study|Withdrawal by Subject|2|||
161968727|NCT02509039|584933759|FG000|Overall Study|Adverse Event|0|||
161968728|NCT02509039|584933760|FG001|Overall Study|Adverse Event|1|||
161968729|NCT02509039|584933761|FG002|Overall Study|Adverse Event|1|||
161753201|NCT00565812|584135717|FG001|Overall Study|Jury Duty|0|||
161753202|NCT00565812|584135718|FG002|Overall Study|Jury Duty|0|||
161753203|NCT00565812|584135716|FG000|Overall Study|Relocated Out of Area|5|||
161753204|NCT00565812|584135717|FG001|Overall Study|Relocated Out of Area|8|||
161753205|NCT00565812|584135718|FG002|Overall Study|Relocated Out of Area|9|||
161753206|NCT00565812|584135716|FG000|Overall Study|Sponsor Decision|1|||
161753207|NCT00565812|584135717|FG001|Overall Study|Sponsor Decision|5|||
161753208|NCT00565812|584135718|FG002|Overall Study|Sponsor Decision|1|||
161968730|NCT02509039|584933762|FG003|Overall Study|Adverse Event|1|||
161753209|NCT00565812|584135716|FG000|Overall Study|Domestic Reasons|7|||
161753210|NCT00565812|584135717|FG001|Overall Study|Domestic Reasons|1|||
161968731|NCT02509039|584933759|FG000|Overall Study|Withdrawal by Subject|0|||
161753211|NCT00565812|584135718|FG002|Overall Study|Domestic Reasons|3|||
161753212|NCT00565812|584135716|FG000|Overall Study|Research Site Closure|6|||
161968732|NCT02509039|584933760|FG001|Overall Study|Withdrawal by Subject|0|||
161968733|NCT02509039|584933761|FG002|Overall Study|Withdrawal by Subject|1|||
161968734|NCT02509039|584933762|FG003|Overall Study|Withdrawal by Subject|0|||
161968735|NCT02509039|584933759|FG000|Overall Study|Progressive disease|2|||
161968736|NCT02509039|584933760|FG001|Overall Study|Progressive disease|2|||
161968737|NCT02509039|584933761|FG002|Overall Study|Progressive disease|1|||
161968738|NCT02509039|584933762|FG003|Overall Study|Progressive disease|5|||
161968739|NCT02509039|584933759|FG000|Overall Study|Study terminated by Sponsor|1|||
161968740|NCT02509039|584933760|FG001|Overall Study|Study terminated by Sponsor|0|||
161968741|NCT02509039|584933761|FG002|Overall Study|Study terminated by Sponsor|0|||
161968742|NCT02509039|584933762|FG003|Overall Study|Study terminated by Sponsor|0|||
161968743|NCT03943550|584933763|FG000|Overall Study|Adverse Event|0|||
161968744|NCT03943550|584933764|FG001|Overall Study|Adverse Event|0|||
162032790|NCT00266877|585177479|FG001|Overall Study|Death|1|||
162032791|NCT00266877|585177480|FG002|Overall Study|Death|1|||
162032792|NCT00266877|585177478|FG000|Overall Study|Adverse Event|6|||
162032793|NCT00266877|585177479|FG001|Overall Study|Adverse Event|4|||
162032794|NCT00266877|585177480|FG002|Overall Study|Adverse Event|1|||
162032795|NCT00266877|585177478|FG000|Overall Study|Physician Decision|2|||
162032796|NCT00266877|585177479|FG001|Overall Study|Physician Decision|1|||
162032797|NCT00266877|585177480|FG002|Overall Study|Physician Decision|1|||
162032798|NCT00266877|585177478|FG000|Overall Study|Withdrawal by Subject|3|||
162032799|NCT00266877|585177479|FG001|Overall Study|Withdrawal by Subject|1|||
162032800|NCT00266877|585177480|FG002|Overall Study|Withdrawal by Subject|1|||
162032801|NCT00266877|585177478|FG000|Overall Study|Disease Progression|72|||
162032802|NCT00266877|585177479|FG001|Overall Study|Disease Progression|37|||
162032803|NCT00266877|585177480|FG002|Overall Study|Disease Progression|23|||
162032804|NCT00266877|585177478|FG000|Overall Study|Symptomatic Deterioration|6|||
162032805|NCT00266877|585177479|FG001|Overall Study|Symptomatic Deterioration|3|||
162032806|NCT00266877|585177480|FG002|Overall Study|Symptomatic Deterioration|1|||
162032807|NCT00266877|585177478|FG000|Overall Study|Hospitalization|1|||
162032808|NCT00266877|585177479|FG001|Overall Study|Hospitalization|0|||
162032809|NCT00266877|585177480|FG002|Overall Study|Hospitalization|0|||
161753213|NCT00565812|584135717|FG001|Overall Study|Research Site Closure|1|||
161753214|NCT00565812|584135718|FG002|Overall Study|Research Site Closure|8|||
161753215|NCT00565812|584135716|FG000|Overall Study|Surgical Intervention|0|||
161753216|NCT00565812|584135717|FG001|Overall Study|Surgical Intervention|1|||
161753217|NCT00565812|584135718|FG002|Overall Study|Surgical Intervention|2|||
161753218|NCT00565812|584135716|FG000|Overall Study|Low Compliance|1|||
161753219|NCT00565812|584135717|FG001|Overall Study|Low Compliance|0|||
161753220|NCT00565812|584135718|FG002|Overall Study|Low Compliance|1|||
161753221|NCT00565812|584135716|FG000|Overall Study|Follow-up Visit Not Completed|2|||
161753222|NCT00565812|584135717|FG001|Overall Study|Follow-up Visit Not Completed|0|||
161753223|NCT00565812|584135718|FG002|Overall Study|Follow-up Visit Not Completed|1|||
161753224|NCT00565812|584135716|FG000|Overall Study|Physician Decision|2|||
161753225|NCT00565812|584135717|FG001|Overall Study|Physician Decision|0|||
161753226|NCT00565812|584135718|FG002|Overall Study|Physician Decision|0|||
161753227|NCT04857892|584135727|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
161753228|NCT04857892|584135728|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
161753229|NCT04857892|584135729|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
161753230|NCT04857892|584135730|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
161753231|NCT04857892|584135731|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
161753232|NCT04857892|584135727|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
161753233|NCT04857892|584135728|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
161753234|NCT04857892|584135729|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
161968745|NCT03943550|584933765|FG002|Overall Study|Adverse Event|1|||
161968746|NCT03943550|584933763|FG000|Overall Study|Lost to Follow-up|0|||
161968747|NCT03943550|584933764|FG001|Overall Study|Lost to Follow-up|0|||
161968748|NCT03943550|584933765|FG002|Overall Study|Lost to Follow-up|1|||
162032810|NCT00266877|585177478|FG000|Overall Study|Concomitant Radiotherapy|0|||
162032811|NCT00266877|585177479|FG001|Overall Study|Concomitant Radiotherapy|1|||
162032812|NCT00266877|585177480|FG002|Overall Study|Concomitant Radiotherapy|0|||
162032813|NCT01924429|585177484|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
162032814|NCT01924429|585177485|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
161753235|NCT04857892|584135730|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
161753236|NCT04857892|584135731|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
161753237|NCT04857892|584135727|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
161753238|NCT04857892|584135728|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
161968749|NCT03943550|584933763|FG000|Overall Study|Progressive Disease|0|||
161968750|NCT03943550|584933764|FG001|Overall Study|Progressive Disease|0|||
161968751|NCT03943550|584933765|FG002|Overall Study|Progressive Disease|2|||
161968752|NCT03943550|584933763|FG000|Overall Study|Participant Moved Out of the Country|0|||
161968753|NCT03943550|584933764|FG001|Overall Study|Participant Moved Out of the Country|1|||
162032815|NCT01150474|585177486|FG000|Overall Study|Withdrawal by Subject|5|||
161753239|NCT04857892|584135729|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
161753240|NCT04857892|584135730|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
161753241|NCT04857892|584135731|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
161753242|NCT05104749|584135732|FG000|Overall Study|Lost to Follow-up|2|||
161753243|NCT05104749|584135733|FG001|Overall Study|Lost to Follow-up|3|||
161753244|NCT00901394|584135734|FG000|Overall Study|Physician Decision|1|||
161753245|NCT00901394|584135735|FG001|Overall Study|Physician Decision|1|||
161753246|NCT00901394|584135736|FG002|Overall Study|Physician Decision|2|||
161753247|NCT04964557|584135737|FG000|Overall Study|Withdrawal by Subject|3|||
161753248|NCT04964557|584135738|FG001|Overall Study|Withdrawal by Subject|2|||
161753249|NCT04964557|584135737|FG000|Overall Study|Lost to Follow-up|1|||
161753250|NCT04964557|584135738|FG001|Overall Study|Lost to Follow-up|2|||
161753251|NCT04964557|584135737|FG000|Overall Study|Physician Decision|2|||
161753252|NCT04964557|584135738|FG001|Overall Study|Physician Decision|0|||
161753253|NCT04964557|584135737|FG000|Overall Study|Death|3|||
161753254|NCT04964557|584135738|FG001|Overall Study|Death|0|||
161753255|NCT04964557|584135737|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
161753256|NCT04964557|584135738|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
161753257|NCT00251589|584135739|FG000|Overall Study|Adverse Event|5|||
161753258|NCT00251589|584135740|FG001|Overall Study|Adverse Event|1|||
161753259|NCT00251589|584135741|FG002|Overall Study|Adverse Event|2|||
161753260|NCT00251589|584135742|FG003|Overall Study|Adverse Event|1|||
161753261|NCT00251589|584135739|FG000|Overall Study|Withdrawal by Subject|1|||
161753262|NCT00251589|584135740|FG001|Overall Study|Withdrawal by Subject|1|||
161753263|NCT00251589|584135741|FG002|Overall Study|Withdrawal by Subject|0|||
161753264|NCT00251589|584135742|FG003|Overall Study|Withdrawal by Subject|0|||
161753265|NCT00251589|584135739|FG000|Overall Study|Discontinued due to progressive disease|9|||
161753266|NCT00251589|584135740|FG001|Overall Study|Discontinued due to progressive disease|1|||
161753267|NCT00251589|584135741|FG002|Overall Study|Discontinued due to progressive disease|0|||
161753268|NCT00251589|584135742|FG003|Overall Study|Discontinued due to progressive disease|1|||
161753269|NCT02632344|584137497|FG000|Overall Study|Adverse Event|3|||
161753270|NCT02632344|584137497|FG000|Overall Study|Lack of Efficacy|3|||
161753271|NCT02632344|584137497|FG000|Overall Study|Withdrawal by Subject|2|||
161753272|NCT04984876|584137498|FG000|Overall Study|Subject decision|2|||
161753273|NCT04984876|584137499|FG001|Overall Study|Subject decision|10|||
161753274|NCT04984876|584137500|FG002|Overall Study|Subject decision|3|||
161753275|NCT04984876|584137501|FG003|Overall Study|Subject decision|3|||
161753276|NCT04984876|584137502|FG004|Overall Study|Subject decision|3|||
161753277|NCT04984876|584137503|FG005|Overall Study|Subject decision|0|||
161753278|NCT04984876|584137498|FG000|Overall Study|Guardian decision|0|||
161753279|NCT04984876|584137499|FG001|Overall Study|Guardian decision|1|||
161753280|NCT04984876|584137500|FG002|Overall Study|Guardian decision|0|||
161753281|NCT04984876|584137501|FG003|Overall Study|Guardian decision|2|||
161753282|NCT04984876|584137502|FG004|Overall Study|Guardian decision|0|||
161753283|NCT04984876|584137503|FG005|Overall Study|Guardian decision|1|||
161753284|NCT04984876|584137498|FG000|Overall Study|Lost to Follow-up|0|||
161753285|NCT04984876|584137499|FG001|Overall Study|Lost to Follow-up|0|||
161753286|NCT04984876|584137500|FG002|Overall Study|Lost to Follow-up|1|||
161753287|NCT04984876|584137501|FG003|Overall Study|Lost to Follow-up|1|||
161753288|NCT04984876|584137502|FG004|Overall Study|Lost to Follow-up|0|||
161753289|NCT04984876|584137503|FG005|Overall Study|Lost to Follow-up|0|||
161753290|NCT04984876|584137498|FG000|Overall Study|Physician Decision|1|||
161753291|NCT04984876|584137499|FG001|Overall Study|Physician Decision|0|||
161753292|NCT04984876|584137500|FG002|Overall Study|Physician Decision|0|||
161753293|NCT04984876|584137501|FG003|Overall Study|Physician Decision|1|||
161753294|NCT04984876|584137502|FG004|Overall Study|Physician Decision|0|||
161753295|NCT04984876|584137503|FG005|Overall Study|Physician Decision|0|||
161753296|NCT04984876|584137498|FG000|Overall Study|Adverse Event|0|||
161753297|NCT04984876|584137499|FG001|Overall Study|Adverse Event|0|||
161753298|NCT04984876|584137500|FG002|Overall Study|Adverse Event|1|||
161753299|NCT04984876|584137501|FG003|Overall Study|Adverse Event|0|||
161753300|NCT04984876|584137502|FG004|Overall Study|Adverse Event|0|||
161753301|NCT04984876|584137503|FG005|Overall Study|Adverse Event|0|||
161753302|NCT01077193|584137506|FG000|Overall Study|Lost to Follow-up|1|||
161753303|NCT01077193|584137506|FG000|Overall Study|Withdrawal by Subject|2|||
161753304|NCT01077193|584137506|FG000|Overall Study|Lack of Efficacy|1|||
161968754|NCT03943550|584933765|FG002|Overall Study|Participant Moved Out of the Country|0|||
161753305|NCT01077193|584137506|FG000|Overall Study|Study Terminated by Sponsor|40|||
161968755|NCT03359785|584933766|FG000|Overall Study|Protocol Violation|0|||
161753306|NCT04960202|584137507|FG000|Overall Study|Other|5|||
161753307|NCT04960202|584137508|FG001|Overall Study|Other|0|||
161968756|NCT03359785|584933767|FG001|Overall Study|Protocol Violation|1|||
161753308|NCT04960202|584137507|FG000|Overall Study|Withdrawal by Subject|37|||
161844919|NCT02980874|584474684|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
161753309|NCT04960202|584137508|FG001|Overall Study|Withdrawal by Subject|43|||
161753310|NCT04960202|584137507|FG000|Overall Study|Lost to Follow-up|20|||
161753311|NCT04960202|584137508|FG001|Overall Study|Lost to Follow-up|16|||
161968757|NCT03359785|584933768|FG002|Overall Study|Protocol Violation|0|||
161968758|NCT03359785|584933769|FG003|Overall Study|Protocol Violation|0|||
161968759|NCT03359785|584933766|FG000|Overall Study|Early study termination due to study pause|0|||
161968760|NCT03359785|584933767|FG001|Overall Study|Early study termination due to study pause|0|||
161968761|NCT03359785|584933768|FG002|Overall Study|Early study termination due to study pause|2|||
161968762|NCT03359785|584933769|FG003|Overall Study|Early study termination due to study pause|0|||
161968763|NCT03359785|584933766|FG000|Overall Study|Withdrawal by Subject|2|||
161968764|NCT03359785|584933767|FG001|Overall Study|Withdrawal by Subject|2|||
161968765|NCT03359785|584933768|FG002|Overall Study|Withdrawal by Subject|0|||
161968766|NCT03359785|584933769|FG003|Overall Study|Withdrawal by Subject|0|||
161968767|NCT03650803|584933775|FG000|Overall Study|Lost to Follow-up|6|||
161968768|NCT00367744|584933776|FG000|Overall Study|Lost to Follow-up|4|||
161968769|NCT00367744|584933777|FG001|Overall Study|Lost to Follow-up|5|||
161968770|NCT03664674|584933778|FG000|Overall Study|Adverse Event|1|||
161968771|NCT03664674|584933779|FG001|Overall Study|Adverse Event|1|||
161968772|NCT03664674|584933778|FG000|Overall Study|Physician Decision|0|||
161968773|NCT03664674|584933779|FG001|Overall Study|Physician Decision|1|||
161968774|NCT03664674|584933778|FG000|Overall Study|Withdrawal by Subject|2|||
161968775|NCT03664674|584933779|FG001|Overall Study|Withdrawal by Subject|0|||
161753312|NCT04960202|584137507|FG000|Overall Study|Death|0|||
161753313|NCT04960202|584137508|FG001|Overall Study|Death|15|||
161753314|NCT03687827|584137512|FG000|Treatment Period 1|Death|0|||
161753315|NCT03687827|584137513|FG001|Treatment Period 1|Death|1|||
161753316|NCT03687827|584137512|FG000|Treatment Period 1|Lost to Follow-up|2|||
161753317|NCT03687827|584137513|FG001|Treatment Period 1|Lost to Follow-up|2|||
161753318|NCT03687827|584137512|FG000|Treatment Period 1|Physician Decision|5|||
161753319|NCT03687827|584137513|FG001|Treatment Period 1|Physician Decision|2|||
161753320|NCT03687827|584137512|FG000|Treatment Period 1|Withdrawal by Subject|7|||
161753321|NCT03687827|584137513|FG001|Treatment Period 1|Withdrawal by Subject|3|||
161753322|NCT03687827|584137512|FG000|Treatment Period 2|Physician Decision|4|||
161753323|NCT03687827|584137513|FG001|Treatment Period 2|Physician Decision|1|||
161753324|NCT03687827|584137512|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161753325|NCT03687827|584137513|FG001|Treatment Period 2|Withdrawal by Subject|2|||
161753326|NCT03377452|584137516|FG000|Overall Study|Refused assessment|0|||
161753327|NCT03377452|584137517|FG001|Overall Study|Refused assessment|2|||
161753328|NCT03377452|584137516|FG000|Overall Study|Lost to Follow-up|5|||
161753329|NCT03377452|584137517|FG001|Overall Study|Lost to Follow-up|4|||
161753330|NCT03464136|584137518|FG000|Overall Study|Lost to Follow-up|5|||
161753331|NCT03464136|584137519|FG001|Overall Study|Lost to Follow-up|8|||
161753332|NCT03464136|584137518|FG000|Overall Study|Withdrawal by Subject|16|||
161753333|NCT03464136|584137519|FG001|Overall Study|Withdrawal by Subject|13|||
161753334|NCT03464136|584137518|FG000|Overall Study|Death|1|||
161753335|NCT03464136|584137519|FG001|Overall Study|Death|0|||
161753336|NCT03464136|584137518|FG000|Overall Study|Other|8|||
161753337|NCT03464136|584137519|FG001|Overall Study|Other|4|||
161753338|NCT03146403|584137520|FG000|Overall Study|Withdrawal by Subject|0|||
161753339|NCT03146403|584137521|FG001|Overall Study|Withdrawal by Subject|3|||
161753340|NCT03146403|584137520|FG000|Overall Study|Lost to Follow-up|2|||
161753341|NCT03146403|584137521|FG001|Overall Study|Lost to Follow-up|0|||
161753342|NCT00481988|584137522|FG000|Overall Study|Withdrawal by Subject|1|||
161753343|NCT00481988|584137523|FG001|Overall Study|Withdrawal by Subject|1|||
161753344|NCT02182999|584137524|FG000|Overall Study|Adverse Event|4|||
161753345|NCT02182999|584137525|FG001|Overall Study|Adverse Event|3|||
161753346|NCT02182999|584137524|FG000|Overall Study|Physician Decision|1|||
161753347|NCT02182999|584137525|FG001|Overall Study|Physician Decision|0|||
161753348|NCT02252588|584137527|FG000|Overall Study|Withdrawal by Subject|4|||
161753349|NCT02252588|584137528|FG001|Overall Study|Withdrawal by Subject|0|||
161753350|NCT00638690|584137533|FG000|Overall Study|Death|655|||
161753351|NCT00638690|584137534|FG001|Overall Study|Death|335|||
161753352|NCT00638690|584137533|FG000|Overall Study|Withdrawal by Subject|22|||
161753353|NCT00638690|584137534|FG001|Overall Study|Withdrawal by Subject|5|||
161753354|NCT00638690|584137533|FG000|Overall Study|Lost to Follow-up|4|||
161968776|NCT04584346|584933786|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
161968777|NCT04584346|584933787|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
161753355|NCT00638690|584137534|FG001|Overall Study|Lost to Follow-up|2|||
161753356|NCT02203916|584137537|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161753357|NCT02203916|584137538|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
161968778|NCT06107803|584933796|FG000|Overall Study|Adverse Event|1|||
161968779|NCT06107803|584933796|FG000|Overall Study|Withdrawal by Subject|2|||
161753358|NCT02203916|584137539|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
161753359|NCT02203916|584137537|FG000|Overall Study|Major Protocol Deviation|1|||
161968780|NCT06107803|584933796|FG000|Overall Study|Protocol Violation|1|||
161968781|NCT04173260|584933797|FG000|Overall Study|Early termination|4|||
161968782|NCT03070223|584933800|FG000|Overall Study|Lost to Follow-up|34|||
161753360|NCT02203916|584137538|FG001|Overall Study|Major Protocol Deviation|1|||
161753361|NCT02203916|584137539|FG002|Overall Study|Major Protocol Deviation|0|||
161968783|NCT03070223|584933801|FG001|Overall Study|Lost to Follow-up|27|||
161753362|NCT02203916|584137537|FG000|Overall Study|Lost to Follow-up|0|||
161753363|NCT02203916|584137538|FG001|Overall Study|Lost to Follow-up|1|||
161753364|NCT02203916|584137539|FG002|Overall Study|Lost to Follow-up|0|||
161753365|NCT02203916|584137537|FG000|Overall Study|Voluntary Withdrawal|3|||
161753366|NCT02203916|584137538|FG001|Overall Study|Voluntary Withdrawal|3|||
161753367|NCT02203916|584137539|FG002|Overall Study|Voluntary Withdrawal|8|||
161753368|NCT02203916|584137537|FG000|Overall Study|Lack of Efficacy|3|||
161753369|NCT02203916|584137538|FG001|Overall Study|Lack of Efficacy|0|||
161753370|NCT02203916|584137539|FG002|Overall Study|Lack of Efficacy|0|||
161753371|NCT02203916|584137537|FG000|Overall Study|Reason Not Specified|0|||
161753372|NCT02203916|584137538|FG001|Overall Study|Reason Not Specified|2|||
161753373|NCT02203916|584137539|FG002|Overall Study|Reason Not Specified|1|||
161753374|NCT03152110|584137550|FG000|Overall Study|Withdrawal by Subject|3|||
161753375|NCT00552344|584137560|FG000|Overall Study|Lack of Efficacy|55|||
161753376|NCT00552344|584137560|FG000|Overall Study|Loss of efficacy|75|||
161753377|NCT00552344|584137560|FG000|Overall Study|Lost to Follow-up|8|||
161753378|NCT00552344|584137560|FG000|Overall Study|Withdrawal by Subject|48|||
161753379|NCT00552344|584137560|FG000|Overall Study|SAE, non-fatal|6|||
161753380|NCT00552344|584137560|FG000|Overall Study|AE, non-serious non-fatal|38|||
161753381|NCT00552344|584137560|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
161753382|NCT00552344|584137560|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
161753383|NCT00552344|584137560|FG000|Overall Study|Other Reason|22|||
161753384|NCT04247828|584137563|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
161753385|NCT03077711|584137564|FG000|Overall Study|Lost to Follow-up|2|||
161753386|NCT03077711|584137565|FG001|Overall Study|Lost to Follow-up|2|||
161753387|NCT03077711|584137564|FG000|Overall Study|noncompliant taking medication|2|||
161753388|NCT03077711|584137565|FG001|Overall Study|noncompliant taking medication|0|||
161753389|NCT01819194|584137568|FG000|Overall Study|Loss of study articles|2|||
161753390|NCT00045630|584137569|FG000|Overall Study|Adverse Event|1|||
161753391|NCT00045630|584137569|FG000|Overall Study|Refusal unrelated to adverse event|1|||
161753392|NCT00045630|584137569|FG000|Overall Study|Progression/relapse|1|||
161753393|NCT00045630|584137569|FG000|Overall Study|Death|1|||
161753394|NCT00045630|584137569|FG000|Overall Study|Ineligible|2|||
161753395|NCT01448707|584137576|FG000|Overall Study|Adverse Event|3|||
161753396|NCT01448707|584137577|FG001|Overall Study|Adverse Event|1|||
161753397|NCT01448707|584137576|FG000|Overall Study|Lost to Follow-up|2|||
161753398|NCT01448707|584137577|FG001|Overall Study|Lost to Follow-up|6|||
161753399|NCT01448707|584137576|FG000|Overall Study|Withdrawal by Subject|6|||
161753400|NCT01448707|584137577|FG001|Overall Study|Withdrawal by Subject|7|||
161753401|NCT01448707|584137576|FG000|Overall Study|Other|7|||
161753402|NCT01448707|584137577|FG001|Overall Study|Other|4|||
161753403|NCT00383708|584137581|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
161753404|NCT00383708|584137581|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
161753405|NCT00383708|584137581|FG000|Run-in Period|Protocol Violation|4|||
161753406|NCT00383708|584137581|FG000|Run-in Period|Adverse Event|2|||
161753407|NCT00383708|584137581|FG000|Run-in Period|Claustrophobia|1|||
161753408|NCT00383708|584137581|FG000|Co-administration Period|Adverse Event|5|||
161753409|NCT02033850|584137582|FG000|Overall Study|Death|1|||
161753410|NCT02033850|584137583|FG001|Overall Study|Death|0|||
161753411|NCT02033850|584137582|FG000|Overall Study|unrelated medical reason|1|||
161753412|NCT02033850|584137583|FG001|Overall Study|unrelated medical reason|1|||
161753413|NCT02820038|584137584|FG000|Overall Study|Lost to Follow-up|7|||
161753414|NCT02820038|584137585|FG001|Overall Study|Lost to Follow-up|11|||
161753415|NCT02820038|584137586|FG002|Overall Study|Lost to Follow-up|2|||
161753416|NCT02820038|584137587|FG003|Overall Study|Lost to Follow-up|9|||
161753417|NCT02820038|584137584|FG000|Overall Study|Withdrawal by Subject|3|||
161753418|NCT02820038|584137585|FG001|Overall Study|Withdrawal by Subject|14|||
161753419|NCT02820038|584137586|FG002|Overall Study|Withdrawal by Subject|3|||
161753420|NCT02820038|584137587|FG003|Overall Study|Withdrawal by Subject|13|||
161753421|NCT03215667|584137588|FG000|Overall Study|Physician Decision|4|||
161753422|NCT00333970|584137590|FG000|Overall Study|Withdrawal by Subject|13|||
161753423|NCT00333970|584137591|FG001|Overall Study|Withdrawal by Subject|7|||
161968784|NCT03070223|584933800|FG000|Overall Study|Withdrawal by Subject|12|||
161968785|NCT03070223|584933801|FG001|Overall Study|Withdrawal by Subject|22|||
161968786|NCT03070223|584933800|FG000|Overall Study|Protocol Violation|0|||
161968787|NCT03070223|584933801|FG001|Overall Study|Protocol Violation|1|||
161968788|NCT02308163|584933802|FG000|Overall Study|Not fulfill eligible criteria|1|||
161968789|NCT02308163|584933803|FG001|Overall Study|Not fulfill eligible criteria|2|||
161968790|NCT02308163|584933804|FG002|Overall Study|Not fulfill eligible criteria|0|||
161968791|NCT02308163|584933805|FG003|Overall Study|Not fulfill eligible criteria|1|||
161968792|NCT02308163|584933806|FG004|Overall Study|Not fulfill eligible criteria|1|||
161753424|NCT00560794|584137592|FG000|Overall Study|Adverse Event|2|||
161753425|NCT00560794|584137592|FG000|Overall Study|Patient was not Compliant|1|||
161753426|NCT00560794|584137592|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
161753427|NCT00560794|584137592|FG000|Overall Study|Hematological Relapse|1|||
161753428|NCT00560794|584137592|FG000|Overall Study|Received Bone Marrow Transplant|6|||
161753429|NCT00441480|584137593|FG000|Overall Study|Protocol Violation|1|||
161968793|NCT02308163|584933802|FG000|Overall Study|Adverse Event|9|||
161968794|NCT02308163|584933803|FG001|Overall Study|Adverse Event|5|||
161968795|NCT02308163|584933804|FG002|Overall Study|Adverse Event|2|||
161968796|NCT02308163|584933805|FG003|Overall Study|Adverse Event|2|||
161968797|NCT02308163|584933806|FG004|Overall Study|Adverse Event|11|||
161968798|NCT02308163|584933802|FG000|Overall Study|Lack of Efficacy|11|||
161753430|NCT00441480|584137594|FG001|Overall Study|Protocol Violation|1|||
161753431|NCT00441480|584137593|FG000|Overall Study|Withdrawal by Subject|2|||
161753432|NCT00441480|584137594|FG001|Overall Study|Withdrawal by Subject|3|||
161753433|NCT00614991|584137595|FG000|Overall Study|Adverse Event|3|||
161753434|NCT00614991|584137596|FG001|Overall Study|Adverse Event|3|||
161753435|NCT00614991|584137597|FG002|Overall Study|Adverse Event|0|||
161753436|NCT00614991|584137598|FG003|Overall Study|Adverse Event|0|||
161753437|NCT00614991|584137599|FG004|Overall Study|Adverse Event|1|||
161753438|NCT00614991|584137600|FG005|Overall Study|Adverse Event|0|||
161753439|NCT00899678|584137601|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
161753440|NCT00899678|584137602|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
161753441|NCT00899678|584137603|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
161753442|NCT00899678|584137601|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
161753443|NCT00899678|584137602|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
161753444|NCT00899678|584137603|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
161753445|NCT00899678|584137601|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
161753446|NCT00899678|584137602|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
161753447|NCT00899678|584137603|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
161753448|NCT00899678|584137601|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
161753449|NCT00899678|584137602|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
161753450|NCT00899678|584137603|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
161753451|NCT00899678|584137601|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
161753452|NCT00899678|584137602|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
161753453|NCT00899678|584137603|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
161753454|NCT00899678|584137601|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
161753455|NCT00899678|584137602|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
161753456|NCT00899678|584137603|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
161753457|NCT00899678|584137601|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
161753458|NCT00899678|584137602|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
161753459|NCT00899678|584137603|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
161753460|NCT00899678|584137601|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
161753461|NCT00899678|584137602|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
161753462|NCT00899678|584137603|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
161753463|NCT00899678|584137601|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
161753464|NCT00899678|584137602|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
161753465|NCT00899678|584137603|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
161753466|NCT01922739|584137606|FG000|Titration/Adjustment Period|Adverse Event|3|||
161753467|NCT01922739|584137606|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
161753468|NCT01922739|584137606|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
161753469|NCT01922739|584137606|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
161753470|NCT01922739|584137606|FG000|Open-label Treatment Period|Adverse Event|6|||
161753471|NCT01922739|584137606|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
161753472|NCT01922739|584137606|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
161753473|NCT01922739|584137606|FG000|Open-label Treatment Period|Protocol Violation|5|||
161753474|NCT01922739|584137606|FG000|Open-label Treatment Period|Pregnancy|1|||
161753475|NCT01922739|584137606|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
161753476|NCT01922739|584137606|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
161753477|NCT01922739|584137606|FG000|Open-label Treatment Period|Physician Decision|1|||
161753478|NCT01922739|584137606|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
161753479|NCT02963766|584137607|FG000|Double-Blind Period|Adverse Event|1|||
161753480|NCT02963766|584137608|FG001|Double-Blind Period|Adverse Event|0|||
161753481|NCT02963766|584137609|FG002|Double-Blind Period|Adverse Event|1|||
161753482|NCT02963766|584137607|FG000|Double-Blind Period|Physician Decision|1|||
161753483|NCT02963766|584137608|FG001|Double-Blind Period|Physician Decision|0|||
161753484|NCT02963766|584137609|FG002|Double-Blind Period|Physician Decision|0|||
161753485|NCT02963766|584137607|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161753486|NCT02963766|584137608|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161968799|NCT02308163|584933803|FG001|Overall Study|Lack of Efficacy|3|||
161968800|NCT02308163|584933804|FG002|Overall Study|Lack of Efficacy|8|||
161753487|NCT02963766|584137609|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161753488|NCT02963766|584137607|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
161753489|NCT02963766|584137608|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
161753490|NCT02963766|584137609|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
161753491|NCT02963766|584137607|FG000|Double-Blind Period|Protocol Violation|1|||
161753492|NCT02963766|584137608|FG001|Double-Blind Period|Protocol Violation|0|||
161968801|NCT02308163|584933805|FG003|Overall Study|Lack of Efficacy|4|||
161753493|NCT02963766|584137609|FG002|Double-Blind Period|Protocol Violation|0|||
161753494|NCT02963766|584137607|FG000|Double-Blind Period|Lost to Follow-up|0|||
161753495|NCT02963766|584137608|FG001|Double-Blind Period|Lost to Follow-up|1|||
161753496|NCT02963766|584137609|FG002|Double-Blind Period|Lost to Follow-up|0|||
161753497|NCT02963766|584137607|FG000|Open Label Extension (OLE)|Physician Decision|1|||
161753498|NCT02963766|584137608|FG001|Open Label Extension (OLE)|Physician Decision|2|||
161753499|NCT02963766|584137609|FG002|Open Label Extension (OLE)|Physician Decision|2|||
161753500|NCT02963766|584137607|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
161753501|NCT02963766|584137608|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
161753502|NCT02963766|584137609|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
161753503|NCT02290340|584137612|FG000|Overall Study|Lost to Follow-up|0|||
161753504|NCT02290340|584137613|FG001|Overall Study|Lost to Follow-up|0|||
161753505|NCT02290340|584137614|FG002|Overall Study|Lost to Follow-up|0|||
161753506|NCT02290340|584137615|FG003|Overall Study|Lost to Follow-up|1|||
161968802|NCT02308163|584933806|FG004|Overall Study|Lack of Efficacy|6|||
161753507|NCT02290340|584137612|FG000|Overall Study|Withdrawal by Subject|1|||
161753508|NCT02290340|584137613|FG001|Overall Study|Withdrawal by Subject|0|||
161753509|NCT02290340|584137614|FG002|Overall Study|Withdrawal by Subject|0|||
161753510|NCT02290340|584137615|FG003|Overall Study|Withdrawal by Subject|0|||
161753511|NCT02290340|584137612|FG000|Overall Study|Other|1|||
161753512|NCT02290340|584137613|FG001|Overall Study|Other|0|||
161753513|NCT02290340|584137614|FG002|Overall Study|Other|0|||
161753514|NCT02290340|584137615|FG003|Overall Study|Other|1|||
161753515|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Adverse Event|22|||
161753516|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Adverse Event|0|||
161753517|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
161753518|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
161753519|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
161753520|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
161968803|NCT02308163|584933802|FG000|Overall Study|Withdrawal of consent|2|||
161968804|NCT02308163|584933803|FG001|Overall Study|Withdrawal of consent|3|||
161968805|NCT02308163|584933804|FG002|Overall Study|Withdrawal of consent|0|||
161968806|NCT02308163|584933805|FG003|Overall Study|Withdrawal of consent|2|||
161968807|NCT02308163|584933806|FG004|Overall Study|Withdrawal of consent|6|||
161968808|NCT02308163|584933802|FG000|Overall Study|Protocol Violation|3|||
161968809|NCT02308163|584933803|FG001|Overall Study|Protocol Violation|3|||
161968810|NCT02308163|584933804|FG002|Overall Study|Protocol Violation|3|||
161968811|NCT02308163|584933805|FG003|Overall Study|Protocol Violation|2|||
161968812|NCT02308163|584933806|FG004|Overall Study|Protocol Violation|5|||
161968813|NCT02308163|584933802|FG000|Overall Study|Lab data met discontinuation criteria|3|||
161968814|NCT02308163|584933803|FG001|Overall Study|Lab data met discontinuation criteria|0|||
161968815|NCT02308163|584933804|FG002|Overall Study|Lab data met discontinuation criteria|0|||
161968816|NCT02308163|584933805|FG003|Overall Study|Lab data met discontinuation criteria|2|||
161968817|NCT02308163|584933806|FG004|Overall Study|Lab data met discontinuation criteria|0|||
161968818|NCT02308163|584933802|FG000|Overall Study|Miscellaneous|2|||
161968819|NCT02308163|584933803|FG001|Overall Study|Miscellaneous|2|||
161968820|NCT02308163|584933804|FG002|Overall Study|Miscellaneous|1|||
161968821|NCT02308163|584933805|FG003|Overall Study|Miscellaneous|0|||
161968822|NCT02308163|584933806|FG004|Overall Study|Miscellaneous|5|||
161968823|NCT00118846|584933813|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
161968824|NCT00118846|584933814|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
161968825|NCT00118846|584933813|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
161968826|NCT00118846|584933814|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
161968827|NCT00118846|584933813|FG000|Overall Study|Physician Decision|1|||
161968828|NCT00118846|584933814|FG001|Overall Study|Physician Decision|0|||
161968829|NCT00118846|584933813|FG000|Overall Study|Medical condition|2|||
161753521|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
161753522|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
161753523|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
161968830|NCT00118846|584933814|FG001|Overall Study|Medical condition|2|||
161968831|NCT00118846|584933813|FG000|Overall Study|Lost to Follow-up|0|||
161753524|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
161753525|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
161753526|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
161968832|NCT00118846|584933814|FG001|Overall Study|Lost to Follow-up|2|||
161968833|NCT00118846|584933813|FG000|Overall Study|Personal reason|4|||
161968834|NCT00118846|584933814|FG001|Overall Study|Personal reason|5|||
161753527|NCT02493868|584137621|FG000|Induction Phase: DE Participants|Other|8|||
161753528|NCT02493868|584137622|FG001|Induction Phase: DE Participants|Other|0|||
161753529|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
161968835|NCT00443053|584933815|FG000|Overall Study|Adverse Event|2|||
161968836|NCT00443053|584933816|FG001|Overall Study|Adverse Event|1|||
161968837|NCT00443053|584933815|FG000|Overall Study|Withdrawal by Subject|9|||
161968838|NCT00443053|584933816|FG001|Overall Study|Withdrawal by Subject|18|||
161753530|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
161753531|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
161753532|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
161753533|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
161753534|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
161753535|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
161753536|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
161753537|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
161753538|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
161753539|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
161753540|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
161753541|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
161753542|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
161753543|NCT02493868|584137621|FG000|Optimization Phase: DE+TE Participants|Other|10|||
161753544|NCT02493868|584137622|FG001|Optimization Phase: DE+TE Participants|Other|2|||
161753545|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
161753546|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
161753547|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
161753548|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
161753549|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
161753550|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
161753551|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
161753552|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
161753553|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
161753554|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
161753555|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
161753556|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
161753557|NCT02493868|584137621|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
161753558|NCT02493868|584137622|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
161753559|NCT02493868|584137621|FG000|Follow-up Phase|Lost to Follow-up|1|||
161753560|NCT02493868|584137622|FG001|Follow-up Phase|Lost to Follow-up|0|||
161753561|NCT02493868|584137621|FG000|Follow-up Phase|Withdrawal by Subject|3|||
161753562|NCT02493868|584137622|FG001|Follow-up Phase|Withdrawal by Subject|0|||
161753563|NCT02493868|584137621|FG000|Follow-up Phase|Investigator Decision|5|||
161753564|NCT02493868|584137622|FG001|Follow-up Phase|Investigator Decision|1|||
161753565|NCT02493868|584137621|FG000|Follow-up Phase|Other|2|||
161753566|NCT02493868|584137622|FG001|Follow-up Phase|Other|1|||
161753567|NCT02407236|584137623|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
161753568|NCT02407236|584137624|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
161753569|NCT02407236|584137625|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
161753570|NCT02407236|584137626|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
161753571|NCT02407236|584137627|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
161753572|NCT02407236|584137628|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
161753573|NCT02407236|584137629|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
161753574|NCT02407236|584137630|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
161753575|NCT02407236|584137631|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
161753576|NCT02407236|584137632|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
161753577|NCT02407236|584137633|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
161753578|NCT02407236|584137634|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
161753579|NCT02407236|584137635|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
161753580|NCT02407236|584137623|FG000|Induction Study (8 Weeks)|Death|0|||
161753581|NCT02407236|584137624|FG001|Induction Study (8 Weeks)|Death|0|||
161753582|NCT02407236|584137625|FG002|Induction Study (8 Weeks)|Death|1|||
161753583|NCT02407236|584137626|FG003|Induction Study (8 Weeks)|Death|0|||
161753584|NCT02407236|584137627|FG004|Induction Study (8 Weeks)|Death|0|||
161753585|NCT02407236|584137628|FG005|Induction Study (8 Weeks)|Death|0|||
161753586|NCT02407236|584137629|FG006|Induction Study (8 Weeks)|Death|0|||
161753587|NCT02407236|584137630|FG007|Induction Study (8 Weeks)|Death|0|||
161753588|NCT02407236|584137631|FG008|Induction Study (8 Weeks)|Death|0|||
161753589|NCT02407236|584137632|FG009|Induction Study (8 Weeks)|Death|0|||
161753590|NCT02407236|584137633|FG010|Induction Study (8 Weeks)|Death|0|||
161753591|NCT02407236|584137634|FG011|Induction Study (8 Weeks)|Death|0|||
161753592|NCT02407236|584137635|FG012|Induction Study (8 Weeks)|Death|0|||
161753593|NCT02407236|584137623|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
161753594|NCT02407236|584137624|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
161753595|NCT02407236|584137625|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
161753596|NCT02407236|584137626|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753597|NCT02407236|584137627|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753598|NCT02407236|584137628|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753599|NCT02407236|584137629|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753600|NCT02407236|584137630|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161968839|NCT00443053|584933815|FG000|Overall Study|Lost to Follow-up|4|||
161968840|NCT00443053|584933816|FG001|Overall Study|Lost to Follow-up|5|||
161968841|NCT00443053|584933815|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
161968842|NCT00443053|584933816|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
161968843|NCT00443053|584933815|FG000|Overall Study|Noncompliance|2|||
161968844|NCT00443053|584933816|FG001|Overall Study|Noncompliance|1|||
161968845|NCT00443053|584933815|FG000|Overall Study|Other|3|||
161968846|NCT00443053|584933816|FG001|Overall Study|Other|4|||
161968847|NCT00443053|584933815|FG000|Overall Study|Physician Decision|0|||
161968848|NCT00443053|584933816|FG001|Overall Study|Physician Decision|4|||
161968849|NCT00541866|584933817|FG000|Overall Study|Adverse Event|3|||
161968850|NCT00541866|584933818|FG001|Overall Study|Adverse Event|0|||
161968851|NCT00541866|584933819|FG002|Overall Study|Adverse Event|0|||
161968852|NCT00541866|584933820|FG003|Overall Study|Adverse Event|0|||
161968853|NCT00541866|584933821|FG004|Overall Study|Adverse Event|0|||
161968854|NCT00541866|584933817|FG000|Overall Study|Death|1|||
161968855|NCT00541866|584933818|FG001|Overall Study|Death|0|||
161968856|NCT00541866|584933819|FG002|Overall Study|Death|0|||
161968857|NCT00541866|584933820|FG003|Overall Study|Death|0|||
161968858|NCT00541866|584933821|FG004|Overall Study|Death|0|||
161968859|NCT00541866|584933817|FG000|Overall Study|Lack of Efficacy|19|||
161968860|NCT00541866|584933818|FG001|Overall Study|Lack of Efficacy|15|||
161968861|NCT00541866|584933819|FG002|Overall Study|Lack of Efficacy|10|||
161968862|NCT00541866|584933820|FG003|Overall Study|Lack of Efficacy|12|||
161968863|NCT00541866|584933821|FG004|Overall Study|Lack of Efficacy|14|||
161968864|NCT00541866|584933817|FG000|Overall Study|Not Reported or Other|11|||
161968865|NCT00541866|584933818|FG001|Overall Study|Not Reported or Other|3|||
161968866|NCT00541866|584933819|FG002|Overall Study|Not Reported or Other|3|||
161968867|NCT00541866|584933820|FG003|Overall Study|Not Reported or Other|3|||
161968868|NCT00541866|584933821|FG004|Overall Study|Not Reported or Other|1|||
161753601|NCT02407236|584137631|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753602|NCT02407236|584137632|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161968869|NCT00541866|584933817|FG000|Overall Study|Physician Decision|0|||
161968870|NCT00541866|584933818|FG001|Overall Study|Physician Decision|0|||
161968871|NCT00541866|584933819|FG002|Overall Study|Physician Decision|2|||
161968872|NCT00541866|584933820|FG003|Overall Study|Physician Decision|1|||
161968873|NCT00541866|584933821|FG004|Overall Study|Physician Decision|0|||
161968874|NCT00578877|584933825|FG000|Overall Study|Lost to Follow-up|8|||
161968875|NCT00578877|584933826|FG001|Overall Study|Lost to Follow-up|10|||
161968876|NCT00578877|584933825|FG000|Overall Study|early discontinue|61|||
161968877|NCT00578877|584933826|FG001|Overall Study|early discontinue|101|||
161968878|NCT00578877|584933825|FG000|Overall Study|did not provide follow-up data|12|||
161968879|NCT00578877|584933826|FG001|Overall Study|did not provide follow-up data|17|||
161968880|NCT01202188|584933832|FG000|Overall Study|Protocol deviation|14|||
161968881|NCT01202188|584933833|FG001|Overall Study|Protocol deviation|8|||
161968882|NCT01202188|584933834|FG002|Overall Study|Protocol deviation|12|||
161968883|NCT01202188|584933835|FG003|Overall Study|Protocol deviation|10|||
161968884|NCT01202188|584933836|FG004|Overall Study|Protocol deviation|11|||
161968885|NCT01202188|584933832|FG000|Overall Study|Subject withdrew consent|12|||
161968886|NCT01202188|584933833|FG001|Overall Study|Subject withdrew consent|13|||
161968887|NCT01202188|584933834|FG002|Overall Study|Subject withdrew consent|22|||
161968888|NCT01202188|584933835|FG003|Overall Study|Subject withdrew consent|11|||
161968889|NCT01202188|584933836|FG004|Overall Study|Subject withdrew consent|13|||
161753603|NCT02407236|584137633|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753604|NCT02407236|584137634|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753605|NCT02407236|584137635|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161753606|NCT02407236|584137623|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753607|NCT02407236|584137624|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753608|NCT02407236|584137625|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
161753609|NCT02407236|584137626|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753610|NCT02407236|584137627|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753611|NCT02407236|584137628|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161968890|NCT01202188|584933832|FG000|Overall Study|Adverse Event|5|||
161968891|NCT01202188|584933833|FG001|Overall Study|Adverse Event|23|||
161968892|NCT01202188|584933834|FG002|Overall Study|Adverse Event|13|||
161968893|NCT01202188|584933835|FG003|Overall Study|Adverse Event|10|||
161968894|NCT01202188|584933836|FG004|Overall Study|Adverse Event|10|||
161968895|NCT01202188|584933832|FG000|Overall Study|Administrative problems|3|||
161968896|NCT01202188|584933833|FG001|Overall Study|Administrative problems|2|||
161968897|NCT01202188|584933834|FG002|Overall Study|Administrative problems|1|||
161753612|NCT02407236|584137629|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161968898|NCT01202188|584933835|FG003|Overall Study|Administrative problems|1|||
161968899|NCT01202188|584933836|FG004|Overall Study|Administrative problems|2|||
161968900|NCT01202188|584933832|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161753613|NCT02407236|584137630|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753614|NCT02407236|584137631|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161968901|NCT01202188|584933833|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
161968902|NCT01202188|584933834|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161968903|NCT01202188|584933835|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
161968904|NCT01202188|584933836|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
161968905|NCT01202188|584933832|FG000|Overall Study|Lost to Follow-up|1|||
161968906|NCT01202188|584933833|FG001|Overall Study|Lost to Follow-up|1|||
161968907|NCT01202188|584933834|FG002|Overall Study|Lost to Follow-up|0|||
161968908|NCT01202188|584933835|FG003|Overall Study|Lost to Follow-up|4|||
161968909|NCT01202188|584933836|FG004|Overall Study|Lost to Follow-up|1|||
161968910|NCT01202188|584933832|FG000|Overall Study|Death|1|||
161968911|NCT01202188|584933833|FG001|Overall Study|Death|1|||
161968912|NCT01202188|584933834|FG002|Overall Study|Death|1|||
161968913|NCT01202188|584933835|FG003|Overall Study|Death|1|||
161968914|NCT01202188|584933836|FG004|Overall Study|Death|0|||
161968915|NCT01202188|584933832|FG000|Overall Study|Abnormal test procedure result (s)|0|||
161968916|NCT01202188|584933833|FG001|Overall Study|Abnormal test procedure result (s)|0|||
161968917|NCT01202188|584933834|FG002|Overall Study|Abnormal test procedure result (s)|2|||
161968918|NCT01202188|584933835|FG003|Overall Study|Abnormal test procedure result (s)|0|||
161968919|NCT01202188|584933836|FG004|Overall Study|Abnormal test procedure result (s)|0|||
161968920|NCT01330628|584933837|FG000|Overall Study|Death|2|||
161968921|NCT01330628|584933838|FG001|Overall Study|Death|3|||
161968922|NCT01330628|584933837|FG000|Overall Study|Lost to Follow-up|5|||
161968923|NCT01330628|584933838|FG001|Overall Study|Lost to Follow-up|6|||
161968924|NCT01330628|584933837|FG000|Overall Study|Adverse Event|44|||
161968925|NCT01330628|584933838|FG001|Overall Study|Adverse Event|25|||
161968926|NCT01330628|584933837|FG000|Overall Study|Withdrawn|18|||
161968927|NCT01330628|584933838|FG001|Overall Study|Withdrawn|6|||
161968928|NCT01330628|584933837|FG000|Overall Study|Didn't receive study treatment|1|||
161968929|NCT01330628|584933838|FG001|Overall Study|Didn't receive study treatment|0|||
161968930|NCT03761394|584933839|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
161968931|NCT03761394|584933840|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
161968932|NCT03761394|584933841|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
161968933|NCT03761394|584933842|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
161968934|NCT03761394|584933839|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
161968935|NCT03761394|584933840|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
161968936|NCT03761394|584933841|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
161968937|NCT03761394|584933842|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
161968938|NCT03761394|584933839|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
161968939|NCT03761394|584933840|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
161968940|NCT03761394|584933841|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
161968941|NCT03761394|584933842|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
161968942|NCT03761394|584933839|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
161968943|NCT03761394|584933840|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
161968944|NCT03761394|584933841|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
161968945|NCT03761394|584933842|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
161968946|NCT01080768|584933855|FG000|Overall Study|Protocol Deviation|2|||
161968947|NCT01080768|584933856|FG001|Overall Study|Protocol Deviation|1|||
161968948|NCT00580034|584933864|FG000|Overall Study|Toxicity|10|||
161753615|NCT02407236|584137632|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753616|NCT02407236|584137633|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753617|NCT02407236|584137634|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753618|NCT02407236|584137635|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161753619|NCT02407236|584137623|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
161753620|NCT02407236|584137624|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
161753621|NCT02407236|584137625|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
161753622|NCT02407236|584137626|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
161753623|NCT02407236|584137627|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
161753624|NCT02407236|584137628|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
161968949|NCT00580034|584933865|FG001|Overall Study|Toxicity|0|||
161753625|NCT02407236|584137629|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
161753626|NCT02407236|584137630|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
161753627|NCT02407236|584137631|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
161968950|NCT01939002|584933866|FG000|Overall Study|Adverse Event|13|||
161968951|NCT01939002|584933867|FG001|Overall Study|Adverse Event|13|||
161968952|NCT01939002|584933866|FG000|Overall Study|Withdrawal by Subject|5|||
162032816|NCT01150474|585177487|FG001|Overall Study|Withdrawal by Subject|2|||
161753628|NCT02407236|584137632|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
161968953|NCT01939002|584933867|FG001|Overall Study|Withdrawal by Subject|3|||
161968954|NCT01939002|584933866|FG000|Overall Study|Other|1|||
161968955|NCT01939002|584933867|FG001|Overall Study|Other|2|||
161968956|NCT00098748|584933871|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
161968957|NCT00098748|584933872|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
161968958|NCT00098748|584933873|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
161753629|NCT02407236|584137633|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
161753630|NCT02407236|584137634|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
161753631|NCT02407236|584137635|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
161753632|NCT02407236|584137623|FG000|Induction Study (8 Weeks)|Other|2|||
161753633|NCT02407236|584137624|FG001|Induction Study (8 Weeks)|Other|1|||
161753634|NCT02407236|584137625|FG002|Induction Study (8 Weeks)|Other|5|||
161753635|NCT02407236|584137626|FG003|Induction Study (8 Weeks)|Other|0|||
161753636|NCT02407236|584137627|FG004|Induction Study (8 Weeks)|Other|0|||
161753637|NCT02407236|584137628|FG005|Induction Study (8 Weeks)|Other|0|||
161753638|NCT02407236|584137629|FG006|Induction Study (8 Weeks)|Other|0|||
161753639|NCT02407236|584137630|FG007|Induction Study (8 Weeks)|Other|0|||
161753640|NCT02407236|584137631|FG008|Induction Study (8 Weeks)|Other|0|||
161753641|NCT02407236|584137632|FG009|Induction Study (8 Weeks)|Other|0|||
161753642|NCT02407236|584137633|FG010|Induction Study (8 Weeks)|Other|0|||
161753643|NCT02407236|584137634|FG011|Induction Study (8 Weeks)|Other|0|||
161753644|NCT02407236|584137635|FG012|Induction Study (8 Weeks)|Other|0|||
161753645|NCT02407236|584137623|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753646|NCT02407236|584137624|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753647|NCT02407236|584137625|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753648|NCT02407236|584137626|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
161753649|NCT02407236|584137627|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
161753650|NCT02407236|584137628|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
161753651|NCT02407236|584137629|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
161753652|NCT02407236|584137630|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
161753653|NCT02407236|584137631|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753654|NCT02407236|584137632|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753655|NCT02407236|584137633|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753656|NCT02407236|584137634|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753657|NCT02407236|584137635|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
161753658|NCT02407236|584137623|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753659|NCT02407236|584137624|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753660|NCT02407236|584137625|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753661|NCT02407236|584137626|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
161753662|NCT02407236|584137627|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
161753663|NCT02407236|584137628|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
161753664|NCT02407236|584137629|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
161753665|NCT02407236|584137630|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
161753666|NCT02407236|584137631|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753667|NCT02407236|584137632|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753668|NCT02407236|584137633|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753669|NCT02407236|584137634|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753670|NCT02407236|584137635|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161753671|NCT02407236|584137623|FG000|Maintenance Study (44 Weeks)|Other|0|||
161753672|NCT02407236|584137624|FG001|Maintenance Study (44 Weeks)|Other|0|||
161753673|NCT02407236|584137625|FG002|Maintenance Study (44 Weeks)|Other|0|||
161753674|NCT02407236|584137626|FG003|Maintenance Study (44 Weeks)|Other|5|||
161753675|NCT02407236|584137627|FG004|Maintenance Study (44 Weeks)|Other|7|||
161753676|NCT02407236|584137628|FG005|Maintenance Study (44 Weeks)|Other|8|||
161753677|NCT02407236|584137629|FG006|Maintenance Study (44 Weeks)|Other|4|||
161753678|NCT02407236|584137630|FG007|Maintenance Study (44 Weeks)|Other|6|||
161753679|NCT02407236|584137631|FG008|Maintenance Study (44 Weeks)|Other|0|||
161753680|NCT02407236|584137632|FG009|Maintenance Study (44 Weeks)|Other|0|||
161753681|NCT02407236|584137633|FG010|Maintenance Study (44 Weeks)|Other|0|||
161753682|NCT02407236|584137634|FG011|Maintenance Study (44 Weeks)|Other|0|||
161753683|NCT02407236|584137635|FG012|Maintenance Study (44 Weeks)|Other|0|||
161753684|NCT02407236|584137623|FG000|Maintenance Study (44 Weeks)|Death|0|||
161753685|NCT02407236|584137624|FG001|Maintenance Study (44 Weeks)|Death|0|||
161753686|NCT02407236|584137625|FG002|Maintenance Study (44 Weeks)|Death|0|||
161753687|NCT02407236|584137626|FG003|Maintenance Study (44 Weeks)|Death|0|||
161753688|NCT02407236|584137627|FG004|Maintenance Study (44 Weeks)|Death|0|||
161753689|NCT02407236|584137628|FG005|Maintenance Study (44 Weeks)|Death|0|||
161968959|NCT00098748|584933871|FG000|Received Study Treatment|Death|2|||
161753690|NCT02407236|584137629|FG006|Maintenance Study (44 Weeks)|Death|0|||
161753691|NCT02407236|584137630|FG007|Maintenance Study (44 Weeks)|Death|1|||
161753692|NCT02407236|584137631|FG008|Maintenance Study (44 Weeks)|Death|0|||
161753693|NCT02407236|584137632|FG009|Maintenance Study (44 Weeks)|Death|0|||
161753694|NCT02407236|584137633|FG010|Maintenance Study (44 Weeks)|Death|0|||
161753695|NCT02407236|584137634|FG011|Maintenance Study (44 Weeks)|Death|0|||
161753696|NCT02407236|584137635|FG012|Maintenance Study (44 Weeks)|Death|0|||
161753697|NCT02407236|584137623|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753698|NCT02407236|584137624|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753699|NCT02407236|584137625|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753700|NCT02407236|584137626|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161968960|NCT00098748|584933872|FG001|Received Study Treatment|Death|1|||
161968961|NCT00098748|584933873|FG002|Received Study Treatment|Death|2|||
161968962|NCT00098748|584933871|FG000|Received Study Treatment|Adverse Event|1|||
161968963|NCT00098748|584933872|FG001|Received Study Treatment|Adverse Event|2|||
161968964|NCT00098748|584933873|FG002|Received Study Treatment|Adverse Event|5|||
161968965|NCT00098748|584933871|FG000|Received Study Treatment|Lack of Efficacy|40|||
161968966|NCT00098748|584933872|FG001|Received Study Treatment|Lack of Efficacy|27|||
161968967|NCT00098748|584933873|FG002|Received Study Treatment|Lack of Efficacy|27|||
161968968|NCT00098748|584933871|FG000|Received Study Treatment|Other|2|||
161968969|NCT00098748|584933872|FG001|Received Study Treatment|Other|2|||
161968970|NCT00098748|584933873|FG002|Received Study Treatment|Other|6|||
161968971|NCT00098748|584933871|FG000|Received Study Treatment|Subject defaulted|3|||
161968972|NCT00098748|584933872|FG001|Received Study Treatment|Subject defaulted|4|||
161968973|NCT00098748|584933873|FG002|Received Study Treatment|Subject defaulted|4|||
161968974|NCT00098748|584933871|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
161968975|NCT00098748|584933872|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
161968976|NCT00098748|584933873|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
161968977|NCT00098748|584933871|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
161968978|NCT00098748|584933872|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
161968979|NCT00098748|584933873|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
161968980|NCT00098748|584933871|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
161968981|NCT00098748|584933872|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
161968982|NCT00098748|584933873|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
161968983|NCT00098748|584933871|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
161968984|NCT00098748|584933872|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
161968985|NCT00098748|584933873|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
161968986|NCT00098748|584933871|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
161968987|NCT00098748|584933872|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
161968988|NCT00098748|584933873|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
161968989|NCT03245736|584935744|FG000|Overall Study|Adverse Event|1|||
161968990|NCT03245736|584935744|FG000|Overall Study|Progressive Disease|4|||
161968991|NCT04098367|584935752|FG000|Overall Study|Adverse Event|0|||
161968992|NCT04098367|584935753|FG001|Overall Study|Adverse Event|0|||
161968993|NCT04098367|584935754|FG002|Overall Study|Adverse Event|1|||
161968994|NCT04098367|584935752|FG000|Overall Study|Lost to Follow-up|1|||
161968995|NCT04098367|584935753|FG001|Overall Study|Lost to Follow-up|5|||
161968996|NCT04098367|584935754|FG002|Overall Study|Lost to Follow-up|2|||
161968997|NCT04098367|584935752|FG000|Overall Study|Withdrawal by Subject|0|||
161968998|NCT04098367|584935753|FG001|Overall Study|Withdrawal by Subject|0|||
161968999|NCT04098367|584935754|FG002|Overall Study|Withdrawal by Subject|1|||
161969000|NCT04098367|584935752|FG000|Overall Study|Sick . Could not attend visit|1|||
161969001|NCT04098367|584935753|FG001|Overall Study|Sick . Could not attend visit|0|||
161969002|NCT04098367|584935754|FG002|Overall Study|Sick . Could not attend visit|0|||
161969003|NCT02251717|584935755|FG000|Overall Study|Adverse Event|0|||
161969004|NCT02251717|584935756|FG001|Overall Study|Adverse Event|1|||
161969005|NCT02251717|584935755|FG000|Overall Study|Withdrew Consent|1|||
161969006|NCT02251717|584935756|FG001|Overall Study|Withdrew Consent|0|||
161969007|NCT00445939|584935760|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
161969008|NCT00445939|584935761|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
161969009|NCT00445939|584935762|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
161969010|NCT00445939|584935763|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
161969011|NCT00445939|584935760|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
161969012|NCT00445939|584935761|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
161969013|NCT00445939|584935762|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
161969014|NCT00445939|584935763|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
161969015|NCT00416715|584935764|FG000|Overall Study|Not evaluable for joint aches|7|||
161969016|NCT00416715|584935764|FG000|Overall Study|Vitamin D levels not evaluable|8|||
161969017|NCT01007435|584935777|FG000|Overall Study|Adverse Event|16|||
161969018|NCT01007435|584935778|FG001|Overall Study|Adverse Event|25|||
161969019|NCT01007435|584935779|FG002|Overall Study|Adverse Event|47|||
161969020|NCT01007435|584935780|FG003|Overall Study|Adverse Event|31|||
161969021|NCT01007435|584935777|FG000|Overall Study|Death|2|||
161969022|NCT01007435|584935778|FG001|Overall Study|Death|4|||
161969023|NCT01007435|584935779|FG002|Overall Study|Death|2|||
161969024|NCT01007435|584935780|FG003|Overall Study|Death|1|||
161969025|NCT01007435|584935777|FG000|Overall Study|Insufficient Therapeutic Response|21|||
161969026|NCT01007435|584935778|FG001|Overall Study|Insufficient Therapeutic Response|7|||
161969027|NCT01007435|584935779|FG002|Overall Study|Insufficient Therapeutic Response|2|||
161969028|NCT01007435|584935780|FG003|Overall Study|Insufficient Therapeutic Response|9|||
161969029|NCT01007435|584935777|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
162032817|NCT01150474|585177486|FG000|Overall Study|Cancer found|1|||
161969030|NCT01007435|584935778|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
161969031|NCT01007435|584935779|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
161969032|NCT01007435|584935780|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
161969033|NCT01007435|584935777|FG000|Overall Study|Other Protocol Violation|2|||
161969034|NCT01007435|584935778|FG001|Overall Study|Other Protocol Violation|0|||
161753701|NCT02407236|584137627|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753702|NCT02407236|584137628|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161969035|NCT01007435|584935779|FG002|Overall Study|Other Protocol Violation|1|||
161969036|NCT01007435|584935780|FG003|Overall Study|Other Protocol Violation|0|||
161969037|NCT01007435|584935777|FG000|Overall Study|Refused Treatment|13|||
161969038|NCT01007435|584935778|FG001|Overall Study|Refused Treatment|13|||
161969039|NCT01007435|584935779|FG002|Overall Study|Refused Treatment|5|||
161969040|NCT01007435|584935780|FG003|Overall Study|Refused Treatment|8|||
161969041|NCT01007435|584935777|FG000|Overall Study|Failure to Return|5|||
161969042|NCT01007435|584935778|FG001|Overall Study|Failure to Return|4|||
161969043|NCT01007435|584935779|FG002|Overall Study|Failure to Return|3|||
161969044|NCT01007435|584935780|FG003|Overall Study|Failure to Return|6|||
161969045|NCT01007435|584935777|FG000|Overall Study|Reason not Specified|1|||
161969046|NCT01007435|584935778|FG001|Overall Study|Reason not Specified|1|||
161969047|NCT01007435|584935779|FG002|Overall Study|Reason not Specified|2|||
161969048|NCT01007435|584935780|FG003|Overall Study|Reason not Specified|1|||
161969049|NCT02576535|584935781|FG000|Overall Study|Withdrawal by Subject|2|||
161969050|NCT02545517|584935782|FG000|Overall Study|Death|2|||
161969051|NCT02545517|584935783|FG001|Overall Study|Death|2|||
161969052|NCT02545517|584935784|FG002|Overall Study|Death|1|||
161969053|NCT02545517|584935782|FG000|Overall Study|Lost to Follow-up|14|||
161969054|NCT02545517|584935783|FG001|Overall Study|Lost to Follow-up|13|||
161969055|NCT02545517|584935784|FG002|Overall Study|Lost to Follow-up|17|||
161969056|NCT02545517|584935782|FG000|Overall Study|Protocol Violation|0|||
161969057|NCT02545517|584935783|FG001|Overall Study|Protocol Violation|1|||
161969058|NCT02545517|584935784|FG002|Overall Study|Protocol Violation|1|||
161969059|NCT02545517|584935782|FG000|Overall Study|Withdrawal by Subject|5|||
161969060|NCT02545517|584935783|FG001|Overall Study|Withdrawal by Subject|8|||
161969061|NCT02545517|584935784|FG002|Overall Study|Withdrawal by Subject|9|||
161969062|NCT02545517|584935782|FG000|Overall Study|Administrative reason|5|||
161969063|NCT02545517|584935783|FG001|Overall Study|Administrative reason|6|||
161969064|NCT02545517|584935784|FG002|Overall Study|Administrative reason|10|||
161969065|NCT02545517|584935782|FG000|Overall Study|Other|2|||
161969066|NCT02545517|584935783|FG001|Overall Study|Other|4|||
161969067|NCT02545517|584935784|FG002|Overall Study|Other|3|||
161969068|NCT03334851|584935785|FG000|Overall Study|Other|0|||
161969069|NCT03334851|584935786|FG001|Overall Study|Other|0|||
161969070|NCT03334851|584935787|FG002|Overall Study|Other|0|||
161969071|NCT03334851|584935788|FG003|Overall Study|Other|0|||
161969072|NCT03334851|584935789|FG004|Overall Study|Other|0|||
161969073|NCT03334851|584935790|FG005|Overall Study|Other|0|||
161969074|NCT03334851|584935791|FG006|Overall Study|Other|0|||
161969075|NCT03334851|584935792|FG007|Overall Study|Other|1|||
161969076|NCT03334851|584935793|FG008|Overall Study|Other|0|||
161969077|NCT03334851|584935794|FG009|Overall Study|Other|0|||
161969078|NCT03334851|584935795|FG010|Overall Study|Other|0|||
161969079|NCT03334851|584935796|FG011|Overall Study|Other|0|||
161969080|NCT03334851|584935797|FG012|Overall Study|Other|0|||
161969081|NCT03334851|584935785|FG000|Overall Study|Adverse Event|0|||
161969082|NCT03334851|584935786|FG001|Overall Study|Adverse Event|0|||
161969083|NCT03334851|584935787|FG002|Overall Study|Adverse Event|0|||
161969084|NCT03334851|584935788|FG003|Overall Study|Adverse Event|0|||
161969085|NCT03334851|584935789|FG004|Overall Study|Adverse Event|0|||
161969086|NCT03334851|584935790|FG005|Overall Study|Adverse Event|0|||
161969087|NCT03334851|584935791|FG006|Overall Study|Adverse Event|0|||
161969088|NCT03334851|584935792|FG007|Overall Study|Adverse Event|1|||
161969089|NCT03334851|584935793|FG008|Overall Study|Adverse Event|0|||
161969090|NCT03334851|584935794|FG009|Overall Study|Adverse Event|0|||
161969091|NCT03334851|584935795|FG010|Overall Study|Adverse Event|0|||
162032818|NCT01150474|585177487|FG001|Overall Study|Cancer found|0|||
161969092|NCT03334851|584935796|FG011|Overall Study|Adverse Event|0|||
161969093|NCT03334851|584935797|FG012|Overall Study|Adverse Event|0|||
161969094|NCT03334851|584935785|FG000|Overall Study|Withdrawal by Subject|0|||
161969095|NCT03334851|584935786|FG001|Overall Study|Withdrawal by Subject|0|||
161969096|NCT03334851|584935787|FG002|Overall Study|Withdrawal by Subject|0|||
161969097|NCT03334851|584935788|FG003|Overall Study|Withdrawal by Subject|0|||
161969098|NCT03334851|584935789|FG004|Overall Study|Withdrawal by Subject|0|||
161969099|NCT03334851|584935790|FG005|Overall Study|Withdrawal by Subject|0|||
161969100|NCT03334851|584935791|FG006|Overall Study|Withdrawal by Subject|0|||
161969101|NCT03334851|584935792|FG007|Overall Study|Withdrawal by Subject|0|||
161969102|NCT03334851|584935793|FG008|Overall Study|Withdrawal by Subject|0|||
161969103|NCT03334851|584935794|FG009|Overall Study|Withdrawal by Subject|0|||
161969104|NCT03334851|584935795|FG010|Overall Study|Withdrawal by Subject|1|||
161969105|NCT03334851|584935796|FG011|Overall Study|Withdrawal by Subject|0|||
161969106|NCT03334851|584935797|FG012|Overall Study|Withdrawal by Subject|1|||
161969107|NCT03334851|584935785|FG000|Overall Study|Lost to Follow-up|0|||
161969108|NCT03334851|584935786|FG001|Overall Study|Lost to Follow-up|0|||
161969109|NCT03334851|584935787|FG002|Overall Study|Lost to Follow-up|0|||
161969110|NCT03334851|584935788|FG003|Overall Study|Lost to Follow-up|0|||
161969111|NCT03334851|584935789|FG004|Overall Study|Lost to Follow-up|0|||
161969112|NCT03334851|584935790|FG005|Overall Study|Lost to Follow-up|0|||
161969113|NCT03334851|584935791|FG006|Overall Study|Lost to Follow-up|0|||
161969114|NCT03334851|584935792|FG007|Overall Study|Lost to Follow-up|0|||
161969115|NCT03334851|584935793|FG008|Overall Study|Lost to Follow-up|0|||
161969116|NCT03334851|584935794|FG009|Overall Study|Lost to Follow-up|0|||
161969117|NCT03334851|584935795|FG010|Overall Study|Lost to Follow-up|2|||
161969118|NCT03334851|584935796|FG011|Overall Study|Lost to Follow-up|1|||
161969119|NCT03334851|584935797|FG012|Overall Study|Lost to Follow-up|0|||
161969120|NCT00791479|584935798|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
161969121|NCT00791479|584935799|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
161969122|NCT00791479|584935800|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
161969123|NCT00791479|584935801|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
161969124|NCT00791479|584935802|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
161969125|NCT00791479|584935803|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
161969126|NCT00791479|584935798|FG000|Overall Study|Adverse Event|0|||
161969127|NCT00791479|584935799|FG001|Overall Study|Adverse Event|1|||
161969128|NCT00791479|584935800|FG002|Overall Study|Adverse Event|0|||
161969129|NCT00791479|584935801|FG003|Overall Study|Adverse Event|2|||
161753703|NCT02407236|584137629|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753704|NCT02407236|584137630|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161753705|NCT02407236|584137631|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
161969130|NCT00791479|584935802|FG004|Overall Study|Adverse Event|0|||
161753706|NCT02407236|584137632|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
161753707|NCT02407236|584137633|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
161753708|NCT02407236|584137634|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
161753709|NCT02407236|584137635|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
161753710|NCT02407236|584137623|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753711|NCT02407236|584137624|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753712|NCT02407236|584137625|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753713|NCT02407236|584137626|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753714|NCT02407236|584137627|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753715|NCT02407236|584137628|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753716|NCT02407236|584137629|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753717|NCT02407236|584137630|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753718|NCT02407236|584137631|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753719|NCT02407236|584137632|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753720|NCT02407236|584137633|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
161753721|NCT02407236|584137634|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753722|NCT02407236|584137635|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161753723|NCT02407236|584137623|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753724|NCT02407236|584137624|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753725|NCT02407236|584137625|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753726|NCT02407236|584137626|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753727|NCT02407236|584137627|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753728|NCT02407236|584137628|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753729|NCT02407236|584137629|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753730|NCT02407236|584137630|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161753731|NCT02407236|584137631|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
161753732|NCT02407236|584137632|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
161753733|NCT02407236|584137633|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
161753734|NCT02407236|584137634|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
161753735|NCT02407236|584137635|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
161753736|NCT02407236|584137623|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
161753737|NCT02407236|584137624|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
161753738|NCT02407236|584137625|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
161753739|NCT02407236|584137626|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
161753740|NCT02407236|584137627|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
161753741|NCT02407236|584137628|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
161753742|NCT02407236|584137629|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
161753743|NCT02407236|584137630|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
161753744|NCT02407236|584137631|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
161969131|NCT00791479|584935803|FG005|Overall Study|Adverse Event|1|||
161969132|NCT00791479|584935798|FG000|Overall Study|Lost to Follow-up|0|||
161969133|NCT00791479|584935799|FG001|Overall Study|Lost to Follow-up|1|||
161969134|NCT00791479|584935800|FG002|Overall Study|Lost to Follow-up|0|||
161969135|NCT00791479|584935801|FG003|Overall Study|Lost to Follow-up|0|||
161969136|NCT00791479|584935802|FG004|Overall Study|Lost to Follow-up|0|||
161969137|NCT00791479|584935803|FG005|Overall Study|Lost to Follow-up|1|||
161969138|NCT00791479|584935798|FG000|Overall Study|Protocol Violation|2|||
161753745|NCT02407236|584137632|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
161753746|NCT02407236|584137633|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
161753747|NCT02407236|584137634|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
161753748|NCT02407236|584137635|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
161753749|NCT03039569|584137638|FG000|Overall Study|Lost to Follow-up|5|||
161753750|NCT03039569|584137639|FG001|Overall Study|Lost to Follow-up|4|||
161753751|NCT01167153|584137640|FG000|Overall Study|Non-effective therapy|1|||
161753752|NCT01167153|584137641|FG001|Overall Study|Non-effective therapy|4|||
161753753|NCT01167153|584137640|FG000|Overall Study|AE including clinical laboratory AE|2|||
161753754|NCT01167153|584137641|FG001|Overall Study|AE including clinical laboratory AE|8|||
161753755|NCT01167153|584137640|FG000|Overall Study|Hypotension|1|||
161753756|NCT01167153|584137641|FG001|Overall Study|Hypotension|0|||
161753757|NCT01167153|584137640|FG000|Overall Study|Lost to Follow-up|7|||
161753758|NCT01167153|584137641|FG001|Overall Study|Lost to Follow-up|9|||
161753759|NCT01167153|584137640|FG000|Overall Study|Non-compliance to concomitant medication|0|||
161753760|NCT01167153|584137641|FG001|Overall Study|Non-compliance to concomitant medication|2|||
161753761|NCT01167153|584137640|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
161753762|NCT01167153|584137641|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
161753763|NCT01167153|584137640|FG000|Overall Study|Withdrawal consent|1|||
161753764|NCT01167153|584137641|FG001|Overall Study|Withdrawal consent|1|||
161753765|NCT01167153|584137640|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
161753766|NCT01167153|584137641|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
161753767|NCT04888507|584139488|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
161753768|NCT00636155|584139489|FG000|Overall Study|Adverse Event|8|||
161753769|NCT00636155|584139489|FG000|Overall Study|Lack of Efficacy|1|||
161753770|NCT00636155|584139489|FG000|Overall Study|Withdrawal by Subject|3|||
161753771|NCT00636155|584139489|FG000|Overall Study|Stem cell transplant|1|||
161753772|NCT00636155|584139489|FG000|Overall Study|Physician Decision|5|||
161753773|NCT00766142|584139490|FG000|Overall Study|Protocol Violation|4|||
161753774|NCT05643170|584139496|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
161753775|NCT05643170|584139496|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
161753776|NCT00777257|584139500|FG000|Overall Study|Adverse Event|3|||
161753777|NCT00777257|584139501|FG001|Overall Study|Adverse Event|1|||
161753778|NCT00777257|584139502|FG002|Overall Study|Adverse Event|0|||
161753779|NCT00777257|584139500|FG000|Overall Study|Lost to Follow-up|3|||
161753780|NCT00777257|584139501|FG001|Overall Study|Lost to Follow-up|3|||
161753781|NCT00777257|584139502|FG002|Overall Study|Lost to Follow-up|2|||
161753782|NCT00777257|584139500|FG000|Overall Study|Protocol Violation|2|||
161753783|NCT00777257|584139501|FG001|Overall Study|Protocol Violation|2|||
161753784|NCT00777257|584139502|FG002|Overall Study|Protocol Violation|2|||
161753785|NCT00777257|584139500|FG000|Overall Study|Withdrawal by Subject|3|||
161753786|NCT00777257|584139501|FG001|Overall Study|Withdrawal by Subject|6|||
161753787|NCT00777257|584139502|FG002|Overall Study|Withdrawal by Subject|5|||
161753788|NCT01431521|584139506|FG000|Overall Study|Withdrawal by Subject|0|||
161753789|NCT01431521|584139507|FG001|Overall Study|Withdrawal by Subject|0|||
161753790|NCT01431521|584139508|FG002|Overall Study|Withdrawal by Subject|1|||
161753791|NCT01431521|584139509|FG003|Overall Study|Withdrawal by Subject|0|||
161753792|NCT02710422|584139510|FG000|Overall Study|Termination of study|9|||
161753793|NCT02710422|584139511|FG001|Overall Study|Termination of study|9|||
161753794|NCT01370499|584139512|FG000|Overall Study|Adverse Event|38|||
161753795|NCT01370499|584139513|FG001|Overall Study|Adverse Event|12|||
161753796|NCT01370499|584139512|FG000|Overall Study|Lack of Efficacy|4|||
161753797|NCT01370499|584139513|FG001|Overall Study|Lack of Efficacy|2|||
161753798|NCT01370499|584139512|FG000|Overall Study|Lost to Follow-up|2|||
161753799|NCT01370499|584139513|FG001|Overall Study|Lost to Follow-up|1|||
161753800|NCT01370499|584139512|FG000|Overall Study|Physician Decision|3|||
161753801|NCT01370499|584139513|FG001|Overall Study|Physician Decision|3|||
161753802|NCT01370499|584139512|FG000|Overall Study|Protocol Violation|5|||
161753803|NCT01370499|584139513|FG001|Overall Study|Protocol Violation|4|||
161753804|NCT01370499|584139512|FG000|Overall Study|Withdrawal by Subject|18|||
161753805|NCT01370499|584139513|FG001|Overall Study|Withdrawal by Subject|7|||
161753806|NCT01370499|584139512|FG000|Overall Study|Sponsor Decision|41|||
161753807|NCT01370499|584139513|FG001|Overall Study|Sponsor Decision|15|||
161753808|NCT02000622|584139514|FG000|Overall Study|Withdrawal by Subject|5|||
161753809|NCT02000622|584139515|FG001|Overall Study|Withdrawal by Subject|7|||
161753810|NCT02000622|584139514|FG000|Overall Study|Lost to Follow-up|4|||
161753811|NCT02000622|584139515|FG001|Overall Study|Lost to Follow-up|0|||
161753812|NCT02000622|584139514|FG000|Overall Study|Death|159|||
161753813|NCT02000622|584139515|FG001|Overall Study|Death|73|||
161753814|NCT02000622|584139514|FG000|Overall Study|Withdrawn due to site closure|1|||
161753815|NCT02000622|584139515|FG001|Overall Study|Withdrawn due to site closure|0|||
161753816|NCT01462045|584139516|FG000|Overall Study|Family matter|0|||
161753817|NCT01462045|584139517|FG001|Overall Study|Family matter|1|||
161753818|NCT01462045|584139518|FG002|Overall Study|Family matter|0|||
161753819|NCT01938391|584139519|FG000|6 Month Follow up|Withdrawal by Subject|1|||
161753820|NCT01938391|584139519|FG000|12 Month Follow up|Physician Decision|1|||
161753821|NCT01938391|584139519|FG000|12 Month Follow up|Withdrawal by Subject|1|||
161753822|NCT04924114|584139523|FG000|Overall Study|Withdrawal by Subject|0|||
161753823|NCT04924114|584139524|FG001|Overall Study|Withdrawal by Subject|2|||
161753824|NCT04924114|584139525|FG002|Overall Study|Withdrawal by Subject|2|||
161753825|NCT04924114|584139526|FG003|Overall Study|Withdrawal by Subject|0|||
161753826|NCT04924114|584139527|FG004|Overall Study|Withdrawal by Subject|2|||
161753827|NCT03558828|584139528|FG000|Overall Study|Lost to Follow-up|4|||
161753828|NCT03558828|584139529|FG001|Overall Study|Lost to Follow-up|3|||
161753829|NCT03558828|584139530|FG002|Overall Study|Lost to Follow-up|3|||
161753830|NCT03558828|584139531|FG003|Overall Study|Lost to Follow-up|5|||
161753831|NCT03558828|584139532|FG004|Overall Study|Lost to Follow-up|2|||
161753832|NCT03558828|584139533|FG005|Overall Study|Lost to Follow-up|3|||
161753833|NCT03558828|584139528|FG000|Overall Study|dropped before the intervention|1|||
161753834|NCT03558828|584139529|FG001|Overall Study|dropped before the intervention|1|||
161753835|NCT03558828|584139530|FG002|Overall Study|dropped before the intervention|0|||
161753836|NCT03558828|584139531|FG003|Overall Study|dropped before the intervention|0|||
161753837|NCT03558828|584139532|FG004|Overall Study|dropped before the intervention|0|||
161753838|NCT03558828|584139533|FG005|Overall Study|dropped before the intervention|0|||
161753839|NCT03671148|584139534|FG000|Overall Study|Adverse Event|3|||
161753840|NCT03671148|584139535|FG001|Overall Study|Adverse Event|2|||
161753841|NCT03671148|584139534|FG000|Overall Study|Withdrawal by Subject|8|||
161753842|NCT03671148|584139535|FG001|Overall Study|Withdrawal by Subject|2|||
161753843|NCT03671148|584139534|FG000|Overall Study|Lost to Follow-up|1|||
161753844|NCT03671148|584139535|FG001|Overall Study|Lost to Follow-up|2|||
161753845|NCT03671148|584139534|FG000|Overall Study|Lack of Efficacy|7|||
161753846|NCT03671148|584139535|FG001|Overall Study|Lack of Efficacy|2|||
161753847|NCT03671148|584139534|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
161753848|NCT03671148|584139535|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
161753849|NCT03671148|584139534|FG000|Overall Study|Other|1|||
161753850|NCT03671148|584139535|FG001|Overall Study|Other|0|||
161753851|NCT03671148|584139534|FG000|Overall Study|Incomplete Randomization Visit|1|||
161753852|NCT03671148|584139535|FG001|Overall Study|Incomplete Randomization Visit|0|||
161753853|NCT00673816|584139536|FG000|Overall Study|Adverse Event|1|||
161753854|NCT00673816|584139536|FG000|Overall Study|Withdrawal by Subject|1|||
161969139|NCT00791479|584935799|FG001|Overall Study|Protocol Violation|1|||
161969140|NCT00791479|584935800|FG002|Overall Study|Protocol Violation|0|||
161969141|NCT00791479|584935801|FG003|Overall Study|Protocol Violation|1|||
161969142|NCT00791479|584935802|FG004|Overall Study|Protocol Violation|0|||
161969143|NCT00791479|584935803|FG005|Overall Study|Protocol Violation|0|||
161969144|NCT00791479|584935798|FG000|Overall Study|Withdrawal by Subject|0|||
161969145|NCT00791479|584935799|FG001|Overall Study|Withdrawal by Subject|0|||
161969146|NCT00791479|584935800|FG002|Overall Study|Withdrawal by Subject|0|||
161969147|NCT00791479|584935801|FG003|Overall Study|Withdrawal by Subject|1|||
161753855|NCT01804842|584139540|FG000|Overall Study|Adverse Event|1|||
161753856|NCT01804842|584139541|FG001|Overall Study|Adverse Event|1|||
161753857|NCT01804842|584139542|FG002|Overall Study|Adverse Event|0|||
161753858|NCT01804842|584139540|FG000|Overall Study|Lost to Follow-up|1|||
161753859|NCT01804842|584139541|FG001|Overall Study|Lost to Follow-up|0|||
161753860|NCT01804842|584139542|FG002|Overall Study|Lost to Follow-up|0|||
161753861|NCT01804842|584139540|FG000|Overall Study|Non-Compliance|1|||
161753862|NCT01804842|584139541|FG001|Overall Study|Non-Compliance|1|||
161753863|NCT01804842|584139542|FG002|Overall Study|Non-Compliance|0|||
161753864|NCT01804842|584139540|FG000|Overall Study|Personal Reason|0|||
161753865|NCT01804842|584139541|FG001|Overall Study|Personal Reason|0|||
161753866|NCT01804842|584139542|FG002|Overall Study|Personal Reason|1|||
161753867|NCT03774875|584139545|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
161753868|NCT03774875|584139546|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
161753869|NCT03774875|584139545|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
161753870|NCT03774875|584139546|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
161753871|NCT03774875|584139545|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
161753872|NCT03774875|584139546|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
161753873|NCT03774875|584139545|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
161753874|NCT03774875|584139546|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
161753875|NCT03774875|584139545|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
161753876|NCT03774875|584139546|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
161753877|NCT03774875|584139545|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
161969148|NCT00791479|584935802|FG004|Overall Study|Withdrawal by Subject|0|||
161969149|NCT00791479|584935803|FG005|Overall Study|Withdrawal by Subject|1|||
161969150|NCT00496197|584935804|FG000|Overall Study|Discontinued study due to death|43|||
161969151|NCT00496197|584935804|FG000|Overall Study|Adverse Event|13|||
162032819|NCT01150474|585177486|FG000|Overall Study|Multiple Studies|0|||
161753878|NCT03774875|584139546|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
161753879|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
161753880|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
161753881|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
161753882|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
161753883|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
161753884|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
161753885|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
161753886|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
161753887|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
161753888|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
161753889|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
161753890|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
161753891|NCT03774875|584139545|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
161753892|NCT03774875|584139546|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
161753893|NCT02352090|584139547|FG000|Overall Study|general malaise|1|||
161753894|NCT02352090|584139548|FG001|Overall Study|general malaise|0|||
161753895|NCT02352090|584139549|FG002|Overall Study|general malaise|0|||
161753896|NCT02352090|584139547|FG000|Overall Study|non-specified mild side-effects|0|||
161753897|NCT02352090|584139548|FG001|Overall Study|non-specified mild side-effects|0|||
161753898|NCT02352090|584139549|FG002|Overall Study|non-specified mild side-effects|2|||
161753899|NCT00413777|584139551|FG000|Fixed-dose Period|Lost to Follow-up|1|||
161753900|NCT00413777|584139552|FG001|Fixed-dose Period|Lost to Follow-up|1|||
161753901|NCT00413777|584139551|FG000|Fixed-dose Period|Adverse Event|2|||
161753902|NCT00413777|584139552|FG001|Fixed-dose Period|Adverse Event|1|||
161753903|NCT00413777|584139551|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
161753904|NCT00413777|584139552|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
161753905|NCT00413777|584139551|FG000|Fixed-dose Period|Withdrew Consent|0|||
161753906|NCT00413777|584139552|FG001|Fixed-dose Period|Withdrew Consent|1|||
161753907|NCT01678313|584139553|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
161753908|NCT01678313|584139554|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
161753909|NCT01678313|584139553|FG000|Completed the 3-month Therapy|Physician Decision|3|||
161753910|NCT01678313|584139554|FG001|Completed the 3-month Therapy|Physician Decision|4|||
161753911|NCT01678313|584139553|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
161753912|NCT01678313|584139554|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
161753913|NCT01678313|584139553|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
161753914|NCT01678313|584139554|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
161753915|NCT05179057|584139555|FG000|Overall Study|Adverse Event|3|||
161969152|NCT00496197|584935804|FG000|Overall Study|Does not meet entrance criteria|5|||
161969153|NCT00496197|584935804|FG000|Overall Study|Insufficient clinical response|3|||
161969154|NCT00496197|584935804|FG000|Overall Study|Insufficient bacteriological response|10|||
161969155|NCT00496197|584935804|FG000|Overall Study|Lost to Follow-up|11|||
161969156|NCT00496197|584935804|FG000|Overall Study|Withdrawal by Subject|11|||
161969157|NCT00496197|584935804|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
161969158|NCT00496197|584935804|FG000|Overall Study|Other|14|||
161969159|NCT00496197|584935804|FG000|Overall Study|Protocol Violation|8|||
161969160|NCT01610713|584935805|FG000|Overall Study|Adverse Event|3|||
161969161|NCT01610713|584935806|FG001|Overall Study|Adverse Event|0|||
161969162|NCT01610713|584935805|FG000|Overall Study|Lack of Efficacy|1|||
161969163|NCT01610713|584935806|FG001|Overall Study|Lack of Efficacy|0|||
161969164|NCT01610713|584935805|FG000|Overall Study|low mood and poor motivation|1|||
161969165|NCT01610713|584935806|FG001|Overall Study|low mood and poor motivation|0|||
161969166|NCT01610713|584935805|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
161969167|NCT01610713|584935806|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
161969168|NCT01610713|584935805|FG000|Overall Study|Lost to Follow-up|0|||
161969169|NCT01610713|584935806|FG001|Overall Study|Lost to Follow-up|1|||
161969170|NCT04979897|584935811|FG000|Overall Study|Death|1|||
161753916|NCT05179057|584139556|FG001|Overall Study|Adverse Event|2|||
161753917|NCT05179057|584139555|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
161753918|NCT05179057|584139556|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
161753919|NCT05179057|584139555|FG000|Overall Study|Study terminated|13|||
161753920|NCT05179057|584139556|FG001|Overall Study|Study terminated|7|||
161753921|NCT05179057|584139555|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
161753922|NCT05179057|584139556|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
161969171|NCT04979897|584935812|FG001|Overall Study|Death|8|||
162032820|NCT01150474|585177487|FG001|Overall Study|Multiple Studies|1|||
161753923|NCT05179057|584139555|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
161969172|NCT04979897|584935811|FG000|Overall Study|Lost to Follow-up|111|||
161969173|NCT04979897|584935812|FG001|Overall Study|Lost to Follow-up|56|||
161969174|NCT04979897|584935811|FG000|Overall Study|Withdrawal by Subject|7|||
161969175|NCT04979897|584935812|FG001|Overall Study|Withdrawal by Subject|2|||
161969176|NCT01774097|584935813|FG000|Overall Study|Withdrawal by Subject|1|||
161969177|NCT01774097|584935814|FG001|Overall Study|Withdrawal by Subject|1|||
161969178|NCT01774097|584935813|FG000|Overall Study|Adverse Event|1|||
162032821|NCT01150474|585177486|FG000|Overall Study|Rectotomy|1|||
162032822|NCT01150474|585177487|FG001|Overall Study|Rectotomy|0|||
161753924|NCT05179057|584139556|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
161753925|NCT03345342|584139557|FG000|Open-Label Phase|Adverse Event|30|||
161753926|NCT03345342|584139558|FG001|Open-Label Phase|Adverse Event|0|||
161753927|NCT03345342|584139559|FG002|Open-Label Phase|Adverse Event|0|||
161753928|NCT03345342|584139560|FG003|Open-Label Phase|Adverse Event|0|||
161753929|NCT03345342|584139561|FG004|Open-Label Phase|Adverse Event|0|||
161753930|NCT03345342|584139557|FG000|Open-Label Phase|Death|1|||
161753931|NCT03345342|584139558|FG001|Open-Label Phase|Death|0|||
161753932|NCT03345342|584139559|FG002|Open-Label Phase|Death|0|||
161753933|NCT03345342|584139560|FG003|Open-Label Phase|Death|0|||
161753934|NCT03345342|584139561|FG004|Open-Label Phase|Death|0|||
161753935|NCT03345342|584139557|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
161753936|NCT03345342|584139558|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
161753937|NCT03345342|584139559|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
161753938|NCT03345342|584139560|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
161753939|NCT03345342|584139561|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
161753940|NCT03345342|584139557|FG000|Open-Label Phase|Lack of Efficacy|6|||
161753941|NCT03345342|584139558|FG001|Open-Label Phase|Lack of Efficacy|0|||
161753942|NCT03345342|584139559|FG002|Open-Label Phase|Lack of Efficacy|0|||
161753943|NCT03345342|584139560|FG003|Open-Label Phase|Lack of Efficacy|0|||
161753944|NCT03345342|584139561|FG004|Open-Label Phase|Lack of Efficacy|0|||
161753945|NCT03345342|584139557|FG000|Open-Label Phase|Lost to Follow-up|9|||
161753946|NCT03345342|584139558|FG001|Open-Label Phase|Lost to Follow-up|0|||
161753947|NCT03345342|584139559|FG002|Open-Label Phase|Lost to Follow-up|0|||
161753948|NCT03345342|584139560|FG003|Open-Label Phase|Lost to Follow-up|0|||
161753949|NCT03345342|584139561|FG004|Open-Label Phase|Lost to Follow-up|0|||
161753950|NCT03345342|584139557|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
161753951|NCT03345342|584139558|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
161753952|NCT03345342|584139559|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
161753953|NCT03345342|584139560|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
161753954|NCT03345342|584139561|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
161753955|NCT03345342|584139557|FG000|Open-Label Phase|Physician Decision|4|||
161753956|NCT03345342|584139558|FG001|Open-Label Phase|Physician Decision|0|||
161753957|NCT03345342|584139559|FG002|Open-Label Phase|Physician Decision|0|||
161753958|NCT03345342|584139560|FG003|Open-Label Phase|Physician Decision|0|||
161753959|NCT03345342|584139561|FG004|Open-Label Phase|Physician Decision|0|||
161753960|NCT03345342|584139557|FG000|Open-Label Phase|Protocol Violation|8|||
161753961|NCT03345342|584139558|FG001|Open-Label Phase|Protocol Violation|0|||
161753962|NCT03345342|584139559|FG002|Open-Label Phase|Protocol Violation|0|||
161753963|NCT03345342|584139560|FG003|Open-Label Phase|Protocol Violation|0|||
161753964|NCT03345342|584139561|FG004|Open-Label Phase|Protocol Violation|0|||
161753965|NCT03345342|584139557|FG000|Open-Label Phase|Withdrawal by Subject|57|||
161753966|NCT03345342|584139558|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161753967|NCT03345342|584139559|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161753968|NCT03345342|584139560|FG003|Open-Label Phase|Withdrawal by Subject|0|||
161753969|NCT03345342|584139561|FG004|Open-Label Phase|Withdrawal by Subject|0|||
161753970|NCT03345342|584139557|FG000|Open-Label Phase|Other|15|||
161753971|NCT03345342|584139558|FG001|Open-Label Phase|Other|0|||
161753972|NCT03345342|584139559|FG002|Open-Label Phase|Other|0|||
161753973|NCT03345342|584139560|FG003|Open-Label Phase|Other|0|||
161753974|NCT03345342|584139561|FG004|Open-Label Phase|Other|0|||
161753975|NCT03345342|584139557|FG000|Double-Blind Phase|Adverse Event|0|||
161753976|NCT03345342|584139558|FG001|Double-Blind Phase|Adverse Event|1|||
161753977|NCT03345342|584139559|FG002|Double-Blind Phase|Adverse Event|6|||
161753978|NCT03345342|584139560|FG003|Double-Blind Phase|Adverse Event|0|||
161753979|NCT03345342|584139561|FG004|Double-Blind Phase|Adverse Event|0|||
161753980|NCT03345342|584139557|FG000|Double-Blind Phase|Death|0|||
161753981|NCT03345342|584139558|FG001|Double-Blind Phase|Death|2|||
161753982|NCT03345342|584139559|FG002|Double-Blind Phase|Death|1|||
161753983|NCT03345342|584139560|FG003|Double-Blind Phase|Death|0|||
161753984|NCT03345342|584139561|FG004|Double-Blind Phase|Death|0|||
161753985|NCT03345342|584139557|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
161969179|NCT01774097|584935814|FG001|Overall Study|Adverse Event|1|||
161969180|NCT00543296|584935815|FG000|Overall Study|Physician Decision|7|||
161753986|NCT03345342|584139558|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
161969181|NCT00934947|584935818|FG000|Overall Study|Adverse Event|0|||
161969182|NCT00934947|584935819|FG001|Overall Study|Adverse Event|2|||
161969183|NCT01703208|584935820|FG000|Overall Study|Death|61|||
161753987|NCT03345342|584139559|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
161753988|NCT03345342|584139560|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
161753989|NCT03345342|584139561|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
161753990|NCT03345342|584139557|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161753991|NCT03345342|584139558|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161753992|NCT03345342|584139559|FG002|Double-Blind Phase|Lost to Follow-up|7|||
161753993|NCT03345342|584139560|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161753994|NCT03345342|584139561|FG004|Double-Blind Phase|Lost to Follow-up|0|||
161753995|NCT03345342|584139557|FG000|Double-Blind Phase|Physician Decision|0|||
161753996|NCT03345342|584139558|FG001|Double-Blind Phase|Physician Decision|1|||
161753997|NCT03345342|584139559|FG002|Double-Blind Phase|Physician Decision|4|||
161753998|NCT03345342|584139560|FG003|Double-Blind Phase|Physician Decision|0|||
161753999|NCT03345342|584139561|FG004|Double-Blind Phase|Physician Decision|0|||
161754000|NCT03345342|584139557|FG000|Double-Blind Phase|Protocol Violation|0|||
161754001|NCT03345342|584139558|FG001|Double-Blind Phase|Protocol Violation|0|||
161754002|NCT03345342|584139559|FG002|Double-Blind Phase|Protocol Violation|1|||
161754003|NCT03345342|584139560|FG003|Double-Blind Phase|Protocol Violation|0|||
161754004|NCT03345342|584139561|FG004|Double-Blind Phase|Protocol Violation|0|||
161754005|NCT03345342|584139557|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161754006|NCT03345342|584139558|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
161754007|NCT03345342|584139559|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
161969184|NCT01703208|584935821|FG001|Overall Study|Death|48|||
161754008|NCT03345342|584139560|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
161754009|NCT03345342|584139561|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161754010|NCT03345342|584139557|FG000|Double-Blind Phase|Other|0|||
161754011|NCT03345342|584139558|FG001|Double-Blind Phase|Other|1|||
161754012|NCT03345342|584139559|FG002|Double-Blind Phase|Other|3|||
161754013|NCT03345342|584139560|FG003|Double-Blind Phase|Other|0|||
161754014|NCT03345342|584139561|FG004|Double-Blind Phase|Other|0|||
161754015|NCT03345342|584139557|FG000|Follow-Up Phase|Adverse Event|0|||
161754016|NCT03345342|584139558|FG001|Follow-Up Phase|Adverse Event|0|||
161754017|NCT03345342|584139559|FG002|Follow-Up Phase|Adverse Event|0|||
161754018|NCT03345342|584139560|FG003|Follow-Up Phase|Adverse Event|0|||
161754019|NCT03345342|584139561|FG004|Follow-Up Phase|Adverse Event|4|||
161754020|NCT03345342|584139557|FG000|Follow-Up Phase|Lost to Follow-up|0|||
161754021|NCT03345342|584139558|FG001|Follow-Up Phase|Lost to Follow-up|0|||
161754022|NCT03345342|584139559|FG002|Follow-Up Phase|Lost to Follow-up|0|||
161754023|NCT03345342|584139560|FG003|Follow-Up Phase|Lost to Follow-up|0|||
161754024|NCT03345342|584139561|FG004|Follow-Up Phase|Lost to Follow-up|6|||
161754025|NCT03345342|584139557|FG000|Follow-Up Phase|Physician Decision|0|||
161754026|NCT03345342|584139558|FG001|Follow-Up Phase|Physician Decision|0|||
161754027|NCT03345342|584139559|FG002|Follow-Up Phase|Physician Decision|0|||
161754028|NCT03345342|584139560|FG003|Follow-Up Phase|Physician Decision|0|||
161754029|NCT03345342|584139561|FG004|Follow-Up Phase|Physician Decision|5|||
161754030|NCT03345342|584139557|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
161754031|NCT03345342|584139558|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
161754032|NCT03345342|584139559|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
161754033|NCT03345342|584139560|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
161754034|NCT03345342|584139561|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
161754035|NCT03345342|584139557|FG000|Follow-Up Phase|Other|0|||
161754036|NCT03345342|584139558|FG001|Follow-Up Phase|Other|0|||
161754037|NCT03345342|584139559|FG002|Follow-Up Phase|Other|0|||
161754038|NCT03345342|584139560|FG003|Follow-Up Phase|Other|3|||
161754039|NCT03345342|584139561|FG004|Follow-Up Phase|Other|1|||
161754040|NCT03375203|584139562|FG000|Overall Study|Protocol Violation|0|||
161754041|NCT03375203|584139563|FG001|Overall Study|Protocol Violation|0|||
161754042|NCT03375203|584139564|FG002|Overall Study|Protocol Violation|1|||
161754043|NCT03375203|584139565|FG003|Overall Study|Protocol Violation|0|||
161754044|NCT03375203|584139566|FG004|Overall Study|Protocol Violation|0|||
161754045|NCT03375203|584139562|FG000|Overall Study|Adverse Event|2|||
161754046|NCT03375203|584139563|FG001|Overall Study|Adverse Event|3|||
161754047|NCT03375203|584139564|FG002|Overall Study|Adverse Event|0|||
161754048|NCT03375203|584139565|FG003|Overall Study|Adverse Event|2|||
161754049|NCT03375203|584139566|FG004|Overall Study|Adverse Event|2|||
161754050|NCT03375203|584139562|FG000|Overall Study|Withdrawal by Subject|3|||
161754051|NCT03375203|584139563|FG001|Overall Study|Withdrawal by Subject|0|||
161754052|NCT03375203|584139564|FG002|Overall Study|Withdrawal by Subject|1|||
161754053|NCT03375203|584139565|FG003|Overall Study|Withdrawal by Subject|0|||
161754054|NCT03375203|584139566|FG004|Overall Study|Withdrawal by Subject|2|||
161754055|NCT03375203|584139562|FG000|Overall Study|Non-compliance with study drug|1|||
161754056|NCT03375203|584139563|FG001|Overall Study|Non-compliance with study drug|0|||
161754057|NCT03375203|584139564|FG002|Overall Study|Non-compliance with study drug|0|||
161754058|NCT03375203|584139565|FG003|Overall Study|Non-compliance with study drug|0|||
161754059|NCT03375203|584139566|FG004|Overall Study|Non-compliance with study drug|0|||
161754060|NCT03375203|584139562|FG000|Overall Study|Randomized, not treated.|0|||
161754061|NCT03375203|584139563|FG001|Overall Study|Randomized, not treated.|1|||
161754062|NCT03375203|584139564|FG002|Overall Study|Randomized, not treated.|0|||
161754063|NCT03375203|584139565|FG003|Overall Study|Randomized, not treated.|0|||
161754064|NCT03375203|584139566|FG004|Overall Study|Randomized, not treated.|0|||
161754065|NCT03107793|584139567|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
161969185|NCT01703208|584935820|FG000|Overall Study|Lack of Efficacy|1|||
161969186|NCT01703208|584935821|FG001|Overall Study|Lack of Efficacy|2|||
161754066|NCT03107793|584139568|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
161754067|NCT03107793|584139569|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
161754068|NCT03107793|584139570|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
161754069|NCT03107793|584139571|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
161754070|NCT03107793|584139567|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
161754071|NCT03107793|584139568|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
161754072|NCT03107793|584139569|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
161754073|NCT03107793|584139570|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
161754074|NCT03107793|584139571|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
161754075|NCT03107793|584139567|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
161754076|NCT03107793|584139568|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
161754077|NCT03107793|584139569|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
161754078|NCT03107793|584139570|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
161754079|NCT03107793|584139571|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
161754080|NCT03107793|584139567|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
161754081|NCT03107793|584139568|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161754082|NCT03107793|584139569|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161754083|NCT03107793|584139570|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161754084|NCT03107793|584139571|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161754085|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161754086|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
161754087|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
161754088|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161754089|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161754090|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161754091|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
161754092|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
161754093|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161754094|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161754095|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
161754096|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
161754097|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
161754098|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
161754099|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
161754100|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161754101|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
161754102|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
161754103|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161754104|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161754105|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
161754106|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
161754107|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
161754108|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
161754109|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
161754110|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
161754111|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
161754112|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
161754113|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
161754114|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
161754115|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161754116|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
161754117|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161754118|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161754119|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161754120|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
161754121|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
161754122|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
161754123|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
161754124|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
161754125|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
161754126|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
161754127|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
161754128|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
161969187|NCT01703208|584935820|FG000|Overall Study|Lost to Follow-up|68|||
161969188|NCT01703208|584935821|FG001|Overall Study|Lost to Follow-up|62|||
161969189|NCT01703208|584935820|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161754129|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
161754130|NCT03107793|584139567|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161754131|NCT03107793|584139568|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
161969190|NCT01703208|584935821|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161969191|NCT01703208|584935820|FG000|Overall Study|Excluded Medication|1|||
161969192|NCT01703208|584935821|FG001|Overall Study|Excluded Medication|2|||
161754132|NCT03107793|584139569|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
161754133|NCT03107793|584139570|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161754134|NCT03107793|584139571|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161969193|NCT01703208|584935820|FG000|Overall Study|Site Discontinued Study Participation|23|||
161969194|NCT01703208|584935821|FG001|Overall Study|Site Discontinued Study Participation|27|||
161969195|NCT01703208|584935820|FG000|Overall Study|Physician Decision|11|||
161969196|NCT01703208|584935821|FG001|Overall Study|Physician Decision|13|||
161969197|NCT01703208|584935820|FG000|Overall Study|Progressive disease|2|||
161969198|NCT01703208|584935821|FG001|Overall Study|Progressive disease|2|||
161969199|NCT01703208|584935820|FG000|Overall Study|Protocol Violation|1|||
161969200|NCT01703208|584935821|FG001|Overall Study|Protocol Violation|1|||
161969201|NCT01703208|584935820|FG000|Overall Study|Study Terminated by Sponsor|1710|||
161969202|NCT01703208|584935821|FG001|Overall Study|Study Terminated by Sponsor|1716|||
161969203|NCT01703208|584935820|FG000|Overall Study|Withdrawal by Subject|205|||
161969204|NCT01703208|584935821|FG001|Overall Study|Withdrawal by Subject|209|||
161969205|NCT01703208|584935820|FG000|Overall Study|Adverse Event|14|||
161969206|NCT01703208|584935821|FG001|Overall Study|Adverse Event|19|||
161969207|NCT01703208|584935820|FG000|Overall Study|Technical Problems|0|||
161969208|NCT01703208|584935821|FG001|Overall Study|Technical Problems|1|||
162032823|NCT01150474|585177486|FG000|Overall Study|Drug did not arrive in time|1|||
162032824|NCT01150474|585177487|FG001|Overall Study|Drug did not arrive in time|0|||
161754135|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
161754136|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
161754137|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
161754138|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
161754139|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
161754140|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
161754141|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
161754142|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
161754143|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
161754144|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
161754145|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
161754146|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
161754147|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
161754148|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
161754149|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
161754150|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Death|0|||
161754151|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Death|0|||
161754152|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Death|0|||
161754153|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Death|0|||
161754154|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Death|1|||
161754155|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
161754156|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
161754157|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
161754158|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
161754159|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
161754160|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
161754161|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
161754162|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
161754163|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
161754164|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
161754165|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
161754166|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
161754167|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
161754168|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
161754169|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
161754170|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
161754171|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
161754172|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
161754173|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
161754174|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
161969209|NCT01703208|584935820|FG000|Overall Study|Protocol Deviation|2|||
161969210|NCT01703208|584935821|FG001|Overall Study|Protocol Deviation|0|||
161969211|NCT00252694|584935827|FG000|Overall Study|Withdrawal by Subject|83|||
161754175|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
161754176|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
161969212|NCT00252694|584935828|FG001|Overall Study|Withdrawal by Subject|91|||
161969213|NCT00252694|584935827|FG000|Overall Study|Death|36|||
161754177|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
161754178|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
161754179|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
161754180|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Other|0|||
161754181|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Other|0|||
161754182|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Other|0|||
161754183|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Other|1|||
161754184|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Other|3|||
161754185|NCT03107793|584139567|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
161754186|NCT03107793|584139568|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
161754187|NCT03107793|584139569|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
161754188|NCT03107793|584139570|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
161754189|NCT03107793|584139571|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
161754190|NCT03277105|584139572|FG000|Overall Study|Death|129|||
161754191|NCT03277105|584139573|FG001|Overall Study|Death|124|||
161754192|NCT03277105|584139572|FG000|Overall Study|Lost to Follow-up|2|||
161754193|NCT03277105|584139573|FG001|Overall Study|Lost to Follow-up|4|||
161754194|NCT03277105|584139572|FG000|Overall Study|Withdrawal by Subject|10|||
161754195|NCT03277105|584139573|FG001|Overall Study|Withdrawal by Subject|10|||
161754196|NCT03277105|584139572|FG000|Overall Study|Other|118|||
161754197|NCT03277105|584139573|FG001|Overall Study|Other|125|||
161754198|NCT05180721|584139577|FG000|Overall Study|Lost to Follow-up|4|||
161754199|NCT02040857|584139581|FG000|Overall Study|Adverse Event|14|||
161754200|NCT02040857|584139581|FG000|Overall Study|Physician Decision|5|||
161754201|NCT02040857|584139581|FG000|Overall Study|Withdrawal by Subject|31|||
161754202|NCT02040857|584139581|FG000|Overall Study|patient non-compliance|3|||
161754203|NCT02040857|584139581|FG000|Overall Study|Lost to Follow-up|2|||
161754204|NCT02040857|584139581|FG000|Overall Study|recurrence|4|||
161754205|NCT02040857|584139581|FG000|Overall Study|ineligible|1|||
161754206|NCT00976963|584139582|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
161754207|NCT00976963|584139583|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
161754208|NCT00976963|584139582|FG000|Overall Study|administrative error|1|||
161754209|NCT00976963|584139583|FG001|Overall Study|administrative error|0|||
161754210|NCT00976963|584139582|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
161754211|NCT00976963|584139583|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
161754212|NCT00608842|584139584|FG000|Overall Study|Participant's Request|0|||
161754213|NCT00608842|584139585|FG001|Overall Study|Participant's Request|1|||
161754214|NCT00608842|584139586|FG002|Overall Study|Participant's Request|2|||
161754215|NCT00608842|584139587|FG003|Overall Study|Participant's Request|1|||
161754216|NCT00608842|584139584|FG000|Overall Study|Lost to Follow-up|1|||
161754217|NCT00608842|584139585|FG001|Overall Study|Lost to Follow-up|0|||
161754218|NCT00608842|584139586|FG002|Overall Study|Lost to Follow-up|0|||
161754219|NCT00608842|584139587|FG003|Overall Study|Lost to Follow-up|0|||
161754220|NCT01024920|584139588|FG000|Overall Study|Progressive disease|47|||
161754221|NCT01024920|584139589|FG001|Overall Study|Progressive disease|25|||
161754222|NCT01024920|584139588|FG000|Overall Study|Adverse Event|8|||
161754223|NCT01024920|584139589|FG001|Overall Study|Adverse Event|4|||
161754224|NCT01024920|584139588|FG000|Overall Study|Lost to Follow-up|0|||
161754225|NCT01024920|584139589|FG001|Overall Study|Lost to Follow-up|1|||
161754226|NCT01024920|584139588|FG000|Overall Study|Patient refusal to continue|4|||
161754227|NCT01024920|584139589|FG001|Overall Study|Patient refusal to continue|0|||
161754228|NCT01024920|584139588|FG000|Overall Study|Other than listed|5|||
161754229|NCT01024920|584139589|FG001|Overall Study|Other than listed|1|||
161754230|NCT01024920|584139588|FG000|Overall Study|Not treated|3|||
161754231|NCT01024920|584139589|FG001|Overall Study|Not treated|0|||
161754232|NCT01024920|584139588|FG000|Overall Study|Protocol Violation|0|||
161754233|NCT01024920|584139589|FG001|Overall Study|Protocol Violation|1|||
161754234|NCT03039790|584139591|FG000|Overall Study|Lost to Follow-up|2|||
161754235|NCT03039790|584139592|FG001|Overall Study|Lost to Follow-up|0|||
161969214|NCT00252694|584935828|FG001|Overall Study|Death|34|||
161754236|NCT03039790|584139593|FG002|Overall Study|Lost to Follow-up|1|||
161969215|NCT00252694|584935827|FG000|Overall Study|Mostly Lost to Follow Up|8|||
161969216|NCT00252694|584935828|FG001|Overall Study|Mostly Lost to Follow Up|13|||
161969217|NCT00252694|584935827|FG000|Overall Study|Patient Moving|17|||
161969218|NCT00252694|584935828|FG001|Overall Study|Patient Moving|16|||
161969219|NCT00096226|584935830|FG000|Overall Study|Ineligible|2|||
161754237|NCT03039790|584139594|FG003|Overall Study|Lost to Follow-up|1|||
161754238|NCT03039790|584139595|FG004|Overall Study|Lost to Follow-up|0|||
161754239|NCT03039790|584139596|FG005|Overall Study|Lost to Follow-up|1|||
161754240|NCT03039790|584139597|FG006|Overall Study|Lost to Follow-up|1|||
161754241|NCT03039790|584139598|FG007|Overall Study|Lost to Follow-up|1|||
161754242|NCT03039790|584139599|FG008|Overall Study|Lost to Follow-up|0|||
161754243|NCT03039790|584139600|FG009|Overall Study|Lost to Follow-up|1|||
161754244|NCT03039790|584139601|FG010|Overall Study|Lost to Follow-up|1|||
161754245|NCT03039790|584139602|FG011|Overall Study|Lost to Follow-up|0|||
161754246|NCT03039790|584139603|FG012|Overall Study|Lost to Follow-up|1|||
161754247|NCT03039790|584139604|FG013|Overall Study|Lost to Follow-up|0|||
161754248|NCT03039790|584139605|FG014|Overall Study|Lost to Follow-up|3|||
161754249|NCT03039790|584139606|FG015|Overall Study|Lost to Follow-up|1|||
161754250|NCT03039790|584139607|FG016|Overall Study|Lost to Follow-up|2|||
161754251|NCT03039790|584139608|FG017|Overall Study|Lost to Follow-up|2|||
161754252|NCT03039790|584139609|FG018|Overall Study|Lost to Follow-up|1|||
161754253|NCT03039790|584139610|FG019|Overall Study|Lost to Follow-up|3|||
161754254|NCT03039790|584139591|FG000|Overall Study|Withdrawal of Consent|1|||
161754255|NCT03039790|584139592|FG001|Overall Study|Withdrawal of Consent|0|||
161754256|NCT03039790|584139593|FG002|Overall Study|Withdrawal of Consent|0|||
161754257|NCT03039790|584139594|FG003|Overall Study|Withdrawal of Consent|1|||
161754258|NCT03039790|584139595|FG004|Overall Study|Withdrawal of Consent|0|||
161754259|NCT03039790|584139596|FG005|Overall Study|Withdrawal of Consent|0|||
161754260|NCT03039790|584139597|FG006|Overall Study|Withdrawal of Consent|0|||
161754261|NCT03039790|584139598|FG007|Overall Study|Withdrawal of Consent|0|||
161754262|NCT03039790|584139599|FG008|Overall Study|Withdrawal of Consent|0|||
161754263|NCT03039790|584139600|FG009|Overall Study|Withdrawal of Consent|1|||
161754264|NCT03039790|584139601|FG010|Overall Study|Withdrawal of Consent|0|||
161754265|NCT03039790|584139602|FG011|Overall Study|Withdrawal of Consent|0|||
161754266|NCT03039790|584139603|FG012|Overall Study|Withdrawal of Consent|2|||
161754267|NCT03039790|584139604|FG013|Overall Study|Withdrawal of Consent|0|||
161754268|NCT03039790|584139605|FG014|Overall Study|Withdrawal of Consent|1|||
161754269|NCT03039790|584139606|FG015|Overall Study|Withdrawal of Consent|5|||
161754270|NCT03039790|584139607|FG016|Overall Study|Withdrawal of Consent|3|||
161754271|NCT03039790|584139608|FG017|Overall Study|Withdrawal of Consent|0|||
161754272|NCT03039790|584139609|FG018|Overall Study|Withdrawal of Consent|2|||
161754273|NCT03039790|584139610|FG019|Overall Study|Withdrawal of Consent|5|||
161754274|NCT03039790|584139591|FG000|Overall Study|Death|0|||
161754275|NCT03039790|584139592|FG001|Overall Study|Death|0|||
161754276|NCT03039790|584139593|FG002|Overall Study|Death|0|||
161754277|NCT03039790|584139594|FG003|Overall Study|Death|0|||
161754278|NCT03039790|584139595|FG004|Overall Study|Death|0|||
161754279|NCT03039790|584139596|FG005|Overall Study|Death|0|||
161754280|NCT03039790|584139597|FG006|Overall Study|Death|0|||
161754281|NCT03039790|584139598|FG007|Overall Study|Death|0|||
161754282|NCT03039790|584139599|FG008|Overall Study|Death|0|||
161754283|NCT03039790|584139600|FG009|Overall Study|Death|0|||
161754284|NCT03039790|584139601|FG010|Overall Study|Death|0|||
161754285|NCT03039790|584139602|FG011|Overall Study|Death|0|||
161754286|NCT03039790|584139603|FG012|Overall Study|Death|0|||
161754287|NCT03039790|584139604|FG013|Overall Study|Death|0|||
161754288|NCT03039790|584139605|FG014|Overall Study|Death|0|||
161754289|NCT03039790|584139606|FG015|Overall Study|Death|1|||
161754290|NCT03039790|584139607|FG016|Overall Study|Death|3|||
161754291|NCT03039790|584139608|FG017|Overall Study|Death|0|||
161754292|NCT03039790|584139609|FG018|Overall Study|Death|2|||
161754293|NCT03039790|584139610|FG019|Overall Study|Death|0|||
161754294|NCT03039790|584139591|FG000|Overall Study|Reason, not Specified|1|||
161754295|NCT03039790|584139592|FG001|Overall Study|Reason, not Specified|0|||
161754296|NCT03039790|584139593|FG002|Overall Study|Reason, not Specified|0|||
161754297|NCT03039790|584139594|FG003|Overall Study|Reason, not Specified|0|||
161754298|NCT03039790|584139595|FG004|Overall Study|Reason, not Specified|0|||
161754299|NCT03039790|584139596|FG005|Overall Study|Reason, not Specified|0|||
161754300|NCT03039790|584139597|FG006|Overall Study|Reason, not Specified|0|||
161754301|NCT03039790|584139598|FG007|Overall Study|Reason, not Specified|0|||
161754302|NCT03039790|584139599|FG008|Overall Study|Reason, not Specified|0|||
161754303|NCT03039790|584139600|FG009|Overall Study|Reason, not Specified|0|||
161754304|NCT03039790|584139601|FG010|Overall Study|Reason, not Specified|0|||
161754305|NCT03039790|584139602|FG011|Overall Study|Reason, not Specified|0|||
161754306|NCT03039790|584139603|FG012|Overall Study|Reason, not Specified|0|||
161754307|NCT03039790|584139604|FG013|Overall Study|Reason, not Specified|0|||
161754308|NCT03039790|584139605|FG014|Overall Study|Reason, not Specified|0|||
161754309|NCT03039790|584139606|FG015|Overall Study|Reason, not Specified|0|||
161754310|NCT03039790|584139607|FG016|Overall Study|Reason, not Specified|2|||
161754311|NCT03039790|584139608|FG017|Overall Study|Reason, not Specified|0|||
161754312|NCT03039790|584139609|FG018|Overall Study|Reason, not Specified|1|||
161969220|NCT00096226|584935830|FG000|Overall Study|Protocol treatment not started|1|||
161969221|NCT02378298|584935833|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
161754313|NCT03039790|584139610|FG019|Overall Study|Reason, not Specified|0|||
161754314|NCT02736929|584139615|FG000|Main Study|Lost to Follow-up|7|||
161754315|NCT02736929|584139616|FG001|Main Study|Lost to Follow-up|1|||
161754316|NCT02736929|584139617|FG002|Main Study|Lost to Follow-up|0|||
161754317|NCT02736929|584139615|FG000|Main Study|Withdrawal by Subject|1|||
161754318|NCT02736929|584139616|FG001|Main Study|Withdrawal by Subject|1|||
161754319|NCT02736929|584139617|FG002|Main Study|Withdrawal by Subject|0|||
161754320|NCT02736929|584139615|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
161754321|NCT02736929|584139616|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
161754322|NCT02736929|584139617|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
161754323|NCT00285649|584139618|FG000|Overall Study|Lost to Follow-up|6|||
161754324|NCT00285649|584139619|FG001|Overall Study|Lost to Follow-up|4|||
161754325|NCT00285649|584139620|FG002|Overall Study|Lost to Follow-up|4|||
161754326|NCT00285649|584139618|FG000|Overall Study|Withdrawal by Subject|3|||
161754327|NCT00285649|584139619|FG001|Overall Study|Withdrawal by Subject|2|||
161754328|NCT00285649|584139620|FG002|Overall Study|Withdrawal by Subject|2|||
161754329|NCT02972593|584139621|FG000|Overall Study|Lost to Follow-up|19|||
161754330|NCT02972593|584139622|FG001|Overall Study|Lost to Follow-up|15|||
161754331|NCT02972593|584139621|FG000|Overall Study|Protocol Violation|1|||
161754332|NCT02972593|584139622|FG001|Overall Study|Protocol Violation|0|||
161754333|NCT03934203|584139625|FG000|Overall Study|Adverse Event|0|||
161754334|NCT03934203|584139626|FG001|Overall Study|Adverse Event|0|||
161754335|NCT03934203|584139627|FG002|Overall Study|Adverse Event|1|||
161754336|NCT03934203|584139628|FG003|Overall Study|Adverse Event|0|||
161754337|NCT03934203|584139629|FG004|Overall Study|Adverse Event|1|||
161754338|NCT03934203|584139630|FG005|Overall Study|Adverse Event|0|||
161754339|NCT03934203|584139631|FG006|Overall Study|Adverse Event|2|||
161754340|NCT03934203|584139632|FG007|Overall Study|Adverse Event|0|||
161754341|NCT03934203|584139633|FG008|Overall Study|Adverse Event|0|||
161754342|NCT03934203|584139634|FG009|Overall Study|Adverse Event|0|||
161754343|NCT03934203|584139635|FG010|Overall Study|Adverse Event|0|||
161754344|NCT03934203|584139636|FG011|Overall Study|Adverse Event|0|||
161754345|NCT03934203|584139637|FG012|Overall Study|Adverse Event|0|||
161754346|NCT03934203|584139638|FG013|Overall Study|Adverse Event|1|||
161754347|NCT03934203|584139639|FG014|Overall Study|Adverse Event|0|||
161754348|NCT00044213|584139647|FG000|Overall Study|Withdrawal by Subject|50|||
161754349|NCT00044213|584139648|FG001|Overall Study|Withdrawal by Subject|65|||
161754350|NCT00044213|584139649|FG002|Overall Study|Withdrawal by Subject|91|||
161754351|NCT00044213|584139650|FG003|Overall Study|Withdrawal by Subject|83|||
161754352|NCT00044213|584139647|FG000|Overall Study|Death|42|||
161754353|NCT00044213|584139648|FG001|Overall Study|Death|42|||
161754354|NCT00044213|584139649|FG002|Overall Study|Death|42|||
161754355|NCT00044213|584139650|FG003|Overall Study|Death|49|||
161754356|NCT00044213|584139647|FG000|Overall Study|Lost to Follow-up|8|||
161754357|NCT00044213|584139648|FG001|Overall Study|Lost to Follow-up|5|||
161754358|NCT00044213|584139649|FG002|Overall Study|Lost to Follow-up|5|||
161754359|NCT00044213|584139650|FG003|Overall Study|Lost to Follow-up|4|||
161754360|NCT00422240|584139651|FG000|Overall Study|Lack of Efficacy|1|||
161754361|NCT00422240|584139652|FG001|Overall Study|Lack of Efficacy|2|||
161754362|NCT00422240|584139653|FG002|Overall Study|Lack of Efficacy|0|||
161754363|NCT00422240|584139654|FG003|Overall Study|Lack of Efficacy|1|||
161754364|NCT00422240|584139651|FG000|Overall Study|Adverse Event|11|||
161754365|NCT00422240|584139652|FG001|Overall Study|Adverse Event|4|||
161754366|NCT00422240|584139653|FG002|Overall Study|Adverse Event|5|||
161754367|NCT00422240|584139654|FG003|Overall Study|Adverse Event|2|||
161754368|NCT00422240|584139651|FG000|Overall Study|Subject request|21|||
161754369|NCT00422240|584139652|FG001|Overall Study|Subject request|17|||
161754370|NCT00422240|584139653|FG002|Overall Study|Subject request|18|||
161754371|NCT00422240|584139654|FG003|Overall Study|Subject request|30|||
161754372|NCT00422240|584139651|FG000|Overall Study|Protocol Violation|0|||
161754373|NCT00422240|584139652|FG001|Overall Study|Protocol Violation|1|||
161754374|NCT00422240|584139653|FG002|Overall Study|Protocol Violation|0|||
161754375|NCT00422240|584139654|FG003|Overall Study|Protocol Violation|1|||
161754376|NCT00422240|584139651|FG000|Overall Study|Lost to Follow-up|31|||
161754377|NCT00422240|584139652|FG001|Overall Study|Lost to Follow-up|32|||
161754378|NCT00422240|584139653|FG002|Overall Study|Lost to Follow-up|19|||
161754379|NCT00422240|584139654|FG003|Overall Study|Lost to Follow-up|34|||
161754380|NCT00422240|584139651|FG000|Overall Study|Other|1|||
161754381|NCT00422240|584139652|FG001|Overall Study|Other|0|||
161754382|NCT00422240|584139653|FG002|Overall Study|Other|0|||
161754383|NCT00422240|584139654|FG003|Overall Study|Other|1|||
161754384|NCT00422240|584139651|FG000|Overall Study|Pregnancy|3|||
161754385|NCT00422240|584139652|FG001|Overall Study|Pregnancy|1|||
161754386|NCT00422240|584139653|FG002|Overall Study|Pregnancy|1|||
161754387|NCT00422240|584139654|FG003|Overall Study|Pregnancy|2|||
161754388|NCT01927068|584139658|FG000|Overall Study|Death|37|||
161754389|NCT01927068|584139659|FG001|Overall Study|Death|3|||
161754390|NCT01927068|584139658|FG000|Overall Study|Withdrawal by Subject|50|||
161754391|NCT01927068|584139659|FG001|Overall Study|Withdrawal by Subject|3|||
161754392|NCT01927068|584139658|FG000|Overall Study|Lost to Follow-up|10|||
161754393|NCT01927068|584139659|FG001|Overall Study|Lost to Follow-up|2|||
161754394|NCT01927068|584139658|FG000|Overall Study|Physician Decision|9|||
161754395|NCT01927068|584139659|FG001|Overall Study|Physician Decision|0|||
161754396|NCT01927068|584139658|FG000|Overall Study|Missed last follow-up visit|2|||
161754397|NCT01927068|584139659|FG001|Overall Study|Missed last follow-up visit|0|||
161754398|NCT00880607|584139660|FG000|Overall Study|Physician Decision|2|||
161754399|NCT00880607|584139661|FG001|Overall Study|Physician Decision|2|||
161754400|NCT00880607|584139660|FG000|Overall Study|Protocol Violation|2|||
161754401|NCT00880607|584139661|FG001|Overall Study|Protocol Violation|1|||
161754402|NCT00880607|584139660|FG000|Overall Study|surgery did not extend past L1 level|3|||
161754403|NCT00880607|584139661|FG001|Overall Study|surgery did not extend past L1 level|0|||
161754404|NCT01624467|584139662|FG000|Overall Study|Withdrawal by Subject|2|||
161754405|NCT01624467|584139662|FG000|Overall Study|Lost to Follow-up|1|||
161754406|NCT01624467|584139662|FG000|Overall Study|Adverse Event|7|||
161754407|NCT01624467|584139662|FG000|Overall Study|Progressive Disease|19|||
161754408|NCT01624467|584139662|FG000|Overall Study|Per Sponsor Requirement|1|||
161754409|NCT01624467|584139662|FG000|Overall Study|Subject Withdrew from Treatment|1|||
161754410|NCT03964493|584139663|FG000|Overall Study|Withdrawal by Subject|4|||
161754411|NCT03964493|584139664|FG001|Overall Study|Withdrawal by Subject|1|||
161754412|NCT03964493|584139663|FG000|Overall Study|Lost to Follow-up|13|||
161754413|NCT03964493|584139664|FG001|Overall Study|Lost to Follow-up|4|||
161754414|NCT02092324|584139665|FG000|Overall Study|Adverse Event|1|||
161754415|NCT02092324|584139665|FG000|Overall Study|Lack of Efficacy|6|||
161754416|NCT02092324|584139665|FG000|Overall Study|Proceed to Transplant|3|||
161754417|NCT02092324|584139665|FG000|Overall Study|Physician Decision|7|||
161754418|NCT02092324|584139665|FG000|Overall Study|Misdiagnosis|2|||
161754419|NCT02224274|584139669|FG000|Overall Study|Death|1|||
161754420|NCT02224274|584139670|FG001|Overall Study|Death|0|||
161754421|NCT00887068|584139671|FG000|Overall Study|Withdrawal by Subject|2|||
161754422|NCT00887068|584139672|FG001|Overall Study|Withdrawal by Subject|0|||
161754423|NCT00887068|584139671|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
161754424|NCT00887068|584139672|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
161754425|NCT00499460|584139673|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
161754426|NCT00499460|584139674|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
161754427|NCT00499460|584139673|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
161754428|NCT00499460|584139674|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
161754429|NCT00499460|584139673|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
161754430|NCT00499460|584139674|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
161754431|NCT03073200|584139683|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161754432|NCT03073200|584139684|FG001|Double Blind Treatment Period|Protocol Violation|0|||
161754433|NCT03073200|584139685|FG002|Double Blind Treatment Period|Protocol Violation|0|||
161754434|NCT03073200|584139686|FG003|Double Blind Treatment Period|Protocol Violation|0|||
161754435|NCT03073200|584139687|FG004|Double Blind Treatment Period|Protocol Violation|0|||
161754436|NCT03073200|584139688|FG005|Double Blind Treatment Period|Protocol Violation|0|||
161754437|NCT03073200|584139689|FG006|Double Blind Treatment Period|Protocol Violation|0|||
161754438|NCT03073200|584139690|FG007|Double Blind Treatment Period|Protocol Violation|0|||
161754439|NCT03073200|584139691|FG008|Double Blind Treatment Period|Protocol Violation|0|||
161754440|NCT03073200|584139692|FG009|Double Blind Treatment Period|Protocol Violation|0|||
161754441|NCT03073200|584139693|FG010|Double Blind Treatment Period|Protocol Violation|0|||
161754442|NCT03073200|584139694|FG011|Double Blind Treatment Period|Protocol Violation|0|||
161754443|NCT03073200|584139695|FG012|Double Blind Treatment Period|Protocol Violation|0|||
161754444|NCT03073200|584139696|FG013|Double Blind Treatment Period|Protocol Violation|0|||
161754445|NCT03073200|584139697|FG014|Double Blind Treatment Period|Protocol Violation|0|||
161754446|NCT03073200|584139683|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161969222|NCT02378298|584935834|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
161969223|NCT02378298|584935835|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
161969224|NCT02378298|584935833|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
161754447|NCT03073200|584139684|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
161754448|NCT03073200|584139685|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754449|NCT03073200|584139686|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754450|NCT03073200|584139687|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754451|NCT03073200|584139688|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754452|NCT03073200|584139689|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754453|NCT03073200|584139690|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754454|NCT03073200|584139691|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754455|NCT03073200|584139692|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754456|NCT03073200|584139693|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754457|NCT03073200|584139694|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754458|NCT03073200|584139695|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754459|NCT03073200|584139696|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161754460|NCT03073200|584139697|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161969225|NCT02378298|584935834|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
161969226|NCT02378298|584935835|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
161969227|NCT02378298|584935833|FG000|Surveillance (19-68 Weeks)|Death|1|||
161754461|NCT03073200|584139683|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
161754462|NCT03073200|584139684|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754463|NCT03073200|584139685|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754464|NCT03073200|584139686|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754465|NCT03073200|584139687|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754466|NCT03073200|584139688|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754467|NCT03073200|584139689|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754468|NCT03073200|584139690|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754469|NCT03073200|584139691|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754470|NCT03073200|584139692|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754471|NCT03073200|584139693|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754472|NCT03073200|584139694|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754473|NCT03073200|584139695|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754474|NCT03073200|584139696|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754475|NCT03073200|584139697|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
161754476|NCT03073200|584139683|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754477|NCT03073200|584139684|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754478|NCT03073200|584139685|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754479|NCT03073200|584139686|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
161754480|NCT03073200|584139687|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
161754481|NCT03073200|584139688|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754482|NCT03073200|584139689|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
161969228|NCT02378298|584935834|FG001|Surveillance (19-68 Weeks)|Death|0|||
161969229|NCT02378298|584935835|FG002|Surveillance (19-68 Weeks)|Death|0|||
161969230|NCT03006458|584935837|FG000|First Intervention|Unsatisfied Vision|0|||
161969231|NCT03006458|584935838|FG001|First Intervention|Unsatisfied Vision|3|||
161969232|NCT01468233|584935841|FG000|Treatment Period 1|Adverse Event|5|||
161969233|NCT01468233|584935842|FG001|Treatment Period 1|Adverse Event|3|||
161969234|NCT01468233|584935843|FG002|Treatment Period 1|Adverse Event|0|||
161969235|NCT01468233|584935844|FG003|Treatment Period 1|Adverse Event|0|||
161969236|NCT01468233|584935845|FG004|Treatment Period 1|Adverse Event|0|||
161969237|NCT01468233|584935846|FG005|Treatment Period 1|Adverse Event|0|||
161969238|NCT01468233|584935841|FG000|Treatment Period 1|Withdrawal by Subject|3|||
161969239|NCT01468233|584935842|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161969240|NCT01468233|584935843|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161969241|NCT01468233|584935844|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161969242|NCT01468233|584935845|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161969243|NCT01468233|584935846|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161969244|NCT01468233|584935841|FG000|Treatment Period 1|Lost to Follow-up|3|||
161969245|NCT01468233|584935842|FG001|Treatment Period 1|Lost to Follow-up|0|||
161969246|NCT01468233|584935843|FG002|Treatment Period 1|Lost to Follow-up|0|||
161969247|NCT01468233|584935844|FG003|Treatment Period 1|Lost to Follow-up|0|||
161969248|NCT01468233|584935845|FG004|Treatment Period 1|Lost to Follow-up|0|||
161969249|NCT01468233|584935846|FG005|Treatment Period 1|Lost to Follow-up|0|||
161969250|NCT01468233|584935841|FG000|Treatment Period 1|Other|1|||
161969251|NCT01468233|584935842|FG001|Treatment Period 1|Other|1|||
161969252|NCT01468233|584935843|FG002|Treatment Period 1|Other|0|||
161969253|NCT01468233|584935844|FG003|Treatment Period 1|Other|0|||
161969254|NCT01468233|584935845|FG004|Treatment Period 1|Other|0|||
161969255|NCT01468233|584935846|FG005|Treatment Period 1|Other|0|||
161969256|NCT01468233|584935841|FG000|Treatment Period 2|Adverse Event|0|||
161969257|NCT01468233|584935842|FG001|Treatment Period 2|Adverse Event|0|||
161969258|NCT01468233|584935843|FG002|Treatment Period 2|Adverse Event|3|||
161969259|NCT01468233|584935844|FG003|Treatment Period 2|Adverse Event|0|||
161969260|NCT01468233|584935845|FG004|Treatment Period 2|Adverse Event|2|||
161969261|NCT01468233|584935846|FG005|Treatment Period 2|Adverse Event|1|||
161969262|NCT01468233|584935841|FG000|Treatment Period 2|Lack of Efficacy|0|||
161969263|NCT01468233|584935842|FG001|Treatment Period 2|Lack of Efficacy|0|||
161969264|NCT01468233|584935843|FG002|Treatment Period 2|Lack of Efficacy|9|||
161969265|NCT01468233|584935844|FG003|Treatment Period 2|Lack of Efficacy|2|||
161969266|NCT01468233|584935845|FG004|Treatment Period 2|Lack of Efficacy|0|||
161969267|NCT01468233|584935846|FG005|Treatment Period 2|Lack of Efficacy|1|||
161969268|NCT01468233|584935841|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161969269|NCT01468233|584935842|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161969270|NCT01468233|584935843|FG002|Treatment Period 2|Withdrawal by Subject|9|||
161969271|NCT01468233|584935844|FG003|Treatment Period 2|Withdrawal by Subject|1|||
161969272|NCT01468233|584935845|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161969273|NCT01468233|584935846|FG005|Treatment Period 2|Withdrawal by Subject|1|||
161969274|NCT01468233|584935841|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
161969275|NCT01468233|584935842|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
161969276|NCT01468233|584935843|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
161969277|NCT01468233|584935844|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
161969278|NCT01468233|584935845|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
161969279|NCT01468233|584935846|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
161969280|NCT01468233|584935841|FG000|Treatment Period 2|Lost to Follow-up|0|||
161969281|NCT01468233|584935842|FG001|Treatment Period 2|Lost to Follow-up|0|||
161969282|NCT01468233|584935843|FG002|Treatment Period 2|Lost to Follow-up|3|||
161969283|NCT01468233|584935844|FG003|Treatment Period 2|Lost to Follow-up|0|||
161969284|NCT01468233|584935845|FG004|Treatment Period 2|Lost to Follow-up|2|||
161969285|NCT01468233|584935846|FG005|Treatment Period 2|Lost to Follow-up|0|||
161969286|NCT01468233|584935841|FG000|Treatment Period 2|Other|0|||
161969287|NCT01468233|584935842|FG001|Treatment Period 2|Other|0|||
161969288|NCT01468233|584935843|FG002|Treatment Period 2|Other|3|||
161969289|NCT01468233|584935844|FG003|Treatment Period 2|Other|0|||
161969290|NCT01468233|584935845|FG004|Treatment Period 2|Other|1|||
161754483|NCT03073200|584139690|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754484|NCT03073200|584139691|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754485|NCT03073200|584139692|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754486|NCT03073200|584139693|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754487|NCT03073200|584139694|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754488|NCT03073200|584139695|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754489|NCT03073200|584139696|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754490|NCT03073200|584139697|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
161754491|NCT03073200|584139683|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
161754492|NCT03073200|584139684|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
161754493|NCT03073200|584139685|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
161754494|NCT03073200|584139686|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
161754495|NCT03073200|584139687|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
161754496|NCT03073200|584139688|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
161754497|NCT03073200|584139689|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
161754498|NCT03073200|584139690|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
161754499|NCT03073200|584139691|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
161754500|NCT03073200|584139692|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
161754501|NCT03073200|584139693|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
161754502|NCT03073200|584139694|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
161754503|NCT03073200|584139695|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
161754504|NCT03073200|584139696|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
161754505|NCT03073200|584139697|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
161754506|NCT03073200|584139683|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754507|NCT03073200|584139684|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754508|NCT03073200|584139685|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754509|NCT03073200|584139686|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754510|NCT03073200|584139687|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
161754511|NCT03073200|584139688|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754512|NCT03073200|584139689|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754513|NCT03073200|584139690|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754514|NCT03073200|584139691|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754515|NCT03073200|584139692|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754516|NCT03073200|584139693|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754517|NCT03073200|584139694|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754518|NCT03073200|584139695|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754519|NCT03073200|584139696|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754520|NCT03073200|584139697|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
161754521|NCT03073200|584139683|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754522|NCT03073200|584139684|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754523|NCT03073200|584139685|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754524|NCT03073200|584139686|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
161754525|NCT03073200|584139687|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
161754526|NCT03073200|584139688|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754527|NCT03073200|584139689|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754528|NCT03073200|584139690|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754529|NCT03073200|584139691|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754530|NCT03073200|584139692|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754531|NCT03073200|584139693|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754532|NCT03073200|584139694|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754533|NCT03073200|584139695|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754534|NCT03073200|584139696|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754535|NCT03073200|584139697|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161754536|NCT03073200|584139683|FG000|Extension Period|Lost to Follow-up|0|||
161754537|NCT03073200|584139684|FG001|Extension Period|Lost to Follow-up|0|||
161754538|NCT03073200|584139685|FG002|Extension Period|Lost to Follow-up|0|||
161754539|NCT03073200|584139686|FG003|Extension Period|Lost to Follow-up|0|||
161969291|NCT01468233|584935846|FG005|Treatment Period 2|Other|0|||
161969292|NCT01574157|584935847|FG000|Overall Study|Withdrawal by Subject|4|||
161969293|NCT01574157|584935848|FG001|Overall Study|Withdrawal by Subject|5|||
161969294|NCT01574157|584935847|FG000|Overall Study|Lost to Follow-up|0|||
161969295|NCT01574157|584935848|FG001|Overall Study|Lost to Follow-up|3|||
161969296|NCT01944098|584935849|FG000|Overall Study|Physician Decision|1|||
161969297|NCT01944098|584935850|FG001|Overall Study|Physician Decision|0|||
161969298|NCT02136680|584935851|FG000|Overall Study|No Longer Interested|1|||
161969299|NCT02136680|584935852|FG001|Overall Study|No Longer Interested|1|||
161969300|NCT02136680|584935851|FG000|Overall Study|No longer receiving care at clinic|3|||
161969301|NCT02136680|584935852|FG001|Overall Study|No longer receiving care at clinic|5|||
161969302|NCT02136680|584935851|FG000|Overall Study|Moved away|5|||
161969303|NCT02136680|584935852|FG001|Overall Study|Moved away|4|||
161969304|NCT02136680|584935851|FG000|Overall Study|Unable to schedule|17|||
161969305|NCT02136680|584935852|FG001|Overall Study|Unable to schedule|16|||
161969306|NCT02136680|584935851|FG000|Overall Study|Study ended before interview due|6|||
161969307|NCT02136680|584935852|FG001|Overall Study|Study ended before interview due|3|||
161969308|NCT01632241|584935853|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
161969309|NCT01632241|584935854|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
161969310|NCT01632241|584935853|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
161969311|NCT01632241|584935854|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
161969312|NCT01632241|584935853|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
161754540|NCT03073200|584139687|FG004|Extension Period|Lost to Follow-up|0|||
161754541|NCT03073200|584139688|FG005|Extension Period|Lost to Follow-up|0|||
161754542|NCT03073200|584139689|FG006|Extension Period|Lost to Follow-up|1|||
161754543|NCT03073200|584139690|FG007|Extension Period|Lost to Follow-up|1|||
161754544|NCT03073200|584139691|FG008|Extension Period|Lost to Follow-up|0|||
161754545|NCT03073200|584139692|FG009|Extension Period|Lost to Follow-up|0|||
161754546|NCT03073200|584139693|FG010|Extension Period|Lost to Follow-up|0|||
161754547|NCT03073200|584139694|FG011|Extension Period|Lost to Follow-up|0|||
161754548|NCT03073200|584139695|FG012|Extension Period|Lost to Follow-up|0|||
161754549|NCT03073200|584139696|FG013|Extension Period|Lost to Follow-up|0|||
161754550|NCT03073200|584139697|FG014|Extension Period|Lost to Follow-up|0|||
161754551|NCT03073200|584139683|FG000|Extension Period|Sponsor Decision|0|||
161754552|NCT03073200|584139684|FG001|Extension Period|Sponsor Decision|0|||
161754553|NCT03073200|584139685|FG002|Extension Period|Sponsor Decision|0|||
161754554|NCT03073200|584139686|FG003|Extension Period|Sponsor Decision|0|||
161754555|NCT03073200|584139687|FG004|Extension Period|Sponsor Decision|0|||
161754556|NCT03073200|584139688|FG005|Extension Period|Sponsor Decision|0|||
161754557|NCT03073200|584139689|FG006|Extension Period|Sponsor Decision|0|||
161754558|NCT03073200|584139690|FG007|Extension Period|Sponsor Decision|0|||
161754559|NCT03073200|584139691|FG008|Extension Period|Sponsor Decision|1|||
161754560|NCT03073200|584139692|FG009|Extension Period|Sponsor Decision|0|||
161754561|NCT03073200|584139693|FG010|Extension Period|Sponsor Decision|0|||
161754562|NCT03073200|584139694|FG011|Extension Period|Sponsor Decision|0|||
161754563|NCT03073200|584139695|FG012|Extension Period|Sponsor Decision|0|||
161754564|NCT03073200|584139696|FG013|Extension Period|Sponsor Decision|0|||
161754565|NCT03073200|584139697|FG014|Extension Period|Sponsor Decision|0|||
161754566|NCT03073200|584139683|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
161754567|NCT03073200|584139684|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
161754568|NCT03073200|584139685|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
161754569|NCT03073200|584139686|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
161754570|NCT03073200|584139687|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
161754571|NCT03073200|584139688|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
161754572|NCT03073200|584139689|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
161754573|NCT03073200|584139690|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
161754574|NCT03073200|584139691|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
161754575|NCT03073200|584139692|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
161754576|NCT03073200|584139693|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
161754577|NCT03073200|584139694|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
161754578|NCT03073200|584139695|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
161754579|NCT03073200|584139696|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
161754580|NCT03073200|584139697|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
161754581|NCT03073200|584139683|FG000|Extension Period|Withdrawal by Subject|0|||
161754582|NCT03073200|584139684|FG001|Extension Period|Withdrawal by Subject|0|||
161754583|NCT03073200|584139685|FG002|Extension Period|Withdrawal by Subject|0|||
161754584|NCT03073200|584139686|FG003|Extension Period|Withdrawal by Subject|0|||
161754585|NCT03073200|584139687|FG004|Extension Period|Withdrawal by Subject|0|||
161754586|NCT03073200|584139688|FG005|Extension Period|Withdrawal by Subject|0|||
161754587|NCT03073200|584139689|FG006|Extension Period|Withdrawal by Subject|1|||
161754588|NCT03073200|584139690|FG007|Extension Period|Withdrawal by Subject|2|||
161844920|NCT02980874|584474683|FG000|Overall Study|Unknown study completion status|1|||
161969313|NCT01632241|584935854|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
161969314|NCT01632241|584935853|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
161969315|NCT01632241|584935854|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
161969316|NCT01632241|584935853|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
161969317|NCT01632241|584935854|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
161754589|NCT03073200|584139691|FG008|Extension Period|Withdrawal by Subject|0|||
161754590|NCT03073200|584139692|FG009|Extension Period|Withdrawal by Subject|0|||
161754591|NCT03073200|584139693|FG010|Extension Period|Withdrawal by Subject|0|||
161754592|NCT03073200|584139694|FG011|Extension Period|Withdrawal by Subject|0|||
161754593|NCT03073200|584139695|FG012|Extension Period|Withdrawal by Subject|0|||
161754594|NCT03073200|584139696|FG013|Extension Period|Withdrawal by Subject|0|||
161754595|NCT03073200|584139697|FG014|Extension Period|Withdrawal by Subject|0|||
161754596|NCT03073200|584139683|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754597|NCT03073200|584139684|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754598|NCT03073200|584139685|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754599|NCT03073200|584139686|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754600|NCT03073200|584139687|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754601|NCT03073200|584139688|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754602|NCT03073200|584139689|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754603|NCT03073200|584139690|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754604|NCT03073200|584139691|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754605|NCT03073200|584139692|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754606|NCT03073200|584139693|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754607|NCT03073200|584139694|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
161754608|NCT03073200|584139695|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754609|NCT03073200|584139696|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754610|NCT03073200|584139697|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
161754611|NCT03073200|584139683|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754612|NCT03073200|584139684|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754613|NCT03073200|584139685|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754614|NCT03073200|584139686|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754615|NCT03073200|584139687|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754616|NCT03073200|584139688|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754617|NCT03073200|584139689|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754618|NCT03073200|584139690|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754619|NCT03073200|584139691|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754620|NCT03073200|584139692|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754621|NCT03073200|584139693|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754622|NCT03073200|584139694|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
161754623|NCT03073200|584139695|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754624|NCT03073200|584139696|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754625|NCT03073200|584139697|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161754626|NCT03073200|584139683|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754627|NCT03073200|584139684|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754628|NCT03073200|584139685|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754629|NCT03073200|584139686|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754630|NCT03073200|584139687|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754631|NCT03073200|584139688|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754632|NCT03073200|584139689|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754633|NCT03073200|584139690|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754634|NCT03073200|584139691|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754635|NCT03073200|584139692|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754636|NCT03073200|584139693|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
161754637|NCT03073200|584139694|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
161754638|NCT03073200|584139695|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754639|NCT03073200|584139696|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754640|NCT03073200|584139697|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161754641|NCT03073200|584139683|FG000|Randomized Withdrawal Period|Adverse Event|0|||
161754642|NCT03073200|584139684|FG001|Randomized Withdrawal Period|Adverse Event|0|||
161754643|NCT03073200|584139685|FG002|Randomized Withdrawal Period|Adverse Event|0|||
161754644|NCT03073200|584139686|FG003|Randomized Withdrawal Period|Adverse Event|0|||
161754645|NCT03073200|584139687|FG004|Randomized Withdrawal Period|Adverse Event|0|||
161754646|NCT03073200|584139688|FG005|Randomized Withdrawal Period|Adverse Event|0|||
161754647|NCT03073200|584139689|FG006|Randomized Withdrawal Period|Adverse Event|0|||
161754648|NCT03073200|584139690|FG007|Randomized Withdrawal Period|Adverse Event|0|||
161754649|NCT03073200|584139691|FG008|Randomized Withdrawal Period|Adverse Event|0|||
161754650|NCT03073200|584139692|FG009|Randomized Withdrawal Period|Adverse Event|0|||
161754651|NCT03073200|584139693|FG010|Randomized Withdrawal Period|Adverse Event|1|||
161969318|NCT01632241|584935853|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
161969319|NCT01632241|584935854|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
161969320|NCT01632241|584935853|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
161754652|NCT03073200|584139694|FG011|Randomized Withdrawal Period|Adverse Event|0|||
161754653|NCT03073200|584139695|FG012|Randomized Withdrawal Period|Adverse Event|0|||
161754654|NCT03073200|584139696|FG013|Randomized Withdrawal Period|Adverse Event|0|||
161969321|NCT01632241|584935854|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
161969322|NCT01632241|584935853|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
161969323|NCT01632241|584935854|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
161969324|NCT01632241|584935853|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
161969325|NCT01632241|584935854|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
161754655|NCT03073200|584139697|FG014|Randomized Withdrawal Period|Adverse Event|0|||
161754656|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754657|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754658|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754659|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754660|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754661|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754662|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754663|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754664|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754665|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754666|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754667|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754668|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754669|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
161754670|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
161754671|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754672|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754673|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754674|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754675|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754676|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754677|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754678|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754679|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754680|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754681|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754682|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754683|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754684|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
161754685|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161754686|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754687|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754688|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754689|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754690|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754691|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754692|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754693|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754694|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754695|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754696|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754697|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754698|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754699|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
161754700|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161754701|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754702|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754703|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754704|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754705|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754706|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754707|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754708|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754709|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754710|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754711|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754712|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754713|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754714|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
161754715|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161754716|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754717|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754718|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754719|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754720|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754721|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754722|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754723|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754724|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754725|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754726|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754727|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754728|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754729|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161754730|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
161754731|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754732|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754733|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754734|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754735|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754736|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754737|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754738|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754739|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754740|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754741|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754742|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754743|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754744|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
161754745|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161754746|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754747|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754748|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754749|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754750|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754751|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754752|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754753|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754754|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754755|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754756|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754757|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754758|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754759|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
161754760|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161754761|NCT03073200|584139683|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754762|NCT03073200|584139684|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754763|NCT03073200|584139685|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754764|NCT03073200|584139686|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754765|NCT03073200|584139687|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754766|NCT03073200|584139688|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754767|NCT03073200|584139689|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754768|NCT03073200|584139690|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754769|NCT03073200|584139691|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754770|NCT03073200|584139692|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754771|NCT03073200|584139693|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754772|NCT03073200|584139694|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754773|NCT03073200|584139695|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754774|NCT03073200|584139696|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
161754775|NCT03073200|584139697|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161754776|NCT01474889|584139698|FG000|Overall Study|Physician Decision|1|||
161754777|NCT01474889|584139699|FG001|Overall Study|Physician Decision|0|||
161754778|NCT01474889|584139700|FG002|Overall Study|Physician Decision|0|||
161754779|NCT01474889|584139698|FG000|Overall Study|Did not meet inclusion|1|||
161754780|NCT01474889|584139699|FG001|Overall Study|Did not meet inclusion|0|||
161754781|NCT01474889|584139700|FG002|Overall Study|Did not meet inclusion|0|||
161754782|NCT01474889|584139698|FG000|Overall Study|Withdrawal by Subject|0|||
161754783|NCT01474889|584139699|FG001|Overall Study|Withdrawal by Subject|1|||
161754784|NCT01474889|584139700|FG002|Overall Study|Withdrawal by Subject|0|||
161754785|NCT02973997|584142257|FG000|Overall Study|Withdrawal by Subject|4|||
161754786|NCT02973997|584142258|FG001|Overall Study|Withdrawal by Subject|0|||
161969326|NCT01632241|584935853|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
161969327|NCT01632241|584935854|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
161969328|NCT01632241|584935853|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
161969329|NCT01632241|584935854|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
161969330|NCT01632241|584935853|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
161969331|NCT01632241|584935854|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
161969332|NCT01632241|584935853|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
161969333|NCT01632241|584935854|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
161969334|NCT01632241|584935853|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
161969335|NCT01632241|584935854|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
161969336|NCT03559517|584935860|FG000|Overall Study|Withdrawal by Subject|1|||
161969337|NCT03559517|584935861|FG001|Overall Study|Withdrawal by Subject|0|||
161969338|NCT03559517|584935862|FG002|Overall Study|Withdrawal by Subject|0|||
161969339|NCT01846299|584935863|FG000|Overall Study|Physician Decision|4|||
161969340|NCT01846299|584935864|FG001|Overall Study|Physician Decision|2|||
161969341|NCT01846299|584935863|FG000|Overall Study|Protocol deviation|1|||
161969342|NCT01846299|584935864|FG001|Overall Study|Protocol deviation|0|||
161969343|NCT01846299|584935863|FG000|Overall Study|Death|1|||
161969344|NCT01846299|584935864|FG001|Overall Study|Death|2|||
161969345|NCT01846299|584935863|FG000|Overall Study|Lost to Follow-up|3|||
161969346|NCT01846299|584935864|FG001|Overall Study|Lost to Follow-up|0|||
161969347|NCT01846299|584935863|FG000|Overall Study|Withdrawal by Subject|1|||
161969348|NCT01846299|584935864|FG001|Overall Study|Withdrawal by Subject|6|||
161969349|NCT01846299|584935863|FG000|Overall Study|Adverse Event|2|||
161969350|NCT01846299|584935864|FG001|Overall Study|Adverse Event|0|||
161969351|NCT01960998|584935865|FG000|Overall Study|Lost to Follow-up|3|||
161754787|NCT02973997|584142257|FG000|Overall Study|Adverse Event|4|||
161754788|NCT02973997|584142258|FG001|Overall Study|Adverse Event|1|||
161754789|NCT02973997|584142257|FG000|Overall Study|Disease Progression|11|||
161754790|NCT02973997|584142258|FG001|Overall Study|Disease Progression|20|||
161754791|NCT02973997|584142257|FG000|Overall Study|Alternative Therapy|3|||
161754792|NCT02973997|584142258|FG001|Overall Study|Alternative Therapy|0|||
161754793|NCT02973997|584142257|FG000|Overall Study|Other complicating disease|0|||
161754794|NCT02973997|584142258|FG001|Overall Study|Other complicating disease|1|||
161754795|NCT02973997|584142257|FG000|Overall Study|Death|0|||
161754796|NCT02973997|584142258|FG001|Overall Study|Death|1|||
161754797|NCT00444951|584142259|FG000|Overall Study|Lost to Follow-up|1|||
161754798|NCT00444951|584142260|FG001|Overall Study|Lost to Follow-up|1|||
161754799|NCT00444951|584142261|FG002|Overall Study|Lost to Follow-up|0|||
161754800|NCT00444951|584142259|FG000|Overall Study|Withdrawal by Subject|4|||
161754801|NCT00444951|584142260|FG001|Overall Study|Withdrawal by Subject|5|||
161754802|NCT00444951|584142261|FG002|Overall Study|Withdrawal by Subject|3|||
161754803|NCT00887822|584142262|FG000|Overall Study|Insufficient therapeutic response|53|||
161754804|NCT00887822|584142263|FG001|Overall Study|Insufficient therapeutic response|55|||
161754805|NCT00887822|584142262|FG000|Overall Study|Adverse Event|14|||
161754806|NCT00887822|584142263|FG001|Overall Study|Adverse Event|17|||
161754807|NCT00887822|584142262|FG000|Overall Study|Failure to return|11|||
161754808|NCT00887822|584142263|FG001|Overall Study|Failure to return|11|||
161754809|NCT00887822|584142262|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
161754810|NCT00887822|584142263|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
161754811|NCT00887822|584142262|FG000|Overall Study|Administrative/Other than specified|5|||
161754812|NCT00887822|584142263|FG001|Overall Study|Administrative/Other than specified|4|||
161754813|NCT00887822|584142262|FG000|Overall Study|Death|2|||
161754814|NCT00887822|584142263|FG001|Overall Study|Death|3|||
161969352|NCT01960998|584935866|FG001|Overall Study|Lost to Follow-up|7|||
161969353|NCT01960998|584935865|FG000|Overall Study|Death|0|||
161969354|NCT01960998|584935866|FG001|Overall Study|Death|1|||
161969355|NCT01960998|584935865|FG000|Overall Study|Withdrawal by Subject|8|||
161969356|NCT01960998|584935866|FG001|Overall Study|Withdrawal by Subject|2|||
161754815|NCT00887822|584142262|FG000|Overall Study|Protocol Violation|0|||
161754816|NCT00887822|584142263|FG001|Overall Study|Protocol Violation|1|||
161754817|NCT00887822|584142262|FG000|Overall Study|Randomized but not treated|0|||
161754818|NCT00887822|584142263|FG001|Overall Study|Randomized but not treated|1|||
161754819|NCT02045979|584142267|FG000|Overall Study|Informed Consent Withdrawn|2|||
161969357|NCT01960998|584935865|FG000|Overall Study|lost computer access|0|||
161754820|NCT02045979|584142268|FG001|Overall Study|Informed Consent Withdrawn|0|||
161754821|NCT02045979|584142269|FG002|Overall Study|Informed Consent Withdrawn|1|||
161754822|NCT02045979|584142267|FG000|Overall Study|not specified above|0|||
161754823|NCT02045979|584142268|FG001|Overall Study|not specified above|1|||
161754824|NCT02045979|584142269|FG002|Overall Study|not specified above|0|||
161754825|NCT00378534|584142275|FG000|Overall Study|Participants did not receive transplant|3|||
161969358|NCT01960998|584935866|FG001|Overall Study|lost computer access|1|||
161969359|NCT00772369|584935870|FG000|Overall Study|Did not return record release form|1|||
161969360|NCT01774253|584935871|FG000|Overall Study|Lack of Efficacy|4|||
161969361|NCT01774253|584935871|FG000|Overall Study|Physician Decision|2|||
161969362|NCT01774253|584935871|FG000|Overall Study|Withdrawal by Subject|2|||
161969363|NCT01774253|584935871|FG000|Overall Study|Death|1|||
161969364|NCT03510468|584935872|FG000|Overall Study|Lost to Follow-up|1|||
161969365|NCT03510468|584935872|FG000|Overall Study|Adverse Event|5|||
161969366|NCT03510468|584935872|FG000|Overall Study|Physician Decision|1|||
161969367|NCT03510468|584935872|FG000|Overall Study|non-compliant with treatment|2|||
161969368|NCT03510468|584935872|FG000|Overall Study|Missed visit|1|||
161969369|NCT00871117|584935874|FG000|Overall Study|Lost to Follow-up|5|||
161969370|NCT00871117|584935875|FG001|Overall Study|Lost to Follow-up|6|||
161969371|NCT00871117|584935874|FG000|Overall Study|Other|0|||
161969372|NCT00871117|584935875|FG001|Overall Study|Other|4|||
161969373|NCT02080481|584935876|FG000|Overall Study|Never received a block.|1|||
161969374|NCT02080481|584935877|FG001|Overall Study|Never received a block.|0|||
161969375|NCT04508751|584935883|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
161969376|NCT04508751|584935884|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
161969377|NCT04508751|584935885|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
161969378|NCT03095027|584937742|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
161969379|NCT03095027|584937743|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
161969380|NCT02982018|584937744|FG000|Overall Study|Incorrect Lens Dispensed|1|||
161969381|NCT02982018|584937745|FG001|Overall Study|Incorrect Lens Dispensed|0|||
161969382|NCT02982018|584937744|FG000|Overall Study|Protocol Violation|1|||
161969383|NCT02982018|584937745|FG001|Overall Study|Protocol Violation|1|||
161969384|NCT02982018|584937744|FG000|Overall Study|Adverse Event|1|||
161969385|NCT02982018|584937745|FG001|Overall Study|Adverse Event|1|||
161969386|NCT02982018|584937744|FG000|Overall Study|Lens Discomfort|2|||
161969387|NCT02982018|584937745|FG001|Overall Study|Lens Discomfort|0|||
161969388|NCT02982018|584937744|FG000|Overall Study|Withdrawal by Subject|0|||
161969389|NCT02982018|584937745|FG001|Overall Study|Withdrawal by Subject|1|||
161969390|NCT01942161|584937746|FG000|Overall Study|Adverse Event|1|||
161969391|NCT01942161|584937747|FG001|Overall Study|Adverse Event|2|||
161969392|NCT01942161|584937748|FG002|Overall Study|Adverse Event|5|||
161969393|NCT01942161|584937746|FG000|Overall Study|Physician Decision|3|||
161969394|NCT01942161|584937747|FG001|Overall Study|Physician Decision|1|||
161969395|NCT01942161|584937748|FG002|Overall Study|Physician Decision|0|||
161969396|NCT01942161|584937746|FG000|Overall Study|Protocol Violation|1|||
161969397|NCT01942161|584937747|FG001|Overall Study|Protocol Violation|0|||
161969398|NCT01942161|584937748|FG002|Overall Study|Protocol Violation|0|||
161969399|NCT01942161|584937746|FG000|Overall Study|Withdrawal by Subject|3|||
161969400|NCT01942161|584937747|FG001|Overall Study|Withdrawal by Subject|3|||
161969401|NCT01942161|584937748|FG002|Overall Study|Withdrawal by Subject|1|||
161969402|NCT01257568|584937752|FG000|Overall Study|Lost to Follow-up|2|||
161969403|NCT01257568|584937752|FG000|Overall Study|Withdrawal by Subject|6|||
161969404|NCT01257568|584937752|FG000|Overall Study|Terminated|1|||
161969405|NCT01257568|584937752|FG000|Overall Study|Component Revision|24|||
161969406|NCT00132691|584937753|FG000|Overall Study|Lost to Follow-up|5|||
161969407|NCT00132691|584937754|FG001|Overall Study|Lost to Follow-up|8|||
161754826|NCT00378534|584142276|FG001|Overall Study|Participants did not receive transplant|0|||
161754827|NCT00425945|584142280|FG000|Overall Study|Concern about Supplement|2|||
161754828|NCT00425945|584142281|FG001|Overall Study|Concern about Supplement|0|||
161754829|NCT00425945|584142280|FG000|Overall Study|Inconvenience|0|||
161754830|NCT00425945|584142281|FG001|Overall Study|Inconvenience|2|||
161754831|NCT00425945|584142280|FG000|Overall Study|Lost to Follow-up|0|||
161754832|NCT00425945|584142281|FG001|Overall Study|Lost to Follow-up|2|||
161754833|NCT00425945|584142280|FG000|Overall Study|Began hypertension medication|1|||
161754834|NCT00425945|584142281|FG001|Overall Study|Began hypertension medication|0|||
161754835|NCT00425945|584142280|FG000|Overall Study|Began cancer treatments|1|||
161754836|NCT00425945|584142281|FG001|Overall Study|Began cancer treatments|0|||
161969408|NCT00132691|584937753|FG000|Overall Study|Missed 2-year visit|4|||
161969409|NCT00132691|584937754|FG001|Overall Study|Missed 2-year visit|4|||
161969410|NCT00132691|584937753|FG000|Overall Study|Death|2|||
161969411|NCT00132691|584937754|FG001|Overall Study|Death|0|||
161969412|NCT00798317|584937755|FG000|Overall Study|Physician Decision|0|||
161969413|NCT00798317|584937756|FG001|Overall Study|Physician Decision|1|||
161969414|NCT00798317|584937755|FG000|Overall Study|Withdrawal by Subject|5|||
161969415|NCT00798317|584937756|FG001|Overall Study|Withdrawal by Subject|4|||
161969416|NCT00798317|584937755|FG000|Overall Study|Lost to Follow-up|2|||
161969417|NCT00798317|584937756|FG001|Overall Study|Lost to Follow-up|2|||
161969418|NCT00798317|584937755|FG000|Overall Study|Adverse Event|2|||
161754837|NCT00425945|584142280|FG000|Overall Study|Moved from area|0|||
161969419|NCT00798317|584937756|FG001|Overall Study|Adverse Event|0|||
161969420|NCT00798317|584937755|FG000|Overall Study|Death|1|||
161969421|NCT00798317|584937756|FG001|Overall Study|Death|0|||
161969422|NCT00919867|584937757|FG000|First Intervention|Withdrawal by Subject|0|||
161969423|NCT00919867|584937758|FG001|First Intervention|Withdrawal by Subject|0|||
161969424|NCT00919867|584937759|FG002|First Intervention|Withdrawal by Subject|1|||
161754838|NCT00425945|584142281|FG001|Overall Study|Moved from area|1|||
161754839|NCT03878160|584142285|FG000|Overall Study|Lost to Follow-up|1|||
161754840|NCT03878160|584142286|FG001|Overall Study|Lost to Follow-up|1|||
161754841|NCT03878160|584142287|FG002|Overall Study|Lost to Follow-up|1|||
161754842|NCT03878160|584142285|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
161754843|NCT03878160|584142286|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
161754844|NCT03878160|584142287|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
161754845|NCT05618808|584142288|FG000|Overall Study|Withdrawal by Subject|3|||
161754846|NCT05618808|584142289|FG001|Overall Study|Withdrawal by Subject|1|||
161754847|NCT05618808|584142290|FG002|Overall Study|Withdrawal by Subject|3|||
161754848|NCT02365506|584142291|FG000|Overall Study|Investigator's Discretion|0|||
161754849|NCT02365506|584142292|FG001|Overall Study|Investigator's Discretion|0|||
161754850|NCT02365506|584142293|FG002|Overall Study|Investigator's Discretion|1|||
161754851|NCT06048367|584142296|FG000|Overall Study|Withdrawal by Subject|0|||
161754852|NCT06048367|584142297|FG001|Overall Study|Withdrawal by Subject|1|||
161754853|NCT06048367|584142298|FG002|Overall Study|Withdrawal by Subject|0|||
161754854|NCT06048367|584142299|FG003|Overall Study|Withdrawal by Subject|0|||
161754855|NCT06048367|584142300|FG004|Overall Study|Withdrawal by Subject|0|||
161754856|NCT06048367|584142296|FG000|Overall Study|Withdrawal by Subject|0|||
161754857|NCT06048367|584142297|FG001|Overall Study|Withdrawal by Subject|0|||
161754858|NCT06048367|584142298|FG002|Overall Study|Withdrawal by Subject|1|||
161754859|NCT06048367|584142299|FG003|Overall Study|Withdrawal by Subject|0|||
161754860|NCT06048367|584142300|FG004|Overall Study|Withdrawal by Subject|0|||
161754861|NCT06048367|584142296|FG000|Overall Study|Withdrawal by Subject|0|||
161754862|NCT06048367|584142297|FG001|Overall Study|Withdrawal by Subject|0|||
161754863|NCT06048367|584142298|FG002|Overall Study|Withdrawal by Subject|0|||
161754864|NCT06048367|584142299|FG003|Overall Study|Withdrawal by Subject|1|||
161754865|NCT06048367|584142300|FG004|Overall Study|Withdrawal by Subject|0|||
161754866|NCT06048367|584142296|FG000|Overall Study|Withdrawal by Subject|0|||
161754867|NCT06048367|584142297|FG001|Overall Study|Withdrawal by Subject|0|||
161754868|NCT06048367|584142298|FG002|Overall Study|Withdrawal by Subject|0|||
161754869|NCT06048367|584142299|FG003|Overall Study|Withdrawal by Subject|1|||
161754870|NCT06048367|584142300|FG004|Overall Study|Withdrawal by Subject|0|||
161754871|NCT03287830|584142305|FG000|Overall Study|Withdrawal by Subject|1|||
161754872|NCT03287830|584142306|FG001|Overall Study|Withdrawal by Subject|1|||
161754873|NCT03287830|584142305|FG000|Overall Study|not meeting inclusion criteria|5|||
161754874|NCT03287830|584142306|FG001|Overall Study|not meeting inclusion criteria|12|||
161754875|NCT03598140|584142309|FG000|Overall Study|enrolled but didn't start|1|||
161754876|NCT03598140|584142310|FG001|Overall Study|enrolled but didn't start|0|||
161754877|NCT02155712|584142314|FG000|Overall Study|Death|12|||
161754878|NCT02155712|584142315|FG001|Overall Study|Death|0|||
161754879|NCT02155712|584142314|FG000|Overall Study|Lost to Follow-up|37|||
161754880|NCT02155712|584142315|FG001|Overall Study|Lost to Follow-up|22|||
161754881|NCT02155712|584142314|FG000|Overall Study|Revision of device|4|||
161754882|NCT02155712|584142315|FG001|Overall Study|Revision of device|3|||
161754883|NCT02155712|584142314|FG000|Overall Study|Withdrawal by Subject|39|||
161754884|NCT02155712|584142315|FG001|Overall Study|Withdrawal by Subject|21|||
161754885|NCT02155712|584142314|FG000|Overall Study|Site termination|77|||
161754886|NCT02155712|584142315|FG001|Overall Study|Site termination|19|||
161754887|NCT02155712|584142314|FG000|Overall Study|Sponsor terminated study early|150|||
161754888|NCT02155712|584142315|FG001|Overall Study|Sponsor terminated study early|0|||
161754889|NCT02155712|584142314|FG000|Overall Study|Missed final 5-year protocol visit|0|||
161754890|NCT02155712|584142315|FG001|Overall Study|Missed final 5-year protocol visit|32|||
161754891|NCT02155712|584142314|FG000|Overall Study|Censored because surgery cancelled|6|||
161754892|NCT02155712|584142315|FG001|Overall Study|Censored because surgery cancelled|10|||
161754893|NCT02155712|584142314|FG000|Overall Study|Censored because study device was not implanted|61|||
161754894|NCT02155712|584142315|FG001|Overall Study|Censored because study device was not implanted|66|||
161754895|NCT02155712|584142314|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
161754896|NCT02155712|584142315|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
161754897|NCT02060903|584142316|FG000|Overall Study|Lost to Follow-up|4|||
161969425|NCT00919867|584937760|FG003|First Intervention|Withdrawal by Subject|0|||
161969426|NCT00919867|584937761|FG004|First Intervention|Withdrawal by Subject|0|||
161969427|NCT00919867|584937762|FG005|First Intervention|Withdrawal by Subject|0|||
161969428|NCT00919867|584937757|FG000|First Intervention|Physician Decision|0|||
161969429|NCT00919867|584937758|FG001|First Intervention|Physician Decision|0|||
161754898|NCT02060903|584142317|FG001|Overall Study|Lost to Follow-up|0|||
161754899|NCT02060903|584142316|FG000|Overall Study|Withdrawal by Subject|0|||
161754900|NCT02060903|584142317|FG001|Overall Study|Withdrawal by Subject|7|||
161754901|NCT02418585|584142318|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
161754902|NCT02418585|584142319|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
161754903|NCT02418585|584142318|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
161754904|NCT02418585|584142319|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
161754905|NCT02418585|584142318|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
161754906|NCT02418585|584142319|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
161754907|NCT02418585|584142318|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
161754908|NCT02418585|584142319|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
161754909|NCT02418585|584142318|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
161754910|NCT02418585|584142319|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
161754911|NCT02418585|584142318|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
161754912|NCT02418585|584142319|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
161754913|NCT02418585|584142318|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
161754914|NCT02418585|584142319|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
161754915|NCT02418585|584142318|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
161754916|NCT02418585|584142319|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
161754917|NCT02418585|584142318|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
161754918|NCT02418585|584142319|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
161754919|NCT02418585|584142318|FG000|Follow-up Phase (24 Weeks)|Other|3|||
161754920|NCT02418585|584142319|FG001|Follow-up Phase (24 Weeks)|Other|2|||
161754921|NCT01688999|584142322|FG000|Overall Study|Withdrawal by Subject|5|||
161754922|NCT01688999|584142323|FG001|Overall Study|Withdrawal by Subject|1|||
161754923|NCT01688999|584142324|FG002|Overall Study|Withdrawal by Subject|1|||
161754924|NCT01688999|584142322|FG000|Overall Study|Adverse Event|2|||
161754925|NCT01688999|584142323|FG001|Overall Study|Adverse Event|0|||
161754926|NCT01688999|584142324|FG002|Overall Study|Adverse Event|2|||
161754927|NCT01688999|584142322|FG000|Overall Study|Ineligible/Not treated|1|||
161754928|NCT01688999|584142323|FG001|Overall Study|Ineligible/Not treated|0|||
161969430|NCT00919867|584937759|FG002|First Intervention|Physician Decision|0|||
161969431|NCT00919867|584937760|FG003|First Intervention|Physician Decision|0|||
161754929|NCT01688999|584142324|FG002|Overall Study|Ineligible/Not treated|0|||
161754930|NCT02768103|584142325|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
161754931|NCT00498368|584142353|FG000|Overall Study|Withdrawal by Subject|3|||
161754932|NCT00498368|584142354|FG001|Overall Study|Withdrawal by Subject|2|||
161754933|NCT01855425|584142362|FG000|Overall Study|Physician Decision|20|||
161754934|NCT02148952|584142369|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
161754935|NCT02148952|584142370|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
161754936|NCT02148952|584142369|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
161754937|NCT02148952|584142370|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
161754938|NCT02148952|584142369|FG000|Follow-Up|Lost to Follow-up|219|||
161754939|NCT02148952|584142370|FG001|Follow-Up|Lost to Follow-up|231|||
161754940|NCT02148952|584142369|FG000|Follow-Up|Withdrawal by Subject|46|||
161754941|NCT02148952|584142370|FG001|Follow-Up|Withdrawal by Subject|48|||
161754942|NCT01600105|584142371|FG000|Total Participants|Withdrawal by Subject|1|||
161754943|NCT01600105|584142372|FG001|Total Participants|Withdrawal by Subject|0|||
161754944|NCT01600105|584142371|FG000|Total Participants|No images in PACS|10|||
161754945|NCT01600105|584142372|FG001|Total Participants|No images in PACS|0|||
161754946|NCT01600105|584142371|FG000|Total Participants|Insufficient image quality|30|||
161754947|NCT01600105|584142372|FG001|Total Participants|Insufficient image quality|10|||
161754948|NCT01600105|584142371|FG000|Sub Study I|Insufficient image quality|0|||
161754949|NCT01600105|584142372|FG001|Sub Study I|Insufficient image quality|10|||
161754950|NCT01600105|584142371|FG000|Sub Study II|Withdrawal by Subject|1|||
161754951|NCT01600105|584142372|FG001|Sub Study II|Withdrawal by Subject|0|||
161754952|NCT01600105|584142371|FG000|Sub Study II|No images in PACS|1|||
161754953|NCT01600105|584142372|FG001|Sub Study II|No images in PACS|0|||
161754954|NCT01600105|584142371|FG000|Sub Study II|Insufficient image quality|3|||
161754955|NCT01600105|584142372|FG001|Sub Study II|Insufficient image quality|0|||
161754956|NCT01600105|584142371|FG000|Sub Study III|Insufficient image quality|5|||
161754957|NCT01600105|584142372|FG001|Sub Study III|Insufficient image quality|0|||
161754958|NCT01600105|584142371|FG000|Sub Study V|Poor Image Quality|2|||
161754959|NCT01600105|584142372|FG001|Sub Study V|Poor Image Quality|0|||
161754960|NCT01263444|584142373|FG000|Overall Study|Adverse Event|8|||
161754961|NCT01263444|584142373|FG000|Overall Study|Withdrawal by Subject|1|||
161754962|NCT01263444|584142373|FG000|Overall Study|Protocol Violation|1|||
161754963|NCT01764022|584142374|FG000|Overall Study|Death|3|||
161754964|NCT01764022|584142375|FG001|Overall Study|Death|5|||
161754965|NCT01764022|584142374|FG000|Overall Study|Withdrawal by Subject|2|||
161754966|NCT01764022|584142375|FG001|Overall Study|Withdrawal by Subject|6|||
161754967|NCT01764022|584142374|FG000|Overall Study|Lack of Efficacy|0|||
161754968|NCT01764022|584142375|FG001|Overall Study|Lack of Efficacy|1|||
161754969|NCT01764022|584142374|FG000|Overall Study|Physician Decision|0|||
161754970|NCT01764022|584142375|FG001|Overall Study|Physician Decision|2|||
161754971|NCT01764022|584142374|FG000|Overall Study|Lost to Follow-up|2|||
161754972|NCT01764022|584142375|FG001|Overall Study|Lost to Follow-up|0|||
161754973|NCT01764022|584142374|FG000|Overall Study|Protocol Violation|1|||
161754974|NCT01764022|584142375|FG001|Overall Study|Protocol Violation|0|||
161754975|NCT01899768|584142376|FG000|Part A|Adverse Event|2|||
161754976|NCT01899768|584142376|FG000|Part A|Withdrawal by Subject|1|||
161754977|NCT01899768|584142376|FG000|Part B|Adverse Event|1|||
161969432|NCT00919867|584937761|FG004|First Intervention|Physician Decision|0|||
161969433|NCT00919867|584937762|FG005|First Intervention|Physician Decision|1|||
161969434|NCT03361189|584937770|FG000|Overall Study|Received heart transplant|1|||
161969435|NCT03361189|584937771|FG001|Overall Study|Received heart transplant|0|||
161969436|NCT03361189|584937770|FG000|Overall Study|Pacemake replacement|0|||
161969437|NCT03361189|584937771|FG001|Overall Study|Pacemake replacement|1|||
161969438|NCT03344549|584937772|FG000|Overall Study|Withdrawal by Subject|3|||
161969439|NCT03344549|584937773|FG001|Overall Study|Withdrawal by Subject|2|||
161969440|NCT03344549|584937772|FG000|Overall Study|Dialysis|2|||
161969441|NCT03344549|584937773|FG001|Overall Study|Dialysis|0|||
161969442|NCT03344549|584937772|FG000|Overall Study|Cancer|1|||
161969443|NCT03344549|584937773|FG001|Overall Study|Cancer|0|||
161969444|NCT03344549|584937772|FG000|Overall Study|Lack of electronic device|1|||
161969445|NCT03344549|584937773|FG001|Overall Study|Lack of electronic device|0|||
161969446|NCT03344549|584937772|FG000|Overall Study|Transportation difficulty|0|||
161969447|NCT03344549|584937773|FG001|Overall Study|Transportation difficulty|13|||
161969448|NCT01685801|584937779|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
161969449|NCT01685801|584937780|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
161969450|NCT01685801|584937781|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
161969451|NCT01685801|584937782|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
161754978|NCT01899768|584142376|FG000|Part B|Withdrawal by Subject|1|||
161754979|NCT04043416|584142378|FG000|Washout|Change in health condition|0|||
161754980|NCT04043416|584142379|FG001|Washout|Change in health condition|1|||
161754981|NCT00414973|584142380|FG000|Overall Study|Withdrawal by Subject|14|||
161754982|NCT00414973|584142381|FG001|Overall Study|Withdrawal by Subject|4|||
161754983|NCT00414973|584142382|FG002|Overall Study|Withdrawal by Subject|1|||
161754984|NCT00414973|584142383|FG003|Overall Study|Withdrawal by Subject|0|||
161754985|NCT00414973|584142380|FG000|Overall Study|Adverse Event|10|||
161754986|NCT00414973|584142381|FG001|Overall Study|Adverse Event|0|||
161754987|NCT00414973|584142382|FG002|Overall Study|Adverse Event|1|||
161754988|NCT00414973|584142383|FG003|Overall Study|Adverse Event|0|||
161754989|NCT00414973|584142380|FG000|Overall Study|Protocol Violation|3|||
161754990|NCT00414973|584142381|FG001|Overall Study|Protocol Violation|4|||
161754991|NCT00414973|584142382|FG002|Overall Study|Protocol Violation|0|||
161754992|NCT00414973|584142383|FG003|Overall Study|Protocol Violation|0|||
161754993|NCT00414973|584142380|FG000|Overall Study|Lost to Follow-up|0|||
161754994|NCT00414973|584142381|FG001|Overall Study|Lost to Follow-up|2|||
161754995|NCT00414973|584142382|FG002|Overall Study|Lost to Follow-up|0|||
161754996|NCT00414973|584142383|FG003|Overall Study|Lost to Follow-up|0|||
161754997|NCT00414973|584142380|FG000|Overall Study|Sponsor Decision|1|||
161754998|NCT00414973|584142381|FG001|Overall Study|Sponsor Decision|0|||
161754999|NCT00414973|584142382|FG002|Overall Study|Sponsor Decision|0|||
161755000|NCT00414973|584142383|FG003|Overall Study|Sponsor Decision|0|||
161755001|NCT00414973|584142380|FG000|Overall Study|Death|0|||
161755002|NCT00414973|584142381|FG001|Overall Study|Death|0|||
161755003|NCT00414973|584142382|FG002|Overall Study|Death|1|||
161755004|NCT00414973|584142383|FG003|Overall Study|Death|0|||
161755005|NCT01466062|584142384|FG000|Overall Study|Adverse Event|1|||
161755006|NCT01466062|584142384|FG000|Overall Study|Withdrawal by Subject|1|||
161755007|NCT00118040|584142385|FG000|Overall Study|Adverse Event|0|||
161755008|NCT00118040|584142386|FG001|Overall Study|Adverse Event|1|||
161755009|NCT00118040|584142387|FG002|Overall Study|Adverse Event|0|||
161755010|NCT00118040|584142385|FG000|Overall Study|Withdrawal by Subject|0|||
161755011|NCT00118040|584142386|FG001|Overall Study|Withdrawal by Subject|0|||
161755012|NCT00118040|584142387|FG002|Overall Study|Withdrawal by Subject|2|||
161755013|NCT00118040|584142385|FG000|Overall Study|Medical Contraindication|0|||
161755014|NCT00118040|584142386|FG001|Overall Study|Medical Contraindication|0|||
161755015|NCT00118040|584142387|FG002|Overall Study|Medical Contraindication|1|||
161755016|NCT00118040|584142385|FG000|Overall Study|Non-Compliant Participant|1|||
161755017|NCT00118040|584142386|FG001|Overall Study|Non-Compliant Participant|1|||
161755018|NCT00118040|584142387|FG002|Overall Study|Non-Compliant Participant|2|||
161755019|NCT00118040|584142385|FG000|Overall Study|Other|0|||
161755020|NCT00118040|584142386|FG001|Overall Study|Other|0|||
161755021|NCT00118040|584142387|FG002|Overall Study|Other|1|||
161969452|NCT01685801|584937779|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
162032825|NCT01150474|585177486|FG000|Overall Study|Drug not administered|1|||
162032826|NCT01150474|585177487|FG001|Overall Study|Drug not administered|0|||
161755022|NCT02865928|584142388|FG000|Overall Study|Withdrawal by Subject|1|||
161755023|NCT02865928|584142389|FG001|Overall Study|Withdrawal by Subject|0|||
161755024|NCT02865928|584142388|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
161755025|NCT02865928|584142389|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
161755026|NCT02865928|584142388|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
161969453|NCT01685801|584937780|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
161969454|NCT01685801|584937781|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
162032827|NCT01150474|585177486|FG000|Overall Study|Surgery Changed|1|||
161969455|NCT01685801|584937782|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
161969456|NCT00113399|584937783|FG000|Overall Study|Death|1|||
161755027|NCT02865928|584142389|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
161755028|NCT01925014|584142390|FG000|Overall Study|Inappropriate enrollment|4|||
161755029|NCT01925014|584142391|FG001|Overall Study|Inappropriate enrollment|6|||
161755030|NCT01925014|584142390|FG000|Overall Study|Withdrawal by Subject|5|||
161755031|NCT01925014|584142391|FG001|Overall Study|Withdrawal by Subject|13|||
161755032|NCT01196091|584142395|FG000|Overall Study|Adverse Event|22|||
161755033|NCT01196091|584142396|FG001|Overall Study|Adverse Event|27|||
161755034|NCT01196091|584142397|FG002|Overall Study|Adverse Event|26|||
161755035|NCT01196091|584142395|FG000|Overall Study|Death|3|||
161755036|NCT01196091|584142396|FG001|Overall Study|Death|2|||
161755037|NCT01196091|584142397|FG002|Overall Study|Death|2|||
161755038|NCT01196091|584142395|FG000|Overall Study|Entry Criteria Not Met|11|||
161755039|NCT01196091|584142396|FG001|Overall Study|Entry Criteria Not Met|11|||
161755040|NCT01196091|584142397|FG002|Overall Study|Entry Criteria Not Met|10|||
161755041|NCT01196091|584142395|FG000|Overall Study|Lack of Efficacy|15|||
161755042|NCT01196091|584142396|FG001|Overall Study|Lack of Efficacy|12|||
161755043|NCT01196091|584142397|FG002|Overall Study|Lack of Efficacy|17|||
161755044|NCT01196091|584142395|FG000|Overall Study|Lost to Follow-up|5|||
161755045|NCT01196091|584142396|FG001|Overall Study|Lost to Follow-up|5|||
161755046|NCT01196091|584142397|FG002|Overall Study|Lost to Follow-up|6|||
161755047|NCT01196091|584142395|FG000|Overall Study|Parent/Caregiver Decision|0|||
161755048|NCT01196091|584142396|FG001|Overall Study|Parent/Caregiver Decision|0|||
161755049|NCT01196091|584142397|FG002|Overall Study|Parent/Caregiver Decision|1|||
161755050|NCT01196091|584142395|FG000|Overall Study|Withdrawal by Subject|16|||
161755051|NCT01196091|584142396|FG001|Overall Study|Withdrawal by Subject|19|||
161755052|NCT01196091|584142397|FG002|Overall Study|Withdrawal by Subject|22|||
161755053|NCT01196091|584142395|FG000|Overall Study|Physician Decision|3|||
161755054|NCT01196091|584142396|FG001|Overall Study|Physician Decision|3|||
161755055|NCT01196091|584142397|FG002|Overall Study|Physician Decision|4|||
161755056|NCT01196091|584142395|FG000|Overall Study|Protocol Violation|1|||
161755057|NCT01196091|584142396|FG001|Overall Study|Protocol Violation|3|||
161755058|NCT01196091|584142397|FG002|Overall Study|Protocol Violation|3|||
161755059|NCT01196091|584142395|FG000|Overall Study|Sponsor Decision|6|||
161755060|NCT01196091|584142396|FG001|Overall Study|Sponsor Decision|5|||
161755061|NCT01196091|584142397|FG002|Overall Study|Sponsor Decision|4|||
161755062|NCT01196091|584142395|FG000|Overall Study|Excluded Site|5|||
161755063|NCT01196091|584142396|FG001|Overall Study|Excluded Site|11|||
161755064|NCT01196091|584142397|FG002|Overall Study|Excluded Site|8|||
161755065|NCT01196091|584142395|FG000|Overall Study|Randomized, No Study Drug Received|1|||
161755066|NCT01196091|584142396|FG001|Overall Study|Randomized, No Study Drug Received|0|||
161755067|NCT01196091|584142397|FG002|Overall Study|Randomized, No Study Drug Received|1|||
161755068|NCT03733249|584142398|FG000|Overall Study|Death|7|||
161755069|NCT03733249|584142398|FG000|Overall Study|Disease relapse|16|||
161755070|NCT03733249|584142398|FG000|Overall Study|Lost to Follow-up|4|||
161755071|NCT03733249|584142398|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
161755072|NCT03733249|584142398|FG000|Overall Study|Withdrawal by Subject|1|||
161755073|NCT04476108|584142399|FG000|Overall Study|Adverse Event|4|||
161755074|NCT04476108|584142400|FG001|Overall Study|Adverse Event|1|||
161755075|NCT04476108|584142399|FG000|Overall Study|Lost to Follow-up|1|||
161755076|NCT04476108|584142400|FG001|Overall Study|Lost to Follow-up|0|||
161755077|NCT04476108|584142399|FG000|Overall Study|Inadvertent Enrollment|1|||
161755078|NCT04476108|584142400|FG001|Overall Study|Inadvertent Enrollment|0|||
161755079|NCT04476108|584142399|FG000|Overall Study|Protocol Violation|1|||
161755080|NCT04476108|584142400|FG001|Overall Study|Protocol Violation|1|||
161755081|NCT04476108|584142399|FG000|Overall Study|Withdrawal by Subject|1|||
161755082|NCT04476108|584142400|FG001|Overall Study|Withdrawal by Subject|1|||
161755083|NCT00471276|584142401|FG000|Overall Study|Death|2|||
161755084|NCT00471276|584142401|FG000|Overall Study|Adverse Event|16|||
161755085|NCT00471276|584142401|FG000|Overall Study|Protocol Violation|1|||
161755086|NCT00471276|584142401|FG000|Overall Study|Objective progression or relapse|54|||
161755087|NCT00471276|584142401|FG000|Overall Study|Global deterioration of health status|1|||
161755088|NCT00471276|584142401|FG000|Overall Study|Other|3|||
161755089|NCT00471276|584142401|FG000|Overall Study|Refused treatment|6|||
161755090|NCT01487863|584142405|FG000|Overall Study|Death|19|||
161755091|NCT01487863|584142406|FG001|Overall Study|Death|19|||
161755092|NCT02324049|584142410|FG000|Part C|Study terminated|11|||
161755093|NCT02159365|584142411|FG000|Overall Study|Disease Progression|23|||
161755094|NCT02159365|584142411|FG000|Overall Study|Other reasons|11|||
161755095|NCT02159365|584142411|FG000|Overall Study|Administrative reason by Sponsor|9|||
161755096|NCT02159365|584142411|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
161755097|NCT02159365|584142411|FG000|Overall Study|Study drug toxicity|7|||
161755098|NCT02159365|584142411|FG000|Overall Study|Maximum clinical benefit|3|||
161755099|NCT02159365|584142411|FG000|Overall Study|Subject request to discontinue treatment|3|||
161755100|NCT02159365|584142411|FG000|Overall Study|Subject withdrew consent|3|||
161755101|NCT02159365|584142411|FG000|Overall Study|Death|1|||
161755102|NCT02159365|584142411|FG000|Overall Study|Lost to Follow-up|1|||
161755103|NCT01437267|584142412|FG000|Overall Study|Withdrawal by Subject|0|||
161969457|NCT00113399|584937784|FG001|Overall Study|Death|1|||
161969458|NCT00113399|584937783|FG000|Overall Study|Withdrawal by Subject|1|||
161969459|NCT00113399|584937784|FG001|Overall Study|Withdrawal by Subject|2|||
161969460|NCT00113399|584937783|FG000|Overall Study|Complete Response|0|||
161969461|NCT00113399|584937784|FG001|Overall Study|Complete Response|1|||
161969462|NCT00113399|584937783|FG000|Overall Study|Other|0|||
161969463|NCT00113399|584937784|FG001|Overall Study|Other|1|||
161969464|NCT03350256|584937785|FG000|Overall Study|Inclusion/exclusion violation|4|||
161969465|NCT03350256|584937785|FG000|Overall Study|Recommended for other therapies|2|||
161969466|NCT03350256|584937785|FG000|Overall Study|Protocol Violation|3|||
162032828|NCT01150474|585177487|FG001|Overall Study|Surgery Changed|0|||
162032829|NCT04231981|585177488|FG000|Overall Study|Adverse Event|1|||
162032830|NCT04231981|585177488|FG000|Overall Study|Death|16|||
162032831|NCT04231981|585177488|FG000|Overall Study|Lost to Follow-up|1|||
162032832|NCT02581943|585177489|FG000|Overall Study|Death|5|||
162032833|NCT02581943|585177490|FG001|Overall Study|Death|2|||
162032834|NCT02581943|585177489|FG000|Overall Study|Disease Progression|12|||
162032835|NCT02581943|585177490|FG001|Overall Study|Disease Progression|15|||
162032836|NCT02581943|585177489|FG000|Overall Study|Withdrawal by Subject|1|||
162032837|NCT02581943|585177490|FG001|Overall Study|Withdrawal by Subject|2|||
162032838|NCT01470989|585177491|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
162032839|NCT01470989|585177492|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
162032840|NCT01470989|585177491|FG000|Overall Study|Adverse Event|2|||
162032841|NCT01470989|585177492|FG001|Overall Study|Adverse Event|5|||
162032842|NCT01470989|585177491|FG000|Overall Study|Abnormal laboratory value|1|||
162032843|NCT01470989|585177492|FG001|Overall Study|Abnormal laboratory value|1|||
162032844|NCT01470989|585177491|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162032845|NCT01470989|585177492|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
162032846|NCT01470989|585177491|FG000|Overall Study|Withdrawal by Subject|19|||
162032847|NCT01470989|585177492|FG001|Overall Study|Withdrawal by Subject|17|||
162032848|NCT01470989|585177491|FG000|Overall Study|Lost to Follow-up|18|||
162032849|NCT01470989|585177492|FG001|Overall Study|Lost to Follow-up|13|||
162032850|NCT01470989|585177491|FG000|Overall Study|Administrative problems|2|||
162032851|NCT01470989|585177492|FG001|Overall Study|Administrative problems|4|||
162032852|NCT01470989|585177491|FG000|Overall Study|Death|2|||
162032853|NCT01470989|585177492|FG001|Overall Study|Death|2|||
162032854|NCT01470989|585177491|FG000|Overall Study|Protocol deviation|1|||
162032855|NCT01470989|585177492|FG001|Overall Study|Protocol deviation|2|||
162032856|NCT01233687|585177493|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
162032857|NCT01233687|585177493|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
162032858|NCT01233687|585177493|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
162032859|NCT02197234|585177496|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
162032860|NCT02197234|585177496|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
162032861|NCT02197234|585177496|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
162032862|NCT02197234|585177496|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
162032863|NCT02197234|585177496|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
162032864|NCT02197234|585177496|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
162032865|NCT03783702|585177497|FG000|Overall Study|Lost to Follow-up|6|||
162032866|NCT03783702|585177498|FG001|Overall Study|Lost to Follow-up|8|||
162032867|NCT03783702|585177497|FG000|Overall Study|Protocol Violation|1|||
162032868|NCT03783702|585177498|FG001|Overall Study|Protocol Violation|3|||
162032869|NCT02119676|585177499|FG000|Overall Study|Adverse Event|9|||
162032870|NCT02119676|585177500|FG001|Overall Study|Adverse Event|17|||
162032871|NCT02119676|585177501|FG002|Overall Study|Adverse Event|10|||
162032872|NCT02119676|585177502|FG003|Overall Study|Adverse Event|10|||
162032873|NCT02119676|585177499|FG000|Overall Study|Disease progression|53|||
162032874|NCT02119676|585177500|FG001|Overall Study|Disease progression|55|||
162032875|NCT02119676|585177501|FG002|Overall Study|Disease progression|68|||
162032876|NCT02119676|585177502|FG003|Overall Study|Disease progression|73|||
162032877|NCT02119676|585177499|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
161755104|NCT01437267|584142413|FG001|Overall Study|Withdrawal by Subject|0|||
161755105|NCT01437267|584142414|FG002|Overall Study|Withdrawal by Subject|0|||
161755106|NCT01437267|584142415|FG003|Overall Study|Withdrawal by Subject|1|||
161755107|NCT01437267|584142416|FG004|Overall Study|Withdrawal by Subject|0|||
161755108|NCT01437267|584142417|FG005|Overall Study|Withdrawal by Subject|0|||
161755109|NCT01437267|584142412|FG000|Overall Study|Protocol Violation|0|||
161755110|NCT01437267|584142413|FG001|Overall Study|Protocol Violation|1|||
162032878|NCT02119676|585177500|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
162032879|NCT02119676|585177501|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
162032880|NCT02119676|585177502|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
161755111|NCT01437267|584142414|FG002|Overall Study|Protocol Violation|0|||
161755112|NCT01437267|584142415|FG003|Overall Study|Protocol Violation|0|||
161969467|NCT03350256|584937785|FG000|Overall Study|Non compliance|2|||
161969468|NCT03350256|584937785|FG000|Overall Study|Denial by insurance|1|||
162032881|NCT02119676|585177499|FG000|Overall Study|Physician Decision|4|||
162032882|NCT02119676|585177500|FG001|Overall Study|Physician Decision|2|||
162032883|NCT02119676|585177501|FG002|Overall Study|Physician Decision|3|||
161969469|NCT03350256|584937785|FG000|Overall Study|Adverse Event|2|||
161969470|NCT03350256|584937785|FG000|Overall Study|Trial failure|12|||
161969471|NCT03350256|584937785|FG000|Overall Study|Did not proceed to permanent implant|3|||
161969472|NCT03350256|584937785|FG000|Overall Study|Withdrawal by Subject|3|||
161969473|NCT03350256|584937785|FG000|Overall Study|Subject moving out of state|1|||
161969474|NCT03350256|584937785|FG000|Overall Study|Lost to Follow-up|1|||
161969475|NCT03350256|584937785|FG000|Overall Study|Lack of Efficacy|2|||
161969476|NCT00666588|584937786|FG000|Overall Study|ineligible|2|||
161755113|NCT01437267|584142416|FG004|Overall Study|Protocol Violation|0|||
161755114|NCT01437267|584142417|FG005|Overall Study|Protocol Violation|0|||
161755115|NCT00033371|584142418|FG000|Overall Study|Adverse Event|1|||
161755116|NCT00033371|584142419|FG001|Overall Study|Adverse Event|5|||
161755117|NCT00033371|584142418|FG000|Overall Study|Lost to Follow-up|2|||
161755118|NCT00033371|584142419|FG001|Overall Study|Lost to Follow-up|1|||
161755119|NCT00033371|584142418|FG000|Overall Study|Withdrawal by Subject|3|||
161755120|NCT00033371|584142419|FG001|Overall Study|Withdrawal by Subject|3|||
161755121|NCT00033371|584142418|FG000|Overall Study|Disease Progression|0|||
161755122|NCT00033371|584142419|FG001|Overall Study|Disease Progression|1|||
161755123|NCT02699125|584142420|FG000|Placebo|Lost to Follow-up|2|||
161755124|NCT02699125|584142421|FG001|Placebo|Lost to Follow-up|0|||
161755125|NCT02699125|584142420|FG000|Placebo|Protocol Violation|1|||
161755126|NCT02699125|584142421|FG001|Placebo|Protocol Violation|0|||
161755127|NCT02699125|584142420|FG000|Placebo|Withdrawal by Subject|0|||
161755128|NCT02699125|584142421|FG001|Placebo|Withdrawal by Subject|4|||
161755129|NCT02699125|584142420|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
161755130|NCT02699125|584142421|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
161755131|NCT03799627|584142424|FG000|Overall Study|Adverse Event|1|||
161755132|NCT03799627|584142425|FG001|Overall Study|Adverse Event|2|||
161755133|NCT03799627|584142426|FG002|Overall Study|Adverse Event|0|||
161755134|NCT03799627|584142427|FG003|Overall Study|Adverse Event|0|||
161755135|NCT03799627|584142428|FG004|Overall Study|Adverse Event|2|||
161755136|NCT03799627|584142429|FG005|Overall Study|Adverse Event|5|||
161755137|NCT03799627|584142430|FG006|Overall Study|Adverse Event|0|||
161755138|NCT03799627|584142431|FG007|Overall Study|Adverse Event|2|||
161755139|NCT03799627|584142432|FG008|Overall Study|Adverse Event|0|||
161755140|NCT03799627|584142424|FG000|Overall Study|Physician Decision|2|||
161755141|NCT03799627|584142425|FG001|Overall Study|Physician Decision|2|||
161755142|NCT03799627|584142426|FG002|Overall Study|Physician Decision|0|||
161755143|NCT03799627|584142427|FG003|Overall Study|Physician Decision|0|||
161755144|NCT03799627|584142428|FG004|Overall Study|Physician Decision|2|||
161755145|NCT03799627|584142429|FG005|Overall Study|Physician Decision|2|||
161755146|NCT03799627|584142430|FG006|Overall Study|Physician Decision|0|||
161755147|NCT03799627|584142431|FG007|Overall Study|Physician Decision|0|||
161755148|NCT03799627|584142432|FG008|Overall Study|Physician Decision|0|||
161755149|NCT03799627|584142424|FG000|Overall Study|Withdrawal by Subject|1|||
161755150|NCT03799627|584142425|FG001|Overall Study|Withdrawal by Subject|1|||
161755151|NCT03799627|584142426|FG002|Overall Study|Withdrawal by Subject|0|||
161755152|NCT03799627|584142427|FG003|Overall Study|Withdrawal by Subject|2|||
161755153|NCT03799627|584142428|FG004|Overall Study|Withdrawal by Subject|0|||
161755154|NCT03799627|584142429|FG005|Overall Study|Withdrawal by Subject|3|||
161755155|NCT03799627|584142430|FG006|Overall Study|Withdrawal by Subject|0|||
161755156|NCT03799627|584142431|FG007|Overall Study|Withdrawal by Subject|0|||
161755157|NCT03799627|584142432|FG008|Overall Study|Withdrawal by Subject|0|||
161755158|NCT03799627|584142424|FG000|Overall Study|Lack of Efficacy|0|||
161755159|NCT03799627|584142425|FG001|Overall Study|Lack of Efficacy|0|||
161755160|NCT03799627|584142426|FG002|Overall Study|Lack of Efficacy|0|||
161755161|NCT03799627|584142427|FG003|Overall Study|Lack of Efficacy|1|||
161755162|NCT03799627|584142428|FG004|Overall Study|Lack of Efficacy|0|||
161755163|NCT03799627|584142429|FG005|Overall Study|Lack of Efficacy|0|||
161755164|NCT03799627|584142430|FG006|Overall Study|Lack of Efficacy|0|||
161755165|NCT03799627|584142431|FG007|Overall Study|Lack of Efficacy|0|||
161755166|NCT03799627|584142432|FG008|Overall Study|Lack of Efficacy|0|||
161755167|NCT03799627|584142424|FG000|Overall Study|Lost to Follow-up|0|||
161755168|NCT03799627|584142425|FG001|Overall Study|Lost to Follow-up|0|||
161969477|NCT00666588|584937787|FG001|Overall Study|ineligible|0|||
161755169|NCT03799627|584142426|FG002|Overall Study|Lost to Follow-up|0|||
161755170|NCT03799627|584142427|FG003|Overall Study|Lost to Follow-up|0|||
161755171|NCT03799627|584142428|FG004|Overall Study|Lost to Follow-up|0|||
161969478|NCT00666588|584937788|FG002|Overall Study|ineligible|0|||
161755172|NCT03799627|584142429|FG005|Overall Study|Lost to Follow-up|0|||
161755173|NCT03799627|584142430|FG006|Overall Study|Lost to Follow-up|1|||
161755174|NCT03799627|584142431|FG007|Overall Study|Lost to Follow-up|0|||
161755175|NCT03799627|584142432|FG008|Overall Study|Lost to Follow-up|1|||
161755176|NCT03799627|584142424|FG000|Overall Study|Death|0|||
161755177|NCT03799627|584142425|FG001|Overall Study|Death|0|||
161755178|NCT03799627|584142426|FG002|Overall Study|Death|0|||
161755179|NCT03799627|584142427|FG003|Overall Study|Death|1|||
161755180|NCT03799627|584142428|FG004|Overall Study|Death|0|||
161969479|NCT00666588|584937789|FG003|Overall Study|ineligible|2|||
161969480|NCT00666588|584937786|FG000|Overall Study|inevaluable|2|||
161969481|NCT00666588|584937787|FG001|Overall Study|inevaluable|0|||
161969482|NCT00666588|584937788|FG002|Overall Study|inevaluable|0|||
161755181|NCT03799627|584142429|FG005|Overall Study|Death|0|||
161755182|NCT03799627|584142430|FG006|Overall Study|Death|0|||
161755183|NCT03799627|584142431|FG007|Overall Study|Death|0|||
161755184|NCT03799627|584142432|FG008|Overall Study|Death|0|||
161755185|NCT03799627|584142424|FG000|Overall Study|Study Drug Put on Hold|1|||
161755186|NCT03799627|584142425|FG001|Overall Study|Study Drug Put on Hold|0|||
161755187|NCT03799627|584142426|FG002|Overall Study|Study Drug Put on Hold|0|||
161755188|NCT03799627|584142427|FG003|Overall Study|Study Drug Put on Hold|0|||
161755189|NCT03799627|584142428|FG004|Overall Study|Study Drug Put on Hold|0|||
161755190|NCT03799627|584142429|FG005|Overall Study|Study Drug Put on Hold|0|||
161755191|NCT03799627|584142430|FG006|Overall Study|Study Drug Put on Hold|0|||
161755192|NCT03799627|584142431|FG007|Overall Study|Study Drug Put on Hold|0|||
161755193|NCT03799627|584142432|FG008|Overall Study|Study Drug Put on Hold|0|||
161755194|NCT03799627|584142424|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
161755195|NCT03799627|584142425|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
161755196|NCT03799627|584142426|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
161755197|NCT03799627|584142427|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
161755198|NCT03799627|584142428|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
161755199|NCT03799627|584142429|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
161755200|NCT03799627|584142430|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
161755201|NCT03799627|584142431|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
161755202|NCT03799627|584142432|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
161755203|NCT03799627|584142424|FG000|Overall Study|Kidney Transplantation|1|||
161755204|NCT03799627|584142425|FG001|Overall Study|Kidney Transplantation|0|||
161755205|NCT03799627|584142426|FG002|Overall Study|Kidney Transplantation|0|||
161755206|NCT03799627|584142427|FG003|Overall Study|Kidney Transplantation|1|||
161755207|NCT03799627|584142428|FG004|Overall Study|Kidney Transplantation|1|||
161755208|NCT03799627|584142429|FG005|Overall Study|Kidney Transplantation|0|||
161755209|NCT03799627|584142430|FG006|Overall Study|Kidney Transplantation|0|||
161755210|NCT03799627|584142431|FG007|Overall Study|Kidney Transplantation|0|||
161755211|NCT03799627|584142432|FG008|Overall Study|Kidney Transplantation|0|||
161755212|NCT03799627|584142424|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
161755213|NCT03799627|584142425|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
161755214|NCT03799627|584142426|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
161755215|NCT03799627|584142427|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
161755216|NCT03799627|584142428|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
161755217|NCT03799627|584142429|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
161755218|NCT03799627|584142430|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
161755219|NCT03799627|584142431|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
161755220|NCT03799627|584142432|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
161755221|NCT03799627|584142424|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755222|NCT03799627|584142425|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
161755223|NCT03799627|584142426|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755224|NCT03799627|584142427|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755225|NCT03799627|584142428|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755226|NCT03799627|584142429|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755227|NCT03799627|584142430|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755228|NCT03799627|584142431|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755229|NCT03799627|584142432|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161755230|NCT03799627|584142424|FG000|Overall Study|Met Exclusion Criteria|0|||
161755231|NCT03799627|584142425|FG001|Overall Study|Met Exclusion Criteria|0|||
161755232|NCT03799627|584142426|FG002|Overall Study|Met Exclusion Criteria|0|||
161755233|NCT03799627|584142427|FG003|Overall Study|Met Exclusion Criteria|1|||
161755234|NCT03799627|584142428|FG004|Overall Study|Met Exclusion Criteria|0|||
161755235|NCT03799627|584142429|FG005|Overall Study|Met Exclusion Criteria|0|||
161844921|NCT02980874|584474684|FG001|Overall Study|Unknown study completion status|0|||
161844922|NCT02450526|584474685|FG000|DB Period (Cycle 1)|Adverse Event|0|||
161844923|NCT02450526|584474686|FG001|DB Period (Cycle 1)|Adverse Event|0|||
161844924|NCT02450526|584474687|FG002|DB Period (Cycle 1)|Adverse Event|2|||
161844925|NCT02450526|584474688|FG003|DB Period (Cycle 1)|Adverse Event|0|||
161844926|NCT02450526|584474689|FG004|DB Period (Cycle 1)|Adverse Event|0|||
161844927|NCT02450526|584474685|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
161844928|NCT02450526|584474686|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
161844929|NCT02450526|584474687|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
161844930|NCT02450526|584474688|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
161844931|NCT02450526|584474689|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
161969483|NCT00666588|584937789|FG003|Overall Study|inevaluable|0|||
161755236|NCT03799627|584142430|FG006|Overall Study|Met Exclusion Criteria|0|||
161755237|NCT03799627|584142431|FG007|Overall Study|Met Exclusion Criteria|0|||
161755238|NCT03799627|584142432|FG008|Overall Study|Met Exclusion Criteria|0|||
161969484|NCT01187446|584937792|FG000|Overall Study|Patient started non-protocol therapy|0|||
161755239|NCT03799627|584142424|FG000|Overall Study|Investigational Product Noncompliance|0|||
161755240|NCT03799627|584142425|FG001|Overall Study|Investigational Product Noncompliance|0|||
161755241|NCT03799627|584142426|FG002|Overall Study|Investigational Product Noncompliance|0|||
161755242|NCT03799627|584142427|FG003|Overall Study|Investigational Product Noncompliance|1|||
161755243|NCT03799627|584142428|FG004|Overall Study|Investigational Product Noncompliance|0|||
161755244|NCT03799627|584142429|FG005|Overall Study|Investigational Product Noncompliance|0|||
161755245|NCT03799627|584142430|FG006|Overall Study|Investigational Product Noncompliance|0|||
161755246|NCT03799627|584142431|FG007|Overall Study|Investigational Product Noncompliance|0|||
161755247|NCT03799627|584142432|FG008|Overall Study|Investigational Product Noncompliance|0|||
161755248|NCT03799627|584142424|FG000|Overall Study|Participant Relocation|0|||
161755249|NCT03799627|584142425|FG001|Overall Study|Participant Relocation|0|||
161755250|NCT03799627|584142426|FG002|Overall Study|Participant Relocation|0|||
161755251|NCT03799627|584142427|FG003|Overall Study|Participant Relocation|1|||
161755252|NCT03799627|584142428|FG004|Overall Study|Participant Relocation|0|||
161755253|NCT03799627|584142429|FG005|Overall Study|Participant Relocation|1|||
161755254|NCT03799627|584142430|FG006|Overall Study|Participant Relocation|0|||
161755255|NCT03799627|584142431|FG007|Overall Study|Participant Relocation|0|||
161755256|NCT03799627|584142432|FG008|Overall Study|Participant Relocation|0|||
161755257|NCT03799627|584142424|FG000|Overall Study|Eurofin Issue|0|||
161755258|NCT03799627|584142425|FG001|Overall Study|Eurofin Issue|0|||
161755259|NCT03799627|584142426|FG002|Overall Study|Eurofin Issue|0|||
161755260|NCT03799627|584142427|FG003|Overall Study|Eurofin Issue|0|||
161755261|NCT03799627|584142428|FG004|Overall Study|Eurofin Issue|1|||
161755262|NCT03799627|584142429|FG005|Overall Study|Eurofin Issue|0|||
161755263|NCT03799627|584142430|FG006|Overall Study|Eurofin Issue|0|||
161755264|NCT03799627|584142431|FG007|Overall Study|Eurofin Issue|0|||
161755265|NCT03799627|584142432|FG008|Overall Study|Eurofin Issue|0|||
161755266|NCT03799627|584142424|FG000|Overall Study|Noncompliance with Site Instructions|0|||
161755267|NCT03799627|584142425|FG001|Overall Study|Noncompliance with Site Instructions|0|||
161755268|NCT03799627|584142426|FG002|Overall Study|Noncompliance with Site Instructions|0|||
161755269|NCT03799627|584142427|FG003|Overall Study|Noncompliance with Site Instructions|0|||
161755270|NCT03799627|584142428|FG004|Overall Study|Noncompliance with Site Instructions|1|||
161755271|NCT03799627|584142429|FG005|Overall Study|Noncompliance with Site Instructions|0|||
161755272|NCT03799627|584142430|FG006|Overall Study|Noncompliance with Site Instructions|0|||
161755273|NCT03799627|584142431|FG007|Overall Study|Noncompliance with Site Instructions|0|||
161755274|NCT03799627|584142432|FG008|Overall Study|Noncompliance with Site Instructions|0|||
161755275|NCT03799627|584142424|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755276|NCT03799627|584142425|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755277|NCT03799627|584142426|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755278|NCT03799627|584142427|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755279|NCT03799627|584142428|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
161755280|NCT03799627|584142429|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755281|NCT03799627|584142430|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755282|NCT03799627|584142431|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755283|NCT03799627|584142432|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161755284|NCT03799627|584142424|FG000|Overall Study|Changes In Hemoglobin Values|1|||
161755285|NCT03799627|584142425|FG001|Overall Study|Changes In Hemoglobin Values|2|||
161755286|NCT03799627|584142426|FG002|Overall Study|Changes In Hemoglobin Values|1|||
161755287|NCT03799627|584142427|FG003|Overall Study|Changes In Hemoglobin Values|0|||
161755288|NCT03799627|584142428|FG004|Overall Study|Changes In Hemoglobin Values|0|||
161755289|NCT03799627|584142429|FG005|Overall Study|Changes In Hemoglobin Values|2|||
161755290|NCT03799627|584142430|FG006|Overall Study|Changes In Hemoglobin Values|1|||
161755291|NCT03799627|584142431|FG007|Overall Study|Changes In Hemoglobin Values|0|||
161755292|NCT03799627|584142432|FG008|Overall Study|Changes In Hemoglobin Values|1|||
161755293|NCT00398138|584142441|FG000|Overall Study|Adverse Event|2|||
161755294|NCT03418376|584142447|FG000|Overall Study|Musculoskeletal injury|1|||
161755295|NCT03418376|584142448|FG001|Overall Study|Musculoskeletal injury|2|||
161755296|NCT03418376|584142449|FG002|Overall Study|Musculoskeletal injury|1|||
161755297|NCT03418376|584142450|FG003|Overall Study|Musculoskeletal injury|0|||
161755298|NCT03418376|584142447|FG000|Overall Study|Personal reasons|0|||
161755299|NCT03418376|584142448|FG001|Overall Study|Personal reasons|2|||
161755300|NCT03418376|584142449|FG002|Overall Study|Personal reasons|2|||
161755301|NCT03418376|584142450|FG003|Overall Study|Personal reasons|1|||
161755302|NCT03418376|584142447|FG000|Overall Study|Exacerbation|0|||
161755303|NCT03418376|584142448|FG001|Overall Study|Exacerbation|1|||
161755304|NCT03418376|584142449|FG002|Overall Study|Exacerbation|0|||
161755305|NCT03418376|584142450|FG003|Overall Study|Exacerbation|0|||
161755306|NCT00814307|584142451|FG000|Overall Study|Randomized but not treated|1|||
161755307|NCT00814307|584142452|FG001|Overall Study|Randomized but not treated|0|||
161844932|NCT02450526|584474685|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
161844933|NCT02450526|584474686|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
161755308|NCT00814307|584142453|FG002|Overall Study|Randomized but not treated|0|||
161755309|NCT00814307|584142454|FG003|Overall Study|Randomized but not treated|0|||
161755310|NCT00814307|584142451|FG000|Overall Study|Adverse Event|3|||
161755311|NCT00814307|584142452|FG001|Overall Study|Adverse Event|9|||
161755312|NCT00814307|584142453|FG002|Overall Study|Adverse Event|3|||
161755313|NCT00814307|584142454|FG003|Overall Study|Adverse Event|2|||
161755314|NCT00814307|584142451|FG000|Overall Study|Lack of Efficacy|1|||
161755315|NCT00814307|584142452|FG001|Overall Study|Lack of Efficacy|1|||
161755316|NCT00814307|584142453|FG002|Overall Study|Lack of Efficacy|3|||
161755317|NCT00814307|584142454|FG003|Overall Study|Lack of Efficacy|4|||
161755318|NCT00814307|584142451|FG000|Overall Study|Other|1|||
161755319|NCT00814307|584142452|FG001|Overall Study|Other|2|||
161755320|NCT00814307|584142453|FG002|Overall Study|Other|0|||
161755321|NCT00814307|584142454|FG003|Overall Study|Other|1|||
161755322|NCT00814307|584142451|FG000|Overall Study|Protocol Violation|2|||
161755323|NCT00814307|584142452|FG001|Overall Study|Protocol Violation|8|||
161755324|NCT00814307|584142453|FG002|Overall Study|Protocol Violation|1|||
161755325|NCT00814307|584142454|FG003|Overall Study|Protocol Violation|1|||
161755326|NCT00814307|584142451|FG000|Overall Study|Withdrawal by Subject|4|||
161755327|NCT00814307|584142452|FG001|Overall Study|Withdrawal by Subject|6|||
161755328|NCT00814307|584142453|FG002|Overall Study|Withdrawal by Subject|0|||
161755329|NCT00814307|584142454|FG003|Overall Study|Withdrawal by Subject|2|||
161755330|NCT00814307|584142451|FG000|Overall Study|Death|0|||
161755331|NCT00814307|584142452|FG001|Overall Study|Death|1|||
161755332|NCT00814307|584142453|FG002|Overall Study|Death|0|||
161755333|NCT00814307|584142454|FG003|Overall Study|Death|0|||
161755334|NCT03039192|584142455|FG000|Overall Study|Lost to Follow-up|4|||
161755335|NCT03039192|584142456|FG001|Overall Study|Lost to Follow-up|4|||
161755336|NCT03039192|584142455|FG000|Overall Study|Adverse event, serious fatal|0|||
161755337|NCT03039192|584142456|FG001|Overall Study|Adverse event, serious fatal|1|||
161755338|NCT03039192|584142455|FG000|Overall Study|Adverse event, non-fatal|0|||
161755339|NCT03039192|584142456|FG001|Overall Study|Adverse event, non-fatal|2|||
161755340|NCT03039192|584142455|FG000|Overall Study|Withdrawal by Subject|6|||
161755341|NCT03039192|584142456|FG001|Overall Study|Withdrawal by Subject|9|||
161755342|NCT03039192|584142455|FG000|Overall Study|Discontinued from treatment phase|19|||
161755343|NCT03039192|584142456|FG001|Overall Study|Discontinued from treatment phase|12|||
161755344|NCT03039192|584142455|FG000|Overall Study|Other|3|||
161755345|NCT03039192|584142456|FG001|Overall Study|Other|2|||
161755346|NCT03277794|584142457|FG000|Overall Study|Lost to Follow-up|2|||
161755347|NCT03277794|584142458|FG001|Overall Study|Lost to Follow-up|4|||
161755348|NCT03277794|584142457|FG000|Overall Study|Withdrew due to high acuity|1|||
161755349|NCT03277794|584142458|FG001|Overall Study|Withdrew due to high acuity|0|||
161755350|NCT02177812|584142462|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161755351|NCT02177812|584142463|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161755352|NCT02177812|584142464|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161755353|NCT02177812|584142465|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161755354|NCT02177812|584142466|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161755355|NCT02177812|584142467|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
161755356|NCT02177812|584142468|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
161755357|NCT02177812|584142469|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
161755358|NCT02177812|584142470|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161755359|NCT02177812|584142462|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755360|NCT02177812|584142463|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755361|NCT02177812|584142464|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755362|NCT02177812|584142465|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755363|NCT02177812|584142466|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755364|NCT02177812|584142467|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
161755365|NCT02177812|584142468|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
161755366|NCT02177812|584142469|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755367|NCT02177812|584142470|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161755368|NCT02177812|584142462|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
161755369|NCT02177812|584142463|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
161755370|NCT02177812|584142464|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
161755371|NCT02177812|584142465|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
161755372|NCT02177812|584142466|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
161755373|NCT02177812|584142467|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
161755374|NCT02177812|584142468|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
161755375|NCT02177812|584142469|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
161755376|NCT02177812|584142470|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
161755377|NCT00089999|584142471|FG000|Overall Study|Adverse Event|4|||
161755378|NCT00089999|584142472|FG001|Overall Study|Adverse Event|7|||
161755379|NCT00089999|584142471|FG000|Overall Study|Withdrawal by Subject|0|||
161755380|NCT00089999|584142472|FG001|Overall Study|Withdrawal by Subject|4|||
161755381|NCT00089999|584142471|FG000|Overall Study|Lost to Follow-up|2|||
161755382|NCT00089999|584142472|FG001|Overall Study|Lost to Follow-up|1|||
161755383|NCT00089999|584142471|FG000|Overall Study|Radiological Progression of Cancer|52|||
161844934|NCT02450526|584474687|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
161844935|NCT02450526|584474688|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
161844936|NCT02450526|584474689|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
161844937|NCT02450526|584474685|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
161844938|NCT02450526|584474686|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
161844939|NCT02450526|584474687|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
161844940|NCT02450526|584474688|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
161844941|NCT02450526|584474689|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
161844942|NCT02450526|584474685|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
161844943|NCT02450526|584474686|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
161844944|NCT02450526|584474687|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
161844945|NCT02450526|584474688|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
161844946|NCT02450526|584474689|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
161844947|NCT02450526|584474685|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
161844948|NCT02450526|584474686|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
161844949|NCT02450526|584474687|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
161844950|NCT02450526|584474688|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
161844951|NCT02450526|584474689|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
161844952|NCT02450526|584474685|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
161844953|NCT02450526|584474686|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
161844954|NCT02450526|584474687|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
161844955|NCT02450526|584474688|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
161844956|NCT02450526|584474689|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
161844957|NCT02450526|584474685|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
161844958|NCT02450526|584474686|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
161844959|NCT02450526|584474687|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
161844960|NCT02450526|584474688|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
161844961|NCT02450526|584474689|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
161844962|NCT00911807|584474690|FG000|Overall Study|Adverse Event|2|||
161844963|NCT00911807|584474691|FG001|Overall Study|Adverse Event|1|||
161844964|NCT00911807|584474692|FG002|Overall Study|Adverse Event|5|||
161844965|NCT00911807|584474690|FG000|Overall Study|Death|0|||
161844966|NCT00911807|584474691|FG001|Overall Study|Death|0|||
161844967|NCT00911807|584474692|FG002|Overall Study|Death|1|||
161844968|NCT00911807|584474690|FG000|Overall Study|Protocol Violation|6|||
161844969|NCT00911807|584474691|FG001|Overall Study|Protocol Violation|4|||
161844970|NCT00911807|584474692|FG002|Overall Study|Protocol Violation|9|||
161844971|NCT00911807|584474690|FG000|Overall Study|Withdrawal by Subject|8|||
161844972|NCT00911807|584474691|FG001|Overall Study|Withdrawal by Subject|10|||
161844973|NCT00911807|584474692|FG002|Overall Study|Withdrawal by Subject|7|||
161844974|NCT00911807|584474690|FG000|Overall Study|Organizational reasons|1|||
161844975|NCT00911807|584474691|FG001|Overall Study|Organizational reasons|3|||
161844976|NCT00911807|584474692|FG002|Overall Study|Organizational reasons|1|||
161844977|NCT00855803|584474694|FG000|Overall Study|Death|2|||
161844978|NCT00855803|584474694|FG000|Overall Study|Lost to Follow-up|2|||
161844979|NCT00855803|584474694|FG000|Overall Study|Technical inability to undergo procedure|2|||
161844980|NCT00855803|584474694|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
161844981|NCT00855803|584474694|FG000|Overall Study|Withdrawal by Subject|3|||
161844982|NCT00855803|584474694|FG000|Overall Study|Physician Decision|3|||
161844983|NCT00809159|584474695|FG000|Part 1|Adverse Event|1|||
161844984|NCT00809159|584474696|FG001|Part 1|Adverse Event|1|||
161844985|NCT00809159|584474697|FG002|Part 1|Adverse Event|0|||
161844986|NCT00809159|584474698|FG003|Part 1|Adverse Event|0|||
161844987|NCT00809159|584474699|FG004|Part 1|Adverse Event|0|||
161844988|NCT00809159|584474700|FG005|Part 1|Adverse Event|0|||
161844989|NCT00809159|584474695|FG000|Part 1|Lost to Follow-up|1|||
161844990|NCT00809159|584474696|FG001|Part 1|Lost to Follow-up|0|||
161844991|NCT00809159|584474697|FG002|Part 1|Lost to Follow-up|0|||
161844992|NCT00809159|584474698|FG003|Part 1|Lost to Follow-up|0|||
161844993|NCT00809159|584474699|FG004|Part 1|Lost to Follow-up|0|||
161844994|NCT00809159|584474700|FG005|Part 1|Lost to Follow-up|0|||
161844995|NCT00809159|584474695|FG000|Part 1|Withdrawal by Subject|3|||
161844996|NCT00809159|584474696|FG001|Part 1|Withdrawal by Subject|1|||
161844997|NCT00809159|584474697|FG002|Part 1|Withdrawal by Subject|0|||
161844998|NCT00809159|584474698|FG003|Part 1|Withdrawal by Subject|0|||
161844999|NCT00809159|584474699|FG004|Part 1|Withdrawal by Subject|0|||
161845000|NCT00809159|584474700|FG005|Part 1|Withdrawal by Subject|0|||
161845001|NCT00809159|584474695|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
161845002|NCT00809159|584474696|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
161845003|NCT00809159|584474697|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
161845004|NCT00809159|584474698|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
161845005|NCT00809159|584474699|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
161845006|NCT00809159|584474700|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
161845007|NCT00809159|584474695|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
161845008|NCT00809159|584474696|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
161845009|NCT00809159|584474697|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
161845010|NCT00809159|584474698|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
161845011|NCT00809159|584474699|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
161755384|NCT00089999|584142472|FG001|Overall Study|Radiological Progression of Cancer|44|||
161755385|NCT00089999|584142471|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
161755386|NCT00089999|584142472|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
161755387|NCT00089999|584142471|FG000|Overall Study|Death|3|||
161755388|NCT00089999|584142472|FG001|Overall Study|Death|3|||
161755389|NCT00089999|584142471|FG000|Overall Study|Poor General Condition|1|||
161755390|NCT00089999|584142472|FG001|Overall Study|Poor General Condition|0|||
161755391|NCT00089999|584142471|FG000|Overall Study|Clinical Progression|1|||
161755392|NCT00089999|584142472|FG001|Overall Study|Clinical Progression|2|||
161755393|NCT00089999|584142471|FG000|Overall Study|Physician Decision|2|||
161755394|NCT00089999|584142472|FG001|Overall Study|Physician Decision|2|||
161755395|NCT00089999|584142471|FG000|Overall Study|Patient Underwent Surgery|2|||
161755396|NCT00089999|584142472|FG001|Overall Study|Patient Underwent Surgery|0|||
161755397|NCT00089999|584142471|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
161755398|NCT00089999|584142472|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
161755399|NCT02266004|584144319|FG000|Overall Study|unrelated adverse event|1|||
161755400|NCT02266004|584144319|FG000|Overall Study|Physician Decision|1|||
161755401|NCT00537771|584144320|FG000|Overall Study|Withdrawal by Subject|6|||
161755402|NCT00537771|584144321|FG001|Overall Study|Withdrawal by Subject|23|||
161755403|NCT00537771|584144320|FG000|Overall Study|Adverse Event|8|||
161755404|NCT00537771|584144321|FG001|Overall Study|Adverse Event|15|||
161755405|NCT00537771|584144320|FG000|Overall Study|Lost to Follow-up|9|||
161755406|NCT00537771|584144321|FG001|Overall Study|Lost to Follow-up|15|||
161755407|NCT00537771|584144320|FG000|Overall Study|Protocol Violation|2|||
161755408|NCT00537771|584144321|FG001|Overall Study|Protocol Violation|6|||
161755409|NCT00537771|584144320|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
161755410|NCT00537771|584144321|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
161755411|NCT02465489|584144324|FG000|Overall Study|Adverse Event|5|||
161755412|NCT00850135|584144325|FG000|Overall Study|Physician Decision|1|||
161755413|NCT02253992|584144326|FG000|Overall Study|Study drug toxicity|1|||
161755414|NCT02253992|584144327|FG001|Overall Study|Study drug toxicity|0|||
161755415|NCT02253992|584144328|FG002|Overall Study|Study drug toxicity|10|||
161755416|NCT02253992|584144326|FG000|Overall Study|Disease progression|4|||
161755417|NCT02253992|584144327|FG001|Overall Study|Disease progression|3|||
161755418|NCT02253992|584144328|FG002|Overall Study|Disease progression|98|||
161755419|NCT02253992|584144326|FG000|Overall Study|Withdrawal by Subject|0|||
161755420|NCT02253992|584144327|FG001|Overall Study|Withdrawal by Subject|0|||
161755421|NCT02253992|584144328|FG002|Overall Study|Withdrawal by Subject|3|||
161755422|NCT02253992|584144326|FG000|Overall Study|Adverse Event|0|||
161755423|NCT02253992|584144327|FG001|Overall Study|Adverse Event|0|||
161755424|NCT02253992|584144328|FG002|Overall Study|Adverse Event|8|||
161755425|NCT02253992|584144326|FG000|Overall Study|Death|0|||
161755426|NCT02253992|584144327|FG001|Overall Study|Death|0|||
161755427|NCT02253992|584144328|FG002|Overall Study|Death|1|||
161755428|NCT02253992|584144326|FG000|Overall Study|Subject discontinued study drug|1|||
161755429|NCT02253992|584144327|FG001|Overall Study|Subject discontinued study drug|0|||
161755430|NCT02253992|584144328|FG002|Overall Study|Subject discontinued study drug|1|||
161755431|NCT02253992|584144326|FG000|Overall Study|Completed treatment as per protocol|0|||
161755432|NCT02253992|584144327|FG001|Overall Study|Completed treatment as per protocol|1|||
161755433|NCT02253992|584144328|FG002|Overall Study|Completed treatment as per protocol|22|||
161755434|NCT02253992|584144326|FG000|Overall Study|Other|0|||
161755435|NCT02253992|584144327|FG001|Overall Study|Other|0|||
161755436|NCT02253992|584144328|FG002|Overall Study|Other|1|||
161755437|NCT03198728|584144329|FG000|Overall Study|Adverse Event|10|||
161755438|NCT03198728|584144330|FG001|Overall Study|Adverse Event|5|||
161755439|NCT03198728|584144329|FG000|Overall Study|Lost to Follow-up|21|||
161755440|NCT03198728|584144330|FG001|Overall Study|Lost to Follow-up|7|||
161755441|NCT03198728|584144329|FG000|Overall Study|Physician Decision|7|||
161755442|NCT03198728|584144330|FG001|Overall Study|Physician Decision|2|||
161755443|NCT03198728|584144329|FG000|Overall Study|Withdrawal by Subject|14|||
161755444|NCT03198728|584144330|FG001|Overall Study|Withdrawal by Subject|10|||
161755445|NCT04051944|584144331|FG000|Overall Study|Study ending|1|||
161755446|NCT04051944|584144332|FG001|Overall Study|Study ending|1|||
161755447|NCT04051944|584144331|FG000|Overall Study|Early study termination by participant|1|||
161755448|NCT04051944|584144332|FG001|Overall Study|Early study termination by participant|0|||
161755449|NCT04051944|584144331|FG000|Overall Study|Withdrawal by Subject|2|||
161755450|NCT04051944|584144332|FG001|Overall Study|Withdrawal by Subject|2|||
161755451|NCT04051944|584144331|FG000|Overall Study|Lack of Efficacy|3|||
161755452|NCT04051944|584144332|FG001|Overall Study|Lack of Efficacy|0|||
161755453|NCT04051944|584144331|FG000|Overall Study|Adverse event, non- fatal|1|||
161755454|NCT04051944|584144332|FG001|Overall Study|Adverse event, non- fatal|1|||
161755455|NCT03083470|584144333|FG000|Overall Study|Lost to Follow-up|0|||
161845012|NCT00809159|584474700|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
161845013|NCT00809159|584474695|FG000|Part 1 and 2|Administrative problems|0|||
162032884|NCT02119676|585177502|FG003|Overall Study|Physician Decision|2|||
161755456|NCT03083470|584144334|FG001|Overall Study|Lost to Follow-up|0|||
161755457|NCT03083470|584144335|FG002|Overall Study|Lost to Follow-up|0|||
161755458|NCT03083470|584144336|FG003|Overall Study|Lost to Follow-up|0|||
161755459|NCT03083470|584144337|FG004|Overall Study|Lost to Follow-up|1|||
161755460|NCT03083470|584144333|FG000|Overall Study|Withdrawal by Subject|0|||
161755461|NCT03083470|584144334|FG001|Overall Study|Withdrawal by Subject|0|||
161755462|NCT03083470|584144335|FG002|Overall Study|Withdrawal by Subject|0|||
161755463|NCT03083470|584144336|FG003|Overall Study|Withdrawal by Subject|0|||
161755464|NCT03083470|584144337|FG004|Overall Study|Withdrawal by Subject|1|||
161755465|NCT01512693|584144338|FG000|Overall Study|Withdrawal by Subject|0|||
161755466|NCT01512693|584144339|FG001|Overall Study|Withdrawal by Subject|1|||
161755467|NCT02139280|584144340|FG000|Overall Study|No longer eligible|2|||
161755468|NCT02139280|584144341|FG001|Overall Study|No longer eligible|0|||
161755469|NCT00736450|584144348|FG000|Overall Study|Not ABC gene eligible|19|||
161755470|NCT00736450|584144348|FG000|Overall Study|Withdrawal by Subject|5|||
161755471|NCT00736450|584144348|FG000|Overall Study|Physician Decision|1|||
161755472|NCT04731922|584144352|FG000|Overall Study|Adverse Event|0|||
161755473|NCT04731922|584144353|FG001|Overall Study|Adverse Event|0|||
161755474|NCT04731922|584144354|FG002|Overall Study|Adverse Event|0|||
161755475|NCT04731922|584144355|FG003|Overall Study|Adverse Event|0|||
161755476|NCT04731922|584144356|FG004|Overall Study|Adverse Event|0|||
161755477|NCT04731922|584144357|FG005|Overall Study|Adverse Event|0|||
161755478|NCT04731922|584144358|FG006|Overall Study|Adverse Event|0|||
161755479|NCT04731922|584144359|FG007|Overall Study|Adverse Event|0|||
161755480|NCT04731922|584144360|FG008|Overall Study|Adverse Event|0|||
161755481|NCT04731922|584144361|FG009|Overall Study|Adverse Event|0|||
161755482|NCT04731922|584144362|FG010|Overall Study|Adverse Event|1|||
161755483|NCT04731922|584144363|FG011|Overall Study|Adverse Event|0|||
161755484|NCT04731922|584144364|FG012|Overall Study|Adverse Event|0|||
161755485|NCT04731922|584144365|FG013|Overall Study|Adverse Event|0|||
161755486|NCT04731922|584144366|FG014|Overall Study|Adverse Event|0|||
161755487|NCT04731922|584144367|FG015|Overall Study|Adverse Event|0|||
161755488|NCT04731922|584144368|FG016|Overall Study|Adverse Event|0|||
161755489|NCT04731922|584144352|FG000|Overall Study|Lost to Follow-up|0|||
161755490|NCT04731922|584144353|FG001|Overall Study|Lost to Follow-up|0|||
161755491|NCT04731922|584144354|FG002|Overall Study|Lost to Follow-up|0|||
161755492|NCT04731922|584144355|FG003|Overall Study|Lost to Follow-up|1|||
161755493|NCT04731922|584144356|FG004|Overall Study|Lost to Follow-up|0|||
161755494|NCT04731922|584144357|FG005|Overall Study|Lost to Follow-up|1|||
161755495|NCT04731922|584144358|FG006|Overall Study|Lost to Follow-up|0|||
161755496|NCT04731922|584144359|FG007|Overall Study|Lost to Follow-up|0|||
161755497|NCT04731922|584144360|FG008|Overall Study|Lost to Follow-up|0|||
161755498|NCT04731922|584144361|FG009|Overall Study|Lost to Follow-up|0|||
161755499|NCT04731922|584144362|FG010|Overall Study|Lost to Follow-up|0|||
161755500|NCT04731922|584144363|FG011|Overall Study|Lost to Follow-up|0|||
161755501|NCT04731922|584144364|FG012|Overall Study|Lost to Follow-up|0|||
161755502|NCT04731922|584144365|FG013|Overall Study|Lost to Follow-up|0|||
161755503|NCT04731922|584144366|FG014|Overall Study|Lost to Follow-up|0|||
161755504|NCT04731922|584144367|FG015|Overall Study|Lost to Follow-up|0|||
161755505|NCT04731922|584144368|FG016|Overall Study|Lost to Follow-up|0|||
161755506|NCT04731922|584144352|FG000|Overall Study|Withdrawal by Subject|1|||
161755507|NCT04731922|584144353|FG001|Overall Study|Withdrawal by Subject|0|||
161755508|NCT04731922|584144354|FG002|Overall Study|Withdrawal by Subject|0|||
161755509|NCT04731922|584144355|FG003|Overall Study|Withdrawal by Subject|0|||
161755510|NCT04731922|584144356|FG004|Overall Study|Withdrawal by Subject|1|||
161755511|NCT04731922|584144357|FG005|Overall Study|Withdrawal by Subject|0|||
161755512|NCT04731922|584144358|FG006|Overall Study|Withdrawal by Subject|1|||
161755513|NCT04731922|584144359|FG007|Overall Study|Withdrawal by Subject|0|||
161755514|NCT04731922|584144360|FG008|Overall Study|Withdrawal by Subject|0|||
161755515|NCT04731922|584144361|FG009|Overall Study|Withdrawal by Subject|0|||
161755516|NCT04731922|584144362|FG010|Overall Study|Withdrawal by Subject|0|||
161755517|NCT04731922|584144363|FG011|Overall Study|Withdrawal by Subject|0|||
161755518|NCT04731922|584144364|FG012|Overall Study|Withdrawal by Subject|0|||
161755519|NCT04731922|584144365|FG013|Overall Study|Withdrawal by Subject|1|||
161755520|NCT04731922|584144366|FG014|Overall Study|Withdrawal by Subject|0|||
161755521|NCT04731922|584144367|FG015|Overall Study|Withdrawal by Subject|0|||
161755522|NCT04731922|584144368|FG016|Overall Study|Withdrawal by Subject|0|||
161755523|NCT04731922|584144352|FG000|Overall Study|Other|0|||
162032885|NCT02119676|585177499|FG000|Overall Study|Death|9|||
161755524|NCT04731922|584144353|FG001|Overall Study|Other|0|||
162032886|NCT02119676|585177500|FG001|Overall Study|Death|3|||
161755525|NCT04731922|584144354|FG002|Overall Study|Other|0|||
161755526|NCT04731922|584144355|FG003|Overall Study|Other|0|||
161755527|NCT04731922|584144356|FG004|Overall Study|Other|0|||
161755528|NCT04731922|584144357|FG005|Overall Study|Other|0|||
161755529|NCT04731922|584144358|FG006|Overall Study|Other|1|||
161755530|NCT04731922|584144359|FG007|Overall Study|Other|0|||
161755531|NCT04731922|584144360|FG008|Overall Study|Other|0|||
161755532|NCT04731922|584144361|FG009|Overall Study|Other|0|||
161755533|NCT04731922|584144362|FG010|Overall Study|Other|0|||
161755534|NCT04731922|584144363|FG011|Overall Study|Other|0|||
161755535|NCT04731922|584144364|FG012|Overall Study|Other|0|||
161755536|NCT04731922|584144365|FG013|Overall Study|Other|0|||
161845014|NCT00809159|584474696|FG001|Part 1 and 2|Administrative problems|0|||
161845015|NCT00809159|584474697|FG002|Part 1 and 2|Administrative problems|0|||
161845016|NCT00809159|584474698|FG003|Part 1 and 2|Administrative problems|1|||
161845017|NCT00809159|584474699|FG004|Part 1 and 2|Administrative problems|0|||
161845018|NCT00809159|584474700|FG005|Part 1 and 2|Administrative problems|0|||
161845019|NCT00809159|584474695|FG000|Part 1 and 2|Adverse Event|0|||
161845020|NCT00809159|584474696|FG001|Part 1 and 2|Adverse Event|0|||
161845021|NCT00809159|584474697|FG002|Part 1 and 2|Adverse Event|1|||
161845022|NCT00809159|584474698|FG003|Part 1 and 2|Adverse Event|0|||
161845023|NCT00809159|584474699|FG004|Part 1 and 2|Adverse Event|1|||
161845024|NCT00809159|584474700|FG005|Part 1 and 2|Adverse Event|1|||
161845025|NCT00809159|584474695|FG000|Part 1 and 2|Lost to Follow-up|0|||
161845026|NCT00809159|584474696|FG001|Part 1 and 2|Lost to Follow-up|0|||
161845027|NCT00809159|584474697|FG002|Part 1 and 2|Lost to Follow-up|1|||
161845028|NCT00809159|584474698|FG003|Part 1 and 2|Lost to Follow-up|1|||
161845029|NCT00809159|584474699|FG004|Part 1 and 2|Lost to Follow-up|0|||
161845030|NCT00809159|584474700|FG005|Part 1 and 2|Lost to Follow-up|0|||
161845031|NCT00809159|584474695|FG000|Part 1 and 2|Withdrawal by Subject|0|||
161845032|NCT00809159|584474696|FG001|Part 1 and 2|Withdrawal by Subject|0|||
161845033|NCT00809159|584474697|FG002|Part 1 and 2|Withdrawal by Subject|4|||
161755537|NCT04731922|584144366|FG014|Overall Study|Other|0|||
161755538|NCT04731922|584144367|FG015|Overall Study|Other|0|||
161755539|NCT04731922|584144368|FG016|Overall Study|Other|0|||
161755540|NCT04157751|584144369|FG000|Overall Study|Withdrawal by Subject|12|||
161755541|NCT04157751|584144370|FG001|Overall Study|Withdrawal by Subject|17|||
161755542|NCT04157751|584144369|FG000|Overall Study|Lost to Follow-up|6|||
161755543|NCT04157751|584144370|FG001|Overall Study|Lost to Follow-up|2|||
161755544|NCT04157751|584144369|FG000|Overall Study|Adverse Event|34|||
161755545|NCT04157751|584144370|FG001|Overall Study|Adverse Event|23|||
161755546|NCT04157751|584144369|FG000|Overall Study|Not treated|1|||
161755547|NCT04157751|584144370|FG001|Overall Study|Not treated|5|||
161755548|NCT04157751|584144369|FG000|Overall Study|Other reason not stated above|10|||
161755549|NCT04157751|584144370|FG001|Overall Study|Other reason not stated above|10|||
161755550|NCT00981747|584144377|FG000|Losartan|Withdrawal by Subject|1|||
161755551|NCT00981747|584144377|FG000|Losartan|Death|1|||
161755552|NCT00981747|584144377|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
161755553|NCT01810380|584144387|FG000|Overall Study|Randomised not treated|2|||
161755554|NCT01810380|584144388|FG001|Overall Study|Randomised not treated|1|||
161755555|NCT01810380|584144389|FG002|Overall Study|Randomised not treated|1|||
161755556|NCT01810380|584144387|FG000|Overall Study|Adverse Event|11|||
161755557|NCT01810380|584144388|FG001|Overall Study|Adverse Event|14|||
161755558|NCT01810380|584144389|FG002|Overall Study|Adverse Event|4|||
161755559|NCT01810380|584144387|FG000|Overall Study|Lack of Efficacy|24|||
161755560|NCT01810380|584144388|FG001|Overall Study|Lack of Efficacy|10|||
161755561|NCT01810380|584144389|FG002|Overall Study|Lack of Efficacy|11|||
161755562|NCT01810380|584144387|FG000|Overall Study|Protocol Violation|1|||
161755563|NCT01810380|584144388|FG001|Overall Study|Protocol Violation|0|||
161755564|NCT01810380|584144389|FG002|Overall Study|Protocol Violation|1|||
161755565|NCT01810380|584144387|FG000|Overall Study|Withdrawal by Subject|6|||
161755566|NCT01810380|584144388|FG001|Overall Study|Withdrawal by Subject|0|||
161755567|NCT01810380|584144389|FG002|Overall Study|Withdrawal by Subject|6|||
161755568|NCT01810380|584144387|FG000|Overall Study|Administrative or other reasons|11|||
161755569|NCT01810380|584144388|FG001|Overall Study|Administrative or other reasons|13|||
161755570|NCT01810380|584144389|FG002|Overall Study|Administrative or other reasons|9|||
161755571|NCT01390038|584144390|FG000|Overall Study|Death|1|||
161755572|NCT01390038|584144390|FG000|Overall Study|Lost to Follow-up|1|||
161755573|NCT01390038|584144390|FG000|Overall Study|Withdrawal by Subject|4|||
161755574|NCT01390038|584144390|FG000|Overall Study|Simpliciti System Removal|2|||
161755575|NCT03148795|584144395|FG000|Overall Study|Progressive Disease|1|||
161755576|NCT00441012|584144396|FG000|Overall Study|Adverse Event|0|||
161755577|NCT00441012|584144397|FG001|Overall Study|Adverse Event|1|||
161755578|NCT00441012|584144396|FG000|Overall Study|Lost to Follow-up|3|||
161755579|NCT00441012|584144397|FG001|Overall Study|Lost to Follow-up|3|||
161755580|NCT00441012|584144396|FG000|Overall Study|Protocol Violation|10|||
161845034|NCT00809159|584474698|FG003|Part 1 and 2|Withdrawal by Subject|0|||
161845035|NCT00809159|584474699|FG004|Part 1 and 2|Withdrawal by Subject|0|||
161845036|NCT00809159|584474700|FG005|Part 1 and 2|Withdrawal by Subject|1|||
161845037|NCT03918109|584474705|FG000|Overall Study|Withdrawal by Subject|0|||
161845038|NCT03918109|584474706|FG001|Overall Study|Withdrawal by Subject|0|||
161755581|NCT00441012|584144397|FG001|Overall Study|Protocol Violation|9|||
161755582|NCT00441012|584144396|FG000|Overall Study|Withdrawal by Subject|4|||
161755583|NCT00441012|584144397|FG001|Overall Study|Withdrawal by Subject|0|||
161755584|NCT00441012|584144396|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
161755585|NCT00441012|584144397|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
161755586|NCT04489940|584144398|FG000|Overall Study|Other|2|||
161845039|NCT03918109|584474707|FG002|Overall Study|Withdrawal by Subject|2|||
161755587|NCT04489940|584144398|FG000|Overall Study|Withdrawal by Subject|2|||
161755588|NCT04489940|584144398|FG000|Overall Study|Death|5|||
161845040|NCT03918109|584474708|FG003|Overall Study|Withdrawal by Subject|1|||
161845041|NCT03918109|584474705|FG000|Overall Study|Lost to Follow-up|0|||
161845042|NCT03918109|584474706|FG001|Overall Study|Lost to Follow-up|0|||
161845043|NCT03918109|584474707|FG002|Overall Study|Lost to Follow-up|0|||
161845044|NCT03918109|584474708|FG003|Overall Study|Lost to Follow-up|1|||
161845045|NCT03050060|584474713|FG000|Overall Study|Adverse Event|7|||
161845046|NCT03050060|584474713|FG000|Overall Study|Withdrawal by Subject|1|||
161845047|NCT03050060|584474713|FG000|Overall Study|Progression|7|||
161845048|NCT04568031|584474714|FG000|Overall Study|Lost to Follow-up|1|||
161845049|NCT04568031|584474715|FG001|Overall Study|Lost to Follow-up|0|||
161845050|NCT04568031|584474716|FG002|Overall Study|Lost to Follow-up|0|||
161845051|NCT04568031|584474717|FG003|Overall Study|Lost to Follow-up|0|||
161845052|NCT04568031|584474714|FG000|Overall Study|Physician Decision|1|||
161845053|NCT04568031|584474715|FG001|Overall Study|Physician Decision|0|||
161845054|NCT04568031|584474716|FG002|Overall Study|Physician Decision|1|||
161845055|NCT04568031|584474717|FG003|Overall Study|Physician Decision|0|||
161845056|NCT04568031|584474714|FG000|Overall Study|Withdrawal by Subject|1|||
161845057|NCT04568031|584474715|FG001|Overall Study|Withdrawal by Subject|0|||
161845058|NCT04568031|584474716|FG002|Overall Study|Withdrawal by Subject|4|||
161845059|NCT04568031|584474717|FG003|Overall Study|Withdrawal by Subject|1|||
161845060|NCT02304458|584474718|FG000|Overall Study|Adverse Event|0|||
161845061|NCT02304458|584474719|FG001|Overall Study|Adverse Event|0|||
161845062|NCT02304458|584474720|FG002|Overall Study|Adverse Event|7|||
161845063|NCT02304458|584474721|FG003|Overall Study|Adverse Event|0|||
161845064|NCT02304458|584474722|FG004|Overall Study|Adverse Event|0|||
161845065|NCT02304458|584474723|FG005|Overall Study|Adverse Event|0|||
161845066|NCT02304458|584474724|FG006|Overall Study|Adverse Event|3|||
161845067|NCT02304458|584474725|FG007|Overall Study|Adverse Event|4|||
161845068|NCT02304458|584474718|FG000|Overall Study|Death|0|||
161845069|NCT02304458|584474719|FG001|Overall Study|Death|0|||
161845070|NCT02304458|584474720|FG002|Overall Study|Death|2|||
161845071|NCT02304458|584474721|FG003|Overall Study|Death|0|||
161845072|NCT02304458|584474722|FG004|Overall Study|Death|0|||
161845073|NCT02304458|584474723|FG005|Overall Study|Death|0|||
161845074|NCT02304458|584474724|FG006|Overall Study|Death|1|||
161845075|NCT02304458|584474725|FG007|Overall Study|Death|0|||
161845076|NCT02304458|584474718|FG000|Overall Study|Lack of Efficacy|4|||
161969485|NCT01187446|584937793|FG001|Overall Study|Patient started non-protocol therapy|1|||
161969486|NCT00823212|584937795|FG000|Overall Study|Death|8|||
161969487|NCT00823212|584937796|FG001|Overall Study|Death|10|||
161969488|NCT00823212|584937795|FG000|Overall Study|Withdrawal by Subject|6|||
161845077|NCT02304458|584474719|FG001|Overall Study|Lack of Efficacy|6|||
161845078|NCT02304458|584474720|FG002|Overall Study|Lack of Efficacy|38|||
161845079|NCT02304458|584474721|FG003|Overall Study|Lack of Efficacy|5|||
161845080|NCT02304458|584474722|FG004|Overall Study|Lack of Efficacy|6|||
161969489|NCT00823212|584937796|FG001|Overall Study|Withdrawal by Subject|1|||
161969490|NCT00823212|584937795|FG000|Overall Study|Incarcerated|0|||
161969491|NCT00823212|584937796|FG001|Overall Study|Incarcerated|1|||
161969492|NCT00823212|584937795|FG000|Overall Study|Missed 12-month visit|21|||
161969493|NCT00823212|584937796|FG001|Overall Study|Missed 12-month visit|21|||
161969494|NCT03405935|584937801|FG000|Overall Study|Adverse Event|3|||
161969495|NCT03405935|584937801|FG000|Overall Study|Death|2|||
161969496|NCT03405935|584937801|FG000|Overall Study|Withdrawal by Subject|1|||
161969497|NCT03405935|584937801|FG000|Overall Study|Lost to Follow-up|2|||
161969498|NCT04659174|584937811|FG000|Overall Study|Sponsor decision to discontinue study|0|||
161969499|NCT04659174|584937812|FG001|Overall Study|Sponsor decision to discontinue study|2|||
161969500|NCT04659174|584937811|FG000|Overall Study|Lost to Follow-up|9|||
161969501|NCT04659174|584937812|FG001|Overall Study|Lost to Follow-up|11|||
161969502|NCT04659174|584937811|FG000|Overall Study|Adverse Event|8|||
161969503|NCT04659174|584937812|FG001|Overall Study|Adverse Event|5|||
161969504|NCT04659174|584937811|FG000|Overall Study|Withdrawal by Subject|17|||
161969505|NCT04659174|584937812|FG001|Overall Study|Withdrawal by Subject|33|||
161845081|NCT02304458|584474723|FG005|Overall Study|Lack of Efficacy|6|||
161845082|NCT02304458|584474724|FG006|Overall Study|Lack of Efficacy|21|||
161845083|NCT02304458|584474725|FG007|Overall Study|Lack of Efficacy|4|||
161845084|NCT02304458|584474718|FG000|Overall Study|Physician Decision|2|||
161845085|NCT02304458|584474719|FG001|Overall Study|Physician Decision|0|||
161845086|NCT02304458|584474720|FG002|Overall Study|Physician Decision|16|||
161845087|NCT02304458|584474721|FG003|Overall Study|Physician Decision|1|||
161969506|NCT04659174|584937811|FG000|Overall Study|Progressive disease|0|||
161969507|NCT04659174|584937812|FG001|Overall Study|Progressive disease|2|||
161969508|NCT04659174|584937811|FG000|Overall Study|Other reasons|0|||
161969509|NCT04659174|584937812|FG001|Overall Study|Other reasons|2|||
161845088|NCT02304458|584474722|FG004|Overall Study|Physician Decision|0|||
161845089|NCT02304458|584474723|FG005|Overall Study|Physician Decision|0|||
161845090|NCT02304458|584474724|FG006|Overall Study|Physician Decision|3|||
161845091|NCT02304458|584474725|FG007|Overall Study|Physician Decision|0|||
161845092|NCT02304458|584474718|FG000|Overall Study|Protocol Violation|0|||
161845093|NCT02304458|584474719|FG001|Overall Study|Protocol Violation|0|||
161845094|NCT02304458|584474720|FG002|Overall Study|Protocol Violation|1|||
161969510|NCT04659174|584937811|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
162032887|NCT02119676|585177501|FG002|Overall Study|Death|2|||
161755589|NCT04489940|584144398|FG000|Overall Study|Lost to Follow-up|1|||
161755590|NCT04498468|584144399|FG000|Overall Study|Lost to Follow-up|3|||
161755591|NCT02774291|584144400|FG000|Overall Study|Lost to Follow-up|1|||
161755592|NCT00149890|584144404|FG000|Overall Study|Adverse Event|1|||
161755593|NCT00149890|584144405|FG001|Overall Study|Adverse Event|8|||
161755594|NCT00149890|584144404|FG000|Overall Study|Lack of Efficacy|8|||
161755595|NCT00149890|584144405|FG001|Overall Study|Lack of Efficacy|9|||
161755596|NCT00149890|584144404|FG000|Overall Study|Protocol Violation|1|||
161755597|NCT00149890|584144405|FG001|Overall Study|Protocol Violation|0|||
161755598|NCT00149890|584144404|FG000|Overall Study|Lost to Follow-up|1|||
161755599|NCT00149890|584144405|FG001|Overall Study|Lost to Follow-up|0|||
161755600|NCT00149890|584144404|FG000|Overall Study|Graft Loss|2|||
161755601|NCT00149890|584144405|FG001|Overall Study|Graft Loss|1|||
161755602|NCT01387594|584144406|FG000|Overall Study|Withdrawal by Subject|0|||
161755603|NCT01387594|584144407|FG001|Overall Study|Withdrawal by Subject|2|||
161755604|NCT01387594|584144406|FG000|Overall Study|Lost to Follow-up|0|||
161755605|NCT01387594|584144407|FG001|Overall Study|Lost to Follow-up|1|||
161755606|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
161755607|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
161755608|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
161755609|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
161755610|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
161755611|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
161755612|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
161755613|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
161755614|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
161755615|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
161755616|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
161755617|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
161755618|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
161755619|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
161755620|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
161755621|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
161755622|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
161755623|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
161755624|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
161755625|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
161755626|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
161755627|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
161755628|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
161755629|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
161755630|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
161755631|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
161755632|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
161755633|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
161755634|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
161755635|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
161755636|NCT04757376|584144410|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
161755637|NCT04757376|584144411|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
161755638|NCT04757376|584144412|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
161755639|NCT04757376|584144413|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
161755640|NCT04757376|584144414|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
161755641|NCT04757376|584144410|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
161755642|NCT04757376|584144411|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
161755643|NCT04757376|584144412|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
161755644|NCT04757376|584144413|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
161755645|NCT04757376|584144414|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
161755646|NCT01307046|584144415|FG000|Overall Study|Adverse Event|3|||
161755647|NCT01307046|584144416|FG001|Overall Study|Adverse Event|3|||
161755648|NCT01307046|584144415|FG000|Overall Study|Lack of Efficacy|0|||
161755649|NCT01307046|584144416|FG001|Overall Study|Lack of Efficacy|2|||
161755650|NCT01307046|584144415|FG000|Overall Study|Physician Decision|2|||
161845095|NCT02304458|584474721|FG003|Overall Study|Protocol Violation|0|||
161845096|NCT02304458|584474722|FG004|Overall Study|Protocol Violation|0|||
161845097|NCT02304458|584474723|FG005|Overall Study|Protocol Violation|0|||
161845098|NCT02304458|584474724|FG006|Overall Study|Protocol Violation|0|||
161845099|NCT02304458|584474725|FG007|Overall Study|Protocol Violation|0|||
161845100|NCT02304458|584474718|FG000|Overall Study|Withdrawal by Subject|1|||
161845101|NCT02304458|584474719|FG001|Overall Study|Withdrawal by Subject|0|||
161845102|NCT02304458|584474720|FG002|Overall Study|Withdrawal by Subject|7|||
161845103|NCT02304458|584474721|FG003|Overall Study|Withdrawal by Subject|0|||
161845104|NCT02304458|584474722|FG004|Overall Study|Withdrawal by Subject|0|||
161845105|NCT02304458|584474723|FG005|Overall Study|Withdrawal by Subject|0|||
161845106|NCT02304458|584474724|FG006|Overall Study|Withdrawal by Subject|1|||
161845107|NCT02304458|584474725|FG007|Overall Study|Withdrawal by Subject|0|||
161845108|NCT00186043|584474726|FG000|Overall Study|Lack of Efficacy|1|||
161845109|NCT00186043|584474727|FG001|Overall Study|Lack of Efficacy|3|||
161845110|NCT00186043|584474726|FG000|Overall Study|Lost to Follow-up|4|||
161845111|NCT00186043|584474727|FG001|Overall Study|Lost to Follow-up|6|||
161845112|NCT00186043|584474726|FG000|Overall Study|Withdrawal by Subject|1|||
161845113|NCT00186043|584474727|FG001|Overall Study|Withdrawal by Subject|0|||
161845114|NCT00186043|584474726|FG000|Overall Study|Adverse Event|7|||
161845115|NCT00186043|584474727|FG001|Overall Study|Adverse Event|3|||
161845116|NCT00186043|584474726|FG000|Overall Study|Protocol Violation|2|||
161845117|NCT00186043|584474727|FG001|Overall Study|Protocol Violation|1|||
161845118|NCT04874636|584474728|FG000|Overall Study|Adverse Event|17|||
161845119|NCT04874636|584474729|FG001|Overall Study|Adverse Event|7|||
161845120|NCT04874636|584474728|FG000|Overall Study|Lost to Follow-up|1|||
161845121|NCT04874636|584474729|FG001|Overall Study|Lost to Follow-up|0|||
161845122|NCT04874636|584474728|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161845123|NCT04874636|584474729|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161845124|NCT04874636|584474728|FG000|Overall Study|Physician Decision|1|||
161845125|NCT04874636|584474729|FG001|Overall Study|Physician Decision|0|||
161845126|NCT04874636|584474728|FG000|Overall Study|Withdrawal by Subject|6|||
161845127|NCT04874636|584474729|FG001|Overall Study|Withdrawal by Subject|5|||
161845128|NCT04188301|584474732|FG000|Month 3|Lost to Follow-up|0|||
161845129|NCT04188301|584474733|FG001|Month 3|Lost to Follow-up|0|||
161845130|NCT04188301|584474734|FG002|Month 3|Lost to Follow-up|1|||
161845131|NCT04188301|584474732|FG000|Month 12|Lost to Follow-up|0|||
161845132|NCT04188301|584474733|FG001|Month 12|Lost to Follow-up|0|||
161845133|NCT04188301|584474734|FG002|Month 12|Lost to Follow-up|2|||
161845134|NCT04188301|584474732|FG000|Month 12|Death|1|||
161845135|NCT04188301|584474733|FG001|Month 12|Death|1|||
161845136|NCT04188301|584474734|FG002|Month 12|Death|0|||
161845137|NCT04188301|584474732|FG000|Month 18|Lost to Follow-up|6|||
161845138|NCT04188301|584474733|FG001|Month 18|Lost to Follow-up|0|||
161845139|NCT04188301|584474734|FG002|Month 18|Lost to Follow-up|0|||
161845140|NCT02582866|584474739|FG000|Overall Study|Death|1|||
161845141|NCT02582866|584474739|FG000|Overall Study|Lack of Efficacy|2|||
161845142|NCT02582866|584474739|FG000|Overall Study|Lost to Follow-up|2|||
161845143|NCT02582866|584474739|FG000|Overall Study|Withdrawal by Subject|7|||
161845144|NCT02582866|584474739|FG000|Overall Study|Investigator decision|5|||
161845145|NCT02582866|584474739|FG000|Overall Study|Participant wants to get pregnant|1|||
161845146|NCT02582866|584474739|FG000|Overall Study|Pregnancy|2|||
161845147|NCT02582866|584474739|FG000|Overall Study|Sponsor decision|1|||
161845148|NCT02582866|584474739|FG000|Overall Study|Withdrawal due to personal reasons|1|||
161845149|NCT03567382|584474740|FG000|Overall Study|Lost to Follow-up|1|||
161845150|NCT03567382|584474741|FG001|Overall Study|Lost to Follow-up|21|||
161845151|NCT03567382|584474742|FG002|Overall Study|Lost to Follow-up|1|||
161845152|NCT03567382|584474743|FG003|Overall Study|Lost to Follow-up|21|||
161845153|NCT03567382|584474740|FG000|Overall Study|Withdrawal by Subject|2|||
161845154|NCT03567382|584474741|FG001|Overall Study|Withdrawal by Subject|14|||
161845155|NCT03567382|584474742|FG002|Overall Study|Withdrawal by Subject|1|||
161845156|NCT03567382|584474743|FG003|Overall Study|Withdrawal by Subject|12|||
161845157|NCT03246646|584474746|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
161845158|NCT03246646|584474747|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
161845159|NCT03246646|584474746|FG000|Overall Study|Withdrawal by Subject|3|||
161845160|NCT03246646|584474747|FG001|Overall Study|Withdrawal by Subject|0|||
161845161|NCT03246646|584474746|FG000|Overall Study|Lost to Follow-up|7|||
161845162|NCT03246646|584474747|FG001|Overall Study|Lost to Follow-up|0|||
161845163|NCT00319982|584474750|FG000|Overall Study|Withdrawal by Subject|1|||
161845164|NCT00319982|584474751|FG001|Overall Study|Withdrawal by Subject|0|||
161845165|NCT00758680|584474752|FG000|Overall Study|Adverse Event|0|||
161845166|NCT00758680|584474753|FG001|Overall Study|Adverse Event|0|||
161845167|NCT00758680|584474754|FG002|Overall Study|Adverse Event|0|||
161845168|NCT00758680|584474755|FG003|Overall Study|Adverse Event|0|||
161845169|NCT00758680|584474756|FG004|Overall Study|Adverse Event|0|||
161845170|NCT00758680|584474757|FG005|Overall Study|Adverse Event|0|||
161845171|NCT00758680|584474758|FG006|Overall Study|Adverse Event|0|||
161845172|NCT00758680|584474759|FG007|Overall Study|Adverse Event|1|||
161845173|NCT00758680|584474760|FG008|Overall Study|Adverse Event|0|||
161845174|NCT00758680|584474761|FG009|Overall Study|Adverse Event|1|||
161845175|NCT00758680|584474752|FG000|Overall Study|Laboratory Adverse Event|0|||
161845176|NCT00758680|584474753|FG001|Overall Study|Laboratory Adverse Event|0|||
162032888|NCT02119676|585177502|FG003|Overall Study|Death|1|||
162032889|NCT02119676|585177499|FG000|Overall Study|Noncompliance|0|||
162032890|NCT02119676|585177500|FG001|Overall Study|Noncompliance|1|||
161845177|NCT00758680|584474754|FG002|Overall Study|Laboratory Adverse Event|0|||
161845178|NCT00758680|584474755|FG003|Overall Study|Laboratory Adverse Event|0|||
161845179|NCT00758680|584474756|FG004|Overall Study|Laboratory Adverse Event|0|||
161845180|NCT00758680|584474757|FG005|Overall Study|Laboratory Adverse Event|0|||
161845181|NCT00758680|584474758|FG006|Overall Study|Laboratory Adverse Event|0|||
161845182|NCT00758680|584474759|FG007|Overall Study|Laboratory Adverse Event|0|||
161845183|NCT00758680|584474760|FG008|Overall Study|Laboratory Adverse Event|1|||
161845184|NCT00758680|584474761|FG009|Overall Study|Laboratory Adverse Event|0|||
161845185|NCT00758680|584474752|FG000|Overall Study|Withdrawal by Subject|0|||
161845186|NCT00758680|584474753|FG001|Overall Study|Withdrawal by Subject|0|||
161845187|NCT00758680|584474754|FG002|Overall Study|Withdrawal by Subject|0|||
161845188|NCT00758680|584474755|FG003|Overall Study|Withdrawal by Subject|0|||
161845189|NCT00758680|584474756|FG004|Overall Study|Withdrawal by Subject|0|||
161845190|NCT00758680|584474757|FG005|Overall Study|Withdrawal by Subject|0|||
161845191|NCT00758680|584474758|FG006|Overall Study|Withdrawal by Subject|1|||
161845192|NCT00758680|584474759|FG007|Overall Study|Withdrawal by Subject|0|||
161845193|NCT00758680|584474760|FG008|Overall Study|Withdrawal by Subject|1|||
161845194|NCT00758680|584474761|FG009|Overall Study|Withdrawal by Subject|0|||
161845195|NCT03480386|584474762|FG000|Overall Study|Did not complete measures at 3-months|17|||
161845196|NCT03480386|584474763|FG001|Overall Study|Did not complete measures at 3-months|14|||
161845197|NCT03480386|584474762|FG000|Overall Study|No baseline measures|11|||
161845198|NCT03480386|584474763|FG001|Overall Study|No baseline measures|14|||
161845199|NCT03480386|584474762|FG000|Overall Study|Death|0|||
161845200|NCT03480386|584474763|FG001|Overall Study|Death|5|||
161845201|NCT03480386|584474762|FG000|Overall Study|Withdrawal by Subject|12|||
161845202|NCT03480386|584474763|FG001|Overall Study|Withdrawal by Subject|8|||
161845203|NCT03480386|584474762|FG000|Overall Study|Lost to Follow-up|2|||
161845204|NCT03480386|584474763|FG001|Overall Study|Lost to Follow-up|1|||
161845205|NCT03480386|584474762|FG000|Overall Study|Complicating disease|0|||
161845206|NCT03480386|584474763|FG001|Overall Study|Complicating disease|1|||
161845207|NCT03480386|584474762|FG000|Overall Study|Disease progression|3|||
161845208|NCT03480386|584474763|FG001|Overall Study|Disease progression|0|||
161845209|NCT03480386|584474762|FG000|Overall Study|Became ineligible|0|||
161845210|NCT03480386|584474763|FG001|Overall Study|Became ineligible|2|||
161845211|NCT02201290|584474764|FG000|Overall Study|Withdrawal by Subject|2|||
161845212|NCT02201290|584474764|FG000|Overall Study|Lack of Efficacy|2|||
161845213|NCT02201290|584474764|FG000|Overall Study|Adverse Event|1|||
161845214|NCT04639713|584474765|FG000|Overall Study|Protocol Noncompliance|2|||
161845215|NCT04639713|584474765|FG000|Overall Study|Withdrawal by Subject|1|||
161845216|NCT03589768|584476951|FG000|Overall Study|Death|1|||
161845217|NCT03589768|584476952|FG001|Overall Study|Death|0|||
161845218|NCT03589768|584476953|FG002|Overall Study|Death|8|||
161845219|NCT03589768|584476954|FG003|Overall Study|Death|3|||
161845220|NCT03589768|584476951|FG000|Overall Study|Withdrawal by Subject|2|||
161845221|NCT03589768|584476952|FG001|Overall Study|Withdrawal by Subject|0|||
161845222|NCT03589768|584476953|FG002|Overall Study|Withdrawal by Subject|0|||
161845223|NCT03589768|584476954|FG003|Overall Study|Withdrawal by Subject|0|||
161845224|NCT03589768|584476951|FG000|Overall Study|Protocol Violation|1|||
161845225|NCT03589768|584476952|FG001|Overall Study|Protocol Violation|0|||
161845226|NCT03589768|584476953|FG002|Overall Study|Protocol Violation|0|||
161845227|NCT03589768|584476954|FG003|Overall Study|Protocol Violation|0|||
161845228|NCT00191113|584476957|FG000|Core Study|Withdrawal by Subject|25|||
161845229|NCT00191113|584476958|FG001|Core Study|Withdrawal by Subject|9|||
161845230|NCT00191113|584476957|FG000|Core Study|Protocol Violation|6|||
161845231|NCT00191113|584476958|FG001|Core Study|Protocol Violation|2|||
161845232|NCT00191113|584476957|FG000|Core Study|Lost to Follow-up|3|||
161845233|NCT00191113|584476958|FG001|Core Study|Lost to Follow-up|0|||
161845234|NCT00191113|584476957|FG000|Core Study|Adverse Event|0|||
161845235|NCT00191113|584476958|FG001|Core Study|Adverse Event|2|||
161845236|NCT00191113|584476957|FG000|Core Study|Lack of Efficacy|0|||
162032891|NCT02119676|585177501|FG002|Overall Study|Noncompliance|0|||
162032892|NCT02119676|585177502|FG003|Overall Study|Noncompliance|0|||
161845237|NCT00191113|584476958|FG001|Core Study|Lack of Efficacy|2|||
161845238|NCT00191113|584476957|FG000|Core Study|Death|1|||
161845239|NCT00191113|584476958|FG001|Core Study|Death|0|||
161845240|NCT01555671|584476961|FG000|Overall Study|Physician Decision|20|||
161845241|NCT01555671|584476962|FG001|Overall Study|Physician Decision|25|||
161845242|NCT00631657|584476963|FG000|6-Month Treatment Period|Adverse Event|47|||
161845243|NCT00631657|584476964|FG001|6-Month Treatment Period|Adverse Event|0|||
161845244|NCT00631657|584476965|FG002|6-Month Treatment Period|Adverse Event|7|||
161845245|NCT00631657|584476963|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
161845246|NCT00631657|584476964|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
162032893|NCT02119676|585177499|FG000|Overall Study|Lost to Follow-up|0|||
161845247|NCT00631657|584476965|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
161845248|NCT00631657|584476963|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
161845249|NCT00631657|584476964|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
161845250|NCT00631657|584476965|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
161845251|NCT00631657|584476963|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
161845252|NCT00631657|584476964|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
161845253|NCT00631657|584476965|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
161845254|NCT00631657|584476963|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
161845255|NCT00631657|584476964|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
161845256|NCT00631657|584476965|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
161845257|NCT00631657|584476963|FG000|6-Month Treatment Period|Other|16|||
161845258|NCT00631657|584476964|FG001|6-Month Treatment Period|Other|0|||
161845259|NCT00631657|584476965|FG002|6-Month Treatment Period|Other|4|||
161845260|NCT00631657|584476963|FG000|6-Month Treatment Period|Not Treated|2|||
161845261|NCT00631657|584476964|FG001|6-Month Treatment Period|Not Treated|0|||
161845262|NCT00631657|584476965|FG002|6-Month Treatment Period|Not Treated|1|||
161845263|NCT00631657|584476963|FG000|7-Day Discontinuation Period|Not Treated|1|||
161845264|NCT00631657|584476964|FG001|7-Day Discontinuation Period|Not Treated|1|||
161845265|NCT00631657|584476965|FG002|7-Day Discontinuation Period|Not Treated|1|||
161845266|NCT00631657|584476963|FG000|7-Day Discontinuation Period|Other|1|||
161845267|NCT00631657|584476964|FG001|7-Day Discontinuation Period|Other|0|||
161845268|NCT00631657|584476965|FG002|7-Day Discontinuation Period|Other|0|||
161845269|NCT04003896|584476966|FG000|Overall Study|Withdrawal by Subject|3|||
161845270|NCT04003896|584476966|FG000|Overall Study|Physician Decision|1|||
161845271|NCT03929757|584476969|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
161845272|NCT03929757|584476970|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
161845273|NCT03929757|584476971|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
161845274|NCT03929757|584476969|FG000|Main Study: Up to Day 365|Other|1|||
161845275|NCT03929757|584476970|FG001|Main Study: Up to Day 365|Other|0|||
161845276|NCT03929757|584476971|FG002|Main Study: Up to Day 365|Other|0|||
161845277|NCT03929757|584476969|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
161845278|NCT03929757|584476970|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
161845279|NCT03929757|584476971|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
161845280|NCT01154816|584476972|FG000|Overall Study|Withdrawal by Subject|1|||
161845281|NCT01154816|584476973|FG001|Overall Study|Withdrawal by Subject|0|||
161845282|NCT01154816|584476974|FG002|Overall Study|Withdrawal by Subject|0|||
161845283|NCT01154816|584476975|FG003|Overall Study|Withdrawal by Subject|1|||
161845284|NCT01154816|584476976|FG004|Overall Study|Withdrawal by Subject|0|||
161845285|NCT01154816|584476977|FG005|Overall Study|Withdrawal by Subject|0|||
161845286|NCT01154816|584476978|FG006|Overall Study|Withdrawal by Subject|0|||
161845287|NCT01154816|584476979|FG007|Overall Study|Withdrawal by Subject|0|||
161845288|NCT01154816|584476980|FG008|Overall Study|Withdrawal by Subject|1|||
161845289|NCT01154816|584476981|FG009|Overall Study|Withdrawal by Subject|3|||
161845290|NCT01154816|584476982|FG010|Overall Study|Withdrawal by Subject|0|||
161845291|NCT01154816|584476983|FG011|Overall Study|Withdrawal by Subject|0|||
161845292|NCT01154816|584476972|FG000|Overall Study|Progressive Disease|13|||
161845293|NCT01154816|584476973|FG001|Overall Study|Progressive Disease|8|||
161845294|NCT01154816|584476974|FG002|Overall Study|Progressive Disease|9|||
161845295|NCT01154816|584476975|FG003|Overall Study|Progressive Disease|9|||
161845296|NCT01154816|584476976|FG004|Overall Study|Progressive Disease|8|||
161845297|NCT01154816|584476977|FG005|Overall Study|Progressive Disease|8|||
161845298|NCT01154816|584476978|FG006|Overall Study|Progressive Disease|5|||
161845299|NCT01154816|584476979|FG007|Overall Study|Progressive Disease|6|||
161845300|NCT01154816|584476980|FG008|Overall Study|Progressive Disease|8|||
161845301|NCT01154816|584476981|FG009|Overall Study|Progressive Disease|6|||
161845302|NCT01154816|584476982|FG010|Overall Study|Progressive Disease|10|||
161845303|NCT01154816|584476983|FG011|Overall Study|Progressive Disease|3|||
161845304|NCT01154816|584476972|FG000|Overall Study|Physician Decision|1|||
161845305|NCT01154816|584476973|FG001|Overall Study|Physician Decision|0|||
161845306|NCT01154816|584476974|FG002|Overall Study|Physician Decision|1|||
161845307|NCT01154816|584476975|FG003|Overall Study|Physician Decision|0|||
161845308|NCT01154816|584476976|FG004|Overall Study|Physician Decision|2|||
161969511|NCT04659174|584937812|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
161969512|NCT04659174|584937811|FG000|Overall Study|Alcohol or illegal drug use|0|||
161845309|NCT01154816|584476977|FG005|Overall Study|Physician Decision|0|||
161845310|NCT01154816|584476978|FG006|Overall Study|Physician Decision|0|||
161845311|NCT01154816|584476979|FG007|Overall Study|Physician Decision|0|||
161845312|NCT01154816|584476980|FG008|Overall Study|Physician Decision|0|||
161845313|NCT01154816|584476981|FG009|Overall Study|Physician Decision|1|||
161845314|NCT01154816|584476982|FG010|Overall Study|Physician Decision|1|||
161845315|NCT01154816|584476983|FG011|Overall Study|Physician Decision|1|||
161845316|NCT01154816|584476972|FG000|Overall Study|Adverse Event|5|||
161969513|NCT04659174|584937812|FG001|Overall Study|Alcohol or illegal drug use|3|||
161845317|NCT01154816|584476973|FG001|Overall Study|Adverse Event|2|||
161845318|NCT01154816|584476974|FG002|Overall Study|Adverse Event|0|||
161969514|NCT04659174|584937811|FG000|Overall Study|Violation of entry criteria|1|||
161845319|NCT01154816|584476975|FG003|Overall Study|Adverse Event|0|||
161845320|NCT01154816|584476976|FG004|Overall Study|Adverse Event|0|||
161845321|NCT01154816|584476977|FG005|Overall Study|Adverse Event|0|||
161845322|NCT01154816|584476978|FG006|Overall Study|Adverse Event|1|||
161845323|NCT01154816|584476979|FG007|Overall Study|Adverse Event|1|||
161845324|NCT01154816|584476980|FG008|Overall Study|Adverse Event|0|||
161845325|NCT01154816|584476981|FG009|Overall Study|Adverse Event|0|||
161845326|NCT01154816|584476982|FG010|Overall Study|Adverse Event|0|||
161845327|NCT01154816|584476983|FG011|Overall Study|Adverse Event|0|||
161845328|NCT00806286|584476984|FG000|Overall Study|Adverse Event|5|||
161845329|NCT00806286|584476985|FG001|Overall Study|Adverse Event|2|||
161845330|NCT00806286|584476986|FG002|Overall Study|Adverse Event|0|||
161845331|NCT00806286|584476984|FG000|Overall Study|Disease progression|31|||
161845332|NCT00806286|584476985|FG001|Overall Study|Disease progression|38|||
161845333|NCT00806286|584476986|FG002|Overall Study|Disease progression|1|||
161845334|NCT00806286|584476984|FG000|Overall Study|Death|1|||
161845335|NCT00806286|584476985|FG001|Overall Study|Death|6|||
161845336|NCT00806286|584476986|FG002|Overall Study|Death|0|||
161845337|NCT00806286|584476984|FG000|Overall Study|Lost to Follow-up|0|||
161845338|NCT00806286|584476985|FG001|Overall Study|Lost to Follow-up|1|||
161845339|NCT00806286|584476986|FG002|Overall Study|Lost to Follow-up|0|||
161845340|NCT00806286|584476984|FG000|Overall Study|Withdrawal by Subject|8|||
161845341|NCT00806286|584476985|FG001|Overall Study|Withdrawal by Subject|3|||
161845342|NCT00806286|584476986|FG002|Overall Study|Withdrawal by Subject|1|||
161845343|NCT00806286|584476984|FG000|Overall Study|Physician Decision|2|||
161845344|NCT00806286|584476985|FG001|Overall Study|Physician Decision|2|||
161845345|NCT00806286|584476986|FG002|Overall Study|Physician Decision|0|||
161845346|NCT00806286|584476984|FG000|Overall Study|Due to a variety of reasons|7|||
161845347|NCT00806286|584476985|FG001|Overall Study|Due to a variety of reasons|2|||
161845348|NCT00806286|584476986|FG002|Overall Study|Due to a variety of reasons|1|||
161845349|NCT00686075|584476987|FG000|Overall Study|Withdrawal by Subject|4|||
161845350|NCT00686075|584476988|FG001|Overall Study|Withdrawal by Subject|3|||
161845351|NCT00686075|584476989|FG002|Overall Study|Withdrawal by Subject|3|||
161845352|NCT00686075|584476990|FG003|Overall Study|Withdrawal by Subject|7|||
161845353|NCT00686075|584476991|FG004|Overall Study|Withdrawal by Subject|1|||
161845354|NCT00686075|584476992|FG005|Overall Study|Withdrawal by Subject|0|||
161845355|NCT00686075|584476993|FG006|Overall Study|Withdrawal by Subject|0|||
161845356|NCT00686075|584476994|FG007|Overall Study|Withdrawal by Subject|2|||
161845357|NCT00686075|584476995|FG008|Overall Study|Withdrawal by Subject|4|||
161845358|NCT00686075|584476996|FG009|Overall Study|Withdrawal by Subject|6|||
161845359|NCT00686075|584476987|FG000|Overall Study|Lost to Follow-up|3|||
161845360|NCT00686075|584476988|FG001|Overall Study|Lost to Follow-up|6|||
161845361|NCT00686075|584476989|FG002|Overall Study|Lost to Follow-up|3|||
161845362|NCT00686075|584476990|FG003|Overall Study|Lost to Follow-up|2|||
161845363|NCT00686075|584476991|FG004|Overall Study|Lost to Follow-up|3|||
161845364|NCT00686075|584476992|FG005|Overall Study|Lost to Follow-up|3|||
161845365|NCT00686075|584476993|FG006|Overall Study|Lost to Follow-up|0|||
161845366|NCT00686075|584476994|FG007|Overall Study|Lost to Follow-up|0|||
161845367|NCT00686075|584476995|FG008|Overall Study|Lost to Follow-up|2|||
161845368|NCT00686075|584476996|FG009|Overall Study|Lost to Follow-up|3|||
161845369|NCT00686075|584476987|FG000|Overall Study|Other|1|||
161845370|NCT00686075|584476988|FG001|Overall Study|Other|1|||
161845371|NCT00686075|584476989|FG002|Overall Study|Other|0|||
161845372|NCT00686075|584476990|FG003|Overall Study|Other|0|||
161845373|NCT00686075|584476991|FG004|Overall Study|Other|0|||
161845374|NCT00686075|584476992|FG005|Overall Study|Other|0|||
161845375|NCT00686075|584476993|FG006|Overall Study|Other|0|||
161845376|NCT00686075|584476994|FG007|Overall Study|Other|0|||
161845377|NCT00686075|584476995|FG008|Overall Study|Other|0|||
161845378|NCT00686075|584476996|FG009|Overall Study|Other|1|||
161845379|NCT04713553|584476997|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
161845380|NCT04713553|584476998|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
161845381|NCT04713553|584476999|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
161845382|NCT04713553|584477000|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
161845383|NCT04713553|584477001|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
161969515|NCT04659174|584937812|FG001|Overall Study|Violation of entry criteria|0|||
161969516|NCT04659174|584937811|FG000|Overall Study|Death|0|||
161969517|NCT04659174|584937812|FG001|Overall Study|Death|1|||
161845384|NCT04713553|584477002|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
161845385|NCT04713553|584477003|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
161845386|NCT04713553|584476997|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161845387|NCT04713553|584476998|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161845388|NCT04713553|584476999|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161845389|NCT04713553|584477000|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
161845390|NCT04713553|584477001|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161845391|NCT04713553|584477002|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161845392|NCT04713553|584477003|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161845393|NCT04713553|584476997|FG000|Primary Study (2 Months)|Other|1|||
161969518|NCT02781792|584937813|FG000|Overall Study|Adverse Event|1|||
161969519|NCT02781792|584937814|FG001|Overall Study|Adverse Event|2|||
161969520|NCT02781792|584937813|FG000|Overall Study|Withdrawal by Subject|3|||
161969521|NCT02781792|584937814|FG001|Overall Study|Withdrawal by Subject|1|||
161969522|NCT02781792|584937813|FG000|Overall Study|Lack of Efficacy|1|||
161969523|NCT02781792|584937814|FG001|Overall Study|Lack of Efficacy|1|||
161845394|NCT04713553|584476998|FG001|Primary Study (2 Months)|Other|2|||
161845395|NCT04713553|584476999|FG002|Primary Study (2 Months)|Other|0|||
161845396|NCT04713553|584477000|FG003|Primary Study (2 Months)|Other|0|||
161845397|NCT04713553|584477001|FG004|Primary Study (2 Months)|Other|1|||
161845398|NCT04713553|584477002|FG005|Primary Study (2 Months)|Other|0|||
161845399|NCT04713553|584477003|FG006|Primary Study (2 Months)|Other|0|||
161845400|NCT04713553|584476997|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
161845401|NCT04713553|584476998|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
161845402|NCT04713553|584476999|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
161845403|NCT04713553|584477000|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
161845404|NCT04713553|584477001|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
161845405|NCT04713553|584477002|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
161845406|NCT04713553|584477003|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
161845407|NCT04713553|584476997|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
161845408|NCT04713553|584476998|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
161845409|NCT04713553|584476999|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
161845410|NCT04713553|584477000|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
161845411|NCT04713553|584477001|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
161845412|NCT04713553|584477002|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
161845413|NCT04713553|584477003|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
161845414|NCT03783039|584477004|FG000|Overall Study|Death|2|||
161845415|NCT03783039|584477005|FG001|Overall Study|Death|1|||
161845416|NCT01199471|584477006|FG000|Overall Study|Protocol Violation|4|||
161845417|NCT01199471|584477006|FG000|Overall Study|Withdrawal by Subject|1|||
161845418|NCT01199471|584477006|FG000|Overall Study|Physician Decision|1|||
161845419|NCT02006693|584477007|FG000|Overall Study|No Reason Specified|6|||
161845420|NCT02006693|584477008|FG001|Overall Study|No Reason Specified|8|||
161845421|NCT02006693|584477007|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
161845422|NCT02006693|584477008|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
161845423|NCT02006693|584477007|FG000|Overall Study|XEN Implant Explantation|0|||
161845424|NCT02006693|584477008|FG001|Overall Study|XEN Implant Explantation|1|||
161845425|NCT02006693|584477007|FG000|Overall Study|Death|2|||
161845426|NCT02006693|584477008|FG001|Overall Study|Death|2|||
161845427|NCT02006693|584477007|FG000|Overall Study|Lost to Follow-up|4|||
161845428|NCT02006693|584477008|FG001|Overall Study|Lost to Follow-up|1|||
161845429|NCT02006693|584477007|FG000|Overall Study|Patient Decision|4|||
161845430|NCT02006693|584477008|FG001|Overall Study|Patient Decision|0|||
161845431|NCT03151408|584477009|FG000|Overall Study|Adverse Event|24|||
161845432|NCT03151408|584477010|FG001|Overall Study|Adverse Event|23|||
161845433|NCT03151408|584477009|FG000|Overall Study|Death|46|||
161845434|NCT03151408|584477010|FG001|Overall Study|Death|26|||
161845435|NCT03151408|584477009|FG000|Overall Study|Physician Decision|13|||
161845436|NCT03151408|584477010|FG001|Overall Study|Physician Decision|19|||
161845437|NCT03151408|584477009|FG000|Overall Study|Withdrawal by Subject|16|||
161845438|NCT03151408|584477010|FG001|Overall Study|Withdrawal by Subject|20|||
161845439|NCT03151408|584477009|FG000|Overall Study|Progressive disease|45|||
161845440|NCT03151408|584477010|FG001|Overall Study|Progressive disease|61|||
161845441|NCT03151408|584477009|FG000|Overall Study|non-compliance by patient|1|||
161845442|NCT03151408|584477010|FG001|Overall Study|non-compliance by patient|0|||
161845443|NCT03151408|584477009|FG000|Overall Study|other reasons|56|||
161845444|NCT03151408|584477010|FG001|Overall Study|other reasons|52|||
161969524|NCT02781792|584937813|FG000|Overall Study|Hospice|0|||
161969525|NCT02781792|584937814|FG001|Overall Study|Hospice|1|||
161969526|NCT03447314|584937819|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
161969527|NCT03447314|584937820|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
161969528|NCT03447314|584937821|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
161969529|NCT03447314|584937822|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
161969530|NCT03447314|584937823|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
161969531|NCT03447314|584937824|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
161969532|NCT03447314|584937825|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
161845445|NCT03151408|584477009|FG000|Overall Study|randomized and not treated|2|||
161845446|NCT03151408|584477010|FG001|Overall Study|randomized and not treated|2|||
161845447|NCT01119508|584477011|FG000|Overall Study|Adverse Event|56|||
161969533|NCT03447314|584937826|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161845448|NCT01119508|584477011|FG000|Overall Study|Withdrawal by Subject|2|||
161845449|NCT01119508|584477011|FG000|Overall Study|Died before tumor response evaluation|1|||
161845450|NCT00265395|584477012|FG000|Overall Study|Adverse Event|3|||
161845451|NCT00265395|584477013|FG001|Overall Study|Adverse Event|6|||
161969534|NCT03447314|584937827|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161969535|NCT03447314|584937828|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161755651|NCT01307046|584144416|FG001|Overall Study|Physician Decision|0|||
161755652|NCT01307046|584144415|FG000|Overall Study|Withdrawal by Subject|1|||
161755653|NCT01307046|584144416|FG001|Overall Study|Withdrawal by Subject|1|||
161755654|NCT01307046|584144415|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
161755655|NCT01307046|584144416|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
161755656|NCT01307046|584144415|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
161755657|NCT01307046|584144416|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
161755658|NCT03898323|584144417|FG000|Overall Study|Physician Decision|1|||
161755659|NCT03954704|584144427|FG000|Overall Study|Death|1|||
161755660|NCT03954704|584144428|FG001|Overall Study|Death|1|||
161755661|NCT03954704|584144429|FG002|Overall Study|Death|1|||
161755662|NCT03954704|584144430|FG003|Overall Study|Death|3|||
161755663|NCT03954704|584144431|FG004|Overall Study|Death|2|||
161755664|NCT03954704|584144432|FG005|Overall Study|Death|2|||
161755665|NCT03954704|584144433|FG006|Overall Study|Death|0|||
161755666|NCT03954704|584144427|FG000|Overall Study|Withdrew Consent|0|||
161755667|NCT03954704|584144428|FG001|Overall Study|Withdrew Consent|0|||
161755668|NCT03954704|584144429|FG002|Overall Study|Withdrew Consent|1|||
161755669|NCT03954704|584144430|FG003|Overall Study|Withdrew Consent|0|||
161755670|NCT03954704|584144431|FG004|Overall Study|Withdrew Consent|0|||
161755671|NCT03954704|584144432|FG005|Overall Study|Withdrew Consent|1|||
161755672|NCT03954704|584144433|FG006|Overall Study|Withdrew Consent|0|||
161755673|NCT03954704|584144427|FG000|Overall Study|Lost to Follow-up|0|||
161755674|NCT03954704|584144428|FG001|Overall Study|Lost to Follow-up|0|||
161755675|NCT03954704|584144429|FG002|Overall Study|Lost to Follow-up|0|||
161755676|NCT03954704|584144430|FG003|Overall Study|Lost to Follow-up|0|||
161755677|NCT03954704|584144431|FG004|Overall Study|Lost to Follow-up|0|||
161755678|NCT03954704|584144432|FG005|Overall Study|Lost to Follow-up|0|||
161755679|NCT03954704|584144433|FG006|Overall Study|Lost to Follow-up|1|||
161755680|NCT03954704|584144427|FG000|Overall Study|Study Terminated by Sponsor|0|||
161755681|NCT03954704|584144428|FG001|Overall Study|Study Terminated by Sponsor|0|||
161755682|NCT03954704|584144429|FG002|Overall Study|Study Terminated by Sponsor|1|||
161755683|NCT03954704|584144430|FG003|Overall Study|Study Terminated by Sponsor|0|||
161755684|NCT03954704|584144431|FG004|Overall Study|Study Terminated by Sponsor|1|||
161755685|NCT03954704|584144432|FG005|Overall Study|Study Terminated by Sponsor|4|||
161755686|NCT03954704|584144433|FG006|Overall Study|Study Terminated by Sponsor|2|||
161755687|NCT03954704|584144427|FG000|Overall Study|Enrolled but not Treated|0|||
161755688|NCT03954704|584144428|FG001|Overall Study|Enrolled but not Treated|0|||
161755689|NCT03954704|584144429|FG002|Overall Study|Enrolled but not Treated|0|||
161755690|NCT03954704|584144430|FG003|Overall Study|Enrolled but not Treated|0|||
161755691|NCT03954704|584144431|FG004|Overall Study|Enrolled but not Treated|0|||
161755692|NCT03954704|584144432|FG005|Overall Study|Enrolled but not Treated|1|||
161755693|NCT03954704|584144433|FG006|Overall Study|Enrolled but not Treated|0|||
161755694|NCT00397891|584144436|FG000|Overall Study|Withdrawal by Subject|1|||
161755695|NCT00397891|584144437|FG001|Overall Study|Withdrawal by Subject|0|||
161755696|NCT00397891|584144438|FG002|Overall Study|Withdrawal by Subject|0|||
161755697|NCT00397891|584144439|FG003|Overall Study|Withdrawal by Subject|0|||
161755698|NCT00397891|584144440|FG004|Overall Study|Withdrawal by Subject|1|||
161755699|NCT02569398|584144447|FG000|Overall Study|Adverse Event|0|||
161755700|NCT02569398|584144448|FG001|Overall Study|Adverse Event|1|||
161755701|NCT02569398|584144449|FG002|Overall Study|Adverse Event|6|||
161755702|NCT02569398|584144447|FG000|Overall Study|Withdrawal by Subject|43|||
161755703|NCT02569398|584144448|FG001|Overall Study|Withdrawal by Subject|43|||
161755704|NCT02569398|584144449|FG002|Overall Study|Withdrawal by Subject|30|||
161755705|NCT02569398|584144447|FG000|Overall Study|Study terminated by sponsor|130|||
161755706|NCT02569398|584144448|FG001|Overall Study|Study terminated by sponsor|131|||
161755707|NCT02569398|584144449|FG002|Overall Study|Study terminated by sponsor|134|||
161755708|NCT02569398|584144447|FG000|Overall Study|Other|12|||
161755709|NCT02569398|584144448|FG001|Overall Study|Other|14|||
161755710|NCT02569398|584144449|FG002|Overall Study|Other|13|||
161755711|NCT02116361|584144452|FG000|Overall Study|Pregnancy|0|||
161755712|NCT02116361|584144453|FG001|Overall Study|Pregnancy|0|||
161755713|NCT02116361|584144454|FG002|Overall Study|Pregnancy|0|||
161755714|NCT02116361|584144455|FG003|Overall Study|Pregnancy|1|||
161755715|NCT02116361|584144452|FG000|Overall Study|Protocol Violation|1|||
161755716|NCT02116361|584144453|FG001|Overall Study|Protocol Violation|0|||
161755717|NCT02116361|584144454|FG002|Overall Study|Protocol Violation|0|||
161755718|NCT02116361|584144455|FG003|Overall Study|Protocol Violation|2|||
161845452|NCT00265395|584477012|FG000|Overall Study|Lost to Follow-up|2|||
161755719|NCT02116361|584144452|FG000|Overall Study|Physician Decision|2|||
161845453|NCT00265395|584477013|FG001|Overall Study|Lost to Follow-up|1|||
161755720|NCT02116361|584144453|FG001|Overall Study|Physician Decision|3|||
161755721|NCT02116361|584144454|FG002|Overall Study|Physician Decision|0|||
161755722|NCT02116361|584144455|FG003|Overall Study|Physician Decision|0|||
161755723|NCT02116361|584144452|FG000|Overall Study|Adverse Event|1|||
161755724|NCT02116361|584144453|FG001|Overall Study|Adverse Event|0|||
161845454|NCT00265395|584477012|FG000|Overall Study|Withdrawal by Subject|1|||
161755725|NCT02116361|584144454|FG002|Overall Study|Adverse Event|0|||
161755726|NCT02116361|584144455|FG003|Overall Study|Adverse Event|3|||
161969536|NCT03447314|584937829|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
161969537|NCT03447314|584937830|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
161969538|NCT03447314|584937831|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161969539|NCT03447314|584937832|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161969540|NCT03447314|584937833|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161969541|NCT03447314|584937834|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161969542|NCT03447314|584937835|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161969543|NCT03447314|584937836|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
161969544|NCT03447314|584937819|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
161969545|NCT03447314|584937820|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969546|NCT03447314|584937821|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
161969547|NCT03447314|584937822|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969548|NCT03447314|584937823|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969549|NCT03447314|584937824|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
161969550|NCT03447314|584937825|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
161969551|NCT03447314|584937826|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969552|NCT03447314|584937827|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969553|NCT03447314|584937828|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969554|NCT03447314|584937829|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969555|NCT03447314|584937830|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969556|NCT03447314|584937831|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969557|NCT03447314|584937832|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969558|NCT03447314|584937833|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969559|NCT03447314|584937834|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969560|NCT03447314|584937835|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969561|NCT03447314|584937836|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
161969562|NCT03447314|584937819|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969563|NCT03447314|584937820|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969564|NCT03447314|584937821|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
161969565|NCT03447314|584937822|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969566|NCT03447314|584937823|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969567|NCT03447314|584937824|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969568|NCT03447314|584937825|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969569|NCT03447314|584937826|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969570|NCT03447314|584937827|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969571|NCT03447314|584937828|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969572|NCT03447314|584937829|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969573|NCT03447314|584937830|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969574|NCT03447314|584937831|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969575|NCT03447314|584937832|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969576|NCT03447314|584937833|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969577|NCT03447314|584937834|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969578|NCT03447314|584937835|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969579|NCT03447314|584937836|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
161969580|NCT03447314|584937819|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969581|NCT03447314|584937820|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969582|NCT03447314|584937821|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
161969583|NCT03447314|584937822|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969584|NCT03447314|584937823|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969585|NCT03447314|584937824|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969586|NCT03447314|584937825|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969587|NCT03447314|584937826|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969588|NCT03447314|584937827|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969589|NCT03447314|584937828|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969590|NCT03447314|584937829|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969591|NCT03447314|584937830|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
162032894|NCT02119676|585177500|FG001|Overall Study|Lost to Follow-up|0|||
162032895|NCT02119676|585177501|FG002|Overall Study|Lost to Follow-up|1|||
162032896|NCT02119676|585177502|FG003|Overall Study|Lost to Follow-up|0|||
161755727|NCT02116361|584144452|FG000|Overall Study|Other Reasons|3|||
161755728|NCT02116361|584144453|FG001|Overall Study|Other Reasons|3|||
161755729|NCT02116361|584144454|FG002|Overall Study|Other Reasons|3|||
161755730|NCT02116361|584144455|FG003|Overall Study|Other Reasons|3|||
161755731|NCT02116361|584144452|FG000|Overall Study|Lack of Efficacy|5|||
161755732|NCT02116361|584144453|FG001|Overall Study|Lack of Efficacy|7|||
161755733|NCT02116361|584144454|FG002|Overall Study|Lack of Efficacy|4|||
161845455|NCT00265395|584477013|FG001|Overall Study|Withdrawal by Subject|6|||
161845456|NCT00265395|584477012|FG000|Overall Study|Protocol Violation|2|||
161845457|NCT00265395|584477013|FG001|Overall Study|Protocol Violation|2|||
161845458|NCT00265395|584477012|FG000|Overall Study|Lack of Efficacy|0|||
161845459|NCT00265395|584477013|FG001|Overall Study|Lack of Efficacy|1|||
161845460|NCT00265395|584477012|FG000|Overall Study|Administrative|0|||
161845461|NCT00265395|584477013|FG001|Overall Study|Administrative|1|||
161845462|NCT00837473|584477016|FG000|Overall Study|Lost to Follow-up|1|||
161845463|NCT00837473|584477016|FG000|Overall Study|Withdrawal by Subject|2|||
161845464|NCT03400943|584477017|FG000|Treatment Period 1|Adverse Event|0|||
161845465|NCT03400943|584477018|FG001|Treatment Period 1|Adverse Event|0|||
161845466|NCT03400943|584477019|FG002|Treatment Period 1|Adverse Event|0|||
161845467|NCT03400943|584477020|FG003|Treatment Period 1|Adverse Event|1|||
161845468|NCT03400943|584477017|FG000|Treatment Period 1|Lost to Follow-up|1|||
161845469|NCT03400943|584477018|FG001|Treatment Period 1|Lost to Follow-up|0|||
161845470|NCT03400943|584477019|FG002|Treatment Period 1|Lost to Follow-up|0|||
161969592|NCT03447314|584937831|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969593|NCT03447314|584937832|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969594|NCT03447314|584937833|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161845471|NCT03400943|584477020|FG003|Treatment Period 1|Lost to Follow-up|0|||
161845472|NCT03400943|584477017|FG000|Treatment Period 1|Protocol Violation|0|||
161845473|NCT03400943|584477018|FG001|Treatment Period 1|Protocol Violation|1|||
161845474|NCT03400943|584477019|FG002|Treatment Period 1|Protocol Violation|1|||
161845475|NCT03400943|584477020|FG003|Treatment Period 1|Protocol Violation|0|||
161845476|NCT03400943|584477017|FG000|Treatment Period 1|Study terminated by sponsor|2|||
161845477|NCT03400943|584477018|FG001|Treatment Period 1|Study terminated by sponsor|0|||
161845478|NCT03400943|584477019|FG002|Treatment Period 1|Study terminated by sponsor|0|||
161845479|NCT03400943|584477020|FG003|Treatment Period 1|Study terminated by sponsor|1|||
161845480|NCT03400943|584477017|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161845481|NCT03400943|584477018|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161845482|NCT03400943|584477019|FG002|Treatment Period 1|Withdrawal by Subject|3|||
161845483|NCT03400943|584477020|FG003|Treatment Period 1|Withdrawal by Subject|1|||
161845484|NCT03400943|584477017|FG000|Treatment Period 1|Other|2|||
161845485|NCT03400943|584477018|FG001|Treatment Period 1|Other|1|||
161845486|NCT03400943|584477019|FG002|Treatment Period 1|Other|2|||
161845487|NCT03400943|584477020|FG003|Treatment Period 1|Other|2|||
161845488|NCT03400943|584477017|FG000|Post-treatment Period 1|Adverse Event|2|||
161845489|NCT03400943|584477018|FG001|Post-treatment Period 1|Adverse Event|0|||
161845490|NCT03400943|584477019|FG002|Post-treatment Period 1|Adverse Event|0|||
161845491|NCT03400943|584477020|FG003|Post-treatment Period 1|Adverse Event|0|||
161845492|NCT03400943|584477017|FG000|Post-treatment Period 1|Protocol Violation|1|||
161845493|NCT03400943|584477018|FG001|Post-treatment Period 1|Protocol Violation|0|||
161845494|NCT03400943|584477019|FG002|Post-treatment Period 1|Protocol Violation|0|||
161845495|NCT03400943|584477020|FG003|Post-treatment Period 1|Protocol Violation|0|||
161845496|NCT03400943|584477017|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
161845497|NCT03400943|584477018|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
161845498|NCT03400943|584477019|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
161845499|NCT03400943|584477020|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
161845500|NCT03400943|584477017|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
161845501|NCT03400943|584477018|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
161845502|NCT03400943|584477019|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
161845503|NCT03400943|584477020|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
161845504|NCT03400943|584477017|FG000|Post-treatment Period 1|Other|2|||
161845505|NCT03400943|584477018|FG001|Post-treatment Period 1|Other|0|||
161845506|NCT03400943|584477019|FG002|Post-treatment Period 1|Other|4|||
161845507|NCT03400943|584477020|FG003|Post-treatment Period 1|Other|5|||
161969595|NCT03447314|584937834|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969596|NCT03447314|584937835|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969597|NCT03447314|584937836|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
161969598|NCT03447314|584937819|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161845508|NCT03400943|584477017|FG000|Treatment Period 2|Study terminated by sponsor|0|||
161845509|NCT03400943|584477018|FG001|Treatment Period 2|Study terminated by sponsor|1|||
161845510|NCT03400943|584477019|FG002|Treatment Period 2|Study terminated by sponsor|0|||
161845511|NCT03400943|584477020|FG003|Treatment Period 2|Study terminated by sponsor|0|||
161845512|NCT03400943|584477017|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161845513|NCT03400943|584477018|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161845514|NCT03400943|584477019|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161845515|NCT03400943|584477020|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161845516|NCT03400943|584477017|FG000|Treatment Period 2|Other|1|||
161845517|NCT03400943|584477018|FG001|Treatment Period 2|Other|6|||
161845518|NCT03400943|584477019|FG002|Treatment Period 2|Other|0|||
161845519|NCT03400943|584477020|FG003|Treatment Period 2|Other|0|||
161845520|NCT03400943|584477017|FG000|Follow-up Period|Withdrawal by Subject|1|||
161845521|NCT03400943|584477018|FG001|Follow-up Period|Withdrawal by Subject|0|||
161845522|NCT03400943|584477019|FG002|Follow-up Period|Withdrawal by Subject|0|||
161845523|NCT03400943|584477020|FG003|Follow-up Period|Withdrawal by Subject|0|||
161845524|NCT02563106|584477021|FG000|Overall Study|Withdrawal by Subject|7|||
161845525|NCT02563106|584477022|FG001|Overall Study|Withdrawal by Subject|8|||
161845526|NCT02563106|584477021|FG000|Overall Study|Adverse Event|17|||
161845527|NCT02563106|584477022|FG001|Overall Study|Adverse Event|15|||
161845528|NCT02563106|584477021|FG000|Overall Study|Protocol Violation|1|||
161845529|NCT02563106|584477022|FG001|Overall Study|Protocol Violation|0|||
161845530|NCT02563106|584477021|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
161845531|NCT02563106|584477022|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
161845532|NCT02563106|584477021|FG000|Overall Study|Lost to Follow-up|3|||
161845533|NCT02563106|584477022|FG001|Overall Study|Lost to Follow-up|2|||
161845534|NCT02563106|584477021|FG000|Overall Study|Physician Decision|3|||
161845535|NCT02563106|584477022|FG001|Overall Study|Physician Decision|1|||
161845536|NCT02563106|584477021|FG000|Overall Study|Other reason - not specified|2|||
161845537|NCT02563106|584477022|FG001|Overall Study|Other reason - not specified|1|||
161845538|NCT02338193|584477023|FG000|Overall Study|Withdrawal by Subject|0|||
161845539|NCT02338193|584477024|FG001|Overall Study|Withdrawal by Subject|0|||
161845540|NCT02338193|584477025|FG002|Overall Study|Withdrawal by Subject|2|||
161845541|NCT02338193|584477023|FG000|Overall Study|Pregnancy|0|||
161845542|NCT02338193|584477024|FG001|Overall Study|Pregnancy|1|||
161845543|NCT02338193|584477025|FG002|Overall Study|Pregnancy|1|||
161845544|NCT02338193|584477023|FG000|Overall Study|Noncompliant with visits|2|||
161969599|NCT03447314|584937820|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969600|NCT03447314|584937821|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969601|NCT03447314|584937822|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969602|NCT03447314|584937823|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969603|NCT03447314|584937824|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969604|NCT03447314|584937825|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969605|NCT03447314|584937826|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969606|NCT03447314|584937827|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969607|NCT03447314|584937828|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969608|NCT03447314|584937829|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
161969609|NCT03447314|584937830|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969610|NCT03447314|584937831|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969611|NCT03447314|584937832|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969612|NCT03447314|584937833|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969613|NCT03447314|584937834|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969614|NCT03447314|584937835|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969615|NCT03447314|584937836|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161969616|NCT03447314|584937819|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969617|NCT03447314|584937820|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969618|NCT03447314|584937821|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969619|NCT03447314|584937822|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
161969620|NCT03447314|584937823|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969621|NCT03447314|584937824|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
161969622|NCT03447314|584937825|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969623|NCT03447314|584937826|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969624|NCT03447314|584937827|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969625|NCT03447314|584937828|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969626|NCT03447314|584937829|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969627|NCT03447314|584937830|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969628|NCT03447314|584937831|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
162032897|NCT02119676|585177499|FG000|Overall Study|Protocol deviation|0|||
161845545|NCT02338193|584477024|FG001|Overall Study|Noncompliant with visits|2|||
161845546|NCT02338193|584477025|FG002|Overall Study|Noncompliant with visits|7|||
161845547|NCT02338193|584477023|FG000|Overall Study|moved out of state|0|||
161845548|NCT02338193|584477024|FG001|Overall Study|moved out of state|1|||
161845549|NCT02338193|584477025|FG002|Overall Study|moved out of state|0|||
161845550|NCT02338193|584477023|FG000|Overall Study|intolerant of side effects|1|||
161845551|NCT02338193|584477024|FG001|Overall Study|intolerant of side effects|0|||
161845552|NCT02338193|584477025|FG002|Overall Study|intolerant of side effects|0|||
161845553|NCT01136967|584477030|FG000|Overall Study|Adverse Event|9|||
161969629|NCT03447314|584937832|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969630|NCT03447314|584937833|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969631|NCT03447314|584937834|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969632|NCT03447314|584937835|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969633|NCT03447314|584937836|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
161969634|NCT01920568|584937838|FG000|Overall Study|Adverse Event|27|||
161755734|NCT02116361|584144455|FG003|Overall Study|Lack of Efficacy|3|||
161755735|NCT02116361|584144452|FG000|Overall Study|Lost to Follow-up|4|||
161755736|NCT02116361|584144453|FG001|Overall Study|Lost to Follow-up|5|||
161755737|NCT02116361|584144454|FG002|Overall Study|Lost to Follow-up|7|||
161755738|NCT02116361|584144455|FG003|Overall Study|Lost to Follow-up|5|||
161755739|NCT02116361|584144452|FG000|Overall Study|Personal Reasons|6|||
161755740|NCT02116361|584144453|FG001|Overall Study|Personal Reasons|6|||
161755741|NCT02116361|584144454|FG002|Overall Study|Personal Reasons|4|||
161755742|NCT02116361|584144455|FG003|Overall Study|Personal Reasons|9|||
161755743|NCT02116361|584144452|FG000|Overall Study|Investigator Decision - Relapse|9|||
161755744|NCT02116361|584144453|FG001|Overall Study|Investigator Decision - Relapse|7|||
161755745|NCT02116361|584144454|FG002|Overall Study|Investigator Decision - Relapse|8|||
161755746|NCT02116361|584144455|FG003|Overall Study|Investigator Decision - Relapse|5|||
161755747|NCT02571972|584144456|FG000|Overall Study|Protocol Violation|2|||
161755748|NCT02571972|584144456|FG000|Overall Study|Withdrawal by Subject|2|||
161755749|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
161755750|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
161755751|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
161755752|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
161755753|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
161755754|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
161755755|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
161755756|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
161755757|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
161755758|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
161755759|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
161755760|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
161755761|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
161755762|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161755763|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161755764|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161755765|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
161755766|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
161755767|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
161755768|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
161755769|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
161755770|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
161755771|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
161755772|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
161755773|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
161755774|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
161755775|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
161755776|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
161755777|NCT03227224|584144457|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
161755778|NCT03227224|584144458|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
161755779|NCT03227224|584144459|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
161755780|NCT03227224|584144460|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
161755781|NCT03227224|584144457|FG000|Follow-up Phase (2 Weeks)|Other|4|||
161755782|NCT03227224|584144458|FG001|Follow-up Phase (2 Weeks)|Other|4|||
161755783|NCT03227224|584144459|FG002|Follow-up Phase (2 Weeks)|Other|6|||
161755784|NCT03227224|584144460|FG003|Follow-up Phase (2 Weeks)|Other|3|||
161755785|NCT04195750|584144463|FG000|Overall Study|Death|245|||
161755786|NCT04195750|584144464|FG001|Overall Study|Death|253|||
161755787|NCT04195750|584144465|FG002|Overall Study|Death|5|||
161755788|NCT04195750|584144463|FG000|Overall Study|Physician Decision|0|||
161969635|NCT01920568|584937839|FG001|Overall Study|Adverse Event|8|||
161755789|NCT04195750|584144464|FG001|Overall Study|Physician Decision|1|||
161755790|NCT04195750|584144465|FG002|Overall Study|Physician Decision|0|||
161755791|NCT04195750|584144463|FG000|Overall Study|Withdrawal by Subject|9|||
161755792|NCT04195750|584144464|FG001|Overall Study|Withdrawal by Subject|8|||
161969636|NCT01920568|584937838|FG000|Overall Study|Protocol Violation|5|||
161755793|NCT04195750|584144465|FG002|Overall Study|Withdrawal by Subject|0|||
161755794|NCT04195750|584144463|FG000|Overall Study|Ongoing|120|||
161969637|NCT01920568|584937839|FG001|Overall Study|Protocol Violation|3|||
161969638|NCT01920568|584937838|FG000|Overall Study|Lost to Follow-up|2|||
161969639|NCT01920568|584937839|FG001|Overall Study|Lost to Follow-up|2|||
161969640|NCT01920568|584937838|FG000|Overall Study|Physician Decision|13|||
161969641|NCT01920568|584937839|FG001|Overall Study|Physician Decision|4|||
161969642|NCT01920568|584937838|FG000|Overall Study|Withdrawal by Subject|79|||
161969643|NCT01920568|584937839|FG001|Overall Study|Withdrawal by Subject|55|||
161969644|NCT01920568|584937838|FG000|Overall Study|Death due to disease progression|25|||
161969645|NCT01920568|584937839|FG001|Overall Study|Death due to disease progression|12|||
161969646|NCT04049266|584937843|FG000|Overall Study|Adverse Event|16|||
161969647|NCT04049266|584937844|FG001|Overall Study|Adverse Event|9|||
161969648|NCT04049266|584937843|FG000|Overall Study|Non-compliance with study drug|0|||
161969649|NCT04049266|584937844|FG001|Overall Study|Non-compliance with study drug|3|||
161969650|NCT04049266|584937843|FG000|Overall Study|Withdrawal by Subject|6|||
161969651|NCT04049266|584937844|FG001|Overall Study|Withdrawal by Subject|10|||
161969652|NCT04049266|584937843|FG000|Overall Study|Lost to Follow-up|2|||
161969653|NCT04049266|584937844|FG001|Overall Study|Lost to Follow-up|2|||
161969654|NCT04049266|584937843|FG000|Overall Study|Progressive disease|11|||
161969655|NCT04049266|584937844|FG001|Overall Study|Progressive disease|2|||
161969656|NCT04049266|584937843|FG000|Overall Study|Physician Decision|1|||
161969657|NCT04049266|584937844|FG001|Overall Study|Physician Decision|0|||
161969658|NCT04049266|584937843|FG000|Overall Study|Patient moved out of state|1|||
161969659|NCT04049266|584937844|FG001|Overall Study|Patient moved out of state|0|||
161969660|NCT04600076|584937846|FG000|Overall Study|Lost to Follow-up|3|||
161969661|NCT01639339|584937847|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
161969662|NCT01639339|584937848|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
161969663|NCT01639339|584937847|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
161969664|NCT01639339|584937848|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
161969665|NCT01639339|584937847|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
161969666|NCT01639339|584937848|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
161969667|NCT01639339|584937847|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
161969668|NCT01639339|584937848|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
161969669|NCT01639339|584937847|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
161969670|NCT01639339|584937848|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
161969671|NCT01639339|584937847|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
161969672|NCT01639339|584937848|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
161969673|NCT01639339|584937847|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
161969674|NCT01639339|584937848|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
161969675|NCT01639339|584937847|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
161969676|NCT01639339|584937848|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
161969677|NCT01639339|584937847|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
161969678|NCT01639339|584937848|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
161969679|NCT01639339|584937847|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
161969680|NCT01639339|584937848|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
161969681|NCT02891681|584937849|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
161969682|NCT02891681|584937850|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
161969683|NCT02891681|584937851|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
161969684|NCT02891681|584937849|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
161969685|NCT02891681|584937850|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
161969686|NCT02891681|584937851|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
161969687|NCT02891681|584937849|FG000|Overall Study|Taken off study after first imaging appointment|1|||
161969688|NCT02891681|584937850|FG001|Overall Study|Taken off study after first imaging appointment|0|||
161969689|NCT02891681|584937851|FG002|Overall Study|Taken off study after first imaging appointment|0|||
161969690|NCT01170598|584937852|FG000|Overall Study|Withdrawal by Subject|1|||
161969691|NCT01170598|584937852|FG000|Overall Study|Death|3|||
161969692|NCT01170598|584937852|FG000|Overall Study|Lost to Follow-up|1|||
161969693|NCT01170598|584937852|FG000|Overall Study|Refused|1|||
161969694|NCT01271712|584937853|FG000|Double Blind Treatment|Death|2|||
161969695|NCT01271712|584937854|FG001|Double Blind Treatment|Death|0|||
161969696|NCT01271712|584937853|FG000|Double Blind Treatment|Lack of Efficacy|1|||
161755795|NCT04195750|584144464|FG001|Overall Study|Ongoing|110|||
161755796|NCT04195750|584144465|FG002|Overall Study|Ongoing|4|||
161755797|NCT02406027|584144466|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161969697|NCT01271712|584937854|FG001|Double Blind Treatment|Lack of Efficacy|0|||
161969698|NCT01271712|584937853|FG000|Double Blind Treatment|Adverse Event|9|||
161969699|NCT01271712|584937854|FG001|Double Blind Treatment|Adverse Event|4|||
161969700|NCT01271712|584937853|FG000|Double Blind Treatment|Progressive disease|23|||
161969701|NCT01271712|584937854|FG001|Double Blind Treatment|Progressive disease|3|||
161969702|NCT01271712|584937853|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
162032898|NCT02119676|585177500|FG001|Overall Study|Protocol deviation|0|||
161755798|NCT02406027|584144467|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
161755799|NCT02406027|584144468|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
161755800|NCT02406027|584144469|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161755801|NCT02406027|584144470|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161755802|NCT02406027|584144471|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161755803|NCT02406027|584144472|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161755804|NCT02406027|584144466|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
161755805|NCT02406027|584144467|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161755806|NCT02406027|584144468|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
161755807|NCT02406027|584144469|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161755808|NCT02406027|584144470|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161755809|NCT02406027|584144471|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161969703|NCT01271712|584937854|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
161969704|NCT01271712|584937853|FG000|Double Blind Treatment|Non compliance with study drug|2|||
161969705|NCT01271712|584937854|FG001|Double Blind Treatment|Non compliance with study drug|0|||
161969706|NCT01271712|584937853|FG000|Double Blind Treatment|receive no study drug|1|||
161969707|NCT01271712|584937854|FG001|Double Blind Treatment|receive no study drug|0|||
161969708|NCT01271712|584937853|FG000|Open Label Treatment|Death|6|||
161969709|NCT01271712|584937854|FG001|Open Label Treatment|Death|5|||
161969710|NCT01271712|584937853|FG000|Open Label Treatment|Withdrawal by Subject|6|||
161969711|NCT01271712|584937854|FG001|Open Label Treatment|Withdrawal by Subject|11|||
161969712|NCT01271712|584937853|FG000|Open Label Treatment|Physician Decision|2|||
161969713|NCT01271712|584937854|FG001|Open Label Treatment|Physician Decision|0|||
161969714|NCT01271712|584937853|FG000|Open Label Treatment|Adverse Event|14|||
161969715|NCT01271712|584937854|FG001|Open Label Treatment|Adverse Event|8|||
161969716|NCT01271712|584937853|FG000|Open Label Treatment|Progressive disease|59|||
161969717|NCT01271712|584937854|FG001|Open Label Treatment|Progressive disease|32|||
161969718|NCT01271712|584937853|FG000|Open Label Treatment|transferred to rollover study|1|||
161969719|NCT01271712|584937854|FG001|Open Label Treatment|transferred to rollover study|0|||
161969720|NCT01271712|584937853|FG000|Open Label Treatment|Non-compliance with study drug|1|||
161969721|NCT01271712|584937854|FG001|Open Label Treatment|Non-compliance with study drug|0|||
161969722|NCT01271712|584937853|FG000|Open Label Treatment|Protocol Violation|0|||
161969723|NCT01271712|584937854|FG001|Open Label Treatment|Protocol Violation|1|||
161969724|NCT01271712|584937853|FG000|Open Label Treatment|Switching to other therapy|2|||
161969725|NCT01271712|584937854|FG001|Open Label Treatment|Switching to other therapy|1|||
161969726|NCT01271712|584937853|FG000|Safety Follow-up|Death|11|||
161969727|NCT01271712|584937854|FG001|Safety Follow-up|Death|7|||
161969728|NCT01271712|584937853|FG000|Safety Follow-up|Withdrawal by Subject|4|||
161969729|NCT01271712|584937854|FG001|Safety Follow-up|Withdrawal by Subject|2|||
161969730|NCT01271712|584937853|FG000|Safety Follow-up|Protocol Violation|1|||
161969731|NCT01271712|584937854|FG001|Safety Follow-up|Protocol Violation|1|||
161969732|NCT01271712|584937853|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
161969733|NCT01271712|584937854|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
161969734|NCT01271712|584937853|FG000|Safety Follow-up|No follow-up|1|||
161969735|NCT01271712|584937854|FG001|Safety Follow-up|No follow-up|1|||
161969736|NCT01271712|584937853|FG000|Safety Follow-up|Progressive disease|1|||
161969737|NCT01271712|584937854|FG001|Safety Follow-up|Progressive disease|0|||
161969738|NCT01271712|584937853|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
161969739|NCT01271712|584937854|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
161969740|NCT02685748|584937857|FG000|Overall Study|Withdrawal by Subject|3|||
161969741|NCT02685748|584937858|FG001|Overall Study|Withdrawal by Subject|2|||
161969742|NCT04669262|584937868|FG000|Overall Study|Withdrawal by Subject|0|||
161969743|NCT04669262|584937869|FG001|Overall Study|Withdrawal by Subject|0|||
161969744|NCT04669262|584937870|FG002|Overall Study|Withdrawal by Subject|0|||
161969745|NCT04669262|584937871|FG003|Overall Study|Withdrawal by Subject|1|||
161969746|NCT04669262|584937868|FG000|Overall Study|Randomized but Not Treated|0|||
161969747|NCT04669262|584937869|FG001|Overall Study|Randomized but Not Treated|1|||
161969748|NCT04669262|584937870|FG002|Overall Study|Randomized but Not Treated|0|||
161969749|NCT04669262|584937871|FG003|Overall Study|Randomized but Not Treated|0|||
161969750|NCT01638013|584937872|FG000|Overall Study|Adverse Event|36|||
161969751|NCT01638013|584937873|FG001|Overall Study|Adverse Event|29|||
161969752|NCT01638013|584937874|FG002|Overall Study|Adverse Event|48|||
161969753|NCT01638013|584937872|FG000|Overall Study|Lack of Efficacy|39|||
161969754|NCT01638013|584937873|FG001|Overall Study|Lack of Efficacy|11|||
161755810|NCT02406027|584144472|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161755811|NCT02406027|584144466|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
161755812|NCT02406027|584144467|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
161755813|NCT02406027|584144468|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
161755814|NCT02406027|584144469|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
161969755|NCT01638013|584937874|FG002|Overall Study|Lack of Efficacy|14|||
161969756|NCT01638013|584937872|FG000|Overall Study|Protocol Violation|10|||
161969757|NCT01638013|584937873|FG001|Overall Study|Protocol Violation|7|||
161755815|NCT02406027|584144470|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
161755816|NCT02406027|584144471|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
161755817|NCT02406027|584144472|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
161755818|NCT02406027|584144466|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
161755819|NCT02406027|584144467|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161755820|NCT02406027|584144468|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
161755821|NCT02406027|584144469|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161755822|NCT02406027|584144470|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161755823|NCT02406027|584144471|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161755824|NCT02406027|584144472|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161755825|NCT02406027|584144466|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
161755826|NCT02406027|584144467|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
161755827|NCT02406027|584144468|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
161755828|NCT02406027|584144469|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
161755829|NCT02406027|584144470|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
161755830|NCT02406027|584144471|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
161755831|NCT02406027|584144472|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
161755832|NCT02406027|584144466|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
161755833|NCT02406027|584144467|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
161755834|NCT02406027|584144468|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
161755835|NCT02406027|584144469|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
161755836|NCT02406027|584144470|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
161755837|NCT02406027|584144471|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
161755838|NCT02406027|584144472|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
161755839|NCT02406027|584144466|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
161755840|NCT02406027|584144467|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
161755841|NCT02406027|584144468|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
161755842|NCT02406027|584144469|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
161755843|NCT02406027|584144470|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
161755844|NCT02406027|584144471|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
161755845|NCT02406027|584144472|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
161755846|NCT02406027|584144466|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
161755847|NCT02406027|584144467|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
161755848|NCT02406027|584144468|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
161755849|NCT02406027|584144469|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
161755850|NCT02406027|584144470|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
161755851|NCT02406027|584144471|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
161755852|NCT02406027|584144472|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
161755853|NCT02406027|584144466|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161755854|NCT02406027|584144467|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161755855|NCT02406027|584144468|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161755856|NCT02406027|584144469|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161755857|NCT02406027|584144470|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161755858|NCT02406027|584144471|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
161755859|NCT02406027|584144472|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161755860|NCT02406027|584144466|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161755861|NCT02406027|584144467|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161755862|NCT02406027|584144468|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161755863|NCT02406027|584144469|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161755864|NCT02406027|584144470|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
161755865|NCT02406027|584144471|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161755866|NCT02406027|584144472|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161755867|NCT03782376|584144473|FG000|Overall Study|Lost to Follow-up|2|||
161755868|NCT03782376|584144474|FG001|Overall Study|Lost to Follow-up|2|||
161755869|NCT03782376|584144473|FG000|Overall Study|Withdrawal by Subject|7|||
161755870|NCT03782376|584144474|FG001|Overall Study|Withdrawal by Subject|11|||
161755871|NCT03782376|584144473|FG000|Overall Study|Death|1|||
161755872|NCT03782376|584144474|FG001|Overall Study|Death|0|||
161755873|NCT03782376|584144473|FG000|Overall Study|Other|16|||
161755874|NCT03782376|584144474|FG001|Overall Study|Other|17|||
161755875|NCT02659098|584144475|FG000|Overall Study|Withdrawal by Subject|7|||
161755876|NCT04363944|584144476|FG000|Overall Study|Withdrawal by Subject|2|||
161755877|NCT04363944|584144477|FG001|Overall Study|Withdrawal by Subject|0|||
161755878|NCT03559192|584144478|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
161755879|NCT03559192|584144479|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
161755880|NCT03559192|584144480|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
161755881|NCT03559192|584144478|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
161755882|NCT03559192|584144479|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
161755883|NCT03559192|584144480|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
161755884|NCT03559192|584144478|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
161755885|NCT03559192|584144479|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
161755886|NCT03559192|584144480|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
161755887|NCT03559192|584144478|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
161755888|NCT03559192|584144479|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
161755889|NCT03559192|584144480|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
161755890|NCT03559192|584144478|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
161755891|NCT03559192|584144479|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
161755892|NCT03559192|584144480|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
161755893|NCT03559192|584144478|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
161755894|NCT03559192|584144479|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
161755895|NCT03559192|584144480|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
161755896|NCT03559192|584144478|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
161755897|NCT03559192|584144479|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
161755898|NCT03559192|584144480|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
161755899|NCT03559192|584144478|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
161755900|NCT03559192|584144479|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
161755901|NCT03559192|584144480|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
161755902|NCT03559192|584144478|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
161755903|NCT03559192|584144479|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
161755904|NCT03559192|584144480|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
161755905|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
161755906|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
161755907|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Death|0|||
161755908|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Death|4|||
161755909|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
161755910|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
161755911|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
161755912|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
161755913|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
161755914|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
161755915|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
161755916|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
161755917|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
161755918|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
161755919|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Other|4|||
161755920|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Other|3|||
161755921|NCT03517722|584144481|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
161755922|NCT03517722|584144482|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
161755923|NCT03517722|584144481|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
161755924|NCT03517722|584144482|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
161755925|NCT03517722|584144481|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
161755926|NCT03517722|584144482|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
161755927|NCT03517722|584144481|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
161755928|NCT03517722|584144482|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
161755929|NCT03517722|584144481|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
161755930|NCT03517722|584144482|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
161755931|NCT02254304|584144488|FG000|Overall Study|Adverse Event|2|||
161755932|NCT02254304|584144489|FG001|Overall Study|Adverse Event|1|||
161755933|NCT02254304|584144488|FG000|Overall Study|Lost to Follow-up|2|||
161755934|NCT02254304|584144489|FG001|Overall Study|Lost to Follow-up|2|||
161755935|NCT02254304|584144488|FG000|Overall Study|Protocol Violation|1|||
161755936|NCT02254304|584144489|FG001|Overall Study|Protocol Violation|0|||
161755937|NCT02254304|584144488|FG000|Overall Study|Withdrawal by Subject|3|||
161755938|NCT02254304|584144489|FG001|Overall Study|Withdrawal by Subject|0|||
161755939|NCT02254304|584144488|FG000|Overall Study|Injection site pain and Injection fear|1|||
161755940|NCT02254304|584144489|FG001|Overall Study|Injection site pain and Injection fear|0|||
161755941|NCT02254304|584144488|FG000|Overall Study|Personal causes|4|||
161755942|NCT02254304|584144489|FG001|Overall Study|Personal causes|1|||
161755943|NCT02254304|584144488|FG000|Overall Study|Personal decision|1|||
161845554|NCT01136967|584477031|FG001|Overall Study|Adverse Event|12|||
161969758|NCT01638013|584937874|FG002|Overall Study|Protocol Violation|11|||
161969759|NCT01638013|584937872|FG000|Overall Study|Met discontinuation criteria|4|||
161755944|NCT02254304|584144489|FG001|Overall Study|Personal decision|0|||
161755945|NCT00952419|584144490|FG000|Overall Study|Adverse Event|2|||
161755946|NCT00952419|584144491|FG001|Overall Study|Adverse Event|0|||
161755947|NCT00952419|584144492|FG002|Overall Study|Adverse Event|0|||
161755948|NCT00952419|584144490|FG000|Overall Study|Protocol Violation|3|||
161755949|NCT00952419|584144491|FG001|Overall Study|Protocol Violation|7|||
161755950|NCT00952419|584144492|FG002|Overall Study|Protocol Violation|0|||
161755951|NCT00952419|584144490|FG000|Overall Study|Withdrawal by Subject|1|||
161755952|NCT00952419|584144491|FG001|Overall Study|Withdrawal by Subject|3|||
161755953|NCT00952419|584144492|FG002|Overall Study|Withdrawal by Subject|0|||
161755954|NCT03573804|584144493|FG000|Overall Study|claustrophobia or MRI table problems|10|||
161755955|NCT05166603|584144497|FG000|Overall Study|Withdrawal by Subject|68|||
161755956|NCT05166603|584144498|FG001|Overall Study|Withdrawal by Subject|0|||
161755957|NCT04418427|584146188|FG000|Overall Study|Death|0|||
161755958|NCT04418427|584146189|FG001|Overall Study|Death|1|||
161755959|NCT04418427|584146190|FG002|Overall Study|Death|0|||
161755960|NCT04418427|584146188|FG000|Overall Study|Lost to Follow-up|0|||
161755961|NCT04418427|584146189|FG001|Overall Study|Lost to Follow-up|2|||
161755962|NCT04418427|584146190|FG002|Overall Study|Lost to Follow-up|2|||
161755963|NCT04418427|584146188|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
161755964|NCT04418427|584146189|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
161755965|NCT04418427|584146190|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
161755966|NCT04418427|584146188|FG000|Overall Study|Pre-existing medical condition|0|||
161755967|NCT04418427|584146189|FG001|Overall Study|Pre-existing medical condition|1|||
161755968|NCT04418427|584146190|FG002|Overall Study|Pre-existing medical condition|0|||
161755969|NCT01673373|584146193|FG000|Overall Study|Death|2|||
161755970|NCT00366444|584146195|FG000|Overall Study|Withdrawal by Subject|1|||
161755971|NCT00366444|584146196|FG001|Overall Study|Withdrawal by Subject|1|||
161755972|NCT00366444|584146195|FG000|Overall Study|Lack of Efficacy|0|||
161755973|NCT00366444|584146196|FG001|Overall Study|Lack of Efficacy|1|||
161755974|NCT01654224|584146201|FG000|Overall Study|Lost to Follow-up|2|||
161755975|NCT01654224|584146202|FG001|Overall Study|Lost to Follow-up|2|||
161755976|NCT01654224|584146201|FG000|Overall Study|Did not receive allocation|1|||
161755977|NCT01654224|584146202|FG001|Overall Study|Did not receive allocation|8|||
161755978|NCT01654224|584146201|FG000|Overall Study|Insufficient blood sample|3|||
161755979|NCT01654224|584146202|FG001|Overall Study|Insufficient blood sample|2|||
161755980|NCT00166504|584146204|FG000|Overall Study|Adverse Event|3|||
161755981|NCT00166504|584146205|FG001|Overall Study|Adverse Event|3|||
161755982|NCT00166504|584146204|FG000|Overall Study|Lost to Follow-up|1|||
161755983|NCT00166504|584146205|FG001|Overall Study|Lost to Follow-up|1|||
161755984|NCT00166504|584146204|FG000|Overall Study|Withdrawal by Subject|1|||
161755985|NCT00166504|584146205|FG001|Overall Study|Withdrawal by Subject|0|||
161755986|NCT04969900|584146206|FG000|Overall Study|Physician Decision|1|||
161755987|NCT04969900|584146207|FG001|Overall Study|Physician Decision|1|||
161755988|NCT04969900|584146206|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
161755989|NCT04969900|584146207|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
161755990|NCT03261037|584146210|FG000|Overall Study|Withdrawal by Subject|2|||
161755991|NCT03261037|584146211|FG001|Overall Study|Withdrawal by Subject|13|||
161755992|NCT03261037|584146212|FG002|Overall Study|Withdrawal by Subject|0|||
161755993|NCT03261037|584146213|FG003|Overall Study|Withdrawal by Subject|18|||
161755994|NCT03261037|584146210|FG000|Overall Study|Non-compliance with study procedures|0|||
161755995|NCT03261037|584146211|FG001|Overall Study|Non-compliance with study procedures|2|||
161755996|NCT03261037|584146212|FG002|Overall Study|Non-compliance with study procedures|0|||
161755997|NCT03261037|584146213|FG003|Overall Study|Non-compliance with study procedures|6|||
161755998|NCT03261037|584146210|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
161755999|NCT03261037|584146211|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
161756000|NCT03261037|584146212|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
161756001|NCT03261037|584146213|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
161756002|NCT03261037|584146210|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
161756003|NCT03261037|584146211|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
161756004|NCT03261037|584146212|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
161756005|NCT03261037|584146213|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
161756006|NCT03261037|584146210|FG000|Overall Study|Diagnosed but protocol deviation|1|||
161756007|NCT03261037|584146211|FG001|Overall Study|Diagnosed but protocol deviation|0|||
161756008|NCT03261037|584146212|FG002|Overall Study|Diagnosed but protocol deviation|0|||
161756009|NCT03261037|584146213|FG003|Overall Study|Diagnosed but protocol deviation|0|||
161756010|NCT03261037|584146210|FG000|Overall Study|Participant did not want to continue the study|0|||
161756011|NCT03261037|584146211|FG001|Overall Study|Participant did not want to continue the study|1|||
162032899|NCT02119676|585177501|FG002|Overall Study|Protocol deviation|1|||
161756012|NCT03261037|584146212|FG002|Overall Study|Participant did not want to continue the study|0|||
161756013|NCT03261037|584146213|FG003|Overall Study|Participant did not want to continue the study|0|||
161756014|NCT03261037|584146210|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
161756015|NCT03261037|584146211|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
161756016|NCT03261037|584146212|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
161845555|NCT01136967|584477030|FG000|Overall Study|Participant Choice|8|||
161845556|NCT01136967|584477031|FG001|Overall Study|Participant Choice|3|||
161845557|NCT01136967|584477030|FG000|Overall Study|Lost to Follow-up|0|||
161845558|NCT01136967|584477031|FG001|Overall Study|Lost to Follow-up|1|||
161845559|NCT01136967|584477030|FG000|Overall Study|Withdrawal by Subject|1|||
161845560|NCT01136967|584477031|FG001|Overall Study|Withdrawal by Subject|2|||
161845561|NCT01136967|584477030|FG000|Overall Study|Clinical Progression|3|||
161845562|NCT01136967|584477031|FG001|Overall Study|Clinical Progression|5|||
161845563|NCT01136967|584477030|FG000|Overall Study|Radiation|1|||
161845564|NCT01136967|584477031|FG001|Overall Study|Radiation|0|||
161845565|NCT01136967|584477030|FG000|Overall Study|Non-compliance|1|||
161845566|NCT01136967|584477031|FG001|Overall Study|Non-compliance|0|||
161845567|NCT01136967|584477030|FG000|Overall Study|Investigator's Choice|1|||
161845568|NCT01136967|584477031|FG001|Overall Study|Investigator's Choice|1|||
161845569|NCT01136967|584477030|FG000|Overall Study|Increase in Lesion Size|0|||
161845570|NCT01136967|584477031|FG001|Overall Study|Increase in Lesion Size|2|||
161845571|NCT01136967|584477030|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
161845572|NCT01136967|584477031|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
161845573|NCT03317834|584477032|FG000|Overall Study|Death|2|||
161845574|NCT03317834|584477032|FG000|Overall Study|Device Revision|5|||
161845575|NCT03317834|584477032|FG000|Overall Study|Withdrawal by Subject|13|||
161845576|NCT03317834|584477032|FG000|Overall Study|Lost to Follow-up|13|||
161845577|NCT03839823|584477036|FG000|Overall Study|Adverse Event|8|||
161845578|NCT03839823|584477037|FG001|Overall Study|Adverse Event|4|||
161845579|NCT03839823|584477036|FG000|Overall Study|Death|1|||
161845580|NCT03839823|584477037|FG001|Overall Study|Death|0|||
161845581|NCT03839823|584477036|FG000|Overall Study|Physician Decision|1|||
161845582|NCT03839823|584477037|FG001|Overall Study|Physician Decision|5|||
161845583|NCT03839823|584477036|FG000|Overall Study|Progressive Disease (PD)|65|||
161845584|NCT03839823|584477037|FG001|Overall Study|Progressive Disease (PD)|65|||
161845585|NCT03839823|584477036|FG000|Overall Study|Subject Decision|2|||
161845586|NCT03839823|584477037|FG001|Overall Study|Subject Decision|9|||
161845587|NCT03839823|584477036|FG000|Overall Study|Not Treated|0|||
161845588|NCT03839823|584477037|FG001|Overall Study|Not Treated|10|||
161845589|NCT01716715|584477038|FG000|Overall Study|Never Treated|2|||
161845590|NCT01716715|584477039|FG001|Overall Study|Never Treated|4|||
161845591|NCT04228783|584477040|FG000|Overall Study|Adverse Event|1|||
161845592|NCT04228783|584477041|FG001|Overall Study|Adverse Event|0|||
161845593|NCT04228783|584477042|FG002|Overall Study|Adverse Event|2|||
161845594|NCT04228783|584477043|FG003|Overall Study|Adverse Event|0|||
161845595|NCT04228783|584477044|FG004|Overall Study|Adverse Event|0|||
161845596|NCT04228783|584477045|FG005|Overall Study|Adverse Event|1|||
161845597|NCT04228783|584477040|FG000|Overall Study|Death|0|||
161845598|NCT04228783|584477041|FG001|Overall Study|Death|0|||
161845599|NCT04228783|584477042|FG002|Overall Study|Death|0|||
161845600|NCT04228783|584477043|FG003|Overall Study|Death|0|||
161845601|NCT04228783|584477044|FG004|Overall Study|Death|1|||
161845602|NCT04228783|584477045|FG005|Overall Study|Death|0|||
161845603|NCT04228783|584477040|FG000|Overall Study|Lost to Follow-up|36|||
161845604|NCT04228783|584477041|FG001|Overall Study|Lost to Follow-up|36|||
161845605|NCT04228783|584477042|FG002|Overall Study|Lost to Follow-up|28|||
161845606|NCT04228783|584477043|FG003|Overall Study|Lost to Follow-up|6|||
161845607|NCT04228783|584477044|FG004|Overall Study|Lost to Follow-up|14|||
161845608|NCT04228783|584477045|FG005|Overall Study|Lost to Follow-up|3|||
161845609|NCT04228783|584477040|FG000|Overall Study|Physician Decision|1|||
161845610|NCT04228783|584477041|FG001|Overall Study|Physician Decision|2|||
161845611|NCT04228783|584477042|FG002|Overall Study|Physician Decision|0|||
161845612|NCT04228783|584477043|FG003|Overall Study|Physician Decision|0|||
161969760|NCT01638013|584937873|FG001|Overall Study|Met discontinuation criteria|0|||
161969761|NCT01638013|584937874|FG002|Overall Study|Met discontinuation criteria|7|||
161969762|NCT01638013|584937872|FG000|Overall Study|Subject Lost to Follow up|1|||
161969763|NCT01638013|584937873|FG001|Overall Study|Subject Lost to Follow up|0|||
161969764|NCT01638013|584937874|FG002|Overall Study|Subject Lost to Follow up|1|||
161969765|NCT01638013|584937872|FG000|Overall Study|Miscellaneous|25|||
161969766|NCT01638013|584937873|FG001|Overall Study|Miscellaneous|19|||
161969767|NCT01638013|584937874|FG002|Overall Study|Miscellaneous|23|||
161969768|NCT01638013|584937872|FG000|Overall Study|Withdrawal of Consent|16|||
161845613|NCT04228783|584477044|FG004|Overall Study|Physician Decision|0|||
161969769|NCT01638013|584937873|FG001|Overall Study|Withdrawal of Consent|12|||
161845614|NCT04228783|584477045|FG005|Overall Study|Physician Decision|0|||
161845615|NCT04228783|584477040|FG000|Overall Study|Protocol Violation|0|||
161969770|NCT01638013|584937874|FG002|Overall Study|Withdrawal of Consent|16|||
161845616|NCT04228783|584477041|FG001|Overall Study|Protocol Violation|0|||
161845617|NCT04228783|584477042|FG002|Overall Study|Protocol Violation|0|||
161845618|NCT04228783|584477043|FG003|Overall Study|Protocol Violation|1|||
161969771|NCT01638013|584937872|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
161845619|NCT04228783|584477044|FG004|Overall Study|Protocol Violation|0|||
161845620|NCT04228783|584477045|FG005|Overall Study|Protocol Violation|0|||
161845621|NCT04228783|584477040|FG000|Overall Study|Withdrawal by Subject|6|||
161845622|NCT04228783|584477041|FG001|Overall Study|Withdrawal by Subject|10|||
161969772|NCT01638013|584937873|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
161969773|NCT01638013|584937874|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
161969774|NCT03549871|584937879|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
162032900|NCT02119676|585177502|FG003|Overall Study|Protocol deviation|0|||
161756017|NCT03261037|584146213|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
161756018|NCT03261037|584146210|FG000|Overall Study|Participant presented clinical improvement|0|||
161756019|NCT03261037|584146211|FG001|Overall Study|Participant presented clinical improvement|2|||
161756020|NCT03261037|584146212|FG002|Overall Study|Participant presented clinical improvement|0|||
161756021|NCT03261037|584146213|FG003|Overall Study|Participant presented clinical improvement|0|||
161756022|NCT03261037|584146210|FG000|Overall Study|Technical difficulties|0|||
161756023|NCT03261037|584146211|FG001|Overall Study|Technical difficulties|0|||
161756024|NCT03261037|584146212|FG002|Overall Study|Technical difficulties|0|||
161756025|NCT03261037|584146213|FG003|Overall Study|Technical difficulties|1|||
161756026|NCT03261037|584146210|FG000|Overall Study|Equipment failed to work|0|||
161756027|NCT03261037|584146211|FG001|Overall Study|Equipment failed to work|0|||
161756028|NCT03261037|584146212|FG002|Overall Study|Equipment failed to work|0|||
161756029|NCT03261037|584146213|FG003|Overall Study|Equipment failed to work|1|||
161756030|NCT03261037|584146210|FG000|Overall Study|End of study for participant and no follow up|0|||
161756031|NCT03261037|584146211|FG001|Overall Study|End of study for participant and no follow up|0|||
161756032|NCT03261037|584146212|FG002|Overall Study|End of study for participant and no follow up|0|||
161756033|NCT03261037|584146213|FG003|Overall Study|End of study for participant and no follow up|1|||
161756034|NCT03261037|584146210|FG000|Overall Study|Participant was too weak to continue in study|1|||
161756035|NCT03261037|584146211|FG001|Overall Study|Participant was too weak to continue in study|0|||
161756036|NCT03261037|584146212|FG002|Overall Study|Participant was too weak to continue in study|0|||
161756037|NCT03261037|584146213|FG003|Overall Study|Participant was too weak to continue in study|0|||
161756038|NCT04423718|584146214|FG000|Main Study|Adverse Event|9|||
161756039|NCT04423718|584146215|FG001|Main Study|Adverse Event|5|||
161756040|NCT04423718|584146216|FG002|Main Study|Adverse Event|8|||
161756041|NCT04423718|584146214|FG000|Main Study|Physician Decision|3|||
161756042|NCT04423718|584146215|FG001|Main Study|Physician Decision|3|||
161756043|NCT04423718|584146216|FG002|Main Study|Physician Decision|2|||
161756044|NCT04423718|584146214|FG000|Main Study|Protocol Violation|0|||
161756045|NCT04423718|584146215|FG001|Main Study|Protocol Violation|0|||
161756046|NCT04423718|584146216|FG002|Main Study|Protocol Violation|1|||
161756047|NCT04423718|584146214|FG000|Main Study|Lost to Follow-up|3|||
161756048|NCT04423718|584146215|FG001|Main Study|Lost to Follow-up|3|||
161756049|NCT04423718|584146216|FG002|Main Study|Lost to Follow-up|4|||
161756050|NCT04423718|584146214|FG000|Main Study|Lack of Efficacy|2|||
161756051|NCT04423718|584146215|FG001|Main Study|Lack of Efficacy|1|||
161756052|NCT04423718|584146216|FG002|Main Study|Lack of Efficacy|0|||
161756053|NCT04423718|584146214|FG000|Main Study|Withdrawal by Subject|14|||
161756054|NCT04423718|584146215|FG001|Main Study|Withdrawal by Subject|20|||
161756055|NCT04423718|584146216|FG002|Main Study|Withdrawal by Subject|20|||
161756056|NCT04423718|584146214|FG000|Main Study|Death|10|||
161756057|NCT04423718|584146215|FG001|Main Study|Death|7|||
161756058|NCT04423718|584146216|FG002|Main Study|Death|7|||
161756059|NCT04423718|584146214|FG000|Main Study|COVID-19 pandemic|2|||
161756060|NCT04423718|584146215|FG001|Main Study|COVID-19 pandemic|2|||
161756061|NCT04423718|584146216|FG002|Main Study|COVID-19 pandemic|2|||
161756062|NCT04423718|584146214|FG000|Main Study|Other|7|||
161756063|NCT04423718|584146215|FG001|Main Study|Other|3|||
161756064|NCT04423718|584146216|FG002|Main Study|Other|2|||
161756065|NCT04423718|584146214|FG000|Extension Phase|Other|1|||
161756066|NCT04423718|584146215|FG001|Extension Phase|Other|0|||
161756067|NCT04423718|584146216|FG002|Extension Phase|Other|0|||
161756068|NCT04423718|584146214|FG000|Extension Phase|Logistical problems|0|||
161756069|NCT04423718|584146215|FG001|Extension Phase|Logistical problems|1|||
161756070|NCT04423718|584146216|FG002|Extension Phase|Logistical problems|1|||
161756071|NCT04423718|584146214|FG000|Extension Phase|Physician Decision|1|||
161756072|NCT04423718|584146215|FG001|Extension Phase|Physician Decision|0|||
161756073|NCT04423718|584146216|FG002|Extension Phase|Physician Decision|1|||
161756074|NCT04423718|584146214|FG000|Extension Phase|Lack of Efficacy|2|||
161756075|NCT04423718|584146215|FG001|Extension Phase|Lack of Efficacy|0|||
161756076|NCT04423718|584146216|FG002|Extension Phase|Lack of Efficacy|1|||
161756077|NCT04423718|584146214|FG000|Extension Phase|Lost to Follow-up|0|||
161756078|NCT04423718|584146215|FG001|Extension Phase|Lost to Follow-up|2|||
161756079|NCT04423718|584146216|FG002|Extension Phase|Lost to Follow-up|3|||
161756080|NCT04423718|584146214|FG000|Extension Phase|Adverse Event|2|||
161756081|NCT04423718|584146215|FG001|Extension Phase|Adverse Event|3|||
161756082|NCT04423718|584146216|FG002|Extension Phase|Adverse Event|1|||
161756083|NCT04423718|584146214|FG000|Extension Phase|Death|4|||
161845623|NCT04228783|584477042|FG002|Overall Study|Withdrawal by Subject|19|||
161756084|NCT04423718|584146215|FG001|Extension Phase|Death|7|||
161756085|NCT04423718|584146216|FG002|Extension Phase|Death|2|||
161756086|NCT04423718|584146214|FG000|Extension Phase|Withdrawal by Subject|11|||
161756087|NCT04423718|584146215|FG001|Extension Phase|Withdrawal by Subject|11|||
161756088|NCT04423718|584146216|FG002|Extension Phase|Withdrawal by Subject|7|||
161756089|NCT02881151|584146219|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
161756090|NCT00589602|584146221|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
161756091|NCT05298774|584146225|FG000|Overall Study|Physician Decision|3|||
161756092|NCT05298774|584146225|FG000|Overall Study|Withdrawal by Subject|2|||
161756093|NCT05298774|584146225|FG000|Overall Study|Lost to Follow-up|3|||
161756094|NCT05298774|584146225|FG000|Overall Study|Screen failure|1|||
161756095|NCT04992507|584146226|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
161756096|NCT04992507|584146227|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
161756097|NCT04992507|584146226|FG000|Overall Study|Death|0|||
161756098|NCT04992507|584146227|FG001|Overall Study|Death|1|||
161756099|NCT03887052|584146228|FG000|Overall Study|Adverse Event|2|||
161756100|NCT03887052|584146228|FG000|Overall Study|Physician Decision|2|||
161756101|NCT03887052|584146228|FG000|Overall Study|Withdrawal by Subject|3|||
161756102|NCT03887052|584146228|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
161756103|NCT03887052|584146228|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
161756104|NCT04517253|584146231|FG000|Primary Treatment Period|Adverse Event|1|||
161756105|NCT04517253|584146232|FG001|Primary Treatment Period|Adverse Event|0|||
161756106|NCT04517253|584146233|FG002|Primary Treatment Period|Adverse Event|0|||
161756107|NCT04517253|584146231|FG000|Primary Treatment Period|Death|0|||
161756108|NCT04517253|584146232|FG001|Primary Treatment Period|Death|1|||
161756109|NCT04517253|584146233|FG002|Primary Treatment Period|Death|0|||
161756110|NCT04517253|584146231|FG000|Maintenance Period|Withdrawal by Subject|1|||
161756111|NCT04517253|584146232|FG001|Maintenance Period|Withdrawal by Subject|0|||
161756112|NCT04517253|584146233|FG002|Maintenance Period|Withdrawal by Subject|0|||
161756113|NCT04517253|584146231|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
161756114|NCT04517253|584146232|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
161756115|NCT04517253|584146233|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
161756116|NCT01023516|584146234|FG000|Overall Study|Voluntary discontinuation|7|||
161756117|NCT01023516|584146235|FG001|Overall Study|Voluntary discontinuation|5|||
161756118|NCT01023516|584146234|FG000|Overall Study|Adverse Event|9|||
161756119|NCT01023516|584146235|FG001|Overall Study|Adverse Event|6|||
161756120|NCT01023516|584146234|FG000|Overall Study|Safety reason|0|||
161756121|NCT01023516|584146235|FG001|Overall Study|Safety reason|3|||
161756122|NCT01023516|584146234|FG000|Overall Study|Study-specific criteria|4|||
161756123|NCT01023516|584146235|FG001|Overall Study|Study-specific criteria|2|||
161756124|NCT01023516|584146234|FG000|Overall Study|Incorrect enrolment|4|||
161756125|NCT01023516|584146235|FG001|Overall Study|Incorrect enrolment|2|||
161756126|NCT01266876|584146236|FG000|Overall Study|Adverse Event|0|||
161756127|NCT01266876|584146237|FG001|Overall Study|Adverse Event|0|||
161756128|NCT01266876|584146238|FG002|Overall Study|Adverse Event|0|||
161756129|NCT01266876|584146239|FG003|Overall Study|Adverse Event|1|||
161756130|NCT01266876|584146240|FG004|Overall Study|Adverse Event|0|||
161756131|NCT01058395|584146241|FG000|Overall Study|Death|2|||
161756132|NCT01058395|584146242|FG001|Overall Study|Death|1|||
161756133|NCT01058395|584146241|FG000|Overall Study|Lost to Follow-up|1|||
161756134|NCT01058395|584146242|FG001|Overall Study|Lost to Follow-up|0|||
161756135|NCT05016037|584146244|FG000|Overall Study|Lost to Follow-up|2|||
161756136|NCT00557323|584146245|FG000|Overall Study|Death|3|||
161756137|NCT00557323|584146245|FG000|Overall Study|Withdrawal by Subject|2|||
161756138|NCT00557323|584146245|FG000|Overall Study|Administrative change|2|||
161756139|NCT04007367|584146249|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
161756140|NCT04007367|584146250|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
161756141|NCT04007367|584146251|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
161756142|NCT04007367|584146249|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
161756143|NCT04007367|584146250|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
161756144|NCT04007367|584146251|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
161756145|NCT04007367|584146249|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
161756146|NCT04007367|584146250|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
161756147|NCT04007367|584146251|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
161756148|NCT04007367|584146249|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
161756149|NCT04007367|584146250|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
161756150|NCT04007367|584146251|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
161756151|NCT04007367|584146249|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
161756152|NCT04007367|584146250|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
161756153|NCT04007367|584146251|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
162032901|NCT02119676|585177499|FG000|Overall Study|Other, unspecified|2|||
161756154|NCT02010567|584146253|FG000|Overall Study|Adverse Event|0|||
161756155|NCT02010567|584146254|FG001|Overall Study|Adverse Event|0|||
161756156|NCT02010567|584146255|FG002|Overall Study|Adverse Event|1|||
161756157|NCT02010567|584146256|FG003|Overall Study|Adverse Event|0|||
161756158|NCT02010567|584146257|FG004|Overall Study|Adverse Event|1|||
161756159|NCT00372489|584146258|FG000|Overall Study|Adverse Event|18|||
161756160|NCT00372489|584146258|FG000|Overall Study|Lack of Efficacy|1|||
161756161|NCT00372489|584146258|FG000|Overall Study|Lost to Follow-up|3|||
161756162|NCT00372489|584146258|FG000|Overall Study|Physician Decision|3|||
161756163|NCT00372489|584146258|FG000|Overall Study|Withdrawal by Subject|5|||
161756164|NCT00372489|584146258|FG000|Overall Study|Patient Relocation|2|||
161756165|NCT00372489|584146258|FG000|Overall Study|Renal transplant|6|||
161756166|NCT00372489|584146258|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
161756167|NCT03323086|584146260|FG000|Overall Study|Lost to Follow-up|3|||
161756168|NCT03323086|584146261|FG001|Overall Study|Lost to Follow-up|2|||
161756169|NCT00623766|584146264|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
161756170|NCT00623766|584146265|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
161756171|NCT00623766|584146264|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
161756172|NCT00623766|584146265|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
161756173|NCT00623766|584146264|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
161756174|NCT00623766|584146265|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
161756175|NCT00623766|584146264|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
161756176|NCT00623766|584146265|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
161756177|NCT00623766|584146264|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
161756178|NCT00623766|584146265|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
161756179|NCT00796549|584146266|FG000|Overall Study|Adverse Event|11|||
161756180|NCT00796549|584146266|FG000|Overall Study|not entered|149|||
161756181|NCT00796549|584146266|FG000|Overall Study|Other|2|||
161756182|NCT00796549|584146266|FG000|Overall Study|Progressive disease|56|||
161756183|NCT00606229|584146270|FG000|Overall Study|Adverse Event|11|||
161756184|NCT00606229|584146270|FG000|Overall Study|Lack of Efficacy|1|||
161756185|NCT00606229|584146270|FG000|Overall Study|Withdrawal by Subject|4|||
161756186|NCT00606229|584146270|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
161756187|NCT00606229|584146270|FG000|Overall Study|change of residence or other commitments|2|||
161756188|NCT03523715|584146271|FG000|Overall Study|Lost to Follow-up|11|||
161756189|NCT03523715|584146272|FG001|Overall Study|Lost to Follow-up|14|||
161756190|NCT03523715|584146271|FG000|Overall Study|Did not meet inclusion criteria|1|||
161756191|NCT03523715|584146272|FG001|Overall Study|Did not meet inclusion criteria|0|||
161756192|NCT03523715|584146271|FG000|Overall Study|Internally inconsistent reporting|0|||
161756193|NCT03523715|584146272|FG001|Overall Study|Internally inconsistent reporting|2|||
161756194|NCT01526928|584146273|FG000|Overall Study|Progressive Disease|35|||
161756195|NCT01526928|584146274|FG001|Overall Study|Progressive Disease|17|||
161756196|NCT01526928|584146275|FG002|Overall Study|Progressive Disease|150|||
161756197|NCT01526928|584146276|FG003|Overall Study|Progressive Disease|182|||
161756198|NCT01526928|584146277|FG004|Overall Study|Progressive Disease|76|||
161756199|NCT01526928|584146278|FG005|Overall Study|Progressive Disease|4|||
161756200|NCT01526928|584146273|FG000|Overall Study|Adverse Event|2|||
161756201|NCT01526928|584146274|FG001|Overall Study|Adverse Event|1|||
161756202|NCT01526928|584146275|FG002|Overall Study|Adverse Event|29|||
161756203|NCT01526928|584146276|FG003|Overall Study|Adverse Event|40|||
161756204|NCT01526928|584146277|FG004|Overall Study|Adverse Event|13|||
161756205|NCT01526928|584146278|FG005|Overall Study|Adverse Event|2|||
161756206|NCT01526928|584146273|FG000|Overall Study|Death|0|||
161756207|NCT01526928|584146274|FG001|Overall Study|Death|0|||
161756208|NCT01526928|584146275|FG002|Overall Study|Death|3|||
161756209|NCT01526928|584146276|FG003|Overall Study|Death|0|||
161756210|NCT01526928|584146277|FG004|Overall Study|Death|0|||
161756211|NCT01526928|584146278|FG005|Overall Study|Death|0|||
161756212|NCT01526928|584146273|FG000|Overall Study|Withdrawal by Subject|1|||
161756213|NCT01526928|584146274|FG001|Overall Study|Withdrawal by Subject|0|||
161756214|NCT01526928|584146275|FG002|Overall Study|Withdrawal by Subject|13|||
161756215|NCT01526928|584146276|FG003|Overall Study|Withdrawal by Subject|11|||
161756216|NCT01526928|584146277|FG004|Overall Study|Withdrawal by Subject|3|||
161756217|NCT01526928|584146278|FG005|Overall Study|Withdrawal by Subject|0|||
161756218|NCT01526928|584146273|FG000|Overall Study|Physician Decision|0|||
161756219|NCT01526928|584146274|FG001|Overall Study|Physician Decision|0|||
161756220|NCT01526928|584146275|FG002|Overall Study|Physician Decision|2|||
161756221|NCT01526928|584146276|FG003|Overall Study|Physician Decision|5|||
161756222|NCT01526928|584146277|FG004|Overall Study|Physician Decision|0|||
161756223|NCT01526928|584146278|FG005|Overall Study|Physician Decision|0|||
161756224|NCT01526928|584146273|FG000|Overall Study|Other Reason|0|||
161756225|NCT01526928|584146274|FG001|Overall Study|Other Reason|1|||
161756226|NCT01526928|584146275|FG002|Overall Study|Other Reason|11|||
161756227|NCT01526928|584146276|FG003|Overall Study|Other Reason|4|||
161756228|NCT01526928|584146277|FG004|Overall Study|Other Reason|1|||
161756229|NCT01526928|584146278|FG005|Overall Study|Other Reason|0|||
161756230|NCT01526928|584146273|FG000|Overall Study|Lost to Follow-up|0|||
161756231|NCT01526928|584146274|FG001|Overall Study|Lost to Follow-up|0|||
161756232|NCT01526928|584146275|FG002|Overall Study|Lost to Follow-up|0|||
161756233|NCT01526928|584146276|FG003|Overall Study|Lost to Follow-up|1|||
161756234|NCT01526928|584146277|FG004|Overall Study|Lost to Follow-up|0|||
161756235|NCT01526928|584146278|FG005|Overall Study|Lost to Follow-up|0|||
161756236|NCT01526928|584146273|FG000|Overall Study|Protocol Deviation|0|||
161756237|NCT01526928|584146274|FG001|Overall Study|Protocol Deviation|0|||
162032902|NCT02119676|585177500|FG001|Overall Study|Other, unspecified|1|||
161756238|NCT01526928|584146275|FG002|Overall Study|Protocol Deviation|0|||
161756239|NCT01526928|584146276|FG003|Overall Study|Protocol Deviation|2|||
161756240|NCT01526928|584146277|FG004|Overall Study|Protocol Deviation|0|||
161756241|NCT01526928|584146278|FG005|Overall Study|Protocol Deviation|0|||
161756242|NCT01526928|584146273|FG000|Overall Study|Missing|0|||
161756243|NCT01526928|584146274|FG001|Overall Study|Missing|0|||
161756244|NCT01526928|584146275|FG002|Overall Study|Missing|1|||
161756245|NCT01526928|584146276|FG003|Overall Study|Missing|0|||
161756246|NCT01526928|584146277|FG004|Overall Study|Missing|2|||
161756247|NCT01526928|584146278|FG005|Overall Study|Missing|0|||
161756248|NCT00942422|584146279|FG000|Overall Study|Withdrawal by Subject|1|||
161756249|NCT00942422|584146279|FG000|Overall Study|Death|1|||
161756250|NCT00942422|584146279|FG000|Overall Study|Progressive diease|1|||
161756251|NCT05559203|584146287|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
161756252|NCT01947894|584146292|FG000|Overall Study|Other|3|||
161756253|NCT01947894|584146293|FG001|Overall Study|Other|4|||
161756254|NCT01947894|584146294|FG002|Overall Study|Other|3|||
161756255|NCT01947894|584146292|FG000|Overall Study|Withdrawal by Subject|12|||
161756256|NCT01947894|584146293|FG001|Overall Study|Withdrawal by Subject|4|||
161756257|NCT01947894|584146294|FG002|Overall Study|Withdrawal by Subject|1|||
161756258|NCT01947894|584146292|FG000|Overall Study|Death|12|||
161756259|NCT01947894|584146293|FG001|Overall Study|Death|1|||
161756260|NCT01947894|584146294|FG002|Overall Study|Death|0|||
161756261|NCT01947894|584146292|FG000|Overall Study|Physician Decision|2|||
161756262|NCT01947894|584146293|FG001|Overall Study|Physician Decision|0|||
161756263|NCT01947894|584146294|FG002|Overall Study|Physician Decision|0|||
161756264|NCT01947894|584146292|FG000|Overall Study|Adverse Event|5|||
161756265|NCT01947894|584146293|FG001|Overall Study|Adverse Event|1|||
161756266|NCT01947894|584146294|FG002|Overall Study|Adverse Event|0|||
161756267|NCT01947894|584146292|FG000|Overall Study|Switched to other growth hormone brand|53|||
161756268|NCT01947894|584146293|FG001|Overall Study|Switched to other growth hormone brand|8|||
161756269|NCT01947894|584146294|FG002|Overall Study|Switched to other growth hormone brand|23|||
161756270|NCT01302691|584146295|FG000|Overall Study|Adverse Event|2|||
161756271|NCT01302691|584146296|FG001|Overall Study|Adverse Event|0|||
161756272|NCT01302691|584146295|FG000|Overall Study|Death|0|||
161756273|NCT01302691|584146296|FG001|Overall Study|Death|1|||
161756274|NCT01302691|584146295|FG000|Overall Study|Lost to Follow-up|1|||
161756275|NCT01302691|584146296|FG001|Overall Study|Lost to Follow-up|0|||
161756276|NCT01302691|584146295|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
161756277|NCT01302691|584146296|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
161756278|NCT01302691|584146295|FG000|Overall Study|Physician Decision|0|||
161756279|NCT01302691|584146296|FG001|Overall Study|Physician Decision|1|||
161756280|NCT01302691|584146295|FG000|Overall Study|Protocol Violation|1|||
161756281|NCT01302691|584146296|FG001|Overall Study|Protocol Violation|0|||
161756282|NCT02829775|584146298|FG000|Overall Study|Death|1|||
161756283|NCT02829775|584146298|FG000|Overall Study|Withdrawal by Subject|3|||
161756284|NCT02829775|584146298|FG000|Overall Study|Disease remission|1|||
161756285|NCT02725268|584146307|FG000|Overall Study|Death|58|||
161756286|NCT02725268|584146308|FG001|Overall Study|Death|59|||
161756287|NCT02725268|584146309|FG002|Overall Study|Death|30|||
161756288|NCT02725268|584146310|FG003|Overall Study|Death|16|||
161756289|NCT02725268|584146307|FG000|Overall Study|Lost to Follow-up|4|||
161756290|NCT02725268|584146308|FG001|Overall Study|Lost to Follow-up|3|||
161756291|NCT02725268|584146309|FG002|Overall Study|Lost to Follow-up|0|||
161756292|NCT02725268|584146310|FG003|Overall Study|Lost to Follow-up|1|||
161756293|NCT02725268|584146307|FG000|Overall Study|Site Terminated by Sponsor|0|||
161756294|NCT02725268|584146308|FG001|Overall Study|Site Terminated by Sponsor|1|||
161756295|NCT02725268|584146309|FG002|Overall Study|Site Terminated by Sponsor|0|||
161756296|NCT02725268|584146310|FG003|Overall Study|Site Terminated by Sponsor|0|||
161756297|NCT02725268|584146307|FG000|Overall Study|Withdrawal by Subject|8|||
161756298|NCT02725268|584146308|FG001|Overall Study|Withdrawal by Subject|6|||
161756299|NCT02725268|584146309|FG002|Overall Study|Withdrawal by Subject|8|||
161756300|NCT02725268|584146310|FG003|Overall Study|Withdrawal by Subject|1|||
161756301|NCT02725268|584146307|FG000|Overall Study|Reason not Specified|2|||
161756302|NCT02725268|584146308|FG001|Overall Study|Reason not Specified|1|||
161756303|NCT02725268|584146309|FG002|Overall Study|Reason not Specified|0|||
161756304|NCT02725268|584146310|FG003|Overall Study|Reason not Specified|0|||
161756305|NCT00262314|584146316|FG000|Overall Study|Changing physicians|38|||
162032903|NCT02119676|585177501|FG002|Overall Study|Other, unspecified|3|||
161756306|NCT00262314|584146316|FG000|Overall Study|Death|12|||
161756307|NCT00262314|584146316|FG000|Overall Study|Patient's decision|92|||
161756308|NCT00262314|584146316|FG000|Overall Study|Other|95|||
161756309|NCT00262314|584146316|FG000|Overall Study|Lost to Follow-up|70|||
161756310|NCT00262314|584146316|FG000|Overall Study|Administrative withdrawal|30|||
161756311|NCT00117572|584146321|FG000|Overall Study|Site withdrew before starting treatment|2|||
161756312|NCT00117572|584146322|FG001|Overall Study|Site withdrew before starting treatment|3|||
161756313|NCT00117572|584146321|FG000|Overall Study|Withdrawal by Subject|3|||
161756314|NCT00117572|584146322|FG001|Overall Study|Withdrawal by Subject|3|||
161756315|NCT00117572|584146321|FG000|Overall Study|Protocol Violation|1|||
161756316|NCT00117572|584146322|FG001|Overall Study|Protocol Violation|0|||
161969775|NCT03549871|584937880|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
161969776|NCT03549871|584937879|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
161969777|NCT03549871|584937880|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
161969778|NCT03549871|584937879|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
161969779|NCT03549871|584937880|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
161969780|NCT03549871|584937879|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
161969781|NCT03549871|584937880|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
161969782|NCT03549871|584937879|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
161756317|NCT04973085|584146323|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
161756318|NCT04973085|584146324|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
161756319|NCT00090766|584146327|FG000|Overall Study|Nephrectomy Planned|0|||
161756320|NCT00090766|584146328|FG001|Overall Study|Nephrectomy Planned|0|||
161756321|NCT00090766|584146329|FG002|Overall Study|Nephrectomy Planned|1|||
161756322|NCT00090766|584146327|FG000|Overall Study|Death|1|||
161756323|NCT00090766|584146328|FG001|Overall Study|Death|0|||
161756324|NCT00090766|584146329|FG002|Overall Study|Death|0|||
161756325|NCT00090766|584146327|FG000|Overall Study|Admin|0|||
161756326|NCT00090766|584146328|FG001|Overall Study|Admin|2|||
161756327|NCT00090766|584146329|FG002|Overall Study|Admin|0|||
161756328|NCT00090766|584146327|FG000|Overall Study|Lost to Follow-up|2|||
161756329|NCT00090766|584146328|FG001|Overall Study|Lost to Follow-up|0|||
161756330|NCT00090766|584146329|FG002|Overall Study|Lost to Follow-up|2|||
161756331|NCT00804986|584146330|FG000|Overall Study|Adverse Event|0|||
161756332|NCT00804986|584146331|FG001|Overall Study|Adverse Event|1|||
161756333|NCT00804986|584146332|FG002|Overall Study|Adverse Event|2|||
161756334|NCT00804986|584146333|FG003|Overall Study|Adverse Event|1|||
161756335|NCT00804986|584146334|FG004|Overall Study|Adverse Event|3|||
161756336|NCT00804986|584146335|FG005|Overall Study|Adverse Event|0|||
161756337|NCT00804986|584146330|FG000|Overall Study|Lack of Efficacy|0|||
161756338|NCT00804986|584146331|FG001|Overall Study|Lack of Efficacy|0|||
161756339|NCT00804986|584146332|FG002|Overall Study|Lack of Efficacy|0|||
161756340|NCT00804986|584146333|FG003|Overall Study|Lack of Efficacy|1|||
161756341|NCT00804986|584146334|FG004|Overall Study|Lack of Efficacy|0|||
161756342|NCT00804986|584146335|FG005|Overall Study|Lack of Efficacy|3|||
161756343|NCT00804986|584146330|FG000|Overall Study|Lost to Follow-up|0|||
161756344|NCT00804986|584146331|FG001|Overall Study|Lost to Follow-up|0|||
161756345|NCT00804986|584146332|FG002|Overall Study|Lost to Follow-up|0|||
161756346|NCT00804986|584146333|FG003|Overall Study|Lost to Follow-up|1|||
161756347|NCT00804986|584146334|FG004|Overall Study|Lost to Follow-up|1|||
161756348|NCT00804986|584146335|FG005|Overall Study|Lost to Follow-up|3|||
161756349|NCT00804986|584146330|FG000|Overall Study|Protocol Violation|0|||
161756350|NCT00804986|584146331|FG001|Overall Study|Protocol Violation|1|||
161756351|NCT00804986|584146332|FG002|Overall Study|Protocol Violation|0|||
161756352|NCT00804986|584146333|FG003|Overall Study|Protocol Violation|1|||
161756353|NCT00804986|584146334|FG004|Overall Study|Protocol Violation|0|||
161756354|NCT00804986|584146335|FG005|Overall Study|Protocol Violation|0|||
161756355|NCT00804986|584146330|FG000|Overall Study|Withdrawal by Subject|0|||
161756356|NCT00804986|584146331|FG001|Overall Study|Withdrawal by Subject|3|||
161756357|NCT00804986|584146332|FG002|Overall Study|Withdrawal by Subject|0|||
161756358|NCT00804986|584146333|FG003|Overall Study|Withdrawal by Subject|3|||
161756359|NCT00804986|584146334|FG004|Overall Study|Withdrawal by Subject|5|||
161756360|NCT00804986|584146335|FG005|Overall Study|Withdrawal by Subject|3|||
161756361|NCT00804986|584146330|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
161756362|NCT00804986|584146331|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
161756363|NCT00804986|584146332|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
161756364|NCT00804986|584146333|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
161756365|NCT00804986|584146334|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
161756366|NCT00804986|584146335|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
161845624|NCT04228783|584477043|FG003|Overall Study|Withdrawal by Subject|1|||
161756367|NCT00804986|584146330|FG000|Overall Study|Sponsor Decision|0|||
161756368|NCT00804986|584146331|FG001|Overall Study|Sponsor Decision|1|||
161756369|NCT00804986|584146332|FG002|Overall Study|Sponsor Decision|0|||
161756370|NCT00804986|584146333|FG003|Overall Study|Sponsor Decision|0|||
161756371|NCT00804986|584146334|FG004|Overall Study|Sponsor Decision|0|||
161756372|NCT00804986|584146335|FG005|Overall Study|Sponsor Decision|0|||
161756373|NCT00804986|584146330|FG000|Overall Study|Physician Decision|1|||
161756374|NCT00804986|584146331|FG001|Overall Study|Physician Decision|0|||
161756375|NCT00804986|584146332|FG002|Overall Study|Physician Decision|0|||
161756376|NCT00804986|584146333|FG003|Overall Study|Physician Decision|0|||
161756377|NCT00804986|584146334|FG004|Overall Study|Physician Decision|0|||
161756378|NCT00804986|584146335|FG005|Overall Study|Physician Decision|0|||
161756379|NCT04035473|584146341|FG000|Screening/Baseline|Death|0|||
161756380|NCT04035473|584146342|FG001|Screening/Baseline|Death|1|||
161756381|NCT04035473|584146341|FG000|Screening/Baseline|Adverse Event|0|||
161756382|NCT04035473|584146342|FG001|Screening/Baseline|Adverse Event|1|||
161845625|NCT04228783|584477044|FG004|Overall Study|Withdrawal by Subject|2|||
161969783|NCT03549871|584937880|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
161969784|NCT03549871|584937879|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
161969785|NCT03549871|584937880|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
161969786|NCT03549871|584937879|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
161969787|NCT03549871|584937880|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
161969788|NCT03549871|584937879|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
161969789|NCT03549871|584937880|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
161969790|NCT03549871|584937879|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
161969791|NCT03549871|584937880|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
161969792|NCT03549871|584937879|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
161969793|NCT03549871|584937880|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
161969794|NCT03549871|584937879|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
161969795|NCT03549871|584937880|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
161969796|NCT01133626|584937881|FG000|Overall Study|Adverse Event|0|||
161969797|NCT01133626|584937882|FG001|Overall Study|Adverse Event|1|||
161969798|NCT01133626|584937883|FG002|Overall Study|Adverse Event|0|||
161969799|NCT01133626|584937881|FG000|Overall Study|Withdrawal by Subject|1|||
161969800|NCT01133626|584937882|FG001|Overall Study|Withdrawal by Subject|2|||
161969801|NCT01133626|584937883|FG002|Overall Study|Withdrawal by Subject|2|||
161969802|NCT01133626|584937881|FG000|Overall Study|Other|0|||
161969803|NCT01133626|584937882|FG001|Overall Study|Other|2|||
161969804|NCT01133626|584937883|FG002|Overall Study|Other|0|||
161969805|NCT03551665|584937886|FG000|Overall Study|Lost to Follow-up|11|||
161969806|NCT03551665|584937887|FG001|Overall Study|Lost to Follow-up|2|||
161969807|NCT00840060|584939123|FG000|Overall Study|Withdrawal by Subject|1|||
161969808|NCT00840060|584939124|FG001|Overall Study|Withdrawal by Subject|0|||
161969809|NCT00840060|584939123|FG000|Overall Study|Change in emotional/behavioral status|0|||
161969810|NCT00840060|584939124|FG001|Overall Study|Change in emotional/behavioral status|1|||
161969811|NCT01103063|584939125|FG000|Overall Study|Adverse Event|3|||
161969812|NCT01103063|584939126|FG001|Overall Study|Adverse Event|1|||
161969813|NCT01103063|584939125|FG000|Overall Study|Lost to Follow-up|68|||
161969814|NCT01103063|584939126|FG001|Overall Study|Lost to Follow-up|51|||
161969815|NCT01103063|584939125|FG000|Overall Study|Withdrawal by Subject|60|||
161969816|NCT01103063|584939126|FG001|Overall Study|Withdrawal by Subject|15|||
161969817|NCT01103063|584939125|FG000|Overall Study|Other|16|||
161969818|NCT01103063|584939126|FG001|Overall Study|Other|11|||
161969819|NCT01103063|584939125|FG000|Overall Study|Protocol Violation|1|||
161969820|NCT01103063|584939126|FG001|Overall Study|Protocol Violation|0|||
161969821|NCT01103063|584939125|FG000|Overall Study|Study terminated by Sponsor|326|||
161969822|NCT01103063|584939126|FG001|Overall Study|Study terminated by Sponsor|342|||
161969823|NCT01103063|584939125|FG000|Overall Study|Death|3|||
161969824|NCT01103063|584939126|FG001|Overall Study|Death|1|||
161969825|NCT03899064|584939129|FG000|Overall Study|Lost to Follow-up|1|||
161969826|NCT03899064|584939129|FG000|Overall Study|Protocol Violation|2|||
161969827|NCT03899064|584939129|FG000|Overall Study|Withdrawal by Subject|2|||
161969828|NCT03899064|584939129|FG000|Overall Study|Other|2|||
161969829|NCT03283098|584939130|FG000|Overall Study|Withdrawal by Subject|0|||
161969830|NCT03283098|584939131|FG001|Overall Study|Withdrawal by Subject|1|||
161969831|NCT01069861|584939137|FG000|Overall Study|Death|1|||
161969832|NCT01069861|584939137|FG000|Overall Study|Adverse Event|1|||
161969833|NCT01069861|584939137|FG000|Overall Study|Did not meet entrance criteria|1|||
161969834|NCT00354107|584939138|FG000|Overall Study|Adverse Event|2|||
161969835|NCT00354107|584939138|FG000|Overall Study|Physician Decision|2|||
161969836|NCT00354107|584939138|FG000|Overall Study|Withdrawal by Subject|1|||
161969837|NCT03136497|584939144|FG000|Overall Study|Screen Failure|1|||
161969838|NCT03136497|584939145|FG001|Overall Study|Screen Failure|0|||
161969839|NCT03136497|584939146|FG002|Overall Study|Screen Failure|0|||
161969840|NCT00557310|584939147|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
161969841|NCT00557310|584939147|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
161969842|NCT00557310|584939147|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
161969843|NCT00557310|584939147|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
161969844|NCT00557310|584939147|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
161969845|NCT00557310|584939147|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
161969846|NCT02351349|584939148|FG000|Overall Study|Withdrawal by Subject|2|||
161969847|NCT02351349|584939149|FG001|Overall Study|Withdrawal by Subject|3|||
161969848|NCT02649218|584939150|FG000|Overall Study|Adverse Event|8|||
161969849|NCT02649218|584939150|FG000|Overall Study|Lack of Efficacy|8|||
161969850|NCT02649218|584939150|FG000|Overall Study|Pregnancy|3|||
161969851|NCT02649218|584939150|FG000|Overall Study|Protocol Violation|3|||
161969852|NCT02649218|584939150|FG000|Overall Study|Physician Decision|1|||
161969853|NCT02649218|584939150|FG000|Overall Study|Withdrawal by Subject|2|||
161969854|NCT01224821|584939151|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
161969855|NCT01224821|584939151|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
162032904|NCT02119676|585177502|FG003|Overall Study|Other, unspecified|4|||
161756383|NCT04035473|584146341|FG000|Follow-up Period|Adverse Event|2|||
161756384|NCT04035473|584146342|FG001|Follow-up Period|Adverse Event|0|||
161756385|NCT00796224|584146343|FG000|Overall Study|Adverse Event|1|||
161756386|NCT00796224|584146344|FG001|Overall Study|Adverse Event|0|||
161756387|NCT00796224|584146343|FG000|Overall Study|Protocol Violation|0|||
161756388|NCT00796224|584146344|FG001|Overall Study|Protocol Violation|1|||
161756389|NCT03763942|584147847|FG000|Overall Study|Lost to Follow-up|114|||
161756390|NCT03763942|584147848|FG001|Overall Study|Lost to Follow-up|54|||
161756391|NCT03763942|584147847|FG000|Overall Study|Protocol Violation|1|||
161756392|NCT03763942|584147848|FG001|Overall Study|Protocol Violation|0|||
161756393|NCT03763942|584147847|FG000|Overall Study|Withdrawal by Subject|2|||
161756394|NCT03763942|584147848|FG001|Overall Study|Withdrawal by Subject|0|||
161756395|NCT03763942|584147847|FG000|Overall Study|Other|2|||
161756396|NCT03763942|584147848|FG001|Overall Study|Other|3|||
161756397|NCT02200510|584147849|FG000|Overall Study|Death|1|||
161756398|NCT02200510|584147850|FG001|Overall Study|Death|1|||
161756399|NCT02200510|584147849|FG000|Overall Study|Protocol Violation|0|||
161756400|NCT02200510|584147850|FG001|Overall Study|Protocol Violation|1|||
161756401|NCT02200510|584147849|FG000|Overall Study|Lost to Follow-up|7|||
161756402|NCT02200510|584147850|FG001|Overall Study|Lost to Follow-up|1|||
161756403|NCT02200510|584147849|FG000|Overall Study|potential COI - joined study team|1|||
161756404|NCT02200510|584147850|FG001|Overall Study|potential COI - joined study team|0|||
161756405|NCT04284787|584147856|FG000|Overall Study|Disease Progression|9|||
161756406|NCT04284787|584147857|FG001|Overall Study|Disease Progression|12|||
161756407|NCT04284787|584147856|FG000|Overall Study|Physician Decision|12|||
161756408|NCT04284787|584147857|FG001|Overall Study|Physician Decision|7|||
161756409|NCT04284787|584147856|FG000|Overall Study|Transplant|5|||
161756410|NCT04284787|584147857|FG001|Overall Study|Transplant|4|||
161756411|NCT04284787|584147856|FG000|Overall Study|Death|1|||
161756412|NCT04284787|584147857|FG001|Overall Study|Death|2|||
161756413|NCT04284787|584147856|FG000|Overall Study|Adverse Event|0|||
161756414|NCT04284787|584147857|FG001|Overall Study|Adverse Event|4|||
161756415|NCT04284787|584147856|FG000|Overall Study|Non-adherence|2|||
161756416|NCT04284787|584147857|FG001|Overall Study|Non-adherence|0|||
161756417|NCT04284787|584147856|FG000|Overall Study|Lack of Efficacy|2|||
161756418|NCT04284787|584147857|FG001|Overall Study|Lack of Efficacy|0|||
161756419|NCT01874353|584147858|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
161756420|NCT01874353|584147859|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
161756421|NCT01874353|584147860|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
161756422|NCT01874353|584147861|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
161756423|NCT01874353|584147858|FG000|Overall Study|Lost to Follow-up|2|||
161756424|NCT01874353|584147859|FG001|Overall Study|Lost to Follow-up|2|||
161756425|NCT01874353|584147860|FG002|Overall Study|Lost to Follow-up|2|||
161756426|NCT01874353|584147861|FG003|Overall Study|Lost to Follow-up|0|||
161756427|NCT01874353|584147858|FG000|Overall Study|Death|110|||
161756428|NCT01874353|584147859|FG001|Overall Study|Death|60|||
161756429|NCT01874353|584147860|FG002|Overall Study|Death|13|||
161756430|NCT01874353|584147861|FG003|Overall Study|Death|7|||
161756431|NCT01874353|584147858|FG000|Overall Study|Withdrawal by Subject|13|||
161756432|NCT01874353|584147859|FG001|Overall Study|Withdrawal by Subject|11|||
161756433|NCT01874353|584147860|FG002|Overall Study|Withdrawal by Subject|0|||
161756434|NCT01874353|584147861|FG003|Overall Study|Withdrawal by Subject|0|||
161756435|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
161756436|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
161756437|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Death|1|||
161756438|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Death|1|||
161756439|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
161756440|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
161756441|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
161756442|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
161756443|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
161756444|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
161756445|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
161845626|NCT04228783|584477045|FG005|Overall Study|Withdrawal by Subject|0|||
161845627|NCT04228783|584477040|FG000|Overall Study|Other|4|||
161969856|NCT01224821|584939151|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
161969857|NCT01224821|584939151|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
161969858|NCT01224821|584939151|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
161969859|NCT01224821|584939151|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
161969860|NCT01224821|584939151|FG000|Long-Term Follow-Up|Death|2|||
161969861|NCT01224821|584939151|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
161756446|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
161969862|NCT02174523|584939152|FG000|Overall Study|Withdrawal by Subject|1|||
161756447|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
161845628|NCT04228783|584477041|FG001|Overall Study|Other|3|||
161756448|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
161756449|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
161756450|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
161756451|NCT03728881|584147862|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
161756452|NCT03728881|584147863|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
161756453|NCT03728881|584147862|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
161756454|NCT03728881|584147863|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
161756455|NCT03728881|584147862|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
161756456|NCT03728881|584147863|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
161756457|NCT04651777|584147864|FG000|Overall Study|Adverse Event|1|||
161756458|NCT04651777|584147864|FG000|Overall Study|Withdrawal by Subject|2|||
161756459|NCT05505734|584147865|FG000|Overall Study|Withdrawal by Subject|51|||
161756460|NCT05505734|584147866|FG001|Overall Study|Withdrawal by Subject|64|||
161756461|NCT05505734|584147865|FG000|Overall Study|Adverse Event|6|||
161756462|NCT05505734|584147866|FG001|Overall Study|Adverse Event|20|||
161756463|NCT05505734|584147865|FG000|Overall Study|Protocol Violation|8|||
161756464|NCT05505734|584147866|FG001|Overall Study|Protocol Violation|15|||
161756465|NCT05505734|584147865|FG000|Overall Study|Lack of therapeutic response|0|||
161756466|NCT05505734|584147866|FG001|Overall Study|Lack of therapeutic response|1|||
161756467|NCT05505734|584147865|FG000|Overall Study|Lost to Follow-up|247|||
161756468|NCT05505734|584147866|FG001|Overall Study|Lost to Follow-up|237|||
161756469|NCT05505734|584147865|FG000|Overall Study|Physician Decision|22|||
161756470|NCT05505734|584147866|FG001|Overall Study|Physician Decision|13|||
161756471|NCT05505734|584147865|FG000|Overall Study|Death|2|||
161756472|NCT05505734|584147866|FG001|Overall Study|Death|1|||
161756473|NCT05505734|584147865|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161756474|NCT05505734|584147866|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161756475|NCT05505734|584147865|FG000|Overall Study|Pregnancy|1|||
161756476|NCT05505734|584147866|FG001|Overall Study|Pregnancy|0|||
161756477|NCT05505734|584147865|FG000|Overall Study|Other|17|||
161756478|NCT05505734|584147866|FG001|Overall Study|Other|13|||
161756479|NCT03575351|584147867|FG000|Overall Study|Adverse Event|1|||
161756480|NCT03575351|584147868|FG001|Overall Study|Adverse Event|0|||
161756481|NCT03575351|584147867|FG000|Overall Study|Death|2|||
161756482|NCT03575351|584147868|FG001|Overall Study|Death|2|||
161756483|NCT03575351|584147867|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
161756484|NCT03575351|584147868|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
161756485|NCT03575351|584147867|FG000|Overall Study|Lack of Efficacy|28|||
161756486|NCT03575351|584147868|FG001|Overall Study|Lack of Efficacy|0|||
161756487|NCT03575351|584147867|FG000|Overall Study|Withdrawal by Subject|1|||
161756488|NCT03575351|584147868|FG001|Overall Study|Withdrawal by Subject|1|||
161756489|NCT03575351|584147867|FG000|Overall Study|Physician Decision|3|||
161756490|NCT03575351|584147868|FG001|Overall Study|Physician Decision|0|||
161756491|NCT03575351|584147867|FG000|Overall Study|Disease relapse|15|||
161756492|NCT03575351|584147868|FG001|Overall Study|Disease relapse|6|||
161756493|NCT03575351|584147867|FG000|Overall Study|Study drug manufacturing failure|0|||
161756494|NCT03575351|584147868|FG001|Overall Study|Study drug manufacturing failure|1|||
161756495|NCT03575351|584147867|FG000|Overall Study|other reasons|5|||
161756496|NCT03575351|584147868|FG001|Overall Study|other reasons|0|||
161756497|NCT04288089|584147869|FG000|Overall Study|Ongoing Treatment|2|||
161756498|NCT04288089|584147870|FG001|Overall Study|Ongoing Treatment|1|||
161756499|NCT04288089|584147871|FG002|Overall Study|Ongoing Treatment|1|||
161756500|NCT04288089|584147872|FG003|Overall Study|Ongoing Treatment|4|||
161756501|NCT03715205|584147873|FG000|Overall Study|Death|13|||
161756502|NCT03715205|584147873|FG000|Overall Study|Lost to Follow-up|2|||
161756503|NCT03715205|584147873|FG000|Overall Study|Physician Decision|93|||
161756504|NCT03715205|584147873|FG000|Overall Study|Withdrawal by Subject|26|||
161756505|NCT00355615|584147879|FG000|Randomized Double Blind Period|Adverse Event|1|||
161756506|NCT00355615|584147880|FG001|Randomized Double Blind Period|Adverse Event|0|||
161756507|NCT00355615|584147881|FG002|Randomized Double Blind Period|Adverse Event|0|||
162032905|NCT02119676|585177499|FG000|Overall Study|Did not receive study med|2|||
162032906|NCT02119676|585177500|FG001|Overall Study|Did not receive study med|2|||
162032907|NCT02119676|585177501|FG002|Overall Study|Did not receive study med|4|||
162032908|NCT02119676|585177502|FG003|Overall Study|Did not receive study med|5|||
161756508|NCT00355615|584147882|FG003|Randomized Double Blind Period|Adverse Event|0|||
161756509|NCT00355615|584147883|FG004|Randomized Double Blind Period|Adverse Event|0|||
161756510|NCT00355615|584147879|FG000|Randomized Double Blind Period|Protocol Violation|0|||
161756511|NCT00355615|584147880|FG001|Randomized Double Blind Period|Protocol Violation|0|||
161756512|NCT00355615|584147881|FG002|Randomized Double Blind Period|Protocol Violation|1|||
161845629|NCT04228783|584477042|FG002|Overall Study|Other|2|||
161845630|NCT04228783|584477043|FG003|Overall Study|Other|1|||
161845631|NCT04228783|584477044|FG004|Overall Study|Other|0|||
162032909|NCT00219544|585177503|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
161756513|NCT00355615|584147882|FG003|Randomized Double Blind Period|Protocol Violation|1|||
161756514|NCT00355615|584147883|FG004|Randomized Double Blind Period|Protocol Violation|0|||
161969863|NCT02174523|584939153|FG001|Overall Study|Withdrawal by Subject|0|||
161969864|NCT00794365|584939154|FG000|Overall Study|Lost to Follow-up|38|||
161969865|NCT00794365|584939154|FG000|Overall Study|Other|17|||
161969866|NCT00794365|584939154|FG000|Overall Study|Poor Compliance|11|||
161969867|NCT00794365|584939154|FG000|Overall Study|Adverse Event|10|||
161969868|NCT00794365|584939154|FG000|Overall Study|Lack of Efficacy|3|||
161969869|NCT03941964|584939157|FG000|Overall Study|Adverse Event|1|||
161969870|NCT03941964|584939158|FG001|Overall Study|Adverse Event|8|||
161969871|NCT03941964|584939157|FG000|Overall Study|Progressive disease|7|||
161969872|NCT03941964|584939158|FG001|Overall Study|Progressive disease|3|||
161969873|NCT03941964|584939157|FG000|Overall Study|Lack of Efficacy|0|||
161969874|NCT03941964|584939158|FG001|Overall Study|Lack of Efficacy|1|||
161969875|NCT03941964|584939157|FG000|Overall Study|Death|3|||
161969876|NCT03941964|584939158|FG001|Overall Study|Death|1|||
161969877|NCT03941964|584939157|FG000|Overall Study|Withdrew consent|1|||
161969878|NCT03941964|584939158|FG001|Overall Study|Withdrew consent|3|||
161969879|NCT03941964|584939157|FG000|Overall Study|Physician Decision|9|||
161969880|NCT03941964|584939158|FG001|Overall Study|Physician Decision|2|||
161969881|NCT03941964|584939157|FG000|Overall Study|Other, not specified|2|||
161969882|NCT03941964|584939158|FG001|Overall Study|Other, not specified|1|||
161969883|NCT00790647|584939159|FG000|Overall Study|Adverse Event|1|||
161969884|NCT00027378|584939160|FG000|Overall Study|Physician Decision|0|||
161969885|NCT00027378|584939161|FG001|Overall Study|Physician Decision|3|||
161969886|NCT02701777|584939162|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
161969887|NCT02701777|584939163|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
161969888|NCT02701777|584939164|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
161969889|NCT02701777|584939165|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
162032910|NCT00219544|585177504|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
162032911|NCT00219544|585177503|FG000|Single Blind Treatment Period|Adverse Event|9|||
161969890|NCT02701777|584939162|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
161969891|NCT02701777|584939163|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
161969892|NCT02701777|584939164|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
161969893|NCT02701777|584939165|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
161969894|NCT00737568|584939166|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
161969895|NCT00737568|584939167|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
161969896|NCT00737568|584939166|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
161969897|NCT00737568|584939167|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
161969898|NCT00737568|584939166|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
161969899|NCT00737568|584939167|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
161969900|NCT00737568|584939166|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
161969901|NCT00737568|584939167|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
161969902|NCT00737568|584939166|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
161969903|NCT00737568|584939167|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
161969904|NCT00737568|584939166|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
161969905|NCT00737568|584939167|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
161969906|NCT00737568|584939166|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
161969907|NCT00737568|584939167|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
161969908|NCT00737568|584939166|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
161969909|NCT00737568|584939167|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
161969910|NCT00737568|584939166|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
161969911|NCT00737568|584939167|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
161969912|NCT00855933|584939168|FG000|Overall Study|Withdrawal by Subject|0|||
161969913|NCT00855933|584939169|FG001|Overall Study|Withdrawal by Subject|1|||
161969914|NCT00951080|584939170|FG000|Overall Study|Adverse Event|3|||
161969915|NCT00951080|584939171|FG001|Overall Study|Adverse Event|3|||
161969916|NCT00951080|584939170|FG000|Overall Study|Lost to Follow-up|0|||
161969917|NCT00951080|584939171|FG001|Overall Study|Lost to Follow-up|1|||
162032912|NCT00219544|585177504|FG001|Single Blind Treatment Period|Adverse Event|0|||
162032913|NCT00219544|585177503|FG000|Single Blind Treatment Period|Protocol Violation|4|||
162032914|NCT00219544|585177504|FG001|Single Blind Treatment Period|Protocol Violation|0|||
162032915|NCT00219544|585177503|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
161756515|NCT00355615|584147879|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
162032916|NCT00219544|585177504|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
161969918|NCT00951080|584939170|FG000|Overall Study|Physician Decision|4|||
161969919|NCT00951080|584939171|FG001|Overall Study|Physician Decision|1|||
161969920|NCT00951080|584939170|FG000|Overall Study|Other|19|||
161969921|NCT00951080|584939171|FG001|Overall Study|Other|22|||
161969922|NCT05463744|584939172|FG000|Treatment Period|Withdrawal by Subject|19|||
161969923|NCT05463744|584939173|FG001|Treatment Period|Withdrawal by Subject|16|||
161969924|NCT05463744|584939172|FG000|Treatment Period|Adverse Event|4|||
161969925|NCT05463744|584939173|FG001|Treatment Period|Adverse Event|4|||
161969926|NCT05463744|584939172|FG000|Treatment Period|Pregnancy|0|||
161756516|NCT00355615|584147880|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
161756517|NCT00355615|584147881|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
161756518|NCT00355615|584147882|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
161756519|NCT00355615|584147883|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
161756520|NCT00355615|584147879|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
161756521|NCT00355615|584147880|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
161756522|NCT00355615|584147881|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
161756523|NCT00355615|584147882|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
161756524|NCT00355615|584147883|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
161756525|NCT00355615|584147879|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
161756526|NCT00355615|584147880|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
161756527|NCT00355615|584147881|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
161756528|NCT00355615|584147882|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
161756529|NCT00355615|584147883|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
161756530|NCT00355615|584147879|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
161756531|NCT00355615|584147880|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
161756532|NCT00355615|584147881|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
161756533|NCT00355615|584147882|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
161756534|NCT00355615|584147883|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
161756535|NCT04259346|584147884|FG000|Overall Study|Lost to Follow-up|1|||
161756536|NCT04259346|584147885|FG001|Overall Study|Lost to Follow-up|3|||
161756537|NCT04259346|584147884|FG000|Overall Study|Protocol Violation|1|||
161756538|NCT04259346|584147885|FG001|Overall Study|Protocol Violation|0|||
161756539|NCT04259346|584147884|FG000|Overall Study|Withdrawal by Subject|1|||
161756540|NCT04259346|584147885|FG001|Overall Study|Withdrawal by Subject|0|||
161756541|NCT04259346|584147884|FG000|Overall Study|Adverse Event|1|||
161756542|NCT04259346|584147885|FG001|Overall Study|Adverse Event|1|||
161756543|NCT00085644|584147886|FG000|Double-Blind Period|Adverse Event|5|||
161969927|NCT05463744|584939173|FG001|Treatment Period|Pregnancy|3|||
161969928|NCT05463744|584939172|FG000|Treatment Period|Lost to Follow-up|1|||
161969929|NCT05463744|584939173|FG001|Treatment Period|Lost to Follow-up|3|||
161969930|NCT05463744|584939172|FG000|Treatment Period|Inadvertent enrollment|2|||
161969931|NCT05463744|584939173|FG001|Treatment Period|Inadvertent enrollment|1|||
161969932|NCT05463744|584939172|FG000|Treatment Period|Death|0|||
161969933|NCT05463744|584939173|FG001|Treatment Period|Death|1|||
161969934|NCT05463744|584939172|FG000|Treatment Period|Non-compliance with Study Drug|1|||
161969935|NCT05463744|584939173|FG001|Treatment Period|Non-compliance with Study Drug|0|||
161969936|NCT05463744|584939172|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
161969937|NCT05463744|584939173|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
161969938|NCT05463744|584939172|FG000|Treatment Period|Physician Decision|0|||
161969939|NCT05463744|584939173|FG001|Treatment Period|Physician Decision|1|||
161969940|NCT05463744|584939172|FG000|Follow-Up Period|Withdrawal by Subject|3|||
161756544|NCT00085644|584147887|FG001|Double-Blind Period|Adverse Event|2|||
161756545|NCT00085644|584147888|FG002|Double-Blind Period|Adverse Event|0|||
161756546|NCT00085644|584147886|FG000|Double-Blind Period|Withdrawal by Subject|3|||
161756547|NCT00085644|584147887|FG001|Double-Blind Period|Withdrawal by Subject|0|||
161756548|NCT00085644|584147888|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161756549|NCT00085644|584147886|FG000|Double-Blind Period|Lost to Follow-up|2|||
161756550|NCT00085644|584147887|FG001|Double-Blind Period|Lost to Follow-up|1|||
161756551|NCT00085644|584147888|FG002|Double-Blind Period|Lost to Follow-up|0|||
161756552|NCT00085644|584147886|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
161756553|NCT00085644|584147887|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
161756554|NCT00085644|584147888|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
161756555|NCT00085644|584147886|FG000|Double-Blind Period|Contemplating pregnancy|1|||
161756556|NCT00085644|584147887|FG001|Double-Blind Period|Contemplating pregnancy|0|||
161756557|NCT00085644|584147888|FG002|Double-Blind Period|Contemplating pregnancy|0|||
161756558|NCT00085644|584147886|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
161756559|NCT00085644|584147887|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
161756560|NCT00085644|584147888|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
161756561|NCT00085644|584147886|FG000|Open-Label Period|Adverse Event|0|||
161756562|NCT00085644|584147887|FG001|Open-Label Period|Adverse Event|0|||
161756563|NCT00085644|584147888|FG002|Open-Label Period|Adverse Event|38|||
161756564|NCT00085644|584147886|FG000|Open-Label Period|Withdrawal by Subject|0|||
161756565|NCT00085644|584147887|FG001|Open-Label Period|Withdrawal by Subject|0|||
161756566|NCT00085644|584147888|FG002|Open-Label Period|Withdrawal by Subject|29|||
161756567|NCT00085644|584147886|FG000|Open-Label Period|Lost to Follow-up|0|||
161845632|NCT04228783|584477045|FG005|Overall Study|Other|0|||
161845633|NCT00626392|584477046|FG000|Run-in Period|Adverse Event|0|||
161845634|NCT00626392|584477047|FG001|Run-in Period|Adverse Event|0|||
161969941|NCT05463744|584939173|FG001|Follow-Up Period|Withdrawal by Subject|1|||
161969942|NCT05463744|584939172|FG000|Follow-Up Period|Lost to Follow-up|1|||
161969943|NCT05463744|584939173|FG001|Follow-Up Period|Lost to Follow-up|1|||
161756568|NCT00085644|584147887|FG001|Open-Label Period|Lost to Follow-up|0|||
161756569|NCT00085644|584147888|FG002|Open-Label Period|Lost to Follow-up|13|||
161756570|NCT00085644|584147886|FG000|Open-Label Period|Lack of Efficacy|0|||
161756571|NCT00085644|584147887|FG001|Open-Label Period|Lack of Efficacy|0|||
161756572|NCT00085644|584147888|FG002|Open-Label Period|Lack of Efficacy|15|||
161756573|NCT00085644|584147886|FG000|Open-Label Period|Pregnancy|0|||
161756574|NCT00085644|584147887|FG001|Open-Label Period|Pregnancy|0|||
161756575|NCT00085644|584147888|FG002|Open-Label Period|Pregnancy|3|||
161756576|NCT00085644|584147886|FG000|Open-Label Period|Contemplating pregnancy|0|||
161756577|NCT00085644|584147887|FG001|Open-Label Period|Contemplating pregnancy|0|||
161756578|NCT00085644|584147888|FG002|Open-Label Period|Contemplating pregnancy|3|||
161756579|NCT00085644|584147886|FG000|Open-Label Period|Protocol Violation|0|||
161756580|NCT00085644|584147887|FG001|Open-Label Period|Protocol Violation|0|||
161756581|NCT00085644|584147888|FG002|Open-Label Period|Protocol Violation|4|||
161756582|NCT00085644|584147886|FG000|Open-Label Period|Personal reason|0|||
161756583|NCT00085644|584147887|FG001|Open-Label Period|Personal reason|0|||
161756584|NCT00085644|584147888|FG002|Open-Label Period|Personal reason|4|||
161756585|NCT03330106|584147896|FG000|Part A|Withdrawal by Subject|1|||
161756586|NCT03330106|584147897|FG001|Part A|Withdrawal by Subject|1|||
161756587|NCT03330106|584147898|FG002|Part A|Withdrawal by Subject|0|||
161756588|NCT03330106|584147899|FG003|Part A|Withdrawal by Subject|0|||
161756589|NCT03330106|584147896|FG000|Part A|Death|2|||
161756590|NCT03330106|584147897|FG001|Part A|Death|1|||
161756591|NCT03330106|584147898|FG002|Part A|Death|0|||
161756592|NCT03330106|584147899|FG003|Part A|Death|0|||
161756593|NCT03330106|584147896|FG000|Part A|Adverse Event|0|||
161756594|NCT03330106|584147897|FG001|Part A|Adverse Event|1|||
161845635|NCT00626392|584477048|FG002|Run-in Period|Adverse Event|1|||
161845636|NCT00626392|584477049|FG003|Run-in Period|Adverse Event|0|||
161845637|NCT00626392|584477050|FG004|Run-in Period|Adverse Event|1|||
161845638|NCT00626392|584477051|FG005|Run-in Period|Adverse Event|0|||
161845639|NCT00626392|584477046|FG000|Run-in Period|Withdrawal by Subject|0|||
161845640|NCT00626392|584477047|FG001|Run-in Period|Withdrawal by Subject|1|||
161845641|NCT00626392|584477048|FG002|Run-in Period|Withdrawal by Subject|1|||
161845642|NCT00626392|584477049|FG003|Run-in Period|Withdrawal by Subject|1|||
161845643|NCT00626392|584477050|FG004|Run-in Period|Withdrawal by Subject|3|||
161845644|NCT00626392|584477051|FG005|Run-in Period|Withdrawal by Subject|1|||
161845645|NCT00626392|584477046|FG000|Run-in Period|Noncompliance|1|||
161845646|NCT00626392|584477047|FG001|Run-in Period|Noncompliance|0|||
161845647|NCT00626392|584477048|FG002|Run-in Period|Noncompliance|1|||
161845648|NCT00626392|584477049|FG003|Run-in Period|Noncompliance|0|||
161845649|NCT00626392|584477050|FG004|Run-in Period|Noncompliance|0|||
161845650|NCT00626392|584477051|FG005|Run-in Period|Noncompliance|0|||
161845651|NCT00626392|584477046|FG000|Coadministration Period|Adverse Event|3|||
161845652|NCT00626392|584477047|FG001|Coadministration Period|Adverse Event|1|||
161845653|NCT00626392|584477048|FG002|Coadministration Period|Adverse Event|7|||
161845654|NCT00626392|584477049|FG003|Coadministration Period|Adverse Event|4|||
161845655|NCT00626392|584477050|FG004|Coadministration Period|Adverse Event|3|||
161845656|NCT00626392|584477051|FG005|Coadministration Period|Adverse Event|4|||
161845657|NCT00626392|584477046|FG000|Coadministration Period|Withdrawal by Subject|1|||
161845658|NCT00626392|584477047|FG001|Coadministration Period|Withdrawal by Subject|1|||
161845659|NCT00626392|584477048|FG002|Coadministration Period|Withdrawal by Subject|0|||
161845660|NCT00626392|584477049|FG003|Coadministration Period|Withdrawal by Subject|1|||
161845661|NCT00626392|584477050|FG004|Coadministration Period|Withdrawal by Subject|0|||
161845662|NCT00626392|584477051|FG005|Coadministration Period|Withdrawal by Subject|1|||
161845663|NCT00626392|584477046|FG000|Coadministration Period|Protocol Violation|0|||
161845664|NCT00626392|584477047|FG001|Coadministration Period|Protocol Violation|1|||
161845665|NCT00626392|584477048|FG002|Coadministration Period|Protocol Violation|0|||
161845666|NCT00626392|584477049|FG003|Coadministration Period|Protocol Violation|1|||
161845667|NCT00626392|584477050|FG004|Coadministration Period|Protocol Violation|1|||
161845668|NCT00626392|584477051|FG005|Coadministration Period|Protocol Violation|0|||
161845669|NCT00626392|584477046|FG000|Coadministration Period|Other|0|||
161969944|NCT01904149|584939177|FG000|Overall Study|Adverse Event|3|||
161969945|NCT01904149|584939178|FG001|Overall Study|Adverse Event|4|||
161845670|NCT00626392|584477047|FG001|Coadministration Period|Other|2|||
161969946|NCT01904149|584939179|FG002|Overall Study|Adverse Event|0|||
161756595|NCT03330106|584147898|FG002|Part A|Adverse Event|0|||
161756596|NCT03330106|584147899|FG003|Part A|Adverse Event|0|||
161756597|NCT03330106|584147896|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
161756598|NCT03330106|584147897|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
161756599|NCT03330106|584147898|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
161845671|NCT00626392|584477048|FG002|Coadministration Period|Other|3|||
161845672|NCT00626392|584477049|FG003|Coadministration Period|Other|1|||
161845673|NCT00626392|584477050|FG004|Coadministration Period|Other|1|||
161845674|NCT00626392|584477051|FG005|Coadministration Period|Other|1|||
161845675|NCT03327792|584477052|FG000|Overall Study|Adverse Event|4|||
161969947|NCT01904149|584939180|FG003|Overall Study|Adverse Event|1|||
161969948|NCT01904149|584939181|FG004|Overall Study|Adverse Event|1|||
161969949|NCT01904149|584939182|FG005|Overall Study|Adverse Event|2|||
161969950|NCT01904149|584939177|FG000|Overall Study|Lack of Efficacy|0|||
161969951|NCT01904149|584939178|FG001|Overall Study|Lack of Efficacy|3|||
161969952|NCT01904149|584939179|FG002|Overall Study|Lack of Efficacy|1|||
161969953|NCT01904149|584939180|FG003|Overall Study|Lack of Efficacy|3|||
161969954|NCT01904149|584939181|FG004|Overall Study|Lack of Efficacy|3|||
161969955|NCT01904149|584939182|FG005|Overall Study|Lack of Efficacy|1|||
161969956|NCT01904149|584939177|FG000|Overall Study|Withdrawal by Subject|1|||
161969957|NCT01904149|584939178|FG001|Overall Study|Withdrawal by Subject|3|||
161969958|NCT01904149|584939179|FG002|Overall Study|Withdrawal by Subject|1|||
161969959|NCT01904149|584939180|FG003|Overall Study|Withdrawal by Subject|0|||
161969960|NCT01904149|584939181|FG004|Overall Study|Withdrawal by Subject|1|||
161969961|NCT01904149|584939182|FG005|Overall Study|Withdrawal by Subject|0|||
161969962|NCT01904149|584939177|FG000|Overall Study|Protocol Violation|0|||
161969963|NCT01904149|584939178|FG001|Overall Study|Protocol Violation|1|||
161969964|NCT01904149|584939179|FG002|Overall Study|Protocol Violation|0|||
161969965|NCT01904149|584939180|FG003|Overall Study|Protocol Violation|0|||
161969966|NCT01904149|584939181|FG004|Overall Study|Protocol Violation|0|||
161969967|NCT01904149|584939182|FG005|Overall Study|Protocol Violation|0|||
161969968|NCT01904149|584939177|FG000|Overall Study|non compliance with study drug|1|||
161969969|NCT01904149|584939178|FG001|Overall Study|non compliance with study drug|0|||
161969970|NCT01904149|584939179|FG002|Overall Study|non compliance with study drug|0|||
161969971|NCT01904149|584939180|FG003|Overall Study|non compliance with study drug|0|||
161969972|NCT01904149|584939181|FG004|Overall Study|non compliance with study drug|0|||
161969973|NCT01904149|584939182|FG005|Overall Study|non compliance with study drug|0|||
161969974|NCT01357161|584939183|FG000|Part 1 (Open Label Run-in)|Death|5|||
161969975|NCT01357161|584939184|FG001|Part 1 (Open Label Run-in)|Death|0|||
161969976|NCT01357161|584939185|FG002|Part 1 (Open Label Run-in)|Death|0|||
161969977|NCT01357161|584939183|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
161969978|NCT01357161|584939184|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
161969979|NCT01357161|584939185|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
161969980|NCT01357161|584939183|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
161969981|NCT01357161|584939184|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
161969982|NCT01357161|584939185|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
161969983|NCT01357161|584939183|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
161969984|NCT01357161|584939184|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
161969985|NCT01357161|584939185|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
161969986|NCT01357161|584939183|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
161969987|NCT01357161|584939184|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
161969988|NCT01357161|584939185|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
161969989|NCT01357161|584939183|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
161969990|NCT01357161|584939184|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
161969991|NCT01357161|584939185|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
161969992|NCT01357161|584939183|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
161969993|NCT01357161|584939184|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
161969994|NCT01357161|584939185|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
161969995|NCT01357161|584939183|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
161969996|NCT01357161|584939184|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
161969997|NCT01357161|584939185|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
161969998|NCT01357161|584939183|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
161969999|NCT01357161|584939184|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
161970000|NCT01357161|584939185|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
161970001|NCT01357161|584939183|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
161970002|NCT01357161|584939184|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
161970003|NCT01357161|584939185|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
161970004|NCT01357161|584939183|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
161970005|NCT01357161|584939184|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
161970006|NCT01357161|584939185|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
161970007|NCT01824823|584939186|FG000|Overall Study|Lack of Efficacy|1|||
161970008|NCT01824823|584939187|FG001|Overall Study|Lack of Efficacy|1|||
161970009|NCT01824823|584939186|FG000|Overall Study|Off-treatment reason not submitted|1|||
161970010|NCT01824823|584939187|FG001|Overall Study|Off-treatment reason not submitted|0|||
161970011|NCT03349645|584939190|FG000|Overall Study|Sponsor Terminated Study|75|||
161970012|NCT03349645|584939190|FG000|Overall Study|Withdrawal by Subject|4|||
161970013|NCT03349645|584939190|FG000|Overall Study|Protocol Violation|1|||
161970014|NCT03349645|584939190|FG000|Overall Study|Other|2|||
161970015|NCT02927925|584939191|FG000|Overall Study|Death|16|||
161970016|NCT02927925|584939191|FG000|Overall Study|Physician Decision|1|||
161970017|NCT02927925|584939191|FG000|Overall Study|Withdrawal by Subject|11|||
161970018|NCT02927925|584939191|FG000|Overall Study|Other|3|||
161845676|NCT03327792|584477053|FG001|Overall Study|Adverse Event|0|||
161970019|NCT02927925|584939191|FG000|Overall Study|Disease progression at clinical cutoff|1|||
161970020|NCT02910401|584939192|FG000|Overall Study|Study closure Study closure|0|||
161970021|NCT02910401|584939193|FG001|Overall Study|Study closure Study closure|0|||
161970022|NCT02910401|584939194|FG002|Overall Study|Study closure Study closure|2|||
161970023|NCT02910401|584939192|FG000|Overall Study|Physician Decision|1|||
161970024|NCT02910401|584939193|FG001|Overall Study|Physician Decision|0|||
161970025|NCT02910401|584939194|FG002|Overall Study|Physician Decision|0|||
161970026|NCT00433160|584939198|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
161970027|NCT00433160|584939199|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
161970028|NCT00433160|584939198|FG000|52-Week Double-Blind (DB) Period|Death|0|||
161970029|NCT00433160|584939199|FG001|52-Week Double-Blind (DB) Period|Death|0|||
161970030|NCT00433160|584939198|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
161970031|NCT00433160|584939199|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
161970032|NCT00433160|584939198|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
162032917|NCT00219544|585177503|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
162032918|NCT00219544|585177504|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
161756600|NCT03330106|584147899|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
161756601|NCT03330106|584147896|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
161756602|NCT03330106|584147897|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
161756603|NCT03330106|584147898|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
161756604|NCT03330106|584147899|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
161756605|NCT03330106|584147896|FG000|Part A|Progressive Disease|0|||
161756606|NCT03330106|584147897|FG001|Part A|Progressive Disease|1|||
161756607|NCT03330106|584147898|FG002|Part A|Progressive Disease|0|||
161756608|NCT03330106|584147899|FG003|Part A|Progressive Disease|0|||
161756609|NCT03330106|584147896|FG000|Part B|Lost to Follow-up|0|||
161756610|NCT03330106|584147897|FG001|Part B|Lost to Follow-up|0|||
161756611|NCT03330106|584147898|FG002|Part B|Lost to Follow-up|0|||
161756612|NCT03330106|584147899|FG003|Part B|Lost to Follow-up|1|||
161756613|NCT03330106|584147896|FG000|Part B|Withdrawal by Subject|0|||
161756614|NCT03330106|584147897|FG001|Part B|Withdrawal by Subject|0|||
161756615|NCT03330106|584147898|FG002|Part B|Withdrawal by Subject|4|||
161756616|NCT03330106|584147899|FG003|Part B|Withdrawal by Subject|0|||
161756617|NCT03330106|584147896|FG000|Part B|Death|0|||
161756618|NCT03330106|584147897|FG001|Part B|Death|0|||
161756619|NCT03330106|584147898|FG002|Part B|Death|2|||
161756620|NCT03330106|584147899|FG003|Part B|Death|0|||
161756621|NCT03330106|584147896|FG000|Part B|Clinical Progression|0|||
161756622|NCT03330106|584147897|FG001|Part B|Clinical Progression|0|||
161756623|NCT03330106|584147898|FG002|Part B|Clinical Progression|1|||
161756624|NCT03330106|584147899|FG003|Part B|Clinical Progression|1|||
161756625|NCT03330106|584147896|FG000|Part B|Symptomatic Deterioration|0|||
161756626|NCT03330106|584147897|FG001|Part B|Symptomatic Deterioration|0|||
161756627|NCT03330106|584147898|FG002|Part B|Symptomatic Deterioration|0|||
161756628|NCT03330106|584147899|FG003|Part B|Symptomatic Deterioration|1|||
161756629|NCT03330106|584147896|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
161756630|NCT03330106|584147897|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
161756631|NCT03330106|584147898|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
161756632|NCT03330106|584147899|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
161756633|NCT03330106|584147896|FG000|Part B|Progressive Disease|0|||
161756634|NCT03330106|584147897|FG001|Part B|Progressive Disease|0|||
161756635|NCT03330106|584147898|FG002|Part B|Progressive Disease|11|||
161756636|NCT03330106|584147899|FG003|Part B|Progressive Disease|4|||
161756637|NCT00486889|584147902|FG000|Overall Study|Death|3|||
161756638|NCT00486889|584147902|FG000|Overall Study|Non-compliant|2|||
161756639|NCT00486889|584147902|FG000|Overall Study|Withdrawal by Subject|6|||
161756640|NCT02750501|584147903|FG000|Overall Study|Adverse Event|4|||
161756641|NCT02750501|584147903|FG000|Overall Study|Physician Decision|1|||
161756642|NCT02750501|584147903|FG000|Overall Study|Protocol Violation|1|||
161756643|NCT02750501|584147903|FG000|Overall Study|G-tube came out|1|||
161756644|NCT02750501|584147903|FG000|Overall Study|Non-compliant use of PERT|1|||
161756645|NCT00893763|584147904|FG000|Overall Study|extubated|110|||
161756646|NCT00893763|584147905|FG001|Overall Study|extubated|110|||
161756647|NCT01738594|584147906|FG000|Registration and Treatment Start|Adverse Event|0|||
161756648|NCT01738594|584147907|FG001|Registration and Treatment Start|Adverse Event|1|||
161970033|NCT00433160|584939199|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
161756649|NCT01738594|584147908|FG002|Registration and Treatment Start|Adverse Event|0|||
161756650|NCT01738594|584147909|FG003|Registration and Treatment Start|Adverse Event|0|||
161756651|NCT01738594|584147910|FG004|Registration and Treatment Start|Adverse Event|0|||
161756652|NCT01738594|584147911|FG005|Registration and Treatment Start|Adverse Event|0|||
161756653|NCT01738594|584147912|FG006|Registration and Treatment Start|Adverse Event|0|||
161756654|NCT01738594|584147913|FG007|Registration and Treatment Start|Adverse Event|0|||
161970034|NCT00433160|584939198|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
161756655|NCT01738594|584147906|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161756656|NCT01738594|584147907|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161845677|NCT03327792|584477052|FG000|Overall Study|Family/Personal issues|3|||
161845678|NCT03327792|584477053|FG001|Overall Study|Family/Personal issues|2|||
161845679|NCT03327792|584477052|FG000|Overall Study|Lost to Follow-up|0|||
161845680|NCT03327792|584477053|FG001|Overall Study|Lost to Follow-up|1|||
161845681|NCT04576923|584477054|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
161845682|NCT03151811|584477058|FG000|Overall Study|Randomized But Not Treated|18|||
161845683|NCT03151811|584477059|FG001|Overall Study|Randomized But Not Treated|3|||
161845684|NCT03151811|584477058|FG000|Overall Study|Progressive Disease|130|||
161845685|NCT03151811|584477059|FG001|Overall Study|Progressive Disease|170|||
161845686|NCT03151811|584477058|FG000|Overall Study|Adverse Event|49|||
161845687|NCT03151811|584477059|FG001|Overall Study|Adverse Event|40|||
161845688|NCT03151811|584477058|FG000|Overall Study|Lack of Efficacy|6|||
161845689|NCT03151811|584477059|FG001|Overall Study|Lack of Efficacy|8|||
161845690|NCT03151811|584477058|FG000|Overall Study|Physician Decision|21|||
161845691|NCT03151811|584477059|FG001|Overall Study|Physician Decision|9|||
161845692|NCT03151811|584477058|FG000|Overall Study|Withdrawal by Subject|17|||
161845693|NCT03151811|584477059|FG001|Overall Study|Withdrawal by Subject|7|||
161845694|NCT03151811|584477058|FG000|Overall Study|Lost to Follow-up|0|||
161845695|NCT03151811|584477059|FG001|Overall Study|Lost to Follow-up|1|||
161845696|NCT03151811|584477058|FG000|Overall Study|Study Terminated by Sponsor|5|||
161845697|NCT03151811|584477059|FG001|Overall Study|Study Terminated by Sponsor|11|||
161845698|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
161845699|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
161845700|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
161845701|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
161845702|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
161845703|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
161845704|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
161845705|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
161845706|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
161845707|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
161845708|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Death|1|||
161845709|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Death|0|||
161845710|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Death|0|||
161845711|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Death|0|||
161845712|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Death|0|||
161845713|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
161845714|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
161845715|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
161845716|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
161845717|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
161845718|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
161845719|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
161845720|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
161845721|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
161845722|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
161845723|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
161845724|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
161845725|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
161845726|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
161845727|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
161845728|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
161845729|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
161845730|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
161845731|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
161845732|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161970035|NCT00433160|584939199|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
161970036|NCT00433160|584939198|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
161970037|NCT00433160|584939199|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
161970038|NCT00433160|584939198|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
161845733|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
161845734|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161845735|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161845736|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161845737|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161845738|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Other|4|||
161845739|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Other|4|||
161845740|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Other|3|||
161845741|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Other|1|||
161756657|NCT01738594|584147908|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161756658|NCT01738594|584147909|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161756659|NCT01738594|584147910|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161756660|NCT01738594|584147911|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
161756661|NCT01738594|584147912|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161756662|NCT01738594|584147913|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161756663|NCT01738594|584147906|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756664|NCT01738594|584147907|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
161756665|NCT01738594|584147908|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756666|NCT01738594|584147909|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756667|NCT01738594|584147910|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756668|NCT01738594|584147911|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756669|NCT01738594|584147912|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756670|NCT01738594|584147913|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
161756671|NCT01738594|584147906|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756672|NCT01738594|584147907|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756673|NCT01738594|584147908|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756674|NCT01738594|584147909|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756675|NCT01738594|584147910|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756676|NCT01738594|584147911|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
161756677|NCT01738594|584147912|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756678|NCT01738594|584147913|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161756679|NCT01738594|584147906|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756680|NCT01738594|584147907|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756681|NCT01738594|584147908|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756682|NCT01738594|584147909|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756683|NCT01738594|584147910|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756684|NCT01738594|584147911|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
161756685|NCT01738594|584147912|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756686|NCT01738594|584147913|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161756687|NCT01738594|584147906|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756688|NCT01738594|584147907|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756689|NCT01738594|584147908|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756690|NCT01738594|584147909|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756691|NCT01738594|584147910|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
161756692|NCT01738594|584147911|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756693|NCT01738594|584147912|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756694|NCT01738594|584147913|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161756695|NCT01738594|584147906|FG000|Follow up for 1 Year|Death|0|||
161756696|NCT01738594|584147907|FG001|Follow up for 1 Year|Death|0|||
161756697|NCT01738594|584147908|FG002|Follow up for 1 Year|Death|0|||
161756698|NCT01738594|584147909|FG003|Follow up for 1 Year|Death|0|||
161756699|NCT01738594|584147910|FG004|Follow up for 1 Year|Death|0|||
161756700|NCT01738594|584147911|FG005|Follow up for 1 Year|Death|1|||
161756701|NCT01738594|584147912|FG006|Follow up for 1 Year|Death|0|||
161756702|NCT01738594|584147913|FG007|Follow up for 1 Year|Death|0|||
161756703|NCT01738594|584147906|FG000|Follow up for 1 Year|Other|0|||
161756704|NCT01738594|584147907|FG001|Follow up for 1 Year|Other|0|||
161756705|NCT01738594|584147908|FG002|Follow up for 1 Year|Other|0|||
161756706|NCT01738594|584147909|FG003|Follow up for 1 Year|Other|0|||
161756707|NCT01738594|584147910|FG004|Follow up for 1 Year|Other|0|||
161756708|NCT01738594|584147911|FG005|Follow up for 1 Year|Other|2|||
161756709|NCT01738594|584147912|FG006|Follow up for 1 Year|Other|0|||
161756710|NCT01738594|584147913|FG007|Follow up for 1 Year|Other|0|||
161756711|NCT04430036|584147914|FG000|Safety Run in Phase|Progression of disease|2|||
161756712|NCT04107935|584147915|FG000|Overall Study|Death|1|||
161756713|NCT04107935|584147916|FG001|Overall Study|Death|0|||
161756714|NCT01842334|584147917|FG000|Overall Study|Withdrawal by Subject|3|||
161756715|NCT01842334|584147918|FG001|Overall Study|Withdrawal by Subject|3|||
161756716|NCT01842334|584147917|FG000|Overall Study|Moved away mid-study|0|||
161756717|NCT01842334|584147918|FG001|Overall Study|Moved away mid-study|1|||
161756718|NCT00376675|584147919|FG000|Overall Study|Withdrawal by Subject|9|||
161756719|NCT00376675|584147920|FG001|Overall Study|Withdrawal by Subject|2|||
161756720|NCT00376675|584147919|FG000|Overall Study|Adverse Event|10|||
161756721|NCT00376675|584147920|FG001|Overall Study|Adverse Event|5|||
161756722|NCT00376675|584147919|FG000|Overall Study|Other Reason|1|||
161756723|NCT00376675|584147920|FG001|Overall Study|Other Reason|7|||
161756724|NCT01332851|584147923|FG000|Overall Study|Withdrawal by Subject|4|||
161756725|NCT01332851|584147924|FG001|Overall Study|Withdrawal by Subject|2|||
161970039|NCT00433160|584939199|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
161970040|NCT00433160|584939198|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
161970041|NCT00433160|584939199|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
161970042|NCT00433160|584939198|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
161970043|NCT00433160|584939199|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
161970044|NCT00433160|584939198|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
161970045|NCT00433160|584939199|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
161756726|NCT01332851|584147923|FG000|Overall Study|Lost to Follow-up|7|||
161756727|NCT01332851|584147924|FG001|Overall Study|Lost to Follow-up|11|||
161756728|NCT00422903|584147925|FG000|Overall Study|Disease Progression|3|||
161756729|NCT00422903|584147926|FG001|Overall Study|Disease Progression|1|||
161756730|NCT00422903|584147925|FG000|Overall Study|Adverse Event|0|||
161756731|NCT00422903|584147926|FG001|Overall Study|Adverse Event|2|||
161756732|NCT00422903|584147925|FG000|Overall Study|Informed Consent Withdrawn|1|||
161756733|NCT00422903|584147926|FG001|Overall Study|Informed Consent Withdrawn|2|||
161756734|NCT03446612|584147927|FG000|Overall Study|Protocol defined stopping criteria|0|||
161756735|NCT03446612|584147928|FG001|Overall Study|Protocol defined stopping criteria|1|||
161756736|NCT01678560|584147935|FG000|Overall Study|Physician Decision|4|||
161756737|NCT01678560|584147936|FG001|Overall Study|Physician Decision|4|||
161756738|NCT01678560|584147935|FG000|Overall Study|Death|0|||
161756739|NCT01678560|584147936|FG001|Overall Study|Death|1|||
161756740|NCT01678560|584147935|FG000|Overall Study|Withdrawal by Subject|0|||
161756741|NCT01678560|584147936|FG001|Overall Study|Withdrawal by Subject|1|||
161756742|NCT02201472|584147937|FG000|Overall Study|Lack of Efficacy|2|||
161756743|NCT01300767|584147938|FG000|Overall Study|Discomfort|2|||
161756744|NCT01300767|584147938|FG000|Overall Study|Biomicroscopy|1|||
161756745|NCT01300767|584147938|FG000|Overall Study|Unacceptable fit|1|||
161756746|NCT01188811|584147943|FG000|Overall Study|Withdrawal by Subject|0|||
161756747|NCT01188811|584147944|FG001|Overall Study|Withdrawal by Subject|2|||
161756748|NCT01188811|584147943|FG000|Overall Study|Adverse Event|6|||
161756749|NCT01188811|584147944|FG001|Overall Study|Adverse Event|0|||
161756750|NCT00654368|584147945|FG000|Overall Study|Ineligibility determined|6|||
161756751|NCT00654368|584147946|FG001|Overall Study|Ineligibility determined|0|||
161756752|NCT00654368|584147947|FG002|Overall Study|Ineligibility determined|0|||
161756753|NCT00654368|584147945|FG000|Overall Study|Protocol deviation|3|||
161756754|NCT00654368|584147946|FG001|Overall Study|Protocol deviation|2|||
161756755|NCT00654368|584147947|FG002|Overall Study|Protocol deviation|1|||
161756756|NCT00654368|584147945|FG000|Overall Study|Non-compliance|2|||
161756757|NCT00654368|584147946|FG001|Overall Study|Non-compliance|1|||
161756758|NCT00654368|584147947|FG002|Overall Study|Non-compliance|2|||
161756759|NCT00654368|584147945|FG000|Overall Study|Withdrawal by Subject|5|||
161756760|NCT00654368|584147946|FG001|Overall Study|Withdrawal by Subject|2|||
161756761|NCT00654368|584147947|FG002|Overall Study|Withdrawal by Subject|2|||
161756762|NCT00654368|584147945|FG000|Overall Study|Disease progression|21|||
161756763|NCT00654368|584147946|FG001|Overall Study|Disease progression|31|||
161756764|NCT00654368|584147947|FG002|Overall Study|Disease progression|13|||
161756765|NCT00654368|584147945|FG000|Overall Study|Requirement for alternative therapy|1|||
161756766|NCT00654368|584147946|FG001|Overall Study|Requirement for alternative therapy|1|||
161756767|NCT00654368|584147947|FG002|Overall Study|Requirement for alternative therapy|1|||
161756768|NCT00654368|584147945|FG000|Overall Study|Physician Decision|0|||
161756769|NCT00654368|584147946|FG001|Overall Study|Physician Decision|0|||
161756770|NCT00654368|584147947|FG002|Overall Study|Physician Decision|2|||
161756771|NCT00654368|584147945|FG000|Overall Study|Death|1|||
161756772|NCT00654368|584147946|FG001|Overall Study|Death|0|||
161756773|NCT00654368|584147947|FG002|Overall Study|Death|0|||
161756774|NCT00654368|584147945|FG000|Overall Study|Pregnancy|0|||
161756775|NCT00654368|584147946|FG001|Overall Study|Pregnancy|0|||
161756776|NCT00654368|584147947|FG002|Overall Study|Pregnancy|2|||
161756777|NCT00654368|584147945|FG000|Overall Study|Other|0|||
161756778|NCT00654368|584147946|FG001|Overall Study|Other|2|||
161756779|NCT00654368|584147947|FG002|Overall Study|Other|3|||
161970046|NCT00433160|584939198|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
161756780|NCT00654368|584147945|FG000|Overall Study|Adverse Event|14|||
161756781|NCT00654368|584147946|FG001|Overall Study|Adverse Event|9|||
161756782|NCT00654368|584147947|FG002|Overall Study|Adverse Event|6|||
161756783|NCT01602744|584147948|FG000|Overall Study|Death|17|||
161756784|NCT01602744|584147949|FG001|Overall Study|Death|15|||
161970047|NCT00433160|584939199|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
161970048|NCT00433160|584939198|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
161756785|NCT01602744|584147948|FG000|Overall Study|Lost to Follow-up|13|||
161756786|NCT01602744|584147949|FG001|Overall Study|Lost to Follow-up|8|||
161756787|NCT00959699|584147950|FG000|Treatment Period|Adverse Event|3|||
161756788|NCT00959699|584147951|FG001|Treatment Period|Adverse Event|13|||
161756789|NCT00959699|584147950|FG000|Treatment Period|Lack of Efficacy|15|||
161756790|NCT00959699|584147951|FG001|Treatment Period|Lack of Efficacy|6|||
161756791|NCT00959699|584147950|FG000|Treatment Period|Lost to Follow-up|0|||
161756792|NCT00959699|584147951|FG001|Treatment Period|Lost to Follow-up|1|||
161756793|NCT00959699|584147950|FG000|Treatment Period|Withdrawal by Subject|1|||
161756794|NCT00959699|584147951|FG001|Treatment Period|Withdrawal by Subject|3|||
161756795|NCT00959699|584147950|FG000|Treatment Period|Non-Compliance with Protocol|0|||
161756796|NCT00959699|584147951|FG001|Treatment Period|Non-Compliance with Protocol|1|||
161756797|NCT00959699|584147950|FG000|Treatment Period|Did not receive treatment|0|||
161756798|NCT00959699|584147951|FG001|Treatment Period|Did not receive treatment|1|||
161756799|NCT00959699|584147950|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
161756800|NCT00959699|584147951|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
161756801|NCT00959699|584147950|FG000|Follow-up Period|Lost to Follow-up|3|||
161756802|NCT00959699|584147951|FG001|Follow-up Period|Lost to Follow-up|2|||
161756803|NCT00959699|584147950|FG000|Follow-up Period|Withdrawal by Subject|3|||
161756804|NCT00959699|584147951|FG001|Follow-up Period|Withdrawal by Subject|4|||
161756805|NCT04228445|584147952|FG000|Overall Study|Lost to Follow-up|1|||
161756806|NCT04228445|584147953|FG001|Overall Study|Lost to Follow-up|1|||
161756807|NCT04228445|584147952|FG000|Overall Study|Physician Decision|1|||
161756808|NCT04228445|584147953|FG001|Overall Study|Physician Decision|2|||
161756809|NCT04228445|584147952|FG000|Overall Study|Withdrawal by Subject|0|||
161756810|NCT04228445|584147953|FG001|Overall Study|Withdrawal by Subject|1|||
161756811|NCT04228445|584147952|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
161756812|NCT04228445|584147953|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
161756813|NCT00606294|584147954|FG000|Overall Study|Withdrawal by Subject|36|||
161756814|NCT00606294|584147955|FG001|Overall Study|Withdrawal by Subject|0|||
161756815|NCT03924427|584147956|FG000|Overall Study|Adverse Event|4|||
161756816|NCT03924427|584147956|FG000|Overall Study|Lack of Efficacy|1|||
161756817|NCT03924427|584147956|FG000|Overall Study|Withdrawal by Subject|1|||
161756818|NCT00609167|584147963|FG000|Overall Study|Withdrawal by Subject|1|||
161756819|NCT00609167|584147964|FG001|Overall Study|Withdrawal by Subject|0|||
161756820|NCT00609167|584147963|FG000|Overall Study|Lack of Efficacy|1|||
161756821|NCT00609167|584147964|FG001|Overall Study|Lack of Efficacy|0|||
161756822|NCT00609167|584147963|FG000|Overall Study|Adverse Event|5|||
161756823|NCT00609167|584147964|FG001|Overall Study|Adverse Event|1|||
161756824|NCT00609167|584147963|FG000|Overall Study|Disease Progression|1|||
161756825|NCT00609167|584147964|FG001|Overall Study|Disease Progression|0|||
161756826|NCT00609167|584147963|FG000|Overall Study|Stem Cell Transplant|0|||
161756827|NCT00609167|584147964|FG001|Overall Study|Stem Cell Transplant|6|||
161756828|NCT00712270|584147965|FG000|Overall Study|Withdrawal by Subject|11|||
161756829|NCT00712270|584147965|FG000|Overall Study|Screen Failure|3|||
161756830|NCT03935594|584147966|FG000|Overall Study|Physician Decision|3|||
161756831|NCT01435122|584147967|FG000|Overall Study|Early withdrawal due to toxicity|8|||
161756832|NCT04412668|584147968|FG000|Overall Study|Death - multiple comorbidities|2|||
161756833|NCT04412668|584147969|FG001|Overall Study|Death - multiple comorbidities|0|||
161756834|NCT04412668|584147970|FG002|Overall Study|Death - multiple comorbidities|0|||
161756835|NCT04412668|584147968|FG000|Overall Study|Withdrawal by Subject|3|||
161756836|NCT04412668|584147969|FG001|Overall Study|Withdrawal by Subject|0|||
161756837|NCT04412668|584147970|FG002|Overall Study|Withdrawal by Subject|0|||
161756838|NCT04412668|584147968|FG000|Overall Study|Other than Specified|2|||
161756839|NCT04412668|584147969|FG001|Overall Study|Other than Specified|0|||
161756840|NCT04412668|584147970|FG002|Overall Study|Other than Specified|0|||
161756841|NCT03864627|584147971|FG000|Overall Study|Adverse Event|0|||
161756842|NCT03864627|584147972|FG001|Overall Study|Adverse Event|1|||
161756843|NCT03864627|584147971|FG000|Overall Study|Lack of Efficacy|0|||
161756844|NCT03864627|584147972|FG001|Overall Study|Lack of Efficacy|1|||
161756845|NCT03864627|584147971|FG000|Overall Study|Lost to Follow-up|0|||
161756846|NCT03864627|584147972|FG001|Overall Study|Lost to Follow-up|1|||
161756847|NCT03864627|584147971|FG000|Overall Study|Withdrawal by Subject|4|||
161756848|NCT03864627|584147972|FG001|Overall Study|Withdrawal by Subject|8|||
161756849|NCT03864627|584147971|FG000|Overall Study|Study terminated by sponsor|0|||
161756850|NCT03864627|584147972|FG001|Overall Study|Study terminated by sponsor|1|||
161756851|NCT01388491|584147973|FG000|Overall Study|Adverse Event|10|||
161756852|NCT01388491|584147974|FG001|Overall Study|Adverse Event|9|||
161756853|NCT01388491|584147973|FG000|Overall Study|Sponsor Request|9|||
161756854|NCT01388491|584147974|FG001|Overall Study|Sponsor Request|7|||
161756855|NCT01388491|584147973|FG000|Overall Study|Withdrawal by Subject|6|||
161756856|NCT01388491|584147974|FG001|Overall Study|Withdrawal by Subject|10|||
161756857|NCT01388491|584147973|FG000|Overall Study|Lost to Follow-up|4|||
161756858|NCT01388491|584147974|FG001|Overall Study|Lost to Follow-up|3|||
161756859|NCT01388491|584147973|FG000|Overall Study|Protocol Violation|2|||
161756860|NCT01388491|584147974|FG001|Overall Study|Protocol Violation|0|||
161756861|NCT01388491|584147973|FG000|Overall Study|Noncompliance|2|||
161756862|NCT01388491|584147974|FG001|Overall Study|Noncompliance|0|||
161756863|NCT01388491|584147973|FG000|Overall Study|Pregnancy|1|||
161756864|NCT01388491|584147974|FG001|Overall Study|Pregnancy|0|||
161756865|NCT00112840|584147975|FG000|Overall Study|Physician Decision|1|||
161756866|NCT00112840|584147976|FG001|Overall Study|Physician Decision|0|||
161756867|NCT00112840|584147977|FG002|Overall Study|Physician Decision|0|||
161756868|NCT00112840|584147975|FG000|Overall Study|Withdrawal by Subject|1|||
161756869|NCT00112840|584147976|FG001|Overall Study|Withdrawal by Subject|0|||
161756870|NCT00112840|584147977|FG002|Overall Study|Withdrawal by Subject|1|||
161756871|NCT00112840|584147975|FG000|Overall Study|Protocol Violation|0|||
161756872|NCT00112840|584147976|FG001|Overall Study|Protocol Violation|0|||
161756873|NCT00112840|584147977|FG002|Overall Study|Protocol Violation|5|||
161756874|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
161756875|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
161756876|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
161756877|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
161756878|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Other|13|||
161756879|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
161756880|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
161756881|NCT02497287|584147978|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
161756882|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
161756883|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
161756884|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
161756885|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
161756886|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
161845742|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Other|0|||
161845743|NCT01081834|584477068|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
161845744|NCT01081834|584477069|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
161845745|NCT01081834|584477070|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
161845746|NCT01081834|584477071|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
161970049|NCT00433160|584939199|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
161970050|NCT00433160|584939198|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
161970051|NCT00433160|584939199|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
161970052|NCT00433160|584939198|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
161970053|NCT00433160|584939199|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
161970054|NCT00433160|584939198|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
161970055|NCT00433160|584939199|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
161970056|NCT00433160|584939198|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
161970057|NCT00433160|584939199|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
161970058|NCT02240368|584939203|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
161970059|NCT02240368|584939204|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
161970060|NCT02240368|584939205|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
161970061|NCT02240368|584939203|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
161970062|NCT02240368|584939204|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
161970063|NCT02240368|584939205|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
161970064|NCT03372460|584939206|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
161970065|NCT03372460|584939207|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
161970066|NCT00916058|584939215|FG000|Phase 1|Screen Failure|0|||
161970067|NCT00916058|584939216|FG001|Phase 1|Screen Failure|0|||
161970068|NCT00916058|584939217|FG002|Phase 1|Screen Failure|0|||
161970069|NCT00916058|584939218|FG003|Phase 1|Screen Failure|0|||
161970070|NCT00916058|584939219|FG004|Phase 1|Screen Failure|0|||
161970071|NCT00916058|584939220|FG005|Phase 1|Screen Failure|1|||
161970072|NCT00916058|584939221|FG006|Phase 1|Screen Failure|0|||
161970073|NCT00916058|584939215|FG000|Phase 2|Screen Failure|0|||
161970074|NCT00916058|584939216|FG001|Phase 2|Screen Failure|0|||
161970075|NCT00916058|584939217|FG002|Phase 2|Screen Failure|0|||
161970076|NCT00916058|584939218|FG003|Phase 2|Screen Failure|0|||
161970077|NCT00916058|584939219|FG004|Phase 2|Screen Failure|0|||
161970078|NCT00916058|584939220|FG005|Phase 2|Screen Failure|0|||
161970079|NCT00916058|584939221|FG006|Phase 2|Screen Failure|3|||
161970080|NCT03222973|584939222|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
161970081|NCT03222973|584939223|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
161970082|NCT03222973|584939224|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
161970083|NCT03222973|584939225|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
161970084|NCT03222973|584939222|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
161970085|NCT03222973|584939223|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
161970086|NCT03222973|584939224|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
161970087|NCT03222973|584939225|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
161970088|NCT03222973|584939222|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
161970089|NCT03222973|584939223|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
161970090|NCT03222973|584939224|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
161970091|NCT03222973|584939225|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
161970092|NCT03222973|584939222|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
161970093|NCT03222973|584939223|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
161970094|NCT03222973|584939224|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
161970095|NCT03222973|584939225|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
161970096|NCT03222973|584939222|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
161756887|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
161756888|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
161970097|NCT03222973|584939223|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
161970098|NCT03222973|584939224|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
161970099|NCT03222973|584939225|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
161970100|NCT03222973|584939222|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
161970101|NCT03222973|584939223|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
161970102|NCT03222973|584939224|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
161970103|NCT03222973|584939225|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
161970104|NCT03222973|584939222|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
161970105|NCT03222973|584939223|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
161970106|NCT03222973|584939224|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
161970107|NCT03222973|584939225|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
161970108|NCT03222973|584939222|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
161970109|NCT03222973|584939223|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
161970110|NCT03222973|584939224|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
161970111|NCT03222973|584939225|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
161970112|NCT03222973|584939222|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
161970113|NCT03222973|584939223|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
161970114|NCT03222973|584939224|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
161970115|NCT03222973|584939225|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
161970116|NCT03222973|584939222|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
161970117|NCT03222973|584939223|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
161970118|NCT03222973|584939224|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
161970119|NCT03222973|584939225|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
161970120|NCT03222973|584939222|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
161970121|NCT03222973|584939223|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
161970122|NCT03222973|584939224|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
161970123|NCT03222973|584939225|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
161970124|NCT03222973|584939222|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
161970125|NCT03222973|584939223|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
161756889|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
161970126|NCT03222973|584939224|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
161970127|NCT03222973|584939225|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
161970128|NCT02439450|584939226|FG000|Overall Study|Adverse Event|4|||
161970129|NCT02439450|584939227|FG001|Overall Study|Adverse Event|1|||
161756890|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
161756891|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
161756892|NCT02497287|584147978|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
161756893|NCT02497287|584147978|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
161756894|NCT02497287|584147978|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
161756895|NCT02497287|584147978|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
161756896|NCT02497287|584147978|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
161756897|NCT02497287|584147978|FG000|Follow-up Phase (4 Week)|Other|1|||
161756898|NCT03128307|584147982|FG000|Overall Study|Lost to Follow-up|29|||
161756899|NCT03128307|584147982|FG000|Overall Study|Withdrawal by Subject|5|||
161756900|NCT01592773|584149601|FG000|Overall Study|Study Terminated by Sponsor|582|||
161756901|NCT01592773|584149601|FG000|Overall Study|Withdrawal by Subject|35|||
161756902|NCT01592773|584149601|FG000|Overall Study|Lost to Follow-up|19|||
161756903|NCT01592773|584149601|FG000|Overall Study|Adverse Event|17|||
161756904|NCT01592773|584149601|FG000|Overall Study|Lack of Efficacy|9|||
161756905|NCT01592773|584149601|FG000|Overall Study|Protocol Violation|2|||
161756906|NCT01592773|584149601|FG000|Overall Study|Inclusion/exclusion not meet|1|||
161756907|NCT01592773|584149601|FG000|Overall Study|Other Reason|1|||
161756908|NCT00121485|584149602|FG000|Overall Study|Not implanted|1|||
161756909|NCT00121485|584149603|FG001|Overall Study|Not implanted|5|||
161756910|NCT00121485|584149602|FG000|Overall Study|Crossover|0|||
161756911|NCT00121485|584149603|FG001|Overall Study|Crossover|2|||
161756912|NCT04124952|584149605|FG000|Overall Study|Lost to Follow-up|1|||
161756913|NCT02145429|584149606|FG000|Overall Study|Death|4|||
161756914|NCT02145429|584149607|FG001|Overall Study|Death|5|||
161756915|NCT02145429|584149606|FG000|Overall Study|Lost to Follow-up|4|||
161756916|NCT02145429|584149607|FG001|Overall Study|Lost to Follow-up|3|||
161756917|NCT02145429|584149606|FG000|Overall Study|Withdrawal by Subject|8|||
161756918|NCT02145429|584149607|FG001|Overall Study|Withdrawal by Subject|3|||
161756919|NCT00732472|584149608|FG000|Overall Study|Adverse Event|0|||
161756920|NCT00732472|584149609|FG001|Overall Study|Adverse Event|1|||
161756921|NCT00732472|584149610|FG002|Overall Study|Adverse Event|1|||
162032919|NCT00219544|585177503|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
161756922|NCT00732472|584149611|FG003|Overall Study|Adverse Event|1|||
161756923|NCT00732472|584149608|FG000|Overall Study|Protocol Violation|0|||
161756924|NCT00732472|584149609|FG001|Overall Study|Protocol Violation|0|||
161756925|NCT00732472|584149610|FG002|Overall Study|Protocol Violation|0|||
161756926|NCT00732472|584149611|FG003|Overall Study|Protocol Violation|1|||
161756927|NCT00732472|584149608|FG000|Overall Study|Withdrawal by Subject|0|||
161756928|NCT00732472|584149609|FG001|Overall Study|Withdrawal by Subject|2|||
161756929|NCT00732472|584149610|FG002|Overall Study|Withdrawal by Subject|0|||
161970130|NCT02439450|584939228|FG002|Overall Study|Adverse Event|0|||
161970131|NCT02439450|584939229|FG003|Overall Study|Adverse Event|0|||
161970132|NCT02439450|584939226|FG000|Overall Study|Withdrawal by Subject|1|||
161970133|NCT02439450|584939227|FG001|Overall Study|Withdrawal by Subject|2|||
161970134|NCT02439450|584939228|FG002|Overall Study|Withdrawal by Subject|0|||
161970135|NCT02439450|584939229|FG003|Overall Study|Withdrawal by Subject|0|||
161970136|NCT02439450|584939226|FG000|Overall Study|Death|3|||
161970137|NCT02439450|584939227|FG001|Overall Study|Death|0|||
161970138|NCT02439450|584939228|FG002|Overall Study|Death|0|||
161756930|NCT00732472|584149611|FG003|Overall Study|Withdrawal by Subject|1|||
161756931|NCT02559115|584149614|FG000|Overall Study|Withdrawal by Subject|3|||
161756932|NCT02623699|584149615|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756933|NCT02623699|584149616|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
161756934|NCT02623699|584149617|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756935|NCT02623699|584149618|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756936|NCT02623699|584149619|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756937|NCT02623699|584149620|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756938|NCT02623699|584149621|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756939|NCT02623699|584149622|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756940|NCT02623699|584149623|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756941|NCT02623699|584149624|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756942|NCT02623699|584149625|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756943|NCT02623699|584149626|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161756944|NCT02623699|584149615|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756945|NCT02623699|584149616|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756946|NCT02623699|584149617|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756947|NCT02623699|584149618|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756948|NCT02623699|584149619|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756949|NCT02623699|584149620|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756950|NCT02623699|584149621|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
161756951|NCT02623699|584149622|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756952|NCT02623699|584149623|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756953|NCT02623699|584149624|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756954|NCT02623699|584149625|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756955|NCT02623699|584149626|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161756956|NCT02623699|584149615|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756957|NCT02623699|584149616|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756958|NCT02623699|584149617|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756959|NCT02623699|584149618|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756960|NCT02623699|584149619|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756961|NCT02623699|584149620|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
161756962|NCT02623699|584149621|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756963|NCT02623699|584149622|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756964|NCT02623699|584149623|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756965|NCT02623699|584149624|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756966|NCT02623699|584149625|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756967|NCT02623699|584149626|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161756968|NCT02623699|584149615|FG000|Part B (Up to 289 Days)|Death|0|||
161756969|NCT02623699|584149616|FG001|Part B (Up to 289 Days)|Death|0|||
161756970|NCT02623699|584149617|FG002|Part B (Up to 289 Days)|Death|0|||
161756971|NCT02623699|584149618|FG003|Part B (Up to 289 Days)|Death|0|||
161756972|NCT02623699|584149619|FG004|Part B (Up to 289 Days)|Death|0|||
161756973|NCT02623699|584149620|FG005|Part B (Up to 289 Days)|Death|1|||
161756974|NCT02623699|584149621|FG006|Part B (Up to 289 Days)|Death|1|||
161756975|NCT02623699|584149622|FG007|Part B (Up to 289 Days)|Death|0|||
161756976|NCT02623699|584149623|FG008|Part B (Up to 289 Days)|Death|1|||
161756977|NCT02623699|584149624|FG009|Part B (Up to 289 Days)|Death|0|||
161756978|NCT02623699|584149625|FG010|Part B (Up to 289 Days)|Death|0|||
161756979|NCT02623699|584149626|FG011|Part B (Up to 289 Days)|Death|0|||
161756980|NCT02623699|584149615|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
161756981|NCT02623699|584149616|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
161756982|NCT02623699|584149617|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
161756983|NCT02623699|584149618|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
161756984|NCT02623699|584149619|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
161970139|NCT02439450|584939229|FG003|Overall Study|Death|1|||
161756985|NCT02623699|584149620|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
161756986|NCT02623699|584149621|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
161756987|NCT02623699|584149622|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
161756988|NCT02623699|584149623|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
161756989|NCT02623699|584149624|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
161756990|NCT02623699|584149625|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
161970140|NCT02439450|584939226|FG000|Overall Study|Progressive Disease|18|||
161970141|NCT02439450|584939227|FG001|Overall Study|Progressive Disease|41|||
161756991|NCT02623699|584149626|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
161756992|NCT02623699|584149615|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161756993|NCT02623699|584149616|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161970142|NCT02439450|584939228|FG002|Overall Study|Progressive Disease|2|||
161845747|NCT01081834|584477072|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
161845748|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161845749|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161845750|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161845751|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161845752|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161845753|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Death|1|||
161845754|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Death|0|||
161845755|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Death|0|||
161845756|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Death|0|||
161845757|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Death|0|||
161845758|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
161845759|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
161845760|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161845761|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161845762|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161845763|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161845764|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161845765|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161845766|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161845767|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161845768|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161845769|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
161845770|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161845771|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161845772|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161845773|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
161845774|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161845775|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
161845776|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161845777|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161845778|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
161845779|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
161845780|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
161845781|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
161845782|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
161845783|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Other|4|||
161845784|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Other|5|||
161845785|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Other|4|||
161845786|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Other|0|||
161845787|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Other|0|||
161845788|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
161845789|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
161845790|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
161845791|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
161845792|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
161845793|NCT01081834|584477068|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161845794|NCT01081834|584477069|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
161845795|NCT01081834|584477070|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161845796|NCT01081834|584477071|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161970143|NCT02439450|584939229|FG003|Overall Study|Progressive Disease|3|||
161845797|NCT01081834|584477072|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161970144|NCT03730961|584939234|FG000|Overall Study|Adverse Event|0|||
161970145|NCT03730961|584939235|FG001|Overall Study|Adverse Event|1|||
161970146|NCT01646645|584939238|FG000|Overall Study|No Treated|1|||
161970147|NCT01646645|584939238|FG000|Overall Study|Inevaluable Donor|29|||
161970148|NCT00717522|584939239|FG000|Overall Study|Disease Progression|5|||
161970149|NCT00717522|584939239|FG000|Overall Study|Adverse Event|1|||
161970150|NCT00717522|584939239|FG000|Overall Study|Death|1|||
161970151|NCT01799239|584939240|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
161970152|NCT01799239|584939241|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
161970153|NCT01799239|584939240|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
161970154|NCT01799239|584939241|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
161970155|NCT01799239|584939240|FG000|Period 1 (7 Days)|Protocol Violation|0|||
161970156|NCT01799239|584939241|FG001|Period 1 (7 Days)|Protocol Violation|1|||
161970157|NCT01799239|584939240|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
161845798|NCT02045147|584477073|FG000|Overall Study|Withdrawal by Subject|2|||
161845799|NCT02045147|584477074|FG001|Overall Study|Withdrawal by Subject|0|||
161845800|NCT02045147|584477075|FG002|Overall Study|Withdrawal by Subject|0|||
161845801|NCT02045147|584477076|FG003|Overall Study|Withdrawal by Subject|0|||
161845802|NCT02045147|584477077|FG004|Overall Study|Withdrawal by Subject|0|||
161845803|NCT02045147|584477078|FG005|Overall Study|Withdrawal by Subject|0|||
161845804|NCT02045147|584477079|FG006|Overall Study|Withdrawal by Subject|0|||
161845805|NCT02045147|584477080|FG007|Overall Study|Withdrawal by Subject|1|||
161845806|NCT02045147|584477073|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
161845807|NCT02045147|584477074|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
161845808|NCT02045147|584477075|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
161845809|NCT02045147|584477076|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
161845810|NCT02045147|584477077|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
161756994|NCT02623699|584149617|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161756995|NCT02623699|584149618|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161756996|NCT02623699|584149619|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161756997|NCT02623699|584149620|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161756998|NCT02623699|584149621|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161756999|NCT02623699|584149622|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161757000|NCT02623699|584149623|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161757001|NCT02623699|584149624|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161757002|NCT02623699|584149625|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
161757003|NCT02623699|584149626|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
161757004|NCT02623699|584149615|FG000|Part C (Up to 236 Days)|Death|0|||
161757005|NCT02623699|584149616|FG001|Part C (Up to 236 Days)|Death|0|||
161757006|NCT02623699|584149617|FG002|Part C (Up to 236 Days)|Death|0|||
161757007|NCT02623699|584149618|FG003|Part C (Up to 236 Days)|Death|0|||
161757008|NCT02623699|584149619|FG004|Part C (Up to 236 Days)|Death|0|||
161757009|NCT02623699|584149620|FG005|Part C (Up to 236 Days)|Death|0|||
161757010|NCT02623699|584149621|FG006|Part C (Up to 236 Days)|Death|0|||
161757011|NCT02623699|584149622|FG007|Part C (Up to 236 Days)|Death|0|||
161757012|NCT02623699|584149623|FG008|Part C (Up to 236 Days)|Death|0|||
161757013|NCT02623699|584149624|FG009|Part C (Up to 236 Days)|Death|0|||
161757014|NCT02623699|584149625|FG010|Part C (Up to 236 Days)|Death|0|||
161757015|NCT02623699|584149626|FG011|Part C (Up to 236 Days)|Death|1|||
161757016|NCT02623699|584149615|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
161757017|NCT02623699|584149616|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
161757018|NCT02623699|584149617|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
161757019|NCT02623699|584149618|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
161757020|NCT02623699|584149619|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
161757021|NCT02623699|584149620|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
161757022|NCT02623699|584149621|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
161757023|NCT02623699|584149622|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
161757024|NCT02623699|584149623|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
161757025|NCT02623699|584149624|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
161757026|NCT02623699|584149625|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
161757027|NCT02623699|584149626|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
161757028|NCT01426009|584149627|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
161757029|NCT01426009|584149627|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
161757030|NCT01426009|584149627|FG000|Washout 1|Withdrawal by Subject|1|||
161757031|NCT01426009|584149627|FG000|Washout 1|Personal Reasons|1|||
161757032|NCT01426009|584149627|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
161757033|NCT01426009|584149627|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
161757034|NCT01426009|584149627|FG000|Washout 2|electrive surgery|1|||
161757035|NCT01426009|584149627|FG000|Washout 3|personal reasons|1|||
161757036|NCT01426009|584149627|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
161757037|NCT01426009|584149627|FG000|Washout 4|Lost to Follow-up|1|||
161757038|NCT00515099|584149633|FG000|Overall Study|Lost to Follow-up|0|||
161757039|NCT00515099|584149634|FG001|Overall Study|Lost to Follow-up|4|||
161757040|NCT00515099|584149633|FG000|Overall Study|Withdrawal by Subject|2|||
161757041|NCT00515099|584149634|FG001|Overall Study|Withdrawal by Subject|0|||
161757042|NCT00515099|584149633|FG000|Overall Study|IRB Recommendation|1|||
161757043|NCT00515099|584149634|FG001|Overall Study|IRB Recommendation|0|||
161757044|NCT03342404|584149635|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
161845811|NCT02045147|584477078|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
161757045|NCT03342404|584149636|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
161757046|NCT03342404|584149635|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
161757047|NCT03342404|584149636|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
161757048|NCT03342404|584149635|FG000|Blinded Treatment Phase|Adverse Event|5|||
161757049|NCT03342404|584149636|FG001|Blinded Treatment Phase|Adverse Event|4|||
161757050|NCT03342404|584149635|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
161757051|NCT03342404|584149636|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
161757052|NCT03342404|584149635|FG000|Blinded Treatment Phase|Other reasons|1|||
161845812|NCT02045147|584477079|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
161845813|NCT02045147|584477080|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
161845814|NCT04839692|584477081|FG000|Overall Study|Withdrawal by Subject|0|||
161845815|NCT04839692|584477082|FG001|Overall Study|Withdrawal by Subject|3|||
161845816|NCT04839692|584477081|FG000|Overall Study|Physician Decision|1|||
161845817|NCT04839692|584477082|FG001|Overall Study|Physician Decision|0|||
161845818|NCT00049530|584477083|FG000|Overall Study|Lack of Efficacy|25|||
161845819|NCT00049530|584477083|FG000|Overall Study|Adverse Event|2|||
161845820|NCT00049530|584477083|FG000|Overall Study|Death|1|||
161845821|NCT00049530|584477083|FG000|Overall Study|symptomatic deterioration|1|||
161845822|NCT00049530|584477083|FG000|Overall Study|ineligible|3|||
161845823|NCT03511326|584477085|FG000|Overall Study|Withdrawal by Subject|1|||
161970158|NCT01799239|584939241|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
161845824|NCT00849186|584477088|FG000|Overall Study|Adverse Event|2|||
161845825|NCT00849186|584477088|FG000|Overall Study|Withdrawal by Subject|1|||
161845826|NCT00849186|584477088|FG000|Overall Study|not treated|6|||
161845827|NCT00849186|584477088|FG000|Overall Study|Other|1|||
161845828|NCT00936897|584477091|FG000|Overall Study|Withdrawal by Subject|9|||
161845829|NCT00936897|584477092|FG001|Overall Study|Withdrawal by Subject|19|||
161845830|NCT00936897|584477091|FG000|Overall Study|Adverse Event|4|||
161845831|NCT00936897|584477092|FG001|Overall Study|Adverse Event|13|||
161845832|NCT00936897|584477091|FG000|Overall Study|Other|3|||
161845833|NCT00936897|584477092|FG001|Overall Study|Other|9|||
161845834|NCT00936897|584477091|FG000|Overall Study|Lost to Follow-up|1|||
161845835|NCT00936897|584477092|FG001|Overall Study|Lost to Follow-up|10|||
161845836|NCT00936897|584477091|FG000|Overall Study|Administrative Decision|1|||
161845837|NCT00936897|584477092|FG001|Overall Study|Administrative Decision|2|||
161845838|NCT00936897|584477091|FG000|Overall Study|Protocol Violation|1|||
161845839|NCT00936897|584477092|FG001|Overall Study|Protocol Violation|1|||
161845840|NCT00936897|584477091|FG000|Overall Study|Ineligibility Determined|0|||
161845841|NCT00936897|584477092|FG001|Overall Study|Ineligibility Determined|3|||
161845842|NCT00936897|584477091|FG000|Overall Study|Noncompliance|0|||
161845843|NCT00936897|584477092|FG001|Overall Study|Noncompliance|2|||
161845844|NCT00936897|584477091|FG000|Overall Study|Death|0|||
161845845|NCT00936897|584477092|FG001|Overall Study|Death|1|||
161845846|NCT00417170|584477093|FG000|Overall Study|Adverse Event|1|||
161845847|NCT00417170|584477094|FG001|Overall Study|Adverse Event|1|||
161845848|NCT00417170|584477093|FG000|Overall Study|Withdrawal by Subject|1|||
161845849|NCT00417170|584477094|FG001|Overall Study|Withdrawal by Subject|1|||
161845850|NCT00417170|584477093|FG000|Overall Study|Lost to Follow-up|0|||
161845851|NCT00417170|584477094|FG001|Overall Study|Lost to Follow-up|1|||
161845852|NCT04058067|584477095|FG000|Overall Study|Adverse Event|2|||
161845853|NCT04058067|584477096|FG001|Overall Study|Adverse Event|0|||
161845854|NCT04058067|584477095|FG000|Overall Study|Death|0|||
161845855|NCT04058067|584477096|FG001|Overall Study|Death|1|||
161845856|NCT04058067|584477095|FG000|Overall Study|Physician Decision|3|||
161845857|NCT04058067|584477096|FG001|Overall Study|Physician Decision|1|||
161845858|NCT04058067|584477095|FG000|Overall Study|Protocol Violation|0|||
161845859|NCT04058067|584477096|FG001|Overall Study|Protocol Violation|1|||
161845860|NCT04058067|584477095|FG000|Overall Study|Withdrawal by Subject|7|||
161845861|NCT04058067|584477096|FG001|Overall Study|Withdrawal by Subject|8|||
161845862|NCT01001988|584477099|FG000|Overall Study|Protocol Violation|84|||
161845863|NCT01001988|584477099|FG000|Overall Study|Withdrawal by Subject|18|||
161845864|NCT01001988|584477099|FG000|Overall Study|Lost to Follow-up|15|||
161845865|NCT01844856|584477100|FG000|Overall Study|Lost to Follow-up|15|||
161845866|NCT01844856|584477101|FG001|Overall Study|Lost to Follow-up|3|||
161845867|NCT01844856|584477100|FG000|Overall Study|Adverse Event|3|||
161845868|NCT01844856|584477101|FG001|Overall Study|Adverse Event|6|||
161970159|NCT01799239|584939240|FG000|Period 2 (7 Days)|Protocol Violation|1|||
161970160|NCT01799239|584939241|FG001|Period 2 (7 Days)|Protocol Violation|0|||
161970161|NCT04209114|584939242|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
161970162|NCT04209114|584939243|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
161845869|NCT01844856|584477100|FG000|Overall Study|Withdrawal by Subject|3|||
161845870|NCT01844856|584477101|FG001|Overall Study|Withdrawal by Subject|2|||
161845871|NCT01844856|584477100|FG000|Overall Study|Noncompliance|2|||
161845872|NCT01844856|584477101|FG001|Overall Study|Noncompliance|3|||
161845873|NCT01844856|584477100|FG000|Overall Study|Enterococcus Resistant|0|||
161845874|NCT01844856|584477101|FG001|Overall Study|Enterococcus Resistant|1|||
161845875|NCT01844856|584477100|FG000|Overall Study|Inadvertently Not Scheduled|1|||
161845876|NCT01844856|584477101|FG001|Overall Study|Inadvertently Not Scheduled|0|||
161970163|NCT04209114|584939244|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
161845877|NCT01844856|584477100|FG000|Overall Study|Randomized but was a Screen Failure|0|||
161845878|NCT01844856|584477101|FG001|Overall Study|Randomized but was a Screen Failure|1|||
161845879|NCT01221363|584477102|FG000|Overall Study|Pregnancy|1|||
161845880|NCT01221363|584477103|FG001|Overall Study|Pregnancy|0|||
161845881|NCT01221363|584477102|FG000|Overall Study|Withdrawal by Subject|11|||
161845882|NCT01221363|584477103|FG001|Overall Study|Withdrawal by Subject|5|||
161970164|NCT04209114|584939242|FG000|Pre-Treatment Phase|Other reasons|0|||
161845883|NCT04628793|584477104|FG000|Overall Study|Study terminated by sponsor|0|||
161845884|NCT04628793|584477105|FG001|Overall Study|Study terminated by sponsor|0|||
161845885|NCT04628793|584477106|FG002|Overall Study|Study terminated by sponsor|8|||
161845886|NCT04628793|584477104|FG000|Overall Study|Withdrawal by Subject|2|||
161845887|NCT04628793|584477105|FG001|Overall Study|Withdrawal by Subject|3|||
161845888|NCT04628793|584477106|FG002|Overall Study|Withdrawal by Subject|0|||
161757053|NCT03342404|584149636|FG001|Blinded Treatment Phase|Other reasons|0|||
161757054|NCT03342404|584149635|FG000|Blinded Treatment Phase|Physician Decision|1|||
161757055|NCT03342404|584149636|FG001|Blinded Treatment Phase|Physician Decision|0|||
161757056|NCT03342404|584149635|FG000|Blinded Treatment Phase|Death|1|||
161757057|NCT03342404|584149636|FG001|Blinded Treatment Phase|Death|0|||
161757058|NCT03342404|584149635|FG000|Open-Label Phase|Lost to Follow-up|0|||
161757059|NCT03342404|584149636|FG001|Open-Label Phase|Lost to Follow-up|1|||
161757060|NCT03342404|584149635|FG000|Open-Label Phase|Other reasons|0|||
161757061|NCT03342404|584149636|FG001|Open-Label Phase|Other reasons|1|||
161757062|NCT03342404|584149635|FG000|Open-Label Phase|Adverse Event|0|||
161757063|NCT03342404|584149636|FG001|Open-Label Phase|Adverse Event|3|||
161757064|NCT03342404|584149635|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161757065|NCT03342404|584149636|FG001|Open-Label Phase|Withdrawal by Subject|6|||
161757066|NCT00592072|584149637|FG000|Wash Out Period|Lost to Follow-up|1|||
161757067|NCT00592072|584149638|FG001|Wash Out Period|Lost to Follow-up|1|||
161757068|NCT05333289|584149639|FG000|Overall Study|Other|1|||
161757069|NCT05333289|584149640|FG001|Overall Study|Other|0|||
161757070|NCT05333289|584149641|FG002|Overall Study|Other|0|||
161757071|NCT05333289|584149642|FG003|Overall Study|Other|1|||
161757072|NCT05333289|584149643|FG004|Overall Study|Other|1|||
161757073|NCT05333289|584149644|FG005|Overall Study|Other|2|||
161757074|NCT05333289|584149645|FG006|Overall Study|Other|2|||
161757075|NCT05333289|584149646|FG007|Overall Study|Other|0|||
161757076|NCT05333289|584149639|FG000|Overall Study|Withdrawal by Subject|1|||
161757077|NCT05333289|584149640|FG001|Overall Study|Withdrawal by Subject|2|||
161757078|NCT05333289|584149641|FG002|Overall Study|Withdrawal by Subject|2|||
161757079|NCT05333289|584149642|FG003|Overall Study|Withdrawal by Subject|1|||
161757080|NCT05333289|584149643|FG004|Overall Study|Withdrawal by Subject|1|||
161757081|NCT05333289|584149644|FG005|Overall Study|Withdrawal by Subject|2|||
161757082|NCT05333289|584149645|FG006|Overall Study|Withdrawal by Subject|1|||
161757083|NCT05333289|584149646|FG007|Overall Study|Withdrawal by Subject|3|||
161757084|NCT05333289|584149639|FG000|Overall Study|Protocol Violation|1|||
161757085|NCT05333289|584149640|FG001|Overall Study|Protocol Violation|0|||
161757086|NCT05333289|584149641|FG002|Overall Study|Protocol Violation|0|||
161757087|NCT05333289|584149642|FG003|Overall Study|Protocol Violation|0|||
161757088|NCT05333289|584149643|FG004|Overall Study|Protocol Violation|0|||
161757089|NCT05333289|584149644|FG005|Overall Study|Protocol Violation|0|||
161757090|NCT05333289|584149645|FG006|Overall Study|Protocol Violation|0|||
161757091|NCT05333289|584149646|FG007|Overall Study|Protocol Violation|0|||
161757092|NCT05333289|584149639|FG000|Overall Study|Physician Decision|0|||
161757093|NCT05333289|584149640|FG001|Overall Study|Physician Decision|0|||
161757094|NCT05333289|584149641|FG002|Overall Study|Physician Decision|1|||
161757095|NCT05333289|584149642|FG003|Overall Study|Physician Decision|0|||
161757096|NCT05333289|584149643|FG004|Overall Study|Physician Decision|0|||
161757097|NCT05333289|584149644|FG005|Overall Study|Physician Decision|2|||
161757098|NCT05333289|584149645|FG006|Overall Study|Physician Decision|0|||
161757099|NCT05333289|584149646|FG007|Overall Study|Physician Decision|0|||
161757100|NCT05333289|584149639|FG000|Overall Study|Lost to Follow-up|6|||
161757101|NCT05333289|584149640|FG001|Overall Study|Lost to Follow-up|0|||
161757102|NCT05333289|584149641|FG002|Overall Study|Lost to Follow-up|1|||
161757103|NCT05333289|584149642|FG003|Overall Study|Lost to Follow-up|6|||
161757104|NCT05333289|584149643|FG004|Overall Study|Lost to Follow-up|3|||
161757105|NCT05333289|584149644|FG005|Overall Study|Lost to Follow-up|3|||
161757106|NCT05333289|584149645|FG006|Overall Study|Lost to Follow-up|2|||
161757107|NCT05333289|584149646|FG007|Overall Study|Lost to Follow-up|1|||
161757108|NCT05333289|584149639|FG000|Overall Study|Death|1|||
161757109|NCT05333289|584149640|FG001|Overall Study|Death|0|||
161757110|NCT05333289|584149641|FG002|Overall Study|Death|0|||
161757111|NCT05333289|584149642|FG003|Overall Study|Death|0|||
161757112|NCT05333289|584149643|FG004|Overall Study|Death|0|||
161757113|NCT05333289|584149644|FG005|Overall Study|Death|0|||
161757114|NCT05333289|584149645|FG006|Overall Study|Death|0|||
161757115|NCT05333289|584149646|FG007|Overall Study|Death|0|||
161757116|NCT00772889|584149650|FG000|Overall Study|Adverse Event|7|||
161757117|NCT00772889|584149651|FG001|Overall Study|Adverse Event|4|||
161757118|NCT00772889|584149652|FG002|Overall Study|Adverse Event|0|||
161757119|NCT00772889|584149650|FG000|Overall Study|Withdrawal by Subject|9|||
161757120|NCT00772889|584149651|FG001|Overall Study|Withdrawal by Subject|8|||
161757121|NCT00772889|584149652|FG002|Overall Study|Withdrawal by Subject|9|||
161757122|NCT00772889|584149650|FG000|Overall Study|Lost to Follow-up|6|||
161757123|NCT00772889|584149651|FG001|Overall Study|Lost to Follow-up|6|||
161757124|NCT00772889|584149652|FG002|Overall Study|Lost to Follow-up|7|||
161757125|NCT00403390|584149654|FG000|Overall Study|Withdrawal by Subject|1|||
161757126|NCT00403390|584149655|FG001|Overall Study|Withdrawal by Subject|0|||
161757127|NCT00403390|584149654|FG000|Overall Study|samples lost|1|||
161757128|NCT00403390|584149655|FG001|Overall Study|samples lost|0|||
161757129|NCT00403390|584149654|FG000|Overall Study|non-compliant|1|||
161757130|NCT00403390|584149655|FG001|Overall Study|non-compliant|0|||
161757131|NCT01878175|584149656|FG000|Overall Study|Developed contraindicated health problem|2|||
161757132|NCT01796106|584149657|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
161757133|NCT01796106|584149658|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
161757134|NCT01249157|584149661|FG000|Overall Study|Withdrawal by Subject|1|||
161757135|NCT03796195|584149662|FG000|Overall Study|Study closed early|1|||
161757136|NCT04445051|584149663|FG000|Overall Study|Adverse Event|0|||
161757137|NCT04445051|584149664|FG001|Overall Study|Adverse Event|0|||
161757138|NCT04445051|584149665|FG002|Overall Study|Adverse Event|1|||
161757139|NCT04445051|584149666|FG003|Overall Study|Adverse Event|0|||
161757140|NCT04445051|584149667|FG004|Overall Study|Adverse Event|0|||
161757141|NCT04445051|584149668|FG005|Overall Study|Adverse Event|0|||
161757142|NCT02392468|584149671|FG000|Overall Study|Adverse Event|0|||
161757143|NCT02392468|584149672|FG001|Overall Study|Adverse Event|1|||
161757144|NCT02392468|584149673|FG002|Overall Study|Adverse Event|0|||
161757145|NCT02392468|584149674|FG003|Overall Study|Adverse Event|0|||
161757146|NCT02392468|584149675|FG004|Overall Study|Adverse Event|0|||
161757147|NCT02392468|584149676|FG005|Overall Study|Adverse Event|1|||
161757148|NCT01039428|584149677|FG000|Overall Study|Protocol Violation|1|||
161757149|NCT01039428|584149678|FG001|Overall Study|Protocol Violation|0|||
161757150|NCT01039428|584149677|FG000|Overall Study|Withdrawal by Subject|1|||
161757151|NCT01039428|584149678|FG001|Overall Study|Withdrawal by Subject|0|||
161757152|NCT01313039|584149679|FG000|Overall Study|Physician Decision|1|||
161757153|NCT01313039|584149679|FG000|Overall Study|Adverse Event|1|||
161757154|NCT03630016|584149680|FG000|Overall Study|Poor Sensor Placement|1|||
161757155|NCT05083949|584149681|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
161757156|NCT05083949|584149682|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
161757157|NCT05083949|584149681|FG000|Period 1|Adverse Event|1|||
161757158|NCT05083949|584149682|FG001|Period 1|Adverse Event|1|||
161757159|NCT05083949|584149681|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
161757160|NCT05083949|584149682|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
161757161|NCT05083949|584149681|FG000|Period 2|Adverse Event|0|||
161757162|NCT05083949|584149682|FG001|Period 2|Adverse Event|2|||
161757163|NCT02470429|584149683|FG000|Overall Study|Adverse Event|1|||
161757164|NCT02470429|584149684|FG001|Overall Study|Adverse Event|0|||
161757165|NCT02470429|584149683|FG000|Overall Study|Withdrawal by Subject|1|||
161757166|NCT02470429|584149684|FG001|Overall Study|Withdrawal by Subject|0|||
161757167|NCT01976624|584149685|FG000|Overall Study|Participants contraindicated|2|||
161757168|NCT01976624|584149685|FG000|Overall Study|Participants age less than 19 years|12|||
161757169|NCT01316380|584149686|FG000|Overall Study|Adverse Event|0|||
161757170|NCT01316380|584149687|FG001|Overall Study|Adverse Event|2|||
161757171|NCT01316380|584149688|FG002|Overall Study|Adverse Event|1|||
161757172|NCT01316380|584149686|FG000|Overall Study|Protocol Violation|0|||
161757173|NCT01316380|584149687|FG001|Overall Study|Protocol Violation|0|||
161757174|NCT01316380|584149688|FG002|Overall Study|Protocol Violation|1|||
161757175|NCT01316380|584149686|FG000|Overall Study|Withdrawal by Subject|1|||
161757176|NCT01316380|584149687|FG001|Overall Study|Withdrawal by Subject|2|||
161757177|NCT01316380|584149688|FG002|Overall Study|Withdrawal by Subject|0|||
161757178|NCT01316380|584149686|FG000|Overall Study|Other|0|||
161757179|NCT01316380|584149687|FG001|Overall Study|Other|1|||
161757180|NCT01316380|584149688|FG002|Overall Study|Other|1|||
161757181|NCT01316380|584149686|FG000|Overall Study|Not treated|1|||
161757182|NCT01316380|584149687|FG001|Overall Study|Not treated|0|||
161757183|NCT01316380|584149688|FG002|Overall Study|Not treated|0|||
161757184|NCT00471315|584149690|FG000|Overall Study|Adverse Event|7|||
161757185|NCT00471315|584149690|FG000|Overall Study|Withdrawal by Subject|1|||
161757186|NCT02574520|584149694|FG000|Overall Study|Not dosed|2|||
161757187|NCT02574520|584149695|FG001|Overall Study|Not dosed|0|||
161757188|NCT02574520|584149696|FG002|Overall Study|Not dosed|5|||
161757189|NCT02574520|584149697|FG003|Overall Study|Not dosed|4|||
161757190|NCT02574520|584149694|FG000|Overall Study|Adverse Event|0|||
161757191|NCT02574520|584149695|FG001|Overall Study|Adverse Event|0|||
161757192|NCT02574520|584149696|FG002|Overall Study|Adverse Event|0|||
161757193|NCT02574520|584149697|FG003|Overall Study|Adverse Event|1|||
161757194|NCT02574520|584149694|FG000|Overall Study|Withdrawal by Subject|0|||
161845889|NCT04628793|584477104|FG000|Overall Study|Lost to Follow-up|0|||
161845890|NCT04628793|584477105|FG001|Overall Study|Lost to Follow-up|1|||
161757195|NCT02574520|584149695|FG001|Overall Study|Withdrawal by Subject|0|||
161757196|NCT02574520|584149696|FG002|Overall Study|Withdrawal by Subject|0|||
161757197|NCT02574520|584149697|FG003|Overall Study|Withdrawal by Subject|1|||
161757198|NCT02574520|584149694|FG000|Overall Study|Other|0|||
161757199|NCT02574520|584149695|FG001|Overall Study|Other|0|||
161757200|NCT02574520|584149696|FG002|Overall Study|Other|0|||
161757201|NCT02574520|584149697|FG003|Overall Study|Other|2|||
161757202|NCT01365091|584149700|FG000|Period 1|Adverse Event|1|||
161970165|NCT04209114|584939243|FG001|Pre-Treatment Phase|Other reasons|0|||
161757203|NCT01365091|584149701|FG001|Period 1|Adverse Event|0|||
161757204|NCT01365091|584149702|FG002|Period 1|Adverse Event|2|||
161757205|NCT01365091|584149703|FG003|Period 1|Adverse Event|3|||
161757206|NCT01365091|584149700|FG000|Period 1|Positive test result for drugs of abuse|1|||
161757207|NCT01365091|584149701|FG001|Period 1|Positive test result for drugs of abuse|0|||
161757208|NCT01365091|584149702|FG002|Period 1|Positive test result for drugs of abuse|0|||
161757209|NCT01365091|584149703|FG003|Period 1|Positive test result for drugs of abuse|0|||
161757210|NCT01365091|584149700|FG000|Period 1|No longer met study criteria|0|||
161757211|NCT01365091|584149701|FG001|Period 1|No longer met study criteria|1|||
161757212|NCT01365091|584149702|FG002|Period 1|No longer met study criteria|0|||
161757213|NCT01365091|584149703|FG003|Period 1|No longer met study criteria|0|||
161757214|NCT01365091|584149700|FG000|Period 1|Withdrawal by Subject|0|||
161757215|NCT01365091|584149701|FG001|Period 1|Withdrawal by Subject|1|||
161757216|NCT01365091|584149702|FG002|Period 1|Withdrawal by Subject|0|||
161757217|NCT01365091|584149703|FG003|Period 1|Withdrawal by Subject|0|||
161757218|NCT01365091|584149700|FG000|Period 1|Personal reasons|0|||
161757219|NCT01365091|584149701|FG001|Period 1|Personal reasons|0|||
161757220|NCT01365091|584149702|FG002|Period 1|Personal reasons|1|||
161757221|NCT01365091|584149703|FG003|Period 1|Personal reasons|0|||
161757222|NCT01365091|584149700|FG000|Period 2|Withdrawal by Subject|1|||
161757223|NCT01365091|584149701|FG001|Period 2|Withdrawal by Subject|0|||
161757224|NCT01365091|584149702|FG002|Period 2|Withdrawal by Subject|0|||
161757225|NCT01365091|584149703|FG003|Period 2|Withdrawal by Subject|0|||
161757226|NCT01365091|584149700|FG000|Period 2|Adverse Event|0|||
161757227|NCT01365091|584149701|FG001|Period 2|Adverse Event|0|||
161757228|NCT01365091|584149702|FG002|Period 2|Adverse Event|1|||
161757229|NCT01365091|584149703|FG003|Period 2|Adverse Event|0|||
161757230|NCT05307523|584149705|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
161757231|NCT05307523|584149706|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
161757232|NCT05307523|584149705|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
161757233|NCT05307523|584149706|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
161757234|NCT05116683|584149708|FG000|Overall Study|Physician Decision|4|||
161757235|NCT00683774|584149719|FG000|Overall Study|Withdrawal by Subject|0|||
161757236|NCT00683774|584149720|FG001|Overall Study|Withdrawal by Subject|1|||
161757237|NCT00683774|584149719|FG000|Overall Study|Physician Decision|3|||
161757238|NCT00683774|584149720|FG001|Overall Study|Physician Decision|0|||
161757239|NCT02875366|584149721|FG000|Overall Study|Adverse Event|0|||
161757240|NCT02875366|584149722|FG001|Overall Study|Adverse Event|2|||
161757241|NCT02875366|584149721|FG000|Overall Study|Noncompliance|0|||
161757242|NCT02875366|584149722|FG001|Overall Study|Noncompliance|1|||
161757243|NCT03595176|584149723|FG000|Overall Study|Death|0|||
161757244|NCT03595176|584149724|FG001|Overall Study|Death|2|||
161757245|NCT03595176|584149723|FG000|Overall Study|Lost to Follow-up|0|||
161757246|NCT03595176|584149724|FG001|Overall Study|Lost to Follow-up|1|||
161757247|NCT02735044|584149726|FG000|Overall Study|Adverse Event|3|||
161757248|NCT02735044|584149727|FG001|Overall Study|Adverse Event|3|||
161757249|NCT02735044|584149726|FG000|Overall Study|Lack of Efficacy|1|||
161757250|NCT02735044|584149727|FG001|Overall Study|Lack of Efficacy|0|||
161757251|NCT02735044|584149726|FG000|Overall Study|Poor compliance to protocol|7|||
161757252|NCT02735044|584149727|FG001|Overall Study|Poor compliance to protocol|7|||
161757253|NCT02735044|584149726|FG000|Overall Study|Randomized and not treated|0|||
161757254|NCT02735044|584149727|FG001|Overall Study|Randomized and not treated|2|||
161757255|NCT02735044|584149726|FG000|Overall Study|Other, not specified above|5|||
161757256|NCT02735044|584149727|FG001|Overall Study|Other, not specified above|11|||
161757257|NCT01682759|584149729|FG000|Overall Study|Death|2|||
161757258|NCT01682759|584149730|FG001|Overall Study|Death|1|||
161757259|NCT01682759|584149729|FG000|Overall Study|Lost to Follow-up|10|||
161757260|NCT01682759|584149730|FG001|Overall Study|Lost to Follow-up|13|||
161757261|NCT01682759|584149729|FG000|Overall Study|Physician Decision|1|||
161757262|NCT01682759|584149730|FG001|Overall Study|Physician Decision|1|||
161970166|NCT04209114|584939244|FG002|Pre-Treatment Phase|Other reasons|1|||
161970167|NCT04209114|584939242|FG000|Pre-Treatment Phase|Death|0|||
161757263|NCT01682759|584149729|FG000|Overall Study|Withdrawal by Subject|56|||
161757264|NCT01682759|584149730|FG001|Overall Study|Withdrawal by Subject|55|||
161757265|NCT00412113|584149731|FG000|Overall Study|Adverse Event|11|||
161757266|NCT00412113|584149732|FG001|Overall Study|Adverse Event|15|||
161757267|NCT00412113|584149731|FG000|Overall Study|did not receive treatment|1|||
161757268|NCT00412113|584149732|FG001|Overall Study|did not receive treatment|0|||
161757269|NCT01201967|584149733|FG000|Overall Study|Lost to Follow-up|6|||
161757270|NCT01201967|584149734|FG001|Overall Study|Lost to Follow-up|5|||
161757271|NCT01226472|584149735|FG000|Overall Study|Progressive Disease|1|||
161757272|NCT00740116|584151585|FG000|Overall Study|Withdrawal by Subject|1|||
161757273|NCT00740116|584151586|FG001|Overall Study|Withdrawal by Subject|1|||
161757274|NCT00740116|584151585|FG000|Overall Study|Protocol Violation|1|||
161757275|NCT00740116|584151586|FG001|Overall Study|Protocol Violation|4|||
161757276|NCT00621764|584151587|FG000|Overall Study|Protocol Violation|0|||
161757277|NCT00621764|584151588|FG001|Overall Study|Protocol Violation|0|||
161757278|NCT00621764|584151589|FG002|Overall Study|Protocol Violation|0|||
161757279|NCT00621764|584151590|FG003|Overall Study|Protocol Violation|1|||
161845891|NCT04628793|584477106|FG002|Overall Study|Lost to Follow-up|0|||
161845892|NCT01329549|584477113|FG000|Overall Study|Withdrawal by Subject|1|||
161845893|NCT01329549|584477113|FG000|Overall Study|Adverse Event|1|||
161845894|NCT01756079|584477114|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
161845895|NCT01756079|584477114|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
161845896|NCT01756079|584477114|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
161845897|NCT01756079|584477114|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
161845898|NCT01756079|584477114|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
161845899|NCT02677714|584477115|FG000|Overall Study|Withdrawal by Subject|2|||
161845900|NCT02677714|584477116|FG001|Overall Study|Withdrawal by Subject|0|||
161845901|NCT03421730|584477117|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845902|NCT03421730|584477118|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
161845903|NCT03421730|584477119|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845904|NCT03421730|584477120|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845905|NCT03421730|584477121|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845906|NCT03421730|584477122|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845907|NCT03421730|584477123|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845908|NCT03421730|584477124|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845909|NCT03421730|584477125|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845910|NCT03421730|584477126|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845911|NCT03421730|584477127|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845912|NCT03421730|584477128|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161845913|NCT03421730|584477117|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845914|NCT03421730|584477118|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845915|NCT03421730|584477119|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845916|NCT03421730|584477120|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845917|NCT03421730|584477121|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
161845918|NCT03421730|584477122|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845919|NCT03421730|584477123|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845920|NCT03421730|584477124|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845921|NCT03421730|584477125|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845922|NCT03421730|584477126|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845923|NCT03421730|584477127|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845924|NCT03421730|584477128|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161845925|NCT01661062|584477137|FG000|Overall Study|Completed Treatment Off Study|3|||
161845926|NCT01661062|584477137|FG000|Overall Study|Withdrawal by Subject|2|||
161845927|NCT02387983|584477139|FG000|Overall Study|Adverse Event|4|||
161845928|NCT02387983|584477139|FG000|Overall Study|Protocol Violation|1|||
161845929|NCT02387983|584477139|FG000|Overall Study|Withdrawal by Subject|2|||
161845930|NCT02730351|584477140|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
161845931|NCT02730351|584477141|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
161845932|NCT02730351|584477140|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
161845933|NCT02730351|584477141|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
161845934|NCT02730351|584477140|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
161845935|NCT02730351|584477141|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
161845936|NCT02730351|584477140|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
161845937|NCT02730351|584477141|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
161845938|NCT02730351|584477140|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
161845939|NCT02730351|584477141|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
161845940|NCT00530218|584477142|FG000|Overall Study|CMV Not Detected|13|||
161845941|NCT00530218|584477142|FG000|Overall Study|Death|12|||
161845942|NCT06281171|584477147|FG000|Timepoint 2|Lost to Follow-up|6|||
161845943|NCT06281171|584477148|FG001|Timepoint 2|Lost to Follow-up|4|||
161845944|NCT06281171|584477147|FG000|Timepoint 3|Lost to Follow-up|0|||
161970168|NCT04209114|584939243|FG001|Pre-Treatment Phase|Death|0|||
161970169|NCT04209114|584939244|FG002|Pre-Treatment Phase|Death|1|||
161970170|NCT04209114|584939242|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
161970171|NCT04209114|584939243|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
161970172|NCT04209114|584939244|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
161970173|NCT04209114|584939242|FG000|Treatment Phase|Other reasons|5|||
161970174|NCT04209114|584939243|FG001|Treatment Phase|Other reasons|3|||
161970175|NCT04209114|584939244|FG002|Treatment Phase|Other reasons|0|||
161970176|NCT04209114|584939242|FG000|Treatment Phase|Lost to Follow-up|1|||
161970177|NCT04209114|584939243|FG001|Treatment Phase|Lost to Follow-up|0|||
161970178|NCT04209114|584939244|FG002|Treatment Phase|Lost to Follow-up|0|||
161970179|NCT04209114|584939242|FG000|Treatment Phase|Participant withdrew consent|1|||
161970180|NCT04209114|584939243|FG001|Treatment Phase|Participant withdrew consent|0|||
161970181|NCT04209114|584939244|FG002|Treatment Phase|Participant withdrew consent|0|||
161970182|NCT04209114|584939242|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
161970183|NCT04209114|584939243|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
161970184|NCT04209114|584939244|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
161970185|NCT04209114|584939242|FG000|Treatment Phase|Death|4|||
161970186|NCT04209114|584939243|FG001|Treatment Phase|Death|1|||
161970187|NCT04209114|584939244|FG002|Treatment Phase|Death|0|||
161970188|NCT04209114|584939242|FG000|Treatment Phase|Study drug toxicity|4|||
161970189|NCT04209114|584939243|FG001|Treatment Phase|Study drug toxicity|6|||
161970190|NCT04209114|584939244|FG002|Treatment Phase|Study drug toxicity|0|||
161970191|NCT04209114|584939242|FG000|Treatment Phase|Disease progression|6|||
161970192|NCT04209114|584939243|FG001|Treatment Phase|Disease progression|9|||
161970193|NCT04209114|584939244|FG002|Treatment Phase|Disease progression|0|||
161757280|NCT02499172|584151591|FG000|Overall Study|Financial reason|0|||
161757281|NCT02499172|584151592|FG001|Overall Study|Financial reason|0|||
161757282|NCT02499172|584151593|FG002|Overall Study|Financial reason|523|||
161757283|NCT02499172|584151594|FG003|Overall Study|Financial reason|436|||
161757284|NCT02499172|584151591|FG000|Overall Study|Lost to Follow-up|65|||
161757285|NCT02499172|584151592|FG001|Overall Study|Lost to Follow-up|64|||
161757286|NCT02499172|584151593|FG002|Overall Study|Lost to Follow-up|0|||
161757287|NCT02499172|584151594|FG003|Overall Study|Lost to Follow-up|0|||
161757288|NCT01293123|584151595|FG000|Overall Study|Lost to Follow-up|0|||
161757289|NCT01293123|584151596|FG001|Overall Study|Lost to Follow-up|1|||
161757290|NCT01888965|584151606|FG000|Overall Study|Adverse Event|5|||
161757291|NCT01888965|584151606|FG000|Overall Study|Lack of Efficacy|4|||
161757292|NCT04076579|584151607|FG000|Overall Study|Adverse Event|2|||
161757293|NCT04076579|584151608|FG001|Overall Study|Adverse Event|0|||
161757294|NCT04076579|584151607|FG000|Overall Study|discontinued due to toxicity|1|||
161757295|NCT04076579|584151608|FG001|Overall Study|discontinued due to toxicity|0|||
161757296|NCT04076579|584151607|FG000|Overall Study|Physician Decision|1|||
161757297|NCT04076579|584151608|FG001|Overall Study|Physician Decision|0|||
161757298|NCT04076579|584151607|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
161757299|NCT04076579|584151608|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
161757300|NCT04076579|584151607|FG000|Overall Study|Noncompliance|0|||
161757301|NCT04076579|584151608|FG001|Overall Study|Noncompliance|1|||
161757302|NCT04076579|584151607|FG000|Overall Study|Withdrawal by Subject|0|||
161757303|NCT04076579|584151608|FG001|Overall Study|Withdrawal by Subject|2|||
161757304|NCT00186121|584151609|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
161757305|NCT00186121|584151609|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
161757306|NCT00186121|584151609|FG000|Overall Study|Not eligible (no treatment)|1|||
161757307|NCT03650387|584151610|FG000|Overall Study|Withdrawal by Subject|13|||
161757308|NCT03650387|584151610|FG000|Overall Study|Lost to Follow-up|12|||
161757309|NCT03650387|584151610|FG000|Overall Study|Adverse Event (Not related)|1|||
161757310|NCT03650387|584151610|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
161757311|NCT00417248|584151611|FG000|Overall Study|Study Terminated|6|||
161757312|NCT00417248|584151611|FG000|Overall Study|Death|1|||
161757313|NCT00417248|584151611|FG000|Overall Study|Lack of Efficacy|1|||
161757314|NCT05815758|584151612|FG000|Overall Study|Adverse Event|6|||
161757315|NCT05815758|584151613|FG001|Overall Study|Adverse Event|2|||
161757316|NCT05815758|584151612|FG000|Overall Study|Lost to Follow-up|14|||
161757317|NCT05815758|584151613|FG001|Overall Study|Lost to Follow-up|1|||
161757318|NCT05815758|584151612|FG000|Overall Study|Withdrawal by Subject|6|||
161757319|NCT05815758|584151613|FG001|Overall Study|Withdrawal by Subject|6|||
161757320|NCT05815758|584151612|FG000|Overall Study|Protocol Violation|1|||
161757321|NCT05815758|584151613|FG001|Overall Study|Protocol Violation|1|||
161757322|NCT05815758|584151612|FG000|Overall Study|Discontinued|4|||
161757323|NCT05815758|584151613|FG001|Overall Study|Discontinued|4|||
161757324|NCT03661983|584151614|FG000|Open Label Stabilization Phase|Adverse Event|5|||
161757325|NCT03661983|584151615|FG001|Open Label Stabilization Phase|Adverse Event|0|||
161757326|NCT03661983|584151616|FG002|Open Label Stabilization Phase|Adverse Event|0|||
161757327|NCT03661983|584151617|FG003|Open Label Stabilization Phase|Adverse Event|0|||
161757328|NCT03661983|584151614|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
161757329|NCT03661983|584151615|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
161757330|NCT03661983|584151616|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
161757331|NCT03661983|584151617|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
161757332|NCT03661983|584151614|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
161757333|NCT03661983|584151615|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
161757334|NCT03661983|584151616|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
161757335|NCT03661983|584151617|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
161757336|NCT03661983|584151614|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
161757337|NCT03661983|584151615|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
161845945|NCT06281171|584477148|FG001|Timepoint 3|Lost to Follow-up|5|||
161970194|NCT01444027|584939257|FG000|Overall Study|Withdrawal by Subject|4|||
161970195|NCT01444027|584939258|FG001|Overall Study|Withdrawal by Subject|10|||
161845946|NCT01822275|584477149|FG000|Overall Study|Withdrawal by Subject|3|||
161845947|NCT01822275|584477149|FG000|Overall Study|Adverse Event|3|||
161845948|NCT01822275|584477149|FG000|Overall Study|Progression|14|||
161845949|NCT01822275|584477149|FG000|Overall Study|Physician Decision|2|||
161845950|NCT00513682|584477150|FG000|Washout Phase|Adverse Event|2|||
161845951|NCT03276780|584477151|FG000|Overall Study|Withdrawal by Subject|5|||
161845952|NCT03276780|584477152|FG001|Overall Study|Withdrawal by Subject|3|||
161845953|NCT03276780|584477151|FG000|Overall Study|Lost to Follow-up|3|||
161845954|NCT03276780|584477152|FG001|Overall Study|Lost to Follow-up|5|||
161845955|NCT03276780|584477151|FG000|Overall Study|Moved out of state|1|||
161845956|NCT03276780|584477152|FG001|Overall Study|Moved out of state|1|||
161845957|NCT03276780|584477151|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
161845958|NCT03276780|584477152|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
161845959|NCT03276780|584477151|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
161845960|NCT03276780|584477152|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
161845961|NCT00510289|584477153|FG000|Overall Study|Withdrawal by Subject|7|||
161845962|NCT00510289|584477153|FG000|Overall Study|Refused bone marrow biopsy|2|||
161845963|NCT00510289|584477153|FG000|Overall Study|Lost to Follow-up|1|||
161845964|NCT00510289|584477153|FG000|Overall Study|Progressed prior to starting drug|2|||
161845965|NCT03258853|584477158|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
161845966|NCT03258853|584477159|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
161845967|NCT04241315|584478924|FG000|Overall Study|Withdrawal by Subject|0|||
161845968|NCT04241315|584478925|FG001|Overall Study|Withdrawal by Subject|1|||
161845969|NCT03047330|584478926|FG000|Sleep Block 1|Withdrawal by Subject|3|||
161845970|NCT00663026|584478933|FG000|Overall Study|Lost to Follow-up|1|||
161845971|NCT00663026|584478934|FG001|Overall Study|Lost to Follow-up|0|||
161845972|NCT00663026|584478935|FG002|Overall Study|Lost to Follow-up|0|||
161845973|NCT00663026|584478933|FG000|Overall Study|Other|1|||
161845974|NCT00663026|584478934|FG001|Overall Study|Other|2|||
161845975|NCT00663026|584478935|FG002|Overall Study|Other|0|||
161845976|NCT00663026|584478933|FG000|Overall Study|Adverse Event|0|||
161845977|NCT00663026|584478934|FG001|Overall Study|Adverse Event|2|||
161845978|NCT00663026|584478935|FG002|Overall Study|Adverse Event|3|||
161845979|NCT00663026|584478933|FG000|Overall Study|Caregiver Request|0|||
161845980|NCT00663026|584478934|FG001|Overall Study|Caregiver Request|2|||
161845981|NCT00663026|584478935|FG002|Overall Study|Caregiver Request|0|||
161845982|NCT00663026|584478933|FG000|Overall Study|Withdrawal by Subject|0|||
161845983|NCT00663026|584478934|FG001|Overall Study|Withdrawal by Subject|0|||
161845984|NCT00663026|584478935|FG002|Overall Study|Withdrawal by Subject|1|||
161845985|NCT01392963|584478939|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
161845986|NCT01392963|584478940|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
161845987|NCT01392963|584478939|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
161845988|NCT01392963|584478940|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
161845989|NCT01392963|584478939|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
161845990|NCT01392963|584478940|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
161845991|NCT01735955|584478941|FG000|Overall Study|Administrative problems|1|||
161845992|NCT01735955|584478941|FG000|Overall Study|Patient/guardian decision|1|||
161845993|NCT01735955|584478941|FG000|Overall Study|Patient withdrew consent|2|||
161845994|NCT01735955|584478941|FG000|Overall Study|Physician Decision|4|||
161845995|NCT01735955|584478941|FG000|Overall Study|Disease progression|24|||
161845996|NCT01735955|584478941|FG000|Overall Study|Adverse Event|5|||
161845997|NCT01475097|584478942|FG000|Overall Study|Protocol Violation|1|||
161845998|NCT01475097|584478943|FG001|Overall Study|Protocol Violation|1|||
161845999|NCT01305044|584478944|FG000|Overall Study|Withdrawal by Subject|3|||
161846000|NCT01305044|584478945|FG001|Overall Study|Withdrawal by Subject|6|||
161846001|NCT00492024|584478946|FG000|Treatment|Adverse Event|3|||
161757338|NCT03661983|584151616|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
161757339|NCT03661983|584151617|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
161757340|NCT03661983|584151614|FG000|Double-blind Randomized Phase|Adverse Event|0|||
161757341|NCT03661983|584151615|FG001|Double-blind Randomized Phase|Adverse Event|1|||
161757342|NCT03661983|584151616|FG002|Double-blind Randomized Phase|Adverse Event|0|||
161757343|NCT03661983|584151617|FG003|Double-blind Randomized Phase|Adverse Event|0|||
161757344|NCT03661983|584151614|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
161757345|NCT03661983|584151615|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
161757346|NCT03661983|584151616|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
161757347|NCT03661983|584151617|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
161846002|NCT00492024|584478947|FG001|Treatment|Adverse Event|1|||
161846003|NCT00492024|584478946|FG000|Treatment|Lack of Efficacy|21|||
161846004|NCT00492024|584478947|FG001|Treatment|Lack of Efficacy|20|||
161846005|NCT00492024|584478946|FG000|Treatment|Lost to Follow-up|3|||
161846006|NCT00492024|584478947|FG001|Treatment|Lost to Follow-up|1|||
161846007|NCT00492024|584478946|FG000|Treatment|Withdrawal by Subject|2|||
161846008|NCT00492024|584478947|FG001|Treatment|Withdrawal by Subject|0|||
161846009|NCT00492024|584478946|FG000|Follow up|Lack of Efficacy|0|||
161846010|NCT00492024|584478947|FG001|Follow up|Lack of Efficacy|1|||
161846011|NCT00492024|584478946|FG000|Follow up|Lost to Follow-up|1|||
161846012|NCT00492024|584478947|FG001|Follow up|Lost to Follow-up|1|||
161846013|NCT03247816|584478948|FG000|Overall Study|Adverse Event|12|||
161846014|NCT03247816|584478948|FG000|Overall Study|Physician Decision|3|||
161846015|NCT03247816|584478948|FG000|Overall Study|Lack of Efficacy|1|||
161846016|NCT03247816|584478948|FG000|Overall Study|Lost to Follow-up|10|||
161846017|NCT03247816|584478948|FG000|Overall Study|Missing Feraccru stop date|3|||
161846018|NCT02861014|584478949|FG000|Primary Analysis|Adverse Event|7|||
161846019|NCT02861014|584478949|FG000|Primary Analysis|Death|1|||
161846020|NCT02861014|584478949|FG000|Primary Analysis|Lack of Efficacy|3|||
161846021|NCT02861014|584478949|FG000|Primary Analysis|Physician Decision|2|||
161846022|NCT02861014|584478949|FG000|Primary Analysis|Pregnancy|4|||
161846023|NCT02861014|584478949|FG000|Primary Analysis|Protocol Violation|2|||
161846024|NCT02861014|584478949|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
161846025|NCT02861014|584478949|FG000|Primary Analysis|Withdrawal by Subject|14|||
161846026|NCT02861014|584478949|FG000|Primary Analysis|Commercial ocrelizumab|3|||
161846027|NCT02861014|584478949|FG000|Safety Follow-up|Adverse Event|1|||
161846028|NCT02861014|584478949|FG000|Safety Follow-up|Pregnancy|1|||
161846029|NCT02861014|584478949|FG000|Safety Follow-up|Withdrawal by Subject|9|||
161846030|NCT02861014|584478949|FG000|Safety Follow-up|Study terminated by sponsor|1|||
161846031|NCT02861014|584478949|FG000|Safety Follow-up|Physician Decision|1|||
161846032|NCT02861014|584478949|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
161846033|NCT02861014|584478949|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
161846034|NCT00926783|584478952|FG000|Overall Study|Incomplete CFAE Procedures|3|||
161846035|NCT00926783|584478953|FG001|Overall Study|Incomplete CFAE Procedures|3|||
161846036|NCT01439009|584478954|FG000|Overall Study|Physician Decision|5|||
161846037|NCT01439009|584478955|FG001|Overall Study|Physician Decision|3|||
161846038|NCT01439009|584478954|FG000|Overall Study|Protocol Violation|2|||
161846039|NCT01439009|584478955|FG001|Overall Study|Protocol Violation|0|||
161846040|NCT01439009|584478954|FG000|Overall Study|Deviation of exclusion criteria|1|||
161846041|NCT01439009|584478955|FG001|Overall Study|Deviation of exclusion criteria|0|||
161846042|NCT00696787|584478957|FG000|Overall Study|Adverse Event|1|||
161846043|NCT00696787|584478958|FG001|Overall Study|Adverse Event|0|||
161846044|NCT00696787|584478959|FG002|Overall Study|Adverse Event|6|||
161846045|NCT00696787|584478957|FG000|Overall Study|Discontinuation by Sponsor|9|||
161846046|NCT00696787|584478958|FG001|Overall Study|Discontinuation by Sponsor|13|||
161846047|NCT00696787|584478959|FG002|Overall Study|Discontinuation by Sponsor|14|||
161846048|NCT00696787|584478957|FG000|Overall Study|Lack of Efficacy|0|||
161846049|NCT00696787|584478958|FG001|Overall Study|Lack of Efficacy|1|||
161846050|NCT00696787|584478959|FG002|Overall Study|Lack of Efficacy|0|||
161846051|NCT00696787|584478957|FG000|Overall Study|Lost to Follow-up|4|||
161846052|NCT00696787|584478958|FG001|Overall Study|Lost to Follow-up|0|||
161846053|NCT00696787|584478959|FG002|Overall Study|Lost to Follow-up|3|||
161846054|NCT00696787|584478957|FG000|Overall Study|Withdrawal by Subject|0|||
161846055|NCT00696787|584478958|FG001|Overall Study|Withdrawal by Subject|3|||
161846056|NCT00696787|584478959|FG002|Overall Study|Withdrawal by Subject|2|||
161846057|NCT00696787|584478957|FG000|Overall Study|Failed to return|1|||
161846058|NCT00696787|584478958|FG001|Overall Study|Failed to return|3|||
161846059|NCT00696787|584478959|FG002|Overall Study|Failed to return|1|||
161846060|NCT00867503|584478961|FG000|Overall Study|Withdrawal by Subject|1|||
161846061|NCT02704403|584478962|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
161846062|NCT02704403|584478963|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
161846063|NCT02704403|584478962|FG000|Overall Study|Administrative reasons by sponsor|1251|||
161846064|NCT02704403|584478963|FG001|Overall Study|Administrative reasons by sponsor|616|||
161846065|NCT02704403|584478962|FG000|Overall Study|Death|4|||
161846066|NCT02704403|584478963|FG001|Overall Study|Death|3|||
161846067|NCT02704403|584478962|FG000|Overall Study|Endpoint event|52|||
161846068|NCT02704403|584478963|FG001|Overall Study|Endpoint event|24|||
161846069|NCT02704403|584478962|FG000|Overall Study|Lost to Follow-up|22|||
161846070|NCT02704403|584478963|FG001|Overall Study|Lost to Follow-up|11|||
161846071|NCT02704403|584478962|FG000|Overall Study|Protocol Violation|15|||
161846072|NCT02704403|584478963|FG001|Overall Study|Protocol Violation|15|||
161846073|NCT02704403|584478962|FG000|Overall Study|Adverse Event|2|||
161970196|NCT01444027|584939259|FG002|Overall Study|Withdrawal by Subject|24|||
161970197|NCT01444027|584939257|FG000|Overall Study|Lost to Follow-up|26|||
161970198|NCT01444027|584939258|FG001|Overall Study|Lost to Follow-up|20|||
161846074|NCT02704403|584478963|FG001|Overall Study|Adverse Event|0|||
161846075|NCT02704403|584478962|FG000|Overall Study|Withdrawal by Subject|85|||
161846076|NCT02704403|584478963|FG001|Overall Study|Withdrawal by Subject|45|||
161846077|NCT02704403|584478962|FG000|Overall Study|Investigator decision|1|||
161846078|NCT02704403|584478963|FG001|Overall Study|Investigator decision|1|||
161846079|NCT02704403|584478962|FG000|Overall Study|Follow-up not possible|1|||
161846080|NCT02704403|584478963|FG001|Overall Study|Follow-up not possible|2|||
161970199|NCT01444027|584939259|FG002|Overall Study|Lost to Follow-up|14|||
161846081|NCT00927394|584478972|FG000|Overall Study|Adverse Event|14|||
161846082|NCT00927394|584478973|FG001|Overall Study|Adverse Event|9|||
161970200|NCT03966885|584940911|FG000|Overall Study|Death|1|||
161970201|NCT03966885|584940912|FG001|Overall Study|Death|0|||
161970202|NCT03966885|584940911|FG000|Overall Study|Lost to Follow-up|1|||
161970203|NCT03966885|584940912|FG001|Overall Study|Lost to Follow-up|2|||
161970204|NCT03966885|584940911|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
161970205|NCT03966885|584940912|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
161970206|NCT03966885|584940911|FG000|Overall Study|Moved from study area.|0|||
161970207|NCT03966885|584940912|FG001|Overall Study|Moved from study area.|2|||
161970208|NCT01514240|584940913|FG000|Overall Study|Adverse Event|4|||
161970209|NCT01514240|584940914|FG001|Overall Study|Adverse Event|4|||
161757348|NCT03661983|584151614|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
161970210|NCT01514240|584940913|FG000|Overall Study|Subject Decision|2|||
161970211|NCT01514240|584940914|FG001|Overall Study|Subject Decision|7|||
161970212|NCT00509093|584940915|FG000|Overall Study|Adverse Event|10|||
161970213|NCT00509093|584940915|FG000|Overall Study|Disease Progression|9|||
161970214|NCT00509093|584940915|FG000|Overall Study|Transformed into MDS|1|||
161970215|NCT00509093|584940915|FG000|Overall Study|Withdrawal by Subject|3|||
161970216|NCT00509093|584940915|FG000|Overall Study|Physician Decision|1|||
161970217|NCT05013424|584940916|FG000|Overall Study|Lost to Follow-up|1|||
161970218|NCT05013424|584940917|FG001|Overall Study|Lost to Follow-up|1|||
161970219|NCT05013424|584940918|FG002|Overall Study|Lost to Follow-up|1|||
161970220|NCT05013424|584940916|FG000|Overall Study|Withdrawal by Subject|0|||
161970221|NCT05013424|584940917|FG001|Overall Study|Withdrawal by Subject|1|||
161970222|NCT05013424|584940918|FG002|Overall Study|Withdrawal by Subject|0|||
161757349|NCT03661983|584151615|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
161757350|NCT03661983|584151616|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
161757351|NCT03661983|584151617|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
161757352|NCT03661983|584151614|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
161757353|NCT03661983|584151615|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
161757354|NCT03661983|584151616|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
161757355|NCT03661983|584151617|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
161757356|NCT02903966|584151618|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
161757357|NCT02903966|584151619|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
161757358|NCT02903966|584151618|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
161757359|NCT02903966|584151619|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
161757360|NCT02903966|584151618|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
161757361|NCT02903966|584151619|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
161757362|NCT00934791|584151620|FG000|Overall Study|Withdrawal by Subject|1|||
161757363|NCT00934791|584151621|FG001|Overall Study|Withdrawal by Subject|0|||
161757364|NCT01320033|584151623|FG000|Overall Study|Lack of Efficacy|0|||
161757365|NCT01320033|584151624|FG001|Overall Study|Lack of Efficacy|0|||
161757366|NCT01320033|584151625|FG002|Overall Study|Lack of Efficacy|1|||
161757367|NCT01320033|584151623|FG000|Overall Study|Adverse Event|9|||
161757368|NCT01320033|584151624|FG001|Overall Study|Adverse Event|7|||
161757369|NCT01320033|584151625|FG002|Overall Study|Adverse Event|8|||
161757370|NCT01320033|584151623|FG000|Overall Study|Withdrawal by Subject|22|||
161757371|NCT01320033|584151624|FG001|Overall Study|Withdrawal by Subject|23|||
161757372|NCT01320033|584151625|FG002|Overall Study|Withdrawal by Subject|23|||
161757373|NCT01320033|584151623|FG000|Overall Study|Protocol Violation|3|||
161757374|NCT01320033|584151624|FG001|Overall Study|Protocol Violation|5|||
161757375|NCT01320033|584151625|FG002|Overall Study|Protocol Violation|3|||
161757376|NCT01320033|584151623|FG000|Overall Study|Lost to Follow-up|22|||
161757377|NCT01320033|584151624|FG001|Overall Study|Lost to Follow-up|26|||
161757378|NCT01320033|584151625|FG002|Overall Study|Lost to Follow-up|17|||
161757379|NCT01320033|584151623|FG000|Overall Study|Other|2|||
161757380|NCT01320033|584151624|FG001|Overall Study|Other|3|||
161757381|NCT01320033|584151625|FG002|Overall Study|Other|1|||
161757382|NCT02425891|584151626|FG000|Overall Study|Death|333|||
161757383|NCT02425891|584151627|FG001|Overall Study|Death|314|||
161757384|NCT02425891|584151626|FG000|Overall Study|Lost to Follow-up|4|||
161757385|NCT02425891|584151627|FG001|Overall Study|Lost to Follow-up|6|||
161757386|NCT02425891|584151626|FG000|Overall Study|Non-Compliance|1|||
161757387|NCT02425891|584151627|FG001|Overall Study|Non-Compliance|1|||
161757388|NCT02425891|584151626|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
161757389|NCT02425891|584151627|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
161757390|NCT02425891|584151626|FG000|Overall Study|Physician Decision|0|||
161757391|NCT02425891|584151627|FG001|Overall Study|Physician Decision|1|||
161757392|NCT02425891|584151626|FG000|Overall Study|Protocol Violation|1|||
161757393|NCT02425891|584151627|FG001|Overall Study|Protocol Violation|1|||
161757394|NCT02425891|584151626|FG000|Overall Study|Study Terminated By Sponsor|85|||
161757395|NCT02425891|584151627|FG001|Overall Study|Study Terminated By Sponsor|95|||
161757396|NCT02425891|584151626|FG000|Overall Study|Withdrawal by Subject|27|||
161757397|NCT02425891|584151627|FG001|Overall Study|Withdrawal by Subject|32|||
161970223|NCT04143217|584940925|FG000|Overall Study|Withdrawal by Subject|42|||
161970224|NCT04143217|584940925|FG000|Overall Study|Adverse Event|29|||
161757398|NCT00963469|584151628|FG000|Overall Study|Adverse Event|15|||
161757399|NCT00963469|584151629|FG001|Overall Study|Adverse Event|11|||
161757400|NCT00963469|584151630|FG002|Overall Study|Adverse Event|1|||
161970225|NCT04143217|584940925|FG000|Overall Study|Lost to Follow-up|29|||
161970226|NCT04143217|584940925|FG000|Overall Study|Lack of Efficacy|15|||
161970227|NCT04143217|584940925|FG000|Overall Study|Physician Decision|1|||
161970228|NCT04143217|584940925|FG000|Overall Study|Non-Compliance With Study Drug|6|||
161970229|NCT04143217|584940925|FG000|Overall Study|Other, Multiple Categories|11|||
161970230|NCT03538444|584940936|FG000|Overall Study|opioid withdrawal|1|||
161970231|NCT03538444|584940937|FG001|Overall Study|opioid withdrawal|0|||
161970232|NCT01451931|584940938|FG000|Overall Study|Lost to Follow-up|17|||
161970233|NCT01451931|584940939|FG001|Overall Study|Lost to Follow-up|36|||
161970234|NCT01451931|584940940|FG002|Overall Study|Lost to Follow-up|21|||
161970235|NCT01451931|584940938|FG000|Overall Study|Withdrawal by Subject|16|||
161970236|NCT01451931|584940939|FG001|Overall Study|Withdrawal by Subject|22|||
161970237|NCT01451931|584940940|FG002|Overall Study|Withdrawal by Subject|22|||
161970238|NCT04422561|584940946|FG000|Overall Study|Lost to Follow-up|25|||
161970239|NCT04422561|584940947|FG001|Overall Study|Lost to Follow-up|11|||
161970240|NCT03640052|584940948|FG000|Overall Study|Lost to Follow-up|0|||
161970241|NCT03640052|584940949|FG001|Overall Study|Lost to Follow-up|1|||
161970242|NCT03640052|584940950|FG002|Overall Study|Lost to Follow-up|0|||
161970243|NCT03640052|584940951|FG003|Overall Study|Lost to Follow-up|0|||
161970244|NCT03640052|584940952|FG004|Overall Study|Lost to Follow-up|0|||
161970245|NCT05479097|584940958|FG000|Overall Study|Withdrawal by Subject|2|||
161970246|NCT04126564|584940959|FG000|Overall Study|Withdrawal by Subject|0|||
161970247|NCT04126564|584940960|FG001|Overall Study|Withdrawal by Subject|2|||
161970248|NCT04126564|584940959|FG000|Overall Study|Lost to Follow-up|0|||
161970249|NCT04126564|584940960|FG001|Overall Study|Lost to Follow-up|1|||
161970250|NCT00230282|584940964|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
161970251|NCT00230282|584940964|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
161970252|NCT00230282|584940964|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
161970253|NCT00230282|584940964|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
161970254|NCT00457821|584940972|FG000|Part 2|Withdrawal by Subject|0|||
161970255|NCT00457821|584940973|FG001|Part 2|Withdrawal by Subject|0|||
161970256|NCT00457821|584940974|FG002|Part 2|Withdrawal by Subject|0|||
161970257|NCT00457821|584940975|FG003|Part 2|Withdrawal by Subject|0|||
161970258|NCT00457821|584940976|FG004|Part 2|Withdrawal by Subject|0|||
161970259|NCT00457821|584940977|FG005|Part 2|Withdrawal by Subject|0|||
161970260|NCT00457821|584940978|FG006|Part 2|Withdrawal by Subject|0|||
161970261|NCT00457821|584940979|FG007|Part 2|Withdrawal by Subject|1|||
161970262|NCT02437409|584940988|FG000|Overall Study|Withdrawal by Subject|3|||
161970263|NCT02437409|584940988|FG000|Overall Study|Screening failure|12|||
161970264|NCT01369680|584940990|FG000|Overall Study|Lost to Follow-up|0|||
161970265|NCT01369680|584940991|FG001|Overall Study|Lost to Follow-up|0|||
161970266|NCT01369680|584940992|FG002|Overall Study|Lost to Follow-up|1|||
161970267|NCT01369680|584940993|FG003|Overall Study|Lost to Follow-up|2|||
161970268|NCT02851407|584940996|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161757401|NCT00963469|584151628|FG000|Overall Study|Lack of Efficacy|10|||
161757402|NCT00963469|584151629|FG001|Overall Study|Lack of Efficacy|7|||
161757403|NCT00963469|584151630|FG002|Overall Study|Lack of Efficacy|2|||
161757404|NCT00963469|584151628|FG000|Overall Study|Lost to Follow-up|1|||
161757405|NCT00963469|584151629|FG001|Overall Study|Lost to Follow-up|1|||
161757406|NCT00963469|584151630|FG002|Overall Study|Lost to Follow-up|0|||
161757407|NCT00963469|584151628|FG000|Overall Study|Protocol Violation|5|||
161757408|NCT00963469|584151629|FG001|Overall Study|Protocol Violation|5|||
161757409|NCT00963469|584151630|FG002|Overall Study|Protocol Violation|3|||
161757410|NCT00963469|584151628|FG000|Overall Study|Withdrawal by Subject|4|||
161757411|NCT00963469|584151629|FG001|Overall Study|Withdrawal by Subject|1|||
161757412|NCT00963469|584151630|FG002|Overall Study|Withdrawal by Subject|1|||
161757413|NCT00963469|584151628|FG000|Overall Study|Pre-randomization Adverse Event|1|||
161757414|NCT00963469|584151629|FG001|Overall Study|Pre-randomization Adverse Event|2|||
161757415|NCT00963469|584151630|FG002|Overall Study|Pre-randomization Adverse Event|0|||
161757416|NCT00963469|584151628|FG000|Overall Study|Moved|1|||
161757417|NCT00963469|584151629|FG001|Overall Study|Moved|0|||
161757418|NCT00963469|584151630|FG002|Overall Study|Moved|0|||
161757419|NCT00963469|584151628|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
161757420|NCT00963469|584151629|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
161757421|NCT00963469|584151630|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
161757422|NCT02943577|584151632|FG000|Overall Study|Protocol Violation|0|||
161757423|NCT02943577|584151633|FG001|Overall Study|Protocol Violation|1|||
161757424|NCT02943577|584151632|FG000|Overall Study|Adverse Event|3|||
161757425|NCT02943577|584151633|FG001|Overall Study|Adverse Event|2|||
161757426|NCT02943577|584151632|FG000|Overall Study|Lost to Follow-up|0|||
161970269|NCT02851407|584940997|FG001|Overall Study|Withdrawal by parent/guardian|7|||
161970270|NCT02851407|584940996|FG000|Overall Study|Protocol deviation|0|||
161970271|NCT02851407|584940997|FG001|Overall Study|Protocol deviation|1|||
161970272|NCT02851407|584940996|FG000|Overall Study|Transferred to another hospital to continue|1|||
161970273|NCT02851407|584940997|FG001|Overall Study|Transferred to another hospital to continue|0|||
161970274|NCT02851407|584940996|FG000|Overall Study|Other Death|30|||
161970275|NCT02851407|584940997|FG001|Overall Study|Other Death|20|||
161846083|NCT00927394|584478972|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
161846084|NCT00927394|584478973|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
161970276|NCT02851407|584940996|FG000|Overall Study|Adverse event, serious fatal|6|||
161970277|NCT02851407|584940997|FG001|Overall Study|Adverse event, serious fatal|8|||
161970278|NCT02851407|584940996|FG000|Overall Study|Consent withdrawn by participant|5|||
161970279|NCT02851407|584940997|FG001|Overall Study|Consent withdrawn by participant|3|||
161970280|NCT02851407|584940996|FG000|Overall Study|Screen failure|2|||
161970281|NCT02851407|584940997|FG001|Overall Study|Screen failure|1|||
161970282|NCT02851407|584940996|FG000|Overall Study|Disease relapse|9|||
161970283|NCT02851407|584940997|FG001|Overall Study|Disease relapse|6|||
161970284|NCT02851407|584940996|FG000|Overall Study|Physician Decision|7|||
161970285|NCT02851407|584940997|FG001|Overall Study|Physician Decision|6|||
161970286|NCT02851407|584940996|FG000|Overall Study|Transferred to hospital closer to home|0|||
161970287|NCT02851407|584940997|FG001|Overall Study|Transferred to hospital closer to home|1|||
161970288|NCT02851407|584940996|FG000|Overall Study|Enrolled in an investigational study|0|||
161970289|NCT02851407|584940997|FG001|Overall Study|Enrolled in an investigational study|1|||
161970290|NCT02851407|584940996|FG000|Overall Study|Early recovery|1|||
161970291|NCT02851407|584940997|FG001|Overall Study|Early recovery|0|||
161970292|NCT02851407|584940996|FG000|Overall Study|Adverse event, non-fatal|7|||
161970293|NCT02851407|584940997|FG001|Overall Study|Adverse event, non-fatal|5|||
161970294|NCT02851407|584940996|FG000|Overall Study|Lost to Follow-up|0|||
161970295|NCT02851407|584940997|FG001|Overall Study|Lost to Follow-up|2|||
161970296|NCT01713283|584941000|FG000|Overall Study|Lack of Efficacy|10|||
161970297|NCT01713283|584941001|FG001|Overall Study|Lack of Efficacy|2|||
161970298|NCT01713283|584941000|FG000|Overall Study|Lost to Follow-up|1|||
161970299|NCT01713283|584941001|FG001|Overall Study|Lost to Follow-up|1|||
161970300|NCT02585830|584941002|FG000|Overall Study|Withdrawal by Subject|3|||
161970301|NCT00835640|584941003|FG000|Second Intervention|Protocol Violation|1|||
161970302|NCT00835640|584941004|FG001|Second Intervention|Protocol Violation|0|||
161970303|NCT00350272|584941005|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
161970304|NCT00350272|584941006|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
161970305|NCT00350272|584941005|FG000|Blinded 12-Week Treatment|Death|1|||
161970306|NCT00350272|584941006|FG001|Blinded 12-Week Treatment|Death|0|||
161970307|NCT00350272|584941005|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
161970308|NCT00350272|584941006|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
161970309|NCT00350272|584941005|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
161970310|NCT00350272|584941006|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
161970311|NCT00350272|584941005|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
161970312|NCT00350272|584941006|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
161970313|NCT00350272|584941005|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
161970314|NCT00350272|584941006|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
161970315|NCT00350272|584941005|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
161970316|NCT00350272|584941006|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
161846085|NCT00927394|584478972|FG000|Overall Study|Withdrawal by Subject|20|||
161846086|NCT00927394|584478973|FG001|Overall Study|Withdrawal by Subject|24|||
161846087|NCT00927394|584478972|FG000|Overall Study|Lost to Follow-up|8|||
161846088|NCT00927394|584478973|FG001|Overall Study|Lost to Follow-up|14|||
161846089|NCT00927394|584478972|FG000|Overall Study|Administrative Problem|1|||
161846090|NCT00927394|584478973|FG001|Overall Study|Administrative Problem|0|||
161846091|NCT00927394|584478972|FG000|Overall Study|Death|1|||
161846092|NCT00927394|584478973|FG001|Overall Study|Death|1|||
161846093|NCT00927394|584478972|FG000|Overall Study|Protocol deviation|16|||
161846094|NCT00927394|584478973|FG001|Overall Study|Protocol deviation|13|||
161846095|NCT00927394|584478972|FG000|Overall Study|Randomized in error|0|||
161846096|NCT00927394|584478973|FG001|Overall Study|Randomized in error|1|||
161846097|NCT04623086|584478974|FG000|Overall Study|Withdrawal by Subject|0|||
161846098|NCT04623086|584478975|FG001|Overall Study|Withdrawal by Subject|0|||
161970317|NCT00350272|584941005|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
161970318|NCT00350272|584941006|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
161970319|NCT00350272|584941005|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
161846099|NCT04623086|584478976|FG002|Overall Study|Withdrawal by Subject|10|||
161846100|NCT03464630|584478977|FG000|Overall Study|Lost to Follow-up|62|||
161846101|NCT03464630|584478978|FG001|Overall Study|Lost to Follow-up|52|||
161970320|NCT00350272|584941006|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
161970321|NCT00350272|584941005|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
161970322|NCT00350272|584941006|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
161970323|NCT00350272|584941005|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
161970324|NCT00350272|584941006|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
161846102|NCT03464630|584478977|FG000|Overall Study|Withdrawal by Subject|16|||
161846103|NCT03464630|584478978|FG001|Overall Study|Withdrawal by Subject|10|||
161846104|NCT03464630|584478977|FG000|Overall Study|Passive Disengagement|8|||
161846105|NCT03464630|584478978|FG001|Overall Study|Passive Disengagement|4|||
161846106|NCT00715624|584478979|FG000|Overall Study|Adverse Event|12|||
161846107|NCT00715624|584478980|FG001|Overall Study|Adverse Event|37|||
161970325|NCT00812006|584941007|FG000|Overall Study|Lost to Follow-up|0|||
161757427|NCT02943577|584151633|FG001|Overall Study|Lost to Follow-up|1|||
161757428|NCT02943577|584151632|FG000|Overall Study|Withdrawal by Subject|1|||
161757429|NCT02943577|584151633|FG001|Overall Study|Withdrawal by Subject|1|||
161757430|NCT02943577|584151632|FG000|Overall Study|Pregnancy|1|||
161757431|NCT02943577|584151633|FG001|Overall Study|Pregnancy|0|||
161757432|NCT00081263|584151651|FG000|Overall Study|clerical error|1|||
161757433|NCT00081263|584151652|FG001|Overall Study|clerical error|0|||
161757434|NCT00081263|584151651|FG000|Overall Study|wrong cell type|7|||
161757435|NCT00081263|584151652|FG001|Overall Study|wrong cell type|5|||
161757436|NCT00081263|584151651|FG000|Overall Study|improper pre-protocol therapy|0|||
161757437|NCT00081263|584151652|FG001|Overall Study|improper pre-protocol therapy|1|||
161757438|NCT00081263|584151651|FG000|Overall Study|Inadequate pathology|0|||
161757439|NCT00081263|584151652|FG001|Overall Study|Inadequate pathology|1|||
161757440|NCT00081263|584151651|FG000|Overall Study|Never treated|4|||
161757441|NCT00081263|584151652|FG001|Overall Study|Never treated|5|||
161757442|NCT00081263|584151651|FG000|Overall Study|Inadequate data|5|||
161757443|NCT00081263|584151652|FG001|Overall Study|Inadequate data|10|||
161757444|NCT01852591|584151653|FG000|Overall Study|Withdrawal by Subject|2|||
161757445|NCT01852591|584151653|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
161757446|NCT01267955|584151660|FG000|Stage 1 (6 Months)|Death|3|||
161757447|NCT01267955|584151660|FG000|Stage 2 (6 Months)|Death|5|||
161757448|NCT01267955|584151660|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
161757449|NCT01263470|584151662|FG000|Overall Study|Adverse Event|2|||
161757450|NCT01263470|584151663|FG001|Overall Study|Adverse Event|2|||
161757451|NCT01263470|584151664|FG002|Overall Study|Adverse Event|1|||
161757452|NCT01263470|584151665|FG003|Overall Study|Adverse Event|1|||
161757453|NCT01263470|584151666|FG004|Overall Study|Adverse Event|2|||
161757454|NCT01263470|584151667|FG005|Overall Study|Adverse Event|2|||
161757455|NCT01263470|584151662|FG000|Overall Study|Protocol Violation|0|||
161757456|NCT01263470|584151663|FG001|Overall Study|Protocol Violation|1|||
161757457|NCT01263470|584151664|FG002|Overall Study|Protocol Violation|0|||
161757458|NCT01263470|584151665|FG003|Overall Study|Protocol Violation|0|||
161757459|NCT01263470|584151666|FG004|Overall Study|Protocol Violation|0|||
161757460|NCT01263470|584151667|FG005|Overall Study|Protocol Violation|1|||
161757461|NCT01263470|584151662|FG000|Overall Study|Withdrawal by Subject|0|||
161757462|NCT01263470|584151663|FG001|Overall Study|Withdrawal by Subject|1|||
161757463|NCT01263470|584151664|FG002|Overall Study|Withdrawal by Subject|1|||
161757464|NCT01263470|584151665|FG003|Overall Study|Withdrawal by Subject|2|||
161757465|NCT01263470|584151666|FG004|Overall Study|Withdrawal by Subject|0|||
161757466|NCT01263470|584151667|FG005|Overall Study|Withdrawal by Subject|2|||
161757467|NCT01263470|584151662|FG000|Overall Study|Lack of Efficacy|0|||
161757468|NCT01263470|584151663|FG001|Overall Study|Lack of Efficacy|0|||
161757469|NCT01263470|584151664|FG002|Overall Study|Lack of Efficacy|2|||
161757470|NCT01263470|584151665|FG003|Overall Study|Lack of Efficacy|0|||
161757471|NCT01263470|584151666|FG004|Overall Study|Lack of Efficacy|0|||
161757472|NCT01263470|584151667|FG005|Overall Study|Lack of Efficacy|0|||
161757473|NCT01263470|584151662|FG000|Overall Study|Participant Unavailability|0|||
161757474|NCT01263470|584151663|FG001|Overall Study|Participant Unavailability|1|||
161757475|NCT01263470|584151664|FG002|Overall Study|Participant Unavailability|0|||
161757476|NCT01263470|584151665|FG003|Overall Study|Participant Unavailability|0|||
161757477|NCT01263470|584151666|FG004|Overall Study|Participant Unavailability|0|||
161757478|NCT01263470|584151667|FG005|Overall Study|Participant Unavailability|0|||
161757479|NCT01263470|584151662|FG000|Overall Study|Study Drug Non-compliance|0|||
161757480|NCT01263470|584151663|FG001|Overall Study|Study Drug Non-compliance|0|||
161757481|NCT01263470|584151664|FG002|Overall Study|Study Drug Non-compliance|0|||
161757482|NCT01263470|584151665|FG003|Overall Study|Study Drug Non-compliance|0|||
161757483|NCT01263470|584151666|FG004|Overall Study|Study Drug Non-compliance|1|||
161757484|NCT01263470|584151667|FG005|Overall Study|Study Drug Non-compliance|0|||
161757485|NCT00610714|584151668|FG000|Overall Study|Adverse Event|3|||
161757486|NCT00610714|584151669|FG001|Overall Study|Adverse Event|1|||
161757487|NCT00610714|584151668|FG000|Overall Study|Death|12|||
161757488|NCT00610714|584151669|FG001|Overall Study|Death|18|||
161757489|NCT00610714|584151668|FG000|Overall Study|Withdrawal by Subject|9|||
161757490|NCT00610714|584151669|FG001|Overall Study|Withdrawal by Subject|3|||
161757491|NCT00610714|584151668|FG000|Overall Study|Study completion at 120 PFS events|2|||
161757492|NCT00610714|584151669|FG001|Overall Study|Study completion at 120 PFS events|2|||
161757493|NCT01327573|584151670|FG000|Overall Study|Physician Decision|3|||
161757494|NCT01327573|584151671|FG001|Overall Study|Physician Decision|1|||
161757495|NCT01108263|584151672|FG000|Overall Study|Adverse Event|0|||
161970326|NCT00812006|584941008|FG001|Overall Study|Lost to Follow-up|0|||
161970327|NCT00812006|584941009|FG002|Overall Study|Lost to Follow-up|2|||
161970328|NCT00812006|584941007|FG000|Overall Study|Physician Decision|0|||
161970329|NCT00812006|584941008|FG001|Overall Study|Physician Decision|0|||
161757496|NCT01108263|584151673|FG001|Overall Study|Adverse Event|1|||
161757497|NCT03070119|584151675|FG000|Overall Study|Adverse Event|0|||
161757498|NCT03070119|584151676|FG001|Overall Study|Adverse Event|0|||
161757499|NCT03070119|584151677|FG002|Overall Study|Adverse Event|1|||
161757500|NCT03070119|584151675|FG000|Overall Study|Lost to Follow-up|0|||
161970330|NCT00812006|584941009|FG002|Overall Study|Physician Decision|1|||
161757501|NCT03070119|584151676|FG001|Overall Study|Lost to Follow-up|1|||
161757502|NCT03070119|584151677|FG002|Overall Study|Lost to Follow-up|0|||
161757503|NCT03070119|584151675|FG000|Overall Study|Consent Withdrawn|6|||
161757504|NCT03070119|584151676|FG001|Overall Study|Consent Withdrawn|5|||
161757505|NCT03070119|584151677|FG002|Overall Study|Consent Withdrawn|3|||
161757506|NCT03070119|584151675|FG000|Overall Study|Investigator Decision|0|||
161757507|NCT03070119|584151676|FG001|Overall Study|Investigator Decision|0|||
161970331|NCT00812006|584941007|FG000|Overall Study|Withdrawal by Subject|2|||
161970332|NCT00812006|584941008|FG001|Overall Study|Withdrawal by Subject|1|||
161970333|NCT00812006|584941009|FG002|Overall Study|Withdrawal by Subject|1|||
161970334|NCT00812006|584941007|FG000|Overall Study|Lack of Qualifying Event|4|||
161970335|NCT00812006|584941008|FG001|Overall Study|Lack of Qualifying Event|2|||
161970336|NCT00812006|584941009|FG002|Overall Study|Lack of Qualifying Event|2|||
161970337|NCT00068250|584941010|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
161970338|NCT00068250|584941011|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
161970339|NCT00068250|584941012|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
161970340|NCT00068250|584941013|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
161970341|NCT00235391|584941015|FG000|Overall Study|Adverse Event|4|||
161970342|NCT00235391|584941016|FG001|Overall Study|Adverse Event|5|||
161970343|NCT00235391|584941017|FG002|Overall Study|Adverse Event|10|||
161970344|NCT00235391|584941018|FG003|Overall Study|Adverse Event|72|||
161970345|NCT00235391|584941019|FG004|Overall Study|Adverse Event|5|||
161970346|NCT00235391|584941020|FG005|Overall Study|Adverse Event|2|||
161970347|NCT00235391|584941015|FG000|Overall Study|Abnormal laboratory value(s)|3|||
161970348|NCT00235391|584941016|FG001|Overall Study|Abnormal laboratory value(s)|5|||
161970349|NCT00235391|584941017|FG002|Overall Study|Abnormal laboratory value(s)|4|||
161970350|NCT00235391|584941018|FG003|Overall Study|Abnormal laboratory value(s)|27|||
161970351|NCT00235391|584941019|FG004|Overall Study|Abnormal laboratory value(s)|1|||
161970352|NCT00235391|584941020|FG005|Overall Study|Abnormal laboratory value(s)|2|||
161970353|NCT00235391|584941015|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161970354|NCT00235391|584941016|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161970355|NCT00235391|584941017|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161970356|NCT00235391|584941018|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
161970357|NCT00235391|584941019|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
161970358|NCT00235391|584941020|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
161970359|NCT00235391|584941015|FG000|Overall Study|Condition no longer requires treatment|3|||
161970360|NCT00235391|584941016|FG001|Overall Study|Condition no longer requires treatment|0|||
161970361|NCT00235391|584941017|FG002|Overall Study|Condition no longer requires treatment|0|||
161970362|NCT00235391|584941018|FG003|Overall Study|Condition no longer requires treatment|11|||
161970363|NCT00235391|584941019|FG004|Overall Study|Condition no longer requires treatment|1|||
161970364|NCT00235391|584941020|FG005|Overall Study|Condition no longer requires treatment|0|||
161970365|NCT00235391|584941015|FG000|Overall Study|Protocol deviation|0|||
161970366|NCT00235391|584941016|FG001|Overall Study|Protocol deviation|0|||
161970367|NCT00235391|584941017|FG002|Overall Study|Protocol deviation|1|||
161970368|NCT00235391|584941018|FG003|Overall Study|Protocol deviation|11|||
161970369|NCT00235391|584941019|FG004|Overall Study|Protocol deviation|0|||
161970370|NCT00235391|584941020|FG005|Overall Study|Protocol deviation|0|||
161970371|NCT00235391|584941015|FG000|Overall Study|Withdrawal by Subject|2|||
161970372|NCT00235391|584941016|FG001|Overall Study|Withdrawal by Subject|3|||
161970373|NCT00235391|584941017|FG002|Overall Study|Withdrawal by Subject|3|||
161970374|NCT00235391|584941018|FG003|Overall Study|Withdrawal by Subject|61|||
161970375|NCT00235391|584941019|FG004|Overall Study|Withdrawal by Subject|5|||
161970376|NCT00235391|584941020|FG005|Overall Study|Withdrawal by Subject|0|||
161970377|NCT00235391|584941015|FG000|Overall Study|Lost to Follow-up|0|||
161970378|NCT00235391|584941016|FG001|Overall Study|Lost to Follow-up|3|||
161970379|NCT00235391|584941017|FG002|Overall Study|Lost to Follow-up|3|||
161970380|NCT00235391|584941018|FG003|Overall Study|Lost to Follow-up|16|||
161970381|NCT00235391|584941019|FG004|Overall Study|Lost to Follow-up|0|||
161970382|NCT00235391|584941020|FG005|Overall Study|Lost to Follow-up|0|||
161970383|NCT00235391|584941015|FG000|Overall Study|Administrative problems|0|||
161970384|NCT00235391|584941016|FG001|Overall Study|Administrative problems|0|||
161970385|NCT00235391|584941017|FG002|Overall Study|Administrative problems|0|||
161970386|NCT00235391|584941018|FG003|Overall Study|Administrative problems|1|||
161970387|NCT00235391|584941019|FG004|Overall Study|Administrative problems|0|||
161970388|NCT00235391|584941020|FG005|Overall Study|Administrative problems|0|||
161970389|NCT00235391|584941015|FG000|Overall Study|Death|0|||
161970390|NCT00235391|584941016|FG001|Overall Study|Death|0|||
161970391|NCT00235391|584941017|FG002|Overall Study|Death|1|||
161970392|NCT00235391|584941018|FG003|Overall Study|Death|4|||
161970393|NCT00235391|584941019|FG004|Overall Study|Death|0|||
161846108|NCT00715624|584478979|FG000|Overall Study|Lack of Efficacy|11|||
161970394|NCT00235391|584941020|FG005|Overall Study|Death|0|||
161757508|NCT03070119|584151677|FG002|Overall Study|Investigator Decision|1|||
161757509|NCT03070119|584151675|FG000|Overall Study|Death|7|||
161970395|NCT00075725|584941021|FG000|Overall Study|Adverse Event|6|||
161970396|NCT00075725|584941022|FG001|Overall Study|Adverse Event|6|||
161970397|NCT00075725|584941023|FG002|Overall Study|Adverse Event|20|||
161970398|NCT00075725|584941024|FG003|Overall Study|Adverse Event|8|||
161970399|NCT00075725|584941025|FG004|Overall Study|Adverse Event|4|||
161970400|NCT00075725|584941026|FG005|Overall Study|Adverse Event|38|||
161970401|NCT00075725|584941027|FG006|Overall Study|Adverse Event|3|||
161970402|NCT00075725|584941028|FG007|Overall Study|Adverse Event|51|||
161970403|NCT00075725|584941029|FG008|Overall Study|Adverse Event|15|||
161970404|NCT00075725|584941030|FG009|Overall Study|Adverse Event|4|||
161970405|NCT00075725|584941031|FG010|Overall Study|Adverse Event|2|||
161970406|NCT00075725|584941032|FG011|Overall Study|Adverse Event|2|||
161970407|NCT00075725|584941021|FG000|Overall Study|Death|3|||
161970408|NCT00075725|584941022|FG001|Overall Study|Death|5|||
161970409|NCT00075725|584941023|FG002|Overall Study|Death|10|||
161970410|NCT00075725|584941024|FG003|Overall Study|Death|2|||
161970411|NCT00075725|584941025|FG004|Overall Study|Death|3|||
161970412|NCT00075725|584941026|FG005|Overall Study|Death|25|||
161970413|NCT00075725|584941027|FG006|Overall Study|Death|4|||
161970414|NCT00075725|584941028|FG007|Overall Study|Death|22|||
161970415|NCT00075725|584941029|FG008|Overall Study|Death|14|||
161970416|NCT00075725|584941030|FG009|Overall Study|Death|4|||
161970417|NCT00075725|584941031|FG010|Overall Study|Death|3|||
161970418|NCT00075725|584941032|FG011|Overall Study|Death|0|||
161970419|NCT00075725|584941021|FG000|Overall Study|Lost to Follow-up|1|||
161970420|NCT00075725|584941022|FG001|Overall Study|Lost to Follow-up|1|||
161970421|NCT00075725|584941023|FG002|Overall Study|Lost to Follow-up|4|||
161970422|NCT00075725|584941024|FG003|Overall Study|Lost to Follow-up|1|||
161970423|NCT00075725|584941025|FG004|Overall Study|Lost to Follow-up|0|||
161970424|NCT00075725|584941026|FG005|Overall Study|Lost to Follow-up|13|||
161970425|NCT00075725|584941027|FG006|Overall Study|Lost to Follow-up|2|||
161970426|NCT00075725|584941028|FG007|Overall Study|Lost to Follow-up|4|||
161970427|NCT00075725|584941029|FG008|Overall Study|Lost to Follow-up|1|||
161970428|NCT00075725|584941030|FG009|Overall Study|Lost to Follow-up|0|||
161970429|NCT00075725|584941031|FG010|Overall Study|Lost to Follow-up|0|||
161970430|NCT00075725|584941032|FG011|Overall Study|Lost to Follow-up|0|||
161970431|NCT00075725|584941021|FG000|Overall Study|Physician Decision|2|||
161970432|NCT00075725|584941022|FG001|Overall Study|Physician Decision|6|||
161970433|NCT00075725|584941023|FG002|Overall Study|Physician Decision|5|||
161970434|NCT00075725|584941024|FG003|Overall Study|Physician Decision|8|||
161970435|NCT00075725|584941025|FG004|Overall Study|Physician Decision|4|||
161970436|NCT00075725|584941026|FG005|Overall Study|Physician Decision|19|||
161970437|NCT00075725|584941027|FG006|Overall Study|Physician Decision|3|||
161970438|NCT00075725|584941028|FG007|Overall Study|Physician Decision|17|||
161970439|NCT00075725|584941029|FG008|Overall Study|Physician Decision|5|||
161970440|NCT00075725|584941030|FG009|Overall Study|Physician Decision|0|||
161970441|NCT00075725|584941031|FG010|Overall Study|Physician Decision|1|||
161970442|NCT00075725|584941032|FG011|Overall Study|Physician Decision|0|||
161970443|NCT00075725|584941021|FG000|Overall Study|Pregnancy|0|||
161970444|NCT00075725|584941022|FG001|Overall Study|Pregnancy|0|||
161970445|NCT00075725|584941023|FG002|Overall Study|Pregnancy|0|||
161970446|NCT00075725|584941024|FG003|Overall Study|Pregnancy|0|||
161970447|NCT00075725|584941025|FG004|Overall Study|Pregnancy|0|||
161970448|NCT00075725|584941026|FG005|Overall Study|Pregnancy|1|||
161970449|NCT00075725|584941027|FG006|Overall Study|Pregnancy|0|||
161970450|NCT00075725|584941028|FG007|Overall Study|Pregnancy|1|||
161970451|NCT00075725|584941029|FG008|Overall Study|Pregnancy|0|||
161970452|NCT00075725|584941030|FG009|Overall Study|Pregnancy|0|||
161970453|NCT00075725|584941031|FG010|Overall Study|Pregnancy|0|||
161970454|NCT00075725|584941032|FG011|Overall Study|Pregnancy|0|||
161970455|NCT00075725|584941021|FG000|Overall Study|Protocol Violation|1|||
161970456|NCT00075725|584941022|FG001|Overall Study|Protocol Violation|1|||
161970457|NCT00075725|584941023|FG002|Overall Study|Protocol Violation|0|||
161970458|NCT00075725|584941024|FG003|Overall Study|Protocol Violation|3|||
161970459|NCT00075725|584941025|FG004|Overall Study|Protocol Violation|3|||
161970460|NCT00075725|584941026|FG005|Overall Study|Protocol Violation|2|||
161970461|NCT00075725|584941027|FG006|Overall Study|Protocol Violation|1|||
161970462|NCT00075725|584941028|FG007|Overall Study|Protocol Violation|2|||
161970463|NCT00075725|584941029|FG008|Overall Study|Protocol Violation|3|||
161970464|NCT00075725|584941030|FG009|Overall Study|Protocol Violation|0|||
161970465|NCT00075725|584941031|FG010|Overall Study|Protocol Violation|0|||
161970466|NCT00075725|584941032|FG011|Overall Study|Protocol Violation|1|||
161970467|NCT00075725|584941021|FG000|Overall Study|Withdrawal by Subject|12|||
161970468|NCT00075725|584941022|FG001|Overall Study|Withdrawal by Subject|3|||
161970469|NCT00075725|584941023|FG002|Overall Study|Withdrawal by Subject|6|||
161970470|NCT00075725|584941024|FG003|Overall Study|Withdrawal by Subject|10|||
161970471|NCT00075725|584941025|FG004|Overall Study|Withdrawal by Subject|6|||
161970472|NCT00075725|584941026|FG005|Overall Study|Withdrawal by Subject|27|||
162032920|NCT00219544|585177504|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
161970473|NCT00075725|584941027|FG006|Overall Study|Withdrawal by Subject|7|||
161970474|NCT00075725|584941028|FG007|Overall Study|Withdrawal by Subject|31|||
161970475|NCT00075725|584941029|FG008|Overall Study|Withdrawal by Subject|10|||
161970476|NCT00075725|584941030|FG009|Overall Study|Withdrawal by Subject|2|||
161970477|NCT00075725|584941031|FG010|Overall Study|Withdrawal by Subject|0|||
161970478|NCT00075725|584941032|FG011|Overall Study|Withdrawal by Subject|0|||
161970479|NCT00075725|584941021|FG000|Overall Study|Disease Progression, all other reasons|17|||
161970480|NCT00075725|584941022|FG001|Overall Study|Disease Progression, all other reasons|5|||
161970481|NCT00075725|584941023|FG002|Overall Study|Disease Progression, all other reasons|33|||
161970482|NCT00075725|584941024|FG003|Overall Study|Disease Progression, all other reasons|6|||
161970483|NCT00075725|584941025|FG004|Overall Study|Disease Progression, all other reasons|21|||
161970484|NCT00075725|584941026|FG005|Overall Study|Disease Progression, all other reasons|59|||
161970485|NCT00075725|584941027|FG006|Overall Study|Disease Progression, all other reasons|20|||
161970486|NCT00075725|584941028|FG007|Overall Study|Disease Progression, all other reasons|46|||
161970487|NCT00075725|584941029|FG008|Overall Study|Disease Progression, all other reasons|21|||
161970488|NCT00075725|584941030|FG009|Overall Study|Disease Progression, all other reasons|4|||
161970489|NCT00075725|584941031|FG010|Overall Study|Disease Progression, all other reasons|0|||
161970490|NCT00075725|584941032|FG011|Overall Study|Disease Progression, all other reasons|5|||
161970491|NCT00075725|584941021|FG000|Overall Study|Patient off treatment|0|||
161970492|NCT00075725|584941022|FG001|Overall Study|Patient off treatment|0|||
161970493|NCT00075725|584941023|FG002|Overall Study|Patient off treatment|1|||
161970494|NCT00075725|584941024|FG003|Overall Study|Patient off treatment|2|||
161970495|NCT00075725|584941025|FG004|Overall Study|Patient off treatment|1|||
161970496|NCT00075725|584941026|FG005|Overall Study|Patient off treatment|0|||
161970497|NCT00075725|584941027|FG006|Overall Study|Patient off treatment|0|||
161970498|NCT00075725|584941028|FG007|Overall Study|Patient off treatment|2|||
161970499|NCT00075725|584941029|FG008|Overall Study|Patient off treatment|1|||
161970500|NCT00075725|584941030|FG009|Overall Study|Patient off treatment|0|||
161970501|NCT00075725|584941031|FG010|Overall Study|Patient off treatment|0|||
161970502|NCT00075725|584941032|FG011|Overall Study|Patient off treatment|0|||
161970503|NCT00075725|584941021|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
161970504|NCT00075725|584941022|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
161970505|NCT00075725|584941023|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
161970506|NCT00075725|584941024|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
161970507|NCT00075725|584941025|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
161970508|NCT00075725|584941026|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
161970509|NCT00075725|584941027|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
161970510|NCT00075725|584941028|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
161970511|NCT00075725|584941029|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
161970512|NCT00075725|584941030|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
161970513|NCT00075725|584941031|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
161970514|NCT00075725|584941032|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
161970515|NCT00075725|584941021|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
161970516|NCT00075725|584941022|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
161970517|NCT00075725|584941023|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
161970518|NCT00075725|584941024|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
161970519|NCT00075725|584941025|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
161970520|NCT00075725|584941026|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
161970521|NCT00075725|584941027|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
161970522|NCT00075725|584941028|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
161970523|NCT00075725|584941029|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
161970524|NCT00075725|584941030|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
161970525|NCT00075725|584941031|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
161970526|NCT00075725|584941032|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
161970527|NCT00075725|584941021|FG000|Overall Study|Pt non compliant with therapy|2|||
161970528|NCT00075725|584941022|FG001|Overall Study|Pt non compliant with therapy|1|||
161970529|NCT00075725|584941023|FG002|Overall Study|Pt non compliant with therapy|1|||
161970530|NCT00075725|584941024|FG003|Overall Study|Pt non compliant with therapy|0|||
161970531|NCT00075725|584941025|FG004|Overall Study|Pt non compliant with therapy|2|||
161970532|NCT00075725|584941026|FG005|Overall Study|Pt non compliant with therapy|14|||
161970533|NCT00075725|584941027|FG006|Overall Study|Pt non compliant with therapy|2|||
161970534|NCT00075725|584941028|FG007|Overall Study|Pt non compliant with therapy|5|||
161970535|NCT00075725|584941029|FG008|Overall Study|Pt non compliant with therapy|3|||
161970536|NCT00075725|584941030|FG009|Overall Study|Pt non compliant with therapy|0|||
161970537|NCT00075725|584941031|FG010|Overall Study|Pt non compliant with therapy|0|||
161970538|NCT00075725|584941032|FG011|Overall Study|Pt non compliant with therapy|0|||
161970539|NCT00075725|584941021|FG000|Overall Study|Pt age out of range for treatment|0|||
161970540|NCT00075725|584941022|FG001|Overall Study|Pt age out of range for treatment|1|||
161970541|NCT00075725|584941023|FG002|Overall Study|Pt age out of range for treatment|0|||
161970542|NCT00075725|584941024|FG003|Overall Study|Pt age out of range for treatment|0|||
161970543|NCT00075725|584941025|FG004|Overall Study|Pt age out of range for treatment|0|||
161970544|NCT00075725|584941026|FG005|Overall Study|Pt age out of range for treatment|1|||
161970545|NCT00075725|584941027|FG006|Overall Study|Pt age out of range for treatment|0|||
161757510|NCT03070119|584151676|FG001|Overall Study|Death|14|||
161757511|NCT03070119|584151677|FG002|Overall Study|Death|5|||
161846109|NCT00715624|584478980|FG001|Overall Study|Lack of Efficacy|11|||
161846110|NCT00715624|584478979|FG000|Overall Study|Lost to Follow-up|1|||
161846111|NCT00715624|584478980|FG001|Overall Study|Lost to Follow-up|2|||
161846112|NCT00715624|584478979|FG000|Overall Study|Protocol Violation|1|||
161846113|NCT00715624|584478980|FG001|Overall Study|Protocol Violation|0|||
161846114|NCT00715624|584478979|FG000|Overall Study|Withdrawal by Subject|11|||
161846115|NCT00715624|584478980|FG001|Overall Study|Withdrawal by Subject|25|||
161846116|NCT00715624|584478979|FG000|Overall Study|Familial and personal reasons|10|||
161846117|NCT00715624|584478980|FG001|Overall Study|Familial and personal reasons|22|||
161846118|NCT00715624|584478979|FG000|Overall Study|Poor compliance|6|||
161846119|NCT00715624|584478980|FG001|Overall Study|Poor compliance|13|||
161846120|NCT00715624|584478979|FG000|Overall Study|Sponsor decision|0|||
161846121|NCT00715624|584478980|FG001|Overall Study|Sponsor decision|4|||
161846122|NCT00715624|584478979|FG000|Overall Study|Incorrect randomization (not treated)|0|||
161846123|NCT00715624|584478980|FG001|Overall Study|Incorrect randomization (not treated)|1|||
161846124|NCT00715624|584478979|FG000|Overall Study|Other|0|||
161846125|NCT00715624|584478980|FG001|Overall Study|Other|1|||
161846126|NCT04524364|584478984|FG000|Overall Study|Physician Decision|3|||
161846127|NCT04524364|584478985|FG001|Overall Study|Physician Decision|6|||
161846128|NCT04524364|584478984|FG000|Overall Study|Adverse Event|0|||
161846129|NCT04524364|584478985|FG001|Overall Study|Adverse Event|1|||
161846130|NCT04524364|584478984|FG000|Overall Study|Investigational device deficiency|0|||
161846131|NCT04524364|584478985|FG001|Overall Study|Investigational device deficiency|1|||
161846132|NCT04524364|584478984|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
161846133|NCT04524364|584478985|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
161846134|NCT04524364|584478984|FG000|Overall Study|Device unavailability|0|||
161846135|NCT04524364|584478985|FG001|Overall Study|Device unavailability|2|||
161846136|NCT04524364|584478984|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
161846137|NCT04524364|584478985|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
161846138|NCT04524364|584478984|FG000|Overall Study|Low International normalized ratio (INR)|1|||
161846139|NCT04524364|584478985|FG001|Overall Study|Low International normalized ratio (INR)|0|||
161846140|NCT00229723|584478986|FG000|Concomitant Phase|Adverse Event|4|||
161846141|NCT00229723|584478987|FG001|Concomitant Phase|Adverse Event|2|||
161846142|NCT00229723|584478988|FG002|Concomitant Phase|Adverse Event|5|||
161846143|NCT00229723|584478989|FG003|Concomitant Phase|Adverse Event|2|||
161846144|NCT00229723|584478990|FG004|Concomitant Phase|Adverse Event|0|||
161846145|NCT00229723|584478991|FG005|Concomitant Phase|Adverse Event|1|||
161846146|NCT00229723|584478992|FG006|Concomitant Phase|Adverse Event|2|||
161846147|NCT00229723|584478986|FG000|Concomitant Phase|Objective disease progression|0|||
161846148|NCT00229723|584478987|FG001|Concomitant Phase|Objective disease progression|0|||
161846149|NCT00229723|584478988|FG002|Concomitant Phase|Objective disease progression|0|||
161846150|NCT00229723|584478989|FG003|Concomitant Phase|Objective disease progression|0|||
161846151|NCT00229723|584478990|FG004|Concomitant Phase|Objective disease progression|0|||
161846152|NCT00229723|584478991|FG005|Concomitant Phase|Objective disease progression|0|||
161846153|NCT00229723|584478992|FG006|Concomitant Phase|Objective disease progression|0|||
161846154|NCT00229723|584478986|FG000|Concomitant Phase|Clinical progression|0|||
161846155|NCT00229723|584478987|FG001|Concomitant Phase|Clinical progression|0|||
161846156|NCT00229723|584478988|FG002|Concomitant Phase|Clinical progression|0|||
161846157|NCT00229723|584478989|FG003|Concomitant Phase|Clinical progression|0|||
161846158|NCT00229723|584478990|FG004|Concomitant Phase|Clinical progression|0|||
161846159|NCT00229723|584478991|FG005|Concomitant Phase|Clinical progression|0|||
161846160|NCT00229723|584478992|FG006|Concomitant Phase|Clinical progression|1|||
161846161|NCT00229723|584478986|FG000|Concomitant Phase|Lost to Follow-up|0|||
161846162|NCT00229723|584478987|FG001|Concomitant Phase|Lost to Follow-up|0|||
161846163|NCT00229723|584478988|FG002|Concomitant Phase|Lost to Follow-up|0|||
161846164|NCT00229723|584478989|FG003|Concomitant Phase|Lost to Follow-up|0|||
161846165|NCT00229723|584478990|FG004|Concomitant Phase|Lost to Follow-up|1|||
161970546|NCT00075725|584941028|FG007|Overall Study|Pt age out of range for treatment|1|||
161970547|NCT00075725|584941029|FG008|Overall Study|Pt age out of range for treatment|0|||
161970548|NCT00075725|584941030|FG009|Overall Study|Pt age out of range for treatment|0|||
161970549|NCT00075725|584941031|FG010|Overall Study|Pt age out of range for treatment|0|||
161970550|NCT00075725|584941032|FG011|Overall Study|Pt age out of range for treatment|0|||
161970551|NCT00075725|584941021|FG000|Overall Study|Insurance issues|0|||
161846166|NCT00229723|584478991|FG005|Concomitant Phase|Lost to Follow-up|0|||
161846167|NCT00229723|584478992|FG006|Concomitant Phase|Lost to Follow-up|0|||
161846168|NCT00229723|584478986|FG000|Concomitant Phase|Informed consent withdrawn|3|||
161846169|NCT00229723|584478987|FG001|Concomitant Phase|Informed consent withdrawn|2|||
161846170|NCT00229723|584478988|FG002|Concomitant Phase|Informed consent withdrawn|0|||
161846171|NCT00229723|584478989|FG003|Concomitant Phase|Informed consent withdrawn|2|||
161846172|NCT00229723|584478990|FG004|Concomitant Phase|Informed consent withdrawn|0|||
161846173|NCT00229723|584478991|FG005|Concomitant Phase|Informed consent withdrawn|0|||
161846174|NCT00229723|584478992|FG006|Concomitant Phase|Informed consent withdrawn|0|||
161970552|NCT00075725|584941022|FG001|Overall Study|Insurance issues|1|||
161970553|NCT00075725|584941023|FG002|Overall Study|Insurance issues|0|||
161970554|NCT00075725|584941024|FG003|Overall Study|Insurance issues|1|||
161970555|NCT00075725|584941025|FG004|Overall Study|Insurance issues|1|||
161970556|NCT00075725|584941026|FG005|Overall Study|Insurance issues|1|||
161970557|NCT00075725|584941027|FG006|Overall Study|Insurance issues|0|||
161970558|NCT00075725|584941028|FG007|Overall Study|Insurance issues|1|||
161970559|NCT00075725|584941029|FG008|Overall Study|Insurance issues|0|||
161970560|NCT00075725|584941030|FG009|Overall Study|Insurance issues|0|||
161970561|NCT00075725|584941031|FG010|Overall Study|Insurance issues|0|||
161970562|NCT00075725|584941032|FG011|Overall Study|Insurance issues|0|||
161757512|NCT03070119|584151675|FG000|Overall Study|Disease Progression|5|||
161757513|NCT03070119|584151676|FG001|Overall Study|Disease Progression|7|||
161757514|NCT03070119|584151677|FG002|Overall Study|Disease Progression|7|||
161757515|NCT03070119|584151675|FG000|Overall Study|Reason not Specified|2|||
161757516|NCT03070119|584151676|FG001|Overall Study|Reason not Specified|2|||
161757517|NCT03070119|584151677|FG002|Overall Study|Reason not Specified|1|||
161757518|NCT02974621|584151678|FG000|Overall Study|Didn't receive study treatment|1|||
161757519|NCT02974621|584151679|FG001|Overall Study|Didn't receive study treatment|10|||
161757520|NCT01996865|584151680|FG000|Induction Period|Protocol Violation|1|||
161757521|NCT01996865|584151681|FG001|Induction Period|Protocol Violation|0|||
161757522|NCT01996865|584151682|FG002|Induction Period|Protocol Violation|0|||
161757523|NCT01996865|584151680|FG000|Induction Period|Progressive Disease|4|||
161757524|NCT01996865|584151681|FG001|Induction Period|Progressive Disease|0|||
161757525|NCT01996865|584151682|FG002|Induction Period|Progressive Disease|0|||
161757526|NCT01996865|584151680|FG000|Induction Period|Lost to Follow-up|10|||
161757527|NCT01996865|584151681|FG001|Induction Period|Lost to Follow-up|0|||
161757528|NCT01996865|584151682|FG002|Induction Period|Lost to Follow-up|0|||
161757529|NCT01996865|584151680|FG000|Induction Period|Other Reasons|13|||
161757530|NCT01996865|584151681|FG001|Induction Period|Other Reasons|0|||
161757531|NCT01996865|584151682|FG002|Induction Period|Other Reasons|0|||
161757532|NCT01996865|584151680|FG000|Induction Period|Adverse Event|20|||
161757533|NCT01996865|584151681|FG001|Induction Period|Adverse Event|0|||
161757534|NCT01996865|584151682|FG002|Induction Period|Adverse Event|0|||
161757535|NCT01996865|584151680|FG000|Induction Period|Withdrawal by Subject|60|||
161757536|NCT01996865|584151681|FG001|Induction Period|Withdrawal by Subject|0|||
161757537|NCT01996865|584151682|FG002|Induction Period|Withdrawal by Subject|0|||
161757538|NCT01996865|584151680|FG000|Induction Period|Death|111|||
161757539|NCT01996865|584151681|FG001|Induction Period|Death|0|||
161757540|NCT01996865|584151682|FG002|Induction Period|Death|0|||
161757541|NCT01996865|584151680|FG000|Maintenance Period|Protocol Violation|0|||
161757542|NCT01996865|584151681|FG001|Maintenance Period|Protocol Violation|1|||
161757543|NCT01996865|584151682|FG002|Maintenance Period|Protocol Violation|1|||
161757544|NCT01996865|584151680|FG000|Maintenance Period|Other reasons|0|||
161757545|NCT01996865|584151681|FG001|Maintenance Period|Other reasons|8|||
161757546|NCT01996865|584151682|FG002|Maintenance Period|Other reasons|5|||
161757547|NCT01996865|584151680|FG000|Maintenance Period|Progressive Disease|0|||
161757548|NCT01996865|584151681|FG001|Maintenance Period|Progressive Disease|6|||
161757549|NCT01996865|584151682|FG002|Maintenance Period|Progressive Disease|23|||
161757550|NCT01996865|584151680|FG000|Maintenance Period|Withdrawal by Subject|0|||
161757551|NCT01996865|584151681|FG001|Maintenance Period|Withdrawal by Subject|18|||
161757552|NCT01996865|584151682|FG002|Maintenance Period|Withdrawal by Subject|4|||
161757553|NCT01996865|584151680|FG000|Maintenance Period|Adverse Event|0|||
161757554|NCT01996865|584151681|FG001|Maintenance Period|Adverse Event|7|||
161757555|NCT01996865|584151682|FG002|Maintenance Period|Adverse Event|7|||
161757556|NCT01996865|584151680|FG000|Maintenance Period|Death|0|||
161757557|NCT01996865|584151681|FG001|Maintenance Period|Death|15|||
161757558|NCT01996865|584151682|FG002|Maintenance Period|Death|3|||
161757559|NCT01996865|584151680|FG000|Maintenance Period|Lost to Follow-up|0|||
161757560|NCT01996865|584151681|FG001|Maintenance Period|Lost to Follow-up|2|||
161757561|NCT01996865|584151682|FG002|Maintenance Period|Lost to Follow-up|0|||
161757562|NCT05304611|584151685|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757563|NCT05304611|584151686|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757564|NCT05304611|584151687|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757565|NCT05304611|584151688|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757566|NCT05304611|584151689|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757567|NCT05304611|584151690|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757568|NCT05304611|584151691|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
161757569|NCT05304611|584151692|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757570|NCT05304611|584151693|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
161757571|NCT05304611|584151694|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757572|NCT05304611|584151695|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757573|NCT05304611|584151696|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
161757574|NCT05304611|584151685|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
161757575|NCT05304611|584151686|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
161757576|NCT05304611|584151687|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
161757577|NCT05304611|584151688|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
161970563|NCT00075725|584941021|FG000|Overall Study|MRD positive after extended ind|0|||
161846175|NCT00229723|584478986|FG000|Concomitant Phase|Severe non-compliance|0|||
161846176|NCT00229723|584478987|FG001|Concomitant Phase|Severe non-compliance|1|||
161846177|NCT00229723|584478988|FG002|Concomitant Phase|Severe non-compliance|0|||
161846178|NCT00229723|584478989|FG003|Concomitant Phase|Severe non-compliance|0|||
161846179|NCT00229723|584478990|FG004|Concomitant Phase|Severe non-compliance|1|||
161846180|NCT00229723|584478991|FG005|Concomitant Phase|Severe non-compliance|0|||
161846181|NCT00229723|584478992|FG006|Concomitant Phase|Severe non-compliance|0|||
161846182|NCT00229723|584478986|FG000|Concomitant Phase|Other|3|||
161846183|NCT00229723|584478987|FG001|Concomitant Phase|Other|0|||
161846184|NCT00229723|584478988|FG002|Concomitant Phase|Other|1|||
161846185|NCT00229723|584478989|FG003|Concomitant Phase|Other|1|||
161846186|NCT00229723|584478990|FG004|Concomitant Phase|Other|0|||
161846187|NCT00229723|584478991|FG005|Concomitant Phase|Other|2|||
161846188|NCT00229723|584478992|FG006|Concomitant Phase|Other|0|||
161846189|NCT00229723|584478986|FG000|Maintenance Phase|Adverse Event|7|||
161846190|NCT00229723|584478987|FG001|Maintenance Phase|Adverse Event|2|||
161846191|NCT00229723|584478988|FG002|Maintenance Phase|Adverse Event|1|||
161846192|NCT00229723|584478989|FG003|Maintenance Phase|Adverse Event|4|||
161846193|NCT00229723|584478990|FG004|Maintenance Phase|Adverse Event|7|||
161846194|NCT00229723|584478991|FG005|Maintenance Phase|Adverse Event|5|||
161846195|NCT00229723|584478992|FG006|Maintenance Phase|Adverse Event|2|||
161846196|NCT00229723|584478986|FG000|Maintenance Phase|Objective disease progression|5|||
161846197|NCT00229723|584478987|FG001|Maintenance Phase|Objective disease progression|5|||
161846198|NCT00229723|584478988|FG002|Maintenance Phase|Objective disease progression|3|||
161846199|NCT00229723|584478989|FG003|Maintenance Phase|Objective disease progression|6|||
161846200|NCT00229723|584478990|FG004|Maintenance Phase|Objective disease progression|2|||
161846201|NCT00229723|584478991|FG005|Maintenance Phase|Objective disease progression|9|||
161846202|NCT00229723|584478992|FG006|Maintenance Phase|Objective disease progression|5|||
161846203|NCT00229723|584478986|FG000|Maintenance Phase|Clinical progression|4|||
161846204|NCT00229723|584478987|FG001|Maintenance Phase|Clinical progression|1|||
161846205|NCT00229723|584478988|FG002|Maintenance Phase|Clinical progression|2|||
161846206|NCT00229723|584478989|FG003|Maintenance Phase|Clinical progression|2|||
161846207|NCT00229723|584478990|FG004|Maintenance Phase|Clinical progression|1|||
161846208|NCT00229723|584478991|FG005|Maintenance Phase|Clinical progression|1|||
161846209|NCT00229723|584478992|FG006|Maintenance Phase|Clinical progression|1|||
161846210|NCT00229723|584478986|FG000|Maintenance Phase|Lost to Follow-up|0|||
161846211|NCT00229723|584478987|FG001|Maintenance Phase|Lost to Follow-up|1|||
161846212|NCT00229723|584478988|FG002|Maintenance Phase|Lost to Follow-up|2|||
161846213|NCT00229723|584478989|FG003|Maintenance Phase|Lost to Follow-up|2|||
161846214|NCT00229723|584478990|FG004|Maintenance Phase|Lost to Follow-up|0|||
161846215|NCT00229723|584478991|FG005|Maintenance Phase|Lost to Follow-up|0|||
161846216|NCT00229723|584478992|FG006|Maintenance Phase|Lost to Follow-up|1|||
161846217|NCT00229723|584478986|FG000|Maintenance Phase|Informed consent withdrawn|1|||
161846218|NCT00229723|584478987|FG001|Maintenance Phase|Informed consent withdrawn|0|||
161846219|NCT00229723|584478988|FG002|Maintenance Phase|Informed consent withdrawn|0|||
161846220|NCT00229723|584478989|FG003|Maintenance Phase|Informed consent withdrawn|1|||
161846221|NCT00229723|584478990|FG004|Maintenance Phase|Informed consent withdrawn|1|||
161846222|NCT00229723|584478991|FG005|Maintenance Phase|Informed consent withdrawn|1|||
161846223|NCT00229723|584478992|FG006|Maintenance Phase|Informed consent withdrawn|0|||
161846224|NCT00229723|584478986|FG000|Maintenance Phase|Severe non-compliance|3|||
161846225|NCT00229723|584478987|FG001|Maintenance Phase|Severe non-compliance|1|||
161846226|NCT00229723|584478988|FG002|Maintenance Phase|Severe non-compliance|0|||
161846227|NCT00229723|584478989|FG003|Maintenance Phase|Severe non-compliance|0|||
161757578|NCT05304611|584151689|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
161757579|NCT05304611|584151690|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
161757580|NCT05304611|584151691|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
161757581|NCT05304611|584151692|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
161757582|NCT05304611|584151693|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
161757583|NCT05304611|584151694|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
161757584|NCT05304611|584151695|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
161757585|NCT05304611|584151696|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
161757586|NCT05304611|584151685|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
161757587|NCT05304611|584151686|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
161757588|NCT05304611|584151687|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
161757589|NCT05304611|584151688|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
161757590|NCT05304611|584151689|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
161757591|NCT05304611|584151690|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
161757592|NCT05304611|584151691|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
161846228|NCT00229723|584478990|FG004|Maintenance Phase|Severe non-compliance|1|||
161846229|NCT00229723|584478991|FG005|Maintenance Phase|Severe non-compliance|0|||
161846230|NCT00229723|584478992|FG006|Maintenance Phase|Severe non-compliance|0|||
161846231|NCT00229723|584478986|FG000|Maintenance Phase|Other|5|||
161846232|NCT00229723|584478987|FG001|Maintenance Phase|Other|4|||
161846233|NCT00229723|584478988|FG002|Maintenance Phase|Other|1|||
161846234|NCT00229723|584478989|FG003|Maintenance Phase|Other|2|||
161846235|NCT00229723|584478990|FG004|Maintenance Phase|Other|3|||
161970564|NCT00075725|584941022|FG001|Overall Study|MRD positive after extended ind|1|||
161970565|NCT00075725|584941023|FG002|Overall Study|MRD positive after extended ind|1|||
161970566|NCT00075725|584941024|FG003|Overall Study|MRD positive after extended ind|0|||
161970567|NCT00075725|584941025|FG004|Overall Study|MRD positive after extended ind|1|||
161970568|NCT00075725|584941026|FG005|Overall Study|MRD positive after extended ind|2|||
161970569|NCT00075725|584941027|FG006|Overall Study|MRD positive after extended ind|0|||
161970570|NCT00075725|584941028|FG007|Overall Study|MRD positive after extended ind|1|||
161970571|NCT00075725|584941029|FG008|Overall Study|MRD positive after extended ind|0|||
161970572|NCT00075725|584941030|FG009|Overall Study|MRD positive after extended ind|0|||
161970573|NCT00075725|584941031|FG010|Overall Study|MRD positive after extended ind|0|||
161970574|NCT00075725|584941032|FG011|Overall Study|MRD positive after extended ind|0|||
161970575|NCT00075725|584941021|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
161970576|NCT00075725|584941022|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
161970577|NCT00075725|584941023|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
161970578|NCT00075725|584941024|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
161970579|NCT00075725|584941025|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
161970580|NCT00075725|584941026|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
161970581|NCT00075725|584941027|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
161970582|NCT00075725|584941028|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
161970583|NCT00075725|584941029|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
161970584|NCT00075725|584941030|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
161970585|NCT00075725|584941031|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
161970586|NCT00075725|584941032|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
161970587|NCT00075725|584941021|FG000|Overall Study|Inevaluable|1|||
161970588|NCT00075725|584941022|FG001|Overall Study|Inevaluable|1|||
161970589|NCT00075725|584941023|FG002|Overall Study|Inevaluable|4|||
161970590|NCT00075725|584941024|FG003|Overall Study|Inevaluable|2|||
161970591|NCT00075725|584941025|FG004|Overall Study|Inevaluable|2|||
161970592|NCT00075725|584941026|FG005|Overall Study|Inevaluable|9|||
161970593|NCT00075725|584941027|FG006|Overall Study|Inevaluable|1|||
161970594|NCT00075725|584941028|FG007|Overall Study|Inevaluable|11|||
161970595|NCT00075725|584941029|FG008|Overall Study|Inevaluable|2|||
161970596|NCT00075725|584941030|FG009|Overall Study|Inevaluable|0|||
161970597|NCT00075725|584941031|FG010|Overall Study|Inevaluable|1|||
161970598|NCT00075725|584941032|FG011|Overall Study|Inevaluable|0|||
161970599|NCT00075725|584941021|FG000|Overall Study|Other|4|||
161970600|NCT00075725|584941022|FG001|Overall Study|Other|2|||
161970601|NCT00075725|584941023|FG002|Overall Study|Other|1|||
161970602|NCT00075725|584941024|FG003|Overall Study|Other|1|||
161970603|NCT00075725|584941025|FG004|Overall Study|Other|1|||
161970604|NCT00075725|584941026|FG005|Overall Study|Other|4|||
161970605|NCT00075725|584941027|FG006|Overall Study|Other|2|||
161970606|NCT00075725|584941028|FG007|Overall Study|Other|9|||
161970607|NCT00075725|584941029|FG008|Overall Study|Other|2|||
161970608|NCT00075725|584941030|FG009|Overall Study|Other|1|||
161970609|NCT00075725|584941031|FG010|Overall Study|Other|0|||
161970610|NCT00075725|584941032|FG011|Overall Study|Other|3|||
161970611|NCT00075725|584941021|FG000|Overall Study|Pt trying to find a BM donor|0|||
161970612|NCT00075725|584941022|FG001|Overall Study|Pt trying to find a BM donor|1|||
161970613|NCT00075725|584941023|FG002|Overall Study|Pt trying to find a BM donor|0|||
161970614|NCT00075725|584941024|FG003|Overall Study|Pt trying to find a BM donor|0|||
161970615|NCT00075725|584941025|FG004|Overall Study|Pt trying to find a BM donor|0|||
161970616|NCT00075725|584941026|FG005|Overall Study|Pt trying to find a BM donor|0|||
161970617|NCT00075725|584941027|FG006|Overall Study|Pt trying to find a BM donor|0|||
161970618|NCT00075725|584941028|FG007|Overall Study|Pt trying to find a BM donor|0|||
161970619|NCT00075725|584941029|FG008|Overall Study|Pt trying to find a BM donor|0|||
161970620|NCT00075725|584941030|FG009|Overall Study|Pt trying to find a BM donor|0|||
161970621|NCT00075725|584941031|FG010|Overall Study|Pt trying to find a BM donor|0|||
161970622|NCT00075725|584941032|FG011|Overall Study|Pt trying to find a BM donor|0|||
161970623|NCT00075725|584941021|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
161757593|NCT05304611|584151692|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
161757594|NCT05304611|584151693|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
161757595|NCT05304611|584151694|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
161757596|NCT05304611|584151695|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
161757597|NCT05304611|584151696|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
161757598|NCT00963820|584151701|FG000|Dose Escalation Phase|Progressive Disease|3|||
161970624|NCT00075725|584941022|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
161970625|NCT00075725|584941023|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
161970626|NCT00075725|584941024|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
161757599|NCT00963820|584151702|FG001|Dose Escalation Phase|Progressive Disease|3|||
161970627|NCT00075725|584941025|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
161970628|NCT00075725|584941026|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
161970629|NCT00075725|584941027|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
161970630|NCT00075725|584941028|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
161757600|NCT00963820|584151703|FG002|Dose Escalation Phase|Progressive Disease|3|||
161757601|NCT00963820|584151704|FG003|Dose Escalation Phase|Progressive Disease|3|||
161757602|NCT00963820|584151705|FG004|Dose Escalation Phase|Progressive Disease|4|||
161757603|NCT00963820|584151706|FG005|Dose Escalation Phase|Progressive Disease|3|||
161757604|NCT00963820|584151707|FG006|Dose Escalation Phase|Progressive Disease|3|||
161757605|NCT00963820|584151708|FG007|Dose Escalation Phase|Progressive Disease|2|||
161757606|NCT00963820|584151709|FG008|Dose Escalation Phase|Progressive Disease|0|||
161757607|NCT00963820|584151710|FG009|Dose Escalation Phase|Progressive Disease|0|||
161757608|NCT00963820|584151711|FG010|Dose Escalation Phase|Progressive Disease|0|||
161757609|NCT00963820|584151712|FG011|Dose Escalation Phase|Progressive Disease|0|||
161757610|NCT00963820|584151701|FG000|Dose Escalation Phase|Adverse Event|0|||
161757611|NCT00963820|584151702|FG001|Dose Escalation Phase|Adverse Event|0|||
161757612|NCT00963820|584151703|FG002|Dose Escalation Phase|Adverse Event|0|||
161757613|NCT00963820|584151704|FG003|Dose Escalation Phase|Adverse Event|0|||
161757614|NCT00963820|584151705|FG004|Dose Escalation Phase|Adverse Event|0|||
161757615|NCT00963820|584151706|FG005|Dose Escalation Phase|Adverse Event|0|||
161757616|NCT00963820|584151707|FG006|Dose Escalation Phase|Adverse Event|3|||
161757617|NCT00963820|584151708|FG007|Dose Escalation Phase|Adverse Event|1|||
161757618|NCT00963820|584151709|FG008|Dose Escalation Phase|Adverse Event|0|||
161757619|NCT00963820|584151710|FG009|Dose Escalation Phase|Adverse Event|0|||
161757620|NCT00963820|584151711|FG010|Dose Escalation Phase|Adverse Event|0|||
161757621|NCT00963820|584151712|FG011|Dose Escalation Phase|Adverse Event|0|||
161757622|NCT00963820|584151701|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
161757623|NCT00963820|584151702|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
161757624|NCT00963820|584151703|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
161757625|NCT00963820|584151704|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161757626|NCT00963820|584151705|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
161757627|NCT00963820|584151706|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
161757628|NCT00963820|584151707|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
161757629|NCT00963820|584151708|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
161757630|NCT00963820|584151709|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
161757631|NCT00963820|584151710|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
161757632|NCT00963820|584151711|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
161757633|NCT00963820|584151712|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
161757634|NCT00963820|584151701|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757635|NCT00963820|584151702|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757636|NCT00963820|584151703|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757637|NCT00963820|584151704|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757638|NCT00963820|584151705|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757639|NCT00963820|584151706|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757640|NCT00963820|584151707|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
161757641|NCT00963820|584151708|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757642|NCT00963820|584151709|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757643|NCT00963820|584151710|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757644|NCT00963820|584151711|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757645|NCT00963820|584151712|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161757646|NCT00963820|584151701|FG000|Expansion Phase|Progressive Disease|0|||
161757647|NCT00963820|584151702|FG001|Expansion Phase|Progressive Disease|0|||
161757648|NCT00963820|584151703|FG002|Expansion Phase|Progressive Disease|0|||
161757649|NCT00963820|584151704|FG003|Expansion Phase|Progressive Disease|0|||
161757650|NCT00963820|584151705|FG004|Expansion Phase|Progressive Disease|0|||
161757651|NCT00963820|584151706|FG005|Expansion Phase|Progressive Disease|0|||
161757652|NCT00963820|584151707|FG006|Expansion Phase|Progressive Disease|0|||
161757653|NCT00963820|584151708|FG007|Expansion Phase|Progressive Disease|0|||
161757654|NCT00963820|584151709|FG008|Expansion Phase|Progressive Disease|8|||
161757655|NCT00963820|584151710|FG009|Expansion Phase|Progressive Disease|6|||
161757656|NCT00963820|584151711|FG010|Expansion Phase|Progressive Disease|4|||
161757657|NCT00963820|584151712|FG011|Expansion Phase|Progressive Disease|2|||
161970631|NCT00075725|584941029|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
161970632|NCT00075725|584941030|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
161970633|NCT00075725|584941031|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
161970634|NCT00075725|584941032|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
161757658|NCT00963820|584151701|FG000|Expansion Phase|Adverse Event|0|||
161757659|NCT00963820|584151702|FG001|Expansion Phase|Adverse Event|0|||
161757660|NCT00963820|584151703|FG002|Expansion Phase|Adverse Event|0|||
161757661|NCT00963820|584151704|FG003|Expansion Phase|Adverse Event|0|||
161757662|NCT00963820|584151705|FG004|Expansion Phase|Adverse Event|0|||
161757663|NCT00963820|584151706|FG005|Expansion Phase|Adverse Event|0|||
161757664|NCT00963820|584151707|FG006|Expansion Phase|Adverse Event|0|||
161757665|NCT00963820|584151708|FG007|Expansion Phase|Adverse Event|0|||
161757666|NCT00963820|584151709|FG008|Expansion Phase|Adverse Event|1|||
161757667|NCT00963820|584151710|FG009|Expansion Phase|Adverse Event|3|||
161757668|NCT00963820|584151711|FG010|Expansion Phase|Adverse Event|0|||
161846236|NCT00229723|584478991|FG005|Maintenance Phase|Other|3|||
161846237|NCT00229723|584478992|FG006|Maintenance Phase|Other|1|||
161846238|NCT02309138|584478993|FG000|Overall Study|Withdrawal by Subject|44|||
161846239|NCT02309138|584478994|FG001|Overall Study|Withdrawal by Subject|15|||
161846240|NCT02309138|584478993|FG000|Overall Study|Protocol Violation|4|||
161846241|NCT02309138|584478994|FG001|Overall Study|Protocol Violation|2|||
161846242|NCT02309138|584478993|FG000|Overall Study|delivered before visit 2|0|||
161846243|NCT02309138|584478994|FG001|Overall Study|delivered before visit 2|1|||
161846244|NCT00735397|584479000|FG000|Overall Study|Adverse Event|194|||
161846245|NCT00735397|584479000|FG000|Overall Study|Lost to Follow-up|33|||
161846246|NCT00735397|584479000|FG000|Overall Study|Participant choice|252|||
161846247|NCT00735397|584479000|FG000|Overall Study|Inadequate therapeutic effect|202|||
161846248|NCT00735397|584479000|FG000|Overall Study|Administrative/Other|502|||
161846249|NCT00380744|584479001|FG000|Overall Study|Death|0|||
161846250|NCT00380744|584479002|FG001|Overall Study|Death|0|||
161846251|NCT00380744|584479003|FG002|Overall Study|Death|0|||
161846252|NCT00380744|584479004|FG003|Overall Study|Death|0|||
161846253|NCT00380744|584479005|FG004|Overall Study|Death|0|||
161846254|NCT00380744|584479006|FG005|Overall Study|Death|0|||
161846255|NCT00380744|584479007|FG006|Overall Study|Death|1|||
161846256|NCT00380744|584479001|FG000|Overall Study|Withdrawal by Subject|1|||
161846257|NCT00380744|584479002|FG001|Overall Study|Withdrawal by Subject|0|||
161846258|NCT00380744|584479003|FG002|Overall Study|Withdrawal by Subject|0|||
161846259|NCT00380744|584479004|FG003|Overall Study|Withdrawal by Subject|0|||
161846260|NCT00380744|584479005|FG004|Overall Study|Withdrawal by Subject|0|||
161846261|NCT00380744|584479006|FG005|Overall Study|Withdrawal by Subject|0|||
161846262|NCT00380744|584479007|FG006|Overall Study|Withdrawal by Subject|0|||
161846263|NCT01338870|584479012|FG000|Overall Study|Lost to Follow-up|0|||
161846264|NCT01338870|584479013|FG001|Overall Study|Lost to Follow-up|0|||
161846265|NCT01338870|584479014|FG002|Overall Study|Lost to Follow-up|1|||
161846266|NCT01338870|584479015|FG003|Overall Study|Lost to Follow-up|0|||
161846267|NCT01338870|584479016|FG004|Overall Study|Lost to Follow-up|1|||
161846268|NCT01338870|584479017|FG005|Overall Study|Lost to Follow-up|0|||
161846269|NCT01338870|584479012|FG000|Overall Study|Withdrawal by Subject|2|||
161846270|NCT01338870|584479013|FG001|Overall Study|Withdrawal by Subject|3|||
161846271|NCT01338870|584479014|FG002|Overall Study|Withdrawal by Subject|4|||
161846272|NCT01338870|584479015|FG003|Overall Study|Withdrawal by Subject|0|||
161846273|NCT01338870|584479016|FG004|Overall Study|Withdrawal by Subject|0|||
161846274|NCT01338870|584479017|FG005|Overall Study|Withdrawal by Subject|2|||
161846275|NCT01338870|584479012|FG000|Overall Study|Other|3|||
161846276|NCT01338870|584479013|FG001|Overall Study|Other|3|||
161846277|NCT01338870|584479014|FG002|Overall Study|Other|3|||
161846278|NCT01338870|584479015|FG003|Overall Study|Other|2|||
161846279|NCT01338870|584479016|FG004|Overall Study|Other|0|||
161846280|NCT01338870|584479017|FG005|Overall Study|Other|2|||
161846281|NCT01338870|584479012|FG000|Overall Study|Protocol Violation|0|||
161846282|NCT01338870|584479013|FG001|Overall Study|Protocol Violation|2|||
161846283|NCT01338870|584479014|FG002|Overall Study|Protocol Violation|2|||
161846284|NCT01338870|584479015|FG003|Overall Study|Protocol Violation|2|||
161846285|NCT01338870|584479016|FG004|Overall Study|Protocol Violation|1|||
161846286|NCT01338870|584479017|FG005|Overall Study|Protocol Violation|1|||
161846287|NCT01338870|584479012|FG000|Overall Study|Adverse Event|4|||
161846288|NCT01338870|584479013|FG001|Overall Study|Adverse Event|4|||
161846289|NCT01338870|584479014|FG002|Overall Study|Adverse Event|1|||
161846290|NCT01338870|584479015|FG003|Overall Study|Adverse Event|5|||
161846291|NCT01338870|584479016|FG004|Overall Study|Adverse Event|4|||
161846292|NCT01338870|584479017|FG005|Overall Study|Adverse Event|1|||
161846293|NCT01955083|584479018|FG000|Overall Study|Lost to Follow-up|1|||
161846294|NCT01955083|584479019|FG001|Overall Study|Lost to Follow-up|1|||
161846295|NCT01559389|584479030|FG000|Overall Study|Withdrawal by Subject|20|||
161846296|NCT01559389|584479031|FG001|Overall Study|Withdrawal by Subject|20|||
161846297|NCT02871492|584479032|FG000|Overall Study|Lost to Follow-up|6|||
161846298|NCT02871492|584479033|FG001|Overall Study|Lost to Follow-up|3|||
161846299|NCT02871492|584479034|FG002|Overall Study|Lost to Follow-up|5|||
161846300|NCT02871492|584479032|FG000|Overall Study|Withdrawal by Subject|0|||
161846301|NCT02871492|584479033|FG001|Overall Study|Withdrawal by Subject|0|||
161846302|NCT02871492|584479034|FG002|Overall Study|Withdrawal by Subject|1|||
161846303|NCT04546724|584479035|FG000|Overall Study|Withdrawal by Subject|145|||
161846304|NCT04546724|584479036|FG001|Overall Study|Withdrawal by Subject|41|||
161846305|NCT04546724|584479035|FG000|Overall Study|Adverse Event|1|||
161846306|NCT04546724|584479036|FG001|Overall Study|Adverse Event|1|||
161846307|NCT04546724|584479035|FG000|Overall Study|Lost to Follow-up|186|||
161846308|NCT04546724|584479036|FG001|Overall Study|Lost to Follow-up|63|||
161846309|NCT04546724|584479035|FG000|Overall Study|Physician Decision|8|||
161846310|NCT04546724|584479036|FG001|Overall Study|Physician Decision|2|||
162032921|NCT00989573|585177505|FG000|Overall Study|Adverse Event|8|||
161846311|NCT04546724|584479035|FG000|Overall Study|Death|2|||
161846312|NCT04546724|584479036|FG001|Overall Study|Death|1|||
161846313|NCT04546724|584479035|FG000|Overall Study|subject has been out of town|1|||
161846314|NCT04546724|584479036|FG001|Overall Study|subject has been out of town|0|||
161970635|NCT00075725|584941021|FG000|Overall Study|Unsuccessful institutional transfer|0|||
161970636|NCT00075725|584941022|FG001|Overall Study|Unsuccessful institutional transfer|0|||
161970637|NCT00075725|584941023|FG002|Overall Study|Unsuccessful institutional transfer|2|||
161970638|NCT00075725|584941024|FG003|Overall Study|Unsuccessful institutional transfer|0|||
161970639|NCT00075725|584941025|FG004|Overall Study|Unsuccessful institutional transfer|0|||
161970640|NCT00075725|584941026|FG005|Overall Study|Unsuccessful institutional transfer|0|||
161970641|NCT00075725|584941027|FG006|Overall Study|Unsuccessful institutional transfer|0|||
161970642|NCT00075725|584941028|FG007|Overall Study|Unsuccessful institutional transfer|0|||
161970643|NCT00075725|584941029|FG008|Overall Study|Unsuccessful institutional transfer|0|||
161970644|NCT00075725|584941030|FG009|Overall Study|Unsuccessful institutional transfer|1|||
161970645|NCT00075725|584941031|FG010|Overall Study|Unsuccessful institutional transfer|0|||
161970646|NCT00075725|584941032|FG011|Overall Study|Unsuccessful institutional transfer|0|||
161970647|NCT00075725|584941021|FG000|Overall Study|specimen(s) not submitted|0|||
161970648|NCT00075725|584941022|FG001|Overall Study|specimen(s) not submitted|0|||
161970649|NCT00075725|584941023|FG002|Overall Study|specimen(s) not submitted|2|||
161970650|NCT00075725|584941024|FG003|Overall Study|specimen(s) not submitted|0|||
161970651|NCT00075725|584941025|FG004|Overall Study|specimen(s) not submitted|0|||
161970652|NCT00075725|584941026|FG005|Overall Study|specimen(s) not submitted|0|||
161970653|NCT00075725|584941027|FG006|Overall Study|specimen(s) not submitted|0|||
161970654|NCT00075725|584941028|FG007|Overall Study|specimen(s) not submitted|0|||
161970655|NCT00075725|584941029|FG008|Overall Study|specimen(s) not submitted|0|||
161970656|NCT00075725|584941030|FG009|Overall Study|specimen(s) not submitted|0|||
161970657|NCT00075725|584941031|FG010|Overall Study|specimen(s) not submitted|0|||
161970658|NCT00075725|584941032|FG011|Overall Study|specimen(s) not submitted|0|||
161970659|NCT00075725|584941021|FG000|Overall Study|Pt went to transplant|0|||
161970660|NCT00075725|584941022|FG001|Overall Study|Pt went to transplant|0|||
161970661|NCT00075725|584941023|FG002|Overall Study|Pt went to transplant|0|||
161970662|NCT00075725|584941024|FG003|Overall Study|Pt went to transplant|1|||
161970663|NCT00075725|584941025|FG004|Overall Study|Pt went to transplant|0|||
161970664|NCT00075725|584941026|FG005|Overall Study|Pt went to transplant|1|||
161970665|NCT00075725|584941027|FG006|Overall Study|Pt went to transplant|0|||
161970666|NCT00075725|584941028|FG007|Overall Study|Pt went to transplant|0|||
161970667|NCT00075725|584941029|FG008|Overall Study|Pt went to transplant|0|||
161970668|NCT00075725|584941030|FG009|Overall Study|Pt went to transplant|0|||
161970669|NCT00075725|584941031|FG010|Overall Study|Pt went to transplant|0|||
161970670|NCT00075725|584941032|FG011|Overall Study|Pt went to transplant|0|||
161970671|NCT00075725|584941021|FG000|Overall Study|Pt received additional steroids|0|||
161970672|NCT00075725|584941022|FG001|Overall Study|Pt received additional steroids|0|||
161970673|NCT00075725|584941023|FG002|Overall Study|Pt received additional steroids|0|||
161970674|NCT00075725|584941024|FG003|Overall Study|Pt received additional steroids|1|||
161970675|NCT00075725|584941025|FG004|Overall Study|Pt received additional steroids|0|||
161970676|NCT00075725|584941026|FG005|Overall Study|Pt received additional steroids|0|||
161970677|NCT00075725|584941027|FG006|Overall Study|Pt received additional steroids|0|||
161970678|NCT00075725|584941028|FG007|Overall Study|Pt received additional steroids|0|||
161970679|NCT00075725|584941029|FG008|Overall Study|Pt received additional steroids|0|||
161970680|NCT00075725|584941030|FG009|Overall Study|Pt received additional steroids|0|||
161970681|NCT00075725|584941031|FG010|Overall Study|Pt received additional steroids|0|||
161970682|NCT00075725|584941032|FG011|Overall Study|Pt received additional steroids|0|||
161970683|NCT00075725|584941021|FG000|Overall Study|Pt relocated|0|||
161970684|NCT00075725|584941022|FG001|Overall Study|Pt relocated|0|||
161970685|NCT00075725|584941023|FG002|Overall Study|Pt relocated|0|||
161970686|NCT00075725|584941024|FG003|Overall Study|Pt relocated|2|||
161970687|NCT00075725|584941025|FG004|Overall Study|Pt relocated|0|||
161970688|NCT00075725|584941026|FG005|Overall Study|Pt relocated|1|||
161970689|NCT00075725|584941027|FG006|Overall Study|Pt relocated|1|||
161970690|NCT00075725|584941028|FG007|Overall Study|Pt relocated|2|||
161970691|NCT00075725|584941029|FG008|Overall Study|Pt relocated|1|||
161970692|NCT00075725|584941030|FG009|Overall Study|Pt relocated|0|||
161970693|NCT00075725|584941031|FG010|Overall Study|Pt relocated|0|||
161970694|NCT00075725|584941032|FG011|Overall Study|Pt relocated|0|||
161970695|NCT00075725|584941021|FG000|Overall Study|Institution Terminated|0|||
161970696|NCT00075725|584941022|FG001|Overall Study|Institution Terminated|0|||
161970697|NCT00075725|584941023|FG002|Overall Study|Institution Terminated|0|||
162032922|NCT00989573|585177506|FG001|Overall Study|Adverse Event|12|||
162032923|NCT00989573|585177507|FG002|Overall Study|Adverse Event|4|||
161970698|NCT00075725|584941024|FG003|Overall Study|Institution Terminated|0|||
161970699|NCT00075725|584941025|FG004|Overall Study|Institution Terminated|1|||
161970700|NCT00075725|584941026|FG005|Overall Study|Institution Terminated|0|||
162032924|NCT00989573|585177505|FG000|Overall Study|Physician Decision|0|||
162032925|NCT00989573|585177506|FG001|Overall Study|Physician Decision|2|||
161970701|NCT00075725|584941027|FG006|Overall Study|Institution Terminated|0|||
161970702|NCT00075725|584941028|FG007|Overall Study|Institution Terminated|3|||
162032926|NCT00989573|585177507|FG002|Overall Study|Physician Decision|0|||
162032927|NCT00989573|585177505|FG000|Overall Study|Protocol Violation|1|||
162032928|NCT00989573|585177506|FG001|Overall Study|Protocol Violation|1|||
161757669|NCT00963820|584151712|FG011|Expansion Phase|Adverse Event|0|||
161757670|NCT00963820|584151701|FG000|Expansion Phase|Withdrawal by Subject|0|||
161757671|NCT00963820|584151702|FG001|Expansion Phase|Withdrawal by Subject|0|||
161757672|NCT00963820|584151703|FG002|Expansion Phase|Withdrawal by Subject|0|||
161757673|NCT00963820|584151704|FG003|Expansion Phase|Withdrawal by Subject|0|||
161757674|NCT00963820|584151705|FG004|Expansion Phase|Withdrawal by Subject|0|||
161757675|NCT00963820|584151706|FG005|Expansion Phase|Withdrawal by Subject|0|||
161757676|NCT00963820|584151707|FG006|Expansion Phase|Withdrawal by Subject|0|||
161757677|NCT00963820|584151708|FG007|Expansion Phase|Withdrawal by Subject|0|||
161757678|NCT00963820|584151709|FG008|Expansion Phase|Withdrawal by Subject|1|||
161757679|NCT00963820|584151710|FG009|Expansion Phase|Withdrawal by Subject|0|||
161757680|NCT00963820|584151711|FG010|Expansion Phase|Withdrawal by Subject|1|||
161757681|NCT00963820|584151712|FG011|Expansion Phase|Withdrawal by Subject|1|||
161757682|NCT00963820|584151701|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757683|NCT00963820|584151702|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757684|NCT00963820|584151703|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757685|NCT00963820|584151704|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757686|NCT00963820|584151705|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757687|NCT00963820|584151706|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757688|NCT00963820|584151707|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757689|NCT00963820|584151708|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757690|NCT00963820|584151709|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757691|NCT00963820|584151710|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757692|NCT00963820|584151711|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161757693|NCT00963820|584151712|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
161757694|NCT02354690|584151713|FG000|Overall Study|Physician Decision|1|||
161757695|NCT04556175|584151721|FG000|Overall Study|Study terminated due to COVID-19|8|||
161757696|NCT04556175|584151722|FG001|Overall Study|Study terminated due to COVID-19|8|||
161757697|NCT05549505|584151724|FG000|Overall Study|Lost to Follow-up|2|||
161757698|NCT05549505|584151725|FG001|Overall Study|Lost to Follow-up|0|||
161757699|NCT05549505|584151724|FG000|Overall Study|Withdrawal by Subject|3|||
161757700|NCT05549505|584151725|FG001|Overall Study|Withdrawal by Subject|3|||
161757701|NCT05549505|584151724|FG000|Overall Study|Other: Miscellaneous|3|||
161757702|NCT05549505|584151725|FG001|Overall Study|Other: Miscellaneous|6|||
161757703|NCT02756845|584151728|FG000|Overall Study|Death|12|||
161757704|NCT02756845|584151729|FG001|Overall Study|Death|2|||
161757705|NCT02756845|584151728|FG000|Overall Study|Withdrawal by Subject|1|||
161757706|NCT02756845|584151729|FG001|Overall Study|Withdrawal by Subject|0|||
161757707|NCT02005211|584151734|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161757708|NCT02005211|584151735|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161757709|NCT02005211|584151736|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161757710|NCT02005211|584151737|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161757711|NCT02005211|584151738|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
161757712|NCT02005211|584151739|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161757713|NCT02005211|584151740|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161757714|NCT00397631|584151743|FG000|Overall Study|Adverse Event|5|||
161757715|NCT00397631|584151744|FG001|Overall Study|Adverse Event|6|||
161757716|NCT00397631|584151743|FG000|Overall Study|Lack of Efficacy|7|||
161757717|NCT00397631|584151744|FG001|Overall Study|Lack of Efficacy|10|||
161757718|NCT00397631|584151743|FG000|Overall Study|Lost to Follow-up|8|||
161757719|NCT00397631|584151744|FG001|Overall Study|Lost to Follow-up|9|||
161757720|NCT00397631|584151743|FG000|Overall Study|Physician Decision|2|||
161757721|NCT00397631|584151744|FG001|Overall Study|Physician Decision|0|||
161757722|NCT00397631|584151743|FG000|Overall Study|Protocol Violation|0|||
161757723|NCT00397631|584151744|FG001|Overall Study|Protocol Violation|1|||
161757724|NCT00397631|584151743|FG000|Overall Study|Withdrawal by Subject|7|||
161757725|NCT00397631|584151744|FG001|Overall Study|Withdrawal by Subject|14|||
161757726|NCT00397631|584151743|FG000|Overall Study|protocol discontinuation criteria|1|||
161757727|NCT00397631|584151744|FG001|Overall Study|protocol discontinuation criteria|4|||
161757728|NCT02202161|584151745|FG000|Overall Study|Adverse Event|1|||
161757729|NCT02202161|584151746|FG001|Overall Study|Adverse Event|1|||
161757730|NCT02202161|584151747|FG002|Overall Study|Adverse Event|0|||
161757731|NCT02202161|584151748|FG003|Overall Study|Adverse Event|0|||
161757732|NCT02202161|584151749|FG004|Overall Study|Adverse Event|0|||
161757733|NCT02202161|584151750|FG005|Overall Study|Adverse Event|1|||
161757734|NCT02202161|584151751|FG006|Overall Study|Adverse Event|0|||
161757735|NCT02202161|584151752|FG007|Overall Study|Adverse Event|0|||
161757736|NCT02202161|584151745|FG000|Overall Study|Did not meet continuation criteria|0|||
161757737|NCT02202161|584151746|FG001|Overall Study|Did not meet continuation criteria|0|||
161757738|NCT02202161|584151747|FG002|Overall Study|Did not meet continuation criteria|0|||
161757739|NCT02202161|584151748|FG003|Overall Study|Did not meet continuation criteria|0|||
161757740|NCT02202161|584151749|FG004|Overall Study|Did not meet continuation criteria|0|||
161757741|NCT02202161|584151750|FG005|Overall Study|Did not meet continuation criteria|0|||
161970703|NCT00075725|584941029|FG008|Overall Study|Institution Terminated|0|||
161970704|NCT00075725|584941030|FG009|Overall Study|Institution Terminated|0|||
161970705|NCT00075725|584941031|FG010|Overall Study|Institution Terminated|0|||
161970706|NCT00075725|584941032|FG011|Overall Study|Institution Terminated|0|||
161970707|NCT00075725|584941021|FG000|Overall Study|Study Closure|1|||
161970708|NCT00075725|584941022|FG001|Overall Study|Study Closure|0|||
161970709|NCT00075725|584941023|FG002|Overall Study|Study Closure|0|||
161970710|NCT00075725|584941024|FG003|Overall Study|Study Closure|0|||
161970711|NCT00075725|584941025|FG004|Overall Study|Study Closure|1|||
161970712|NCT00075725|584941026|FG005|Overall Study|Study Closure|3|||
161970713|NCT00075725|584941027|FG006|Overall Study|Study Closure|0|||
161970714|NCT00075725|584941028|FG007|Overall Study|Study Closure|1|||
161970715|NCT00075725|584941029|FG008|Overall Study|Study Closure|0|||
161970716|NCT00075725|584941030|FG009|Overall Study|Study Closure|0|||
161970717|NCT00075725|584941031|FG010|Overall Study|Study Closure|0|||
161970718|NCT00075725|584941032|FG011|Overall Study|Study Closure|0|||
161970719|NCT00075725|584941021|FG000|Overall Study|Other complications|0|||
161970720|NCT00075725|584941022|FG001|Overall Study|Other complications|0|||
161970721|NCT00075725|584941023|FG002|Overall Study|Other complications|0|||
161970722|NCT00075725|584941024|FG003|Overall Study|Other complications|0|||
161970723|NCT00075725|584941025|FG004|Overall Study|Other complications|0|||
162032929|NCT00989573|585177507|FG002|Overall Study|Protocol Violation|1|||
161757742|NCT02202161|584151751|FG006|Overall Study|Did not meet continuation criteria|0|||
161757743|NCT02202161|584151752|FG007|Overall Study|Did not meet continuation criteria|3|||
161846315|NCT04546724|584479035|FG000|Overall Study|subject is incarcerated|2|||
161846316|NCT04546724|584479036|FG001|Overall Study|subject is incarcerated|0|||
161757744|NCT02202161|584151745|FG000|Overall Study|Physician Decision|0|||
161757745|NCT02202161|584151746|FG001|Overall Study|Physician Decision|0|||
161757746|NCT02202161|584151747|FG002|Overall Study|Physician Decision|0|||
161757747|NCT02202161|584151748|FG003|Overall Study|Physician Decision|0|||
161757748|NCT02202161|584151749|FG004|Overall Study|Physician Decision|0|||
161757749|NCT02202161|584151750|FG005|Overall Study|Physician Decision|0|||
161757750|NCT02202161|584151751|FG006|Overall Study|Physician Decision|0|||
161757751|NCT02202161|584151752|FG007|Overall Study|Physician Decision|3|||
161846317|NCT04546724|584479035|FG000|Overall Study|subject is relocating|12|||
161846318|NCT04546724|584479036|FG001|Overall Study|subject is relocating|4|||
161846319|NCT04546724|584479035|FG000|Overall Study|Subject in another study|1|||
161846320|NCT04546724|584479036|FG001|Overall Study|Subject in another study|1|||
161846321|NCT03583086|584479037|FG000|Overall Study|Death|2|||
161846322|NCT03583086|584479038|FG001|Overall Study|Death|6|||
161846323|NCT03583086|584479039|FG002|Overall Study|Death|12|||
161846324|NCT03583086|584479040|FG003|Overall Study|Death|10|||
161846325|NCT03583086|584479041|FG004|Overall Study|Death|14|||
161846326|NCT03583086|584479042|FG005|Overall Study|Death|14|||
161846327|NCT03583086|584479043|FG006|Overall Study|Death|4|||
161846328|NCT03583086|584479037|FG000|Overall Study|Withdrawal by Subject|0|||
161846329|NCT03583086|584479038|FG001|Overall Study|Withdrawal by Subject|0|||
161846330|NCT03583086|584479039|FG002|Overall Study|Withdrawal by Subject|1|||
161846331|NCT03583086|584479040|FG003|Overall Study|Withdrawal by Subject|0|||
161846332|NCT03583086|584479041|FG004|Overall Study|Withdrawal by Subject|0|||
161846333|NCT03583086|584479042|FG005|Overall Study|Withdrawal by Subject|0|||
161846334|NCT03583086|584479043|FG006|Overall Study|Withdrawal by Subject|1|||
161846335|NCT03583086|584479037|FG000|Overall Study|Refused follow-up|0|||
161846336|NCT03583086|584479038|FG001|Overall Study|Refused follow-up|0|||
161846337|NCT03583086|584479039|FG002|Overall Study|Refused follow-up|1|||
161846338|NCT03583086|584479040|FG003|Overall Study|Refused follow-up|0|||
161846339|NCT03583086|584479041|FG004|Overall Study|Refused follow-up|1|||
161846340|NCT03583086|584479042|FG005|Overall Study|Refused follow-up|0|||
161846341|NCT03583086|584479043|FG006|Overall Study|Refused follow-up|0|||
161846342|NCT03583086|584479037|FG000|Overall Study|Declining Performance Status|0|||
161846343|NCT03583086|584479038|FG001|Overall Study|Declining Performance Status|0|||
161846344|NCT03583086|584479039|FG002|Overall Study|Declining Performance Status|1|||
161846345|NCT03583086|584479040|FG003|Overall Study|Declining Performance Status|0|||
161846346|NCT03583086|584479041|FG004|Overall Study|Declining Performance Status|0|||
161846347|NCT03583086|584479042|FG005|Overall Study|Declining Performance Status|0|||
161846348|NCT03583086|584479043|FG006|Overall Study|Declining Performance Status|0|||
161970724|NCT00075725|584941026|FG005|Overall Study|Other complications|1|||
161970725|NCT00075725|584941027|FG006|Overall Study|Other complications|0|||
162032930|NCT00989573|585177505|FG000|Overall Study|Withdrawal by Subject|4|||
161757752|NCT02202161|584151745|FG000|Overall Study|Withdrawal by Subject|0|||
161757753|NCT02202161|584151746|FG001|Overall Study|Withdrawal by Subject|0|||
161757754|NCT02202161|584151747|FG002|Overall Study|Withdrawal by Subject|0|||
161846349|NCT03583086|584479037|FG000|Overall Study|Still on study|0|||
161846350|NCT03583086|584479038|FG001|Overall Study|Still on study|0|||
161846351|NCT03583086|584479039|FG002|Overall Study|Still on study|0|||
161846352|NCT03583086|584479040|FG003|Overall Study|Still on study|1|||
161846353|NCT03583086|584479041|FG004|Overall Study|Still on study|0|||
161970726|NCT00075725|584941028|FG007|Overall Study|Other complications|0|||
162032931|NCT00989573|585177506|FG001|Overall Study|Withdrawal by Subject|7|||
161757755|NCT02202161|584151748|FG003|Overall Study|Withdrawal by Subject|0|||
161757756|NCT02202161|584151749|FG004|Overall Study|Withdrawal by Subject|1|||
161757757|NCT02202161|584151750|FG005|Overall Study|Withdrawal by Subject|0|||
161757758|NCT02202161|584151751|FG006|Overall Study|Withdrawal by Subject|0|||
161757759|NCT02202161|584151752|FG007|Overall Study|Withdrawal by Subject|0|||
161757760|NCT03685643|584151755|FG000|Overall Study|Lost to Follow-up|14|||
161757761|NCT03685643|584151756|FG001|Overall Study|Lost to Follow-up|22|||
161757762|NCT03797144|584151757|FG000|Enrollment|Protocol Violation|4|||
161757763|NCT03797144|584151758|FG001|Enrollment|Protocol Violation|1|||
161757764|NCT03797144|584151757|FG000|Surgery|Protocol Violation|1|||
161757765|NCT03797144|584151758|FG001|Surgery|Protocol Violation|0|||
161757766|NCT03797144|584151757|FG000|3 Month|Early termination cut-off date|2|||
161757767|NCT03797144|584151758|FG001|3 Month|Early termination cut-off date|0|||
161757768|NCT03797144|584151757|FG000|12 Month|Early termination cut-off date|8|||
161757769|NCT03797144|584151758|FG001|12 Month|Early termination cut-off date|9|||
161757770|NCT03797144|584151757|FG000|24 Month|Early termination cut-off date|1|||
161757771|NCT03797144|584151758|FG001|24 Month|Early termination cut-off date|1|||
161757772|NCT03299166|584151761|FG000|Overall Study|Adverse Event|9|||
161757773|NCT03299166|584151762|FG001|Overall Study|Adverse Event|4|||
161757774|NCT03299166|584151761|FG000|Overall Study|Withdrawal by Subject|6|||
161757775|NCT03299166|584151762|FG001|Overall Study|Withdrawal by Subject|5|||
161757776|NCT03299166|584151761|FG000|Overall Study|Physician Decision|1|||
161757777|NCT03299166|584151762|FG001|Overall Study|Physician Decision|1|||
161757778|NCT03299166|584151761|FG000|Overall Study|Sponsor Decision|3|||
161757779|NCT03299166|584151762|FG001|Overall Study|Sponsor Decision|0|||
161757780|NCT03299166|584151761|FG000|Overall Study|Lost to Follow-up|2|||
161757781|NCT03299166|584151762|FG001|Overall Study|Lost to Follow-up|4|||
161757782|NCT03299166|584151761|FG000|Overall Study|Randomization Error|0|||
161757783|NCT03299166|584151762|FG001|Overall Study|Randomization Error|1|||
161757784|NCT03299166|584151761|FG000|Overall Study|Subject unable to return due to COVID|1|||
161757785|NCT03299166|584151762|FG001|Overall Study|Subject unable to return due to COVID|0|||
161757786|NCT03299166|584151761|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
161757787|NCT03299166|584151762|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
161757788|NCT00707486|584151767|FG000|Overall Study|Withdrawal by Subject|1|||
161757789|NCT01885104|584151776|FG000|Overall Study|Withdrawal of Consent|1|||
161757790|NCT01885104|584151777|FG001|Overall Study|Withdrawal of Consent|0|||
161757791|NCT01885104|584151776|FG000|Overall Study|Lost to Follow-up|0|||
161757792|NCT01885104|584151777|FG001|Overall Study|Lost to Follow-up|1|||
161757793|NCT01885104|584151776|FG000|Overall Study|Physician Decision|1|||
161757794|NCT01885104|584151777|FG001|Overall Study|Physician Decision|0|||
161757795|NCT00126425|584151779|FG000|Overall Study|Withdrawal by Subject|17|||
161757796|NCT00126425|584151780|FG001|Overall Study|Withdrawal by Subject|1|||
161757797|NCT00126425|584151779|FG000|Overall Study|Lost to Follow-up|8|||
161757798|NCT00126425|584151780|FG001|Overall Study|Lost to Follow-up|4|||
161757799|NCT00126425|584151779|FG000|Overall Study|Protocol Violation|9|||
161757800|NCT00126425|584151780|FG001|Overall Study|Protocol Violation|6|||
161757801|NCT00126425|584151779|FG000|Overall Study|Adverse Event|1|||
161757802|NCT00126425|584151780|FG001|Overall Study|Adverse Event|0|||
161757803|NCT00126425|584151779|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
161757804|NCT00126425|584151780|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
161757805|NCT00126425|584151779|FG000|Overall Study|Other|5|||
161757806|NCT00126425|584151780|FG001|Overall Study|Other|0|||
161757807|NCT01894776|584151781|FG000|Overall Study|Withdrawal by Subject|1|||
161757808|NCT01855919|584153952|FG000|Overall Study|Adverse Event|16|||
161757809|NCT01855919|584153953|FG001|Overall Study|Adverse Event|8|||
161757810|NCT01855919|584153952|FG000|Overall Study|Lack of Efficacy|1|||
161757811|NCT01855919|584153953|FG001|Overall Study|Lack of Efficacy|3|||
161757812|NCT01855919|584153952|FG000|Overall Study|Withdrawal by Subject|4|||
161757813|NCT01855919|584153953|FG001|Overall Study|Withdrawal by Subject|10|||
161757814|NCT01855919|584153952|FG000|Overall Study|Entry Criteria Not Met|1|||
161757815|NCT01855919|584153953|FG001|Overall Study|Entry Criteria Not Met|1|||
161757816|NCT01855919|584153952|FG000|Overall Study|Protocol Violation|1|||
161757817|NCT01855919|584153953|FG001|Overall Study|Protocol Violation|4|||
161757818|NCT01625897|584153956|FG000|Overall Study|Adverse Event|27|||
161846354|NCT03583086|584479042|FG005|Overall Study|Still on study|0|||
161970727|NCT00075725|584941029|FG008|Overall Study|Other complications|0|||
161757819|NCT01625897|584153957|FG001|Overall Study|Adverse Event|10|||
161757820|NCT01625897|584153956|FG000|Overall Study|Physician Decision|0|||
161757821|NCT01625897|584153957|FG001|Overall Study|Physician Decision|1|||
161970728|NCT00075725|584941030|FG009|Overall Study|Other complications|0|||
161757822|NCT01625897|584153956|FG000|Overall Study|Withdrawal by Subject|25|||
161757823|NCT01625897|584153957|FG001|Overall Study|Withdrawal by Subject|3|||
161757824|NCT03455530|584153958|FG000|Overall Study|Withdrawal by Subject|9|||
161970729|NCT00075725|584941031|FG010|Overall Study|Other complications|0|||
161757825|NCT03455530|584153959|FG001|Overall Study|Withdrawal by Subject|1|||
161757826|NCT03455530|584153960|FG002|Overall Study|Withdrawal by Subject|3|||
161757827|NCT03455530|584153961|FG003|Overall Study|Withdrawal by Subject|3|||
161757828|NCT02972658|584153966|FG000|Overall Study|Adverse Event|0|||
161757829|NCT02972658|584153967|FG001|Overall Study|Adverse Event|3|||
161757830|NCT02972658|584153968|FG002|Overall Study|Adverse Event|0|||
161757831|NCT02972658|584153969|FG003|Overall Study|Adverse Event|2|||
161757832|NCT02972658|584153966|FG000|Overall Study|Other-determined by Investigator|1|||
161757833|NCT02972658|584153967|FG001|Overall Study|Other-determined by Investigator|1|||
161757834|NCT02972658|584153968|FG002|Overall Study|Other-determined by Investigator|0|||
161757835|NCT02972658|584153969|FG003|Overall Study|Other-determined by Investigator|0|||
161757836|NCT02972658|584153966|FG000|Overall Study|Death|0|||
161757837|NCT02972658|584153967|FG001|Overall Study|Death|0|||
161757838|NCT02972658|584153968|FG002|Overall Study|Death|0|||
161757839|NCT02972658|584153969|FG003|Overall Study|Death|1|||
161757840|NCT02972658|584153966|FG000|Overall Study|Lost to Follow-up|0|||
161757841|NCT02972658|584153967|FG001|Overall Study|Lost to Follow-up|1|||
161757842|NCT02972658|584153968|FG002|Overall Study|Lost to Follow-up|1|||
161757843|NCT02972658|584153969|FG003|Overall Study|Lost to Follow-up|2|||
161757844|NCT02972658|584153966|FG000|Overall Study|Progressive Disease|0|||
161757845|NCT02972658|584153967|FG001|Overall Study|Progressive Disease|1|||
161757846|NCT02972658|584153968|FG002|Overall Study|Progressive Disease|0|||
161757847|NCT02972658|584153969|FG003|Overall Study|Progressive Disease|1|||
161757848|NCT02972658|584153966|FG000|Overall Study|Withdrawal by Subject|4|||
161757849|NCT02972658|584153967|FG001|Overall Study|Withdrawal by Subject|4|||
161757850|NCT02972658|584153968|FG002|Overall Study|Withdrawal by Subject|1|||
161757851|NCT02972658|584153969|FG003|Overall Study|Withdrawal by Subject|6|||
161757852|NCT02972658|584153966|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
161757853|NCT02972658|584153967|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
161757854|NCT02972658|584153968|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
161757855|NCT02972658|584153969|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
161757856|NCT02972658|584153966|FG000|Overall Study|Sponsor Decision|70|||
161757857|NCT02972658|584153967|FG001|Overall Study|Sponsor Decision|127|||
161757858|NCT02972658|584153968|FG002|Overall Study|Sponsor Decision|72|||
161757859|NCT02972658|584153969|FG003|Overall Study|Sponsor Decision|119|||
161757860|NCT03958149|584153974|FG000|Overall Study|Withdrawal by Subject|0|||
161757861|NCT03958149|584153975|FG001|Overall Study|Withdrawal by Subject|1|||
161757862|NCT02785588|584153978|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
161757863|NCT02785588|584153978|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
161757864|NCT03037489|584153979|FG000|Overall Study|Adverse Event|4|||
161757865|NCT03037489|584153980|FG001|Overall Study|Adverse Event|0|||
161757866|NCT03037489|584153979|FG000|Overall Study|Withdrawal by Subject|3|||
161757867|NCT03037489|584153980|FG001|Overall Study|Withdrawal by Subject|0|||
161757868|NCT00724243|584153982|FG000|Overall Study|Lack of Efficacy|10|||
161757869|NCT00724243|584153982|FG000|Overall Study|Adverse Event|5|||
161757870|NCT03031327|584153983|FG000|Overall Study|Withdrawal by Subject|0|||
161757871|NCT03031327|584153984|FG001|Overall Study|Withdrawal by Subject|1|||
161757872|NCT03031327|584153985|FG002|Overall Study|Withdrawal by Subject|1|||
161757873|NCT00669240|584153986|FG000|Overall Study|Lack of Efficacy|33|||
161757874|NCT00669240|584153986|FG000|Overall Study|Withdrawal by Subject|42|||
161757875|NCT00669240|584153986|FG000|Overall Study|Lost to Follow-up|34|||
161757876|NCT00669240|584153986|FG000|Overall Study|Adverse Event|21|||
161757877|NCT00669240|584153986|FG000|Overall Study|Other|19|||
161757878|NCT00669240|584153986|FG000|Overall Study|Enrolled but not treated|15|||
161757879|NCT00669240|584153986|FG000|Overall Study|Enrolled but no dosing record|1|||
161757880|NCT01997892|584153989|FG000|Overall Study|Physician Decision|2|||
161757881|NCT01997892|584153989|FG000|Overall Study|Lost to Follow-up|6|||
161757882|NCT01997892|584153989|FG000|Overall Study|Death|14|||
161757883|NCT01997892|584153989|FG000|Overall Study|Renal transplant|8|||
161757884|NCT01997892|584153989|FG000|Overall Study|Other|3|||
161757885|NCT01997892|584153989|FG000|Overall Study|Study completion data not recorded|35|||
161757886|NCT02531633|584153990|FG000|Part A (52 Weeks)|Sponsor request|24|||
161757887|NCT02531633|584153991|FG001|Part A (52 Weeks)|Sponsor request|24|||
161757888|NCT02531633|584153992|FG002|Part A (52 Weeks)|Sponsor request|18|||
161757889|NCT02531633|584153993|FG003|Part A (52 Weeks)|Sponsor request|18|||
161757890|NCT02531633|584153994|FG004|Part A (52 Weeks)|Sponsor request|19|||
161970730|NCT00075725|584941032|FG011|Overall Study|Other complications|0|||
161970731|NCT00075725|584941021|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
161970732|NCT00075725|584941022|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
161970733|NCT00075725|584941023|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
161970734|NCT00075725|584941024|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
161970735|NCT00075725|584941025|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
161757891|NCT02531633|584153995|FG005|Part A (52 Weeks)|Sponsor request|0|||
161757892|NCT02531633|584153996|FG006|Part A (52 Weeks)|Sponsor request|0|||
161757893|NCT02531633|584153997|FG007|Part A (52 Weeks)|Sponsor request|0|||
161757894|NCT02531633|584153998|FG008|Part A (52 Weeks)|Sponsor request|0|||
161757895|NCT02531633|584153999|FG009|Part A (52 Weeks)|Sponsor request|0|||
161757896|NCT02531633|584153990|FG000|Part A (52 Weeks)|Protocol Violation|1|||
161757897|NCT02531633|584153991|FG001|Part A (52 Weeks)|Protocol Violation|0|||
161757898|NCT02531633|584153992|FG002|Part A (52 Weeks)|Protocol Violation|0|||
161846355|NCT03583086|584479043|FG006|Overall Study|Still on study|1|||
161846356|NCT03583086|584479037|FG000|Overall Study|Disease progression|0|||
161846357|NCT03583086|584479038|FG001|Overall Study|Disease progression|0|||
161846358|NCT03583086|584479039|FG002|Overall Study|Disease progression|0|||
161846359|NCT03583086|584479040|FG003|Overall Study|Disease progression|0|||
161846360|NCT03583086|584479041|FG004|Overall Study|Disease progression|0|||
161846361|NCT03583086|584479042|FG005|Overall Study|Disease progression|0|||
161846362|NCT03583086|584479043|FG006|Overall Study|Disease progression|1|||
161846363|NCT03583086|584479037|FG000|Overall Study|Undergoing radiation therapy|0|||
161846364|NCT03583086|584479038|FG001|Overall Study|Undergoing radiation therapy|0|||
161846365|NCT03583086|584479039|FG002|Overall Study|Undergoing radiation therapy|0|||
161846366|NCT03583086|584479040|FG003|Overall Study|Undergoing radiation therapy|0|||
161846367|NCT03583086|584479041|FG004|Overall Study|Undergoing radiation therapy|0|||
161846368|NCT03583086|584479042|FG005|Overall Study|Undergoing radiation therapy|0|||
161846369|NCT03583086|584479043|FG006|Overall Study|Undergoing radiation therapy|1|||
161846370|NCT03583086|584479037|FG000|Overall Study|Lost to Follow-up|0|||
161846371|NCT03583086|584479038|FG001|Overall Study|Lost to Follow-up|0|||
161846372|NCT03583086|584479039|FG002|Overall Study|Lost to Follow-up|0|||
161846373|NCT03583086|584479040|FG003|Overall Study|Lost to Follow-up|0|||
161846374|NCT03583086|584479041|FG004|Overall Study|Lost to Follow-up|0|||
161846375|NCT03583086|584479042|FG005|Overall Study|Lost to Follow-up|1|||
161757899|NCT02531633|584153993|FG003|Part A (52 Weeks)|Protocol Violation|0|||
161757900|NCT02531633|584153994|FG004|Part A (52 Weeks)|Protocol Violation|0|||
161757901|NCT02531633|584153995|FG005|Part A (52 Weeks)|Protocol Violation|0|||
161757902|NCT02531633|584153996|FG006|Part A (52 Weeks)|Protocol Violation|0|||
161757903|NCT02531633|584153997|FG007|Part A (52 Weeks)|Protocol Violation|0|||
161757904|NCT02531633|584153998|FG008|Part A (52 Weeks)|Protocol Violation|0|||
161757905|NCT02531633|584153999|FG009|Part A (52 Weeks)|Protocol Violation|0|||
161757906|NCT02531633|584153990|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
161757907|NCT02531633|584153991|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
161757908|NCT02531633|584153992|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
161757909|NCT02531633|584153993|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
161757910|NCT02531633|584153994|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
161757911|NCT02531633|584153995|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
161757912|NCT02531633|584153996|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
161757913|NCT02531633|584153997|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
161757914|NCT02531633|584153998|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
161757915|NCT02531633|584153999|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
161757916|NCT02531633|584153990|FG000|Part A (52 Weeks)|Physician Decision|1|||
161757917|NCT02531633|584153991|FG001|Part A (52 Weeks)|Physician Decision|4|||
161757918|NCT02531633|584153992|FG002|Part A (52 Weeks)|Physician Decision|3|||
161757919|NCT02531633|584153993|FG003|Part A (52 Weeks)|Physician Decision|1|||
161757920|NCT02531633|584153994|FG004|Part A (52 Weeks)|Physician Decision|0|||
161757921|NCT02531633|584153995|FG005|Part A (52 Weeks)|Physician Decision|0|||
161757922|NCT02531633|584153996|FG006|Part A (52 Weeks)|Physician Decision|0|||
161757923|NCT02531633|584153997|FG007|Part A (52 Weeks)|Physician Decision|0|||
161757924|NCT02531633|584153998|FG008|Part A (52 Weeks)|Physician Decision|0|||
161757925|NCT02531633|584153999|FG009|Part A (52 Weeks)|Physician Decision|0|||
161757926|NCT02531633|584153990|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
161757927|NCT02531633|584153991|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
161757928|NCT02531633|584153992|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
161757929|NCT02531633|584153993|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
161757930|NCT02531633|584153994|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
161757931|NCT02531633|584153995|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
161757932|NCT02531633|584153996|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
161757933|NCT02531633|584153997|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
161757934|NCT02531633|584153998|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
161757935|NCT02531633|584153999|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
161757936|NCT02531633|584153990|FG000|Part A (52 Weeks)|Other|2|||
161757937|NCT02531633|584153991|FG001|Part A (52 Weeks)|Other|0|||
161757938|NCT02531633|584153992|FG002|Part A (52 Weeks)|Other|0|||
161757939|NCT02531633|584153993|FG003|Part A (52 Weeks)|Other|0|||
161757940|NCT02531633|584153994|FG004|Part A (52 Weeks)|Other|0|||
161757941|NCT02531633|584153995|FG005|Part A (52 Weeks)|Other|0|||
161757942|NCT02531633|584153996|FG006|Part A (52 Weeks)|Other|0|||
161757943|NCT02531633|584153997|FG007|Part A (52 Weeks)|Other|0|||
161846376|NCT03583086|584479043|FG006|Overall Study|Lost to Follow-up|0|||
161846377|NCT03583086|584479037|FG000|Overall Study|Adverse Event|0|||
161846378|NCT03583086|584479038|FG001|Overall Study|Adverse Event|0|||
161846379|NCT03583086|584479039|FG002|Overall Study|Adverse Event|0|||
161846380|NCT03583086|584479040|FG003|Overall Study|Adverse Event|0|||
161846381|NCT03583086|584479041|FG004|Overall Study|Adverse Event|0|||
161757944|NCT02531633|584153998|FG008|Part A (52 Weeks)|Other|0|||
161757945|NCT02531633|584153999|FG009|Part A (52 Weeks)|Other|0|||
161757946|NCT02531633|584153990|FG000|Part B (104 Weeks)|Sponsor request|0|||
161757947|NCT02531633|584153991|FG001|Part B (104 Weeks)|Sponsor request|0|||
161757948|NCT02531633|584153992|FG002|Part B (104 Weeks)|Sponsor request|0|||
162032932|NCT00989573|585177507|FG002|Overall Study|Withdrawal by Subject|3|||
162032933|NCT01445886|585177509|FG000|Overall Study|Lost to Follow-up|2|||
162032934|NCT01445886|585177509|FG000|Overall Study|Protocol Violation|3|||
162032935|NCT03473548|585177510|FG000|Overall Study|Did not attempt HST testing|3|||
162032936|NCT03473548|585177511|FG001|Overall Study|Did not attempt HST testing|0|||
162032937|NCT02207946|585177522|FG000|Overall Study|Lost to Follow-up|1|||
162032938|NCT02207946|585177523|FG001|Overall Study|Lost to Follow-up|0|||
162032939|NCT02207946|585177522|FG000|Overall Study|Adverse Event|0|||
162032940|NCT02207946|585177523|FG001|Overall Study|Adverse Event|1|||
162032941|NCT02829944|585177524|FG000|Overall Study|Physician Decision|0|||
162032942|NCT02829944|585177525|FG001|Overall Study|Physician Decision|1|||
162032943|NCT02829944|585177524|FG000|Overall Study|Screen Failure|2|||
162032944|NCT02829944|585177525|FG001|Overall Study|Screen Failure|2|||
162032945|NCT02829944|585177524|FG000|Overall Study|Inadequate Neuraxial Block|1|||
162032946|NCT02829944|585177525|FG001|Overall Study|Inadequate Neuraxial Block|1|||
162032947|NCT02829944|585177524|FG000|Overall Study|Withdrawal by Subject|2|||
162032948|NCT02829944|585177525|FG001|Overall Study|Withdrawal by Subject|1|||
162032949|NCT02829944|585177524|FG000|Overall Study|Catheter Displacement|1|||
162032950|NCT02829944|585177525|FG001|Overall Study|Catheter Displacement|0|||
162032951|NCT02829944|585177524|FG000|Overall Study|Catheter broke|0|||
162032952|NCT02829944|585177525|FG001|Overall Study|Catheter broke|1|||
162032953|NCT02829944|585177524|FG000|Overall Study|Staff unavailable|0|||
162032954|NCT02829944|585177525|FG001|Overall Study|Staff unavailable|1|||
161757949|NCT02531633|584153993|FG003|Part B (104 Weeks)|Sponsor request|0|||
161757950|NCT02531633|584153994|FG004|Part B (104 Weeks)|Sponsor request|0|||
161757951|NCT02531633|584153995|FG005|Part B (104 Weeks)|Sponsor request|8|||
161757952|NCT02531633|584153996|FG006|Part B (104 Weeks)|Sponsor request|5|||
161757953|NCT02531633|584153997|FG007|Part B (104 Weeks)|Sponsor request|3|||
161757954|NCT02531633|584153998|FG008|Part B (104 Weeks)|Sponsor request|5|||
161757955|NCT02531633|584153999|FG009|Part B (104 Weeks)|Sponsor request|4|||
161757956|NCT02531633|584153990|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
161757957|NCT02531633|584153991|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
161757958|NCT02531633|584153992|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
161757959|NCT02531633|584153993|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
161757960|NCT02531633|584153994|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
161757961|NCT02531633|584153995|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
161757962|NCT02531633|584153996|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
161757963|NCT02531633|584153997|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
161757964|NCT02531633|584153998|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
161757965|NCT02531633|584153999|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
161757966|NCT04097925|584154006|FG000|Overall Study|Withdrawal by Subject|1|||
161757967|NCT02608099|584154007|FG000|Overall Study|Ablation procedure not initiated|3|||
161757968|NCT02608099|584154008|FG001|Overall Study|Ablation procedure not initiated|2|||
161757969|NCT00087594|584154013|FG000|Overall Study|Adverse Event|2|||
161757970|NCT00087594|584154014|FG001|Overall Study|Adverse Event|3|||
161757971|NCT00087594|584154013|FG000|Overall Study|Lost to Follow-up|0|||
161757972|NCT00087594|584154014|FG001|Overall Study|Lost to Follow-up|2|||
161757973|NCT00087594|584154013|FG000|Overall Study|Withdrawal by Subject|4|||
161757974|NCT00087594|584154014|FG001|Overall Study|Withdrawal by Subject|2|||
161757975|NCT00087594|584154013|FG000|Overall Study|Lack of Efficacy|2|||
161757976|NCT00087594|584154014|FG001|Overall Study|Lack of Efficacy|5|||
161757977|NCT01952041|584154018|FG000|Overall Study|Lost to Follow-up|9|||
161757978|NCT01952041|584154019|FG001|Overall Study|Lost to Follow-up|16|||
161757979|NCT01952041|584154018|FG000|Overall Study|Withdrawal by Subject|7|||
161757980|NCT01952041|584154019|FG001|Overall Study|Withdrawal by Subject|5|||
161757981|NCT01952041|584154018|FG000|Overall Study|Death|1|||
161757982|NCT01952041|584154019|FG001|Overall Study|Death|0|||
161757983|NCT01736176|584154020|FG000|Overall Study|Adverse Event|3|||
161757984|NCT01736176|584154020|FG000|Overall Study|Withdrawal by Subject|4|||
161757985|NCT01736176|584154020|FG000|Overall Study|Lack of Efficacy|3|||
161757986|NCT01736176|584154020|FG000|Overall Study|Unable to Complete PEG Placement|1|||
161757987|NCT01569568|584154021|FG000|Overall Study|Physician Decision|0|||
161757988|NCT01569568|584154022|FG001|Overall Study|Physician Decision|2|||
161757989|NCT00290355|584154027|FG000|Overall Study|Serious adverse event|7|||
161757990|NCT00290355|584154028|FG001|Overall Study|Serious adverse event|4|||
161757991|NCT00290355|584154027|FG000|Overall Study|Study product reactogenicity|1|||
161757992|NCT00290355|584154028|FG001|Overall Study|Study product reactogenicity|0|||
161846382|NCT03583086|584479042|FG005|Overall Study|Adverse Event|1|||
161757993|NCT00290355|584154027|FG000|Overall Study|Protocol Violation|1|||
161757994|NCT00290355|584154028|FG001|Overall Study|Protocol Violation|0|||
161757995|NCT00290355|584154027|FG000|Overall Study|Withdrawal by Subject|2|||
161757996|NCT00290355|584154028|FG001|Overall Study|Withdrawal by Subject|0|||
161757997|NCT00290355|584154027|FG000|Overall Study|Migrated / moved from the study area|1|||
161757998|NCT00290355|584154028|FG001|Overall Study|Migrated / moved from the study area|0|||
161846383|NCT03583086|584479043|FG006|Overall Study|Adverse Event|0|||
162032955|NCT05856760|585177526|FG000|Overall Study|Adverse Event|2|||
162032956|NCT05856760|585177526|FG000|Overall Study|Physician Decision|1|||
161846384|NCT00396812|584479047|FG000|Overall Study|Physician Decision|1|||
161846385|NCT03201445|584479049|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
161846386|NCT03201445|584479050|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
161846387|NCT03201445|584479049|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
161846388|NCT03201445|584479050|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
161846389|NCT03201445|584479049|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
161846390|NCT03201445|584479050|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
161846391|NCT03201445|584479049|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
161846392|NCT03201445|584479050|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
161846393|NCT03201445|584479049|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
161846394|NCT03201445|584479050|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
161846395|NCT03201445|584479049|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
161846396|NCT03201445|584479050|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
161846397|NCT03201445|584479049|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
161846398|NCT03201445|584479050|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
161846399|NCT03201445|584479049|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
161846400|NCT03201445|584479050|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
161970736|NCT00075725|584941026|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
161970737|NCT00075725|584941027|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
161970738|NCT00075725|584941028|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
161970739|NCT00075725|584941029|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
161970740|NCT00075725|584941030|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
161970741|NCT00075725|584941031|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
161970742|NCT00075725|584941032|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
161970743|NCT00075725|584941021|FG000|Overall Study|Pt incarcerated|0|||
161970744|NCT00075725|584941022|FG001|Overall Study|Pt incarcerated|0|||
161970745|NCT00075725|584941023|FG002|Overall Study|Pt incarcerated|0|||
161970746|NCT00075725|584941024|FG003|Overall Study|Pt incarcerated|0|||
161970747|NCT00075725|584941025|FG004|Overall Study|Pt incarcerated|0|||
161970748|NCT00075725|584941026|FG005|Overall Study|Pt incarcerated|0|||
161970749|NCT00075725|584941027|FG006|Overall Study|Pt incarcerated|0|||
161970750|NCT00075725|584941028|FG007|Overall Study|Pt incarcerated|1|||
161970751|NCT00075725|584941029|FG008|Overall Study|Pt incarcerated|0|||
161970752|NCT00075725|584941030|FG009|Overall Study|Pt incarcerated|0|||
161970753|NCT00075725|584941031|FG010|Overall Study|Pt incarcerated|0|||
161970754|NCT00075725|584941032|FG011|Overall Study|Pt incarcerated|0|||
161970755|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Death|1|||
161970756|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Death|1|||
161970757|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Death|0|||
161970758|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Death|0|||
161970759|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Death|1|||
161970760|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Death|0|||
161970761|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Death|0|||
161970762|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Death|0|||
161970763|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Death|0|||
161970764|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Death|0|||
161970765|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
161970766|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
161970767|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
161970768|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
161970769|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
161970770|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
161970771|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
161970772|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
161970773|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
161970774|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
161970775|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161970776|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161970777|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161970778|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161970779|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
161970780|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161970781|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161970782|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
162032957|NCT05856760|585177526|FG000|Overall Study|Protocol Violation|1|||
161970783|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161970784|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161970785|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
161970786|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161846401|NCT03201445|584479049|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
161846402|NCT03201445|584479050|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
161970787|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161970788|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
162032958|NCT05856760|585177526|FG000|Overall Study|Withdrawal by Subject|3|||
162032959|NCT04675151|585177527|FG000|Overall Study|Protocol Violation|1|||
161757999|NCT00290355|584154027|FG000|Overall Study|Lost to Follow-up|3|||
161758000|NCT00290355|584154028|FG001|Overall Study|Lost to Follow-up|1|||
161758001|NCT00290355|584154027|FG000|Overall Study|Other|2|||
161758002|NCT00290355|584154028|FG001|Overall Study|Other|0|||
161758003|NCT03345849|584154029|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
161758004|NCT03345849|584154030|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
161758005|NCT03345849|584154031|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
161758006|NCT03345849|584154032|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
161758007|NCT03345849|584154029|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
161758008|NCT03345849|584154030|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
161758009|NCT03345849|584154031|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
161758010|NCT03345849|584154032|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
161758011|NCT03345849|584154029|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
161758012|NCT03345849|584154030|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
161758013|NCT03345849|584154031|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
161758014|NCT03345849|584154032|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
161758015|NCT03345849|584154029|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
161758016|NCT03345849|584154030|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
161758017|NCT03345849|584154031|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
161758018|NCT03345849|584154032|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
161758019|NCT03345849|584154029|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
161758020|NCT03345849|584154030|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
161758021|NCT03345849|584154031|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
161758022|NCT03345849|584154032|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
161758023|NCT03345849|584154029|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
161758024|NCT03345849|584154030|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
161758025|NCT03345849|584154031|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
161758026|NCT03345849|584154032|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
161758027|NCT03345849|584154029|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
161758028|NCT03345849|584154030|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
161758029|NCT03345849|584154031|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
161758030|NCT03345849|584154032|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
161758031|NCT03345849|584154029|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
161758032|NCT03345849|584154030|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
161758033|NCT03345849|584154031|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
161758034|NCT03345849|584154032|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
161758035|NCT03345849|584154029|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161758036|NCT03345849|584154030|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161758037|NCT03345849|584154031|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161758038|NCT03345849|584154032|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
161758039|NCT03345849|584154029|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
161758040|NCT03345849|584154030|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
161758041|NCT03345849|584154031|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
161758042|NCT03345849|584154032|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
161758043|NCT03345849|584154029|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
161758044|NCT03345849|584154030|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
161758045|NCT03345849|584154031|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
161758046|NCT03345849|584154032|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
161758047|NCT03991936|584154033|FG000|Overall Study|Lost to Follow-up|1|||
161758048|NCT03991936|584154034|FG001|Overall Study|Lost to Follow-up|1|||
161758049|NCT03991936|584154035|FG002|Overall Study|Lost to Follow-up|1|||
161758050|NCT03991936|584154036|FG003|Overall Study|Lost to Follow-up|1|||
161758051|NCT03991936|584154037|FG004|Overall Study|Lost to Follow-up|1|||
161758052|NCT00939055|584154038|FG000|Overall Study|Discontinuation prior to procedure|4|||
161758053|NCT00939055|584154039|FG001|Overall Study|Discontinuation prior to procedure|0|||
161758054|NCT00584987|584154040|FG000|Overall Study|Protocol Violation|1|||
161846403|NCT03201445|584479049|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
161846404|NCT03201445|584479050|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
161846405|NCT03201445|584479049|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
161758055|NCT00584987|584154041|FG001|Overall Study|Protocol Violation|1|||
161758056|NCT00584987|584154042|FG002|Overall Study|Protocol Violation|1|||
161758057|NCT00584987|584154043|FG003|Overall Study|Protocol Violation|0|||
161846406|NCT03201445|584479050|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
161758058|NCT00584987|584154040|FG000|Overall Study|Adverse Event|0|||
161758059|NCT00584987|584154041|FG001|Overall Study|Adverse Event|0|||
161846407|NCT03201445|584479049|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
161846408|NCT03201445|584479050|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
161846409|NCT03201445|584479049|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
161846410|NCT03201445|584479050|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
161846411|NCT03201445|584479049|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
161846412|NCT03201445|584479050|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
161846413|NCT03201445|584479049|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
161846414|NCT03201445|584479050|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
161846415|NCT03201445|584479049|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
161846416|NCT03201445|584479050|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
161846417|NCT03201445|584479049|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
161846418|NCT03201445|584479050|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
161846419|NCT03201445|584479049|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
161846420|NCT03201445|584479050|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
161846421|NCT03201445|584479049|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
161846422|NCT03201445|584479050|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
161846423|NCT03201445|584479049|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
161846424|NCT03201445|584479050|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
161846425|NCT03201445|584479049|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
161846426|NCT03201445|584479050|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
161846427|NCT01228019|584479051|FG000|Overall Study|Dose Violation|70|||
161846428|NCT01228019|584479051|FG000|Overall Study|Duplicate enrollment|1|||
161846429|NCT01228019|584479051|FG000|Overall Study|Missing pre-treatment data|72|||
161846430|NCT01228019|584479051|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
161846431|NCT01228019|584479051|FG000|Overall Study|Violation of Entry Criterion|9|||
161846432|NCT01346293|584479054|FG000|Overall Study|Protocol Violation|30|||
161846433|NCT01346293|584479055|FG001|Overall Study|Protocol Violation|9|||
161846434|NCT01346293|584479054|FG000|Overall Study|Lost to Follow-up|21|||
161846435|NCT01346293|584479055|FG001|Overall Study|Lost to Follow-up|8|||
161846436|NCT01346293|584479054|FG000|Overall Study|Withdrawal by Subject|15|||
161846437|NCT01346293|584479055|FG001|Overall Study|Withdrawal by Subject|4|||
161970789|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161970790|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161970791|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161970792|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161970793|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161970794|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
161970795|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
161970796|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161970797|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161970798|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
161970799|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
161970800|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161970801|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161970802|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161970803|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
162032960|NCT04675151|585177528|FG001|Overall Study|Protocol Violation|0|||
161758060|NCT00584987|584154042|FG002|Overall Study|Adverse Event|0|||
161758061|NCT00584987|584154043|FG003|Overall Study|Adverse Event|1|||
161758062|NCT01944462|584154047|FG000|PPPP Educational Program|Lost to Follow-up|60|||
161758063|NCT00808028|584154048|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
161758064|NCT00808028|584154049|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
161758065|NCT00808028|584154050|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
161758066|NCT00808028|584154051|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
161758067|NCT00808028|584154048|FG000|Stage 1 (6 Months)|Other|1|||
161758068|NCT00808028|584154049|FG001|Stage 1 (6 Months)|Other|0|||
161758069|NCT00808028|584154050|FG002|Stage 1 (6 Months)|Other|2|||
161758070|NCT00808028|584154051|FG003|Stage 1 (6 Months)|Other|4|||
161758071|NCT00808028|584154048|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
161758072|NCT00808028|584154049|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
161758073|NCT00808028|584154050|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
161758074|NCT00808028|584154051|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
161758075|NCT00808028|584154048|FG000|Stage 1 (6 Months)|Adverse Event|0|||
161758076|NCT00808028|584154049|FG001|Stage 1 (6 Months)|Adverse Event|0|||
161758077|NCT00808028|584154050|FG002|Stage 1 (6 Months)|Adverse Event|1|||
161758078|NCT00808028|584154051|FG003|Stage 1 (6 Months)|Adverse Event|2|||
161758079|NCT00808028|584154048|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
161758080|NCT00808028|584154049|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
161758081|NCT00808028|584154050|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
161758082|NCT00808028|584154051|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
161970804|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
161970805|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
161970806|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161970807|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161970808|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
161970809|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161970810|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161970811|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161970812|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161970813|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161970814|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
161970815|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
161970816|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
161970817|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
161970818|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
161970819|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
161970820|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
161970821|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
161970822|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
161970823|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
161970824|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
161970825|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
162032961|NCT04675151|585177529|FG002|Overall Study|Protocol Violation|0|||
162032962|NCT04675151|585177530|FG003|Overall Study|Protocol Violation|1|||
161758083|NCT00808028|584154048|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
161758084|NCT00808028|584154049|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
161758085|NCT00808028|584154050|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
161758086|NCT00808028|584154051|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
161758087|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
161758088|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
161758089|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
161758090|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
161758091|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
161758092|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
161758093|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
161758094|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
161758095|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
161758096|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
161758097|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
161758098|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
161758099|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
161758100|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
161758101|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
161758102|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
161758103|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
161758104|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
161758105|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
161758106|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
161758107|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
161758108|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
161758109|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
161758110|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
161758111|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
161758112|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
161758113|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
161758114|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
161758115|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
161758116|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
161758117|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
161758118|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
161758119|NCT00808028|584154048|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
161758120|NCT00808028|584154049|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
161758121|NCT00808028|584154050|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
161758122|NCT00808028|584154051|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
161758123|NCT00723489|584154055|FG000|Overall Study|Physician Decision|0|||
161758124|NCT00723489|584154056|FG001|Overall Study|Physician Decision|1|||
161758125|NCT00723489|584154057|FG002|Overall Study|Physician Decision|0|||
161758126|NCT00723489|584154058|FG003|Overall Study|Physician Decision|0|||
161758127|NCT00723489|584154055|FG000|Overall Study|Pregnancy|0|||
161846438|NCT01346293|584479054|FG000|Overall Study|Other|1|||
161846439|NCT01346293|584479055|FG001|Overall Study|Other|0|||
161846440|NCT01844505|584479059|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
161846441|NCT01844505|584479060|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
161846442|NCT01844505|584479061|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
161846443|NCT01844505|584479059|FG000|Treatment Period|Other Reasons|120|||
161846444|NCT01844505|584479060|FG001|Treatment Period|Other Reasons|136|||
161846445|NCT01844505|584479061|FG002|Treatment Period|Other Reasons|58|||
161846446|NCT01844505|584479059|FG000|Treatment Period|Lost to Follow-up|9|||
161846447|NCT01844505|584479060|FG001|Treatment Period|Lost to Follow-up|11|||
161846448|NCT01844505|584479061|FG002|Treatment Period|Lost to Follow-up|6|||
161846449|NCT01844505|584479059|FG000|Treatment Period|Death|175|||
161846450|NCT01844505|584479060|FG001|Treatment Period|Death|154|||
161846451|NCT01844505|584479061|FG002|Treatment Period|Death|228|||
161846452|NCT00128830|584479062|FG000|Overall Study|Adverse Event|10|||
161846453|NCT00128830|584479062|FG000|Overall Study|Withdrawal by Subject|14|||
161846454|NCT00128830|584479062|FG000|Overall Study|Lost to Follow-up|4|||
161846455|NCT00128830|584479062|FG000|Overall Study|Reached a virologic endpoint|29|||
161846456|NCT00128830|584479062|FG000|Overall Study|Non-compliant|4|||
161846457|NCT00128830|584479062|FG000|Overall Study|Discontinued or ineligible for study|2|||
161846458|NCT00128830|584479062|FG000|Overall Study|Other|9|||
161846459|NCT00311402|584479063|FG000|Overall Study|Adverse Event|118|||
161846460|NCT00311402|584479064|FG001|Overall Study|Adverse Event|105|||
161846461|NCT00311402|584479063|FG000|Overall Study|Lost to Follow-up|0|||
161846462|NCT00311402|584479064|FG001|Overall Study|Lost to Follow-up|3|||
161846463|NCT00311402|584479063|FG000|Overall Study|Withdrawal by Subject|17|||
161846464|NCT00311402|584479064|FG001|Overall Study|Withdrawal by Subject|18|||
161846465|NCT00311402|584479063|FG000|Overall Study|Lack of Efficacy|58|||
161846466|NCT00311402|584479064|FG001|Overall Study|Lack of Efficacy|42|||
161846467|NCT00311402|584479063|FG000|Overall Study|Protocol Violation|7|||
161846468|NCT00311402|584479064|FG001|Overall Study|Protocol Violation|6|||
161846469|NCT00311402|584479063|FG000|Overall Study|IRB's rejection etc.|10|||
161846470|NCT00311402|584479064|FG001|Overall Study|IRB's rejection etc.|3|||
161846471|NCT02640053|584479065|FG000|Overall Study|Withdrawal by Subject|2|||
161846472|NCT02640053|584479066|FG001|Overall Study|Withdrawal by Subject|1|||
161846473|NCT02640053|584479065|FG000|Overall Study|Adverse Event|1|||
161846474|NCT02640053|584479066|FG001|Overall Study|Adverse Event|1|||
161846475|NCT02640053|584479065|FG000|Overall Study|Alternative Therapy|1|||
161846476|NCT02640053|584479066|FG001|Overall Study|Alternative Therapy|1|||
161846477|NCT02640053|584479065|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
161846478|NCT02640053|584479066|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
161846479|NCT02754856|584479068|FG000|Overall Study|Withdrawal by Subject|1|||
161846480|NCT03477903|584479071|FG000|Overall Study|Study Terminated by Sponsor|1|||
161846481|NCT00474266|584479072|FG000|Overall Study|Withdrawal by Subject|7|||
161846482|NCT00474266|584479073|FG001|Overall Study|Withdrawal by Subject|20|||
161846483|NCT00474266|584479074|FG002|Overall Study|Withdrawal by Subject|4|||
161758128|NCT00723489|584154056|FG001|Overall Study|Pregnancy|0|||
161758129|NCT00723489|584154057|FG002|Overall Study|Pregnancy|0|||
161758130|NCT00723489|584154058|FG003|Overall Study|Pregnancy|1|||
161758131|NCT00723489|584154055|FG000|Overall Study|Withdrawal by Subject|0|||
161758132|NCT00723489|584154056|FG001|Overall Study|Withdrawal by Subject|0|||
161758133|NCT00723489|584154057|FG002|Overall Study|Withdrawal by Subject|0|||
161758134|NCT00723489|584154058|FG003|Overall Study|Withdrawal by Subject|1|||
161758135|NCT00723489|584154055|FG000|Overall Study|Seropositive at baseline|1|||
161758136|NCT00723489|584154056|FG001|Overall Study|Seropositive at baseline|0|||
161758137|NCT00723489|584154057|FG002|Overall Study|Seropositive at baseline|0|||
161758138|NCT00723489|584154058|FG003|Overall Study|Seropositive at baseline|0|||
161758139|NCT00723489|584154055|FG000|Overall Study|Prohibited Medication|0|||
161758140|NCT00723489|584154056|FG001|Overall Study|Prohibited Medication|0|||
161758141|NCT00723489|584154057|FG002|Overall Study|Prohibited Medication|0|||
161758142|NCT00723489|584154058|FG003|Overall Study|Prohibited Medication|1|||
161758143|NCT00723489|584154055|FG000|Overall Study|Samples Collected Out of Window|0|||
161758144|NCT00723489|584154056|FG001|Overall Study|Samples Collected Out of Window|3|||
161758145|NCT00723489|584154057|FG002|Overall Study|Samples Collected Out of Window|0|||
161758146|NCT00723489|584154058|FG003|Overall Study|Samples Collected Out of Window|0|||
161846484|NCT00474266|584479075|FG003|Overall Study|Withdrawal by Subject|7|||
161846485|NCT02329847|584479076|FG000|Overall Study|Death|4|||
161846486|NCT02329847|584479077|FG001|Overall Study|Death|4|||
161846487|NCT02329847|584479078|FG002|Overall Study|Death|22|||
161846488|NCT02329847|584479079|FG003|Overall Study|Death|12|||
161846489|NCT02329847|584479080|FG004|Overall Study|Death|20|||
161846490|NCT02329847|584479081|FG005|Overall Study|Death|13|||
161758147|NCT01599585|584154059|FG000|Overall Study|Withdrawal by Subject|16|||
161846491|NCT02329847|584479076|FG000|Overall Study|Lost to Follow-up|0|||
161846492|NCT02329847|584479077|FG001|Overall Study|Lost to Follow-up|0|||
161846493|NCT02329847|584479078|FG002|Overall Study|Lost to Follow-up|2|||
161846494|NCT02329847|584479079|FG003|Overall Study|Lost to Follow-up|3|||
161970826|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
161970827|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
161970828|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161970829|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
161970830|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161970831|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161970832|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161970833|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161970834|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161970835|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
161970836|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161970837|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161970838|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
161970839|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
161970840|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161970841|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161970842|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161970843|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161970844|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
161970845|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161970846|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161970847|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161970848|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161970849|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161970850|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161970851|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161970852|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161970853|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161970854|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161970855|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970856|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970857|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
161970858|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970859|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
161970860|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970861|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970862|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970863|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970864|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970865|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
161970866|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
161970867|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
161970868|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
161970869|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
161970870|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
161970871|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
161970872|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
161970873|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
161970874|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
161970875|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161970876|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161970877|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161846495|NCT02329847|584479080|FG004|Overall Study|Lost to Follow-up|0|||
161846496|NCT02329847|584479081|FG005|Overall Study|Lost to Follow-up|1|||
161846497|NCT02329847|584479076|FG000|Overall Study|Physician Decision|0|||
161846498|NCT02329847|584479077|FG001|Overall Study|Physician Decision|0|||
161846499|NCT02329847|584479078|FG002|Overall Study|Physician Decision|0|||
161846500|NCT02329847|584479079|FG003|Overall Study|Physician Decision|0|||
161846501|NCT02329847|584479080|FG004|Overall Study|Physician Decision|1|||
161846502|NCT02329847|584479081|FG005|Overall Study|Physician Decision|0|||
161846503|NCT02329847|584479076|FG000|Overall Study|Withdrawal by Subject|2|||
161846504|NCT02329847|584479077|FG001|Overall Study|Withdrawal by Subject|1|||
161846505|NCT02329847|584479078|FG002|Overall Study|Withdrawal by Subject|5|||
161846506|NCT02329847|584479079|FG003|Overall Study|Withdrawal by Subject|7|||
161846507|NCT02329847|584479080|FG004|Overall Study|Withdrawal by Subject|8|||
161846508|NCT02329847|584479081|FG005|Overall Study|Withdrawal by Subject|3|||
161846509|NCT02329847|584479076|FG000|Overall Study|Other|1|||
161846510|NCT02329847|584479077|FG001|Overall Study|Other|2|||
161846511|NCT02329847|584479078|FG002|Overall Study|Other|6|||
161846512|NCT02329847|584479079|FG003|Overall Study|Other|13|||
161846513|NCT02329847|584479080|FG004|Overall Study|Other|10|||
161846514|NCT02329847|584479081|FG005|Overall Study|Other|3|||
161846515|NCT05330468|584479082|FG000|Overall Study|Death|6|||
161846516|NCT05330468|584479082|FG000|Overall Study|Withdrawal by Subject|4|||
161970878|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
161970879|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
161970880|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161970881|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161758148|NCT01599585|584154060|FG001|Overall Study|Withdrawal by Subject|9|||
161758149|NCT01599585|584154059|FG000|Overall Study|Lost to Follow-up|3|||
161758150|NCT01599585|584154060|FG001|Overall Study|Lost to Follow-up|5|||
161758151|NCT01599585|584154059|FG000|Overall Study|randomized did not start treatment|3|||
161758152|NCT01599585|584154060|FG001|Overall Study|randomized did not start treatment|3|||
161758153|NCT03657576|584154061|FG000|Overall Study|Death|0|||
161758154|NCT03657576|584154062|FG001|Overall Study|Death|1|||
161758155|NCT03657576|584154063|FG002|Overall Study|Death|1|||
161758156|NCT03657576|584154064|FG003|Overall Study|Death|0|||
161758157|NCT03657576|584154065|FG004|Overall Study|Death|0|||
161758158|NCT03657576|584154066|FG005|Overall Study|Death|0|||
161758159|NCT03657576|584154061|FG000|Overall Study|Withdrawal by Subject|0|||
161758160|NCT03657576|584154062|FG001|Overall Study|Withdrawal by Subject|0|||
161758161|NCT03657576|584154063|FG002|Overall Study|Withdrawal by Subject|0|||
161758162|NCT03657576|584154064|FG003|Overall Study|Withdrawal by Subject|1|||
161758163|NCT03657576|584154065|FG004|Overall Study|Withdrawal by Subject|0|||
161758164|NCT03657576|584154066|FG005|Overall Study|Withdrawal by Subject|0|||
161758165|NCT03657576|584154061|FG000|Overall Study|Screen Fail|0|||
161758166|NCT03657576|584154062|FG001|Overall Study|Screen Fail|0|||
161758167|NCT03657576|584154063|FG002|Overall Study|Screen Fail|0|||
161758168|NCT03657576|584154064|FG003|Overall Study|Screen Fail|0|||
161758169|NCT03657576|584154065|FG004|Overall Study|Screen Fail|0|||
161758170|NCT03657576|584154066|FG005|Overall Study|Screen Fail|5|||
161758171|NCT03657576|584154061|FG000|Overall Study|Disease Progression|1|||
161758172|NCT03657576|584154062|FG001|Overall Study|Disease Progression|1|||
161758173|NCT03657576|584154063|FG002|Overall Study|Disease Progression|0|||
161758174|NCT03657576|584154064|FG003|Overall Study|Disease Progression|5|||
161758175|NCT03657576|584154065|FG004|Overall Study|Disease Progression|0|||
161758176|NCT03657576|584154066|FG005|Overall Study|Disease Progression|0|||
161758177|NCT03657576|584154061|FG000|Overall Study|Insurance Coverage|0|||
161758178|NCT03657576|584154062|FG001|Overall Study|Insurance Coverage|0|||
161758179|NCT03657576|584154063|FG002|Overall Study|Insurance Coverage|0|||
161758180|NCT03657576|584154064|FG003|Overall Study|Insurance Coverage|1|||
161758181|NCT03657576|584154065|FG004|Overall Study|Insurance Coverage|0|||
161758182|NCT03657576|584154066|FG005|Overall Study|Insurance Coverage|0|||
161758183|NCT04437511|584154067|FG000|Overall Study|Adverse Event|50|||
161758184|NCT04437511|584154068|FG001|Overall Study|Adverse Event|21|||
161758185|NCT04437511|584154067|FG000|Overall Study|Death|15|||
161758186|NCT04437511|584154068|FG001|Overall Study|Death|10|||
161758187|NCT04437511|584154067|FG000|Overall Study|Lost to Follow-up|11|||
161758188|NCT04437511|584154068|FG001|Overall Study|Lost to Follow-up|11|||
161758189|NCT04437511|584154067|FG000|Overall Study|Physician Decision|19|||
161758190|NCT04437511|584154068|FG001|Overall Study|Physician Decision|10|||
161846517|NCT05330468|584479082|FG000|Overall Study|Lost to Follow-up|4|||
161846518|NCT02828241|584479085|FG000|Overall Study|Adverse Event|7|||
161846519|NCT02828241|584479086|FG001|Overall Study|Adverse Event|2|||
161758191|NCT04437511|584154067|FG000|Overall Study|Progressive Disease|4|||
161758192|NCT04437511|584154068|FG001|Overall Study|Progressive Disease|7|||
161758193|NCT04437511|584154067|FG000|Overall Study|Withdrawal by Subject|111|||
161758194|NCT04437511|584154068|FG001|Overall Study|Withdrawal by Subject|94|||
161758195|NCT04437511|584154067|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
161758196|NCT04437511|584154068|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
161846520|NCT02828241|584479085|FG000|Overall Study|Protocol Violation|1|||
161970882|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161970883|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161970884|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161970885|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
161970886|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161970887|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
161970888|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
161970889|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
161970890|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161970891|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161970892|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161970893|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161970894|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161846521|NCT02828241|584479086|FG001|Overall Study|Protocol Violation|0|||
161846522|NCT04572893|584479087|FG000|Part A|Adverse Event|1|||
161846523|NCT04572893|584479088|FG001|Part A|Adverse Event|0|||
161846524|NCT04572893|584479089|FG002|Part A|Adverse Event|0|||
161846525|NCT04572893|584479090|FG003|Part A|Adverse Event|0|||
161846526|NCT04572893|584479091|FG004|Part A|Adverse Event|0|||
161846527|NCT04572893|584479092|FG005|Part A|Adverse Event|0|||
161846528|NCT04572893|584479093|FG006|Part A|Adverse Event|0|||
161846529|NCT04572893|584479087|FG000|Part B|Withdrawal by Subject|0|||
161846530|NCT04572893|584479088|FG001|Part B|Withdrawal by Subject|0|||
161846531|NCT04572893|584479089|FG002|Part B|Withdrawal by Subject|0|||
161846532|NCT04572893|584479090|FG003|Part B|Withdrawal by Subject|0|||
161846533|NCT04572893|584479091|FG004|Part B|Withdrawal by Subject|0|||
161846534|NCT04572893|584479092|FG005|Part B|Withdrawal by Subject|1|||
161846535|NCT04572893|584479093|FG006|Part B|Withdrawal by Subject|0|||
161846536|NCT04572893|584479087|FG000|Part B|Study terminated by sponsor|0|||
161846537|NCT04572893|584479088|FG001|Part B|Study terminated by sponsor|0|||
161846538|NCT04572893|584479089|FG002|Part B|Study terminated by sponsor|0|||
161846539|NCT04572893|584479090|FG003|Part B|Study terminated by sponsor|0|||
161846540|NCT04572893|584479091|FG004|Part B|Study terminated by sponsor|7|||
161846541|NCT04572893|584479092|FG005|Part B|Study terminated by sponsor|5|||
161846542|NCT04572893|584479093|FG006|Part B|Study terminated by sponsor|3|||
161846543|NCT04572893|584479087|FG000|Part B|Lost to Follow-up|0|||
161846544|NCT04572893|584479088|FG001|Part B|Lost to Follow-up|0|||
161846545|NCT04572893|584479089|FG002|Part B|Lost to Follow-up|0|||
161846546|NCT04572893|584479090|FG003|Part B|Lost to Follow-up|0|||
161846547|NCT04572893|584479091|FG004|Part B|Lost to Follow-up|0|||
161846548|NCT04572893|584479092|FG005|Part B|Lost to Follow-up|0|||
161846549|NCT04572893|584479093|FG006|Part B|Lost to Follow-up|1|||
161846550|NCT04572893|584479087|FG000|Part B|Adverse Event|0|||
161846551|NCT04572893|584479088|FG001|Part B|Adverse Event|0|||
161846552|NCT04572893|584479089|FG002|Part B|Adverse Event|0|||
161846553|NCT04572893|584479090|FG003|Part B|Adverse Event|0|||
161846554|NCT04572893|584479091|FG004|Part B|Adverse Event|1|||
161846555|NCT04572893|584479092|FG005|Part B|Adverse Event|1|||
161846556|NCT04572893|584479093|FG006|Part B|Adverse Event|0|||
161846557|NCT01197755|584479101|FG000|Overall Study|Adverse Event|8|||
161846558|NCT01197755|584479102|FG001|Overall Study|Adverse Event|10|||
161846559|NCT01197755|584479103|FG002|Overall Study|Adverse Event|10|||
161846560|NCT01197755|584479101|FG000|Overall Study|Study-specific discontinuation criteria|2|||
161846561|NCT01197755|584479102|FG001|Overall Study|Study-specific discontinuation criteria|1|||
161846562|NCT01197755|584479103|FG002|Overall Study|Study-specific discontinuation criteria|0|||
161846563|NCT01197755|584479101|FG000|Overall Study|Entered the long-term extension study|18|||
161846564|NCT01197755|584479102|FG001|Overall Study|Entered the long-term extension study|21|||
161846565|NCT01197755|584479103|FG002|Overall Study|Entered the long-term extension study|35|||
161846566|NCT01197755|584479101|FG000|Overall Study|Lack of therapeutic response|0|||
161846567|NCT01197755|584479102|FG001|Overall Study|Lack of therapeutic response|7|||
161970895|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
161970896|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970897|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161846568|NCT01197755|584479103|FG002|Overall Study|Lack of therapeutic response|4|||
161846569|NCT01197755|584479101|FG000|Overall Study|Severe non-compliance to the protocol|2|||
161846570|NCT01197755|584479102|FG001|Overall Study|Severe non-compliance to the protocol|1|||
161846571|NCT01197755|584479103|FG002|Overall Study|Severe non-compliance to the protocol|2|||
161846572|NCT01197755|584479101|FG000|Overall Study|Withdrawal by Subject|1|||
161846573|NCT01197755|584479102|FG001|Overall Study|Withdrawal by Subject|0|||
161846574|NCT01197755|584479103|FG002|Overall Study|Withdrawal by Subject|0|||
161846575|NCT01197755|584479101|FG000|Overall Study|Lost to Follow-up|0|||
161846576|NCT01197755|584479102|FG001|Overall Study|Lost to Follow-up|0|||
161846577|NCT01197755|584479103|FG002|Overall Study|Lost to Follow-up|1|||
161846578|NCT01197755|584479101|FG000|Overall Study|eg, change in circumstances|7|||
161846579|NCT01197755|584479102|FG001|Overall Study|eg, change in circumstances|3|||
161846580|NCT01197755|584479103|FG002|Overall Study|eg, change in circumstances|2|||
161846581|NCT01372774|584479107|FG000|Overall Study|Withdrawal prior to treatment|4|||
161846582|NCT01372774|584479108|FG001|Overall Study|Withdrawal prior to treatment|5|||
161846583|NCT00070499|584480306|FG000|Overall Study|Adverse Event|6|||
161846584|NCT00070499|584480307|FG001|Overall Study|Adverse Event|6|||
161846585|NCT00070499|584480308|FG002|Overall Study|Adverse Event|19|||
161846586|NCT00070499|584480309|FG003|Overall Study|Adverse Event|15|||
161846587|NCT00070499|584480306|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
161846588|NCT00070499|584480307|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
161846589|NCT00070499|584480308|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
161846590|NCT00070499|584480309|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
161846591|NCT00070499|584480306|FG000|Overall Study|Progression/relapse|4|||
161846592|NCT00070499|584480307|FG001|Overall Study|Progression/relapse|2|||
161846593|NCT00070499|584480308|FG002|Overall Study|Progression/relapse|1|||
161846594|NCT00070499|584480309|FG003|Overall Study|Progression/relapse|4|||
161846595|NCT00070499|584480306|FG000|Overall Study|Death|1|||
161846596|NCT00070499|584480307|FG001|Overall Study|Death|1|||
161846597|NCT00070499|584480308|FG002|Overall Study|Death|1|||
161846598|NCT00070499|584480309|FG003|Overall Study|Death|2|||
161846599|NCT00070499|584480306|FG000|Overall Study|Other - not protocol specified|7|||
161846600|NCT00070499|584480307|FG001|Overall Study|Other - not protocol specified|3|||
161846601|NCT00070499|584480308|FG002|Overall Study|Other - not protocol specified|12|||
161846602|NCT00070499|584480309|FG003|Overall Study|Other - not protocol specified|20|||
161846603|NCT00070499|584480306|FG000|Overall Study|Still on protocol treatment|10|||
161846604|NCT00070499|584480307|FG001|Overall Study|Still on protocol treatment|4|||
161846605|NCT00070499|584480308|FG002|Overall Study|Still on protocol treatment|79|||
161846606|NCT00070499|584480309|FG003|Overall Study|Still on protocol treatment|57|||
161846607|NCT00070499|584480306|FG000|Overall Study|Did not start treatment|1|||
161846608|NCT00070499|584480307|FG001|Overall Study|Did not start treatment|0|||
161846609|NCT00070499|584480308|FG002|Overall Study|Did not start treatment|0|||
161846610|NCT00070499|584480309|FG003|Overall Study|Did not start treatment|2|||
161846611|NCT00070499|584480306|FG000|Overall Study|Not eligible|2|||
161846612|NCT00070499|584480307|FG001|Overall Study|Not eligible|5|||
161846613|NCT00070499|584480308|FG002|Overall Study|Not eligible|3|||
161846614|NCT00070499|584480309|FG003|Overall Study|Not eligible|2|||
161846615|NCT00805467|584480310|FG000|Overall Study|Lack of Efficacy|0|||
161846616|NCT00805467|584480311|FG001|Overall Study|Lack of Efficacy|8|||
161846617|NCT00805467|584480312|FG002|Overall Study|Lack of Efficacy|13|||
161846618|NCT00805467|584480313|FG003|Overall Study|Lack of Efficacy|86|||
161846619|NCT00805467|584480310|FG000|Overall Study|Lost to Follow-up|0|||
161846620|NCT00805467|584480311|FG001|Overall Study|Lost to Follow-up|1|||
161970898|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970899|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
161970900|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970901|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161758197|NCT04437511|584154067|FG000|Overall Study|Continuing Study|7|||
161758198|NCT04437511|584154068|FG001|Overall Study|Continuing Study|5|||
161758199|NCT03093350|584154071|FG000|Overall Study|Death|1|||
161758200|NCT03093350|584154071|FG000|Overall Study|Signed consent, never began treartment|1|||
161758201|NCT00777036|584154072|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
161758202|NCT00777036|584154073|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
161758203|NCT00777036|584154074|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
161758204|NCT00777036|584154075|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
161758205|NCT00777036|584154072|FG000|On Treatment|Administrative Reason By Sponsor|1|||
161758206|NCT00777036|584154073|FG001|On Treatment|Administrative Reason By Sponsor|0|||
161758207|NCT00777036|584154074|FG002|On Treatment|Administrative Reason By Sponsor|9|||
161758208|NCT00777036|584154075|FG003|On Treatment|Administrative Reason By Sponsor|0|||
161758209|NCT00777036|584154072|FG000|On Treatment|Failure to Meet Study Criteria|0|||
161758210|NCT00777036|584154073|FG001|On Treatment|Failure to Meet Study Criteria|1|||
161758211|NCT00777036|584154074|FG002|On Treatment|Failure to Meet Study Criteria|4|||
161758212|NCT00777036|584154075|FG003|On Treatment|Failure to Meet Study Criteria|0|||
161758213|NCT00777036|584154072|FG000|On Treatment|Pregnancy|1|||
161758214|NCT00777036|584154073|FG001|On Treatment|Pregnancy|0|||
161758215|NCT00777036|584154074|FG002|On Treatment|Pregnancy|1|||
161758216|NCT00777036|584154075|FG003|On Treatment|Pregnancy|0|||
161758217|NCT00777036|584154072|FG000|On Treatment|Non-compliance with Study Drug|1|||
161846621|NCT00805467|584480312|FG002|Overall Study|Lost to Follow-up|7|||
161846622|NCT00805467|584480313|FG003|Overall Study|Lost to Follow-up|21|||
161846623|NCT00805467|584480310|FG000|Overall Study|Withdrawal by Subject|0|||
161970902|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970903|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
161970904|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
162032963|NCT04035486|585177531|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
161758218|NCT00777036|584154073|FG001|On Treatment|Non-compliance with Study Drug|0|||
161758219|NCT00777036|584154074|FG002|On Treatment|Non-compliance with Study Drug|1|||
161758220|NCT00777036|584154075|FG003|On Treatment|Non-compliance with Study Drug|0|||
161758221|NCT00777036|584154072|FG000|On Treatment|Maximum Clinical Benefit|2|||
161758222|NCT00777036|584154073|FG001|On Treatment|Maximum Clinical Benefit|0|||
161758223|NCT00777036|584154074|FG002|On Treatment|Maximum Clinical Benefit|5|||
161758224|NCT00777036|584154075|FG003|On Treatment|Maximum Clinical Benefit|0|||
161758225|NCT00777036|584154072|FG000|On Treatment|Withdrawal by Subject|0|||
161758226|NCT00777036|584154073|FG001|On Treatment|Withdrawal by Subject|2|||
161758227|NCT00777036|584154074|FG002|On Treatment|Withdrawal by Subject|2|||
161758228|NCT00777036|584154075|FG003|On Treatment|Withdrawal by Subject|0|||
161758229|NCT00777036|584154072|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
161758230|NCT00777036|584154073|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
161758231|NCT00777036|584154074|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
161758232|NCT00777036|584154075|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
161758233|NCT00777036|584154072|FG000|On Treatment|Death|0|||
161758234|NCT00777036|584154073|FG001|On Treatment|Death|2|||
161758235|NCT00777036|584154074|FG002|On Treatment|Death|0|||
161758236|NCT00777036|584154075|FG003|On Treatment|Death|0|||
161758237|NCT00777036|584154072|FG000|On Treatment|Study Drug Toxicity|1|||
161758238|NCT00777036|584154073|FG001|On Treatment|Study Drug Toxicity|0|||
161758239|NCT00777036|584154074|FG002|On Treatment|Study Drug Toxicity|4|||
161758240|NCT00777036|584154075|FG003|On Treatment|Study Drug Toxicity|0|||
161758241|NCT00777036|584154072|FG000|On Treatment|Progressive Disease|6|||
161758242|NCT00777036|584154073|FG001|On Treatment|Progressive Disease|4|||
161758243|NCT00777036|584154074|FG002|On Treatment|Progressive Disease|7|||
161758244|NCT00777036|584154075|FG003|On Treatment|Progressive Disease|0|||
161758245|NCT00777036|584154072|FG000|On Treatment|Not Reported|0|||
161758246|NCT00777036|584154073|FG001|On Treatment|Not Reported|0|||
161758247|NCT00777036|584154074|FG002|On Treatment|Not Reported|2|||
161758248|NCT00777036|584154075|FG003|On Treatment|Not Reported|0|||
161758249|NCT00777036|584154072|FG000|On Treatment|Site Closed|0|||
161758250|NCT00777036|584154073|FG001|On Treatment|Site Closed|1|||
161758251|NCT00777036|584154074|FG002|On Treatment|Site Closed|1|||
161758252|NCT00777036|584154075|FG003|On Treatment|Site Closed|0|||
161758253|NCT00777036|584154072|FG000|Follow-Up|Withdrawal by Subject|0|||
161758254|NCT00777036|584154073|FG001|Follow-Up|Withdrawal by Subject|0|||
161758255|NCT00777036|584154074|FG002|Follow-Up|Withdrawal by Subject|5|||
161758256|NCT00777036|584154075|FG003|Follow-Up|Withdrawal by Subject|0|||
161758257|NCT00777036|584154072|FG000|Follow-Up|Death|1|||
161758258|NCT00777036|584154073|FG001|Follow-Up|Death|9|||
161758259|NCT00777036|584154074|FG002|Follow-Up|Death|0|||
161758260|NCT00777036|584154075|FG003|Follow-Up|Death|0|||
161758261|NCT00777036|584154072|FG000|Follow-Up|Lost to Follow-up|3|||
161758262|NCT00777036|584154073|FG001|Follow-Up|Lost to Follow-up|0|||
161758263|NCT00777036|584154074|FG002|Follow-Up|Lost to Follow-up|0|||
161758264|NCT00777036|584154075|FG003|Follow-Up|Lost to Follow-up|0|||
161758265|NCT00777036|584154072|FG000|Follow-Up|Reason Not Specified|4|||
161758266|NCT00777036|584154073|FG001|Follow-Up|Reason Not Specified|0|||
161758267|NCT00777036|584154074|FG002|Follow-Up|Reason Not Specified|13|||
161758268|NCT00777036|584154075|FG003|Follow-Up|Reason Not Specified|0|||
161758269|NCT00777036|584154072|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
161758270|NCT00777036|584154073|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
161758271|NCT00777036|584154074|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
161758272|NCT00777036|584154075|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
161758273|NCT05564039|584154078|FG000|Overall Study|Adverse Event|1|||
161758274|NCT05564039|584154079|FG001|Overall Study|Adverse Event|0|||
161758275|NCT05564039|584154078|FG000|Overall Study|Death|1|||
161758276|NCT05564039|584154079|FG001|Overall Study|Death|1|||
161758277|NCT05564039|584154078|FG000|Overall Study|Lost to Follow-up|3|||
161758278|NCT05564039|584154079|FG001|Overall Study|Lost to Follow-up|2|||
161758279|NCT05564039|584154078|FG000|Overall Study|Withdrawal by Subject|2|||
161758280|NCT05564039|584154079|FG001|Overall Study|Withdrawal by Subject|0|||
161758281|NCT05564039|584154078|FG000|Overall Study|Inadvertent enrollment|3|||
161758282|NCT05564039|584154079|FG001|Overall Study|Inadvertent enrollment|6|||
161758283|NCT00729560|584154080|FG000|Overall Study|Withdrawal by Subject|3|||
161758284|NCT03233308|584154081|FG000|Overall Study|Adverse Event|1|||
161758285|NCT03233308|584154081|FG000|Overall Study|Protocol Violation|1|||
161758286|NCT03662789|584154082|FG000|Overall Study|Lost to Follow-up|1|||
161758287|NCT03662789|584154083|FG001|Overall Study|Lost to Follow-up|2|||
161758288|NCT03662789|584154082|FG000|Overall Study|Could not perform treadmill test|4|||
161758289|NCT03662789|584154083|FG001|Overall Study|Could not perform treadmill test|4|||
161758290|NCT03662789|584154082|FG000|Overall Study|Death|0|||
161758291|NCT03662789|584154083|FG001|Overall Study|Death|1|||
161758292|NCT02136134|584154084|FG000|Overall Study|Death|170|||
161758293|NCT02136134|584154085|FG001|Overall Study|Death|148|||
161758294|NCT02136134|584154084|FG000|Overall Study|Withdrawal by Subject|19|||
161758295|NCT02136134|584154085|FG001|Overall Study|Withdrawal by Subject|10|||
161758296|NCT02136134|584154084|FG000|Overall Study|Lost to Follow-up|3|||
161758297|NCT02136134|584154085|FG001|Overall Study|Lost to Follow-up|3|||
161758298|NCT02136134|584154084|FG000|Overall Study|Uspecified|55|||
161758299|NCT02136134|584154085|FG001|Overall Study|Uspecified|90|||
161758300|NCT00638989|584154086|FG000|Overall Study|Lost to Follow-up|0|||
161758301|NCT00638989|584154087|FG001|Overall Study|Lost to Follow-up|0|||
161758302|NCT00638989|584154088|FG002|Overall Study|Lost to Follow-up|1|||
161758303|NCT05245071|584154089|FG000|Overall Study|Progressive disease|18|||
161758304|NCT05245071|584154089|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
161758305|NCT05245071|584154089|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
161758306|NCT01602822|584154090|FG000|Overall Study|Adverse Event|11|||
161758307|NCT00853112|584154094|FG000|Overall Study|Randomized but not treated|0|||
161758308|NCT00853112|584154095|FG001|Overall Study|Randomized but not treated|1|||
161758309|NCT00853112|584154096|FG002|Overall Study|Randomized but not treated|0|||
161758310|NCT00853112|584154097|FG003|Overall Study|Randomized but not treated|2|||
161758311|NCT00853112|584154098|FG004|Overall Study|Randomized but not treated|0|||
161758312|NCT00853112|584154099|FG005|Overall Study|Randomized but not treated|0|||
161758313|NCT00853112|584154100|FG006|Overall Study|Randomized but not treated|1|||
161758314|NCT01553591|584154101|FG000|Overall Study|Voluntarily withdrew|94|||
161758315|NCT01553591|584154102|FG001|Overall Study|Voluntarily withdrew|79|||
161758316|NCT01553591|584154103|FG002|Overall Study|Voluntarily withdrew|96|||
161758317|NCT01553591|584154101|FG000|Overall Study|Adverse Event|36|||
161758318|NCT01553591|584154102|FG001|Overall Study|Adverse Event|45|||
161758319|NCT01553591|584154103|FG002|Overall Study|Adverse Event|16|||
161758320|NCT01553591|584154101|FG000|Overall Study|Lost to Follow-up|25|||
161758321|NCT01553591|584154102|FG001|Overall Study|Lost to Follow-up|23|||
161758322|NCT01553591|584154103|FG002|Overall Study|Lost to Follow-up|16|||
161758323|NCT01553591|584154101|FG000|Overall Study|Physician decision: other|11|||
161758324|NCT01553591|584154102|FG001|Overall Study|Physician decision: other|14|||
161758325|NCT01553591|584154103|FG002|Overall Study|Physician decision: other|16|||
161758326|NCT01553591|584154101|FG000|Overall Study|Physician decision: lack of efficacy|2|||
161758327|NCT01553591|584154102|FG001|Overall Study|Physician decision: lack of efficacy|3|||
161758328|NCT01553591|584154103|FG002|Overall Study|Physician decision: lack of efficacy|7|||
161758329|NCT01553591|584154101|FG000|Overall Study|Protocol Violation|3|||
161758330|NCT01553591|584154102|FG001|Overall Study|Protocol Violation|4|||
161758331|NCT01553591|584154103|FG002|Overall Study|Protocol Violation|4|||
161758332|NCT01553591|584154101|FG000|Overall Study|Sponsor decision|1|||
161758333|NCT01553591|584154102|FG001|Overall Study|Sponsor decision|0|||
161758334|NCT01553591|584154103|FG002|Overall Study|Sponsor decision|3|||
161758335|NCT01553591|584154101|FG000|Overall Study|Randomized and never dispensed drug|0|||
161970905|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161970906|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161970907|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161970908|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161970909|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
161970910|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161970911|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161970912|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161970913|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161970914|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161970915|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161970916|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
161970917|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161970918|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161970919|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
161970920|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161970921|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161970922|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161970923|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161970924|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161970925|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
161970926|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161758336|NCT01553591|584154102|FG001|Overall Study|Randomized and never dispensed drug|1|||
161758337|NCT01553591|584154103|FG002|Overall Study|Randomized and never dispensed drug|0|||
161758338|NCT02477800|584154104|FG000|Placebo-Controlled Period|Adverse Event|16|||
161758339|NCT02477800|584154105|FG001|Placebo-Controlled Period|Adverse Event|25|||
161758340|NCT02477800|584154106|FG002|Placebo-Controlled Period|Adverse Event|28|||
161758341|NCT02477800|584154107|FG003|Placebo-Controlled Period|Adverse Event|0|||
161758342|NCT02477800|584154108|FG004|Placebo-Controlled Period|Adverse Event|0|||
161758343|NCT02477800|584154109|FG005|Placebo-Controlled Period|Adverse Event|0|||
161758344|NCT02477800|584154110|FG006|Placebo-Controlled Period|Adverse Event|0|||
161758345|NCT02477800|584154104|FG000|Placebo-Controlled Period|Change of Treatment|1|||
161758346|NCT02477800|584154105|FG001|Placebo-Controlled Period|Change of Treatment|2|||
161758347|NCT02477800|584154106|FG002|Placebo-Controlled Period|Change of Treatment|1|||
161758348|NCT02477800|584154107|FG003|Placebo-Controlled Period|Change of Treatment|0|||
161758349|NCT02477800|584154108|FG004|Placebo-Controlled Period|Change of Treatment|0|||
161758350|NCT02477800|584154109|FG005|Placebo-Controlled Period|Change of Treatment|0|||
161758351|NCT02477800|584154110|FG006|Placebo-Controlled Period|Change of Treatment|0|||
161758352|NCT02477800|584154104|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
161758353|NCT02477800|584154105|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
161758354|NCT02477800|584154106|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
161758355|NCT02477800|584154107|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
161758356|NCT02477800|584154108|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
161758357|NCT02477800|584154109|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
161758358|NCT02477800|584154110|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
161758359|NCT02477800|584154104|FG000|Placebo-Controlled Period|Death|0|||
161758360|NCT02477800|584154105|FG001|Placebo-Controlled Period|Death|3|||
161758361|NCT02477800|584154106|FG002|Placebo-Controlled Period|Death|2|||
161758362|NCT02477800|584154107|FG003|Placebo-Controlled Period|Death|0|||
161758363|NCT02477800|584154108|FG004|Placebo-Controlled Period|Death|0|||
161758364|NCT02477800|584154109|FG005|Placebo-Controlled Period|Death|0|||
161758365|NCT02477800|584154110|FG006|Placebo-Controlled Period|Death|0|||
161758366|NCT02477800|584154104|FG000|Placebo-Controlled Period|Disease Progression|1|||
161758367|NCT02477800|584154105|FG001|Placebo-Controlled Period|Disease Progression|0|||
161758368|NCT02477800|584154106|FG002|Placebo-Controlled Period|Disease Progression|1|||
161758369|NCT02477800|584154107|FG003|Placebo-Controlled Period|Disease Progression|0|||
161758370|NCT02477800|584154108|FG004|Placebo-Controlled Period|Disease Progression|0|||
161758371|NCT02477800|584154109|FG005|Placebo-Controlled Period|Disease Progression|0|||
161758372|NCT02477800|584154110|FG006|Placebo-Controlled Period|Disease Progression|0|||
161758373|NCT02477800|584154104|FG000|Placebo-Controlled Period|Investigator Decision|3|||
161758374|NCT02477800|584154105|FG001|Placebo-Controlled Period|Investigator Decision|2|||
161758375|NCT02477800|584154106|FG002|Placebo-Controlled Period|Investigator Decision|1|||
161758376|NCT02477800|584154107|FG003|Placebo-Controlled Period|Investigator Decision|0|||
161758377|NCT02477800|584154108|FG004|Placebo-Controlled Period|Investigator Decision|0|||
161758378|NCT02477800|584154109|FG005|Placebo-Controlled Period|Investigator Decision|0|||
161758379|NCT02477800|584154110|FG006|Placebo-Controlled Period|Investigator Decision|0|||
161758380|NCT02477800|584154104|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
161758381|NCT02477800|584154105|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
161758382|NCT02477800|584154106|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
161758383|NCT02477800|584154107|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
161758384|NCT02477800|584154108|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
161758385|NCT02477800|584154109|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
161758386|NCT02477800|584154110|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
161758387|NCT02477800|584154104|FG000|Placebo-Controlled Period|Relocation|2|||
161758388|NCT02477800|584154105|FG001|Placebo-Controlled Period|Relocation|0|||
161758389|NCT02477800|584154106|FG002|Placebo-Controlled Period|Relocation|0|||
161758390|NCT02477800|584154107|FG003|Placebo-Controlled Period|Relocation|0|||
161758391|NCT02477800|584154108|FG004|Placebo-Controlled Period|Relocation|0|||
161758392|NCT02477800|584154109|FG005|Placebo-Controlled Period|Relocation|0|||
161758393|NCT02477800|584154110|FG006|Placebo-Controlled Period|Relocation|0|||
161758394|NCT02477800|584154104|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
161758395|NCT02477800|584154105|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
161758396|NCT02477800|584154106|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
161758397|NCT02477800|584154107|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
161758398|NCT02477800|584154108|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
161758399|NCT02477800|584154109|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
161758400|NCT02477800|584154110|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
161758401|NCT02477800|584154104|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
161758402|NCT02477800|584154105|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
161758403|NCT02477800|584154106|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161970927|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161970928|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161758404|NCT02477800|584154107|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161758405|NCT02477800|584154108|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161846624|NCT00805467|584480311|FG001|Overall Study|Withdrawal by Subject|6|||
161846625|NCT00805467|584480312|FG002|Overall Study|Withdrawal by Subject|45|||
161846626|NCT00805467|584480313|FG003|Overall Study|Withdrawal by Subject|50|||
161846627|NCT00805467|584480310|FG000|Overall Study|Protocol Violation|0|||
161846628|NCT00805467|584480311|FG001|Overall Study|Protocol Violation|3|||
161846629|NCT00805467|584480312|FG002|Overall Study|Protocol Violation|0|||
161846630|NCT00805467|584480313|FG003|Overall Study|Protocol Violation|5|||
161846631|NCT00805467|584480310|FG000|Overall Study|Adverse Event|0|||
161846632|NCT00805467|584480311|FG001|Overall Study|Adverse Event|13|||
161846633|NCT00805467|584480312|FG002|Overall Study|Adverse Event|26|||
161846634|NCT00805467|584480313|FG003|Overall Study|Adverse Event|57|||
161970929|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
161970930|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161970931|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161970932|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161970933|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161970934|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
161970935|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
161970936|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161970937|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
161970938|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161970939|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
161970940|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161970941|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161970942|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161970943|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161970944|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
161970945|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Other|5|||
161970946|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Other|1|||
161970947|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Other|0|||
161970948|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Other|3|||
161970949|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Other|0|||
161970950|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Other|0|||
161970951|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Other|0|||
161970952|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Other|0|||
161970953|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Other|0|||
161970954|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Other|0|||
161970955|NCT03352557|584941033|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
161970956|NCT03352557|584941034|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
161970957|NCT03352557|584941035|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
161970958|NCT03352557|584941036|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
161970959|NCT03352557|584941037|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
161970960|NCT03352557|584941038|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
161970961|NCT03352557|584941039|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
161970962|NCT03352557|584941040|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
161970963|NCT03352557|584941041|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
161970964|NCT03352557|584941042|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
161970965|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|Death|0|||
161970966|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|Death|0|||
161970967|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|Death|0|||
161970968|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|Death|0|||
161970969|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|Death|0|||
161970970|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|Death|1|||
161970971|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|Death|0|||
161846635|NCT00805467|584480310|FG000|Overall Study|Death|0|||
161846636|NCT00805467|584480311|FG001|Overall Study|Death|2|||
161846637|NCT00805467|584480312|FG002|Overall Study|Death|7|||
161846638|NCT00805467|584480313|FG003|Overall Study|Death|5|||
161846639|NCT00805467|584480310|FG000|Overall Study|Physician Decision|0|||
161846640|NCT00805467|584480311|FG001|Overall Study|Physician Decision|1|||
161970972|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|Death|1|||
161970973|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|Death|1|||
161970974|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|Death|1|||
161970975|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161970976|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161970977|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161970978|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161970979|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161846641|NCT00805467|584480312|FG002|Overall Study|Physician Decision|2|||
161846642|NCT00805467|584480313|FG003|Overall Study|Physician Decision|6|||
161846643|NCT00805467|584480310|FG000|Overall Study|Not reported|0|||
161846644|NCT00805467|584480311|FG001|Overall Study|Not reported|0|||
161846645|NCT00805467|584480312|FG002|Overall Study|Not reported|3|||
161846646|NCT00805467|584480313|FG003|Overall Study|Not reported|7|||
161846647|NCT04240392|584480315|FG000|Overall Study|Withdrawal by Subject|13|||
161846648|NCT04240392|584480316|FG001|Overall Study|Withdrawal by Subject|4|||
161846649|NCT04240392|584480315|FG000|Overall Study|Lost to Follow-up|11|||
161846650|NCT04240392|584480316|FG001|Overall Study|Lost to Follow-up|12|||
161846651|NCT04345601|584480329|FG000|Overall Study|Death|0|||
161846652|NCT04345601|584480330|FG001|Overall Study|Death|3|||
161846653|NCT04345601|584480331|FG002|Overall Study|Death|2|||
161846654|NCT04345601|584480329|FG000|Overall Study|Lost to Follow-up|0|||
161846655|NCT04345601|584480330|FG001|Overall Study|Lost to Follow-up|0|||
161846656|NCT04345601|584480331|FG002|Overall Study|Lost to Follow-up|2|||
161846657|NCT00660907|584480333|FG000|Overall Study|Incorrect Enrollment|1|||
161846658|NCT00660907|584480334|FG001|Overall Study|Incorrect Enrollment|1|||
161846659|NCT00660907|584480333|FG000|Overall Study|Adverse Event|33|||
161846660|NCT00660907|584480334|FG001|Overall Study|Adverse Event|19|||
161846661|NCT00660907|584480333|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
161846662|NCT00660907|584480334|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
161846663|NCT00660907|584480333|FG000|Overall Study|Withdrawal by Subject|23|||
161846664|NCT00660907|584480334|FG001|Overall Study|Withdrawal by Subject|32|||
161846665|NCT00660907|584480333|FG000|Overall Study|Lost to Follow-up|3|||
161846666|NCT00660907|584480334|FG001|Overall Study|Lost to Follow-up|3|||
161846667|NCT00660907|584480333|FG000|Overall Study|Poor/Non-Compliance|5|||
161846668|NCT00660907|584480334|FG001|Overall Study|Poor/Non-Compliance|1|||
161846669|NCT00660907|584480333|FG000|Overall Study|Safety|1|||
161846670|NCT00660907|584480334|FG001|Overall Study|Safety|0|||
161846671|NCT00660907|584480333|FG000|Overall Study|Death|1|||
161846672|NCT00660907|584480334|FG001|Overall Study|Death|3|||
161846673|NCT00660907|584480333|FG000|Overall Study|Various|11|||
161846674|NCT00660907|584480334|FG001|Overall Study|Various|8|||
161846675|NCT01908907|584480335|FG000|Overall Study|Physician Decision|1|||
161846676|NCT01908907|584480336|FG001|Overall Study|Physician Decision|0|||
161846677|NCT01908907|584480335|FG000|Overall Study|Protocol Violation|1|||
161846678|NCT01908907|584480336|FG001|Overall Study|Protocol Violation|0|||
161846679|NCT04975191|584480337|FG000|Overall Study|Protocol Violation|1|||
161846680|NCT04975191|584480338|FG001|Overall Study|Protocol Violation|2|||
161846681|NCT04975191|584480339|FG002|Overall Study|Protocol Violation|2|||
161846682|NCT04975191|584480340|FG003|Overall Study|Protocol Violation|2|||
161846683|NCT04975191|584480337|FG000|Overall Study|Lost to Follow-up|13|||
161846684|NCT04975191|584480338|FG001|Overall Study|Lost to Follow-up|3|||
161846685|NCT04975191|584480339|FG002|Overall Study|Lost to Follow-up|8|||
161846686|NCT04975191|584480340|FG003|Overall Study|Lost to Follow-up|8|||
161846687|NCT02152605|584480345|FG000|Overall Study|Adverse Event|6|||
161846688|NCT02152605|584480346|FG001|Overall Study|Adverse Event|8|||
161846689|NCT02152605|584480345|FG000|Overall Study|Lack of Efficacy|7|||
161846690|NCT02152605|584480346|FG001|Overall Study|Lack of Efficacy|4|||
161846691|NCT02152605|584480345|FG000|Overall Study|Protocol deviation|1|||
161846692|NCT02152605|584480346|FG001|Overall Study|Protocol deviation|4|||
161846693|NCT02152605|584480345|FG000|Overall Study|Lost to Follow-up|1|||
161846694|NCT02152605|584480346|FG001|Overall Study|Lost to Follow-up|0|||
161846695|NCT02152605|584480345|FG000|Overall Study|Withdrew consent|4|||
161846696|NCT02152605|584480346|FG001|Overall Study|Withdrew consent|2|||
161846697|NCT00537303|584480353|FG000|Overall Study|Adverse Event|1|||
161846698|NCT00537303|584480354|FG001|Overall Study|Adverse Event|4|||
161846699|NCT00537303|584480353|FG000|Overall Study|Lack of Efficacy|6|||
161846700|NCT00537303|584480354|FG001|Overall Study|Lack of Efficacy|7|||
161846701|NCT00537303|584480353|FG000|Overall Study|Protocol Violation|8|||
161846702|NCT00537303|584480354|FG001|Overall Study|Protocol Violation|4|||
161846703|NCT00537303|584480353|FG000|Overall Study|Withdrawal criteria|3|||
161846704|NCT00537303|584480354|FG001|Overall Study|Withdrawal criteria|3|||
161846705|NCT00537303|584480353|FG000|Overall Study|Unclassified|8|||
161846706|NCT00537303|584480354|FG001|Overall Study|Unclassified|7|||
161846707|NCT01724489|584480355|FG000|Overall Study|Adverse Event|8|||
161846708|NCT01724489|584480356|FG001|Overall Study|Adverse Event|3|||
161846709|NCT01724489|584480355|FG000|Overall Study|Surgery, medication|1|||
162032964|NCT04035486|585177532|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
161846710|NCT01724489|584480356|FG001|Overall Study|Surgery, medication|1|||
161846711|NCT01724489|584480355|FG000|Overall Study|Lost to Follow-up|1|||
161846712|NCT01724489|584480356|FG001|Overall Study|Lost to Follow-up|2|||
161846713|NCT01724489|584480355|FG000|Overall Study|Withdrawal by Subject|6|||
161846714|NCT01724489|584480356|FG001|Overall Study|Withdrawal by Subject|6|||
161846715|NCT01473524|584480357|FG000|DB Phase|Adverse Event|4|||
161846716|NCT01473524|584480358|FG001|DB Phase|Adverse Event|8|||
161846717|NCT01473524|584480359|FG002|DB Phase|Adverse Event|2|||
161846718|NCT01473524|584480360|FG003|DB Phase|Adverse Event|0|||
161846719|NCT01473524|584480361|FG004|DB Phase|Adverse Event|0|||
161846720|NCT01473524|584480362|FG005|DB Phase|Adverse Event|0|||
161846721|NCT01473524|584480357|FG000|DB Phase|Death|1|||
161846722|NCT01473524|584480358|FG001|DB Phase|Death|0|||
161846723|NCT01473524|584480359|FG002|DB Phase|Death|0|||
161846724|NCT01473524|584480360|FG003|DB Phase|Death|0|||
161846725|NCT01473524|584480361|FG004|DB Phase|Death|0|||
161846726|NCT01473524|584480362|FG005|DB Phase|Death|0|||
161846727|NCT01473524|584480357|FG000|DB Phase|Withdrawal by Subject|2|||
161970980|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
161970981|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161970982|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161970983|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161970984|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
161758406|NCT02477800|584154109|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161758407|NCT02477800|584154110|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161758408|NCT02477800|584154104|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
161758409|NCT02477800|584154105|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
161758410|NCT02477800|584154106|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
161758411|NCT02477800|584154107|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
161758412|NCT02477800|584154108|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
161758413|NCT02477800|584154109|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
161758414|NCT02477800|584154110|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
161758415|NCT02477800|584154104|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
161758416|NCT02477800|584154105|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
161758417|NCT02477800|584154106|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
161758418|NCT02477800|584154107|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161758419|NCT02477800|584154108|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161758420|NCT02477800|584154109|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161758421|NCT02477800|584154110|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161758422|NCT02477800|584154104|FG000|Placebo-Controlled Period|Reason not Specified|161|||
161758423|NCT02477800|584154105|FG001|Placebo-Controlled Period|Reason not Specified|161|||
161758424|NCT02477800|584154106|FG002|Placebo-Controlled Period|Reason not Specified|189|||
161758425|NCT02477800|584154107|FG003|Placebo-Controlled Period|Reason not Specified|0|||
161758426|NCT02477800|584154108|FG004|Placebo-Controlled Period|Reason not Specified|0|||
161758427|NCT02477800|584154109|FG005|Placebo-Controlled Period|Reason not Specified|0|||
161758428|NCT02477800|584154110|FG006|Placebo-Controlled Period|Reason not Specified|0|||
161758429|NCT02477800|584154104|FG000|Long Term Extension Period|Adverse Event|0|||
161758430|NCT02477800|584154105|FG001|Long Term Extension Period|Adverse Event|0|||
161758431|NCT02477800|584154106|FG002|Long Term Extension Period|Adverse Event|0|||
161758432|NCT02477800|584154107|FG003|Long Term Extension Period|Adverse Event|6|||
161758433|NCT02477800|584154108|FG004|Long Term Extension Period|Adverse Event|2|||
161758434|NCT02477800|584154109|FG005|Long Term Extension Period|Adverse Event|4|||
161970985|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161970986|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161970987|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161970988|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161970989|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161970990|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161970991|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161970992|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161970993|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
161970994|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
161970995|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
162032965|NCT04035486|585177533|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
162032966|NCT04035486|585177534|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
161758435|NCT02477800|584154110|FG006|Long Term Extension Period|Adverse Event|3|||
161758436|NCT02477800|584154104|FG000|Long Term Extension Period|Death|0|||
161758437|NCT02477800|584154105|FG001|Long Term Extension Period|Death|0|||
161758438|NCT02477800|584154106|FG002|Long Term Extension Period|Death|0|||
161758439|NCT02477800|584154107|FG003|Long Term Extension Period|Death|1|||
161758440|NCT02477800|584154108|FG004|Long Term Extension Period|Death|1|||
161758441|NCT02477800|584154109|FG005|Long Term Extension Period|Death|1|||
161758442|NCT02477800|584154110|FG006|Long Term Extension Period|Death|2|||
161758443|NCT02477800|584154104|FG000|Long Term Extension Period|Consent Withdrawn|0|||
161758444|NCT02477800|584154105|FG001|Long Term Extension Period|Consent Withdrawn|0|||
161758445|NCT02477800|584154106|FG002|Long Term Extension Period|Consent Withdrawn|0|||
161758446|NCT02477800|584154107|FG003|Long Term Extension Period|Consent Withdrawn|10|||
161758447|NCT02477800|584154108|FG004|Long Term Extension Period|Consent Withdrawn|4|||
161758448|NCT02477800|584154109|FG005|Long Term Extension Period|Consent Withdrawn|13|||
161758449|NCT02477800|584154110|FG006|Long Term Extension Period|Consent Withdrawn|16|||
161758450|NCT02477800|584154104|FG000|Long Term Extension Period|Disease Progression|0|||
161758451|NCT02477800|584154105|FG001|Long Term Extension Period|Disease Progression|0|||
161758452|NCT02477800|584154106|FG002|Long Term Extension Period|Disease Progression|0|||
161758453|NCT02477800|584154107|FG003|Long Term Extension Period|Disease Progression|3|||
161758454|NCT02477800|584154108|FG004|Long Term Extension Period|Disease Progression|1|||
161758455|NCT02477800|584154109|FG005|Long Term Extension Period|Disease Progression|1|||
161758456|NCT02477800|584154110|FG006|Long Term Extension Period|Disease Progression|0|||
161846728|NCT01473524|584480358|FG001|DB Phase|Withdrawal by Subject|1|||
161846729|NCT01473524|584480359|FG002|DB Phase|Withdrawal by Subject|1|||
161846730|NCT01473524|584480360|FG003|DB Phase|Withdrawal by Subject|0|||
161846731|NCT01473524|584480361|FG004|DB Phase|Withdrawal by Subject|0|||
161846732|NCT01473524|584480362|FG005|DB Phase|Withdrawal by Subject|0|||
161846733|NCT01473524|584480357|FG000|LTSE Phase|Withdrawal by Subject|0|||
161846734|NCT01473524|584480358|FG001|LTSE Phase|Withdrawal by Subject|0|||
161846735|NCT01473524|584480359|FG002|LTSE Phase|Withdrawal by Subject|0|||
161846736|NCT01473524|584480360|FG003|LTSE Phase|Withdrawal by Subject|3|||
161846737|NCT01473524|584480361|FG004|LTSE Phase|Withdrawal by Subject|3|||
161846738|NCT01473524|584480362|FG005|LTSE Phase|Withdrawal by Subject|6|||
161846739|NCT01473524|584480357|FG000|LTSE Phase|Death|0|||
161846740|NCT01473524|584480358|FG001|LTSE Phase|Death|0|||
161846741|NCT01473524|584480359|FG002|LTSE Phase|Death|0|||
161846742|NCT01473524|584480360|FG003|LTSE Phase|Death|0|||
161846743|NCT01473524|584480361|FG004|LTSE Phase|Death|1|||
161846744|NCT01473524|584480362|FG005|LTSE Phase|Death|0|||
161846745|NCT01473524|584480357|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
161846746|NCT01473524|584480358|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
161846747|NCT01473524|584480359|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
161846748|NCT01473524|584480360|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
161846749|NCT01473524|584480361|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
161846750|NCT01473524|584480362|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
161846751|NCT01473524|584480357|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
161846752|NCT01473524|584480358|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
161846753|NCT01473524|584480359|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
161846754|NCT01473524|584480360|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
161846755|NCT01473524|584480361|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
161846756|NCT01473524|584480362|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
161846757|NCT01473524|584480357|FG000|LTSE Phase|Lost to Follow-up|0|||
161846758|NCT01473524|584480358|FG001|LTSE Phase|Lost to Follow-up|0|||
161846759|NCT01473524|584480359|FG002|LTSE Phase|Lost to Follow-up|0|||
161846760|NCT01473524|584480360|FG003|LTSE Phase|Lost to Follow-up|1|||
161846761|NCT01473524|584480361|FG004|LTSE Phase|Lost to Follow-up|3|||
161970996|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
161970997|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
161758457|NCT02477800|584154104|FG000|Long Term Extension Period|Investigator Decision|0|||
161758458|NCT02477800|584154105|FG001|Long Term Extension Period|Investigator Decision|0|||
161758459|NCT02477800|584154106|FG002|Long Term Extension Period|Investigator Decision|0|||
161758460|NCT02477800|584154107|FG003|Long Term Extension Period|Investigator Decision|0|||
161758461|NCT02477800|584154108|FG004|Long Term Extension Period|Investigator Decision|0|||
161758462|NCT02477800|584154109|FG005|Long Term Extension Period|Investigator Decision|0|||
161758463|NCT02477800|584154110|FG006|Long Term Extension Period|Investigator Decision|2|||
161758464|NCT02477800|584154104|FG000|Long Term Extension Period|Lost to Follow-up|0|||
161758465|NCT02477800|584154105|FG001|Long Term Extension Period|Lost to Follow-up|0|||
161758466|NCT02477800|584154106|FG002|Long Term Extension Period|Lost to Follow-up|0|||
161758467|NCT02477800|584154107|FG003|Long Term Extension Period|Lost to Follow-up|0|||
161758468|NCT02477800|584154108|FG004|Long Term Extension Period|Lost to Follow-up|1|||
161758469|NCT02477800|584154109|FG005|Long Term Extension Period|Lost to Follow-up|3|||
161758470|NCT02477800|584154110|FG006|Long Term Extension Period|Lost to Follow-up|0|||
161758471|NCT02477800|584154104|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
161758472|NCT02477800|584154105|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
161758473|NCT02477800|584154106|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
161758474|NCT02477800|584154107|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
161758475|NCT02477800|584154108|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
161758476|NCT02477800|584154109|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
161758477|NCT02477800|584154110|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
161758478|NCT02477800|584154104|FG000|Long Term Extension Period|Study Visit Burden|0|||
161758479|NCT02477800|584154105|FG001|Long Term Extension Period|Study Visit Burden|0|||
161758480|NCT02477800|584154106|FG002|Long Term Extension Period|Study Visit Burden|0|||
161758481|NCT02477800|584154107|FG003|Long Term Extension Period|Study Visit Burden|3|||
161758482|NCT02477800|584154108|FG004|Long Term Extension Period|Study Visit Burden|0|||
161758483|NCT02477800|584154109|FG005|Long Term Extension Period|Study Visit Burden|2|||
161758484|NCT02477800|584154110|FG006|Long Term Extension Period|Study Visit Burden|2|||
161846762|NCT01473524|584480362|FG005|LTSE Phase|Lost to Follow-up|2|||
161846763|NCT01473524|584480357|FG000|LTSE Phase|Principal Investigator Decision|0|||
161846764|NCT01473524|584480358|FG001|LTSE Phase|Principal Investigator Decision|0|||
161846765|NCT01473524|584480359|FG002|LTSE Phase|Principal Investigator Decision|0|||
161846766|NCT01473524|584480360|FG003|LTSE Phase|Principal Investigator Decision|1|||
161846767|NCT01473524|584480361|FG004|LTSE Phase|Principal Investigator Decision|1|||
161846768|NCT01473524|584480362|FG005|LTSE Phase|Principal Investigator Decision|3|||
161846769|NCT01473524|584480357|FG000|LTSE Phase|Liver Transplantation|0|||
161846770|NCT01473524|584480358|FG001|LTSE Phase|Liver Transplantation|0|||
161846771|NCT01473524|584480359|FG002|LTSE Phase|Liver Transplantation|0|||
161758485|NCT02477800|584154104|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
161758486|NCT02477800|584154105|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
161758487|NCT02477800|584154106|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
161758488|NCT02477800|584154107|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
161758489|NCT02477800|584154108|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
161758490|NCT02477800|584154109|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
161758491|NCT02477800|584154110|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
161758492|NCT02477800|584154104|FG000|Long Term Extension Period|Reason not Specified|0|||
161758493|NCT02477800|584154105|FG001|Long Term Extension Period|Reason not Specified|0|||
161758494|NCT02477800|584154106|FG002|Long Term Extension Period|Reason not Specified|0|||
161758495|NCT02477800|584154107|FG003|Long Term Extension Period|Reason not Specified|126|||
161758496|NCT02477800|584154108|FG004|Long Term Extension Period|Reason not Specified|140|||
161758497|NCT02477800|584154109|FG005|Long Term Extension Period|Reason not Specified|270|||
161758498|NCT02477800|584154110|FG006|Long Term Extension Period|Reason not Specified|224|||
161758499|NCT00423592|584154112|FG000|Overall Study|Adverse Event (through Week 12)|2|||
161758500|NCT00423592|584154112|FG000|Overall Study|Adverse Event (post Week 12)|5|||
161758501|NCT00062647|584154113|FG000|Overall Study|Death|2|||
161758502|NCT00062647|584154114|FG001|Overall Study|Death|2|||
161758503|NCT00062647|584154113|FG000|Overall Study|Adverse Event|1|||
161758504|NCT00062647|584154114|FG001|Overall Study|Adverse Event|1|||
161758505|NCT00062647|584154113|FG000|Overall Study|Withdrawal by Subject|2|||
161758506|NCT00062647|584154114|FG001|Overall Study|Withdrawal by Subject|1|||
161758507|NCT00062647|584154113|FG000|Overall Study|Protocol Violation|1|||
161758508|NCT00062647|584154114|FG001|Overall Study|Protocol Violation|0|||
161758509|NCT00062647|584154113|FG000|Overall Study|Lost to Follow-up|1|||
161758510|NCT00062647|584154114|FG001|Overall Study|Lost to Follow-up|2|||
161758511|NCT00062647|584154113|FG000|Overall Study|Failed continuation criteria|4|||
161758512|NCT00062647|584154114|FG001|Overall Study|Failed continuation criteria|2|||
161758513|NCT00062647|584154113|FG000|Overall Study|Other|4|||
161758514|NCT00062647|584154114|FG001|Overall Study|Other|4|||
161758515|NCT00062647|584154113|FG000|Overall Study|Never received study treatment|1|||
161758516|NCT00062647|584154114|FG001|Overall Study|Never received study treatment|1|||
161758517|NCT00002981|584154117|FG000|Overall Study|Inevaluable|6|||
161758518|NCT00255008|584154118|FG000|Overall Study|Adverse Event|1|||
161758519|NCT00255008|584154119|FG001|Overall Study|Adverse Event|1|||
161758520|NCT00255008|584154120|FG002|Overall Study|Adverse Event|2|||
161758521|NCT00255008|584154121|FG003|Overall Study|Adverse Event|0|||
161758522|NCT00255008|584154118|FG000|Overall Study|Lost to Follow-up|1|||
161758523|NCT00255008|584154119|FG001|Overall Study|Lost to Follow-up|0|||
161758524|NCT00255008|584154120|FG002|Overall Study|Lost to Follow-up|1|||
161758525|NCT00255008|584154121|FG003|Overall Study|Lost to Follow-up|2|||
161758526|NCT00255008|584154118|FG000|Overall Study|Did not meet viral reduction criteria|4|||
161758527|NCT00255008|584154119|FG001|Overall Study|Did not meet viral reduction criteria|5|||
161758528|NCT00255008|584154120|FG002|Overall Study|Did not meet viral reduction criteria|0|||
161758529|NCT00255008|584154121|FG003|Overall Study|Did not meet viral reduction criteria|1|||
161758530|NCT00255008|584154118|FG000|Overall Study|Withdrew consent|0|||
161758531|NCT00255008|584154119|FG001|Overall Study|Withdrew consent|0|||
161758532|NCT00255008|584154120|FG002|Overall Study|Withdrew consent|2|||
161758533|NCT00255008|584154121|FG003|Overall Study|Withdrew consent|0|||
161758534|NCT00255008|584154118|FG000|Overall Study|Sponsor request|18|||
161758535|NCT00255008|584154119|FG001|Overall Study|Sponsor request|3|||
161758536|NCT00255008|584154120|FG002|Overall Study|Sponsor request|8|||
161758537|NCT00255008|584154121|FG003|Overall Study|Sponsor request|17|||
161758538|NCT00255008|584154118|FG000|Overall Study|Adverse lab experience|1|||
161758539|NCT00255008|584154119|FG001|Overall Study|Adverse lab experience|0|||
161758540|NCT00255008|584154120|FG002|Overall Study|Adverse lab experience|0|||
161758541|NCT00255008|584154121|FG003|Overall Study|Adverse lab experience|0|||
161758542|NCT00255008|584154118|FG000|Overall Study|Other|7|||
161758543|NCT00255008|584154119|FG001|Overall Study|Other|0|||
161758544|NCT00255008|584154120|FG002|Overall Study|Other|3|||
161758545|NCT00255008|584154121|FG003|Overall Study|Other|2|||
161758546|NCT00322387|584154126|FG000|Treatment Period|Adverse Event|0|||
161758547|NCT00322387|584154127|FG001|Treatment Period|Adverse Event|1|||
161758548|NCT00322387|584154126|FG000|Follow-up Period|Final assessment not done|1|||
161758549|NCT00322387|584154127|FG001|Follow-up Period|Final assessment not done|3|||
161758550|NCT00322387|584154126|FG000|Follow-up Period|Death|1|||
161758551|NCT00322387|584154127|FG001|Follow-up Period|Death|0|||
161758552|NCT02415595|584154128|FG000|Overall Study|Administrative reason by sponsor|39|||
161758553|NCT02415595|584154129|FG001|Overall Study|Administrative reason by sponsor|40|||
161758554|NCT02415595|584154130|FG002|Overall Study|Administrative reason by sponsor|41|||
161758555|NCT02415595|584154131|FG003|Overall Study|Administrative reason by sponsor|39|||
161758556|NCT02415595|584154128|FG000|Overall Study|Adverse Event|1|||
161758557|NCT02415595|584154129|FG001|Overall Study|Adverse Event|3|||
161758558|NCT02415595|584154130|FG002|Overall Study|Adverse Event|5|||
161758559|NCT02415595|584154131|FG003|Overall Study|Adverse Event|10|||
161758560|NCT02415595|584154128|FG000|Overall Study|Lack of Efficacy|4|||
161846772|NCT01473524|584480360|FG003|LTSE Phase|Liver Transplantation|0|||
161846773|NCT01473524|584480361|FG004|LTSE Phase|Liver Transplantation|0|||
161846774|NCT01473524|584480362|FG005|LTSE Phase|Liver Transplantation|1|||
161846775|NCT01473524|584480357|FG000|LTSE Phase|Pregnancy|0|||
161846776|NCT01473524|584480358|FG001|LTSE Phase|Pregnancy|0|||
161846777|NCT01473524|584480359|FG002|LTSE Phase|Pregnancy|0|||
161846778|NCT01473524|584480360|FG003|LTSE Phase|Pregnancy|1|||
161846779|NCT01473524|584480361|FG004|LTSE Phase|Pregnancy|0|||
161846780|NCT01473524|584480362|FG005|LTSE Phase|Pregnancy|0|||
161846781|NCT01473524|584480357|FG000|LTSE Phase|Protocol Violation|0|||
161846782|NCT01473524|584480358|FG001|LTSE Phase|Protocol Violation|0|||
161846783|NCT01473524|584480359|FG002|LTSE Phase|Protocol Violation|0|||
161846784|NCT01473524|584480360|FG003|LTSE Phase|Protocol Violation|0|||
161846785|NCT01473524|584480361|FG004|LTSE Phase|Protocol Violation|0|||
161846786|NCT01473524|584480362|FG005|LTSE Phase|Protocol Violation|1|||
161846787|NCT01544179|584480363|FG000|Overall Study|Death|50|||
161846788|NCT01544179|584480364|FG001|Overall Study|Death|37|||
161846789|NCT01544179|584480363|FG000|Overall Study|Lost to Follow-up|0|||
161846790|NCT01544179|584480364|FG001|Overall Study|Lost to Follow-up|1|||
161846791|NCT01544179|584480363|FG000|Overall Study|Adverse Event|0|||
161846792|NCT01544179|584480364|FG001|Overall Study|Adverse Event|1|||
161846793|NCT01544179|584480363|FG000|Overall Study|Withdrawal by Subject|12|||
161846794|NCT01544179|584480364|FG001|Overall Study|Withdrawal by Subject|7|||
161846795|NCT01544179|584480363|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
161846796|NCT01544179|584480364|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161846797|NCT03146962|584480367|FG000|Overall Study|Lost to Follow-up|1|||
161846798|NCT03146962|584480368|FG001|Overall Study|Lost to Follow-up|1|||
161846799|NCT03146962|584480369|FG002|Overall Study|Lost to Follow-up|0|||
161846800|NCT03146962|584480370|FG003|Overall Study|Lost to Follow-up|0|||
161846801|NCT03146962|584480371|FG004|Overall Study|Lost to Follow-up|0|||
161846802|NCT03146962|584480372|FG005|Overall Study|Lost to Follow-up|0|||
161846803|NCT03146962|584480373|FG006|Overall Study|Lost to Follow-up|0|||
161846804|NCT03146962|584480374|FG007|Overall Study|Lost to Follow-up|0|||
161846805|NCT03146962|584480375|FG008|Overall Study|Lost to Follow-up|0|||
161846806|NCT03146962|584480376|FG009|Overall Study|Lost to Follow-up|0|||
161846807|NCT03146962|584480367|FG000|Overall Study|Adverse Event|0|||
161846808|NCT03146962|584480368|FG001|Overall Study|Adverse Event|3|||
161846809|NCT03146962|584480369|FG002|Overall Study|Adverse Event|0|||
161846810|NCT03146962|584480370|FG003|Overall Study|Adverse Event|0|||
161846811|NCT03146962|584480371|FG004|Overall Study|Adverse Event|0|||
161846812|NCT03146962|584480372|FG005|Overall Study|Adverse Event|0|||
161846813|NCT03146962|584480373|FG006|Overall Study|Adverse Event|0|||
161846814|NCT03146962|584480374|FG007|Overall Study|Adverse Event|1|||
161846815|NCT03146962|584480375|FG008|Overall Study|Adverse Event|0|||
161846816|NCT03146962|584480376|FG009|Overall Study|Adverse Event|0|||
161846817|NCT03146962|584480367|FG000|Overall Study|Withdrawal by Subject|0|||
161846818|NCT03146962|584480368|FG001|Overall Study|Withdrawal by Subject|0|||
161846819|NCT03146962|584480369|FG002|Overall Study|Withdrawal by Subject|0|||
161846820|NCT03146962|584480370|FG003|Overall Study|Withdrawal by Subject|0|||
161846821|NCT03146962|584480371|FG004|Overall Study|Withdrawal by Subject|1|||
161846822|NCT03146962|584480372|FG005|Overall Study|Withdrawal by Subject|0|||
161846823|NCT03146962|584480373|FG006|Overall Study|Withdrawal by Subject|0|||
161846824|NCT03146962|584480374|FG007|Overall Study|Withdrawal by Subject|0|||
161846825|NCT03146962|584480375|FG008|Overall Study|Withdrawal by Subject|0|||
161846826|NCT03146962|584480376|FG009|Overall Study|Withdrawal by Subject|0|||
161846827|NCT03146962|584480367|FG000|Overall Study|Death|0|||
161846828|NCT03146962|584480368|FG001|Overall Study|Death|1|||
161846829|NCT03146962|584480369|FG002|Overall Study|Death|0|||
161846830|NCT03146962|584480370|FG003|Overall Study|Death|0|||
161846831|NCT03146962|584480371|FG004|Overall Study|Death|0|||
161846832|NCT03146962|584480372|FG005|Overall Study|Death|0|||
161846833|NCT03146962|584480373|FG006|Overall Study|Death|0|||
161846834|NCT03146962|584480374|FG007|Overall Study|Death|0|||
161846835|NCT03146962|584480375|FG008|Overall Study|Death|0|||
161846836|NCT03146962|584480376|FG009|Overall Study|Death|0|||
161846837|NCT03146962|584480367|FG000|Overall Study|COVID Precautions|1|||
161846838|NCT03146962|584480368|FG001|Overall Study|COVID Precautions|0|||
161846839|NCT03146962|584480369|FG002|Overall Study|COVID Precautions|0|||
161846840|NCT03146962|584480370|FG003|Overall Study|COVID Precautions|0|||
161846841|NCT03146962|584480371|FG004|Overall Study|COVID Precautions|0|||
161846842|NCT03146962|584480372|FG005|Overall Study|COVID Precautions|0|||
161846843|NCT03146962|584480373|FG006|Overall Study|COVID Precautions|0|||
161846844|NCT03146962|584480374|FG007|Overall Study|COVID Precautions|0|||
161846845|NCT03146962|584480375|FG008|Overall Study|COVID Precautions|0|||
161846846|NCT03146962|584480376|FG009|Overall Study|COVID Precautions|0|||
161846847|NCT03146962|584480367|FG000|Overall Study|Physician Decision|0|||
161846848|NCT03146962|584480368|FG001|Overall Study|Physician Decision|0|||
161846849|NCT03146962|584480369|FG002|Overall Study|Physician Decision|0|||
161846850|NCT03146962|584480370|FG003|Overall Study|Physician Decision|0|||
161846851|NCT03146962|584480371|FG004|Overall Study|Physician Decision|0|||
161846852|NCT03146962|584480372|FG005|Overall Study|Physician Decision|0|||
161970998|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
161758561|NCT02415595|584154129|FG001|Overall Study|Lack of Efficacy|4|||
161758562|NCT02415595|584154130|FG002|Overall Study|Lack of Efficacy|0|||
161758563|NCT02415595|584154131|FG003|Overall Study|Lack of Efficacy|0|||
161758564|NCT02415595|584154128|FG000|Overall Study|Lost to Follow-up|1|||
161758565|NCT02415595|584154129|FG001|Overall Study|Lost to Follow-up|3|||
161758566|NCT02415595|584154130|FG002|Overall Study|Lost to Follow-up|1|||
161758567|NCT02415595|584154131|FG003|Overall Study|Lost to Follow-up|1|||
161758568|NCT02415595|584154128|FG000|Overall Study|Poor/Non-compliance|1|||
161758569|NCT02415595|584154129|FG001|Overall Study|Poor/Non-compliance|0|||
161758570|NCT02415595|584154130|FG002|Overall Study|Poor/Non-compliance|1|||
161758571|NCT02415595|584154131|FG003|Overall Study|Poor/Non-compliance|0|||
161758572|NCT02415595|584154128|FG000|Overall Study|Reached stopping criteria|0|||
161758573|NCT02415595|584154129|FG001|Overall Study|Reached stopping criteria|1|||
161758574|NCT02415595|584154130|FG002|Overall Study|Reached stopping criteria|1|||
161758575|NCT02415595|584154131|FG003|Overall Study|Reached stopping criteria|0|||
161758576|NCT02415595|584154128|FG000|Overall Study|Withdrawal by Subject|4|||
161758577|NCT02415595|584154129|FG001|Overall Study|Withdrawal by Subject|0|||
161846853|NCT03146962|584480373|FG006|Overall Study|Physician Decision|0|||
161846854|NCT03146962|584480374|FG007|Overall Study|Physician Decision|0|||
161846855|NCT03146962|584480375|FG008|Overall Study|Physician Decision|0|||
161846856|NCT03146962|584480376|FG009|Overall Study|Physician Decision|1|||
161846857|NCT03146962|584480367|FG000|Overall Study|Started New Treatment|0|||
161846858|NCT03146962|584480368|FG001|Overall Study|Started New Treatment|1|||
161846859|NCT03146962|584480369|FG002|Overall Study|Started New Treatment|0|||
161846860|NCT03146962|584480370|FG003|Overall Study|Started New Treatment|0|||
161846861|NCT03146962|584480371|FG004|Overall Study|Started New Treatment|0|||
161846862|NCT03146962|584480372|FG005|Overall Study|Started New Treatment|0|||
161846863|NCT03146962|584480373|FG006|Overall Study|Started New Treatment|0|||
161846864|NCT03146962|584480374|FG007|Overall Study|Started New Treatment|0|||
161846865|NCT03146962|584480375|FG008|Overall Study|Started New Treatment|0|||
161846866|NCT03146962|584480376|FG009|Overall Study|Started New Treatment|0|||
161846867|NCT01635283|584480379|FG000|Overall Study|Tumor Progression|3|||
161846868|NCT01635283|584480379|FG000|Overall Study|Lost to Follow-up|1|||
161846869|NCT04516759|584480380|FG000|Overall Study|Withdrawal by Subject|1|||
161846870|NCT04516759|584480381|FG001|Overall Study|Withdrawal by Subject|1|||
161846871|NCT04516759|584480380|FG000|Overall Study|Other|0|||
161846872|NCT04516759|584480381|FG001|Overall Study|Other|1|||
161846873|NCT01268501|584480389|FG000|Overall Study|Lost to Follow-up|1|||
161846874|NCT01268501|584480389|FG000|Overall Study|Withdrawal by Subject|3|||
161846875|NCT01268501|584480389|FG000|Overall Study|Unacceptable Subjective Vision|3|||
161846876|NCT01268501|584480389|FG000|Overall Study|Handling Difficulties|2|||
161846877|NCT00724048|584480390|FG000|Overall Study|Adverse Event|1|||
161846878|NCT00724048|584480391|FG001|Overall Study|Adverse Event|1|||
161846879|NCT00724048|584480392|FG002|Overall Study|Adverse Event|1|||
161846880|NCT00724048|584480393|FG003|Overall Study|Adverse Event|0|||
161846881|NCT00724048|584480390|FG000|Overall Study|Lost to Follow-up|0|||
161846882|NCT00724048|584480391|FG001|Overall Study|Lost to Follow-up|1|||
161846883|NCT00724048|584480392|FG002|Overall Study|Lost to Follow-up|0|||
161846884|NCT00724048|584480393|FG003|Overall Study|Lost to Follow-up|0|||
161846885|NCT00724048|584480390|FG000|Overall Study|Withdrawal by Subject|1|||
161846886|NCT00724048|584480391|FG001|Overall Study|Withdrawal by Subject|2|||
161846887|NCT00724048|584480392|FG002|Overall Study|Withdrawal by Subject|1|||
161846888|NCT00724048|584480393|FG003|Overall Study|Withdrawal by Subject|2|||
161846889|NCT00724048|584480390|FG000|Overall Study|Investigator decision|0|||
161846890|NCT00724048|584480391|FG001|Overall Study|Investigator decision|0|||
161846891|NCT00724048|584480392|FG002|Overall Study|Investigator decision|1|||
161846892|NCT00724048|584480393|FG003|Overall Study|Investigator decision|0|||
161846893|NCT00724048|584480390|FG000|Overall Study|Did not tolerate study drug|0|||
161846894|NCT00724048|584480391|FG001|Overall Study|Did not tolerate study drug|0|||
161846895|NCT00724048|584480392|FG002|Overall Study|Did not tolerate study drug|0|||
161846896|NCT00724048|584480393|FG003|Overall Study|Did not tolerate study drug|1|||
161846897|NCT00724048|584480390|FG000|Overall Study|Other than specified|1|||
161758578|NCT02415595|584154130|FG002|Overall Study|Withdrawal by Subject|1|||
161758579|NCT02415595|584154131|FG003|Overall Study|Withdrawal by Subject|3|||
161758580|NCT02415595|584154128|FG000|Overall Study|Other|0|||
161758581|NCT02415595|584154129|FG001|Overall Study|Other|1|||
161758582|NCT02415595|584154130|FG002|Overall Study|Other|1|||
161846898|NCT00724048|584480391|FG001|Overall Study|Other than specified|1|||
161846899|NCT00724048|584480392|FG002|Overall Study|Other than specified|0|||
161846900|NCT00724048|584480393|FG003|Overall Study|Other than specified|0|||
161846901|NCT04874155|584480394|FG000|Overall Study|Lost to Follow-up|1|||
161846902|NCT04874155|584480395|FG001|Overall Study|Lost to Follow-up|1|||
161846903|NCT04874155|584480394|FG000|Overall Study|Withdrawal by Subject|2|||
161846904|NCT04874155|584480395|FG001|Overall Study|Withdrawal by Subject|2|||
161846905|NCT02774642|584480398|FG000|Overall Study|Lost to Follow-up|9|||
161846906|NCT02774642|584480399|FG001|Overall Study|Lost to Follow-up|7|||
161846907|NCT00477295|584480400|FG000|Overall Study|Adverse Event|31|||
161846908|NCT00477295|584480401|FG001|Overall Study|Adverse Event|35|||
161846909|NCT00477295|584480400|FG000|Overall Study|Withdrawal by Subject|35|||
161846910|NCT00477295|584480401|FG001|Overall Study|Withdrawal by Subject|24|||
161846911|NCT00477295|584480400|FG000|Overall Study|Lack of Efficacy|23|||
161846912|NCT00477295|584480401|FG001|Overall Study|Lack of Efficacy|23|||
161846913|NCT00477295|584480400|FG000|Overall Study|Protocol Violation|3|||
161846914|NCT00477295|584480401|FG001|Overall Study|Protocol Violation|8|||
161846915|NCT00477295|584480400|FG000|Overall Study|Physician Decision|4|||
161846916|NCT00477295|584480401|FG001|Overall Study|Physician Decision|5|||
161846917|NCT00477295|584480400|FG000|Overall Study|Lost to Follow-up|21|||
161846918|NCT00477295|584480401|FG001|Overall Study|Lost to Follow-up|11|||
161846919|NCT00477295|584480400|FG000|Overall Study|Other|4|||
161846920|NCT00477295|584480401|FG001|Overall Study|Other|3|||
161846921|NCT01425723|584480404|FG000|Overall Study|Lack of Efficacy|0|||
161846922|NCT01425723|584480405|FG001|Overall Study|Lack of Efficacy|1|||
161846923|NCT01425723|584480404|FG000|Overall Study|Withdrawal by Subject|1|||
161846924|NCT01425723|584480405|FG001|Overall Study|Withdrawal by Subject|4|||
161846925|NCT01425723|584480404|FG000|Overall Study|Lost to Follow-up|0|||
161846926|NCT01425723|584480405|FG001|Overall Study|Lost to Follow-up|3|||
161846927|NCT01425723|584480404|FG000|Overall Study|Physician Decision|2|||
161846928|NCT01425723|584480405|FG001|Overall Study|Physician Decision|0|||
161846929|NCT01425723|584480404|FG000|Overall Study|Other|1|||
161846930|NCT01425723|584480405|FG001|Overall Study|Other|10|||
161846931|NCT03835221|584480406|FG000|Methafilcon A|Withdrawal by Subject|1|||
161846932|NCT00861198|584480407|FG000|Overall Study|SpyGlass Failed|5|||
161846933|NCT02288182|584480408|FG000|Overall Study|Adverse Event|0|||
161846934|NCT02288182|584480409|FG001|Overall Study|Adverse Event|1|||
161846935|NCT02288182|584480408|FG000|Overall Study|Lost to Follow-up|0|||
161846936|NCT02288182|584480409|FG001|Overall Study|Lost to Follow-up|1|||
161846937|NCT04619992|584480411|FG000|Overall Study|Withdrawal by Subject|1|||
161846938|NCT04619992|584480412|FG001|Overall Study|Withdrawal by Subject|0|||
161846939|NCT03365011|584480413|FG000|Overall Study|Withdrawal by Subject|1|||
161846940|NCT03365011|584480414|FG001|Overall Study|Withdrawal by Subject|2|||
161846941|NCT03582826|584480415|FG000|Overall Study|Lost to Follow-up|39|||
161846942|NCT03582826|584480416|FG001|Overall Study|Lost to Follow-up|0|||
161846943|NCT03582826|584480415|FG000|Overall Study|Withdrawal by Subject|2|||
161846944|NCT03582826|584480416|FG001|Overall Study|Withdrawal by Subject|0|||
161846945|NCT00499174|584480417|FG000|Overall Study|Physician Decision|78|||
161846946|NCT00499174|584480418|FG001|Overall Study|Physician Decision|9|||
161846947|NCT01214915|584480419|FG000|Overall Study|Adverse Event|8|||
161846948|NCT01214915|584480419|FG000|Overall Study|Lack of Efficacy|3|||
161846949|NCT00574912|584480420|FG000|Overall Study|Could not place IV lines.|3|||
161846950|NCT00574912|584480420|FG000|Overall Study|scheduling conflicts|3|||
161846951|NCT00574912|584480420|FG000|Overall Study|Physician Decision|2|||
161846952|NCT04730349|584480429|FG000|Overall Study|Participant withdrew consent|1|||
161846953|NCT04730349|584480430|FG001|Overall Study|Participant withdrew consent|0|||
161846954|NCT04730349|584480429|FG000|Overall Study|Disease progression|6|||
161846955|NCT04730349|584480430|FG001|Overall Study|Disease progression|4|||
161846956|NCT04730349|584480429|FG000|Overall Study|Study drug toxicity|0|||
161846957|NCT04730349|584480430|FG001|Overall Study|Study drug toxicity|1|||
161846958|NCT00638027|584480431|FG000|Overall Study|Adverse Event|0|||
161846959|NCT00638027|584480432|FG001|Overall Study|Adverse Event|2|||
161846960|NCT00371397|584480433|FG000|Session 1|Withdrawal by Subject|1|||
161846961|NCT00371397|584480434|FG001|Session 1|Withdrawal by Subject|0|||
161846962|NCT00371397|584480435|FG002|Session 1|Withdrawal by Subject|0|||
161846963|NCT00371397|584480436|FG003|Session 1|Withdrawal by Subject|0|||
161846964|NCT00371397|584480437|FG004|Session 1|Withdrawal by Subject|0|||
161846965|NCT00371397|584480438|FG005|Session 1|Withdrawal by Subject|0|||
161970999|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
161846966|NCT00371397|584480439|FG006|Session 1|Withdrawal by Subject|0|||
161971000|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
161971001|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
161971002|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
161971003|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
161846967|NCT00371397|584480440|FG007|Session 1|Withdrawal by Subject|1|||
161846968|NCT00371397|584480441|FG008|Session 1|Withdrawal by Subject|0|||
161846969|NCT00371397|584480442|FG009|Session 1|Withdrawal by Subject|0|||
161846970|NCT00371397|584480443|FG010|Session 1|Withdrawal by Subject|0|||
161846971|NCT00371397|584480444|FG011|Session 1|Withdrawal by Subject|0|||
161846972|NCT03753763|584480445|FG000|Overall Study|Adverse Event|2|||
161846973|NCT03753763|584480446|FG001|Overall Study|Adverse Event|0|||
161846974|NCT03753763|584480445|FG000|Overall Study|Withdrawal by Subject|3|||
161846975|NCT03753763|584480446|FG001|Overall Study|Withdrawal by Subject|1|||
161846976|NCT03753763|584480445|FG000|Overall Study|clinical deterioration|1|||
161846977|NCT03753763|584480446|FG001|Overall Study|clinical deterioration|0|||
161846978|NCT01104779|584480447|FG000|Overall Study|Protocol Violation|1|||
161846979|NCT01104779|584480448|FG001|Overall Study|Protocol Violation|2|||
161971004|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
161758583|NCT02415595|584154131|FG003|Overall Study|Other|0|||
161758584|NCT03074318|584154134|FG000|Overall Study|Adverse Event|0|||
161758585|NCT03074318|584154135|FG001|Overall Study|Adverse Event|1|||
161758586|NCT03074318|584154136|FG002|Overall Study|Adverse Event|1|||
161758587|NCT03074318|584154137|FG003|Overall Study|Adverse Event|1|||
161758588|NCT03074318|584154134|FG000|Overall Study|Death|1|||
161758589|NCT03074318|584154135|FG001|Overall Study|Death|0|||
161758590|NCT03074318|584154136|FG002|Overall Study|Death|0|||
161758591|NCT03074318|584154137|FG003|Overall Study|Death|0|||
161758592|NCT03074318|584154134|FG000|Overall Study|Withdrawal by Subject|1|||
161758593|NCT03074318|584154135|FG001|Overall Study|Withdrawal by Subject|2|||
161758594|NCT03074318|584154136|FG002|Overall Study|Withdrawal by Subject|2|||
161758595|NCT03074318|584154137|FG003|Overall Study|Withdrawal by Subject|4|||
161758596|NCT03074318|584154134|FG000|Overall Study|Trial Closure|2|||
161758597|NCT03074318|584154135|FG001|Overall Study|Trial Closure|2|||
161758598|NCT03074318|584154136|FG002|Overall Study|Trial Closure|3|||
161758599|NCT03074318|584154137|FG003|Overall Study|Trial Closure|11|||
161758600|NCT00686699|584155354|FG000|Treatment Period 1|Adverse Event|0|||
161758601|NCT00686699|584155355|FG001|Treatment Period 1|Adverse Event|2|||
161758602|NCT00908895|584155356|FG000|Overall Study|Lost to Follow-up|1|||
161758603|NCT00908895|584155357|FG001|Overall Study|Lost to Follow-up|3|||
161758604|NCT00908895|584155356|FG000|Overall Study|algodystrophy|2|||
161758605|NCT00908895|584155357|FG001|Overall Study|algodystrophy|2|||
161758606|NCT00908895|584155356|FG000|Overall Study|Adverse Event|1|||
161758607|NCT00908895|584155357|FG001|Overall Study|Adverse Event|1|||
161758608|NCT03793010|584155358|FG000|Overall Study|Withdrawal by Subject|5|||
161758609|NCT03793010|584155359|FG001|Overall Study|Withdrawal by Subject|7|||
161758610|NCT03793010|584155358|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
161758611|NCT03793010|584155359|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
161758612|NCT03793010|584155358|FG000|Overall Study|Lost to Follow-up|1|||
161758613|NCT03793010|584155359|FG001|Overall Study|Lost to Follow-up|2|||
161758614|NCT03793010|584155358|FG000|Overall Study|Patient couldn't sit still for injection|1|||
161758615|NCT03793010|584155359|FG001|Overall Study|Patient couldn't sit still for injection|0|||
161758616|NCT03793010|584155358|FG000|Overall Study|Withdrew to pursue other treatment|1|||
161758617|NCT03793010|584155359|FG001|Overall Study|Withdrew to pursue other treatment|0|||
161758618|NCT03793010|584155358|FG000|Overall Study|Did not meet eligibility criteria|1|||
161758619|NCT03793010|584155359|FG001|Overall Study|Did not meet eligibility criteria|0|||
161758620|NCT00364611|584155362|FG000|Overall Study|Did not receive study medication|0|||
161758621|NCT00364611|584155363|FG001|Overall Study|Did not receive study medication|1|||
161758622|NCT00364611|584155362|FG000|Overall Study|Adverse Event|7|||
161758623|NCT00364611|584155363|FG001|Overall Study|Adverse Event|4|||
161758624|NCT00364611|584155362|FG000|Overall Study|Participant's Request|3|||
161758625|NCT00364611|584155363|FG001|Overall Study|Participant's Request|4|||
161758626|NCT00364611|584155362|FG000|Overall Study|Disease Progression|38|||
161758627|NCT00364611|584155363|FG001|Overall Study|Disease Progression|8|||
161758628|NCT00364611|584155362|FG000|Overall Study|Investigator decision|2|||
161758629|NCT00364611|584155363|FG001|Overall Study|Investigator decision|2|||
161758630|NCT00364611|584155362|FG000|Overall Study|Found Ineligible|1|||
161758631|NCT00364611|584155363|FG001|Overall Study|Found Ineligible|0|||
161758632|NCT00364611|584155362|FG000|Overall Study|Presumed CR on Study|0|||
161758633|NCT00364611|584155363|FG001|Overall Study|Presumed CR on Study|1|||
161758634|NCT00364611|584155362|FG000|Overall Study|Receiving Liver Ablation|0|||
161758635|NCT00364611|584155363|FG001|Overall Study|Receiving Liver Ablation|1|||
161758636|NCT02059174|584155389|FG000|Period 1|Withdrawal by Subject|0|||
161758637|NCT02059174|584155390|FG001|Period 1|Withdrawal by Subject|2|||
161758638|NCT02059174|584155389|FG000|Period 2|Withdrawal by Subject|0|||
161758639|NCT02059174|584155390|FG001|Period 2|Withdrawal by Subject|2|||
161758640|NCT02059174|584155389|FG000|Period 2|Protocol Violation|1|||
161758641|NCT02059174|584155390|FG001|Period 2|Protocol Violation|0|||
161758642|NCT02059174|584155389|FG000|Period 3|Physician Decision|1|||
161758643|NCT02059174|584155390|FG001|Period 3|Physician Decision|0|||
161758644|NCT00768040|584155391|FG000|Overall Study|Adverse Event|3|||
161758645|NCT00768040|584155392|FG001|Overall Study|Adverse Event|2|||
161758646|NCT00768040|584155391|FG000|Overall Study|Abnormal laboratory value|1|||
161758647|NCT00768040|584155392|FG001|Overall Study|Abnormal laboratory value|1|||
161758648|NCT02511106|584155397|FG000|Overall Study|Lost to Follow-up|6|||
161758649|NCT02511106|584155398|FG001|Overall Study|Lost to Follow-up|4|||
161758650|NCT02511106|584155397|FG000|Overall Study|Withdrawal by Subject|24|||
161758651|NCT02511106|584155398|FG001|Overall Study|Withdrawal by Subject|21|||
161758652|NCT02511106|584155397|FG000|Overall Study|Death|42|||
161758653|NCT02511106|584155398|FG001|Overall Study|Death|82|||
161758654|NCT02511106|584155397|FG000|Overall Study|Ongoing study at data cut-off|3|||
161758655|NCT02511106|584155398|FG001|Overall Study|Ongoing study at data cut-off|2|||
161758656|NCT02511106|584155397|FG000|Overall Study|Without specified reason|3|||
161758657|NCT02511106|584155398|FG001|Overall Study|Without specified reason|0|||
161758658|NCT01222767|584155399|FG000|Overall Study|Progressive disease|13|||
161758659|NCT01222767|584155399|FG000|Overall Study|Adverse Event|2|||
161758660|NCT01222767|584155399|FG000|Overall Study|Surgical resection|1|||
161758661|NCT01222767|584155399|FG000|Overall Study|Never treated|1|||
161758662|NCT02773849|584155400|FG000|Overall Study|Lost to Follow-up|11|||
161758663|NCT02773849|584155400|FG000|Overall Study|Death|26|||
161758664|NCT02773849|584155400|FG000|Overall Study|Withdrawal by Subject|5|||
161758665|NCT02773849|584155400|FG000|Overall Study|Withdrawal of Consent|9|||
161758666|NCT02773849|584155400|FG000|Overall Study|Other: not due to lack of tolerability|11|||
161758667|NCT02274311|584155407|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
161758668|NCT00508001|584155408|FG000|Overall Study|Adverse Event|2|||
161758669|NCT00508001|584155409|FG001|Overall Study|Adverse Event|0|||
161758670|NCT00508001|584155410|FG002|Overall Study|Adverse Event|4|||
161758671|NCT00508001|584155408|FG000|Overall Study|condition under investigation worsened|13|||
161758672|NCT00508001|584155409|FG001|Overall Study|condition under investigation worsened|7|||
161758673|NCT00508001|584155410|FG002|Overall Study|condition under investigation worsened|1|||
161758674|NCT00508001|584155408|FG000|Overall Study|Death|0|||
161758675|NCT00508001|584155409|FG001|Overall Study|Death|1|||
161758676|NCT00508001|584155410|FG002|Overall Study|Death|1|||
161758677|NCT00508001|584155408|FG000|Overall Study|Withdrawal by Subject|4|||
161758678|NCT00508001|584155409|FG001|Overall Study|Withdrawal by Subject|4|||
161758679|NCT00508001|584155410|FG002|Overall Study|Withdrawal by Subject|1|||
161758680|NCT01685372|584155411|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
161758681|NCT01685372|584155412|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
161758682|NCT01626859|584155413|FG000|Overall Study|Adverse Event|1|||
161758683|NCT01626859|584155414|FG001|Overall Study|Adverse Event|3|||
161758684|NCT01626859|584155415|FG002|Overall Study|Adverse Event|2|||
161758685|NCT01626859|584155413|FG000|Overall Study|Physician Decision|0|||
161758686|NCT01626859|584155414|FG001|Overall Study|Physician Decision|1|||
161758687|NCT01626859|584155415|FG002|Overall Study|Physician Decision|0|||
161758688|NCT01626859|584155413|FG000|Overall Study|Withdrawal by Subject|1|||
161758689|NCT01626859|584155414|FG001|Overall Study|Withdrawal by Subject|4|||
161758690|NCT01626859|584155415|FG002|Overall Study|Withdrawal by Subject|2|||
161758691|NCT03457636|584155426|FG000|Overall Study|Lost to Follow-up|2|||
161758692|NCT01828567|584155429|FG000|Overall Study|Lost to Follow-up|27|||
161758693|NCT01828567|584155430|FG001|Overall Study|Lost to Follow-up|9|||
161758694|NCT01828567|584155429|FG000|Overall Study|Excluded - did not meet criteria|4|||
161758695|NCT01828567|584155430|FG001|Overall Study|Excluded - did not meet criteria|1|||
161758696|NCT03325010|584155440|FG000|Overall Study|Adverse Event|3|||
161758697|NCT03325010|584155441|FG001|Overall Study|Adverse Event|8|||
161758698|NCT03325010|584155440|FG000|Overall Study|Protocol Violation|1|||
161758699|NCT03325010|584155441|FG001|Overall Study|Protocol Violation|8|||
161758700|NCT03325010|584155440|FG000|Overall Study|Withdrawal by Subject|1|||
161758701|NCT03325010|584155441|FG001|Overall Study|Withdrawal by Subject|3|||
161758702|NCT03325010|584155440|FG000|Overall Study|Lost to Follow-up|1|||
161758703|NCT03325010|584155441|FG001|Overall Study|Lost to Follow-up|0|||
161758704|NCT03325010|584155440|FG000|Overall Study|Physician Decision|1|||
161758705|NCT03325010|584155441|FG001|Overall Study|Physician Decision|1|||
161758706|NCT03325010|584155440|FG000|Overall Study|Lack of Efficacy|2|||
161758707|NCT03325010|584155441|FG001|Overall Study|Lack of Efficacy|0|||
161758708|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
161758709|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
161758710|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
161758711|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161758712|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
161758713|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161758714|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161758715|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161758716|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
161758717|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
161758718|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161758719|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161758720|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
161758721|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
161758722|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
161758723|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
161758724|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
161758725|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
161758726|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
161758727|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
161758728|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
161758729|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
161758730|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
161758731|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
161758732|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Screen failure|0|||
161758733|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Screen failure|1|||
161758734|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Screen failure|2|||
161758735|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Screen failure|0|||
161971005|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161971006|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161971007|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161971008|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161971009|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161971010|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
161971011|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
161971012|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
161971013|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
161971014|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
161971015|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161971016|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161971017|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161971018|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161971019|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161971020|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161971021|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161971022|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161971023|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
161971024|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161971025|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
161971026|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
161971027|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
161971028|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
161971029|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
161971030|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
161971031|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
161971032|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
161971033|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
161971034|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
161971035|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161971036|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161971037|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161971038|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161971039|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161971040|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161971041|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161971042|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
161971043|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
161971044|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
161971045|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161758736|NCT02614261|584155442|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
161758737|NCT02614261|584155443|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
161758738|NCT02614261|584155444|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
161758739|NCT02614261|584155445|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161758740|NCT02614261|584155442|FG000|Open-Label Extension Phase|Adverse Event|23|||
161758741|NCT02614261|584155443|FG001|Open-Label Extension Phase|Adverse Event|12|||
161758742|NCT02614261|584155444|FG002|Open-Label Extension Phase|Adverse Event|11|||
161758743|NCT02614261|584155445|FG003|Open-Label Extension Phase|Adverse Event|0|||
161758744|NCT02614261|584155442|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
161758745|NCT02614261|584155443|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
161758746|NCT02614261|584155444|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
161758747|NCT02614261|584155445|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
161758748|NCT02614261|584155442|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
161758749|NCT02614261|584155443|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
161758750|NCT02614261|584155444|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
161758751|NCT02614261|584155445|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
161758752|NCT02614261|584155442|FG000|Open-Label Extension Phase|Physician Decision|2|||
161758753|NCT02614261|584155443|FG001|Open-Label Extension Phase|Physician Decision|0|||
161758754|NCT02614261|584155444|FG002|Open-Label Extension Phase|Physician Decision|0|||
161758755|NCT02614261|584155445|FG003|Open-Label Extension Phase|Physician Decision|0|||
161758756|NCT02614261|584155442|FG000|Open-Label Extension Phase|Pregnancy|1|||
161758757|NCT02614261|584155443|FG001|Open-Label Extension Phase|Pregnancy|2|||
161758758|NCT02614261|584155444|FG002|Open-Label Extension Phase|Pregnancy|1|||
161758759|NCT02614261|584155445|FG003|Open-Label Extension Phase|Pregnancy|0|||
161758760|NCT02614261|584155442|FG000|Open-Label Extension Phase|Protocol Violation|3|||
161758761|NCT02614261|584155443|FG001|Open-Label Extension Phase|Protocol Violation|4|||
161758762|NCT02614261|584155444|FG002|Open-Label Extension Phase|Protocol Violation|1|||
161758763|NCT02614261|584155445|FG003|Open-Label Extension Phase|Protocol Violation|0|||
161758764|NCT02614261|584155442|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
161758765|NCT02614261|584155443|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
161758766|NCT02614261|584155444|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
161758767|NCT02614261|584155445|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
161758768|NCT02614261|584155442|FG000|Follow-up Phase|Adverse Event|2|||
161758769|NCT02614261|584155443|FG001|Follow-up Phase|Adverse Event|0|||
161758770|NCT02614261|584155444|FG002|Follow-up Phase|Adverse Event|1|||
161758771|NCT02614261|584155445|FG003|Follow-up Phase|Adverse Event|0|||
161758772|NCT02614261|584155442|FG000|Follow-up Phase|Lost to Follow-up|12|||
161758773|NCT02614261|584155443|FG001|Follow-up Phase|Lost to Follow-up|5|||
161758774|NCT02614261|584155444|FG002|Follow-up Phase|Lost to Follow-up|2|||
161758775|NCT02614261|584155445|FG003|Follow-up Phase|Lost to Follow-up|0|||
161758776|NCT02614261|584155442|FG000|Follow-up Phase|Physician Decision|5|||
161758777|NCT02614261|584155443|FG001|Follow-up Phase|Physician Decision|1|||
161758778|NCT02614261|584155444|FG002|Follow-up Phase|Physician Decision|0|||
161758779|NCT02614261|584155445|FG003|Follow-up Phase|Physician Decision|0|||
161758780|NCT02614261|584155442|FG000|Follow-up Phase|Pregnancy|0|||
161758781|NCT02614261|584155443|FG001|Follow-up Phase|Pregnancy|1|||
161758782|NCT02614261|584155444|FG002|Follow-up Phase|Pregnancy|0|||
161758783|NCT02614261|584155445|FG003|Follow-up Phase|Pregnancy|0|||
161758784|NCT02614261|584155442|FG000|Follow-up Phase|Protocol Violation|1|||
161758785|NCT02614261|584155443|FG001|Follow-up Phase|Protocol Violation|0|||
161758786|NCT02614261|584155444|FG002|Follow-up Phase|Protocol Violation|0|||
161758787|NCT02614261|584155445|FG003|Follow-up Phase|Protocol Violation|0|||
161758788|NCT02614261|584155442|FG000|Follow-up Phase|Withdrawal by Subject|12|||
161758789|NCT02614261|584155443|FG001|Follow-up Phase|Withdrawal by Subject|4|||
161758790|NCT02614261|584155444|FG002|Follow-up Phase|Withdrawal by Subject|11|||
161758791|NCT02614261|584155445|FG003|Follow-up Phase|Withdrawal by Subject|0|||
161758792|NCT02614261|584155442|FG000|Israel Addendum|Withdrawal by Subject|0|||
161758793|NCT02614261|584155443|FG001|Israel Addendum|Withdrawal by Subject|0|||
161758794|NCT02614261|584155444|FG002|Israel Addendum|Withdrawal by Subject|0|||
161758795|NCT02614261|584155445|FG003|Israel Addendum|Withdrawal by Subject|4|||
161758796|NCT04350372|584155447|FG000|Overall Study|Death|1|||
161758797|NCT03512275|584155449|FG000|Overall Study|Withdrawal by Subject|1|||
161758798|NCT03512275|584155450|FG001|Overall Study|Withdrawal by Subject|3|||
161758799|NCT03512275|584155449|FG000|Overall Study|Physician Decision|0|||
161758800|NCT03512275|584155450|FG001|Overall Study|Physician Decision|1|||
161758801|NCT03512275|584155449|FG000|Overall Study|Lost to Follow-up|0|||
161758802|NCT03512275|584155450|FG001|Overall Study|Lost to Follow-up|3|||
161758803|NCT03512275|584155449|FG000|Overall Study|Other|1|||
161758804|NCT03512275|584155450|FG001|Overall Study|Other|0|||
161758805|NCT00113555|584155451|FG000|Overall Study|Baseline Failure|59|||
161758806|NCT00113555|584155451|FG000|Overall Study|Permanently Explanted|7|||
161758807|NCT00113555|584155451|FG000|Overall Study|Death|1|||
161758808|NCT00113555|584155451|FG000|Overall Study|Missed Followup|4|||
161758809|NCT00113555|584155451|FG000|Overall Study|Lost to Follow-up|8|||
161758810|NCT04474366|584155452|FG000|Overall Study|Lost to Follow-up|2|||
161758811|NCT04474366|584155453|FG001|Overall Study|Lost to Follow-up|5|||
161758812|NCT01700140|584155454|FG000|Overall Study|Use of rescue drugs|3|||
161758813|NCT01700140|584155455|FG001|Overall Study|Use of rescue drugs|3|||
161758814|NCT01700140|584155456|FG002|Overall Study|Use of rescue drugs|1|||
161758815|NCT01700140|584155454|FG000|Overall Study|Discontinuation of radiotherapy|1|||
161758816|NCT01700140|584155455|FG001|Overall Study|Discontinuation of radiotherapy|0|||
161758817|NCT01700140|584155456|FG002|Overall Study|Discontinuation of radiotherapy|0|||
161758818|NCT01700140|584155454|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
161758819|NCT01700140|584155455|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
161758820|NCT01700140|584155456|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
161758821|NCT01700140|584155454|FG000|Overall Study|Aggravation of symptoms|1|||
161758822|NCT01700140|584155455|FG001|Overall Study|Aggravation of symptoms|0|||
161758823|NCT01700140|584155456|FG002|Overall Study|Aggravation of symptoms|0|||
161758824|NCT01700140|584155454|FG000|Overall Study|Adverse Event|0|||
161758825|NCT01700140|584155455|FG001|Overall Study|Adverse Event|1|||
161758826|NCT01700140|584155456|FG002|Overall Study|Adverse Event|0|||
161758827|NCT01700140|584155454|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
161758828|NCT01700140|584155455|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
161758829|NCT01700140|584155456|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
161758830|NCT01060124|584155457|FG000|Overall Study|Other|16|||
161758831|NCT01060124|584155457|FG000|Overall Study|Adverse Event|14|||
161758832|NCT01060124|584155457|FG000|Overall Study|Withdrawal by Subject|7|||
161758833|NCT00102804|584155460|FG000|Overall Study|Progressive Disease (PD)|307|||
161758834|NCT00102804|584155461|FG001|Overall Study|Progressive Disease (PD)|196|||
161758835|NCT00102804|584155460|FG000|Overall Study|Withdrawal by Subject|46|||
161758836|NCT00102804|584155461|FG001|Overall Study|Withdrawal by Subject|7|||
161758837|NCT00102804|584155460|FG000|Overall Study|Adverse Event|37|||
161758838|NCT00102804|584155461|FG001|Overall Study|Adverse Event|3|||
161758839|NCT00102804|584155460|FG000|Overall Study|Physician Decision|24|||
161758840|NCT00102804|584155461|FG001|Overall Study|Physician Decision|6|||
161758841|NCT00102804|584155460|FG000|Overall Study|Death|5|||
161758842|NCT00102804|584155461|FG001|Overall Study|Death|6|||
161758843|NCT00102804|584155460|FG000|Overall Study|Enrollment Criteria Not Met|6|||
161758844|NCT00102804|584155461|FG001|Overall Study|Enrollment Criteria Not Met|0|||
161758845|NCT00102804|584155460|FG000|Overall Study|Lost to Follow-up|4|||
161758846|NCT00102804|584155461|FG001|Overall Study|Lost to Follow-up|1|||
161758847|NCT00102804|584155460|FG000|Overall Study|Protocol Violation|2|||
161758848|NCT00102804|584155461|FG001|Overall Study|Protocol Violation|1|||
161758849|NCT00102804|584155460|FG000|Overall Study|Satisfactory Response|2|||
161758850|NCT00102804|584155461|FG001|Overall Study|Satisfactory Response|0|||
161758851|NCT00102804|584155460|FG000|Overall Study|Sponsor Decision|1|||
161758852|NCT00102804|584155461|FG001|Overall Study|Sponsor Decision|0|||
161758853|NCT00102804|584155460|FG000|Overall Study|Alive, Receiving Treatment|7|||
161758854|NCT00102804|584155461|FG001|Overall Study|Alive, Receiving Treatment|2|||
161758855|NCT03858686|584155462|FG000|Period 1|Adverse Event|1|||
161758856|NCT03858686|584155463|FG001|Period 1|Adverse Event|1|||
161758857|NCT03858686|584155462|FG000|Period 1|Lack of compliance|0|||
161758858|NCT03858686|584155463|FG001|Period 1|Lack of compliance|1|||
161758859|NCT03858686|584155462|FG000|Period 1|Adverse Event|0|||
161758860|NCT03858686|584155463|FG001|Period 1|Adverse Event|1|||
161758861|NCT03858686|584155462|FG000|Period 2|Adverse Event|0|||
161758862|NCT03858686|584155463|FG001|Period 2|Adverse Event|1|||
161758863|NCT02299206|584155470|FG000|Overall Study|Lost to Follow-up|1|||
161758864|NCT02299206|584155470|FG000|Overall Study|Withdrawal by Subject|1|||
161758865|NCT00691054|584155471|FG000|Overall Study|Withdrawal by Subject|1|||
161758866|NCT00518336|584155472|FG000|Year 7|Lost to Follow-up|2|||
161758867|NCT00518336|584155473|FG001|Year 7|Lost to Follow-up|0|||
161758868|NCT00518336|584155472|FG000|Year 7|Could not attend in time|0|||
161758869|NCT00518336|584155473|FG001|Year 7|Could not attend in time|3|||
161758870|NCT00518336|584155472|FG000|Year 8|Lost to Follow-up|1|||
161758871|NCT00518336|584155473|FG001|Year 8|Lost to Follow-up|1|||
161758872|NCT00518336|584155472|FG000|Year 8|Could not attend in time|0|||
161758873|NCT00518336|584155473|FG001|Year 8|Could not attend in time|1|||
161758874|NCT00518336|584155472|FG000|Year 9|Migrated/moved from study area|1|||
161758875|NCT00518336|584155473|FG001|Year 9|Migrated/moved from study area|1|||
161758876|NCT00518336|584155472|FG000|Year 9|Lost to Follow-up|3|||
161758877|NCT00518336|584155473|FG001|Year 9|Lost to Follow-up|0|||
161758878|NCT00518336|584155472|FG000|Year 9|Personal reasons|1|||
161758879|NCT00518336|584155473|FG001|Year 9|Personal reasons|0|||
161758880|NCT02314637|584156689|FG000|Overall Study|Adverse Event|4|||
161758881|NCT02314637|584156690|FG001|Overall Study|Adverse Event|8|||
161758882|NCT02314637|584156689|FG000|Overall Study|Lack of Efficacy|1|||
161758883|NCT02314637|584156690|FG001|Overall Study|Lack of Efficacy|0|||
161758884|NCT02314637|584156689|FG000|Overall Study|Physician Decision|5|||
161758885|NCT02314637|584156690|FG001|Overall Study|Physician Decision|2|||
161758886|NCT02314637|584156689|FG000|Overall Study|Withdrawal by Subject|5|||
161758887|NCT02314637|584156690|FG001|Overall Study|Withdrawal by Subject|4|||
161758888|NCT02314637|584156689|FG000|Overall Study|Other Reason|1|||
161971046|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161971047|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
162032967|NCT04035486|585177531|FG000|Overall Study|Death|6|||
161758889|NCT02314637|584156690|FG001|Overall Study|Other Reason|0|||
161758890|NCT04221945|584156694|FG000|Overall Study|Death|103|||
161758891|NCT04221945|584156695|FG001|Overall Study|Death|140|||
161758892|NCT04221945|584156694|FG000|Overall Study|Lost to Follow-up|5|||
161758893|NCT04221945|584156695|FG001|Overall Study|Lost to Follow-up|8|||
161758894|NCT04221945|584156694|FG000|Overall Study|Withdrawal by Subject|21|||
161758895|NCT04221945|584156695|FG001|Overall Study|Withdrawal by Subject|11|||
161758896|NCT04221945|584156694|FG000|Overall Study|Participants Ongoing|400|||
161758897|NCT04221945|584156695|FG001|Overall Study|Participants Ongoing|372|||
161758898|NCT00974090|584156697|FG000|Period 1: Double Blind Period|Adverse Event|2|||
161758899|NCT00974090|584156698|FG001|Period 1: Double Blind Period|Adverse Event|1|||
161758900|NCT00974090|584156697|FG000|Period 1: Double Blind Period|Physician Decision|1|||
161758901|NCT00974090|584156698|FG001|Period 1: Double Blind Period|Physician Decision|0|||
161758902|NCT00974090|584156697|FG000|Period 2: Open-label Period|Adverse Event|4|||
161758903|NCT00974090|584156698|FG001|Period 2: Open-label Period|Adverse Event|6|||
161846980|NCT01104779|584480449|FG002|Overall Study|Protocol Violation|2|||
161846981|NCT01104779|584480447|FG000|Overall Study|Lack of Efficacy|26|||
161846982|NCT01104779|584480448|FG001|Overall Study|Lack of Efficacy|12|||
161846983|NCT01104779|584480449|FG002|Overall Study|Lack of Efficacy|13|||
161846984|NCT01104779|584480447|FG000|Overall Study|Adverse Event|13|||
161846985|NCT01104779|584480448|FG001|Overall Study|Adverse Event|14|||
161846986|NCT01104779|584480449|FG002|Overall Study|Adverse Event|13|||
161846987|NCT01104779|584480447|FG000|Overall Study|Did not meet inc/exc criteria|1|||
161846988|NCT01104779|584480448|FG001|Overall Study|Did not meet inc/exc criteria|1|||
161846989|NCT01104779|584480449|FG002|Overall Study|Did not meet inc/exc criteria|1|||
161846990|NCT01104779|584480447|FG000|Overall Study|Other reasons|0|||
161846991|NCT01104779|584480448|FG001|Overall Study|Other reasons|1|||
161846992|NCT01104779|584480449|FG002|Overall Study|Other reasons|0|||
161846993|NCT01104779|584480447|FG000|Overall Study|Lost to Follow-up|2|||
161846994|NCT01104779|584480448|FG001|Overall Study|Lost to Follow-up|0|||
161846995|NCT01104779|584480449|FG002|Overall Study|Lost to Follow-up|1|||
161846996|NCT01104779|584480447|FG000|Overall Study|Withdrawal by Subject|16|||
161846997|NCT01104779|584480448|FG001|Overall Study|Withdrawal by Subject|25|||
161846998|NCT01104779|584480449|FG002|Overall Study|Withdrawal by Subject|32|||
161846999|NCT02342639|584480450|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
161847000|NCT02342639|584480451|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
161847001|NCT02342639|584480450|FG000|Overall Study|Protocol Violation|0|||
161847002|NCT02342639|584480451|FG001|Overall Study|Protocol Violation|2|||
161847003|NCT00871741|584480462|FG000|Overall Study|Premature study termination|9|||
161847004|NCT00871741|584480463|FG001|Overall Study|Premature study termination|7|||
161847005|NCT01565850|584480464|FG000|Overall Study|Adverse Event|0|||
161847006|NCT01565850|584480465|FG001|Overall Study|Adverse Event|1|||
161847007|NCT01565850|584480464|FG000|Overall Study|Lost to Follow-up|12|||
161847008|NCT01565850|584480465|FG001|Overall Study|Lost to Follow-up|4|||
161847009|NCT01565850|584480464|FG000|Overall Study|Investigator's Discretion|2|||
161847010|NCT01565850|584480465|FG001|Overall Study|Investigator's Discretion|1|||
161847011|NCT01565850|584480464|FG000|Overall Study|Participant noncompliance|2|||
161847012|NCT01565850|584480465|FG001|Overall Study|Participant noncompliance|0|||
161847013|NCT01565850|584480464|FG000|Overall Study|Withdrew Consent|4|||
161847014|NCT01565850|584480465|FG001|Overall Study|Withdrew Consent|2|||
161847015|NCT03395405|584482286|FG000|Overall Study|Death|0|||
161847016|NCT03395405|584482287|FG001|Overall Study|Death|2|||
161847017|NCT03395405|584482286|FG000|Overall Study|Lost to Follow-up|0|||
161847018|NCT03395405|584482287|FG001|Overall Study|Lost to Follow-up|1|||
161847019|NCT03395405|584482286|FG000|Overall Study|Protocol Violation|0|||
161847020|NCT03395405|584482287|FG001|Overall Study|Protocol Violation|1|||
161847021|NCT03395405|584482286|FG000|Overall Study|Withdrawal by Subject|3|||
161847022|NCT03395405|584482287|FG001|Overall Study|Withdrawal by Subject|1|||
161847023|NCT03395405|584482286|FG000|Overall Study|COVID-19 Pandemic|1|||
161847024|NCT03395405|584482287|FG001|Overall Study|COVID-19 Pandemic|0|||
161847025|NCT04324073|584482288|FG000|Overall Study|withdrew consent|0|||
161847026|NCT04324073|584482289|FG001|Overall Study|withdrew consent|4|||
161847027|NCT04324073|584482290|FG002|Overall Study|withdrew consent|2|||
161847028|NCT04324073|584482291|FG003|Overall Study|withdrew consent|8|||
161847029|NCT01200069|584482297|FG000|Overall Study|Withdrawal by Subject|0|||
161847030|NCT01200069|584482298|FG001|Overall Study|Withdrawal by Subject|1|||
161847031|NCT03665441|584482301|FG000|Overall Study|survival follow up ongoing|23|||
161847032|NCT03665441|584482302|FG001|Overall Study|survival follow up ongoing|0|||
161847033|NCT03665441|584482301|FG000|Overall Study|Patients ongoing on treatment|9|||
161847034|NCT03665441|584482302|FG001|Overall Study|Patients ongoing on treatment|6|||
161847035|NCT03665441|584482301|FG000|Overall Study|Randomized but not treated|7|||
161847036|NCT03665441|584482302|FG001|Overall Study|Randomized but not treated|11|||
161847037|NCT05307510|584482303|FG000|Overall Study|Lost to Follow-up|3|||
161847038|NCT05307510|584482304|FG001|Overall Study|Lost to Follow-up|6|||
161847039|NCT05307510|584482303|FG000|Overall Study|Withdrawal by Subject|0|||
161847040|NCT05307510|584482304|FG001|Overall Study|Withdrawal by Subject|1|||
161847041|NCT03610516|584482305|FG000|Treatment Epoch|Adverse Event|3|||
161847042|NCT03610516|584482306|FG001|Treatment Epoch|Adverse Event|1|||
161847043|NCT03610516|584482305|FG000|Treatment Epoch|Death|1|||
161847044|NCT03610516|584482306|FG001|Treatment Epoch|Death|0|||
161847045|NCT03610516|584482305|FG000|Treatment Epoch|Lack of Efficacy|0|||
161847046|NCT03610516|584482306|FG001|Treatment Epoch|Lack of Efficacy|1|||
161847047|NCT03610516|584482305|FG000|Treatment Epoch|No longer requires treatment|1|||
161847048|NCT03610516|584482306|FG001|Treatment Epoch|No longer requires treatment|0|||
161847049|NCT03610516|584482305|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
161847050|NCT03610516|584482306|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
161847051|NCT03610516|584482305|FG000|Treatment Epoch|Physician Decision|8|||
161847052|NCT03610516|584482306|FG001|Treatment Epoch|Physician Decision|5|||
161847053|NCT03610516|584482305|FG000|Treatment Epoch|Protocol Deviation|1|||
161847054|NCT03610516|584482306|FG001|Treatment Epoch|Protocol Deviation|0|||
161847055|NCT03610516|584482305|FG000|Treatment Epoch|Withdrawal by Subject|3|||
161847056|NCT03610516|584482306|FG001|Treatment Epoch|Withdrawal by Subject|1|||
161847057|NCT03610516|584482305|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
161847058|NCT03610516|584482306|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
161847059|NCT03610516|584482305|FG000|Post-Treatment Follow-up|Death|1|||
161847060|NCT03610516|584482306|FG001|Post-Treatment Follow-up|Death|0|||
161847061|NCT00761657|584482309|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
161847062|NCT00761657|584482310|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
161847063|NCT00761657|584482311|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
161847064|NCT00761657|584482312|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
161847065|NCT00761657|584482313|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
161847066|NCT00761657|584482314|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
161847067|NCT00761657|584482315|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
161847068|NCT00761657|584482316|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
161847069|NCT00761657|584482317|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
161847070|NCT00761657|584482309|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847071|NCT00761657|584482310|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847072|NCT00761657|584482311|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
161847073|NCT00761657|584482312|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
161847074|NCT00761657|584482313|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847075|NCT00761657|584482314|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847076|NCT00761657|584482315|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847077|NCT00761657|584482316|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847078|NCT00761657|584482317|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161847079|NCT00761657|584482309|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
161847080|NCT00761657|584482310|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
161847081|NCT00761657|584482311|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
161847082|NCT00761657|584482312|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
161847083|NCT00761657|584482313|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
161847084|NCT00761657|584482314|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
161847085|NCT00761657|584482315|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
161847086|NCT00761657|584482316|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
161847087|NCT00761657|584482317|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
161847088|NCT00761657|584482309|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
161847089|NCT00761657|584482310|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
161847090|NCT00761657|584482311|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
161847091|NCT00761657|584482312|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
161847092|NCT00761657|584482313|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
161847093|NCT00761657|584482314|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
161847094|NCT00761657|584482315|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
161847095|NCT00761657|584482316|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
161847096|NCT00761657|584482317|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
161847097|NCT00478244|584482326|FG000|Overall Study|Did not receive transplant|1|||
161847098|NCT01396512|584482330|FG000|Overall Study|Withdrawal by Subject|0|||
161847099|NCT01396512|584482331|FG001|Overall Study|Withdrawal by Subject|1|||
161847100|NCT01564537|584482332|FG000|Overall Study|Site Terminated by Sponsor|1|||
161847101|NCT01564537|584482333|FG001|Overall Study|Site Terminated by Sponsor|0|||
161847102|NCT01564537|584482332|FG000|Overall Study|Withdrawal by Subject|12|||
161847103|NCT01564537|584482333|FG001|Overall Study|Withdrawal by Subject|14|||
161847104|NCT01564537|584482332|FG000|Overall Study|Lost to Follow-up|7|||
161847105|NCT01564537|584482333|FG001|Overall Study|Lost to Follow-up|3|||
161847106|NCT01564537|584482332|FG000|Overall Study|Reason not specified|81|||
161847107|NCT01564537|584482333|FG001|Overall Study|Reason not specified|82|||
161847108|NCT05776862|584482345|FG000|Overall Study|Adverse Event|0|||
161847109|NCT05776862|584482346|FG001|Overall Study|Adverse Event|1|||
161847110|NCT05776862|584482345|FG000|Overall Study|non-compliance|1|||
161847111|NCT05776862|584482346|FG001|Overall Study|non-compliance|0|||
161847112|NCT02448706|584482347|FG000|Overall Study|Withdrawal by Subject|4|||
161847113|NCT02448706|584482348|FG001|Overall Study|Withdrawal by Subject|3|||
161847114|NCT02448706|584482347|FG000|Overall Study|Protocol Violation|1|||
161847115|NCT02448706|584482348|FG001|Overall Study|Protocol Violation|1|||
161847116|NCT01664130|584482355|FG000|Overall Study|competing secondary disease|2|||
161847117|NCT02679235|584482356|FG000|Overall Study|Withdrawal by Subject|3|||
161847118|NCT02679235|584482356|FG000|Overall Study|Adverse Event|1|||
162032968|NCT04035486|585177532|FG001|Overall Study|Death|3|||
161847119|NCT00923273|584482357|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
161847120|NCT00923273|584482358|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
161847121|NCT00923273|584482359|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
161847122|NCT00923273|584482360|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
161847123|NCT00923273|584482361|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
161847124|NCT00923273|584482357|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
161847125|NCT00923273|584482358|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
161847126|NCT00923273|584482359|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
161847127|NCT00923273|584482360|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
162032969|NCT04035486|585177533|FG002|Overall Study|Death|70|||
161847128|NCT00923273|584482361|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
161847129|NCT02383810|584482364|FG000|Overall Study|Physician Decision|1|||
161847130|NCT02383810|584482365|FG001|Overall Study|Physician Decision|1|||
161847131|NCT02383810|584482366|FG002|Overall Study|Physician Decision|0|||
161847132|NCT02383810|584482367|FG003|Overall Study|Physician Decision|0|||
161847133|NCT02383810|584482368|FG004|Overall Study|Physician Decision|0|||
161847134|NCT02383810|584482369|FG005|Overall Study|Physician Decision|0|||
161847135|NCT02383810|584482370|FG006|Overall Study|Physician Decision|0|||
161971048|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161847136|NCT02383810|584482371|FG007|Overall Study|Physician Decision|0|||
161847137|NCT02383810|584482364|FG000|Overall Study|Withdrawal by Subject|2|||
161847138|NCT02383810|584482365|FG001|Overall Study|Withdrawal by Subject|3|||
161847139|NCT02383810|584482366|FG002|Overall Study|Withdrawal by Subject|3|||
161847140|NCT02383810|584482367|FG003|Overall Study|Withdrawal by Subject|3|||
161847141|NCT02383810|584482368|FG004|Overall Study|Withdrawal by Subject|0|||
161847142|NCT02383810|584482369|FG005|Overall Study|Withdrawal by Subject|0|||
161847143|NCT02383810|584482370|FG006|Overall Study|Withdrawal by Subject|0|||
161847144|NCT02383810|584482371|FG007|Overall Study|Withdrawal by Subject|0|||
161847145|NCT02383810|584482364|FG000|Overall Study|Adverse Event|0|||
161847146|NCT02383810|584482365|FG001|Overall Study|Adverse Event|2|||
161847147|NCT02383810|584482366|FG002|Overall Study|Adverse Event|4|||
161847148|NCT02383810|584482367|FG003|Overall Study|Adverse Event|5|||
161847149|NCT02383810|584482368|FG004|Overall Study|Adverse Event|0|||
161847150|NCT02383810|584482369|FG005|Overall Study|Adverse Event|1|||
161847151|NCT02383810|584482370|FG006|Overall Study|Adverse Event|1|||
161847152|NCT02383810|584482371|FG007|Overall Study|Adverse Event|0|||
161847153|NCT02383810|584482364|FG000|Overall Study|Lost to Follow-up|0|||
161847154|NCT02383810|584482365|FG001|Overall Study|Lost to Follow-up|1|||
161847155|NCT02383810|584482366|FG002|Overall Study|Lost to Follow-up|0|||
161847156|NCT02383810|584482367|FG003|Overall Study|Lost to Follow-up|1|||
161847157|NCT02383810|584482368|FG004|Overall Study|Lost to Follow-up|0|||
161847158|NCT02383810|584482369|FG005|Overall Study|Lost to Follow-up|0|||
161847159|NCT02383810|584482370|FG006|Overall Study|Lost to Follow-up|0|||
161847160|NCT02383810|584482371|FG007|Overall Study|Lost to Follow-up|0|||
161847161|NCT02383810|584482364|FG000|Overall Study|other|0|||
161847162|NCT02383810|584482365|FG001|Overall Study|other|0|||
161847163|NCT02383810|584482366|FG002|Overall Study|other|0|||
161847164|NCT02383810|584482367|FG003|Overall Study|other|2|||
161847165|NCT02383810|584482368|FG004|Overall Study|other|0|||
161847166|NCT02383810|584482369|FG005|Overall Study|other|0|||
161847167|NCT02383810|584482370|FG006|Overall Study|other|0|||
161847168|NCT02383810|584482371|FG007|Overall Study|other|0|||
161847169|NCT02383810|584482364|FG000|Overall Study|subject did not receive study treatment|0|||
161847170|NCT02383810|584482365|FG001|Overall Study|subject did not receive study treatment|1|||
161847171|NCT02383810|584482366|FG002|Overall Study|subject did not receive study treatment|0|||
161847172|NCT02383810|584482367|FG003|Overall Study|subject did not receive study treatment|0|||
161847173|NCT02383810|584482368|FG004|Overall Study|subject did not receive study treatment|0|||
161847174|NCT02383810|584482369|FG005|Overall Study|subject did not receive study treatment|0|||
161847175|NCT02383810|584482370|FG006|Overall Study|subject did not receive study treatment|0|||
161847176|NCT02383810|584482371|FG007|Overall Study|subject did not receive study treatment|0|||
161971049|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161971050|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161971051|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161971052|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
161971053|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161971054|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
161971055|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161971056|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161971057|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161971058|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161971059|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161847177|NCT01438996|584482374|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
161847178|NCT01438996|584482375|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
161847179|NCT01438996|584482376|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
161847180|NCT02246114|584482377|FG000|Overall Study|miscarriage|1|||
161847181|NCT02246114|584482378|FG001|Overall Study|miscarriage|0|||
161847182|NCT02278055|584482385|FG000|Overall Study|Adverse Event|1|||
161847183|NCT02278055|584482385|FG000|Overall Study|Lost to Follow-up|1|||
161847184|NCT02278055|584482385|FG000|Overall Study|Withdrawal by Subject|2|||
161847185|NCT02278055|584482385|FG000|Overall Study|Progressive Disease|4|||
161847186|NCT01934335|584482386|FG000|Overall Study|Withdrawal by Subject|1|||
161847187|NCT01934335|584482387|FG001|Overall Study|Withdrawal by Subject|1|||
161847188|NCT01111825|584482388|FG000|Overall Study|Withdrawal by Subject|0|||
161847189|NCT01111825|584482389|FG001|Overall Study|Withdrawal by Subject|0|||
161847190|NCT01111825|584482390|FG002|Overall Study|Withdrawal by Subject|1|||
161847191|NCT01111825|584482391|FG003|Overall Study|Withdrawal by Subject|0|||
161847192|NCT01111825|584482388|FG000|Overall Study|Lost to Follow-up|0|||
161847193|NCT01111825|584482389|FG001|Overall Study|Lost to Follow-up|0|||
161847194|NCT01111825|584482390|FG002|Overall Study|Lost to Follow-up|3|||
161847195|NCT01111825|584482391|FG003|Overall Study|Lost to Follow-up|1|||
161847196|NCT01111825|584482388|FG000|Overall Study|Adverse Event|2|||
161847197|NCT01111825|584482389|FG001|Overall Study|Adverse Event|1|||
161847198|NCT01111825|584482390|FG002|Overall Study|Adverse Event|4|||
161847199|NCT01111825|584482391|FG003|Overall Study|Adverse Event|0|||
161847200|NCT01111825|584482388|FG000|Overall Study|Disease Progression|1|||
161847201|NCT01111825|584482389|FG001|Overall Study|Disease Progression|0|||
161847202|NCT01111825|584482390|FG002|Overall Study|Disease Progression|0|||
161847203|NCT01111825|584482391|FG003|Overall Study|Disease Progression|0|||
161847204|NCT01111825|584482388|FG000|Overall Study|Discontinuation by Sponsor|0|||
161847205|NCT01111825|584482389|FG001|Overall Study|Discontinuation by Sponsor|0|||
161847206|NCT01111825|584482390|FG002|Overall Study|Discontinuation by Sponsor|0|||
161847207|NCT01111825|584482391|FG003|Overall Study|Discontinuation by Sponsor|20|||
161847208|NCT00469144|584482392|FG000|Overall Study|Death|0|||
161847209|NCT00469144|584482393|FG001|Overall Study|Death|1|||
161847210|NCT00469144|584482392|FG000|Overall Study|No Response|5|||
161847211|NCT00469144|584482393|FG001|Overall Study|No Response|5|||
161847212|NCT00469144|584482392|FG000|Overall Study|Progressive Disease|1|||
161847213|NCT00469144|584482393|FG001|Overall Study|Progressive Disease|0|||
161847214|NCT01994291|584482394|FG000|Overall Study|Adverse Event|4|||
161847215|NCT01994291|584482395|FG001|Overall Study|Adverse Event|1|||
161847216|NCT01994291|584482396|FG002|Overall Study|Adverse Event|3|||
161847217|NCT01994291|584482394|FG000|Overall Study|Lost to Follow-up|1|||
161847218|NCT01994291|584482395|FG001|Overall Study|Lost to Follow-up|1|||
161847219|NCT01994291|584482396|FG002|Overall Study|Lost to Follow-up|0|||
161847220|NCT01994291|584482394|FG000|Overall Study|Does not meet entrance criteria|1|||
161847221|NCT01994291|584482395|FG001|Overall Study|Does not meet entrance criteria|0|||
161847222|NCT01994291|584482396|FG002|Overall Study|Does not meet entrance criteria|0|||
161847223|NCT01994291|584482394|FG000|Overall Study|Medication error without associated AE|1|||
161847224|NCT01994291|584482395|FG001|Overall Study|Medication error without associated AE|0|||
161847225|NCT01994291|584482396|FG002|Overall Study|Medication error without associated AE|1|||
161847226|NCT01994291|584482394|FG000|Overall Study|Protocol Violation|1|||
161847227|NCT01994291|584482395|FG001|Overall Study|Protocol Violation|0|||
161847228|NCT01994291|584482396|FG002|Overall Study|Protocol Violation|0|||
161847229|NCT01994291|584482394|FG000|Overall Study|Withdrawal by Subject|6|||
161847230|NCT01994291|584482395|FG001|Overall Study|Withdrawal by Subject|3|||
161847231|NCT01994291|584482396|FG002|Overall Study|Withdrawal by Subject|5|||
161847232|NCT01994291|584482394|FG000|Overall Study|Other|1|||
161847233|NCT01994291|584482395|FG001|Overall Study|Other|2|||
161847234|NCT01994291|584482396|FG002|Overall Study|Other|0|||
161847235|NCT01147107|584482406|FG000|Overall Study|Lack of Efficacy|5|||
161847236|NCT01147107|584482407|FG001|Overall Study|Lack of Efficacy|0|||
161847237|NCT01147107|584482406|FG000|Overall Study|Withdrawal by Subject|1|||
161847238|NCT01147107|584482407|FG001|Overall Study|Withdrawal by Subject|1|||
161847239|NCT04435184|584482408|FG000|Overall Study|follow-up blood draws missing|3|||
161847240|NCT04435184|584482409|FG001|Overall Study|follow-up blood draws missing|5|||
161847241|NCT02365558|584482413|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
161847242|NCT02365558|584482414|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
161847243|NCT02365558|584482413|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
161847244|NCT02365558|584482414|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
161847245|NCT00369317|584482415|FG000|Overall Study|Adverse Event|3|||
161847246|NCT00369317|584482415|FG000|Overall Study|Death|1|||
161847247|NCT00369317|584482415|FG000|Overall Study|Lack of Efficacy|5|||
161847248|NCT00369317|584482415|FG000|Overall Study|Physician Decision|2|||
161847249|NCT00369317|584482415|FG000|Overall Study|Withdrawal by Subject|8|||
161847250|NCT00369317|584482415|FG000|Overall Study|Ineligible|1|||
162032970|NCT04035486|585177534|FG003|Overall Study|Death|77|||
161847251|NCT02722148|584482426|FG000|Overall Study|Lost to Follow-up|2|||
161847252|NCT02722148|584482426|FG000|Overall Study|Non compliant with treatment regimen|3|||
161847253|NCT00073021|584482427|FG000|Overall Study|Protocol Violation|2|||
161847254|NCT00073021|584482428|FG001|Overall Study|Protocol Violation|1|||
161847255|NCT00073021|584482427|FG000|Overall Study|Adverse Event|4|||
161847256|NCT00073021|584482428|FG001|Overall Study|Adverse Event|4|||
161847257|NCT00073021|584482427|FG000|Overall Study|Withdrawal by Subject|6|||
161847258|NCT00073021|584482428|FG001|Overall Study|Withdrawal by Subject|5|||
161847259|NCT00073021|584482427|FG000|Overall Study|Physician Decision|3|||
161847260|NCT00073021|584482428|FG001|Overall Study|Physician Decision|1|||
161847261|NCT00073021|584482427|FG000|Overall Study|Lack of Efficacy|11|||
161847262|NCT00073021|584482428|FG001|Overall Study|Lack of Efficacy|5|||
161847263|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
161847264|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
161758904|NCT00974090|584156697|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
161758905|NCT00974090|584156698|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
161758906|NCT00974090|584156697|FG000|Period 2: Open-label Period|Physician Decision|0|||
161758907|NCT00974090|584156698|FG001|Period 2: Open-label Period|Physician Decision|3|||
161758908|NCT00974090|584156697|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
161758909|NCT00974090|584156698|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
161758910|NCT01626872|584156699|FG000|Overall Study|Physician Decision|13|||
161758911|NCT01626872|584156700|FG001|Overall Study|Physician Decision|9|||
161758912|NCT01626872|584156701|FG002|Overall Study|Physician Decision|6|||
161758913|NCT01626872|584156699|FG000|Overall Study|Withdrawal by Subject|19|||
161758914|NCT01626872|584156700|FG001|Overall Study|Withdrawal by Subject|27|||
161758915|NCT01626872|584156701|FG002|Overall Study|Withdrawal by Subject|8|||
161758916|NCT01626872|584156699|FG000|Overall Study|Adverse Event (including Death)|20|||
161758917|NCT01626872|584156700|FG001|Overall Study|Adverse Event (including Death)|28|||
161758918|NCT01626872|584156701|FG002|Overall Study|Adverse Event (including Death)|8|||
161758919|NCT01626872|584156699|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
161758920|NCT01626872|584156700|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
161758921|NCT01626872|584156701|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
161758922|NCT05626751|584156702|FG000|Overall Study|Lost to Follow-up|1|||
161758923|NCT05626751|584156703|FG001|Overall Study|Lost to Follow-up|2|||
161758924|NCT05626751|584156704|FG002|Overall Study|Lost to Follow-up|1|||
161758925|NCT05626751|584156702|FG000|Overall Study|Trial Terminated by Sponsor|39|||
161758926|NCT05626751|584156703|FG001|Overall Study|Trial Terminated by Sponsor|30|||
161758927|NCT05626751|584156704|FG002|Overall Study|Trial Terminated by Sponsor|37|||
161758928|NCT05626751|584156702|FG000|Overall Study|Withdrawal by Subject|7|||
161758929|NCT05626751|584156703|FG001|Overall Study|Withdrawal by Subject|5|||
161758930|NCT05626751|584156704|FG002|Overall Study|Withdrawal by Subject|5|||
161758931|NCT01625000|584156705|FG000|Overall Study|Physician Decision|15|||
161758932|NCT01625000|584156706|FG001|Overall Study|Physician Decision|7|||
161758933|NCT01625000|584156707|FG002|Overall Study|Physician Decision|7|||
161758934|NCT01625000|584156708|FG003|Overall Study|Physician Decision|2|||
161758935|NCT01625000|584156709|FG004|Overall Study|Physician Decision|15|||
161758936|NCT01625000|584156705|FG000|Overall Study|Protocol Violation|3|||
161758937|NCT01625000|584156706|FG001|Overall Study|Protocol Violation|10|||
161758938|NCT01625000|584156707|FG002|Overall Study|Protocol Violation|4|||
161758939|NCT01625000|584156708|FG003|Overall Study|Protocol Violation|1|||
161758940|NCT01625000|584156709|FG004|Overall Study|Protocol Violation|2|||
161758941|NCT01625000|584156705|FG000|Overall Study|Withdrawal by Subject|19|||
161758942|NCT01625000|584156706|FG001|Overall Study|Withdrawal by Subject|16|||
161758943|NCT01625000|584156707|FG002|Overall Study|Withdrawal by Subject|11|||
161758944|NCT01625000|584156708|FG003|Overall Study|Withdrawal by Subject|9|||
161758945|NCT01625000|584156709|FG004|Overall Study|Withdrawal by Subject|17|||
161758946|NCT01625000|584156705|FG000|Overall Study|Adverse Event (including Death)|15|||
161758947|NCT01625000|584156706|FG001|Overall Study|Adverse Event (including Death)|19|||
161758948|NCT01625000|584156707|FG002|Overall Study|Adverse Event (including Death)|11|||
161758949|NCT01625000|584156708|FG003|Overall Study|Adverse Event (including Death)|7|||
161758950|NCT01625000|584156709|FG004|Overall Study|Adverse Event (including Death)|21|||
161758951|NCT03912064|584156710|FG000|Overall Study|Withdrawal by Subject|2|||
161758952|NCT03912064|584156711|FG001|Overall Study|Withdrawal by Subject|0|||
161758953|NCT03912064|584156712|FG002|Overall Study|Withdrawal by Subject|0|||
161758954|NCT03912064|584156710|FG000|Overall Study|Adverse reaction to Ipilimumab|2|||
161758955|NCT03912064|584156711|FG001|Overall Study|Adverse reaction to Ipilimumab|0|||
161758956|NCT03912064|584156712|FG002|Overall Study|Adverse reaction to Ipilimumab|1|||
161758957|NCT03912064|584156710|FG000|Overall Study|Progression/Relapse|7|||
161758958|NCT03912064|584156711|FG001|Overall Study|Progression/Relapse|3|||
161758959|NCT03912064|584156712|FG002|Overall Study|Progression/Relapse|0|||
161758960|NCT03912064|584156710|FG000|Overall Study|Prolonged treatment delays|3|||
161758961|NCT03912064|584156711|FG001|Overall Study|Prolonged treatment delays|2|||
161758962|NCT03912064|584156712|FG002|Overall Study|Prolonged treatment delays|0|||
161758963|NCT03912064|584156710|FG000|Overall Study|Prohibited concomitant treatments|3|||
161758964|NCT03912064|584156711|FG001|Overall Study|Prohibited concomitant treatments|1|||
161758965|NCT03912064|584156712|FG002|Overall Study|Prohibited concomitant treatments|0|||
161758966|NCT01026194|584156713|FG000|Period 1：Double Blind Period|Adverse Event|2|||
161758967|NCT01026194|584156714|FG001|Period 1：Double Blind Period|Adverse Event|1|||
161758968|NCT01026194|584156713|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
161758969|NCT01026194|584156714|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
161758970|NCT01026194|584156713|FG000|Period 1：Double Blind Period|Physician Decision|0|||
161758971|NCT01026194|584156714|FG001|Period 1：Double Blind Period|Physician Decision|4|||
161758972|NCT01026194|584156713|FG000|Period 2：Open-label Period|Adverse Event|4|||
161758973|NCT01026194|584156714|FG001|Period 2：Open-label Period|Adverse Event|5|||
161758974|NCT01026194|584156713|FG000|Period 2：Open-label Period|Physician Decision|3|||
161758975|NCT01026194|584156714|FG001|Period 2：Open-label Period|Physician Decision|1|||
161758976|NCT01026194|584156713|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
161758977|NCT01026194|584156714|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
161758978|NCT04295759|584156715|FG000|Overall Study|Lack of Efficacy|9|||
161758979|NCT04295759|584156715|FG000|Overall Study|Death|1|||
161758980|NCT04295759|584156715|FG000|Overall Study|Withdrawal by Subject|2|||
161758981|NCT04295759|584156715|FG000|Overall Study|Deemed ineligible|1|||
161758982|NCT05740566|584156716|FG000|Overall Study|Death|151|||
161758983|NCT05740566|584156717|FG001|Overall Study|Death|111|||
161758984|NCT05740566|584156716|FG000|Overall Study|Withdrawal by Subject|2|||
161758985|NCT05740566|584156717|FG001|Overall Study|Withdrawal by Subject|0|||
161758986|NCT05740566|584156716|FG000|Overall Study|Ongoing in study|102|||
161758987|NCT05740566|584156717|FG001|Overall Study|Ongoing in study|143|||
161758988|NCT00829010|584156720|FG000|Overall Study|Adverse Event|1|||
161758989|NCT00829010|584156721|FG001|Overall Study|Adverse Event|0|||
161758990|NCT00829010|584156722|FG002|Overall Study|Adverse Event|0|||
161758991|NCT00829010|584156723|FG003|Overall Study|Adverse Event|0|||
161758992|NCT00829010|584156724|FG004|Overall Study|Adverse Event|0|||
161758993|NCT00829010|584156720|FG000|Overall Study|Withdrawal by Subject|0|||
161758994|NCT00829010|584156721|FG001|Overall Study|Withdrawal by Subject|1|||
161758995|NCT00829010|584156722|FG002|Overall Study|Withdrawal by Subject|1|||
161758996|NCT00829010|584156723|FG003|Overall Study|Withdrawal by Subject|0|||
161758997|NCT00829010|584156724|FG004|Overall Study|Withdrawal by Subject|2|||
161758998|NCT00829010|584156720|FG000|Overall Study|Lost to Follow-up|1|||
161758999|NCT00829010|584156721|FG001|Overall Study|Lost to Follow-up|0|||
161759000|NCT00829010|584156722|FG002|Overall Study|Lost to Follow-up|2|||
161759001|NCT00829010|584156723|FG003|Overall Study|Lost to Follow-up|0|||
161759002|NCT00829010|584156724|FG004|Overall Study|Lost to Follow-up|0|||
161759003|NCT00829010|584156720|FG000|Overall Study|Fatality|5|||
161759004|NCT00829010|584156721|FG001|Overall Study|Fatality|4|||
161759005|NCT00829010|584156722|FG002|Overall Study|Fatality|0|||
161759006|NCT00829010|584156723|FG003|Overall Study|Fatality|3|||
161759007|NCT00829010|584156724|FG004|Overall Study|Fatality|0|||
161759008|NCT00829010|584156720|FG000|Overall Study|Migrated/Moved from study area|3|||
161759009|NCT00829010|584156721|FG001|Overall Study|Migrated/Moved from study area|4|||
161759010|NCT00829010|584156722|FG002|Overall Study|Migrated/Moved from study area|0|||
161759011|NCT00829010|584156723|FG003|Overall Study|Migrated/Moved from study area|5|||
161759012|NCT00829010|584156724|FG004|Overall Study|Migrated/Moved from study area|0|||
161759013|NCT06210035|584156725|FG000|Overall Study|Withdrawal by Subject|3|||
161759014|NCT06210035|584156726|FG001|Overall Study|Withdrawal by Subject|0|||
161759015|NCT06210035|584156727|FG002|Overall Study|Withdrawal by Subject|0|||
161759016|NCT01029691|584156728|FG000|Continued APAP to Delivery|Death|0|||
161759017|NCT01029691|584156729|FG001|Continued APAP to Delivery|Death|0|||
161759018|NCT01029691|584156730|FG002|Continued APAP to Delivery|Death|1|||
161759019|NCT05616221|584156735|FG000|Overall Study|Withdrawal by Subject|0|||
161759020|NCT05616221|584156736|FG001|Overall Study|Withdrawal by Subject|1|||
161759021|NCT05616221|584156737|FG002|Overall Study|Withdrawal by Subject|0|||
161759022|NCT05616221|584156738|FG003|Overall Study|Withdrawal by Subject|0|||
161759023|NCT05616221|584156739|FG004|Overall Study|Withdrawal by Subject|0|||
161759024|NCT05616221|584156740|FG005|Overall Study|Withdrawal by Subject|0|||
161759025|NCT05616221|584156735|FG000|Overall Study|Adverse Event|0|||
161759026|NCT05616221|584156736|FG001|Overall Study|Adverse Event|2|||
161759027|NCT05616221|584156737|FG002|Overall Study|Adverse Event|0|||
161759028|NCT05616221|584156738|FG003|Overall Study|Adverse Event|0|||
161759029|NCT05616221|584156739|FG004|Overall Study|Adverse Event|2|||
161759030|NCT05616221|584156740|FG005|Overall Study|Adverse Event|0|||
161759031|NCT04880733|584156741|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
161759032|NCT04880733|584156742|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
161759033|NCT04880733|584156743|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
161759034|NCT04880733|584156741|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
161759035|NCT04880733|584156742|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
161759036|NCT04880733|584156743|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
161759037|NCT04880733|584156741|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
161971060|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161759038|NCT04880733|584156742|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
161759039|NCT04880733|584156743|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
161759040|NCT04880733|584156741|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
161759041|NCT04880733|584156742|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
161759042|NCT04880733|584156743|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
161759043|NCT04880733|584156741|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
161971061|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161759044|NCT04880733|584156742|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
161759045|NCT04880733|584156743|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
161759046|NCT00862992|584156744|FG000|Overall Study|Adverse Event|2|||
161759047|NCT00862992|584156745|FG001|Overall Study|Adverse Event|1|||
161759048|NCT00862992|584156746|FG002|Overall Study|Adverse Event|1|||
161759049|NCT00862992|584156744|FG000|Overall Study|Physician Decision|1|||
161759050|NCT00862992|584156745|FG001|Overall Study|Physician Decision|0|||
161759051|NCT00862992|584156746|FG002|Overall Study|Physician Decision|0|||
161759052|NCT00862992|584156744|FG000|Overall Study|Withdrawal by Subject|0|||
161759053|NCT00862992|584156745|FG001|Overall Study|Withdrawal by Subject|0|||
161759054|NCT00862992|584156746|FG002|Overall Study|Withdrawal by Subject|2|||
161759055|NCT05492877|584156747|FG000|Overall Study|Adverse Event|11|||
161759056|NCT05492877|584156748|FG001|Overall Study|Adverse Event|7|||
161759057|NCT05492877|584156747|FG000|Overall Study|Death|1|||
161759058|NCT05492877|584156748|FG001|Overall Study|Death|0|||
161759059|NCT05492877|584156747|FG000|Overall Study|Lost to Follow-up|1|||
161759060|NCT05492877|584156748|FG001|Overall Study|Lost to Follow-up|1|||
161759061|NCT05492877|584156747|FG000|Overall Study|Physician Decision|1|||
161759062|NCT05492877|584156748|FG001|Overall Study|Physician Decision|2|||
161759063|NCT05492877|584156747|FG000|Overall Study|Protocol Violation|1|||
161759064|NCT05492877|584156748|FG001|Overall Study|Protocol Violation|1|||
161759065|NCT05492877|584156747|FG000|Overall Study|Withdrawal by Subject|3|||
161759066|NCT05492877|584156748|FG001|Overall Study|Withdrawal by Subject|7|||
161759067|NCT05492877|584156747|FG000|Overall Study|Reason not specified|6|||
161759068|NCT05492877|584156748|FG001|Overall Study|Reason not specified|4|||
161759069|NCT00528840|584156757|FG000|Overall Study|Lost to Follow-up|10|||
161759070|NCT00528840|584156757|FG000|Overall Study|Adverse Event|1|||
161759071|NCT00528840|584156757|FG000|Overall Study|Withdrawal by Subject|17|||
161759072|NCT00528840|584156757|FG000|Overall Study|Death|2|||
161759073|NCT00528840|584156757|FG000|Overall Study|Administrative Reasons|1|||
161759074|NCT00528840|584156757|FG000|Overall Study|Other|2|||
161759075|NCT01603628|584156758|FG000|Overall Study|Personal Reasons|1|||
161759076|NCT01603628|584156759|FG001|Overall Study|Personal Reasons|1|||
161759077|NCT01603628|584156760|FG002|Overall Study|Personal Reasons|2|||
161759078|NCT01603628|584156758|FG000|Overall Study|Protocol Violation|1|||
161759079|NCT01603628|584156759|FG001|Overall Study|Protocol Violation|1|||
161759080|NCT01603628|584156760|FG002|Overall Study|Protocol Violation|0|||
161759081|NCT01603628|584156758|FG000|Overall Study|Lost to Follow-up|0|||
161759082|NCT01603628|584156759|FG001|Overall Study|Lost to Follow-up|1|||
161759083|NCT01603628|584156760|FG002|Overall Study|Lost to Follow-up|0|||
161759084|NCT01603628|584156758|FG000|Overall Study|Other Miscellaneous Reason|1|||
161759085|NCT01603628|584156759|FG001|Overall Study|Other Miscellaneous Reason|0|||
161759086|NCT01603628|584156760|FG002|Overall Study|Other Miscellaneous Reason|0|||
161759087|NCT01969565|584156761|FG000|Overall Study|Withdrawal by Subject|1|||
161759088|NCT00832091|584156762|FG000|Overall Study|Adverse Event|1|||
161759089|NCT00832091|584156763|FG001|Overall Study|Adverse Event|1|||
161759090|NCT00832091|584156762|FG000|Overall Study|Protocol Violation|1|||
161759091|NCT00832091|584156763|FG001|Overall Study|Protocol Violation|0|||
161759092|NCT00832091|584156762|FG000|Overall Study|Withdrawal by Subject|2|||
161759093|NCT00832091|584156763|FG001|Overall Study|Withdrawal by Subject|1|||
161759094|NCT00832091|584156762|FG000|Overall Study|Prohibited Medication|1|||
161759095|NCT00832091|584156763|FG001|Overall Study|Prohibited Medication|0|||
161759096|NCT02087241|584156765|FG000|Overall Study|Death|2|||
161759097|NCT02087241|584156766|FG001|Overall Study|Death|1|||
161759098|NCT02087241|584156767|FG002|Overall Study|Death|1|||
161759099|NCT02087241|584156768|FG003|Overall Study|Death|1|||
161759100|NCT02087241|584156765|FG000|Overall Study|Withdrawal by Subject|1|||
161759101|NCT02087241|584156766|FG001|Overall Study|Withdrawal by Subject|0|||
161759102|NCT02087241|584156767|FG002|Overall Study|Withdrawal by Subject|0|||
161759103|NCT02087241|584156768|FG003|Overall Study|Withdrawal by Subject|1|||
161759104|NCT02087241|584156765|FG000|Overall Study|Progressive Disease|0|||
161759105|NCT02087241|584156766|FG001|Overall Study|Progressive Disease|0|||
161759106|NCT02087241|584156767|FG002|Overall Study|Progressive Disease|0|||
161759107|NCT02087241|584156768|FG003|Overall Study|Progressive Disease|1|||
161759108|NCT02087241|584156765|FG000|Overall Study|Study Terminated by Sponsor|0|||
161759109|NCT02087241|584156766|FG001|Overall Study|Study Terminated by Sponsor|2|||
161971062|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
161971063|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161971064|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
161759110|NCT02087241|584156767|FG002|Overall Study|Study Terminated by Sponsor|0|||
161759111|NCT02087241|584156768|FG003|Overall Study|Study Terminated by Sponsor|4|||
161759112|NCT01955005|584156769|FG000|Overall Study|Withdrawal by Subject|3|||
161759113|NCT01955005|584156770|FG001|Overall Study|Withdrawal by Subject|5|||
161759114|NCT00836953|584156771|FG000|Overall Study|Withdrawal by Subject|1|||
161759115|NCT00836953|584156771|FG000|Overall Study|Lost to Follow-up|1|||
161759116|NCT02943668|584156772|FG000|Overall Study|Disease Progression|1|||
161759117|NCT01200758|584156773|FG000|Stage I|Death|0|||
161759118|NCT01200758|584156774|FG001|Stage I|Death|1|||
161759119|NCT01200758|584156775|FG002|Stage I|Death|0|||
161759120|NCT01200758|584156776|FG003|Stage I|Death|0|||
161759121|NCT01200758|584156773|FG000|Stage I|Physician Decision|1|||
161759122|NCT01200758|584156774|FG001|Stage I|Physician Decision|1|||
162032971|NCT04035486|585177531|FG000|Overall Study|Screen Failure|0|||
161759123|NCT01200758|584156775|FG002|Stage I|Physician Decision|0|||
161759124|NCT01200758|584156776|FG003|Stage I|Physician Decision|0|||
161759125|NCT01200758|584156773|FG000|Stage I|Lack of Efficacy|2|||
161971065|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161759126|NCT01200758|584156774|FG001|Stage I|Lack of Efficacy|1|||
161759127|NCT01200758|584156775|FG002|Stage I|Lack of Efficacy|0|||
161759128|NCT01200758|584156776|FG003|Stage I|Lack of Efficacy|0|||
161759129|NCT01200758|584156773|FG000|Stage I|Adverse Event|5|||
161759130|NCT01200758|584156774|FG001|Stage I|Adverse Event|5|||
161759131|NCT01200758|584156775|FG002|Stage I|Adverse Event|0|||
161759132|NCT01200758|584156776|FG003|Stage I|Adverse Event|0|||
161759133|NCT01200758|584156773|FG000|Stage I|Withdrawal by Subject|1|||
161759134|NCT01200758|584156774|FG001|Stage I|Withdrawal by Subject|2|||
161759135|NCT01200758|584156775|FG002|Stage I|Withdrawal by Subject|0|||
161759136|NCT01200758|584156776|FG003|Stage I|Withdrawal by Subject|0|||
161759137|NCT01200758|584156773|FG000|Stage I|Disease Progression|9|||
161759138|NCT01200758|584156774|FG001|Stage I|Disease Progression|7|||
161759139|NCT01200758|584156775|FG002|Stage I|Disease Progression|0|||
161759140|NCT01200758|584156776|FG003|Stage I|Disease Progression|0|||
161759141|NCT01200758|584156773|FG000|Stage 2|Disease Progression|0|||
161759142|NCT01200758|584156774|FG001|Stage 2|Disease Progression|0|||
161759143|NCT01200758|584156775|FG002|Stage 2|Disease Progression|16|||
161759144|NCT01200758|584156776|FG003|Stage 2|Disease Progression|21|||
161759145|NCT01200758|584156773|FG000|Stage 2|Lack of Efficacy|0|||
161759146|NCT01200758|584156774|FG001|Stage 2|Lack of Efficacy|0|||
161759147|NCT01200758|584156775|FG002|Stage 2|Lack of Efficacy|4|||
161759148|NCT01200758|584156776|FG003|Stage 2|Lack of Efficacy|2|||
161759149|NCT01200758|584156773|FG000|Stage 2|Physician Decision|0|||
161759150|NCT01200758|584156774|FG001|Stage 2|Physician Decision|0|||
161759151|NCT01200758|584156775|FG002|Stage 2|Physician Decision|5|||
161759152|NCT01200758|584156776|FG003|Stage 2|Physician Decision|7|||
161759153|NCT01200758|584156773|FG000|Stage 2|Adverse Event|0|||
161759154|NCT01200758|584156774|FG001|Stage 2|Adverse Event|0|||
161759155|NCT01200758|584156775|FG002|Stage 2|Adverse Event|5|||
161759156|NCT01200758|584156776|FG003|Stage 2|Adverse Event|9|||
161759157|NCT01200758|584156773|FG000|Stage 2|Withdrawal by Subject|0|||
161759158|NCT01200758|584156774|FG001|Stage 2|Withdrawal by Subject|0|||
161759159|NCT01200758|584156775|FG002|Stage 2|Withdrawal by Subject|4|||
161759160|NCT01200758|584156776|FG003|Stage 2|Withdrawal by Subject|1|||
161759161|NCT01200758|584156773|FG000|Stage 2|Lost to Follow-up|0|||
161759162|NCT01200758|584156774|FG001|Stage 2|Lost to Follow-up|0|||
161759163|NCT01200758|584156775|FG002|Stage 2|Lost to Follow-up|3|||
161759164|NCT01200758|584156776|FG003|Stage 2|Lost to Follow-up|1|||
161759165|NCT01200758|584156773|FG000|Stage 2|Protocol Violation|0|||
161759166|NCT01200758|584156774|FG001|Stage 2|Protocol Violation|0|||
161759167|NCT01200758|584156775|FG002|Stage 2|Protocol Violation|1|||
161759168|NCT01200758|584156776|FG003|Stage 2|Protocol Violation|4|||
161759169|NCT01200758|584156773|FG000|Stage 2|Death|0|||
161759170|NCT01200758|584156774|FG001|Stage 2|Death|0|||
161759171|NCT01200758|584156775|FG002|Stage 2|Death|3|||
161759172|NCT01200758|584156776|FG003|Stage 2|Death|5|||
161759173|NCT02711553|584156779|FG000|Overall Study|Withdrawal by Subject|2|||
161759174|NCT02711553|584156780|FG001|Overall Study|Withdrawal by Subject|1|||
161759175|NCT02711553|584156781|FG002|Overall Study|Withdrawal by Subject|1|||
161759176|NCT02711553|584156782|FG003|Overall Study|Withdrawal by Subject|0|||
161759177|NCT02711553|584156779|FG000|Overall Study|Lost to Follow-up|3|||
161759178|NCT02711553|584156780|FG001|Overall Study|Lost to Follow-up|3|||
161759179|NCT02711553|584156781|FG002|Overall Study|Lost to Follow-up|6|||
161759180|NCT02711553|584156782|FG003|Overall Study|Lost to Follow-up|3|||
161759181|NCT02711553|584156779|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
161759182|NCT02711553|584156780|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
161759183|NCT02711553|584156781|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
161759184|NCT02711553|584156782|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
161759185|NCT04048876|584156789|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
161759186|NCT04048876|584156790|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
161759187|NCT04048876|584156791|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
161759188|NCT04048876|584156792|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
161759189|NCT04048876|584156789|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
161759190|NCT04048876|584156790|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
161759191|NCT04048876|584156791|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
161759192|NCT04048876|584156792|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
161759193|NCT04048876|584156789|FG000|Placebo Controlled Phase|Adverse Event|0|||
161759194|NCT04048876|584156790|FG001|Placebo Controlled Phase|Adverse Event|1|||
161759195|NCT04048876|584156791|FG002|Placebo Controlled Phase|Adverse Event|0|||
161759196|NCT04048876|584156792|FG003|Placebo Controlled Phase|Adverse Event|0|||
161759197|NCT04048876|584156789|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
161759198|NCT04048876|584156790|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
161759199|NCT04048876|584156791|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
161759200|NCT04048876|584156792|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
161759201|NCT04063865|584156794|FG000|Overall Study|Physician Decision|1|||
161759202|NCT04063865|584156795|FG001|Overall Study|Physician Decision|3|||
161759203|NCT04063865|584156794|FG000|Overall Study|Study Closed Prior to Completion|4|||
161759204|NCT04063865|584156795|FG001|Overall Study|Study Closed Prior to Completion|4|||
161759205|NCT04063865|584156794|FG000|Overall Study|Withdrawal by Subject|1|||
161759206|NCT04063865|584156795|FG001|Overall Study|Withdrawal by Subject|1|||
161759207|NCT00320190|584156796|FG000|First 12 Months|Completed but did not enter extension|5|||
161759208|NCT00320190|584156797|FG001|First 12 Months|Completed but did not enter extension|3|||
161759209|NCT00320190|584156796|FG000|First 12 Months|Sponsor terminated study|2|||
161759210|NCT00320190|584156797|FG001|First 12 Months|Sponsor terminated study|2|||
161759211|NCT00320190|584156796|FG000|First 12 Months|Lost to Follow-up|0|||
161759212|NCT00320190|584156797|FG001|First 12 Months|Lost to Follow-up|1|||
161759213|NCT00320190|584156796|FG000|First 12 Months|Enrollment failure|0|||
161759214|NCT00320190|584156797|FG001|First 12 Months|Enrollment failure|1|||
161759215|NCT00320190|584156796|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
161759216|NCT00320190|584156797|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
161759217|NCT00320190|584156796|FG000|First 12 Months|Investigator request|0|||
161759218|NCT00320190|584156797|FG001|First 12 Months|Investigator request|1|||
161759219|NCT00320190|584156796|FG000|First 12 Months|Study drug toxicity|0|||
161759220|NCT00320190|584156797|FG001|First 12 Months|Study drug toxicity|1|||
161759221|NCT00320190|584156796|FG000|First 12 Months|Withdrawal by Subject|0|||
161759222|NCT00320190|584156797|FG001|First 12 Months|Withdrawal by Subject|1|||
161759223|NCT00320190|584156796|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
161759224|NCT00320190|584156797|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
161759225|NCT00320190|584156796|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
161759226|NCT00320190|584156797|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
161759227|NCT00320190|584156796|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
161759228|NCT00320190|584156797|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
161759229|NCT03399786|584156798|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
161759230|NCT03399786|584156799|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161759231|NCT03399786|584156800|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161759232|NCT03399786|584156801|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161759233|NCT03399786|584156798|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
161759234|NCT03399786|584156799|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
161759235|NCT03399786|584156800|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
161759236|NCT03399786|584156801|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
161759237|NCT03399786|584156798|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
161759238|NCT03399786|584156799|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
161759239|NCT03399786|584156800|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
161759240|NCT03399786|584156801|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
161759241|NCT01004861|584158279|FG000|Overall Study|Disease progression|3|||
161759242|NCT01004861|584158280|FG001|Overall Study|Disease progression|4|||
161759243|NCT01004861|584158281|FG002|Overall Study|Disease progression|5|||
161759244|NCT01004861|584158282|FG003|Overall Study|Disease progression|4|||
161759245|NCT01004861|584158283|FG004|Overall Study|Disease progression|4|||
161971066|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161971067|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161759246|NCT01004861|584158284|FG005|Overall Study|Disease progression|4|||
161759247|NCT01004861|584158285|FG006|Overall Study|Disease progression|5|||
161759248|NCT01004861|584158286|FG007|Overall Study|Disease progression|1|||
161759249|NCT01004861|584158287|FG008|Overall Study|Disease progression|4|||
161759250|NCT01004861|584158288|FG009|Overall Study|Disease progression|7|||
161759251|NCT01004861|584158289|FG010|Overall Study|Disease progression|6|||
161759252|NCT01004861|584158290|FG011|Overall Study|Disease progression|3|||
161759253|NCT01004861|584158291|FG012|Overall Study|Disease progression|8|||
161759254|NCT01004861|584158279|FG000|Overall Study|Physician Decision|0|||
161759255|NCT01004861|584158280|FG001|Overall Study|Physician Decision|2|||
161759256|NCT01004861|584158281|FG002|Overall Study|Physician Decision|1|||
161759257|NCT01004861|584158282|FG003|Overall Study|Physician Decision|1|||
161759258|NCT01004861|584158283|FG004|Overall Study|Physician Decision|1|||
161759259|NCT01004861|584158284|FG005|Overall Study|Physician Decision|0|||
161759260|NCT01004861|584158285|FG006|Overall Study|Physician Decision|0|||
161759261|NCT01004861|584158286|FG007|Overall Study|Physician Decision|1|||
161759262|NCT01004861|584158287|FG008|Overall Study|Physician Decision|0|||
161759263|NCT01004861|584158288|FG009|Overall Study|Physician Decision|0|||
161759264|NCT01004861|584158289|FG010|Overall Study|Physician Decision|0|||
161759265|NCT01004861|584158290|FG011|Overall Study|Physician Decision|0|||
161759266|NCT01004861|584158291|FG012|Overall Study|Physician Decision|3|||
161759267|NCT01004861|584158279|FG000|Overall Study|Adverse Event|0|||
161759268|NCT01004861|584158280|FG001|Overall Study|Adverse Event|0|||
161759269|NCT01004861|584158281|FG002|Overall Study|Adverse Event|0|||
161759270|NCT01004861|584158282|FG003|Overall Study|Adverse Event|1|||
161759271|NCT01004861|584158283|FG004|Overall Study|Adverse Event|0|||
161759272|NCT01004861|584158284|FG005|Overall Study|Adverse Event|2|||
161759273|NCT01004861|584158285|FG006|Overall Study|Adverse Event|1|||
161759274|NCT01004861|584158286|FG007|Overall Study|Adverse Event|1|||
161759275|NCT01004861|584158287|FG008|Overall Study|Adverse Event|13|||
161759276|NCT01004861|584158288|FG009|Overall Study|Adverse Event|1|||
161759277|NCT01004861|584158289|FG010|Overall Study|Adverse Event|1|||
161759278|NCT01004861|584158290|FG011|Overall Study|Adverse Event|0|||
161759279|NCT01004861|584158291|FG012|Overall Study|Adverse Event|2|||
161759280|NCT01004861|584158279|FG000|Overall Study|Protocol Violation|0|||
161759281|NCT01004861|584158280|FG001|Overall Study|Protocol Violation|0|||
161759282|NCT01004861|584158281|FG002|Overall Study|Protocol Violation|0|||
161759283|NCT01004861|584158282|FG003|Overall Study|Protocol Violation|0|||
161759284|NCT01004861|584158283|FG004|Overall Study|Protocol Violation|1|||
161759285|NCT01004861|584158284|FG005|Overall Study|Protocol Violation|0|||
161759286|NCT01004861|584158285|FG006|Overall Study|Protocol Violation|0|||
161759287|NCT01004861|584158286|FG007|Overall Study|Protocol Violation|0|||
161759288|NCT01004861|584158287|FG008|Overall Study|Protocol Violation|0|||
161759289|NCT01004861|584158288|FG009|Overall Study|Protocol Violation|0|||
161759290|NCT01004861|584158289|FG010|Overall Study|Protocol Violation|0|||
161759291|NCT01004861|584158290|FG011|Overall Study|Protocol Violation|0|||
161759292|NCT01004861|584158291|FG012|Overall Study|Protocol Violation|0|||
161759293|NCT01004861|584158279|FG000|Overall Study|Lost to Follow-up|0|||
161759294|NCT01004861|584158280|FG001|Overall Study|Lost to Follow-up|0|||
161759295|NCT01004861|584158281|FG002|Overall Study|Lost to Follow-up|0|||
161759296|NCT01004861|584158282|FG003|Overall Study|Lost to Follow-up|0|||
161759297|NCT01004861|584158283|FG004|Overall Study|Lost to Follow-up|0|||
161759298|NCT01004861|584158284|FG005|Overall Study|Lost to Follow-up|0|||
161759299|NCT01004861|584158285|FG006|Overall Study|Lost to Follow-up|0|||
161759300|NCT01004861|584158286|FG007|Overall Study|Lost to Follow-up|1|||
161759301|NCT01004861|584158287|FG008|Overall Study|Lost to Follow-up|3|||
161759302|NCT01004861|584158288|FG009|Overall Study|Lost to Follow-up|0|||
161759303|NCT01004861|584158289|FG010|Overall Study|Lost to Follow-up|0|||
161759304|NCT01004861|584158290|FG011|Overall Study|Lost to Follow-up|1|||
161759305|NCT01004861|584158291|FG012|Overall Study|Lost to Follow-up|0|||
161759306|NCT01004861|584158279|FG000|Overall Study|Non-compliance|0|||
161759307|NCT01004861|584158280|FG001|Overall Study|Non-compliance|0|||
161759308|NCT01004861|584158281|FG002|Overall Study|Non-compliance|0|||
161759309|NCT01004861|584158282|FG003|Overall Study|Non-compliance|0|||
161759310|NCT01004861|584158283|FG004|Overall Study|Non-compliance|0|||
161759311|NCT01004861|584158284|FG005|Overall Study|Non-compliance|0|||
161759312|NCT01004861|584158285|FG006|Overall Study|Non-compliance|0|||
161759313|NCT01004861|584158286|FG007|Overall Study|Non-compliance|0|||
161759314|NCT01004861|584158287|FG008|Overall Study|Non-compliance|5|||
161759315|NCT01004861|584158288|FG009|Overall Study|Non-compliance|0|||
161759316|NCT01004861|584158289|FG010|Overall Study|Non-compliance|0|||
161759317|NCT01004861|584158290|FG011|Overall Study|Non-compliance|0|||
161759318|NCT01004861|584158291|FG012|Overall Study|Non-compliance|1|||
161759319|NCT01004861|584158279|FG000|Overall Study|Other|0|||
161759320|NCT01004861|584158280|FG001|Overall Study|Other|0|||
161759321|NCT01004861|584158281|FG002|Overall Study|Other|0|||
161759322|NCT01004861|584158282|FG003|Overall Study|Other|0|||
161759323|NCT01004861|584158283|FG004|Overall Study|Other|0|||
161759324|NCT01004861|584158284|FG005|Overall Study|Other|0|||
161759325|NCT01004861|584158285|FG006|Overall Study|Other|0|||
161759326|NCT01004861|584158286|FG007|Overall Study|Other|0|||
161759327|NCT01004861|584158287|FG008|Overall Study|Other|0|||
161759328|NCT01004861|584158288|FG009|Overall Study|Other|2|||
161759329|NCT01004861|584158289|FG010|Overall Study|Other|1|||
161759330|NCT01004861|584158290|FG011|Overall Study|Other|2|||
161759331|NCT01004861|584158291|FG012|Overall Study|Other|3|||
161759332|NCT01004861|584158279|FG000|Overall Study|Patient decision|0|||
161759333|NCT01004861|584158280|FG001|Overall Study|Patient decision|0|||
161759334|NCT01004861|584158281|FG002|Overall Study|Patient decision|0|||
161759335|NCT01004861|584158282|FG003|Overall Study|Patient decision|0|||
161759336|NCT01004861|584158283|FG004|Overall Study|Patient decision|1|||
161759337|NCT01004861|584158284|FG005|Overall Study|Patient decision|0|||
161759338|NCT01004861|584158285|FG006|Overall Study|Patient decision|1|||
161971068|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
162032972|NCT04035486|585177532|FG001|Overall Study|Screen Failure|0|||
161759339|NCT01004861|584158286|FG007|Overall Study|Patient decision|0|||
161759340|NCT01004861|584158287|FG008|Overall Study|Patient decision|7|||
161759341|NCT01004861|584158288|FG009|Overall Study|Patient decision|1|||
161847265|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161759342|NCT01004861|584158289|FG010|Overall Study|Patient decision|1|||
161759343|NCT01004861|584158290|FG011|Overall Study|Patient decision|2|||
161759344|NCT01004861|584158291|FG012|Overall Study|Patient decision|3|||
161759345|NCT01004861|584158279|FG000|Overall Study|Transitioned to Phase 4 study|0|||
161759346|NCT01004861|584158280|FG001|Overall Study|Transitioned to Phase 4 study|0|||
161759347|NCT01004861|584158281|FG002|Overall Study|Transitioned to Phase 4 study|0|||
161759348|NCT01004861|584158282|FG003|Overall Study|Transitioned to Phase 4 study|0|||
161759349|NCT01004861|584158283|FG004|Overall Study|Transitioned to Phase 4 study|0|||
161759350|NCT01004861|584158284|FG005|Overall Study|Transitioned to Phase 4 study|0|||
161759351|NCT01004861|584158285|FG006|Overall Study|Transitioned to Phase 4 study|0|||
161759352|NCT01004861|584158286|FG007|Overall Study|Transitioned to Phase 4 study|0|||
161759353|NCT01004861|584158287|FG008|Overall Study|Transitioned to Phase 4 study|2|||
161759354|NCT01004861|584158288|FG009|Overall Study|Transitioned to Phase 4 study|0|||
161759355|NCT01004861|584158289|FG010|Overall Study|Transitioned to Phase 4 study|0|||
161971069|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161971070|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161971071|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161759356|NCT01004861|584158290|FG011|Overall Study|Transitioned to Phase 4 study|0|||
161759357|NCT01004861|584158291|FG012|Overall Study|Transitioned to Phase 4 study|0|||
161759358|NCT01004861|584158279|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759359|NCT01004861|584158280|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759360|NCT01004861|584158281|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759361|NCT01004861|584158282|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759362|NCT01004861|584158283|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759363|NCT01004861|584158284|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759364|NCT01004861|584158285|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759365|NCT01004861|584158286|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759366|NCT01004861|584158287|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
161759367|NCT01004861|584158288|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759368|NCT01004861|584158289|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759369|NCT01004861|584158290|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759370|NCT01004861|584158291|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161759371|NCT01004861|584158279|FG000|Overall Study|Patient withdrew|0|||
161759372|NCT01004861|584158280|FG001|Overall Study|Patient withdrew|0|||
161759373|NCT01004861|584158281|FG002|Overall Study|Patient withdrew|0|||
161759374|NCT01004861|584158282|FG003|Overall Study|Patient withdrew|0|||
161759375|NCT01004861|584158283|FG004|Overall Study|Patient withdrew|0|||
161759376|NCT01004861|584158284|FG005|Overall Study|Patient withdrew|0|||
161759377|NCT01004861|584158285|FG006|Overall Study|Patient withdrew|0|||
161759378|NCT01004861|584158286|FG007|Overall Study|Patient withdrew|0|||
161759379|NCT01004861|584158287|FG008|Overall Study|Patient withdrew|1|||
161759380|NCT01004861|584158288|FG009|Overall Study|Patient withdrew|0|||
161759381|NCT01004861|584158289|FG010|Overall Study|Patient withdrew|0|||
161759382|NCT01004861|584158290|FG011|Overall Study|Patient withdrew|0|||
161759383|NCT01004861|584158291|FG012|Overall Study|Patient withdrew|0|||
161759384|NCT01004861|584158279|FG000|Overall Study|Surgical resection|0|||
161759385|NCT01004861|584158280|FG001|Overall Study|Surgical resection|0|||
161759386|NCT01004861|584158281|FG002|Overall Study|Surgical resection|0|||
161759387|NCT01004861|584158282|FG003|Overall Study|Surgical resection|0|||
161759388|NCT01004861|584158283|FG004|Overall Study|Surgical resection|0|||
161759389|NCT01004861|584158284|FG005|Overall Study|Surgical resection|0|||
161759390|NCT01004861|584158285|FG006|Overall Study|Surgical resection|0|||
161759391|NCT01004861|584158286|FG007|Overall Study|Surgical resection|0|||
161759392|NCT01004861|584158287|FG008|Overall Study|Surgical resection|1|||
161759393|NCT01004861|584158288|FG009|Overall Study|Surgical resection|0|||
161759394|NCT01004861|584158289|FG010|Overall Study|Surgical resection|0|||
161759395|NCT01004861|584158290|FG011|Overall Study|Surgical resection|0|||
161759396|NCT01004861|584158291|FG012|Overall Study|Surgical resection|0|||
161759397|NCT01004861|584158279|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759398|NCT01004861|584158280|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759399|NCT01004861|584158281|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759400|NCT01004861|584158282|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759401|NCT01004861|584158283|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759402|NCT01004861|584158284|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759403|NCT01004861|584158285|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759404|NCT01004861|584158286|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759405|NCT01004861|584158287|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
161759406|NCT01004861|584158288|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759407|NCT01004861|584158289|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
162032973|NCT04035486|585177533|FG002|Overall Study|Screen Failure|1|||
161759408|NCT01004861|584158290|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759409|NCT01004861|584158291|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161759410|NCT01004861|584158279|FG000|Overall Study|Study termination by Sponsor|0|||
161759411|NCT01004861|584158280|FG001|Overall Study|Study termination by Sponsor|0|||
161759412|NCT01004861|584158281|FG002|Overall Study|Study termination by Sponsor|0|||
161759413|NCT01004861|584158282|FG003|Overall Study|Study termination by Sponsor|0|||
161759414|NCT01004861|584158283|FG004|Overall Study|Study termination by Sponsor|0|||
161759415|NCT01004861|584158284|FG005|Overall Study|Study termination by Sponsor|0|||
161759416|NCT01004861|584158285|FG006|Overall Study|Study termination by Sponsor|0|||
161759417|NCT01004861|584158286|FG007|Overall Study|Study termination by Sponsor|0|||
161759418|NCT01004861|584158287|FG008|Overall Study|Study termination by Sponsor|1|||
161759419|NCT01004861|584158288|FG009|Overall Study|Study termination by Sponsor|0|||
161759420|NCT01004861|584158289|FG010|Overall Study|Study termination by Sponsor|0|||
161759421|NCT01004861|584158290|FG011|Overall Study|Study termination by Sponsor|0|||
161759422|NCT01004861|584158291|FG012|Overall Study|Study termination by Sponsor|0|||
161759423|NCT04610827|584158293|FG000|Overall Study|Withdrawal by Subject|1|||
161759424|NCT04610827|584158294|FG001|Overall Study|Withdrawal by Subject|1|||
161759425|NCT04610827|584158295|FG002|Overall Study|Withdrawal by Subject|0|||
161759426|NCT01823991|584158296|FG000|Overall Study|Withdrawal by Subject|8|||
161759427|NCT01823991|584158297|FG001|Overall Study|Withdrawal by Subject|5|||
161759428|NCT00805194|584158298|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
161759429|NCT00805194|584158299|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
161759430|NCT00805194|584158298|FG000|Overall Study|Worsening or AE of underlying disease|64|||
161759431|NCT00805194|584158299|FG001|Overall Study|Worsening or AE of underlying disease|70|||
161759432|NCT00805194|584158298|FG000|Overall Study|Other AE|84|||
161759433|NCT00805194|584158299|FG001|Overall Study|Other AE|73|||
161759434|NCT00805194|584158298|FG000|Overall Study|Protocol Violation|9|||
161759435|NCT00805194|584158299|FG001|Overall Study|Protocol Violation|9|||
161759436|NCT00805194|584158298|FG000|Overall Study|Lost to Follow-up|5|||
161759437|NCT00805194|584158299|FG001|Overall Study|Lost to Follow-up|5|||
161759438|NCT00805194|584158298|FG000|Overall Study|Withdrawal by Subject|60|||
161759439|NCT00805194|584158299|FG001|Overall Study|Withdrawal by Subject|42|||
161759440|NCT00805194|584158298|FG000|Overall Study|Not treated|3|||
161759441|NCT00805194|584158299|FG001|Overall Study|Not treated|4|||
161759442|NCT00805194|584158298|FG000|Overall Study|Reasons other than stated above|20|||
161759443|NCT00805194|584158299|FG001|Overall Study|Reasons other than stated above|16|||
161759444|NCT02185040|584158303|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
161759445|NCT02185040|584158304|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
161759446|NCT02185040|584158305|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
161759447|NCT02185040|584158306|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
161759448|NCT02185040|584158307|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
161759449|NCT02185040|584158308|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
161759450|NCT02185040|584158309|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
161759451|NCT02185040|584158303|FG000|Part 1 Treatment Phase|Adverse Event|1|||
161759452|NCT02185040|584158304|FG001|Part 1 Treatment Phase|Adverse Event|0|||
161759453|NCT02185040|584158305|FG002|Part 1 Treatment Phase|Adverse Event|0|||
161759454|NCT02185040|584158306|FG003|Part 1 Treatment Phase|Adverse Event|2|||
161847266|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847267|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847268|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847269|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847270|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847271|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847272|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847273|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847274|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847275|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161759455|NCT02185040|584158307|FG004|Part 1 Treatment Phase|Adverse Event|3|||
161759456|NCT02185040|584158308|FG005|Part 1 Treatment Phase|Adverse Event|0|||
161759457|NCT02185040|584158309|FG006|Part 1 Treatment Phase|Adverse Event|0|||
161759458|NCT02185040|584158303|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161759459|NCT02185040|584158304|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
161759460|NCT02185040|584158305|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161759461|NCT02185040|584158306|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161759462|NCT02185040|584158307|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161759463|NCT02185040|584158308|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161759464|NCT02185040|584158309|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161759465|NCT02185040|584158303|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
161759466|NCT02185040|584158304|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
161759467|NCT02185040|584158305|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
161759468|NCT02185040|584158306|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
161847276|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161847277|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
161759469|NCT02185040|584158307|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
161759470|NCT02185040|584158308|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
161759471|NCT02185040|584158309|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
161759472|NCT02185040|584158303|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
161759473|NCT02185040|584158304|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
161759474|NCT02185040|584158305|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
161759475|NCT02185040|584158306|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
161759476|NCT02185040|584158307|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
161759477|NCT02185040|584158308|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
161759478|NCT02185040|584158309|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
161759479|NCT02185040|584158303|FG000|Active Treatment Extension Phase|Adverse Event|0|||
161759480|NCT02185040|584158304|FG001|Active Treatment Extension Phase|Adverse Event|0|||
161759481|NCT02185040|584158305|FG002|Active Treatment Extension Phase|Adverse Event|0|||
161759482|NCT02185040|584158306|FG003|Active Treatment Extension Phase|Adverse Event|0|||
161759483|NCT02185040|584158307|FG004|Active Treatment Extension Phase|Adverse Event|0|||
161759484|NCT02185040|584158308|FG005|Active Treatment Extension Phase|Adverse Event|1|||
161759485|NCT02185040|584158309|FG006|Active Treatment Extension Phase|Adverse Event|4|||
161759486|NCT02185040|584158303|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161759487|NCT02185040|584158304|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161847278|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
161847279|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847280|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847281|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847282|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847283|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847284|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847285|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847286|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847287|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847288|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847289|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847290|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161847291|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
161847292|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
161847293|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847294|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847295|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847296|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847297|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847298|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847299|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847300|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847301|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847302|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847303|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847304|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161847305|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
161847306|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
161847307|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847308|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847309|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847310|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847311|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
162032974|NCT04035486|585177534|FG003|Overall Study|Screen Failure|1|||
161759488|NCT02185040|584158305|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161847312|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847313|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847314|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847315|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847316|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847317|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847318|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161847319|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
161847320|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
161847321|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847322|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161759489|NCT02185040|584158306|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161759490|NCT02185040|584158307|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161847323|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847324|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847325|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847326|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847327|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847328|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847329|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847330|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847331|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847332|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161847333|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
161847334|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
161847335|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847336|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847337|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847338|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847339|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847340|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847341|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847342|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847343|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847344|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161971072|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
161971073|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
161971074|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
161971075|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161971076|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161971077|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161971078|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161971079|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161759491|NCT02185040|584158308|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
161759492|NCT02185040|584158309|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
161759493|NCT02185040|584158303|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
161759494|NCT02185040|584158304|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
161759495|NCT02185040|584158305|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
161759496|NCT02185040|584158306|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
161759497|NCT02185040|584158307|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
161759498|NCT02185040|584158308|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
161759499|NCT02185040|584158309|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
161759500|NCT02094612|584158314|FG000|Overall Study|Lost to Follow-up|47|||
161759501|NCT02094612|584158315|FG001|Overall Study|Lost to Follow-up|47|||
161759502|NCT02094612|584158314|FG000|Overall Study|Never started ADHD medication|32|||
161759503|NCT02094612|584158315|FG001|Overall Study|Never started ADHD medication|23|||
161759504|NCT04167514|584158316|FG000|Overall Study|Adverse event, not serious|0|||
161759505|NCT04167514|584158317|FG001|Overall Study|Adverse event, not serious|1|||
161759506|NCT04167514|584158316|FG000|Overall Study|Lost to Follow-up|1|||
161759507|NCT04167514|584158317|FG001|Overall Study|Lost to Follow-up|0|||
161759508|NCT04167514|584158316|FG000|Overall Study|Participant Decision|2|||
161759509|NCT04167514|584158317|FG001|Overall Study|Participant Decision|4|||
161759510|NCT04167514|584158316|FG000|Overall Study|Physician Decision|3|||
161759511|NCT04167514|584158317|FG001|Overall Study|Physician Decision|2|||
161759512|NCT04167514|584158316|FG000|Overall Study|Death|14|||
161759513|NCT04167514|584158317|FG001|Overall Study|Death|18|||
161759514|NCT04167514|584158316|FG000|Overall Study|Enrolled but treatment not administered|2|||
161759515|NCT04167514|584158317|FG001|Overall Study|Enrolled but treatment not administered|0|||
161759516|NCT04167514|584158316|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
161759517|NCT04167514|584158317|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
161759518|NCT04167514|584158316|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
161759519|NCT04167514|584158317|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
161759520|NCT02646891|584158318|FG000|Overall Study|Adverse Event|0|||
161759521|NCT02646891|584158319|FG001|Overall Study|Adverse Event|1|||
161759522|NCT02646891|584158320|FG002|Overall Study|Adverse Event|0|||
161847345|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161847346|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161759523|NCT02646891|584158321|FG003|Overall Study|Adverse Event|0|||
161759524|NCT02646891|584158322|FG004|Overall Study|Adverse Event|0|||
161759525|NCT02646891|584158323|FG005|Overall Study|Adverse Event|0|||
161847347|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
161847348|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
161847349|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847350|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847351|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847352|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847353|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847354|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847355|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847356|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847357|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847358|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847359|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847360|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161847361|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
161847362|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
161847363|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847364|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847365|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847366|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847367|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847368|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847369|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847370|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847371|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847372|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847373|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847374|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161847375|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
161847376|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
161847377|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847378|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847379|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847380|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847381|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847382|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847383|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847384|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847385|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847386|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847387|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161759526|NCT02646891|584158324|FG006|Overall Study|Adverse Event|0|||
161759527|NCT02646891|584158325|FG007|Overall Study|Adverse Event|0|||
161759528|NCT02646891|584158326|FG008|Overall Study|Adverse Event|0|||
161759529|NCT02646891|584158327|FG009|Overall Study|Adverse Event|0|||
161759530|NCT02646891|584158318|FG000|Overall Study|Lost to Follow-up|0|||
161759531|NCT02646891|584158319|FG001|Overall Study|Lost to Follow-up|0|||
161759532|NCT02646891|584158320|FG002|Overall Study|Lost to Follow-up|0|||
161759533|NCT02646891|584158321|FG003|Overall Study|Lost to Follow-up|0|||
161759534|NCT02646891|584158322|FG004|Overall Study|Lost to Follow-up|0|||
161759535|NCT02646891|584158323|FG005|Overall Study|Lost to Follow-up|0|||
161759536|NCT02646891|584158324|FG006|Overall Study|Lost to Follow-up|2|||
161759537|NCT02646891|584158325|FG007|Overall Study|Lost to Follow-up|2|||
161759538|NCT02646891|584158326|FG008|Overall Study|Lost to Follow-up|2|||
161759539|NCT02646891|584158327|FG009|Overall Study|Lost to Follow-up|2|||
161759540|NCT02646891|584158318|FG000|Overall Study|Protocol Violation|0|||
161759541|NCT02646891|584158319|FG001|Overall Study|Protocol Violation|0|||
161759542|NCT02646891|584158320|FG002|Overall Study|Protocol Violation|0|||
161759543|NCT02646891|584158321|FG003|Overall Study|Protocol Violation|0|||
161847388|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161847389|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
161971080|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
161971081|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161971082|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161759544|NCT02646891|584158322|FG004|Overall Study|Protocol Violation|0|||
161759545|NCT02646891|584158323|FG005|Overall Study|Protocol Violation|0|||
161759546|NCT02646891|584158324|FG006|Overall Study|Protocol Violation|1|||
161759547|NCT02646891|584158325|FG007|Overall Study|Protocol Violation|1|||
161759548|NCT02646891|584158326|FG008|Overall Study|Protocol Violation|0|||
161759549|NCT02646891|584158327|FG009|Overall Study|Protocol Violation|0|||
161759550|NCT02646891|584158318|FG000|Overall Study|Withdrawal by Subject|2|||
161759551|NCT02646891|584158319|FG001|Overall Study|Withdrawal by Subject|0|||
161759552|NCT02646891|584158320|FG002|Overall Study|Withdrawal by Subject|1|||
161759553|NCT02646891|584158321|FG003|Overall Study|Withdrawal by Subject|0|||
161759554|NCT02646891|584158322|FG004|Overall Study|Withdrawal by Subject|0|||
161759555|NCT02646891|584158323|FG005|Overall Study|Withdrawal by Subject|0|||
161759556|NCT02646891|584158324|FG006|Overall Study|Withdrawal by Subject|5|||
161759557|NCT02646891|584158325|FG007|Overall Study|Withdrawal by Subject|9|||
161759558|NCT02646891|584158326|FG008|Overall Study|Withdrawal by Subject|7|||
161759559|NCT02646891|584158327|FG009|Overall Study|Withdrawal by Subject|3|||
161759560|NCT02646891|584158318|FG000|Overall Study|Death|0|||
161759561|NCT02646891|584158319|FG001|Overall Study|Death|0|||
161759562|NCT02646891|584158320|FG002|Overall Study|Death|0|||
161759563|NCT02646891|584158321|FG003|Overall Study|Death|0|||
161759564|NCT02646891|584158322|FG004|Overall Study|Death|0|||
161759565|NCT02646891|584158323|FG005|Overall Study|Death|0|||
161759566|NCT02646891|584158324|FG006|Overall Study|Death|1|||
161759567|NCT02646891|584158325|FG007|Overall Study|Death|1|||
161759568|NCT02646891|584158326|FG008|Overall Study|Death|1|||
161759569|NCT02646891|584158327|FG009|Overall Study|Death|0|||
161759570|NCT01542632|584158328|FG000|Overall Study|Withdrawal of Consent|0|||
161759571|NCT01542632|584158329|FG001|Overall Study|Withdrawal of Consent|0|||
161759572|NCT01542632|584158330|FG002|Overall Study|Withdrawal of Consent|0|||
161759573|NCT01542632|584158331|FG003|Overall Study|Withdrawal of Consent|2|||
161759574|NCT01542632|584158332|FG004|Overall Study|Withdrawal of Consent|3|||
161759575|NCT01542632|584158333|FG005|Overall Study|Withdrawal of Consent|0|||
161759576|NCT01542632|584158328|FG000|Overall Study|Adverse Event|0|||
161759577|NCT01542632|584158329|FG001|Overall Study|Adverse Event|0|||
161759578|NCT01542632|584158330|FG002|Overall Study|Adverse Event|1|||
161759579|NCT01542632|584158331|FG003|Overall Study|Adverse Event|0|||
161759580|NCT01542632|584158332|FG004|Overall Study|Adverse Event|0|||
161759581|NCT01542632|584158333|FG005|Overall Study|Adverse Event|0|||
161759582|NCT01542632|584158328|FG000|Overall Study|Lost to Follow-up|0|||
161759583|NCT01542632|584158329|FG001|Overall Study|Lost to Follow-up|1|||
161759584|NCT01542632|584158330|FG002|Overall Study|Lost to Follow-up|0|||
161759585|NCT01542632|584158331|FG003|Overall Study|Lost to Follow-up|0|||
161759586|NCT01542632|584158332|FG004|Overall Study|Lost to Follow-up|0|||
161759587|NCT01542632|584158333|FG005|Overall Study|Lost to Follow-up|0|||
161759588|NCT01542632|584158328|FG000|Overall Study|Sponsor/Investigator Decision|0|||
161759589|NCT01542632|584158329|FG001|Overall Study|Sponsor/Investigator Decision|0|||
161759590|NCT01542632|584158330|FG002|Overall Study|Sponsor/Investigator Decision|0|||
161759591|NCT01542632|584158331|FG003|Overall Study|Sponsor/Investigator Decision|0|||
161759592|NCT01542632|584158332|FG004|Overall Study|Sponsor/Investigator Decision|1|||
161759593|NCT01542632|584158333|FG005|Overall Study|Sponsor/Investigator Decision|0|||
161971083|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
161971084|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
161971085|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161971086|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161971087|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161971088|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161971089|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161971090|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161971091|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161971092|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161971093|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
161971094|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
161971095|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161971096|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161971097|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161971098|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161971099|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161971100|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161971101|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161971102|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
161971103|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
161971104|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
161971105|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161971106|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161759594|NCT00033514|584158334|FG000|Overall Study|Lost to Follow-up|1|||
161759595|NCT00033514|584158335|FG001|Overall Study|Lost to Follow-up|1|||
161759596|NCT00033514|584158334|FG000|Overall Study|Withdrawal by Subject|0|||
161759597|NCT00033514|584158335|FG001|Overall Study|Withdrawal by Subject|3|||
161759598|NCT03225833|584158338|FG000|Overall Study|Adverse Event|0|||
161759599|NCT03225833|584158339|FG001|Overall Study|Adverse Event|1|||
161759600|NCT03225833|584158340|FG002|Overall Study|Adverse Event|2|||
161759601|NCT03225833|584158341|FG003|Overall Study|Adverse Event|0|||
161759602|NCT03225833|584158342|FG004|Overall Study|Adverse Event|0|||
161759603|NCT03225833|584158343|FG005|Overall Study|Adverse Event|2|||
161759604|NCT03225833|584158338|FG000|Overall Study|Withdrawal by Subject|1|||
161759605|NCT03225833|584158339|FG001|Overall Study|Withdrawal by Subject|0|||
161759606|NCT03225833|584158340|FG002|Overall Study|Withdrawal by Subject|0|||
161759607|NCT03225833|584158341|FG003|Overall Study|Withdrawal by Subject|0|||
161759608|NCT03225833|584158342|FG004|Overall Study|Withdrawal by Subject|1|||
161759609|NCT03225833|584158343|FG005|Overall Study|Withdrawal by Subject|0|||
161759610|NCT03225833|584158338|FG000|Overall Study|Termination of Study by Sponsor|4|||
161759611|NCT03225833|584158339|FG001|Overall Study|Termination of Study by Sponsor|0|||
161759612|NCT03225833|584158340|FG002|Overall Study|Termination of Study by Sponsor|0|||
161759613|NCT03225833|584158341|FG003|Overall Study|Termination of Study by Sponsor|0|||
161759614|NCT03225833|584158342|FG004|Overall Study|Termination of Study by Sponsor|0|||
161759615|NCT03225833|584158343|FG005|Overall Study|Termination of Study by Sponsor|7|||
161759616|NCT03225833|584158338|FG000|Overall Study|Sponsor Decision|0|||
161759617|NCT03225833|584158339|FG001|Overall Study|Sponsor Decision|0|||
161759618|NCT03225833|584158340|FG002|Overall Study|Sponsor Decision|0|||
161759619|NCT03225833|584158341|FG003|Overall Study|Sponsor Decision|0|||
161759620|NCT03225833|584158342|FG004|Overall Study|Sponsor Decision|0|||
161759621|NCT03225833|584158343|FG005|Overall Study|Sponsor Decision|1|||
161759622|NCT06029127|584158345|FG000|Overall Study|Withdrawal by Subject|2|||
161759623|NCT06029127|584158346|FG001|Overall Study|Withdrawal by Subject|0|||
161759624|NCT06029127|584158345|FG000|Overall Study|Lost to Follow-up|1|||
161759625|NCT06029127|584158346|FG001|Overall Study|Lost to Follow-up|0|||
161759626|NCT06029127|584158345|FG000|Overall Study|Study Closed by Sponsor|6|||
161759627|NCT06029127|584158346|FG001|Overall Study|Study Closed by Sponsor|6|||
161759628|NCT06029127|584158345|FG000|Overall Study|Death|12|||
161759629|NCT06029127|584158346|FG001|Overall Study|Death|7|||
161759630|NCT06029127|584158345|FG000|Overall Study|Declined Follow-Up Contact|0|||
161759631|NCT06029127|584158346|FG001|Overall Study|Declined Follow-Up Contact|1|||
161759632|NCT02871791|584158348|FG000|Phase 1b|Death|0|||
161759633|NCT02871791|584158349|FG001|Phase 1b|Death|1|||
161759634|NCT02871791|584158348|FG000|Phase 1b|progressive disease|6|||
161759635|NCT02871791|584158349|FG001|Phase 1b|progressive disease|2|||
161971107|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161971108|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161971109|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161971110|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161971111|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161971112|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
161971113|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
161971114|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
161971115|NCT03352557|584941033|FG000|LTE Period: Week 80 to Week 173|Other|0|||
161971116|NCT03352557|584941034|FG001|LTE Period: Week 80 to Week 173|Other|0|||
161971117|NCT03352557|584941035|FG002|LTE Period: Week 80 to Week 173|Other|0|||
161971118|NCT03352557|584941036|FG003|LTE Period: Week 80 to Week 173|Other|0|||
162032975|NCT04035486|585177531|FG000|Overall Study|Withdrawal by Subject|1|||
161759636|NCT02871791|584158348|FG000|Phase 2|Death|1|||
161759637|NCT02871791|584158349|FG001|Phase 2|Death|0|||
161759638|NCT02871791|584158348|FG000|Phase 2|Lost to Follow-up|2|||
161759639|NCT02871791|584158349|FG001|Phase 2|Lost to Follow-up|0|||
161759640|NCT00129376|584158350|FG000|Overall Study|Adverse Event|1|||
161759641|NCT00129376|584158350|FG000|Overall Study|Lack of Efficacy|1|||
161759642|NCT03737318|584158358|FG000|Phase 2 (Generalization)|Withdrawal by Subject|4|||
161759643|NCT03737318|584158359|FG001|Phase 2 (Generalization)|Withdrawal by Subject|1|||
161759644|NCT03737318|584158360|FG002|Phase 2 (Generalization)|Withdrawal by Subject|1|||
161759645|NCT04554394|584158361|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
161759646|NCT04554394|584158362|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
161759647|NCT04554394|584158361|FG000|Overall Study|Withdrawal by Subject|2|||
161759648|NCT04554394|584158362|FG001|Overall Study|Withdrawal by Subject|2|||
161759649|NCT04554394|584158361|FG000|Overall Study|Lost to Follow-up|2|||
161759650|NCT04554394|584158362|FG001|Overall Study|Lost to Follow-up|2|||
161759651|NCT04554394|584158361|FG000|Overall Study|Physician Decision|1|||
161759652|NCT04554394|584158362|FG001|Overall Study|Physician Decision|1|||
161847390|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
161971119|NCT03352557|584941037|FG004|LTE Period: Week 80 to Week 173|Other|0|||
161971120|NCT03352557|584941038|FG005|LTE Period: Week 80 to Week 173|Other|0|||
161759653|NCT01766401|584158363|FG000|Overall Study|Adverse Event|7|||
161759654|NCT01766401|584158364|FG001|Overall Study|Adverse Event|22|||
161971121|NCT03352557|584941039|FG006|LTE Period: Week 80 to Week 173|Other|0|||
161759655|NCT01766401|584158363|FG000|Overall Study|Lack of Efficacy|1|||
161759656|NCT01766401|584158364|FG001|Overall Study|Lack of Efficacy|2|||
161759657|NCT01766401|584158363|FG000|Overall Study|Protocol Violation|3|||
161759658|NCT01766401|584158364|FG001|Overall Study|Protocol Violation|8|||
161759659|NCT01766401|584158363|FG000|Overall Study|Withdrawal by Subject|15|||
161971122|NCT03352557|584941040|FG007|LTE Period: Week 80 to Week 173|Other|1|||
161759660|NCT01766401|584158364|FG001|Overall Study|Withdrawal by Subject|12|||
161759661|NCT01766401|584158363|FG000|Overall Study|Lost to Follow-up|10|||
161971123|NCT03352557|584941041|FG008|LTE Period: Week 80 to Week 173|Other|0|||
161971124|NCT03352557|584941042|FG009|LTE Period: Week 80 to Week 173|Other|0|||
161971125|NCT04677660|584941043|FG000|Overall Study|Lost to Follow-up|0|||
161971126|NCT04677660|584941044|FG001|Overall Study|Lost to Follow-up|2|||
161971127|NCT04677660|584941043|FG000|Overall Study|Withdrawal by Subject|0|||
161971128|NCT04677660|584941044|FG001|Overall Study|Withdrawal by Subject|1|||
161759662|NCT01766401|584158364|FG001|Overall Study|Lost to Follow-up|11|||
161759663|NCT01766401|584158363|FG000|Overall Study|Pregnancy|1|||
161759664|NCT01766401|584158364|FG001|Overall Study|Pregnancy|1|||
161759665|NCT00886587|584158365|FG000|Overall Study|Adverse Event|2|||
161759666|NCT00886587|584158366|FG001|Overall Study|Adverse Event|1|||
161759667|NCT00886587|584158365|FG000|Overall Study|Protocol Violation|2|||
161759668|NCT00886587|584158366|FG001|Overall Study|Protocol Violation|0|||
161759669|NCT00886587|584158365|FG000|Overall Study|Withdrawal by Subject|0|||
161759670|NCT00886587|584158366|FG001|Overall Study|Withdrawal by Subject|1|||
161759671|NCT01108068|584158370|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
161971129|NCT04677660|584941043|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
161971130|NCT04677660|584941044|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
161971131|NCT03242772|584941045|FG000|Overall Study|Lost to Follow-up|2|||
161971132|NCT03242772|584941046|FG001|Overall Study|Lost to Follow-up|0|||
161759672|NCT01108068|584158371|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
161759673|NCT00398086|584158372|FG000|Overall Study|Unacceptable Toxicity|2|||
161971133|NCT03242772|584941045|FG000|Overall Study|Physician Decision|0|||
161971134|NCT03242772|584941046|FG001|Overall Study|Physician Decision|1|||
161971135|NCT03242772|584941045|FG000|Overall Study|Withdrawal by Subject|1|||
161971136|NCT03242772|584941046|FG001|Overall Study|Withdrawal by Subject|0|||
161971137|NCT02499900|584941047|FG000|Core Study Period|Other|1|||
161971138|NCT02499900|584941048|FG001|Core Study Period|Other|4|||
161971139|NCT02499900|584941047|FG000|Core Study Period|Lost to Follow-up|1|||
161971140|NCT02499900|584941048|FG001|Core Study Period|Lost to Follow-up|2|||
161971141|NCT02499900|584941047|FG000|Core Study Period|Per sponsor request|0|||
161971142|NCT02499900|584941048|FG001|Core Study Period|Per sponsor request|1|||
161971143|NCT02499900|584941047|FG000|Core Study Period|Pregnancy|1|||
161971144|NCT02499900|584941048|FG001|Core Study Period|Pregnancy|0|||
161971145|NCT02499900|584941047|FG000|Core Study Period|Protocol Violation|3|||
161971146|NCT02499900|584941048|FG001|Core Study Period|Protocol Violation|0|||
161971147|NCT02499900|584941047|FG000|Core Study Period|Withdrawal by Subject|11|||
161971148|NCT02499900|584941048|FG001|Core Study Period|Withdrawal by Subject|10|||
161971149|NCT02499900|584941047|FG000|Core Study Period|Adverse Event|18|||
161971150|NCT02499900|584941048|FG001|Core Study Period|Adverse Event|14|||
161971151|NCT02499900|584941047|FG000|Core Study Period|Death|0|||
161971152|NCT02499900|584941048|FG001|Core Study Period|Death|1|||
161971153|NCT02499900|584941047|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
161971154|NCT02499900|584941048|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
161971155|NCT02499900|584941047|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
161971156|NCT02499900|584941048|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
161971157|NCT02499900|584941047|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
161971158|NCT02499900|584941048|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
161759674|NCT00398086|584158373|FG001|Overall Study|Unacceptable Toxicity|8|||
161759675|NCT00398086|584158374|FG002|Overall Study|Unacceptable Toxicity|2|||
161759676|NCT00398086|584158372|FG000|Overall Study|Adverse Event|1|||
161759677|NCT00398086|584158373|FG001|Overall Study|Adverse Event|4|||
161759678|NCT00398086|584158374|FG002|Overall Study|Adverse Event|0|||
161759679|NCT00398086|584158372|FG000|Overall Study|Physician Decision|1|||
161759680|NCT00398086|584158373|FG001|Overall Study|Physician Decision|4|||
161759681|NCT00398086|584158374|FG002|Overall Study|Physician Decision|0|||
161759682|NCT00398086|584158372|FG000|Overall Study|Withdrawal by Subject|5|||
161759683|NCT00398086|584158373|FG001|Overall Study|Withdrawal by Subject|7|||
161759684|NCT00398086|584158374|FG002|Overall Study|Withdrawal by Subject|0|||
161759685|NCT01021553|584158375|FG000|Overall Study|Adverse Event|1|||
161759686|NCT01021553|584158376|FG001|Overall Study|Adverse Event|0|||
161759687|NCT01021553|584158377|FG002|Overall Study|Adverse Event|0|||
161759688|NCT01021553|584158375|FG000|Overall Study|Lack of Efficacy|2|||
161971159|NCT02499900|584941047|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
161971160|NCT02499900|584941048|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
161971161|NCT02499900|584941047|FG000|Extension Study Period|Adverse Event|2|||
161971162|NCT02499900|584941048|FG001|Extension Study Period|Adverse Event|4|||
161759689|NCT01021553|584158376|FG001|Overall Study|Lack of Efficacy|2|||
161759690|NCT01021553|584158377|FG002|Overall Study|Lack of Efficacy|0|||
161971163|NCT02499900|584941047|FG000|Extension Study Period|Withdrawal by Subject|5|||
161971164|NCT02499900|584941048|FG001|Extension Study Period|Withdrawal by Subject|2|||
161971165|NCT02499900|584941047|FG000|Extension Study Period|Physician Decision|2|||
161759691|NCT01021553|584158375|FG000|Overall Study|Protocol Violation|0|||
161759692|NCT01021553|584158376|FG001|Overall Study|Protocol Violation|2|||
161759693|NCT01021553|584158377|FG002|Overall Study|Protocol Violation|2|||
161759694|NCT01021553|584158375|FG000|Overall Study|Lost to Follow-up|0|||
161759695|NCT01021553|584158376|FG001|Overall Study|Lost to Follow-up|0|||
161759696|NCT01021553|584158377|FG002|Overall Study|Lost to Follow-up|1|||
161759697|NCT01021553|584158375|FG000|Overall Study|Withdrawal by Subject|1|||
161759698|NCT01021553|584158376|FG001|Overall Study|Withdrawal by Subject|1|||
161759699|NCT01021553|584158377|FG002|Overall Study|Withdrawal by Subject|0|||
161759700|NCT00696774|584158378|FG000|Period II|Adverse Event|0|||
161759701|NCT00696774|584158379|FG001|Period II|Adverse Event|0|||
161759702|NCT00696774|584158380|FG002|Period II|Adverse Event|15|||
161759703|NCT00696774|584158378|FG000|Period II|Lost to Follow-up|0|||
161759704|NCT00696774|584158379|FG001|Period II|Lost to Follow-up|0|||
161759705|NCT00696774|584158380|FG002|Period II|Lost to Follow-up|4|||
161847391|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847392|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847393|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847394|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847395|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847396|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847397|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847398|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847399|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847400|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847401|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847402|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161847403|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
161847404|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
161847405|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847406|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847407|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162032976|NCT04035486|585177532|FG001|Overall Study|Withdrawal by Subject|1|||
162032977|NCT04035486|585177533|FG002|Overall Study|Withdrawal by Subject|11|||
162032978|NCT04035486|585177534|FG003|Overall Study|Withdrawal by Subject|9|||
162032979|NCT01730937|585177535|FG000|Overall Study|Protocol Violation|5|||
162032980|NCT01730937|585177536|FG001|Overall Study|Protocol Violation|11|||
162032981|NCT03947684|585177537|FG000|Overall Study|Lost to Follow-up|13|||
162032982|NCT03947684|585177538|FG001|Overall Study|Lost to Follow-up|5|||
162032983|NCT03947684|585177539|FG002|Overall Study|Lost to Follow-up|1|||
162032984|NCT03947684|585177537|FG000|Overall Study|Withdrawal by Subject|11|||
162032985|NCT03947684|585177538|FG001|Overall Study|Withdrawal by Subject|4|||
162032986|NCT03947684|585177539|FG002|Overall Study|Withdrawal by Subject|0|||
162032987|NCT03947684|585177537|FG000|Overall Study|Physician Decision|1|||
162032988|NCT03947684|585177538|FG001|Overall Study|Physician Decision|0|||
162032989|NCT03947684|585177539|FG002|Overall Study|Physician Decision|0|||
162032990|NCT03947684|585177537|FG000|Overall Study|Lack of adherence to study protocol|2|||
162032991|NCT03947684|585177538|FG001|Overall Study|Lack of adherence to study protocol|0|||
162032992|NCT03947684|585177539|FG002|Overall Study|Lack of adherence to study protocol|0|||
162032993|NCT01107418|585178564|FG000|Overall Study|Disease Progression|45|||
162032994|NCT01107418|585178564|FG000|Overall Study|Adverse Event|3|||
162032995|NCT01107418|585178564|FG000|Overall Study|Withdrawal by Subject|1|||
162032996|NCT01107418|585178564|FG000|Overall Study|Study Closing|1|||
162032997|NCT01107418|585178564|FG000|Overall Study|Started Other Therapy|1|||
162032998|NCT01107418|585178564|FG000|Overall Study|Entered Extension Study|1|||
162032999|NCT04078178|585178565|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
162033000|NCT04078178|585178566|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
161759706|NCT00696774|584158378|FG000|Period II|Protocol Violation|0|||
161759707|NCT00696774|584158379|FG001|Period II|Protocol Violation|0|||
161759708|NCT00696774|584158380|FG002|Period II|Protocol Violation|11|||
161759709|NCT00696774|584158378|FG000|Period II|Withdrawal by Subject|0|||
161759710|NCT00696774|584158379|FG001|Period II|Withdrawal by Subject|0|||
161847408|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847409|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847410|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
162033001|NCT04078178|585178565|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
162033002|NCT04078178|585178566|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
162033003|NCT04078178|585178565|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
162033004|NCT04078178|585178566|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
162033005|NCT04078178|585178565|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
162033006|NCT04078178|585178566|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
162033007|NCT04078178|585178565|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
161971166|NCT02499900|584941048|FG001|Extension Study Period|Physician Decision|5|||
161971167|NCT02499900|584941047|FG000|Extension Study Period|Pregnancy|1|||
161971168|NCT02499900|584941048|FG001|Extension Study Period|Pregnancy|2|||
161971169|NCT02499900|584941047|FG000|Extension Study Period|Lost to Follow-up|2|||
161971170|NCT02499900|584941048|FG001|Extension Study Period|Lost to Follow-up|5|||
161971171|NCT02499900|584941047|FG000|Extension Study Period|Other|0|||
161971172|NCT02499900|584941048|FG001|Extension Study Period|Other|2|||
161971173|NCT01560637|584941049|FG000|Overall Study|Adverse Event|63|||
161971174|NCT01560637|584941049|FG000|Overall Study|Death|69|||
161971175|NCT01560637|584941049|FG000|Overall Study|Lost to Follow-up|8|||
161971176|NCT01560637|584941049|FG000|Overall Study|Protocol Violation|8|||
161971177|NCT01560637|584941049|FG000|Overall Study|Withdrawal by Subject|24|||
161971178|NCT01560637|584941049|FG000|Overall Study|Progressive Disease|20|||
161971179|NCT01560637|584941049|FG000|Overall Study|Other Reason Not Specified|6|||
161971180|NCT01089023|584941050|FG000|Overall Study|Lost to Follow-up|3|||
161759711|NCT00696774|584158380|FG002|Period II|Withdrawal by Subject|4|||
161759712|NCT00696774|584158378|FG000|Period II|Sponsor Decision|0|||
161971181|NCT01089023|584941050|FG000|Overall Study|Adverse Event|1|||
161971182|NCT01089023|584941050|FG000|Overall Study|Withdrawal by Subject|1|||
161971183|NCT01089023|584941050|FG000|Overall Study|Protocol Violation|1|||
161971184|NCT01089023|584941050|FG000|Overall Study|Lack of Efficacy|1|||
161971185|NCT02434354|584941055|FG000|Overall Study|screen fail|3|||
161971186|NCT01185964|584941057|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
161759713|NCT00696774|584158379|FG001|Period II|Sponsor Decision|0|||
161759714|NCT00696774|584158380|FG002|Period II|Sponsor Decision|0|||
161759715|NCT00696774|584158378|FG000|Period II|Lack of Efficacy|0|||
161759716|NCT00696774|584158379|FG001|Period II|Lack of Efficacy|0|||
161759717|NCT00696774|584158380|FG002|Period II|Lack of Efficacy|2|||
161759718|NCT00696774|584158378|FG000|Period III|Adverse Event|1|||
161759719|NCT00696774|584158379|FG001|Period III|Adverse Event|1|||
161759720|NCT00696774|584158380|FG002|Period III|Adverse Event|0|||
161759721|NCT00696774|584158378|FG000|Period III|Lost to Follow-up|2|||
161759722|NCT00696774|584158379|FG001|Period III|Lost to Follow-up|1|||
161759723|NCT00696774|584158380|FG002|Period III|Lost to Follow-up|0|||
161759724|NCT00696774|584158378|FG000|Period III|Protocol Violation|1|||
161759725|NCT00696774|584158379|FG001|Period III|Protocol Violation|1|||
161759726|NCT00696774|584158380|FG002|Period III|Protocol Violation|0|||
161759727|NCT00696774|584158378|FG000|Period III|Withdrawal by Subject|1|||
161759728|NCT00696774|584158379|FG001|Period III|Withdrawal by Subject|2|||
161759729|NCT00696774|584158380|FG002|Period III|Withdrawal by Subject|0|||
161759730|NCT00696774|584158378|FG000|Period III|Sponsor Decision|2|||
161759731|NCT00696774|584158379|FG001|Period III|Sponsor Decision|0|||
161759732|NCT00696774|584158380|FG002|Period III|Sponsor Decision|0|||
161759733|NCT00696774|584158378|FG000|Period III|Lack of Efficacy|0|||
161759734|NCT00696774|584158379|FG001|Period III|Lack of Efficacy|2|||
161759735|NCT00696774|584158380|FG002|Period III|Lack of Efficacy|0|||
161759736|NCT01950364|584158381|FG000|Overall Study|Adverse Event|3|||
161759737|NCT01950364|584158382|FG001|Overall Study|Adverse Event|0|||
161759738|NCT01950364|584158381|FG000|Overall Study|Stem Cell Transplant|2|||
161759739|NCT01950364|584158382|FG001|Overall Study|Stem Cell Transplant|6|||
161759740|NCT01950364|584158381|FG000|Overall Study|Disease Progression|5|||
161759741|NCT01950364|584158382|FG001|Overall Study|Disease Progression|2|||
161759742|NCT01950364|584158381|FG000|Overall Study|Withdrawal by Subject|0|||
161759743|NCT01950364|584158382|FG001|Overall Study|Withdrawal by Subject|1|||
161759744|NCT01950364|584158381|FG000|Overall Study|Protocol Violation|0|||
161759745|NCT01950364|584158382|FG001|Overall Study|Protocol Violation|1|||
161759746|NCT00033293|584158389|FG000|Overall Study|Death|0|||
161759747|NCT00033293|584158390|FG001|Overall Study|Death|1|||
161759748|NCT00033293|584158389|FG000|Overall Study|Lack of Efficacy|5|||
161759749|NCT00033293|584158390|FG001|Overall Study|Lack of Efficacy|8|||
161759750|NCT00033293|584158389|FG000|Overall Study|Lost to Follow-up|0|||
161759751|NCT00033293|584158390|FG001|Overall Study|Lost to Follow-up|1|||
161759752|NCT00033293|584158389|FG000|Overall Study|Physician Decision|3|||
161759753|NCT00033293|584158390|FG001|Overall Study|Physician Decision|1|||
161759754|NCT00033293|584158389|FG000|Overall Study|Withdrawal by Subject|1|||
161759755|NCT00033293|584158390|FG001|Overall Study|Withdrawal by Subject|0|||
161759756|NCT00033293|584158389|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
161971187|NCT01185964|584941058|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
161759757|NCT00033293|584158390|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
161759758|NCT00033293|584158389|FG000|Overall Study|Treatment refused|0|||
161759759|NCT00033293|584158390|FG001|Overall Study|Treatment refused|6|||
161759760|NCT00935701|584158391|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
161759761|NCT02201251|584158392|FG000|Overall Study|Adverse Event|1|||
161971188|NCT01185964|584941059|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
161971189|NCT01185964|584941060|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
161971190|NCT01185964|584941057|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
161971191|NCT01185964|584941058|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
161759762|NCT02201251|584158393|FG001|Overall Study|Adverse Event|1|||
161759763|NCT02201251|584158392|FG000|Overall Study|Protocol Violation|1|||
161847411|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847412|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847413|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847414|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847415|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847416|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161847417|NCT03982199|584482429|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
161847418|NCT03982199|584482430|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
161847419|NCT03982199|584482431|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847420|NCT03982199|584482432|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847421|NCT03982199|584482433|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847422|NCT03982199|584482434|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847423|NCT03982199|584482435|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847424|NCT03982199|584482436|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847425|NCT03982199|584482437|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847426|NCT03982199|584482438|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847427|NCT03982199|584482439|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847428|NCT03982199|584482440|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847429|NCT03982199|584482441|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847430|NCT03982199|584482442|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161847431|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847432|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847433|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847434|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
161847435|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847436|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847437|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847438|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847439|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847440|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847441|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847442|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847443|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847444|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161847445|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847446|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847447|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
161847448|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847449|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847450|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847451|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847452|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847453|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847454|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847455|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847456|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847457|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847458|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161847459|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847460|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847461|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
161847462|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847463|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847464|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847465|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847466|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847467|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847468|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847469|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847470|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162033008|NCT04078178|585178566|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
161847471|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161847472|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
162033009|NCT05710185|585178567|FG000|Overall Study|Adverse Event|1|||
161971192|NCT01185964|584941059|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
161759764|NCT02201251|584158393|FG001|Overall Study|Protocol Violation|0|||
161759765|NCT02201251|584158392|FG000|Overall Study|Noncompliance with Study Drug|0|||
161759766|NCT02201251|584158393|FG001|Overall Study|Noncompliance with Study Drug|1|||
161759767|NCT02201251|584158392|FG000|Overall Study|Withdrawal by Subject|2|||
161759768|NCT02201251|584158393|FG001|Overall Study|Withdrawal by Subject|1|||
161759769|NCT01197794|584158396|FG000|Overall Study|Adverse Event|3|||
161759770|NCT01197794|584158397|FG001|Overall Study|Adverse Event|2|||
161759771|NCT01197794|584158398|FG002|Overall Study|Adverse Event|4|||
161759772|NCT01197794|584158399|FG003|Overall Study|Adverse Event|4|||
161759773|NCT01197794|584158400|FG004|Overall Study|Adverse Event|4|||
161759774|NCT01197794|584158401|FG005|Overall Study|Adverse Event|2|||
161759775|NCT01197794|584158402|FG006|Overall Study|Adverse Event|3|||
161759776|NCT01197794|584158396|FG000|Overall Study|Protocol Violation|0|||
161759777|NCT01197794|584158397|FG001|Overall Study|Protocol Violation|0|||
161759778|NCT01197794|584158398|FG002|Overall Study|Protocol Violation|0|||
161759779|NCT01197794|584158399|FG003|Overall Study|Protocol Violation|0|||
161759780|NCT01197794|584158400|FG004|Overall Study|Protocol Violation|2|||
161759781|NCT01197794|584158401|FG005|Overall Study|Protocol Violation|0|||
161759782|NCT01197794|584158402|FG006|Overall Study|Protocol Violation|1|||
161759783|NCT01197794|584158396|FG000|Overall Study|Development of study withdrawal criteria|3|||
161759784|NCT01197794|584158397|FG001|Overall Study|Development of study withdrawal criteria|0|||
161759785|NCT01197794|584158398|FG002|Overall Study|Development of study withdrawal criteria|0|||
161759786|NCT01197794|584158399|FG003|Overall Study|Development of study withdrawal criteria|1|||
161759787|NCT01197794|584158400|FG004|Overall Study|Development of study withdrawal criteria|0|||
161759788|NCT01197794|584158401|FG005|Overall Study|Development of study withdrawal criteria|0|||
161759789|NCT01197794|584158402|FG006|Overall Study|Development of study withdrawal criteria|1|||
161759790|NCT01197794|584158396|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
161759791|NCT01197794|584158397|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
161759792|NCT01197794|584158398|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
161759793|NCT01197794|584158399|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
161759794|NCT01197794|584158400|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
161759795|NCT01197794|584158401|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
161759796|NCT01197794|584158402|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
161759797|NCT01197794|584158396|FG000|Overall Study|Withdrawal by Subject|3|||
161759798|NCT01197794|584158397|FG001|Overall Study|Withdrawal by Subject|3|||
161759799|NCT01197794|584158398|FG002|Overall Study|Withdrawal by Subject|4|||
161759800|NCT01197794|584158399|FG003|Overall Study|Withdrawal by Subject|1|||
161759801|NCT01197794|584158400|FG004|Overall Study|Withdrawal by Subject|1|||
161759802|NCT01197794|584158401|FG005|Overall Study|Withdrawal by Subject|5|||
161759803|NCT01197794|584158402|FG006|Overall Study|Withdrawal by Subject|6|||
161759804|NCT01197794|584158396|FG000|Overall Study|Lost to Follow-up|1|||
161759805|NCT01197794|584158397|FG001|Overall Study|Lost to Follow-up|1|||
161759806|NCT01197794|584158398|FG002|Overall Study|Lost to Follow-up|0|||
161759807|NCT01197794|584158399|FG003|Overall Study|Lost to Follow-up|1|||
161759808|NCT01197794|584158400|FG004|Overall Study|Lost to Follow-up|0|||
161759809|NCT01197794|584158401|FG005|Overall Study|Lost to Follow-up|1|||
161759810|NCT01197794|584158402|FG006|Overall Study|Lost to Follow-up|0|||
161759811|NCT01197794|584158396|FG000|Overall Study|Other|1|||
161759812|NCT01197794|584158397|FG001|Overall Study|Other|1|||
161759813|NCT01197794|584158398|FG002|Overall Study|Other|3|||
161759814|NCT01197794|584158399|FG003|Overall Study|Other|0|||
161759815|NCT01197794|584158400|FG004|Overall Study|Other|2|||
161759816|NCT01197794|584158401|FG005|Overall Study|Other|2|||
161759817|NCT01197794|584158402|FG006|Overall Study|Other|4|||
161759818|NCT04055844|584158403|FG000|Overall Study|Adverse Event|12|||
161759819|NCT04055844|584158403|FG000|Overall Study|Poor Performance|1|||
161759820|NCT04055844|584158403|FG000|Overall Study|Death|1|||
161759821|NCT00572728|584158404|FG000|Overall Study|Withdrawal by Subject|10|||
161759822|NCT00572728|584158404|FG000|Overall Study|Ineligible|3|||
161759823|NCT00572728|584158404|FG000|Overall Study|Enrolled under Amendment 4|5|||
161759824|NCT00572728|584158404|FG000|Overall Study|Offstudy due to complicating disease|1|||
161759825|NCT00572728|584158404|FG000|Overall Study|FLT1 not completed|4|||
161759826|NCT00572728|584158404|FG000|Overall Study|First Chemotherapy not initiated|2|||
161759827|NCT00572728|584158404|FG000|Overall Study|FLT2 not completed|5|||
161759828|NCT00572728|584158404|FG000|Overall Study|Second chemotherapy not initiated|1|||
161759829|NCT00572728|584158404|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
161759830|NCT00572728|584158404|FG000|Overall Study|Pathology missing|1|||
161759831|NCT01833806|584158411|FG000|Overall Study|Alternative treatment|2|||
161759832|NCT01833806|584158411|FG000|Overall Study|Death|5|||
161759833|NCT01833806|584158411|FG000|Overall Study|Physician Decision|1|||
161759834|NCT01833806|584158411|FG000|Overall Study|Lost to Follow-up|1|||
161759835|NCT03231228|584158418|FG000|Overall Study|Lost to Follow-up|2|||
161759836|NCT03231228|584158419|FG001|Overall Study|Lost to Follow-up|0|||
161759837|NCT03231228|584158418|FG000|Overall Study|Physician Decision|1|||
161759838|NCT03231228|584158419|FG001|Overall Study|Physician Decision|0|||
161759839|NCT01868594|584158420|FG000|Overall Study|Do not meet inclusion criteria|4|||
161759840|NCT01868594|584158421|FG001|Overall Study|Do not meet inclusion criteria|3|||
161759841|NCT04490057|584158422|FG000|Stage 1|Death|1|||
161759842|NCT04490057|584158423|FG001|Stage 1|Death|2|||
161759843|NCT04490057|584158424|FG002|Stage 1|Death|0|||
161759844|NCT04490057|584158425|FG003|Stage 1|Death|0|||
161759845|NCT04490057|584158426|FG004|Stage 1|Death|0|||
161759846|NCT04490057|584158427|FG005|Stage 1|Death|0|||
161759847|NCT04490057|584158428|FG006|Stage 1|Death|0|||
161759848|NCT04490057|584158429|FG007|Stage 1|Death|0|||
161759849|NCT04490057|584158422|FG000|Stage 1|Withdrawal by Subject|2|||
161759850|NCT04490057|584158423|FG001|Stage 1|Withdrawal by Subject|0|||
161759851|NCT04490057|584158424|FG002|Stage 1|Withdrawal by Subject|0|||
161759852|NCT04490057|584158425|FG003|Stage 1|Withdrawal by Subject|0|||
161759853|NCT04490057|584158426|FG004|Stage 1|Withdrawal by Subject|0|||
161759854|NCT04490057|584158427|FG005|Stage 1|Withdrawal by Subject|0|||
161759855|NCT04490057|584158428|FG006|Stage 1|Withdrawal by Subject|0|||
161759856|NCT04490057|584158429|FG007|Stage 1|Withdrawal by Subject|0|||
161759857|NCT04490057|584158422|FG000|Stage 2|Death|0|||
161759858|NCT04490057|584158423|FG001|Stage 2|Death|0|||
161759859|NCT04490057|584158424|FG002|Stage 2|Death|0|||
161759860|NCT04490057|584158425|FG003|Stage 2|Death|0|||
161759861|NCT04490057|584158426|FG004|Stage 2|Death|1|||
161759862|NCT04490057|584158427|FG005|Stage 2|Death|0|||
161759863|NCT04490057|584158428|FG006|Stage 2|Death|0|||
161759864|NCT04490057|584158429|FG007|Stage 2|Death|0|||
161759865|NCT04490057|584158422|FG000|Stage 2|Lost to Follow-up|0|||
161759866|NCT04490057|584158423|FG001|Stage 2|Lost to Follow-up|0|||
161759867|NCT04490057|584158424|FG002|Stage 2|Lost to Follow-up|0|||
161759868|NCT04490057|584158425|FG003|Stage 2|Lost to Follow-up|11|||
161759869|NCT04490057|584158426|FG004|Stage 2|Lost to Follow-up|17|||
161759870|NCT04490057|584158427|FG005|Stage 2|Lost to Follow-up|4|||
161759871|NCT04490057|584158428|FG006|Stage 2|Lost to Follow-up|21|||
161759872|NCT04490057|584158429|FG007|Stage 2|Lost to Follow-up|14|||
161759873|NCT02598661|584158432|FG000|Overall Study|Death|27|||
161759874|NCT02598661|584158433|FG001|Overall Study|Death|34|||
161759875|NCT02598661|584158434|FG002|Overall Study|Death|14|||
161759876|NCT02598661|584158435|FG003|Overall Study|Death|1|||
161759877|NCT02598661|584158436|FG004|Overall Study|Death|0|||
161759878|NCT02598661|584158432|FG000|Overall Study|Lost to Follow-up|2|||
161759879|NCT02598661|584158433|FG001|Overall Study|Lost to Follow-up|3|||
161759880|NCT02598661|584158434|FG002|Overall Study|Lost to Follow-up|2|||
161759881|NCT02598661|584158435|FG003|Overall Study|Lost to Follow-up|0|||
161971193|NCT01185964|584941060|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
162033010|NCT05710185|585178567|FG000|Overall Study|Lack of Efficacy|1|||
161759882|NCT02598661|584158436|FG004|Overall Study|Lost to Follow-up|0|||
161759883|NCT02598661|584158432|FG000|Overall Study|Withdrawal by Subject|13|||
161759884|NCT02598661|584158433|FG001|Overall Study|Withdrawal by Subject|24|||
161759885|NCT02598661|584158434|FG002|Overall Study|Withdrawal by Subject|14|||
161759886|NCT02598661|584158435|FG003|Overall Study|Withdrawal by Subject|1|||
161759887|NCT02598661|584158436|FG004|Overall Study|Withdrawal by Subject|1|||
161759888|NCT02598661|584158432|FG000|Overall Study|Adverse Event|0|||
161759889|NCT02598661|584158433|FG001|Overall Study|Adverse Event|0|||
161759890|NCT02598661|584158434|FG002|Overall Study|Adverse Event|1|||
161759891|NCT02598661|584158435|FG003|Overall Study|Adverse Event|0|||
161759892|NCT02598661|584158436|FG004|Overall Study|Adverse Event|0|||
161759893|NCT02598661|584158432|FG000|Overall Study|Randomized, Never Treated|0|||
161759894|NCT02598661|584158433|FG001|Overall Study|Randomized, Never Treated|0|||
161759895|NCT02598661|584158434|FG002|Overall Study|Randomized, Never Treated|0|||
161759896|NCT02598661|584158435|FG003|Overall Study|Randomized, Never Treated|0|||
161759897|NCT02598661|584158436|FG004|Overall Study|Randomized, Never Treated|1|||
161759898|NCT03053180|584160194|FG000|Overall Study|Failure to Return|1|||
161759899|NCT01465958|584160199|FG000|Run-in Phase|Protocol Violation|1|||
161759900|NCT01465958|584160200|FG001|Run-in Phase|Protocol Violation|0|||
161759901|NCT01465958|584160199|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
161759902|NCT01465958|584160200|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
161759903|NCT00211536|584160203|FG000|Overall Study|Withdrawal by Subject|2|||
161759904|NCT00211536|584160204|FG001|Overall Study|Withdrawal by Subject|2|||
161759905|NCT00211536|584160203|FG000|Overall Study|Physician Decision|0|||
161759906|NCT00211536|584160204|FG001|Overall Study|Physician Decision|5|||
161759907|NCT00211536|584160203|FG000|Overall Study|Adverse Event|2|||
161759908|NCT00211536|584160204|FG001|Overall Study|Adverse Event|0|||
161759909|NCT02583399|584160205|FG000|Overall Study|Able to be discharged|3|||
161759910|NCT02583399|584160205|FG000|Overall Study|Wanted to use a restricted medication|3|||
161759911|NCT00718887|584160206|FG000|Overall Study|Withdrawal by Subject|3|||
161759912|NCT00718887|584160207|FG001|Overall Study|Withdrawal by Subject|2|||
161759913|NCT00718887|584160206|FG000|Overall Study|Not identified|2|||
161759914|NCT00718887|584160207|FG001|Overall Study|Not identified|7|||
161759915|NCT03557801|584160210|FG000|Overall Study|Protocol Violation|1|||
161759916|NCT03557801|584160211|FG001|Overall Study|Protocol Violation|0|||
161759917|NCT03557801|584160212|FG002|Overall Study|Protocol Violation|0|||
161759918|NCT03557801|584160210|FG000|Overall Study|Withdrawal by Subject|1|||
161759919|NCT03557801|584160211|FG001|Overall Study|Withdrawal by Subject|0|||
161759920|NCT03557801|584160212|FG002|Overall Study|Withdrawal by Subject|3|||
161759921|NCT03557801|584160210|FG000|Overall Study|Lost to Follow-up|0|||
161759922|NCT03557801|584160211|FG001|Overall Study|Lost to Follow-up|1|||
161759923|NCT03557801|584160212|FG002|Overall Study|Lost to Follow-up|0|||
161759924|NCT00535236|584160213|FG000|Overall Study|Adverse Event|1|||
161759925|NCT00535236|584160214|FG001|Overall Study|Adverse Event|0|||
161759926|NCT00535236|584160215|FG002|Overall Study|Adverse Event|9|||
161759927|NCT00535236|584160216|FG003|Overall Study|Adverse Event|3|||
161759928|NCT00535236|584160217|FG004|Overall Study|Adverse Event|3|||
161759929|NCT00535236|584160218|FG005|Overall Study|Adverse Event|0|||
161759930|NCT00535236|584160219|FG006|Overall Study|Adverse Event|5|||
161759931|NCT00535236|584160220|FG007|Overall Study|Adverse Event|1|||
161759932|NCT00535236|584160221|FG008|Overall Study|Adverse Event|2|||
161759933|NCT00535236|584160222|FG009|Overall Study|Adverse Event|1|||
161759934|NCT00535236|584160213|FG000|Overall Study|Lost to Follow-up|1|||
161759935|NCT00535236|584160214|FG001|Overall Study|Lost to Follow-up|2|||
161759936|NCT00535236|584160215|FG002|Overall Study|Lost to Follow-up|0|||
161759937|NCT00535236|584160216|FG003|Overall Study|Lost to Follow-up|0|||
161759938|NCT00535236|584160217|FG004|Overall Study|Lost to Follow-up|2|||
161759939|NCT00535236|584160218|FG005|Overall Study|Lost to Follow-up|0|||
161759940|NCT00535236|584160219|FG006|Overall Study|Lost to Follow-up|0|||
161759941|NCT00535236|584160220|FG007|Overall Study|Lost to Follow-up|0|||
161759942|NCT00535236|584160221|FG008|Overall Study|Lost to Follow-up|6|||
161759943|NCT00535236|584160222|FG009|Overall Study|Lost to Follow-up|1|||
161759944|NCT00535236|584160213|FG000|Overall Study|Physician Decision|0|||
161759945|NCT00535236|584160214|FG001|Overall Study|Physician Decision|0|||
161759946|NCT00535236|584160215|FG002|Overall Study|Physician Decision|0|||
161759947|NCT00535236|584160216|FG003|Overall Study|Physician Decision|0|||
161759948|NCT00535236|584160217|FG004|Overall Study|Physician Decision|1|||
161759949|NCT00535236|584160218|FG005|Overall Study|Physician Decision|0|||
161759950|NCT00535236|584160219|FG006|Overall Study|Physician Decision|1|||
161759951|NCT00535236|584160220|FG007|Overall Study|Physician Decision|0|||
161759952|NCT00535236|584160221|FG008|Overall Study|Physician Decision|0|||
161759953|NCT00535236|584160222|FG009|Overall Study|Physician Decision|0|||
161759954|NCT00535236|584160213|FG000|Overall Study|Protocol Violation|2|||
161759955|NCT00535236|584160214|FG001|Overall Study|Protocol Violation|0|||
161759956|NCT00535236|584160215|FG002|Overall Study|Protocol Violation|1|||
161759957|NCT00535236|584160216|FG003|Overall Study|Protocol Violation|0|||
161759958|NCT00535236|584160217|FG004|Overall Study|Protocol Violation|0|||
161759959|NCT00535236|584160218|FG005|Overall Study|Protocol Violation|0|||
161759960|NCT00535236|584160219|FG006|Overall Study|Protocol Violation|0|||
161759961|NCT00535236|584160220|FG007|Overall Study|Protocol Violation|0|||
161759962|NCT00535236|584160221|FG008|Overall Study|Protocol Violation|1|||
161759963|NCT00535236|584160222|FG009|Overall Study|Protocol Violation|0|||
161759964|NCT00535236|584160213|FG000|Overall Study|Withdrawal by Subject|3|||
161759965|NCT00535236|584160214|FG001|Overall Study|Withdrawal by Subject|0|||
161759966|NCT00535236|584160215|FG002|Overall Study|Withdrawal by Subject|2|||
161759967|NCT00535236|584160216|FG003|Overall Study|Withdrawal by Subject|1|||
161759968|NCT00535236|584160217|FG004|Overall Study|Withdrawal by Subject|6|||
161759969|NCT00535236|584160218|FG005|Overall Study|Withdrawal by Subject|1|||
161759970|NCT00535236|584160219|FG006|Overall Study|Withdrawal by Subject|5|||
161759971|NCT00535236|584160220|FG007|Overall Study|Withdrawal by Subject|0|||
161759972|NCT00535236|584160221|FG008|Overall Study|Withdrawal by Subject|4|||
161759973|NCT00535236|584160222|FG009|Overall Study|Withdrawal by Subject|2|||
161759974|NCT03558503|584160223|FG000|Overall Study|Adverse Event|1|||
161759975|NCT03558503|584160223|FG000|Overall Study|Death|1|||
161759976|NCT03558503|584160223|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
161759977|NCT00561795|584160224|FG000|Overall Study|Adverse Event|3|||
161759978|NCT00561795|584160225|FG001|Overall Study|Adverse Event|3|||
161759979|NCT00561795|584160226|FG002|Overall Study|Adverse Event|0|||
161759980|NCT00561795|584160227|FG003|Overall Study|Adverse Event|0|||
161759981|NCT00561795|584160224|FG000|Overall Study|Study Closed/Terminated|0|||
161759982|NCT00561795|584160225|FG001|Overall Study|Study Closed/Terminated|3|||
161759983|NCT00561795|584160226|FG002|Overall Study|Study Closed/Terminated|0|||
161759984|NCT00561795|584160227|FG003|Overall Study|Study Closed/Terminated|0|||
161759985|NCT00561795|584160224|FG000|Overall Study|Physician Decision|1|||
161759986|NCT00561795|584160225|FG001|Overall Study|Physician Decision|0|||
161759987|NCT00561795|584160226|FG002|Overall Study|Physician Decision|0|||
161759988|NCT00561795|584160227|FG003|Overall Study|Physician Decision|0|||
161759989|NCT04564027|584160230|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
161759990|NCT04564027|584160231|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
161759991|NCT04564027|584160232|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
161759992|NCT04564027|584160233|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
161759993|NCT05827978|584160234|FG000|Overall Study|Adverse Event|1|||
161759994|NCT05827978|584160235|FG001|Overall Study|Adverse Event|0|||
161759995|NCT05827978|584160236|FG002|Overall Study|Adverse Event|0|||
161759996|NCT05827978|584160237|FG003|Overall Study|Adverse Event|1|||
161759997|NCT05827978|584160238|FG004|Overall Study|Adverse Event|0|||
161759998|NCT05827978|584160239|FG005|Overall Study|Adverse Event|0|||
162033011|NCT05313009|585178568|FG000|Overall Study|Death|1|||
161759999|NCT05827978|584160234|FG000|Overall Study|Death|1|||
161760000|NCT05827978|584160235|FG001|Overall Study|Death|5|||
161760001|NCT05827978|584160236|FG002|Overall Study|Death|2|||
161760002|NCT05827978|584160237|FG003|Overall Study|Death|3|||
161760003|NCT05827978|584160238|FG004|Overall Study|Death|1|||
161760004|NCT05827978|584160239|FG005|Overall Study|Death|3|||
161760005|NCT05827978|584160234|FG000|Overall Study|Lost to Follow-up|57|||
161760006|NCT05827978|584160235|FG001|Overall Study|Lost to Follow-up|88|||
161760007|NCT05827978|584160236|FG002|Overall Study|Lost to Follow-up|54|||
161760008|NCT05827978|584160237|FG003|Overall Study|Lost to Follow-up|47|||
161760009|NCT05827978|584160238|FG004|Overall Study|Lost to Follow-up|25|||
161760010|NCT05827978|584160239|FG005|Overall Study|Lost to Follow-up|10|||
161760011|NCT05827978|584160234|FG000|Overall Study|Noncompliance with Study Procedures|0|||
161760012|NCT05827978|584160235|FG001|Overall Study|Noncompliance with Study Procedures|1|||
161760013|NCT05827978|584160236|FG002|Overall Study|Noncompliance with Study Procedures|1|||
161760014|NCT05827978|584160237|FG003|Overall Study|Noncompliance with Study Procedures|1|||
161760015|NCT05827978|584160238|FG004|Overall Study|Noncompliance with Study Procedures|1|||
161760016|NCT05827978|584160239|FG005|Overall Study|Noncompliance with Study Procedures|0|||
161760017|NCT05827978|584160234|FG000|Overall Study|Physician Decision|2|||
161760018|NCT05827978|584160235|FG001|Overall Study|Physician Decision|0|||
161760019|NCT05827978|584160236|FG002|Overall Study|Physician Decision|1|||
161760020|NCT05827978|584160237|FG003|Overall Study|Physician Decision|2|||
161760021|NCT05827978|584160238|FG004|Overall Study|Physician Decision|1|||
161760022|NCT05827978|584160239|FG005|Overall Study|Physician Decision|1|||
161760023|NCT05827978|584160234|FG000|Overall Study|Protocol Violation|5|||
161760024|NCT05827978|584160235|FG001|Overall Study|Protocol Violation|2|||
161760025|NCT05827978|584160236|FG002|Overall Study|Protocol Violation|0|||
161760026|NCT05827978|584160237|FG003|Overall Study|Protocol Violation|0|||
161760027|NCT05827978|584160238|FG004|Overall Study|Protocol Violation|0|||
161760028|NCT05827978|584160239|FG005|Overall Study|Protocol Violation|0|||
161760029|NCT05827978|584160234|FG000|Overall Study|Withdrawal by Subject|17|||
161760030|NCT05827978|584160235|FG001|Overall Study|Withdrawal by Subject|16|||
161760031|NCT05827978|584160236|FG002|Overall Study|Withdrawal by Subject|10|||
161760032|NCT05827978|584160237|FG003|Overall Study|Withdrawal by Subject|12|||
161760033|NCT05827978|584160238|FG004|Overall Study|Withdrawal by Subject|10|||
161760034|NCT05827978|584160239|FG005|Overall Study|Withdrawal by Subject|9|||
161760035|NCT05827978|584160234|FG000|Overall Study|Other Than Specified|0|||
161760036|NCT05827978|584160235|FG001|Overall Study|Other Than Specified|0|||
161760037|NCT05827978|584160236|FG002|Overall Study|Other Than Specified|1|||
161760038|NCT05827978|584160237|FG003|Overall Study|Other Than Specified|0|||
161760039|NCT05827978|584160238|FG004|Overall Study|Other Than Specified|2|||
161760040|NCT05827978|584160239|FG005|Overall Study|Other Than Specified|0|||
161760041|NCT04566445|584160240|FG000|Overall Study|Death|4|||
161760042|NCT04566445|584160241|FG001|Overall Study|Death|1|||
161760043|NCT04566445|584160242|FG002|Overall Study|Death|1|||
161760044|NCT04566445|584160240|FG000|Overall Study|Lost to Follow-up|3|||
161760045|NCT04566445|584160241|FG001|Overall Study|Lost to Follow-up|1|||
161760046|NCT04566445|584160242|FG002|Overall Study|Lost to Follow-up|1|||
161760047|NCT04566445|584160240|FG000|Overall Study|Study terminated by sponsor|11|||
161760048|NCT04566445|584160241|FG001|Overall Study|Study terminated by sponsor|17|||
161760049|NCT04566445|584160242|FG002|Overall Study|Study terminated by sponsor|32|||
161760050|NCT04566445|584160240|FG000|Overall Study|Withdrawal by Subject|12|||
161760051|NCT04566445|584160241|FG001|Overall Study|Withdrawal by Subject|14|||
161760052|NCT04566445|584160242|FG002|Overall Study|Withdrawal by Subject|13|||
161760053|NCT04566445|584160240|FG000|Overall Study|Randomized but not treated due to AE|2|||
161760054|NCT04566445|584160241|FG001|Overall Study|Randomized but not treated due to AE|1|||
161760055|NCT04566445|584160242|FG002|Overall Study|Randomized but not treated due to AE|0|||
161971194|NCT01185964|584941057|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
161971195|NCT01185964|584941058|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
161971196|NCT01185964|584941059|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
161971197|NCT01185964|584941060|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
161971198|NCT01185964|584941057|FG000|Phase 1b and Phase 2|Adverse Event|1|||
161760056|NCT04566445|584160240|FG000|Overall Study|Adverse Event|1|||
161760057|NCT04566445|584160241|FG001|Overall Study|Adverse Event|1|||
161760058|NCT04566445|584160242|FG002|Overall Study|Adverse Event|0|||
161760059|NCT04785144|584160243|FG000|Overall Study|Withdrawal by Subject|4|||
161760060|NCT04785144|584160244|FG001|Overall Study|Withdrawal by Subject|1|||
161760061|NCT04785144|584160245|FG002|Overall Study|Withdrawal by Subject|0|||
161760062|NCT04785144|584160246|FG003|Overall Study|Withdrawal by Subject|0|||
161760063|NCT04785144|584160247|FG004|Overall Study|Withdrawal by Subject|0|||
161760064|NCT04785144|584160248|FG005|Overall Study|Withdrawal by Subject|2|||
161760065|NCT04785144|584160249|FG006|Overall Study|Withdrawal by Subject|2|||
161760066|NCT04785144|584160250|FG007|Overall Study|Withdrawal by Subject|0|||
161760067|NCT04785144|584160251|FG008|Overall Study|Withdrawal by Subject|1|||
161760068|NCT04785144|584160252|FG009|Overall Study|Withdrawal by Subject|0|||
161760069|NCT04785144|584160243|FG000|Overall Study|Lost to Follow-up|1|||
161760070|NCT04785144|584160244|FG001|Overall Study|Lost to Follow-up|0|||
161760071|NCT04785144|584160245|FG002|Overall Study|Lost to Follow-up|0|||
161760072|NCT04785144|584160246|FG003|Overall Study|Lost to Follow-up|0|||
161760073|NCT04785144|584160247|FG004|Overall Study|Lost to Follow-up|1|||
161760074|NCT04785144|584160248|FG005|Overall Study|Lost to Follow-up|2|||
161760075|NCT04785144|584160249|FG006|Overall Study|Lost to Follow-up|1|||
161760076|NCT04785144|584160250|FG007|Overall Study|Lost to Follow-up|2|||
161760077|NCT04785144|584160251|FG008|Overall Study|Lost to Follow-up|4|||
161760078|NCT04785144|584160252|FG009|Overall Study|Lost to Follow-up|1|||
161760079|NCT04785144|584160243|FG000|Overall Study|Protocol Violation|0|||
161760080|NCT04785144|584160244|FG001|Overall Study|Protocol Violation|0|||
161760081|NCT04785144|584160245|FG002|Overall Study|Protocol Violation|0|||
161760082|NCT04785144|584160246|FG003|Overall Study|Protocol Violation|0|||
161760083|NCT04785144|584160247|FG004|Overall Study|Protocol Violation|0|||
161760084|NCT04785144|584160248|FG005|Overall Study|Protocol Violation|0|||
161760085|NCT04785144|584160249|FG006|Overall Study|Protocol Violation|1|||
161760086|NCT04785144|584160250|FG007|Overall Study|Protocol Violation|0|||
161760087|NCT04785144|584160251|FG008|Overall Study|Protocol Violation|0|||
161760088|NCT04785144|584160252|FG009|Overall Study|Protocol Violation|0|||
161760089|NCT04785144|584160243|FG000|Overall Study|Physician Decision|0|||
161760090|NCT04785144|584160244|FG001|Overall Study|Physician Decision|0|||
161760091|NCT04785144|584160245|FG002|Overall Study|Physician Decision|0|||
161760092|NCT04785144|584160246|FG003|Overall Study|Physician Decision|0|||
161760093|NCT04785144|584160247|FG004|Overall Study|Physician Decision|0|||
161760094|NCT04785144|584160248|FG005|Overall Study|Physician Decision|0|||
161760095|NCT04785144|584160249|FG006|Overall Study|Physician Decision|0|||
161760096|NCT04785144|584160250|FG007|Overall Study|Physician Decision|0|||
161760097|NCT04785144|584160251|FG008|Overall Study|Physician Decision|0|||
161760098|NCT04785144|584160252|FG009|Overall Study|Physician Decision|1|||
161760099|NCT04785144|584160243|FG000|Overall Study|Unable to continue due to work schedule|0|||
161760100|NCT04785144|584160244|FG001|Overall Study|Unable to continue due to work schedule|0|||
161760101|NCT04785144|584160245|FG002|Overall Study|Unable to continue due to work schedule|0|||
161760102|NCT04785144|584160246|FG003|Overall Study|Unable to continue due to work schedule|0|||
161760103|NCT04785144|584160247|FG004|Overall Study|Unable to continue due to work schedule|0|||
161760104|NCT04785144|584160248|FG005|Overall Study|Unable to continue due to work schedule|0|||
161760105|NCT04785144|584160249|FG006|Overall Study|Unable to continue due to work schedule|0|||
161760106|NCT04785144|584160250|FG007|Overall Study|Unable to continue due to work schedule|0|||
161760107|NCT04785144|584160251|FG008|Overall Study|Unable to continue due to work schedule|0|||
161760108|NCT04785144|584160252|FG009|Overall Study|Unable to continue due to work schedule|1|||
161760109|NCT00137267|584160255|FG000|Overall Study|Lost to Follow-up|15|||
161760110|NCT00137267|584160256|FG001|Overall Study|Lost to Follow-up|21|||
161760111|NCT02061540|584160260|FG000|Overall Study|Adverse Event|2|||
161760112|NCT02061540|584160260|FG000|Overall Study|Withdrawal by Subject|2|||
161760113|NCT04005755|584160261|FG000|Overall Study|Adverse Event|6|||
161760114|NCT04005755|584160261|FG000|Overall Study|Physician Decision|3|||
161760115|NCT04005755|584160261|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
161760116|NCT04005755|584160261|FG000|Overall Study|Withdrawal by Subject|3|||
161760117|NCT04005755|584160261|FG000|Overall Study|Lost to Follow-up|1|||
161760118|NCT02289833|584160263|FG000|Overall Study|Study discontinuation|0|||
161760119|NCT02289833|584160264|FG001|Overall Study|Study discontinuation|1|||
161760120|NCT02289833|584160263|FG000|Overall Study|Lost to Follow-up|4|||
161760121|NCT02289833|584160264|FG001|Overall Study|Lost to Follow-up|0|||
161760122|NCT02289833|584160263|FG000|Overall Study|Death|23|||
161760123|NCT02289833|584160264|FG001|Overall Study|Death|16|||
161760124|NCT02561273|584160265|FG000|Overall Study|Protocol Violation|1|||
161760125|NCT02561273|584160266|FG001|Overall Study|Protocol Violation|0|||
161760126|NCT02723019|584160267|FG000|Overall Study|Death|17|||
161760127|NCT02723019|584160268|FG001|Overall Study|Death|13|||
161760128|NCT02723019|584160267|FG000|Overall Study|Withdrawal by Subject|11|||
161760129|NCT02723019|584160268|FG001|Overall Study|Withdrawal by Subject|7|||
161760130|NCT02723019|584160267|FG000|Overall Study|Lost to Follow-up|57|||
161760131|NCT02723019|584160268|FG001|Overall Study|Lost to Follow-up|70|||
161760132|NCT00611767|584160270|FG000|Overall Study|Withdrawal by Subject|4|||
161760133|NCT00611767|584160271|FG001|Overall Study|Withdrawal by Subject|1|||
161760134|NCT00611767|584160270|FG000|Overall Study|Thiopental not available|3|||
161760135|NCT00611767|584160271|FG001|Overall Study|Thiopental not available|0|||
161760136|NCT00611767|584160270|FG000|Overall Study|didn't like the medication|1|||
161760137|NCT00611767|584160271|FG001|Overall Study|didn't like the medication|1|||
161760138|NCT00611767|584160270|FG000|Overall Study|Physician Decision|1|||
161760139|NCT00611767|584160271|FG001|Overall Study|Physician Decision|0|||
161760140|NCT01562327|584160276|FG000|Overall Study|Adverse Event|2|||
161760141|NCT01562327|584160276|FG000|Overall Study|Lack of Efficacy|1|||
161760142|NCT01562327|584160276|FG000|Overall Study|Participant drop-out|1|||
161760143|NCT01562327|584160276|FG000|Overall Study|Infusion not received at 6 month window|4|||
161760144|NCT00170846|584160277|FG000|Overall Study|Subject withdrew Informed Consent|5|||
161760145|NCT00170846|584160278|FG001|Overall Study|Subject withdrew Informed Consent|12|||
161760146|NCT00170846|584160279|FG002|Overall Study|Subject withdrew Informed Consent|8|||
161760147|NCT00170846|584160277|FG000|Overall Study|Lost to Follow-up|6|||
161971199|NCT01185964|584941058|FG001|Phase 1b and Phase 2|Adverse Event|0|||
161971200|NCT01185964|584941059|FG002|Phase 1b and Phase 2|Adverse Event|2|||
161971201|NCT01185964|584941060|FG003|Phase 1b and Phase 2|Adverse Event|0|||
161971202|NCT01185964|584941057|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
161971203|NCT01185964|584941058|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
161971204|NCT01185964|584941059|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
161971205|NCT01185964|584941060|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
161971206|NCT01185964|584941057|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
161971207|NCT01185964|584941058|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
161971208|NCT01185964|584941059|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
161971209|NCT01185964|584941060|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
161971210|NCT01185964|584941057|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
161971211|NCT01185964|584941058|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
161971212|NCT01185964|584941059|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
161971213|NCT01185964|584941060|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
161971214|NCT01185964|584941057|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
161971215|NCT01185964|584941058|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
161971216|NCT01185964|584941059|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
161971217|NCT01185964|584941060|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
161971218|NCT03576755|584941074|FG000|Overall Study|Withdrawal by Subject|1|||
161971219|NCT03576755|584941075|FG001|Overall Study|Withdrawal by Subject|0|||
161971220|NCT03576755|584941076|FG002|Overall Study|Withdrawal by Subject|0|||
161971221|NCT03576755|584941077|FG003|Overall Study|Withdrawal by Subject|0|||
161971222|NCT04962230|584941078|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
161971223|NCT04962230|584941078|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
161971224|NCT02836873|584941079|FG000|Overall Study|Protocol Violation|0|||
161971225|NCT02836873|584941080|FG001|Overall Study|Protocol Violation|1|||
161760148|NCT00170846|584160278|FG001|Overall Study|Lost to Follow-up|3|||
161760149|NCT00170846|584160279|FG002|Overall Study|Lost to Follow-up|2|||
161760150|NCT00170846|584160277|FG000|Overall Study|Death|0|||
161760151|NCT00170846|584160278|FG001|Overall Study|Death|3|||
161760152|NCT00170846|584160279|FG002|Overall Study|Death|3|||
161760153|NCT00170846|584160277|FG000|Overall Study|Reason Missing|0|||
161760154|NCT00170846|584160278|FG001|Overall Study|Reason Missing|1|||
161760155|NCT00170846|584160279|FG002|Overall Study|Reason Missing|0|||
161760156|NCT02795182|584160288|FG000|Overall Study|Death|5|||
161760157|NCT02795182|584160289|FG001|Overall Study|Death|4|||
161760158|NCT02795182|584160290|FG002|Overall Study|Death|4|||
161760159|NCT02795182|584160291|FG003|Overall Study|Death|18|||
161760160|NCT02795182|584160288|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
161760161|NCT02795182|584160289|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
161760162|NCT02795182|584160290|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
161760163|NCT02795182|584160291|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
161760164|NCT02795182|584160288|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
161760165|NCT02795182|584160289|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
161760166|NCT02795182|584160290|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
161760167|NCT02795182|584160291|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
161760168|NCT02795182|584160288|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
161760169|NCT02795182|584160289|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
161760170|NCT02795182|584160290|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
161760171|NCT02795182|584160291|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
161760172|NCT02795182|584160288|FG000|Overall Study|Withdrawal by Subject|4|||
161760173|NCT02795182|584160289|FG001|Overall Study|Withdrawal by Subject|0|||
161760174|NCT02795182|584160290|FG002|Overall Study|Withdrawal by Subject|0|||
161760175|NCT02795182|584160291|FG003|Overall Study|Withdrawal by Subject|3|||
161760176|NCT02795182|584160288|FG000|Overall Study|Lost to Follow-up|0|||
161760177|NCT02795182|584160289|FG001|Overall Study|Lost to Follow-up|0|||
161760178|NCT02795182|584160290|FG002|Overall Study|Lost to Follow-up|1|||
161760179|NCT02795182|584160291|FG003|Overall Study|Lost to Follow-up|1|||
161760180|NCT02795182|584160288|FG000|Overall Study|Roll Over to Long Term Extension|3|||
161760181|NCT02795182|584160289|FG001|Overall Study|Roll Over to Long Term Extension|3|||
161760182|NCT02795182|584160290|FG002|Overall Study|Roll Over to Long Term Extension|2|||
161760183|NCT02795182|584160291|FG003|Overall Study|Roll Over to Long Term Extension|5|||
161760184|NCT02795182|584160288|FG000|Overall Study|Progressive Disease|0|||
161760185|NCT02795182|584160289|FG001|Overall Study|Progressive Disease|1|||
161760186|NCT02795182|584160290|FG002|Overall Study|Progressive Disease|0|||
161847473|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161971226|NCT02836873|584941079|FG000|Overall Study|Adverse Event|1|||
161971227|NCT02836873|584941080|FG001|Overall Study|Adverse Event|4|||
161847474|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847475|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
161847476|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
161847477|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847478|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847479|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847480|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847481|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847482|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847483|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847484|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847485|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847486|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161847487|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847488|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847489|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847490|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
161847491|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847492|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847493|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847494|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847495|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847496|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847497|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847498|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847499|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847500|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161847501|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847502|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847503|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
161847504|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
161847505|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847506|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847507|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847508|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847509|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847510|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847511|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847512|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847513|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847514|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161847515|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847516|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847517|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847518|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847519|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847520|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847521|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847522|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847523|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
161847524|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847525|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847526|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847527|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847528|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161847529|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847530|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847531|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847532|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847533|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847534|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847535|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847536|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
162033012|NCT05313009|585178569|FG001|Overall Study|Death|0|||
161760187|NCT02795182|584160291|FG003|Overall Study|Progressive Disease|4|||
161760188|NCT02795182|584160288|FG000|Overall Study|Physician Decision|0|||
161760189|NCT02795182|584160289|FG001|Overall Study|Physician Decision|0|||
161760190|NCT02795182|584160290|FG002|Overall Study|Physician Decision|0|||
161760191|NCT02795182|584160291|FG003|Overall Study|Physician Decision|1|||
161760192|NCT02724111|584160292|FG000|Overall Study|Protocol Violation|2|||
161760193|NCT02724111|584160293|FG001|Overall Study|Protocol Violation|5|||
161760194|NCT02996500|584160294|FG000|Overall Study|Adverse Event|1|||
161760195|NCT02996500|584160295|FG001|Overall Study|Adverse Event|1|||
161760196|NCT02996500|584160296|FG002|Overall Study|Adverse Event|4|||
161760197|NCT02996500|584160297|FG003|Overall Study|Adverse Event|3|||
161760198|NCT02996500|584160298|FG004|Overall Study|Adverse Event|1|||
161760199|NCT02996500|584160299|FG005|Overall Study|Adverse Event|2|||
161760200|NCT02996500|584160294|FG000|Overall Study|Lack of Efficacy|0|||
161760201|NCT02996500|584160295|FG001|Overall Study|Lack of Efficacy|0|||
161760202|NCT02996500|584160296|FG002|Overall Study|Lack of Efficacy|0|||
161760203|NCT02996500|584160297|FG003|Overall Study|Lack of Efficacy|0|||
161760204|NCT02996500|584160298|FG004|Overall Study|Lack of Efficacy|2|||
161760205|NCT02996500|584160299|FG005|Overall Study|Lack of Efficacy|0|||
161760206|NCT02996500|584160294|FG000|Overall Study|Lost to Follow-up|1|||
161760207|NCT02996500|584160295|FG001|Overall Study|Lost to Follow-up|0|||
161760208|NCT02996500|584160296|FG002|Overall Study|Lost to Follow-up|0|||
161760209|NCT02996500|584160297|FG003|Overall Study|Lost to Follow-up|0|||
161760210|NCT02996500|584160298|FG004|Overall Study|Lost to Follow-up|0|||
161760211|NCT02996500|584160299|FG005|Overall Study|Lost to Follow-up|1|||
161760212|NCT02996500|584160294|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161760213|NCT02996500|584160295|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161760214|NCT02996500|584160296|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
161760215|NCT02996500|584160297|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
161760216|NCT02996500|584160298|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
161760217|NCT02996500|584160299|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
161760218|NCT02996500|584160294|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161760219|NCT02996500|584160295|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161760220|NCT02996500|584160296|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161760221|NCT02996500|584160297|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161760222|NCT02996500|584160298|FG004|Overall Study|Non-Compliance With Study Drug|0|||
161760223|NCT02996500|584160299|FG005|Overall Study|Non-Compliance With Study Drug|1|||
161760224|NCT02996500|584160294|FG000|Overall Study|Progressive Disease|1|||
161760225|NCT02996500|584160295|FG001|Overall Study|Progressive Disease|0|||
161760226|NCT02996500|584160296|FG002|Overall Study|Progressive Disease|0|||
161760227|NCT02996500|584160297|FG003|Overall Study|Progressive Disease|0|||
161760228|NCT02996500|584160298|FG004|Overall Study|Progressive Disease|0|||
161760229|NCT02996500|584160299|FG005|Overall Study|Progressive Disease|0|||
161760230|NCT02996500|584160294|FG000|Overall Study|Other|2|||
161760231|NCT02996500|584160295|FG001|Overall Study|Other|0|||
161760232|NCT02996500|584160296|FG002|Overall Study|Other|2|||
161760233|NCT02996500|584160297|FG003|Overall Study|Other|0|||
161760234|NCT02996500|584160298|FG004|Overall Study|Other|0|||
161760235|NCT02996500|584160299|FG005|Overall Study|Other|0|||
161760236|NCT02996500|584160294|FG000|Overall Study|Protocol Violation|0|||
161760237|NCT02996500|584160295|FG001|Overall Study|Protocol Violation|0|||
161760238|NCT02996500|584160296|FG002|Overall Study|Protocol Violation|0|||
161760239|NCT02996500|584160297|FG003|Overall Study|Protocol Violation|1|||
161760240|NCT02996500|584160298|FG004|Overall Study|Protocol Violation|0|||
161760241|NCT02996500|584160299|FG005|Overall Study|Protocol Violation|0|||
161760242|NCT02996500|584160294|FG000|Overall Study|Withdrawal by Subject|3|||
161760243|NCT02996500|584160295|FG001|Overall Study|Withdrawal by Subject|0|||
161760244|NCT02996500|584160296|FG002|Overall Study|Withdrawal by Subject|3|||
161760245|NCT02996500|584160297|FG003|Overall Study|Withdrawal by Subject|0|||
161760246|NCT02996500|584160298|FG004|Overall Study|Withdrawal by Subject|2|||
161760247|NCT02996500|584160299|FG005|Overall Study|Withdrawal by Subject|0|||
161760248|NCT02187224|584160300|FG000|Overall Study|Did not show up for test day|1|||
161760249|NCT02187224|584160301|FG001|Overall Study|Did not show up for test day|0|||
161760250|NCT01010776|584160302|FG000|Main Phase|Withdrawal by Subject|14|||
161760251|NCT01010776|584160302|FG000|Main Phase|Lack of Efficacy|8|||
161760252|NCT01010776|584160302|FG000|Main Phase|Adverse Event|7|||
161760253|NCT01010776|584160302|FG000|Main Phase|Lost to Follow-up|6|||
161971228|NCT02836873|584941079|FG000|Overall Study|Withdrawal by Subject|2|||
161760254|NCT01010776|584160302|FG000|Main Phase|Non-compliance to study medication|5|||
161760255|NCT01010776|584160302|FG000|Main Phase|Selection failure|2|||
161760256|NCT01010776|584160302|FG000|Main Phase|Inform consent withdrawal|1|||
161760257|NCT01010776|584160302|FG000|Main Phase|Other|1|||
161760258|NCT01010776|584160302|FG000|Main Phase|Did not received study medication|5|||
161760259|NCT01010776|584160302|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
161760260|NCT01010776|584160302|FG000|Extension Phase|Other|3|||
161760261|NCT02332876|584160303|FG000|Overall Study|Lost to Follow-up|1|||
161760262|NCT02332876|584160304|FG001|Overall Study|Lost to Follow-up|1|||
161760263|NCT02573012|584160308|FG000|Overall Study|Adverse Event|5|||
161760264|NCT02573012|584160309|FG001|Overall Study|Adverse Event|5|||
161760265|NCT02573012|584160308|FG000|Overall Study|Lack of Efficacy|5|||
161760266|NCT02573012|584160309|FG001|Overall Study|Lack of Efficacy|4|||
161760267|NCT02573012|584160308|FG000|Overall Study|Non-compliance|1|||
161760268|NCT02573012|584160309|FG001|Overall Study|Non-compliance|2|||
161760269|NCT02573012|584160308|FG000|Overall Study|Withdrawal by Subject|2|||
161760270|NCT02573012|584160309|FG001|Overall Study|Withdrawal by Subject|2|||
161760271|NCT02573012|584160308|FG000|Overall Study|Study Ended per Protocol|1|||
161760272|NCT02573012|584160309|FG001|Overall Study|Study Ended per Protocol|0|||
161760273|NCT02573012|584160308|FG000|Overall Study|Physician Decision|1|||
161760274|NCT02573012|584160309|FG001|Overall Study|Physician Decision|2|||
161760275|NCT00882362|584160310|FG000|Overall Study|Adverse Event|13|||
161760276|NCT00882362|584160311|FG001|Overall Study|Adverse Event|10|||
161760277|NCT00882362|584160310|FG000|Overall Study|Withdrawal by Subject|13|||
161760278|NCT00882362|584160311|FG001|Overall Study|Withdrawal by Subject|10|||
161760279|NCT00882362|584160310|FG000|Overall Study|Lack of Efficacy|3|||
161760280|NCT00882362|584160311|FG001|Overall Study|Lack of Efficacy|0|||
161760281|NCT00882362|584160310|FG000|Overall Study|Protocol Violation|7|||
161760282|NCT00882362|584160311|FG001|Overall Study|Protocol Violation|2|||
161760283|NCT00882362|584160310|FG000|Overall Study|Pregnancy|1|||
161760284|NCT00882362|584160311|FG001|Overall Study|Pregnancy|0|||
161760285|NCT00882362|584160310|FG000|Overall Study|Physician Decision|5|||
161760286|NCT00882362|584160311|FG001|Overall Study|Physician Decision|1|||
161760287|NCT00882362|584160310|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
161760288|NCT00882362|584160311|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
161760289|NCT00882362|584160310|FG000|Overall Study|change of residence or other commitments|5|||
161760290|NCT00882362|584160311|FG001|Overall Study|change of residence or other commitments|0|||
161760291|NCT02382276|584160314|FG000|Overall Study|Withdrawal by Subject|4|||
161760292|NCT02382276|584160315|FG001|Overall Study|Withdrawal by Subject|8|||
161760293|NCT02382276|584160316|FG002|Overall Study|Withdrawal by Subject|5|||
161760294|NCT02382276|584160314|FG000|Overall Study|Adverse Event|7|||
161760295|NCT02382276|584160315|FG001|Overall Study|Adverse Event|2|||
161760296|NCT02382276|584160316|FG002|Overall Study|Adverse Event|32|||
161760297|NCT02382276|584160314|FG000|Overall Study|Physician Decision|0|||
161760298|NCT02382276|584160315|FG001|Overall Study|Physician Decision|0|||
161760299|NCT02382276|584160316|FG002|Overall Study|Physician Decision|2|||
161760300|NCT01222416|584160317|FG000|Overall Study|ineligible;metastasis|3|||
161760301|NCT01222416|584160318|FG001|Overall Study|ineligible;metastasis|0|||
161760302|NCT01222416|584160317|FG000|Overall Study|Adverse Event|4|||
161760303|NCT01222416|584160318|FG001|Overall Study|Adverse Event|0|||
161760304|NCT01222416|584160317|FG000|Overall Study|Withdrawal by Subject|5|||
161760305|NCT01222416|584160318|FG001|Overall Study|Withdrawal by Subject|0|||
161760306|NCT01222416|584160317|FG000|Overall Study|scheduling|6|||
161760307|NCT01222416|584160318|FG001|Overall Study|scheduling|0|||
161760308|NCT01222416|584160317|FG000|Overall Study|missed view/scan|1|||
161760309|NCT01222416|584160318|FG001|Overall Study|missed view/scan|0|||
161760310|NCT01222416|584160317|FG000|Overall Study|Death|1|||
161760311|NCT01222416|584160318|FG001|Overall Study|Death|0|||
161760312|NCT03049852|584160332|FG000|Overall Study|Lost to Follow-up|0|||
161760313|NCT03049852|584160333|FG001|Overall Study|Lost to Follow-up|1|||
161760314|NCT03049852|584160334|FG002|Overall Study|Lost to Follow-up|0|||
161760315|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
161760316|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161760317|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161760318|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161760319|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161760320|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161760321|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
161760322|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161760323|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161760324|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161760325|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161760326|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161760327|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
161760328|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161760329|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161760330|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161760331|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161760332|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161760333|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Other|14|||
161760334|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Other|0|||
161760335|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Other|0|||
161760336|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Other|0|||
161760337|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Other|0|||
161760338|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Other|0|||
161760339|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
161760340|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
161760341|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
161760342|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
161760343|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
161760344|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
161760345|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
161760346|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161760347|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161760348|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161760349|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161760350|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161760351|NCT02141854|584160335|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
161760352|NCT02141854|584160336|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161760353|NCT02141854|584160337|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161760354|NCT02141854|584160338|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161760355|NCT02141854|584160339|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161760356|NCT02141854|584160340|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161760357|NCT02141854|584160335|FG000|Treatment Period|Protocol Violation|0|||
161760358|NCT02141854|584160336|FG001|Treatment Period|Protocol Violation|1|||
161760359|NCT02141854|584160337|FG002|Treatment Period|Protocol Violation|0|||
161760360|NCT02141854|584160338|FG003|Treatment Period|Protocol Violation|2|||
161760361|NCT02141854|584160339|FG004|Treatment Period|Protocol Violation|2|||
161760362|NCT02141854|584160340|FG005|Treatment Period|Protocol Violation|1|||
161760363|NCT02141854|584160335|FG000|Treatment Period|Noncompliance|0|||
161760364|NCT02141854|584160336|FG001|Treatment Period|Noncompliance|0|||
161760365|NCT02141854|584160337|FG002|Treatment Period|Noncompliance|0|||
161760366|NCT02141854|584160338|FG003|Treatment Period|Noncompliance|1|||
161760367|NCT02141854|584160339|FG004|Treatment Period|Noncompliance|0|||
161760368|NCT02141854|584160340|FG005|Treatment Period|Noncompliance|0|||
161760369|NCT02141854|584160335|FG000|Treatment Period|Lack of Efficacy|0|||
161760370|NCT02141854|584160336|FG001|Treatment Period|Lack of Efficacy|0|||
161760371|NCT02141854|584160337|FG002|Treatment Period|Lack of Efficacy|0|||
161760372|NCT02141854|584160338|FG003|Treatment Period|Lack of Efficacy|1|||
161760373|NCT02141854|584160339|FG004|Treatment Period|Lack of Efficacy|1|||
161760374|NCT02141854|584160340|FG005|Treatment Period|Lack of Efficacy|7|||
161760375|NCT02141854|584160335|FG000|Treatment Period|Pregnancy|0|||
161760376|NCT02141854|584160336|FG001|Treatment Period|Pregnancy|1|||
161760377|NCT02141854|584160337|FG002|Treatment Period|Pregnancy|0|||
161760378|NCT02141854|584160338|FG003|Treatment Period|Pregnancy|0|||
161760379|NCT02141854|584160339|FG004|Treatment Period|Pregnancy|0|||
161760380|NCT02141854|584160340|FG005|Treatment Period|Pregnancy|0|||
161760381|NCT02141854|584160335|FG000|Treatment Period|Other|0|||
161760382|NCT02141854|584160336|FG001|Treatment Period|Other|1|||
161760383|NCT02141854|584160337|FG002|Treatment Period|Other|2|||
161760384|NCT02141854|584160338|FG003|Treatment Period|Other|0|||
161760385|NCT02141854|584160339|FG004|Treatment Period|Other|1|||
161760386|NCT02141854|584160340|FG005|Treatment Period|Other|2|||
161760387|NCT02141854|584160335|FG000|Treatment Period|Adverse Event|0|||
161760388|NCT02141854|584160336|FG001|Treatment Period|Adverse Event|2|||
161760389|NCT02141854|584160337|FG002|Treatment Period|Adverse Event|2|||
161760390|NCT02141854|584160338|FG003|Treatment Period|Adverse Event|0|||
161760391|NCT02141854|584160339|FG004|Treatment Period|Adverse Event|2|||
161760392|NCT02141854|584160340|FG005|Treatment Period|Adverse Event|2|||
161760393|NCT02141854|584160335|FG000|Treatment Period|Withdrawal by Subject|0|||
161760394|NCT02141854|584160336|FG001|Treatment Period|Withdrawal by Subject|2|||
161760395|NCT02141854|584160337|FG002|Treatment Period|Withdrawal by Subject|3|||
161760396|NCT02141854|584160338|FG003|Treatment Period|Withdrawal by Subject|3|||
161760397|NCT02141854|584160339|FG004|Treatment Period|Withdrawal by Subject|4|||
161760398|NCT02141854|584160340|FG005|Treatment Period|Withdrawal by Subject|7|||
161760399|NCT02141854|584160335|FG000|Treatment Period|Disease progression|0|||
161760400|NCT02141854|584160336|FG001|Treatment Period|Disease progression|2|||
161760401|NCT02141854|584160337|FG002|Treatment Period|Disease progression|1|||
161847537|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
161847538|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847539|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161760402|NCT02141854|584160338|FG003|Treatment Period|Disease progression|3|||
161760403|NCT02141854|584160339|FG004|Treatment Period|Disease progression|0|||
161760404|NCT02141854|584160340|FG005|Treatment Period|Disease progression|18|||
161760405|NCT02141854|584160335|FG000|Treatment Period|Lost to Follow-up|0|||
161760406|NCT02141854|584160336|FG001|Treatment Period|Lost to Follow-up|1|||
161760407|NCT02141854|584160337|FG002|Treatment Period|Lost to Follow-up|1|||
161760408|NCT02141854|584160338|FG003|Treatment Period|Lost to Follow-up|1|||
161760409|NCT02141854|584160339|FG004|Treatment Period|Lost to Follow-up|0|||
161760410|NCT02141854|584160340|FG005|Treatment Period|Lost to Follow-up|1|||
161760411|NCT03258762|584160341|FG000|Overall Study|Lost to Follow-up|0|||
161760412|NCT03258762|584160342|FG001|Overall Study|Lost to Follow-up|1|||
161760413|NCT02545049|584160343|FG000|Overall Study|Withdrawal by Subject|1|||
161760414|NCT02545049|584160344|FG001|Overall Study|Withdrawal by Subject|7|||
161760415|NCT02545049|584160343|FG000|Overall Study|Lost to Follow-up|4|||
161760416|NCT02545049|584160344|FG001|Overall Study|Lost to Follow-up|6|||
161760417|NCT02545049|584160343|FG000|Overall Study|GCP violations|37|||
161760418|NCT02545049|584160344|FG001|Overall Study|GCP violations|48|||
161760419|NCT00027027|584162201|FG000|Overall Study|Adverse Event|0|||
161760420|NCT00027027|584162202|FG001|Overall Study|Adverse Event|0|||
161760421|NCT00027027|584162203|FG002|Overall Study|Adverse Event|1|||
161760422|NCT00027027|584162204|FG003|Overall Study|Adverse Event|0|||
161760423|NCT00027027|584162205|FG004|Overall Study|Adverse Event|1|||
161760424|NCT00027027|584162201|FG000|Overall Study|Admitted for Signs of PD|0|||
161760425|NCT00027027|584162202|FG001|Overall Study|Admitted for Signs of PD|0|||
161760426|NCT00027027|584162203|FG002|Overall Study|Admitted for Signs of PD|0|||
161760427|NCT00027027|584162204|FG003|Overall Study|Admitted for Signs of PD|0|||
161760428|NCT00027027|584162205|FG004|Overall Study|Admitted for Signs of PD|1|||
161760429|NCT00027027|584162201|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
161760430|NCT00027027|584162202|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
161760431|NCT00027027|584162203|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
161760432|NCT00027027|584162204|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
161760433|NCT00027027|584162205|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
161760434|NCT00027027|584162201|FG000|Overall Study|PD Requiring Surgery|0|||
161760435|NCT00027027|584162202|FG001|Overall Study|PD Requiring Surgery|0|||
161760436|NCT00027027|584162203|FG002|Overall Study|PD Requiring Surgery|1|||
161760437|NCT00027027|584162204|FG003|Overall Study|PD Requiring Surgery|0|||
161760438|NCT00027027|584162205|FG004|Overall Study|PD Requiring Surgery|0|||
161760439|NCT00027027|584162201|FG000|Overall Study|Physician Decision Due To PD|2|||
161847540|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847541|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847542|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161847543|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847544|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847545|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847546|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847547|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847548|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847549|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847550|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847551|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
161847552|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847553|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847554|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847555|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847556|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161847557|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847558|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847559|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847560|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847561|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847562|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847563|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847564|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847565|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
161847566|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847567|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847568|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847569|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847570|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161847571|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847572|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847573|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161760440|NCT00027027|584162202|FG001|Overall Study|Physician Decision Due To PD|3|||
161760441|NCT00027027|584162203|FG002|Overall Study|Physician Decision Due To PD|2|||
161760442|NCT00027027|584162204|FG003|Overall Study|Physician Decision Due To PD|3|||
161760443|NCT00027027|584162205|FG004|Overall Study|Physician Decision Due To PD|5|||
161760444|NCT00027027|584162201|FG000|Overall Study|Withdrawal by Subject|0|||
161760445|NCT00027027|584162202|FG001|Overall Study|Withdrawal by Subject|0|||
161760446|NCT00027027|584162203|FG002|Overall Study|Withdrawal by Subject|0|||
161760447|NCT00027027|584162204|FG003|Overall Study|Withdrawal by Subject|0|||
161971229|NCT02836873|584941080|FG001|Overall Study|Withdrawal by Subject|2|||
161971230|NCT02836873|584941079|FG000|Overall Study|Lost to Follow-up|1|||
161760448|NCT00027027|584162205|FG004|Overall Study|Withdrawal by Subject|1|||
161760449|NCT02306148|584162210|FG000|Overall Study|Adverse Event|12|||
161760450|NCT02306148|584162211|FG001|Overall Study|Adverse Event|6|||
161760451|NCT02306148|584162210|FG000|Overall Study|Lost to Follow-up|1|||
161760452|NCT02306148|584162211|FG001|Overall Study|Lost to Follow-up|4|||
161760453|NCT04397757|584162212|FG000|Overall Study|Death|3|||
161760454|NCT04397757|584162213|FG001|Overall Study|Death|11|||
161760455|NCT04397757|584162212|FG000|Overall Study|Withdrawal by Subject|2|||
161760456|NCT04397757|584162213|FG001|Overall Study|Withdrawal by Subject|0|||
161760457|NCT04397757|584162212|FG000|Overall Study|Lost to Follow-up|4|||
161760458|NCT04397757|584162213|FG001|Overall Study|Lost to Follow-up|3|||
161971231|NCT02836873|584941080|FG001|Overall Study|Lost to Follow-up|3|||
161760459|NCT04657003|584162220|FG000|Overall Study|Adverse Event|5|||
161760460|NCT04657003|584162221|FG001|Overall Study|Adverse Event|1|||
161760461|NCT04657003|584162222|FG002|Overall Study|Adverse Event|5|||
161760462|NCT04657003|584162220|FG000|Overall Study|Death|0|||
161760463|NCT04657003|584162221|FG001|Overall Study|Death|2|||
161760464|NCT04657003|584162222|FG002|Overall Study|Death|0|||
161760465|NCT04657003|584162220|FG000|Overall Study|Lost to Follow-up|8|||
161760466|NCT04657003|584162221|FG001|Overall Study|Lost to Follow-up|4|||
161760467|NCT04657003|584162222|FG002|Overall Study|Lost to Follow-up|10|||
161760468|NCT04657003|584162220|FG000|Overall Study|Other - As Reported by Investigator|3|||
161760469|NCT04657003|584162221|FG001|Overall Study|Other - As Reported by Investigator|2|||
161760470|NCT04657003|584162222|FG002|Overall Study|Other - As Reported by Investigator|2|||
161760471|NCT04657003|584162220|FG000|Overall Study|Pregnancy|2|||
161760472|NCT04657003|584162221|FG001|Overall Study|Pregnancy|0|||
161760473|NCT04657003|584162222|FG002|Overall Study|Pregnancy|2|||
161760474|NCT04657003|584162220|FG000|Overall Study|Withdrawal by Subject|16|||
161760475|NCT04657003|584162221|FG001|Overall Study|Withdrawal by Subject|7|||
161760476|NCT04657003|584162222|FG002|Overall Study|Withdrawal by Subject|10|||
161760477|NCT05158244|584162225|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
161760478|NCT05158244|584162226|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
161760479|NCT05158244|584162227|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
161760480|NCT05158244|584162228|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
161760481|NCT05158244|584162229|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
161760482|NCT05158244|584162225|FG000|Overall Study|Withdrawal by Subject|0|||
161760483|NCT05158244|584162226|FG001|Overall Study|Withdrawal by Subject|0|||
161760484|NCT05158244|584162227|FG002|Overall Study|Withdrawal by Subject|1|||
161760485|NCT05158244|584162228|FG003|Overall Study|Withdrawal by Subject|0|||
161760486|NCT05158244|584162229|FG004|Overall Study|Withdrawal by Subject|0|||
161760487|NCT02408016|584162231|FG000|Overall Study|Death|6|||
161760488|NCT02408016|584162232|FG001|Overall Study|Death|1|||
161760489|NCT02408016|584162233|FG002|Overall Study|Death|0|||
161760490|NCT02408016|584162231|FG000|Overall Study|Physician Decision|0|||
161760491|NCT02408016|584162232|FG001|Overall Study|Physician Decision|2|||
161760492|NCT02408016|584162233|FG002|Overall Study|Physician Decision|0|||
161760493|NCT00775138|584162234|FG000|Overall Study|Withdrawal by Subject|0|||
161760494|NCT00775138|584162235|FG001|Overall Study|Withdrawal by Subject|0|||
161760495|NCT00775138|584162236|FG002|Overall Study|Withdrawal by Subject|2|||
161760496|NCT00775138|584162237|FG003|Overall Study|Withdrawal by Subject|2|||
161760497|NCT00775138|584162234|FG000|Overall Study|Adverse Event|0|||
161760498|NCT00775138|584162235|FG001|Overall Study|Adverse Event|0|||
161760499|NCT00775138|584162236|FG002|Overall Study|Adverse Event|1|||
161760500|NCT00775138|584162237|FG003|Overall Study|Adverse Event|0|||
161760501|NCT00712712|584162240|FG000|Overall Study|Protocol Violation|11|||
161760502|NCT00712712|584162240|FG000|Overall Study|Radiofrequency not done|3|||
161760503|NCT00712712|584162240|FG000|Overall Study|Death|8|||
161760504|NCT00712712|584162240|FG000|Overall Study|Withdrawal by Subject|1|||
161760505|NCT00958191|584162247|FG000|Overall Study|Death|4|||
161760506|NCT00958191|584162247|FG000|Overall Study|Lost to Follow-up|5|||
161760507|NCT00958191|584162247|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
161760508|NCT00958191|584162247|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
161760509|NCT00958191|584162247|FG000|Overall Study|Revision of study device|4|||
161760510|NCT00958191|584162247|FG000|Overall Study|Site termination|11|||
161760511|NCT00958191|584162247|FG000|Overall Study|No 5 yr x-rays|56|||
161760512|NCT01642004|584162248|FG000|Randomization|Adverse Event unrelated to study drug|1|||
161760513|NCT01642004|584162249|FG001|Randomization|Adverse Event unrelated to study drug|0|||
161971232|NCT02836873|584941079|FG000|Overall Study|Physician Decision|0|||
161971233|NCT02836873|584941080|FG001|Overall Study|Physician Decision|1|||
161760514|NCT01642004|584162248|FG000|Randomization|Participant withdrew consent|1|||
161971234|NCT02836873|584941079|FG000|Overall Study|Other|1|||
161760515|NCT01642004|584162249|FG001|Randomization|Participant withdrew consent|6|||
161760516|NCT01642004|584162248|FG000|Randomization|No longer meets study criteria|2|||
161760517|NCT01642004|584162249|FG001|Randomization|No longer meets study criteria|2|||
161760518|NCT01642004|584162248|FG000|Treatment|Disease progression|95|||
161760519|NCT01642004|584162249|FG001|Treatment|Disease progression|79|||
161760520|NCT01642004|584162248|FG000|Treatment|Study drug toxicity|10|||
161760521|NCT01642004|584162249|FG001|Treatment|Study drug toxicity|13|||
161760522|NCT01642004|584162248|FG000|Treatment|Death|1|||
161760523|NCT01642004|584162249|FG001|Treatment|Death|1|||
161760524|NCT01642004|584162248|FG000|Treatment|Adverse event unrelated to study drug|9|||
161760525|NCT01642004|584162249|FG001|Treatment|Adverse event unrelated to study drug|13|||
161760526|NCT01642004|584162248|FG000|Treatment|Maximum clinical benefit|1|||
161760527|NCT01642004|584162249|FG001|Treatment|Maximum clinical benefit|9|||
161760528|NCT01642004|584162248|FG000|Treatment|Poor/non-compliance|1|||
161760529|NCT01642004|584162249|FG001|Treatment|Poor/non-compliance|0|||
161760530|NCT01642004|584162248|FG000|Treatment|No longer meets study criteria|1|||
161760531|NCT01642004|584162249|FG001|Treatment|No longer meets study criteria|2|||
161760532|NCT01642004|584162248|FG000|Treatment|Other reasons|2|||
161760533|NCT01642004|584162249|FG001|Treatment|Other reasons|0|||
161760534|NCT01642004|584162248|FG000|Treatment|Not reported|0|||
161760535|NCT01642004|584162249|FG001|Treatment|Not reported|3|||
161760536|NCT01642004|584162248|FG000|Treatment|Participant request to discontinue study treatment|6|||
161760537|NCT01642004|584162249|FG001|Treatment|Participant request to discontinue study treatment|4|||
161760538|NCT01642004|584162248|FG000|Treatment|Participant withdrew consent|5|||
161760539|NCT01642004|584162249|FG001|Treatment|Participant withdrew consent|5|||
161760540|NCT02718625|584162250|FG000|Overall Study|Adverse Event|0|||
161760541|NCT02718625|584162251|FG001|Overall Study|Adverse Event|1|||
161760542|NCT02718625|584162250|FG000|Overall Study|Termination of Study by Sponsor|0|||
161760543|NCT02718625|584162251|FG001|Overall Study|Termination of Study by Sponsor|1|||
161760544|NCT01818765|584162254|FG000|Overall Study|Death|2|||
161760545|NCT00811395|584162255|FG000|Extension Treatment|Adverse Event|1|||
161760546|NCT00811395|584162256|FG001|Extension Treatment|Adverse Event|2|||
161760547|NCT00811395|584162257|FG002|Extension Treatment|Adverse Event|2|||
161760548|NCT00811395|584162258|FG003|Extension Treatment|Adverse Event|2|||
161760549|NCT00811395|584162259|FG004|Extension Treatment|Adverse Event|0|||
161760550|NCT00811395|584162260|FG005|Extension Treatment|Adverse Event|1|||
161760551|NCT00811395|584162255|FG000|Extension Treatment|Progressive disease|1|||
161760552|NCT00811395|584162256|FG001|Extension Treatment|Progressive disease|1|||
161760553|NCT00811395|584162257|FG002|Extension Treatment|Progressive disease|0|||
161760554|NCT00811395|584162258|FG003|Extension Treatment|Progressive disease|0|||
161760555|NCT00811395|584162259|FG004|Extension Treatment|Progressive disease|0|||
161760556|NCT00811395|584162260|FG005|Extension Treatment|Progressive disease|0|||
161760557|NCT00811395|584162255|FG000|Extension Treatment|Participant did not wish to continue|0|||
161760558|NCT00811395|584162256|FG001|Extension Treatment|Participant did not wish to continue|3|||
161760559|NCT00811395|584162257|FG002|Extension Treatment|Participant did not wish to continue|0|||
161760560|NCT00811395|584162258|FG003|Extension Treatment|Participant did not wish to continue|1|||
161760561|NCT00811395|584162259|FG004|Extension Treatment|Participant did not wish to continue|0|||
161760562|NCT00811395|584162260|FG005|Extension Treatment|Participant did not wish to continue|1|||
161760563|NCT00811395|584162255|FG000|Extension Treatment|Other than above|0|||
161760564|NCT00811395|584162256|FG001|Extension Treatment|Other than above|0|||
161760565|NCT00811395|584162257|FG002|Extension Treatment|Other than above|1|||
161760566|NCT00811395|584162258|FG003|Extension Treatment|Other than above|0|||
161847574|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161971235|NCT02836873|584941080|FG001|Overall Study|Other|0|||
161971236|NCT00853125|584941089|FG000|Overall Study|Study participant's donor was CMV +|1|||
161760567|NCT00811395|584162259|FG004|Extension Treatment|Other than above|0|||
161760568|NCT00811395|584162260|FG005|Extension Treatment|Other than above|0|||
161760569|NCT01947127|584162261|FG000|Overall Study|Protocol Violation|18|||
161760570|NCT01947127|584162262|FG001|Overall Study|Protocol Violation|38|||
161760571|NCT01947127|584162261|FG000|Overall Study|Withdrawal by Subject|1|||
161760572|NCT01947127|584162262|FG001|Overall Study|Withdrawal by Subject|1|||
161760573|NCT01947127|584162261|FG000|Overall Study|Data loss|4|||
161760574|NCT01947127|584162262|FG001|Overall Study|Data loss|4|||
161760575|NCT01756833|584162265|FG000|Overall Study|Withdrawal by Subject|4|||
161760576|NCT01756833|584162266|FG001|Overall Study|Withdrawal by Subject|3|||
161760577|NCT00952588|584162267|FG000|Overall Study|Death|28|||
161760578|NCT00952588|584162268|FG001|Overall Study|Death|13|||
161760579|NCT00952588|584162267|FG000|Overall Study|Withdrawal by Subject|2|||
161760580|NCT00952588|584162268|FG001|Overall Study|Withdrawal by Subject|5|||
161760581|NCT00952588|584162267|FG000|Overall Study|Adverse Event|2|||
161760582|NCT00952588|584162268|FG001|Overall Study|Adverse Event|3|||
161760583|NCT00952588|584162267|FG000|Overall Study|Lost to Follow-up|2|||
161760584|NCT00952588|584162268|FG001|Overall Study|Lost to Follow-up|0|||
161760585|NCT00952588|584162267|FG000|Overall Study|Physician Decision|0|||
161971237|NCT02914548|584941094|FG000|Overall Study|Adverse Event|15|||
161971238|NCT02914548|584941095|FG001|Overall Study|Adverse Event|7|||
161971239|NCT02914548|584941096|FG002|Overall Study|Adverse Event|15|||
161760586|NCT00952588|584162268|FG001|Overall Study|Physician Decision|1|||
161760587|NCT00952588|584162267|FG000|Overall Study|Lack of Efficacy|2|||
161760588|NCT00952588|584162268|FG001|Overall Study|Lack of Efficacy|2|||
161760589|NCT00808132|584162269|FG000|Overall Study|Adverse Event|34|||
161760590|NCT00808132|584162270|FG001|Overall Study|Adverse Event|33|||
161760591|NCT00808132|584162271|FG002|Overall Study|Adverse Event|16|||
161760592|NCT00808132|584162272|FG003|Overall Study|Adverse Event|31|||
161760593|NCT00808132|584162273|FG004|Overall Study|Adverse Event|33|||
161760594|NCT00808132|584162269|FG000|Overall Study|Death|0|||
161760595|NCT00808132|584162270|FG001|Overall Study|Death|0|||
161760596|NCT00808132|584162271|FG002|Overall Study|Death|0|||
161760597|NCT00808132|584162272|FG003|Overall Study|Death|0|||
161760598|NCT00808132|584162273|FG004|Overall Study|Death|1|||
161760599|NCT00808132|584162269|FG000|Overall Study|Physician Decision|0|||
161760600|NCT00808132|584162270|FG001|Overall Study|Physician Decision|1|||
161760601|NCT00808132|584162271|FG002|Overall Study|Physician Decision|0|||
161760602|NCT00808132|584162272|FG003|Overall Study|Physician Decision|0|||
161760603|NCT00808132|584162273|FG004|Overall Study|Physician Decision|0|||
161760604|NCT00808132|584162269|FG000|Overall Study|Lost to Follow-up|8|||
161760605|NCT00808132|584162270|FG001|Overall Study|Lost to Follow-up|10|||
161760606|NCT00808132|584162271|FG002|Overall Study|Lost to Follow-up|11|||
161760607|NCT00808132|584162272|FG003|Overall Study|Lost to Follow-up|8|||
161760608|NCT00808132|584162273|FG004|Overall Study|Lost to Follow-up|9|||
161760609|NCT00808132|584162269|FG000|Overall Study|Protocol Violation|8|||
161760610|NCT00808132|584162270|FG001|Overall Study|Protocol Violation|9|||
161760611|NCT00808132|584162271|FG002|Overall Study|Protocol Violation|4|||
161760612|NCT00808132|584162272|FG003|Overall Study|Protocol Violation|9|||
161760613|NCT00808132|584162273|FG004|Overall Study|Protocol Violation|5|||
161760614|NCT00808132|584162269|FG000|Overall Study|Withdrawal by Subject|27|||
161760615|NCT00808132|584162270|FG001|Overall Study|Withdrawal by Subject|18|||
161760616|NCT00808132|584162271|FG002|Overall Study|Withdrawal by Subject|2|||
161760617|NCT00808132|584162272|FG003|Overall Study|Withdrawal by Subject|7|||
161760618|NCT00808132|584162273|FG004|Overall Study|Withdrawal by Subject|16|||
161760619|NCT00808132|584162269|FG000|Overall Study|Other|6|||
161760620|NCT00808132|584162270|FG001|Overall Study|Other|4|||
161760621|NCT00808132|584162271|FG002|Overall Study|Other|6|||
161760622|NCT00808132|584162272|FG003|Overall Study|Other|2|||
161760623|NCT00808132|584162273|FG004|Overall Study|Other|15|||
161760624|NCT00808132|584162269|FG000|Overall Study|Randomized, but not treated|10|||
161760625|NCT00808132|584162270|FG001|Overall Study|Randomized, but not treated|7|||
161760626|NCT00808132|584162271|FG002|Overall Study|Randomized, but not treated|9|||
161760627|NCT00808132|584162272|FG003|Overall Study|Randomized, but not treated|8|||
161760628|NCT00808132|584162273|FG004|Overall Study|Randomized, but not treated|9|||
161760629|NCT00808132|584162269|FG000|Overall Study|Unsatisfactory response|5|||
161760630|NCT00808132|584162270|FG001|Overall Study|Unsatisfactory response|6|||
161760631|NCT00808132|584162271|FG002|Overall Study|Unsatisfactory response|6|||
161760632|NCT00808132|584162272|FG003|Overall Study|Unsatisfactory response|4|||
161760633|NCT00808132|584162273|FG004|Overall Study|Unsatisfactory response|12|||
161760634|NCT00887913|584162276|FG000|Overall Study|Withdrawal by Subject|6|||
161760635|NCT01469637|584162277|FG000|First Intervention|Unacceptable behavior|0|||
161760636|NCT01469637|584162278|FG001|First Intervention|Unacceptable behavior|1|||
161760637|NCT01469637|584162277|FG000|Second Intervention|Incarcerated|1|||
161760638|NCT01469637|584162278|FG001|Second Intervention|Incarcerated|0|||
161760639|NCT01371721|584162279|FG000|Overall Study|Adverse Event|5|||
161760640|NCT01371721|584162280|FG001|Overall Study|Adverse Event|4|||
161760641|NCT01371721|584162281|FG002|Overall Study|Adverse Event|5|||
161760642|NCT01371721|584162279|FG000|Overall Study|Protocol Violation|6|||
161760643|NCT01371721|584162280|FG001|Overall Study|Protocol Violation|4|||
161760644|NCT01371721|584162281|FG002|Overall Study|Protocol Violation|5|||
161760645|NCT01371721|584162279|FG000|Overall Study|Lost to Follow-up|8|||
161760646|NCT01371721|584162280|FG001|Overall Study|Lost to Follow-up|2|||
161760647|NCT01371721|584162281|FG002|Overall Study|Lost to Follow-up|6|||
161760648|NCT01371721|584162279|FG000|Overall Study|Withdrawal by Subject|5|||
161760649|NCT01371721|584162280|FG001|Overall Study|Withdrawal by Subject|7|||
161760650|NCT01371721|584162281|FG002|Overall Study|Withdrawal by Subject|11|||
161760651|NCT01371721|584162279|FG000|Overall Study|Other|2|||
161760652|NCT01371721|584162280|FG001|Overall Study|Other|3|||
161760653|NCT01371721|584162281|FG002|Overall Study|Other|0|||
161760654|NCT01371721|584162279|FG000|Overall Study|Lack of Efficacy|2|||
161760655|NCT01371721|584162280|FG001|Overall Study|Lack of Efficacy|4|||
161760656|NCT01371721|584162281|FG002|Overall Study|Lack of Efficacy|3|||
161760657|NCT01371721|584162279|FG000|Overall Study|Randomized but not treated|1|||
161760658|NCT01371721|584162280|FG001|Overall Study|Randomized but not treated|0|||
161760659|NCT01371721|584162281|FG002|Overall Study|Randomized but not treated|0|||
161760660|NCT01055457|584162286|FG000|Overall Study|Lost to Follow-up|0|||
161760661|NCT01055457|584162287|FG001|Overall Study|Lost to Follow-up|1|||
161760662|NCT01055457|584162288|FG002|Overall Study|Lost to Follow-up|0|||
161760663|NCT01055457|584162289|FG003|Overall Study|Lost to Follow-up|0|||
161760664|NCT01055457|584162290|FG004|Overall Study|Lost to Follow-up|0|||
162033013|NCT03269552|585178572|FG000|Overall Study|Adverse Event|2|||
161760665|NCT01055457|584162291|FG005|Overall Study|Lost to Follow-up|1|||
161760666|NCT01055457|584162292|FG006|Overall Study|Lost to Follow-up|0|||
161760667|NCT01055457|584162293|FG007|Overall Study|Lost to Follow-up|0|||
161760668|NCT01055457|584162294|FG008|Overall Study|Lost to Follow-up|0|||
161760669|NCT01055457|584162295|FG009|Overall Study|Lost to Follow-up|0|||
161760670|NCT01055457|584162286|FG000|Overall Study|Protocol Violation|0|||
161760671|NCT01055457|584162287|FG001|Overall Study|Protocol Violation|0|||
161760672|NCT01055457|584162288|FG002|Overall Study|Protocol Violation|1|||
161760673|NCT01055457|584162289|FG003|Overall Study|Protocol Violation|1|||
161760674|NCT01055457|584162290|FG004|Overall Study|Protocol Violation|1|||
161760675|NCT01055457|584162291|FG005|Overall Study|Protocol Violation|2|||
161760676|NCT01055457|584162292|FG006|Overall Study|Protocol Violation|1|||
161760677|NCT01055457|584162293|FG007|Overall Study|Protocol Violation|0|||
161760678|NCT01055457|584162294|FG008|Overall Study|Protocol Violation|0|||
161760679|NCT01055457|584162295|FG009|Overall Study|Protocol Violation|1|||
161760680|NCT01055457|584162286|FG000|Overall Study|Subject Disinterest|0|||
161760681|NCT01055457|584162287|FG001|Overall Study|Subject Disinterest|0|||
161760682|NCT01055457|584162288|FG002|Overall Study|Subject Disinterest|0|||
161760683|NCT01055457|584162289|FG003|Overall Study|Subject Disinterest|0|||
161760684|NCT01055457|584162290|FG004|Overall Study|Subject Disinterest|0|||
161760685|NCT01055457|584162291|FG005|Overall Study|Subject Disinterest|0|||
161760686|NCT01055457|584162292|FG006|Overall Study|Subject Disinterest|0|||
161760687|NCT01055457|584162293|FG007|Overall Study|Subject Disinterest|1|||
161760688|NCT01055457|584162294|FG008|Overall Study|Subject Disinterest|0|||
161760689|NCT01055457|584162295|FG009|Overall Study|Subject Disinterest|0|||
161760690|NCT01055457|584162286|FG000|Overall Study|Subject Ineligible|1|||
161760691|NCT01055457|584162287|FG001|Overall Study|Subject Ineligible|0|||
161760692|NCT01055457|584162288|FG002|Overall Study|Subject Ineligible|1|||
161760693|NCT01055457|584162289|FG003|Overall Study|Subject Ineligible|0|||
161760694|NCT01055457|584162290|FG004|Overall Study|Subject Ineligible|1|||
161760695|NCT01055457|584162291|FG005|Overall Study|Subject Ineligible|0|||
161760696|NCT01055457|584162292|FG006|Overall Study|Subject Ineligible|0|||
161760697|NCT01055457|584162293|FG007|Overall Study|Subject Ineligible|0|||
161760698|NCT01055457|584162294|FG008|Overall Study|Subject Ineligible|0|||
161760699|NCT01055457|584162295|FG009|Overall Study|Subject Ineligible|0|||
161760700|NCT01055457|584162286|FG000|Overall Study|Discomfort|0|||
161760701|NCT01055457|584162287|FG001|Overall Study|Discomfort|0|||
161760702|NCT01055457|584162288|FG002|Overall Study|Discomfort|0|||
161760703|NCT01055457|584162289|FG003|Overall Study|Discomfort|0|||
161760704|NCT01055457|584162290|FG004|Overall Study|Discomfort|1|||
161760705|NCT01055457|584162291|FG005|Overall Study|Discomfort|0|||
161760706|NCT01055457|584162292|FG006|Overall Study|Discomfort|0|||
161760707|NCT01055457|584162293|FG007|Overall Study|Discomfort|0|||
161760708|NCT01055457|584162294|FG008|Overall Study|Discomfort|0|||
161760709|NCT01055457|584162295|FG009|Overall Study|Discomfort|0|||
161760710|NCT01055457|584162286|FG000|Overall Study|Pregnancy|0|||
161760711|NCT01055457|584162287|FG001|Overall Study|Pregnancy|0|||
161760712|NCT01055457|584162288|FG002|Overall Study|Pregnancy|0|||
161760713|NCT01055457|584162289|FG003|Overall Study|Pregnancy|1|||
161760714|NCT01055457|584162290|FG004|Overall Study|Pregnancy|0|||
161760715|NCT01055457|584162291|FG005|Overall Study|Pregnancy|0|||
161760716|NCT01055457|584162292|FG006|Overall Study|Pregnancy|0|||
161760717|NCT01055457|584162293|FG007|Overall Study|Pregnancy|0|||
161760718|NCT01055457|584162294|FG008|Overall Study|Pregnancy|0|||
161760719|NCT01055457|584162295|FG009|Overall Study|Pregnancy|0|||
161760720|NCT01055457|584162286|FG000|Overall Study|Adverse Event|0|||
161760721|NCT01055457|584162287|FG001|Overall Study|Adverse Event|0|||
161760722|NCT01055457|584162288|FG002|Overall Study|Adverse Event|0|||
161760723|NCT01055457|584162289|FG003|Overall Study|Adverse Event|1|||
161760724|NCT01055457|584162290|FG004|Overall Study|Adverse Event|0|||
161760725|NCT01055457|584162291|FG005|Overall Study|Adverse Event|0|||
161760726|NCT01055457|584162292|FG006|Overall Study|Adverse Event|0|||
161760727|NCT01055457|584162293|FG007|Overall Study|Adverse Event|0|||
161760728|NCT01055457|584162294|FG008|Overall Study|Adverse Event|0|||
161760729|NCT01055457|584162295|FG009|Overall Study|Adverse Event|0|||
161847575|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161760730|NCT01347840|584162302|FG000|Overall Study|Withdrawal by Subject|1|||
161760731|NCT00415623|584162306|FG000|Overall Study|Adverse Event|3|||
161760732|NCT00415623|584162307|FG001|Overall Study|Adverse Event|4|||
161760733|NCT00415623|584162306|FG000|Overall Study|Death|1|||
161760734|NCT00415623|584162307|FG001|Overall Study|Death|0|||
161760735|NCT00415623|584162306|FG000|Overall Study|Withdrawal by Subject|1|||
161760736|NCT00415623|584162307|FG001|Overall Study|Withdrawal by Subject|1|||
161760737|NCT01708915|584162310|FG000|Overall Study|Adverse Event|1|||
161760738|NCT01708915|584162311|FG001|Overall Study|Adverse Event|0|||
161760739|NCT01708915|584162312|FG002|Overall Study|Adverse Event|9|||
161760740|NCT01708915|584162313|FG003|Overall Study|Adverse Event|13|||
161760741|NCT01708915|584162310|FG000|Overall Study|Lack of Efficacy|84|||
161760742|NCT01708915|584162311|FG001|Overall Study|Lack of Efficacy|60|||
161760743|NCT01708915|584162312|FG002|Overall Study|Lack of Efficacy|35|||
161760744|NCT01708915|584162313|FG003|Overall Study|Lack of Efficacy|15|||
161760745|NCT01708915|584162310|FG000|Overall Study|Protocol Violation|0|||
161760746|NCT01708915|584162311|FG001|Overall Study|Protocol Violation|0|||
161760747|NCT01708915|584162312|FG002|Overall Study|Protocol Violation|0|||
161760748|NCT01708915|584162313|FG003|Overall Study|Protocol Violation|1|||
161760749|NCT01708915|584162310|FG000|Overall Study|Withdrawal by Subject|0|||
161760750|NCT01708915|584162311|FG001|Overall Study|Withdrawal by Subject|1|||
161760751|NCT01708915|584162312|FG002|Overall Study|Withdrawal by Subject|2|||
161760752|NCT01708915|584162313|FG003|Overall Study|Withdrawal by Subject|2|||
161760753|NCT01708915|584162310|FG000|Overall Study|Other reasons than stated above|1|||
161760754|NCT01708915|584162311|FG001|Overall Study|Other reasons than stated above|1|||
161760755|NCT01708915|584162312|FG002|Overall Study|Other reasons than stated above|0|||
161760756|NCT01708915|584162313|FG003|Overall Study|Other reasons than stated above|2|||
161760757|NCT03267576|584162314|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
161760758|NCT03267576|584162315|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
161760759|NCT03267576|584162314|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
161760760|NCT03267576|584162315|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
161760761|NCT01369069|584162316|FG000|Overall Study|Lost to Follow-up|8|||
161760762|NCT01369069|584162317|FG001|Overall Study|Lost to Follow-up|9|||
161760763|NCT01369069|584162316|FG000|Overall Study|Withdrawal by Subject|9|||
161760764|NCT01369069|584162317|FG001|Overall Study|Withdrawal by Subject|7|||
161760765|NCT01268514|584162321|FG000|Overall Study|Adverse Event|20|||
161760766|NCT01268514|584162321|FG000|Overall Study|Death|8|||
161760767|NCT01268514|584162321|FG000|Overall Study|Lost to Follow-up|5|||
161760768|NCT01268514|584162321|FG000|Overall Study|Withdrawal by Subject|3|||
161760769|NCT01268514|584162321|FG000|Overall Study|Withdrawal by Surgeon|5|||
161760770|NCT02168816|584162324|FG000|Overall Study|Lost to Follow-up|2|||
161760771|NCT02168816|584162325|FG001|Overall Study|Lost to Follow-up|2|||
161760772|NCT02709889|584162328|FG000|Overall Study|Withdrawal by Subject|11|||
161760773|NCT02709889|584162329|FG001|Overall Study|Withdrawal by Subject|10|||
161760774|NCT02709889|584162330|FG002|Overall Study|Withdrawal by Subject|2|||
161760775|NCT02709889|584162331|FG003|Overall Study|Withdrawal by Subject|12|||
161760776|NCT02709889|584162328|FG000|Overall Study|Death|25|||
161760777|NCT02709889|584162329|FG001|Overall Study|Death|38|||
161760778|NCT02709889|584162330|FG002|Overall Study|Death|4|||
161760779|NCT02709889|584162331|FG003|Overall Study|Death|44|||
161760780|NCT02709889|584162328|FG000|Overall Study|Physician Decision|1|||
161760781|NCT02709889|584162329|FG001|Overall Study|Physician Decision|2|||
161760782|NCT02709889|584162330|FG002|Overall Study|Physician Decision|3|||
161760783|NCT02709889|584162331|FG003|Overall Study|Physician Decision|5|||
161760784|NCT02709889|584162328|FG000|Overall Study|Lost to Follow-up|2|||
161760785|NCT02709889|584162329|FG001|Overall Study|Lost to Follow-up|0|||
161760786|NCT02709889|584162330|FG002|Overall Study|Lost to Follow-up|0|||
161760787|NCT02709889|584162331|FG003|Overall Study|Lost to Follow-up|4|||
161760788|NCT02709889|584162328|FG000|Overall Study|Study Terminated by Sponsor|4|||
161760789|NCT02709889|584162329|FG001|Overall Study|Study Terminated by Sponsor|6|||
161760790|NCT02709889|584162330|FG002|Overall Study|Study Terminated by Sponsor|2|||
161760791|NCT02709889|584162331|FG003|Overall Study|Study Terminated by Sponsor|17|||
161760792|NCT02709889|584162328|FG000|Overall Study|Other, Not Specified|0|||
161760793|NCT02709889|584162329|FG001|Overall Study|Other, Not Specified|1|||
161760794|NCT02709889|584162330|FG002|Overall Study|Other, Not Specified|1|||
161760795|NCT02709889|584162331|FG003|Overall Study|Other, Not Specified|6|||
161760796|NCT01066546|584162332|FG000|Overall Study|Study terminated by sponsor|5|||
161760797|NCT00125268|584162337|FG000|Overall Study|Withdrawal by Subject|1|||
161760798|NCT00125268|584162338|FG001|Overall Study|Withdrawal by Subject|1|||
161760799|NCT00925522|584162339|FG000|Overall Study|study closed -- business decision|20|||
161760800|NCT02561572|584162344|FG000|Overall Study|Inadequate time before surgery|2|||
161760801|NCT02561572|584162345|FG001|Overall Study|Inadequate time before surgery|1|||
161760802|NCT02561572|584162344|FG000|Overall Study|Protocol Violation|0|||
161760803|NCT02561572|584162345|FG001|Overall Study|Protocol Violation|1|||
161760804|NCT02691468|584162346|FG000|Overall Study|Bronchial blocker use|2|||
161760805|NCT02691468|584162347|FG001|Overall Study|Bronchial blocker use|1|||
161760806|NCT02691468|584162346|FG000|Overall Study|Lost to Follow-up|2|||
161760807|NCT02691468|584162347|FG001|Overall Study|Lost to Follow-up|1|||
161760808|NCT02691468|584162346|FG000|Overall Study|Failure to advance FOB|2|||
161760809|NCT02691468|584162347|FG001|Overall Study|Failure to advance FOB|0|||
161760810|NCT01190020|584162350|FG000|Overall Study|Adverse Event|2|||
161760811|NCT01190020|584162351|FG001|Overall Study|Adverse Event|0|||
161847576|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847577|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161971240|NCT02914548|584941094|FG000|Overall Study|Physician Decision|2|||
161760812|NCT01190020|584162350|FG000|Overall Study|Lost to Follow-up|2|||
161760813|NCT01190020|584162351|FG001|Overall Study|Lost to Follow-up|0|||
161760814|NCT01190020|584162350|FG000|Overall Study|Withdrawal by Subject|3|||
161760815|NCT01190020|584162351|FG001|Overall Study|Withdrawal by Subject|0|||
161760816|NCT00656799|584162356|FG000|Overall Study|Death|2|||
161760817|NCT02422186|584162357|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
161760818|NCT02422186|584162358|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
161760819|NCT02422186|584162357|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
161760820|NCT02422186|584162358|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
161760821|NCT02422186|584162357|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
161760822|NCT02422186|584162358|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
161760823|NCT02422186|584162357|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
161760824|NCT02422186|584162358|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
161760825|NCT02422186|584162357|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
161760826|NCT02422186|584162358|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
161760827|NCT02422186|584162357|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
161760828|NCT02422186|584162358|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
161760829|NCT02422186|584162357|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
161760830|NCT02422186|584162358|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
161760831|NCT02422186|584162357|FG000|Follow-up Phase (2 Weeks)|Other|3|||
161760832|NCT02422186|584162358|FG001|Follow-up Phase (2 Weeks)|Other|0|||
161760833|NCT05281094|584162359|FG000|Overall Study|Adverse Event|1|||
161760834|NCT05281094|584162360|FG001|Overall Study|Adverse Event|0|||
161760835|NCT05281094|584162359|FG000|Overall Study|Lost to Follow-up|29|||
161760836|NCT05281094|584162360|FG001|Overall Study|Lost to Follow-up|22|||
161760837|NCT05281094|584162359|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
161760838|NCT05281094|584162360|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
161760839|NCT05281094|584162359|FG000|Overall Study|Death|1|||
161760840|NCT05281094|584162360|FG001|Overall Study|Death|2|||
161760841|NCT05281094|584162359|FG000|Overall Study|Not pre-specified reason|8|||
161760842|NCT05281094|584162360|FG001|Overall Study|Not pre-specified reason|5|||
161760843|NCT04191096|584162361|FG000|Overall Study|Death|102|||
161760844|NCT04191096|584162362|FG001|Overall Study|Death|89|||
161760845|NCT04191096|584162361|FG000|Overall Study|Lost to Follow-up|1|||
161760846|NCT04191096|584162362|FG001|Overall Study|Lost to Follow-up|1|||
161760847|NCT04191096|584162361|FG000|Overall Study|Withdrawal by Subject|5|||
161760848|NCT04191096|584162362|FG001|Overall Study|Withdrawal by Subject|5|||
161760849|NCT04191096|584162361|FG000|Overall Study|Participants Ongoing|518|||
161760850|NCT04191096|584162362|FG001|Overall Study|Participants Ongoing|530|||
161760851|NCT02683668|584162366|FG000|Period 2|Withdrawal by Subject|0|||
161760852|NCT02683668|584162367|FG001|Period 2|Withdrawal by Subject|1|||
161760853|NCT02683668|584162368|FG002|Period 2|Withdrawal by Subject|0|||
161760854|NCT02390167|584164583|FG000|Overall Study|Lost to Follow-up|1|||
161760855|NCT01265719|584164585|FG000|Overall Study|Does not meet entrance criteria|0|||
161760856|NCT01265719|584164586|FG001|Overall Study|Does not meet entrance criteria|3|||
161760857|NCT01265719|584164585|FG000|Overall Study|Other reasons|2|||
161760858|NCT01265719|584164586|FG001|Overall Study|Other reasons|0|||
161760859|NCT01265719|584164585|FG000|Overall Study|Withdrawal by Subject|8|||
161760860|NCT01265719|584164586|FG001|Overall Study|Withdrawal by Subject|3|||
161760861|NCT01265719|584164585|FG000|Overall Study|Lost to Follow-up|2|||
161760862|NCT01265719|584164586|FG001|Overall Study|Lost to Follow-up|7|||
161760863|NCT01265719|584164585|FG000|Overall Study|Adverse Event|2|||
161760864|NCT01265719|584164586|FG001|Overall Study|Adverse Event|0|||
161760865|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
161760866|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
161760867|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
161760868|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
161760869|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
161760870|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
161760871|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
161760872|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
161760873|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Death|0|||
161760874|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Death|0|||
161760875|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Death|0|||
161760876|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Death|1|||
161760877|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Death|1|||
161760878|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Death|0|||
161760879|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Death|2|||
161760880|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Death|0|||
161760881|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161760882|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161760883|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161760884|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
161760885|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161847578|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847579|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
161760886|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161760887|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161760888|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161760889|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161760890|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161760891|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161760892|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
161760893|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161760894|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161971241|NCT02914548|584941095|FG001|Overall Study|Physician Decision|2|||
161971242|NCT02914548|584941096|FG002|Overall Study|Physician Decision|0|||
161971243|NCT02914548|584941094|FG000|Overall Study|Protocol Violation|1|||
161971244|NCT02914548|584941095|FG001|Overall Study|Protocol Violation|0|||
161971245|NCT02914548|584941096|FG002|Overall Study|Protocol Violation|0|||
161760895|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161971246|NCT02914548|584941094|FG000|Overall Study|Withdrawal by Subject|3|||
161971247|NCT02914548|584941095|FG001|Overall Study|Withdrawal by Subject|4|||
161760896|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161760897|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161760898|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161760899|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161760900|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
161760901|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161760902|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
161760903|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161760904|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
161760905|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161760906|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161760907|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161760908|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
161760909|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161760910|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
161760911|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
161760912|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161760913|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161760914|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161760915|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161760916|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161760917|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
161760918|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161760919|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
161760920|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
161760921|NCT02442765|584164587|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161760922|NCT02442765|584164588|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161760923|NCT02442765|584164589|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161760924|NCT02442765|584164590|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161760925|NCT02442765|584164591|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
161760926|NCT02442765|584164592|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161760927|NCT02442765|584164593|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161760928|NCT02442765|584164594|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
161760929|NCT00003389|584164595|FG000|Overall Study|Disease progression|6|||
161760930|NCT00003389|584164596|FG001|Overall Study|Disease progression|1|||
161760931|NCT00003389|584164595|FG000|Overall Study|Adverse Event|13|||
161760932|NCT00003389|584164596|FG001|Overall Study|Adverse Event|2|||
161760933|NCT00003389|584164595|FG000|Overall Study|Death|0|||
161760934|NCT00003389|584164596|FG001|Overall Study|Death|3|||
161760935|NCT00003389|584164595|FG000|Overall Study|Withdrawal by Subject|12|||
161760936|NCT00003389|584164596|FG001|Overall Study|Withdrawal by Subject|5|||
161760937|NCT00003389|584164595|FG000|Overall Study|Alternative therapy|2|||
161760938|NCT00003389|584164596|FG001|Overall Study|Alternative therapy|1|||
161760939|NCT00003389|584164595|FG000|Overall Study|Complicating disease|1|||
161760940|NCT00003389|584164596|FG001|Overall Study|Complicating disease|0|||
161760941|NCT00003389|584164595|FG000|Overall Study|Off-treatment reason missing|31|||
161760942|NCT00003389|584164596|FG001|Overall Study|Off-treatment reason missing|21|||
161760943|NCT00003389|584164595|FG000|Overall Study|Ineligible|33|||
161760944|NCT00003389|584164596|FG001|Overall Study|Ineligible|27|||
161760945|NCT02554721|584164597|FG000|Overall Study|Adverse Event|1|||
161760946|NCT02554721|584164598|FG001|Overall Study|Adverse Event|0|||
161760947|NCT02554721|584164599|FG002|Overall Study|Adverse Event|0|||
161760948|NCT02554721|584164600|FG003|Overall Study|Adverse Event|0|||
161760949|NCT02554721|584164601|FG004|Overall Study|Adverse Event|1|||
161760950|NCT02554721|584164597|FG000|Overall Study|Noncompliance|0|||
161760951|NCT02554721|584164598|FG001|Overall Study|Noncompliance|0|||
161760952|NCT02554721|584164599|FG002|Overall Study|Noncompliance|0|||
161760953|NCT02554721|584164600|FG003|Overall Study|Noncompliance|0|||
161971248|NCT02914548|584941096|FG002|Overall Study|Withdrawal by Subject|4|||
161971249|NCT02914548|584941094|FG000|Overall Study|>40% of body surface area|0|||
161847580|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161971250|NCT02914548|584941095|FG001|Overall Study|>40% of body surface area|1|||
162033014|NCT02186301|585178573|FG000|Overall Study|Progressive Disease|7|||
162033015|NCT02186301|585178574|FG001|Overall Study|Progressive Disease|22|||
162033016|NCT02186301|585178575|FG002|Overall Study|Progressive Disease|27|||
162033017|NCT02186301|585178573|FG000|Overall Study|Adverse Event|5|||
161760954|NCT02554721|584164601|FG004|Overall Study|Noncompliance|1|||
161760955|NCT01693562|584164604|FG000|Escalation Phase|Withdrawal by Subject|0|||
161760956|NCT01693562|584164605|FG001|Escalation Phase|Withdrawal by Subject|1|||
161760957|NCT01693562|584164606|FG002|Escalation Phase|Withdrawal by Subject|0|||
161760958|NCT01693562|584164607|FG003|Escalation Phase|Withdrawal by Subject|0|||
161760959|NCT01693562|584164608|FG004|Escalation Phase|Withdrawal by Subject|0|||
161760960|NCT01693562|584164609|FG005|Escalation Phase|Withdrawal by Subject|2|||
161760961|NCT01693562|584164610|FG006|Escalation Phase|Withdrawal by Subject|0|||
161760962|NCT01693562|584164611|FG007|Escalation Phase|Withdrawal by Subject|0|||
161760963|NCT01693562|584164612|FG008|Escalation Phase|Withdrawal by Subject|0|||
161760964|NCT01693562|584164613|FG009|Escalation Phase|Withdrawal by Subject|0|||
161760965|NCT01693562|584164614|FG010|Escalation Phase|Withdrawal by Subject|0|||
161760966|NCT01693562|584164615|FG011|Escalation Phase|Withdrawal by Subject|0|||
161760967|NCT01693562|584164616|FG012|Escalation Phase|Withdrawal by Subject|0|||
161760968|NCT01693562|584164617|FG013|Escalation Phase|Withdrawal by Subject|0|||
161760969|NCT01693562|584164618|FG014|Escalation Phase|Withdrawal by Subject|0|||
161760970|NCT01693562|584164619|FG015|Escalation Phase|Withdrawal by Subject|0|||
161760971|NCT01693562|584164620|FG016|Escalation Phase|Withdrawal by Subject|0|||
161760972|NCT01693562|584164621|FG017|Escalation Phase|Withdrawal by Subject|0|||
161760973|NCT01693562|584164622|FG018|Escalation Phase|Withdrawal by Subject|0|||
161760974|NCT01693562|584164623|FG019|Escalation Phase|Withdrawal by Subject|0|||
161760975|NCT01693562|584164624|FG020|Escalation Phase|Withdrawal by Subject|0|||
161760976|NCT01693562|584164625|FG021|Escalation Phase|Withdrawal by Subject|0|||
161760977|NCT01693562|584164626|FG022|Escalation Phase|Withdrawal by Subject|0|||
161760978|NCT01693562|584164604|FG000|Escalation Phase|Death|4|||
161760979|NCT01693562|584164605|FG001|Escalation Phase|Death|2|||
161760980|NCT01693562|584164606|FG002|Escalation Phase|Death|0|||
161760981|NCT01693562|584164607|FG003|Escalation Phase|Death|3|||
161760982|NCT01693562|584164608|FG004|Escalation Phase|Death|6|||
161760983|NCT01693562|584164609|FG005|Escalation Phase|Death|4|||
161760984|NCT01693562|584164610|FG006|Escalation Phase|Death|0|||
161760985|NCT01693562|584164611|FG007|Escalation Phase|Death|0|||
161760986|NCT01693562|584164612|FG008|Escalation Phase|Death|0|||
161760987|NCT01693562|584164613|FG009|Escalation Phase|Death|0|||
161760988|NCT01693562|584164614|FG010|Escalation Phase|Death|0|||
161760989|NCT01693562|584164615|FG011|Escalation Phase|Death|0|||
161760990|NCT01693562|584164616|FG012|Escalation Phase|Death|0|||
161760991|NCT01693562|584164617|FG013|Escalation Phase|Death|0|||
161760992|NCT01693562|584164618|FG014|Escalation Phase|Death|0|||
161760993|NCT01693562|584164619|FG015|Escalation Phase|Death|0|||
161760994|NCT01693562|584164620|FG016|Escalation Phase|Death|0|||
161760995|NCT01693562|584164621|FG017|Escalation Phase|Death|0|||
161760996|NCT01693562|584164622|FG018|Escalation Phase|Death|0|||
161760997|NCT01693562|584164623|FG019|Escalation Phase|Death|0|||
161760998|NCT01693562|584164624|FG020|Escalation Phase|Death|0|||
161760999|NCT01693562|584164625|FG021|Escalation Phase|Death|0|||
161761000|NCT01693562|584164626|FG022|Escalation Phase|Death|0|||
161761001|NCT01693562|584164604|FG000|Escalation Phase|Lost to Follow-up|0|||
161761002|NCT01693562|584164605|FG001|Escalation Phase|Lost to Follow-up|1|||
161761003|NCT01693562|584164606|FG002|Escalation Phase|Lost to Follow-up|1|||
161761004|NCT01693562|584164607|FG003|Escalation Phase|Lost to Follow-up|0|||
161761005|NCT01693562|584164608|FG004|Escalation Phase|Lost to Follow-up|0|||
161761006|NCT01693562|584164609|FG005|Escalation Phase|Lost to Follow-up|0|||
161761007|NCT01693562|584164610|FG006|Escalation Phase|Lost to Follow-up|0|||
161761008|NCT01693562|584164611|FG007|Escalation Phase|Lost to Follow-up|0|||
161761009|NCT01693562|584164612|FG008|Escalation Phase|Lost to Follow-up|0|||
161761010|NCT01693562|584164613|FG009|Escalation Phase|Lost to Follow-up|0|||
161761011|NCT01693562|584164614|FG010|Escalation Phase|Lost to Follow-up|0|||
161761012|NCT01693562|584164615|FG011|Escalation Phase|Lost to Follow-up|0|||
161761013|NCT01693562|584164616|FG012|Escalation Phase|Lost to Follow-up|0|||
161761014|NCT01693562|584164617|FG013|Escalation Phase|Lost to Follow-up|0|||
161761015|NCT01693562|584164618|FG014|Escalation Phase|Lost to Follow-up|0|||
162033018|NCT02186301|585178574|FG001|Overall Study|Adverse Event|5|||
162033019|NCT02186301|585178575|FG002|Overall Study|Adverse Event|5|||
161761016|NCT01693562|584164619|FG015|Escalation Phase|Lost to Follow-up|0|||
161761017|NCT01693562|584164620|FG016|Escalation Phase|Lost to Follow-up|0|||
161761018|NCT01693562|584164621|FG017|Escalation Phase|Lost to Follow-up|0|||
161761019|NCT01693562|584164622|FG018|Escalation Phase|Lost to Follow-up|0|||
161761020|NCT01693562|584164623|FG019|Escalation Phase|Lost to Follow-up|0|||
161761021|NCT01693562|584164624|FG020|Escalation Phase|Lost to Follow-up|0|||
161761022|NCT01693562|584164625|FG021|Escalation Phase|Lost to Follow-up|0|||
161761023|NCT01693562|584164626|FG022|Escalation Phase|Lost to Follow-up|0|||
161761024|NCT01693562|584164604|FG000|Escalation Phase|Other|0|||
161761025|NCT01693562|584164605|FG001|Escalation Phase|Other|0|||
161761026|NCT01693562|584164606|FG002|Escalation Phase|Other|2|||
162033020|NCT02186301|585178573|FG000|Overall Study|Death|1|||
161971251|NCT02914548|584941096|FG002|Overall Study|>40% of body surface area|1|||
161761027|NCT01693562|584164607|FG003|Escalation Phase|Other|0|||
161761028|NCT01693562|584164608|FG004|Escalation Phase|Other|0|||
161761029|NCT01693562|584164609|FG005|Escalation Phase|Other|1|||
161761030|NCT01693562|584164610|FG006|Escalation Phase|Other|0|||
161761031|NCT01693562|584164611|FG007|Escalation Phase|Other|0|||
161761032|NCT01693562|584164612|FG008|Escalation Phase|Other|0|||
161761033|NCT01693562|584164613|FG009|Escalation Phase|Other|0|||
161761034|NCT01693562|584164614|FG010|Escalation Phase|Other|0|||
161761035|NCT01693562|584164615|FG011|Escalation Phase|Other|0|||
161761036|NCT01693562|584164616|FG012|Escalation Phase|Other|0|||
161761037|NCT01693562|584164617|FG013|Escalation Phase|Other|0|||
161761038|NCT01693562|584164618|FG014|Escalation Phase|Other|0|||
161761039|NCT01693562|584164619|FG015|Escalation Phase|Other|0|||
161761040|NCT01693562|584164620|FG016|Escalation Phase|Other|0|||
161761041|NCT01693562|584164621|FG017|Escalation Phase|Other|0|||
161761042|NCT01693562|584164622|FG018|Escalation Phase|Other|0|||
161761043|NCT01693562|584164623|FG019|Escalation Phase|Other|0|||
161761044|NCT01693562|584164624|FG020|Escalation Phase|Other|0|||
161761045|NCT01693562|584164625|FG021|Escalation Phase|Other|0|||
161761046|NCT01693562|584164626|FG022|Escalation Phase|Other|0|||
161761047|NCT01693562|584164604|FG000|Exploration Phase|Withdrawal by Subject|0|||
161761048|NCT01693562|584164605|FG001|Exploration Phase|Withdrawal by Subject|0|||
161761049|NCT01693562|584164606|FG002|Exploration Phase|Withdrawal by Subject|0|||
161761050|NCT01693562|584164607|FG003|Exploration Phase|Withdrawal by Subject|0|||
161761051|NCT01693562|584164608|FG004|Exploration Phase|Withdrawal by Subject|0|||
161761052|NCT01693562|584164609|FG005|Exploration Phase|Withdrawal by Subject|0|||
161761053|NCT01693562|584164610|FG006|Exploration Phase|Withdrawal by Subject|2|||
161761054|NCT01693562|584164611|FG007|Exploration Phase|Withdrawal by Subject|0|||
161761055|NCT01693562|584164612|FG008|Exploration Phase|Withdrawal by Subject|0|||
161761056|NCT01693562|584164613|FG009|Exploration Phase|Withdrawal by Subject|0|||
161761057|NCT01693562|584164614|FG010|Exploration Phase|Withdrawal by Subject|0|||
161761058|NCT01693562|584164615|FG011|Exploration Phase|Withdrawal by Subject|0|||
161761059|NCT01693562|584164616|FG012|Exploration Phase|Withdrawal by Subject|0|||
161761060|NCT01693562|584164617|FG013|Exploration Phase|Withdrawal by Subject|0|||
161761061|NCT01693562|584164618|FG014|Exploration Phase|Withdrawal by Subject|0|||
161761062|NCT01693562|584164619|FG015|Exploration Phase|Withdrawal by Subject|0|||
161761063|NCT01693562|584164620|FG016|Exploration Phase|Withdrawal by Subject|0|||
161761064|NCT01693562|584164621|FG017|Exploration Phase|Withdrawal by Subject|0|||
161761065|NCT01693562|584164622|FG018|Exploration Phase|Withdrawal by Subject|0|||
161761066|NCT01693562|584164623|FG019|Exploration Phase|Withdrawal by Subject|0|||
161761067|NCT01693562|584164624|FG020|Exploration Phase|Withdrawal by Subject|0|||
161761068|NCT01693562|584164625|FG021|Exploration Phase|Withdrawal by Subject|0|||
161761069|NCT01693562|584164626|FG022|Exploration Phase|Withdrawal by Subject|0|||
161761070|NCT01693562|584164604|FG000|Exploration Phase|Death|0|||
161761071|NCT01693562|584164605|FG001|Exploration Phase|Death|0|||
161761072|NCT01693562|584164606|FG002|Exploration Phase|Death|0|||
161761073|NCT01693562|584164607|FG003|Exploration Phase|Death|0|||
161761074|NCT01693562|584164608|FG004|Exploration Phase|Death|0|||
161761075|NCT01693562|584164609|FG005|Exploration Phase|Death|0|||
161761076|NCT01693562|584164610|FG006|Exploration Phase|Death|17|||
161761077|NCT01693562|584164611|FG007|Exploration Phase|Death|0|||
161761078|NCT01693562|584164612|FG008|Exploration Phase|Death|0|||
161761079|NCT01693562|584164613|FG009|Exploration Phase|Death|0|||
161761080|NCT01693562|584164614|FG010|Exploration Phase|Death|0|||
161761081|NCT01693562|584164615|FG011|Exploration Phase|Death|0|||
161761082|NCT01693562|584164616|FG012|Exploration Phase|Death|0|||
161761083|NCT01693562|584164617|FG013|Exploration Phase|Death|0|||
161761084|NCT01693562|584164618|FG014|Exploration Phase|Death|0|||
161761085|NCT01693562|584164619|FG015|Exploration Phase|Death|0|||
161761086|NCT01693562|584164620|FG016|Exploration Phase|Death|0|||
161761087|NCT01693562|584164621|FG017|Exploration Phase|Death|0|||
161761088|NCT01693562|584164622|FG018|Exploration Phase|Death|0|||
161761089|NCT01693562|584164623|FG019|Exploration Phase|Death|0|||
161761090|NCT01693562|584164624|FG020|Exploration Phase|Death|0|||
161761091|NCT01693562|584164625|FG021|Exploration Phase|Death|0|||
161761092|NCT01693562|584164626|FG022|Exploration Phase|Death|0|||
161971252|NCT03746600|584941097|FG000|Overall Study|Withdrawal by Subject|3|||
161761093|NCT01693562|584164604|FG000|Exploration Phase|Other|0|||
161761094|NCT01693562|584164605|FG001|Exploration Phase|Other|0|||
161761095|NCT01693562|584164606|FG002|Exploration Phase|Other|0|||
161971253|NCT03746600|584941098|FG001|Overall Study|Withdrawal by Subject|3|||
161761096|NCT01693562|584164607|FG003|Exploration Phase|Other|0|||
161761097|NCT01693562|584164608|FG004|Exploration Phase|Other|0|||
161761098|NCT01693562|584164609|FG005|Exploration Phase|Other|0|||
161761099|NCT01693562|584164610|FG006|Exploration Phase|Other|2|||
161761100|NCT01693562|584164611|FG007|Exploration Phase|Other|0|||
161761101|NCT01693562|584164612|FG008|Exploration Phase|Other|0|||
161761102|NCT01693562|584164613|FG009|Exploration Phase|Other|0|||
161761103|NCT01693562|584164614|FG010|Exploration Phase|Other|0|||
161761104|NCT01693562|584164615|FG011|Exploration Phase|Other|0|||
161761105|NCT01693562|584164616|FG012|Exploration Phase|Other|0|||
161761106|NCT01693562|584164617|FG013|Exploration Phase|Other|0|||
161761107|NCT01693562|584164618|FG014|Exploration Phase|Other|0|||
161761108|NCT01693562|584164619|FG015|Exploration Phase|Other|0|||
161761109|NCT01693562|584164620|FG016|Exploration Phase|Other|0|||
161761110|NCT01693562|584164621|FG017|Exploration Phase|Other|0|||
161761111|NCT01693562|584164622|FG018|Exploration Phase|Other|0|||
161761112|NCT01693562|584164623|FG019|Exploration Phase|Other|0|||
161761113|NCT01693562|584164624|FG020|Exploration Phase|Other|0|||
161761114|NCT01693562|584164625|FG021|Exploration Phase|Other|0|||
161761115|NCT01693562|584164626|FG022|Exploration Phase|Other|0|||
161761116|NCT01693562|584164604|FG000|Expansion Phase|Withdrawal by Subject|0|||
161761117|NCT01693562|584164605|FG001|Expansion Phase|Withdrawal by Subject|0|||
161761118|NCT01693562|584164606|FG002|Expansion Phase|Withdrawal by Subject|0|||
161761119|NCT01693562|584164607|FG003|Expansion Phase|Withdrawal by Subject|0|||
161761120|NCT01693562|584164608|FG004|Expansion Phase|Withdrawal by Subject|0|||
161761121|NCT01693562|584164609|FG005|Expansion Phase|Withdrawal by Subject|0|||
161761122|NCT01693562|584164610|FG006|Expansion Phase|Withdrawal by Subject|0|||
161761123|NCT01693562|584164611|FG007|Expansion Phase|Withdrawal by Subject|16|||
161761124|NCT01693562|584164612|FG008|Expansion Phase|Withdrawal by Subject|2|||
161761125|NCT01693562|584164613|FG009|Expansion Phase|Withdrawal by Subject|54|||
161761126|NCT01693562|584164614|FG010|Expansion Phase|Withdrawal by Subject|2|||
161761127|NCT01693562|584164615|FG011|Expansion Phase|Withdrawal by Subject|2|||
161761128|NCT01693562|584164616|FG012|Expansion Phase|Withdrawal by Subject|3|||
161761129|NCT01693562|584164617|FG013|Expansion Phase|Withdrawal by Subject|5|||
161761130|NCT01693562|584164618|FG014|Expansion Phase|Withdrawal by Subject|16|||
161761131|NCT01693562|584164619|FG015|Expansion Phase|Withdrawal by Subject|7|||
161761132|NCT01693562|584164620|FG016|Expansion Phase|Withdrawal by Subject|40|||
161761133|NCT01693562|584164621|FG017|Expansion Phase|Withdrawal by Subject|4|||
161761134|NCT01693562|584164622|FG018|Expansion Phase|Withdrawal by Subject|8|||
161761135|NCT01693562|584164623|FG019|Expansion Phase|Withdrawal by Subject|3|||
161761136|NCT01693562|584164624|FG020|Expansion Phase|Withdrawal by Subject|1|||
161761137|NCT01693562|584164625|FG021|Expansion Phase|Withdrawal by Subject|8|||
161761138|NCT01693562|584164626|FG022|Expansion Phase|Withdrawal by Subject|1|||
161761139|NCT01693562|584164604|FG000|Expansion Phase|Death|0|||
161761140|NCT01693562|584164605|FG001|Expansion Phase|Death|0|||
161761141|NCT01693562|584164606|FG002|Expansion Phase|Death|0|||
161761142|NCT01693562|584164607|FG003|Expansion Phase|Death|0|||
161761143|NCT01693562|584164608|FG004|Expansion Phase|Death|0|||
161761144|NCT01693562|584164609|FG005|Expansion Phase|Death|0|||
161761145|NCT01693562|584164610|FG006|Expansion Phase|Death|0|||
161761146|NCT01693562|584164611|FG007|Expansion Phase|Death|42|||
161761147|NCT01693562|584164612|FG008|Expansion Phase|Death|17|||
161761148|NCT01693562|584164613|FG009|Expansion Phase|Death|208|||
161761149|NCT01693562|584164614|FG010|Expansion Phase|Death|30|||
161761150|NCT01693562|584164615|FG011|Expansion Phase|Death|8|||
161761151|NCT01693562|584164616|FG012|Expansion Phase|Death|19|||
161761152|NCT01693562|584164617|FG013|Expansion Phase|Death|42|||
161761153|NCT01693562|584164618|FG014|Expansion Phase|Death|23|||
161761154|NCT01693562|584164619|FG015|Expansion Phase|Death|23|||
161761155|NCT01693562|584164620|FG016|Expansion Phase|Death|128|||
161761156|NCT01693562|584164621|FG017|Expansion Phase|Death|16|||
161761157|NCT01693562|584164622|FG018|Expansion Phase|Death|36|||
161761158|NCT01693562|584164623|FG019|Expansion Phase|Death|16|||
161761159|NCT01693562|584164624|FG020|Expansion Phase|Death|17|||
161761160|NCT01693562|584164625|FG021|Expansion Phase|Death|35|||
161761161|NCT01693562|584164626|FG022|Expansion Phase|Death|7|||
161761162|NCT01693562|584164604|FG000|Expansion Phase|Lost to Follow-up|0|||
161761163|NCT01693562|584164605|FG001|Expansion Phase|Lost to Follow-up|0|||
161761164|NCT01693562|584164606|FG002|Expansion Phase|Lost to Follow-up|0|||
161761165|NCT01693562|584164607|FG003|Expansion Phase|Lost to Follow-up|0|||
161971254|NCT03746600|584941097|FG000|Overall Study|dismissed from study|1|||
161971255|NCT03746600|584941098|FG001|Overall Study|dismissed from study|0|||
161971256|NCT03746600|584941097|FG000|Overall Study|Lost to Follow-up|1|||
161971257|NCT03746600|584941098|FG001|Overall Study|Lost to Follow-up|0|||
161761166|NCT01693562|584164608|FG004|Expansion Phase|Lost to Follow-up|0|||
161761167|NCT01693562|584164609|FG005|Expansion Phase|Lost to Follow-up|0|||
161761168|NCT01693562|584164610|FG006|Expansion Phase|Lost to Follow-up|0|||
161761169|NCT01693562|584164611|FG007|Expansion Phase|Lost to Follow-up|1|||
161761170|NCT01693562|584164612|FG008|Expansion Phase|Lost to Follow-up|2|||
161761171|NCT01693562|584164613|FG009|Expansion Phase|Lost to Follow-up|10|||
161761172|NCT01693562|584164614|FG010|Expansion Phase|Lost to Follow-up|4|||
161761173|NCT01693562|584164615|FG011|Expansion Phase|Lost to Follow-up|4|||
161761174|NCT01693562|584164616|FG012|Expansion Phase|Lost to Follow-up|1|||
161761175|NCT01693562|584164617|FG013|Expansion Phase|Lost to Follow-up|3|||
161761176|NCT01693562|584164618|FG014|Expansion Phase|Lost to Follow-up|0|||
161761177|NCT01693562|584164619|FG015|Expansion Phase|Lost to Follow-up|1|||
161761178|NCT01693562|584164620|FG016|Expansion Phase|Lost to Follow-up|1|||
161761179|NCT01693562|584164621|FG017|Expansion Phase|Lost to Follow-up|0|||
161761180|NCT01693562|584164622|FG018|Expansion Phase|Lost to Follow-up|2|||
161971258|NCT02374814|584941106|FG000|Overall Study|Lost to Follow-up|1|||
161761181|NCT01693562|584164623|FG019|Expansion Phase|Lost to Follow-up|1|||
161761182|NCT01693562|584164624|FG020|Expansion Phase|Lost to Follow-up|2|||
161761183|NCT01693562|584164625|FG021|Expansion Phase|Lost to Follow-up|2|||
161761184|NCT01693562|584164626|FG022|Expansion Phase|Lost to Follow-up|1|||
161761185|NCT01693562|584164604|FG000|Expansion Phase|Other|0|||
161761186|NCT01693562|584164605|FG001|Expansion Phase|Other|0|||
161761187|NCT01693562|584164606|FG002|Expansion Phase|Other|0|||
161761188|NCT01693562|584164607|FG003|Expansion Phase|Other|0|||
161761189|NCT01693562|584164608|FG004|Expansion Phase|Other|0|||
161761190|NCT01693562|584164609|FG005|Expansion Phase|Other|0|||
161761191|NCT01693562|584164610|FG006|Expansion Phase|Other|0|||
161761192|NCT01693562|584164611|FG007|Expansion Phase|Other|3|||
161761193|NCT01693562|584164612|FG008|Expansion Phase|Other|1|||
161761194|NCT01693562|584164613|FG009|Expansion Phase|Other|28|||
161761195|NCT01693562|584164614|FG010|Expansion Phase|Other|4|||
161761196|NCT01693562|584164615|FG011|Expansion Phase|Other|7|||
161761197|NCT01693562|584164616|FG012|Expansion Phase|Other|0|||
161761198|NCT01693562|584164617|FG013|Expansion Phase|Other|1|||
161761199|NCT01693562|584164618|FG014|Expansion Phase|Other|1|||
161761200|NCT01693562|584164619|FG015|Expansion Phase|Other|0|||
161761201|NCT01693562|584164620|FG016|Expansion Phase|Other|28|||
161761202|NCT01693562|584164621|FG017|Expansion Phase|Other|0|||
161761203|NCT01693562|584164622|FG018|Expansion Phase|Other|1|||
161761204|NCT01693562|584164623|FG019|Expansion Phase|Other|0|||
161761205|NCT01693562|584164624|FG020|Expansion Phase|Other|1|||
161761206|NCT01693562|584164625|FG021|Expansion Phase|Other|17|||
161761207|NCT01693562|584164626|FG022|Expansion Phase|Other|1|||
161761208|NCT05466240|584164628|FG000|Overall Study|Adverse Event|1|||
161761209|NCT05466240|584164629|FG001|Overall Study|Adverse Event|0|||
161761210|NCT05466240|584164628|FG000|Overall Study|Withdrawal by Subject|1|||
161761211|NCT05466240|584164629|FG001|Overall Study|Withdrawal by Subject|0|||
161847581|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847582|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161761212|NCT02759939|584164630|FG000|Overall Study|Missing data on first outcome assessed|11|||
161847583|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847584|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161847585|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847586|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847587|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847588|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847589|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847590|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
161847591|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847592|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
161847593|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
161847594|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847595|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847596|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847597|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847598|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161847599|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161971259|NCT02374814|584941107|FG001|Overall Study|Lost to Follow-up|1|||
161971260|NCT02374814|584941108|FG002|Overall Study|Lost to Follow-up|0|||
161971261|NCT02374814|584941109|FG003|Overall Study|Lost to Follow-up|1|||
161971262|NCT02374814|584941110|FG004|Overall Study|Lost to Follow-up|0|||
161971263|NCT02374814|584941111|FG005|Overall Study|Lost to Follow-up|0|||
161761213|NCT02759939|584164631|FG001|Overall Study|Missing data on first outcome assessed|2|||
161761214|NCT02759939|584164632|FG002|Overall Study|Missing data on first outcome assessed|5|||
161761215|NCT02759939|584164633|FG003|Overall Study|Missing data on first outcome assessed|2|||
161761216|NCT02759939|584164630|FG000|Overall Study|Ineligible for T2 and T3|310|||
161761217|NCT02759939|584164631|FG001|Overall Study|Ineligible for T2 and T3|179|||
161761218|NCT02759939|584164632|FG002|Overall Study|Ineligible for T2 and T3|366|||
161971264|NCT02374814|584941106|FG000|Overall Study|Withdrawal by Subject|0|||
161971265|NCT02374814|584941107|FG001|Overall Study|Withdrawal by Subject|0|||
161971266|NCT02374814|584941108|FG002|Overall Study|Withdrawal by Subject|1|||
161971267|NCT02374814|584941109|FG003|Overall Study|Withdrawal by Subject|1|||
161761219|NCT02759939|584164633|FG003|Overall Study|Ineligible for T2 and T3|391|||
161761220|NCT02759939|584164630|FG000|Overall Study|Lost to Follow-up|735|||
161761221|NCT02759939|584164631|FG001|Overall Study|Lost to Follow-up|791|||
161761222|NCT02759939|584164632|FG002|Overall Study|Lost to Follow-up|783|||
161761223|NCT02759939|584164633|FG003|Overall Study|Lost to Follow-up|650|||
161761224|NCT04735432|584164636|FG000|Overall Study|Other - due to personal reason|1|||
161761225|NCT04735432|584164637|FG001|Overall Study|Other - due to personal reason|0|||
161761226|NCT04735432|584164636|FG000|Overall Study|Adverse Event|2|||
161761227|NCT04735432|584164637|FG001|Overall Study|Adverse Event|0|||
161761228|NCT00626327|584164638|FG000|Overall Study|Withdrawal by Subject|21|||
161761229|NCT00626327|584164639|FG001|Overall Study|Withdrawal by Subject|29|||
161761230|NCT00626327|584164640|FG002|Overall Study|Withdrawal by Subject|30|||
161761231|NCT00626327|584164638|FG000|Overall Study|Adverse Event|1|||
161761232|NCT00626327|584164639|FG001|Overall Study|Adverse Event|0|||
161761233|NCT00626327|584164640|FG002|Overall Study|Adverse Event|0|||
161761234|NCT00626327|584164638|FG000|Overall Study|Lost to Follow-up|24|||
161761235|NCT00626327|584164639|FG001|Overall Study|Lost to Follow-up|21|||
161761236|NCT00626327|584164640|FG002|Overall Study|Lost to Follow-up|23|||
161761237|NCT00626327|584164638|FG000|Overall Study|Inappropriate enrollment|4|||
161761238|NCT00626327|584164639|FG001|Overall Study|Inappropriate enrollment|5|||
161761239|NCT00626327|584164640|FG002|Overall Study|Inappropriate enrollment|3|||
161761240|NCT00626327|584164638|FG000|Overall Study|Administrative Reason|2|||
161761241|NCT00626327|584164639|FG001|Overall Study|Administrative Reason|0|||
161761242|NCT00626327|584164640|FG002|Overall Study|Administrative Reason|6|||
161761243|NCT00626327|584164638|FG000|Overall Study|Protocol Violation|26|||
161761244|NCT00626327|584164639|FG001|Overall Study|Protocol Violation|4|||
161761245|NCT00626327|584164640|FG002|Overall Study|Protocol Violation|26|||
161761246|NCT00945945|584164641|FG000|Overall Study|Adverse Event|15|||
161761247|NCT00945945|584164642|FG001|Overall Study|Adverse Event|35|||
161761248|NCT00945945|584164641|FG000|Overall Study|Withdrawal by Subject|7|||
161761249|NCT00945945|584164642|FG001|Overall Study|Withdrawal by Subject|10|||
161761250|NCT00945945|584164641|FG000|Overall Study|Lost to Follow-up|4|||
161761251|NCT00945945|584164642|FG001|Overall Study|Lost to Follow-up|5|||
161761252|NCT00945945|584164641|FG000|Overall Study|Lack of Efficacy|6|||
161761253|NCT00945945|584164642|FG001|Overall Study|Lack of Efficacy|2|||
161761254|NCT00945945|584164641|FG000|Overall Study|Protocol Violation|4|||
161761255|NCT00945945|584164642|FG001|Overall Study|Protocol Violation|2|||
161761256|NCT00945945|584164641|FG000|Overall Study|Entry Criteria Not Met|0|||
161761257|NCT00945945|584164642|FG001|Overall Study|Entry Criteria Not Met|1|||
161761258|NCT03347279|584164645|FG000|Overall Study|Withdrawal by Subject|8|||
161761259|NCT03347279|584164646|FG001|Overall Study|Withdrawal by Subject|15|||
161761260|NCT03347279|584164645|FG000|Overall Study|Death|0|||
161761261|NCT03347279|584164646|FG001|Overall Study|Death|2|||
161761262|NCT03347279|584164645|FG000|Overall Study|Lost to Follow-up|5|||
161761263|NCT03347279|584164646|FG001|Overall Study|Lost to Follow-up|2|||
161761264|NCT03347279|584164645|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
161761265|NCT03347279|584164646|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
161761266|NCT03818399|584164647|FG000|Overall Study|Lost to Follow-up|11|||
161761267|NCT03818399|584164647|FG000|Overall Study|Withdrawal by Subject|1|||
161761268|NCT03818399|584164647|FG000|Overall Study|Protocol Violation|2|||
161761269|NCT04880642|584164648|FG000|Randomization|Withdrawal by Subject|2|||
161761270|NCT04880642|584164649|FG001|Randomization|Withdrawal by Subject|3|||
161761271|NCT04880642|584164648|FG000|Treatment Period|Adverse Event|0|||
161761272|NCT04880642|584164649|FG001|Treatment Period|Adverse Event|1|||
161761273|NCT04880642|584164648|FG000|Treatment Period|Death|6|||
161761274|NCT04880642|584164649|FG001|Treatment Period|Death|6|||
161761275|NCT04880642|584164648|FG000|Treatment Period|Lost to Follow-up|1|||
161761276|NCT04880642|584164649|FG001|Treatment Period|Lost to Follow-up|0|||
161761277|NCT04880642|584164648|FG000|Treatment Period|Protocol Violation|0|||
161761278|NCT04880642|584164649|FG001|Treatment Period|Protocol Violation|1|||
161761279|NCT04880642|584164648|FG000|Treatment Period|Withdrawal by Subject|5|||
161761280|NCT04880642|584164649|FG001|Treatment Period|Withdrawal by Subject|3|||
161761281|NCT04880642|584164648|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
161761282|NCT04880642|584164649|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
161761283|NCT04880642|584164648|FG000|Follow-up|Death|4|||
161761284|NCT04880642|584164649|FG001|Follow-up|Death|3|||
161761285|NCT04880642|584164648|FG000|Follow-up|Withdrawal by Subject|1|||
161761286|NCT04880642|584164649|FG001|Follow-up|Withdrawal by Subject|0|||
161761287|NCT00141297|584164651|FG000|Overall Study|Adverse Event|0|||
161761288|NCT00141297|584164652|FG001|Overall Study|Adverse Event|0|||
161761289|NCT00141297|584164653|FG002|Overall Study|Adverse Event|1|||
161761290|NCT00141297|584164654|FG003|Overall Study|Adverse Event|0|||
161761291|NCT00141297|584164655|FG004|Overall Study|Adverse Event|1|||
161761292|NCT00141297|584164656|FG005|Overall Study|Adverse Event|1|||
161761293|NCT00141297|584164657|FG006|Overall Study|Adverse Event|0|||
161761294|NCT00141297|584164658|FG007|Overall Study|Adverse Event|1|||
161761295|NCT00141297|584164659|FG008|Overall Study|Adverse Event|1|||
161761296|NCT00141297|584164660|FG009|Overall Study|Adverse Event|0|||
161761297|NCT00141297|584164651|FG000|Overall Study|Death|1|||
161761298|NCT00141297|584164652|FG001|Overall Study|Death|0|||
161761299|NCT00141297|584164653|FG002|Overall Study|Death|0|||
161761300|NCT00141297|584164654|FG003|Overall Study|Death|0|||
161761301|NCT00141297|584164655|FG004|Overall Study|Death|0|||
161761302|NCT00141297|584164656|FG005|Overall Study|Death|0|||
162033021|NCT02186301|585178574|FG001|Overall Study|Death|0|||
161761303|NCT00141297|584164657|FG006|Overall Study|Death|0|||
161761304|NCT00141297|584164658|FG007|Overall Study|Death|0|||
161761305|NCT00141297|584164659|FG008|Overall Study|Death|1|||
161761306|NCT00141297|584164660|FG009|Overall Study|Death|0|||
161761307|NCT00141297|584164651|FG000|Overall Study|Withdrawal by Subject|0|||
161761308|NCT00141297|584164652|FG001|Overall Study|Withdrawal by Subject|0|||
161761309|NCT00141297|584164653|FG002|Overall Study|Withdrawal by Subject|0|||
161761310|NCT00141297|584164654|FG003|Overall Study|Withdrawal by Subject|0|||
161761311|NCT00141297|584164655|FG004|Overall Study|Withdrawal by Subject|0|||
161761312|NCT00141297|584164656|FG005|Overall Study|Withdrawal by Subject|0|||
161761313|NCT00141297|584164657|FG006|Overall Study|Withdrawal by Subject|0|||
161761314|NCT00141297|584164658|FG007|Overall Study|Withdrawal by Subject|0|||
161761315|NCT00141297|584164659|FG008|Overall Study|Withdrawal by Subject|1|||
161761316|NCT00141297|584164660|FG009|Overall Study|Withdrawal by Subject|0|||
161761317|NCT00141297|584164651|FG000|Overall Study|Other|0|||
161761318|NCT00141297|584164652|FG001|Overall Study|Other|0|||
161761319|NCT00141297|584164653|FG002|Overall Study|Other|0|||
161761320|NCT00141297|584164654|FG003|Overall Study|Other|1|||
161761321|NCT00141297|584164655|FG004|Overall Study|Other|5|||
161761322|NCT00141297|584164656|FG005|Overall Study|Other|0|||
161761323|NCT00141297|584164657|FG006|Overall Study|Other|0|||
161761324|NCT00141297|584164658|FG007|Overall Study|Other|0|||
161761325|NCT00141297|584164659|FG008|Overall Study|Other|2|||
161761326|NCT00141297|584164660|FG009|Overall Study|Other|0|||
161761327|NCT00141297|584164651|FG000|Overall Study|Progressive Disease|2|||
161761328|NCT00141297|584164652|FG001|Overall Study|Progressive Disease|3|||
161761329|NCT00141297|584164653|FG002|Overall Study|Progressive Disease|6|||
161761330|NCT00141297|584164654|FG003|Overall Study|Progressive Disease|2|||
161761331|NCT00141297|584164655|FG004|Overall Study|Progressive Disease|15|||
161761332|NCT00141297|584164656|FG005|Overall Study|Progressive Disease|2|||
161761333|NCT00141297|584164657|FG006|Overall Study|Progressive Disease|3|||
161761334|NCT00141297|584164658|FG007|Overall Study|Progressive Disease|3|||
161761335|NCT00141297|584164659|FG008|Overall Study|Progressive Disease|15|||
161761336|NCT00141297|584164660|FG009|Overall Study|Progressive Disease|6|||
161761337|NCT00141297|584164651|FG000|Overall Study|Transitioned|0|||
161761338|NCT00141297|584164652|FG001|Overall Study|Transitioned|0|||
161761339|NCT00141297|584164653|FG002|Overall Study|Transitioned|0|||
161761340|NCT00141297|584164654|FG003|Overall Study|Transitioned|0|||
161761341|NCT00141297|584164655|FG004|Overall Study|Transitioned|1|||
161761342|NCT00141297|584164656|FG005|Overall Study|Transitioned|0|||
161761343|NCT00141297|584164657|FG006|Overall Study|Transitioned|0|||
161761344|NCT00141297|584164658|FG007|Overall Study|Transitioned|0|||
161761345|NCT00141297|584164659|FG008|Overall Study|Transitioned|0|||
161761346|NCT00141297|584164660|FG009|Overall Study|Transitioned|0|||
161761347|NCT02987205|584164661|FG000|Overall Study|Adverse Event|1|||
161761348|NCT02987205|584164661|FG000|Overall Study|Withdrawal by Subject|3|||
161761349|NCT02807376|584164663|FG000|Overall Study|Intra-operative exclusion criteria|3|||
161761350|NCT02807376|584164664|FG001|Overall Study|Intra-operative exclusion criteria|0|||
161761351|NCT02807376|584164663|FG000|Overall Study|Lost to Follow-up|0|||
161761352|NCT02807376|584164664|FG001|Overall Study|Lost to Follow-up|1|||
161761353|NCT03228836|584164667|FG000|Overall Study|Adverse Event|3|||
161761354|NCT03228836|584164667|FG000|Overall Study|Withdrawal by Subject|1|||
161761355|NCT03228836|584164667|FG000|Overall Study|Death|1|||
161761356|NCT03228836|584164667|FG000|Overall Study|Physician Decision|1|||
161761357|NCT03228836|584164667|FG000|Overall Study|Disease Progression|7|||
161761358|NCT03228836|584164667|FG000|Overall Study|Other|4|||
161761359|NCT00948389|584164668|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
161761360|NCT00948389|584164669|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
161761361|NCT00948389|584164670|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
161761362|NCT00948389|584164671|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
161761363|NCT00948389|584164672|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
161761364|NCT00948389|584164668|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
161761365|NCT00948389|584164669|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
161761366|NCT00948389|584164670|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
161761367|NCT00948389|584164671|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
161761368|NCT00948389|584164672|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
161761369|NCT00948389|584164668|FG000|Overall Study|Both Progression and Toxicity|1|||
161761370|NCT00948389|584164669|FG001|Overall Study|Both Progression and Toxicity|0|||
161761371|NCT00948389|584164670|FG002|Overall Study|Both Progression and Toxicity|0|||
161761372|NCT00948389|584164671|FG003|Overall Study|Both Progression and Toxicity|0|||
161761373|NCT00948389|584164672|FG004|Overall Study|Both Progression and Toxicity|0|||
161761374|NCT03018340|584164685|FG000|Overall Study|Adverse Event|1|||
161761375|NCT03018340|584164686|FG001|Overall Study|Adverse Event|2|||
161761376|NCT03018340|584164685|FG000|Overall Study|Withdrawal by Subject|0|||
161761377|NCT03018340|584164686|FG001|Overall Study|Withdrawal by Subject|8|||
161761378|NCT03018340|584164685|FG000|Overall Study|Lack of Efficacy|0|||
161761379|NCT03018340|584164686|FG001|Overall Study|Lack of Efficacy|1|||
161761380|NCT03018340|584164685|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
161761381|NCT03018340|584164686|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
161761382|NCT03018340|584164685|FG000|Overall Study|Lost to Follow-up|1|||
161761383|NCT03018340|584164686|FG001|Overall Study|Lost to Follow-up|7|||
161761384|NCT03018340|584164685|FG000|Overall Study|Protocol Violation|3|||
161761385|NCT03018340|584164686|FG001|Overall Study|Protocol Violation|7|||
161761386|NCT03018340|584164685|FG000|Overall Study|Not further specified|0|||
161761387|NCT03018340|584164686|FG001|Overall Study|Not further specified|1|||
161761388|NCT04652102|584164687|FG000|Overall Study|Adverse Event|14|||
161761389|NCT04652102|584164688|FG001|Overall Study|Adverse Event|13|||
161761390|NCT04652102|584164687|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
161761391|NCT04652102|584164688|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
161761392|NCT04652102|584164687|FG000|Overall Study|Physician Decision|78|||
161761393|NCT04652102|584164688|FG001|Overall Study|Physician Decision|40|||
161761394|NCT04652102|584164687|FG000|Overall Study|Study Ended by Sponsor|64|||
161761395|NCT04652102|584164688|FG001|Overall Study|Study Ended by Sponsor|17|||
161761396|NCT04652102|584164687|FG000|Overall Study|Withdrawal by Subject|4625|||
161761397|NCT04652102|584164688|FG001|Overall Study|Withdrawal by Subject|5594|||
161761398|NCT04652102|584164687|FG000|Overall Study|Lost to Follow-up|2019|||
161761399|NCT04652102|584164688|FG001|Overall Study|Lost to Follow-up|1082|||
161761400|NCT04652102|584164687|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
161761401|NCT04652102|584164688|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
161761402|NCT04652102|584164687|FG000|Overall Study|Miscellaneous|80|||
161761403|NCT04652102|584164688|FG001|Overall Study|Miscellaneous|64|||
161761404|NCT02192190|584164689|FG000|Overall Study|Adverse Event|1|||
161761405|NCT02192190|584164690|FG001|Overall Study|Adverse Event|1|||
161761406|NCT02192190|584164691|FG002|Overall Study|Adverse Event|0|||
161761407|NCT02192190|584164692|FG003|Overall Study|Adverse Event|0|||
161761408|NCT02192190|584164693|FG004|Overall Study|Adverse Event|0|||
161761409|NCT02192190|584164694|FG005|Overall Study|Adverse Event|0|||
161761410|NCT02192190|584164689|FG000|Overall Study|Lost to Follow-up|3|||
161761411|NCT02192190|584164690|FG001|Overall Study|Lost to Follow-up|3|||
161761412|NCT02192190|584164691|FG002|Overall Study|Lost to Follow-up|2|||
161761413|NCT02192190|584164692|FG003|Overall Study|Lost to Follow-up|1|||
161761414|NCT02192190|584164693|FG004|Overall Study|Lost to Follow-up|4|||
161761415|NCT02192190|584164694|FG005|Overall Study|Lost to Follow-up|3|||
161761416|NCT02192190|584164689|FG000|Overall Study|Physician Decision|2|||
161761417|NCT02192190|584164690|FG001|Overall Study|Physician Decision|0|||
161761418|NCT02192190|584164691|FG002|Overall Study|Physician Decision|0|||
161761419|NCT02192190|584164692|FG003|Overall Study|Physician Decision|0|||
161761420|NCT02192190|584164693|FG004|Overall Study|Physician Decision|0|||
161761421|NCT02192190|584164694|FG005|Overall Study|Physician Decision|0|||
161761422|NCT02192190|584164689|FG000|Overall Study|Terminated by Sponsor|43|||
161761423|NCT02192190|584164690|FG001|Overall Study|Terminated by Sponsor|23|||
161761424|NCT02192190|584164691|FG002|Overall Study|Terminated by Sponsor|20|||
161761425|NCT02192190|584164692|FG003|Overall Study|Terminated by Sponsor|23|||
161761426|NCT02192190|584164693|FG004|Overall Study|Terminated by Sponsor|21|||
161761427|NCT02192190|584164694|FG005|Overall Study|Terminated by Sponsor|23|||
161761428|NCT02192190|584164689|FG000|Overall Study|Withdrawal by Subject|4|||
161761429|NCT02192190|584164690|FG001|Overall Study|Withdrawal by Subject|1|||
161761430|NCT02192190|584164691|FG002|Overall Study|Withdrawal by Subject|2|||
161761431|NCT02192190|584164692|FG003|Overall Study|Withdrawal by Subject|1|||
161761432|NCT02192190|584164693|FG004|Overall Study|Withdrawal by Subject|5|||
161761433|NCT02192190|584164694|FG005|Overall Study|Withdrawal by Subject|3|||
161761434|NCT02192190|584164689|FG000|Overall Study|Could not Keep Visit Schedule|1|||
161761435|NCT02192190|584164690|FG001|Overall Study|Could not Keep Visit Schedule|0|||
161761436|NCT02192190|584164691|FG002|Overall Study|Could not Keep Visit Schedule|0|||
161761437|NCT02192190|584164692|FG003|Overall Study|Could not Keep Visit Schedule|0|||
161761438|NCT02192190|584164693|FG004|Overall Study|Could not Keep Visit Schedule|0|||
161761439|NCT02192190|584164694|FG005|Overall Study|Could not Keep Visit Schedule|0|||
161761440|NCT02192190|584164689|FG000|Overall Study|Positive Drug Screen|0|||
161761441|NCT02192190|584164690|FG001|Overall Study|Positive Drug Screen|0|||
161761442|NCT02192190|584164691|FG002|Overall Study|Positive Drug Screen|0|||
161761443|NCT02192190|584164692|FG003|Overall Study|Positive Drug Screen|1|||
161761444|NCT02192190|584164693|FG004|Overall Study|Positive Drug Screen|0|||
161761445|NCT02192190|584164694|FG005|Overall Study|Positive Drug Screen|0|||
161761446|NCT02192190|584164689|FG000|Overall Study|Inadequate Pain Relief|0|||
161761447|NCT02192190|584164690|FG001|Overall Study|Inadequate Pain Relief|1|||
161761448|NCT02192190|584164691|FG002|Overall Study|Inadequate Pain Relief|1|||
161761449|NCT02192190|584164692|FG003|Overall Study|Inadequate Pain Relief|0|||
161761450|NCT02192190|584164693|FG004|Overall Study|Inadequate Pain Relief|0|||
161761451|NCT02192190|584164694|FG005|Overall Study|Inadequate Pain Relief|0|||
161761452|NCT00890201|584164695|FG000|Overall Study|Protocol Violation|5|||
161761453|NCT00890201|584164696|FG001|Overall Study|Protocol Violation|56|||
161761454|NCT01846208|584164697|FG000|Overall Study|Withdrew prior to treatment|1|||
161761455|NCT01846208|584164698|FG001|Overall Study|Withdrew prior to treatment|1|||
161761456|NCT01846208|584164699|FG002|Overall Study|Withdrew prior to treatment|1|||
161761457|NCT01846208|584164697|FG000|Overall Study|Dosing Symptoms|1|||
161761458|NCT01846208|584164698|FG001|Overall Study|Dosing Symptoms|2|||
161761459|NCT01846208|584164699|FG002|Overall Study|Dosing Symptoms|6|||
161761460|NCT01846208|584164697|FG000|Overall Study|Withdrawal by Subject|5|||
161761461|NCT01846208|584164698|FG001|Overall Study|Withdrawal by Subject|0|||
161761462|NCT01846208|584164699|FG002|Overall Study|Withdrawal by Subject|0|||
161761463|NCT01846208|584164697|FG000|Overall Study|Non-compliance|1|||
161761464|NCT01846208|584164698|FG001|Overall Study|Non-compliance|1|||
161761465|NCT01846208|584164699|FG002|Overall Study|Non-compliance|0|||
161761466|NCT01846208|584164697|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
161761467|NCT01846208|584164698|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
161761468|NCT01846208|584164699|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
161761469|NCT01846208|584164697|FG000|Overall Study|Refused SU OFC|0|||
161761470|NCT01846208|584164698|FG001|Overall Study|Refused SU OFC|0|||
161761471|NCT01846208|584164699|FG002|Overall Study|Refused SU OFC|1|||
161761472|NCT01432938|584164700|FG000|First Intervention|Protocol Violation|1|||
161761473|NCT01432938|584164701|FG001|First Intervention|Protocol Violation|0|||
161761474|NCT01432938|584164700|FG000|First Intervention|Physician Decision|1|||
161761475|NCT01432938|584164701|FG001|First Intervention|Physician Decision|0|||
161761476|NCT01432938|584164700|FG000|Second Intervention|Adverse Event|1|||
161761477|NCT01432938|584164701|FG001|Second Intervention|Adverse Event|0|||
161761478|NCT01424306|584164702|FG000|Overall Study|Protocol Violation|0|||
161761479|NCT01424306|584164703|FG001|Overall Study|Protocol Violation|0|||
161761480|NCT01424306|584164704|FG002|Overall Study|Protocol Violation|0|||
161761481|NCT01424306|584164705|FG003|Overall Study|Protocol Violation|0|||
161761482|NCT01424306|584164706|FG004|Overall Study|Protocol Violation|1|||
161761483|NCT01424306|584164707|FG005|Overall Study|Protocol Violation|0|||
161761484|NCT01875874|584164711|FG000|Overall Study|Death|3|||
161761485|NCT01601873|584164712|FG000|Overall Study|Lost to Follow-up|2|||
161761486|NCT01601873|584164713|FG001|Overall Study|Lost to Follow-up|3|||
161761487|NCT00374127|584164714|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
161761488|NCT00374127|584164714|FG000|Overall Study|Blood could not be drawn.|2|||
161761489|NCT00374127|584164714|FG000|Overall Study|Protocol Violation|5|||
161761490|NCT00374127|584164714|FG000|Overall Study|Pregnancy|1|||
161761491|NCT00281528|584164718|FG000|Overall Study|Progressive Disease|28|||
161761492|NCT00281528|584164719|FG001|Overall Study|Progressive Disease|18|||
161761493|NCT00281528|584164720|FG002|Overall Study|Progressive Disease|27|||
161761494|NCT00281528|584164718|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
161761495|NCT00281528|584164719|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
161761496|NCT00281528|584164720|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
161761497|NCT00281528|584164718|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
161761498|NCT00281528|584164719|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
161761499|NCT00281528|584164720|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
161761500|NCT00281528|584164718|FG000|Overall Study|Physician Decision|11|||
161761501|NCT00281528|584164719|FG001|Overall Study|Physician Decision|4|||
161761502|NCT00281528|584164720|FG002|Overall Study|Physician Decision|5|||
161761503|NCT00281528|584164718|FG000|Overall Study|Protocol Violation|1|||
161761504|NCT00281528|584164719|FG001|Overall Study|Protocol Violation|0|||
161761505|NCT00281528|584164720|FG002|Overall Study|Protocol Violation|1|||
161761506|NCT00281528|584164718|FG000|Overall Study|Withdrawal by Subject|5|||
161761507|NCT00281528|584164719|FG001|Overall Study|Withdrawal by Subject|5|||
161761508|NCT00281528|584164720|FG002|Overall Study|Withdrawal by Subject|7|||
161761509|NCT00281528|584164718|FG000|Overall Study|Other|6|||
161761510|NCT00281528|584164719|FG001|Overall Study|Other|3|||
161761511|NCT00281528|584164720|FG002|Overall Study|Other|5|||
161761512|NCT02520141|584164723|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
161761513|NCT00703781|584164724|FG000|Overall Study|Withdrawal by Subject|1|||
161761514|NCT00703781|584164725|FG001|Overall Study|Withdrawal by Subject|2|||
161761515|NCT00703781|584164724|FG000|Overall Study|Cancelled surgery|1|||
161761516|NCT00703781|584164725|FG001|Overall Study|Cancelled surgery|0|||
161761517|NCT01225211|584164726|FG000|Overall Study|Adverse Event|0|||
161761518|NCT01225211|584164727|FG001|Overall Study|Adverse Event|0|||
161761519|NCT01225211|584164728|FG002|Overall Study|Adverse Event|1|||
161761520|NCT01225211|584164729|FG003|Overall Study|Adverse Event|0|||
161761521|NCT01225211|584164730|FG004|Overall Study|Adverse Event|0|||
161761522|NCT01225211|584164731|FG005|Overall Study|Adverse Event|0|||
161761523|NCT01225211|584164732|FG006|Overall Study|Adverse Event|0|||
161761524|NCT01225211|584164733|FG007|Overall Study|Adverse Event|0|||
162033022|NCT02186301|585178575|FG002|Overall Study|Death|0|||
162033023|NCT02186301|585178573|FG000|Overall Study|Withdrawal by Subject|5|||
161761525|NCT01225211|584164734|FG008|Overall Study|Adverse Event|0|||
161761526|NCT01225211|584164735|FG009|Overall Study|Adverse Event|1|||
161761527|NCT01225211|584164726|FG000|Overall Study|Withdrawal by Subject|0|||
161761528|NCT01225211|584164727|FG001|Overall Study|Withdrawal by Subject|0|||
161761529|NCT01225211|584164728|FG002|Overall Study|Withdrawal by Subject|0|||
161761530|NCT01225211|584164729|FG003|Overall Study|Withdrawal by Subject|0|||
161761531|NCT01225211|584164730|FG004|Overall Study|Withdrawal by Subject|0|||
161761532|NCT01225211|584164731|FG005|Overall Study|Withdrawal by Subject|0|||
161761533|NCT01225211|584164732|FG006|Overall Study|Withdrawal by Subject|1|||
161761534|NCT01225211|584164733|FG007|Overall Study|Withdrawal by Subject|0|||
161761535|NCT01225211|584164734|FG008|Overall Study|Withdrawal by Subject|1|||
161761536|NCT01225211|584164735|FG009|Overall Study|Withdrawal by Subject|3|||
161761537|NCT01225211|584164726|FG000|Overall Study|Other|0|||
161761538|NCT01225211|584164727|FG001|Overall Study|Other|0|||
161761539|NCT01225211|584164728|FG002|Overall Study|Other|0|||
161761540|NCT01225211|584164729|FG003|Overall Study|Other|0|||
161761541|NCT01225211|584164730|FG004|Overall Study|Other|0|||
161761542|NCT01225211|584164731|FG005|Overall Study|Other|0|||
161761543|NCT01225211|584164732|FG006|Overall Study|Other|0|||
161761544|NCT01225211|584164733|FG007|Overall Study|Other|0|||
161761545|NCT01225211|584164734|FG008|Overall Study|Other|0|||
161761546|NCT01225211|584164735|FG009|Overall Study|Other|1|||
161761547|NCT01984294|584164740|FG000|Overall Study|Randomized but Never Treated|0|||
161761548|NCT01984294|584164741|FG001|Overall Study|Randomized but Never Treated|0|||
161761549|NCT01984294|584164742|FG002|Overall Study|Randomized but Never Treated|1|||
161761550|NCT01984294|584164740|FG000|Overall Study|Lack of Efficacy|4|||
161761551|NCT01984294|584164741|FG001|Overall Study|Lack of Efficacy|2|||
161761552|NCT01984294|584164742|FG002|Overall Study|Lack of Efficacy|6|||
161761553|NCT01984294|584164740|FG000|Overall Study|Adverse Event|0|||
161761554|NCT01984294|584164741|FG001|Overall Study|Adverse Event|1|||
161761555|NCT01984294|584164742|FG002|Overall Study|Adverse Event|0|||
161761556|NCT01987609|584164745|FG000|Overall Study|Adverse Event|1|||
161761557|NCT00537810|584164750|FG000|Overall Study|Withdrawal by Subject|4|||
161761558|NCT00537810|584164751|FG001|Overall Study|Withdrawal by Subject|11|||
161761559|NCT00537810|584164752|FG002|Overall Study|Withdrawal by Subject|4|||
161761560|NCT00537810|584164753|FG003|Overall Study|Withdrawal by Subject|3|||
161761561|NCT00537810|584164750|FG000|Overall Study|Medically withdrawn|2|||
161761562|NCT00537810|584164751|FG001|Overall Study|Medically withdrawn|2|||
161761563|NCT00537810|584164752|FG002|Overall Study|Medically withdrawn|0|||
161761564|NCT00537810|584164753|FG003|Overall Study|Medically withdrawn|1|||
161761565|NCT03452397|584164754|FG000|Overall Study|Adverse Event|1|||
161761566|NCT03452397|584164755|FG001|Overall Study|Adverse Event|0|||
161761567|NCT03452397|584164756|FG002|Overall Study|Adverse Event|0|||
161761568|NCT03452397|584164757|FG003|Overall Study|Adverse Event|0|||
161761569|NCT03452397|584164754|FG000|Overall Study|Administrative reason|0|||
161761570|NCT03452397|584164755|FG001|Overall Study|Administrative reason|0|||
161761571|NCT03452397|584164756|FG002|Overall Study|Administrative reason|1|||
161761572|NCT03452397|584164757|FG003|Overall Study|Administrative reason|1|||
161761573|NCT03452397|584164754|FG000|Overall Study|Withdrawal by Subject|0|||
161761574|NCT03452397|584164755|FG001|Overall Study|Withdrawal by Subject|0|||
161761575|NCT03452397|584164756|FG002|Overall Study|Withdrawal by Subject|1|||
161761576|NCT03452397|584164757|FG003|Overall Study|Withdrawal by Subject|0|||
161761577|NCT00410514|584164758|FG000|Overall Study|Adverse Event|2|||
161761578|NCT00410514|584164759|FG001|Overall Study|Adverse Event|2|||
161761579|NCT00410514|584164760|FG002|Overall Study|Adverse Event|2|||
161761580|NCT00410514|584164758|FG000|Overall Study|Protocol Violation|0|||
161761581|NCT00410514|584164759|FG001|Overall Study|Protocol Violation|1|||
161761582|NCT00410514|584164760|FG002|Overall Study|Protocol Violation|1|||
161761583|NCT00410514|584164758|FG000|Overall Study|Lost to Follow-up|0|||
161761584|NCT00410514|584164759|FG001|Overall Study|Lost to Follow-up|0|||
161761585|NCT00410514|584164760|FG002|Overall Study|Lost to Follow-up|2|||
161761586|NCT00410514|584164758|FG000|Overall Study|Non-compliant with study procedures|0|||
161761587|NCT00410514|584164759|FG001|Overall Study|Non-compliant with study procedures|0|||
161761588|NCT00410514|584164760|FG002|Overall Study|Non-compliant with study procedures|2|||
161761589|NCT02449915|584164762|FG000|Overall Study|Exclusion criteria - drug use|1|||
161761590|NCT02449915|584164763|FG001|Overall Study|Exclusion criteria - drug use|0|||
161761591|NCT02449915|584164762|FG000|Overall Study|Withdrawal by Subject|0|||
161761592|NCT02449915|584164763|FG001|Overall Study|Withdrawal by Subject|2|||
161761593|NCT02449915|584164762|FG000|Overall Study|Intraoperative surgical findings|1|||
161761594|NCT02449915|584164763|FG001|Overall Study|Intraoperative surgical findings|1|||
161761595|NCT02449915|584164762|FG000|Overall Study|Abnormal preop lab|0|||
161761596|NCT02449915|584164763|FG001|Overall Study|Abnormal preop lab|1|||
161761597|NCT01436357|584164764|FG000|Overall Study|Death|5|||
161761598|NCT01436357|584164765|FG001|Overall Study|Death|1|||
161761599|NCT01436357|584164764|FG000|Overall Study|Enrolled but not vaccinated|1|||
161761600|NCT01436357|584164765|FG001|Overall Study|Enrolled but not vaccinated|1|||
161761601|NCT01436357|584164764|FG000|Overall Study|Incarceration|18|||
161761602|NCT01436357|584164765|FG001|Overall Study|Incarceration|20|||
161761603|NCT01436357|584164764|FG000|Overall Study|Lost to Follow-up|67|||
161847600|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161761604|NCT01436357|584164765|FG001|Overall Study|Lost to Follow-up|61|||
161761605|NCT01436357|584164764|FG000|Overall Study|Protocol Violation|1|||
161847601|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847602|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847603|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847604|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161761606|NCT01436357|584164765|FG001|Overall Study|Protocol Violation|0|||
161761607|NCT01436357|584164764|FG000|Overall Study|Withdrawal by Subject|26|||
161761608|NCT01436357|584164765|FG001|Overall Study|Withdrawal by Subject|38|||
161761609|NCT01436357|584164764|FG000|Overall Study|Physician Decision|3|||
161761610|NCT01436357|584164765|FG001|Overall Study|Physician Decision|4|||
161971268|NCT02374814|584941110|FG004|Overall Study|Withdrawal by Subject|0|||
161971269|NCT02374814|584941111|FG005|Overall Study|Withdrawal by Subject|0|||
161971270|NCT00884039|584941112|FG000|Overall Study|Withdrawal by Subject|0|||
161971271|NCT00884039|584941113|FG001|Overall Study|Withdrawal by Subject|1|||
161971272|NCT00884039|584941112|FG000|Overall Study|Lack of Efficacy|2|||
161971273|NCT00884039|584941113|FG001|Overall Study|Lack of Efficacy|0|||
161971274|NCT05291936|584941114|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
161971275|NCT05291936|584941115|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
161971276|NCT05291936|584941114|FG000|Period 1|Withdrew Consent during study|1|||
161971277|NCT05291936|584941115|FG001|Period 1|Withdrew Consent during study|0|||
161971278|NCT05291936|584941114|FG000|Period 2|Adverse Event|0|||
161971279|NCT05291936|584941115|FG001|Period 2|Adverse Event|1|||
161971280|NCT05291936|584941114|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
161971281|NCT05291936|584941115|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
161971282|NCT01300819|584941116|FG000|Overall Study|Adverse Event|9|||
161971283|NCT01300819|584941117|FG001|Overall Study|Adverse Event|27|||
161971284|NCT01300819|584941116|FG000|Overall Study|Lack of Efficacy|2|||
161971285|NCT01300819|584941117|FG001|Overall Study|Lack of Efficacy|1|||
161971286|NCT01300819|584941116|FG000|Overall Study|Withdrawal by Subject|10|||
161971287|NCT01300819|584941117|FG001|Overall Study|Withdrawal by Subject|12|||
161971288|NCT01300819|584941116|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
161971289|NCT01300819|584941117|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
161971290|NCT01300819|584941116|FG000|Overall Study|Refusal to down titrate study drug|0|||
161971291|NCT01300819|584941117|FG001|Overall Study|Refusal to down titrate study drug|1|||
161971292|NCT01300819|584941116|FG000|Overall Study|Administrative reason|0|||
161971293|NCT01300819|584941117|FG001|Overall Study|Administrative reason|1|||
161971294|NCT01300819|584941116|FG000|Overall Study|Safety follow up not done by mistake|0|||
161971295|NCT01300819|584941117|FG001|Overall Study|Safety follow up not done by mistake|1|||
161971296|NCT01300819|584941116|FG000|Overall Study|Follow up call was not done|1|||
161971297|NCT01300819|584941117|FG001|Overall Study|Follow up call was not done|0|||
161971298|NCT02210832|584943277|FG000|Overall Study|Pregnancy termination .|3|||
161971299|NCT02210832|584943278|FG001|Overall Study|Pregnancy termination .|4|||
161971300|NCT02210832|584943279|FG002|Overall Study|Pregnancy termination .|1|||
161971301|NCT02210832|584943277|FG000|Overall Study|Lost to Follow-up|26|||
161971302|NCT02210832|584943278|FG001|Overall Study|Lost to Follow-up|32|||
161971303|NCT02210832|584943279|FG002|Overall Study|Lost to Follow-up|17|||
161971304|NCT00471887|584943282|FG000|Overall Study|Adverse Event|9|||
161971305|NCT03710876|584943287|FG000|Overall Study|Death|0|||
161971306|NCT03710876|584943288|FG001|Overall Study|Death|2|||
161971307|NCT03710876|584943287|FG000|Overall Study|Withdrawal by Subject|0|||
161971308|NCT03710876|584943288|FG001|Overall Study|Withdrawal by Subject|2|||
161971309|NCT01278407|584943289|FG000|Confirmatory Phase|Adverse Event|5|||
161971310|NCT01278407|584943290|FG001|Confirmatory Phase|Adverse Event|10|||
161971311|NCT01278407|584943291|FG002|Confirmatory Phase|Adverse Event|1|||
161971312|NCT01278407|584943292|FG003|Confirmatory Phase|Adverse Event|0|||
161971313|NCT01278407|584943293|FG004|Confirmatory Phase|Adverse Event|0|||
161971314|NCT01278407|584943289|FG000|Confirmatory Phase|Participant's Choice|3|||
161971315|NCT01278407|584943290|FG001|Confirmatory Phase|Participant's Choice|5|||
161971316|NCT01278407|584943291|FG002|Confirmatory Phase|Participant's Choice|3|||
161971317|NCT01278407|584943292|FG003|Confirmatory Phase|Participant's Choice|0|||
161971318|NCT01278407|584943293|FG004|Confirmatory Phase|Participant's Choice|0|||
161971319|NCT01278407|584943289|FG000|Confirmatory Phase|Other|1|||
161971320|NCT01278407|584943290|FG001|Confirmatory Phase|Other|1|||
161971321|NCT01278407|584943291|FG002|Confirmatory Phase|Other|2|||
161971322|NCT01278407|584943292|FG003|Confirmatory Phase|Other|0|||
161971323|NCT01278407|584943293|FG004|Confirmatory Phase|Other|0|||
161971324|NCT01278407|584943289|FG000|Extension Phase|Adverse Event|0|||
161971325|NCT01278407|584943290|FG001|Extension Phase|Adverse Event|0|||
161971326|NCT01278407|584943291|FG002|Extension Phase|Adverse Event|0|||
161971327|NCT01278407|584943292|FG003|Extension Phase|Adverse Event|7|||
161971328|NCT01278407|584943293|FG004|Extension Phase|Adverse Event|16|||
161971329|NCT01278407|584943289|FG000|Extension Phase|Participant's Choice|0|||
161971330|NCT01278407|584943290|FG001|Extension Phase|Participant's Choice|0|||
161971331|NCT01278407|584943291|FG002|Extension Phase|Participant's Choice|0|||
161971332|NCT01278407|584943292|FG003|Extension Phase|Participant's Choice|4|||
161971333|NCT01278407|584943293|FG004|Extension Phase|Participant's Choice|11|||
161971334|NCT01278407|584943289|FG000|Extension Phase|Other|0|||
161971335|NCT01278407|584943290|FG001|Extension Phase|Other|0|||
161971336|NCT01278407|584943291|FG002|Extension Phase|Other|0|||
161971337|NCT01278407|584943292|FG003|Extension Phase|Other|1|||
161971338|NCT01278407|584943293|FG004|Extension Phase|Other|3|||
161971339|NCT02534935|584943295|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
161971340|NCT02534935|584943296|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
161971341|NCT02534935|584943297|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
161971342|NCT02534935|584943295|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
161971343|NCT02534935|584943296|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
161761611|NCT01436357|584164764|FG000|Overall Study|Moved out of area|1|||
161971344|NCT02534935|584943297|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
161761612|NCT01436357|584164765|FG001|Overall Study|Moved out of area|2|||
161761613|NCT01436357|584164764|FG000|Overall Study|Subject in rehab|0|||
161761614|NCT01436357|584164765|FG001|Overall Study|Subject in rehab|1|||
161761615|NCT04223778|584164776|FG000|Overall Study|Death|1|||
161761616|NCT04223778|584164777|FG001|Overall Study|Death|1|||
161761617|NCT04223778|584164776|FG000|Overall Study|Lost to Follow-up|4|||
161761618|NCT04223778|584164777|FG001|Overall Study|Lost to Follow-up|5|||
161761619|NCT04223778|584164776|FG000|Overall Study|Physician Decision|10|||
161761620|NCT04223778|584164777|FG001|Overall Study|Physician Decision|6|||
161761621|NCT04223778|584164776|FG000|Overall Study|Withdrawal by Subject|35|||
161761622|NCT04223778|584164777|FG001|Overall Study|Withdrawal by Subject|17|||
161761623|NCT04223778|584164776|FG000|Overall Study|Not Reported|7|||
161761624|NCT04223778|584164777|FG001|Overall Study|Not Reported|8|||
161761625|NCT03893630|584164780|FG000|Overall Study|Lost to Follow-up|5|||
161761626|NCT03893630|584164781|FG001|Overall Study|Lost to Follow-up|4|||
161761627|NCT03893630|584164782|FG002|Overall Study|Lost to Follow-up|2|||
161761628|NCT03893630|584164780|FG000|Overall Study|Withdrawal by Subject|3|||
161761629|NCT03893630|584164781|FG001|Overall Study|Withdrawal by Subject|6|||
161761630|NCT03893630|584164782|FG002|Overall Study|Withdrawal by Subject|3|||
161761631|NCT03893630|584164780|FG000|Overall Study|Discontinued Intervention|0|||
161761632|NCT03893630|584164781|FG001|Overall Study|Discontinued Intervention|4|||
161761633|NCT03893630|584164782|FG002|Overall Study|Discontinued Intervention|2|||
161761634|NCT00303602|584165982|FG000|Overall Study|Adverse Event|2|||
161761635|NCT00303602|584165983|FG001|Overall Study|Adverse Event|2|||
161761636|NCT00303602|584165982|FG000|Overall Study|Withdrawal by Subject|5|||
161761637|NCT00303602|584165983|FG001|Overall Study|Withdrawal by Subject|6|||
161761638|NCT00303602|584165982|FG000|Overall Study|Lost to Follow-up|5|||
161761639|NCT00303602|584165983|FG001|Overall Study|Lost to Follow-up|2|||
161761640|NCT00303602|584165982|FG000|Overall Study|Protocol entry criteria not met|2|||
161761641|NCT00303602|584165983|FG001|Overall Study|Protocol entry criteria not met|2|||
161761642|NCT00303602|584165982|FG000|Overall Study|Physician Decision|2|||
161761643|NCT00303602|584165983|FG001|Overall Study|Physician Decision|1|||
161761644|NCT00303602|584165982|FG000|Overall Study|Noncompliance|2|||
161761645|NCT00303602|584165983|FG001|Overall Study|Noncompliance|2|||
161761646|NCT00303602|584165982|FG000|Overall Study|Protocol Violation|1|||
161761647|NCT00303602|584165983|FG001|Overall Study|Protocol Violation|0|||
161761648|NCT00750867|584165990|FG000|Overall Study|Adverse Event|2|||
161761649|NCT00394654|584165991|FG000|Overall Study|Lost to Follow-up|1|||
161761650|NCT00394654|584165992|FG001|Overall Study|Lost to Follow-up|0|||
161761651|NCT00394654|584165991|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
161761652|NCT00394654|584165992|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
161761653|NCT00474539|584165993|FG000|Infant Series|Withdrawal by Subject|3|||
161761654|NCT00474539|584165994|FG001|Infant Series|Withdrawal by Subject|4|||
161761655|NCT00474539|584165993|FG000|Infant Series|Randomization error|5|||
161761656|NCT00474539|584165994|FG001|Infant Series|Randomization error|0|||
161761657|NCT00474539|584165993|FG000|Infant Series|Lost to Follow-up|2|||
161761658|NCT00474539|584165994|FG001|Infant Series|Lost to Follow-up|1|||
161761659|NCT00474539|584165993|FG000|Infant Series|Protocol Violation|0|||
161761660|NCT00474539|584165994|FG001|Infant Series|Protocol Violation|1|||
161761661|NCT00474539|584165993|FG000|After Infant Series|Lost to Follow-up|3|||
161761662|NCT00474539|584165994|FG001|After Infant Series|Lost to Follow-up|0|||
161761663|NCT00474539|584165993|FG000|After Infant Series|Withdrawal by Subject|1|||
161761664|NCT00474539|584165994|FG001|After Infant Series|Withdrawal by Subject|0|||
161761665|NCT00474539|584165993|FG000|Toddler Dose|Protocol Violation|1|||
161761666|NCT00474539|584165994|FG001|Toddler Dose|Protocol Violation|0|||
161761667|NCT03442595|584165995|FG000|Overall Study|Lost to Follow-up|94|||
161761668|NCT03442595|584165996|FG001|Overall Study|Lost to Follow-up|0|||
161761669|NCT01060150|584166001|FG000|Overall Study|Adverse Event|6|||
161761670|NCT01060150|584166001|FG000|Overall Study|Lost to Follow-up|1|||
161761671|NCT01060150|584166001|FG000|Overall Study|Protocol Violation|6|||
161761672|NCT01060150|584166001|FG000|Overall Study|Withdrawal by Subject|8|||
161761673|NCT01060150|584166001|FG000|Overall Study|Enrolled, but not treated|2|||
161761674|NCT01836549|584166002|FG000|Overall Study|Did not receive study drug|0|||
161761675|NCT01836549|584166003|FG001|Overall Study|Did not receive study drug|0|||
161761676|NCT01836549|584166004|FG002|Overall Study|Did not receive study drug|1|||
161761677|NCT01836549|584166005|FG003|Overall Study|Did not receive study drug|0|||
161971345|NCT02534935|584943295|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
161971346|NCT02534935|584943296|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
161761678|NCT01836549|584166006|FG004|Overall Study|Did not receive study drug|0|||
161761679|NCT01836549|584166007|FG005|Overall Study|Did not receive study drug|0|||
161761680|NCT01836549|584166008|FG006|Overall Study|Did not receive study drug|0|||
161761681|NCT01836549|584166002|FG000|Overall Study|Patient declared ineligible|0|||
161761682|NCT01836549|584166003|FG001|Overall Study|Patient declared ineligible|0|||
161761683|NCT01836549|584166004|FG002|Overall Study|Patient declared ineligible|0|||
161761684|NCT01836549|584166005|FG003|Overall Study|Patient declared ineligible|1|||
161847605|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847606|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847607|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
161847608|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847609|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847610|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847611|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847612|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161847613|NCT03982199|584482429|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847614|NCT03982199|584482430|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847615|NCT03982199|584482431|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847616|NCT03982199|584482432|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847617|NCT03982199|584482433|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847618|NCT03982199|584482434|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
161847619|NCT03982199|584482435|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847620|NCT03982199|584482436|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
161847621|NCT03982199|584482437|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
161847622|NCT03982199|584482438|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847623|NCT03982199|584482439|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847624|NCT03982199|584482440|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847625|NCT03982199|584482441|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847626|NCT03982199|584482442|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161847627|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847628|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847629|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847630|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847631|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847632|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847633|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847634|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847635|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161847636|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
161847637|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
161847638|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
161847639|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
161847640|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
161847641|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847642|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847643|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847644|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161971347|NCT02534935|584943297|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
161971348|NCT02534935|584943295|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
161971349|NCT02534935|584943296|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
161761685|NCT01836549|584166006|FG004|Overall Study|Patient declared ineligible|0|||
161761686|NCT01836549|584166007|FG005|Overall Study|Patient declared ineligible|0|||
161761687|NCT01836549|584166008|FG006|Overall Study|Patient declared ineligible|0|||
161761688|NCT01836549|584166002|FG000|Overall Study|Patient inevaluable to start therapy|0|||
161761689|NCT01836549|584166003|FG001|Overall Study|Patient inevaluable to start therapy|0|||
161761690|NCT01836549|584166004|FG002|Overall Study|Patient inevaluable to start therapy|0|||
161761691|NCT01836549|584166005|FG003|Overall Study|Patient inevaluable to start therapy|0|||
161761692|NCT01836549|584166006|FG004|Overall Study|Patient inevaluable to start therapy|0|||
161761693|NCT01836549|584166007|FG005|Overall Study|Patient inevaluable to start therapy|0|||
161761694|NCT01836549|584166008|FG006|Overall Study|Patient inevaluable to start therapy|1|||
161761695|NCT00381706|584166009|FG000|Overall Study|Never treated|7|||
161761696|NCT00381706|584166010|FG001|Overall Study|Never treated|2|||
161761697|NCT00381706|584166011|FG002|Overall Study|Never treated|1|||
161761698|NCT02364999|584166012|FG000|Overall Study|Death|136|||
161761699|NCT02364999|584166013|FG001|Overall Study|Death|138|||
161761700|NCT02364999|584166012|FG000|Overall Study|Lost to Follow-up|10|||
161761701|NCT02364999|584166013|FG001|Overall Study|Lost to Follow-up|15|||
161761702|NCT02364999|584166012|FG000|Overall Study|Protocol Violation|3|||
161761703|NCT02364999|584166013|FG001|Overall Study|Protocol Violation|2|||
161761704|NCT02364999|584166012|FG000|Overall Study|Withdrawal by Subject|14|||
161761705|NCT02364999|584166013|FG001|Overall Study|Withdrawal by Subject|14|||
162033024|NCT02186301|585178574|FG001|Overall Study|Withdrawal by Subject|1|||
162033025|NCT02186301|585178575|FG002|Overall Study|Withdrawal by Subject|3|||
162033026|NCT02186301|585178573|FG000|Overall Study|Physician Decision|1|||
162033027|NCT02186301|585178574|FG001|Overall Study|Physician Decision|0|||
162033028|NCT02186301|585178575|FG002|Overall Study|Physician Decision|1|||
162033029|NCT02186301|585178573|FG000|Overall Study|Study Terminated by Sponsor|1|||
162033030|NCT02186301|585178574|FG001|Overall Study|Study Terminated by Sponsor|0|||
162033031|NCT02186301|585178575|FG002|Overall Study|Study Terminated by Sponsor|11|||
162033032|NCT02186301|585178573|FG000|Overall Study|Protocol Deviation|0|||
162033033|NCT02186301|585178574|FG001|Overall Study|Protocol Deviation|2|||
162033034|NCT02186301|585178575|FG002|Overall Study|Protocol Deviation|0|||
162033035|NCT02186301|585178573|FG000|Overall Study|Missing|0|||
162033036|NCT02186301|585178574|FG001|Overall Study|Missing|0|||
162033037|NCT02186301|585178575|FG002|Overall Study|Missing|2|||
162033038|NCT02186301|585178573|FG000|Overall Study|Other|0|||
162033039|NCT02186301|585178574|FG001|Overall Study|Other|0|||
162033040|NCT02186301|585178575|FG002|Overall Study|Other|1|||
162033041|NCT01343823|585178576|FG000|Overall Study|Study Terminated|1|||
162033042|NCT01343823|585178577|FG001|Overall Study|Study Terminated|0|||
162033043|NCT01343823|585178578|FG002|Overall Study|Study Terminated|0|||
162033044|NCT01343823|585178579|FG003|Overall Study|Study Terminated|1|||
162033045|NCT01343823|585178576|FG000|Overall Study|Withdrawal by Subject|1|||
162033046|NCT01343823|585178577|FG001|Overall Study|Withdrawal by Subject|0|||
162033047|NCT01343823|585178578|FG002|Overall Study|Withdrawal by Subject|0|||
162033048|NCT01343823|585178579|FG003|Overall Study|Withdrawal by Subject|0|||
162033049|NCT03468543|585178582|FG000|Overall Study|Protocol stopping rules met|3|||
162033050|NCT00807027|585178586|FG000|Overall Study|Withdrawal by Subject|13|||
162033051|NCT00807027|585178587|FG001|Overall Study|Withdrawal by Subject|14|||
162033052|NCT00807027|585178586|FG000|Overall Study|Protocol Violation|1|||
162033053|NCT00807027|585178587|FG001|Overall Study|Protocol Violation|1|||
162033054|NCT00807027|585178586|FG000|Overall Study|Adverse Event|2|||
162033055|NCT00807027|585178587|FG001|Overall Study|Adverse Event|2|||
162033056|NCT01117792|585178588|FG000|Overall Study|Death|1|||
162033057|NCT01117792|585178588|FG000|Overall Study|Adverse Event|3|||
162033058|NCT05867342|585178589|FG000|Overall Study|Investigator Decision|3|||
162033059|NCT05867342|585178590|FG001|Overall Study|Investigator Decision|3|||
162033060|NCT00723203|585178591|FG000|Overall Study|Withdrawal by Subject|3|||
162033061|NCT00274924|585178592|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
162033062|NCT00274924|585178593|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
162033063|NCT00274924|585178594|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
162033064|NCT00274924|585178592|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
161971350|NCT02534935|584943297|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
161971351|NCT02534935|584943295|FG000|Stage 1: 24 Months|Adverse Event|0|||
161971352|NCT02534935|584943296|FG001|Stage 1: 24 Months|Adverse Event|2|||
161971353|NCT02534935|584943297|FG002|Stage 1: 24 Months|Adverse Event|0|||
161971354|NCT02534935|584943295|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
161971355|NCT02534935|584943296|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
161971356|NCT02534935|584943297|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
161971357|NCT02534935|584943295|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
161971358|NCT02534935|584943296|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
161971359|NCT02534935|584943297|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
161971360|NCT01460719|584943298|FG000|Overall Study|Adverse Event|1|||
161971361|NCT01460719|584943298|FG000|Overall Study|Withdrawal by Subject|1|||
161971362|NCT03602885|584943304|FG000|Overall Study|Lost to Follow-up|3|||
161971363|NCT03602885|584943305|FG001|Overall Study|Lost to Follow-up|0|||
161971364|NCT01007123|584943310|FG000|Overall Study|Adverse Event|3|||
161971365|NCT01007123|584943311|FG001|Overall Study|Adverse Event|4|||
161971366|NCT01007123|584943312|FG002|Overall Study|Adverse Event|7|||
161971367|NCT01007123|584943313|FG003|Overall Study|Adverse Event|1|||
162033065|NCT00274924|585178593|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
162033066|NCT00274924|585178594|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
162033067|NCT00274924|585178592|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
162033068|NCT00274924|585178593|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
162033069|NCT00274924|585178594|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
162033070|NCT00274924|585178592|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
162033071|NCT00274924|585178593|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
161971368|NCT01007123|584943310|FG000|Overall Study|Lack of Efficacy|1|||
162033072|NCT00274924|585178594|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
161971369|NCT01007123|584943311|FG001|Overall Study|Lack of Efficacy|0|||
161971370|NCT01007123|584943312|FG002|Overall Study|Lack of Efficacy|1|||
162033073|NCT00274924|585178592|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
161971371|NCT01007123|584943313|FG003|Overall Study|Lack of Efficacy|4|||
161971372|NCT01007123|584943310|FG000|Overall Study|Protocol Violation|1|||
162033074|NCT00274924|585178593|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
162033075|NCT00274924|585178594|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
162033076|NCT00274924|585178592|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
161847645|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847646|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847647|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847648|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847649|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847650|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
161847651|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847652|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847653|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847654|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161847655|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847656|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847657|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847658|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847659|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847660|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847661|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847662|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847663|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847664|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847665|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847666|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847667|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161847668|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
161847669|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847670|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847671|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847672|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847673|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847674|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847675|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847676|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847677|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847678|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847679|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
161847680|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
161847681|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
161847682|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161847683|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847684|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847685|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847686|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847687|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847688|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847689|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847690|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847691|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847692|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847693|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161971373|NCT01007123|584943311|FG001|Overall Study|Protocol Violation|1|||
161971374|NCT01007123|584943312|FG002|Overall Study|Protocol Violation|2|||
161761706|NCT02364999|584166012|FG000|Overall Study|Other|0|||
161761707|NCT02364999|584166013|FG001|Overall Study|Other|1|||
161761708|NCT02364999|584166012|FG000|Overall Study|Randomized but did not receive treatment|2|||
161761709|NCT02364999|584166013|FG001|Overall Study|Randomized but did not receive treatment|3|||
161761710|NCT00550615|584166014|FG000|Overall Study|Withdrawal by Subject|0|||
161761711|NCT00550615|584166015|FG001|Overall Study|Withdrawal by Subject|0|||
161761712|NCT00550615|584166016|FG002|Overall Study|Withdrawal by Subject|2|||
161761713|NCT00550615|584166017|FG003|Overall Study|Withdrawal by Subject|3|||
161761714|NCT00550615|584166014|FG000|Overall Study|Not evaluable|0|||
161761715|NCT00550615|584166015|FG001|Overall Study|Not evaluable|0|||
161761716|NCT00550615|584166016|FG002|Overall Study|Not evaluable|2|||
161761717|NCT00550615|584166017|FG003|Overall Study|Not evaluable|7|||
161761718|NCT01234337|584166018|FG000|Overall Study|Adverse Event|58|||
161761719|NCT01234337|584166019|FG001|Overall Study|Adverse Event|21|||
161761720|NCT01234337|584166018|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
161761721|NCT01234337|584166019|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
161761722|NCT01234337|584166018|FG000|Overall Study|Investi. decision not protocol driven|5|||
161761723|NCT01234337|584166019|FG001|Overall Study|Investi. decision not protocol driven|6|||
161761724|NCT01234337|584166018|FG000|Overall Study|Non-compliant with study medication|3|||
161761725|NCT01234337|584166019|FG001|Overall Study|Non-compliant with study medication|2|||
161761726|NCT01234337|584166018|FG000|Overall Study|Randomized but not treated|6|||
161761727|NCT01234337|584166019|FG001|Overall Study|Randomized but not treated|4|||
161761728|NCT01234337|584166018|FG000|Overall Study|Lost to Follow-up|0|||
161761729|NCT01234337|584166019|FG001|Overall Study|Lost to Follow-up|1|||
161761730|NCT01234337|584166018|FG000|Overall Study|Protocol Violation|2|||
161761731|NCT01234337|584166019|FG001|Overall Study|Protocol Violation|3|||
161761732|NCT01234337|584166018|FG000|Overall Study|Withdrawal by Subject|11|||
161761733|NCT01234337|584166019|FG001|Overall Study|Withdrawal by Subject|9|||
161761734|NCT01234337|584166018|FG000|Overall Study|Death|0|||
161761735|NCT01234337|584166019|FG001|Overall Study|Death|1|||
161761736|NCT01234337|584166018|FG000|Overall Study|Switch to commercial drug|0|||
161761737|NCT01234337|584166019|FG001|Overall Study|Switch to commercial drug|1|||
161761738|NCT02181504|584166023|FG000|Overall Study|Adverse Event|1|||
161761739|NCT02181504|584166024|FG001|Overall Study|Adverse Event|1|||
161761740|NCT02181504|584166025|FG002|Overall Study|Adverse Event|1|||
161761741|NCT00545584|584166032|FG000|Overall Study|Only one reason for discontinuation|62|||
161761742|NCT00545584|584166033|FG001|Overall Study|Only one reason for discontinuation|61|||
161761743|NCT00545584|584166034|FG002|Overall Study|Only one reason for discontinuation|48|||
161761744|NCT00545584|584166032|FG000|Overall Study|Two or more reasons for discontinuation|17|||
161761745|NCT00545584|584166033|FG001|Overall Study|Two or more reasons for discontinuation|19|||
161761746|NCT00545584|584166034|FG002|Overall Study|Two or more reasons for discontinuation|8|||
161761747|NCT00135694|584166040|FG000|Overall Study|Adverse Event|17|||
161761748|NCT00135694|584166041|FG001|Overall Study|Adverse Event|4|||
161761749|NCT00135694|584166042|FG002|Overall Study|Adverse Event|0|||
161761750|NCT00135694|584166040|FG000|Overall Study|Death|14|||
161761751|NCT00135694|584166041|FG001|Overall Study|Death|1|||
161761752|NCT00135694|584166042|FG002|Overall Study|Death|2|||
161761753|NCT00135694|584166040|FG000|Overall Study|Lost to Follow-up|8|||
161761754|NCT00135694|584166041|FG001|Overall Study|Lost to Follow-up|7|||
161761755|NCT00135694|584166042|FG002|Overall Study|Lost to Follow-up|1|||
161761756|NCT00135694|584166040|FG000|Overall Study|Withdrawal by Subject|41|||
161761757|NCT00135694|584166041|FG001|Overall Study|Withdrawal by Subject|7|||
161761758|NCT00135694|584166042|FG002|Overall Study|Withdrawal by Subject|4|||
161761759|NCT00135694|584166040|FG000|Overall Study|Protocol Violation|19|||
161761760|NCT00135694|584166041|FG001|Overall Study|Protocol Violation|1|||
161761761|NCT00135694|584166042|FG002|Overall Study|Protocol Violation|0|||
161761762|NCT00135694|584166040|FG000|Overall Study|Hepatitis C related reasons|39|||
161761763|NCT00135694|584166041|FG001|Overall Study|Hepatitis C related reasons|1|||
161761764|NCT00135694|584166042|FG002|Overall Study|Hepatitis C related reasons|0|||
161761765|NCT00135694|584166040|FG000|Overall Study|Ineligible for Random assignment|42|||
161761766|NCT00135694|584166041|FG001|Overall Study|Ineligible for Random assignment|0|||
161761767|NCT00135694|584166042|FG002|Overall Study|Ineligible for Random assignment|0|||
161761768|NCT02584660|584166043|FG000|Overall Study|Adverse Event|4|||
161761769|NCT02584660|584166044|FG001|Overall Study|Adverse Event|0|||
161761770|NCT02584660|584166043|FG000|Overall Study|Lost to Follow-up|3|||
161761771|NCT02584660|584166044|FG001|Overall Study|Lost to Follow-up|4|||
161761772|NCT02584660|584166043|FG000|Overall Study|Protocol Violation|0|||
161761773|NCT02584660|584166044|FG001|Overall Study|Protocol Violation|1|||
161761774|NCT02584660|584166043|FG000|Overall Study|Withdrawal by Subject|0|||
161761775|NCT02584660|584166044|FG001|Overall Study|Withdrawal by Subject|2|||
161761776|NCT02584660|584166043|FG000|Overall Study|Other|0|||
161761777|NCT02584660|584166044|FG001|Overall Study|Other|1|||
161761778|NCT00461552|584166045|FG000|Overall Study|Drug Dispensing error|0|||
161761779|NCT00461552|584166046|FG001|Overall Study|Drug Dispensing error|2|||
161761780|NCT00660816|584166047|FG000|Overall Study|Adverse Event|1|||
161761781|NCT00660816|584166048|FG001|Overall Study|Adverse Event|2|||
161761782|NCT00660816|584166047|FG000|Overall Study|Withdrawal by Subject|1|||
161761783|NCT00660816|584166048|FG001|Overall Study|Withdrawal by Subject|0|||
161761784|NCT00660816|584166047|FG000|Overall Study|Death|0|||
161761785|NCT00660816|584166048|FG001|Overall Study|Death|2|||
161761786|NCT00660816|584166047|FG000|Overall Study|Lack of Efficacy|1|||
161761787|NCT00660816|584166048|FG001|Overall Study|Lack of Efficacy|0|||
161761788|NCT00660816|584166047|FG000|Overall Study|Physician Decision|0|||
161761789|NCT00660816|584166048|FG001|Overall Study|Physician Decision|2|||
161761790|NCT00660816|584166047|FG000|Overall Study|Protocol Violation|1|||
161761791|NCT00660816|584166048|FG001|Overall Study|Protocol Violation|0|||
161761792|NCT00660816|584166047|FG000|Overall Study|Disease Progression|16|||
161761793|NCT00660816|584166048|FG001|Overall Study|Disease Progression|12|||
161761794|NCT00660816|584166047|FG000|Overall Study|Complicating Disease|0|||
161761795|NCT00660816|584166048|FG001|Overall Study|Complicating Disease|1|||
161761796|NCT00374452|584166049|FG000|Overall Study|Left clinic before intervention started|4|||
161761797|NCT00374452|584166050|FG001|Overall Study|Left clinic before intervention started|1|||
161761798|NCT00374452|584166049|FG000|Overall Study|Change in job role before intervention|0|||
161761799|NCT00374452|584166050|FG001|Overall Study|Change in job role before intervention|1|||
161761800|NCT00374452|584166049|FG000|Overall Study|Left clinic after intervention started|1|||
161761801|NCT00374452|584166050|FG001|Overall Study|Left clinic after intervention started|1|||
161761802|NCT00374452|584166049|FG000|Overall Study|Withdrawal by Subject|0|||
161761803|NCT00374452|584166050|FG001|Overall Study|Withdrawal by Subject|2|||
161761804|NCT02877134|584166051|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761805|NCT02877134|584166052|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
161761806|NCT02877134|584166053|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761807|NCT02877134|584166054|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761808|NCT02877134|584166055|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761809|NCT02877134|584166056|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
161761810|NCT02877134|584166057|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761811|NCT02877134|584166058|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761812|NCT02877134|584166059|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761813|NCT02877134|584166060|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761814|NCT02877134|584166061|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761815|NCT02877134|584166062|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
161761816|NCT02877134|584166051|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761817|NCT02877134|584166052|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
161761818|NCT02877134|584166053|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761819|NCT02877134|584166054|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
161761820|NCT02877134|584166055|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761821|NCT02877134|584166056|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761822|NCT02877134|584166057|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
161761823|NCT02877134|584166058|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761824|NCT02877134|584166059|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761825|NCT02877134|584166060|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761826|NCT02877134|584166061|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761827|NCT02877134|584166062|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161761828|NCT02877134|584166051|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
161761829|NCT02877134|584166052|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
161761830|NCT02877134|584166053|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
161761831|NCT02877134|584166054|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
161761832|NCT02877134|584166055|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
161761833|NCT02877134|584166056|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
161761834|NCT02877134|584166057|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
161761835|NCT02877134|584166058|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161761836|NCT02877134|584166059|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161761837|NCT02877134|584166060|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161761838|NCT02877134|584166061|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161761839|NCT02877134|584166062|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161761840|NCT02877134|584166051|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
161761841|NCT02877134|584166052|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
161761842|NCT02877134|584166053|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
161761843|NCT02877134|584166054|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
161761844|NCT02877134|584166055|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
161761845|NCT02877134|584166056|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
161761846|NCT02877134|584166057|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
161761847|NCT02877134|584166058|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
161761848|NCT02877134|584166059|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
161761849|NCT02877134|584166060|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
161761850|NCT02877134|584166061|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
161761851|NCT02877134|584166062|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
161761852|NCT02877134|584166051|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761853|NCT02877134|584166052|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761854|NCT02877134|584166053|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761855|NCT02877134|584166054|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761856|NCT02877134|584166055|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761857|NCT02877134|584166056|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761858|NCT02877134|584166057|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761859|NCT02877134|584166058|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761860|NCT02877134|584166059|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
161761861|NCT02877134|584166060|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761862|NCT02877134|584166061|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161847694|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161971375|NCT01007123|584943313|FG003|Overall Study|Protocol Violation|1|||
161761863|NCT02877134|584166062|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161761864|NCT02877134|584166051|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761865|NCT02877134|584166052|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761866|NCT02877134|584166053|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761867|NCT02877134|584166054|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761868|NCT02877134|584166055|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761869|NCT02877134|584166056|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761870|NCT02877134|584166057|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161761871|NCT02877134|584166058|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
161761872|NCT02877134|584166059|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
161761873|NCT02877134|584166060|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
161761874|NCT02877134|584166061|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
161761875|NCT02877134|584166062|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
161761876|NCT02877134|584166051|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761877|NCT02877134|584166052|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761878|NCT02877134|584166053|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761879|NCT02877134|584166054|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761880|NCT02877134|584166055|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761881|NCT02877134|584166056|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761882|NCT02877134|584166057|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761883|NCT02877134|584166058|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
161761884|NCT02877134|584166059|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
161761885|NCT02877134|584166060|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
161761886|NCT02877134|584166061|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761887|NCT02877134|584166062|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161761888|NCT02877134|584166051|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
161761889|NCT02877134|584166052|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
161761890|NCT02877134|584166053|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
161761891|NCT02877134|584166054|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
161761892|NCT02877134|584166055|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
161761893|NCT02877134|584166056|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
161761894|NCT02877134|584166057|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
161761895|NCT02877134|584166058|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
161761896|NCT02877134|584166059|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
161761897|NCT02877134|584166060|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
161761898|NCT02877134|584166061|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
161761899|NCT02877134|584166062|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
161761900|NCT00523744|584166063|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
161761901|NCT00523744|584166063|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
161761902|NCT00523744|584166063|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
161761903|NCT00523744|584166063|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
161761904|NCT00523744|584166063|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
161761905|NCT00523744|584166063|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
161761906|NCT01289028|584166064|FG000|Overall Study|Progressive Disease|49|||
161761907|NCT01289028|584166064|FG000|Overall Study|Adverse Event|14|||
161761908|NCT01289028|584166064|FG000|Overall Study|Withdrawal by Subject|6|||
161761909|NCT01289028|584166064|FG000|Overall Study|Death|4|||
161761910|NCT01289028|584166064|FG000|Overall Study|Lack of Efficacy|2|||
161761911|NCT01289028|584166064|FG000|Overall Study|No longer required|2|||
161761912|NCT01289028|584166064|FG000|Overall Study|Lost to Follow-up|2|||
161761913|NCT01289028|584166064|FG000|Overall Study|New Cancer Therapy|2|||
161761914|NCT01289028|584166064|FG000|Overall Study|Abnormal Lab Value|1|||
161761915|NCT01289028|584166064|FG000|Overall Study|Missing reason for discon|1|||
161761916|NCT00998985|584166071|FG000|Overall Study|Withdrawal by Subject|0|||
161761917|NCT00998985|584166072|FG001|Overall Study|Withdrawal by Subject|0|||
161761918|NCT00998985|584166073|FG002|Overall Study|Withdrawal by Subject|0|||
161761919|NCT00998985|584166074|FG003|Overall Study|Withdrawal by Subject|0|||
161761920|NCT00998985|584166075|FG004|Overall Study|Withdrawal by Subject|0|||
161761921|NCT00998985|584166076|FG005|Overall Study|Withdrawal by Subject|0|||
161761922|NCT00998985|584166077|FG006|Overall Study|Withdrawal by Subject|0|||
161761923|NCT00998985|584166078|FG007|Overall Study|Withdrawal by Subject|0|||
161761924|NCT00998985|584166079|FG008|Overall Study|Withdrawal by Subject|1|||
161761925|NCT00998985|584166080|FG009|Overall Study|Withdrawal by Subject|0|||
161761926|NCT00998985|584166081|FG010|Overall Study|Withdrawal by Subject|0|||
161761927|NCT00998985|584166082|FG011|Overall Study|Withdrawal by Subject|0|||
161761928|NCT00998985|584166083|FG012|Overall Study|Withdrawal by Subject|0|||
161761929|NCT00998985|584166084|FG013|Overall Study|Withdrawal by Subject|0|||
161761930|NCT00998985|584166071|FG000|Overall Study|Protocol Violation|0|||
161761931|NCT00998985|584166072|FG001|Overall Study|Protocol Violation|0|||
161761932|NCT00998985|584166073|FG002|Overall Study|Protocol Violation|0|||
161761933|NCT00998985|584166074|FG003|Overall Study|Protocol Violation|0|||
161971376|NCT01007123|584943310|FG000|Overall Study|Withdrawal by Subject|1|||
161971377|NCT01007123|584943311|FG001|Overall Study|Withdrawal by Subject|0|||
161971378|NCT01007123|584943312|FG002|Overall Study|Withdrawal by Subject|1|||
161971379|NCT01007123|584943313|FG003|Overall Study|Withdrawal by Subject|0|||
161971380|NCT01007123|584943310|FG000|Overall Study|Lost to Follow-up|0|||
161971381|NCT01007123|584943311|FG001|Overall Study|Lost to Follow-up|1|||
161761934|NCT00998985|584166075|FG004|Overall Study|Protocol Violation|0|||
161761935|NCT00998985|584166076|FG005|Overall Study|Protocol Violation|1|||
161761936|NCT00998985|584166077|FG006|Overall Study|Protocol Violation|0|||
161761937|NCT00998985|584166078|FG007|Overall Study|Protocol Violation|0|||
161761938|NCT00998985|584166079|FG008|Overall Study|Protocol Violation|0|||
161761939|NCT00998985|584166080|FG009|Overall Study|Protocol Violation|0|||
161761940|NCT00998985|584166081|FG010|Overall Study|Protocol Violation|0|||
161761941|NCT00998985|584166082|FG011|Overall Study|Protocol Violation|0|||
161761942|NCT00998985|584166083|FG012|Overall Study|Protocol Violation|0|||
161761943|NCT00998985|584166084|FG013|Overall Study|Protocol Violation|0|||
161761944|NCT00542425|584166092|FG000|Initial 24 Weeks|Administrative reasons|0|||
161761945|NCT00542425|584166093|FG001|Initial 24 Weeks|Administrative reasons|0|||
161761946|NCT00542425|584166094|FG002|Initial 24 Weeks|Administrative reasons|1|||
161761947|NCT00542425|584166095|FG003|Initial 24 Weeks|Administrative reasons|1|||
161761948|NCT00542425|584166096|FG004|Initial 24 Weeks|Administrative reasons|0|||
161761949|NCT00542425|584166092|FG000|Initial 24 Weeks|Adverse Event|0|||
161761950|NCT00542425|584166093|FG001|Initial 24 Weeks|Adverse Event|1|||
161761951|NCT00542425|584166094|FG002|Initial 24 Weeks|Adverse Event|1|||
161761952|NCT00542425|584166095|FG003|Initial 24 Weeks|Adverse Event|3|||
161761953|NCT00542425|584166096|FG004|Initial 24 Weeks|Adverse Event|2|||
161761954|NCT00542425|584166092|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
161761955|NCT00542425|584166093|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
161761956|NCT00542425|584166094|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
161761957|NCT00542425|584166095|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
161761958|NCT00542425|584166096|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
161761959|NCT00542425|584166092|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
161761960|NCT00542425|584166093|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
161761961|NCT00542425|584166094|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
161761962|NCT00542425|584166095|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
161761963|NCT00542425|584166096|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
161761964|NCT00542425|584166092|FG000|Initial 24 Weeks|Non-compliance|0|||
161761965|NCT00542425|584166093|FG001|Initial 24 Weeks|Non-compliance|0|||
161761966|NCT00542425|584166094|FG002|Initial 24 Weeks|Non-compliance|0|||
161761967|NCT00542425|584166095|FG003|Initial 24 Weeks|Non-compliance|1|||
161761968|NCT00542425|584166096|FG004|Initial 24 Weeks|Non-compliance|1|||
161761969|NCT00542425|584166092|FG000|Initial 24 Weeks|Protocol Violation|0|||
161761970|NCT00542425|584166093|FG001|Initial 24 Weeks|Protocol Violation|0|||
161761971|NCT00542425|584166094|FG002|Initial 24 Weeks|Protocol Violation|0|||
161761972|NCT00542425|584166095|FG003|Initial 24 Weeks|Protocol Violation|1|||
161761973|NCT00542425|584166096|FG004|Initial 24 Weeks|Protocol Violation|0|||
161761974|NCT00542425|584166092|FG000|Initial 24 Weeks|Refusal of treatment|2|||
161761975|NCT00542425|584166093|FG001|Initial 24 Weeks|Refusal of treatment|2|||
161761976|NCT00542425|584166094|FG002|Initial 24 Weeks|Refusal of treatment|1|||
161761977|NCT00542425|584166095|FG003|Initial 24 Weeks|Refusal of treatment|4|||
161761978|NCT00542425|584166096|FG004|Initial 24 Weeks|Refusal of treatment|1|||
161761979|NCT00542425|584166092|FG000|Initial 24 Weeks|Other|0|||
161761980|NCT00542425|584166093|FG001|Initial 24 Weeks|Other|2|||
161761981|NCT00542425|584166094|FG002|Initial 24 Weeks|Other|1|||
161761982|NCT00542425|584166095|FG003|Initial 24 Weeks|Other|0|||
161761983|NCT00542425|584166096|FG004|Initial 24 Weeks|Other|0|||
161761984|NCT00542425|584166092|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
161761985|NCT00542425|584166093|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
161761986|NCT00542425|584166094|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
161761987|NCT00542425|584166095|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
161761988|NCT00542425|584166096|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
161761989|NCT00542425|584166092|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
161971382|NCT01007123|584943312|FG002|Overall Study|Lost to Follow-up|0|||
161761990|NCT00542425|584166093|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
161971383|NCT01007123|584943313|FG003|Overall Study|Lost to Follow-up|0|||
161971384|NCT02838901|584943314|FG000|Overall Study|Withdrawal by Subject|1|||
161761991|NCT00542425|584166094|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
161761992|NCT00542425|584166095|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
161761993|NCT00542425|584166096|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
161761994|NCT00542425|584166092|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
161761995|NCT00542425|584166093|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
161761996|NCT00542425|584166094|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
161761997|NCT00542425|584166095|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
161761998|NCT00542425|584166096|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
161761999|NCT00542425|584166092|FG000|Extended 24 Weeks of Treatment|Other|1|||
161762000|NCT00542425|584166093|FG001|Extended 24 Weeks of Treatment|Other|1|||
161847695|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161847696|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
161847697|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847698|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847699|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847700|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847701|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161762001|NCT00542425|584166094|FG002|Extended 24 Weeks of Treatment|Other|0|||
161762002|NCT00542425|584166095|FG003|Extended 24 Weeks of Treatment|Other|0|||
161762003|NCT00542425|584166096|FG004|Extended 24 Weeks of Treatment|Other|1|||
161762004|NCT02096471|584166099|FG000|Overall Study|Adverse Event|1|||
161762005|NCT02096471|584166099|FG000|Overall Study|Lack of Efficacy|7|||
161762006|NCT02096471|584166099|FG000|Overall Study|Withdrawal by Subject|3|||
161762007|NCT02096471|584166099|FG000|Overall Study|Non-Compliant|2|||
161847702|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847703|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847704|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847705|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847706|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847707|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847708|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161847709|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
161847710|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
161847711|NCT03982199|584482429|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847712|NCT03982199|584482430|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847713|NCT03982199|584482431|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847714|NCT03982199|584482432|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847715|NCT03982199|584482433|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847716|NCT03982199|584482434|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847717|NCT03982199|584482435|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847718|NCT03982199|584482436|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847719|NCT03982199|584482437|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847720|NCT03982199|584482438|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847721|NCT03982199|584482439|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847722|NCT03982199|584482440|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847723|NCT03982199|584482441|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
161847724|NCT03982199|584482442|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161847725|NCT03433755|584482443|FG000|Overall Study|Lost to Follow-up|1|||
161847726|NCT03433755|584482444|FG001|Overall Study|Lost to Follow-up|0|||
161847727|NCT03433755|584482445|FG002|Overall Study|Lost to Follow-up|0|||
161847728|NCT03433755|584482446|FG003|Overall Study|Lost to Follow-up|0|||
161847729|NCT03433755|584482443|FG000|Overall Study|Decision by Sponsor|1|||
161847730|NCT03433755|584482444|FG001|Overall Study|Decision by Sponsor|0|||
161847731|NCT03433755|584482445|FG002|Overall Study|Decision by Sponsor|0|||
161847732|NCT03433755|584482446|FG003|Overall Study|Decision by Sponsor|0|||
161847733|NCT05065567|584482448|FG000|Overall Study|Lost to Follow-up|10|||
161847734|NCT05065567|584482449|FG001|Overall Study|Lost to Follow-up|9|||
161847735|NCT05065567|584482450|FG002|Overall Study|Lost to Follow-up|6|||
161847736|NCT05323123|584482451|FG000|Overall Study|Withdrawal by Subject|2|||
161847737|NCT05323123|584482452|FG001|Overall Study|Withdrawal by Subject|1|||
161847738|NCT05323123|584482451|FG000|Overall Study|Lost to Follow-up|4|||
161847739|NCT05323123|584482452|FG001|Overall Study|Lost to Follow-up|2|||
161847740|NCT05323123|584482451|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
161847741|NCT05323123|584482452|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
161847742|NCT05529472|584482453|FG000|Overall Study|Withdrawal by Subject|1|||
161847743|NCT05529472|584482454|FG001|Overall Study|Withdrawal by Subject|1|||
161847744|NCT02886624|584484074|FG000|12-week Post Treatment Follow-up|Death|1|||
161847745|NCT02886624|584484074|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
161847746|NCT00359801|584484079|FG000|Overall Study|Lost to Follow-up|72|||
161847747|NCT00359801|584484080|FG001|Overall Study|Lost to Follow-up|58|||
161847748|NCT00359801|584484079|FG000|Overall Study|Withdrawal by Subject|143|||
161847749|NCT00359801|584484080|FG001|Overall Study|Withdrawal by Subject|96|||
161762008|NCT03344562|584166100|FG000|Overall Study|Withdrawal by Subject|2|||
161847750|NCT00359801|584484079|FG000|Overall Study|Other|66|||
161847751|NCT00359801|584484080|FG001|Overall Study|Other|46|||
161847752|NCT00359801|584484079|FG000|Overall Study|Final Status Unknown: missing data|7|||
161847753|NCT00359801|584484080|FG001|Overall Study|Final Status Unknown: missing data|4|||
161847754|NCT00359801|584484079|FG000|Overall Study|Sponsor Decision|17|||
161847755|NCT00359801|584484080|FG001|Overall Study|Sponsor Decision|16|||
161762009|NCT03344562|584166101|FG001|Overall Study|Withdrawal by Subject|0|||
161762010|NCT02736474|584166102|FG000|Overall Study|Lost to Follow-up|0|||
161762011|NCT02736474|584166103|FG001|Overall Study|Lost to Follow-up|1|||
161762012|NCT02463331|584166104|FG000|Overall Study|Adverse Event|4|||
161762013|NCT02463331|584166105|FG001|Overall Study|Adverse Event|2|||
161762014|NCT02463331|584166104|FG000|Overall Study|Lost to Follow-up|1|||
161762015|NCT02463331|584166105|FG001|Overall Study|Lost to Follow-up|1|||
161762016|NCT02463331|584166104|FG000|Overall Study|Pregnancy|2|||
161762017|NCT02463331|584166105|FG001|Overall Study|Pregnancy|3|||
161762018|NCT02463331|584166104|FG000|Overall Study|Lack of Efficacy|6|||
161762019|NCT02463331|584166105|FG001|Overall Study|Lack of Efficacy|0|||
161762020|NCT02463331|584166104|FG000|Overall Study|Physician Decision|3|||
161762021|NCT02463331|584166105|FG001|Overall Study|Physician Decision|0|||
161762022|NCT02483611|584166106|FG000|Overall Study|Protocol Violation|0|||
161762023|NCT02483611|584166107|FG001|Overall Study|Protocol Violation|0|||
161762024|NCT02483611|584166108|FG002|Overall Study|Protocol Violation|1|||
161762025|NCT02590406|584166109|FG000|Overall Study|Adverse Event|1|||
161762026|NCT02590406|584166110|FG001|Overall Study|Adverse Event|0|||
161762027|NCT02590406|584166109|FG000|Overall Study|Saturometer malfunction|0|||
161762028|NCT02590406|584166110|FG001|Overall Study|Saturometer malfunction|1|||
161762029|NCT01021293|584166113|FG000|Overall Study|Serious Adverse Event|2|||
161762030|NCT01021293|584166114|FG001|Overall Study|Serious Adverse Event|1|||
161762031|NCT01021293|584166113|FG000|Overall Study|Adverse Event|2|||
161762032|NCT01021293|584166114|FG001|Overall Study|Adverse Event|1|||
161762033|NCT01021293|584166113|FG000|Overall Study|Withdrawal by Subject|1|||
161762034|NCT01021293|584166114|FG001|Overall Study|Withdrawal by Subject|3|||
161762035|NCT01021293|584166113|FG000|Overall Study|Migrated/moved from study area|6|||
161762036|NCT01021293|584166114|FG001|Overall Study|Migrated/moved from study area|18|||
161762037|NCT01021293|584166113|FG000|Overall Study|Lost to Follow-up|1|||
161762038|NCT01021293|584166114|FG001|Overall Study|Lost to Follow-up|1|||
161762039|NCT00631969|584166115|FG000|Overall Study|Adverse Event|3|||
161762040|NCT00631969|584166116|FG001|Overall Study|Adverse Event|1|||
161762041|NCT00631969|584166115|FG000|Overall Study|Lack of Efficacy|2|||
161762042|NCT00631969|584166116|FG001|Overall Study|Lack of Efficacy|8|||
161762043|NCT00631969|584166115|FG000|Overall Study|Lost to Follow-up|2|||
161762044|NCT00631969|584166116|FG001|Overall Study|Lost to Follow-up|1|||
161762045|NCT00631969|584166115|FG000|Overall Study|Protocol Violation|1|||
161762046|NCT00631969|584166116|FG001|Overall Study|Protocol Violation|1|||
161762047|NCT00631969|584166115|FG000|Overall Study|Consent Withdrawn|5|||
161762048|NCT00631969|584166116|FG001|Overall Study|Consent Withdrawn|7|||
161762049|NCT00631969|584166115|FG000|Overall Study|Noncompliant With Study Medication|0|||
161762050|NCT00631969|584166116|FG001|Overall Study|Noncompliant With Study Medication|1|||
161762051|NCT00631969|584166115|FG000|Overall Study|No Drug Exposure|2|||
161762052|NCT00631969|584166116|FG001|Overall Study|No Drug Exposure|2|||
161762053|NCT04335929|584167833|FG000|Overall Study|Lost to Follow-up|10|||
161762054|NCT02491463|584167835|FG000|Overall Study|Withdrawal by Subject|1|||
161762055|NCT02491463|584167836|FG001|Overall Study|Withdrawal by Subject|2|||
161762056|NCT02491463|584167837|FG002|Overall Study|Withdrawal by Subject|0|||
161762057|NCT02491463|584167838|FG003|Overall Study|Withdrawal by Subject|0|||
161762058|NCT02491463|584167835|FG000|Overall Study|Migrated/moved from study area|1|||
161762059|NCT02491463|584167836|FG001|Overall Study|Migrated/moved from study area|5|||
161762060|NCT02491463|584167837|FG002|Overall Study|Migrated/moved from study area|1|||
161762061|NCT02491463|584167838|FG003|Overall Study|Migrated/moved from study area|1|||
161762062|NCT02491463|584167835|FG000|Overall Study|Lost to Follow-up|0|||
161762063|NCT02491463|584167836|FG001|Overall Study|Lost to Follow-up|3|||
161762064|NCT02491463|584167837|FG002|Overall Study|Lost to Follow-up|3|||
161762065|NCT02491463|584167838|FG003|Overall Study|Lost to Follow-up|0|||
161762066|NCT01491802|584167839|FG000|Overall Study|Adverse Event|1|||
161762067|NCT01491802|584167840|FG001|Overall Study|Adverse Event|1|||
161847756|NCT02929056|584484085|FG000|Overall Study|Lost to Follow-up|0|||
161971385|NCT02838901|584943315|FG001|Overall Study|Withdrawal by Subject|1|||
161971386|NCT02838901|584943314|FG000|Overall Study|Lost to Follow-up|1|||
161971387|NCT02838901|584943315|FG001|Overall Study|Lost to Follow-up|1|||
161971388|NCT04431713|584943316|FG000|Overall Study|Withdrawal by Subject|2|||
161971389|NCT04431713|584943317|FG001|Overall Study|Withdrawal by Subject|0|||
161971390|NCT04431713|584943316|FG000|Overall Study|Death|2|||
161971391|NCT04431713|584943317|FG001|Overall Study|Death|2|||
161762068|NCT01491802|584167839|FG000|Overall Study|Withdrawal by Subject|0|||
161762069|NCT01491802|584167840|FG001|Overall Study|Withdrawal by Subject|1|||
161762070|NCT01864746|584167843|FG000|Overall Study|Disease recurrence|25|||
161762071|NCT01864746|584167844|FG001|Overall Study|Disease recurrence|40|||
161762072|NCT01864746|584167843|FG000|Overall Study|Second primary invasive nonbreast|2|||
161762073|NCT01864746|584167844|FG001|Overall Study|Second primary invasive nonbreast|3|||
161762074|NCT01864746|584167843|FG000|Overall Study|Death|2|||
161762075|NCT01864746|584167844|FG001|Overall Study|Death|1|||
161762076|NCT01864746|584167843|FG000|Overall Study|Adverse Event|33|||
161762077|NCT01864746|584167844|FG001|Overall Study|Adverse Event|5|||
161762078|NCT01864746|584167843|FG000|Overall Study|Withdrawal by Subject|56|||
161762079|NCT01864746|584167844|FG001|Overall Study|Withdrawal by Subject|41|||
161762080|NCT01864746|584167843|FG000|Overall Study|Physician Decision|5|||
161762081|NCT01864746|584167844|FG001|Overall Study|Physician Decision|6|||
161762082|NCT00663208|584167845|FG000|Treatment Period|Lost to Follow-up|0|||
161762083|NCT00663208|584167846|FG001|Treatment Period|Lost to Follow-up|1|||
161762084|NCT00663208|584167847|FG002|Treatment Period|Lost to Follow-up|0|||
161762085|NCT00663208|584167848|FG003|Treatment Period|Lost to Follow-up|0|||
161762086|NCT00663208|584167849|FG004|Treatment Period|Lost to Follow-up|0|||
161762087|NCT00663208|584167850|FG005|Treatment Period|Lost to Follow-up|0|||
161762088|NCT00663208|584167851|FG006|Treatment Period|Lost to Follow-up|0|||
161762089|NCT00663208|584167845|FG000|Follow-up Period|Lost to Follow-up|2|||
161762090|NCT00663208|584167846|FG001|Follow-up Period|Lost to Follow-up|0|||
161762091|NCT00663208|584167847|FG002|Follow-up Period|Lost to Follow-up|3|||
161762092|NCT00663208|584167848|FG003|Follow-up Period|Lost to Follow-up|2|||
161762093|NCT00663208|584167849|FG004|Follow-up Period|Lost to Follow-up|0|||
161762094|NCT00663208|584167850|FG005|Follow-up Period|Lost to Follow-up|0|||
161762095|NCT00663208|584167851|FG006|Follow-up Period|Lost to Follow-up|0|||
161762096|NCT00663208|584167845|FG000|Follow-up Period|Other reason|1|||
161762097|NCT00663208|584167846|FG001|Follow-up Period|Other reason|0|||
161762098|NCT00663208|584167847|FG002|Follow-up Period|Other reason|0|||
161762099|NCT00663208|584167848|FG003|Follow-up Period|Other reason|0|||
161762100|NCT00663208|584167849|FG004|Follow-up Period|Other reason|0|||
161762101|NCT00663208|584167850|FG005|Follow-up Period|Other reason|0|||
161762102|NCT00663208|584167851|FG006|Follow-up Period|Other reason|1|||
161762103|NCT01005966|584167852|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
161762104|NCT01005966|584167853|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
161762105|NCT01005966|584167854|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
161762106|NCT01005966|584167855|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
161762107|NCT01005966|584167856|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
161762108|NCT01005966|584167852|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
161762109|NCT01005966|584167853|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
161762110|NCT01005966|584167854|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
161762111|NCT01005966|584167855|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
161762112|NCT01005966|584167856|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
161762113|NCT01005966|584167852|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
161762114|NCT01005966|584167853|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
161762115|NCT01005966|584167854|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
161762116|NCT01005966|584167855|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
161762117|NCT01005966|584167856|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
161762118|NCT01005966|584167852|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
161762119|NCT01005966|584167853|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
161762120|NCT01005966|584167854|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
161762121|NCT01005966|584167855|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
161762122|NCT01005966|584167856|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
161762123|NCT01005966|584167852|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161762124|NCT01005966|584167853|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161762125|NCT01005966|584167854|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161762126|NCT01005966|584167855|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
161762127|NCT01005966|584167856|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161762128|NCT01005966|584167852|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161762129|NCT01005966|584167853|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161762130|NCT01005966|584167854|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
161762131|NCT01005966|584167855|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161762132|NCT01005966|584167856|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161762133|NCT01005966|584167852|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
161762134|NCT01005966|584167853|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
161762135|NCT01005966|584167854|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
161762136|NCT01005966|584167855|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
161762137|NCT01005966|584167856|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
161762138|NCT01005966|584167852|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
161762139|NCT01005966|584167853|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
161762140|NCT01005966|584167854|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
161762141|NCT01005966|584167855|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
161762142|NCT01005966|584167856|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
161762143|NCT01005966|584167852|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
161762144|NCT01005966|584167853|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
161847757|NCT02929056|584484086|FG001|Overall Study|Lost to Follow-up|1|||
161762145|NCT01005966|584167854|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
161762146|NCT01005966|584167855|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
161762147|NCT01005966|584167856|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
161762148|NCT01451203|584167857|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
161762149|NCT01451203|584167858|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
161762150|NCT01451203|584167857|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
161762151|NCT01451203|584167858|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
161762152|NCT01451203|584167857|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
162033077|NCT00274924|585178593|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
162033078|NCT00274924|585178594|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
162033079|NCT00274924|585178592|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
162033080|NCT00274924|585178593|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
162033081|NCT00274924|585178594|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
161762153|NCT01451203|584167858|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
161762154|NCT01451203|584167857|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
161762155|NCT01451203|584167858|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
161762156|NCT01451203|584167857|FG000|Double-blind Treatment Period|Adverse Event|6|||
161762157|NCT01451203|584167858|FG001|Double-blind Treatment Period|Adverse Event|9|||
161762158|NCT01451203|584167857|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
161762159|NCT01451203|584167858|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
161762160|NCT01451203|584167857|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
161762161|NCT01451203|584167858|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
161762162|NCT01451203|584167857|FG000|Double-blind Treatment Period|Investigator decision|2|||
161762163|NCT01451203|584167858|FG001|Double-blind Treatment Period|Investigator decision|0|||
161762164|NCT01451203|584167857|FG000|Post-treatment Period|Consent withdrawn|2|||
161762165|NCT01451203|584167858|FG001|Post-treatment Period|Consent withdrawn|4|||
161762166|NCT01451203|584167857|FG000|Post-treatment Period|Lack of Efficacy|12|||
161762167|NCT01451203|584167858|FG001|Post-treatment Period|Lack of Efficacy|28|||
161762168|NCT01451203|584167857|FG000|Post-treatment Period|Adverse Event|0|||
161762169|NCT01451203|584167858|FG001|Post-treatment Period|Adverse Event|1|||
161762170|NCT01451203|584167857|FG000|Post-treatment Period|Investigator decision|0|||
161762171|NCT01451203|584167858|FG001|Post-treatment Period|Investigator decision|1|||
161762172|NCT00039377|584167859|FG000|Initial Registration|Adverse Event|2|||
161762173|NCT00039377|584167860|FG001|Initial Registration|Adverse Event|0|||
161762174|NCT00039377|584167861|FG002|Initial Registration|Adverse Event|0|||
161762175|NCT00039377|584167862|FG003|Initial Registration|Adverse Event|0|||
161762176|NCT00039377|584167859|FG000|Initial Registration|Relapsed|6|||
161762177|NCT00039377|584167860|FG001|Initial Registration|Relapsed|0|||
161762178|NCT00039377|584167861|FG002|Initial Registration|Relapsed|0|||
161762179|NCT00039377|584167862|FG003|Initial Registration|Relapsed|0|||
161762180|NCT00039377|584167859|FG000|Initial Registration|Received non-protocol therapy|11|||
161762181|NCT00039377|584167860|FG001|Initial Registration|Received non-protocol therapy|0|||
161762182|NCT00039377|584167861|FG002|Initial Registration|Received non-protocol therapy|0|||
161762183|NCT00039377|584167862|FG003|Initial Registration|Received non-protocol therapy|0|||
161762184|NCT00039377|584167859|FG000|Initial Registration|Withdrawal by Subject|3|||
161762185|NCT00039377|584167860|FG001|Initial Registration|Withdrawal by Subject|0|||
161762186|NCT00039377|584167861|FG002|Initial Registration|Withdrawal by Subject|0|||
161762187|NCT00039377|584167862|FG003|Initial Registration|Withdrawal by Subject|0|||
161762188|NCT01347931|584167863|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
161762189|NCT03890731|584167864|FG000|Overall Study|Progressive disease|1|||
161762190|NCT03890731|584167864|FG000|Overall Study|Patient's decision|1|||
161762191|NCT03890731|584167864|FG000|Overall Study|Adverse Event|4|||
161762192|NCT01716585|584167865|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
161762193|NCT01716585|584167866|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
161762194|NCT01716585|584167865|FG000|Double-blind Treatment|Adverse Event|2|||
161762195|NCT01716585|584167866|FG001|Double-blind Treatment|Adverse Event|1|||
161762196|NCT01716585|584167865|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
161762197|NCT01716585|584167866|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
161762198|NCT01716585|584167865|FG000|Double-blind Treatment|Lost to Follow-up|2|||
161762199|NCT01716585|584167866|FG001|Double-blind Treatment|Lost to Follow-up|0|||
161762200|NCT01716585|584167865|FG000|Double-blind Treatment|Subject Noncompliant|1|||
161762201|NCT01716585|584167866|FG001|Double-blind Treatment|Subject Noncompliant|0|||
161762202|NCT01716585|584167865|FG000|Double-blind Treatment|Other|1|||
161762203|NCT01716585|584167866|FG001|Double-blind Treatment|Other|0|||
161762204|NCT01716585|584167865|FG000|Open-label Treatment|Adverse Event|0|||
161762205|NCT01716585|584167866|FG001|Open-label Treatment|Adverse Event|2|||
161762206|NCT01716585|584167865|FG000|Open-label Treatment|Virologic Failure|0|||
161762207|NCT01716585|584167866|FG001|Open-label Treatment|Virologic Failure|2|||
161762208|NCT01716585|584167865|FG000|Open-label Treatment|Withdrawal by Subject|0|||
162033082|NCT00274924|585178592|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
162033083|NCT00274924|585178593|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
161762209|NCT01716585|584167866|FG001|Open-label Treatment|Withdrawal by Subject|3|||
161762210|NCT04235959|584167867|FG000|Overall Study|Protocol Violation|0|||
161762211|NCT04235959|584167868|FG001|Overall Study|Protocol Violation|1|||
161762212|NCT04235959|584167869|FG002|Overall Study|Protocol Violation|0|||
161762213|NCT04235959|584167867|FG000|Overall Study|Adverse Event|1|||
161762214|NCT04235959|584167868|FG001|Overall Study|Adverse Event|0|||
161762215|NCT04235959|584167869|FG002|Overall Study|Adverse Event|0|||
161762216|NCT00125138|584167870|FG000|Overall Study|Adverse Event|1|||
161847758|NCT02245412|584484092|FG000|Treatment Period|Death|1|||
161847759|NCT02245412|584484093|FG001|Treatment Period|Death|1|||
161847760|NCT02245412|584484094|FG002|Treatment Period|Death|0|||
161847761|NCT02245412|584484092|FG000|Treatment Period|Physician Decision|1|||
161847762|NCT02245412|584484093|FG001|Treatment Period|Physician Decision|1|||
161847763|NCT02245412|584484094|FG002|Treatment Period|Physician Decision|0|||
161847764|NCT02245412|584484092|FG000|Treatment Period|Withdrawal by Subject|2|||
161847765|NCT02245412|584484093|FG001|Treatment Period|Withdrawal by Subject|1|||
161847766|NCT02245412|584484094|FG002|Treatment Period|Withdrawal by Subject|0|||
161847767|NCT02245412|584484092|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
161847768|NCT02245412|584484093|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
161847769|NCT02245412|584484094|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
161847770|NCT02245412|584484092|FG000|Follow-Up Period|Death|4|||
161847771|NCT02245412|584484093|FG001|Follow-Up Period|Death|2|||
161847772|NCT02245412|584484094|FG002|Follow-Up Period|Death|1|||
161847773|NCT02245412|584484092|FG000|Follow-Up Period|Physician Decision|1|||
161847774|NCT02245412|584484093|FG001|Follow-Up Period|Physician Decision|0|||
161847775|NCT02245412|584484094|FG002|Follow-Up Period|Physician Decision|0|||
161847776|NCT02245412|584484092|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
161847777|NCT02245412|584484093|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
161847778|NCT02245412|584484094|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
161847779|NCT00459043|584484095|FG000|Overall Study|Withdrawal by Subject|1|||
161847780|NCT00459043|584484096|FG001|Overall Study|Withdrawal by Subject|0|||
161847781|NCT00450801|584484099|FG000|Overall Study|Death|1|||
161847782|NCT00324649|584484100|FG000|Overall Study|Adverse Event|1|||
161847783|NCT00324649|584484101|FG001|Overall Study|Adverse Event|4|||
161847784|NCT00324649|584484100|FG000|Overall Study|Withdrawal by Subject|0|||
161847785|NCT00324649|584484101|FG001|Overall Study|Withdrawal by Subject|1|||
161847786|NCT00324649|584484100|FG000|Overall Study|Noncompliance|1|||
161847787|NCT00324649|584484101|FG001|Overall Study|Noncompliance|0|||
161847788|NCT02618759|584484102|FG000|Overall Study|Lost to Follow-up|0|||
161847789|NCT02618759|584484103|FG001|Overall Study|Lost to Follow-up|1|||
161847790|NCT02618759|584484102|FG000|Overall Study|Withdrawal by Subject|1|||
161847791|NCT02618759|584484103|FG001|Overall Study|Withdrawal by Subject|0|||
161847792|NCT02618759|584484102|FG000|Overall Study|Other Reasons|1|||
161847793|NCT02618759|584484103|FG001|Overall Study|Other Reasons|4|||
161847794|NCT02500043|584484110|FG000|Overall Study|Randomized, but not Treated|2|||
161847795|NCT02500043|584484111|FG001|Overall Study|Randomized, but not Treated|2|||
161847796|NCT02500043|584484110|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
161847797|NCT02500043|584484111|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
161847798|NCT02500043|584484110|FG000|Overall Study|Adverse Event|33|||
161847799|NCT02500043|584484111|FG001|Overall Study|Adverse Event|11|||
161847800|NCT02500043|584484110|FG000|Overall Study|Clinical Progression|54|||
161847801|NCT02500043|584484111|FG001|Overall Study|Clinical Progression|35|||
161847802|NCT02500043|584484110|FG000|Overall Study|Radiological Progression|192|||
161847803|NCT02500043|584484111|FG001|Overall Study|Radiological Progression|110|||
161847804|NCT02500043|584484110|FG000|Overall Study|Physician's Decision|11|||
161762217|NCT00125138|584167871|FG001|Overall Study|Adverse Event|0|||
161762218|NCT00125138|584167872|FG002|Overall Study|Adverse Event|3|||
161762219|NCT00125138|584167873|FG003|Overall Study|Adverse Event|2|||
161762220|NCT00125138|584167870|FG000|Overall Study|Withdrawal by Subject|2|||
161762221|NCT00125138|584167871|FG001|Overall Study|Withdrawal by Subject|3|||
161762222|NCT00125138|584167872|FG002|Overall Study|Withdrawal by Subject|1|||
161762223|NCT00125138|584167873|FG003|Overall Study|Withdrawal by Subject|1|||
161762224|NCT00125138|584167870|FG000|Overall Study|Lack of Efficacy|0|||
161762225|NCT00125138|584167871|FG001|Overall Study|Lack of Efficacy|0|||
161762226|NCT00125138|584167872|FG002|Overall Study|Lack of Efficacy|0|||
161762227|NCT00125138|584167873|FG003|Overall Study|Lack of Efficacy|1|||
161762228|NCT00125138|584167870|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
161762229|NCT00125138|584167871|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
161847805|NCT02500043|584484111|FG001|Overall Study|Physician's Decision|3|||
161847806|NCT02500043|584484110|FG000|Overall Study|Withdrawal by Subject|14|||
161847807|NCT02500043|584484111|FG001|Overall Study|Withdrawal by Subject|4|||
161847808|NCT02500043|584484110|FG000|Overall Study|Death|11|||
161847809|NCT02500043|584484111|FG001|Overall Study|Death|2|||
161847810|NCT02500043|584484110|FG000|Overall Study|Protocol Deviation|1|||
161847811|NCT02500043|584484111|FG001|Overall Study|Protocol Deviation|0|||
161847812|NCT00580788|584484112|FG000|Overall Study|Adverse Event|0|||
161847813|NCT00580788|584484113|FG001|Overall Study|Adverse Event|0|||
161847814|NCT00580788|584484114|FG002|Overall Study|Adverse Event|0|||
161847815|NCT00580788|584484115|FG003|Overall Study|Adverse Event|1|||
161762230|NCT00125138|584167872|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
161762231|NCT00125138|584167873|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
161762232|NCT00286156|584167874|FG000|Overall Study|Missed 12 month visit|0|||
161762233|NCT00286156|584167875|FG001|Overall Study|Missed 12 month visit|0|||
161762234|NCT00286156|584167876|FG002|Overall Study|Missed 12 month visit|1|||
161847816|NCT03301649|584484116|FG000|Overall Study|Need alternate therapy due to live lice|17|||
161762235|NCT00286156|584167874|FG000|Overall Study|AE: pulmonary embolus|0|||
161762236|NCT00286156|584167875|FG001|Overall Study|AE: pulmonary embolus|1|||
161762237|NCT00286156|584167876|FG002|Overall Study|AE: pulmonary embolus|0|||
161762238|NCT00286156|584167874|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
161762239|NCT00286156|584167875|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
161762240|NCT00286156|584167876|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
161762241|NCT00286156|584167874|FG000|Overall Study|AE: pneumonia|1|||
161762242|NCT00286156|584167875|FG001|Overall Study|AE: pneumonia|0|||
161762243|NCT00286156|584167876|FG002|Overall Study|AE: pneumonia|0|||
161762244|NCT02870348|584167877|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
161762245|NCT00672139|584167878|FG000|Overall Study|Death|14|||
161762246|NCT00672139|584167879|FG001|Overall Study|Death|23|||
161762247|NCT00672139|584167878|FG000|Overall Study|Withdrawal by Subject|2|||
161762248|NCT00672139|584167879|FG001|Overall Study|Withdrawal by Subject|11|||
161762249|NCT00672139|584167878|FG000|Overall Study|Adverse Event|4|||
161762250|NCT00672139|584167879|FG001|Overall Study|Adverse Event|7|||
161762251|NCT00672139|584167878|FG000|Overall Study|Physician Decision|2|||
161762252|NCT00672139|584167879|FG001|Overall Study|Physician Decision|0|||
161762253|NCT00672139|584167878|FG000|Overall Study|Lack of Efficacy|4|||
161762254|NCT00672139|584167879|FG001|Overall Study|Lack of Efficacy|1|||
161762255|NCT00672139|584167878|FG000|Overall Study|Protocol Violation|1|||
161762256|NCT00672139|584167879|FG001|Overall Study|Protocol Violation|1|||
161762257|NCT00672139|584167878|FG000|Overall Study|hospice discharge, caregiver requests|3|||
161762258|NCT00672139|584167879|FG001|Overall Study|hospice discharge, caregiver requests|2|||
161762259|NCT02381795|584167880|FG000|Overall Study|Withdrawal by Subject|1|||
161762260|NCT02381795|584167880|FG000|Overall Study|Study Terminated|2|||
161762261|NCT01488994|584167885|FG000|Overall Study|Withdrawal by Subject|0|||
161762262|NCT01488994|584167886|FG001|Overall Study|Withdrawal by Subject|1|||
161762263|NCT02908841|584167887|FG000|Overall Study|Physician Decision|4|||
161762264|NCT02908841|584167888|FG001|Overall Study|Physician Decision|0|||
161762265|NCT03798366|584167889|FG000|Overall Study|Lost to Follow-up|0|||
161762266|NCT03798366|584167890|FG001|Overall Study|Lost to Follow-up|1|||
161762267|NCT01412333|584167891|FG000|Overall Study|Adverse Event|40|||
161762268|NCT01412333|584167892|FG001|Overall Study|Adverse Event|42|||
161762269|NCT01412333|584167891|FG000|Overall Study|Death|5|||
161762270|NCT01412333|584167892|FG001|Overall Study|Death|6|||
161762271|NCT01412333|584167891|FG000|Overall Study|Lack of Efficacy|22|||
161762272|NCT01412333|584167892|FG001|Overall Study|Lack of Efficacy|10|||
161762273|NCT01412333|584167891|FG000|Overall Study|Lost to Follow-up|15|||
161762274|NCT01412333|584167892|FG001|Overall Study|Lost to Follow-up|12|||
161762275|NCT01412333|584167891|FG000|Overall Study|Non-Compliance|3|||
161762276|NCT01412333|584167892|FG001|Overall Study|Non-Compliance|7|||
161762277|NCT01412333|584167891|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161762278|NCT01412333|584167892|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161762279|NCT01412333|584167891|FG000|Overall Study|Other|30|||
161762280|NCT01412333|584167892|FG001|Overall Study|Other|33|||
161762281|NCT01412333|584167891|FG000|Overall Study|Physician Decision|11|||
161762282|NCT01412333|584167892|FG001|Overall Study|Physician Decision|16|||
161762283|NCT01412333|584167891|FG000|Overall Study|Pregnancy|6|||
161762284|NCT01412333|584167892|FG001|Overall Study|Pregnancy|4|||
161762285|NCT01412333|584167891|FG000|Overall Study|Protocol Violation|1|||
161762286|NCT01412333|584167892|FG001|Overall Study|Protocol Violation|2|||
161762287|NCT01412333|584167891|FG000|Overall Study|Study Terminated By Sponsor|3|||
161762288|NCT01412333|584167892|FG001|Overall Study|Study Terminated By Sponsor|2|||
161762289|NCT01412333|584167891|FG000|Overall Study|Withdrawal by Subject|51|||
161762290|NCT01412333|584167892|FG001|Overall Study|Withdrawal by Subject|54|||
161762291|NCT01412333|584167891|FG000|Overall Study|Missing|1|||
161762292|NCT01412333|584167892|FG001|Overall Study|Missing|3|||
161762293|NCT01117428|584167893|FG000|Overall Study|Lack of Efficacy|1|||
161762294|NCT01117428|584167894|FG001|Overall Study|Lack of Efficacy|0|||
161762295|NCT01117428|584167895|FG002|Overall Study|Lack of Efficacy|0|||
161762296|NCT01117428|584167896|FG003|Overall Study|Lack of Efficacy|0|||
161762297|NCT01117428|584167897|FG004|Overall Study|Lack of Efficacy|0|||
161762298|NCT01117428|584167898|FG005|Overall Study|Lack of Efficacy|0|||
161971392|NCT02285114|584943319|FG000|Main Phase|Investigator's Discretion|0|||
161971393|NCT02285114|584943320|FG001|Main Phase|Investigator's Discretion|2|||
161762299|NCT01117428|584167893|FG000|Overall Study|Adverse Event|4|||
161762300|NCT01117428|584167894|FG001|Overall Study|Adverse Event|0|||
161762301|NCT01117428|584167895|FG002|Overall Study|Adverse Event|0|||
161762302|NCT01117428|584167896|FG003|Overall Study|Adverse Event|0|||
161762303|NCT01117428|584167897|FG004|Overall Study|Adverse Event|1|||
161762304|NCT01117428|584167898|FG005|Overall Study|Adverse Event|2|||
161762305|NCT01117428|584167893|FG000|Overall Study|Death|0|||
161762306|NCT01117428|584167894|FG001|Overall Study|Death|1|||
161762307|NCT01117428|584167895|FG002|Overall Study|Death|2|||
161762308|NCT01117428|584167896|FG003|Overall Study|Death|0|||
161762309|NCT01117428|584167897|FG004|Overall Study|Death|0|||
161762310|NCT01117428|584167898|FG005|Overall Study|Death|1|||
161762311|NCT01117428|584167893|FG000|Overall Study|Physician Decision|0|||
161762312|NCT01117428|584167894|FG001|Overall Study|Physician Decision|1|||
161762313|NCT01117428|584167895|FG002|Overall Study|Physician Decision|0|||
161762314|NCT01117428|584167896|FG003|Overall Study|Physician Decision|0|||
161762315|NCT01117428|584167897|FG004|Overall Study|Physician Decision|0|||
161762316|NCT01117428|584167898|FG005|Overall Study|Physician Decision|0|||
161762317|NCT01117428|584167893|FG000|Overall Study|Withdrawal by Subject|0|||
161762318|NCT01117428|584167894|FG001|Overall Study|Withdrawal by Subject|0|||
161762319|NCT01117428|584167895|FG002|Overall Study|Withdrawal by Subject|1|||
161762320|NCT01117428|584167896|FG003|Overall Study|Withdrawal by Subject|0|||
161762321|NCT01117428|584167897|FG004|Overall Study|Withdrawal by Subject|0|||
161762322|NCT01117428|584167898|FG005|Overall Study|Withdrawal by Subject|0|||
161762323|NCT01117428|584167893|FG000|Overall Study|Progressive disease|15|||
161762324|NCT01117428|584167894|FG001|Overall Study|Progressive disease|27|||
161762325|NCT01117428|584167895|FG002|Overall Study|Progressive disease|10|||
161762326|NCT01117428|584167896|FG003|Overall Study|Progressive disease|12|||
161762327|NCT01117428|584167897|FG004|Overall Study|Progressive disease|16|||
161762328|NCT01117428|584167898|FG005|Overall Study|Progressive disease|17|||
161762329|NCT02195531|584167899|FG000|Overall Study|Withdrawal by Subject|1|||
161762330|NCT02195531|584167900|FG001|Overall Study|Withdrawal by Subject|1|||
161762331|NCT02195531|584167901|FG002|Overall Study|Withdrawal by Subject|1|||
161762332|NCT01034709|584167905|FG000|Overall Study|Protocol Violation|9|||
161762333|NCT01034709|584167906|FG001|Overall Study|Protocol Violation|16|||
161762334|NCT01657253|584167909|FG000|Overall Study|Lost to Follow-up|6|||
161762335|NCT01657253|584167910|FG001|Overall Study|Lost to Follow-up|5|||
161762336|NCT01657253|584167909|FG000|Overall Study|Withdrawal by Subject|11|||
161762337|NCT01657253|584167910|FG001|Overall Study|Withdrawal by Subject|12|||
161762338|NCT01657253|584167909|FG000|Overall Study|Adverse Event|0|||
161762339|NCT01657253|584167910|FG001|Overall Study|Adverse Event|1|||
161762340|NCT01970540|584167911|FG000|Overall Study|Non-treatment-related AE|0|||
161762341|NCT01970540|584167912|FG001|Overall Study|Non-treatment-related AE|0|||
161762342|NCT01970540|584167913|FG002|Overall Study|Non-treatment-related AE|1|||
161762343|NCT01970540|584167911|FG000|Overall Study|Progressive disease|55|||
161762344|NCT01970540|584167912|FG001|Overall Study|Progressive disease|23|||
161762345|NCT01970540|584167913|FG002|Overall Study|Progressive disease|10|||
161762346|NCT01970540|584167911|FG000|Overall Study|Treatment delay over protocol|0|||
161762347|NCT01970540|584167912|FG001|Overall Study|Treatment delay over protocol|0|||
161762348|NCT01970540|584167913|FG002|Overall Study|Treatment delay over protocol|1|||
161762349|NCT01970540|584167911|FG000|Overall Study|Physician Decision|7|||
161762350|NCT01970540|584167912|FG001|Overall Study|Physician Decision|2|||
161762351|NCT01970540|584167913|FG002|Overall Study|Physician Decision|0|||
161762352|NCT01970540|584167911|FG000|Overall Study|Clinical progression|0|||
161762353|NCT01970540|584167912|FG001|Overall Study|Clinical progression|1|||
161762354|NCT01970540|584167913|FG002|Overall Study|Clinical progression|1|||
161762355|NCT01970540|584167911|FG000|Overall Study|End of study|2|||
161762356|NCT01970540|584167912|FG001|Overall Study|End of study|0|||
161762357|NCT01970540|584167913|FG002|Overall Study|End of study|2|||
161762358|NCT01970540|584167911|FG000|Overall Study|Adverse Event|0|||
161762359|NCT01970540|584167912|FG001|Overall Study|Adverse Event|2|||
161762360|NCT01970540|584167913|FG002|Overall Study|Adverse Event|1|||
161762361|NCT01970540|584167911|FG000|Overall Study|Treatment-related AE|4|||
161762362|NCT01970540|584167912|FG001|Overall Study|Treatment-related AE|0|||
161762363|NCT01970540|584167913|FG002|Overall Study|Treatment-related AE|2|||
161762364|NCT01970540|584167911|FG000|Overall Study|Withdrawal by Subject|4|||
161762365|NCT01970540|584167912|FG001|Overall Study|Withdrawal by Subject|0|||
161762366|NCT01970540|584167913|FG002|Overall Study|Withdrawal by Subject|1|||
161762367|NCT01970540|584167911|FG000|Overall Study|Clinical deterioration|1|||
161762368|NCT01970540|584167912|FG001|Overall Study|Clinical deterioration|0|||
161762369|NCT01970540|584167913|FG002|Overall Study|Clinical deterioration|0|||
161762370|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Adverse Event|30|||
161762371|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Adverse Event|25|||
161762372|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Adverse Event|23|||
161762373|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Adverse Event|14|||
161762374|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Death|0|||
161762375|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Death|0|||
161762376|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Death|1|||
161762377|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Death|0|||
161762378|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Physician Decision|0|||
161762379|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Physician Decision|1|||
161762380|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Physician Decision|0|||
161971394|NCT02285114|584943321|FG002|Main Phase|Investigator's Discretion|0|||
161762381|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Physician Decision|1|||
161762382|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
161971395|NCT02285114|584943322|FG003|Main Phase|Investigator's Discretion|0|||
161971396|NCT02285114|584943323|FG004|Main Phase|Investigator's Discretion|0|||
161762383|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
161847817|NCT03301649|584484117|FG001|Overall Study|Need alternate therapy due to live lice|25|||
161971397|NCT02285114|584943324|FG005|Main Phase|Investigator's Discretion|0|||
161762384|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
161762385|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
161762386|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Other|6|||
161762387|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Other|1|||
161762388|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Other|0|||
161762389|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Other|2|||
161762390|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
161762391|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
161762392|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
161762393|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
161762394|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
161762395|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
161762396|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
161762397|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
161762398|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
161762399|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
161762400|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
161762401|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
161762402|NCT00242710|584167915|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
161762403|NCT00242710|584167916|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
161762404|NCT00242710|584167917|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
161762405|NCT00242710|584167918|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
161762406|NCT00242710|584167915|FG000|Period Between Core Study and Extension|Adverse Event|2|||
161762407|NCT00242710|584167916|FG001|Period Between Core Study and Extension|Adverse Event|3|||
161762408|NCT00242710|584167917|FG002|Period Between Core Study and Extension|Adverse Event|5|||
161762409|NCT00242710|584167918|FG003|Period Between Core Study and Extension|Adverse Event|2|||
161762410|NCT00242710|584167915|FG000|Period Between Core Study and Extension|Physician Decision|1|||
161762411|NCT00242710|584167916|FG001|Period Between Core Study and Extension|Physician Decision|1|||
161762412|NCT00242710|584167917|FG002|Period Between Core Study and Extension|Physician Decision|0|||
161762413|NCT00242710|584167918|FG003|Period Between Core Study and Extension|Physician Decision|0|||
161762414|NCT00242710|584167915|FG000|Period Between Core Study and Extension|Other|24|||
161762415|NCT00242710|584167916|FG001|Period Between Core Study and Extension|Other|24|||
161762416|NCT00242710|584167917|FG002|Period Between Core Study and Extension|Other|9|||
161762417|NCT00242710|584167918|FG003|Period Between Core Study and Extension|Other|11|||
161762418|NCT00242710|584167915|FG000|Period Between Core Study and Extension|Extension not Available|17|||
161762419|NCT00242710|584167916|FG001|Period Between Core Study and Extension|Extension not Available|21|||
161762420|NCT00242710|584167917|FG002|Period Between Core Study and Extension|Extension not Available|8|||
161762421|NCT00242710|584167918|FG003|Period Between Core Study and Extension|Extension not Available|7|||
161762422|NCT00242710|584167915|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
161762423|NCT00242710|584167916|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
161762424|NCT00242710|584167917|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
161762425|NCT00242710|584167918|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
161762426|NCT00242710|584167915|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
161762427|NCT00242710|584167916|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
161762428|NCT00242710|584167917|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
161762429|NCT00242710|584167918|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
161762430|NCT00242710|584167915|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
161762431|NCT00242710|584167916|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
161762432|NCT00242710|584167917|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
161762433|NCT00242710|584167918|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
161762434|NCT00242710|584167915|FG000|Study Extension (up to Year 2)|Death|0|||
161762435|NCT00242710|584167916|FG001|Study Extension (up to Year 2)|Death|0|||
161762436|NCT00242710|584167917|FG002|Study Extension (up to Year 2)|Death|0|||
161762437|NCT00242710|584167918|FG003|Study Extension (up to Year 2)|Death|1|||
161762438|NCT00242710|584167915|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
161762439|NCT00242710|584167916|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
161762440|NCT00242710|584167917|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
161762441|NCT00242710|584167918|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
161762442|NCT00242710|584167915|FG000|Study Extension (up to Year 2)|Other|3|||
161762443|NCT00242710|584167916|FG001|Study Extension (up to Year 2)|Other|5|||
161762444|NCT00242710|584167917|FG002|Study Extension (up to Year 2)|Other|4|||
161762445|NCT00242710|584167918|FG003|Study Extension (up to Year 2)|Other|3|||
161762446|NCT00242710|584167915|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
161762447|NCT00242710|584167916|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
161762448|NCT00242710|584167917|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
161762449|NCT00242710|584167918|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
161762450|NCT00242710|584167915|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
161762451|NCT00242710|584167916|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
161762452|NCT00242710|584167917|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
161762453|NCT00242710|584167918|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
161762454|NCT01057394|584167919|FG000|Overall Study|Not eligible|0|||
161762455|NCT01057394|584167920|FG001|Overall Study|Not eligible|2|||
161762456|NCT00579527|584167921|FG000|Overall Study|Death|4|||
161762457|NCT00203294|584167922|FG000|Overall Study|Withdrawal by Subject|8|||
161762458|NCT00203294|584167923|FG001|Overall Study|Withdrawal by Subject|13|||
161762459|NCT02177942|584167933|FG000|Overall Study|Adverse Event|1|||
161762460|NCT02177942|584167934|FG001|Overall Study|Adverse Event|0|||
161762461|NCT02177942|584167933|FG000|Overall Study|Lost to Follow-up|1|||
161762462|NCT02177942|584167934|FG001|Overall Study|Lost to Follow-up|1|||
161762463|NCT02177942|584167933|FG000|Overall Study|Protocol Violation|4|||
161762464|NCT02177942|584167934|FG001|Overall Study|Protocol Violation|6|||
161762465|NCT02177942|584167933|FG000|Overall Study|Withdrawal by Subject|71|||
161762466|NCT02177942|584167934|FG001|Overall Study|Withdrawal by Subject|81|||
161762467|NCT01948791|584167938|FG000|Overall Study|Adverse Event|12|||
161762468|NCT01948791|584167938|FG000|Overall Study|Lack of Efficacy|3|||
161762469|NCT01948791|584167938|FG000|Overall Study|Protocol Violation|2|||
161762470|NCT01948791|584167938|FG000|Overall Study|Withdrawal by Subject|5|||
161762471|NCT01948791|584167938|FG000|Overall Study|Lost to Follow-up|6|||
161762472|NCT01948791|584167938|FG000|Overall Study|Management issues|1|||
161762473|NCT01948791|584167938|FG000|Overall Study|Others|7|||
161762474|NCT01948791|584167938|FG000|Overall Study|Screening failure|35|||
161762475|NCT02555722|584167946|FG000|Week 2|Adverse Event|0|||
161762476|NCT02555722|584167947|FG001|Week 2|Adverse Event|1|||
161762477|NCT02555722|584167946|FG000|Week 2|Withdrawal by Subject|1|||
161762478|NCT02555722|584167947|FG001|Week 2|Withdrawal by Subject|0|||
161762479|NCT02555722|584167946|FG000|Month 1|Lens Discomfort|1|||
161762480|NCT02555722|584167947|FG001|Month 1|Lens Discomfort|0|||
161762481|NCT02555722|584167946|FG000|Month 2|Withdrawal by Subject|3|||
161762482|NCT02555722|584167947|FG001|Month 2|Withdrawal by Subject|0|||
161762483|NCT02555722|584167946|FG000|Month 2|Lost to Follow-up|1|||
161762484|NCT02555722|584167947|FG001|Month 2|Lost to Follow-up|0|||
161762485|NCT00702949|584167948|FG000|Overall Study|Refusal|3|||
161762486|NCT00702949|584167949|FG001|Overall Study|Refusal|2|||
161762487|NCT00702949|584167950|FG002|Overall Study|Refusal|2|||
161762488|NCT00702949|584167948|FG000|Overall Study|Adverse Event|1|||
161762489|NCT00702949|584167949|FG001|Overall Study|Adverse Event|6|||
161762490|NCT00702949|584167950|FG002|Overall Study|Adverse Event|3|||
161762491|NCT00702949|584167948|FG000|Overall Study|Other Medical Reason/unknown|1|||
161762492|NCT00702949|584167949|FG001|Overall Study|Other Medical Reason/unknown|1|||
161762493|NCT00702949|584167950|FG002|Overall Study|Other Medical Reason/unknown|3|||
161762494|NCT00598585|584167951|FG000|Overall Study|Lost to Follow-up|1|||
161762495|NCT00598585|584167952|FG001|Overall Study|Lost to Follow-up|0|||
161762496|NCT01040728|584167953|FG000|Overall Study|Adverse Event|4|||
161762497|NCT01040728|584167954|FG001|Overall Study|Adverse Event|8|||
161762498|NCT01040728|584167955|FG002|Overall Study|Adverse Event|0|||
161762499|NCT01040728|584167956|FG003|Overall Study|Adverse Event|4|||
161762500|NCT01040728|584167953|FG000|Overall Study|Withdrawal by Subject|0|||
161762501|NCT01040728|584167954|FG001|Overall Study|Withdrawal by Subject|1|||
161762502|NCT01040728|584167955|FG002|Overall Study|Withdrawal by Subject|1|||
161762503|NCT01040728|584167956|FG003|Overall Study|Withdrawal by Subject|0|||
161762504|NCT01040728|584167953|FG000|Overall Study|Protocol Violation|0|||
161762505|NCT01040728|584167954|FG001|Overall Study|Protocol Violation|0|||
161762506|NCT01040728|584167955|FG002|Overall Study|Protocol Violation|0|||
161762507|NCT01040728|584167956|FG003|Overall Study|Protocol Violation|1|||
161762508|NCT01040728|584167953|FG000|Overall Study|Lack of Efficacy|0|||
161762509|NCT01040728|584167954|FG001|Overall Study|Lack of Efficacy|1|||
161762510|NCT01040728|584167955|FG002|Overall Study|Lack of Efficacy|0|||
161762511|NCT01040728|584167956|FG003|Overall Study|Lack of Efficacy|1|||
161762512|NCT01040728|584167953|FG000|Overall Study|Other reasons not listed above|0|||
161762513|NCT01040728|584167954|FG001|Overall Study|Other reasons not listed above|1|||
161762514|NCT01040728|584167955|FG002|Overall Study|Other reasons not listed above|0|||
161762515|NCT01040728|584167956|FG003|Overall Study|Other reasons not listed above|0|||
161762516|NCT03196973|584167959|FG000|Overall Study|Adverse Event|1|||
161762517|NCT03196973|584167960|FG001|Overall Study|Adverse Event|1|||
161762518|NCT03196973|584167961|FG002|Overall Study|Adverse Event|2|||
161762519|NCT03196973|584167959|FG000|Overall Study|Lack of Efficacy|2|||
161762520|NCT03196973|584167960|FG001|Overall Study|Lack of Efficacy|6|||
161762521|NCT03196973|584167961|FG002|Overall Study|Lack of Efficacy|1|||
161762522|NCT03196973|584167959|FG000|Overall Study|Lost to Follow-up|4|||
161762523|NCT03196973|584167960|FG001|Overall Study|Lost to Follow-up|3|||
161762524|NCT03196973|584167961|FG002|Overall Study|Lost to Follow-up|2|||
161762525|NCT03196973|584167959|FG000|Overall Study|Consent withdrawn|2|||
161762526|NCT03196973|584167960|FG001|Overall Study|Consent withdrawn|1|||
161762527|NCT03196973|584167961|FG002|Overall Study|Consent withdrawn|0|||
161762528|NCT03196973|584167959|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
161762529|NCT03196973|584167960|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
161762530|NCT03196973|584167961|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
161847818|NCT03301649|584484118|FG002|Overall Study|Need alternate therapy due to live lice|81|||
161847819|NCT03301649|584484116|FG000|Overall Study|Lost to Follow-up|11|||
161847820|NCT03301649|584484117|FG001|Overall Study|Lost to Follow-up|11|||
161847821|NCT03301649|584484118|FG002|Overall Study|Lost to Follow-up|3|||
161847822|NCT03301649|584484116|FG000|Overall Study|Protocol Violation|0|||
161847823|NCT03301649|584484117|FG001|Overall Study|Protocol Violation|1|||
161847824|NCT03301649|584484118|FG002|Overall Study|Protocol Violation|1|||
161847825|NCT03301649|584484116|FG000|Overall Study|Withdrawal by Subject|10|||
161847826|NCT03301649|584484117|FG001|Overall Study|Withdrawal by Subject|4|||
161847827|NCT03301649|584484118|FG002|Overall Study|Withdrawal by Subject|0|||
161847828|NCT03301649|584484116|FG000|Overall Study|Other than specified|5|||
161847829|NCT03301649|584484117|FG001|Overall Study|Other than specified|3|||
161847830|NCT03301649|584484118|FG002|Overall Study|Other than specified|0|||
161847831|NCT01403051|584484119|FG000|Overall Study|Protocol Violation|2|||
161847832|NCT01403051|584484120|FG001|Overall Study|Protocol Violation|0|||
161847833|NCT01403051|584484119|FG000|Overall Study|Death|1|||
161847834|NCT01403051|584484120|FG001|Overall Study|Death|0|||
161847835|NCT01403051|584484119|FG000|Overall Study|Withdrawal by Subject|2|||
161847836|NCT01403051|584484120|FG001|Overall Study|Withdrawal by Subject|1|||
161847837|NCT01403051|584484119|FG000|Overall Study|Lost to Follow-up|5|||
161847838|NCT01403051|584484120|FG001|Overall Study|Lost to Follow-up|5|||
161847839|NCT02932306|584484133|FG000|Overall Study|Withdrawal by Subject|16|||
161847840|NCT02932306|584484134|FG001|Overall Study|Withdrawal by Subject|25|||
161847841|NCT02932306|584484133|FG000|Overall Study|Adverse Event|3|||
161847842|NCT02932306|584484134|FG001|Overall Study|Adverse Event|0|||
161847843|NCT02932306|584484133|FG000|Overall Study|Pregnancy|2|||
161847844|NCT02932306|584484134|FG001|Overall Study|Pregnancy|0|||
161847845|NCT02932306|584484133|FG000|Overall Study|Protocol Violation|1|||
161847846|NCT02932306|584484134|FG001|Overall Study|Protocol Violation|1|||
161847847|NCT02932306|584484133|FG000|Overall Study|Noncompliance with Study Drug|1|||
161847848|NCT02932306|584484134|FG001|Overall Study|Noncompliance with Study Drug|1|||
161847849|NCT02932306|584484133|FG000|Overall Study|Lost to Follow-up|36|||
161847850|NCT02932306|584484134|FG001|Overall Study|Lost to Follow-up|40|||
161847851|NCT02932306|584484133|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
161847852|NCT02932306|584484134|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
161847853|NCT02932306|584484133|FG000|Overall Study|Lack of Efficacy|0|||
161847854|NCT02932306|584484134|FG001|Overall Study|Lack of Efficacy|2|||
161847855|NCT02932306|584484133|FG000|Overall Study|Worsening condition|2|||
161847856|NCT02932306|584484134|FG001|Overall Study|Worsening condition|0|||
161847857|NCT02932306|584484133|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
161847858|NCT02932306|584484134|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
161847859|NCT02065700|584484135|FG000|Overall Study|Adverse Event|165|||
161847860|NCT02065700|584484136|FG001|Overall Study|Adverse Event|101|||
161847861|NCT02065700|584484135|FG000|Overall Study|Withdrawal by Subject|90|||
161847862|NCT02065700|584484136|FG001|Overall Study|Withdrawal by Subject|29|||
161847863|NCT02065700|584484135|FG000|Overall Study|Lost to Follow-up|12|||
161847864|NCT02065700|584484136|FG001|Overall Study|Lost to Follow-up|9|||
161847865|NCT02065700|584484135|FG000|Overall Study|Physician Decision|2|||
161847866|NCT02065700|584484136|FG001|Overall Study|Physician Decision|0|||
161847867|NCT02065700|584484135|FG000|Overall Study|Sponsor Request|38|||
161847868|NCT02065700|584484136|FG001|Overall Study|Sponsor Request|15|||
161847869|NCT02065700|584484135|FG000|Overall Study|Treatment Failure|3|||
161847870|NCT02065700|584484136|FG001|Overall Study|Treatment Failure|2|||
161847871|NCT02065700|584484135|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
161847872|NCT02065700|584484136|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
161847873|NCT02065700|584484135|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
161847874|NCT02065700|584484136|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
161847875|NCT02065700|584484135|FG000|Overall Study|Non-compliance with Study Procedures|2|||
161847876|NCT02065700|584484136|FG001|Overall Study|Non-compliance with Study Procedures|0|||
161847877|NCT02065700|584484135|FG000|Overall Study|Not Defined|21|||
161847878|NCT02065700|584484136|FG001|Overall Study|Not Defined|3|||
161847879|NCT02315196|584484137|FG000|Overall Study|Withdrew consent|9|||
161847880|NCT01635218|584484138|FG000|Overall Study|Lost to Follow-up|3|||
161847881|NCT01635218|584484139|FG001|Overall Study|Lost to Follow-up|7|||
161847882|NCT01635218|584484140|FG002|Overall Study|Lost to Follow-up|6|||
161847883|NCT03559400|584484141|FG000|Overall Study|Lost to Follow-up|9|||
161847884|NCT03559400|584484142|FG001|Overall Study|Lost to Follow-up|7|||
161847885|NCT03559400|584484141|FG000|Overall Study|Death|0|||
161847886|NCT03559400|584484142|FG001|Overall Study|Death|2|||
161847887|NCT03262038|584484143|FG000|Overall Study|Withdrawal by Subject|0|||
161847888|NCT03262038|584484144|FG001|Overall Study|Withdrawal by Subject|1|||
161847889|NCT04933968|584484145|FG000|Overall Study|Adverse Event|0|||
161847890|NCT04933968|584484146|FG001|Overall Study|Adverse Event|0|||
161847891|NCT04933968|584484147|FG002|Overall Study|Adverse Event|1|||
161847892|NCT04933968|584484148|FG003|Overall Study|Adverse Event|1|||
161971398|NCT02285114|584943319|FG000|Main Phase|Enrolled but Never Treated|1|||
161847893|NCT04933968|584484149|FG004|Overall Study|Adverse Event|0|||
161847894|NCT04933968|584484150|FG005|Overall Study|Adverse Event|0|||
161762531|NCT01610414|584167964|FG000|Study Start - Month 13|Serious Adverse Event|65|||
161762532|NCT01610414|584167965|FG001|Study Start - Month 13|Serious Adverse Event|67|||
161762533|NCT01610414|584167964|FG000|Study Start - Month 13|Adverse Event|14|||
161762534|NCT01610414|584167965|FG001|Study Start - Month 13|Adverse Event|14|||
161762535|NCT01610414|584167964|FG000|Study Start - Month 13|Protocol Violation|3|||
161762536|NCT01610414|584167965|FG001|Study Start - Month 13|Protocol Violation|1|||
161762537|NCT01610414|584167964|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
161762538|NCT01610414|584167965|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
161762539|NCT01610414|584167964|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
161762540|NCT01610414|584167965|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
161762541|NCT01610414|584167964|FG000|Study Start - Month 13|Lost to Follow-up|4|||
161762542|NCT01610414|584167965|FG001|Study Start - Month 13|Lost to Follow-up|6|||
161762543|NCT01610414|584167964|FG000|Study Start - Month 13|Suspected HZ episode|1|||
161762544|NCT01610414|584167965|FG001|Study Start - Month 13|Suspected HZ episode|3|||
161762545|NCT01610414|584167964|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
161762546|NCT01610414|584167965|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
161762547|NCT01610414|584167964|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
161762548|NCT01610414|584167965|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
161762549|NCT01610414|584167964|FG000|Month 13 - Month 25|Adverse Event|8|||
161762550|NCT01610414|584167965|FG001|Month 13 - Month 25|Adverse Event|4|||
161762551|NCT01610414|584167964|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
161762552|NCT01610414|584167965|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
161762553|NCT01610414|584167964|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
161762554|NCT01610414|584167965|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
161762555|NCT01610414|584167964|FG000|Month 13 - Month 25|Protocol Violation|0|||
161762556|NCT01610414|584167965|FG001|Month 13 - Month 25|Protocol Violation|2|||
161762557|NCT01610414|584167964|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
161762558|NCT01610414|584167965|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
161762559|NCT01610414|584167964|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
161762560|NCT01610414|584167965|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
161762561|NCT01610414|584167964|FG000|After Month 25|Study end not reached|48|||
161762562|NCT01610414|584167965|FG001|After Month 25|Study end not reached|53|||
161762563|NCT00472043|584167967|FG000|Overall Study|Withdrawal by Subject|1|||
161762564|NCT00472043|584167968|FG001|Overall Study|Withdrawal by Subject|0|||
161762565|NCT00472043|584167967|FG000|Overall Study|Death|1|||
161762566|NCT00472043|584167968|FG001|Overall Study|Death|0|||
161762567|NCT00826540|584167971|FG000|Overall Study|ineligible|3|||
161762568|NCT00826540|584167971|FG000|Overall Study|Withdrawal by Subject|1|||
161762569|NCT04009824|584167972|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
161762570|NCT04009824|584167973|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
161762571|NCT04009824|584167974|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
161762572|NCT04009824|584167975|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
161762573|NCT04009824|584167976|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
161762574|NCT01024946|584167977|FG000|Overall Study|Screen Failure|3|||
161762575|NCT01024946|584167977|FG000|Overall Study|Withdrawal by Subject|1|||
161762576|NCT01024946|584167977|FG000|Overall Study|Adverse Event|1|||
161762577|NCT03147495|584167978|FG000|Overall Study|Physician Decision|0|||
161762578|NCT03147495|584167979|FG001|Overall Study|Physician Decision|6|||
161762579|NCT02608892|584167980|FG000|Overall Study|Lost to Follow-up|1|||
161762580|NCT02608892|584167981|FG001|Overall Study|Lost to Follow-up|0|||
161762581|NCT03032523|584167982|FG000|Overall Study|Withdrawal by Subject|2|||
161762582|NCT03032523|584167983|FG001|Overall Study|Withdrawal by Subject|2|||
161762583|NCT03032523|584167982|FG000|Overall Study|Physician Decision|1|||
161762584|NCT03032523|584167983|FG001|Overall Study|Physician Decision|0|||
161762585|NCT00957723|584167984|FG000|Overall Study|Death|3|||
161762586|NCT00957723|584167984|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
161762587|NCT00957723|584167984|FG000|Overall Study|Lost to Follow-up|8|||
161762588|NCT00957723|584167984|FG000|Overall Study|Withdrawal by Subject|24|||
161762589|NCT00957723|584167984|FG000|Overall Study|Investigative Site Terminated|61|||
161762590|NCT00957723|584167984|FG000|Overall Study|Intercurrent Illness|2|||
161762591|NCT00957723|584167984|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
161762592|NCT05375838|584167985|FG000|Overall Study|Other|0|||
161762593|NCT05375838|584167986|FG001|Overall Study|Other|0|||
161762594|NCT05375838|584167987|FG002|Overall Study|Other|0|||
161762595|NCT05375838|584167988|FG003|Overall Study|Other|1|||
161762596|NCT05375838|584167989|FG004|Overall Study|Other|1|||
161762597|NCT05375838|584167990|FG005|Overall Study|Other|0|||
161971399|NCT02285114|584943320|FG001|Main Phase|Enrolled but Never Treated|0|||
161762598|NCT05375838|584167985|FG000|Overall Study|Withdrawal by Subject|2|||
161762599|NCT05375838|584167986|FG001|Overall Study|Withdrawal by Subject|1|||
161971400|NCT02285114|584943321|FG002|Main Phase|Enrolled but Never Treated|0|||
161762600|NCT05375838|584167987|FG002|Overall Study|Withdrawal by Subject|3|||
161762601|NCT05375838|584167988|FG003|Overall Study|Withdrawal by Subject|2|||
161762602|NCT05375838|584167989|FG004|Overall Study|Withdrawal by Subject|2|||
161847895|NCT04933968|584484145|FG000|Overall Study|Lost to Follow-up|1|||
161971401|NCT02285114|584943322|FG003|Main Phase|Enrolled but Never Treated|0|||
161971402|NCT02285114|584943323|FG004|Main Phase|Enrolled but Never Treated|0|||
161971403|NCT02285114|584943324|FG005|Main Phase|Enrolled but Never Treated|0|||
161971404|NCT02285114|584943319|FG000|Main Phase|Withdrew Consent|0|||
161971405|NCT02285114|584943320|FG001|Main Phase|Withdrew Consent|0|||
161762603|NCT05375838|584167990|FG005|Overall Study|Withdrawal by Subject|0|||
161762604|NCT05375838|584167985|FG000|Overall Study|Protocol Violation|0|||
161762605|NCT05375838|584167986|FG001|Overall Study|Protocol Violation|0|||
161762606|NCT05375838|584167987|FG002|Overall Study|Protocol Violation|0|||
161762607|NCT05375838|584167988|FG003|Overall Study|Protocol Violation|0|||
161762608|NCT05375838|584167989|FG004|Overall Study|Protocol Violation|1|||
161762609|NCT05375838|584167990|FG005|Overall Study|Protocol Violation|0|||
161762610|NCT05375838|584167985|FG000|Overall Study|Physician Decision|0|||
161762611|NCT05375838|584167986|FG001|Overall Study|Physician Decision|1|||
161762612|NCT05375838|584167987|FG002|Overall Study|Physician Decision|0|||
161762613|NCT05375838|584167988|FG003|Overall Study|Physician Decision|0|||
161762614|NCT05375838|584167989|FG004|Overall Study|Physician Decision|0|||
161762615|NCT05375838|584167990|FG005|Overall Study|Physician Decision|1|||
161762616|NCT05375838|584167985|FG000|Overall Study|Lost to Follow-up|2|||
161762617|NCT05375838|584167986|FG001|Overall Study|Lost to Follow-up|7|||
161762618|NCT05375838|584167987|FG002|Overall Study|Lost to Follow-up|0|||
161762619|NCT05375838|584167988|FG003|Overall Study|Lost to Follow-up|4|||
161762620|NCT05375838|584167989|FG004|Overall Study|Lost to Follow-up|2|||
161762621|NCT05375838|584167990|FG005|Overall Study|Lost to Follow-up|3|||
161762622|NCT00877890|584167991|FG000|Overall Study|Adverse Event|6|||
161762623|NCT00877890|584167992|FG001|Overall Study|Adverse Event|6|||
161762624|NCT00877890|584167991|FG000|Overall Study|Lost to Follow-up|5|||
161762625|NCT00877890|584167992|FG001|Overall Study|Lost to Follow-up|5|||
161762626|NCT00877890|584167991|FG000|Overall Study|Protocol Violation|0|||
161762627|NCT00877890|584167992|FG001|Overall Study|Protocol Violation|1|||
161762628|NCT00877890|584167991|FG000|Overall Study|Withdrawal of Consent|6|||
161762629|NCT00877890|584167992|FG001|Overall Study|Withdrawal of Consent|12|||
161762630|NCT00877890|584167991|FG000|Overall Study|Investigator Decision|0|||
161762631|NCT00877890|584167992|FG001|Overall Study|Investigator Decision|2|||
161762632|NCT00877890|584167991|FG000|Overall Study|Loss of Glucose Control|3|||
161762633|NCT00877890|584167992|FG001|Overall Study|Loss of Glucose Control|4|||
161762634|NCT00984009|584167993|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
161762635|NCT02178592|584167994|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
161762636|NCT02178592|584167995|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
161762637|NCT02178592|584167994|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
161762638|NCT02178592|584167995|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
161762639|NCT02178592|584167994|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
161762640|NCT02178592|584167995|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
161762641|NCT02178592|584167994|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
161762642|NCT02178592|584167995|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
161762643|NCT02178592|584167994|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
161762644|NCT02178592|584167995|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
161762645|NCT02178592|584167994|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
161762646|NCT02178592|584167995|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
161762647|NCT02178592|584167994|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
161762648|NCT02178592|584167995|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
161762649|NCT02178592|584167994|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
161762650|NCT02178592|584167995|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
161762651|NCT02178592|584167994|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
161762652|NCT02178592|584167995|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
161762653|NCT02178592|584167994|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
161762654|NCT02178592|584167995|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
161762655|NCT02178592|584167994|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
161762656|NCT02178592|584167995|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
161762657|NCT02178592|584167994|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
161762658|NCT02178592|584167995|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
161971406|NCT02285114|584943321|FG002|Main Phase|Withdrew Consent|1|||
161762659|NCT02036476|584168006|FG000|Overall Study|Withdrawal by Subject|2|||
161762660|NCT02036476|584168006|FG000|Overall Study|Progressive Disease|4|||
161762661|NCT02036476|584168006|FG000|Overall Study|Unacceptable Toxicity|2|||
161762662|NCT02698176|584168007|FG000|Overall Study|Progressive disease|4|||
161762663|NCT02698176|584168008|FG001|Overall Study|Progressive disease|3|||
161762664|NCT02698176|584168009|FG002|Overall Study|Progressive disease|1|||
161762665|NCT02698176|584168010|FG003|Overall Study|Progressive disease|0|||
161762666|NCT02698176|584168007|FG000|Overall Study|Adverse Event|2|||
161762667|NCT02698176|584168008|FG001|Overall Study|Adverse Event|0|||
161762668|NCT02698176|584168009|FG002|Overall Study|Adverse Event|0|||
161971407|NCT02285114|584943322|FG003|Main Phase|Withdrew Consent|0|||
161971408|NCT02285114|584943323|FG004|Main Phase|Withdrew Consent|0|||
161971409|NCT02285114|584943324|FG005|Main Phase|Withdrew Consent|0|||
162033084|NCT00274924|585178594|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
162033085|NCT00274924|585178592|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
162033086|NCT00274924|585178593|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
162033087|NCT00274924|585178594|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
162033088|NCT00274924|585178592|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
162033089|NCT00274924|585178593|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
162033090|NCT00274924|585178594|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
162033091|NCT00274924|585178592|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
162033092|NCT00274924|585178593|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
162033093|NCT00274924|585178594|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
162033094|NCT00274924|585178592|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
162033095|NCT00274924|585178593|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
162033096|NCT00274924|585178594|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
162033097|NCT00274924|585178592|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
162033098|NCT00274924|585178593|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
162033099|NCT00274924|585178594|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
162033100|NCT01903525|585178597|FG000|Overall Study|Lost to Follow-up|5|||
162033101|NCT01903525|585178598|FG001|Overall Study|Lost to Follow-up|9|||
162033102|NCT01903525|585178597|FG000|Overall Study|Adverse Event|0|||
162033103|NCT01903525|585178598|FG001|Overall Study|Adverse Event|1|||
162033104|NCT01673282|585178600|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
162033105|NCT01673282|585178601|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
162033106|NCT01673282|585178600|FG000|Overall Study|Lack of Efficacy|9|||
162033107|NCT01673282|585178601|FG001|Overall Study|Lack of Efficacy|2|||
162033108|NCT01673282|585178600|FG000|Overall Study|Lost to Follow-up|11|||
162033109|NCT01673282|585178601|FG001|Overall Study|Lost to Follow-up|10|||
162033110|NCT01673282|585178600|FG000|Overall Study|Withdrawal by Subject|3|||
162033111|NCT01673282|585178601|FG001|Overall Study|Withdrawal by Subject|3|||
162033112|NCT01673282|585178600|FG000|Overall Study|Other|1|||
162033113|NCT01673282|585178601|FG001|Overall Study|Other|6|||
162033114|NCT04365257|585178602|FG000|Overall Study|Physician Decision|1|||
162033115|NCT04365257|585178603|FG001|Overall Study|Physician Decision|0|||
162033116|NCT04365257|585178602|FG000|Overall Study|Patient Noncompliance|1|||
162033117|NCT04365257|585178603|FG001|Overall Study|Patient Noncompliance|0|||
162033118|NCT04365257|585178602|FG000|Overall Study|Withdrawal by Subject|0|||
162033119|NCT04365257|585178603|FG001|Overall Study|Withdrawal by Subject|1|||
162033120|NCT02129777|585178608|FG000|Double-Blind Period|Adverse Event|0|||
162033121|NCT02129777|585178609|FG001|Double-Blind Period|Adverse Event|0|||
162033122|NCT02129777|585178610|FG002|Double-Blind Period|Adverse Event|0|||
161971410|NCT02285114|584943319|FG000|Extension Phase|Investigator's Discretion|0|||
161971411|NCT02285114|584943320|FG001|Extension Phase|Investigator's Discretion|0|||
161971412|NCT02285114|584943321|FG002|Extension Phase|Investigator's Discretion|0|||
161971413|NCT02285114|584943322|FG003|Extension Phase|Investigator's Discretion|14|||
161971414|NCT02285114|584943323|FG004|Extension Phase|Investigator's Discretion|1|||
161971415|NCT02285114|584943324|FG005|Extension Phase|Investigator's Discretion|0|||
161971416|NCT02285114|584943319|FG000|Extension Phase|Lost to Follow-up|0|||
161971417|NCT02285114|584943320|FG001|Extension Phase|Lost to Follow-up|0|||
161971418|NCT02285114|584943321|FG002|Extension Phase|Lost to Follow-up|0|||
161971419|NCT02285114|584943322|FG003|Extension Phase|Lost to Follow-up|1|||
162033123|NCT02129777|585178611|FG003|Double-Blind Period|Adverse Event|0|||
162033124|NCT02129777|585178612|FG004|Double-Blind Period|Adverse Event|1|||
162033125|NCT02129777|585178613|FG005|Double-Blind Period|Adverse Event|0|||
162033126|NCT02129777|585178614|FG006|Double-Blind Period|Adverse Event|0|||
162033127|NCT02129777|585178608|FG000|Double-Blind Period|Lost to Follow-up|1|||
162033128|NCT02129777|585178609|FG001|Double-Blind Period|Lost to Follow-up|1|||
161971420|NCT02285114|584943323|FG004|Extension Phase|Lost to Follow-up|1|||
161971421|NCT02285114|584943324|FG005|Extension Phase|Lost to Follow-up|0|||
162033129|NCT02129777|585178610|FG002|Double-Blind Period|Lost to Follow-up|1|||
162033130|NCT02129777|585178611|FG003|Double-Blind Period|Lost to Follow-up|2|||
162033131|NCT02129777|585178612|FG004|Double-Blind Period|Lost to Follow-up|0|||
162033132|NCT02129777|585178613|FG005|Double-Blind Period|Lost to Follow-up|0|||
162033133|NCT02129777|585178614|FG006|Double-Blind Period|Lost to Follow-up|0|||
162033134|NCT02129777|585178608|FG000|Double-Blind Period|Withdrawal by Subject|2|||
162033135|NCT02129777|585178609|FG001|Double-Blind Period|Withdrawal by Subject|4|||
162033136|NCT02129777|585178610|FG002|Double-Blind Period|Withdrawal by Subject|3|||
162033137|NCT02129777|585178611|FG003|Double-Blind Period|Withdrawal by Subject|2|||
162033138|NCT02129777|585178612|FG004|Double-Blind Period|Withdrawal by Subject|3|||
162033139|NCT02129777|585178613|FG005|Double-Blind Period|Withdrawal by Subject|0|||
162033140|NCT02129777|585178614|FG006|Double-Blind Period|Withdrawal by Subject|0|||
162033141|NCT02129777|585178608|FG000|Double-Blind Period|Pregnancy|0|||
162033142|NCT02129777|585178609|FG001|Double-Blind Period|Pregnancy|0|||
162033143|NCT02129777|585178610|FG002|Double-Blind Period|Pregnancy|0|||
162033144|NCT02129777|585178611|FG003|Double-Blind Period|Pregnancy|0|||
161971422|NCT02285114|584943319|FG000|Extension Phase|Non-compliance with Study Drug|0|||
161762669|NCT02698176|584168010|FG003|Overall Study|Adverse Event|0|||
161762670|NCT02698176|584168007|FG000|Overall Study|Clinical progression|3|||
161762671|NCT02698176|584168008|FG001|Overall Study|Clinical progression|0|||
161762672|NCT02698176|584168009|FG002|Overall Study|Clinical progression|0|||
161762673|NCT02698176|584168010|FG003|Overall Study|Clinical progression|0|||
161762674|NCT02985684|584168012|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
161762675|NCT02985684|584168012|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
161762676|NCT02985684|584168012|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
161762677|NCT01084096|584169638|FG000|Overall Study|Lost to Follow-up|1501|||
161762678|NCT01084096|584169639|FG001|Overall Study|Lost to Follow-up|1833|||
161762679|NCT01084096|584169638|FG000|Overall Study|Withdrawal by Subject|3|||
161762680|NCT01084096|584169639|FG001|Overall Study|Withdrawal by Subject|0|||
161762681|NCT01084096|584169638|FG000|Overall Study|Woman had a miscarriage|21|||
161762682|NCT01084096|584169639|FG001|Overall Study|Woman had a miscarriage|17|||
161762683|NCT00027846|584169640|FG000|Overall Study|Lost to Follow-up|0|||
161762684|NCT00027846|584169641|FG001|Overall Study|Lost to Follow-up|41|||
161762685|NCT00027846|584169642|FG002|Overall Study|Lost to Follow-up|9|||
161762686|NCT00027846|584169640|FG000|Overall Study|Withdrawal by Subject|0|||
161762687|NCT00027846|584169641|FG001|Overall Study|Withdrawal by Subject|14|||
161762688|NCT00027846|584169642|FG002|Overall Study|Withdrawal by Subject|7|||
161762689|NCT00027846|584169640|FG000|Overall Study|Ineligible for study|2|||
161762690|NCT00027846|584169641|FG001|Overall Study|Ineligible for study|6|||
161762691|NCT00027846|584169642|FG002|Overall Study|Ineligible for study|14|||
161762692|NCT00027846|584169640|FG000|Overall Study|Entry into another COG therapeutic study|0|||
161762693|NCT00027846|584169641|FG001|Overall Study|Entry into another COG therapeutic study|5|||
161762694|NCT00027846|584169642|FG002|Overall Study|Entry into another COG therapeutic study|2|||
161762695|NCT00027846|584169640|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
161762696|NCT00027846|584169641|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
161762697|NCT00027846|584169642|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
161762698|NCT02033369|584169643|FG000|Overall Study|Physician Decision|1|||
161762699|NCT02033369|584169644|FG001|Overall Study|Physician Decision|2|||
161762700|NCT02033369|584169643|FG000|Overall Study|Not a good demographic match|0|||
161762701|NCT02033369|584169644|FG001|Overall Study|Not a good demographic match|2|||
161762702|NCT02033369|584169643|FG000|Overall Study|Withdrawal by Subject|1|||
161971423|NCT02285114|584943320|FG001|Extension Phase|Non-compliance with Study Drug|0|||
161971424|NCT02285114|584943321|FG002|Extension Phase|Non-compliance with Study Drug|0|||
161971425|NCT02285114|584943322|FG003|Extension Phase|Non-compliance with Study Drug|2|||
161971426|NCT02285114|584943323|FG004|Extension Phase|Non-compliance with Study Drug|0|||
161971427|NCT02285114|584943324|FG005|Extension Phase|Non-compliance with Study Drug|0|||
161971428|NCT02285114|584943319|FG000|Extension Phase|Pregnancy|0|||
161971429|NCT02285114|584943320|FG001|Extension Phase|Pregnancy|0|||
161971430|NCT02285114|584943321|FG002|Extension Phase|Pregnancy|0|||
161762703|NCT02033369|584169644|FG001|Overall Study|Withdrawal by Subject|1|||
161762704|NCT02033369|584169643|FG000|Overall Study|Lost to Follow-up|1|||
161762705|NCT02033369|584169644|FG001|Overall Study|Lost to Follow-up|0|||
161762706|NCT02033369|584169643|FG000|Overall Study|Protocol Violation|2|||
161762707|NCT02033369|584169644|FG001|Overall Study|Protocol Violation|0|||
161762708|NCT01249404|584169647|FG000|Overall Study|Study treatment not received|0|||
161762709|NCT01249404|584169648|FG001|Overall Study|Study treatment not received|1|||
161762710|NCT01249404|584169649|FG002|Overall Study|Study treatment not received|2|||
161762711|NCT01249404|584169647|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
161762712|NCT01249404|584169648|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
161762713|NCT01249404|584169649|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
161762714|NCT01249404|584169647|FG000|Overall Study|Adverse Event|2|||
161762715|NCT01249404|584169648|FG001|Overall Study|Adverse Event|2|||
161762716|NCT01249404|584169649|FG002|Overall Study|Adverse Event|2|||
161762717|NCT01249404|584169647|FG000|Overall Study|Withdrawal by Subject|2|||
161762718|NCT01249404|584169648|FG001|Overall Study|Withdrawal by Subject|2|||
161762719|NCT01249404|584169649|FG002|Overall Study|Withdrawal by Subject|0|||
161762720|NCT01249404|584169647|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
161762721|NCT01249404|584169648|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
161762722|NCT01249404|584169649|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
161762723|NCT01249404|584169647|FG000|Overall Study|Non compliance to visit schedule|0|||
161762724|NCT01249404|584169648|FG001|Overall Study|Non compliance to visit schedule|1|||
161762725|NCT01249404|584169649|FG002|Overall Study|Non compliance to visit schedule|0|||
161762726|NCT03758612|584169650|FG000|Washout Period|Withdrawal by Subject|0|||
161762727|NCT03758612|584169651|FG001|Washout Period|Withdrawal by Subject|0|||
161762728|NCT03758612|584169652|FG002|Washout Period|Withdrawal by Subject|2|||
161762729|NCT03758612|584169653|FG003|Washout Period|Withdrawal by Subject|0|||
161762730|NCT03758612|584169654|FG004|Washout Period|Withdrawal by Subject|0|||
161762731|NCT03758612|584169655|FG005|Washout Period|Withdrawal by Subject|0|||
161762732|NCT03758612|584169656|FG006|Washout Period|Withdrawal by Subject|0|||
161762733|NCT03758612|584169657|FG007|Washout Period|Withdrawal by Subject|0|||
161847896|NCT04933968|584484146|FG001|Overall Study|Lost to Follow-up|0|||
162033145|NCT02129777|585178612|FG004|Double-Blind Period|Pregnancy|1|||
162033146|NCT02129777|585178613|FG005|Double-Blind Period|Pregnancy|0|||
162033147|NCT02129777|585178614|FG006|Double-Blind Period|Pregnancy|0|||
162033148|NCT02129777|585178608|FG000|Double-Blind Period|Lack of Efficacy|3|||
162033149|NCT02129777|585178609|FG001|Double-Blind Period|Lack of Efficacy|1|||
162033150|NCT02129777|585178610|FG002|Double-Blind Period|Lack of Efficacy|0|||
162033151|NCT02129777|585178611|FG003|Double-Blind Period|Lack of Efficacy|3|||
162033152|NCT02129777|585178612|FG004|Double-Blind Period|Lack of Efficacy|2|||
162033153|NCT02129777|585178613|FG005|Double-Blind Period|Lack of Efficacy|0|||
162033154|NCT02129777|585178614|FG006|Double-Blind Period|Lack of Efficacy|0|||
162033155|NCT02129777|585178608|FG000|Double-Blind Period|Other|1|||
162033156|NCT02129777|585178609|FG001|Double-Blind Period|Other|2|||
162033157|NCT02129777|585178610|FG002|Double-Blind Period|Other|0|||
162033158|NCT02129777|585178611|FG003|Double-Blind Period|Other|0|||
162033159|NCT02129777|585178612|FG004|Double-Blind Period|Other|0|||
162033160|NCT02129777|585178613|FG005|Double-Blind Period|Other|0|||
162033161|NCT02129777|585178614|FG006|Double-Blind Period|Other|0|||
162033162|NCT02129777|585178608|FG000|Open-Label Period|Lack of Efficacy|0|||
162033163|NCT02129777|585178609|FG001|Open-Label Period|Lack of Efficacy|0|||
162033164|NCT02129777|585178610|FG002|Open-Label Period|Lack of Efficacy|0|||
162033165|NCT02129777|585178611|FG003|Open-Label Period|Lack of Efficacy|0|||
162033166|NCT02129777|585178612|FG004|Open-Label Period|Lack of Efficacy|0|||
162033167|NCT02129777|585178613|FG005|Open-Label Period|Lack of Efficacy|0|||
162033168|NCT02129777|585178614|FG006|Open-Label Period|Lack of Efficacy|5|||
162033169|NCT02129777|585178608|FG000|Open-Label Period|Lost to Follow-up|0|||
162033170|NCT02129777|585178609|FG001|Open-Label Period|Lost to Follow-up|0|||
162033171|NCT02129777|585178610|FG002|Open-Label Period|Lost to Follow-up|0|||
162033172|NCT02129777|585178611|FG003|Open-Label Period|Lost to Follow-up|0|||
162033173|NCT02129777|585178612|FG004|Open-Label Period|Lost to Follow-up|0|||
162033174|NCT02129777|585178613|FG005|Open-Label Period|Lost to Follow-up|1|||
162033175|NCT02129777|585178614|FG006|Open-Label Period|Lost to Follow-up|1|||
162033176|NCT02129777|585178608|FG000|Open-Label Period|Withdrawal by Subject|0|||
162033177|NCT02129777|585178609|FG001|Open-Label Period|Withdrawal by Subject|0|||
162033178|NCT02129777|585178610|FG002|Open-Label Period|Withdrawal by Subject|0|||
162033179|NCT02129777|585178611|FG003|Open-Label Period|Withdrawal by Subject|0|||
162033180|NCT02129777|585178612|FG004|Open-Label Period|Withdrawal by Subject|0|||
162033181|NCT02129777|585178613|FG005|Open-Label Period|Withdrawal by Subject|1|||
162033182|NCT02129777|585178614|FG006|Open-Label Period|Withdrawal by Subject|3|||
162033183|NCT02129777|585178608|FG000|Open-Label Period|Study Termination|0|||
162033184|NCT02129777|585178609|FG001|Open-Label Period|Study Termination|0|||
162033185|NCT02129777|585178610|FG002|Open-Label Period|Study Termination|0|||
162033186|NCT02129777|585178611|FG003|Open-Label Period|Study Termination|0|||
162033187|NCT02129777|585178612|FG004|Open-Label Period|Study Termination|0|||
162033188|NCT02129777|585178613|FG005|Open-Label Period|Study Termination|10|||
162033189|NCT02129777|585178614|FG006|Open-Label Period|Study Termination|39|||
162033190|NCT01609478|585178622|FG000|Overall Study|Adverse Event|3|||
162033191|NCT01609478|585178623|FG001|Overall Study|Adverse Event|1|||
162033192|NCT01609478|585178624|FG002|Overall Study|Adverse Event|5|||
162033193|NCT01609478|585178622|FG000|Overall Study|Protocol Deviation|0|||
162033194|NCT01609478|585178623|FG001|Overall Study|Protocol Deviation|1|||
162033195|NCT01609478|585178624|FG002|Overall Study|Protocol Deviation|1|||
162033196|NCT01609478|585178622|FG000|Overall Study|Non-Compliance with study treatment|1|||
162033197|NCT01609478|585178623|FG001|Overall Study|Non-Compliance with study treatment|0|||
162033198|NCT01609478|585178624|FG002|Overall Study|Non-Compliance with study treatment|0|||
162033199|NCT01609478|585178622|FG000|Overall Study|Physician Decision|1|||
162033200|NCT01609478|585178623|FG001|Overall Study|Physician Decision|0|||
162033201|NCT01609478|585178624|FG002|Overall Study|Physician Decision|1|||
162033202|NCT01609478|585178622|FG000|Overall Study|Withdrawal by Subject|2|||
162033203|NCT01609478|585178623|FG001|Overall Study|Withdrawal by Subject|0|||
162033204|NCT01609478|585178624|FG002|Overall Study|Withdrawal by Subject|2|||
162033205|NCT04973137|585178625|FG000|Double Blind Phase|Adverse Event|4|||
162033206|NCT04973137|585178626|FG001|Double Blind Phase|Adverse Event|0|||
162033207|NCT04973137|585178625|FG000|Double Blind Phase|Death|25|||
162033208|NCT04973137|585178626|FG001|Double Blind Phase|Death|15|||
162033209|NCT04973137|585178625|FG000|Double Blind Phase|Physician Decision|5|||
162033210|NCT04973137|585178626|FG001|Double Blind Phase|Physician Decision|1|||
162033211|NCT04973137|585178625|FG000|Double Blind Phase|Withdrawal by Subject|6|||
162033212|NCT04973137|585178626|FG001|Double Blind Phase|Withdrawal by Subject|1|||
162033213|NCT04973137|585178625|FG000|Double Blind Phase|Other|2|||
162033214|NCT04973137|585178626|FG001|Double Blind Phase|Other|2|||
162033215|NCT04973137|585178625|FG000|Open Label Extension Phase|Death|3|||
162033216|NCT04973137|585178626|FG001|Open Label Extension Phase|Death|0|||
162033217|NCT04973137|585178625|FG000|Open Label Extension Phase|Physician Decision|0|||
162033218|NCT04973137|585178626|FG001|Open Label Extension Phase|Physician Decision|1|||
162033219|NCT04973137|585178625|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
162033220|NCT04973137|585178626|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
162033221|NCT04973137|585178625|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
161971431|NCT02285114|584943322|FG003|Extension Phase|Pregnancy|1|||
161971432|NCT02285114|584943323|FG004|Extension Phase|Pregnancy|0|||
161971433|NCT02285114|584943324|FG005|Extension Phase|Pregnancy|0|||
161971434|NCT00320255|584943325|FG000|Overall Study|Lack of Efficacy|1|||
161971435|NCT00320255|584943326|FG001|Overall Study|Lack of Efficacy|0|||
161762734|NCT03758612|584169658|FG008|Washout Period|Withdrawal by Subject|0|||
161762735|NCT03758612|584169659|FG009|Washout Period|Withdrawal by Subject|0|||
161762736|NCT03758612|584169660|FG010|Washout Period|Withdrawal by Subject|0|||
161762737|NCT03758612|584169661|FG011|Washout Period|Withdrawal by Subject|0|||
161762738|NCT03758612|584169650|FG000|Period 2|Protocol Violation|0|||
161762739|NCT03758612|584169651|FG001|Period 2|Protocol Violation|0|||
161762740|NCT03758612|584169652|FG002|Period 2|Protocol Violation|0|||
161762741|NCT03758612|584169653|FG003|Period 2|Protocol Violation|0|||
161762742|NCT03758612|584169654|FG004|Period 2|Protocol Violation|1|||
161762743|NCT03758612|584169655|FG005|Period 2|Protocol Violation|0|||
161762744|NCT03758612|584169656|FG006|Period 2|Protocol Violation|0|||
161762745|NCT03758612|584169657|FG007|Period 2|Protocol Violation|0|||
161762746|NCT03758612|584169658|FG008|Period 2|Protocol Violation|0|||
161762747|NCT03758612|584169659|FG009|Period 2|Protocol Violation|0|||
161762748|NCT03758612|584169660|FG010|Period 2|Protocol Violation|0|||
161762749|NCT03758612|584169661|FG011|Period 2|Protocol Violation|0|||
161762750|NCT02500901|584169662|FG000|Overall Study|Disease ProgressionDD|2|||
161762751|NCT01191190|584169663|FG000|Overall Study|Withdrawal by Subject|1|||
161762752|NCT00348686|584169670|FG000|Overall Study|Withdrawal by Subject|45|||
161762753|NCT00348686|584169670|FG000|Overall Study|Adverse Event|5|||
161762754|NCT00348686|584169670|FG000|Overall Study|Protocol Violation|6|||
161762755|NCT00348686|584169670|FG000|Overall Study|Lost to Follow-up|2|||
161762756|NCT00348686|584169670|FG000|Overall Study|Multiple Reasons|8|||
161762757|NCT01258738|584169673|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
161762758|NCT01258738|584169674|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
161762759|NCT01258738|584169673|FG000|Double-blind Period|Withdrawal by Subject|2|||
161762760|NCT01258738|584169674|FG001|Double-blind Period|Withdrawal by Subject|2|||
161762761|NCT01258738|584169673|FG000|Double-blind Period|Protocol Violation|1|||
161762762|NCT01258738|584169674|FG001|Double-blind Period|Protocol Violation|1|||
161762763|NCT01258738|584169673|FG000|Double-blind Period|Adverse Event|3|||
161762764|NCT01258738|584169674|FG001|Double-blind Period|Adverse Event|1|||
161762765|NCT01258738|584169673|FG000|Open-label Period|Did not meet inclusion criteria|0|||
161762766|NCT01258738|584169674|FG001|Open-label Period|Did not meet inclusion criteria|1|||
161762767|NCT01258738|584169673|FG000|Open-label Period|Insufficient clinical response|5|||
161762768|NCT01258738|584169674|FG001|Open-label Period|Insufficient clinical response|3|||
161762769|NCT01258738|584169673|FG000|Open-label Period|Lost to Follow-up|0|||
161762770|NCT01258738|584169674|FG001|Open-label Period|Lost to Follow-up|2|||
161762771|NCT01258738|584169673|FG000|Open-label Period|Withdrawal by Subject|5|||
161762772|NCT01258738|584169674|FG001|Open-label Period|Withdrawal by Subject|6|||
161762773|NCT01258738|584169673|FG000|Open-label Period|Protocol Violation|2|||
161762774|NCT01258738|584169674|FG001|Open-label Period|Protocol Violation|2|||
161762775|NCT01258738|584169673|FG000|Open-label Period|Adverse Event|4|||
161762776|NCT01258738|584169674|FG001|Open-label Period|Adverse Event|5|||
161762777|NCT01258738|584169673|FG000|Open-label Period|Other Reasons|0|||
161762778|NCT01258738|584169674|FG001|Open-label Period|Other Reasons|1|||
161762779|NCT01258738|584169673|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
161762780|NCT01258738|584169674|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
161762781|NCT00689611|584169675|FG000|Overall Study|Death|6|||
161762782|NCT00689611|584169676|FG001|Overall Study|Death|9|||
161762783|NCT00689611|584169675|FG000|Overall Study|Withdrawal by Subject|8|||
161762784|NCT00689611|584169676|FG001|Overall Study|Withdrawal by Subject|9|||
161762785|NCT00689611|584169675|FG000|Overall Study|Lost to Follow-up|27|||
161762786|NCT00689611|584169676|FG001|Overall Study|Lost to Follow-up|28|||
161762787|NCT00568399|584169678|FG000|Overall Study|Death|2|||
161762788|NCT00568399|584169678|FG000|Overall Study|Adverse Event|5|||
161762789|NCT00568399|584169678|FG000|Overall Study|Withdrawal by Subject|8|||
161762790|NCT02967562|584169683|FG000|Overall Study|Consent not obtained|1|||
161762791|NCT02967562|584169684|FG001|Overall Study|Consent not obtained|0|||
161762792|NCT02967562|584169683|FG000|Overall Study|High leak precluding analysis|1|||
161762793|NCT02967562|584169684|FG001|Overall Study|High leak precluding analysis|1|||
161762794|NCT00405756|584169685|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
161762795|NCT00405756|584169686|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
161762796|NCT00405756|584169687|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
161762797|NCT00405756|584169685|FG000|Double-blind Treatment|Adverse Event|31|||
161762798|NCT00405756|584169686|FG001|Double-blind Treatment|Adverse Event|27|||
161971436|NCT00320255|584943327|FG002|Overall Study|Lack of Efficacy|0|||
161762799|NCT00405756|584169687|FG002|Double-blind Treatment|Adverse Event|12|||
161762800|NCT00405756|584169685|FG000|Double-blind Treatment|Disease Progression|47|||
161762801|NCT00405756|584169686|FG001|Double-blind Treatment|Disease Progression|81|||
161762802|NCT00405756|584169687|FG002|Double-blind Treatment|Disease Progression|102|||
161762803|NCT00405756|584169685|FG000|Double-blind Treatment|Lack of Efficacy|1|||
161971437|NCT00320255|584943328|FG003|Overall Study|Lack of Efficacy|0|||
161847897|NCT04933968|584484147|FG002|Overall Study|Lost to Follow-up|1|||
161847898|NCT04933968|584484148|FG003|Overall Study|Lost to Follow-up|0|||
161971438|NCT00320255|584943329|FG004|Overall Study|Lack of Efficacy|0|||
161971439|NCT00320255|584943330|FG005|Overall Study|Lack of Efficacy|0|||
161971440|NCT00320255|584943325|FG000|Overall Study|Adverse Event|5|||
161971441|NCT00320255|584943326|FG001|Overall Study|Adverse Event|2|||
161971442|NCT00320255|584943327|FG002|Overall Study|Adverse Event|3|||
161971443|NCT00320255|584943328|FG003|Overall Study|Adverse Event|2|||
161971444|NCT00320255|584943329|FG004|Overall Study|Adverse Event|0|||
161971445|NCT00320255|584943330|FG005|Overall Study|Adverse Event|0|||
161971446|NCT00320255|584943325|FG000|Overall Study|Withdrawal by Subject|1|||
161971447|NCT00320255|584943326|FG001|Overall Study|Withdrawal by Subject|2|||
161971448|NCT00320255|584943327|FG002|Overall Study|Withdrawal by Subject|2|||
161971449|NCT00320255|584943328|FG003|Overall Study|Withdrawal by Subject|4|||
161971450|NCT00320255|584943329|FG004|Overall Study|Withdrawal by Subject|0|||
161971451|NCT00320255|584943330|FG005|Overall Study|Withdrawal by Subject|0|||
161971452|NCT00320255|584943325|FG000|Overall Study|Poor compliance/noncompliance|1|||
161971453|NCT00320255|584943326|FG001|Overall Study|Poor compliance/noncompliance|1|||
161971454|NCT00320255|584943327|FG002|Overall Study|Poor compliance/noncompliance|0|||
161971455|NCT00320255|584943328|FG003|Overall Study|Poor compliance/noncompliance|1|||
161971456|NCT00320255|584943329|FG004|Overall Study|Poor compliance/noncompliance|0|||
161971457|NCT00320255|584943330|FG005|Overall Study|Poor compliance/noncompliance|0|||
161971458|NCT00320255|584943325|FG000|Overall Study|No longer meets study criteria|0|||
161971459|NCT00320255|584943326|FG001|Overall Study|No longer meets study criteria|0|||
161971460|NCT00320255|584943327|FG002|Overall Study|No longer meets study criteria|0|||
161971461|NCT00320255|584943328|FG003|Overall Study|No longer meets study criteria|1|||
161971462|NCT00320255|584943329|FG004|Overall Study|No longer meets study criteria|0|||
161971463|NCT00320255|584943330|FG005|Overall Study|No longer meets study criteria|0|||
161971464|NCT00320255|584943325|FG000|Overall Study|Other|3|||
161971465|NCT00320255|584943326|FG001|Overall Study|Other|2|||
161971466|NCT00320255|584943327|FG002|Overall Study|Other|1|||
161971467|NCT00320255|584943328|FG003|Overall Study|Other|0|||
161971468|NCT00320255|584943329|FG004|Overall Study|Other|0|||
161971469|NCT00320255|584943330|FG005|Overall Study|Other|0|||
161971470|NCT00683917|584943333|FG000|Overall Study|Study prematurely terminated|10|||
161971471|NCT03022097|584943339|FG000|Overall Study|Adverse Event|3|||
161971472|NCT03022097|584943340|FG001|Overall Study|Adverse Event|4|||
161971473|NCT03022097|584943341|FG002|Overall Study|Adverse Event|1|||
161971474|NCT03022097|584943342|FG003|Overall Study|Adverse Event|3|||
161971475|NCT03022097|584943339|FG000|Overall Study|Progressive Disease|2|||
161971476|NCT03022097|584943340|FG001|Overall Study|Progressive Disease|0|||
161971477|NCT03022097|584943341|FG002|Overall Study|Progressive Disease|5|||
161971478|NCT03022097|584943342|FG003|Overall Study|Progressive Disease|2|||
161971479|NCT03022097|584943339|FG000|Overall Study|Lack of Efficacy|0|||
161971480|NCT03022097|584943340|FG001|Overall Study|Lack of Efficacy|0|||
161971481|NCT03022097|584943341|FG002|Overall Study|Lack of Efficacy|3|||
161971482|NCT03022097|584943342|FG003|Overall Study|Lack of Efficacy|3|||
161971483|NCT03022097|584943339|FG000|Overall Study|Protocol Violation|1|||
161971484|NCT03022097|584943340|FG001|Overall Study|Protocol Violation|0|||
161971485|NCT03022097|584943341|FG002|Overall Study|Protocol Violation|1|||
161971486|NCT03022097|584943342|FG003|Overall Study|Protocol Violation|0|||
161971487|NCT03022097|584943339|FG000|Overall Study|Withdrawal by Subject|11|||
161971488|NCT03022097|584943340|FG001|Overall Study|Withdrawal by Subject|13|||
161971489|NCT03022097|584943341|FG002|Overall Study|Withdrawal by Subject|15|||
161971490|NCT03022097|584943342|FG003|Overall Study|Withdrawal by Subject|21|||
161971491|NCT03022097|584943339|FG000|Overall Study|Lost to Follow-up|0|||
161971492|NCT03022097|584943340|FG001|Overall Study|Lost to Follow-up|0|||
161971493|NCT03022097|584943341|FG002|Overall Study|Lost to Follow-up|1|||
161971494|NCT03022097|584943342|FG003|Overall Study|Lost to Follow-up|1|||
161971495|NCT03022097|584943339|FG000|Overall Study|Other|4|||
161971496|NCT03022097|584943340|FG001|Overall Study|Other|1|||
161971497|NCT03022097|584943341|FG002|Overall Study|Other|6|||
161971498|NCT03022097|584943342|FG003|Overall Study|Other|4|||
161847899|NCT04933968|584484149|FG004|Overall Study|Lost to Follow-up|0|||
161971499|NCT03022097|584943339|FG000|Overall Study|Due to COVID-19 pandemic|0|||
161971500|NCT03022097|584943340|FG001|Overall Study|Due to COVID-19 pandemic|1|||
161971501|NCT03022097|584943341|FG002|Overall Study|Due to COVID-19 pandemic|0|||
161971502|NCT03022097|584943342|FG003|Overall Study|Due to COVID-19 pandemic|0|||
161971503|NCT00623545|584943343|FG000|Overall Study|Adverse Event|6|||
161971504|NCT00623545|584943343|FG000|Overall Study|Withdrawal by Subject|4|||
161971505|NCT04239222|584943344|FG000|Baseline|Withdrawal by Subject|0|||
161971506|NCT04239222|584943345|FG001|Baseline|Withdrawal by Subject|0|||
161971507|NCT04239222|584943346|FG002|Baseline|Withdrawal by Subject|1|||
161971508|NCT04239222|584943347|FG003|Baseline|Withdrawal by Subject|1|||
161971509|NCT04239222|584943344|FG000|First Foot Assignment|Withdrawal by Subject|0|||
161971510|NCT04239222|584943345|FG001|First Foot Assignment|Withdrawal by Subject|0|||
161847900|NCT04933968|584484150|FG005|Overall Study|Lost to Follow-up|0|||
161971511|NCT04239222|584943346|FG002|First Foot Assignment|Withdrawal by Subject|1|||
161762804|NCT00405756|584169686|FG001|Double-blind Treatment|Lack of Efficacy|4|||
161762805|NCT00405756|584169687|FG002|Double-blind Treatment|Lack of Efficacy|2|||
161762806|NCT00405756|584169685|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
161762807|NCT00405756|584169686|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
161762808|NCT00405756|584169687|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
161762809|NCT00405756|584169685|FG000|Double-blind Treatment|Lost to Follow-up|1|||
161762810|NCT00405756|584169686|FG001|Double-blind Treatment|Lost to Follow-up|0|||
161762811|NCT00405756|584169687|FG002|Double-blind Treatment|Lost to Follow-up|0|||
161762812|NCT00405756|584169685|FG000|Double-blind Treatment|Death|4|||
161762813|NCT00405756|584169686|FG001|Double-blind Treatment|Death|4|||
161762814|NCT00405756|584169687|FG002|Double-blind Treatment|Death|4|||
161762815|NCT00405756|584169685|FG000|Double-blind Treatment|Protocol Violation|1|||
161762816|NCT00405756|584169686|FG001|Double-blind Treatment|Protocol Violation|0|||
161762817|NCT00405756|584169687|FG002|Double-blind Treatment|Protocol Violation|2|||
161762818|NCT00405756|584169685|FG000|Double-blind Treatment|Other|7|||
161762819|NCT00405756|584169686|FG001|Double-blind Treatment|Other|4|||
161762820|NCT00405756|584169687|FG002|Double-blind Treatment|Other|4|||
161762821|NCT00405756|584169685|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
161762822|NCT00405756|584169686|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
161762823|NCT00405756|584169687|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
161762824|NCT00405756|584169685|FG000|Open-label Extension|Adverse Event|1|||
161762825|NCT00405756|584169686|FG001|Open-label Extension|Adverse Event|3|||
161762826|NCT00405756|584169687|FG002|Open-label Extension|Adverse Event|7|||
161762827|NCT00405756|584169685|FG000|Open-label Extension|Disease Progression|8|||
161762828|NCT00405756|584169686|FG001|Open-label Extension|Disease Progression|23|||
161762829|NCT00405756|584169687|FG002|Open-label Extension|Disease Progression|26|||
161762830|NCT00405756|584169685|FG000|Open-label Extension|Withdrawal by Subject|2|||
161762831|NCT00405756|584169686|FG001|Open-label Extension|Withdrawal by Subject|3|||
161762832|NCT00405756|584169687|FG002|Open-label Extension|Withdrawal by Subject|3|||
161762833|NCT00405756|584169685|FG000|Open-label Extension|Death|1|||
161762834|NCT00405756|584169686|FG001|Open-label Extension|Death|2|||
161762835|NCT00405756|584169687|FG002|Open-label Extension|Death|4|||
161762836|NCT00405756|584169685|FG000|Open-label Extension|Other|0|||
161762837|NCT00405756|584169686|FG001|Open-label Extension|Other|1|||
161762838|NCT00405756|584169687|FG002|Open-label Extension|Other|7|||
161762839|NCT00405756|584169685|FG000|Follow-up|Ongoing in Follow-up Period|52|||
161762840|NCT00405756|584169686|FG001|Follow-up|Ongoing in Follow-up Period|51|||
161762841|NCT00405756|584169687|FG002|Follow-up|Ongoing in Follow-up Period|60|||
161762842|NCT00405756|584169685|FG000|Follow-up|Death|21|||
161762843|NCT00405756|584169686|FG001|Follow-up|Death|31|||
161762844|NCT00405756|584169687|FG002|Follow-up|Death|24|||
161762845|NCT00405756|584169685|FG000|Follow-up|Lost to Follow-up|2|||
161762846|NCT00405756|584169686|FG001|Follow-up|Lost to Follow-up|8|||
161762847|NCT00405756|584169687|FG002|Follow-up|Lost to Follow-up|4|||
161762848|NCT01051856|584169694|FG000|Overall Study|Withdrawal by Subject|1|||
161762849|NCT01051856|584169695|FG001|Overall Study|Withdrawal by Subject|0|||
161762850|NCT02176226|584169696|FG000|Overall Study|Lost to Follow-up|3|||
161762851|NCT02176226|584169696|FG000|Overall Study|Withdrew prior to treatment|6|||
161762852|NCT01072500|584169699|FG000|Overall Study|Death|2|||
161762853|NCT01072500|584169700|FG001|Overall Study|Death|2|||
161762854|NCT01072500|584169699|FG000|Overall Study|Lost to Follow-up|5|||
161762855|NCT01072500|584169700|FG001|Overall Study|Lost to Follow-up|2|||
161762856|NCT01072500|584169699|FG000|Overall Study|Withdrawal by Subject|17|||
161762857|NCT01072500|584169700|FG001|Overall Study|Withdrawal by Subject|10|||
161762858|NCT00103207|584169701|FG000|Overall Study|Adverse Event|3|||
161762859|NCT00103207|584169701|FG000|Overall Study|Death|1|||
161762860|NCT00103207|584169701|FG000|Overall Study|Withdrawal by Subject|2|||
161762861|NCT00103207|584169701|FG000|Overall Study|Other complicating disease|1|||
161762862|NCT00103207|584169701|FG000|Overall Study|Ineligible|4|||
161762863|NCT00103207|584169701|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
161762864|NCT01611558|584169702|FG000|Induction Phase|Study drug toxicity|15|||
161762865|NCT01611558|584169702|FG000|Induction Phase|Disease progression|18|||
161762866|NCT01611558|584169702|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
161762867|NCT01611558|584169702|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
161762868|NCT01611558|584169702|FG000|Induction Phase|Death|1|||
161762869|NCT01611558|584169702|FG000|Maintenance Phase|Withdrawal by Subject|1|||
161762870|NCT01611558|584169702|FG000|Maintenance Phase|Elevated Uric acid|1|||
161762871|NCT04005885|584169717|FG000|First Intervention|Withdrawal by Subject|1|||
161762872|NCT04005885|584169718|FG001|First Intervention|Withdrawal by Subject|1|||
161762873|NCT04005885|584169717|FG000|Second Intervention|Withdrawal by Subject|0|||
161762874|NCT04005885|584169718|FG001|Second Intervention|Withdrawal by Subject|2|||
161762875|NCT01038635|584169720|FG000|Overall Study|Disease Progression|2|||
161762876|NCT01038635|584169721|FG001|Overall Study|Disease Progression|0|||
161762877|NCT01038635|584169722|FG002|Overall Study|Disease Progression|0|||
161762878|NCT01038635|584169723|FG003|Overall Study|Disease Progression|0|||
161762879|NCT01038635|584169724|FG004|Overall Study|Disease Progression|0|||
161762880|NCT01038635|584169725|FG005|Overall Study|Disease Progression|0|||
161847901|NCT04933968|584484145|FG000|Overall Study|Randomized not treated|1|||
161847902|NCT04933968|584484146|FG001|Overall Study|Randomized not treated|0|||
161847903|NCT04933968|584484147|FG002|Overall Study|Randomized not treated|0|||
161847904|NCT04933968|584484148|FG003|Overall Study|Randomized not treated|0|||
161847905|NCT04933968|584484149|FG004|Overall Study|Randomized not treated|0|||
161847906|NCT04933968|584484150|FG005|Overall Study|Randomized not treated|0|||
161847907|NCT04933968|584484145|FG000|Overall Study|Sponsor terminated study|0|||
161847908|NCT04933968|584484146|FG001|Overall Study|Sponsor terminated study|0|||
161847909|NCT04933968|584484147|FG002|Overall Study|Sponsor terminated study|0|||
161847910|NCT04933968|584484148|FG003|Overall Study|Sponsor terminated study|1|||
161847911|NCT04933968|584484149|FG004|Overall Study|Sponsor terminated study|2|||
161847912|NCT04933968|584484150|FG005|Overall Study|Sponsor terminated study|0|||
161847913|NCT04933968|584484145|FG000|Overall Study|Other|0|||
161847914|NCT04933968|584484146|FG001|Overall Study|Other|0|||
161847915|NCT04933968|584484147|FG002|Overall Study|Other|0|||
161847916|NCT04933968|584484148|FG003|Overall Study|Other|1|||
161847917|NCT04933968|584484149|FG004|Overall Study|Other|0|||
161847918|NCT04933968|584484150|FG005|Overall Study|Other|0|||
161847919|NCT04933968|584484145|FG000|Overall Study|Missing|1|||
161847920|NCT04933968|584484146|FG001|Overall Study|Missing|3|||
161847921|NCT04933968|584484147|FG002|Overall Study|Missing|2|||
161847922|NCT04933968|584484148|FG003|Overall Study|Missing|1|||
161847923|NCT04933968|584484149|FG004|Overall Study|Missing|1|||
161847924|NCT04933968|584484150|FG005|Overall Study|Missing|0|||
161847925|NCT03323437|584484153|FG000|Overall Study|Withdrawal by Subject|0|||
161847926|NCT03323437|584484154|FG001|Overall Study|Withdrawal by Subject|4|||
161847927|NCT01377987|584484157|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
161847928|NCT01377987|584484158|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
161847929|NCT00168818|584484159|FG000|Overall Study|Adverse Event|23|||
161847930|NCT00168818|584484160|FG001|Overall Study|Adverse Event|29|||
161847931|NCT00168818|584484161|FG002|Overall Study|Adverse Event|31|||
161847932|NCT00168818|584484159|FG000|Overall Study|Protocol Violation|16|||
161847933|NCT00168818|584484160|FG001|Overall Study|Protocol Violation|11|||
161847934|NCT00168818|584484161|FG002|Overall Study|Protocol Violation|11|||
161847935|NCT00168818|584484159|FG000|Overall Study|Lost to Follow-up|13|||
161847936|NCT00168818|584484160|FG001|Overall Study|Lost to Follow-up|4|||
161847937|NCT00168818|584484161|FG002|Overall Study|Lost to Follow-up|15|||
161847938|NCT00168818|584484159|FG000|Overall Study|Withdrawal by Subject|43|||
161847939|NCT00168818|584484160|FG001|Overall Study|Withdrawal by Subject|41|||
161847940|NCT00168818|584484161|FG002|Overall Study|Withdrawal by Subject|37|||
161847941|NCT00168818|584484159|FG000|Overall Study|Other|22|||
161847942|NCT00168818|584484160|FG001|Overall Study|Other|24|||
161847943|NCT00168818|584484161|FG002|Overall Study|Other|30|||
161847944|NCT00168818|584484159|FG000|Treatment|Adverse Event|77|||
161847945|NCT00168818|584484160|FG001|Treatment|Adverse Event|89|||
161847946|NCT00168818|584484161|FG002|Treatment|Adverse Event|68|||
161847947|NCT00168818|584484159|FG000|Treatment|Protocol Violation|8|||
161847948|NCT00168818|584484160|FG001|Treatment|Protocol Violation|11|||
161847949|NCT00168818|584484161|FG002|Treatment|Protocol Violation|11|||
161847950|NCT00168818|584484159|FG000|Treatment|Lost to Follow-up|0|||
161847951|NCT00168818|584484160|FG001|Treatment|Lost to Follow-up|2|||
161847952|NCT00168818|584484161|FG002|Treatment|Lost to Follow-up|1|||
161847953|NCT00168818|584484159|FG000|Treatment|Withdrawal by Subject|25|||
161847954|NCT00168818|584484160|FG001|Treatment|Withdrawal by Subject|20|||
161847955|NCT00168818|584484161|FG002|Treatment|Withdrawal by Subject|22|||
161847956|NCT00168818|584484159|FG000|Treatment|Other|23|||
161847957|NCT00168818|584484160|FG001|Treatment|Other|29|||
161847958|NCT00168818|584484161|FG002|Treatment|Other|31|||
161847959|NCT01775189|584484162|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161847960|NCT01775189|584484163|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
161847961|NCT01775189|584484164|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161847962|NCT01775189|584484165|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161847963|NCT01775189|584484166|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161847964|NCT01775189|584484167|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161847965|NCT01775189|584484168|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161971512|NCT04239222|584943347|FG003|First Foot Assignment|Withdrawal by Subject|0|||
161971513|NCT04239222|584943344|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
161971514|NCT04239222|584943345|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
161971515|NCT04239222|584943346|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
161847966|NCT01775189|584484162|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161847967|NCT01775189|584484163|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
161847968|NCT01775189|584484164|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161847969|NCT01775189|584484165|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161847970|NCT01775189|584484166|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161847971|NCT01775189|584484167|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161847972|NCT01775189|584484168|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161847973|NCT01775189|584484162|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161971516|NCT04239222|584943347|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
161971517|NCT00445848|584943350|FG000|Overall Study|Adverse Event|14|||
161971518|NCT00445848|584943350|FG000|Overall Study|Withdrawal by Subject|4|||
161971519|NCT00445848|584943350|FG000|Overall Study|Progression|62|||
161971520|NCT00445848|584943350|FG000|Overall Study|Other-Not protocol specified|5|||
161971521|NCT01777542|584943351|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
161971522|NCT01777542|584943352|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
161971523|NCT05605691|584943355|FG000|Overall Study|Lost to Follow-up|1|||
161971524|NCT03298984|584943362|FG000|Overall Study|Physician Decision|1|||
161971525|NCT03298984|584943363|FG001|Overall Study|Physician Decision|0|||
161971526|NCT03298984|584943364|FG002|Overall Study|Physician Decision|0|||
161971527|NCT03298984|584943365|FG003|Overall Study|Physician Decision|6|||
161971528|NCT03298984|584943362|FG000|Overall Study|Lack of Efficacy|0|||
161971529|NCT03298984|584943363|FG001|Overall Study|Lack of Efficacy|1|||
161971530|NCT03298984|584943364|FG002|Overall Study|Lack of Efficacy|1|||
161971531|NCT03298984|584943365|FG003|Overall Study|Lack of Efficacy|4|||
161971532|NCT03298984|584943362|FG000|Overall Study|Relapsed disease (following remission)|0|||
161971533|NCT03298984|584943363|FG001|Overall Study|Relapsed disease (following remission)|0|||
161971534|NCT03298984|584943364|FG002|Overall Study|Relapsed disease (following remission)|1|||
161971535|NCT03298984|584943365|FG003|Overall Study|Relapsed disease (following remission)|1|||
161971536|NCT03298984|584943362|FG000|Overall Study|Adverse Event|0|||
161971537|NCT03298984|584943363|FG001|Overall Study|Adverse Event|0|||
161971538|NCT03298984|584943364|FG002|Overall Study|Adverse Event|0|||
161971539|NCT03298984|584943365|FG003|Overall Study|Adverse Event|1|||
161971540|NCT03298984|584943362|FG000|Overall Study|Death|0|||
161971541|NCT03298984|584943363|FG001|Overall Study|Death|0|||
161971542|NCT03298984|584943364|FG002|Overall Study|Death|0|||
161971543|NCT03298984|584943365|FG003|Overall Study|Death|2|||
161971544|NCT03298984|584943362|FG000|Overall Study|Insurance Company Decision|0|||
161971545|NCT03298984|584943363|FG001|Overall Study|Insurance Company Decision|0|||
161971546|NCT03298984|584943364|FG002|Overall Study|Insurance Company Decision|0|||
161971547|NCT03298984|584943365|FG003|Overall Study|Insurance Company Decision|1|||
161762881|NCT01038635|584169726|FG006|Overall Study|Disease Progression|1|||
161762882|NCT01038635|584169727|FG007|Overall Study|Disease Progression|4|||
161762883|NCT01038635|584169728|FG008|Overall Study|Disease Progression|0|||
161762884|NCT01038635|584169720|FG000|Overall Study|Death|0|||
161762885|NCT01038635|584169721|FG001|Overall Study|Death|0|||
161762886|NCT01038635|584169722|FG002|Overall Study|Death|0|||
161762887|NCT01038635|584169723|FG003|Overall Study|Death|0|||
161762888|NCT01038635|584169724|FG004|Overall Study|Death|1|||
161762889|NCT01038635|584169725|FG005|Overall Study|Death|0|||
161762890|NCT01038635|584169726|FG006|Overall Study|Death|1|||
161762891|NCT01038635|584169727|FG007|Overall Study|Death|1|||
161762892|NCT01038635|584169728|FG008|Overall Study|Death|2|||
161762893|NCT01227252|584169729|FG000|Overall Study|Sponsor Decision|0|||
161762894|NCT01227252|584169730|FG001|Overall Study|Sponsor Decision|1|||
161762895|NCT01227252|584169731|FG002|Overall Study|Sponsor Decision|0|||
161762896|NCT01227252|584169732|FG003|Overall Study|Sponsor Decision|0|||
161762897|NCT01227252|584169729|FG000|Overall Study|Lost to Follow-up|0|||
161762898|NCT01227252|584169730|FG001|Overall Study|Lost to Follow-up|1|||
161762899|NCT01227252|584169731|FG002|Overall Study|Lost to Follow-up|0|||
161762900|NCT01227252|584169732|FG003|Overall Study|Lost to Follow-up|0|||
161762901|NCT01227252|584169729|FG000|Overall Study|Withdrawal by Subject|0|||
161762902|NCT01227252|584169730|FG001|Overall Study|Withdrawal by Subject|1|||
161762903|NCT01227252|584169731|FG002|Overall Study|Withdrawal by Subject|0|||
161762904|NCT01227252|584169732|FG003|Overall Study|Withdrawal by Subject|0|||
161762905|NCT01683058|584169733|FG000|Overall Study|Lost to Follow-up|9|||
161762906|NCT01683058|584169733|FG000|Overall Study|Adverse Event|6|||
161762907|NCT01683058|584169733|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
161762908|NCT01683058|584169733|FG000|Overall Study|Withdrawal by Subject|7|||
161762909|NCT01683058|584169733|FG000|Overall Study|Lack of Efficacy|2|||
161762910|NCT01195636|584169734|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
161762911|NCT01195636|584169735|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
161762912|NCT01195636|584169734|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
161762913|NCT01195636|584169735|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
161762914|NCT01195636|584169734|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161762915|NCT01195636|584169735|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
161762916|NCT01195636|584169734|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
161971548|NCT01571284|584943366|FG000|Overall Study|Participant's decision|84|||
161762917|NCT01195636|584169735|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
161762918|NCT01195636|584169734|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
161971549|NCT01571284|584943366|FG000|Overall Study|Lost to Follow-up|3|||
161971550|NCT01571284|584943366|FG000|Overall Study|Enrolled but not treated|2|||
161971551|NCT01571284|584943366|FG000|Overall Study|Other than specified above|80|||
161971552|NCT03385265|584943367|FG000|Overall Study|Withdrawal by Subject|5|||
161971553|NCT03385265|584943368|FG001|Overall Study|Withdrawal by Subject|2|||
161971554|NCT03385265|584943369|FG002|Overall Study|Withdrawal by Subject|5|||
161847974|NCT01775189|584484163|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
161847975|NCT01775189|584484164|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
161847976|NCT01775189|584484165|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161847977|NCT01775189|584484166|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161847978|NCT01775189|584484167|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161847979|NCT01775189|584484168|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161847980|NCT01775189|584484162|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161847981|NCT01775189|584484163|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161847982|NCT01775189|584484164|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161847983|NCT01775189|584484165|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161847984|NCT01775189|584484166|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161847985|NCT01775189|584484167|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
161847986|NCT01775189|584484168|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161847987|NCT01775189|584484162|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161847988|NCT01775189|584484163|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161847989|NCT01775189|584484164|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161847990|NCT01775189|584484165|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
161847991|NCT01775189|584484166|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161847992|NCT01775189|584484167|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161847993|NCT01775189|584484168|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161847994|NCT01775189|584484162|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161847995|NCT01775189|584484163|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161847996|NCT01775189|584484164|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161847997|NCT01775189|584484165|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
161847998|NCT01775189|584484166|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161847999|NCT01775189|584484167|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161848000|NCT01775189|584484168|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
161848001|NCT02227446|584484169|FG000|Overall Study|not eligible post randomization|18|||
161848002|NCT02227446|584484170|FG001|Overall Study|not eligible post randomization|29|||
161848003|NCT02227446|584484169|FG000|Overall Study|Withdrawal by Subject|4|||
161848004|NCT02227446|584484170|FG001|Overall Study|Withdrawal by Subject|5|||
161848005|NCT03016975|584484178|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
161848006|NCT03016975|584484179|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
161848007|NCT03016975|584484180|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
161848008|NCT03016975|584484178|FG000|At 6 Months Follow-up|Death|2|||
161848009|NCT03016975|584484179|FG001|At 6 Months Follow-up|Death|0|||
161848010|NCT03016975|584484180|FG002|At 6 Months Follow-up|Death|0|||
161848011|NCT03016975|584484178|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
161848012|NCT03016975|584484179|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
161848013|NCT03016975|584484180|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
161848014|NCT03016975|584484178|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
161848015|NCT03016975|584484179|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
161848016|NCT03016975|584484180|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
161848017|NCT03016975|584484178|FG000|At 6 Months Follow-up|Aborted implant|1|||
161848018|NCT03016975|584484179|FG001|At 6 Months Follow-up|Aborted implant|0|||
161848019|NCT03016975|584484180|FG002|At 6 Months Follow-up|Aborted implant|0|||
161848020|NCT03016975|584484178|FG000|At 2 Year Follow-up|Death|1|||
161848021|NCT03016975|584484179|FG001|At 2 Year Follow-up|Death|0|||
161848022|NCT03016975|584484180|FG002|At 2 Year Follow-up|Death|0|||
161848023|NCT03016975|584484178|FG000|At 3 Year Follow-up|Death|1|||
161848024|NCT03016975|584484179|FG001|At 3 Year Follow-up|Death|0|||
161848025|NCT03016975|584484180|FG002|At 3 Year Follow-up|Death|0|||
161848026|NCT03016975|584484178|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
161848027|NCT03016975|584484179|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
161848028|NCT03016975|584484180|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
161848029|NCT03016975|584484178|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
161848030|NCT03016975|584484179|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
161848031|NCT03016975|584484180|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
161848032|NCT02901548|584484181|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
161848033|NCT04893018|584484182|FG000|Overall Study|Lost to Follow-up|1|||
161848034|NCT04893018|584484183|FG001|Overall Study|Lost to Follow-up|0|||
161848035|NCT04893018|584484182|FG000|Overall Study|Withdrawal by Subject|2|||
161848036|NCT04893018|584484183|FG001|Overall Study|Withdrawal by Subject|0|||
161971555|NCT03385265|584943370|FG003|Overall Study|Withdrawal by Subject|2|||
161971556|NCT04465877|584943377|FG000|Overall Study|Noncompliant with study requirements|0|||
161971557|NCT04465877|584943378|FG001|Overall Study|Noncompliant with study requirements|0|||
161971558|NCT04465877|584943379|FG002|Overall Study|Noncompliant with study requirements|1|||
161971559|NCT04465877|584943380|FG003|Overall Study|Noncompliant with study requirements|0|||
161971560|NCT02323204|584943381|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
162033222|NCT04973137|585178626|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
162033223|NCT04973137|585178625|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
162033224|NCT04973137|585178626|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
162033225|NCT05040971|585178627|FG000|Overall Study|Withdrawal by Subject|0|||
162033226|NCT05040971|585178628|FG001|Overall Study|Withdrawal by Subject|2|||
162033227|NCT05040971|585178627|FG000|Overall Study|Lost to Follow-up|8|||
162033228|NCT05040971|585178628|FG001|Overall Study|Lost to Follow-up|3|||
162033229|NCT05040971|585178627|FG000|Overall Study|Death|2|||
162033230|NCT05040971|585178628|FG001|Overall Study|Death|0|||
162033231|NCT04391569|585178631|FG000|Overall Study|Death|15|||
162033232|NCT04391569|585178632|FG001|Overall Study|Death|10|||
162033233|NCT04391569|585178631|FG000|Overall Study|Withdrawal by Subject|1|||
162033234|NCT04391569|585178632|FG001|Overall Study|Withdrawal by Subject|0|||
162033235|NCT04391569|585178631|FG000|Overall Study|Lost to Follow-up|3|||
162033236|NCT04391569|585178632|FG001|Overall Study|Lost to Follow-up|2|||
162033237|NCT04391569|585178631|FG000|Overall Study|Lack of Efficacy|0|||
162033238|NCT04391569|585178632|FG001|Overall Study|Lack of Efficacy|1|||
162033239|NCT04391569|585178631|FG000|Overall Study|Participant discharged to hospice facility|0|||
162033240|NCT04391569|585178632|FG001|Overall Study|Participant discharged to hospice facility|1|||
162033241|NCT04391569|585178631|FG000|Overall Study|Participant family decision|1|||
162033242|NCT04391569|585178632|FG001|Overall Study|Participant family decision|0|||
162033243|NCT04391569|585178631|FG000|Overall Study|Participant discharged prematurely|1|||
162033244|NCT04391569|585178632|FG001|Overall Study|Participant discharged prematurely|0|||
162033245|NCT00938886|585178663|FG000|Overall Study|Death|0|||
162033246|NCT00938886|585178664|FG001|Overall Study|Death|1|||
162033247|NCT00938886|585178663|FG000|Overall Study|Withdrawal by Subject|4|||
162033248|NCT00938886|585178664|FG001|Overall Study|Withdrawal by Subject|7|||
162033249|NCT00938886|585178663|FG000|Overall Study|Lost to Follow-up|3|||
162033250|NCT00938886|585178664|FG001|Overall Study|Lost to Follow-up|2|||
162033251|NCT03044574|585178665|FG000|Overall Study|Lost to Follow-up|37|||
162033252|NCT03044574|585178666|FG001|Overall Study|Lost to Follow-up|45|||
162033253|NCT00645788|585178667|FG000|Overall Study|Did not receive study drug|1|||
162033254|NCT00645788|585178668|FG001|Overall Study|Did not receive study drug|1|||
162033255|NCT00645788|585178669|FG002|Overall Study|Did not receive study drug|0|||
162033256|NCT00645788|585178670|FG003|Overall Study|Did not receive study drug|0|||
162033257|NCT00645788|585178667|FG000|Overall Study|Adverse Event|4|||
162033258|NCT00645788|585178668|FG001|Overall Study|Adverse Event|9|||
162033259|NCT00645788|585178669|FG002|Overall Study|Adverse Event|5|||
162033260|NCT00645788|585178670|FG003|Overall Study|Adverse Event|3|||
162033261|NCT00645788|585178667|FG000|Overall Study|Lost to Follow-up|1|||
162033262|NCT00645788|585178668|FG001|Overall Study|Lost to Follow-up|0|||
162033263|NCT00645788|585178669|FG002|Overall Study|Lost to Follow-up|0|||
162033264|NCT00645788|585178670|FG003|Overall Study|Lost to Follow-up|0|||
162033265|NCT00645788|585178667|FG000|Overall Study|Protocol Violation|1|||
162033266|NCT00645788|585178668|FG001|Overall Study|Protocol Violation|0|||
162033267|NCT00645788|585178669|FG002|Overall Study|Protocol Violation|2|||
162033268|NCT00645788|585178670|FG003|Overall Study|Protocol Violation|0|||
162033269|NCT00645788|585178667|FG000|Overall Study|Withdrawal by Subject|0|||
162033270|NCT00645788|585178668|FG001|Overall Study|Withdrawal by Subject|1|||
162033271|NCT00645788|585178669|FG002|Overall Study|Withdrawal by Subject|0|||
162033272|NCT00645788|585178670|FG003|Overall Study|Withdrawal by Subject|2|||
162033273|NCT00645788|585178667|FG000|Overall Study|Pulmonary exacerbation|13|||
162033274|NCT00645788|585178668|FG001|Overall Study|Pulmonary exacerbation|16|||
162033275|NCT00645788|585178669|FG002|Overall Study|Pulmonary exacerbation|11|||
162033276|NCT00645788|585178670|FG003|Overall Study|Pulmonary exacerbation|9|||
162033277|NCT03875235|585178673|FG000|Overall Study|Ongoing study treatment|63|||
162033278|NCT03875235|585178674|FG001|Overall Study|Ongoing study treatment|20|||
162033279|NCT03875235|585178673|FG000|Overall Study|Off treatment|77|||
162033280|NCT03875235|585178674|FG001|Overall Study|Off treatment|91|||
162033281|NCT03875235|585178673|FG000|Overall Study|Withdrawal by Subject|3|||
162033282|NCT03875235|585178674|FG001|Overall Study|Withdrawal by Subject|10|||
161762919|NCT01195636|584169735|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
161762920|NCT01195636|584169734|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
161762921|NCT01195636|584169735|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
161762922|NCT01195636|584169734|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
161762923|NCT01195636|584169735|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
161762924|NCT01195636|584169734|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161762925|NCT01195636|584169735|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
161762926|NCT01566981|584169736|FG000|Overall Study|Lost to Follow-up|5|||
162033283|NCT03875235|585178673|FG000|Overall Study|Death|198|||
162033284|NCT03875235|585178674|FG001|Overall Study|Death|223|||
161762927|NCT01566981|584169737|FG001|Overall Study|Lost to Follow-up|8|||
161762928|NCT02405091|584169738|FG000|Overall Study|Adverse Event|16|||
161762929|NCT02405091|584169739|FG001|Overall Study|Adverse Event|10|||
162033285|NCT04268823|585178679|FG000|Overall Study|Adverse Event|1|||
162033286|NCT04268823|585178680|FG001|Overall Study|Adverse Event|0|||
162033287|NCT04268823|585178679|FG000|Overall Study|Participant Decision|1|||
161762930|NCT02405091|584169740|FG002|Overall Study|Adverse Event|0|||
161762931|NCT02405091|584169738|FG000|Overall Study|Protocol Violation|1|||
161762932|NCT02405091|584169739|FG001|Overall Study|Protocol Violation|0|||
161762933|NCT02405091|584169740|FG002|Overall Study|Protocol Violation|0|||
161762934|NCT02405091|584169738|FG000|Overall Study|Noncompliance|1|||
161762935|NCT02405091|584169739|FG001|Overall Study|Noncompliance|6|||
161762936|NCT02405091|584169740|FG002|Overall Study|Noncompliance|2|||
161762937|NCT02405091|584169738|FG000|Overall Study|Withdrawal by Subject|4|||
161762938|NCT02405091|584169739|FG001|Overall Study|Withdrawal by Subject|8|||
161762939|NCT02405091|584169740|FG002|Overall Study|Withdrawal by Subject|0|||
161762940|NCT02405091|584169738|FG000|Overall Study|Death|0|||
161762941|NCT02405091|584169739|FG001|Overall Study|Death|1|||
161762942|NCT02405091|584169740|FG002|Overall Study|Death|0|||
161762943|NCT02405091|584169738|FG000|Overall Study|Lost to Follow-up|5|||
161762944|NCT02405091|584169739|FG001|Overall Study|Lost to Follow-up|6|||
161762945|NCT02405091|584169740|FG002|Overall Study|Lost to Follow-up|0|||
161762946|NCT02405091|584169738|FG000|Overall Study|Physician Decision|2|||
161762947|NCT02405091|584169739|FG001|Overall Study|Physician Decision|2|||
161762948|NCT02405091|584169740|FG002|Overall Study|Physician Decision|0|||
161762949|NCT01012037|584169750|FG000|Overall Study|Adverse Event|0|||
161762950|NCT01012037|584169751|FG001|Overall Study|Adverse Event|8|||
161762951|NCT01012037|584169752|FG002|Overall Study|Adverse Event|3|||
161762952|NCT01012037|584169750|FG000|Overall Study|Protocol Violation|0|||
161762953|NCT01012037|584169751|FG001|Overall Study|Protocol Violation|3|||
161762954|NCT01012037|584169752|FG002|Overall Study|Protocol Violation|5|||
161762955|NCT01012037|584169750|FG000|Overall Study|Withdrawal by Subject|0|||
161762956|NCT01012037|584169751|FG001|Overall Study|Withdrawal by Subject|4|||
161762957|NCT01012037|584169752|FG002|Overall Study|Withdrawal by Subject|1|||
161762958|NCT01012037|584169750|FG000|Overall Study|Other reason (not specified)|1|||
161762959|NCT01012037|584169751|FG001|Overall Study|Other reason (not specified)|1|||
161762960|NCT01012037|584169752|FG002|Overall Study|Other reason (not specified)|1|||
161762961|NCT00590031|584169756|FG000|Overall Study|Adverse Event|3|||
161762962|NCT00590031|584169756|FG000|Overall Study|Withdrawal by Subject|1|||
161762963|NCT00590031|584169756|FG000|Overall Study|Metastatic Disease|1|||
161762964|NCT00590031|584169756|FG000|Overall Study|Admin Hold|1|||
161762965|NCT01809327|584169757|FG000|Overall Study|Lost to Follow-up|5|||
161762966|NCT01809327|584169758|FG001|Overall Study|Lost to Follow-up|2|||
161762967|NCT01809327|584169759|FG002|Overall Study|Lost to Follow-up|4|||
161762968|NCT01809327|584169760|FG003|Overall Study|Lost to Follow-up|2|||
161762969|NCT01809327|584169761|FG004|Overall Study|Lost to Follow-up|3|||
161762970|NCT01809327|584169757|FG000|Overall Study|Withdrawal by Subject|6|||
161762971|NCT01809327|584169758|FG001|Overall Study|Withdrawal by Subject|4|||
161762972|NCT01809327|584169759|FG002|Overall Study|Withdrawal by Subject|4|||
161762973|NCT01809327|584169760|FG003|Overall Study|Withdrawal by Subject|2|||
161762974|NCT01809327|584169761|FG004|Overall Study|Withdrawal by Subject|5|||
161762975|NCT01809327|584169757|FG000|Overall Study|Adverse Event|4|||
161762976|NCT01809327|584169758|FG001|Overall Study|Adverse Event|3|||
161762977|NCT01809327|584169759|FG002|Overall Study|Adverse Event|7|||
161762978|NCT01809327|584169760|FG003|Overall Study|Adverse Event|4|||
161762979|NCT01809327|584169761|FG004|Overall Study|Adverse Event|8|||
161762980|NCT01809327|584169757|FG000|Overall Study|Death|1|||
161762981|NCT01809327|584169758|FG001|Overall Study|Death|0|||
161762982|NCT01809327|584169759|FG002|Overall Study|Death|0|||
161762983|NCT01809327|584169760|FG003|Overall Study|Death|0|||
161762984|NCT01809327|584169761|FG004|Overall Study|Death|0|||
161762985|NCT01809327|584169757|FG000|Overall Study|Protocol Violation|0|||
161762986|NCT01809327|584169758|FG001|Overall Study|Protocol Violation|1|||
161762987|NCT01809327|584169759|FG002|Overall Study|Protocol Violation|0|||
161762988|NCT01809327|584169760|FG003|Overall Study|Protocol Violation|0|||
161848037|NCT04893018|584484182|FG000|Overall Study|Study Terminated|1|||
161848038|NCT04893018|584484183|FG001|Overall Study|Study Terminated|2|||
161762989|NCT01809327|584169761|FG004|Overall Study|Protocol Violation|0|||
161762990|NCT01809327|584169757|FG000|Overall Study|Physician Decision|1|||
161848039|NCT03336528|584484184|FG000|Overall Study|Protocol Violation|1|||
161971561|NCT02323204|584943382|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
161971562|NCT02323204|584943383|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
161762991|NCT01809327|584169758|FG001|Overall Study|Physician Decision|1|||
161762992|NCT01809327|584169759|FG002|Overall Study|Physician Decision|0|||
161762993|NCT01809327|584169760|FG003|Overall Study|Physician Decision|0|||
161762994|NCT01809327|584169761|FG004|Overall Study|Physician Decision|0|||
161762995|NCT01809327|584169757|FG000|Overall Study|Pregnancy|1|||
161762996|NCT01809327|584169758|FG001|Overall Study|Pregnancy|0|||
161762997|NCT01809327|584169759|FG002|Overall Study|Pregnancy|0|||
161762998|NCT01809327|584169760|FG003|Overall Study|Pregnancy|0|||
161762999|NCT01809327|584169761|FG004|Overall Study|Pregnancy|0|||
161763000|NCT01809327|584169757|FG000|Overall Study|Other|14|||
161971563|NCT02323204|584943384|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
161763001|NCT01809327|584169758|FG001|Overall Study|Other|15|||
161763002|NCT01809327|584169759|FG002|Overall Study|Other|7|||
161763003|NCT01809327|584169760|FG003|Overall Study|Other|4|||
161763004|NCT01809327|584169761|FG004|Overall Study|Other|9|||
161848040|NCT03336528|584484185|FG001|Overall Study|Protocol Violation|1|||
161848041|NCT03336528|584484184|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
161848042|NCT03336528|584484185|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
161848043|NCT03336528|584484184|FG000|Overall Study|Did not receive study medication|1|||
161848044|NCT03336528|584484185|FG001|Overall Study|Did not receive study medication|2|||
161848045|NCT00811928|584484186|FG000|Overall Study|AEs and SAEs Including Death|7|||
161848046|NCT00811928|584484187|FG001|Overall Study|AEs and SAEs Including Death|11|||
161848047|NCT00811928|584484186|FG000|Overall Study|Withdrawal by Subject|18|||
161848048|NCT00811928|584484187|FG001|Overall Study|Withdrawal by Subject|12|||
161848049|NCT00811928|584484186|FG000|Overall Study|Did Not Take Study Drug|3|||
161848050|NCT00811928|584484187|FG001|Overall Study|Did Not Take Study Drug|0|||
161848051|NCT00811928|584484186|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
161848052|NCT00811928|584484187|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
161848053|NCT00811928|584484186|FG000|Overall Study|Investigator Decision|2|||
161848054|NCT00811928|584484187|FG001|Overall Study|Investigator Decision|1|||
161848055|NCT00811928|584484186|FG000|Overall Study|Poor Compliance|2|||
161848056|NCT00811928|584484187|FG001|Overall Study|Poor Compliance|5|||
161848057|NCT01085357|584484188|FG000|Overall Study|Adverse Event|1|||
161848058|NCT01085357|584484189|FG001|Overall Study|Adverse Event|1|||
161848059|NCT01085357|584484188|FG000|Overall Study|Subject Decision|4|||
161848060|NCT01085357|584484189|FG001|Overall Study|Subject Decision|3|||
161848061|NCT01085357|584484188|FG000|Overall Study|Investigator Decision|1|||
161848062|NCT01085357|584484189|FG001|Overall Study|Investigator Decision|1|||
161848063|NCT01085357|584484188|FG000|Overall Study|Death|11|||
161848064|NCT01085357|584484189|FG001|Overall Study|Death|1|||
161848065|NCT01085357|584484188|FG000|Overall Study|Lost to Follow-up|2|||
161848066|NCT01085357|584484189|FG001|Overall Study|Lost to Follow-up|0|||
161848067|NCT00314951|584484192|FG000|Treatment|Didn't meet criteria for mITT population|16|||
161848068|NCT00314951|584484193|FG001|Treatment|Didn't meet criteria for mITT population|11|||
161848069|NCT00314951|584484192|FG000|Follow-up|mITT failure|44|||
161848070|NCT00314951|584484193|FG001|Follow-up|mITT failure|34|||
161848071|NCT02910011|584484194|FG000|Overall Study|Physician Decision|2|||
161848072|NCT00920790|584484195|FG000|Overall Study|aggravation of general condition|14|||
161848073|NCT00838435|584484196|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
161848074|NCT00838435|584484196|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
161848075|NCT00838435|584484196|FG000|Part 2 (7 Years)|Adverse Event|2|||
161848076|NCT00838435|584484196|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
161848077|NCT00838435|584484196|FG000|Part 2 (7 Years)|Physician Decision|1|||
161848078|NCT00838435|584484196|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
161848079|NCT00838435|584484196|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
161848080|NCT02348723|584484197|FG000|Overall Study|No ablation|21|||
161848081|NCT02348723|584484198|FG001|Overall Study|No ablation|20|||
161848082|NCT02348723|584484197|FG000|Overall Study|Non-compliant with Protocol|1|||
161848083|NCT02348723|584484198|FG001|Overall Study|Non-compliant with Protocol|0|||
161848084|NCT02348723|584484197|FG000|Overall Study|Lost to Follow-up|1|||
161848085|NCT02348723|584484198|FG001|Overall Study|Lost to Follow-up|1|||
161848086|NCT02348723|584484197|FG000|Overall Study|Consent withdrawn|1|||
161848087|NCT02348723|584484198|FG001|Overall Study|Consent withdrawn|3|||
161848088|NCT02348723|584484197|FG000|Overall Study|Reason other than specified|1|||
161848089|NCT02348723|584484198|FG001|Overall Study|Reason other than specified|1|||
161848090|NCT02348723|584484197|FG000|Overall Study|Adverse Event|3|||
161848091|NCT02348723|584484198|FG001|Overall Study|Adverse Event|1|||
161848092|NCT00678886|584484199|FG000|Overall Study|Withdrawal by Subject|0|||
161848093|NCT00678886|584484200|FG001|Overall Study|Withdrawal by Subject|0|||
161848094|NCT00678886|584484201|FG002|Overall Study|Withdrawal by Subject|4|||
161848095|NCT00678886|584484202|FG003|Overall Study|Withdrawal by Subject|6|||
161848096|NCT00678886|584484199|FG000|Overall Study|Physician Decision|0|||
161848097|NCT00678886|584484200|FG001|Overall Study|Physician Decision|0|||
161848098|NCT00678886|584484201|FG002|Overall Study|Physician Decision|1|||
161848099|NCT00678886|584484202|FG003|Overall Study|Physician Decision|1|||
161848100|NCT00678886|584484199|FG000|Overall Study|Lost to Follow-up|0|||
161848101|NCT00678886|584484200|FG001|Overall Study|Lost to Follow-up|0|||
161848102|NCT00678886|584484201|FG002|Overall Study|Lost to Follow-up|3|||
161848103|NCT00678886|584484202|FG003|Overall Study|Lost to Follow-up|2|||
161848104|NCT00678886|584484199|FG000|Overall Study|Other|0|||
161848105|NCT00678886|584484200|FG001|Overall Study|Other|0|||
161848106|NCT00678886|584484201|FG002|Overall Study|Other|1|||
161971564|NCT02323204|584943381|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
161848107|NCT00678886|584484202|FG003|Overall Study|Other|0|||
161848108|NCT04693416|584484203|FG000|Overall Study|Lost to Follow-up|13|||
161971565|NCT02323204|584943382|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
161848109|NCT04693416|584484204|FG001|Overall Study|Lost to Follow-up|0|||
161848110|NCT02290223|584484205|FG000|6 Months|Lost to Follow-up|9|||
161971566|NCT02323204|584943383|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
161848111|NCT02290223|584484206|FG001|6 Months|Lost to Follow-up|6|||
161971567|NCT02323204|584943384|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
161848112|NCT02290223|584484205|FG000|6 Months|Withdrawal by Subject|5|||
161763005|NCT01166386|584169763|FG000|Overall Study|Withdrawal by Subject|3|||
161763006|NCT01166386|584169764|FG001|Overall Study|Withdrawal by Subject|5|||
161763007|NCT02802735|584169765|FG000|Overall Study|Withdrawal by Subject|0|||
161763008|NCT02802735|584169766|FG001|Overall Study|Withdrawal by Subject|1|||
161763009|NCT02802735|584169767|FG002|Overall Study|Withdrawal by Subject|0|||
161763010|NCT02802735|584169768|FG003|Overall Study|Withdrawal by Subject|0|||
161763011|NCT02802735|584169769|FG004|Overall Study|Withdrawal by Subject|0|||
161763012|NCT03922711|584169772|FG000|Overall Study|Adverse Event|3|||
161763013|NCT03922711|584169773|FG001|Overall Study|Adverse Event|2|||
161763014|NCT03922711|584169774|FG002|Overall Study|Adverse Event|2|||
161763015|NCT03922711|584169772|FG000|Overall Study|Protocol Violation|1|||
161763016|NCT03922711|584169773|FG001|Overall Study|Protocol Violation|0|||
161763017|NCT03922711|584169774|FG002|Overall Study|Protocol Violation|0|||
161763018|NCT03922711|584169772|FG000|Overall Study|Withdrawal by Subject|0|||
161763019|NCT03922711|584169773|FG001|Overall Study|Withdrawal by Subject|3|||
161763020|NCT03922711|584169774|FG002|Overall Study|Withdrawal by Subject|1|||
161763021|NCT03922711|584169772|FG000|Overall Study|Not further specified|0|||
161763022|NCT03922711|584169773|FG001|Overall Study|Not further specified|0|||
161763023|NCT03922711|584169774|FG002|Overall Study|Not further specified|1|||
161763024|NCT00420212|584169777|FG000|Overall Study|Adverse Event|22|||
161763025|NCT00420212|584169778|FG001|Overall Study|Adverse Event|40|||
161763026|NCT00420212|584169779|FG002|Overall Study|Adverse Event|36|||
161763027|NCT00420212|584169777|FG000|Overall Study|Lost to Follow-up|9|||
161763028|NCT00420212|584169778|FG001|Overall Study|Lost to Follow-up|11|||
161763029|NCT00420212|584169779|FG002|Overall Study|Lost to Follow-up|11|||
161763030|NCT00420212|584169777|FG000|Overall Study|Withdrawal by Subject|31|||
161763031|NCT00420212|584169778|FG001|Overall Study|Withdrawal by Subject|22|||
161763032|NCT00420212|584169779|FG002|Overall Study|Withdrawal by Subject|19|||
161763033|NCT00420212|584169777|FG000|Overall Study|Physician Decision|4|||
161763034|NCT00420212|584169778|FG001|Overall Study|Physician Decision|4|||
161763035|NCT00420212|584169779|FG002|Overall Study|Physician Decision|3|||
161763036|NCT00420212|584169777|FG000|Overall Study|Protocol Violation|4|||
161763037|NCT00420212|584169778|FG001|Overall Study|Protocol Violation|4|||
161763038|NCT00420212|584169779|FG002|Overall Study|Protocol Violation|8|||
161763039|NCT00420212|584169777|FG000|Overall Study|Death|0|||
161763040|NCT00420212|584169778|FG001|Overall Study|Death|0|||
161763041|NCT00420212|584169779|FG002|Overall Study|Death|1|||
161763042|NCT00420212|584169777|FG000|Overall Study|Other-Unspecified|21|||
161763043|NCT00420212|584169778|FG001|Overall Study|Other-Unspecified|14|||
161763044|NCT00420212|584169779|FG002|Overall Study|Other-Unspecified|18|||
161763045|NCT02390362|584169780|FG000|Overall Study|Withdrawal by Subject|0|||
161763046|NCT02390362|584169781|FG001|Overall Study|Withdrawal by Subject|1|||
161763047|NCT02067104|584169786|FG000|Overall Study|Study termination due to low accrual|4|||
161763048|NCT02067104|584169787|FG001|Overall Study|Study termination due to low accrual|5|||
161763049|NCT02610231|584169788|FG000|Overall Study|Withdrawal by Subject|27|||
161763050|NCT02610231|584169788|FG000|Overall Study|Adverse Event|20|||
161763051|NCT02610231|584169788|FG000|Overall Study|Death|5|||
161763052|NCT02610231|584169788|FG000|Overall Study|Surgery|2|||
161763053|NCT02610231|584169788|FG000|Overall Study|Physician Decision|1|||
161763054|NCT02610231|584169788|FG000|Overall Study|Non Compliance|2|||
161763055|NCT02610231|584169788|FG000|Overall Study|Other|3|||
161763056|NCT01279954|584169791|FG000|Overall Study|Lack of Efficacy|3|||
161763057|NCT01279954|584169792|FG001|Overall Study|Lack of Efficacy|4|||
161763058|NCT02140762|584169793|FG000|Overall Study|Adverse Event|1|||
161763059|NCT02140762|584169794|FG001|Overall Study|Adverse Event|1|||
161763060|NCT02140762|584169793|FG000|Overall Study|Lost to Follow-up|9|||
161763061|NCT02140762|584169794|FG001|Overall Study|Lost to Follow-up|5|||
161763062|NCT02140762|584169793|FG000|Overall Study|Protocol Violation|1|||
161763063|NCT02140762|584169794|FG001|Overall Study|Protocol Violation|1|||
161763064|NCT02140762|584169793|FG000|Overall Study|Withdrawal by Subject|6|||
161763065|NCT02140762|584169794|FG001|Overall Study|Withdrawal by Subject|4|||
161763066|NCT02140762|584169793|FG000|Overall Study|Other|0|||
161763067|NCT02140762|584169794|FG001|Overall Study|Other|1|||
161971568|NCT02323204|584943381|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
161971569|NCT02323204|584943382|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
161763068|NCT01711359|584169796|FG000|Treatment Period|Withdrawal by Subject|18|||
161763069|NCT01711359|584169797|FG001|Treatment Period|Withdrawal by Subject|7|||
161763070|NCT01711359|584169798|FG002|Treatment Period|Withdrawal by Subject|13|||
161763071|NCT01711359|584169796|FG000|Treatment Period|Lack of Efficacy|13|||
161763072|NCT01711359|584169797|FG001|Treatment Period|Lack of Efficacy|2|||
161763073|NCT01711359|584169798|FG002|Treatment Period|Lack of Efficacy|2|||
161763074|NCT01711359|584169796|FG000|Treatment Period|Adverse Event|8|||
161848113|NCT02290223|584484206|FG001|6 Months|Withdrawal by Subject|0|||
161763075|NCT01711359|584169797|FG001|Treatment Period|Adverse Event|10|||
161763076|NCT01711359|584169798|FG002|Treatment Period|Adverse Event|24|||
161763077|NCT01711359|584169796|FG000|Treatment Period|Physician Decision|4|||
161763078|NCT01711359|584169797|FG001|Treatment Period|Physician Decision|3|||
161763079|NCT01711359|584169798|FG002|Treatment Period|Physician Decision|2|||
161763080|NCT01711359|584169796|FG000|Treatment Period|Death|3|||
161971570|NCT02323204|584943383|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
161971571|NCT02323204|584943384|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
161971572|NCT02323204|584943381|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
161971573|NCT02323204|584943382|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
161971574|NCT02323204|584943383|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
161971575|NCT02323204|584943384|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
161971576|NCT02323204|584943381|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
161971577|NCT02323204|584943382|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
161971578|NCT02323204|584943383|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
161971579|NCT02323204|584943384|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
161971580|NCT02323204|584943381|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
161971581|NCT02323204|584943382|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
161971582|NCT02323204|584943383|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
161971583|NCT02323204|584943384|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
161971584|NCT02323204|584943381|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
161971585|NCT02323204|584943382|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
161971586|NCT02323204|584943383|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
161971587|NCT02323204|584943384|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
161971588|NCT02323204|584943381|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
161971589|NCT02323204|584943382|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
161971590|NCT02323204|584943383|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
161971591|NCT02323204|584943384|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
161971592|NCT02323204|584943381|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
161971593|NCT02323204|584943382|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
161971594|NCT02323204|584943383|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
161971595|NCT02323204|584943384|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
161971596|NCT03440918|584943390|FG000|Overall Study|Protocol Violation|0|||
161971597|NCT03440918|584943391|FG001|Overall Study|Protocol Violation|16|||
161971598|NCT04346108|584943392|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
161971599|NCT04346108|584943393|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
161971600|NCT04346108|584943394|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
161971601|NCT04346108|584943392|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
161971602|NCT04346108|584943393|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
161971603|NCT04346108|584943394|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
161971604|NCT01598753|584943395|FG000|Overall Study|Adverse Event|1|||
161971605|NCT01598753|584943396|FG001|Overall Study|Adverse Event|9|||
161971606|NCT01598753|584943397|FG002|Overall Study|Adverse Event|1|||
161971607|NCT01598753|584943398|FG003|Overall Study|Adverse Event|7|||
161971608|NCT01598753|584943395|FG000|Overall Study|Lost to Follow-up|4|||
161971609|NCT01598753|584943396|FG001|Overall Study|Lost to Follow-up|3|||
161971610|NCT01598753|584943397|FG002|Overall Study|Lost to Follow-up|7|||
161971611|NCT01598753|584943398|FG003|Overall Study|Lost to Follow-up|5|||
161971612|NCT01598753|584943395|FG000|Overall Study|Physician Decision|0|||
162033288|NCT04268823|585178680|FG001|Overall Study|Participant Decision|0|||
162033289|NCT03505671|585180049|FG000|Overall Study|Withdrawal by Subject|2|||
161763081|NCT01711359|584169797|FG001|Treatment Period|Death|0|||
161763082|NCT01711359|584169798|FG002|Treatment Period|Death|0|||
161763083|NCT01711359|584169796|FG000|Treatment Period|Entry Criteria Not Met|1|||
161763084|NCT01711359|584169797|FG001|Treatment Period|Entry Criteria Not Met|0|||
161763085|NCT01711359|584169798|FG002|Treatment Period|Entry Criteria Not Met|0|||
161763086|NCT01711359|584169796|FG000|Treatment Period|Sponsor Decision|1|||
161763087|NCT01711359|584169797|FG001|Treatment Period|Sponsor Decision|0|||
161763088|NCT01711359|584169798|FG002|Treatment Period|Sponsor Decision|0|||
161763089|NCT01711359|584169796|FG000|Treatment Period|Lost to Follow-up|1|||
161763090|NCT01711359|584169797|FG001|Treatment Period|Lost to Follow-up|1|||
161763091|NCT01711359|584169798|FG002|Treatment Period|Lost to Follow-up|1|||
161763092|NCT01711359|584169796|FG000|Treatment Period|Randomized, Not Treated|3|||
161763093|NCT01711359|584169797|FG001|Treatment Period|Randomized, Not Treated|1|||
161763094|NCT01711359|584169798|FG002|Treatment Period|Randomized, Not Treated|0|||
161763095|NCT01385098|584169799|FG000|Overall Study|Adverse Event|10|||
161763096|NCT01385098|584169799|FG000|Overall Study|Lost to Follow-up|4|||
161763097|NCT00795717|584169800|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
161763098|NCT00795717|584169801|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
161763099|NCT00795717|584169800|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
161763100|NCT00795717|584169801|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
161848114|NCT02290223|584484205|FG000|6 Months|deceased (not related to study)|2|||
162033290|NCT03505671|585180050|FG001|Overall Study|Withdrawal by Subject|1|||
161763101|NCT00795717|584169800|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
161763102|NCT00795717|584169801|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
161763103|NCT00795717|584169800|FG000|Phase II|too busy|0|||
161763104|NCT00795717|584169801|FG001|Phase II|too busy|1|||
161848115|NCT02290223|584484206|FG001|6 Months|deceased (not related to study)|0|||
161848116|NCT02290223|584484205|FG000|12 Months|Lost to Follow-up|16|||
161848117|NCT02290223|584484206|FG001|12 Months|Lost to Follow-up|10|||
161848118|NCT02290223|584484205|FG000|12 Months|Refusal|0|||
161848119|NCT02290223|584484206|FG001|12 Months|Refusal|1|||
161848120|NCT05293639|584484207|FG000|Overall Study|Withdrawal by Subject|1|||
161848121|NCT05293639|584484208|FG001|Overall Study|Withdrawal by Subject|1|||
161848122|NCT05293639|584484209|FG002|Overall Study|Withdrawal by Subject|2|||
161848123|NCT05293639|584484207|FG000|Overall Study|Death|0|||
161848124|NCT05293639|584484208|FG001|Overall Study|Death|1|||
161848125|NCT05293639|584484209|FG002|Overall Study|Death|0|||
161848126|NCT05293639|584484207|FG000|Overall Study|Lost to Follow-up|0|||
161848127|NCT05293639|584484208|FG001|Overall Study|Lost to Follow-up|0|||
161848128|NCT05293639|584484209|FG002|Overall Study|Lost to Follow-up|5|||
161848129|NCT05293639|584484207|FG000|Overall Study|Other|0|||
161848130|NCT05293639|584484208|FG001|Overall Study|Other|0|||
161848131|NCT05293639|584484209|FG002|Overall Study|Other|1|||
161848132|NCT01860677|584484213|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
161848133|NCT01860677|584484214|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
161848134|NCT01671332|584484215|FG000|Overall Study|Withdrawal by Subject|1|||
161848135|NCT01671332|584484216|FG001|Overall Study|Withdrawal by Subject|1|||
161848136|NCT01458106|584484217|FG000|Overall Study|Withdrawal by Subject|2|||
161848137|NCT01458106|584484218|FG001|Overall Study|Withdrawal by Subject|0|||
161848138|NCT01458106|584484217|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
161848139|NCT01458106|584484218|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
161848140|NCT01458106|584484217|FG000|Overall Study|Withdrawn Per Protocol|0|||
161848141|NCT01458106|584484218|FG001|Overall Study|Withdrawn Per Protocol|1|||
161848142|NCT01056289|584486243|FG000|Open-label Phase|Adverse Event|29|||
161848143|NCT01056289|584486244|FG001|Open-label Phase|Adverse Event|0|||
161848144|NCT01056289|584486245|FG002|Open-label Phase|Adverse Event|0|||
161848145|NCT01056289|584486246|FG003|Open-label Phase|Adverse Event|0|||
161848146|NCT01056289|584486243|FG000|Open-label Phase|Lost to Follow-up|30|||
161848147|NCT01056289|584486244|FG001|Open-label Phase|Lost to Follow-up|0|||
161848148|NCT01056289|584486245|FG002|Open-label Phase|Lost to Follow-up|0|||
161848149|NCT01056289|584486246|FG003|Open-label Phase|Lost to Follow-up|0|||
161848150|NCT01056289|584486243|FG000|Open-label Phase|Other|9|||
161848151|NCT01056289|584486244|FG001|Open-label Phase|Other|0|||
161971613|NCT01598753|584943396|FG001|Overall Study|Physician Decision|1|||
161971614|NCT01598753|584943397|FG002|Overall Study|Physician Decision|0|||
161971615|NCT01598753|584943398|FG003|Overall Study|Physician Decision|2|||
161971616|NCT01598753|584943395|FG000|Overall Study|Withdrawal by Subject|7|||
161971617|NCT01598753|584943396|FG001|Overall Study|Withdrawal by Subject|2|||
161971618|NCT01598753|584943397|FG002|Overall Study|Withdrawal by Subject|0|||
161971619|NCT01598753|584943398|FG003|Overall Study|Withdrawal by Subject|1|||
162033291|NCT03505671|585180049|FG000|Overall Study|Lost to Follow-up|1|||
161763105|NCT04728815|584169804|FG000|Overall Study|Lost to Follow-up|3|||
161848152|NCT01056289|584486245|FG002|Open-label Phase|Other|0|||
161971620|NCT02275117|584943399|FG000|Overall Study|Adverse Event|0|||
161971621|NCT02275117|584943400|FG001|Overall Study|Adverse Event|0|||
161971622|NCT02275117|584943401|FG002|Overall Study|Adverse Event|0|||
161763106|NCT04728815|584169805|FG001|Overall Study|Lost to Follow-up|0|||
161763107|NCT04728815|584169806|FG002|Overall Study|Lost to Follow-up|0|||
161763108|NCT04728815|584169807|FG003|Overall Study|Lost to Follow-up|1|||
161763109|NCT04728815|584169808|FG004|Overall Study|Lost to Follow-up|1|||
161763110|NCT04728815|584169809|FG005|Overall Study|Lost to Follow-up|0|||
161763111|NCT04728815|584169810|FG006|Overall Study|Lost to Follow-up|2|||
161763112|NCT04728815|584169811|FG007|Overall Study|Lost to Follow-up|0|||
161763113|NCT04728815|584169804|FG000|Overall Study|Physician Decision|0|||
161763114|NCT04728815|584169805|FG001|Overall Study|Physician Decision|0|||
161763115|NCT04728815|584169806|FG002|Overall Study|Physician Decision|1|||
161848153|NCT01056289|584486246|FG003|Open-label Phase|Other|0|||
161848154|NCT01056289|584486243|FG000|Open-label Phase|Protocol Violation|6|||
161848155|NCT01056289|584486244|FG001|Open-label Phase|Protocol Violation|0|||
161848156|NCT01056289|584486245|FG002|Open-label Phase|Protocol Violation|0|||
161971623|NCT02275117|584943402|FG003|Overall Study|Adverse Event|0|||
161971624|NCT02275117|584943403|FG004|Overall Study|Adverse Event|1|||
161971625|NCT02275117|584943399|FG000|Overall Study|Lack of Efficacy|6|||
161848157|NCT01056289|584486246|FG003|Open-label Phase|Protocol Violation|0|||
162033292|NCT03505671|585180050|FG001|Overall Study|Lost to Follow-up|0|||
161848158|NCT01056289|584486243|FG000|Open-label Phase|Withdrawal by Subject|26|||
161848159|NCT01056289|584486244|FG001|Open-label Phase|Withdrawal by Subject|0|||
161848160|NCT01056289|584486245|FG002|Open-label Phase|Withdrawal by Subject|0|||
161848161|NCT01056289|584486246|FG003|Open-label Phase|Withdrawal by Subject|0|||
161848162|NCT01056289|584486243|FG000|Open-label Phase|Lack of Efficacy|18|||
161971626|NCT02275117|584943400|FG001|Overall Study|Lack of Efficacy|7|||
161971627|NCT02275117|584943401|FG002|Overall Study|Lack of Efficacy|5|||
161848163|NCT01056289|584486244|FG001|Open-label Phase|Lack of Efficacy|0|||
162033293|NCT02038829|585180051|FG000|Washout Period 1|Death|0|||
161763116|NCT04728815|584169807|FG003|Overall Study|Physician Decision|0|||
161763117|NCT04728815|584169808|FG004|Overall Study|Physician Decision|0|||
161848164|NCT01056289|584486245|FG002|Open-label Phase|Lack of Efficacy|0|||
161848165|NCT01056289|584486246|FG003|Open-label Phase|Lack of Efficacy|0|||
161848166|NCT01056289|584486243|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
161848167|NCT01056289|584486244|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
161848168|NCT01056289|584486245|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
161848169|NCT01056289|584486246|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
161848170|NCT01056289|584486243|FG000|Double-blind Phase|Adverse Event|0|||
161848171|NCT01056289|584486244|FG001|Double-blind Phase|Adverse Event|1|||
161848172|NCT01056289|584486245|FG002|Double-blind Phase|Adverse Event|2|||
161848173|NCT01056289|584486246|FG003|Double-blind Phase|Adverse Event|1|||
161848174|NCT01056289|584486243|FG000|Double-blind Phase|Lost to Follow-up|0|||
161848175|NCT01056289|584486244|FG001|Double-blind Phase|Lost to Follow-up|2|||
161848176|NCT01056289|584486245|FG002|Double-blind Phase|Lost to Follow-up|2|||
161848177|NCT01056289|584486246|FG003|Double-blind Phase|Lost to Follow-up|2|||
161848178|NCT01056289|584486243|FG000|Double-blind Phase|Other|0|||
161848179|NCT01056289|584486244|FG001|Double-blind Phase|Other|0|||
161848180|NCT01056289|584486245|FG002|Double-blind Phase|Other|1|||
161848181|NCT01056289|584486246|FG003|Double-blind Phase|Other|2|||
161848182|NCT01056289|584486243|FG000|Double-blind Phase|Protocol Violation|0|||
161848183|NCT01056289|584486244|FG001|Double-blind Phase|Protocol Violation|0|||
161848184|NCT01056289|584486245|FG002|Double-blind Phase|Protocol Violation|1|||
161848185|NCT01056289|584486246|FG003|Double-blind Phase|Protocol Violation|1|||
161848186|NCT01056289|584486243|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161848187|NCT01056289|584486244|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161848188|NCT01056289|584486245|FG002|Double-blind Phase|Withdrawal by Subject|4|||
161848189|NCT01056289|584486246|FG003|Double-blind Phase|Withdrawal by Subject|2|||
161848190|NCT01056289|584486243|FG000|Double-blind Phase|Discontinuation symptom|0|||
161848191|NCT01056289|584486244|FG001|Double-blind Phase|Discontinuation symptom|1|||
161848192|NCT01056289|584486245|FG002|Double-blind Phase|Discontinuation symptom|2|||
161848193|NCT01056289|584486246|FG003|Double-blind Phase|Discontinuation symptom|2|||
161848194|NCT01056289|584486243|FG000|Double-blind Phase|Physician Decision|0|||
161848195|NCT01056289|584486244|FG001|Double-blind Phase|Physician Decision|0|||
161848196|NCT01056289|584486245|FG002|Double-blind Phase|Physician Decision|1|||
161848197|NCT01056289|584486246|FG003|Double-blind Phase|Physician Decision|0|||
161848198|NCT00270855|584486255|FG000|Overall Study|Withdrawal by Subject|8|||
161848199|NCT00270855|584486256|FG001|Overall Study|Withdrawal by Subject|8|||
161848200|NCT03156504|584486260|FG000|Overall Study|Withdrawal by Subject|1|||
161848201|NCT05048329|584486261|FG000|Overall Study|Withdrawal by Subject|1|||
161848202|NCT05048329|584486261|FG000|Overall Study|Screenfail|1|||
161848203|NCT00282919|584486262|FG000|Overall Study|Lack of Efficacy|4|||
161848204|NCT00282919|584486262|FG000|Overall Study|Withdrawal by Subject|1|||
161848205|NCT00282919|584486262|FG000|Overall Study|Asymptomatic Parasitemia|2|||
161848206|NCT03257865|584486268|FG000|Overall Study|Adverse Event|4|||
161848207|NCT03257865|584486269|FG001|Overall Study|Adverse Event|8|||
161848208|NCT03257865|584486268|FG000|Overall Study|Lack of Efficacy|1|||
161848209|NCT03257865|584486269|FG001|Overall Study|Lack of Efficacy|2|||
161848210|NCT03257865|584486268|FG000|Overall Study|Non-compliance with Study Drug|0|||
161848211|NCT03257865|584486269|FG001|Overall Study|Non-compliance with Study Drug|2|||
161848212|NCT03257865|584486268|FG000|Overall Study|Withdrawal by Subject|23|||
161848213|NCT03257865|584486269|FG001|Overall Study|Withdrawal by Subject|17|||
161848214|NCT03257865|584486268|FG000|Overall Study|Physician Decision|3|||
161848215|NCT03257865|584486269|FG001|Overall Study|Physician Decision|1|||
161848216|NCT03257865|584486268|FG000|Overall Study|Other|0|||
161848217|NCT03257865|584486269|FG001|Overall Study|Other|1|||
161848218|NCT03257865|584486268|FG000|Overall Study|Lost to Follow-up|4|||
161848219|NCT03257865|584486269|FG001|Overall Study|Lost to Follow-up|4|||
161848220|NCT02549027|584486270|FG000|Washout After Period 4|Withdrawal by Subject|0|||
161848221|NCT02549027|584486271|FG001|Washout After Period 4|Withdrawal by Subject|1|||
161848222|NCT02549027|584486272|FG002|Washout After Period 4|Withdrawal by Subject|1|||
161848223|NCT02549027|584486273|FG003|Washout After Period 4|Withdrawal by Subject|1|||
161848224|NCT02549027|584486274|FG004|Washout After Period 4|Withdrawal by Subject|0|||
161848225|NCT02549027|584486275|FG005|Washout After Period 4|Withdrawal by Subject|0|||
161848226|NCT02549027|584486270|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161848227|NCT02549027|584486271|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
162033294|NCT02038829|585180052|FG001|Washout Period 1|Death|0|||
162033295|NCT02038829|585180053|FG002|Washout Period 1|Death|0|||
162033296|NCT02038829|585180054|FG003|Washout Period 1|Death|0|||
161848228|NCT02549027|584486272|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161848229|NCT02549027|584486273|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161848230|NCT02549027|584486274|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
161848231|NCT02549027|584486275|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161848232|NCT05384171|584486281|FG000|Overall Study|Lost to Follow-up|9|||
161848233|NCT05384171|584486282|FG001|Overall Study|Lost to Follow-up|9|||
161848234|NCT05384171|584486281|FG000|Overall Study|Withdrawal by Subject|3|||
161848235|NCT05384171|584486282|FG001|Overall Study|Withdrawal by Subject|0|||
162033297|NCT02038829|585180055|FG004|Washout Period 1|Death|1|||
161848236|NCT01421511|584486283|FG000|Overall Study|Lost to Follow-up|11|||
161971628|NCT02275117|584943402|FG003|Overall Study|Lack of Efficacy|2|||
161763118|NCT04728815|584169809|FG005|Overall Study|Physician Decision|0|||
161763119|NCT04728815|584169810|FG006|Overall Study|Physician Decision|0|||
161763120|NCT04728815|584169811|FG007|Overall Study|Physician Decision|0|||
161763121|NCT04728815|584169804|FG000|Overall Study|Treatment drop|0|||
161763122|NCT04728815|584169805|FG001|Overall Study|Treatment drop|2|||
161763123|NCT04728815|584169806|FG002|Overall Study|Treatment drop|1|||
161763124|NCT04728815|584169807|FG003|Overall Study|Treatment drop|0|||
161763125|NCT04728815|584169808|FG004|Overall Study|Treatment drop|3|||
161763126|NCT04728815|584169809|FG005|Overall Study|Treatment drop|1|||
161763127|NCT04728815|584169810|FG006|Overall Study|Treatment drop|3|||
161763128|NCT04728815|584169811|FG007|Overall Study|Treatment drop|0|||
161763129|NCT04728815|584169804|FG000|Overall Study|Study drop|0|||
161763130|NCT04728815|584169805|FG001|Overall Study|Study drop|3|||
161763131|NCT04728815|584169806|FG002|Overall Study|Study drop|3|||
161763132|NCT04728815|584169807|FG003|Overall Study|Study drop|0|||
161763133|NCT04728815|584169808|FG004|Overall Study|Study drop|0|||
161763134|NCT04728815|584169809|FG005|Overall Study|Study drop|0|||
161763135|NCT04728815|584169810|FG006|Overall Study|Study drop|7|||
161763136|NCT04728815|584169811|FG007|Overall Study|Study drop|0|||
161763137|NCT05315297|584169812|FG000|Overall Study|Lost to Follow-up|6|||
161763138|NCT05315297|584169813|FG001|Overall Study|Lost to Follow-up|4|||
161763139|NCT05315297|584169812|FG000|Overall Study|Withdrawal by Subject|0|||
161763140|NCT05315297|584169813|FG001|Overall Study|Withdrawal by Subject|1|||
161763141|NCT02551874|584171693|FG000|Overall Study|Lost to Follow-up|0|||
161763142|NCT02551874|584171694|FG001|Overall Study|Lost to Follow-up|2|||
161763143|NCT02551874|584171693|FG000|Overall Study|Pregnancy|0|||
161763144|NCT02551874|584171694|FG001|Overall Study|Pregnancy|1|||
161763145|NCT02551874|584171693|FG000|Overall Study|Reason not reported|10|||
161763146|NCT02551874|584171694|FG001|Overall Study|Reason not reported|4|||
161763147|NCT02551874|584171693|FG000|Overall Study|Did not receive randomized treatment|0|||
161763148|NCT02551874|584171694|FG001|Overall Study|Did not receive randomized treatment|7|||
161763149|NCT02551874|584171693|FG000|Overall Study|Did not enter long-term study|18|||
161763150|NCT02551874|584171694|FG001|Overall Study|Did not enter long-term study|25|||
161848237|NCT01421511|584486284|FG001|Overall Study|Lost to Follow-up|14|||
161848238|NCT01421511|584486283|FG000|Overall Study|Randomized but didn't receive study drug|1|||
161848239|NCT01421511|584486284|FG001|Overall Study|Randomized but didn't receive study drug|7|||
161848240|NCT01421511|584486283|FG000|Overall Study|Physician Decision|0|||
161848241|NCT01421511|584486284|FG001|Overall Study|Physician Decision|1|||
161848242|NCT01421511|584486283|FG000|Overall Study|Withdrawal by Subject|6|||
161848243|NCT01421511|584486284|FG001|Overall Study|Withdrawal by Subject|5|||
161848244|NCT01421511|584486283|FG000|Overall Study|Death|1|||
161848245|NCT01421511|584486284|FG001|Overall Study|Death|1|||
161848246|NCT02242045|584486285|FG000|Overall Study|Investigator's Discretion|1|||
161848247|NCT02242045|584486285|FG000|Overall Study|Progressive Disease|2|||
161848248|NCT02242045|584486285|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
161848249|NCT02242045|584486285|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
161848250|NCT00749892|584486286|FG000|Overall Study|Withdrawal by Subject|3|||
161848251|NCT00106964|584486288|FG000|Overall Study|Lost to Follow-up|8|||
161848252|NCT00106964|584486289|FG001|Overall Study|Lost to Follow-up|6|||
161848253|NCT00106964|584486290|FG002|Overall Study|Lost to Follow-up|2|||
161848254|NCT00106964|584486288|FG000|Overall Study|Pregnancy|2|||
161848255|NCT00106964|584486289|FG001|Overall Study|Pregnancy|3|||
161848256|NCT00106964|584486290|FG002|Overall Study|Pregnancy|2|||
161848257|NCT00106964|584486288|FG000|Overall Study|Death|1|||
161848258|NCT00106964|584486289|FG001|Overall Study|Death|1|||
161848259|NCT00106964|584486290|FG002|Overall Study|Death|0|||
161848260|NCT00106964|584486288|FG000|Overall Study|Incarceration|0|||
161848261|NCT00106964|584486289|FG001|Overall Study|Incarceration|1|||
161848262|NCT00106964|584486290|FG002|Overall Study|Incarceration|0|||
161763151|NCT04067310|584171696|FG000|Overall Study|Physician Decision|2|||
161763152|NCT04067310|584171697|FG001|Overall Study|Physician Decision|6|||
161848263|NCT00106964|584486288|FG000|Overall Study|Site Funding Terminated|0|||
161763153|NCT04067310|584171696|FG000|Overall Study|Lost to Follow-up|0|||
161763154|NCT04067310|584171697|FG001|Overall Study|Lost to Follow-up|1|||
161971629|NCT02275117|584943403|FG004|Overall Study|Lack of Efficacy|10|||
161763155|NCT04067310|584171696|FG000|Overall Study|Withdrawal by Subject|3|||
161763156|NCT04067310|584171697|FG001|Overall Study|Withdrawal by Subject|0|||
161848264|NCT00106964|584486289|FG001|Overall Study|Site Funding Terminated|1|||
161763157|NCT01041027|584171698|FG000|Overall Study|Withdrawal by Subject|2|||
161763158|NCT01041027|584171698|FG000|Overall Study|Protocol Violation|1|||
161763159|NCT01041027|584171698|FG000|Overall Study|Delayed Radiation Therapy|1|||
161763160|NCT01041027|584171698|FG000|Overall Study|Adverse Event|4|||
161763161|NCT02493712|584171699|FG000|Overall Study|Withdrawal by Subject|1|||
161763162|NCT02493712|584171700|FG001|Overall Study|Withdrawal by Subject|0|||
161848265|NCT00106964|584486290|FG002|Overall Study|Site Funding Terminated|1|||
161848266|NCT00106964|584486288|FG000|Overall Study|Failure to adhere|2|||
161848267|NCT00106964|584486289|FG001|Overall Study|Failure to adhere|0|||
161848268|NCT00106964|584486290|FG002|Overall Study|Failure to adhere|0|||
161848269|NCT00106964|584486288|FG000|Overall Study|Did not meet eligibility criteria|0|||
161848270|NCT00106964|584486289|FG001|Overall Study|Did not meet eligibility criteria|2|||
161848271|NCT00106964|584486290|FG002|Overall Study|Did not meet eligibility criteria|2|||
161848272|NCT00106964|584486288|FG000|Overall Study|Required disallowed medication|0|||
161848273|NCT00106964|584486289|FG001|Overall Study|Required disallowed medication|1|||
161848274|NCT00106964|584486290|FG002|Overall Study|Required disallowed medication|0|||
161848275|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
161848276|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
161848277|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
161848278|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
161848279|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
161848280|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
161971630|NCT02275117|584943399|FG000|Overall Study|Lost to Follow-up|11|||
161971631|NCT02275117|584943400|FG001|Overall Study|Lost to Follow-up|16|||
161971632|NCT02275117|584943401|FG002|Overall Study|Lost to Follow-up|15|||
161971633|NCT02275117|584943402|FG003|Overall Study|Lost to Follow-up|16|||
161971634|NCT02275117|584943403|FG004|Overall Study|Lost to Follow-up|8|||
161971635|NCT02275117|584943399|FG000|Overall Study|Physician Decision|0|||
161971636|NCT02275117|584943400|FG001|Overall Study|Physician Decision|1|||
161971637|NCT02275117|584943401|FG002|Overall Study|Physician Decision|1|||
161971638|NCT02275117|584943402|FG003|Overall Study|Physician Decision|0|||
161971639|NCT02275117|584943403|FG004|Overall Study|Physician Decision|1|||
161971640|NCT02275117|584943399|FG000|Overall Study|Protocol Violation|1|||
161971641|NCT02275117|584943400|FG001|Overall Study|Protocol Violation|0|||
161971642|NCT02275117|584943401|FG002|Overall Study|Protocol Violation|1|||
161971643|NCT02275117|584943402|FG003|Overall Study|Protocol Violation|1|||
161971644|NCT02275117|584943403|FG004|Overall Study|Protocol Violation|0|||
161971645|NCT02275117|584943399|FG000|Overall Study|Withdrawal by Subject|6|||
161971646|NCT02275117|584943400|FG001|Overall Study|Withdrawal by Subject|4|||
161971647|NCT02275117|584943401|FG002|Overall Study|Withdrawal by Subject|7|||
161971648|NCT02275117|584943402|FG003|Overall Study|Withdrawal by Subject|3|||
161971649|NCT02275117|584943403|FG004|Overall Study|Withdrawal by Subject|3|||
161971650|NCT02275117|584943399|FG000|Overall Study|Terminated by Sponsor|4|||
161971651|NCT02275117|584943400|FG001|Overall Study|Terminated by Sponsor|4|||
161971652|NCT02275117|584943401|FG002|Overall Study|Terminated by Sponsor|4|||
161971653|NCT02275117|584943402|FG003|Overall Study|Terminated by Sponsor|6|||
161971654|NCT02275117|584943403|FG004|Overall Study|Terminated by Sponsor|4|||
161971655|NCT02275117|584943399|FG000|Overall Study|Worsening of Study Indication|0|||
161971656|NCT02275117|584943400|FG001|Overall Study|Worsening of Study Indication|1|||
161971657|NCT02275117|584943401|FG002|Overall Study|Worsening of Study Indication|2|||
161971658|NCT02275117|584943402|FG003|Overall Study|Worsening of Study Indication|0|||
161971659|NCT02275117|584943403|FG004|Overall Study|Worsening of Study Indication|0|||
161971660|NCT02275117|584943399|FG000|Overall Study|Study Burden|5|||
161971661|NCT02275117|584943400|FG001|Overall Study|Study Burden|4|||
161971662|NCT02275117|584943401|FG002|Overall Study|Study Burden|7|||
161971663|NCT02275117|584943402|FG003|Overall Study|Study Burden|5|||
161971664|NCT02275117|584943403|FG004|Overall Study|Study Burden|7|||
161971665|NCT02275117|584943399|FG000|Overall Study|Other|1|||
161971666|NCT02275117|584943400|FG001|Overall Study|Other|0|||
161971667|NCT02275117|584943401|FG002|Overall Study|Other|0|||
161971668|NCT02275117|584943402|FG003|Overall Study|Other|0|||
161971669|NCT02275117|584943403|FG004|Overall Study|Other|2|||
161848281|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
161848282|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
161971670|NCT01081301|584943407|FG000|Overall Study|Bereaved|3|||
161971671|NCT01081301|584943407|FG000|Overall Study|Too busy|5|||
161971672|NCT01081301|584943407|FG000|Overall Study|Patient too ill|2|||
161971673|NCT01081301|584943407|FG000|Overall Study|Lost to Follow-up|4|||
161971674|NCT02014480|584943408|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
161971675|NCT02014480|584943409|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
161971676|NCT02014480|584943410|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
161971677|NCT02014480|584943411|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
161971678|NCT02014480|584943412|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
161971679|NCT02014480|584943413|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
161971680|NCT02014480|584943408|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161971681|NCT02014480|584943409|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161971682|NCT02014480|584943410|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161971683|NCT02014480|584943411|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
161971684|NCT02014480|584943412|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161971685|NCT02014480|584943413|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161971686|NCT02014480|584943408|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161971687|NCT02014480|584943409|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161971688|NCT02014480|584943410|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
161848283|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
161848284|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
161848285|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
161848286|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
161848287|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
161848288|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
161848289|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
161848290|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
161848291|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
161848292|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
161848293|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
161848294|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
161848295|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
161848296|NCT04040192|584486291|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
161848297|NCT04040192|584486292|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
161848298|NCT04040192|584486293|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
161848299|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
161848300|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
161848301|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
161848302|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
161848303|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
161848304|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
161848305|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
161848306|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
161848307|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
161848308|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
161848309|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
161848310|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
161848311|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
161848312|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
161848313|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
161971689|NCT02014480|584943411|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161971690|NCT02014480|584943412|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161971691|NCT02014480|584943413|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161971692|NCT02014480|584943408|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
161763163|NCT02493712|584171701|FG002|Overall Study|Withdrawal by Subject|2|||
161763164|NCT02493712|584171699|FG000|Overall Study|Protocol Violation|0|||
161763165|NCT02493712|584171700|FG001|Overall Study|Protocol Violation|0|||
161763166|NCT02493712|584171701|FG002|Overall Study|Protocol Violation|1|||
161763167|NCT02493712|584171699|FG000|Overall Study|Lost to Follow-up|1|||
161763168|NCT02493712|584171700|FG001|Overall Study|Lost to Follow-up|0|||
161763169|NCT02493712|584171701|FG002|Overall Study|Lost to Follow-up|0|||
161763170|NCT02493712|584171699|FG000|Overall Study|Physician Decision|0|||
161763171|NCT02493712|584171700|FG001|Overall Study|Physician Decision|1|||
161971693|NCT02014480|584943409|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
161971694|NCT02014480|584943410|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
161971695|NCT02014480|584943411|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
161971696|NCT02014480|584943412|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161971697|NCT02014480|584943413|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161971698|NCT02014480|584943408|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161763172|NCT02493712|584171701|FG002|Overall Study|Physician Decision|0|||
161763173|NCT02493712|584171699|FG000|Overall Study|Lack of Efficacy|0|||
161763174|NCT02493712|584171700|FG001|Overall Study|Lack of Efficacy|5|||
161763175|NCT02493712|584171701|FG002|Overall Study|Lack of Efficacy|3|||
161763176|NCT02528643|584171702|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
161763177|NCT02528643|584171703|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
161763178|NCT02528643|584171702|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
161763179|NCT02528643|584171703|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
161763180|NCT02528643|584171702|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
161848314|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
161971699|NCT02014480|584943409|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
161971700|NCT02014480|584943410|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161971701|NCT02014480|584943411|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161971702|NCT02014480|584943412|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161763181|NCT02528643|584171703|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
161848315|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
161971703|NCT02014480|584943413|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161763182|NCT02528643|584171702|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
161763183|NCT02528643|584171703|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
161763184|NCT02528643|584171702|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
161763185|NCT02528643|584171703|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
161763186|NCT02528643|584171702|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
161763187|NCT02528643|584171703|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
161763188|NCT02528643|584171702|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
161763189|NCT02528643|584171703|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
161763190|NCT02058940|584171704|FG000|Overall Study|Discharged from Critical Care Unit|1|||
161763191|NCT04144140|584171705|FG000|Overall Study|Other|0|||
161763192|NCT04144140|584171706|FG001|Overall Study|Other|0|||
161763193|NCT04144140|584171707|FG002|Overall Study|Other|0|||
161763194|NCT04144140|584171708|FG003|Overall Study|Other|0|||
161763195|NCT04144140|584171709|FG004|Overall Study|Other|0|||
161763196|NCT04144140|584171710|FG005|Overall Study|Other|1|||
161763197|NCT04144140|584171711|FG006|Overall Study|Other|0|||
161763198|NCT02146274|584171712|FG000|Overall Study|Protocol Violation|73|||
161763199|NCT02039687|584171715|FG000|Overall Study|Adverse Event|0|||
161763200|NCT02039687|584171716|FG001|Overall Study|Adverse Event|0|||
161763201|NCT02039687|584171717|FG002|Overall Study|Adverse Event|1|||
161763202|NCT02039687|584171718|FG003|Overall Study|Adverse Event|0|||
161763203|NCT02039687|584171715|FG000|Overall Study|Withdrawal by Subject|0|||
161763204|NCT02039687|584171716|FG001|Overall Study|Withdrawal by Subject|1|||
161763205|NCT02039687|584171717|FG002|Overall Study|Withdrawal by Subject|0|||
161763206|NCT02039687|584171718|FG003|Overall Study|Withdrawal by Subject|0|||
161763207|NCT02039687|584171715|FG000|Overall Study|treatment assignment could not be confir|0|||
161763208|NCT02039687|584171716|FG001|Overall Study|treatment assignment could not be confir|0|||
161763209|NCT02039687|584171717|FG002|Overall Study|treatment assignment could not be confir|2|||
161763210|NCT02039687|584171718|FG003|Overall Study|treatment assignment could not be confir|0|||
161763211|NCT01640353|584171729|FG000|Overall Study|Withdrew prior to treatment|10|||
161763212|NCT01640353|584171729|FG000|Overall Study|Withdrawn from analysis at term site|12|||
161763213|NCT01640353|584171729|FG000|Overall Study|Withdrawal by Subject|5|||
161763214|NCT01640353|584171729|FG000|Overall Study|Death|2|||
161763215|NCT01640353|584171729|FG000|Overall Study|Early site termination|3|||
161763216|NCT01640353|584171729|FG000|Overall Study|Lost to Follow-up|12|||
161763217|NCT01640353|584171729|FG000|Overall Study|Physician Decision|1|||
161763218|NCT01967134|584171730|FG000|Overall Study|Lost to Follow-up|0|||
161763219|NCT01967134|584171731|FG001|Overall Study|Lost to Follow-up|1|||
161763220|NCT01967134|584171732|FG002|Overall Study|Lost to Follow-up|0|||
161763221|NCT00443534|584171733|FG000|Overall Study|Lack of Efficacy|67|||
161763222|NCT00443534|584171733|FG000|Overall Study|Adverse Event|16|||
161763223|NCT00443534|584171733|FG000|Overall Study|Death|9|||
161763224|NCT00443534|584171733|FG000|Overall Study|Withdrawal by Subject|8|||
161763225|NCT00443534|584171733|FG000|Overall Study|Study Terminated by Sponsor|12|||
161763226|NCT00443534|584171733|FG000|Overall Study|Other|10|||
161763227|NCT00443534|584171733|FG000|Overall Study|Enrolled, Not Treated|1|||
161763228|NCT00305773|584171735|FG000|Overall Study|Death|3|||
161763229|NCT00305773|584171736|FG001|Overall Study|Death|2|||
161763230|NCT00305773|584171735|FG000|Overall Study|Adverse Event|1|||
161763231|NCT00305773|584171736|FG001|Overall Study|Adverse Event|2|||
161763232|NCT00305773|584171735|FG000|Overall Study|Alternative Treatment|4|||
161763233|NCT00305773|584171736|FG001|Overall Study|Alternative Treatment|4|||
161763234|NCT00305773|584171735|FG000|Overall Study|Physician Decision|1|||
161763235|NCT00305773|584171736|FG001|Overall Study|Physician Decision|1|||
161763236|NCT00305773|584171735|FG000|Overall Study|Withdrawal by Subject|1|||
161763237|NCT00305773|584171736|FG001|Overall Study|Withdrawal by Subject|4|||
161763238|NCT00305773|584171735|FG000|Overall Study|Disease Progression|1|||
161763239|NCT00305773|584171736|FG001|Overall Study|Disease Progression|3|||
161763240|NCT00305773|584171735|FG000|Overall Study|All other reasons|3|||
161763241|NCT00305773|584171736|FG001|Overall Study|All other reasons|2|||
161763242|NCT02679222|584171737|FG000|Overall Study|No time for project|1|||
161763243|NCT03419741|584171738|FG000|Overall Study|Adverse Event|1|||
161763244|NCT03419741|584171739|FG001|Overall Study|Adverse Event|0|||
161763245|NCT03419741|584171738|FG000|Overall Study|Withdrawal by Subject|1|||
161763246|NCT03419741|584171739|FG001|Overall Study|Withdrawal by Subject|2|||
161763247|NCT04354870|584171740|FG000|Overall Study|Lost to Follow-up|32|||
161763248|NCT04354870|584171741|FG001|Overall Study|Lost to Follow-up|12|||
161763249|NCT04354870|584171740|FG000|Overall Study|Withdrawal by Subject|10|||
161763250|NCT04354870|584171741|FG001|Overall Study|Withdrawal by Subject|16|||
161763251|NCT04354870|584171740|FG000|Overall Study|Did not complete all study visits|6|||
161848316|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
161763252|NCT04354870|584171741|FG001|Overall Study|Did not complete all study visits|5|||
161763253|NCT03384316|584171742|FG000|Overall Study|Screen failure|0|||
161763254|NCT03384316|584171743|FG001|Overall Study|Screen failure|1|||
161848317|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
161763255|NCT00413231|584171744|FG000|0 to 30-day Post Treatment|Death|5|||
161848318|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
161848319|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
161848320|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
161848321|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
161848322|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
161848323|NCT04040192|584486291|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
161848324|NCT04040192|584486292|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
161848325|NCT04040192|584486293|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
161848326|NCT03207243|584486294|FG000|Overall Study|Adverse Event|2|||
161848327|NCT03207243|584486295|FG001|Overall Study|Adverse Event|2|||
161848328|NCT03207243|584486294|FG000|Overall Study|Loss of Asthma Control|47|||
161848329|NCT03207243|584486295|FG001|Overall Study|Loss of Asthma Control|31|||
161848330|NCT03207243|584486294|FG000|Overall Study|Withdrawal by Subject|2|||
161848331|NCT03207243|584486295|FG001|Overall Study|Withdrawal by Subject|4|||
161848332|NCT03207243|584486294|FG000|Overall Study|Physician Decision|1|||
161848333|NCT03207243|584486295|FG001|Overall Study|Physician Decision|1|||
161848334|NCT03207243|584486294|FG000|Overall Study|Lost to Follow-up|0|||
161848335|NCT03207243|584486295|FG001|Overall Study|Lost to Follow-up|1|||
161848336|NCT03207243|584486294|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
161848337|NCT03207243|584486295|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
161763256|NCT00413231|584171744|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
161763257|NCT00413231|584171744|FG000|30-day to 365-day Post Treatment|Death|13|||
161763258|NCT00413231|584171744|FG000|365-day to 60-month Post Treatment|Death|36|||
161763259|NCT00413231|584171744|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
161763260|NCT00413231|584171744|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
161763261|NCT00413231|584171744|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
161763262|NCT04450394|584171749|FG000|Overall Study|Adverse Event|2|||
161763263|NCT04450394|584171750|FG001|Overall Study|Adverse Event|0|||
161763264|NCT04450394|584171751|FG002|Overall Study|Adverse Event|0|||
161763265|NCT04450394|584171749|FG000|Overall Study|Death|0|||
161763266|NCT04450394|584171750|FG001|Overall Study|Death|1|||
161763267|NCT04450394|584171751|FG002|Overall Study|Death|0|||
161763268|NCT04450394|584171749|FG000|Overall Study|Lost to Follow-up|0|||
161763269|NCT04450394|584171750|FG001|Overall Study|Lost to Follow-up|3|||
161763270|NCT04450394|584171751|FG002|Overall Study|Lost to Follow-up|0|||
161763271|NCT04450394|584171749|FG000|Overall Study|Physician Decision|0|||
161763272|NCT04450394|584171750|FG001|Overall Study|Physician Decision|1|||
161763273|NCT04450394|584171751|FG002|Overall Study|Physician Decision|0|||
161763274|NCT04450394|584171749|FG000|Overall Study|Protocol Violation|2|||
161763275|NCT04450394|584171750|FG001|Overall Study|Protocol Violation|0|||
161763276|NCT04450394|584171751|FG002|Overall Study|Protocol Violation|0|||
161763277|NCT04450394|584171749|FG000|Overall Study|Withdrawal by Subject|6|||
161763278|NCT04450394|584171750|FG001|Overall Study|Withdrawal by Subject|9|||
161763279|NCT04450394|584171751|FG002|Overall Study|Withdrawal by Subject|0|||
161763280|NCT01066819|584171755|FG000|Overall Study|Adverse Event|18|||
161763281|NCT01066819|584171756|FG001|Overall Study|Adverse Event|1|||
161763282|NCT01066819|584171757|FG002|Overall Study|Adverse Event|6|||
161763283|NCT01066819|584171758|FG003|Overall Study|Adverse Event|0|||
161763284|NCT01066819|584171759|FG004|Overall Study|Adverse Event|0|||
161763285|NCT01066819|584171760|FG005|Overall Study|Adverse Event|0|||
161763286|NCT01066819|584171755|FG000|Overall Study|Death|5|||
161763287|NCT01066819|584171756|FG001|Overall Study|Death|0|||
161763288|NCT01066819|584171757|FG002|Overall Study|Death|1|||
161763289|NCT01066819|584171758|FG003|Overall Study|Death|0|||
161763290|NCT01066819|584171759|FG004|Overall Study|Death|0|||
161763291|NCT01066819|584171760|FG005|Overall Study|Death|0|||
161763292|NCT01066819|584171755|FG000|Overall Study|Lack of Efficacy|22|||
161763293|NCT01066819|584171756|FG001|Overall Study|Lack of Efficacy|1|||
161763294|NCT01066819|584171757|FG002|Overall Study|Lack of Efficacy|2|||
161848338|NCT03207243|584486294|FG000|Overall Study|Protocol Violation|0|||
161848339|NCT03207243|584486295|FG001|Overall Study|Protocol Violation|3|||
161971704|NCT02014480|584943408|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
161971705|NCT02014480|584943409|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
161971706|NCT02014480|584943410|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
161971707|NCT02014480|584943411|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
161763295|NCT01066819|584171758|FG003|Overall Study|Lack of Efficacy|1|||
161763296|NCT01066819|584171759|FG004|Overall Study|Lack of Efficacy|0|||
161763297|NCT01066819|584171760|FG005|Overall Study|Lack of Efficacy|0|||
161763298|NCT01066819|584171755|FG000|Overall Study|Physician Decision|6|||
161848340|NCT00603837|584486302|FG000|Overall Study|Physician Decision|3|||
161848341|NCT00603837|584486303|FG001|Overall Study|Physician Decision|0|||
161848342|NCT01352416|584486304|FG000|Overall Study|Physician Decision|1|||
161848343|NCT01352416|584486305|FG001|Overall Study|Physician Decision|2|||
161848344|NCT01352416|584486306|FG002|Overall Study|Physician Decision|2|||
161763299|NCT01066819|584171756|FG001|Overall Study|Physician Decision|2|||
161763300|NCT01066819|584171757|FG002|Overall Study|Physician Decision|3|||
161763301|NCT01066819|584171758|FG003|Overall Study|Physician Decision|0|||
161763302|NCT01066819|584171759|FG004|Overall Study|Physician Decision|0|||
161763303|NCT01066819|584171760|FG005|Overall Study|Physician Decision|0|||
161763304|NCT01066819|584171755|FG000|Overall Study|Protocol Violation|12|||
161763305|NCT01066819|584171756|FG001|Overall Study|Protocol Violation|6|||
161763306|NCT01066819|584171757|FG002|Overall Study|Protocol Violation|0|||
161763307|NCT01066819|584171758|FG003|Overall Study|Protocol Violation|0|||
161763308|NCT01066819|584171759|FG004|Overall Study|Protocol Violation|0|||
161763309|NCT01066819|584171760|FG005|Overall Study|Protocol Violation|0|||
161763310|NCT01066819|584171755|FG000|Overall Study|Withdrawal by Subject|29|||
161763311|NCT01066819|584171756|FG001|Overall Study|Withdrawal by Subject|11|||
161763312|NCT01066819|584171757|FG002|Overall Study|Withdrawal by Subject|6|||
161763313|NCT01066819|584171758|FG003|Overall Study|Withdrawal by Subject|0|||
161763314|NCT01066819|584171759|FG004|Overall Study|Withdrawal by Subject|0|||
161763315|NCT01066819|584171760|FG005|Overall Study|Withdrawal by Subject|0|||
161763316|NCT01066819|584171755|FG000|Overall Study|Administrative|6|||
161763317|NCT01066819|584171756|FG001|Overall Study|Administrative|4|||
161763318|NCT01066819|584171757|FG002|Overall Study|Administrative|2|||
161763319|NCT01066819|584171758|FG003|Overall Study|Administrative|0|||
161763320|NCT01066819|584171759|FG004|Overall Study|Administrative|0|||
161763321|NCT01066819|584171760|FG005|Overall Study|Administrative|0|||
161763322|NCT01066819|584171755|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
161763323|NCT01066819|584171756|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
161763324|NCT01066819|584171757|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
161763325|NCT01066819|584171758|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
161763326|NCT01066819|584171759|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
161763327|NCT01066819|584171760|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
161763328|NCT01066819|584171755|FG000|Overall Study|Early termination|2|||
161763329|NCT01066819|584171756|FG001|Overall Study|Early termination|0|||
161763330|NCT01066819|584171757|FG002|Overall Study|Early termination|0|||
161763331|NCT01066819|584171758|FG003|Overall Study|Early termination|0|||
161763332|NCT01066819|584171759|FG004|Overall Study|Early termination|0|||
161763333|NCT01066819|584171760|FG005|Overall Study|Early termination|0|||
161763334|NCT01066819|584171755|FG000|Overall Study|Failed to return|298|||
161763335|NCT01066819|584171756|FG001|Overall Study|Failed to return|107|||
161763336|NCT01066819|584171757|FG002|Overall Study|Failed to return|68|||
161763337|NCT01066819|584171758|FG003|Overall Study|Failed to return|7|||
161763338|NCT01066819|584171759|FG004|Overall Study|Failed to return|2|||
161763339|NCT01066819|584171760|FG005|Overall Study|Failed to return|3|||
161763340|NCT01066819|584171755|FG000|Overall Study|Lab test not done|9|||
161763341|NCT01066819|584171756|FG001|Overall Study|Lab test not done|0|||
161763342|NCT01066819|584171757|FG002|Overall Study|Lab test not done|2|||
161763343|NCT01066819|584171758|FG003|Overall Study|Lab test not done|1|||
161763344|NCT01066819|584171759|FG004|Overall Study|Lab test not done|0|||
161763345|NCT01066819|584171760|FG005|Overall Study|Lab test not done|0|||
161763346|NCT01066819|584171755|FG000|Overall Study|Miscellaneous|28|||
161763347|NCT01066819|584171756|FG001|Overall Study|Miscellaneous|10|||
161763348|NCT01066819|584171757|FG002|Overall Study|Miscellaneous|18|||
161763349|NCT01066819|584171758|FG003|Overall Study|Miscellaneous|1|||
161763350|NCT01066819|584171759|FG004|Overall Study|Miscellaneous|0|||
161763351|NCT01066819|584171760|FG005|Overall Study|Miscellaneous|0|||
161763352|NCT01066819|584171755|FG000|Overall Study|Non responders|123|||
161763353|NCT01066819|584171756|FG001|Overall Study|Non responders|2|||
161763354|NCT01066819|584171757|FG002|Overall Study|Non responders|7|||
161763355|NCT01066819|584171758|FG003|Overall Study|Non responders|2|||
161763356|NCT01066819|584171759|FG004|Overall Study|Non responders|0|||
161763357|NCT01066819|584171760|FG005|Overall Study|Non responders|1|||
161763358|NCT01066819|584171755|FG000|Overall Study|Not categorised|9|||
161763359|NCT01066819|584171756|FG001|Overall Study|Not categorised|2|||
161763360|NCT01066819|584171757|FG002|Overall Study|Not categorised|6|||
161763361|NCT01066819|584171758|FG003|Overall Study|Not categorised|1|||
161763362|NCT01066819|584171759|FG004|Overall Study|Not categorised|0|||
161763363|NCT01066819|584171760|FG005|Overall Study|Not categorised|0|||
161763364|NCT01066819|584171755|FG000|Overall Study|Relapse|16|||
161763365|NCT01066819|584171756|FG001|Overall Study|Relapse|4|||
161763366|NCT01066819|584171757|FG002|Overall Study|Relapse|3|||
161763367|NCT01066819|584171758|FG003|Overall Study|Relapse|0|||
161763368|NCT01066819|584171759|FG004|Overall Study|Relapse|0|||
161763369|NCT01066819|584171760|FG005|Overall Study|Relapse|0|||
161763370|NCT01066819|584171755|FG000|Overall Study|Results not available|1|||
161763371|NCT01066819|584171756|FG001|Overall Study|Results not available|0|||
161763372|NCT01066819|584171757|FG002|Overall Study|Results not available|0|||
161763373|NCT01066819|584171758|FG003|Overall Study|Results not available|0|||
161763374|NCT01066819|584171759|FG004|Overall Study|Results not available|0|||
161763375|NCT01066819|584171760|FG005|Overall Study|Results not available|0|||
161763376|NCT01066819|584171755|FG000|Overall Study|Screen failure|1|||
161763377|NCT01066819|584171756|FG001|Overall Study|Screen failure|0|||
161763378|NCT01066819|584171757|FG002|Overall Study|Screen failure|0|||
161763379|NCT01066819|584171758|FG003|Overall Study|Screen failure|0|||
161763380|NCT01066819|584171759|FG004|Overall Study|Screen failure|0|||
161763381|NCT01066819|584171760|FG005|Overall Study|Screen failure|0|||
161763382|NCT01066819|584171755|FG000|Overall Study|Spontaneous cure|1|||
161763383|NCT01066819|584171756|FG001|Overall Study|Spontaneous cure|0|||
161763384|NCT01066819|584171757|FG002|Overall Study|Spontaneous cure|0|||
161763385|NCT01066819|584171758|FG003|Overall Study|Spontaneous cure|0|||
161763386|NCT01066819|584171759|FG004|Overall Study|Spontaneous cure|0|||
161763387|NCT01066819|584171760|FG005|Overall Study|Spontaneous cure|0|||
161763388|NCT01066819|584171755|FG000|Overall Study|Treatment never started|85|||
161763389|NCT01066819|584171756|FG001|Overall Study|Treatment never started|19|||
161763390|NCT01066819|584171757|FG002|Overall Study|Treatment never started|19|||
161763391|NCT01066819|584171758|FG003|Overall Study|Treatment never started|3|||
161763392|NCT01066819|584171759|FG004|Overall Study|Treatment never started|2|||
161763393|NCT01066819|584171760|FG005|Overall Study|Treatment never started|2|||
161763394|NCT01066819|584171755|FG000|Overall Study|Treatment stopped|12|||
161763395|NCT01066819|584171756|FG001|Overall Study|Treatment stopped|1|||
161763396|NCT01066819|584171757|FG002|Overall Study|Treatment stopped|2|||
161763397|NCT01066819|584171758|FG003|Overall Study|Treatment stopped|1|||
161763398|NCT01066819|584171759|FG004|Overall Study|Treatment stopped|0|||
161763399|NCT01066819|584171760|FG005|Overall Study|Treatment stopped|0|||
161763400|NCT01066819|584171755|FG000|Overall Study|Other|5|||
161763401|NCT01066819|584171756|FG001|Overall Study|Other|1|||
161763402|NCT01066819|584171757|FG002|Overall Study|Other|1|||
161763403|NCT01066819|584171758|FG003|Overall Study|Other|0|||
161763404|NCT01066819|584171759|FG004|Overall Study|Other|0|||
161763405|NCT01066819|584171760|FG005|Overall Study|Other|0|||
161763406|NCT02719028|584171761|FG000|Overall Study|Adverse Event|2|||
161763407|NCT02719028|584171762|FG001|Overall Study|Adverse Event|1|||
161763408|NCT02719028|584171763|FG002|Overall Study|Adverse Event|4|||
161848345|NCT01352416|584486307|FG003|Overall Study|Physician Decision|1|||
161848346|NCT02960490|584486308|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
161848347|NCT02960490|584486309|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
161848348|NCT02960490|584486310|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848349|NCT02960490|584486311|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848350|NCT02960490|584486312|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848351|NCT02960490|584486313|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848352|NCT02960490|584486314|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848353|NCT02960490|584486315|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848354|NCT02960490|584486316|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848355|NCT02960490|584486317|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161848356|NCT02960490|584486308|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848357|NCT02960490|584486309|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
161848358|NCT02960490|584486310|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848359|NCT02960490|584486311|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848360|NCT02960490|584486312|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848361|NCT02960490|584486313|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848362|NCT02960490|584486314|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848363|NCT02960490|584486315|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848364|NCT02960490|584486316|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848365|NCT02960490|584486317|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161848366|NCT02960490|584486308|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
161848367|NCT02960490|584486309|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
161848368|NCT02960490|584486310|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848369|NCT02960490|584486311|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848370|NCT02960490|584486312|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848371|NCT02960490|584486313|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848372|NCT02960490|584486314|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848373|NCT02960490|584486315|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848374|NCT02960490|584486316|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848375|NCT02960490|584486317|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161848376|NCT02960490|584486308|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
161848377|NCT02960490|584486309|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
161763409|NCT02719028|584171764|FG003|Overall Study|Adverse Event|8|||
161763410|NCT02719028|584171761|FG000|Overall Study|Physician Decision|0|||
161763411|NCT02719028|584171762|FG001|Overall Study|Physician Decision|1|||
161763412|NCT02719028|584171763|FG002|Overall Study|Physician Decision|1|||
161763413|NCT02719028|584171764|FG003|Overall Study|Physician Decision|1|||
161763414|NCT02719028|584171761|FG000|Overall Study|Use of prohibited medication|0|||
161848378|NCT02960490|584486310|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161763415|NCT02719028|584171762|FG001|Overall Study|Use of prohibited medication|0|||
161763416|NCT02719028|584171763|FG002|Overall Study|Use of prohibited medication|1|||
161763417|NCT02719028|584171764|FG003|Overall Study|Use of prohibited medication|0|||
161763418|NCT02719028|584171761|FG000|Overall Study|Protocol Violation|0|||
161848379|NCT02960490|584486311|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848380|NCT02960490|584486312|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848381|NCT02960490|584486313|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848382|NCT02960490|584486314|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848383|NCT02960490|584486315|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848384|NCT02960490|584486316|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848385|NCT02960490|584486317|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161848386|NCT02960490|584486308|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848387|NCT02960490|584486309|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848388|NCT02960490|584486310|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
161848389|NCT02960490|584486311|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
161848390|NCT02960490|584486312|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848391|NCT02960490|584486313|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
161848392|NCT02960490|584486314|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848393|NCT02960490|584486315|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848394|NCT02960490|584486316|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848395|NCT02960490|584486317|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161848396|NCT02960490|584486308|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848397|NCT02960490|584486309|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848398|NCT02960490|584486310|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
161848399|NCT02960490|584486311|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848400|NCT02960490|584486312|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
161848401|NCT02960490|584486313|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848402|NCT02960490|584486314|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848403|NCT02960490|584486315|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848404|NCT02960490|584486316|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848405|NCT02960490|584486317|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161848406|NCT02960490|584486308|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
161848407|NCT02960490|584486309|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
161848408|NCT02960490|584486310|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
161848409|NCT02960490|584486311|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
161848410|NCT02960490|584486312|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
161848411|NCT02960490|584486313|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
161848412|NCT02960490|584486314|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
161848413|NCT02960490|584486315|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
161848414|NCT02960490|584486316|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
161848415|NCT02960490|584486317|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
161848416|NCT02960490|584486308|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848417|NCT02960490|584486309|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848418|NCT02960490|584486310|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848419|NCT02960490|584486311|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848420|NCT02960490|584486312|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848421|NCT02960490|584486313|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848422|NCT02960490|584486314|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
161848423|NCT02960490|584486315|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
161848424|NCT02960490|584486316|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
161848425|NCT02960490|584486317|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161848426|NCT02960490|584486308|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161971708|NCT02014480|584943412|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
161971709|NCT02014480|584943413|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
161971710|NCT02014480|584943408|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161971711|NCT02014480|584943409|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161971712|NCT02014480|584943410|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161971713|NCT02014480|584943411|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161971714|NCT02014480|584943412|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161971715|NCT02014480|584943413|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
161971716|NCT01338610|584943414|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
161971717|NCT01338610|584943415|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
161971718|NCT01338610|584943416|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
161971719|NCT01338610|584943414|FG000|Overall Study|Protocol Violation|1|||
161971720|NCT01338610|584943415|FG001|Overall Study|Protocol Violation|0|||
161971721|NCT01338610|584943416|FG002|Overall Study|Protocol Violation|1|||
161848427|NCT02960490|584486309|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848428|NCT02960490|584486310|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848429|NCT02960490|584486311|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848430|NCT02960490|584486312|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161971722|NCT01338610|584943414|FG000|Overall Study|Adverse Event|3|||
161848431|NCT02960490|584486313|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848432|NCT02960490|584486314|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848433|NCT02960490|584486315|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
161848434|NCT02960490|584486316|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848435|NCT02960490|584486317|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161848436|NCT02960490|584486308|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161848437|NCT02960490|584486309|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161848438|NCT02960490|584486310|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161848439|NCT02960490|584486311|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161848440|NCT02960490|584486312|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161848441|NCT02960490|584486313|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161848442|NCT02960490|584486314|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
161848443|NCT02960490|584486315|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
161848444|NCT02960490|584486316|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
161848445|NCT02960490|584486317|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
161848446|NCT02960490|584486308|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848447|NCT02960490|584486309|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848448|NCT02960490|584486310|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848449|NCT02960490|584486311|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848450|NCT02960490|584486312|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848451|NCT02960490|584486313|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848452|NCT02960490|584486314|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
161848453|NCT02960490|584486315|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848454|NCT02960490|584486316|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848455|NCT02960490|584486317|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161848456|NCT02960490|584486308|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848457|NCT02960490|584486309|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848458|NCT02960490|584486310|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848459|NCT02960490|584486311|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848460|NCT02960490|584486312|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848461|NCT02960490|584486313|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848462|NCT02960490|584486314|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848463|NCT02960490|584486315|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
161848464|NCT02960490|584486316|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848465|NCT02960490|584486317|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
161848466|NCT02368314|584486318|FG000|Overall Study|Withdrawal by Subject|2|||
161848467|NCT02368314|584486319|FG001|Overall Study|Withdrawal by Subject|1|||
161848468|NCT02368314|584486318|FG000|Overall Study|Adverse Event|1|||
161848469|NCT02368314|584486319|FG001|Overall Study|Adverse Event|2|||
161848470|NCT04411914|584486320|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
161848471|NCT04411914|584486321|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
161848472|NCT04106661|584486325|FG000|Overall Study|Protocol Violation|3|||
161848473|NCT04106661|584486326|FG001|Overall Study|Protocol Violation|0|||
161848474|NCT04106661|584486325|FG000|Overall Study|Scheduling difficulties|1|||
161848475|NCT04106661|584486326|FG001|Overall Study|Scheduling difficulties|1|||
161848476|NCT00233402|584486327|FG000|Overall Study|No pathology data|12|||
161848477|NCT00233402|584486328|FG001|Overall Study|No pathology data|9|||
161848478|NCT00233402|584486327|FG000|Overall Study|No Ta/T1|89|||
161848479|NCT00233402|584486328|FG001|Overall Study|No Ta/T1|94|||
161848480|NCT00233402|584486327|FG000|Overall Study|Lost to follow up etc|3|||
161848481|NCT00233402|584486328|FG001|Overall Study|Lost to follow up etc|21|||
161848482|NCT03280381|584486329|FG000|Overall Study|Physician Decision|0|||
161848483|NCT03280381|584486330|FG001|Overall Study|Physician Decision|2|||
161848484|NCT03503864|584486331|FG000|Overall Study|Protocol Violation|6|||
161848485|NCT03503864|584486331|FG000|Overall Study|Withdrawal by Subject|7|||
161848486|NCT00423319|584486332|FG000|Overall Study|Death|2|||
161971723|NCT01338610|584943415|FG001|Overall Study|Adverse Event|0|||
161971724|NCT01338610|584943416|FG002|Overall Study|Adverse Event|0|||
161971725|NCT00724854|584943417|FG000|Overall Study|Lack of Efficacy|187|||
161971726|NCT00724854|584943418|FG001|Overall Study|Lack of Efficacy|13|||
161971727|NCT00724854|584943417|FG000|Overall Study|Lost to Follow-up|87|||
161848487|NCT00423319|584486333|FG001|Overall Study|Death|0|||
161848488|NCT00423319|584486332|FG000|Overall Study|Adverse Event|93|||
161848489|NCT00423319|584486333|FG001|Overall Study|Adverse Event|112|||
161971728|NCT00724854|584943418|FG001|Overall Study|Lost to Follow-up|10|||
161971729|NCT00724854|584943417|FG000|Overall Study|Adverse Event|62|||
161971730|NCT00724854|584943418|FG001|Overall Study|Adverse Event|4|||
161848490|NCT00423319|584486332|FG000|Overall Study|Withdrawal by Subject|86|||
161848491|NCT00423319|584486333|FG001|Overall Study|Withdrawal by Subject|99|||
161971731|NCT00724854|584943417|FG000|Overall Study|Other|42|||
161971732|NCT00724854|584943418|FG001|Overall Study|Other|3|||
161971733|NCT00724854|584943417|FG000|Overall Study|Death|11|||
162033298|NCT02038829|585180056|FG005|Washout Period 1|Death|0|||
162033299|NCT02038829|585180057|FG006|Washout Period 1|Death|0|||
162033300|NCT02038829|585180058|FG007|Washout Period 1|Death|0|||
162033301|NCT02038829|585180059|FG008|Washout Period 1|Death|0|||
162033302|NCT02038829|585180060|FG009|Washout Period 1|Death|0|||
162033303|NCT02038829|585180061|FG010|Washout Period 1|Death|0|||
162033304|NCT02038829|585180062|FG011|Washout Period 1|Death|0|||
162033305|NCT02038829|585180051|FG000|Treatment Period 2|Adverse Event|0|||
162033306|NCT02038829|585180052|FG001|Treatment Period 2|Adverse Event|0|||
162033307|NCT02038829|585180053|FG002|Treatment Period 2|Adverse Event|0|||
162033308|NCT02038829|585180054|FG003|Treatment Period 2|Adverse Event|0|||
162033309|NCT02038829|585180055|FG004|Treatment Period 2|Adverse Event|0|||
162033310|NCT02038829|585180056|FG005|Treatment Period 2|Adverse Event|0|||
162033311|NCT02038829|585180057|FG006|Treatment Period 2|Adverse Event|0|||
162033312|NCT02038829|585180058|FG007|Treatment Period 2|Adverse Event|0|||
162033313|NCT02038829|585180059|FG008|Treatment Period 2|Adverse Event|0|||
162033314|NCT02038829|585180060|FG009|Treatment Period 2|Adverse Event|0|||
162033315|NCT02038829|585180061|FG010|Treatment Period 2|Adverse Event|1|||
162033316|NCT02038829|585180062|FG011|Treatment Period 2|Adverse Event|0|||
162033317|NCT02038829|585180051|FG000|Treatment Period 2|Withdrawal by Subject|1|||
162033318|NCT02038829|585180052|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162033319|NCT02038829|585180053|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162033320|NCT02038829|585180054|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162033321|NCT02038829|585180055|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162033322|NCT02038829|585180056|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162033323|NCT02038829|585180057|FG006|Treatment Period 2|Withdrawal by Subject|0|||
162033324|NCT02038829|585180058|FG007|Treatment Period 2|Withdrawal by Subject|0|||
162033325|NCT02038829|585180059|FG008|Treatment Period 2|Withdrawal by Subject|0|||
162033326|NCT02038829|585180060|FG009|Treatment Period 2|Withdrawal by Subject|0|||
162033327|NCT02038829|585180061|FG010|Treatment Period 2|Withdrawal by Subject|0|||
162033328|NCT02038829|585180062|FG011|Treatment Period 2|Withdrawal by Subject|0|||
162033329|NCT02038829|585180051|FG000|Washout Period 2|Adverse Event|0|||
162033330|NCT02038829|585180052|FG001|Washout Period 2|Adverse Event|0|||
162033331|NCT02038829|585180053|FG002|Washout Period 2|Adverse Event|0|||
162033332|NCT02038829|585180054|FG003|Washout Period 2|Adverse Event|0|||
162033333|NCT02038829|585180055|FG004|Washout Period 2|Adverse Event|0|||
162033334|NCT02038829|585180056|FG005|Washout Period 2|Adverse Event|0|||
162033335|NCT02038829|585180057|FG006|Washout Period 2|Adverse Event|0|||
162033336|NCT02038829|585180058|FG007|Washout Period 2|Adverse Event|0|||
162033337|NCT02038829|585180059|FG008|Washout Period 2|Adverse Event|1|||
162033338|NCT02038829|585180060|FG009|Washout Period 2|Adverse Event|0|||
162033339|NCT02038829|585180061|FG010|Washout Period 2|Adverse Event|0|||
162033340|NCT02038829|585180062|FG011|Washout Period 2|Adverse Event|0|||
162033341|NCT02038829|585180051|FG000|Washout Period 2|Withdrawal by Subject|0|||
162033342|NCT02038829|585180052|FG001|Washout Period 2|Withdrawal by Subject|0|||
161763419|NCT02719028|584171762|FG001|Overall Study|Protocol Violation|0|||
161763420|NCT02719028|584171763|FG002|Overall Study|Protocol Violation|0|||
161763421|NCT02719028|584171764|FG003|Overall Study|Protocol Violation|1|||
161763422|NCT01539720|584171768|FG000|Overall Study|Screen Fail|15|||
161763423|NCT01539720|584171769|FG001|Overall Study|Screen Fail|3|||
161763424|NCT01539720|584171768|FG000|Overall Study|Lost to Follow-up|14|||
161763425|NCT01539720|584171769|FG001|Overall Study|Lost to Follow-up|7|||
161763426|NCT00298766|584171770|FG000|Overall Study|Adverse Event|18|||
161763427|NCT00298766|584171770|FG000|Overall Study|Death|2|||
161763428|NCT00298766|584171770|FG000|Overall Study|Withdrawal by Subject|9|||
161763429|NCT00298766|584171770|FG000|Overall Study|Treatment ongoing|4|||
161763430|NCT00298766|584171770|FG000|Overall Study|Progression of amyloid markers|4|||
161763431|NCT00298766|584171770|FG000|Overall Study|Deterioration in KPS and organ function|1|||
161763432|NCT00298766|584171770|FG000|Overall Study|Subjects overall condition deterioration|4|||
161763433|NCT00298766|584171770|FG000|Overall Study|Other|4|||
161763434|NCT03287960|584171777|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
161763435|NCT03287960|584171777|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
161763436|NCT03812224|584171778|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
161763437|NCT03812224|584171779|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161763438|NCT03812224|584171778|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
161763439|NCT03812224|584171779|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
162033343|NCT02038829|585180053|FG002|Washout Period 2|Withdrawal by Subject|0|||
162033344|NCT02038829|585180054|FG003|Washout Period 2|Withdrawal by Subject|0|||
162033345|NCT02038829|585180055|FG004|Washout Period 2|Withdrawal by Subject|0|||
162033346|NCT02038829|585180056|FG005|Washout Period 2|Withdrawal by Subject|1|||
162033347|NCT02038829|585180057|FG006|Washout Period 2|Withdrawal by Subject|0|||
161763440|NCT03812224|584171778|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
161763441|NCT03812224|584171779|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
161763442|NCT03812224|584171778|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
162033348|NCT02038829|585180058|FG007|Washout Period 2|Withdrawal by Subject|0|||
162033349|NCT02038829|585180059|FG008|Washout Period 2|Withdrawal by Subject|0|||
162033350|NCT02038829|585180060|FG009|Washout Period 2|Withdrawal by Subject|0|||
162033351|NCT02038829|585180061|FG010|Washout Period 2|Withdrawal by Subject|0|||
162033352|NCT02038829|585180062|FG011|Washout Period 2|Withdrawal by Subject|0|||
161971734|NCT00724854|584943418|FG001|Overall Study|Death|0|||
161971735|NCT00724854|584943417|FG000|Overall Study|Change of treatment|7|||
161971736|NCT00724854|584943418|FG001|Overall Study|Change of treatment|0|||
161971737|NCT00724854|584943417|FG000|Overall Study|Withdrawal by Subject|5|||
161971738|NCT00724854|584943418|FG001|Overall Study|Withdrawal by Subject|0|||
161971739|NCT00724854|584943417|FG000|Overall Study|Adverse event + lack of efficacy|2|||
161971740|NCT00724854|584943418|FG001|Overall Study|Adverse event + lack of efficacy|1|||
161971741|NCT01865812|584943419|FG000|Primary Treatment Phase|Adverse Event|2|||
161971742|NCT01865812|584943420|FG001|Primary Treatment Phase|Adverse Event|0|||
161971743|NCT01865812|584943419|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
161971744|NCT01865812|584943420|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
161971745|NCT01865812|584943419|FG000|Long-term Safety Extension Phase|Pruritus|0|||
161971746|NCT01865812|584943420|FG001|Long-term Safety Extension Phase|Pruritus|3|||
161971747|NCT01865812|584943419|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
161971748|NCT01865812|584943420|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
161971749|NCT01865812|584943419|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
161971750|NCT01865812|584943420|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
161971751|NCT02046226|584943421|FG000|Overall Study|Lost to Follow-up|7|||
161971752|NCT01095653|584943422|FG000|Overall Study|Lack of Efficacy|3|||
161971753|NCT01095653|584943423|FG001|Overall Study|Lack of Efficacy|0|||
161971754|NCT01095653|584943424|FG002|Overall Study|Lack of Efficacy|0|||
161848492|NCT00423319|584486332|FG000|Overall Study|Lost to Follow-up|4|||
161848493|NCT00423319|584486333|FG001|Overall Study|Lost to Follow-up|3|||
161848494|NCT00423319|584486332|FG000|Overall Study|Poor compliance or noncompliance|1|||
161848495|NCT00423319|584486333|FG001|Overall Study|Poor compliance or noncompliance|1|||
161848496|NCT00423319|584486332|FG000|Overall Study|No longer meets study criteria|15|||
161848497|NCT00423319|584486333|FG001|Overall Study|No longer meets study criteria|15|||
161848498|NCT00423319|584486332|FG000|Overall Study|Other|23|||
161848499|NCT00423319|584486333|FG001|Overall Study|Other|22|||
161848500|NCT02639052|584486334|FG000|Overall Study|Lost to Follow-up|1|||
161848501|NCT02655666|584486337|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
161848502|NCT00895414|584486338|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
161848503|NCT00895414|584486339|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
161848504|NCT00895414|584486338|FG000|First Intervention (14 Days)|Physician Decision|0|||
161848505|NCT00895414|584486339|FG001|First Intervention (14 Days)|Physician Decision|1|||
161848506|NCT02087189|584486340|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
161848507|NCT00478426|584486345|FG000|Overall Study|Withdrawal by Subject|1|||
161848508|NCT00789737|584486346|FG000|Overall Study|Withdrawal by Subject|13|||
161848509|NCT00789737|584486347|FG001|Overall Study|Withdrawal by Subject|22|||
161848510|NCT00789737|584486346|FG000|Overall Study|Lost to Follow-up|10|||
161848511|NCT00789737|584486347|FG001|Overall Study|Lost to Follow-up|14|||
161848512|NCT00789737|584486346|FG000|Overall Study|Adverse Event|8|||
161848513|NCT00789737|584486347|FG001|Overall Study|Adverse Event|8|||
161848514|NCT00789737|584486346|FG000|Overall Study|Protocol Violation|3|||
161848515|NCT00789737|584486347|FG001|Overall Study|Protocol Violation|0|||
161848516|NCT00789737|584486346|FG000|Overall Study|Lack of Efficacy|3|||
161848517|NCT00789737|584486347|FG001|Overall Study|Lack of Efficacy|0|||
161848518|NCT00789737|584486346|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
161848519|NCT00789737|584486347|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
161848520|NCT00789737|584486346|FG000|Overall Study|Other|11|||
161848521|NCT00789737|584486347|FG001|Overall Study|Other|7|||
161848522|NCT01189487|584486348|FG000|Overall Study|Lack of Efficacy|2|||
161848523|NCT01189487|584486348|FG000|Overall Study|Adverse Event|1|||
161848524|NCT04630158|584486349|FG000|Overall Study|Adverse Event|1|||
161848525|NCT04630158|584486350|FG001|Overall Study|Adverse Event|1|||
161971755|NCT01095653|584943422|FG000|Overall Study|Adverse Event|1|||
161971756|NCT01095653|584943423|FG001|Overall Study|Adverse Event|4|||
161971757|NCT01095653|584943424|FG002|Overall Study|Adverse Event|4|||
161971758|NCT01095653|584943422|FG000|Overall Study|Lost to Follow-up|1|||
161971759|NCT01095653|584943423|FG001|Overall Study|Lost to Follow-up|0|||
161971760|NCT01095653|584943424|FG002|Overall Study|Lost to Follow-up|4|||
161848526|NCT04630158|584486351|FG002|Overall Study|Adverse Event|1|||
161848527|NCT04630158|584486349|FG000|Overall Study|Physician Decision|0|||
161848528|NCT04630158|584486350|FG001|Overall Study|Physician Decision|2|||
161848529|NCT04630158|584486351|FG002|Overall Study|Physician Decision|0|||
161848530|NCT04630158|584486349|FG000|Overall Study|Protocol Violation|1|||
161848531|NCT04630158|584486350|FG001|Overall Study|Protocol Violation|0|||
161848532|NCT04630158|584486351|FG002|Overall Study|Protocol Violation|1|||
161848533|NCT04630158|584486349|FG000|Overall Study|Withdrawal by Subject|2|||
161848534|NCT04630158|584486350|FG001|Overall Study|Withdrawal by Subject|1|||
161848535|NCT04630158|584486351|FG002|Overall Study|Withdrawal by Subject|2|||
161971761|NCT01095653|584943422|FG000|Overall Study|Withdrawal by Subject|4|||
161848536|NCT03136965|584486355|FG000|Overall Study|Lost to Follow-up|0|||
161848537|NCT03136965|584486356|FG001|Overall Study|Lost to Follow-up|1|||
161848538|NCT03136965|584486357|FG002|Overall Study|Lost to Follow-up|0|||
161971762|NCT01095653|584943423|FG001|Overall Study|Withdrawal by Subject|5|||
161848539|NCT01210612|584486359|FG000|Overall Study|Withdrawal by Subject|0|||
161848540|NCT01210612|584486360|FG001|Overall Study|Withdrawal by Subject|2|||
161848541|NCT02752087|584486361|FG000|Washout|Physician Decision|1|||
161848542|NCT02752087|584486362|FG001|Washout|Physician Decision|0|||
161848543|NCT02458287|584486363|FG000|Overall Study|Adverse Event|0|||
161848544|NCT02458287|584486364|FG001|Overall Study|Adverse Event|0|||
161848545|NCT02458287|584486365|FG002|Overall Study|Adverse Event|0|||
161848546|NCT02458287|584486366|FG003|Overall Study|Adverse Event|1|||
161848547|NCT02458287|584486363|FG000|Overall Study|Lost to Follow-up|0|||
161848548|NCT02458287|584486364|FG001|Overall Study|Lost to Follow-up|1|||
161848549|NCT02458287|584486365|FG002|Overall Study|Lost to Follow-up|1|||
161848550|NCT02458287|584486366|FG003|Overall Study|Lost to Follow-up|0|||
161848551|NCT02458287|584486363|FG000|Overall Study|Protocol Violation|0|||
161848552|NCT02458287|584486364|FG001|Overall Study|Protocol Violation|1|||
161848553|NCT02458287|584486365|FG002|Overall Study|Protocol Violation|0|||
161848554|NCT02458287|584486366|FG003|Overall Study|Protocol Violation|0|||
161848555|NCT02458287|584486363|FG000|Overall Study|Withdrawal by Subject|0|||
161848556|NCT02458287|584486364|FG001|Overall Study|Withdrawal by Subject|2|||
161848557|NCT02458287|584486365|FG002|Overall Study|Withdrawal by Subject|2|||
161848558|NCT02458287|584486366|FG003|Overall Study|Withdrawal by Subject|1|||
161848559|NCT02458287|584486363|FG000|Overall Study|Relocated Out of State|0|||
161848560|NCT02458287|584486364|FG001|Overall Study|Relocated Out of State|0|||
161848561|NCT02458287|584486365|FG002|Overall Study|Relocated Out of State|0|||
161848562|NCT02458287|584486366|FG003|Overall Study|Relocated Out of State|1|||
161848563|NCT00843635|584486367|FG000|Overall Study|Adverse Event|2|||
161848564|NCT00843635|584486368|FG001|Overall Study|Adverse Event|2|||
161848565|NCT00843635|584486369|FG002|Overall Study|Adverse Event|0|||
161848566|NCT00813800|584486372|FG000|Overall Study|Screen Failure after Consent|2|||
161848567|NCT00813800|584486372|FG000|Overall Study|Adverse Event|1|||
161848568|NCT00813800|584486372|FG000|Overall Study|Worsening of depression|2|||
161848569|NCT00813800|584486372|FG000|Overall Study|Physician Decision|1|||
161848570|NCT00418821|584486379|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
161848571|NCT02823652|584486380|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
161848572|NCT02823652|584486381|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
161848573|NCT02823652|584486382|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
161848574|NCT02823652|584486380|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
161848575|NCT02823652|584486381|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
161848576|NCT02823652|584486382|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
161848577|NCT02823652|584486380|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
161848578|NCT02823652|584486381|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
161848579|NCT02823652|584486382|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
161848580|NCT02823652|584486380|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
161848581|NCT02823652|584486381|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
161848582|NCT02823652|584486382|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
161848583|NCT04428333|584486383|FG000|Overall Study|Physician Decision|5|||
161848584|NCT04428333|584486384|FG001|Overall Study|Physician Decision|6|||
161848585|NCT04428333|584486383|FG000|Overall Study|Withdrawal by Subject|1|||
161848586|NCT04428333|584486384|FG001|Overall Study|Withdrawal by Subject|3|||
161848587|NCT04428333|584486383|FG000|Overall Study|Study Terminated By Sponsor|14|||
161848588|NCT04428333|584486384|FG001|Overall Study|Study Terminated By Sponsor|16|||
161848589|NCT04853992|584486385|FG000|Treatment Period A|Adverse Event|0|||
161848590|NCT04853992|584486386|FG001|Treatment Period A|Adverse Event|1|||
161848591|NCT04853992|584486385|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
161848592|NCT04853992|584486386|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
161848593|NCT02269163|584486387|FG000|Overall Study|Lost to Follow-up|1|||
161848594|NCT02269163|584486388|FG001|Overall Study|Lost to Follow-up|0|||
161848595|NCT02269163|584486387|FG000|Overall Study|Major protocol violation|0|||
161848596|NCT02269163|584486388|FG001|Overall Study|Major protocol violation|1|||
161848597|NCT02269163|584486387|FG000|Overall Study|Other|2|||
161971763|NCT01095653|584943424|FG002|Overall Study|Withdrawal by Subject|3|||
161971764|NCT01095653|584943422|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
161971765|NCT01095653|584943423|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
161971766|NCT01095653|584943424|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
161971767|NCT02692040|584943428|FG000|Overall Study|Protocol Violation|0|||
161848598|NCT02269163|584486388|FG001|Overall Study|Other|2|||
161848599|NCT02269163|584486387|FG000|Overall Study|Withdrawal by Subject|0|||
161848600|NCT02269163|584486388|FG001|Overall Study|Withdrawal by Subject|3|||
161848601|NCT02269163|584486387|FG000|Overall Study|Physician Decision|0|||
161848602|NCT02269163|584486388|FG001|Overall Study|Physician Decision|1|||
161848603|NCT02351960|584486389|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
161848604|NCT02351960|584486390|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
161848605|NCT02351960|584486389|FG000|Overall Study|Voluntary Withdrawal|5|||
161848606|NCT02351960|584486390|FG001|Overall Study|Voluntary Withdrawal|4|||
161971768|NCT02692040|584943429|FG001|Overall Study|Protocol Violation|0|||
161971769|NCT02692040|584943430|FG002|Overall Study|Protocol Violation|0|||
161971770|NCT02692040|584943431|FG003|Overall Study|Protocol Violation|0|||
161971771|NCT02692040|584943432|FG004|Overall Study|Protocol Violation|0|||
161971772|NCT02692040|584943433|FG005|Overall Study|Protocol Violation|0|||
161971773|NCT02692040|584943434|FG006|Overall Study|Protocol Violation|0|||
161971774|NCT02692040|584943435|FG007|Overall Study|Protocol Violation|0|||
161971775|NCT02692040|584943436|FG008|Overall Study|Protocol Violation|0|||
161971776|NCT02692040|584943437|FG009|Overall Study|Protocol Violation|0|||
161971777|NCT02692040|584943438|FG010|Overall Study|Protocol Violation|0|||
161971778|NCT02692040|584943439|FG011|Overall Study|Protocol Violation|0|||
161971779|NCT02692040|584943440|FG012|Overall Study|Protocol Violation|1|||
161971780|NCT02692040|584943441|FG013|Overall Study|Protocol Violation|0|||
161971781|NCT02692040|584943442|FG014|Overall Study|Protocol Violation|0|||
161971782|NCT02692040|584943443|FG015|Overall Study|Protocol Violation|0|||
161971783|NCT02692040|584943444|FG016|Overall Study|Protocol Violation|0|||
161971784|NCT02692040|584943428|FG000|Overall Study|Adverse Event|0|||
161971785|NCT02692040|584943429|FG001|Overall Study|Adverse Event|0|||
161971786|NCT02692040|584943430|FG002|Overall Study|Adverse Event|0|||
161971787|NCT02692040|584943431|FG003|Overall Study|Adverse Event|0|||
161971788|NCT02692040|584943432|FG004|Overall Study|Adverse Event|0|||
161971789|NCT02692040|584943433|FG005|Overall Study|Adverse Event|0|||
161971790|NCT02692040|584943434|FG006|Overall Study|Adverse Event|0|||
161971791|NCT02692040|584943435|FG007|Overall Study|Adverse Event|0|||
161971792|NCT02692040|584943436|FG008|Overall Study|Adverse Event|0|||
161971793|NCT02692040|584943437|FG009|Overall Study|Adverse Event|0|||
161971794|NCT02692040|584943438|FG010|Overall Study|Adverse Event|0|||
161971795|NCT02692040|584943439|FG011|Overall Study|Adverse Event|0|||
161971796|NCT02692040|584943440|FG012|Overall Study|Adverse Event|0|||
161971797|NCT02692040|584943441|FG013|Overall Study|Adverse Event|3|||
161971798|NCT02692040|584943442|FG014|Overall Study|Adverse Event|1|||
161971799|NCT02692040|584943443|FG015|Overall Study|Adverse Event|1|||
161971800|NCT02692040|584943444|FG016|Overall Study|Adverse Event|0|||
161971801|NCT00171925|584943445|FG000|Overall Study|Adverse Event|10|||
161971802|NCT00171925|584943446|FG001|Overall Study|Adverse Event|6|||
161971803|NCT00171925|584943445|FG000|Overall Study|Protocol Violation|1|||
161971804|NCT00171925|584943446|FG001|Overall Study|Protocol Violation|1|||
161971805|NCT00171925|584943445|FG000|Overall Study|Withdrawal by Subject|6|||
161971806|NCT00171925|584943446|FG001|Overall Study|Withdrawal by Subject|9|||
161971807|NCT00171925|584943445|FG000|Overall Study|Lost to Follow-up|2|||
161971808|NCT00171925|584943446|FG001|Overall Study|Lost to Follow-up|2|||
161971809|NCT00171925|584943445|FG000|Overall Study|Administrative problems|10|||
161971810|NCT00171925|584943446|FG001|Overall Study|Administrative problems|11|||
161971811|NCT00171925|584943445|FG000|Overall Study|Death|1|||
161971812|NCT00171925|584943446|FG001|Overall Study|Death|2|||
161971813|NCT01819129|584943449|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
161971814|NCT01819129|584943450|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
161971815|NCT01819129|584943449|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
161971816|NCT01819129|584943450|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
161971817|NCT01819129|584943449|FG000|Overall Study|Other, Subject moved out of the country|0|||
161971818|NCT01819129|584943450|FG001|Overall Study|Other, Subject moved out of the country|1|||
161971819|NCT01819129|584943449|FG000|Overall Study|Withdrawal by Subject|15|||
161971820|NCT01819129|584943450|FG001|Overall Study|Withdrawal by Subject|15|||
161971821|NCT01819129|584943449|FG000|Overall Study|Lost to Follow-up|5|||
161971822|NCT01819129|584943450|FG001|Overall Study|Lost to Follow-up|2|||
161848607|NCT02351960|584486389|FG000|Overall Study|Significant Protocol Deviation|0|||
161848608|NCT02351960|584486390|FG001|Overall Study|Significant Protocol Deviation|5|||
161848609|NCT03866902|584486391|FG000|Overall Study|Lost to Follow-up|98|||
161848610|NCT03866902|584486392|FG001|Overall Study|Lost to Follow-up|82|||
161848611|NCT03866902|584486391|FG000|Overall Study|Pregnancy|18|||
161848612|NCT03866902|584486392|FG001|Overall Study|Pregnancy|24|||
161848613|NCT02092467|584486394|FG000|Overall Study|Death|49|||
161848614|NCT02092467|584486395|FG001|Overall Study|Death|66|||
161848615|NCT02092467|584486396|FG002|Overall Study|Death|38|||
161848616|NCT02092467|584486394|FG000|Overall Study|Lost to Follow-up|38|||
161848617|NCT02092467|584486395|FG001|Overall Study|Lost to Follow-up|35|||
161848618|NCT02092467|584486396|FG002|Overall Study|Lost to Follow-up|40|||
161971823|NCT01819129|584943449|FG000|Overall Study|Lack of Efficacy|0|||
161971824|NCT01819129|584943450|FG001|Overall Study|Lack of Efficacy|1|||
161971825|NCT01819129|584943449|FG000|Overall Study|Adverse Event|1|||
161971826|NCT01819129|584943450|FG001|Overall Study|Adverse Event|4|||
161971827|NCT01819129|584943449|FG000|Overall Study|Death|1|||
161971828|NCT01819129|584943450|FG001|Overall Study|Death|1|||
161971829|NCT01819129|584943449|FG000|Overall Study|Withdrawal Criteria|20|||
161971830|NCT01819129|584943450|FG001|Overall Study|Withdrawal Criteria|15|||
161971831|NCT02752958|584943451|FG000|Overall Study|Adverse Event|3|||
161971832|NCT02752958|584943451|FG000|Overall Study|Lost to Follow-up|1|||
161971833|NCT02752958|584943451|FG000|Overall Study|Protocol Violation|1|||
161971834|NCT02752958|584943451|FG000|Overall Study|Withdrawal by Subject|2|||
161848619|NCT02092467|584486394|FG000|Overall Study|Global Deterioration of Health Status|1|||
161848620|NCT02092467|584486395|FG001|Overall Study|Global Deterioration of Health Status|0|||
161971835|NCT02752958|584943451|FG000|Overall Study|Other (Reason not specified)|2|||
161971836|NCT00054691|584943455|FG000|Overall Study|Unmeasurable Disease|2|||
161971837|NCT00054691|584943455|FG000|Overall Study|Noncompliant|1|||
161971838|NCT02142283|584943456|FG000|Overall Study|Death|20|||
161971839|NCT02142283|584943457|FG001|Overall Study|Death|18|||
161971840|NCT02142283|584943456|FG000|Overall Study|Withdrawal by Subject|1|||
161971841|NCT02142283|584943457|FG001|Overall Study|Withdrawal by Subject|3|||
161971842|NCT02460783|584943458|FG000|Overall Study|Withdrawal by Subject|1|||
161971843|NCT02460783|584943459|FG001|Overall Study|Withdrawal by Subject|3|||
161971844|NCT02460783|584943458|FG000|Overall Study|Lost to Follow-up|1|||
161971845|NCT02460783|584943459|FG001|Overall Study|Lost to Follow-up|1|||
161971846|NCT00747344|584943460|FG000|Controlled Period|Adverse Event|3|||
161971847|NCT00747344|584943461|FG001|Controlled Period|Adverse Event|0|||
161971848|NCT00747344|584943462|FG002|Controlled Period|Adverse Event|0|||
161971849|NCT00747344|584943463|FG003|Controlled Period|Adverse Event|0|||
161971850|NCT00747344|584943460|FG000|Controlled Period|Lack of Efficacy|2|||
161971851|NCT00747344|584943461|FG001|Controlled Period|Lack of Efficacy|1|||
161971852|NCT00747344|584943462|FG002|Controlled Period|Lack of Efficacy|0|||
161971853|NCT00747344|584943463|FG003|Controlled Period|Lack of Efficacy|0|||
161971854|NCT00747344|584943460|FG000|Controlled Period|Other|0|||
161971855|NCT00747344|584943461|FG001|Controlled Period|Other|3|||
161971856|NCT00747344|584943462|FG002|Controlled Period|Other|0|||
161971857|NCT00747344|584943463|FG003|Controlled Period|Other|0|||
161971858|NCT00747344|584943460|FG000|After Controlled Period|Adverse Event|0|||
161971859|NCT00747344|584943461|FG001|After Controlled Period|Adverse Event|0|||
161971860|NCT00747344|584943462|FG002|After Controlled Period|Adverse Event|0|||
161763443|NCT03812224|584171779|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
161763444|NCT00303719|584171782|FG000|Overall Study|Not evaluable, prior therapies|0|||
161763445|NCT00303719|584171783|FG001|Overall Study|Not evaluable, prior therapies|30|||
161763446|NCT00303719|584171782|FG000|Overall Study|Lost to Follow-up|0|||
161763447|NCT00303719|584171783|FG001|Overall Study|Lost to Follow-up|7|||
161763448|NCT01641952|584171784|FG000|Overall Study|Lost to Follow-up|28|||
161763449|NCT01641952|584171784|FG000|Overall Study|Adverse Event|6|||
161971861|NCT00747344|584943463|FG003|After Controlled Period|Adverse Event|1|||
161971862|NCT01484834|584943464|FG000|Overall Study|Lost to Follow-up|5|||
161971863|NCT01484834|584943465|FG001|Overall Study|Lost to Follow-up|8|||
161971864|NCT01484834|584943466|FG002|Overall Study|Lost to Follow-up|1|||
161971865|NCT01484834|584943467|FG003|Overall Study|Lost to Follow-up|4|||
161971866|NCT02032407|584945774|FG000|Overall Study|Lost to Follow-up|2|||
161971867|NCT02032407|584945774|FG000|Overall Study|Pregnancy|1|||
161971868|NCT02032407|584945774|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161971869|NCT00428220|584945775|FG000|Overall Study|Participant died|8|||
161971870|NCT00428220|584945775|FG000|Overall Study|Global deterioration of health status|7|||
161971871|NCT00428220|584945775|FG000|Overall Study|Lost to Follow-up|4|||
161971872|NCT00428220|584945775|FG000|Overall Study|Objective progression or relapse|123|||
161971873|NCT00428220|584945775|FG000|Overall Study|Participant refused continued treatment|7|||
161971874|NCT00428220|584945775|FG000|Overall Study|Adverse Event|51|||
161971875|NCT00428220|584945775|FG000|Overall Study|Other|23|||
161971876|NCT00549900|584945776|FG000|Overall Study|Adverse Event|1|||
161971877|NCT03187834|584945780|FG000|Overall Study|Lost to Follow-up|0|||
161971878|NCT03187834|584945781|FG001|Overall Study|Lost to Follow-up|1|||
161971879|NCT03187834|584945782|FG002|Overall Study|Lost to Follow-up|2|||
161971880|NCT03187834|584945783|FG003|Overall Study|Lost to Follow-up|2|||
161971881|NCT03187834|584945780|FG000|Overall Study|Had invalid anthropometric measurements|5|||
161971882|NCT03187834|584945781|FG001|Overall Study|Had invalid anthropometric measurements|3|||
161971883|NCT03187834|584945782|FG002|Overall Study|Had invalid anthropometric measurements|4|||
161971884|NCT03187834|584945783|FG003|Overall Study|Had invalid anthropometric measurements|2|||
161971885|NCT03559699|584945786|FG000|Overall Study|Withdrawal by Subject|6|||
161971886|NCT03559699|584945786|FG000|Overall Study|Lost to Follow-up|1|||
161971887|NCT00031460|584945787|FG000|Overall Study|Lost to Follow-up|0|||
161971888|NCT00031460|584945788|FG001|Overall Study|Lost to Follow-up|1|||
161971889|NCT00031460|584945787|FG000|Overall Study|Withdrawal by Subject|1|||
161971890|NCT00031460|584945788|FG001|Overall Study|Withdrawal by Subject|1|||
161971891|NCT00031460|584945787|FG000|Overall Study|Non-Compliant|1|||
161971892|NCT00031460|584945788|FG001|Overall Study|Non-Compliant|1|||
161971893|NCT00031460|584945787|FG000|Overall Study|Death|0|||
161971894|NCT00031460|584945788|FG001|Overall Study|Death|1|||
161763450|NCT00656136|584171787|FG000|Overall Study|Progressive disease|177|||
161763451|NCT00656136|584171788|FG001|Overall Study|Progressive disease|322|||
161763452|NCT00656136|584171787|FG000|Overall Study|Other Adverse Event|5|||
161763453|NCT00656136|584171788|FG001|Overall Study|Other Adverse Event|51|||
161763454|NCT00656136|584171787|FG000|Overall Study|Protocol Violation|2|||
161763455|NCT00656136|584171788|FG001|Overall Study|Protocol Violation|3|||
161763456|NCT00656136|584171787|FG000|Overall Study|Patient refused to take study medication|7|||
161971895|NCT00031460|584945787|FG000|Overall Study|Reactivation of Disease|5|||
161971896|NCT00031460|584945788|FG001|Overall Study|Reactivation of Disease|9|||
161971897|NCT00031460|584945787|FG000|Overall Study|Disruption of blinded drug supply|2|||
161971898|NCT00031460|584945788|FG001|Overall Study|Disruption of blinded drug supply|0|||
161971899|NCT00031460|584945787|FG000|Overall Study|Confirmed unevaluable|0|||
161971900|NCT00031460|584945788|FG001|Overall Study|Confirmed unevaluable|1|||
161971901|NCT01930890|584945792|FG000|Overall Study|Study Termination|14|||
161971902|NCT01930890|584945793|FG001|Overall Study|Study Termination|28|||
161971903|NCT01930890|584945794|FG002|Overall Study|Study Termination|13|||
161971904|NCT01930890|584945795|FG003|Overall Study|Study Termination|25|||
161848621|NCT02092467|584486396|FG002|Overall Study|Global Deterioration of Health Status|0|||
161848622|NCT02092467|584486394|FG000|Overall Study|Other|32|||
161848623|NCT02092467|584486395|FG001|Overall Study|Other|30|||
161848624|NCT02092467|584486396|FG002|Overall Study|Other|24|||
161848625|NCT02092467|584486394|FG000|Overall Study|Withdrawal by Subject|282|||
161848626|NCT02092467|584486395|FG001|Overall Study|Withdrawal by Subject|327|||
161848627|NCT02092467|584486396|FG002|Overall Study|Withdrawal by Subject|289|||
161848628|NCT02092467|584486394|FG000|Overall Study|Randomized but not treated|2|||
161848629|NCT02092467|584486395|FG001|Overall Study|Randomized but not treated|1|||
161848630|NCT02092467|584486396|FG002|Overall Study|Randomized but not treated|7|||
161848631|NCT01284621|584486397|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161848632|NCT01284621|584486398|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161848633|NCT01284621|584486399|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161848634|NCT01284621|584486400|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161848635|NCT01284621|584486401|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
161848636|NCT01284621|584486402|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161848637|NCT02377427|584486405|FG000|Part A (Up to Week 20)|Physician Decision|1|||
161848638|NCT02377427|584486406|FG001|Part A (Up to Week 20)|Physician Decision|0|||
161848639|NCT02377427|584486407|FG002|Part A (Up to Week 20)|Physician Decision|0|||
161848640|NCT02377427|584486408|FG003|Part A (Up to Week 20)|Physician Decision|0|||
161848641|NCT02377427|584486409|FG004|Part A (Up to Week 20)|Physician Decision|0|||
161848642|NCT02377427|584486405|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
161848643|NCT02377427|584486406|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
161848644|NCT02377427|584486407|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
161848645|NCT02377427|584486408|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
161848646|NCT02377427|584486409|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
161848647|NCT02377427|584486405|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
161848648|NCT02377427|584486406|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
161848649|NCT02377427|584486407|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
161848650|NCT02377427|584486408|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
161848651|NCT02377427|584486409|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
161848652|NCT02377427|584486405|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
161848653|NCT02377427|584486406|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
161848654|NCT02377427|584486407|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
161848655|NCT02377427|584486408|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
161848656|NCT02377427|584486409|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
161848657|NCT02293863|584486410|FG000|Overall Study|Death|4|||
161848658|NCT02293863|584486411|FG001|Overall Study|Death|6|||
161848659|NCT02293863|584486412|FG002|Overall Study|Death|4|||
161848660|NCT02293863|584486410|FG000|Overall Study|Lost to Follow-up|2|||
161848661|NCT02293863|584486411|FG001|Overall Study|Lost to Follow-up|2|||
161848662|NCT02293863|584486412|FG002|Overall Study|Lost to Follow-up|2|||
161848663|NCT02293863|584486410|FG000|Overall Study|Withdrawal by Subject|3|||
161848664|NCT02293863|584486411|FG001|Overall Study|Withdrawal by Subject|3|||
161848665|NCT02293863|584486412|FG002|Overall Study|Withdrawal by Subject|1|||
161848666|NCT02293863|584486410|FG000|Overall Study|Reason Not Specified|0|||
161848667|NCT02293863|584486411|FG001|Overall Study|Reason Not Specified|2|||
161848668|NCT02293863|584486412|FG002|Overall Study|Reason Not Specified|2|||
161848669|NCT03155945|584486413|FG000|Overall Study|Lost to Follow-up|0|||
161848670|NCT03155945|584486414|FG001|Overall Study|Lost to Follow-up|1|||
161848671|NCT03155945|584486413|FG000|Overall Study|Withdrawal by Subject|0|||
161848672|NCT03155945|584486414|FG001|Overall Study|Withdrawal by Subject|1|||
161848673|NCT03155945|584486413|FG000|Overall Study|Other Reason|0|||
161848674|NCT03155945|584486414|FG001|Overall Study|Other Reason|1|||
161971905|NCT01930890|584945792|FG000|Overall Study|Death|0|||
161971906|NCT01930890|584945793|FG001|Overall Study|Death|0|||
161848675|NCT00416884|584486415|FG000|Overall Study|Study terminated due to low accrual|1|||
161848676|NCT03408639|584488670|FG000|Overall Study|Death|5|||
161848677|NCT03408639|584488671|FG001|Overall Study|Death|5|||
161848678|NCT03408639|584488670|FG000|Overall Study|Lost to Follow-up|1|||
161848679|NCT03408639|584488671|FG001|Overall Study|Lost to Follow-up|4|||
161848680|NCT03408639|584488670|FG000|Overall Study|Withdrawal by Subject|2|||
161848681|NCT03408639|584488671|FG001|Overall Study|Withdrawal by Subject|7|||
161848682|NCT03408639|584488670|FG000|Overall Study|Physician Decision|3|||
161848683|NCT03408639|584488671|FG001|Overall Study|Physician Decision|6|||
161848684|NCT00213135|584488681|FG000|Overall Study|Adverse Event|9|||
161848685|NCT00213135|584488682|FG001|Overall Study|Adverse Event|5|||
161971907|NCT01930890|584945794|FG002|Overall Study|Death|0|||
161971908|NCT01930890|584945795|FG003|Overall Study|Death|1|||
161971909|NCT01930890|584945792|FG000|Overall Study|Investigator Decision|0|||
161971910|NCT01930890|584945793|FG001|Overall Study|Investigator Decision|1|||
161971911|NCT01930890|584945794|FG002|Overall Study|Investigator Decision|0|||
161971912|NCT01930890|584945795|FG003|Overall Study|Investigator Decision|0|||
161971913|NCT01930890|584945792|FG000|Overall Study|Consent Withdrawn|0|||
161971914|NCT01930890|584945793|FG001|Overall Study|Consent Withdrawn|3|||
161971915|NCT01930890|584945794|FG002|Overall Study|Consent Withdrawn|0|||
161971916|NCT01930890|584945795|FG003|Overall Study|Consent Withdrawn|1|||
161971917|NCT01930890|584945792|FG000|Overall Study|Adverse Event|0|||
161971918|NCT01930890|584945793|FG001|Overall Study|Adverse Event|1|||
161971919|NCT01930890|584945794|FG002|Overall Study|Adverse Event|0|||
161971920|NCT01930890|584945795|FG003|Overall Study|Adverse Event|0|||
161971921|NCT01176565|584945798|FG000|Overall Study|Lost to Follow-up|12|||
161971922|NCT01176565|584945799|FG001|Overall Study|Lost to Follow-up|16|||
161971923|NCT01176565|584945798|FG000|Overall Study|Withdrawal by Subject|7|||
161971924|NCT01176565|584945799|FG001|Overall Study|Withdrawal by Subject|1|||
161971925|NCT01176565|584945798|FG000|Overall Study|Not Analyzed (any other reason)|1|||
161971926|NCT01176565|584945799|FG001|Overall Study|Not Analyzed (any other reason)|2|||
161971927|NCT02754141|584945800|FG000|Overall Study|Disease progression|11|||
161971928|NCT02754141|584945801|FG001|Overall Study|Disease progression|7|||
161971929|NCT02754141|584945802|FG002|Overall Study|Disease progression|8|||
161971930|NCT02754141|584945803|FG003|Overall Study|Disease progression|5|||
161971931|NCT02754141|584945804|FG004|Overall Study|Disease progression|7|||
161971932|NCT02754141|584945805|FG005|Overall Study|Disease progression|7|||
161971933|NCT02754141|584945806|FG006|Overall Study|Disease progression|7|||
161971934|NCT02754141|584945807|FG007|Overall Study|Disease progression|6|||
161971935|NCT02754141|584945808|FG008|Overall Study|Disease progression|11|||
161971936|NCT02754141|584945809|FG009|Overall Study|Disease progression|16|||
161971937|NCT02754141|584945810|FG010|Overall Study|Disease progression|18|||
161971938|NCT02754141|584945811|FG011|Overall Study|Disease progression|13|||
161971939|NCT02754141|584945812|FG012|Overall Study|Disease progression|10|||
161971940|NCT02754141|584945813|FG013|Overall Study|Disease progression|12|||
161971941|NCT02754141|584945814|FG014|Overall Study|Disease progression|12|||
161971942|NCT02754141|584945815|FG015|Overall Study|Disease progression|14|||
161971943|NCT02754141|584945816|FG016|Overall Study|Disease progression|0|||
161971944|NCT02754141|584945817|FG017|Overall Study|Disease progression|1|||
161971945|NCT02754141|584945800|FG000|Overall Study|Study drug toxicity|1|||
161971946|NCT02754141|584945801|FG001|Overall Study|Study drug toxicity|1|||
161971947|NCT02754141|584945802|FG002|Overall Study|Study drug toxicity|0|||
161971948|NCT02754141|584945803|FG003|Overall Study|Study drug toxicity|0|||
161971949|NCT02754141|584945804|FG004|Overall Study|Study drug toxicity|0|||
161971950|NCT02754141|584945805|FG005|Overall Study|Study drug toxicity|0|||
161971951|NCT02754141|584945806|FG006|Overall Study|Study drug toxicity|0|||
161971952|NCT02754141|584945807|FG007|Overall Study|Study drug toxicity|0|||
161971953|NCT02754141|584945808|FG008|Overall Study|Study drug toxicity|0|||
161971954|NCT02754141|584945809|FG009|Overall Study|Study drug toxicity|0|||
161971955|NCT02754141|584945810|FG010|Overall Study|Study drug toxicity|2|||
161971956|NCT02754141|584945811|FG011|Overall Study|Study drug toxicity|1|||
161971957|NCT02754141|584945812|FG012|Overall Study|Study drug toxicity|1|||
161971958|NCT02754141|584945813|FG013|Overall Study|Study drug toxicity|0|||
162033353|NCT02038829|585180051|FG000|Treatment Period 4|Adverse Event|0|||
162033354|NCT02038829|585180052|FG001|Treatment Period 4|Adverse Event|1|||
162033355|NCT02038829|585180053|FG002|Treatment Period 4|Adverse Event|0|||
161971959|NCT02754141|584945814|FG014|Overall Study|Study drug toxicity|0|||
161971960|NCT02754141|584945815|FG015|Overall Study|Study drug toxicity|0|||
161971961|NCT02754141|584945816|FG016|Overall Study|Study drug toxicity|0|||
161971962|NCT02754141|584945817|FG017|Overall Study|Study drug toxicity|0|||
161971963|NCT02754141|584945800|FG000|Overall Study|AE unrelated to study drug|1|||
161971964|NCT02754141|584945801|FG001|Overall Study|AE unrelated to study drug|1|||
161971965|NCT02754141|584945802|FG002|Overall Study|AE unrelated to study drug|0|||
162033356|NCT02038829|585180054|FG003|Treatment Period 4|Adverse Event|0|||
161971966|NCT02754141|584945803|FG003|Overall Study|AE unrelated to study drug|1|||
161971967|NCT02754141|584945804|FG004|Overall Study|AE unrelated to study drug|3|||
161971968|NCT02754141|584945805|FG005|Overall Study|AE unrelated to study drug|2|||
161971969|NCT02754141|584945806|FG006|Overall Study|AE unrelated to study drug|1|||
161971970|NCT02754141|584945807|FG007|Overall Study|AE unrelated to study drug|0|||
161971971|NCT02754141|584945808|FG008|Overall Study|AE unrelated to study drug|0|||
162033357|NCT02038829|585180055|FG004|Treatment Period 4|Adverse Event|0|||
161971972|NCT02754141|584945809|FG009|Overall Study|AE unrelated to study drug|0|||
161971973|NCT02754141|584945810|FG010|Overall Study|AE unrelated to study drug|0|||
161971974|NCT02754141|584945811|FG011|Overall Study|AE unrelated to study drug|0|||
161971975|NCT02754141|584945812|FG012|Overall Study|AE unrelated to study drug|0|||
161971976|NCT02754141|584945813|FG013|Overall Study|AE unrelated to study drug|0|||
161971977|NCT02754141|584945814|FG014|Overall Study|AE unrelated to study drug|0|||
161971978|NCT02754141|584945815|FG015|Overall Study|AE unrelated to study drug|0|||
161971979|NCT02754141|584945816|FG016|Overall Study|AE unrelated to study drug|0|||
161971980|NCT02754141|584945817|FG017|Overall Study|AE unrelated to study drug|0|||
161971981|NCT02754141|584945800|FG000|Overall Study|Request to discontinue|0|||
161848686|NCT00213135|584488683|FG002|Overall Study|Adverse Event|5|||
161848687|NCT00213135|584488681|FG000|Overall Study|Lost to Follow-up|11|||
161848688|NCT00213135|584488682|FG001|Overall Study|Lost to Follow-up|8|||
161848689|NCT00213135|584488683|FG002|Overall Study|Lost to Follow-up|4|||
161848690|NCT00213135|584488681|FG000|Overall Study|Protocol Violation|4|||
161848691|NCT00213135|584488682|FG001|Overall Study|Protocol Violation|4|||
161848692|NCT00213135|584488683|FG002|Overall Study|Protocol Violation|10|||
161848693|NCT00213135|584488681|FG000|Overall Study|Death|1|||
161848694|NCT00213135|584488682|FG001|Overall Study|Death|1|||
161848695|NCT00213135|584488683|FG002|Overall Study|Death|2|||
161848696|NCT00213135|584488681|FG000|Overall Study|Disease progression|4|||
161848697|NCT00213135|584488682|FG001|Overall Study|Disease progression|5|||
161848698|NCT00213135|584488683|FG002|Overall Study|Disease progression|21|||
161848699|NCT00213135|584488681|FG000|Overall Study|Other|21|||
161848700|NCT00213135|584488682|FG001|Overall Study|Other|12|||
161848701|NCT00213135|584488683|FG002|Overall Study|Other|15|||
161848702|NCT01924754|584488688|FG000|Overall Study|Lost to Follow-up|1|||
161848703|NCT01924754|584488689|FG001|Overall Study|Lost to Follow-up|2|||
161848704|NCT01924754|584488690|FG002|Overall Study|Lost to Follow-up|1|||
161848705|NCT01924754|584488688|FG000|Overall Study|Pregnancy|0|||
161848706|NCT01924754|584488689|FG001|Overall Study|Pregnancy|1|||
161848707|NCT01924754|584488690|FG002|Overall Study|Pregnancy|2|||
161848708|NCT03132155|584488691|FG000|Overall Study|Lack of Efficacy|6|||
161848709|NCT03132155|584488691|FG000|Overall Study|Lost to Follow-up|1|||
161848710|NCT03132155|584488691|FG000|Overall Study|Withdrawal by Subject|1|||
161848711|NCT02925403|584488697|FG000|Overall Study|Lost to Follow-up|0|||
161848712|NCT02925403|584488698|FG001|Overall Study|Lost to Follow-up|1|||
161848713|NCT00402116|584488699|FG000|Overall Study|Jaw infection after surgery-other|1|||
161848714|NCT00402116|584488700|FG001|Overall Study|Jaw infection after surgery-other|0|||
161848715|NCT00402116|584488701|FG002|Overall Study|Jaw infection after surgery-other|0|||
161848716|NCT00402116|584488699|FG000|Overall Study|Withdrawal by Subject|1|||
161848717|NCT00402116|584488700|FG001|Overall Study|Withdrawal by Subject|0|||
161848718|NCT00402116|584488701|FG002|Overall Study|Withdrawal by Subject|5|||
161848719|NCT00402116|584488699|FG000|Overall Study|Treatment completed per protocol|1|||
161848720|NCT00402116|584488700|FG001|Overall Study|Treatment completed per protocol|1|||
161848721|NCT00402116|584488701|FG002|Overall Study|Treatment completed per protocol|2|||
161848722|NCT00402116|584488699|FG000|Overall Study|other complicating disease|0|||
161848723|NCT00402116|584488700|FG001|Overall Study|other complicating disease|0|||
161848724|NCT00402116|584488701|FG002|Overall Study|other complicating disease|2|||
161848725|NCT00402116|584488699|FG000|Overall Study|Disease Progression|0|||
161848726|NCT00402116|584488700|FG001|Overall Study|Disease Progression|4|||
161848727|NCT00402116|584488701|FG002|Overall Study|Disease Progression|38|||
161848728|NCT00402116|584488699|FG000|Overall Study|mistaken thrombocytopenia|0|||
161848729|NCT00402116|584488700|FG001|Overall Study|mistaken thrombocytopenia|0|||
161848730|NCT00402116|584488701|FG002|Overall Study|mistaken thrombocytopenia|1|||
161848731|NCT00402116|584488699|FG000|Overall Study|decline related hyponatremia/tumor|0|||
161848732|NCT00402116|584488700|FG001|Overall Study|decline related hyponatremia/tumor|0|||
161848733|NCT00402116|584488701|FG002|Overall Study|decline related hyponatremia/tumor|1|||
161848734|NCT00402116|584488699|FG000|Overall Study|Adverse Event|0|||
161848735|NCT00402116|584488700|FG001|Overall Study|Adverse Event|1|||
161848736|NCT00402116|584488701|FG002|Overall Study|Adverse Event|6|||
161848737|NCT02899195|584488702|FG000|Concurrent Durvalumab|Adverse Event|4|||
161848738|NCT02899195|584488702|FG000|Concurrent Durvalumab|Physician Decision|1|||
161848739|NCT02899195|584488702|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
161848740|NCT02899195|584488702|FG000|Concurrent Durvalumab|Progressive Disease|5|||
161848741|NCT02899195|584488702|FG000|Maintenance Durvalumab|Adverse Event|1|||
161848742|NCT02899195|584488702|FG000|Maintenance Durvalumab|Physician Decision|1|||
161848743|NCT02899195|584488702|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
161848744|NCT02899195|584488702|FG000|Maintenance Durvalumab|Progressive Disease|31|||
161848745|NCT04778904|584488703|FG000|Overall Study|Protocol Violation|1|||
161848746|NCT04778904|584488704|FG001|Overall Study|Protocol Violation|0|||
161848747|NCT04778904|584488705|FG002|Overall Study|Protocol Violation|0|||
161848748|NCT04778904|584488706|FG003|Overall Study|Protocol Violation|0|||
161848749|NCT04778904|584488703|FG000|Overall Study|Withdrawal by Subject|0|||
161848750|NCT04778904|584488704|FG001|Overall Study|Withdrawal by Subject|0|||
161971982|NCT02754141|584945801|FG001|Overall Study|Request to discontinue|0|||
161971983|NCT02754141|584945802|FG002|Overall Study|Request to discontinue|0|||
161971984|NCT02754141|584945803|FG003|Overall Study|Request to discontinue|0|||
161971985|NCT02754141|584945804|FG004|Overall Study|Request to discontinue|0|||
161848751|NCT04778904|584488705|FG002|Overall Study|Withdrawal by Subject|1|||
161848752|NCT04778904|584488706|FG003|Overall Study|Withdrawal by Subject|0|||
161848753|NCT03452137|584488707|FG000|Overall Study|Death|67|||
161848754|NCT03452137|584488708|FG001|Overall Study|Death|70|||
161848755|NCT03452137|584488707|FG000|Overall Study|Lost to Follow-up|4|||
161848756|NCT03452137|584488708|FG001|Overall Study|Lost to Follow-up|2|||
161848757|NCT03452137|584488707|FG000|Overall Study|Physician Decision|0|||
161848758|NCT03452137|584488708|FG001|Overall Study|Physician Decision|1|||
161971986|NCT02754141|584945805|FG005|Overall Study|Request to discontinue|0|||
161848759|NCT03452137|584488707|FG000|Overall Study|Study Terminated by Sponsor|120|||
161848760|NCT03452137|584488708|FG001|Overall Study|Study Terminated by Sponsor|121|||
161848761|NCT03452137|584488707|FG000|Overall Study|Withdrawal by Subject|12|||
161848762|NCT03452137|584488708|FG001|Overall Study|Withdrawal by Subject|9|||
161848763|NCT04138043|584488709|FG000|Overall Study|Withdrawal by Subject|0|||
161848764|NCT04138043|584488710|FG001|Overall Study|Withdrawal by Subject|1|||
161848765|NCT03772717|584488711|FG000|Overall Study|Withdrawal by Subject|2|||
161848766|NCT02856802|584488712|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
161848767|NCT02856802|584488713|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
161848768|NCT02856802|584488712|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
161848769|NCT02856802|584488713|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
161848770|NCT02856802|584488712|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
161848771|NCT02856802|584488713|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
161848772|NCT02856802|584488712|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
161848773|NCT02856802|584488713|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
161848774|NCT02856802|584488712|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
161848775|NCT02856802|584488713|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
161848776|NCT02856802|584488712|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
161848777|NCT02856802|584488713|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
161848778|NCT00587860|584488714|FG000|Overall Study|Lost to Follow-up|2|||
161848779|NCT00587860|584488715|FG001|Overall Study|Lost to Follow-up|2|||
161848780|NCT00587860|584488714|FG000|Overall Study|Withdrawal by Subject|3|||
161848781|NCT00587860|584488715|FG001|Overall Study|Withdrawal by Subject|3|||
161848782|NCT01659125|584488716|FG000|Overall Study|Withdrawal by Subject|2|||
161848783|NCT01659125|584488716|FG000|Overall Study|Lost to Follow-up|7|||
161848784|NCT01659125|584488716|FG000|Overall Study|Technical Problem|1|||
161848785|NCT01659125|584488716|FG000|Overall Study|Time Constraints|2|||
161848786|NCT01659125|584488716|FG000|Overall Study|Failed to Start Treatment|2|||
161848787|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
161848788|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
161848789|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
161848790|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
161848791|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
161848792|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
161848793|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
161848794|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
161848795|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
161848796|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
161848797|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
161848798|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
161848799|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
161848800|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
161848801|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
161848802|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
161848803|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
161848804|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
161848805|NCT00261443|584488717|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
161848806|NCT00261443|584488718|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
161848807|NCT00261443|584488719|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
161848808|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
161848809|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
161848810|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
161848811|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
161848812|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
161848813|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
161848814|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
161848815|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
161848816|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
161971987|NCT02754141|584945806|FG006|Overall Study|Request to discontinue|0|||
161971988|NCT02754141|584945807|FG007|Overall Study|Request to discontinue|0|||
161848817|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
161848818|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
161848819|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
161848820|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
161848821|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
161848822|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
161848823|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
161971989|NCT02754141|584945808|FG008|Overall Study|Request to discontinue|1|||
161971990|NCT02754141|584945809|FG009|Overall Study|Request to discontinue|0|||
161971991|NCT02754141|584945810|FG010|Overall Study|Request to discontinue|0|||
161971992|NCT02754141|584945811|FG011|Overall Study|Request to discontinue|0|||
161971993|NCT02754141|584945812|FG012|Overall Study|Request to discontinue|0|||
161971994|NCT02754141|584945813|FG013|Overall Study|Request to discontinue|1|||
161971995|NCT02754141|584945814|FG014|Overall Study|Request to discontinue|1|||
161971996|NCT02754141|584945815|FG015|Overall Study|Request to discontinue|0|||
162033358|NCT02038829|585180056|FG005|Treatment Period 4|Adverse Event|0|||
162033359|NCT02038829|585180057|FG006|Treatment Period 4|Adverse Event|0|||
162033360|NCT02038829|585180058|FG007|Treatment Period 4|Adverse Event|0|||
161763457|NCT00656136|584171788|FG001|Overall Study|Patient refused to take study medication|10|||
161763458|NCT00656136|584171787|FG000|Overall Study|Unknown and others|4|||
161763459|NCT00656136|584171788|FG001|Overall Study|Unknown and others|4|||
161763460|NCT03633461|584171798|FG000|Overall Study|Lost to Follow-up|0|||
161763461|NCT03633461|584171799|FG001|Overall Study|Lost to Follow-up|1|||
161763462|NCT02516306|584171806|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
161763463|NCT02516306|584171807|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
161763464|NCT02607865|584171810|FG000|Overall Study|Lost to Follow-up|9|||
161763465|NCT02607865|584171811|FG001|Overall Study|Lost to Follow-up|7|||
161763466|NCT02607865|584171812|FG002|Overall Study|Lost to Follow-up|7|||
161763467|NCT02607865|584171813|FG003|Overall Study|Lost to Follow-up|5|||
161763468|NCT02607865|584171810|FG000|Overall Study|Withdrawal by Subject|18|||
161763469|NCT02607865|584171811|FG001|Overall Study|Withdrawal by Subject|18|||
161763470|NCT02607865|584171812|FG002|Overall Study|Withdrawal by Subject|17|||
161763471|NCT02607865|584171813|FG003|Overall Study|Withdrawal by Subject|8|||
161763472|NCT02607865|584171810|FG000|Overall Study|Death|5|||
161763473|NCT02607865|584171811|FG001|Overall Study|Death|4|||
161763474|NCT02607865|584171812|FG002|Overall Study|Death|1|||
161763475|NCT02607865|584171813|FG003|Overall Study|Death|3|||
161763476|NCT02607865|584171810|FG000|Overall Study|Unclassified|1|||
161763477|NCT02607865|584171811|FG001|Overall Study|Unclassified|1|||
161763478|NCT02607865|584171812|FG002|Overall Study|Unclassified|2|||
161763479|NCT02607865|584171813|FG003|Overall Study|Unclassified|0|||
161763480|NCT03227692|584171814|FG000|Overall Study|Protocol Violation|1|||
161763481|NCT03227692|584171815|FG001|Overall Study|Protocol Violation|1|||
161763482|NCT03227692|584171814|FG000|Overall Study|Lost to Follow-up|4|||
161763483|NCT03227692|584171815|FG001|Overall Study|Lost to Follow-up|2|||
161763484|NCT03227692|584171814|FG000|Overall Study|Adverse Event|0|||
161763485|NCT03227692|584171815|FG001|Overall Study|Adverse Event|2|||
161763486|NCT02447952|584171816|FG000|Overall Study|Adverse Event|2|||
161763487|NCT02447952|584171816|FG000|Overall Study|Physician Decision|1|||
161763488|NCT02447952|584171816|FG000|Overall Study|Withdrawal by Subject|4|||
161763489|NCT01351415|584171820|FG000|Overall Study|Withdrawal by Subject|15|||
161763490|NCT01351415|584171821|FG001|Overall Study|Withdrawal by Subject|17|||
161763491|NCT01351415|584171820|FG000|Overall Study|Trial termination by the Sponsor|28|||
161763492|NCT01351415|584171821|FG001|Overall Study|Trial termination by the Sponsor|19|||
161763493|NCT01351415|584171820|FG000|Overall Study|Lost to Follow-up|5|||
161763494|NCT01351415|584171821|FG001|Overall Study|Lost to Follow-up|7|||
161763495|NCT01351415|584171820|FG000|Overall Study|Death|190|||
161763496|NCT01351415|584171821|FG001|Overall Study|Death|187|||
161763497|NCT01351415|584171820|FG000|Overall Study|Physician Decision|2|||
161763498|NCT01351415|584171821|FG001|Overall Study|Physician Decision|3|||
161763499|NCT01351415|584171820|FG000|Overall Study|Reason unknown|0|||
161763500|NCT01351415|584171821|FG001|Overall Study|Reason unknown|2|||
161763501|NCT01351415|584171820|FG000|Overall Study|Never Started|5|||
161763502|NCT01351415|584171821|FG001|Overall Study|Never Started|5|||
161971997|NCT02754141|584945816|FG016|Overall Study|Request to discontinue|0|||
162033361|NCT02038829|585180059|FG008|Treatment Period 4|Adverse Event|0|||
162033362|NCT02038829|585180060|FG009|Treatment Period 4|Adverse Event|0|||
162033363|NCT02038829|585180061|FG010|Treatment Period 4|Adverse Event|0|||
162033364|NCT02038829|585180062|FG011|Treatment Period 4|Adverse Event|0|||
161763503|NCT00247962|584171822|FG000|Overall Study|Adverse Event|15|||
161971998|NCT02754141|584945817|FG017|Overall Study|Request to discontinue|0|||
161971999|NCT02754141|584945800|FG000|Overall Study|Withdrew consent|0|||
161972000|NCT02754141|584945801|FG001|Overall Study|Withdrew consent|0|||
161972001|NCT02754141|584945802|FG002|Overall Study|Withdrew consent|0|||
161972002|NCT02754141|584945803|FG003|Overall Study|Withdrew consent|0|||
161972003|NCT02754141|584945804|FG004|Overall Study|Withdrew consent|0|||
161972004|NCT02754141|584945805|FG005|Overall Study|Withdrew consent|0|||
162033365|NCT02038829|585180051|FG000|Washout Period 4|Adverse Event|0|||
161763504|NCT00247962|584171823|FG001|Overall Study|Adverse Event|12|||
161763505|NCT00247962|584171822|FG000|Overall Study|Lost to Follow-up|3|||
161848824|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
161972005|NCT02754141|584945806|FG006|Overall Study|Withdrew consent|0|||
161972006|NCT02754141|584945807|FG007|Overall Study|Withdrew consent|0|||
162033366|NCT02038829|585180052|FG001|Washout Period 4|Adverse Event|0|||
161763506|NCT00247962|584171823|FG001|Overall Study|Lost to Follow-up|1|||
161763507|NCT00247962|584171822|FG000|Overall Study|Physician Decision|0|||
161972007|NCT02754141|584945808|FG008|Overall Study|Withdrew consent|0|||
162033367|NCT02038829|585180053|FG002|Washout Period 4|Adverse Event|0|||
161972008|NCT02754141|584945809|FG009|Overall Study|Withdrew consent|1|||
161972009|NCT02754141|584945810|FG010|Overall Study|Withdrew consent|0|||
161972010|NCT02754141|584945811|FG011|Overall Study|Withdrew consent|0|||
161972011|NCT02754141|584945812|FG012|Overall Study|Withdrew consent|0|||
161972012|NCT02754141|584945813|FG013|Overall Study|Withdrew consent|0|||
161972013|NCT02754141|584945814|FG014|Overall Study|Withdrew consent|0|||
161972014|NCT02754141|584945815|FG015|Overall Study|Withdrew consent|0|||
161972015|NCT02754141|584945816|FG016|Overall Study|Withdrew consent|0|||
161763508|NCT00247962|584171823|FG001|Overall Study|Physician Decision|1|||
161763509|NCT00247962|584171822|FG000|Overall Study|Protocol Violation|1|||
161763510|NCT00247962|584171823|FG001|Overall Study|Protocol Violation|1|||
161763511|NCT00247962|584171822|FG000|Overall Study|Withdrawal by Subject|3|||
161763512|NCT00247962|584171823|FG001|Overall Study|Withdrawal by Subject|2|||
161763513|NCT00247962|584171822|FG000|Overall Study|Lack of Efficacy|4|||
161763514|NCT00247962|584171823|FG001|Overall Study|Lack of Efficacy|2|||
161763515|NCT03525613|584171825|FG000|Overall Study|Adverse Event|11|||
161763516|NCT03525613|584171826|FG001|Overall Study|Adverse Event|8|||
161763517|NCT03525613|584171827|FG002|Overall Study|Adverse Event|3|||
161763518|NCT03525613|584171828|FG003|Overall Study|Adverse Event|3|||
161763519|NCT03525613|584171825|FG000|Overall Study|Lost to Follow-up|4|||
161763520|NCT03525613|584171826|FG001|Overall Study|Lost to Follow-up|5|||
161763521|NCT03525613|584171827|FG002|Overall Study|Lost to Follow-up|3|||
161763522|NCT03525613|584171828|FG003|Overall Study|Lost to Follow-up|2|||
161763523|NCT03525613|584171825|FG000|Overall Study|Physician Decision|0|||
161763524|NCT03525613|584171826|FG001|Overall Study|Physician Decision|1|||
161763525|NCT03525613|584171827|FG002|Overall Study|Physician Decision|0|||
161763526|NCT03525613|584171828|FG003|Overall Study|Physician Decision|1|||
161763527|NCT03525613|584171825|FG000|Overall Study|Consent Withdrawal|25|||
161763528|NCT03525613|584171826|FG001|Overall Study|Consent Withdrawal|16|||
161763529|NCT03525613|584171827|FG002|Overall Study|Consent Withdrawal|12|||
161763530|NCT03525613|584171828|FG003|Overall Study|Consent Withdrawal|9|||
161763531|NCT03525613|584171825|FG000|Overall Study|Death|20|||
161763532|NCT03525613|584171826|FG001|Overall Study|Death|9|||
161763533|NCT03525613|584171827|FG002|Overall Study|Death|7|||
161763534|NCT03525613|584171828|FG003|Overall Study|Death|1|||
161763535|NCT03525613|584171825|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
161763536|NCT03525613|584171826|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
161763537|NCT03525613|584171827|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
161763538|NCT03525613|584171828|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
161763539|NCT03480360|584171829|FG000|Overall Study|Death|2|||
161763540|NCT03117309|584171836|FG000|Overall Study|Not meeting inclusion criteria|0|||
161763541|NCT03117309|584171837|FG001|Overall Study|Not meeting inclusion criteria|1|||
161763542|NCT02120469|584171838|FG000|Overall Study|HER-2/neu-amplified|1|||
161763543|NCT02120469|584171839|FG001|Overall Study|HER-2/neu-amplified|0|||
161763544|NCT02120469|584171840|FG002|Overall Study|HER-2/neu-amplified|1|||
161763545|NCT02583711|584171841|FG000|Overall Study|Withdrawal by Subject|0|||
161763546|NCT02583711|584171842|FG001|Overall Study|Withdrawal by Subject|10|||
161763547|NCT02583711|584171843|FG002|Overall Study|Withdrawal by Subject|0|||
161763548|NCT00392210|584171844|FG000|First Voiding Trial|Physician Decision|2|||
161763549|NCT00392210|584171845|FG001|First Voiding Trial|Physician Decision|2|||
161763550|NCT01021423|584171853|FG000|Overall Study|Study terminated|4|||
161763551|NCT01021423|584171854|FG001|Overall Study|Study terminated|5|||
161763552|NCT00122317|584171855|FG000|Overall Study|Death|3|||
161763553|NCT00122317|584171855|FG000|Overall Study|Adverse Event|4|||
161763554|NCT00122317|584171855|FG000|Overall Study|Physician Decision|2|||
161763555|NCT00122317|584171855|FG000|Overall Study|patient non-compliance|1|||
161763556|NCT00122317|584171855|FG000|Overall Study|Withdrawal by Subject|1|||
161763557|NCT03756285|584171856|FG000|Overall Study|Lost to Follow-up|0|||
161763558|NCT03756285|584171857|FG001|Overall Study|Lost to Follow-up|1|||
161763559|NCT03756285|584171856|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
161763560|NCT03756285|584171857|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
161763561|NCT03756285|584171856|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
161763562|NCT03756285|584171857|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
161763563|NCT06334055|584171858|FG000|Overall Study|Adverse Event|4|||
161763564|NCT06334055|584171858|FG000|Overall Study|Disqualified|72|||
161763565|NCT00957034|584171859|FG000|Overall Study|Adverse Event|0|||
161763566|NCT00957034|584171860|FG001|Overall Study|Adverse Event|1|||
161763567|NCT00957034|584171861|FG002|Overall Study|Adverse Event|1|||
161763568|NCT00957034|584171859|FG000|Overall Study|Sponsor Terminated Study|6|||
161763569|NCT00957034|584171860|FG001|Overall Study|Sponsor Terminated Study|1|||
161763570|NCT00957034|584171861|FG002|Overall Study|Sponsor Terminated Study|5|||
161972016|NCT02754141|584945817|FG017|Overall Study|Withdrew consent|0|||
161763571|NCT00957034|584171859|FG000|Overall Study|Withdrawal by Subject|0|||
161763572|NCT00957034|584171860|FG001|Overall Study|Withdrawal by Subject|2|||
161763573|NCT00957034|584171861|FG002|Overall Study|Withdrawal by Subject|0|||
161763574|NCT01503229|584174189|FG000|Overall Study|Withdrew consent|1|||
161848825|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
161848826|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
161848827|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
161848828|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
161848829|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
161848830|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
161848831|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
161848832|NCT00261443|584488717|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
161848833|NCT00261443|584488718|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
161848834|NCT00261443|584488719|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
161848835|NCT00261443|584488717|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
161848836|NCT00261443|584488718|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
161848837|NCT00261443|584488719|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
161848838|NCT00261443|584488717|FG000|3: Assessment of Relapse|Adverse Event|0|||
161848839|NCT00261443|584488718|FG001|3: Assessment of Relapse|Adverse Event|15|||
161848840|NCT00261443|584488719|FG002|3: Assessment of Relapse|Adverse Event|19|||
161848841|NCT00261443|584488717|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
161848842|NCT00261443|584488718|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
161848843|NCT00261443|584488719|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
161848844|NCT00261443|584488717|FG000|3: Assessment of Relapse|Death|0|||
161848845|NCT00261443|584488718|FG001|3: Assessment of Relapse|Death|0|||
161848846|NCT00261443|584488719|FG002|3: Assessment of Relapse|Death|1|||
161848847|NCT00261443|584488717|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
161848848|NCT00261443|584488718|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
161848849|NCT00261443|584488719|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
161848850|NCT00261443|584488717|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
161848851|NCT00261443|584488718|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
161848852|NCT00261443|584488719|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
161848853|NCT00261443|584488717|FG000|3: Assessment of Relapse|Pregnancy|0|||
161848854|NCT00261443|584488718|FG001|3: Assessment of Relapse|Pregnancy|2|||
161848855|NCT00261443|584488719|FG002|3: Assessment of Relapse|Pregnancy|1|||
161848856|NCT00261443|584488717|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
161848857|NCT00261443|584488718|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
161848858|NCT00261443|584488719|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
161848859|NCT00261443|584488717|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
161848860|NCT00261443|584488718|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
161848861|NCT00261443|584488719|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
161848862|NCT00261443|584488717|FG000|3: Assessment of Relapse|Other Reasons|0|||
161848863|NCT00261443|584488718|FG001|3: Assessment of Relapse|Other Reasons|4|||
161848864|NCT00261443|584488719|FG002|3: Assessment of Relapse|Other Reasons|3|||
161848865|NCT00261443|584488717|FG000|4: Extension Phase|Adverse Event|0|||
161848866|NCT00261443|584488718|FG001|4: Extension Phase|Adverse Event|1|||
161848867|NCT00261443|584488719|FG002|4: Extension Phase|Adverse Event|0|||
161848868|NCT00261443|584488717|FG000|4: Extension Phase|Withdrawal by Subject|0|||
161848869|NCT00261443|584488718|FG001|4: Extension Phase|Withdrawal by Subject|1|||
161848870|NCT00261443|584488719|FG002|4: Extension Phase|Withdrawal by Subject|2|||
161848871|NCT00261443|584488717|FG000|4: Extension Phase|Lost to Follow-up|0|||
161848872|NCT00261443|584488718|FG001|4: Extension Phase|Lost to Follow-up|1|||
161848873|NCT00261443|584488719|FG002|4: Extension Phase|Lost to Follow-up|0|||
161848874|NCT02755649|584488720|FG000|Overall Study|Transitioned into OLE study|99|||
161848875|NCT02755649|584488721|FG001|Overall Study|Transitioned into OLE study|98|||
161848876|NCT02755649|584488722|FG002|Overall Study|Transitioned into OLE study|100|||
161848877|NCT02755649|584488720|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
161848878|NCT02755649|584488721|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
161848879|NCT02755649|584488722|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
161848880|NCT02755649|584488720|FG000|Overall Study|Physician Decision|0|||
161848881|NCT02755649|584488721|FG001|Overall Study|Physician Decision|0|||
161848882|NCT02755649|584488722|FG002|Overall Study|Physician Decision|2|||
161848883|NCT02755649|584488720|FG000|Overall Study|Withdrawal by Subject|0|||
161848884|NCT02755649|584488721|FG001|Overall Study|Withdrawal by Subject|1|||
161848885|NCT02755649|584488722|FG002|Overall Study|Withdrawal by Subject|0|||
161848886|NCT02755649|584488720|FG000|Overall Study|Undecided|1|||
161848887|NCT02755649|584488721|FG001|Overall Study|Undecided|0|||
161848888|NCT02755649|584488722|FG002|Overall Study|Undecided|0|||
161848889|NCT01286753|584488723|FG000|Overall Study|Adverse Event|7|||
161848890|NCT01286753|584488724|FG001|Overall Study|Adverse Event|6|||
161848891|NCT01286753|584488723|FG000|Overall Study|Progression|11|||
161848892|NCT01286753|584488724|FG001|Overall Study|Progression|13|||
161848893|NCT01286753|584488723|FG000|Overall Study|Refused Treatment|1|||
161848894|NCT01286753|584488724|FG001|Overall Study|Refused Treatment|0|||
161848895|NCT01286753|584488723|FG000|Overall Study|Withdrawal of Consent|0|||
161848896|NCT01286753|584488724|FG001|Overall Study|Withdrawal of Consent|2|||
161972017|NCT02754141|584945800|FG000|Overall Study|Maximum clinical benefit|0|||
161972018|NCT02754141|584945801|FG001|Overall Study|Maximum clinical benefit|0|||
161763575|NCT01354964|584174190|FG000|Overall Study|Lost to Follow-up|2|||
161763576|NCT01354964|584174191|FG001|Overall Study|Lost to Follow-up|0|||
161763577|NCT01354964|584174190|FG000|Overall Study|IV access issues|1|||
161763578|NCT01354964|584174191|FG001|Overall Study|IV access issues|1|||
161763579|NCT01354964|584174190|FG000|Overall Study|Physician Decision|1|||
161763580|NCT01354964|584174191|FG001|Overall Study|Physician Decision|0|||
161763581|NCT00711009|584174192|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
161763582|NCT00711009|584174193|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
161763583|NCT00711009|584174192|FG000|Overall Study|Withdrawal by Subject|4|||
161763584|NCT00711009|584174193|FG001|Overall Study|Withdrawal by Subject|2|||
161763585|NCT00711009|584174192|FG000|Overall Study|Lost to Follow-up|3|||
161763586|NCT00711009|584174193|FG001|Overall Study|Lost to Follow-up|9|||
161763587|NCT00711009|584174192|FG000|Overall Study|Participant Noncompliant|0|||
161763588|NCT00711009|584174193|FG001|Overall Study|Participant Noncompliant|1|||
161763589|NCT00711009|584174192|FG000|Overall Study|Virologic Failure|2|||
161763590|NCT00711009|584174193|FG001|Overall Study|Virologic Failure|1|||
161763591|NCT00711009|584174192|FG000|Overall Study|Pregnancy|1|||
161763592|NCT00711009|584174193|FG001|Overall Study|Pregnancy|0|||
161763593|NCT00711009|584174192|FG000|Overall Study|Site closing|0|||
161763594|NCT00711009|584174193|FG001|Overall Study|Site closing|1|||
161763595|NCT00711009|584174192|FG000|Overall Study|Dose adjustment|1|||
161763596|NCT00711009|584174193|FG001|Overall Study|Dose adjustment|0|||
161763597|NCT02534324|584174194|FG000|Overall Study|Protocol Violation|4|||
161763598|NCT02534324|584174195|FG001|Overall Study|Protocol Violation|1|||
161763599|NCT02534324|584174194|FG000|Overall Study|Lost to Follow-up|20|||
161763600|NCT02534324|584174195|FG001|Overall Study|Lost to Follow-up|7|||
161763601|NCT02534324|584174194|FG000|Overall Study|Adverse Event|1|||
161763602|NCT02534324|584174195|FG001|Overall Study|Adverse Event|0|||
161763603|NCT05604781|584174196|FG000|Overall Study|Lost to Follow-up|3|||
161763604|NCT05604781|584174196|FG000|Overall Study|Adverse Event|1|||
161763605|NCT01459016|584174197|FG000|Overall Study|Withdrawal by Subject|11|||
161763606|NCT01459016|584174197|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
161763607|NCT02889861|584174198|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
161763608|NCT00959192|584174206|FG000|Overall Study|Adverse Event|1|||
161763609|NCT00959192|584174207|FG001|Overall Study|Adverse Event|1|||
161763610|NCT00959192|584174208|FG002|Overall Study|Adverse Event|1|||
161763611|NCT00959192|584174209|FG003|Overall Study|Adverse Event|0|||
161763612|NCT00959192|584174206|FG000|Overall Study|Investigator Request|1|||
161763613|NCT00959192|584174207|FG001|Overall Study|Investigator Request|0|||
161763614|NCT00959192|584174208|FG002|Overall Study|Investigator Request|0|||
161763615|NCT00959192|584174209|FG003|Overall Study|Investigator Request|0|||
161763616|NCT00959192|584174206|FG000|Overall Study|Caregiver Request|0|||
161763617|NCT00959192|584174207|FG001|Overall Study|Caregiver Request|0|||
161763618|NCT00959192|584174208|FG002|Overall Study|Caregiver Request|2|||
161763619|NCT00959192|584174209|FG003|Overall Study|Caregiver Request|1|||
161763620|NCT02194699|584174210|FG000|Randomised|Did not receive treatment|1|||
161763621|NCT02194699|584174211|FG001|Randomised|Did not receive treatment|5|||
161763622|NCT02194699|584174210|FG000|Randomised|Without potential for 52 weeks of IP|5|||
161763623|NCT02194699|584174211|FG001|Randomised|Without potential for 52 weeks of IP|5|||
161763624|NCT02194699|584174210|FG000|Randomised|Duplicate patient|2|||
161763625|NCT02194699|584174211|FG001|Randomised|Duplicate patient|1|||
161763626|NCT02194699|584174210|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
161763627|NCT02194699|584174211|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
161763628|NCT02194699|584174210|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
161763629|NCT02194699|584174211|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
161763630|NCT02194699|584174210|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
161763631|NCT02194699|584174211|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
161763632|NCT02194699|584174210|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
161763633|NCT02194699|584174211|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
161763634|NCT02194699|584174210|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
161763635|NCT02194699|584174211|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
161763636|NCT02194699|584174210|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
161763637|NCT02194699|584174211|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
161763638|NCT01667731|584174213|FG000|Overall Study|Enrolled but not treated|0|||
161763639|NCT01667731|584174214|FG001|Overall Study|Enrolled but not treated|0|||
161763640|NCT01667731|584174215|FG002|Overall Study|Enrolled but not treated|0|||
161763641|NCT01667731|584174216|FG003|Overall Study|Enrolled but not treated|0|||
161763642|NCT01667731|584174217|FG004|Overall Study|Enrolled but not treated|1|||
161763643|NCT01667731|584174213|FG000|Overall Study|Efficacy Failure|1|||
161763644|NCT01667731|584174214|FG001|Overall Study|Efficacy Failure|12|||
161763645|NCT01667731|584174215|FG002|Overall Study|Efficacy Failure|0|||
161763646|NCT01667731|584174216|FG003|Overall Study|Efficacy Failure|1|||
161763647|NCT01667731|584174217|FG004|Overall Study|Efficacy Failure|24|||
161763648|NCT01667731|584174213|FG000|Overall Study|Lost to Follow-up|2|||
161848897|NCT01286753|584488723|FG000|Overall Study|Discontinued to Join Extension Study|6|||
161848898|NCT01286753|584488724|FG001|Overall Study|Discontinued to Join Extension Study|4|||
161848899|NCT01286753|584488723|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
161848900|NCT01286753|584488724|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
161848901|NCT02126826|584488728|FG000|Overall Study|Withdrawal by Subject|0|||
161848902|NCT02126826|584488729|FG001|Overall Study|Withdrawal by Subject|0|||
161848903|NCT02126826|584488730|FG002|Overall Study|Withdrawal by Subject|0|||
161848904|NCT02126826|584488731|FG003|Overall Study|Withdrawal by Subject|1|||
161848905|NCT02126826|584488732|FG004|Overall Study|Withdrawal by Subject|0|||
161848906|NCT02126826|584488733|FG005|Overall Study|Withdrawal by Subject|0|||
161848907|NCT02126826|584488734|FG006|Overall Study|Withdrawal by Subject|0|||
161848908|NCT00887289|584488735|FG000|Overall Study|Lack of Efficacy|14|||
161848909|NCT00887289|584488735|FG000|Overall Study|Adverse Event|27|||
161848910|NCT00887289|584488735|FG000|Overall Study|Withdrawal by Subject|26|||
161848911|NCT00887289|584488735|FG000|Overall Study|Lost to Follow-up|8|||
161848912|NCT00887289|584488735|FG000|Overall Study|Other|20|||
161848913|NCT00591773|584488736|FG000|Overall Study|Adverse Event|9|||
161848914|NCT00591773|584488737|FG001|Overall Study|Adverse Event|9|||
161848915|NCT00591773|584488738|FG002|Overall Study|Adverse Event|6|||
161848916|NCT00591773|584488736|FG000|Overall Study|Protocol Violation|2|||
161848917|NCT00591773|584488737|FG001|Overall Study|Protocol Violation|3|||
161848918|NCT00591773|584488738|FG002|Overall Study|Protocol Violation|0|||
161848919|NCT00591773|584488736|FG000|Overall Study|Lost to Follow-up|1|||
161848920|NCT00591773|584488737|FG001|Overall Study|Lost to Follow-up|4|||
161848921|NCT00591773|584488738|FG002|Overall Study|Lost to Follow-up|1|||
161848922|NCT00591773|584488736|FG000|Overall Study|Withdrawal by Subject|2|||
161848923|NCT00591773|584488737|FG001|Overall Study|Withdrawal by Subject|5|||
161848924|NCT00591773|584488738|FG002|Overall Study|Withdrawal by Subject|3|||
161848925|NCT00591773|584488736|FG000|Overall Study|Lack of Efficacy|1|||
161848926|NCT00591773|584488737|FG001|Overall Study|Lack of Efficacy|2|||
161848927|NCT00591773|584488738|FG002|Overall Study|Lack of Efficacy|2|||
161848928|NCT00591773|584488736|FG000|Overall Study|Other|1|||
161848929|NCT00591773|584488737|FG001|Overall Study|Other|1|||
161848930|NCT00591773|584488738|FG002|Overall Study|Other|4|||
161848931|NCT02135614|584488739|FG000|Overall Study|Randomized but Not Treated|2|||
161848932|NCT02135614|584488740|FG001|Overall Study|Randomized but Not Treated|1|||
161848933|NCT02135614|584488739|FG000|Overall Study|Adverse Event|0|||
161848934|NCT02135614|584488740|FG001|Overall Study|Adverse Event|1|||
161848935|NCT02135614|584488739|FG000|Overall Study|Death|1|||
161848936|NCT02135614|584488740|FG001|Overall Study|Death|0|||
161848937|NCT02135614|584488739|FG000|Overall Study|Investigator's Discretion|0|||
161848938|NCT02135614|584488740|FG001|Overall Study|Investigator's Discretion|1|||
161848939|NCT02135614|584488739|FG000|Overall Study|Withdrew Consent|2|||
161848940|NCT02135614|584488740|FG001|Overall Study|Withdrew Consent|2|||
161848941|NCT02135614|584488739|FG000|Overall Study|Lost to Follow-up|3|||
161848942|NCT02135614|584488740|FG001|Overall Study|Lost to Follow-up|0|||
161848943|NCT03022084|584488741|FG000|Overall Study|Lost to Follow-up|2|||
161848944|NCT03022084|584488742|FG001|Overall Study|Lost to Follow-up|3|||
161848945|NCT00554606|584488744|FG000|Overall Study|Adverse Event|3|||
161848946|NCT00554606|584488744|FG000|Overall Study|Abnormal laboratory values|1|||
161848947|NCT00554606|584488744|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
161848948|NCT00554606|584488744|FG000|Overall Study|Subject withdrew consent|2|||
161848949|NCT00554606|584488744|FG000|Overall Study|Lost to Follow-up|2|||
161848950|NCT00554606|584488744|FG000|Overall Study|Administrative problems|60|||
162033368|NCT02038829|585180054|FG003|Washout Period 4|Adverse Event|0|||
162033369|NCT02038829|585180055|FG004|Washout Period 4|Adverse Event|0|||
162033370|NCT02038829|585180056|FG005|Washout Period 4|Adverse Event|0|||
162033371|NCT02038829|585180057|FG006|Washout Period 4|Adverse Event|1|||
161848951|NCT00554606|584488744|FG000|Overall Study|Death|1|||
161848952|NCT00554606|584488744|FG000|Overall Study|Protocol deviation|2|||
161848953|NCT00605540|584488745|FG000|Overall Study|Death|15|||
161848954|NCT00605540|584488745|FG000|Overall Study|Lost to Follow-up|23|||
161848955|NCT00509366|584488746|FG000|Overall Study|Not Treated (Screen Failure)|1|||
161848956|NCT00509366|584488747|FG001|Overall Study|Not Treated (Screen Failure)|1|||
162033372|NCT02038829|585180058|FG007|Washout Period 4|Adverse Event|0|||
162033373|NCT02038829|585180059|FG008|Washout Period 4|Adverse Event|0|||
161848957|NCT00509366|584488748|FG002|Overall Study|Not Treated (Screen Failure)|1|||
161848958|NCT00509366|584488749|FG003|Overall Study|Not Treated (Screen Failure)|0|||
161848959|NCT00509366|584488750|FG004|Overall Study|Not Treated (Screen Failure)|0|||
161848960|NCT02119819|584488753|FG000|Overall Study|Adverse Event|3|||
161848961|NCT02119819|584488754|FG001|Overall Study|Adverse Event|1|||
161848962|NCT02119819|584488755|FG002|Overall Study|Adverse Event|2|||
161848963|NCT02119819|584488756|FG003|Overall Study|Adverse Event|3|||
161848964|NCT02119819|584488757|FG004|Overall Study|Adverse Event|0|||
161848965|NCT02119819|584488758|FG005|Overall Study|Adverse Event|1|||
162033374|NCT02038829|585180060|FG009|Washout Period 4|Adverse Event|0|||
161848966|NCT02119819|584488753|FG000|Overall Study|Lack of Efficacy|0|||
161848967|NCT02119819|584488754|FG001|Overall Study|Lack of Efficacy|0|||
162033375|NCT02038829|585180061|FG010|Washout Period 4|Adverse Event|0|||
161972019|NCT02754141|584945802|FG002|Overall Study|Maximum clinical benefit|0|||
161972020|NCT02754141|584945803|FG003|Overall Study|Maximum clinical benefit|1|||
161972021|NCT02754141|584945804|FG004|Overall Study|Maximum clinical benefit|0|||
161972022|NCT02754141|584945805|FG005|Overall Study|Maximum clinical benefit|0|||
161972023|NCT02754141|584945806|FG006|Overall Study|Maximum clinical benefit|0|||
161972024|NCT02754141|584945807|FG007|Overall Study|Maximum clinical benefit|0|||
161972025|NCT02754141|584945808|FG008|Overall Study|Maximum clinical benefit|0|||
161972026|NCT02754141|584945809|FG009|Overall Study|Maximum clinical benefit|0|||
161972027|NCT02754141|584945810|FG010|Overall Study|Maximum clinical benefit|0|||
161972028|NCT02754141|584945811|FG011|Overall Study|Maximum clinical benefit|0|||
161972029|NCT02754141|584945812|FG012|Overall Study|Maximum clinical benefit|0|||
161972030|NCT02754141|584945813|FG013|Overall Study|Maximum clinical benefit|0|||
161972031|NCT02754141|584945814|FG014|Overall Study|Maximum clinical benefit|0|||
161972032|NCT02754141|584945815|FG015|Overall Study|Maximum clinical benefit|0|||
161972033|NCT02754141|584945816|FG016|Overall Study|Maximum clinical benefit|0|||
161972034|NCT02754141|584945817|FG017|Overall Study|Maximum clinical benefit|0|||
161972035|NCT02754141|584945800|FG000|Overall Study|No longer meets study criteria|0|||
161972036|NCT02754141|584945801|FG001|Overall Study|No longer meets study criteria|0|||
161972037|NCT02754141|584945802|FG002|Overall Study|No longer meets study criteria|0|||
161972038|NCT02754141|584945803|FG003|Overall Study|No longer meets study criteria|1|||
161972039|NCT02754141|584945804|FG004|Overall Study|No longer meets study criteria|0|||
161972040|NCT02754141|584945805|FG005|Overall Study|No longer meets study criteria|0|||
161972041|NCT02754141|584945806|FG006|Overall Study|No longer meets study criteria|0|||
161972042|NCT02754141|584945807|FG007|Overall Study|No longer meets study criteria|0|||
161972043|NCT02754141|584945808|FG008|Overall Study|No longer meets study criteria|0|||
161972044|NCT02754141|584945809|FG009|Overall Study|No longer meets study criteria|0|||
161972045|NCT02754141|584945810|FG010|Overall Study|No longer meets study criteria|0|||
161972046|NCT02754141|584945811|FG011|Overall Study|No longer meets study criteria|0|||
161972047|NCT02754141|584945812|FG012|Overall Study|No longer meets study criteria|0|||
161972048|NCT02754141|584945813|FG013|Overall Study|No longer meets study criteria|0|||
161972049|NCT02754141|584945814|FG014|Overall Study|No longer meets study criteria|0|||
161972050|NCT02754141|584945815|FG015|Overall Study|No longer meets study criteria|0|||
161972051|NCT02754141|584945816|FG016|Overall Study|No longer meets study criteria|0|||
161972052|NCT02754141|584945817|FG017|Overall Study|No longer meets study criteria|0|||
161972053|NCT02754141|584945800|FG000|Overall Study|Other reasons|0|||
161972054|NCT02754141|584945801|FG001|Overall Study|Other reasons|0|||
161972055|NCT02754141|584945802|FG002|Overall Study|Other reasons|0|||
161972056|NCT02754141|584945803|FG003|Overall Study|Other reasons|0|||
161972057|NCT02754141|584945804|FG004|Overall Study|Other reasons|0|||
161972058|NCT02754141|584945805|FG005|Overall Study|Other reasons|0|||
161972059|NCT02754141|584945806|FG006|Overall Study|Other reasons|0|||
161972060|NCT02754141|584945807|FG007|Overall Study|Other reasons|1|||
161972061|NCT02754141|584945808|FG008|Overall Study|Other reasons|0|||
161972062|NCT02754141|584945809|FG009|Overall Study|Other reasons|0|||
161972063|NCT02754141|584945810|FG010|Overall Study|Other reasons|0|||
161972064|NCT02754141|584945811|FG011|Overall Study|Other reasons|0|||
161972065|NCT02754141|584945812|FG012|Overall Study|Other reasons|2|||
161972066|NCT02754141|584945813|FG013|Overall Study|Other reasons|0|||
161972067|NCT02754141|584945814|FG014|Overall Study|Other reasons|0|||
161972068|NCT02754141|584945815|FG015|Overall Study|Other reasons|0|||
161972069|NCT02754141|584945816|FG016|Overall Study|Other reasons|0|||
161972070|NCT02754141|584945817|FG017|Overall Study|Other reasons|0|||
161972071|NCT02754141|584945800|FG000|Overall Study|Completed treatment as per protocol|0|||
161972072|NCT02754141|584945801|FG001|Overall Study|Completed treatment as per protocol|1|||
161972073|NCT02754141|584945802|FG002|Overall Study|Completed treatment as per protocol|0|||
161972074|NCT02754141|584945803|FG003|Overall Study|Completed treatment as per protocol|0|||
161972075|NCT02754141|584945804|FG004|Overall Study|Completed treatment as per protocol|0|||
161972076|NCT02754141|584945805|FG005|Overall Study|Completed treatment as per protocol|0|||
161972077|NCT02754141|584945806|FG006|Overall Study|Completed treatment as per protocol|0|||
161972078|NCT02754141|584945807|FG007|Overall Study|Completed treatment as per protocol|0|||
162033376|NCT02038829|585180062|FG011|Washout Period 4|Adverse Event|0|||
162033377|NCT02038829|585180051|FG000|Treatment Period 6|Adverse Event|0|||
161848968|NCT02119819|584488755|FG002|Overall Study|Lack of Efficacy|0|||
161972079|NCT02754141|584945808|FG008|Overall Study|Completed treatment as per protocol|0|||
161972080|NCT02754141|584945809|FG009|Overall Study|Completed treatment as per protocol|0|||
161972081|NCT02754141|584945810|FG010|Overall Study|Completed treatment as per protocol|0|||
161972082|NCT02754141|584945811|FG011|Overall Study|Completed treatment as per protocol|0|||
161972083|NCT02754141|584945812|FG012|Overall Study|Completed treatment as per protocol|1|||
161972084|NCT02754141|584945813|FG013|Overall Study|Completed treatment as per protocol|0|||
161972085|NCT02754141|584945814|FG014|Overall Study|Completed treatment as per protocol|0|||
161972086|NCT02754141|584945815|FG015|Overall Study|Completed treatment as per protocol|0|||
161972087|NCT02754141|584945816|FG016|Overall Study|Completed treatment as per protocol|0|||
161972088|NCT02754141|584945817|FG017|Overall Study|Completed treatment as per protocol|0|||
161972089|NCT02754141|584945800|FG000|Overall Study|Not completing monotherapy|0|||
161848969|NCT02119819|584488756|FG003|Overall Study|Lack of Efficacy|0|||
161848970|NCT02119819|584488757|FG004|Overall Study|Lack of Efficacy|0|||
161848971|NCT02119819|584488758|FG005|Overall Study|Lack of Efficacy|1|||
161848972|NCT02119819|584488753|FG000|Overall Study|Lost to Follow-up|0|||
161848973|NCT02119819|584488754|FG001|Overall Study|Lost to Follow-up|0|||
161848974|NCT02119819|584488755|FG002|Overall Study|Lost to Follow-up|1|||
161848975|NCT02119819|584488756|FG003|Overall Study|Lost to Follow-up|2|||
161848976|NCT02119819|584488757|FG004|Overall Study|Lost to Follow-up|1|||
161848977|NCT02119819|584488758|FG005|Overall Study|Lost to Follow-up|2|||
161972090|NCT02754141|584945801|FG001|Overall Study|Not completing monotherapy|0|||
161972091|NCT02754141|584945802|FG002|Overall Study|Not completing monotherapy|0|||
161972092|NCT02754141|584945803|FG003|Overall Study|Not completing monotherapy|0|||
161972093|NCT02754141|584945804|FG004|Overall Study|Not completing monotherapy|0|||
161972094|NCT02754141|584945805|FG005|Overall Study|Not completing monotherapy|0|||
161972095|NCT02754141|584945806|FG006|Overall Study|Not completing monotherapy|0|||
161972096|NCT02754141|584945807|FG007|Overall Study|Not completing monotherapy|0|||
161972097|NCT02754141|584945808|FG008|Overall Study|Not completing monotherapy|0|||
161972098|NCT02754141|584945809|FG009|Overall Study|Not completing monotherapy|0|||
161972099|NCT02754141|584945810|FG010|Overall Study|Not completing monotherapy|0|||
161972100|NCT02754141|584945811|FG011|Overall Study|Not completing monotherapy|0|||
161972101|NCT02754141|584945812|FG012|Overall Study|Not completing monotherapy|0|||
161972102|NCT02754141|584945813|FG013|Overall Study|Not completing monotherapy|1|||
161972103|NCT02754141|584945814|FG014|Overall Study|Not completing monotherapy|0|||
161972104|NCT02754141|584945815|FG015|Overall Study|Not completing monotherapy|0|||
161972105|NCT02754141|584945816|FG016|Overall Study|Not completing monotherapy|0|||
161972106|NCT02754141|584945817|FG017|Overall Study|Not completing monotherapy|0|||
161972107|NCT02680041|584945821|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
161972108|NCT02680041|584945821|FG000|Overall Study|Lost to Follow-up|2|||
161972109|NCT01344538|584945822|FG000|Overall Study|Adverse Event|1|||
161972110|NCT01344538|584945823|FG001|Overall Study|Adverse Event|1|||
161763649|NCT01667731|584174214|FG001|Overall Study|Lost to Follow-up|3|||
161763650|NCT01667731|584174215|FG002|Overall Study|Lost to Follow-up|1|||
161763651|NCT01667731|584174216|FG003|Overall Study|Lost to Follow-up|1|||
161763652|NCT01667731|584174217|FG004|Overall Study|Lost to Follow-up|2|||
161763653|NCT01667731|584174213|FG000|Overall Study|Subject Withdrew Consent|2|||
161763654|NCT01667731|584174214|FG001|Overall Study|Subject Withdrew Consent|0|||
161763655|NCT01667731|584174215|FG002|Overall Study|Subject Withdrew Consent|1|||
161763656|NCT01667731|584174216|FG003|Overall Study|Subject Withdrew Consent|0|||
161763657|NCT01667731|584174217|FG004|Overall Study|Subject Withdrew Consent|1|||
161763658|NCT01667731|584174213|FG000|Overall Study|Death|0|||
161763659|NCT01667731|584174214|FG001|Overall Study|Death|1|||
161763660|NCT01667731|584174215|FG002|Overall Study|Death|0|||
161763661|NCT01667731|584174216|FG003|Overall Study|Death|0|||
161763662|NCT01667731|584174217|FG004|Overall Study|Death|0|||
161763663|NCT02516605|584174226|FG000|Overall Study|Protocol Violation|0|||
161763664|NCT02516605|584174227|FG001|Overall Study|Protocol Violation|0|||
161763665|NCT02516605|584174228|FG002|Overall Study|Protocol Violation|0|||
161763666|NCT02516605|584174229|FG003|Overall Study|Protocol Violation|0|||
161763667|NCT02516605|584174230|FG004|Overall Study|Protocol Violation|1|||
161763668|NCT02516605|584174226|FG000|Overall Study|Withdrawal by Subject|0|||
161763669|NCT02516605|584174227|FG001|Overall Study|Withdrawal by Subject|0|||
161763670|NCT02516605|584174228|FG002|Overall Study|Withdrawal by Subject|0|||
161763671|NCT02516605|584174229|FG003|Overall Study|Withdrawal by Subject|1|||
161763672|NCT02516605|584174230|FG004|Overall Study|Withdrawal by Subject|0|||
161763673|NCT02643420|584174231|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
161763674|NCT02643420|584174232|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
161763675|NCT02643420|584174231|FG000|Overall Study|Withdrawal by Subject|25|||
161763676|NCT02643420|584174232|FG001|Overall Study|Withdrawal by Subject|19|||
161763677|NCT02643420|584174231|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
161763678|NCT02643420|584174232|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
161763679|NCT02643420|584174231|FG000|Overall Study|Lost to Follow-up|6|||
161848978|NCT02119819|584488753|FG000|Overall Study|Physician Decision|1|||
161848979|NCT02119819|584488754|FG001|Overall Study|Physician Decision|1|||
161972111|NCT01344538|584945822|FG000|Overall Study|Lost to Follow-up|1|||
161972112|NCT01344538|584945823|FG001|Overall Study|Lost to Follow-up|0|||
161972113|NCT01655381|584945824|FG000|Overall Study|Investigator Decision|1|||
161972114|NCT01655381|584945824|FG000|Overall Study|Moved to Another City|1|||
161763680|NCT02643420|584174232|FG001|Overall Study|Lost to Follow-up|10|||
161848980|NCT02119819|584488755|FG002|Overall Study|Physician Decision|0|||
161972115|NCT01655381|584945824|FG000|Overall Study|Insufficient Treatment Response|1|||
161972116|NCT02324205|584945825|FG000|Overall Study|Withdrawal by Subject|37|||
161972117|NCT04195438|584945826|FG000|Overall Study|Withdrawal by Subject|1|||
161972118|NCT01156389|584945827|FG000|Overall Study|Elevated liver enzymes|4|||
162033378|NCT02038829|585180052|FG001|Treatment Period 6|Adverse Event|0|||
161763681|NCT02643420|584174231|FG000|Overall Study|Investigator Decision|2|||
161763682|NCT02643420|584174232|FG001|Overall Study|Investigator Decision|4|||
161763683|NCT02643420|584174231|FG000|Overall Study|Sponsor decision|1|||
162033379|NCT02038829|585180053|FG002|Treatment Period 6|Adverse Event|1|||
162033380|NCT02038829|585180054|FG003|Treatment Period 6|Adverse Event|0|||
162033381|NCT02038829|585180055|FG004|Treatment Period 6|Adverse Event|0|||
162033382|NCT02038829|585180056|FG005|Treatment Period 6|Adverse Event|0|||
162033383|NCT02038829|585180057|FG006|Treatment Period 6|Adverse Event|0|||
162033384|NCT02038829|585180058|FG007|Treatment Period 6|Adverse Event|0|||
162033385|NCT02038829|585180059|FG008|Treatment Period 6|Adverse Event|0|||
162033386|NCT02038829|585180060|FG009|Treatment Period 6|Adverse Event|0|||
162033387|NCT02038829|585180061|FG010|Treatment Period 6|Adverse Event|0|||
162033388|NCT02038829|585180062|FG011|Treatment Period 6|Adverse Event|0|||
162033389|NCT00749580|585180063|FG000|Overall Study|Lost to Follow-up|4|||
162033390|NCT00749580|585180064|FG001|Overall Study|Lost to Follow-up|8|||
162033391|NCT00749580|585180063|FG000|Overall Study|Adverse Event|0|||
161972119|NCT01156389|584945828|FG001|Overall Study|Elevated liver enzymes|0|||
161972120|NCT01156389|584945827|FG000|Overall Study|Vomiting|0|||
161972121|NCT01156389|584945828|FG001|Overall Study|Vomiting|1|||
161972122|NCT00937404|584945831|FG000|Overall Study|Protocol Violation|1|||
161972123|NCT00937404|584945831|FG000|Overall Study|Withdrawal by Subject|1|||
161972124|NCT00090233|584945832|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
161972125|NCT00090233|584945833|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
161972126|NCT00090233|584945832|FG000|Overall Study|Adverse Event|214|||
161972127|NCT00090233|584945833|FG001|Overall Study|Adverse Event|198|||
161972128|NCT00090233|584945832|FG000|Overall Study|Lost to Follow-up|68|||
161972129|NCT00090233|584945833|FG001|Overall Study|Lost to Follow-up|95|||
161972130|NCT00090233|584945832|FG000|Overall Study|Protocol Violation|960|||
161972131|NCT00090233|584945833|FG001|Overall Study|Protocol Violation|1022|||
161972132|NCT00090233|584945832|FG000|Overall Study|Withdrawal by Subject|182|||
161972133|NCT00090233|584945833|FG001|Overall Study|Withdrawal by Subject|211|||
161972134|NCT00090233|584945832|FG000|Overall Study|Moved|203|||
161972135|NCT00090233|584945833|FG001|Overall Study|Moved|189|||
161972136|NCT00090233|584945832|FG000|Overall Study|Other|1211|||
161972137|NCT00090233|584945833|FG001|Overall Study|Other|1160|||
161972138|NCT00090233|584945832|FG000|Overall Study|Data not available at data cut-off point|1552|||
161972139|NCT00090233|584945833|FG001|Overall Study|Data not available at data cut-off point|1563|||
161972140|NCT04863248|584945834|FG000|Overall Study|Sponsor Terminated|4|||
161972141|NCT04863248|584945835|FG001|Overall Study|Sponsor Terminated|1|||
161972142|NCT04863248|584945834|FG000|Overall Study|Death|0|||
161972143|NCT04863248|584945835|FG001|Overall Study|Death|1|||
161972144|NCT04863248|584945834|FG000|Overall Study|Withdrawal by Subject|0|||
161972145|NCT04863248|584945835|FG001|Overall Study|Withdrawal by Subject|1|||
161972146|NCT01779869|584945836|FG000|Overall Study|Physician Decision|2|||
161972147|NCT02536300|584945837|FG000|Overall Study|Investigator's Discretion|17|||
161972148|NCT02536300|584945838|FG001|Overall Study|Investigator's Discretion|11|||
161972149|NCT02536300|584945839|FG002|Overall Study|Investigator's Discretion|2|||
161972150|NCT02536300|584945837|FG000|Overall Study|Progressive Disease|11|||
161972151|NCT02536300|584945838|FG001|Overall Study|Progressive Disease|7|||
161972152|NCT02536300|584945839|FG002|Overall Study|Progressive Disease|6|||
161972153|NCT02536300|584945837|FG000|Overall Study|Study Terminated by Sponsor|6|||
161972154|NCT02536300|584945838|FG001|Overall Study|Study Terminated by Sponsor|4|||
161972155|NCT02536300|584945839|FG002|Overall Study|Study Terminated by Sponsor|7|||
161972156|NCT02536300|584945837|FG000|Overall Study|Death|7|||
161972157|NCT02536300|584945838|FG001|Overall Study|Death|0|||
161972158|NCT02536300|584945839|FG002|Overall Study|Death|5|||
161972159|NCT02536300|584945837|FG000|Overall Study|Withdrew Consent|4|||
162033392|NCT00749580|585180064|FG001|Overall Study|Adverse Event|1|||
162033393|NCT05128929|585180066|FG000|Overall Study|Adverse Event|0|||
162033394|NCT05128929|585180067|FG001|Overall Study|Adverse Event|1|||
162033395|NCT03553836|585180068|FG000|Overall Study|Ongoing in Study|460|||
162033396|NCT03553836|585180069|FG001|Overall Study|Ongoing in Study|459|||
161763684|NCT02643420|584174232|FG001|Overall Study|Sponsor decision|1|||
161763685|NCT02643420|584174231|FG000|Overall Study|Death|0|||
161763686|NCT02643420|584174232|FG001|Overall Study|Death|2|||
161972160|NCT02536300|584945838|FG001|Overall Study|Withdrew Consent|2|||
162033397|NCT03553836|585180068|FG000|Overall Study|Withdrawal by Subject|9|||
162033398|NCT03553836|585180069|FG001|Overall Study|Withdrawal by Subject|10|||
162033399|NCT03553836|585180068|FG000|Overall Study|Lost to Follow-up|1|||
162033400|NCT03553836|585180069|FG001|Overall Study|Lost to Follow-up|3|||
161972161|NCT02536300|584945839|FG002|Overall Study|Withdrew Consent|0|||
161972162|NCT02536300|584945837|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
161972163|NCT02536300|584945838|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
161972164|NCT02536300|584945839|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
161972165|NCT02536300|584945837|FG000|Overall Study|Enrolled but Never Treated|0|||
161972166|NCT02536300|584945838|FG001|Overall Study|Enrolled but Never Treated|0|||
161972167|NCT02536300|584945839|FG002|Overall Study|Enrolled but Never Treated|1|||
161972168|NCT02536300|584945837|FG000|Overall Study|Non-compliance With Study Drug|1|||
162033401|NCT03553836|585180068|FG000|Overall Study|Death|17|||
162033402|NCT03553836|585180069|FG001|Overall Study|Death|17|||
161763687|NCT02643420|584174231|FG000|Overall Study|Reason not Specified|8|||
161763688|NCT02643420|584174232|FG001|Overall Study|Reason not Specified|7|||
161763689|NCT02127970|584174233|FG000|Overall Study|Adverse Event|2|||
161763690|NCT02127970|584174234|FG001|Overall Study|Adverse Event|1|||
161763691|NCT02127970|584174233|FG000|Overall Study|Death|1|||
161763692|NCT02127970|584174234|FG001|Overall Study|Death|1|||
161763693|NCT02127970|584174233|FG000|Overall Study|Lost to Follow-up|14|||
161763694|NCT02127970|584174234|FG001|Overall Study|Lost to Follow-up|14|||
161763695|NCT02127970|584174233|FG000|Overall Study|Reason not Specified|4|||
161763696|NCT02127970|584174234|FG001|Overall Study|Reason not Specified|7|||
161763697|NCT02127970|584174233|FG000|Overall Study|Pregnancy|0|||
161763698|NCT02127970|584174234|FG001|Overall Study|Pregnancy|1|||
161763699|NCT02127970|584174233|FG000|Overall Study|Subject Withdrew Consent|5|||
161763700|NCT02127970|584174234|FG001|Overall Study|Subject Withdrew Consent|3|||
161763701|NCT01710709|584174235|FG000|Overall Study|Lost to Follow-up|29|||
161763702|NCT01710709|584174235|FG000|Overall Study|Adverse Event|48|||
161763703|NCT01710709|584174235|FG000|Overall Study|Participant met withdrawal criteria|33|||
161763704|NCT01710709|584174235|FG000|Overall Study|Participant withdrawn by investigator|2|||
161763705|NCT01710709|584174235|FG000|Overall Study|Withdrawal by Subject|53|||
161763706|NCT01710709|584174235|FG000|Overall Study|Protocol Violation|5|||
161763707|NCT01710709|584174235|FG000|Overall Study|Lack of Efficacy|3|||
161763708|NCT01398176|584174237|FG000|Overall Study|Lost to Follow-up|1|||
161763709|NCT01398176|584174238|FG001|Overall Study|Lost to Follow-up|3|||
161763710|NCT01398176|584174237|FG000|Overall Study|Physician Decision|2|||
161763711|NCT01398176|584174238|FG001|Overall Study|Physician Decision|3|||
161763712|NCT00542321|584174239|FG000|Overall Study|Death|0|||
161763713|NCT00542321|584174240|FG001|Overall Study|Death|1|||
161763714|NCT01871870|584174244|FG000|Overall Study|Hardware issues|7|||
161763715|NCT01871870|584174244|FG000|Overall Study|hyperglycemia|2|||
161763716|NCT00253747|584174250|FG000|Overall Study|Lost to Follow-up|13|||
161763717|NCT00253747|584174251|FG001|Overall Study|Lost to Follow-up|14|||
161763718|NCT00253747|584174250|FG000|Overall Study|Withdrawal by Subject|10|||
161763719|NCT00253747|584174251|FG001|Overall Study|Withdrawal by Subject|11|||
161763720|NCT00253747|584174250|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
161763721|NCT00253747|584174251|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
161763722|NCT02275052|584174254|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161763723|NCT02275052|584174255|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
161763724|NCT02275052|584174256|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161763725|NCT02275052|584174257|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161763726|NCT02275052|584174254|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
161763727|NCT02275052|584174255|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
161763728|NCT02275052|584174256|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
161763729|NCT02275052|584174257|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
161763730|NCT02275052|584174254|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
161763731|NCT02275052|584174255|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
161763732|NCT02275052|584174256|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161763733|NCT02275052|584174257|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161763734|NCT02275052|584174254|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
161763735|NCT02275052|584174255|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
161763736|NCT02275052|584174256|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
161763737|NCT02275052|584174257|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
161763738|NCT02275052|584174254|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
161763739|NCT02275052|584174255|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
161763740|NCT02275052|584174256|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
161763741|NCT02275052|584174257|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
161763742|NCT02275052|584174254|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
161763743|NCT02275052|584174255|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
161763744|NCT02275052|584174256|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
161763745|NCT02275052|584174257|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
161763746|NCT02275052|584174254|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
161763747|NCT02275052|584174255|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
161763748|NCT02275052|584174256|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
161763749|NCT02275052|584174257|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
161763750|NCT02275052|584174254|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
161763751|NCT02275052|584174255|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
161763752|NCT02275052|584174256|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
161763753|NCT02275052|584174257|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
161763754|NCT02275052|584174254|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161763755|NCT02275052|584174255|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161763756|NCT02275052|584174256|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161763757|NCT02275052|584174257|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
161848981|NCT02119819|584488756|FG003|Overall Study|Physician Decision|0|||
161848982|NCT02119819|584488757|FG004|Overall Study|Physician Decision|0|||
161848983|NCT02119819|584488758|FG005|Overall Study|Physician Decision|1|||
161848984|NCT02119819|584488753|FG000|Overall Study|Withdrawal by Subject|5|||
161848985|NCT02119819|584488754|FG001|Overall Study|Withdrawal by Subject|3|||
161848986|NCT02119819|584488755|FG002|Overall Study|Withdrawal by Subject|0|||
161848987|NCT02119819|584488756|FG003|Overall Study|Withdrawal by Subject|0|||
161848988|NCT02119819|584488757|FG004|Overall Study|Withdrawal by Subject|6|||
161848989|NCT02119819|584488758|FG005|Overall Study|Withdrawal by Subject|10|||
161848990|NCT02119819|584488753|FG000|Overall Study|Jury Duty|0|||
161848991|NCT02119819|584488754|FG001|Overall Study|Jury Duty|0|||
161848992|NCT02119819|584488755|FG002|Overall Study|Jury Duty|1|||
161848993|NCT02119819|584488756|FG003|Overall Study|Jury Duty|0|||
161848994|NCT02119819|584488757|FG004|Overall Study|Jury Duty|0|||
161848995|NCT02119819|584488758|FG005|Overall Study|Jury Duty|0|||
161848996|NCT02119819|584488753|FG000|Overall Study|Protocol Violation|0|||
161848997|NCT02119819|584488754|FG001|Overall Study|Protocol Violation|0|||
161848998|NCT02119819|584488755|FG002|Overall Study|Protocol Violation|0|||
161848999|NCT02119819|584488756|FG003|Overall Study|Protocol Violation|1|||
161849000|NCT02119819|584488757|FG004|Overall Study|Protocol Violation|0|||
161849001|NCT02119819|584488758|FG005|Overall Study|Protocol Violation|0|||
161849002|NCT02119819|584488753|FG000|Overall Study|Left the city to get a job|0|||
161849003|NCT02119819|584488754|FG001|Overall Study|Left the city to get a job|0|||
161849004|NCT02119819|584488755|FG002|Overall Study|Left the city to get a job|0|||
161849005|NCT02119819|584488756|FG003|Overall Study|Left the city to get a job|1|||
161849006|NCT02119819|584488757|FG004|Overall Study|Left the city to get a job|0|||
161849007|NCT02119819|584488758|FG005|Overall Study|Left the city to get a job|0|||
161849008|NCT04497948|584488761|FG000|Overall Study|Death|2|||
161849009|NCT04611529|584488765|FG000|2-day Follow up|Lost to Follow-up|5|||
161849010|NCT04611529|584488766|FG001|2-day Follow up|Lost to Follow-up|6|||
161849011|NCT04611529|584488767|FG002|2-day Follow up|Lost to Follow-up|3|||
161849012|NCT00856375|584488828|FG000|Overall Study|Other|0|||
161849013|NCT00856375|584488829|FG001|Overall Study|Other|1|||
161849014|NCT00856375|584488828|FG000|Overall Study|Death|32|||
161849015|NCT00856375|584488829|FG001|Overall Study|Death|30|||
161849016|NCT00856375|584488828|FG000|Overall Study|Sponsor Terminated Study|7|||
161849017|NCT00856375|584488829|FG001|Overall Study|Sponsor Terminated Study|7|||
161849018|NCT00856375|584488828|FG000|Overall Study|Withdrawal by Subject|2|||
161849019|NCT00856375|584488829|FG001|Overall Study|Withdrawal by Subject|1|||
161849020|NCT00856375|584488828|FG000|Overall Study|Lost to Follow-up|1|||
161849021|NCT00856375|584488829|FG001|Overall Study|Lost to Follow-up|2|||
161849022|NCT02121392|584488832|FG000|Prior to Intervention|Protocol Violation|40|||
161849023|NCT02121392|584488833|FG001|Prior to Intervention|Protocol Violation|35|||
161849024|NCT02121392|584488832|FG000|Prior to Intervention|Withdrawal by Subject|8|||
161849025|NCT02121392|584488833|FG001|Prior to Intervention|Withdrawal by Subject|6|||
161849026|NCT02121392|584488832|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
161849027|NCT02121392|584488833|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
161849028|NCT02121392|584488832|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
161849029|NCT02121392|584488833|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
161849030|NCT01851330|584488834|FG000|Overall Study|Lack of Efficacy|10|||
161849031|NCT01851330|584488835|FG001|Overall Study|Lack of Efficacy|9|||
161849032|NCT01851330|584488836|FG002|Overall Study|Lack of Efficacy|2|||
161849033|NCT01851330|584488834|FG000|Overall Study|Lost to Follow-up|1|||
161849034|NCT01851330|584488835|FG001|Overall Study|Lost to Follow-up|6|||
161849035|NCT01851330|584488836|FG002|Overall Study|Lost to Follow-up|9|||
161849036|NCT01851330|584488834|FG000|Overall Study|Withdrew Consent|2|||
161849037|NCT01851330|584488835|FG001|Overall Study|Withdrew Consent|1|||
161849038|NCT01851330|584488836|FG002|Overall Study|Withdrew Consent|0|||
161849039|NCT01851330|584488834|FG000|Overall Study|Investigator's Discretion|0|||
161849040|NCT01851330|584488835|FG001|Overall Study|Investigator's Discretion|0|||
161849041|NCT01851330|584488836|FG002|Overall Study|Investigator's Discretion|1|||
161849042|NCT02648932|584488837|FG000|Overall Study|No transplant|3|||
161849043|NCT02648932|584488838|FG001|Overall Study|No transplant|1|||
161849044|NCT01199016|584488839|FG000|Overall Study|No longer meets eligibility criteria|4|||
161849045|NCT01199016|584488839|FG000|Overall Study|Entrance criteria|5|||
161849046|NCT01199016|584488839|FG000|Overall Study|Protocol Violation|9|||
161849047|NCT01199016|584488839|FG000|Overall Study|Other|13|||
161849048|NCT01199016|584488839|FG000|Overall Study|Withdrawal by Subject|21|||
161849049|NCT01199016|584488839|FG000|Overall Study|Lost to Follow-up|25|||
161849050|NCT01266031|584488850|FG000|Overall Study|Not treated|0|||
161849051|NCT01266031|584488851|FG001|Overall Study|Not treated|3|||
161849052|NCT01266031|584488852|FG002|Overall Study|Not treated|2|||
161849053|NCT02842073|584488858|FG000|Overall Study|Withdrawal by Subject|1|||
161972169|NCT02536300|584945838|FG001|Overall Study|Non-compliance With Study Drug|0|||
161849054|NCT00195338|584488859|FG000|Overall Study|Lost to Follow-up|2|||
161849055|NCT00195338|584488859|FG000|Overall Study|Adverse Event|5|||
161849056|NCT00195338|584488859|FG000|Overall Study|Lack of Efficacy|1|||
161849057|NCT00195338|584488859|FG000|Overall Study|Early closure of the site|4|||
161849058|NCT02047734|584488862|FG000|Overall Study|Adverse Event|18|||
161972170|NCT02536300|584945839|FG002|Overall Study|Non-compliance With Study Drug|0|||
161972171|NCT02536300|584945837|FG000|Overall Study|Protocol Violation|0|||
161763758|NCT02275052|584174254|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
161763759|NCT02275052|584174255|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
161763760|NCT02275052|584174256|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
161763761|NCT02275052|584174257|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
161763762|NCT02275052|584174254|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161763763|NCT02275052|584174255|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161763764|NCT02275052|584174256|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161763765|NCT02275052|584174257|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
161763766|NCT05102734|584174258|FG000|Overall Study|Did not require vasopressors|1|||
161763767|NCT05102734|584174259|FG001|Overall Study|Did not require vasopressors|0|||
161763768|NCT05102734|584174258|FG000|Overall Study|Did not have functioning PA catheter|1|||
161763769|NCT05102734|584174259|FG001|Overall Study|Did not have functioning PA catheter|0|||
161763770|NCT05102734|584174258|FG000|Overall Study|Inadequate video quality|2|||
161763771|NCT05102734|584174259|FG001|Overall Study|Inadequate video quality|0|||
161763772|NCT03055806|584174265|FG000|Overall Study|Adverse Event|0|||
161763773|NCT03055806|584174266|FG001|Overall Study|Adverse Event|0|||
161763774|NCT03055806|584174267|FG002|Overall Study|Adverse Event|1|||
161763775|NCT03055806|584174268|FG003|Overall Study|Adverse Event|1|||
161763776|NCT03055806|584174265|FG000|Overall Study|Lost to Follow-up|0|||
161763777|NCT03055806|584174266|FG001|Overall Study|Lost to Follow-up|3|||
161763778|NCT03055806|584174267|FG002|Overall Study|Lost to Follow-up|6|||
161763779|NCT03055806|584174268|FG003|Overall Study|Lost to Follow-up|7|||
161763780|NCT03055806|584174265|FG000|Overall Study|Physician Decision|1|||
161763781|NCT03055806|584174266|FG001|Overall Study|Physician Decision|0|||
161763782|NCT03055806|584174267|FG002|Overall Study|Physician Decision|0|||
161763783|NCT03055806|584174268|FG003|Overall Study|Physician Decision|1|||
161763784|NCT03055806|584174265|FG000|Overall Study|Protocol Violation|1|||
161763785|NCT03055806|584174266|FG001|Overall Study|Protocol Violation|0|||
161763786|NCT03055806|584174267|FG002|Overall Study|Protocol Violation|0|||
161763787|NCT03055806|584174268|FG003|Overall Study|Protocol Violation|0|||
161763788|NCT03055806|584174265|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
161763789|NCT03055806|584174266|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
161763790|NCT03055806|584174267|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
161763791|NCT03055806|584174268|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
161763792|NCT03055806|584174265|FG000|Overall Study|Withdrawal of consent to continue study|2|||
161763793|NCT03055806|584174266|FG001|Overall Study|Withdrawal of consent to continue study|3|||
161763794|NCT03055806|584174267|FG002|Overall Study|Withdrawal of consent to continue study|4|||
161763795|NCT03055806|584174268|FG003|Overall Study|Withdrawal of consent to continue study|6|||
161763796|NCT03055806|584174265|FG000|Overall Study|Partner not willing to try intercourse|1|||
161763797|NCT03055806|584174266|FG001|Overall Study|Partner not willing to try intercourse|0|||
161763798|NCT03055806|584174267|FG002|Overall Study|Partner not willing to try intercourse|0|||
161763799|NCT03055806|584174268|FG003|Overall Study|Partner not willing to try intercourse|0|||
161763800|NCT04601194|584174269|FG000|Overall Study|Lost to Follow-up|7|||
161763801|NCT02630459|584174270|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161763802|NCT02630459|584174271|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
161763803|NCT02630459|584174272|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161763804|NCT02630459|584174273|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
161763805|NCT02630459|584174274|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161763806|NCT02630459|584174275|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161763807|NCT02630459|584174276|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161763808|NCT02630459|584174277|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161763809|NCT02630459|584174270|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763810|NCT02630459|584174271|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763811|NCT02630459|584174272|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
161763812|NCT02630459|584174273|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763813|NCT02630459|584174274|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763814|NCT02630459|584174275|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763815|NCT02630459|584174276|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763816|NCT02630459|584174277|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161763817|NCT02630459|584174270|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
161763818|NCT02630459|584174271|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
161763819|NCT02630459|584174272|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
161763820|NCT02630459|584174273|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
161763821|NCT02630459|584174274|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
161972172|NCT02536300|584945838|FG001|Overall Study|Protocol Violation|1|||
161972173|NCT02536300|584945839|FG002|Overall Study|Protocol Violation|0|||
161972174|NCT01691105|584945847|FG000|1 Month Follow-up|Lost to Follow-up|41|||
162033403|NCT05660850|585180070|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
162033404|NCT05660850|585180071|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
162033405|NCT05660850|585180072|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
162033406|NCT05660850|585180073|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
162033407|NCT02604017|585180074|FG000|Overall Study|Withdrew Consent|0|||
162033408|NCT02604017|585180075|FG001|Overall Study|Withdrew Consent|2|||
162033409|NCT02604017|585180074|FG000|Overall Study|Lost to Follow-up|5|||
162033410|NCT02604017|585180075|FG001|Overall Study|Lost to Follow-up|6|||
162033411|NCT02604017|585180074|FG000|Overall Study|Other|1|||
162033412|NCT02604017|585180075|FG001|Overall Study|Other|0|||
162033413|NCT01653782|585180081|FG000|Overall Study|Withdrawal by Subject|9|||
162033414|NCT01653782|585180082|FG001|Overall Study|Withdrawal by Subject|15|||
162033415|NCT01653782|585180083|FG002|Overall Study|Withdrawal by Subject|4|||
162033416|NCT01653782|585180081|FG000|Overall Study|Lost to Follow-up|7|||
162033417|NCT01653782|585180082|FG001|Overall Study|Lost to Follow-up|3|||
162033418|NCT01653782|585180083|FG002|Overall Study|Lost to Follow-up|2|||
162033419|NCT01315236|585180087|FG000|Double-blind Phase|Death|1|||
162033420|NCT01315236|585180088|FG001|Double-blind Phase|Death|0|||
162033421|NCT01315236|585180087|FG000|Double-blind Phase|Adverse Event|1|||
162033422|NCT01315236|585180088|FG001|Double-blind Phase|Adverse Event|0|||
162033423|NCT01315236|585180087|FG000|Double-blind Phase|Withdrawal of Consent|1|||
162033424|NCT01315236|585180088|FG001|Double-blind Phase|Withdrawal of Consent|0|||
162033425|NCT01315236|585180087|FG000|Double-blind Phase|Lost to Follow-up|1|||
162033426|NCT01315236|585180088|FG001|Double-blind Phase|Lost to Follow-up|0|||
162033427|NCT01315236|585180087|FG000|Open-label Phase|Death|1|||
162033428|NCT01315236|585180088|FG001|Open-label Phase|Death|0|||
162033429|NCT01315236|585180087|FG000|Open-label Phase|Adverse Event|0|||
162033430|NCT01315236|585180088|FG001|Open-label Phase|Adverse Event|1|||
162033431|NCT01315236|585180087|FG000|Open-label Phase|Other|0|||
162033432|NCT01315236|585180088|FG001|Open-label Phase|Other|1|||
162033433|NCT01315236|585180087|FG000|12-Month Follow-up Period|Death|0|||
162033434|NCT01315236|585180088|FG001|12-Month Follow-up Period|Death|1|||
162033435|NCT01315236|585180087|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
162033436|NCT01315236|585180088|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
162033437|NCT02497976|585180091|FG000|Overall Study|Withdrawal by Subject|2|||
162033438|NCT02497976|585180092|FG001|Overall Study|Withdrawal by Subject|0|||
162033439|NCT02497976|585180091|FG000|Overall Study|Moved out of area|0|||
162033440|NCT02497976|585180092|FG001|Overall Study|Moved out of area|1|||
162033441|NCT00058539|585180096|FG000|Overall Study|Disease progression|24|||
162033442|NCT00058539|585180096|FG000|Overall Study|Adverse Event|3|||
162033443|NCT00058539|585180096|FG000|Overall Study|Withdrawal by Subject|5|||
162033444|NCT00058539|585180096|FG000|Overall Study|Physician Decision|9|||
162033445|NCT00058539|585180096|FG000|Overall Study|Death|1|||
162033446|NCT02483533|585180097|FG000|Overall Study|Lack of Efficacy|50|||
162033447|NCT02483533|585180098|FG001|Overall Study|Lack of Efficacy|50|||
162033448|NCT01323920|585180099|FG000|Overall Study|Death|5|||
162033449|NCT01323920|585180099|FG000|Overall Study|Withdrawal by Subject|1|||
162033450|NCT00768469|585180100|FG000|Overall Study|Adverse Event|0|||
162033451|NCT00768469|585180101|FG001|Overall Study|Adverse Event|2|||
162033452|NCT00768469|585180100|FG000|Overall Study|Disease Progression|3|||
162033453|NCT00768469|585180101|FG001|Overall Study|Disease Progression|4|||
162033454|NCT00768469|585180100|FG000|Overall Study|Withdrawal by Subject|0|||
162033455|NCT00768469|585180101|FG001|Overall Study|Withdrawal by Subject|1|||
162033456|NCT01293799|585180105|FG000|Overall Study|Kidney transplantation|109|||
162033457|NCT01293799|585180106|FG001|Overall Study|Kidney transplantation|96|||
162033458|NCT01293799|585180105|FG000|Overall Study|Transfer to hemodialysis|70|||
162033459|NCT01293799|585180106|FG001|Overall Study|Transfer to hemodialysis|90|||
162033460|NCT01293799|585180105|FG000|Overall Study|Death|27|||
162033461|NCT01293799|585180106|FG001|Overall Study|Death|29|||
162033462|NCT01293799|585180105|FG000|Overall Study|Transfer to assisted PD|24|||
162033463|NCT01293799|585180106|FG001|Overall Study|Transfer to assisted PD|18|||
162033464|NCT01293799|585180105|FG000|Overall Study|Withdrawal by Subject|26|||
162033465|NCT01293799|585180106|FG001|Overall Study|Withdrawal by Subject|0|||
162033466|NCT01293799|585180105|FG000|Overall Study|Investigator decision|5|||
161763822|NCT02630459|584174275|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
161763823|NCT02630459|584174276|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
161763824|NCT02630459|584174277|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
161763825|NCT02630459|584174270|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
161763826|NCT02630459|584174271|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161763827|NCT02630459|584174272|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161763828|NCT02630459|584174273|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161763829|NCT02630459|584174274|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161763830|NCT02630459|584174275|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
162033467|NCT01293799|585180106|FG001|Overall Study|Investigator decision|2|||
161763831|NCT02630459|584174276|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161849059|NCT02047734|584488863|FG001|Overall Study|Adverse Event|13|||
161849060|NCT02047734|584488864|FG002|Overall Study|Adverse Event|13|||
161849061|NCT02047734|584488862|FG000|Overall Study|Lack of Efficacy|4|||
161849062|NCT02047734|584488863|FG001|Overall Study|Lack of Efficacy|5|||
161849063|NCT02047734|584488864|FG002|Overall Study|Lack of Efficacy|1|||
161849064|NCT02047734|584488862|FG000|Overall Study|Protocol Violation|3|||
161849065|NCT02047734|584488863|FG001|Overall Study|Protocol Violation|1|||
161849066|NCT02047734|584488864|FG002|Overall Study|Protocol Violation|1|||
161849067|NCT02047734|584488862|FG000|Overall Study|Lost to Follow-up|1|||
161849068|NCT02047734|584488863|FG001|Overall Study|Lost to Follow-up|4|||
161972175|NCT01691105|584945848|FG001|1 Month Follow-up|Lost to Follow-up|38|||
161972176|NCT01691105|584945847|FG000|1 Month Follow-up|Death|2|||
161972177|NCT01691105|584945848|FG001|1 Month Follow-up|Death|3|||
161972178|NCT01691105|584945847|FG000|6 Month Follow-up|Lost to Follow-up|39|||
161972179|NCT01691105|584945848|FG001|6 Month Follow-up|Lost to Follow-up|58|||
161972180|NCT01691105|584945847|FG000|6 Month Follow-up|Death|13|||
161849069|NCT02047734|584488864|FG002|Overall Study|Lost to Follow-up|0|||
161849070|NCT02047734|584488862|FG000|Overall Study|Death|0|||
161849071|NCT02047734|584488863|FG001|Overall Study|Death|1|||
161849072|NCT02047734|584488864|FG002|Overall Study|Death|0|||
161849073|NCT02047734|584488862|FG000|Overall Study|Withdrawal by Subject|30|||
161849074|NCT02047734|584488863|FG001|Overall Study|Withdrawal by Subject|31|||
161849075|NCT02047734|584488864|FG002|Overall Study|Withdrawal by Subject|19|||
161849076|NCT02047734|584488862|FG000|Overall Study|Physician Decision|7|||
161849077|NCT02047734|584488863|FG001|Overall Study|Physician Decision|6|||
161849078|NCT02047734|584488864|FG002|Overall Study|Physician Decision|5|||
161849079|NCT02047734|584488862|FG000|Overall Study|Miscellaneous|2|||
161849080|NCT02047734|584488863|FG001|Overall Study|Miscellaneous|4|||
161849081|NCT02047734|584488864|FG002|Overall Study|Miscellaneous|6|||
161849082|NCT02047734|584488862|FG000|Overall Study|Did Not Receive Study Drug|2|||
161849083|NCT02047734|584488863|FG001|Overall Study|Did Not Receive Study Drug|4|||
161849084|NCT02047734|584488864|FG002|Overall Study|Did Not Receive Study Drug|1|||
161849085|NCT01333397|584488865|FG000|Overall Study|Lost to Follow-up|1|||
161849086|NCT01333397|584488866|FG001|Overall Study|Lost to Follow-up|0|||
161849087|NCT01333397|584488867|FG002|Overall Study|Lost to Follow-up|0|||
161849088|NCT01333397|584488868|FG003|Overall Study|Lost to Follow-up|1|||
161849089|NCT01333397|584488869|FG004|Overall Study|Lost to Follow-up|0|||
161849090|NCT01994850|584488875|FG000|Overall Study|Physician Decision|1|||
161849091|NCT01994850|584488875|FG000|Overall Study|Withdrawal by Subject|1|||
161849092|NCT00182325|584488881|FG000|Overall Study|Lost to Follow-up|7|||
161849093|NCT00182325|584488882|FG001|Overall Study|Lost to Follow-up|7|||
161849094|NCT00182325|584488881|FG000|Overall Study|Miscarriage|5|||
161849095|NCT00182325|584488882|FG001|Overall Study|Miscarriage|3|||
161849096|NCT00182325|584488881|FG000|Overall Study|Did not complete survey|22|||
161849097|NCT00182325|584488882|FG001|Overall Study|Did not complete survey|43|||
161849098|NCT02015065|584488886|FG000|Overall Study|Death on study|1|||
161849099|NCT02015065|584488887|FG001|Overall Study|Death on study|2|||
161849100|NCT02015065|584488888|FG002|Overall Study|Death on study|1|||
161849101|NCT01420965|584488889|FG000|Overall Study|Withdrawal by Subject|1|||
161849102|NCT01420965|584488890|FG001|Overall Study|Withdrawal by Subject|0|||
161972181|NCT01691105|584945848|FG001|6 Month Follow-up|Death|13|||
161972182|NCT01691105|584945847|FG000|12 Month Follow-up|Lost to Follow-up|50|||
161972183|NCT01691105|584945848|FG001|12 Month Follow-up|Lost to Follow-up|71|||
161972184|NCT01691105|584945847|FG000|12 Month Follow-up|Death|22|||
161972185|NCT01691105|584945848|FG001|12 Month Follow-up|Death|30|||
161972186|NCT01691105|584945847|FG000|12 Month Biochemical Verification|Death|22|||
161972187|NCT01691105|584945848|FG001|12 Month Biochemical Verification|Death|30|||
161972188|NCT01691105|584945847|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
161972189|NCT01691105|584945848|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
161972190|NCT01691105|584945847|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
162033468|NCT01293799|585180105|FG000|Overall Study|Kidney function improved|6|||
161972191|NCT01691105|584945848|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
162033469|NCT01293799|585180106|FG001|Overall Study|Kidney function improved|7|||
161849103|NCT01420965|584488891|FG002|Overall Study|Withdrawal by Subject|0|||
161849104|NCT01420965|584488889|FG000|Overall Study|Adverse Event|0|||
161849105|NCT01420965|584488890|FG001|Overall Study|Adverse Event|1|||
161849106|NCT01420965|584488891|FG002|Overall Study|Adverse Event|0|||
161849107|NCT01292226|584488928|FG000|Overall Study|Adverse Event|5|||
161972192|NCT00957944|584945849|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
161972193|NCT00957944|584945850|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
161972194|NCT01482169|584945852|FG000|Overall Study|Physician Decision|2|||
162033470|NCT01293799|585180105|FG000|Overall Study|Other causes|6|||
161849108|NCT01292226|584488928|FG000|Overall Study|Death|1|||
161849109|NCT01292226|584488928|FG000|Overall Study|Graft loss|1|||
161849110|NCT01292226|584488928|FG000|Overall Study|Protocol Violation|3|||
161849111|NCT01292226|584488928|FG000|Overall Study|Withdrawal by Subject|1|||
161849112|NCT01292226|584488928|FG000|Overall Study|Other|2|||
161849113|NCT00468650|584488931|FG000|Overall Study|Lost to Follow-up|4|||
161849114|NCT00468650|584488931|FG000|Overall Study|Withdrawal by Subject|2|||
161972195|NCT01030874|584945853|FG000|Overall Study|Withdrawal by Subject|1|||
161972196|NCT01030874|584945854|FG001|Overall Study|Withdrawal by Subject|0|||
161972197|NCT01030874|584945853|FG000|Overall Study|Discharged in first 2 weeks|17|||
161972198|NCT01030874|584945854|FG001|Overall Study|Discharged in first 2 weeks|16|||
161763832|NCT02630459|584174277|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161763833|NCT02630459|584174270|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161763834|NCT02630459|584174271|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161763835|NCT02630459|584174272|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161763836|NCT02630459|584174273|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161763837|NCT02630459|584174274|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
161763838|NCT02630459|584174275|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
161763839|NCT02630459|584174276|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161763840|NCT02630459|584174277|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161763841|NCT02630459|584174270|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161763842|NCT02630459|584174271|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161763843|NCT02630459|584174272|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161763844|NCT02630459|584174273|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161763845|NCT02630459|584174274|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
161763846|NCT02630459|584174275|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
161763847|NCT02630459|584174276|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161763848|NCT02630459|584174277|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161763849|NCT02630459|584174270|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763850|NCT02630459|584174271|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763851|NCT02630459|584174272|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763852|NCT02630459|584174273|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763853|NCT02630459|584174274|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
161763854|NCT02630459|584174275|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763855|NCT02630459|584174276|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763856|NCT02630459|584174277|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161763857|NCT00846027|584174278|FG000|Overall Study|Death|3|||
161763858|NCT00846027|584174278|FG000|Overall Study|Disease Progression|30|||
161763859|NCT00846027|584174278|FG000|Overall Study|Toxicity|12|||
161763860|NCT00846027|584174278|FG000|Overall Study|Patient Decision|7|||
161763861|NCT00846027|584174278|FG000|Overall Study|Investigator Discretion|29|||
161763862|NCT00846027|584174278|FG000|Overall Study|Protocol Violation|2|||
161763863|NCT00846027|584174278|FG000|Overall Study|Subject Not Treated|7|||
161763864|NCT04905563|584174281|FG000|Overall Study|Withdrawal by Subject|1|||
161763865|NCT04905563|584174282|FG001|Overall Study|Withdrawal by Subject|0|||
161763866|NCT04905563|584174281|FG000|Overall Study|Standard of care orders entered by resident|1|||
161763867|NCT04905563|584174282|FG001|Overall Study|Standard of care orders entered by resident|0|||
161763868|NCT04905563|584174281|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
161763869|NCT04905563|584174282|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
161763870|NCT04905563|584174281|FG000|Overall Study|Withdrawal by Subject|0|||
161763871|NCT04905563|584174282|FG001|Overall Study|Withdrawal by Subject|1|||
161763872|NCT01797302|584174283|FG000|Overall Study|Lost to Follow-up|16|||
161763873|NCT01797302|584174284|FG001|Overall Study|Lost to Follow-up|23|||
161763874|NCT01797302|584174285|FG002|Overall Study|Lost to Follow-up|22|||
161763875|NCT01797302|584174283|FG000|Overall Study|Withdrawal by Subject|1|||
161763876|NCT01797302|584174284|FG001|Overall Study|Withdrawal by Subject|3|||
161763877|NCT01797302|584174285|FG002|Overall Study|Withdrawal by Subject|4|||
161763878|NCT02418000|584174286|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
161763879|NCT02418000|584174287|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763880|NCT02418000|584174288|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763881|NCT02418000|584174289|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763882|NCT02418000|584174290|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763883|NCT02418000|584174286|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
161763884|NCT02418000|584174287|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
161763885|NCT02418000|584174288|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
161763886|NCT02418000|584174289|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
161763887|NCT02418000|584174290|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
161763888|NCT02418000|584174286|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
161763889|NCT02418000|584174287|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
161763890|NCT02418000|584174288|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
161763891|NCT02418000|584174289|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
161763892|NCT02418000|584174290|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
161763893|NCT02418000|584174286|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
161849115|NCT00468650|584488931|FG000|Overall Study|Protocol Violation|1|||
161849116|NCT00642278|584488932|FG000|Overall Study|Adverse Event|2|||
161972199|NCT02279719|584945855|FG000|Overall Study|Patients randomized but never treated|0|||
161849117|NCT00642278|584488933|FG001|Overall Study|Adverse Event|1|||
161849118|NCT00642278|584488934|FG002|Overall Study|Adverse Event|3|||
161849119|NCT00642278|584488935|FG003|Overall Study|Adverse Event|1|||
161849120|NCT00642278|584488936|FG004|Overall Study|Adverse Event|2|||
161849121|NCT00642278|584488937|FG005|Overall Study|Adverse Event|2|||
161849122|NCT00642278|584488938|FG006|Overall Study|Adverse Event|0|||
161849123|NCT00642278|584488932|FG000|Overall Study|Lack of Efficacy|0|||
161849124|NCT00642278|584488933|FG001|Overall Study|Lack of Efficacy|1|||
161849125|NCT00642278|584488934|FG002|Overall Study|Lack of Efficacy|0|||
161849126|NCT00642278|584488935|FG003|Overall Study|Lack of Efficacy|0|||
161849127|NCT00642278|584488936|FG004|Overall Study|Lack of Efficacy|0|||
161849128|NCT00642278|584488937|FG005|Overall Study|Lack of Efficacy|0|||
161849129|NCT00642278|584488938|FG006|Overall Study|Lack of Efficacy|0|||
161849130|NCT00642278|584488932|FG000|Overall Study|Lost to Follow-up|5|||
161849131|NCT00642278|584488933|FG001|Overall Study|Lost to Follow-up|1|||
161849132|NCT00642278|584488934|FG002|Overall Study|Lost to Follow-up|0|||
161849133|NCT00642278|584488935|FG003|Overall Study|Lost to Follow-up|1|||
161849134|NCT00642278|584488936|FG004|Overall Study|Lost to Follow-up|0|||
161849135|NCT00642278|584488937|FG005|Overall Study|Lost to Follow-up|1|||
161849136|NCT00642278|584488938|FG006|Overall Study|Lost to Follow-up|1|||
161849137|NCT00642278|584488932|FG000|Overall Study|Physician Decision|0|||
161849138|NCT00642278|584488933|FG001|Overall Study|Physician Decision|0|||
161849139|NCT00642278|584488934|FG002|Overall Study|Physician Decision|0|||
161849140|NCT00642278|584488935|FG003|Overall Study|Physician Decision|1|||
161849141|NCT00642278|584488936|FG004|Overall Study|Physician Decision|0|||
161849142|NCT00642278|584488937|FG005|Overall Study|Physician Decision|0|||
161849143|NCT00642278|584488938|FG006|Overall Study|Physician Decision|0|||
161849144|NCT00642278|584488932|FG000|Overall Study|Protocol Violation|0|||
161849145|NCT00642278|584488933|FG001|Overall Study|Protocol Violation|0|||
161849146|NCT00642278|584488934|FG002|Overall Study|Protocol Violation|1|||
161849147|NCT00642278|584488935|FG003|Overall Study|Protocol Violation|1|||
161849148|NCT00642278|584488936|FG004|Overall Study|Protocol Violation|0|||
161849149|NCT00642278|584488937|FG005|Overall Study|Protocol Violation|1|||
161849150|NCT00642278|584488938|FG006|Overall Study|Protocol Violation|2|||
161849151|NCT00642278|584488932|FG000|Overall Study|Withdrawal by Subject|1|||
161849152|NCT00642278|584488933|FG001|Overall Study|Withdrawal by Subject|1|||
161849153|NCT00642278|584488934|FG002|Overall Study|Withdrawal by Subject|1|||
161849154|NCT00642278|584488935|FG003|Overall Study|Withdrawal by Subject|3|||
161849155|NCT00642278|584488936|FG004|Overall Study|Withdrawal by Subject|6|||
161849156|NCT00642278|584488937|FG005|Overall Study|Withdrawal by Subject|2|||
161849157|NCT00642278|584488938|FG006|Overall Study|Withdrawal by Subject|2|||
161849158|NCT00642278|584488932|FG000|Overall Study|Noncompliance with study drug regimen|0|||
161849159|NCT00642278|584488933|FG001|Overall Study|Noncompliance with study drug regimen|0|||
161849160|NCT00642278|584488934|FG002|Overall Study|Noncompliance with study drug regimen|0|||
161849161|NCT00642278|584488935|FG003|Overall Study|Noncompliance with study drug regimen|1|||
161849162|NCT00642278|584488936|FG004|Overall Study|Noncompliance with study drug regimen|0|||
161849163|NCT00642278|584488937|FG005|Overall Study|Noncompliance with study drug regimen|0|||
161849164|NCT00642278|584488938|FG006|Overall Study|Noncompliance with study drug regimen|0|||
161849165|NCT00642278|584488932|FG000|Overall Study|Other|2|||
161849166|NCT00642278|584488933|FG001|Overall Study|Other|1|||
161849167|NCT00642278|584488934|FG002|Overall Study|Other|0|||
161849168|NCT00642278|584488935|FG003|Overall Study|Other|1|||
161849169|NCT00642278|584488936|FG004|Overall Study|Other|0|||
161849170|NCT00642278|584488937|FG005|Overall Study|Other|1|||
161849171|NCT00642278|584488938|FG006|Overall Study|Other|0|||
161849172|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
161849173|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161849174|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
161849175|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161849176|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161849177|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
161849178|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161849179|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161849180|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
161849181|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
161849182|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
161849183|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
161849184|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
161849185|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
161849186|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
161849187|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
161849188|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161849189|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161849190|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161849191|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161972200|NCT02279719|584945856|FG001|Overall Study|Patients randomized but never treated|0|||
161972201|NCT02279719|584945857|FG002|Overall Study|Patients randomized but never treated|0|||
161972202|NCT02279719|584945858|FG003|Overall Study|Patients randomized but never treated|0|||
161972203|NCT02279719|584945859|FG004|Overall Study|Patients randomized but never treated|3|||
161972204|NCT02279719|584945860|FG005|Overall Study|Patients randomized but never treated|0|||
161972205|NCT02279719|584945861|FG006|Overall Study|Patients randomized but never treated|3|||
161972206|NCT04706273|584945862|FG000|Overall Study|Withdrawal by Subject|27|||
161972207|NCT04706273|584945862|FG000|Overall Study|Physician Decision|1|||
161972208|NCT04706273|584945862|FG000|Overall Study|Lost to Follow-up|42|||
161972209|NCT04706273|584945862|FG000|Overall Study|Death|85|||
161972210|NCT04706273|584945862|FG000|Overall Study|Amputation that removes study device|2|||
161972211|NCT04706273|584945862|FG000|Overall Study|Surgical bypass|3|||
161972212|NCT04706273|584945862|FG000|Overall Study|Changing hospital|23|||
161763894|NCT02418000|584174287|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
161763895|NCT02418000|584174288|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763896|NCT02418000|584174289|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763897|NCT02418000|584174290|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
161763898|NCT02418000|584174286|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
161763899|NCT02418000|584174287|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
161763900|NCT02418000|584174288|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
161763901|NCT02418000|584174289|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
161763902|NCT02418000|584174290|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
161763903|NCT02418000|584174286|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763904|NCT02418000|584174287|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763905|NCT02418000|584174288|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
161763906|NCT02418000|584174289|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763907|NCT02418000|584174290|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763908|NCT02418000|584174286|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763909|NCT02418000|584174287|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763910|NCT02418000|584174288|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763911|NCT02418000|584174289|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
161763912|NCT02418000|584174290|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763913|NCT02418000|584174286|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
161763914|NCT02418000|584174287|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
161763915|NCT02418000|584174288|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
161763916|NCT02418000|584174289|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
161763917|NCT02418000|584174290|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
161763918|NCT02418000|584174286|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763919|NCT02418000|584174287|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763920|NCT02418000|584174288|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763921|NCT02418000|584174289|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161763922|NCT02418000|584174290|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
161763923|NCT00490815|584174291|FG000|Overall Study|Adverse Event|2|||
161763924|NCT00490815|584174292|FG001|Overall Study|Adverse Event|3|||
161763925|NCT00490815|584174291|FG000|Overall Study|Withdrawal by Subject|4|||
161763926|NCT00490815|584174292|FG001|Overall Study|Withdrawal by Subject|0|||
161763927|NCT00490815|584174291|FG000|Overall Study|Lost to Follow-up|1|||
161763928|NCT00490815|584174292|FG001|Overall Study|Lost to Follow-up|3|||
161763929|NCT00490815|584174291|FG000|Overall Study|Death|1|||
161763930|NCT00490815|584174292|FG001|Overall Study|Death|3|||
161763931|NCT01904760|584174293|FG000|Overall Study|Protocol Violation|1|||
161763932|NCT01904760|584174294|FG001|Overall Study|Protocol Violation|0|||
161763933|NCT04249076|584174296|FG000|Overall Study|Adverse Event|1|||
161763934|NCT04249076|584174297|FG001|Overall Study|Adverse Event|1|||
161763935|NCT04249076|584174296|FG000|Overall Study|Protocol Violation|1|||
161763936|NCT04249076|584174297|FG001|Overall Study|Protocol Violation|2|||
161763937|NCT04249076|584174296|FG000|Overall Study|Lack of Efficacy|0|||
161763938|NCT04249076|584174297|FG001|Overall Study|Lack of Efficacy|1|||
161763939|NCT04249076|584174296|FG000|Overall Study|Withdrawal by Subject|0|||
161763940|NCT04249076|584174297|FG001|Overall Study|Withdrawal by Subject|1|||
161763941|NCT00783263|584174298|FG000|Overall Study|Adverse Event|3|||
161763942|NCT00783263|584174299|FG001|Overall Study|Adverse Event|0|||
161763943|NCT00783263|584174300|FG002|Overall Study|Adverse Event|2|||
161763944|NCT00783263|584174301|FG003|Overall Study|Adverse Event|1|||
161763945|NCT00783263|584174298|FG000|Overall Study|Lost to Follow-up|1|||
161763946|NCT00783263|584174299|FG001|Overall Study|Lost to Follow-up|1|||
161763947|NCT00783263|584174300|FG002|Overall Study|Lost to Follow-up|0|||
161763948|NCT00783263|584174301|FG003|Overall Study|Lost to Follow-up|0|||
161763949|NCT00783263|584174298|FG000|Overall Study|Withdrawal by Subject|0|||
161972213|NCT04706273|584945862|FG000|Overall Study|Unable to attend hospital|2|||
161972214|NCT03541187|584945865|FG000|Overall Study|Lost to Follow-up|2|||
161972215|NCT03541187|584945866|FG001|Overall Study|Lost to Follow-up|6|||
161849192|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
161849193|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
161849194|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
161849195|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
161849196|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
161849197|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
161849198|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
161849199|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
161849200|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
161849201|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
161849202|NCT03713619|584488939|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
161849203|NCT03713619|584488940|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
161849204|NCT03713619|584488941|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
161849205|NCT03713619|584488942|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
161849206|NCT03713619|584488943|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
161849207|NCT03713619|584488939|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
161849208|NCT03713619|584488940|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
161849209|NCT03713619|584488941|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
161849210|NCT03713619|584488942|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
161849211|NCT03713619|584488943|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
161849212|NCT03713619|584488939|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
161849213|NCT03713619|584488940|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161849214|NCT03713619|584488941|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161849215|NCT03713619|584488942|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
161849216|NCT03713619|584488943|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161849217|NCT03713619|584488939|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
161849218|NCT03713619|584488940|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
161849219|NCT03713619|584488941|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
161849220|NCT03713619|584488942|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
161849221|NCT03713619|584488943|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
161849222|NCT03713619|584488939|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
161849223|NCT03713619|584488940|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
161849224|NCT03713619|584488941|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
161849225|NCT03713619|584488942|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
161849226|NCT03713619|584488943|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
161849227|NCT03713619|584488939|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
161849228|NCT03713619|584488940|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
161849229|NCT03713619|584488941|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
161849230|NCT03713619|584488942|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
161849231|NCT03713619|584488943|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
161849232|NCT03713619|584488939|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
161849233|NCT03713619|584488940|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
161849234|NCT03713619|584488941|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
161849235|NCT03713619|584488942|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
161849236|NCT03713619|584488943|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
161849237|NCT03553576|584488944|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
161849238|NCT03553576|584488945|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
161849239|NCT03553576|584488944|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
161849240|NCT03553576|584488945|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
161849241|NCT03553576|584488944|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
161849242|NCT03553576|584488945|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
161849243|NCT03553576|584488944|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
161849244|NCT03553576|584488945|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
161972216|NCT03541187|584945865|FG000|Overall Study|Pregnancy|0|||
161972217|NCT03541187|584945866|FG001|Overall Study|Pregnancy|1|||
161972218|NCT03541187|584945865|FG000|Overall Study|Withdrawal by Subject|6|||
161972219|NCT03541187|584945866|FG001|Overall Study|Withdrawal by Subject|2|||
161972220|NCT03541187|584945865|FG000|Overall Study|Moved out of town|1|||
161972221|NCT03541187|584945866|FG001|Overall Study|Moved out of town|0|||
161972222|NCT03541187|584945865|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
161972223|NCT03541187|584945866|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
161972224|NCT03541187|584945865|FG000|Overall Study|Did not meet randomization criteria|1|||
161972225|NCT03541187|584945866|FG001|Overall Study|Did not meet randomization criteria|1|||
161972226|NCT03541187|584945865|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
161972227|NCT03541187|584945866|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
162033471|NCT01293799|585180106|FG001|Overall Study|Other causes|3|||
162033472|NCT02283177|585180109|FG000|Overall Study|Withdrawal by Subject|1|||
162033473|NCT02283177|585180110|FG001|Overall Study|Withdrawal by Subject|1|||
162033474|NCT02635646|585180112|FG000|Overall Study|Lost to Follow-up|24|||
162033475|NCT02635646|585180113|FG001|Overall Study|Lost to Follow-up|25|||
162033476|NCT02635646|585180112|FG000|Overall Study|Pregnancy|1|||
162033477|NCT02635646|585180113|FG001|Overall Study|Pregnancy|1|||
162033478|NCT00327470|585180122|FG000|Overall Study|Randomized, but not treated|0|||
162033479|NCT00327470|585180123|FG001|Overall Study|Randomized, but not treated|2|||
162033480|NCT00327470|585180122|FG000|Overall Study|Adverse Event|9|||
162033481|NCT00327470|585180123|FG001|Overall Study|Adverse Event|14|||
162033482|NCT00327470|585180122|FG000|Overall Study|Lack of Efficacy|7|||
162033483|NCT00327470|585180123|FG001|Overall Study|Lack of Efficacy|19|||
161849245|NCT03553576|584488944|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
161849246|NCT03553576|584488945|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
161849247|NCT03553576|584488944|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
161849248|NCT03553576|584488945|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
161849249|NCT03553576|584488944|FG000|Overall Study|Physician Decision|2|||
161849250|NCT03553576|584488945|FG001|Overall Study|Physician Decision|5|||
161849251|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
161849252|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
161849253|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
161849254|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
161849255|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
161849256|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
161849257|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
161849258|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
161849259|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
161849260|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
161849261|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
161849262|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
161849263|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
161849264|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
161849265|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
161849266|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
161849267|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
161849268|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
161849269|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
161849270|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
161849271|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
161849272|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
161849273|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
161849274|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
161849275|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
161849276|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
161849277|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
161849278|NCT02552212|584488946|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
161849279|NCT02552212|584488947|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
161849280|NCT02552212|584488948|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
161849281|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
161849282|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
161849283|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
161849284|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
161849285|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
161849286|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
161849287|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
161849288|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
161849289|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
161849290|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
161849291|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
161849292|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
162033484|NCT00327470|585180122|FG000|Overall Study|Other|5|||
162033485|NCT00327470|585180123|FG001|Overall Study|Other|9|||
162033486|NCT00327470|585180122|FG000|Overall Study|Lost to Follow-up|1|||
162033487|NCT00327470|585180123|FG001|Overall Study|Lost to Follow-up|3|||
162033488|NCT00327470|585180122|FG000|Overall Study|Withdrawal by Subject|6|||
162033489|NCT00327470|585180123|FG001|Overall Study|Withdrawal by Subject|12|||
162033490|NCT00327470|585180122|FG000|Overall Study|Death|1|||
162033491|NCT00327470|585180123|FG001|Overall Study|Death|4|||
162033492|NCT00745615|585180130|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
161849293|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
161849294|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
161849295|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
161849296|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
161849297|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
161849298|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
161849299|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
161849300|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
161849301|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
161849302|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
161849303|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
161849304|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
161849305|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
161849306|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
161849307|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
161849308|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
161849309|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
161849310|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
161849311|NCT02552212|584488946|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
161849312|NCT02552212|584488947|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
161849313|NCT02552212|584488948|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
161849314|NCT01094886|584488951|FG000|Overall Study|Adverse Event|2|||
161849315|NCT01094886|584488951|FG000|Overall Study|Withdrawal by Subject|5|||
161849316|NCT02013674|584488952|FG000|Overall Study|Death|0|||
161849317|NCT02013674|584488953|FG001|Overall Study|Death|1|||
161849318|NCT02013674|584488952|FG000|Overall Study|Lost to Follow-up|1|||
161849319|NCT02013674|584488953|FG001|Overall Study|Lost to Follow-up|0|||
161849320|NCT01371747|584491062|FG000|Overall Study|Adverse Event|4|||
161849321|NCT01371747|584491063|FG001|Overall Study|Adverse Event|2|||
161849322|NCT01371747|584491064|FG002|Overall Study|Adverse Event|7|||
161849323|NCT01371747|584491065|FG003|Overall Study|Adverse Event|2|||
161849324|NCT01371747|584491066|FG004|Overall Study|Adverse Event|2|||
161849325|NCT01371747|584491067|FG005|Overall Study|Adverse Event|2|||
161849326|NCT01371747|584491062|FG000|Overall Study|Death|1|||
161849327|NCT01371747|584491063|FG001|Overall Study|Death|0|||
161849328|NCT01371747|584491064|FG002|Overall Study|Death|4|||
161849329|NCT01371747|584491065|FG003|Overall Study|Death|1|||
161849330|NCT01371747|584491066|FG004|Overall Study|Death|2|||
161849331|NCT01371747|584491067|FG005|Overall Study|Death|0|||
161849332|NCT01371747|584491062|FG000|Overall Study|Abnormal Renal Function|0|||
161849333|NCT01371747|584491063|FG001|Overall Study|Abnormal Renal Function|2|||
161849334|NCT01371747|584491064|FG002|Overall Study|Abnormal Renal Function|0|||
161849335|NCT01371747|584491065|FG003|Overall Study|Abnormal Renal Function|1|||
161849336|NCT01371747|584491066|FG004|Overall Study|Abnormal Renal Function|0|||
161849337|NCT01371747|584491067|FG005|Overall Study|Abnormal Renal Function|1|||
161849338|NCT01371747|584491062|FG000|Overall Study|High Serum Potassium Results|1|||
161849339|NCT01371747|584491063|FG001|Overall Study|High Serum Potassium Results|1|||
161849340|NCT01371747|584491064|FG002|Overall Study|High Serum Potassium Results|1|||
161849341|NCT01371747|584491065|FG003|Overall Study|High Serum Potassium Results|2|||
161849342|NCT01371747|584491066|FG004|Overall Study|High Serum Potassium Results|0|||
161849343|NCT01371747|584491067|FG005|Overall Study|High Serum Potassium Results|2|||
161849344|NCT01371747|584491062|FG000|Overall Study|Low Serum Potassium Results|1|||
161849345|NCT01371747|584491063|FG001|Overall Study|Low Serum Potassium Results|1|||
161849346|NCT01371747|584491064|FG002|Overall Study|Low Serum Potassium Results|1|||
161849347|NCT01371747|584491065|FG003|Overall Study|Low Serum Potassium Results|1|||
161849348|NCT01371747|584491066|FG004|Overall Study|Low Serum Potassium Results|0|||
161849349|NCT01371747|584491067|FG005|Overall Study|Low Serum Potassium Results|3|||
161849350|NCT01371747|584491062|FG000|Overall Study|Protocol Violation|0|||
161849351|NCT01371747|584491063|FG001|Overall Study|Protocol Violation|0|||
161849352|NCT01371747|584491064|FG002|Overall Study|Protocol Violation|1|||
161849353|NCT01371747|584491065|FG003|Overall Study|Protocol Violation|0|||
161849354|NCT01371747|584491066|FG004|Overall Study|Protocol Violation|0|||
161849355|NCT01371747|584491067|FG005|Overall Study|Protocol Violation|0|||
161849356|NCT01371747|584491062|FG000|Overall Study|Non-Compliance|3|||
161849357|NCT01371747|584491063|FG001|Overall Study|Non-Compliance|4|||
161849358|NCT01371747|584491064|FG002|Overall Study|Non-Compliance|3|||
161849359|NCT01371747|584491065|FG003|Overall Study|Non-Compliance|0|||
161849360|NCT01371747|584491066|FG004|Overall Study|Non-Compliance|0|||
161849361|NCT01371747|584491067|FG005|Overall Study|Non-Compliance|1|||
161849362|NCT01371747|584491062|FG000|Overall Study|Physician Decision|0|||
161849363|NCT01371747|584491063|FG001|Overall Study|Physician Decision|0|||
161849364|NCT01371747|584491064|FG002|Overall Study|Physician Decision|0|||
161849365|NCT01371747|584491065|FG003|Overall Study|Physician Decision|0|||
161849366|NCT01371747|584491066|FG004|Overall Study|Physician Decision|1|||
161849367|NCT01371747|584491067|FG005|Overall Study|Physician Decision|0|||
161972228|NCT03541187|584945865|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
161972229|NCT03541187|584945866|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
161972230|NCT00869050|584945870|FG000|Overall Study|Screen Failure|3|||
161972231|NCT03263923|584945871|FG000|Overall Study|Withdrawal by Subject|10|||
161972232|NCT03263923|584945872|FG001|Overall Study|Withdrawal by Subject|8|||
161972233|NCT03263923|584945871|FG000|Overall Study|Lost to Follow-up|15|||
161972234|NCT03263923|584945872|FG001|Overall Study|Lost to Follow-up|13|||
161972235|NCT01118520|584945873|FG000|Overall Study|AAA repair|9|||
161972236|NCT01118520|584945874|FG001|Overall Study|AAA repair|7|||
161972237|NCT01118520|584945875|FG002|Overall Study|AAA repair|9|||
161972238|NCT01118520|584945873|FG000|Overall Study|Adverse Event|3|||
161972239|NCT01118520|584945874|FG001|Overall Study|Adverse Event|3|||
161972240|NCT01118520|584945875|FG002|Overall Study|Adverse Event|3|||
161972241|NCT01118520|584945873|FG000|Overall Study|Withdrawal by Subject|8|||
161849368|NCT01371747|584491062|FG000|Overall Study|Withdrawal by Subject|6|||
161849369|NCT01371747|584491063|FG001|Overall Study|Withdrawal by Subject|12|||
161849370|NCT01371747|584491064|FG002|Overall Study|Withdrawal by Subject|5|||
161849371|NCT01371747|584491065|FG003|Overall Study|Withdrawal by Subject|2|||
161849372|NCT01371747|584491066|FG004|Overall Study|Withdrawal by Subject|2|||
161849373|NCT01371747|584491067|FG005|Overall Study|Withdrawal by Subject|4|||
161849374|NCT01371747|584491062|FG000|Overall Study|Other Reasons|2|||
161849375|NCT01371747|584491063|FG001|Overall Study|Other Reasons|1|||
161849376|NCT01371747|584491064|FG002|Overall Study|Other Reasons|2|||
161849377|NCT01371747|584491065|FG003|Overall Study|Other Reasons|0|||
161849378|NCT01371747|584491066|FG004|Overall Study|Other Reasons|0|||
161849379|NCT01371747|584491067|FG005|Overall Study|Other Reasons|1|||
161849380|NCT03092219|584491068|FG000|Overall Study|Protocol Violation|7|||
161849381|NCT03092219|584491069|FG001|Overall Study|Protocol Violation|4|||
161849382|NCT05013008|584491073|FG000|Overall Study|Exclusion from mBFAS|5|||
161849383|NCT05013008|584491074|FG001|Overall Study|Exclusion from mBFAS|25|||
161849384|NCT02094417|584491078|FG000|Overall Study|Adverse Event|0|||
161849385|NCT02094417|584491079|FG001|Overall Study|Adverse Event|0|||
161849386|NCT02094417|584491080|FG002|Overall Study|Adverse Event|0|||
161849387|NCT02094417|584491081|FG003|Overall Study|Adverse Event|1|||
161849388|NCT02094417|584491078|FG000|Overall Study|Eligibility criteria|0|||
161849389|NCT02094417|584491079|FG001|Overall Study|Eligibility criteria|1|||
161849390|NCT02094417|584491080|FG002|Overall Study|Eligibility criteria|0|||
161849391|NCT02094417|584491081|FG003|Overall Study|Eligibility criteria|0|||
161849392|NCT02094417|584491078|FG000|Overall Study|No responder|4|||
161849393|NCT02094417|584491079|FG001|Overall Study|No responder|4|||
161849394|NCT02094417|584491080|FG002|Overall Study|No responder|4|||
161849395|NCT02094417|584491081|FG003|Overall Study|No responder|3|||
161849396|NCT02094417|584491078|FG000|Overall Study|Unable to conduct observations or assess|0|||
161849397|NCT02094417|584491079|FG001|Overall Study|Unable to conduct observations or assess|1|||
161849398|NCT02094417|584491080|FG002|Overall Study|Unable to conduct observations or assess|0|||
161849399|NCT02094417|584491081|FG003|Overall Study|Unable to conduct observations or assess|0|||
161849400|NCT02094417|584491078|FG000|Overall Study|Withdrawal by Subject|1|||
161849401|NCT02094417|584491079|FG001|Overall Study|Withdrawal by Subject|2|||
161849402|NCT02094417|584491080|FG002|Overall Study|Withdrawal by Subject|1|||
161849403|NCT02094417|584491081|FG003|Overall Study|Withdrawal by Subject|3|||
161849404|NCT01443728|584491084|FG000|Overall Study|Lost to Follow-up|2|||
161849405|NCT01443728|584491085|FG001|Overall Study|Lost to Follow-up|0|||
161849406|NCT01443728|584491084|FG000|Overall Study|Withdrawal by Subject|1|||
161849407|NCT01443728|584491085|FG001|Overall Study|Withdrawal by Subject|1|||
161849408|NCT01443728|584491084|FG000|Overall Study|Adverse Event|0|||
161849409|NCT01443728|584491085|FG001|Overall Study|Adverse Event|2|||
161849410|NCT04971187|584491086|FG000|Overall Study|Screen failures|2|||
161849411|NCT04981717|584491092|FG000|Overall Study|Protocol Violation|0|||
161849412|NCT04981717|584491093|FG001|Overall Study|Protocol Violation|3|||
161849413|NCT04981717|584491092|FG000|Overall Study|Adverse Event|1|||
161849414|NCT04981717|584491093|FG001|Overall Study|Adverse Event|3|||
161849415|NCT04981717|584491092|FG000|Overall Study|Pregnancy|1|||
161849416|NCT04981717|584491093|FG001|Overall Study|Pregnancy|0|||
161849417|NCT04981717|584491092|FG000|Overall Study|Physician Decision|1|||
161849418|NCT04981717|584491093|FG001|Overall Study|Physician Decision|0|||
161849419|NCT04981717|584491092|FG000|Overall Study|Sponsor Request|157|||
161972242|NCT01118520|584945874|FG001|Overall Study|Withdrawal by Subject|13|||
161972243|NCT01118520|584945875|FG002|Overall Study|Withdrawal by Subject|8|||
161849420|NCT04981717|584491093|FG001|Overall Study|Sponsor Request|172|||
161849421|NCT04981717|584491092|FG000|Overall Study|Lost to Follow-up|4|||
161849422|NCT04981717|584491093|FG001|Overall Study|Lost to Follow-up|5|||
161849423|NCT04981717|584491092|FG000|Overall Study|Withdrawal by Subject|50|||
161849424|NCT04981717|584491093|FG001|Overall Study|Withdrawal by Subject|37|||
161849425|NCT02207634|584491094|FG000|Overall Study|Withdrawal by Subject|21|||
161849426|NCT02207634|584491095|FG001|Overall Study|Withdrawal by Subject|31|||
161972244|NCT03883113|584945894|FG000|Overall Study|Physician Decision|4|||
161972245|NCT03883113|584945895|FG001|Overall Study|Physician Decision|2|||
161849427|NCT02207634|584491094|FG000|Overall Study|Lost to Follow-up|1|||
161849428|NCT02207634|584491095|FG001|Overall Study|Lost to Follow-up|0|||
161849429|NCT01207583|584491098|FG000|Overall Study|Withdrawal by Subject|0|||
161849430|NCT01207583|584491099|FG001|Overall Study|Withdrawal by Subject|3|||
161849431|NCT01207583|584491100|FG002|Overall Study|Withdrawal by Subject|1|||
161849432|NCT01207583|584491098|FG000|Overall Study|Participant failed to return|1|||
161849433|NCT01207583|584491099|FG001|Overall Study|Participant failed to return|0|||
161849434|NCT01207583|584491100|FG002|Overall Study|Participant failed to return|0|||
161849435|NCT01207583|584491098|FG000|Overall Study|Lost to Follow-up|0|||
161849436|NCT01207583|584491099|FG001|Overall Study|Lost to Follow-up|2|||
161849437|NCT01207583|584491100|FG002|Overall Study|Lost to Follow-up|0|||
161849438|NCT01433549|584491102|FG000|Phase 2: Second Study Product|Adverse Event|0|||
161849439|NCT01433549|584491103|FG001|Phase 2: Second Study Product|Adverse Event|1|||
161849440|NCT01696058|584491105|FG000|Overall Study|Adverse Event|21|||
161849441|NCT01696058|584491106|FG001|Overall Study|Adverse Event|11|||
161849442|NCT01696058|584491105|FG000|Overall Study|Lack of Efficacy|2|||
161849443|NCT01696058|584491106|FG001|Overall Study|Lack of Efficacy|3|||
161849444|NCT01696058|584491105|FG000|Overall Study|Protocol Violation|9|||
161849445|NCT01696058|584491106|FG001|Overall Study|Protocol Violation|3|||
161849446|NCT01696058|584491105|FG000|Overall Study|Lost to Follow-up|2|||
161849447|NCT01696058|584491106|FG001|Overall Study|Lost to Follow-up|5|||
161849448|NCT01696058|584491105|FG000|Overall Study|Withdrawal by Subject|4|||
161849449|NCT01696058|584491106|FG001|Overall Study|Withdrawal by Subject|6|||
161849450|NCT01696058|584491105|FG000|Overall Study|Other reason prematurely discontinued|5|||
161849451|NCT01696058|584491106|FG001|Overall Study|Other reason prematurely discontinued|3|||
161849452|NCT02186834|584491108|FG000|Dose Escalation|Death|0|||
161849453|NCT02186834|584491109|FG001|Dose Escalation|Death|0|||
161849454|NCT02186834|584491110|FG002|Dose Escalation|Death|0|||
161849455|NCT02186834|584491111|FG003|Dose Escalation|Death|1|||
161849456|NCT02186834|584491112|FG004|Dose Escalation|Death|0|||
161849457|NCT02186834|584491113|FG005|Dose Escalation|Death|0|||
161849458|NCT02186834|584491108|FG000|Treatment at RP2D|Died prior to treatment|0|||
161849459|NCT02186834|584491109|FG001|Treatment at RP2D|Died prior to treatment|0|||
161849460|NCT02186834|584491110|FG002|Treatment at RP2D|Died prior to treatment|0|||
161849461|NCT02186834|584491111|FG003|Treatment at RP2D|Died prior to treatment|0|||
161849462|NCT02186834|584491112|FG004|Treatment at RP2D|Died prior to treatment|0|||
161849463|NCT02186834|584491113|FG005|Treatment at RP2D|Died prior to treatment|1|||
161849464|NCT04581369|584491114|FG000|Overall Study|Death|7|||
161849465|NCT04581369|584491115|FG001|Overall Study|Death|6|||
161849466|NCT04581369|584491116|FG002|Overall Study|Death|0|||
161849467|NCT04581369|584491114|FG000|Overall Study|Lost to Follow-up|7|||
161849468|NCT04581369|584491115|FG001|Overall Study|Lost to Follow-up|3|||
161849469|NCT04581369|584491116|FG002|Overall Study|Lost to Follow-up|0|||
161849470|NCT04581369|584491114|FG000|Overall Study|liver transplant|2|||
161849471|NCT04581369|584491115|FG001|Overall Study|liver transplant|2|||
161849472|NCT04581369|584491116|FG002|Overall Study|liver transplant|0|||
161849473|NCT04581369|584491114|FG000|Overall Study|transitioned to hospice care|0|||
161849474|NCT04581369|584491115|FG001|Overall Study|transitioned to hospice care|5|||
161849475|NCT04581369|584491116|FG002|Overall Study|transitioned to hospice care|0|||
161849476|NCT04746794|584491119|FG000|Overall Study|Did not complete any study assessment|50303|||
161849477|NCT04746794|584491120|FG001|Overall Study|Did not complete any study assessment|44997|||
161849478|NCT02538965|584491121|FG000|Treatment Period|Other = Death due to disease progression|1|||
161849479|NCT02538965|584491121|FG000|Treatment Period|Adverse Event|2|||
161849480|NCT02538965|584491121|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
161849481|NCT02538965|584491121|FG000|Treatment Period|Treatment Failure|9|||
161849482|NCT02538965|584491121|FG000|Treatment Period|Disease Progression|1|||
161849483|NCT02538965|584491121|FG000|Treatment Period|Physician Decision|2|||
161849484|NCT02538965|584491121|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
161849485|NCT02538965|584491121|FG000|Follow-Up Period|Withdrawal by Parent|4|||
161849486|NCT00875797|584491122|FG000|Overall Study|Protocol Violation|6|||
161849487|NCT00875797|584491123|FG001|Overall Study|Protocol Violation|3|||
161849488|NCT00253448|584491126|FG000|Overall Study|Withdrawal by Subject|1|||
161849489|NCT02564887|584491128|FG000|Overall Study|Lost to Follow-up|6|||
161849490|NCT02564887|584491129|FG001|Overall Study|Lost to Follow-up|0|||
161849491|NCT02052011|584491132|FG000|Overall Study|Lost to Follow-up|3|||
161849492|NCT02052011|584491133|FG001|Overall Study|Lost to Follow-up|0|||
161849493|NCT02052011|584491132|FG000|Overall Study|Withdrawal by Subject|1|||
161849494|NCT02052011|584491133|FG001|Overall Study|Withdrawal by Subject|2|||
161849495|NCT00000620|584491134|FG000|Overall Study|Death|86|||
161849496|NCT00000620|584491135|FG001|Overall Study|Death|67|||
161849497|NCT00000620|584491136|FG002|Overall Study|Death|112|||
161849498|NCT00000620|584491137|FG003|Overall Study|Death|126|||
161849499|NCT00000620|584491138|FG004|Overall Study|Death|64|||
161849500|NCT00000620|584491139|FG005|Overall Study|Death|77|||
161849501|NCT00000620|584491140|FG006|Overall Study|Death|91|||
161849502|NCT00000620|584491141|FG007|Overall Study|Death|95|||
161849503|NCT00000620|584491134|FG000|Overall Study|Lost to Follow-up|14|||
161849504|NCT00000620|584491135|FG001|Overall Study|Lost to Follow-up|14|||
161972246|NCT03883113|584945894|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
161972247|NCT03883113|584945895|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
161972248|NCT03883113|584945894|FG000|Overall Study|Pregnancy|1|||
161972249|NCT03883113|584945895|FG001|Overall Study|Pregnancy|0|||
161972250|NCT03883113|584945894|FG000|Overall Study|Adverse Event|0|||
161972251|NCT03883113|584945895|FG001|Overall Study|Adverse Event|1|||
161972252|NCT03883113|584945894|FG000|Overall Study|Withdrawal by Subject|1|||
161972253|NCT03883113|584945895|FG001|Overall Study|Withdrawal by Subject|2|||
161972254|NCT03883113|584945894|FG000|Overall Study|Lost to Follow-up|1|||
161972255|NCT03883113|584945895|FG001|Overall Study|Lost to Follow-up|0|||
161972256|NCT01396265|584945896|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
161972257|NCT01767493|584945897|FG000|Overall Study|screen failures|3|||
161972258|NCT03023826|584945899|FG000|Period 1|Withdrawal by Subject|0|||
161972259|NCT03023826|584945900|FG001|Period 1|Withdrawal by Subject|0|||
161972260|NCT03023826|584945901|FG002|Period 1|Withdrawal by Subject|0|||
161972261|NCT03023826|584945902|FG003|Period 1|Withdrawal by Subject|0|||
161972262|NCT03023826|584945903|FG004|Period 1|Withdrawal by Subject|1|||
161972263|NCT03023826|584945904|FG005|Period 1|Withdrawal by Subject|0|||
161972264|NCT00977938|584945905|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
161972265|NCT00977938|584945906|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
161972266|NCT00977938|584945907|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
161972267|NCT00977938|584945908|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
161972268|NCT00977938|584945905|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
161972269|NCT00977938|584945906|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
161972270|NCT00977938|584945907|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
161972271|NCT00977938|584945908|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
161972272|NCT00977938|584945905|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
161972273|NCT00977938|584945906|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
161972274|NCT00977938|584945907|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
161972275|NCT00977938|584945908|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
161972276|NCT00977938|584945905|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
161972277|NCT00977938|584945906|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
161972278|NCT00977938|584945907|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
161972279|NCT00977938|584945908|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
161972280|NCT00977938|584945905|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
161972281|NCT00977938|584945906|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
161972282|NCT00977938|584945907|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
161972283|NCT00977938|584945908|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
161972284|NCT00977938|584945905|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
161972285|NCT00977938|584945906|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
161972286|NCT00977938|584945907|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
161972287|NCT00977938|584945908|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
161972288|NCT01371643|584945910|FG000|Overall Study|Withdrawal by Subject|3|||
161972289|NCT01371643|584945911|FG001|Overall Study|Withdrawal by Subject|0|||
161972290|NCT02182440|584945921|FG000|Overall Study|Adverse Event|0|||
161972291|NCT02182440|584945922|FG001|Overall Study|Adverse Event|1|||
161972292|NCT02182440|584945923|FG002|Overall Study|Adverse Event|0|||
161972293|NCT02182440|584945924|FG003|Overall Study|Adverse Event|0|||
161972294|NCT02182440|584945921|FG000|Overall Study|Death|31|||
161972295|NCT02182440|584945922|FG001|Overall Study|Death|8|||
161972296|NCT02182440|584945923|FG002|Overall Study|Death|5|||
161972297|NCT02182440|584945924|FG003|Overall Study|Death|16|||
161972298|NCT02182440|584945921|FG000|Overall Study|Protocol Violation|0|||
161972299|NCT02182440|584945922|FG001|Overall Study|Protocol Violation|1|||
161972300|NCT02182440|584945923|FG002|Overall Study|Protocol Violation|0|||
161972301|NCT02182440|584945924|FG003|Overall Study|Protocol Violation|0|||
161972302|NCT02182440|584945921|FG000|Overall Study|Physician Decision|1|||
161972303|NCT02182440|584945922|FG001|Overall Study|Physician Decision|0|||
161972304|NCT02182440|584945923|FG002|Overall Study|Physician Decision|0|||
161972305|NCT02182440|584945924|FG003|Overall Study|Physician Decision|0|||
161972306|NCT02182440|584945921|FG000|Overall Study|Withdrawal by Subject|1|||
161972307|NCT02182440|584945922|FG001|Overall Study|Withdrawal by Subject|1|||
161972308|NCT02182440|584945923|FG002|Overall Study|Withdrawal by Subject|3|||
161972309|NCT02182440|584945924|FG003|Overall Study|Withdrawal by Subject|4|||
161972310|NCT02182440|584945921|FG000|Overall Study|different, e.g adm other hospital|12|||
161972311|NCT02182440|584945922|FG001|Overall Study|different, e.g adm other hospital|3|||
161972312|NCT02182440|584945923|FG002|Overall Study|different, e.g adm other hospital|3|||
161972313|NCT02182440|584945924|FG003|Overall Study|different, e.g adm other hospital|10|||
161972314|NCT00072293|584945927|FG000|Overall Study|Lost to Follow-up|1|||
161972315|NCT00072293|584945928|FG001|Overall Study|Lost to Follow-up|1|||
161972316|NCT00072293|584945927|FG000|Overall Study|Withdrawal by Subject|0|||
161763950|NCT00783263|584174299|FG001|Overall Study|Withdrawal by Subject|1|||
161972317|NCT00072293|584945928|FG001|Overall Study|Withdrawal by Subject|1|||
161972318|NCT03754582|584945929|FG000|Treatment Phase|Adverse Event|0|||
161972319|NCT03754582|584945930|FG001|Treatment Phase|Adverse Event|1|||
161972320|NCT03754582|584945931|FG002|Treatment Phase|Adverse Event|0|||
161972321|NCT03754582|584945929|FG000|Follow-up Phase|Other|0|||
161972322|NCT03754582|584945930|FG001|Follow-up Phase|Other|0|||
161972323|NCT03754582|584945931|FG002|Follow-up Phase|Other|1|||
161972324|NCT01561755|584945932|FG000|Overall Study|Lost to Follow-up|0|||
161972325|NCT01561755|584945933|FG001|Overall Study|Lost to Follow-up|1|||
161972326|NCT01605227|584945934|FG000|Overall Study|Did not receive study treatment|2|||
161972327|NCT01605227|584945935|FG001|Overall Study|Did not receive study treatment|3|||
161972328|NCT01605227|584945934|FG000|Overall Study|Adverse Event|228|||
161972329|NCT01605227|584945935|FG001|Overall Study|Adverse Event|42|||
161972330|NCT01605227|584945934|FG000|Overall Study|Progressive Disease|132|||
161972331|NCT01605227|584945935|FG001|Overall Study|Progressive Disease|128|||
161972332|NCT01605227|584945934|FG000|Overall Study|Clinical Deterioration|227|||
161972333|NCT01605227|584945935|FG001|Overall Study|Clinical Deterioration|133|||
161972334|NCT01605227|584945934|FG000|Overall Study|Lost to Follow-up|1|||
161972335|NCT01605227|584945935|FG001|Overall Study|Lost to Follow-up|0|||
161972336|NCT01605227|584945934|FG000|Overall Study|Protocol Violation|1|||
161972337|NCT01605227|584945935|FG001|Overall Study|Protocol Violation|0|||
161972338|NCT01605227|584945934|FG000|Overall Study|Physician Decision|9|||
161972339|NCT01605227|584945935|FG001|Overall Study|Physician Decision|7|||
161972340|NCT01605227|584945934|FG000|Overall Study|Withdrawal by Subject|18|||
161972341|NCT01605227|584945935|FG001|Overall Study|Withdrawal by Subject|14|||
161972342|NCT01605227|584945934|FG000|Overall Study|Sponsor Decision|2|||
161972343|NCT01605227|584945935|FG001|Overall Study|Sponsor Decision|0|||
161972344|NCT01605227|584945934|FG000|Overall Study|Started New Therapy|1|||
161972345|NCT01605227|584945935|FG001|Overall Study|Started New Therapy|0|||
161972346|NCT01605227|584945934|FG000|Overall Study|Subject Decision|0|||
161972347|NCT01605227|584945935|FG001|Overall Study|Subject Decision|1|||
161972348|NCT01605227|584945934|FG000|Overall Study|Dose Held >6 weeks|0|||
161972349|NCT01605227|584945935|FG001|Overall Study|Dose Held >6 weeks|1|||
161972350|NCT01166958|584945936|FG000|Overall Study|Withdrawal by Subject|1|||
161972351|NCT01166958|584945937|FG001|Overall Study|Withdrawal by Subject|0|||
161972352|NCT01286987|584945938|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
161972353|NCT01286987|584945939|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
161972354|NCT01286987|584945940|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
161972355|NCT01286987|584945941|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
161763951|NCT00783263|584174300|FG002|Overall Study|Withdrawal by Subject|1|||
161763952|NCT00783263|584174301|FG003|Overall Study|Withdrawal by Subject|2|||
161763953|NCT00106626|584174302|FG000|Overall Study|Adverse Event|5|||
161763954|NCT00106626|584174303|FG001|Overall Study|Adverse Event|4|||
161763955|NCT00106626|584174304|FG002|Overall Study|Adverse Event|3|||
161763956|NCT00106626|584174305|FG003|Overall Study|Adverse Event|3|||
161763957|NCT00106626|584174302|FG000|Overall Study|Progressive Disease|4|||
161763958|NCT00106626|584174303|FG001|Overall Study|Progressive Disease|1|||
161763959|NCT00106626|584174304|FG002|Overall Study|Progressive Disease|9|||
161763960|NCT00106626|584174305|FG003|Overall Study|Progressive Disease|10|||
161763961|NCT00106626|584174302|FG000|Overall Study|Received radiation on new therapy|1|||
161763962|NCT00106626|584174303|FG001|Overall Study|Received radiation on new therapy|0|||
161763963|NCT00106626|584174304|FG002|Overall Study|Received radiation on new therapy|0|||
161763964|NCT00106626|584174305|FG003|Overall Study|Received radiation on new therapy|0|||
161763965|NCT00106626|584174302|FG000|Overall Study|> 14 day delay in therapy start|0|||
161763966|NCT00106626|584174303|FG001|Overall Study|> 14 day delay in therapy start|1|||
161763967|NCT00106626|584174304|FG002|Overall Study|> 14 day delay in therapy start|0|||
161763968|NCT00106626|584174305|FG003|Overall Study|> 14 day delay in therapy start|0|||
161763969|NCT00732199|584174310|FG000|Overall Study|Withdrawal by Subject|25|||
161763970|NCT00732199|584174311|FG001|Overall Study|Withdrawal by Subject|18|||
161763971|NCT00732199|584174310|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
161763972|NCT00732199|584174311|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
161763973|NCT03018028|584174324|FG000|Overall Study|Withdrawal by Subject|3|||
161763974|NCT03018028|584174325|FG001|Overall Study|Withdrawal by Subject|0|||
161763975|NCT03018028|584174326|FG002|Overall Study|Withdrawal by Subject|1|||
161763976|NCT03018028|584174327|FG003|Overall Study|Withdrawal by Subject|2|||
161763977|NCT03018028|584174328|FG004|Overall Study|Withdrawal by Subject|0|||
161763978|NCT02519777|584174330|FG000|Overall Study|Death|1|||
161763979|NCT02519777|584174331|FG001|Overall Study|Death|0|||
161763980|NCT02519777|584174332|FG002|Overall Study|Death|0|||
161763981|NCT02519777|584174330|FG000|Overall Study|Lost to Follow-up|0|||
161763982|NCT02519777|584174331|FG001|Overall Study|Lost to Follow-up|4|||
161763983|NCT02519777|584174332|FG002|Overall Study|Lost to Follow-up|2|||
161763984|NCT02519777|584174330|FG000|Overall Study|Withdrawal by Subject|3|||
161763985|NCT02519777|584174331|FG001|Overall Study|Withdrawal by Subject|1|||
161763986|NCT02519777|584174332|FG002|Overall Study|Withdrawal by Subject|0|||
161763987|NCT02519777|584174330|FG000|Overall Study|Severe Debilitation|1|||
161763988|NCT02519777|584174331|FG001|Overall Study|Severe Debilitation|1|||
161763989|NCT02519777|584174332|FG002|Overall Study|Severe Debilitation|1|||
161763990|NCT02519777|584174330|FG000|Overall Study|Not able to get to clinic|1|||
161849505|NCT00000620|584491136|FG002|Overall Study|Lost to Follow-up|14|||
161972356|NCT01286987|584945942|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
161972357|NCT01286987|584945943|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
161763991|NCT02519777|584174331|FG001|Overall Study|Not able to get to clinic|2|||
161763992|NCT02519777|584174332|FG002|Overall Study|Not able to get to clinic|1|||
161763993|NCT01284127|584174334|FG000|Overall Study|Adverse Event|2|||
161763994|NCT01284127|584174334|FG000|Overall Study|Withdrawal by Subject|4|||
161763995|NCT01284127|584174334|FG000|Overall Study|Physician Decision|1|||
161763996|NCT00256204|584174336|FG000|Overall Study|Adverse Event|10|||
161763997|NCT00256204|584174337|FG001|Overall Study|Adverse Event|14|||
161763998|NCT00256204|584174338|FG002|Overall Study|Adverse Event|16|||
161763999|NCT00256204|584174339|FG003|Overall Study|Adverse Event|14|||
161764000|NCT00256204|584174336|FG000|Overall Study|Death|0|||
161764001|NCT00256204|584174337|FG001|Overall Study|Death|1|||
161764002|NCT00256204|584174338|FG002|Overall Study|Death|0|||
161764003|NCT00256204|584174339|FG003|Overall Study|Death|0|||
161764004|NCT00256204|584174336|FG000|Overall Study|Lost to Follow-up|1|||
161764005|NCT00256204|584174337|FG001|Overall Study|Lost to Follow-up|1|||
161764006|NCT00256204|584174338|FG002|Overall Study|Lost to Follow-up|1|||
161764007|NCT00256204|584174339|FG003|Overall Study|Lost to Follow-up|2|||
161764008|NCT00256204|584174336|FG000|Overall Study|Protocol Violation|1|||
161764009|NCT00256204|584174337|FG001|Overall Study|Protocol Violation|0|||
161764010|NCT00256204|584174338|FG002|Overall Study|Protocol Violation|2|||
161764011|NCT00256204|584174339|FG003|Overall Study|Protocol Violation|1|||
161764012|NCT00256204|584174336|FG000|Overall Study|Physician Decision|0|||
161764013|NCT00256204|584174337|FG001|Overall Study|Physician Decision|0|||
161764014|NCT00256204|584174338|FG002|Overall Study|Physician Decision|1|||
161764015|NCT00256204|584174339|FG003|Overall Study|Physician Decision|2|||
161764016|NCT00256204|584174336|FG000|Overall Study|Withdrawal by Subject|17|||
161764017|NCT00256204|584174337|FG001|Overall Study|Withdrawal by Subject|6|||
161764018|NCT00256204|584174338|FG002|Overall Study|Withdrawal by Subject|7|||
161764019|NCT00256204|584174339|FG003|Overall Study|Withdrawal by Subject|5|||
161764020|NCT00256204|584174336|FG000|Overall Study|Need for additional prohibited treatment|38|||
161764021|NCT00256204|584174337|FG001|Overall Study|Need for additional prohibited treatment|28|||
161764022|NCT00256204|584174338|FG002|Overall Study|Need for additional prohibited treatment|27|||
161764023|NCT00256204|584174339|FG003|Overall Study|Need for additional prohibited treatment|25|||
161764024|NCT00994890|584174345|FG000|Overall Study|Adverse Event|13|||
161764025|NCT00994890|584174346|FG001|Overall Study|Adverse Event|9|||
161764026|NCT00994890|584174347|FG002|Overall Study|Adverse Event|11|||
161764027|NCT00994890|584174345|FG000|Overall Study|Lack of Efficacy|0|||
161764028|NCT00994890|584174346|FG001|Overall Study|Lack of Efficacy|0|||
161764029|NCT00994890|584174347|FG002|Overall Study|Lack of Efficacy|1|||
161764030|NCT00994890|584174345|FG000|Overall Study|Lost to Follow-up|6|||
161764031|NCT00994890|584174346|FG001|Overall Study|Lost to Follow-up|1|||
161764032|NCT00994890|584174347|FG002|Overall Study|Lost to Follow-up|3|||
161764033|NCT00994890|584174345|FG000|Overall Study|No longer willing to participate|8|||
161764034|NCT00994890|584174346|FG001|Overall Study|No longer willing to participate|5|||
161764035|NCT00994890|584174347|FG002|Overall Study|No longer willing to participate|13|||
161764036|NCT00994890|584174345|FG000|Overall Study|Protocol Violation|2|||
161764037|NCT00994890|584174346|FG001|Overall Study|Protocol Violation|4|||
161764038|NCT00994890|584174347|FG002|Overall Study|Protocol Violation|0|||
161764039|NCT00994890|584174345|FG000|Overall Study|Study terminated by sponsor|199|||
161764040|NCT00994890|584174346|FG001|Overall Study|Study terminated by sponsor|201|||
161764041|NCT00994890|584174347|FG002|Overall Study|Study terminated by sponsor|197|||
161764042|NCT00994890|584174345|FG000|Overall Study|Randomized, but not treated|1|||
161764043|NCT00994890|584174346|FG001|Overall Study|Randomized, but not treated|0|||
161764044|NCT00994890|584174347|FG002|Overall Study|Randomized, but not treated|0|||
161764045|NCT00994890|584174345|FG000|Overall Study|Other|2|||
161764046|NCT00994890|584174346|FG001|Overall Study|Other|2|||
161764047|NCT00994890|584174347|FG002|Overall Study|Other|1|||
161764048|NCT00699582|584174348|FG000|Overall Study|Adverse Event|4|||
161764049|NCT00699582|584174349|FG001|Overall Study|Adverse Event|11|||
161764050|NCT00699582|584174350|FG002|Overall Study|Adverse Event|23|||
161849506|NCT00000620|584491137|FG003|Overall Study|Lost to Follow-up|14|||
161764051|NCT00699582|584174348|FG000|Overall Study|Withdrawal by Subject|6|||
161764052|NCT00699582|584174349|FG001|Overall Study|Withdrawal by Subject|7|||
161764053|NCT00699582|584174350|FG002|Overall Study|Withdrawal by Subject|4|||
161764054|NCT00699582|584174348|FG000|Overall Study|Lack of Efficacy|1|||
161764055|NCT00699582|584174349|FG001|Overall Study|Lack of Efficacy|0|||
161764056|NCT00699582|584174350|FG002|Overall Study|Lack of Efficacy|1|||
161764057|NCT00699582|584174348|FG000|Overall Study|Progressive Disease|1|||
161764058|NCT00699582|584174349|FG001|Overall Study|Progressive Disease|0|||
161764059|NCT00699582|584174350|FG002|Overall Study|Progressive Disease|0|||
161764060|NCT00699582|584174348|FG000|Overall Study|Administrative/Other|4|||
161764061|NCT00699582|584174349|FG001|Overall Study|Administrative/Other|3|||
161764062|NCT00699582|584174350|FG002|Overall Study|Administrative/Other|0|||
161764063|NCT00699582|584174348|FG000|Overall Study|Randomized, Not Treated|2|||
161764064|NCT00699582|584174349|FG001|Overall Study|Randomized, Not Treated|1|||
162033493|NCT00745615|585180131|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
162033494|NCT00745615|585180132|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
162033495|NCT00745615|585180133|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
162033496|NCT00745615|585180134|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
162033497|NCT00745615|585180135|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
162033498|NCT00745615|585180130|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
162033499|NCT00745615|585180131|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
162033500|NCT00745615|585180132|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
162033501|NCT00745615|585180133|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
162033502|NCT00745615|585180134|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
162033503|NCT00745615|585180135|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
162033504|NCT00745615|585180130|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
162033505|NCT00745615|585180131|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
162033506|NCT00745615|585180132|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
162033507|NCT00745615|585180133|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
162033508|NCT00745615|585180134|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
162033509|NCT00745615|585180135|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
162033510|NCT00745615|585180130|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
162033511|NCT00745615|585180131|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
162033512|NCT00745615|585180132|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
162033513|NCT00745615|585180133|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
162033514|NCT00745615|585180134|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
162033515|NCT00745615|585180135|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
162033516|NCT00745615|585180130|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
162033517|NCT00745615|585180131|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
162033518|NCT00745615|585180132|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
162033519|NCT00745615|585180133|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
162033520|NCT00745615|585180134|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
162033521|NCT00745615|585180135|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
162033522|NCT00745615|585180130|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
162033523|NCT00745615|585180131|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
162033524|NCT00745615|585180132|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
162033525|NCT00745615|585180133|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
162033526|NCT00745615|585180134|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
162033527|NCT00745615|585180135|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
162033528|NCT00745615|585180130|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
162033529|NCT00745615|585180131|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
162033530|NCT00745615|585180132|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
162033531|NCT00745615|585180133|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
162033532|NCT00745615|585180134|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
162033533|NCT00745615|585180135|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
162033534|NCT00745615|585180130|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
162033535|NCT00745615|585180131|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
162033536|NCT00745615|585180132|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
162033537|NCT00745615|585180133|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
162033538|NCT00745615|585180134|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
162033539|NCT00745615|585180135|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
162033540|NCT00745615|585180130|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
162033541|NCT00745615|585180131|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
162033542|NCT00745615|585180132|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
162033543|NCT00745615|585180133|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
162033544|NCT00745615|585180134|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
162033545|NCT00745615|585180135|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
162033546|NCT00745615|585180130|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
162033547|NCT00745615|585180131|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
162033548|NCT00745615|585180132|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
162033549|NCT00745615|585180133|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
162033550|NCT00745615|585180134|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
162033551|NCT00745615|585180135|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
162033552|NCT00745615|585180130|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
162033553|NCT00745615|585180131|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
162033554|NCT00745615|585180132|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
162033555|NCT00745615|585180133|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
162033556|NCT00745615|585180134|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
162033557|NCT00745615|585180135|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
161764065|NCT00699582|584174350|FG002|Overall Study|Randomized, Not Treated|0|||
162033558|NCT00745615|585180130|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
162033559|NCT00745615|585180131|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
162033560|NCT00745615|585180132|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
162033561|NCT00745615|585180133|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
162033562|NCT00745615|585180134|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
162033563|NCT00745615|585180135|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
162033564|NCT00745615|585180130|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
162033565|NCT00745615|585180131|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
162033566|NCT00745615|585180132|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
162033567|NCT00745615|585180133|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
162033568|NCT00745615|585180134|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
162033569|NCT00745615|585180135|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
162033570|NCT00745615|585180130|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
162033571|NCT00745615|585180131|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
162033572|NCT00745615|585180132|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
162033573|NCT00745615|585180133|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
162033574|NCT00745615|585180134|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
162033575|NCT00745615|585180135|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
162033576|NCT00570232|585180136|FG000|Overall Study|Adverse Event|10|||
162033577|NCT00570232|585180136|FG000|Overall Study|discontinued due to medical condition|3|||
162033578|NCT00570232|585180136|FG000|Overall Study|discontinued due to recurrence|8|||
162033579|NCT00570232|585180136|FG000|Overall Study|discontinued due to noncompliance|2|||
162033580|NCT01076075|585180137|FG000|Overall Study|Adverse Event|3|||
161972358|NCT01286987|584945944|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
161972359|NCT01286987|584945945|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
161972360|NCT01286987|584945946|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
161972361|NCT01286987|584945947|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
161972362|NCT01286987|584945948|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
161972363|NCT01286987|584945949|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
161972364|NCT01286987|584945950|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
161972365|NCT01286987|584945951|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
161972366|NCT01286987|584945952|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
161972367|NCT01286987|584945938|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
161972368|NCT01286987|584945939|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
161972369|NCT01286987|584945940|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
161972370|NCT01286987|584945941|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
161972371|NCT01286987|584945942|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
161972372|NCT01286987|584945943|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
161972373|NCT01286987|584945944|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
161972374|NCT01286987|584945945|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
161972375|NCT01286987|584945946|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
161972376|NCT01286987|584945947|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
161972377|NCT01286987|584945948|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
161972378|NCT01286987|584945949|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
161972379|NCT01286987|584945950|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
161972380|NCT01286987|584945951|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
161972381|NCT01286987|584945952|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
161972382|NCT01286987|584945938|FG000|Part 1: Dose Escalation|Physician Decision|0|||
161972383|NCT01286987|584945939|FG001|Part 1: Dose Escalation|Physician Decision|0|||
161972384|NCT01286987|584945940|FG002|Part 1: Dose Escalation|Physician Decision|0|||
161972385|NCT01286987|584945941|FG003|Part 1: Dose Escalation|Physician Decision|0|||
161972386|NCT01286987|584945942|FG004|Part 1: Dose Escalation|Physician Decision|1|||
161972387|NCT01286987|584945943|FG005|Part 1: Dose Escalation|Physician Decision|0|||
161972388|NCT01286987|584945944|FG006|Part 1: Dose Escalation|Physician Decision|0|||
161972389|NCT01286987|584945945|FG007|Part 1: Dose Escalation|Physician Decision|0|||
161972390|NCT01286987|584945946|FG008|Part 1: Dose Escalation|Physician Decision|0|||
161972391|NCT01286987|584945947|FG009|Part 1: Dose Escalation|Physician Decision|0|||
161972392|NCT01286987|584945948|FG010|Part 1: Dose Escalation|Physician Decision|0|||
161972393|NCT01286987|584945949|FG011|Part 1: Dose Escalation|Physician Decision|0|||
161972394|NCT01286987|584945950|FG012|Part 1: Dose Escalation|Physician Decision|0|||
161972395|NCT01286987|584945951|FG013|Part 1: Dose Escalation|Physician Decision|0|||
161972396|NCT01286987|584945952|FG014|Part 1: Dose Escalation|Physician Decision|0|||
161972397|NCT01286987|584945938|FG000|Part 2: Dose Expansion|Death|0|||
162033581|NCT01076075|585180138|FG001|Overall Study|Adverse Event|9|||
162033582|NCT01076075|585180137|FG000|Overall Study|Lack of Efficacy|5|||
162033583|NCT01076075|585180138|FG001|Overall Study|Lack of Efficacy|4|||
162033584|NCT01076075|585180137|FG000|Overall Study|Lost to Follow-up|6|||
162033585|NCT01076075|585180138|FG001|Overall Study|Lost to Follow-up|5|||
162033586|NCT01076075|585180137|FG000|Overall Study|other|19|||
162033587|NCT01076075|585180138|FG001|Overall Study|other|9|||
162033588|NCT01076075|585180137|FG000|Overall Study|Protocol Violation|0|||
162033589|NCT01076075|585180138|FG001|Overall Study|Protocol Violation|1|||
162033590|NCT01076075|585180137|FG000|Overall Study|Withdrawal by Subject|8|||
162033591|NCT01076075|585180138|FG001|Overall Study|Withdrawal by Subject|19|||
162033592|NCT01163032|585180143|FG000|Randomization Phase|Withdrawal by Subject|2|||
162033593|NCT01163032|585180144|FG001|Randomization Phase|Withdrawal by Subject|3|||
162033594|NCT01163032|585180145|FG002|Randomization Phase|Withdrawal by Subject|0|||
162033595|NCT01163032|585180143|FG000|Randomization Phase|Adverse Event|3|||
162033596|NCT01163032|585180144|FG001|Randomization Phase|Adverse Event|3|||
162033597|NCT01163032|585180145|FG002|Randomization Phase|Adverse Event|0|||
162033598|NCT01163032|585180143|FG000|Randomization Phase|Protocol Violation|0|||
162033599|NCT01163032|585180144|FG001|Randomization Phase|Protocol Violation|1|||
162033600|NCT01163032|585180145|FG002|Randomization Phase|Protocol Violation|0|||
162033601|NCT01163032|585180143|FG000|Randomization Phase|Various*|5|||
162033602|NCT01163032|585180144|FG001|Randomization Phase|Various*|4|||
162033603|NCT01163032|585180145|FG002|Randomization Phase|Various*|0|||
162033604|NCT01163032|585180143|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
162033605|NCT01163032|585180144|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
162033606|NCT01163032|585180145|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
162033607|NCT01163032|585180143|FG000|Open Label Extension Phase|Adverse Event|0|||
162033608|NCT01163032|585180144|FG001|Open Label Extension Phase|Adverse Event|0|||
162033609|NCT01163032|585180145|FG002|Open Label Extension Phase|Adverse Event|3|||
162033610|NCT01163032|585180143|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
162033611|NCT01163032|585180144|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
162033612|NCT01163032|585180145|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
162033613|NCT01163032|585180143|FG000|Open Label Extension Phase|Protocol Violation|0|||
162033614|NCT01163032|585180144|FG001|Open Label Extension Phase|Protocol Violation|0|||
162033615|NCT01163032|585180145|FG002|Open Label Extension Phase|Protocol Violation|1|||
162033616|NCT01163032|585180143|FG000|Open Label Extension Phase|Study Termination|0|||
162033617|NCT01163032|585180144|FG001|Open Label Extension Phase|Study Termination|0|||
162033618|NCT01163032|585180145|FG002|Open Label Extension Phase|Study Termination|7|||
162033619|NCT01163032|585180143|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
162033620|NCT01163032|585180144|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
162033621|NCT01163032|585180145|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
162033622|NCT02751931|585180147|FG000|Overall Study|Adverse Event|3|||
162033623|NCT02751931|585180148|FG001|Overall Study|Adverse Event|0|||
162033624|NCT02751931|585180147|FG000|Overall Study|Other: Miscelleneous|10|||
162033625|NCT02751931|585180148|FG001|Overall Study|Other: Miscelleneous|8|||
162033626|NCT03326206|585180154|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
162033627|NCT03326206|585180155|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
162033628|NCT03326206|585180154|FG000|Overall Study - 24 months|Death|8|||
162033629|NCT03326206|585180155|FG001|Overall Study - 24 months|Death|92|||
162033630|NCT03326206|585180154|FG000|Overall Study - 24 months|Observational data not available|43|||
162033631|NCT03326206|585180155|FG001|Overall Study - 24 months|Observational data not available|2879|||
162033632|NCT03326206|585180154|FG000|12 months|Unable to match cases with controls|17|||
162033633|NCT03326206|585180155|FG001|12 months|Unable to match cases with controls|22721|||
162033634|NCT03326206|585180154|FG000|12 months|Death|2|||
162033635|NCT03326206|585180155|FG001|12 months|Death|50|||
161764066|NCT01849289|584174351|FG000|Overall Study|Adverse Event|3|||
161764067|NCT01849289|584174352|FG001|Overall Study|Adverse Event|3|||
161764068|NCT01849289|584174351|FG000|Overall Study|Protocol Violation|3|||
161764069|NCT01849289|584174352|FG001|Overall Study|Protocol Violation|3|||
161764070|NCT01849289|584174351|FG000|Overall Study|Withdrawal criteria|1|||
161764071|NCT01849289|584174352|FG001|Overall Study|Withdrawal criteria|0|||
161764072|NCT01849289|584174351|FG000|Overall Study|Unclassified|25|||
161764073|NCT01849289|584174352|FG001|Overall Study|Unclassified|18|||
161764074|NCT01142791|584174363|FG000|Overall Study|Alternative Treatment|1|||
161764075|NCT01142791|584174364|FG001|Overall Study|Alternative Treatment|0|||
161764076|NCT01142791|584174363|FG000|Overall Study|Lost to Follow-up|1|||
161764077|NCT01142791|584174364|FG001|Overall Study|Lost to Follow-up|0|||
161764078|NCT01142791|584174363|FG000|Overall Study|Withdrawal by Subject|5|||
161764079|NCT01142791|584174364|FG001|Overall Study|Withdrawal by Subject|0|||
161764080|NCT01142791|584174363|FG000|Overall Study|Received only 1 sonication|0|||
161764081|NCT01142791|584174364|FG001|Overall Study|Received only 1 sonication|6|||
162033636|NCT03326206|585180154|FG000|12 months|Observational data not available|49|||
161764082|NCT02975206|584174366|FG000|Overall Study|Withdrawal by Subject|14|||
161764083|NCT02975206|584174367|FG001|Overall Study|Withdrawal by Subject|11|||
161764084|NCT02975206|584174368|FG002|Overall Study|Withdrawal by Subject|11|||
162033637|NCT03326206|585180155|FG001|12 months|Observational data not available|2921|||
162033638|NCT04090411|585180156|FG000|Induction Period|Adverse Event|3|||
162033639|NCT04090411|585180157|FG001|Induction Period|Adverse Event|1|||
162033640|NCT04090411|585180158|FG002|Induction Period|Adverse Event|1|||
162033641|NCT04090411|585180159|FG003|Induction Period|Adverse Event|1|||
162033642|NCT04090411|585180160|FG004|Induction Period|Adverse Event|0|||
161764085|NCT02975206|584174366|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
161972398|NCT01286987|584945939|FG001|Part 2: Dose Expansion|Death|0|||
161972399|NCT01286987|584945940|FG002|Part 2: Dose Expansion|Death|0|||
161972400|NCT01286987|584945941|FG003|Part 2: Dose Expansion|Death|0|||
161972401|NCT01286987|584945942|FG004|Part 2: Dose Expansion|Death|0|||
161972402|NCT01286987|584945943|FG005|Part 2: Dose Expansion|Death|0|||
162033643|NCT04090411|585180161|FG005|Induction Period|Adverse Event|0|||
162033644|NCT04090411|585180162|FG006|Induction Period|Adverse Event|0|||
162033645|NCT04090411|585180163|FG007|Induction Period|Adverse Event|0|||
162033646|NCT04090411|585180164|FG008|Induction Period|Adverse Event|0|||
162033647|NCT04090411|585180165|FG009|Induction Period|Adverse Event|0|||
162033648|NCT04090411|585180166|FG010|Induction Period|Adverse Event|0|||
162033649|NCT04090411|585180167|FG011|Induction Period|Adverse Event|0|||
162033650|NCT04090411|585180168|FG012|Induction Period|Adverse Event|0|||
162033651|NCT04090411|585180156|FG000|Induction Period|Lack of Efficacy|0|||
162033652|NCT04090411|585180157|FG001|Induction Period|Lack of Efficacy|0|||
162033653|NCT04090411|585180158|FG002|Induction Period|Lack of Efficacy|1|||
162033654|NCT04090411|585180159|FG003|Induction Period|Lack of Efficacy|1|||
162033655|NCT04090411|585180160|FG004|Induction Period|Lack of Efficacy|0|||
162033656|NCT04090411|585180161|FG005|Induction Period|Lack of Efficacy|0|||
162033657|NCT04090411|585180162|FG006|Induction Period|Lack of Efficacy|0|||
162033658|NCT04090411|585180163|FG007|Induction Period|Lack of Efficacy|0|||
162033659|NCT04090411|585180164|FG008|Induction Period|Lack of Efficacy|0|||
162033660|NCT04090411|585180165|FG009|Induction Period|Lack of Efficacy|0|||
162033661|NCT04090411|585180166|FG010|Induction Period|Lack of Efficacy|0|||
162033662|NCT04090411|585180167|FG011|Induction Period|Lack of Efficacy|0|||
161972403|NCT01286987|584945944|FG006|Part 2: Dose Expansion|Death|0|||
161972404|NCT01286987|584945945|FG007|Part 2: Dose Expansion|Death|0|||
161972405|NCT01286987|584945946|FG008|Part 2: Dose Expansion|Death|0|||
161972406|NCT01286987|584945947|FG009|Part 2: Dose Expansion|Death|0|||
161972407|NCT01286987|584945948|FG010|Part 2: Dose Expansion|Death|0|||
161972408|NCT01286987|584945949|FG011|Part 2: Dose Expansion|Death|0|||
161972409|NCT01286987|584945950|FG012|Part 2: Dose Expansion|Death|1|||
161764086|NCT02975206|584174367|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
161764087|NCT02975206|584174368|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
161764088|NCT01981096|584174369|FG000|Overall Study|Parent illness|1|||
161764089|NCT01981096|584174370|FG001|Overall Study|Parent illness|0|||
161764090|NCT01981096|584174369|FG000|Overall Study|Withdrawal by Subject|0|||
161764091|NCT01981096|584174370|FG001|Overall Study|Withdrawal by Subject|1|||
161764092|NCT01981096|584174369|FG000|Overall Study|Lost to Follow-up|2|||
161764093|NCT01981096|584174370|FG001|Overall Study|Lost to Follow-up|0|||
161764094|NCT04129242|584174372|FG000|Overall Study|Physician Decision|1|||
161764095|NCT04129242|584174373|FG001|Overall Study|Physician Decision|1|||
161764096|NCT04129242|584174372|FG000|Overall Study|Protocol Violation|0|||
161764097|NCT04129242|584174373|FG001|Overall Study|Protocol Violation|1|||
161764098|NCT01899729|584174376|FG000|Overall Study|Adverse Event|1|||
161764099|NCT01899729|584174377|FG001|Overall Study|Adverse Event|0|||
161764100|NCT01899729|584174378|FG002|Overall Study|Adverse Event|0|||
161764101|NCT01899729|584174379|FG003|Overall Study|Adverse Event|0|||
161764102|NCT01899729|584174380|FG004|Overall Study|Adverse Event|1|||
161764103|NCT01899729|584174376|FG000|Overall Study|Withdrawal by Subject|1|||
161764104|NCT01899729|584174377|FG001|Overall Study|Withdrawal by Subject|2|||
161764105|NCT01899729|584174378|FG002|Overall Study|Withdrawal by Subject|0|||
161764106|NCT01899729|584174379|FG003|Overall Study|Withdrawal by Subject|0|||
161764107|NCT01899729|584174380|FG004|Overall Study|Withdrawal by Subject|0|||
161764108|NCT01899729|584174376|FG000|Overall Study|Lack of Efficacy|0|||
161764109|NCT01899729|584174377|FG001|Overall Study|Lack of Efficacy|0|||
161764110|NCT01899729|584174378|FG002|Overall Study|Lack of Efficacy|2|||
161764111|NCT01899729|584174379|FG003|Overall Study|Lack of Efficacy|0|||
161764112|NCT01899729|584174380|FG004|Overall Study|Lack of Efficacy|1|||
161764113|NCT01454531|584174381|FG000|Overall Study|Adverse Event|14|||
161764114|NCT01454531|584174381|FG000|Overall Study|Withdrawal by Subject|5|||
161764115|NCT01454531|584174381|FG000|Overall Study|Lost to Follow-up|1|||
161764116|NCT01454531|584174381|FG000|Overall Study|Physician Decision|1|||
161764117|NCT01454531|584174381|FG000|Overall Study|Delay in IMP administration|1|||
161764118|NCT01454531|584174381|FG000|Overall Study|Other|1|||
161764119|NCT03922945|584176103|FG000|Overall Study|Adverse Event|1|||
162033663|NCT04090411|585180168|FG012|Induction Period|Lack of Efficacy|0|||
162033664|NCT04090411|585180156|FG000|Induction Period|Physician Decision|0|||
162033665|NCT04090411|585180157|FG001|Induction Period|Physician Decision|0|||
162033666|NCT04090411|585180158|FG002|Induction Period|Physician Decision|1|||
162033667|NCT04090411|585180159|FG003|Induction Period|Physician Decision|0|||
161764120|NCT03922945|584176104|FG001|Overall Study|Adverse Event|1|||
161764121|NCT03922945|584176105|FG002|Overall Study|Adverse Event|2|||
161972410|NCT01286987|584945951|FG013|Part 2: Dose Expansion|Death|1|||
162033668|NCT04090411|585180160|FG004|Induction Period|Physician Decision|0|||
162033669|NCT04090411|585180161|FG005|Induction Period|Physician Decision|0|||
161764122|NCT03922945|584176103|FG000|Overall Study|Lost to Follow-up|13|||
161764123|NCT03922945|584176104|FG001|Overall Study|Lost to Follow-up|9|||
161764124|NCT03922945|584176105|FG002|Overall Study|Lost to Follow-up|20|||
161764125|NCT03922945|584176103|FG000|Overall Study|Lack of Efficacy|2|||
161849507|NCT00000620|584491138|FG004|Overall Study|Lost to Follow-up|15|||
161849508|NCT00000620|584491139|FG005|Overall Study|Lost to Follow-up|15|||
161849509|NCT00000620|584491140|FG006|Overall Study|Lost to Follow-up|13|||
161849510|NCT00000620|584491141|FG007|Overall Study|Lost to Follow-up|14|||
161849511|NCT00000620|584491134|FG000|Overall Study|Withdrawal by Subject|40|||
161849512|NCT00000620|584491135|FG001|Overall Study|Withdrawal by Subject|27|||
161849513|NCT00000620|584491136|FG002|Overall Study|Withdrawal by Subject|28|||
161849514|NCT00000620|584491137|FG003|Overall Study|Withdrawal by Subject|27|||
161849515|NCT00000620|584491138|FG004|Overall Study|Withdrawal by Subject|30|||
161849516|NCT00000620|584491139|FG005|Overall Study|Withdrawal by Subject|32|||
161849517|NCT00000620|584491140|FG006|Overall Study|Withdrawal by Subject|32|||
161849518|NCT00000620|584491141|FG007|Overall Study|Withdrawal by Subject|21|||
161849519|NCT00000620|584491134|FG000|Overall Study|missed closeout visit|22|||
161849520|NCT00000620|584491135|FG001|Overall Study|missed closeout visit|28|||
161849521|NCT00000620|584491136|FG002|Overall Study|missed closeout visit|16|||
161849522|NCT00000620|584491137|FG003|Overall Study|missed closeout visit|11|||
161849523|NCT00000620|584491138|FG004|Overall Study|missed closeout visit|26|||
161849524|NCT00000620|584491139|FG005|Overall Study|missed closeout visit|28|||
161849525|NCT00000620|584491140|FG006|Overall Study|missed closeout visit|13|||
161849526|NCT00000620|584491141|FG007|Overall Study|missed closeout visit|16|||
161849527|NCT01590797|584491142|FG000|Overall Study|Adverse Event|4|||
161849528|NCT01590797|584491143|FG001|Overall Study|Adverse Event|3|||
161849529|NCT01590797|584491142|FG000|Overall Study|Lack of Efficacy|0|||
161849530|NCT01590797|584491143|FG001|Overall Study|Lack of Efficacy|2|||
161849531|NCT01590797|584491142|FG000|Overall Study|Lost to Follow-up|0|||
161849532|NCT01590797|584491143|FG001|Overall Study|Lost to Follow-up|1|||
161849533|NCT01590797|584491142|FG000|Overall Study|Protocol Violation|4|||
161849534|NCT01590797|584491143|FG001|Overall Study|Protocol Violation|1|||
161849535|NCT01590797|584491142|FG000|Overall Study|Withdrawal by Subject|7|||
161849536|NCT01590797|584491143|FG001|Overall Study|Withdrawal by Subject|5|||
161849537|NCT01590797|584491142|FG000|Overall Study|Other Protocol Specified Criteria|2|||
161849538|NCT01590797|584491143|FG001|Overall Study|Other Protocol Specified Criteria|4|||
161849539|NCT03106987|584491144|FG000|Overall Study|Death|37|||
161849540|NCT03106987|584491145|FG001|Overall Study|Death|22|||
161849541|NCT03106987|584491146|FG002|Overall Study|Death|12|||
161849542|NCT03106987|584491147|FG003|Overall Study|Death|8|||
161849543|NCT03106987|584491144|FG000|Overall Study|Lost to Follow-up|2|||
161849544|NCT03106987|584491145|FG001|Overall Study|Lost to Follow-up|0|||
161849545|NCT03106987|584491146|FG002|Overall Study|Lost to Follow-up|2|||
161849546|NCT03106987|584491147|FG003|Overall Study|Lost to Follow-up|2|||
161849547|NCT03106987|584491144|FG000|Overall Study|Withdrawal by Subject|5|||
161849548|NCT03106987|584491145|FG001|Overall Study|Withdrawal by Subject|1|||
161849549|NCT03106987|584491146|FG002|Overall Study|Withdrawal by Subject|4|||
161849550|NCT03106987|584491147|FG003|Overall Study|Withdrawal by Subject|1|||
161849551|NCT01307111|584491148|FG000|IUD Insertion|Lost to Follow-up|2|||
161849552|NCT01307111|584491149|FG001|IUD Insertion|Lost to Follow-up|0|||
161849553|NCT01307111|584491148|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
161849554|NCT01307111|584491149|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
161849555|NCT02114385|584491154|FG000|Overall Study|Withdrawal by Subject|3|||
161849556|NCT02114385|584491155|FG001|Overall Study|Withdrawal by Subject|2|||
161849557|NCT02114385|584491154|FG000|Overall Study|Lost to Follow-up|0|||
161849558|NCT02114385|584491155|FG001|Overall Study|Lost to Follow-up|6|||
161849559|NCT02460679|584491156|FG000|Overall Study|Investigator Decision|1|||
161849560|NCT02460679|584491156|FG000|Overall Study|Withdrawal by Subject|4|||
161849561|NCT00339144|584491165|FG000|Overall Study|Disease progression|5|||
161849562|NCT00339144|584491166|FG001|Overall Study|Disease progression|2|||
161849563|NCT00339144|584491167|FG002|Overall Study|Disease progression|2|||
161849564|NCT00339144|584491165|FG000|Overall Study|Study drug toxicity|3|||
161849565|NCT00339144|584491166|FG001|Overall Study|Study drug toxicity|1|||
161849566|NCT00339144|584491167|FG002|Overall Study|Study drug toxicity|1|||
161972411|NCT01286987|584945952|FG014|Part 2: Dose Expansion|Death|0|||
161972412|NCT01286987|584945938|FG000|Part 2: Dose Expansion|Physician Decision|0|||
161972413|NCT01286987|584945939|FG001|Part 2: Dose Expansion|Physician Decision|0|||
161849567|NCT00339144|584491165|FG000|Overall Study|Participant's request to discontinuation|1|||
161972414|NCT01286987|584945940|FG002|Part 2: Dose Expansion|Physician Decision|0|||
161849568|NCT00339144|584491166|FG001|Overall Study|Participant's request to discontinuation|0|||
161849569|NCT00339144|584491167|FG002|Overall Study|Participant's request to discontinuation|1|||
161849570|NCT01267994|584491171|FG000|Overall Study|Adverse Event|2|||
161849571|NCT04642365|584491179|FG000|Overall Study|Death|3|||
161849572|NCT04642365|584491180|FG001|Overall Study|Death|2|||
161849573|NCT04642365|584491181|FG002|Overall Study|Death|4|||
161849574|NCT04642365|584491182|FG003|Overall Study|Death|5|||
161849575|NCT04642365|584491183|FG004|Overall Study|Death|5|||
161849576|NCT04642365|584491184|FG005|Overall Study|Death|3|||
161849577|NCT04642365|584491185|FG006|Overall Study|Death|2|||
161849578|NCT04642365|584491186|FG007|Overall Study|Death|1|||
161849579|NCT04642365|584491179|FG000|Overall Study|Physician Decision|1|||
161849580|NCT04642365|584491180|FG001|Overall Study|Physician Decision|0|||
161849581|NCT04642365|584491181|FG002|Overall Study|Physician Decision|0|||
161849582|NCT04642365|584491182|FG003|Overall Study|Physician Decision|0|||
161849583|NCT04642365|584491183|FG004|Overall Study|Physician Decision|0|||
161849584|NCT04642365|584491184|FG005|Overall Study|Physician Decision|0|||
161849585|NCT04642365|584491185|FG006|Overall Study|Physician Decision|0|||
161849586|NCT04642365|584491186|FG007|Overall Study|Physician Decision|0|||
161849587|NCT04642365|584491179|FG000|Overall Study|Progressive Disease|1|||
161849588|NCT04642365|584491180|FG001|Overall Study|Progressive Disease|1|||
161849589|NCT04642365|584491181|FG002|Overall Study|Progressive Disease|1|||
161849590|NCT04642365|584491182|FG003|Overall Study|Progressive Disease|0|||
161849591|NCT04642365|584491183|FG004|Overall Study|Progressive Disease|0|||
161849592|NCT04642365|584491184|FG005|Overall Study|Progressive Disease|0|||
161849593|NCT04642365|584491185|FG006|Overall Study|Progressive Disease|1|||
161764126|NCT03922945|584176104|FG001|Overall Study|Lack of Efficacy|0|||
161764127|NCT03922945|584176105|FG002|Overall Study|Lack of Efficacy|1|||
161764128|NCT03922945|584176103|FG000|Overall Study|Protocol Non-Compliance|0|||
161764129|NCT03922945|584176104|FG001|Overall Study|Protocol Non-Compliance|0|||
161764130|NCT03922945|584176105|FG002|Overall Study|Protocol Non-Compliance|1|||
161764131|NCT03922945|584176103|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
161764132|NCT03922945|584176104|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
161849594|NCT04642365|584491186|FG007|Overall Study|Progressive Disease|0|||
161849595|NCT04642365|584491179|FG000|Overall Study|Study Terminated By Sponsor|0|||
161849596|NCT04642365|584491180|FG001|Overall Study|Study Terminated By Sponsor|2|||
161849597|NCT04642365|584491181|FG002|Overall Study|Study Terminated By Sponsor|1|||
161849598|NCT04642365|584491182|FG003|Overall Study|Study Terminated By Sponsor|1|||
161849599|NCT04642365|584491183|FG004|Overall Study|Study Terminated By Sponsor|1|||
161849600|NCT04642365|584491184|FG005|Overall Study|Study Terminated By Sponsor|2|||
161849601|NCT04642365|584491185|FG006|Overall Study|Study Terminated By Sponsor|2|||
161849602|NCT04642365|584491186|FG007|Overall Study|Study Terminated By Sponsor|1|||
161849603|NCT04642365|584491179|FG000|Overall Study|Symptomatic Deterioration|1|||
161849604|NCT04642365|584491180|FG001|Overall Study|Symptomatic Deterioration|1|||
161849605|NCT04642365|584491181|FG002|Overall Study|Symptomatic Deterioration|0|||
161849606|NCT04642365|584491182|FG003|Overall Study|Symptomatic Deterioration|0|||
161849607|NCT04642365|584491183|FG004|Overall Study|Symptomatic Deterioration|0|||
161849608|NCT04642365|584491184|FG005|Overall Study|Symptomatic Deterioration|1|||
161849609|NCT04642365|584491185|FG006|Overall Study|Symptomatic Deterioration|0|||
161849610|NCT04642365|584491186|FG007|Overall Study|Symptomatic Deterioration|0|||
161849611|NCT04642365|584491179|FG000|Overall Study|Withdrawal by Subject|0|||
161849612|NCT04642365|584491180|FG001|Overall Study|Withdrawal by Subject|0|||
161849613|NCT04642365|584491181|FG002|Overall Study|Withdrawal by Subject|1|||
161849614|NCT04642365|584491182|FG003|Overall Study|Withdrawal by Subject|1|||
161849615|NCT04642365|584491183|FG004|Overall Study|Withdrawal by Subject|0|||
161849616|NCT04642365|584491184|FG005|Overall Study|Withdrawal by Subject|0|||
161849617|NCT04642365|584491185|FG006|Overall Study|Withdrawal by Subject|2|||
161849618|NCT04642365|584491186|FG007|Overall Study|Withdrawal by Subject|0|||
161849619|NCT04642365|584491179|FG000|Overall Study|Adverse Event|0|||
161849620|NCT04642365|584491180|FG001|Overall Study|Adverse Event|0|||
161849621|NCT04642365|584491181|FG002|Overall Study|Adverse Event|0|||
161849622|NCT04642365|584491182|FG003|Overall Study|Adverse Event|0|||
161849623|NCT04642365|584491183|FG004|Overall Study|Adverse Event|0|||
161849624|NCT04642365|584491184|FG005|Overall Study|Adverse Event|0|||
161849625|NCT04642365|584491185|FG006|Overall Study|Adverse Event|0|||
161849626|NCT04642365|584491186|FG007|Overall Study|Adverse Event|1|||
161849627|NCT01144715|584491187|FG000|Overall Study|Lost to Follow-up|2|||
161849628|NCT01144715|584491188|FG001|Overall Study|Lost to Follow-up|1|||
161849629|NCT01144715|584491187|FG000|Overall Study|Withdrawal by Subject|2|||
161849630|NCT01144715|584491188|FG001|Overall Study|Withdrawal by Subject|1|||
161849631|NCT01144715|584491187|FG000|Overall Study|Adverse Event|0|||
161849632|NCT01144715|584491188|FG001|Overall Study|Adverse Event|1|||
161972415|NCT01286987|584945941|FG003|Part 2: Dose Expansion|Physician Decision|0|||
161972416|NCT01286987|584945942|FG004|Part 2: Dose Expansion|Physician Decision|0|||
161972417|NCT01286987|584945943|FG005|Part 2: Dose Expansion|Physician Decision|0|||
161764133|NCT03922945|584176105|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
161764134|NCT03922945|584176103|FG000|Overall Study|All Other Personal Reasons|1|||
161849633|NCT02728843|584491189|FG000|Overall Study|Adverse Event|0|||
161849634|NCT02728843|584491190|FG001|Overall Study|Adverse Event|2|||
161849635|NCT02728843|584491191|FG002|Overall Study|Adverse Event|3|||
161849636|NCT02728843|584491192|FG003|Overall Study|Adverse Event|1|||
161849637|NCT02728843|584491193|FG004|Overall Study|Adverse Event|2|||
161849638|NCT02728843|584491189|FG000|Overall Study|Lack of Efficacy|0|||
161849639|NCT02728843|584491190|FG001|Overall Study|Lack of Efficacy|1|||
161849640|NCT02728843|584491191|FG002|Overall Study|Lack of Efficacy|1|||
161849641|NCT02728843|584491192|FG003|Overall Study|Lack of Efficacy|0|||
161849642|NCT02728843|584491193|FG004|Overall Study|Lack of Efficacy|0|||
161849643|NCT02728843|584491189|FG000|Overall Study|Protocol Violation|2|||
161849644|NCT02728843|584491190|FG001|Overall Study|Protocol Violation|0|||
161849645|NCT02728843|584491191|FG002|Overall Study|Protocol Violation|4|||
161972418|NCT01286987|584945944|FG006|Part 2: Dose Expansion|Physician Decision|0|||
161972419|NCT01286987|584945945|FG007|Part 2: Dose Expansion|Physician Decision|0|||
161972420|NCT01286987|584945946|FG008|Part 2: Dose Expansion|Physician Decision|0|||
161972421|NCT01286987|584945947|FG009|Part 2: Dose Expansion|Physician Decision|0|||
161972422|NCT01286987|584945948|FG010|Part 2: Dose Expansion|Physician Decision|1|||
161972423|NCT01286987|584945949|FG011|Part 2: Dose Expansion|Physician Decision|1|||
161972424|NCT01286987|584945950|FG012|Part 2: Dose Expansion|Physician Decision|0|||
161972425|NCT01286987|584945951|FG013|Part 2: Dose Expansion|Physician Decision|1|||
161972426|NCT01286987|584945952|FG014|Part 2: Dose Expansion|Physician Decision|0|||
161972427|NCT01286987|584945938|FG000|Part 2: Dose Expansion|Other|0|||
161972428|NCT01286987|584945939|FG001|Part 2: Dose Expansion|Other|0|||
161972429|NCT01286987|584945940|FG002|Part 2: Dose Expansion|Other|0|||
161972430|NCT01286987|584945941|FG003|Part 2: Dose Expansion|Other|0|||
161972431|NCT01286987|584945942|FG004|Part 2: Dose Expansion|Other|0|||
161972432|NCT01286987|584945943|FG005|Part 2: Dose Expansion|Other|0|||
161972433|NCT01286987|584945944|FG006|Part 2: Dose Expansion|Other|0|||
161972434|NCT01286987|584945945|FG007|Part 2: Dose Expansion|Other|0|||
161972435|NCT01286987|584945946|FG008|Part 2: Dose Expansion|Other|0|||
161972436|NCT01286987|584945947|FG009|Part 2: Dose Expansion|Other|0|||
161972437|NCT01286987|584945948|FG010|Part 2: Dose Expansion|Other|0|||
161972438|NCT01286987|584945949|FG011|Part 2: Dose Expansion|Other|0|||
161972439|NCT01286987|584945950|FG012|Part 2: Dose Expansion|Other|0|||
161972440|NCT01286987|584945951|FG013|Part 2: Dose Expansion|Other|1|||
161972441|NCT01286987|584945952|FG014|Part 2: Dose Expansion|Other|0|||
161972442|NCT01286987|584945938|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
161972443|NCT01286987|584945939|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
161972444|NCT01286987|584945940|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
161972445|NCT01286987|584945941|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
161972446|NCT01286987|584945942|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
161972447|NCT01286987|584945943|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
161972448|NCT01286987|584945944|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
161972449|NCT01286987|584945945|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
161972450|NCT01286987|584945946|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
161972451|NCT01286987|584945947|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
161972452|NCT01286987|584945948|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
161972453|NCT01286987|584945949|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
161972454|NCT01286987|584945950|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
161972455|NCT01286987|584945951|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
161972456|NCT01286987|584945952|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
161972457|NCT01286987|584945938|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
161972458|NCT01286987|584945939|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
161972459|NCT01286987|584945940|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
161972460|NCT01286987|584945941|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
161972461|NCT01286987|584945942|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
161972462|NCT01286987|584945943|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
161972463|NCT01286987|584945944|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
161972464|NCT01286987|584945945|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
161972465|NCT01286987|584945946|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
161972466|NCT01286987|584945947|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
161972467|NCT01286987|584945948|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
161972468|NCT01286987|584945949|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
161972469|NCT01286987|584945950|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
161972470|NCT01286987|584945951|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
161972471|NCT01286987|584945952|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
161972472|NCT01286987|584945938|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972473|NCT01286987|584945939|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972474|NCT01286987|584945940|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972475|NCT01286987|584945941|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972476|NCT01286987|584945942|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972477|NCT01286987|584945943|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972478|NCT01286987|584945944|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972479|NCT01286987|584945945|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972480|NCT01286987|584945946|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972481|NCT01286987|584945947|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972482|NCT01286987|584945948|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
161972483|NCT01286987|584945949|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972484|NCT01286987|584945950|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972485|NCT01286987|584945951|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972486|NCT01286987|584945952|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161972487|NCT00624819|584945953|FG000|Follow-up Period: Year 4|Parents decision|0|||
161972488|NCT00624819|584945954|FG001|Follow-up Period: Year 4|Parents decision|0|||
161972489|NCT00624819|584945955|FG002|Follow-up Period: Year 4|Parents decision|1|||
161972490|NCT00624819|584945956|FG003|Follow-up Period: Year 4|Parents decision|0|||
161849646|NCT02728843|584491192|FG003|Overall Study|Protocol Violation|2|||
161849647|NCT02728843|584491193|FG004|Overall Study|Protocol Violation|2|||
161849648|NCT02728843|584491189|FG000|Overall Study|Withdrawal by Subject|1|||
161849649|NCT02728843|584491190|FG001|Overall Study|Withdrawal by Subject|0|||
161849650|NCT02728843|584491191|FG002|Overall Study|Withdrawal by Subject|0|||
161849651|NCT02728843|584491192|FG003|Overall Study|Withdrawal by Subject|1|||
161849652|NCT02728843|584491193|FG004|Overall Study|Withdrawal by Subject|0|||
161849653|NCT02728843|584491189|FG000|Overall Study|Use of rescue medication|0|||
161849654|NCT02728843|584491190|FG001|Overall Study|Use of rescue medication|2|||
161849655|NCT02728843|584491191|FG002|Overall Study|Use of rescue medication|0|||
161849656|NCT02728843|584491192|FG003|Overall Study|Use of rescue medication|2|||
161849657|NCT02728843|584491193|FG004|Overall Study|Use of rescue medication|1|||
161849658|NCT00205803|584491196|FG000|Infant Series|Lost to Follow-up|10|||
161849659|NCT00205803|584491197|FG001|Infant Series|Lost to Follow-up|4|||
161849660|NCT00205803|584491196|FG000|Infant Series|Withdrawal by Subject|2|||
161849661|NCT00205803|584491197|FG001|Infant Series|Withdrawal by Subject|5|||
161849662|NCT00205803|584491196|FG000|Infant Series|Physician Decision|3|||
161849663|NCT00205803|584491197|FG001|Infant Series|Physician Decision|1|||
161849664|NCT00205803|584491196|FG000|Infant Series|Protocol Violation|1|||
161849665|NCT00205803|584491197|FG001|Infant Series|Protocol Violation|0|||
161849666|NCT00205803|584491196|FG000|Infant Series|Lost Kaiser coverage|0|||
161849667|NCT00205803|584491197|FG001|Infant Series|Lost Kaiser coverage|1|||
161849668|NCT00205803|584491196|FG000|Infant Series|Non-compliant|1|||
161849669|NCT00205803|584491197|FG001|Infant Series|Non-compliant|0|||
161849670|NCT00205803|584491196|FG000|Infant Series|Sponsor request|1|||
161849671|NCT00205803|584491197|FG001|Infant Series|Sponsor request|0|||
161849672|NCT00205803|584491196|FG000|After Infant Series|Adverse Event|1|||
161849673|NCT00205803|584491197|FG001|After Infant Series|Adverse Event|1|||
161849674|NCT00205803|584491196|FG000|After Infant Series|Protocol Violation|1|||
161849675|NCT00205803|584491197|FG001|After Infant Series|Protocol Violation|1|||
161849676|NCT00205803|584491196|FG000|After Infant Series|Lost to Follow-up|2|||
161849677|NCT00205803|584491197|FG001|After Infant Series|Lost to Follow-up|1|||
161849678|NCT00205803|584491196|FG000|After Infant Series|Physician Decision|3|||
161849679|NCT00205803|584491197|FG001|After Infant Series|Physician Decision|2|||
161849680|NCT00205803|584491196|FG000|After Infant Series|Withdrawal by Subject|1|||
161849681|NCT00205803|584491197|FG001|After Infant Series|Withdrawal by Subject|4|||
161849682|NCT00205803|584491196|FG000|After Infant Series|Other|10|||
161849683|NCT00205803|584491197|FG001|After Infant Series|Other|4|||
161849684|NCT00205803|584491196|FG000|Toddler Dose|Lost to Follow-up|2|||
161849685|NCT00205803|584491197|FG001|Toddler Dose|Lost to Follow-up|3|||
161849686|NCT00197496|584491201|FG000|Baseline to Discharge|not interested|1|||
161849687|NCT00197496|584491202|FG001|Baseline to Discharge|not interested|0|||
161849688|NCT00197496|584491201|FG000|Baseline to Discharge|MRSA|1|||
161849689|NCT00197496|584491202|FG001|Baseline to Discharge|MRSA|0|||
161849690|NCT00197496|584491201|FG000|Baseline to Discharge|Physician Decision|0|||
161849691|NCT00197496|584491202|FG001|Baseline to Discharge|Physician Decision|1|||
161849692|NCT00197496|584491201|FG000|Baseline to Discharge|Protocol Violation|0|||
161849693|NCT00197496|584491202|FG001|Baseline to Discharge|Protocol Violation|1|||
161849694|NCT00197496|584491201|FG000|Follow-up|Lost to Follow-up|2|||
161972491|NCT00624819|584945953|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
161972492|NCT00624819|584945954|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
161972493|NCT00624819|584945955|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
161972494|NCT00624819|584945956|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
161972495|NCT02847858|584945957|FG000|Overall Study|Lost to Follow-up|401|||
161972496|NCT02847858|584945958|FG001|Overall Study|Lost to Follow-up|269|||
161972497|NCT02826421|584945961|FG000|Overall Study|Adverse Event|1|||
161972498|NCT02826421|584945962|FG001|Overall Study|Adverse Event|0|||
161972499|NCT02826421|584945963|FG002|Overall Study|Adverse Event|0|||
161972500|NCT02826421|584945964|FG003|Overall Study|Adverse Event|1|||
161972501|NCT02826421|584945961|FG000|Overall Study|Withdrawal by Subject|1|||
161972502|NCT02826421|584945962|FG001|Overall Study|Withdrawal by Subject|3|||
161972503|NCT02826421|584945963|FG002|Overall Study|Withdrawal by Subject|1|||
161972504|NCT02826421|584945964|FG003|Overall Study|Withdrawal by Subject|1|||
161972505|NCT02826421|584945961|FG000|Overall Study|Reason not given|1|||
161972506|NCT02826421|584945962|FG001|Overall Study|Reason not given|0|||
162033670|NCT04090411|585180162|FG006|Induction Period|Physician Decision|0|||
161849695|NCT00197496|584491202|FG001|Follow-up|Lost to Follow-up|1|||
162033671|NCT04090411|585180163|FG007|Induction Period|Physician Decision|0|||
161849696|NCT00857584|584491205|FG000|Overall Study|Lack of Efficacy|1|||
161849697|NCT00857584|584491206|FG001|Overall Study|Lack of Efficacy|2|||
161849698|NCT00857584|584491205|FG000|Overall Study|Adverse Event|2|||
161849699|NCT00857584|584491206|FG001|Overall Study|Adverse Event|2|||
161849700|NCT00857584|584491205|FG000|Overall Study|Physician Decision|1|||
161849701|NCT00857584|584491206|FG001|Overall Study|Physician Decision|1|||
161849702|NCT02533375|584491207|FG000|Overall Study|Lack of Efficacy|3|||
161849703|NCT02533375|584491207|FG000|Overall Study|Adverse Event|2|||
161849704|NCT00673387|584491208|FG000|Overall Study|Withdrawal by Subject|15|||
161972507|NCT02826421|584945963|FG002|Overall Study|Reason not given|1|||
161849705|NCT00673387|584491209|FG001|Overall Study|Withdrawal by Subject|16|||
161972508|NCT02826421|584945964|FG003|Overall Study|Reason not given|0|||
161972509|NCT02210221|584945967|FG000|Overall Study|Lack of Efficacy|7|||
161972510|NCT02210221|584945967|FG000|Overall Study|Withdrawal by Subject|43|||
161972511|NCT00405964|584945972|FG000|Overall Study|Treatment Failure|17|||
161972512|NCT00405964|584945973|FG001|Overall Study|Treatment Failure|45|||
161972513|NCT00405964|584945972|FG000|Overall Study|Adverse Event|7|||
161972514|NCT00405964|584945973|FG001|Overall Study|Adverse Event|16|||
161972515|NCT00405964|584945972|FG000|Overall Study|Lost to Follow-up|5|||
161972516|NCT00405964|584945973|FG001|Overall Study|Lost to Follow-up|5|||
161972517|NCT00405964|584945972|FG000|Overall Study|Withdrawal by Subject|19|||
161972518|NCT00405964|584945973|FG001|Overall Study|Withdrawal by Subject|23|||
161972519|NCT00405964|584945972|FG000|Overall Study|Protocol Violation|11|||
161972520|NCT00405964|584945973|FG001|Overall Study|Protocol Violation|6|||
161972521|NCT03271047|584945974|FG000|Phase 1b: Dose Finding Period|Death|8|||
161972522|NCT03271047|584945975|FG001|Phase 1b: Dose Finding Period|Death|8|||
161972523|NCT03271047|584945976|FG002|Phase 1b: Dose Finding Period|Death|0|||
161972524|NCT03271047|584945977|FG003|Phase 1b: Dose Finding Period|Death|0|||
161972525|NCT03271047|584945974|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
161972526|NCT03271047|584945975|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
161972527|NCT03271047|584945976|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
161972528|NCT03271047|584945977|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
161972529|NCT03271047|584945974|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
161972530|NCT03271047|584945975|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
161849706|NCT00673387|584491210|FG002|Overall Study|Withdrawal by Subject|20|||
161849707|NCT00673387|584491211|FG003|Overall Study|Withdrawal by Subject|16|||
161849708|NCT00673387|584491212|FG004|Overall Study|Withdrawal by Subject|18|||
161849709|NCT00673387|584491213|FG005|Overall Study|Withdrawal by Subject|21|||
161849710|NCT00673387|584491214|FG006|Overall Study|Withdrawal by Subject|15|||
161849711|NCT00673387|584491215|FG007|Overall Study|Withdrawal by Subject|21|||
161849712|NCT00673387|584491208|FG000|Overall Study|Adverse Event|3|||
161849713|NCT00673387|584491209|FG001|Overall Study|Adverse Event|1|||
161849714|NCT00673387|584491210|FG002|Overall Study|Adverse Event|5|||
161849715|NCT00673387|584491211|FG003|Overall Study|Adverse Event|2|||
161849716|NCT00673387|584491212|FG004|Overall Study|Adverse Event|6|||
161849717|NCT00673387|584491213|FG005|Overall Study|Adverse Event|2|||
161849718|NCT00673387|584491214|FG006|Overall Study|Adverse Event|5|||
161849719|NCT00673387|584491215|FG007|Overall Study|Adverse Event|5|||
161849720|NCT00673387|584491208|FG000|Overall Study|Physician Decision|0|||
161849721|NCT00673387|584491209|FG001|Overall Study|Physician Decision|0|||
161972531|NCT03271047|584945976|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
161972532|NCT03271047|584945977|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
161972533|NCT03271047|584945974|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
161972534|NCT03271047|584945975|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
161972535|NCT03271047|584945976|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
161972536|NCT03271047|584945977|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
161972537|NCT03271047|584945974|FG000|Randomized Phase 2 Period|Other|0|||
161972538|NCT03271047|584945975|FG001|Randomized Phase 2 Period|Other|0|||
161972539|NCT03271047|584945976|FG002|Randomized Phase 2 Period|Other|0|||
161972540|NCT03271047|584945977|FG003|Randomized Phase 2 Period|Other|1|||
161972541|NCT03271047|584945974|FG000|Randomized Phase 2 Period|Death|0|||
161972542|NCT03271047|584945975|FG001|Randomized Phase 2 Period|Death|0|||
161972543|NCT03271047|584945976|FG002|Randomized Phase 2 Period|Death|20|||
161972544|NCT03271047|584945977|FG003|Randomized Phase 2 Period|Death|21|||
161972545|NCT03271047|584945974|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
161972546|NCT03271047|584945975|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
161972547|NCT03271047|584945976|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
161972548|NCT03271047|584945977|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
161972549|NCT03271047|584945974|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
161972550|NCT03271047|584945975|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
161972551|NCT03271047|584945976|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
161972552|NCT03271047|584945977|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
161972553|NCT03271047|584945974|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
161849722|NCT00673387|584491210|FG002|Overall Study|Physician Decision|0|||
161972554|NCT03271047|584945975|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
161972555|NCT03271047|584945976|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
161972556|NCT03271047|584945977|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
161972557|NCT00711802|584945978|FG000|Overall Study|Not treated (no further detail)|2|||
161972558|NCT00711802|584945979|FG001|Overall Study|Not treated (no further detail)|1|||
161972559|NCT00711802|584945980|FG002|Overall Study|Not treated (no further detail)|2|||
161849723|NCT00673387|584491211|FG003|Overall Study|Physician Decision|0|||
161849724|NCT00673387|584491212|FG004|Overall Study|Physician Decision|0|||
161849725|NCT00673387|584491213|FG005|Overall Study|Physician Decision|5|||
161849726|NCT00673387|584491214|FG006|Overall Study|Physician Decision|1|||
161972560|NCT00711802|584945981|FG003|Overall Study|Not treated (no further detail)|0|||
161972561|NCT00711802|584945982|FG004|Overall Study|Not treated (no further detail)|2|||
161972562|NCT00711802|584945983|FG005|Overall Study|Not treated (no further detail)|0|||
161972563|NCT00711802|584945984|FG006|Overall Study|Not treated (no further detail)|0|||
161972564|NCT00711802|584945985|FG007|Overall Study|Not treated (no further detail)|0|||
161972565|NCT00711802|584945978|FG000|Overall Study|Adverse Event|0|||
161972566|NCT00711802|584945979|FG001|Overall Study|Adverse Event|0|||
161972567|NCT00711802|584945980|FG002|Overall Study|Adverse Event|0|||
161972568|NCT00711802|584945981|FG003|Overall Study|Adverse Event|0|||
161972569|NCT00711802|584945982|FG004|Overall Study|Adverse Event|1|||
161972570|NCT00711802|584945983|FG005|Overall Study|Adverse Event|1|||
161972571|NCT00711802|584945984|FG006|Overall Study|Adverse Event|0|||
161972572|NCT00711802|584945985|FG007|Overall Study|Adverse Event|0|||
161972573|NCT00711802|584945978|FG000|Overall Study|Microbiological failure|0|||
161972574|NCT00711802|584945979|FG001|Overall Study|Microbiological failure|1|||
161972575|NCT00711802|584945980|FG002|Overall Study|Microbiological failure|0|||
161972576|NCT00711802|584945981|FG003|Overall Study|Microbiological failure|0|||
161972577|NCT00711802|584945982|FG004|Overall Study|Microbiological failure|0|||
161972578|NCT00711802|584945983|FG005|Overall Study|Microbiological failure|1|||
161972579|NCT00711802|584945984|FG006|Overall Study|Microbiological failure|0|||
161972580|NCT00711802|584945985|FG007|Overall Study|Microbiological failure|0|||
161972581|NCT00711802|584945978|FG000|Overall Study|Protocol Violation|0|||
161972582|NCT00711802|584945979|FG001|Overall Study|Protocol Violation|0|||
161972583|NCT00711802|584945980|FG002|Overall Study|Protocol Violation|0|||
161972584|NCT00711802|584945981|FG003|Overall Study|Protocol Violation|1|||
161972585|NCT00711802|584945982|FG004|Overall Study|Protocol Violation|0|||
161972586|NCT00711802|584945983|FG005|Overall Study|Protocol Violation|0|||
161972587|NCT00711802|584945984|FG006|Overall Study|Protocol Violation|0|||
161972588|NCT00711802|584945985|FG007|Overall Study|Protocol Violation|0|||
161972589|NCT00711802|584945978|FG000|Overall Study|Physician Decision|0|||
161972590|NCT00711802|584945979|FG001|Overall Study|Physician Decision|2|||
161972591|NCT00711802|584945980|FG002|Overall Study|Physician Decision|0|||
161972592|NCT00711802|584945981|FG003|Overall Study|Physician Decision|0|||
161972593|NCT00711802|584945982|FG004|Overall Study|Physician Decision|0|||
161972594|NCT00711802|584945983|FG005|Overall Study|Physician Decision|0|||
161972595|NCT00711802|584945984|FG006|Overall Study|Physician Decision|0|||
161972596|NCT00711802|584945985|FG007|Overall Study|Physician Decision|0|||
161972597|NCT00711802|584945978|FG000|Overall Study|Withdrawal by Subject|0|||
161972598|NCT00711802|584945979|FG001|Overall Study|Withdrawal by Subject|1|||
161972599|NCT00711802|584945980|FG002|Overall Study|Withdrawal by Subject|0|||
161972600|NCT00711802|584945981|FG003|Overall Study|Withdrawal by Subject|1|||
161972601|NCT00711802|584945982|FG004|Overall Study|Withdrawal by Subject|0|||
161972602|NCT00711802|584945983|FG005|Overall Study|Withdrawal by Subject|0|||
161972603|NCT00711802|584945984|FG006|Overall Study|Withdrawal by Subject|0|||
161972604|NCT00711802|584945985|FG007|Overall Study|Withdrawal by Subject|0|||
161972605|NCT00711802|584945978|FG000|Overall Study|Lost to Follow-up|0|||
161972606|NCT00711802|584945979|FG001|Overall Study|Lost to Follow-up|0|||
161972607|NCT00711802|584945980|FG002|Overall Study|Lost to Follow-up|3|||
161972608|NCT00711802|584945981|FG003|Overall Study|Lost to Follow-up|1|||
161972609|NCT00711802|584945982|FG004|Overall Study|Lost to Follow-up|10|||
161972610|NCT00711802|584945983|FG005|Overall Study|Lost to Follow-up|6|||
161972611|NCT00711802|584945984|FG006|Overall Study|Lost to Follow-up|4|||
161972612|NCT00711802|584945985|FG007|Overall Study|Lost to Follow-up|2|||
161972613|NCT00711802|584945978|FG000|Overall Study|Reason not reported|0|||
161972614|NCT00711802|584945979|FG001|Overall Study|Reason not reported|1|||
161972615|NCT00711802|584945980|FG002|Overall Study|Reason not reported|1|||
161972616|NCT00711802|584945981|FG003|Overall Study|Reason not reported|0|||
161972617|NCT00711802|584945982|FG004|Overall Study|Reason not reported|1|||
161972618|NCT00711802|584945983|FG005|Overall Study|Reason not reported|0|||
161972619|NCT00711802|584945984|FG006|Overall Study|Reason not reported|1|||
161972620|NCT00711802|584945985|FG007|Overall Study|Reason not reported|0|||
161972621|NCT00391391|584945986|FG000|Overall Study|Adverse Event|0|||
161972622|NCT00391391|584945987|FG001|Overall Study|Adverse Event|0|||
161972623|NCT00391391|584945988|FG002|Overall Study|Adverse Event|0|||
161972624|NCT00391391|584945989|FG003|Overall Study|Adverse Event|1|||
161972625|NCT00391391|584945986|FG000|Overall Study|Lost to Follow-up|1|||
161972626|NCT00391391|584945987|FG001|Overall Study|Lost to Follow-up|3|||
161972627|NCT00391391|584945988|FG002|Overall Study|Lost to Follow-up|7|||
161972628|NCT00391391|584945989|FG003|Overall Study|Lost to Follow-up|4|||
161972629|NCT00391391|584945986|FG000|Overall Study|Protocol Violation|2|||
161972630|NCT00391391|584945987|FG001|Overall Study|Protocol Violation|3|||
161972631|NCT00391391|584945988|FG002|Overall Study|Protocol Violation|6|||
161764135|NCT03922945|584176104|FG001|Overall Study|All Other Personal Reasons|1|||
161764136|NCT03922945|584176105|FG002|Overall Study|All Other Personal Reasons|2|||
161972632|NCT00391391|584945989|FG003|Overall Study|Protocol Violation|7|||
161972633|NCT00391391|584945986|FG000|Overall Study|Withdrawal by Subject|6|||
161972634|NCT00391391|584945987|FG001|Overall Study|Withdrawal by Subject|4|||
161972635|NCT00391391|584945988|FG002|Overall Study|Withdrawal by Subject|10|||
161972636|NCT00391391|584945989|FG003|Overall Study|Withdrawal by Subject|7|||
161849727|NCT00673387|584491215|FG007|Overall Study|Physician Decision|1|||
161849728|NCT00673387|584491208|FG000|Overall Study|Protocol Violation|3|||
161849729|NCT00673387|584491209|FG001|Overall Study|Protocol Violation|0|||
161849730|NCT00673387|584491210|FG002|Overall Study|Protocol Violation|1|||
161849731|NCT00673387|584491211|FG003|Overall Study|Protocol Violation|2|||
161849732|NCT00673387|584491212|FG004|Overall Study|Protocol Violation|0|||
161849733|NCT00673387|584491213|FG005|Overall Study|Protocol Violation|1|||
161849734|NCT00673387|584491214|FG006|Overall Study|Protocol Violation|1|||
161849735|NCT00673387|584491215|FG007|Overall Study|Protocol Violation|3|||
161849736|NCT00673387|584491208|FG000|Overall Study|Lost to Follow-up|8|||
161849737|NCT00673387|584491209|FG001|Overall Study|Lost to Follow-up|6|||
161849738|NCT00673387|584491210|FG002|Overall Study|Lost to Follow-up|5|||
161849739|NCT00673387|584491211|FG003|Overall Study|Lost to Follow-up|6|||
161849740|NCT00673387|584491212|FG004|Overall Study|Lost to Follow-up|6|||
161849741|NCT00673387|584491213|FG005|Overall Study|Lost to Follow-up|5|||
161849742|NCT00673387|584491214|FG006|Overall Study|Lost to Follow-up|8|||
161849743|NCT00673387|584491215|FG007|Overall Study|Lost to Follow-up|5|||
161849744|NCT00960115|584491216|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
161849745|NCT00960115|584491217|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
161849746|NCT01102374|584491218|FG000|Overall Study|Death|9|||
161849747|NCT01102374|584491219|FG001|Overall Study|Death|13|||
161849748|NCT01102374|584491218|FG000|Overall Study|Lost to Follow-up|7|||
161849749|NCT01102374|584491219|FG001|Overall Study|Lost to Follow-up|6|||
161849750|NCT02952898|584491220|FG000|Overall Study|Withdrawal by Subject|10|||
161849751|NCT02952898|584491221|FG001|Overall Study|Withdrawal by Subject|8|||
161849752|NCT02952898|584491222|FG002|Overall Study|Withdrawal by Subject|8|||
161849753|NCT02952898|584491220|FG000|Overall Study|Adverse Event|8|||
161849754|NCT02952898|584491221|FG001|Overall Study|Adverse Event|8|||
161849755|NCT02952898|584491222|FG002|Overall Study|Adverse Event|3|||
161849756|NCT02952898|584491220|FG000|Overall Study|Lost to Follow-up|3|||
161849757|NCT02952898|584491221|FG001|Overall Study|Lost to Follow-up|2|||
161849758|NCT02952898|584491222|FG002|Overall Study|Lost to Follow-up|2|||
161849759|NCT02952898|584491220|FG000|Overall Study|Non-compliance with study drug|1|||
161849760|NCT02952898|584491221|FG001|Overall Study|Non-compliance with study drug|1|||
161849761|NCT02952898|584491222|FG002|Overall Study|Non-compliance with study drug|2|||
161849762|NCT00477633|584491223|FG000|Overall Study|Did not receive treatment|23|||
161849763|NCT00477633|584491223|FG000|Overall Study|Adverse Event|143|||
161849764|NCT00477633|584491223|FG000|Overall Study|Pregnancy|23|||
161849765|NCT00477633|584491223|FG000|Overall Study|Lost to Follow-up|271|||
161849766|NCT00477633|584491223|FG000|Overall Study|Withdrawal by Subject|149|||
161849767|NCT00477633|584491223|FG000|Overall Study|Protocol Violation|25|||
161849768|NCT00477633|584491223|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
161849769|NCT02968849|584491224|FG000|Overall Study|Death|8|||
161849770|NCT02968849|584491225|FG001|Overall Study|Death|10|||
161849771|NCT02968849|584491224|FG000|Overall Study|Lost to Follow-up|31|||
161849772|NCT02968849|584491225|FG001|Overall Study|Lost to Follow-up|29|||
161849773|NCT02968849|584491224|FG000|Overall Study|Withdrawal by Subject|73|||
161849774|NCT02968849|584491225|FG001|Overall Study|Withdrawal by Subject|64|||
161849775|NCT02968849|584491224|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
161849776|NCT02968849|584491225|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
161849777|NCT02968849|584491224|FG000|Overall Study|Physician Decision|6|||
161849778|NCT02968849|584491225|FG001|Overall Study|Physician Decision|9|||
161849779|NCT02968849|584491224|FG000|Overall Study|Other|16|||
161849780|NCT02968849|584491225|FG001|Overall Study|Other|10|||
161972637|NCT02649855|584945990|FG000|Overall Study|Refused further treatment|2|||
161972638|NCT02649855|584945991|FG001|Overall Study|Refused further treatment|1|||
161972639|NCT02649855|584945992|FG002|Overall Study|Refused further treatment|1|||
161972640|NCT02649855|584945990|FG000|Overall Study|Withdrew consent|0|||
161972641|NCT02649855|584945991|FG001|Overall Study|Withdrew consent|1|||
161972642|NCT02649855|584945992|FG002|Overall Study|Withdrew consent|0|||
161972643|NCT02649855|584945990|FG000|Overall Study|Switched to alternative treatment|0|||
161849781|NCT02203331|584491228|FG000|Overall Study|Pregnancy|1|||
161972644|NCT02649855|584945991|FG001|Overall Study|Switched to alternative treatment|1|||
161972645|NCT02649855|584945992|FG002|Overall Study|Switched to alternative treatment|1|||
161972646|NCT02649855|584945990|FG000|Overall Study|Principal investigator discretion|0|||
161972647|NCT02649855|584945991|FG001|Overall Study|Principal investigator discretion|1|||
161849782|NCT02203331|584491229|FG001|Overall Study|Pregnancy|0|||
161849783|NCT02203331|584491230|FG002|Overall Study|Pregnancy|0|||
161849784|NCT02203331|584491231|FG003|Overall Study|Pregnancy|0|||
161849785|NCT02203331|584491232|FG004|Overall Study|Pregnancy|2|||
161849786|NCT02203331|584491233|FG005|Overall Study|Pregnancy|0|||
161849787|NCT02203331|584491228|FG000|Overall Study|Withdrawal by Subject|1|||
161849788|NCT02203331|584491229|FG001|Overall Study|Withdrawal by Subject|0|||
161849789|NCT02203331|584491230|FG002|Overall Study|Withdrawal by Subject|1|||
161849790|NCT02203331|584491231|FG003|Overall Study|Withdrawal by Subject|0|||
161849791|NCT02203331|584491232|FG004|Overall Study|Withdrawal by Subject|0|||
161849792|NCT02203331|584491233|FG005|Overall Study|Withdrawal by Subject|3|||
161849793|NCT02203331|584491228|FG000|Overall Study|Adverse Event|4|||
161849794|NCT02203331|584491229|FG001|Overall Study|Adverse Event|8|||
161849795|NCT02203331|584491230|FG002|Overall Study|Adverse Event|3|||
161849796|NCT02203331|584491231|FG003|Overall Study|Adverse Event|4|||
161849797|NCT02203331|584491232|FG004|Overall Study|Adverse Event|3|||
161849798|NCT02203331|584491233|FG005|Overall Study|Adverse Event|3|||
161849799|NCT02203331|584491228|FG000|Overall Study|Other Reasons|1|||
161849800|NCT02203331|584491229|FG001|Overall Study|Other Reasons|2|||
161849801|NCT02203331|584491230|FG002|Overall Study|Other Reasons|0|||
161849802|NCT02203331|584491231|FG003|Overall Study|Other Reasons|2|||
161849803|NCT02203331|584491232|FG004|Overall Study|Other Reasons|0|||
161849804|NCT02203331|584491233|FG005|Overall Study|Other Reasons|0|||
161849805|NCT02203331|584491228|FG000|Overall Study|Lack of Efficacy|0|||
161849806|NCT02203331|584491229|FG001|Overall Study|Lack of Efficacy|2|||
161849807|NCT02203331|584491230|FG002|Overall Study|Lack of Efficacy|1|||
161849808|NCT02203331|584491231|FG003|Overall Study|Lack of Efficacy|0|||
161849809|NCT02203331|584491232|FG004|Overall Study|Lack of Efficacy|0|||
161849810|NCT02203331|584491233|FG005|Overall Study|Lack of Efficacy|1|||
161849811|NCT02203331|584491228|FG000|Overall Study|Protocol Violation|0|||
161849812|NCT02203331|584491229|FG001|Overall Study|Protocol Violation|2|||
161849813|NCT02203331|584491230|FG002|Overall Study|Protocol Violation|0|||
161849814|NCT02203331|584491231|FG003|Overall Study|Protocol Violation|1|||
161849815|NCT02203331|584491232|FG004|Overall Study|Protocol Violation|1|||
161849816|NCT02203331|584491233|FG005|Overall Study|Protocol Violation|0|||
161849817|NCT02203331|584491228|FG000|Overall Study|Lost to Follow-up|0|||
161849818|NCT02203331|584491229|FG001|Overall Study|Lost to Follow-up|0|||
161849819|NCT02203331|584491230|FG002|Overall Study|Lost to Follow-up|0|||
161849820|NCT02203331|584491231|FG003|Overall Study|Lost to Follow-up|0|||
161849821|NCT02203331|584491232|FG004|Overall Study|Lost to Follow-up|1|||
161849822|NCT02203331|584491233|FG005|Overall Study|Lost to Follow-up|0|||
161849823|NCT02542605|584491234|FG000|Part B: Challenge Phase|Sponsor decision|1|||
161849824|NCT02542605|584491235|FG001|Part B: Challenge Phase|Sponsor decision|0|||
161849825|NCT02542605|584491236|FG002|Part B: Challenge Phase|Sponsor decision|0|||
161849826|NCT02542605|584491234|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
161849827|NCT02542605|584491235|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
161849828|NCT02542605|584491236|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
161849829|NCT00278889|584491237|FG000|Overall Study|Withdrawal by Subject|0|||
161849830|NCT00278889|584491238|FG001|Overall Study|Withdrawal by Subject|5|||
161849831|NCT00278889|584491239|FG002|Overall Study|Withdrawal by Subject|3|||
161849832|NCT00278889|584491237|FG000|Overall Study|Lost to Follow-up|1|||
161849833|NCT00278889|584491238|FG001|Overall Study|Lost to Follow-up|1|||
161849834|NCT00278889|584491239|FG002|Overall Study|Lost to Follow-up|0|||
161849835|NCT00278889|584491237|FG000|Overall Study|Death|24|||
161849836|NCT00278889|584491238|FG001|Overall Study|Death|21|||
161849837|NCT00278889|584491239|FG002|Overall Study|Death|17|||
161849838|NCT00704730|584491240|FG000|Overall Study|Adverse Event|35|||
161849839|NCT00704730|584491241|FG001|Overall Study|Adverse Event|9|||
161849840|NCT00704730|584491240|FG000|Overall Study|Death|11|||
161849841|NCT00704730|584491241|FG001|Overall Study|Death|5|||
161849842|NCT00704730|584491240|FG000|Overall Study|Physician Decision|2|||
161849843|NCT00704730|584491241|FG001|Overall Study|Physician Decision|0|||
161849844|NCT00704730|584491240|FG000|Overall Study|Did not receive drug|5|||
161849845|NCT00704730|584491241|FG001|Overall Study|Did not receive drug|2|||
161849846|NCT00704730|584491240|FG000|Overall Study|Disease progression per PI|58|||
161849847|NCT00704730|584491241|FG001|Overall Study|Disease progression per PI|67|||
161849848|NCT00704730|584491240|FG000|Overall Study|data unavailable|1|||
161849849|NCT00704730|584491241|FG001|Overall Study|data unavailable|0|||
161849850|NCT00704730|584491240|FG000|Overall Study|Withdrawal by Subject|9|||
161849851|NCT00704730|584491241|FG001|Overall Study|Withdrawal by Subject|13|||
161849852|NCT05833139|584492766|FG000|Study Period 2|Adverse Event|1|||
161849853|NCT03996447|584492769|FG000|First MRI Examination|Adverse Event|2|||
161849854|NCT03996447|584492770|FG001|First MRI Examination|Adverse Event|0|||
161849855|NCT03996447|584492769|FG000|First MRI Examination|Withdrawal by Subject|1|||
161972648|NCT02649855|584945992|FG002|Overall Study|Principal investigator discretion|1|||
161849856|NCT03996447|584492770|FG001|First MRI Examination|Withdrawal by Subject|2|||
161849857|NCT03996447|584492769|FG000|First MRI Examination|Protocol Violation|0|||
161849858|NCT03996447|584492770|FG001|First MRI Examination|Protocol Violation|1|||
161849859|NCT03996447|584492769|FG000|Washout|Adverse Event|2|||
161849860|NCT03996447|584492770|FG001|Washout|Adverse Event|0|||
161849861|NCT03996447|584492769|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
161849862|NCT03996447|584492770|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
161849863|NCT03996447|584492769|FG000|Washout|Withdrawal by Subject|0|||
161849864|NCT03996447|584492770|FG001|Washout|Withdrawal by Subject|1|||
161849865|NCT03996447|584492769|FG000|Washout|Other reason|1|||
161849866|NCT03996447|584492770|FG001|Washout|Other reason|1|||
161849867|NCT00369486|584492772|FG000|4-Week Visit|Missed visit|2|||
161849868|NCT00369486|584492773|FG001|4-Week Visit|Missed visit|2|||
161849869|NCT00369486|584492774|FG002|4-Week Visit|Missed visit|0|||
161849870|NCT00369486|584492775|FG003|4-Week Visit|Missed visit|2|||
161849871|NCT00369486|584492776|FG004|4-Week Visit|Missed visit|1|||
161972649|NCT02649855|584945990|FG000|Overall Study|No treatment, per protocol|1|||
161972650|NCT02649855|584945991|FG001|Overall Study|No treatment, per protocol|0|||
161972651|NCT02649855|584945992|FG002|Overall Study|No treatment, per protocol|0|||
161764137|NCT00313716|584176106|FG000|Overall Study|Death|3|||
161764138|NCT00313716|584176107|FG001|Overall Study|Death|2|||
161764139|NCT00313716|584176108|FG002|Overall Study|Death|9|||
161764140|NCT00313716|584176109|FG003|Overall Study|Death|3|||
161764141|NCT00313716|584176110|FG004|Overall Study|Death|5|||
161764142|NCT00313716|584176111|FG005|Overall Study|Death|9|||
161764143|NCT00313716|584176106|FG000|Overall Study|Lost to Follow-up|2|||
161764144|NCT00313716|584176107|FG001|Overall Study|Lost to Follow-up|5|||
161764145|NCT00313716|584176108|FG002|Overall Study|Lost to Follow-up|2|||
161764146|NCT00313716|584176109|FG003|Overall Study|Lost to Follow-up|1|||
161764147|NCT00313716|584176110|FG004|Overall Study|Lost to Follow-up|0|||
161764148|NCT00313716|584176111|FG005|Overall Study|Lost to Follow-up|4|||
161764149|NCT00313716|584176106|FG000|Overall Study|Withdrawal by Subject|0|||
161764150|NCT00313716|584176107|FG001|Overall Study|Withdrawal by Subject|1|||
161764151|NCT00313716|584176108|FG002|Overall Study|Withdrawal by Subject|1|||
161764152|NCT00313716|584176109|FG003|Overall Study|Withdrawal by Subject|0|||
161764153|NCT00313716|584176110|FG004|Overall Study|Withdrawal by Subject|1|||
161764154|NCT00313716|584176111|FG005|Overall Study|Withdrawal by Subject|0|||
161764155|NCT01603615|584176124|FG000|Overall Study|Did not Receive Treatment|7|||
161764156|NCT01603615|584176124|FG000|Overall Study|Lost to Follow-up|9|||
161764157|NCT01603615|584176124|FG000|Overall Study|Personal Reasons|17|||
161764158|NCT01603615|584176124|FG000|Overall Study|Other Miscellaneous|1|||
161764159|NCT03490734|584176139|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
161764160|NCT03490734|584176140|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
161764161|NCT03490734|584176141|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
161764162|NCT03490734|584176142|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
161764163|NCT03490734|584176139|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
161764164|NCT03490734|584176140|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
161764165|NCT03490734|584176141|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
161764166|NCT03490734|584176142|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
161764167|NCT03490734|584176139|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
161764168|NCT03490734|584176140|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
161764169|NCT03490734|584176141|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
161764170|NCT03490734|584176142|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
161764171|NCT03490734|584176139|FG000|Post-intervention Scan Visit|Adverse Event|2|||
161764172|NCT03490734|584176140|FG001|Post-intervention Scan Visit|Adverse Event|0|||
161764173|NCT03490734|584176141|FG002|Post-intervention Scan Visit|Adverse Event|0|||
161764174|NCT03490734|584176142|FG003|Post-intervention Scan Visit|Adverse Event|0|||
161764175|NCT03490734|584176139|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
161764176|NCT03490734|584176140|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
161764177|NCT03490734|584176141|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
161764178|NCT03490734|584176142|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
161764179|NCT03490734|584176139|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
161764180|NCT03490734|584176140|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
161764181|NCT03490734|584176141|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
161764182|NCT03490734|584176142|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
161764183|NCT04491591|584176148|FG000|Overall Study|Accidently randomized|3|||
161764184|NCT04491591|584176149|FG001|Overall Study|Accidently randomized|1|||
161764185|NCT04491591|584176150|FG002|Overall Study|Accidently randomized|0|||
161764186|NCT04491591|584176148|FG000|Overall Study|Did not complete survey|28|||
161764187|NCT04491591|584176149|FG001|Overall Study|Did not complete survey|20|||
161764188|NCT04491591|584176150|FG002|Overall Study|Did not complete survey|3|||
161764189|NCT04212221|584176153|FG000|Overall Study|Remained on Treatment|0|||
161764190|NCT04212221|584176154|FG001|Overall Study|Remained on Treatment|0|||
161764191|NCT04212221|584176155|FG002|Overall Study|Remained on Treatment|0|||
161764192|NCT04212221|584176156|FG003|Overall Study|Remained on Treatment|1|||
161764193|NCT04212221|584176157|FG004|Overall Study|Remained on Treatment|0|||
161764194|NCT04212221|584176158|FG005|Overall Study|Remained on Treatment|0|||
161764195|NCT04212221|584176159|FG006|Overall Study|Remained on Treatment|3|||
161764196|NCT04212221|584176160|FG007|Overall Study|Remained on Treatment|9|||
161764197|NCT04212221|584176153|FG000|Overall Study|Adverse Event|0|||
161764198|NCT04212221|584176154|FG001|Overall Study|Adverse Event|0|||
161764199|NCT04212221|584176155|FG002|Overall Study|Adverse Event|0|||
161764200|NCT04212221|584176156|FG003|Overall Study|Adverse Event|0|||
161764201|NCT04212221|584176157|FG004|Overall Study|Adverse Event|0|||
161764202|NCT04212221|584176158|FG005|Overall Study|Adverse Event|0|||
161764203|NCT04212221|584176159|FG006|Overall Study|Adverse Event|2|||
161764204|NCT04212221|584176160|FG007|Overall Study|Adverse Event|3|||
161764205|NCT04212221|584176153|FG000|Overall Study|Death|0|||
161764206|NCT04212221|584176154|FG001|Overall Study|Death|0|||
161764207|NCT04212221|584176155|FG002|Overall Study|Death|0|||
161764208|NCT04212221|584176156|FG003|Overall Study|Death|0|||
161764209|NCT04212221|584176157|FG004|Overall Study|Death|0|||
162033672|NCT04090411|585180164|FG008|Induction Period|Physician Decision|0|||
162033673|NCT04090411|585180165|FG009|Induction Period|Physician Decision|0|||
162033674|NCT04090411|585180166|FG010|Induction Period|Physician Decision|0|||
162033675|NCT04090411|585180167|FG011|Induction Period|Physician Decision|0|||
162033676|NCT04090411|585180168|FG012|Induction Period|Physician Decision|0|||
162033677|NCT04090411|585180156|FG000|Induction Period|Protocol Violation|0|||
162033678|NCT04090411|585180157|FG001|Induction Period|Protocol Violation|0|||
162033679|NCT04090411|585180158|FG002|Induction Period|Protocol Violation|0|||
162033680|NCT04090411|585180159|FG003|Induction Period|Protocol Violation|1|||
162033681|NCT04090411|585180160|FG004|Induction Period|Protocol Violation|0|||
162033682|NCT04090411|585180161|FG005|Induction Period|Protocol Violation|0|||
162033683|NCT04090411|585180162|FG006|Induction Period|Protocol Violation|0|||
162033684|NCT04090411|585180163|FG007|Induction Period|Protocol Violation|0|||
162033685|NCT04090411|585180164|FG008|Induction Period|Protocol Violation|0|||
162033686|NCT04090411|585180165|FG009|Induction Period|Protocol Violation|0|||
162033687|NCT04090411|585180166|FG010|Induction Period|Protocol Violation|0|||
162033688|NCT04090411|585180167|FG011|Induction Period|Protocol Violation|0|||
162033689|NCT04090411|585180168|FG012|Induction Period|Protocol Violation|0|||
162033690|NCT04090411|585180156|FG000|Induction Period|Withdrawal by Subject|2|||
162033691|NCT04090411|585180157|FG001|Induction Period|Withdrawal by Subject|0|||
162033692|NCT04090411|585180158|FG002|Induction Period|Withdrawal by Subject|1|||
162033693|NCT04090411|585180159|FG003|Induction Period|Withdrawal by Subject|5|||
162033694|NCT04090411|585180160|FG004|Induction Period|Withdrawal by Subject|0|||
162033695|NCT04090411|585180161|FG005|Induction Period|Withdrawal by Subject|0|||
162033696|NCT04090411|585180162|FG006|Induction Period|Withdrawal by Subject|0|||
162033697|NCT04090411|585180163|FG007|Induction Period|Withdrawal by Subject|0|||
162033698|NCT04090411|585180164|FG008|Induction Period|Withdrawal by Subject|0|||
162033699|NCT04090411|585180165|FG009|Induction Period|Withdrawal by Subject|0|||
162033700|NCT04090411|585180166|FG010|Induction Period|Withdrawal by Subject|0|||
162033701|NCT04090411|585180167|FG011|Induction Period|Withdrawal by Subject|0|||
162033702|NCT04090411|585180168|FG012|Induction Period|Withdrawal by Subject|0|||
162033703|NCT04090411|585180156|FG000|Chronic Period|Adverse Event|0|||
162033704|NCT04090411|585180157|FG001|Chronic Period|Adverse Event|0|||
162033705|NCT04090411|585180158|FG002|Chronic Period|Adverse Event|0|||
162033706|NCT04090411|585180159|FG003|Chronic Period|Adverse Event|0|||
162033707|NCT04090411|585180160|FG004|Chronic Period|Adverse Event|0|||
162033708|NCT04090411|585180161|FG005|Chronic Period|Adverse Event|1|||
162033709|NCT04090411|585180162|FG006|Chronic Period|Adverse Event|0|||
162033710|NCT04090411|585180163|FG007|Chronic Period|Adverse Event|3|||
162033711|NCT04090411|585180164|FG008|Chronic Period|Adverse Event|0|||
162033712|NCT04090411|585180165|FG009|Chronic Period|Adverse Event|0|||
162033713|NCT04090411|585180166|FG010|Chronic Period|Adverse Event|5|||
162033714|NCT04090411|585180167|FG011|Chronic Period|Adverse Event|1|||
162033715|NCT04090411|585180168|FG012|Chronic Period|Adverse Event|1|||
162033716|NCT04090411|585180156|FG000|Chronic Period|Lack of Efficacy|0|||
162033717|NCT04090411|585180157|FG001|Chronic Period|Lack of Efficacy|0|||
162033718|NCT04090411|585180158|FG002|Chronic Period|Lack of Efficacy|0|||
162033719|NCT04090411|585180159|FG003|Chronic Period|Lack of Efficacy|0|||
162033720|NCT04090411|585180160|FG004|Chronic Period|Lack of Efficacy|0|||
162033721|NCT04090411|585180161|FG005|Chronic Period|Lack of Efficacy|0|||
162033722|NCT04090411|585180162|FG006|Chronic Period|Lack of Efficacy|1|||
162033723|NCT04090411|585180163|FG007|Chronic Period|Lack of Efficacy|4|||
162033724|NCT04090411|585180164|FG008|Chronic Period|Lack of Efficacy|2|||
161764210|NCT04212221|584176158|FG005|Overall Study|Death|0|||
161764211|NCT04212221|584176159|FG006|Overall Study|Death|0|||
161764212|NCT04212221|584176160|FG007|Overall Study|Death|2|||
161764213|NCT04212221|584176153|FG000|Overall Study|Disease progression according to irRECIST|1|||
161764214|NCT04212221|584176154|FG001|Overall Study|Disease progression according to irRECIST|2|||
161764215|NCT04212221|584176155|FG002|Overall Study|Disease progression according to irRECIST|3|||
161764216|NCT04212221|584176156|FG003|Overall Study|Disease progression according to irRECIST|3|||
161764217|NCT04212221|584176157|FG004|Overall Study|Disease progression according to irRECIST|2|||
161764218|NCT04212221|584176158|FG005|Overall Study|Disease progression according to irRECIST|2|||
161764219|NCT04212221|584176159|FG006|Overall Study|Disease progression according to irRECIST|21|||
161764220|NCT04212221|584176160|FG007|Overall Study|Disease progression according to irRECIST|17|||
161764221|NCT04212221|584176153|FG000|Overall Study|Global Deterioration of Health Status|0|||
161764222|NCT04212221|584176154|FG001|Overall Study|Global Deterioration of Health Status|0|||
162033725|NCT04090411|585180165|FG009|Chronic Period|Lack of Efficacy|2|||
162033726|NCT04090411|585180166|FG010|Chronic Period|Lack of Efficacy|2|||
162033727|NCT04090411|585180167|FG011|Chronic Period|Lack of Efficacy|1|||
162033728|NCT04090411|585180168|FG012|Chronic Period|Lack of Efficacy|2|||
162033729|NCT04090411|585180156|FG000|Chronic Period|Relocation|0|||
162033730|NCT04090411|585180157|FG001|Chronic Period|Relocation|0|||
162033731|NCT04090411|585180158|FG002|Chronic Period|Relocation|0|||
162033732|NCT04090411|585180159|FG003|Chronic Period|Relocation|0|||
162033733|NCT04090411|585180160|FG004|Chronic Period|Relocation|0|||
162033734|NCT04090411|585180161|FG005|Chronic Period|Relocation|0|||
162033735|NCT04090411|585180162|FG006|Chronic Period|Relocation|0|||
161849872|NCT00369486|584492772|FG000|4-Week Visit|Dropped|0|||
161849873|NCT00369486|584492773|FG001|4-Week Visit|Dropped|0|||
161849874|NCT00369486|584492774|FG002|4-Week Visit|Dropped|1|||
161849875|NCT00369486|584492775|FG003|4-Week Visit|Dropped|0|||
161849876|NCT00369486|584492776|FG004|4-Week Visit|Dropped|0|||
161849877|NCT00369486|584492772|FG000|8-Week Visit|Missed visit|0|||
161849878|NCT00369486|584492773|FG001|8-Week Visit|Missed visit|1|||
161849879|NCT00369486|584492774|FG002|8-Week Visit|Missed visit|0|||
161849880|NCT00369486|584492775|FG003|8-Week Visit|Missed visit|0|||
161849881|NCT00369486|584492776|FG004|8-Week Visit|Missed visit|1|||
161849882|NCT00369486|584492772|FG000|8-Week Visit|Dropped|0|||
161849883|NCT00369486|584492773|FG001|8-Week Visit|Dropped|0|||
161849884|NCT00369486|584492774|FG002|8-Week Visit|Dropped|0|||
161849885|NCT00369486|584492775|FG003|8-Week Visit|Dropped|1|||
161764223|NCT04212221|584176155|FG002|Overall Study|Global Deterioration of Health Status|0|||
161764224|NCT04212221|584176156|FG003|Overall Study|Global Deterioration of Health Status|0|||
161764225|NCT04212221|584176157|FG004|Overall Study|Global Deterioration of Health Status|0|||
161764226|NCT04212221|584176158|FG005|Overall Study|Global Deterioration of Health Status|0|||
161849886|NCT00369486|584492776|FG004|8-Week Visit|Dropped|0|||
161849887|NCT00369486|584492772|FG000|17-Week Visit|Missed visit|0|||
161849888|NCT00369486|584492773|FG001|17-Week Visit|Missed visit|0|||
161849889|NCT00369486|584492774|FG002|17-Week Visit|Missed visit|1|||
161849890|NCT00369486|584492775|FG003|17-Week Visit|Missed visit|1|||
161849891|NCT00369486|584492776|FG004|17-Week Visit|Missed visit|1|||
161849892|NCT00369486|584492772|FG000|34-Week Visit|Dropped|0|||
161972652|NCT02649855|584945990|FG000|Overall Study|Initiate new treatment|1|||
161972653|NCT02649855|584945991|FG001|Overall Study|Initiate new treatment|0|||
161972654|NCT02649855|584945992|FG002|Overall Study|Initiate new treatment|0|||
161972655|NCT02191605|584947628|FG000|Overall Study|Lost to Follow-up|9|||
161972656|NCT02191605|584947629|FG001|Overall Study|Lost to Follow-up|4|||
161972657|NCT02191605|584947630|FG002|Overall Study|Lost to Follow-up|7|||
161972658|NCT02191605|584947631|FG003|Overall Study|Lost to Follow-up|3|||
161972659|NCT02191605|584947632|FG004|Overall Study|Lost to Follow-up|4|||
161972660|NCT03647267|584947633|FG000|Overall Study|Lost to Follow-up|1|||
161972661|NCT03647267|584947634|FG001|Overall Study|Lost to Follow-up|0|||
161972662|NCT03131596|584947641|FG000|Overall Study|Protocol Violation|3|||
161972663|NCT03131596|584947642|FG001|Overall Study|Protocol Violation|3|||
161972664|NCT03131596|584947641|FG000|Overall Study|Lost to Follow-up|3|||
161972665|NCT03131596|584947642|FG001|Overall Study|Lost to Follow-up|0|||
161972666|NCT00734071|584947643|FG000|Overall Study|Adverse Event|4|||
161972667|NCT00734071|584947644|FG001|Overall Study|Adverse Event|3|||
161972668|NCT00734071|584947643|FG000|Overall Study|Lack of Efficacy|3|||
161764227|NCT04212221|584176159|FG006|Overall Study|Global Deterioration of Health Status|0|||
161764228|NCT04212221|584176160|FG007|Overall Study|Global Deterioration of Health Status|2|||
161764229|NCT04212221|584176153|FG000|Overall Study|Investigator's Decision|0|||
161764230|NCT04212221|584176154|FG001|Overall Study|Investigator's Decision|0|||
161764231|NCT04212221|584176155|FG002|Overall Study|Investigator's Decision|0|||
161764232|NCT04212221|584176156|FG003|Overall Study|Investigator's Decision|1|||
161764233|NCT04212221|584176157|FG004|Overall Study|Investigator's Decision|0|||
161764234|NCT04212221|584176158|FG005|Overall Study|Investigator's Decision|0|||
161764235|NCT04212221|584176159|FG006|Overall Study|Investigator's Decision|3|||
161764236|NCT04212221|584176160|FG007|Overall Study|Investigator's Decision|0|||
161764237|NCT04212221|584176153|FG000|Overall Study|Participant refused to continue treatment|0|||
161764238|NCT04212221|584176154|FG001|Overall Study|Participant refused to continue treatment|1|||
161764239|NCT04212221|584176155|FG002|Overall Study|Participant refused to continue treatment|0|||
161764240|NCT04212221|584176156|FG003|Overall Study|Participant refused to continue treatment|1|||
161764241|NCT04212221|584176157|FG004|Overall Study|Participant refused to continue treatment|1|||
161764242|NCT04212221|584176158|FG005|Overall Study|Participant refused to continue treatment|2|||
161764243|NCT04212221|584176159|FG006|Overall Study|Participant refused to continue treatment|4|||
161764244|NCT04212221|584176160|FG007|Overall Study|Participant refused to continue treatment|2|||
161764245|NCT04212221|584176153|FG000|Overall Study|Protocol Violation|0|||
161764246|NCT04212221|584176154|FG001|Overall Study|Protocol Violation|0|||
161764247|NCT04212221|584176155|FG002|Overall Study|Protocol Violation|0|||
161764248|NCT04212221|584176156|FG003|Overall Study|Protocol Violation|0|||
161764249|NCT04212221|584176157|FG004|Overall Study|Protocol Violation|0|||
161764250|NCT04212221|584176158|FG005|Overall Study|Protocol Violation|0|||
161849893|NCT00369486|584492773|FG001|34-Week Visit|Dropped|1|||
161849894|NCT00369486|584492774|FG002|34-Week Visit|Dropped|1|||
161849895|NCT00369486|584492775|FG003|34-Week Visit|Dropped|3|||
161972669|NCT00734071|584947644|FG001|Overall Study|Lack of Efficacy|1|||
161972670|NCT00734071|584947643|FG000|Overall Study|Noncompliance|2|||
161972671|NCT00734071|584947644|FG001|Overall Study|Noncompliance|2|||
161849896|NCT00369486|584492776|FG004|34-Week Visit|Dropped|3|||
161849897|NCT01810302|584492783|FG000|Overall Study|Death|1|||
161849898|NCT01810302|584492784|FG001|Overall Study|Death|0|||
161849899|NCT01810302|584492783|FG000|Overall Study|Physician Decision|0|||
161849900|NCT01810302|584492784|FG001|Overall Study|Physician Decision|1|||
161972672|NCT00734071|584947643|FG000|Overall Study|Protocol Deviations|3|||
161972673|NCT00734071|584947644|FG001|Overall Study|Protocol Deviations|4|||
161849901|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #1|24|||
161849902|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #1|0|||
161849903|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
161849904|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
161849905|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849906|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849907|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
161849908|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
161849909|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
161849910|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
161849911|NCT03888066|584492785|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849912|NCT03888066|584492786|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849913|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849914|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849915|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
161849916|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
161849917|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849918|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849919|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
161849920|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849921|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #2|5|||
161849922|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #2|0|||
161849923|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
161849924|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
161849925|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
161849926|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
161849927|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
161849928|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
161849929|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #3|11|||
161849930|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #3|0|||
161849931|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
161849932|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
161849933|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
161849934|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161849935|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849936|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849937|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #4|3|||
161849938|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #4|0|||
161849939|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
161849940|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
161849941|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
161849942|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
161849943|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
161849944|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161849945|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
161849946|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
161849947|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
161849948|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849949|NCT03888066|584492785|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
161849950|NCT03888066|584492786|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161849951|NCT03888066|584492785|FG000|Run-in Phase|AE (Adverse Event)|17|||
161849952|NCT03888066|584492786|FG001|Run-in Phase|AE (Adverse Event)|0|||
161849953|NCT03888066|584492785|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
161849954|NCT03888066|584492786|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
161849955|NCT03888066|584492785|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161849956|NCT03888066|584492786|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849957|NCT03888066|584492785|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
162033736|NCT04090411|585180163|FG007|Chronic Period|Relocation|1|||
162033737|NCT04090411|585180164|FG008|Chronic Period|Relocation|0|||
161849958|NCT03888066|584492786|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
162033738|NCT04090411|585180165|FG009|Chronic Period|Relocation|0|||
161849959|NCT03888066|584492785|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
162033739|NCT04090411|585180166|FG010|Chronic Period|Relocation|0|||
162033740|NCT04090411|585180167|FG011|Chronic Period|Relocation|0|||
162033741|NCT04090411|585180168|FG012|Chronic Period|Relocation|0|||
162033742|NCT04090411|585180156|FG000|Chronic Period|Physician Decision|0|||
162033743|NCT04090411|585180157|FG001|Chronic Period|Physician Decision|0|||
162033744|NCT04090411|585180158|FG002|Chronic Period|Physician Decision|0|||
162033745|NCT04090411|585180159|FG003|Chronic Period|Physician Decision|0|||
162033746|NCT04090411|585180160|FG004|Chronic Period|Physician Decision|1|||
162033747|NCT04090411|585180161|FG005|Chronic Period|Physician Decision|0|||
162033748|NCT04090411|585180162|FG006|Chronic Period|Physician Decision|0|||
162033749|NCT04090411|585180163|FG007|Chronic Period|Physician Decision|1|||
162033750|NCT04090411|585180164|FG008|Chronic Period|Physician Decision|0|||
162033751|NCT04090411|585180165|FG009|Chronic Period|Physician Decision|0|||
162033752|NCT04090411|585180166|FG010|Chronic Period|Physician Decision|0|||
162033753|NCT04090411|585180167|FG011|Chronic Period|Physician Decision|1|||
162033754|NCT04090411|585180168|FG012|Chronic Period|Physician Decision|1|||
162033755|NCT04090411|585180156|FG000|Chronic Period|Protocol Violation|0|||
162033756|NCT04090411|585180157|FG001|Chronic Period|Protocol Violation|0|||
162033757|NCT04090411|585180158|FG002|Chronic Period|Protocol Violation|0|||
162033758|NCT04090411|585180159|FG003|Chronic Period|Protocol Violation|0|||
162033759|NCT04090411|585180160|FG004|Chronic Period|Protocol Violation|0|||
162033760|NCT04090411|585180161|FG005|Chronic Period|Protocol Violation|0|||
162033761|NCT04090411|585180162|FG006|Chronic Period|Protocol Violation|0|||
162033762|NCT04090411|585180163|FG007|Chronic Period|Protocol Violation|0|||
162033763|NCT04090411|585180164|FG008|Chronic Period|Protocol Violation|0|||
162033764|NCT04090411|585180165|FG009|Chronic Period|Protocol Violation|0|||
162033765|NCT04090411|585180166|FG010|Chronic Period|Protocol Violation|0|||
162033766|NCT04090411|585180167|FG011|Chronic Period|Protocol Violation|0|||
162033767|NCT04090411|585180168|FG012|Chronic Period|Protocol Violation|1|||
162033768|NCT04090411|585180156|FG000|Chronic Period|Withdrawal by Subject|0|||
162033769|NCT04090411|585180157|FG001|Chronic Period|Withdrawal by Subject|0|||
162033770|NCT04090411|585180158|FG002|Chronic Period|Withdrawal by Subject|0|||
162033771|NCT04090411|585180159|FG003|Chronic Period|Withdrawal by Subject|0|||
162033772|NCT04090411|585180160|FG004|Chronic Period|Withdrawal by Subject|0|||
162033773|NCT04090411|585180161|FG005|Chronic Period|Withdrawal by Subject|1|||
162033774|NCT04090411|585180162|FG006|Chronic Period|Withdrawal by Subject|1|||
162033775|NCT04090411|585180163|FG007|Chronic Period|Withdrawal by Subject|3|||
162033776|NCT04090411|585180164|FG008|Chronic Period|Withdrawal by Subject|3|||
162033777|NCT04090411|585180165|FG009|Chronic Period|Withdrawal by Subject|3|||
162033778|NCT04090411|585180166|FG010|Chronic Period|Withdrawal by Subject|1|||
162033779|NCT04090411|585180167|FG011|Chronic Period|Withdrawal by Subject|3|||
162033780|NCT04090411|585180168|FG012|Chronic Period|Withdrawal by Subject|0|||
162033781|NCT01958827|585180176|FG000|Overall Study|Adverse Event|3|||
162033782|NCT01958827|585180176|FG000|Overall Study|Lack of Efficacy|6|||
162033783|NCT01958827|585180176|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
161849960|NCT03888066|584492786|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161849961|NCT03888066|584492785|FG000|Run-in Phase|Withdrawal by Subject|43|||
161849962|NCT03888066|584492786|FG001|Run-in Phase|Withdrawal by Subject|0|||
161849963|NCT03888066|584492785|FG000|Run-in Phase|AE; Physician Decision|1|||
161849964|NCT03888066|584492786|FG001|Run-in Phase|AE; Physician Decision|0|||
161849965|NCT03888066|584492785|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
161849966|NCT03888066|584492786|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161849967|NCT03888066|584492785|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
161849968|NCT03888066|584492786|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
161849969|NCT03888066|584492785|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
161849970|NCT03888066|584492786|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161849971|NCT03888066|584492785|FG000|Run-in Phase|Death|1|||
162033784|NCT03764033|585180180|FG000|Treatment Phase|Withdrawal by Subject|8|||
162033785|NCT03764033|585180181|FG001|Treatment Phase|Withdrawal by Subject|3|||
162033786|NCT03764033|585180180|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
161849972|NCT03888066|584492786|FG001|Run-in Phase|Death|0|||
162033787|NCT03764033|585180181|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
161849973|NCT03888066|584492785|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
161849974|NCT03888066|584492786|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
161849975|NCT03888066|584492785|FG000|Run-in Phase|Physician Decision|1|||
161849976|NCT03888066|584492786|FG001|Run-in Phase|Physician Decision|0|||
161849977|NCT03888066|584492785|FG000|Run-in Phase|Protocol Violation|13|||
162033788|NCT03764033|585180180|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
161849978|NCT03888066|584492786|FG001|Run-in Phase|Protocol Violation|0|||
162033789|NCT03764033|585180181|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
162033790|NCT04594369|585180182|FG000|Overall Study|Adverse Event|10|||
162033791|NCT04594369|585180183|FG001|Overall Study|Adverse Event|10|||
162033792|NCT04594369|585180184|FG002|Overall Study|Adverse Event|9|||
162033793|NCT04594369|585180182|FG000|Overall Study|Death|2|||
162033794|NCT04594369|585180183|FG001|Overall Study|Death|4|||
161849979|NCT03888066|584492785|FG000|Run-in Phase|Sponsor Request|34|||
161849980|NCT03888066|584492786|FG001|Run-in Phase|Sponsor Request|0|||
161849981|NCT03888066|584492785|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
161849982|NCT03888066|584492786|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
161849983|NCT03888066|584492785|FG000|Run-in Phase|Withdrawal Of Consent|1|||
161849984|NCT03888066|584492786|FG001|Run-in Phase|Withdrawal Of Consent|0|||
161849985|NCT03888066|584492785|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
161849986|NCT03888066|584492786|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
161849987|NCT03888066|584492785|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
161849988|NCT03888066|584492786|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
161849989|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
161849990|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
161849991|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
161849992|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
161849993|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
161849994|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
161849995|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
161849996|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
161849997|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
161849998|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
161849999|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
161850000|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
161850001|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
161850002|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
161850003|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
161850004|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
161850005|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
161850006|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
161850007|NCT03888066|584492785|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
161850008|NCT03888066|584492786|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
161850009|NCT03278626|584492787|FG000|Overall Study|Death|2|||
161850010|NCT03278626|584492787|FG000|Overall Study|Toxicity|1|||
161850011|NCT03278626|584492787|FG000|Overall Study|Disease Progression|2|||
161850012|NCT02856555|584492788|FG000|Overall Study|Adverse Event|1|||
161850013|NCT02856555|584492789|FG001|Overall Study|Adverse Event|0|||
161850014|NCT02856555|584492790|FG002|Overall Study|Adverse Event|0|||
161850015|NCT02856555|584492788|FG000|Overall Study|Lost to Follow-up|1|||
161850016|NCT02856555|584492789|FG001|Overall Study|Lost to Follow-up|3|||
161850017|NCT02856555|584492790|FG002|Overall Study|Lost to Follow-up|0|||
161850018|NCT02856555|584492788|FG000|Overall Study|Withdrawal by Subject|3|||
161850019|NCT02856555|584492789|FG001|Overall Study|Withdrawal by Subject|0|||
161850020|NCT02856555|584492790|FG002|Overall Study|Withdrawal by Subject|0|||
161850021|NCT02856555|584492788|FG000|Overall Study|Randomized but Never Treated|0|||
161850022|NCT02856555|584492789|FG001|Overall Study|Randomized but Never Treated|1|||
161850023|NCT02856555|584492790|FG002|Overall Study|Randomized but Never Treated|0|||
161850024|NCT03333941|584492791|FG000|Overall Study|Lost to Follow-up|10|||
161850025|NCT03333941|584492791|FG000|Overall Study|Death|2|||
161850026|NCT03333941|584492791|FG000|Overall Study|Adverse Event|1|||
161850027|NCT02077140|584492792|FG000|Overall Study|Lost to Follow-up|4|||
161850028|NCT02077140|584492793|FG001|Overall Study|Lost to Follow-up|1|||
161850029|NCT02077140|584492794|FG002|Overall Study|Lost to Follow-up|2|||
161850030|NCT02077140|584492795|FG003|Overall Study|Lost to Follow-up|2|||
161850031|NCT02077140|584492796|FG004|Overall Study|Lost to Follow-up|3|||
161850032|NCT02077140|584492792|FG000|Overall Study|Withdrawal by Subject|0|||
161850033|NCT02077140|584492793|FG001|Overall Study|Withdrawal by Subject|1|||
161850034|NCT02077140|584492794|FG002|Overall Study|Withdrawal by Subject|0|||
161850035|NCT02077140|584492795|FG003|Overall Study|Withdrawal by Subject|2|||
161850036|NCT02077140|584492796|FG004|Overall Study|Withdrawal by Subject|2|||
161850037|NCT00974922|584492797|FG000|Overall Study|study terminated|24|||
161850038|NCT00287586|584492798|FG000|Overall Study|Withdrew Consent|19|||
161850039|NCT00287586|584492799|FG001|Overall Study|Withdrew Consent|30|||
161850040|NCT00287586|584492798|FG000|Overall Study|Lost to Follow-up|5|||
161850041|NCT00287586|584492799|FG001|Overall Study|Lost to Follow-up|4|||
161850042|NCT00287586|584492798|FG000|Overall Study|Death|2|||
161850043|NCT00287586|584492799|FG001|Overall Study|Death|3|||
161850044|NCT00287586|584492798|FG000|Overall Study|Elevated Hematocrit|3|||
161850045|NCT00287586|584492799|FG001|Overall Study|Elevated Hematocrit|0|||
161850046|NCT00287586|584492798|FG000|Overall Study|Rash|3|||
161850047|NCT00287586|584492799|FG001|Overall Study|Rash|0|||
161850048|NCT00287586|584492798|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
161850049|NCT00287586|584492799|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
161850050|NCT00287586|584492798|FG000|Overall Study|Stroke|2|||
161850051|NCT00287586|584492799|FG001|Overall Study|Stroke|0|||
161850052|NCT00287586|584492798|FG000|Overall Study|Myocardial Infarction|1|||
161850053|NCT00287586|584492799|FG001|Overall Study|Myocardial Infarction|0|||
161850054|NCT00287586|584492798|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
161850055|NCT00287586|584492799|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
161850056|NCT00287586|584492798|FG000|Overall Study|Cognitive Impairment|1|||
161850057|NCT00287586|584492799|FG001|Overall Study|Cognitive Impairment|0|||
161850058|NCT00287586|584492798|FG000|Overall Study|Pancreatic Cancer|1|||
161850059|NCT00287586|584492799|FG001|Overall Study|Pancreatic Cancer|3|||
161850060|NCT00287586|584492798|FG000|Overall Study|Sleep Apnea|1|||
161850061|NCT00287586|584492799|FG001|Overall Study|Sleep Apnea|0|||
161850062|NCT00287586|584492798|FG000|Overall Study|Shoulder Pain|1|||
161850063|NCT00287586|584492799|FG001|Overall Study|Shoulder Pain|0|||
161850064|NCT00287586|584492798|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
161850065|NCT00287586|584492799|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
161850066|NCT00287586|584492798|FG000|Overall Study|Nonadherence|1|||
161850067|NCT00287586|584492799|FG001|Overall Study|Nonadherence|1|||
161850068|NCT00287586|584492798|FG000|Overall Study|Enrolled in Another Study|1|||
161850069|NCT00287586|584492799|FG001|Overall Study|Enrolled in Another Study|0|||
161850070|NCT00287586|584492798|FG000|Overall Study|Major Depression|0|||
161850071|NCT00287586|584492799|FG001|Overall Study|Major Depression|2|||
161850072|NCT00287586|584492798|FG000|Overall Study|Lung Cancer|0|||
161850073|NCT00287586|584492799|FG001|Overall Study|Lung Cancer|2|||
161850074|NCT00287586|584492798|FG000|Overall Study|Elevated IPSS Score|0|||
161850075|NCT00287586|584492799|FG001|Overall Study|Elevated IPSS Score|1|||
161850076|NCT00287586|584492798|FG000|Overall Study|Retroperitoneal Cancer|0|||
161850077|NCT00287586|584492799|FG001|Overall Study|Retroperitoneal Cancer|1|||
161850078|NCT00287586|584492798|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
161850079|NCT00287586|584492799|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
161850080|NCT00287586|584492798|FG000|Overall Study|Mood Swings and Irritability|0|||
161850081|NCT00287586|584492799|FG001|Overall Study|Mood Swings and Irritability|1|||
161850082|NCT00287586|584492798|FG000|Overall Study|Bradycardia|0|||
161850083|NCT00287586|584492799|FG001|Overall Study|Bradycardia|1|||
161850084|NCT00287586|584492798|FG000|Overall Study|Itchy Swollen Eyes|0|||
161850085|NCT00287586|584492799|FG001|Overall Study|Itchy Swollen Eyes|1|||
161850086|NCT00287586|584492798|FG000|Overall Study|Recurrent Melanoma|0|||
161850087|NCT00287586|584492799|FG001|Overall Study|Recurrent Melanoma|1|||
161850088|NCT01762800|584492801|FG000|Overall Study|Adverse Event|8|||
161850089|NCT01762800|584492802|FG001|Overall Study|Adverse Event|13|||
161850090|NCT01762800|584492801|FG000|Overall Study|Lack of Efficacy|3|||
161850091|NCT01762800|584492802|FG001|Overall Study|Lack of Efficacy|2|||
161850092|NCT01762800|584492801|FG000|Overall Study|Study Closed/Terminated|0|||
161850093|NCT01762800|584492802|FG001|Overall Study|Study Closed/Terminated|1|||
161850094|NCT01762800|584492801|FG000|Overall Study|Physician Decision|1|||
161850095|NCT01762800|584492802|FG001|Overall Study|Physician Decision|1|||
161850096|NCT01762800|584492801|FG000|Overall Study|Withdrawal by Subject|7|||
161850097|NCT01762800|584492802|FG001|Overall Study|Withdrawal by Subject|4|||
161850098|NCT02640482|584492803|FG000|Overall Study|Lost to Follow-up|3|||
161850099|NCT02640482|584492804|FG001|Overall Study|Lost to Follow-up|0|||
161850100|NCT00113763|584492805|FG000|Overall Study|Adverse Event|5|||
161850101|NCT00113763|584492806|FG001|Overall Study|Adverse Event|2|||
161850102|NCT00113763|584492805|FG000|Overall Study|Disease Progression|28|||
161850103|NCT00113763|584492806|FG001|Overall Study|Disease Progression|14|||
161850104|NCT00113763|584492805|FG000|Overall Study|Lost to Follow-up|10|||
161850105|NCT00113763|584492806|FG001|Overall Study|Lost to Follow-up|0|||
161850106|NCT00113763|584492805|FG000|Overall Study|Withdrawal by Subject|1|||
161850107|NCT00113763|584492806|FG001|Overall Study|Withdrawal by Subject|4|||
161850108|NCT00113763|584492805|FG000|Overall Study|Other|27|||
161850109|NCT00113763|584492806|FG001|Overall Study|Other|6|||
161850110|NCT00113763|584492805|FG000|Overall Study|Non-compliance|1|||
161850111|NCT00113763|584492806|FG001|Overall Study|Non-compliance|0|||
161850112|NCT00113763|584492805|FG000|Overall Study|Ongoing|1|||
161850113|NCT00113763|584492806|FG001|Overall Study|Ongoing|0|||
161850114|NCT00517881|584492807|FG000|Overall Study|Protocol Violation|2|||
161850115|NCT00517881|584492807|FG000|Overall Study|Adverse Event|1|||
161850116|NCT00517881|584492807|FG000|Overall Study|Renal transplantation|2|||
161850117|NCT03743415|584492808|FG000|Overall Study|Death|5|||
162033795|NCT04594369|585180184|FG002|Overall Study|Death|8|||
162033796|NCT04594369|585180182|FG000|Overall Study|Lost to Follow-up|10|||
161850118|NCT03743415|584492809|FG001|Overall Study|Death|3|||
161850119|NCT03743415|584492810|FG002|Overall Study|Death|1|||
161850120|NCT03743415|584492811|FG003|Overall Study|Death|4|||
161850121|NCT03743415|584492812|FG004|Overall Study|Death|0|||
161850122|NCT03743415|584492813|FG005|Overall Study|Death|0|||
161850123|NCT03743415|584492814|FG006|Overall Study|Death|0|||
161850124|NCT03743415|584492815|FG007|Overall Study|Death|0|||
161850125|NCT03743415|584492816|FG008|Overall Study|Death|1|||
161850126|NCT03743415|584492817|FG009|Overall Study|Death|0|||
161850127|NCT03743415|584492808|FG000|Overall Study|Withdrawal by Subject|1|||
162033797|NCT04594369|585180183|FG001|Overall Study|Lost to Follow-up|2|||
161850128|NCT03743415|584492809|FG001|Overall Study|Withdrawal by Subject|0|||
161850129|NCT03743415|584492810|FG002|Overall Study|Withdrawal by Subject|4|||
161972674|NCT00734071|584947643|FG000|Overall Study|Voluntary Withdrawal|9|||
161972675|NCT00734071|584947644|FG001|Overall Study|Voluntary Withdrawal|7|||
161972676|NCT00734071|584947643|FG000|Overall Study|Lost to Follow-up|16|||
161972677|NCT00734071|584947644|FG001|Overall Study|Lost to Follow-up|8|||
161972678|NCT00734071|584947643|FG000|Overall Study|Other|1|||
161972679|NCT00734071|584947644|FG001|Overall Study|Other|2|||
161972680|NCT03654885|584947645|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
161972681|NCT03654885|584947646|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
161972682|NCT03654885|584947645|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
161972683|NCT03654885|584947646|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
161972684|NCT03654885|584947645|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
161972685|NCT03654885|584947646|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
161972686|NCT03654885|584947645|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
161972687|NCT03654885|584947646|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
161972688|NCT03654885|584947645|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
161972689|NCT03654885|584947646|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
161972690|NCT03654885|584947645|FG000|Overall Study|Adverse Event in Study Eye|3|||
161972691|NCT03654885|584947646|FG001|Overall Study|Adverse Event in Study Eye|0|||
161972692|NCT03654885|584947645|FG000|Overall Study|Consent Withdrawn|1|||
161972693|NCT03654885|584947646|FG001|Overall Study|Consent Withdrawn|0|||
161972694|NCT03654885|584947645|FG000|Overall Study|Death|3|||
161972695|NCT03654885|584947646|FG001|Overall Study|Death|1|||
161972696|NCT03654885|584947645|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
161972697|NCT03654885|584947646|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
161972698|NCT03654885|584947645|FG000|Overall Study|Lost to Follow-up|3|||
161972699|NCT03654885|584947646|FG001|Overall Study|Lost to Follow-up|3|||
161972700|NCT05275582|584947647|FG000|Overall Study|Lost to Follow-up|1|||
161972701|NCT05275582|584947648|FG001|Overall Study|Lost to Follow-up|0|||
161972702|NCT05275582|584947647|FG000|Overall Study|Withdrawal by Subject|0|||
161972703|NCT05275582|584947648|FG001|Overall Study|Withdrawal by Subject|2|||
161972704|NCT05275582|584947647|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
161972705|NCT05275582|584947648|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
161972706|NCT05275582|584947647|FG000|Overall Study|Death|1|||
161972707|NCT05275582|584947648|FG001|Overall Study|Death|0|||
161972708|NCT05275582|584947647|FG000|Overall Study|Protocol Violation|1|||
161972709|NCT05275582|584947648|FG001|Overall Study|Protocol Violation|0|||
161972710|NCT05320393|584947650|FG000|Overall Study|Withdrawal by Subject|1|||
161972711|NCT05320393|584947651|FG001|Overall Study|Withdrawal by Subject|0|||
161972712|NCT05320393|584947652|FG002|Overall Study|Withdrawal by Subject|2|||
161972713|NCT05320393|584947650|FG000|Overall Study|Lost to Follow-up|1|||
161972714|NCT05320393|584947651|FG001|Overall Study|Lost to Follow-up|2|||
161972715|NCT05320393|584947652|FG002|Overall Study|Lost to Follow-up|1|||
161972716|NCT05320393|584947650|FG000|Overall Study|Moved; too much driving|0|||
161972717|NCT05320393|584947651|FG001|Overall Study|Moved; too much driving|0|||
161972718|NCT05320393|584947652|FG002|Overall Study|Moved; too much driving|2|||
161972719|NCT05320393|584947650|FG000|Overall Study|Did not receive treatment|0|||
161972720|NCT05320393|584947651|FG001|Overall Study|Did not receive treatment|0|||
161972721|NCT05320393|584947652|FG002|Overall Study|Did not receive treatment|1|||
161972722|NCT04411420|584947653|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
161972723|NCT04411420|584947654|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
161972724|NCT04411420|584947653|FG000|Survey Subset|Lost to Follow-up|134|||
161972725|NCT04411420|584947654|FG001|Survey Subset|Lost to Follow-up|120|||
161972726|NCT00613925|584947659|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
161972727|NCT00613925|584947660|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
161972728|NCT00350623|584947663|FG000|Overall Study|Lost to Follow-up|8|||
161972729|NCT00350623|584947664|FG001|Overall Study|Lost to Follow-up|3|||
161972730|NCT00350623|584947665|FG002|Overall Study|Lost to Follow-up|4|||
161972731|NCT00350623|584947663|FG000|Overall Study|Withdrawal by Subject|0|||
161972732|NCT00350623|584947664|FG001|Overall Study|Withdrawal by Subject|1|||
161972733|NCT00350623|584947665|FG002|Overall Study|Withdrawal by Subject|1|||
161972734|NCT00350623|584947663|FG000|Overall Study|patient traveling outside the country|0|||
161972735|NCT00350623|584947664|FG001|Overall Study|patient traveling outside the country|0|||
161972736|NCT00350623|584947665|FG002|Overall Study|patient traveling outside the country|1|||
161972737|NCT03199053|584947683|FG000|ST Period|Withdrawal by Subject|2|||
161972738|NCT03199053|584947684|FG001|ST Period|Withdrawal by Subject|4|||
162033798|NCT04594369|585180184|FG002|Overall Study|Lost to Follow-up|4|||
161972739|NCT03199053|584947685|FG002|ST Period|Withdrawal by Subject|6|||
161972740|NCT03199053|584947683|FG000|ST Period|Withdrawal by parent/guardian|1|||
161972741|NCT03199053|584947684|FG001|ST Period|Withdrawal by parent/guardian|1|||
161972742|NCT03199053|584947685|FG002|ST Period|Withdrawal by parent/guardian|1|||
161972743|NCT03199053|584947683|FG000|ST Period|Lost to Follow-up|2|||
161850130|NCT03743415|584492811|FG003|Overall Study|Withdrawal by Subject|5|||
161850131|NCT03743415|584492812|FG004|Overall Study|Withdrawal by Subject|5|||
161850132|NCT03743415|584492813|FG005|Overall Study|Withdrawal by Subject|2|||
161850133|NCT03743415|584492814|FG006|Overall Study|Withdrawal by Subject|2|||
161850134|NCT03743415|584492815|FG007|Overall Study|Withdrawal by Subject|5|||
161850135|NCT03743415|584492816|FG008|Overall Study|Withdrawal by Subject|9|||
161850136|NCT03743415|584492817|FG009|Overall Study|Withdrawal by Subject|10|||
161850137|NCT03743415|584492808|FG000|Overall Study|Lost to Follow-up|2|||
161850138|NCT03743415|584492809|FG001|Overall Study|Lost to Follow-up|0|||
161850139|NCT03743415|584492810|FG002|Overall Study|Lost to Follow-up|2|||
161850140|NCT03743415|584492811|FG003|Overall Study|Lost to Follow-up|1|||
161850141|NCT03743415|584492812|FG004|Overall Study|Lost to Follow-up|1|||
161850142|NCT03743415|584492813|FG005|Overall Study|Lost to Follow-up|0|||
161850143|NCT03743415|584492814|FG006|Overall Study|Lost to Follow-up|1|||
161850144|NCT03743415|584492815|FG007|Overall Study|Lost to Follow-up|4|||
161850145|NCT03743415|584492816|FG008|Overall Study|Lost to Follow-up|13|||
161850146|NCT03743415|584492817|FG009|Overall Study|Lost to Follow-up|13|||
161850147|NCT01422187|584492818|FG000|Overall Study|Personal reason|1|||
161850148|NCT01422187|584492819|FG001|Overall Study|Personal reason|0|||
161850149|NCT01422187|584492820|FG002|Overall Study|Personal reason|0|||
161850150|NCT01422187|584492818|FG000|Overall Study|Lost to Follow-up|0|||
161850151|NCT01422187|584492819|FG001|Overall Study|Lost to Follow-up|1|||
161850152|NCT01422187|584492820|FG002|Overall Study|Lost to Follow-up|0|||
161850153|NCT00741286|584492824|FG000|Overall Study|Lost to Follow-up|15|||
161850154|NCT00741286|584492825|FG001|Overall Study|Lost to Follow-up|10|||
161850155|NCT00741286|584492824|FG000|Overall Study|Adverse Event|1|||
161850156|NCT00741286|584492825|FG001|Overall Study|Adverse Event|6|||
161850157|NCT00741286|584492824|FG000|Overall Study|Protocol Violation|3|||
161850158|NCT00741286|584492825|FG001|Overall Study|Protocol Violation|2|||
161850159|NCT00741286|584492824|FG000|Overall Study|Primary Outcome|1|||
161850160|NCT00741286|584492825|FG001|Overall Study|Primary Outcome|1|||
161850161|NCT00582010|584492829|FG000|Overall Study|Death|0|||
161850162|NCT00582010|584492830|FG001|Overall Study|Death|1|||
161850163|NCT05320887|584492833|FG000|Overall Study|Lost to Follow-up|0|||
161850164|NCT05320887|584492834|FG001|Overall Study|Lost to Follow-up|3|||
161850165|NCT05320887|584492835|FG002|Overall Study|Lost to Follow-up|0|||
161850166|NCT05320887|584492836|FG003|Overall Study|Lost to Follow-up|0|||
161850167|NCT02463357|584492837|FG000|Overall Study|Withdrawal by Subject|1|||
161850168|NCT02463357|584492838|FG001|Overall Study|Withdrawal by Subject|0|||
161850169|NCT02463357|584492839|FG002|Overall Study|Withdrawal by Subject|0|||
161850170|NCT02463357|584492840|FG003|Overall Study|Withdrawal by Subject|0|||
161850171|NCT02463357|584492841|FG004|Overall Study|Withdrawal by Subject|0|||
161850172|NCT02463357|584492837|FG000|Overall Study|Withdrawal by Subject|0|||
161850173|NCT02463357|584492838|FG001|Overall Study|Withdrawal by Subject|0|||
161850174|NCT02463357|584492839|FG002|Overall Study|Withdrawal by Subject|0|||
161850175|NCT02463357|584492840|FG003|Overall Study|Withdrawal by Subject|0|||
161850176|NCT02463357|584492841|FG004|Overall Study|Withdrawal by Subject|1|||
161850177|NCT00378573|584492843|FG000|Treatment Period|Adverse Event|9|||
161850178|NCT00378573|584492843|FG000|Treatment Period|Physician Decision|1|||
161850179|NCT00378573|584492843|FG000|Treatment Period|Withdrawal by Subject|2|||
161850180|NCT00378573|584492843|FG000|Treatment Period|Disease Progression|4|||
161850181|NCT00378573|584492843|FG000|Treatment Period|Sponsor decision to close study|1|||
161850182|NCT00378573|584492843|FG000|Follow-up|Death|12|||
161850183|NCT00378573|584492843|FG000|Follow-up|Lost to Follow-up|1|||
161850184|NCT00378573|584492843|FG000|Follow-up|Withdrawal by Subject|1|||
161850185|NCT02892149|584492844|FG000|Overall Study|Death|262|||
161850186|NCT02892149|584492845|FG001|Overall Study|Death|278|||
161850187|NCT02892149|584492844|FG000|Overall Study|Withdrawal by Subject|53|||
161850188|NCT02892149|584492845|FG001|Overall Study|Withdrawal by Subject|47|||
161850189|NCT02892149|584492844|FG000|Overall Study|Lost to Follow-up|37|||
161850190|NCT02892149|584492845|FG001|Overall Study|Lost to Follow-up|31|||
161850191|NCT00252239|584492855|FG000|Overall Study|Withdrawal by Subject|1|||
161850192|NCT00252239|584492856|FG001|Overall Study|Withdrawal by Subject|0|||
161850193|NCT00252239|584492857|FG002|Overall Study|Withdrawal by Subject|0|||
161850194|NCT00252239|584492858|FG003|Overall Study|Withdrawal by Subject|1|||
161850195|NCT00252239|584492855|FG000|Overall Study|Lost to Follow-up|0|||
161850196|NCT00252239|584492856|FG001|Overall Study|Lost to Follow-up|0|||
161850197|NCT00252239|584492857|FG002|Overall Study|Lost to Follow-up|2|||
161850198|NCT00252239|584492858|FG003|Overall Study|Lost to Follow-up|0|||
161850199|NCT02181790|584492863|FG000|Overall Study|study terminated|2|||
161850200|NCT02181790|584492864|FG001|Overall Study|study terminated|0|||
161850201|NCT03276078|584492865|FG000|Overall Study|Adverse Event|1|||
161850202|NCT02785952|584492866|FG000|Overall Study|Adverse Event|31|||
161850203|NCT02785952|584492867|FG001|Overall Study|Adverse Event|19|||
161850204|NCT02785952|584492866|FG000|Overall Study|Refusal unrelated to adverse events|10|||
161850205|NCT02785952|584492867|FG001|Overall Study|Refusal unrelated to adverse events|5|||
161850206|NCT02785952|584492866|FG000|Overall Study|Disease progression/relapse|61|||
161850207|NCT02785952|584492867|FG001|Overall Study|Disease progression/relapse|89|||
161850208|NCT02785952|584492866|FG000|Overall Study|Death|11|||
161850209|NCT02785952|584492867|FG001|Overall Study|Death|7|||
161850210|NCT02785952|584492866|FG000|Overall Study|Other- not protocol specified|6|||
161850211|NCT02785952|584492867|FG001|Overall Study|Other- not protocol specified|4|||
161850212|NCT02785952|584492866|FG000|Overall Study|On protocol treatment|6|||
161850213|NCT02785952|584492867|FG001|Overall Study|On protocol treatment|3|||
161850214|NCT00090363|584492868|FG000|Overall Study|Lost to Follow-up|1|||
161850215|NCT00090363|584492869|FG001|Overall Study|Lost to Follow-up|2|||
161850216|NCT00090363|584492870|FG002|Overall Study|Lost to Follow-up|1|||
161850217|NCT00090363|584492868|FG000|Overall Study|Withdrawal by Subject|7|||
161850218|NCT00090363|584492869|FG001|Overall Study|Withdrawal by Subject|7|||
161850219|NCT00090363|584492870|FG002|Overall Study|Withdrawal by Subject|6|||
161850220|NCT00090363|584492868|FG000|Overall Study|Study-specific discontinuation criteria|75|||
161850221|NCT00090363|584492869|FG001|Overall Study|Study-specific discontinuation criteria|74|||
161850222|NCT00090363|584492870|FG002|Overall Study|Study-specific discontinuation criteria|62|||
161850223|NCT00090363|584492868|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161850224|NCT00090363|584492869|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161850225|NCT00090363|584492870|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161850226|NCT00090363|584492868|FG000|Overall Study|Consent expired|7|||
161850227|NCT00090363|584492869|FG001|Overall Study|Consent expired|10|||
161850228|NCT00090363|584492870|FG002|Overall Study|Consent expired|9|||
161850229|NCT00090363|584492868|FG000|Overall Study|Reasons not specified|2|||
161850230|NCT00090363|584492869|FG001|Overall Study|Reasons not specified|1|||
161850231|NCT00090363|584492870|FG002|Overall Study|Reasons not specified|1|||
161850232|NCT00090363|584492868|FG000|Overall Study|Continuing on study off treatment|14|||
161850233|NCT00090363|584492869|FG001|Overall Study|Continuing on study off treatment|13|||
161850234|NCT00090363|584492870|FG002|Overall Study|Continuing on study off treatment|16|||
161850235|NCT05038800|584492872|FG000|Overall Study|Death|1|||
161850236|NCT05038800|584492873|FG001|Overall Study|Death|1|||
161850237|NCT05038800|584492874|FG002|Overall Study|Death|5|||
161850238|NCT05038800|584492875|FG003|Overall Study|Death|3|||
161850239|NCT05038800|584492876|FG004|Overall Study|Death|1|||
161850240|NCT05038800|584492872|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161850241|NCT05038800|584492873|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161850242|NCT05038800|584492874|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161850243|NCT05038800|584492875|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161850244|NCT05038800|584492876|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161850245|NCT05038800|584492872|FG000|Overall Study|Lack of Efficacy|0|||
161850246|NCT05038800|584492873|FG001|Overall Study|Lack of Efficacy|0|||
161850247|NCT05038800|584492874|FG002|Overall Study|Lack of Efficacy|0|||
161850248|NCT05038800|584492875|FG003|Overall Study|Lack of Efficacy|0|||
161850249|NCT05038800|584492876|FG004|Overall Study|Lack of Efficacy|1|||
161850250|NCT00121134|584492877|FG000|Overall Study|Progression of Disease|5|||
161850251|NCT00121134|584492878|FG001|Overall Study|Progression of Disease|3|||
161850252|NCT00121134|584492879|FG002|Overall Study|Progression of Disease|4|||
161850253|NCT00121134|584492880|FG003|Overall Study|Progression of Disease|2|||
161850254|NCT00121134|584492877|FG000|Overall Study|Toxicity|4|||
161850255|NCT00121134|584492878|FG001|Overall Study|Toxicity|7|||
161850256|NCT00121134|584492879|FG002|Overall Study|Toxicity|13|||
161850257|NCT00121134|584492880|FG003|Overall Study|Toxicity|5|||
161972744|NCT03199053|584947684|FG001|ST Period|Lost to Follow-up|0|||
161972745|NCT03199053|584947685|FG002|ST Period|Lost to Follow-up|1|||
161972746|NCT03199053|584947683|FG000|LT Period|Withdrawal by Subject|1|||
161972747|NCT03199053|584947684|FG001|LT Period|Withdrawal by Subject|3|||
161972748|NCT03199053|584947685|FG002|LT Period|Withdrawal by Subject|3|||
161972749|NCT03199053|584947683|FG000|LT Period|Withdrawal by parent/guardian|0|||
161972750|NCT03199053|584947684|FG001|LT Period|Withdrawal by parent/guardian|0|||
161972751|NCT03199053|584947685|FG002|LT Period|Withdrawal by parent/guardian|1|||
161972752|NCT03199053|584947683|FG000|LT Period|Lost to Follow-up|0|||
161972753|NCT03199053|584947684|FG001|LT Period|Lost to Follow-up|1|||
161972754|NCT03199053|584947685|FG002|LT Period|Lost to Follow-up|1|||
161972755|NCT03199053|584947683|FG000|LT Period|Miscellaneous|0|||
161972756|NCT03199053|584947684|FG001|LT Period|Miscellaneous|0|||
161850258|NCT00121134|584492877|FG000|Overall Study|Physician Decision|6|||
161850259|NCT00121134|584492878|FG001|Overall Study|Physician Decision|4|||
161850260|NCT00121134|584492879|FG002|Overall Study|Physician Decision|4|||
161850261|NCT00121134|584492880|FG003|Overall Study|Physician Decision|1|||
161850262|NCT00121134|584492877|FG000|Overall Study|Treatment Delay|1|||
161850263|NCT00121134|584492878|FG001|Overall Study|Treatment Delay|0|||
161850264|NCT00121134|584492879|FG002|Overall Study|Treatment Delay|0|||
161850265|NCT00121134|584492880|FG003|Overall Study|Treatment Delay|0|||
161972757|NCT03199053|584947685|FG002|LT Period|Miscellaneous|2|||
161972758|NCT03199053|584947683|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
161972759|NCT03199053|584947684|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
161850266|NCT00121134|584492877|FG000|Overall Study|Intercurrent Illness|0|||
161850267|NCT00121134|584492878|FG001|Overall Study|Intercurrent Illness|0|||
161850268|NCT00121134|584492879|FG002|Overall Study|Intercurrent Illness|0|||
162033799|NCT04594369|585180182|FG000|Overall Study|Physician Decision|2|||
161764251|NCT04212221|584176159|FG006|Overall Study|Protocol Violation|0|||
161764252|NCT04212221|584176160|FG007|Overall Study|Protocol Violation|1|||
161764253|NCT02692560|584176165|FG000|Overall Study|Withdrawal by Subject|0|||
161764254|NCT02692560|584176166|FG001|Overall Study|Withdrawal by Subject|6|||
161764255|NCT00715949|584176171|FG000|Overall Study|could not finish first test|4|||
161764256|NCT01326910|584176172|FG000|Overall Study|Withdrawal by Subject|3|||
161764257|NCT01326910|584176173|FG001|Overall Study|Withdrawal by Subject|2|||
161764258|NCT01326910|584176172|FG000|Overall Study|Protocol Violation|1|||
161764259|NCT01326910|584176173|FG001|Overall Study|Protocol Violation|1|||
161764260|NCT02274766|584176176|FG000|Overall Study|Withdrawal by Subject|3|||
161764261|NCT02274766|584176177|FG001|Overall Study|Withdrawal by Subject|6|||
161764262|NCT02274766|584176176|FG000|Overall Study|Did Not Receive Study Drug|1|||
161764263|NCT02274766|584176177|FG001|Overall Study|Did Not Receive Study Drug|1|||
161764264|NCT02274766|584176176|FG000|Overall Study|Subject Unwilling to Proceed|0|||
161764265|NCT02274766|584176177|FG001|Overall Study|Subject Unwilling to Proceed|1|||
161764266|NCT02274766|584176176|FG000|Overall Study|Adverse Event|0|||
161764267|NCT02274766|584176177|FG001|Overall Study|Adverse Event|1|||
161764268|NCT00806494|584176189|FG000|Overall Study|Adverse Event|29|||
161764269|NCT00806494|584176189|FG000|Overall Study|Lack of Efficacy|6|||
161764270|NCT00806494|584176189|FG000|Overall Study|Lost to Follow-up|10|||
161764271|NCT00806494|584176189|FG000|Overall Study|Other|30|||
161764272|NCT00806494|584176189|FG000|Overall Study|Withdrawal by Subject|5|||
161764273|NCT02417935|584176190|FG000|Treatment Period|Adverse Event|12|||
161764274|NCT02417935|584176191|FG001|Treatment Period|Adverse Event|10|||
161764275|NCT02417935|584176190|FG000|Treatment Period|Lost to Follow-up|1|||
161764276|NCT02417935|584176191|FG001|Treatment Period|Lost to Follow-up|0|||
161764277|NCT02417935|584176190|FG000|Treatment Period|Entry Criteria not met|0|||
161764278|NCT02417935|584176191|FG001|Treatment Period|Entry Criteria not met|1|||
161764279|NCT02417935|584176190|FG000|Treatment Period|Protocol Violation|2|||
161764280|NCT02417935|584176191|FG001|Treatment Period|Protocol Violation|1|||
161764281|NCT02417935|584176190|FG000|Treatment Period|Withdrawal by Subject|3|||
161764282|NCT02417935|584176191|FG001|Treatment Period|Withdrawal by Subject|3|||
161764283|NCT02417935|584176190|FG000|Treatment Period|Physician Decision|3|||
161764284|NCT02417935|584176191|FG001|Treatment Period|Physician Decision|1|||
161764285|NCT02850276|584176194|FG000|Overall Study|screen failure|43|||
161764286|NCT02850276|584176194|FG000|Overall Study|Withdrawal by Subject|14|||
161764287|NCT02850276|584176194|FG000|Overall Study|Physician Decision|2|||
161764288|NCT02850276|584176194|FG000|Overall Study|Lost to Follow-up|2|||
161764289|NCT04815291|584176195|FG000|Overall Study|Lost to Follow-up|1|||
161764290|NCT04815291|584176195|FG000|Overall Study|Physician Decision|4|||
161764291|NCT04815291|584176195|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
161764292|NCT00095836|584176198|FG000|Overall Study|Lost to Follow-up|1|||
161764293|NCT00095836|584176198|FG000|Overall Study|Adverse Event|1|||
161764294|NCT00095836|584176198|FG000|Overall Study|Death|2|||
161764295|NCT00989664|584176199|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
161764296|NCT00989664|584176199|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
161764297|NCT00989664|584176199|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
161764298|NCT00989664|584176199|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
161764299|NCT00989664|584176199|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
161764300|NCT00989664|584176199|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
161764301|NCT00989664|584176199|FG000|Long-Term Follow-Up|Death|3|||
161764302|NCT00962780|584176203|FG000|Overall Study|Death|0|||
161764303|NCT00962780|584176204|FG001|Overall Study|Death|1|||
161764304|NCT00962780|584176203|FG000|Overall Study|Protocol Violation|9|||
161764305|NCT00962780|584176204|FG001|Overall Study|Protocol Violation|4|||
161764306|NCT00962780|584176203|FG000|Overall Study|Withdrawal by Subject|1|||
161764307|NCT00962780|584176204|FG001|Overall Study|Withdrawal by Subject|8|||
161764308|NCT00962780|584176203|FG000|Overall Study|Other|0|||
161764309|NCT00962780|584176204|FG001|Overall Study|Other|1|||
161764310|NCT02646332|584176205|FG000|Overall Study|Lost to Follow-up|0|||
161764311|NCT02646332|584176206|FG001|Overall Study|Lost to Follow-up|3|||
161764312|NCT02363322|584176207|FG000|Overall Study|Lost to Follow-up|1|||
161764313|NCT02363322|584176208|FG001|Overall Study|Lost to Follow-up|0|||
161764314|NCT01775995|584176209|FG000|Overall Study|Lost to Follow-up|1|||
161764315|NCT01775995|584176210|FG001|Overall Study|Lost to Follow-up|1|||
161764316|NCT02909504|584176211|FG000|Overall Study|Adverse Event|2|||
161764317|NCT02909504|584176211|FG000|Overall Study|Lack of Efficacy|3|||
161764318|NCT02909504|584176211|FG000|Overall Study|Withdrawal by Subject|4|||
161764319|NCT02909504|584176211|FG000|Overall Study|Pregnancy|1|||
161764320|NCT02909504|584176211|FG000|Overall Study|Subject moved|1|||
161764321|NCT02909504|584176211|FG000|Overall Study|Lost to Follow-up|1|||
161764322|NCT02055976|584176212|FG000|Overall Study|Other|0|||
161764323|NCT02055976|584176213|FG001|Overall Study|Other|0|||
161764324|NCT02055976|584176214|FG002|Overall Study|Other|1|||
161764325|NCT02055976|584176215|FG003|Overall Study|Other|0|||
161764326|NCT02055976|584176216|FG004|Overall Study|Other|0|||
161764327|NCT02055976|584176217|FG005|Overall Study|Other|0|||
161764328|NCT02055976|584176218|FG006|Overall Study|Other|0|||
162033800|NCT04594369|585180183|FG001|Overall Study|Physician Decision|2|||
161764329|NCT02055976|584176219|FG007|Overall Study|Other|0|||
161764330|NCT02055976|584176220|FG008|Overall Study|Other|0|||
161764331|NCT02055976|584176212|FG000|Overall Study|Adverse Event|0|||
161764332|NCT02055976|584176213|FG001|Overall Study|Adverse Event|0|||
161764333|NCT02055976|584176214|FG002|Overall Study|Adverse Event|0|||
161764334|NCT02055976|584176215|FG003|Overall Study|Adverse Event|0|||
161764335|NCT02055976|584176216|FG004|Overall Study|Adverse Event|0|||
161764336|NCT02055976|584176217|FG005|Overall Study|Adverse Event|1|||
161764337|NCT02055976|584176218|FG006|Overall Study|Adverse Event|1|||
161764338|NCT02055976|584176219|FG007|Overall Study|Adverse Event|0|||
161764339|NCT02055976|584176220|FG008|Overall Study|Adverse Event|0|||
161764340|NCT02055976|584176212|FG000|Overall Study|Does not meet entrance criteria|0|||
161764341|NCT02055976|584176213|FG001|Overall Study|Does not meet entrance criteria|0|||
161764342|NCT02055976|584176214|FG002|Overall Study|Does not meet entrance criteria|0|||
161764343|NCT02055976|584176215|FG003|Overall Study|Does not meet entrance criteria|0|||
161764344|NCT02055976|584176216|FG004|Overall Study|Does not meet entrance criteria|0|||
161764345|NCT02055976|584176217|FG005|Overall Study|Does not meet entrance criteria|0|||
161764346|NCT02055976|584176218|FG006|Overall Study|Does not meet entrance criteria|1|||
161764347|NCT02055976|584176219|FG007|Overall Study|Does not meet entrance criteria|0|||
161764348|NCT02055976|584176220|FG008|Overall Study|Does not meet entrance criteria|0|||
161764349|NCT02055976|584176212|FG000|Overall Study|Lost to Follow-up|0|||
161764350|NCT02055976|584176213|FG001|Overall Study|Lost to Follow-up|0|||
161764351|NCT02055976|584176214|FG002|Overall Study|Lost to Follow-up|0|||
161764352|NCT02055976|584176215|FG003|Overall Study|Lost to Follow-up|1|||
161764353|NCT02055976|584176216|FG004|Overall Study|Lost to Follow-up|0|||
161764354|NCT02055976|584176217|FG005|Overall Study|Lost to Follow-up|0|||
161764355|NCT02055976|584176218|FG006|Overall Study|Lost to Follow-up|0|||
161764356|NCT02055976|584176219|FG007|Overall Study|Lost to Follow-up|0|||
161764357|NCT02055976|584176220|FG008|Overall Study|Lost to Follow-up|0|||
161764358|NCT02504424|584176223|FG000|Overall Study|Withdrawal by Subject|2|||
161764359|NCT00426842|584176225|FG000|Overall Study|Lost to Follow-up|1|||
161764360|NCT01277666|584176228|FG000|Overall Study|Adverse Event|26|||
161764361|NCT01277666|584176229|FG001|Overall Study|Adverse Event|25|||
161764362|NCT01277666|584176230|FG002|Overall Study|Adverse Event|20|||
161764363|NCT01277666|584176228|FG000|Overall Study|Lack of Efficacy|8|||
161764364|NCT01277666|584176229|FG001|Overall Study|Lack of Efficacy|20|||
161764365|NCT01277666|584176230|FG002|Overall Study|Lack of Efficacy|12|||
161764366|NCT01277666|584176228|FG000|Overall Study|Protocol Violation|2|||
161764367|NCT01277666|584176229|FG001|Overall Study|Protocol Violation|3|||
161764368|NCT01277666|584176230|FG002|Overall Study|Protocol Violation|2|||
161764369|NCT01277666|584176228|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
161764370|NCT01277666|584176229|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
161764371|NCT01277666|584176230|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
161764372|NCT01277666|584176228|FG000|Overall Study|Lost to Follow-up|1|||
161764373|NCT01277666|584176229|FG001|Overall Study|Lost to Follow-up|1|||
161764374|NCT01277666|584176230|FG002|Overall Study|Lost to Follow-up|2|||
161764375|NCT01277666|584176228|FG000|Overall Study|Withdrawal by Subject|7|||
161764376|NCT01277666|584176229|FG001|Overall Study|Withdrawal by Subject|8|||
161764377|NCT01277666|584176230|FG002|Overall Study|Withdrawal by Subject|6|||
161764378|NCT01277666|584176228|FG000|Overall Study|Death|0|||
161764379|NCT01277666|584176229|FG001|Overall Study|Death|0|||
161764380|NCT01277666|584176230|FG002|Overall Study|Death|1|||
161764381|NCT01657903|584176232|FG000|Overall Study|Lost to Follow-up|1|||
161764382|NCT01657903|584176232|FG000|Overall Study|Withdrawal by Subject|1|||
161764383|NCT00554840|584176233|FG000|Overall Study|Physician Decision|0|||
161764384|NCT00554840|584176234|FG001|Overall Study|Physician Decision|1|||
161764385|NCT02312934|584176237|FG000|Overall Study|Lost to Follow-up|1|||
161764386|NCT02312934|584176238|FG001|Overall Study|Lost to Follow-up|0|||
161764387|NCT02312934|584176237|FG000|Overall Study|Physician Decision|1|||
161764388|NCT02312934|584176238|FG001|Overall Study|Physician Decision|0|||
161764389|NCT02886338|584176239|FG000|Overall Study|Withdrawal by Subject|1|||
161764390|NCT01156012|584176241|FG000|Overall Study|Adverse Event|3|||
161764391|NCT01156012|584176242|FG001|Overall Study|Adverse Event|1|||
161764392|NCT01156012|584176241|FG000|Overall Study|Lost to Follow-up|1|||
161764393|NCT01156012|584176242|FG001|Overall Study|Lost to Follow-up|0|||
161764394|NCT01156012|584176241|FG000|Overall Study|Withdrawal by Subject|1|||
161764395|NCT01156012|584176242|FG001|Overall Study|Withdrawal by Subject|0|||
161764396|NCT01156012|584176241|FG000|Overall Study|use of commercial drug instead of study|0|||
161764397|NCT01156012|584176242|FG001|Overall Study|use of commercial drug instead of study|1|||
161764398|NCT01156012|584176241|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
161764399|NCT01156012|584176242|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
161764400|NCT03395704|584176243|FG000|Overall Study|Adverse Event|2|||
161764401|NCT03395704|584176244|FG001|Overall Study|Adverse Event|1|||
161764402|NCT03395704|584176243|FG000|Overall Study|Withdrawal by Subject|2|||
161850269|NCT00121134|584492880|FG003|Overall Study|Intercurrent Illness|1|||
161850270|NCT00121134|584492877|FG000|Overall Study|Patient Personal Reasons|0|||
161850271|NCT00121134|584492878|FG001|Overall Study|Patient Personal Reasons|1|||
161850272|NCT00121134|584492879|FG002|Overall Study|Patient Personal Reasons|0|||
161850273|NCT00121134|584492880|FG003|Overall Study|Patient Personal Reasons|0|||
161850274|NCT02478320|584492886|FG000|Overall Study|Adverse Event|2|||
161850275|NCT02478320|584492887|FG001|Overall Study|Adverse Event|0|||
161850276|NCT02478320|584492886|FG000|Overall Study|Death|1|||
161850277|NCT02478320|584492887|FG001|Overall Study|Death|0|||
161850278|NCT02478320|584492886|FG000|Overall Study|Lack of Efficacy|4|||
161850279|NCT02478320|584492887|FG001|Overall Study|Lack of Efficacy|0|||
161850280|NCT02478320|584492886|FG000|Overall Study|Withdrawal by Subject|2|||
161850281|NCT02478320|584492887|FG001|Overall Study|Withdrawal by Subject|0|||
161850282|NCT02478320|584492886|FG000|Overall Study|Screen Failure|3|||
161850283|NCT02478320|584492887|FG001|Overall Study|Screen Failure|0|||
161850284|NCT03185013|584492888|FG000|Overall Study|Withdrawal by Subject|5|||
161850285|NCT03185013|584492889|FG001|Overall Study|Withdrawal by Subject|3|||
161850286|NCT03185013|584492888|FG000|Overall Study|Adverse Event|1|||
161850287|NCT03185013|584492889|FG001|Overall Study|Adverse Event|0|||
161850288|NCT03185013|584492888|FG000|Overall Study|Progressive Disease|1|||
161850289|NCT03185013|584492889|FG001|Overall Study|Progressive Disease|0|||
161850290|NCT03185013|584492888|FG000|Overall Study|Lost to Follow-up|8|||
161850291|NCT03185013|584492889|FG001|Overall Study|Lost to Follow-up|2|||
161850292|NCT03185013|584492888|FG000|Overall Study|Physician Decision|1|||
161850293|NCT03185013|584492889|FG001|Overall Study|Physician Decision|0|||
161850294|NCT03185013|584492888|FG000|Overall Study|Protocol Deviation|2|||
161850295|NCT03185013|584492889|FG001|Overall Study|Protocol Deviation|0|||
161850296|NCT03185013|584492888|FG000|Overall Study|Reason not Specified|3|||
161850297|NCT03185013|584492889|FG001|Overall Study|Reason not Specified|2|||
161850298|NCT03185013|584492888|FG000|Overall Study|Death|1|||
161850299|NCT03185013|584492889|FG001|Overall Study|Death|0|||
161850300|NCT01104792|584492893|FG000|Overall Study|Adverse Event|77|||
161850301|NCT01104792|584492893|FG000|Overall Study|Insufficient Therapeutic Response|22|||
161850302|NCT01104792|584492893|FG000|Overall Study|Protocol Violation|45|||
161850303|NCT01104792|584492893|FG000|Overall Study|Withdrawal of Consent|179|||
161850304|NCT01104792|584492893|FG000|Overall Study|Lost to Follow-up|43|||
161850305|NCT01104792|584492893|FG000|Overall Study|Reasons Not Specified|27|||
161850306|NCT01104792|584492893|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
161850307|NCT02071849|584492895|FG000|6-month Primary Endpoint|Did not receive device|4|||
161850308|NCT02071849|584492895|FG000|6-month Primary Endpoint|Adverse Event|1|||
161850309|NCT02071849|584492895|FG000|2-year Extended Follow-up|Adverse Event|1|||
161850310|NCT03255655|584492896|FG000|Overall Study|Lost to Follow-up|7|||
161850311|NCT03255655|584492897|FG001|Overall Study|Lost to Follow-up|4|||
161850312|NCT02056392|584492903|FG000|Overall Study|Lost to Follow-up|0|||
161850313|NCT02056392|584492904|FG001|Overall Study|Lost to Follow-up|1|||
161850314|NCT02056392|584492905|FG002|Overall Study|Lost to Follow-up|2|||
161850315|NCT02056392|584492906|FG003|Overall Study|Lost to Follow-up|0|||
161850316|NCT02056392|584492907|FG004|Overall Study|Lost to Follow-up|0|||
161850317|NCT02056392|584492908|FG005|Overall Study|Lost to Follow-up|0|||
161850318|NCT02056392|584492903|FG000|Overall Study|Protocol Violation|1|||
161850319|NCT02056392|584492904|FG001|Overall Study|Protocol Violation|0|||
161850320|NCT02056392|584492905|FG002|Overall Study|Protocol Violation|1|||
161850321|NCT02056392|584492906|FG003|Overall Study|Protocol Violation|0|||
161850322|NCT02056392|584492907|FG004|Overall Study|Protocol Violation|0|||
161850323|NCT02056392|584492908|FG005|Overall Study|Protocol Violation|0|||
161850324|NCT02056392|584492903|FG000|Overall Study|Withdrawal by Subject|1|||
161850325|NCT02056392|584492904|FG001|Overall Study|Withdrawal by Subject|0|||
161850326|NCT02056392|584492905|FG002|Overall Study|Withdrawal by Subject|0|||
161850327|NCT02056392|584492906|FG003|Overall Study|Withdrawal by Subject|0|||
161850328|NCT02056392|584492907|FG004|Overall Study|Withdrawal by Subject|1|||
161850329|NCT02056392|584492908|FG005|Overall Study|Withdrawal by Subject|0|||
161850330|NCT00103610|584492909|FG000|Overall Study|Entered Rescue Procedure|10|||
161850331|NCT00103610|584492910|FG001|Overall Study|Entered Rescue Procedure|52|||
161850332|NCT00103610|584492909|FG000|Overall Study|Death|16|||
161850333|NCT00103610|584492910|FG001|Overall Study|Death|12|||
161850334|NCT00103610|584492909|FG000|Overall Study|Elective Withdrawal|4|||
161850335|NCT00103610|584492910|FG001|Overall Study|Elective Withdrawal|0|||
161850336|NCT00103610|584492909|FG000|Overall Study|Lost to Follow-up|3|||
161850337|NCT00103610|584492910|FG001|Overall Study|Lost to Follow-up|1|||
161850338|NCT00103610|584492909|FG000|Overall Study|Adverse Event|2|||
161850339|NCT00103610|584492910|FG001|Overall Study|Adverse Event|2|||
161850340|NCT00103610|584492909|FG000|Overall Study|Other|2|||
161850341|NCT00103610|584492910|FG001|Overall Study|Other|7|||
161850342|NCT00103610|584492909|FG000|Overall Study|Failed mobilization|1|||
161850343|NCT00103610|584492910|FG001|Overall Study|Failed mobilization|5|||
161850344|NCT00103610|584492909|FG000|Overall Study|Noncompliance|0|||
161850345|NCT00103610|584492910|FG001|Overall Study|Noncompliance|1|||
161850346|NCT00658021|584492911|FG000|28-Week Treatment Period|Adverse Event|3|||
161850347|NCT00658021|584492912|FG001|28-Week Treatment Period|Adverse Event|1|||
161850348|NCT00658021|584492913|FG002|28-Week Treatment Period|Adverse Event|0|||
161850349|NCT00658021|584492911|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
161850350|NCT00658021|584492912|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
161850351|NCT00658021|584492913|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
161850352|NCT00658021|584492911|FG000|28-Week Treatment Period|Protocol Violation|0|||
161850353|NCT00658021|584492912|FG001|28-Week Treatment Period|Protocol Violation|2|||
161850354|NCT00658021|584492913|FG002|28-Week Treatment Period|Protocol Violation|1|||
161850355|NCT00658021|584492911|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
161850356|NCT00658021|584492912|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
161850357|NCT00658021|584492913|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
161850358|NCT00658021|584492911|FG000|28-Week Treatment Period|Physician Decision|1|||
161850359|NCT00658021|584492912|FG001|28-Week Treatment Period|Physician Decision|2|||
161850360|NCT00658021|584492913|FG002|28-Week Treatment Period|Physician Decision|1|||
161850361|NCT00658021|584492911|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
161850362|NCT00658021|584492912|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
161850363|NCT00658021|584492913|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
161850364|NCT00658021|584492911|FG000|28-Week Treatment Period|Loss of glucose control|1|||
161850365|NCT00658021|584492912|FG001|28-Week Treatment Period|Loss of glucose control|1|||
161850366|NCT00658021|584492913|FG002|28-Week Treatment Period|Loss of glucose control|10|||
161850367|NCT00658021|584492911|FG000|28-Week Treatment Period|Other|2|||
161850368|NCT00658021|584492912|FG001|28-Week Treatment Period|Other|3|||
161850369|NCT00658021|584492913|FG002|28-Week Treatment Period|Other|1|||
161850370|NCT00658021|584492911|FG000|28-Week Treatment Period|Did not receive treatment|2|||
161850371|NCT00658021|584492912|FG001|28-Week Treatment Period|Did not receive treatment|0|||
161850372|NCT00658021|584492913|FG002|28-Week Treatment Period|Did not receive treatment|0|||
161850373|NCT00658021|584492911|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
161850374|NCT00658021|584492912|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
161850375|NCT00658021|584492913|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
161850376|NCT00658021|584492911|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
161850377|NCT00658021|584492912|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
161850378|NCT00658021|584492913|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
161850379|NCT01806506|584492914|FG000|Overall Study|Lost to Follow-up|2|||
161850380|NCT01806506|584492915|FG001|Overall Study|Lost to Follow-up|1|||
161850381|NCT05819203|584492920|FG000|Overall Study|Protocol Violation|1|||
161850382|NCT05819203|584492921|FG001|Overall Study|Protocol Violation|2|||
161850383|NCT05819203|584492920|FG000|Overall Study|Withdrawal by Subject|1|||
161850384|NCT05819203|584492921|FG001|Overall Study|Withdrawal by Subject|0|||
161850385|NCT04844762|584492926|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850386|NCT04844762|584492927|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850387|NCT04844762|584492928|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
161850388|NCT04844762|584492929|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850389|NCT04844762|584492930|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850390|NCT04844762|584492931|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850391|NCT04844762|584492926|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
161850392|NCT04844762|584492927|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
161850393|NCT04844762|584492928|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
161850394|NCT04844762|584492929|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
161850395|NCT04844762|584492930|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
161850396|NCT04844762|584492931|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
161850397|NCT04844762|584492926|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850398|NCT04844762|584492927|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850399|NCT04844762|584492928|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161850400|NCT04844762|584492929|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
161850401|NCT04844762|584492930|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850402|NCT04844762|584492931|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161850403|NCT04844762|584492926|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850404|NCT04844762|584492927|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850405|NCT04844762|584492928|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
161850406|NCT04844762|584492929|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
161972760|NCT03199053|584947685|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
161972761|NCT03199053|584947683|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
161850407|NCT04844762|584492930|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
161850408|NCT04844762|584492931|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850409|NCT04844762|584492926|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
161850410|NCT04844762|584492927|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
161972762|NCT03199053|584947684|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
161972763|NCT03199053|584947685|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
162033801|NCT04594369|585180184|FG002|Overall Study|Physician Decision|3|||
161850411|NCT04844762|584492928|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850412|NCT04844762|584492929|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850413|NCT04844762|584492930|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850414|NCT04844762|584492931|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850415|NCT04844762|584492926|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161850416|NCT04844762|584492927|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850417|NCT04844762|584492928|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850418|NCT04844762|584492929|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850419|NCT04844762|584492930|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850420|NCT04844762|584492931|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850421|NCT04844762|584492926|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850422|NCT04844762|584492927|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850423|NCT04844762|584492928|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850424|NCT04844762|584492929|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850425|NCT04844762|584492930|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
161850426|NCT04844762|584492931|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161850427|NCT04844762|584492926|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
161850428|NCT04844762|584492927|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850429|NCT04844762|584492928|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850430|NCT04844762|584492929|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850431|NCT04844762|584492930|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850432|NCT04844762|584492931|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161850433|NCT04844762|584492926|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161850434|NCT04844762|584492927|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850435|NCT04844762|584492928|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850436|NCT04844762|584492929|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850437|NCT04844762|584492930|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161850438|NCT04844762|584492931|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161850439|NCT04844762|584492926|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161850440|NCT04844762|584492927|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
161850441|NCT04844762|584492928|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161850442|NCT04844762|584492929|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161850443|NCT04844762|584492930|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161850444|NCT04844762|584492931|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161850445|NCT04844762|584492926|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161850446|NCT04844762|584492927|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161850447|NCT04844762|584492928|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161850448|NCT04844762|584492929|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
161850449|NCT04844762|584492930|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161850450|NCT04844762|584492931|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161850451|NCT02099682|584492932|FG000|Overall Study|Data Not Available|51|||
161850452|NCT02099682|584492932|FG000|Overall Study|Lost to Follow-up|31|||
161850453|NCT02099682|584492932|FG000|Overall Study|Other|29|||
161850454|NCT02802631|584492933|FG000|Overall Study|Withdrawal by Subject|1|||
161850455|NCT02802631|584492934|FG001|Overall Study|Withdrawal by Subject|0|||
161850456|NCT02802631|584492935|FG002|Overall Study|Withdrawal by Subject|0|||
161850457|NCT02802631|584492936|FG003|Overall Study|Withdrawal by Subject|0|||
161850458|NCT02802631|584492937|FG004|Overall Study|Withdrawal by Subject|0|||
161850459|NCT02802631|584492938|FG005|Overall Study|Withdrawal by Subject|0|||
161850460|NCT02802631|584492939|FG006|Overall Study|Withdrawal by Subject|0|||
161850461|NCT02802631|584492940|FG007|Overall Study|Withdrawal by Subject|0|||
161850462|NCT02802631|584492933|FG000|Overall Study|Physician Decision|1|||
161850463|NCT02802631|584492934|FG001|Overall Study|Physician Decision|0|||
161850464|NCT02802631|584492935|FG002|Overall Study|Physician Decision|0|||
161850465|NCT02802631|584492936|FG003|Overall Study|Physician Decision|0|||
161850466|NCT02802631|584492937|FG004|Overall Study|Physician Decision|0|||
161850467|NCT02802631|584492938|FG005|Overall Study|Physician Decision|0|||
161850468|NCT02802631|584492939|FG006|Overall Study|Physician Decision|1|||
161850469|NCT02802631|584492940|FG007|Overall Study|Physician Decision|0|||
161972764|NCT03199053|584947683|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
161850470|NCT02802631|584492933|FG000|Overall Study|Adverse Event|0|||
161850471|NCT02802631|584492934|FG001|Overall Study|Adverse Event|2|||
161850472|NCT02802631|584492935|FG002|Overall Study|Adverse Event|0|||
161850473|NCT02802631|584492936|FG003|Overall Study|Adverse Event|1|||
161850474|NCT02802631|584492937|FG004|Overall Study|Adverse Event|6|||
161850475|NCT02802631|584492938|FG005|Overall Study|Adverse Event|1|||
161850476|NCT02802631|584492939|FG006|Overall Study|Adverse Event|4|||
161850477|NCT02802631|584492940|FG007|Overall Study|Adverse Event|0|||
161972765|NCT03199053|584947684|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
161972766|NCT03199053|584947685|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
161972767|NCT03199053|584947683|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
161850478|NCT02802631|584492933|FG000|Overall Study|Sponsor Decision|0|||
161850479|NCT02802631|584492934|FG001|Overall Study|Sponsor Decision|0|||
161850480|NCT02802631|584492935|FG002|Overall Study|Sponsor Decision|6|||
161850481|NCT02802631|584492936|FG003|Overall Study|Sponsor Decision|0|||
161850482|NCT02802631|584492937|FG004|Overall Study|Sponsor Decision|2|||
161850483|NCT02802631|584492938|FG005|Overall Study|Sponsor Decision|0|||
161850484|NCT02802631|584492939|FG006|Overall Study|Sponsor Decision|0|||
161850485|NCT02802631|584492940|FG007|Overall Study|Sponsor Decision|4|||
161850486|NCT03316547|584492942|FG000|Overall Study|Death|3|||
161850487|NCT03316547|584492943|FG001|Overall Study|Death|1|||
161850488|NCT03316547|584492942|FG000|Overall Study|Lost to Follow-up|6|||
161850489|NCT03316547|584492943|FG001|Overall Study|Lost to Follow-up|6|||
161850490|NCT03316547|584492942|FG000|Overall Study|Withdrawal by Subject|3|||
161850491|NCT03316547|584492943|FG001|Overall Study|Withdrawal by Subject|2|||
161850492|NCT03316547|584492942|FG000|Overall Study|Transfer to another hospital|6|||
161850493|NCT03316547|584492943|FG001|Overall Study|Transfer to another hospital|4|||
161850494|NCT05292183|584494440|FG000|Overall Study|Adverse Event|1|||
161850495|NCT02017015|584494445|FG000|Overall Study|Adverse Event|9|||
161850496|NCT02017015|584494445|FG000|Overall Study|Withdrawal by Subject|21|||
161850497|NCT02017015|584494445|FG000|Overall Study|Death|4|||
161850498|NCT02017015|584494445|FG000|Overall Study|Progressive Disease|31|||
161850499|NCT02017015|584494445|FG000|Overall Study|Non-compliance with study drug|2|||
161850500|NCT02017015|584494445|FG000|Overall Study|Physician Decision|2|||
161850501|NCT01277601|584494446|FG000|Overall Study|Adverse Event|5|||
161850502|NCT01277601|584494447|FG001|Overall Study|Adverse Event|3|||
161850503|NCT01277601|584494448|FG002|Overall Study|Adverse Event|0|||
161850504|NCT01277601|584494449|FG003|Overall Study|Adverse Event|7|||
161850505|NCT01277601|584494446|FG000|Overall Study|Withdrawal by Subject|18|||
161850506|NCT01277601|584494447|FG001|Overall Study|Withdrawal by Subject|21|||
161850507|NCT01277601|584494448|FG002|Overall Study|Withdrawal by Subject|8|||
161850508|NCT01277601|584494449|FG003|Overall Study|Withdrawal by Subject|17|||
161850509|NCT01277601|584494446|FG000|Overall Study|Lost to Follow-up|7|||
161850510|NCT01277601|584494447|FG001|Overall Study|Lost to Follow-up|9|||
161850511|NCT01277601|584494448|FG002|Overall Study|Lost to Follow-up|4|||
161850512|NCT01277601|584494449|FG003|Overall Study|Lost to Follow-up|2|||
161850513|NCT01277601|584494446|FG000|Overall Study|Physician Decision|3|||
161850514|NCT01277601|584494447|FG001|Overall Study|Physician Decision|5|||
161850515|NCT01277601|584494448|FG002|Overall Study|Physician Decision|1|||
161850516|NCT01277601|584494449|FG003|Overall Study|Physician Decision|6|||
161850517|NCT01277601|584494446|FG000|Overall Study|Pregnancy|2|||
161850518|NCT01277601|584494447|FG001|Overall Study|Pregnancy|2|||
161850519|NCT01277601|584494448|FG002|Overall Study|Pregnancy|4|||
161850520|NCT01277601|584494449|FG003|Overall Study|Pregnancy|1|||
161850521|NCT01277601|584494446|FG000|Overall Study|Noncompliance with Study Drug|1|||
161850522|NCT01277601|584494447|FG001|Overall Study|Noncompliance with Study Drug|3|||
161850523|NCT01277601|584494448|FG002|Overall Study|Noncompliance with Study Drug|2|||
161850524|NCT01277601|584494449|FG003|Overall Study|Noncompliance with Study Drug|0|||
161850525|NCT01277601|584494446|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
161850526|NCT01277601|584494447|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
161850527|NCT01277601|584494448|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
161850528|NCT01277601|584494449|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
161850529|NCT01277601|584494446|FG000|Overall Study|Protocol Violation|0|||
161850530|NCT01277601|584494447|FG001|Overall Study|Protocol Violation|2|||
161850531|NCT01277601|584494448|FG002|Overall Study|Protocol Violation|5|||
161850532|NCT01277601|584494449|FG003|Overall Study|Protocol Violation|0|||
161850533|NCT01277601|584494446|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
161850534|NCT01277601|584494447|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
161850535|NCT01277601|584494448|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
161850536|NCT01277601|584494449|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
161972768|NCT03199053|584947684|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
161972769|NCT03199053|584947685|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
161850537|NCT02260570|584494451|FG000|Overall Study|Withdrawal by Subject|2|||
161850538|NCT02260570|584494452|FG001|Overall Study|Withdrawal by Subject|1|||
161850539|NCT02260570|584494451|FG000|Overall Study|Physician Decision|1|||
161850540|NCT02260570|584494452|FG001|Overall Study|Physician Decision|1|||
161972770|NCT01323270|584947687|FG000|Overall Study|Withdrawal by Subject|19|||
161972771|NCT01323270|584947688|FG001|Overall Study|Withdrawal by Subject|10|||
161972772|NCT01323270|584947687|FG000|Overall Study|Protocol Violation|9|||
161850541|NCT04034927|584494453|FG000|Overall Study|Adverse Event|4|||
161850542|NCT04034927|584494454|FG001|Overall Study|Adverse Event|9|||
161850543|NCT04034927|584494453|FG000|Overall Study|Death|0|||
161850544|NCT04034927|584494454|FG001|Overall Study|Death|1|||
161850545|NCT04034927|584494453|FG000|Overall Study|Withdrawal by Subject|0|||
161850546|NCT04034927|584494454|FG001|Overall Study|Withdrawal by Subject|3|||
161850547|NCT04034927|584494453|FG000|Overall Study|Still on Treatment|2|||
161850548|NCT04034927|584494454|FG001|Overall Study|Still on Treatment|1|||
161850549|NCT04034927|584494453|FG000|Overall Study|Other|1|||
161850550|NCT04034927|584494454|FG001|Overall Study|Other|1|||
161850551|NCT00094861|584494457|FG000|Overall Study|Adverse Event|5|||
161850552|NCT00094861|584494458|FG001|Overall Study|Adverse Event|2|||
161850553|NCT00094861|584494457|FG000|Overall Study|Withdrawal by Subject|5|||
161850554|NCT00094861|584494458|FG001|Overall Study|Withdrawal by Subject|3|||
161850555|NCT00094861|584494457|FG000|Overall Study|Physician Decision|1|||
161850556|NCT00094861|584494458|FG001|Overall Study|Physician Decision|1|||
161850557|NCT00094861|584494457|FG000|Overall Study|Lost to Follow-up|0|||
161850558|NCT00094861|584494458|FG001|Overall Study|Lost to Follow-up|1|||
161850559|NCT00094861|584494457|FG000|Overall Study|Death|4|||
161850560|NCT00094861|584494458|FG001|Overall Study|Death|2|||
161850561|NCT00094861|584494457|FG000|Overall Study|Other|3|||
161850562|NCT00094861|584494458|FG001|Overall Study|Other|0|||
161850563|NCT00264550|584494459|FG000|Overall Study|Death|0|||
161850564|NCT00264550|584494460|FG001|Overall Study|Death|3|||
161850565|NCT00264550|584494461|FG002|Overall Study|Death|0|||
161850566|NCT00264550|584494462|FG003|Overall Study|Death|0|||
161850567|NCT00264550|584494459|FG000|Overall Study|Lost to Follow-up|3|||
161850568|NCT00264550|584494460|FG001|Overall Study|Lost to Follow-up|1|||
161850569|NCT00264550|584494461|FG002|Overall Study|Lost to Follow-up|1|||
161850570|NCT00264550|584494462|FG003|Overall Study|Lost to Follow-up|1|||
161850571|NCT00264550|584494459|FG000|Overall Study|Adverse Event|23|||
161850572|NCT00264550|584494460|FG001|Overall Study|Adverse Event|18|||
161850573|NCT00264550|584494461|FG002|Overall Study|Adverse Event|9|||
161850574|NCT00264550|584494462|FG003|Overall Study|Adverse Event|14|||
161850575|NCT00264550|584494459|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161850576|NCT00264550|584494460|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
161850577|NCT00264550|584494461|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
161850578|NCT00264550|584494462|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
161850579|NCT00264550|584494459|FG000|Overall Study|Discontinued oral study agent|0|||
161850580|NCT00264550|584494460|FG001|Overall Study|Discontinued oral study agent|1|||
161850581|NCT00264550|584494461|FG002|Overall Study|Discontinued oral study agent|0|||
161850582|NCT00264550|584494462|FG003|Overall Study|Discontinued oral study agent|0|||
161850583|NCT00264550|584494459|FG000|Overall Study|Other|13|||
161850584|NCT00264550|584494460|FG001|Overall Study|Other|7|||
161850585|NCT00264550|584494461|FG002|Overall Study|Other|3|||
161850586|NCT00264550|584494462|FG003|Overall Study|Other|9|||
161850587|NCT02129608|584494463|FG000|Overall Study|Lost to Follow-up|0|||
161850588|NCT02129608|584494464|FG001|Overall Study|Lost to Follow-up|1|||
161850589|NCT02129608|584494465|FG002|Overall Study|Lost to Follow-up|1|||
161850590|NCT02129608|584494463|FG000|Overall Study|Withdrawal by Subject|0|||
161850591|NCT02129608|584494464|FG001|Overall Study|Withdrawal by Subject|0|||
161850592|NCT02129608|584494465|FG002|Overall Study|Withdrawal by Subject|2|||
161850593|NCT00451204|584494466|FG000|Overall Study|Adverse Event|4|||
161850594|NCT00451204|584494467|FG001|Overall Study|Adverse Event|6|||
161850595|NCT00451204|584494466|FG000|Overall Study|Lack of Efficacy|4|||
161850596|NCT00451204|584494467|FG001|Overall Study|Lack of Efficacy|4|||
161850597|NCT00451204|584494466|FG000|Overall Study|Lost to Follow-up|4|||
161850598|NCT00451204|584494467|FG001|Overall Study|Lost to Follow-up|4|||
161850599|NCT00451204|584494466|FG000|Overall Study|Protocol Violation|1|||
161850600|NCT00451204|584494467|FG001|Overall Study|Protocol Violation|0|||
161850601|NCT00451204|584494466|FG000|Overall Study|Patient refusal|8|||
161850602|NCT00451204|584494467|FG001|Overall Study|Patient refusal|4|||
161850603|NCT00451204|584494466|FG000|Overall Study|Other|1|||
161850604|NCT00451204|584494467|FG001|Overall Study|Other|2|||
161972773|NCT01323270|584947688|FG001|Overall Study|Protocol Violation|7|||
161972774|NCT01323270|584947687|FG000|Overall Study|Lost to Follow-up|4|||
161972775|NCT01323270|584947688|FG001|Overall Study|Lost to Follow-up|6|||
161972776|NCT01323270|584947687|FG000|Overall Study|Adverse Event|8|||
161850605|NCT00425373|584494472|FG000|Overall Study|Adverse Event|2|||
161850606|NCT00425373|584494473|FG001|Overall Study|Adverse Event|2|||
161972777|NCT01323270|584947688|FG001|Overall Study|Adverse Event|0|||
161850607|NCT00425373|584494474|FG002|Overall Study|Adverse Event|0|||
161850608|NCT00425373|584494475|FG003|Overall Study|Adverse Event|1|||
161850609|NCT00425373|584494476|FG004|Overall Study|Adverse Event|4|||
161850610|NCT00425373|584494477|FG005|Overall Study|Adverse Event|6|||
161850611|NCT00425373|584494478|FG006|Overall Study|Adverse Event|2|||
161850612|NCT00425373|584494479|FG007|Overall Study|Adverse Event|3|||
161850613|NCT00425373|584494480|FG008|Overall Study|Adverse Event|8|||
161850614|NCT00425373|584494472|FG000|Overall Study|Lost to Follow-up|0|||
161850615|NCT00425373|584494473|FG001|Overall Study|Lost to Follow-up|1|||
161850616|NCT00425373|584494474|FG002|Overall Study|Lost to Follow-up|0|||
161850617|NCT00425373|584494475|FG003|Overall Study|Lost to Follow-up|0|||
161850618|NCT00425373|584494476|FG004|Overall Study|Lost to Follow-up|1|||
161850619|NCT00425373|584494477|FG005|Overall Study|Lost to Follow-up|0|||
161850620|NCT00425373|584494478|FG006|Overall Study|Lost to Follow-up|0|||
161850621|NCT00425373|584494479|FG007|Overall Study|Lost to Follow-up|0|||
161850622|NCT00425373|584494480|FG008|Overall Study|Lost to Follow-up|0|||
161972778|NCT01323270|584947687|FG000|Overall Study|Other|0|||
161972779|NCT01323270|584947688|FG001|Overall Study|Other|3|||
161972780|NCT01323270|584947687|FG000|Overall Study|Physician Decision|0|||
161972781|NCT01323270|584947688|FG001|Overall Study|Physician Decision|2|||
161972782|NCT01323270|584947687|FG000|Overall Study|Not eligible|1|||
161972783|NCT01323270|584947688|FG001|Overall Study|Not eligible|1|||
161972784|NCT01323270|584947687|FG000|Overall Study|Death|1|||
161972785|NCT01323270|584947688|FG001|Overall Study|Death|0|||
161972786|NCT01323270|584947687|FG000|Overall Study|Randomized, but not vaccinated|1|||
161972787|NCT01323270|584947688|FG001|Overall Study|Randomized, but not vaccinated|0|||
161972788|NCT02229214|584947691|FG000|Overall Study|Adverse Event|2|||
161972789|NCT02229214|584947692|FG001|Overall Study|Adverse Event|0|||
161972790|NCT02229214|584947691|FG000|Overall Study|Withdrawal by Subject|4|||
161972791|NCT02229214|584947692|FG001|Overall Study|Withdrawal by Subject|0|||
161972792|NCT00246025|584947699|FG000|Overall Study|Adverse Event|7|||
161972793|NCT00246025|584947700|FG001|Overall Study|Adverse Event|9|||
161972794|NCT00246025|584947701|FG002|Overall Study|Adverse Event|9|||
161972795|NCT00246025|584947702|FG003|Overall Study|Adverse Event|10|||
161972796|NCT00246025|584947699|FG000|Overall Study|Withdrawal by Subject|3|||
161972797|NCT00246025|584947700|FG001|Overall Study|Withdrawal by Subject|0|||
161972798|NCT00246025|584947701|FG002|Overall Study|Withdrawal by Subject|1|||
161972799|NCT00246025|584947702|FG003|Overall Study|Withdrawal by Subject|2|||
161972800|NCT00246025|584947699|FG000|Overall Study|unsuitable medical history was found|0|||
161972801|NCT00246025|584947700|FG001|Overall Study|unsuitable medical history was found|0|||
161972802|NCT00246025|584947701|FG002|Overall Study|unsuitable medical history was found|0|||
161972803|NCT00246025|584947702|FG003|Overall Study|unsuitable medical history was found|1|||
161972804|NCT03305081|584947705|FG000|Overall Study|Lost to Follow-up|10|||
161972805|NCT03305081|584947706|FG001|Overall Study|Lost to Follow-up|15|||
161972806|NCT00241631|584947713|FG000|Run in (2 Weeks)|Physician Decision|3|||
161972807|NCT00241631|584947714|FG001|Run in (2 Weeks)|Physician Decision|3|||
161972808|NCT00241631|584947713|FG000|Phase 1 (4 Weeks)|sore throat|1|||
161972809|NCT00241631|584947714|FG001|Phase 1 (4 Weeks)|sore throat|0|||
161972810|NCT00241631|584947713|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
161972811|NCT00241631|584947714|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
161972812|NCT00241631|584947713|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
161972813|NCT00241631|584947714|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
161972814|NCT00241631|584947713|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
161972815|NCT00241631|584947714|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
161972816|NCT01218100|584947715|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
161972817|NCT01218100|584947716|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
161972818|NCT01218100|584947717|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
161972819|NCT01218100|584947718|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
161972820|NCT01218100|584947715|FG000|Overall Study|Adverse Event|4|||
161972821|NCT01218100|584947716|FG001|Overall Study|Adverse Event|6|||
161972822|NCT01218100|584947717|FG002|Overall Study|Adverse Event|6|||
161972823|NCT01218100|584947718|FG003|Overall Study|Adverse Event|7|||
161972824|NCT01218100|584947715|FG000|Overall Study|Lack of Efficacy|9|||
161972825|NCT01218100|584947716|FG001|Overall Study|Lack of Efficacy|6|||
161972826|NCT01218100|584947717|FG002|Overall Study|Lack of Efficacy|5|||
161972827|NCT01218100|584947718|FG003|Overall Study|Lack of Efficacy|12|||
161972828|NCT01218100|584947715|FG000|Overall Study|Protocol Violation|0|||
161972829|NCT01218100|584947716|FG001|Overall Study|Protocol Violation|0|||
161972830|NCT01218100|584947717|FG002|Overall Study|Protocol Violation|1|||
161972831|NCT01218100|584947718|FG003|Overall Study|Protocol Violation|1|||
161972832|NCT01218100|584947715|FG000|Overall Study|Withdrawal by Subject|5|||
161972833|NCT01218100|584947716|FG001|Overall Study|Withdrawal by Subject|2|||
161972834|NCT01218100|584947717|FG002|Overall Study|Withdrawal by Subject|6|||
161972835|NCT01218100|584947718|FG003|Overall Study|Withdrawal by Subject|7|||
161972836|NCT01218100|584947715|FG000|Overall Study|Lost to Follow-up|3|||
161972837|NCT01218100|584947716|FG001|Overall Study|Lost to Follow-up|8|||
161850623|NCT00425373|584494472|FG000|Overall Study|Protocol Violation|1|||
161850624|NCT00425373|584494473|FG001|Overall Study|Protocol Violation|0|||
161850625|NCT00425373|584494474|FG002|Overall Study|Protocol Violation|1|||
161850626|NCT00425373|584494475|FG003|Overall Study|Protocol Violation|0|||
161850627|NCT00425373|584494476|FG004|Overall Study|Protocol Violation|0|||
161850628|NCT00425373|584494477|FG005|Overall Study|Protocol Violation|0|||
161972838|NCT01218100|584947717|FG002|Overall Study|Lost to Follow-up|2|||
161972839|NCT01218100|584947718|FG003|Overall Study|Lost to Follow-up|1|||
161972840|NCT01218100|584947715|FG000|Overall Study|Other Reason|2|||
161972841|NCT01218100|584947716|FG001|Overall Study|Other Reason|2|||
161850629|NCT00425373|584494478|FG006|Overall Study|Protocol Violation|0|||
161972842|NCT01218100|584947717|FG002|Overall Study|Other Reason|6|||
161972843|NCT01218100|584947718|FG003|Overall Study|Other Reason|4|||
161972844|NCT02437305|584947719|FG000|Overall Study|Lost to Follow-up|18|||
161972845|NCT02437305|584947720|FG001|Overall Study|Lost to Follow-up|12|||
161972846|NCT01170065|584947721|FG000|Overall Study|Adverse Event|17|||
161972847|NCT01170065|584947722|FG001|Overall Study|Adverse Event|50|||
161972848|NCT01170065|584947723|FG002|Overall Study|Adverse Event|10|||
161850630|NCT00425373|584494479|FG007|Overall Study|Protocol Violation|5|||
161850631|NCT00425373|584494480|FG008|Overall Study|Protocol Violation|3|||
161850632|NCT00425373|584494472|FG000|Overall Study|Withdrawal by Subject|2|||
161850633|NCT00425373|584494473|FG001|Overall Study|Withdrawal by Subject|0|||
161850634|NCT00425373|584494474|FG002|Overall Study|Withdrawal by Subject|2|||
161850635|NCT00425373|584494475|FG003|Overall Study|Withdrawal by Subject|1|||
161850636|NCT00425373|584494476|FG004|Overall Study|Withdrawal by Subject|4|||
161850637|NCT00425373|584494477|FG005|Overall Study|Withdrawal by Subject|0|||
161850638|NCT00425373|584494478|FG006|Overall Study|Withdrawal by Subject|2|||
161850639|NCT00425373|584494479|FG007|Overall Study|Withdrawal by Subject|2|||
161850640|NCT00425373|584494480|FG008|Overall Study|Withdrawal by Subject|2|||
161850641|NCT00425373|584494472|FG000|Overall Study|Lack of Efficacy|0|||
161850642|NCT00425373|584494473|FG001|Overall Study|Lack of Efficacy|0|||
161850643|NCT00425373|584494474|FG002|Overall Study|Lack of Efficacy|0|||
161850644|NCT00425373|584494475|FG003|Overall Study|Lack of Efficacy|0|||
161850645|NCT00425373|584494476|FG004|Overall Study|Lack of Efficacy|1|||
161850646|NCT00425373|584494477|FG005|Overall Study|Lack of Efficacy|3|||
161850647|NCT00425373|584494478|FG006|Overall Study|Lack of Efficacy|3|||
161850648|NCT00425373|584494479|FG007|Overall Study|Lack of Efficacy|0|||
161850649|NCT00425373|584494480|FG008|Overall Study|Lack of Efficacy|5|||
161850650|NCT02620579|584494496|FG000|Overall Study|Physician Decision|0|||
161850651|NCT02620579|584494497|FG001|Overall Study|Physician Decision|0|||
161850652|NCT02620579|584494498|FG002|Overall Study|Physician Decision|0|||
161850653|NCT02620579|584494499|FG003|Overall Study|Physician Decision|1|||
161850654|NCT02620579|584494496|FG000|Overall Study|Withdrawal by Subject|0|||
161850655|NCT02620579|584494497|FG001|Overall Study|Withdrawal by Subject|1|||
161850656|NCT02620579|584494498|FG002|Overall Study|Withdrawal by Subject|1|||
161850657|NCT02620579|584494499|FG003|Overall Study|Withdrawal by Subject|0|||
161850658|NCT01721317|584494500|FG000|Overall Study|Study Closed / Terminated|2|||
161850659|NCT01721317|584494501|FG001|Overall Study|Study Closed / Terminated|2|||
161850660|NCT01721317|584494500|FG000|Overall Study|Physician Decision|0|||
161850661|NCT01721317|584494501|FG001|Overall Study|Physician Decision|1|||
161850662|NCT01721317|584494500|FG000|Overall Study|Withdrawal by Subject|0|||
161850663|NCT01721317|584494501|FG001|Overall Study|Withdrawal by Subject|1|||
161850664|NCT02661217|584494504|FG000|Overall Study|Physician Decision|12|||
161850665|NCT02661217|584494505|FG001|Overall Study|Physician Decision|15|||
161972849|NCT01170065|584947721|FG000|Overall Study|Lost to Follow-up|1|||
161972850|NCT01170065|584947722|FG001|Overall Study|Lost to Follow-up|4|||
161972851|NCT01170065|584947723|FG002|Overall Study|Lost to Follow-up|1|||
161972852|NCT01170065|584947721|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
161972853|NCT01170065|584947722|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
161972854|NCT01170065|584947723|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
161972855|NCT01170065|584947721|FG000|Overall Study|Reason other than specified|3|||
161972856|NCT01170065|584947722|FG001|Overall Study|Reason other than specified|8|||
161972857|NCT01170065|584947723|FG002|Overall Study|Reason other than specified|3|||
161972858|NCT01170065|584947721|FG000|Overall Study|Ongoing after planned observation time|5|||
161972859|NCT01170065|584947722|FG001|Overall Study|Ongoing after planned observation time|26|||
161972860|NCT01170065|584947723|FG002|Overall Study|Ongoing after planned observation time|10|||
161972861|NCT03220581|584947725|FG000|Overall Study|Withdrawal by Subject|0|||
161972862|NCT03220581|584947726|FG001|Overall Study|Withdrawal by Subject|1|||
161972863|NCT03220581|584947725|FG000|Overall Study|Lost to Follow-up|3|||
161972864|NCT03220581|584947726|FG001|Overall Study|Lost to Follow-up|6|||
161972865|NCT01071200|584947727|FG000|Overall Study|Lack of ovarian response|1|||
161972866|NCT01071200|584947728|FG001|Overall Study|Lack of ovarian response|1|||
161972867|NCT01071200|584947727|FG000|Overall Study|No fertilization|4|||
161972868|NCT01071200|584947728|FG001|Overall Study|No fertilization|0|||
161972869|NCT01071200|584947727|FG000|Overall Study|No oocytes retrieved|1|||
161972870|NCT01071200|584947728|FG001|Overall Study|No oocytes retrieved|1|||
161972871|NCT01071200|584947727|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
161972872|NCT01071200|584947728|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
161972873|NCT01071200|584947727|FG000|Overall Study|No viable embryos|0|||
161972874|NCT01071200|584947728|FG001|Overall Study|No viable embryos|1|||
161972875|NCT01920893|584947729|FG000|Overall Study|Adverse Event|5|||
161972876|NCT01920893|584947730|FG001|Overall Study|Adverse Event|2|||
161972877|NCT01920893|584947729|FG000|Overall Study|Lack of Efficacy|2|||
161972878|NCT01920893|584947730|FG001|Overall Study|Lack of Efficacy|0|||
161972879|NCT03444766|584947731|FG000|Overall Study|Other Reasons|2|||
161972880|NCT03444766|584947731|FG000|Overall Study|Participant Withdrew Consent|5|||
161850666|NCT02661217|584494504|FG000|Overall Study|Lost to Follow-up|1|||
161850667|NCT02661217|584494505|FG001|Overall Study|Lost to Follow-up|4|||
161850668|NCT02661217|584494504|FG000|Overall Study|Protocol Deviation|0|||
161850669|NCT02661217|584494505|FG001|Overall Study|Protocol Deviation|4|||
161972881|NCT03444766|584947731|FG000|Overall Study|Lost to Follow-up|2|||
161972882|NCT03444766|584947731|FG000|Overall Study|Death|2|||
161972883|NCT03444766|584947731|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
161972884|NCT03444766|584947731|FG000|Overall Study|Disease Progression|49|||
161972885|NCT02446418|584947732|FG000|Overall Study|Adverse Event|4|||
161972886|NCT02446418|584947733|FG001|Overall Study|Adverse Event|8|||
161850670|NCT02661217|584494504|FG000|Overall Study|Non-compliance with study treatment|5|||
161850671|NCT02661217|584494505|FG001|Overall Study|Non-compliance with study treatment|5|||
161850672|NCT02661217|584494504|FG000|Overall Study|Death|21|||
161850673|NCT02661217|584494505|FG001|Overall Study|Death|15|||
161850674|NCT02661217|584494504|FG000|Overall Study|Adverse Event|10|||
161850675|NCT02661217|584494505|FG001|Overall Study|Adverse Event|8|||
161850676|NCT02661217|584494504|FG000|Overall Study|Withdrawal by Subject|15|||
161850677|NCT02661217|584494505|FG001|Overall Study|Withdrawal by Subject|19|||
161850678|NCT02661217|584494504|FG000|Overall Study|Did not enter follow-up epoch|7|||
161850679|NCT02661217|584494505|FG001|Overall Study|Did not enter follow-up epoch|10|||
161850680|NCT02661217|584494504|FG000|Overall Study|Death - no study drug received|1|||
161850681|NCT02661217|584494505|FG001|Overall Study|Death - no study drug received|2|||
161850682|NCT02661217|584494504|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
161850683|NCT02661217|584494505|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
161850684|NCT00958893|584494508|FG000|Overall Study|Study prematurely terminated|4|||
161850685|NCT03066258|584494512|FG000|Overall Study|Death|1|||
161850686|NCT03066258|584494513|FG001|Overall Study|Death|0|||
161850687|NCT03066258|584494514|FG002|Overall Study|Death|0|||
161850688|NCT03066258|584494515|FG003|Overall Study|Death|0|||
161850689|NCT03066258|584494516|FG004|Overall Study|Death|1|||
161850690|NCT02165735|584494517|FG000|Overall Study|Lost to Follow-up|12|||
161850691|NCT02165735|584494518|FG001|Overall Study|Lost to Follow-up|10|||
161850692|NCT02165735|584494517|FG000|Overall Study|Withdrawal by Subject|3|||
161850693|NCT02165735|584494518|FG001|Overall Study|Withdrawal by Subject|0|||
161850694|NCT02165735|584494517|FG000|Overall Study|Participant indicated lack of time|1|||
161850695|NCT02165735|584494518|FG001|Overall Study|Participant indicated lack of time|3|||
161850696|NCT02165735|584494517|FG000|Overall Study|Protocol Violation|0|||
161850697|NCT02165735|584494518|FG001|Overall Study|Protocol Violation|1|||
161850698|NCT02784795|584494519|FG000|Overall Study|Progressive Disease|2|||
161850699|NCT02784795|584494520|FG001|Overall Study|Progressive Disease|1|||
161850700|NCT02784795|584494521|FG002|Overall Study|Progressive Disease|1|||
161850701|NCT02784795|584494522|FG003|Overall Study|Progressive Disease|0|||
161850702|NCT02784795|584494523|FG004|Overall Study|Progressive Disease|2|||
161850703|NCT02784795|584494524|FG005|Overall Study|Progressive Disease|0|||
161850704|NCT02784795|584494525|FG006|Overall Study|Progressive Disease|2|||
161850705|NCT02784795|584494526|FG007|Overall Study|Progressive Disease|0|||
161850706|NCT02784795|584494527|FG008|Overall Study|Progressive Disease|0|||
161850707|NCT02784795|584494528|FG009|Overall Study|Progressive Disease|0|||
161850708|NCT02784795|584494529|FG010|Overall Study|Progressive Disease|1|||
161850709|NCT02784795|584494530|FG011|Overall Study|Progressive Disease|0|||
161850710|NCT02784795|584494519|FG000|Overall Study|Adverse Event|1|||
161850711|NCT02784795|584494520|FG001|Overall Study|Adverse Event|0|||
161850712|NCT02784795|584494521|FG002|Overall Study|Adverse Event|0|||
161850713|NCT02784795|584494522|FG003|Overall Study|Adverse Event|1|||
161850714|NCT02784795|584494523|FG004|Overall Study|Adverse Event|0|||
161850715|NCT02784795|584494524|FG005|Overall Study|Adverse Event|0|||
161850716|NCT02784795|584494525|FG006|Overall Study|Adverse Event|1|||
161850717|NCT02784795|584494526|FG007|Overall Study|Adverse Event|0|||
161850718|NCT02784795|584494527|FG008|Overall Study|Adverse Event|0|||
161850719|NCT02784795|584494528|FG009|Overall Study|Adverse Event|0|||
161850720|NCT02784795|584494529|FG010|Overall Study|Adverse Event|0|||
161850721|NCT02784795|584494530|FG011|Overall Study|Adverse Event|2|||
161850722|NCT02784795|584494519|FG000|Overall Study|Withdrawal by Subject|1|||
161850723|NCT02784795|584494520|FG001|Overall Study|Withdrawal by Subject|0|||
161850724|NCT02784795|584494521|FG002|Overall Study|Withdrawal by Subject|2|||
161850725|NCT02784795|584494522|FG003|Overall Study|Withdrawal by Subject|1|||
161850726|NCT02784795|584494523|FG004|Overall Study|Withdrawal by Subject|3|||
161850727|NCT02784795|584494524|FG005|Overall Study|Withdrawal by Subject|0|||
161850728|NCT02784795|584494525|FG006|Overall Study|Withdrawal by Subject|0|||
161850729|NCT02784795|584494526|FG007|Overall Study|Withdrawal by Subject|1|||
161850730|NCT02784795|584494527|FG008|Overall Study|Withdrawal by Subject|0|||
161850731|NCT02784795|584494528|FG009|Overall Study|Withdrawal by Subject|0|||
161850732|NCT02784795|584494529|FG010|Overall Study|Withdrawal by Subject|0|||
161850733|NCT02784795|584494530|FG011|Overall Study|Withdrawal by Subject|2|||
161850734|NCT02784795|584494519|FG000|Overall Study|Death|0|||
161850735|NCT02784795|584494520|FG001|Overall Study|Death|0|||
161850736|NCT02784795|584494521|FG002|Overall Study|Death|0|||
161850737|NCT02784795|584494522|FG003|Overall Study|Death|0|||
161850738|NCT02784795|584494523|FG004|Overall Study|Death|1|||
161850739|NCT02784795|584494524|FG005|Overall Study|Death|0|||
161850740|NCT02784795|584494525|FG006|Overall Study|Death|0|||
161850741|NCT02784795|584494526|FG007|Overall Study|Death|0|||
161850742|NCT02784795|584494527|FG008|Overall Study|Death|0|||
161850743|NCT02784795|584494528|FG009|Overall Study|Death|0|||
161850744|NCT02784795|584494529|FG010|Overall Study|Death|0|||
161850745|NCT02784795|584494530|FG011|Overall Study|Death|0|||
161850746|NCT02784795|584494519|FG000|Overall Study|Physician Decision|0|||
161850747|NCT02784795|584494520|FG001|Overall Study|Physician Decision|0|||
161850748|NCT02784795|584494521|FG002|Overall Study|Physician Decision|0|||
161850749|NCT02784795|584494522|FG003|Overall Study|Physician Decision|0|||
161850750|NCT02784795|584494523|FG004|Overall Study|Physician Decision|0|||
161850751|NCT02784795|584494524|FG005|Overall Study|Physician Decision|0|||
161850752|NCT02784795|584494525|FG006|Overall Study|Physician Decision|1|||
161850753|NCT02784795|584494526|FG007|Overall Study|Physician Decision|0|||
161850754|NCT02784795|584494527|FG008|Overall Study|Physician Decision|0|||
161850755|NCT02784795|584494528|FG009|Overall Study|Physician Decision|0|||
161850756|NCT02784795|584494529|FG010|Overall Study|Physician Decision|0|||
161850757|NCT02784795|584494530|FG011|Overall Study|Physician Decision|0|||
161850758|NCT00595309|584494531|FG000|Overall Study|Lost to Follow-up|1|||
161850759|NCT00595309|584494531|FG000|Overall Study|planned vaccination against yellow fever|1|||
161850760|NCT00595309|584494531|FG000|Overall Study|acute infection after V0|1|||
161850761|NCT00595309|584494531|FG000|Overall Study|personal reason|1|||
161850762|NCT00101283|584494532|FG000|Overall Study|Withdrawal by Subject|0|||
161850763|NCT00101283|584494533|FG001|Overall Study|Withdrawal by Subject|1|||
161850764|NCT00101283|584494532|FG000|Overall Study|Insurance Refusal|0|||
161850765|NCT00101283|584494533|FG001|Overall Study|Insurance Refusal|1|||
161850766|NCT00101283|584494532|FG000|Overall Study|Prostate Cancer Recurrence|0|||
161850767|NCT00101283|584494533|FG001|Overall Study|Prostate Cancer Recurrence|1|||
161850768|NCT02756208|584494536|FG000|Overall Study|Withdrawal by Subject|1|||
161850769|NCT02756208|584494537|FG001|Overall Study|Withdrawal by Subject|0|||
161850770|NCT02756208|584494538|FG002|Overall Study|Withdrawal by Subject|1|||
161850771|NCT02756208|584494539|FG003|Overall Study|Withdrawal by Subject|3|||
161850772|NCT02756208|584494536|FG000|Overall Study|Lost to Follow-up|3|||
161850773|NCT02756208|584494537|FG001|Overall Study|Lost to Follow-up|1|||
161850774|NCT02756208|584494538|FG002|Overall Study|Lost to Follow-up|1|||
161850775|NCT02756208|584494539|FG003|Overall Study|Lost to Follow-up|1|||
161850776|NCT02756208|584494536|FG000|Overall Study|Physician Decision|1|||
161850777|NCT02756208|584494537|FG001|Overall Study|Physician Decision|0|||
161850778|NCT02756208|584494538|FG002|Overall Study|Physician Decision|0|||
161850779|NCT02756208|584494539|FG003|Overall Study|Physician Decision|0|||
161850780|NCT02756208|584494536|FG000|Overall Study|Protocol Violation|0|||
161850781|NCT02756208|584494537|FG001|Overall Study|Protocol Violation|1|||
161850782|NCT02756208|584494538|FG002|Overall Study|Protocol Violation|0|||
161850783|NCT02756208|584494539|FG003|Overall Study|Protocol Violation|0|||
161850784|NCT03485365|584494540|FG000|Overall Study|Protocol Violation|0|||
161850785|NCT03485365|584494541|FG001|Overall Study|Protocol Violation|0|||
161850786|NCT03485365|584494542|FG002|Overall Study|Protocol Violation|0|||
161850787|NCT03485365|584494543|FG003|Overall Study|Protocol Violation|1|||
161850788|NCT03485365|584494544|FG004|Overall Study|Protocol Violation|0|||
161850789|NCT03485365|584494545|FG005|Overall Study|Protocol Violation|0|||
161850790|NCT03485365|584494546|FG006|Overall Study|Protocol Violation|1|||
161850791|NCT03485365|584494547|FG007|Overall Study|Protocol Violation|0|||
161850792|NCT03485365|584494548|FG008|Overall Study|Protocol Violation|0|||
161850793|NCT01275430|584494554|FG000|Overall Study|Adverse Event|1|||
161850794|NCT01275430|584494554|FG000|Overall Study|No Contrast Injection|6|||
161850795|NCT01275430|584494554|FG000|Overall Study|Device Malfunction|1|||
161850796|NCT01275430|584494554|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
161850797|NCT04988087|584494555|FG000|Overall Study|Adverse Event|4|||
161850798|NCT04988087|584494556|FG001|Overall Study|Adverse Event|0|||
161850799|NCT04988087|584494557|FG002|Overall Study|Adverse Event|0|||
161850800|NCT04988087|584494558|FG003|Overall Study|Adverse Event|0|||
161850801|NCT04988087|584494555|FG000|Overall Study|Withdrawal by Subject|1|||
161850802|NCT04988087|584494556|FG001|Overall Study|Withdrawal by Subject|1|||
161850803|NCT04988087|584494557|FG002|Overall Study|Withdrawal by Subject|0|||
161850804|NCT04988087|584494558|FG003|Overall Study|Withdrawal by Subject|0|||
161850805|NCT04988087|584494555|FG000|Overall Study|Technical problems|7|||
161850806|NCT04988087|584494556|FG001|Overall Study|Technical problems|9|||
161850807|NCT04988087|584494557|FG002|Overall Study|Technical problems|1|||
161850808|NCT04988087|584494558|FG003|Overall Study|Technical problems|2|||
161850809|NCT02613182|584494559|FG000|Overall Study|Death|6|||
161850810|NCT02613182|584494559|FG000|Overall Study|Physician Decision|1|||
161850811|NCT02613182|584494559|FG000|Overall Study|Study Terminated by Sponsor|21|||
161850812|NCT02613182|584494559|FG000|Overall Study|Withdrawal by Subject|6|||
161850813|NCT03968978|584494560|FG000|Overall Study|Adverse Event|1|||
161850814|NCT03968978|584494561|FG001|Overall Study|Adverse Event|0|||
161850815|NCT00863772|584494562|FG000|Overall Study|Adverse Event|1|||
161850816|NCT00863772|584494563|FG001|Overall Study|Adverse Event|4|||
161850817|NCT00863772|584494564|FG002|Overall Study|Adverse Event|0|||
161850818|NCT00863772|584494562|FG000|Overall Study|Lack of Efficacy|4|||
161850819|NCT00863772|584494563|FG001|Overall Study|Lack of Efficacy|2|||
161850820|NCT00863772|584494564|FG002|Overall Study|Lack of Efficacy|4|||
161850821|NCT00863772|584494562|FG000|Overall Study|Lost to Follow-up|5|||
161850822|NCT00863772|584494563|FG001|Overall Study|Lost to Follow-up|1|||
161850823|NCT00863772|584494564|FG002|Overall Study|Lost to Follow-up|1|||
161850824|NCT00863772|584494562|FG000|Overall Study|Protocol Violation|2|||
161850825|NCT00863772|584494563|FG001|Overall Study|Protocol Violation|0|||
161850826|NCT00863772|584494564|FG002|Overall Study|Protocol Violation|2|||
161850827|NCT00863772|584494562|FG000|Overall Study|Withdrawal by Subject|4|||
161850828|NCT00863772|584494563|FG001|Overall Study|Withdrawal by Subject|7|||
161850829|NCT00863772|584494564|FG002|Overall Study|Withdrawal by Subject|5|||
161850830|NCT00863772|584494562|FG000|Overall Study|Study terminated by sponsor|44|||
161850831|NCT00863772|584494563|FG001|Overall Study|Study terminated by sponsor|45|||
161850832|NCT00863772|584494564|FG002|Overall Study|Study terminated by sponsor|36|||
161850833|NCT00863772|584494562|FG000|Overall Study|Entered extension study|6|||
161850834|NCT00863772|584494563|FG001|Overall Study|Entered extension study|4|||
161850835|NCT00863772|584494564|FG002|Overall Study|Entered extension study|9|||
161850836|NCT00863772|584494562|FG000|Overall Study|Other|1|||
161850837|NCT00863772|584494563|FG001|Overall Study|Other|2|||
161850838|NCT00863772|584494564|FG002|Overall Study|Other|4|||
161850839|NCT00863772|584494562|FG000|Overall Study|Randomized but not Treated|1|||
161850840|NCT00863772|584494563|FG001|Overall Study|Randomized but not Treated|0|||
161850841|NCT00863772|584494564|FG002|Overall Study|Randomized but not Treated|0|||
161850842|NCT03014180|584494569|FG000|Overall Study|Protocol Violation|2|||
161850843|NCT04400682|584494570|FG000|Period 1|Withdrawal by Subject|1|||
161850844|NCT04400682|584494571|FG001|Period 1|Withdrawal by Subject|4|||
161850845|NCT04784533|584494572|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
161850846|NCT04784533|584494573|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
161850847|NCT04784533|584494574|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850848|NCT04784533|584494575|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850849|NCT04784533|584494576|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850850|NCT04784533|584494577|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850851|NCT04784533|584494578|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850852|NCT04784533|584494579|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850853|NCT04784533|584494580|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850854|NCT04784533|584494581|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161850855|NCT04784533|584494572|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
161850856|NCT04784533|584494573|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
161850857|NCT04784533|584494574|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850858|NCT04784533|584494575|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850859|NCT04784533|584494576|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850860|NCT04784533|584494577|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850861|NCT04784533|584494578|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850862|NCT04784533|584494579|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850863|NCT04784533|584494580|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850864|NCT04784533|584494581|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161850865|NCT04784533|584494572|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850866|NCT04784533|584494573|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
161850867|NCT04784533|584494574|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850868|NCT04784533|584494575|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850869|NCT04784533|584494576|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850870|NCT04784533|584494577|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850871|NCT04784533|584494578|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850872|NCT04784533|584494579|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850873|NCT04784533|584494580|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850874|NCT04784533|584494581|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161850875|NCT04784533|584494572|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
161850876|NCT04784533|584494573|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850877|NCT04784533|584494574|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850878|NCT04784533|584494575|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850879|NCT04784533|584494576|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850880|NCT04784533|584494577|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850881|NCT04784533|584494578|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850882|NCT04784533|584494579|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850883|NCT04784533|584494580|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850884|NCT04784533|584494581|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161850885|NCT04784533|584494572|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
161850886|NCT04784533|584494573|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
161850887|NCT04784533|584494574|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850888|NCT04784533|584494575|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850889|NCT04784533|584494576|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161972887|NCT02446418|584947732|FG000|Overall Study|Physician Decision|5|||
161972888|NCT02446418|584947733|FG001|Overall Study|Physician Decision|1|||
161972889|NCT02446418|584947732|FG000|Overall Study|Withdrawal by Subject|3|||
161972890|NCT02446418|584947733|FG001|Overall Study|Withdrawal by Subject|3|||
161850890|NCT04784533|584494577|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850891|NCT04784533|584494578|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850892|NCT04784533|584494579|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850893|NCT04784533|584494580|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850894|NCT04784533|584494581|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161850895|NCT04784533|584494572|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
161850896|NCT04784533|584494573|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
161850897|NCT04784533|584494574|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850898|NCT04784533|584494575|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850899|NCT04784533|584494576|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850900|NCT04784533|584494577|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850901|NCT04784533|584494578|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850902|NCT04784533|584494579|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850903|NCT04784533|584494580|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850904|NCT04784533|584494581|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161850905|NCT04784533|584494572|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850906|NCT04784533|584494573|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850907|NCT04784533|584494574|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
161850908|NCT04784533|584494575|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850909|NCT04784533|584494576|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850910|NCT04784533|584494577|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850911|NCT04784533|584494578|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850912|NCT04784533|584494579|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850913|NCT04784533|584494580|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850914|NCT04784533|584494581|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161850915|NCT04784533|584494572|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850916|NCT04784533|584494573|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850917|NCT04784533|584494574|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850918|NCT04784533|584494575|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850919|NCT04784533|584494576|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850920|NCT04784533|584494577|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850921|NCT04784533|584494578|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850922|NCT04784533|584494579|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850923|NCT04784533|584494580|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
161850924|NCT04784533|584494581|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161850925|NCT04784533|584494572|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850926|NCT04784533|584494573|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850927|NCT04784533|584494574|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850928|NCT04784533|584494575|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850929|NCT04784533|584494576|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850930|NCT04784533|584494577|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850931|NCT04784533|584494578|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850932|NCT04784533|584494579|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161850933|NCT04784533|584494580|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
161850934|NCT04784533|584494581|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
161850935|NCT02105974|584494582|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
161850936|NCT02105974|584494583|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
161850937|NCT02105974|584494584|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
161850938|NCT02105974|584494582|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
161850939|NCT02105974|584494583|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
161850940|NCT02105974|584494584|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
161850941|NCT02105974|584494582|FG000|2 Week Run-in Period|Adverse Event|6|||
161850942|NCT02105974|584494583|FG001|2 Week Run-in Period|Adverse Event|0|||
161850943|NCT02105974|584494584|FG002|2 Week Run-in Period|Adverse Event|0|||
161850944|NCT02105974|584494582|FG000|2 Week Run-in Period|Study closed/terminated|1|||
161850945|NCT02105974|584494583|FG001|2 Week Run-in Period|Study closed/terminated|0|||
161850946|NCT02105974|584494584|FG002|2 Week Run-in Period|Study closed/terminated|0|||
161850947|NCT02105974|584494582|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
161850948|NCT02105974|584494583|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
161850949|NCT02105974|584494584|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
161850950|NCT02105974|584494582|FG000|2 Week Run-in Period|Withdrew consent|23|||
161850951|NCT02105974|584494583|FG001|2 Week Run-in Period|Withdrew consent|0|||
161850952|NCT02105974|584494584|FG002|2 Week Run-in Period|Withdrew consent|0|||
161850953|NCT02105974|584494582|FG000|2 Week Run-in Period|Investigator discretion|8|||
161850954|NCT02105974|584494583|FG001|2 Week Run-in Period|Investigator discretion|0|||
161850955|NCT02105974|584494584|FG002|2 Week Run-in Period|Investigator discretion|0|||
161850956|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
161850957|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
162033802|NCT04594369|585180182|FG000|Overall Study|Protocol deviation|1|||
162033803|NCT04594369|585180183|FG001|Overall Study|Protocol deviation|3|||
162033804|NCT04594369|585180184|FG002|Overall Study|Protocol deviation|2|||
162033805|NCT04594369|585180182|FG000|Overall Study|Withdrawal by Subject|40|||
162033806|NCT04594369|585180183|FG001|Overall Study|Withdrawal by Subject|32|||
162033807|NCT04594369|585180184|FG002|Overall Study|Withdrawal by Subject|37|||
162033808|NCT04594369|585180182|FG000|Overall Study|Reason not specified|60|||
162033809|NCT04594369|585180183|FG001|Overall Study|Reason not specified|56|||
162033810|NCT04594369|585180184|FG002|Overall Study|Reason not specified|43|||
162033811|NCT01006603|585180185|FG000|Overall Study|Withdrawal by Subject|17|||
162033812|NCT01006603|585180186|FG001|Overall Study|Withdrawal by Subject|19|||
162033813|NCT01006603|585180185|FG000|Overall Study|Lost to Follow-up|0|||
162033814|NCT01006603|585180186|FG001|Overall Study|Lost to Follow-up|1|||
162033815|NCT01006603|585180185|FG000|Overall Study|Safety reason|1|||
162033816|NCT01006603|585180186|FG001|Overall Study|Safety reason|1|||
162033817|NCT01006603|585180185|FG000|Overall Study|Protocol Violation|1|||
162033818|NCT01006603|585180186|FG001|Overall Study|Protocol Violation|3|||
162033819|NCT01006603|585180185|FG000|Overall Study|Incorrect enrolment|0|||
162033820|NCT01006603|585180186|FG001|Overall Study|Incorrect enrolment|2|||
162033821|NCT01006603|585180185|FG000|Overall Study|Adverse Event|15|||
162033822|NCT01006603|585180186|FG001|Overall Study|Adverse Event|7|||
162033823|NCT01006603|585180185|FG000|Overall Study|Death|1|||
162033824|NCT01006603|585180186|FG001|Overall Study|Death|1|||
162033825|NCT01006603|585180185|FG000|Overall Study|Study specific discontinuation criteria|33|||
162033826|NCT01006603|585180186|FG001|Overall Study|Study specific discontinuation criteria|34|||
162033827|NCT01006603|585180185|FG000|Overall Study|Other|3|||
161764403|NCT03395704|584176244|FG001|Overall Study|Withdrawal by Subject|1|||
161764404|NCT03395704|584176243|FG000|Overall Study|Physician Decision|0|||
161764405|NCT03395704|584176244|FG001|Overall Study|Physician Decision|1|||
161764406|NCT02927990|584178765|FG000|Overall Study|Protocol Violation|4|||
161764407|NCT02927990|584178765|FG000|Overall Study|Physician Decision|9|||
161764408|NCT02927990|584178765|FG000|Overall Study|Room switched and therefore no study device available|15|||
161764409|NCT02927990|584178765|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
161764410|NCT00960323|584178766|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
161764411|NCT01524900|584178772|FG000|Overall Study|Lost to Follow-up|3|||
161764412|NCT01524900|584178773|FG001|Overall Study|Lost to Follow-up|12|||
161764413|NCT01524900|584178774|FG002|Overall Study|Lost to Follow-up|1|||
161764414|NCT01524900|584178775|FG003|Overall Study|Lost to Follow-up|0|||
161764415|NCT01524900|584178776|FG004|Overall Study|Lost to Follow-up|0|||
161764416|NCT01524900|584178772|FG000|Overall Study|Other reason than stated above|1|||
161764417|NCT01524900|584178773|FG001|Overall Study|Other reason than stated above|1|||
161764418|NCT01524900|584178774|FG002|Overall Study|Other reason than stated above|0|||
161764419|NCT01524900|584178775|FG003|Overall Study|Other reason than stated above|0|||
161764420|NCT01524900|584178776|FG004|Overall Study|Other reason than stated above|0|||
161764421|NCT01524900|584178772|FG000|Overall Study|No reason documented|2|||
161764422|NCT01524900|584178773|FG001|Overall Study|No reason documented|1|||
161764423|NCT01524900|584178774|FG002|Overall Study|No reason documented|0|||
161764424|NCT01524900|584178775|FG003|Overall Study|No reason documented|1|||
161764425|NCT01524900|584178776|FG004|Overall Study|No reason documented|0|||
161764426|NCT00772031|584178777|FG000|Overall Study|Early termination of trial|12|||
161764427|NCT00772031|584178778|FG001|Overall Study|Early termination of trial|10|||
161764428|NCT00772031|584178777|FG000|Overall Study|Lost to Follow-up|20|||
161764429|NCT00772031|584178778|FG001|Overall Study|Lost to Follow-up|33|||
161764430|NCT00532441|584178779|FG000|Overall Study|Death|1|||
161764431|NCT00532441|584178780|FG001|Overall Study|Death|0|||
161764432|NCT00303329|584178781|FG000|Overall Study|Adverse Event|7|||
161764433|NCT00303329|584178782|FG001|Overall Study|Adverse Event|14|||
161764434|NCT00303329|584178781|FG000|Overall Study|Abnormal Laboratory Values|0|||
161764435|NCT00303329|584178782|FG001|Overall Study|Abnormal Laboratory Values|1|||
161764436|NCT00303329|584178781|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
161764437|NCT00303329|584178782|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161764438|NCT00303329|584178781|FG000|Overall Study|Condition no longer requires study drug|0|||
161764439|NCT00303329|584178782|FG001|Overall Study|Condition no longer requires study drug|8|||
161764440|NCT00303329|584178781|FG000|Overall Study|Protocol Violation|3|||
161764441|NCT00303329|584178782|FG001|Overall Study|Protocol Violation|0|||
161764442|NCT00303329|584178781|FG000|Overall Study|Withdrawal by Subject|9|||
161764443|NCT00303329|584178782|FG001|Overall Study|Withdrawal by Subject|15|||
161764444|NCT00303329|584178781|FG000|Overall Study|Lost to Follow-up|0|||
161764445|NCT00303329|584178782|FG001|Overall Study|Lost to Follow-up|1|||
161764446|NCT00303329|584178781|FG000|Overall Study|Administrative problems|1|||
161764447|NCT00303329|584178782|FG001|Overall Study|Administrative problems|0|||
161764448|NCT00303329|584178781|FG000|Overall Study|Death|2|||
161764449|NCT00303329|584178782|FG001|Overall Study|Death|12|||
162033828|NCT01006603|585180186|FG001|Overall Study|Other|7|||
162033829|NCT02477696|585180191|FG000|Overall Study|Death|89|||
162033830|NCT02477696|585180192|FG001|Overall Study|Death|106|||
162033831|NCT02477696|585180191|FG000|Overall Study|Lost to Follow-up|7|||
161850958|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
161850959|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
161850960|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
161850961|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
161850962|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
161850963|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
161850964|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
161850965|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
161850966|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
161850967|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
161850968|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
161850969|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
161850970|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
161850971|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
161850972|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
161850973|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
161850974|NCT02105974|584494582|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
161850975|NCT02105974|584494583|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
161850976|NCT02105974|584494584|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
161850977|NCT03597464|584494592|FG000|Overall Study|Withdrawal by Subject|4|||
161850978|NCT03597464|584494593|FG001|Overall Study|Withdrawal by Subject|5|||
161850979|NCT03597464|584494592|FG000|Overall Study|Lost to Follow-up|3|||
161850980|NCT03597464|584494593|FG001|Overall Study|Lost to Follow-up|1|||
161850981|NCT03597464|584494592|FG000|Overall Study|Pregnancy|3|||
161850982|NCT03597464|584494593|FG001|Overall Study|Pregnancy|1|||
161850983|NCT03597464|584494592|FG000|Overall Study|Lack of Efficacy|2|||
161850984|NCT03597464|584494593|FG001|Overall Study|Lack of Efficacy|0|||
161850985|NCT03597464|584494592|FG000|Overall Study|Physician Decision|2|||
161850986|NCT03597464|584494593|FG001|Overall Study|Physician Decision|2|||
161850987|NCT03597464|584494592|FG000|Overall Study|Protocol Violation|1|||
161850988|NCT03597464|584494593|FG001|Overall Study|Protocol Violation|1|||
161850989|NCT03597464|584494592|FG000|Overall Study|Adverse Event|0|||
161850990|NCT03597464|584494593|FG001|Overall Study|Adverse Event|2|||
161850991|NCT03597464|584494592|FG000|Overall Study|Death|0|||
161850992|NCT03597464|584494593|FG001|Overall Study|Death|3|||
161850993|NCT02847260|584496098|FG000|Overall Study|Adverse Event|3|||
161850994|NCT02847260|584496098|FG000|Overall Study|Withdrawal by Subject|2|||
161850995|NCT02847260|584496098|FG000|Overall Study|Clinical Deterioration|1|||
161850996|NCT02847260|584496098|FG000|Overall Study|Physician Decision|1|||
161850997|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
161850998|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
161850999|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
161851000|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
161851001|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
161851002|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
161851003|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
161851004|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
161851005|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
161851006|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
161851007|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
161851008|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
161851009|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
161851010|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
161851011|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
161851012|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161851013|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161851014|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161851015|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161851016|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161851017|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
161851018|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
161851019|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
161851020|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
161851021|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
161851022|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161851023|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161851024|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161851025|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161851026|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161851027|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
161851028|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
161972891|NCT02446418|584947732|FG000|Overall Study|Lost to Follow-up|2|||
161972892|NCT02446418|584947733|FG001|Overall Study|Lost to Follow-up|2|||
161851029|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
161851030|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
161851031|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
161851032|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161851033|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161851034|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161851035|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161851036|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161851037|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851038|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851039|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851040|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
161851041|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851042|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851043|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851044|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851045|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851046|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161851047|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
161851048|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
161851049|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
161851050|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
161851051|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
161851052|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
161851053|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
161851054|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
161851055|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
161851056|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
161851057|NCT03104400|584496099|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851058|NCT03104400|584496100|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851059|NCT03104400|584496101|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851060|NCT03104400|584496102|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
161851061|NCT03104400|584496103|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851062|NCT03104400|584496104|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851063|NCT03104400|584496105|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851064|NCT03104400|584496106|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851065|NCT03104400|584496107|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851066|NCT03104400|584496108|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161851067|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
161851068|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
161851069|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
161851070|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
161851071|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
161851072|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
161851073|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
161851074|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
161851075|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
161851076|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
161851077|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161851078|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161851079|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161851080|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161851081|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161851082|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
161851083|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
161851084|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
161851085|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
161851086|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
161851087|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161851088|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161851089|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161851090|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161851091|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161851092|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
161851093|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
161851094|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
161851095|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
161851096|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
161851097|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161851098|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161851099|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161972893|NCT02446418|584947732|FG000|Overall Study|Protocol Violation|1|||
161851100|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161851101|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161851102|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
161851103|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
161851104|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
161851105|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
161851106|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
161851107|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161972894|NCT02446418|584947733|FG001|Overall Study|Protocol Violation|2|||
161972895|NCT02446418|584947732|FG000|Overall Study|Lack of Efficacy|2|||
161972896|NCT02446418|584947733|FG001|Overall Study|Lack of Efficacy|0|||
161972897|NCT02446418|584947732|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
161972898|NCT02446418|584947733|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
161972899|NCT03421743|584947736|FG000|Overall Study|Lack of Efficacy|1|||
161972900|NCT03421743|584947737|FG001|Overall Study|Lack of Efficacy|0|||
161972901|NCT03421743|584947736|FG000|Overall Study|Adverse Event|2|||
161972902|NCT03421743|584947737|FG001|Overall Study|Adverse Event|1|||
161972903|NCT03421743|584947736|FG000|Overall Study|Withdrawal by Subject|0|||
161972904|NCT03421743|584947737|FG001|Overall Study|Withdrawal by Subject|1|||
161972905|NCT00435162|584947738|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
161972906|NCT00435162|584947739|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
161972907|NCT00435162|584947740|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
161972908|NCT00435162|584947741|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
161972909|NCT00435162|584947742|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
161972910|NCT00435162|584947743|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
161972911|NCT03093974|584947746|FG000|Overall Study|Withdrawal by Subject|32|||
161972912|NCT03093974|584947747|FG001|Overall Study|Withdrawal by Subject|27|||
161972913|NCT03093974|584947746|FG000|Overall Study|Adverse Event|17|||
161972914|NCT03093974|584947747|FG001|Overall Study|Adverse Event|24|||
161972915|NCT03093974|584947746|FG000|Overall Study|Death|0|||
161972916|NCT03093974|584947747|FG001|Overall Study|Death|1|||
161972917|NCT03093974|584947746|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161972918|NCT03093974|584947747|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161972919|NCT03093974|584947746|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
161972920|NCT03093974|584947747|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
161972921|NCT03093974|584947746|FG000|Overall Study|Lost to Follow-up|0|||
161972922|NCT03093974|584947747|FG001|Overall Study|Lost to Follow-up|1|||
161972923|NCT03093974|584947746|FG000|Overall Study|Other|1|||
161972924|NCT03093974|584947747|FG001|Overall Study|Other|2|||
161972925|NCT01009346|584947750|FG000|Overall Study|Adverse Event|4|||
161972926|NCT00033540|584947753|FG000|Overall Study|Adverse Event|14|||
161972927|NCT00033540|584947753|FG000|Overall Study|Death|1|||
161972928|NCT00033540|584947753|FG000|Overall Study|Progression|26|||
161972929|NCT00033540|584947753|FG000|Overall Study|Withdrawal by Subject|6|||
161972930|NCT00033540|584947753|FG000|Overall Study|Other|5|||
161972931|NCT00033540|584947753|FG000|Overall Study|Ineligible|3|||
161972932|NCT00033540|584947753|FG000|Overall Study|Never received treatment|2|||
161972933|NCT01253265|584947756|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
161972934|NCT01253265|584947757|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
161972935|NCT01253265|584947758|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
161972936|NCT01253265|584947759|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
161972937|NCT01253265|584947760|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
161972938|NCT01253265|584947756|FG000|Overall Study|Withdrawal by Subject|0|||
161972939|NCT01253265|584947757|FG001|Overall Study|Withdrawal by Subject|0|||
161972940|NCT01253265|584947758|FG002|Overall Study|Withdrawal by Subject|0|||
161972941|NCT01253265|584947759|FG003|Overall Study|Withdrawal by Subject|0|||
161972942|NCT01253265|584947760|FG004|Overall Study|Withdrawal by Subject|1|||
161972943|NCT00066469|584947763|FG000|Overall Study|Death|3|||
161972944|NCT00066469|584947763|FG000|Overall Study|Lack of Efficacy|9|||
161972945|NCT00066469|584947763|FG000|Overall Study|Lost to Follow-up|1|||
161972946|NCT00066469|584947763|FG000|Overall Study|Physician Decision|1|||
161972947|NCT00066469|584947763|FG000|Overall Study|Withdrawal by Subject|1|||
161972948|NCT00066469|584947763|FG000|Overall Study|ineligible|1|||
161972949|NCT00882908|584947766|FG000|Overall Study|Adverse Event|0|||
161972950|NCT00882908|584947767|FG001|Overall Study|Adverse Event|0|||
161972951|NCT00882908|584947768|FG002|Overall Study|Adverse Event|1|||
161972952|NCT00882908|584947769|FG003|Overall Study|Adverse Event|0|||
161972953|NCT00882908|584947770|FG004|Overall Study|Adverse Event|1|||
161972954|NCT00882908|584947766|FG000|Overall Study|Lost to Follow-up|3|||
161851108|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161851109|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161972955|NCT00882908|584947767|FG001|Overall Study|Lost to Follow-up|5|||
161972956|NCT00882908|584947768|FG002|Overall Study|Lost to Follow-up|3|||
161972957|NCT00882908|584947769|FG003|Overall Study|Lost to Follow-up|1|||
161972958|NCT00882908|584947770|FG004|Overall Study|Lost to Follow-up|2|||
161972959|NCT00882908|584947766|FG000|Overall Study|Protocol Violation|0|||
161972960|NCT00882908|584947767|FG001|Overall Study|Protocol Violation|1|||
161972961|NCT00882908|584947768|FG002|Overall Study|Protocol Violation|0|||
162033832|NCT02477696|585180192|FG001|Overall Study|Lost to Follow-up|5|||
162033833|NCT02477696|585180191|FG000|Overall Study|Withdrawal by Subject|37|||
161851110|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161851111|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161851112|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161851113|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
161851114|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161851115|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
161851116|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
161851117|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851118|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851119|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851120|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851121|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851122|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851123|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851124|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
161851125|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
161851126|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161851127|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
161851128|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
161851129|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
161851130|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
161851131|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
161851132|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
161851133|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
161851134|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
161851135|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
161851136|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
161851137|NCT03104400|584496099|FG000|Period 2 Week 56 - 260)|Other|0|||
161851138|NCT03104400|584496100|FG001|Period 2 Week 56 - 260)|Other|0|||
161851139|NCT03104400|584496101|FG002|Period 2 Week 56 - 260)|Other|0|||
161851140|NCT03104400|584496102|FG003|Period 2 Week 56 - 260)|Other|0|||
161851141|NCT03104400|584496103|FG004|Period 2 Week 56 - 260)|Other|0|||
161851142|NCT03104400|584496104|FG005|Period 2 Week 56 - 260)|Other|0|||
161851143|NCT03104400|584496105|FG006|Period 2 Week 56 - 260)|Other|0|||
161851144|NCT03104400|584496106|FG007|Period 2 Week 56 - 260)|Other|0|||
161851145|NCT03104400|584496107|FG008|Period 2 Week 56 - 260)|Other|1|||
161851146|NCT03104400|584496108|FG009|Period 2 Week 56 - 260)|Other|1|||
161851147|NCT00129389|584496111|FG000|Overall Study|Adverse Event|19|||
161851148|NCT00129389|584496112|FG001|Overall Study|Adverse Event|87|||
161851149|NCT00129389|584496111|FG000|Overall Study|Death|0|||
161851150|NCT00129389|584496112|FG001|Overall Study|Death|1|||
161851151|NCT00129389|584496111|FG000|Overall Study|Lost to Follow-up|2|||
161851152|NCT00129389|584496112|FG001|Overall Study|Lost to Follow-up|1|||
161851153|NCT00129389|584496111|FG000|Overall Study|Physician Decision|0|||
161851154|NCT00129389|584496112|FG001|Overall Study|Physician Decision|4|||
161851155|NCT00129389|584496111|FG000|Overall Study|Protocol Violation|0|||
161851156|NCT00129389|584496112|FG001|Overall Study|Protocol Violation|6|||
161851157|NCT00129389|584496111|FG000|Overall Study|Withdrawal by Subject|9|||
161851158|NCT00129389|584496112|FG001|Overall Study|Withdrawal by Subject|23|||
161851159|NCT00129389|584496111|FG000|Overall Study|Relapse|1|||
161851160|NCT00129389|584496112|FG001|Overall Study|Relapse|0|||
161851161|NCT00129389|584496111|FG000|Overall Study|Not eligible|1|||
161851162|NCT00129389|584496112|FG001|Overall Study|Not eligible|2|||
161851163|NCT00129389|584496111|FG000|Overall Study|Crossed to the other arm|1|||
161851164|NCT00129389|584496112|FG001|Overall Study|Crossed to the other arm|16|||
161851165|NCT01191944|584496116|FG000|Overall Study|Adverse Event|11|||
162033834|NCT02477696|585180192|FG001|Overall Study|Withdrawal by Subject|34|||
162033835|NCT02477696|585180191|FG000|Overall Study|Physician Decision|7|||
162033836|NCT02477696|585180192|FG001|Overall Study|Physician Decision|9|||
161851166|NCT01191944|584496117|FG001|Overall Study|Adverse Event|12|||
161851167|NCT01191944|584496116|FG000|Overall Study|Protocol Violation|1|||
161851168|NCT01191944|584496117|FG001|Overall Study|Protocol Violation|2|||
161851169|NCT01191944|584496116|FG000|Overall Study|Withdrawal by Subject|4|||
161851170|NCT01191944|584496117|FG001|Overall Study|Withdrawal by Subject|2|||
161851171|NCT01191944|584496116|FG000|Overall Study|Other|1|||
161851172|NCT01191944|584496117|FG001|Overall Study|Other|3|||
161851173|NCT02794246|584496122|FG000|Overall Study|Withdrawal by Subject|2|||
161851174|NCT02794246|584496122|FG000|Overall Study|Physician Decision|4|||
161851175|NCT04602546|584496123|FG000|Overall Study|Training|2|||
161851176|NCT04602546|584496124|FG001|Overall Study|Training|2|||
161851177|NCT04602546|584496125|FG002|Overall Study|Training|1|||
161851178|NCT04602546|584496126|FG003|Overall Study|Training|2|||
161851179|NCT04602546|584496127|FG004|Overall Study|Training|0|||
162033837|NCT02477696|585180191|FG000|Overall Study|Study terminated by sponsor|103|||
161851180|NCT04602546|584496123|FG000|Overall Study|Randomized with disqualified data|2|||
161851181|NCT04602546|584496124|FG001|Overall Study|Randomized with disqualified data|0|||
161851182|NCT04602546|584496125|FG002|Overall Study|Randomized with disqualified data|2|||
161851183|NCT04602546|584496126|FG003|Overall Study|Randomized with disqualified data|5|||
161851184|NCT04602546|584496127|FG004|Overall Study|Randomized with disqualified data|3|||
161851185|NCT01831258|584496129|FG000|Overall Study|Withdrawal by Subject|2|||
161851186|NCT01831258|584496130|FG001|Overall Study|Withdrawal by Subject|1|||
161851187|NCT01831258|584496129|FG000|Overall Study|Lost to Follow-up|3|||
161851188|NCT01831258|584496130|FG001|Overall Study|Lost to Follow-up|2|||
161851189|NCT01753297|584496135|FG000|Overall Study|Lost to Follow-up|7|||
161851190|NCT01753297|584496136|FG001|Overall Study|Lost to Follow-up|2|||
161851191|NCT01753297|584496135|FG000|Overall Study|Withdrawal by Subject|26|||
161851192|NCT01753297|584496136|FG001|Overall Study|Withdrawal by Subject|23|||
161851193|NCT01753297|584496135|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
161851194|NCT01753297|584496136|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
161851195|NCT01753297|584496135|FG000|Overall Study|Death|0|||
161851196|NCT01753297|584496136|FG001|Overall Study|Death|2|||
161851197|NCT01753297|584496135|FG000|Overall Study|Did not attend end of study visit|7|||
161851198|NCT01753297|584496136|FG001|Overall Study|Did not attend end of study visit|8|||
161851199|NCT02533180|584496137|FG000|Overall Study|Death|0|||
161851200|NCT02533180|584496138|FG001|Overall Study|Death|2|||
161851201|NCT02533180|584496137|FG000|Overall Study|Lost to Follow-up|0|||
161851202|NCT02533180|584496138|FG001|Overall Study|Lost to Follow-up|1|||
161851203|NCT02533180|584496137|FG000|Overall Study|Physician Decision|0|||
161851204|NCT02533180|584496138|FG001|Overall Study|Physician Decision|1|||
161851205|NCT02533180|584496137|FG000|Overall Study|Withdrawal by Subject|2|||
161851206|NCT02533180|584496138|FG001|Overall Study|Withdrawal by Subject|5|||
161851207|NCT02533180|584496137|FG000|Overall Study|Screen Failure|37|||
161851208|NCT02533180|584496138|FG001|Overall Study|Screen Failure|0|||
161851209|NCT02533180|584496137|FG000|Overall Study|Protocol Deviation|0|||
161851210|NCT02533180|584496138|FG001|Overall Study|Protocol Deviation|1|||
161851211|NCT02533180|584496137|FG000|Overall Study|Non-compliance|0|||
161851212|NCT02533180|584496138|FG001|Overall Study|Non-compliance|1|||
161851213|NCT01174043|584496140|FG000|Overall Study|Disease progression|5|||
161851214|NCT01174043|584496140|FG000|Overall Study|Adverse Event|3|||
161851215|NCT01174043|584496140|FG000|Overall Study|Death|1|||
161851216|NCT01174043|584496140|FG000|Overall Study|Withdrawal by Subject|2|||
161851217|NCT00794339|584496145|FG000|Overall Study|Withdrawal by Subject|3|||
161851218|NCT00794339|584496145|FG000|Overall Study|Ineligible|4|||
161851219|NCT00794339|584496145|FG000|Overall Study|Tx prior to ATSM|3|||
161851220|NCT00794339|584496145|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
161851221|NCT00794339|584496145|FG000|Overall Study|Tx not per protocol|1|||
161851222|NCT01118975|584496150|FG000|Overall Study|Adverse Event|0|||
161851223|NCT01118975|584496151|FG001|Overall Study|Adverse Event|1|||
161851224|NCT01371539|584496154|FG000|Period One: One Week|Lost to Follow-up|0|||
161851225|NCT01371539|584496155|FG001|Period One: One Week|Lost to Follow-up|1|||
161851226|NCT01371539|584496154|FG000|Period Two: One Week|Lost to Follow-up|0|||
161851227|NCT01371539|584496155|FG001|Period Two: One Week|Lost to Follow-up|1|||
161851228|NCT01371539|584496154|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
161851229|NCT01371539|584496155|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
161851230|NCT01371539|584496154|FG000|Period Two: One Week|Time/job conflict|0|||
161851231|NCT01371539|584496155|FG001|Period Two: One Week|Time/job conflict|1|||
161851232|NCT01399658|584496156|FG000|Overall Study|Ineligible|1|||
161851233|NCT01399658|584496156|FG000|Overall Study|Machine Technical Issue|3|||
161851234|NCT01399658|584496156|FG000|Overall Study|Alternative therapy|1|||
161851235|NCT01399658|584496156|FG000|Overall Study|No reason given|1|||
161851236|NCT04315506|584496160|FG000|Overall Study|Lost to Follow-up|74|||
161851237|NCT04315506|584496161|FG001|Overall Study|Lost to Follow-up|82|||
161851238|NCT04315506|584496160|FG000|Overall Study|Withdrawal by Subject|8|||
161851239|NCT04315506|584496161|FG001|Overall Study|Withdrawal by Subject|8|||
161972962|NCT00882908|584947769|FG003|Overall Study|Protocol Violation|0|||
161972963|NCT00882908|584947770|FG004|Overall Study|Protocol Violation|0|||
161972964|NCT00882908|584947766|FG000|Overall Study|Withdrawal by Subject|0|||
161972965|NCT00882908|584947767|FG001|Overall Study|Withdrawal by Subject|0|||
161972966|NCT00882908|584947768|FG002|Overall Study|Withdrawal by Subject|3|||
161972967|NCT00882908|584947769|FG003|Overall Study|Withdrawal by Subject|5|||
161972968|NCT00882908|584947770|FG004|Overall Study|Withdrawal by Subject|2|||
161972969|NCT00882908|584947766|FG000|Overall Study|Subject reached a virologic endpoint|0|||
161972970|NCT00882908|584947767|FG001|Overall Study|Subject reached a virologic endpoint|0|||
162033838|NCT02477696|585180192|FG001|Overall Study|Study terminated by sponsor|99|||
161851240|NCT04315506|584496160|FG000|Overall Study|Physician Decision|0|||
161851241|NCT04315506|584496161|FG001|Overall Study|Physician Decision|1|||
161851242|NCT00704132|584496163|FG000|Overall Study|Clinical Adverse Experience|1|||
161851243|NCT00704132|584496164|FG001|Overall Study|Clinical Adverse Experience|0|||
161851244|NCT00704132|584496163|FG000|Overall Study|Lack of Efficacy|0|||
161851245|NCT00704132|584496164|FG001|Overall Study|Lack of Efficacy|1|||
161972971|NCT00882908|584947768|FG002|Overall Study|Subject reached a virologic endpoint|0|||
161764450|NCT00303329|584178781|FG000|Overall Study|Stopped at end of core|3|||
161764451|NCT00303329|584178782|FG001|Overall Study|Stopped at end of core|9|||
161764452|NCT00303329|584178781|FG000|Overall Study|Stopped at end of extension 1|1|||
161764453|NCT00303329|584178782|FG001|Overall Study|Stopped at end of extension 1|0|||
161764454|NCT01101321|584178785|FG000|Period 1|Withdrawal by Subject|1|||
161764455|NCT01101321|584178786|FG001|Period 1|Withdrawal by Subject|1|||
161764456|NCT01101321|584178785|FG000|Period 1|Adverse Event|3|||
161764457|NCT01101321|584178786|FG001|Period 1|Adverse Event|3|||
161764458|NCT03339999|584178787|FG000|Overall Study|Adverse Event|1|||
161764459|NCT03339999|584178788|FG001|Overall Study|Adverse Event|2|||
161764460|NCT03339999|584178789|FG002|Overall Study|Adverse Event|2|||
161764461|NCT03339999|584178790|FG003|Overall Study|Adverse Event|1|||
161764462|NCT03339999|584178787|FG000|Overall Study|Lack of Efficacy|0|||
161764463|NCT03339999|584178788|FG001|Overall Study|Lack of Efficacy|1|||
161764464|NCT03339999|584178789|FG002|Overall Study|Lack of Efficacy|0|||
161764465|NCT03339999|584178790|FG003|Overall Study|Lack of Efficacy|0|||
161764466|NCT03339999|584178787|FG000|Overall Study|Lost to Follow-up|0|||
161764467|NCT03339999|584178788|FG001|Overall Study|Lost to Follow-up|0|||
161764468|NCT03339999|584178789|FG002|Overall Study|Lost to Follow-up|0|||
161764469|NCT03339999|584178790|FG003|Overall Study|Lost to Follow-up|1|||
161764470|NCT03339999|584178787|FG000|Overall Study|Study Terminated by Sponsor|6|||
161764471|NCT03339999|584178788|FG001|Overall Study|Study Terminated by Sponsor|3|||
161764472|NCT03339999|584178789|FG002|Overall Study|Study Terminated by Sponsor|4|||
161764473|NCT03339999|584178790|FG003|Overall Study|Study Terminated by Sponsor|3|||
161764474|NCT00525499|584178791|FG000|Overall Study|Lost to Follow-up|2|||
161764475|NCT00525499|584178792|FG001|Overall Study|Lost to Follow-up|4|||
161764476|NCT00525499|584178793|FG002|Overall Study|Lost to Follow-up|1|||
161764477|NCT00525499|584178794|FG003|Overall Study|Lost to Follow-up|4|||
161764478|NCT00525499|584178791|FG000|Overall Study|Adverse Event|0|||
161764479|NCT00525499|584178792|FG001|Overall Study|Adverse Event|1|||
161764480|NCT00525499|584178793|FG002|Overall Study|Adverse Event|0|||
161764481|NCT00525499|584178794|FG003|Overall Study|Adverse Event|1|||
161764482|NCT00525499|584178791|FG000|Overall Study|Withdrawal by Subject|5|||
161764483|NCT00525499|584178792|FG001|Overall Study|Withdrawal by Subject|1|||
161764484|NCT00525499|584178793|FG002|Overall Study|Withdrawal by Subject|5|||
161764485|NCT00525499|584178794|FG003|Overall Study|Withdrawal by Subject|2|||
161764486|NCT00525499|584178791|FG000|Overall Study|Protocol Violation|0|||
161764487|NCT00525499|584178792|FG001|Overall Study|Protocol Violation|1|||
161764488|NCT00525499|584178793|FG002|Overall Study|Protocol Violation|1|||
161764489|NCT00525499|584178794|FG003|Overall Study|Protocol Violation|0|||
161764490|NCT01856920|584178797|FG000|Overall Study|Disease Progression On Study|3|||
161764491|NCT01856920|584178798|FG001|Overall Study|Disease Progression On Study|4|||
161764492|NCT01856920|584178797|FG000|Overall Study|Disease Progression before Treatment|1|||
161764493|NCT01856920|584178798|FG001|Overall Study|Disease Progression before Treatment|0|||
161764494|NCT01856920|584178797|FG000|Overall Study|Ineligible|0|||
161764495|NCT01856920|584178798|FG001|Overall Study|Ineligible|1|||
161764496|NCT01856920|584178797|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
161764497|NCT01856920|584178798|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
161764498|NCT01856920|584178797|FG000|Overall Study|Refused further Treatment|5|||
161764499|NCT01856920|584178798|FG001|Overall Study|Refused further Treatment|1|||
161764500|NCT01856920|584178797|FG000|Overall Study|Other Reasons|0|||
161764501|NCT01856920|584178798|FG001|Overall Study|Other Reasons|1|||
161764502|NCT01856920|584178797|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
161764503|NCT01856920|584178798|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
161764504|NCT03287089|584178804|FG000|Overall Study|Lost to Follow-up|0|||
161764505|NCT03287089|584178805|FG001|Overall Study|Lost to Follow-up|2|||
161764506|NCT03287089|584178804|FG000|Overall Study|Physician Decision|0|||
161764507|NCT03287089|584178805|FG001|Overall Study|Physician Decision|2|||
161764508|NCT03287089|584178804|FG000|Overall Study|Withdrawal by Subject|0|||
161764509|NCT03287089|584178805|FG001|Overall Study|Withdrawal by Subject|2|||
161764510|NCT01729559|584178806|FG000|Overall Study|Protocol Violation|31|||
161764511|NCT01729559|584178807|FG001|Overall Study|Protocol Violation|28|||
161972972|NCT00882908|584947769|FG003|Overall Study|Subject reached a virologic endpoint|0|||
161764512|NCT02452034|584178812|FG000|Overall Study|Adverse Event|0|||
161764513|NCT02452034|584178813|FG001|Overall Study|Adverse Event|0|||
161764514|NCT02452034|584178814|FG002|Overall Study|Adverse Event|0|||
161764515|NCT02452034|584178815|FG003|Overall Study|Adverse Event|0|||
161764516|NCT02452034|584178816|FG004|Overall Study|Adverse Event|0|||
161764517|NCT02452034|584178817|FG005|Overall Study|Adverse Event|1|||
161764518|NCT02452034|584178812|FG000|Overall Study|Death|0|||
161764519|NCT02452034|584178813|FG001|Overall Study|Death|0|||
161764520|NCT02452034|584178814|FG002|Overall Study|Death|0|||
161764521|NCT02452034|584178815|FG003|Overall Study|Death|0|||
161764522|NCT02452034|584178816|FG004|Overall Study|Death|1|||
161764523|NCT02452034|584178817|FG005|Overall Study|Death|1|||
161764524|NCT02452034|584178812|FG000|Overall Study|Physician Decision|0|||
161764525|NCT02452034|584178813|FG001|Overall Study|Physician Decision|1|||
161764526|NCT02452034|584178814|FG002|Overall Study|Physician Decision|1|||
161972973|NCT00882908|584947770|FG004|Overall Study|Subject reached a virologic endpoint|1|||
161972974|NCT00882908|584947766|FG000|Overall Study|Study terminated in error|0|||
161972975|NCT00882908|584947767|FG001|Overall Study|Study terminated in error|0|||
161972976|NCT00882908|584947768|FG002|Overall Study|Study terminated in error|0|||
161972977|NCT00882908|584947769|FG003|Overall Study|Study terminated in error|1|||
161972978|NCT00882908|584947770|FG004|Overall Study|Study terminated in error|0|||
161972979|NCT03283150|584947771|FG000|Overall Study|Withdrawal by Subject|6|||
161972980|NCT03283150|584947772|FG001|Overall Study|Withdrawal by Subject|0|||
161972981|NCT03283150|584947773|FG002|Overall Study|Withdrawal by Subject|0|||
161972982|NCT00581828|584947774|FG000|Overall Study|Protocol Violation|1|||
161972983|NCT02981407|584947775|FG000|Overall Study|Withdrawal by Subject|2|||
161972984|NCT02981407|584947776|FG001|Overall Study|Withdrawal by Subject|0|||
161972985|NCT02410824|584947779|FG000|First Intervention (One Week)|Headache|0|||
161972986|NCT02410824|584947780|FG001|First Intervention (One Week)|Headache|1|||
161972987|NCT00392808|584947781|FG000|Overall Study|Lost to Follow-up|3|||
161972988|NCT00392808|584947782|FG001|Overall Study|Lost to Follow-up|2|||
161972989|NCT00392808|584947783|FG002|Overall Study|Lost to Follow-up|1|||
161972990|NCT00392808|584947784|FG003|Overall Study|Lost to Follow-up|2|||
161972991|NCT00392808|584947781|FG000|Overall Study|Unable to withdraw blood|3|||
161972992|NCT00392808|584947782|FG001|Overall Study|Unable to withdraw blood|1|||
161972993|NCT00392808|584947783|FG002|Overall Study|Unable to withdraw blood|1|||
161972994|NCT00392808|584947784|FG003|Overall Study|Unable to withdraw blood|2|||
161972995|NCT02436408|584947785|FG000|Overall Study|Death|1|||
161972996|NCT02084238|584947786|FG000|Overall Study|Lost to Follow-up|2|||
161972997|NCT01038713|584947787|FG000|Overall Study|Patient to hospice|1|||
161972998|NCT01038713|584947788|FG001|Overall Study|Patient to hospice|1|||
161972999|NCT01038713|584947789|FG002|Overall Study|Patient to hospice|1|||
161973000|NCT01038713|584947787|FG000|Overall Study|Lost to Follow-up|3|||
161973001|NCT01038713|584947788|FG001|Overall Study|Lost to Follow-up|0|||
161973002|NCT01038713|584947789|FG002|Overall Study|Lost to Follow-up|0|||
161973003|NCT01038713|584947787|FG000|Overall Study|Neuroendocrine Tumor|0|||
161973004|NCT01038713|584947788|FG001|Overall Study|Neuroendocrine Tumor|1|||
161973005|NCT01038713|584947789|FG002|Overall Study|Neuroendocrine Tumor|0|||
161973006|NCT01038713|584947787|FG000|Overall Study|died from PEP|0|||
161973007|NCT01038713|584947788|FG001|Overall Study|died from PEP|1|||
161973008|NCT01038713|584947789|FG002|Overall Study|died from PEP|0|||
161973009|NCT01038713|584947787|FG000|Overall Study|Autoimmune Pancreatitis|1|||
161973010|NCT01038713|584947788|FG001|Overall Study|Autoimmune Pancreatitis|0|||
161973011|NCT01038713|584947789|FG002|Overall Study|Autoimmune Pancreatitis|0|||
161973012|NCT02818036|584947790|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
161973013|NCT02818036|584947791|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
161973014|NCT02818036|584947790|FG000|Overall Study|Withdrawal by Subject|1|||
161973015|NCT02818036|584947791|FG001|Overall Study|Withdrawal by Subject|0|||
161973016|NCT01154283|584947792|FG000|0-6 Weeks|Withdrawal by Subject|7|||
161973017|NCT01154283|584947793|FG001|0-6 Weeks|Withdrawal by Subject|2|||
161973018|NCT01154283|584947792|FG000|0-6 Weeks|Death|0|||
161973019|NCT01154283|584947793|FG001|0-6 Weeks|Death|1|||
161973020|NCT01154283|584947792|FG000|7-12 Weeks|Death|1|||
161973021|NCT01154283|584947793|FG001|7-12 Weeks|Death|0|||
161973022|NCT01154283|584947792|FG000|7-12 Weeks|Withdrawal by Subject|0|||
161973023|NCT01154283|584947793|FG001|7-12 Weeks|Withdrawal by Subject|1|||
161973024|NCT03777917|584947794|FG000|Overall Study|Withdrawal by Subject|1|||
161973025|NCT03777917|584947795|FG001|Overall Study|Withdrawal by Subject|0|||
161973026|NCT03777917|584947794|FG000|Overall Study|Physician Decision|1|||
161973027|NCT03777917|584947795|FG001|Overall Study|Physician Decision|0|||
161973028|NCT03777917|584947794|FG000|Overall Study|Lost to Follow-up|6|||
161973029|NCT03777917|584947795|FG001|Overall Study|Lost to Follow-up|2|||
161973030|NCT03777917|584947794|FG000|Overall Study|Other|1|||
161973031|NCT03777917|584947795|FG001|Overall Study|Other|0|||
161973032|NCT00320372|584947796|FG000|Overall Study|Physician Decision|4|||
161973033|NCT00320372|584947797|FG001|Overall Study|Physician Decision|7|||
161973034|NCT00320372|584947796|FG000|Overall Study|Death|7|||
161973035|NCT00320372|584947797|FG001|Overall Study|Death|8|||
161973036|NCT00320372|584947796|FG000|Overall Study|Withdrawal by Subject|55|||
161973037|NCT00320372|584947797|FG001|Overall Study|Withdrawal by Subject|37|||
161973038|NCT00320372|584947796|FG000|Overall Study|Non-Compliance|40|||
161973039|NCT00320372|584947797|FG001|Overall Study|Non-Compliance|39|||
161973040|NCT00320372|584947796|FG000|Overall Study|Did not Meet (I/E)|3|||
161973041|NCT00320372|584947797|FG001|Overall Study|Did not Meet (I/E)|1|||
161973042|NCT00320372|584947796|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
161973043|NCT00320372|584947797|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
161973044|NCT04063787|584947798|FG000|Overall Study|Inadequate Doppler data|4|||
161973045|NCT04063787|584947798|FG000|Overall Study|Lost to Follow-up|2|||
161973046|NCT04063787|584947798|FG000|Overall Study|Death|3|||
161973047|NCT01416441|584947799|FG000|Overall Study|Lost to Follow-up|5|||
161973048|NCT01416441|584947799|FG000|Overall Study|Adverse Event|6|||
161973049|NCT01416441|584947799|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
161973050|NCT01416441|584947799|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
161851246|NCT00704132|584496163|FG000|Overall Study|Withdrawal by Subject|0|||
161851247|NCT00704132|584496164|FG001|Overall Study|Withdrawal by Subject|1|||
161851248|NCT00442962|584496165|FG000|Overall Study|Pregnancy|1|||
161851249|NCT00442962|584496165|FG000|Overall Study|Lost to Follow-up|7|||
161851250|NCT04238650|584496166|FG000|Overall Study|Withdrawal by Subject|0|||
161851251|NCT04238650|584496167|FG001|Overall Study|Withdrawal by Subject|1|||
161851252|NCT03348163|584496168|FG000|Overall Study|Withdrawal by Subject|2|||
161851253|NCT03348163|584496169|FG001|Overall Study|Withdrawal by Subject|0|||
161851254|NCT02585778|584496170|FG000|Overall Study|Adverse Event|17|||
161851255|NCT02585778|584496171|FG001|Overall Study|Adverse Event|4|||
161851256|NCT02585778|584496170|FG000|Overall Study|Participant did not wish to continue|9|||
161851257|NCT02585778|584496171|FG001|Overall Study|Participant did not wish to continue|4|||
161851258|NCT02585778|584496170|FG000|Overall Study|Poor compliance to study protocol|0|||
161851259|NCT02585778|584496171|FG001|Overall Study|Poor compliance to study protocol|2|||
161851260|NCT02585778|584496170|FG000|Overall Study|Death|0|||
161851261|NCT02585778|584496171|FG001|Overall Study|Death|1|||
161851262|NCT02585778|584496170|FG000|Overall Study|Randomized but not treated|1|||
161851263|NCT02585778|584496171|FG001|Overall Study|Randomized but not treated|2|||
161851264|NCT02585778|584496170|FG000|Overall Study|Other than specified above|6|||
161851265|NCT02585778|584496171|FG001|Overall Study|Other than specified above|2|||
161851266|NCT03682107|584496177|FG000|Overall Study|Withdrawal by Subject|0|||
161851267|NCT03682107|584496178|FG001|Overall Study|Withdrawal by Subject|1|||
161851268|NCT03682107|584496179|FG002|Overall Study|Withdrawal by Subject|0|||
161851269|NCT03682107|584496180|FG003|Overall Study|Withdrawal by Subject|0|||
161851270|NCT03682107|584496181|FG004|Overall Study|Withdrawal by Subject|0|||
161851271|NCT05211726|584496182|FG000|Overall Study|Withdrawal by Subject|2|||
161851272|NCT05211726|584496183|FG001|Overall Study|Withdrawal by Subject|3|||
161851273|NCT05211726|584496182|FG000|Overall Study|Protocol Violation|0|||
161851274|NCT05211726|584496183|FG001|Overall Study|Protocol Violation|1|||
161851275|NCT01038297|584496184|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
161851276|NCT01038297|584496185|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
161851277|NCT01038297|584496186|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
161851278|NCT02714426|584496192|FG000|Overall Study|Withdrawal by Subject|2|||
161851279|NCT02714426|584496193|FG001|Overall Study|Withdrawal by Subject|2|||
161851280|NCT00908310|584496196|FG000|Overall Study|Death|37|||
161851281|NCT00908310|584496196|FG000|Overall Study|Withdrawal by Subject|7|||
161851282|NCT00908310|584496196|FG000|Overall Study|Lost to Follow-up|7|||
161851283|NCT00908310|584496196|FG000|Overall Study|Screening failure|5|||
161851284|NCT00908310|584496196|FG000|Overall Study|Other reasons|4|||
161851285|NCT00725205|584496199|FG000|Overall Study|Adverse Event|22|||
161973051|NCT01416441|584947799|FG000|Overall Study|Investigator Withdrew Subject|2|||
161973052|NCT01416441|584947799|FG000|Overall Study|Subject Withdrew Consent|12|||
161764527|NCT02452034|584178815|FG003|Overall Study|Physician Decision|0|||
161764528|NCT02452034|584178816|FG004|Overall Study|Physician Decision|0|||
161764529|NCT02452034|584178817|FG005|Overall Study|Physician Decision|0|||
161764530|NCT02452034|584178812|FG000|Overall Study|Protocol Violation|0|||
161764531|NCT02452034|584178813|FG001|Overall Study|Protocol Violation|0|||
161764532|NCT02452034|584178814|FG002|Overall Study|Protocol Violation|0|||
161764533|NCT02452034|584178815|FG003|Overall Study|Protocol Violation|0|||
161764534|NCT02452034|584178816|FG004|Overall Study|Protocol Violation|0|||
161764535|NCT02452034|584178817|FG005|Overall Study|Protocol Violation|1|||
161764536|NCT02452034|584178812|FG000|Overall Study|Screen Failure|1|||
161764537|NCT02452034|584178813|FG001|Overall Study|Screen Failure|0|||
161764538|NCT02452034|584178814|FG002|Overall Study|Screen Failure|0|||
161764539|NCT02452034|584178815|FG003|Overall Study|Screen Failure|1|||
161764540|NCT02452034|584178816|FG004|Overall Study|Screen Failure|0|||
161764541|NCT02452034|584178817|FG005|Overall Study|Screen Failure|0|||
161764542|NCT02452034|584178812|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
161764543|NCT02452034|584178813|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
161764544|NCT02452034|584178814|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
161764545|NCT02452034|584178815|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
161764546|NCT02452034|584178816|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
161764547|NCT02452034|584178817|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
161764548|NCT01453439|584178822|FG000|Treatment Phase|Withdrawal by Subject|13|||
161764549|NCT01453439|584178823|FG001|Treatment Phase|Withdrawal by Subject|10|||
161764550|NCT01453439|584178822|FG000|Treatment Phase|Suicidal Ideation|2|||
161764551|NCT01453439|584178823|FG001|Treatment Phase|Suicidal Ideation|0|||
161764552|NCT01453439|584178822|FG000|Treatment Phase|Need for higher level of care|1|||
161764553|NCT01453439|584178823|FG001|Treatment Phase|Need for higher level of care|1|||
161851286|NCT00725205|584496199|FG000|Overall Study|Investigator Discontinued|1|||
161851287|NCT00725205|584496199|FG000|Overall Study|Non-compliance With Protocol|14|||
161851288|NCT00725205|584496199|FG000|Overall Study|Other|8|||
161851289|NCT00725205|584496199|FG000|Overall Study|Protocol Defined Clinical Event|1|||
161851290|NCT00725205|584496199|FG000|Overall Study|Treatment Failure|41|||
161851291|NCT02212379|584496203|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
161973053|NCT01416441|584947799|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
161764554|NCT01453439|584178822|FG000|Treatment Phase|Therapist conflict of interest|1|||
161764555|NCT01453439|584178823|FG001|Treatment Phase|Therapist conflict of interest|0|||
161764556|NCT01453439|584178822|FG000|Follow-up|Withdrawal by Subject|0|||
161764557|NCT01453439|584178823|FG001|Follow-up|Withdrawal by Subject|1|||
161764558|NCT01453439|584178822|FG000|Follow-up|Lost to Follow-up|5|||
161764559|NCT01453439|584178823|FG001|Follow-up|Lost to Follow-up|10|||
161764560|NCT01014442|584178824|FG000|Overall Study|Adverse Event|0|||
161764561|NCT01014442|584178825|FG001|Overall Study|Adverse Event|8|||
161764562|NCT01014442|584178824|FG000|Overall Study|Withdrawal by Subject|4|||
161764563|NCT01014442|584178825|FG001|Overall Study|Withdrawal by Subject|4|||
161764564|NCT01014442|584178824|FG000|Overall Study|Protocol Violation|2|||
161764565|NCT01014442|584178825|FG001|Overall Study|Protocol Violation|5|||
161764566|NCT01014442|584178824|FG000|Overall Study|Lack of Compliance|0|||
161764567|NCT01014442|584178825|FG001|Overall Study|Lack of Compliance|1|||
161764568|NCT01014442|584178824|FG000|Overall Study|Unspecified Reason|1|||
161764569|NCT01014442|584178825|FG001|Overall Study|Unspecified Reason|1|||
161764570|NCT02074059|584178826|FG000|Overall Study|Death|0|||
161764571|NCT02074059|584178827|FG001|Overall Study|Death|0|||
161764572|NCT02074059|584178828|FG002|Overall Study|Death|0|||
161764573|NCT02074059|584178829|FG003|Overall Study|Death|0|||
161764574|NCT02074059|584178830|FG004|Overall Study|Death|1|||
161764575|NCT02074059|584178831|FG005|Overall Study|Death|1|||
161764576|NCT02764229|584178837|FG000|Overall Study|Withdrawal by Subject|15|||
161764577|NCT02764229|584178837|FG000|Overall Study|Adverse Event|9|||
161764578|NCT02764229|584178837|FG000|Overall Study|Physician Decision|5|||
161764579|NCT02764229|584178837|FG000|Overall Study|Lost to Follow-up|3|||
161764580|NCT02764229|584178837|FG000|Overall Study|Lack of Efficacy|1|||
161764581|NCT02764229|584178837|FG000|Overall Study|Study Stopped by Sponsor|69|||
161764582|NCT00672490|584178838|FG000|Overall Study|Withdrawal by Subject|8|||
161764583|NCT00672490|584178839|FG001|Overall Study|Withdrawal by Subject|8|||
161764584|NCT00672490|584178838|FG000|Overall Study|Lack of Compliance|2|||
161764585|NCT00672490|584178839|FG001|Overall Study|Lack of Compliance|7|||
161764586|NCT00672490|584178838|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
161764587|NCT00672490|584178839|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
161764588|NCT00672490|584178838|FG000|Overall Study|Adverse Event|5|||
161764589|NCT00672490|584178839|FG001|Overall Study|Adverse Event|8|||
161764590|NCT00672490|584178838|FG000|Overall Study|Violation of Concomitant Medicine|1|||
161764591|NCT00672490|584178839|FG001|Overall Study|Violation of Concomitant Medicine|0|||
161764592|NCT00672490|584178838|FG000|Overall Study|Intolerance|0|||
161764593|NCT00672490|584178839|FG001|Overall Study|Intolerance|2|||
161764594|NCT00672490|584178838|FG000|Overall Study|Lost to Follow-up|1|||
161764595|NCT00672490|584178839|FG001|Overall Study|Lost to Follow-up|5|||
161764596|NCT00672490|584178838|FG000|Overall Study|No reason was provided|6|||
161764597|NCT00672490|584178839|FG001|Overall Study|No reason was provided|2|||
161764598|NCT02242305|584178849|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
161764599|NCT02242305|584178850|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
161764600|NCT02242305|584178849|FG000|Overall Study|Adverse Event|1|||
161764601|NCT02242305|584178850|FG001|Overall Study|Adverse Event|0|||
161764602|NCT02242305|584178849|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
161764603|NCT02242305|584178850|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
161764604|NCT02242305|584178849|FG000|Overall Study|Subject withdraws inform consent|0|||
161764605|NCT02242305|584178850|FG001|Overall Study|Subject withdraws inform consent|4|||
161764606|NCT02242305|584178849|FG000|Overall Study|Lost to Follow-up|2|||
161764607|NCT02242305|584178850|FG001|Overall Study|Lost to Follow-up|0|||
161764608|NCT02543801|584178854|FG000|Overall Study|Protocol Violation|1|||
161764609|NCT02543801|584178855|FG001|Overall Study|Protocol Violation|2|||
161764610|NCT02543801|584178856|FG002|Overall Study|Protocol Violation|0|||
161764611|NCT02543801|584178857|FG003|Overall Study|Protocol Violation|0|||
161764612|NCT01756846|584178858|FG000|Overall Study|Lost to Follow-up|5|||
161764613|NCT01756846|584178859|FG001|Overall Study|Lost to Follow-up|10|||
161764614|NCT01756846|584178858|FG000|Overall Study|Withdrawal by Subject|1|||
161764615|NCT01756846|584178859|FG001|Overall Study|Withdrawal by Subject|2|||
161764616|NCT00082628|584178866|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
161764617|NCT00082628|584178867|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
161764618|NCT00082628|584178868|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
161764619|NCT00082628|584178869|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
161764620|NCT00082628|584178870|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
161764621|NCT00082628|584178866|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
161764622|NCT00082628|584178867|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
161764623|NCT00082628|584178868|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
161764624|NCT00082628|584178869|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
161764625|NCT00082628|584178870|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
161764626|NCT00082628|584178866|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
161851292|NCT02212379|584496203|FG000|From Baseline to Week 48|Adverse Event|7|||
161851293|NCT02212379|584496203|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
161851294|NCT02212379|584496203|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
161851295|NCT02212379|584496203|FG000|From Week 48 to Week 96|Adverse Event|1|||
161851296|NCT02212379|584496203|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
161851297|NCT02682927|584496212|FG000|Overall Study|Adverse Event|0|||
161851298|NCT02682927|584496213|FG001|Overall Study|Adverse Event|0|||
161851299|NCT02682927|584496214|FG002|Overall Study|Adverse Event|5|||
161851300|NCT02682927|584496215|FG003|Overall Study|Adverse Event|1|||
161851301|NCT02682927|584496216|FG004|Overall Study|Adverse Event|0|||
161851302|NCT02682927|584496217|FG005|Overall Study|Adverse Event|2|||
161851303|NCT02682927|584496212|FG000|Overall Study|Death|0|||
161851304|NCT02682927|584496213|FG001|Overall Study|Death|0|||
161851305|NCT02682927|584496214|FG002|Overall Study|Death|0|||
161851306|NCT02682927|584496215|FG003|Overall Study|Death|1|||
161851307|NCT02682927|584496216|FG004|Overall Study|Death|0|||
161851308|NCT02682927|584496217|FG005|Overall Study|Death|0|||
161851309|NCT02682927|584496212|FG000|Overall Study|Lack of Efficacy|1|||
161851310|NCT02682927|584496213|FG001|Overall Study|Lack of Efficacy|0|||
161851311|NCT02682927|584496214|FG002|Overall Study|Lack of Efficacy|0|||
161851312|NCT02682927|584496215|FG003|Overall Study|Lack of Efficacy|1|||
161851313|NCT02682927|584496216|FG004|Overall Study|Lack of Efficacy|0|||
161851314|NCT02682927|584496217|FG005|Overall Study|Lack of Efficacy|0|||
161851315|NCT02682927|584496212|FG000|Overall Study|Other|0|||
161851316|NCT02682927|584496213|FG001|Overall Study|Other|0|||
161851317|NCT02682927|584496214|FG002|Overall Study|Other|0|||
161851318|NCT02682927|584496215|FG003|Overall Study|Other|2|||
161851319|NCT02682927|584496216|FG004|Overall Study|Other|0|||
161851320|NCT02682927|584496217|FG005|Overall Study|Other|0|||
161851321|NCT02682927|584496212|FG000|Overall Study|Withdrawal by Subject|2|||
161851322|NCT02682927|584496213|FG001|Overall Study|Withdrawal by Subject|0|||
161851323|NCT02682927|584496214|FG002|Overall Study|Withdrawal by Subject|1|||
161851324|NCT02682927|584496215|FG003|Overall Study|Withdrawal by Subject|0|||
161851325|NCT02682927|584496216|FG004|Overall Study|Withdrawal by Subject|1|||
161851326|NCT02682927|584496217|FG005|Overall Study|Withdrawal by Subject|1|||
161851327|NCT03462459|584496218|FG000|Overall Study|Death|1|||
161851328|NCT03462459|584496219|FG001|Overall Study|Death|0|||
161851329|NCT03462459|584496218|FG000|Overall Study|Lack of Efficacy|2|||
161851330|NCT03462459|584496219|FG001|Overall Study|Lack of Efficacy|4|||
161851331|NCT03462459|584496218|FG000|Overall Study|Lost to Follow-up|1|||
161851332|NCT03462459|584496219|FG001|Overall Study|Lost to Follow-up|3|||
161851333|NCT03462459|584496218|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
161851334|NCT03462459|584496219|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
161851335|NCT03462459|584496218|FG000|Overall Study|Withdrawal by Subject|3|||
161851336|NCT03462459|584496219|FG001|Overall Study|Withdrawal by Subject|2|||
161851337|NCT03462459|584496218|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
161851338|NCT03462459|584496219|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
161851339|NCT01177059|584496220|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
161851340|NCT01177059|584496220|FG000|Overall Study|Withdrew consent|2|||
161851341|NCT01177059|584496220|FG000|Overall Study|Lost to Follow-up|18|||
161851342|NCT01243775|584496221|FG000|Overall Study|Withdrawal by Subject|2|||
161851343|NCT04051619|584496222|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
161851344|NCT04051619|584496223|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
161851345|NCT04051619|584496222|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
161851346|NCT04051619|584496223|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
161851347|NCT05938621|584498338|FG000|Overall Study|Lost to Follow-up|1|||
161851348|NCT05938621|584498339|FG001|Overall Study|Lost to Follow-up|5|||
161851349|NCT05938621|584498340|FG002|Overall Study|Lost to Follow-up|2|||
161851350|NCT05938621|584498341|FG003|Overall Study|Lost to Follow-up|2|||
161851351|NCT03922529|584498346|FG000|Overall Study|Withdrawal by Subject|13|||
161851352|NCT03922529|584498347|FG001|Overall Study|Withdrawal by Subject|12|||
161851353|NCT03922529|584498346|FG000|Overall Study|Death|7|||
161851354|NCT03922529|584498347|FG001|Overall Study|Death|12|||
161851355|NCT03922529|584498346|FG000|Overall Study|Lost to Follow-up|12|||
161851356|NCT03922529|584498347|FG001|Overall Study|Lost to Follow-up|19|||
161851357|NCT03922529|584498346|FG000|Overall Study|Adverse Event|1|||
161851358|NCT03922529|584498347|FG001|Overall Study|Adverse Event|0|||
161851359|NCT03922529|584498346|FG000|Overall Study|Death after withdrawal|1|||
161851360|NCT03922529|584498347|FG001|Overall Study|Death after withdrawal|0|||
161851361|NCT03922529|584498346|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
161851362|NCT03922529|584498347|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
161973054|NCT04030247|584949501|FG000|Overall Study|Withdrawal by Subject|4|||
161851363|NCT03922529|584498346|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
161851364|NCT03922529|584498347|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
161851365|NCT02731638|584498348|FG000|Overall Study|Lost to Follow-up|6|||
161851366|NCT02731638|584498349|FG001|Overall Study|Lost to Follow-up|9|||
161851367|NCT04158245|584498350|FG000|Overall Study|Lost to Follow-up|1|||
161851368|NCT01275729|584498351|FG000|Overall Study|Death|3|||
161851369|NCT01275729|584498351|FG000|Overall Study|Withdrawal by Subject|1|||
161851370|NCT00447876|584498354|FG000|Overall Study|Withdrawal by Subject|1|||
161851371|NCT00447876|584498355|FG001|Overall Study|Withdrawal by Subject|4|||
161851372|NCT00447876|584498354|FG000|Overall Study|Lost to Follow-up|1|||
161851373|NCT00447876|584498355|FG001|Overall Study|Lost to Follow-up|0|||
161851374|NCT00447876|584498354|FG000|Overall Study|Deterioration of symptomology|1|||
161851375|NCT00447876|584498355|FG001|Overall Study|Deterioration of symptomology|0|||
161851376|NCT04172597|584498356|FG000|Overall Study|Disease Progression|0|||
161851377|NCT04172597|584498357|FG001|Overall Study|Disease Progression|0|||
161851378|NCT04172597|584498358|FG002|Overall Study|Disease Progression|0|||
161851379|NCT04172597|584498359|FG003|Overall Study|Disease Progression|0|||
161851380|NCT04172597|584498360|FG004|Overall Study|Disease Progression|1|||
161851381|NCT02952586|584498364|FG000|Lead-In Phase (7 Days)|Death|0|||
161851382|NCT02952586|584498365|FG001|Lead-In Phase (7 Days)|Death|1|||
161851383|NCT02952586|584498364|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
161851384|NCT02952586|584498365|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
161851385|NCT02952586|584498364|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
161851386|NCT02952586|584498365|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
161851387|NCT02952586|584498364|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
161851388|NCT02952586|584498365|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
161851389|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
161851390|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
161851391|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
161851392|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
161851393|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
161851394|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
161851395|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
161851396|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
161851397|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
161851398|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
161851399|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
161851400|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
161851401|NCT02952586|584498364|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
161851402|NCT02952586|584498365|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
161851403|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Death|3|||
161851404|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Death|8|||
161851405|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
161851406|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
161851407|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
161851408|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
161851409|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
161851410|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
161851411|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
161851412|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
161851413|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
161851414|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
161851415|NCT02952586|584498364|FG000|CRT for Cisplatin (63 Days)|Other|1|||
161851416|NCT02952586|584498365|FG001|CRT for Cisplatin (63 Days)|Other|1|||
161851417|NCT02952586|584498364|FG000|CRT for IMRT (63 Days)|Death|5|||
161851418|NCT02952586|584498365|FG001|CRT for IMRT (63 Days)|Death|8|||
161851419|NCT02952586|584498364|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
161851420|NCT02952586|584498365|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
161851421|NCT02952586|584498364|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
161851422|NCT02952586|584498365|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
161851423|NCT02952586|584498364|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
161851424|NCT02952586|584498365|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
161851425|NCT02952586|584498364|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
161851426|NCT02952586|584498365|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
161851427|NCT02952586|584498364|FG000|CRT for IMRT (63 Days)|Other|1|||
161851428|NCT02952586|584498365|FG001|CRT for IMRT (63 Days)|Other|0|||
161851429|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Death|17|||
161851430|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Death|11|||
161851431|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
161851432|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
161851433|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
161851434|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
161851435|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
161851436|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
161851437|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
161851438|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
161851439|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
161851440|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
161851441|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
161851442|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
161851443|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
161851444|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
161851445|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Other|2|||
161851446|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Other|1|||
161851447|NCT02952586|584498364|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
161851448|NCT02952586|584498365|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
161851449|NCT02952586|584498364|FG000|Follow-Up Phase (90 Days)|Death|12|||
161851450|NCT02952586|584498365|FG001|Follow-Up Phase (90 Days)|Death|10|||
161851451|NCT02952586|584498364|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
161851452|NCT02952586|584498365|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
161851453|NCT02952586|584498364|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
161851454|NCT02952586|584498365|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
161851455|NCT02952586|584498364|FG000|Follow-Up Phase (90 Days)|Other|7|||
161851456|NCT02952586|584498365|FG001|Follow-Up Phase (90 Days)|Other|5|||
161851457|NCT02952586|584498364|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
161851458|NCT02952586|584498365|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
161851459|NCT02952586|584498364|FG000|LT Follow-up (up to 45 Months)|Death|51|||
161851460|NCT02952586|584498365|FG001|LT Follow-up (up to 45 Months)|Death|31|||
161851461|NCT02952586|584498364|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
161851462|NCT02952586|584498365|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
161851463|NCT02952586|584498364|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
161851464|NCT02952586|584498365|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
161851465|NCT02952586|584498364|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
161851466|NCT02952586|584498365|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
161851467|NCT00492778|584498368|FG000|Overall Study|Ineligible by Pathology Review|8|||
161851468|NCT00492778|584498369|FG001|Overall Study|Ineligible by Pathology Review|1|||
161851469|NCT03717012|584498384|FG000|Overall Study|Due to trial termination|1|||
161851470|NCT03717012|584498385|FG001|Overall Study|Due to trial termination|2|||
161851471|NCT03717012|584498384|FG000|Overall Study|Protocol Violation|0|||
161851472|NCT03717012|584498385|FG001|Overall Study|Protocol Violation|2|||
161851473|NCT03717012|584498384|FG000|Overall Study|Adverse Event|0|||
161851474|NCT03717012|584498385|FG001|Overall Study|Adverse Event|1|||
161851475|NCT03717012|584498384|FG000|Overall Study|Lung transplant|0|||
161851476|NCT03717012|584498385|FG001|Overall Study|Lung transplant|1|||
161851477|NCT00789035|584498386|FG000|Overall Study|Adverse Event|0|||
161851478|NCT00789035|584498387|FG001|Overall Study|Adverse Event|2|||
161851479|NCT00789035|584498388|FG002|Overall Study|Adverse Event|0|||
161851480|NCT00789035|584498389|FG003|Overall Study|Adverse Event|1|||
161851481|NCT00789035|584498390|FG004|Overall Study|Adverse Event|3|||
161851482|NCT00789035|584498386|FG000|Overall Study|Lack of Efficacy|3|||
161851483|NCT00789035|584498387|FG001|Overall Study|Lack of Efficacy|0|||
161851484|NCT00789035|584498388|FG002|Overall Study|Lack of Efficacy|0|||
161851485|NCT00789035|584498389|FG003|Overall Study|Lack of Efficacy|0|||
161851486|NCT00789035|584498390|FG004|Overall Study|Lack of Efficacy|2|||
161851487|NCT00789035|584498386|FG000|Overall Study|Protocol Violation|1|||
161851488|NCT00789035|584498387|FG001|Overall Study|Protocol Violation|0|||
161851489|NCT00789035|584498388|FG002|Overall Study|Protocol Violation|0|||
161851490|NCT00789035|584498389|FG003|Overall Study|Protocol Violation|0|||
161851491|NCT00789035|584498390|FG004|Overall Study|Protocol Violation|0|||
161851492|NCT00789035|584498386|FG000|Overall Study|Withdrawal by Subject|0|||
161851493|NCT00789035|584498387|FG001|Overall Study|Withdrawal by Subject|2|||
161851494|NCT00789035|584498388|FG002|Overall Study|Withdrawal by Subject|0|||
161851495|NCT00789035|584498389|FG003|Overall Study|Withdrawal by Subject|0|||
161851496|NCT00789035|584498390|FG004|Overall Study|Withdrawal by Subject|0|||
161851497|NCT00789035|584498386|FG000|Overall Study|Other reason not defined above|2|||
161851498|NCT00789035|584498387|FG001|Overall Study|Other reason not defined above|3|||
161851499|NCT00789035|584498388|FG002|Overall Study|Other reason not defined above|1|||
161851500|NCT00789035|584498389|FG003|Overall Study|Other reason not defined above|0|||
161851501|NCT00789035|584498390|FG004|Overall Study|Other reason not defined above|1|||
161851502|NCT00362336|584498391|FG000|Overall Study|Serious Adverse Event|1|||
162033839|NCT02477696|585180191|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
161851503|NCT00362336|584498392|FG001|Overall Study|Serious Adverse Event|0|||
161851504|NCT00362336|584498393|FG002|Overall Study|Serious Adverse Event|1|||
161851505|NCT00362336|584498391|FG000|Overall Study|Protocol Violation|0|||
161851506|NCT00362336|584498392|FG001|Overall Study|Protocol Violation|0|||
161851507|NCT00362336|584498393|FG002|Overall Study|Protocol Violation|1|||
161851508|NCT00362336|584498391|FG000|Overall Study|Lost to Follow-up|6|||
161851509|NCT00362336|584498392|FG001|Overall Study|Lost to Follow-up|4|||
162033840|NCT02477696|585180192|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
162033841|NCT02477696|585180191|FG000|Overall Study|Missing/Unknown|2|||
162033842|NCT02477696|585180192|FG001|Overall Study|Missing/Unknown|0|||
162033843|NCT02003365|585181112|FG000|Overall Study|Lost to Follow-up|0|||
162033844|NCT02003365|585181113|FG001|Overall Study|Lost to Follow-up|0|||
162033845|NCT02003365|585181114|FG002|Overall Study|Lost to Follow-up|1|||
162033846|NCT02582255|585181119|FG000|Overall Study|Protocol Violation|0|||
162033847|NCT02582255|585181120|FG001|Overall Study|Protocol Violation|3|||
162033848|NCT01709578|585181121|FG000|Overall Study|Rescued and entered in long term safety|63|||
162033849|NCT01709578|585181122|FG001|Overall Study|Rescued and entered in long term safety|25|||
162033850|NCT01709578|585181123|FG002|Overall Study|Rescued and entered in long term safety|26|||
162033851|NCT01709578|585181121|FG000|Overall Study|Adverse Event|9|||
162033852|NCT01709578|585181122|FG001|Overall Study|Adverse Event|18|||
162033853|NCT01709578|585181123|FG002|Overall Study|Adverse Event|17|||
161973055|NCT04030247|584949501|FG000|Overall Study|Lost to Follow-up|13|||
161973056|NCT01309269|584949504|FG000|Overall Study|Adverse Event|56|||
161973057|NCT01309269|584949504|FG000|Overall Study|Withdrawal by Subject|25|||
161973058|NCT01309269|584949504|FG000|Overall Study|Lack of Acceptance|15|||
161973059|NCT01309269|584949504|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
161973060|NCT01309269|584949504|FG000|Overall Study|Kidney Transplant|25|||
161973061|NCT01309269|584949504|FG000|Overall Study|Administrative Problems|141|||
161973062|NCT01309269|584949504|FG000|Overall Study|Other|256|||
161973063|NCT01309269|584949504|FG000|Overall Study|Other|1|||
161973064|NCT01309269|584949504|FG000|Overall Study|Study Completion Data Not Recorded|95|||
161973065|NCT01309269|584949504|FG000|Overall Study|Enrolled but not Treated|107|||
162033854|NCT01709578|585181121|FG000|Overall Study|Lack of Efficacy|5|||
162033855|NCT01709578|585181122|FG001|Overall Study|Lack of Efficacy|4|||
162033856|NCT01709578|585181123|FG002|Overall Study|Lack of Efficacy|2|||
162033857|NCT01709578|585181121|FG000|Overall Study|Poor compliance to protocol|1|||
162033858|NCT01709578|585181122|FG001|Overall Study|Poor compliance to protocol|2|||
162033859|NCT01709578|585181123|FG002|Overall Study|Poor compliance to protocol|1|||
162033860|NCT01709578|585181121|FG000|Overall Study|Other, not related to safety or efficacy|2|||
162033861|NCT01709578|585181122|FG001|Overall Study|Other, not related to safety or efficacy|7|||
162033862|NCT01709578|585181123|FG002|Overall Study|Other, not related to safety or efficacy|5|||
162033863|NCT04050371|585181124|FG000|Overall Study|Withdrawal by Subject|1|||
162033864|NCT04050371|585181125|FG001|Overall Study|Withdrawal by Subject|0|||
161851510|NCT00362336|584498393|FG002|Overall Study|Lost to Follow-up|0|||
161973066|NCT05079477|584949521|FG000|Overall Study|Lost to Follow-up|2|||
161973067|NCT05079477|584949522|FG001|Overall Study|Lost to Follow-up|0|||
161973068|NCT05079477|584949521|FG000|Overall Study|Withdrawal by Subject|1|||
161973069|NCT05079477|584949522|FG001|Overall Study|Withdrawal by Subject|0|||
161973070|NCT05079477|584949521|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
161973071|NCT05079477|584949522|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
161973072|NCT05079477|584949521|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
161973073|NCT05079477|584949522|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
161973074|NCT02091284|584949523|FG000|Overall Study|Withdrawal by Subject|2|||
161973075|NCT02091284|584949524|FG001|Overall Study|Withdrawal by Subject|1|||
161973076|NCT02091284|584949523|FG000|Overall Study|unreliable data|1|||
161973077|NCT02091284|584949524|FG001|Overall Study|unreliable data|0|||
161973078|NCT01703117|584949530|FG000|Overall Study|Adverse Event|4|||
161973079|NCT01703117|584949531|FG001|Overall Study|Adverse Event|3|||
161973080|NCT01703117|584949530|FG000|Overall Study|Withdrawal by Subject|0|||
161973081|NCT01703117|584949531|FG001|Overall Study|Withdrawal by Subject|1|||
161851511|NCT00362336|584498391|FG000|Overall Study|Withdrawal by Subject|3|||
161851512|NCT00362336|584498392|FG001|Overall Study|Withdrawal by Subject|3|||
161851513|NCT00362336|584498393|FG002|Overall Study|Withdrawal by Subject|1|||
161851514|NCT04414618|584498394|FG000|Overall Study|Death|3|||
161851515|NCT04414618|584498395|FG001|Overall Study|Death|3|||
161851516|NCT04414618|584498394|FG000|Overall Study|Withdrawal by Subject|2|||
161851517|NCT04414618|584498395|FG001|Overall Study|Withdrawal by Subject|1|||
161851518|NCT04414618|584498394|FG000|Overall Study|Lost to Follow-up|2|||
161851519|NCT04414618|584498395|FG001|Overall Study|Lost to Follow-up|3|||
161973082|NCT00096174|584949533|FG000|Overall Study|Lack of Efficacy|9|||
161973083|NCT00096174|584949533|FG000|Overall Study|Adverse Event|15|||
161973084|NCT00096174|584949533|FG000|Overall Study|Death|6|||
161973085|NCT00096174|584949533|FG000|Overall Study|Withdrawal by Subject|15|||
162033865|NCT00597701|585181126|FG000|Overall Study|Withdrawal by Subject|5|||
162033866|NCT00597701|585181127|FG001|Overall Study|Withdrawal by Subject|5|||
161973086|NCT00096174|584949533|FG000|Overall Study|Not started protocol therapy|3|||
162033867|NCT00597701|585181126|FG000|Overall Study|Death|0|||
162033868|NCT00597701|585181127|FG001|Overall Study|Death|1|||
162033869|NCT00597701|585181126|FG000|Overall Study|Physician Decision|2|||
161851520|NCT04414618|584498394|FG000|Overall Study|Physician Decision|1|||
161973087|NCT00096174|584949533|FG000|Overall Study|Ineligible|6|||
161973088|NCT00096174|584949533|FG000|Overall Study|other reason|8|||
161973089|NCT00330928|584949539|FG000|Overall Study|Lost to Follow-up|6|||
161973090|NCT00330928|584949539|FG000|Overall Study|Physician Decision|9|||
161973091|NCT00330928|584949539|FG000|Overall Study|Death|1|||
161973092|NCT00330928|584949539|FG000|Overall Study|IVUS could not be performed.|1|||
161973093|NCT03028480|584949540|FG000|Overall Study|No revisit after the first prescription date|2|||
161973094|NCT03028480|584949540|FG000|Overall Study|Did not use the drug|1|||
161973095|NCT03028480|584949540|FG000|Overall Study|Violation of the enrollment deadline|10|||
161973096|NCT03028480|584949540|FG000|Overall Study|Case report forms were not collected|21|||
161973097|NCT00759356|584949545|FG000|Overall Study|Adverse Event|0|||
161973098|NCT00759356|584949546|FG001|Overall Study|Adverse Event|1|||
161973099|NCT00759356|584949545|FG000|Overall Study|Withdrawal by Subject|0|||
161764627|NCT00082628|584178867|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
161764628|NCT00082628|584178868|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
161764629|NCT00082628|584178869|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
161764630|NCT00082628|584178870|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
161764631|NCT00082628|584178866|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
161764632|NCT00082628|584178867|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
161764633|NCT00082628|584178868|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
161764634|NCT00082628|584178869|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
161764635|NCT00082628|584178870|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
161764636|NCT00082628|584178866|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
161764637|NCT00082628|584178867|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
161764638|NCT00082628|584178868|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
161764639|NCT00082628|584178869|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
161764640|NCT00082628|584178870|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
161764641|NCT00082628|584178866|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
161764642|NCT00082628|584178867|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
161764643|NCT00082628|584178868|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
161764644|NCT00082628|584178869|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
161764645|NCT00082628|584178870|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
161764646|NCT00082628|584178866|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
161764647|NCT00082628|584178867|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
161764648|NCT00082628|584178868|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
161764649|NCT00082628|584178869|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
161764650|NCT00082628|584178870|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
161764651|NCT03481634|584178873|FG000|Overall Study|Withdrawal by Subject|16|||
161764652|NCT03481634|584178874|FG001|Overall Study|Withdrawal by Subject|19|||
161764653|NCT03481634|584178875|FG002|Overall Study|Withdrawal by Subject|14|||
161764654|NCT03481634|584178873|FG000|Overall Study|Protocol Violation|1|||
161764655|NCT03481634|584178874|FG001|Overall Study|Protocol Violation|0|||
161764656|NCT03481634|584178875|FG002|Overall Study|Protocol Violation|1|||
161764657|NCT03481634|584178873|FG000|Overall Study|Progressive disease|0|||
161764658|NCT03481634|584178874|FG001|Overall Study|Progressive disease|1|||
161764659|NCT03481634|584178875|FG002|Overall Study|Progressive disease|0|||
161764660|NCT03481634|584178873|FG000|Overall Study|Physician Decision|3|||
161764661|NCT03481634|584178874|FG001|Overall Study|Physician Decision|0|||
161764662|NCT03481634|584178875|FG002|Overall Study|Physician Decision|1|||
161764663|NCT03481634|584178873|FG000|Overall Study|Lost to Follow-up|3|||
161764664|NCT03481634|584178874|FG001|Overall Study|Lost to Follow-up|4|||
161764665|NCT03481634|584178875|FG002|Overall Study|Lost to Follow-up|4|||
161764666|NCT03481634|584178873|FG000|Overall Study|Death|4|||
161764667|NCT03481634|584178874|FG001|Overall Study|Death|8|||
161764668|NCT03481634|584178875|FG002|Overall Study|Death|7|||
161764669|NCT03481634|584178873|FG000|Overall Study|Adverse Event|6|||
161764670|NCT03481634|584178874|FG001|Overall Study|Adverse Event|3|||
161764671|NCT03481634|584178875|FG002|Overall Study|Adverse Event|7|||
161764672|NCT00352027|584178878|FG000|Overall Study|Progressive disease|3|||
161764673|NCT04118127|584178879|FG000|Overall Study|Trial terminated by sponsor|0|||
161764674|NCT04118127|584178880|FG001|Overall Study|Trial terminated by sponsor|12|||
161764675|NCT04118127|584178879|FG000|Overall Study|Adverse Event|1|||
161764676|NCT04118127|584178880|FG001|Overall Study|Adverse Event|2|||
161764677|NCT04118127|584178879|FG000|Overall Study|Physician Decision|0|||
161764678|NCT04118127|584178880|FG001|Overall Study|Physician Decision|1|||
161764679|NCT04118127|584178879|FG000|Overall Study|Withdrawal by Subject|2|||
161764680|NCT04118127|584178880|FG001|Overall Study|Withdrawal by Subject|1|||
161764681|NCT01874288|584178881|FG000|Overall Study|Withdrawal by Subject|1|||
161764682|NCT01874288|584178882|FG001|Overall Study|Withdrawal by Subject|0|||
161764683|NCT01874288|584178883|FG002|Overall Study|Withdrawal by Subject|2|||
161764684|NCT01874288|584178884|FG003|Overall Study|Withdrawal by Subject|1|||
161973100|NCT00759356|584949546|FG001|Overall Study|Withdrawal by Subject|2|||
161973101|NCT00759356|584949545|FG000|Overall Study|Subject was unable to return|1|||
161851521|NCT04414618|584498395|FG001|Overall Study|Physician Decision|0|||
161851522|NCT00658879|584498396|FG000|Overall Study|Protocol Violation|1|||
161851523|NCT02640690|584498397|FG000|Overall Study|Lost to Follow-up|7|||
161851524|NCT02640690|584498398|FG001|Overall Study|Lost to Follow-up|7|||
161851525|NCT02640690|584498397|FG000|Overall Study|Withdrawal by Subject|16|||
161851526|NCT02640690|584498398|FG001|Overall Study|Withdrawal by Subject|20|||
161851527|NCT02640690|584498397|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
161851528|NCT02640690|584498398|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
161851529|NCT01520870|584498399|FG000|Overall Study|Withdrawal by Subject|2|||
161851530|NCT01645787|584498400|FG000|Washout (2 Weeks)|Adverse Event|1|||
161851531|NCT01645787|584498401|FG001|Washout (2 Weeks)|Adverse Event|0|||
161851532|NCT02289456|584498402|FG000|Induction Period|Death|2|||
161851533|NCT02289456|584498402|FG000|Induction Period|Adverse Event|11|||
161851534|NCT02289456|584498402|FG000|Induction Period|Progressive Disease (PD)|4|||
161851535|NCT02289456|584498402|FG000|Induction Period|Symptomatic Deterioration|4|||
161851536|NCT02289456|584498402|FG000|Induction Period|Withdrawal by Subject|2|||
161851537|NCT02289456|584498402|FG000|Induction Period|Miscellaneous|1|||
161851538|NCT02289456|584498402|FG000|Monotherapy Period|Death|1|||
161851539|NCT02289456|584498402|FG000|Monotherapy Period|Adverse Event|1|||
161851540|NCT02289456|584498402|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
161851541|NCT02289456|584498402|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
161851542|NCT02289456|584498402|FG000|Monotherapy Period|Withdrawal by Subject|2|||
161851543|NCT02289456|584498402|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
161851544|NCT02289456|584498402|FG000|Monotherapy Period|Miscellaneous|1|||
161851545|NCT02806024|584498404|FG000|Overall Study|Night Delivery|1|||
161851546|NCT02806024|584498405|FG001|Overall Study|Night Delivery|1|||
161851547|NCT02806024|584498404|FG000|Overall Study|DVT during antepartum admission|0|||
161851548|NCT02806024|584498405|FG001|Overall Study|DVT during antepartum admission|1|||
161851549|NCT01098474|584498406|FG000|Active Phase|Other|0|||
161851550|NCT01098474|584498407|FG001|Active Phase|Other|0|||
161851551|NCT01098474|584498408|FG002|Active Phase|Other|3|||
161851552|NCT01098474|584498409|FG003|Active Phase|Other|0|||
161851553|NCT01098474|584498410|FG004|Active Phase|Other|0|||
161851554|NCT01098474|584498411|FG005|Active Phase|Other|0|||
161851555|NCT01098474|584498406|FG000|Active Phase|Withdrawal by Subject|1|||
161851556|NCT01098474|584498407|FG001|Active Phase|Withdrawal by Subject|1|||
161851557|NCT01098474|584498408|FG002|Active Phase|Withdrawal by Subject|2|||
161851558|NCT01098474|584498409|FG003|Active Phase|Withdrawal by Subject|0|||
161851559|NCT01098474|584498410|FG004|Active Phase|Withdrawal by Subject|0|||
161851560|NCT01098474|584498411|FG005|Active Phase|Withdrawal by Subject|0|||
161851561|NCT01098474|584498406|FG000|Active Phase|Lost to Follow-up|1|||
161851562|NCT01098474|584498407|FG001|Active Phase|Lost to Follow-up|0|||
161851563|NCT01098474|584498408|FG002|Active Phase|Lost to Follow-up|0|||
161851564|NCT01098474|584498409|FG003|Active Phase|Lost to Follow-up|0|||
161851565|NCT01098474|584498410|FG004|Active Phase|Lost to Follow-up|0|||
161851566|NCT01098474|584498411|FG005|Active Phase|Lost to Follow-up|0|||
161851567|NCT01098474|584498406|FG000|Follow Up Phase|Travelled out of study area|0|||
161851568|NCT01098474|584498407|FG001|Follow Up Phase|Travelled out of study area|0|||
161851569|NCT01098474|584498408|FG002|Follow Up Phase|Travelled out of study area|0|||
161851570|NCT01098474|584498409|FG003|Follow Up Phase|Travelled out of study area|0|||
161851571|NCT01098474|584498410|FG004|Follow Up Phase|Travelled out of study area|1|||
161851572|NCT01098474|584498411|FG005|Follow Up Phase|Travelled out of study area|0|||
161851573|NCT01098474|584498406|FG000|Follow Up Phase|Other|0|||
161851574|NCT01098474|584498407|FG001|Follow Up Phase|Other|0|||
161851575|NCT01098474|584498408|FG002|Follow Up Phase|Other|0|||
161851576|NCT01098474|584498409|FG003|Follow Up Phase|Other|0|||
161851577|NCT01098474|584498410|FG004|Follow Up Phase|Other|0|||
161851578|NCT01098474|584498411|FG005|Follow Up Phase|Other|4|||
161851579|NCT01098474|584498406|FG000|Follow Up Phase|Withdrawal by Subject|0|||
161851580|NCT01098474|584498407|FG001|Follow Up Phase|Withdrawal by Subject|0|||
161851581|NCT01098474|584498408|FG002|Follow Up Phase|Withdrawal by Subject|0|||
161851582|NCT01098474|584498409|FG003|Follow Up Phase|Withdrawal by Subject|2|||
161851583|NCT01098474|584498410|FG004|Follow Up Phase|Withdrawal by Subject|0|||
161851584|NCT01098474|584498411|FG005|Follow Up Phase|Withdrawal by Subject|1|||
161851585|NCT01098474|584498406|FG000|Follow Up Phase|Lost to Follow-up|0|||
161851586|NCT01098474|584498407|FG001|Follow Up Phase|Lost to Follow-up|0|||
161851587|NCT01098474|584498408|FG002|Follow Up Phase|Lost to Follow-up|0|||
161851588|NCT01098474|584498409|FG003|Follow Up Phase|Lost to Follow-up|0|||
161851589|NCT01098474|584498410|FG004|Follow Up Phase|Lost to Follow-up|1|||
161851590|NCT01098474|584498411|FG005|Follow Up Phase|Lost to Follow-up|0|||
161851591|NCT02797171|584498412|FG000|Overall Study|Lost to Follow-up|2|||
161851592|NCT02797171|584498413|FG001|Overall Study|Lost to Follow-up|0|||
161851593|NCT02797171|584498414|FG002|Overall Study|Lost to Follow-up|2|||
161851594|NCT02797171|584498415|FG003|Overall Study|Lost to Follow-up|1|||
161851595|NCT02797171|584498416|FG004|Overall Study|Lost to Follow-up|2|||
161851596|NCT02797171|584498417|FG005|Overall Study|Lost to Follow-up|0|||
161851597|NCT02797171|584498412|FG000|Overall Study|Withdrawal by Subject|1|||
161851598|NCT02797171|584498413|FG001|Overall Study|Withdrawal by Subject|1|||
161851599|NCT02797171|584498414|FG002|Overall Study|Withdrawal by Subject|0|||
161851600|NCT02797171|584498415|FG003|Overall Study|Withdrawal by Subject|0|||
161851601|NCT02797171|584498416|FG004|Overall Study|Withdrawal by Subject|0|||
161851602|NCT02797171|584498417|FG005|Overall Study|Withdrawal by Subject|0|||
161851603|NCT02797171|584498412|FG000|Overall Study|Protocol Violation|1|||
161851604|NCT02797171|584498413|FG001|Overall Study|Protocol Violation|0|||
161851605|NCT02797171|584498414|FG002|Overall Study|Protocol Violation|0|||
161851606|NCT02797171|584498415|FG003|Overall Study|Protocol Violation|0|||
161851607|NCT02797171|584498416|FG004|Overall Study|Protocol Violation|0|||
161851608|NCT02797171|584498417|FG005|Overall Study|Protocol Violation|0|||
161851609|NCT02797171|584498412|FG000|Overall Study|Participant unable to adhere|0|||
161851610|NCT02797171|584498413|FG001|Overall Study|Participant unable to adhere|1|||
161851611|NCT02797171|584498414|FG002|Overall Study|Participant unable to adhere|0|||
161851612|NCT02797171|584498415|FG003|Overall Study|Participant unable to adhere|0|||
161851613|NCT02797171|584498416|FG004|Overall Study|Participant unable to adhere|0|||
161851614|NCT02797171|584498417|FG005|Overall Study|Participant unable to adhere|0|||
161851615|NCT02797171|584498412|FG000|Overall Study|Not Randomized|0|||
161851616|NCT02797171|584498413|FG001|Overall Study|Not Randomized|0|||
161851617|NCT02797171|584498414|FG002|Overall Study|Not Randomized|0|||
161851618|NCT02797171|584498415|FG003|Overall Study|Not Randomized|0|||
161851619|NCT02797171|584498416|FG004|Overall Study|Not Randomized|0|||
161851620|NCT02797171|584498417|FG005|Overall Study|Not Randomized|1|||
161851621|NCT00626561|584498418|FG000|Overall Study|Withdrawal by Subject|2|||
161851622|NCT00626561|584498418|FG000|Overall Study|Disease Progression|2|||
161851623|NCT01372748|584498423|FG000|Overall Study|Lost to Follow-up|16|||
161851624|NCT01372748|584498424|FG001|Overall Study|Lost to Follow-up|34|||
161851625|NCT01372748|584498423|FG000|Overall Study|Withdrawal by Subject|7|||
161851626|NCT01372748|584498424|FG001|Overall Study|Withdrawal by Subject|5|||
161851627|NCT00134901|584498425|FG000|Overall Study|Lost to Follow-up|5|||
161851628|NCT00134901|584498426|FG001|Overall Study|Lost to Follow-up|5|||
161851629|NCT00134901|584498425|FG000|Overall Study|discontinued intervention|12|||
161851630|NCT00134901|584498426|FG001|Overall Study|discontinued intervention|10|||
161851631|NCT00606632|584498427|FG000|Overall Study|Withdrawal by Subject|13|||
161851632|NCT00606632|584498427|FG000|Overall Study|Miscellaneous reasons|9|||
161851633|NCT00711880|584498428|FG000|Overall Study|Adverse Event|11|||
161851634|NCT00711880|584498429|FG001|Overall Study|Adverse Event|2|||
161851635|NCT00711880|584498428|FG000|Overall Study|Patient non-compliance|1|||
161851636|NCT00711880|584498429|FG001|Overall Study|Patient non-compliance|0|||
161851637|NCT00711880|584498428|FG000|Overall Study|Lack of Efficacy|1|||
161851638|NCT00711880|584498429|FG001|Overall Study|Lack of Efficacy|5|||
161851639|NCT03908437|584498430|FG000|Overall Study|Death|0|||
161851640|NCT03908437|584498431|FG001|Overall Study|Death|1|||
161851641|NCT03908437|584498430|FG000|Overall Study|Lost to Follow-up|31|||
161851642|NCT03908437|584498431|FG001|Overall Study|Lost to Follow-up|24|||
161851643|NCT03633825|584498432|FG000|Enrollment|Did not post on network|5066|||
161851644|NCT03633825|584498433|FG001|Enrollment|Did not post on network|5080|||
161851645|NCT03633825|584498432|FG000|Enrollment|Post not classified as crisis|13967|||
161851646|NCT03633825|584498433|FG001|Enrollment|Post not classified as crisis|13757|||
161851647|NCT03633825|584498432|FG000|Follow up|Lost to Follow-up|478|||
161851648|NCT03633825|584498433|FG001|Follow up|Lost to Follow-up|450|||
161851649|NCT04841577|584498434|FG000|Overall Study|Adverse Event|5|||
161851650|NCT04841577|584498435|FG001|Overall Study|Adverse Event|10|||
161851651|NCT04841577|584498434|FG000|Overall Study|Lost to Follow-up|8|||
161851652|NCT04841577|584498435|FG001|Overall Study|Lost to Follow-up|7|||
161851653|NCT04841577|584498434|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
161973102|NCT00759356|584949546|FG001|Overall Study|Subject was unable to return|0|||
161973103|NCT02403635|584949549|FG000|Overall Study|Not eligible|9|||
161973104|NCT02509052|584949555|FG000|Overall Study|Non compliance|0|||
161973105|NCT02509052|584949556|FG001|Overall Study|Non compliance|0|||
161973106|NCT02509052|584949557|FG002|Overall Study|Non compliance|1|||
161973107|NCT00585221|584949558|FG000|Overall Study|Protocol Violation|8|||
161973108|NCT03554772|584949561|FG000|Overall Study|Lost to Follow-up|0|||
161973109|NCT03554772|584949562|FG001|Overall Study|Lost to Follow-up|0|||
161973110|NCT03554772|584949563|FG002|Overall Study|Lost to Follow-up|0|||
161973111|NCT03554772|584949564|FG003|Overall Study|Lost to Follow-up|2|||
161851654|NCT04841577|584498435|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
161851655|NCT04841577|584498434|FG000|Overall Study|Other|0|||
161851656|NCT04841577|584498435|FG001|Overall Study|Other|1|||
161851657|NCT05246670|584498438|FG000|Overall Study|Withdrawal by Subject|2|||
161851658|NCT05246670|584498439|FG001|Overall Study|Withdrawal by Subject|3|||
161851659|NCT05246670|584498440|FG002|Overall Study|Withdrawal by Subject|0|||
161851660|NCT05246670|584498441|FG003|Overall Study|Withdrawal by Subject|1|||
161851661|NCT05246670|584498438|FG000|Overall Study|Adverse Event|0|||
161851662|NCT05246670|584498439|FG001|Overall Study|Adverse Event|0|||
161973112|NCT00694096|584949565|FG000|Overall Study|Withdrawal by Subject|5|||
162033870|NCT00597701|585181127|FG001|Overall Study|Physician Decision|0|||
161973113|NCT02680574|584949572|FG000|Overall Study|Death|137|||
161973114|NCT02680574|584949573|FG001|Overall Study|Death|137|||
161851663|NCT05246670|584498440|FG002|Overall Study|Adverse Event|1|||
161851664|NCT05246670|584498441|FG003|Overall Study|Adverse Event|0|||
161851665|NCT05246670|584498438|FG000|Overall Study|Physician Decision|1|||
161851666|NCT05246670|584498439|FG001|Overall Study|Physician Decision|0|||
161851667|NCT05246670|584498440|FG002|Overall Study|Physician Decision|0|||
161851668|NCT05246670|584498441|FG003|Overall Study|Physician Decision|0|||
161851669|NCT05246670|584498438|FG000|Overall Study|Protocol Violation|1|||
161851670|NCT05246670|584498439|FG001|Overall Study|Protocol Violation|0|||
161851671|NCT05246670|584498440|FG002|Overall Study|Protocol Violation|0|||
161851672|NCT05246670|584498441|FG003|Overall Study|Protocol Violation|0|||
161851673|NCT00356525|584498442|FG000|Overall Study|Progressive Disease|8|||
161851674|NCT00356525|584498443|FG001|Overall Study|Progressive Disease|5|||
161851675|NCT00356525|584498444|FG002|Overall Study|Progressive Disease|4|||
161851676|NCT00356525|584498445|FG003|Overall Study|Progressive Disease|2|||
161851677|NCT00356525|584498442|FG000|Overall Study|Adverse Event|1|||
161851678|NCT00356525|584498443|FG001|Overall Study|Adverse Event|3|||
161851679|NCT00356525|584498444|FG002|Overall Study|Adverse Event|1|||
161851680|NCT00356525|584498445|FG003|Overall Study|Adverse Event|1|||
161851681|NCT00356525|584498442|FG000|Overall Study|Lost to Follow-up|1|||
161851682|NCT00356525|584498443|FG001|Overall Study|Lost to Follow-up|0|||
161851683|NCT00356525|584498444|FG002|Overall Study|Lost to Follow-up|0|||
161973115|NCT02680574|584949572|FG000|Overall Study|Withdrawal by Subject|17|||
161973116|NCT02680574|584949573|FG001|Overall Study|Withdrawal by Subject|9|||
161973117|NCT02680574|584949572|FG000|Overall Study|Lost to Follow-up|4|||
161973118|NCT02680574|584949573|FG001|Overall Study|Lost to Follow-up|6|||
161851684|NCT00356525|584498445|FG003|Overall Study|Lost to Follow-up|0|||
161851685|NCT00356525|584498442|FG000|Overall Study|Physician Decision|2|||
161851686|NCT00356525|584498443|FG001|Overall Study|Physician Decision|2|||
161851687|NCT00356525|584498444|FG002|Overall Study|Physician Decision|2|||
161851688|NCT00356525|584498445|FG003|Overall Study|Physician Decision|1|||
161851689|NCT00356525|584498442|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
161851690|NCT00356525|584498443|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
161851691|NCT00356525|584498444|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
161851692|NCT00356525|584498445|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
161851693|NCT00356525|584498442|FG000|Overall Study|Withdrawal by Subject|1|||
161851694|NCT00356525|584498443|FG001|Overall Study|Withdrawal by Subject|1|||
161851695|NCT00356525|584498444|FG002|Overall Study|Withdrawal by Subject|0|||
161851696|NCT00356525|584498445|FG003|Overall Study|Withdrawal by Subject|3|||
161851697|NCT00356525|584498442|FG000|Overall Study|Death|0|||
161851698|NCT00356525|584498443|FG001|Overall Study|Death|0|||
161851699|NCT00356525|584498444|FG002|Overall Study|Death|0|||
161851700|NCT00356525|584498445|FG003|Overall Study|Death|1|||
161851701|NCT00356525|584498442|FG000|Overall Study|Sponsor Decision|0|||
161851702|NCT00356525|584498443|FG001|Overall Study|Sponsor Decision|0|||
161851703|NCT00356525|584498444|FG002|Overall Study|Sponsor Decision|0|||
161851704|NCT00356525|584498445|FG003|Overall Study|Sponsor Decision|1|||
161851705|NCT00652340|584498446|FG000|Overall Study|Had not progressed.|4|||
161851706|NCT00652340|584498447|FG001|Overall Study|Had not progressed.|3|||
161851707|NCT00214383|584498450|FG000|Overall Study|Lost to Follow-up|16|||
161851708|NCT00214383|584498451|FG001|Overall Study|Lost to Follow-up|26|||
161851709|NCT04152291|584498452|FG000|Overall Study|Covid-19 restrictions|27|||
161851710|NCT04152291|584498452|FG000|Overall Study|Withdrawal by Subject|3|||
161851711|NCT03597295|584498453|FG000|Overall Study|Death|70|||
161851712|NCT03597295|584498453|FG000|Overall Study|Lost to Follow-up|7|||
161851713|NCT00879411|584498454|FG000|Overall Study|lost to follow-up (non-AE)|162|||
161851714|NCT05124691|584498455|FG000|Phase II|Eligibility criteria|0|||
161851715|NCT05124691|584498456|FG001|Phase II|Eligibility criteria|1|||
161851716|NCT05124691|584498457|FG002|Phase II|Eligibility criteria|0|||
161851717|NCT05124691|584498455|FG000|Phase II|Withdrawal by Subject|6|||
161851718|NCT05124691|584498456|FG001|Phase II|Withdrawal by Subject|2|||
161851719|NCT05124691|584498457|FG002|Phase II|Withdrawal by Subject|3|||
161973119|NCT02078102|584949579|FG000|Overall Study|Adverse Event|1|||
161851720|NCT05124691|584498455|FG000|Phase III|Withdrawal by Subject|6|||
161851721|NCT05124691|584498456|FG001|Phase III|Withdrawal by Subject|4|||
161851722|NCT05124691|584498457|FG002|Phase III|Withdrawal by Subject|4|||
161851723|NCT05124691|584498455|FG000|Phase III|Lost to Follow-up|1|||
161851724|NCT05124691|584498456|FG001|Phase III|Lost to Follow-up|0|||
161851725|NCT05124691|584498457|FG002|Phase III|Lost to Follow-up|0|||
161851726|NCT00428116|584498458|FG000|Overall Study|Death|1|||
161851727|NCT00428116|584498459|FG001|Overall Study|Death|0|||
161851728|NCT00428116|584498458|FG000|Overall Study|Withdrawal by Subject|1|||
161851729|NCT00428116|584498459|FG001|Overall Study|Withdrawal by Subject|0|||
161851730|NCT00428116|584498458|FG000|Overall Study|Lost to Follow-up|1|||
161851731|NCT00428116|584498459|FG001|Overall Study|Lost to Follow-up|0|||
161851732|NCT01890434|584498460|FG000|Overall Study|Adverse Event|8|||
161851733|NCT01890434|584498460|FG000|Overall Study|PCI at external hospital|1|||
161851734|NCT01890434|584498460|FG000|Overall Study|Assessment discrepancy|1|||
161851735|NCT01890434|584498460|FG000|Overall Study|CRC didn't contact participant for FU|1|||
161851736|NCT01890434|584498460|FG000|Overall Study|Could not get whole set of images|1|||
161973120|NCT02078102|584949580|FG001|Overall Study|Adverse Event|0|||
161973121|NCT02078102|584949579|FG000|Overall Study|Withdrawal by Subject|1|||
161764685|NCT01874288|584178885|FG004|Overall Study|Withdrawal by Subject|1|||
161764686|NCT01874288|584178881|FG000|Overall Study|Physician Decision|0|||
161764687|NCT01874288|584178882|FG001|Overall Study|Physician Decision|0|||
161764688|NCT01874288|584178883|FG002|Overall Study|Physician Decision|0|||
161764689|NCT01874288|584178884|FG003|Overall Study|Physician Decision|1|||
161764690|NCT01874288|584178885|FG004|Overall Study|Physician Decision|0|||
161764691|NCT01874288|584178881|FG000|Overall Study|Progressive disease|2|||
161764692|NCT01874288|584178882|FG001|Overall Study|Progressive disease|0|||
161764693|NCT01874288|584178883|FG002|Overall Study|Progressive disease|3|||
161764694|NCT01874288|584178884|FG003|Overall Study|Progressive disease|5|||
161764695|NCT01874288|584178885|FG004|Overall Study|Progressive disease|1|||
161764696|NCT03099304|584178886|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
161764697|NCT03099304|584178887|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
161764698|NCT03099304|584178888|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
161764699|NCT03099304|584178889|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
161764700|NCT03099304|584178890|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
161764701|NCT03099304|584178891|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
161764702|NCT03099304|584178886|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
161764703|NCT03099304|584178887|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
161764704|NCT03099304|584178888|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
161764705|NCT03099304|584178889|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
161764706|NCT03099304|584178890|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
161764707|NCT03099304|584178891|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
161764708|NCT03099304|584178886|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
161764709|NCT03099304|584178887|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
161764710|NCT03099304|584178888|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
161764711|NCT03099304|584178889|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
161764712|NCT03099304|584178890|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
161764713|NCT03099304|584178891|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
161764714|NCT03099304|584178886|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
161764715|NCT03099304|584178887|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
161764716|NCT03099304|584178888|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
161764717|NCT03099304|584178889|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
161764718|NCT03099304|584178890|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
161764719|NCT03099304|584178891|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
161764720|NCT03099304|584178886|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
161764721|NCT03099304|584178887|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
161764722|NCT03099304|584178888|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
161764723|NCT03099304|584178889|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
161764724|NCT03099304|584178890|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
161764725|NCT03099304|584178891|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
161764726|NCT03099304|584178886|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161764727|NCT03099304|584178887|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161764728|NCT03099304|584178888|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
161764729|NCT03099304|584178889|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161764730|NCT03099304|584178890|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161764731|NCT03099304|584178891|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161764732|NCT03099304|584178886|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
161764733|NCT03099304|584178887|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
161764734|NCT03099304|584178888|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
161764735|NCT03099304|584178889|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
161764736|NCT03099304|584178890|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
161764737|NCT03099304|584178891|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
161764738|NCT03099304|584178886|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
161764739|NCT03099304|584178887|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
161764740|NCT03099304|584178888|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
161764741|NCT03099304|584178889|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
161764742|NCT03099304|584178890|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
161764743|NCT03099304|584178891|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
161764744|NCT03099304|584178886|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
161764745|NCT03099304|584178887|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
161764746|NCT03099304|584178888|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
161764747|NCT03099304|584178889|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
161764748|NCT03099304|584178890|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
161764749|NCT03099304|584178891|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
161764750|NCT03099304|584178886|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
161764751|NCT03099304|584178887|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
161764752|NCT03099304|584178888|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
161764753|NCT03099304|584178889|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
161764754|NCT03099304|584178890|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
161764755|NCT03099304|584178891|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
161764756|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
161764757|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
161764758|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
161764759|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
161764760|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
161764761|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
161764762|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
161764763|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
161764764|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
161764765|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
161764766|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
161764767|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
161764768|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
161764769|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
161764770|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
161764771|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
161764772|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
161764773|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
161764774|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
161764775|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
161764776|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
161764777|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
161764778|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
161764779|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
161764780|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
161764781|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
161764782|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
161764783|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
161764784|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
161764785|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
161764786|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
161764787|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
161764788|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
161764789|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
161764790|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
161764791|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
161764792|NCT03099304|584178886|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
161764793|NCT03099304|584178887|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
161764794|NCT03099304|584178888|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
161764795|NCT03099304|584178889|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
161764796|NCT03099304|584178890|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
161764797|NCT03099304|584178891|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
161764798|NCT00636506|584178892|FG000|Overall Study|Lost to Follow-up|8|||
161764799|NCT00636506|584178892|FG000|Overall Study|Explanted|1|||
161764800|NCT00636506|584178892|FG000|Overall Study|Withdrawal by Subject|6|||
161764801|NCT00636506|584178892|FG000|Overall Study|Procedure aborted|1|||
161764802|NCT01624974|584178893|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
161764803|NCT01624974|584178894|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
161764804|NCT01624974|584178893|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
161764805|NCT01624974|584178894|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
161764806|NCT01624974|584178893|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
161764807|NCT01624974|584178894|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
161764808|NCT01624974|584178893|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
161764809|NCT01624974|584178894|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
161764810|NCT01624974|584178893|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
161764811|NCT01624974|584178894|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
161764812|NCT01624974|584178893|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
161764813|NCT01624974|584178894|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
161764814|NCT01624974|584178893|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
161764815|NCT01624974|584178894|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
161764816|NCT01624974|584178893|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
161764817|NCT01624974|584178894|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
161764818|NCT01624974|584178893|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
161764819|NCT01624974|584178894|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
161764820|NCT01624974|584178893|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
161764821|NCT01624974|584178894|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
161851737|NCT01890434|584498460|FG000|Overall Study|Decline to return for GSPECT|1|||
161851738|NCT01890434|584498460|FG000|Overall Study|GSPECT at rest was not done|1|||
161851739|NCT01890434|584498460|FG000|Overall Study|Participant didn't complete MRI|1|||
161851740|NCT01890434|584498460|FG000|Overall Study|Uncontactable by phone|1|||
161851741|NCT01890434|584498460|FG000|Overall Study|Moved out of position|1|||
161851742|NCT01890434|584498460|FG000|Overall Study|Unable to contact|1|||
161851743|NCT01890434|584498460|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
161851744|NCT02257385|584498466|FG000|Overall Study|Adverse Event|12|||
161851745|NCT02257385|584498467|FG001|Overall Study|Adverse Event|8|||
161851746|NCT02257385|584498466|FG000|Overall Study|Lack of Efficacy|1|||
161851747|NCT02257385|584498467|FG001|Overall Study|Lack of Efficacy|2|||
161851748|NCT02257385|584498466|FG000|Overall Study|Protocol Violation|5|||
161851749|NCT02257385|584498467|FG001|Overall Study|Protocol Violation|7|||
161851750|NCT02257385|584498466|FG000|Overall Study|Lost to Follow-up|0|||
161851751|NCT02257385|584498467|FG001|Overall Study|Lost to Follow-up|1|||
161851752|NCT02257385|584498466|FG000|Overall Study|Withdrawal by Subject|4|||
161851753|NCT02257385|584498467|FG001|Overall Study|Withdrawal by Subject|4|||
161851754|NCT01449370|584498474|FG000|Overall Study|Disease Progression|5|||
161851755|NCT01449370|584498475|FG001|Overall Study|Disease Progression|4|||
161851756|NCT01449370|584498476|FG002|Overall Study|Disease Progression|8|||
161851757|NCT01449370|584498477|FG003|Overall Study|Disease Progression|3|||
161851758|NCT01449370|584498478|FG004|Overall Study|Disease Progression|3|||
161851759|NCT01449370|584498479|FG005|Overall Study|Disease Progression|3|||
161851760|NCT01449370|584498480|FG006|Overall Study|Disease Progression|3|||
161851761|NCT01449370|584498481|FG007|Overall Study|Disease Progression|2|||
161851762|NCT01449370|584498482|FG008|Overall Study|Disease Progression|9|||
161851763|NCT01449370|584498483|FG009|Overall Study|Disease Progression|1|||
161851764|NCT01449370|584498484|FG010|Overall Study|Disease Progression|3|||
161851765|NCT01449370|584498485|FG011|Overall Study|Disease Progression|3|||
161851766|NCT01449370|584498486|FG012|Overall Study|Disease Progression|2|||
161851767|NCT01449370|584498487|FG013|Overall Study|Disease Progression|8|||
161851768|NCT01449370|584498488|FG014|Overall Study|Disease Progression|3|||
161851769|NCT01449370|584498489|FG015|Overall Study|Disease Progression|1|||
161851770|NCT01449370|584498490|FG016|Overall Study|Disease Progression|4|||
161851771|NCT01449370|584498491|FG017|Overall Study|Disease Progression|3|||
161851772|NCT01449370|584498492|FG018|Overall Study|Disease Progression|1|||
161851773|NCT01449370|584498493|FG019|Overall Study|Disease Progression|2|||
161851774|NCT01449370|584498494|FG020|Overall Study|Disease Progression|5|||
161851775|NCT01449370|584498495|FG021|Overall Study|Disease Progression|2|||
161851776|NCT01449370|584498496|FG022|Overall Study|Disease Progression|3|||
161851777|NCT01449370|584498497|FG023|Overall Study|Disease Progression|7|||
161851778|NCT01449370|584498498|FG024|Overall Study|Disease Progression|3|||
161851779|NCT01449370|584498474|FG000|Overall Study|Adverse Event|1|||
161851780|NCT01449370|584498475|FG001|Overall Study|Adverse Event|2|||
161851781|NCT01449370|584498476|FG002|Overall Study|Adverse Event|0|||
161851782|NCT01449370|584498477|FG003|Overall Study|Adverse Event|1|||
161851783|NCT01449370|584498478|FG004|Overall Study|Adverse Event|0|||
161851784|NCT01449370|584498479|FG005|Overall Study|Adverse Event|0|||
161851785|NCT01449370|584498480|FG006|Overall Study|Adverse Event|0|||
161851786|NCT01449370|584498481|FG007|Overall Study|Adverse Event|0|||
161851787|NCT01449370|584498482|FG008|Overall Study|Adverse Event|1|||
161851788|NCT01449370|584498483|FG009|Overall Study|Adverse Event|1|||
161851789|NCT01449370|584498484|FG010|Overall Study|Adverse Event|0|||
161851790|NCT01449370|584498485|FG011|Overall Study|Adverse Event|0|||
161851791|NCT01449370|584498486|FG012|Overall Study|Adverse Event|0|||
161851792|NCT01449370|584498487|FG013|Overall Study|Adverse Event|2|||
161851793|NCT01449370|584498488|FG014|Overall Study|Adverse Event|0|||
161851794|NCT01449370|584498489|FG015|Overall Study|Adverse Event|1|||
161851795|NCT01449370|584498490|FG016|Overall Study|Adverse Event|0|||
161851796|NCT01449370|584498491|FG017|Overall Study|Adverse Event|0|||
161851797|NCT01449370|584498492|FG018|Overall Study|Adverse Event|1|||
161851798|NCT01449370|584498493|FG019|Overall Study|Adverse Event|1|||
161851799|NCT01449370|584498494|FG020|Overall Study|Adverse Event|0|||
161851800|NCT01449370|584498495|FG021|Overall Study|Adverse Event|1|||
161851801|NCT01449370|584498496|FG022|Overall Study|Adverse Event|0|||
161851802|NCT01449370|584498497|FG023|Overall Study|Adverse Event|1|||
161851803|NCT01449370|584498498|FG024|Overall Study|Adverse Event|3|||
161851804|NCT01449370|584498474|FG000|Overall Study|Participant Decision|0|||
161851805|NCT01449370|584498475|FG001|Overall Study|Participant Decision|0|||
161851806|NCT01449370|584498476|FG002|Overall Study|Participant Decision|0|||
161851807|NCT01449370|584498477|FG003|Overall Study|Participant Decision|0|||
161851808|NCT01449370|584498478|FG004|Overall Study|Participant Decision|0|||
161851809|NCT01449370|584498479|FG005|Overall Study|Participant Decision|0|||
161851810|NCT01449370|584498480|FG006|Overall Study|Participant Decision|0|||
161851811|NCT01449370|584498481|FG007|Overall Study|Participant Decision|1|||
161851812|NCT01449370|584498482|FG008|Overall Study|Participant Decision|1|||
161851813|NCT01449370|584498483|FG009|Overall Study|Participant Decision|0|||
161851814|NCT01449370|584498484|FG010|Overall Study|Participant Decision|0|||
161851815|NCT01449370|584498485|FG011|Overall Study|Participant Decision|0|||
161851816|NCT01449370|584498486|FG012|Overall Study|Participant Decision|1|||
161851817|NCT01449370|584498487|FG013|Overall Study|Participant Decision|1|||
161851818|NCT01449370|584498488|FG014|Overall Study|Participant Decision|0|||
161851819|NCT01449370|584498489|FG015|Overall Study|Participant Decision|1|||
161851820|NCT01449370|584498490|FG016|Overall Study|Participant Decision|3|||
161851821|NCT01449370|584498491|FG017|Overall Study|Participant Decision|0|||
161851822|NCT01449370|584498492|FG018|Overall Study|Participant Decision|1|||
161851823|NCT01449370|584498493|FG019|Overall Study|Participant Decision|0|||
161851824|NCT01449370|584498494|FG020|Overall Study|Participant Decision|0|||
161851825|NCT01449370|584498495|FG021|Overall Study|Participant Decision|1|||
161851826|NCT01449370|584498496|FG022|Overall Study|Participant Decision|0|||
161851827|NCT01449370|584498497|FG023|Overall Study|Participant Decision|0|||
161851828|NCT01449370|584498498|FG024|Overall Study|Participant Decision|1|||
161851829|NCT01449370|584498474|FG000|Overall Study|Lost to Follow-up|0|||
161851830|NCT01449370|584498475|FG001|Overall Study|Lost to Follow-up|0|||
161851831|NCT01449370|584498476|FG002|Overall Study|Lost to Follow-up|0|||
161851832|NCT01449370|584498477|FG003|Overall Study|Lost to Follow-up|0|||
161851833|NCT01449370|584498478|FG004|Overall Study|Lost to Follow-up|0|||
161851834|NCT01449370|584498479|FG005|Overall Study|Lost to Follow-up|0|||
161851835|NCT01449370|584498480|FG006|Overall Study|Lost to Follow-up|0|||
161851836|NCT01449370|584498481|FG007|Overall Study|Lost to Follow-up|0|||
161851837|NCT01449370|584498482|FG008|Overall Study|Lost to Follow-up|0|||
161851838|NCT01449370|584498483|FG009|Overall Study|Lost to Follow-up|0|||
161851839|NCT01449370|584498484|FG010|Overall Study|Lost to Follow-up|0|||
161851840|NCT01449370|584498485|FG011|Overall Study|Lost to Follow-up|0|||
161851841|NCT01449370|584498486|FG012|Overall Study|Lost to Follow-up|0|||
161851842|NCT01449370|584498487|FG013|Overall Study|Lost to Follow-up|0|||
161851843|NCT01449370|584498488|FG014|Overall Study|Lost to Follow-up|0|||
161851844|NCT01449370|584498489|FG015|Overall Study|Lost to Follow-up|0|||
161851845|NCT01449370|584498490|FG016|Overall Study|Lost to Follow-up|0|||
161851846|NCT01449370|584498491|FG017|Overall Study|Lost to Follow-up|0|||
161851847|NCT01449370|584498492|FG018|Overall Study|Lost to Follow-up|0|||
161851848|NCT01449370|584498493|FG019|Overall Study|Lost to Follow-up|0|||
161851849|NCT01449370|584498494|FG020|Overall Study|Lost to Follow-up|1|||
161851850|NCT01449370|584498495|FG021|Overall Study|Lost to Follow-up|0|||
161851851|NCT01449370|584498496|FG022|Overall Study|Lost to Follow-up|0|||
161851852|NCT01449370|584498497|FG023|Overall Study|Lost to Follow-up|0|||
161851853|NCT01449370|584498498|FG024|Overall Study|Lost to Follow-up|0|||
161851854|NCT01449370|584498474|FG000|Overall Study|Other|0|||
161851855|NCT01449370|584498475|FG001|Overall Study|Other|0|||
161851856|NCT01449370|584498476|FG002|Overall Study|Other|0|||
161851857|NCT01449370|584498477|FG003|Overall Study|Other|0|||
161851858|NCT01449370|584498478|FG004|Overall Study|Other|0|||
161851859|NCT01449370|584498479|FG005|Overall Study|Other|0|||
161851860|NCT01449370|584498480|FG006|Overall Study|Other|0|||
161851861|NCT01449370|584498481|FG007|Overall Study|Other|0|||
161851862|NCT01449370|584498482|FG008|Overall Study|Other|1|||
161851863|NCT01449370|584498483|FG009|Overall Study|Other|1|||
161851864|NCT01449370|584498484|FG010|Overall Study|Other|0|||
161851865|NCT01449370|584498485|FG011|Overall Study|Other|0|||
161851866|NCT01449370|584498486|FG012|Overall Study|Other|0|||
161851867|NCT01449370|584498487|FG013|Overall Study|Other|0|||
161851868|NCT01449370|584498488|FG014|Overall Study|Other|0|||
161851869|NCT01449370|584498489|FG015|Overall Study|Other|0|||
161851870|NCT01449370|584498490|FG016|Overall Study|Other|0|||
161973122|NCT02078102|584949580|FG001|Overall Study|Withdrawal by Subject|0|||
161973123|NCT02078102|584949579|FG000|Overall Study|Physician Decision|0|||
161973124|NCT02078102|584949580|FG001|Overall Study|Physician Decision|1|||
161973125|NCT02185014|584949583|FG000|Overall Study|Adverse Event|18|||
161973126|NCT02185014|584949583|FG000|Overall Study|Withdrew Consent|8|||
161973127|NCT02185014|584949583|FG000|Overall Study|Lost to Follow-up|4|||
161973128|NCT02185014|584949583|FG000|Overall Study|Lack of Efficacy|14|||
161973129|NCT02185014|584949583|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
161851871|NCT01449370|584498491|FG017|Overall Study|Other|0|||
161851872|NCT01449370|584498492|FG018|Overall Study|Other|0|||
161851873|NCT01449370|584498493|FG019|Overall Study|Other|0|||
161851874|NCT01449370|584498494|FG020|Overall Study|Other|0|||
161851875|NCT01449370|584498495|FG021|Overall Study|Other|0|||
161851876|NCT01449370|584498496|FG022|Overall Study|Other|1|||
161851877|NCT01449370|584498497|FG023|Overall Study|Other|1|||
161851878|NCT01449370|584498498|FG024|Overall Study|Other|0|||
161851879|NCT01449370|584498474|FG000|Overall Study|Medication Prohibited by Protocol|0|||
161851880|NCT01449370|584498475|FG001|Overall Study|Medication Prohibited by Protocol|0|||
161851881|NCT01449370|584498476|FG002|Overall Study|Medication Prohibited by Protocol|0|||
161851882|NCT01449370|584498477|FG003|Overall Study|Medication Prohibited by Protocol|0|||
161973130|NCT02185014|584949583|FG000|Overall Study|Subject Noncompliance|1|||
161851883|NCT01449370|584498478|FG004|Overall Study|Medication Prohibited by Protocol|0|||
161851884|NCT01449370|584498479|FG005|Overall Study|Medication Prohibited by Protocol|0|||
161851885|NCT01449370|584498480|FG006|Overall Study|Medication Prohibited by Protocol|0|||
161851886|NCT01449370|584498481|FG007|Overall Study|Medication Prohibited by Protocol|0|||
161973131|NCT02185014|584949583|FG000|Overall Study|Other|4|||
161851887|NCT01449370|584498482|FG008|Overall Study|Medication Prohibited by Protocol|0|||
161851888|NCT01449370|584498483|FG009|Overall Study|Medication Prohibited by Protocol|0|||
161851889|NCT01449370|584498484|FG010|Overall Study|Medication Prohibited by Protocol|0|||
161851890|NCT01449370|584498485|FG011|Overall Study|Medication Prohibited by Protocol|0|||
161851891|NCT01449370|584498486|FG012|Overall Study|Medication Prohibited by Protocol|0|||
161851892|NCT01449370|584498487|FG013|Overall Study|Medication Prohibited by Protocol|0|||
161851893|NCT01449370|584498488|FG014|Overall Study|Medication Prohibited by Protocol|0|||
161851894|NCT01449370|584498489|FG015|Overall Study|Medication Prohibited by Protocol|0|||
161851895|NCT01449370|584498490|FG016|Overall Study|Medication Prohibited by Protocol|0|||
161851896|NCT01449370|584498491|FG017|Overall Study|Medication Prohibited by Protocol|0|||
161851897|NCT01449370|584498492|FG018|Overall Study|Medication Prohibited by Protocol|0|||
161851898|NCT01449370|584498493|FG019|Overall Study|Medication Prohibited by Protocol|0|||
161851899|NCT01449370|584498494|FG020|Overall Study|Medication Prohibited by Protocol|0|||
161851900|NCT01449370|584498495|FG021|Overall Study|Medication Prohibited by Protocol|0|||
161851901|NCT01449370|584498496|FG022|Overall Study|Medication Prohibited by Protocol|0|||
161851902|NCT01449370|584498497|FG023|Overall Study|Medication Prohibited by Protocol|1|||
161851903|NCT01449370|584498498|FG024|Overall Study|Medication Prohibited by Protocol|0|||
161851904|NCT01449370|584498474|FG000|Overall Study|Death|0|||
161851905|NCT01449370|584498475|FG001|Overall Study|Death|0|||
161851906|NCT01449370|584498476|FG002|Overall Study|Death|0|||
161851907|NCT01449370|584498477|FG003|Overall Study|Death|0|||
161851908|NCT01449370|584498478|FG004|Overall Study|Death|0|||
161851909|NCT01449370|584498479|FG005|Overall Study|Death|0|||
161851910|NCT01449370|584498480|FG006|Overall Study|Death|0|||
161851911|NCT01449370|584498481|FG007|Overall Study|Death|0|||
161851912|NCT01449370|584498482|FG008|Overall Study|Death|0|||
161851913|NCT01449370|584498483|FG009|Overall Study|Death|0|||
161851914|NCT01449370|584498484|FG010|Overall Study|Death|0|||
161851915|NCT01449370|584498485|FG011|Overall Study|Death|0|||
161851916|NCT01449370|584498486|FG012|Overall Study|Death|0|||
161851917|NCT01449370|584498487|FG013|Overall Study|Death|0|||
161851918|NCT01449370|584498488|FG014|Overall Study|Death|0|||
161851919|NCT01449370|584498489|FG015|Overall Study|Death|0|||
161851920|NCT01449370|584498490|FG016|Overall Study|Death|0|||
161851921|NCT01449370|584498491|FG017|Overall Study|Death|0|||
161851922|NCT01449370|584498492|FG018|Overall Study|Death|0|||
161851923|NCT01449370|584498493|FG019|Overall Study|Death|0|||
161851924|NCT01449370|584498494|FG020|Overall Study|Death|0|||
161851925|NCT01449370|584498495|FG021|Overall Study|Death|0|||
161851926|NCT01449370|584498496|FG022|Overall Study|Death|0|||
161851927|NCT01449370|584498497|FG023|Overall Study|Death|0|||
161851928|NCT01449370|584498498|FG024|Overall Study|Death|1|||
161851929|NCT00086281|584498499|FG000|Phase 1|Adverse Event|0|||
161851930|NCT00086281|584498500|FG001|Phase 1|Adverse Event|0|||
161851931|NCT00086281|584498501|FG002|Phase 1|Adverse Event|0|||
161851932|NCT00086281|584498502|FG003|Phase 1|Adverse Event|0|||
161851933|NCT00086281|584498503|FG004|Phase 1|Adverse Event|0|||
161851934|NCT00086281|584498504|FG005|Phase 1|Adverse Event|0|||
161851935|NCT00086281|584498505|FG006|Phase 1|Adverse Event|0|||
161851936|NCT00086281|584498506|FG007|Phase 1|Adverse Event|0|||
161851937|NCT00086281|584498507|FG008|Phase 1|Adverse Event|0|||
161851938|NCT00086281|584498508|FG009|Phase 1|Adverse Event|1|||
161851939|NCT00086281|584498509|FG010|Phase 1|Adverse Event|2|||
161851940|NCT00086281|584498510|FG011|Phase 1|Adverse Event|1|||
161851941|NCT00086281|584498511|FG012|Phase 1|Adverse Event|1|||
161851942|NCT00086281|584498512|FG013|Phase 1|Adverse Event|1|||
161851943|NCT00086281|584498513|FG014|Phase 1|Adverse Event|2|||
161973132|NCT02141490|584949584|FG000|Overall Study|Screening failures|4|||
161973133|NCT02141490|584949585|FG001|Overall Study|Screening failures|0|||
161973134|NCT02141490|584949586|FG002|Overall Study|Screening failures|0|||
161973135|NCT01813721|584949587|FG000|Overall Study|Ineligibility determined|63|||
161973136|NCT01813721|584949587|FG000|Overall Study|Withdrawal by Subject|1|||
161851944|NCT00086281|584498499|FG000|Phase 1|Protocol Violation|0|||
161851945|NCT00086281|584498500|FG001|Phase 1|Protocol Violation|0|||
161851946|NCT00086281|584498501|FG002|Phase 1|Protocol Violation|0|||
161851947|NCT00086281|584498502|FG003|Phase 1|Protocol Violation|0|||
161851948|NCT00086281|584498503|FG004|Phase 1|Protocol Violation|0|||
161851949|NCT00086281|584498504|FG005|Phase 1|Protocol Violation|0|||
161851950|NCT00086281|584498505|FG006|Phase 1|Protocol Violation|0|||
161851951|NCT00086281|584498506|FG007|Phase 1|Protocol Violation|0|||
161851952|NCT00086281|584498507|FG008|Phase 1|Protocol Violation|0|||
161851953|NCT00086281|584498508|FG009|Phase 1|Protocol Violation|0|||
161851954|NCT00086281|584498509|FG010|Phase 1|Protocol Violation|1|||
161851955|NCT00086281|584498510|FG011|Phase 1|Protocol Violation|0|||
161973137|NCT02387164|584949588|FG000|Overall Study|Lost to Follow-up|2|||
161973138|NCT02387164|584949589|FG001|Overall Study|Lost to Follow-up|0|||
161851956|NCT00086281|584498511|FG012|Phase 1|Protocol Violation|0|||
161851957|NCT00086281|584498512|FG013|Phase 1|Protocol Violation|0|||
161851958|NCT00086281|584498513|FG014|Phase 1|Protocol Violation|0|||
161851959|NCT00086281|584498499|FG000|Phase 1|Serious Adverse Event|0|||
161851960|NCT00086281|584498500|FG001|Phase 1|Serious Adverse Event|0|||
161973139|NCT02387164|584949588|FG000|Overall Study|Diagnosed|1|||
161851961|NCT00086281|584498501|FG002|Phase 1|Serious Adverse Event|0|||
161851962|NCT00086281|584498502|FG003|Phase 1|Serious Adverse Event|0|||
161851963|NCT00086281|584498503|FG004|Phase 1|Serious Adverse Event|0|||
161851964|NCT00086281|584498504|FG005|Phase 1|Serious Adverse Event|0|||
161851965|NCT00086281|584498505|FG006|Phase 1|Serious Adverse Event|0|||
161851966|NCT00086281|584498506|FG007|Phase 1|Serious Adverse Event|0|||
161851967|NCT00086281|584498507|FG008|Phase 1|Serious Adverse Event|0|||
161851968|NCT00086281|584498508|FG009|Phase 1|Serious Adverse Event|0|||
161851969|NCT00086281|584498509|FG010|Phase 1|Serious Adverse Event|0|||
161851970|NCT00086281|584498510|FG011|Phase 1|Serious Adverse Event|0|||
161851971|NCT00086281|584498511|FG012|Phase 1|Serious Adverse Event|0|||
161851972|NCT00086281|584498512|FG013|Phase 1|Serious Adverse Event|0|||
161851973|NCT00086281|584498513|FG014|Phase 1|Serious Adverse Event|1|||
161851974|NCT00086281|584498499|FG000|Phase 2|Adverse Event|0|||
161851975|NCT00086281|584498500|FG001|Phase 2|Adverse Event|0|||
161851976|NCT00086281|584498501|FG002|Phase 2|Adverse Event|0|||
161851977|NCT00086281|584498502|FG003|Phase 2|Adverse Event|0|||
161851978|NCT00086281|584498503|FG004|Phase 2|Adverse Event|0|||
161851979|NCT00086281|584498504|FG005|Phase 2|Adverse Event|0|||
161851980|NCT00086281|584498505|FG006|Phase 2|Adverse Event|0|||
161851981|NCT00086281|584498506|FG007|Phase 2|Adverse Event|0|||
161851982|NCT00086281|584498507|FG008|Phase 2|Adverse Event|0|||
161851983|NCT00086281|584498508|FG009|Phase 2|Adverse Event|0|||
161851984|NCT00086281|584498509|FG010|Phase 2|Adverse Event|0|||
161851985|NCT00086281|584498510|FG011|Phase 2|Adverse Event|0|||
161851986|NCT00086281|584498511|FG012|Phase 2|Adverse Event|1|||
161851987|NCT00086281|584498512|FG013|Phase 2|Adverse Event|1|||
161851988|NCT00086281|584498513|FG014|Phase 2|Adverse Event|0|||
161851989|NCT03456453|584498517|FG000|Overall Study|Withdrawal by Subject|2|||
161851990|NCT03456453|584498518|FG001|Overall Study|Withdrawal by Subject|0|||
161851991|NCT03456453|584498517|FG000|Overall Study|Not released to community|1|||
161851992|NCT03456453|584498518|FG001|Overall Study|Not released to community|5|||
161851993|NCT03456453|584498517|FG000|Overall Study|Lost to Follow-up|0|||
161851994|NCT03456453|584498518|FG001|Overall Study|Lost to Follow-up|2|||
161851995|NCT00896480|584498519|FG000|Overall Study|Disease progression/recurrence|21|||
161851996|NCT01004003|584498520|FG000|Overall Study|Progressive disease|2|||
161851997|NCT01004003|584498521|FG001|Overall Study|Progressive disease|1|||
161851998|NCT01004003|584498522|FG002|Overall Study|Progressive disease|1|||
161851999|NCT01004003|584498523|FG003|Overall Study|Progressive disease|0|||
161852000|NCT01004003|584498524|FG004|Overall Study|Progressive disease|2|||
161852001|NCT01004003|584498525|FG005|Overall Study|Progressive disease|1|||
161852002|NCT01004003|584498526|FG006|Overall Study|Progressive disease|1|||
161973140|NCT02387164|584949589|FG001|Overall Study|Diagnosed|2|||
161973141|NCT02133664|584949592|FG000|Overall Study|Lost to Follow-up|2|||
161973142|NCT02133664|584949593|FG001|Overall Study|Lost to Follow-up|1|||
161973143|NCT02133664|584949592|FG000|Overall Study|Adverse Event|3|||
161973144|NCT02133664|584949593|FG001|Overall Study|Adverse Event|6|||
161973145|NCT03906656|584949594|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
161973146|NCT03906656|584949595|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
161973147|NCT03906656|584949594|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
161973148|NCT03906656|584949595|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
161973149|NCT03906656|584949594|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
161973150|NCT03906656|584949595|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
161973151|NCT03906656|584949594|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
161852003|NCT01004003|584498527|FG007|Overall Study|Progressive disease|39|||
161852004|NCT01004003|584498528|FG008|Overall Study|Progressive disease|22|||
161852005|NCT01004003|584498520|FG000|Overall Study|Adverse Event|4|||
161973152|NCT03906656|584949595|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
161973153|NCT03906656|584949594|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
161973154|NCT03906656|584949595|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
161973155|NCT03906656|584949594|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
161973156|NCT03906656|584949595|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
161852006|NCT01004003|584498521|FG001|Overall Study|Adverse Event|2|||
161973157|NCT03906656|584949594|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
161852007|NCT01004003|584498522|FG002|Overall Study|Adverse Event|3|||
161852008|NCT01004003|584498523|FG003|Overall Study|Adverse Event|3|||
161852009|NCT01004003|584498524|FG004|Overall Study|Adverse Event|2|||
161852010|NCT01004003|584498525|FG005|Overall Study|Adverse Event|2|||
161852011|NCT01004003|584498526|FG006|Overall Study|Adverse Event|7|||
161852012|NCT01004003|584498527|FG007|Overall Study|Adverse Event|21|||
161973158|NCT03906656|584949595|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
161852013|NCT01004003|584498528|FG008|Overall Study|Adverse Event|6|||
161852014|NCT01004003|584498520|FG000|Overall Study|Refused to continue taking trial med.|0|||
161852015|NCT01004003|584498521|FG001|Overall Study|Refused to continue taking trial med.|0|||
161852016|NCT01004003|584498522|FG002|Overall Study|Refused to continue taking trial med.|0|||
161852017|NCT01004003|584498523|FG003|Overall Study|Refused to continue taking trial med.|0|||
161852018|NCT01004003|584498524|FG004|Overall Study|Refused to continue taking trial med.|0|||
161764822|NCT01624974|584178893|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
161764823|NCT01624974|584178894|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
161764824|NCT01624974|584178893|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
161764825|NCT01624974|584178894|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
161764826|NCT02607735|584178895|FG000|Primary Study|Randomized but Never Treated|1|||
161764827|NCT02607735|584178896|FG001|Primary Study|Randomized but Never Treated|0|||
161764828|NCT02607735|584178897|FG002|Primary Study|Randomized but Never Treated|0|||
161764829|NCT02607735|584178895|FG000|Primary Study|Lost to Follow-up|4|||
161764830|NCT02607735|584178896|FG001|Primary Study|Lost to Follow-up|0|||
161764831|NCT02607735|584178897|FG002|Primary Study|Lost to Follow-up|0|||
161764832|NCT02607735|584178895|FG000|Primary Study|Withdrew Consent|2|||
161764833|NCT02607735|584178896|FG001|Primary Study|Withdrew Consent|0|||
161764834|NCT02607735|584178897|FG002|Primary Study|Withdrew Consent|0|||
161764835|NCT02607735|584178895|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
161764836|NCT02607735|584178896|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
161764837|NCT02607735|584178897|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
161764838|NCT02607735|584178895|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
161764839|NCT02607735|584178896|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
161764840|NCT02607735|584178897|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
161764841|NCT01376908|584178898|FG000|Overall Study|Protocol Violation|1|||
161764842|NCT01376908|584178899|FG001|Overall Study|Protocol Violation|1|||
161764843|NCT01376908|584178898|FG000|Overall Study|Withdrawal by Subject|1|||
161764844|NCT01376908|584178899|FG001|Overall Study|Withdrawal by Subject|2|||
161764845|NCT01681836|584178904|FG000|Second Intervention|Withdrawal by Subject|0|||
161764846|NCT01681836|584178905|FG001|Second Intervention|Withdrawal by Subject|1|||
161764847|NCT00742391|584178908|FG000|Overall Study|Adverse Event|2|||
161764848|NCT00742391|584178909|FG001|Overall Study|Adverse Event|1|||
161764849|NCT00742391|584178908|FG000|Overall Study|Lost to Follow-up|1|||
161764850|NCT00742391|584178909|FG001|Overall Study|Lost to Follow-up|0|||
161764851|NCT00742391|584178908|FG000|Overall Study|Protocol Violation|1|||
161764852|NCT00742391|584178909|FG001|Overall Study|Protocol Violation|0|||
161764853|NCT02394028|584178910|FG000|Induction Phase|Adverse Event|2|||
161764854|NCT02394028|584178911|FG001|Induction Phase|Adverse Event|4|||
161764855|NCT02394028|584178912|FG002|Induction Phase|Adverse Event|1|||
161764856|NCT02394028|584178913|FG003|Induction Phase|Adverse Event|2|||
161764857|NCT02394028|584178914|FG004|Induction Phase|Adverse Event|5|||
161764858|NCT02394028|584178915|FG005|Induction Phase|Adverse Event|2|||
161764859|NCT02394028|584178916|FG006|Induction Phase|Adverse Event|0|||
161764860|NCT02394028|584178917|FG007|Induction Phase|Adverse Event|0|||
161764861|NCT02394028|584178918|FG008|Induction Phase|Adverse Event|0|||
161764862|NCT02394028|584178919|FG009|Induction Phase|Adverse Event|0|||
161764863|NCT02394028|584178920|FG010|Induction Phase|Adverse Event|0|||
161764864|NCT02394028|584178910|FG000|Induction Phase|Lack of Efficacy|3|||
161764865|NCT02394028|584178911|FG001|Induction Phase|Lack of Efficacy|6|||
161764866|NCT02394028|584178912|FG002|Induction Phase|Lack of Efficacy|2|||
161764867|NCT02394028|584178913|FG003|Induction Phase|Lack of Efficacy|17|||
161764868|NCT02394028|584178914|FG004|Induction Phase|Lack of Efficacy|14|||
161764869|NCT02394028|584178915|FG005|Induction Phase|Lack of Efficacy|8|||
161764870|NCT02394028|584178916|FG006|Induction Phase|Lack of Efficacy|17|||
161764871|NCT02394028|584178917|FG007|Induction Phase|Lack of Efficacy|23|||
161764872|NCT02394028|584178918|FG008|Induction Phase|Lack of Efficacy|0|||
161764873|NCT02394028|584178919|FG009|Induction Phase|Lack of Efficacy|0|||
161764874|NCT02394028|584178920|FG010|Induction Phase|Lack of Efficacy|0|||
161764875|NCT02394028|584178910|FG000|Induction Phase|Lost to Follow-up|1|||
161764876|NCT02394028|584178911|FG001|Induction Phase|Lost to Follow-up|0|||
161764877|NCT02394028|584178912|FG002|Induction Phase|Lost to Follow-up|0|||
161764878|NCT02394028|584178913|FG003|Induction Phase|Lost to Follow-up|1|||
161764879|NCT02394028|584178914|FG004|Induction Phase|Lost to Follow-up|0|||
161764880|NCT02394028|584178915|FG005|Induction Phase|Lost to Follow-up|0|||
161764881|NCT02394028|584178916|FG006|Induction Phase|Lost to Follow-up|1|||
161764882|NCT02394028|584178917|FG007|Induction Phase|Lost to Follow-up|0|||
161764883|NCT02394028|584178918|FG008|Induction Phase|Lost to Follow-up|0|||
161764884|NCT02394028|584178919|FG009|Induction Phase|Lost to Follow-up|0|||
161764885|NCT02394028|584178920|FG010|Induction Phase|Lost to Follow-up|0|||
161764886|NCT02394028|584178910|FG000|Induction Phase|Non-compliance|0|||
161764887|NCT02394028|584178911|FG001|Induction Phase|Non-compliance|1|||
161764888|NCT02394028|584178912|FG002|Induction Phase|Non-compliance|3|||
161764889|NCT02394028|584178913|FG003|Induction Phase|Non-compliance|1|||
161764890|NCT02394028|584178914|FG004|Induction Phase|Non-compliance|3|||
161764891|NCT02394028|584178915|FG005|Induction Phase|Non-compliance|0|||
161764892|NCT02394028|584178916|FG006|Induction Phase|Non-compliance|1|||
161764893|NCT02394028|584178917|FG007|Induction Phase|Non-compliance|1|||
161764894|NCT02394028|584178918|FG008|Induction Phase|Non-compliance|0|||
161764895|NCT02394028|584178919|FG009|Induction Phase|Non-compliance|0|||
161764896|NCT02394028|584178920|FG010|Induction Phase|Non-compliance|0|||
161764897|NCT02394028|584178910|FG000|Induction Phase|Physician Decision|0|||
161764898|NCT02394028|584178911|FG001|Induction Phase|Physician Decision|0|||
161973159|NCT03906656|584949594|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
161852019|NCT01004003|584498525|FG005|Overall Study|Refused to continue taking trial med.|0|||
161852020|NCT01004003|584498526|FG006|Overall Study|Refused to continue taking trial med.|0|||
161852021|NCT01004003|584498527|FG007|Overall Study|Refused to continue taking trial med.|0|||
161852022|NCT01004003|584498528|FG008|Overall Study|Refused to continue taking trial med.|2|||
161852023|NCT01004003|584498520|FG000|Overall Study|Other|0|||
161852024|NCT01004003|584498521|FG001|Overall Study|Other|0|||
161852025|NCT01004003|584498522|FG002|Overall Study|Other|0|||
161852026|NCT01004003|584498523|FG003|Overall Study|Other|0|||
161852027|NCT01004003|584498524|FG004|Overall Study|Other|0|||
161852028|NCT01004003|584498525|FG005|Overall Study|Other|1|||
161852029|NCT01004003|584498526|FG006|Overall Study|Other|0|||
161852030|NCT01004003|584498527|FG007|Overall Study|Other|0|||
161852031|NCT01004003|584498528|FG008|Overall Study|Other|0|||
161852032|NCT00351533|584498532|FG000|Overall Study|Extubated before first BAL|1|||
161852033|NCT00351533|584498533|FG001|Overall Study|Extubated before first BAL|0|||
161852034|NCT00351533|584498532|FG000|Overall Study|Lost to Follow-up|1|||
161852035|NCT00351533|584498533|FG001|Overall Study|Lost to Follow-up|3|||
161852036|NCT00351533|584498532|FG000|Overall Study|Physician Decision|0|||
161852037|NCT00351533|584498533|FG001|Overall Study|Physician Decision|1|||
161852038|NCT00351533|584498532|FG000|Overall Study|Withdrawal by Subject|0|||
161852039|NCT00351533|584498533|FG001|Overall Study|Withdrawal by Subject|1|||
161852040|NCT00315731|584498536|FG000|Overall Study|Lost to Follow-up|1|||
161852041|NCT00315731|584498536|FG000|Overall Study|Death|5|||
161852042|NCT01680497|584498538|FG000|Overall Study|Lost to Follow-up|2|||
161852043|NCT04123561|584498540|FG000|Overall Study|Lost to Follow-up|20|||
161852044|NCT04123561|584498541|FG001|Overall Study|Lost to Follow-up|12|||
161852045|NCT04123561|584498542|FG002|Overall Study|Lost to Follow-up|5|||
161852046|NCT04123561|584498540|FG000|Overall Study|Withdrawal by Subject|9|||
161852047|NCT04123561|584498541|FG001|Overall Study|Withdrawal by Subject|7|||
161852048|NCT04123561|584498542|FG002|Overall Study|Withdrawal by Subject|9|||
161852049|NCT04123561|584498540|FG000|Overall Study|Lack of Efficacy|7|||
161852050|NCT04123561|584498541|FG001|Overall Study|Lack of Efficacy|8|||
161852051|NCT04123561|584498542|FG002|Overall Study|Lack of Efficacy|6|||
161852052|NCT04123561|584498540|FG000|Overall Study|Adverse Event|5|||
161852053|NCT04123561|584498541|FG001|Overall Study|Adverse Event|2|||
161852054|NCT04123561|584498542|FG002|Overall Study|Adverse Event|3|||
161852055|NCT04123561|584498540|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
161852056|NCT04123561|584498541|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
161852057|NCT04123561|584498542|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
161852058|NCT04123561|584498540|FG000|Overall Study|Death|0|||
161852059|NCT04123561|584498541|FG001|Overall Study|Death|0|||
161852060|NCT04123561|584498542|FG002|Overall Study|Death|1|||
161852061|NCT04123561|584498540|FG000|Overall Study|Protocol Violation|0|||
161852062|NCT04123561|584498541|FG001|Overall Study|Protocol Violation|1|||
161852063|NCT04123561|584498542|FG002|Overall Study|Protocol Violation|0|||
161852064|NCT02454608|584499704|FG000|Double-Blind Period|Lack of Efficacy|0|||
161852065|NCT02454608|584499705|FG001|Double-Blind Period|Lack of Efficacy|2|||
161852066|NCT02454608|584499706|FG002|Double-Blind Period|Lack of Efficacy|0|||
161852067|NCT02454608|584499704|FG000|Open Label Period|Lost to Follow-up|0|||
161852068|NCT02454608|584499705|FG001|Open Label Period|Lost to Follow-up|0|||
161852069|NCT02454608|584499706|FG002|Open Label Period|Lost to Follow-up|11|||
161852070|NCT02454608|584499704|FG000|Open Label Period|Withdrawal by Subject|0|||
161852071|NCT02454608|584499705|FG001|Open Label Period|Withdrawal by Subject|0|||
161852072|NCT02454608|584499706|FG002|Open Label Period|Withdrawal by Subject|8|||
161852073|NCT02465398|584499707|FG000|Overall Study|Death|7|||
161852074|NCT02465398|584499707|FG000|Overall Study|Revision|7|||
161852075|NCT02465398|584499707|FG000|Overall Study|did not receive study device|1|||
161852076|NCT02465398|584499707|FG000|Overall Study|Withdrawal by Subject|1|||
161852077|NCT02465398|584499707|FG000|Overall Study|Lost to Follow-up|14|||
161852078|NCT02540850|584499708|FG000|Overall Study|Lost to Follow-up|69|||
161852079|NCT02540850|584499709|FG001|Overall Study|Lost to Follow-up|66|||
161852080|NCT02540850|584499710|FG002|Overall Study|Lost to Follow-up|34|||
161852081|NCT03760185|584499721|FG000|Overall Study|Lost to Follow-up|1|||
161852082|NCT03760185|584499722|FG001|Overall Study|Lost to Follow-up|1|||
161852083|NCT02473523|584499723|FG000|Overall Study|Death|1|||
161852084|NCT02473523|584499723|FG000|Overall Study|Lost to Follow-up|1|||
161852085|NCT02111603|584499726|FG000|Overall Study|Withdrawal by Subject|1|||
161852086|NCT00976911|584499727|FG000|Overall Study|Withdrawal by Subject|4|||
161852087|NCT00976911|584499728|FG001|Overall Study|Withdrawal by Subject|6|||
161852088|NCT00976911|584499727|FG000|Overall Study|Death|138|||
161852089|NCT00976911|584499728|FG001|Overall Study|Death|126|||
161852090|NCT00976911|584499727|FG000|Overall Study|Adverse Event|0|||
161852091|NCT00976911|584499728|FG001|Overall Study|Adverse Event|1|||
161852092|NCT00976911|584499727|FG000|Overall Study|Protocol Violation|2|||
161852093|NCT00976911|584499728|FG001|Overall Study|Protocol Violation|0|||
161852094|NCT00976911|584499727|FG000|Overall Study|Other|8|||
161852095|NCT00976911|584499728|FG001|Overall Study|Other|9|||
161852096|NCT00976911|584499727|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
161852097|NCT00976911|584499728|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
161852098|NCT02954991|584499729|FG000|Overall Study|Death|92|||
161852099|NCT02954991|584499730|FG001|Overall Study|Death|11|||
161852100|NCT02954991|584499731|FG002|Overall Study|Death|2|||
161852101|NCT02954991|584499729|FG000|Overall Study|Lost to Follow-up|3|||
161852102|NCT02954991|584499730|FG001|Overall Study|Lost to Follow-up|2|||
161852103|NCT02954991|584499731|FG002|Overall Study|Lost to Follow-up|0|||
161852104|NCT02954991|584499729|FG000|Overall Study|Withdrawal by Subject|9|||
161852105|NCT02954991|584499730|FG001|Overall Study|Withdrawal by Subject|8|||
161852106|NCT02954991|584499731|FG002|Overall Study|Withdrawal by Subject|1|||
161852107|NCT02954991|584499729|FG000|Overall Study|Study Terminated by Sponsor|18|||
161852108|NCT02954991|584499730|FG001|Overall Study|Study Terminated by Sponsor|10|||
161852109|NCT02954991|584499731|FG002|Overall Study|Study Terminated by Sponsor|1|||
161852110|NCT02954991|584499729|FG000|Overall Study|Miscellaneous|2|||
161852111|NCT02954991|584499730|FG001|Overall Study|Miscellaneous|1|||
161852112|NCT02954991|584499731|FG002|Overall Study|Miscellaneous|1|||
161852113|NCT00576316|584499732|FG000|Overall Study|Adverse Event|9|||
161852114|NCT00576316|584499732|FG000|Overall Study|Withdrawal by Subject|2|||
161852115|NCT00576316|584499732|FG000|Overall Study|Protocol Violation|9|||
161852116|NCT02552303|584499735|FG000|Allocation|Withdrawal by Subject|2|||
161852117|NCT02552303|584499736|FG001|Allocation|Withdrawal by Subject|1|||
161852118|NCT02552303|584499737|FG002|Allocation|Withdrawal by Subject|1|||
161852119|NCT02552303|584499738|FG003|Allocation|Withdrawal by Subject|1|||
161852120|NCT02552303|584499735|FG000|Allocation|ineligible|1|||
161852121|NCT02552303|584499736|FG001|Allocation|ineligible|1|||
161852122|NCT02552303|584499737|FG002|Allocation|ineligible|0|||
161852123|NCT02552303|584499738|FG003|Allocation|ineligible|0|||
161852124|NCT02552303|584499735|FG000|Follow-Up|Lost to Follow-up|0|||
161852125|NCT02552303|584499736|FG001|Follow-Up|Lost to Follow-up|0|||
161852126|NCT02552303|584499737|FG002|Follow-Up|Lost to Follow-up|1|||
161852127|NCT02552303|584499738|FG003|Follow-Up|Lost to Follow-up|0|||
161852128|NCT02552303|584499735|FG000|Follow-Up|ineligible|0|||
161852129|NCT02552303|584499736|FG001|Follow-Up|ineligible|2|||
161852130|NCT02552303|584499737|FG002|Follow-Up|ineligible|0|||
161852131|NCT02552303|584499738|FG003|Follow-Up|ineligible|0|||
161852132|NCT01582152|584499739|FG000|Overall Study|Disease Progression|4|||
161852133|NCT01582152|584499740|FG001|Overall Study|Disease Progression|5|||
161852134|NCT01582152|584499739|FG000|Overall Study|Adverse Event|2|||
161852135|NCT01582152|584499740|FG001|Overall Study|Adverse Event|1|||
161852136|NCT03055624|584499741|FG000|Overall Study|Study closed|9|||
161852137|NCT02437903|584499744|FG000|Overall Study|Adverse Event|1|||
161852138|NCT02437903|584499744|FG000|Overall Study|Withdrawal by Subject|1|||
161852139|NCT02437903|584499744|FG000|Overall Study|Lost to Follow-up|3|||
161852140|NCT00230178|584499745|FG000|Overall Study|Adverse Event|1|||
161852141|NCT00230178|584499746|FG001|Overall Study|Adverse Event|5|||
161852142|NCT00230178|584499747|FG002|Overall Study|Adverse Event|2|||
161852143|NCT00230178|584499745|FG000|Overall Study|Withdrawal by Subject|0|||
161852144|NCT00230178|584499746|FG001|Overall Study|Withdrawal by Subject|0|||
161852145|NCT00230178|584499747|FG002|Overall Study|Withdrawal by Subject|1|||
161852146|NCT00230178|584499745|FG000|Overall Study|Various other reasons|3|||
161852147|NCT00230178|584499746|FG001|Overall Study|Various other reasons|2|||
161852148|NCT00230178|584499747|FG002|Overall Study|Various other reasons|4|||
161852149|NCT02252406|584499754|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
161852150|NCT02252406|584499755|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
161852151|NCT02252406|584499754|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
161852152|NCT02252406|584499755|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
161852153|NCT02252406|584499754|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
161852154|NCT02252406|584499755|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
161852155|NCT02252406|584499754|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
161852156|NCT02252406|584499755|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
161852157|NCT02252406|584499754|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
161852158|NCT02252406|584499755|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
161852159|NCT00005957|584499756|FG000|Overall Study|No treated|3|||
161852160|NCT00005957|584499757|FG001|Overall Study|No treated|9|||
161852161|NCT00005957|584499756|FG000|Overall Study|Crossover to the other arm|5|||
161852162|NCT00005957|584499757|FG001|Overall Study|Crossover to the other arm|19|||
161852163|NCT01609023|584499758|FG000|Overall Study|Lack of Efficacy|3|||
161852164|NCT01609023|584499758|FG000|Overall Study|Withdrawal by Subject|4|||
161852165|NCT01609023|584499758|FG000|Overall Study|Lost to Follow-up|8|||
161852166|NCT01609023|584499758|FG000|Overall Study|Toxicity|3|||
161852167|NCT01609023|584499758|FG000|Overall Study|Disease progression|10|||
161852168|NCT01609023|584499758|FG000|Overall Study|Physician Decision|2|||
161852169|NCT01609023|584499758|FG000|Overall Study|Death|2|||
161852170|NCT01609023|584499758|FG000|Overall Study|Personal reasons|1|||
161852171|NCT00799825|584499759|FG000|Overall Study|Adverse Event|1|||
161852172|NCT00799825|584499759|FG000|Overall Study|Withdrawal by Subject|6|||
161852173|NCT00799825|584499759|FG000|Overall Study|Lost to Follow-up|38|||
161852174|NCT00799825|584499759|FG000|Overall Study|Pregnancy|3|||
161852175|NCT04974749|584499760|FG000|Overall Study|Withdrawal by Subject|2|||
161852176|NCT04974749|584499760|FG000|Overall Study|Gestation|1|||
161852177|NCT00796107|584499766|FG000|Overall Study|Lack of Efficacy|1|||
161852178|NCT00796107|584499766|FG000|Overall Study|Progressive Disease|5|||
161852179|NCT02681510|584499774|FG000|Overall Study|Withdrawal by Subject|1|||
161852180|NCT02681510|584499774|FG000|Overall Study|Lost to Follow-up|9|||
161852181|NCT02075515|584499775|FG000|Overall Study|Serious Adverse Event|1|||
161852182|NCT02075515|584499776|FG001|Overall Study|Serious Adverse Event|1|||
161852183|NCT02075515|584499777|FG002|Overall Study|Serious Adverse Event|1|||
161852184|NCT02075515|584499775|FG000|Overall Study|Non-Serious Adverse Event|0|||
161852185|NCT02075515|584499776|FG001|Overall Study|Non-Serious Adverse Event|1|||
161852186|NCT02075515|584499777|FG002|Overall Study|Non-Serious Adverse Event|0|||
161852187|NCT02075515|584499775|FG000|Overall Study|Withdrawal by Subject|2|||
161852188|NCT02075515|584499776|FG001|Overall Study|Withdrawal by Subject|0|||
161852189|NCT02075515|584499777|FG002|Overall Study|Withdrawal by Subject|1|||
161852190|NCT02075515|584499775|FG000|Overall Study|Lost to Follow-up|1|||
161852191|NCT02075515|584499776|FG001|Overall Study|Lost to Follow-up|3|||
161852192|NCT02075515|584499777|FG002|Overall Study|Lost to Follow-up|6|||
161852193|NCT00741338|584499788|FG000|Overall Study|Adverse Event|0|||
161852194|NCT00741338|584499789|FG001|Overall Study|Adverse Event|1|||
161852195|NCT03593395|584499790|FG000|Overall Study|Lost to Follow-up|48|||
161852196|NCT03593395|584499791|FG001|Overall Study|Lost to Follow-up|3|||
161852197|NCT03593395|584499790|FG000|Overall Study|Withdrawal by Subject|5|||
161852198|NCT03593395|584499791|FG001|Overall Study|Withdrawal by Subject|24|||
161852199|NCT03593395|584499790|FG000|Overall Study|Death|2|||
161852200|NCT03593395|584499791|FG001|Overall Study|Death|3|||
161852201|NCT03593395|584499790|FG000|Overall Study|Physician Decision|0|||
161852202|NCT03593395|584499791|FG001|Overall Study|Physician Decision|6|||
161852203|NCT03593395|584499790|FG000|Overall Study|Participant Relocated|19|||
161852204|NCT03593395|584499791|FG001|Overall Study|Participant Relocated|3|||
161852205|NCT03593395|584499790|FG000|Overall Study|No Information|1|||
161852206|NCT03593395|584499791|FG001|Overall Study|No Information|7|||
161852207|NCT02370238|584499798|FG000|Overall Study|Death|42|||
161852208|NCT02370238|584499799|FG001|Overall Study|Death|35|||
161852209|NCT02370238|584499798|FG000|Overall Study|Lost to Follow-up|1|||
161852210|NCT02370238|584499799|FG001|Overall Study|Lost to Follow-up|3|||
161852211|NCT02370238|584499798|FG000|Overall Study|Withdrawal by Subject|2|||
161852212|NCT02370238|584499799|FG001|Overall Study|Withdrawal by Subject|6|||
161852213|NCT02370238|584499798|FG000|Overall Study|Other|2|||
161852214|NCT02370238|584499799|FG001|Overall Study|Other|1|||
161852215|NCT03837743|584499805|FG000|Overall Study|Adverse Event|1|||
161852216|NCT03837743|584499805|FG000|Overall Study|Withdrawal by Subject|2|||
161852217|NCT01685840|584499808|FG000|Overall Study|Death|77|||
161852218|NCT01685840|584499809|FG001|Overall Study|Death|66|||
161852219|NCT01685840|584499808|FG000|Overall Study|Lost to Follow-up|27|||
161852220|NCT01685840|584499809|FG001|Overall Study|Lost to Follow-up|25|||
161852221|NCT01685840|584499808|FG000|Overall Study|Physician Decision|3|||
161852222|NCT01685840|584499809|FG001|Overall Study|Physician Decision|7|||
161852223|NCT01685840|584499808|FG000|Overall Study|Withdrawal by Subject|14|||
161852224|NCT01685840|584499809|FG001|Overall Study|Withdrawal by Subject|17|||
161852225|NCT01685840|584499808|FG000|Overall Study|Futility|197|||
161852226|NCT01685840|584499809|FG001|Overall Study|Futility|200|||
161852227|NCT01685840|584499808|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
161852228|NCT01685840|584499809|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
161852229|NCT00710866|584499810|FG000|Overall Study|Protocol Violation|5|||
161852230|NCT00710866|584499811|FG001|Overall Study|Protocol Violation|4|||
161852231|NCT00710866|584499810|FG000|Overall Study|Withdrawal by Subject|2|||
161852232|NCT00710866|584499811|FG001|Overall Study|Withdrawal by Subject|1|||
161852233|NCT00710866|584499810|FG000|Overall Study|Lost to Follow-up|1|||
161852234|NCT00710866|584499811|FG001|Overall Study|Lost to Follow-up|0|||
161852235|NCT00710866|584499810|FG000|Overall Study|Failed to meet eligibility|1|||
161852236|NCT00710866|584499811|FG001|Overall Study|Failed to meet eligibility|1|||
161852237|NCT03371459|584499816|FG000|Washout|Lost to Follow-up|0|||
161852238|NCT03371459|584499817|FG001|Washout|Lost to Follow-up|1|||
161852239|NCT01885195|584499820|FG000|Overall Study|Adverse Event|29|||
161852240|NCT01885195|584499820|FG000|Overall Study|Death|1|||
161852241|NCT01885195|584499820|FG000|Overall Study|Disease Progression|67|||
161852242|NCT01885195|584499820|FG000|Overall Study|Protocol Deviation|2|||
161852243|NCT01885195|584499820|FG000|Overall Study|Physician Decision|3|||
161852244|NCT01885195|584499820|FG000|Overall Study|Patient/guardian decision|8|||
161852245|NCT01589497|584499821|FG000|Overall Study|Withdrawal by Subject|0|||
161852246|NCT01589497|584499822|FG001|Overall Study|Withdrawal by Subject|1|||
161852247|NCT01589497|584499823|FG002|Overall Study|Withdrawal by Subject|0|||
161852248|NCT01589497|584499824|FG003|Overall Study|Withdrawal by Subject|1|||
161852249|NCT01589497|584499821|FG000|Overall Study|Death|1|||
161852250|NCT01589497|584499822|FG001|Overall Study|Death|0|||
161852251|NCT01589497|584499823|FG002|Overall Study|Death|0|||
161852252|NCT01589497|584499824|FG003|Overall Study|Death|0|||
161852253|NCT01589497|584499821|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
161852254|NCT01589497|584499822|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
161852255|NCT01589497|584499823|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
161852256|NCT01589497|584499824|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
161852257|NCT03390426|584499825|FG000|Overall Study|Protocol Violation|0|||
161852258|NCT03390426|584499826|FG001|Overall Study|Protocol Violation|1|||
161852259|NCT00259272|584499827|FG000|Overall Study|Adverse Event|2|||
161852260|NCT00259272|584499828|FG001|Overall Study|Adverse Event|1|||
161852261|NCT00259272|584499829|FG002|Overall Study|Adverse Event|0|||
161852262|NCT00259272|584499830|FG003|Overall Study|Adverse Event|3|||
161852263|NCT00259272|584499827|FG000|Overall Study|Lack of Efficacy|5|||
161852264|NCT00259272|584499828|FG001|Overall Study|Lack of Efficacy|1|||
161852265|NCT00259272|584499829|FG002|Overall Study|Lack of Efficacy|2|||
161852266|NCT00259272|584499830|FG003|Overall Study|Lack of Efficacy|6|||
161852267|NCT00259272|584499827|FG000|Overall Study|Physician Decision|1|||
161852268|NCT00259272|584499828|FG001|Overall Study|Physician Decision|2|||
161852269|NCT00259272|584499829|FG002|Overall Study|Physician Decision|1|||
161852270|NCT00259272|584499830|FG003|Overall Study|Physician Decision|3|||
161852271|NCT00259272|584499827|FG000|Overall Study|Protocol Violation|2|||
161852272|NCT00259272|584499828|FG001|Overall Study|Protocol Violation|0|||
161852273|NCT00259272|584499829|FG002|Overall Study|Protocol Violation|0|||
161852274|NCT00259272|584499830|FG003|Overall Study|Protocol Violation|1|||
161852275|NCT00259272|584499827|FG000|Overall Study|Sponsor Decision|0|||
161852276|NCT00259272|584499828|FG001|Overall Study|Sponsor Decision|1|||
161852277|NCT00259272|584499829|FG002|Overall Study|Sponsor Decision|0|||
161852278|NCT00259272|584499830|FG003|Overall Study|Sponsor Decision|0|||
161852279|NCT00259272|584499827|FG000|Overall Study|Withdrawal by Subject|4|||
161852280|NCT00259272|584499828|FG001|Overall Study|Withdrawal by Subject|2|||
161852281|NCT00259272|584499829|FG002|Overall Study|Withdrawal by Subject|2|||
161852282|NCT00259272|584499830|FG003|Overall Study|Withdrawal by Subject|7|||
161852283|NCT00259272|584499827|FG000|Overall Study|Lost to Follow-up|1|||
161852284|NCT00259272|584499828|FG001|Overall Study|Lost to Follow-up|0|||
161852285|NCT00259272|584499829|FG002|Overall Study|Lost to Follow-up|0|||
161852286|NCT00259272|584499830|FG003|Overall Study|Lost to Follow-up|1|||
161852287|NCT01290302|584501764|FG000|Overall Study|Adverse Event|2|||
161852288|NCT01290302|584501765|FG001|Overall Study|Adverse Event|0|||
161852289|NCT01290302|584501764|FG000|Overall Study|Withdrawal by Subject|1|||
161852290|NCT01290302|584501765|FG001|Overall Study|Withdrawal by Subject|0|||
161852291|NCT01290302|584501764|FG000|Overall Study|Physician Decision|0|||
161852292|NCT01290302|584501765|FG001|Overall Study|Physician Decision|2|||
161852293|NCT01290302|584501764|FG000|Overall Study|Expiration of time for screening window|1|||
161852294|NCT01290302|584501765|FG001|Overall Study|Expiration of time for screening window|0|||
161852295|NCT03816878|584501768|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
161852296|NCT03816878|584501769|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
161852297|NCT03816878|584501768|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
161852298|NCT03816878|584501769|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
161852299|NCT03355469|584501770|FG000|Overall Study|COVID-19|3|||
161852300|NCT03355469|584501771|FG001|Overall Study|COVID-19|2|||
161852301|NCT03355469|584501772|FG002|Overall Study|COVID-19|3|||
161852302|NCT03355469|584501773|FG003|Overall Study|COVID-19|3|||
161852303|NCT03355469|584501770|FG000|Overall Study|Lost to Follow-up|1|||
161852304|NCT03355469|584501771|FG001|Overall Study|Lost to Follow-up|0|||
161852305|NCT03355469|584501772|FG002|Overall Study|Lost to Follow-up|1|||
161852306|NCT03355469|584501773|FG003|Overall Study|Lost to Follow-up|0|||
161852307|NCT03355469|584501770|FG000|Overall Study|Withdrawal by Subject|2|||
161852308|NCT03355469|584501771|FG001|Overall Study|Withdrawal by Subject|1|||
161852309|NCT03355469|584501772|FG002|Overall Study|Withdrawal by Subject|0|||
161852310|NCT03355469|584501773|FG003|Overall Study|Withdrawal by Subject|3|||
161852311|NCT02291510|584501774|FG000|Overall Study|Adverse Event|0|||
161852312|NCT02291510|584501775|FG001|Overall Study|Adverse Event|0|||
161973160|NCT03906656|584949595|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
161973161|NCT03906656|584949594|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
161973162|NCT03906656|584949595|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
161973163|NCT03906656|584949594|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
161973164|NCT03906656|584949595|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
161973165|NCT03906656|584949594|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
161852313|NCT02291510|584501776|FG002|Overall Study|Adverse Event|0|||
161852314|NCT02291510|584501777|FG003|Overall Study|Adverse Event|1|||
161852315|NCT04856930|584501782|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
161852316|NCT04856930|584501783|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
161852317|NCT04856930|584501784|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
161852318|NCT04856930|584501782|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
161852319|NCT04856930|584501783|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
161852320|NCT04856930|584501784|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
161852321|NCT04856930|584501782|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
161852322|NCT04856930|584501783|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
161852323|NCT04856930|584501784|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
161973166|NCT03906656|584949595|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
161973167|NCT03906656|584949594|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
161973168|NCT03906656|584949595|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
161973169|NCT03906656|584949594|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
161973170|NCT03906656|584949595|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
161973171|NCT03906656|584949594|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
161973172|NCT03906656|584949595|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
161973173|NCT03906656|584949594|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
161973174|NCT03906656|584949595|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
161973175|NCT03906656|584949594|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
161973176|NCT03906656|584949595|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
161973177|NCT03906656|584949594|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
161973178|NCT03906656|584949595|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
161973179|NCT03906656|584949594|FG000|Home Use 2 (3 Months)|Death|2|||
161973180|NCT03906656|584949595|FG001|Home Use 2 (3 Months)|Death|0|||
161973181|NCT03906656|584949594|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
161973182|NCT03906656|584949595|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
161973183|NCT03906656|584949594|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
161973184|NCT03906656|584949595|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
161973185|NCT01036529|584949596|FG000|Overall Study|Adverse Event|0|||
161973186|NCT01036529|584949597|FG001|Overall Study|Adverse Event|1|||
161973187|NCT01036529|584949596|FG000|Overall Study|Lost to Follow-up|0|||
161973188|NCT01036529|584949597|FG001|Overall Study|Lost to Follow-up|1|||
161973189|NCT01036529|584949596|FG000|Overall Study|Physician Decision|1|||
161973190|NCT01036529|584949597|FG001|Overall Study|Physician Decision|0|||
161973191|NCT01036529|584949596|FG000|Overall Study|Withdrawal by Subject|1|||
161973192|NCT01036529|584949597|FG001|Overall Study|Withdrawal by Subject|1|||
161973193|NCT01036529|584949596|FG000|Overall Study|Sponsor study termination|11|||
161973194|NCT01036529|584949597|FG001|Overall Study|Sponsor study termination|12|||
161973195|NCT00343915|584949599|FG000|Primary Study|Withdrawal by Subject|1|||
161973196|NCT00343915|584949600|FG001|Primary Study|Withdrawal by Subject|0|||
161973197|NCT00343915|584949599|FG000|Primary Study|Lost to Follow-up|2|||
161973198|NCT00343915|584949600|FG001|Primary Study|Lost to Follow-up|3|||
161973199|NCT00343915|584949599|FG000|Primary Study|Other|1|||
161973200|NCT00343915|584949600|FG001|Primary Study|Other|0|||
161973201|NCT01719003|584949601|FG000|Overall Study|Non compliant with protocol|1|||
161973202|NCT01719003|584949602|FG001|Overall Study|Non compliant with protocol|1|||
161973203|NCT01719003|584949603|FG002|Overall Study|Non compliant with protocol|0|||
161973204|NCT01719003|584949604|FG003|Overall Study|Non compliant with protocol|1|||
161973205|NCT01719003|584949605|FG004|Overall Study|Non compliant with protocol|2|||
161973206|NCT01719003|584949606|FG005|Overall Study|Non compliant with protocol|1|||
161973207|NCT01719003|584949607|FG006|Overall Study|Non compliant with protocol|2|||
161973208|NCT01719003|584949608|FG007|Overall Study|Non compliant with protocol|3|||
161973209|NCT01719003|584949609|FG008|Overall Study|Non compliant with protocol|0|||
161973210|NCT01719003|584949601|FG000|Overall Study|Adverse Event|6|||
161973211|NCT01719003|584949602|FG001|Overall Study|Adverse Event|5|||
161973212|NCT01719003|584949603|FG002|Overall Study|Adverse Event|4|||
161973213|NCT01719003|584949604|FG003|Overall Study|Adverse Event|3|||
161973214|NCT01719003|584949605|FG004|Overall Study|Adverse Event|4|||
161973215|NCT01719003|584949606|FG005|Overall Study|Adverse Event|3|||
161973216|NCT01719003|584949607|FG006|Overall Study|Adverse Event|6|||
161973217|NCT01719003|584949608|FG007|Overall Study|Adverse Event|5|||
161973218|NCT01719003|584949609|FG008|Overall Study|Adverse Event|0|||
161973219|NCT01719003|584949601|FG000|Overall Study|Lost to Follow-up|0|||
161973220|NCT01719003|584949602|FG001|Overall Study|Lost to Follow-up|6|||
161973221|NCT01719003|584949603|FG002|Overall Study|Lost to Follow-up|7|||
161973222|NCT01719003|584949604|FG003|Overall Study|Lost to Follow-up|2|||
161973223|NCT01719003|584949605|FG004|Overall Study|Lost to Follow-up|3|||
161973224|NCT01719003|584949606|FG005|Overall Study|Lost to Follow-up|4|||
161973225|NCT01719003|584949607|FG006|Overall Study|Lost to Follow-up|3|||
161973226|NCT01719003|584949608|FG007|Overall Study|Lost to Follow-up|2|||
161973227|NCT01719003|584949609|FG008|Overall Study|Lost to Follow-up|2|||
161973228|NCT01719003|584949601|FG000|Overall Study|Refusal to continue, not due to AE|2|||
161973229|NCT01719003|584949602|FG001|Overall Study|Refusal to continue, not due to AE|5|||
161973230|NCT01719003|584949603|FG002|Overall Study|Refusal to continue, not due to AE|4|||
161973231|NCT01719003|584949604|FG003|Overall Study|Refusal to continue, not due to AE|4|||
161973232|NCT01719003|584949605|FG004|Overall Study|Refusal to continue, not due to AE|4|||
161973233|NCT01719003|584949606|FG005|Overall Study|Refusal to continue, not due to AE|3|||
161973234|NCT01719003|584949607|FG006|Overall Study|Refusal to continue, not due to AE|8|||
161973235|NCT01719003|584949608|FG007|Overall Study|Refusal to continue, not due to AE|7|||
161973236|NCT01719003|584949609|FG008|Overall Study|Refusal to continue, not due to AE|1|||
161973237|NCT01719003|584949601|FG000|Overall Study|Reason other than those specified|0|||
161973238|NCT01719003|584949602|FG001|Overall Study|Reason other than those specified|0|||
161973239|NCT01719003|584949603|FG002|Overall Study|Reason other than those specified|2|||
161973240|NCT01719003|584949604|FG003|Overall Study|Reason other than those specified|3|||
161973241|NCT01719003|584949605|FG004|Overall Study|Reason other than those specified|4|||
161973242|NCT01719003|584949606|FG005|Overall Study|Reason other than those specified|1|||
161973243|NCT01719003|584949607|FG006|Overall Study|Reason other than those specified|0|||
161973244|NCT01719003|584949608|FG007|Overall Study|Reason other than those specified|3|||
161973245|NCT01719003|584949609|FG008|Overall Study|Reason other than those specified|1|||
161973246|NCT01719003|584949601|FG000|Overall Study|Lack of Efficacy|0|||
161973247|NCT01719003|584949602|FG001|Overall Study|Lack of Efficacy|0|||
161973248|NCT01719003|584949603|FG002|Overall Study|Lack of Efficacy|0|||
161973249|NCT01719003|584949604|FG003|Overall Study|Lack of Efficacy|0|||
161973250|NCT01719003|584949605|FG004|Overall Study|Lack of Efficacy|0|||
161973251|NCT01719003|584949606|FG005|Overall Study|Lack of Efficacy|0|||
161973252|NCT01719003|584949607|FG006|Overall Study|Lack of Efficacy|1|||
161973253|NCT01719003|584949608|FG007|Overall Study|Lack of Efficacy|0|||
161973254|NCT01719003|584949609|FG008|Overall Study|Lack of Efficacy|0|||
161973255|NCT00700102|584949610|FG000|Overall Study|Died|394|||
161973256|NCT00700102|584949611|FG001|Overall Study|Died|385|||
161973257|NCT00700102|584949610|FG000|Overall Study|Lost to Follow-up|8|||
161973258|NCT00700102|584949611|FG001|Overall Study|Lost to Follow-up|10|||
161973259|NCT01667562|584949612|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
161973260|NCT01667562|584949613|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
161973261|NCT01667562|584949612|FG000|Erlotinib Phase|Lost to Follow-up|0|||
161973262|NCT01667562|584949613|FG001|Erlotinib Phase|Lost to Follow-up|1|||
161973263|NCT01667562|584949612|FG000|Erlotinib Phase|Adverse Event|0|||
161973264|NCT01667562|584949613|FG001|Erlotinib Phase|Adverse Event|1|||
161973265|NCT01667562|584949612|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
161973266|NCT01667562|584949613|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
161973267|NCT02525939|584949614|FG000|Overall Study|Lost to Follow-up|27|||
161973268|NCT02525939|584949615|FG001|Overall Study|Lost to Follow-up|24|||
161973269|NCT02525939|584949614|FG000|Overall Study|Physician Decision|0|||
161973270|NCT02525939|584949615|FG001|Overall Study|Physician Decision|1|||
161973271|NCT02525939|584949614|FG000|Overall Study|Withdrawal by Subject|24|||
161973272|NCT02525939|584949615|FG001|Overall Study|Withdrawal by Subject|39|||
161973273|NCT02525939|584949614|FG000|Overall Study|Death|180|||
161973274|NCT02525939|584949615|FG001|Overall Study|Death|179|||
161973275|NCT02130986|584949616|FG000|Overall Study|Withdrawal by Subject|4|||
161973276|NCT02130986|584949617|FG001|Overall Study|Withdrawal by Subject|4|||
161973277|NCT02130986|584949616|FG000|Overall Study|Lost to Follow-up|151|||
161973278|NCT02130986|584949617|FG001|Overall Study|Lost to Follow-up|160|||
161973279|NCT01129882|584949618|FG000|Overall Study|Adverse Event|39|||
161973280|NCT01129882|584949618|FG000|Overall Study|Death|6|||
161973281|NCT01129882|584949618|FG000|Overall Study|Lack of Efficacy|5|||
161973282|NCT01129882|584949618|FG000|Overall Study|Lost to Follow-up|13|||
161973283|NCT01129882|584949618|FG000|Overall Study|Physician Decision|27|||
161973284|NCT01129882|584949618|FG000|Overall Study|Protocol Deviation|3|||
161973285|NCT01129882|584949618|FG000|Overall Study|Withdrawal Criteria Met|19|||
161973286|NCT01129882|584949618|FG000|Overall Study|Trial Termination by Sponsor|6|||
161973287|NCT01129882|584949618|FG000|Overall Study|Withdrawal by Subject|160|||
161973288|NCT01028716|584949619|FG000|Overall Study|Physician Decision|1|||
161973289|NCT00536874|584949620|FG000|Overall Study|Adverse Event|1|||
161973290|NCT00536874|584949620|FG000|Overall Study|Death|2|||
161973291|NCT00536874|584949620|FG000|Overall Study|Withdrawal by Subject|1|||
161973292|NCT00762996|584949621|FG000|Period One|Protocol Violation|0|||
161973293|NCT00762996|584949622|FG001|Period One|Protocol Violation|0|||
161973294|NCT00762996|584949623|FG002|Period One|Protocol Violation|1|||
161973295|NCT00762996|584949624|FG003|Period One|Protocol Violation|0|||
161973296|NCT00762996|584949621|FG000|Period One|ineligible|0|||
161973297|NCT00762996|584949622|FG001|Period One|ineligible|0|||
161973298|NCT00762996|584949623|FG002|Period One|ineligible|1|||
161973299|NCT00762996|584949624|FG003|Period One|ineligible|1|||
161973300|NCT00762996|584949621|FG000|Period One|Adverse Event|0|||
161973301|NCT00762996|584949622|FG001|Period One|Adverse Event|0|||
161973302|NCT00762996|584949623|FG002|Period One|Adverse Event|1|||
161764899|NCT02394028|584178912|FG002|Induction Phase|Physician Decision|1|||
161764900|NCT02394028|584178913|FG003|Induction Phase|Physician Decision|4|||
161764901|NCT02394028|584178914|FG004|Induction Phase|Physician Decision|0|||
161764902|NCT02394028|584178915|FG005|Induction Phase|Physician Decision|2|||
161973303|NCT00762996|584949624|FG003|Period One|Adverse Event|0|||
161973304|NCT00762996|584949621|FG000|Period One|Withdrawal by Subject|0|||
161973305|NCT00762996|584949622|FG001|Period One|Withdrawal by Subject|0|||
161973306|NCT00762996|584949623|FG002|Period One|Withdrawal by Subject|1|||
161764903|NCT02394028|584178916|FG006|Induction Phase|Physician Decision|1|||
161973307|NCT00762996|584949624|FG003|Period One|Withdrawal by Subject|0|||
161973308|NCT01853072|584949626|FG000|Overall Study|Adverse event prior to treatment|0|||
161973309|NCT01853072|584949627|FG001|Overall Study|Adverse event prior to treatment|1|||
161973310|NCT01853072|584949626|FG000|Overall Study|Adverse Event|0|||
161973311|NCT01853072|584949627|FG001|Overall Study|Adverse Event|3|||
161973312|NCT01853072|584949626|FG000|Overall Study|Death|1|||
161973313|NCT01853072|584949627|FG001|Overall Study|Death|4|||
161973314|NCT01853072|584949626|FG000|Overall Study|Lost to Follow-up|0|||
161973315|NCT01853072|584949627|FG001|Overall Study|Lost to Follow-up|3|||
161973316|NCT01853072|584949626|FG000|Overall Study|Non-compliance with study drug|0|||
161973317|NCT01853072|584949627|FG001|Overall Study|Non-compliance with study drug|1|||
161973318|NCT01853072|584949626|FG000|Overall Study|Physician Decision|1|||
161973319|NCT01853072|584949627|FG001|Overall Study|Physician Decision|1|||
161973320|NCT01853072|584949626|FG000|Overall Study|Withdrawal by Subject|1|||
161973321|NCT01853072|584949627|FG001|Overall Study|Withdrawal by Subject|2|||
161973322|NCT01853072|584949626|FG000|Overall Study|Reason not specified|9|||
161973323|NCT01853072|584949627|FG001|Overall Study|Reason not specified|6|||
161973324|NCT01287221|584949628|FG000|Overall Study|Lack of Perceived Benefit|1|||
161973325|NCT01287221|584949629|FG001|Overall Study|Lack of Perceived Benefit|1|||
161973326|NCT01287221|584949628|FG000|Overall Study|Adverse Event|3|||
161973327|NCT01287221|584949629|FG001|Overall Study|Adverse Event|3|||
161973328|NCT01287221|584949628|FG000|Overall Study|Withdrawal by Subject|0|||
161973329|NCT01287221|584949629|FG001|Overall Study|Withdrawal by Subject|1|||
161973330|NCT00930969|584949630|FG000|Overall Study|Death|5|||
161973331|NCT00930969|584949630|FG000|Overall Study|Lost to Follow-up|1|||
161973332|NCT00930969|584949630|FG000|Overall Study|Physician Decision|13|||
161973333|NCT00930969|584949630|FG000|Overall Study|Withdrawal by Subject|19|||
161973334|NCT00657150|584949631|FG000|Overall Study|Adverse Event|19|||
161973335|NCT00657150|584949632|FG001|Overall Study|Adverse Event|10|||
161973336|NCT00657150|584949631|FG000|Overall Study|Non-compliant with protocol|5|||
161973337|NCT00657150|584949632|FG001|Overall Study|Non-compliant with protocol|9|||
161973338|NCT00657150|584949631|FG000|Overall Study|Lost to Follow-up|2|||
161973339|NCT00657150|584949632|FG001|Overall Study|Lost to Follow-up|0|||
161973340|NCT00657150|584949631|FG000|Overall Study|Withdrawal by Subject|51|||
161973341|NCT00657150|584949632|FG001|Overall Study|Withdrawal by Subject|36|||
161973342|NCT00657150|584949631|FG000|Overall Study|Other|38|||
161973343|NCT00657150|584949632|FG001|Overall Study|Other|38|||
161973344|NCT00657150|584949631|FG000|Treatment|Adverse Event|60|||
161973345|NCT00657150|584949632|FG001|Treatment|Adverse Event|53|||
161973346|NCT00657150|584949631|FG000|Treatment|Non-compliant with protocol|10|||
161973347|NCT00657150|584949632|FG001|Treatment|Non-compliant with protocol|9|||
161973348|NCT00657150|584949631|FG000|Treatment|Lost to Follow-up|1|||
161973349|NCT00657150|584949632|FG001|Treatment|Lost to Follow-up|0|||
161973350|NCT00657150|584949631|FG000|Treatment|Withdrawal by Subject|23|||
161973351|NCT00657150|584949632|FG001|Treatment|Withdrawal by Subject|20|||
161973352|NCT00657150|584949631|FG000|Treatment|Other|13|||
161973353|NCT00657150|584949632|FG001|Treatment|Other|15|||
161973354|NCT01319721|584949640|FG000|Overall Study|Lost to Follow-up|1|||
161973355|NCT01319721|584949641|FG001|Overall Study|Lost to Follow-up|6|||
161973356|NCT02653495|584949642|FG000|Overall Study|Lost to Follow-up|2|||
161973357|NCT02653495|584949643|FG001|Overall Study|Lost to Follow-up|0|||
161973358|NCT02653495|584949642|FG000|Overall Study|Screening Failure|10|||
161973359|NCT02653495|584949643|FG001|Overall Study|Screening Failure|0|||
161973360|NCT03515941|584949644|FG000|Overall Study|Adverse Event|1|||
161973361|NCT03515941|584949645|FG001|Overall Study|Adverse Event|0|||
161973362|NCT00468845|584949646|FG000|Overall Study|Adverse Event|9|||
161973363|NCT00468845|584949647|FG001|Overall Study|Adverse Event|14|||
161973364|NCT00468845|584949648|FG002|Overall Study|Adverse Event|11|||
161852324|NCT04856930|584501782|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
161852325|NCT04856930|584501783|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
161852326|NCT04856930|584501784|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
161852327|NCT04856930|584501782|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
161852328|NCT04856930|584501783|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
161852329|NCT04856930|584501784|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
161852330|NCT04856930|584501782|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
161852331|NCT04856930|584501783|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
161852332|NCT04856930|584501784|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
161973365|NCT00468845|584949646|FG000|Overall Study|Lost to Follow-up|2|||
161973366|NCT00468845|584949647|FG001|Overall Study|Lost to Follow-up|1|||
161973367|NCT00468845|584949648|FG002|Overall Study|Lost to Follow-up|2|||
161973368|NCT00468845|584949646|FG000|Overall Study|Other|4|||
161973369|NCT00468845|584949647|FG001|Overall Study|Other|9|||
161852333|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
161852334|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
161973370|NCT00468845|584949648|FG002|Overall Study|Other|5|||
161973371|NCT00468845|584949646|FG000|Overall Study|No longer willing to participate|5|||
161973372|NCT00468845|584949647|FG001|Overall Study|No longer willing to participate|6|||
161973373|NCT00468845|584949648|FG002|Overall Study|No longer willing to participate|10|||
161973374|NCT00468845|584949646|FG000|Overall Study|Randomized, not treated|1|||
161973375|NCT00468845|584949647|FG001|Overall Study|Randomized, not treated|4|||
161973376|NCT00468845|584949648|FG002|Overall Study|Randomized, not treated|2|||
161973377|NCT02761694|584949649|FG000|Overall Study|Lack of Efficacy|0|||
161973378|NCT02761694|584949650|FG001|Overall Study|Lack of Efficacy|0|||
161973379|NCT02761694|584949651|FG002|Overall Study|Lack of Efficacy|0|||
161973380|NCT02761694|584949652|FG003|Overall Study|Lack of Efficacy|0|||
161973381|NCT02761694|584949653|FG004|Overall Study|Lack of Efficacy|0|||
161973382|NCT02761694|584949654|FG005|Overall Study|Lack of Efficacy|0|||
161973383|NCT02761694|584949655|FG006|Overall Study|Lack of Efficacy|6|||
161973384|NCT02761694|584949656|FG007|Overall Study|Lack of Efficacy|0|||
161973385|NCT02761694|584949657|FG008|Overall Study|Lack of Efficacy|0|||
161973386|NCT02761694|584949658|FG009|Overall Study|Lack of Efficacy|1|||
161973387|NCT02761694|584949659|FG010|Overall Study|Lack of Efficacy|1|||
161973388|NCT02761694|584949660|FG011|Overall Study|Lack of Efficacy|4|||
161973389|NCT02761694|584949649|FG000|Overall Study|Death|0|||
161973390|NCT02761694|584949650|FG001|Overall Study|Death|0|||
161973391|NCT02761694|584949651|FG002|Overall Study|Death|0|||
161973392|NCT02761694|584949652|FG003|Overall Study|Death|0|||
161973393|NCT02761694|584949653|FG004|Overall Study|Death|0|||
161973394|NCT02761694|584949654|FG005|Overall Study|Death|0|||
161973395|NCT02761694|584949655|FG006|Overall Study|Death|2|||
161973396|NCT02761694|584949656|FG007|Overall Study|Death|0|||
161973397|NCT02761694|584949657|FG008|Overall Study|Death|2|||
161973398|NCT02761694|584949658|FG009|Overall Study|Death|2|||
161973399|NCT02761694|584949659|FG010|Overall Study|Death|1|||
161973400|NCT02761694|584949660|FG011|Overall Study|Death|0|||
161973401|NCT02761694|584949649|FG000|Overall Study|Physician Decision|0|||
161973402|NCT02761694|584949650|FG001|Overall Study|Physician Decision|0|||
161973403|NCT02761694|584949651|FG002|Overall Study|Physician Decision|0|||
161973404|NCT02761694|584949652|FG003|Overall Study|Physician Decision|0|||
161973405|NCT02761694|584949653|FG004|Overall Study|Physician Decision|0|||
161973406|NCT02761694|584949654|FG005|Overall Study|Physician Decision|0|||
161973407|NCT02761694|584949655|FG006|Overall Study|Physician Decision|1|||
161973408|NCT02761694|584949656|FG007|Overall Study|Physician Decision|0|||
161973409|NCT02761694|584949657|FG008|Overall Study|Physician Decision|0|||
161973410|NCT02761694|584949658|FG009|Overall Study|Physician Decision|0|||
161973411|NCT02761694|584949659|FG010|Overall Study|Physician Decision|0|||
161973412|NCT02761694|584949660|FG011|Overall Study|Physician Decision|0|||
161973413|NCT02761694|584949649|FG000|Overall Study|Withdrawal by Subject|0|||
161973414|NCT02761694|584949650|FG001|Overall Study|Withdrawal by Subject|0|||
161764904|NCT02394028|584178917|FG007|Induction Phase|Physician Decision|0|||
161764905|NCT02394028|584178918|FG008|Induction Phase|Physician Decision|0|||
161764906|NCT02394028|584178919|FG009|Induction Phase|Physician Decision|0|||
161764907|NCT02394028|584178920|FG010|Induction Phase|Physician Decision|0|||
161764908|NCT02394028|584178910|FG000|Induction Phase|Protocol Violation|0|||
161764909|NCT02394028|584178911|FG001|Induction Phase|Protocol Violation|2|||
161764910|NCT02394028|584178912|FG002|Induction Phase|Protocol Violation|0|||
161764911|NCT02394028|584178913|FG003|Induction Phase|Protocol Violation|3|||
161764912|NCT02394028|584178914|FG004|Induction Phase|Protocol Violation|0|||
161764913|NCT02394028|584178915|FG005|Induction Phase|Protocol Violation|1|||
161764914|NCT02394028|584178916|FG006|Induction Phase|Protocol Violation|1|||
161764915|NCT02394028|584178917|FG007|Induction Phase|Protocol Violation|0|||
161764916|NCT02394028|584178918|FG008|Induction Phase|Protocol Violation|0|||
161764917|NCT02394028|584178919|FG009|Induction Phase|Protocol Violation|0|||
161764918|NCT02394028|584178920|FG010|Induction Phase|Protocol Violation|0|||
161764919|NCT02394028|584178910|FG000|Induction Phase|Withdrawal by Subject|1|||
161764920|NCT02394028|584178911|FG001|Induction Phase|Withdrawal by Subject|2|||
161764921|NCT02394028|584178912|FG002|Induction Phase|Withdrawal by Subject|4|||
161764922|NCT02394028|584178913|FG003|Induction Phase|Withdrawal by Subject|6|||
161764923|NCT02394028|584178914|FG004|Induction Phase|Withdrawal by Subject|7|||
161764924|NCT02394028|584178915|FG005|Induction Phase|Withdrawal by Subject|4|||
161764925|NCT02394028|584178916|FG006|Induction Phase|Withdrawal by Subject|3|||
161764926|NCT02394028|584178917|FG007|Induction Phase|Withdrawal by Subject|6|||
161764927|NCT02394028|584178918|FG008|Induction Phase|Withdrawal by Subject|0|||
161764928|NCT02394028|584178919|FG009|Induction Phase|Withdrawal by Subject|0|||
161764929|NCT02394028|584178920|FG010|Induction Phase|Withdrawal by Subject|0|||
161764930|NCT02394028|584178910|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764931|NCT02394028|584178911|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764932|NCT02394028|584178912|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764933|NCT02394028|584178913|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
161973415|NCT02761694|584949651|FG002|Overall Study|Withdrawal by Subject|0|||
161973416|NCT02761694|584949652|FG003|Overall Study|Withdrawal by Subject|1|||
161973417|NCT02761694|584949653|FG004|Overall Study|Withdrawal by Subject|0|||
161973418|NCT02761694|584949654|FG005|Overall Study|Withdrawal by Subject|0|||
161973419|NCT02761694|584949655|FG006|Overall Study|Withdrawal by Subject|4|||
161973420|NCT02761694|584949656|FG007|Overall Study|Withdrawal by Subject|0|||
161973421|NCT02761694|584949657|FG008|Overall Study|Withdrawal by Subject|2|||
161764934|NCT02394028|584178914|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
161973422|NCT02761694|584949658|FG009|Overall Study|Withdrawal by Subject|1|||
161973423|NCT02761694|584949659|FG010|Overall Study|Withdrawal by Subject|0|||
161973424|NCT02761694|584949660|FG011|Overall Study|Withdrawal by Subject|0|||
161764935|NCT02394028|584178915|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764936|NCT02394028|584178916|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
161764937|NCT02394028|584178917|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764938|NCT02394028|584178918|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764939|NCT02394028|584178919|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764940|NCT02394028|584178920|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
161764941|NCT02394028|584178910|FG000|Induction Phase|Sponsor decision|0|||
161764942|NCT02394028|584178911|FG001|Induction Phase|Sponsor decision|1|||
161764943|NCT02394028|584178912|FG002|Induction Phase|Sponsor decision|2|||
161764944|NCT02394028|584178913|FG003|Induction Phase|Sponsor decision|0|||
161764945|NCT02394028|584178914|FG004|Induction Phase|Sponsor decision|0|||
161764946|NCT02394028|584178915|FG005|Induction Phase|Sponsor decision|0|||
161764947|NCT02394028|584178916|FG006|Induction Phase|Sponsor decision|0|||
161764948|NCT02394028|584178917|FG007|Induction Phase|Sponsor decision|0|||
161764949|NCT02394028|584178918|FG008|Induction Phase|Sponsor decision|0|||
161764950|NCT02394028|584178919|FG009|Induction Phase|Sponsor decision|0|||
161764951|NCT02394028|584178920|FG010|Induction Phase|Sponsor decision|0|||
161764952|NCT02394028|584178910|FG000|Induction Phase|Technical reason|0|||
161764953|NCT02394028|584178911|FG001|Induction Phase|Technical reason|0|||
161764954|NCT02394028|584178912|FG002|Induction Phase|Technical reason|0|||
161764955|NCT02394028|584178913|FG003|Induction Phase|Technical reason|1|||
161764956|NCT02394028|584178914|FG004|Induction Phase|Technical reason|0|||
161764957|NCT02394028|584178915|FG005|Induction Phase|Technical reason|0|||
161764958|NCT02394028|584178916|FG006|Induction Phase|Technical reason|0|||
161764959|NCT02394028|584178917|FG007|Induction Phase|Technical reason|0|||
161764960|NCT02394028|584178918|FG008|Induction Phase|Technical reason|0|||
161764961|NCT02394028|584178919|FG009|Induction Phase|Technical reason|0|||
161764962|NCT02394028|584178920|FG010|Induction Phase|Technical reason|0|||
161764963|NCT02394028|584178910|FG000|Induction Phase|:ack of calculation|0|||
161764964|NCT02394028|584178911|FG001|Induction Phase|:ack of calculation|0|||
161764965|NCT02394028|584178912|FG002|Induction Phase|:ack of calculation|0|||
161764966|NCT02394028|584178913|FG003|Induction Phase|:ack of calculation|0|||
161764967|NCT02394028|584178914|FG004|Induction Phase|:ack of calculation|0|||
161764968|NCT02394028|584178915|FG005|Induction Phase|:ack of calculation|0|||
161764969|NCT02394028|584178916|FG006|Induction Phase|:ack of calculation|0|||
161764970|NCT02394028|584178917|FG007|Induction Phase|:ack of calculation|1|||
161764971|NCT02394028|584178918|FG008|Induction Phase|:ack of calculation|0|||
161764972|NCT02394028|584178919|FG009|Induction Phase|:ack of calculation|0|||
161764973|NCT02394028|584178920|FG010|Induction Phase|:ack of calculation|0|||
161764974|NCT02394028|584178910|FG000|Maintenance Phase|Protocol Violation|0|||
161764975|NCT02394028|584178911|FG001|Maintenance Phase|Protocol Violation|0|||
161764976|NCT02394028|584178912|FG002|Maintenance Phase|Protocol Violation|0|||
161764977|NCT02394028|584178913|FG003|Maintenance Phase|Protocol Violation|0|||
161764978|NCT02394028|584178914|FG004|Maintenance Phase|Protocol Violation|0|||
161764979|NCT02394028|584178915|FG005|Maintenance Phase|Protocol Violation|0|||
161764980|NCT02394028|584178916|FG006|Maintenance Phase|Protocol Violation|0|||
161764981|NCT02394028|584178917|FG007|Maintenance Phase|Protocol Violation|0|||
161764982|NCT02394028|584178918|FG008|Maintenance Phase|Protocol Violation|0|||
161764983|NCT02394028|584178919|FG009|Maintenance Phase|Protocol Violation|0|||
161764984|NCT02394028|584178920|FG010|Maintenance Phase|Protocol Violation|1|||
161764985|NCT02394028|584178910|FG000|Maintenance Phase|Physician Decision|0|||
161764986|NCT02394028|584178911|FG001|Maintenance Phase|Physician Decision|0|||
161764987|NCT02394028|584178912|FG002|Maintenance Phase|Physician Decision|0|||
161764988|NCT02394028|584178913|FG003|Maintenance Phase|Physician Decision|0|||
161764989|NCT02394028|584178914|FG004|Maintenance Phase|Physician Decision|0|||
161764990|NCT02394028|584178915|FG005|Maintenance Phase|Physician Decision|0|||
161764991|NCT02394028|584178916|FG006|Maintenance Phase|Physician Decision|0|||
161764992|NCT02394028|584178917|FG007|Maintenance Phase|Physician Decision|0|||
161764993|NCT02394028|584178918|FG008|Maintenance Phase|Physician Decision|1|||
161764994|NCT02394028|584178919|FG009|Maintenance Phase|Physician Decision|3|||
161764995|NCT02394028|584178920|FG010|Maintenance Phase|Physician Decision|2|||
161764996|NCT02394028|584178910|FG000|Maintenance Phase|Lack of Efficacy|0|||
161764997|NCT02394028|584178911|FG001|Maintenance Phase|Lack of Efficacy|0|||
161764998|NCT02394028|584178912|FG002|Maintenance Phase|Lack of Efficacy|0|||
161764999|NCT02394028|584178913|FG003|Maintenance Phase|Lack of Efficacy|0|||
161765000|NCT02394028|584178914|FG004|Maintenance Phase|Lack of Efficacy|0|||
161765001|NCT02394028|584178915|FG005|Maintenance Phase|Lack of Efficacy|0|||
161765002|NCT02394028|584178916|FG006|Maintenance Phase|Lack of Efficacy|0|||
161765003|NCT02394028|584178917|FG007|Maintenance Phase|Lack of Efficacy|0|||
161765004|NCT02394028|584178918|FG008|Maintenance Phase|Lack of Efficacy|7|||
161765005|NCT02394028|584178919|FG009|Maintenance Phase|Lack of Efficacy|25|||
161765006|NCT02394028|584178920|FG010|Maintenance Phase|Lack of Efficacy|33|||
161765007|NCT02394028|584178910|FG000|Maintenance Phase|Death|0|||
161765008|NCT02394028|584178911|FG001|Maintenance Phase|Death|0|||
161852335|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
161852336|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
161852337|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
162033871|NCT00597701|585181126|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
161765009|NCT02394028|584178912|FG002|Maintenance Phase|Death|0|||
161765010|NCT02394028|584178913|FG003|Maintenance Phase|Death|0|||
161765011|NCT02394028|584178914|FG004|Maintenance Phase|Death|0|||
161765012|NCT02394028|584178915|FG005|Maintenance Phase|Death|0|||
161765013|NCT02394028|584178916|FG006|Maintenance Phase|Death|0|||
161765014|NCT02394028|584178917|FG007|Maintenance Phase|Death|0|||
161765015|NCT02394028|584178918|FG008|Maintenance Phase|Death|0|||
161765016|NCT02394028|584178919|FG009|Maintenance Phase|Death|0|||
161765017|NCT02394028|584178920|FG010|Maintenance Phase|Death|1|||
161765018|NCT02394028|584178910|FG000|Maintenance Phase|Adverse Event|0|||
161765019|NCT02394028|584178911|FG001|Maintenance Phase|Adverse Event|0|||
161765020|NCT02394028|584178912|FG002|Maintenance Phase|Adverse Event|0|||
161765021|NCT02394028|584178913|FG003|Maintenance Phase|Adverse Event|0|||
161765022|NCT02394028|584178914|FG004|Maintenance Phase|Adverse Event|0|||
161765023|NCT02394028|584178915|FG005|Maintenance Phase|Adverse Event|0|||
161765024|NCT02394028|584178916|FG006|Maintenance Phase|Adverse Event|0|||
161765025|NCT02394028|584178917|FG007|Maintenance Phase|Adverse Event|0|||
161765026|NCT02394028|584178918|FG008|Maintenance Phase|Adverse Event|1|||
161765027|NCT02394028|584178919|FG009|Maintenance Phase|Adverse Event|1|||
161765028|NCT02394028|584178920|FG010|Maintenance Phase|Adverse Event|3|||
161765029|NCT02394028|584178910|FG000|Maintenance Phase|Site closure|0|||
161765030|NCT02394028|584178911|FG001|Maintenance Phase|Site closure|0|||
161765031|NCT02394028|584178912|FG002|Maintenance Phase|Site closure|0|||
161765032|NCT02394028|584178913|FG003|Maintenance Phase|Site closure|0|||
161765033|NCT02394028|584178914|FG004|Maintenance Phase|Site closure|0|||
161765034|NCT02394028|584178915|FG005|Maintenance Phase|Site closure|0|||
161765035|NCT02394028|584178916|FG006|Maintenance Phase|Site closure|0|||
161765036|NCT02394028|584178917|FG007|Maintenance Phase|Site closure|0|||
161765037|NCT02394028|584178918|FG008|Maintenance Phase|Site closure|0|||
161765038|NCT02394028|584178919|FG009|Maintenance Phase|Site closure|1|||
161765039|NCT02394028|584178920|FG010|Maintenance Phase|Site closure|0|||
161765040|NCT02394028|584178910|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161765041|NCT02394028|584178911|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161765042|NCT02394028|584178912|FG002|Maintenance Phase|Withdrawal by Subject|0|||
161765043|NCT02394028|584178913|FG003|Maintenance Phase|Withdrawal by Subject|0|||
161765044|NCT02394028|584178914|FG004|Maintenance Phase|Withdrawal by Subject|0|||
161765045|NCT02394028|584178915|FG005|Maintenance Phase|Withdrawal by Subject|0|||
161765046|NCT02394028|584178916|FG006|Maintenance Phase|Withdrawal by Subject|0|||
161765047|NCT02394028|584178917|FG007|Maintenance Phase|Withdrawal by Subject|0|||
161765048|NCT02394028|584178918|FG008|Maintenance Phase|Withdrawal by Subject|3|||
161765049|NCT02394028|584178919|FG009|Maintenance Phase|Withdrawal by Subject|12|||
161765050|NCT02394028|584178920|FG010|Maintenance Phase|Withdrawal by Subject|12|||
161765051|NCT00866606|584178923|FG000|Overall Study|Lost to Follow-up|3|||
161765052|NCT00866606|584178923|FG000|Overall Study|Adverse Event|1|||
161765053|NCT01058356|584178935|FG000|Overall Study|Adverse Event|5|||
161765054|NCT01058356|584178935|FG000|Overall Study|Administration of contraindicated drugs|12|||
161765055|NCT01058356|584178935|FG000|Overall Study|Withdrawal by Subject|21|||
161765056|NCT01058356|584178935|FG000|Overall Study|Lost to Follow-up|4|||
161765057|NCT02993783|584178936|FG000|Overall Study|Reason not Specified|6|||
161765058|NCT02993783|584178937|FG001|Overall Study|Reason not Specified|9|||
161765059|NCT00606021|584178940|FG000|Induction Phase|Death|73|||
161765060|NCT00606021|584178941|FG001|Induction Phase|Death|0|||
161765061|NCT00606021|584178942|FG002|Induction Phase|Death|0|||
161765062|NCT00606021|584178940|FG000|Induction Phase|Physician Decision|2|||
161765063|NCT00606021|584178941|FG001|Induction Phase|Physician Decision|0|||
161765064|NCT00606021|584178942|FG002|Induction Phase|Physician Decision|0|||
161765065|NCT00606021|584178940|FG000|Induction Phase|Withdrawal by Subject|2|||
161765066|NCT00606021|584178941|FG001|Induction Phase|Withdrawal by Subject|0|||
161765067|NCT00606021|584178942|FG002|Induction Phase|Withdrawal by Subject|0|||
161765068|NCT00606021|584178940|FG000|Induction Phase|Lost to Follow-up|10|||
161765069|NCT00606021|584178941|FG001|Induction Phase|Lost to Follow-up|0|||
161765070|NCT00606021|584178942|FG002|Induction Phase|Lost to Follow-up|0|||
161852338|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
161765071|NCT00606021|584178940|FG000|Maintenance Phase|Death|0|||
161765072|NCT00606021|584178941|FG001|Maintenance Phase|Death|17|||
161765073|NCT00606021|584178942|FG002|Maintenance Phase|Death|15|||
161765074|NCT00606021|584178940|FG000|Maintenance Phase|Physician Decision|0|||
161765075|NCT00606021|584178941|FG001|Maintenance Phase|Physician Decision|1|||
161765076|NCT00606021|584178942|FG002|Maintenance Phase|Physician Decision|0|||
161765077|NCT00606021|584178940|FG000|Maintenance Phase|Lost to Follow-up|0|||
161765078|NCT00606021|584178941|FG001|Maintenance Phase|Lost to Follow-up|5|||
161765079|NCT00606021|584178942|FG002|Maintenance Phase|Lost to Follow-up|2|||
161765080|NCT03480841|584178943|FG000|Overall Study|Lost to Follow-up|2|||
161765081|NCT01362049|584178944|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
161765082|NCT01362049|584178945|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
161765083|NCT01362049|584178946|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
161852339|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
161852340|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
161852341|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
161852342|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
161852343|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
161852344|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
161852345|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
161852346|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
161852347|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
161852348|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
161852349|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
161852350|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
161852351|NCT04856930|584501782|FG000|Extension Period (16 Weeks)|Other than specified|0|||
161852352|NCT04856930|584501783|FG001|Extension Period (16 Weeks)|Other than specified|0|||
161852353|NCT04856930|584501784|FG002|Extension Period (16 Weeks)|Other than specified|1|||
161852354|NCT04856930|584501782|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
161852355|NCT04856930|584501783|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
161852356|NCT04856930|584501784|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
161852357|NCT04856930|584501782|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
161852358|NCT04856930|584501783|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
161852359|NCT04856930|584501784|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
161852360|NCT04856930|584501782|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
161852361|NCT04856930|584501783|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
161852362|NCT04856930|584501784|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
161852363|NCT04856930|584501782|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
161852364|NCT04856930|584501783|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
161852365|NCT04856930|584501784|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
161852366|NCT00678210|584501786|FG000|Overall Study|Adverse Event|1|||
161852367|NCT00678210|584501787|FG001|Overall Study|Adverse Event|2|||
161852368|NCT00678210|584501788|FG002|Overall Study|Adverse Event|3|||
161852369|NCT00678210|584501789|FG003|Overall Study|Adverse Event|3|||
161852370|NCT00678210|584501786|FG000|Overall Study|Lack of Efficacy|2|||
161852371|NCT00678210|584501787|FG001|Overall Study|Lack of Efficacy|3|||
161852372|NCT00678210|584501788|FG002|Overall Study|Lack of Efficacy|1|||
161852373|NCT00678210|584501789|FG003|Overall Study|Lack of Efficacy|9|||
161852374|NCT00678210|584501786|FG000|Overall Study|Lost to Follow-up|4|||
161852375|NCT00678210|584501787|FG001|Overall Study|Lost to Follow-up|2|||
161852376|NCT00678210|584501788|FG002|Overall Study|Lost to Follow-up|0|||
161852377|NCT00678210|584501789|FG003|Overall Study|Lost to Follow-up|1|||
161852378|NCT00678210|584501786|FG000|Overall Study|Withdrawal by Subject|3|||
161852379|NCT00678210|584501787|FG001|Overall Study|Withdrawal by Subject|4|||
161852380|NCT00678210|584501788|FG002|Overall Study|Withdrawal by Subject|1|||
161852381|NCT00678210|584501789|FG003|Overall Study|Withdrawal by Subject|7|||
161852382|NCT00678210|584501786|FG000|Overall Study|Other|1|||
161852383|NCT00678210|584501787|FG001|Overall Study|Other|0|||
161852384|NCT00678210|584501788|FG002|Overall Study|Other|1|||
161852385|NCT00678210|584501789|FG003|Overall Study|Other|0|||
161852386|NCT00615199|584501790|FG000|Overall Study|Adverse Event|3|||
161852387|NCT00615199|584501791|FG001|Overall Study|Adverse Event|1|||
161852388|NCT00615199|584501792|FG002|Overall Study|Adverse Event|1|||
161852389|NCT00615199|584501793|FG003|Overall Study|Adverse Event|0|||
161852390|NCT00615199|584501790|FG000|Overall Study|Lack of Efficacy|2|||
161973425|NCT02761694|584949649|FG000|Overall Study|Lost to Follow-up|0|||
161973426|NCT02761694|584949650|FG001|Overall Study|Lost to Follow-up|0|||
161973427|NCT02761694|584949651|FG002|Overall Study|Lost to Follow-up|0|||
161973428|NCT02761694|584949652|FG003|Overall Study|Lost to Follow-up|0|||
161765084|NCT01362049|584178947|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
161765085|NCT01362049|584178944|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
161765086|NCT01362049|584178945|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
161765087|NCT01362049|584178946|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
161765088|NCT01362049|584178947|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
161765089|NCT04524663|584180452|FG000|Overall Study|Withdrawal by Subject|0|||
161765090|NCT04524663|584180453|FG001|Overall Study|Withdrawal by Subject|2|||
161765091|NCT00911508|584180454|FG000|Overall Study|Lost to Follow-up|27|||
161765092|NCT00911508|584180455|FG001|Overall Study|Lost to Follow-up|18|||
161765093|NCT00911508|584180454|FG000|Overall Study|Withdrawal by Subject|79|||
161765094|NCT00911508|584180455|FG001|Overall Study|Withdrawal by Subject|112|||
161765095|NCT04308668|584180456|FG000|Overall Study|Lost to Follow-up|32|||
161765096|NCT04308668|584180457|FG001|Overall Study|Lost to Follow-up|38|||
161765097|NCT04308668|584180456|FG000|Overall Study|Withdrawal by Subject|4|||
161765098|NCT04308668|584180457|FG001|Overall Study|Withdrawal by Subject|4|||
161765099|NCT01266967|584180458|FG000|Overall Study|Death|69|||
161765100|NCT01266967|584180459|FG001|Overall Study|Death|61|||
161852391|NCT00615199|584501791|FG001|Overall Study|Lack of Efficacy|0|||
161852392|NCT00615199|584501792|FG002|Overall Study|Lack of Efficacy|0|||
161852393|NCT00615199|584501793|FG003|Overall Study|Lack of Efficacy|1|||
161852394|NCT00615199|584501790|FG000|Overall Study|Lost to Follow-up|1|||
161852395|NCT00615199|584501791|FG001|Overall Study|Lost to Follow-up|0|||
161852396|NCT00615199|584501792|FG002|Overall Study|Lost to Follow-up|0|||
161852397|NCT00615199|584501793|FG003|Overall Study|Lost to Follow-up|0|||
161852398|NCT00615199|584501790|FG000|Overall Study|Other|0|||
161852399|NCT00615199|584501791|FG001|Overall Study|Other|0|||
161852400|NCT00615199|584501792|FG002|Overall Study|Other|0|||
161852401|NCT00615199|584501793|FG003|Overall Study|Other|1|||
161852402|NCT00615199|584501790|FG000|Overall Study|Withdrawal by Subject|2|||
161852403|NCT00615199|584501791|FG001|Overall Study|Withdrawal by Subject|1|||
161852404|NCT00615199|584501792|FG002|Overall Study|Withdrawal by Subject|0|||
161852405|NCT00615199|584501793|FG003|Overall Study|Withdrawal by Subject|0|||
161852406|NCT04825912|584501794|FG000|Overall Study|Death|3|||
161852407|NCT04825912|584501794|FG000|Overall Study|Withdrawal by Subject|1|||
161852408|NCT00459355|584501797|FG000|Overall Study|Subject no longer met inc criteria|20|||
161852409|NCT00459355|584501798|FG001|Overall Study|Subject no longer met inc criteria|18|||
161852410|NCT01009814|584501801|FG000|Overall Study|No longer met study criteria|1|||
161852411|NCT01009814|584501802|FG001|Overall Study|No longer met study criteria|1|||
161852412|NCT01009814|584501803|FG002|Overall Study|No longer met study criteria|0|||
161852413|NCT01009814|584501804|FG003|Overall Study|No longer met study criteria|0|||
161852414|NCT01009814|584501805|FG004|Overall Study|No longer met study criteria|0|||
161852415|NCT00618371|584501806|FG000|Overall Study|Withdrawal by Subject|2|||
161852416|NCT01173120|584501807|FG000|Overall Study|Lack of Efficacy|2|||
161852417|NCT01173120|584501807|FG000|Overall Study|Lost to Follow-up|1|||
161852418|NCT01173120|584501807|FG000|Overall Study|Participant Decision|2|||
161852419|NCT01173120|584501807|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
161852420|NCT01173120|584501807|FG000|Overall Study|Switch-Participant Decision|12|||
161852421|NCT01173120|584501807|FG000|Overall Study|Switch-Difficulty With Device|12|||
161852422|NCT01383707|584501811|FG000|Overall Study|Consent withdrawal|6|||
161852423|NCT01383707|584501811|FG000|Overall Study|Death|19|||
161852424|NCT01383707|584501811|FG000|Overall Study|Other|8|||
161852425|NCT01383707|584501811|FG000|Overall Study|Sponsor's decision|2|||
161852426|NCT01383707|584501811|FG000|Overall Study|Adverse Event|14|||
161852427|NCT01383707|584501811|FG000|Overall Study|Progressive disease|23|||
161852428|NCT01977417|584501815|FG000|Overall Study|Adverse Event|1|||
161852429|NCT01977417|584501816|FG001|Overall Study|Adverse Event|0|||
161852430|NCT01977417|584501815|FG000|Overall Study|Withdrawal by Subject|2|||
161852431|NCT01977417|584501816|FG001|Overall Study|Withdrawal by Subject|4|||
161852432|NCT01977417|584501815|FG000|Overall Study|Female enrollment goal met|0|||
161852433|NCT01977417|584501816|FG001|Overall Study|Female enrollment goal met|2|||
161852434|NCT02906358|584501817|FG000|Overall Study|Withdrawal by Subject|10|||
161852435|NCT02906358|584501818|FG001|Overall Study|Withdrawal by Subject|7|||
161852436|NCT02906358|584501817|FG000|Overall Study|Lost to Follow-up|12|||
161852437|NCT02906358|584501818|FG001|Overall Study|Lost to Follow-up|15|||
161852438|NCT02699684|584501819|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
161852439|NCT02699684|584501820|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
161852440|NCT01625988|584501827|FG000|Overall Study|Lost to Follow-up|5|||
161852441|NCT01625988|584501828|FG001|Overall Study|Lost to Follow-up|6|||
161852442|NCT01625988|584501827|FG000|Overall Study|Withdrawal by Subject|8|||
161852443|NCT01625988|584501828|FG001|Overall Study|Withdrawal by Subject|3|||
161852444|NCT01625988|584501827|FG000|Overall Study|Adverse Event|0|||
161852445|NCT01625988|584501828|FG001|Overall Study|Adverse Event|1|||
161852446|NCT01625988|584501827|FG000|Overall Study|Lack of Efficacy|0|||
161852447|NCT01625988|584501828|FG001|Overall Study|Lack of Efficacy|1|||
161852448|NCT01625988|584501827|FG000|Overall Study|Randomized Inappropriately|1|||
161852449|NCT01625988|584501828|FG001|Overall Study|Randomized Inappropriately|0|||
161852450|NCT01625988|584501827|FG000|Overall Study|Protocol Violation|0|||
161852451|NCT01625988|584501828|FG001|Overall Study|Protocol Violation|2|||
161852452|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
161852453|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
161852454|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
161852455|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
161852456|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
161852457|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
161852458|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
161852459|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
161852460|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161852461|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161973429|NCT02761694|584949653|FG004|Overall Study|Lost to Follow-up|0|||
161852462|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161852463|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161852464|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161852465|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
161852466|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
161852467|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
161852468|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
161852469|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
161852470|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
161852471|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
161852472|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
161852473|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161852474|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
161852475|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161852476|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161852477|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
161852478|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
161852479|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
161852480|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
161852481|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
161852482|NCT03713632|584501831|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
161852483|NCT03713632|584501832|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
161852484|NCT03713632|584501833|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
161852485|NCT03713632|584501834|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
161852486|NCT03713632|584501835|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
161852487|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
161852488|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
161852489|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
161852490|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
161852491|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
161852492|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
161852493|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
161852494|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
161852495|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
161852496|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
161852497|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
161852498|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
161852499|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
161852500|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
161852501|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
161852502|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
161852503|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
161852504|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
161852505|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
161852506|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
161852507|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
161852508|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
161852509|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
161852510|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
161852511|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
161852512|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
161852513|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
161852514|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
161852515|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
161852516|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
161852517|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Death|0|||
161852518|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Death|1|||
161852519|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Death|0|||
161852520|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Death|0|||
161852521|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Death|0|||
161852522|NCT03713632|584501831|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161852523|NCT03713632|584501832|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
161852524|NCT03713632|584501833|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161852525|NCT03713632|584501834|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161852526|NCT03713632|584501835|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161852527|NCT01524978|584501836|FG000|Overall Study|Other|16|||
161852528|NCT01524978|584501837|FG001|Overall Study|Other|2|||
161852529|NCT01524978|584501838|FG002|Overall Study|Other|1|||
161852530|NCT01524978|584501839|FG003|Overall Study|Other|2|||
161852531|NCT01524978|584501840|FG004|Overall Study|Other|1|||
161852532|NCT01524978|584501841|FG005|Overall Study|Other|3|||
161852533|NCT01524978|584501842|FG006|Overall Study|Other|17|||
161852534|NCT01524978|584501843|FG007|Overall Study|Other|1|||
161852535|NCT01524978|584501844|FG008|Overall Study|Other|2|||
161852536|NCT01524978|584501845|FG009|Overall Study|Other|2|||
161852537|NCT01524978|584501846|FG010|Overall Study|Other|5|||
161852538|NCT01524978|584501836|FG000|Overall Study|Withdrawal by Subject|12|||
161852539|NCT01524978|584501837|FG001|Overall Study|Withdrawal by Subject|0|||
161852540|NCT01524978|584501838|FG002|Overall Study|Withdrawal by Subject|1|||
161852541|NCT01524978|584501839|FG003|Overall Study|Withdrawal by Subject|1|||
161852542|NCT01524978|584501840|FG004|Overall Study|Withdrawal by Subject|3|||
161852543|NCT01524978|584501841|FG005|Overall Study|Withdrawal by Subject|1|||
161852544|NCT01524978|584501842|FG006|Overall Study|Withdrawal by Subject|6|||
161852545|NCT01524978|584501843|FG007|Overall Study|Withdrawal by Subject|2|||
161852546|NCT01524978|584501844|FG008|Overall Study|Withdrawal by Subject|4|||
161852547|NCT01524978|584501845|FG009|Overall Study|Withdrawal by Subject|0|||
161852548|NCT01524978|584501846|FG010|Overall Study|Withdrawal by Subject|5|||
161852549|NCT01524978|584501836|FG000|Overall Study|Lost to Follow-up|0|||
161852550|NCT01524978|584501837|FG001|Overall Study|Lost to Follow-up|0|||
161852551|NCT01524978|584501838|FG002|Overall Study|Lost to Follow-up|3|||
161852552|NCT01524978|584501839|FG003|Overall Study|Lost to Follow-up|0|||
161852553|NCT01524978|584501840|FG004|Overall Study|Lost to Follow-up|1|||
161852554|NCT01524978|584501841|FG005|Overall Study|Lost to Follow-up|1|||
161852555|NCT01524978|584501842|FG006|Overall Study|Lost to Follow-up|2|||
161852556|NCT01524978|584501843|FG007|Overall Study|Lost to Follow-up|0|||
161852557|NCT01524978|584501844|FG008|Overall Study|Lost to Follow-up|1|||
161852558|NCT01524978|584501845|FG009|Overall Study|Lost to Follow-up|1|||
161852559|NCT01524978|584501846|FG010|Overall Study|Lost to Follow-up|1|||
161852560|NCT01524978|584501836|FG000|Overall Study|Death|34|||
161852561|NCT01524978|584501837|FG001|Overall Study|Death|2|||
161852562|NCT01524978|584501838|FG002|Overall Study|Death|5|||
161852563|NCT01524978|584501839|FG003|Overall Study|Death|24|||
161852564|NCT01524978|584501840|FG004|Overall Study|Death|4|||
161852565|NCT01524978|584501841|FG005|Overall Study|Death|4|||
161852566|NCT01524978|584501842|FG006|Overall Study|Death|1|||
161852567|NCT01524978|584501843|FG007|Overall Study|Death|9|||
161852568|NCT01524978|584501844|FG008|Overall Study|Death|5|||
161852569|NCT01524978|584501845|FG009|Overall Study|Death|6|||
161852570|NCT01524978|584501846|FG010|Overall Study|Death|17|||
161852571|NCT03971474|584501847|FG000|Overall Study|Adverse Event|11|||
161852572|NCT03971474|584501848|FG001|Overall Study|Adverse Event|7|||
161852573|NCT03971474|584501847|FG000|Overall Study|Refusal unrelated to adverse event|5|||
161852574|NCT03971474|584501848|FG001|Overall Study|Refusal unrelated to adverse event|1|||
161852575|NCT03971474|584501847|FG000|Overall Study|Progression/relapse|40|||
161852576|NCT03971474|584501848|FG001|Overall Study|Progression/relapse|47|||
161852577|NCT03971474|584501847|FG000|Overall Study|Death|6|||
161852578|NCT03971474|584501848|FG001|Overall Study|Death|3|||
161852579|NCT03971474|584501847|FG000|Overall Study|Other - not protocol specified|5|||
161852580|NCT03971474|584501848|FG001|Overall Study|Other - not protocol specified|4|||
161852581|NCT03971474|584501847|FG000|Overall Study|On treatment|0|||
161852582|NCT03971474|584501848|FG001|Overall Study|On treatment|7|||
161852583|NCT01023035|584501850|FG000|Treatment Period|Adverse Event|27|||
161852584|NCT01023035|584501851|FG001|Treatment Period|Adverse Event|32|||
161852585|NCT01023035|584501852|FG002|Treatment Period|Adverse Event|50|||
161852586|NCT01023035|584501850|FG000|Treatment Period|Non-Medical Reasons|19|||
161852587|NCT01023035|584501851|FG001|Treatment Period|Non-Medical Reasons|22|||
161852588|NCT01023035|584501852|FG002|Treatment Period|Non-Medical Reasons|44|||
161852589|NCT01023035|584501850|FG000|Treatment Period|Treatment Failure|26|||
161852590|NCT01023035|584501851|FG001|Treatment Period|Treatment Failure|31|||
161852591|NCT01023035|584501852|FG002|Treatment Period|Treatment Failure|24|||
161852592|NCT01023035|584501850|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
161852593|NCT01023035|584501851|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
161852594|NCT01023035|584501852|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
161852595|NCT01023035|584501850|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
161852596|NCT01023035|584501851|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
161852597|NCT01023035|584501852|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
161852598|NCT01937871|584501854|FG000|Overall Study|Adverse Event|6|||
161852599|NCT01937871|584501855|FG001|Overall Study|Adverse Event|6|||
161852600|NCT01937871|584501856|FG002|Overall Study|Adverse Event|2|||
161852601|NCT01937871|584501854|FG000|Overall Study|Lost to Follow-up|8|||
161852602|NCT01937871|584501855|FG001|Overall Study|Lost to Follow-up|2|||
161852603|NCT01937871|584501856|FG002|Overall Study|Lost to Follow-up|4|||
161852604|NCT01937871|584501854|FG000|Overall Study|Withdrawal by Subject|9|||
161852605|NCT01937871|584501855|FG001|Overall Study|Withdrawal by Subject|6|||
161852606|NCT01937871|584501856|FG002|Overall Study|Withdrawal by Subject|4|||
161852607|NCT01937871|584501854|FG000|Overall Study|Physician Decision|0|||
161852608|NCT01937871|584501855|FG001|Overall Study|Physician Decision|1|||
161852609|NCT01937871|584501856|FG002|Overall Study|Physician Decision|0|||
161852610|NCT01937871|584501854|FG000|Overall Study|Entry Criteria Not Met|1|||
161852611|NCT01937871|584501855|FG001|Overall Study|Entry Criteria Not Met|2|||
161852612|NCT01937871|584501856|FG002|Overall Study|Entry Criteria Not Met|1|||
161852613|NCT01482312|584501857|FG000|Period 1, 90 Minutes of Wear|Other|1|||
161852614|NCT01482312|584501858|FG001|Period 1, 90 Minutes of Wear|Other|0|||
161852615|NCT01482312|584501859|FG002|Period 1, 90 Minutes of Wear|Other|0|||
161852616|NCT01482312|584501857|FG000|Period 2, 90 Minutes of Wear|Other|1|||
161852617|NCT01482312|584501858|FG001|Period 2, 90 Minutes of Wear|Other|0|||
161852618|NCT01482312|584501859|FG002|Period 2, 90 Minutes of Wear|Other|0|||
161852619|NCT01295320|584501860|FG000|Overall Study|Adverse Event|2|||
161852620|NCT01295320|584501860|FG000|Overall Study|Lost to Follow-up|4|||
161852621|NCT01295320|584501860|FG000|Overall Study|Withdrawal by Subject|2|||
161852622|NCT01295320|584501860|FG000|Overall Study|Subject was bedridden|1|||
161852623|NCT01295320|584501860|FG000|Overall Study|Unable to travel|1|||
161852624|NCT00462904|584501861|FG000|Overall Study|Lost to Follow-up|1|||
161852625|NCT02652949|584501862|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
161852626|NCT02652949|584501862|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
161852627|NCT02652949|584501862|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
161852628|NCT02652949|584501862|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
161852629|NCT02652949|584501862|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
161852630|NCT02652949|584501862|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
161852631|NCT02652949|584501862|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
161852632|NCT02652949|584501862|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
161852633|NCT02652949|584501862|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
161852634|NCT02652949|584501862|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
161852635|NCT02652949|584501862|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
161852636|NCT02652949|584501862|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
161852637|NCT02652949|584501862|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
161852638|NCT02652949|584501862|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
161852639|NCT02652949|584501862|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
161852640|NCT02652949|584501862|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
161852641|NCT02652949|584501862|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
161852642|NCT01973595|584501863|FG000|Washout|Withdrawal by Subject|1|||
161852643|NCT01973595|584501864|FG001|Washout|Withdrawal by Subject|0|||
161852644|NCT01973595|584501865|FG002|Washout|Withdrawal by Subject|1|||
161852645|NCT01973595|584501866|FG003|Washout|Withdrawal by Subject|0|||
161852646|NCT02125877|584501867|FG000|Overall Study|Physician Decision|1|||
161852647|NCT02125877|584501868|FG001|Overall Study|Physician Decision|0|||
161852648|NCT02125877|584501867|FG000|Overall Study|Death|0|||
161852649|NCT02125877|584501868|FG001|Overall Study|Death|1|||
161852650|NCT02125877|584501867|FG000|Overall Study|Administrative problems|0|||
161852651|NCT02125877|584501868|FG001|Overall Study|Administrative problems|1|||
161852652|NCT02125877|584501867|FG000|Overall Study|Participant/guardian decision|0|||
161852653|NCT02125877|584501868|FG001|Overall Study|Participant/guardian decision|2|||
161852654|NCT02125877|584501867|FG000|Overall Study|Withdrawal by Subject|2|||
161852655|NCT02125877|584501868|FG001|Overall Study|Withdrawal by Subject|1|||
161852656|NCT02125877|584501867|FG000|Overall Study|Protocol deviation|4|||
161852657|NCT02125877|584501868|FG001|Overall Study|Protocol deviation|1|||
161852658|NCT02125877|584501867|FG000|Overall Study|Adverse Event|6|||
161852659|NCT02125877|584501868|FG001|Overall Study|Adverse Event|4|||
161852660|NCT01141205|584501869|FG000|Overall Study|Physician Decision|1|||
161852661|NCT01141205|584501870|FG001|Overall Study|Physician Decision|1|||
161852662|NCT01141205|584501869|FG000|Overall Study|Lost to Follow-up|1|||
161852663|NCT01141205|584501870|FG001|Overall Study|Lost to Follow-up|0|||
161852664|NCT01141205|584501869|FG000|Overall Study|Withdrawal by Subject|1|||
161852665|NCT01141205|584501870|FG001|Overall Study|Withdrawal by Subject|1|||
161852666|NCT01822366|584501871|FG000|Overall Study|Lost to Follow-up|5|||
161852667|NCT01822366|584501872|FG001|Overall Study|Lost to Follow-up|1|||
161852668|NCT01822366|584501873|FG002|Overall Study|Lost to Follow-up|5|||
161852669|NCT01822366|584501874|FG003|Overall Study|Lost to Follow-up|1|||
161852670|NCT01822366|584501871|FG000|Overall Study|Withdrawal by Subject|0|||
161852671|NCT01822366|584501872|FG001|Overall Study|Withdrawal by Subject|6|||
161852672|NCT01822366|584501873|FG002|Overall Study|Withdrawal by Subject|0|||
161852673|NCT01822366|584501874|FG003|Overall Study|Withdrawal by Subject|6|||
161852674|NCT01822366|584501871|FG000|Overall Study|Partial Intervention Completion|0|||
161852675|NCT01822366|584501872|FG001|Overall Study|Partial Intervention Completion|15|||
161852676|NCT01822366|584501873|FG002|Overall Study|Partial Intervention Completion|0|||
161852677|NCT01822366|584501874|FG003|Overall Study|Partial Intervention Completion|15|||
161852678|NCT05199090|584501875|FG000|Overall Study|Adverse Event|1|||
161852679|NCT05199090|584501876|FG001|Overall Study|Adverse Event|4|||
161852680|NCT05199090|584501877|FG002|Overall Study|Adverse Event|0|||
161852681|NCT05199090|584501878|FG003|Overall Study|Adverse Event|0|||
161973430|NCT02761694|584949654|FG005|Overall Study|Lost to Follow-up|0|||
161852682|NCT05199090|584501879|FG004|Overall Study|Adverse Event|0|||
161852683|NCT05199090|584501880|FG005|Overall Study|Adverse Event|0|||
161852684|NCT05199090|584501875|FG000|Overall Study|Lost to Follow-up|1|||
161852685|NCT05199090|584501876|FG001|Overall Study|Lost to Follow-up|0|||
161852686|NCT05199090|584501877|FG002|Overall Study|Lost to Follow-up|1|||
161852687|NCT05199090|584501878|FG003|Overall Study|Lost to Follow-up|4|||
161852688|NCT05199090|584501879|FG004|Overall Study|Lost to Follow-up|0|||
161973431|NCT02761694|584949655|FG006|Overall Study|Lost to Follow-up|1|||
161973432|NCT02761694|584949656|FG007|Overall Study|Lost to Follow-up|0|||
161765101|NCT01266967|584180458|FG000|Overall Study|Study Closed/Terminated|15|||
161765102|NCT01266967|584180459|FG001|Overall Study|Study Closed/Terminated|17|||
161765103|NCT01266967|584180458|FG000|Overall Study|Lost to Follow-up|2|||
161765104|NCT01266967|584180459|FG001|Overall Study|Lost to Follow-up|1|||
161765105|NCT01266967|584180458|FG000|Overall Study|Physician Decision|0|||
161765106|NCT01266967|584180459|FG001|Overall Study|Physician Decision|1|||
161765107|NCT01266967|584180458|FG000|Overall Study|Withdrawal by Subject|3|||
161765108|NCT01266967|584180459|FG001|Overall Study|Withdrawal by Subject|3|||
161765109|NCT01519700|584180460|FG000|Overall Study|Death|1|||
161765110|NCT01519700|584180461|FG001|Overall Study|Death|0|||
161765111|NCT01519700|584180462|FG002|Overall Study|Death|0|||
161765112|NCT01519700|584180463|FG003|Overall Study|Death|0|||
161765113|NCT01519700|584180460|FG000|Overall Study|Lost to Follow-up|0|||
161765114|NCT01519700|584180461|FG001|Overall Study|Lost to Follow-up|0|||
161765115|NCT01519700|584180462|FG002|Overall Study|Lost to Follow-up|1|||
161765116|NCT01519700|584180463|FG003|Overall Study|Lost to Follow-up|1|||
161765117|NCT01519700|584180460|FG000|Overall Study|Physician Decision|1|||
161765118|NCT01519700|584180461|FG001|Overall Study|Physician Decision|1|||
161765119|NCT01519700|584180462|FG002|Overall Study|Physician Decision|3|||
161765120|NCT01519700|584180463|FG003|Overall Study|Physician Decision|0|||
161765121|NCT01519700|584180460|FG000|Overall Study|Withdrawal by Subject|5|||
161765122|NCT01519700|584180461|FG001|Overall Study|Withdrawal by Subject|3|||
161765123|NCT01519700|584180462|FG002|Overall Study|Withdrawal by Subject|3|||
161765124|NCT01519700|584180463|FG003|Overall Study|Withdrawal by Subject|2|||
161765125|NCT01519700|584180460|FG000|Overall Study|Other Reason|2|||
161765126|NCT01519700|584180461|FG001|Overall Study|Other Reason|2|||
161765127|NCT01519700|584180462|FG002|Overall Study|Other Reason|0|||
161765128|NCT01519700|584180463|FG003|Overall Study|Other Reason|4|||
161765129|NCT05111548|584180464|FG000|Overall Study|Withdrawal by Subject|2|||
161765130|NCT05111548|584180465|FG001|Overall Study|Withdrawal by Subject|1|||
161765131|NCT05111548|584180464|FG000|Overall Study|Adverse Event|1|||
161765132|NCT05111548|584180465|FG001|Overall Study|Adverse Event|0|||
161765133|NCT00561912|584180472|FG000|Overall Study|ineligible|1|||
161765134|NCT03938857|584180473|FG000|Overall Study|Physician Decision|1|||
161765135|NCT03938857|584180474|FG001|Overall Study|Physician Decision|0|||
161765136|NCT03938857|584180475|FG002|Overall Study|Physician Decision|0|||
161765137|NCT03938857|584180476|FG003|Overall Study|Physician Decision|0|||
161765138|NCT02577107|584180477|FG000|Overall Study|Protocol deviation|0|||
161765139|NCT02577107|584180478|FG001|Overall Study|Protocol deviation|1|||
161765140|NCT00577382|584180479|FG000|Overall Study|Adverse Event|0|||
161765141|NCT00577382|584180480|FG001|Overall Study|Adverse Event|6|||
161765142|NCT00577382|584180479|FG000|Overall Study|Withdrawal by Subject|0|||
161765143|NCT00577382|584180480|FG001|Overall Study|Withdrawal by Subject|1|||
161765144|NCT00577382|584180479|FG000|Overall Study|Progressive Disease|17|||
161765145|NCT00577382|584180480|FG001|Overall Study|Progressive Disease|19|||
161765146|NCT00577382|584180479|FG000|Overall Study|Intercurrent Illness|1|||
161765147|NCT00577382|584180480|FG001|Overall Study|Intercurrent Illness|2|||
161765148|NCT00577382|584180479|FG000|Overall Study|Death|1|||
161765149|NCT00577382|584180480|FG001|Overall Study|Death|1|||
161765150|NCT00577382|584180479|FG000|Overall Study|Lost to Follow-up|2|||
161765151|NCT00577382|584180480|FG001|Overall Study|Lost to Follow-up|2|||
161765152|NCT01345162|584180481|FG000|Overall Study|Protocol Violation|2|||
161765153|NCT01345162|584180482|FG001|Overall Study|Protocol Violation|4|||
161765154|NCT03007472|584180484|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
161765155|NCT03007472|584180484|FG000|Overall Study|Death|2|||
161765156|NCT03007472|584180484|FG000|Overall Study|Loss to Follow Up|1|||
161765157|NCT02988115|584180485|FG000|Overall Study|Adverse Event|6|||
161765158|NCT02988115|584180486|FG001|Overall Study|Adverse Event|1|||
161765159|NCT02988115|584180485|FG000|Overall Study|Sponsor Decision|5|||
161765160|NCT02988115|584180486|FG001|Overall Study|Sponsor Decision|2|||
161765161|NCT02988115|584180485|FG000|Overall Study|Withdrawal by Subject|1|||
161765162|NCT02988115|584180486|FG001|Overall Study|Withdrawal by Subject|1|||
161765163|NCT02988115|584180485|FG000|Overall Study|Withdrawn by Mistake|1|||
161765164|NCT02988115|584180486|FG001|Overall Study|Withdrawn by Mistake|0|||
161765165|NCT02988115|584180485|FG000|Overall Study|Lost to Follow-up|1|||
161765166|NCT02988115|584180486|FG001|Overall Study|Lost to Follow-up|0|||
161765167|NCT01731951|584180487|FG000|Overall Study|Documented Disease Progression|1|||
161765168|NCT01731951|584180488|FG001|Overall Study|Documented Disease Progression|0|||
161765169|NCT01731951|584180489|FG002|Overall Study|Documented Disease Progression|0|||
161765170|NCT01731951|584180490|FG003|Overall Study|Documented Disease Progression|0|||
161765171|NCT01731951|584180491|FG004|Overall Study|Documented Disease Progression|0|||
161765172|NCT01731951|584180492|FG005|Overall Study|Documented Disease Progression|0|||
161973433|NCT02761694|584949657|FG008|Overall Study|Lost to Follow-up|0|||
161973434|NCT02761694|584949658|FG009|Overall Study|Lost to Follow-up|0|||
161973435|NCT02761694|584949659|FG010|Overall Study|Lost to Follow-up|0|||
161765173|NCT01731951|584180487|FG000|Overall Study|Lost to Follow-up|2|||
161765174|NCT01731951|584180488|FG001|Overall Study|Lost to Follow-up|0|||
161973436|NCT02761694|584949660|FG011|Overall Study|Lost to Follow-up|1|||
161973437|NCT02761694|584949649|FG000|Overall Study|Adverse Event|0|||
161765175|NCT01731951|584180489|FG002|Overall Study|Lost to Follow-up|0|||
161765176|NCT01731951|584180490|FG003|Overall Study|Lost to Follow-up|1|||
161852689|NCT05199090|584501880|FG005|Overall Study|Lost to Follow-up|5|||
161852690|NCT05199090|584501875|FG000|Overall Study|Physician Decision|0|||
161852691|NCT05199090|584501876|FG001|Overall Study|Physician Decision|0|||
161852692|NCT05199090|584501877|FG002|Overall Study|Physician Decision|0|||
161852693|NCT05199090|584501878|FG003|Overall Study|Physician Decision|0|||
161852694|NCT05199090|584501879|FG004|Overall Study|Physician Decision|0|||
161852695|NCT05199090|584501880|FG005|Overall Study|Physician Decision|1|||
161852696|NCT05199090|584501875|FG000|Overall Study|Study terminated by sponsor|0|||
161852697|NCT05199090|584501876|FG001|Overall Study|Study terminated by sponsor|6|||
161852698|NCT05199090|584501877|FG002|Overall Study|Study terminated by sponsor|0|||
161852699|NCT05199090|584501878|FG003|Overall Study|Study terminated by sponsor|0|||
161852700|NCT05199090|584501879|FG004|Overall Study|Study terminated by sponsor|0|||
161852701|NCT05199090|584501880|FG005|Overall Study|Study terminated by sponsor|5|||
161852702|NCT05199090|584501875|FG000|Overall Study|Subject decision|0|||
161852703|NCT05199090|584501876|FG001|Overall Study|Subject decision|4|||
161852704|NCT05199090|584501877|FG002|Overall Study|Subject decision|0|||
161852705|NCT05199090|584501878|FG003|Overall Study|Subject decision|2|||
161852706|NCT05199090|584501879|FG004|Overall Study|Subject decision|5|||
161852707|NCT05199090|584501880|FG005|Overall Study|Subject decision|2|||
161852708|NCT03489109|584501881|FG000|Overall Study|Lost to Follow-up|1|||
161852709|NCT03489109|584501882|FG001|Overall Study|Lost to Follow-up|2|||
161852710|NCT04868968|584501883|FG000|Overall Study|Lost to Follow-up|1|||
161852711|NCT00384930|584501886|FG000|Overall Study|Adverse Event|5|||
161852712|NCT00384930|584501887|FG001|Overall Study|Adverse Event|4|||
161765177|NCT01731951|584180491|FG004|Overall Study|Lost to Follow-up|3|||
161765178|NCT01731951|584180492|FG005|Overall Study|Lost to Follow-up|1|||
161765179|NCT01731951|584180487|FG000|Overall Study|Withdrawal of Consent|1|||
161765180|NCT01731951|584180488|FG001|Overall Study|Withdrawal of Consent|0|||
161765181|NCT01731951|584180489|FG002|Overall Study|Withdrawal of Consent|0|||
161765182|NCT01731951|584180490|FG003|Overall Study|Withdrawal of Consent|0|||
161765183|NCT01731951|584180491|FG004|Overall Study|Withdrawal of Consent|0|||
161765184|NCT01731951|584180492|FG005|Overall Study|Withdrawal of Consent|2|||
161765185|NCT01731951|584180487|FG000|Overall Study|Death|13|||
161765186|NCT01731951|584180488|FG001|Overall Study|Death|15|||
161765187|NCT01731951|584180489|FG002|Overall Study|Death|9|||
161765188|NCT01731951|584180490|FG003|Overall Study|Death|8|||
161765189|NCT01731951|584180491|FG004|Overall Study|Death|9|||
161765190|NCT01731951|584180492|FG005|Overall Study|Death|6|||
161765191|NCT00649220|584180499|FG000|Overall Study|Adverse Event|2|||
161765192|NCT00649220|584180499|FG000|Overall Study|Withdrawal by Subject|1|||
161765193|NCT01977651|584180500|FG000|4 Month Treatment Period|Adverse Event|34|||
161765194|NCT01977651|584180500|FG000|4 Month Treatment Period|Death|3|||
161765195|NCT01977651|584180500|FG000|4 Month Treatment Period|Progressive Disease|43|||
161765196|NCT01977651|584180500|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
161765197|NCT01977651|584180500|FG000|4 Month Treatment Period|Physician Decision|4|||
161765198|NCT01977651|584180500|FG000|1 Year Extension Period|Adverse Event|14|||
161765199|NCT01977651|584180500|FG000|1 Year Extension Period|Death|10|||
161765200|NCT01977651|584180500|FG000|1 Year Extension Period|Lost to Follow-up|2|||
161765201|NCT01977651|584180500|FG000|1 Year Extension Period|Progressive Disease|86|||
161765202|NCT01977651|584180500|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
161765203|NCT01977651|584180500|FG000|1 Year Extension Period|Physician Decision|6|||
161765204|NCT01977651|584180500|FG000|1 Year Extension Period|Miscellaneous|1|||
161765205|NCT01977651|584180500|FG000|Post 1 Year Extension Period|Adverse Event|5|||
161765206|NCT01977651|584180500|FG000|Post 1 Year Extension Period|Death|13|||
161765207|NCT01977651|584180500|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
161765208|NCT01977651|584180500|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
161765209|NCT01977651|584180500|FG000|Post 1 Year Extension Period|Physician Decision|4|||
161765210|NCT01977651|584180500|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
161765211|NCT02906644|584180506|FG000|First 2 Weeks|Withdrawal by Subject|0|||
161765212|NCT02906644|584180507|FG001|First 2 Weeks|Withdrawal by Subject|2|||
161765213|NCT02906644|584180506|FG000|First 2 Weeks|Physician Decision|1|||
161765214|NCT02906644|584180507|FG001|First 2 Weeks|Physician Decision|1|||
161765215|NCT02906644|584180506|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
161765216|NCT02906644|584180507|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
161765217|NCT02906644|584180506|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
161765218|NCT02906644|584180507|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
161765219|NCT03672006|584180510|FG000|Overall Study|exclusion criteria met|0|||
161765220|NCT03672006|584180511|FG001|Overall Study|exclusion criteria met|1|||
161852713|NCT00384930|584501888|FG002|Overall Study|Adverse Event|12|||
161852714|NCT00384930|584501889|FG003|Overall Study|Adverse Event|11|||
161852715|NCT00384930|584501890|FG004|Overall Study|Adverse Event|14|||
161852716|NCT00384930|584501886|FG000|Overall Study|Entry Criteria Not Met|2|||
161852717|NCT00384930|584501887|FG001|Overall Study|Entry Criteria Not Met|6|||
161852718|NCT00384930|584501888|FG002|Overall Study|Entry Criteria Not Met|7|||
161973438|NCT02761694|584949650|FG001|Overall Study|Adverse Event|0|||
161973439|NCT02761694|584949651|FG002|Overall Study|Adverse Event|0|||
161973440|NCT02761694|584949652|FG003|Overall Study|Adverse Event|0|||
161973441|NCT02761694|584949653|FG004|Overall Study|Adverse Event|0|||
161973442|NCT02761694|584949654|FG005|Overall Study|Adverse Event|0|||
161973443|NCT02761694|584949655|FG006|Overall Study|Adverse Event|1|||
161973444|NCT02761694|584949656|FG007|Overall Study|Adverse Event|0|||
161973445|NCT02761694|584949657|FG008|Overall Study|Adverse Event|1|||
161973446|NCT02761694|584949658|FG009|Overall Study|Adverse Event|0|||
161973447|NCT02761694|584949659|FG010|Overall Study|Adverse Event|0|||
161973448|NCT02761694|584949660|FG011|Overall Study|Adverse Event|1|||
161973449|NCT02761694|584949649|FG000|Overall Study|Other|4|||
161973450|NCT02761694|584949650|FG001|Overall Study|Other|4|||
161973451|NCT02761694|584949651|FG002|Overall Study|Other|1|||
161973452|NCT02761694|584949652|FG003|Overall Study|Other|2|||
161973453|NCT02761694|584949653|FG004|Overall Study|Other|3|||
161973454|NCT02761694|584949654|FG005|Overall Study|Other|3|||
161973455|NCT02761694|584949655|FG006|Overall Study|Other|18|||
161973456|NCT02761694|584949656|FG007|Overall Study|Other|8|||
161973457|NCT02761694|584949657|FG008|Overall Study|Other|0|||
161973458|NCT02761694|584949658|FG009|Overall Study|Other|1|||
161973459|NCT02761694|584949659|FG010|Overall Study|Other|1|||
161973460|NCT02761694|584949660|FG011|Overall Study|Other|0|||
161973461|NCT02395055|584949669|FG000|Overall Study|Withdrawal by Subject|7|||
161973462|NCT02395055|584949670|FG001|Overall Study|Withdrawal by Subject|3|||
161973463|NCT01896271|584949671|FG000|Overall Study|Physician Decision|10|||
161973464|NCT03959982|584952209|FG000|Overall Study|Withdrawal by Subject|1|||
161973465|NCT03959982|584952210|FG001|Overall Study|Withdrawal by Subject|0|||
161973466|NCT03959982|584952209|FG000|Overall Study|Physician Decision|2|||
161973467|NCT03959982|584952210|FG001|Overall Study|Physician Decision|0|||
161973468|NCT03959982|584952209|FG000|Overall Study|Lost to Follow-up|1|||
161973469|NCT03959982|584952210|FG001|Overall Study|Lost to Follow-up|0|||
161973470|NCT00240110|584952212|FG000|Overall Study|Lost to Follow-up|6|||
161973471|NCT00240110|584952213|FG001|Overall Study|Lost to Follow-up|7|||
161973472|NCT02080260|584952215|FG000|Overall Study|Death|18|||
161973473|NCT02080260|584952215|FG000|Overall Study|Withdrawal by Subject|1|||
161973474|NCT05438602|584952220|FG000|Treatment (15 Days)|Adverse Event|2|||
161973475|NCT05438602|584952221|FG001|Treatment (15 Days)|Adverse Event|1|||
161973476|NCT05438602|584952222|FG002|Treatment (15 Days)|Adverse Event|3|||
161973477|NCT05438602|584952220|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
161973478|NCT05438602|584952221|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
161973479|NCT05438602|584952222|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
161973480|NCT05438602|584952220|FG000|Treatment (15 Days)|Other|0|||
161973481|NCT05438602|584952221|FG001|Treatment (15 Days)|Other|0|||
161973482|NCT05438602|584952222|FG002|Treatment (15 Days)|Other|1|||
161973483|NCT05438602|584952220|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
161973484|NCT05438602|584952221|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
161973485|NCT05438602|584952222|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
161973486|NCT05438602|584952220|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
161973487|NCT05438602|584952221|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
161973488|NCT05438602|584952222|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
161973489|NCT05438602|584952220|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
161973490|NCT05438602|584952221|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
161973491|NCT05438602|584952222|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
161973492|NCT05438602|584952220|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
161973493|NCT05438602|584952221|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
161973494|NCT05438602|584952222|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
161973495|NCT05438602|584952220|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
161973496|NCT05438602|584952221|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
161973497|NCT05438602|584952222|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
161973498|NCT05438602|584952220|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
161765221|NCT03288987|584180512|FG000|Overall Study|Protocol Violation|10|||
161765222|NCT03288987|584180513|FG001|Overall Study|Protocol Violation|4|||
161765223|NCT00608426|584180514|FG000|Overall Study|Death|32|||
161973499|NCT05438602|584952221|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
161973500|NCT05438602|584952222|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
161973501|NCT05438602|584952220|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
161973502|NCT05438602|584952221|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
161973503|NCT05438602|584952222|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
161973504|NCT02853435|584952223|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
161973505|NCT02853435|584952224|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
161973506|NCT02853435|584952225|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
161973507|NCT02853435|584952226|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
161973508|NCT02853435|584952227|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
161973509|NCT02853435|584952228|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
161973510|NCT03747120|584952231|FG000|Overall Study|treatment related toxicity|3|||
161973511|NCT03747120|584952232|FG001|Overall Study|treatment related toxicity|0|||
161973512|NCT03747120|584952233|FG002|Overall Study|treatment related toxicity|0|||
161973513|NCT03747120|584952231|FG000|Overall Study|Withdrawal by Subject|0|||
161973514|NCT03747120|584952232|FG001|Overall Study|Withdrawal by Subject|1|||
161973515|NCT03747120|584952233|FG002|Overall Study|Withdrawal by Subject|2|||
161973516|NCT03383783|584952240|FG000|Overall Study|Withdrawal by Subject|2|||
161973517|NCT01340937|584952242|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
161973518|NCT01340937|584952243|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
161973519|NCT01340937|584952244|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
161973520|NCT01340937|584952245|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
161973521|NCT01340937|584952242|FG000|Period 1: Infant Series|Adverse Event|0|||
161973522|NCT01340937|584952243|FG001|Period 1: Infant Series|Adverse Event|1|||
161973523|NCT01340937|584952244|FG002|Period 1: Infant Series|Adverse Event|4|||
161973524|NCT01340937|584952245|FG003|Period 1: Infant Series|Adverse Event|0|||
161973525|NCT01340937|584952242|FG000|Period 1: Infant Series|Death|2|||
161973526|NCT01340937|584952243|FG001|Period 1: Infant Series|Death|0|||
161973527|NCT01340937|584952244|FG002|Period 1: Infant Series|Death|2|||
161973528|NCT01340937|584952245|FG003|Period 1: Infant Series|Death|0|||
161973529|NCT01340937|584952242|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
161973530|NCT01340937|584952243|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
161973531|NCT01340937|584952244|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
161973532|NCT01340937|584952245|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
161973533|NCT01340937|584952242|FG000|Period 1: Infant Series|Physician Decision|2|||
161973534|NCT01340937|584952243|FG001|Period 1: Infant Series|Physician Decision|3|||
161973535|NCT01340937|584952244|FG002|Period 1: Infant Series|Physician Decision|1|||
161973536|NCT01340937|584952245|FG003|Period 1: Infant Series|Physician Decision|0|||
161973537|NCT01340937|584952242|FG000|Period 1: Infant Series|Protocol Violation|1|||
161973538|NCT01340937|584952243|FG001|Period 1: Infant Series|Protocol Violation|4|||
161973539|NCT01340937|584952244|FG002|Period 1: Infant Series|Protocol Violation|4|||
161973540|NCT01340937|584952245|FG003|Period 1: Infant Series|Protocol Violation|3|||
161973541|NCT01340937|584952242|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
161973542|NCT01340937|584952243|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
161973543|NCT01340937|584952244|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
161973544|NCT01340937|584952245|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
161973545|NCT01340937|584952242|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
161973546|NCT01340937|584952243|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
161973547|NCT01340937|584952244|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
161765224|NCT00608426|584180515|FG001|Overall Study|Death|36|||
161765225|NCT00608426|584180514|FG000|Overall Study|Lost to Follow-up|485|||
161765226|NCT00608426|584180515|FG001|Overall Study|Lost to Follow-up|521|||
161765227|NCT00608426|584180514|FG000|Overall Study|refused, health issues, wrong address|319|||
161765228|NCT00608426|584180515|FG001|Overall Study|refused, health issues, wrong address|348|||
161765229|NCT00761891|584180516|FG000|Overall Study|Withdrawal by Subject|10|||
161765230|NCT00368069|584180517|FG000|Overall Study|Adverse Event|5|||
161765231|NCT00368069|584180518|FG001|Overall Study|Adverse Event|2|||
161765232|NCT00368069|584180517|FG000|Overall Study|Lack of Efficacy|0|||
161765233|NCT00368069|584180518|FG001|Overall Study|Lack of Efficacy|1|||
161765234|NCT00368069|584180517|FG000|Overall Study|Lost to Follow-up|1|||
161765235|NCT00368069|584180518|FG001|Overall Study|Lost to Follow-up|0|||
161765236|NCT00368069|584180517|FG000|Overall Study|Protocol Violation|0|||
161765237|NCT00368069|584180518|FG001|Overall Study|Protocol Violation|2|||
161765238|NCT00368069|584180517|FG000|Overall Study|Withdrawal of Consent|2|||
161765239|NCT00368069|584180518|FG001|Overall Study|Withdrawal of Consent|1|||
161765240|NCT00368069|584180517|FG000|Overall Study|no blood sampling possible|0|||
161765241|NCT00368069|584180518|FG001|Overall Study|no blood sampling possible|1|||
161765242|NCT02135848|584180531|FG000|Overall Study|Adverse Event|2|||
161765243|NCT02135848|584180532|FG001|Overall Study|Adverse Event|0|||
161765244|NCT02135848|584180531|FG000|Overall Study|Withdrawal by Subject|1|||
161765245|NCT02135848|584180532|FG001|Overall Study|Withdrawal by Subject|1|||
161765246|NCT02030067|584180533|FG000|Overall Study|Disease Progression|1|||
161765247|NCT02030067|584180534|FG001|Overall Study|Disease Progression|1|||
161765248|NCT02030067|584180535|FG002|Overall Study|Disease Progression|2|||
161765249|NCT02030067|584180536|FG003|Overall Study|Disease Progression|2|||
161765250|NCT02030067|584180537|FG004|Overall Study|Disease Progression|3|||
161765251|NCT02030067|584180538|FG005|Overall Study|Disease Progression|2|||
161765252|NCT02030067|584180539|FG006|Overall Study|Disease Progression|3|||
161852719|NCT00384930|584501889|FG003|Overall Study|Entry Criteria Not Met|8|||
161765253|NCT02030067|584180540|FG007|Overall Study|Disease Progression|3|||
161765254|NCT02030067|584180541|FG008|Overall Study|Disease Progression|4|||
161765255|NCT02030067|584180542|FG009|Overall Study|Disease Progression|3|||
161852720|NCT00384930|584501890|FG004|Overall Study|Entry Criteria Not Met|4|||
161765256|NCT02030067|584180543|FG010|Overall Study|Disease Progression|7|||
161765257|NCT02030067|584180544|FG011|Overall Study|Disease Progression|2|||
161973548|NCT01340937|584952245|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
161973549|NCT01340937|584952242|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
161973550|NCT01340937|584952243|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
161973551|NCT01340937|584952244|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
161973552|NCT01340937|584952245|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
161973553|NCT01340937|584952242|FG000|Period 2: Interim Period|Adverse Event|1|||
161973554|NCT01340937|584952243|FG001|Period 2: Interim Period|Adverse Event|0|||
161973555|NCT01340937|584952244|FG002|Period 2: Interim Period|Adverse Event|1|||
161973556|NCT01340937|584952245|FG003|Period 2: Interim Period|Adverse Event|0|||
161973557|NCT01340937|584952242|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
161973558|NCT01340937|584952243|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
161973559|NCT01340937|584952244|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
161973560|NCT01340937|584952245|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
161973561|NCT01340937|584952242|FG000|Period 2: Interim Period|Physician Decision|0|||
161973562|NCT01340937|584952243|FG001|Period 2: Interim Period|Physician Decision|1|||
161973563|NCT01340937|584952244|FG002|Period 2: Interim Period|Physician Decision|1|||
161973564|NCT01340937|584952245|FG003|Period 2: Interim Period|Physician Decision|0|||
161973565|NCT01340937|584952242|FG000|Period 2: Interim Period|Protocol Violation|5|||
161973566|NCT01340937|584952243|FG001|Period 2: Interim Period|Protocol Violation|3|||
161973567|NCT01340937|584952244|FG002|Period 2: Interim Period|Protocol Violation|6|||
161973568|NCT01340937|584952245|FG003|Period 2: Interim Period|Protocol Violation|3|||
161973569|NCT01340937|584952242|FG000|Period 2: Interim Period|Technical problems|4|||
161973570|NCT01340937|584952243|FG001|Period 2: Interim Period|Technical problems|4|||
161973571|NCT01340937|584952244|FG002|Period 2: Interim Period|Technical problems|6|||
161973572|NCT01340937|584952245|FG003|Period 2: Interim Period|Technical problems|3|||
161973573|NCT01340937|584952242|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
161973574|NCT01340937|584952243|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
161973575|NCT01340937|584952244|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
161973576|NCT01340937|584952245|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
161973577|NCT01340937|584952242|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
161973578|NCT01340937|584952243|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
161973579|NCT01340937|584952244|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
161765258|NCT02030067|584180545|FG012|Overall Study|Disease Progression|59|||
161765259|NCT02030067|584180533|FG000|Overall Study|Withdrawal by Subject|0|||
161765260|NCT02030067|584180534|FG001|Overall Study|Withdrawal by Subject|0|||
161765261|NCT02030067|584180535|FG002|Overall Study|Withdrawal by Subject|0|||
161765262|NCT02030067|584180536|FG003|Overall Study|Withdrawal by Subject|1|||
161765263|NCT02030067|584180537|FG004|Overall Study|Withdrawal by Subject|0|||
161765264|NCT02030067|584180538|FG005|Overall Study|Withdrawal by Subject|0|||
161765265|NCT02030067|584180539|FG006|Overall Study|Withdrawal by Subject|0|||
161765266|NCT02030067|584180540|FG007|Overall Study|Withdrawal by Subject|1|||
161765267|NCT02030067|584180541|FG008|Overall Study|Withdrawal by Subject|0|||
161765268|NCT02030067|584180542|FG009|Overall Study|Withdrawal by Subject|0|||
161765269|NCT02030067|584180543|FG010|Overall Study|Withdrawal by Subject|3|||
161765270|NCT02030067|584180544|FG011|Overall Study|Withdrawal by Subject|0|||
161765271|NCT02030067|584180545|FG012|Overall Study|Withdrawal by Subject|6|||
161765272|NCT02030067|584180533|FG000|Overall Study|Physician Decision|0|||
161765273|NCT02030067|584180534|FG001|Overall Study|Physician Decision|0|||
161765274|NCT02030067|584180535|FG002|Overall Study|Physician Decision|0|||
161765275|NCT02030067|584180536|FG003|Overall Study|Physician Decision|0|||
161765276|NCT02030067|584180537|FG004|Overall Study|Physician Decision|0|||
161765277|NCT02030067|584180538|FG005|Overall Study|Physician Decision|0|||
161765278|NCT02030067|584180539|FG006|Overall Study|Physician Decision|0|||
161765279|NCT02030067|584180540|FG007|Overall Study|Physician Decision|0|||
161765280|NCT02030067|584180541|FG008|Overall Study|Physician Decision|0|||
161765281|NCT02030067|584180542|FG009|Overall Study|Physician Decision|0|||
161765282|NCT02030067|584180543|FG010|Overall Study|Physician Decision|1|||
161765283|NCT02030067|584180544|FG011|Overall Study|Physician Decision|0|||
161765284|NCT02030067|584180545|FG012|Overall Study|Physician Decision|3|||
161765285|NCT02030067|584180533|FG000|Overall Study|other reasons|0|||
161765286|NCT02030067|584180534|FG001|Overall Study|other reasons|0|||
161765287|NCT02030067|584180535|FG002|Overall Study|other reasons|0|||
161765288|NCT02030067|584180536|FG003|Overall Study|other reasons|0|||
161765289|NCT02030067|584180537|FG004|Overall Study|other reasons|0|||
161765290|NCT02030067|584180538|FG005|Overall Study|other reasons|1|||
161765291|NCT02030067|584180539|FG006|Overall Study|other reasons|0|||
161765292|NCT02030067|584180540|FG007|Overall Study|other reasons|0|||
161765293|NCT02030067|584180541|FG008|Overall Study|other reasons|2|||
161765294|NCT02030067|584180542|FG009|Overall Study|other reasons|0|||
161765295|NCT02030067|584180543|FG010|Overall Study|other reasons|0|||
161765296|NCT02030067|584180544|FG011|Overall Study|other reasons|0|||
161765297|NCT02030067|584180545|FG012|Overall Study|other reasons|4|||
161765298|NCT02030067|584180533|FG000|Overall Study|Adverse Event|0|||
161765299|NCT02030067|584180534|FG001|Overall Study|Adverse Event|0|||
161765300|NCT02030067|584180535|FG002|Overall Study|Adverse Event|0|||
161765301|NCT02030067|584180536|FG003|Overall Study|Adverse Event|0|||
161765302|NCT02030067|584180537|FG004|Overall Study|Adverse Event|0|||
161852721|NCT00384930|584501886|FG000|Overall Study|Lack of Efficacy|1|||
161852722|NCT00384930|584501887|FG001|Overall Study|Lack of Efficacy|1|||
161852723|NCT00384930|584501888|FG002|Overall Study|Lack of Efficacy|2|||
161852724|NCT00384930|584501889|FG003|Overall Study|Lack of Efficacy|1|||
161852725|NCT00384930|584501890|FG004|Overall Study|Lack of Efficacy|2|||
161852726|NCT00384930|584501886|FG000|Overall Study|Lost to Follow-up|5|||
161852727|NCT00384930|584501887|FG001|Overall Study|Lost to Follow-up|3|||
161852728|NCT00384930|584501888|FG002|Overall Study|Lost to Follow-up|0|||
161852729|NCT00384930|584501889|FG003|Overall Study|Lost to Follow-up|4|||
161852730|NCT00384930|584501890|FG004|Overall Study|Lost to Follow-up|6|||
161852731|NCT00384930|584501886|FG000|Overall Study|Physician Decision|0|||
161852732|NCT00384930|584501887|FG001|Overall Study|Physician Decision|1|||
161852733|NCT00384930|584501888|FG002|Overall Study|Physician Decision|1|||
161852734|NCT00384930|584501889|FG003|Overall Study|Physician Decision|0|||
161852735|NCT00384930|584501890|FG004|Overall Study|Physician Decision|1|||
161852736|NCT00384930|584501886|FG000|Overall Study|Protocol Violation|1|||
161852737|NCT00384930|584501887|FG001|Overall Study|Protocol Violation|0|||
161852738|NCT00384930|584501888|FG002|Overall Study|Protocol Violation|1|||
161852739|NCT00384930|584501889|FG003|Overall Study|Protocol Violation|6|||
161852740|NCT00384930|584501890|FG004|Overall Study|Protocol Violation|4|||
161852741|NCT00384930|584501886|FG000|Overall Study|Sponsor Decision|3|||
161852742|NCT00384930|584501887|FG001|Overall Study|Sponsor Decision|4|||
161852743|NCT00384930|584501888|FG002|Overall Study|Sponsor Decision|0|||
161852744|NCT00384930|584501889|FG003|Overall Study|Sponsor Decision|5|||
161852745|NCT00384930|584501890|FG004|Overall Study|Sponsor Decision|0|||
161852746|NCT00384930|584501886|FG000|Overall Study|Withdrawal by Subject|9|||
161852747|NCT00384930|584501887|FG001|Overall Study|Withdrawal by Subject|7|||
161852748|NCT00384930|584501888|FG002|Overall Study|Withdrawal by Subject|7|||
161852749|NCT00384930|584501889|FG003|Overall Study|Withdrawal by Subject|6|||
161852750|NCT00384930|584501890|FG004|Overall Study|Withdrawal by Subject|16|||
161852751|NCT00384930|584501886|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
161852752|NCT00384930|584501887|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
161852753|NCT00384930|584501888|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
161852754|NCT00384930|584501889|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
161852755|NCT00384930|584501890|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
161852756|NCT02552732|584501893|FG000|Overall Study|Lost to Follow-up|2|||
161852757|NCT02552732|584501893|FG000|Overall Study|Physician Decision|1|||
161852758|NCT02552732|584501893|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
161852759|NCT02552732|584501893|FG000|Overall Study|Withdrawal by Subject|6|||
161852760|NCT01547130|584501896|FG000|Overall Study|Lost to Follow-up|9|||
161852761|NCT01547130|584501897|FG001|Overall Study|Lost to Follow-up|5|||
161852762|NCT00025259|584501899|FG000|Overall Study|Death|1|||
161852763|NCT00025259|584501900|FG001|Overall Study|Death|3|||
161852764|NCT00025259|584501901|FG002|Overall Study|Death|0|||
161852765|NCT00025259|584501902|FG003|Overall Study|Death|3|||
161852766|NCT00025259|584501903|FG004|Overall Study|Death|0|||
161852767|NCT00025259|584501904|FG005|Overall Study|Death|1|||
161852768|NCT00025259|584501905|FG006|Overall Study|Death|2|||
161852769|NCT00025259|584501899|FG000|Overall Study|Lack of Efficacy|2|||
161852770|NCT00025259|584501900|FG001|Overall Study|Lack of Efficacy|46|||
161852771|NCT00025259|584501901|FG002|Overall Study|Lack of Efficacy|60|||
161852772|NCT00025259|584501902|FG003|Overall Study|Lack of Efficacy|78|||
161852773|NCT00025259|584501903|FG004|Overall Study|Lack of Efficacy|11|||
161852774|NCT00025259|584501904|FG005|Overall Study|Lack of Efficacy|30|||
161852775|NCT00025259|584501905|FG006|Overall Study|Lack of Efficacy|38|||
161852776|NCT00025259|584501899|FG000|Overall Study|Lost to Follow-up|2|||
161852777|NCT00025259|584501900|FG001|Overall Study|Lost to Follow-up|9|||
161852778|NCT00025259|584501901|FG002|Overall Study|Lost to Follow-up|13|||
161852779|NCT00025259|584501902|FG003|Overall Study|Lost to Follow-up|13|||
161852780|NCT00025259|584501903|FG004|Overall Study|Lost to Follow-up|1|||
161852781|NCT00025259|584501904|FG005|Overall Study|Lost to Follow-up|3|||
161852782|NCT00025259|584501905|FG006|Overall Study|Lost to Follow-up|1|||
161852783|NCT00025259|584501899|FG000|Overall Study|Physician Decision|12|||
161852784|NCT00025259|584501900|FG001|Overall Study|Physician Decision|1|||
161852785|NCT00025259|584501901|FG002|Overall Study|Physician Decision|0|||
161852786|NCT00025259|584501902|FG003|Overall Study|Physician Decision|5|||
161852787|NCT00025259|584501903|FG004|Overall Study|Physician Decision|4|||
161852788|NCT00025259|584501904|FG005|Overall Study|Physician Decision|2|||
161852789|NCT00025259|584501905|FG006|Overall Study|Physician Decision|1|||
161852790|NCT00025259|584501899|FG000|Overall Study|Protocol Violation|3|||
161852791|NCT00025259|584501900|FG001|Overall Study|Protocol Violation|2|||
161852792|NCT00025259|584501901|FG002|Overall Study|Protocol Violation|2|||
161852793|NCT00025259|584501902|FG003|Overall Study|Protocol Violation|1|||
161852794|NCT00025259|584501903|FG004|Overall Study|Protocol Violation|2|||
161852795|NCT00025259|584501904|FG005|Overall Study|Protocol Violation|1|||
161852796|NCT00025259|584501905|FG006|Overall Study|Protocol Violation|3|||
161852797|NCT00025259|584501899|FG000|Overall Study|Withdrawal by Subject|9|||
161852798|NCT00025259|584501900|FG001|Overall Study|Withdrawal by Subject|27|||
161852799|NCT00025259|584501901|FG002|Overall Study|Withdrawal by Subject|6|||
161852800|NCT00025259|584501902|FG003|Overall Study|Withdrawal by Subject|14|||
161852801|NCT00025259|584501903|FG004|Overall Study|Withdrawal by Subject|11|||
161852802|NCT00025259|584501904|FG005|Overall Study|Withdrawal by Subject|8|||
161852803|NCT00025259|584501905|FG006|Overall Study|Withdrawal by Subject|3|||
161852804|NCT00025259|584501899|FG000|Overall Study|Ineligible|14|||
161852805|NCT00025259|584501900|FG001|Overall Study|Ineligible|1|||
161852806|NCT00025259|584501901|FG002|Overall Study|Ineligible|0|||
161852807|NCT00025259|584501902|FG003|Overall Study|Ineligible|0|||
161852808|NCT00025259|584501903|FG004|Overall Study|Ineligible|6|||
161852809|NCT00025259|584501904|FG005|Overall Study|Ineligible|0|||
161852810|NCT00025259|584501905|FG006|Overall Study|Ineligible|1|||
161852811|NCT00025259|584501899|FG000|Overall Study|Randomization error|1|||
161852812|NCT00025259|584501900|FG001|Overall Study|Randomization error|0|||
161852813|NCT00025259|584501901|FG002|Overall Study|Randomization error|0|||
161852814|NCT00025259|584501902|FG003|Overall Study|Randomization error|0|||
161852815|NCT00025259|584501903|FG004|Overall Study|Randomization error|1|||
161852816|NCT00025259|584501904|FG005|Overall Study|Randomization error|7|||
161852817|NCT00025259|584501905|FG006|Overall Study|Randomization error|2|||
161852818|NCT00025259|584501899|FG000|Overall Study|Adverse Event|1|||
161852819|NCT00025259|584501900|FG001|Overall Study|Adverse Event|0|||
161852820|NCT00025259|584501901|FG002|Overall Study|Adverse Event|0|||
161852821|NCT00025259|584501902|FG003|Overall Study|Adverse Event|0|||
161852822|NCT00025259|584501903|FG004|Overall Study|Adverse Event|0|||
161852823|NCT00025259|584501904|FG005|Overall Study|Adverse Event|0|||
161852824|NCT00025259|584501905|FG006|Overall Study|Adverse Event|0|||
161852825|NCT04324021|584501909|FG000|Overall Study|Adverse Event|1|||
161852826|NCT04324021|584501910|FG001|Overall Study|Adverse Event|0|||
161852827|NCT04324021|584501911|FG002|Overall Study|Adverse Event|0|||
161852828|NCT04324021|584501909|FG000|Overall Study|Lack of Efficacy|0|||
161852829|NCT04324021|584501910|FG001|Overall Study|Lack of Efficacy|0|||
161852830|NCT04324021|584501911|FG002|Overall Study|Lack of Efficacy|1|||
161852831|NCT04324021|584501909|FG000|Overall Study|Death|1|||
161852832|NCT04324021|584501910|FG001|Overall Study|Death|1|||
161852833|NCT04324021|584501911|FG002|Overall Study|Death|0|||
161852834|NCT00246324|584501912|FG000|Overall Study|Withdrawal by Subject|1|||
161852835|NCT01098487|584501914|FG000|Overall Study|Adverse Event|22|||
161852836|NCT01098487|584501914|FG000|Overall Study|Lack of Efficacy|11|||
161852837|NCT01098487|584501914|FG000|Overall Study|Withdrawal by Subject|7|||
161852838|NCT01098487|584501914|FG000|Overall Study|Lost to Follow-up|3|||
161852839|NCT01098487|584501914|FG000|Overall Study|Physician Decision|1|||
161852840|NCT00345631|584501915|FG000|Overall Study|Withdrawal by Subject|1|||
161852841|NCT00345631|584501916|FG001|Overall Study|Withdrawal by Subject|0|||
161852842|NCT00345631|584501917|FG002|Overall Study|Withdrawal by Subject|1|||
161852843|NCT00345631|584501915|FG000|Overall Study|Adverse Event|0|||
161852844|NCT00345631|584501916|FG001|Overall Study|Adverse Event|1|||
161852845|NCT00345631|584501917|FG002|Overall Study|Adverse Event|0|||
161852846|NCT00345631|584501915|FG000|Overall Study|Lost to Follow-up|3|||
161852847|NCT00345631|584501916|FG001|Overall Study|Lost to Follow-up|7|||
161852848|NCT00345631|584501917|FG002|Overall Study|Lost to Follow-up|4|||
161852849|NCT00345631|584501915|FG000|Overall Study|Other reasons|0|||
161852850|NCT00345631|584501916|FG001|Overall Study|Other reasons|0|||
161852851|NCT00345631|584501917|FG002|Overall Study|Other reasons|1|||
161852852|NCT03301623|584501928|FG000|Overall Study|Death|3|||
161852853|NCT03301623|584501929|FG001|Overall Study|Death|1|||
161852854|NCT03301623|584501928|FG000|Overall Study|Withdrawal by Subject|11|||
161852855|NCT03301623|584501929|FG001|Overall Study|Withdrawal by Subject|13|||
161852856|NCT03301623|584501928|FG000|Overall Study|Lost to Follow-up|3|||
161852857|NCT03301623|584501929|FG001|Overall Study|Lost to Follow-up|1|||
161852858|NCT02516553|584501930|FG000|Overall Study|Progressive disease|2|||
161852859|NCT02516553|584501931|FG001|Overall Study|Progressive disease|2|||
161852860|NCT02516553|584501932|FG002|Overall Study|Progressive disease|3|||
161852861|NCT02516553|584501933|FG003|Overall Study|Progressive disease|5|||
161852862|NCT02516553|584501934|FG004|Overall Study|Progressive disease|3|||
161852863|NCT02516553|584501935|FG005|Overall Study|Progressive disease|0|||
161852864|NCT02516553|584501936|FG006|Overall Study|Progressive disease|5|||
161852865|NCT02516553|584501937|FG007|Overall Study|Progressive disease|5|||
161852866|NCT02516553|584501938|FG008|Overall Study|Progressive disease|11|||
161852867|NCT02516553|584501939|FG009|Overall Study|Progressive disease|3|||
161852868|NCT02516553|584501940|FG010|Overall Study|Progressive disease|10|||
161852869|NCT02516553|584501941|FG011|Overall Study|Progressive disease|8|||
161852870|NCT02516553|584501942|FG012|Overall Study|Progressive disease|8|||
161852871|NCT02516553|584501943|FG013|Overall Study|Progressive disease|2|||
161852872|NCT02516553|584501944|FG014|Overall Study|Progressive disease|2|||
161852873|NCT02516553|584501945|FG015|Overall Study|Progressive disease|2|||
161852874|NCT02516553|584501946|FG016|Overall Study|Progressive disease|1|||
161852875|NCT02516553|584501947|FG017|Overall Study|Progressive disease|9|||
161852876|NCT02516553|584501948|FG018|Overall Study|Progressive disease|12|||
161852877|NCT02516553|584501949|FG019|Overall Study|Progressive disease|7|||
161852878|NCT02516553|584501950|FG020|Overall Study|Progressive disease|16|||
161852879|NCT02516553|584501951|FG021|Overall Study|Progressive disease|18|||
161852880|NCT02516553|584501930|FG000|Overall Study|Dose limiting toxicity|0|||
161852881|NCT02516553|584501931|FG001|Overall Study|Dose limiting toxicity|0|||
161852882|NCT02516553|584501932|FG002|Overall Study|Dose limiting toxicity|0|||
161852883|NCT02516553|584501933|FG003|Overall Study|Dose limiting toxicity|0|||
161852884|NCT02516553|584501934|FG004|Overall Study|Dose limiting toxicity|3|||
161852885|NCT02516553|584501935|FG005|Overall Study|Dose limiting toxicity|1|||
161852886|NCT02516553|584501936|FG006|Overall Study|Dose limiting toxicity|1|||
161852887|NCT02516553|584501937|FG007|Overall Study|Dose limiting toxicity|0|||
161852888|NCT02516553|584501938|FG008|Overall Study|Dose limiting toxicity|1|||
161852889|NCT02516553|584501939|FG009|Overall Study|Dose limiting toxicity|0|||
161852890|NCT02516553|584501940|FG010|Overall Study|Dose limiting toxicity|0|||
161852891|NCT02516553|584501941|FG011|Overall Study|Dose limiting toxicity|1|||
161852892|NCT02516553|584501942|FG012|Overall Study|Dose limiting toxicity|0|||
161852893|NCT02516553|584501943|FG013|Overall Study|Dose limiting toxicity|1|||
161852894|NCT02516553|584501944|FG014|Overall Study|Dose limiting toxicity|0|||
161852895|NCT02516553|584501945|FG015|Overall Study|Dose limiting toxicity|0|||
161852896|NCT02516553|584501946|FG016|Overall Study|Dose limiting toxicity|1|||
161852897|NCT02516553|584501947|FG017|Overall Study|Dose limiting toxicity|1|||
161852898|NCT02516553|584501948|FG018|Overall Study|Dose limiting toxicity|0|||
161852899|NCT02516553|584501949|FG019|Overall Study|Dose limiting toxicity|2|||
161852900|NCT02516553|584501950|FG020|Overall Study|Dose limiting toxicity|0|||
161852901|NCT02516553|584501951|FG021|Overall Study|Dose limiting toxicity|0|||
161852902|NCT02516553|584501930|FG000|Overall Study|Other Adverse Events|0|||
161852903|NCT02516553|584501931|FG001|Overall Study|Other Adverse Events|0|||
161852904|NCT02516553|584501932|FG002|Overall Study|Other Adverse Events|0|||
161852905|NCT02516553|584501933|FG003|Overall Study|Other Adverse Events|1|||
161852906|NCT02516553|584501934|FG004|Overall Study|Other Adverse Events|0|||
161852907|NCT02516553|584501935|FG005|Overall Study|Other Adverse Events|1|||
161852908|NCT02516553|584501936|FG006|Overall Study|Other Adverse Events|0|||
161852909|NCT02516553|584501937|FG007|Overall Study|Other Adverse Events|0|||
161852910|NCT02516553|584501938|FG008|Overall Study|Other Adverse Events|0|||
161852911|NCT02516553|584501939|FG009|Overall Study|Other Adverse Events|1|||
161852912|NCT02516553|584501940|FG010|Overall Study|Other Adverse Events|3|||
161852913|NCT02516553|584501941|FG011|Overall Study|Other Adverse Events|2|||
161852914|NCT02516553|584501942|FG012|Overall Study|Other Adverse Events|0|||
161852915|NCT02516553|584501943|FG013|Overall Study|Other Adverse Events|1|||
161852916|NCT02516553|584501944|FG014|Overall Study|Other Adverse Events|0|||
161973580|NCT01340937|584952245|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
161973581|NCT01340937|584952242|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
161973582|NCT01340937|584952243|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
161973583|NCT01340937|584952244|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
161973584|NCT01340937|584952245|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
161973585|NCT01340937|584952242|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
161973586|NCT01340937|584952243|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
161973587|NCT01340937|584952244|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
161973588|NCT01340937|584952245|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
161973589|NCT00046930|584952246|FG000|Overall Study|Ineligible|12|||
161973590|NCT00046930|584952247|FG001|Overall Study|Ineligible|4|||
161973591|NCT00440310|584952248|FG000|Overall Study|Lost to Follow-up|4|||
161973592|NCT00440310|584952249|FG001|Overall Study|Lost to Follow-up|5|||
161973593|NCT00440310|584952248|FG000|Overall Study|Protocol Violation|0|||
161973594|NCT00440310|584952249|FG001|Overall Study|Protocol Violation|1|||
161973595|NCT00440310|584952248|FG000|Overall Study|Withdrawal by Subject|15|||
161973596|NCT00440310|584952249|FG001|Overall Study|Withdrawal by Subject|14|||
161973597|NCT00440310|584952248|FG000|Overall Study|No Reply at EOS|7|||
161973598|NCT00440310|584952249|FG001|Overall Study|No Reply at EOS|7|||
161973599|NCT00440310|584952248|FG000|Overall Study|Other|1|||
161973600|NCT00440310|584952249|FG001|Overall Study|Other|0|||
161973601|NCT00440310|584952248|FG000|Overall Study|Status Unknown|1|||
161973602|NCT00440310|584952249|FG001|Overall Study|Status Unknown|3|||
161973603|NCT01657760|584952250|FG000|Overall Study|Withdrawal by Subject|0|||
161973604|NCT01657760|584952251|FG001|Overall Study|Withdrawal by Subject|0|||
161973605|NCT01657760|584952252|FG002|Overall Study|Withdrawal by Subject|0|||
161973606|NCT01657760|584952253|FG003|Overall Study|Withdrawal by Subject|1|||
161973607|NCT01657760|584952250|FG000|Overall Study|Physician Decision|1|||
161973608|NCT01657760|584952251|FG001|Overall Study|Physician Decision|1|||
161973609|NCT01657760|584952252|FG002|Overall Study|Physician Decision|1|||
161973610|NCT01657760|584952253|FG003|Overall Study|Physician Decision|2|||
161973611|NCT02469415|584952254|FG000|Overall Study|Withdrawal by Subject|1|||
161973612|NCT02469415|584952254|FG000|Overall Study|Investigational agent placed on hold|2|||
161973613|NCT02119156|584952255|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
161973614|NCT02119156|584952256|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
161973615|NCT02119156|584952257|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
161973616|NCT02119156|584952255|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
161852917|NCT02516553|584501945|FG015|Overall Study|Other Adverse Events|0|||
161852918|NCT02516553|584501946|FG016|Overall Study|Other Adverse Events|0|||
161973617|NCT02119156|584952256|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
161973618|NCT02119156|584952257|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
161973619|NCT02119156|584952255|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
161973620|NCT02119156|584952256|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
161973621|NCT02119156|584952257|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
161973622|NCT02119156|584952255|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
161973623|NCT02119156|584952256|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
161973624|NCT02119156|584952257|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
161973625|NCT02119156|584952255|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
161973626|NCT02119156|584952256|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
161973627|NCT02119156|584952257|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
161973628|NCT02317809|584952270|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
161973629|NCT02317809|584952271|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
161973630|NCT02317809|584952270|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
161973631|NCT02317809|584952271|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
161973632|NCT00953524|584952272|FG000|Overall Study|Adverse Event|2|||
161973633|NCT00953524|584952273|FG001|Overall Study|Adverse Event|0|||
161973634|NCT00953524|584952274|FG002|Overall Study|Adverse Event|1|||
161973635|NCT00953524|584952275|FG003|Overall Study|Adverse Event|2|||
161973636|NCT00953524|584952272|FG000|Overall Study|Protocol Violation|18|||
161973637|NCT00953524|584952273|FG001|Overall Study|Protocol Violation|10|||
161973638|NCT00953524|584952274|FG002|Overall Study|Protocol Violation|11|||
161973639|NCT00953524|584952275|FG003|Overall Study|Protocol Violation|6|||
161973640|NCT00953524|584952272|FG000|Overall Study|Lost to Follow-up|0|||
161973641|NCT00953524|584952273|FG001|Overall Study|Lost to Follow-up|1|||
161973642|NCT00953524|584952274|FG002|Overall Study|Lost to Follow-up|1|||
161973643|NCT00953524|584952275|FG003|Overall Study|Lost to Follow-up|0|||
161973644|NCT00953524|584952272|FG000|Overall Study|Withdrawal by Subject|2|||
161973645|NCT00953524|584952273|FG001|Overall Study|Withdrawal by Subject|4|||
161973646|NCT00953524|584952274|FG002|Overall Study|Withdrawal by Subject|1|||
161973647|NCT00953524|584952275|FG003|Overall Study|Withdrawal by Subject|0|||
161973648|NCT03362931|584952277|FG000|Overall Study|Adverse Event|1|||
161973649|NCT03362931|584952277|FG000|Overall Study|Death|2|||
161973650|NCT01998893|584952278|FG000|Overall Study|Adverse Event|2|||
161973651|NCT01998893|584952278|FG000|Overall Study|Death|1|||
161973652|NCT01998893|584952278|FG000|Overall Study|Lost to Follow-up|8|||
161973653|NCT01998893|584952278|FG000|Overall Study|Physician Decision|2|||
161973654|NCT01998893|584952278|FG000|Overall Study|Protocol Violation|2|||
161973655|NCT01998893|584952278|FG000|Overall Study|Withdrawal by Subject|1|||
161973656|NCT01998893|584952278|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
161973657|NCT03276052|584952279|FG000|Overall Study|Withdrawal by Subject|5|||
161973658|NCT03276052|584952279|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
161973659|NCT05136898|584952284|FG000|Overall Study|Adverse Event|2|||
161973660|NCT01994863|584952285|FG000|Period 1|Adverse Event|4|||
161973661|NCT01994863|584952286|FG001|Period 1|Adverse Event|0|||
161973662|NCT01994863|584952285|FG000|Period 1|Withdrawal by Subject|1|||
161973663|NCT01994863|584952286|FG001|Period 1|Withdrawal by Subject|0|||
161973664|NCT01994863|584952285|FG000|Period 1|Trial stopped by sponsor|1|||
161973665|NCT01994863|584952286|FG001|Period 1|Trial stopped by sponsor|3|||
161973666|NCT01994863|584952285|FG000|Period 1|Lack of Efficacy|1|||
161973667|NCT01994863|584952286|FG001|Period 1|Lack of Efficacy|0|||
161973668|NCT01994863|584952285|FG000|Period 2|Adverse Event|0|||
161765303|NCT02030067|584180538|FG005|Overall Study|Adverse Event|0|||
161765304|NCT02030067|584180539|FG006|Overall Study|Adverse Event|0|||
161765305|NCT02030067|584180540|FG007|Overall Study|Adverse Event|0|||
161765306|NCT02030067|584180541|FG008|Overall Study|Adverse Event|0|||
161765307|NCT02030067|584180542|FG009|Overall Study|Adverse Event|0|||
161765308|NCT02030067|584180543|FG010|Overall Study|Adverse Event|0|||
161765309|NCT02030067|584180544|FG011|Overall Study|Adverse Event|1|||
161765310|NCT02030067|584180545|FG012|Overall Study|Adverse Event|8|||
161765311|NCT00265382|584180546|FG000|Overall Study|Adverse Event|21|||
161765312|NCT00265382|584180546|FG000|Overall Study|Laboratory Abnormality|1|||
161765313|NCT00265382|584180546|FG000|Overall Study|Lost to Follow-up|3|||
161765314|NCT00265382|584180546|FG000|Overall Study|Lack of Efficacy|6|||
161765315|NCT00265382|584180546|FG000|Overall Study|Miscellaneous|6|||
161973669|NCT01994863|584952286|FG001|Period 2|Adverse Event|1|||
161973670|NCT01994863|584952285|FG000|Period 2|Lack of Efficacy|0|||
161765316|NCT00265382|584180546|FG000|Overall Study|Withdrawal by Subject|13|||
161765317|NCT00265382|584180546|FG000|Overall Study|Study terminated by sponsor|94|||
161973671|NCT01994863|584952286|FG001|Period 2|Lack of Efficacy|2|||
161973672|NCT01994863|584952285|FG000|Period 2|Withdrawal by Subject|1|||
161765318|NCT00265382|584180546|FG000|Overall Study|Death|1|||
161973673|NCT01994863|584952286|FG001|Period 2|Withdrawal by Subject|1|||
161973674|NCT03784846|584952289|FG000|Pre-COVID Study|Lost to Follow-up|3|||
161973675|NCT03784846|584952290|FG001|Pre-COVID Study|Lost to Follow-up|3|||
161973676|NCT03784846|584952291|FG002|Pre-COVID Study|Lost to Follow-up|2|||
161765319|NCT00760994|584180553|FG000|Overall Study|Lost to Follow-up|4|||
161765320|NCT00760994|584180554|FG001|Overall Study|Lost to Follow-up|4|||
161765321|NCT00760994|584180555|FG002|Overall Study|Lost to Follow-up|3|||
161765322|NCT03258710|584180556|FG000|Overall Study|Adverse Event|1|||
161765323|NCT03258710|584180556|FG000|Overall Study|Protocol-defined stopping criteria|1|||
161765324|NCT03258710|584180556|FG000|Overall Study|Physician Decision|1|||
161765325|NCT03451630|584180557|FG000|Overall Study|Death|15|||
161765326|NCT03451630|584180558|FG001|Overall Study|Death|16|||
161765327|NCT03451630|584180559|FG002|Overall Study|Death|11|||
161765328|NCT03451630|584180557|FG000|Overall Study|Lost to Follow-up|9|||
161973677|NCT03784846|584952289|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
161973678|NCT03784846|584952290|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
161973679|NCT03784846|584952291|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
161973680|NCT03784846|584952289|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
161973681|NCT03784846|584952290|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
161973682|NCT03784846|584952291|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
161973683|NCT03784846|584952289|FG000|Post-COVID Study|Lost to Follow-up|3|||
161973684|NCT03784846|584952290|FG001|Post-COVID Study|Lost to Follow-up|5|||
161973685|NCT03784846|584952291|FG002|Post-COVID Study|Lost to Follow-up|1|||
161973686|NCT03784846|584952289|FG000|Post-COVID Study|Withdrawal by Subject|1|||
161973687|NCT03784846|584952290|FG001|Post-COVID Study|Withdrawal by Subject|2|||
161973688|NCT03784846|584952291|FG002|Post-COVID Study|Withdrawal by Subject|0|||
161973689|NCT00931723|584952292|FG000|Overall Study|Withdrawal by Subject|11|||
161973690|NCT00931723|584952293|FG001|Overall Study|Withdrawal by Subject|13|||
161973691|NCT00931723|584952292|FG000|Overall Study|Adverse Event|6|||
161973692|NCT00931723|584952293|FG001|Overall Study|Adverse Event|13|||
161973693|NCT00931723|584952292|FG000|Overall Study|Lithium found in blood|0|||
161973694|NCT00931723|584952293|FG001|Overall Study|Lithium found in blood|1|||
161973695|NCT00931723|584952292|FG000|Overall Study|Condition under investigation worsened|1|||
161973696|NCT00931723|584952293|FG001|Overall Study|Condition under investigation worsened|2|||
161973697|NCT00931723|584952292|FG000|Overall Study|Lost to Follow-up|1|||
161973698|NCT00931723|584952293|FG001|Overall Study|Lost to Follow-up|2|||
161973699|NCT00931723|584952292|FG000|Overall Study|Study-specific discontinuation criteria|1|||
161973700|NCT00931723|584952293|FG001|Overall Study|Study-specific discontinuation criteria|1|||
161973701|NCT00931723|584952292|FG000|Overall Study|Severe non-compliance to protocol|2|||
161973702|NCT00931723|584952293|FG001|Overall Study|Severe non-compliance to protocol|0|||
161973703|NCT00931723|584952292|FG000|Overall Study|Safety reasons|0|||
161973704|NCT00931723|584952293|FG001|Overall Study|Safety reasons|1|||
161973705|NCT00931723|584952292|FG000|Overall Study|Took prohibited concomitant medication|0|||
161973706|NCT00931723|584952293|FG001|Overall Study|Took prohibited concomitant medication|1|||
161973707|NCT00931723|584952292|FG000|Overall Study|Lack or insufficient theraputic response|2|||
161973708|NCT00931723|584952293|FG001|Overall Study|Lack or insufficient theraputic response|5|||
161973709|NCT00931723|584952292|FG000|Overall Study|Sponsor decision|1|||
161973710|NCT00931723|584952293|FG001|Overall Study|Sponsor decision|0|||
161973711|NCT00931723|584952292|FG000|Overall Study|Late hospital discharge|1|||
161973712|NCT00931723|584952293|FG001|Overall Study|Late hospital discharge|0|||
161973713|NCT01643850|584952294|FG000|Overall Study|Withdrawal by Subject|0|||
161973714|NCT01643850|584952295|FG001|Overall Study|Withdrawal by Subject|0|||
161973715|NCT01643850|584952296|FG002|Overall Study|Withdrawal by Subject|0|||
161973716|NCT01643850|584952297|FG003|Overall Study|Withdrawal by Subject|0|||
161973717|NCT01643850|584952298|FG004|Overall Study|Withdrawal by Subject|1|||
161973718|NCT01643850|584952299|FG005|Overall Study|Withdrawal by Subject|0|||
161973719|NCT01643850|584952300|FG006|Overall Study|Withdrawal by Subject|0|||
161973720|NCT01643850|584952301|FG007|Overall Study|Withdrawal by Subject|0|||
161973721|NCT01643850|584952302|FG008|Overall Study|Withdrawal by Subject|0|||
161973722|NCT01643850|584952294|FG000|Overall Study|Lost to Follow-up|0|||
161973723|NCT01643850|584952295|FG001|Overall Study|Lost to Follow-up|0|||
161973724|NCT01643850|584952296|FG002|Overall Study|Lost to Follow-up|0|||
161973725|NCT01643850|584952297|FG003|Overall Study|Lost to Follow-up|0|||
161973726|NCT01643850|584952298|FG004|Overall Study|Lost to Follow-up|0|||
161973727|NCT01643850|584952299|FG005|Overall Study|Lost to Follow-up|0|||
161973728|NCT01643850|584952300|FG006|Overall Study|Lost to Follow-up|1|||
161973729|NCT01643850|584952301|FG007|Overall Study|Lost to Follow-up|0|||
161973730|NCT01643850|584952302|FG008|Overall Study|Lost to Follow-up|1|||
161973731|NCT01643850|584952294|FG000|Overall Study|Adverse Event|0|||
161973732|NCT01643850|584952295|FG001|Overall Study|Adverse Event|0|||
161973733|NCT01643850|584952296|FG002|Overall Study|Adverse Event|0|||
161973734|NCT01643850|584952297|FG003|Overall Study|Adverse Event|0|||
161973735|NCT01643850|584952298|FG004|Overall Study|Adverse Event|1|||
161973736|NCT01643850|584952299|FG005|Overall Study|Adverse Event|0|||
161765329|NCT03451630|584180558|FG001|Overall Study|Lost to Follow-up|0|||
161765330|NCT03451630|584180559|FG002|Overall Study|Lost to Follow-up|4|||
161765331|NCT03451630|584180557|FG000|Overall Study|Withdrawal by Subject|0|||
161973737|NCT01643850|584952300|FG006|Overall Study|Adverse Event|0|||
161973738|NCT01643850|584952301|FG007|Overall Study|Adverse Event|0|||
161973739|NCT01643850|584952302|FG008|Overall Study|Adverse Event|0|||
161973740|NCT01643850|584952294|FG000|Overall Study|Administrative Problems|0|||
161852919|NCT02516553|584501947|FG017|Overall Study|Other Adverse Events|2|||
161852920|NCT02516553|584501948|FG018|Overall Study|Other Adverse Events|1|||
161852921|NCT02516553|584501949|FG019|Overall Study|Other Adverse Events|2|||
161852922|NCT02516553|584501950|FG020|Overall Study|Other Adverse Events|2|||
161852923|NCT02516553|584501951|FG021|Overall Study|Other Adverse Events|1|||
161852924|NCT02516553|584501930|FG000|Overall Study|Refused to continue trial medication|0|||
161852925|NCT02516553|584501931|FG001|Overall Study|Refused to continue trial medication|0|||
161852926|NCT02516553|584501932|FG002|Overall Study|Refused to continue trial medication|0|||
161852927|NCT02516553|584501933|FG003|Overall Study|Refused to continue trial medication|0|||
161852928|NCT02516553|584501934|FG004|Overall Study|Refused to continue trial medication|0|||
161852929|NCT02516553|584501935|FG005|Overall Study|Refused to continue trial medication|0|||
161852930|NCT02516553|584501936|FG006|Overall Study|Refused to continue trial medication|0|||
161852931|NCT02516553|584501937|FG007|Overall Study|Refused to continue trial medication|0|||
161852932|NCT02516553|584501938|FG008|Overall Study|Refused to continue trial medication|0|||
161852933|NCT02516553|584501939|FG009|Overall Study|Refused to continue trial medication|0|||
161852934|NCT02516553|584501940|FG010|Overall Study|Refused to continue trial medication|1|||
161852935|NCT02516553|584501941|FG011|Overall Study|Refused to continue trial medication|0|||
161852936|NCT02516553|584501942|FG012|Overall Study|Refused to continue trial medication|0|||
161852937|NCT02516553|584501943|FG013|Overall Study|Refused to continue trial medication|0|||
161852938|NCT02516553|584501944|FG014|Overall Study|Refused to continue trial medication|0|||
161852939|NCT02516553|584501945|FG015|Overall Study|Refused to continue trial medication|0|||
161852940|NCT02516553|584501946|FG016|Overall Study|Refused to continue trial medication|0|||
161852941|NCT02516553|584501947|FG017|Overall Study|Refused to continue trial medication|0|||
161852942|NCT02516553|584501948|FG018|Overall Study|Refused to continue trial medication|1|||
161852943|NCT02516553|584501949|FG019|Overall Study|Refused to continue trial medication|0|||
161852944|NCT02516553|584501950|FG020|Overall Study|Refused to continue trial medication|0|||
161852945|NCT02516553|584501951|FG021|Overall Study|Refused to continue trial medication|1|||
161852946|NCT02516553|584501930|FG000|Overall Study|other reasons than listed|0|||
161852947|NCT02516553|584501931|FG001|Overall Study|other reasons than listed|0|||
161852948|NCT02516553|584501932|FG002|Overall Study|other reasons than listed|0|||
161852949|NCT02516553|584501933|FG003|Overall Study|other reasons than listed|0|||
161852950|NCT02516553|584501934|FG004|Overall Study|other reasons than listed|0|||
161852951|NCT02516553|584501935|FG005|Overall Study|other reasons than listed|0|||
161852952|NCT02516553|584501936|FG006|Overall Study|other reasons than listed|0|||
161852953|NCT02516553|584501937|FG007|Overall Study|other reasons than listed|1|||
161852954|NCT02516553|584501938|FG008|Overall Study|other reasons than listed|1|||
161852955|NCT02516553|584501939|FG009|Overall Study|other reasons than listed|0|||
161852956|NCT02516553|584501940|FG010|Overall Study|other reasons than listed|1|||
161852957|NCT02516553|584501941|FG011|Overall Study|other reasons than listed|1|||
161852958|NCT02516553|584501942|FG012|Overall Study|other reasons than listed|0|||
161852959|NCT02516553|584501943|FG013|Overall Study|other reasons than listed|0|||
161852960|NCT02516553|584501944|FG014|Overall Study|other reasons than listed|0|||
161852961|NCT02516553|584501945|FG015|Overall Study|other reasons than listed|0|||
161852962|NCT02516553|584501946|FG016|Overall Study|other reasons than listed|0|||
161852963|NCT02516553|584501947|FG017|Overall Study|other reasons than listed|0|||
161852964|NCT02516553|584501948|FG018|Overall Study|other reasons than listed|0|||
161852965|NCT02516553|584501949|FG019|Overall Study|other reasons than listed|0|||
161852966|NCT02516553|584501950|FG020|Overall Study|other reasons than listed|2|||
161765332|NCT03451630|584180558|FG001|Overall Study|Withdrawal by Subject|3|||
161765333|NCT03451630|584180559|FG002|Overall Study|Withdrawal by Subject|0|||
161765334|NCT03451630|584180557|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
161765335|NCT03451630|584180558|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
161765336|NCT03451630|584180559|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
161765337|NCT00545740|584180561|FG000|Overall Study|Lack of Efficacy|34|||
161765338|NCT00545740|584180562|FG001|Overall Study|Lack of Efficacy|35|||
161765339|NCT00545740|584180563|FG002|Overall Study|Lack of Efficacy|47|||
161765340|NCT00545740|584180564|FG003|Overall Study|Lack of Efficacy|36|||
161765341|NCT00545740|584180561|FG000|Overall Study|Withdrawal by Subject|17|||
161765342|NCT00545740|584180562|FG001|Overall Study|Withdrawal by Subject|15|||
161765343|NCT00545740|584180563|FG002|Overall Study|Withdrawal by Subject|16|||
161765344|NCT00545740|584180564|FG003|Overall Study|Withdrawal by Subject|18|||
161765345|NCT00545740|584180561|FG000|Overall Study|Adverse Event|10|||
161765346|NCT00545740|584180562|FG001|Overall Study|Adverse Event|18|||
161765347|NCT00545740|584180563|FG002|Overall Study|Adverse Event|19|||
161852967|NCT02516553|584501951|FG021|Overall Study|other reasons than listed|2|||
161852968|NCT01374269|584501954|FG000|Overall Study|Withdrawal by Subject|4|||
161852969|NCT01374269|584501955|FG001|Overall Study|Withdrawal by Subject|0|||
161852970|NCT01374269|584501954|FG000|Overall Study|Lost to Follow-up|1|||
161852971|NCT01374269|584501955|FG001|Overall Study|Lost to Follow-up|3|||
161852972|NCT01374269|584501954|FG000|Overall Study|closed research|1|||
161973741|NCT01643850|584952295|FG001|Overall Study|Administrative Problems|0|||
161852973|NCT01374269|584501955|FG001|Overall Study|closed research|2|||
161852974|NCT00708227|584501960|FG000|Overall Study|Physician Decision|0|||
161852975|NCT00708227|584501961|FG001|Overall Study|Physician Decision|3|||
161852976|NCT00708227|584501962|FG002|Overall Study|Physician Decision|1|||
161852977|NCT00708227|584501963|FG003|Overall Study|Physician Decision|2|||
161852978|NCT00708227|584501960|FG000|Overall Study|Withdrawal by Subject|1|||
161852979|NCT00708227|584501961|FG001|Overall Study|Withdrawal by Subject|2|||
161852980|NCT00708227|584501962|FG002|Overall Study|Withdrawal by Subject|0|||
161852981|NCT00708227|584501963|FG003|Overall Study|Withdrawal by Subject|1|||
161852982|NCT04007991|584501964|FG000|Overall Study|Withdrawal by Subject|1|||
161852983|NCT04007991|584501965|FG001|Overall Study|Withdrawal by Subject|1|||
161852984|NCT04007991|584501964|FG000|Overall Study|Physician Decision|1|||
161852985|NCT04007991|584501965|FG001|Overall Study|Physician Decision|1|||
161852986|NCT04007991|584501964|FG000|Overall Study|Non-compliance with Study Drug|0|||
161852987|NCT04007991|584501965|FG001|Overall Study|Non-compliance with Study Drug|1|||
161852988|NCT04007991|584501964|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
161852989|NCT04007991|584501965|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
161852990|NCT04007991|584501964|FG000|Overall Study|Adverse event, non-fatal|5|||
161852991|NCT04007991|584501965|FG001|Overall Study|Adverse event, non-fatal|0|||
161852992|NCT04007991|584501964|FG000|Overall Study|Lost to Follow-up|2|||
161852993|NCT04007991|584501965|FG001|Overall Study|Lost to Follow-up|1|||
161852994|NCT03654599|584501968|FG000|Overall Study|Lost to Follow-up|14|||
161852995|NCT03654599|584501969|FG001|Overall Study|Lost to Follow-up|12|||
161852996|NCT03654599|584501968|FG000|Overall Study|Death|8|||
161852997|NCT03654599|584501969|FG001|Overall Study|Death|6|||
161852998|NCT03654599|584501968|FG000|Overall Study|Withdrawal by Subject|6|||
161852999|NCT03654599|584501969|FG001|Overall Study|Withdrawal by Subject|4|||
161853000|NCT02551666|584501971|FG000|Overall Study|Withdrawal by Subject|1|||
161853001|NCT02551666|584501972|FG001|Overall Study|Withdrawal by Subject|3|||
161853002|NCT04559347|584503630|FG000|Overall Study|Death|1|||
161853003|NCT04559347|584503631|FG001|Overall Study|Death|0|||
161853004|NCT04559347|584503630|FG000|Overall Study|Thoracotomy conversion|1|||
161853005|NCT04559347|584503631|FG001|Overall Study|Thoracotomy conversion|1|||
161853006|NCT04559347|584503630|FG000|Overall Study|Provider unavailable|2|||
161853007|NCT04559347|584503631|FG001|Overall Study|Provider unavailable|1|||
161853008|NCT04559347|584503630|FG000|Overall Study|Other|2|||
161853009|NCT04559347|584503631|FG001|Overall Study|Other|1|||
161853010|NCT02653625|584503632|FG000|Overall Study|Adverse Event|1|||
161853011|NCT02653625|584503632|FG000|Overall Study|Non-compliance with Study Drug|1|||
161853012|NCT02653625|584503632|FG000|Overall Study|Protocol Violation|1|||
161853013|NCT02653625|584503632|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
161853014|NCT03965689|584503633|FG000|Overall Study|Too sick to get study intervention|2|||
161853015|NCT00764881|584503635|FG000|Overall Study|Adverse Event|5|||
161853016|NCT00764881|584503636|FG001|Overall Study|Adverse Event|1|||
161853017|NCT00764881|584503635|FG000|Overall Study|Withdrawal by Subject|1|||
161853018|NCT00764881|584503636|FG001|Overall Study|Withdrawal by Subject|3|||
161853019|NCT00764881|584503635|FG000|Overall Study|Protocol Violation|2|||
161853020|NCT00764881|584503636|FG001|Overall Study|Protocol Violation|2|||
161853021|NCT00764881|584503635|FG000|Overall Study|Lost to Follow-up|2|||
161853022|NCT00764881|584503636|FG001|Overall Study|Lost to Follow-up|0|||
161853023|NCT00764881|584503635|FG000|Overall Study|Noncompliant|1|||
161853024|NCT00764881|584503636|FG001|Overall Study|Noncompliant|0|||
161853025|NCT00764881|584503635|FG000|Overall Study|Accidentally discontinued study drug|1|||
161853026|NCT00764881|584503636|FG001|Overall Study|Accidentally discontinued study drug|0|||
161853027|NCT00764881|584503635|FG000|Overall Study|Wished to become pregnant|1|||
161853028|NCT00764881|584503636|FG001|Overall Study|Wished to become pregnant|0|||
161853029|NCT00764881|584503635|FG000|Overall Study|Carcinoma detected|1|||
161853030|NCT00764881|584503636|FG001|Overall Study|Carcinoma detected|0|||
161853031|NCT00764881|584503635|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
161973742|NCT01643850|584952296|FG002|Overall Study|Administrative Problems|1|||
161973743|NCT01643850|584952297|FG003|Overall Study|Administrative Problems|0|||
161973744|NCT01643850|584952298|FG004|Overall Study|Administrative Problems|1|||
161973745|NCT01643850|584952299|FG005|Overall Study|Administrative Problems|0|||
161973746|NCT01643850|584952300|FG006|Overall Study|Administrative Problems|0|||
161853032|NCT00764881|584503636|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
161853033|NCT00764881|584503635|FG000|Overall Study|no treatment or no observation|2|||
161853034|NCT00764881|584503636|FG001|Overall Study|no treatment or no observation|2|||
161853035|NCT01214655|584503637|FG000|Part A|Progressive Disease|7|||
161853036|NCT01214655|584503638|FG001|Part A|Progressive Disease|0|||
161853037|NCT01214655|584503639|FG002|Part A|Progressive Disease|0|||
161853038|NCT01214655|584503637|FG000|Part A|Physician Decision|1|||
161853039|NCT01214655|584503638|FG001|Part A|Physician Decision|0|||
161853040|NCT01214655|584503639|FG002|Part A|Physician Decision|0|||
161853041|NCT01214655|584503637|FG000|Part B|Progressive disease|0|||
161853042|NCT01214655|584503638|FG001|Part B|Progressive disease|10|||
161853043|NCT01214655|584503639|FG002|Part B|Progressive disease|0|||
161853044|NCT01214655|584503637|FG000|Part B|Death|0|||
162033872|NCT00597701|585181127|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
162033873|NCT04617795|585181132|FG000|Main Study|Lost to Follow-up|1|||
162033874|NCT04617795|585181133|FG001|Main Study|Lost to Follow-up|0|||
162033875|NCT00472459|585181134|FG000|Overall Study|Adverse Event|13|||
162033876|NCT00472459|585181135|FG001|Overall Study|Adverse Event|13|||
162033877|NCT00472459|585181134|FG000|Overall Study|Withdrawal by Subject|5|||
162033878|NCT00472459|585181135|FG001|Overall Study|Withdrawal by Subject|5|||
162033879|NCT00472459|585181134|FG000|Overall Study|Protocol Violation|3|||
161853045|NCT01214655|584503638|FG001|Part B|Death|1|||
161853046|NCT01214655|584503639|FG002|Part B|Death|0|||
161853047|NCT01214655|584503637|FG000|Part B|Withdrawal by Subject|0|||
161853048|NCT01214655|584503638|FG001|Part B|Withdrawal by Subject|2|||
161853049|NCT01214655|584503639|FG002|Part B|Withdrawal by Subject|0|||
161853050|NCT01214655|584503637|FG000|Part C|Progressive Disease|0|||
161853051|NCT01214655|584503638|FG001|Part C|Progressive Disease|0|||
161853052|NCT01214655|584503639|FG002|Part C|Progressive Disease|5|||
161853053|NCT01214655|584503637|FG000|Part C|Death|0|||
161853054|NCT01214655|584503638|FG001|Part C|Death|0|||
161853055|NCT01214655|584503639|FG002|Part C|Death|1|||
161853056|NCT01214655|584503637|FG000|Part C|Physician Decision|0|||
161853057|NCT01214655|584503638|FG001|Part C|Physician Decision|0|||
161853058|NCT01214655|584503639|FG002|Part C|Physician Decision|1|||
161853059|NCT01611857|584503640|FG000|Overall Study|Withdrawal by Subject|0|||
161853060|NCT01611857|584503641|FG001|Overall Study|Withdrawal by Subject|2|||
161853061|NCT02439970|584503642|FG000|Overall Study|Study Terminated|2|||
161853062|NCT02439970|584503643|FG001|Overall Study|Study Terminated|3|||
161853063|NCT01121562|584503644|FG000|Overall Study|Objective progression or relapse|8|||
161973747|NCT01643850|584952301|FG007|Overall Study|Administrative Problems|0|||
161973748|NCT01643850|584952302|FG008|Overall Study|Administrative Problems|0|||
161973749|NCT03054350|584952303|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
161973750|NCT03054350|584952304|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
161973751|NCT03054350|584952305|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
161973752|NCT03054350|584952306|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
161973753|NCT03054350|584952307|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
161973754|NCT03054350|584952308|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
161973755|NCT03054350|584952303|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
161973756|NCT03054350|584952304|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
161973757|NCT03054350|584952305|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
161973758|NCT03054350|584952306|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
161973759|NCT03054350|584952307|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
161973760|NCT03054350|584952308|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
161973761|NCT03054350|584952303|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
161973762|NCT03054350|584952304|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
161973763|NCT03054350|584952305|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
161973764|NCT03054350|584952306|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
161973765|NCT03054350|584952307|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
161973766|NCT03054350|584952308|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
161973767|NCT03054350|584952303|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
161973768|NCT03054350|584952304|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
161973769|NCT03054350|584952305|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
161973770|NCT03054350|584952306|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
161973771|NCT03054350|584952307|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
161973772|NCT03054350|584952308|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
161973773|NCT01133405|584952309|FG000|Period 1|Withdrawal by Subject|0|||
161973774|NCT01133405|584952310|FG001|Period 1|Withdrawal by Subject|1|||
161973775|NCT01133405|584952311|FG002|Period 1|Withdrawal by Subject|0|||
161973776|NCT01133405|584952312|FG003|Period 1|Withdrawal by Subject|1|||
161973777|NCT01133405|584952313|FG004|Period 1|Withdrawal by Subject|0|||
161973778|NCT01133405|584952314|FG005|Period 1|Withdrawal by Subject|1|||
161973779|NCT01133405|584952315|FG006|Period 1|Withdrawal by Subject|0|||
161973780|NCT01133405|584952316|FG007|Period 1|Withdrawal by Subject|0|||
162033880|NCT00472459|585181135|FG001|Overall Study|Protocol Violation|3|||
162033881|NCT00472459|585181134|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
162033882|NCT00472459|585181135|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
161853064|NCT01121562|584503644|FG000|Overall Study|Withdrawal by Subject|1|||
162033883|NCT00472459|585181134|FG000|Overall Study|Lost to Follow-up|1|||
162033884|NCT00472459|585181135|FG001|Overall Study|Lost to Follow-up|1|||
161853065|NCT01121562|584503644|FG000|Overall Study|Adverse Event|1|||
161853066|NCT01121562|584503644|FG000|Overall Study|Sponsor Decision|1|||
161853067|NCT01121562|584503644|FG000|Overall Study|Met study discontinuation criteria|1|||
161853068|NCT01495702|584503645|FG000|Randomized Phase|Randomized But Not Treated|1|||
161853069|NCT01495702|584503646|FG001|Randomized Phase|Randomized But Not Treated|4|||
161853070|NCT01495702|584503645|FG000|Randomized Phase|Adverse Event|2|||
161853071|NCT01495702|584503646|FG001|Randomized Phase|Adverse Event|2|||
161853072|NCT01495702|584503645|FG000|Randomized Phase|Death|1|||
161853073|NCT01495702|584503646|FG001|Randomized Phase|Death|0|||
161853074|NCT01495702|584503645|FG000|Randomized Phase|Lack of Efficacy|2|||
161853075|NCT01495702|584503646|FG001|Randomized Phase|Lack of Efficacy|0|||
161853076|NCT01495702|584503645|FG000|Randomized Phase|Investigators Discretion|2|||
161853077|NCT01495702|584503646|FG001|Randomized Phase|Investigators Discretion|0|||
161853078|NCT01495702|584503645|FG000|Randomized Phase|Withdrew Consent|10|||
161853079|NCT01495702|584503646|FG001|Randomized Phase|Withdrew Consent|18|||
161853080|NCT01495702|584503645|FG000|Randomized Phase|Lost to Follow-up|4|||
161853081|NCT01495702|584503646|FG001|Randomized Phase|Lost to Follow-up|3|||
161853082|NCT01495702|584503645|FG000|Randomized Phase|Participant Noncompliance|1|||
161853083|NCT01495702|584503646|FG001|Randomized Phase|Participant Noncompliance|0|||
161853084|NCT01495702|584503645|FG000|Randomized Phase|Protocol Violation|3|||
161853085|NCT01495702|584503646|FG001|Randomized Phase|Protocol Violation|1|||
161853086|NCT00616421|584503647|FG000|Overall Study|Withdrawal by Subject|9|||
161853087|NCT00616421|584503648|FG001|Overall Study|Withdrawal by Subject|11|||
161853088|NCT00616421|584503649|FG002|Overall Study|Withdrawal by Subject|8|||
161853089|NCT00616421|584503647|FG000|Overall Study|Lost to Follow-up|12|||
161853090|NCT00616421|584503648|FG001|Overall Study|Lost to Follow-up|26|||
161853091|NCT00616421|584503649|FG002|Overall Study|Lost to Follow-up|30|||
161853092|NCT00616421|584503647|FG000|Overall Study|Inappropriate enrollment|3|||
161853093|NCT00616421|584503648|FG001|Overall Study|Inappropriate enrollment|0|||
161853094|NCT00616421|584503649|FG002|Overall Study|Inappropriate enrollment|1|||
161853095|NCT00616421|584503647|FG000|Overall Study|Administrative reason|1|||
161853096|NCT00616421|584503648|FG001|Overall Study|Administrative reason|0|||
161853097|NCT00616421|584503649|FG002|Overall Study|Administrative reason|0|||
161853098|NCT00616421|584503647|FG000|Overall Study|Protocol Violation|0|||
161853099|NCT00616421|584503648|FG001|Overall Study|Protocol Violation|1|||
161853100|NCT00616421|584503649|FG002|Overall Study|Protocol Violation|2|||
161853101|NCT00616421|584503647|FG000|Overall Study|Unable to classify|1|||
161853102|NCT00616421|584503648|FG001|Overall Study|Unable to classify|0|||
161853103|NCT00616421|584503649|FG002|Overall Study|Unable to classify|0|||
161853104|NCT04152863|584503650|FG000|Overall Study|Death|13|||
161853105|NCT04152863|584503651|FG001|Overall Study|Death|12|||
161853106|NCT04152863|584503652|FG002|Overall Study|Death|7|||
161853107|NCT04152863|584503650|FG000|Overall Study|Physician Decision|1|||
161853108|NCT04152863|584503651|FG001|Overall Study|Physician Decision|1|||
161853109|NCT04152863|584503652|FG002|Overall Study|Physician Decision|1|||
161853110|NCT04152863|584503650|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
161853111|NCT04152863|584503651|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
161853112|NCT04152863|584503652|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
161853113|NCT04152863|584503650|FG000|Overall Study|Withdrawal by Subject|2|||
161853114|NCT04152863|584503651|FG001|Overall Study|Withdrawal by Subject|1|||
161853115|NCT04152863|584503652|FG002|Overall Study|Withdrawal by Subject|3|||
161853116|NCT01644617|584503656|FG000|Overall Study|Withdrawal by Subject|3|||
161853117|NCT01644617|584503657|FG001|Overall Study|Withdrawal by Subject|4|||
161853118|NCT01644617|584503658|FG002|Overall Study|Withdrawal by Subject|1|||
161853119|NCT01644617|584503656|FG000|Overall Study|Lost to Follow-up|0|||
161853120|NCT01644617|584503657|FG001|Overall Study|Lost to Follow-up|1|||
161853121|NCT01644617|584503658|FG002|Overall Study|Lost to Follow-up|0|||
161853122|NCT01644617|584503656|FG000|Overall Study|Adverse Event|3|||
161853123|NCT01644617|584503657|FG001|Overall Study|Adverse Event|0|||
161853124|NCT01644617|584503658|FG002|Overall Study|Adverse Event|6|||
161853125|NCT05445492|584503667|FG000|Overall Study|Physician Decision|1|||
161853126|NCT04289363|584503669|FG000|Overall Study|Lost to Follow-up|14|||
161853127|NCT04289363|584503670|FG001|Overall Study|Lost to Follow-up|0|||
161973781|NCT01133405|584952317|FG008|Period 1|Withdrawal by Subject|0|||
161973782|NCT01133405|584952318|FG009|Period 1|Withdrawal by Subject|0|||
161973783|NCT01133405|584952309|FG000|Period 1|Physician Decision|0|||
161973784|NCT01133405|584952310|FG001|Period 1|Physician Decision|0|||
161853128|NCT03790657|584503671|FG000|Overall Study|Adverse Event|1|||
161973785|NCT01133405|584952311|FG002|Period 1|Physician Decision|0|||
161973786|NCT01133405|584952312|FG003|Period 1|Physician Decision|1|||
161853129|NCT03790657|584503672|FG001|Overall Study|Adverse Event|1|||
161973787|NCT01133405|584952313|FG004|Period 1|Physician Decision|0|||
161973788|NCT01133405|584952314|FG005|Period 1|Physician Decision|0|||
161973789|NCT01133405|584952315|FG006|Period 1|Physician Decision|0|||
161853130|NCT03790657|584503671|FG000|Overall Study|Withdrawal by Subject|1|||
161853131|NCT03790657|584503672|FG001|Overall Study|Withdrawal by Subject|1|||
161853132|NCT03126435|584503673|FG000|Overall Study|Death|90|||
161853133|NCT03126435|584503674|FG001|Overall Study|Death|84|||
161973790|NCT01133405|584952316|FG007|Period 1|Physician Decision|0|||
161973791|NCT01133405|584952317|FG008|Period 1|Physician Decision|0|||
161853134|NCT03126435|584503673|FG000|Overall Study|Lost to Follow-up|4|||
161853135|NCT03126435|584503674|FG001|Overall Study|Lost to Follow-up|3|||
161853136|NCT03126435|584503673|FG000|Overall Study|Physician Decision|0|||
161853137|NCT03126435|584503674|FG001|Overall Study|Physician Decision|1|||
162033885|NCT04850313|585181136|FG000|Overall Study|Withdrawal by Subject|0|||
162033886|NCT04850313|585181137|FG001|Overall Study|Withdrawal by Subject|1|||
162033887|NCT04393298|585181144|FG000|Overall Study|Adverse Event|0|||
161853138|NCT03126435|584503673|FG000|Overall Study|Withdrawal by Subject|6|||
161853139|NCT03126435|584503674|FG001|Overall Study|Withdrawal by Subject|12|||
161853140|NCT03126435|584503673|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
161853141|NCT03126435|584503674|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
161853142|NCT01807065|584503675|FG000|Overall Study|Receive no sip-T due to IV access|1|||
161853143|NCT01807065|584503676|FG001|Overall Study|Receive no sip-T due to IV access|1|||
161853144|NCT01699815|584503677|FG000|Overall Study|Protocol Violation|4|||
161853145|NCT01699815|584503678|FG001|Overall Study|Protocol Violation|7|||
161853146|NCT01699815|584503677|FG000|Overall Study|record could not be located|1|||
162033888|NCT04393298|585181145|FG001|Overall Study|Adverse Event|0|||
162033889|NCT04393298|585181146|FG002|Overall Study|Adverse Event|0|||
162033890|NCT04393298|585181147|FG003|Overall Study|Adverse Event|0|||
161853147|NCT01699815|584503678|FG001|Overall Study|record could not be located|0|||
161853148|NCT01699815|584503677|FG000|Overall Study|Adverse Event|0|||
161853149|NCT01699815|584503678|FG001|Overall Study|Adverse Event|1|||
161853150|NCT00699816|584503681|FG000|Overall Study|Protocol Violation|1|||
161853151|NCT00699816|584503682|FG001|Overall Study|Protocol Violation|3|||
161853152|NCT00560391|584503683|FG000|Overall Study|Still on treatment|0|||
161853153|NCT00560391|584503684|FG001|Overall Study|Still on treatment|0|||
161853154|NCT00560391|584503685|FG002|Overall Study|Still on treatment|0|||
161853155|NCT00560391|584503686|FG003|Overall Study|Still on treatment|1|||
161853156|NCT00560391|584503687|FG004|Overall Study|Still on treatment|2|||
162033891|NCT04393298|585181148|FG004|Overall Study|Adverse Event|1|||
162033892|NCT04393298|585181149|FG005|Overall Study|Adverse Event|0|||
162033893|NCT04393298|585181150|FG006|Overall Study|Adverse Event|0|||
162033894|NCT04393298|585181151|FG007|Overall Study|Adverse Event|0|||
162033895|NCT04393298|585181152|FG008|Overall Study|Adverse Event|2|||
162033896|NCT04393298|585181153|FG009|Overall Study|Adverse Event|0|||
162033897|NCT04393298|585181154|FG010|Overall Study|Adverse Event|0|||
162033898|NCT04393298|585181155|FG011|Overall Study|Adverse Event|0|||
162033899|NCT04393298|585181156|FG012|Overall Study|Adverse Event|1|||
162033900|NCT04393298|585181157|FG013|Overall Study|Adverse Event|1|||
162033901|NCT04393298|585181158|FG014|Overall Study|Adverse Event|0|||
162033902|NCT04393298|585181144|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033903|NCT04393298|585181145|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033904|NCT04393298|585181146|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
162033905|NCT04393298|585181147|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033906|NCT04393298|585181148|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033907|NCT04393298|585181149|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033908|NCT04393298|585181150|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033909|NCT04393298|585181151|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033910|NCT04393298|585181152|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033911|NCT04393298|585181153|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033912|NCT04393298|585181154|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033913|NCT04393298|585181155|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033914|NCT04393298|585181156|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033915|NCT04393298|585181157|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
162033916|NCT04393298|585181158|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
162033917|NCT04393298|585181144|FG000|Overall Study|Lack of Efficacy|0|||
162033918|NCT04393298|585181145|FG001|Overall Study|Lack of Efficacy|0|||
161853157|NCT03668808|584503688|FG000|First Intervention|Withdrawal by Subject|2|||
161853158|NCT03668808|584503689|FG001|First Intervention|Withdrawal by Subject|2|||
161853159|NCT01895777|584503690|FG000|Overall Study|Adverse Event|1|||
161853160|NCT01895777|584503691|FG001|Overall Study|Adverse Event|2|||
161853161|NCT01895777|584503690|FG000|Overall Study|Lost to Follow-up|2|||
161853162|NCT01895777|584503691|FG001|Overall Study|Lost to Follow-up|0|||
161853163|NCT01895777|584503690|FG000|Overall Study|Not treated|1|||
161853164|NCT01895777|584503691|FG001|Overall Study|Not treated|0|||
162033919|NCT04393298|585181146|FG002|Overall Study|Lack of Efficacy|0|||
162033920|NCT04393298|585181147|FG003|Overall Study|Lack of Efficacy|0|||
162033921|NCT04393298|585181148|FG004|Overall Study|Lack of Efficacy|0|||
162033922|NCT04393298|585181149|FG005|Overall Study|Lack of Efficacy|0|||
162033923|NCT04393298|585181150|FG006|Overall Study|Lack of Efficacy|0|||
162033924|NCT04393298|585181151|FG007|Overall Study|Lack of Efficacy|0|||
161853165|NCT01895777|584503690|FG000|Overall Study|Other reasons|3|||
161853166|NCT01895777|584503691|FG001|Overall Study|Other reasons|2|||
161853167|NCT01895777|584503690|FG000|Overall Study|Non-compliance with the CTP|2|||
161853168|NCT01895777|584503691|FG001|Overall Study|Non-compliance with the CTP|1|||
161853169|NCT04223752|584503696|FG000|Overall Study|Participant enrolled in error|0|||
161853170|NCT04223752|584503697|FG001|Overall Study|Participant enrolled in error|0|||
161853171|NCT04223752|584503698|FG002|Overall Study|Participant enrolled in error|0|||
161973792|NCT01133405|584952318|FG009|Period 1|Physician Decision|0|||
161973793|NCT01133405|584952309|FG000|Period 1|Discontinued after randomization|1|||
161973794|NCT01133405|584952310|FG001|Period 1|Discontinued after randomization|0|||
161973795|NCT01133405|584952311|FG002|Period 1|Discontinued after randomization|0|||
161973796|NCT01133405|584952312|FG003|Period 1|Discontinued after randomization|0|||
161765348|NCT00545740|584180564|FG003|Overall Study|Adverse Event|9|||
161765349|NCT00545740|584180561|FG000|Overall Study|Lost to Follow-up|7|||
161765350|NCT00545740|584180562|FG001|Overall Study|Lost to Follow-up|5|||
161765351|NCT00545740|584180563|FG002|Overall Study|Lost to Follow-up|5|||
161765352|NCT00545740|584180564|FG003|Overall Study|Lost to Follow-up|6|||
161765353|NCT00545740|584180561|FG000|Overall Study|Protocol Violation|1|||
161765354|NCT00545740|584180562|FG001|Overall Study|Protocol Violation|3|||
161765355|NCT00545740|584180563|FG002|Overall Study|Protocol Violation|1|||
161765356|NCT00545740|584180564|FG003|Overall Study|Protocol Violation|0|||
161765357|NCT00545740|584180561|FG000|Overall Study|Non-compliance|0|||
161765358|NCT00545740|584180562|FG001|Overall Study|Non-compliance|2|||
161765359|NCT00545740|584180563|FG002|Overall Study|Non-compliance|1|||
161765360|NCT00545740|584180564|FG003|Overall Study|Non-compliance|0|||
161765361|NCT00545740|584180561|FG000|Overall Study|Moved|2|||
161765362|NCT00545740|584180562|FG001|Overall Study|Moved|0|||
161765363|NCT00545740|584180563|FG002|Overall Study|Moved|1|||
161765364|NCT00545740|584180564|FG003|Overall Study|Moved|0|||
161765365|NCT00545740|584180561|FG000|Overall Study|Diverticulitis attack|0|||
161765366|NCT00545740|584180562|FG001|Overall Study|Diverticulitis attack|0|||
161765367|NCT00545740|584180563|FG002|Overall Study|Diverticulitis attack|1|||
161765368|NCT00545740|584180564|FG003|Overall Study|Diverticulitis attack|1|||
161765369|NCT00545740|584180561|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
161765370|NCT00545740|584180562|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
161765371|NCT00545740|584180563|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
161765372|NCT00545740|584180564|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
161765373|NCT00545740|584180561|FG000|Overall Study|Site closure|1|||
161765374|NCT00545740|584180562|FG001|Overall Study|Site closure|0|||
161765375|NCT00545740|584180563|FG002|Overall Study|Site closure|0|||
161765376|NCT00545740|584180564|FG003|Overall Study|Site closure|0|||
161765377|NCT00545740|584180561|FG000|Overall Study|Missed visit|1|||
161765378|NCT00545740|584180562|FG001|Overall Study|Missed visit|0|||
161765379|NCT00545740|584180563|FG002|Overall Study|Missed visit|0|||
161765380|NCT00545740|584180564|FG003|Overall Study|Missed visit|0|||
161765381|NCT00545740|584180561|FG000|Overall Study|Physician Decision|0|||
161765382|NCT00545740|584180562|FG001|Overall Study|Physician Decision|0|||
161765383|NCT00545740|584180563|FG002|Overall Study|Physician Decision|3|||
161765384|NCT00545740|584180564|FG003|Overall Study|Physician Decision|0|||
161765385|NCT00545740|584180561|FG000|Overall Study|Accepted only monthly telephone calls|1|||
161765386|NCT00545740|584180562|FG001|Overall Study|Accepted only monthly telephone calls|0|||
161765387|NCT00545740|584180563|FG002|Overall Study|Accepted only monthly telephone calls|0|||
161765388|NCT00545740|584180564|FG003|Overall Study|Accepted only monthly telephone calls|0|||
161765389|NCT00545740|584180561|FG000|Overall Study|Sponsor decision|0|||
161765390|NCT00545740|584180562|FG001|Overall Study|Sponsor decision|1|||
161765391|NCT00545740|584180563|FG002|Overall Study|Sponsor decision|0|||
161765392|NCT00545740|584180564|FG003|Overall Study|Sponsor decision|0|||
161765393|NCT00545740|584180561|FG000|Overall Study|Lack of time|0|||
161765394|NCT00545740|584180562|FG001|Overall Study|Lack of time|1|||
161765395|NCT00545740|584180563|FG002|Overall Study|Lack of time|0|||
161765396|NCT00545740|584180564|FG003|Overall Study|Lack of time|0|||
161765397|NCT00545740|584180561|FG000|Overall Study|Non-adherence to visits|0|||
161765398|NCT00545740|584180562|FG001|Overall Study|Non-adherence to visits|1|||
161765399|NCT00545740|584180563|FG002|Overall Study|Non-adherence to visits|0|||
161765400|NCT00545740|584180564|FG003|Overall Study|Non-adherence to visits|0|||
161765401|NCT00545740|584180561|FG000|Overall Study|Patient difficulties|0|||
161765402|NCT00545740|584180562|FG001|Overall Study|Patient difficulties|1|||
161765403|NCT00545740|584180563|FG002|Overall Study|Patient difficulties|0|||
161765404|NCT00545740|584180564|FG003|Overall Study|Patient difficulties|0|||
161765405|NCT00545740|584180561|FG000|Overall Study|Husband against study|0|||
161973797|NCT01133405|584952313|FG004|Period 1|Discontinued after randomization|0|||
161973798|NCT01133405|584952314|FG005|Period 1|Discontinued after randomization|0|||
161973799|NCT01133405|584952315|FG006|Period 1|Discontinued after randomization|1|||
161765406|NCT00545740|584180562|FG001|Overall Study|Husband against study|0|||
161765407|NCT00545740|584180563|FG002|Overall Study|Husband against study|1|||
161765408|NCT00545740|584180564|FG003|Overall Study|Husband against study|0|||
161765409|NCT02117024|584180565|FG000|Overall Study|Progressive Disease|26|||
161765410|NCT02117024|584180566|FG001|Overall Study|Progressive Disease|9|||
161765411|NCT02117024|584180565|FG000|Overall Study|Significant Clinical Progression|7|||
161973800|NCT01133405|584952316|FG007|Period 1|Discontinued after randomization|0|||
161765412|NCT02117024|584180566|FG001|Overall Study|Significant Clinical Progression|4|||
161765413|NCT02117024|584180565|FG000|Overall Study|Death|5|||
161765414|NCT02117024|584180566|FG001|Overall Study|Death|0|||
161765415|NCT02117024|584180565|FG000|Overall Study|Withdrawal by Subject|3|||
161765416|NCT02117024|584180566|FG001|Overall Study|Withdrawal by Subject|1|||
161973801|NCT01133405|584952317|FG008|Period 1|Discontinued after randomization|0|||
161973802|NCT01133405|584952318|FG009|Period 1|Discontinued after randomization|0|||
161973803|NCT01133405|584952309|FG000|Period 1|Received drug only in period 2|0|||
161973804|NCT01133405|584952310|FG001|Period 1|Received drug only in period 2|1|||
161973805|NCT01133405|584952311|FG002|Period 1|Received drug only in period 2|0|||
161973806|NCT01133405|584952312|FG003|Period 1|Received drug only in period 2|2|||
161973807|NCT01133405|584952313|FG004|Period 1|Received drug only in period 2|0|||
161973808|NCT01133405|584952314|FG005|Period 1|Received drug only in period 2|1|||
161973809|NCT01133405|584952315|FG006|Period 1|Received drug only in period 2|0|||
161973810|NCT01133405|584952316|FG007|Period 1|Received drug only in period 2|0|||
161973811|NCT01133405|584952317|FG008|Period 1|Received drug only in period 2|0|||
161973812|NCT01133405|584952318|FG009|Period 1|Received drug only in period 2|0|||
161973813|NCT01133405|584952309|FG000|Period 1|Received drug only in period 3|0|||
161973814|NCT01133405|584952310|FG001|Period 1|Received drug only in period 3|1|||
161973815|NCT01133405|584952311|FG002|Period 1|Received drug only in period 3|1|||
161973816|NCT01133405|584952312|FG003|Period 1|Received drug only in period 3|0|||
161973817|NCT01133405|584952313|FG004|Period 1|Received drug only in period 3|0|||
161973818|NCT01133405|584952314|FG005|Period 1|Received drug only in period 3|0|||
161973819|NCT01133405|584952315|FG006|Period 1|Received drug only in period 3|0|||
161973820|NCT01133405|584952316|FG007|Period 1|Received drug only in period 3|0|||
161973821|NCT01133405|584952317|FG008|Period 1|Received drug only in period 3|0|||
161973822|NCT01133405|584952318|FG009|Period 1|Received drug only in period 3|0|||
161973823|NCT01133405|584952309|FG000|Period 2|Adverse Event|0|||
161973824|NCT01133405|584952310|FG001|Period 2|Adverse Event|0|||
161973825|NCT01133405|584952311|FG002|Period 2|Adverse Event|1|||
161973826|NCT01133405|584952312|FG003|Period 2|Adverse Event|0|||
161973827|NCT01133405|584952313|FG004|Period 2|Adverse Event|0|||
161973828|NCT01133405|584952314|FG005|Period 2|Adverse Event|0|||
161973829|NCT01133405|584952315|FG006|Period 2|Adverse Event|0|||
161973830|NCT01133405|584952316|FG007|Period 2|Adverse Event|0|||
161973831|NCT01133405|584952317|FG008|Period 2|Adverse Event|0|||
161973832|NCT01133405|584952318|FG009|Period 2|Adverse Event|0|||
161973833|NCT01133405|584952309|FG000|Period 2|Withdrawal by Subject|0|||
161973834|NCT01133405|584952310|FG001|Period 2|Withdrawal by Subject|0|||
161973835|NCT01133405|584952311|FG002|Period 2|Withdrawal by Subject|0|||
161973836|NCT01133405|584952312|FG003|Period 2|Withdrawal by Subject|1|||
161973837|NCT01133405|584952313|FG004|Period 2|Withdrawal by Subject|0|||
161973838|NCT01133405|584952314|FG005|Period 2|Withdrawal by Subject|1|||
161973839|NCT01133405|584952315|FG006|Period 2|Withdrawal by Subject|0|||
161973840|NCT01133405|584952316|FG007|Period 2|Withdrawal by Subject|0|||
161973841|NCT01133405|584952317|FG008|Period 2|Withdrawal by Subject|0|||
161973842|NCT01133405|584952318|FG009|Period 2|Withdrawal by Subject|0|||
161973843|NCT01133405|584952309|FG000|Period 2|Entry Criteria Not Met|0|||
161973844|NCT01133405|584952310|FG001|Period 2|Entry Criteria Not Met|1|||
161973845|NCT01133405|584952311|FG002|Period 2|Entry Criteria Not Met|0|||
161973846|NCT01133405|584952312|FG003|Period 2|Entry Criteria Not Met|0|||
161973847|NCT01133405|584952313|FG004|Period 2|Entry Criteria Not Met|0|||
161973848|NCT01133405|584952314|FG005|Period 2|Entry Criteria Not Met|0|||
161973849|NCT01133405|584952315|FG006|Period 2|Entry Criteria Not Met|0|||
161973850|NCT01133405|584952316|FG007|Period 2|Entry Criteria Not Met|0|||
161973851|NCT01133405|584952317|FG008|Period 2|Entry Criteria Not Met|0|||
161973852|NCT01133405|584952318|FG009|Period 2|Entry Criteria Not Met|0|||
161973853|NCT01133405|584952309|FG000|Period 2|Physician Decision|0|||
161973854|NCT01133405|584952310|FG001|Period 2|Physician Decision|0|||
161973855|NCT01133405|584952311|FG002|Period 2|Physician Decision|0|||
161973856|NCT01133405|584952312|FG003|Period 2|Physician Decision|0|||
161973857|NCT01133405|584952313|FG004|Period 2|Physician Decision|0|||
161973858|NCT01133405|584952314|FG005|Period 2|Physician Decision|1|||
161973859|NCT01133405|584952315|FG006|Period 2|Physician Decision|0|||
161973860|NCT01133405|584952316|FG007|Period 2|Physician Decision|0|||
161973861|NCT01133405|584952317|FG008|Period 2|Physician Decision|0|||
161973862|NCT01133405|584952318|FG009|Period 2|Physician Decision|0|||
161853172|NCT04223752|584503699|FG003|Overall Study|Participant enrolled in error|0|||
161973863|NCT00867087|584952321|FG000|Overall Study|Other|1|||
161853173|NCT04223752|584503700|FG004|Overall Study|Participant enrolled in error|1|||
161853174|NCT04223752|584503696|FG000|Overall Study|Death|0|||
161853175|NCT04223752|584503697|FG001|Overall Study|Death|0|||
161853176|NCT04223752|584503698|FG002|Overall Study|Death|0|||
161973864|NCT00867087|584952321|FG000|Overall Study|Withdrawal by Subject|4|||
161973865|NCT00867087|584952321|FG000|Overall Study|Death|37|||
161973866|NCT03300024|584952322|FG000|Overall Study|Physician Decision|4|||
161973867|NCT03300024|584952323|FG001|Overall Study|Physician Decision|6|||
161973868|NCT01238835|584952324|FG000|Overall Study|Death|124|||
161973869|NCT01238835|584952324|FG000|Overall Study|Withdrawal by Subject|9|||
161853177|NCT04223752|584503699|FG003|Overall Study|Death|2|||
161973870|NCT01238835|584952324|FG000|Overall Study|Lost to Follow-up|1|||
161973871|NCT01238835|584952324|FG000|Overall Study|Site early discontinuation|2|||
161973872|NCT02088073|584952325|FG000|Acute Phase|Withdrawal by Subject|5|||
161973873|NCT02088073|584952326|FG001|Acute Phase|Withdrawal by Subject|0|||
161973874|NCT02088073|584952327|FG002|Acute Phase|Withdrawal by Subject|0|||
161973875|NCT02088073|584952328|FG003|Acute Phase|Withdrawal by Subject|0|||
161973876|NCT02088073|584952329|FG004|Acute Phase|Withdrawal by Subject|0|||
161973877|NCT02088073|584952325|FG000|Acute Phase|Hyperkalemia|2|||
161973878|NCT02088073|584952326|FG001|Acute Phase|Hyperkalemia|0|||
161973879|NCT02088073|584952327|FG002|Acute Phase|Hyperkalemia|0|||
161973880|NCT02088073|584952328|FG003|Acute Phase|Hyperkalemia|0|||
161973881|NCT02088073|584952329|FG004|Acute Phase|Hyperkalemia|0|||
161973882|NCT02088073|584952325|FG000|Maintanance Phase|Withdrawal by Subject|0|||
161973883|NCT02088073|584952326|FG001|Maintanance Phase|Withdrawal by Subject|2|||
161973884|NCT02088073|584952327|FG002|Maintanance Phase|Withdrawal by Subject|0|||
161973885|NCT02088073|584952328|FG003|Maintanance Phase|Withdrawal by Subject|0|||
161973886|NCT02088073|584952329|FG004|Maintanance Phase|Withdrawal by Subject|0|||
161973887|NCT02088073|584952325|FG000|Maintanance Phase|Adverse Event|0|||
161973888|NCT02088073|584952326|FG001|Maintanance Phase|Adverse Event|0|||
161973889|NCT02088073|584952327|FG002|Maintanance Phase|Adverse Event|3|||
161973890|NCT02088073|584952328|FG003|Maintanance Phase|Adverse Event|0|||
161973891|NCT02088073|584952329|FG004|Maintanance Phase|Adverse Event|1|||
161973892|NCT02088073|584952325|FG000|Maintanance Phase|Physician Decision|0|||
161973893|NCT02088073|584952326|FG001|Maintanance Phase|Physician Decision|0|||
161973894|NCT02088073|584952327|FG002|Maintanance Phase|Physician Decision|0|||
161973895|NCT02088073|584952328|FG003|Maintanance Phase|Physician Decision|0|||
161973896|NCT02088073|584952329|FG004|Maintanance Phase|Physician Decision|1|||
161973897|NCT02088073|584952325|FG000|Maintanance Phase|Sponsor's decision|0|||
161973898|NCT02088073|584952326|FG001|Maintanance Phase|Sponsor's decision|2|||
161973899|NCT02088073|584952327|FG002|Maintanance Phase|Sponsor's decision|0|||
161973900|NCT02088073|584952328|FG003|Maintanance Phase|Sponsor's decision|2|||
161973901|NCT02088073|584952329|FG004|Maintanance Phase|Sponsor's decision|1|||
161973902|NCT02088073|584952325|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
161973903|NCT02088073|584952326|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
161973904|NCT02088073|584952327|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
161973905|NCT02088073|584952328|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
161973906|NCT02088073|584952329|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
161973907|NCT02088073|584952325|FG000|Maintanance Phase|Miscellaneous|0|||
161973908|NCT02088073|584952326|FG001|Maintanance Phase|Miscellaneous|2|||
161973909|NCT02088073|584952327|FG002|Maintanance Phase|Miscellaneous|1|||
161973910|NCT02088073|584952328|FG003|Maintanance Phase|Miscellaneous|2|||
161973911|NCT02088073|584952329|FG004|Maintanance Phase|Miscellaneous|1|||
161973912|NCT02088073|584952325|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
161973913|NCT02088073|584952326|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
161973914|NCT02088073|584952327|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
161973915|NCT02088073|584952328|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
161973916|NCT02088073|584952329|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
161973917|NCT02088073|584952325|FG000|Maintanance Phase|Subject compliance|0|||
161973918|NCT02088073|584952326|FG001|Maintanance Phase|Subject compliance|1|||
161973919|NCT02088073|584952327|FG002|Maintanance Phase|Subject compliance|0|||
161973920|NCT02088073|584952328|FG003|Maintanance Phase|Subject compliance|0|||
161973921|NCT02088073|584952329|FG004|Maintanance Phase|Subject compliance|0|||
161973922|NCT02419131|584952334|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
161973923|NCT02419131|584952335|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
161973924|NCT02419131|584952336|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
161973925|NCT02419131|584952334|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
161973926|NCT02419131|584952335|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
161973927|NCT02419131|584952336|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
161973928|NCT00089986|584952337|FG000|Overall Study|Adverse Event|6|||
161973929|NCT00089986|584952338|FG001|Overall Study|Adverse Event|9|||
161973930|NCT00089986|584952339|FG002|Overall Study|Adverse Event|6|||
161973931|NCT00089986|584952337|FG000|Overall Study|Lost to Follow-up|3|||
161973932|NCT00089986|584952338|FG001|Overall Study|Lost to Follow-up|1|||
161973933|NCT00089986|584952339|FG002|Overall Study|Lost to Follow-up|1|||
161973934|NCT00089986|584952337|FG000|Overall Study|Protocol Violation|0|||
161973935|NCT00089986|584952338|FG001|Overall Study|Protocol Violation|1|||
161973936|NCT00089986|584952339|FG002|Overall Study|Protocol Violation|0|||
161973937|NCT00089986|584952337|FG000|Overall Study|Patient transferred to another hospital|2|||
161973938|NCT00089986|584952338|FG001|Overall Study|Patient transferred to another hospital|1|||
161973939|NCT00089986|584952339|FG002|Overall Study|Patient transferred to another hospital|0|||
161973940|NCT00089986|584952337|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
161973941|NCT00089986|584952338|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
161973942|NCT00089986|584952339|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
161973943|NCT00089986|584952337|FG000|Overall Study|Hemohlobin stopping rule|0|||
161973944|NCT00089986|584952338|FG001|Overall Study|Hemohlobin stopping rule|1|||
161973945|NCT00089986|584952339|FG002|Overall Study|Hemohlobin stopping rule|0|||
161973946|NCT00089986|584952337|FG000|Overall Study|Investigator decision to withdrew|0|||
161973947|NCT00089986|584952338|FG001|Overall Study|Investigator decision to withdrew|1|||
161973948|NCT00089986|584952339|FG002|Overall Study|Investigator decision to withdrew|0|||
162033925|NCT04393298|585181152|FG008|Overall Study|Lack of Efficacy|0|||
162033926|NCT04393298|585181153|FG009|Overall Study|Lack of Efficacy|0|||
162033927|NCT04393298|585181154|FG010|Overall Study|Lack of Efficacy|0|||
162033928|NCT04393298|585181155|FG011|Overall Study|Lack of Efficacy|0|||
162033929|NCT04393298|585181156|FG012|Overall Study|Lack of Efficacy|0|||
162033930|NCT04393298|585181157|FG013|Overall Study|Lack of Efficacy|0|||
162033931|NCT04393298|585181158|FG014|Overall Study|Lack of Efficacy|1|||
162033932|NCT04393298|585181144|FG000|Overall Study|Progression|1|||
162033933|NCT04393298|585181145|FG001|Overall Study|Progression|0|||
162033934|NCT04393298|585181146|FG002|Overall Study|Progression|0|||
162033935|NCT04393298|585181147|FG003|Overall Study|Progression|0|||
162033936|NCT04393298|585181148|FG004|Overall Study|Progression|0|||
162033937|NCT04393298|585181149|FG005|Overall Study|Progression|0|||
162033938|NCT04393298|585181150|FG006|Overall Study|Progression|0|||
162033939|NCT04393298|585181151|FG007|Overall Study|Progression|0|||
162033940|NCT04393298|585181152|FG008|Overall Study|Progression|0|||
162033941|NCT04393298|585181153|FG009|Overall Study|Progression|0|||
162033942|NCT04393298|585181154|FG010|Overall Study|Progression|1|||
161765417|NCT02117024|584180565|FG000|Overall Study|Protocol Violation|1|||
161765418|NCT02117024|584180566|FG001|Overall Study|Protocol Violation|0|||
161765419|NCT02117024|584180565|FG000|Overall Study|Adverse Event|1|||
161765420|NCT02117024|584180566|FG001|Overall Study|Adverse Event|2|||
161765421|NCT02117024|584180565|FG000|Overall Study|Randomized in Error|1|||
161765422|NCT02117024|584180566|FG001|Overall Study|Randomized in Error|0|||
161765423|NCT02117024|584180565|FG000|Overall Study|Patient returned to primary oncologist|0|||
161765424|NCT02117024|584180566|FG001|Overall Study|Patient returned to primary oncologist|1|||
161765425|NCT02117024|584180565|FG000|Overall Study|Patient took treatment break|0|||
161765426|NCT02117024|584180566|FG001|Overall Study|Patient took treatment break|1|||
161765427|NCT02117024|584180565|FG000|Overall Study|Physician Decision|0|||
161765428|NCT02117024|584180566|FG001|Overall Study|Physician Decision|2|||
161765429|NCT00565721|584180567|FG000|Overall Study|Screen Failure|2|||
161765430|NCT00565721|584180567|FG000|Overall Study|Lost to Follow-up|6|||
161765431|NCT00565721|584180567|FG000|Overall Study|Technical Problems|1|||
161765432|NCT00565721|584180567|FG000|Overall Study|Physician Decision|2|||
161765433|NCT00565721|584180567|FG000|Overall Study|Other reasons|6|||
161765434|NCT02813681|584180570|FG000|Overall Study|Physician Decision|5|||
161765435|NCT02813681|584180571|FG001|Overall Study|Physician Decision|5|||
161765436|NCT02813681|584180572|FG002|Overall Study|Physician Decision|0|||
161765437|NCT02813681|584180570|FG000|Overall Study|Lost to Follow-up|0|||
161765438|NCT02813681|584180571|FG001|Overall Study|Lost to Follow-up|1|||
161765439|NCT02813681|584180572|FG002|Overall Study|Lost to Follow-up|0|||
161765440|NCT00529152|584180573|FG000|Overall Study|Adverse Event|2|||
161765441|NCT00529152|584180573|FG000|Overall Study|Withdrawal by Subject|2|||
161765442|NCT00529152|584180573|FG000|Overall Study|Lost to Follow-up|1|||
161765443|NCT04062240|584180577|FG000|Overall Study|equipment malfunction|1|||
161765444|NCT03961529|584180578|FG000|Overall Study|Adverse Event|13|||
161765445|NCT03961529|584180579|FG001|Overall Study|Adverse Event|5|||
161765446|NCT03961529|584180580|FG002|Overall Study|Adverse Event|2|||
161765447|NCT03961529|584180578|FG000|Overall Study|Withdrawal by Subject|17|||
161765448|NCT03961529|584180579|FG001|Overall Study|Withdrawal by Subject|2|||
161765449|NCT03961529|584180580|FG002|Overall Study|Withdrawal by Subject|1|||
161765450|NCT03961529|584180578|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161765451|NCT03961529|584180579|FG001|Overall Study|Withdrawal by parent/guardian|7|||
161765452|NCT03961529|584180580|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161765453|NCT03961529|584180578|FG000|Overall Study|Physician Decision|2|||
161765454|NCT03961529|584180579|FG001|Overall Study|Physician Decision|1|||
161765455|NCT03961529|584180580|FG002|Overall Study|Physician Decision|1|||
161765456|NCT03961529|584180578|FG000|Overall Study|Lost to Follow-up|2|||
161765457|NCT03961529|584180579|FG001|Overall Study|Lost to Follow-up|1|||
161765458|NCT03961529|584180580|FG002|Overall Study|Lost to Follow-up|0|||
161765459|NCT03961529|584180578|FG000|Overall Study|Lack of Efficacy|2|||
161765460|NCT03961529|584180579|FG001|Overall Study|Lack of Efficacy|0|||
161765461|NCT03961529|584180580|FG002|Overall Study|Lack of Efficacy|1|||
161765462|NCT03961529|584180578|FG000|Overall Study|Other|6|||
161765463|NCT03961529|584180579|FG001|Overall Study|Other|1|||
161765464|NCT03961529|584180580|FG002|Overall Study|Other|0|||
161765465|NCT03500419|584180581|FG000|Overall Study|Withdrawal by Subject|2|||
161765466|NCT03500419|584180582|FG001|Overall Study|Withdrawal by Subject|25|||
161765467|NCT01497899|584180583|FG000|Double-Blind Phase|Randomized but not Treated|1|||
161765468|NCT01497899|584180584|FG001|Double-Blind Phase|Randomized but not Treated|0|||
161765469|NCT01497899|584180585|FG002|Double-Blind Phase|Randomized but not Treated|0|||
162033943|NCT04393298|585181155|FG011|Overall Study|Progression|1|||
162033944|NCT04393298|585181156|FG012|Overall Study|Progression|0|||
161765470|NCT01497899|584180586|FG003|Double-Blind Phase|Randomized but not Treated|0|||
161765471|NCT01497899|584180583|FG000|Double-Blind Phase|Adverse Event|1|||
161765472|NCT01497899|584180584|FG001|Double-Blind Phase|Adverse Event|0|||
161765473|NCT01497899|584180585|FG002|Double-Blind Phase|Adverse Event|0|||
161765474|NCT01497899|584180586|FG003|Double-Blind Phase|Adverse Event|0|||
161765475|NCT01497899|584180583|FG000|Double-Blind Phase|Lack of Efficacy|0|||
162033945|NCT04393298|585181157|FG013|Overall Study|Progression|0|||
161765476|NCT01497899|584180584|FG001|Double-Blind Phase|Lack of Efficacy|1|||
161765477|NCT01497899|584180585|FG002|Double-Blind Phase|Lack of Efficacy|0|||
161765478|NCT01497899|584180586|FG003|Double-Blind Phase|Lack of Efficacy|0|||
161765479|NCT01497899|584180583|FG000|Double-Blind Phase|Investigator's Discretion|1|||
161765480|NCT01497899|584180584|FG001|Double-Blind Phase|Investigator's Discretion|0|||
161765481|NCT01497899|584180585|FG002|Double-Blind Phase|Investigator's Discretion|0|||
161765482|NCT01497899|584180586|FG003|Double-Blind Phase|Investigator's Discretion|0|||
161765483|NCT01497899|584180583|FG000|Double-Blind Phase|Withdrew Consent|0|||
161765484|NCT01497899|584180584|FG001|Double-Blind Phase|Withdrew Consent|1|||
161765485|NCT01497899|584180585|FG002|Double-Blind Phase|Withdrew Consent|0|||
161765486|NCT01497899|584180586|FG003|Double-Blind Phase|Withdrew Consent|0|||
161765487|NCT01497899|584180583|FG000|Double-Blind Phase|Lost to Follow-up|3|||
161765488|NCT01497899|584180584|FG001|Double-Blind Phase|Lost to Follow-up|2|||
161765489|NCT01497899|584180585|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161765490|NCT01497899|584180586|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161765491|NCT01497899|584180583|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
161765492|NCT01497899|584180584|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
161765493|NCT01497899|584180585|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
161765494|NCT01497899|584180586|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
161765495|NCT01497899|584180583|FG000|Open-Label Extension Phase|Adverse Event|1|||
161765496|NCT01497899|584180584|FG001|Open-Label Extension Phase|Adverse Event|0|||
161765497|NCT01497899|584180585|FG002|Open-Label Extension Phase|Adverse Event|0|||
161765498|NCT01497899|584180586|FG003|Open-Label Extension Phase|Adverse Event|0|||
161765499|NCT01497899|584180583|FG000|Open-Label Extension Phase|Death|1|||
161765500|NCT01497899|584180584|FG001|Open-Label Extension Phase|Death|0|||
161765501|NCT01497899|584180585|FG002|Open-Label Extension Phase|Death|0|||
161765502|NCT01497899|584180586|FG003|Open-Label Extension Phase|Death|0|||
161765503|NCT01497899|584180583|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
161765504|NCT01497899|584180584|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
161765505|NCT01497899|584180585|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
161765506|NCT01497899|584180586|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
161765507|NCT01497899|584180583|FG000|Open-Label Extension Phase|Pregnancy|0|||
161765508|NCT01497899|584180584|FG001|Open-Label Extension Phase|Pregnancy|1|||
161765509|NCT01497899|584180585|FG002|Open-Label Extension Phase|Pregnancy|1|||
161765510|NCT01497899|584180586|FG003|Open-Label Extension Phase|Pregnancy|0|||
161765511|NCT01497899|584180583|FG000|Open-Label Extension Phase|Protocol Violation|0|||
161765512|NCT01497899|584180584|FG001|Open-Label Extension Phase|Protocol Violation|0|||
161765513|NCT01497899|584180585|FG002|Open-Label Extension Phase|Protocol Violation|1|||
161765514|NCT01497899|584180586|FG003|Open-Label Extension Phase|Protocol Violation|0|||
161765515|NCT01497899|584180583|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
161765516|NCT01497899|584180584|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
161765517|NCT01497899|584180585|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
161765518|NCT01497899|584180586|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
161765519|NCT02142712|584180589|FG000|Overall Study|Lost to Follow-up|1|||
161765520|NCT02142712|584180590|FG001|Overall Study|Lost to Follow-up|1|||
161765521|NCT02142712|584180591|FG002|Overall Study|Lost to Follow-up|1|||
161765522|NCT02142712|584180592|FG003|Overall Study|Lost to Follow-up|0|||
161765523|NCT01854918|584180593|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
161765524|NCT01854918|584180594|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
161765525|NCT01854918|584180593|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
161765526|NCT01854918|584180594|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
161765527|NCT01854918|584180593|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
161765528|NCT01854918|584180594|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
161765529|NCT01854918|584180593|FG000|SOC-controlled Period (Year 1)|Death|5|||
161765530|NCT01854918|584180594|FG001|SOC-controlled Period (Year 1)|Death|5|||
161765531|NCT01854918|584180593|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
161765532|NCT01854918|584180594|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
161765533|NCT01854918|584180593|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
161765534|NCT01854918|584180594|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
161765535|NCT01854918|584180593|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
161765536|NCT01854918|584180594|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
161765537|NCT01854918|584180593|FG000|All-IP Period (Years 2 and 3)|Death|5|||
161765538|NCT01854918|584180594|FG001|All-IP Period (Years 2 and 3)|Death|16|||
161765539|NCT02828982|584180598|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161765540|NCT02828982|584180599|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161765541|NCT02475564|584180600|FG000|Overall Study|Withdrawal by Subject|1|||
161765542|NCT02475564|584180601|FG001|Overall Study|Withdrawal by Subject|0|||
161765543|NCT02475564|584180600|FG000|Overall Study|Lost to Follow-up|2|||
161765544|NCT02475564|584180601|FG001|Overall Study|Lost to Follow-up|1|||
161765545|NCT02475564|584180600|FG000|Overall Study|Intense Menstrual bleeding|1|||
161765546|NCT02475564|584180601|FG001|Overall Study|Intense Menstrual bleeding|0|||
161765547|NCT02705755|584180602|FG000|Part A (6 Days)|Adverse Event|1|||
161765548|NCT02705755|584180603|FG001|Part A (6 Days)|Adverse Event|0|||
161765549|NCT02705755|584180604|FG002|Part A (6 Days)|Adverse Event|0|||
161765550|NCT02705755|584180605|FG003|Part A (6 Days)|Adverse Event|0|||
161765551|NCT02705755|584180602|FG000|Part A (6 Days)|Physician Decision|3|||
161765552|NCT02705755|584180603|FG001|Part A (6 Days)|Physician Decision|0|||
161765553|NCT02705755|584180604|FG002|Part A (6 Days)|Physician Decision|0|||
161765554|NCT02705755|584180605|FG003|Part A (6 Days)|Physician Decision|0|||
161765555|NCT02705755|584180602|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
161765556|NCT02705755|584180603|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
161765557|NCT02705755|584180604|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
161765558|NCT02705755|584180605|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
161765559|NCT02705755|584180602|FG000|Part C (20 Weeks)|Physician Decision|0|||
161765560|NCT02705755|584180603|FG001|Part C (20 Weeks)|Physician Decision|0|||
161765561|NCT02705755|584180604|FG002|Part C (20 Weeks)|Physician Decision|0|||
161765562|NCT02705755|584180605|FG003|Part C (20 Weeks)|Physician Decision|2|||
161765563|NCT02705755|584180602|FG000|Part C (20 Weeks)|Adverse Event|0|||
161765564|NCT02705755|584180603|FG001|Part C (20 Weeks)|Adverse Event|0|||
161765565|NCT02705755|584180604|FG002|Part C (20 Weeks)|Adverse Event|0|||
161765566|NCT02705755|584180605|FG003|Part C (20 Weeks)|Adverse Event|6|||
161765567|NCT02705755|584180602|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
161765568|NCT02705755|584180603|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
161765569|NCT02705755|584180604|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
161765570|NCT02705755|584180605|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
161765571|NCT01906489|584180606|FG000|Overall Study|Adverse Event|10|||
161765572|NCT01906489|584180607|FG001|Overall Study|Adverse Event|3|||
161765573|NCT01906489|584180606|FG000|Overall Study|Worsening of CKD|6|||
161765574|NCT01906489|584180607|FG001|Overall Study|Worsening of CKD|4|||
161765575|NCT01906489|584180606|FG000|Overall Study|Withdrawal by Subject|5|||
161765576|NCT01906489|584180607|FG001|Overall Study|Withdrawal by Subject|0|||
161765577|NCT01906489|584180606|FG000|Overall Study|Worsening of Anemia|1|||
161765578|NCT01906489|584180607|FG001|Overall Study|Worsening of Anemia|0|||
161765579|NCT01906489|584180606|FG000|Overall Study|Protocol Violation|0|||
161765580|NCT01906489|584180607|FG001|Overall Study|Protocol Violation|1|||
161765581|NCT01906489|584180606|FG000|Overall Study|Non- Compliance|1|||
161765582|NCT01906489|584180607|FG001|Overall Study|Non- Compliance|0|||
161765583|NCT01906489|584180606|FG000|Overall Study|Sponsor Decision|1|||
161765584|NCT01906489|584180607|FG001|Overall Study|Sponsor Decision|0|||
161765585|NCT01906489|584180606|FG000|Overall Study|Lost to Follow-up|1|||
161765586|NCT01906489|584180607|FG001|Overall Study|Lost to Follow-up|1|||
161765587|NCT01906489|584180606|FG000|Overall Study|Other|1|||
161765588|NCT01906489|584180607|FG001|Overall Study|Other|0|||
161765589|NCT03458234|584180608|FG000|Overall Study|Withdrawal by Subject|1|||
161765590|NCT03359811|584182893|FG000|Overall Study|Protocol Violation|2|||
161765591|NCT03359811|584182894|FG001|Overall Study|Protocol Violation|0|||
161765592|NCT02528331|584182907|FG000|Overall Study|Withdrawal by Subject|2|||
161765593|NCT00386152|584182908|FG000|Overall Study|Adverse Event|6|||
161765594|NCT00386152|584182909|FG001|Overall Study|Adverse Event|5|||
161765595|NCT00386152|584182910|FG002|Overall Study|Adverse Event|4|||
161765596|NCT00386152|584182908|FG000|Overall Study|Chang from original chemo stratification|4|||
161765597|NCT00386152|584182909|FG001|Overall Study|Chang from original chemo stratification|5|||
161765598|NCT00386152|584182910|FG002|Overall Study|Chang from original chemo stratification|6|||
161765599|NCT00386152|584182908|FG000|Overall Study|Death|3|||
161765600|NCT00386152|584182909|FG001|Overall Study|Death|0|||
161765601|NCT00386152|584182910|FG002|Overall Study|Death|1|||
161765602|NCT00386152|584182908|FG000|Overall Study|Disease progression|7|||
161765603|NCT00386152|584182909|FG001|Overall Study|Disease progression|4|||
161765604|NCT00386152|584182910|FG002|Overall Study|Disease progression|5|||
161765605|NCT00386152|584182908|FG000|Overall Study|Physician Decision|13|||
161765606|NCT00386152|584182909|FG001|Overall Study|Physician Decision|10|||
161765607|NCT00386152|584182910|FG002|Overall Study|Physician Decision|4|||
161765608|NCT00386152|584182908|FG000|Overall Study|Lost to Follow-up|1|||
162033946|NCT04393298|585181158|FG014|Overall Study|Progression|0|||
162033947|NCT04393298|585181144|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
162033948|NCT04393298|585181145|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
161765609|NCT00386152|584182909|FG001|Overall Study|Lost to Follow-up|0|||
161765610|NCT00386152|584182910|FG002|Overall Study|Lost to Follow-up|0|||
161765611|NCT00386152|584182908|FG000|Overall Study|Completed chemotherapy|4|||
161765612|NCT00386152|584182909|FG001|Overall Study|Completed chemotherapy|5|||
161765613|NCT00386152|584182910|FG002|Overall Study|Completed chemotherapy|1|||
161765614|NCT00386152|584182908|FG000|Overall Study|Protocol Violation|3|||
161765615|NCT00386152|584182909|FG001|Overall Study|Protocol Violation|5|||
161765616|NCT00386152|584182910|FG002|Overall Study|Protocol Violation|2|||
161765617|NCT00386152|584182908|FG000|Overall Study|Withdrawal by Subject|3|||
161765618|NCT00386152|584182909|FG001|Overall Study|Withdrawal by Subject|6|||
161765619|NCT00386152|584182910|FG002|Overall Study|Withdrawal by Subject|10|||
161765620|NCT03380091|584182912|FG000|Overall Study|Withdrawal by Subject|2|||
161765621|NCT03380091|584182913|FG001|Overall Study|Withdrawal by Subject|1|||
161765622|NCT04594213|584182914|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
161765623|NCT04594213|584182915|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
161765624|NCT04594213|584182916|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
161765625|NCT04594213|584182917|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
161765626|NCT04594213|584182918|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
161765627|NCT04594213|584182919|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
161765628|NCT04594213|584182914|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161765629|NCT04594213|584182915|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
161765630|NCT04594213|584182916|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161765631|NCT04594213|584182917|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161765632|NCT04594213|584182918|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161765633|NCT04594213|584182919|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161765634|NCT04594213|584182914|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
161765635|NCT04594213|584182915|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161765636|NCT04594213|584182916|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
161765637|NCT04594213|584182917|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161765638|NCT04594213|584182918|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161765639|NCT04594213|584182919|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161765640|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161765641|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161765642|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161765643|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161765644|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
161765645|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161765646|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161765647|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161765648|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161765649|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
161765650|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
161765651|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
161765652|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161765653|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161765654|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161765655|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161765656|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161765657|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
161765658|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161765659|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161765660|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161765661|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
161765662|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161765663|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161765664|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161765665|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161765666|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161765667|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
161765668|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161765669|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161765670|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
161765671|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
161765672|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
161765673|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
161765674|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
161765675|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
161765676|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
161765677|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
161765678|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
161765679|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
161765680|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
161765681|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
161765682|NCT04594213|584182914|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
161765683|NCT04594213|584182915|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
161765684|NCT04594213|584182916|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
161765685|NCT04594213|584182917|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
161765686|NCT04594213|584182918|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
161765687|NCT04594213|584182919|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
161765688|NCT01980056|584182921|FG000|Overall Study|Death|1|||
161765689|NCT01980056|584182922|FG001|Overall Study|Death|1|||
161765690|NCT01980056|584182923|FG002|Overall Study|Death|0|||
161765691|NCT00104299|584182924|FG000|Overall Study|Adverse Event|3|||
161765692|NCT00104299|584182925|FG001|Overall Study|Adverse Event|1|||
161973949|NCT00089986|584952337|FG000|Overall Study|Enrollment in another study|0|||
161973950|NCT00089986|584952338|FG001|Overall Study|Enrollment in another study|1|||
161973951|NCT00089986|584952339|FG002|Overall Study|Enrollment in another study|0|||
161973952|NCT00089986|584952337|FG000|Overall Study|Family decision|0|||
161973953|NCT00089986|584952338|FG001|Overall Study|Family decision|1|||
161973954|NCT00089986|584952339|FG002|Overall Study|Family decision|0|||
161973955|NCT00089986|584952337|FG000|Overall Study|Do not resuscitate (DNR)|0|||
161973956|NCT00089986|584952338|FG001|Overall Study|Do not resuscitate (DNR)|0|||
161973957|NCT00089986|584952339|FG002|Overall Study|Do not resuscitate (DNR)|1|||
161973958|NCT00089986|584952337|FG000|Overall Study|Withdrawal by Subject|3|||
161973959|NCT00089986|584952338|FG001|Overall Study|Withdrawal by Subject|6|||
161973960|NCT00089986|584952339|FG002|Overall Study|Withdrawal by Subject|2|||
161973961|NCT02334683|584952340|FG000|First 12 Week Period|Lost to Follow-up|1|||
161973962|NCT02334683|584952341|FG001|First 12 Week Period|Lost to Follow-up|0|||
161973963|NCT02334683|584952340|FG000|Second 12 Week Period|Adverse Event|0|||
161973964|NCT02334683|584952341|FG001|Second 12 Week Period|Adverse Event|1|||
161973965|NCT03958656|584952342|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
161973966|NCT03958656|584952343|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
161973967|NCT03958656|584952344|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
161973968|NCT03958656|584952345|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
161973969|NCT03958656|584952342|FG000|Overall Study|No longer meets eligibility criteria|0|||
161973970|NCT03958656|584952343|FG001|Overall Study|No longer meets eligibility criteria|0|||
161973971|NCT03958656|584952344|FG002|Overall Study|No longer meets eligibility criteria|1|||
161973972|NCT03958656|584952345|FG003|Overall Study|No longer meets eligibility criteria|0|||
161973973|NCT03958656|584952342|FG000|Overall Study|Started anti-cancer treatment|0|||
161973974|NCT03958656|584952343|FG001|Overall Study|Started anti-cancer treatment|0|||
161973975|NCT03958656|584952344|FG002|Overall Study|Started anti-cancer treatment|1|||
161973976|NCT03958656|584952345|FG003|Overall Study|Started anti-cancer treatment|0|||
161973977|NCT03831880|584952348|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
161973978|NCT03831880|584952349|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
161973979|NCT03831880|584952348|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
161973980|NCT03831880|584952349|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
161973981|NCT03158012|584952352|FG000|Overall Study|Withdrawal by Subject|0|||
161973982|NCT03158012|584952353|FG001|Overall Study|Withdrawal by Subject|1|||
161973983|NCT02788201|584952354|FG000|Overall Study|Death|1|||
161973984|NCT02788201|584952355|FG001|Overall Study|Death|1|||
161973985|NCT02788201|584952356|FG002|Overall Study|Death|1|||
161973986|NCT02788201|584952357|FG003|Overall Study|Death|1|||
161973987|NCT02788201|584952358|FG004|Overall Study|Death|0|||
161973988|NCT02788201|584952359|FG005|Overall Study|Death|1|||
161973989|NCT02788201|584952354|FG000|Overall Study|Ineligible|0|||
161973990|NCT02788201|584952355|FG001|Overall Study|Ineligible|0|||
161973991|NCT02788201|584952356|FG002|Overall Study|Ineligible|0|||
161973992|NCT02788201|584952357|FG003|Overall Study|Ineligible|0|||
161973993|NCT02788201|584952358|FG004|Overall Study|Ineligible|0|||
161973994|NCT02788201|584952359|FG005|Overall Study|Ineligible|1|||
161973995|NCT02788201|584952354|FG000|Overall Study|Withdrawal by Subject|0|||
161973996|NCT02788201|584952355|FG001|Overall Study|Withdrawal by Subject|0|||
161973997|NCT02788201|584952356|FG002|Overall Study|Withdrawal by Subject|0|||
161973998|NCT02788201|584952357|FG003|Overall Study|Withdrawal by Subject|0|||
161973999|NCT02788201|584952358|FG004|Overall Study|Withdrawal by Subject|0|||
161974000|NCT02788201|584952359|FG005|Overall Study|Withdrawal by Subject|1|||
161974001|NCT02969590|584952363|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
161974002|NCT02969590|584952364|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
161974003|NCT02969590|584952365|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
161974004|NCT01414205|584952366|FG000|Overall Study|Death|5|||
161974005|NCT01414205|584952367|FG001|Overall Study|Death|1|||
161974006|NCT01414205|584952366|FG000|Overall Study|Lost to Follow-up|1|||
161974007|NCT01414205|584952367|FG001|Overall Study|Lost to Follow-up|4|||
161974008|NCT01414205|584952366|FG000|Overall Study|Physician Decision|0|||
161974009|NCT01414205|584952367|FG001|Overall Study|Physician Decision|1|||
161974010|NCT01414205|584952366|FG000|Overall Study|Randomized but not Treated|1|||
161974011|NCT01414205|584952367|FG001|Overall Study|Randomized but not Treated|1|||
161974012|NCT01166373|584952368|FG000|Overall Study|Lost to Follow-up|3|||
161974013|NCT01166373|584952369|FG001|Overall Study|Lost to Follow-up|2|||
161974014|NCT01166373|584952370|FG002|Overall Study|Lost to Follow-up|2|||
161974015|NCT01166373|584952371|FG003|Overall Study|Lost to Follow-up|2|||
161765693|NCT00104299|584182924|FG000|Overall Study|Death|2|||
161765694|NCT00104299|584182925|FG001|Overall Study|Death|2|||
161765695|NCT00104299|584182924|FG000|Overall Study|Withdrawal by Subject|2|||
161765696|NCT00104299|584182925|FG001|Overall Study|Withdrawal by Subject|6|||
161765697|NCT00104299|584182924|FG000|Overall Study|Physician Decision|1|||
161765698|NCT00104299|584182925|FG001|Overall Study|Physician Decision|1|||
161765699|NCT00104299|584182924|FG000|Overall Study|To have renal transplant|1|||
161974016|NCT01166373|584952368|FG000|Overall Study|Withdrawal by Subject|1|||
161765700|NCT00104299|584182925|FG001|Overall Study|To have renal transplant|0|||
161765701|NCT01707667|584182926|FG000|Period 1|expulsion of colonic sensor catheter|1|||
161765702|NCT01707667|584182927|FG001|Period 1|expulsion of colonic sensor catheter|0|||
161765703|NCT03802331|584182928|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
161765704|NCT03802331|584182929|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
161765705|NCT03432819|584182933|FG000|Overall Study|Lost to Follow-up|2|||
161765706|NCT03432819|584182934|FG001|Overall Study|Lost to Follow-up|2|||
161974017|NCT01166373|584952369|FG001|Overall Study|Withdrawal by Subject|2|||
161765707|NCT03432819|584182933|FG000|Overall Study|Withdrawal by Subject|5|||
161765708|NCT03432819|584182934|FG001|Overall Study|Withdrawal by Subject|3|||
161765709|NCT01474993|584182935|FG000|Overall Study|Lost to Follow-up|1|||
161765710|NCT01474993|584182936|FG001|Overall Study|Lost to Follow-up|2|||
161765711|NCT01474993|584182935|FG000|Overall Study|Adverse Event|0|||
161765712|NCT01474993|584182936|FG001|Overall Study|Adverse Event|1|||
161765713|NCT02041533|584182937|FG000|Pre-Treatment Period|Disease Progression|1|||
161765714|NCT02041533|584182938|FG001|Pre-Treatment Period|Disease Progression|1|||
161765715|NCT02041533|584182937|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
161765716|NCT02041533|584182938|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
161765717|NCT02041533|584182937|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
161974018|NCT01166373|584952370|FG002|Overall Study|Withdrawal by Subject|2|||
161974019|NCT01166373|584952371|FG003|Overall Study|Withdrawal by Subject|3|||
161974020|NCT01166373|584952368|FG000|Overall Study|Physician Decision|1|||
161974021|NCT01166373|584952369|FG001|Overall Study|Physician Decision|0|||
161974022|NCT01166373|584952370|FG002|Overall Study|Physician Decision|0|||
161974023|NCT01166373|584952371|FG003|Overall Study|Physician Decision|0|||
161765718|NCT02041533|584182938|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
161765719|NCT02041533|584182937|FG000|Treatment Period|Disease progression|189|||
161765720|NCT02041533|584182938|FG001|Treatment Period|Disease progression|146|||
161765721|NCT02041533|584182937|FG000|Treatment Period|Study drug toxicity|30|||
161765722|NCT02041533|584182938|FG001|Treatment Period|Study drug toxicity|34|||
161765723|NCT02041533|584182937|FG000|Treatment Period|Death|1|||
161765724|NCT02041533|584182938|FG001|Treatment Period|Death|0|||
161765725|NCT02041533|584182937|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
161765726|NCT02041533|584182938|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
161765727|NCT02041533|584182937|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
161765728|NCT02041533|584182938|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
161765729|NCT02041533|584182937|FG000|Treatment Period|Participant withdrew consent|2|||
161765730|NCT02041533|584182938|FG001|Treatment Period|Participant withdrew consent|2|||
161765731|NCT02041533|584182937|FG000|Treatment Period|Maximum clinical benefit|0|||
161765732|NCT02041533|584182938|FG001|Treatment Period|Maximum clinical benefit|18|||
161765733|NCT02041533|584182937|FG000|Treatment Period|Poor/Non-compliance|1|||
161765734|NCT02041533|584182938|FG001|Treatment Period|Poor/Non-compliance|0|||
161765735|NCT02041533|584182937|FG000|Treatment Period|Administrative reason by sponsor|1|||
161765736|NCT02041533|584182938|FG001|Treatment Period|Administrative reason by sponsor|0|||
161765737|NCT02041533|584182937|FG000|Treatment Period|Other reasons|9|||
161765738|NCT02041533|584182938|FG001|Treatment Period|Other reasons|2|||
161765739|NCT02041533|584182937|FG000|Treatment Period|Not Reported|0|||
161765740|NCT02041533|584182938|FG001|Treatment Period|Not Reported|1|||
161765741|NCT01957111|584182939|FG000|Overall Study|Withdrawal by Subject|1|||
161765742|NCT01957111|584182940|FG001|Overall Study|Withdrawal by Subject|1|||
161765743|NCT01646255|584182941|FG000|Overall Study|Adverse Event|7|||
161765744|NCT01646255|584182942|FG001|Overall Study|Adverse Event|8|||
161765745|NCT01646255|584182941|FG000|Overall Study|Lack of Efficacy|2|||
161765746|NCT01646255|584182942|FG001|Overall Study|Lack of Efficacy|0|||
161765747|NCT01646255|584182941|FG000|Overall Study|Withdrawal by Subject|10|||
161765748|NCT01646255|584182942|FG001|Overall Study|Withdrawal by Subject|6|||
161765749|NCT01646255|584182941|FG000|Overall Study|Compliance is not well|1|||
161765750|NCT01646255|584182942|FG001|Overall Study|Compliance is not well|0|||
161765751|NCT01646255|584182941|FG000|Overall Study|Inclusion Criteria Deviation|1|||
161765752|NCT01646255|584182942|FG001|Overall Study|Inclusion Criteria Deviation|0|||
161765753|NCT01468844|584182943|FG000|Overall Study|Adverse Event|1|||
161765754|NCT01468844|584182944|FG001|Overall Study|Adverse Event|0|||
161765755|NCT01468844|584182943|FG000|Overall Study|Withdrawal by Subject|1|||
161765756|NCT01468844|584182944|FG001|Overall Study|Withdrawal by Subject|0|||
161974024|NCT00681564|584952372|FG000|Overall Study|Lost to Follow-up|6|||
161765757|NCT01241318|584182951|FG000|Overall Study|Woman: false pregnancies|27|||
161765758|NCT01241318|584182952|FG001|Overall Study|Woman: false pregnancies|15|||
161765759|NCT01241318|584182951|FG000|Overall Study|Woman: miscarriage/abortion|46|||
161765760|NCT01241318|584182952|FG001|Overall Study|Woman: miscarriage/abortion|38|||
161765761|NCT01241318|584182951|FG000|Overall Study|Withdrawal by Subject|175|||
161765762|NCT01241318|584182952|FG001|Overall Study|Withdrawal by Subject|46|||
161765763|NCT01241318|584182951|FG000|Overall Study|Lost to Follow-up|740|||
161765764|NCT01241318|584182952|FG001|Overall Study|Lost to Follow-up|455|||
161765765|NCT01241318|584182951|FG000|Overall Study|Death|2|||
161765766|NCT01241318|584182952|FG001|Overall Study|Death|4|||
161765767|NCT01241318|584182951|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
162033949|NCT04393298|585181146|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033950|NCT04393298|585181147|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033951|NCT04393298|585181148|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033952|NCT04393298|585181149|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033953|NCT04393298|585181150|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033954|NCT04393298|585181151|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033955|NCT04393298|585181152|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033956|NCT04393298|585181153|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033957|NCT04393298|585181154|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033958|NCT04393298|585181155|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033959|NCT04393298|585181156|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033960|NCT04393298|585181157|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033961|NCT04393298|585181158|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
162033962|NCT04393298|585181144|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033963|NCT04393298|585181145|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
162033964|NCT04393298|585181146|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033965|NCT04393298|585181147|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033966|NCT04393298|585181148|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033967|NCT04393298|585181149|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033968|NCT04393298|585181150|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033969|NCT04393298|585181151|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033970|NCT04393298|585181152|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033971|NCT04393298|585181153|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033972|NCT04393298|585181154|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033973|NCT04393298|585181155|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033974|NCT04393298|585181156|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033975|NCT04393298|585181157|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033976|NCT04393298|585181158|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
162033977|NCT04393298|585181144|FG000|Overall Study|Clinical Progression|0|||
162033978|NCT04393298|585181145|FG001|Overall Study|Clinical Progression|2|||
162033979|NCT04393298|585181146|FG002|Overall Study|Clinical Progression|0|||
162033980|NCT04393298|585181147|FG003|Overall Study|Clinical Progression|0|||
162033981|NCT04393298|585181148|FG004|Overall Study|Clinical Progression|0|||
162033982|NCT04393298|585181149|FG005|Overall Study|Clinical Progression|0|||
162033983|NCT04393298|585181150|FG006|Overall Study|Clinical Progression|0|||
162033984|NCT04393298|585181151|FG007|Overall Study|Clinical Progression|0|||
162033985|NCT04393298|585181152|FG008|Overall Study|Clinical Progression|0|||
162033986|NCT04393298|585181153|FG009|Overall Study|Clinical Progression|0|||
162033987|NCT04393298|585181154|FG010|Overall Study|Clinical Progression|0|||
162033988|NCT04393298|585181155|FG011|Overall Study|Clinical Progression|0|||
162033989|NCT04393298|585181156|FG012|Overall Study|Clinical Progression|0|||
162033990|NCT04393298|585181157|FG013|Overall Study|Clinical Progression|0|||
162033991|NCT04393298|585181158|FG014|Overall Study|Clinical Progression|0|||
162033992|NCT04393298|585181144|FG000|Overall Study|Disease Progression|0|||
162033993|NCT04393298|585181145|FG001|Overall Study|Disease Progression|1|||
162033994|NCT04393298|585181146|FG002|Overall Study|Disease Progression|0|||
162033995|NCT04393298|585181147|FG003|Overall Study|Disease Progression|0|||
162033996|NCT04393298|585181148|FG004|Overall Study|Disease Progression|0|||
162033997|NCT04393298|585181149|FG005|Overall Study|Disease Progression|3|||
162033998|NCT04393298|585181150|FG006|Overall Study|Disease Progression|2|||
162033999|NCT04393298|585181151|FG007|Overall Study|Disease Progression|1|||
162034000|NCT04393298|585181152|FG008|Overall Study|Disease Progression|2|||
162034001|NCT04393298|585181153|FG009|Overall Study|Disease Progression|1|||
162034002|NCT04393298|585181154|FG010|Overall Study|Disease Progression|0|||
162034003|NCT04393298|585181155|FG011|Overall Study|Disease Progression|3|||
162034004|NCT04393298|585181156|FG012|Overall Study|Disease Progression|0|||
162034005|NCT04393298|585181157|FG013|Overall Study|Disease Progression|0|||
162034006|NCT04393298|585181158|FG014|Overall Study|Disease Progression|1|||
162034007|NCT04393298|585181144|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
162034008|NCT04393298|585181145|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
162034009|NCT04393298|585181146|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
162034010|NCT04393298|585181147|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
162034011|NCT04393298|585181148|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
162034012|NCT04393298|585181149|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
162034013|NCT04393298|585181150|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
162034014|NCT04393298|585181151|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
162034015|NCT04393298|585181152|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
162034016|NCT04393298|585181153|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161853178|NCT04223752|584503700|FG004|Overall Study|Death|1|||
161765768|NCT01241318|584182952|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
161765769|NCT01241318|584182951|FG000|Overall Study|Woman: Stillborn infant|129|||
161765770|NCT01241318|584182952|FG001|Overall Study|Woman: Stillborn infant|146|||
161765771|NCT02355665|584182953|FG000|Overall Study|Adverse Event|16|||
161765772|NCT02355665|584182954|FG001|Overall Study|Adverse Event|24|||
161765773|NCT02355665|584182953|FG000|Overall Study|Protocol Violation|2|||
161765774|NCT02355665|584182954|FG001|Overall Study|Protocol Violation|0|||
161853179|NCT03340974|584503701|FG000|Completion of Study -Long Term Follow up|Death|8|||
161853180|NCT03340974|584503702|FG001|Completion of Study -Long Term Follow up|Death|5|||
161853181|NCT03340974|584503703|FG002|Completion of Study -Long Term Follow up|Death|5|||
161853182|NCT03340974|584503704|FG003|Completion of Study -Long Term Follow up|Death|7|||
161853183|NCT03340974|584503701|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
161853184|NCT03340974|584503702|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
161853185|NCT03340974|584503703|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
161853186|NCT03340974|584503704|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
161853187|NCT03340974|584503701|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
161853188|NCT03340974|584503702|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
161853189|NCT03340974|584503703|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
161853190|NCT03340974|584503704|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
161853191|NCT03340974|584503701|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
161853192|NCT03340974|584503702|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
161853193|NCT03340974|584503703|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
161853194|NCT03340974|584503704|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
161853195|NCT01128543|584503708|FG000|Overall Study|Withdrawal by Subject|3|||
161853196|NCT01128543|584503708|FG000|Overall Study|Protocol Violation|1|||
161853197|NCT02374346|584503712|FG000|Overall Study|operated or discharged during weekend|48|||
161853198|NCT00396565|584503721|FG000|Overall Study|Physician Decision|3|||
161853199|NCT00396565|584503722|FG001|Overall Study|Physician Decision|1|||
161853200|NCT00396565|584503723|FG002|Overall Study|Physician Decision|2|||
161853201|NCT00396565|584503721|FG000|Overall Study|Adverse Event|5|||
161853202|NCT00396565|584503722|FG001|Overall Study|Adverse Event|13|||
161853203|NCT00396565|584503723|FG002|Overall Study|Adverse Event|3|||
161853204|NCT00396565|584503721|FG000|Overall Study|Withdrawal by Subject|8|||
161853205|NCT00396565|584503722|FG001|Overall Study|Withdrawal by Subject|13|||
161853206|NCT00396565|584503723|FG002|Overall Study|Withdrawal by Subject|1|||
161853207|NCT00396565|584503721|FG000|Overall Study|Lack of Efficacy|32|||
161853208|NCT00396565|584503722|FG001|Overall Study|Lack of Efficacy|64|||
161974025|NCT00681564|584952373|FG001|Overall Study|Lost to Follow-up|6|||
161853209|NCT00396565|584503723|FG002|Overall Study|Lack of Efficacy|11|||
161853210|NCT04487067|584503725|FG000|Overall Study|Adverse Event|3|||
161853211|NCT04487067|584503725|FG000|Overall Study|Death Other Than Progressive Disease|60|||
161853212|NCT04487067|584503725|FG000|Overall Study|Death Due To Progressive Disease|40|||
161853213|NCT04487067|584503725|FG000|Overall Study|Lost to Follow-up|3|||
161853214|NCT04487067|584503725|FG000|Overall Study|Progressive Disease|1|||
161853215|NCT04487067|584503725|FG000|Overall Study|Protocol Violation|3|||
161853216|NCT04487067|584503725|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
161853217|NCT04487067|584503725|FG000|Overall Study|Withdrawal by Subject|15|||
161853218|NCT05299528|584503726|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161853219|NCT05299528|584503727|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
161853220|NCT05299528|584503728|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161853221|NCT05299528|584503729|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161853222|NCT05299528|584503730|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161853223|NCT05299528|584503731|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161853224|NCT05299528|584503732|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161853225|NCT05299528|584503726|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161853226|NCT05299528|584503727|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161853227|NCT05299528|584503728|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161853228|NCT05299528|584503729|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161974026|NCT00681564|584952372|FG000|Overall Study|Withdrawal by Subject|0|||
161974027|NCT00681564|584952373|FG001|Overall Study|Withdrawal by Subject|1|||
161974028|NCT00681564|584952372|FG000|Overall Study|Death|0|||
161974029|NCT00681564|584952373|FG001|Overall Study|Death|1|||
161974030|NCT02370641|584952374|FG000|Overall Study|dropped study|4|||
161974031|NCT02370641|584952375|FG001|Overall Study|dropped study|2|||
161974032|NCT02370095|584952377|FG000|Overall Study|Withdrawal by Subject|0|||
161974033|NCT02370095|584952378|FG001|Overall Study|Withdrawal by Subject|1|||
161974034|NCT02966795|584952379|FG000|Overall Study|Patient Left the Country|0|||
161765775|NCT02355665|584182953|FG000|Overall Study|Withdrawal by Subject|90|||
161853229|NCT05299528|584503730|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161853230|NCT05299528|584503731|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
161853231|NCT05299528|584503732|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161853232|NCT05299528|584503726|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
161853233|NCT05299528|584503727|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
161853234|NCT05299528|584503728|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
161853235|NCT05299528|584503729|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
161853236|NCT05299528|584503730|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
161853237|NCT05299528|584503731|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
161853238|NCT05299528|584503732|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
161853239|NCT04877457|584503733|FG000|Overall Study|Early termination of study due to low enrollment|2|||
161853240|NCT04877457|584503734|FG001|Overall Study|Early termination of study due to low enrollment|1|||
161853241|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
161853242|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
161853243|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
161853244|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Death|1|||
161853245|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Death|3|||
161853246|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Death|1|||
161853247|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
161853248|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
161974035|NCT02966795|584952380|FG001|Overall Study|Patient Left the Country|1|||
161974036|NCT00432744|584952381|FG000|Months 0-6|Withdrawal by Subject|4|||
161974037|NCT00432744|584952382|FG001|Months 0-6|Withdrawal by Subject|4|||
161974038|NCT00432744|584952381|FG000|Months 0-6|Too disabled to score|1|||
161974039|NCT00432744|584952382|FG001|Months 0-6|Too disabled to score|0|||
161974040|NCT00432744|584952381|FG000|Months 7 - 12|Withdrawal by Subject|1|||
161974041|NCT00432744|584952382|FG001|Months 7 - 12|Withdrawal by Subject|0|||
161974042|NCT00432744|584952381|FG000|Months 7 - 12|Too disabled to score|0|||
161974043|NCT00432744|584952382|FG001|Months 7 - 12|Too disabled to score|1|||
161974044|NCT00787930|584952383|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
161974045|NCT01294462|584952384|FG000|Overall Study|Lost to Follow-up|1|||
161974046|NCT01294462|584952385|FG001|Overall Study|Lost to Follow-up|0|||
161974047|NCT01294462|584952384|FG000|Overall Study|Withdrawal by Subject|65|||
161974048|NCT01294462|584952385|FG001|Overall Study|Withdrawal by Subject|63|||
161974049|NCT02743780|584952386|FG000|Part 3 (7 Days)|Adverse Event|0|||
161974050|NCT02743780|584952387|FG001|Part 3 (7 Days)|Adverse Event|0|||
161974051|NCT02743780|584952388|FG002|Part 3 (7 Days)|Adverse Event|1|||
161974052|NCT02743780|584952389|FG003|Part 3 (7 Days)|Adverse Event|0|||
161974053|NCT02743780|584952390|FG004|Part 3 (7 Days)|Adverse Event|0|||
161974054|NCT03002623|584952394|FG000|Overall Study|Lost to Follow-up|1|||
161974055|NCT03002623|584952395|FG001|Overall Study|Lost to Follow-up|0|||
161974056|NCT03002623|584952394|FG000|Overall Study|Physician Decision|1|||
161974057|NCT03002623|584952395|FG001|Overall Study|Physician Decision|1|||
161974058|NCT01460407|584952398|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
161974059|NCT01460407|584952399|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
161974060|NCT00526110|584952400|FG000|Overall Study|Adverse Event|2|||
161974061|NCT00526110|584952401|FG001|Overall Study|Adverse Event|9|||
161974062|NCT00526110|584952400|FG000|Overall Study|Disease Progression|0|||
161974063|NCT00526110|584952401|FG001|Overall Study|Disease Progression|19|||
161974064|NCT00526110|584952400|FG000|Overall Study|Maximal Response|0|||
161974065|NCT00526110|584952401|FG001|Overall Study|Maximal Response|6|||
161974066|NCT00526110|584952400|FG000|Overall Study|Withdrawal by Subject|0|||
161974067|NCT00526110|584952401|FG001|Overall Study|Withdrawal by Subject|2|||
161974068|NCT00526110|584952400|FG000|Overall Study|Poor Tolerance|0|||
161974069|NCT00526110|584952401|FG001|Overall Study|Poor Tolerance|5|||
161974070|NCT01400243|584952402|FG000|Overall Study|Protocol Violation|8|||
161974071|NCT01400243|584952403|FG001|Overall Study|Protocol Violation|11|||
161974072|NCT00953680|584952404|FG000|Period 1|Withdrawal by Subject|0|||
161974073|NCT00953680|584952405|FG001|Period 1|Withdrawal by Subject|1|||
161974074|NCT03762616|584952407|FG000|Overall Study|Protocol Violation|2|||
161974075|NCT00758589|584954605|FG000|Overall Study|Adverse Event|3|||
161974076|NCT00758589|584954606|FG001|Overall Study|Adverse Event|2|||
161974077|NCT00758589|584954607|FG002|Overall Study|Adverse Event|5|||
161974078|NCT00758589|584954608|FG003|Overall Study|Adverse Event|4|||
161974079|NCT00758589|584954605|FG000|Overall Study|Withdrawal by Subject|0|||
161974080|NCT00758589|584954606|FG001|Overall Study|Withdrawal by Subject|1|||
161974081|NCT00758589|584954607|FG002|Overall Study|Withdrawal by Subject|1|||
161974082|NCT00758589|584954608|FG003|Overall Study|Withdrawal by Subject|1|||
162034017|NCT04393298|585181154|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
161974083|NCT00758589|584954605|FG000|Overall Study|Palm stopped to work|0|||
161974084|NCT00758589|584954606|FG001|Overall Study|Palm stopped to work|0|||
161974085|NCT00758589|584954607|FG002|Overall Study|Palm stopped to work|0|||
161974086|NCT00758589|584954608|FG003|Overall Study|Palm stopped to work|1|||
161974087|NCT00583791|584954610|FG000|Overall Study|Other|67|||
161974088|NCT00583791|584954610|FG000|Overall Study|Death|6|||
161853249|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
161853250|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
161853251|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
161853252|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
161853253|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
161853254|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
161853255|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
161853256|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
161853257|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
161853258|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
161853259|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
161853260|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
161853261|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
161853262|NCT00299130|584503735|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
161853263|NCT00299130|584503736|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
161853264|NCT00299130|584503737|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
161853265|NCT00299130|584503735|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
161853266|NCT00299130|584503736|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
161853267|NCT00299130|584503737|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
161853268|NCT00299130|584503735|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
161853269|NCT00299130|584503736|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
161853270|NCT00299130|584503737|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
161853271|NCT00299130|584503735|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
161853272|NCT00299130|584503736|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
161853273|NCT00299130|584503737|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
161853274|NCT00299130|584503735|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
161853275|NCT00299130|584503736|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
161853276|NCT00299130|584503737|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
161853277|NCT00299130|584503735|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
161853278|NCT00299130|584503736|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
161853279|NCT00299130|584503737|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
161853280|NCT00299130|584503735|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
161853281|NCT00299130|584503736|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
161853282|NCT00299130|584503737|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
161853283|NCT00299130|584503735|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
161853284|NCT00299130|584503736|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
161853285|NCT00299130|584503737|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
161853286|NCT00299130|584503735|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
161853287|NCT00299130|584503736|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
161853288|NCT00299130|584503737|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
161853289|NCT00299130|584503735|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
161853290|NCT00299130|584503736|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
161853291|NCT00299130|584503737|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
161853292|NCT02211417|584503738|FG000|Overall Study|Withdrawal by Subject|11|||
161853293|NCT02211417|584503739|FG001|Overall Study|Withdrawal by Subject|8|||
161853294|NCT02211417|584503738|FG000|Overall Study|Protocol Violation|1|||
161853295|NCT02211417|584503739|FG001|Overall Study|Protocol Violation|0|||
161853296|NCT02211417|584503738|FG000|Overall Study|Pregnancy|0|||
161853297|NCT02211417|584503739|FG001|Overall Study|Pregnancy|1|||
161853298|NCT02211417|584503738|FG000|Overall Study|Lost to Follow-up|2|||
161853299|NCT02211417|584503739|FG001|Overall Study|Lost to Follow-up|3|||
161853300|NCT02211417|584503738|FG000|Overall Study|Adverse Event|1|||
161853301|NCT02211417|584503739|FG001|Overall Study|Adverse Event|4|||
161853302|NCT01198132|584503740|FG000|Overall Study|Withdrawal by Subject|4|||
161853303|NCT01198132|584503741|FG001|Overall Study|Withdrawal by Subject|5|||
161853304|NCT01198132|584503740|FG000|Overall Study|Physician Decision|5|||
161853305|NCT01198132|584503741|FG001|Overall Study|Physician Decision|4|||
161853306|NCT01198132|584503740|FG000|Overall Study|Other Unspecified|3|||
161853307|NCT01198132|584503741|FG001|Overall Study|Other Unspecified|6|||
161853308|NCT01198132|584503740|FG000|Overall Study|Lack of Efficacy|2|||
161853309|NCT01198132|584503741|FG001|Overall Study|Lack of Efficacy|3|||
161853310|NCT01198132|584503740|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
161853311|NCT01198132|584503741|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
161853312|NCT01198132|584503740|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
161853313|NCT01198132|584503741|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
161853314|NCT01198132|584503740|FG000|Overall Study|Adverse Event|0|||
161853315|NCT01198132|584503741|FG001|Overall Study|Adverse Event|1|||
161853316|NCT01198132|584503740|FG000|Overall Study|Protocol Violation|1|||
161853317|NCT01198132|584503741|FG001|Overall Study|Protocol Violation|0|||
161853318|NCT01277211|584503742|FG000|Overall Study|Adverse Event|60|||
161853319|NCT01277211|584503743|FG001|Overall Study|Adverse Event|22|||
161853320|NCT01277211|584503742|FG000|Overall Study|Pregnancy|9|||
161853321|NCT01277211|584503743|FG001|Overall Study|Pregnancy|4|||
161853322|NCT01277211|584503742|FG000|Overall Study|Lost to Follow-up|14|||
161853323|NCT01277211|584503743|FG001|Overall Study|Lost to Follow-up|9|||
161853324|NCT01277211|584503742|FG000|Overall Study|Did not wish to continue|17|||
161853325|NCT01277211|584503743|FG001|Overall Study|Did not wish to continue|0|||
161853326|NCT01277211|584503742|FG000|Overall Study|Withdrew Consent|9|||
161853327|NCT01277211|584503743|FG001|Overall Study|Withdrew Consent|9|||
161853328|NCT01277211|584503742|FG000|Overall Study|Non-compliance with protocol|13|||
161853329|NCT01277211|584503743|FG001|Overall Study|Non-compliance with protocol|4|||
161853330|NCT01277211|584503742|FG000|Overall Study|Did not meet protocol eligibility|1|||
161853331|NCT01277211|584503743|FG001|Overall Study|Did not meet protocol eligibility|0|||
161853332|NCT01277211|584503742|FG000|Overall Study|Administrative|3|||
161853333|NCT01277211|584503743|FG001|Overall Study|Administrative|0|||
161853334|NCT01277211|584503742|FG000|Overall Study|Pregnancy wish|0|||
161853335|NCT01277211|584503743|FG001|Overall Study|Pregnancy wish|2|||
161853336|NCT01277211|584503742|FG000|Overall Study|Discontinued prior to treatment|24|||
161853337|NCT01277211|584503743|FG001|Overall Study|Discontinued prior to treatment|13|||
161853338|NCT04697069|584503744|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
161853339|NCT04697069|584503745|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
161853340|NCT04697069|584503744|FG000|Overall Study|Study termination|2|||
161853341|NCT04697069|584503745|FG001|Overall Study|Study termination|1|||
161853342|NCT05180227|584503746|FG000|Overall Study|Hypertension at screening|1|||
161853343|NCT05180227|584503746|FG000|Overall Study|Lost to Follow-up|1|||
161853344|NCT04614246|584503747|FG000|Overall Study|Adverse Event|0|||
161853345|NCT04614246|584503748|FG001|Overall Study|Adverse Event|1|||
161853346|NCT04614246|584503749|FG002|Overall Study|Adverse Event|1|||
161853347|NCT04614246|584503750|FG003|Overall Study|Adverse Event|2|||
161853348|NCT04614246|584503751|FG004|Overall Study|Adverse Event|1|||
161853349|NCT04614246|584503747|FG000|Overall Study|Lost to Follow-up|0|||
161853350|NCT04614246|584503748|FG001|Overall Study|Lost to Follow-up|1|||
161853351|NCT04614246|584503749|FG002|Overall Study|Lost to Follow-up|0|||
161853352|NCT04614246|584503750|FG003|Overall Study|Lost to Follow-up|1|||
161853353|NCT04614246|584503751|FG004|Overall Study|Lost to Follow-up|3|||
161853354|NCT04614246|584503747|FG000|Overall Study|Other reason|0|||
161853355|NCT04614246|584503748|FG001|Overall Study|Other reason|1|||
161853356|NCT04614246|584503749|FG002|Overall Study|Other reason|2|||
161853357|NCT04614246|584503750|FG003|Overall Study|Other reason|0|||
161853358|NCT04614246|584503751|FG004|Overall Study|Other reason|0|||
161853359|NCT04614246|584503747|FG000|Overall Study|Withdrawal by Subject|4|||
161853360|NCT04614246|584503748|FG001|Overall Study|Withdrawal by Subject|2|||
161853361|NCT04614246|584503749|FG002|Overall Study|Withdrawal by Subject|4|||
161853362|NCT04614246|584503750|FG003|Overall Study|Withdrawal by Subject|3|||
161853363|NCT04614246|584503751|FG004|Overall Study|Withdrawal by Subject|4|||
161853364|NCT04614246|584503747|FG000|Overall Study|Physician Decision|0|||
161853365|NCT04614246|584503748|FG001|Overall Study|Physician Decision|2|||
161974089|NCT00203021|584954611|FG000|Overall Study|Death|4|||
161974090|NCT00203021|584954612|FG001|Overall Study|Death|1|||
161974091|NCT00203021|584954611|FG000|Overall Study|Adverse Event|10|||
161974092|NCT00203021|584954612|FG001|Overall Study|Adverse Event|5|||
161765776|NCT02355665|584182954|FG001|Overall Study|Withdrawal by Subject|100|||
161765777|NCT02355665|584182953|FG000|Overall Study|Lost to Follow-up|131|||
161765778|NCT02355665|584182954|FG001|Overall Study|Lost to Follow-up|103|||
161765779|NCT02355665|584182953|FG000|Overall Study|Death|4|||
161765780|NCT02355665|584182954|FG001|Overall Study|Death|2|||
161765781|NCT02355665|584182953|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
161765782|NCT02355665|584182954|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
161853366|NCT04614246|584503749|FG002|Overall Study|Physician Decision|1|||
161853367|NCT04614246|584503750|FG003|Overall Study|Physician Decision|0|||
161853368|NCT04614246|584503751|FG004|Overall Study|Physician Decision|0|||
161853369|NCT04614246|584503747|FG000|Overall Study|Study terminated by sponsor|10|||
161853370|NCT04614246|584503748|FG001|Overall Study|Study terminated by sponsor|15|||
161853371|NCT04614246|584503749|FG002|Overall Study|Study terminated by sponsor|12|||
161853372|NCT04614246|584503750|FG003|Overall Study|Study terminated by sponsor|13|||
161853373|NCT04614246|584503751|FG004|Overall Study|Study terminated by sponsor|9|||
161853374|NCT04614246|584503747|FG000|Overall Study|Pregnancy|2|||
161853375|NCT04614246|584503748|FG001|Overall Study|Pregnancy|0|||
161853376|NCT04614246|584503749|FG002|Overall Study|Pregnancy|1|||
161853377|NCT04614246|584503750|FG003|Overall Study|Pregnancy|0|||
161974093|NCT00203021|584954611|FG000|Overall Study|Withdrawal by Subject|45|||
161974094|NCT00203021|584954612|FG001|Overall Study|Withdrawal by Subject|48|||
161765783|NCT02380703|584182957|FG000|Overall Study|Withdrawal by Subject|12|||
161765784|NCT02380703|584182958|FG001|Overall Study|Withdrawal by Subject|9|||
161765785|NCT02380703|584182957|FG000|Overall Study|Lost to Follow-up|12|||
161853378|NCT04614246|584503751|FG004|Overall Study|Pregnancy|0|||
161853379|NCT02185053|584503752|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
161974095|NCT00203021|584954611|FG000|Overall Study|Lost to Follow-up|9|||
161974096|NCT00203021|584954612|FG001|Overall Study|Lost to Follow-up|7|||
161974097|NCT00203021|584954611|FG000|Overall Study|Other than specified|11|||
161974098|NCT00203021|584954612|FG001|Overall Study|Other than specified|16|||
161974099|NCT03204890|584954613|FG000|Overall Study|Withdrawal by Subject|1|||
161974100|NCT04524455|584954624|FG000|Overall Study|Death|3|||
161974101|NCT04524455|584954625|FG001|Overall Study|Death|3|||
161974102|NCT04524455|584954624|FG000|Overall Study|Decision by Sponsor|0|||
161974103|NCT04524455|584954625|FG001|Overall Study|Decision by Sponsor|2|||
161974104|NCT04524455|584954624|FG000|Overall Study|Withdrawal of Consent From Study|1|||
161974105|NCT04524455|584954625|FG001|Overall Study|Withdrawal of Consent From Study|0|||
161974106|NCT04524455|584954624|FG000|Overall Study|Lost to Follow-up|0|||
162034018|NCT04393298|585181155|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
162034019|NCT04393298|585181156|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
162034020|NCT04393298|585181157|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
162034021|NCT04393298|585181158|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
162034022|NCT04393298|585181144|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034023|NCT04393298|585181145|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
161765786|NCT02380703|584182958|FG001|Overall Study|Lost to Follow-up|12|||
161765787|NCT02380703|584182957|FG000|Overall Study|Caregiver death|1|||
161765788|NCT02380703|584182958|FG001|Overall Study|Caregiver death|0|||
161765789|NCT02380703|584182957|FG000|Overall Study|Person with dementia (PWD) death|7|||
161765790|NCT02380703|584182958|FG001|Overall Study|Person with dementia (PWD) death|8|||
161765791|NCT02380703|584182957|FG000|Overall Study|Entered Long-term Care|4|||
161765792|NCT02380703|584182958|FG001|Overall Study|Entered Long-term Care|7|||
161765793|NCT00266695|584182959|FG000|Overall Study|Adverse Event|1|||
161765794|NCT00266695|584182959|FG000|Overall Study|Death|9|||
161765795|NCT00266695|584182959|FG000|Overall Study|Physician Decision|1|||
161765796|NCT00266695|584182959|FG000|Overall Study|Lost to Follow-up|3|||
161765797|NCT00266695|584182959|FG000|Overall Study|Withdrawal by Subject|15|||
161765798|NCT03607994|584182960|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
161765799|NCT03607994|584182961|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
161765800|NCT02853318|584182968|FG000|Overall Study|Withdrawal by Subject|1|||
161765801|NCT04490499|584182971|FG000|Overall Study|Withdrawal by Subject|2|||
161765802|NCT01882439|584182977|FG000|Overall Study|Adverse event related to study drug|3|||
161765803|NCT01882439|584182978|FG001|Overall Study|Adverse event related to study drug|8|||
161765804|NCT01882439|584182979|FG002|Overall Study|Adverse event related to study drug|1|||
161765805|NCT01882439|584182980|FG003|Overall Study|Adverse event related to study drug|2|||
161765806|NCT01882439|584182977|FG000|Overall Study|Pregnancy|0|||
161765807|NCT01882439|584182978|FG001|Overall Study|Pregnancy|1|||
161765808|NCT01882439|584182979|FG002|Overall Study|Pregnancy|0|||
161765809|NCT01882439|584182980|FG003|Overall Study|Pregnancy|0|||
161765810|NCT01882439|584182977|FG000|Overall Study|Protocol Violation|2|||
161765811|NCT01882439|584182978|FG001|Overall Study|Protocol Violation|2|||
161765812|NCT01882439|584182979|FG002|Overall Study|Protocol Violation|0|||
161765813|NCT01882439|584182980|FG003|Overall Study|Protocol Violation|1|||
161765814|NCT01882439|584182977|FG000|Overall Study|No longer willing to participate|1|||
161765815|NCT01882439|584182978|FG001|Overall Study|No longer willing to participate|4|||
161765816|NCT01882439|584182979|FG002|Overall Study|No longer willing to participate|2|||
161765817|NCT01882439|584182980|FG003|Overall Study|No longer willing to participate|3|||
161765818|NCT01882439|584182977|FG000|Overall Study|Medication error with no associated AE|0|||
161765819|NCT01882439|584182978|FG001|Overall Study|Medication error with no associated AE|0|||
161765820|NCT01882439|584182979|FG002|Overall Study|Medication error with no associated AE|2|||
161765821|NCT01882439|584182980|FG003|Overall Study|Medication error with no associated AE|0|||
161765822|NCT01882439|584182977|FG000|Overall Study|Insufficient clinical response|1|||
161765823|NCT01882439|584182978|FG001|Overall Study|Insufficient clinical response|4|||
161765824|NCT01882439|584182979|FG002|Overall Study|Insufficient clinical response|4|||
161765825|NCT01882439|584182980|FG003|Overall Study|Insufficient clinical response|2|||
161765826|NCT01882439|584182977|FG000|Overall Study|Adverse event unrelated to study drug|2|||
161765827|NCT01882439|584182978|FG001|Overall Study|Adverse event unrelated to study drug|2|||
161765828|NCT01882439|584182979|FG002|Overall Study|Adverse event unrelated to study drug|1|||
161765829|NCT01882439|584182980|FG003|Overall Study|Adverse event unrelated to study drug|1|||
161765830|NCT03125902|584182985|FG000|Overall Study|Adverse Event|0|||
161765831|NCT03125902|584182986|FG001|Overall Study|Adverse Event|1|||
161765832|NCT03125902|584182985|FG000|Overall Study|Death|119|||
161765833|NCT03125902|584182986|FG001|Overall Study|Death|229|||
161765834|NCT03125902|584182985|FG000|Overall Study|Lost to Follow-up|4|||
161765835|NCT03125902|584182986|FG001|Overall Study|Lost to Follow-up|13|||
161765836|NCT03125902|584182985|FG000|Overall Study|Other|0|||
161765837|NCT03125902|584182986|FG001|Overall Study|Other|4|||
161765838|NCT03125902|584182985|FG000|Overall Study|Physician Decision|2|||
161765839|NCT03125902|584182986|FG001|Overall Study|Physician Decision|1|||
161974107|NCT04524455|584954625|FG001|Overall Study|Lost to Follow-up|1|||
161974108|NCT01688739|584954626|FG000|Overall Study|Administrative Decision|1|||
161853380|NCT02185053|584503753|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
161853381|NCT02185053|584503754|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
161853382|NCT02185053|584503752|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
161853383|NCT02185053|584503753|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
161853384|NCT02185053|584503754|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
161853385|NCT02185053|584503752|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
161853386|NCT02185053|584503753|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
161853387|NCT02185053|584503754|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
161853388|NCT02185053|584503752|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
161853389|NCT02185053|584503753|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
161853390|NCT02185053|584503754|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
161853391|NCT02185053|584503752|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
161853392|NCT02185053|584503753|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
161853393|NCT02185053|584503754|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
161853394|NCT02185053|584503752|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
161853395|NCT02185053|584503753|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
161853396|NCT02185053|584503754|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
161853397|NCT02185053|584503752|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
161853398|NCT02185053|584503753|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
161974109|NCT01688739|584954627|FG001|Overall Study|Administrative Decision|0|||
161974110|NCT01688739|584954628|FG002|Overall Study|Administrative Decision|0|||
161974111|NCT01688739|584954629|FG003|Overall Study|Administrative Decision|0|||
161974112|NCT01688739|584954630|FG004|Overall Study|Administrative Decision|0|||
161974113|NCT01688739|584954631|FG005|Overall Study|Administrative Decision|0|||
161853399|NCT02185053|584503754|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
161853400|NCT02185053|584503752|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
161853401|NCT02185053|584503753|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
161853402|NCT02185053|584503754|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
161853403|NCT02521376|584503762|FG000|Overall Study|Enrolled, But Not Treated|1|||
161853404|NCT02521376|584503763|FG001|Overall Study|Enrolled, But Not Treated|0|||
161853405|NCT02521376|584503764|FG002|Overall Study|Enrolled, But Not Treated|0|||
161853406|NCT02521376|584503765|FG003|Overall Study|Enrolled, But Not Treated|0|||
161853407|NCT00340678|584503766|FG000|Overall Study|Lost to Follow-up|1|||
161853408|NCT00340678|584503767|FG001|Overall Study|Lost to Follow-up|0|||
161853409|NCT00340678|584503768|FG002|Overall Study|Lost to Follow-up|0|||
161974114|NCT01688739|584954632|FG006|Overall Study|Administrative Decision|0|||
161974115|NCT01688739|584954633|FG007|Overall Study|Administrative Decision|0|||
161974116|NCT01688739|584954634|FG008|Overall Study|Administrative Decision|0|||
161974117|NCT01688739|584954635|FG009|Overall Study|Administrative Decision|0|||
161974118|NCT00490776|584954638|FG000|Overall Study|Withdrawal by Subject|1|||
161974119|NCT00490776|584954638|FG000|Overall Study|Administrative Problems|1|||
161974120|NCT00490776|584954638|FG000|Overall Study|Death|1|||
161974121|NCT00490776|584954638|FG000|Overall Study|New Cancer Therapy|1|||
161974122|NCT00490776|584954638|FG000|Overall Study|Disease Progression|5|||
161974123|NCT00940485|584954646|FG000|Overall Study|HBeAb positive at Baseline|3|||
161974124|NCT00940485|584954647|FG001|Overall Study|HBeAb positive at Baseline|2|||
161974125|NCT00940485|584954646|FG000|Overall Study|Lost to Follow-up|2|||
161974126|NCT00940485|584954647|FG001|Overall Study|Lost to Follow-up|3|||
161974127|NCT00940485|584954646|FG000|Overall Study|Adverse Event|8|||
161974128|NCT00940485|584954647|FG001|Overall Study|Adverse Event|0|||
161974129|NCT00940485|584954646|FG000|Overall Study|Withdrawal by Subject|1|||
161974130|NCT00940485|584954647|FG001|Overall Study|Withdrawal by Subject|1|||
161974131|NCT00940485|584954646|FG000|Overall Study|Others|1|||
161974132|NCT00940485|584954647|FG001|Overall Study|Others|1|||
161974133|NCT01113580|584954648|FG000|Overall Study|Protocol Violation|1|||
161974134|NCT01113580|584954649|FG001|Overall Study|Protocol Violation|0|||
161974135|NCT04599166|584954652|FG000|Overall Study|Technological failure connecting to study app|80|||
161974136|NCT01974752|584954653|FG000|Overall Study|Death|33|||
161974137|NCT01974752|584954654|FG001|Overall Study|Death|11|||
161974138|NCT01974752|584954653|FG000|Overall Study|Lost to Follow-up|2|||
161974139|NCT01974752|584954654|FG001|Overall Study|Lost to Follow-up|0|||
161974140|NCT01974752|584954653|FG000|Overall Study|Withdrawal by Subject|2|||
161853410|NCT00340678|584503769|FG003|Overall Study|Lost to Follow-up|0|||
161853411|NCT01653912|584503770|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161974141|NCT01974752|584954654|FG001|Overall Study|Withdrawal by Subject|3|||
161974142|NCT01974752|584954653|FG000|Overall Study|Other Eligibility Criteria|0|||
161974143|NCT01974752|584954654|FG001|Overall Study|Other Eligibility Criteria|1|||
161974144|NCT02435680|584954655|FG000|Overall Study|Physician Decision|3|||
161974145|NCT02435680|584954656|FG001|Overall Study|Physician Decision|0|||
161974146|NCT02435680|584954657|FG002|Overall Study|Physician Decision|0|||
161974147|NCT02435680|584954655|FG000|Overall Study|subject / guardian decision|0|||
161974148|NCT02435680|584954656|FG001|Overall Study|subject / guardian decision|3|||
161974149|NCT02435680|584954657|FG002|Overall Study|subject / guardian decision|2|||
161853412|NCT01653912|584503771|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
161853413|NCT01653912|584503772|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161853414|NCT01653912|584503773|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161853415|NCT01653912|584503774|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161853416|NCT01653912|584503775|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161853417|NCT01653912|584503770|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161853418|NCT01653912|584503771|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161853419|NCT01653912|584503772|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
161974150|NCT02435680|584954655|FG000|Overall Study|Adverse Event|8|||
161974151|NCT02435680|584954656|FG001|Overall Study|Adverse Event|3|||
161974152|NCT02435680|584954657|FG002|Overall Study|Adverse Event|2|||
161974153|NCT02435680|584954655|FG000|Overall Study|progressive disease|10|||
161765840|NCT03125902|584182985|FG000|Overall Study|Progressive Disease|0|||
161765841|NCT03125902|584182986|FG001|Overall Study|Progressive Disease|3|||
161765842|NCT03125902|584182985|FG000|Overall Study|Study Terminated By Sponsor|74|||
161765843|NCT03125902|584182986|FG001|Overall Study|Study Terminated By Sponsor|143|||
161765844|NCT03125902|584182985|FG000|Overall Study|Withdrawal by Subject|21|||
161765845|NCT03125902|584182986|FG001|Overall Study|Withdrawal by Subject|37|||
161765846|NCT01997333|584182987|FG000|Randomization and Treatment|Disease Progression|70|||
161765847|NCT01997333|584182988|FG001|Randomization and Treatment|Disease Progression|159|||
161765848|NCT01997333|584182987|FG000|Randomization and Treatment|Adverse Event|10|||
161765849|NCT01997333|584182988|FG001|Randomization and Treatment|Adverse Event|32|||
161765850|NCT01997333|584182987|FG000|Randomization and Treatment|Physician Decision|0|||
161765851|NCT01997333|584182988|FG001|Randomization and Treatment|Physician Decision|4|||
161765852|NCT01997333|584182987|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
161765853|NCT01997333|584182988|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
161765854|NCT01997333|584182987|FG000|Randomization and Treatment|Did not receive treatment|17|||
161765855|NCT01997333|584182988|FG001|Randomization and Treatment|Did not receive treatment|5|||
161765856|NCT01997333|584182987|FG000|Survival Follow up|Withdrawal by Subject|15|||
161765857|NCT01997333|584182988|FG001|Survival Follow up|Withdrawal by Subject|6|||
161765858|NCT01997333|584182987|FG000|Survival Follow up|Lost to Follow-up|0|||
161765859|NCT01997333|584182988|FG001|Survival Follow up|Lost to Follow-up|6|||
161765860|NCT01997333|584182987|FG000|Survival Follow up|Various|1|||
161765861|NCT01997333|584182988|FG001|Survival Follow up|Various|2|||
161765862|NCT02269709|584182989|FG000|Time of Enrollment|Withdrawal by Subject|3|||
161765863|NCT02269709|584182989|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
161765864|NCT02269709|584182989|FG000|Six Month Follow-up|Lost to Follow-up|12|||
161765865|NCT04411472|584182992|FG000|Overall Study|Adverse Event|5|||
161765866|NCT04411472|584182993|FG001|Overall Study|Adverse Event|10|||
161765867|NCT04411472|584182994|FG002|Overall Study|Adverse Event|1|||
161765868|NCT04411472|584182995|FG003|Overall Study|Adverse Event|0|||
161765869|NCT04411472|584182996|FG004|Overall Study|Adverse Event|0|||
161765870|NCT04411472|584182997|FG005|Overall Study|Adverse Event|0|||
161765871|NCT04411472|584182992|FG000|Overall Study|Protocol Violation|1|||
161765872|NCT04411472|584182993|FG001|Overall Study|Protocol Violation|0|||
161765873|NCT04411472|584182994|FG002|Overall Study|Protocol Violation|0|||
161765874|NCT04411472|584182995|FG003|Overall Study|Protocol Violation|0|||
161765875|NCT04411472|584182996|FG004|Overall Study|Protocol Violation|0|||
161765876|NCT04411472|584182997|FG005|Overall Study|Protocol Violation|0|||
161765877|NCT04411472|584182992|FG000|Overall Study|Withdrawal by Subject|0|||
161765878|NCT04411472|584182993|FG001|Overall Study|Withdrawal by Subject|1|||
161765879|NCT04411472|584182994|FG002|Overall Study|Withdrawal by Subject|0|||
161765880|NCT04411472|584182995|FG003|Overall Study|Withdrawal by Subject|1|||
161765881|NCT04411472|584182996|FG004|Overall Study|Withdrawal by Subject|0|||
161765882|NCT04411472|584182997|FG005|Overall Study|Withdrawal by Subject|0|||
161765883|NCT04411472|584182992|FG000|Overall Study|Physician Decision|1|||
161765884|NCT04411472|584182993|FG001|Overall Study|Physician Decision|0|||
161765885|NCT04411472|584182994|FG002|Overall Study|Physician Decision|0|||
161765886|NCT04411472|584182995|FG003|Overall Study|Physician Decision|0|||
161765887|NCT04411472|584182996|FG004|Overall Study|Physician Decision|0|||
161765888|NCT04411472|584182997|FG005|Overall Study|Physician Decision|0|||
161765889|NCT04411472|584182992|FG000|Overall Study|Study terminated by sponsor|17|||
161765890|NCT04411472|584182993|FG001|Overall Study|Study terminated by sponsor|20|||
161765891|NCT04411472|584182994|FG002|Overall Study|Study terminated by sponsor|3|||
161765892|NCT04411472|584182995|FG003|Overall Study|Study terminated by sponsor|0|||
161765893|NCT04411472|584182996|FG004|Overall Study|Study terminated by sponsor|0|||
161765894|NCT04411472|584182997|FG005|Overall Study|Study terminated by sponsor|0|||
161765895|NCT00440232|584182998|FG000|Overall Study|Lost to Follow-up|1|||
161765896|NCT00440232|584182999|FG001|Overall Study|Lost to Follow-up|1|||
161974154|NCT02435680|584954656|FG001|Overall Study|progressive disease|7|||
161765897|NCT00440232|584182998|FG000|Overall Study|Unable to treat within allowed time|0|||
161765898|NCT00440232|584182999|FG001|Overall Study|Unable to treat within allowed time|1|||
161765899|NCT00440232|584182998|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
161765900|NCT00440232|584182999|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
161765901|NCT01747655|584183000|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
161853420|NCT01653912|584503773|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161853421|NCT01653912|584503774|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161853422|NCT01653912|584503775|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161853423|NCT01653912|584503770|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161853424|NCT01653912|584503771|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161853425|NCT01653912|584503772|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161853426|NCT01653912|584503773|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
161853427|NCT01653912|584503774|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161853428|NCT01653912|584503775|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161853429|NCT01653912|584503770|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853430|NCT01653912|584503771|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853431|NCT01653912|584503772|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853432|NCT01653912|584503773|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
161853433|NCT01653912|584503774|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853434|NCT01653912|584503775|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853435|NCT01653912|584503770|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161853436|NCT01653912|584503771|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161853437|NCT01653912|584503772|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161853438|NCT01653912|584503773|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161853439|NCT01653912|584503774|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161853440|NCT01653912|584503775|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
161853441|NCT01653912|584503770|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161853442|NCT01653912|584503771|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161853443|NCT01653912|584503772|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161853444|NCT01653912|584503773|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161853445|NCT01653912|584503774|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161853446|NCT01653912|584503775|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
161853447|NCT01653912|584503770|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853448|NCT01653912|584503771|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853449|NCT01653912|584503772|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853450|NCT01653912|584503773|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853451|NCT01653912|584503774|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161853452|NCT01653912|584503775|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
161853453|NCT01987479|584503776|FG000|Overall Study|Protocol Violation|1|||
161853454|NCT01987479|584503776|FG000|Overall Study|Physician Decision|2|||
161853455|NCT01987479|584503776|FG000|Overall Study|Participant/legal guardian decision|1|||
161853456|NCT01987479|584503776|FG000|Overall Study|Other|5|||
161853457|NCT01987479|584503776|FG000|Overall Study|Lost to Follow-up|1|||
161853458|NCT01987479|584503776|FG000|Overall Study|Adverse Event|7|||
161853459|NCT01954745|584503777|FG000|Overall Study|Radiological Progression|11|||
161853460|NCT01954745|584503777|FG000|Overall Study|Clinical Progression|5|||
161853461|NCT01954745|584503777|FG000|Overall Study|Adverse Event|2|||
161853462|NCT01954745|584503777|FG000|Overall Study|Death|1|||
161853463|NCT05314816|584503778|FG000|Overall Study|Lost to Follow-up|5|||
161853464|NCT05314816|584503779|FG001|Overall Study|Lost to Follow-up|0|||
161853465|NCT05314816|584503780|FG002|Overall Study|Lost to Follow-up|1|||
161853466|NCT05314816|584503778|FG000|Overall Study|Protocol Violation|13|||
161853467|NCT05314816|584503779|FG001|Overall Study|Protocol Violation|8|||
161853468|NCT05314816|584503780|FG002|Overall Study|Protocol Violation|0|||
161853469|NCT05422625|584503781|FG000|Overall Study|Withdrawal by Subject|1|||
161853470|NCT05422625|584503782|FG001|Overall Study|Withdrawal by Subject|0|||
161853471|NCT01059786|584506195|FG000|Overall Study|Did not receive 6 cycles.|0|||
161853472|NCT01059786|584506196|FG001|Overall Study|Did not receive 6 cycles.|0|||
161853473|NCT01059786|584506197|FG002|Overall Study|Did not receive 6 cycles.|4|||
161853474|NCT01059786|584506198|FG003|Overall Study|Did not receive 6 cycles.|1|||
161853475|NCT01059786|584506199|FG004|Overall Study|Did not receive 6 cycles.|0|||
161853476|NCT04205812|584506200|FG000|Randomized Treatment Period|Ongoing|28|||
161853477|NCT04205812|584506201|FG001|Randomized Treatment Period|Ongoing|138|||
161853478|NCT04205812|584506200|FG000|Randomized Treatment Period|Death|94|||
161853479|NCT04205812|584506201|FG001|Randomized Treatment Period|Death|226|||
161853480|NCT04205812|584506200|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
161853481|NCT04205812|584506201|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
161853482|NCT04205812|584506200|FG000|Randomized Treatment Period|Physician Decision|1|||
161853483|NCT04205812|584506201|FG001|Randomized Treatment Period|Physician Decision|4|||
161853484|NCT04205812|584506200|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
161853485|NCT04205812|584506201|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
161853486|NCT04205812|584506200|FG000|Randomized Treatment Period|Progressive Disease|0|||
161853487|NCT04205812|584506201|FG001|Randomized Treatment Period|Progressive Disease|1|||
161853488|NCT04205812|584506200|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
161853489|NCT04205812|584506201|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
161853490|NCT04205812|584506200|FG000|Monotherapy Treatment Period|Ongoing|17|||
161853491|NCT04205812|584506201|FG001|Monotherapy Treatment Period|Ongoing|0|||
161853492|NCT04205812|584506200|FG000|Monotherapy Treatment Period|Death|39|||
161765902|NCT01747655|584183001|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
161765903|NCT01747655|584183000|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
161765904|NCT01747655|584183001|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
161765905|NCT01747655|584183000|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
161974155|NCT02435680|584954657|FG002|Overall Study|progressive disease|11|||
161974156|NCT02435680|584954655|FG000|Overall Study|not treated|0|||
161974157|NCT02435680|584954656|FG001|Overall Study|not treated|0|||
161974158|NCT02435680|584954657|FG002|Overall Study|not treated|1|||
161974159|NCT02233738|584954658|FG000|Overall Study|Lost to Follow-up|5|||
161974160|NCT02233738|584954659|FG001|Overall Study|Lost to Follow-up|12|||
161974161|NCT02233738|584954658|FG000|Overall Study|Death|0|||
161974162|NCT02233738|584954659|FG001|Overall Study|Death|1|||
161974163|NCT02233738|584954658|FG000|Overall Study|Withdrawal by Subject|0|||
161974164|NCT02233738|584954659|FG001|Overall Study|Withdrawal by Subject|1|||
161974165|NCT02233738|584954658|FG000|Overall Study|Did not return after Baseline|3|||
161974166|NCT02233738|584954659|FG001|Overall Study|Did not return after Baseline|2|||
161974167|NCT00294645|584954660|FG000|Overall Study|Death|10|||
161974168|NCT00294645|584954661|FG001|Overall Study|Death|18|||
161974169|NCT00294645|584954660|FG000|Overall Study|Lost to Follow-up|1|||
161974170|NCT00294645|584954661|FG001|Overall Study|Lost to Follow-up|10|||
161974171|NCT00294645|584954660|FG000|Overall Study|Withdrawal by Subject|18|||
161974172|NCT00294645|584954661|FG001|Overall Study|Withdrawal by Subject|34|||
161974173|NCT00294645|584954660|FG000|Overall Study|Physician Decision|15|||
161974174|NCT00294645|584954661|FG001|Overall Study|Physician Decision|20|||
161974175|NCT00294645|584954660|FG000|Overall Study|Other|4|||
161974176|NCT00294645|584954661|FG001|Overall Study|Other|10|||
161974177|NCT00554619|584954664|FG000|Overall Study|Adverse Event|1|||
161974178|NCT00554619|584954664|FG000|Overall Study|Physician Decision|1|||
161974179|NCT00554619|584954664|FG000|Overall Study|Liver Function Test Abnormality|1|||
161974180|NCT00907803|584954666|FG000|Overall Study|Withdrawal of consent - long commute|1|||
161974181|NCT00907803|584954667|FG001|Overall Study|Withdrawal of consent - long commute|0|||
161974182|NCT00907803|584954668|FG002|Overall Study|Withdrawal of consent - long commute|0|||
161974183|NCT00907803|584954666|FG000|Overall Study|Adverse Event|2|||
161974184|NCT00907803|584954667|FG001|Overall Study|Adverse Event|0|||
161974185|NCT00907803|584954668|FG002|Overall Study|Adverse Event|0|||
161974186|NCT00907803|584954666|FG000|Overall Study|Withdrawal by Subject|0|||
161974187|NCT00907803|584954667|FG001|Overall Study|Withdrawal by Subject|1|||
161974188|NCT00907803|584954668|FG002|Overall Study|Withdrawal by Subject|0|||
161974189|NCT00907803|584954666|FG000|Overall Study|Lost to Follow-up|0|||
161974190|NCT00907803|584954667|FG001|Overall Study|Lost to Follow-up|1|||
161974191|NCT00907803|584954668|FG002|Overall Study|Lost to Follow-up|0|||
161974192|NCT00907803|584954666|FG000|Overall Study|Protocol Violation|0|||
161974193|NCT00907803|584954667|FG001|Overall Study|Protocol Violation|1|||
161974194|NCT00907803|584954668|FG002|Overall Study|Protocol Violation|0|||
161974195|NCT04612842|584954669|FG000|Overall Study|Lost to Follow-up|20|||
161974196|NCT04612842|584954670|FG001|Overall Study|Lost to Follow-up|11|||
161974197|NCT04612842|584954669|FG000|Overall Study|Withdrawal by Subject|26|||
161974198|NCT04612842|584954670|FG001|Overall Study|Withdrawal by Subject|15|||
161974199|NCT04612842|584954669|FG000|Overall Study|Death|2|||
161974200|NCT04612842|584954670|FG001|Overall Study|Death|2|||
161974201|NCT05426031|584954671|FG000|Overall Study|Circulatory Arrest|3|||
161974202|NCT05426031|584954672|FG001|Overall Study|Circulatory Arrest|2|||
161974203|NCT03060512|584954673|FG000|Overall Study|Adverse Event|4|||
161974204|NCT03060512|584954674|FG001|Overall Study|Adverse Event|6|||
161974205|NCT03060512|584954673|FG000|Overall Study|Lost to Follow-up|1|||
161974206|NCT03060512|584954674|FG001|Overall Study|Lost to Follow-up|1|||
161974207|NCT03060512|584954673|FG000|Overall Study|Withdrawal by Subject|1|||
161974208|NCT03060512|584954674|FG001|Overall Study|Withdrawal by Subject|0|||
161974209|NCT03060512|584954673|FG000|Overall Study|Non-compliance with study medication|1|||
161765906|NCT01747655|584183001|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
161765907|NCT03769753|584183002|FG000|Overall Study|Not Treated|6|||
161974210|NCT03060512|584954674|FG001|Overall Study|Non-compliance with study medication|2|||
161974211|NCT04065074|584954678|FG000|Overall Study|Adverse Event|1|||
161974212|NCT04065074|584954678|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
161974213|NCT01062841|584954679|FG000|Overall Study|Indwelling Device Removed|41|||
161974214|NCT01062841|584954680|FG001|Overall Study|Indwelling Device Removed|48|||
161974215|NCT01062841|584954679|FG000|Overall Study|Death|3|||
161974216|NCT01062841|584954680|FG001|Overall Study|Death|5|||
161974217|NCT01062841|584954679|FG000|Overall Study|Withdrawal by Subject|2|||
161974218|NCT01062841|584954680|FG001|Overall Study|Withdrawal by Subject|0|||
161974219|NCT01062841|584954679|FG000|Overall Study|Withdrawal by Study|3|||
161974220|NCT01062841|584954680|FG001|Overall Study|Withdrawal by Study|0|||
161974221|NCT02498067|584954681|FG000|Overall Study|Lost to Follow-up|22|||
161974222|NCT02498067|584954681|FG000|Overall Study|Did not meet inclusion criteria|11|||
161974223|NCT01874275|584954682|FG000|Overall Study|Lost to Follow-up|1|||
161974224|NCT01874275|584954683|FG001|Overall Study|Lost to Follow-up|0|||
161974225|NCT02214225|584954688|FG000|Overall Study|Lost to Follow-up|46|||
161974226|NCT02214225|584954689|FG001|Overall Study|Lost to Follow-up|18|||
161765908|NCT03769753|584183002|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
161765909|NCT00684073|584183003|FG000|Selection|Selection/non-selection criteria|3|||
161765910|NCT00684073|584183003|FG000|Selection|Death|1|||
161765911|NCT00684073|584183003|FG000|Selection|noncompliance|1|||
161765912|NCT00684073|584183003|FG000|Selection|Lost to Follow-up|1|||
161765913|NCT00684073|584183003|FG000|Selection|request of the sponsor|1|||
161765914|NCT00684073|584183003|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
161765915|NCT01259388|584183005|FG000|Overall Study|Adverse Event|3|||
161765916|NCT01259388|584183006|FG001|Overall Study|Adverse Event|0|||
161765917|NCT01259388|584183005|FG000|Overall Study|Withdrawal by Subject|1|||
161765918|NCT01259388|584183006|FG001|Overall Study|Withdrawal by Subject|1|||
161765919|NCT01259388|584183005|FG000|Overall Study|Physician Decision|1|||
161765920|NCT01259388|584183006|FG001|Overall Study|Physician Decision|0|||
161765921|NCT00620815|584183007|FG000|Overall Study|Adverse Event|1|||
161765922|NCT00620815|584183008|FG001|Overall Study|Adverse Event|1|||
161765923|NCT00620815|584183009|FG002|Overall Study|Adverse Event|2|||
161765924|NCT00620815|584183007|FG000|Overall Study|Withdrawal by Subject|1|||
161765925|NCT00620815|584183008|FG001|Overall Study|Withdrawal by Subject|2|||
161765926|NCT00620815|584183009|FG002|Overall Study|Withdrawal by Subject|0|||
161765927|NCT00620815|584183007|FG000|Overall Study|Lost to Follow-up|1|||
161765928|NCT00620815|584183008|FG001|Overall Study|Lost to Follow-up|6|||
161765929|NCT00620815|584183009|FG002|Overall Study|Lost to Follow-up|3|||
161765930|NCT00620815|584183007|FG000|Overall Study|Inappropriate enrolment|0|||
161765931|NCT00620815|584183008|FG001|Overall Study|Inappropriate enrolment|0|||
161765932|NCT00620815|584183009|FG002|Overall Study|Inappropriate enrolment|1|||
161765933|NCT00620815|584183007|FG000|Overall Study|Protocol Violation|1|||
161765934|NCT00620815|584183008|FG001|Overall Study|Protocol Violation|2|||
161765935|NCT00620815|584183009|FG002|Overall Study|Protocol Violation|1|||
161765936|NCT00983827|584183010|FG000|Overall Study|Withdrawal by Subject|1|||
161765937|NCT01230827|584183011|FG000|Overall Study|Lost to Follow-up|0|||
161765938|NCT01230827|584183012|FG001|Overall Study|Lost to Follow-up|0|||
161765939|NCT01230827|584183013|FG002|Overall Study|Lost to Follow-up|1|||
161765940|NCT01230827|584183014|FG003|Overall Study|Lost to Follow-up|3|||
161765941|NCT01230827|584183011|FG000|Overall Study|Withdrawal by Subject|1|||
161765942|NCT01230827|584183012|FG001|Overall Study|Withdrawal by Subject|0|||
161765943|NCT01230827|584183013|FG002|Overall Study|Withdrawal by Subject|3|||
161765944|NCT01230827|584183014|FG003|Overall Study|Withdrawal by Subject|2|||
161765945|NCT01230827|584183011|FG000|Overall Study|Lack of Efficacy|14|||
161765946|NCT01230827|584183012|FG001|Overall Study|Lack of Efficacy|1|||
161765947|NCT01230827|584183013|FG002|Overall Study|Lack of Efficacy|2|||
161765948|NCT01230827|584183014|FG003|Overall Study|Lack of Efficacy|3|||
161765949|NCT01230827|584183011|FG000|Overall Study|Adverse Event|4|||
161765950|NCT01230827|584183012|FG001|Overall Study|Adverse Event|2|||
161765951|NCT01230827|584183013|FG002|Overall Study|Adverse Event|3|||
161765952|NCT01230827|584183014|FG003|Overall Study|Adverse Event|7|||
161765953|NCT01230827|584183011|FG000|Overall Study|Recovery|0|||
161765954|NCT01230827|584183012|FG001|Overall Study|Recovery|6|||
161765955|NCT01230827|584183013|FG002|Overall Study|Recovery|0|||
161765956|NCT01230827|584183014|FG003|Overall Study|Recovery|0|||
161765957|NCT01230827|584183011|FG000|Overall Study|Study terminated by Sponsor|0|||
161765958|NCT01230827|584183012|FG001|Overall Study|Study terminated by Sponsor|2|||
161765959|NCT01230827|584183013|FG002|Overall Study|Study terminated by Sponsor|56|||
161765960|NCT01230827|584183014|FG003|Overall Study|Study terminated by Sponsor|63|||
161765961|NCT01888367|584183017|FG000|Overall Study|Physician Decision|3|||
161765962|NCT01888367|584183018|FG001|Overall Study|Physician Decision|4|||
161765963|NCT01888367|584183019|FG002|Overall Study|Physician Decision|2|||
161765964|NCT01888367|584183017|FG000|Overall Study|Death|2|||
161765965|NCT01888367|584183018|FG001|Overall Study|Death|0|||
161765966|NCT01888367|584183019|FG002|Overall Study|Death|1|||
161765967|NCT01888367|584183017|FG000|Overall Study|Withdrawal by Subject|1|||
161765968|NCT01888367|584183018|FG001|Overall Study|Withdrawal by Subject|0|||
161765969|NCT01888367|584183019|FG002|Overall Study|Withdrawal by Subject|1|||
161765970|NCT01888367|584183017|FG000|Overall Study|Lost to Follow-up|1|||
161765971|NCT01888367|584183018|FG001|Overall Study|Lost to Follow-up|1|||
161765972|NCT01888367|584183019|FG002|Overall Study|Lost to Follow-up|0|||
161765973|NCT01888367|584183017|FG000|Overall Study|Protocol Violation|0|||
161765974|NCT01888367|584183018|FG001|Overall Study|Protocol Violation|0|||
161765975|NCT01888367|584183019|FG002|Overall Study|Protocol Violation|1|||
161765976|NCT01888367|584183017|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
161974227|NCT02214225|584954690|FG002|Overall Study|Lost to Follow-up|18|||
161974228|NCT02214225|584954688|FG000|Overall Study|Withdrawal by Subject|2|||
161765977|NCT01888367|584183018|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
161765978|NCT01888367|584183019|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
161765979|NCT02728804|584183020|FG000|Overall Study|Ineligible|3|||
161765980|NCT02728804|584183020|FG000|Overall Study|Did not complete baseline questionnaire|9|||
161765981|NCT02728804|584183020|FG000|Overall Study|Death|99|||
161765982|NCT00591786|584183021|FG000|Overall Study|Withdrawal of Informed Consent|0|||
161765983|NCT00591786|584183022|FG001|Overall Study|Withdrawal of Informed Consent|0|||
161974229|NCT02214225|584954689|FG001|Overall Study|Withdrawal by Subject|0|||
161974230|NCT02214225|584954690|FG002|Overall Study|Withdrawal by Subject|2|||
161974231|NCT02214225|584954688|FG000|Overall Study|Death|5|||
161974232|NCT02214225|584954689|FG001|Overall Study|Death|0|||
161974233|NCT02214225|584954690|FG002|Overall Study|Death|1|||
161974234|NCT02214225|584954688|FG000|Overall Study|randomized in error, not vaccinated|2|||
161974235|NCT02214225|584954689|FG001|Overall Study|randomized in error, not vaccinated|1|||
161974236|NCT02214225|584954690|FG002|Overall Study|randomized in error, not vaccinated|1|||
161974237|NCT03987932|584954691|FG000|Overall Study|Lost to Follow-up|2|||
161765984|NCT00591786|584183023|FG002|Overall Study|Withdrawal of Informed Consent|1|||
161765985|NCT00591786|584183024|FG003|Overall Study|Withdrawal of Informed Consent|0|||
161765986|NCT00591786|584183025|FG004|Overall Study|Withdrawal of Informed Consent|0|||
161765987|NCT00591786|584183026|FG005|Overall Study|Withdrawal of Informed Consent|0|||
161765988|NCT00591786|584183027|FG006|Overall Study|Withdrawal of Informed Consent|0|||
161765989|NCT00591786|584183028|FG007|Overall Study|Withdrawal of Informed Consent|0|||
161765990|NCT00591786|584183029|FG008|Overall Study|Withdrawal of Informed Consent|0|||
161765991|NCT00591786|584183030|FG009|Overall Study|Withdrawal of Informed Consent|0|||
161765992|NCT01920061|584183032|FG000|Overall Study|Death|1|||
161765993|NCT01920061|584183033|FG001|Overall Study|Death|1|||
161765994|NCT01920061|584183034|FG002|Overall Study|Death|0|||
161765995|NCT01920061|584183035|FG003|Overall Study|Death|1|||
161765996|NCT01920061|584183036|FG004|Overall Study|Death|1|||
161765997|NCT01920061|584183037|FG005|Overall Study|Death|0|||
161765998|NCT01920061|584183038|FG006|Overall Study|Death|0|||
161765999|NCT01920061|584183039|FG007|Overall Study|Death|1|||
161766000|NCT01920061|584183040|FG008|Overall Study|Death|0|||
161766001|NCT01920061|584183041|FG009|Overall Study|Death|1|||
161766002|NCT01920061|584183042|FG010|Overall Study|Death|0|||
161766003|NCT01920061|584183043|FG011|Overall Study|Death|1|||
161766004|NCT01920061|584183044|FG012|Overall Study|Death|0|||
161766005|NCT01920061|584183045|FG013|Overall Study|Death|2|||
161766006|NCT01920061|584183046|FG014|Overall Study|Death|0|||
161766007|NCT01920061|584183047|FG015|Overall Study|Death|0|||
161766008|NCT01920061|584183048|FG016|Overall Study|Death|0|||
161766009|NCT01920061|584183049|FG017|Overall Study|Death|0|||
161766010|NCT01920061|584183050|FG018|Overall Study|Death|1|||
161766011|NCT01920061|584183051|FG019|Overall Study|Death|0|||
161766012|NCT01920061|584183032|FG000|Overall Study|Lost to Follow-up|0|||
161766013|NCT01920061|584183033|FG001|Overall Study|Lost to Follow-up|2|||
161766014|NCT01920061|584183034|FG002|Overall Study|Lost to Follow-up|0|||
161766015|NCT01920061|584183035|FG003|Overall Study|Lost to Follow-up|0|||
161766016|NCT01920061|584183036|FG004|Overall Study|Lost to Follow-up|0|||
161766017|NCT01920061|584183037|FG005|Overall Study|Lost to Follow-up|0|||
161766018|NCT01920061|584183038|FG006|Overall Study|Lost to Follow-up|1|||
161766019|NCT01920061|584183039|FG007|Overall Study|Lost to Follow-up|0|||
161766020|NCT01920061|584183040|FG008|Overall Study|Lost to Follow-up|0|||
161766021|NCT01920061|584183041|FG009|Overall Study|Lost to Follow-up|0|||
161766022|NCT01920061|584183042|FG010|Overall Study|Lost to Follow-up|3|||
161766023|NCT01920061|584183043|FG011|Overall Study|Lost to Follow-up|0|||
161766024|NCT01920061|584183044|FG012|Overall Study|Lost to Follow-up|0|||
161766025|NCT01920061|584183045|FG013|Overall Study|Lost to Follow-up|0|||
161766026|NCT01920061|584183046|FG014|Overall Study|Lost to Follow-up|0|||
161766027|NCT01920061|584183047|FG015|Overall Study|Lost to Follow-up|0|||
161766028|NCT01920061|584183048|FG016|Overall Study|Lost to Follow-up|0|||
161766029|NCT01920061|584183049|FG017|Overall Study|Lost to Follow-up|1|||
161766030|NCT01920061|584183050|FG018|Overall Study|Lost to Follow-up|4|||
161766031|NCT01920061|584183051|FG019|Overall Study|Lost to Follow-up|3|||
161766032|NCT01920061|584183032|FG000|Overall Study|Other|1|||
161766033|NCT01920061|584183033|FG001|Overall Study|Other|1|||
161766034|NCT01920061|584183034|FG002|Overall Study|Other|2|||
161766035|NCT01920061|584183035|FG003|Overall Study|Other|1|||
161766036|NCT01920061|584183036|FG004|Overall Study|Other|0|||
161766037|NCT01920061|584183037|FG005|Overall Study|Other|1|||
161766038|NCT01920061|584183038|FG006|Overall Study|Other|0|||
161766039|NCT01920061|584183039|FG007|Overall Study|Other|0|||
161766040|NCT01920061|584183040|FG008|Overall Study|Other|0|||
161766041|NCT01920061|584183041|FG009|Overall Study|Other|1|||
161974238|NCT03987932|584954692|FG001|Overall Study|Lost to Follow-up|1|||
161766042|NCT01920061|584183042|FG010|Overall Study|Other|1|||
161974239|NCT03987932|584954693|FG002|Overall Study|Lost to Follow-up|1|||
161766043|NCT01920061|584183043|FG011|Overall Study|Other|2|||
161766044|NCT01920061|584183044|FG012|Overall Study|Other|1|||
161766045|NCT01920061|584183045|FG013|Overall Study|Other|4|||
161766046|NCT01920061|584183046|FG014|Overall Study|Other|0|||
161766047|NCT01920061|584183047|FG015|Overall Study|Other|1|||
161766048|NCT01920061|584183048|FG016|Overall Study|Other|1|||
161766049|NCT01920061|584183049|FG017|Overall Study|Other|0|||
161766050|NCT01920061|584183050|FG018|Overall Study|Other|1|||
161766051|NCT01920061|584183051|FG019|Overall Study|Other|1|||
161766052|NCT01920061|584183032|FG000|Overall Study|Participant refused further follow-up|0|||
161766053|NCT01920061|584183033|FG001|Overall Study|Participant refused further follow-up|0|||
161766054|NCT01920061|584183034|FG002|Overall Study|Participant refused further follow-up|0|||
161766055|NCT01920061|584183035|FG003|Overall Study|Participant refused further follow-up|0|||
161766056|NCT01920061|584183036|FG004|Overall Study|Participant refused further follow-up|1|||
161766057|NCT01920061|584183037|FG005|Overall Study|Participant refused further follow-up|1|||
161766058|NCT01920061|584183038|FG006|Overall Study|Participant refused further follow-up|0|||
161766059|NCT01920061|584183039|FG007|Overall Study|Participant refused further follow-up|0|||
161766060|NCT01920061|584183040|FG008|Overall Study|Participant refused further follow-up|1|||
161766061|NCT01920061|584183041|FG009|Overall Study|Participant refused further follow-up|0|||
161766062|NCT01920061|584183042|FG010|Overall Study|Participant refused further follow-up|1|||
161766063|NCT01920061|584183043|FG011|Overall Study|Participant refused further follow-up|0|||
161766064|NCT01920061|584183044|FG012|Overall Study|Participant refused further follow-up|1|||
161766065|NCT01920061|584183045|FG013|Overall Study|Participant refused further follow-up|0|||
161766066|NCT01920061|584183046|FG014|Overall Study|Participant refused further follow-up|1|||
161766067|NCT01920061|584183047|FG015|Overall Study|Participant refused further follow-up|2|||
161766068|NCT01920061|584183048|FG016|Overall Study|Participant refused further follow-up|1|||
161766069|NCT01920061|584183049|FG017|Overall Study|Participant refused further follow-up|1|||
161766070|NCT01920061|584183050|FG018|Overall Study|Participant refused further follow-up|0|||
161766071|NCT01920061|584183051|FG019|Overall Study|Participant refused further follow-up|0|||
161766072|NCT00453349|584183054|FG000|Randomized|Adverse Event|12|||
161766073|NCT00453349|584183055|FG001|Randomized|Adverse Event|11|||
161766074|NCT00453349|584183054|FG000|Randomized|Lack of Efficacy|2|||
161766075|NCT00453349|584183055|FG001|Randomized|Lack of Efficacy|1|||
161766076|NCT00453349|584183054|FG000|Randomized|Lost to Follow-up|7|||
161766077|NCT00453349|584183055|FG001|Randomized|Lost to Follow-up|5|||
161766078|NCT00453349|584183054|FG000|Randomized|Protocol Violation|1|||
161766079|NCT00453349|584183055|FG001|Randomized|Protocol Violation|1|||
161766080|NCT00453349|584183054|FG000|Randomized|Withdrawal by Subject|3|||
161766081|NCT00453349|584183055|FG001|Randomized|Withdrawal by Subject|5|||
161766082|NCT00453349|584183054|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
161766083|NCT00453349|584183055|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
161766084|NCT00453349|584183054|FG000|Completed Study|Adverse Event|12|||
161766085|NCT00453349|584183055|FG001|Completed Study|Adverse Event|11|||
161766086|NCT00453349|584183054|FG000|Completed Study|Lack of Efficacy|2|||
161766087|NCT00453349|584183055|FG001|Completed Study|Lack of Efficacy|1|||
161766088|NCT00453349|584183054|FG000|Completed Study|Lost to Follow-up|7|||
161766089|NCT00453349|584183055|FG001|Completed Study|Lost to Follow-up|5|||
161766090|NCT00453349|584183054|FG000|Completed Study|Protocol Violation|1|||
161766091|NCT00453349|584183055|FG001|Completed Study|Protocol Violation|1|||
161766092|NCT00453349|584183054|FG000|Completed Study|Withdrawal by Subject|3|||
161766093|NCT00453349|584183055|FG001|Completed Study|Withdrawal by Subject|5|||
161766094|NCT00453349|584183054|FG000|Completed Study|Lost to follow up after study treatment|2|||
161766095|NCT00453349|584183055|FG001|Completed Study|Lost to follow up after study treatment|11|||
161766096|NCT00805142|584183056|FG000|Titration Period|Adverse Event|3|||
161766097|NCT00805142|584183057|FG001|Titration Period|Adverse Event|3|||
161766098|NCT00805142|584183056|FG000|Titration Period|Lack of Efficacy|1|||
161766099|NCT00805142|584183057|FG001|Titration Period|Lack of Efficacy|1|||
161766100|NCT00805142|584183056|FG000|Titration Period|Lost to Follow-up|0|||
161766101|NCT00805142|584183057|FG001|Titration Period|Lost to Follow-up|1|||
161766102|NCT00805142|584183056|FG000|Titration Period|Disease Progression|2|||
161766103|NCT00805142|584183057|FG001|Titration Period|Disease Progression|1|||
161766104|NCT00805142|584183056|FG000|Titration Period|Withdrawal of consent|0|||
161766105|NCT00805142|584183057|FG001|Titration Period|Withdrawal of consent|1|||
161766106|NCT00805142|584183056|FG000|Titration Period|Other|0|||
161766107|NCT00805142|584183057|FG001|Titration Period|Other|3|||
161766108|NCT00805142|584183056|FG000|Maintenance Period|Adverse Event|0|||
161766109|NCT00805142|584183057|FG001|Maintenance Period|Adverse Event|1|||
161766110|NCT00805142|584183056|FG000|Maintenance Period|Other|0|||
161766111|NCT00805142|584183057|FG001|Maintenance Period|Other|1|||
161766112|NCT00422942|584183058|FG000|Overall Study|Study terminated by Sponsor|3|||
161766113|NCT04823494|584184634|FG000|Overall Study|Programming software malfunction.|1|||
161766114|NCT04823494|584184635|FG001|Overall Study|Programming software malfunction.|0|||
161766115|NCT04823494|584184634|FG000|Overall Study|Withdrawal by Subject|1|||
161766116|NCT04823494|584184635|FG001|Overall Study|Withdrawal by Subject|0|||
161766117|NCT04823494|584184634|FG000|Overall Study|Devices lost|0|||
161766118|NCT04823494|584184635|FG001|Overall Study|Devices lost|1|||
161766119|NCT03691831|584184636|FG000|Overall Study|Lost to Follow-up|16|||
161766120|NCT03691831|584184637|FG001|Overall Study|Lost to Follow-up|12|||
161766121|NCT03691831|584184636|FG000|Overall Study|Withdrawal by Subject|9|||
161766122|NCT03691831|584184637|FG001|Overall Study|Withdrawal by Subject|17|||
161766123|NCT03691831|584184636|FG000|Overall Study|Investigator Decision|2|||
161766124|NCT03691831|584184637|FG001|Overall Study|Investigator Decision|2|||
161766125|NCT01884675|584184638|FG000|Overall Study|Study closed/terminated|3|||
161766126|NCT01884675|584184639|FG001|Overall Study|Study closed/terminated|2|||
161766127|NCT01682876|584184642|FG000|Overall Study|Administrative reason|4|||
161766128|NCT01682876|584184643|FG001|Overall Study|Administrative reason|4|||
161766129|NCT01682876|584184644|FG002|Overall Study|Administrative reason|0|||
162034024|NCT04393298|585181146|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
162034025|NCT04393298|585181147|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034026|NCT04393298|585181148|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034027|NCT04393298|585181149|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034028|NCT04393298|585181150|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034029|NCT04393298|585181151|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034030|NCT04393298|585181152|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034031|NCT04393298|585181153|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034032|NCT04393298|585181154|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034033|NCT04393298|585181155|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034034|NCT04393298|585181156|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034035|NCT04393298|585181157|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034036|NCT04393298|585181158|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
162034037|NCT04393298|585181144|FG000|Overall Study|Progressive Disease (PD)|0|||
162034038|NCT04393298|585181145|FG001|Overall Study|Progressive Disease (PD)|0|||
162034039|NCT04393298|585181146|FG002|Overall Study|Progressive Disease (PD)|0|||
162034040|NCT04393298|585181147|FG003|Overall Study|Progressive Disease (PD)|3|||
162034041|NCT04393298|585181148|FG004|Overall Study|Progressive Disease (PD)|0|||
162034042|NCT04393298|585181149|FG005|Overall Study|Progressive Disease (PD)|0|||
162034043|NCT04393298|585181150|FG006|Overall Study|Progressive Disease (PD)|0|||
162034044|NCT04393298|585181151|FG007|Overall Study|Progressive Disease (PD)|0|||
162034045|NCT04393298|585181152|FG008|Overall Study|Progressive Disease (PD)|0|||
162034046|NCT04393298|585181153|FG009|Overall Study|Progressive Disease (PD)|0|||
162034047|NCT04393298|585181154|FG010|Overall Study|Progressive Disease (PD)|0|||
162034048|NCT04393298|585181155|FG011|Overall Study|Progressive Disease (PD)|0|||
162034049|NCT04393298|585181156|FG012|Overall Study|Progressive Disease (PD)|0|||
162034050|NCT04393298|585181157|FG013|Overall Study|Progressive Disease (PD)|0|||
162034051|NCT04393298|585181158|FG014|Overall Study|Progressive Disease (PD)|0|||
162034052|NCT04393298|585181144|FG000|Overall Study|Started a New Cancer Treatment|0|||
162034053|NCT04393298|585181145|FG001|Overall Study|Started a New Cancer Treatment|0|||
162034054|NCT04393298|585181146|FG002|Overall Study|Started a New Cancer Treatment|0|||
162034055|NCT04393298|585181147|FG003|Overall Study|Started a New Cancer Treatment|0|||
162034056|NCT04393298|585181148|FG004|Overall Study|Started a New Cancer Treatment|1|||
162034057|NCT04393298|585181149|FG005|Overall Study|Started a New Cancer Treatment|0|||
162034058|NCT04393298|585181150|FG006|Overall Study|Started a New Cancer Treatment|0|||
162034059|NCT04393298|585181151|FG007|Overall Study|Started a New Cancer Treatment|0|||
162034060|NCT04393298|585181152|FG008|Overall Study|Started a New Cancer Treatment|0|||
162034061|NCT04393298|585181153|FG009|Overall Study|Started a New Cancer Treatment|0|||
162034062|NCT04393298|585181154|FG010|Overall Study|Started a New Cancer Treatment|0|||
162034063|NCT04393298|585181155|FG011|Overall Study|Started a New Cancer Treatment|0|||
162034064|NCT04393298|585181156|FG012|Overall Study|Started a New Cancer Treatment|0|||
162034065|NCT04393298|585181157|FG013|Overall Study|Started a New Cancer Treatment|0|||
162034066|NCT04393298|585181158|FG014|Overall Study|Started a New Cancer Treatment|0|||
162034067|NCT04393298|585181144|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034068|NCT04393298|585181145|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034069|NCT04393298|585181146|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034070|NCT04393298|585181147|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034071|NCT04393298|585181148|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
162034072|NCT04393298|585181149|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034073|NCT04393298|585181150|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034074|NCT04393298|585181151|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034075|NCT04393298|585181152|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034076|NCT04393298|585181153|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034077|NCT04393298|585181154|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034078|NCT04393298|585181155|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034079|NCT04393298|585181156|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034080|NCT04393298|585181157|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034081|NCT04393298|585181158|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
162034082|NCT04393298|585181144|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162034083|NCT04393298|585181145|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162034084|NCT04393298|585181146|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162034085|NCT04393298|585181147|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162034086|NCT04393298|585181148|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162034087|NCT04393298|585181149|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
162034088|NCT04393298|585181150|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162034089|NCT04393298|585181151|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161853493|NCT04205812|584506201|FG001|Monotherapy Treatment Period|Death|0|||
162034090|NCT04393298|585181152|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162034091|NCT04393298|585181153|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162034092|NCT04393298|585181154|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162034093|NCT04393298|585181155|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161766130|NCT01682876|584184645|FG003|Overall Study|Administrative reason|3|||
161974240|NCT03987932|584954691|FG000|Overall Study|Non-study related elective surgery|0|||
161974241|NCT03987932|584954692|FG001|Overall Study|Non-study related elective surgery|0|||
161974242|NCT03987932|584954693|FG002|Overall Study|Non-study related elective surgery|1|||
161974243|NCT01669421|584954694|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
161974244|NCT01669421|584954694|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
161974245|NCT02813668|584954700|FG000|Overall Study|Death|4|||
161974246|NCT02813668|584954700|FG000|Overall Study|Lost to Follow-up|509|||
161974247|NCT02813668|584954700|FG000|Overall Study|Withdrawal by Subject|148|||
161974248|NCT02813668|584954700|FG000|Overall Study|No longer at worksite|85|||
161974249|NCT02813668|584954700|FG000|Overall Study|Medical reasons not related to the study|4|||
161974250|NCT02961790|584954701|FG000|Overall Study|Canceled|4|||
161974251|NCT02961790|584954702|FG001|Overall Study|Canceled|5|||
161974252|NCT02961790|584954703|FG002|Overall Study|Canceled|1|||
161974253|NCT02961790|584954704|FG003|Overall Study|Canceled|4|||
161974254|NCT02961790|584954701|FG000|Overall Study|without baseline data|4|||
161974255|NCT02961790|584954702|FG001|Overall Study|without baseline data|0|||
161974256|NCT02961790|584954703|FG002|Overall Study|without baseline data|1|||
161974257|NCT02961790|584954704|FG003|Overall Study|without baseline data|0|||
161974258|NCT02961790|584954701|FG000|Overall Study|without post baseline data|7|||
161974259|NCT02961790|584954702|FG001|Overall Study|without post baseline data|6|||
161974260|NCT02961790|584954703|FG002|Overall Study|without post baseline data|4|||
161974261|NCT02961790|584954704|FG003|Overall Study|without post baseline data|1|||
161974262|NCT02594098|584954707|FG000|Overall Study|Lack of Efficacy|17|||
161974263|NCT02594098|584954708|FG001|Overall Study|Lack of Efficacy|6|||
161974264|NCT02594098|584954707|FG000|Overall Study|Withdrawal by Subject|1|||
161974265|NCT02594098|584954708|FG001|Overall Study|Withdrawal by Subject|3|||
161974266|NCT02594098|584954707|FG000|Overall Study|Terminated participation|6|||
161974267|NCT02594098|584954708|FG001|Overall Study|Terminated participation|2|||
161974268|NCT02594098|584954707|FG000|Overall Study|Seek alternative treatment|2|||
161974269|NCT02594098|584954708|FG001|Overall Study|Seek alternative treatment|1|||
161974270|NCT02594098|584954707|FG000|Overall Study|Other|0|||
161974271|NCT02594098|584954708|FG001|Overall Study|Other|1|||
161974272|NCT01866423|584954709|FG000|Overall Study|Lack of Efficacy|3|||
161974273|NCT01866423|584954709|FG000|Overall Study|Sponsor Decision|1|||
161974274|NCT00541099|584954716|FG000|Overall Study|Ineligible|3|||
161974275|NCT00434759|584954720|FG000|Overall Study|Lack of Efficacy|5|||
161974276|NCT00434759|584954721|FG001|Overall Study|Lack of Efficacy|4|||
161974277|NCT00434759|584954720|FG000|Overall Study|Withdrawal by Subject|17|||
162034094|NCT04393298|585181156|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
161766131|NCT01682876|584184642|FG000|Overall Study|Adverse Event|0|||
161766132|NCT01682876|584184643|FG001|Overall Study|Adverse Event|0|||
161766133|NCT01682876|584184644|FG002|Overall Study|Adverse Event|0|||
161766134|NCT01682876|584184645|FG003|Overall Study|Adverse Event|1|||
161766135|NCT01682876|584184642|FG000|Overall Study|Lost to Follow-up|11|||
161766136|NCT01682876|584184643|FG001|Overall Study|Lost to Follow-up|15|||
161766137|NCT01682876|584184644|FG002|Overall Study|Lost to Follow-up|9|||
161766138|NCT01682876|584184645|FG003|Overall Study|Lost to Follow-up|11|||
161766139|NCT01682876|584184642|FG000|Overall Study|Protocol Violation|1|||
161766140|NCT01682876|584184643|FG001|Overall Study|Protocol Violation|1|||
161766141|NCT01682876|584184644|FG002|Overall Study|Protocol Violation|1|||
161766142|NCT01682876|584184645|FG003|Overall Study|Protocol Violation|1|||
161766143|NCT01682876|584184642|FG000|Overall Study|Withdrawal by Subject|4|||
161766144|NCT01682876|584184643|FG001|Overall Study|Withdrawal by Subject|0|||
161766145|NCT01682876|584184644|FG002|Overall Study|Withdrawal by Subject|0|||
161766146|NCT01682876|584184645|FG003|Overall Study|Withdrawal by Subject|2|||
161766147|NCT01682876|584184642|FG000|Overall Study|Other|1|||
161766148|NCT01682876|584184643|FG001|Overall Study|Other|0|||
161766149|NCT01682876|584184644|FG002|Overall Study|Other|1|||
161974278|NCT00434759|584954721|FG001|Overall Study|Withdrawal by Subject|1|||
161974279|NCT00434759|584954720|FG000|Overall Study|family affairs|2|||
161974280|NCT00434759|584954721|FG001|Overall Study|family affairs|0|||
161766150|NCT01682876|584184645|FG003|Overall Study|Other|1|||
161766151|NCT04120116|584184646|FG000|Overall Study|Lost to Follow-up|0|||
161766152|NCT04120116|584184647|FG001|Overall Study|Lost to Follow-up|1|||
161766153|NCT04120116|584184648|FG002|Overall Study|Lost to Follow-up|0|||
161974281|NCT00461305|584954726|FG000|Treatment|Adverse Event|26|||
161974282|NCT00461305|584954727|FG001|Treatment|Adverse Event|3|||
161974283|NCT00461305|584954726|FG000|Treatment|Lost to Follow-up|4|||
161974284|NCT00461305|584954727|FG001|Treatment|Lost to Follow-up|2|||
161974285|NCT00461305|584954726|FG000|Treatment|Protocol Violation|13|||
161974286|NCT00461305|584954727|FG001|Treatment|Protocol Violation|2|||
161974287|NCT00461305|584954726|FG000|Treatment|Withdrawal by Subject|48|||
161974288|NCT00461305|584954727|FG001|Treatment|Withdrawal by Subject|2|||
161974289|NCT00461305|584954726|FG000|Treatment|Never dispensed|5|||
161974290|NCT00461305|584954727|FG001|Treatment|Never dispensed|0|||
161974291|NCT00461305|584954726|FG000|Treatment|Study drug not taken|1|||
161974292|NCT00461305|584954727|FG001|Treatment|Study drug not taken|0|||
161974293|NCT00461305|584954726|FG000|Treatment|Partially missing diary|2|||
161974294|NCT00461305|584954727|FG001|Treatment|Partially missing diary|0|||
161974295|NCT00461305|584954726|FG000|Treatment|Other (missing drug etc)|2|||
161974296|NCT00461305|584954727|FG001|Treatment|Other (missing drug etc)|0|||
161974297|NCT00461305|584954726|FG000|Continued Treatment|Adverse Event|26|||
161974298|NCT00461305|584954727|FG001|Continued Treatment|Adverse Event|0|||
161766154|NCT04120116|584184649|FG003|Overall Study|Lost to Follow-up|2|||
161766155|NCT04120116|584184646|FG000|Overall Study|Withdrawal by Subject|1|||
161766156|NCT04120116|584184647|FG001|Overall Study|Withdrawal by Subject|0|||
161766157|NCT04120116|584184648|FG002|Overall Study|Withdrawal by Subject|1|||
161766158|NCT04120116|584184649|FG003|Overall Study|Withdrawal by Subject|1|||
161766159|NCT04120116|584184646|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
161766160|NCT04120116|584184647|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
161766161|NCT04120116|584184648|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
161766162|NCT04120116|584184649|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
161766163|NCT02210559|584184654|FG000|Overall Study|Progressive Disease|3|||
161766164|NCT02210559|584184655|FG001|Overall Study|Progressive Disease|2|||
161766165|NCT02210559|584184654|FG000|Overall Study|Adverse Event|2|||
161766166|NCT02210559|584184655|FG001|Overall Study|Adverse Event|2|||
161766167|NCT02210559|584184654|FG000|Overall Study|Physician Decision|1|||
161766168|NCT02210559|584184655|FG001|Overall Study|Physician Decision|0|||
161766169|NCT02210559|584184654|FG000|Overall Study|Withdrawal by Subject|0|||
161766170|NCT02210559|584184655|FG001|Overall Study|Withdrawal by Subject|1|||
161766171|NCT02210559|584184654|FG000|Overall Study|Other than specified|0|||
161766172|NCT02210559|584184655|FG001|Overall Study|Other than specified|1|||
161766173|NCT02546193|584184656|FG000|Overall Study|Withdrawal by Subject|2|||
161766174|NCT02546193|584184657|FG001|Overall Study|Withdrawal by Subject|0|||
161766175|NCT02546193|584184658|FG002|Overall Study|Withdrawal by Subject|1|||
161766176|NCT02546193|584184659|FG003|Overall Study|Withdrawal by Subject|0|||
161766177|NCT02546193|584184656|FG000|Overall Study|Not eligible at time of induction|4|||
161766178|NCT02546193|584184657|FG001|Overall Study|Not eligible at time of induction|6|||
161766179|NCT02546193|584184658|FG002|Overall Study|Not eligible at time of induction|1|||
161766180|NCT02546193|584184659|FG003|Overall Study|Not eligible at time of induction|0|||
161766181|NCT00792467|584184660|FG000|Overall Study|progression of disease|17|||
161766182|NCT00792467|584184660|FG000|Overall Study|Adverse Event|1|||
161766183|NCT00792467|584184660|FG000|Overall Study|patient request|1|||
161766184|NCT00792467|584184660|FG000|Overall Study|Lost to Follow-up|1|||
161766185|NCT00792467|584184660|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
161766186|NCT00792467|584184660|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
161766187|NCT01287403|584184664|FG000|1st Intervention (1 Day)|Adverse Event|1|||
161766188|NCT01098266|584184665|FG000|Overall Study|Physician Decision|1|||
161766189|NCT01098266|584184666|FG001|Overall Study|Physician Decision|0|||
161766190|NCT01098266|584184665|FG000|Overall Study|Death|3|||
161766191|NCT01098266|584184666|FG001|Overall Study|Death|2|||
161766192|NCT01098266|584184665|FG000|Overall Study|Withdrawal by Subject|3|||
161766193|NCT01098266|584184666|FG001|Overall Study|Withdrawal by Subject|5|||
161766194|NCT00438815|584184667|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
161766195|NCT00438815|584184667|FG000|Overall Study|3-month follow-up no longer required|12|||
161766196|NCT00438815|584184667|FG000|Overall Study|Noncompliance with protocol requirements|9|||
161766197|NCT00438815|584184667|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
161766198|NCT00438815|584184667|FG000|Overall Study|Lost to Follow-up|6|||
161766199|NCT00438815|584184667|FG000|Overall Study|Withdrawal by Subject|6|||
161766200|NCT00438815|584184667|FG000|Overall Study|Death|1|||
161766201|NCT01733758|584184668|FG000|Overall Study|Adverse Event|5|||
161766202|NCT01733758|584184669|FG001|Overall Study|Adverse Event|7|||
161766203|NCT01733758|584184670|FG002|Overall Study|Adverse Event|8|||
161766204|NCT01733758|584184671|FG003|Overall Study|Adverse Event|1|||
161766205|NCT01733758|584184668|FG000|Overall Study|Withdrawal by Subject|1|||
161766206|NCT01733758|584184669|FG001|Overall Study|Withdrawal by Subject|1|||
161766207|NCT01733758|584184670|FG002|Overall Study|Withdrawal by Subject|5|||
161766208|NCT01733758|584184671|FG003|Overall Study|Withdrawal by Subject|3|||
161766209|NCT01733758|584184668|FG000|Overall Study|Persistent Hyperglycemia|3|||
161974299|NCT00461305|584954726|FG000|Continued Treatment|Lost to Follow-up|4|||
161766210|NCT01733758|584184669|FG001|Overall Study|Persistent Hyperglycemia|2|||
161766211|NCT01733758|584184670|FG002|Overall Study|Persistent Hyperglycemia|0|||
161766212|NCT01733758|584184671|FG003|Overall Study|Persistent Hyperglycemia|0|||
161766213|NCT01733758|584184668|FG000|Overall Study|Protocol Violation|0|||
161766214|NCT01733758|584184669|FG001|Overall Study|Protocol Violation|1|||
161974300|NCT00461305|584954727|FG001|Continued Treatment|Lost to Follow-up|0|||
161974301|NCT00461305|584954726|FG000|Continued Treatment|Protocol Violation|13|||
161853494|NCT04205812|584506200|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
161853495|NCT04205812|584506201|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
161853496|NCT04205812|584506200|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
161853497|NCT04205812|584506201|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
161853498|NCT00371033|584506202|FG000|Overall Study|Lost to Follow-up|3|||
161853499|NCT00371033|584506203|FG001|Overall Study|Lost to Follow-up|2|||
161853500|NCT00371033|584506202|FG000|Overall Study|No longer interested|2|||
161853501|NCT00371033|584506203|FG001|Overall Study|No longer interested|0|||
161853502|NCT00371033|584506202|FG000|Overall Study|Uknown|3|||
161853503|NCT00371033|584506203|FG001|Overall Study|Uknown|1|||
161853504|NCT03130777|584506207|FG000|Overall Study|Death|0|||
161853505|NCT03130777|584506208|FG001|Overall Study|Death|1|||
161853506|NCT03130777|584506207|FG000|Overall Study|Did not meet eligibility criteria|1|||
161853507|NCT03130777|584506208|FG001|Overall Study|Did not meet eligibility criteria|0|||
161853508|NCT05929651|584506212|FG000|Overall Study|Protocol Deviation|1|||
161853509|NCT05929651|584506212|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
161853510|NCT05026177|584506213|FG000|Overall Study|Adverse Event|33|||
161853511|NCT05026177|584506214|FG001|Overall Study|Adverse Event|33|||
161853512|NCT05026177|584506215|FG002|Overall Study|Adverse Event|17|||
161853513|NCT05026177|584506213|FG000|Overall Study|Lost to Follow-up|7|||
161853514|NCT05026177|584506214|FG001|Overall Study|Lost to Follow-up|6|||
161853515|NCT05026177|584506215|FG002|Overall Study|Lost to Follow-up|8|||
161853516|NCT05026177|584506213|FG000|Overall Study|Noncompliance with study drug|6|||
161853517|NCT05026177|584506214|FG001|Overall Study|Noncompliance with study drug|2|||
161853518|NCT05026177|584506215|FG002|Overall Study|Noncompliance with study drug|1|||
161853519|NCT05026177|584506213|FG000|Overall Study|Physician Decision|4|||
161853520|NCT05026177|584506214|FG001|Overall Study|Physician Decision|1|||
161853521|NCT05026177|584506215|FG002|Overall Study|Physician Decision|0|||
161853522|NCT05026177|584506213|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
161853523|NCT05026177|584506214|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
161853524|NCT05026177|584506215|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
161853525|NCT05026177|584506213|FG000|Overall Study|Withdrawal by Subject|53|||
161853526|NCT05026177|584506214|FG001|Overall Study|Withdrawal by Subject|51|||
161853527|NCT05026177|584506215|FG002|Overall Study|Withdrawal by Subject|55|||
161853528|NCT05026177|584506213|FG000|Overall Study|Protocol Violation|0|||
161853529|NCT05026177|584506214|FG001|Overall Study|Protocol Violation|1|||
161853530|NCT05026177|584506215|FG002|Overall Study|Protocol Violation|0|||
161853531|NCT05026177|584506213|FG000|Overall Study|Study terminated by sponsor|70|||
161853532|NCT05026177|584506214|FG001|Overall Study|Study terminated by sponsor|74|||
161853533|NCT05026177|584506215|FG002|Overall Study|Study terminated by sponsor|67|||
161853534|NCT05026177|584506213|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
161853535|NCT05026177|584506214|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
161853536|NCT05026177|584506215|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
161853537|NCT05026177|584506213|FG000|Overall Study|Starting alternative treatment|0|||
161853538|NCT05026177|584506214|FG001|Overall Study|Starting alternative treatment|1|||
161853539|NCT05026177|584506215|FG002|Overall Study|Starting alternative treatment|1|||
161853540|NCT05026177|584506213|FG000|Overall Study|Noncompliance with study procedures|0|||
161853541|NCT05026177|584506214|FG001|Overall Study|Noncompliance with study procedures|1|||
161853542|NCT05026177|584506215|FG002|Overall Study|Noncompliance with study procedures|1|||
161853543|NCT05026177|584506213|FG000|Overall Study|Met stopping criteria|0|||
161853544|NCT05026177|584506214|FG001|Overall Study|Met stopping criteria|0|||
161853545|NCT05026177|584506215|FG002|Overall Study|Met stopping criteria|1|||
161853546|NCT05026177|584506213|FG000|Overall Study|Health issues preventing continuation|0|||
161853547|NCT05026177|584506214|FG001|Overall Study|Health issues preventing continuation|0|||
161853548|NCT05026177|584506215|FG002|Overall Study|Health issues preventing continuation|1|||
161853549|NCT05026177|584506213|FG000|Overall Study|Randomized in error, not treated|0|||
161853550|NCT05026177|584506214|FG001|Overall Study|Randomized in error, not treated|0|||
161853551|NCT05026177|584506215|FG002|Overall Study|Randomized in error, not treated|2|||
161853552|NCT05109611|584506218|FG000|Overall Study|Adverse Event|13|||
161853553|NCT05109611|584506219|FG001|Overall Study|Adverse Event|10|||
161853554|NCT05109611|584506218|FG000|Overall Study|Withdrawal by Subject|1|||
161853555|NCT05109611|584506219|FG001|Overall Study|Withdrawal by Subject|0|||
161853556|NCT05109611|584506218|FG000|Overall Study|Lost to Follow-up|1|||
161974302|NCT00461305|584954727|FG001|Continued Treatment|Protocol Violation|0|||
161974303|NCT00461305|584954726|FG000|Continued Treatment|Withdrawal by Subject|48|||
161974304|NCT00461305|584954727|FG001|Continued Treatment|Withdrawal by Subject|0|||
161853557|NCT05109611|584506219|FG001|Overall Study|Lost to Follow-up|2|||
161853558|NCT05109611|584506218|FG000|Overall Study|Protocol Violation|0|||
161853559|NCT05109611|584506219|FG001|Overall Study|Protocol Violation|4|||
161853560|NCT05109611|584506218|FG000|Overall Study|Information unavailable|1|||
161853561|NCT05109611|584506219|FG001|Overall Study|Information unavailable|1|||
161853562|NCT03203850|584506223|FG000|Overall Study|Subject/guardian decision|4|||
161974305|NCT00461305|584954726|FG000|Continued Treatment|Partially missing diary|2|||
161974306|NCT00461305|584954727|FG001|Continued Treatment|Partially missing diary|0|||
162034095|NCT04393298|585181157|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162034096|NCT04393298|585181158|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
162034097|NCT04393298|585181144|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034098|NCT04393298|585181145|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034099|NCT04393298|585181146|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034100|NCT04393298|585181147|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034101|NCT04393298|585181148|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034102|NCT04393298|585181149|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
162034103|NCT04393298|585181150|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034104|NCT04393298|585181151|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034105|NCT04393298|585181152|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034106|NCT04393298|585181153|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034107|NCT04393298|585181154|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034108|NCT04393298|585181155|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034109|NCT04393298|585181156|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034110|NCT04393298|585181157|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
162034111|NCT04393298|585181158|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
162034112|NCT04393298|585181144|FG000|Overall Study|Death|0|||
162034113|NCT04393298|585181145|FG001|Overall Study|Death|0|||
162034114|NCT04393298|585181146|FG002|Overall Study|Death|0|||
162034115|NCT04393298|585181147|FG003|Overall Study|Death|0|||
162034116|NCT04393298|585181148|FG004|Overall Study|Death|0|||
162034117|NCT04393298|585181149|FG005|Overall Study|Death|1|||
162034118|NCT04393298|585181150|FG006|Overall Study|Death|1|||
162034119|NCT04393298|585181151|FG007|Overall Study|Death|0|||
162034120|NCT04393298|585181152|FG008|Overall Study|Death|1|||
162034121|NCT04393298|585181153|FG009|Overall Study|Death|1|||
162034122|NCT04393298|585181154|FG010|Overall Study|Death|0|||
162034123|NCT04393298|585181155|FG011|Overall Study|Death|1|||
162034124|NCT04393298|585181156|FG012|Overall Study|Death|1|||
162034125|NCT04393298|585181157|FG013|Overall Study|Death|0|||
162034126|NCT04393298|585181158|FG014|Overall Study|Death|1|||
161766215|NCT01733758|584184670|FG002|Overall Study|Protocol Violation|2|||
161766216|NCT01733758|584184671|FG003|Overall Study|Protocol Violation|2|||
161766217|NCT01733758|584184668|FG000|Overall Study|Non-compliance|1|||
161766218|NCT01733758|584184669|FG001|Overall Study|Non-compliance|0|||
161766219|NCT01733758|584184670|FG002|Overall Study|Non-compliance|0|||
161766220|NCT01733758|584184671|FG003|Overall Study|Non-compliance|0|||
161766221|NCT01733758|584184668|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
161766222|NCT01733758|584184669|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
161766223|NCT01733758|584184670|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
161766224|NCT01733758|584184671|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
161766225|NCT01733758|584184668|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
161766226|NCT01733758|584184669|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
161766227|NCT01733758|584184670|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
161766228|NCT01733758|584184671|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
161766229|NCT02545270|584184676|FG000|Overall Study|technical difficulties|0|||
161766230|NCT02545270|584184677|FG001|Overall Study|technical difficulties|1|||
161974307|NCT00461305|584954726|FG000|Continued Treatment|Other (missing drug etc)|2|||
161974308|NCT00461305|584954727|FG001|Continued Treatment|Other (missing drug etc)|0|||
161974309|NCT02513823|584954728|FG000|Overall Study|Lost to Follow-up|4|||
161974310|NCT02513823|584954728|FG000|Overall Study|Physician Decision|1|||
161974311|NCT04342689|584954729|FG000|Overall Study|Withdrawal by Subject|32|||
161974312|NCT04342689|584954730|FG001|Overall Study|Withdrawal by Subject|33|||
161974313|NCT04342689|584954729|FG000|Overall Study|Lost to Follow-up|10|||
161974314|NCT04342689|584954730|FG001|Overall Study|Lost to Follow-up|12|||
161974315|NCT01011933|584954732|FG000|Overall Study|Wrong cell type|1|||
161974316|NCT01011933|584954732|FG000|Overall Study|Improper pre-protocol Rx|1|||
161974317|NCT01011933|584954732|FG000|Overall Study|Inadequate pathology|1|||
161974318|NCT01011933|584954732|FG000|Overall Study|Never treated|1|||
161974319|NCT00475865|584954733|FG000|Overall Study|Adverse Event|0|||
161974320|NCT00475865|584954734|FG001|Overall Study|Adverse Event|3|||
161974321|NCT00475865|584954735|FG002|Overall Study|Adverse Event|4|||
161974322|NCT00475865|584954733|FG000|Overall Study|Lack of Efficacy|1|||
161974323|NCT00475865|584954734|FG001|Overall Study|Lack of Efficacy|0|||
161974324|NCT00475865|584954735|FG002|Overall Study|Lack of Efficacy|0|||
162034127|NCT04393298|585181144|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161766231|NCT02545270|584184678|FG002|Overall Study|technical difficulties|0|||
161766232|NCT02545270|584184676|FG000|Overall Study|Videos being too similar to other|0|||
161766233|NCT02545270|584184677|FG001|Overall Study|Videos being too similar to other|0|||
161766234|NCT02545270|584184678|FG002|Overall Study|Videos being too similar to other|2|||
161766235|NCT00727246|584184679|FG000|Overall Study|could not complete MRI|0|||
161974325|NCT00475865|584954733|FG000|Overall Study|Progressive disease|0|||
161974326|NCT00475865|584954734|FG001|Overall Study|Progressive disease|1|||
161853563|NCT03203850|584506224|FG001|Overall Study|Subject/guardian decision|3|||
161853564|NCT03203850|584506223|FG000|Overall Study|Adverse Event|3|||
161853565|NCT03203850|584506224|FG001|Overall Study|Adverse Event|0|||
161853566|NCT03203850|584506223|FG000|Overall Study|Death|1|||
161853567|NCT03203850|584506224|FG001|Overall Study|Death|0|||
161853568|NCT02717455|584506225|FG000|Overall Study|Adverse Event|1|||
161853569|NCT02717455|584506226|FG001|Overall Study|Adverse Event|0|||
161853570|NCT02717455|584506227|FG002|Overall Study|Adverse Event|0|||
161853571|NCT02717455|584506228|FG003|Overall Study|Adverse Event|2|||
161853572|NCT02717455|584506229|FG004|Overall Study|Adverse Event|2|||
161853573|NCT02717455|584506230|FG005|Overall Study|Adverse Event|2|||
161853574|NCT02717455|584506225|FG000|Overall Study|Withdrawal by Subject|1|||
161853575|NCT02717455|584506226|FG001|Overall Study|Withdrawal by Subject|1|||
161853576|NCT02717455|584506227|FG002|Overall Study|Withdrawal by Subject|0|||
161853577|NCT02717455|584506228|FG003|Overall Study|Withdrawal by Subject|2|||
161853578|NCT02717455|584506229|FG004|Overall Study|Withdrawal by Subject|2|||
161853579|NCT02717455|584506230|FG005|Overall Study|Withdrawal by Subject|1|||
161853580|NCT02717455|584506225|FG000|Overall Study|Death|1|||
161766236|NCT00727246|584184680|FG001|Overall Study|could not complete MRI|1|||
161766237|NCT00727246|584184681|FG002|Overall Study|could not complete MRI|0|||
161766238|NCT00727246|584184682|FG003|Overall Study|could not complete MRI|1|||
161766239|NCT00727246|584184679|FG000|Overall Study|incidental finding|0|||
161766240|NCT00727246|584184680|FG001|Overall Study|incidental finding|0|||
161766241|NCT00727246|584184681|FG002|Overall Study|incidental finding|0|||
161766242|NCT00727246|584184682|FG003|Overall Study|incidental finding|1|||
161766243|NCT00727246|584184679|FG000|Overall Study|withdrawn|0|||
161766244|NCT00727246|584184680|FG001|Overall Study|withdrawn|0|||
161766245|NCT00727246|584184681|FG002|Overall Study|withdrawn|1|||
161766246|NCT00727246|584184682|FG003|Overall Study|withdrawn|0|||
161766247|NCT00661362|584184683|FG000|Overall Study|Adverse Event|5|||
161766248|NCT00661362|584184684|FG001|Overall Study|Adverse Event|4|||
161766249|NCT00661362|584184683|FG000|Overall Study|Incorrect enrollment|2|||
161766250|NCT00661362|584184684|FG001|Overall Study|Incorrect enrollment|0|||
161766251|NCT00661362|584184683|FG000|Overall Study|Study specific discontinuation criteria|4|||
161766252|NCT00661362|584184684|FG001|Overall Study|Study specific discontinuation criteria|11|||
161766253|NCT00661362|584184683|FG000|Overall Study|Withdrawal by Subject|13|||
161766254|NCT00661362|584184684|FG001|Overall Study|Withdrawal by Subject|23|||
161766255|NCT00661362|584184683|FG000|Overall Study|Lost to Follow-up|3|||
161766256|NCT00661362|584184684|FG001|Overall Study|Lost to Follow-up|1|||
161766257|NCT00661362|584184683|FG000|Overall Study|Severe non-compliance to protocol|0|||
161766258|NCT00661362|584184684|FG001|Overall Study|Severe non-compliance to protocol|1|||
161766259|NCT00661362|584184683|FG000|Overall Study|Safety reasons|1|||
161766260|NCT00661362|584184684|FG001|Overall Study|Safety reasons|0|||
161766261|NCT00661362|584184683|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
161766262|NCT00661362|584184684|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
161766263|NCT00535262|584184687|FG000|Overall Study|No funding|3|||
161766264|NCT04382066|584184690|FG000|Overall Study|Adverse Event|1|||
161766265|NCT04382066|584184691|FG001|Overall Study|Adverse Event|0|||
161766266|NCT04382066|584184692|FG002|Overall Study|Adverse Event|0|||
161766267|NCT04382066|584184690|FG000|Overall Study|Death|1|||
161766268|NCT04382066|584184691|FG001|Overall Study|Death|0|||
161766269|NCT04382066|584184692|FG002|Overall Study|Death|1|||
161766270|NCT04738123|584184693|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
161766271|NCT04738123|584184694|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
161766272|NCT04738123|584184693|FG000|Overall Study|Progressive Disease|0|||
161766273|NCT04738123|584184694|FG001|Overall Study|Progressive Disease|4|||
161766274|NCT04738123|584184693|FG000|Overall Study|Adverse Event|8|||
161766275|NCT04738123|584184694|FG001|Overall Study|Adverse Event|7|||
161974327|NCT00475865|584954735|FG002|Overall Study|Progressive disease|2|||
161974328|NCT00475865|584954733|FG000|Overall Study|Participant did not wish to continue|1|||
161766276|NCT04738123|584184693|FG000|Overall Study|Other Reasons|0|||
161766277|NCT04738123|584184694|FG001|Overall Study|Other Reasons|1|||
161766278|NCT04738123|584184693|FG000|Overall Study|Suicidal or assaultive behavior|0|||
161853581|NCT02717455|584506226|FG001|Overall Study|Death|0|||
161766279|NCT04738123|584184694|FG001|Overall Study|Suicidal or assaultive behavior|2|||
161766280|NCT04738123|584184693|FG000|Overall Study|Protocol Violation|2|||
161853582|NCT02717455|584506227|FG002|Overall Study|Death|0|||
161853583|NCT02717455|584506228|FG003|Overall Study|Death|0|||
161853584|NCT02717455|584506229|FG004|Overall Study|Death|1|||
161853585|NCT02717455|584506230|FG005|Overall Study|Death|0|||
161853586|NCT02717455|584506225|FG000|Overall Study|Did not receive study drug|0|||
161853587|NCT02717455|584506226|FG001|Overall Study|Did not receive study drug|0|||
161766281|NCT04738123|584184694|FG001|Overall Study|Protocol Violation|2|||
161766282|NCT04738123|584184693|FG000|Overall Study|Consent Withdrawn|35|||
161766283|NCT04738123|584184694|FG001|Overall Study|Consent Withdrawn|22|||
161766284|NCT00779506|584184695|FG000|Overall Study|Screening Failed|2|||
161766285|NCT00779506|584184695|FG000|Overall Study|Adverse Event|4|||
161853588|NCT02717455|584506227|FG002|Overall Study|Did not receive study drug|0|||
161853589|NCT02717455|584506228|FG003|Overall Study|Did not receive study drug|1|||
161853590|NCT02717455|584506229|FG004|Overall Study|Did not receive study drug|0|||
161853591|NCT02717455|584506230|FG005|Overall Study|Did not receive study drug|1|||
161853592|NCT02717455|584506225|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161853593|NCT02717455|584506226|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161853594|NCT02717455|584506227|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161853595|NCT02717455|584506228|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161853596|NCT02717455|584506229|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161853597|NCT02717455|584506230|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
161853598|NCT02717455|584506225|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
161853599|NCT02717455|584506226|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
161853600|NCT02717455|584506227|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
161853601|NCT02717455|584506228|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
161853602|NCT02717455|584506229|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
161853603|NCT02717455|584506230|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
161853604|NCT01433055|584506231|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
161853605|NCT01433055|584506232|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
161853606|NCT01433055|584506231|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
161853607|NCT01433055|584506232|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
161853608|NCT00733005|584506238|FG000|Overall Study|Adverse Event|0|||
161853609|NCT00733005|584506239|FG001|Overall Study|Adverse Event|1|||
161853610|NCT00733005|584506238|FG000|Overall Study|Treatment Failure|0|||
161853611|NCT00733005|584506239|FG001|Overall Study|Treatment Failure|1|||
161853612|NCT00733005|584506238|FG000|Overall Study|Withdrawal by Subject|0|||
161853613|NCT00733005|584506239|FG001|Overall Study|Withdrawal by Subject|1|||
161853614|NCT00733005|584506238|FG000|Overall Study|Protocol Violation|2|||
161853615|NCT00733005|584506239|FG001|Overall Study|Protocol Violation|0|||
161853616|NCT01769456|584506240|FG000|Overall Study|Lost to Follow-up|19|||
161853617|NCT01769456|584506240|FG000|Overall Study|Withdrawal by Subject|3|||
161853618|NCT01769456|584506240|FG000|Overall Study|Did not receive PCC intervention|6|||
161853619|NCT01769456|584506240|FG000|Overall Study|Moved out of the area|3|||
161853620|NCT01769456|584506240|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
161853621|NCT01769456|584506240|FG000|Overall Study|Parental request to youth to withdraw|1|||
161853622|NCT05244122|584506247|FG000|Overall Study|Withdrawal by Subject|318|||
161853623|NCT05377749|584506254|FG000|3 Weeks|Lost to Follow-up|2|||
161853624|NCT05377749|584506255|FG001|3 Weeks|Lost to Follow-up|4|||
161853625|NCT05377749|584506254|FG000|3 Weeks|Withdrawal by Subject|1|||
161853626|NCT05377749|584506255|FG001|3 Weeks|Withdrawal by Subject|1|||
161853627|NCT02969382|584506256|FG000|Overall Study|Adverse Event|8|||
161853628|NCT02969382|584506257|FG001|Overall Study|Adverse Event|10|||
161853629|NCT02969382|584506256|FG000|Overall Study|Lack of Efficacy|4|||
161853630|NCT02969382|584506257|FG001|Overall Study|Lack of Efficacy|5|||
161853631|NCT02969382|584506256|FG000|Overall Study|Death|0|||
161853632|NCT02969382|584506257|FG001|Overall Study|Death|1|||
161853633|NCT02969382|584506256|FG000|Overall Study|PROTOCOL DEVIATION|0|||
161853634|NCT02969382|584506257|FG001|Overall Study|PROTOCOL DEVIATION|1|||
161853635|NCT02969382|584506256|FG000|Overall Study|Withdrawal by Subject|14|||
161853636|NCT02969382|584506257|FG001|Overall Study|Withdrawal by Subject|9|||
161853637|NCT02090725|584506258|FG000|Overall Study|Withdrawal by Subject|1|||
161853638|NCT02090725|584506258|FG000|Overall Study|participants moved from area|3|||
161853639|NCT05256134|584506261|FG000|Overall Study|Study Terminated by Sponsor|11|||
161853640|NCT05256134|584506262|FG001|Overall Study|Study Terminated by Sponsor|10|||
161853641|NCT05256134|584506261|FG000|Overall Study|Withdrawal by Subject|1|||
161853642|NCT05256134|584506262|FG001|Overall Study|Withdrawal by Subject|3|||
161853643|NCT00886015|584506269|FG000|Overall Study|Death|0|||
161853644|NCT00886015|584506270|FG001|Overall Study|Death|2|||
161853645|NCT02013817|584506271|FG000|Overall Study|Adverse Event|12|||
161853646|NCT02013817|584506271|FG000|Overall Study|Withdrawal by Subject|4|||
161853647|NCT02013817|584506271|FG000|Overall Study|Death|2|||
161853648|NCT02013817|584506271|FG000|Overall Study|Other|9|||
161853649|NCT01692626|584506272|FG000|Overall Study|Death|0|||
161853650|NCT01692626|584506273|FG001|Overall Study|Death|1|||
161974329|NCT00475865|584954734|FG001|Overall Study|Participant did not wish to continue|0|||
161974330|NCT00475865|584954735|FG002|Overall Study|Participant did not wish to continue|0|||
161974331|NCT00475865|584954733|FG000|Overall Study|Other than above|0|||
161974332|NCT00475865|584954734|FG001|Overall Study|Other than above|1|||
161974333|NCT00475865|584954735|FG002|Overall Study|Other than above|0|||
161974334|NCT00787202|584954736|FG000|Overall Study|Adverse Event|3|||
161974335|NCT00787202|584954737|FG001|Overall Study|Adverse Event|2|||
161853651|NCT01692626|584506272|FG000|Overall Study|Adverse Event|2|||
161853652|NCT01692626|584506273|FG001|Overall Study|Adverse Event|3|||
161974336|NCT00787202|584954738|FG002|Overall Study|Adverse Event|0|||
161853653|NCT01692626|584506272|FG000|Overall Study|Protocol Violation|1|||
161853654|NCT01692626|584506273|FG001|Overall Study|Protocol Violation|2|||
161853655|NCT01692626|584506272|FG000|Overall Study|Withdrawal by Subject|1|||
161853656|NCT01692626|584506273|FG001|Overall Study|Withdrawal by Subject|0|||
161853657|NCT00855894|584506274|FG000|Overall Study|Death|31|||
161853658|NCT00855894|584506274|FG000|Overall Study|Patient's decision|1|||
161853659|NCT00855894|584506274|FG000|Overall Study|Disease progression|1|||
161853660|NCT01145508|584506275|FG000|Overall Study|Adverse Event|1|||
161853661|NCT01145508|584506276|FG001|Overall Study|Adverse Event|0|||
161853662|NCT01145508|584506275|FG000|Overall Study|Death|1|||
161853663|NCT01145508|584506276|FG001|Overall Study|Death|0|||
161853664|NCT01145508|584506275|FG000|Overall Study|Physician Decision|2|||
161853665|NCT01145508|584506276|FG001|Overall Study|Physician Decision|1|||
161853666|NCT01145508|584506275|FG000|Overall Study|Never started treatment|1|||
161853667|NCT01145508|584506276|FG001|Overall Study|Never started treatment|1|||
161853668|NCT01569295|584506289|FG000|Overall Study|Progressive Disease|75|||
161853669|NCT01569295|584506290|FG001|Overall Study|Progressive Disease|139|||
161853670|NCT01569295|584506289|FG000|Overall Study|Adverse Event|39|||
161853671|NCT01569295|584506290|FG001|Overall Study|Adverse Event|14|||
161853672|NCT01569295|584506289|FG000|Overall Study|Withdrawal by Subject|25|||
161853673|NCT01569295|584506290|FG001|Overall Study|Withdrawal by Subject|12|||
161853674|NCT01569295|584506289|FG000|Overall Study|Death|19|||
161853675|NCT01569295|584506290|FG001|Overall Study|Death|15|||
161853676|NCT01569295|584506289|FG000|Overall Study|Physician Decision|13|||
161853677|NCT01569295|584506290|FG001|Overall Study|Physician Decision|18|||
161853678|NCT01569295|584506289|FG000|Overall Study|Study Terminated by Sponsor|24|||
161853679|NCT01569295|584506290|FG001|Overall Study|Study Terminated by Sponsor|2|||
161853680|NCT01569295|584506289|FG000|Overall Study|Other Reason not Specified|3|||
161853681|NCT01569295|584506290|FG001|Overall Study|Other Reason not Specified|5|||
161853682|NCT01569295|584506289|FG000|Overall Study|Non-Compliance with Study Drug|6|||
161853683|NCT01569295|584506290|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161853684|NCT01569295|584506289|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
161853685|NCT01569295|584506290|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
161853686|NCT01569295|584506289|FG000|Overall Study|Lost to Follow-up|1|||
161853687|NCT01569295|584506290|FG001|Overall Study|Lost to Follow-up|1|||
161853688|NCT00280735|584506291|FG000|Overall Study|Adverse Event|5|||
161853689|NCT00280735|584506291|FG000|Overall Study|Lack of Efficacy|3|||
161853690|NCT00280735|584506291|FG000|Overall Study|Withdrawal by Subject|8|||
161853691|NCT00280735|584506291|FG000|Overall Study|Intercurrent Illness|2|||
161853692|NCT02064296|584506295|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
161853693|NCT02064296|584506296|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
161853694|NCT02064296|584506297|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
161853695|NCT02064296|584506295|FG000|Intervention|Withdrawal by Subject|0|||
161853696|NCT02064296|584506296|FG001|Intervention|Withdrawal by Subject|1|||
161853697|NCT02064296|584506297|FG002|Intervention|Withdrawal by Subject|2|||
161853698|NCT05061420|584506305|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
161853699|NCT05061420|584506306|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
161853700|NCT05061420|584506307|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
161853701|NCT05061420|584506305|FG000|Overall Study|Progressive disease|11|||
161853702|NCT05061420|584506306|FG001|Overall Study|Progressive disease|15|||
161853703|NCT05061420|584506307|FG002|Overall Study|Progressive disease|14|||
161853704|NCT05061420|584506305|FG000|Overall Study|Withdrawal by Subject|2|||
161853705|NCT05061420|584506306|FG001|Overall Study|Withdrawal by Subject|0|||
161853706|NCT05061420|584506307|FG002|Overall Study|Withdrawal by Subject|1|||
161853707|NCT05061420|584506305|FG000|Overall Study|Not related to COVID-19|2|||
161853708|NCT05061420|584506306|FG001|Overall Study|Not related to COVID-19|0|||
161853709|NCT05061420|584506307|FG002|Overall Study|Not related to COVID-19|0|||
161853710|NCT01814553|584506308|FG000|Overall Study|PD per clinical progression|6|||
161974337|NCT00787202|584954739|FG003|Overall Study|Adverse Event|0|||
161974338|NCT00787202|584954740|FG004|Overall Study|Adverse Event|2|||
161974339|NCT00787202|584954736|FG000|Overall Study|Lack of Efficacy|5|||
161974340|NCT00787202|584954737|FG001|Overall Study|Lack of Efficacy|6|||
161974341|NCT00787202|584954738|FG002|Overall Study|Lack of Efficacy|5|||
161974342|NCT00787202|584954739|FG003|Overall Study|Lack of Efficacy|2|||
161853711|NCT01814553|584506309|FG001|Overall Study|PD per clinical progression|8|||
161853712|NCT01814553|584506308|FG000|Overall Study|Other Adverse Event|4|||
161853713|NCT01814553|584506309|FG001|Overall Study|Other Adverse Event|5|||
161853714|NCT01814553|584506308|FG000|Overall Study|Withdrawal by Subject|1|||
161853715|NCT01814553|584506309|FG001|Overall Study|Withdrawal by Subject|1|||
161853716|NCT01814553|584506308|FG000|Overall Study|Other than stated|7|||
161853717|NCT01814553|584506309|FG001|Overall Study|Other than stated|8|||
161853718|NCT03138655|584506313|FG000|Overall Study|Adverse Event|2|||
161853719|NCT03138655|584506314|FG001|Overall Study|Adverse Event|1|||
161853720|NCT03138655|584506315|FG002|Overall Study|Adverse Event|2|||
161853721|NCT03138655|584506316|FG003|Overall Study|Adverse Event|1|||
161853722|NCT03138655|584506317|FG004|Overall Study|Adverse Event|1|||
161853723|NCT03138655|584506318|FG005|Overall Study|Adverse Event|4|||
161853724|NCT03138655|584506319|FG006|Overall Study|Adverse Event|2|||
161853725|NCT03138655|584506320|FG007|Overall Study|Adverse Event|2|||
161853726|NCT03138655|584506313|FG000|Overall Study|Withdrawal by Subject|0|||
161853727|NCT03138655|584506314|FG001|Overall Study|Withdrawal by Subject|1|||
161853728|NCT03138655|584506315|FG002|Overall Study|Withdrawal by Subject|0|||
161853729|NCT03138655|584506316|FG003|Overall Study|Withdrawal by Subject|0|||
161853730|NCT03138655|584506317|FG004|Overall Study|Withdrawal by Subject|0|||
161853731|NCT03138655|584506318|FG005|Overall Study|Withdrawal by Subject|0|||
161853732|NCT03138655|584506319|FG006|Overall Study|Withdrawal by Subject|1|||
161853733|NCT03138655|584506320|FG007|Overall Study|Withdrawal by Subject|0|||
161853734|NCT03138655|584506313|FG000|Overall Study|Reason not Specified|1|||
161853735|NCT03138655|584506314|FG001|Overall Study|Reason not Specified|0|||
161853736|NCT03138655|584506315|FG002|Overall Study|Reason not Specified|0|||
161853737|NCT03138655|584506316|FG003|Overall Study|Reason not Specified|2|||
161853738|NCT03138655|584506317|FG004|Overall Study|Reason not Specified|1|||
161853739|NCT03138655|584506318|FG005|Overall Study|Reason not Specified|1|||
161853740|NCT03138655|584506319|FG006|Overall Study|Reason not Specified|0|||
161853741|NCT03138655|584506320|FG007|Overall Study|Reason not Specified|0|||
161853742|NCT04036110|584506326|FG000|Overall Study|Lost to Follow-up|3|||
161853743|NCT04036110|584506327|FG001|Overall Study|Lost to Follow-up|2|||
161853744|NCT04036110|584506328|FG002|Overall Study|Lost to Follow-up|1|||
161853745|NCT04036110|584506326|FG000|Overall Study|Study Suspended|4|||
161853746|NCT04036110|584506327|FG001|Overall Study|Study Suspended|5|||
161853747|NCT04036110|584506328|FG002|Overall Study|Study Suspended|1|||
161853748|NCT00534404|584506331|FG000|Overall Study|Death|0|||
161853749|NCT00534404|584506332|FG001|Overall Study|Death|0|||
161853750|NCT00534404|584506333|FG002|Overall Study|Death|2|||
161853751|NCT00534404|584506331|FG000|Overall Study|Withdrawal by Subject|8|||
161853752|NCT00534404|584506332|FG001|Overall Study|Withdrawal by Subject|2|||
161853753|NCT00534404|584506333|FG002|Overall Study|Withdrawal by Subject|38|||
161853754|NCT00534404|584506331|FG000|Overall Study|Removed by study staff|2|||
161853755|NCT00534404|584506332|FG001|Overall Study|Removed by study staff|3|||
161853756|NCT00534404|584506333|FG002|Overall Study|Removed by study staff|1|||
161853757|NCT00534404|584506331|FG000|Overall Study|Lost to Follow-up|170|||
161853758|NCT00534404|584506332|FG001|Overall Study|Lost to Follow-up|138|||
161853759|NCT00534404|584506333|FG002|Overall Study|Lost to Follow-up|201|||
161853760|NCT04759768|584506334|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
161853761|NCT04759768|584506335|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
161853762|NCT04759768|584506334|FG000|Washout (7 Days)|Physician Decision|0|||
161853763|NCT04759768|584506335|FG001|Washout (7 Days)|Physician Decision|1|||
161853764|NCT02996487|584506336|FG000|Overall Study|Lost to Follow-up|1|||
161853765|NCT02996487|584506337|FG001|Overall Study|Lost to Follow-up|1|||
161853766|NCT02996487|584506338|FG002|Overall Study|Lost to Follow-up|0|||
161853767|NCT02996487|584506336|FG000|Overall Study|Death|0|||
161853768|NCT02996487|584506337|FG001|Overall Study|Death|1|||
161853769|NCT02996487|584506338|FG002|Overall Study|Death|0|||
161853770|NCT02996487|584506336|FG000|Overall Study|Withdrawal by Subject|2|||
161853771|NCT02996487|584506337|FG001|Overall Study|Withdrawal by Subject|3|||
161853772|NCT02996487|584506338|FG002|Overall Study|Withdrawal by Subject|0|||
161853773|NCT02800642|584506339|FG000|Overall Study|Death|3|||
161853774|NCT02800642|584506339|FG000|Overall Study|Other|10|||
161853775|NCT02800642|584506339|FG000|Overall Study|Physician Decision|2|||
161853776|NCT02800642|584506339|FG000|Overall Study|Adverse Event|6|||
161853777|NCT02800642|584506339|FG000|Overall Study|Withdrawal by Subject|3|||
161853778|NCT02800642|584506339|FG000|Overall Study|Lost to Follow-up|1|||
161853779|NCT02027428|584506340|FG000|Induction|Never treated|7|||
161853780|NCT02027428|584506341|FG001|Induction|Never treated|0|||
161974343|NCT00787202|584954740|FG004|Overall Study|Lack of Efficacy|1|||
161974344|NCT00787202|584954736|FG000|Overall Study|Lost to Follow-up|1|||
161974345|NCT00787202|584954737|FG001|Overall Study|Lost to Follow-up|0|||
161974346|NCT00787202|584954738|FG002|Overall Study|Lost to Follow-up|0|||
161853781|NCT02027428|584506342|FG002|Induction|Never treated|0|||
161853782|NCT02027428|584506340|FG000|Induction|Progressive disease|77|||
161974347|NCT00787202|584954739|FG003|Overall Study|Lost to Follow-up|0|||
161853783|NCT02027428|584506341|FG001|Induction|Progressive disease|0|||
161974348|NCT00787202|584954740|FG004|Overall Study|Lost to Follow-up|0|||
161974349|NCT00787202|584954736|FG000|Overall Study|Withdrawal by Subject|2|||
161974350|NCT00787202|584954737|FG001|Overall Study|Withdrawal by Subject|2|||
161853784|NCT02027428|584506342|FG002|Induction|Progressive disease|0|||
161853785|NCT02027428|584506340|FG000|Induction|Adverse Event|51|||
161853786|NCT02027428|584506341|FG001|Induction|Adverse Event|0|||
161853787|NCT02027428|584506342|FG002|Induction|Adverse Event|0|||
161853788|NCT02027428|584506340|FG000|Induction|Withdrawal by Subject|22|||
161853789|NCT02027428|584506341|FG001|Induction|Withdrawal by Subject|0|||
161853790|NCT02027428|584506342|FG002|Induction|Withdrawal by Subject|0|||
161853791|NCT02027428|584506340|FG000|Induction|Death|21|||
161853792|NCT02027428|584506341|FG001|Induction|Death|0|||
161853793|NCT02027428|584506342|FG002|Induction|Death|0|||
161853794|NCT02027428|584506340|FG000|Induction|Symptomatic deterioration|16|||
161853795|NCT02027428|584506341|FG001|Induction|Symptomatic deterioration|0|||
161974351|NCT00787202|584954738|FG002|Overall Study|Withdrawal by Subject|2|||
161974352|NCT00787202|584954739|FG003|Overall Study|Withdrawal by Subject|0|||
161974353|NCT00787202|584954740|FG004|Overall Study|Withdrawal by Subject|0|||
161974354|NCT00787202|584954736|FG000|Overall Study|Protocol Violation|2|||
161974355|NCT00787202|584954737|FG001|Overall Study|Protocol Violation|1|||
161974356|NCT00787202|584954738|FG002|Overall Study|Protocol Violation|0|||
161766286|NCT00779506|584184695|FG000|Overall Study|Lack of Efficacy|11|||
161766287|NCT00779506|584184695|FG000|Overall Study|Protocol Violation|5|||
161766288|NCT00779506|584184695|FG000|Overall Study|Withdrawal by Subject|6|||
161766289|NCT00779506|584184695|FG000|Overall Study|Lost to Follow-up|1|||
161766290|NCT03982069|584184696|FG000|Overall Study|Lost to Follow-up|5|||
161766291|NCT03982069|584184697|FG001|Overall Study|Lost to Follow-up|5|||
161766292|NCT03982069|584184698|FG002|Overall Study|Lost to Follow-up|3|||
161766293|NCT03982069|584184699|FG003|Overall Study|Lost to Follow-up|5|||
161766294|NCT03982069|584184696|FG000|Overall Study|Physician Decision|0|||
161766295|NCT03982069|584184697|FG001|Overall Study|Physician Decision|1|||
161766296|NCT03982069|584184698|FG002|Overall Study|Physician Decision|0|||
161766297|NCT03982069|584184699|FG003|Overall Study|Physician Decision|0|||
161766298|NCT03982069|584184696|FG000|Overall Study|Withdrawal by Subject|2|||
161766299|NCT03982069|584184697|FG001|Overall Study|Withdrawal by Subject|1|||
161766300|NCT03982069|584184698|FG002|Overall Study|Withdrawal by Subject|5|||
161766301|NCT03982069|584184699|FG003|Overall Study|Withdrawal by Subject|2|||
161766302|NCT03982069|584184696|FG000|Overall Study|Specimen loss|3|||
161766303|NCT03982069|584184697|FG001|Overall Study|Specimen loss|3|||
161766304|NCT03982069|584184698|FG002|Overall Study|Specimen loss|1|||
161766305|NCT03982069|584184699|FG003|Overall Study|Specimen loss|1|||
161766306|NCT00787527|584184702|FG000|Overall Study|Toxicity|3|||
161766307|NCT00083616|584184703|FG000|Overall Study|Disease Progression|16|||
161766308|NCT00083616|584184703|FG000|Overall Study|Lost to Follow-up|1|||
161766309|NCT00083616|584184703|FG000|Overall Study|Physician Decision|2|||
161766310|NCT00083616|584184703|FG000|Overall Study|Withdrawal by Subject|3|||
161766311|NCT00083616|584184703|FG000|Overall Study|Ineligibility determined|2|||
161766312|NCT00083616|584184703|FG000|Overall Study|Non-compliance|1|||
161766313|NCT00083616|584184703|FG000|Overall Study|Other|6|||
161766314|NCT00914940|584184704|FG000|D0 to D100 Post-transplant|Death|2|||
161766315|NCT00914940|584184704|FG000|D101 to 2 Years Post-transplant|Death|8|||
161766316|NCT00914940|584184704|FG000|2 Years to 5 Years Post-transplant|Death|3|||
161766317|NCT01724021|584184705|FG000|Overall Study|Adverse Event|11|||
161766318|NCT01724021|584184706|FG001|Overall Study|Adverse Event|6|||
161766319|NCT01724021|584184705|FG000|Overall Study|Death|46|||
161766320|NCT01724021|584184706|FG001|Overall Study|Death|58|||
161766321|NCT01724021|584184705|FG000|Overall Study|Participant request/ Withdrew consent|18|||
161766322|NCT01724021|584184706|FG001|Overall Study|Participant request/ Withdrew consent|14|||
161766323|NCT01724021|584184705|FG000|Overall Study|Lost to Follow-up|15|||
161766324|NCT01724021|584184706|FG001|Overall Study|Lost to Follow-up|15|||
161766325|NCT01724021|584184705|FG000|Overall Study|Reason Not Specified|36|||
161766326|NCT01724021|584184706|FG001|Overall Study|Reason Not Specified|39|||
161766327|NCT01724021|584184705|FG000|Overall Study|Missing|1|||
161766328|NCT01724021|584184706|FG001|Overall Study|Missing|1|||
161766329|NCT02500706|584184709|FG000|Overall Study|Adverse Event|0|||
161766330|NCT02500706|584184710|FG001|Overall Study|Adverse Event|0|||
161766331|NCT02500706|584184711|FG002|Overall Study|Adverse Event|1|||
161766332|NCT02500706|584184709|FG000|Overall Study|Lost to Follow-up|0|||
161766333|NCT02500706|584184710|FG001|Overall Study|Lost to Follow-up|1|||
161766334|NCT02500706|584184711|FG002|Overall Study|Lost to Follow-up|1|||
161766335|NCT02500706|584184709|FG000|Overall Study|Withdrawal by Subject|4|||
161766336|NCT02500706|584184710|FG001|Overall Study|Withdrawal by Subject|6|||
161766337|NCT02500706|584184711|FG002|Overall Study|Withdrawal by Subject|4|||
161766338|NCT02500706|584184709|FG000|Overall Study|Unclassified|0|||
161766339|NCT02500706|584184710|FG001|Overall Study|Unclassified|0|||
161766340|NCT02500706|584184711|FG002|Overall Study|Unclassified|1|||
161766341|NCT03644173|584184714|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
161766342|NCT03644173|584184714|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
161766343|NCT03644173|584184714|FG000|Participants at the 1-month Follow up|Death|2|||
161766344|NCT03644173|584184714|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
161766345|NCT03323385|584184715|FG000|Overall Study|Withdrawal by Subject|1|||
161766346|NCT03323385|584184716|FG001|Overall Study|Withdrawal by Subject|2|||
161766347|NCT03323385|584184715|FG000|Overall Study|Noncompliance|0|||
161766348|NCT03323385|584184716|FG001|Overall Study|Noncompliance|1|||
161766349|NCT01000311|584184721|FG000|Overall Study|Adverse Event|2|||
161766350|NCT01000311|584184722|FG001|Overall Study|Adverse Event|5|||
161766351|NCT01000311|584184721|FG000|Overall Study|Withdrawal by Subject|16|||
161766352|NCT01000311|584184722|FG001|Overall Study|Withdrawal by Subject|24|||
161974357|NCT00787202|584954739|FG003|Overall Study|Protocol Violation|0|||
161974358|NCT00787202|584954740|FG004|Overall Study|Protocol Violation|1|||
161766353|NCT01000311|584184721|FG000|Overall Study|Lost to Follow-up|15|||
161766354|NCT01000311|584184722|FG001|Overall Study|Lost to Follow-up|24|||
161766355|NCT01000311|584184721|FG000|Overall Study|Protocol Violation|1|||
162034128|NCT04393298|585181145|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
162034129|NCT04393298|585181146|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
162034130|NCT04393298|585181147|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
162034131|NCT04393298|585181148|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
162034132|NCT04393298|585181149|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
162034133|NCT04393298|585181150|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161766356|NCT01000311|584184722|FG001|Overall Study|Protocol Violation|2|||
161766357|NCT01000311|584184721|FG000|Overall Study|Inappropriate enrollment|2|||
161766358|NCT01000311|584184722|FG001|Overall Study|Inappropriate enrollment|0|||
161766359|NCT01000311|584184721|FG000|Overall Study|Administrative reason|9|||
161974359|NCT00787202|584954736|FG000|Overall Study|Randomized, not treated|1|||
161974360|NCT00787202|584954737|FG001|Overall Study|Randomized, not treated|0|||
161974361|NCT00787202|584954738|FG002|Overall Study|Randomized, not treated|0|||
161974362|NCT00787202|584954739|FG003|Overall Study|Randomized, not treated|0|||
161974363|NCT00787202|584954740|FG004|Overall Study|Randomized, not treated|0|||
161974364|NCT01360398|584954741|FG000|Overall Study|Withdrawal by Subject|14|||
161974365|NCT01360398|584954741|FG000|Overall Study|Other|7|||
161974366|NCT01360398|584954741|FG000|Overall Study|Migrated/moved from study area|1|||
161766360|NCT01000311|584184722|FG001|Overall Study|Administrative reason|15|||
161766361|NCT00819052|584184723|FG000|Overall Study|Adverse Event|0|||
161766362|NCT00819052|584184724|FG001|Overall Study|Adverse Event|5|||
161766363|NCT00819052|584184723|FG000|Overall Study|Protocol Violation|1|||
161766364|NCT00819052|584184724|FG001|Overall Study|Protocol Violation|2|||
161766365|NCT00819052|584184723|FG000|Overall Study|Lost to Follow-up|1|||
161766366|NCT00819052|584184724|FG001|Overall Study|Lost to Follow-up|2|||
161766367|NCT00819052|584184723|FG000|Overall Study|Withdrawal by Subject|1|||
161766368|NCT00819052|584184724|FG001|Overall Study|Withdrawal by Subject|2|||
161766369|NCT00819052|584184723|FG000|Overall Study|Lack of Efficacy|1|||
161766370|NCT00819052|584184724|FG001|Overall Study|Lack of Efficacy|1|||
161766371|NCT00819052|584184723|FG000|Overall Study|Pregnancy|1|||
161766372|NCT00819052|584184724|FG001|Overall Study|Pregnancy|2|||
161766373|NCT00819052|584184723|FG000|Overall Study|Death or events leading to death|1|||
161766374|NCT00819052|584184724|FG001|Overall Study|Death or events leading to death|0|||
161766375|NCT00362297|584184725|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
161766376|NCT00362297|584184726|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
161766377|NCT00982111|584184731|FG000|Overall Study|Adverse Event|1|||
161974367|NCT02153346|584954742|FG000|Overall Study|Lost to Follow-up|11|||
161974368|NCT01822535|584954743|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
161974369|NCT01822535|584954744|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
161974370|NCT01822535|584954743|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
161974371|NCT01822535|584954744|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
161974372|NCT01822535|584954743|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
161974373|NCT01822535|584954744|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
161974374|NCT02278614|584954747|FG000|Overall Study|Withdrawal by Subject|3|||
161974375|NCT02278614|584954748|FG001|Overall Study|Withdrawal by Subject|5|||
161974376|NCT02278614|584954747|FG000|Overall Study|Adverse Event|1|||
161974377|NCT02278614|584954748|FG001|Overall Study|Adverse Event|0|||
161974378|NCT02278614|584954747|FG000|Overall Study|left eye was not eligible|1|||
161974379|NCT02278614|584954748|FG001|Overall Study|left eye was not eligible|0|||
161974380|NCT02279498|584954749|FG000|Overall Study|Adverse Event|3|||
161974381|NCT02279498|584954750|FG001|Overall Study|Adverse Event|0|||
161974382|NCT02279498|584954749|FG000|Overall Study|Lack of Efficacy|4|||
161974383|NCT02279498|584954750|FG001|Overall Study|Lack of Efficacy|0|||
161974384|NCT02279498|584954749|FG000|Overall Study|Lost to Follow-up|0|||
161974385|NCT02279498|584954750|FG001|Overall Study|Lost to Follow-up|1|||
161974386|NCT02279498|584954749|FG000|Overall Study|Withdrawal by Subject|9|||
161974387|NCT02279498|584954750|FG001|Overall Study|Withdrawal by Subject|2|||
161974388|NCT02279498|584954749|FG000|Overall Study|Undefined|2|||
161974389|NCT02279498|584954750|FG001|Overall Study|Undefined|1|||
161974390|NCT00737711|584954753|FG000|Overall Study|Adverse Event|2|||
161974391|NCT00737711|584954753|FG000|Overall Study|Death|8|||
161974392|NCT00737711|584954753|FG000|Overall Study|Failure to return|4|||
161974393|NCT00737711|584954753|FG000|Overall Study|Protocol Violation|1|||
161766378|NCT00982111|584184732|FG001|Overall Study|Adverse Event|1|||
161974394|NCT00737711|584954753|FG000|Overall Study|Withdrawal by Subject|5|||
161974395|NCT00737711|584954753|FG000|Overall Study|Blood transfusion|6|||
161974396|NCT00737711|584954753|FG000|Overall Study|Other|5|||
161974397|NCT02739321|584954754|FG000|Overall Study|Lack of Efficacy|1|||
161974398|NCT02739321|584954755|FG001|Overall Study|Lack of Efficacy|1|||
161974399|NCT02739321|584954754|FG000|Overall Study|Lost to Follow-up|1|||
161974400|NCT02739321|584954755|FG001|Overall Study|Lost to Follow-up|1|||
161974401|NCT02739321|584954754|FG000|Overall Study|Withdrawal by Subject|1|||
161974402|NCT02739321|584954755|FG001|Overall Study|Withdrawal by Subject|2|||
161974403|NCT02558400|584954756|FG000|Overall Study|Adverse Event|47|||
161974404|NCT02558400|584954757|FG001|Overall Study|Adverse Event|53|||
161974405|NCT02558400|584954758|FG002|Overall Study|Adverse Event|4|||
161974406|NCT02558400|584954756|FG000|Overall Study|Withdrawal by Subject|13|||
161974407|NCT02558400|584954757|FG001|Overall Study|Withdrawal by Subject|9|||
161974408|NCT02558400|584954758|FG002|Overall Study|Withdrawal by Subject|8|||
161974409|NCT02558400|584954756|FG000|Overall Study|Non-Compliant|0|||
161974410|NCT02558400|584954757|FG001|Overall Study|Non-Compliant|1|||
161974411|NCT02558400|584954758|FG002|Overall Study|Non-Compliant|3|||
161974412|NCT02558400|584954756|FG000|Overall Study|Lost to Follow-up|5|||
161974413|NCT02558400|584954757|FG001|Overall Study|Lost to Follow-up|5|||
161974414|NCT02558400|584954758|FG002|Overall Study|Lost to Follow-up|4|||
161974415|NCT02558400|584954756|FG000|Overall Study|Lack of Efficacy|0|||
161974416|NCT02558400|584954757|FG001|Overall Study|Lack of Efficacy|13|||
161974417|NCT02558400|584954758|FG002|Overall Study|Lack of Efficacy|1|||
161974418|NCT02558400|584954756|FG000|Overall Study|Disallowed Concurrent Medication|6|||
161974419|NCT02558400|584954757|FG001|Overall Study|Disallowed Concurrent Medication|7|||
161974420|NCT02558400|584954758|FG002|Overall Study|Disallowed Concurrent Medication|5|||
161974421|NCT02558400|584954756|FG000|Overall Study|Physician Decision|2|||
161974422|NCT02558400|584954757|FG001|Overall Study|Physician Decision|2|||
161974423|NCT02558400|584954758|FG002|Overall Study|Physician Decision|0|||
161974424|NCT02558400|584954756|FG000|Overall Study|Protocol Violation|6|||
161853796|NCT02027428|584506342|FG002|Induction|Symptomatic deterioration|0|||
161853797|NCT02027428|584506340|FG000|Induction|Study terminated by sponsor|12|||
161853798|NCT02027428|584506341|FG001|Induction|Study terminated by sponsor|0|||
161853799|NCT02027428|584506342|FG002|Induction|Study terminated by sponsor|0|||
161853800|NCT02027428|584506340|FG000|Induction|Protocol Violation|1|||
161853801|NCT02027428|584506341|FG001|Induction|Protocol Violation|0|||
161853802|NCT02027428|584506342|FG002|Induction|Protocol Violation|0|||
161853803|NCT02027428|584506340|FG000|Induction|Miscellaneous|14|||
161853804|NCT02027428|584506341|FG001|Induction|Miscellaneous|0|||
161853805|NCT02027428|584506342|FG002|Induction|Miscellaneous|0|||
161853806|NCT02027428|584506340|FG000|Induction|Induction Treatment Ongoing|4|||
161853807|NCT02027428|584506341|FG001|Induction|Induction Treatment Ongoing|0|||
161853808|NCT02027428|584506342|FG002|Induction|Induction Treatment Ongoing|0|||
161853809|NCT02027428|584506340|FG000|Maintenance|Death|0|||
161853810|NCT02027428|584506341|FG001|Maintenance|Death|3|||
161853811|NCT02027428|584506342|FG002|Maintenance|Death|2|||
161853812|NCT02027428|584506340|FG000|Maintenance|Adverse Event|0|||
161853813|NCT02027428|584506341|FG001|Maintenance|Adverse Event|21|||
161853814|NCT02027428|584506342|FG002|Maintenance|Adverse Event|1|||
161853815|NCT02027428|584506340|FG000|Maintenance|Progressive disease|0|||
161853816|NCT02027428|584506341|FG001|Maintenance|Progressive disease|84|||
161853817|NCT02027428|584506342|FG002|Maintenance|Progressive disease|47|||
161853818|NCT02027428|584506340|FG000|Maintenance|Symptomatic deterioration|0|||
161853819|NCT02027428|584506341|FG001|Maintenance|Symptomatic deterioration|4|||
161853820|NCT02027428|584506342|FG002|Maintenance|Symptomatic deterioration|1|||
161853821|NCT02027428|584506340|FG000|Maintenance|Withdrawal by Subject|0|||
161853822|NCT02027428|584506341|FG001|Maintenance|Withdrawal by Subject|6|||
161853823|NCT02027428|584506342|FG002|Maintenance|Withdrawal by Subject|5|||
161853824|NCT02027428|584506340|FG000|Maintenance|Protocol Violation|0|||
161853825|NCT02027428|584506341|FG001|Maintenance|Protocol Violation|0|||
161853826|NCT02027428|584506342|FG002|Maintenance|Protocol Violation|1|||
161853827|NCT02027428|584506340|FG000|Maintenance|Other|0|||
161853828|NCT02027428|584506341|FG001|Maintenance|Other|6|||
161853829|NCT02027428|584506342|FG002|Maintenance|Other|3|||
161853830|NCT02027428|584506340|FG000|Survival Follow-up|Death|0|||
161853831|NCT02027428|584506341|FG001|Survival Follow-up|Death|78|||
161853832|NCT02027428|584506342|FG002|Survival Follow-up|Death|45|||
161853833|NCT02027428|584506340|FG000|Survival Follow-up|Lost to Follow-up|0|||
161853834|NCT02027428|584506341|FG001|Survival Follow-up|Lost to Follow-up|1|||
161853835|NCT02027428|584506342|FG002|Survival Follow-up|Lost to Follow-up|1|||
161853836|NCT02859142|584506343|FG000|Overall Study|Adverse Event|1|||
161853837|NCT02859142|584506344|FG001|Overall Study|Adverse Event|2|||
161853838|NCT02859142|584506343|FG000|Overall Study|Lost to Follow-up|1|||
161853839|NCT02859142|584506344|FG001|Overall Study|Lost to Follow-up|4|||
161974425|NCT02558400|584954757|FG001|Overall Study|Protocol Violation|3|||
161974426|NCT02558400|584954758|FG002|Overall Study|Protocol Violation|8|||
161974427|NCT02558400|584954756|FG000|Overall Study|Death|0|||
161974428|NCT02558400|584954757|FG001|Overall Study|Death|1|||
161974429|NCT02558400|584954758|FG002|Overall Study|Death|0|||
161974430|NCT02558400|584954756|FG000|Overall Study|Ineligible for the study|0|||
161974431|NCT02558400|584954757|FG001|Overall Study|Ineligible for the study|2|||
161853840|NCT02859142|584506343|FG000|Overall Study|Withdrawal by Subject|2|||
161853841|NCT02859142|584506344|FG001|Overall Study|Withdrawal by Subject|0|||
161853842|NCT02859142|584506343|FG000|Overall Study|Scheduling difficulties|0|||
161853843|NCT02859142|584506344|FG001|Overall Study|Scheduling difficulties|3|||
161853844|NCT02676765|584506345|FG000|Overall Study|Lost to Follow-up|0|||
161853845|NCT02676765|584506346|FG001|Overall Study|Lost to Follow-up|1|||
161853846|NCT00490841|584506347|FG000|Overall Study|Death|5|||
161853847|NCT00490841|584506347|FG000|Overall Study|Withdrawal by Subject|4|||
161974432|NCT02558400|584954758|FG002|Overall Study|Ineligible for the study|0|||
161853848|NCT00490841|584506347|FG000|Overall Study|Lost to Follow-up|1|||
161974433|NCT02230683|584954762|FG000|Overall Study|Adverse Event|1|||
161853849|NCT00490841|584506347|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
161853850|NCT03452943|584506348|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
161853851|NCT03452943|584506349|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
161853852|NCT03452943|584506348|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
161853853|NCT03452943|584506349|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
161853854|NCT03452943|584506348|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
161853855|NCT03452943|584506349|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
161853856|NCT03452943|584506348|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
161853857|NCT03452943|584506349|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
161853858|NCT03452943|584506348|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
161853859|NCT03452943|584506349|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
161853860|NCT03452943|584506348|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
161853861|NCT03452943|584506349|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
161853862|NCT01107197|584506355|FG000|Overall Study|Death|12|||
161853863|NCT01107197|584506356|FG001|Overall Study|Death|10|||
161853864|NCT01107197|584506355|FG000|Overall Study|Lost to Follow-up|5|||
161853865|NCT01107197|584506356|FG001|Overall Study|Lost to Follow-up|8|||
161853866|NCT01107197|584506355|FG000|Overall Study|Withdrawal by Subject|3|||
161853867|NCT01107197|584506356|FG001|Overall Study|Withdrawal by Subject|5|||
161853868|NCT01301729|584506358|FG000|Overall Study|Withdrawal by Subject|2|||
161853869|NCT01301729|584506358|FG000|Overall Study|Participant did not Return for Treatment|1|||
161853870|NCT01301729|584506358|FG000|Overall Study|Violated Selection Criteria|1|||
161853871|NCT03071276|584506359|FG000|Overall Study|Adverse Event|1|||
161853872|NCT03071276|584506359|FG000|Overall Study|Lack of Efficacy|14|||
161853873|NCT05794503|584506360|FG000|Overall Study|Operation Cancelled|2|||
161853874|NCT05794503|584506361|FG001|Overall Study|Operation Cancelled|0|||
161853875|NCT05794503|584506360|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
161853876|NCT05794503|584506361|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
161853877|NCT05794503|584506360|FG000|Overall Study|Protocol Violation|1|||
161853878|NCT05794503|584506361|FG001|Overall Study|Protocol Violation|0|||
161853879|NCT00447993|584506362|FG000|Overall Study|Lost to Follow-up|0|||
161853880|NCT00447993|584506363|FG001|Overall Study|Lost to Follow-up|0|||
161853881|NCT00447993|584506364|FG002|Overall Study|Lost to Follow-up|2|||
161853882|NCT00447993|584506365|FG003|Overall Study|Lost to Follow-up|2|||
161853883|NCT00447993|584506362|FG000|Overall Study|Withdrawal by Subject|0|||
161853884|NCT00447993|584506363|FG001|Overall Study|Withdrawal by Subject|0|||
161853885|NCT00447993|584506364|FG002|Overall Study|Withdrawal by Subject|2|||
161853886|NCT00447993|584506365|FG003|Overall Study|Withdrawal by Subject|2|||
161853887|NCT02924727|584506366|FG000|Overall Study|Withdrawal by Subject|2|||
161853888|NCT02924727|584506367|FG001|Overall Study|Withdrawal by Subject|4|||
161853889|NCT02924727|584506366|FG000|Overall Study|Lost to Follow-up|2|||
161853890|NCT02924727|584506367|FG001|Overall Study|Lost to Follow-up|5|||
161853891|NCT02924727|584506366|FG000|Overall Study|Death|221|||
161853892|NCT02924727|584506367|FG001|Overall Study|Death|247|||
161974434|NCT00624780|584954763|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
161974435|NCT00624780|584954764|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
161974436|NCT00624780|584954765|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
161974437|NCT00624780|584954766|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
161974438|NCT00624780|584954767|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
161974439|NCT00624780|584954768|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
161974440|NCT00624780|584954763|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
161974441|NCT00624780|584954764|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
161766379|NCT00982111|584184731|FG000|Overall Study|Progressive Disease|46|||
161766380|NCT00982111|584184732|FG001|Overall Study|Progressive Disease|39|||
161766381|NCT00982111|584184731|FG000|Overall Study|Lost to Follow-up|9|||
161766382|NCT00982111|584184732|FG001|Overall Study|Lost to Follow-up|6|||
161766383|NCT00982111|584184731|FG000|Overall Study|New Anti-Cancer Therapy|5|||
161766384|NCT00982111|584184732|FG001|Overall Study|New Anti-Cancer Therapy|5|||
161766385|NCT00982111|584184731|FG000|Overall Study|Medical Decision|1|||
161766386|NCT00982111|584184732|FG001|Overall Study|Medical Decision|0|||
161766387|NCT00982111|584184731|FG000|Overall Study|Withdrawal by Subject|17|||
161766388|NCT00982111|584184732|FG001|Overall Study|Withdrawal by Subject|19|||
161766389|NCT00982111|584184731|FG000|Overall Study|Global Study End|0|||
161766390|NCT00982111|584184732|FG001|Overall Study|Global Study End|1|||
161766391|NCT00982111|584184731|FG000|Overall Study|Sponsor's Decision|0|||
161766392|NCT00982111|584184732|FG001|Overall Study|Sponsor's Decision|1|||
161766393|NCT01070381|584184733|FG000|Period 2, 1 Week of Wear|Handling|0|||
161766394|NCT01070381|584184734|FG001|Period 2, 1 Week of Wear|Handling|1|||
161766395|NCT01070381|584184733|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
161766396|NCT01070381|584184734|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
161766397|NCT02146352|584184740|FG000|Overall Study|Death|1|||
161766398|NCT02146352|584184740|FG000|Overall Study|Patient entered hospice care|1|||
161766399|NCT02918006|584184741|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
161766400|NCT02918006|584184742|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
161853893|NCT02924727|584506366|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
161853894|NCT02924727|584506367|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
161853895|NCT00338728|584506368|FG000|Overall Study|Screen Failure|14|||
161853896|NCT04380961|584506373|FG000|Overall Study|Lost to Follow-up|17|||
161853897|NCT04380961|584506374|FG001|Overall Study|Lost to Follow-up|11|||
161853898|NCT04380961|584506373|FG000|Overall Study|Withdrawal by Subject|3|||
161853899|NCT04380961|584506374|FG001|Overall Study|Withdrawal by Subject|0|||
161853900|NCT04380961|584506373|FG000|Overall Study|Death|22|||
161853901|NCT04380961|584506374|FG001|Overall Study|Death|16|||
161853902|NCT04380961|584506373|FG000|Overall Study|Other|1|||
161853903|NCT04380961|584506374|FG001|Overall Study|Other|0|||
161853904|NCT04380961|584506373|FG000|Overall Study|Randomized but Not Treated|1|||
161853905|NCT04380961|584506374|FG001|Overall Study|Randomized but Not Treated|2|||
161853906|NCT04803305|584506375|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
161853907|NCT04803305|584506376|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
161853908|NCT04803305|584506375|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
161853909|NCT04803305|584506376|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
161853910|NCT04803305|584506375|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
161853911|NCT04803305|584506376|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
161853912|NCT04803305|584506375|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
161853913|NCT04803305|584506376|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
161853914|NCT04803305|584506375|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
161853915|NCT04803305|584506376|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
161853916|NCT04803305|584506375|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
161853917|NCT04803305|584506376|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
161853918|NCT04803305|584506375|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
161853919|NCT04803305|584506376|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
161853920|NCT04803305|584506375|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
161853921|NCT04803305|584506376|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
161853922|NCT01862484|584506378|FG000|Overall Study|Lack of Efficacy|1|||
161853923|NCT01862484|584506379|FG001|Overall Study|Lack of Efficacy|1|||
161853924|NCT01862484|584506378|FG000|Overall Study|Lost to Follow-up|1|||
161853925|NCT01862484|584506379|FG001|Overall Study|Lost to Follow-up|2|||
161853926|NCT01862484|584506378|FG000|Overall Study|Protocol Violation|0|||
161853927|NCT01862484|584506379|FG001|Overall Study|Protocol Violation|2|||
161853928|NCT01862484|584506378|FG000|Overall Study|Withdrawal by Subject|0|||
161853929|NCT01862484|584506379|FG001|Overall Study|Withdrawal by Subject|3|||
161853930|NCT00996892|584506380|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
161853931|NCT00996892|584506381|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
161853932|NCT00996892|584506382|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
161853933|NCT00996892|584506383|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
161853934|NCT00996892|584506384|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
161853935|NCT00996892|584506385|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
161853936|NCT00996892|584506386|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
161853937|NCT00996892|584506387|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
161853938|NCT00996892|584506388|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
161853939|NCT00996892|584506389|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
161853940|NCT00996892|584506390|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
161853941|NCT00996892|584506391|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
161853942|NCT00996892|584506392|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
161853943|NCT00996892|584506393|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
161853944|NCT00996892|584506394|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
161853945|NCT00996892|584506395|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
161853946|NCT00996892|584506396|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
161853947|NCT00996892|584506397|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
161853948|NCT00996892|584506398|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
161853949|NCT00996892|584506399|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
161853950|NCT00996892|584506380|FG000|Dose-Escalation Stage 1|Death|1|||
161853951|NCT00996892|584506381|FG001|Dose-Escalation Stage 1|Death|0|||
161853952|NCT00996892|584506382|FG002|Dose-Escalation Stage 1|Death|0|||
161853953|NCT00996892|584506383|FG003|Dose-Escalation Stage 1|Death|0|||
161853954|NCT00996892|584506384|FG004|Dose-Escalation Stage 1|Death|0|||
161853955|NCT00996892|584506385|FG005|Dose-Escalation Stage 1|Death|1|||
161853956|NCT00996892|584506386|FG006|Dose-Escalation Stage 1|Death|0|||
161853957|NCT00996892|584506387|FG007|Dose-Escalation Stage 1|Death|0|||
161853958|NCT00996892|584506388|FG008|Dose-Escalation Stage 1|Death|0|||
161853959|NCT00996892|584506389|FG009|Dose-Escalation Stage 1|Death|0|||
161853960|NCT00996892|584506390|FG010|Dose-Escalation Stage 1|Death|0|||
161853961|NCT00996892|584506391|FG011|Dose-Escalation Stage 1|Death|0|||
161853962|NCT00996892|584506392|FG012|Dose-Escalation Stage 1|Death|0|||
161853963|NCT00996892|584506393|FG013|Dose-Escalation Stage 1|Death|0|||
161853964|NCT00996892|584506394|FG014|Dose-Escalation Stage 1|Death|0|||
162034134|NCT04393298|585181151|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161853965|NCT00996892|584506395|FG015|Dose-Escalation Stage 1|Death|0|||
161853966|NCT00996892|584506396|FG016|Dose-Escalation Stage 1|Death|0|||
161974442|NCT00624780|584954765|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
161974443|NCT00624780|584954766|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
161974444|NCT00624780|584954767|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
161974445|NCT00624780|584954768|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
161974446|NCT00624780|584954763|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
161974447|NCT00624780|584954764|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
161974448|NCT00624780|584954765|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
161974449|NCT00624780|584954766|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
161974450|NCT00624780|584954767|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
161974451|NCT00624780|584954768|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
161974452|NCT00624780|584954763|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
161974453|NCT00624780|584954764|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
161974454|NCT00624780|584954765|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
161974455|NCT00624780|584954766|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
161974456|NCT00624780|584954767|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
161974457|NCT00624780|584954768|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
161974458|NCT00624780|584954763|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
161974459|NCT00624780|584954764|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
161974460|NCT00624780|584954765|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
161974461|NCT00624780|584954766|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
161974462|NCT00624780|584954767|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
161974463|NCT00624780|584954768|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
161974464|NCT00624780|584954763|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
161974465|NCT00624780|584954764|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
161974466|NCT00624780|584954765|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
161974467|NCT00624780|584954766|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
161974468|NCT00624780|584954767|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
161974469|NCT00624780|584954768|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
161974470|NCT00624780|584954763|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
161974471|NCT00624780|584954764|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
161974472|NCT00624780|584954765|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
161974473|NCT00624780|584954766|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
161974474|NCT00624780|584954767|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
161974475|NCT00624780|584954768|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
161974476|NCT00624780|584954763|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
161974477|NCT00624780|584954764|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
161974478|NCT00624780|584954765|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
161974479|NCT00624780|584954766|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
161974480|NCT00624780|584954767|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
161974481|NCT00624780|584954768|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
161974482|NCT00624780|584954763|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
161974483|NCT00624780|584954764|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
161974484|NCT00624780|584954765|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
161766401|NCT02918006|584184743|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
161766402|NCT02918006|584184741|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
161766403|NCT02918006|584184742|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
161766404|NCT02918006|584184743|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
161766405|NCT02918006|584184741|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
161766406|NCT02918006|584184742|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
161766407|NCT02918006|584184743|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
161766408|NCT02918006|584184741|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
161766409|NCT02918006|584184742|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
161766410|NCT02918006|584184743|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
161766411|NCT02918006|584184741|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
161766412|NCT02918006|584184742|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
161766413|NCT02918006|584184743|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
161766414|NCT02918006|584184741|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
161766415|NCT02918006|584184742|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
161766416|NCT02918006|584184743|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
161766417|NCT02918006|584184741|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
161766418|NCT02918006|584184742|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
161766419|NCT02918006|584184743|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
161766420|NCT02918006|584184741|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
161974485|NCT00624780|584954766|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
161974486|NCT00624780|584954767|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
161766421|NCT02918006|584184742|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
161766422|NCT02918006|584184743|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
161766423|NCT02918006|584184741|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
161766424|NCT02918006|584184742|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
161766425|NCT02918006|584184743|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
161766426|NCT03969589|584184744|FG000|Overall Study|Lost to Follow-up|3|||
161766427|NCT03969589|584184745|FG001|Overall Study|Lost to Follow-up|2|||
161766428|NCT03969589|584184744|FG000|Overall Study|Declined Follow-Up|0|||
161766429|NCT03969589|584184745|FG001|Overall Study|Declined Follow-Up|1|||
161766430|NCT03091920|584184749|FG000|Overall Study|Adverse Event|0|||
161766431|NCT03091920|584184750|FG001|Overall Study|Adverse Event|1|||
161766432|NCT03091920|584184751|FG002|Overall Study|Adverse Event|0|||
161766433|NCT01513460|584184756|FG000|Overall Study|Death|0|||
161766434|NCT01513460|584184757|FG001|Overall Study|Death|0|||
161766435|NCT01513460|584184758|FG002|Overall Study|Death|1|||
161766436|NCT01513460|584184756|FG000|Overall Study|Lost to Follow-up|0|||
161766437|NCT01513460|584184757|FG001|Overall Study|Lost to Follow-up|0|||
161766438|NCT01513460|584184758|FG002|Overall Study|Lost to Follow-up|2|||
161766439|NCT01513460|584184756|FG000|Overall Study|Abnormal laboratory value|1|||
161766440|NCT01513460|584184757|FG001|Overall Study|Abnormal laboratory value|0|||
161766441|NCT01513460|584184758|FG002|Overall Study|Abnormal laboratory value|1|||
161766442|NCT01513460|584184756|FG000|Overall Study|Lack of Efficacy|1|||
161766443|NCT01513460|584184757|FG001|Overall Study|Lack of Efficacy|2|||
161766444|NCT01513460|584184758|FG002|Overall Study|Lack of Efficacy|5|||
161766445|NCT01513460|584184756|FG000|Overall Study|Protocol deviations|3|||
161766446|NCT01513460|584184757|FG001|Overall Study|Protocol deviations|4|||
161766447|NCT01513460|584184758|FG002|Overall Study|Protocol deviations|3|||
161766448|NCT01513460|584184756|FG000|Overall Study|Withdrawal by Subject|7|||
161766449|NCT01513460|584184757|FG001|Overall Study|Withdrawal by Subject|8|||
161766450|NCT01513460|584184758|FG002|Overall Study|Withdrawal by Subject|21|||
161766451|NCT01513460|584184756|FG000|Overall Study|Adverse Event|16|||
161766452|NCT01513460|584184757|FG001|Overall Study|Adverse Event|18|||
161766453|NCT01513460|584184758|FG002|Overall Study|Adverse Event|23|||
161766454|NCT01513460|584184756|FG000|Overall Study|Abnormal test procedure|1|||
161766455|NCT01513460|584184757|FG001|Overall Study|Abnormal test procedure|0|||
161766456|NCT01513460|584184758|FG002|Overall Study|Abnormal test procedure|0|||
161766457|NCT00489216|584184759|FG000|Overall Study|Adverse Event|1|||
161766458|NCT01078389|584187097|FG000|Overall Study|Adverse Event|10|||
161766459|NCT01078389|584187098|FG001|Overall Study|Adverse Event|6|||
161766460|NCT01078389|584187097|FG000|Overall Study|Major Protocol Deviation|2|||
161766461|NCT01078389|584187098|FG001|Overall Study|Major Protocol Deviation|0|||
161766462|NCT01078389|584187097|FG000|Overall Study|Lost to Follow-up|23|||
161766463|NCT01078389|584187098|FG001|Overall Study|Lost to Follow-up|23|||
161766464|NCT01078389|584187097|FG000|Overall Study|Voluntary Withdrawal|20|||
161766465|NCT01078389|584187098|FG001|Overall Study|Voluntary Withdrawal|36|||
161766466|NCT01078389|584187097|FG000|Overall Study|Other|9|||
161766467|NCT01078389|584187098|FG001|Overall Study|Other|2|||
161766468|NCT03726320|584187099|FG000|Overall Study|Lost to Follow-up|2|||
161766469|NCT03726320|584187100|FG001|Overall Study|Lost to Follow-up|4|||
161766470|NCT03726320|584187101|FG002|Overall Study|Lost to Follow-up|0|||
161766471|NCT03726320|584187099|FG000|Overall Study|Time Constraints|4|||
161766472|NCT03726320|584187100|FG001|Overall Study|Time Constraints|1|||
161766473|NCT03726320|584187101|FG002|Overall Study|Time Constraints|0|||
161766474|NCT03726320|584187099|FG000|Overall Study|Ineligible after enrollment|3|||
161766475|NCT03726320|584187100|FG001|Overall Study|Ineligible after enrollment|3|||
161766476|NCT03726320|584187101|FG002|Overall Study|Ineligible after enrollment|0|||
161766477|NCT03726320|584187099|FG000|Overall Study|Clinic / insurance issue|2|||
161766478|NCT03726320|584187100|FG001|Overall Study|Clinic / insurance issue|0|||
161766479|NCT03726320|584187101|FG002|Overall Study|Clinic / insurance issue|0|||
161766480|NCT03726320|584187099|FG000|Overall Study|Language barrier|1|||
161766481|NCT03726320|584187100|FG001|Overall Study|Language barrier|0|||
161766482|NCT03726320|584187101|FG002|Overall Study|Language barrier|0|||
161766483|NCT03726320|584187099|FG000|Overall Study|Provider left the clinic|0|||
161766484|NCT03726320|584187100|FG001|Overall Study|Provider left the clinic|0|||
161766485|NCT03726320|584187101|FG002|Overall Study|Provider left the clinic|1|||
161766486|NCT02198040|584187104|FG000|Overall Study|Work reasons|0|||
161766487|NCT02198040|584187105|FG001|Overall Study|Work reasons|1|||
161766488|NCT02198040|584187106|FG002|Overall Study|Work reasons|0|||
161766489|NCT02198040|584187104|FG000|Overall Study|Withdrawal by Subject|0|||
161766490|NCT02198040|584187105|FG001|Overall Study|Withdrawal by Subject|0|||
161766491|NCT02198040|584187106|FG002|Overall Study|Withdrawal by Subject|1|||
161766492|NCT00337935|584187107|FG000|Overall Study|Adverse Event|2|||
161766493|NCT00337935|584187108|FG001|Overall Study|Adverse Event|5|||
161766494|NCT00337935|584187107|FG000|Overall Study|Death|2|||
161766495|NCT00337935|584187108|FG001|Overall Study|Death|8|||
161766496|NCT00337935|584187107|FG000|Overall Study|Physician Decision|1|||
161766497|NCT00337935|584187108|FG001|Overall Study|Physician Decision|1|||
161766498|NCT00337935|584187107|FG000|Overall Study|Lost to Follow-up|0|||
161766499|NCT00337935|584187108|FG001|Overall Study|Lost to Follow-up|1|||
161766500|NCT00337935|584187107|FG000|Overall Study|Protocol Violation|4|||
161766501|NCT00337935|584187108|FG001|Overall Study|Protocol Violation|3|||
161766502|NCT00337935|584187107|FG000|Overall Study|Withdrawal by Subject|1|||
161766503|NCT00337935|584187108|FG001|Overall Study|Withdrawal by Subject|7|||
161766504|NCT00337935|584187107|FG000|Overall Study|Other|0|||
161766505|NCT00337935|584187108|FG001|Overall Study|Other|1|||
161766506|NCT00337935|584187107|FG000|Overall Study|Lack of Efficacy|0|||
161766507|NCT00337935|584187108|FG001|Overall Study|Lack of Efficacy|1|||
161766508|NCT02361307|584187109|FG000|Overall Study|Unstable medical condition.|0|||
161766509|NCT02361307|584187110|FG001|Overall Study|Unstable medical condition.|1|||
161766510|NCT01189201|584187115|FG000|Overall Study|Adverse Event|1|||
161766511|NCT01277757|584187116|FG000|Overall Study|Disease Progression|1|||
161766512|NCT01277757|584187116|FG000|Overall Study|Withdrawal by Subject|1|||
161766513|NCT00240331|584187122|FG000|Overall Study|Withdrawal by Subject|125|||
161766514|NCT00240331|584187123|FG001|Overall Study|Withdrawal by Subject|132|||
161766515|NCT00240331|584187122|FG000|Overall Study|Option selected by investigator|1|||
161766516|NCT00240331|584187123|FG001|Overall Study|Option selected by investigator|2|||
161766517|NCT01409382|584187124|FG000|Overall Study|Lost to Follow-up|1|||
161766518|NCT01409382|584187125|FG001|Overall Study|Lost to Follow-up|1|||
161766519|NCT01409382|584187124|FG000|Overall Study|Protocol Violation|0|||
161766520|NCT01409382|584187125|FG001|Overall Study|Protocol Violation|3|||
161766521|NCT01409382|584187124|FG000|Overall Study|Multiple pregnancy|2|||
161766522|NCT01409382|584187125|FG001|Overall Study|Multiple pregnancy|4|||
161766523|NCT01409382|584187124|FG000|Overall Study|Still pregnant when study ended|13|||
161766524|NCT01409382|584187125|FG001|Overall Study|Still pregnant when study ended|2|||
161766525|NCT01409382|584187124|FG000|Overall Study|Did not manage to get pregnant|64|||
161766526|NCT01409382|584187125|FG001|Overall Study|Did not manage to get pregnant|70|||
161766527|NCT01409382|584187124|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
161766528|NCT01409382|584187125|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
161766529|NCT01233076|584187126|FG000|Period 2, One Week|Lost to Follow-up|1|||
161766530|NCT01233076|584187127|FG001|Period 2, One Week|Lost to Follow-up|0|||
161766531|NCT04563845|584187128|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766532|NCT04563845|584187129|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766533|NCT04563845|584187130|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766534|NCT04563845|584187131|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766535|NCT04563845|584187132|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766536|NCT04563845|584187133|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766537|NCT04563845|584187134|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766538|NCT04563845|584187135|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
161766539|NCT04563845|584187136|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766540|NCT04563845|584187137|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766541|NCT04563845|584187138|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766542|NCT04563845|584187139|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766543|NCT04563845|584187140|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766544|NCT04563845|584187141|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161766545|NCT04563845|584187128|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766546|NCT04563845|584187129|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766547|NCT04563845|584187130|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766548|NCT04563845|584187131|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766549|NCT04563845|584187132|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
161766550|NCT04563845|584187133|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766551|NCT04563845|584187134|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766552|NCT04563845|584187135|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766553|NCT04563845|584187136|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766554|NCT04563845|584187137|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766555|NCT04563845|584187138|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766556|NCT04563845|584187139|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766557|NCT04563845|584187140|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766558|NCT04563845|584187141|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161766559|NCT00965458|584187148|FG000|Overall Study|Adverse Event|1|||
161766560|NCT00965458|584187149|FG001|Overall Study|Adverse Event|0|||
161766561|NCT00965458|584187148|FG000|Overall Study|Lost to Follow-up|1|||
161766562|NCT00965458|584187149|FG001|Overall Study|Lost to Follow-up|3|||
161766563|NCT00965458|584187148|FG000|Overall Study|Withdrawal by Subject|0|||
161766564|NCT00965458|584187149|FG001|Overall Study|Withdrawal by Subject|1|||
161766565|NCT04177862|584187151|FG000|Overall Study|Protocol Violation|2|||
161766566|NCT04177862|584187152|FG001|Overall Study|Protocol Violation|7|||
161766567|NCT01846039|584187153|FG000|Overall Study|Protocol Violation|1|||
161974487|NCT00624780|584954768|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
161853967|NCT00996892|584506397|FG017|Dose-Escalation Stage 1|Death|0|||
161766568|NCT01846039|584187153|FG000|Overall Study|Subject Withdrew Consent|1|||
161766569|NCT05637515|584187154|FG000|Overall Study|Withdrawal by Subject|17|||
161974488|NCT00624780|584954763|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
161974489|NCT00624780|584954764|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
161974490|NCT00624780|584954765|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
161974491|NCT00624780|584954766|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
161974492|NCT00624780|584954767|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
161974493|NCT00624780|584954768|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
161974494|NCT00624780|584954763|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
161974495|NCT00624780|584954764|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
161766570|NCT05637515|584187155|FG001|Overall Study|Withdrawal by Subject|17|||
161766571|NCT04516291|584187157|FG000|Treatment Period (24 Weeks)|Other|1|||
161766572|NCT04516291|584187158|FG001|Treatment Period (24 Weeks)|Other|0|||
161766573|NCT04516291|584187159|FG002|Treatment Period (24 Weeks)|Other|0|||
161766574|NCT04516291|584187160|FG003|Treatment Period (24 Weeks)|Other|2|||
161766575|NCT04516291|584187161|FG004|Treatment Period (24 Weeks)|Other|2|||
161766576|NCT04516291|584187162|FG005|Treatment Period (24 Weeks)|Other|4|||
161766577|NCT04516291|584187163|FG006|Treatment Period (24 Weeks)|Other|2|||
161766578|NCT04516291|584187164|FG007|Treatment Period (24 Weeks)|Other|0|||
161766579|NCT04516291|584187157|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161766580|NCT04516291|584187158|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
161766581|NCT04516291|584187159|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161766582|NCT04516291|584187160|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161766583|NCT04516291|584187161|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161766584|NCT04516291|584187162|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161766585|NCT04516291|584187163|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161766586|NCT04516291|584187164|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161766587|NCT04516291|584187157|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766588|NCT04516291|584187158|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766589|NCT04516291|584187159|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766590|NCT04516291|584187160|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
161766591|NCT04516291|584187161|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766592|NCT04516291|584187162|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766593|NCT04516291|584187163|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766594|NCT04516291|584187164|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
161766595|NCT04516291|584187157|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766596|NCT04516291|584187158|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161766597|NCT04516291|584187159|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766598|NCT04516291|584187160|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766599|NCT04516291|584187161|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766600|NCT04516291|584187162|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766601|NCT04516291|584187163|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766602|NCT04516291|584187164|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161766603|NCT04516291|584187157|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
161766604|NCT04516291|584187158|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
161766605|NCT04516291|584187159|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
161766606|NCT04516291|584187160|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
161766607|NCT04516291|584187161|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
161766608|NCT04516291|584187162|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
161766609|NCT04516291|584187163|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
161766610|NCT04516291|584187164|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
161766611|NCT04516291|584187157|FG000|Follow-up Period (12 Weeks)|Other|0|||
161766612|NCT04516291|584187158|FG001|Follow-up Period (12 Weeks)|Other|1|||
161766613|NCT04516291|584187159|FG002|Follow-up Period (12 Weeks)|Other|0|||
161766614|NCT04516291|584187160|FG003|Follow-up Period (12 Weeks)|Other|2|||
161766615|NCT04516291|584187161|FG004|Follow-up Period (12 Weeks)|Other|0|||
161766616|NCT04516291|584187162|FG005|Follow-up Period (12 Weeks)|Other|0|||
161766617|NCT04516291|584187163|FG006|Follow-up Period (12 Weeks)|Other|0|||
161766618|NCT04516291|584187164|FG007|Follow-up Period (12 Weeks)|Other|0|||
161766619|NCT04516291|584187157|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766620|NCT04516291|584187158|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766621|NCT04516291|584187159|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766622|NCT04516291|584187160|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766623|NCT04516291|584187161|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
161766624|NCT04516291|584187162|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766625|NCT04516291|584187163|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766626|NCT04516291|584187164|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161766627|NCT04516291|584187157|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
161766628|NCT04516291|584187158|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
161766629|NCT04516291|584187159|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
161766630|NCT04516291|584187160|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
161853968|NCT00996892|584506398|FG018|Dose-Escalation Stage 1|Death|0|||
161766631|NCT04516291|584187161|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
161766632|NCT04516291|584187162|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
161974496|NCT00624780|584954765|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
161974497|NCT00624780|584954766|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
161853969|NCT00996892|584506399|FG019|Dose-Escalation Stage 1|Death|0|||
161853970|NCT00996892|584506380|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
161853971|NCT00996892|584506381|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
161853972|NCT00996892|584506382|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
161853973|NCT00996892|584506383|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
161853974|NCT00996892|584506384|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
161853975|NCT00996892|584506385|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
161853976|NCT00996892|584506386|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
161853977|NCT00996892|584506387|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
161853978|NCT00996892|584506388|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
161853979|NCT00996892|584506389|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
161853980|NCT00996892|584506390|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
161853981|NCT00996892|584506391|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
161853982|NCT00996892|584506392|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
161853983|NCT00996892|584506393|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
161853984|NCT00996892|584506394|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
161853985|NCT00996892|584506395|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
161853986|NCT00996892|584506396|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
161853987|NCT00996892|584506397|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
161853988|NCT00996892|584506398|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
161853989|NCT00996892|584506399|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
161853990|NCT00996892|584506380|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161853991|NCT00996892|584506381|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
161853992|NCT00996892|584506382|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161853993|NCT00996892|584506383|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
161853994|NCT00996892|584506384|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
161853995|NCT00996892|584506385|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
161853996|NCT00996892|584506386|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
161853997|NCT00996892|584506387|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161853998|NCT00996892|584506388|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161853999|NCT00996892|584506389|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854000|NCT00996892|584506390|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854001|NCT00996892|584506391|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854002|NCT00996892|584506392|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854003|NCT00996892|584506393|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854004|NCT00996892|584506394|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854005|NCT00996892|584506395|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854006|NCT00996892|584506396|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854007|NCT00996892|584506397|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854008|NCT00996892|584506398|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854009|NCT00996892|584506399|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161854010|NCT00996892|584506380|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
161854011|NCT00996892|584506381|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
161854012|NCT00996892|584506382|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
161854013|NCT00996892|584506383|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
161854014|NCT00996892|584506384|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
161854015|NCT00996892|584506385|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
161854016|NCT00996892|584506386|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
161854017|NCT00996892|584506387|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
161854018|NCT00996892|584506388|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
161854019|NCT00996892|584506389|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
161854020|NCT00996892|584506390|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
161854021|NCT00996892|584506391|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
161854022|NCT00996892|584506392|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
161854023|NCT00996892|584506393|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
161854024|NCT00996892|584506394|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
161854025|NCT00996892|584506395|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
161854026|NCT00996892|584506396|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
161854027|NCT00996892|584506397|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
161854028|NCT00996892|584506398|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
161854029|NCT00996892|584506399|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
161854030|NCT00996892|584506380|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
161854031|NCT00996892|584506381|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
161854032|NCT00996892|584506382|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
161854033|NCT00996892|584506383|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
161854034|NCT00996892|584506384|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
161854035|NCT00996892|584506385|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
161854036|NCT00996892|584506386|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
161854037|NCT00996892|584506387|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
161854038|NCT00996892|584506388|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
161854039|NCT00996892|584506389|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
161766633|NCT04516291|584187163|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
161766634|NCT04516291|584187164|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
161766635|NCT01855607|584187165|FG000|Overall Study|Withdrawal by Subject|1|||
161766636|NCT01855607|584187165|FG000|Overall Study|Study was terminated|11|||
161766637|NCT02181634|584187166|FG000|Overall Study|Lack of Efficacy|33|||
161766638|NCT02181634|584187166|FG000|Overall Study|Adverse Event|17|||
161766639|NCT02181634|584187166|FG000|Overall Study|Physician Decision|8|||
161766640|NCT02181634|584187166|FG000|Overall Study|Withdrawal by Subject|5|||
161766641|NCT02181634|584187166|FG000|Overall Study|Death|2|||
161766642|NCT02181634|584187166|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
161766643|NCT02181634|584187166|FG000|Overall Study|Ineligible|1|||
161766644|NCT02181634|584187166|FG000|Overall Study|Max number of dose reduction|1|||
161766645|NCT02181634|584187166|FG000|Overall Study|Symptomatic progression|1|||
161766646|NCT02181634|584187166|FG000|Overall Study|Patient opted to proceed to surgery|1|||
161766647|NCT03824704|584187172|FG000|Overall Study|Study Terminated by Sponsor|1|||
161766648|NCT02155660|584187180|FG000|Overall Study|Other Reason|8|||
161766649|NCT02155660|584187181|FG001|Overall Study|Other Reason|6|||
161766650|NCT02155660|584187182|FG002|Overall Study|Other Reason|10|||
161766651|NCT02155660|584187183|FG003|Overall Study|Other Reason|10|||
161766652|NCT02155660|584187180|FG000|Overall Study|Study-specific withdrawal criteria|0|||
161766653|NCT02155660|584187181|FG001|Overall Study|Study-specific withdrawal criteria|1|||
161766654|NCT02155660|584187182|FG002|Overall Study|Study-specific withdrawal criteria|1|||
161766655|NCT02155660|584187183|FG003|Overall Study|Study-specific withdrawal criteria|1|||
161766656|NCT02155660|584187180|FG000|Overall Study|Severe non-compliance|0|||
161766657|NCT02155660|584187181|FG001|Overall Study|Severe non-compliance|4|||
161766658|NCT02155660|584187182|FG002|Overall Study|Severe non-compliance|0|||
161766659|NCT02155660|584187183|FG003|Overall Study|Severe non-compliance|1|||
161766660|NCT02155660|584187180|FG000|Overall Study|Adverse Event|2|||
161766661|NCT02155660|584187181|FG001|Overall Study|Adverse Event|6|||
161766662|NCT02155660|584187182|FG002|Overall Study|Adverse Event|3|||
161766663|NCT02155660|584187183|FG003|Overall Study|Adverse Event|1|||
161766664|NCT02155660|584187180|FG000|Overall Study|Lost to Follow-up|3|||
161766665|NCT02155660|584187181|FG001|Overall Study|Lost to Follow-up|6|||
161766666|NCT02155660|584187182|FG002|Overall Study|Lost to Follow-up|5|||
161766667|NCT02155660|584187183|FG003|Overall Study|Lost to Follow-up|8|||
161766668|NCT02155660|584187180|FG000|Overall Study|Death|17|||
161766669|NCT02155660|584187181|FG001|Overall Study|Death|19|||
161766670|NCT02155660|584187182|FG002|Overall Study|Death|17|||
161766671|NCT02155660|584187183|FG003|Overall Study|Death|19|||
161766672|NCT02155660|584187180|FG000|Overall Study|Withdrawal by Subject|28|||
161766673|NCT02155660|584187181|FG001|Overall Study|Withdrawal by Subject|31|||
161766674|NCT02155660|584187182|FG002|Overall Study|Withdrawal by Subject|24|||
161766675|NCT02155660|584187183|FG003|Overall Study|Withdrawal by Subject|21|||
161766676|NCT03730987|584187184|FG000|Overall Study|Lost to Follow-up|2|||
161766677|NCT03730987|584187185|FG001|Overall Study|Lost to Follow-up|0|||
161766678|NCT03730987|584187186|FG002|Overall Study|Lost to Follow-up|2|||
161766679|NCT03730987|584187187|FG003|Overall Study|Lost to Follow-up|0|||
161766680|NCT02087085|584187188|FG000|Overall Study|Adverse Event|10|||
161766681|NCT02087085|584187189|FG001|Overall Study|Adverse Event|14|||
161766682|NCT02087085|584187188|FG000|Overall Study|Lack of Efficacy|4|||
161766683|NCT02087085|584187189|FG001|Overall Study|Lack of Efficacy|3|||
161766684|NCT02087085|584187188|FG000|Overall Study|Lost to Follow-up|6|||
161766685|NCT02087085|584187189|FG001|Overall Study|Lost to Follow-up|4|||
161766686|NCT02087085|584187188|FG000|Overall Study|Withdrawal by Subject|9|||
161766687|NCT02087085|584187189|FG001|Overall Study|Withdrawal by Subject|11|||
161766688|NCT02087085|584187188|FG000|Overall Study|Protocol Violation|1|||
161766689|NCT02087085|584187189|FG001|Overall Study|Protocol Violation|0|||
161766690|NCT02087085|584187188|FG000|Overall Study|Study Terminated by Sponsor|87|||
161766691|NCT02087085|584187189|FG001|Overall Study|Study Terminated by Sponsor|80|||
161766692|NCT02087085|584187188|FG000|Overall Study|Other Miscellaneous Reasons|3|||
161766693|NCT02087085|584187189|FG001|Overall Study|Other Miscellaneous Reasons|4|||
161766694|NCT02505945|584187190|FG000|Overall Study|Withdrawal by Subject|13|||
161766695|NCT02505945|584187191|FG001|Overall Study|Withdrawal by Subject|2|||
161766696|NCT02505945|584187190|FG000|Overall Study|Adverse Event|1|||
161854040|NCT00996892|584506390|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
161854041|NCT00996892|584506391|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
161766697|NCT02505945|584187191|FG001|Overall Study|Adverse Event|0|||
161766698|NCT02505945|584187190|FG000|Overall Study|Physician Decision|2|||
161766699|NCT02505945|584187191|FG001|Overall Study|Physician Decision|1|||
161766700|NCT02505945|584187190|FG000|Overall Study|Lost to Follow-up|6|||
161766701|NCT02505945|584187191|FG001|Overall Study|Lost to Follow-up|1|||
161766702|NCT00635804|584187192|FG000|Overall Study|Adverse Event|0|||
161766703|NCT00635804|584187193|FG001|Overall Study|Adverse Event|0|||
161766704|NCT00635804|584187194|FG002|Overall Study|Adverse Event|0|||
161766705|NCT00635804|584187195|FG003|Overall Study|Adverse Event|0|||
161766706|NCT00635804|584187196|FG004|Overall Study|Adverse Event|0|||
161766707|NCT00635804|584187197|FG005|Overall Study|Adverse Event|1|||
161766708|NCT00635804|584187198|FG006|Overall Study|Adverse Event|0|||
161854042|NCT00996892|584506392|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
161854043|NCT00996892|584506393|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
161854044|NCT00996892|584506394|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
161854045|NCT00996892|584506395|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
161854046|NCT00996892|584506396|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
161854047|NCT00996892|584506397|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
161854048|NCT00996892|584506398|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
161854049|NCT00996892|584506399|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
161854050|NCT00996892|584506380|FG000|Dose-Escalation Stage 1A|Death|0|||
161854051|NCT00996892|584506381|FG001|Dose-Escalation Stage 1A|Death|0|||
161854052|NCT00996892|584506382|FG002|Dose-Escalation Stage 1A|Death|0|||
161854053|NCT00996892|584506383|FG003|Dose-Escalation Stage 1A|Death|0|||
161854054|NCT00996892|584506384|FG004|Dose-Escalation Stage 1A|Death|0|||
161854055|NCT00996892|584506385|FG005|Dose-Escalation Stage 1A|Death|0|||
161854056|NCT00996892|584506386|FG006|Dose-Escalation Stage 1A|Death|0|||
161854057|NCT00996892|584506387|FG007|Dose-Escalation Stage 1A|Death|0|||
161854058|NCT00996892|584506388|FG008|Dose-Escalation Stage 1A|Death|0|||
161854059|NCT00996892|584506389|FG009|Dose-Escalation Stage 1A|Death|2|||
161854060|NCT00996892|584506390|FG010|Dose-Escalation Stage 1A|Death|0|||
161854061|NCT00996892|584506391|FG011|Dose-Escalation Stage 1A|Death|1|||
161854062|NCT00996892|584506392|FG012|Dose-Escalation Stage 1A|Death|1|||
161854063|NCT00996892|584506393|FG013|Dose-Escalation Stage 1A|Death|0|||
161854064|NCT00996892|584506394|FG014|Dose-Escalation Stage 1A|Death|0|||
161854065|NCT00996892|584506395|FG015|Dose-Escalation Stage 1A|Death|0|||
161854066|NCT00996892|584506396|FG016|Dose-Escalation Stage 1A|Death|0|||
161854067|NCT00996892|584506397|FG017|Dose-Escalation Stage 1A|Death|0|||
161854068|NCT00996892|584506398|FG018|Dose-Escalation Stage 1A|Death|0|||
161854069|NCT00996892|584506399|FG019|Dose-Escalation Stage 1A|Death|0|||
161854070|NCT00996892|584506380|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
161854071|NCT00996892|584506381|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
161854072|NCT00996892|584506382|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
161854073|NCT00996892|584506383|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
161854074|NCT00996892|584506384|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
161854075|NCT00996892|584506385|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
161854076|NCT00996892|584506386|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
161854077|NCT00996892|584506387|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
161854078|NCT00996892|584506388|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
161854079|NCT00996892|584506389|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
161854080|NCT00996892|584506390|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
161854081|NCT00996892|584506391|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
161854082|NCT00996892|584506392|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
161854083|NCT00996892|584506393|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
161854084|NCT00996892|584506394|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
161854085|NCT00996892|584506395|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
161854086|NCT00996892|584506396|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
161854087|NCT00996892|584506397|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
161854088|NCT00996892|584506398|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
161854089|NCT00996892|584506399|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
161854090|NCT00996892|584506380|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854091|NCT00996892|584506381|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854092|NCT00996892|584506382|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854093|NCT00996892|584506383|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854094|NCT00996892|584506384|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854095|NCT00996892|584506385|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854096|NCT00996892|584506386|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854097|NCT00996892|584506387|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854098|NCT00996892|584506388|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854099|NCT00996892|584506389|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
161854100|NCT00996892|584506390|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
161854101|NCT00996892|584506391|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
161854102|NCT00996892|584506392|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
161854103|NCT00996892|584506393|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854104|NCT00996892|584506394|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854105|NCT00996892|584506395|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854106|NCT00996892|584506396|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854107|NCT00996892|584506397|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854108|NCT00996892|584506398|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854109|NCT00996892|584506399|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161854110|NCT00996892|584506380|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
161854111|NCT00996892|584506381|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
161854112|NCT00996892|584506382|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
161854113|NCT00996892|584506383|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
161854114|NCT00996892|584506384|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
161854115|NCT00996892|584506385|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
161854116|NCT00996892|584506386|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
161854117|NCT00996892|584506387|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
161854118|NCT00996892|584506388|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
161854119|NCT00996892|584506389|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
161854120|NCT00996892|584506390|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
161854121|NCT00996892|584506391|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
161854122|NCT00996892|584506392|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
161854123|NCT00996892|584506393|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
161854124|NCT00996892|584506394|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
161854125|NCT00996892|584506395|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
161854126|NCT00996892|584506396|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
161854127|NCT00996892|584506397|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
161854128|NCT00996892|584506398|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
161854129|NCT00996892|584506399|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
161854130|NCT00996892|584506380|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
161854131|NCT00996892|584506381|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
161854132|NCT00996892|584506382|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
161854133|NCT00996892|584506383|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
161854134|NCT00996892|584506384|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
161854135|NCT00996892|584506385|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
161854136|NCT00996892|584506386|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
161854137|NCT00996892|584506387|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
161854138|NCT00996892|584506388|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
161854139|NCT00996892|584506389|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
161854140|NCT00996892|584506390|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
161854141|NCT00996892|584506391|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
161854142|NCT00996892|584506392|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
161854143|NCT00996892|584506393|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
161854144|NCT00996892|584506394|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
161854145|NCT00996892|584506395|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
161854146|NCT00996892|584506396|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
161854147|NCT00996892|584506397|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
161854148|NCT00996892|584506398|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
161854149|NCT00996892|584506399|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
161854150|NCT00996892|584506380|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
161854151|NCT00996892|584506381|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
161854152|NCT00996892|584506382|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
161854153|NCT00996892|584506383|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
161854154|NCT00996892|584506384|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
161854155|NCT00996892|584506385|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
161854156|NCT00996892|584506386|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
161854157|NCT00996892|584506387|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
161854158|NCT00996892|584506388|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
161854159|NCT00996892|584506389|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
161854160|NCT00996892|584506390|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
161854161|NCT00996892|584506391|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
161854162|NCT00996892|584506392|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
161854163|NCT00996892|584506393|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
161854164|NCT00996892|584506394|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
161854165|NCT00996892|584506395|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
161854166|NCT00996892|584506396|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
161854167|NCT00996892|584506397|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
161854168|NCT00996892|584506398|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
161854169|NCT00996892|584506399|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
161854170|NCT00996892|584506380|FG000|Expansion Stage 2|Adverse Event|0|||
161854171|NCT00996892|584506381|FG001|Expansion Stage 2|Adverse Event|0|||
161854172|NCT00996892|584506382|FG002|Expansion Stage 2|Adverse Event|0|||
161854173|NCT00996892|584506383|FG003|Expansion Stage 2|Adverse Event|0|||
161854174|NCT00996892|584506384|FG004|Expansion Stage 2|Adverse Event|0|||
161974498|NCT00624780|584954767|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
161974499|NCT00624780|584954768|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
161974500|NCT00624780|584954763|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
161974501|NCT00624780|584954764|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
161974502|NCT00624780|584954765|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
161974503|NCT00624780|584954766|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
161974504|NCT00624780|584954767|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
161974505|NCT00624780|584954768|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
161974506|NCT00624780|584954763|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
161854175|NCT00996892|584506385|FG005|Expansion Stage 2|Adverse Event|0|||
161854176|NCT00996892|584506386|FG006|Expansion Stage 2|Adverse Event|0|||
161854177|NCT00996892|584506387|FG007|Expansion Stage 2|Adverse Event|0|||
161854178|NCT00996892|584506388|FG008|Expansion Stage 2|Adverse Event|0|||
161854179|NCT00996892|584506389|FG009|Expansion Stage 2|Adverse Event|0|||
161854180|NCT00996892|584506390|FG010|Expansion Stage 2|Adverse Event|0|||
161854181|NCT00996892|584506391|FG011|Expansion Stage 2|Adverse Event|0|||
161854182|NCT00996892|584506392|FG012|Expansion Stage 2|Adverse Event|0|||
161854183|NCT00996892|584506393|FG013|Expansion Stage 2|Adverse Event|0|||
161854184|NCT00996892|584506394|FG014|Expansion Stage 2|Adverse Event|0|||
161854185|NCT00996892|584506395|FG015|Expansion Stage 2|Adverse Event|0|||
161854186|NCT00996892|584506396|FG016|Expansion Stage 2|Adverse Event|0|||
161854187|NCT00996892|584506397|FG017|Expansion Stage 2|Adverse Event|0|||
161854188|NCT00996892|584506398|FG018|Expansion Stage 2|Adverse Event|3|||
161854189|NCT00996892|584506399|FG019|Expansion Stage 2|Adverse Event|0|||
161854190|NCT00996892|584506380|FG000|Expansion Stage 2|Death|0|||
161854191|NCT00996892|584506381|FG001|Expansion Stage 2|Death|0|||
161854192|NCT00996892|584506382|FG002|Expansion Stage 2|Death|0|||
161854193|NCT00996892|584506383|FG003|Expansion Stage 2|Death|0|||
161854194|NCT00996892|584506384|FG004|Expansion Stage 2|Death|0|||
161854195|NCT00996892|584506385|FG005|Expansion Stage 2|Death|0|||
161854196|NCT00996892|584506386|FG006|Expansion Stage 2|Death|0|||
161854197|NCT00996892|584506387|FG007|Expansion Stage 2|Death|0|||
161854198|NCT00996892|584506388|FG008|Expansion Stage 2|Death|0|||
161854199|NCT00996892|584506389|FG009|Expansion Stage 2|Death|0|||
161854200|NCT00996892|584506390|FG010|Expansion Stage 2|Death|0|||
161854201|NCT00996892|584506391|FG011|Expansion Stage 2|Death|0|||
161854202|NCT00996892|584506392|FG012|Expansion Stage 2|Death|0|||
161854203|NCT00996892|584506393|FG013|Expansion Stage 2|Death|0|||
161854204|NCT00996892|584506394|FG014|Expansion Stage 2|Death|0|||
161854205|NCT00996892|584506395|FG015|Expansion Stage 2|Death|0|||
161854206|NCT00996892|584506396|FG016|Expansion Stage 2|Death|0|||
161854207|NCT00996892|584506397|FG017|Expansion Stage 2|Death|0|||
161854208|NCT00996892|584506398|FG018|Expansion Stage 2|Death|2|||
161854209|NCT00996892|584506399|FG019|Expansion Stage 2|Death|0|||
161854210|NCT00996892|584506380|FG000|Expansion Stage 2|Physician Decision|0|||
161854211|NCT00996892|584506381|FG001|Expansion Stage 2|Physician Decision|0|||
161854212|NCT00996892|584506382|FG002|Expansion Stage 2|Physician Decision|0|||
161854213|NCT00996892|584506383|FG003|Expansion Stage 2|Physician Decision|0|||
161854214|NCT00996892|584506384|FG004|Expansion Stage 2|Physician Decision|0|||
161854215|NCT00996892|584506385|FG005|Expansion Stage 2|Physician Decision|0|||
161854216|NCT00996892|584506386|FG006|Expansion Stage 2|Physician Decision|0|||
161854217|NCT00996892|584506387|FG007|Expansion Stage 2|Physician Decision|0|||
161854218|NCT00996892|584506388|FG008|Expansion Stage 2|Physician Decision|0|||
161854219|NCT00996892|584506389|FG009|Expansion Stage 2|Physician Decision|0|||
161854220|NCT00996892|584506390|FG010|Expansion Stage 2|Physician Decision|0|||
161854221|NCT00996892|584506391|FG011|Expansion Stage 2|Physician Decision|0|||
161854222|NCT00996892|584506392|FG012|Expansion Stage 2|Physician Decision|0|||
161854223|NCT00996892|584506393|FG013|Expansion Stage 2|Physician Decision|0|||
161854224|NCT00996892|584506394|FG014|Expansion Stage 2|Physician Decision|0|||
161854225|NCT00996892|584506395|FG015|Expansion Stage 2|Physician Decision|0|||
161854226|NCT00996892|584506396|FG016|Expansion Stage 2|Physician Decision|0|||
161854227|NCT00996892|584506397|FG017|Expansion Stage 2|Physician Decision|0|||
161854228|NCT00996892|584506398|FG018|Expansion Stage 2|Physician Decision|1|||
161854229|NCT00996892|584506399|FG019|Expansion Stage 2|Physician Decision|0|||
161854230|NCT00996892|584506380|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
161854231|NCT00996892|584506381|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
161854232|NCT00996892|584506382|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
161854233|NCT00996892|584506383|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
161854234|NCT00996892|584506384|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
161854235|NCT00996892|584506385|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
161854236|NCT00996892|584506386|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
161854237|NCT00996892|584506387|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
161854238|NCT00996892|584506388|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
161854239|NCT00996892|584506389|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
161854240|NCT00996892|584506390|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
161854241|NCT00996892|584506391|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
161854242|NCT00996892|584506392|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
161854243|NCT00996892|584506393|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
161854244|NCT00996892|584506394|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
161854245|NCT00996892|584506395|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
161854246|NCT00996892|584506396|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
161854247|NCT00996892|584506397|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
161854248|NCT00996892|584506398|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
161854249|NCT00996892|584506399|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
161854250|NCT00996892|584506380|FG000|Expansion Stage 2|Disease Progression|0|||
161854251|NCT00996892|584506381|FG001|Expansion Stage 2|Disease Progression|0|||
161854252|NCT00996892|584506382|FG002|Expansion Stage 2|Disease Progression|0|||
161854253|NCT00996892|584506383|FG003|Expansion Stage 2|Disease Progression|0|||
161854254|NCT00996892|584506384|FG004|Expansion Stage 2|Disease Progression|0|||
161854255|NCT00996892|584506385|FG005|Expansion Stage 2|Disease Progression|0|||
161854256|NCT00996892|584506386|FG006|Expansion Stage 2|Disease Progression|0|||
161854257|NCT00996892|584506387|FG007|Expansion Stage 2|Disease Progression|0|||
161854258|NCT00996892|584506388|FG008|Expansion Stage 2|Disease Progression|0|||
161854259|NCT00996892|584506389|FG009|Expansion Stage 2|Disease Progression|0|||
161854260|NCT00996892|584506390|FG010|Expansion Stage 2|Disease Progression|0|||
161854261|NCT00996892|584506391|FG011|Expansion Stage 2|Disease Progression|0|||
161854262|NCT00996892|584506392|FG012|Expansion Stage 2|Disease Progression|0|||
161854263|NCT00996892|584506393|FG013|Expansion Stage 2|Disease Progression|0|||
161854264|NCT00996892|584506394|FG014|Expansion Stage 2|Disease Progression|0|||
161854265|NCT00996892|584506395|FG015|Expansion Stage 2|Disease Progression|0|||
161854266|NCT00996892|584506396|FG016|Expansion Stage 2|Disease Progression|0|||
161854267|NCT00996892|584506397|FG017|Expansion Stage 2|Disease Progression|0|||
161854268|NCT00996892|584506398|FG018|Expansion Stage 2|Disease Progression|28|||
161854269|NCT00996892|584506399|FG019|Expansion Stage 2|Disease Progression|0|||
161854270|NCT00996892|584506380|FG000|Expansion Stage 2A|Adverse Event|0|||
161854271|NCT00996892|584506381|FG001|Expansion Stage 2A|Adverse Event|0|||
161854272|NCT00996892|584506382|FG002|Expansion Stage 2A|Adverse Event|0|||
161854273|NCT00996892|584506383|FG003|Expansion Stage 2A|Adverse Event|0|||
161854274|NCT00996892|584506384|FG004|Expansion Stage 2A|Adverse Event|0|||
161854275|NCT00996892|584506385|FG005|Expansion Stage 2A|Adverse Event|0|||
161854276|NCT00996892|584506386|FG006|Expansion Stage 2A|Adverse Event|0|||
161854277|NCT00996892|584506387|FG007|Expansion Stage 2A|Adverse Event|0|||
161854278|NCT00996892|584506388|FG008|Expansion Stage 2A|Adverse Event|0|||
161854279|NCT00996892|584506389|FG009|Expansion Stage 2A|Adverse Event|0|||
161854280|NCT00996892|584506390|FG010|Expansion Stage 2A|Adverse Event|0|||
161854281|NCT00996892|584506391|FG011|Expansion Stage 2A|Adverse Event|0|||
161854282|NCT00996892|584506392|FG012|Expansion Stage 2A|Adverse Event|0|||
161854283|NCT00996892|584506393|FG013|Expansion Stage 2A|Adverse Event|0|||
161854284|NCT00996892|584506394|FG014|Expansion Stage 2A|Adverse Event|0|||
161854285|NCT00996892|584506395|FG015|Expansion Stage 2A|Adverse Event|0|||
161854286|NCT00996892|584506396|FG016|Expansion Stage 2A|Adverse Event|0|||
161854287|NCT00996892|584506397|FG017|Expansion Stage 2A|Adverse Event|0|||
161854288|NCT00996892|584506398|FG018|Expansion Stage 2A|Adverse Event|0|||
161854289|NCT00996892|584506399|FG019|Expansion Stage 2A|Adverse Event|8|||
161854290|NCT00996892|584506380|FG000|Expansion Stage 2A|Physician Decision|0|||
161854291|NCT00996892|584506381|FG001|Expansion Stage 2A|Physician Decision|0|||
161854292|NCT00996892|584506382|FG002|Expansion Stage 2A|Physician Decision|0|||
161854293|NCT00996892|584506383|FG003|Expansion Stage 2A|Physician Decision|0|||
161854294|NCT00996892|584506384|FG004|Expansion Stage 2A|Physician Decision|0|||
161854295|NCT00996892|584506385|FG005|Expansion Stage 2A|Physician Decision|0|||
161854296|NCT00996892|584506386|FG006|Expansion Stage 2A|Physician Decision|0|||
161854297|NCT00996892|584506387|FG007|Expansion Stage 2A|Physician Decision|0|||
161854298|NCT00996892|584506388|FG008|Expansion Stage 2A|Physician Decision|0|||
161854299|NCT00996892|584506389|FG009|Expansion Stage 2A|Physician Decision|0|||
161854300|NCT00996892|584506390|FG010|Expansion Stage 2A|Physician Decision|0|||
161854301|NCT00996892|584506391|FG011|Expansion Stage 2A|Physician Decision|0|||
161854302|NCT00996892|584506392|FG012|Expansion Stage 2A|Physician Decision|0|||
161854303|NCT00996892|584506393|FG013|Expansion Stage 2A|Physician Decision|0|||
161854304|NCT00996892|584506394|FG014|Expansion Stage 2A|Physician Decision|0|||
161854305|NCT00996892|584506395|FG015|Expansion Stage 2A|Physician Decision|0|||
161854306|NCT00996892|584506396|FG016|Expansion Stage 2A|Physician Decision|0|||
161854307|NCT00996892|584506397|FG017|Expansion Stage 2A|Physician Decision|0|||
161854308|NCT00996892|584506398|FG018|Expansion Stage 2A|Physician Decision|0|||
161854309|NCT00996892|584506399|FG019|Expansion Stage 2A|Physician Decision|2|||
161854310|NCT00996892|584506380|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
161854311|NCT00996892|584506381|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
161854312|NCT00996892|584506382|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
161854313|NCT00996892|584506383|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
161854314|NCT00996892|584506384|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
161854315|NCT00996892|584506385|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
161854316|NCT00996892|584506386|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
161854317|NCT00996892|584506387|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
161854318|NCT00996892|584506388|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
161854319|NCT00996892|584506389|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
161854320|NCT00996892|584506390|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
161854321|NCT00996892|584506391|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
161854322|NCT00996892|584506392|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
161854323|NCT00996892|584506393|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
161854324|NCT00996892|584506394|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
161854325|NCT00996892|584506395|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
161854326|NCT00996892|584506396|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
161854327|NCT00996892|584506397|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
161854328|NCT00996892|584506398|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
161854329|NCT00996892|584506399|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
161854330|NCT00996892|584506380|FG000|Expansion Stage 2A|Disease Progression|0|||
161854331|NCT00996892|584506381|FG001|Expansion Stage 2A|Disease Progression|0|||
161974507|NCT00624780|584954764|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
161974508|NCT00624780|584954765|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
161974509|NCT00624780|584954766|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
161974510|NCT00624780|584954767|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
161974511|NCT00624780|584954768|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
161974512|NCT00624780|584954763|FG000|Follow-up (Week 26)|Death|0|||
161974513|NCT00624780|584954764|FG001|Follow-up (Week 26)|Death|0|||
161974514|NCT00624780|584954765|FG002|Follow-up (Week 26)|Death|1|||
161974515|NCT00624780|584954766|FG003|Follow-up (Week 26)|Death|0|||
161974516|NCT00624780|584954767|FG004|Follow-up (Week 26)|Death|0|||
161974517|NCT00624780|584954768|FG005|Follow-up (Week 26)|Death|0|||
161974518|NCT00624780|584954763|FG000|Follow-up (Week 26)|Adverse Event|0|||
161974519|NCT00624780|584954764|FG001|Follow-up (Week 26)|Adverse Event|0|||
161974520|NCT00624780|584954765|FG002|Follow-up (Week 26)|Adverse Event|0|||
161974521|NCT00624780|584954766|FG003|Follow-up (Week 26)|Adverse Event|0|||
161974522|NCT00624780|584954767|FG004|Follow-up (Week 26)|Adverse Event|1|||
161974523|NCT00624780|584954768|FG005|Follow-up (Week 26)|Adverse Event|0|||
161974524|NCT00624780|584954763|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
161974525|NCT00624780|584954764|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
161974526|NCT00624780|584954765|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
161974527|NCT00624780|584954766|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
161974528|NCT00624780|584954767|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
161974529|NCT00624780|584954768|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
161974530|NCT00624780|584954763|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
161974531|NCT00624780|584954764|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
161974532|NCT00624780|584954765|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
161974533|NCT00624780|584954766|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
161974534|NCT00624780|584954767|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
161974535|NCT00624780|584954768|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
161974536|NCT00624780|584954763|FG000|Follow-up (Week 26)|Other|1|||
161974537|NCT00624780|584954764|FG001|Follow-up (Week 26)|Other|1|||
161974538|NCT00624780|584954765|FG002|Follow-up (Week 26)|Other|0|||
161974539|NCT00624780|584954766|FG003|Follow-up (Week 26)|Other|0|||
161974540|NCT00624780|584954767|FG004|Follow-up (Week 26)|Other|0|||
161974541|NCT00624780|584954768|FG005|Follow-up (Week 26)|Other|0|||
161974542|NCT04068519|584954770|FG000|Dose Verification|Death|15|||
161974543|NCT04068519|584954770|FG000|Dose Verification|Withdrawal by Subject|1|||
161974544|NCT04068519|584954770|FG000|Pharmacokinetic Sub-study|Death|35|||
161974545|NCT04068519|584954770|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
161974546|NCT04068519|584954770|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
161974547|NCT04068519|584954770|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
161974548|NCT04068519|584954770|FG000|Indication Expansion|Death|152|||
161974549|NCT04068519|584954770|FG000|Indication Expansion|Withdrawal by Subject|10|||
161974550|NCT04068519|584954770|FG000|Indication Expansion|Lost to Follow-up|7|||
161974551|NCT00969761|584954771|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
161974552|NCT00969761|584954772|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161974553|NCT00969761|584954773|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161974554|NCT00969761|584954774|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
161974555|NCT00969761|584954775|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161974556|NCT00969761|584954776|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161974557|NCT00969761|584954777|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161974558|NCT00969761|584954778|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161974559|NCT00969761|584954779|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
161974560|NCT00969761|584954780|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
161974561|NCT00969761|584954781|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161974562|NCT00969761|584954782|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
161974563|NCT00969761|584954771|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161974564|NCT00969761|584954772|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161974565|NCT00969761|584954773|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
161974566|NCT00969761|584954774|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161974567|NCT00969761|584954775|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161974568|NCT00969761|584954776|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161766709|NCT00635804|584187199|FG007|Overall Study|Adverse Event|0|||
161766710|NCT00635804|584187192|FG000|Overall Study|Withdrawal by Subject|1|||
161974569|NCT00969761|584954777|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
162034135|NCT04393298|585181152|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161974570|NCT00969761|584954778|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161974571|NCT00969761|584954779|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161974572|NCT00969761|584954780|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161766711|NCT00635804|584187193|FG001|Overall Study|Withdrawal by Subject|0|||
161974573|NCT00969761|584954781|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161854332|NCT00996892|584506382|FG002|Expansion Stage 2A|Disease Progression|0|||
161854333|NCT00996892|584506383|FG003|Expansion Stage 2A|Disease Progression|0|||
161854334|NCT00996892|584506384|FG004|Expansion Stage 2A|Disease Progression|0|||
161854335|NCT00996892|584506385|FG005|Expansion Stage 2A|Disease Progression|0|||
161854336|NCT00996892|584506386|FG006|Expansion Stage 2A|Disease Progression|0|||
161854337|NCT00996892|584506387|FG007|Expansion Stage 2A|Disease Progression|0|||
161854338|NCT00996892|584506388|FG008|Expansion Stage 2A|Disease Progression|0|||
161854339|NCT00996892|584506389|FG009|Expansion Stage 2A|Disease Progression|0|||
161854340|NCT00996892|584506390|FG010|Expansion Stage 2A|Disease Progression|0|||
161854341|NCT00996892|584506391|FG011|Expansion Stage 2A|Disease Progression|0|||
161854342|NCT00996892|584506392|FG012|Expansion Stage 2A|Disease Progression|0|||
161854343|NCT00996892|584506393|FG013|Expansion Stage 2A|Disease Progression|0|||
161854344|NCT00996892|584506394|FG014|Expansion Stage 2A|Disease Progression|0|||
161854345|NCT00996892|584506395|FG015|Expansion Stage 2A|Disease Progression|0|||
161854346|NCT00996892|584506396|FG016|Expansion Stage 2A|Disease Progression|0|||
161854347|NCT00996892|584506397|FG017|Expansion Stage 2A|Disease Progression|0|||
161854348|NCT00996892|584506398|FG018|Expansion Stage 2A|Disease Progression|0|||
161854349|NCT00996892|584506399|FG019|Expansion Stage 2A|Disease Progression|31|||
161854350|NCT00993421|584506400|FG000|Overall Study|Adverse Event|2|||
161854351|NCT00993421|584506401|FG001|Overall Study|Adverse Event|7|||
161854352|NCT00993421|584506402|FG002|Overall Study|Adverse Event|6|||
161854353|NCT00993421|584506403|FG003|Overall Study|Adverse Event|9|||
161854354|NCT00993421|584506404|FG004|Overall Study|Adverse Event|5|||
161854355|NCT00993421|584506405|FG005|Overall Study|Adverse Event|7|||
161854356|NCT00993421|584506406|FG006|Overall Study|Adverse Event|1|||
161854357|NCT00993421|584506400|FG000|Overall Study|Sponsor Decision|36|||
161854358|NCT00993421|584506401|FG001|Overall Study|Sponsor Decision|31|||
161854359|NCT00993421|584506402|FG002|Overall Study|Sponsor Decision|28|||
161854360|NCT00993421|584506403|FG003|Overall Study|Sponsor Decision|30|||
161854361|NCT00993421|584506404|FG004|Overall Study|Sponsor Decision|38|||
161854362|NCT00993421|584506405|FG005|Overall Study|Sponsor Decision|30|||
161854363|NCT00993421|584506406|FG006|Overall Study|Sponsor Decision|29|||
161854364|NCT00993421|584506400|FG000|Overall Study|Lost to Follow-up|3|||
161854365|NCT00993421|584506401|FG001|Overall Study|Lost to Follow-up|5|||
161854366|NCT00993421|584506402|FG002|Overall Study|Lost to Follow-up|5|||
161854367|NCT00993421|584506403|FG003|Overall Study|Lost to Follow-up|0|||
161854368|NCT00993421|584506404|FG004|Overall Study|Lost to Follow-up|0|||
161854369|NCT00993421|584506405|FG005|Overall Study|Lost to Follow-up|0|||
161854370|NCT00993421|584506406|FG006|Overall Study|Lost to Follow-up|6|||
161854371|NCT00993421|584506400|FG000|Overall Study|Withdrawal by Subject|3|||
161854372|NCT00993421|584506401|FG001|Overall Study|Withdrawal by Subject|2|||
161854373|NCT00993421|584506402|FG002|Overall Study|Withdrawal by Subject|3|||
161854374|NCT00993421|584506403|FG003|Overall Study|Withdrawal by Subject|3|||
161854375|NCT00993421|584506404|FG004|Overall Study|Withdrawal by Subject|3|||
161854376|NCT00993421|584506405|FG005|Overall Study|Withdrawal by Subject|5|||
161854377|NCT00993421|584506406|FG006|Overall Study|Withdrawal by Subject|3|||
161854378|NCT00993421|584506400|FG000|Overall Study|Death|0|||
161854379|NCT00993421|584506401|FG001|Overall Study|Death|0|||
161854380|NCT00993421|584506402|FG002|Overall Study|Death|0|||
161854381|NCT00993421|584506403|FG003|Overall Study|Death|0|||
161854382|NCT00993421|584506404|FG004|Overall Study|Death|0|||
161854383|NCT00993421|584506405|FG005|Overall Study|Death|0|||
161854384|NCT00993421|584506406|FG006|Overall Study|Death|1|||
161854385|NCT00993421|584506400|FG000|Overall Study|Entry Criteria Exclusion|0|||
161854386|NCT00993421|584506401|FG001|Overall Study|Entry Criteria Exclusion|0|||
161854387|NCT00993421|584506402|FG002|Overall Study|Entry Criteria Exclusion|1|||
161854388|NCT00993421|584506403|FG003|Overall Study|Entry Criteria Exclusion|3|||
161854389|NCT00993421|584506404|FG004|Overall Study|Entry Criteria Exclusion|0|||
161854390|NCT00993421|584506405|FG005|Overall Study|Entry Criteria Exclusion|1|||
161854391|NCT00993421|584506406|FG006|Overall Study|Entry Criteria Exclusion|0|||
161854392|NCT00993421|584506400|FG000|Overall Study|Physician Decision|0|||
161974574|NCT00969761|584954782|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
161974575|NCT00969761|584954771|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161974576|NCT00969761|584954772|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161974577|NCT00969761|584954773|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
161854393|NCT00993421|584506401|FG001|Overall Study|Physician Decision|0|||
161854394|NCT00993421|584506402|FG002|Overall Study|Physician Decision|0|||
161854395|NCT00993421|584506403|FG003|Overall Study|Physician Decision|0|||
161854396|NCT00993421|584506404|FG004|Overall Study|Physician Decision|0|||
161854397|NCT00993421|584506405|FG005|Overall Study|Physician Decision|1|||
161854398|NCT00993421|584506406|FG006|Overall Study|Physician Decision|1|||
161854399|NCT00993421|584506400|FG000|Overall Study|Protocol Violation|0|||
161854400|NCT00993421|584506401|FG001|Overall Study|Protocol Violation|0|||
161854401|NCT00993421|584506402|FG002|Overall Study|Protocol Violation|0|||
161854402|NCT00993421|584506403|FG003|Overall Study|Protocol Violation|0|||
161854403|NCT00993421|584506404|FG004|Overall Study|Protocol Violation|0|||
161854404|NCT00993421|584506405|FG005|Overall Study|Protocol Violation|2|||
161854405|NCT00993421|584506406|FG006|Overall Study|Protocol Violation|1|||
161854406|NCT02759692|584506407|FG000|Period 1|Test article no longer available|1|||
161854407|NCT02759692|584506408|FG001|Period 1|Test article no longer available|1|||
161854408|NCT02759692|584506407|FG000|Period 1|No longer meets eligibility criteria.|1|||
161854409|NCT02759692|584506408|FG001|Period 1|No longer meets eligibility criteria.|0|||
161854410|NCT02759692|584506407|FG000|Period 1|Miss-Randomized|1|||
161854411|NCT02759692|584506408|FG001|Period 1|Miss-Randomized|1|||
161854412|NCT02759692|584506407|FG000|Period 2|Lost to Follow-up|1|||
161854413|NCT02759692|584506408|FG001|Period 2|Lost to Follow-up|0|||
161854414|NCT02759692|584506407|FG000|Period 2|Test article no longer available|0|||
161854415|NCT02759692|584506408|FG001|Period 2|Test article no longer available|1|||
161854416|NCT04042376|584506414|FG000|Overall Study|Withdrawal by Subject|1|||
161854417|NCT04042376|584506414|FG000|Overall Study|Death|3|||
161854418|NCT02514447|584508039|FG000|Overall Study|Withdrawal by Subject|3|||
161854419|NCT02514447|584508040|FG001|Overall Study|Withdrawal by Subject|1|||
161854420|NCT02514447|584508041|FG002|Overall Study|Withdrawal by Subject|1|||
161854421|NCT02514447|584508042|FG003|Overall Study|Withdrawal by Subject|0|||
161854422|NCT02514447|584508043|FG004|Overall Study|Withdrawal by Subject|0|||
161854423|NCT02514447|584508044|FG005|Overall Study|Withdrawal by Subject|0|||
161854424|NCT02514447|584508045|FG006|Overall Study|Withdrawal by Subject|0|||
161854425|NCT02514447|584508046|FG007|Overall Study|Withdrawal by Subject|1|||
161854426|NCT02514447|584508047|FG008|Overall Study|Withdrawal by Subject|1|||
161854427|NCT02514447|584508039|FG000|Overall Study|Death|24|||
161854428|NCT02514447|584508040|FG001|Overall Study|Death|28|||
161854429|NCT02514447|584508041|FG002|Overall Study|Death|29|||
161854430|NCT02514447|584508042|FG003|Overall Study|Death|0|||
161854431|NCT02514447|584508043|FG004|Overall Study|Death|3|||
161854432|NCT02514447|584508044|FG005|Overall Study|Death|4|||
161854433|NCT02514447|584508045|FG006|Overall Study|Death|8|||
161854434|NCT02514447|584508046|FG007|Overall Study|Death|6|||
161974578|NCT00969761|584954774|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161974579|NCT00969761|584954775|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161974580|NCT00969761|584954776|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161974581|NCT00969761|584954777|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161974582|NCT00969761|584954778|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161974583|NCT00969761|584954779|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161974584|NCT00969761|584954780|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161766712|NCT00635804|584187194|FG002|Overall Study|Withdrawal by Subject|0|||
161766713|NCT00635804|584187195|FG003|Overall Study|Withdrawal by Subject|0|||
161766714|NCT00635804|584187196|FG004|Overall Study|Withdrawal by Subject|0|||
161766715|NCT00635804|584187197|FG005|Overall Study|Withdrawal by Subject|0|||
161766716|NCT00635804|584187198|FG006|Overall Study|Withdrawal by Subject|0|||
161766717|NCT00635804|584187199|FG007|Overall Study|Withdrawal by Subject|0|||
161766718|NCT01425268|584187207|FG000|Overall Study|Withdrawal by Subject|2|||
161766719|NCT01425268|584187208|FG001|Overall Study|Withdrawal by Subject|0|||
161766720|NCT01425268|584187207|FG000|Overall Study|Sponsor Decision|5|||
161766721|NCT01425268|584187208|FG001|Overall Study|Sponsor Decision|0|||
161766722|NCT01425268|584187207|FG000|Overall Study|Physician Decision|1|||
161766723|NCT01425268|584187208|FG001|Overall Study|Physician Decision|0|||
161766724|NCT00719706|584187209|FG000|Overall Study|Adverse Event|5|||
161766725|NCT00719706|584187210|FG001|Overall Study|Adverse Event|4|||
161766726|NCT00719706|584187209|FG000|Overall Study|Withdrawal by Subject|1|||
161766727|NCT00719706|584187210|FG001|Overall Study|Withdrawal by Subject|2|||
161766728|NCT00719706|584187209|FG000|Overall Study|Protocol Violation|3|||
161766729|NCT00719706|584187210|FG001|Overall Study|Protocol Violation|0|||
161766730|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
161766731|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
161766732|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
161766733|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
161766734|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
161766735|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
161766736|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
161766737|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
161766738|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
161766739|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
161854435|NCT02514447|584508047|FG008|Overall Study|Death|5|||
161854436|NCT02514447|584508039|FG000|Overall Study|Lost to Follow-up|1|||
161854437|NCT02514447|584508040|FG001|Overall Study|Lost to Follow-up|0|||
161766740|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
161766741|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
161854438|NCT02514447|584508041|FG002|Overall Study|Lost to Follow-up|0|||
161766742|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
161854439|NCT02514447|584508042|FG003|Overall Study|Lost to Follow-up|0|||
161854440|NCT02514447|584508043|FG004|Overall Study|Lost to Follow-up|0|||
161974585|NCT00969761|584954781|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161974586|NCT00969761|584954782|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
161974587|NCT00969761|584954771|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161766743|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
161766744|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
161766745|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|Other|6|||
161766746|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|Other|6|||
161766747|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|Other|7|||
161766748|NCT02681094|584187211|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
161766749|NCT02681094|584187212|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
161766750|NCT02681094|584187213|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
161766751|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|Participant decision|7|||
161766752|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|Participant decision|10|||
161766753|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|Participant decision|9|||
161766754|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
161766755|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
161766756|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
161766757|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
161766758|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
161766759|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
161766760|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
161766761|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
161766762|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
161766763|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
161766764|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
161766765|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
161766766|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|Other|6|||
161766767|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|Other|6|||
161766768|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|Other|7|||
161766769|NCT02681094|584187211|FG000|2 - Enrolled Participants Set|No treatment given|0|||
161766770|NCT02681094|584187212|FG001|2 - Enrolled Participants Set|No treatment given|1|||
161766771|NCT02681094|584187213|FG002|2 - Enrolled Participants Set|No treatment given|1|||
161766772|NCT01072175|584187214|FG000|Part A (Drug-Drug Interaction)|Death|1|||
161766773|NCT01072175|584187215|FG001|Part A (Drug-Drug Interaction)|Death|0|||
161766774|NCT01072175|584187216|FG002|Part A (Drug-Drug Interaction)|Death|0|||
161766775|NCT01072175|584187217|FG003|Part A (Drug-Drug Interaction)|Death|0|||
161766776|NCT01072175|584187218|FG004|Part A (Drug-Drug Interaction)|Death|0|||
161766777|NCT01072175|584187219|FG005|Part A (Drug-Drug Interaction)|Death|0|||
161766778|NCT01072175|584187220|FG006|Part A (Drug-Drug Interaction)|Death|0|||
161766779|NCT01072175|584187221|FG007|Part A (Drug-Drug Interaction)|Death|0|||
161766780|NCT01072175|584187222|FG008|Part A (Drug-Drug Interaction)|Death|0|||
161766781|NCT01072175|584187223|FG009|Part A (Drug-Drug Interaction)|Death|0|||
161766782|NCT01072175|584187224|FG010|Part A (Drug-Drug Interaction)|Death|0|||
161766783|NCT01072175|584187225|FG011|Part A (Drug-Drug Interaction)|Death|0|||
161766784|NCT01072175|584187226|FG012|Part A (Drug-Drug Interaction)|Death|0|||
161766785|NCT01072175|584187214|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
161766786|NCT01072175|584187215|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766787|NCT01072175|584187216|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766788|NCT01072175|584187217|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766789|NCT01072175|584187218|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766790|NCT01072175|584187219|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766791|NCT01072175|584187220|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766792|NCT01072175|584187221|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766793|NCT01072175|584187222|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766794|NCT01072175|584187223|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766795|NCT01072175|584187224|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161854441|NCT02514447|584508044|FG005|Overall Study|Lost to Follow-up|0|||
161854442|NCT02514447|584508045|FG006|Overall Study|Lost to Follow-up|0|||
161854443|NCT02514447|584508046|FG007|Overall Study|Lost to Follow-up|0|||
161854444|NCT02514447|584508047|FG008|Overall Study|Lost to Follow-up|1|||
161974588|NCT00969761|584954772|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161974589|NCT00969761|584954773|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161766796|NCT01072175|584187225|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766797|NCT01072175|584187226|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161766798|NCT01072175|584187214|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
161766799|NCT01072175|584187215|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766800|NCT01072175|584187216|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766801|NCT01072175|584187217|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161974590|NCT00969761|584954774|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161974591|NCT00969761|584954775|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161974592|NCT00969761|584954776|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161974593|NCT00969761|584954777|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161974594|NCT00969761|584954778|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161974595|NCT00969761|584954779|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
161974596|NCT00969761|584954780|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161974597|NCT00969761|584954781|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161974598|NCT00969761|584954782|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
161974599|NCT00969761|584954771|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
161974600|NCT00969761|584954772|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
161974601|NCT00969761|584954773|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
161974602|NCT00969761|584954774|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
161974603|NCT00969761|584954775|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
161974604|NCT00969761|584954776|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
161974605|NCT00969761|584954777|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
161974606|NCT00969761|584954778|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
161974607|NCT00969761|584954779|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
161974608|NCT00969761|584954780|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
161974609|NCT00969761|584954781|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
161974610|NCT00969761|584954782|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
161974611|NCT00969761|584954771|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161974612|NCT00969761|584954772|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161974613|NCT00969761|584954773|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161974614|NCT00969761|584954774|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
161974615|NCT00969761|584954775|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
161974616|NCT00969761|584954776|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161974617|NCT00969761|584954777|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161974618|NCT00969761|584954778|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161974619|NCT00969761|584954779|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
161974620|NCT00969761|584954780|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161974621|NCT00969761|584954781|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161974622|NCT00969761|584954782|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
161974623|NCT00570037|584956405|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
161974624|NCT00570037|584956406|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
161974625|NCT03946124|584956407|FG000|Overall Study|Withdrawal by Subject|19|||
161974626|NCT02118597|584956416|FG000|Overall Study|Sponsor terminated the study|14|||
161974627|NCT02118597|584956416|FG000|Overall Study|Serious Adverse Event|1|||
161974628|NCT02118597|584956416|FG000|Overall Study|Investigator's decision|1|||
161974629|NCT01891344|584956417|FG000|Overall Study|Ongoing|6|||
161974630|NCT01891344|584956418|FG001|Overall Study|Ongoing|2|||
161974631|NCT01891344|584956419|FG002|Overall Study|Ongoing|0|||
161974632|NCT01891344|584956420|FG003|Overall Study|Ongoing|1|||
161974633|NCT01891344|584956421|FG004|Overall Study|Ongoing|4|||
161974634|NCT01891344|584956422|FG005|Overall Study|Ongoing|1|||
161974635|NCT01891344|584956423|FG006|Overall Study|Ongoing|0|||
161766802|NCT01072175|584187218|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766803|NCT01072175|584187219|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766804|NCT01072175|584187220|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766805|NCT01072175|584187221|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766806|NCT01072175|584187222|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766807|NCT01072175|584187223|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766808|NCT01072175|584187224|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766809|NCT01072175|584187225|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766810|NCT01072175|584187226|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161766811|NCT01072175|584187214|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
161766812|NCT01072175|584187215|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
161766813|NCT01072175|584187216|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
161766814|NCT01072175|584187217|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
161766815|NCT01072175|584187218|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
161766816|NCT01072175|584187219|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
161766817|NCT01072175|584187220|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
161766818|NCT01072175|584187221|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
161766819|NCT01072175|584187222|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
161766820|NCT01072175|584187223|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
161766821|NCT01072175|584187224|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
161766822|NCT01072175|584187225|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
161766823|NCT01072175|584187226|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
161854445|NCT02514447|584508039|FG000|Overall Study|Sponsor Termination of Study|0|||
161854446|NCT02514447|584508040|FG001|Overall Study|Sponsor Termination of Study|1|||
161854447|NCT02514447|584508041|FG002|Overall Study|Sponsor Termination of Study|1|||
161854448|NCT02514447|584508042|FG003|Overall Study|Sponsor Termination of Study|0|||
161854449|NCT02514447|584508043|FG004|Overall Study|Sponsor Termination of Study|0|||
161854450|NCT02514447|584508044|FG005|Overall Study|Sponsor Termination of Study|0|||
161854451|NCT02514447|584508045|FG006|Overall Study|Sponsor Termination of Study|0|||
161854452|NCT02514447|584508046|FG007|Overall Study|Sponsor Termination of Study|0|||
161854453|NCT02514447|584508047|FG008|Overall Study|Sponsor Termination of Study|0|||
161854454|NCT02514447|584508039|FG000|Overall Study|Study completion per Investigator|1|||
161854455|NCT02514447|584508040|FG001|Overall Study|Study completion per Investigator|0|||
161854456|NCT02514447|584508041|FG002|Overall Study|Study completion per Investigator|1|||
161854457|NCT02514447|584508042|FG003|Overall Study|Study completion per Investigator|2|||
161854458|NCT02514447|584508043|FG004|Overall Study|Study completion per Investigator|0|||
161854459|NCT02514447|584508044|FG005|Overall Study|Study completion per Investigator|0|||
161854460|NCT02514447|584508045|FG006|Overall Study|Study completion per Investigator|0|||
161854461|NCT02514447|584508046|FG007|Overall Study|Study completion per Investigator|0|||
161854462|NCT02514447|584508047|FG008|Overall Study|Study completion per Investigator|1|||
161854463|NCT01434810|584508055|FG000|Overall Study|Did not receive treatment|11|||
161854464|NCT01434810|584508056|FG001|Overall Study|Did not receive treatment|3|||
161854465|NCT01434810|584508055|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
161854466|NCT01434810|584508056|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
161854467|NCT02794870|584508058|FG000|Overall Study|Withdrawal by Subject|2|||
161854468|NCT02794870|584508059|FG001|Overall Study|Withdrawal by Subject|0|||
161854469|NCT02540083|584508066|FG000|Overall Study|Withdrawal by Subject|16|||
161854470|NCT02301390|584508067|FG000|Overall Study|Withdrawal by Subject|3|||
161854471|NCT02301390|584508068|FG001|Overall Study|Withdrawal by Subject|5|||
161854472|NCT02301390|584508067|FG000|Overall Study|Protocol Violation|1|||
161854473|NCT02301390|584508068|FG001|Overall Study|Protocol Violation|0|||
161854474|NCT02301390|584508067|FG000|Overall Study|Physician Decision|1|||
161854475|NCT02301390|584508068|FG001|Overall Study|Physician Decision|0|||
161854476|NCT02301390|584508067|FG000|Overall Study|Lost to Follow-up|0|||
161854477|NCT02301390|584508068|FG001|Overall Study|Lost to Follow-up|1|||
161854478|NCT02301390|584508067|FG000|Overall Study|Death|2|||
161854479|NCT02301390|584508068|FG001|Overall Study|Death|2|||
161854480|NCT02301390|584508067|FG000|Overall Study|Procedure not completed|0|||
161854481|NCT02301390|584508068|FG001|Overall Study|Procedure not completed|4|||
161854482|NCT02301390|584508067|FG000|Overall Study|Missed multiple visits|1|||
161854483|NCT02301390|584508068|FG001|Overall Study|Missed multiple visits|1|||
161854484|NCT02301390|584508067|FG000|Overall Study|study terminated|2|||
161854485|NCT02301390|584508068|FG001|Overall Study|study terminated|0|||
161854486|NCT00185588|584508069|FG000|Overall Study|Adverse Event|3|||
161854487|NCT00185588|584508070|FG001|Overall Study|Adverse Event|1|||
161854488|NCT00185588|584508071|FG002|Overall Study|Adverse Event|4|||
161854489|NCT00185588|584508072|FG003|Overall Study|Adverse Event|2|||
161854490|NCT00185588|584508069|FG000|Overall Study|Lost to Follow-up|0|||
161854491|NCT00185588|584508070|FG001|Overall Study|Lost to Follow-up|0|||
161854492|NCT00185588|584508071|FG002|Overall Study|Lost to Follow-up|1|||
161854493|NCT00185588|584508072|FG003|Overall Study|Lost to Follow-up|2|||
161854494|NCT00185588|584508069|FG000|Overall Study|Withdrawal by Subject|0|||
161854495|NCT00185588|584508070|FG001|Overall Study|Withdrawal by Subject|1|||
161854496|NCT00185588|584508071|FG002|Overall Study|Withdrawal by Subject|0|||
161854497|NCT00185588|584508072|FG003|Overall Study|Withdrawal by Subject|0|||
161854498|NCT00185588|584508069|FG000|Overall Study|Physician Decision|0|||
161854499|NCT00185588|584508070|FG001|Overall Study|Physician Decision|0|||
161854500|NCT00185588|584508071|FG002|Overall Study|Physician Decision|1|||
161854501|NCT00185588|584508072|FG003|Overall Study|Physician Decision|0|||
161854502|NCT00398866|584508073|FG000|Overall Study|Adverse Event|1|||
161854503|NCT00398866|584508074|FG001|Overall Study|Adverse Event|0|||
161854504|NCT00398866|584508075|FG002|Overall Study|Adverse Event|0|||
161854505|NCT00398866|584508073|FG000|Overall Study|Lack of Efficacy|0|||
161854506|NCT00398866|584508074|FG001|Overall Study|Lack of Efficacy|0|||
161854507|NCT00398866|584508075|FG002|Overall Study|Lack of Efficacy|1|||
161854508|NCT00398866|584508073|FG000|Overall Study|Lost to Follow-up|7|||
161854509|NCT00398866|584508074|FG001|Overall Study|Lost to Follow-up|6|||
161854510|NCT00398866|584508075|FG002|Overall Study|Lost to Follow-up|4|||
161854511|NCT00398866|584508073|FG000|Overall Study|Withdrawal by Subject|5|||
161854512|NCT00398866|584508074|FG001|Overall Study|Withdrawal by Subject|1|||
161854513|NCT00398866|584508075|FG002|Overall Study|Withdrawal by Subject|2|||
161854514|NCT00398866|584508073|FG000|Overall Study|Unable to complete requirements of study|1|||
161854515|NCT00398866|584508074|FG001|Overall Study|Unable to complete requirements of study|1|||
161854516|NCT00398866|584508075|FG002|Overall Study|Unable to complete requirements of study|1|||
161854517|NCT02481869|584508080|FG000|Overall Study|Lost to Follow-up|3|||
161854518|NCT02481869|584508081|FG001|Overall Study|Lost to Follow-up|4|||
161854519|NCT02481869|584508080|FG000|Overall Study|Withdrawal by Subject|2|||
161854520|NCT02481869|584508081|FG001|Overall Study|Withdrawal by Subject|0|||
161854521|NCT01153425|584508087|FG000|Overall Study|Withdrawal by Subject|3|||
161854522|NCT01153425|584508088|FG001|Overall Study|Withdrawal by Subject|3|||
161854523|NCT03154125|584508089|FG000|Overall Study|Lost to Follow-up|11|||
161854524|NCT03154125|584508090|FG001|Overall Study|Lost to Follow-up|11|||
161854525|NCT03154125|584508091|FG002|Overall Study|Lost to Follow-up|0|||
161854526|NCT03154125|584508089|FG000|Overall Study|Withdrawal by Subject|49|||
161854527|NCT03154125|584508090|FG001|Overall Study|Withdrawal by Subject|55|||
161854528|NCT03154125|584508091|FG002|Overall Study|Withdrawal by Subject|8|||
161854529|NCT03154125|584508089|FG000|Overall Study|Physician Decision|13|||
161854530|NCT03154125|584508090|FG001|Overall Study|Physician Decision|6|||
161854531|NCT03154125|584508091|FG002|Overall Study|Physician Decision|0|||
161854532|NCT03154125|584508089|FG000|Overall Study|Protocol Violation|3|||
161854533|NCT03154125|584508090|FG001|Overall Study|Protocol Violation|5|||
161854534|NCT03154125|584508091|FG002|Overall Study|Protocol Violation|0|||
161854535|NCT00810511|584508092|FG000|Overall Study|Protocol Violation|0|||
161854536|NCT00810511|584508093|FG001|Overall Study|Protocol Violation|1|||
161854537|NCT00810511|584508092|FG000|Overall Study|Lack of Efficacy|9|||
161854538|NCT00810511|584508093|FG001|Overall Study|Lack of Efficacy|1|||
161854539|NCT00810511|584508092|FG000|Overall Study|death in the family|0|||
161854540|NCT00810511|584508093|FG001|Overall Study|death in the family|1|||
161854541|NCT00810511|584508092|FG000|Overall Study|Lost to Follow-up|1|||
161854542|NCT00810511|584508093|FG001|Overall Study|Lost to Follow-up|0|||
161854543|NCT00810511|584508092|FG000|Overall Study|deposits on contact lens|0|||
161854544|NCT00810511|584508093|FG001|Overall Study|deposits on contact lens|1|||
161854545|NCT04342819|584508095|FG000|Overall Study|Declined|4|||
161854546|NCT04342819|584508095|FG000|Overall Study|Not meeeting selection criteria|1|||
161854547|NCT00911300|584508096|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
161854548|NCT00911300|584508097|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
161854549|NCT00911300|584508096|FG000|Overall Study|Death|1|||
161854550|NCT00911300|584508097|FG001|Overall Study|Death|0|||
161854551|NCT00911300|584508096|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
161854552|NCT00911300|584508097|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
161854553|NCT00911300|584508096|FG000|Overall Study|Adverse Event|14|||
161854554|NCT00911300|584508097|FG001|Overall Study|Adverse Event|6|||
161854555|NCT00911300|584508096|FG000|Overall Study|Protocol Violation|3|||
161854556|NCT00911300|584508097|FG001|Overall Study|Protocol Violation|2|||
161854557|NCT00911300|584508096|FG000|Overall Study|Consent Withdrawn|4|||
161854558|NCT00911300|584508097|FG001|Overall Study|Consent Withdrawn|12|||
161854559|NCT00911300|584508096|FG000|Overall Study|Coronary Angiography Performed|1|||
161854560|NCT00911300|584508097|FG001|Overall Study|Coronary Angiography Performed|0|||
161854561|NCT00911300|584508096|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
161854562|NCT00911300|584508097|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
161766824|NCT01072175|584187214|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766825|NCT01072175|584187215|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766826|NCT01072175|584187216|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
161766827|NCT01072175|584187217|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766828|NCT01072175|584187218|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
161766829|NCT01072175|584187219|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766830|NCT01072175|584187220|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766831|NCT01072175|584187221|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766832|NCT01072175|584187222|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766833|NCT01072175|584187223|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766834|NCT01072175|584187224|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766835|NCT01072175|584187225|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766836|NCT01072175|584187226|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161766837|NCT01072175|584187214|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766838|NCT01072175|584187215|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
161766839|NCT01072175|584187216|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766840|NCT01072175|584187217|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
161766841|NCT01072175|584187218|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
161766842|NCT01072175|584187219|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766843|NCT01072175|584187220|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766844|NCT01072175|584187221|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766845|NCT01072175|584187222|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766846|NCT01072175|584187223|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161854563|NCT00911300|584508096|FG000|Overall Study|Received Commercial Treatment|1|||
161974636|NCT01891344|584956424|FG007|Overall Study|Ongoing|0|||
161766847|NCT01072175|584187224|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161854564|NCT00911300|584508097|FG001|Overall Study|Received Commercial Treatment|0|||
161854565|NCT00911300|584508096|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
161854566|NCT00911300|584508097|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
161974637|NCT01852825|584956425|FG000|Overall Study|Withdrawal by Subject|2|||
161854567|NCT00911300|584508096|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
162034136|NCT04393298|585181153|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
161766848|NCT01072175|584187225|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766849|NCT01072175|584187226|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161766850|NCT01072175|584187214|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766851|NCT01072175|584187215|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766852|NCT01072175|584187216|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
161766853|NCT01072175|584187217|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
161766854|NCT01072175|584187218|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
161766855|NCT01072175|584187219|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766856|NCT01072175|584187220|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766857|NCT01072175|584187221|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766858|NCT01072175|584187222|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766859|NCT01072175|584187223|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766860|NCT01072175|584187224|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766861|NCT01072175|584187225|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766862|NCT01072175|584187226|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161766863|NCT01072175|584187214|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766864|NCT01072175|584187215|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
161766865|NCT01072175|584187216|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766866|NCT01072175|584187217|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
161766867|NCT01072175|584187218|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
161766868|NCT01072175|584187219|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766869|NCT01072175|584187220|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766870|NCT01072175|584187221|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766871|NCT01072175|584187222|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766872|NCT01072175|584187223|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766873|NCT01072175|584187224|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766874|NCT01072175|584187225|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766875|NCT01072175|584187226|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161766876|NCT01072175|584187214|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
161766877|NCT01072175|584187215|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
161766878|NCT01072175|584187216|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
161766879|NCT01072175|584187217|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
161766880|NCT01072175|584187218|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
161766881|NCT01072175|584187219|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
161766882|NCT01072175|584187220|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
161766883|NCT01072175|584187221|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
161766884|NCT01072175|584187222|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
161766885|NCT01072175|584187223|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
161766886|NCT01072175|584187224|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
161766887|NCT01072175|584187225|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
161766888|NCT01072175|584187226|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
161766889|NCT01072175|584187214|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766890|NCT01072175|584187215|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766891|NCT01072175|584187216|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766892|NCT01072175|584187217|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766893|NCT01072175|584187218|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766894|NCT01072175|584187219|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
161766895|NCT01072175|584187220|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
161766896|NCT01072175|584187221|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
161766897|NCT01072175|584187222|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766898|NCT01072175|584187223|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766899|NCT01072175|584187224|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766900|NCT01072175|584187225|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766901|NCT01072175|584187226|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161766902|NCT01072175|584187214|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766903|NCT01072175|584187215|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766904|NCT01072175|584187216|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766905|NCT01072175|584187217|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766906|NCT01072175|584187218|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766907|NCT01072175|584187219|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766908|NCT01072175|584187220|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
161766909|NCT01072175|584187221|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
161766910|NCT01072175|584187222|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766911|NCT01072175|584187223|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
162034137|NCT04393298|585181154|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
162034138|NCT04393298|585181155|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
162034139|NCT04393298|585181156|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
162034140|NCT04393298|585181157|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
162034141|NCT04393298|585181158|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
162034142|NCT04393298|585181144|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
162034143|NCT04393298|585181145|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
162034144|NCT04393298|585181146|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
162034145|NCT04393298|585181147|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
162034146|NCT04393298|585181148|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
162034147|NCT04393298|585181149|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
162034148|NCT04393298|585181150|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
162034149|NCT04393298|585181151|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
162034150|NCT04393298|585181152|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
162034151|NCT04393298|585181153|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
162034152|NCT04393298|585181154|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
162034153|NCT04393298|585181155|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
162034154|NCT04393298|585181156|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
162034155|NCT04393298|585181157|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
162034156|NCT04393298|585181158|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
161766912|NCT01072175|584187224|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766913|NCT01072175|584187225|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766914|NCT01072175|584187226|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161766915|NCT01072175|584187214|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766916|NCT01072175|584187215|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766917|NCT01072175|584187216|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766918|NCT01072175|584187217|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766919|NCT01072175|584187218|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766920|NCT01072175|584187219|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
161766921|NCT01072175|584187220|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
161766922|NCT01072175|584187221|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
161766923|NCT01072175|584187222|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766924|NCT01072175|584187223|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766925|NCT01072175|584187224|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766926|NCT01072175|584187225|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766927|NCT01072175|584187226|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161766928|NCT01072175|584187214|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766929|NCT01072175|584187215|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766930|NCT01072175|584187216|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766931|NCT01072175|584187217|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766932|NCT01072175|584187218|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766933|NCT01072175|584187219|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
161766934|NCT01072175|584187220|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
161766935|NCT01072175|584187221|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766936|NCT01072175|584187222|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766937|NCT01072175|584187223|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766938|NCT01072175|584187224|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766939|NCT01072175|584187225|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766940|NCT01072175|584187226|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161766941|NCT01072175|584187214|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766942|NCT01072175|584187215|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766943|NCT01072175|584187216|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766944|NCT01072175|584187217|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766945|NCT01072175|584187218|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766946|NCT01072175|584187219|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766947|NCT01072175|584187220|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766948|NCT01072175|584187221|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766949|NCT01072175|584187222|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
161766950|NCT01072175|584187223|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766951|NCT01072175|584187224|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766952|NCT01072175|584187225|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766953|NCT01072175|584187226|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161766954|NCT01072175|584187214|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766955|NCT01072175|584187215|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766956|NCT01072175|584187216|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161974638|NCT01852825|584956426|FG001|Overall Study|Withdrawal by Subject|0|||
161974639|NCT01852825|584956427|FG002|Overall Study|Withdrawal by Subject|0|||
161766957|NCT01072175|584187217|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766958|NCT01072175|584187218|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766959|NCT01072175|584187219|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766960|NCT01072175|584187220|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766961|NCT01072175|584187221|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766962|NCT01072175|584187222|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
161766963|NCT01072175|584187223|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766964|NCT01072175|584187224|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766965|NCT01072175|584187225|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766966|NCT01072175|584187226|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161766967|NCT01072175|584187214|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766968|NCT01072175|584187215|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766969|NCT01072175|584187216|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766970|NCT01072175|584187217|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766971|NCT01072175|584187218|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766972|NCT01072175|584187219|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766973|NCT01072175|584187220|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766974|NCT01072175|584187221|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766975|NCT01072175|584187222|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
161766976|NCT01072175|584187223|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766977|NCT01072175|584187224|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766978|NCT01072175|584187225|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766979|NCT01072175|584187226|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161766980|NCT01072175|584187214|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766981|NCT01072175|584187215|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766982|NCT01072175|584187216|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766983|NCT01072175|584187217|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766984|NCT01072175|584187218|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766985|NCT01072175|584187219|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766986|NCT01072175|584187220|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766987|NCT01072175|584187221|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766988|NCT01072175|584187222|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
161766989|NCT01072175|584187223|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766990|NCT01072175|584187224|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766991|NCT01072175|584187225|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766992|NCT01072175|584187226|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161766993|NCT01072175|584187214|FG000|Part D (HPMC Capsules)|Death|0|||
161766994|NCT01072175|584187215|FG001|Part D (HPMC Capsules)|Death|0|||
161766995|NCT01072175|584187216|FG002|Part D (HPMC Capsules)|Death|0|||
161766996|NCT01072175|584187217|FG003|Part D (HPMC Capsules)|Death|0|||
161766997|NCT01072175|584187218|FG004|Part D (HPMC Capsules)|Death|0|||
161766998|NCT01072175|584187219|FG005|Part D (HPMC Capsules)|Death|0|||
161766999|NCT01072175|584187220|FG006|Part D (HPMC Capsules)|Death|0|||
161767000|NCT01072175|584187221|FG007|Part D (HPMC Capsules)|Death|0|||
161767001|NCT01072175|584187222|FG008|Part D (HPMC Capsules)|Death|0|||
161767002|NCT01072175|584187223|FG009|Part D (HPMC Capsules)|Death|10|||
161767003|NCT01072175|584187224|FG010|Part D (HPMC Capsules)|Death|12|||
161767004|NCT01072175|584187225|FG011|Part D (HPMC Capsules)|Death|28|||
161767005|NCT01072175|584187226|FG012|Part D (HPMC Capsules)|Death|26|||
161767006|NCT01072175|584187214|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
161767007|NCT01072175|584187215|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
161767008|NCT01072175|584187216|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
161767009|NCT01072175|584187217|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
161767010|NCT01072175|584187218|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
161767011|NCT01072175|584187219|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
161767012|NCT01072175|584187220|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
161767013|NCT01072175|584187221|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
161767014|NCT01072175|584187222|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
161767015|NCT01072175|584187223|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
161767016|NCT01072175|584187224|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
161767017|NCT01072175|584187225|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
161767018|NCT01072175|584187226|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
161767019|NCT01072175|584187214|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767020|NCT01072175|584187215|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767021|NCT01072175|584187216|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161974640|NCT01665430|584956428|FG000|Overall Study|Adverse Event|1|||
161854568|NCT00911300|584508097|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
161854569|NCT00911300|584508096|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
161854570|NCT00911300|584508097|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
161854571|NCT00911300|584508096|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
161854572|NCT00911300|584508097|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
161854573|NCT00911300|584508096|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
161854574|NCT00911300|584508097|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
161854575|NCT00911300|584508096|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
161854576|NCT00911300|584508097|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
161854577|NCT00911300|584508096|FG000|Overall Study|International Normalized Ratio Too High|0|||
161854578|NCT00911300|584508097|FG001|Overall Study|International Normalized Ratio Too High|1|||
161854579|NCT00911300|584508096|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
161854580|NCT00911300|584508097|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
161854581|NCT00911300|584508096|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
161854582|NCT00911300|584508097|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
161854583|NCT00911300|584508096|FG000|Overall Study|Physician Decision|0|||
161854584|NCT00911300|584508097|FG001|Overall Study|Physician Decision|1|||
161854585|NCT00911300|584508096|FG000|Overall Study|Treatment Stopped by Mistake|0|||
161854586|NCT00911300|584508097|FG001|Overall Study|Treatment Stopped by Mistake|1|||
161854587|NCT00911300|584508096|FG000|Overall Study|Randomized; No Study Medication Received|0|||
161854588|NCT00911300|584508097|FG001|Overall Study|Randomized; No Study Medication Received|2|||
161854589|NCT00666328|584508101|FG000|Overall Study|Death|2|||
161854590|NCT00666328|584508101|FG000|Overall Study|Lost to Follow-up|2|||
161854591|NCT00666328|584508101|FG000|Overall Study|No longer met eligibility criteria|1|||
161854592|NCT02288325|584508102|FG000|Run-in Period|Adverse Event|48|||
161854593|NCT02288325|584508103|FG001|Run-in Period|Adverse Event|0|||
161854594|NCT02288325|584508104|FG002|Run-in Period|Adverse Event|0|||
161854595|NCT02288325|584508102|FG000|Run-in Period|Lack of Efficacy|16|||
161854596|NCT02288325|584508103|FG001|Run-in Period|Lack of Efficacy|0|||
161974641|NCT01665430|584956428|FG000|Overall Study|Withdrawal by Subject|6|||
161974642|NCT01665430|584956428|FG000|Overall Study|Other Unspecified|2|||
161974643|NCT02310230|584956429|FG000|Overall Study|Physician Decision|1|||
161974644|NCT02310230|584956430|FG001|Overall Study|Physician Decision|3|||
161974645|NCT02310230|584956429|FG000|Overall Study|monitor baseline taken after induction|2|||
161974646|NCT02310230|584956430|FG001|Overall Study|monitor baseline taken after induction|7|||
161974647|NCT02310230|584956429|FG000|Overall Study|Poor signal quality|5|||
161974648|NCT02310230|584956430|FG001|Overall Study|Poor signal quality|8|||
161974649|NCT02310230|584956429|FG000|Overall Study|Case cancelled|1|||
161974650|NCT02310230|584956430|FG001|Overall Study|Case cancelled|0|||
161974651|NCT03593681|584956431|FG000|Overall Study|Inadequate sample collected|12|||
161974652|NCT03593681|584956431|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
161974653|NCT03593681|584956431|FG000|Overall Study|Protocol Violation|3|||
161974654|NCT03593681|584956431|FG000|Overall Study|Withdrawal by Subject|3|||
161974655|NCT03593681|584956431|FG000|Overall Study|Procedure not attempted|3|||
161974656|NCT03593681|584956431|FG000|Overall Study|Adverse Event|2|||
161974657|NCT03593681|584956431|FG000|Overall Study|Physician Decision|1|||
161974658|NCT01149486|584956434|FG000|First Intervention|Adverse Event|0|||
161974659|NCT01149486|584956435|FG001|First Intervention|Adverse Event|1|||
161974660|NCT04662073|584956436|FG000|Overall Study|Withdrawal by Subject|1|||
161974661|NCT04662073|584956437|FG001|Overall Study|Withdrawal by Subject|0|||
161974662|NCT00598078|584956440|FG000|Period 2 (Day 2)|Adverse Event|1|||
161974663|NCT00598078|584956441|FG001|Period 2 (Day 2)|Adverse Event|0|||
161974664|NCT01479595|584956445|FG000|Overall Study|Protocol deviation|0|||
161974665|NCT01479595|584956446|FG001|Overall Study|Protocol deviation|1|||
161974666|NCT01479595|584956445|FG000|Overall Study|Adverse Event|2|||
161974667|NCT01479595|584956446|FG001|Overall Study|Adverse Event|1|||
161974668|NCT03366103|584956447|FG000|Overall Study|Disease Progression|3|||
161974669|NCT03366103|584956448|FG001|Overall Study|Disease Progression|1|||
161974670|NCT03366103|584956449|FG002|Overall Study|Disease Progression|0|||
161974671|NCT03366103|584956447|FG000|Overall Study|Adverse Event|0|||
161974672|NCT03366103|584956448|FG001|Overall Study|Adverse Event|1|||
161974673|NCT03366103|584956449|FG002|Overall Study|Adverse Event|0|||
161974674|NCT02120365|584956450|FG000|Overall Study|Withdrawal by Subject|0|||
161974675|NCT02120365|584956451|FG001|Overall Study|Withdrawal by Subject|0|||
161974676|NCT02120365|584956452|FG002|Overall Study|Withdrawal by Subject|2|||
161974677|NCT02120365|584956453|FG003|Overall Study|Withdrawal by Subject|4|||
161974678|NCT02120365|584956454|FG004|Overall Study|Withdrawal by Subject|0|||
161974679|NCT02120365|584956455|FG005|Overall Study|Withdrawal by Subject|2|||
161974680|NCT01344629|584956458|FG000|Crossover Period 2|Withdrawal by Subject|0|||
161974681|NCT01344629|584956459|FG001|Crossover Period 2|Withdrawal by Subject|1|||
161974682|NCT00900146|584956460|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
161854597|NCT02288325|584508104|FG002|Run-in Period|Lack of Efficacy|0|||
161974683|NCT00900146|584956461|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
161974684|NCT00900146|584956462|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
161854598|NCT02288325|584508102|FG000|Run-in Period|Withdrawal of Consent|28|||
161854599|NCT02288325|584508103|FG001|Run-in Period|Withdrawal of Consent|0|||
161854600|NCT02288325|584508104|FG002|Run-in Period|Withdrawal of Consent|0|||
161854601|NCT02288325|584508102|FG000|Run-in Period|Lost to Follow-up|25|||
161854602|NCT02288325|584508103|FG001|Run-in Period|Lost to Follow-up|0|||
161854603|NCT02288325|584508104|FG002|Run-in Period|Lost to Follow-up|0|||
161854604|NCT02288325|584508102|FG000|Run-in Period|Protocol Violation|17|||
161854605|NCT02288325|584508103|FG001|Run-in Period|Protocol Violation|0|||
161854606|NCT02288325|584508104|FG002|Run-in Period|Protocol Violation|0|||
161854607|NCT02288325|584508102|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
161854608|NCT02288325|584508103|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
161854609|NCT02288325|584508104|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
161854610|NCT02288325|584508102|FG000|Run-in Period|Reason not Specified|8|||
161854611|NCT02288325|584508103|FG001|Run-in Period|Reason not Specified|0|||
161854612|NCT02288325|584508104|FG002|Run-in Period|Reason not Specified|0|||
161854613|NCT02288325|584508102|FG000|Stabilization Period|Adverse Event|13|||
161854614|NCT02288325|584508103|FG001|Stabilization Period|Adverse Event|0|||
161854615|NCT02288325|584508104|FG002|Stabilization Period|Adverse Event|0|||
161854616|NCT02288325|584508102|FG000|Stabilization Period|Lack of Efficacy|22|||
161854617|NCT02288325|584508103|FG001|Stabilization Period|Lack of Efficacy|0|||
161974685|NCT00900146|584956463|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
161974686|NCT00900146|584956464|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
161974687|NCT00900146|584956460|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
161974688|NCT00900146|584956461|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
161974689|NCT00900146|584956462|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
161974690|NCT00900146|584956463|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
161974691|NCT00900146|584956464|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
161974692|NCT00900146|584956460|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
161974693|NCT00900146|584956461|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
161974694|NCT00900146|584956462|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
161974695|NCT00900146|584956463|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
161974696|NCT00900146|584956464|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
161974697|NCT00900146|584956460|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
161974698|NCT00900146|584956461|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
161974699|NCT00900146|584956462|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
161974700|NCT00900146|584956463|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
161974701|NCT00900146|584956464|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
161974702|NCT00900146|584956460|FG000|Intermediate: Period III|Lost to Follow-up|2|||
161974703|NCT00900146|584956461|FG001|Intermediate: Period III|Lost to Follow-up|0|||
161974704|NCT00900146|584956462|FG002|Intermediate: Period III|Lost to Follow-up|0|||
161974705|NCT00900146|584956463|FG003|Intermediate: Period III|Lost to Follow-up|0|||
161974706|NCT00900146|584956464|FG004|Intermediate: Period III|Lost to Follow-up|1|||
161974707|NCT00900146|584956460|FG000|Intermediate: Period III|Administrative problems|85|||
161974708|NCT00900146|584956461|FG001|Intermediate: Period III|Administrative problems|92|||
161974709|NCT00900146|584956462|FG002|Intermediate: Period III|Administrative problems|84|||
161974710|NCT00900146|584956463|FG003|Intermediate: Period III|Administrative problems|90|||
161974711|NCT00900146|584956464|FG004|Intermediate: Period III|Administrative problems|163|||
161974712|NCT02305849|584956468|FG000|Overall Study|Adverse Event|10|||
161974713|NCT02305849|584956469|FG001|Overall Study|Adverse Event|12|||
161974714|NCT02305849|584956470|FG002|Overall Study|Adverse Event|7|||
161974715|NCT02305849|584956471|FG003|Overall Study|Adverse Event|3|||
161974716|NCT02305849|584956468|FG000|Overall Study|Lack of Efficacy|10|||
161974717|NCT02305849|584956469|FG001|Overall Study|Lack of Efficacy|6|||
161974718|NCT02305849|584956470|FG002|Overall Study|Lack of Efficacy|3|||
161974719|NCT02305849|584956471|FG003|Overall Study|Lack of Efficacy|9|||
161974720|NCT02305849|584956468|FG000|Overall Study|Withdrawal by Subject|2|||
161974721|NCT02305849|584956469|FG001|Overall Study|Withdrawal by Subject|2|||
161974722|NCT02305849|584956470|FG002|Overall Study|Withdrawal by Subject|1|||
161974723|NCT02305849|584956471|FG003|Overall Study|Withdrawal by Subject|4|||
161974724|NCT02305849|584956468|FG000|Overall Study|Lost to Follow-up|0|||
161974725|NCT02305849|584956469|FG001|Overall Study|Lost to Follow-up|2|||
161974726|NCT02305849|584956470|FG002|Overall Study|Lost to Follow-up|0|||
161974727|NCT02305849|584956471|FG003|Overall Study|Lost to Follow-up|0|||
161974728|NCT02305849|584956468|FG000|Overall Study|Protocol Violation|3|||
161974729|NCT02305849|584956469|FG001|Overall Study|Protocol Violation|2|||
161854618|NCT02288325|584508104|FG002|Stabilization Period|Lack of Efficacy|0|||
161854619|NCT02288325|584508102|FG000|Stabilization Period|Withdrawal of Consent|23|||
161854620|NCT02288325|584508103|FG001|Stabilization Period|Withdrawal of Consent|0|||
161854621|NCT02288325|584508104|FG002|Stabilization Period|Withdrawal of Consent|0|||
161854622|NCT02288325|584508102|FG000|Stabilization Period|Lost to Follow-up|12|||
161854623|NCT02288325|584508103|FG001|Stabilization Period|Lost to Follow-up|0|||
161854624|NCT02288325|584508104|FG002|Stabilization Period|Lost to Follow-up|0|||
161854625|NCT02288325|584508102|FG000|Stabilization Period|Protocol Violation|8|||
161854626|NCT02288325|584508103|FG001|Stabilization Period|Protocol Violation|0|||
161854627|NCT02288325|584508104|FG002|Stabilization Period|Protocol Violation|0|||
161854628|NCT02288325|584508102|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
161854629|NCT02288325|584508103|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
161854630|NCT02288325|584508104|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
161854631|NCT02288325|584508102|FG000|Stabilization Period|Reason not Specified|15|||
161854632|NCT02288325|584508103|FG001|Stabilization Period|Reason not Specified|0|||
161854633|NCT02288325|584508104|FG002|Stabilization Period|Reason not Specified|0|||
161854634|NCT02288325|584508102|FG000|Double-blind Treatment Period|Adverse Event|0|||
161854635|NCT02288325|584508103|FG001|Double-blind Treatment Period|Adverse Event|2|||
161854636|NCT02288325|584508104|FG002|Double-blind Treatment Period|Adverse Event|5|||
161854637|NCT02288325|584508102|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
161854638|NCT02288325|584508103|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
161854639|NCT02288325|584508104|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
161854640|NCT02288325|584508102|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161854641|NCT02288325|584508103|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
161854642|NCT02288325|584508104|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
161854643|NCT02288325|584508102|FG000|Double-blind Treatment Period|Protocol Violation|0|||
161854644|NCT02288325|584508103|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161854645|NCT02288325|584508104|FG002|Double-blind Treatment Period|Protocol Violation|2|||
161854646|NCT02288325|584508102|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
161854647|NCT02288325|584508103|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
161854648|NCT02288325|584508104|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
161854649|NCT02288325|584508102|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
161854650|NCT02288325|584508103|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
161854651|NCT02288325|584508104|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
161854652|NCT03607487|584508108|FG000|Overall Study|Withdrawal by Subject|2|||
161854653|NCT03607487|584508109|FG001|Overall Study|Withdrawal by Subject|0|||
161854654|NCT03607487|584508110|FG002|Overall Study|Withdrawal by Subject|0|||
161854655|NCT03607487|584508111|FG003|Overall Study|Withdrawal by Subject|1|||
161854656|NCT04759703|584508113|FG000|Overall Study|Withdrawal by Subject|4|||
161854657|NCT04759703|584508114|FG001|Overall Study|Withdrawal by Subject|9|||
161854658|NCT04759703|584508113|FG000|Overall Study|Adverse Event|1|||
161854659|NCT04759703|584508114|FG001|Overall Study|Adverse Event|0|||
161854660|NCT04759703|584508113|FG000|Overall Study|Lost to Follow-up|2|||
161854661|NCT04759703|584508114|FG001|Overall Study|Lost to Follow-up|0|||
161854662|NCT04186845|584508122|FG000|Overall Study|Death|2|||
161854663|NCT04186845|584508122|FG000|Overall Study|Lost to Follow-up|1|||
161854664|NCT04186845|584508122|FG000|Overall Study|Physician Decision|1|||
161854665|NCT04186845|584508122|FG000|Overall Study|Protocol Violation|1|||
161854666|NCT04186845|584508122|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
161854667|NCT04186845|584508122|FG000|Overall Study|Biopsy ordered but not done|1|||
161854668|NCT04186845|584508122|FG000|Overall Study|It was previously confirmed|1|||
161854669|NCT04186845|584508122|FG000|Overall Study|Patient cancelled scheduled scans|2|||
161854670|NCT04186845|584508122|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
161854671|NCT04186845|584508122|FG000|Overall Study|Subject refused confirmatory imaging|1|||
161854672|NCT04186845|584508122|FG000|Overall Study|Too small to biopsy|1|||
161854673|NCT04138823|584508123|FG000|Overall Study|Clinical disease progression|0|||
161854674|NCT04138823|584508124|FG001|Overall Study|Clinical disease progression|0|||
161854675|NCT04138823|584508125|FG002|Overall Study|Clinical disease progression|1|||
161854676|NCT04138823|584508123|FG000|Overall Study|Objective disease progression|3|||
161854677|NCT04138823|584508124|FG001|Overall Study|Objective disease progression|2|||
161854678|NCT04138823|584508125|FG002|Overall Study|Objective disease progression|5|||
161854679|NCT03151304|584508126|FG000|Overall Study|Termination of study by Sponsor|23|||
161854680|NCT03151304|584508126|FG000|Overall Study|missing|3|||
161854681|NCT03151304|584508126|FG000|Overall Study|Withdrawal by Subject|8|||
161854682|NCT03151304|584508126|FG000|Overall Study|multiple reasons|30|||
161854683|NCT04868500|584508127|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
161854684|NCT04868500|584508128|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
161974730|NCT02305849|584956470|FG002|Overall Study|Protocol Violation|1|||
161974731|NCT02305849|584956471|FG003|Overall Study|Protocol Violation|1|||
161974732|NCT02305849|584956468|FG000|Overall Study|Lab data met discontinuation criteria|0|||
161974733|NCT02305849|584956469|FG001|Overall Study|Lab data met discontinuation criteria|1|||
161854685|NCT04868500|584508127|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
161854686|NCT04868500|584508128|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
161854687|NCT02466685|584508129|FG000|Overall Study|Adverse Event|5|||
161854688|NCT02466685|584508130|FG001|Overall Study|Adverse Event|2|||
161854689|NCT02466685|584508129|FG000|Overall Study|Lost to Follow-up|1|||
161854690|NCT02466685|584508130|FG001|Overall Study|Lost to Follow-up|1|||
161974734|NCT02305849|584956470|FG002|Overall Study|Lab data met discontinuation criteria|2|||
161974735|NCT02305849|584956471|FG003|Overall Study|Lab data met discontinuation criteria|1|||
161767022|NCT01072175|584187217|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767023|NCT01072175|584187218|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767024|NCT01072175|584187219|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767025|NCT01072175|584187220|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767026|NCT01072175|584187221|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767027|NCT01072175|584187222|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767028|NCT01072175|584187223|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161767029|NCT01072175|584187224|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
161767030|NCT01072175|584187225|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
161767031|NCT01072175|584187226|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
161767032|NCT01072175|584187214|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767033|NCT01072175|584187215|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767034|NCT01072175|584187216|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767035|NCT01072175|584187217|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767036|NCT01072175|584187218|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767037|NCT01072175|584187219|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767038|NCT01072175|584187220|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767039|NCT01072175|584187221|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767040|NCT01072175|584187222|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
161767041|NCT01072175|584187223|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
161767042|NCT01072175|584187224|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
161767043|NCT01072175|584187225|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
161767044|NCT01072175|584187226|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
161767045|NCT01072175|584187214|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767046|NCT01072175|584187215|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767047|NCT01072175|584187216|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767048|NCT01072175|584187217|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767049|NCT01072175|584187218|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767050|NCT01072175|584187219|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767051|NCT01072175|584187220|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767052|NCT01072175|584187221|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767053|NCT01072175|584187222|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767054|NCT01072175|584187223|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767055|NCT01072175|584187224|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
161767056|NCT01072175|584187225|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
161767057|NCT01072175|584187226|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161767058|NCT02839330|584187227|FG000|Overall Study|Adverse Event|0|||
161767059|NCT02839330|584187228|FG001|Overall Study|Adverse Event|1|||
161767060|NCT02839330|584187229|FG002|Overall Study|Adverse Event|2|||
161767061|NCT02839330|584187230|FG003|Overall Study|Adverse Event|2|||
161767062|NCT02839330|584187227|FG000|Overall Study|Death|4|||
161767063|NCT02839330|584187228|FG001|Overall Study|Death|6|||
161767064|NCT02839330|584187229|FG002|Overall Study|Death|1|||
161767065|NCT02839330|584187230|FG003|Overall Study|Death|1|||
161767066|NCT02839330|584187227|FG000|Overall Study|Withdrawal by Subject|27|||
161767067|NCT02839330|584187228|FG001|Overall Study|Withdrawal by Subject|19|||
161767068|NCT02839330|584187229|FG002|Overall Study|Withdrawal by Subject|11|||
161767069|NCT02839330|584187230|FG003|Overall Study|Withdrawal by Subject|13|||
161767070|NCT02839330|584187227|FG000|Overall Study|Lost to Follow-up|22|||
161767071|NCT02839330|584187228|FG001|Overall Study|Lost to Follow-up|27|||
161767072|NCT02839330|584187229|FG002|Overall Study|Lost to Follow-up|29|||
161767073|NCT02839330|584187230|FG003|Overall Study|Lost to Follow-up|25|||
161767074|NCT02839330|584187227|FG000|Overall Study|Administrative Reason|0|||
161767075|NCT02839330|584187228|FG001|Overall Study|Administrative Reason|0|||
161767076|NCT02839330|584187229|FG002|Overall Study|Administrative Reason|0|||
161767077|NCT02839330|584187230|FG003|Overall Study|Administrative Reason|1|||
161767078|NCT02839330|584187227|FG000|Overall Study|Protocol Violation|1|||
161767079|NCT02839330|584187228|FG001|Overall Study|Protocol Violation|2|||
161767080|NCT02839330|584187229|FG002|Overall Study|Protocol Violation|2|||
161767081|NCT02839330|584187230|FG003|Overall Study|Protocol Violation|3|||
161767082|NCT02839330|584187227|FG000|Overall Study|Other reason, not specified|4|||
161767083|NCT02839330|584187228|FG001|Overall Study|Other reason, not specified|3|||
161767084|NCT02839330|584187229|FG002|Overall Study|Other reason, not specified|3|||
161767085|NCT02839330|584187230|FG003|Overall Study|Other reason, not specified|6|||
161767086|NCT00682539|584187231|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
161767087|NCT00682539|584187232|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
161767088|NCT00682539|584187233|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
161767089|NCT00682539|584187231|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
161767090|NCT00682539|584187232|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
161767091|NCT00682539|584187233|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
161767092|NCT02477215|584187243|FG000|Dose Escalation Phase|Physician Decision|1|||
161767093|NCT02477215|584187244|FG001|Dose Escalation Phase|Physician Decision|2|||
161767094|NCT02477215|584187245|FG002|Dose Escalation Phase|Physician Decision|0|||
161767095|NCT02477215|584187243|FG000|Fixed Dose Phase|Physician Decision|0|||
161854691|NCT02466685|584508129|FG000|Overall Study|Withdrawal by Subject|1|||
161854692|NCT02466685|584508130|FG001|Overall Study|Withdrawal by Subject|0|||
161854693|NCT02466685|584508129|FG000|Overall Study|Physician Decision|1|||
161854694|NCT02466685|584508130|FG001|Overall Study|Physician Decision|1|||
161854695|NCT02565511|584508131|FG000|Overall Study|Study terminated by Sponsor|35|||
161854696|NCT02565511|584508132|FG001|Overall Study|Study terminated by Sponsor|22|||
161854697|NCT02565511|584508133|FG002|Overall Study|Study terminated by Sponsor|235|||
161854698|NCT02565511|584508134|FG003|Overall Study|Study terminated by Sponsor|156|||
161854699|NCT02565511|584508131|FG000|Overall Study|Withdrawal by Subject|3|||
161854700|NCT02565511|584508132|FG001|Overall Study|Withdrawal by Subject|0|||
161854701|NCT02565511|584508133|FG002|Overall Study|Withdrawal by Subject|12|||
161854702|NCT02565511|584508134|FG003|Overall Study|Withdrawal by Subject|5|||
161854703|NCT02565511|584508131|FG000|Overall Study|Adverse Event|0|||
161854704|NCT02565511|584508132|FG001|Overall Study|Adverse Event|0|||
161854705|NCT02565511|584508133|FG002|Overall Study|Adverse Event|1|||
161854706|NCT02565511|584508134|FG003|Overall Study|Adverse Event|1|||
161854707|NCT02565511|584508131|FG000|Overall Study|Lost to Follow-up|4|||
161854708|NCT02565511|584508132|FG001|Overall Study|Lost to Follow-up|1|||
161854709|NCT02565511|584508133|FG002|Overall Study|Lost to Follow-up|0|||
161854710|NCT02565511|584508134|FG003|Overall Study|Lost to Follow-up|1|||
161854711|NCT02565511|584508131|FG000|Overall Study|Physician Decision|0|||
161854712|NCT02565511|584508132|FG001|Overall Study|Physician Decision|0|||
161854713|NCT02565511|584508133|FG002|Overall Study|Physician Decision|0|||
161854714|NCT02565511|584508134|FG003|Overall Study|Physician Decision|1|||
161854715|NCT02565511|584508131|FG000|Overall Study|Protocol deviation|0|||
161854716|NCT02565511|584508132|FG001|Overall Study|Protocol deviation|0|||
161854717|NCT02565511|584508133|FG002|Overall Study|Protocol deviation|3|||
161854718|NCT02565511|584508134|FG003|Overall Study|Protocol deviation|0|||
161854719|NCT01941498|584508135|FG000|Overall Study|Relocated out of state|1|||
161854720|NCT02006732|584508136|FG000|Overall Study|Adverse Event|10|||
161854721|NCT02006732|584508137|FG001|Overall Study|Adverse Event|7|||
161854722|NCT02006732|584508138|FG002|Overall Study|Adverse Event|4|||
161854723|NCT02006732|584508139|FG003|Overall Study|Adverse Event|2|||
161854724|NCT02006732|584508136|FG000|Overall Study|Lack of Efficacy|6|||
161854725|NCT02006732|584508137|FG001|Overall Study|Lack of Efficacy|3|||
161854726|NCT02006732|584508138|FG002|Overall Study|Lack of Efficacy|1|||
161854727|NCT02006732|584508139|FG003|Overall Study|Lack of Efficacy|1|||
161854728|NCT02006732|584508136|FG000|Overall Study|Protocol Violation|1|||
161854729|NCT02006732|584508137|FG001|Overall Study|Protocol Violation|1|||
161854730|NCT02006732|584508138|FG002|Overall Study|Protocol Violation|0|||
161854731|NCT02006732|584508139|FG003|Overall Study|Protocol Violation|0|||
161854732|NCT02006732|584508136|FG000|Overall Study|Lost to Follow-up|0|||
161854733|NCT02006732|584508137|FG001|Overall Study|Lost to Follow-up|1|||
161854734|NCT02006732|584508138|FG002|Overall Study|Lost to Follow-up|0|||
161854735|NCT02006732|584508139|FG003|Overall Study|Lost to Follow-up|0|||
161854736|NCT02006732|584508136|FG000|Overall Study|Withdrawal by Subject|3|||
161854737|NCT02006732|584508137|FG001|Overall Study|Withdrawal by Subject|0|||
161854738|NCT02006732|584508138|FG002|Overall Study|Withdrawal by Subject|4|||
161854739|NCT02006732|584508139|FG003|Overall Study|Withdrawal by Subject|1|||
161854740|NCT01755091|584508140|FG000|Overall Study|Withdrawal by Subject|6|||
161854741|NCT01755091|584508141|FG001|Overall Study|Withdrawal by Subject|1|||
161854742|NCT01755091|584508142|FG002|Overall Study|Withdrawal by Subject|3|||
161854743|NCT01755091|584508140|FG000|Overall Study|Adverse Event|1|||
161854744|NCT01755091|584508141|FG001|Overall Study|Adverse Event|1|||
161854745|NCT01755091|584508142|FG002|Overall Study|Adverse Event|1|||
161854746|NCT01755091|584508140|FG000|Overall Study|Lost to Follow-up|1|||
161854747|NCT01755091|584508141|FG001|Overall Study|Lost to Follow-up|0|||
161854748|NCT01755091|584508142|FG002|Overall Study|Lost to Follow-up|1|||
161854749|NCT01755091|584508140|FG000|Overall Study|Physician Decision|1|||
161854750|NCT01755091|584508141|FG001|Overall Study|Physician Decision|1|||
161854751|NCT01755091|584508142|FG002|Overall Study|Physician Decision|2|||
161854752|NCT02969044|584508143|FG000|Overall Study|Withdrawal by Subject|2|||
161854753|NCT02969044|584508144|FG001|Overall Study|Withdrawal by Subject|6|||
161854754|NCT02969044|584508143|FG000|Overall Study|Adverse Event|3|||
161854755|NCT02969044|584508144|FG001|Overall Study|Adverse Event|0|||
161854756|NCT01330303|584508146|FG000|Period 1|Adverse Event|1|||
161854757|NCT01330303|584508147|FG001|Period 1|Adverse Event|0|||
161854758|NCT01330303|584508146|FG000|Period 1|Protocol Violation|0|||
161854759|NCT01330303|584508147|FG001|Period 1|Protocol Violation|1|||
161854760|NCT01330303|584508146|FG000|Period 1|Withdrawal by Subject|0|||
161854761|NCT01330303|584508147|FG001|Period 1|Withdrawal by Subject|1|||
161854762|NCT00796757|584508148|FG000|Overall Study|Withdrawal by Subject|14|||
161854763|NCT00796757|584508148|FG000|Overall Study|Death|61|||
161854764|NCT00796757|584508148|FG000|Overall Study|Protocol Violation|1|||
161854765|NCT00796757|584508148|FG000|Overall Study|Participant noncompliance|1|||
161854766|NCT00796757|584508148|FG000|Overall Study|Investigator's decision|2|||
161854767|NCT00796757|584508148|FG000|Overall Study|Other|7|||
161854768|NCT03516513|584508149|FG000|Overall Study|Withdrawal by Subject|2|||
161854769|NCT03516513|584508150|FG001|Overall Study|Withdrawal by Subject|2|||
161974736|NCT02305849|584956468|FG000|Overall Study|Miscellaneous|1|||
161854770|NCT03516513|584508151|FG002|Overall Study|Withdrawal by Subject|0|||
161854771|NCT03516513|584508152|FG003|Overall Study|Withdrawal by Subject|0|||
161854772|NCT02593110|584508154|FG000|Overall Study|Withdrawal by Subject|0|||
161854773|NCT02593110|584508155|FG001|Overall Study|Withdrawal by Subject|3|||
161854774|NCT02593110|584508156|FG002|Overall Study|Withdrawal by Subject|3|||
161854775|NCT02593110|584508157|FG003|Overall Study|Withdrawal by Subject|2|||
161854776|NCT02593110|584508154|FG000|Overall Study|Death|0|||
161854777|NCT02593110|584508155|FG001|Overall Study|Death|0|||
161854778|NCT02593110|584508156|FG002|Overall Study|Death|1|||
161854779|NCT02593110|584508157|FG003|Overall Study|Death|0|||
161854780|NCT03548337|584508158|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
161854781|NCT03548337|584508159|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
161854782|NCT03548337|584508158|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
161854783|NCT03548337|584508159|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
161854784|NCT03548337|584508158|FG000|Infant Series|Lost to Follow-up|2|||
161854785|NCT03548337|584508159|FG001|Infant Series|Lost to Follow-up|1|||
161854786|NCT03548337|584508158|FG000|Infant Series|Adverse Event|0|||
161854787|NCT03548337|584508159|FG001|Infant Series|Adverse Event|2|||
161854788|NCT03548337|584508158|FG000|Infant Series|Randomized but Not Vaccinated|1|||
161854789|NCT03548337|584508159|FG001|Infant Series|Randomized but Not Vaccinated|0|||
161854790|NCT03548337|584508158|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
161854791|NCT03548337|584508159|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
161854792|NCT01130597|584508160|FG000|Overall Study|Protocol-specified (High K+)|1|||
161854793|NCT01130597|584508160|FG000|Overall Study|Adverse Event|4|||
161854794|NCT01130597|584508160|FG000|Overall Study|Death|1|||
161854795|NCT01130597|584508160|FG000|Overall Study|Protocol Violation|1|||
161854796|NCT03052127|584508165|FG000|Overall Study|Withdrawal by Subject|0|||
161854797|NCT03052127|584508166|FG001|Overall Study|Withdrawal by Subject|0|||
161854798|NCT03052127|584508167|FG002|Overall Study|Withdrawal by Subject|0|||
161854799|NCT03052127|584508168|FG003|Overall Study|Withdrawal by Subject|0|||
161974737|NCT02305849|584956469|FG001|Overall Study|Miscellaneous|2|||
161974738|NCT02305849|584956470|FG002|Overall Study|Miscellaneous|4|||
161974739|NCT02305849|584956471|FG003|Overall Study|Miscellaneous|1|||
161974740|NCT02305849|584956468|FG000|Overall Study|Not fulfill eligibility criteria|1|||
161974741|NCT02305849|584956469|FG001|Overall Study|Not fulfill eligibility criteria|1|||
161974742|NCT02305849|584956470|FG002|Overall Study|Not fulfill eligibility criteria|0|||
161767096|NCT02477215|584187244|FG001|Fixed Dose Phase|Physician Decision|7|||
161767097|NCT02477215|584187245|FG002|Fixed Dose Phase|Physician Decision|0|||
161767098|NCT00508872|584187246|FG000|Overall Study|Lost to Follow-up|1|||
161767099|NCT00508872|584187246|FG000|Overall Study|Physician Decision|1|||
161767100|NCT00883896|584187247|FG000|Overall Study|Lost to Follow-up|0|||
161767101|NCT00883896|584187248|FG001|Overall Study|Lost to Follow-up|0|||
161767102|NCT00883896|584187249|FG002|Overall Study|Lost to Follow-up|0|||
161767103|NCT00883896|584187250|FG003|Overall Study|Lost to Follow-up|2|||
161767104|NCT00883896|584187247|FG000|Overall Study|Withdrawal by Subject|5|||
161767105|NCT00883896|584187248|FG001|Overall Study|Withdrawal by Subject|0|||
161767106|NCT00883896|584187249|FG002|Overall Study|Withdrawal by Subject|1|||
161767107|NCT00883896|584187250|FG003|Overall Study|Withdrawal by Subject|3|||
161767108|NCT00883896|584187247|FG000|Overall Study|Lack of Efficacy|0|||
161767109|NCT00883896|584187248|FG001|Overall Study|Lack of Efficacy|0|||
161767110|NCT00883896|584187249|FG002|Overall Study|Lack of Efficacy|0|||
161767111|NCT00883896|584187250|FG003|Overall Study|Lack of Efficacy|2|||
161767112|NCT00883896|584187247|FG000|Overall Study|Other|1|||
161767113|NCT00883896|584187248|FG001|Overall Study|Other|0|||
161767114|NCT00883896|584187249|FG002|Overall Study|Other|0|||
161767115|NCT00883896|584187250|FG003|Overall Study|Other|0|||
161767116|NCT00310440|584187251|FG000|Overall Study|Lost to Follow-up|17|||
161767117|NCT00310440|584187252|FG001|Overall Study|Lost to Follow-up|8|||
161767118|NCT00310440|584187251|FG000|Overall Study|Withdrawal by Subject|2|||
161767119|NCT00310440|584187252|FG001|Overall Study|Withdrawal by Subject|1|||
161767120|NCT00310440|584187251|FG000|Overall Study|Missed 12 Month Visit|7|||
161767121|NCT00310440|584187252|FG001|Overall Study|Missed 12 Month Visit|4|||
161767122|NCT01654666|584187260|FG000|Overall Study|Protocol Violation|7|||
161767123|NCT01654666|584187261|FG001|Overall Study|Protocol Violation|4|||
161854800|NCT03052127|584508169|FG004|Overall Study|Withdrawal by Subject|0|||
161854801|NCT03052127|584508170|FG005|Overall Study|Withdrawal by Subject|0|||
161974743|NCT02305849|584956471|FG003|Overall Study|Not fulfill eligibility criteria|0|||
162034157|NCT04393298|585181144|FG000|Overall Study|Patient Passed Away|0|||
161767124|NCT01654666|584187262|FG002|Overall Study|Protocol Violation|8|||
161767125|NCT01654666|584187260|FG000|Overall Study|Lost to Follow-up|4|||
161767126|NCT01654666|584187261|FG001|Overall Study|Lost to Follow-up|5|||
161767127|NCT01654666|584187262|FG002|Overall Study|Lost to Follow-up|5|||
161767128|NCT01654666|584187260|FG000|Overall Study|Withdrawal by Subject|4|||
161767129|NCT01654666|584187261|FG001|Overall Study|Withdrawal by Subject|4|||
161767130|NCT01654666|584187262|FG002|Overall Study|Withdrawal by Subject|1|||
161854802|NCT03052127|584508171|FG006|Overall Study|Withdrawal by Subject|0|||
161854803|NCT03052127|584508172|FG007|Overall Study|Withdrawal by Subject|1|||
161854804|NCT03052127|584508173|FG008|Overall Study|Withdrawal by Subject|1|||
161767131|NCT01177943|584187264|FG000|First Intervention|Withdrawal by Subject|2|||
161767132|NCT01177943|584187265|FG001|First Intervention|Withdrawal by Subject|0|||
161767133|NCT04225026|584187271|FG000|Overall Study|Withdrawal by Subject|4|||
161767134|NCT04225026|584187271|FG000|Overall Study|Adverse Event|1|||
161767135|NCT04225026|584187271|FG000|Overall Study|Other|1|||
161767136|NCT04225026|584187271|FG000|Overall Study|Death|11|||
161767137|NCT04225026|584187271|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
161767138|NCT03742271|584187283|FG000|Overall Study|Unsatisfactory Visual Response|1|||
161767139|NCT03742271|584187283|FG000|Overall Study|Withdrawal by Subject|3|||
161767140|NCT03742271|584187283|FG000|Overall Study|Lost to Follow-up|4|||
161767141|NCT03742271|584187283|FG000|Overall Study|Failed Insertion & removal|3|||
161767142|NCT03742271|584187283|FG000|Overall Study|Protocol Violation|1|||
161767143|NCT01843933|584187284|FG000|Overall Study|Data lost|6|||
161767144|NCT01843933|584187285|FG001|Overall Study|Data lost|4|||
161767145|NCT00690612|584188869|FG000|Overall Study|Adverse Event|1|||
161767146|NCT00690612|584188869|FG000|Overall Study|Withdrawal by Subject|2|||
161767147|NCT03808298|584188870|FG000|Overall Study|Adverse Event|3|||
161767148|NCT03808298|584188870|FG000|Overall Study|Physician Decision|1|||
161767149|NCT03808298|584188870|FG000|Overall Study|Withdrawal by Subject|1|||
161767150|NCT03808298|584188870|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
161767151|NCT01858701|584188873|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
161767152|NCT01858701|584188874|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
161767153|NCT01858701|584188873|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
161767154|NCT01858701|584188874|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
161767155|NCT01858701|584188873|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
161854805|NCT03052127|584508174|FG009|Overall Study|Withdrawal by Subject|1|||
161854806|NCT03052127|584508175|FG010|Overall Study|Withdrawal by Subject|0|||
161854807|NCT03052127|584508176|FG011|Overall Study|Withdrawal by Subject|0|||
161854808|NCT03052127|584508165|FG000|Overall Study|Discontinuation by Sponsor|0|||
161854809|NCT03052127|584508166|FG001|Overall Study|Discontinuation by Sponsor|0|||
161854810|NCT03052127|584508167|FG002|Overall Study|Discontinuation by Sponsor|0|||
161854811|NCT03052127|584508168|FG003|Overall Study|Discontinuation by Sponsor|0|||
161854812|NCT03052127|584508169|FG004|Overall Study|Discontinuation by Sponsor|0|||
161854813|NCT03052127|584508170|FG005|Overall Study|Discontinuation by Sponsor|0|||
161854814|NCT03052127|584508171|FG006|Overall Study|Discontinuation by Sponsor|0|||
161854815|NCT03052127|584508172|FG007|Overall Study|Discontinuation by Sponsor|0|||
161767156|NCT01858701|584188874|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
161767157|NCT01858701|584188873|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
161767158|NCT01858701|584188874|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
161767159|NCT01674010|584188875|FG000|Open Treatment Phase 1|Adverse Event|10|||
161767160|NCT01674010|584188876|FG001|Open Treatment Phase 1|Adverse Event|0|||
161767161|NCT01674010|584188877|FG002|Open Treatment Phase 1|Adverse Event|0|||
161854816|NCT03052127|584508173|FG008|Overall Study|Discontinuation by Sponsor|4|||
161854817|NCT03052127|584508174|FG009|Overall Study|Discontinuation by Sponsor|2|||
161854818|NCT03052127|584508175|FG010|Overall Study|Discontinuation by Sponsor|5|||
161854819|NCT03052127|584508176|FG011|Overall Study|Discontinuation by Sponsor|13|||
161854820|NCT03052127|584508165|FG000|Overall Study|Inability to comply with trial requirements|0|||
161854821|NCT03052127|584508166|FG001|Overall Study|Inability to comply with trial requirements|0|||
161854822|NCT03052127|584508167|FG002|Overall Study|Inability to comply with trial requirements|1|||
161854823|NCT03052127|584508168|FG003|Overall Study|Inability to comply with trial requirements|0|||
161854824|NCT03052127|584508169|FG004|Overall Study|Inability to comply with trial requirements|0|||
161854825|NCT03052127|584508170|FG005|Overall Study|Inability to comply with trial requirements|0|||
161854826|NCT03052127|584508171|FG006|Overall Study|Inability to comply with trial requirements|0|||
161854827|NCT03052127|584508172|FG007|Overall Study|Inability to comply with trial requirements|0|||
161854828|NCT03052127|584508173|FG008|Overall Study|Inability to comply with trial requirements|0|||
161854829|NCT03052127|584508174|FG009|Overall Study|Inability to comply with trial requirements|0|||
161854830|NCT03052127|584508175|FG010|Overall Study|Inability to comply with trial requirements|0|||
161854831|NCT03052127|584508176|FG011|Overall Study|Inability to comply with trial requirements|0|||
161854832|NCT03052127|584508165|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
161974744|NCT05590000|584956472|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
161974745|NCT00355342|584956473|FG000|Overall Study|Adverse Event|13|||
161974746|NCT00355342|584956474|FG001|Overall Study|Adverse Event|15|||
161767162|NCT01674010|584188875|FG000|Open Treatment Phase 1|Death|1|||
161767163|NCT01674010|584188876|FG001|Open Treatment Phase 1|Death|0|||
161767164|NCT01674010|584188877|FG002|Open Treatment Phase 1|Death|0|||
161767165|NCT01674010|584188875|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
161767166|NCT01674010|584188876|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
161767167|NCT01674010|584188877|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
161767168|NCT01674010|584188875|FG000|Open Treatment Phase 1|Physician Decision|9|||
161854833|NCT03052127|584508166|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854834|NCT03052127|584508167|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854835|NCT03052127|584508168|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854836|NCT03052127|584508169|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
161854837|NCT03052127|584508170|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
161854838|NCT03052127|584508171|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
161854839|NCT03052127|584508172|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854840|NCT03052127|584508173|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854841|NCT03052127|584508174|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854842|NCT03052127|584508175|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854843|NCT03052127|584508176|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161854844|NCT03694327|584508177|FG000|Overall Study|Lost to Follow-up|13|||
161854845|NCT03694327|584508178|FG001|Overall Study|Lost to Follow-up|23|||
161854846|NCT01464931|584508181|FG000|Overall Study|Withdrawal by Subject|1|||
161854847|NCT01464931|584508182|FG001|Overall Study|Withdrawal by Subject|0|||
161854848|NCT01982812|584508183|FG000|Overall Study|Death|1|||
161854849|NCT01982812|584508184|FG001|Overall Study|Death|5|||
161854850|NCT01982812|584508183|FG000|Overall Study|Adverse Event|0|||
161854851|NCT01982812|584508184|FG001|Overall Study|Adverse Event|5|||
161854852|NCT00307437|584508186|FG000|Controlled Period|Adverse Event|7|||
161854853|NCT00307437|584508187|FG001|Controlled Period|Adverse Event|2|||
161854854|NCT00307437|584508188|FG002|Controlled Period|Adverse Event|5|||
161854855|NCT00307437|584508189|FG003|Controlled Period|Adverse Event|0|||
161854856|NCT00307437|584508190|FG004|Controlled Period|Adverse Event|0|||
161854857|NCT00307437|584508191|FG005|Controlled Period|Adverse Event|0|||
161854858|NCT00307437|584508192|FG006|Controlled Period|Adverse Event|0|||
161854859|NCT00307437|584508186|FG000|Controlled Period|Death|0|||
161854860|NCT00307437|584508187|FG001|Controlled Period|Death|0|||
161854861|NCT00307437|584508188|FG002|Controlled Period|Death|1|||
161854862|NCT00307437|584508189|FG003|Controlled Period|Death|0|||
161854863|NCT00307437|584508190|FG004|Controlled Period|Death|0|||
161854864|NCT00307437|584508191|FG005|Controlled Period|Death|0|||
161854865|NCT00307437|584508192|FG006|Controlled Period|Death|0|||
161854866|NCT00307437|584508186|FG000|Controlled Period|Lack of Efficacy|2|||
161854867|NCT00307437|584508187|FG001|Controlled Period|Lack of Efficacy|0|||
161854868|NCT00307437|584508188|FG002|Controlled Period|Lack of Efficacy|0|||
161854869|NCT00307437|584508189|FG003|Controlled Period|Lack of Efficacy|0|||
161854870|NCT00307437|584508190|FG004|Controlled Period|Lack of Efficacy|0|||
161854871|NCT00307437|584508191|FG005|Controlled Period|Lack of Efficacy|0|||
161854872|NCT00307437|584508192|FG006|Controlled Period|Lack of Efficacy|0|||
161854873|NCT00307437|584508186|FG000|Controlled Period|Lost to Follow-up|2|||
161854874|NCT00307437|584508187|FG001|Controlled Period|Lost to Follow-up|3|||
161854875|NCT00307437|584508188|FG002|Controlled Period|Lost to Follow-up|0|||
161854876|NCT00307437|584508189|FG003|Controlled Period|Lost to Follow-up|0|||
161854877|NCT00307437|584508190|FG004|Controlled Period|Lost to Follow-up|0|||
161854878|NCT00307437|584508191|FG005|Controlled Period|Lost to Follow-up|0|||
161767169|NCT01674010|584188876|FG001|Open Treatment Phase 1|Physician Decision|0|||
161767170|NCT01674010|584188877|FG002|Open Treatment Phase 1|Physician Decision|0|||
161767171|NCT01674010|584188875|FG000|Open Treatment Phase 1|Protocol Violation|7|||
161767172|NCT01674010|584188876|FG001|Open Treatment Phase 1|Protocol Violation|0|||
161767173|NCT01674010|584188877|FG002|Open Treatment Phase 1|Protocol Violation|0|||
161767174|NCT01674010|584188875|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
161767175|NCT01674010|584188876|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
161767176|NCT01674010|584188877|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
161767177|NCT01674010|584188875|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
161767178|NCT01674010|584188876|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
161854879|NCT00307437|584508192|FG006|Controlled Period|Lost to Follow-up|0|||
161854880|NCT00307437|584508186|FG000|Controlled Period|Other|5|||
161854881|NCT00307437|584508187|FG001|Controlled Period|Other|1|||
161974747|NCT00355342|584956473|FG000|Overall Study|Lost to Follow-up|4|||
161767179|NCT01674010|584188877|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
161767180|NCT01674010|584188875|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
161767181|NCT01674010|584188876|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
161767182|NCT01674010|584188877|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
161767183|NCT01674010|584188875|FG000|Randomization Phase 2|Adverse Event|0|||
161767184|NCT01674010|584188876|FG001|Randomization Phase 2|Adverse Event|1|||
161767185|NCT01674010|584188877|FG002|Randomization Phase 2|Adverse Event|1|||
161854882|NCT00307437|584508188|FG002|Controlled Period|Other|3|||
161854883|NCT00307437|584508189|FG003|Controlled Period|Other|0|||
161854884|NCT00307437|584508190|FG004|Controlled Period|Other|0|||
161854885|NCT00307437|584508191|FG005|Controlled Period|Other|0|||
161854886|NCT00307437|584508192|FG006|Controlled Period|Other|0|||
161974748|NCT00355342|584956474|FG001|Overall Study|Lost to Follow-up|2|||
161767186|NCT01674010|584188875|FG000|Randomization Phase 2|Lost to Follow-up|0|||
161767187|NCT01674010|584188876|FG001|Randomization Phase 2|Lost to Follow-up|1|||
161767188|NCT01674010|584188877|FG002|Randomization Phase 2|Lost to Follow-up|2|||
161854887|NCT00307437|584508186|FG000|After Controlled Period|Adverse Event|0|||
161854888|NCT00307437|584508187|FG001|After Controlled Period|Adverse Event|0|||
161974749|NCT00355342|584956473|FG000|Overall Study|Withdrawal by Subject|14|||
161854889|NCT00307437|584508188|FG002|After Controlled Period|Adverse Event|0|||
161854890|NCT00307437|584508189|FG003|After Controlled Period|Adverse Event|18|||
161854891|NCT00307437|584508190|FG004|After Controlled Period|Adverse Event|16|||
161854892|NCT00307437|584508191|FG005|After Controlled Period|Adverse Event|31|||
161854893|NCT00307437|584508192|FG006|After Controlled Period|Adverse Event|40|||
161854894|NCT00307437|584508186|FG000|After Controlled Period|Death|0|||
161854895|NCT00307437|584508187|FG001|After Controlled Period|Death|0|||
161854896|NCT00307437|584508188|FG002|After Controlled Period|Death|0|||
161854897|NCT00307437|584508189|FG003|After Controlled Period|Death|3|||
161854898|NCT00307437|584508190|FG004|After Controlled Period|Death|1|||
161854899|NCT00307437|584508191|FG005|After Controlled Period|Death|1|||
161854900|NCT00307437|584508192|FG006|After Controlled Period|Death|3|||
161854901|NCT00307437|584508186|FG000|After Controlled Period|Lack of Efficacy|0|||
161854902|NCT00307437|584508187|FG001|After Controlled Period|Lack of Efficacy|0|||
161854903|NCT00307437|584508188|FG002|After Controlled Period|Lack of Efficacy|0|||
161854904|NCT00307437|584508189|FG003|After Controlled Period|Lack of Efficacy|15|||
161854905|NCT00307437|584508190|FG004|After Controlled Period|Lack of Efficacy|17|||
161854906|NCT00307437|584508191|FG005|After Controlled Period|Lack of Efficacy|37|||
161767189|NCT01674010|584188875|FG000|Randomization Phase 2|Mood episode recurrence|0|||
161767190|NCT01674010|584188876|FG001|Randomization Phase 2|Mood episode recurrence|8|||
161767191|NCT01674010|584188877|FG002|Randomization Phase 2|Mood episode recurrence|2|||
161767192|NCT01674010|584188875|FG000|Randomization Phase 2|Physician Decision|0|||
161767193|NCT01674010|584188876|FG001|Randomization Phase 2|Physician Decision|0|||
161767194|NCT01674010|584188877|FG002|Randomization Phase 2|Physician Decision|2|||
161767195|NCT01674010|584188875|FG000|Randomization Phase 2|Pregnancy|0|||
161767196|NCT01674010|584188876|FG001|Randomization Phase 2|Pregnancy|1|||
161767197|NCT01674010|584188877|FG002|Randomization Phase 2|Pregnancy|1|||
161767198|NCT01674010|584188875|FG000|Randomization Phase 2|Protocol Violation|0|||
161767199|NCT01674010|584188876|FG001|Randomization Phase 2|Protocol Violation|1|||
161767200|NCT01674010|584188877|FG002|Randomization Phase 2|Protocol Violation|1|||
161767201|NCT01674010|584188875|FG000|Randomization Phase 2|Sponsor Decision|0|||
161767202|NCT01674010|584188876|FG001|Randomization Phase 2|Sponsor Decision|42|||
161767203|NCT01674010|584188877|FG002|Randomization Phase 2|Sponsor Decision|45|||
161767204|NCT01674010|584188875|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
161767205|NCT01674010|584188876|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
161767206|NCT01674010|584188877|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
161767207|NCT01020812|584188878|FG000|Overall Study|Physician Decision|1|||
161767208|NCT01020812|584188878|FG000|Overall Study|Withdrawal by Subject|1|||
161767209|NCT01020812|584188878|FG000|Overall Study|Protocol Violation|1|||
161767210|NCT01801475|584188887|FG000|Overall Study|Withdrawal by Subject|0|||
161767211|NCT01801475|584188888|FG001|Overall Study|Withdrawal by Subject|0|||
161767212|NCT01801475|584188889|FG002|Overall Study|Withdrawal by Subject|0|||
161767213|NCT01801475|584188890|FG003|Overall Study|Withdrawal by Subject|0|||
161767214|NCT01801475|584188891|FG004|Overall Study|Withdrawal by Subject|1|||
161767215|NCT01786707|584188894|FG000|Overall Study|Lost to Follow-up|1|||
161854907|NCT00307437|584508192|FG006|After Controlled Period|Lack of Efficacy|24|||
161854908|NCT00307437|584508186|FG000|After Controlled Period|Lost to Follow-up|0|||
161854909|NCT00307437|584508187|FG001|After Controlled Period|Lost to Follow-up|0|||
161854910|NCT00307437|584508188|FG002|After Controlled Period|Lost to Follow-up|0|||
161854911|NCT00307437|584508189|FG003|After Controlled Period|Lost to Follow-up|7|||
161854912|NCT00307437|584508190|FG004|After Controlled Period|Lost to Follow-up|12|||
161854913|NCT00307437|584508191|FG005|After Controlled Period|Lost to Follow-up|13|||
161854914|NCT00307437|584508192|FG006|After Controlled Period|Lost to Follow-up|18|||
161854915|NCT00307437|584508186|FG000|After Controlled Period|Other|0|||
161854916|NCT00307437|584508187|FG001|After Controlled Period|Other|0|||
161854917|NCT00307437|584508188|FG002|After Controlled Period|Other|0|||
161854918|NCT00307437|584508189|FG003|After Controlled Period|Other|15|||
161854919|NCT00307437|584508190|FG004|After Controlled Period|Other|9|||
161974750|NCT00355342|584956474|FG001|Overall Study|Withdrawal by Subject|11|||
161974751|NCT00355342|584956473|FG000|Overall Study|Sponsor terminated study|2|||
161974752|NCT00355342|584956474|FG001|Overall Study|Sponsor terminated study|2|||
161974753|NCT00355342|584956473|FG000|Overall Study|Overcompliant-PI discretion|1|||
161974754|NCT00355342|584956474|FG001|Overall Study|Overcompliant-PI discretion|0|||
161767216|NCT01786707|584188895|FG001|Overall Study|Lost to Follow-up|1|||
161854920|NCT00307437|584508191|FG005|After Controlled Period|Other|40|||
161767217|NCT00421928|584188896|FG000|Overall Study|Adverse Event|61|||
161767218|NCT00421928|584188897|FG001|Overall Study|Adverse Event|140|||
161767219|NCT00421928|584188898|FG002|Overall Study|Adverse Event|22|||
161767220|NCT00421928|584188896|FG000|Overall Study|Lost to Follow-up|5|||
161767221|NCT00421928|584188897|FG001|Overall Study|Lost to Follow-up|0|||
161767222|NCT00421928|584188898|FG002|Overall Study|Lost to Follow-up|3|||
161767223|NCT00421928|584188896|FG000|Overall Study|Withdrawal by Subject|50|||
161854921|NCT00307437|584508192|FG006|After Controlled Period|Other|28|||
161854922|NCT03017612|584508196|FG000|Overall Study|Adverse Event|2|||
161854923|NCT01893346|584508197|FG000|Overall Study|Lost to Follow-up|0|||
161854924|NCT01893346|584508198|FG001|Overall Study|Lost to Follow-up|1|||
161974755|NCT00355342|584956473|FG000|Overall Study|Use of prohibited medication|1|||
161974756|NCT00355342|584956474|FG001|Overall Study|Use of prohibited medication|0|||
161974757|NCT00355342|584956473|FG000|Overall Study|COPD exacerbation|1|||
161767224|NCT00421928|584188897|FG001|Overall Study|Withdrawal by Subject|48|||
161767225|NCT00421928|584188898|FG002|Overall Study|Withdrawal by Subject|43|||
161767226|NCT00421928|584188896|FG000|Overall Study|Lack of Efficacy|15|||
161767227|NCT00421928|584188897|FG001|Overall Study|Lack of Efficacy|7|||
161767228|NCT00421928|584188898|FG002|Overall Study|Lack of Efficacy|35|||
161767229|NCT00421928|584188896|FG000|Overall Study|Study drug non-compliant|6|||
161767230|NCT00421928|584188897|FG001|Overall Study|Study drug non-compliant|7|||
161767231|NCT00421928|584188898|FG002|Overall Study|Study drug non-compliant|4|||
161767232|NCT00421928|584188896|FG000|Overall Study|All other|26|||
161767233|NCT00421928|584188897|FG001|Overall Study|All other|21|||
161767234|NCT00421928|584188898|FG002|Overall Study|All other|27|||
161767235|NCT00421928|584188896|FG000|Overall Study|Death|0|||
161767236|NCT00421928|584188897|FG001|Overall Study|Death|1|||
161767237|NCT00421928|584188898|FG002|Overall Study|Death|0|||
161767238|NCT00346775|584188905|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
161767239|NCT00346775|584188906|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
161767240|NCT00346775|584188905|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
161767241|NCT00346775|584188906|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
161767242|NCT00346775|584188905|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
161767243|NCT00346775|584188906|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
161767244|NCT02946515|584188907|FG000|Overall Study|Lost to Follow-up|2|||
161767245|NCT02946515|584188908|FG001|Overall Study|Lost to Follow-up|1|||
161767246|NCT01096017|584188918|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
161767247|NCT01096017|584188919|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
161767248|NCT01545375|584188920|FG000|Overall Study|Adverse Event|2|||
161767249|NCT01545375|584188921|FG001|Overall Study|Adverse Event|1|||
161767250|NCT01545375|584188920|FG000|Overall Study|Lost to Follow-up|34|||
161767251|NCT01545375|584188921|FG001|Overall Study|Lost to Follow-up|31|||
161767252|NCT01545375|584188920|FG000|Overall Study|Protocol Violation|3|||
161767253|NCT01545375|584188921|FG001|Overall Study|Protocol Violation|3|||
161767254|NCT01545375|584188920|FG000|Overall Study|Withdrawal by Subject|58|||
161767255|NCT01545375|584188921|FG001|Overall Study|Withdrawal by Subject|55|||
161767256|NCT00594958|584188923|FG000|Overall Study|Withdrawal by Subject|1|||
161767257|NCT00594958|584188924|FG001|Overall Study|Withdrawal by Subject|0|||
161767258|NCT00594958|584188925|FG002|Overall Study|Withdrawal by Subject|1|||
161767259|NCT00594958|584188923|FG000|Overall Study|Adverse Event|4|||
161767260|NCT00594958|584188924|FG001|Overall Study|Adverse Event|1|||
161767261|NCT00594958|584188925|FG002|Overall Study|Adverse Event|2|||
161767262|NCT00594958|584188923|FG000|Overall Study|Pregnancy|0|||
161767263|NCT00594958|584188924|FG001|Overall Study|Pregnancy|2|||
161767264|NCT00594958|584188925|FG002|Overall Study|Pregnancy|0|||
161767265|NCT00594958|584188923|FG000|Overall Study|Protocol Violation|1|||
161767266|NCT00594958|584188924|FG001|Overall Study|Protocol Violation|0|||
161767267|NCT00594958|584188925|FG002|Overall Study|Protocol Violation|2|||
161767268|NCT00594958|584188923|FG000|Overall Study|Lost to Follow-up|5|||
161767269|NCT00594958|584188924|FG001|Overall Study|Lost to Follow-up|0|||
161767270|NCT00594958|584188925|FG002|Overall Study|Lost to Follow-up|3|||
161767271|NCT00594958|584188923|FG000|Overall Study|administrative|3|||
161767272|NCT00594958|584188924|FG001|Overall Study|administrative|0|||
161767273|NCT00594958|584188925|FG002|Overall Study|administrative|2|||
161767274|NCT03233009|584188926|FG000|Overall Study|Lost to Follow-up|1|||
161767275|NCT03039686|584188927|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
161767276|NCT03039686|584188928|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
161767277|NCT03039686|584188929|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
161767278|NCT03039686|584188927|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
161767279|NCT03039686|584188928|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
161767280|NCT03039686|584188929|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
161767281|NCT03039686|584188927|FG000|Double-blind Period|Withdrawal by Subject|2|||
161767282|NCT03039686|584188928|FG001|Double-blind Period|Withdrawal by Subject|2|||
161767283|NCT03039686|584188929|FG002|Double-blind Period|Withdrawal by Subject|1|||
161767284|NCT03039686|584188927|FG000|Double-blind Period|Death|0|||
161767285|NCT03039686|584188928|FG001|Double-blind Period|Death|0|||
161767286|NCT03039686|584188929|FG002|Double-blind Period|Death|1|||
161767287|NCT03039686|584188927|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
161767288|NCT03039686|584188928|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
161767289|NCT03039686|584188929|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
161767290|NCT03039686|584188927|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
161767291|NCT03039686|584188928|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
161767292|NCT03039686|584188929|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
161767293|NCT03039686|584188927|FG000|Open Label Period|Withdrawal by Subject|0|||
161767294|NCT03039686|584188928|FG001|Open Label Period|Withdrawal by Subject|3|||
161767295|NCT03039686|584188929|FG002|Open Label Period|Withdrawal by Subject|1|||
161767296|NCT02158949|584188930|FG000|Overall Study|Withdrawal by Subject|1|||
162034158|NCT04393298|585181145|FG001|Overall Study|Patient Passed Away|0|||
161767297|NCT02158949|584188931|FG001|Overall Study|Withdrawal by Subject|0|||
161767298|NCT02158949|584188930|FG000|Overall Study|Lost to Follow-up|5|||
161767299|NCT02158949|584188931|FG001|Overall Study|Lost to Follow-up|11|||
161767300|NCT00475657|584188933|FG000|Overall Study|Death|1|||
161767301|NCT00475657|584188933|FG000|Overall Study|Sponsor's Decision|3|||
161767302|NCT00408408|584188934|FG000|Overall Study|No follow up data|2|||
161767303|NCT00408408|584188935|FG001|Overall Study|No follow up data|3|||
161767304|NCT00408408|584188936|FG002|Overall Study|No follow up data|0|||
161767305|NCT00408408|584188937|FG003|Overall Study|No follow up data|7|||
161767306|NCT00408408|584188938|FG004|Overall Study|No follow up data|5|||
161767307|NCT00408408|584188939|FG005|Overall Study|No follow up data|3|||
161767308|NCT02898662|584188946|FG000|Overall Study|Adverse Event|1|||
161767309|NCT02898662|584188947|FG001|Overall Study|Adverse Event|0|||
161767310|NCT02898662|584188946|FG000|Overall Study|Loss of asthma control|23|||
161767311|NCT02898662|584188947|FG001|Overall Study|Loss of asthma control|24|||
161767312|NCT02898662|584188946|FG000|Overall Study|Withdrawal by Subject|4|||
161767313|NCT02898662|584188947|FG001|Overall Study|Withdrawal by Subject|1|||
161767314|NCT02898662|584188946|FG000|Overall Study|Technical issue|0|||
161767315|NCT02898662|584188947|FG001|Overall Study|Technical issue|1|||
161767316|NCT02898662|584188946|FG000|Overall Study|Randomized in error|0|||
161767317|NCT02898662|584188947|FG001|Overall Study|Randomized in error|1|||
161767318|NCT02898662|584188946|FG000|Overall Study|Subject decision|1|||
161767319|NCT02898662|584188947|FG001|Overall Study|Subject decision|0|||
161767320|NCT02898662|584188946|FG000|Overall Study|Other|0|||
161767321|NCT02898662|584188947|FG001|Overall Study|Other|1|||
161767322|NCT00399542|584188948|FG000|Overall Study|Adverse Event|18|||
161767323|NCT00399542|584188949|FG001|Overall Study|Adverse Event|15|||
161767324|NCT00399542|584188948|FG000|Overall Study|Protocol Violation|13|||
161767325|NCT00399542|584188949|FG001|Overall Study|Protocol Violation|3|||
161767326|NCT00399542|584188948|FG000|Overall Study|Withdrawal by Subject|28|||
161767327|NCT00399542|584188949|FG001|Overall Study|Withdrawal by Subject|10|||
161767328|NCT00399542|584188948|FG000|Overall Study|Lack of Efficacy|18|||
161767329|NCT00399542|584188949|FG001|Overall Study|Lack of Efficacy|8|||
161767330|NCT00399542|584188948|FG000|Overall Study|Lost to Follow-up|6|||
161767331|NCT00399542|584188949|FG001|Overall Study|Lost to Follow-up|6|||
161767332|NCT00399542|584188948|FG000|Overall Study|Other|1|||
161767333|NCT00399542|584188949|FG001|Overall Study|Other|0|||
161767334|NCT00399542|584188948|FG000|Overall Study|Physician Decision|0|||
161767335|NCT00399542|584188949|FG001|Overall Study|Physician Decision|1|||
161767336|NCT00917553|584188950|FG000|Overall Study|Lost to Follow-up|2|||
161767337|NCT00917553|584188951|FG001|Overall Study|Lost to Follow-up|1|||
161767338|NCT01616173|584188952|FG000|Overall Study|Lost to Follow-up|0|||
161767339|NCT01616173|584188953|FG001|Overall Study|Lost to Follow-up|2|||
161767340|NCT01616173|584188954|FG002|Overall Study|Lost to Follow-up|0|||
161767341|NCT03172026|584188958|FG000|Overall Study|Withdrawal by Subject|1|||
161767342|NCT03172026|584188959|FG001|Overall Study|Withdrawal by Subject|0|||
161767343|NCT03172026|584188958|FG000|Overall Study|COVID restrictions|1|||
161767344|NCT03172026|584188959|FG001|Overall Study|COVID restrictions|0|||
161767345|NCT01430559|584188963|FG000|Overall Study|Adverse Event|7|||
161854925|NCT01893346|584508199|FG002|Overall Study|Lost to Follow-up|0|||
161854926|NCT01893346|584508200|FG003|Overall Study|Lost to Follow-up|0|||
161854927|NCT01893346|584508197|FG000|Overall Study|Protocol Violation|1|||
161854928|NCT01893346|584508198|FG001|Overall Study|Protocol Violation|0|||
161854929|NCT01893346|584508199|FG002|Overall Study|Protocol Violation|0|||
161854930|NCT01893346|584508200|FG003|Overall Study|Protocol Violation|0|||
161854931|NCT01893346|584508197|FG000|Overall Study|Withdrawal by Subject|2|||
161854932|NCT01893346|584508198|FG001|Overall Study|Withdrawal by Subject|0|||
161854933|NCT01893346|584508199|FG002|Overall Study|Withdrawal by Subject|0|||
161854934|NCT01893346|584508200|FG003|Overall Study|Withdrawal by Subject|0|||
161854935|NCT00985491|584508201|FG000|Overall Study|Adverse Event|8|||
161854936|NCT00985491|584508201|FG000|Overall Study|device migration|7|||
161854937|NCT00985491|584508201|FG000|Overall Study|Withdrawal by Subject|1|||
161854938|NCT00985491|584508201|FG000|Overall Study|implant failure|3|||
161854939|NCT02121652|584509678|FG000|Overall Study|Lost to Follow-up|2|||
161854940|NCT02121652|584509679|FG001|Overall Study|Lost to Follow-up|1|||
161854941|NCT02121652|584509678|FG000|Overall Study|Death|1|||
161854942|NCT02121652|584509679|FG001|Overall Study|Death|0|||
161854943|NCT02121652|584509678|FG000|Overall Study|Withdrawal by Subject|3|||
161854944|NCT02121652|584509679|FG001|Overall Study|Withdrawal by Subject|3|||
161854945|NCT01090414|584509680|FG000|Study 101-99|Progressive Disease|28|||
161854946|NCT01090414|584509681|FG001|Study 101-99|Progressive Disease|48|||
162034159|NCT04393298|585181146|FG002|Overall Study|Patient Passed Away|0|||
161767346|NCT01430559|584188964|FG001|Overall Study|Adverse Event|3|||
161767347|NCT01430559|584188963|FG000|Overall Study|Entry criteria not met|1|||
161767348|NCT01430559|584188964|FG001|Overall Study|Entry criteria not met|1|||
161767349|NCT01430559|584188963|FG000|Overall Study|Lost to Follow-up|1|||
161767350|NCT01430559|584188964|FG001|Overall Study|Lost to Follow-up|0|||
161767351|NCT01430559|584188963|FG000|Overall Study|Medication error|1|||
161767352|NCT01430559|584188964|FG001|Overall Study|Medication error|0|||
161767353|NCT01430559|584188963|FG000|Overall Study|Withdrawal by Subject|3|||
161767354|NCT01430559|584188964|FG001|Overall Study|Withdrawal by Subject|2|||
161767355|NCT01430559|584188963|FG000|Overall Study|Protocol Violation|1|||
161767356|NCT01430559|584188964|FG001|Overall Study|Protocol Violation|0|||
161767357|NCT01430559|584188963|FG000|Overall Study|Other|3|||
161767358|NCT01430559|584188964|FG001|Overall Study|Other|3|||
161767359|NCT01430559|584188963|FG000|Overall Study|Randomized, Not Treated|3|||
161767360|NCT01430559|584188964|FG001|Overall Study|Randomized, Not Treated|3|||
161767361|NCT00504595|584188965|FG000|Overall Study|Lack of Efficacy|1|||
161767362|NCT00504595|584188966|FG001|Overall Study|Lack of Efficacy|0|||
161767363|NCT00504595|584188967|FG002|Overall Study|Lack of Efficacy|0|||
161767364|NCT00504595|584188968|FG003|Overall Study|Lack of Efficacy|0|||
161767365|NCT00504595|584188965|FG000|Overall Study|Other|0|||
161767366|NCT00504595|584188966|FG001|Overall Study|Other|0|||
161767367|NCT00504595|584188967|FG002|Overall Study|Other|2|||
161767368|NCT00504595|584188968|FG003|Overall Study|Other|0|||
161767369|NCT01220024|584188969|FG000|Overall Study|Lost to Follow-up|1|||
161767370|NCT01220024|584188970|FG001|Overall Study|Lost to Follow-up|1|||
161767371|NCT00174460|584188972|FG000|Overall Study|Withdrawal by Subject|0|||
161767372|NCT00174460|584188973|FG001|Overall Study|Withdrawal by Subject|1|||
161767373|NCT00579059|584188974|FG000|Overall Study|Study Canceled at 1 Year|21|||
161767374|NCT00579059|584188975|FG001|Overall Study|Study Canceled at 1 Year|10|||
161767375|NCT00779142|584188976|FG000|Overall Study|Screen Failures|3|||
161767376|NCT04652245|584188977|FG000|Wash-Out Period|Adverse Event|0|||
161767377|NCT04652245|584188978|FG001|Wash-Out Period|Adverse Event|2|||
161767378|NCT04652245|584188977|FG000|Wash-Out Period|Withdrawal by Subject|0|||
161767379|NCT04652245|584188978|FG001|Wash-Out Period|Withdrawal by Subject|2|||
161767380|NCT03137433|584188983|FG000|Overall Study|Withdrawal by Subject|11|||
161767381|NCT03137433|584188984|FG001|Overall Study|Withdrawal by Subject|11|||
161767382|NCT03137433|584188983|FG000|Overall Study|Lost to Follow-up|5|||
161767383|NCT03137433|584188984|FG001|Overall Study|Lost to Follow-up|6|||
161767384|NCT03137433|584188983|FG000|Overall Study|Physician Decision|2|||
161767385|NCT03137433|584188984|FG001|Overall Study|Physician Decision|0|||
161767386|NCT03137433|584188983|FG000|Overall Study|Moved out of study area|1|||
161767387|NCT03137433|584188984|FG001|Overall Study|Moved out of study area|0|||
161767388|NCT03137433|584188983|FG000|Overall Study|Too far out of window due to COVID|0|||
161767389|NCT03137433|584188984|FG001|Overall Study|Too far out of window due to COVID|1|||
161767390|NCT01288911|584188985|FG000|Double-blind Period|Death|11|||
161767391|NCT01288911|584188986|FG001|Double-blind Period|Death|7|||
161767392|NCT01288911|584188985|FG000|Double-blind Period|Lost to Follow-up|0|||
161767393|NCT01288911|584188986|FG001|Double-blind Period|Lost to Follow-up|2|||
161767394|NCT01288911|584188985|FG000|Double-blind Period|Progressive Disease|75|||
161767395|NCT01288911|584188986|FG001|Double-blind Period|Progressive Disease|103|||
161767396|NCT01288911|584188985|FG000|Double-blind Period|Protocol Violation|1|||
161767397|NCT01288911|584188986|FG001|Double-blind Period|Protocol Violation|0|||
161767398|NCT01288911|584188985|FG000|Double-blind Period|Withdrawal by Subject|25|||
161767399|NCT01288911|584188986|FG001|Double-blind Period|Withdrawal by Subject|26|||
161767400|NCT01288911|584188985|FG000|Double-blind Period|Miscellaneous Reason|29|||
161767401|NCT01288911|584188986|FG001|Double-blind Period|Miscellaneous Reason|42|||
161767402|NCT01288911|584188985|FG000|Double-blind Period|Randomized but never received study drug|1|||
161767403|NCT01288911|584188986|FG001|Double-blind Period|Randomized but never received study drug|2|||
161767404|NCT01288911|584188985|FG000|Open-label Period (All Enzalutamide)|Death|0|||
161767405|NCT01288911|584188986|FG001|Open-label Period (All Enzalutamide)|Death|1|||
161767406|NCT01288911|584188985|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
161767407|NCT01288911|584188986|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
161767408|NCT01288911|584188985|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
161767409|NCT01288911|584188986|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
161767410|NCT01288911|584188985|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
161767411|NCT01288911|584188986|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
161767412|NCT01288911|584188985|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
161767413|NCT01288911|584188986|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
161854947|NCT01090414|584509682|FG002|Study 101-99|Progressive Disease|10|||
161854948|NCT01090414|584509683|FG003|Study 101-99|Progressive Disease|4|||
161854949|NCT01090414|584509680|FG000|Study 101-99|Adverse Event|10|||
161854950|NCT01090414|584509681|FG001|Study 101-99|Adverse Event|28|||
161767414|NCT01288911|584188985|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
161854951|NCT01090414|584509682|FG002|Study 101-99|Adverse Event|18|||
161854952|NCT01090414|584509683|FG003|Study 101-99|Adverse Event|0|||
161854953|NCT01090414|584509680|FG000|Study 101-99|Investigator Request|1|||
161854954|NCT01090414|584509681|FG001|Study 101-99|Investigator Request|11|||
161854955|NCT01090414|584509682|FG002|Study 101-99|Investigator Request|4|||
161767415|NCT01288911|584188986|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
161767416|NCT02543918|584188987|FG000|Overall Study|Never treated|0|||
161767417|NCT02543918|584188988|FG001|Overall Study|Never treated|1|||
161767418|NCT02543918|584188987|FG000|Overall Study|Lost to Follow-up|1|||
161854956|NCT01090414|584509683|FG003|Study 101-99|Investigator Request|0|||
161854957|NCT01090414|584509680|FG000|Study 101-99|Death|3|||
161854958|NCT01090414|584509681|FG001|Study 101-99|Death|8|||
161854959|NCT01090414|584509682|FG002|Study 101-99|Death|1|||
161854960|NCT01090414|584509683|FG003|Study 101-99|Death|0|||
161854961|NCT01090414|584509680|FG000|Study 101-99|Sponsor Discontinued Study|0|||
161767419|NCT02543918|584188988|FG001|Overall Study|Lost to Follow-up|1|||
161767420|NCT02543918|584188987|FG000|Overall Study|Withdrawal by Subject|1|||
161767421|NCT02543918|584188988|FG001|Overall Study|Withdrawal by Subject|1|||
161767422|NCT02543918|584188987|FG000|Overall Study|Adverse Event|1|||
161767423|NCT02543918|584188988|FG001|Overall Study|Adverse Event|1|||
161767424|NCT00486720|584188991|FG000|Overall Study|Adverse Event|1|||
161767425|NCT00486720|584188992|FG001|Overall Study|Adverse Event|2|||
161767426|NCT00486720|584188991|FG000|Overall Study|Lack of Efficacy|4|||
161767427|NCT00486720|584188992|FG001|Overall Study|Lack of Efficacy|6|||
161854962|NCT01090414|584509681|FG001|Study 101-99|Sponsor Discontinued Study|7|||
161854963|NCT01090414|584509682|FG002|Study 101-99|Sponsor Discontinued Study|5|||
161854964|NCT01090414|584509683|FG003|Study 101-99|Sponsor Discontinued Study|0|||
161854965|NCT01090414|584509680|FG000|Study 101-99|Other (Unknown Reasons)|3|||
161854966|NCT01090414|584509681|FG001|Study 101-99|Other (Unknown Reasons)|3|||
161854967|NCT01090414|584509682|FG002|Study 101-99|Other (Unknown Reasons)|0|||
161854968|NCT01090414|584509683|FG003|Study 101-99|Other (Unknown Reasons)|0|||
161854969|NCT01090414|584509680|FG000|Study 101-99|Withdrew Consent|0|||
161854970|NCT01090414|584509681|FG001|Study 101-99|Withdrew Consent|2|||
161854971|NCT01090414|584509682|FG002|Study 101-99|Withdrew Consent|3|||
161854972|NCT01090414|584509683|FG003|Study 101-99|Withdrew Consent|1|||
161854973|NCT01090414|584509680|FG000|Study 101-99|Participant Request|3|||
161854974|NCT01090414|584509681|FG001|Study 101-99|Participant Request|1|||
161854975|NCT01090414|584509682|FG002|Study 101-99|Participant Request|0|||
161854976|NCT01090414|584509683|FG003|Study 101-99|Participant Request|0|||
161854977|NCT03022370|584509684|FG000|Overall Study|Death|6|||
161854978|NCT03022370|584509685|FG001|Overall Study|Death|12|||
161854979|NCT03022370|584509684|FG000|Overall Study|Lost to Follow-up|174|||
161854980|NCT03022370|584509685|FG001|Overall Study|Lost to Follow-up|109|||
161854981|NCT00668317|584509686|FG000|Overall Study|Adverse Event|2|||
161854982|NCT04753216|584509687|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
161854983|NCT04753216|584509687|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
161854984|NCT04753216|584509687|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
161854985|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
161854986|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Death|1|||
161854987|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
161854988|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
161854989|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
161854990|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
161854991|NCT02001987|584509689|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
161854992|NCT02001987|584509689|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
161854993|NCT02001987|584509689|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
161854994|NCT02001987|584509689|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
161854995|NCT02001987|584509689|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
161854996|NCT02001987|584509689|FG000|LTE Period (52 Weeks)|Other|3|||
161854997|NCT01965860|584509690|FG000|Overall Study|Pregnancy|1|||
161854998|NCT01965860|584509691|FG001|Overall Study|Pregnancy|0|||
161854999|NCT01965860|584509692|FG002|Overall Study|Pregnancy|1|||
161855000|NCT01965860|584509690|FG000|Overall Study|Logistics|1|||
161855001|NCT01965860|584509691|FG001|Overall Study|Logistics|0|||
161855002|NCT01965860|584509692|FG002|Overall Study|Logistics|0|||
161855003|NCT00769379|584509699|FG000|Overall Study|No follow up data mapped to Other.|3|||
161855004|NCT00769379|584509700|FG001|Overall Study|No follow up data mapped to Other.|13|||
161855005|NCT01884337|584509701|FG000|Treatment|Adverse Event|2|||
161855006|NCT01884337|584509702|FG001|Treatment|Adverse Event|2|||
161855007|NCT01884337|584509701|FG000|Treatment|Subj. request to discont. treatment|2|||
161855008|NCT01884337|584509702|FG001|Treatment|Subj. request to discont. treatment|0|||
161855009|NCT01884337|584509701|FG000|Follow-up Period|Lost to Follow-up|1|||
161855010|NCT01884337|584509702|FG001|Follow-up Period|Lost to Follow-up|1|||
161855011|NCT02455518|584509703|FG000|Overall Study|Protocol Violation|0|||
161855012|NCT02455518|584509704|FG001|Overall Study|Protocol Violation|1|||
161855013|NCT02455518|584509705|FG002|Overall Study|Protocol Violation|1|||
161855014|NCT02455518|584509706|FG003|Overall Study|Protocol Violation|3|||
161855015|NCT02508935|584509707|FG000|Overall Study|Withdrawal by Subject|1|||
161855016|NCT02508935|584509707|FG000|Overall Study|Withdrawal by Caregiver|8|||
161855017|NCT02508935|584509707|FG000|Overall Study|Pain Score <4|1|||
161855018|NCT02508935|584509707|FG000|Overall Study|Emesis|3|||
161855019|NCT02508935|584509707|FG000|Overall Study|Adverse Event|3|||
161855020|NCT02508935|584509707|FG000|Overall Study|Protocol Violation|1|||
161855021|NCT02508935|584509707|FG000|Overall Study|Physician Decision|1|||
161767428|NCT00486720|584188991|FG000|Overall Study|Physician Decision|1|||
161767429|NCT00486720|584188992|FG001|Overall Study|Physician Decision|2|||
161767430|NCT00486720|584188991|FG000|Overall Study|Protocol Violation|1|||
161855022|NCT02508935|584509707|FG000|Overall Study|Trial terminated by sponsor|5|||
161855023|NCT01332292|584509724|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
161855024|NCT01332292|584509725|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
161767431|NCT00486720|584188992|FG001|Overall Study|Protocol Violation|0|||
161767432|NCT00486720|584188991|FG000|Overall Study|Withdrawal by Subject|3|||
161767433|NCT00486720|584188992|FG001|Overall Study|Withdrawal by Subject|1|||
161767434|NCT00486720|584188991|FG000|Overall Study|Progressive Disease|0|||
161767435|NCT00486720|584188992|FG001|Overall Study|Progressive Disease|1|||
161767436|NCT02452892|584188995|FG000|Week 1 Initial Randommization|Adverse Event|1|||
161767437|NCT02452892|584188996|FG001|Week 1 Initial Randommization|Adverse Event|0|||
161767438|NCT02452892|584188997|FG002|Week 1 Initial Randommization|Adverse Event|0|||
161767439|NCT02452892|584188998|FG003|Week 1 Initial Randommization|Adverse Event|0|||
161767440|NCT02452892|584188995|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
161767441|NCT02452892|584188996|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
161767442|NCT02452892|584188997|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
161767443|NCT02452892|584188998|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
161767444|NCT02452892|584188995|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
161767445|NCT02452892|584188996|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
161767446|NCT02452892|584188997|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
161767447|NCT02452892|584188998|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
161767448|NCT02452892|584188995|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
161767449|NCT02452892|584188996|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
161767450|NCT02452892|584188997|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
161767451|NCT02452892|584188998|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
161767452|NCT02452892|584188995|FG000|Follow-up|Withdrawal by Subject|0|||
161767453|NCT02452892|584188996|FG001|Follow-up|Withdrawal by Subject|0|||
161767454|NCT02452892|584188997|FG002|Follow-up|Withdrawal by Subject|0|||
161767455|NCT02452892|584188998|FG003|Follow-up|Withdrawal by Subject|1|||
161767456|NCT02452892|584188995|FG000|Follow-up|Subject left town on Day 42|1|||
161767457|NCT02452892|584188996|FG001|Follow-up|Subject left town on Day 42|0|||
161767458|NCT02452892|584188997|FG002|Follow-up|Subject left town on Day 42|0|||
161767459|NCT02452892|584188998|FG003|Follow-up|Subject left town on Day 42|0|||
161767460|NCT03137173|584189001|FG000|Overall Study|Withdrawal by Subject|8|||
161767461|NCT03137173|584189002|FG001|Overall Study|Withdrawal by Subject|13|||
161767462|NCT03137173|584189001|FG000|Overall Study|Death|1|||
161767463|NCT03137173|584189002|FG001|Overall Study|Death|3|||
161767464|NCT03137173|584189001|FG000|Overall Study|Physician Decision|1|||
161855025|NCT01332292|584509724|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
161855026|NCT01332292|584509725|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
161855027|NCT01332292|584509724|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
161855028|NCT01332292|584509725|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
161855029|NCT00104572|584509726|FG000|Overall Study|Withdrawal by Subject|3|||
161974758|NCT00355342|584956474|FG001|Overall Study|COPD exacerbation|1|||
161974759|NCT00355342|584956473|FG000|Overall Study|Dispensed wrong study drug kit|1|||
161974760|NCT00355342|584956474|FG001|Overall Study|Dispensed wrong study drug kit|0|||
161974761|NCT00355342|584956473|FG000|Overall Study|Non-compliance with Dexa scans|1|||
161974762|NCT00355342|584956474|FG001|Overall Study|Non-compliance with Dexa scans|0|||
161974763|NCT00355342|584956473|FG000|Overall Study|Withdrawal by participant and physician|1|||
161767465|NCT03137173|584189002|FG001|Overall Study|Physician Decision|0|||
161767466|NCT03137173|584189001|FG000|Overall Study|Lost to Follow-up|13|||
161767467|NCT03137173|584189002|FG001|Overall Study|Lost to Follow-up|18|||
161767468|NCT03137173|584189001|FG000|Overall Study|Other reasons|3|||
161767469|NCT03137173|584189002|FG001|Overall Study|Other reasons|2|||
161767470|NCT05060003|584189003|FG000|Overall Study|ctDNA negative|7|||
161767471|NCT01373294|584189004|FG000|Overall Study|Adverse Event|1|||
161767472|NCT01373294|584189005|FG001|Overall Study|Adverse Event|0|||
161767473|NCT00423267|584189006|FG000|Period A|Withdrawal by Subject|0|||
161767474|NCT00423267|584189007|FG001|Period A|Withdrawal by Subject|1|||
161767475|NCT00423267|584189006|FG000|Period A|Non-compliance with protocol|1|||
161767476|NCT00423267|584189007|FG001|Period A|Non-compliance with protocol|0|||
161767477|NCT00423267|584189006|FG000|Period A|Administrative|1|||
161767478|NCT00423267|584189007|FG001|Period A|Administrative|0|||
161767479|NCT01333865|584189008|FG000|Overall Study|Adverse Event|2|||
161767480|NCT03512028|584189009|FG000|Overall Study|Withdrawal by Subject|2|||
161855030|NCT00104572|584509727|FG001|Overall Study|Withdrawal by Subject|3|||
161855031|NCT00104572|584509728|FG002|Overall Study|Withdrawal by Subject|0|||
161855032|NCT00098774|584509729|FG000|Overall Study|Adverse Event|2|||
161855033|NCT00098774|584509729|FG000|Overall Study|Disease Progression|9|||
161974764|NCT00355342|584956474|FG001|Overall Study|Withdrawal by participant and physician|0|||
161974765|NCT00355342|584956473|FG000|Overall Study|Participant relocated|0|||
161767481|NCT03512028|584189010|FG001|Overall Study|Withdrawal by Subject|0|||
161767482|NCT03512028|584189009|FG000|Overall Study|Protocol Violation|2|||
161767483|NCT03512028|584189010|FG001|Overall Study|Protocol Violation|0|||
161767484|NCT00554229|584189015|FG000|Overall Study|Lost to Follow-up|3|||
161767485|NCT00554229|584189016|FG001|Overall Study|Lost to Follow-up|6|||
161767486|NCT00554229|584189015|FG000|Overall Study|Withdrawal by Subject|29|||
161767487|NCT00554229|584189016|FG001|Overall Study|Withdrawal by Subject|37|||
161767488|NCT00554229|584189015|FG000|Overall Study|Adverse Event|71|||
161767489|NCT00554229|584189016|FG001|Overall Study|Adverse Event|39|||
161767490|NCT00554229|584189015|FG000|Overall Study|Protocol Violation|3|||
161767491|NCT00554229|584189016|FG001|Overall Study|Protocol Violation|3|||
161767492|NCT00554229|584189015|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
161767493|NCT00554229|584189016|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
161767494|NCT00554229|584189015|FG000|Overall Study|Randomised but no treatment received|1|||
161767495|NCT00554229|584189016|FG001|Overall Study|Randomised but no treatment received|0|||
161767496|NCT00517634|584189017|FG000|Second Treatment Period|Withdrawal by Subject|0|||
161767497|NCT00517634|584189018|FG001|Second Treatment Period|Withdrawal by Subject|0|||
161767498|NCT00517634|584189019|FG002|Second Treatment Period|Withdrawal by Subject|0|||
161767499|NCT00517634|584189020|FG003|Second Treatment Period|Withdrawal by Subject|0|||
161767500|NCT00517634|584189021|FG004|Second Treatment Period|Withdrawal by Subject|1|||
161767501|NCT00517634|584189022|FG005|Second Treatment Period|Withdrawal by Subject|0|||
161767502|NCT03143855|584189023|FG000|Overall Study|Withdrawal by Subject|4|||
161767503|NCT03143855|584189024|FG001|Overall Study|Withdrawal by Subject|3|||
161767504|NCT03143855|584189023|FG000|Overall Study|Protocol Violation|1|||
161767505|NCT03143855|584189024|FG001|Overall Study|Protocol Violation|0|||
161767506|NCT03143855|584189023|FG000|Overall Study|Participant experienced withdrawal|0|||
161767507|NCT03143855|584189024|FG001|Overall Study|Participant experienced withdrawal|1|||
161767508|NCT00701064|584189027|FG000|Overall Study|Protocol Violation|1|||
161767509|NCT00701064|584189028|FG001|Overall Study|Protocol Violation|1|||
161767510|NCT00701064|584189027|FG000|Overall Study|Withdrawal by Subject|1|||
161767511|NCT00701064|584189028|FG001|Overall Study|Withdrawal by Subject|1|||
161767512|NCT00701064|584189027|FG000|Overall Study|initiated other PTSD treatment|2|||
161767513|NCT00701064|584189028|FG001|Overall Study|initiated other PTSD treatment|2|||
161767514|NCT02098733|584189029|FG000|Overall Study|Data Not Available|5|||
161767515|NCT02098733|584189029|FG000|Overall Study|Lost to Follow-up|5|||
161767516|NCT00939094|584189030|FG000|Overall Study|Adverse Event|9|||
161767517|NCT00939094|584189031|FG001|Overall Study|Adverse Event|0|||
161767518|NCT00939094|584189030|FG000|Overall Study|Withdrawal by Subject|1|||
161767519|NCT00939094|584189031|FG001|Overall Study|Withdrawal by Subject|6|||
161767520|NCT00939094|584189030|FG000|Overall Study|Lost to Follow-up|1|||
161767521|NCT00939094|584189031|FG001|Overall Study|Lost to Follow-up|1|||
161767522|NCT00939094|584189030|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161767523|NCT00939094|584189031|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161767524|NCT00939094|584189030|FG000|Overall Study|Severe non-compliance to protocol|0|||
161767525|NCT00939094|584189031|FG001|Overall Study|Severe non-compliance to protocol|1|||
161767526|NCT00939094|584189030|FG000|Overall Study|Study stopped by sponsor|0|||
161767527|NCT00939094|584189031|FG001|Overall Study|Study stopped by sponsor|2|||
161767528|NCT00939094|584189030|FG000|Overall Study|Abnormal ECG findings|1|||
161767529|NCT00939094|584189031|FG001|Overall Study|Abnormal ECG findings|0|||
161767530|NCT01002573|584190664|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
161767531|NCT01002573|584190665|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
161767532|NCT02713490|584190669|FG000|Overall Study|Withdrawal by Subject|2|||
161767533|NCT02713490|584190670|FG001|Overall Study|Withdrawal by Subject|1|||
161767534|NCT02713490|584190669|FG000|Overall Study|Did not receive study drug|1|||
161767535|NCT02713490|584190670|FG001|Overall Study|Did not receive study drug|0|||
161767536|NCT02713490|584190669|FG000|Overall Study|Met exclusion criteria|0|||
161767537|NCT02713490|584190670|FG001|Overall Study|Met exclusion criteria|1|||
161767538|NCT00134563|584190676|FG000|Overall Study|Not treated due to protocol violation|0|||
161767539|NCT00134563|584190677|FG001|Overall Study|Not treated due to protocol violation|1|||
161767540|NCT00134563|584190678|FG002|Overall Study|Not treated due to protocol violation|1|||
161767541|NCT00134563|584190676|FG000|Overall Study|Adverse Event|29|||
161767542|NCT00134563|584190677|FG001|Overall Study|Adverse Event|37|||
161767543|NCT00134563|584190678|FG002|Overall Study|Adverse Event|38|||
162034160|NCT04393298|585181147|FG003|Overall Study|Patient Passed Away|0|||
162034161|NCT04393298|585181148|FG004|Overall Study|Patient Passed Away|0|||
162034162|NCT04393298|585181149|FG005|Overall Study|Patient Passed Away|0|||
161767544|NCT00134563|584190676|FG000|Overall Study|Lack of Efficacy|24|||
162034163|NCT04393298|585181150|FG006|Overall Study|Patient Passed Away|0|||
162034164|NCT04393298|585181151|FG007|Overall Study|Patient Passed Away|1|||
162034165|NCT04393298|585181152|FG008|Overall Study|Patient Passed Away|0|||
162034166|NCT04393298|585181153|FG009|Overall Study|Patient Passed Away|0|||
162034167|NCT04393298|585181154|FG010|Overall Study|Patient Passed Away|0|||
162034168|NCT04393298|585181155|FG011|Overall Study|Patient Passed Away|0|||
161767545|NCT00134563|584190677|FG001|Overall Study|Lack of Efficacy|14|||
161767546|NCT00134563|584190678|FG002|Overall Study|Lack of Efficacy|17|||
161767547|NCT00134563|584190676|FG000|Overall Study|Protocol Violation|3|||
161767548|NCT00134563|584190677|FG001|Overall Study|Protocol Violation|2|||
161767549|NCT00134563|584190678|FG002|Overall Study|Protocol Violation|5|||
161767550|NCT00134563|584190676|FG000|Overall Study|Lost to Follow-up|4|||
161767551|NCT00134563|584190677|FG001|Overall Study|Lost to Follow-up|0|||
161767552|NCT00134563|584190678|FG002|Overall Study|Lost to Follow-up|2|||
161767553|NCT00134563|584190676|FG000|Overall Study|progressive disease|11|||
161767554|NCT00134563|584190677|FG001|Overall Study|progressive disease|4|||
161767555|NCT00134563|584190678|FG002|Overall Study|progressive disease|2|||
161767556|NCT00134563|584190676|FG000|Overall Study|did not wish to continue|33|||
161767557|NCT00134563|584190677|FG001|Overall Study|did not wish to continue|32|||
161767558|NCT00134563|584190678|FG002|Overall Study|did not wish to continue|26|||
161767559|NCT00134563|584190676|FG000|Overall Study|Reason other than above|0|||
161767560|NCT00134563|584190677|FG001|Overall Study|Reason other than above|2|||
161767561|NCT00134563|584190678|FG002|Overall Study|Reason other than above|5|||
161767562|NCT03382639|584190679|FG000|Overall Study|Adverse Event|2|||
161767563|NCT03382639|584190680|FG001|Overall Study|Adverse Event|0|||
161767564|NCT03382639|584190681|FG002|Overall Study|Adverse Event|1|||
161767565|NCT03382639|584190682|FG003|Overall Study|Adverse Event|1|||
161767566|NCT03382639|584190679|FG000|Overall Study|Lost to Follow-up|1|||
161767567|NCT03382639|584190680|FG001|Overall Study|Lost to Follow-up|0|||
161767568|NCT03382639|584190681|FG002|Overall Study|Lost to Follow-up|0|||
161767569|NCT03382639|584190682|FG003|Overall Study|Lost to Follow-up|0|||
161767570|NCT03382639|584190679|FG000|Overall Study|Withdrawal by Subject|4|||
161767571|NCT03382639|584190680|FG001|Overall Study|Withdrawal by Subject|3|||
161767572|NCT03382639|584190681|FG002|Overall Study|Withdrawal by Subject|2|||
161767573|NCT03382639|584190682|FG003|Overall Study|Withdrawal by Subject|3|||
161767574|NCT03382639|584190679|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
161767575|NCT03382639|584190680|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
161767576|NCT03382639|584190681|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
161767577|NCT03382639|584190682|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
161767578|NCT03382639|584190679|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
161767579|NCT03382639|584190680|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
161767580|NCT03382639|584190681|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
161767581|NCT03382639|584190682|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
161767582|NCT03382639|584190679|FG000|Overall Study|Other|2|||
161767583|NCT03382639|584190680|FG001|Overall Study|Other|0|||
161767584|NCT03382639|584190681|FG002|Overall Study|Other|0|||
161767585|NCT03382639|584190682|FG003|Overall Study|Other|3|||
161767586|NCT02406586|584190683|FG000|Overall Study|Lost to Follow-up|0|||
161767587|NCT02406586|584190684|FG001|Overall Study|Lost to Follow-up|4|||
161767588|NCT02406586|584190685|FG002|Overall Study|Lost to Follow-up|2|||
161767589|NCT02406586|584190683|FG000|Overall Study|Withdrawal by Subject|1|||
161767590|NCT02406586|584190684|FG001|Overall Study|Withdrawal by Subject|0|||
161767591|NCT02406586|584190685|FG002|Overall Study|Withdrawal by Subject|0|||
161767592|NCT00285857|584190688|FG000|Overall Study|Withdrawal by Subject|2|||
161767593|NCT00285857|584190688|FG000|Overall Study|Inadequate initial breast cytology|1|||
161767594|NCT00285857|584190688|FG000|Overall Study|Adverse Event|1|||
161767595|NCT06104423|584190693|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
161767596|NCT06104423|584190694|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
161767597|NCT06104423|584190695|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
161767598|NCT06104423|584190693|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
161767599|NCT06104423|584190694|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
161767600|NCT06104423|584190695|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
161767601|NCT00351611|584190700|FG000|Overall Study|Adverse Event|11|||
161767602|NCT00351611|584190701|FG001|Overall Study|Adverse Event|3|||
161767603|NCT00351611|584190700|FG000|Overall Study|Death|1|||
161767604|NCT00351611|584190701|FG001|Overall Study|Death|0|||
161767605|NCT00351611|584190700|FG000|Overall Study|Lost to Follow-up|1|||
161767606|NCT00351611|584190701|FG001|Overall Study|Lost to Follow-up|0|||
161767607|NCT00351611|584190700|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
161767608|NCT00351611|584190701|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
161767609|NCT00351611|584190700|FG000|Overall Study|Other|1|||
161767610|NCT00351611|584190701|FG001|Overall Study|Other|0|||
161767611|NCT00351611|584190700|FG000|Overall Study|Protocol Violation|0|||
161767612|NCT00351611|584190701|FG001|Overall Study|Protocol Violation|2|||
161767613|NCT01589185|584190702|FG000|Overall Study|Death|1|||
161855034|NCT00098774|584509729|FG000|Overall Study|Withdrawal by Subject|1|||
161767614|NCT01589185|584190703|FG001|Overall Study|Death|2|||
161767615|NCT01589185|584190704|FG002|Overall Study|Death|2|||
161767616|NCT01589185|584190705|FG003|Overall Study|Death|0|||
161767617|NCT01589185|584190706|FG004|Overall Study|Death|1|||
161767618|NCT01589185|584190702|FG000|Overall Study|Lost to Follow-up|1|||
161767619|NCT01589185|584190703|FG001|Overall Study|Lost to Follow-up|0|||
161767620|NCT01589185|584190704|FG002|Overall Study|Lost to Follow-up|2|||
161767621|NCT01589185|584190705|FG003|Overall Study|Lost to Follow-up|3|||
161767622|NCT01589185|584190706|FG004|Overall Study|Lost to Follow-up|0|||
161767623|NCT02708524|584190707|FG000|Overall Study|Adverse Event|0|||
161767624|NCT02708524|584190708|FG001|Overall Study|Adverse Event|1|||
161767625|NCT02708524|584190709|FG002|Overall Study|Adverse Event|0|||
161767626|NCT02708524|584190710|FG003|Overall Study|Adverse Event|0|||
161767627|NCT02708524|584190707|FG000|Overall Study|Lens Discomfort|1|||
161767628|NCT02708524|584190708|FG001|Overall Study|Lens Discomfort|0|||
161767629|NCT02708524|584190709|FG002|Overall Study|Lens Discomfort|1|||
161767630|NCT02708524|584190710|FG003|Overall Study|Lens Discomfort|0|||
161767631|NCT02708524|584190707|FG000|Overall Study|Lost to Follow-up|1|||
161767632|NCT02708524|584190708|FG001|Overall Study|Lost to Follow-up|1|||
161767633|NCT02708524|584190709|FG002|Overall Study|Lost to Follow-up|1|||
161767634|NCT02708524|584190710|FG003|Overall Study|Lost to Follow-up|0|||
161767635|NCT02708524|584190707|FG000|Overall Study|Protocol Violation|0|||
161767636|NCT02708524|584190708|FG001|Overall Study|Protocol Violation|1|||
161767637|NCT02708524|584190709|FG002|Overall Study|Protocol Violation|0|||
161767638|NCT02708524|584190710|FG003|Overall Study|Protocol Violation|0|||
161767639|NCT02708524|584190707|FG000|Overall Study|Withdrawal by Subject|1|||
161767640|NCT02708524|584190708|FG001|Overall Study|Withdrawal by Subject|1|||
161767641|NCT02708524|584190709|FG002|Overall Study|Withdrawal by Subject|0|||
161767642|NCT02708524|584190710|FG003|Overall Study|Withdrawal by Subject|0|||
161767643|NCT02708524|584190707|FG000|Overall Study|Dispensed incorrect study lens|0|||
161767644|NCT02708524|584190708|FG001|Overall Study|Dispensed incorrect study lens|1|||
161767645|NCT02708524|584190709|FG002|Overall Study|Dispensed incorrect study lens|1|||
161767646|NCT02708524|584190710|FG003|Overall Study|Dispensed incorrect study lens|0|||
161767647|NCT02708524|584190707|FG000|Overall Study|Did not wear lens at final visit|0|||
161767648|NCT02708524|584190708|FG001|Overall Study|Did not wear lens at final visit|1|||
161767649|NCT02708524|584190709|FG002|Overall Study|Did not wear lens at final visit|0|||
161974766|NCT00355342|584956474|FG001|Overall Study|Participant relocated|1|||
161974767|NCT00355342|584956473|FG000|Overall Study|Participant discontinued study drug|0|||
161767650|NCT02708524|584190710|FG003|Overall Study|Did not wear lens at final visit|0|||
161767651|NCT02708524|584190707|FG000|Overall Study|Subject lost study lens|1|||
161767652|NCT02708524|584190708|FG001|Overall Study|Subject lost study lens|0|||
161767653|NCT02708524|584190709|FG002|Overall Study|Subject lost study lens|0|||
161767654|NCT02708524|584190710|FG003|Overall Study|Subject lost study lens|0|||
161767655|NCT03781167|584190716|FG000|Overall Study|Adverse Event|23|||
161767656|NCT03781167|584190717|FG001|Overall Study|Adverse Event|25|||
161767657|NCT03781167|584190716|FG000|Overall Study|Withdrew consent|16|||
161767658|NCT03781167|584190717|FG001|Overall Study|Withdrew consent|12|||
161767659|NCT03781167|584190716|FG000|Overall Study|Lost to Follow-up|0|||
161767660|NCT03781167|584190717|FG001|Overall Study|Lost to Follow-up|1|||
161767661|NCT03781167|584190716|FG000|Overall Study|Lack of Efficacy|4|||
161767662|NCT03781167|584190717|FG001|Overall Study|Lack of Efficacy|5|||
161767663|NCT03781167|584190716|FG000|Overall Study|Difficulty with drug delivery system|2|||
161767664|NCT03781167|584190717|FG001|Overall Study|Difficulty with drug delivery system|3|||
161767665|NCT03781167|584190716|FG000|Overall Study|Other, not specified|2|||
161767666|NCT03781167|584190717|FG001|Overall Study|Other, not specified|2|||
161767667|NCT00462501|584190718|FG000|Overall Study|Not treated|3|||
161767668|NCT00462501|584190718|FG000|Overall Study|Adverse Event|2|||
161767669|NCT00679354|584190723|FG000|Overall Study|Death|3|||
161767670|NCT00679354|584190723|FG000|Overall Study|Lack of Efficacy|22|||
161767671|NCT00679354|584190723|FG000|Overall Study|Physician Decision|4|||
161767672|NCT00679354|584190723|FG000|Overall Study|Ineligible|1|||
161767673|NCT01258803|584190724|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
161767674|NCT01258803|584190725|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
161767675|NCT01258803|584190726|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
161767676|NCT01258803|584190727|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
161767677|NCT01258803|584190728|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
161767678|NCT01258803|584190729|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
161767679|NCT01258803|584190724|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161767680|NCT01258803|584190725|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
161767681|NCT01258803|584190726|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161767682|NCT01258803|584190727|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161767683|NCT01258803|584190728|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161767684|NCT01258803|584190729|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161767685|NCT01258803|584190724|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161767686|NCT01258803|584190725|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161767687|NCT01258803|584190726|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
161767688|NCT01258803|584190727|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161767689|NCT01258803|584190728|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161767690|NCT01258803|584190729|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161767691|NCT01552408|584190730|FG000|Overall Study|Lost to Follow-up|2|||
161767692|NCT01552408|584190731|FG001|Overall Study|Lost to Follow-up|0|||
161767693|NCT01552408|584190730|FG000|Overall Study|Relocation|0|||
161767694|NCT01552408|584190731|FG001|Overall Study|Relocation|1|||
161767695|NCT01552408|584190730|FG000|Overall Study|Withdrawal by Subject|2|||
161767696|NCT01552408|584190731|FG001|Overall Study|Withdrawal by Subject|1|||
161767697|NCT01016912|584190735|FG000|End of Treatment Period|Lack of Efficacy|0|||
161767698|NCT01016912|584190736|FG001|End of Treatment Period|Lack of Efficacy|1|||
161767699|NCT01016912|584190737|FG002|End of Treatment Period|Lack of Efficacy|0|||
161767700|NCT01016912|584190738|FG003|End of Treatment Period|Lack of Efficacy|4|||
161767701|NCT01016912|584190739|FG004|End of Treatment Period|Lack of Efficacy|4|||
161767702|NCT01016912|584190735|FG000|End of Treatment Period|Adverse Event|0|||
161767703|NCT01016912|584190736|FG001|End of Treatment Period|Adverse Event|1|||
161767704|NCT01016912|584190737|FG002|End of Treatment Period|Adverse Event|1|||
161767705|NCT01016912|584190738|FG003|End of Treatment Period|Adverse Event|0|||
161767706|NCT01016912|584190739|FG004|End of Treatment Period|Adverse Event|0|||
161767707|NCT01016912|584190735|FG000|End of Treatment Period|Completed double-blind period only|0|||
161767708|NCT01016912|584190736|FG001|End of Treatment Period|Completed double-blind period only|1|||
161767709|NCT01016912|584190737|FG002|End of Treatment Period|Completed double-blind period only|0|||
161767710|NCT01016912|584190738|FG003|End of Treatment Period|Completed double-blind period only|0|||
161767711|NCT01016912|584190739|FG004|End of Treatment Period|Completed double-blind period only|0|||
161767712|NCT01016912|584190735|FG000|Follow-up Period|Other reason|0|||
161767713|NCT01016912|584190736|FG001|Follow-up Period|Other reason|0|||
161767714|NCT01016912|584190737|FG002|Follow-up Period|Other reason|1|||
161767715|NCT01016912|584190738|FG003|Follow-up Period|Other reason|1|||
161767716|NCT01016912|584190739|FG004|Follow-up Period|Other reason|0|||
161767717|NCT01853397|584190742|FG000|Overall Study|Withdrawal by Subject|0|||
161767718|NCT01853397|584190743|FG001|Overall Study|Withdrawal by Subject|0|||
161767719|NCT01853397|584190744|FG002|Overall Study|Withdrawal by Subject|0|||
161767720|NCT01853397|584190745|FG003|Overall Study|Withdrawal by Subject|1|||
161767721|NCT01853397|584190742|FG000|Overall Study|Subject Noncompliance|0|||
161767722|NCT01853397|584190743|FG001|Overall Study|Subject Noncompliance|0|||
161767723|NCT01853397|584190744|FG002|Overall Study|Subject Noncompliance|0|||
161767724|NCT01853397|584190745|FG003|Overall Study|Subject Noncompliance|1|||
161767725|NCT01632345|584190746|FG000|Treatment: Part I|Adverse Event|1|||
161767726|NCT01632345|584190747|FG001|Treatment: Part I|Adverse Event|4|||
161767727|NCT01632345|584190748|FG002|Treatment: Part I|Adverse Event|2|||
161767728|NCT01632345|584190749|FG003|Treatment: Part I|Adverse Event|1|||
161767729|NCT01632345|584190750|FG004|Treatment: Part I|Adverse Event|3|||
161767730|NCT01632345|584190751|FG005|Treatment: Part I|Adverse Event|0|||
161767731|NCT01632345|584190752|FG006|Treatment: Part I|Adverse Event|0|||
161767732|NCT01632345|584190746|FG000|Treatment: Part I|Lack of Efficacy|0|||
161767733|NCT01632345|584190747|FG001|Treatment: Part I|Lack of Efficacy|1|||
161767734|NCT01632345|584190748|FG002|Treatment: Part I|Lack of Efficacy|0|||
161767735|NCT01632345|584190749|FG003|Treatment: Part I|Lack of Efficacy|1|||
161767736|NCT01632345|584190750|FG004|Treatment: Part I|Lack of Efficacy|1|||
161767737|NCT01632345|584190751|FG005|Treatment: Part I|Lack of Efficacy|0|||
161767738|NCT01632345|584190752|FG006|Treatment: Part I|Lack of Efficacy|0|||
161767739|NCT01632345|584190746|FG000|Treatment: Part I|Lost to Follow-up|3|||
161767740|NCT01632345|584190747|FG001|Treatment: Part I|Lost to Follow-up|2|||
161767741|NCT01632345|584190748|FG002|Treatment: Part I|Lost to Follow-up|1|||
161767742|NCT01632345|584190749|FG003|Treatment: Part I|Lost to Follow-up|3|||
161767743|NCT01632345|584190750|FG004|Treatment: Part I|Lost to Follow-up|4|||
161767744|NCT01632345|584190751|FG005|Treatment: Part I|Lost to Follow-up|0|||
161767745|NCT01632345|584190752|FG006|Treatment: Part I|Lost to Follow-up|0|||
161767746|NCT01632345|584190746|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
161767747|NCT01632345|584190747|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
161767748|NCT01632345|584190748|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
161767749|NCT01632345|584190749|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
161767750|NCT01632345|584190750|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
161767751|NCT01632345|584190751|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
161767752|NCT01632345|584190752|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
161767753|NCT01632345|584190746|FG000|Treatment: Part I|Physician Decision|2|||
161767754|NCT01632345|584190747|FG001|Treatment: Part I|Physician Decision|1|||
161767755|NCT01632345|584190748|FG002|Treatment: Part I|Physician Decision|0|||
161767756|NCT01632345|584190749|FG003|Treatment: Part I|Physician Decision|0|||
161767757|NCT01632345|584190750|FG004|Treatment: Part I|Physician Decision|1|||
161767758|NCT01632345|584190751|FG005|Treatment: Part I|Physician Decision|0|||
161767759|NCT01632345|584190752|FG006|Treatment: Part I|Physician Decision|0|||
161767760|NCT01632345|584190746|FG000|Treatment: Part I|Pregnancy|0|||
161767761|NCT01632345|584190747|FG001|Treatment: Part I|Pregnancy|1|||
161767762|NCT01632345|584190748|FG002|Treatment: Part I|Pregnancy|0|||
161767763|NCT01632345|584190749|FG003|Treatment: Part I|Pregnancy|0|||
161767764|NCT01632345|584190750|FG004|Treatment: Part I|Pregnancy|0|||
161767765|NCT01632345|584190751|FG005|Treatment: Part I|Pregnancy|0|||
161767766|NCT01632345|584190752|FG006|Treatment: Part I|Pregnancy|0|||
161767767|NCT01632345|584190746|FG000|Treatment: Part I|Protocol Deviation|0|||
161767768|NCT01632345|584190747|FG001|Treatment: Part I|Protocol Deviation|0|||
161767769|NCT01632345|584190748|FG002|Treatment: Part I|Protocol Deviation|1|||
161767770|NCT01632345|584190749|FG003|Treatment: Part I|Protocol Deviation|1|||
161767771|NCT01632345|584190750|FG004|Treatment: Part I|Protocol Deviation|0|||
161767772|NCT01632345|584190751|FG005|Treatment: Part I|Protocol Deviation|0|||
161767773|NCT01632345|584190752|FG006|Treatment: Part I|Protocol Deviation|0|||
161767774|NCT01632345|584190746|FG000|Treatment: Part I|Withdrawal by Subject|3|||
161767775|NCT01632345|584190747|FG001|Treatment: Part I|Withdrawal by Subject|4|||
161767776|NCT01632345|584190748|FG002|Treatment: Part I|Withdrawal by Subject|4|||
161767777|NCT01632345|584190749|FG003|Treatment: Part I|Withdrawal by Subject|1|||
161767778|NCT01632345|584190750|FG004|Treatment: Part I|Withdrawal by Subject|4|||
161767779|NCT01632345|584190751|FG005|Treatment: Part I|Withdrawal by Subject|0|||
161767780|NCT01632345|584190752|FG006|Treatment: Part I|Withdrawal by Subject|0|||
161767781|NCT01632345|584190746|FG000|Treatment: Part II|Adverse Event|0|||
161767782|NCT01632345|584190747|FG001|Treatment: Part II|Adverse Event|0|||
161767783|NCT01632345|584190748|FG002|Treatment: Part II|Adverse Event|0|||
161767784|NCT01632345|584190749|FG003|Treatment: Part II|Adverse Event|0|||
161767785|NCT01632345|584190750|FG004|Treatment: Part II|Adverse Event|0|||
161767786|NCT01632345|584190751|FG005|Treatment: Part II|Adverse Event|3|||
161767787|NCT01632345|584190752|FG006|Treatment: Part II|Adverse Event|8|||
161767788|NCT01632345|584190746|FG000|Treatment: Part II|Lost to Follow-up|0|||
161767789|NCT01632345|584190747|FG001|Treatment: Part II|Lost to Follow-up|0|||
161767790|NCT01632345|584190748|FG002|Treatment: Part II|Lost to Follow-up|0|||
161767791|NCT01632345|584190749|FG003|Treatment: Part II|Lost to Follow-up|0|||
161767792|NCT01632345|584190750|FG004|Treatment: Part II|Lost to Follow-up|0|||
161767793|NCT01632345|584190751|FG005|Treatment: Part II|Lost to Follow-up|3|||
161767794|NCT01632345|584190752|FG006|Treatment: Part II|Lost to Follow-up|1|||
161767795|NCT01632345|584190746|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
161767796|NCT01632345|584190747|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
161767797|NCT01632345|584190748|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
161767798|NCT01632345|584190749|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
161767799|NCT01632345|584190750|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
161767800|NCT01632345|584190751|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
161767801|NCT01632345|584190752|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
161767802|NCT01632345|584190746|FG000|Treatment: Part II|Withdrawal by Subject|0|||
161767803|NCT01632345|584190747|FG001|Treatment: Part II|Withdrawal by Subject|0|||
161767804|NCT01632345|584190748|FG002|Treatment: Part II|Withdrawal by Subject|0|||
161767805|NCT01632345|584190749|FG003|Treatment: Part II|Withdrawal by Subject|0|||
161767806|NCT01632345|584190750|FG004|Treatment: Part II|Withdrawal by Subject|0|||
161767807|NCT01632345|584190751|FG005|Treatment: Part II|Withdrawal by Subject|2|||
161767808|NCT01632345|584190752|FG006|Treatment: Part II|Withdrawal by Subject|2|||
161767809|NCT00089505|584190753|FG000|Overall Study|Death|4|||
161767810|NCT00089505|584190754|FG001|Overall Study|Death|1|||
161767811|NCT00089505|584190755|FG002|Overall Study|Death|5|||
161767812|NCT00089505|584190756|FG003|Overall Study|Death|8|||
161767813|NCT00089505|584190753|FG000|Overall Study|Withdrawal by Subject|3|||
161767814|NCT00089505|584190754|FG001|Overall Study|Withdrawal by Subject|0|||
161767815|NCT00089505|584190755|FG002|Overall Study|Withdrawal by Subject|6|||
161767816|NCT00089505|584190756|FG003|Overall Study|Withdrawal by Subject|6|||
161767817|NCT00089505|584190753|FG000|Overall Study|Lost to Follow-up|1|||
161767818|NCT00089505|584190754|FG001|Overall Study|Lost to Follow-up|1|||
161767819|NCT00089505|584190755|FG002|Overall Study|Lost to Follow-up|9|||
161767820|NCT00089505|584190756|FG003|Overall Study|Lost to Follow-up|7|||
161767821|NCT00089505|584190753|FG000|Overall Study|Physician Decision|1|||
161767822|NCT00089505|584190754|FG001|Overall Study|Physician Decision|0|||
161767823|NCT00089505|584190755|FG002|Overall Study|Physician Decision|0|||
161767824|NCT00089505|584190756|FG003|Overall Study|Physician Decision|0|||
161767825|NCT00089505|584190753|FG000|Overall Study|Protocol Violation|0|||
162034169|NCT04393298|585181156|FG012|Overall Study|Patient Passed Away|0|||
162034170|NCT04393298|585181157|FG013|Overall Study|Patient Passed Away|0|||
162034171|NCT04393298|585181158|FG014|Overall Study|Patient Passed Away|0|||
161767826|NCT00089505|584190754|FG001|Overall Study|Protocol Violation|0|||
161767827|NCT00089505|584190755|FG002|Overall Study|Protocol Violation|1|||
161767828|NCT00089505|584190756|FG003|Overall Study|Protocol Violation|0|||
161767829|NCT02431559|584190757|FG000|Overall Study|Adverse Event|0|||
161767830|NCT02431559|584190758|FG001|Overall Study|Adverse Event|1|||
161767831|NCT02431559|584190759|FG002|Overall Study|Adverse Event|0|||
161767832|NCT02431559|584190760|FG003|Overall Study|Adverse Event|4|||
161767833|NCT02431559|584190757|FG000|Overall Study|Progressive disease|2|||
161767834|NCT02431559|584190758|FG001|Overall Study|Progressive disease|1|||
161767835|NCT02431559|584190759|FG002|Overall Study|Progressive disease|4|||
161767836|NCT02431559|584190760|FG003|Overall Study|Progressive disease|22|||
161767837|NCT02431559|584190757|FG000|Overall Study|Withdrawal by Subject|0|||
161767838|NCT02431559|584190758|FG001|Overall Study|Withdrawal by Subject|1|||
161767839|NCT02431559|584190759|FG002|Overall Study|Withdrawal by Subject|0|||
161767840|NCT02431559|584190760|FG003|Overall Study|Withdrawal by Subject|4|||
161767841|NCT02431559|584190757|FG000|Overall Study|Physician Decision|0|||
161767842|NCT02431559|584190758|FG001|Overall Study|Physician Decision|0|||
161767843|NCT02431559|584190759|FG002|Overall Study|Physician Decision|0|||
161767844|NCT02431559|584190760|FG003|Overall Study|Physician Decision|1|||
161767845|NCT01005875|584190766|FG000|Overall Study|Death|3|||
161767846|NCT00606931|584190767|FG000|Overall Study|Withdrawal by Subject|3|||
161767847|NCT05047601|584190768|FG000|Overall Study|Lost to Follow-up|9|||
161767848|NCT05047601|584190769|FG001|Overall Study|Lost to Follow-up|11|||
161767849|NCT05047601|584190770|FG002|Overall Study|Lost to Follow-up|7|||
161767850|NCT05047601|584190768|FG000|Overall Study|Withdrawal by Subject|25|||
161767851|NCT05047601|584190769|FG001|Overall Study|Withdrawal by Subject|36|||
161767852|NCT05047601|584190770|FG002|Overall Study|Withdrawal by Subject|23|||
161767853|NCT05047601|584190768|FG000|Overall Study|Other|10|||
161767854|NCT05047601|584190769|FG001|Overall Study|Other|6|||
161767855|NCT05047601|584190770|FG002|Overall Study|Other|5|||
161767856|NCT00286234|584190771|FG000|Overall Study|Protocol Violation|1|||
161767857|NCT00286234|584190772|FG001|Overall Study|Protocol Violation|2|||
161767858|NCT00286234|584190773|FG002|Overall Study|Protocol Violation|0|||
161767859|NCT00286234|584190774|FG003|Overall Study|Protocol Violation|1|||
161767860|NCT00286234|584190771|FG000|Overall Study|Physician Decision|1|||
161767861|NCT00286234|584190772|FG001|Overall Study|Physician Decision|0|||
161767862|NCT00286234|584190773|FG002|Overall Study|Physician Decision|0|||
161767863|NCT00286234|584190774|FG003|Overall Study|Physician Decision|1|||
161767864|NCT00286234|584190771|FG000|Overall Study|Adverse Event|0|||
161767865|NCT00286234|584190772|FG001|Overall Study|Adverse Event|0|||
161767866|NCT00286234|584190773|FG002|Overall Study|Adverse Event|0|||
161767867|NCT00286234|584190774|FG003|Overall Study|Adverse Event|1|||
161767868|NCT00286234|584190771|FG000|Overall Study|Adverse Event|0|||
161767869|NCT00286234|584190772|FG001|Overall Study|Adverse Event|0|||
161767870|NCT00286234|584190773|FG002|Overall Study|Adverse Event|0|||
161767871|NCT00286234|584190774|FG003|Overall Study|Adverse Event|1|||
161767872|NCT02924129|584190785|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
161767873|NCT02924129|584190786|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
161767874|NCT02924129|584190785|FG000|Overall Study|Withdrawal by Subject|2|||
161767875|NCT02924129|584190786|FG001|Overall Study|Withdrawal by Subject|2|||
161767876|NCT02924129|584190785|FG000|Overall Study|Physician Decision|1|||
161767877|NCT02924129|584190786|FG001|Overall Study|Physician Decision|0|||
161767878|NCT02924129|584190785|FG000|Overall Study|Missed Visit|0|||
161767879|NCT02924129|584190786|FG001|Overall Study|Missed Visit|1|||
161767880|NCT00302731|584190790|FG000|Overall Study|Lost to Follow-up|1|||
161767881|NCT00302731|584190791|FG001|Overall Study|Lost to Follow-up|2|||
161767882|NCT00302731|584190792|FG002|Overall Study|Lost to Follow-up|0|||
161767883|NCT00302731|584190793|FG003|Overall Study|Lost to Follow-up|0|||
161767884|NCT00302731|584190790|FG000|Overall Study|Adverse Event|0|||
161767885|NCT00302731|584190791|FG001|Overall Study|Adverse Event|2|||
161767886|NCT00302731|584190792|FG002|Overall Study|Adverse Event|2|||
161767887|NCT00302731|584190793|FG003|Overall Study|Adverse Event|0|||
161767888|NCT00302731|584190790|FG000|Overall Study|Withdrawal by Subject|1|||
161767889|NCT00302731|584190791|FG001|Overall Study|Withdrawal by Subject|1|||
161767890|NCT00302731|584190792|FG002|Overall Study|Withdrawal by Subject|0|||
161767891|NCT00302731|584190793|FG003|Overall Study|Withdrawal by Subject|0|||
161767892|NCT00302731|584190790|FG000|Overall Study|Protocol Violation|1|||
161767893|NCT00302731|584190791|FG001|Overall Study|Protocol Violation|0|||
161767894|NCT00302731|584190792|FG002|Overall Study|Protocol Violation|0|||
161767895|NCT00302731|584190793|FG003|Overall Study|Protocol Violation|0|||
161767896|NCT00302731|584190790|FG000|Overall Study|cancer unrelated to study discovered|1|||
161767897|NCT00302731|584190791|FG001|Overall Study|cancer unrelated to study discovered|0|||
161767898|NCT00302731|584190792|FG002|Overall Study|cancer unrelated to study discovered|1|||
161767899|NCT00302731|584190793|FG003|Overall Study|cancer unrelated to study discovered|0|||
161767900|NCT01610752|584190796|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
161767901|NCT01610752|584190797|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
161767902|NCT01610752|584190798|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
161974768|NCT00355342|584956474|FG001|Overall Study|Participant discontinued study drug|1|||
161974769|NCT00355342|584956473|FG000|Overall Study|Study management|0|||
161974770|NCT00355342|584956474|FG001|Overall Study|Study management|1|||
161974771|NCT00355342|584956473|FG000|Overall Study|Protocol Violation|0|||
161974772|NCT00355342|584956474|FG001|Overall Study|Protocol Violation|1|||
161974773|NCT00355342|584956473|FG000|Overall Study|Use of protocol excluded medication|0|||
161974774|NCT00355342|584956474|FG001|Overall Study|Use of protocol excluded medication|1|||
161767903|NCT00283062|584190799|FG000|Overall Study|Did not receive any study medication|5|||
161767904|NCT00283062|584190800|FG001|Overall Study|Did not receive any study medication|4|||
161767905|NCT00283062|584190801|FG002|Overall Study|Did not receive any study medication|36|||
161767906|NCT00283062|584190802|FG003|Overall Study|Did not receive any study medication|45|||
161767907|NCT00283062|584190799|FG000|Overall Study|Adverse Event|2|||
161767908|NCT00283062|584190800|FG001|Overall Study|Adverse Event|0|||
161767909|NCT00283062|584190801|FG002|Overall Study|Adverse Event|1|||
161767910|NCT00283062|584190802|FG003|Overall Study|Adverse Event|0|||
161767911|NCT00283062|584190799|FG000|Overall Study|Lost to Follow-up|1|||
161767912|NCT00283062|584190800|FG001|Overall Study|Lost to Follow-up|0|||
161767913|NCT00283062|584190801|FG002|Overall Study|Lost to Follow-up|1|||
161767914|NCT00283062|584190802|FG003|Overall Study|Lost to Follow-up|0|||
161767915|NCT00283062|584190799|FG000|Overall Study|Progressive disease|0|||
161767916|NCT00283062|584190800|FG001|Overall Study|Progressive disease|0|||
161767917|NCT00283062|584190801|FG002|Overall Study|Progressive disease|1|||
161767918|NCT00283062|584190802|FG003|Overall Study|Progressive disease|0|||
161767919|NCT00283062|584190799|FG000|Overall Study|Participant did not wish to continue|3|||
161767920|NCT00283062|584190800|FG001|Overall Study|Participant did not wish to continue|2|||
161767921|NCT00283062|584190801|FG002|Overall Study|Participant did not wish to continue|1|||
161767922|NCT00283062|584190802|FG003|Overall Study|Participant did not wish to continue|0|||
161767923|NCT00283062|584190799|FG000|Overall Study|Undefined|0|||
161767924|NCT00283062|584190800|FG001|Overall Study|Undefined|1|||
161767925|NCT00283062|584190801|FG002|Overall Study|Undefined|1|||
161767926|NCT00283062|584190802|FG003|Overall Study|Undefined|4|||
161767927|NCT00283062|584190799|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
161767928|NCT00283062|584190800|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
161767929|NCT00283062|584190801|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
161767930|NCT00283062|584190802|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
161767931|NCT00252499|584190805|FG000|Overall Study|Lost to Follow-up|1|||
161767932|NCT00252499|584190806|FG001|Overall Study|Lost to Follow-up|0|||
161767933|NCT00252499|584190807|FG002|Overall Study|Lost to Follow-up|0|||
161767934|NCT01535638|584190808|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
161767935|NCT01535638|584190809|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
161767936|NCT01535638|584190810|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
161855035|NCT00098774|584509729|FG000|Overall Study|Failed (to respond) during induction|4|||
161855036|NCT00098774|584509729|FG000|Overall Study|Physician Decision|2|||
161855037|NCT03097991|584509730|FG000|Overall Study|Didn't meet study criteria|8|||
161855038|NCT03097991|584509731|FG001|Overall Study|Didn't meet study criteria|0|||
161855039|NCT03097991|584509730|FG000|Overall Study|Withdrawal by Subject|12|||
161855040|NCT03097991|584509731|FG001|Overall Study|Withdrawal by Subject|6|||
161855041|NCT03097991|584509730|FG000|Overall Study|Death of Baby|3|||
161855042|NCT03097991|584509731|FG001|Overall Study|Death of Baby|1|||
161855043|NCT03097991|584509730|FG000|Overall Study|Lost to Follow-up|24|||
161855044|NCT03097991|584509731|FG001|Overall Study|Lost to Follow-up|38|||
161855045|NCT03097991|584509730|FG000|Overall Study|Adverse Event|3|||
161855046|NCT03097991|584509731|FG001|Overall Study|Adverse Event|5|||
161855047|NCT04502212|584509732|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
161855048|NCT04502212|584509732|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
161855049|NCT01320150|584509735|FG000|Overall Study|Protocol Violation|15|||
161855050|NCT01320150|584509735|FG000|Overall Study|Withdrawal by Subject|5|||
161855051|NCT01320150|584509735|FG000|Overall Study|Death|2|||
161855052|NCT01320150|584509735|FG000|Overall Study|Lost to Follow-up|44|||
161855053|NCT00919854|584509736|FG000|Overall Study|Adverse Event|1|||
161855054|NCT00143247|584509743|FG000|Overall Study|Death|8|||
161855055|NCT00143247|584509743|FG000|Overall Study|Adverse Event|19|||
161855056|NCT00143247|584509743|FG000|Overall Study|Lack of Efficacy|3|||
161855057|NCT00143247|584509743|FG000|Overall Study|Withdrawal by Subject|55|||
161855058|NCT00143247|584509743|FG000|Overall Study|Study terminated by sponsor|31|||
161855059|NCT00143247|584509743|FG000|Overall Study|Protocol Violation|15|||
161855060|NCT00143247|584509743|FG000|Overall Study|Lost to Follow-up|12|||
161855061|NCT00143247|584509743|FG000|Overall Study|following inaccurate lab adverse event|1|||
161855062|NCT00143247|584509743|FG000|Overall Study|Other|12|||
161855063|NCT00489827|584509744|FG000|Overall Study|Intraoperative exclusion criteria|1|||
161855064|NCT00489827|584509745|FG001|Overall Study|Intraoperative exclusion criteria|1|||
161855065|NCT00489827|584509744|FG000|Overall Study|Intraoperative exclusion criteria|1|||
161855066|NCT00489827|584509745|FG001|Overall Study|Intraoperative exclusion criteria|1|||
161855067|NCT02766283|584509746|FG000|Overall Study|Lost to Follow-up|27|||
161855068|NCT00721227|584509747|FG000|Overall Study|Lost to Follow-up|3|||
161855069|NCT00721227|584509748|FG001|Overall Study|Lost to Follow-up|0|||
161855070|NCT00721227|584509747|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
161855071|NCT00721227|584509748|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
161855072|NCT01632280|584509762|FG000|Overall Study|Withdrawal by Subject|1|||
161855073|NCT01632280|584509763|FG001|Overall Study|Withdrawal by Subject|0|||
161855074|NCT03086551|584509764|FG000|First Intervention|Failure to meet inclusion criterion|1|||
161855075|NCT03086551|584509765|FG001|First Intervention|Failure to meet inclusion criterion|0|||
161855076|NCT03086551|584509764|FG000|First Intervention|Lost to Follow-up|0|||
161855077|NCT03086551|584509765|FG001|First Intervention|Lost to Follow-up|1|||
161855078|NCT03086551|584509764|FG000|Washout|Lost to Follow-up|1|||
161855079|NCT03086551|584509765|FG001|Washout|Lost to Follow-up|2|||
161855080|NCT03086551|584509764|FG000|Washout|Withdrawal by Subject|2|||
161855081|NCT03086551|584509765|FG001|Washout|Withdrawal by Subject|1|||
161855082|NCT03736031|584509769|FG000|Overall Study|Death|2|||
161855083|NCT03736031|584509770|FG001|Overall Study|Death|4|||
161855084|NCT03736031|584509769|FG000|Overall Study|Lost to Follow-up|21|||
161855085|NCT03736031|584509770|FG001|Overall Study|Lost to Follow-up|2|||
161855086|NCT03736031|584509769|FG000|Overall Study|Withdrawal by Subject|9|||
161855087|NCT03736031|584509770|FG001|Overall Study|Withdrawal by Subject|0|||
161855088|NCT00451178|584509771|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
161855089|NCT00451178|584509772|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
161855090|NCT00451178|584509771|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
161855091|NCT00451178|584509772|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
161767937|NCT01535638|584190811|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
161767938|NCT01535638|584190812|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
161767939|NCT01535638|584190813|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
161767940|NCT01535638|584190808|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
161767941|NCT01535638|584190809|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
161767942|NCT01535638|584190810|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
161767943|NCT01535638|584190811|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
161767944|NCT01535638|584190812|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
161767945|NCT01535638|584190813|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
161767946|NCT03524664|584190814|FG000|Overall Study|Withdrawal by Subject|1|||
161767947|NCT03524664|584190815|FG001|Overall Study|Withdrawal by Subject|2|||
161767948|NCT03524664|584190814|FG000|Overall Study|Lost to Follow-up|4|||
161767949|NCT03524664|584190815|FG001|Overall Study|Lost to Follow-up|13|||
161767950|NCT01482598|584190816|FG000|Overall Study|Death|7|||
161767951|NCT01482598|584190817|FG001|Overall Study|Death|10|||
161767952|NCT01482598|584190816|FG000|Overall Study|Physician Decision|0|||
161767953|NCT01482598|584190817|FG001|Overall Study|Physician Decision|3|||
161767954|NCT01482598|584190816|FG000|Overall Study|Withdrawal by Subject|4|||
161767955|NCT01482598|584190817|FG001|Overall Study|Withdrawal by Subject|5|||
161767956|NCT01482598|584190816|FG000|Overall Study|Lost to Follow-up|5|||
161767957|NCT01482598|584190817|FG001|Overall Study|Lost to Follow-up|4|||
161767958|NCT02694562|584190818|FG000|Overall Study|Death|8|||
161767959|NCT02694562|584190818|FG000|Overall Study|Protocol Violation|4|||
161767960|NCT02694562|584190818|FG000|Overall Study|Lost to Follow-up|3|||
161767961|NCT02694562|584190818|FG000|Overall Study|Screen Failure|2|||
161767962|NCT02694562|584190818|FG000|Overall Study|Physician Decision|1|||
161767963|NCT03702166|584190819|FG000|Overall Study|Lost to Follow-up|1|||
161767964|NCT03702166|584190819|FG000|Overall Study|Withdrawal by Subject|1|||
161767965|NCT00827112|584190820|FG000|Overall Study|Adverse Event|2|||
161767966|NCT00827112|584190821|FG001|Overall Study|Adverse Event|0|||
161767967|NCT00827112|584190820|FG000|Overall Study|Lack of Efficacy|2|||
161767968|NCT00827112|584190821|FG001|Overall Study|Lack of Efficacy|0|||
161767969|NCT00827112|584190820|FG000|Overall Study|Lost to Follow-up|3|||
161767970|NCT00827112|584190821|FG001|Overall Study|Lost to Follow-up|2|||
161767971|NCT00827112|584190820|FG000|Overall Study|Pregnancy|0|||
161767972|NCT00827112|584190821|FG001|Overall Study|Pregnancy|1|||
161767973|NCT00827112|584190820|FG000|Overall Study|Protocol Violation|0|||
161767974|NCT00827112|584190821|FG001|Overall Study|Protocol Violation|2|||
161767975|NCT00827112|584190820|FG000|Overall Study|Withdrawal by Subject|2|||
161767976|NCT00827112|584190821|FG001|Overall Study|Withdrawal by Subject|1|||
161767977|NCT00827112|584190820|FG000|Overall Study|Randomized but not treated|5|||
161767978|NCT00827112|584190821|FG001|Overall Study|Randomized but not treated|3|||
161767979|NCT00827112|584190820|FG000|Overall Study|Other|1|||
161767980|NCT00827112|584190821|FG001|Overall Study|Other|3|||
161767981|NCT03529162|584190826|FG000|Overall Study|Lost to Follow-up|2|||
161767982|NCT03529162|584190827|FG001|Overall Study|Lost to Follow-up|2|||
161767983|NCT00784836|584190828|FG000|Overall Study|Early Study Termination|3|||
161767984|NCT02613910|584190829|FG000|Overall Study|Termination of study|1|||
161767985|NCT03077646|584190830|FG000|Overall Study|Lost to Follow-up|29|||
161767986|NCT03077646|584190831|FG001|Overall Study|Lost to Follow-up|30|||
161767987|NCT03077646|584190832|FG002|Overall Study|Lost to Follow-up|31|||
161767988|NCT00765726|584190833|FG000|Overall Study|Withdrawal by Subject|1|||
161767989|NCT00765726|584190833|FG000|Overall Study|Discontinuation of study by sponsor|8|||
161767990|NCT02993731|584190834|FG000|Overall Study|Study Termination|101|||
161767991|NCT02993731|584190835|FG001|Overall Study|Study Termination|105|||
161767992|NCT02028182|584192520|FG000|Overall Study|Protocol Violation|2|||
161767993|NCT01684930|584192521|FG000|Overall Study|Withdrawal by Subject|3|||
161767994|NCT01684930|584192522|FG001|Overall Study|Withdrawal by Subject|1|||
161767995|NCT01945866|584192523|FG000|Overall Study|Eyes did not complete or were dropped|2|||
161767996|NCT01945866|584192524|FG001|Overall Study|Eyes did not complete or were dropped|0|||
161767997|NCT01336647|584192525|FG000|Overall Study|Lost to Follow-up|4|||
161767998|NCT01336647|584192526|FG001|Overall Study|Lost to Follow-up|1|||
161767999|NCT01336647|584192527|FG002|Overall Study|Lost to Follow-up|3|||
161768000|NCT01018680|584192528|FG000|Overall Study|Adverse Event|23|||
161768001|NCT01018680|584192529|FG001|Overall Study|Adverse Event|40|||
161768002|NCT01018680|584192528|FG000|Overall Study|Withdrawal by Subject|10|||
161768003|NCT01018680|584192529|FG001|Overall Study|Withdrawal by Subject|10|||
161768004|NCT01018680|584192528|FG000|Overall Study|Protocol Violation|5|||
161768005|NCT01018680|584192529|FG001|Overall Study|Protocol Violation|8|||
161768006|NCT01018680|584192528|FG000|Overall Study|Sponsor Decision|6|||
161768007|NCT01018680|584192529|FG001|Overall Study|Sponsor Decision|7|||
161768008|NCT01018680|584192528|FG000|Overall Study|Lack of Efficacy|8|||
161768009|NCT01018680|584192529|FG001|Overall Study|Lack of Efficacy|2|||
161768010|NCT01018680|584192528|FG000|Overall Study|Lost to Follow-up|5|||
161768011|NCT01018680|584192529|FG001|Overall Study|Lost to Follow-up|3|||
161768012|NCT01018680|584192528|FG000|Overall Study|Entry Criteria Not Met|1|||
162034172|NCT04393298|585181144|FG000|Overall Study|Patient Deceased|0|||
161768013|NCT01018680|584192529|FG001|Overall Study|Entry Criteria Not Met|4|||
161768014|NCT01018680|584192528|FG000|Overall Study|Physician Decision|3|||
161768015|NCT01018680|584192529|FG001|Overall Study|Physician Decision|1|||
161768016|NCT02930889|584192530|FG000|Overall Study|Lost to Follow-up|2|||
161768017|NCT02930889|584192530|FG000|Overall Study|Withdrawal by Subject|6|||
161768018|NCT02930889|584192530|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
161768019|NCT04398030|584192531|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
161768020|NCT04398030|584192532|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
161768021|NCT04398030|584192531|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
161768022|NCT04398030|584192532|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
161768023|NCT05056311|584192533|FG000|Overall Study|Lost to Follow-up|14|||
161768024|NCT05056311|584192533|FG000|Overall Study|Withdrawal by Subject|1|||
161768025|NCT05056311|584192533|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
161768026|NCT01714726|584192534|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
161768027|NCT01714726|584192535|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
161768028|NCT01714726|584192536|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
161768029|NCT01714726|584192537|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
161768030|NCT01714726|584192534|FG000|Double-Blinded Induction Period|Adverse Event|0|||
161768031|NCT01714726|584192535|FG001|Double-Blinded Induction Period|Adverse Event|1|||
161768032|NCT01714726|584192536|FG002|Double-Blinded Induction Period|Adverse Event|0|||
161768033|NCT01714726|584192537|FG003|Double-Blinded Induction Period|Adverse Event|0|||
161768034|NCT01714726|584192534|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
161768035|NCT01714726|584192535|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
161974775|NCT00933244|584956475|FG000|Overall Study|Withdrawal by Subject|5|||
161974776|NCT00933244|584956476|FG001|Overall Study|Withdrawal by Subject|1|||
161974777|NCT00933244|584956477|FG002|Overall Study|Withdrawal by Subject|3|||
161974778|NCT02689076|584956478|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
161974779|NCT02689076|584956479|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
161974780|NCT02689076|584956480|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
161974781|NCT02689076|584956478|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
161974782|NCT02689076|584956479|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
161974783|NCT02689076|584956480|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
161974784|NCT02689076|584956478|FG000|Overall Study|Did not have an HIE match|2|||
161768036|NCT01714726|584192536|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
161768037|NCT01714726|584192537|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
161768038|NCT01714726|584192534|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
161768039|NCT01714726|584192535|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
161768040|NCT01714726|584192536|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
161768041|NCT01714726|584192537|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
161768042|NCT01714726|584192534|FG000|Open-Label Period|Other|0|||
161768043|NCT01714726|584192535|FG001|Open-Label Period|Other|0|||
161768044|NCT01714726|584192536|FG002|Open-Label Period|Other|1|||
161974785|NCT02689076|584956479|FG001|Overall Study|Did not have an HIE match|0|||
161974786|NCT02689076|584956480|FG002|Overall Study|Did not have an HIE match|0|||
161974787|NCT02689076|584956478|FG000|Overall Study|Death during non-VA encounter|2|||
161974788|NCT02689076|584956479|FG001|Overall Study|Death during non-VA encounter|5|||
161974789|NCT02689076|584956480|FG002|Overall Study|Death during non-VA encounter|0|||
161974790|NCT02689076|584956478|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
161974791|NCT02689076|584956479|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
161974792|NCT02689076|584956480|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
161974793|NCT02689076|584956478|FG000|Overall Study|Participant no longer active in VA system|1|||
161974794|NCT02689076|584956479|FG001|Overall Study|Participant no longer active in VA system|0|||
161974795|NCT02689076|584956480|FG002|Overall Study|Participant no longer active in VA system|0|||
161974796|NCT02689076|584956478|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
161974797|NCT02689076|584956479|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
161974798|NCT02689076|584956480|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
161974799|NCT01174004|584956481|FG000|Overall Study|Adverse Event|2|||
161974800|NCT01174004|584956482|FG001|Overall Study|Adverse Event|10|||
161768045|NCT01714726|584192537|FG003|Open-Label Period|Other|3|||
161768046|NCT01714726|584192534|FG000|Open-Label Period|Adverse Event|0|||
161768047|NCT01714726|584192535|FG001|Open-Label Period|Adverse Event|0|||
161768048|NCT01714726|584192536|FG002|Open-Label Period|Adverse Event|1|||
161768049|NCT01714726|584192537|FG003|Open-Label Period|Adverse Event|0|||
161768050|NCT01714726|584192534|FG000|Open-Label Period|Withdrawal by Subject|0|||
161768051|NCT01714726|584192535|FG001|Open-Label Period|Withdrawal by Subject|0|||
161768052|NCT01714726|584192536|FG002|Open-Label Period|Withdrawal by Subject|9|||
161768053|NCT01714726|584192537|FG003|Open-Label Period|Withdrawal by Subject|19|||
161768054|NCT01714726|584192534|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
162034173|NCT04393298|585181145|FG001|Overall Study|Patient Deceased|0|||
161768055|NCT01714726|584192535|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
161768056|NCT01714726|584192536|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
161768057|NCT01714726|584192537|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
161768058|NCT01714726|584192534|FG000|Open-Label Period|Lost to Follow-up|0|||
161768059|NCT01714726|584192535|FG001|Open-Label Period|Lost to Follow-up|0|||
161768060|NCT01714726|584192536|FG002|Open-Label Period|Lost to Follow-up|3|||
161768061|NCT01714726|584192537|FG003|Open-Label Period|Lost to Follow-up|4|||
161768062|NCT00548340|584192539|FG000|Overall Study|Protocol Violation|2|||
161974801|NCT01174004|584956481|FG000|Overall Study|Withdrawal by Subject|2|||
161974802|NCT01174004|584956482|FG001|Overall Study|Withdrawal by Subject|3|||
161974803|NCT01174004|584956481|FG000|Overall Study|At Discretion of Sponsor|2|||
161974804|NCT01174004|584956482|FG001|Overall Study|At Discretion of Sponsor|2|||
161974805|NCT01174004|584956481|FG000|Overall Study|Protocol Violation|0|||
161974806|NCT01174004|584956482|FG001|Overall Study|Protocol Violation|1|||
161974807|NCT01174004|584956481|FG000|Overall Study|Physician Decision|1|||
161974808|NCT01174004|584956482|FG001|Overall Study|Physician Decision|0|||
161974809|NCT01143896|584956488|FG000|Overall Study|Did not complete Baseline Interview|5|||
161974810|NCT01143896|584956489|FG001|Overall Study|Did not complete Baseline Interview|4|||
161974811|NCT01143896|584956488|FG000|Overall Study|Lost to Follow-up|18|||
161974812|NCT01143896|584956489|FG001|Overall Study|Lost to Follow-up|13|||
161974813|NCT01143896|584956488|FG000|Overall Study|Withdrawal by Subject|13|||
161974814|NCT01143896|584956489|FG001|Overall Study|Withdrawal by Subject|5|||
161974815|NCT01143896|584956488|FG000|Overall Study|Death|6|||
161974816|NCT01143896|584956489|FG001|Overall Study|Death|3|||
161974817|NCT00495521|584956490|FG000|Overall Study|Physician Decision|0|||
161974818|NCT00495521|584956491|FG001|Overall Study|Physician Decision|1|||
161974819|NCT01318070|584956492|FG000|Overall Study|Adverse Event|1|||
161974820|NCT01318070|584956493|FG001|Overall Study|Adverse Event|1|||
161974821|NCT01318070|584956494|FG002|Overall Study|Adverse Event|5|||
161974822|NCT01318070|584956492|FG000|Overall Study|Withdrawal by Subject|0|||
161974823|NCT01318070|584956493|FG001|Overall Study|Withdrawal by Subject|1|||
161974824|NCT01318070|584956494|FG002|Overall Study|Withdrawal by Subject|1|||
161974825|NCT01318070|584956492|FG000|Overall Study|Lack of Efficacy|0|||
161974826|NCT01318070|584956493|FG001|Overall Study|Lack of Efficacy|0|||
161974827|NCT01318070|584956494|FG002|Overall Study|Lack of Efficacy|1|||
161974828|NCT01318070|584956492|FG000|Overall Study|Principal Investigator Discretion|1|||
161974829|NCT01318070|584956493|FG001|Overall Study|Principal Investigator Discretion|0|||
161974830|NCT01318070|584956494|FG002|Overall Study|Principal Investigator Discretion|0|||
161974831|NCT02782325|584956497|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
161974832|NCT02782325|584956498|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
161974833|NCT02782325|584956499|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
161974834|NCT02782325|584956497|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
161974835|NCT02782325|584956498|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
161974836|NCT02782325|584956499|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
161974837|NCT00693472|584956500|FG000|Part 1|Adverse Event|1|||
161974838|NCT00693472|584956501|FG001|Part 1|Adverse Event|1|||
161974839|NCT00693472|584956502|FG002|Part 1|Adverse Event|0|||
161974840|NCT00693472|584956503|FG003|Part 1|Adverse Event|0|||
161974841|NCT00693472|584956500|FG000|Part 1|Lost to Follow-up|0|||
161974842|NCT00693472|584956501|FG001|Part 1|Lost to Follow-up|1|||
161974843|NCT00693472|584956502|FG002|Part 1|Lost to Follow-up|0|||
161974844|NCT00693472|584956503|FG003|Part 1|Lost to Follow-up|0|||
161974845|NCT00693472|584956500|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
161974846|NCT00693472|584956501|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
161974847|NCT00693472|584956502|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
161768063|NCT00548340|584192540|FG001|Overall Study|Protocol Violation|3|||
161768064|NCT00548340|584192541|FG002|Overall Study|Protocol Violation|3|||
161768065|NCT00548340|584192539|FG000|Overall Study|Adverse Event|2|||
161768066|NCT00548340|584192540|FG001|Overall Study|Adverse Event|2|||
161768067|NCT00548340|584192541|FG002|Overall Study|Adverse Event|2|||
161974848|NCT00693472|584956503|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
161974849|NCT00693472|584956500|FG000|Part 2|Adverse Event|0|||
161974850|NCT00693472|584956501|FG001|Part 2|Adverse Event|0|||
161974851|NCT00693472|584956502|FG002|Part 2|Adverse Event|1|||
161974852|NCT00693472|584956503|FG003|Part 2|Adverse Event|0|||
161974853|NCT00693472|584956500|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
161974854|NCT00693472|584956501|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
161974855|NCT00693472|584956502|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
161974856|NCT00693472|584956503|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
161974857|NCT00042432|584956506|FG000|Overall Study|Adverse Event|4|||
161974858|NCT00042432|584956507|FG001|Overall Study|Adverse Event|1|||
161974859|NCT00042432|584956506|FG000|Overall Study|Withdrawal by Subject|1|||
161974860|NCT00042432|584956507|FG001|Overall Study|Withdrawal by Subject|3|||
161974861|NCT00042432|584956506|FG000|Overall Study|Death|0|||
161974862|NCT00042432|584956507|FG001|Overall Study|Death|2|||
161974863|NCT00042432|584956506|FG000|Overall Study|Ineligibility determined|1|||
161974864|NCT00042432|584956507|FG001|Overall Study|Ineligibility determined|0|||
162034174|NCT04393298|585181146|FG002|Overall Study|Patient Deceased|0|||
162034175|NCT04393298|585181147|FG003|Overall Study|Patient Deceased|0|||
162034176|NCT04393298|585181148|FG004|Overall Study|Patient Deceased|0|||
162034177|NCT04393298|585181149|FG005|Overall Study|Patient Deceased|0|||
162034178|NCT04393298|585181150|FG006|Overall Study|Patient Deceased|0|||
162034179|NCT04393298|585181151|FG007|Overall Study|Patient Deceased|1|||
162034180|NCT04393298|585181152|FG008|Overall Study|Patient Deceased|0|||
162034181|NCT04393298|585181153|FG009|Overall Study|Patient Deceased|0|||
162034182|NCT04393298|585181154|FG010|Overall Study|Patient Deceased|0|||
162034183|NCT04393298|585181155|FG011|Overall Study|Patient Deceased|0|||
162034184|NCT04393298|585181156|FG012|Overall Study|Patient Deceased|0|||
162034185|NCT04393298|585181157|FG013|Overall Study|Patient Deceased|0|||
162034186|NCT04393298|585181158|FG014|Overall Study|Patient Deceased|0|||
162034187|NCT04393298|585181144|FG000|Overall Study|Patient Discharged to Hospice|0|||
162034188|NCT04393298|585181145|FG001|Overall Study|Patient Discharged to Hospice|0|||
162034189|NCT04393298|585181146|FG002|Overall Study|Patient Discharged to Hospice|0|||
162034190|NCT04393298|585181147|FG003|Overall Study|Patient Discharged to Hospice|0|||
162034191|NCT04393298|585181148|FG004|Overall Study|Patient Discharged to Hospice|0|||
162034192|NCT04393298|585181149|FG005|Overall Study|Patient Discharged to Hospice|0|||
162034193|NCT04393298|585181150|FG006|Overall Study|Patient Discharged to Hospice|0|||
162034194|NCT04393298|585181151|FG007|Overall Study|Patient Discharged to Hospice|0|||
162034195|NCT04393298|585181152|FG008|Overall Study|Patient Discharged to Hospice|1|||
162034196|NCT04393298|585181153|FG009|Overall Study|Patient Discharged to Hospice|0|||
162034197|NCT04393298|585181154|FG010|Overall Study|Patient Discharged to Hospice|0|||
162034198|NCT04393298|585181155|FG011|Overall Study|Patient Discharged to Hospice|0|||
162034199|NCT04393298|585181156|FG012|Overall Study|Patient Discharged to Hospice|0|||
162034200|NCT04393298|585181157|FG013|Overall Study|Patient Discharged to Hospice|0|||
162034201|NCT04393298|585181158|FG014|Overall Study|Patient Discharged to Hospice|0|||
162034202|NCT04393298|585181144|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034203|NCT04393298|585181145|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034204|NCT04393298|585181146|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034205|NCT04393298|585181147|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034206|NCT04393298|585181148|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034207|NCT04393298|585181149|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034208|NCT04393298|585181150|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034209|NCT04393298|585181151|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034210|NCT04393298|585181152|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034211|NCT04393298|585181153|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
162034212|NCT04393298|585181154|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034213|NCT04393298|585181155|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034214|NCT04393298|585181156|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034215|NCT04393298|585181157|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034216|NCT04393298|585181158|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
162034217|NCT04393298|585181144|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
162034218|NCT04393298|585181145|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
162034219|NCT04393298|585181146|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
162034220|NCT04393298|585181147|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
162034221|NCT04393298|585181148|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
162034222|NCT04393298|585181149|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
162034223|NCT04393298|585181150|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
162034224|NCT04393298|585181151|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
162034225|NCT04393298|585181152|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
162034226|NCT04393298|585181153|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
162034227|NCT04393298|585181154|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
162034228|NCT04393298|585181155|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
162034229|NCT04393298|585181156|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
162034230|NCT04393298|585181157|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
162034231|NCT04393298|585181158|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
162034232|NCT01282203|585181168|FG000|Overall Study|Adverse Event|1|||
162034233|NCT03977454|585181169|FG000|Overall Study|immediate postoperative revision|2|||
161768068|NCT00548340|584192539|FG000|Overall Study|Lost to Follow-up|1|||
162034234|NCT03977454|585181170|FG001|Overall Study|immediate postoperative revision|2|||
162034235|NCT04193410|585181173|FG000|Overall Study|Lost to Follow-up|7|||
162034236|NCT04193410|585181174|FG001|Overall Study|Lost to Follow-up|6|||
162034237|NCT01101191|585181179|FG000|Period 1|Withdrawal by Subject|1|||
162034238|NCT01101191|585181180|FG001|Period 1|Withdrawal by Subject|0|||
162034239|NCT01101191|585181179|FG000|Period 1|Adverse Event|1|||
162034240|NCT01101191|585181180|FG001|Period 1|Adverse Event|2|||
162034241|NCT01146860|585181181|FG000|Overall Study|Withdrawal by Subject|0|||
162034242|NCT01146860|585181182|FG001|Overall Study|Withdrawal by Subject|1|||
162034243|NCT04779216|585181183|FG000|Overall Study|Lost to Follow-up|1|||
161768069|NCT00548340|584192540|FG001|Overall Study|Lost to Follow-up|1|||
161768070|NCT00548340|584192541|FG002|Overall Study|Lost to Follow-up|0|||
161768071|NCT00548340|584192539|FG000|Overall Study|Withdrawal by Subject|2|||
161768072|NCT00548340|584192540|FG001|Overall Study|Withdrawal by Subject|4|||
161768073|NCT00548340|584192541|FG002|Overall Study|Withdrawal by Subject|3|||
161768074|NCT00548340|584192539|FG000|Overall Study|Other|1|||
161768075|NCT00548340|584192540|FG001|Overall Study|Other|1|||
161768076|NCT00548340|584192541|FG002|Overall Study|Other|1|||
161768077|NCT02600559|584192542|FG000|Overall Study|Withdrawal by Subject|3|||
161768078|NCT02600559|584192542|FG000|Overall Study|Lost to Follow-up|20|||
161768079|NCT00679042|584192551|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
161768080|NCT00679042|584192551|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
161768081|NCT00679042|584192551|FG000|5-Year Follow Up|Death|1|||
161768082|NCT00679042|584192551|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
161768083|NCT00679042|584192551|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
161768084|NCT02392078|584192552|FG000|Overall Study|Did not have procedure|32|||
161768085|NCT02392078|584192553|FG001|Overall Study|Did not have procedure|43|||
161768086|NCT02392078|584192554|FG002|Overall Study|Did not have procedure|20|||
161768087|NCT02392078|584192555|FG003|Overall Study|Did not have procedure|1|||
161768088|NCT02079077|584192556|FG000|Overall Study|Lost to Follow-up|5|||
161768089|NCT02079077|584192557|FG001|Overall Study|Lost to Follow-up|7|||
161768090|NCT02079077|584192556|FG000|Overall Study|Became STIs Positive|1|||
161768091|NCT02079077|584192557|FG001|Overall Study|Became STIs Positive|2|||
161768092|NCT03868410|584192558|FG000|Overall Study|Physician Decision|0|||
161768093|NCT03868410|584192559|FG001|Overall Study|Physician Decision|1|||
161768094|NCT02624713|584192566|FG000|Overall Study|Lost to Follow-up|14|||
161768095|NCT02624713|584192567|FG001|Overall Study|Lost to Follow-up|0|||
161768096|NCT00148109|584192568|FG000|Overall Study|Lack of Efficacy|10|||
161768097|NCT00148109|584192569|FG001|Overall Study|Lack of Efficacy|18|||
161768098|NCT00148109|584192568|FG000|Overall Study|Adverse Event|0|||
161768099|NCT00148109|584192569|FG001|Overall Study|Adverse Event|2|||
161768100|NCT00148109|584192568|FG000|Overall Study|Withdrawal by Subject|2|||
161768101|NCT00148109|584192569|FG001|Overall Study|Withdrawal by Subject|0|||
161768102|NCT04047472|584192580|FG000|Overall Study|Adverse Event|3|||
161768103|NCT04047472|584192581|FG001|Overall Study|Adverse Event|3|||
161768104|NCT04047472|584192580|FG000|Overall Study|Death|0|||
161768105|NCT04047472|584192581|FG001|Overall Study|Death|1|||
161768106|NCT04047472|584192580|FG000|Overall Study|Lost to Follow-up|1|||
161768107|NCT04047472|584192581|FG001|Overall Study|Lost to Follow-up|0|||
161768108|NCT04047472|584192580|FG000|Overall Study|Physician Decision|1|||
161768109|NCT04047472|584192581|FG001|Overall Study|Physician Decision|2|||
161768110|NCT04047472|584192580|FG000|Overall Study|Protocol Violation|1|||
161768111|NCT04047472|584192581|FG001|Overall Study|Protocol Violation|0|||
161768112|NCT04047472|584192580|FG000|Overall Study|Withdrawal by Subject|10|||
161768113|NCT04047472|584192581|FG001|Overall Study|Withdrawal by Subject|10|||
161768114|NCT01218477|584192582|FG000|Overall Study|Disease progression|2|||
161768115|NCT01218477|584192583|FG001|Overall Study|Disease progression|3|||
161768116|NCT01218477|584192584|FG002|Overall Study|Disease progression|6|||
161768117|NCT01218477|584192585|FG003|Overall Study|Disease progression|2|||
161768118|NCT01218477|584192582|FG000|Overall Study|Study drug toxicity|0|||
161768119|NCT01218477|584192583|FG001|Overall Study|Study drug toxicity|2|||
161768120|NCT01218477|584192584|FG002|Overall Study|Study drug toxicity|5|||
161768121|NCT01218477|584192585|FG003|Overall Study|Study drug toxicity|0|||
161768122|NCT01218477|584192582|FG000|Overall Study|No longer meets study criteria|1|||
161768123|NCT01218477|584192583|FG001|Overall Study|No longer meets study criteria|0|||
161768124|NCT01218477|584192584|FG002|Overall Study|No longer meets study criteria|0|||
161768125|NCT01218477|584192585|FG003|Overall Study|No longer meets study criteria|0|||
161768126|NCT01218477|584192582|FG000|Overall Study|Withdrawal by Subject|0|||
161768127|NCT01218477|584192583|FG001|Overall Study|Withdrawal by Subject|0|||
161768128|NCT01218477|584192584|FG002|Overall Study|Withdrawal by Subject|1|||
161768129|NCT01218477|584192585|FG003|Overall Study|Withdrawal by Subject|0|||
161768130|NCT01218477|584192582|FG000|Overall Study|Prepared for cell transplantation|0|||
161768131|NCT01218477|584192583|FG001|Overall Study|Prepared for cell transplantation|1|||
161768132|NCT01218477|584192584|FG002|Overall Study|Prepared for cell transplantation|1|||
161768133|NCT01218477|584192585|FG003|Overall Study|Prepared for cell transplantation|0|||
161768134|NCT01218477|584192582|FG000|Overall Study|Administrative reason by sponsor|0|||
161768135|NCT01218477|584192583|FG001|Overall Study|Administrative reason by sponsor|0|||
161768136|NCT01218477|584192584|FG002|Overall Study|Administrative reason by sponsor|1|||
161768137|NCT01218477|584192585|FG003|Overall Study|Administrative reason by sponsor|0|||
161768138|NCT01218477|584192582|FG000|Overall Study|Maximum clinical benefit|0|||
161768139|NCT01218477|584192583|FG001|Overall Study|Maximum clinical benefit|2|||
161768140|NCT01218477|584192584|FG002|Overall Study|Maximum clinical benefit|0|||
161768141|NCT01218477|584192585|FG003|Overall Study|Maximum clinical benefit|0|||
161768142|NCT01303159|584192589|FG000|Overall Study|Death|16|||
161768143|NCT01303159|584192589|FG000|Overall Study|Study Termination|7|||
161768144|NCT00496782|584192595|FG000|Overall Study|Protocol Violation|1|||
161768145|NCT00496782|584192596|FG001|Overall Study|Protocol Violation|2|||
161768146|NCT02132312|584192598|FG000|Overall Study|Adverse Event|2|||
161768147|NCT02132312|584192599|FG001|Overall Study|Adverse Event|0|||
161768148|NCT02132312|584192598|FG000|Overall Study|Physician Decision|1|||
161768149|NCT02132312|584192599|FG001|Overall Study|Physician Decision|1|||
161768150|NCT02132312|584192598|FG000|Overall Study|Protocol Violation|0|||
161768151|NCT02132312|584192599|FG001|Overall Study|Protocol Violation|1|||
161768152|NCT02132312|584192598|FG000|Overall Study|Withdrawal by Subject|1|||
161768153|NCT02132312|584192599|FG001|Overall Study|Withdrawal by Subject|0|||
161768154|NCT02132312|584192598|FG000|Overall Study|Lost to Follow-up|2|||
161768155|NCT02132312|584192599|FG001|Overall Study|Lost to Follow-up|1|||
161768156|NCT01348828|584192602|FG000|Overall Study|Death|20|||
161768157|NCT01348828|584192602|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
161768158|NCT01348828|584192602|FG000|Overall Study|Conversion|2|||
161768159|NCT01348828|584192602|FG000|Overall Study|missed visit|1|||
161768160|NCT04246996|584192603|FG000|Overall Study|Physician Decision|1|||
161768161|NCT04246996|584192604|FG001|Overall Study|Physician Decision|1|||
161768162|NCT04246996|584192603|FG000|Overall Study|Did not meet eligibility criteria|1|||
161768163|NCT04246996|584192604|FG001|Overall Study|Did not meet eligibility criteria|4|||
161768164|NCT02442284|584192607|FG000|Overall Study|Adverse Event|1|||
161768165|NCT02442284|584192607|FG000|Overall Study|Withdrew Consent|2|||
161768166|NCT02442284|584192607|FG000|Overall Study|Lost to Follow-up|3|||
161768167|NCT02442284|584192607|FG000|Overall Study|Other|1|||
161768168|NCT01365468|584192611|FG000|Overall Study|Physician Decision|1|||
161768169|NCT01365468|584192612|FG001|Overall Study|Physician Decision|0|||
161768170|NCT01365468|584192611|FG000|Overall Study|Disease progression|1|||
161768171|NCT01365468|584192612|FG001|Overall Study|Disease progression|0|||
161768172|NCT01365468|584192611|FG000|Overall Study|Lost to Follow-up|2|||
161768173|NCT01365468|584192612|FG001|Overall Study|Lost to Follow-up|0|||
161768174|NCT01521494|584192615|FG000|Overall Study|Adverse Event|1|||
161768175|NCT01521494|584192616|FG001|Overall Study|Adverse Event|2|||
161768176|NCT01521494|584192617|FG002|Overall Study|Adverse Event|9|||
161768177|NCT01521494|584192618|FG003|Overall Study|Adverse Event|6|||
161768178|NCT01521494|584192619|FG004|Overall Study|Adverse Event|2|||
161768179|NCT01521494|584192615|FG000|Overall Study|Lack of Efficacy|0|||
161768180|NCT01521494|584192616|FG001|Overall Study|Lack of Efficacy|0|||
161768181|NCT01521494|584192617|FG002|Overall Study|Lack of Efficacy|0|||
161768182|NCT01521494|584192618|FG003|Overall Study|Lack of Efficacy|0|||
161768183|NCT01521494|584192619|FG004|Overall Study|Lack of Efficacy|2|||
161768184|NCT01521494|584192615|FG000|Overall Study|Withdrawal by Subject|1|||
161768185|NCT01521494|584192616|FG001|Overall Study|Withdrawal by Subject|1|||
161768186|NCT01521494|584192617|FG002|Overall Study|Withdrawal by Subject|0|||
161768187|NCT01521494|584192618|FG003|Overall Study|Withdrawal by Subject|2|||
161768188|NCT01521494|584192619|FG004|Overall Study|Withdrawal by Subject|0|||
161768189|NCT01521494|584192615|FG000|Overall Study|Decrease in serum phosphate|0|||
161768190|NCT01521494|584192616|FG001|Overall Study|Decrease in serum phosphate|2|||
161768191|NCT01521494|584192617|FG002|Overall Study|Decrease in serum phosphate|3|||
161768192|NCT01521494|584192618|FG003|Overall Study|Decrease in serum phosphate|12|||
161768193|NCT01521494|584192619|FG004|Overall Study|Decrease in serum phosphate|0|||
161768194|NCT01521494|584192615|FG000|Overall Study|Decrease in serum calcium|0|||
161768195|NCT01521494|584192616|FG001|Overall Study|Decrease in serum calcium|0|||
161768196|NCT01521494|584192617|FG002|Overall Study|Decrease in serum calcium|0|||
161768197|NCT01521494|584192618|FG003|Overall Study|Decrease in serum calcium|1|||
161768198|NCT01521494|584192619|FG004|Overall Study|Decrease in serum calcium|1|||
161768199|NCT01521494|584192615|FG000|Overall Study|Physician Decision|0|||
161768200|NCT01521494|584192616|FG001|Overall Study|Physician Decision|0|||
161768201|NCT01521494|584192617|FG002|Overall Study|Physician Decision|0|||
161768202|NCT01521494|584192618|FG003|Overall Study|Physician Decision|0|||
161768203|NCT01521494|584192619|FG004|Overall Study|Physician Decision|2|||
161768204|NCT00877929|584192620|FG000|Overall Study|Adverse Event|11|||
161768205|NCT00877929|584192621|FG001|Overall Study|Adverse Event|20|||
161768206|NCT00877929|584192620|FG000|Overall Study|Protocol Violation|3|||
161768207|NCT00877929|584192621|FG001|Overall Study|Protocol Violation|3|||
161768208|NCT00877929|584192620|FG000|Overall Study|Lost to Follow-up|0|||
161768209|NCT00877929|584192621|FG001|Overall Study|Lost to Follow-up|1|||
161768210|NCT00877929|584192620|FG000|Overall Study|Withdrawal by Subject|4|||
161768211|NCT00877929|584192621|FG001|Overall Study|Withdrawal by Subject|4|||
161768212|NCT00877929|584192620|FG000|Overall Study|Lack of Efficacy|0|||
161768213|NCT00877929|584192621|FG001|Overall Study|Lack of Efficacy|1|||
161768214|NCT00877929|584192620|FG000|Overall Study|Other reason (not specified)|2|||
161768215|NCT00877929|584192621|FG001|Overall Study|Other reason (not specified)|6|||
161768216|NCT01140646|584192622|FG000|Overall Study|Adverse Event|4|||
161768217|NCT01140646|584192622|FG000|Overall Study|Refused Further Treatment|5|||
161768218|NCT00689728|584192626|FG000|Double-Blind Treatment|Adverse Event|1|||
161768219|NCT00689728|584192627|FG001|Double-Blind Treatment|Adverse Event|0|||
161768220|NCT00689728|584192628|FG002|Double-Blind Treatment|Adverse Event|0|||
161768221|NCT00689728|584192626|FG000|Double-Blind Treatment|Protocol Violation|0|||
161768222|NCT00689728|584192627|FG001|Double-Blind Treatment|Protocol Violation|0|||
161768223|NCT00689728|584192628|FG002|Double-Blind Treatment|Protocol Violation|1|||
162034244|NCT04779216|585181184|FG001|Overall Study|Lost to Follow-up|0|||
161855092|NCT00451178|584509771|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
161855093|NCT00451178|584509772|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
161855094|NCT00451178|584509771|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
161768224|NCT00689728|584192626|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
161768225|NCT00689728|584192627|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
161768226|NCT00689728|584192628|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
161768227|NCT00689728|584192626|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
161768228|NCT00689728|584192627|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
161768229|NCT00689728|584192628|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
161768230|NCT00689728|584192626|FG000|Rescue|Adverse Event|0|||
161768231|NCT00689728|584192627|FG001|Rescue|Adverse Event|1|||
161768232|NCT00689728|584192628|FG002|Rescue|Adverse Event|0|||
161768233|NCT00689728|584192626|FG000|Rescue|Withdrawal by Subject|1|||
161768234|NCT00689728|584192627|FG001|Rescue|Withdrawal by Subject|1|||
161768235|NCT00689728|584192628|FG002|Rescue|Withdrawal by Subject|1|||
161768236|NCT00689728|584192626|FG000|Optional Follow-Up|Adverse Event|1|||
161768237|NCT00689728|584192627|FG001|Optional Follow-Up|Adverse Event|0|||
161768238|NCT00689728|584192628|FG002|Optional Follow-Up|Adverse Event|0|||
161768239|NCT00689728|584192626|FG000|Optional Follow-Up|Lack of Efficacy|0|||
161768240|NCT00689728|584192627|FG001|Optional Follow-Up|Lack of Efficacy|1|||
161768241|NCT00689728|584192628|FG002|Optional Follow-Up|Lack of Efficacy|1|||
161768242|NCT00689728|584192626|FG000|Optional Follow-Up|Lost to Follow-up|0|||
161768243|NCT00689728|584192627|FG001|Optional Follow-Up|Lost to Follow-up|1|||
161768244|NCT00689728|584192628|FG002|Optional Follow-Up|Lost to Follow-up|1|||
161768245|NCT00689728|584192626|FG000|Optional Follow-Up|Protocol Violation|0|||
161768246|NCT00689728|584192627|FG001|Optional Follow-Up|Protocol Violation|0|||
161768247|NCT00689728|584192628|FG002|Optional Follow-Up|Protocol Violation|1|||
161768248|NCT00689728|584192626|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
161768249|NCT00689728|584192627|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
161768250|NCT00689728|584192628|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
161768251|NCT00842829|584192631|FG000|Dose Titration Period|Adverse Event|11|||
161768252|NCT00842829|584192632|FG001|Dose Titration Period|Adverse Event|10|||
161768253|NCT00842829|584192633|FG002|Dose Titration Period|Adverse Event|0|||
161768254|NCT00842829|584192631|FG000|Dose Titration Period|Lack of Efficacy|4|||
161768255|NCT00842829|584192632|FG001|Dose Titration Period|Lack of Efficacy|1|||
161768256|NCT00842829|584192633|FG002|Dose Titration Period|Lack of Efficacy|0|||
161768257|NCT00842829|584192631|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
161768258|NCT00842829|584192632|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
161768259|NCT00842829|584192633|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
161768260|NCT00842829|584192631|FG000|Dose Titration Period|Withdrawal by Subject|2|||
161768261|NCT00842829|584192632|FG001|Dose Titration Period|Withdrawal by Subject|6|||
161768262|NCT00842829|584192633|FG002|Dose Titration Period|Withdrawal by Subject|0|||
161768263|NCT00842829|584192631|FG000|Dose Titration Period|Other|5|||
161768264|NCT00842829|584192632|FG001|Dose Titration Period|Other|4|||
161768265|NCT00842829|584192633|FG002|Dose Titration Period|Other|0|||
161768266|NCT00842829|584192631|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
161768267|NCT00842829|584192632|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
161768268|NCT00842829|584192633|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
161768269|NCT00842829|584192631|FG000|Dose Titration Period|Non-compliance to study drug|2|||
161768270|NCT00842829|584192632|FG001|Dose Titration Period|Non-compliance to study drug|1|||
161768271|NCT00842829|584192633|FG002|Dose Titration Period|Non-compliance to study drug|0|||
161768272|NCT00842829|584192631|FG000|Treatment Period|Adverse Event|0|||
161768273|NCT00842829|584192632|FG001|Treatment Period|Adverse Event|0|||
161768274|NCT00842829|584192633|FG002|Treatment Period|Adverse Event|15|||
161768275|NCT00842829|584192631|FG000|Treatment Period|Lack of Efficacy|0|||
161768276|NCT00842829|584192632|FG001|Treatment Period|Lack of Efficacy|0|||
161768277|NCT00842829|584192633|FG002|Treatment Period|Lack of Efficacy|6|||
161768278|NCT00842829|584192631|FG000|Treatment Period|Unstable persistent cancer pain|0|||
161768279|NCT00842829|584192632|FG001|Treatment Period|Unstable persistent cancer pain|0|||
161768280|NCT00842829|584192633|FG002|Treatment Period|Unstable persistent cancer pain|5|||
161768281|NCT00842829|584192631|FG000|Treatment Period|Withdrawal by Subject|0|||
161768282|NCT00842829|584192632|FG001|Treatment Period|Withdrawal by Subject|0|||
161768283|NCT00842829|584192633|FG002|Treatment Period|Withdrawal by Subject|11|||
161768284|NCT00842829|584192631|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
161855095|NCT00451178|584509772|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
161855096|NCT00451178|584509771|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
161855097|NCT00451178|584509772|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
161768285|NCT00842829|584192632|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
161768286|NCT00842829|584192633|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
161768287|NCT00842829|584192631|FG000|Treatment Period|Protocol Violation|0|||
161768288|NCT00842829|584192632|FG001|Treatment Period|Protocol Violation|0|||
161768289|NCT00842829|584192633|FG002|Treatment Period|Protocol Violation|2|||
161768290|NCT00842829|584192631|FG000|Treatment Period|Other|0|||
161768291|NCT00842829|584192632|FG001|Treatment Period|Other|0|||
161855098|NCT00451178|584509771|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
161855099|NCT00451178|584509772|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
161855100|NCT00451178|584509771|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
161855101|NCT00451178|584509772|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
161855102|NCT00451178|584509771|FG000|Prior to Maintenance Therapy|PD|2|||
161855103|NCT00451178|584509772|FG001|Prior to Maintenance Therapy|PD|0|||
161855104|NCT00451178|584509771|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
161855105|NCT00451178|584509772|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
161855106|NCT00451178|584509771|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
161855107|NCT00451178|584509772|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
161855108|NCT00451178|584509771|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
161855109|NCT00451178|584509772|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
161855110|NCT00451178|584509771|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
161855111|NCT00451178|584509772|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
161855112|NCT00451178|584509771|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
161855113|NCT00451178|584509772|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
161855114|NCT00451178|584509771|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
161974865|NCT00042432|584956506|FG000|Overall Study|Initiation of maintenance dialysis|1|||
161974866|NCT00042432|584956507|FG001|Overall Study|Initiation of maintenance dialysis|1|||
161855115|NCT00451178|584509772|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
161855116|NCT00451178|584509771|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
161855117|NCT00451178|584509772|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
161855118|NCT00352417|584509775|FG000|Overall Study|Adverse Event|1|||
161855119|NCT00352417|584509776|FG001|Overall Study|Adverse Event|0|||
161855120|NCT00352417|584509775|FG000|Overall Study|Protocol Violation|0|||
161855121|NCT00352417|584509776|FG001|Overall Study|Protocol Violation|2|||
161855122|NCT00352417|584509775|FG000|Overall Study|Withdrawal by Subject|1|||
161855123|NCT00352417|584509776|FG001|Overall Study|Withdrawal by Subject|2|||
161855124|NCT00352417|584509775|FG000|Overall Study|Lost to Follow-up|1|||
161855125|NCT00352417|584509776|FG001|Overall Study|Lost to Follow-up|0|||
161855126|NCT00352417|584509775|FG000|Overall Study|Schedule Change|2|||
161855127|NCT00352417|584509776|FG001|Overall Study|Schedule Change|1|||
161855128|NCT00912912|584509777|FG000|Overall Study|Withdrawal by Subject|1|||
161855129|NCT00912912|584509777|FG000|Overall Study|Disease Progression|3|||
161855130|NCT02447744|584509778|FG000|Overall Study|Withdrawal by Subject|3|||
161768292|NCT00842829|584192633|FG002|Treatment Period|Other|18|||
161768293|NCT00842829|584192631|FG000|Treatment Period|Non-compliance to study procedures|0|||
161768294|NCT00842829|584192632|FG001|Treatment Period|Non-compliance to study procedures|0|||
161768295|NCT00842829|584192633|FG002|Treatment Period|Non-compliance to study procedures|4|||
161768296|NCT00842829|584192631|FG000|Treatment Period|Unclear completion status|0|||
161768297|NCT00842829|584192632|FG001|Treatment Period|Unclear completion status|0|||
161768298|NCT00842829|584192633|FG002|Treatment Period|Unclear completion status|1|||
161855131|NCT02447744|584509779|FG001|Overall Study|Withdrawal by Subject|1|||
161974867|NCT00042432|584956506|FG000|Overall Study|Other|2|||
161974868|NCT00042432|584956507|FG001|Overall Study|Other|0|||
161974869|NCT01527383|584956508|FG000|Overall Study|Adverse Event|5|||
161974870|NCT01527383|584956509|FG001|Overall Study|Adverse Event|0|||
161974871|NCT01527383|584956508|FG000|Overall Study|Lost to Follow-up|3|||
161768299|NCT00842829|584192631|FG000|Continuation Period|Adverse Event|0|||
161768300|NCT00842829|584192632|FG001|Continuation Period|Adverse Event|0|||
161768301|NCT00842829|584192633|FG002|Continuation Period|Adverse Event|32|||
161768302|NCT00842829|584192631|FG000|Continuation Period|Lack of Efficacy|0|||
161768303|NCT00842829|584192632|FG001|Continuation Period|Lack of Efficacy|0|||
161768304|NCT00842829|584192633|FG002|Continuation Period|Lack of Efficacy|6|||
161768305|NCT00842829|584192631|FG000|Continuation Period|Unstable persistent cancer pain|0|||
161768306|NCT00842829|584192632|FG001|Continuation Period|Unstable persistent cancer pain|0|||
161768307|NCT00842829|584192633|FG002|Continuation Period|Unstable persistent cancer pain|3|||
161768308|NCT00842829|584192631|FG000|Continuation Period|Withdrawal by Subject|0|||
161768309|NCT00842829|584192632|FG001|Continuation Period|Withdrawal by Subject|0|||
161768310|NCT00842829|584192633|FG002|Continuation Period|Withdrawal by Subject|10|||
161768311|NCT00842829|584192631|FG000|Continuation Period|Other|0|||
161768312|NCT00842829|584192632|FG001|Continuation Period|Other|0|||
161768313|NCT00842829|584192633|FG002|Continuation Period|Other|7|||
161768314|NCT00842829|584192631|FG000|Continuation Period|Non-compliance to study procedures|0|||
161768315|NCT00842829|584192632|FG001|Continuation Period|Non-compliance to study procedures|0|||
161768316|NCT00842829|584192633|FG002|Continuation Period|Non-compliance to study procedures|2|||
161855132|NCT02447744|584509778|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
161855133|NCT02447744|584509779|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
161855134|NCT00306995|584509780|FG000|Study Part I|Withdrawal by Subject|0|||
161855135|NCT00306995|584509781|FG001|Study Part I|Withdrawal by Subject|0|||
161855136|NCT00306995|584509782|FG002|Study Part I|Withdrawal by Subject|0|||
161974872|NCT01527383|584956509|FG001|Overall Study|Lost to Follow-up|0|||
161974873|NCT01527383|584956508|FG000|Overall Study|Physician Decision|2|||
161768317|NCT00842829|584192631|FG000|Continuation Period|Non-compliance to study drug|0|||
161768318|NCT00842829|584192632|FG001|Continuation Period|Non-compliance to study drug|0|||
161768319|NCT00842829|584192633|FG002|Continuation Period|Non-compliance to study drug|1|||
161768320|NCT00660829|584192639|FG000|Overall Study|Adverse Event|3|||
161768321|NCT00660829|584192640|FG001|Overall Study|Adverse Event|4|||
161768322|NCT00660829|584192639|FG000|Overall Study|Lack of Efficacy|2|||
161768323|NCT00660829|584192640|FG001|Overall Study|Lack of Efficacy|3|||
161768324|NCT00660829|584192639|FG000|Overall Study|Non-Compliance|0|||
161855137|NCT00306995|584509783|FG003|Study Part I|Withdrawal by Subject|0|||
161855138|NCT00306995|584509784|FG004|Study Part I|Withdrawal by Subject|0|||
161855139|NCT00306995|584509785|FG005|Study Part I|Withdrawal by Subject|0|||
161855140|NCT00306995|584509786|FG006|Study Part I|Withdrawal by Subject|1|||
161855141|NCT00306995|584509780|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
161855142|NCT00306995|584509781|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
161855143|NCT00306995|584509782|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
161855144|NCT00306995|584509783|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
161855145|NCT00306995|584509784|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
161855146|NCT00306995|584509785|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
161855147|NCT00306995|584509786|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
161855148|NCT06419907|584512269|FG000|Overall Study|Protocol Violation|0|||
161855149|NCT06419907|584512270|FG001|Overall Study|Protocol Violation|3|||
161855150|NCT06419907|584512271|FG002|Overall Study|Protocol Violation|0|||
161855151|NCT06419907|584512272|FG003|Overall Study|Protocol Violation|1|||
161855152|NCT06419907|584512269|FG000|Overall Study|Lost to Follow-up|0|||
161855153|NCT06419907|584512270|FG001|Overall Study|Lost to Follow-up|0|||
161855154|NCT06419907|584512271|FG002|Overall Study|Lost to Follow-up|2|||
161855155|NCT06419907|584512272|FG003|Overall Study|Lost to Follow-up|1|||
161855156|NCT02586688|584512273|FG000|Overall Study|Lost to Follow-up|2|||
161855157|NCT02586688|584512274|FG001|Overall Study|Lost to Follow-up|1|||
161768325|NCT00660829|584192640|FG001|Overall Study|Non-Compliance|4|||
161768326|NCT00660829|584192639|FG000|Overall Study|Withdrawal by Subject|1|||
161768327|NCT00660829|584192640|FG001|Overall Study|Withdrawal by Subject|2|||
161768328|NCT00660829|584192639|FG000|Overall Study|Lost to Follow-up|3|||
161768329|NCT00660829|584192640|FG001|Overall Study|Lost to Follow-up|2|||
161768330|NCT00660829|584192639|FG000|Overall Study|Other|9|||
161768331|NCT00660829|584192640|FG001|Overall Study|Other|4|||
161768332|NCT02127931|584192643|FG000|Overall Study|Glitch in Game|1|||
161855158|NCT02586688|584512273|FG000|Overall Study|Withdrawal by Subject|1|||
161855159|NCT02586688|584512274|FG001|Overall Study|Withdrawal by Subject|1|||
161855160|NCT02586688|584512273|FG000|Overall Study|Adverse Event|3|||
161855161|NCT02586688|584512274|FG001|Overall Study|Adverse Event|1|||
161855162|NCT04856917|584512275|FG000|Overall Study|Withdrawal by Subject|4|||
161855163|NCT04856917|584512276|FG001|Overall Study|Withdrawal by Subject|3|||
161855164|NCT04856917|584512277|FG002|Overall Study|Withdrawal by Subject|1|||
161855165|NCT04856917|584512275|FG000|Overall Study|Lost to Follow-up|3|||
161855166|NCT04856917|584512276|FG001|Overall Study|Lost to Follow-up|1|||
161855167|NCT04856917|584512277|FG002|Overall Study|Lost to Follow-up|1|||
161855168|NCT04856917|584512275|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
161974874|NCT01527383|584956509|FG001|Overall Study|Physician Decision|0|||
161974875|NCT01527383|584956508|FG000|Overall Study|Pregnancy|1|||
161974876|NCT01527383|584956509|FG001|Overall Study|Pregnancy|0|||
161974877|NCT01527383|584956508|FG000|Overall Study|Protocol Violation|1|||
161974878|NCT01527383|584956509|FG001|Overall Study|Protocol Violation|0|||
161768333|NCT03417999|584192644|FG000|Overall Study|Withdrawal by Subject|1|||
161768334|NCT03417999|584192645|FG001|Overall Study|Withdrawal by Subject|0|||
161768335|NCT03417999|584192646|FG002|Overall Study|Withdrawal by Subject|0|||
161974879|NCT01527383|584956508|FG000|Overall Study|Screen failure|1|||
161974880|NCT01527383|584956509|FG001|Overall Study|Screen failure|0|||
161974881|NCT01527383|584956508|FG000|Overall Study|Participant moved|0|||
161768336|NCT03417999|584192644|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
161768337|NCT03417999|584192645|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
161855169|NCT04856917|584512276|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
161855170|NCT04856917|584512277|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
161855171|NCT04856917|584512275|FG000|Overall Study|Other|1|||
161855172|NCT04856917|584512276|FG001|Overall Study|Other|1|||
161855173|NCT04856917|584512277|FG002|Overall Study|Other|0|||
161855174|NCT03573830|584512280|FG000|Overall Study|Dropped without completing treatment|0|||
161855175|NCT03573830|584512281|FG001|Overall Study|Dropped without completing treatment|7|||
161855176|NCT03573830|584512280|FG000|Overall Study|Lost to Follow-up|4|||
161974882|NCT01527383|584956509|FG001|Overall Study|Participant moved|1|||
161974883|NCT01527383|584956508|FG000|Overall Study|Withdrawal by Subject|2|||
161974884|NCT01527383|584956509|FG001|Overall Study|Withdrawal by Subject|3|||
161974885|NCT00849875|584956511|FG000|Overall Study|Death|28|||
161974886|NCT00849875|584956511|FG000|Overall Study|Ongoing (unknown completion status)|11|||
161974887|NCT00849875|584956511|FG000|Overall Study|Others|6|||
161974888|NCT00849875|584956511|FG000|Overall Study|Lost to Follow-up|2|||
161974889|NCT00844805|584956519|FG000|Treatment Phase|Adverse Event|5|||
161768338|NCT03417999|584192646|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
161768339|NCT03417999|584192644|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
161768340|NCT03417999|584192645|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
161768341|NCT03417999|584192646|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
161768342|NCT03417999|584192644|FG000|Overall Study|Inadequate study staff available to process samples|0|||
161768343|NCT03417999|584192645|FG001|Overall Study|Inadequate study staff available to process samples|0|||
161768344|NCT03417999|584192646|FG002|Overall Study|Inadequate study staff available to process samples|1|||
161768345|NCT02612194|584192651|FG000|Overall Study|Death|5|||
161768346|NCT02612194|584192652|FG001|Overall Study|Death|0|||
161768347|NCT02612194|584192653|FG002|Overall Study|Death|2|||
162034245|NCT04779216|585181183|FG000|Overall Study|Withdrawal by Subject|1|||
162034246|NCT04779216|585181184|FG001|Overall Study|Withdrawal by Subject|0|||
162034247|NCT02674854|585181189|FG000|Overall Study|Adverse Event|17|||
162034248|NCT02674854|585181190|FG001|Overall Study|Adverse Event|15|||
162034249|NCT02674854|585181191|FG002|Overall Study|Adverse Event|5|||
162034250|NCT02674854|585181189|FG000|Overall Study|Withdrawal by Subject|1|||
162034251|NCT02674854|585181190|FG001|Overall Study|Withdrawal by Subject|5|||
161768348|NCT02612194|584192651|FG000|Overall Study|Early Study Termination|1|||
161768349|NCT02612194|584192652|FG001|Overall Study|Early Study Termination|0|||
161768350|NCT02612194|584192653|FG002|Overall Study|Early Study Termination|0|||
161768351|NCT02539160|584192654|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
161768352|NCT02539160|584192655|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
161855177|NCT03573830|584512281|FG001|Overall Study|Lost to Follow-up|0|||
161855178|NCT00266630|584512282|FG000|Overall Study|Adverse Event|8|||
161855179|NCT00266630|584512283|FG001|Overall Study|Adverse Event|6|||
161855180|NCT00266630|584512282|FG000|Overall Study|Lack of Efficacy|1|||
161855181|NCT00266630|584512283|FG001|Overall Study|Lack of Efficacy|4|||
161855182|NCT00266630|584512282|FG000|Overall Study|Entry Criteria not met|1|||
161855183|NCT00266630|584512283|FG001|Overall Study|Entry Criteria not met|0|||
161855184|NCT00266630|584512282|FG000|Overall Study|Protocol Violation|1|||
161855185|NCT00266630|584512283|FG001|Overall Study|Protocol Violation|3|||
161855186|NCT00266630|584512282|FG000|Overall Study|Physician Decision|1|||
161855187|NCT00266630|584512283|FG001|Overall Study|Physician Decision|2|||
161855188|NCT00266630|584512282|FG000|Overall Study|Withdrawal by Subject|10|||
161855189|NCT00266630|584512283|FG001|Overall Study|Withdrawal by Subject|2|||
161855190|NCT00266630|584512282|FG000|Overall Study|Lost to Follow-up|1|||
161855191|NCT00266630|584512283|FG001|Overall Study|Lost to Follow-up|0|||
161855192|NCT00266630|584512282|FG000|Overall Study|Other|19|||
161855193|NCT00266630|584512283|FG001|Overall Study|Other|11|||
162034252|NCT02674854|585181191|FG002|Overall Study|Withdrawal by Subject|4|||
161768353|NCT02539160|584192656|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
161768354|NCT02539160|584192657|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
161768355|NCT02539160|584192654|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
161768356|NCT02539160|584192655|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
161768357|NCT02539160|584192656|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
161768358|NCT02539160|584192657|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
161768359|NCT02539160|584192654|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
161768360|NCT02539160|584192655|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
161768361|NCT02539160|584192656|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
161768362|NCT02539160|584192657|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
161768363|NCT00372905|584192658|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
161768364|NCT00372905|584192659|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
161768365|NCT00372905|584192660|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
161768366|NCT00372905|584192661|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
161768367|NCT00372905|584192658|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
161768368|NCT00372905|584192659|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
161768369|NCT00372905|584192660|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
161768370|NCT00372905|584192661|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
161768371|NCT00372905|584192658|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
161768372|NCT00372905|584192659|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
161768373|NCT00372905|584192660|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
161768374|NCT00372905|584192661|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
161768375|NCT00372905|584192658|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
161768376|NCT00372905|584192659|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
162034253|NCT02674854|585181189|FG000|Overall Study|No-compliant subject|1|||
162034254|NCT02674854|585181190|FG001|Overall Study|No-compliant subject|0|||
161768377|NCT00372905|584192660|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
161768378|NCT00372905|584192661|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
161768379|NCT00372905|584192658|FG000|Follow up Until Relapse or Progression|Study closed|0|||
161768380|NCT00372905|584192659|FG001|Follow up Until Relapse or Progression|Study closed|0|||
161855194|NCT03284723|584512288|FG000|Overall Study|Death|0|||
161855195|NCT03284723|584512289|FG001|Overall Study|Death|0|||
162034255|NCT02674854|585181191|FG002|Overall Study|No-compliant subject|1|||
162034256|NCT02674854|585181189|FG000|Overall Study|Lost to Follow-up|1|||
161974890|NCT00844805|584956520|FG001|Treatment Phase|Adverse Event|1|||
161974891|NCT00844805|584956521|FG002|Treatment Phase|Adverse Event|0|||
161768381|NCT00372905|584192660|FG002|Follow up Until Relapse or Progression|Study closed|0|||
161768382|NCT00372905|584192661|FG003|Follow up Until Relapse or Progression|Study closed|3|||
161768383|NCT00372905|584192658|FG000|Follow up Until Relapse or Progression|Other|0|||
161768384|NCT00372905|584192659|FG001|Follow up Until Relapse or Progression|Other|1|||
161768385|NCT00372905|584192660|FG002|Follow up Until Relapse or Progression|Other|0|||
161768386|NCT00372905|584192661|FG003|Follow up Until Relapse or Progression|Other|0|||
161768387|NCT01728454|584192662|FG000|Stage 1 and 2|Pregnancy|1|||
161768388|NCT01728454|584192663|FG001|Stage 1 and 2|Pregnancy|0|||
161768389|NCT01728454|584192664|FG002|Stage 1 and 2|Pregnancy|0|||
161768390|NCT01728454|584192662|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
161768391|NCT01728454|584192663|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
161768392|NCT01728454|584192664|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
161768393|NCT01728454|584192662|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
161768394|NCT01728454|584192663|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
161768395|NCT01728454|584192664|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
161768396|NCT01728454|584192662|FG000|Stage 1 and 2|Lost to Follow-up|1|||
161768397|NCT01728454|584192663|FG001|Stage 1 and 2|Lost to Follow-up|1|||
161768398|NCT01728454|584192664|FG002|Stage 1 and 2|Lost to Follow-up|0|||
161768399|NCT01728454|584192662|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
161768400|NCT01728454|584192663|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
161768401|NCT01728454|584192664|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
161768402|NCT01728454|584192662|FG000|Stage 3|Reason Missing|0|||
161768403|NCT01728454|584192663|FG001|Stage 3|Reason Missing|0|||
161768404|NCT01728454|584192664|FG002|Stage 3|Reason Missing|1|||
161768405|NCT01728454|584192662|FG000|Stage 3|Subject Required Other Treatment|0|||
161768406|NCT01728454|584192663|FG001|Stage 3|Subject Required Other Treatment|1|||
161768407|NCT01728454|584192664|FG002|Stage 3|Subject Required Other Treatment|0|||
161768408|NCT01728454|584192662|FG000|Stage 3|Pregnancy|1|||
161768409|NCT01728454|584192663|FG001|Stage 3|Pregnancy|0|||
161768410|NCT01728454|584192664|FG002|Stage 3|Pregnancy|0|||
161768411|NCT01728454|584192662|FG000|Stage 3|Withdrew Consent|1|||
161768412|NCT01728454|584192663|FG001|Stage 3|Withdrew Consent|0|||
161768413|NCT01728454|584192664|FG002|Stage 3|Withdrew Consent|1|||
161768414|NCT01728454|584192662|FG000|Stage 3|Non-compliance with Protocol|0|||
161768415|NCT01728454|584192663|FG001|Stage 3|Non-compliance with Protocol|0|||
161768416|NCT01728454|584192664|FG002|Stage 3|Non-compliance with Protocol|1|||
161768417|NCT01728454|584192662|FG000|Stage 3|Lost to Follow-up|0|||
161768418|NCT01728454|584192663|FG001|Stage 3|Lost to Follow-up|3|||
161768419|NCT01728454|584192664|FG002|Stage 3|Lost to Follow-up|1|||
161768420|NCT01728454|584192662|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
161768421|NCT01728454|584192663|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
161768422|NCT01728454|584192664|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
161768423|NCT01362062|584192669|FG000|Overall Study|Adverse Event|1|||
161768424|NCT01362062|584192670|FG001|Overall Study|Adverse Event|0|||
161768425|NCT01362062|584192669|FG000|Overall Study|Lost to Follow-up|11|||
161768426|NCT01362062|584192670|FG001|Overall Study|Lost to Follow-up|0|||
161768427|NCT01362062|584192669|FG000|Overall Study|Withdrawal by Subject|2|||
161768428|NCT01362062|584192670|FG001|Overall Study|Withdrawal by Subject|0|||
161768429|NCT01362062|584192669|FG000|Overall Study|Non-compliant participant|2|||
161768430|NCT01362062|584192670|FG001|Overall Study|Non-compliant participant|0|||
161768431|NCT01362062|584192669|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
161768432|NCT01362062|584192670|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
161768433|NCT01362062|584192669|FG000|Overall Study|Had significant improvement|9|||
161768434|NCT01362062|584192670|FG001|Overall Study|Had significant improvement|0|||
161768435|NCT02545504|584192673|FG000|Overall Study|Death|174|||
161768436|NCT02545504|584192674|FG001|Overall Study|Death|168|||
161768437|NCT02545504|584192673|FG000|Overall Study|Unknown reason|30|||
161768438|NCT02545504|584192674|FG001|Overall Study|Unknown reason|32|||
161768439|NCT02545504|584192673|FG000|Overall Study|Withdrew consent|9|||
161768440|NCT02545504|584192674|FG001|Overall Study|Withdrew consent|11|||
161768441|NCT02545504|584192673|FG000|Overall Study|Investigator's discretion|3|||
161768442|NCT02545504|584192674|FG001|Overall Study|Investigator's discretion|1|||
161768443|NCT02545504|584192673|FG000|Overall Study|Lost to Follow-up|2|||
161974892|NCT00844805|584956522|FG003|Treatment Phase|Adverse Event|0|||
161768444|NCT02545504|584192674|FG001|Overall Study|Lost to Follow-up|2|||
161974893|NCT00844805|584956519|FG000|Treatment Phase|Withdrawal by Subject|3|||
161974894|NCT00844805|584956520|FG001|Treatment Phase|Withdrawal by Subject|4|||
161974895|NCT00844805|584956521|FG002|Treatment Phase|Withdrawal by Subject|0|||
161768445|NCT00434876|584192675|FG000|Overall Study|Lost to Follow-up|1|||
161768446|NCT00434876|584192676|FG001|Overall Study|Lost to Follow-up|1|||
161768447|NCT00758394|584192677|FG000|2nd Intervention Order|Lost to Follow-up|0|||
161768448|NCT00758394|584192678|FG001|2nd Intervention Order|Lost to Follow-up|1|||
161768449|NCT00758394|584192679|FG002|2nd Intervention Order|Lost to Follow-up|0|||
161768450|NCT00758394|584192680|FG003|2nd Intervention Order|Lost to Follow-up|0|||
161855196|NCT03284723|584512290|FG002|Overall Study|Death|0|||
161768451|NCT00758394|584192677|FG000|3rd Intervention|Lost to Follow-up|1|||
161768452|NCT00758394|584192678|FG001|3rd Intervention|Lost to Follow-up|0|||
161768453|NCT00758394|584192679|FG002|3rd Intervention|Lost to Follow-up|0|||
161768454|NCT00758394|584192680|FG003|3rd Intervention|Lost to Follow-up|1|||
161768455|NCT02926833|584194482|FG000|Overall Study|Death|1|||
161768456|NCT02926833|584194483|FG001|Overall Study|Death|1|||
161768457|NCT02926833|584194484|FG002|Overall Study|Death|2|||
161768458|NCT02926833|584194485|FG003|Overall Study|Death|13|||
161768459|NCT02926833|584194482|FG000|Overall Study|Lost to Follow-up|1|||
161768460|NCT02926833|584194483|FG001|Overall Study|Lost to Follow-up|2|||
161768461|NCT02926833|584194484|FG002|Overall Study|Lost to Follow-up|0|||
161768462|NCT02926833|584194485|FG003|Overall Study|Lost to Follow-up|3|||
161768463|NCT02926833|584194482|FG000|Overall Study|Full Consent Withdrawal|0|||
161855197|NCT03284723|584512291|FG003|Overall Study|Death|1|||
161855198|NCT03284723|584512292|FG004|Overall Study|Death|0|||
161855199|NCT03284723|584512293|FG005|Overall Study|Death|0|||
161855200|NCT03284723|584512294|FG006|Overall Study|Death|1|||
161855201|NCT03284723|584512295|FG007|Overall Study|Death|0|||
161855202|NCT03284723|584512296|FG008|Overall Study|Death|0|||
161855203|NCT03284723|584512297|FG009|Overall Study|Death|2|||
161855204|NCT03284723|584512298|FG010|Overall Study|Death|1|||
161855205|NCT03284723|584512299|FG011|Overall Study|Death|0|||
161855206|NCT03284723|584512288|FG000|Overall Study|Lost to Follow-up|0|||
161855207|NCT03284723|584512289|FG001|Overall Study|Lost to Follow-up|0|||
161855208|NCT03284723|584512290|FG002|Overall Study|Lost to Follow-up|0|||
161855209|NCT03284723|584512291|FG003|Overall Study|Lost to Follow-up|0|||
161855210|NCT03284723|584512292|FG004|Overall Study|Lost to Follow-up|0|||
161855211|NCT03284723|584512293|FG005|Overall Study|Lost to Follow-up|2|||
161855212|NCT03284723|584512294|FG006|Overall Study|Lost to Follow-up|1|||
161855213|NCT03284723|584512295|FG007|Overall Study|Lost to Follow-up|0|||
161855214|NCT03284723|584512296|FG008|Overall Study|Lost to Follow-up|0|||
161855215|NCT03284723|584512297|FG009|Overall Study|Lost to Follow-up|2|||
161855216|NCT03284723|584512298|FG010|Overall Study|Lost to Follow-up|0|||
161855217|NCT03284723|584512299|FG011|Overall Study|Lost to Follow-up|0|||
161855218|NCT03284723|584512288|FG000|Overall Study|Study Terminated By Sponsor|0|||
161855219|NCT03284723|584512289|FG001|Overall Study|Study Terminated By Sponsor|0|||
161855220|NCT03284723|584512290|FG002|Overall Study|Study Terminated By Sponsor|0|||
161855221|NCT03284723|584512291|FG003|Overall Study|Study Terminated By Sponsor|0|||
161855222|NCT03284723|584512292|FG004|Overall Study|Study Terminated By Sponsor|1|||
161855223|NCT03284723|584512293|FG005|Overall Study|Study Terminated By Sponsor|0|||
161855224|NCT03284723|584512294|FG006|Overall Study|Study Terminated By Sponsor|0|||
161855225|NCT03284723|584512295|FG007|Overall Study|Study Terminated By Sponsor|0|||
161855226|NCT03284723|584512296|FG008|Overall Study|Study Terminated By Sponsor|1|||
161855227|NCT03284723|584512297|FG009|Overall Study|Study Terminated By Sponsor|1|||
161855228|NCT03284723|584512298|FG010|Overall Study|Study Terminated By Sponsor|1|||
161855229|NCT03284723|584512299|FG011|Overall Study|Study Terminated By Sponsor|1|||
161855230|NCT03284723|584512288|FG000|Overall Study|Withdrawal by Subject|0|||
161855231|NCT03284723|584512289|FG001|Overall Study|Withdrawal by Subject|0|||
161855232|NCT03284723|584512290|FG002|Overall Study|Withdrawal by Subject|0|||
161855233|NCT03284723|584512291|FG003|Overall Study|Withdrawal by Subject|0|||
161855234|NCT03284723|584512292|FG004|Overall Study|Withdrawal by Subject|5|||
161855235|NCT03284723|584512293|FG005|Overall Study|Withdrawal by Subject|3|||
161855236|NCT03284723|584512294|FG006|Overall Study|Withdrawal by Subject|1|||
161855237|NCT03284723|584512295|FG007|Overall Study|Withdrawal by Subject|0|||
161855238|NCT03284723|584512296|FG008|Overall Study|Withdrawal by Subject|6|||
161855239|NCT03284723|584512297|FG009|Overall Study|Withdrawal by Subject|0|||
161855240|NCT03284723|584512298|FG010|Overall Study|Withdrawal by Subject|3|||
161768464|NCT02926833|584194483|FG001|Overall Study|Full Consent Withdrawal|0|||
161768465|NCT02926833|584194484|FG002|Overall Study|Full Consent Withdrawal|0|||
161855241|NCT03284723|584512299|FG011|Overall Study|Withdrawal by Subject|1|||
161855242|NCT03284723|584512288|FG000|Overall Study|Other|1|||
161855243|NCT03284723|584512289|FG001|Overall Study|Other|0|||
161855244|NCT03284723|584512290|FG002|Overall Study|Other|1|||
161855245|NCT03284723|584512291|FG003|Overall Study|Other|0|||
161855246|NCT03284723|584512292|FG004|Overall Study|Other|1|||
161855247|NCT03284723|584512293|FG005|Overall Study|Other|0|||
161855248|NCT03284723|584512294|FG006|Overall Study|Other|0|||
161855249|NCT03284723|584512295|FG007|Overall Study|Other|0|||
161855250|NCT03284723|584512296|FG008|Overall Study|Other|0|||
161855251|NCT03284723|584512297|FG009|Overall Study|Other|0|||
161855252|NCT03284723|584512298|FG010|Overall Study|Other|1|||
161855253|NCT03284723|584512299|FG011|Overall Study|Other|0|||
161855254|NCT03284723|584512288|FG000|Overall Study|Adverse Event|0|||
161768466|NCT02926833|584194485|FG003|Overall Study|Full Consent Withdrawal|2|||
161768467|NCT02926833|584194482|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
161768468|NCT02926833|584194483|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
161855255|NCT03284723|584512289|FG001|Overall Study|Adverse Event|0|||
161855256|NCT03284723|584512290|FG002|Overall Study|Adverse Event|0|||
161855257|NCT03284723|584512291|FG003|Overall Study|Adverse Event|0|||
161855258|NCT03284723|584512292|FG004|Overall Study|Adverse Event|0|||
161855259|NCT03284723|584512293|FG005|Overall Study|Adverse Event|0|||
161855260|NCT03284723|584512294|FG006|Overall Study|Adverse Event|0|||
161855261|NCT03284723|584512295|FG007|Overall Study|Adverse Event|0|||
161855262|NCT03284723|584512296|FG008|Overall Study|Adverse Event|1|||
161855263|NCT03284723|584512297|FG009|Overall Study|Adverse Event|0|||
161855264|NCT03284723|584512298|FG010|Overall Study|Adverse Event|0|||
161855265|NCT03284723|584512299|FG011|Overall Study|Adverse Event|0|||
161855266|NCT00064987|584512304|FG000|Overall Study|Physician Decision|3|||
161855267|NCT00064987|584512305|FG001|Overall Study|Physician Decision|0|||
161855268|NCT01499095|584512306|FG000|Overall Study|Randomized But Not Treated|1|||
161855269|NCT01499095|584512307|FG001|Overall Study|Randomized But Not Treated|1|||
161855270|NCT01499095|584512306|FG000|Overall Study|Adverse Event|12|||
161855271|NCT01499095|584512307|FG001|Overall Study|Adverse Event|7|||
161855272|NCT01499095|584512306|FG000|Overall Study|Lack of Efficacy|2|||
161855273|NCT01499095|584512307|FG001|Overall Study|Lack of Efficacy|1|||
161855274|NCT01499095|584512306|FG000|Overall Study|Protocol Violation|6|||
161855275|NCT01499095|584512307|FG001|Overall Study|Protocol Violation|7|||
161855276|NCT01499095|584512306|FG000|Overall Study|Received Rescue Therapy|32|||
161855277|NCT01499095|584512307|FG001|Overall Study|Received Rescue Therapy|40|||
161855278|NCT01499095|584512306|FG000|Overall Study|Diverse Reasons|22|||
161855279|NCT01499095|584512307|FG001|Overall Study|Diverse Reasons|25|||
161855280|NCT01499095|584512306|FG000|Overall Study|Lost to Follow-up|6|||
161855281|NCT01499095|584512307|FG001|Overall Study|Lost to Follow-up|4|||
161855282|NCT01499095|584512306|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
161855283|NCT01499095|584512307|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
161855284|NCT01499095|584512306|FG000|Overall Study|Hypoglycemia|3|||
161855285|NCT01499095|584512307|FG001|Overall Study|Hypoglycemia|1|||
161855286|NCT01499095|584512306|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
161855287|NCT01499095|584512307|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
161855288|NCT01499095|584512306|FG000|Overall Study|Change in Injection Schedule|2|||
161855289|NCT01499095|584512307|FG001|Overall Study|Change in Injection Schedule|0|||
161855290|NCT01499095|584512306|FG000|Overall Study|Perceived Lack of Efficacy|1|||
161855291|NCT01499095|584512307|FG001|Overall Study|Perceived Lack of Efficacy|1|||
161855292|NCT01368497|584512308|FG000|Overall Study|Lost to Follow-up|2|||
161855293|NCT00443729|584512312|FG000|Overall Study|Never Treated|0|||
161855294|NCT00443729|584512313|FG001|Overall Study|Never Treated|1|||
161855295|NCT00443729|584512312|FG000|Overall Study|Lack of Efficacy|4|||
161855296|NCT00443729|584512313|FG001|Overall Study|Lack of Efficacy|2|||
161855297|NCT00443729|584512312|FG000|Overall Study|Lost to Follow-up|0|||
161855298|NCT00443729|584512313|FG001|Overall Study|Lost to Follow-up|1|||
161855299|NCT00443729|584512312|FG000|Overall Study|Physician Decision|2|||
161855300|NCT00443729|584512313|FG001|Overall Study|Physician Decision|1|||
161855301|NCT00443729|584512312|FG000|Overall Study|Protocol Violation|1|||
161855302|NCT00443729|584512313|FG001|Overall Study|Protocol Violation|1|||
161855303|NCT00443729|584512312|FG000|Overall Study|Withdrawal by Subject|3|||
161855304|NCT00443729|584512313|FG001|Overall Study|Withdrawal by Subject|1|||
161855305|NCT00782626|584512317|FG000|Overall Study|Adverse Event|1|||
161855306|NCT00782626|584512317|FG000|Overall Study|Progressive Disease|5|||
161855307|NCT00782626|584512317|FG000|Overall Study|Other Complicating Disease|1|||
161855308|NCT00077207|584512320|FG000|Overall Study|Adverse Event|5|||
161855309|NCT00077207|584512320|FG000|Overall Study|Lack of Efficacy|12|||
161855310|NCT00077207|584512320|FG000|Overall Study|Physician Decision|6|||
161855311|NCT00077207|584512320|FG000|Overall Study|Withdrawal by Subject|6|||
161855312|NCT00077207|584512320|FG000|Overall Study|Ineligible|1|||
161855313|NCT03052751|584512323|FG000|Dosing Period 1|Adverse Event|0|||
161855314|NCT03052751|584512324|FG001|Dosing Period 1|Adverse Event|1|||
161855315|NCT03052751|584512325|FG002|Dosing Period 1|Adverse Event|0|||
161855316|NCT03052751|584512326|FG003|Dosing Period 1|Adverse Event|0|||
161855317|NCT03052751|584512327|FG004|Dosing Period 1|Adverse Event|0|||
161855318|NCT03052751|584512328|FG005|Dosing Period 1|Adverse Event|0|||
161855319|NCT03052751|584512323|FG000|Dosing Period 2|Adverse Event|0|||
161855320|NCT03052751|584512324|FG001|Dosing Period 2|Adverse Event|0|||
161855321|NCT03052751|584512325|FG002|Dosing Period 2|Adverse Event|3|||
161855322|NCT03052751|584512326|FG003|Dosing Period 2|Adverse Event|0|||
161855323|NCT03052751|584512327|FG004|Dosing Period 2|Adverse Event|0|||
161855324|NCT03052751|584512328|FG005|Dosing Period 2|Adverse Event|0|||
161855325|NCT03052751|584512323|FG000|Observation Period|Adverse Event|0|||
161855326|NCT03052751|584512324|FG001|Observation Period|Adverse Event|0|||
161855327|NCT03052751|584512325|FG002|Observation Period|Adverse Event|0|||
161855328|NCT03052751|584512326|FG003|Observation Period|Adverse Event|0|||
161855329|NCT03052751|584512327|FG004|Observation Period|Adverse Event|1|||
161855330|NCT03052751|584512328|FG005|Observation Period|Adverse Event|0|||
161855331|NCT01427608|584512339|FG000|Overall Study|Death|1|||
161855332|NCT01427608|584512340|FG001|Overall Study|Death|0|||
161855333|NCT01427608|584512339|FG000|Overall Study|Withdrawal by Subject|7|||
161855334|NCT01427608|584512340|FG001|Overall Study|Withdrawal by Subject|3|||
161855335|NCT01427608|584512339|FG000|Overall Study|Relapsed-all cause|13|||
161855336|NCT01427608|584512340|FG001|Overall Study|Relapsed-all cause|34|||
161855337|NCT01427608|584512339|FG000|Overall Study|Events not attributed to study meds|0|||
161855338|NCT01427608|584512340|FG001|Overall Study|Events not attributed to study meds|1|||
161855339|NCT01473407|584512341|FG000|Overall Study|Physician Decision|1|||
161855340|NCT01473407|584512342|FG001|Overall Study|Physician Decision|4|||
161855341|NCT01473407|584512341|FG000|Overall Study|Lost to Follow-up|10|||
161768469|NCT02926833|584194484|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
161768470|NCT02926833|584194485|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
161768471|NCT02926833|584194482|FG000|Overall Study|Investigator Decision|0|||
161768472|NCT02926833|584194483|FG001|Overall Study|Investigator Decision|1|||
161768473|NCT02926833|584194484|FG002|Overall Study|Investigator Decision|0|||
161768474|NCT02926833|584194485|FG003|Overall Study|Investigator Decision|0|||
161768475|NCT02926833|584194482|FG000|Overall Study|Adverse Event|0|||
161855342|NCT01473407|584512342|FG001|Overall Study|Lost to Follow-up|4|||
161855343|NCT01473407|584512341|FG000|Overall Study|Adverse Event|8|||
161855344|NCT01473407|584512342|FG001|Overall Study|Adverse Event|8|||
161855345|NCT01473407|584512341|FG000|Overall Study|Randomization Error|3|||
161855346|NCT01473407|584512342|FG001|Overall Study|Randomization Error|1|||
161974896|NCT00844805|584956522|FG003|Treatment Phase|Withdrawal by Subject|0|||
161974897|NCT00844805|584956519|FG000|Treatment Phase|Noncompliance With Protocol|1|||
161974898|NCT00844805|584956520|FG001|Treatment Phase|Noncompliance With Protocol|0|||
161974899|NCT00844805|584956521|FG002|Treatment Phase|Noncompliance With Protocol|0|||
161855347|NCT01473407|584512341|FG000|Overall Study|Withdrawal by Subject|4|||
161855348|NCT01473407|584512342|FG001|Overall Study|Withdrawal by Subject|7|||
161855349|NCT01473407|584512341|FG000|Overall Study|Kidney Transplant|7|||
161855350|NCT01473407|584512342|FG001|Overall Study|Kidney Transplant|6|||
161855351|NCT01473407|584512341|FG000|Overall Study|Vacation/Travel|1|||
161855352|NCT01473407|584512342|FG001|Overall Study|Vacation/Travel|1|||
161855353|NCT01473407|584512341|FG000|Overall Study|Elevated Hemoglobin|1|||
161855354|NCT01473407|584512342|FG001|Overall Study|Elevated Hemoglobin|0|||
161855355|NCT01473407|584512341|FG000|Overall Study|Patient Received Aranesp|1|||
161855356|NCT01473407|584512342|FG001|Overall Study|Patient Received Aranesp|0|||
161855357|NCT01473407|584512341|FG000|Overall Study|Patient Lost Green Card Status|1|||
161855358|NCT01473407|584512342|FG001|Overall Study|Patient Lost Green Card Status|0|||
161855359|NCT01473407|584512341|FG000|Overall Study|Temperature Excursion|2|||
161855360|NCT01473407|584512342|FG001|Overall Study|Temperature Excursion|3|||
161855361|NCT01473407|584512341|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
161855362|NCT01473407|584512342|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
161855363|NCT01473407|584512341|FG000|Overall Study|Sponsor's Decision|10|||
161855364|NCT01473407|584512342|FG001|Overall Study|Sponsor's Decision|10|||
161855365|NCT01473407|584512341|FG000|Overall Study|Site Closure|1|||
161855366|NCT01473407|584512342|FG001|Overall Study|Site Closure|0|||
161855367|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
161855368|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
161855369|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
161855370|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
161855371|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
161855372|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
161855373|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
161855374|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
161855375|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
161855376|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
161855377|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
161855378|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
161855379|NCT02422797|584512343|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
161855380|NCT02422797|584512344|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
161855381|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
161855382|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
161855383|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
161855384|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
161855385|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
161855386|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
161855387|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
161974900|NCT00844805|584956522|FG003|Treatment Phase|Noncompliance With Protocol|0|||
161974901|NCT00844805|584956519|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
161855388|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
161855389|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
161855390|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
161974902|NCT00844805|584956520|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
161855391|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
161855392|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
161974903|NCT00844805|584956521|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
161768476|NCT02926833|584194483|FG001|Overall Study|Adverse Event|0|||
161855393|NCT02422797|584512343|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
161855394|NCT02422797|584512344|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
161855395|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
161855396|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
161855397|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
161855398|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
161855399|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
161855400|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
161768477|NCT02926833|584194484|FG002|Overall Study|Adverse Event|1|||
161768478|NCT02926833|584194485|FG003|Overall Study|Adverse Event|0|||
161768479|NCT02926833|584194482|FG000|Overall Study|Partial Withdrawal of Consent|0|||
161768480|NCT02926833|584194483|FG001|Overall Study|Partial Withdrawal of Consent|0|||
161768481|NCT02926833|584194484|FG002|Overall Study|Partial Withdrawal of Consent|0|||
161768482|NCT02926833|584194485|FG003|Overall Study|Partial Withdrawal of Consent|1|||
161768483|NCT01004822|584194486|FG000|Overall Study|Objective progression or relapse|3|||
161768484|NCT01004822|584194487|FG001|Overall Study|Objective progression or relapse|3|||
161768485|NCT01004822|584194488|FG002|Overall Study|Objective progression or relapse|0|||
161768486|NCT01004822|584194489|FG003|Overall Study|Objective progression or relapse|1|||
161768487|NCT01004822|584194490|FG004|Overall Study|Objective progression or relapse|2|||
161768488|NCT01004822|584194491|FG005|Overall Study|Objective progression or relapse|2|||
161768489|NCT01004822|584194492|FG006|Overall Study|Objective progression or relapse|1|||
161768490|NCT01004822|584194493|FG007|Overall Study|Objective progression or relapse|4|||
161768491|NCT01004822|584194486|FG000|Overall Study|Global deterioration of health status|0|||
161768492|NCT01004822|584194487|FG001|Overall Study|Global deterioration of health status|0|||
161768493|NCT01004822|584194488|FG002|Overall Study|Global deterioration of health status|0|||
161768494|NCT01004822|584194489|FG003|Overall Study|Global deterioration of health status|1|||
161768495|NCT01004822|584194490|FG004|Overall Study|Global deterioration of health status|0|||
161768496|NCT01004822|584194491|FG005|Overall Study|Global deterioration of health status|0|||
161768497|NCT01004822|584194492|FG006|Overall Study|Global deterioration of health status|1|||
161768498|NCT01004822|584194493|FG007|Overall Study|Global deterioration of health status|0|||
161768499|NCT01004822|584194486|FG000|Overall Study|No longer willing to continue|0|||
161768500|NCT01004822|584194487|FG001|Overall Study|No longer willing to continue|0|||
161768501|NCT01004822|584194488|FG002|Overall Study|No longer willing to continue|0|||
161768502|NCT01004822|584194489|FG003|Overall Study|No longer willing to continue|1|||
161768503|NCT01004822|584194490|FG004|Overall Study|No longer willing to continue|2|||
161768504|NCT01004822|584194491|FG005|Overall Study|No longer willing to continue|1|||
161768505|NCT01004822|584194492|FG006|Overall Study|No longer willing to continue|1|||
161768506|NCT01004822|584194493|FG007|Overall Study|No longer willing to continue|0|||
161768507|NCT01004822|584194486|FG000|Overall Study|Adverse Event|0|||
161768508|NCT01004822|584194487|FG001|Overall Study|Adverse Event|0|||
161768509|NCT01004822|584194488|FG002|Overall Study|Adverse Event|0|||
161768510|NCT01004822|584194489|FG003|Overall Study|Adverse Event|0|||
161768511|NCT01004822|584194490|FG004|Overall Study|Adverse Event|0|||
161768512|NCT01004822|584194491|FG005|Overall Study|Adverse Event|0|||
161768513|NCT01004822|584194492|FG006|Overall Study|Adverse Event|1|||
161768514|NCT01004822|584194493|FG007|Overall Study|Adverse Event|1|||
161768515|NCT01004822|584194486|FG000|Overall Study|Other|0|||
161768516|NCT01004822|584194487|FG001|Overall Study|Other|0|||
161768517|NCT01004822|584194488|FG002|Overall Study|Other|4|||
161768518|NCT01004822|584194489|FG003|Overall Study|Other|1|||
161768519|NCT01004822|584194490|FG004|Overall Study|Other|0|||
161768520|NCT01004822|584194491|FG005|Overall Study|Other|1|||
161768521|NCT01004822|584194492|FG006|Overall Study|Other|0|||
161768522|NCT01004822|584194493|FG007|Overall Study|Other|0|||
161768523|NCT03159455|584194496|FG000|Overall Study|Adverse Event|0|||
161768524|NCT03159455|584194497|FG001|Overall Study|Adverse Event|0|||
161768525|NCT03159455|584194498|FG002|Overall Study|Adverse Event|0|||
161768526|NCT03159455|584194499|FG003|Overall Study|Adverse Event|0|||
161768527|NCT03159455|584194500|FG004|Overall Study|Adverse Event|0|||
161768528|NCT03159455|584194501|FG005|Overall Study|Adverse Event|1|||
161768529|NCT03799198|584194507|FG000|Overall Study|Lost to Follow-up|4|||
161768530|NCT03799198|584194508|FG001|Overall Study|Lost to Follow-up|8|||
161768531|NCT03799198|584194507|FG000|Overall Study|Death|0|||
161768532|NCT03799198|584194508|FG001|Overall Study|Death|1|||
161768533|NCT00960869|584194510|FG000|Overall Study|Adverse Event|17|||
161768534|NCT00960869|584194511|FG001|Overall Study|Adverse Event|26|||
161768535|NCT00960869|584194510|FG000|Overall Study|Withdrawal by Subject|16|||
161768536|NCT00960869|584194511|FG001|Overall Study|Withdrawal by Subject|14|||
161768537|NCT00960869|584194510|FG000|Overall Study|Lost to Follow-up|1|||
161768538|NCT00960869|584194511|FG001|Overall Study|Lost to Follow-up|4|||
161768539|NCT00960869|584194510|FG000|Overall Study|Misc|19|||
161768540|NCT00960869|584194511|FG001|Overall Study|Misc|18|||
161768541|NCT02501642|584194512|FG000|Overall Study|Lost to Follow-up|7|||
161768542|NCT02501642|584194513|FG001|Overall Study|Lost to Follow-up|11|||
161974904|NCT00844805|584956522|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
161974905|NCT00844805|584956519|FG000|Follow-Up Phase|Adverse Event|0|||
161974906|NCT00844805|584956520|FG001|Follow-Up Phase|Adverse Event|0|||
161974907|NCT00844805|584956521|FG002|Follow-Up Phase|Adverse Event|1|||
161974908|NCT00844805|584956522|FG003|Follow-Up Phase|Adverse Event|0|||
161974909|NCT00844805|584956519|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
161974910|NCT00844805|584956520|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
161974911|NCT00844805|584956521|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
161768543|NCT01153971|584194517|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
161768544|NCT01153971|584194517|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
161768545|NCT01153971|584194517|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
161768546|NCT01153971|584194517|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
161768547|NCT01153971|584194517|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
161768548|NCT01153971|584194517|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
161768549|NCT01153971|584194517|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
161768550|NCT03410693|584194518|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
161768551|NCT03410693|584194519|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
161768552|NCT03410693|584194518|FG000|Overall Study|Disc trt: Lost to follow up|0|||
161768553|NCT03410693|584194519|FG001|Overall Study|Disc trt: Lost to follow up|1|||
161768554|NCT03410693|584194518|FG000|Overall Study|Disc trt: radiological progression|58|||
161768555|NCT03410693|584194519|FG001|Overall Study|Disc trt: radiological progression|50|||
161768556|NCT03410693|584194518|FG000|Overall Study|Disc trt: Other|1|||
161768557|NCT03410693|584194519|FG001|Overall Study|Disc trt: Other|0|||
161768558|NCT03410693|584194518|FG000|Overall Study|Study drug never administered|1|||
161768559|NCT03410693|584194519|FG001|Overall Study|Study drug never administered|6|||
161768560|NCT03410693|584194518|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
161768561|NCT03410693|584194519|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
161768562|NCT03410693|584194518|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
161768563|NCT03410693|584194519|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
161768564|NCT03410693|584194518|FG000|Overall Study|Disc trt: Physician decision|0|||
161768565|NCT03410693|584194519|FG001|Overall Study|Disc trt: Physician decision|5|||
161768566|NCT03410693|584194518|FG000|Overall Study|Disc trt: clinical progression|1|||
161768567|NCT03410693|584194519|FG001|Overall Study|Disc trt: clinical progression|5|||
161768568|NCT03410693|584194518|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
161768569|NCT03410693|584194519|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
161768570|NCT00953576|584194520|FG000|Overall Study|Adverse Event|0|||
161768571|NCT00953576|584194521|FG001|Overall Study|Adverse Event|1|||
161768572|NCT00953576|584194520|FG000|Overall Study|Ineligible after Consent|2|||
161768573|NCT00953576|584194521|FG001|Overall Study|Ineligible after Consent|0|||
161768574|NCT00501969|584194522|FG000|Overall Study|Major Protocol Violation|4|||
161768575|NCT00501969|584194522|FG000|Overall Study|Lack of Efficacy|29|||
161768576|NCT00501969|584194522|FG000|Overall Study|Adverse Event|76|||
161768577|NCT00501969|584194522|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
161768578|NCT00501969|584194522|FG000|Overall Study|Subject withdrew consent|51|||
161768579|NCT00501969|584194522|FG000|Overall Study|Lost to Follow-up|4|||
161768580|NCT00501969|584194522|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
161768581|NCT00501969|584194522|FG000|Overall Study|Other: Sponsors Request|10|||
161768582|NCT00501969|584194522|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
161768583|NCT00501969|584194522|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
161768584|NCT00501969|584194522|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
161768585|NCT00501969|584194522|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
161768586|NCT00501969|584194522|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
161768587|NCT00501969|584194522|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
161768588|NCT00501969|584194522|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
161768589|NCT00501969|584194522|FG000|Overall Study|Other: As Required by Local EC|2|||
161768590|NCT00501969|584194522|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
161768591|NCT00501969|584194522|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
161768592|NCT00665366|584194523|FG000|Overall Study|Lack of Efficacy|11|||
161768593|NCT00665366|584194524|FG001|Overall Study|Lack of Efficacy|10|||
161768594|NCT00665366|584194523|FG000|Overall Study|Adverse Event|25|||
161768595|NCT00665366|584194524|FG001|Overall Study|Adverse Event|23|||
161768596|NCT00665366|584194523|FG000|Overall Study|Withdrawal by Subject|11|||
161768597|NCT00665366|584194524|FG001|Overall Study|Withdrawal by Subject|14|||
161768598|NCT00665366|584194523|FG000|Overall Study|Lost to Follow-up|3|||
161768599|NCT00665366|584194524|FG001|Overall Study|Lost to Follow-up|5|||
161768600|NCT00665366|584194523|FG000|Overall Study|Poor compliance/noncompliance|3|||
161974912|NCT00844805|584956522|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
161974913|NCT00844805|584956519|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
161974914|NCT00844805|584956520|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
161768601|NCT00665366|584194524|FG001|Overall Study|Poor compliance/noncompliance|5|||
161768602|NCT00665366|584194523|FG000|Overall Study|Pregnancy|1|||
161768603|NCT00665366|584194524|FG001|Overall Study|Pregnancy|0|||
162034257|NCT02674854|585181190|FG001|Overall Study|Lost to Follow-up|0|||
162034258|NCT02674854|585181191|FG002|Overall Study|Lost to Follow-up|2|||
162034259|NCT02674854|585181189|FG000|Overall Study|Lack of Efficacy|0|||
162034260|NCT02674854|585181190|FG001|Overall Study|Lack of Efficacy|3|||
161768604|NCT00665366|584194523|FG000|Overall Study|No longer meets study criteria|0|||
161768605|NCT00665366|584194524|FG001|Overall Study|No longer meets study criteria|1|||
161768606|NCT00665366|584194523|FG000|Overall Study|Other reasons|4|||
161768607|NCT00665366|584194524|FG001|Overall Study|Other reasons|1|||
162034261|NCT02674854|585181191|FG002|Overall Study|Lack of Efficacy|0|||
162034262|NCT02674854|585181189|FG000|Overall Study|Disallowed Concurrent Medication|2|||
162034263|NCT02674854|585181190|FG001|Overall Study|Disallowed Concurrent Medication|2|||
162034264|NCT02674854|585181191|FG002|Overall Study|Disallowed Concurrent Medication|0|||
162034265|NCT02674854|585181189|FG000|Overall Study|Protocol Violation|1|||
162034266|NCT02674854|585181190|FG001|Overall Study|Protocol Violation|1|||
162034267|NCT02674854|585181191|FG002|Overall Study|Protocol Violation|2|||
162034268|NCT02674854|585181189|FG000|Overall Study|Death|0|||
162034269|NCT02674854|585181190|FG001|Overall Study|Death|1|||
162034270|NCT02674854|585181191|FG002|Overall Study|Death|0|||
161768608|NCT03628781|584194525|FG000|Overall Study|Lost to Follow-up|16|||
161768609|NCT03628781|584194526|FG001|Overall Study|Lost to Follow-up|8|||
161768610|NCT03628781|584194525|FG000|Overall Study|Withdrawal by Subject|16|||
161768611|NCT03628781|584194526|FG001|Overall Study|Withdrawal by Subject|1|||
161768612|NCT03778021|584194527|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
161768613|NCT03778021|584194528|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
161768614|NCT02687815|584194529|FG000|Overall Study|Lost to Follow-up|2|||
161768615|NCT02687815|584194530|FG001|Overall Study|Lost to Follow-up|4|||
161768616|NCT02687815|584194529|FG000|Overall Study|Withdrawal by Subject|2|||
161768617|NCT02687815|584194530|FG001|Overall Study|Withdrawal by Subject|4|||
161768618|NCT00379639|584194531|FG000|Overall Study|Disease Progression|3|||
161768619|NCT00379639|584194532|FG001|Overall Study|Disease Progression|3|||
161768620|NCT00379639|584194533|FG002|Overall Study|Disease Progression|3|||
161768621|NCT00379639|584194534|FG003|Overall Study|Disease Progression|4|||
161768622|NCT00379639|584194535|FG004|Overall Study|Disease Progression|4|||
161768623|NCT00379639|584194531|FG000|Overall Study|Physician Decision|0|||
161768624|NCT00379639|584194532|FG001|Overall Study|Physician Decision|2|||
161768625|NCT00379639|584194533|FG002|Overall Study|Physician Decision|1|||
161768626|NCT00379639|584194534|FG003|Overall Study|Physician Decision|1|||
161768627|NCT00379639|584194535|FG004|Overall Study|Physician Decision|0|||
161768628|NCT00379639|584194531|FG000|Overall Study|Symptomatic Deterioration|0|||
161768629|NCT00379639|584194532|FG001|Overall Study|Symptomatic Deterioration|0|||
161768630|NCT00379639|584194533|FG002|Overall Study|Symptomatic Deterioration|1|||
161768631|NCT00379639|584194534|FG003|Overall Study|Symptomatic Deterioration|0|||
161768632|NCT00379639|584194535|FG004|Overall Study|Symptomatic Deterioration|1|||
161768633|NCT00379639|584194531|FG000|Overall Study|Adverse Event|0|||
161768634|NCT00379639|584194532|FG001|Overall Study|Adverse Event|0|||
161768635|NCT00379639|584194533|FG002|Overall Study|Adverse Event|1|||
161768636|NCT00379639|584194534|FG003|Overall Study|Adverse Event|0|||
161768637|NCT00379639|584194535|FG004|Overall Study|Adverse Event|1|||
161768638|NCT00379639|584194531|FG000|Overall Study|Lost to Follow-up|0|||
161768639|NCT00379639|584194532|FG001|Overall Study|Lost to Follow-up|0|||
161768640|NCT00379639|584194533|FG002|Overall Study|Lost to Follow-up|0|||
161768641|NCT00379639|584194534|FG003|Overall Study|Lost to Follow-up|1|||
161768642|NCT00379639|584194535|FG004|Overall Study|Lost to Follow-up|0|||
161768643|NCT00379639|584194531|FG000|Overall Study|Other|0|||
161768644|NCT00379639|584194532|FG001|Overall Study|Other|0|||
161768645|NCT00379639|584194533|FG002|Overall Study|Other|3|||
161768646|NCT00379639|584194534|FG003|Overall Study|Other|0|||
161768647|NCT00379639|584194535|FG004|Overall Study|Other|0|||
161768648|NCT01238861|584194540|FG000|Overall Study|Lost to Follow-up|4|||
161768649|NCT01238861|584194541|FG001|Overall Study|Lost to Follow-up|2|||
162034271|NCT02674854|585181189|FG000|Overall Study|Subject missed V6.2|1|||
161768650|NCT01238861|584194542|FG002|Overall Study|Lost to Follow-up|3|||
161768651|NCT01238861|584194543|FG003|Overall Study|Lost to Follow-up|1|||
161768652|NCT01238861|584194544|FG004|Overall Study|Lost to Follow-up|1|||
161768653|NCT01238861|584194545|FG005|Overall Study|Lost to Follow-up|2|||
161768654|NCT01238861|584194540|FG000|Overall Study|Unplanned surgery|1|||
161768655|NCT01238861|584194541|FG001|Overall Study|Unplanned surgery|0|||
161768656|NCT01238861|584194542|FG002|Overall Study|Unplanned surgery|0|||
161768657|NCT01238861|584194543|FG003|Overall Study|Unplanned surgery|0|||
161768658|NCT01238861|584194544|FG004|Overall Study|Unplanned surgery|0|||
162034272|NCT02674854|585181190|FG001|Overall Study|Subject missed V6.2|0|||
162034273|NCT02674854|585181191|FG002|Overall Study|Subject missed V6.2|0|||
162034274|NCT00879879|585181192|FG000|Overall Study|Death|1|||
161768659|NCT01238861|584194545|FG005|Overall Study|Unplanned surgery|0|||
161768660|NCT01238861|584194540|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
161768661|NCT01238861|584194541|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
161768662|NCT01238861|584194542|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
161768663|NCT01238861|584194543|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
162034275|NCT00879879|585181192|FG000|Overall Study|Withdrawal by Subject|1|||
161768664|NCT01238861|584194544|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
161768665|NCT01238861|584194545|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
161768666|NCT01238861|584194540|FG000|Overall Study|Incorrect enrollment/randomization|0|||
161768667|NCT01238861|584194541|FG001|Overall Study|Incorrect enrollment/randomization|0|||
161768668|NCT01238861|584194542|FG002|Overall Study|Incorrect enrollment/randomization|1|||
161768669|NCT01238861|584194543|FG003|Overall Study|Incorrect enrollment/randomization|0|||
161768670|NCT01238861|584194544|FG004|Overall Study|Incorrect enrollment/randomization|1|||
161768671|NCT01238861|584194545|FG005|Overall Study|Incorrect enrollment/randomization|0|||
161768672|NCT01238861|584194540|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
161768673|NCT01238861|584194541|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
161768674|NCT01238861|584194542|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
161768675|NCT01238861|584194543|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
161768676|NCT01238861|584194544|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
161768677|NCT01238861|584194545|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
161768678|NCT01238861|584194540|FG000|Overall Study|Subject moved out of state/area|0|||
161768679|NCT01238861|584194541|FG001|Overall Study|Subject moved out of state/area|0|||
161768680|NCT01238861|584194542|FG002|Overall Study|Subject moved out of state/area|1|||
161768681|NCT01238861|584194543|FG003|Overall Study|Subject moved out of state/area|1|||
161768682|NCT01238861|584194544|FG004|Overall Study|Subject moved out of state/area|0|||
161768683|NCT01238861|584194545|FG005|Overall Study|Subject moved out of state/area|0|||
161768684|NCT01238861|584194540|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
161768685|NCT01238861|584194541|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
161768686|NCT01238861|584194542|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
161855401|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
161855402|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
161855403|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
161855404|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
161768687|NCT01238861|584194543|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
161768688|NCT01238861|584194544|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
161768689|NCT01238861|584194545|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
161768690|NCT01238861|584194540|FG000|Overall Study|Personal problems|0|||
161768691|NCT01238861|584194541|FG001|Overall Study|Personal problems|0|||
161768692|NCT01238861|584194542|FG002|Overall Study|Personal problems|0|||
161768693|NCT01238861|584194543|FG003|Overall Study|Personal problems|1|||
161768694|NCT01238861|584194544|FG004|Overall Study|Personal problems|0|||
161768695|NCT01238861|584194545|FG005|Overall Study|Personal problems|0|||
161768696|NCT01238861|584194540|FG000|Overall Study|Unable to continue visits|0|||
161768697|NCT01238861|584194541|FG001|Overall Study|Unable to continue visits|0|||
161768698|NCT01238861|584194542|FG002|Overall Study|Unable to continue visits|0|||
161768699|NCT01238861|584194543|FG003|Overall Study|Unable to continue visits|1|||
161768700|NCT01238861|584194544|FG004|Overall Study|Unable to continue visits|0|||
161768701|NCT01238861|584194545|FG005|Overall Study|Unable to continue visits|1|||
161768702|NCT01238861|584194540|FG000|Overall Study|Serious adverse event|0|||
161768703|NCT01238861|584194541|FG001|Overall Study|Serious adverse event|0|||
161768704|NCT01238861|584194542|FG002|Overall Study|Serious adverse event|0|||
161768705|NCT01238861|584194543|FG003|Overall Study|Serious adverse event|0|||
161768706|NCT01238861|584194544|FG004|Overall Study|Serious adverse event|0|||
161768707|NCT01238861|584194545|FG005|Overall Study|Serious adverse event|1|||
161768708|NCT01238861|584194540|FG000|Overall Study|Lack of compliance|0|||
161768709|NCT01238861|584194541|FG001|Overall Study|Lack of compliance|0|||
161768710|NCT01238861|584194542|FG002|Overall Study|Lack of compliance|0|||
161768711|NCT01238861|584194543|FG003|Overall Study|Lack of compliance|0|||
161768712|NCT01238861|584194544|FG004|Overall Study|Lack of compliance|0|||
161768713|NCT01238861|584194545|FG005|Overall Study|Lack of compliance|1|||
161768714|NCT01238861|584194540|FG000|Overall Study|Adverse Event|0|||
161768715|NCT01238861|584194541|FG001|Overall Study|Adverse Event|1|||
161768716|NCT01238861|584194542|FG002|Overall Study|Adverse Event|0|||
161768717|NCT01238861|584194543|FG003|Overall Study|Adverse Event|0|||
161768718|NCT01238861|584194544|FG004|Overall Study|Adverse Event|0|||
161855405|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
161974915|NCT00844805|584956521|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
161768719|NCT01238861|584194545|FG005|Overall Study|Adverse Event|0|||
161768720|NCT01238861|584194540|FG000|Overall Study|Withdrawal by Subject|6|||
161768721|NCT01238861|584194541|FG001|Overall Study|Withdrawal by Subject|5|||
161768722|NCT01238861|584194542|FG002|Overall Study|Withdrawal by Subject|4|||
161768723|NCT01238861|584194543|FG003|Overall Study|Withdrawal by Subject|8|||
161768724|NCT01238861|584194544|FG004|Overall Study|Withdrawal by Subject|10|||
161768725|NCT01238861|584194545|FG005|Overall Study|Withdrawal by Subject|9|||
161768726|NCT01928758|584194547|FG000|Overall Study|Lost to Follow-up|14|||
161768727|NCT01928758|584194548|FG001|Overall Study|Lost to Follow-up|9|||
161768728|NCT01928758|584194547|FG000|Overall Study|Withdrawal by Subject|5|||
161768729|NCT01928758|584194548|FG001|Overall Study|Withdrawal by Subject|2|||
161768730|NCT01928758|584194547|FG000|Overall Study|Adverse Event|3|||
161768731|NCT01928758|584194548|FG001|Overall Study|Adverse Event|5|||
161768732|NCT01928758|584194547|FG000|Overall Study|Protocol Violation|3|||
161768733|NCT01928758|584194548|FG001|Overall Study|Protocol Violation|4|||
161768734|NCT02718131|584194549|FG000|Overall Study|Withdrawal by Subject|1|||
161768735|NCT02718131|584194550|FG001|Overall Study|Withdrawal by Subject|0|||
161768736|NCT02718131|584194549|FG000|Overall Study|Adverse Event|1|||
161768737|NCT02718131|584194550|FG001|Overall Study|Adverse Event|0|||
161768738|NCT02718131|584194549|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
161768739|NCT02718131|584194550|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
161768740|NCT02452320|584194551|FG000|Overall Study|Adverse Event|0|||
161768741|NCT02452320|584194552|FG001|Overall Study|Adverse Event|1|||
161768742|NCT03198559|584194553|FG000|Overall Study|Adverse Event|2|||
161768743|NCT03737812|584194554|FG000|Overall Study|Withdrawal by Subject|1|||
161768744|NCT03737812|584194555|FG001|Overall Study|Withdrawal by Subject|2|||
161768745|NCT03737812|584194556|FG002|Overall Study|Withdrawal by Subject|1|||
161768746|NCT03737812|584194554|FG000|Overall Study|Sponsor Discontinued the Study|4|||
161768747|NCT03737812|584194555|FG001|Overall Study|Sponsor Discontinued the Study|3|||
161768748|NCT03737812|584194556|FG002|Overall Study|Sponsor Discontinued the Study|2|||
161768749|NCT03737812|584194554|FG000|Overall Study|Adverse Event|0|||
161768750|NCT03737812|584194555|FG001|Overall Study|Adverse Event|1|||
161768751|NCT03737812|584194556|FG002|Overall Study|Adverse Event|0|||
161768752|NCT03737812|584194554|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
161768753|NCT03737812|584194555|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
161974916|NCT00844805|584956522|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
161974917|NCT00844805|584956519|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
161974918|NCT00844805|584956520|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
161974919|NCT00844805|584956521|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
161768754|NCT03737812|584194556|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
161768755|NCT01474291|584194560|FG000|Overall Study|Not Evaluable for Efficacy|26|||
161768756|NCT01474291|584194560|FG000|Overall Study|Lack of Treatment Efficacy|88|||
161768757|NCT01474291|584194560|FG000|Overall Study|Adverse Event|53|||
161768758|NCT01474291|584194560|FG000|Overall Study|Lost to Follow-up|29|||
161768759|NCT01474291|584194560|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
161768760|NCT01474291|584194560|FG000|Overall Study|No Reason Reported|10|||
161768761|NCT01474291|584194560|FG000|Overall Study|Death|2|||
161768762|NCT03471507|584194561|FG000|Overall Study|Lost to Follow-up|1|||
161768763|NCT03471507|584194562|FG001|Overall Study|Lost to Follow-up|3|||
161768764|NCT03471507|584194561|FG000|Overall Study|Physician Decision|0|||
161768765|NCT03471507|584194562|FG001|Overall Study|Physician Decision|1|||
161768766|NCT03471507|584194561|FG000|Overall Study|Withdrawal by Subject|2|||
161768767|NCT03471507|584194562|FG001|Overall Study|Withdrawal by Subject|1|||
161768768|NCT01399619|584194564|FG000|Overall Study|Adverse Event|10|||
161768769|NCT01399619|584194565|FG001|Overall Study|Adverse Event|0|||
161768770|NCT01399619|584194566|FG002|Overall Study|Adverse Event|4|||
161768771|NCT01399619|584194567|FG003|Overall Study|Adverse Event|10|||
161855406|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
161855407|NCT02422797|584512343|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
161855408|NCT02422797|584512344|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
161855409|NCT04071405|584512345|FG000|Overall Study|Protocol Violation|3|||
161768772|NCT01399619|584194564|FG000|Overall Study|Lack of Efficacy|9|||
161768773|NCT01399619|584194565|FG001|Overall Study|Lack of Efficacy|0|||
161768774|NCT01399619|584194566|FG002|Overall Study|Lack of Efficacy|5|||
161768775|NCT01399619|584194567|FG003|Overall Study|Lack of Efficacy|0|||
161768776|NCT01399619|584194564|FG000|Overall Study|Withdrawal by Subject|6|||
161768777|NCT01399619|584194565|FG001|Overall Study|Withdrawal by Subject|0|||
161768778|NCT01399619|584194566|FG002|Overall Study|Withdrawal by Subject|3|||
161855410|NCT01027702|584512350|FG000|Overall Study|Received subsequent therapy|1|||
161974920|NCT00844805|584956522|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
161768779|NCT01399619|584194567|FG003|Overall Study|Withdrawal by Subject|4|||
161768780|NCT01399619|584194564|FG000|Overall Study|Protocol Violation|0|||
161768781|NCT01399619|584194565|FG001|Overall Study|Protocol Violation|0|||
161768782|NCT01399619|584194566|FG002|Overall Study|Protocol Violation|0|||
161768783|NCT01399619|584194567|FG003|Overall Study|Protocol Violation|1|||
161768784|NCT01399619|584194564|FG000|Overall Study|Not treated|0|||
161768785|NCT01399619|584194565|FG001|Overall Study|Not treated|0|||
161768786|NCT01399619|584194566|FG002|Overall Study|Not treated|0|||
161768787|NCT01399619|584194567|FG003|Overall Study|Not treated|2|||
161768788|NCT02557308|584194570|FG000|Overall Study|Withdrawal by Subject|11|||
161768789|NCT02557308|584194571|FG001|Overall Study|Withdrawal by Subject|3|||
161768790|NCT02557308|584194572|FG002|Overall Study|Withdrawal by Subject|2|||
161768791|NCT02557308|584194573|FG003|Overall Study|Withdrawal by Subject|0|||
161768792|NCT02557308|584194574|FG004|Overall Study|Withdrawal by Subject|1|||
161768793|NCT02557308|584194575|FG005|Overall Study|Withdrawal by Subject|0|||
161974921|NCT00844805|584956519|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
161768794|NCT02557308|584194576|FG006|Overall Study|Withdrawal by Subject|10|||
161768795|NCT02557308|584194577|FG007|Overall Study|Withdrawal by Subject|1|||
161855411|NCT01027702|584512351|FG001|Overall Study|Received subsequent therapy|2|||
161768796|NCT02557308|584194570|FG000|Overall Study|Disease Progression|0|||
161768797|NCT02557308|584194571|FG001|Overall Study|Disease Progression|1|||
161768798|NCT02557308|584194572|FG002|Overall Study|Disease Progression|0|||
161768799|NCT02557308|584194573|FG003|Overall Study|Disease Progression|0|||
161768800|NCT02557308|584194574|FG004|Overall Study|Disease Progression|0|||
161768801|NCT02557308|584194575|FG005|Overall Study|Disease Progression|0|||
161974922|NCT00844805|584956520|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
161974923|NCT00844805|584956521|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
161974924|NCT00844805|584956522|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
161974925|NCT00259298|584956526|FG000|Overall Study|Withdrawal by Subject|1|||
161974926|NCT00259298|584956526|FG000|Overall Study|Physician Decision|2|||
161974927|NCT04316741|584956528|FG000|Baseline Enrollment|Lost to Follow-up|1|||
161974928|NCT04316741|584956529|FG001|Baseline Enrollment|Lost to Follow-up|1|||
161974929|NCT04316741|584956528|FG000|Immediate Post-Test|Lost to Follow-up|5|||
161768802|NCT02557308|584194576|FG006|Overall Study|Disease Progression|0|||
161768803|NCT02557308|584194577|FG007|Overall Study|Disease Progression|0|||
161768804|NCT02557308|584194570|FG000|Overall Study|Lack of Efficacy|3|||
161768805|NCT02557308|584194571|FG001|Overall Study|Lack of Efficacy|0|||
161768806|NCT02557308|584194572|FG002|Overall Study|Lack of Efficacy|0|||
161768807|NCT02557308|584194573|FG003|Overall Study|Lack of Efficacy|0|||
161768808|NCT02557308|584194574|FG004|Overall Study|Lack of Efficacy|0|||
161768809|NCT02557308|584194575|FG005|Overall Study|Lack of Efficacy|0|||
161768810|NCT02557308|584194576|FG006|Overall Study|Lack of Efficacy|1|||
161768811|NCT02557308|584194577|FG007|Overall Study|Lack of Efficacy|0|||
161768812|NCT02557308|584194570|FG000|Overall Study|Adverse Event|4|||
161768813|NCT02557308|584194571|FG001|Overall Study|Adverse Event|1|||
161768814|NCT02557308|584194572|FG002|Overall Study|Adverse Event|2|||
161768815|NCT02557308|584194573|FG003|Overall Study|Adverse Event|0|||
161768816|NCT02557308|584194574|FG004|Overall Study|Adverse Event|0|||
161768817|NCT02557308|584194575|FG005|Overall Study|Adverse Event|0|||
161768818|NCT02557308|584194576|FG006|Overall Study|Adverse Event|4|||
161768819|NCT02557308|584194577|FG007|Overall Study|Adverse Event|1|||
161768820|NCT02557308|584194570|FG000|Overall Study|Lost to Follow-up|2|||
161768821|NCT02557308|584194571|FG001|Overall Study|Lost to Follow-up|0|||
161768822|NCT02557308|584194572|FG002|Overall Study|Lost to Follow-up|1|||
161768823|NCT02557308|584194573|FG003|Overall Study|Lost to Follow-up|0|||
161768824|NCT02557308|584194574|FG004|Overall Study|Lost to Follow-up|0|||
161768825|NCT02557308|584194575|FG005|Overall Study|Lost to Follow-up|0|||
161768826|NCT02557308|584194576|FG006|Overall Study|Lost to Follow-up|2|||
161768827|NCT02557308|584194577|FG007|Overall Study|Lost to Follow-up|0|||
161768828|NCT02557308|584194570|FG000|Overall Study|Death|1|||
161768829|NCT02557308|584194571|FG001|Overall Study|Death|0|||
161768830|NCT02557308|584194572|FG002|Overall Study|Death|0|||
161768831|NCT02557308|584194573|FG003|Overall Study|Death|0|||
161768832|NCT02557308|584194574|FG004|Overall Study|Death|0|||
161768833|NCT02557308|584194575|FG005|Overall Study|Death|0|||
161768834|NCT02557308|584194576|FG006|Overall Study|Death|0|||
161974930|NCT04316741|584956529|FG001|Immediate Post-Test|Lost to Follow-up|1|||
161974931|NCT04316741|584956528|FG000|1-month Post-test|Lost to Follow-up|7|||
161974932|NCT04316741|584956529|FG001|1-month Post-test|Lost to Follow-up|2|||
161768835|NCT02557308|584194577|FG007|Overall Study|Death|0|||
161768836|NCT02557308|584194570|FG000|Overall Study|Study Close|98|||
161768837|NCT02557308|584194571|FG001|Overall Study|Study Close|18|||
161768838|NCT02557308|584194572|FG002|Overall Study|Study Close|5|||
161768839|NCT02557308|584194573|FG003|Overall Study|Study Close|3|||
161768840|NCT02557308|584194574|FG004|Overall Study|Study Close|1|||
161768841|NCT02557308|584194575|FG005|Overall Study|Study Close|0|||
161768842|NCT02557308|584194576|FG006|Overall Study|Study Close|123|||
161768843|NCT02557308|584194577|FG007|Overall Study|Study Close|5|||
161768844|NCT02557308|584194570|FG000|Overall Study|Except for study close|5|||
161768845|NCT02557308|584194571|FG001|Overall Study|Except for study close|0|||
161768846|NCT02557308|584194572|FG002|Overall Study|Except for study close|0|||
161768847|NCT02557308|584194573|FG003|Overall Study|Except for study close|0|||
161768848|NCT02557308|584194574|FG004|Overall Study|Except for study close|3|||
161768849|NCT02557308|584194575|FG005|Overall Study|Except for study close|0|||
161768850|NCT02557308|584194576|FG006|Overall Study|Except for study close|6|||
161768851|NCT02557308|584194577|FG007|Overall Study|Except for study close|10|||
161768852|NCT03911401|584194578|FG000|Overall Study|Adverse Event|1|||
161768853|NCT03911401|584194579|FG001|Overall Study|Adverse Event|2|||
161974933|NCT04316741|584956528|FG000|3-month Follow-up|Lost to Follow-up|10|||
161974934|NCT04316741|584956529|FG001|3-month Follow-up|Lost to Follow-up|2|||
161974935|NCT02726880|584956530|FG000|Overall Study|Withdrawal by Subject|2|||
161974936|NCT02726880|584956531|FG001|Overall Study|Withdrawal by Subject|0|||
161768854|NCT03911401|584194580|FG002|Overall Study|Adverse Event|5|||
161768855|NCT03911401|584194578|FG000|Overall Study|Lack of Efficacy|1|||
161768856|NCT03911401|584194579|FG001|Overall Study|Lack of Efficacy|1|||
161768857|NCT03911401|584194580|FG002|Overall Study|Lack of Efficacy|8|||
161768858|NCT03911401|584194578|FG000|Overall Study|Physician Decision|0|||
161768859|NCT03911401|584194579|FG001|Overall Study|Physician Decision|0|||
161768860|NCT03911401|584194580|FG002|Overall Study|Physician Decision|1|||
161768861|NCT03911401|584194578|FG000|Overall Study|Withdrawal by Subject|1|||
161768862|NCT03911401|584194579|FG001|Overall Study|Withdrawal by Subject|2|||
161768863|NCT03911401|584194580|FG002|Overall Study|Withdrawal by Subject|0|||
161974937|NCT02726880|584956530|FG000|Overall Study|Lost to Follow-up|1|||
161768864|NCT03911401|584194578|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161768865|NCT03911401|584194579|FG001|Overall Study|Withdrawal by parent/guardian|4|||
161768866|NCT03911401|584194580|FG002|Overall Study|Withdrawal by parent/guardian|11|||
161768867|NCT03417245|584194584|FG000|Overall Study|Adverse Event|1|||
161768868|NCT03417245|584194585|FG001|Overall Study|Adverse Event|0|||
161768869|NCT03417245|584194584|FG000|Overall Study|Protocol Violation|1|||
161768870|NCT03417245|584194585|FG001|Overall Study|Protocol Violation|0|||
161768871|NCT03417245|584194584|FG000|Overall Study|Withdrawal by Subject|1|||
161768872|NCT03417245|584194585|FG001|Overall Study|Withdrawal by Subject|1|||
161768873|NCT02046993|584194586|FG000|Overall Study|Withdrawal by Subject|2|||
161768874|NCT02046993|584194587|FG001|Overall Study|Withdrawal by Subject|10|||
161768875|NCT02046993|584194586|FG000|Overall Study|Lost to Follow-up|1|||
161768876|NCT02046993|584194587|FG001|Overall Study|Lost to Follow-up|1|||
161768877|NCT01590628|584194595|FG000|Overall Study|Death|2|||
161768878|NCT01590628|584194596|FG001|Overall Study|Death|0|||
161768879|NCT00761735|584194597|FG000|Overall Study|Lost to Follow-up|6|||
161768880|NCT00761735|584194597|FG000|Overall Study|Withdrawal by Subject|6|||
161768881|NCT00761735|584194597|FG000|Overall Study|Non-compliance with protocol|1|||
161768882|NCT00761735|584194597|FG000|Overall Study|Administrative|1|||
161768883|NCT00267202|584194598|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
161768884|NCT00267202|584194599|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
161768885|NCT00267202|584194598|FG000|Overall Study|Withdrawal by Subject|12|||
161768886|NCT00267202|584194599|FG001|Overall Study|Withdrawal by Subject|15|||
161768887|NCT00267202|584194598|FG000|Overall Study|Adverse Event|13|||
161768888|NCT00267202|584194599|FG001|Overall Study|Adverse Event|7|||
161768889|NCT00267202|584194598|FG000|Overall Study|Protocol Violation|2|||
161768890|NCT00267202|584194599|FG001|Overall Study|Protocol Violation|3|||
161768891|NCT00267202|584194598|FG000|Overall Study|Administrative problems|2|||
161768892|NCT00267202|584194599|FG001|Overall Study|Administrative problems|1|||
161768893|NCT00267202|584194598|FG000|Overall Study|Lost to Follow-up|3|||
161768894|NCT00267202|584194599|FG001|Overall Study|Lost to Follow-up|0|||
161768895|NCT03326323|584194600|FG000|Overall Study|Unable to receive ANH protocol|3|||
161768896|NCT00920582|584194601|FG000|Overall Study|Lost to Follow-up|5|||
161768897|NCT00920582|584194602|FG001|Overall Study|Lost to Follow-up|1|||
161768898|NCT00920582|584194603|FG002|Overall Study|Lost to Follow-up|2|||
161768899|NCT00920582|584194604|FG003|Overall Study|Lost to Follow-up|0|||
161768900|NCT00920582|584194601|FG000|Overall Study|Withdrawal by Subject|5|||
161768901|NCT00920582|584194602|FG001|Overall Study|Withdrawal by Subject|4|||
161768902|NCT00920582|584194603|FG002|Overall Study|Withdrawal by Subject|6|||
161768903|NCT00920582|584194604|FG003|Overall Study|Withdrawal by Subject|3|||
161768904|NCT00920582|584194601|FG000|Overall Study|Protocol Violation|1|||
161768905|NCT00920582|584194602|FG001|Overall Study|Protocol Violation|0|||
161768906|NCT00920582|584194603|FG002|Overall Study|Protocol Violation|0|||
161768907|NCT00920582|584194604|FG003|Overall Study|Protocol Violation|0|||
161768908|NCT00920582|584194601|FG000|Overall Study|Other|2|||
161768909|NCT00920582|584194602|FG001|Overall Study|Other|1|||
161768910|NCT00920582|584194603|FG002|Overall Study|Other|3|||
161768911|NCT00920582|584194604|FG003|Overall Study|Other|2|||
161768912|NCT00851721|584194609|FG000|Overall Study|planned surgery|1|||
161768913|NCT00851721|584194610|FG001|Overall Study|planned surgery|0|||
161768914|NCT00851721|584194609|FG000|Overall Study|Death|1|||
161768915|NCT00851721|584194610|FG001|Overall Study|Death|0|||
161768916|NCT00851721|584194609|FG000|Overall Study|Adverse Event|0|||
161768917|NCT00851721|584194610|FG001|Overall Study|Adverse Event|1|||
161768918|NCT01333501|584194611|FG000|Overall Study|Adverse Event|3|||
161768919|NCT01333501|584194612|FG001|Overall Study|Adverse Event|1|||
161768920|NCT01333501|584194611|FG000|Overall Study|Abnormal laboratory value|2|||
161768921|NCT01333501|584194612|FG001|Overall Study|Abnormal laboratory value|1|||
161768922|NCT01333501|584194611|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161768923|NCT01333501|584194612|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
161768924|NCT01333501|584194611|FG000|Overall Study|Withdrawn consent|3|||
161768925|NCT01333501|584194612|FG001|Overall Study|Withdrawn consent|12|||
161768926|NCT00955682|584194613|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
161768927|NCT00955682|584194614|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
161768928|NCT04034225|584194615|FG000|Overall Study|Death|3|||
161768929|NCT04034225|584194615|FG000|Overall Study|Withdrawal by Subject|2|||
161768930|NCT04034225|584194615|FG000|Overall Study|Study termination by Sponsor|18|||
161768931|NCT04034225|584194615|FG000|Overall Study|Physician Decision|1|||
161974938|NCT02726880|584956531|FG001|Overall Study|Lost to Follow-up|3|||
161974939|NCT01510145|584956532|FG000|Overall Study|Adverse Event|6|||
161768932|NCT04034225|584194615|FG000|Overall Study|Lack of Efficacy|1|||
161768933|NCT01681004|584194621|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
161768934|NCT01681004|584194622|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
161768935|NCT01681004|584194621|FG000|Study Completion|Lost to Follow-up|8|||
161768936|NCT01681004|584194622|FG001|Study Completion|Lost to Follow-up|3|||
161768937|NCT01681004|584194621|FG000|Study Completion|Physician Decision|1|||
161768938|NCT01681004|584194622|FG001|Study Completion|Physician Decision|3|||
161768939|NCT01681004|584194621|FG000|Study Completion|Site Termination|2|||
161768940|NCT01681004|584194622|FG001|Study Completion|Site Termination|1|||
161768941|NCT01681004|584194621|FG000|Study Completion|Death|1|||
161768942|NCT01681004|584194622|FG001|Study Completion|Death|1|||
161768943|NCT00689299|584194625|FG000|Overall Study|Adverse Event|2|||
161768944|NCT00689299|584194626|FG001|Overall Study|Adverse Event|1|||
161768945|NCT00689299|584194627|FG002|Overall Study|Adverse Event|1|||
161768946|NCT00689299|584194625|FG000|Overall Study|Lost to Follow-up|0|||
161768947|NCT00689299|584194626|FG001|Overall Study|Lost to Follow-up|1|||
161768948|NCT00689299|584194627|FG002|Overall Study|Lost to Follow-up|1|||
161768949|NCT00689299|584194625|FG000|Overall Study|Withdrawal by Subject|4|||
161768950|NCT00689299|584194626|FG001|Overall Study|Withdrawal by Subject|1|||
161768951|NCT00689299|584194627|FG002|Overall Study|Withdrawal by Subject|3|||
161768952|NCT00689299|584194625|FG000|Overall Study|Protocol Violation|1|||
161768953|NCT00689299|584194626|FG001|Overall Study|Protocol Violation|0|||
161768954|NCT00689299|584194627|FG002|Overall Study|Protocol Violation|0|||
161768955|NCT01190839|584194630|FG000|Overall Study|Adverse Event|32|||
161768956|NCT01190839|584194631|FG001|Overall Study|Adverse Event|41|||
161768957|NCT01190839|584194630|FG000|Overall Study|Protocol Violation|2|||
162034276|NCT00879879|585181192|FG000|Overall Study|Physician Decision|1|||
161768958|NCT01190839|584194631|FG001|Overall Study|Protocol Violation|2|||
161768959|NCT01190839|584194630|FG000|Overall Study|Lost to Follow-up|7|||
161768960|NCT01190839|584194631|FG001|Overall Study|Lost to Follow-up|1|||
161768961|NCT01190839|584194630|FG000|Overall Study|Death|1|||
161768962|NCT01190839|584194631|FG001|Overall Study|Death|0|||
161768963|NCT01190839|584194630|FG000|Overall Study|Trial stopped by Sponsor|71|||
161768964|NCT01190839|584194631|FG001|Overall Study|Trial stopped by Sponsor|68|||
161768965|NCT01190839|584194630|FG000|Overall Study|Undefined|35|||
161768966|NCT01190839|584194631|FG001|Overall Study|Undefined|31|||
161768967|NCT01190839|584194630|FG000|Overall Study|Randomized but not treated|2|||
161768968|NCT01190839|584194631|FG001|Overall Study|Randomized but not treated|4|||
161768969|NCT00695318|584194635|FG000|Overall Study|Lost to Follow-up|1|||
161768970|NCT00695318|584194636|FG001|Overall Study|Lost to Follow-up|0|||
161768971|NCT00695318|584194635|FG000|Overall Study|Withdrawal by Subject|2|||
161768972|NCT00695318|584194636|FG001|Overall Study|Withdrawal by Subject|0|||
161768973|NCT00695318|584194635|FG000|Overall Study|Death|1|||
161768974|NCT00695318|584194636|FG001|Overall Study|Death|1|||
161768975|NCT00695318|584194635|FG000|Overall Study|Study Terminated|1|||
161768976|NCT00695318|584194636|FG001|Overall Study|Study Terminated|0|||
161768977|NCT02058966|584194637|FG000|Open-Label Methamphetamine|Adverse Event|1|||
161768978|NCT02058966|584194637|FG000|First Intervention|Withdrawal by Subject|1|||
161768979|NCT01265511|584194638|FG000|Overall Study|Lack of Efficacy|2|||
161768980|NCT01265511|584194639|FG001|Overall Study|Lack of Efficacy|1|||
161768981|NCT01265511|584194638|FG000|Overall Study|Met stopping rules|0|||
161768982|NCT01265511|584194639|FG001|Overall Study|Met stopping rules|2|||
161768983|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
161768984|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
161768985|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
161768986|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
161768987|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
161768988|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
161768989|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
161768990|NCT00950755|584194643|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
161768991|NCT00950755|584194643|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
161768992|NCT00950755|584194643|FG000|Long-Term Follow-Up|Death|8|||
161768993|NCT00508820|584194644|FG000|Overall Study|Adverse Event|6|||
161768994|NCT00508820|584194645|FG001|Overall Study|Adverse Event|10|||
161768995|NCT00508820|584194644|FG000|Overall Study|Death|6|||
161768996|NCT00508820|584194645|FG001|Overall Study|Death|8|||
161768997|NCT00508820|584194644|FG000|Overall Study|Lost to Follow-up|1|||
161768998|NCT00508820|584194645|FG001|Overall Study|Lost to Follow-up|1|||
161768999|NCT00508820|584194644|FG000|Overall Study|Physician Decision|8|||
161769000|NCT00508820|584194645|FG001|Overall Study|Physician Decision|2|||
161769001|NCT00508820|584194644|FG000|Overall Study|Pregnancy|0|||
161769002|NCT00508820|584194645|FG001|Overall Study|Pregnancy|2|||
161769003|NCT00508820|584194644|FG000|Overall Study|Protocol Violation|2|||
161769004|NCT00508820|584194645|FG001|Overall Study|Protocol Violation|0|||
161769005|NCT00508820|584194644|FG000|Overall Study|Withdrawal by Subject|10|||
162034277|NCT00378079|585181194|FG000|Overall Study|Lost to Follow-up|6|||
161769006|NCT00508820|584194645|FG001|Overall Study|Withdrawal by Subject|12|||
161769007|NCT00508820|584194644|FG000|Overall Study|Other|11|||
161769008|NCT00508820|584194645|FG001|Overall Study|Other|2|||
161769009|NCT00508820|584194644|FG000|Overall Study|Noncompliance|1|||
161769010|NCT00508820|584194645|FG001|Overall Study|Noncompliance|0|||
161769011|NCT00508820|584194644|FG000|Overall Study|Requirement for alternative therapy|7|||
161855412|NCT01027702|584512352|FG002|Overall Study|Received subsequent therapy|0|||
161855413|NCT01027702|584512353|FG003|Overall Study|Received subsequent therapy|4|||
161855414|NCT01027702|584512354|FG004|Overall Study|Received subsequent therapy|1|||
161855415|NCT01027702|584512355|FG005|Overall Study|Received subsequent therapy|0|||
161855416|NCT01027702|584512356|FG006|Overall Study|Received subsequent therapy|1|||
161855417|NCT01027702|584512350|FG000|Overall Study|Death|0|||
161855418|NCT01027702|584512351|FG001|Overall Study|Death|0|||
161855419|NCT01027702|584512352|FG002|Overall Study|Death|1|||
161855420|NCT01027702|584512353|FG003|Overall Study|Death|0|||
161855421|NCT01027702|584512354|FG004|Overall Study|Death|0|||
161855422|NCT01027702|584512355|FG005|Overall Study|Death|0|||
161855423|NCT01027702|584512356|FG006|Overall Study|Death|0|||
161855424|NCT00403585|584512357|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
161855425|NCT00403585|584512357|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
161855426|NCT00403585|584512357|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
161855427|NCT02604407|584512358|FG000|Overall Study|Adverse Event|0|||
161855428|NCT02604407|584512359|FG001|Overall Study|Adverse Event|7|||
161855429|NCT02604407|584512360|FG002|Overall Study|Adverse Event|5|||
161855430|NCT02604407|584512358|FG000|Overall Study|Protocol Violation|2|||
161855431|NCT02604407|584512359|FG001|Overall Study|Protocol Violation|0|||
161855432|NCT02604407|584512360|FG002|Overall Study|Protocol Violation|0|||
161855433|NCT02604407|584512358|FG000|Overall Study|Withdrawal by Subject|3|||
161855434|NCT02604407|584512359|FG001|Overall Study|Withdrawal by Subject|3|||
161855435|NCT02604407|584512360|FG002|Overall Study|Withdrawal by Subject|5|||
161855436|NCT02604407|584512358|FG000|Overall Study|Lost to Follow-up|2|||
161855437|NCT02604407|584512359|FG001|Overall Study|Lost to Follow-up|1|||
161855438|NCT02604407|584512360|FG002|Overall Study|Lost to Follow-up|2|||
161855439|NCT02604407|584512358|FG000|Overall Study|Lack of Efficacy|1|||
161855440|NCT02604407|584512359|FG001|Overall Study|Lack of Efficacy|0|||
161855441|NCT02604407|584512360|FG002|Overall Study|Lack of Efficacy|0|||
161855442|NCT02604407|584512358|FG000|Overall Study|Other|3|||
161855443|NCT02604407|584512359|FG001|Overall Study|Other|1|||
161855444|NCT02604407|584512360|FG002|Overall Study|Other|4|||
161855445|NCT02862730|584512363|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161855446|NCT02862730|584512364|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161855447|NCT02862730|584512365|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
161855448|NCT02862730|584512366|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161855449|NCT02862730|584512367|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161855450|NCT02862730|584512368|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161855451|NCT02862730|584512369|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161855452|NCT02862730|584512363|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
161855453|NCT02862730|584512364|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161855454|NCT02862730|584512365|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161855455|NCT02862730|584512366|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161855456|NCT02862730|584512367|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161855457|NCT02862730|584512368|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161855458|NCT02862730|584512369|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161855459|NCT02862730|584512363|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161855460|NCT02862730|584512364|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161855461|NCT02862730|584512365|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
161855462|NCT02862730|584512366|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161855463|NCT02862730|584512367|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
161855464|NCT02862730|584512368|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161855465|NCT02862730|584512369|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161855466|NCT02862730|584512363|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161855467|NCT02862730|584512364|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161855468|NCT02862730|584512365|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161974940|NCT01510145|584956532|FG000|Overall Study|Lost to Follow-up|5|||
161974941|NCT01510145|584956532|FG000|Overall Study|Withdrawal by Subject|6|||
161974942|NCT01510145|584956532|FG000|Overall Study|Relative reported subject withdrew|1|||
161974943|NCT01442064|584956533|FG000|Overall Study|Adverse Event|2|||
161855469|NCT02862730|584512366|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
161974944|NCT01442064|584956534|FG001|Overall Study|Adverse Event|2|||
161855470|NCT02862730|584512367|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161855471|NCT02862730|584512368|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161855472|NCT02862730|584512369|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161855473|NCT00191191|584512370|FG000|Overall Study|Entry Criteria Exclusion|2|||
161855474|NCT00191191|584512371|FG001|Overall Study|Entry Criteria Exclusion|0|||
161855475|NCT00191191|584512370|FG000|Overall Study|Treated with Another Systemic Agent|1|||
161974945|NCT01442064|584956535|FG002|Overall Study|Adverse Event|2|||
162034278|NCT00378079|585181195|FG001|Overall Study|Lost to Follow-up|1|||
161974946|NCT01442064|584956536|FG003|Overall Study|Adverse Event|1|||
161974947|NCT01442064|584956537|FG004|Overall Study|Adverse Event|2|||
161974948|NCT01442064|584956538|FG005|Overall Study|Adverse Event|0|||
161974949|NCT01442064|584956533|FG000|Overall Study|Death|0|||
161974950|NCT01442064|584956534|FG001|Overall Study|Death|1|||
161974951|NCT01442064|584956535|FG002|Overall Study|Death|3|||
161974952|NCT01442064|584956536|FG003|Overall Study|Death|3|||
161974953|NCT01442064|584956537|FG004|Overall Study|Death|1|||
161974954|NCT01442064|584956538|FG005|Overall Study|Death|3|||
161974955|NCT01442064|584956533|FG000|Overall Study|Lost to Follow-up|5|||
161974956|NCT01442064|584956534|FG001|Overall Study|Lost to Follow-up|5|||
161974957|NCT01442064|584956535|FG002|Overall Study|Lost to Follow-up|1|||
161974958|NCT01442064|584956536|FG003|Overall Study|Lost to Follow-up|1|||
161974959|NCT01442064|584956537|FG004|Overall Study|Lost to Follow-up|3|||
161974960|NCT01442064|584956538|FG005|Overall Study|Lost to Follow-up|3|||
161974961|NCT01442064|584956533|FG000|Overall Study|Physician Decision|1|||
161974962|NCT01442064|584956534|FG001|Overall Study|Physician Decision|1|||
161974963|NCT01442064|584956535|FG002|Overall Study|Physician Decision|2|||
161974964|NCT01442064|584956536|FG003|Overall Study|Physician Decision|3|||
161974965|NCT01442064|584956537|FG004|Overall Study|Physician Decision|3|||
161974966|NCT01442064|584956538|FG005|Overall Study|Physician Decision|1|||
161974967|NCT01442064|584956533|FG000|Overall Study|Withdrawal by Subject|6|||
161974968|NCT01442064|584956534|FG001|Overall Study|Withdrawal by Subject|3|||
161974969|NCT01442064|584956535|FG002|Overall Study|Withdrawal by Subject|2|||
161974970|NCT01442064|584956536|FG003|Overall Study|Withdrawal by Subject|2|||
161974971|NCT01442064|584956537|FG004|Overall Study|Withdrawal by Subject|2|||
161974972|NCT01442064|584956538|FG005|Overall Study|Withdrawal by Subject|1|||
161855476|NCT00191191|584512371|FG001|Overall Study|Treated with Another Systemic Agent|1|||
161855477|NCT00191191|584512370|FG000|Overall Study|Adverse Event|11|||
161855478|NCT00191191|584512371|FG001|Overall Study|Adverse Event|21|||
161855479|NCT00191191|584512370|FG000|Overall Study|Progressive Disease|84|||
161855480|NCT00191191|584512371|FG001|Overall Study|Progressive Disease|72|||
161855481|NCT00191191|584512370|FG000|Overall Study|Toxicity After Dose Reduction|7|||
161855482|NCT00191191|584512371|FG001|Overall Study|Toxicity After Dose Reduction|8|||
161855483|NCT00191191|584512370|FG000|Overall Study|Family/Caregiver Decision|5|||
161855484|NCT00191191|584512371|FG001|Overall Study|Family/Caregiver Decision|7|||
161855485|NCT00191191|584512370|FG000|Overall Study|Lost to Follow-up|1|||
161855486|NCT00191191|584512371|FG001|Overall Study|Lost to Follow-up|0|||
161855487|NCT00191191|584512370|FG000|Overall Study|Physician Decision|3|||
161855488|NCT00191191|584512371|FG001|Overall Study|Physician Decision|2|||
161855489|NCT00191191|584512370|FG000|Overall Study|Good Clinical Practice Violation|0|||
161855490|NCT00191191|584512371|FG001|Overall Study|Good Clinical Practice Violation|1|||
161855491|NCT03685344|584512372|FG000|Overall Study|Withdrawal by Subject|1|||
161855492|NCT03685344|584512373|FG001|Overall Study|Withdrawal by Subject|1|||
161855493|NCT03685344|584512374|FG002|Overall Study|Withdrawal by Subject|2|||
161855494|NCT03685344|584512375|FG003|Overall Study|Withdrawal by Subject|0|||
161855495|NCT03685344|584512372|FG000|Overall Study|Physician Decision|1|||
161855496|NCT03685344|584512373|FG001|Overall Study|Physician Decision|1|||
161855497|NCT03685344|584512374|FG002|Overall Study|Physician Decision|5|||
161855498|NCT03685344|584512375|FG003|Overall Study|Physician Decision|0|||
161855499|NCT03685344|584512372|FG000|Overall Study|Death|1|||
161855500|NCT03685344|584512373|FG001|Overall Study|Death|1|||
161855501|NCT03685344|584512374|FG002|Overall Study|Death|0|||
161855502|NCT03685344|584512375|FG003|Overall Study|Death|0|||
161855503|NCT02276807|584512378|FG000|Overall Study|Withdrawal by Subject|8|||
161855504|NCT02276807|584512379|FG001|Overall Study|Withdrawal by Subject|7|||
161855505|NCT02276807|584512378|FG000|Overall Study|Lost to Follow-up|10|||
161855506|NCT02276807|584512379|FG001|Overall Study|Lost to Follow-up|10|||
161855507|NCT00261950|584512381|FG000|Overall Study|Lost to Follow-up|2|||
161855508|NCT00261950|584512381|FG000|Overall Study|Death|6|||
161855509|NCT00261950|584512381|FG000|Overall Study|Withdrawal by Subject|5|||
161855510|NCT00261950|584512381|FG000|Overall Study|Other|1|||
161855511|NCT00261950|584512381|FG000|Overall Study|Physician Decision|1|||
161855512|NCT00261950|584512381|FG000|Overall Study|Protocol specified Criteria|11|||
161855513|NCT00445432|584512386|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
161855514|NCT00445432|584512387|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
161855515|NCT00445432|584512388|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
161855516|NCT00445432|584512389|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
161974973|NCT01442064|584956533|FG000|Overall Study|Sponsor decision|82|||
161974974|NCT01442064|584956534|FG001|Overall Study|Sponsor decision|88|||
161974975|NCT01442064|584956535|FG002|Overall Study|Sponsor decision|92|||
161974976|NCT01442064|584956536|FG003|Overall Study|Sponsor decision|88|||
161974977|NCT01442064|584956537|FG004|Overall Study|Sponsor decision|95|||
161974978|NCT01442064|584956538|FG005|Overall Study|Sponsor decision|87|||
161974979|NCT01442064|584956533|FG000|Overall Study|Subject non-compliance|0|||
161974980|NCT01442064|584956534|FG001|Overall Study|Subject non-compliance|0|||
161974981|NCT01442064|584956535|FG002|Overall Study|Subject non-compliance|0|||
161855517|NCT00445432|584512386|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
161974982|NCT01442064|584956536|FG003|Overall Study|Subject non-compliance|0|||
161974983|NCT01442064|584956537|FG004|Overall Study|Subject non-compliance|0|||
162034279|NCT00378079|585181196|FG002|Overall Study|Lost to Follow-up|0|||
161769012|NCT00508820|584194645|FG001|Overall Study|Requirement for alternative therapy|15|||
161769013|NCT00508820|584194644|FG000|Overall Study|Protocol-specified Criteria|3|||
161769014|NCT00508820|584194645|FG001|Overall Study|Protocol-specified Criteria|12|||
161769015|NCT01789476|584196027|FG000|Overall Study|Lack of Efficacy|6|||
161769016|NCT01789476|584196028|FG001|Overall Study|Lack of Efficacy|2|||
161769017|NCT01789476|584196027|FG000|Overall Study|Adverse Event|1|||
161769018|NCT01789476|584196028|FG001|Overall Study|Adverse Event|0|||
161769019|NCT01789476|584196027|FG000|Overall Study|Unable to get IV access|1|||
161769020|NCT01789476|584196028|FG001|Overall Study|Unable to get IV access|0|||
161769021|NCT03053102|584196029|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
161769022|NCT03053102|584196029|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
161769023|NCT01798056|584196030|FG000|Overall Study|Serious Adverse Event|13|||
161769024|NCT01798056|584196031|FG001|Overall Study|Serious Adverse Event|12|||
161769025|NCT01798056|584196030|FG000|Overall Study|Withdrawal by Subject|12|||
161769026|NCT01798056|584196031|FG001|Overall Study|Withdrawal by Subject|9|||
161769027|NCT01798056|584196030|FG000|Overall Study|Migrated/moved from study area|1|||
161769028|NCT01798056|584196031|FG001|Overall Study|Migrated/moved from study area|1|||
161769029|NCT01798056|584196030|FG000|Overall Study|Lost to Follow-up|1|||
161769030|NCT01798056|584196031|FG001|Overall Study|Lost to Follow-up|1|||
161769031|NCT01798056|584196030|FG000|Overall Study|Other|0|||
161769032|NCT01798056|584196031|FG001|Overall Study|Other|2|||
161769033|NCT01269346|584196034|FG000|Treatment Phase|Disease progression|3|||
161769034|NCT01269346|584196034|FG000|Treatment Phase|Adverse Event|3|||
161769035|NCT01269346|584196034|FG000|Treatment Phase|Withdrawal by Subject|1|||
161769036|NCT01269346|584196034|FG000|Treatment Phase|Other|2|||
161769037|NCT01269346|584196034|FG000|Extension Phase|Adverse Event|6|||
161769038|NCT01269346|584196034|FG000|Extension Phase|Withdrawal by Subject|4|||
161769039|NCT01269346|584196034|FG000|Extension Phase|Disease progression|22|||
161769040|NCT01269346|584196034|FG000|Extension Phase|Physician decision or participant choice|9|||
161769041|NCT01269346|584196034|FG000|Extension Phase|Clinical progression|1|||
161769042|NCT01269346|584196034|FG000|Extension Phase|Started a prohibited con med|1|||
161769043|NCT00247416|584196035|FG000|Overall Study|3 patients were found to be ineligible|1|||
161769044|NCT00247416|584196036|FG001|Overall Study|3 patients were found to be ineligible|2|||
161769045|NCT02660489|584196045|FG000|Overall Study|Lost to Follow-up|1|||
161769046|NCT02660489|584196046|FG001|Overall Study|Lost to Follow-up|1|||
161769047|NCT02660489|584196045|FG000|Overall Study|Adverse Event|1|||
161769048|NCT02660489|584196046|FG001|Overall Study|Adverse Event|3|||
161769049|NCT02660489|584196045|FG000|Overall Study|no rhinovirus infection|4|||
161769050|NCT02660489|584196046|FG001|Overall Study|no rhinovirus infection|4|||
161769051|NCT02322866|584196047|FG000|Overall Study|Adverse Event|6|||
161769052|NCT02322866|584196048|FG001|Overall Study|Adverse Event|11|||
161769053|NCT02322866|584196047|FG000|Overall Study|Withdrawal of Consent|16|||
161769054|NCT02322866|584196048|FG001|Overall Study|Withdrawal of Consent|25|||
161769055|NCT02322866|584196047|FG000|Overall Study|Lost to Follow-up|36|||
161769056|NCT02322866|584196048|FG001|Overall Study|Lost to Follow-up|39|||
161769057|NCT02322866|584196047|FG000|Overall Study|Protocol Violation|1|||
161769058|NCT02322866|584196048|FG001|Overall Study|Protocol Violation|0|||
161769059|NCT02322866|584196047|FG000|Overall Study|Noncompliance with Treatment|3|||
161769060|NCT02322866|584196048|FG001|Overall Study|Noncompliance with Treatment|4|||
161769061|NCT02322866|584196047|FG000|Overall Study|Lack of Efficacy|3|||
161769062|NCT02322866|584196048|FG001|Overall Study|Lack of Efficacy|1|||
161769063|NCT02322866|584196047|FG000|Overall Study|Other Miscellaneous Reasons|6|||
161769064|NCT02322866|584196048|FG001|Overall Study|Other Miscellaneous Reasons|6|||
161769065|NCT03735680|584196051|FG000|Overall Study|Withdrawal by Subject|0|||
161769066|NCT03735680|584196052|FG001|Overall Study|Withdrawal by Subject|1|||
161769067|NCT03735680|584196053|FG002|Overall Study|Withdrawal by Subject|0|||
161769068|NCT03735680|584196054|FG003|Overall Study|Withdrawal by Subject|0|||
161769069|NCT03735680|584196055|FG004|Overall Study|Withdrawal by Subject|0|||
161769070|NCT03735680|584196056|FG005|Overall Study|Withdrawal by Subject|1|||
161769071|NCT03735680|584196051|FG000|Overall Study|Patient unable or unwilling to continue|0|||
161769072|NCT03735680|584196052|FG001|Overall Study|Patient unable or unwilling to continue|0|||
161769073|NCT03735680|584196053|FG002|Overall Study|Patient unable or unwilling to continue|1|||
161769074|NCT03735680|584196054|FG003|Overall Study|Patient unable or unwilling to continue|0|||
161769075|NCT03735680|584196055|FG004|Overall Study|Patient unable or unwilling to continue|0|||
161769076|NCT03735680|584196056|FG005|Overall Study|Patient unable or unwilling to continue|0|||
161769077|NCT03472586|584196073|FG000|Overall Study|Physician Decision|6|||
161769078|NCT03472586|584196073|FG000|Overall Study|Death|6|||
161769079|NCT03472586|584196073|FG000|Overall Study|Adverse Event|1|||
161769080|NCT05064436|584196075|FG000|Overall Study|Other Reasons|1|||
161769081|NCT05064436|584196076|FG001|Overall Study|Other Reasons|0|||
161769082|NCT01342445|584196077|FG000|Overall Study|Experienced side effects|0|||
161769083|NCT01342445|584196078|FG001|Overall Study|Experienced side effects|2|||
161769084|NCT02957149|584196081|FG000|Overall Study|Withdrawal by Subject|5|||
161769085|NCT06045026|584196082|FG000|Overall Study|Lost to Follow-up|60|||
161769086|NCT06045026|584196082|FG000|Overall Study|Adverse Event|12|||
161855518|NCT00445432|584512387|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
161855519|NCT00445432|584512388|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
161855520|NCT00445432|584512389|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
161855521|NCT00445432|584512386|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
161855522|NCT00445432|584512387|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
161855523|NCT00445432|584512388|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
161855524|NCT00445432|584512389|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
161855525|NCT00445432|584512386|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
161855526|NCT00445432|584512387|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
161855527|NCT00445432|584512388|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
161855528|NCT00445432|584512389|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
161855529|NCT00445432|584512386|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
161855530|NCT00445432|584512387|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
161855531|NCT00445432|584512388|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
161855532|NCT00445432|584512389|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
161855533|NCT00445432|584512386|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
161855534|NCT00445432|584512387|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
161855535|NCT00445432|584512388|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
161855536|NCT00445432|584512389|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
161855537|NCT00445432|584512386|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
161855538|NCT00445432|584512387|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
161855539|NCT00445432|584512388|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
161855540|NCT00445432|584512389|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
161855541|NCT02789137|584512390|FG000|Overall Study|Dropped out/Died|58|||
161974984|NCT01442064|584956538|FG005|Overall Study|Subject non-compliance|2|||
161974985|NCT01442064|584956533|FG000|Overall Study|Condition mandated other intervention|1|||
161855542|NCT00799058|584512397|FG000|Overall Study|Withdrawal by Subject|2|||
161855543|NCT00799058|584512398|FG001|Overall Study|Withdrawal by Subject|2|||
161855544|NCT00799058|584512399|FG002|Overall Study|Withdrawal by Subject|2|||
161855545|NCT00799058|584512397|FG000|Overall Study|Lost to Follow-up|1|||
161855546|NCT00799058|584512398|FG001|Overall Study|Lost to Follow-up|2|||
161855547|NCT00799058|584512399|FG002|Overall Study|Lost to Follow-up|1|||
161855548|NCT00799058|584512397|FG000|Overall Study|Adverse Event|0|||
161855549|NCT00799058|584512398|FG001|Overall Study|Adverse Event|2|||
161855550|NCT00799058|584512399|FG002|Overall Study|Adverse Event|0|||
161855551|NCT00799058|584512397|FG000|Overall Study|Pregnancy|1|||
161855552|NCT00799058|584512398|FG001|Overall Study|Pregnancy|0|||
161855553|NCT00799058|584512399|FG002|Overall Study|Pregnancy|0|||
161855554|NCT00799058|584512397|FG000|Overall Study|Not adherent|3|||
161855555|NCT00799058|584512398|FG001|Overall Study|Not adherent|2|||
161855556|NCT00799058|584512399|FG002|Overall Study|Not adherent|1|||
161855557|NCT00799058|584512397|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
161855558|NCT00799058|584512398|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
161855559|NCT00799058|584512399|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
161855560|NCT00799058|584512397|FG000|Overall Study|IP dispensing error|1|||
161855561|NCT00799058|584512398|FG001|Overall Study|IP dispensing error|0|||
161855562|NCT00799058|584512399|FG002|Overall Study|IP dispensing error|0|||
161855563|NCT00799058|584512397|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
161974986|NCT01442064|584956534|FG001|Overall Study|Condition mandated other intervention|1|||
161974987|NCT01442064|584956535|FG002|Overall Study|Condition mandated other intervention|2|||
161974988|NCT01442064|584956536|FG003|Overall Study|Condition mandated other intervention|0|||
161974989|NCT01442064|584956537|FG004|Overall Study|Condition mandated other intervention|0|||
161974990|NCT01442064|584956538|FG005|Overall Study|Condition mandated other intervention|2|||
161974991|NCT01710527|584956541|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
161974992|NCT01710527|584956542|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
161974993|NCT03158272|584956543|FG000|Overall Study|Disease progression|3|||
161974994|NCT03158272|584956544|FG001|Overall Study|Disease progression|3|||
161974995|NCT03158272|584956545|FG002|Overall Study|Disease progression|4|||
162034280|NCT01163318|585181200|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
161855564|NCT00799058|584512398|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
161855565|NCT00799058|584512399|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
161855566|NCT00799058|584512397|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
161855567|NCT00799058|584512398|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
161855568|NCT00799058|584512399|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
162034281|NCT01163318|585181200|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
162034282|NCT01163318|585181200|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
162034283|NCT01163318|585181200|FG000|Overall Study|Participants Without Case Report Form|7|||
162034284|NCT01163318|585181200|FG000|Overall Study|Multiple Reasons Per Participant|224|||
162034285|NCT03587727|585181201|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
161855569|NCT00799058|584512397|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
161855570|NCT00799058|584512398|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
161855571|NCT00799058|584512399|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
161855572|NCT00799058|584512397|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
161855573|NCT00799058|584512398|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
161855574|NCT00799058|584512399|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
161855575|NCT02088697|584512406|FG000|Period I|Physician Decision|1|||
161855576|NCT02088697|584512407|FG001|Period I|Physician Decision|4|||
161855577|NCT02088697|584512406|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
161855578|NCT02088697|584512407|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
161855579|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Other|34|||
161855580|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Other|0|||
161855581|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Other|0|||
161855582|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Other|0|||
161855583|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Death|14|||
161855584|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Death|0|||
161855585|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Death|0|||
161855586|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Death|0|||
161855587|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
161855588|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
161855589|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
161855590|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
161855591|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
161855592|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
161855593|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
161855594|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
161855595|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
161855596|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
161769087|NCT06045026|584196082|FG000|Overall Study|Withdrawal by Subject|3|||
161769088|NCT06045026|584196082|FG000|Overall Study|Enrollment closed|1|||
161769089|NCT05602818|584196086|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
161769090|NCT05602818|584196087|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
161769091|NCT05602818|584196088|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
161769092|NCT05602818|584196089|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
161769093|NCT05602818|584196090|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
161769094|NCT05602818|584196091|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
161769095|NCT05602818|584196092|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
161769096|NCT05602818|584196093|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
161769097|NCT05602818|584196094|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
161769098|NCT05602818|584196095|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
161769099|NCT05602818|584196096|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
161769100|NCT05602818|584196097|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
161769101|NCT05602818|584196086|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
161769102|NCT05602818|584196087|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
161769103|NCT05602818|584196088|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769104|NCT05602818|584196089|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769105|NCT05602818|584196090|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769106|NCT05602818|584196091|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769107|NCT05602818|584196092|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769108|NCT05602818|584196093|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769109|NCT05602818|584196094|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769110|NCT05602818|584196095|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769111|NCT05602818|584196096|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769112|NCT05602818|584196097|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161769113|NCT05602818|584196086|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
161769114|NCT05602818|584196087|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769115|NCT05602818|584196088|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769116|NCT05602818|584196089|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769117|NCT05602818|584196090|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769118|NCT05602818|584196091|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769119|NCT05602818|584196092|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161974996|NCT03158272|584956546|FG003|Overall Study|Disease progression|6|||
161974997|NCT03158272|584956543|FG000|Overall Study|Death|0|||
161974998|NCT03158272|584956544|FG001|Overall Study|Death|0|||
161769120|NCT05602818|584196093|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769121|NCT05602818|584196094|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161855597|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
161855598|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
161855599|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
161855600|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
161855601|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
161855602|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
161855603|NCT01995513|584512408|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
161855604|NCT01995513|584512409|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
161855605|NCT01995513|584512410|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
161855606|NCT01995513|584512411|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
161855607|NCT01995513|584512408|FG000|Period 1: Second Open Label Treatment|Other|0|||
161855608|NCT01995513|584512409|FG001|Period 1: Second Open Label Treatment|Other|2|||
161855609|NCT01995513|584512410|FG002|Period 1: Second Open Label Treatment|Other|0|||
161855610|NCT01995513|584512411|FG003|Period 1: Second Open Label Treatment|Other|0|||
161855611|NCT01995513|584512408|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
161855612|NCT01995513|584512409|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
161855613|NCT01995513|584512410|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
161855614|NCT01995513|584512411|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
161855615|NCT01995513|584512408|FG000|Period 2: Double Blind Treatment|Death|0|||
161855616|NCT01995513|584512409|FG001|Period 2: Double Blind Treatment|Death|0|||
161855617|NCT01995513|584512410|FG002|Period 2: Double Blind Treatment|Death|0|||
161855618|NCT01995513|584512411|FG003|Period 2: Double Blind Treatment|Death|1|||
161855619|NCT01995513|584512408|FG000|Period 2: Double Blind Treatment|Other|0|||
161855620|NCT01995513|584512409|FG001|Period 2: Double Blind Treatment|Other|0|||
161855621|NCT01995513|584512410|FG002|Period 2: Double Blind Treatment|Other|3|||
161855622|NCT01995513|584512411|FG003|Period 2: Double Blind Treatment|Other|3|||
161855623|NCT01995513|584512408|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
161855624|NCT01995513|584512409|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
161855625|NCT01995513|584512410|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
161855626|NCT01995513|584512411|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
161855627|NCT01995513|584512408|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
161855628|NCT01995513|584512409|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
161855629|NCT01995513|584512410|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
161855630|NCT01995513|584512411|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
161855631|NCT01995513|584512408|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
161855632|NCT01995513|584512409|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
161855633|NCT01995513|584512410|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
161855634|NCT01995513|584512411|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
161855635|NCT01995513|584512408|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
161855636|NCT01995513|584512409|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
161855637|NCT01995513|584512410|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
161855638|NCT01995513|584512411|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
161855639|NCT01232452|584512412|FG000|Overall Study|Adverse Event|17|||
161855640|NCT01232452|584512413|FG001|Overall Study|Adverse Event|15|||
161855641|NCT01232452|584512412|FG000|Overall Study|Withdrawal by Subject|11|||
161855642|NCT01232452|584512413|FG001|Overall Study|Withdrawal by Subject|8|||
161855643|NCT01232452|584512412|FG000|Overall Study|Physician Decision|8|||
161855644|NCT01232452|584512413|FG001|Overall Study|Physician Decision|12|||
161855645|NCT01232452|584512412|FG000|Overall Study|Protocol entry criterion not met|0|||
161855646|NCT01232452|584512413|FG001|Overall Study|Protocol entry criterion not met|2|||
161855647|NCT01232452|584512412|FG000|Overall Study|Sponsor Decision|3|||
161855648|NCT01232452|584512413|FG001|Overall Study|Sponsor Decision|1|||
161855649|NCT01232452|584512412|FG000|Overall Study|Protocol Violation|0|||
161855650|NCT01232452|584512413|FG001|Overall Study|Protocol Violation|1|||
161855651|NCT00247676|584512418|FG000|Overall Study|Death|5|||
161855652|NCT00247676|584512418|FG000|Overall Study|Adverse Event|11|||
161855653|NCT00247676|584512418|FG000|Overall Study|Lack of Efficacy|15|||
161855654|NCT00247676|584512418|FG000|Overall Study|Other|3|||
161855655|NCT00247676|584512418|FG000|Overall Study|Withdrawal by Subject|2|||
161855656|NCT03594071|584512419|FG000|Overall Study|Re-operation|3|||
161855657|NCT03594071|584512419|FG000|Overall Study|Missed visit|2|||
161855658|NCT05219448|584512420|FG000|Overall Study|Lost to Follow-up|9|||
161855659|NCT05219448|584512421|FG001|Overall Study|Lost to Follow-up|0|||
161855660|NCT01750190|584512422|FG000|Overall Study|Adverse Event|47|||
161855661|NCT01750190|584512423|FG001|Overall Study|Adverse Event|19|||
161974999|NCT03158272|584956545|FG002|Overall Study|Death|1|||
161975000|NCT03158272|584956546|FG003|Overall Study|Death|0|||
161975001|NCT03158272|584956543|FG000|Overall Study|Other reasons|0|||
161975002|NCT03158272|584956544|FG001|Overall Study|Other reasons|0|||
161855662|NCT01750190|584512422|FG000|Overall Study|Death|38|||
161855663|NCT01750190|584512423|FG001|Overall Study|Death|11|||
161855664|NCT01750190|584512422|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
161855665|NCT01750190|584512423|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
161855666|NCT01750190|584512422|FG000|Overall Study|Lost to Follow-up|28|||
161855667|NCT01750190|584512423|FG001|Overall Study|Lost to Follow-up|7|||
161855668|NCT01750190|584512422|FG000|Overall Study|Physician Decision|16|||
161855669|NCT01750190|584512423|FG001|Overall Study|Physician Decision|17|||
161855670|NCT01750190|584512422|FG000|Overall Study|Protocol Violation|6|||
161855671|NCT01750190|584512423|FG001|Overall Study|Protocol Violation|5|||
161855672|NCT01750190|584512422|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
161855673|NCT01750190|584512423|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
161855674|NCT01750190|584512422|FG000|Overall Study|Withdrawal by Subject|83|||
161855675|NCT01750190|584512423|FG001|Overall Study|Withdrawal by Subject|89|||
161855676|NCT01750190|584512422|FG000|Overall Study|Kidney Transplant|8|||
161855677|NCT01750190|584512423|FG001|Overall Study|Kidney Transplant|4|||
161855678|NCT01750190|584512422|FG000|Overall Study|Dialysis|22|||
161855679|NCT01750190|584512423|FG001|Overall Study|Dialysis|8|||
161855680|NCT01750190|584512422|FG000|Overall Study|Other than Specified|13|||
161855681|NCT01750190|584512423|FG001|Overall Study|Other than Specified|4|||
161855682|NCT02287922|584512424|FG000|Overall Study|Adverse Event|1|||
161855683|NCT02287922|584512425|FG001|Overall Study|Adverse Event|1|||
161855684|NCT02287922|584512426|FG002|Overall Study|Adverse Event|3|||
161855685|NCT02287922|584512427|FG003|Overall Study|Adverse Event|4|||
161855686|NCT02287922|584512424|FG000|Overall Study|Withdrawal by Subject|1|||
161855687|NCT02287922|584512425|FG001|Overall Study|Withdrawal by Subject|1|||
161855688|NCT02287922|584512426|FG002|Overall Study|Withdrawal by Subject|1|||
161855689|NCT02287922|584512427|FG003|Overall Study|Withdrawal by Subject|2|||
161855690|NCT02287922|584512424|FG000|Overall Study|Lost to Follow-up|0|||
161855691|NCT02287922|584512425|FG001|Overall Study|Lost to Follow-up|0|||
161855692|NCT02287922|584512426|FG002|Overall Study|Lost to Follow-up|1|||
161855693|NCT02287922|584512427|FG003|Overall Study|Lost to Follow-up|0|||
161855694|NCT02287922|584512424|FG000|Overall Study|Sponsor's decision|0|||
161855695|NCT02287922|584512425|FG001|Overall Study|Sponsor's decision|0|||
161855696|NCT02287922|584512426|FG002|Overall Study|Sponsor's decision|0|||
161855697|NCT02287922|584512427|FG003|Overall Study|Sponsor's decision|1|||
161855698|NCT02287922|584512424|FG000|Overall Study|Other|1|||
161855699|NCT02287922|584512425|FG001|Overall Study|Other|0|||
161855700|NCT02287922|584512426|FG002|Overall Study|Other|2|||
161855701|NCT02287922|584512427|FG003|Overall Study|Other|0|||
161855702|NCT01526655|584512430|FG000|Overall Study|Withdrawal by Subject|0|||
161855703|NCT01526655|584512431|FG001|Overall Study|Withdrawal by Subject|1|||
161855704|NCT03571828|584512436|FG000|Overall Study|Withdrawal by Subject|1|||
161855705|NCT03571828|584512437|FG001|Overall Study|Withdrawal by Subject|0|||
161855706|NCT03571828|584512436|FG000|Overall Study|Decision by sponsor|5|||
161855707|NCT03571828|584512437|FG001|Overall Study|Decision by sponsor|1|||
161855708|NCT03571828|584512436|FG000|Overall Study|Death|2|||
161855709|NCT03571828|584512437|FG001|Overall Study|Death|0|||
161855710|NCT02232984|584512438|FG000|Overall Study|Withdrawal by Subject|5|||
161855711|NCT02232984|584512438|FG000|Overall Study|Death|1|||
161855712|NCT02232984|584512438|FG000|Overall Study|Investigator withdrawal|10|||
161855713|NCT02232984|584512438|FG000|Overall Study|Device implant unsuccessful|53|||
161855714|NCT02232984|584512438|FG000|Overall Study|not disclosed by site|7|||
161855715|NCT02232984|584512438|FG000|Overall Study|Protocol Violation|1|||
161855716|NCT03762239|584512441|FG000|Overall Study|Appointment to the doctor|1|||
161855717|NCT03762239|584512442|FG001|Overall Study|Appointment to the doctor|1|||
161855718|NCT00548093|584512446|FG000|Overall Study|Death|33|||
161855719|NCT00548093|584512447|FG001|Overall Study|Death|13|||
161855720|NCT00548093|584512446|FG000|Overall Study|Lost to Follow-up|3|||
161855721|NCT00548093|584512447|FG001|Overall Study|Lost to Follow-up|1|||
161855722|NCT00548093|584512446|FG000|Overall Study|Objective progression or relapse|1|||
161855723|NCT00548093|584512447|FG001|Overall Study|Objective progression or relapse|1|||
161855724|NCT00548093|584512446|FG000|Overall Study|Other|11|||
161855725|NCT00548093|584512447|FG001|Overall Study|Other|1|||
161855726|NCT00548093|584512446|FG000|Overall Study|Withdrawal by Subject|1|||
161855727|NCT00548093|584512447|FG001|Overall Study|Withdrawal by Subject|0|||
161855728|NCT00548093|584512446|FG000|Overall Study|Completed post-treatment follow-up|1|||
161855729|NCT00548093|584512447|FG001|Overall Study|Completed post-treatment follow-up|0|||
161855730|NCT02359994|584512449|FG000|Overall Population Study|Adverse Event|1|||
161855731|NCT02359994|584512450|FG001|Overall Population Study|Adverse Event|1|||
161855732|NCT02359994|584512449|FG000|Overall Population Study|Death|1|||
161855733|NCT02359994|584512450|FG001|Overall Population Study|Death|5|||
161855734|NCT02359994|584512449|FG000|Overall Population Study|Lost to Follow-up|1|||
161855735|NCT02359994|584512450|FG001|Overall Population Study|Lost to Follow-up|1|||
161855736|NCT02359994|584512449|FG000|Overall Population Study|Withdrawal by Subject|1|||
161855737|NCT02359994|584512450|FG001|Overall Population Study|Withdrawal by Subject|0|||
161855738|NCT02359994|584512449|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
161855739|NCT02359994|584512450|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
161855740|NCT02359994|584512449|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
161855741|NCT02359994|584512450|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
161855742|NCT02359994|584512449|FG000|Extended Oncology 24-Month Survival|Death|19|||
161855743|NCT02359994|584512450|FG001|Extended Oncology 24-Month Survival|Death|21|||
161855744|NCT02359994|584512449|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
161855745|NCT02359994|584512450|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
161855746|NCT02933255|584512453|FG000|Overall Study|Discontinued due to study closure.|1|||
161855747|NCT02933255|584512454|FG001|Overall Study|Discontinued due to study closure.|0|||
161855748|NCT02215967|584512459|FG000|Overall Study|Patient became ineligible for treatment|0|||
161855749|NCT02215967|584512460|FG001|Overall Study|Patient became ineligible for treatment|0|||
161855750|NCT02215967|584512461|FG002|Overall Study|Patient became ineligible for treatment|0|||
161855751|NCT02215967|584512462|FG003|Overall Study|Patient became ineligible for treatment|3|||
161855752|NCT02215967|584512459|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
161855753|NCT02215967|584512460|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
161855754|NCT02215967|584512461|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
161855755|NCT02215967|584512462|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
161855756|NCT03207867|584512463|FG000|Overall Study|Adverse Event|1|||
161855757|NCT03207867|584512464|FG001|Overall Study|Adverse Event|0|||
161855758|NCT03207867|584512465|FG002|Overall Study|Adverse Event|1|||
161855759|NCT03207867|584512466|FG003|Overall Study|Adverse Event|0|||
161855760|NCT03207867|584512467|FG004|Overall Study|Adverse Event|0|||
161855761|NCT03207867|584512468|FG005|Overall Study|Adverse Event|2|||
161855762|NCT03207867|584512469|FG006|Overall Study|Adverse Event|1|||
161855763|NCT03207867|584512470|FG007|Overall Study|Adverse Event|1|||
161855764|NCT03207867|584512471|FG008|Overall Study|Adverse Event|2|||
161855765|NCT03207867|584512472|FG009|Overall Study|Adverse Event|2|||
161855766|NCT03207867|584512473|FG010|Overall Study|Adverse Event|0|||
161855767|NCT03207867|584512474|FG011|Overall Study|Adverse Event|0|||
161855768|NCT03207867|584512475|FG012|Overall Study|Adverse Event|0|||
161855769|NCT03207867|584512476|FG013|Overall Study|Adverse Event|0|||
161855770|NCT03207867|584512477|FG014|Overall Study|Adverse Event|0|||
161855771|NCT03207867|584512478|FG015|Overall Study|Adverse Event|0|||
161855772|NCT03207867|584512479|FG016|Overall Study|Adverse Event|3|||
161855773|NCT03207867|584512480|FG017|Overall Study|Adverse Event|1|||
161855774|NCT03207867|584512481|FG018|Overall Study|Adverse Event|2|||
161855775|NCT03207867|584512482|FG019|Overall Study|Adverse Event|1|||
161855776|NCT03207867|584512483|FG020|Overall Study|Adverse Event|0|||
161855777|NCT03207867|584512484|FG021|Overall Study|Adverse Event|0|||
161855778|NCT03207867|584512485|FG022|Overall Study|Adverse Event|0|||
161855779|NCT03207867|584512486|FG023|Overall Study|Adverse Event|0|||
161855780|NCT03207867|584512463|FG000|Overall Study|Death|0|||
161855781|NCT03207867|584512464|FG001|Overall Study|Death|0|||
161855782|NCT03207867|584512465|FG002|Overall Study|Death|0|||
161855783|NCT03207867|584512466|FG003|Overall Study|Death|0|||
161855784|NCT03207867|584512467|FG004|Overall Study|Death|0|||
161855785|NCT03207867|584512468|FG005|Overall Study|Death|1|||
161855786|NCT03207867|584512469|FG006|Overall Study|Death|0|||
161855787|NCT03207867|584512470|FG007|Overall Study|Death|3|||
161855788|NCT03207867|584512471|FG008|Overall Study|Death|1|||
161855789|NCT03207867|584512472|FG009|Overall Study|Death|2|||
161855790|NCT03207867|584512473|FG010|Overall Study|Death|0|||
161855791|NCT03207867|584512474|FG011|Overall Study|Death|1|||
161855792|NCT03207867|584512475|FG012|Overall Study|Death|0|||
161855793|NCT03207867|584512476|FG013|Overall Study|Death|1|||
161855794|NCT03207867|584512477|FG014|Overall Study|Death|0|||
161855795|NCT03207867|584512478|FG015|Overall Study|Death|0|||
161855796|NCT03207867|584512479|FG016|Overall Study|Death|0|||
161855797|NCT03207867|584512480|FG017|Overall Study|Death|2|||
161855798|NCT03207867|584512481|FG018|Overall Study|Death|0|||
161855799|NCT03207867|584512482|FG019|Overall Study|Death|1|||
161855800|NCT03207867|584512483|FG020|Overall Study|Death|0|||
161855801|NCT03207867|584512484|FG021|Overall Study|Death|0|||
161855802|NCT03207867|584512485|FG022|Overall Study|Death|0|||
161855803|NCT03207867|584512486|FG023|Overall Study|Death|0|||
161855804|NCT03207867|584512463|FG000|Overall Study|Physician Decision|3|||
161855805|NCT03207867|584512464|FG001|Overall Study|Physician Decision|5|||
161855806|NCT03207867|584512465|FG002|Overall Study|Physician Decision|0|||
161855807|NCT03207867|584512466|FG003|Overall Study|Physician Decision|3|||
161855808|NCT03207867|584512467|FG004|Overall Study|Physician Decision|2|||
161855809|NCT03207867|584512468|FG005|Overall Study|Physician Decision|0|||
161855810|NCT03207867|584512469|FG006|Overall Study|Physician Decision|0|||
161855811|NCT03207867|584512470|FG007|Overall Study|Physician Decision|0|||
161855812|NCT03207867|584512471|FG008|Overall Study|Physician Decision|4|||
161855813|NCT03207867|584512472|FG009|Overall Study|Physician Decision|2|||
161855814|NCT03207867|584512473|FG010|Overall Study|Physician Decision|0|||
161855815|NCT03207867|584512474|FG011|Overall Study|Physician Decision|4|||
161855816|NCT03207867|584512475|FG012|Overall Study|Physician Decision|0|||
161855817|NCT03207867|584512476|FG013|Overall Study|Physician Decision|0|||
161855818|NCT03207867|584512477|FG014|Overall Study|Physician Decision|2|||
161855819|NCT03207867|584512478|FG015|Overall Study|Physician Decision|1|||
161855820|NCT03207867|584512479|FG016|Overall Study|Physician Decision|1|||
161855821|NCT03207867|584512480|FG017|Overall Study|Physician Decision|2|||
161855822|NCT03207867|584512481|FG018|Overall Study|Physician Decision|1|||
161855823|NCT03207867|584512482|FG019|Overall Study|Physician Decision|3|||
161855824|NCT03207867|584512483|FG020|Overall Study|Physician Decision|0|||
161855825|NCT03207867|584512484|FG021|Overall Study|Physician Decision|0|||
161855826|NCT03207867|584512485|FG022|Overall Study|Physician Decision|0|||
161855827|NCT03207867|584512486|FG023|Overall Study|Physician Decision|0|||
161855828|NCT03207867|584512463|FG000|Overall Study|Progressive Disease|7|||
161855829|NCT03207867|584512464|FG001|Overall Study|Progressive Disease|7|||
161855830|NCT03207867|584512465|FG002|Overall Study|Progressive Disease|9|||
161855831|NCT03207867|584512466|FG003|Overall Study|Progressive Disease|10|||
161855832|NCT03207867|584512467|FG004|Overall Study|Progressive Disease|11|||
161855833|NCT03207867|584512468|FG005|Overall Study|Progressive Disease|10|||
161855834|NCT03207867|584512469|FG006|Overall Study|Progressive Disease|9|||
161855835|NCT03207867|584512470|FG007|Overall Study|Progressive Disease|8|||
161855836|NCT03207867|584512471|FG008|Overall Study|Progressive Disease|19|||
161855837|NCT03207867|584512472|FG009|Overall Study|Progressive Disease|23|||
161855838|NCT03207867|584512473|FG010|Overall Study|Progressive Disease|2|||
161855839|NCT03207867|584512474|FG011|Overall Study|Progressive Disease|24|||
161855840|NCT03207867|584512475|FG012|Overall Study|Progressive Disease|3|||
161855841|NCT03207867|584512476|FG013|Overall Study|Progressive Disease|11|||
161855842|NCT03207867|584512477|FG014|Overall Study|Progressive Disease|9|||
161855843|NCT03207867|584512478|FG015|Overall Study|Progressive Disease|5|||
161855844|NCT03207867|584512479|FG016|Overall Study|Progressive Disease|10|||
161855845|NCT03207867|584512480|FG017|Overall Study|Progressive Disease|14|||
161855846|NCT03207867|584512481|FG018|Overall Study|Progressive Disease|13|||
161855847|NCT03207867|584512482|FG019|Overall Study|Progressive Disease|14|||
161855848|NCT03207867|584512483|FG020|Overall Study|Progressive Disease|6|||
161855849|NCT03207867|584512484|FG021|Overall Study|Progressive Disease|3|||
161855850|NCT03207867|584512485|FG022|Overall Study|Progressive Disease|3|||
161855851|NCT03207867|584512486|FG023|Overall Study|Progressive Disease|3|||
161855852|NCT03207867|584512463|FG000|Overall Study|Patient/guardian Decision|0|||
161855853|NCT03207867|584512464|FG001|Overall Study|Patient/guardian Decision|0|||
161855854|NCT03207867|584512465|FG002|Overall Study|Patient/guardian Decision|1|||
161855855|NCT03207867|584512466|FG003|Overall Study|Patient/guardian Decision|1|||
161855856|NCT03207867|584512467|FG004|Overall Study|Patient/guardian Decision|1|||
161855857|NCT03207867|584512468|FG005|Overall Study|Patient/guardian Decision|2|||
161855858|NCT03207867|584512469|FG006|Overall Study|Patient/guardian Decision|1|||
161855859|NCT03207867|584512470|FG007|Overall Study|Patient/guardian Decision|0|||
161855860|NCT03207867|584512471|FG008|Overall Study|Patient/guardian Decision|1|||
161855861|NCT03207867|584512472|FG009|Overall Study|Patient/guardian Decision|0|||
161855862|NCT03207867|584512473|FG010|Overall Study|Patient/guardian Decision|0|||
161855863|NCT03207867|584512474|FG011|Overall Study|Patient/guardian Decision|1|||
161855864|NCT03207867|584512475|FG012|Overall Study|Patient/guardian Decision|0|||
161855865|NCT03207867|584512476|FG013|Overall Study|Patient/guardian Decision|1|||
161855866|NCT03207867|584512477|FG014|Overall Study|Patient/guardian Decision|2|||
161855867|NCT03207867|584512478|FG015|Overall Study|Patient/guardian Decision|0|||
161855868|NCT03207867|584512479|FG016|Overall Study|Patient/guardian Decision|1|||
161855869|NCT03207867|584512480|FG017|Overall Study|Patient/guardian Decision|3|||
161855870|NCT03207867|584512481|FG018|Overall Study|Patient/guardian Decision|4|||
161855871|NCT03207867|584512482|FG019|Overall Study|Patient/guardian Decision|1|||
161855872|NCT03207867|584512483|FG020|Overall Study|Patient/guardian Decision|0|||
161855873|NCT03207867|584512484|FG021|Overall Study|Patient/guardian Decision|0|||
161855874|NCT03207867|584512485|FG022|Overall Study|Patient/guardian Decision|0|||
161855875|NCT03207867|584512486|FG023|Overall Study|Patient/guardian Decision|0|||
161855876|NCT06473519|584514535|FG000|Overall Study|Lost to Follow-up|2|||
161855877|NCT06473519|584514536|FG001|Overall Study|Lost to Follow-up|5|||
161855878|NCT06473519|584514535|FG000|Overall Study|Withdrawal by Subject|1|||
161855879|NCT06473519|584514536|FG001|Overall Study|Withdrawal by Subject|4|||
161855880|NCT06473519|584514535|FG000|Overall Study|Randomized but not vaccinated|1|||
161855881|NCT06473519|584514536|FG001|Overall Study|Randomized but not vaccinated|2|||
161855882|NCT03560037|584514538|FG000|Overall Study|Protocol Violation|1|||
161855883|NCT03560037|584514539|FG001|Overall Study|Protocol Violation|0|||
161975003|NCT03158272|584956545|FG002|Overall Study|Other reasons|1|||
161975004|NCT03158272|584956546|FG003|Overall Study|Other reasons|0|||
161975005|NCT03158272|584956543|FG000|Overall Study|Adverse event unrelated to the drug|0|||
161975006|NCT03158272|584956544|FG001|Overall Study|Adverse event unrelated to the drug|1|||
161855884|NCT03560037|584514538|FG000|Overall Study|Physician Decision|0|||
161855885|NCT03560037|584514539|FG001|Overall Study|Physician Decision|1|||
161855886|NCT03620708|584514540|FG000|Overall Study|Lost to Follow-up|1|||
161855887|NCT03620708|584514541|FG001|Overall Study|Lost to Follow-up|1|||
161855888|NCT03620708|584514542|FG002|Overall Study|Lost to Follow-up|2|||
161855889|NCT03620708|584514540|FG000|Overall Study|Withdrawal by Subject|0|||
161975007|NCT03158272|584956545|FG002|Overall Study|Adverse event unrelated to the drug|0|||
161975008|NCT03158272|584956546|FG003|Overall Study|Adverse event unrelated to the drug|0|||
161975009|NCT01688921|584956547|FG000|Overall Study|Lost to Follow-up|7|||
161855890|NCT03620708|584514541|FG001|Overall Study|Withdrawal by Subject|0|||
161855891|NCT03620708|584514542|FG002|Overall Study|Withdrawal by Subject|1|||
161855892|NCT02498613|584514543|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
161855893|NCT02498613|584514544|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
161855894|NCT02498613|584514545|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
161855895|NCT02498613|584514546|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
161855896|NCT02498613|584514543|FG000|Overall Study|Withdrawal by Subject|3|||
161855897|NCT02498613|584514544|FG001|Overall Study|Withdrawal by Subject|1|||
161855898|NCT02498613|584514545|FG002|Overall Study|Withdrawal by Subject|0|||
161855899|NCT02498613|584514546|FG003|Overall Study|Withdrawal by Subject|0|||
161855900|NCT05168202|584514547|FG000|Overall Study|Progressive Disease|4|||
161855901|NCT05168202|584514548|FG001|Overall Study|Progressive Disease|4|||
161855902|NCT05168202|584514549|FG002|Overall Study|Progressive Disease|2|||
161855903|NCT05168202|584514550|FG003|Overall Study|Progressive Disease|3|||
161855904|NCT05168202|584514551|FG004|Overall Study|Progressive Disease|2|||
161855905|NCT05168202|584514552|FG005|Overall Study|Progressive Disease|3|||
161855906|NCT05168202|584514553|FG006|Overall Study|Progressive Disease|2|||
161855907|NCT05168202|584514547|FG000|Overall Study|Adverse Event|2|||
161855908|NCT05168202|584514548|FG001|Overall Study|Adverse Event|1|||
161855909|NCT05168202|584514549|FG002|Overall Study|Adverse Event|4|||
161855910|NCT05168202|584514550|FG003|Overall Study|Adverse Event|4|||
161855911|NCT05168202|584514551|FG004|Overall Study|Adverse Event|3|||
161855912|NCT05168202|584514552|FG005|Overall Study|Adverse Event|2|||
161855913|NCT05168202|584514553|FG006|Overall Study|Adverse Event|0|||
161855914|NCT05168202|584514547|FG000|Overall Study|Lack of Efficacy|0|||
161855915|NCT05168202|584514548|FG001|Overall Study|Lack of Efficacy|1|||
161855916|NCT05168202|584514549|FG002|Overall Study|Lack of Efficacy|1|||
161855917|NCT05168202|584514550|FG003|Overall Study|Lack of Efficacy|0|||
161855918|NCT05168202|584514551|FG004|Overall Study|Lack of Efficacy|1|||
161855919|NCT05168202|584514552|FG005|Overall Study|Lack of Efficacy|2|||
161855920|NCT05168202|584514553|FG006|Overall Study|Lack of Efficacy|2|||
161855921|NCT05168202|584514547|FG000|Overall Study|Withdrawal by Subject|0|||
161855922|NCT05168202|584514548|FG001|Overall Study|Withdrawal by Subject|0|||
161855923|NCT05168202|584514549|FG002|Overall Study|Withdrawal by Subject|1|||
161855924|NCT05168202|584514550|FG003|Overall Study|Withdrawal by Subject|1|||
161855925|NCT05168202|584514551|FG004|Overall Study|Withdrawal by Subject|1|||
161855926|NCT05168202|584514552|FG005|Overall Study|Withdrawal by Subject|1|||
161855927|NCT05168202|584514553|FG006|Overall Study|Withdrawal by Subject|0|||
161855928|NCT05168202|584514547|FG000|Overall Study|Disease Relapse|0|||
161855929|NCT05168202|584514548|FG001|Overall Study|Disease Relapse|1|||
161855930|NCT05168202|584514549|FG002|Overall Study|Disease Relapse|0|||
161855931|NCT05168202|584514550|FG003|Overall Study|Disease Relapse|1|||
161855932|NCT05168202|584514551|FG004|Overall Study|Disease Relapse|1|||
161855933|NCT05168202|584514552|FG005|Overall Study|Disease Relapse|0|||
161855934|NCT05168202|584514553|FG006|Overall Study|Disease Relapse|0|||
161855935|NCT05168202|584514547|FG000|Overall Study|Other Reasons|0|||
161855936|NCT05168202|584514548|FG001|Overall Study|Other Reasons|0|||
161855937|NCT05168202|584514549|FG002|Overall Study|Other Reasons|0|||
161855938|NCT05168202|584514550|FG003|Overall Study|Other Reasons|0|||
161855939|NCT05168202|584514551|FG004|Overall Study|Other Reasons|0|||
161855940|NCT05168202|584514552|FG005|Overall Study|Other Reasons|2|||
161855941|NCT05168202|584514553|FG006|Overall Study|Other Reasons|1|||
161855942|NCT05168202|584514547|FG000|Overall Study|Physician Decision|0|||
161855943|NCT05168202|584514548|FG001|Overall Study|Physician Decision|1|||
161855944|NCT05168202|584514549|FG002|Overall Study|Physician Decision|1|||
161855945|NCT05168202|584514550|FG003|Overall Study|Physician Decision|0|||
161855946|NCT05168202|584514551|FG004|Overall Study|Physician Decision|0|||
161855947|NCT05168202|584514552|FG005|Overall Study|Physician Decision|0|||
161855948|NCT05168202|584514553|FG006|Overall Study|Physician Decision|0|||
161855949|NCT05168202|584514547|FG000|Overall Study|Study Terminated by Sponsor|0|||
161855950|NCT05168202|584514548|FG001|Overall Study|Study Terminated by Sponsor|0|||
161855951|NCT05168202|584514549|FG002|Overall Study|Study Terminated by Sponsor|0|||
161855952|NCT05168202|584514550|FG003|Overall Study|Study Terminated by Sponsor|1|||
161855953|NCT05168202|584514551|FG004|Overall Study|Study Terminated by Sponsor|0|||
161855954|NCT05168202|584514552|FG005|Overall Study|Study Terminated by Sponsor|0|||
161855955|NCT05168202|584514553|FG006|Overall Study|Study Terminated by Sponsor|0|||
161855956|NCT04011722|584514557|FG000|30 Days|Death|5|||
161855957|NCT04011722|584514558|FG001|30 Days|Death|1|||
161855958|NCT04011722|584514557|FG000|1 Year|Death|13|||
161855959|NCT04011722|584514558|FG001|1 Year|Death|5|||
161855960|NCT04011722|584514557|FG000|1 Year|Withdrawal by Subject|8|||
161855961|NCT04011722|584514558|FG001|1 Year|Withdrawal by Subject|2|||
161975010|NCT01688921|584956548|FG001|Overall Study|Lost to Follow-up|13|||
161975011|NCT01688921|584956547|FG000|Overall Study|Physician Decision|6|||
161855962|NCT04011722|584514557|FG000|1 Year|Missed Visit|6|||
161855963|NCT04011722|584514558|FG001|1 Year|Missed Visit|1|||
161855964|NCT04011722|584514557|FG000|1 Year|Pending Visit|0|||
161855965|NCT04011722|584514558|FG001|1 Year|Pending Visit|11|||
161855966|NCT04011722|584514557|FG000|1 Year|Not Yet Due|0|||
161855967|NCT04011722|584514558|FG001|1 Year|Not Yet Due|9|||
161855968|NCT04011722|584514557|FG000|2 Year|Death|16|||
161855969|NCT04011722|584514558|FG001|2 Year|Death|1|||
161855970|NCT04011722|584514557|FG000|2 Year|Withdrawal by Subject|10|||
161855971|NCT04011722|584514558|FG001|2 Year|Withdrawal by Subject|1|||
161855972|NCT04011722|584514557|FG000|2 Year|Missed Visit|9|||
161855973|NCT04011722|584514558|FG001|2 Year|Missed Visit|0|||
161855974|NCT04011722|584514557|FG000|2 Year|Visit Pending|1|||
161855975|NCT04011722|584514558|FG001|2 Year|Visit Pending|3|||
161855976|NCT04011722|584514557|FG000|2 Year|Not Yet Due|43|||
161855977|NCT04011722|584514558|FG001|2 Year|Not Yet Due|54|||
161855978|NCT04011722|584514557|FG000|3 Year|Death|10|||
161855979|NCT04011722|584514558|FG001|3 Year|Death|0|||
161855980|NCT04011722|584514557|FG000|3 Year|Withdrawal by Subject|2|||
161855981|NCT04011722|584514558|FG001|3 Year|Withdrawal by Subject|0|||
161855982|NCT04011722|584514557|FG000|3 Year|Missed Visit|2|||
161855983|NCT04011722|584514558|FG001|3 Year|Missed Visit|0|||
161855984|NCT04011722|584514557|FG000|3 Year|Pending Visit|34|||
161855985|NCT04011722|584514558|FG001|3 Year|Pending Visit|0|||
161855986|NCT04011722|584514557|FG000|3 Year|Not Yet Due|99|||
161855987|NCT04011722|584514558|FG001|3 Year|Not Yet Due|0|||
161855988|NCT05626231|584514561|FG000|Provider Enrollment|Worked part-time|4|||
161855989|NCT05626231|584514561|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
161855990|NCT05626231|584514561|FG000|Provider Enrollment|Non-clinical employee|1|||
161855991|NCT05626231|584514561|FG000|Provider Enrollment|Provider does not see clients|3|||
161855992|NCT05626231|584514561|FG000|Provider Enrollment|Other|5|||
161855993|NCT06195930|584514562|FG000|Overall Study|Adverse Event|4|||
161855994|NCT00233948|584514569|FG000|Overall Study|Adverse Event|1|||
161855995|NCT00233948|584514570|FG001|Overall Study|Adverse Event|0|||
161855996|NCT00233948|584514571|FG002|Overall Study|Adverse Event|0|||
161855997|NCT00233948|584514572|FG003|Overall Study|Adverse Event|0|||
161855998|NCT00233948|584514573|FG004|Overall Study|Adverse Event|0|||
161855999|NCT00233948|584514574|FG005|Overall Study|Adverse Event|0|||
161856000|NCT01567462|584514575|FG000|Overall Study|Withdrawal by Subject|4|||
161856001|NCT01567462|584514576|FG001|Overall Study|Withdrawal by Subject|7|||
161856002|NCT02548156|584514577|FG000|Washout Period 1|Lost to Follow-up|0|||
161856003|NCT02548156|584514578|FG001|Washout Period 1|Lost to Follow-up|0|||
161856004|NCT02548156|584514579|FG002|Washout Period 1|Lost to Follow-up|0|||
161856005|NCT02548156|584514580|FG003|Washout Period 1|Lost to Follow-up|0|||
161856006|NCT02548156|584514581|FG004|Washout Period 1|Lost to Follow-up|1|||
161856007|NCT02548156|584514582|FG005|Washout Period 1|Lost to Follow-up|0|||
161856008|NCT00444587|584514583|FG000|Overall Study|Death|2|||
161856009|NCT00444587|584514584|FG001|Overall Study|Death|1|||
161856010|NCT00444587|584514583|FG000|Overall Study|Progression of the disease|73|||
161856011|NCT00444587|584514584|FG001|Overall Study|Progression of the disease|8|||
161856012|NCT00444587|584514583|FG000|Overall Study|Refused treatment/did not cooperate|4|||
161856013|NCT00444587|584514584|FG001|Overall Study|Refused treatment/did not cooperate|1|||
161856014|NCT00444587|584514583|FG000|Overall Study|Investigator decision|3|||
161856015|NCT00444587|584514584|FG001|Overall Study|Investigator decision|0|||
161856016|NCT00444587|584514583|FG000|Overall Study|Protocol Violation|1|||
161856017|NCT00444587|584514584|FG001|Overall Study|Protocol Violation|0|||
161856018|NCT00444587|584514583|FG000|Overall Study|Missing|0|||
161856019|NCT00444587|584514584|FG001|Overall Study|Missing|5|||
161856020|NCT00196326|584514585|FG000|Overall Study|Did not meet protocol requirements|64|||
161856021|NCT00196326|584514585|FG000|Overall Study|Non-compliance with the protocol|81|||
161856022|NCT00196326|584514585|FG000|Overall Study|Physician Decision|3|||
161856023|NCT00196326|584514585|FG000|Overall Study|Withdrawal by Subject|225|||
161856024|NCT00196326|584514585|FG000|Overall Study|Adverse Event|253|||
161856025|NCT00196326|584514585|FG000|Overall Study|Pregnancy|34|||
161856026|NCT00196326|584514585|FG000|Overall Study|Lost to Follow-up|304|||
161856027|NCT00196326|584514585|FG000|Overall Study|Other|22|||
161856028|NCT01720225|584514594|FG000|Overall Study|Withdrawal by Subject|0|||
161856029|NCT01720225|584514595|FG001|Overall Study|Withdrawal by Subject|1|||
161856030|NCT01720225|584514594|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
161856031|NCT01720225|584514595|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
161856032|NCT05223920|584514596|FG000|Overall Study|Adverse Event|6|||
161856033|NCT05223920|584514597|FG001|Overall Study|Adverse Event|3|||
161856034|NCT05223920|584514596|FG000|Overall Study|Death|2|||
161856035|NCT05223920|584514597|FG001|Overall Study|Death|0|||
161856036|NCT05223920|584514596|FG000|Overall Study|Disease Progression|1|||
161856037|NCT05223920|584514597|FG001|Overall Study|Disease Progression|2|||
161975012|NCT01688921|584956548|FG001|Overall Study|Physician Decision|1|||
161975013|NCT01688921|584956547|FG000|Overall Study|Protocol Violation|0|||
161856038|NCT05223920|584514596|FG000|Overall Study|Physician Decision|1|||
161856039|NCT05223920|584514597|FG001|Overall Study|Physician Decision|2|||
161856040|NCT05223920|584514596|FG000|Overall Study|Sponsor decision|11|||
161856041|NCT05223920|584514597|FG001|Overall Study|Sponsor decision|9|||
161856042|NCT05223920|584514596|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
161856043|NCT05223920|584514597|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
161856044|NCT05223920|584514596|FG000|Overall Study|Subject decision|1|||
161856045|NCT05223920|584514597|FG001|Overall Study|Subject decision|0|||
161856046|NCT05223920|584514596|FG000|Overall Study|Withdrawal by Subject|1|||
161856047|NCT05223920|584514597|FG001|Overall Study|Withdrawal by Subject|6|||
161856048|NCT00369941|584514598|FG000|Overall Study|Never Treated|1|||
161856049|NCT00369941|584514599|FG001|Overall Study|Never Treated|2|||
161856050|NCT00369941|584514598|FG000|Overall Study|Adverse Event|14|||
161856051|NCT00369941|584514599|FG001|Overall Study|Adverse Event|28|||
161856052|NCT00369941|584514598|FG000|Overall Study|Lack of Efficacy|6|||
161856053|NCT00369941|584514599|FG001|Overall Study|Lack of Efficacy|10|||
161856054|NCT00369941|584514598|FG000|Overall Study|Lost to Follow-up|12|||
161856055|NCT00369941|584514599|FG001|Overall Study|Lost to Follow-up|22|||
161856056|NCT00369941|584514598|FG000|Overall Study|Protocol Violation|5|||
161856057|NCT00369941|584514599|FG001|Overall Study|Protocol Violation|3|||
161856058|NCT00369941|584514598|FG000|Overall Study|Withdrawal by Subject|5|||
161856059|NCT00369941|584514599|FG001|Overall Study|Withdrawal by Subject|18|||
161856060|NCT00369941|584514598|FG000|Overall Study|Pregnancy|4|||
161856061|NCT00369941|584514599|FG001|Overall Study|Pregnancy|2|||
161856062|NCT00369941|584514598|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
161856063|NCT00369941|584514599|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
161856064|NCT00369941|584514598|FG000|Overall Study|Moved|11|||
161856065|NCT00369941|584514599|FG001|Overall Study|Moved|5|||
161856066|NCT00369941|584514598|FG000|Overall Study|Treatment with Prohibited Medication|3|||
161856067|NCT00369941|584514599|FG001|Overall Study|Treatment with Prohibited Medication|1|||
161856068|NCT00369941|584514598|FG000|Overall Study|Employment Interfered with Study Visits|1|||
161856069|NCT00369941|584514599|FG001|Overall Study|Employment Interfered with Study Visits|0|||
161856070|NCT00369941|584514598|FG000|Overall Study|Study Site Terminated|2|||
161856071|NCT00369941|584514599|FG001|Overall Study|Study Site Terminated|0|||
161856072|NCT00369941|584514598|FG000|Overall Study|Miscellaneous|3|||
161856073|NCT00369941|584514599|FG001|Overall Study|Miscellaneous|3|||
161856074|NCT00661193|584514600|FG000|Overall Study|Adverse Event|2|||
161856075|NCT00661193|584514601|FG001|Overall Study|Adverse Event|1|||
161856076|NCT00661193|584514600|FG000|Overall Study|Withdrawal by Subject|3|||
161856077|NCT00661193|584514601|FG001|Overall Study|Withdrawal by Subject|1|||
161856078|NCT00661193|584514600|FG000|Overall Study|Progression|27|||
161856079|NCT00661193|584514601|FG001|Overall Study|Progression|24|||
161856080|NCT00661193|584514600|FG000|Overall Study|Not protocol specified|1|||
161856081|NCT00661193|584514601|FG001|Overall Study|Not protocol specified|0|||
161856082|NCT02964312|584514602|FG000|Overall Study|Lost to Follow-up|28|||
161856083|NCT02964312|584514602|FG000|Overall Study|Withdrawal by Subject|11|||
161856084|NCT02964312|584514602|FG000|Overall Study|Lack of Efficacy|10|||
161856085|NCT02964312|584514602|FG000|Overall Study|Did not consent to long-term FU|14|||
161856086|NCT02964312|584514602|FG000|Overall Study|Death|1|||
161856087|NCT03288714|584514609|FG000|Overall Study|Lost to Follow-up|2|||
161856088|NCT03288714|584514610|FG001|Overall Study|Lost to Follow-up|1|||
161856089|NCT03288714|584514609|FG000|Overall Study|Non-compliance with study schedule|2|||
161856090|NCT03288714|584514610|FG001|Overall Study|Non-compliance with study schedule|0|||
161856091|NCT03288714|584514609|FG000|Overall Study|Withdrawal by Subject|3|||
161856092|NCT03288714|584514610|FG001|Overall Study|Withdrawal by Subject|1|||
161856093|NCT03288714|584514609|FG000|Overall Study|Clinical Worsening|2|||
161856094|NCT03288714|584514610|FG001|Overall Study|Clinical Worsening|1|||
161856095|NCT03288714|584514609|FG000|Overall Study|Adverse Event|1|||
161856096|NCT03288714|584514610|FG001|Overall Study|Adverse Event|0|||
161856097|NCT03280264|584514611|FG000|Overall Study|Adverse Event|1|||
161856098|NCT03280264|584514611|FG000|Overall Study|Physician Decision|1|||
161856099|NCT03280264|584514611|FG000|Overall Study|Withdrawal by Subject|1|||
161856100|NCT00524420|584514619|FG000|Overall Study|Lack of Efficacy|1|||
161856101|NCT00524420|584514620|FG001|Overall Study|Lack of Efficacy|0|||
161856102|NCT00577863|584514621|FG000|Overall Study|Adverse Event|4|||
161856103|NCT00577863|584514622|FG001|Overall Study|Adverse Event|2|||
161856104|NCT00577863|584514621|FG000|Overall Study|Death|1|||
161856105|NCT00577863|584514622|FG001|Overall Study|Death|0|||
161856106|NCT00577863|584514621|FG000|Overall Study|Lost to Follow-up|2|||
161856107|NCT00577863|584514622|FG001|Overall Study|Lost to Follow-up|2|||
161975014|NCT01688921|584956548|FG001|Overall Study|Protocol Violation|1|||
161975015|NCT01688921|584956547|FG000|Overall Study|informed consent|3|||
161975016|NCT01688921|584956548|FG001|Overall Study|informed consent|0|||
161975017|NCT03081858|584958362|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
161975018|NCT03081858|584958363|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
161856108|NCT00577863|584514621|FG000|Overall Study|Entry Criteria Exclusion|1|||
161856109|NCT00577863|584514622|FG001|Overall Study|Entry Criteria Exclusion|0|||
161856110|NCT00577863|584514621|FG000|Overall Study|Withdrawal by Subject|0|||
161856111|NCT00577863|584514622|FG001|Overall Study|Withdrawal by Subject|2|||
161856112|NCT00577863|584514621|FG000|Overall Study|Sponsor Decision|2|||
161856113|NCT00577863|584514622|FG001|Overall Study|Sponsor Decision|7|||
161856114|NCT00577863|584514621|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
161856115|NCT00577863|584514622|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
161856116|NCT02738138|584514626|FG000|Overall Study|Adverse Event|0|||
161856117|NCT02738138|584514627|FG001|Overall Study|Adverse Event|1|||
161856118|NCT02738138|584514626|FG000|Overall Study|Lost to Follow-up|2|||
161856119|NCT02738138|584514627|FG001|Overall Study|Lost to Follow-up|0|||
161856120|NCT02738138|584514626|FG000|Overall Study|Other - not further specified|1|||
161856121|NCT02738138|584514627|FG001|Overall Study|Other - not further specified|0|||
161856122|NCT01960257|584514631|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
161856123|NCT01960257|584514632|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
161856124|NCT01960257|584514633|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
161856125|NCT01960257|584514631|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
161856126|NCT01960257|584514632|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
161856127|NCT01960257|584514633|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
161856128|NCT01960257|584514631|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
161856129|NCT01960257|584514632|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
161856130|NCT01960257|584514633|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
161856131|NCT02038010|584514634|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
161856132|NCT02038010|584514635|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
161856133|NCT02038010|584514636|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
161856134|NCT02038010|584514637|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
161856135|NCT02038010|584514634|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
161856136|NCT02038010|584514635|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
161856137|NCT02038010|584514636|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
161856138|NCT02038010|584514637|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
161856139|NCT02038010|584514634|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
161856140|NCT02038010|584514635|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
161856141|NCT02038010|584514636|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
161856142|NCT02038010|584514637|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
161856143|NCT02038010|584514634|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
161856144|NCT02038010|584514635|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
161856145|NCT02038010|584514636|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
161856146|NCT02038010|584514637|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
161856147|NCT02038010|584514634|FG000|Follow Up|Death|4|||
161856148|NCT02038010|584514635|FG001|Follow Up|Death|3|||
161856149|NCT02038010|584514636|FG002|Follow Up|Death|0|||
161856150|NCT02038010|584514637|FG003|Follow Up|Death|0|||
161856151|NCT02038010|584514634|FG000|Follow Up|Other|3|||
161856152|NCT02038010|584514635|FG001|Follow Up|Other|0|||
161856153|NCT02038010|584514636|FG002|Follow Up|Other|0|||
161856154|NCT02038010|584514637|FG003|Follow Up|Other|0|||
161856155|NCT00958828|584514643|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
161856156|NCT00958828|584514644|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
161856157|NCT00958828|584514643|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
161856158|NCT00958828|584514644|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
161856159|NCT02673775|584514655|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
161856160|NCT02673775|584514656|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
161856161|NCT02673775|584514655|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
161856162|NCT02673775|584514656|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
161856163|NCT02673775|584514655|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
161856164|NCT02673775|584514656|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
161856165|NCT02673775|584514655|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
161856166|NCT02673775|584514656|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
161856167|NCT00535405|584514657|FG000|Overall Study|Adverse Event|6|||
161856168|NCT00535405|584514658|FG001|Overall Study|Adverse Event|8|||
161856169|NCT00535405|584514659|FG002|Overall Study|Adverse Event|3|||
161856170|NCT00535405|584514660|FG003|Overall Study|Adverse Event|8|||
161856171|NCT00535405|584514661|FG004|Overall Study|Adverse Event|6|||
161856172|NCT00535405|584514657|FG000|Overall Study|Lost to Follow-up|1|||
161856173|NCT00535405|584514658|FG001|Overall Study|Lost to Follow-up|3|||
161856174|NCT00535405|584514659|FG002|Overall Study|Lost to Follow-up|3|||
161856175|NCT00535405|584514660|FG003|Overall Study|Lost to Follow-up|2|||
161856176|NCT00535405|584514661|FG004|Overall Study|Lost to Follow-up|1|||
161856177|NCT00535405|584514657|FG000|Overall Study|Physician Decision|3|||
161856178|NCT00535405|584514658|FG001|Overall Study|Physician Decision|2|||
161856179|NCT00535405|584514659|FG002|Overall Study|Physician Decision|0|||
161975019|NCT03081858|584958364|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
161856180|NCT00535405|584514660|FG003|Overall Study|Physician Decision|1|||
161975020|NCT03081858|584958365|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
161975021|NCT02936284|584958370|FG000|Overall Study|Withdrawal by Subject|3|||
161975022|NCT02936284|584958371|FG001|Overall Study|Withdrawal by Subject|1|||
161975023|NCT02936284|584958370|FG000|Overall Study|Lost to Follow-up|7|||
161856181|NCT00535405|584514661|FG004|Overall Study|Physician Decision|1|||
161856182|NCT00535405|584514657|FG000|Overall Study|Protocol Violation|2|||
161856183|NCT00535405|584514658|FG001|Overall Study|Protocol Violation|2|||
161856184|NCT00535405|584514659|FG002|Overall Study|Protocol Violation|2|||
161975024|NCT02936284|584958371|FG001|Overall Study|Lost to Follow-up|8|||
161856185|NCT00535405|584514660|FG003|Overall Study|Protocol Violation|1|||
161856186|NCT00535405|584514661|FG004|Overall Study|Protocol Violation|0|||
161856187|NCT00535405|584514657|FG000|Overall Study|Withdrawal by Subject|5|||
161856188|NCT00535405|584514658|FG001|Overall Study|Withdrawal by Subject|11|||
161856189|NCT00535405|584514659|FG002|Overall Study|Withdrawal by Subject|10|||
161856190|NCT00535405|584514660|FG003|Overall Study|Withdrawal by Subject|10|||
161856191|NCT00535405|584514661|FG004|Overall Study|Withdrawal by Subject|8|||
161856192|NCT03910673|584514665|FG000|Overall Study|Adverse Event|0|||
161856193|NCT03910673|584514666|FG001|Overall Study|Adverse Event|0|||
161856194|NCT03910673|584514667|FG002|Overall Study|Adverse Event|0|||
161856195|NCT03910673|584514668|FG003|Overall Study|Adverse Event|2|||
161856196|NCT03910673|584514669|FG004|Overall Study|Adverse Event|0|||
161856197|NCT04650204|584514685|FG000|Overall Study|Study was Terminated|2|||
161856198|NCT04650204|584514686|FG001|Overall Study|Study was Terminated|1|||
161856199|NCT03164616|584514687|FG000|Overall Study|Death|250|||
161856200|NCT03164616|584514688|FG001|Overall Study|Death|264|||
161856201|NCT03164616|584514689|FG002|Overall Study|Death|279|||
161856202|NCT03164616|584514687|FG000|Overall Study|Lost to Follow-up|2|||
161856203|NCT03164616|584514688|FG001|Overall Study|Lost to Follow-up|2|||
161856204|NCT03164616|584514689|FG002|Overall Study|Lost to Follow-up|2|||
161856205|NCT03164616|584514687|FG000|Overall Study|Withdrawal by Subject|6|||
161856206|NCT03164616|584514688|FG001|Overall Study|Withdrawal by Subject|7|||
161856207|NCT03164616|584514689|FG002|Overall Study|Withdrawal by Subject|16|||
161856208|NCT01911273|584514691|FG000|Overall Study|Progression of Disease|1|||
161856209|NCT01911273|584514692|FG001|Overall Study|Progression of Disease|0|||
161856210|NCT01911273|584514691|FG000|Overall Study|Withdrawal by Subject|0|||
161856211|NCT01911273|584514692|FG001|Overall Study|Withdrawal by Subject|2|||
161856212|NCT02503787|584514697|FG000|Enrollment|Withdrawal by Subject|6|||
161856213|NCT02503787|584514697|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
161856214|NCT02503787|584514697|FG000|Enrollment|Physician Decision|2|||
161856215|NCT02503787|584514697|FG000|Enrollment|Insurance issue|2|||
161856216|NCT02503787|584514697|FG000|Enrollment|Lost to Follow-up|1|||
161856217|NCT02503787|584514697|FG000|Enrollment|Study closure|1|||
161856218|NCT02503787|584514697|FG000|Enrollment|Adverse Event|1|||
161856219|NCT02503787|584514697|FG000|Enrollment|Protocol Violation|1|||
161856220|NCT02503787|584514697|FG000|Enrollment|Inability to implant system|1|||
161856221|NCT02503787|584514697|FG000|Enrollment|Unable to be programmed|1|||
161856222|NCT02503787|584514697|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
161856223|NCT02503787|584514697|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
161856224|NCT02503787|584514697|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
161856225|NCT02503787|584514697|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
161856226|NCT02503787|584514697|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
161856227|NCT02503787|584514697|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
161856228|NCT04787627|584514698|FG000|Overall Study|Withdrawal by Subject|3|||
161856229|NCT04787627|584514699|FG001|Overall Study|Withdrawal by Subject|0|||
161856230|NCT04787627|584514698|FG000|Overall Study|Physician Decision|2|||
161856231|NCT04787627|584514699|FG001|Overall Study|Physician Decision|0|||
161856232|NCT04787627|584514698|FG000|Overall Study|Excluded|0|||
161856233|NCT04787627|584514699|FG001|Overall Study|Excluded|1|||
161856234|NCT00174954|584514702|FG000|Overall Study|Adverse Event|2|||
161856235|NCT00174954|584514702|FG000|Overall Study|No tophi found in MRI|1|||
161856236|NCT00174954|584514702|FG000|Overall Study|Physician Decision|1|||
161856237|NCT00839254|584514703|FG000|Overall Study|Protocol Violation|0|||
161856238|NCT00839254|584514704|FG001|Overall Study|Protocol Violation|1|||
161856239|NCT00839254|584514705|FG002|Overall Study|Protocol Violation|1|||
161856240|NCT00839254|584514706|FG003|Overall Study|Protocol Violation|1|||
161856241|NCT00839254|584514707|FG004|Overall Study|Protocol Violation|0|||
161856242|NCT00839254|584514708|FG005|Overall Study|Protocol Violation|0|||
161856243|NCT00839254|584514709|FG006|Overall Study|Protocol Violation|1|||
161856244|NCT00839254|584514710|FG007|Overall Study|Protocol Violation|2|||
161856245|NCT00839254|584514703|FG000|Overall Study|Physician Decision|0|||
161856246|NCT00839254|584514704|FG001|Overall Study|Physician Decision|1|||
161975025|NCT01610596|584958372|FG000|Overall Study|Lost to Follow-up|0|||
161975026|NCT01610596|584958373|FG001|Overall Study|Lost to Follow-up|1|||
161856247|NCT00839254|584514705|FG002|Overall Study|Physician Decision|0|||
161856248|NCT00839254|584514706|FG003|Overall Study|Physician Decision|0|||
161856249|NCT00839254|584514707|FG004|Overall Study|Physician Decision|0|||
161856250|NCT00839254|584514708|FG005|Overall Study|Physician Decision|0|||
161856251|NCT00839254|584514709|FG006|Overall Study|Physician Decision|0|||
161856252|NCT00839254|584514710|FG007|Overall Study|Physician Decision|1|||
161856253|NCT00839254|584514703|FG000|Overall Study|Wrong treatment number allocation|0|||
161856254|NCT00839254|584514704|FG001|Overall Study|Wrong treatment number allocation|1|||
161856255|NCT00839254|584514705|FG002|Overall Study|Wrong treatment number allocation|0|||
161856256|NCT00839254|584514706|FG003|Overall Study|Wrong treatment number allocation|0|||
161856257|NCT00839254|584514707|FG004|Overall Study|Wrong treatment number allocation|0|||
161856258|NCT00839254|584514708|FG005|Overall Study|Wrong treatment number allocation|1|||
161856259|NCT00839254|584514709|FG006|Overall Study|Wrong treatment number allocation|0|||
161856260|NCT00839254|584514710|FG007|Overall Study|Wrong treatment number allocation|0|||
161856261|NCT00839254|584514703|FG000|Overall Study|Adverse Event|12|||
161856262|NCT00839254|584514704|FG001|Overall Study|Adverse Event|6|||
161856263|NCT00839254|584514705|FG002|Overall Study|Adverse Event|3|||
161856264|NCT00839254|584514706|FG003|Overall Study|Adverse Event|5|||
161856265|NCT00839254|584514707|FG004|Overall Study|Adverse Event|2|||
161856266|NCT00839254|584514708|FG005|Overall Study|Adverse Event|1|||
161856267|NCT00839254|584514709|FG006|Overall Study|Adverse Event|0|||
161856268|NCT00839254|584514710|FG007|Overall Study|Adverse Event|1|||
161856269|NCT00839254|584514703|FG000|Overall Study|Withdrawal by Subject|87|||
161856270|NCT00839254|584514704|FG001|Overall Study|Withdrawal by Subject|53|||
161856271|NCT00839254|584514705|FG002|Overall Study|Withdrawal by Subject|54|||
161856272|NCT00839254|584514706|FG003|Overall Study|Withdrawal by Subject|32|||
161856273|NCT00839254|584514707|FG004|Overall Study|Withdrawal by Subject|27|||
161856274|NCT00839254|584514708|FG005|Overall Study|Withdrawal by Subject|15|||
161856275|NCT00839254|584514709|FG006|Overall Study|Withdrawal by Subject|22|||
161856276|NCT00839254|584514710|FG007|Overall Study|Withdrawal by Subject|9|||
161856277|NCT00839254|584514703|FG000|Overall Study|Wrong group allocation|0|||
161856278|NCT00839254|584514704|FG001|Overall Study|Wrong group allocation|0|||
161856279|NCT00839254|584514705|FG002|Overall Study|Wrong group allocation|0|||
161856280|NCT00839254|584514706|FG003|Overall Study|Wrong group allocation|0|||
161856281|NCT00839254|584514707|FG004|Overall Study|Wrong group allocation|0|||
161856282|NCT00839254|584514708|FG005|Overall Study|Wrong group allocation|0|||
161856283|NCT00839254|584514709|FG006|Overall Study|Wrong group allocation|1|||
161856284|NCT00839254|584514710|FG007|Overall Study|Wrong group allocation|0|||
161856285|NCT00839254|584514703|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
161856286|NCT00839254|584514704|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
161856287|NCT00839254|584514705|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
161856288|NCT00839254|584514706|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
161856289|NCT00839254|584514707|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
161856290|NCT00839254|584514708|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
161856291|NCT00839254|584514709|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
161856292|NCT00839254|584514710|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
161856293|NCT00839254|584514703|FG000|Overall Study|Withdrawn due to non-compliance|2|||
161856294|NCT00839254|584514704|FG001|Overall Study|Withdrawn due to non-compliance|0|||
161856295|NCT00839254|584514705|FG002|Overall Study|Withdrawn due to non-compliance|0|||
161856296|NCT00839254|584514706|FG003|Overall Study|Withdrawn due to non-compliance|0|||
161856297|NCT00839254|584514707|FG004|Overall Study|Withdrawn due to non-compliance|0|||
161856298|NCT00839254|584514708|FG005|Overall Study|Withdrawn due to non-compliance|0|||
161856299|NCT00839254|584514709|FG006|Overall Study|Withdrawn due to non-compliance|0|||
161856300|NCT00839254|584514710|FG007|Overall Study|Withdrawn due to non-compliance|0|||
161856301|NCT00839254|584514703|FG000|Overall Study|Lost to Follow-up|51|||
161856302|NCT00839254|584514704|FG001|Overall Study|Lost to Follow-up|30|||
161856303|NCT00839254|584514705|FG002|Overall Study|Lost to Follow-up|32|||
161856304|NCT00839254|584514706|FG003|Overall Study|Lost to Follow-up|24|||
161856305|NCT00839254|584514707|FG004|Overall Study|Lost to Follow-up|8|||
161856306|NCT00839254|584514708|FG005|Overall Study|Lost to Follow-up|8|||
161856307|NCT00839254|584514709|FG006|Overall Study|Lost to Follow-up|4|||
161856308|NCT00839254|584514710|FG007|Overall Study|Lost to Follow-up|2|||
161856309|NCT04597632|584514711|FG000|Overall Study|Withdrawal by Subject|10|||
161975027|NCT00799591|584958376|FG000|Overall Study|De-escalation of doses|20|||
161975028|NCT00799591|584958376|FG000|Overall Study|Death|14|||
161856310|NCT04597632|584514711|FG000|Overall Study|Lost to Follow-up|1|||
161856311|NCT04597632|584514711|FG000|Overall Study|Death|1|||
161975029|NCT00799591|584958376|FG000|Overall Study|Technical failure|12|||
161975030|NCT00799591|584958376|FG000|Overall Study|Resistant germ|11|||
161975031|NCT00799591|584958376|FG000|Overall Study|New infection|4|||
161975032|NCT00799591|584958376|FG000|Overall Study|Resistance germ and technical failure|2|||
161975033|NCT00799591|584958376|FG000|Overall Study|Persistance of fever undetermined origin|1|||
161975034|NCT00799591|584958376|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
161975035|NCT00799591|584958376|FG000|Overall Study|Infectious origin not probable|1|||
161975036|NCT02098369|584958380|FG000|Overall Study|Withdrawal by Subject|1|||
161975037|NCT02098369|584958381|FG001|Overall Study|Withdrawal by Subject|5|||
161975038|NCT02098369|584958382|FG002|Overall Study|Withdrawal by Subject|0|||
161975039|NCT02098369|584958380|FG000|Overall Study|Lost to Follow-up|5|||
161975040|NCT02098369|584958381|FG001|Overall Study|Lost to Follow-up|1|||
161856312|NCT04597632|584514711|FG000|Overall Study|Adverse Event|5|||
161856313|NCT01823835|584514712|FG000|Overall Study|Adverse Event|0|||
161856314|NCT01823835|584514713|FG001|Overall Study|Adverse Event|0|||
161856315|NCT01823835|584514714|FG002|Overall Study|Adverse Event|0|||
161975041|NCT02098369|584958382|FG002|Overall Study|Lost to Follow-up|3|||
161975042|NCT02098369|584958380|FG000|Overall Study|Death|1|||
161856316|NCT01823835|584514715|FG003|Overall Study|Adverse Event|0|||
161856317|NCT01823835|584514716|FG004|Overall Study|Adverse Event|1|||
161856318|NCT01823835|584514717|FG005|Overall Study|Adverse Event|0|||
161856319|NCT01823835|584514718|FG006|Overall Study|Adverse Event|1|||
161856320|NCT01823835|584514719|FG007|Overall Study|Adverse Event|0|||
161975043|NCT02098369|584958381|FG001|Overall Study|Death|1|||
161975044|NCT02098369|584958382|FG002|Overall Study|Death|1|||
161975045|NCT02098369|584958380|FG000|Overall Study|Other|0|||
161856321|NCT01823835|584514720|FG008|Overall Study|Adverse Event|0|||
161856322|NCT01823835|584514721|FG009|Overall Study|Adverse Event|0|||
161856323|NCT01823835|584514722|FG010|Overall Study|Adverse Event|1|||
161856324|NCT01823835|584514723|FG011|Overall Study|Adverse Event|2|||
161856325|NCT01823835|584514724|FG012|Overall Study|Adverse Event|0|||
161856326|NCT01823835|584514725|FG013|Overall Study|Adverse Event|0|||
161856327|NCT01823835|584514726|FG014|Overall Study|Adverse Event|0|||
161856328|NCT01823835|584514712|FG000|Overall Study|Physician Decision|0|||
161856329|NCT01823835|584514713|FG001|Overall Study|Physician Decision|0|||
161856330|NCT01823835|584514714|FG002|Overall Study|Physician Decision|0|||
161856331|NCT01823835|584514715|FG003|Overall Study|Physician Decision|0|||
161856332|NCT01823835|584514716|FG004|Overall Study|Physician Decision|0|||
161856333|NCT01823835|584514717|FG005|Overall Study|Physician Decision|0|||
161856334|NCT01823835|584514718|FG006|Overall Study|Physician Decision|0|||
161856335|NCT01823835|584514719|FG007|Overall Study|Physician Decision|0|||
161856336|NCT01823835|584514720|FG008|Overall Study|Physician Decision|0|||
161856337|NCT01823835|584514721|FG009|Overall Study|Physician Decision|0|||
161856338|NCT01823835|584514722|FG010|Overall Study|Physician Decision|0|||
161856339|NCT01823835|584514723|FG011|Overall Study|Physician Decision|2|||
161856340|NCT01823835|584514724|FG012|Overall Study|Physician Decision|0|||
161856341|NCT01823835|584514725|FG013|Overall Study|Physician Decision|0|||
161856342|NCT01823835|584514726|FG014|Overall Study|Physician Decision|0|||
161856343|NCT01823835|584514712|FG000|Overall Study|Progressive Disease|3|||
161856344|NCT01823835|584514713|FG001|Overall Study|Progressive Disease|4|||
161856345|NCT01823835|584514714|FG002|Overall Study|Progressive Disease|3|||
161856346|NCT01823835|584514715|FG003|Overall Study|Progressive Disease|6|||
161856347|NCT01823835|584514716|FG004|Overall Study|Progressive Disease|4|||
161856348|NCT01823835|584514717|FG005|Overall Study|Progressive Disease|6|||
161856349|NCT01823835|584514718|FG006|Overall Study|Progressive Disease|5|||
161856350|NCT01823835|584514719|FG007|Overall Study|Progressive Disease|3|||
161856351|NCT01823835|584514720|FG008|Overall Study|Progressive Disease|3|||
161856352|NCT01823835|584514721|FG009|Overall Study|Progressive Disease|18|||
161856353|NCT01823835|584514722|FG010|Overall Study|Progressive Disease|8|||
161856354|NCT01823835|584514723|FG011|Overall Study|Progressive Disease|46|||
161856355|NCT01823835|584514724|FG012|Overall Study|Progressive Disease|18|||
161856356|NCT01823835|584514725|FG013|Overall Study|Progressive Disease|4|||
161856357|NCT01823835|584514726|FG014|Overall Study|Progressive Disease|6|||
161856358|NCT01823835|584514712|FG000|Overall Study|Study Termination|0|||
161856359|NCT01823835|584514713|FG001|Overall Study|Study Termination|0|||
161856360|NCT01823835|584514714|FG002|Overall Study|Study Termination|0|||
161856361|NCT01823835|584514715|FG003|Overall Study|Study Termination|0|||
161856362|NCT01823835|584514716|FG004|Overall Study|Study Termination|1|||
161856363|NCT01823835|584514717|FG005|Overall Study|Study Termination|0|||
161856364|NCT01823835|584514718|FG006|Overall Study|Study Termination|0|||
161856365|NCT01823835|584514719|FG007|Overall Study|Study Termination|0|||
161856366|NCT01823835|584514720|FG008|Overall Study|Study Termination|0|||
161856367|NCT01823835|584514721|FG009|Overall Study|Study Termination|0|||
161856368|NCT01823835|584514722|FG010|Overall Study|Study Termination|0|||
161856369|NCT01823835|584514723|FG011|Overall Study|Study Termination|1|||
161856370|NCT01823835|584514724|FG012|Overall Study|Study Termination|0|||
161856371|NCT01823835|584514725|FG013|Overall Study|Study Termination|0|||
161856372|NCT01823835|584514726|FG014|Overall Study|Study Termination|0|||
161856373|NCT01823835|584514712|FG000|Overall Study|Withdrawal by Subject|0|||
161856374|NCT01823835|584514713|FG001|Overall Study|Withdrawal by Subject|0|||
161856375|NCT01823835|584514714|FG002|Overall Study|Withdrawal by Subject|1|||
161856376|NCT01823835|584514715|FG003|Overall Study|Withdrawal by Subject|0|||
161856377|NCT01823835|584514716|FG004|Overall Study|Withdrawal by Subject|0|||
161856378|NCT01823835|584514717|FG005|Overall Study|Withdrawal by Subject|0|||
161975046|NCT02098369|584958381|FG001|Overall Study|Other|2|||
161975047|NCT02098369|584958382|FG002|Overall Study|Other|1|||
161856379|NCT01823835|584514718|FG006|Overall Study|Withdrawal by Subject|0|||
161975048|NCT02046174|584958385|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
161975049|NCT02046174|584958386|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
161975050|NCT00413920|584958387|FG000|Overall Study|Adverse Event|9|||
161856380|NCT01823835|584514719|FG007|Overall Study|Withdrawal by Subject|0|||
161856381|NCT01823835|584514720|FG008|Overall Study|Withdrawal by Subject|0|||
161856382|NCT01823835|584514721|FG009|Overall Study|Withdrawal by Subject|1|||
161856383|NCT01823835|584514722|FG010|Overall Study|Withdrawal by Subject|1|||
161856384|NCT01823835|584514723|FG011|Overall Study|Withdrawal by Subject|2|||
161856385|NCT01823835|584514724|FG012|Overall Study|Withdrawal by Subject|1|||
161856386|NCT01823835|584514725|FG013|Overall Study|Withdrawal by Subject|0|||
161856387|NCT01823835|584514726|FG014|Overall Study|Withdrawal by Subject|0|||
161856388|NCT00509795|584514727|FG000|Overall Study|Adverse Event|4|||
161856389|NCT00509795|584514728|FG001|Overall Study|Adverse Event|3|||
161856390|NCT00509795|584514729|FG002|Overall Study|Adverse Event|5|||
161856391|NCT00509795|584514730|FG003|Overall Study|Adverse Event|4|||
161856392|NCT00509795|584514727|FG000|Overall Study|Death|3|||
161975051|NCT00413920|584958388|FG001|Overall Study|Adverse Event|11|||
161975052|NCT00413920|584958387|FG000|Overall Study|Lack of Efficacy|11|||
161975053|NCT00413920|584958388|FG001|Overall Study|Lack of Efficacy|9|||
161975054|NCT00413920|584958387|FG000|Overall Study|Death|3|||
161975055|NCT00413920|584958388|FG001|Overall Study|Death|5|||
161975056|NCT00413920|584958387|FG000|Overall Study|Graft Loss|5|||
161975057|NCT00413920|584958388|FG001|Overall Study|Graft Loss|3|||
161975058|NCT00186537|584958391|FG000|Overall Study|Withdrawal by Subject|4|||
161975059|NCT00186537|584958392|FG001|Overall Study|Withdrawal by Subject|0|||
161769122|NCT05602818|584196095|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769123|NCT05602818|584196096|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769124|NCT05602818|584196097|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161769125|NCT05602818|584196086|FG000|Qualification Phase (3 Days)|Other|1|||
161769126|NCT05602818|584196087|FG001|Qualification Phase (3 Days)|Other|0|||
161769127|NCT05602818|584196088|FG002|Qualification Phase (3 Days)|Other|0|||
161769128|NCT05602818|584196089|FG003|Qualification Phase (3 Days)|Other|0|||
161769129|NCT05602818|584196090|FG004|Qualification Phase (3 Days)|Other|0|||
161769130|NCT05602818|584196091|FG005|Qualification Phase (3 Days)|Other|0|||
161769131|NCT05602818|584196092|FG006|Qualification Phase (3 Days)|Other|0|||
161769132|NCT05602818|584196093|FG007|Qualification Phase (3 Days)|Other|0|||
161769133|NCT05602818|584196094|FG008|Qualification Phase (3 Days)|Other|0|||
161769134|NCT05602818|584196095|FG009|Qualification Phase (3 Days)|Other|0|||
161769135|NCT05602818|584196096|FG010|Qualification Phase (3 Days)|Other|0|||
161769136|NCT05602818|584196097|FG011|Qualification Phase (3 Days)|Other|0|||
161769137|NCT05602818|584196086|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769138|NCT05602818|584196087|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
161769139|NCT05602818|584196088|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769140|NCT05602818|584196089|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769141|NCT05602818|584196090|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769142|NCT05602818|584196091|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769143|NCT05602818|584196092|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769144|NCT05602818|584196093|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769145|NCT05602818|584196094|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769146|NCT05602818|584196095|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769147|NCT05602818|584196096|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769148|NCT05602818|584196097|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161769149|NCT05602818|584196086|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
161769150|NCT05602818|584196087|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
161769151|NCT05602818|584196088|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
161769152|NCT05602818|584196089|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
161769153|NCT05602818|584196090|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
161769154|NCT05602818|584196091|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
161769155|NCT05602818|584196092|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
161769156|NCT05602818|584196093|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
161769157|NCT05602818|584196094|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
161769158|NCT05602818|584196095|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
161769159|NCT05602818|584196096|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
161769160|NCT05602818|584196097|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
161769161|NCT05602818|584196086|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769162|NCT05602818|584196087|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769163|NCT05602818|584196088|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769164|NCT05602818|584196089|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769165|NCT05602818|584196090|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769166|NCT05602818|584196091|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769167|NCT05602818|584196092|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769168|NCT05602818|584196093|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769169|NCT05602818|584196094|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769170|NCT05602818|584196095|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161769171|NCT05602818|584196096|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
161769172|NCT05602818|584196097|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
161769173|NCT05602818|584196086|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
161769174|NCT05602818|584196087|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
161769175|NCT05602818|584196088|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
161769176|NCT05602818|584196089|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
161769177|NCT05602818|584196090|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
161769178|NCT05602818|584196091|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
161769179|NCT05602818|584196092|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
161769180|NCT05602818|584196093|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
161769181|NCT05602818|584196094|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
161856393|NCT00509795|584514728|FG001|Overall Study|Death|1|||
161856394|NCT00509795|584514729|FG002|Overall Study|Death|2|||
161856395|NCT00509795|584514730|FG003|Overall Study|Death|7|||
161856396|NCT00509795|584514727|FG000|Overall Study|Lack of Efficacy|0|||
161856397|NCT00509795|584514728|FG001|Overall Study|Lack of Efficacy|0|||
161856398|NCT00509795|584514729|FG002|Overall Study|Lack of Efficacy|2|||
161856399|NCT00509795|584514730|FG003|Overall Study|Lack of Efficacy|2|||
161856400|NCT00509795|584514727|FG000|Overall Study|Lost to Follow-up|1|||
161856401|NCT00509795|584514728|FG001|Overall Study|Lost to Follow-up|2|||
161856402|NCT00509795|584514729|FG002|Overall Study|Lost to Follow-up|4|||
161856403|NCT00509795|584514730|FG003|Overall Study|Lost to Follow-up|4|||
161856404|NCT00509795|584514727|FG000|Overall Study|OTHER|1|||
161856405|NCT00509795|584514728|FG001|Overall Study|OTHER|0|||
161856406|NCT00509795|584514729|FG002|Overall Study|OTHER|4|||
161856407|NCT00509795|584514730|FG003|Overall Study|OTHER|1|||
161856408|NCT00509795|584514727|FG000|Overall Study|Protocol Violation|3|||
161856409|NCT00509795|584514728|FG001|Overall Study|Protocol Violation|0|||
161856410|NCT00509795|584514729|FG002|Overall Study|Protocol Violation|3|||
161856411|NCT00509795|584514730|FG003|Overall Study|Protocol Violation|1|||
161856412|NCT00509795|584514727|FG000|Overall Study|Withdrawal by Subject|10|||
161856413|NCT00509795|584514728|FG001|Overall Study|Withdrawal by Subject|5|||
161856414|NCT00509795|584514729|FG002|Overall Study|Withdrawal by Subject|7|||
161856415|NCT00509795|584514730|FG003|Overall Study|Withdrawal by Subject|8|||
161856416|NCT04895982|584514731|FG000|Overall Study|Withdrawal by Subject|0|||
161856417|NCT04895982|584514732|FG001|Overall Study|Withdrawal by Subject|0|||
161856418|NCT04895982|584514733|FG002|Overall Study|Withdrawal by Subject|0|||
161856419|NCT04895982|584514734|FG003|Overall Study|Withdrawal by Subject|0|||
161856420|NCT04895982|584514735|FG004|Overall Study|Withdrawal by Subject|0|||
161856421|NCT04895982|584514736|FG005|Overall Study|Withdrawal by Subject|1|||
161856422|NCT04895982|584514737|FG006|Overall Study|Withdrawal by Subject|1|||
161856423|NCT04895982|584514738|FG007|Overall Study|Withdrawal by Subject|0|||
161856424|NCT04895982|584514739|FG008|Overall Study|Withdrawal by Subject|0|||
161856425|NCT04895982|584514740|FG009|Overall Study|Withdrawal by Subject|1|||
161856426|NCT04895982|584514741|FG010|Overall Study|Withdrawal by Subject|0|||
161856427|NCT04895982|584514742|FG011|Overall Study|Withdrawal by Subject|1|||
161856428|NCT04895982|584514731|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161856429|NCT04895982|584514732|FG001|Overall Study|Withdrawal by parent/guardian|3|||
161856430|NCT04895982|584514733|FG002|Overall Study|Withdrawal by parent/guardian|3|||
161856431|NCT04895982|584514734|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161856432|NCT04895982|584514735|FG004|Overall Study|Withdrawal by parent/guardian|3|||
161856433|NCT04895982|584514736|FG005|Overall Study|Withdrawal by parent/guardian|2|||
161856434|NCT04895982|584514737|FG006|Overall Study|Withdrawal by parent/guardian|1|||
161856435|NCT04895982|584514738|FG007|Overall Study|Withdrawal by parent/guardian|0|||
161856436|NCT04895982|584514739|FG008|Overall Study|Withdrawal by parent/guardian|3|||
161856437|NCT04895982|584514740|FG009|Overall Study|Withdrawal by parent/guardian|0|||
161856438|NCT04895982|584514741|FG010|Overall Study|Withdrawal by parent/guardian|0|||
161856439|NCT04895982|584514742|FG011|Overall Study|Withdrawal by parent/guardian|0|||
161856440|NCT04895982|584514731|FG000|Overall Study|Other|0|||
161856441|NCT04895982|584514732|FG001|Overall Study|Other|0|||
161856442|NCT04895982|584514733|FG002|Overall Study|Other|1|||
161856443|NCT04895982|584514734|FG003|Overall Study|Other|1|||
161856444|NCT04895982|584514735|FG004|Overall Study|Other|0|||
161975060|NCT00186537|584958393|FG002|Overall Study|Withdrawal by Subject|3|||
161975061|NCT00186537|584958391|FG000|Overall Study|ALT > 1.5 x ULN|3|||
161975062|NCT00186537|584958392|FG001|Overall Study|ALT > 1.5 x ULN|0|||
161975063|NCT00186537|584958393|FG002|Overall Study|ALT > 1.5 x ULN|0|||
161975064|NCT01765426|584958394|FG000|Overall Study|Lost to Follow-up|0|||
161975065|NCT01765426|584958395|FG001|Overall Study|Lost to Follow-up|1|||
161856445|NCT04895982|584514736|FG005|Overall Study|Other|0|||
161856446|NCT04895982|584514737|FG006|Overall Study|Other|0|||
161856447|NCT04895982|584514738|FG007|Overall Study|Other|0|||
161856448|NCT04895982|584514739|FG008|Overall Study|Other|0|||
161856449|NCT04895982|584514740|FG009|Overall Study|Other|1|||
161856450|NCT04895982|584514741|FG010|Overall Study|Other|0|||
161856451|NCT04895982|584514742|FG011|Overall Study|Other|0|||
161856452|NCT04895982|584514731|FG000|Overall Study|Protocol Violation|0|||
161856453|NCT04895982|584514732|FG001|Overall Study|Protocol Violation|0|||
161856454|NCT04895982|584514733|FG002|Overall Study|Protocol Violation|1|||
161856455|NCT04895982|584514734|FG003|Overall Study|Protocol Violation|1|||
161856456|NCT04895982|584514735|FG004|Overall Study|Protocol Violation|1|||
161856457|NCT04895982|584514736|FG005|Overall Study|Protocol Violation|0|||
161856458|NCT04895982|584514737|FG006|Overall Study|Protocol Violation|0|||
161856459|NCT04895982|584514738|FG007|Overall Study|Protocol Violation|1|||
161856460|NCT04895982|584514739|FG008|Overall Study|Protocol Violation|0|||
161856461|NCT04895982|584514740|FG009|Overall Study|Protocol Violation|0|||
161975066|NCT01765426|584958396|FG002|Overall Study|Lost to Follow-up|0|||
161975067|NCT01765426|584958397|FG003|Overall Study|Lost to Follow-up|0|||
161856462|NCT04895982|584514741|FG010|Overall Study|Protocol Violation|0|||
161856463|NCT04895982|584514742|FG011|Overall Study|Protocol Violation|0|||
162034286|NCT03587727|585181201|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
162034287|NCT05217927|585181204|FG000|DBT Phase|Adverse Event|7|||
162034288|NCT05217927|585181205|FG001|DBT Phase|Adverse Event|2|||
162034289|NCT05217927|585181206|FG002|DBT Phase|Adverse Event|5|||
162034290|NCT05217927|585181204|FG000|DBT Phase|Lack of Efficacy|1|||
162034291|NCT05217927|585181205|FG001|DBT Phase|Lack of Efficacy|0|||
162034292|NCT05217927|585181206|FG002|DBT Phase|Lack of Efficacy|0|||
162034293|NCT05217927|585181204|FG000|DBT Phase|Lost to Follow-up|0|||
162034294|NCT05217927|585181205|FG001|DBT Phase|Lost to Follow-up|2|||
162034295|NCT05217927|585181206|FG002|DBT Phase|Lost to Follow-up|0|||
161856464|NCT04895982|584514731|FG000|Overall Study|Lost to Follow-up|0|||
161856465|NCT04895982|584514732|FG001|Overall Study|Lost to Follow-up|0|||
161856466|NCT04895982|584514733|FG002|Overall Study|Lost to Follow-up|1|||
161856467|NCT04895982|584514734|FG003|Overall Study|Lost to Follow-up|0|||
161856468|NCT04895982|584514735|FG004|Overall Study|Lost to Follow-up|0|||
161856469|NCT04895982|584514736|FG005|Overall Study|Lost to Follow-up|1|||
161856470|NCT04895982|584514737|FG006|Overall Study|Lost to Follow-up|0|||
161856471|NCT04895982|584514738|FG007|Overall Study|Lost to Follow-up|0|||
161856472|NCT04895982|584514739|FG008|Overall Study|Lost to Follow-up|1|||
161856473|NCT04895982|584514740|FG009|Overall Study|Lost to Follow-up|0|||
161856474|NCT04895982|584514741|FG010|Overall Study|Lost to Follow-up|0|||
161975068|NCT00545532|584958398|FG000|Overall Study|Withdrawal by Subject|1|||
161975069|NCT00545532|584958399|FG001|Overall Study|Withdrawal by Subject|3|||
161975070|NCT00545532|584958398|FG000|Overall Study|Lost to Follow-up|5|||
161975071|NCT00545532|584958399|FG001|Overall Study|Lost to Follow-up|6|||
161975072|NCT00545532|584958398|FG000|Overall Study|Death|0|||
161975073|NCT00545532|584958399|FG001|Overall Study|Death|1|||
161975074|NCT00334282|584958400|FG000|Overall Study|Lost to Follow-up|11|||
161975075|NCT00334282|584958401|FG001|Overall Study|Lost to Follow-up|5|||
161975076|NCT00334282|584958400|FG000|Overall Study|Withdrawal by Subject|17|||
161975077|NCT00334282|584958401|FG001|Overall Study|Withdrawal by Subject|3|||
161975078|NCT00334282|584958400|FG000|Overall Study|Death|194|||
161975079|NCT00334282|584958401|FG001|Overall Study|Death|100|||
161975080|NCT00276094|584958406|FG000|Overall Study|Adverse Event|15|||
161975081|NCT00276094|584958407|FG001|Overall Study|Adverse Event|13|||
161975082|NCT00276094|584958408|FG002|Overall Study|Adverse Event|11|||
161975083|NCT00276094|584958406|FG000|Overall Study|Withdrawal by Subject|14|||
161975084|NCT00276094|584958407|FG001|Overall Study|Withdrawal by Subject|14|||
161975085|NCT00276094|584958408|FG002|Overall Study|Withdrawal by Subject|12|||
161975086|NCT00276094|584958406|FG000|Overall Study|Protocol Violation|16|||
161975087|NCT00276094|584958407|FG001|Overall Study|Protocol Violation|7|||
161975088|NCT00276094|584958408|FG002|Overall Study|Protocol Violation|10|||
161975089|NCT00276094|584958406|FG000|Overall Study|Lost to Follow-up|8|||
161975090|NCT00276094|584958407|FG001|Overall Study|Lost to Follow-up|6|||
161975091|NCT00276094|584958408|FG002|Overall Study|Lost to Follow-up|4|||
161975092|NCT00276094|584958406|FG000|Overall Study|Other-Subject moved out of country|1|||
161975093|NCT00276094|584958407|FG001|Overall Study|Other-Subject moved out of country|0|||
161975094|NCT00276094|584958408|FG002|Overall Study|Other-Subject moved out of country|0|||
161975095|NCT00276094|584958406|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
161975096|NCT00276094|584958407|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
161975097|NCT00276094|584958408|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
161975098|NCT00276094|584958406|FG000|Overall Study|Other-Lack of efficacy|1|||
161975099|NCT00276094|584958407|FG001|Overall Study|Other-Lack of efficacy|0|||
161975100|NCT00276094|584958408|FG002|Overall Study|Other-Lack of efficacy|0|||
161975101|NCT00276094|584958406|FG000|Overall Study|Other-Refused follow-up visit|1|||
161975102|NCT00276094|584958407|FG001|Overall Study|Other-Refused follow-up visit|0|||
161975103|NCT00276094|584958408|FG002|Overall Study|Other-Refused follow-up visit|0|||
161975104|NCT00276094|584958406|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
161975105|NCT00276094|584958407|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
161975106|NCT00276094|584958408|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
161975107|NCT00276094|584958406|FG000|Overall Study|Other-Relocation|0|||
162034296|NCT05217927|585181204|FG000|DBT Phase|Non-compliance|1|||
161975108|NCT00276094|584958407|FG001|Overall Study|Other-Relocation|1|||
161975109|NCT00276094|584958408|FG002|Overall Study|Other-Relocation|0|||
161975110|NCT00276094|584958406|FG000|Overall Study|Other-Study medication lost|0|||
162034297|NCT05217927|585181205|FG001|DBT Phase|Non-compliance|0|||
161856475|NCT04895982|584514742|FG011|Overall Study|Lost to Follow-up|0|||
161856476|NCT04895982|584514731|FG000|Overall Study|Refused further study procedures|0|||
161856477|NCT04895982|584514732|FG001|Overall Study|Refused further study procedures|0|||
161856478|NCT04895982|584514733|FG002|Overall Study|Refused further study procedures|1|||
161856479|NCT04895982|584514734|FG003|Overall Study|Refused further study procedures|0|||
161975111|NCT00276094|584958407|FG001|Overall Study|Other-Study medication lost|0|||
161975112|NCT00276094|584958408|FG002|Overall Study|Other-Study medication lost|1|||
161975113|NCT00787137|584958411|FG000|Overall Study|Study Termination|0|||
161975114|NCT00787137|584958412|FG001|Overall Study|Study Termination|0|||
161975115|NCT00787137|584958413|FG002|Overall Study|Study Termination|1|||
162034298|NCT05217927|585181206|FG002|DBT Phase|Non-compliance|0|||
162034299|NCT05217927|585181204|FG000|DBT Phase|Pregnancy|0|||
161975116|NCT00554099|584958415|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
161975117|NCT00554099|584958416|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
161975118|NCT00554099|584958417|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
161975119|NCT00554099|584958415|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
161975120|NCT00554099|584958416|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
161975121|NCT00554099|584958417|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
161975122|NCT00554099|584958415|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
161975123|NCT00554099|584958416|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161975124|NCT00554099|584958417|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
161975125|NCT00554099|584958415|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
161975126|NCT00554099|584958416|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
161975127|NCT00554099|584958417|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
161975128|NCT00554099|584958415|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
161975129|NCT00554099|584958416|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
161769182|NCT05602818|584196095|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
161769183|NCT05602818|584196096|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
161769184|NCT05602818|584196097|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
161769185|NCT03814499|584196098|FG000|Overall Study|Lost to Follow-up|3|||
161769186|NCT00598442|584196102|FG000|Overall Study|Adverse Event|3|||
161769187|NCT00598442|584196103|FG001|Overall Study|Adverse Event|0|||
161769188|NCT00598442|584196104|FG002|Overall Study|Adverse Event|0|||
161769189|NCT00598442|584196102|FG000|Overall Study|Death|19|||
161769190|NCT00598442|584196103|FG001|Overall Study|Death|11|||
161769191|NCT00598442|584196104|FG002|Overall Study|Death|11|||
161769192|NCT00598442|584196102|FG000|Overall Study|Lost to Follow-up|4|||
161769193|NCT00598442|584196103|FG001|Overall Study|Lost to Follow-up|3|||
161769194|NCT00598442|584196104|FG002|Overall Study|Lost to Follow-up|3|||
161769195|NCT00598442|584196102|FG000|Overall Study|Physician Decision|2|||
161769196|NCT00598442|584196103|FG001|Overall Study|Physician Decision|1|||
161769197|NCT00598442|584196104|FG002|Overall Study|Physician Decision|1|||
161769198|NCT00598442|584196102|FG000|Overall Study|Withdrawal by Subject|8|||
161769199|NCT00598442|584196103|FG001|Overall Study|Withdrawal by Subject|16|||
161769200|NCT00598442|584196104|FG002|Overall Study|Withdrawal by Subject|6|||
161769201|NCT00598442|584196102|FG000|Overall Study|Noncompliance|0|||
161769202|NCT00598442|584196103|FG001|Overall Study|Noncompliance|2|||
161769203|NCT00598442|584196104|FG002|Overall Study|Noncompliance|1|||
161769204|NCT00598442|584196102|FG000|Overall Study|Relocation|1|||
161769205|NCT00598442|584196103|FG001|Overall Study|Relocation|4|||
161769206|NCT00598442|584196104|FG002|Overall Study|Relocation|0|||
161769207|NCT00598442|584196102|FG000|Overall Study|Renal transplant|0|||
161769208|NCT00598442|584196103|FG001|Overall Study|Renal transplant|0|||
161769209|NCT00598442|584196104|FG002|Overall Study|Renal transplant|1|||
161769210|NCT00598442|584196102|FG000|Overall Study|Site closed by sponsor|5|||
161769211|NCT00598442|584196103|FG001|Overall Study|Site closed by sponsor|2|||
161769212|NCT00598442|584196104|FG002|Overall Study|Site closed by sponsor|1|||
161769213|NCT00598442|584196102|FG000|Overall Study|Started dialysis|1|||
161769214|NCT00598442|584196103|FG001|Overall Study|Started dialysis|0|||
161769215|NCT00598442|584196104|FG002|Overall Study|Started dialysis|0|||
161769216|NCT00229931|584196117|FG000|Overall Study|Death|1|||
161769217|NCT00229931|584196118|FG001|Overall Study|Death|0|||
161769218|NCT00229931|584196117|FG000|Overall Study|Lost to Follow-up|3|||
161769219|NCT00229931|584196118|FG001|Overall Study|Lost to Follow-up|2|||
161769220|NCT02992743|584196119|FG000|Overall Study|Withdrawal by Subject|1|||
161769221|NCT02992743|584196120|FG001|Overall Study|Withdrawal by Subject|1|||
161769222|NCT02992743|584196119|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
161769223|NCT02992743|584196120|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
161769224|NCT02992743|584196119|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
161769225|NCT02992743|584196120|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
161769226|NCT02992743|584196119|FG000|Overall Study|No measurable disease|1|||
161769227|NCT02992743|584196120|FG001|Overall Study|No measurable disease|0|||
161769228|NCT02992743|584196119|FG000|Overall Study|Lost to Follow-up|0|||
161769229|NCT02992743|584196120|FG001|Overall Study|Lost to Follow-up|1|||
161769230|NCT00381680|584196121|FG000|Overall Study|Adverse Event|9|||
161769231|NCT00381680|584196122|FG001|Overall Study|Adverse Event|3|||
161769232|NCT00381680|584196121|FG000|Overall Study|Death|10|||
161769233|NCT00381680|584196122|FG001|Overall Study|Death|7|||
161769234|NCT00381680|584196121|FG000|Overall Study|Lost to Follow-up|3|||
161769235|NCT00381680|584196122|FG001|Overall Study|Lost to Follow-up|2|||
161769236|NCT00381680|584196121|FG000|Overall Study|Physician Decision|25|||
161769237|NCT00381680|584196122|FG001|Overall Study|Physician Decision|6|||
161769238|NCT00381680|584196121|FG000|Overall Study|Withdrawal by Subject|3|||
161769239|NCT00381680|584196122|FG001|Overall Study|Withdrawal by Subject|1|||
161769240|NCT00381680|584196121|FG000|Overall Study|Entry onto another COG Trial|1|||
161769241|NCT00381680|584196122|FG001|Overall Study|Entry onto another COG Trial|2|||
161769242|NCT00381680|584196121|FG000|Overall Study|Alternative Therapy|11|||
161769243|NCT00381680|584196122|FG001|Overall Study|Alternative Therapy|5|||
161769244|NCT00381680|584196121|FG000|Overall Study|Secondary Malignancy|3|||
161856480|NCT04895982|584514735|FG004|Overall Study|Refused further study procedures|0|||
161856481|NCT04895982|584514736|FG005|Overall Study|Refused further study procedures|0|||
161856482|NCT04895982|584514737|FG006|Overall Study|Refused further study procedures|0|||
161856483|NCT04895982|584514738|FG007|Overall Study|Refused further study procedures|0|||
161856484|NCT04895982|584514739|FG008|Overall Study|Refused further study procedures|0|||
161856485|NCT04895982|584514740|FG009|Overall Study|Refused further study procedures|0|||
161856486|NCT04895982|584514741|FG010|Overall Study|Refused further study procedures|0|||
161856487|NCT04895982|584514742|FG011|Overall Study|Refused further study procedures|0|||
161856488|NCT02517463|584514748|FG000|Overall Study|Lost to Follow-up|5|||
161856489|NCT02517463|584514749|FG001|Overall Study|Lost to Follow-up|2|||
161856490|NCT02296931|584514756|FG000|Overall Study|Protocol Violation|0|||
161856491|NCT02296931|584514757|FG001|Overall Study|Protocol Violation|2|||
161856492|NCT02603146|584517097|FG000|Overall Study|Lost to Follow-up|5|||
161856493|NCT02603146|584517098|FG001|Overall Study|Lost to Follow-up|6|||
161856494|NCT02603146|584517097|FG000|Overall Study|Withdrawal by Subject|8|||
161856495|NCT02603146|584517098|FG001|Overall Study|Withdrawal by Subject|10|||
161856496|NCT02603146|584517097|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
161856497|NCT02603146|584517098|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
161856498|NCT02603146|584517097|FG000|Overall Study|Participant moved|2|||
161856499|NCT02603146|584517098|FG001|Overall Study|Participant moved|0|||
161856500|NCT02603146|584517097|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
161856501|NCT02603146|584517098|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
161856502|NCT05221320|584517102|FG000|Overall Study|Lack of Efficacy|3|||
161856503|NCT05221320|584517103|FG001|Overall Study|Lack of Efficacy|7|||
161856504|NCT05221320|584517104|FG002|Overall Study|Lack of Efficacy|10|||
161856505|NCT05221320|584517105|FG003|Overall Study|Lack of Efficacy|1|||
161856506|NCT05221320|584517106|FG004|Overall Study|Lack of Efficacy|0|||
161856507|NCT05221320|584517107|FG005|Overall Study|Lack of Efficacy|0|||
161856508|NCT05221320|584517102|FG000|Overall Study|Physician Decision|1|||
161856509|NCT05221320|584517103|FG001|Overall Study|Physician Decision|0|||
161856510|NCT05221320|584517104|FG002|Overall Study|Physician Decision|3|||
161856511|NCT05221320|584517105|FG003|Overall Study|Physician Decision|1|||
161856512|NCT05221320|584517106|FG004|Overall Study|Physician Decision|0|||
161856513|NCT05221320|584517107|FG005|Overall Study|Physician Decision|0|||
161856514|NCT05221320|584517102|FG000|Overall Study|Withdrawal by Subject|0|||
161856515|NCT05221320|584517103|FG001|Overall Study|Withdrawal by Subject|3|||
161856516|NCT05221320|584517104|FG002|Overall Study|Withdrawal by Subject|1|||
161856517|NCT05221320|584517105|FG003|Overall Study|Withdrawal by Subject|0|||
161856518|NCT05221320|584517106|FG004|Overall Study|Withdrawal by Subject|0|||
161856519|NCT05221320|584517107|FG005|Overall Study|Withdrawal by Subject|0|||
161856520|NCT05221320|584517102|FG000|Overall Study|Death|0|||
161856521|NCT05221320|584517103|FG001|Overall Study|Death|5|||
161856522|NCT05221320|584517104|FG002|Overall Study|Death|6|||
161856523|NCT05221320|584517105|FG003|Overall Study|Death|0|||
161856524|NCT05221320|584517106|FG004|Overall Study|Death|1|||
161856525|NCT05221320|584517107|FG005|Overall Study|Death|0|||
161856526|NCT05016960|584517108|FG000|Overall Study|Withdrawal by Subject|1|||
161856527|NCT05016960|584517109|FG001|Overall Study|Withdrawal by Subject|9|||
161856528|NCT03300817|584517115|FG000|Overall Study|Withdrawal by Subject|1|||
161856529|NCT03300817|584517115|FG000|Overall Study|Adverse Event|1|||
161856530|NCT03300817|584517115|FG000|Overall Study|Subject Found to be Ineligible|2|||
161856531|NCT03729596|584517118|FG000|Overall Study|Death|3|||
161856532|NCT03729596|584517119|FG001|Overall Study|Death|5|||
161856533|NCT03729596|584517120|FG002|Overall Study|Death|4|||
161856534|NCT03729596|584517121|FG003|Overall Study|Death|1|||
161856535|NCT03729596|584517122|FG004|Overall Study|Death|0|||
161856536|NCT03729596|584517123|FG005|Overall Study|Death|34|||
161856537|NCT03729596|584517124|FG006|Overall Study|Death|18|||
161856538|NCT03729596|584517125|FG007|Overall Study|Death|14|||
161856539|NCT03729596|584517126|FG008|Overall Study|Death|19|||
161856540|NCT03729596|584517127|FG009|Overall Study|Death|9|||
161856541|NCT03729596|584517118|FG000|Overall Study|Lost to Follow-up|0|||
161856542|NCT03729596|584517119|FG001|Overall Study|Lost to Follow-up|0|||
161856543|NCT03729596|584517120|FG002|Overall Study|Lost to Follow-up|0|||
161856544|NCT03729596|584517121|FG003|Overall Study|Lost to Follow-up|0|||
161856545|NCT03729596|584517122|FG004|Overall Study|Lost to Follow-up|0|||
161856546|NCT03729596|584517123|FG005|Overall Study|Lost to Follow-up|0|||
161856547|NCT03729596|584517124|FG006|Overall Study|Lost to Follow-up|1|||
161856548|NCT03729596|584517125|FG007|Overall Study|Lost to Follow-up|0|||
161856549|NCT03729596|584517126|FG008|Overall Study|Lost to Follow-up|0|||
161856550|NCT03729596|584517127|FG009|Overall Study|Lost to Follow-up|1|||
161856551|NCT03729596|584517118|FG000|Overall Study|protocol amendment|0|||
161856552|NCT03729596|584517119|FG001|Overall Study|protocol amendment|1|||
161856553|NCT03729596|584517120|FG002|Overall Study|protocol amendment|3|||
161856554|NCT03729596|584517121|FG003|Overall Study|protocol amendment|6|||
161856555|NCT03729596|584517122|FG004|Overall Study|protocol amendment|5|||
161856556|NCT03729596|584517123|FG005|Overall Study|protocol amendment|0|||
161856557|NCT03729596|584517124|FG006|Overall Study|protocol amendment|0|||
161856558|NCT03729596|584517125|FG007|Overall Study|protocol amendment|0|||
161975130|NCT00554099|584958417|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
161975131|NCT00554099|584958415|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
161975132|NCT00554099|584958416|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
161975133|NCT00554099|584958417|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
161975134|NCT00554099|584958415|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
161975135|NCT00554099|584958416|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
161975136|NCT00554099|584958417|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
161975137|NCT00554099|584958415|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
161975138|NCT00554099|584958416|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
161975139|NCT00554099|584958417|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
161769245|NCT00381680|584196122|FG001|Overall Study|Secondary Malignancy|0|||
161769246|NCT00381680|584196121|FG000|Overall Study|Delay initiation|1|||
161769247|NCT00381680|584196122|FG001|Overall Study|Delay initiation|0|||
161769248|NCT00381680|584196121|FG000|Overall Study|Stem Cell Transplant|26|||
161769249|NCT00381680|584196122|FG001|Overall Study|Stem Cell Transplant|10|||
161769250|NCT00381680|584196121|FG000|Overall Study|Relapse|18|||
161769251|NCT00381680|584196122|FG001|Overall Study|Relapse|9|||
161769252|NCT00381680|584196121|FG000|Overall Study|Induction Failure|4|||
161769253|NCT00381680|584196122|FG001|Overall Study|Induction Failure|1|||
161769254|NCT00381680|584196121|FG000|Overall Study|Progression|1|||
161769255|NCT00381680|584196122|FG001|Overall Study|Progression|1|||
161769256|NCT00381680|584196121|FG000|Overall Study|Other not otherwise specified|7|||
161769257|NCT00381680|584196122|FG001|Overall Study|Other not otherwise specified|2|||
161769258|NCT00381680|584196121|FG000|Overall Study|Ineligible|3|||
161769259|NCT00381680|584196122|FG001|Overall Study|Ineligible|1|||
161769260|NCT03290131|584196125|FG000|Overall Study|Adverse Event|22|||
161769261|NCT03290131|584196126|FG001|Overall Study|Adverse Event|57|||
161769262|NCT03290131|584196127|FG002|Overall Study|Adverse Event|11|||
161769263|NCT03290131|584196125|FG000|Overall Study|Withdrawal by Subject|18|||
161769264|NCT03290131|584196126|FG001|Overall Study|Withdrawal by Subject|13|||
161769265|NCT03290131|584196127|FG002|Overall Study|Withdrawal by Subject|8|||
161769266|NCT03290131|584196125|FG000|Overall Study|MS Relapse|2|||
161769267|NCT03290131|584196126|FG001|Overall Study|MS Relapse|1|||
161769268|NCT03290131|584196127|FG002|Overall Study|MS Relapse|0|||
161769269|NCT03290131|584196125|FG000|Overall Study|Unknown reason|0|||
161769270|NCT03290131|584196126|FG001|Overall Study|Unknown reason|1|||
161769271|NCT03290131|584196127|FG002|Overall Study|Unknown reason|0|||
161769272|NCT03099096|584196128|FG000|Overall Study|Adverse Event|1|||
161769273|NCT03099096|584196128|FG000|Overall Study|Physician Decision|1|||
161769274|NCT00361504|584196131|FG000|Overall Study|Withdrawal by Subject|94|||
161769275|NCT00361504|584196132|FG001|Overall Study|Withdrawal by Subject|31|||
161769276|NCT00361504|584196131|FG000|Overall Study|Lost to Follow-up|40|||
161769277|NCT00361504|584196132|FG001|Overall Study|Lost to Follow-up|7|||
161769278|NCT00361504|584196131|FG000|Overall Study|Adverse Event|203|||
161769279|NCT00361504|584196132|FG001|Overall Study|Adverse Event|82|||
161769280|NCT00361504|584196131|FG000|Overall Study|Lack of Efficacy|72|||
161769281|NCT00361504|584196132|FG001|Overall Study|Lack of Efficacy|7|||
161769282|NCT00361504|584196131|FG000|Overall Study|Resolution of Pain|2|||
161769283|NCT00361504|584196132|FG001|Overall Study|Resolution of Pain|0|||
161769284|NCT00361504|584196131|FG000|Overall Study|Study medication non compliant|42|||
161769285|NCT00361504|584196132|FG001|Overall Study|Study medication non compliant|15|||
161769286|NCT00361504|584196131|FG000|Overall Study|All other|28|||
161769287|NCT00361504|584196132|FG001|Overall Study|All other|3|||
161769288|NCT03764813|584196134|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
161769289|NCT03764813|584196135|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
161769290|NCT03764813|584196136|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
161769291|NCT03764813|584196137|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
161769292|NCT01374516|584196139|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
161769293|NCT01374516|584196140|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
161769294|NCT01374516|584196139|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
161769295|NCT01374516|584196140|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
161769296|NCT01374516|584196139|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
161769297|NCT01374516|584196140|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
161769298|NCT01374516|584196139|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
161769299|NCT01374516|584196140|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
161769300|NCT01374516|584196139|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
161769301|NCT01374516|584196140|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
161769302|NCT01374516|584196139|FG000|Surveillance Expansion Period|Protocol Violation|386|||
161769303|NCT01374516|584196140|FG001|Surveillance Expansion Period|Protocol Violation|217|||
161769304|NCT01374516|584196139|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
161975140|NCT00554099|584958415|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
161769305|NCT01374516|584196140|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
161769306|NCT01374516|584196139|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
161769307|NCT01374516|584196140|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
161975141|NCT00554099|584958416|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
161975142|NCT00554099|584958417|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
161975143|NCT02075632|584958418|FG000|Overall Study|Adverse Event|1|||
161975144|NCT02075632|584958419|FG001|Overall Study|Adverse Event|1|||
161975145|NCT02075632|584958418|FG000|Overall Study|Lost to Follow-up|0|||
161975146|NCT02075632|584958419|FG001|Overall Study|Lost to Follow-up|3|||
161975147|NCT02075632|584958418|FG000|Overall Study|Withdrawal by Subject|0|||
161975148|NCT02075632|584958419|FG001|Overall Study|Withdrawal by Subject|1|||
161975149|NCT04957758|584958427|FG000|Overall Study|Adverse Event|1|||
161975150|NCT04957758|584958428|FG001|Overall Study|Adverse Event|0|||
161975151|NCT04957758|584958427|FG000|Overall Study|Lost to Follow-up|0|||
161975152|NCT04957758|584958428|FG001|Overall Study|Lost to Follow-up|2|||
161975153|NCT04957758|584958427|FG000|Overall Study|Withdrawal by Subject|4|||
161975154|NCT04957758|584958428|FG001|Overall Study|Withdrawal by Subject|2|||
161975155|NCT04957758|584958427|FG000|Overall Study|Protocol Violation|0|||
161975156|NCT04957758|584958428|FG001|Overall Study|Protocol Violation|1|||
161975157|NCT03353922|584958429|FG000|Overall Study|Withdrawal by Subject|1|||
161856559|NCT03729596|584517126|FG008|Overall Study|protocol amendment|0|||
161856560|NCT03729596|584517127|FG009|Overall Study|protocol amendment|0|||
161856561|NCT03729596|584517118|FG000|Overall Study|Withdrawal by Subject|0|||
161856562|NCT03729596|584517119|FG001|Overall Study|Withdrawal by Subject|0|||
161856563|NCT03729596|584517120|FG002|Overall Study|Withdrawal by Subject|0|||
161856564|NCT03729596|584517121|FG003|Overall Study|Withdrawal by Subject|0|||
161856565|NCT03729596|584517122|FG004|Overall Study|Withdrawal by Subject|0|||
161856566|NCT03729596|584517123|FG005|Overall Study|Withdrawal by Subject|4|||
161856567|NCT03729596|584517124|FG006|Overall Study|Withdrawal by Subject|2|||
161856568|NCT03729596|584517125|FG007|Overall Study|Withdrawal by Subject|3|||
161856569|NCT03729596|584517126|FG008|Overall Study|Withdrawal by Subject|2|||
161856570|NCT03729596|584517127|FG009|Overall Study|Withdrawal by Subject|3|||
161856571|NCT03729596|584517118|FG000|Overall Study|study terminated by sponsor|0|||
161856572|NCT03729596|584517119|FG001|Overall Study|study terminated by sponsor|0|||
161856573|NCT03729596|584517120|FG002|Overall Study|study terminated by sponsor|0|||
161856574|NCT03729596|584517121|FG003|Overall Study|study terminated by sponsor|0|||
161856575|NCT03729596|584517122|FG004|Overall Study|study terminated by sponsor|1|||
161856576|NCT03729596|584517123|FG005|Overall Study|study terminated by sponsor|3|||
161856577|NCT03729596|584517124|FG006|Overall Study|study terminated by sponsor|0|||
161856578|NCT03729596|584517125|FG007|Overall Study|study terminated by sponsor|1|||
161856579|NCT03729596|584517126|FG008|Overall Study|study terminated by sponsor|0|||
161856580|NCT03729596|584517127|FG009|Overall Study|study terminated by sponsor|0|||
161856581|NCT03713593|584517128|FG000|Overall Study|Sponsor Decision|73|||
161856582|NCT03713593|584517129|FG001|Overall Study|Sponsor Decision|41|||
161856583|NCT03713593|584517128|FG000|Overall Study|Lost to Follow-up|2|||
161856584|NCT03713593|584517129|FG001|Overall Study|Lost to Follow-up|1|||
161975158|NCT03353922|584958430|FG001|Overall Study|Withdrawal by Subject|0|||
161975159|NCT03353922|584958431|FG002|Overall Study|Withdrawal by Subject|1|||
161975160|NCT03353922|584958432|FG003|Overall Study|Withdrawal by Subject|1|||
161975161|NCT03353922|584958433|FG004|Overall Study|Withdrawal by Subject|0|||
161975162|NCT03353922|584958434|FG005|Overall Study|Withdrawal by Subject|0|||
161975163|NCT03353922|584958429|FG000|Overall Study|Adverse Event|0|||
161975164|NCT03353922|584958430|FG001|Overall Study|Adverse Event|1|||
161975165|NCT03353922|584958431|FG002|Overall Study|Adverse Event|0|||
161975166|NCT03353922|584958432|FG003|Overall Study|Adverse Event|0|||
161975167|NCT03353922|584958433|FG004|Overall Study|Adverse Event|0|||
161975168|NCT03353922|584958434|FG005|Overall Study|Adverse Event|0|||
161975169|NCT00740714|584958435|FG000|Overall Study|Withdrawal by Subject|17|||
161975170|NCT00740714|584958436|FG001|Overall Study|Withdrawal by Subject|19|||
161975171|NCT00740714|584958437|FG002|Overall Study|Withdrawal by Subject|29|||
161975172|NCT03688555|584958438|FG000|Treatment Period|Adverse Event|0|||
161975173|NCT03688555|584958439|FG001|Treatment Period|Adverse Event|0|||
161975174|NCT03688555|584958440|FG002|Treatment Period|Adverse Event|1|||
161975175|NCT00886119|584958444|FG000|Period 1|Did not meet inclusion criteria|1|||
161975176|NCT00886119|584958445|FG001|Period 1|Did not meet inclusion criteria|0|||
161975177|NCT00394901|584958446|FG000|Baseline Phase|Protocol Violation|0|||
161975178|NCT00394901|584958447|FG001|Baseline Phase|Protocol Violation|0|||
161975179|NCT00394901|584958448|FG002|Baseline Phase|Protocol Violation|1|||
161975180|NCT00394901|584958449|FG003|Baseline Phase|Protocol Violation|0|||
162034300|NCT05217927|585181205|FG001|DBT Phase|Pregnancy|0|||
161856585|NCT03713593|584517128|FG000|Overall Study|Death|314|||
161856586|NCT03713593|584517129|FG001|Overall Study|Death|349|||
161856587|NCT03713593|584517128|FG000|Overall Study|Withdrawal by Subject|6|||
161856588|NCT03713593|584517129|FG001|Overall Study|Withdrawal by Subject|8|||
161856589|NCT05126693|584517130|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
161856590|NCT05126693|584517131|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
161856591|NCT05126693|584517130|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
161975181|NCT00394901|584958446|FG000|Double-blind Phase|Adverse Event|5|||
161856592|NCT05126693|584517131|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
161975182|NCT00394901|584958447|FG001|Double-blind Phase|Adverse Event|7|||
161975183|NCT00394901|584958448|FG002|Double-blind Phase|Adverse Event|16|||
161975184|NCT00394901|584958449|FG003|Double-blind Phase|Adverse Event|20|||
161975185|NCT00394901|584958446|FG000|Double-blind Phase|Lack of Efficacy|6|||
161975186|NCT00394901|584958447|FG001|Double-blind Phase|Lack of Efficacy|4|||
161769308|NCT01374516|584196139|FG000|Surveillance Expansion Period|Serious adverse event|20|||
161769309|NCT01374516|584196140|FG001|Surveillance Expansion Period|Serious adverse event|5|||
161769310|NCT00450814|584196148|FG000|Overall Study|Failed to complete the initial therapy|0|||
161769311|NCT00450814|584196149|FG001|Overall Study|Failed to complete the initial therapy|0|||
161769312|NCT00450814|584196150|FG002|Overall Study|Failed to complete the initial therapy|0|||
161769313|NCT00450814|584196151|FG003|Overall Study|Failed to complete the initial therapy|1|||
161769314|NCT00450814|584196152|FG004|Overall Study|Failed to complete the initial therapy|1|||
161769315|NCT00450814|584196153|FG005|Overall Study|Failed to complete the initial therapy|1|||
161769316|NCT00450814|584196154|FG006|Overall Study|Failed to complete the initial therapy|0|||
161769317|NCT00450814|584196155|FG007|Overall Study|Failed to complete the initial therapy|0|||
161769318|NCT00450814|584196156|FG008|Overall Study|Failed to complete the initial therapy|0|||
161769319|NCT00450814|584196157|FG009|Overall Study|Failed to complete the initial therapy|0|||
161769320|NCT00450814|584196158|FG010|Overall Study|Failed to complete the initial therapy|0|||
161769321|NCT00450814|584196148|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
161769322|NCT00450814|584196149|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
161769323|NCT00450814|584196150|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
161769324|NCT00450814|584196151|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
161769325|NCT00450814|584196152|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
161769326|NCT00450814|584196153|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
161769327|NCT00450814|584196154|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
161769328|NCT00450814|584196155|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
161769329|NCT00450814|584196156|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
161769330|NCT00450814|584196157|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
161769331|NCT00450814|584196158|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
161769332|NCT03602976|584196163|FG000|Overall Study|Withdrawal by Subject|1|||
161769333|NCT04837807|584196164|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
161769334|NCT04837807|584196165|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
161769335|NCT04629534|584196166|FG000|Overall Study|Physician Decision|1|||
161769336|NCT04629534|584196167|FG001|Overall Study|Physician Decision|0|||
161769337|NCT04629534|584196166|FG000|Overall Study|Protocol Violation|0|||
161769338|NCT04629534|584196167|FG001|Overall Study|Protocol Violation|2|||
161769339|NCT01757821|584196170|FG000|Overall Study|Adverse Event|1|||
161769340|NCT00334893|584196171|FG000|Overall Study|Not Treated|1|||
161769341|NCT00334893|584196172|FG001|Overall Study|Not Treated|0|||
161769342|NCT03556202|584196173|FG000|Extension Treatment Period|Adverse Event|18|||
161769343|NCT03556202|584196174|FG001|Extension Treatment Period|Adverse Event|14|||
161769344|NCT03556202|584196175|FG002|Extension Treatment Period|Adverse Event|9|||
161769345|NCT03556202|584196173|FG000|Extension Treatment Period|Death|2|||
161769346|NCT03556202|584196174|FG001|Extension Treatment Period|Death|6|||
161769347|NCT03556202|584196175|FG002|Extension Treatment Period|Death|0|||
161769348|NCT03556202|584196173|FG000|Extension Treatment Period|Lack of Efficacy|5|||
161769349|NCT03556202|584196174|FG001|Extension Treatment Period|Lack of Efficacy|12|||
161769350|NCT03556202|584196175|FG002|Extension Treatment Period|Lack of Efficacy|18|||
161769351|NCT03556202|584196173|FG000|Extension Treatment Period|Lost to Follow-up|9|||
161769352|NCT03556202|584196174|FG001|Extension Treatment Period|Lost to Follow-up|20|||
161769353|NCT03556202|584196175|FG002|Extension Treatment Period|Lost to Follow-up|2|||
161769354|NCT03556202|584196173|FG000|Extension Treatment Period|Pregnancy|2|||
161769355|NCT03556202|584196174|FG001|Extension Treatment Period|Pregnancy|4|||
161769356|NCT03556202|584196175|FG002|Extension Treatment Period|Pregnancy|3|||
161769357|NCT03556202|584196173|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
161769358|NCT03556202|584196174|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
161769359|NCT03556202|584196175|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
161769360|NCT03556202|584196173|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
161769361|NCT03556202|584196174|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
161769362|NCT03556202|584196175|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
161769363|NCT03556202|584196173|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
161769364|NCT03556202|584196174|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
161769365|NCT03556202|584196175|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
161769366|NCT03556202|584196173|FG000|Extension Treatment Period|Physician Decision|0|||
161769367|NCT03556202|584196174|FG001|Extension Treatment Period|Physician Decision|8|||
161769368|NCT03556202|584196175|FG002|Extension Treatment Period|Physician Decision|2|||
161769369|NCT03556202|584196173|FG000|Extension Treatment Period|Protocol Violation|0|||
161769370|NCT03556202|584196174|FG001|Extension Treatment Period|Protocol Violation|1|||
161769371|NCT03556202|584196175|FG002|Extension Treatment Period|Protocol Violation|1|||
161769372|NCT03556202|584196173|FG000|Extension Treatment Period|Sponsor Decision|0|||
161975187|NCT00394901|584958448|FG002|Double-blind Phase|Lack of Efficacy|1|||
161975188|NCT00394901|584958449|FG003|Double-blind Phase|Lack of Efficacy|3|||
161856593|NCT05126693|584517130|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
161856594|NCT05126693|584517131|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
161856595|NCT03631199|584517136|FG000|Overall Study|Progressive disease|9|||
161856596|NCT03631199|584517137|FG001|Overall Study|Progressive disease|5|||
161856597|NCT03631199|584517138|FG002|Overall Study|Progressive disease|5|||
161856598|NCT03631199|584517139|FG003|Overall Study|Progressive disease|149|||
161856599|NCT03631199|584517140|FG004|Overall Study|Progressive disease|148|||
161856600|NCT03631199|584517136|FG000|Overall Study|Physician Decision|0|||
162034301|NCT05217927|585181206|FG002|DBT Phase|Pregnancy|1|||
161856601|NCT03631199|584517137|FG001|Overall Study|Physician Decision|2|||
161856602|NCT03631199|584517138|FG002|Overall Study|Physician Decision|3|||
161856603|NCT03631199|584517139|FG003|Overall Study|Physician Decision|19|||
161856604|NCT03631199|584517140|FG004|Overall Study|Physician Decision|13|||
161856605|NCT03631199|584517136|FG000|Overall Study|Adverse Event|1|||
161856606|NCT03631199|584517137|FG001|Overall Study|Adverse Event|1|||
161856607|NCT03631199|584517138|FG002|Overall Study|Adverse Event|0|||
161856608|NCT03631199|584517139|FG003|Overall Study|Adverse Event|28|||
161856609|NCT03631199|584517140|FG004|Overall Study|Adverse Event|29|||
161856610|NCT03631199|584517136|FG000|Overall Study|Death|0|||
161856611|NCT03631199|584517137|FG001|Overall Study|Death|1|||
161856612|NCT03631199|584517138|FG002|Overall Study|Death|0|||
161856613|NCT03631199|584517139|FG003|Overall Study|Death|35|||
161856614|NCT03631199|584517140|FG004|Overall Study|Death|48|||
161856615|NCT03631199|584517136|FG000|Overall Study|Subject decision|0|||
161856616|NCT03631199|584517137|FG001|Overall Study|Subject decision|1|||
161856617|NCT03631199|584517138|FG002|Overall Study|Subject decision|0|||
161856618|NCT03631199|584517139|FG003|Overall Study|Subject decision|12|||
161856619|NCT03631199|584517140|FG004|Overall Study|Subject decision|12|||
161856620|NCT03631199|584517136|FG000|Overall Study|No treated|0|||
161856621|NCT03631199|584517137|FG001|Overall Study|No treated|0|||
161856622|NCT03631199|584517138|FG002|Overall Study|No treated|0|||
161856623|NCT03631199|584517139|FG003|Overall Study|No treated|0|||
161856624|NCT03631199|584517140|FG004|Overall Study|No treated|1|||
161856625|NCT03631199|584517136|FG000|Overall Study|Treatment ongoing|0|||
161856626|NCT03631199|584517137|FG001|Overall Study|Treatment ongoing|1|||
161856627|NCT03631199|584517138|FG002|Overall Study|Treatment ongoing|1|||
161856628|NCT03631199|584517139|FG003|Overall Study|Treatment ongoing|76|||
161856629|NCT03631199|584517140|FG004|Overall Study|Treatment ongoing|71|||
161856630|NCT03631199|584517136|FG000|Overall Study|Guardian decision|0|||
161856631|NCT03631199|584517137|FG001|Overall Study|Guardian decision|0|||
161856632|NCT03631199|584517138|FG002|Overall Study|Guardian decision|0|||
161856633|NCT03631199|584517139|FG003|Overall Study|Guardian decision|1|||
161856634|NCT03631199|584517140|FG004|Overall Study|Guardian decision|1|||
161856635|NCT03999996|584517141|FG000|Prior to Booster|Adverse Event|2|||
161856636|NCT03999996|584517142|FG001|Prior to Booster|Adverse Event|0|||
161856637|NCT03999996|584517143|FG002|Prior to Booster|Adverse Event|0|||
161856638|NCT03999996|584517144|FG003|Prior to Booster|Adverse Event|0|||
161856639|NCT03999996|584517141|FG000|Prior to Booster|Lost to Follow-up|17|||
161856640|NCT03999996|584517142|FG001|Prior to Booster|Lost to Follow-up|22|||
161856641|NCT03999996|584517143|FG002|Prior to Booster|Lost to Follow-up|0|||
161856642|NCT03999996|584517144|FG003|Prior to Booster|Lost to Follow-up|0|||
161856643|NCT03999996|584517141|FG000|Prior to Booster|Withdrawal of Consent|51|||
161856644|NCT03999996|584517142|FG001|Prior to Booster|Withdrawal of Consent|8|||
161856645|NCT03999996|584517143|FG002|Prior to Booster|Withdrawal of Consent|0|||
161856646|NCT03999996|584517144|FG003|Prior to Booster|Withdrawal of Consent|0|||
161856647|NCT03999996|584517141|FG000|Prior to Booster|Death|0|||
161856648|NCT03999996|584517142|FG001|Prior to Booster|Death|1|||
161856649|NCT03999996|584517143|FG002|Prior to Booster|Death|0|||
161856650|NCT03999996|584517144|FG003|Prior to Booster|Death|0|||
161856651|NCT03999996|584517141|FG000|Prior to Booster|Reason Not Specified|27|||
161856652|NCT03999996|584517142|FG001|Prior to Booster|Reason Not Specified|4|||
161856653|NCT03999996|584517143|FG002|Prior to Booster|Reason Not Specified|0|||
161856654|NCT03999996|584517144|FG003|Prior to Booster|Reason Not Specified|0|||
162034302|NCT05217927|585181204|FG000|DBT Phase|Protocol Violation|0|||
161856655|NCT03999996|584517141|FG000|Booster Phase|Lost to Follow-up|0|||
161856656|NCT03999996|584517142|FG001|Booster Phase|Lost to Follow-up|0|||
161856657|NCT03999996|584517143|FG002|Booster Phase|Lost to Follow-up|3|||
161856658|NCT03999996|584517144|FG003|Booster Phase|Lost to Follow-up|3|||
161856659|NCT03999996|584517141|FG000|Booster Phase|Withdrawal of Consent|0|||
161856660|NCT03999996|584517142|FG001|Booster Phase|Withdrawal of Consent|0|||
161856661|NCT03999996|584517143|FG002|Booster Phase|Withdrawal of Consent|0|||
161856662|NCT03999996|584517144|FG003|Booster Phase|Withdrawal of Consent|1|||
161856663|NCT03999996|584517141|FG000|Booster Phase|Reason Not Specified|0|||
161856664|NCT03999996|584517142|FG001|Booster Phase|Reason Not Specified|0|||
161856665|NCT03999996|584517143|FG002|Booster Phase|Reason Not Specified|0|||
161856666|NCT03999996|584517144|FG003|Booster Phase|Reason Not Specified|1|||
161856667|NCT03690388|584517145|FG000|Overall Study|Adverse Event|8|||
161856668|NCT03690388|584517146|FG001|Overall Study|Adverse Event|1|||
161856669|NCT03690388|584517145|FG000|Overall Study|Radiographic Progression|14|||
161856670|NCT03690388|584517146|FG001|Overall Study|Radiographic Progression|29|||
161975189|NCT00394901|584958446|FG000|Double-blind Phase|Withdrawal by Subject|2|||
161975190|NCT00394901|584958447|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161975191|NCT00394901|584958448|FG002|Double-blind Phase|Withdrawal by Subject|0|||
161975192|NCT00394901|584958449|FG003|Double-blind Phase|Withdrawal by Subject|0|||
161975193|NCT00394901|584958446|FG000|Double-blind Phase|Lost to Follow-up|0|||
161975194|NCT00394901|584958447|FG001|Double-blind Phase|Lost to Follow-up|0|||
161975195|NCT00394901|584958448|FG002|Double-blind Phase|Lost to Follow-up|0|||
161975196|NCT00394901|584958449|FG003|Double-blind Phase|Lost to Follow-up|1|||
161975197|NCT00394901|584958446|FG000|Double-blind Phase|Protocol Violation|0|||
161975198|NCT00394901|584958447|FG001|Double-blind Phase|Protocol Violation|0|||
161975199|NCT00394901|584958448|FG002|Double-blind Phase|Protocol Violation|0|||
161975200|NCT00394901|584958449|FG003|Double-blind Phase|Protocol Violation|1|||
161975201|NCT00394901|584958446|FG000|Double-blind Phase|Death|1|||
161975202|NCT00394901|584958447|FG001|Double-blind Phase|Death|0|||
161856671|NCT03690388|584517145|FG000|Overall Study|Clinical deterioration|10|||
161856672|NCT03690388|584517146|FG001|Overall Study|Clinical deterioration|6|||
161856673|NCT03690388|584517145|FG000|Overall Study|Withdrawal by Subject|2|||
161856674|NCT03690388|584517146|FG001|Overall Study|Withdrawal by Subject|0|||
161856675|NCT03690388|584517145|FG000|Overall Study|Lack of Efficacy|1|||
161856676|NCT03690388|584517146|FG001|Overall Study|Lack of Efficacy|0|||
161856677|NCT03690388|584517145|FG000|Overall Study|Lost to Follow-up|1|||
161856678|NCT03690388|584517146|FG001|Overall Study|Lost to Follow-up|0|||
161856679|NCT03765788|584517147|FG000|Overall Study|Subject decision|2|||
161856680|NCT03765788|584517148|FG001|Overall Study|Subject decision|3|||
161856681|NCT03765788|584517147|FG000|Overall Study|Physician Decision|2|||
161856682|NCT03765788|584517148|FG001|Overall Study|Physician Decision|4|||
161856683|NCT03765788|584517147|FG000|Overall Study|Death|0|||
161856684|NCT03765788|584517148|FG001|Overall Study|Death|1|||
161856685|NCT03765788|584517147|FG000|Overall Study|Lost to Follow-up|1|||
161856686|NCT03765788|584517148|FG001|Overall Study|Lost to Follow-up|0|||
161856687|NCT00001521|584517149|FG000|Overall Study|Withdrawal by Subject|3|||
161856688|NCT00001521|584517150|FG001|Overall Study|Withdrawal by Subject|3|||
161856689|NCT00001521|584517149|FG000|Overall Study|Physician Decision|1|||
161856690|NCT00001521|584517150|FG001|Overall Study|Physician Decision|1|||
161856691|NCT00001521|584517149|FG000|Overall Study|Noncompliant|6|||
161856692|NCT00001521|584517150|FG001|Overall Study|Noncompliant|3|||
161856693|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
161856694|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
161856695|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
161856696|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
161856697|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
161856698|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
161856699|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
161856700|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
161856701|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
161856702|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
161856703|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
161856704|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
161856705|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
161856706|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
161856707|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
161856708|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
161856709|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
161856710|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
161856711|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
161856712|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
161975203|NCT00394901|584958448|FG002|Double-blind Phase|Death|0|||
161975204|NCT00394901|584958449|FG003|Double-blind Phase|Death|0|||
161975205|NCT00394901|584958446|FG000|Double-blind Phase|Subject's Personal Reason|1|||
161856713|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
161975206|NCT00394901|584958447|FG001|Double-blind Phase|Subject's Personal Reason|0|||
161975207|NCT00394901|584958448|FG002|Double-blind Phase|Subject's Personal Reason|0|||
161975208|NCT00394901|584958449|FG003|Double-blind Phase|Subject's Personal Reason|1|||
161975209|NCT00394901|584958446|FG000|Double-blind Phase|Lack of Compliance|0|||
161975210|NCT00394901|584958447|FG001|Double-blind Phase|Lack of Compliance|3|||
161856714|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
161856715|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
161856716|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
161856717|NCT01130532|584517154|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
161856718|NCT01130532|584517155|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
161975211|NCT00394901|584958448|FG002|Double-blind Phase|Lack of Compliance|0|||
161975212|NCT00394901|584958449|FG003|Double-blind Phase|Lack of Compliance|0|||
161975213|NCT00394901|584958446|FG000|Double-blind Phase|Entry into another study was found|0|||
161975214|NCT00394901|584958447|FG001|Double-blind Phase|Entry into another study was found|0|||
161856719|NCT01130532|584517156|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
161856720|NCT01130532|584517157|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
161856721|NCT01130532|584517154|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
161856722|NCT01130532|584517155|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
161856723|NCT01130532|584517156|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
161856724|NCT01130532|584517157|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
161856725|NCT01130532|584517154|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
161856726|NCT01130532|584517155|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
161856727|NCT01130532|584517156|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
161856728|NCT01130532|584517157|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
161856729|NCT01130532|584517154|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
161856730|NCT01130532|584517155|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
161856731|NCT01130532|584517156|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
161856732|NCT01130532|584517157|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
161856733|NCT01130532|584517154|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
161856734|NCT01130532|584517155|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
161856735|NCT01130532|584517156|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
161856736|NCT01130532|584517157|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
161856737|NCT02656303|584517158|FG000|Overall Study|Adverse Event|3|||
161856738|NCT02656303|584517159|FG001|Overall Study|Adverse Event|2|||
161856739|NCT02656303|584517160|FG002|Overall Study|Adverse Event|0|||
161856740|NCT02656303|584517158|FG000|Overall Study|Death|12|||
161856741|NCT02656303|584517159|FG001|Overall Study|Death|4|||
161856742|NCT02656303|584517160|FG002|Overall Study|Death|1|||
161856743|NCT02656303|584517158|FG000|Overall Study|Lack of Efficacy|1|||
161856744|NCT02656303|584517159|FG001|Overall Study|Lack of Efficacy|0|||
161856745|NCT02656303|584517160|FG002|Overall Study|Lack of Efficacy|0|||
161856746|NCT02656303|584517158|FG000|Overall Study|Non-Compliance with Study|1|||
161856747|NCT02656303|584517159|FG001|Overall Study|Non-Compliance with Study|1|||
161856748|NCT02656303|584517160|FG002|Overall Study|Non-Compliance with Study|0|||
161856749|NCT02656303|584517158|FG000|Overall Study|Investigator Decision|2|||
161856750|NCT02656303|584517159|FG001|Overall Study|Investigator Decision|1|||
161856751|NCT02656303|584517160|FG002|Overall Study|Investigator Decision|0|||
161856752|NCT02656303|584517158|FG000|Overall Study|Progressive Disease|25|||
161856753|NCT02656303|584517159|FG001|Overall Study|Progressive Disease|14|||
161856754|NCT02656303|584517160|FG002|Overall Study|Progressive Disease|10|||
161856755|NCT02656303|584517158|FG000|Overall Study|Study Terminated by Sponsor|20|||
161856756|NCT02656303|584517159|FG001|Overall Study|Study Terminated by Sponsor|7|||
161856757|NCT02656303|584517160|FG002|Overall Study|Study Terminated by Sponsor|5|||
161856758|NCT02656303|584517158|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
161856759|NCT02656303|584517159|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
161856760|NCT02656303|584517160|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
161856761|NCT02656303|584517158|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
161856762|NCT02656303|584517159|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
161856763|NCT02656303|584517160|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
161856764|NCT02656303|584517158|FG000|Overall Study|Reason not Specified|1|||
161856765|NCT02656303|584517159|FG001|Overall Study|Reason not Specified|1|||
161856766|NCT02656303|584517160|FG002|Overall Study|Reason not Specified|2|||
161856767|NCT03041311|584517163|FG000|Overall Study|Death|39|||
161856768|NCT03041311|584517164|FG001|Overall Study|Death|42|||
161856769|NCT03041311|584517163|FG000|Overall Study|Lost to Follow-up|0|||
161856770|NCT03041311|584517164|FG001|Overall Study|Lost to Follow-up|1|||
161856771|NCT03041311|584517163|FG000|Overall Study|Withdrawal by Subject|8|||
161856772|NCT03041311|584517164|FG001|Overall Study|Withdrawal by Subject|5|||
161856773|NCT03041311|584517163|FG000|Overall Study|Sponsor Terminated Study|2|||
161856774|NCT03041311|584517164|FG001|Overall Study|Sponsor Terminated Study|4|||
161856775|NCT03041311|584517163|FG000|Overall Study|Disease Progression|3|||
161856776|NCT03041311|584517164|FG001|Overall Study|Disease Progression|1|||
161856777|NCT03041311|584517163|FG000|Overall Study|Randomized in error, did not receive drug|2|||
161856778|NCT03041311|584517164|FG001|Overall Study|Randomized in error, did not receive drug|0|||
161856779|NCT01842438|584517165|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
161975215|NCT00394901|584958448|FG002|Double-blind Phase|Entry into another study was found|1|||
161975216|NCT00394901|584958449|FG003|Double-blind Phase|Entry into another study was found|0|||
161975217|NCT00394901|584958446|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
161975218|NCT00394901|584958447|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
161856780|NCT01842438|584517166|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
161856781|NCT01842438|584517165|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
161856782|NCT01842438|584517166|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
161856783|NCT01842438|584517165|FG000|T2: 6month Follow-up|Death|0|||
161856784|NCT01842438|584517166|FG001|T2: 6month Follow-up|Death|1|||
161856785|NCT04909853|584517167|FG000|Part 1|Assigned but not treated|0|||
161856786|NCT04909853|584517168|FG001|Part 1|Assigned but not treated|0|||
161856787|NCT04909853|584517169|FG002|Part 1|Assigned but not treated|1|||
161856788|NCT04909853|584517170|FG003|Part 1|Assigned but not treated|0|||
161856789|NCT04909853|584517167|FG000|Part 2|Adverse Event|0|||
161856790|NCT04909853|584517168|FG001|Part 2|Adverse Event|0|||
161856791|NCT04909853|584517169|FG002|Part 2|Adverse Event|0|||
161975219|NCT00394901|584958448|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
161975220|NCT00394901|584958449|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
161975221|NCT01352741|584958455|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
161975222|NCT01352741|584958456|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
161975223|NCT01352741|584958455|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
161975224|NCT01352741|584958456|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
161975225|NCT01352741|584958455|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
161769373|NCT03556202|584196174|FG001|Extension Treatment Period|Sponsor Decision|1|||
161769374|NCT03556202|584196175|FG002|Extension Treatment Period|Sponsor Decision|0|||
161769375|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
161769376|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
161769377|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
161769378|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Death|1|||
161975226|NCT01352741|584958456|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
161975227|NCT01352741|584958455|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
161769379|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Death|0|||
161769380|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Death|0|||
161769381|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
161769382|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
161769383|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
161769384|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
161769385|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
161769386|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
161769387|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
161769388|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
161769389|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
161769390|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
161769391|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
161769392|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
161769393|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
161769394|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
161769395|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
161769396|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
161769397|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
161769398|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
161769399|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
161769400|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
161769401|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
161769402|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
161769403|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
161769404|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
161769405|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
161769406|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
161769407|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
161769408|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
161769409|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
161769410|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
161769411|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
161769412|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
161769413|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
161769414|NCT03556202|584196173|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
161769415|NCT03556202|584196174|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
161769416|NCT03556202|584196175|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
161769417|NCT03319160|584196176|FG000|Overall Study|Data not available.|7|||
161769418|NCT00665002|584196177|FG000|Overall Study|Progression/relapse during treatment|11|||
161769419|NCT00665002|584196177|FG000|Overall Study|Cytogenetic resistance|1|||
161769420|NCT03604159|584196178|FG000|Overall Study|Lost to Follow-up|6|||
161769421|NCT03604159|584196179|FG001|Overall Study|Lost to Follow-up|7|||
161769422|NCT04533204|584196180|FG000|Overall Study|Unable to understand training instructions|1|||
161769423|NCT04533204|584196181|FG001|Overall Study|Unable to understand training instructions|1|||
161769424|NCT02260791|584196185|FG000|Overall Study|Lost to Follow-up|4|||
161769425|NCT02260791|584196186|FG001|Overall Study|Lost to Follow-up|4|||
161769426|NCT02260791|584196185|FG000|Overall Study|Lack of Efficacy|2|||
161769427|NCT02260791|584196186|FG001|Overall Study|Lack of Efficacy|1|||
161769428|NCT02260791|584196185|FG000|Overall Study|Adverse Event|13|||
161769429|NCT02260791|584196186|FG001|Overall Study|Adverse Event|9|||
161769430|NCT02260791|584196185|FG000|Overall Study|Death|1|||
161769431|NCT02260791|584196186|FG001|Overall Study|Death|0|||
161856792|NCT04909853|584517170|FG003|Part 2|Adverse Event|1|||
161856793|NCT04882241|584517178|FG000|Overall Study|Ongoing in study|46|||
161856794|NCT04882241|584517179|FG001|Overall Study|Ongoing in study|48|||
161856795|NCT04882241|584517180|FG002|Overall Study|Ongoing in study|0|||
161856796|NCT04882241|584517181|FG003|Overall Study|Ongoing in study|0|||
161856797|NCT04882241|584517178|FG000|Overall Study|Death|13|||
161856798|NCT04882241|584517179|FG001|Overall Study|Death|13|||
161856799|NCT04882241|584517180|FG002|Overall Study|Death|0|||
161856800|NCT04882241|584517181|FG003|Overall Study|Death|0|||
161856801|NCT03639779|584517187|FG000|Overall Study|Lost to Follow-up|1|||
161856802|NCT02413229|584517190|FG000|Overall Study|Adverse Event|0|||
161856803|NCT02413229|584517191|FG001|Overall Study|Adverse Event|0|||
161856804|NCT02413229|584517192|FG002|Overall Study|Adverse Event|0|||
161856805|NCT02413229|584517193|FG003|Overall Study|Adverse Event|1|||
161856806|NCT02413229|584517194|FG004|Overall Study|Adverse Event|0|||
161856807|NCT02413229|584517195|FG005|Overall Study|Adverse Event|0|||
161856808|NCT02413229|584517196|FG006|Overall Study|Adverse Event|0|||
161856809|NCT02413229|584517197|FG007|Overall Study|Adverse Event|1|||
161856810|NCT02413229|584517190|FG000|Overall Study|Lost to Follow-up|0|||
161856811|NCT02413229|584517191|FG001|Overall Study|Lost to Follow-up|0|||
161856812|NCT02413229|584517192|FG002|Overall Study|Lost to Follow-up|1|||
161856813|NCT02413229|584517193|FG003|Overall Study|Lost to Follow-up|0|||
161856814|NCT02413229|584517194|FG004|Overall Study|Lost to Follow-up|2|||
161856815|NCT02413229|584517195|FG005|Overall Study|Lost to Follow-up|0|||
161856816|NCT02413229|584517196|FG006|Overall Study|Lost to Follow-up|0|||
161856817|NCT02413229|584517197|FG007|Overall Study|Lost to Follow-up|0|||
161856818|NCT02413229|584517190|FG000|Overall Study|Withdrawal by Subject|1|||
161856819|NCT02413229|584517191|FG001|Overall Study|Withdrawal by Subject|1|||
161856820|NCT02413229|584517192|FG002|Overall Study|Withdrawal by Subject|0|||
161856821|NCT02413229|584517193|FG003|Overall Study|Withdrawal by Subject|0|||
161856822|NCT02413229|584517194|FG004|Overall Study|Withdrawal by Subject|1|||
161856823|NCT02413229|584517195|FG005|Overall Study|Withdrawal by Subject|0|||
161856824|NCT02413229|584517196|FG006|Overall Study|Withdrawal by Subject|0|||
161856825|NCT02413229|584517197|FG007|Overall Study|Withdrawal by Subject|2|||
161856826|NCT02413229|584517190|FG000|Overall Study|Progressive Disease|0|||
161856827|NCT02413229|584517191|FG001|Overall Study|Progressive Disease|0|||
161856828|NCT02413229|584517192|FG002|Overall Study|Progressive Disease|0|||
161856829|NCT02413229|584517193|FG003|Overall Study|Progressive Disease|0|||
161856830|NCT02413229|584517194|FG004|Overall Study|Progressive Disease|0|||
161856831|NCT02413229|584517195|FG005|Overall Study|Progressive Disease|0|||
161856832|NCT02413229|584517196|FG006|Overall Study|Progressive Disease|0|||
161856833|NCT02413229|584517197|FG007|Overall Study|Progressive Disease|1|||
161856834|NCT02932462|584517198|FG000|Overall Study|Adverse Event|1|||
161856835|NCT02932462|584517199|FG001|Overall Study|Adverse Event|2|||
161856836|NCT02932462|584517198|FG000|Overall Study|Lost to Follow-up|4|||
161856837|NCT02932462|584517199|FG001|Overall Study|Lost to Follow-up|1|||
161856838|NCT02932462|584517198|FG000|Overall Study|Protocol Violation|0|||
161856839|NCT02932462|584517199|FG001|Overall Study|Protocol Violation|5|||
161856840|NCT02932462|584517198|FG000|Overall Study|Withdrawal by Subject|1|||
161856841|NCT02932462|584517199|FG001|Overall Study|Withdrawal by Subject|4|||
161856842|NCT02932462|584517198|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161856843|NCT02932462|584517199|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161856844|NCT02932462|584517198|FG000|Overall Study|Progressive Disease|1|||
161856845|NCT02932462|584517199|FG001|Overall Study|Progressive Disease|0|||
161856846|NCT05024747|584517203|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
161856847|NCT05024747|584517204|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
161856848|NCT05024747|584517203|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
161856849|NCT05024747|584517204|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
161856850|NCT05024747|584517203|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
161856851|NCT05024747|584517204|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
161856852|NCT00662649|584517206|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
161856853|NCT00662649|584517207|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
161856854|NCT00662649|584517208|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
161856855|NCT00662649|584517209|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
161856856|NCT00662649|584517210|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
161856857|NCT00662649|584517206|FG000|Core Study (24 Months)|Adverse Event|22|||
161856858|NCT00662649|584517207|FG001|Core Study (24 Months)|Adverse Event|13|||
161856859|NCT00662649|584517208|FG002|Core Study (24 Months)|Adverse Event|18|||
161856860|NCT00662649|584517209|FG003|Core Study (24 Months)|Adverse Event|0|||
161856861|NCT00662649|584517210|FG004|Core Study (24 Months)|Adverse Event|0|||
161856862|NCT00662649|584517206|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
161856863|NCT00662649|584517207|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
161856864|NCT00662649|584517208|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
161856865|NCT00662649|584517209|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
161856866|NCT00662649|584517210|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
161856867|NCT00662649|584517206|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
161856868|NCT00662649|584517207|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
161856869|NCT00662649|584517208|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
161856870|NCT00662649|584517209|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
161856871|NCT00662649|584517210|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
161856872|NCT00662649|584517206|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
161856873|NCT00662649|584517207|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
161856874|NCT00662649|584517208|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
161856875|NCT00662649|584517209|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
161856876|NCT00662649|584517210|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
161856877|NCT00662649|584517206|FG000|Core Study (24 Months)|Protocol Violation|5|||
161856878|NCT00662649|584517207|FG001|Core Study (24 Months)|Protocol Violation|5|||
161856879|NCT00662649|584517208|FG002|Core Study (24 Months)|Protocol Violation|4|||
161856880|NCT00662649|584517209|FG003|Core Study (24 Months)|Protocol Violation|0|||
161856881|NCT00662649|584517210|FG004|Core Study (24 Months)|Protocol Violation|0|||
161856882|NCT00662649|584517206|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
161856883|NCT00662649|584517207|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
161856884|NCT00662649|584517208|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
161856885|NCT00662649|584517209|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
161856886|NCT00662649|584517210|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
161856887|NCT00662649|584517206|FG000|Core Study (24 Months)|Death|1|||
161856888|NCT00662649|584517207|FG001|Core Study (24 Months)|Death|0|||
161856889|NCT00662649|584517208|FG002|Core Study (24 Months)|Death|2|||
161856890|NCT00662649|584517209|FG003|Core Study (24 Months)|Death|0|||
161856891|NCT00662649|584517210|FG004|Core Study (24 Months)|Death|0|||
161856892|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
161856893|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
161856894|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
161856895|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
161856896|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
161856897|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
161856898|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
161856899|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
161856900|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
161856901|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
161856902|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
161856903|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
161856904|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
161856905|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
161856906|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
161856907|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
161856908|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
161856909|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
161856910|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
161856911|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
161856912|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
161856913|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
161856914|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
161856915|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
161856916|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
161856917|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
161856918|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
161856919|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
161856920|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
161856921|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
161856922|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
161856923|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
161856924|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
161856925|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
161856926|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
161856927|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
161856928|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
161856929|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
161975228|NCT01352741|584958456|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
161975229|NCT01352741|584958455|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
161975230|NCT01352741|584958456|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
161975231|NCT01352741|584958455|FG000|Open-label Tapentadol Titration Period|Other|4|||
161856930|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
161856931|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
161856932|NCT00662649|584517206|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
161856933|NCT00662649|584517207|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
161856934|NCT00662649|584517208|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
161856935|NCT00662649|584517209|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
161856936|NCT00662649|584517210|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
161856937|NCT02009722|584517217|FG000|Overall Study|Protocol Violation|1|||
161856938|NCT02009722|584517218|FG001|Overall Study|Protocol Violation|2|||
161856939|NCT02009722|584517217|FG000|Overall Study|Did not receive intervention|0|||
161856940|NCT02009722|584517218|FG001|Overall Study|Did not receive intervention|1|||
161856941|NCT02955212|584517219|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
161856942|NCT02955212|584517220|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
161856943|NCT02955212|584517219|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
161856944|NCT02955212|584517220|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
161856945|NCT02955212|584517219|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
161856946|NCT02955212|584517220|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
161856947|NCT02955212|584517219|FG000|Period 1: Double-blind Treatment Period|Other|3|||
161856948|NCT02955212|584517220|FG001|Period 1: Double-blind Treatment Period|Other|2|||
161856949|NCT02955212|584517219|FG000|Period 2: Open-label Extension|Adverse Event|11|||
161856950|NCT02955212|584517220|FG001|Period 2: Open-label Extension|Adverse Event|7|||
161856951|NCT02955212|584517219|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
161856952|NCT02955212|584517220|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
161856953|NCT02955212|584517219|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
161856954|NCT02955212|584517220|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
161856955|NCT02955212|584517219|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
161856956|NCT02955212|584517220|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
161856957|NCT02955212|584517219|FG000|Period 2: Open-label Extension|Other|2|||
161856958|NCT02955212|584517220|FG001|Period 2: Open-label Extension|Other|4|||
161856959|NCT02454933|584517227|FG000|Overall Study|Progressive disease|10|||
161856960|NCT02454933|584517228|FG001|Overall Study|Progressive disease|7|||
161856961|NCT02454933|584517227|FG000|Overall Study|Adverse Event|1|||
161856962|NCT02454933|584517228|FG001|Overall Study|Adverse Event|1|||
161856963|NCT02454933|584517227|FG000|Overall Study|Withdrawal by Subject|0|||
161856964|NCT02454933|584517228|FG001|Overall Study|Withdrawal by Subject|3|||
161856965|NCT02454933|584517227|FG000|Overall Study|Lost to Follow-up|1|||
161856966|NCT02454933|584517228|FG001|Overall Study|Lost to Follow-up|0|||
161856967|NCT02071225|584517234|FG000|Overall Study|Withdrawal of Consent|2|||
161856968|NCT02071225|584517234|FG000|Overall Study|Protocol Deviation|1|||
161856969|NCT02071225|584517234|FG000|Overall Study|Lost to Follow-up|2|||
161856970|NCT02071225|584517234|FG000|Overall Study|Death|25|||
161856971|NCT01342081|584517237|FG000|Overall Study|Did not receive allocated intervention|0|||
161856972|NCT01342081|584517238|FG001|Overall Study|Did not receive allocated intervention|0|||
161856973|NCT01342081|584517239|FG002|Overall Study|Did not receive allocated intervention|1|||
161856974|NCT01342081|584517237|FG000|Overall Study|Adverse Event|1|||
161856975|NCT01342081|584517238|FG001|Overall Study|Adverse Event|0|||
161856976|NCT01342081|584517239|FG002|Overall Study|Adverse Event|0|||
161856977|NCT01342081|584517237|FG000|Overall Study|Physician Decision|0|||
161856978|NCT01342081|584517238|FG001|Overall Study|Physician Decision|1|||
161856979|NCT01342081|584517239|FG002|Overall Study|Physician Decision|0|||
161856980|NCT01342081|584517237|FG000|Overall Study|Withdrawal by Subject|1|||
161856981|NCT01342081|584517238|FG001|Overall Study|Withdrawal by Subject|1|||
161856982|NCT01342081|584517239|FG002|Overall Study|Withdrawal by Subject|0|||
161856983|NCT04720053|584517244|FG000|Overall Study|Lost to Follow-up|12|||
161856984|NCT01942993|584517245|FG000|Overall Study|Lost to Follow-up|1|||
161856985|NCT01942993|584517245|FG000|Overall Study|Physician Decision|1|||
161856986|NCT02906670|584517249|FG000|Cohort 1, QW|Radiological Progression|1|||
161856987|NCT02906670|584517250|FG001|Cohort 1, QW|Radiological Progression|0|||
161856988|NCT02906670|584517251|FG002|Cohort 1, QW|Radiological Progression|0|||
161856989|NCT02906670|584517252|FG003|Cohort 1, QW|Radiological Progression|0|||
161856990|NCT02906670|584517253|FG004|Cohort 1, QW|Radiological Progression|0|||
161856991|NCT02906670|584517254|FG005|Cohort 1, QW|Radiological Progression|0|||
161856992|NCT02906670|584517255|FG006|Cohort 1, QW|Radiological Progression|0|||
161856993|NCT02906670|584517256|FG007|Cohort 1, QW|Radiological Progression|0|||
161856994|NCT02906670|584517257|FG008|Cohort 1, QW|Radiological Progression|0|||
161856995|NCT02906670|584517258|FG009|Cohort 1, QW|Radiological Progression|0|||
161856996|NCT02906670|584517249|FG000|Cohort 2, QW|Radiological Progression|0|||
161856997|NCT02906670|584517250|FG001|Cohort 2, QW|Radiological Progression|1|||
161856998|NCT02906670|584517251|FG002|Cohort 2, QW|Radiological Progression|0|||
161856999|NCT02906670|584517252|FG003|Cohort 2, QW|Radiological Progression|0|||
161857000|NCT02906670|584517253|FG004|Cohort 2, QW|Radiological Progression|0|||
161857001|NCT02906670|584517254|FG005|Cohort 2, QW|Radiological Progression|0|||
161975232|NCT01352741|584958456|FG001|Open-label Tapentadol Titration Period|Other|0|||
161975233|NCT01352741|584958455|FG000|Double-blind Comparative Period|Protocol Violation|2|||
161769432|NCT02260791|584196185|FG000|Overall Study|Withdrawal by Subject|11|||
161769433|NCT02260791|584196186|FG001|Overall Study|Withdrawal by Subject|16|||
161769434|NCT02260791|584196185|FG000|Overall Study|Screen failure|0|||
161769435|NCT02260791|584196186|FG001|Overall Study|Screen failure|1|||
161769436|NCT02260791|584196185|FG000|Overall Study|Protocol deviation|2|||
161769437|NCT02260791|584196186|FG001|Overall Study|Protocol deviation|3|||
161769438|NCT01411917|584196187|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
161769439|NCT01411917|584196188|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
161769440|NCT02354599|584196191|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161769441|NCT02354599|584196192|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
161769442|NCT02354599|584196193|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161769443|NCT02354599|584196194|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
161769444|NCT02354599|584196195|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
161769445|NCT02354599|584196196|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
161769446|NCT02354599|584196191|FG000|Overall Study|Withdrawal by Subject|1|||
161769447|NCT02354599|584196192|FG001|Overall Study|Withdrawal by Subject|1|||
161769448|NCT02354599|584196193|FG002|Overall Study|Withdrawal by Subject|0|||
161769449|NCT02354599|584196194|FG003|Overall Study|Withdrawal by Subject|0|||
161769450|NCT02354599|584196195|FG004|Overall Study|Withdrawal by Subject|0|||
161769451|NCT02354599|584196196|FG005|Overall Study|Withdrawal by Subject|0|||
161769452|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Death|2|||
161769453|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Death|0|||
161769454|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Adverse Event|33|||
161769455|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Adverse Event|31|||
161769456|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
161769457|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
161769458|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
161769459|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
161769460|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
161769461|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
161769462|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Other|7|||
161769463|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Other|8|||
161769464|NCT00280059|584196197|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
161769465|NCT00280059|584196198|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
161769466|NCT00495794|584196201|FG000|Overall Study|Pharmacist did not activate patient|522|||
161769467|NCT00495794|584196202|FG001|Overall Study|Pharmacist did not activate patient|0|||
161769468|NCT00198107|584198458|FG000|Double-Blind Period|Adverse Event|1|||
161769469|NCT00198107|584198459|FG001|Double-Blind Period|Adverse Event|1|||
161769470|NCT00198107|584198460|FG002|Double-Blind Period|Adverse Event|0|||
161769471|NCT00198107|584198458|FG000|Double-Blind Period|Lack of Efficacy|2|||
161769472|NCT00198107|584198459|FG001|Double-Blind Period|Lack of Efficacy|0|||
161769473|NCT00198107|584198460|FG002|Double-Blind Period|Lack of Efficacy|0|||
161769474|NCT00198107|584198458|FG000|Double-Blind Period|Lost to Follow-up|2|||
161769475|NCT00198107|584198459|FG001|Double-Blind Period|Lost to Follow-up|1|||
161769476|NCT00198107|584198460|FG002|Double-Blind Period|Lost to Follow-up|0|||
161769477|NCT00198107|584198458|FG000|Double-Blind Period|Physician Decision|1|||
161769478|NCT00198107|584198459|FG001|Double-Blind Period|Physician Decision|0|||
161769479|NCT00198107|584198460|FG002|Double-Blind Period|Physician Decision|0|||
161769480|NCT00198107|584198458|FG000|Double-Blind Period|Withdrawal by Subject|0|||
161769481|NCT00198107|584198459|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161769482|NCT00198107|584198460|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161769483|NCT00198107|584198458|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
161769484|NCT00198107|584198459|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
161769485|NCT00198107|584198460|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
161769486|NCT02513732|584198461|FG000|Overall Study|Lost to Follow-up|11|||
161769487|NCT02513732|584198461|FG000|Overall Study|Death|9|||
161769488|NCT02513732|584198461|FG000|Overall Study|Changing hospital|2|||
161769489|NCT00467051|584198462|FG000|Overall Study|Adverse Event|2|||
161769490|NCT00934661|584198463|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
161769491|NCT00934661|584198464|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
161769492|NCT01846442|584198469|FG000|Overall Study|Adverse Event|2|||
161769493|NCT01846442|584198470|FG001|Overall Study|Adverse Event|4|||
161975234|NCT01352741|584958456|FG001|Double-blind Comparative Period|Protocol Violation|0|||
161975235|NCT01352741|584958455|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
161975236|NCT01352741|584958456|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
161975237|NCT01352741|584958455|FG000|Double-blind Comparative Period|Adverse Event|16|||
161769494|NCT01846442|584198471|FG002|Overall Study|Adverse Event|2|||
161769495|NCT01846442|584198472|FG003|Overall Study|Adverse Event|1|||
161769496|NCT01846442|584198469|FG000|Overall Study|Lost to Follow-up|0|||
161769497|NCT01846442|584198470|FG001|Overall Study|Lost to Follow-up|0|||
161769498|NCT01846442|584198471|FG002|Overall Study|Lost to Follow-up|1|||
161769499|NCT01846442|584198472|FG003|Overall Study|Lost to Follow-up|0|||
161857002|NCT02906670|584517255|FG006|Cohort 2, QW|Radiological Progression|0|||
161857003|NCT02906670|584517256|FG007|Cohort 2, QW|Radiological Progression|0|||
161857004|NCT02906670|584517257|FG008|Cohort 2, QW|Radiological Progression|0|||
161857005|NCT02906670|584517258|FG009|Cohort 2, QW|Radiological Progression|0|||
161857006|NCT02906670|584517249|FG000|Cohort 3, QW|Radiological Progression|0|||
161857007|NCT02906670|584517250|FG001|Cohort 3, QW|Radiological Progression|0|||
161857008|NCT02906670|584517251|FG002|Cohort 3, QW|Radiological Progression|2|||
161857009|NCT02906670|584517252|FG003|Cohort 3, QW|Radiological Progression|0|||
161857010|NCT02906670|584517253|FG004|Cohort 3, QW|Radiological Progression|0|||
161857011|NCT02906670|584517254|FG005|Cohort 3, QW|Radiological Progression|0|||
161857012|NCT02906670|584517255|FG006|Cohort 3, QW|Radiological Progression|0|||
161857013|NCT02906670|584517256|FG007|Cohort 3, QW|Radiological Progression|0|||
161857014|NCT02906670|584517257|FG008|Cohort 3, QW|Radiological Progression|0|||
161857015|NCT02906670|584517258|FG009|Cohort 3, QW|Radiological Progression|0|||
161857016|NCT02906670|584517249|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857017|NCT02906670|584517250|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857018|NCT02906670|584517251|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
161857019|NCT02906670|584517252|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857020|NCT02906670|584517253|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857021|NCT02906670|584517254|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857022|NCT02906670|584517255|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857023|NCT02906670|584517256|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857024|NCT02906670|584517257|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857025|NCT02906670|584517258|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
161857026|NCT02906670|584517249|FG000|Cohort 4, Q2W|Radiological Progression|0|||
161857027|NCT02906670|584517250|FG001|Cohort 4, Q2W|Radiological Progression|0|||
161857028|NCT02906670|584517251|FG002|Cohort 4, Q2W|Radiological Progression|0|||
161857029|NCT02906670|584517252|FG003|Cohort 4, Q2W|Radiological Progression|0|||
161857030|NCT02906670|584517253|FG004|Cohort 4, Q2W|Radiological Progression|0|||
161857031|NCT02906670|584517254|FG005|Cohort 4, Q2W|Radiological Progression|1|||
161769500|NCT01846442|584198469|FG000|Overall Study|Withdrawal by Subject|3|||
161769501|NCT01846442|584198470|FG001|Overall Study|Withdrawal by Subject|2|||
161769502|NCT01846442|584198471|FG002|Overall Study|Withdrawal by Subject|0|||
161769503|NCT01846442|584198472|FG003|Overall Study|Withdrawal by Subject|1|||
161769504|NCT01846442|584198469|FG000|Overall Study|Left the city/Lost medication|1|||
161769505|NCT01846442|584198470|FG001|Overall Study|Left the city/Lost medication|0|||
161769506|NCT01846442|584198471|FG002|Overall Study|Left the city/Lost medication|1|||
161769507|NCT01846442|584198472|FG003|Overall Study|Left the city/Lost medication|1|||
161769508|NCT02777554|584198475|FG000|Overall Study|Adverse Event|4|||
161769509|NCT02777554|584198476|FG001|Overall Study|Adverse Event|4|||
161769510|NCT02777554|584198477|FG002|Overall Study|Adverse Event|0|||
161769511|NCT02777554|584198478|FG003|Overall Study|Adverse Event|1|||
161975238|NCT01352741|584958456|FG001|Double-blind Comparative Period|Adverse Event|17|||
161769512|NCT02777554|584198479|FG004|Overall Study|Adverse Event|0|||
161769513|NCT02777554|584198480|FG005|Overall Study|Adverse Event|0|||
161769514|NCT02777554|584198475|FG000|Overall Study|Withdrawal by Subject|3|||
161769515|NCT02777554|584198476|FG001|Overall Study|Withdrawal by Subject|1|||
161769516|NCT02777554|584198477|FG002|Overall Study|Withdrawal by Subject|1|||
161769517|NCT02777554|584198478|FG003|Overall Study|Withdrawal by Subject|0|||
161769518|NCT02777554|584198479|FG004|Overall Study|Withdrawal by Subject|0|||
161769519|NCT02777554|584198480|FG005|Overall Study|Withdrawal by Subject|0|||
161769520|NCT02777554|584198475|FG000|Overall Study|Discharged early due to hurricane|22|||
161857032|NCT02906670|584517255|FG006|Cohort 4, Q2W|Radiological Progression|0|||
161857033|NCT02906670|584517256|FG007|Cohort 4, Q2W|Radiological Progression|0|||
161857034|NCT02906670|584517257|FG008|Cohort 4, Q2W|Radiological Progression|0|||
161857035|NCT02906670|584517258|FG009|Cohort 4, Q2W|Radiological Progression|0|||
161857036|NCT02906670|584517249|FG000|Cohort 4, Q2W|Clinical Progression|0|||
161857037|NCT02906670|584517250|FG001|Cohort 4, Q2W|Clinical Progression|0|||
161857038|NCT02906670|584517251|FG002|Cohort 4, Q2W|Clinical Progression|0|||
161857039|NCT02906670|584517252|FG003|Cohort 4, Q2W|Clinical Progression|0|||
161857040|NCT02906670|584517253|FG004|Cohort 4, Q2W|Clinical Progression|0|||
161857041|NCT02906670|584517254|FG005|Cohort 4, Q2W|Clinical Progression|2|||
161857042|NCT02906670|584517255|FG006|Cohort 4, Q2W|Clinical Progression|0|||
161857043|NCT02906670|584517256|FG007|Cohort 4, Q2W|Clinical Progression|0|||
161857044|NCT02906670|584517257|FG008|Cohort 4, Q2W|Clinical Progression|0|||
161857045|NCT02906670|584517258|FG009|Cohort 4, Q2W|Clinical Progression|0|||
161857046|NCT02906670|584517249|FG000|Cohort 5, Q2W|Radiological Progression|0|||
161857047|NCT02906670|584517250|FG001|Cohort 5, Q2W|Radiological Progression|0|||
161975239|NCT01352741|584958455|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
161975240|NCT01352741|584958456|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
161857048|NCT02906670|584517251|FG002|Cohort 5, Q2W|Radiological Progression|0|||
161857049|NCT02906670|584517252|FG003|Cohort 5, Q2W|Radiological Progression|0|||
161857050|NCT02906670|584517253|FG004|Cohort 5, Q2W|Radiological Progression|0|||
161769521|NCT02777554|584198476|FG001|Overall Study|Discharged early due to hurricane|20|||
161769522|NCT02777554|584198477|FG002|Overall Study|Discharged early due to hurricane|0|||
161857051|NCT02906670|584517254|FG005|Cohort 5, Q2W|Radiological Progression|0|||
161857052|NCT02906670|584517255|FG006|Cohort 5, Q2W|Radiological Progression|4|||
161857053|NCT02906670|584517256|FG007|Cohort 5, Q2W|Radiological Progression|0|||
161857054|NCT02906670|584517257|FG008|Cohort 5, Q2W|Radiological Progression|0|||
161857055|NCT02906670|584517258|FG009|Cohort 5, Q2W|Radiological Progression|0|||
161857056|NCT02906670|584517249|FG000|Cohort 5, Q2W|Clinical Progression|0|||
161857057|NCT02906670|584517250|FG001|Cohort 5, Q2W|Clinical Progression|0|||
161857058|NCT02906670|584517251|FG002|Cohort 5, Q2W|Clinical Progression|0|||
161857059|NCT02906670|584517252|FG003|Cohort 5, Q2W|Clinical Progression|0|||
161857060|NCT02906670|584517253|FG004|Cohort 5, Q2W|Clinical Progression|0|||
161857061|NCT02906670|584517254|FG005|Cohort 5, Q2W|Clinical Progression|0|||
161857062|NCT02906670|584517255|FG006|Cohort 5, Q2W|Clinical Progression|1|||
161857063|NCT02906670|584517256|FG007|Cohort 5, Q2W|Clinical Progression|0|||
161857064|NCT02906670|584517257|FG008|Cohort 5, Q2W|Clinical Progression|0|||
161857065|NCT02906670|584517258|FG009|Cohort 5, Q2W|Clinical Progression|0|||
161857066|NCT02906670|584517249|FG000|Cohort 5, Q2W|Adverse Event|0|||
161857067|NCT02906670|584517250|FG001|Cohort 5, Q2W|Adverse Event|0|||
161857068|NCT02906670|584517251|FG002|Cohort 5, Q2W|Adverse Event|0|||
161857069|NCT02906670|584517252|FG003|Cohort 5, Q2W|Adverse Event|0|||
161857070|NCT02906670|584517253|FG004|Cohort 5, Q2W|Adverse Event|0|||
161857071|NCT02906670|584517254|FG005|Cohort 5, Q2W|Adverse Event|0|||
161857072|NCT02906670|584517255|FG006|Cohort 5, Q2W|Adverse Event|1|||
161857073|NCT02906670|584517256|FG007|Cohort 5, Q2W|Adverse Event|0|||
161857074|NCT02906670|584517257|FG008|Cohort 5, Q2W|Adverse Event|0|||
161857075|NCT02906670|584517258|FG009|Cohort 5, Q2W|Adverse Event|0|||
161857076|NCT02906670|584517249|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857077|NCT02906670|584517250|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857078|NCT02906670|584517251|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857079|NCT02906670|584517252|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857080|NCT02906670|584517253|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857081|NCT02906670|584517254|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857082|NCT02906670|584517255|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
161857083|NCT02906670|584517256|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857084|NCT02906670|584517257|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857085|NCT02906670|584517258|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161857086|NCT02906670|584517249|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
161857087|NCT02906670|584517250|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
161857088|NCT02906670|584517251|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
161857089|NCT02906670|584517252|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
161857090|NCT02906670|584517253|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
161857091|NCT02906670|584517254|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
161857092|NCT02906670|584517255|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
161857093|NCT02906670|584517256|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
161857094|NCT02906670|584517257|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
161857095|NCT02906670|584517258|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
161857096|NCT02906670|584517249|FG000|Cohort 5P, Q2W|Adverse Event|0|||
161857097|NCT02906670|584517250|FG001|Cohort 5P, Q2W|Adverse Event|0|||
161857098|NCT02906670|584517251|FG002|Cohort 5P, Q2W|Adverse Event|0|||
161857099|NCT02906670|584517252|FG003|Cohort 5P, Q2W|Adverse Event|0|||
161857100|NCT02906670|584517253|FG004|Cohort 5P, Q2W|Adverse Event|0|||
161857101|NCT02906670|584517254|FG005|Cohort 5P, Q2W|Adverse Event|0|||
161857102|NCT02906670|584517255|FG006|Cohort 5P, Q2W|Adverse Event|0|||
161857103|NCT02906670|584517256|FG007|Cohort 5P, Q2W|Adverse Event|1|||
161857104|NCT02906670|584517257|FG008|Cohort 5P, Q2W|Adverse Event|0|||
161857105|NCT02906670|584517258|FG009|Cohort 5P, Q2W|Adverse Event|0|||
161857106|NCT02906670|584517249|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
161857107|NCT02906670|584517250|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
161857108|NCT02906670|584517251|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
161857109|NCT02906670|584517252|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
161857110|NCT02906670|584517253|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
161857111|NCT02906670|584517254|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
161857112|NCT02906670|584517255|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
161857113|NCT02906670|584517256|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
161857114|NCT02906670|584517257|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
161857115|NCT02906670|584517258|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
161857116|NCT02906670|584517249|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
161857117|NCT02906670|584517250|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
161857118|NCT02906670|584517251|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
161857119|NCT02906670|584517252|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
161857120|NCT02906670|584517253|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
161857121|NCT02906670|584517254|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
162034303|NCT05217927|585181205|FG001|DBT Phase|Protocol Violation|2|||
161857122|NCT02906670|584517255|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
161857123|NCT02906670|584517256|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
161857124|NCT02906670|584517257|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
161857125|NCT02906670|584517258|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
161857126|NCT02906670|584517249|FG000|Cohort 4P, QW|Radiological Progression|0|||
161857127|NCT02906670|584517250|FG001|Cohort 4P, QW|Radiological Progression|0|||
161857128|NCT02906670|584517251|FG002|Cohort 4P, QW|Radiological Progression|0|||
161857129|NCT02906670|584517252|FG003|Cohort 4P, QW|Radiological Progression|3|||
161857130|NCT02906670|584517253|FG004|Cohort 4P, QW|Radiological Progression|0|||
161857131|NCT02906670|584517254|FG005|Cohort 4P, QW|Radiological Progression|0|||
161857132|NCT02906670|584517255|FG006|Cohort 4P, QW|Radiological Progression|0|||
161857133|NCT02906670|584517256|FG007|Cohort 4P, QW|Radiological Progression|0|||
161857134|NCT02906670|584517257|FG008|Cohort 4P, QW|Radiological Progression|0|||
161857135|NCT02906670|584517258|FG009|Cohort 4P, QW|Radiological Progression|0|||
161857136|NCT02906670|584517249|FG000|Cohort 7P, Q2W|Adverse Event|0|||
161857137|NCT02906670|584517250|FG001|Cohort 7P, Q2W|Adverse Event|0|||
161857138|NCT02906670|584517251|FG002|Cohort 7P, Q2W|Adverse Event|0|||
161857139|NCT02906670|584517252|FG003|Cohort 7P, Q2W|Adverse Event|0|||
161857140|NCT02906670|584517253|FG004|Cohort 7P, Q2W|Adverse Event|0|||
161857141|NCT02906670|584517254|FG005|Cohort 7P, Q2W|Adverse Event|0|||
161857142|NCT02906670|584517255|FG006|Cohort 7P, Q2W|Adverse Event|0|||
161857143|NCT02906670|584517256|FG007|Cohort 7P, Q2W|Adverse Event|0|||
161857144|NCT02906670|584517257|FG008|Cohort 7P, Q2W|Adverse Event|0|||
161857145|NCT02906670|584517258|FG009|Cohort 7P, Q2W|Adverse Event|1|||
161857146|NCT02906670|584517249|FG000|Cohort 7P, Q2W|Physician Decision|0|||
161857147|NCT02906670|584517250|FG001|Cohort 7P, Q2W|Physician Decision|0|||
161857148|NCT02906670|584517251|FG002|Cohort 7P, Q2W|Physician Decision|0|||
161857149|NCT02906670|584517252|FG003|Cohort 7P, Q2W|Physician Decision|0|||
161857150|NCT02906670|584517253|FG004|Cohort 7P, Q2W|Physician Decision|0|||
161857151|NCT02906670|584517254|FG005|Cohort 7P, Q2W|Physician Decision|0|||
161857152|NCT02906670|584517255|FG006|Cohort 7P, Q2W|Physician Decision|0|||
161857153|NCT02906670|584517256|FG007|Cohort 7P, Q2W|Physician Decision|0|||
161857154|NCT02906670|584517257|FG008|Cohort 7P, Q2W|Physician Decision|0|||
161857155|NCT02906670|584517258|FG009|Cohort 7P, Q2W|Physician Decision|1|||
161857156|NCT02906670|584517249|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857157|NCT02906670|584517250|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857158|NCT02906670|584517251|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857159|NCT02906670|584517252|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857160|NCT02906670|584517253|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857161|NCT02906670|584517254|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857162|NCT02906670|584517255|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857163|NCT02906670|584517256|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857164|NCT02906670|584517257|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161857165|NCT02906670|584517258|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
161857166|NCT02906670|584517249|FG000|Cohort 5P, QW|Radiological Progression|0|||
161857167|NCT02906670|584517250|FG001|Cohort 5P, QW|Radiological Progression|0|||
161857168|NCT02906670|584517251|FG002|Cohort 5P, QW|Radiological Progression|0|||
161857169|NCT02906670|584517252|FG003|Cohort 5P, QW|Radiological Progression|0|||
161857170|NCT02906670|584517253|FG004|Cohort 5P, QW|Radiological Progression|3|||
161857171|NCT02906670|584517254|FG005|Cohort 5P, QW|Radiological Progression|0|||
161857172|NCT02906670|584517255|FG006|Cohort 5P, QW|Radiological Progression|0|||
161857173|NCT02906670|584517256|FG007|Cohort 5P, QW|Radiological Progression|0|||
161857174|NCT02906670|584517257|FG008|Cohort 5P, QW|Radiological Progression|0|||
161857175|NCT02906670|584517258|FG009|Cohort 5P, QW|Radiological Progression|0|||
161857176|NCT01349192|584517259|FG000|Overall Study|Protocol Violation|0|||
161857177|NCT01349192|584517260|FG001|Overall Study|Protocol Violation|1|||
161857178|NCT01349192|584517259|FG000|Overall Study|Withdrawal by Subject|0|||
161857179|NCT01349192|584517260|FG001|Overall Study|Withdrawal by Subject|2|||
161857180|NCT01349192|584517259|FG000|Overall Study|Lost to Follow-up|1|||
161857181|NCT01349192|584517260|FG001|Overall Study|Lost to Follow-up|3|||
161857182|NCT01349192|584517259|FG000|Overall Study|Failure to adhere to Protocol|2|||
161857183|NCT01349192|584517260|FG001|Overall Study|Failure to adhere to Protocol|0|||
161857184|NCT03749330|584517261|FG000|Overall Study|Clinicians left work in the CICU|0|||
161857185|NCT03749330|584517262|FG001|Overall Study|Clinicians left work in the CICU|2|||
161857186|NCT03749330|584517263|FG002|Overall Study|Clinicians left work in the CICU|0|||
161857187|NCT03749330|584517264|FG003|Overall Study|Clinicians left work in the CICU|0|||
161857188|NCT03749330|584517265|FG004|Overall Study|Clinicians left work in the CICU|0|||
161857189|NCT03749330|584517266|FG005|Overall Study|Clinicians left work in the CICU|0|||
161975241|NCT01352741|584958455|FG000|Double-blind Comparative Period|Death|0|||
161857190|NCT02105467|584517269|FG000|Period 1|Lost to Follow-up|1|||
161857191|NCT02105467|584517270|FG001|Period 1|Lost to Follow-up|0|||
161857192|NCT02105467|584517269|FG000|Period 1|Death|1|||
161857193|NCT02105467|584517270|FG001|Period 1|Death|0|||
161857194|NCT02105467|584517269|FG000|Period 2|Lost to Follow-up|1|||
161975242|NCT01352741|584958456|FG001|Double-blind Comparative Period|Death|1|||
161975243|NCT01352741|584958455|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
161857195|NCT02105467|584517270|FG001|Period 2|Lost to Follow-up|0|||
161857196|NCT02105467|584517269|FG000|Period 2|Death|1|||
161857197|NCT02105467|584517270|FG001|Period 2|Death|0|||
161857198|NCT02105467|584517269|FG000|Period 2|Withdrawal by Subject|0|||
161975244|NCT01352741|584958456|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
161857199|NCT02105467|584517270|FG001|Period 2|Withdrawal by Subject|2|||
161857200|NCT02105467|584517269|FG000|Period 3|Lost to Follow-up|0|||
161857201|NCT02105467|584517270|FG001|Period 3|Lost to Follow-up|1|||
161857202|NCT03908125|584517271|FG000|Overall Study|Withdrawal by Subject|92|||
161857203|NCT03908125|584517271|FG000|Overall Study|Lost to Follow-up|8|||
161857204|NCT02262325|584517272|FG000|Overall Study|Death|16|||
161857205|NCT02262325|584517272|FG000|Overall Study|Lost to Follow-up|1|||
161857206|NCT02815995|584517273|FG000|Overall Study|Disease Progression|3|||
161857207|NCT02815995|584517274|FG001|Overall Study|Disease Progression|7|||
161857208|NCT02815995|584517275|FG002|Overall Study|Disease Progression|2|||
161857209|NCT02815995|584517276|FG003|Overall Study|Disease Progression|4|||
161857210|NCT02815995|584517277|FG004|Overall Study|Disease Progression|3|||
161857211|NCT02815995|584517278|FG005|Overall Study|Disease Progression|9|||
161857212|NCT02815995|584517279|FG006|Overall Study|Disease Progression|3|||
161857213|NCT02815995|584517280|FG007|Overall Study|Disease Progression|1|||
161857214|NCT02815995|584517273|FG000|Overall Study|Adverse Event|1|||
161857215|NCT02815995|584517274|FG001|Overall Study|Adverse Event|2|||
161857216|NCT02815995|584517275|FG002|Overall Study|Adverse Event|2|||
161857217|NCT02815995|584517276|FG003|Overall Study|Adverse Event|0|||
161857218|NCT02815995|584517277|FG004|Overall Study|Adverse Event|0|||
161857219|NCT02815995|584517278|FG005|Overall Study|Adverse Event|1|||
161857220|NCT02815995|584517279|FG006|Overall Study|Adverse Event|0|||
161857221|NCT02815995|584517280|FG007|Overall Study|Adverse Event|0|||
161857222|NCT02815995|584517273|FG000|Overall Study|Pregnancy|0|||
161857223|NCT02815995|584517274|FG001|Overall Study|Pregnancy|0|||
161857224|NCT02815995|584517275|FG002|Overall Study|Pregnancy|0|||
161857225|NCT02815995|584517276|FG003|Overall Study|Pregnancy|0|||
161857226|NCT02815995|584517277|FG004|Overall Study|Pregnancy|0|||
161857227|NCT02815995|584517278|FG005|Overall Study|Pregnancy|0|||
161857228|NCT02815995|584517279|FG006|Overall Study|Pregnancy|1|||
161857229|NCT02815995|584517280|FG007|Overall Study|Pregnancy|0|||
161857230|NCT01071915|584517284|FG000|Overall Study|Adverse Event|3|||
161857231|NCT01071915|584517284|FG000|Overall Study|Physician Decision|2|||
161857232|NCT01071915|584517284|FG000|Overall Study|Withdrawal by Subject|2|||
161857233|NCT01071915|584517284|FG000|Overall Study|Miscellaneous Reasons|2|||
161857234|NCT02016183|584517285|FG000|Overall Study|Case Report Forms Uncollected|13|||
161857235|NCT02016183|584517285|FG000|Overall Study|Protocol Violation|52|||
161857236|NCT00770328|584517286|FG000|Overall Study|Adverse Event|11|||
161857237|NCT00770328|584517287|FG001|Overall Study|Adverse Event|2|||
161857238|NCT00770328|584517286|FG000|Overall Study|Lost to Follow-up|2|||
161857239|NCT00770328|584517287|FG001|Overall Study|Lost to Follow-up|2|||
161857240|NCT02286843|584517290|FG000|Overall Study|Not Treated|4|||
161857241|NCT02286843|584517290|FG000|Overall Study|Protocol Violation|1|||
161857242|NCT02286843|584517290|FG000|Overall Study|Withdrawal by Subject|1|||
161857243|NCT02536846|584517291|FG000|Overall Study|Withdrawal by Subject|1|||
161857244|NCT04388553|584517292|FG000|Overall Study|Protocol Violation|1|||
161857245|NCT04388553|584517293|FG001|Overall Study|Protocol Violation|0|||
161857246|NCT04604795|584517294|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
161857247|NCT04604795|584517295|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
161857248|NCT04604795|584517296|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857249|NCT04604795|584517297|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857250|NCT04604795|584517298|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857251|NCT04604795|584517299|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857252|NCT04604795|584517300|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857253|NCT04604795|584517301|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857254|NCT04604795|584517302|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857255|NCT04604795|584517303|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161857256|NCT04604795|584517294|FG000|Part B: Up to Day 14|Adverse Event|0|||
161857257|NCT04604795|584517295|FG001|Part B: Up to Day 14|Adverse Event|0|||
161857258|NCT04604795|584517296|FG002|Part B: Up to Day 14|Adverse Event|0|||
161857259|NCT04604795|584517297|FG003|Part B: Up to Day 14|Adverse Event|0|||
161857260|NCT04604795|584517298|FG004|Part B: Up to Day 14|Adverse Event|2|||
161857261|NCT04604795|584517299|FG005|Part B: Up to Day 14|Adverse Event|1|||
161857262|NCT04604795|584517300|FG006|Part B: Up to Day 14|Adverse Event|0|||
161857263|NCT04604795|584517301|FG007|Part B: Up to Day 14|Adverse Event|0|||
161857264|NCT04604795|584517302|FG008|Part B: Up to Day 14|Adverse Event|0|||
161857265|NCT04604795|584517303|FG009|Part B: Up to Day 14|Adverse Event|0|||
161857266|NCT04604795|584517294|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857267|NCT04604795|584517295|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857268|NCT04604795|584517296|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857269|NCT04604795|584517297|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857270|NCT04604795|584517298|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857271|NCT04604795|584517299|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857272|NCT04604795|584517300|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857273|NCT04604795|584517301|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161857274|NCT04604795|584517302|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161769523|NCT02777554|584198478|FG003|Overall Study|Discharged early due to hurricane|0|||
161769524|NCT02777554|584198479|FG004|Overall Study|Discharged early due to hurricane|0|||
161769525|NCT02777554|584198480|FG005|Overall Study|Discharged early due to hurricane|0|||
161769526|NCT02777554|584198475|FG000|Overall Study|Other - Miscellaneous|1|||
161769527|NCT02777554|584198476|FG001|Overall Study|Other - Miscellaneous|0|||
161769528|NCT02777554|584198477|FG002|Overall Study|Other - Miscellaneous|0|||
161769529|NCT02777554|584198478|FG003|Overall Study|Other - Miscellaneous|0|||
161769530|NCT02777554|584198479|FG004|Overall Study|Other - Miscellaneous|0|||
161769531|NCT02777554|584198480|FG005|Overall Study|Other - Miscellaneous|0|||
161769532|NCT02147132|584198481|FG000|Overall Study|Lost to Follow-up|1|||
161769533|NCT02147132|584198482|FG001|Overall Study|Lost to Follow-up|0|||
161769534|NCT02147132|584198483|FG002|Overall Study|Lost to Follow-up|0|||
161769535|NCT02147132|584198484|FG003|Overall Study|Lost to Follow-up|0|||
161769536|NCT01013207|584198485|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
161769537|NCT01541644|584198490|FG000|Overall Study|Withdrawal by Subject|3|||
161769538|NCT01458535|584198493|FG000|Overall Study|Other|0|||
161769539|NCT01458535|584198494|FG001|Overall Study|Other|0|||
161769540|NCT01458535|584198495|FG002|Overall Study|Other|0|||
161769541|NCT01458535|584198496|FG003|Overall Study|Other|0|||
161769542|NCT01458535|584198497|FG004|Overall Study|Other|1|||
161769543|NCT01458535|584198498|FG005|Overall Study|Other|1|||
161769544|NCT01458535|584198493|FG000|Overall Study|Withdrawal by Subject|0|||
161769545|NCT01458535|584198494|FG001|Overall Study|Withdrawal by Subject|0|||
161769546|NCT01458535|584198495|FG002|Overall Study|Withdrawal by Subject|2|||
161769547|NCT01458535|584198496|FG003|Overall Study|Withdrawal by Subject|0|||
161769548|NCT01458535|584198497|FG004|Overall Study|Withdrawal by Subject|1|||
161769549|NCT01458535|584198498|FG005|Overall Study|Withdrawal by Subject|1|||
161769550|NCT01458535|584198493|FG000|Overall Study|Lost to Follow-up|0|||
161769551|NCT01458535|584198494|FG001|Overall Study|Lost to Follow-up|2|||
161769552|NCT01458535|584198495|FG002|Overall Study|Lost to Follow-up|0|||
161769553|NCT01458535|584198496|FG003|Overall Study|Lost to Follow-up|3|||
161769554|NCT01458535|584198497|FG004|Overall Study|Lost to Follow-up|2|||
161769555|NCT01458535|584198498|FG005|Overall Study|Lost to Follow-up|2|||
161769556|NCT01458535|584198493|FG000|Overall Study|Adverse Event|0|||
161769557|NCT01458535|584198494|FG001|Overall Study|Adverse Event|0|||
161769558|NCT01458535|584198495|FG002|Overall Study|Adverse Event|0|||
161769559|NCT01458535|584198496|FG003|Overall Study|Adverse Event|1|||
161769560|NCT01458535|584198497|FG004|Overall Study|Adverse Event|0|||
161769561|NCT01458535|584198498|FG005|Overall Study|Adverse Event|0|||
161769562|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
161769563|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
161769564|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769565|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769566|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769567|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769568|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769569|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769570|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769571|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769572|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769573|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161769574|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
161769575|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769576|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769577|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769578|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769579|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769580|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
161769581|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769582|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769583|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769584|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
161769585|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161769586|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769587|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
161769588|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769589|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769590|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769591|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769592|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769593|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769594|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769595|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769596|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769597|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161769598|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
161769599|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
161769600|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
161769601|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
161769602|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
161769603|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
161769604|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
161769605|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
161769606|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
161769607|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
161769608|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
161769609|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
161769610|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769611|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769612|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769613|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769614|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769615|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
161769616|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769617|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769618|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769619|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769620|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769621|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161769622|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769623|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769624|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769625|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769626|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769627|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
161769628|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769629|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769630|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769631|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769632|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769633|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161769634|NCT00151775|584198499|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769635|NCT00151775|584198500|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769636|NCT00151775|584198501|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769637|NCT00151775|584198502|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769638|NCT00151775|584198503|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769639|NCT00151775|584198504|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769640|NCT00151775|584198505|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
161769641|NCT00151775|584198506|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769642|NCT00151775|584198507|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769643|NCT00151775|584198508|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769644|NCT00151775|584198509|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769645|NCT00151775|584198510|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161769646|NCT00151775|584198499|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769647|NCT00151775|584198500|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769648|NCT00151775|584198501|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769649|NCT00151775|584198502|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769650|NCT00151775|584198503|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769651|NCT00151775|584198504|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
161769652|NCT00151775|584198505|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769653|NCT00151775|584198506|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769654|NCT00151775|584198507|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769655|NCT00151775|584198508|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769656|NCT00151775|584198509|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769657|NCT00151775|584198510|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161769658|NCT00151775|584198499|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
161769659|NCT00151775|584198500|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
161857275|NCT04604795|584517303|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
161857276|NCT04604795|584517294|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857277|NCT04604795|584517295|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857278|NCT04604795|584517296|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857279|NCT04604795|584517297|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857280|NCT04604795|584517298|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857281|NCT04604795|584517299|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857282|NCT04604795|584517300|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857283|NCT04604795|584517301|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857284|NCT04604795|584517302|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
161857285|NCT04604795|584517303|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161857286|NCT04604795|584517294|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857287|NCT04604795|584517295|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857288|NCT04604795|584517296|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857289|NCT04604795|584517297|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857290|NCT04604795|584517298|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857291|NCT04604795|584517299|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857292|NCT04604795|584517300|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857293|NCT04604795|584517301|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857294|NCT04604795|584517302|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
161857295|NCT04604795|584517303|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161857296|NCT04604795|584517294|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857297|NCT04604795|584517295|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857298|NCT04604795|584517296|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857299|NCT04604795|584517297|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857300|NCT04604795|584517298|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857301|NCT04604795|584517299|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857302|NCT04604795|584517300|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857303|NCT04604795|584517301|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857304|NCT04604795|584517302|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
161857305|NCT04604795|584517303|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
161857306|NCT01590277|584517306|FG000|Overall Study|Withdrawal by Subject|3|||
161857307|NCT01590277|584517306|FG000|Overall Study|Withdrawal by Subject|2|||
161857308|NCT01590277|584517306|FG000|Overall Study|Withdrawal by Subject|1|||
161857309|NCT01590277|584517306|FG000|Overall Study|Withdrawal by Subject|1|||
161857310|NCT04386616|584517307|FG000|Overall Study|Death|22|||
161857311|NCT04386616|584517308|FG001|Overall Study|Death|22|||
161857312|NCT04386616|584517309|FG002|Overall Study|Death|21|||
161857313|NCT04386616|584517307|FG000|Overall Study|Lost to Follow-up|5|||
161857314|NCT04386616|584517308|FG001|Overall Study|Lost to Follow-up|8|||
161857315|NCT04386616|584517309|FG002|Overall Study|Lost to Follow-up|6|||
161857316|NCT04386616|584517307|FG000|Overall Study|Withdrawal by Subject|2|||
161857317|NCT04386616|584517308|FG001|Overall Study|Withdrawal by Subject|4|||
161857318|NCT04386616|584517309|FG002|Overall Study|Withdrawal by Subject|1|||
161857319|NCT04386616|584517307|FG000|Overall Study|Adverse Event|1|||
161857320|NCT04386616|584517308|FG001|Overall Study|Adverse Event|1|||
161857321|NCT04386616|584517309|FG002|Overall Study|Adverse Event|0|||
161857322|NCT01377012|584517310|FG000|Core Study|Study terminated by Sponsor|47|||
161857323|NCT01377012|584517311|FG001|Core Study|Study terminated by Sponsor|54|||
161857324|NCT01377012|584517312|FG002|Core Study|Study terminated by Sponsor|46|||
161857325|NCT01377012|584517310|FG000|Core Study|Technical problems|1|||
161857326|NCT01377012|584517311|FG001|Core Study|Technical problems|0|||
161857327|NCT01377012|584517312|FG002|Core Study|Technical problems|0|||
161857328|NCT01377012|584517310|FG000|Core Study|Withdrawal by Subject|15|||
161857329|NCT01377012|584517311|FG001|Core Study|Withdrawal by Subject|23|||
161857330|NCT01377012|584517312|FG002|Core Study|Withdrawal by Subject|18|||
161857331|NCT01377012|584517310|FG000|Core Study|Protocol Violation|7|||
161857332|NCT01377012|584517311|FG001|Core Study|Protocol Violation|3|||
161857333|NCT01377012|584517312|FG002|Core Study|Protocol Violation|2|||
161857334|NCT01377012|584517310|FG000|Core Study|Pregnancy|0|||
161857335|NCT01377012|584517311|FG001|Core Study|Pregnancy|0|||
161857336|NCT01377012|584517312|FG002|Core Study|Pregnancy|1|||
161857337|NCT01377012|584517310|FG000|Core Study|Physician Decision|5|||
161857338|NCT01377012|584517311|FG001|Core Study|Physician Decision|4|||
161975245|NCT01352741|584958455|FG000|Double-blind Comparative Period|Other|1|||
161975246|NCT01352741|584958456|FG001|Double-blind Comparative Period|Other|2|||
161857339|NCT01377012|584517312|FG002|Core Study|Physician Decision|10|||
161975247|NCT01352741|584958455|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
161857340|NCT01377012|584517310|FG000|Core Study|Non-Compliant with study treatment|0|||
161857341|NCT01377012|584517311|FG001|Core Study|Non-Compliant with study treatment|0|||
161857342|NCT01377012|584517312|FG002|Core Study|Non-Compliant with study treatment|1|||
161857343|NCT01377012|584517310|FG000|Core Study|No Longer require treatment|0|||
161857344|NCT01377012|584517311|FG001|Core Study|No Longer require treatment|0|||
161857345|NCT01377012|584517312|FG002|Core Study|No Longer require treatment|1|||
161857346|NCT01377012|584517310|FG000|Core Study|Lost to Follow-up|7|||
161857347|NCT01377012|584517311|FG001|Core Study|Lost to Follow-up|5|||
161857348|NCT01377012|584517312|FG002|Core Study|Lost to Follow-up|4|||
161857349|NCT01377012|584517310|FG000|Core Study|Lack of Efficacy|41|||
161857350|NCT01377012|584517311|FG001|Core Study|Lack of Efficacy|28|||
161857351|NCT01377012|584517312|FG002|Core Study|Lack of Efficacy|37|||
161857352|NCT01377012|584517310|FG000|Core Study|Death|1|||
161857353|NCT01377012|584517311|FG001|Core Study|Death|1|||
161857354|NCT01377012|584517312|FG002|Core Study|Death|1|||
161857355|NCT01377012|584517310|FG000|Core Study|Adverse Event|10|||
161857356|NCT01377012|584517311|FG001|Core Study|Adverse Event|14|||
161857357|NCT01377012|584517312|FG002|Core Study|Adverse Event|13|||
161857358|NCT01377012|584517310|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
161857359|NCT01377012|584517311|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
161857360|NCT01377012|584517312|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
161857361|NCT01377012|584517310|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
161857362|NCT01377012|584517311|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
161857363|NCT01377012|584517312|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
161857364|NCT01377012|584517310|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
161857365|NCT01377012|584517311|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
161857366|NCT01377012|584517312|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
161857367|NCT01377012|584517310|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
161857368|NCT01377012|584517311|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
161857369|NCT01377012|584517312|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
161857370|NCT01377012|584517310|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
161857371|NCT01377012|584517311|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
161857372|NCT01377012|584517312|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
161857373|NCT01377012|584517310|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
161857374|NCT01377012|584517311|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
161857375|NCT01377012|584517312|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
161857376|NCT00805961|584517313|FG000|Modality Therapy|Withdrawal by Subject|1|||
161857377|NCT00805961|584517313|FG000|Modality Therapy|Adverse Event|1|||
161857378|NCT00805961|584517313|FG000|Modality Therapy|Disease Progression|2|||
161857379|NCT00805961|584517313|FG000|Treatment-Free Interval|Adverse Event|3|||
161857380|NCT00805961|584517313|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
161857381|NCT00805961|584517313|FG000|Treatment-Free Interval|Physician Decision|1|||
161857382|NCT00805961|584517313|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
161857383|NCT00805961|584517313|FG000|Maintenance Treatment|Lack of Efficacy|13|||
161857384|NCT00805961|584517313|FG000|Maintenance Treatment|Intercurrent Illness|7|||
161857385|NCT00805961|584517313|FG000|Maintenance Treatment|Adverse Event|6|||
161857386|NCT00805961|584517313|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
161857387|NCT00805961|584517313|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
161857388|NCT00805961|584517313|FG000|Maintenance Treatment|Withdrawn Consent|1|||
161857389|NCT05061134|584518990|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
161857390|NCT05061134|584518991|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
161857391|NCT05061134|584518992|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
161857392|NCT05061134|584518990|FG000|Overall Study|Subject not treated|0|||
161857393|NCT05061134|584518991|FG001|Overall Study|Subject not treated|0|||
161857394|NCT05061134|584518992|FG002|Overall Study|Subject not treated|2|||
161857395|NCT05061134|584518990|FG000|Overall Study|Other|0|||
161857396|NCT05061134|584518991|FG001|Overall Study|Other|0|||
161857397|NCT05061134|584518992|FG002|Overall Study|Other|9|||
161857398|NCT05061134|584518990|FG000|Overall Study|Withdrawal by Subject|9|||
161857399|NCT05061134|584518991|FG001|Overall Study|Withdrawal by Subject|8|||
161857400|NCT05061134|584518992|FG002|Overall Study|Withdrawal by Subject|5|||
161857401|NCT05061134|584518990|FG000|Overall Study|Study Terminated by Sponsor|22|||
161857402|NCT05061134|584518991|FG001|Overall Study|Study Terminated by Sponsor|14|||
161857403|NCT05061134|584518992|FG002|Overall Study|Study Terminated by Sponsor|7|||
161857404|NCT05061134|584518990|FG000|Overall Study|Progressive Disease|1|||
161857405|NCT05061134|584518991|FG001|Overall Study|Progressive Disease|2|||
161857406|NCT05061134|584518992|FG002|Overall Study|Progressive Disease|0|||
161857407|NCT05061134|584518990|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
161857408|NCT05061134|584518991|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
161857409|NCT05061134|584518992|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
161857410|NCT05061134|584518990|FG000|Overall Study|Lost to Follow-up|1|||
161857411|NCT05061134|584518991|FG001|Overall Study|Lost to Follow-up|0|||
161857412|NCT05061134|584518992|FG002|Overall Study|Lost to Follow-up|0|||
161857413|NCT05061134|584518990|FG000|Overall Study|Physician Decision|1|||
161857414|NCT05061134|584518991|FG001|Overall Study|Physician Decision|1|||
161857415|NCT05061134|584518992|FG002|Overall Study|Physician Decision|0|||
161857416|NCT05061134|584518990|FG000|Overall Study|Disease progression|1|||
161857417|NCT05061134|584518991|FG001|Overall Study|Disease progression|0|||
161975248|NCT01352741|584958456|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
161975249|NCT01352741|584958455|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
161975250|NCT01352741|584958456|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
161975251|NCT01352741|584958455|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
161975252|NCT01352741|584958456|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
161975253|NCT01352741|584958455|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
161975254|NCT01352741|584958456|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
161975255|NCT01367704|584958457|FG000|Overall Study|Lost to Follow-up|47|||
161975256|NCT01367704|584958458|FG001|Overall Study|Lost to Follow-up|161|||
161975257|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
161975258|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
161975259|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
161975260|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
161975261|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
161975262|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
161975263|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
161975264|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
161975265|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
161975266|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
161975267|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
161975268|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
161975269|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
161975270|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
161975271|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
161975272|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
161975273|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
161975274|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
161975275|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
161975276|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
162034304|NCT05217927|585181206|FG002|DBT Phase|Protocol Violation|1|||
161769660|NCT00151775|584198501|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
161769661|NCT00151775|584198502|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
161769662|NCT00151775|584198503|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
161769663|NCT00151775|584198504|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
161769664|NCT00151775|584198505|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
161769665|NCT00151775|584198506|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
161769666|NCT00151775|584198507|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
161769667|NCT00151775|584198508|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
161769668|NCT00151775|584198509|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
161769669|NCT00151775|584198510|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
161769670|NCT00151775|584198499|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769671|NCT00151775|584198500|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769672|NCT00151775|584198501|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769673|NCT00151775|584198502|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769674|NCT00151775|584198503|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769675|NCT00151775|584198504|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769676|NCT00151775|584198505|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
161769677|NCT00151775|584198506|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769678|NCT00151775|584198507|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769679|NCT00151775|584198508|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769680|NCT00151775|584198509|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769681|NCT00151775|584198510|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161769682|NCT00151775|584198499|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769683|NCT00151775|584198500|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769684|NCT00151775|584198501|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
161769685|NCT00151775|584198502|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769686|NCT00151775|584198503|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769687|NCT00151775|584198504|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769688|NCT00151775|584198505|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769689|NCT00151775|584198506|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769690|NCT00151775|584198507|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769691|NCT00151775|584198508|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769692|NCT00151775|584198509|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769693|NCT00151775|584198510|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161769694|NCT00151775|584198499|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769695|NCT00151775|584198500|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161975277|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
161975278|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
161975279|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
161975280|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
161975281|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
161857418|NCT05061134|584518992|FG002|Overall Study|Disease progression|0|||
161857419|NCT05061134|584518990|FG000|Overall Study|Death|43|||
161857420|NCT05061134|584518991|FG001|Overall Study|Death|23|||
161857421|NCT05061134|584518992|FG002|Overall Study|Death|14|||
161857422|NCT05061134|584518990|FG000|Overall Study|Database lock|2|||
161857423|NCT05061134|584518991|FG001|Overall Study|Database lock|0|||
161857424|NCT05061134|584518992|FG002|Overall Study|Database lock|0|||
161857425|NCT03176134|584518993|FG000|Overall Study|Lost to Follow-up|0|||
161857426|NCT03176134|584518994|FG001|Overall Study|Lost to Follow-up|2|||
161857427|NCT03176134|584518995|FG002|Overall Study|Lost to Follow-up|0|||
161857428|NCT03176134|584518996|FG003|Overall Study|Lost to Follow-up|0|||
161857429|NCT03176134|584518997|FG004|Overall Study|Lost to Follow-up|0|||
161857430|NCT03176134|584518998|FG005|Overall Study|Lost to Follow-up|0|||
161857431|NCT03176134|584518999|FG006|Overall Study|Lost to Follow-up|0|||
161975282|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
161857432|NCT03176134|584519000|FG007|Overall Study|Lost to Follow-up|0|||
161857433|NCT03176134|584518993|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161857434|NCT03176134|584518994|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161857435|NCT03176134|584518995|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
161857436|NCT03176134|584518996|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161857437|NCT03176134|584518997|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161857438|NCT03176134|584518998|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161857439|NCT03176134|584518999|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
161857440|NCT03176134|584519000|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
161857441|NCT03410056|584519005|FG000|Overall Study|Decision by Sponsor|0|||
161857442|NCT03410056|584519006|FG001|Overall Study|Decision by Sponsor|0|||
161857443|NCT03410056|584519007|FG002|Overall Study|Decision by Sponsor|3|||
161857444|NCT03410056|584519008|FG003|Overall Study|Decision by Sponsor|0|||
161857445|NCT03410056|584519009|FG004|Overall Study|Decision by Sponsor|0|||
161857446|NCT03410056|584519010|FG005|Overall Study|Decision by Sponsor|0|||
161857447|NCT03410056|584519011|FG006|Overall Study|Decision by Sponsor|0|||
161857448|NCT03410056|584519005|FG000|Overall Study|Withdrawal by Subject|0|||
161857449|NCT03410056|584519006|FG001|Overall Study|Withdrawal by Subject|2|||
161857450|NCT03410056|584519007|FG002|Overall Study|Withdrawal by Subject|5|||
161857451|NCT03410056|584519008|FG003|Overall Study|Withdrawal by Subject|5|||
161857452|NCT03410056|584519009|FG004|Overall Study|Withdrawal by Subject|0|||
161857453|NCT03410056|584519010|FG005|Overall Study|Withdrawal by Subject|0|||
161857454|NCT03410056|584519011|FG006|Overall Study|Withdrawal by Subject|0|||
161857455|NCT02762929|584519012|FG000|Overall Study|Adverse Event|0|||
161857456|NCT02762929|584519013|FG001|Overall Study|Adverse Event|0|||
161857457|NCT02762929|584519014|FG002|Overall Study|Adverse Event|0|||
161857458|NCT02762929|584519015|FG003|Overall Study|Adverse Event|1|||
161857459|NCT02762929|584519016|FG004|Overall Study|Adverse Event|0|||
161857460|NCT02762929|584519017|FG005|Overall Study|Adverse Event|0|||
161857461|NCT02762929|584519012|FG000|Overall Study|Lost to Follow-up|1|||
161857462|NCT02762929|584519013|FG001|Overall Study|Lost to Follow-up|2|||
161857463|NCT02762929|584519014|FG002|Overall Study|Lost to Follow-up|0|||
161857464|NCT02762929|584519015|FG003|Overall Study|Lost to Follow-up|1|||
161857465|NCT02762929|584519016|FG004|Overall Study|Lost to Follow-up|0|||
161857466|NCT02762929|584519017|FG005|Overall Study|Lost to Follow-up|0|||
161857467|NCT02762929|584519012|FG000|Overall Study|Withdrawal by Subject|0|||
161857468|NCT02762929|584519013|FG001|Overall Study|Withdrawal by Subject|1|||
161857469|NCT02762929|584519014|FG002|Overall Study|Withdrawal by Subject|0|||
161857470|NCT02762929|584519015|FG003|Overall Study|Withdrawal by Subject|0|||
161857471|NCT02762929|584519016|FG004|Overall Study|Withdrawal by Subject|0|||
161975283|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
161975284|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
161975285|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
161975286|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
161975287|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
161975288|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
161857472|NCT02762929|584519017|FG005|Overall Study|Withdrawal by Subject|0|||
161857473|NCT02762929|584519012|FG000|Overall Study|exclusionary medication disclosed late|0|||
161857474|NCT02762929|584519013|FG001|Overall Study|exclusionary medication disclosed late|0|||
161857475|NCT02762929|584519014|FG002|Overall Study|exclusionary medication disclosed late|0|||
161857476|NCT02762929|584519015|FG003|Overall Study|exclusionary medication disclosed late|1|||
161857477|NCT02762929|584519016|FG004|Overall Study|exclusionary medication disclosed late|0|||
161857478|NCT02762929|584519017|FG005|Overall Study|exclusionary medication disclosed late|0|||
161857479|NCT02366689|584519024|FG000|Overall Study|Withdrawal by Subject|1|||
161857480|NCT02366689|584519025|FG001|Overall Study|Withdrawal by Subject|0|||
161857481|NCT02366689|584519026|FG002|Overall Study|Withdrawal by Subject|1|||
161857482|NCT02366689|584519024|FG000|Overall Study|Lost to Follow-up|3|||
161857483|NCT02366689|584519025|FG001|Overall Study|Lost to Follow-up|2|||
161857484|NCT02366689|584519026|FG002|Overall Study|Lost to Follow-up|0|||
161857485|NCT02366689|584519024|FG000|Overall Study|Pregnancy|0|||
161857486|NCT02366689|584519025|FG001|Overall Study|Pregnancy|1|||
161857487|NCT02366689|584519026|FG002|Overall Study|Pregnancy|1|||
161857488|NCT03718832|584519027|FG000|Analysis Sample|Withdrawal by Subject|18|||
161857489|NCT03718832|584519028|FG001|Analysis Sample|Withdrawal by Subject|15|||
161857490|NCT03718832|584519027|FG000|Analysis Sample|Legal hold on data|1|||
161857491|NCT03718832|584519028|FG001|Analysis Sample|Legal hold on data|0|||
161975289|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
161975290|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
161975291|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
161975292|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
161975293|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
161975294|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
161975295|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
161975296|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
162034305|NCT05217927|585181204|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
162034306|NCT05217927|585181205|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
162034307|NCT05217927|585181206|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
161857492|NCT03718832|584519027|FG000|Analysis Sample|Participant from treated household|0|||
161857493|NCT03718832|584519028|FG001|Analysis Sample|Participant from treated household|1|||
161857494|NCT03718832|584519027|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
161857495|NCT03718832|584519028|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
161857496|NCT01996241|584519029|FG000|Overall Study|Lost to Follow-up|252|||
161857497|NCT01996241|584519030|FG001|Overall Study|Lost to Follow-up|235|||
161857498|NCT01068262|584519034|FG000|Overall Study|Adverse Event|2|||
161857499|NCT01068262|584519035|FG001|Overall Study|Adverse Event|0|||
161857500|NCT01068262|584519036|FG002|Overall Study|Adverse Event|1|||
161857501|NCT01068262|584519037|FG003|Overall Study|Adverse Event|0|||
161857502|NCT01068262|584519034|FG000|Overall Study|Protocol Violation|1|||
161857503|NCT01068262|584519035|FG001|Overall Study|Protocol Violation|0|||
161857504|NCT01068262|584519036|FG002|Overall Study|Protocol Violation|0|||
161857505|NCT01068262|584519037|FG003|Overall Study|Protocol Violation|0|||
161857506|NCT01068262|584519034|FG000|Overall Study|Withdrawal by Subject|0|||
161857507|NCT01068262|584519035|FG001|Overall Study|Withdrawal by Subject|1|||
161857508|NCT01068262|584519036|FG002|Overall Study|Withdrawal by Subject|0|||
161857509|NCT01068262|584519037|FG003|Overall Study|Withdrawal by Subject|0|||
161857510|NCT04182490|584519038|FG000|Overall Study|Withdrawal by Subject|3|||
161857511|NCT04182490|584519039|FG001|Overall Study|Withdrawal by Subject|3|||
161857512|NCT04182490|584519038|FG000|Overall Study|Lost to Follow-up|0|||
161857513|NCT04182490|584519039|FG001|Overall Study|Lost to Follow-up|1|||
161857514|NCT04182490|584519038|FG000|Overall Study|Physician Decision|0|||
161857515|NCT04182490|584519039|FG001|Overall Study|Physician Decision|1|||
161857516|NCT01811472|584519045|FG000|Overall Study|Adverse Event|1|||
161857517|NCT01811472|584519046|FG001|Overall Study|Adverse Event|0|||
161857518|NCT01811472|584519047|FG002|Overall Study|Adverse Event|4|||
161857519|NCT01811472|584519045|FG000|Overall Study|Lost to Follow-up|0|||
161857520|NCT01811472|584519046|FG001|Overall Study|Lost to Follow-up|0|||
161857521|NCT01811472|584519047|FG002|Overall Study|Lost to Follow-up|1|||
161857522|NCT01811472|584519045|FG000|Overall Study|Subject/guardian decision|1|||
161975297|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
161975298|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
161975299|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
161975300|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
161975301|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
162034308|NCT05217927|585181204|FG000|DBT Phase|Withdrawal of consent|8|||
162034309|NCT05217927|585181205|FG001|DBT Phase|Withdrawal of consent|5|||
162034310|NCT05217927|585181206|FG002|DBT Phase|Withdrawal of consent|7|||
161857523|NCT01811472|584519046|FG001|Overall Study|Subject/guardian decision|0|||
161857524|NCT01811472|584519047|FG002|Overall Study|Subject/guardian decision|0|||
161857525|NCT01350271|584519056|FG000|Overall Study|Lost to Follow-up|21|||
161857526|NCT01350271|584519057|FG001|Overall Study|Lost to Follow-up|17|||
161857527|NCT01350271|584519058|FG002|Overall Study|Lost to Follow-up|26|||
161857528|NCT01973439|584519059|FG000|Overall Study|Lost samples from one PK Day|2|||
161857529|NCT01973439|584519059|FG000|Overall Study|Vomiting after commencing once daily|1|||
161857530|NCT01973439|584519059|FG000|Overall Study|PK curve incomplete|2|||
161857531|NCT00344448|584519060|FG000|Screening|Withdrawal by Subject|0|||
161857532|NCT00344448|584519061|FG001|Screening|Withdrawal by Subject|1|||
161975302|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
161975303|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
161975304|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
161975305|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
161769696|NCT00151775|584198501|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
161769697|NCT00151775|584198502|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769698|NCT00151775|584198503|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769699|NCT00151775|584198504|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769700|NCT00151775|584198505|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769701|NCT00151775|584198506|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769702|NCT00151775|584198507|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769703|NCT00151775|584198508|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769704|NCT00151775|584198509|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769705|NCT00151775|584198510|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161769706|NCT00151775|584198499|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769707|NCT00151775|584198500|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769708|NCT00151775|584198501|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769709|NCT00151775|584198502|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769710|NCT00151775|584198503|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769711|NCT00151775|584198504|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769712|NCT00151775|584198505|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769713|NCT00151775|584198506|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769714|NCT00151775|584198507|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769715|NCT00151775|584198508|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769716|NCT00151775|584198509|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161769717|NCT00151775|584198510|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
161769718|NCT00151775|584198499|FG000|Period 4: Open Label|Increased blood pressure|0|||
161769719|NCT00151775|584198500|FG001|Period 4: Open Label|Increased blood pressure|0|||
161769720|NCT00151775|584198501|FG002|Period 4: Open Label|Increased blood pressure|0|||
161769721|NCT00151775|584198502|FG003|Period 4: Open Label|Increased blood pressure|0|||
161769722|NCT00151775|584198503|FG004|Period 4: Open Label|Increased blood pressure|1|||
161769723|NCT00151775|584198504|FG005|Period 4: Open Label|Increased blood pressure|0|||
161769724|NCT00151775|584198505|FG006|Period 4: Open Label|Increased blood pressure|0|||
161769725|NCT00151775|584198506|FG007|Period 4: Open Label|Increased blood pressure|0|||
161769726|NCT00151775|584198507|FG008|Period 4: Open Label|Increased blood pressure|0|||
161769727|NCT00151775|584198508|FG009|Period 4: Open Label|Increased blood pressure|1|||
161769728|NCT00151775|584198509|FG010|Period 4: Open Label|Increased blood pressure|0|||
161769729|NCT00151775|584198510|FG011|Period 4: Open Label|Increased blood pressure|0|||
161769730|NCT00151775|584198499|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
161769731|NCT00151775|584198500|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
161769732|NCT00151775|584198501|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
161769733|NCT00151775|584198502|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
161769734|NCT00151775|584198503|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
161769735|NCT00151775|584198504|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
161769736|NCT00151775|584198505|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
161769737|NCT00151775|584198506|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
161769738|NCT00151775|584198507|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
161769739|NCT00151775|584198508|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
161769740|NCT00151775|584198509|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
161769741|NCT00151775|584198510|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
161769742|NCT00151775|584198499|FG000|Period 4: Open Label|Adverse Event|0|||
161769743|NCT00151775|584198500|FG001|Period 4: Open Label|Adverse Event|0|||
161769744|NCT00151775|584198501|FG002|Period 4: Open Label|Adverse Event|0|||
161769745|NCT00151775|584198502|FG003|Period 4: Open Label|Adverse Event|0|||
161769746|NCT00151775|584198503|FG004|Period 4: Open Label|Adverse Event|1|||
161769747|NCT00151775|584198504|FG005|Period 4: Open Label|Adverse Event|0|||
161769748|NCT00151775|584198505|FG006|Period 4: Open Label|Adverse Event|0|||
161769749|NCT00151775|584198506|FG007|Period 4: Open Label|Adverse Event|0|||
161769750|NCT00151775|584198507|FG008|Period 4: Open Label|Adverse Event|0|||
161769751|NCT00151775|584198508|FG009|Period 4: Open Label|Adverse Event|2|||
161769752|NCT00151775|584198509|FG010|Period 4: Open Label|Adverse Event|0|||
161769753|NCT00151775|584198510|FG011|Period 4: Open Label|Adverse Event|0|||
161769754|NCT00151775|584198499|FG000|Period 4: Open Label|Lost to Follow-up|0|||
161769755|NCT00151775|584198500|FG001|Period 4: Open Label|Lost to Follow-up|0|||
161769756|NCT00151775|584198501|FG002|Period 4: Open Label|Lost to Follow-up|0|||
161769757|NCT00151775|584198502|FG003|Period 4: Open Label|Lost to Follow-up|0|||
161769758|NCT00151775|584198503|FG004|Period 4: Open Label|Lost to Follow-up|17|||
161769759|NCT00151775|584198504|FG005|Period 4: Open Label|Lost to Follow-up|0|||
161769760|NCT00151775|584198505|FG006|Period 4: Open Label|Lost to Follow-up|0|||
161769761|NCT00151775|584198506|FG007|Period 4: Open Label|Lost to Follow-up|0|||
161769762|NCT00151775|584198507|FG008|Period 4: Open Label|Lost to Follow-up|0|||
161769763|NCT00151775|584198508|FG009|Period 4: Open Label|Lost to Follow-up|7|||
161769764|NCT00151775|584198509|FG010|Period 4: Open Label|Lost to Follow-up|0|||
161769765|NCT00151775|584198510|FG011|Period 4: Open Label|Lost to Follow-up|0|||
161769766|NCT00151775|584198499|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
161769767|NCT00151775|584198500|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
161769768|NCT00151775|584198501|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
161769769|NCT00151775|584198502|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
161769770|NCT00151775|584198503|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
161769771|NCT00151775|584198504|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
161769772|NCT00151775|584198505|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
161769773|NCT00151775|584198506|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
161769774|NCT00151775|584198507|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
161769775|NCT00151775|584198508|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
161769776|NCT00151775|584198509|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
161769777|NCT00151775|584198510|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
161769778|NCT00151775|584198499|FG000|Period 4: Open Label|Other|0|||
161769779|NCT00151775|584198500|FG001|Period 4: Open Label|Other|0|||
161769780|NCT00151775|584198501|FG002|Period 4: Open Label|Other|0|||
161769781|NCT00151775|584198502|FG003|Period 4: Open Label|Other|0|||
161769782|NCT00151775|584198503|FG004|Period 4: Open Label|Other|1|||
161769783|NCT00151775|584198504|FG005|Period 4: Open Label|Other|0|||
161769784|NCT00151775|584198505|FG006|Period 4: Open Label|Other|0|||
161769785|NCT00151775|584198506|FG007|Period 4: Open Label|Other|0|||
161769786|NCT00151775|584198507|FG008|Period 4: Open Label|Other|0|||
161769787|NCT00151775|584198508|FG009|Period 4: Open Label|Other|3|||
161769788|NCT00151775|584198509|FG010|Period 4: Open Label|Other|0|||
161769789|NCT00151775|584198510|FG011|Period 4: Open Label|Other|0|||
161769790|NCT00151775|584198499|FG000|Period 4: Open Label|Physician Decision|0|||
161769791|NCT00151775|584198500|FG001|Period 4: Open Label|Physician Decision|0|||
161769792|NCT00151775|584198501|FG002|Period 4: Open Label|Physician Decision|0|||
161769793|NCT00151775|584198502|FG003|Period 4: Open Label|Physician Decision|0|||
161769794|NCT00151775|584198503|FG004|Period 4: Open Label|Physician Decision|0|||
161769795|NCT00151775|584198504|FG005|Period 4: Open Label|Physician Decision|0|||
161769796|NCT00151775|584198505|FG006|Period 4: Open Label|Physician Decision|0|||
161769797|NCT00151775|584198506|FG007|Period 4: Open Label|Physician Decision|0|||
161769798|NCT00151775|584198507|FG008|Period 4: Open Label|Physician Decision|0|||
161769799|NCT00151775|584198508|FG009|Period 4: Open Label|Physician Decision|2|||
161769800|NCT00151775|584198509|FG010|Period 4: Open Label|Physician Decision|0|||
161769801|NCT00151775|584198510|FG011|Period 4: Open Label|Physician Decision|0|||
161769802|NCT00151775|584198499|FG000|Period 4: Open Label|Protocol Violation|0|||
161769803|NCT00151775|584198500|FG001|Period 4: Open Label|Protocol Violation|0|||
161769804|NCT00151775|584198501|FG002|Period 4: Open Label|Protocol Violation|0|||
161769805|NCT00151775|584198502|FG003|Period 4: Open Label|Protocol Violation|0|||
161769806|NCT00151775|584198503|FG004|Period 4: Open Label|Protocol Violation|1|||
161769807|NCT00151775|584198504|FG005|Period 4: Open Label|Protocol Violation|0|||
161769808|NCT00151775|584198505|FG006|Period 4: Open Label|Protocol Violation|0|||
161769809|NCT00151775|584198506|FG007|Period 4: Open Label|Protocol Violation|0|||
161769810|NCT00151775|584198507|FG008|Period 4: Open Label|Protocol Violation|0|||
161769811|NCT00151775|584198508|FG009|Period 4: Open Label|Protocol Violation|0|||
161769812|NCT00151775|584198509|FG010|Period 4: Open Label|Protocol Violation|0|||
161769813|NCT00151775|584198510|FG011|Period 4: Open Label|Protocol Violation|0|||
161769814|NCT00474994|584198511|FG000|Overall Study|Patient Not treated|1|||
161769815|NCT00474994|584198511|FG000|Overall Study|Patient evaluable for toxicity only|3|||
161769816|NCT00474994|584198511|FG000|Overall Study|Patient found to be ineligible|1|||
161769817|NCT00278473|584198512|FG000|Overall Study|drop out|4|||
161769818|NCT00278473|584198513|FG001|Overall Study|drop out|3|||
161769819|NCT00761761|584198514|FG000|Overall Study|Lost to Follow-up|3|||
161769820|NCT00761761|584198515|FG001|Overall Study|Lost to Follow-up|1|||
161769821|NCT00761761|584198514|FG000|Overall Study|Withdrawal by Subject|3|||
161769822|NCT00761761|584198515|FG001|Overall Study|Withdrawal by Subject|0|||
161769823|NCT04001790|584198516|FG000|Overall Study|Withdrawal by Subject|1|||
161769824|NCT04001790|584198517|FG001|Overall Study|Withdrawal by Subject|2|||
161769825|NCT01711736|584198518|FG000|Overall Study|Lost to Follow-up|4|||
161769826|NCT01711736|584198519|FG001|Overall Study|Lost to Follow-up|1|||
161769827|NCT01711736|584198518|FG000|Overall Study|Withdrawal by Subject|6|||
161769828|NCT01711736|584198519|FG001|Overall Study|Withdrawal by Subject|6|||
161769829|NCT01711736|584198518|FG000|Overall Study|Migrated/moved from study area|2|||
161769830|NCT01711736|584198519|FG001|Overall Study|Migrated/moved from study area|1|||
161769831|NCT02706327|584198520|FG000|Overall Study|Lost to Follow-up|1|||
161769832|NCT02706327|584198521|FG001|Overall Study|Lost to Follow-up|1|||
161769833|NCT02706327|584198522|FG002|Overall Study|Lost to Follow-up|2|||
161769834|NCT02652793|584198525|FG000|Overall Study|Adverse Event|1|||
161769835|NCT02652793|584198525|FG000|Overall Study|Lost to Follow-up|2|||
161857533|NCT00344448|584519060|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
161857534|NCT00344448|584519061|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
161857535|NCT00344448|584519060|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
161857536|NCT00344448|584519061|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
161857537|NCT00344448|584519060|FG000|Open Label|Withdrawal by Subject|1|||
161857538|NCT00344448|584519061|FG001|Open Label|Withdrawal by Subject|1|||
161857539|NCT00344448|584519060|FG000|Open Label|Study terminated|1|||
161857540|NCT00344448|584519061|FG001|Open Label|Study terminated|0|||
161857541|NCT03519087|584519064|FG000|Clinic Evaluation|Physician Decision|15|||
161857542|NCT03519087|584519065|FG001|Clinic Evaluation|Physician Decision|18|||
161857543|NCT03519087|584519066|FG002|Clinic Evaluation|Physician Decision|0|||
161857544|NCT03519087|584519067|FG003|Clinic Evaluation|Physician Decision|0|||
161857545|NCT03519087|584519068|FG004|Clinic Evaluation|Physician Decision|0|||
161857546|NCT03519087|584519064|FG000|Clinic Evaluation|Protocol Violation|1|||
161857547|NCT03519087|584519065|FG001|Clinic Evaluation|Protocol Violation|0|||
161857548|NCT03519087|584519066|FG002|Clinic Evaluation|Protocol Violation|0|||
161857549|NCT03519087|584519067|FG003|Clinic Evaluation|Protocol Violation|0|||
161857550|NCT03519087|584519068|FG004|Clinic Evaluation|Protocol Violation|0|||
161857551|NCT03519087|584519064|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
161857552|NCT03519087|584519065|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
161857553|NCT03519087|584519066|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
161857554|NCT03519087|584519067|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
161857555|NCT03519087|584519068|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
161857556|NCT03519087|584519064|FG000|Re-randomization for Treatment|Not appropriate|2|||
161857557|NCT03519087|584519065|FG001|Re-randomization for Treatment|Not appropriate|3|||
161857558|NCT03519087|584519066|FG002|Re-randomization for Treatment|Not appropriate|0|||
161857559|NCT03519087|584519067|FG003|Re-randomization for Treatment|Not appropriate|0|||
161857560|NCT03519087|584519068|FG004|Re-randomization for Treatment|Not appropriate|0|||
161857561|NCT03519087|584519064|FG000|Laboratory Testing|Lost to Follow-up|0|||
161857562|NCT03519087|584519065|FG001|Laboratory Testing|Lost to Follow-up|0|||
161857563|NCT03519087|584519066|FG002|Laboratory Testing|Lost to Follow-up|2|||
161857564|NCT03519087|584519067|FG003|Laboratory Testing|Lost to Follow-up|3|||
161857565|NCT03519087|584519068|FG004|Laboratory Testing|Lost to Follow-up|6|||
161857566|NCT03519087|584519064|FG000|Laboratory Testing|Protocol Violation|0|||
161857567|NCT03519087|584519065|FG001|Laboratory Testing|Protocol Violation|0|||
161857568|NCT03519087|584519066|FG002|Laboratory Testing|Protocol Violation|0|||
161857569|NCT03519087|584519067|FG003|Laboratory Testing|Protocol Violation|1|||
161857570|NCT03519087|584519068|FG004|Laboratory Testing|Protocol Violation|0|||
161857571|NCT01137071|584519069|FG000|Overall Study|Disease Progression|11|||
161857572|NCT01137071|584519069|FG000|Overall Study|Withdrawal by Subject|2|||
161857573|NCT01137071|584519069|FG000|Overall Study|Wrongly Included|1|||
161857574|NCT04807400|584519070|FG000|Overall Study|Adverse Event|2|||
161857575|NCT04807400|584519071|FG001|Overall Study|Adverse Event|3|||
161975306|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
161975307|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
161975308|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
161975309|NCT02008357|584958459|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
161975310|NCT02008357|584958460|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
161975311|NCT02008357|584958459|FG000|Open-label Extension Period|Adverse Event|8|||
161975312|NCT02008357|584958460|FG001|Open-label Extension Period|Adverse Event|7|||
161975313|NCT02008357|584958459|FG000|Open-label Extension Period|Death|7|||
161975314|NCT02008357|584958460|FG001|Open-label Extension Period|Death|4|||
161975315|NCT02008357|584958459|FG000|Open-label Extension Period|Lack of Efficacy|9|||
161975316|NCT02008357|584958460|FG001|Open-label Extension Period|Lack of Efficacy|5|||
161975317|NCT02008357|584958459|FG000|Open-label Extension Period|Lost to Follow-up|2|||
161975318|NCT02008357|584958460|FG001|Open-label Extension Period|Lost to Follow-up|2|||
161975319|NCT02008357|584958459|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
161975320|NCT02008357|584958460|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
161975321|NCT02008357|584958459|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
161975322|NCT02008357|584958460|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
161975323|NCT02008357|584958459|FG000|Open-label Extension Period|Safety Risk|2|||
161975324|NCT02008357|584958460|FG001|Open-label Extension Period|Safety Risk|1|||
161975325|NCT02008357|584958459|FG000|Open-label Extension Period|Non-Compliance|0|||
161975326|NCT02008357|584958460|FG001|Open-label Extension Period|Non-Compliance|1|||
161975327|NCT02008357|584958459|FG000|Open-label Extension Period|Investigator Recommendation|0|||
161975328|NCT02008357|584958460|FG001|Open-label Extension Period|Investigator Recommendation|1|||
161857576|NCT04807400|584519072|FG002|Overall Study|Adverse Event|3|||
161857577|NCT04807400|584519070|FG000|Overall Study|Death|2|||
161857578|NCT04807400|584519071|FG001|Overall Study|Death|0|||
161857579|NCT04807400|584519072|FG002|Overall Study|Death|0|||
161857580|NCT04807400|584519070|FG000|Overall Study|Lost to Follow-up|8|||
161857581|NCT04807400|584519071|FG001|Overall Study|Lost to Follow-up|6|||
161857582|NCT04807400|584519072|FG002|Overall Study|Lost to Follow-up|6|||
161857583|NCT04807400|584519070|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161857584|NCT04807400|584519071|FG001|Overall Study|Non-Compliance With Study Drug|4|||
161857585|NCT04807400|584519072|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161975329|NCT02008357|584958459|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
161975330|NCT02008357|584958460|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
161975331|NCT02008357|584958459|FG000|Open-label Extension Period|Coordinating Center Request|2|||
161975332|NCT02008357|584958460|FG001|Open-label Extension Period|Coordinating Center Request|4|||
161975333|NCT02008357|584958459|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
161975334|NCT02008357|584958460|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
161975335|NCT02008357|584958459|FG000|Open-label Extension Period|Study Ended|20|||
161975336|NCT02008357|584958460|FG001|Open-label Extension Period|Study Ended|25|||
161975337|NCT02008357|584958459|FG000|Open-label Extension Period|Personal Reasons|0|||
161975338|NCT02008357|584958460|FG001|Open-label Extension Period|Personal Reasons|1|||
161975339|NCT02008357|584958459|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
161975340|NCT02008357|584958460|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
161975341|NCT02008357|584958459|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
161975342|NCT02008357|584958460|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
161975343|NCT02008357|584958459|FG000|Open-label Extension Period|Other|2|||
161769836|NCT02652793|584198525|FG000|Overall Study|Withdrawal by Subject|1|||
161769837|NCT04963231|584198526|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
161769838|NCT04963231|584198527|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
161769839|NCT04963231|584198528|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
161769840|NCT04963231|584198526|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
161769841|NCT04963231|584198527|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
161769842|NCT04963231|584198528|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
161769843|NCT04963231|584198526|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
161769844|NCT04963231|584198527|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
161769845|NCT04963231|584198528|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
161769846|NCT04963231|584198526|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
161769847|NCT04963231|584198527|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
161857586|NCT04807400|584519070|FG000|Overall Study|Participant Decision|20|||
161857587|NCT04807400|584519071|FG001|Overall Study|Participant Decision|19|||
161857588|NCT04807400|584519072|FG002|Overall Study|Participant Decision|26|||
161975344|NCT02008357|584958460|FG001|Open-label Extension Period|Other|0|||
161975345|NCT02312219|584958462|FG000|Overall Study|Withdrawal by Subject|1|||
161975346|NCT02312219|584958463|FG001|Overall Study|Withdrawal by Subject|2|||
161975347|NCT02312219|584958462|FG000|Overall Study|could not schedule imaging in time|0|||
161975348|NCT02312219|584958463|FG001|Overall Study|could not schedule imaging in time|2|||
161975349|NCT02312219|584958462|FG000|Overall Study|Other|0|||
161975350|NCT02312219|584958463|FG001|Overall Study|Other|1|||
161975351|NCT02312219|584958462|FG000|Overall Study|Not randomized. Ineligible|0|||
161975352|NCT02312219|584958463|FG001|Overall Study|Not randomized. Ineligible|1|||
161975353|NCT04941807|584958464|FG000|Overall Study|Lost to Follow-up|1|||
161975354|NCT04941807|584958465|FG001|Overall Study|Lost to Follow-up|1|||
161975355|NCT03553498|584958466|FG000|Overall Study|Missing primary outcome|1|||
161975356|NCT03553498|584958467|FG001|Overall Study|Missing primary outcome|2|||
161975357|NCT01100567|584958468|FG000|Overall Study|Withdrawal by Subject|5|||
161975358|NCT01100567|584958469|FG001|Overall Study|Withdrawal by Subject|8|||
161975359|NCT01100567|584958468|FG000|Overall Study|Early Hospital Discharge|6|||
161975360|NCT01100567|584958469|FG001|Overall Study|Early Hospital Discharge|4|||
161975361|NCT01100567|584958468|FG000|Overall Study|Lost to Follow-up|1|||
161975362|NCT01100567|584958469|FG001|Overall Study|Lost to Follow-up|2|||
161975363|NCT01100567|584958468|FG000|Overall Study|Physician Decision|0|||
161975364|NCT01100567|584958469|FG001|Overall Study|Physician Decision|1|||
161975365|NCT01100567|584958468|FG000|Overall Study|Deemed ineligible after consent|0|||
161975366|NCT01100567|584958469|FG001|Overall Study|Deemed ineligible after consent|1|||
161975367|NCT02741570|584958470|FG000|Pre-Treatment Period|Other reasons|0|||
161975368|NCT02741570|584958471|FG001|Pre-Treatment Period|Other reasons|3|||
161975369|NCT02741570|584958470|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
161975370|NCT02741570|584958471|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
161975371|NCT02741570|584958470|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
161975372|NCT02741570|584958471|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
161975373|NCT02741570|584958470|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
161975374|NCT02741570|584958471|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
161975375|NCT02741570|584958470|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
161975376|NCT02741570|584958471|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
161975377|NCT02741570|584958470|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
161975378|NCT02741570|584958471|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
161857589|NCT04807400|584519070|FG000|Overall Study|Physician Decision|0|||
161857590|NCT04807400|584519071|FG001|Overall Study|Physician Decision|1|||
161857591|NCT04807400|584519072|FG002|Overall Study|Physician Decision|0|||
161857592|NCT04807400|584519070|FG000|Overall Study|Protocol Violation|4|||
161857593|NCT04807400|584519071|FG001|Overall Study|Protocol Violation|3|||
161857594|NCT04807400|584519072|FG002|Overall Study|Protocol Violation|7|||
161857595|NCT04807400|584519070|FG000|Overall Study|Withdrawal by Subject|13|||
161857596|NCT04807400|584519071|FG001|Overall Study|Withdrawal by Subject|9|||
161857597|NCT04807400|584519072|FG002|Overall Study|Withdrawal by Subject|20|||
161857598|NCT04807400|584519070|FG000|Overall Study|Mis-randomized|1|||
161857599|NCT04807400|584519071|FG001|Overall Study|Mis-randomized|0|||
161857600|NCT04807400|584519072|FG002|Overall Study|Mis-randomized|0|||
161857601|NCT04194645|584519075|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857602|NCT04194645|584519076|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857603|NCT04194645|584519077|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857604|NCT04194645|584519078|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857605|NCT04194645|584519079|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857606|NCT04194645|584519080|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857607|NCT04194645|584519081|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857608|NCT04194645|584519082|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857609|NCT04194645|584519083|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857610|NCT04194645|584519084|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
161857611|NCT04194645|584519085|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857612|NCT04194645|584519086|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857613|NCT04194645|584519087|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857614|NCT04194645|584519088|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857615|NCT04194645|584519089|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161857616|NCT03656744|584519090|FG000|Overall Study|Adverse Event|1|||
161857617|NCT03656744|584519091|FG001|Overall Study|Adverse Event|4|||
161857618|NCT03656744|584519092|FG002|Overall Study|Adverse Event|1|||
161857619|NCT03656744|584519090|FG000|Overall Study|Protocol Violation|1|||
161857620|NCT03656744|584519091|FG001|Overall Study|Protocol Violation|0|||
161857621|NCT03656744|584519092|FG002|Overall Study|Protocol Violation|0|||
161857622|NCT03656744|584519090|FG000|Overall Study|Lost to Follow-up|2|||
161857623|NCT03656744|584519091|FG001|Overall Study|Lost to Follow-up|2|||
161857624|NCT03656744|584519092|FG002|Overall Study|Lost to Follow-up|0|||
161857625|NCT03656744|584519090|FG000|Overall Study|Withdrawal by Subject|0|||
161857626|NCT03656744|584519091|FG001|Overall Study|Withdrawal by Subject|1|||
161857627|NCT03656744|584519092|FG002|Overall Study|Withdrawal by Subject|0|||
161857628|NCT03656744|584519090|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
161857629|NCT03656744|584519091|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
161857630|NCT03656744|584519092|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
161857631|NCT03076775|584519093|FG000|Overall Study|Lost to Follow-up|1|||
161857632|NCT03076775|584519094|FG001|Overall Study|Lost to Follow-up|0|||
161857633|NCT01783886|584519095|FG000|Overall Study|Lost to Follow-up|0|||
161857634|NCT01783886|584519096|FG001|Overall Study|Lost to Follow-up|3|||
161857635|NCT01783886|584519097|FG002|Overall Study|Lost to Follow-up|0|||
161857636|NCT01783886|584519095|FG000|Overall Study|Protocol deviation|0|||
161857637|NCT01783886|584519096|FG001|Overall Study|Protocol deviation|0|||
161857638|NCT01783886|584519097|FG002|Overall Study|Protocol deviation|2|||
161857639|NCT01783886|584519095|FG000|Overall Study|Withdrawal of consent by participant|1|||
161857640|NCT01783886|584519096|FG001|Overall Study|Withdrawal of consent by participant|3|||
161857641|NCT01783886|584519097|FG002|Overall Study|Withdrawal of consent by participant|4|||
161857642|NCT01783886|584519095|FG000|Overall Study|Adverse Event|4|||
161857643|NCT01783886|584519096|FG001|Overall Study|Adverse Event|5|||
161857644|NCT01783886|584519097|FG002|Overall Study|Adverse Event|4|||
161857645|NCT00940316|584519098|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
161857646|NCT00940316|584519099|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
161857647|NCT00940316|584519100|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
161857648|NCT00940316|584519098|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
161857649|NCT00940316|584519099|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
161857650|NCT00940316|584519100|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
161857651|NCT00940316|584519098|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
161857652|NCT00940316|584519099|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
161857653|NCT00940316|584519100|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
161857654|NCT00940316|584519098|FG000|Treated After Cycle 5|Adverse Event|0|||
161857655|NCT00940316|584519099|FG001|Treated After Cycle 5|Adverse Event|0|||
161857656|NCT00940316|584519100|FG002|Treated After Cycle 5|Adverse Event|1|||
161857657|NCT00940316|584519098|FG000|Treated After Cycle 5|Progressive disease|0|||
161857658|NCT00940316|584519099|FG001|Treated After Cycle 5|Progressive disease|1|||
161857659|NCT00940316|584519100|FG002|Treated After Cycle 5|Progressive disease|0|||
161857660|NCT02290405|584519101|FG000|Overall Study|Withdrawal by Subject|1|||
161857661|NCT02290405|584519102|FG001|Overall Study|Withdrawal by Subject|0|||
161857662|NCT00996489|584519103|FG000|Overall Study|Device failure|45|||
161857663|NCT00996489|584519103|FG000|Overall Study|Discontinued|116|||
161857664|NCT03142191|584519104|FG000|Placebo Controlled Period|Death|0|||
161857665|NCT03142191|584519105|FG001|Placebo Controlled Period|Death|1|||
161857666|NCT03142191|584519106|FG002|Placebo Controlled Period|Death|1|||
161857667|NCT03142191|584519107|FG003|Placebo Controlled Period|Death|0|||
161857668|NCT03142191|584519108|FG004|Placebo Controlled Period|Death|0|||
161857669|NCT03142191|584519104|FG000|Placebo Controlled Period|Adverse Event|4|||
161857670|NCT03142191|584519105|FG001|Placebo Controlled Period|Adverse Event|5|||
161857671|NCT03142191|584519106|FG002|Placebo Controlled Period|Adverse Event|1|||
161857672|NCT03142191|584519107|FG003|Placebo Controlled Period|Adverse Event|0|||
161857673|NCT03142191|584519108|FG004|Placebo Controlled Period|Adverse Event|0|||
161857674|NCT03142191|584519104|FG000|Placebo Controlled Period|Progressive Disease|1|||
161857675|NCT03142191|584519105|FG001|Placebo Controlled Period|Progressive Disease|0|||
161857676|NCT03142191|584519106|FG002|Placebo Controlled Period|Progressive Disease|1|||
161857677|NCT03142191|584519107|FG003|Placebo Controlled Period|Progressive Disease|0|||
161857678|NCT03142191|584519108|FG004|Placebo Controlled Period|Progressive Disease|0|||
161857679|NCT03142191|584519104|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
161857680|NCT03142191|584519105|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
161857681|NCT03142191|584519106|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
161857682|NCT03142191|584519107|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
161857683|NCT03142191|584519108|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
161857684|NCT03142191|584519104|FG000|Placebo Controlled Period|Other Reasons|1|||
161857685|NCT03142191|584519105|FG001|Placebo Controlled Period|Other Reasons|0|||
161857686|NCT03142191|584519106|FG002|Placebo Controlled Period|Other Reasons|0|||
161857687|NCT03142191|584519107|FG003|Placebo Controlled Period|Other Reasons|0|||
161857688|NCT03142191|584519108|FG004|Placebo Controlled Period|Other Reasons|0|||
161857689|NCT03142191|584519104|FG000|Active Treatment Extension Period|Death|2|||
161857690|NCT03142191|584519105|FG001|Active Treatment Extension Period|Death|1|||
161857691|NCT03142191|584519106|FG002|Active Treatment Extension Period|Death|1|||
161857692|NCT03142191|584519107|FG003|Active Treatment Extension Period|Death|1|||
161857693|NCT03142191|584519108|FG004|Active Treatment Extension Period|Death|0|||
161857694|NCT03142191|584519104|FG000|Active Treatment Extension Period|Adverse Event|6|||
161857695|NCT03142191|584519105|FG001|Active Treatment Extension Period|Adverse Event|5|||
161857696|NCT03142191|584519106|FG002|Active Treatment Extension Period|Adverse Event|4|||
161857697|NCT03142191|584519107|FG003|Active Treatment Extension Period|Adverse Event|1|||
161857698|NCT03142191|584519108|FG004|Active Treatment Extension Period|Adverse Event|0|||
161857699|NCT03142191|584519104|FG000|Active Treatment Extension Period|Progressive Disease|10|||
161857700|NCT03142191|584519105|FG001|Active Treatment Extension Period|Progressive Disease|5|||
161857701|NCT03142191|584519106|FG002|Active Treatment Extension Period|Progressive Disease|4|||
161857702|NCT03142191|584519107|FG003|Active Treatment Extension Period|Progressive Disease|1|||
161857703|NCT03142191|584519108|FG004|Active Treatment Extension Period|Progressive Disease|2|||
161857704|NCT03142191|584519104|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
161857705|NCT03142191|584519105|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
161857706|NCT03142191|584519106|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
161857707|NCT03142191|584519107|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
161857708|NCT03142191|584519108|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
161857709|NCT03142191|584519104|FG000|Active Treatment Extension Period|Physician Decision|2|||
161975379|NCT02741570|584958470|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
161975380|NCT02741570|584958471|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161975381|NCT02741570|584958470|FG000|Pre-Treatment Period|Death|0|||
161975382|NCT02741570|584958471|FG001|Pre-Treatment Period|Death|1|||
161975383|NCT02741570|584958470|FG000|Pre-Treatment Period|Disease progression|0|||
161975384|NCT02741570|584958471|FG001|Pre-Treatment Period|Disease progression|1|||
161975385|NCT02741570|584958470|FG000|Treatment Period|Other reasons|47|||
161975386|NCT02741570|584958471|FG001|Treatment Period|Other reasons|12|||
161975387|NCT02741570|584958470|FG000|Treatment Period|Poor/non-compliance|0|||
161975388|NCT02741570|584958471|FG001|Treatment Period|Poor/non-compliance|2|||
161975389|NCT02741570|584958470|FG000|Treatment Period|Maximum clinical benefit|4|||
161975390|NCT02741570|584958471|FG001|Treatment Period|Maximum clinical benefit|6|||
161975391|NCT02741570|584958470|FG000|Treatment Period|Lost to Follow-up|1|||
161975392|NCT02741570|584958471|FG001|Treatment Period|Lost to Follow-up|3|||
161975393|NCT02741570|584958470|FG000|Treatment Period|Participant withdrew consent|9|||
161857710|NCT03142191|584519105|FG001|Active Treatment Extension Period|Physician Decision|0|||
161857711|NCT03142191|584519106|FG002|Active Treatment Extension Period|Physician Decision|0|||
161857712|NCT03142191|584519107|FG003|Active Treatment Extension Period|Physician Decision|0|||
161857713|NCT03142191|584519108|FG004|Active Treatment Extension Period|Physician Decision|0|||
161857714|NCT03142191|584519104|FG000|Active Treatment Extension Period|Other Reasons|3|||
161857715|NCT03142191|584519105|FG001|Active Treatment Extension Period|Other Reasons|3|||
161857716|NCT03142191|584519106|FG002|Active Treatment Extension Period|Other Reasons|3|||
161975394|NCT02741570|584958471|FG001|Treatment Period|Participant withdrew consent|13|||
161857717|NCT03142191|584519107|FG003|Active Treatment Extension Period|Other Reasons|8|||
161857718|NCT03142191|584519108|FG004|Active Treatment Extension Period|Other Reasons|3|||
161857719|NCT03142191|584519104|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
161857720|NCT03142191|584519105|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
161857721|NCT03142191|584519106|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
161857722|NCT03142191|584519107|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
161857723|NCT03142191|584519108|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
161857724|NCT01130493|584519113|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
161857725|NCT01130493|584519114|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
161857726|NCT01130493|584519115|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
161857727|NCT01130493|584519113|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
161857728|NCT01130493|584519114|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
161857729|NCT01130493|584519115|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
161857730|NCT01130493|584519113|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
161857731|NCT01130493|584519114|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
161857732|NCT01130493|584519115|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
161857733|NCT01130493|584519113|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
161857734|NCT01130493|584519114|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
161857735|NCT01130493|584519115|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
161857736|NCT01130493|584519113|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
161857737|NCT01130493|584519114|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
161857738|NCT01130493|584519115|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
161857739|NCT01130493|584519113|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
161857740|NCT01130493|584519114|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
161857741|NCT01130493|584519115|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
161857742|NCT01130493|584519113|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
161857743|NCT01130493|584519114|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
161857744|NCT01130493|584519115|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
161857745|NCT01130493|584519113|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
161857746|NCT01130493|584519114|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
161857747|NCT01130493|584519115|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
161857748|NCT01130493|584519113|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
161857749|NCT01130493|584519114|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
161857750|NCT01130493|584519115|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
161857751|NCT01130493|584519113|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
161857752|NCT01130493|584519114|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
161857753|NCT01130493|584519115|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
161857754|NCT01130493|584519113|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
161857755|NCT01130493|584519114|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
161857756|NCT01130493|584519115|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
161857757|NCT01130493|584519113|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
161857758|NCT01130493|584519114|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
161857759|NCT01130493|584519115|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
161857760|NCT01130493|584519113|FG000|Part 2: OLE|Adverse Event|0|||
161857761|NCT01130493|584519114|FG001|Part 2: OLE|Adverse Event|2|||
161857762|NCT01130493|584519115|FG002|Part 2: OLE|Adverse Event|1|||
161857763|NCT01130493|584519113|FG000|Part 2: OLE|Withdrawal by Subject|0|||
161857764|NCT01130493|584519114|FG001|Part 2: OLE|Withdrawal by Subject|1|||
161857765|NCT01130493|584519115|FG002|Part 2: OLE|Withdrawal by Subject|4|||
161857766|NCT03541317|584519118|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
161857767|NCT03541317|584519119|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161857768|NCT03541317|584519120|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161857769|NCT03541317|584519121|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161857770|NCT03541317|584519122|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161857771|NCT03541317|584519123|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161857772|NCT00879086|584519124|FG000|Overall Study|Adverse Event|3|||
161857773|NCT00879086|584519125|FG001|Overall Study|Adverse Event|15|||
161857774|NCT00879086|584519124|FG000|Overall Study|Participant choice|2|||
161857775|NCT00879086|584519125|FG001|Overall Study|Participant choice|2|||
161857776|NCT00879086|584519124|FG000|Overall Study|Progression of disease|40|||
161857777|NCT00879086|584519125|FG001|Overall Study|Progression of disease|26|||
161857778|NCT00879086|584519124|FG000|Overall Study|Withdrawal of consent|2|||
161857779|NCT00879086|584519125|FG001|Overall Study|Withdrawal of consent|1|||
161857780|NCT00879086|584519124|FG000|Overall Study|Other|4|||
161857781|NCT00879086|584519125|FG001|Overall Study|Other|6|||
161975395|NCT02741570|584958470|FG000|Treatment Period|Participant request to discontinue treatment|8|||
161975396|NCT02741570|584958471|FG001|Treatment Period|Participant request to discontinue treatment|23|||
161975397|NCT02741570|584958470|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
161857782|NCT00879086|584519124|FG000|Overall Study|Death|1|||
161857783|NCT00879086|584519125|FG001|Overall Study|Death|2|||
161857784|NCT04728802|584519128|FG000|Overall Study|Withdrawal by Subject|4|||
161857785|NCT04728802|584519129|FG001|Overall Study|Withdrawal by Subject|20|||
161857786|NCT04728802|584519128|FG000|Overall Study|Physician Decision|7|||
161857787|NCT04728802|584519129|FG001|Overall Study|Physician Decision|7|||
161857788|NCT04728802|584519128|FG000|Overall Study|Protocol Violation|10|||
161857789|NCT04728802|584519129|FG001|Overall Study|Protocol Violation|4|||
161857790|NCT04728802|584519128|FG000|Overall Study|Transfer|1|||
161857791|NCT04728802|584519129|FG001|Overall Study|Transfer|0|||
161857792|NCT04728802|584519128|FG000|Overall Study|Death|4|||
161857793|NCT04728802|584519129|FG001|Overall Study|Death|5|||
161857794|NCT04728802|584519128|FG000|Overall Study|Other|3|||
161857795|NCT04728802|584519129|FG001|Overall Study|Other|0|||
161857796|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
161857797|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Off-label use|283|||
161857798|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
161857799|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
161857800|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
161857801|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
161857802|NCT01070953|584519132|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
161857803|NCT01070953|584519132|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
161857804|NCT01070953|584519132|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
161857805|NCT01070953|584519132|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
161857806|NCT04700137|584519133|FG000|Overall Study|Lost to Follow-up|1|||
161857807|NCT04700137|584519134|FG001|Overall Study|Lost to Follow-up|6|||
161857808|NCT04700137|584519135|FG002|Overall Study|Lost to Follow-up|1|||
161857809|NCT04700137|584519136|FG003|Overall Study|Lost to Follow-up|1|||
161857810|NCT04700137|584519133|FG000|Overall Study|Withdrawal by Subject|0|||
161857811|NCT04700137|584519134|FG001|Overall Study|Withdrawal by Subject|0|||
161857812|NCT04700137|584519135|FG002|Overall Study|Withdrawal by Subject|1|||
161857813|NCT04700137|584519136|FG003|Overall Study|Withdrawal by Subject|0|||
161857814|NCT04700137|584519133|FG000|Overall Study|Death|0|||
161857815|NCT04700137|584519134|FG001|Overall Study|Death|0|||
161857816|NCT04700137|584519135|FG002|Overall Study|Death|1|||
161857817|NCT04700137|584519136|FG003|Overall Study|Death|0|||
161857818|NCT03449446|584519139|FG000|Overall Study|Randomized but Never Treated|0|||
161857819|NCT03449446|584519140|FG001|Overall Study|Randomized but Never Treated|0|||
161857820|NCT03449446|584519141|FG002|Overall Study|Randomized but Never Treated|1|||
161857821|NCT03449446|584519142|FG003|Overall Study|Randomized but Never Treated|1|||
161857822|NCT03449446|584519143|FG004|Overall Study|Randomized but Never Treated|1|||
161857823|NCT03449446|584519144|FG005|Overall Study|Randomized but Never Treated|0|||
161857824|NCT03449446|584519145|FG006|Overall Study|Randomized but Never Treated|0|||
161857825|NCT03449446|584519139|FG000|Overall Study|Unknown Reason|33|||
161857826|NCT03449446|584519140|FG001|Overall Study|Unknown Reason|1|||
161857827|NCT03449446|584519141|FG002|Overall Study|Unknown Reason|1|||
161857828|NCT03449446|584519142|FG003|Overall Study|Unknown Reason|1|||
161857829|NCT03449446|584519143|FG004|Overall Study|Unknown Reason|2|||
161857830|NCT03449446|584519144|FG005|Overall Study|Unknown Reason|2|||
161857831|NCT03449446|584519145|FG006|Overall Study|Unknown Reason|0|||
161857832|NCT03449446|584519139|FG000|Overall Study|Withdrew Consent|1|||
161857833|NCT03449446|584519140|FG001|Overall Study|Withdrew Consent|3|||
161857834|NCT03449446|584519141|FG002|Overall Study|Withdrew Consent|1|||
161857835|NCT03449446|584519142|FG003|Overall Study|Withdrew Consent|4|||
161857836|NCT03449446|584519143|FG004|Overall Study|Withdrew Consent|4|||
161857837|NCT03449446|584519144|FG005|Overall Study|Withdrew Consent|4|||
161857838|NCT03449446|584519145|FG006|Overall Study|Withdrew Consent|1|||
161857839|NCT03449446|584519139|FG000|Overall Study|Adverse Event|1|||
161857840|NCT03449446|584519140|FG001|Overall Study|Adverse Event|2|||
161857841|NCT03449446|584519141|FG002|Overall Study|Adverse Event|1|||
161857842|NCT03449446|584519142|FG003|Overall Study|Adverse Event|0|||
161857843|NCT03449446|584519143|FG004|Overall Study|Adverse Event|0|||
161857844|NCT03449446|584519144|FG005|Overall Study|Adverse Event|2|||
161857845|NCT03449446|584519145|FG006|Overall Study|Adverse Event|0|||
161857846|NCT03449446|584519139|FG000|Overall Study|Lost to Follow-up|0|||
161857847|NCT03449446|584519140|FG001|Overall Study|Lost to Follow-up|0|||
161857848|NCT03449446|584519141|FG002|Overall Study|Lost to Follow-up|2|||
161857849|NCT03449446|584519142|FG003|Overall Study|Lost to Follow-up|1|||
161857850|NCT03449446|584519143|FG004|Overall Study|Lost to Follow-up|3|||
161857851|NCT03449446|584519144|FG005|Overall Study|Lost to Follow-up|0|||
161857852|NCT03449446|584519145|FG006|Overall Study|Lost to Follow-up|0|||
161857853|NCT03449446|584519139|FG000|Overall Study|Investigator's Discretion|0|||
161975398|NCT02741570|584958471|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
161857854|NCT03449446|584519140|FG001|Overall Study|Investigator's Discretion|1|||
161857855|NCT03449446|584519141|FG002|Overall Study|Investigator's Discretion|1|||
161857856|NCT03449446|584519142|FG003|Overall Study|Investigator's Discretion|2|||
162034311|NCT05217927|585181204|FG000|DBT Phase|Other|7|||
162034312|NCT05217927|585181205|FG001|DBT Phase|Other|3|||
162034313|NCT05217927|585181206|FG002|DBT Phase|Other|4|||
161857857|NCT03449446|584519143|FG004|Overall Study|Investigator's Discretion|0|||
161857858|NCT03449446|584519144|FG005|Overall Study|Investigator's Discretion|0|||
161857859|NCT03449446|584519145|FG006|Overall Study|Investigator's Discretion|0|||
161857860|NCT03449446|584519139|FG000|Overall Study|Non Compliance with Study Drug|1|||
161857861|NCT03449446|584519140|FG001|Overall Study|Non Compliance with Study Drug|0|||
161857862|NCT03449446|584519141|FG002|Overall Study|Non Compliance with Study Drug|0|||
161857863|NCT03449446|584519142|FG003|Overall Study|Non Compliance with Study Drug|0|||
161857864|NCT03449446|584519143|FG004|Overall Study|Non Compliance with Study Drug|0|||
161857865|NCT03449446|584519144|FG005|Overall Study|Non Compliance with Study Drug|0|||
161857866|NCT03449446|584519145|FG006|Overall Study|Non Compliance with Study Drug|0|||
161857867|NCT03449446|584519139|FG000|Overall Study|Protocol Violation|0|||
161857868|NCT03449446|584519140|FG001|Overall Study|Protocol Violation|0|||
161857869|NCT03449446|584519141|FG002|Overall Study|Protocol Violation|0|||
161857870|NCT03449446|584519142|FG003|Overall Study|Protocol Violation|0|||
161857871|NCT03449446|584519143|FG004|Overall Study|Protocol Violation|1|||
161857872|NCT03449446|584519144|FG005|Overall Study|Protocol Violation|1|||
161857873|NCT03449446|584519145|FG006|Overall Study|Protocol Violation|0|||
161857874|NCT03449446|584519139|FG000|Overall Study|Death|0|||
161857875|NCT03449446|584519140|FG001|Overall Study|Death|0|||
161857876|NCT03449446|584519141|FG002|Overall Study|Death|0|||
161857877|NCT03449446|584519142|FG003|Overall Study|Death|0|||
161857878|NCT03449446|584519143|FG004|Overall Study|Death|1|||
161857879|NCT03449446|584519144|FG005|Overall Study|Death|0|||
161857880|NCT03449446|584519145|FG006|Overall Study|Death|0|||
161857881|NCT03180645|584519158|FG000|Overall Study|Adverse Event|0|||
161857882|NCT03180645|584519159|FG001|Overall Study|Adverse Event|1|||
161857883|NCT03180645|584519160|FG002|Overall Study|Adverse Event|2|||
161857884|NCT04208750|584519161|FG000|Overall Study|Lost to Follow-up|16|||
161857885|NCT04208750|584519162|FG001|Overall Study|Lost to Follow-up|15|||
161857886|NCT02201277|584519163|FG000|Overall Study|Death|3|||
161857887|NCT02201277|584519164|FG001|Overall Study|Death|4|||
161857888|NCT02201277|584519163|FG000|Overall Study|Lost to Follow-up|2|||
161857889|NCT02201277|584519164|FG001|Overall Study|Lost to Follow-up|1|||
161857890|NCT02201277|584519163|FG000|Overall Study|Failed retrieval|1|||
161857891|NCT02201277|584519164|FG001|Overall Study|Failed retrieval|0|||
161857892|NCT02201277|584519163|FG000|Overall Study|Physician Decision|1|||
161857893|NCT02201277|584519164|FG001|Overall Study|Physician Decision|0|||
161857894|NCT05022212|584519167|FG000|Overall Study|Lost to Follow-up|0|||
161857895|NCT05022212|584519168|FG001|Overall Study|Lost to Follow-up|2|||
161857896|NCT02905032|584519169|FG000|Overall Study|Withdrawal by Subject|2|||
161857897|NCT02905032|584519170|FG001|Overall Study|Withdrawal by Subject|0|||
161857898|NCT02905032|584519171|FG002|Overall Study|Withdrawal by Subject|0|||
161857899|NCT02905032|584519169|FG000|Overall Study|Protocol Violation|6|||
161857900|NCT02905032|584519170|FG001|Overall Study|Protocol Violation|12|||
161857901|NCT02905032|584519171|FG002|Overall Study|Protocol Violation|0|||
161857902|NCT00739063|584519172|FG000|Overall Study|Screen failures|8|||
161857903|NCT01625091|584519173|FG000|Intervention|Death|1|||
161857904|NCT01625091|584519174|FG001|Intervention|Death|1|||
161857905|NCT01625091|584519173|FG000|Intervention|Withdrawal by Subject|4|||
161857906|NCT01625091|584519174|FG001|Intervention|Withdrawal by Subject|1|||
161857907|NCT01625091|584519173|FG000|Intervention|Adverse Event|0|||
161857908|NCT01625091|584519174|FG001|Intervention|Adverse Event|2|||
161857909|NCT01625091|584519173|FG000|Intervention|Lost to Follow-up|4|||
161857910|NCT01625091|584519174|FG001|Intervention|Lost to Follow-up|4|||
161857911|NCT01625091|584519173|FG000|Intervention|Study termination|2|||
161857912|NCT01625091|584519174|FG001|Intervention|Study termination|3|||
161857913|NCT01625091|584519173|FG000|Post-intervention|Death|0|||
161857914|NCT01625091|584519174|FG001|Post-intervention|Death|1|||
161857915|NCT01625091|584519173|FG000|Post-intervention|Lost to Follow-up|2|||
161857916|NCT01625091|584519174|FG001|Post-intervention|Lost to Follow-up|0|||
161857917|NCT01625091|584519173|FG000|Post-intervention|Study termination|2|||
161857918|NCT01625091|584519174|FG001|Post-intervention|Study termination|1|||
161857919|NCT02163057|584519175|FG000|Overall Study|Participant Refusal to Continue|2|||
161857920|NCT02163057|584519176|FG001|Overall Study|Participant Refusal to Continue|2|||
161857921|NCT02163057|584519175|FG000|Overall Study|Participant Significant Noncompliance|0|||
161857922|NCT02163057|584519176|FG001|Overall Study|Participant Significant Noncompliance|1|||
161857923|NCT02163057|584519175|FG000|Overall Study|Progression of Disease|1|||
161857924|NCT02163057|584519176|FG001|Overall Study|Progression of Disease|2|||
161857925|NCT01547390|584519177|FG000|Overall Study|Withdrawal by Subject|10|||
161857926|NCT01547390|584519178|FG001|Overall Study|Withdrawal by Subject|7|||
161857927|NCT01547390|584519177|FG000|Overall Study|termination of pregnancy|0|||
161857928|NCT01547390|584519178|FG001|Overall Study|termination of pregnancy|1|||
161857929|NCT01547390|584519177|FG000|Overall Study|Lost to Follow-up|0|||
161857930|NCT01547390|584519178|FG001|Overall Study|Lost to Follow-up|2|||
161857931|NCT01547390|584519177|FG000|Overall Study|Adverse Event|3|||
161857932|NCT01547390|584519178|FG001|Overall Study|Adverse Event|0|||
161975399|NCT02741570|584958470|FG000|Treatment Period|Death|9|||
161975400|NCT02741570|584958471|FG001|Treatment Period|Death|7|||
161975401|NCT02741570|584958470|FG000|Treatment Period|Study drug toxicity|55|||
161975402|NCT02741570|584958471|FG001|Treatment Period|Study drug toxicity|47|||
161975403|NCT02741570|584958470|FG000|Treatment Period|Disease progression|294|||
161975404|NCT02741570|584958471|FG001|Treatment Period|Disease progression|301|||
161975405|NCT02741570|584958470|FG000|Treatment Period|Administrative reason by sponsor|0|||
161975406|NCT02741570|584958471|FG001|Treatment Period|Administrative reason by sponsor|1|||
161975407|NCT01498185|584958472|FG000|Overall Study|Adverse Event|0|||
162034314|NCT05217927|585181204|FG000|DBT Phase|Randomized, not treated|2|||
161769848|NCT04963231|584198528|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
161769849|NCT04963231|584198526|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
161769850|NCT04963231|584198527|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
161769851|NCT04963231|584198528|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
161769852|NCT04963231|584198526|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
161769853|NCT04963231|584198527|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
161769854|NCT04963231|584198528|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
161769855|NCT04963231|584198526|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
161769856|NCT04963231|584198527|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
161769857|NCT04963231|584198528|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
161769858|NCT01059175|584198529|FG000|Overall Study|Death|17|||
161769859|NCT01059175|584198530|FG001|Overall Study|Death|17|||
161769860|NCT01059175|584198529|FG000|Overall Study|Adverse Event|4|||
161769861|NCT01059175|584198530|FG001|Overall Study|Adverse Event|2|||
161769862|NCT01059175|584198529|FG000|Overall Study|Lost to Follow-up|0|||
161769863|NCT01059175|584198530|FG001|Overall Study|Lost to Follow-up|1|||
161769864|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Adverse Event|4|||
161769865|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Adverse Event|3|||
161769866|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Adverse Event|0|||
161769867|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Adverse Event|0|||
161769868|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Death|24|||
161769869|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Death|9|||
161769870|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Death|0|||
161769871|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Death|0|||
161769872|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
161769873|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
161769874|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
161769875|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
161769876|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Physician Decision|4|||
161769877|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Physician Decision|1|||
161769878|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Physician Decision|0|||
161769879|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Physician Decision|0|||
161769880|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Progressive disease|1|||
161769881|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Progressive disease|0|||
161769882|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Progressive disease|0|||
161769883|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Progressive disease|0|||
161769884|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
161769885|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
161769886|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
161769887|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
161769888|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
161769889|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
161769890|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
161769891|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
161769892|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
161769893|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
161769894|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
161769895|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
161769896|NCT04579666|584198531|FG000|RTP (Up to Week 52)|Other|2|||
161769897|NCT04579666|584198532|FG001|RTP (Up to Week 52)|Other|0|||
161769898|NCT04579666|584198533|FG002|RTP (Up to Week 52)|Other|0|||
161769899|NCT04579666|584198534|FG003|RTP (Up to Week 52)|Other|0|||
161769900|NCT04579666|584198531|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
161769901|NCT04579666|584198532|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
161769902|NCT04579666|584198533|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
161769903|NCT04579666|584198534|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
161769904|NCT04579666|584198531|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
161769905|NCT04579666|584198532|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
161769906|NCT04579666|584198533|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
161769907|NCT04579666|584198534|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
161769908|NCT04579666|584198531|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
161769909|NCT04579666|584198532|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
161769910|NCT04579666|584198533|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
161975408|NCT01498185|584958473|FG001|Overall Study|Adverse Event|0|||
161857933|NCT01260701|584519179|FG000|Overall Study|Adverse Event|9|||
161857934|NCT01260701|584519179|FG000|Overall Study|Withdrawal by Subject|2|||
161857935|NCT01260701|584519179|FG000|Overall Study|Progression|53|||
161857936|NCT01260701|584519179|FG000|Overall Study|Death|2|||
161857937|NCT01260701|584519179|FG000|Overall Study|Not protocol specified|3|||
161857938|NCT01260701|584519179|FG000|Overall Study|Under review|1|||
161857939|NCT01260701|584519179|FG000|Overall Study|Ineligible|4|||
161857940|NCT01260701|584519179|FG000|Overall Study|Did not begin protocol therapy|1|||
161857941|NCT04108299|584520690|FG000|Overall Study|Not interested in participating|2|||
161857942|NCT04108299|584520691|FG001|Overall Study|Not interested in participating|1|||
161857943|NCT04108299|584520692|FG002|Overall Study|Not interested in participating|2|||
161857944|NCT04108299|584520693|FG003|Overall Study|Not interested in participating|1|||
161857945|NCT02515331|584520702|FG000|Overall Study|Withdrawal by Subject|0|||
161857946|NCT02515331|584520703|FG001|Overall Study|Withdrawal by Subject|0|||
161857947|NCT02515331|584520704|FG002|Overall Study|Withdrawal by Subject|1|||
161857948|NCT02515331|584520702|FG000|Overall Study|Protocol deviation|0|||
161857949|NCT02515331|584520703|FG001|Overall Study|Protocol deviation|0|||
161857950|NCT02515331|584520704|FG002|Overall Study|Protocol deviation|3|||
161857951|NCT02515331|584520702|FG000|Overall Study|Adverse Event|2|||
161857952|NCT02515331|584520703|FG001|Overall Study|Adverse Event|0|||
161857953|NCT02515331|584520704|FG002|Overall Study|Adverse Event|0|||
161857954|NCT00124748|584520705|FG000|Overall Study|Adverse Event|8|||
161857955|NCT00124748|584520706|FG001|Overall Study|Adverse Event|39|||
161857956|NCT00124748|584520705|FG000|Overall Study|Abnormal laboratory Value|2|||
161857957|NCT00124748|584520706|FG001|Overall Study|Abnormal laboratory Value|2|||
161857958|NCT00124748|584520705|FG000|Overall Study|Abnormal Procedure|0|||
161857959|NCT00124748|584520706|FG001|Overall Study|Abnormal Procedure|1|||
161857960|NCT00124748|584520705|FG000|Overall Study|Lack of Efficacy|20|||
161857961|NCT00124748|584520706|FG001|Overall Study|Lack of Efficacy|41|||
161857962|NCT00124748|584520705|FG000|Overall Study|No longer requires study drug|1|||
161857963|NCT00124748|584520706|FG001|Overall Study|No longer requires study drug|1|||
161857964|NCT00124748|584520705|FG000|Overall Study|Protocol Violation|3|||
161857965|NCT00124748|584520706|FG001|Overall Study|Protocol Violation|1|||
161857966|NCT00124748|584520705|FG000|Overall Study|Withdrawal by Subject|5|||
161857967|NCT00124748|584520706|FG001|Overall Study|Withdrawal by Subject|15|||
161857968|NCT00124748|584520705|FG000|Overall Study|Lost to Follow-up|2|||
161857969|NCT00124748|584520706|FG001|Overall Study|Lost to Follow-up|7|||
161857970|NCT00124748|584520705|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
161857971|NCT00124748|584520706|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
161857972|NCT00124748|584520705|FG000|Overall Study|Death|1|||
161857973|NCT00124748|584520706|FG001|Overall Study|Death|3|||
161857974|NCT00322712|584520707|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
161857975|NCT04176250|584520710|FG000|Overall Study|Adverse Event|0|||
161857976|NCT04176250|584520711|FG001|Overall Study|Adverse Event|1|||
161857977|NCT04176250|584520712|FG002|Overall Study|Adverse Event|0|||
161857978|NCT04176250|584520713|FG003|Overall Study|Adverse Event|1|||
161857979|NCT04176250|584520714|FG004|Overall Study|Adverse Event|0|||
161857980|NCT04176250|584520715|FG005|Overall Study|Adverse Event|1|||
161857981|NCT04176250|584520710|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
161857982|NCT04176250|584520711|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
161857983|NCT04176250|584520712|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
161857984|NCT04176250|584520713|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
161857985|NCT04176250|584520714|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
161857986|NCT04176250|584520715|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
161857987|NCT04176250|584520710|FG000|Overall Study|Withdrawal by Subject|0|||
161857988|NCT04176250|584520711|FG001|Overall Study|Withdrawal by Subject|0|||
161857989|NCT04176250|584520712|FG002|Overall Study|Withdrawal by Subject|0|||
161857990|NCT04176250|584520713|FG003|Overall Study|Withdrawal by Subject|0|||
161857991|NCT04176250|584520714|FG004|Overall Study|Withdrawal by Subject|0|||
161857992|NCT04176250|584520715|FG005|Overall Study|Withdrawal by Subject|1|||
161857993|NCT04176250|584520710|FG000|Overall Study|Randomized in error|0|||
161857994|NCT04176250|584520711|FG001|Overall Study|Randomized in error|0|||
161857995|NCT04176250|584520712|FG002|Overall Study|Randomized in error|0|||
161857996|NCT04176250|584520713|FG003|Overall Study|Randomized in error|0|||
161857997|NCT04176250|584520714|FG004|Overall Study|Randomized in error|1|||
161857998|NCT04176250|584520715|FG005|Overall Study|Randomized in error|0|||
161857999|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
161858000|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
161975409|NCT01498185|584958474|FG002|Overall Study|Adverse Event|0|||
161858001|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
161858002|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858003|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
161858004|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
161858005|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858006|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858007|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858008|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858009|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858010|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858011|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858012|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858013|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858014|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858015|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161858016|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
161858017|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858018|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
161858019|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
161858020|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
161858021|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
161858022|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858023|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858024|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858025|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858026|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858027|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858028|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858029|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858030|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858031|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858032|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161858033|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
161858034|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
161858035|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
161858036|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
161858037|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
161858038|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
161858039|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858040|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858041|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858042|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858043|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858044|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858045|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858046|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858047|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858048|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858049|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161858050|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858051|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
161858052|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
161858053|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858054|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
161858055|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
161858056|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858057|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858058|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858059|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858060|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858061|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858062|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858063|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858064|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858065|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858066|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161858067|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858068|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858069|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
161858070|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
161858071|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161975410|NCT01498185|584958475|FG003|Overall Study|Adverse Event|1|||
161975411|NCT01498185|584958476|FG004|Overall Study|Adverse Event|0|||
161858072|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858073|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858074|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858075|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858076|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858077|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858078|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858079|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858080|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858081|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858082|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858083|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161858084|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858085|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858086|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858087|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858088|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
161858089|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858090|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858091|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858092|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858093|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858094|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858095|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858096|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858097|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858098|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858099|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858100|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161858101|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858102|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
161858103|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858104|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858105|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858106|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858107|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858108|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858109|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858110|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858111|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858112|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858113|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858114|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858115|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858116|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858117|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161858118|NCT00758524|584520716|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858119|NCT00758524|584520717|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
161858120|NCT00758524|584520718|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858121|NCT00758524|584520719|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858122|NCT00758524|584520720|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858123|NCT00758524|584520721|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858124|NCT00758524|584520722|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858125|NCT00758524|584520723|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858126|NCT00758524|584520724|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858127|NCT00758524|584520725|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858128|NCT00758524|584520726|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858129|NCT00758524|584520727|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858130|NCT00758524|584520728|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858131|NCT00758524|584520729|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161975412|NCT01498185|584958472|FG000|Overall Study|Withdrawal by Subject|1|||
161858132|NCT00758524|584520730|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858133|NCT00758524|584520731|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161858134|NCT00758524|584520732|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161975413|NCT01498185|584958473|FG001|Overall Study|Withdrawal by Subject|1|||
161975414|NCT01498185|584958474|FG002|Overall Study|Withdrawal by Subject|0|||
161858135|NCT00758524|584520716|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858136|NCT00758524|584520717|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858137|NCT00758524|584520718|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858138|NCT00758524|584520719|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858139|NCT00758524|584520720|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858140|NCT00758524|584520721|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858141|NCT00758524|584520722|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858142|NCT00758524|584520723|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858143|NCT00758524|584520724|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
161858144|NCT00758524|584520725|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858145|NCT00758524|584520726|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858146|NCT00758524|584520727|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858147|NCT00758524|584520728|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858148|NCT00758524|584520729|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858149|NCT00758524|584520730|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858150|NCT00758524|584520731|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858151|NCT00758524|584520732|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161858152|NCT00758524|584520716|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858153|NCT00758524|584520717|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858154|NCT00758524|584520718|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858155|NCT00758524|584520719|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858156|NCT00758524|584520720|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858157|NCT00758524|584520721|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858158|NCT00758524|584520722|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
161858159|NCT00758524|584520723|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858160|NCT00758524|584520724|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858161|NCT00758524|584520725|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858162|NCT00758524|584520726|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858163|NCT00758524|584520727|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858164|NCT00758524|584520728|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858165|NCT00758524|584520729|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858166|NCT00758524|584520730|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858167|NCT00758524|584520731|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858168|NCT00758524|584520732|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161858169|NCT04688671|584520733|FG000|Overall Study|Adverse Event|3|||
161858170|NCT04688671|584520734|FG001|Overall Study|Adverse Event|1|||
161858171|NCT04688671|584520733|FG000|Overall Study|Withdrawal by Subject|3|||
161858172|NCT04688671|584520734|FG001|Overall Study|Withdrawal by Subject|1|||
161858173|NCT04688671|584520733|FG000|Overall Study|Lack of Efficacy|1|||
161858174|NCT04688671|584520734|FG001|Overall Study|Lack of Efficacy|1|||
161858175|NCT04688671|584520733|FG000|Overall Study|Protocol Violation|1|||
161858176|NCT04688671|584520734|FG001|Overall Study|Protocol Violation|0|||
161858177|NCT04688671|584520733|FG000|Overall Study|Lost to Follow-up|0|||
161858178|NCT04688671|584520734|FG001|Overall Study|Lost to Follow-up|1|||
161858179|NCT02676882|584520739|FG000|Overall Study|Adverse Event|1|||
161858180|NCT02676882|584520740|FG001|Overall Study|Adverse Event|0|||
161858181|NCT02676882|584520739|FG000|Overall Study|Lost to Follow-up|1|||
161858182|NCT02676882|584520740|FG001|Overall Study|Lost to Follow-up|0|||
161858183|NCT02676882|584520739|FG000|Overall Study|Withdrawal by Subject|1|||
161858184|NCT02676882|584520740|FG001|Overall Study|Withdrawal by Subject|2|||
161858185|NCT00811733|584520742|FG000|Overall Study|Investigator Discretion|10|||
161858186|NCT00811733|584520743|FG001|Overall Study|Investigator Discretion|8|||
161858187|NCT00811733|584520742|FG000|Overall Study|Withdrawal by Subject|1|||
161858188|NCT00811733|584520743|FG001|Overall Study|Withdrawal by Subject|2|||
161858189|NCT00793871|584520744|FG000|Overall Study|Death|50|||
161858190|NCT00793871|584520744|FG000|Overall Study|Lost to Follow-up|3|||
161858191|NCT00793871|584520744|FG000|Overall Study|Study terminated by the Sponsor|7|||
161858192|NCT02500589|584520745|FG000|Overall Study|Withdrawal by Subject|11|||
161858193|NCT02500589|584520746|FG001|Overall Study|Withdrawal by Subject|14|||
161858194|NCT02500589|584520745|FG000|Overall Study|Lost to Follow-up|10|||
161858195|NCT02500589|584520746|FG001|Overall Study|Lost to Follow-up|12|||
161858196|NCT02500589|584520745|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
161858197|NCT02500589|584520746|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
161858198|NCT02500589|584520745|FG000|Overall Study|Death|7|||
161858199|NCT02500589|584520746|FG001|Overall Study|Death|5|||
161858200|NCT00245466|584520747|FG000|Overall Study|Adverse Event|2|||
161858201|NCT00245466|584520748|FG001|Overall Study|Adverse Event|8|||
161858202|NCT00245466|584520749|FG002|Overall Study|Adverse Event|4|||
161858203|NCT00245466|584520747|FG000|Overall Study|Low prostate specific antigen suppr|16|||
161858204|NCT00245466|584520748|FG001|Overall Study|Low prostate specific antigen suppr|14|||
161858205|NCT00245466|584520749|FG002|Overall Study|Low prostate specific antigen suppr|5|||
161858206|NCT00245466|584520747|FG000|Overall Study|Insufficient testosterone suppr|12|||
161858207|NCT00245466|584520748|FG001|Overall Study|Insufficient testosterone suppr|12|||
161858208|NCT00245466|584520749|FG002|Overall Study|Insufficient testosterone suppr|21|||
161858209|NCT00245466|584520747|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
161858210|NCT00245466|584520748|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
161858211|NCT00245466|584520749|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
161858212|NCT00245466|584520747|FG000|Overall Study|Withdrawal by Subject|2|||
161858213|NCT00245466|584520748|FG001|Overall Study|Withdrawal by Subject|2|||
161858214|NCT00245466|584520749|FG002|Overall Study|Withdrawal by Subject|1|||
161858215|NCT00245466|584520747|FG000|Overall Study|Lost to Follow-up|3|||
161858216|NCT00245466|584520748|FG001|Overall Study|Lost to Follow-up|0|||
161858217|NCT00245466|584520749|FG002|Overall Study|Lost to Follow-up|0|||
161858218|NCT00245466|584520747|FG000|Overall Study|Disease progression|0|||
161858219|NCT00245466|584520748|FG001|Overall Study|Disease progression|3|||
161858220|NCT00245466|584520749|FG002|Overall Study|Disease progression|1|||
161858221|NCT00245466|584520747|FG000|Overall Study|Protocol Violation|1|||
161858222|NCT00245466|584520748|FG001|Overall Study|Protocol Violation|2|||
161858223|NCT00245466|584520749|FG002|Overall Study|Protocol Violation|2|||
161858224|NCT00245466|584520747|FG000|Overall Study|Death|0|||
161858225|NCT00245466|584520748|FG001|Overall Study|Death|2|||
161858226|NCT00245466|584520749|FG002|Overall Study|Death|0|||
161858227|NCT00245466|584520747|FG000|Overall Study|Administrative reasons|0|||
161858228|NCT00245466|584520748|FG001|Overall Study|Administrative reasons|1|||
161858229|NCT00245466|584520749|FG002|Overall Study|Administrative reasons|0|||
161858230|NCT03885661|584520750|FG000|Overall Study|Withdrawal by Subject|0|||
161858231|NCT03885661|584520751|FG001|Overall Study|Withdrawal by Subject|1|||
161975415|NCT01498185|584958475|FG003|Overall Study|Withdrawal by Subject|2|||
161975416|NCT01498185|584958476|FG004|Overall Study|Withdrawal by Subject|1|||
161975417|NCT01498185|584958472|FG000|Overall Study|No longer met criteria, etc|0|||
161975418|NCT01498185|584958473|FG001|Overall Study|No longer met criteria, etc|0|||
161975419|NCT01498185|584958474|FG002|Overall Study|No longer met criteria, etc|0|||
161975420|NCT01498185|584958475|FG003|Overall Study|No longer met criteria, etc|0|||
161975421|NCT01498185|584958476|FG004|Overall Study|No longer met criteria, etc|2|||
161975422|NCT00946322|584958478|FG000|Pre-treatment|participant failure to follow up|1|||
161975423|NCT00946322|584958478|FG000|Post-treatment|participant failure to follow up|2|||
161975424|NCT01453946|584958479|FG000|Overall Study|Did not receive drug for the taper phase|1|||
161975425|NCT01453946|584958479|FG000|Overall Study|Protocol Violation|2|||
161975426|NCT01453946|584958479|FG000|Overall Study|Lack of Efficacy|3|||
161975427|NCT01453946|584958479|FG000|Overall Study|Adverse Event|3|||
161975428|NCT00846040|584958480|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
161975429|NCT00846040|584958481|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
161975430|NCT00846040|584958482|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
161975431|NCT00846040|584958480|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
161975432|NCT00846040|584958481|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
161975433|NCT00846040|584958482|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
161975434|NCT03352453|584958487|FG000|Overall Study|Miscellaneous Reasons|1|||
161975435|NCT03352453|584958488|FG001|Overall Study|Miscellaneous Reasons|2|||
161975436|NCT03352453|584958487|FG000|Overall Study|Lack of Efficacy|1|||
161975437|NCT03352453|584958488|FG001|Overall Study|Lack of Efficacy|0|||
161975438|NCT03352453|584958487|FG000|Overall Study|Withdrawal by Subject|8|||
161975439|NCT03352453|584958488|FG001|Overall Study|Withdrawal by Subject|14|||
161975440|NCT03352453|584958487|FG000|Overall Study|Study Terminated by Sponsor|2|||
161975441|NCT03352453|584958488|FG001|Overall Study|Study Terminated by Sponsor|1|||
161975442|NCT03352453|584958487|FG000|Overall Study|Protocol Deviation|1|||
161975443|NCT03352453|584958488|FG001|Overall Study|Protocol Deviation|0|||
161975444|NCT03352453|584958487|FG000|Overall Study|Lost to Follow-up|7|||
161975445|NCT03352453|584958488|FG001|Overall Study|Lost to Follow-up|6|||
161975446|NCT03352453|584958487|FG000|Overall Study|Adverse Event|2|||
161975447|NCT03352453|584958488|FG001|Overall Study|Adverse Event|9|||
161975448|NCT02827500|584958491|FG000|Overall Study|Death|7|||
161975449|NCT02827500|584958492|FG001|Overall Study|Death|3|||
161858232|NCT03885661|584520750|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
161858233|NCT03885661|584520751|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
161858234|NCT00856193|584520752|FG000|Period 2|Abnormal test procedure results|0|||
161858235|NCT00856193|584520753|FG001|Period 2|Abnormal test procedure results|1|||
161858236|NCT00856193|584520752|FG000|Period 2|Lost to Follow-up|0|||
161858237|NCT00856193|584520753|FG001|Period 2|Lost to Follow-up|1|||
161858238|NCT05064397|584520754|FG000|Overall Study|Adverse Event|4|||
161975450|NCT02827500|584958491|FG000|Overall Study|Lost to Follow-up|1|||
161975451|NCT02827500|584958492|FG001|Overall Study|Lost to Follow-up|1|||
161975452|NCT02827500|584958491|FG000|Overall Study|Withdrawal by Subject|3|||
161975453|NCT02827500|584958492|FG001|Overall Study|Withdrawal by Subject|1|||
161858239|NCT05064397|584520754|FG000|Overall Study|Lack of Efficacy|12|||
161858240|NCT05064397|584520754|FG000|Overall Study|Withdrawal by Subject|3|||
161858241|NCT05064397|584520754|FG000|Overall Study|Lost to Follow-up|1|||
161858242|NCT05064397|584520754|FG000|Overall Study|Other reasons|3|||
161858243|NCT02324582|584520757|FG000|Overall Study|Screen Failures|0|||
161858244|NCT02324582|584520758|FG001|Overall Study|Screen Failures|5|||
161858245|NCT00129545|584520762|FG000|Overall Study|Death|5|||
161858246|NCT00129545|584520763|FG001|Overall Study|Death|60|||
161858247|NCT00129545|584520764|FG002|Overall Study|Death|44|||
161858248|NCT00129545|584520762|FG000|Overall Study|Withdrawal by Subject|3|||
161858249|NCT00129545|584520763|FG001|Overall Study|Withdrawal by Subject|18|||
161858250|NCT00129545|584520764|FG002|Overall Study|Withdrawal by Subject|44|||
161858251|NCT00129545|584520762|FG000|Overall Study|Lost to Follow-up|2|||
161858252|NCT00129545|584520763|FG001|Overall Study|Lost to Follow-up|22|||
161858253|NCT00129545|584520764|FG002|Overall Study|Lost to Follow-up|13|||
161858254|NCT00129545|584520762|FG000|Overall Study|Physician Decision|0|||
161858255|NCT00129545|584520763|FG001|Overall Study|Physician Decision|3|||
161858256|NCT00129545|584520764|FG002|Overall Study|Physician Decision|10|||
161858257|NCT00129545|584520762|FG000|Overall Study|Device not implanted|16|||
161858258|NCT00129545|584520763|FG001|Overall Study|Device not implanted|61|||
161858259|NCT00129545|584520764|FG002|Overall Study|Device not implanted|0|||
161858260|NCT04660331|584520765|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
161858261|NCT04660331|584520766|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
161858262|NCT04660331|584520767|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
161858263|NCT00111241|584520776|FG000|Overall Study|Lost to Follow-up|1|||
161858264|NCT00111241|584520777|FG001|Overall Study|Lost to Follow-up|0|||
161858265|NCT00111241|584520776|FG000|Overall Study|Withdrawal by Subject|4|||
161858266|NCT00111241|584520777|FG001|Overall Study|Withdrawal by Subject|0|||
161858267|NCT00111241|584520776|FG000|Overall Study|Protocol Violation|9|||
161858268|NCT00111241|584520777|FG001|Overall Study|Protocol Violation|8|||
161858269|NCT00111241|584520776|FG000|Overall Study|Adverse Event|1|||
161858270|NCT00111241|584520777|FG001|Overall Study|Adverse Event|0|||
161858271|NCT02096744|584520788|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
161858272|NCT02096744|584520789|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
161858273|NCT02096744|584520788|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
161858274|NCT02096744|584520789|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
161858275|NCT02096744|584520788|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
161858276|NCT02096744|584520789|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
161858277|NCT05724589|584520795|FG000|Overall Study|Lost to Follow-up|1|||
161858278|NCT00786409|584520796|FG000|Overall Study|Withdrawal by Subject|2|||
161858279|NCT00786409|584520796|FG000|Overall Study|Adverse Event|2|||
161858280|NCT00786409|584520796|FG000|Overall Study|Pregnancy|2|||
161858281|NCT00786409|584520796|FG000|Overall Study|Lost to Follow-up|1|||
161858282|NCT00610129|584520797|FG000|Overall Study|Not treated since patients ineligible|3|||
161858283|NCT01957176|584520806|FG000|Overall Study|Adverse Event|2|||
161858284|NCT01957176|584520807|FG001|Overall Study|Adverse Event|0|||
161858285|NCT01957176|584520806|FG000|Overall Study|Physician Decision|2|||
161858286|NCT01957176|584520807|FG001|Overall Study|Physician Decision|1|||
161858287|NCT01957176|584520806|FG000|Overall Study|Withdrawal by Subject|1|||
161858288|NCT01957176|584520807|FG001|Overall Study|Withdrawal by Subject|0|||
161858289|NCT00866359|584520809|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
161858290|NCT00866359|584520810|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
161858291|NCT00866359|584520811|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
161858292|NCT00866359|584520812|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
161858293|NCT00866359|584520809|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
161858294|NCT00866359|584520810|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
161858295|NCT00866359|584520811|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
161858296|NCT00866359|584520812|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
161858297|NCT00866359|584520809|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
161858298|NCT00866359|584520810|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
161858299|NCT00866359|584520811|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
161858300|NCT00866359|584520812|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
161858301|NCT00866359|584520809|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
161858302|NCT00866359|584520810|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
161858303|NCT00866359|584520811|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
161858304|NCT00866359|584520812|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
161858305|NCT00866359|584520809|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
161858306|NCT00866359|584520810|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
161858307|NCT00866359|584520811|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
161858308|NCT00866359|584520812|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
161858309|NCT00866359|584520809|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
161858310|NCT00866359|584520810|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
161858311|NCT00866359|584520811|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
161858312|NCT00866359|584520812|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
161858313|NCT04917861|584520823|FG000|Main Study (196 Days)|Adverse Event|0|||
161858314|NCT04917861|584520824|FG001|Main Study (196 Days)|Adverse Event|1|||
161858315|NCT04917861|584520825|FG002|Main Study (196 Days)|Adverse Event|0|||
161858316|NCT04917861|584520826|FG003|Main Study (196 Days)|Adverse Event|0|||
161858317|NCT04917861|584520823|FG000|Main Study (196 Days)|Death|0|||
161858318|NCT04917861|584520824|FG001|Main Study (196 Days)|Death|0|||
161858319|NCT04917861|584520825|FG002|Main Study (196 Days)|Death|0|||
161858320|NCT04917861|584520826|FG003|Main Study (196 Days)|Death|1|||
161858321|NCT04917861|584520823|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
161858322|NCT04917861|584520824|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
161858323|NCT04917861|584520825|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
161858324|NCT04917861|584520826|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
161858325|NCT04917861|584520823|FG000|Main Study (196 Days)|Physician Decision|0|||
161858326|NCT04917861|584520824|FG001|Main Study (196 Days)|Physician Decision|0|||
161858327|NCT04917861|584520825|FG002|Main Study (196 Days)|Physician Decision|0|||
161858328|NCT04917861|584520826|FG003|Main Study (196 Days)|Physician Decision|1|||
161858329|NCT04917861|584520823|FG000|Main Study (196 Days)|Pregnancy|1|||
161858330|NCT04917861|584520824|FG001|Main Study (196 Days)|Pregnancy|1|||
161858331|NCT04917861|584520825|FG002|Main Study (196 Days)|Pregnancy|0|||
161858332|NCT04917861|584520826|FG003|Main Study (196 Days)|Pregnancy|0|||
161858333|NCT04917861|584520823|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
161975454|NCT02827500|584958491|FG000|Overall Study|Missing primary endpoint data|3|||
161975455|NCT02827500|584958492|FG001|Overall Study|Missing primary endpoint data|1|||
161975456|NCT02827500|584958491|FG000|Overall Study|Other|5|||
162034315|NCT05217927|585181205|FG001|DBT Phase|Randomized, not treated|3|||
162034316|NCT05217927|585181206|FG002|DBT Phase|Randomized, not treated|2|||
162034317|NCT05217927|585181204|FG000|OLE Phase|Adverse Event|4|||
162034318|NCT05217927|585181205|FG001|OLE Phase|Adverse Event|1|||
162034319|NCT05217927|585181206|FG002|OLE Phase|Adverse Event|1|||
162034320|NCT05217927|585181204|FG000|OLE Phase|Extension phase eligibility failure|1|||
162034321|NCT05217927|585181205|FG001|OLE Phase|Extension phase eligibility failure|0|||
162034322|NCT05217927|585181206|FG002|OLE Phase|Extension phase eligibility failure|0|||
162034323|NCT05217927|585181204|FG000|OLE Phase|Lost to Follow-up|1|||
162034324|NCT05217927|585181205|FG001|OLE Phase|Lost to Follow-up|2|||
162034325|NCT05217927|585181206|FG002|OLE Phase|Lost to Follow-up|1|||
162034326|NCT05217927|585181204|FG000|OLE Phase|Non-compliance|0|||
161975457|NCT02827500|584958492|FG001|Overall Study|Other|1|||
162034327|NCT05217927|585181205|FG001|OLE Phase|Non-compliance|0|||
162034328|NCT05217927|585181206|FG002|OLE Phase|Non-compliance|1|||
162034329|NCT05217927|585181204|FG000|OLE Phase|Other|3|||
162034330|NCT05217927|585181205|FG001|OLE Phase|Other|5|||
161975458|NCT01241760|584958495|FG000|Overall Study|Adverse Event|1|||
161975459|NCT01241760|584958496|FG001|Overall Study|Adverse Event|0|||
161975460|NCT01241760|584958495|FG000|Overall Study|Lost to Follow-up|18|||
161975461|NCT01241760|584958496|FG001|Overall Study|Lost to Follow-up|22|||
161975462|NCT01241760|584958495|FG000|Overall Study|Withdrawal by Subject|13|||
161975463|NCT01241760|584958496|FG001|Overall Study|Withdrawal by Subject|13|||
161975464|NCT01241760|584958495|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
161975465|NCT01241760|584958496|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
161975466|NCT01241760|584958495|FG000|Overall Study|Other|1|||
161975467|NCT01241760|584958496|FG001|Overall Study|Other|1|||
161975468|NCT00514020|584958497|FG000|Overall Study|Adverse Event|6|||
161975469|NCT00514020|584958497|FG000|Overall Study|Withdrawal by Subject|3|||
161975470|NCT00514020|584958497|FG000|Overall Study|Physician Decision|1|||
161975471|NCT00514020|584958497|FG000|Overall Study|disease progression|9|||
161975472|NCT00514020|584958497|FG000|Overall Study|other complicating disease|2|||
161975473|NCT00514020|584958497|FG000|Overall Study|patient went to radiation treatment|1|||
161975474|NCT00514020|584958497|FG000|Overall Study|"patients moved to the no tx group"|6|||
161975475|NCT03697993|584958503|FG000|Overall Study|Became Ineligible after Enrollment|1|||
161975476|NCT03697993|584958504|FG001|Overall Study|Became Ineligible after Enrollment|3|||
161975477|NCT03697993|584958503|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
162034331|NCT05217927|585181206|FG002|OLE Phase|Other|4|||
162034332|NCT05217927|585181204|FG000|OLE Phase|Withdrawal of consent|3|||
161858334|NCT04917861|584520824|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
161975478|NCT03697993|584958504|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
161975479|NCT03697993|584958503|FG000|Overall Study|Lost to Follow-up|3|||
162034333|NCT05217927|585181205|FG001|OLE Phase|Withdrawal of consent|1|||
162034334|NCT05217927|585181206|FG002|OLE Phase|Withdrawal of consent|5|||
161975480|NCT03697993|584958504|FG001|Overall Study|Lost to Follow-up|0|||
161975481|NCT03697993|584958503|FG000|Overall Study|Physician Decision|4|||
162034335|NCT00076024|585182024|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
161858335|NCT04917861|584520825|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
162034336|NCT00076024|585182025|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
162034337|NCT00076024|585182026|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
161858336|NCT04917861|584520826|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
161858337|NCT04917861|584520823|FG000|Main Study (196 Days)|Other Than Specified|1|||
162034338|NCT00076024|585182027|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
162034339|NCT00076024|585182024|FG000|Phase 1, Lead-in|Adverse Event|1|||
161858338|NCT04917861|584520824|FG001|Main Study (196 Days)|Other Than Specified|0|||
161858339|NCT04917861|584520825|FG002|Main Study (196 Days)|Other Than Specified|1|||
161858340|NCT04917861|584520826|FG003|Main Study (196 Days)|Other Than Specified|2|||
161858341|NCT04917861|584520823|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
161858342|NCT04917861|584520824|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
161858343|NCT04917861|584520825|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
161858344|NCT04917861|584520826|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
161858345|NCT04917861|584520823|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
161858346|NCT04917861|584520824|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
161858347|NCT04917861|584520825|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
161858348|NCT04917861|584520826|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
161858349|NCT04917861|584520823|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
161858350|NCT04917861|584520824|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
161858351|NCT04917861|584520825|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
161858352|NCT04917861|584520826|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
161858353|NCT04917861|584520823|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
161858354|NCT04917861|584520824|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
161858355|NCT04917861|584520825|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
161858356|NCT04917861|584520826|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
161858357|NCT04917861|584520823|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
161858358|NCT04917861|584520824|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
161858359|NCT04917861|584520825|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
161858360|NCT04917861|584520826|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
161858361|NCT04917861|584520823|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
161858362|NCT04917861|584520824|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
161858363|NCT04917861|584520825|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
161858364|NCT04917861|584520826|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
161858365|NCT00720382|584520828|FG000|Overall Study|Adverse Event|54|||
161858366|NCT00720382|584520829|FG001|Overall Study|Adverse Event|17|||
161858367|NCT00720382|584520828|FG000|Overall Study|Lack of Efficacy|18|||
161858368|NCT00720382|584520829|FG001|Overall Study|Lack of Efficacy|7|||
161858369|NCT00720382|584520828|FG000|Overall Study|Non-Compliance|15|||
161858370|NCT00720382|584520829|FG001|Overall Study|Non-Compliance|5|||
161858371|NCT00720382|584520828|FG000|Overall Study|Withdrawal by Subject|47|||
161858372|NCT00720382|584520829|FG001|Overall Study|Withdrawal by Subject|11|||
161858373|NCT00720382|584520828|FG000|Overall Study|Lost to Follow-up|28|||
161858374|NCT00720382|584520829|FG001|Overall Study|Lost to Follow-up|14|||
161858375|NCT00720382|584520828|FG000|Overall Study|administrative|14|||
161858376|NCT00720382|584520829|FG001|Overall Study|administrative|5|||
161858377|NCT05192889|584520830|FG000|Block 1: All Eligible Patients|Death|2|||
161858378|NCT05192889|584520831|FG001|Block 1: All Eligible Patients|Death|0|||
161858379|NCT05192889|584520832|FG002|Block 1: All Eligible Patients|Death|0|||
161858380|NCT05192889|584520830|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
161858381|NCT05192889|584520831|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
161858382|NCT05192889|584520832|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
161858383|NCT05192889|584520830|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
161858384|NCT05192889|584520831|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
161858385|NCT05192889|584520832|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
161858386|NCT04075487|584522807|FG000|Overall Study|Withdrawal by Subject|1|||
161858387|NCT00265759|584522810|FG000|Overall Study|Withdrawal by Subject|0|||
161858388|NCT00265759|584522811|FG001|Overall Study|Withdrawal by Subject|1|||
161858389|NCT00265759|584522812|FG002|Overall Study|Withdrawal by Subject|2|||
161858390|NCT00265759|584522813|FG003|Overall Study|Withdrawal by Subject|2|||
161858391|NCT00265759|584522810|FG000|Overall Study|Cancel|0|||
161858392|NCT00265759|584522811|FG001|Overall Study|Cancel|0|||
161858393|NCT00265759|584522812|FG002|Overall Study|Cancel|0|||
161858394|NCT00265759|584522813|FG003|Overall Study|Cancel|3|||
161858395|NCT00265759|584522810|FG000|Overall Study|Ineligible|0|||
161858396|NCT00265759|584522811|FG001|Overall Study|Ineligible|0|||
161858397|NCT00265759|584522812|FG002|Overall Study|Ineligible|0|||
161858398|NCT00265759|584522813|FG003|Overall Study|Ineligible|1|||
161858399|NCT00265759|584522810|FG000|Overall Study|Bilateral disease|0|||
161975482|NCT03697993|584958504|FG001|Overall Study|Physician Decision|0|||
161975483|NCT03697993|584958503|FG000|Overall Study|Initial Urine Culture Negative|0|||
161858400|NCT00265759|584522811|FG001|Overall Study|Bilateral disease|0|||
161858401|NCT00265759|584522812|FG002|Overall Study|Bilateral disease|0|||
161858402|NCT00265759|584522813|FG003|Overall Study|Bilateral disease|2|||
161858403|NCT00265759|584522810|FG000|Overall Study|Discontinued due to intolerability|0|||
161858404|NCT00265759|584522811|FG001|Overall Study|Discontinued due to intolerability|0|||
161858405|NCT00265759|584522812|FG002|Overall Study|Discontinued due to intolerability|0|||
161858406|NCT00265759|584522813|FG003|Overall Study|Discontinued due to intolerability|1|||
161858407|NCT04467840|584522814|FG000|Overall Study|Death|35|||
161858408|NCT04467840|584522815|FG001|Overall Study|Death|39|||
161858409|NCT04467840|584522814|FG000|Overall Study|Withdrawal by Subject|8|||
161858410|NCT04467840|584522815|FG001|Overall Study|Withdrawal by Subject|4|||
161858411|NCT04467840|584522814|FG000|Overall Study|Adverse Event|2|||
161858412|NCT04467840|584522815|FG001|Overall Study|Adverse Event|0|||
161858413|NCT04467840|584522814|FG000|Overall Study|Lost to Follow-up|1|||
161858414|NCT04467840|584522815|FG001|Overall Study|Lost to Follow-up|3|||
161858415|NCT04467840|584522814|FG000|Overall Study|Physician Decision|1|||
161858416|NCT04467840|584522815|FG001|Overall Study|Physician Decision|0|||
161858417|NCT04467840|584522814|FG000|Overall Study|Other|1|||
161858418|NCT04467840|584522815|FG001|Overall Study|Other|5|||
161858419|NCT04467840|584522814|FG000|Overall Study|Missing study completion status|3|||
161858420|NCT04467840|584522815|FG001|Overall Study|Missing study completion status|1|||
161858421|NCT06082843|584522822|FG000|Overall Study|Withdrawal by Subject|0|||
161858422|NCT06082843|584522823|FG001|Overall Study|Withdrawal by Subject|2|||
161858423|NCT06082843|584522822|FG000|Overall Study|Study terminated by sponsor|12|||
161858424|NCT06082843|584522823|FG001|Overall Study|Study terminated by sponsor|8|||
161858425|NCT00696423|584522826|FG000|Overall Study|Lost to Follow-up|0|||
161858426|NCT00696423|584522827|FG001|Overall Study|Lost to Follow-up|5|||
161858427|NCT03989102|584522828|FG000|Year 1|Withdrawal by Subject|6|||
161858428|NCT03989102|584522829|FG001|Year 1|Withdrawal by Subject|2|||
161858429|NCT03989102|584522830|FG002|Year 1|Withdrawal by Subject|7|||
161858430|NCT03989102|584522828|FG000|Year 1|Lost to Follow-up|5|||
161858431|NCT03989102|584522829|FG001|Year 1|Lost to Follow-up|2|||
161858432|NCT03989102|584522830|FG002|Year 1|Lost to Follow-up|5|||
161858433|NCT03989102|584522828|FG000|Year 1|Subject met withdrawal criteria|1|||
161858434|NCT03989102|584522829|FG001|Year 1|Subject met withdrawal criteria|0|||
161858435|NCT03989102|584522830|FG002|Year 1|Subject met withdrawal criteria|1|||
161858436|NCT03989102|584522828|FG000|Year 2|Lost to Follow-up|7|||
161858437|NCT03989102|584522829|FG001|Year 2|Lost to Follow-up|3|||
161858438|NCT03989102|584522830|FG002|Year 2|Lost to Follow-up|4|||
161858439|NCT03989102|584522828|FG000|Year 2|Withdrawal by Subject|3|||
161858440|NCT03989102|584522829|FG001|Year 2|Withdrawal by Subject|1|||
161858441|NCT03989102|584522830|FG002|Year 2|Withdrawal by Subject|2|||
161858442|NCT03989102|584522828|FG000|Year 2|Subject non-compliant|3|||
161858443|NCT03989102|584522829|FG001|Year 2|Subject non-compliant|2|||
161858444|NCT03989102|584522830|FG002|Year 2|Subject non-compliant|0|||
161858445|NCT03989102|584522828|FG000|Year 2|Travel|1|||
161858446|NCT03989102|584522829|FG001|Year 2|Travel|0|||
161858447|NCT03989102|584522830|FG002|Year 2|Travel|1|||
161858448|NCT03989102|584522828|FG000|Year 2|P16 missing|4|||
161858449|NCT03989102|584522829|FG001|Year 2|P16 missing|2|||
161858450|NCT03989102|584522830|FG002|Year 2|P16 missing|1|||
161858451|NCT03989102|584522828|FG000|Year 2|P11 missing|1|||
161858452|NCT03989102|584522829|FG001|Year 2|P11 missing|3|||
161858453|NCT03989102|584522830|FG002|Year 2|P11 missing|7|||
161858454|NCT03989102|584522828|FG000|Year 2|Definitive displacement outside the study site|0|||
161858455|NCT03989102|584522829|FG001|Year 2|Definitive displacement outside the study site|1|||
161858456|NCT03989102|584522830|FG002|Year 2|Definitive displacement outside the study site|0|||
161858457|NCT03989102|584522828|FG000|Year 2|Subject missed last study visit|0|||
161858458|NCT03989102|584522829|FG001|Year 2|Subject missed last study visit|1|||
161858459|NCT03989102|584522830|FG002|Year 2|Subject missed last study visit|0|||
161858460|NCT03989102|584522828|FG000|Year 2|Death|0|||
161858461|NCT03989102|584522829|FG001|Year 2|Death|1|||
161858462|NCT03989102|584522830|FG002|Year 2|Death|0|||
161858463|NCT03989102|584522828|FG000|Year 2|Subject not reachable|0|||
161858464|NCT03989102|584522829|FG001|Year 2|Subject not reachable|0|||
161858465|NCT03989102|584522830|FG002|Year 2|Subject not reachable|1|||
161858466|NCT03989102|584522828|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
161858467|NCT03989102|584522829|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
162034340|NCT00076024|585182025|FG001|Phase 1, Lead-in|Adverse Event|0|||
162034341|NCT00076024|585182026|FG002|Phase 1, Lead-in|Adverse Event|0|||
161769911|NCT04579666|584198534|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
161769912|NCT04579666|584198531|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
161769913|NCT04579666|584198532|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
161769914|NCT04579666|584198533|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
161769915|NCT04579666|584198534|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
161769916|NCT04579666|584198531|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
161769917|NCT04579666|584198532|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
161769918|NCT04579666|584198533|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
161769919|NCT04579666|584198534|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
161769920|NCT05450198|584198535|FG000|Overall Study|Withdrawal by Subject|1|||
161769921|NCT05450198|584198536|FG001|Overall Study|Withdrawal by Subject|1|||
161769922|NCT05450198|584198537|FG002|Overall Study|Withdrawal by Subject|2|||
161858468|NCT03989102|584522830|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
161769923|NCT05450198|584198538|FG003|Overall Study|Withdrawal by Subject|0|||
161858469|NCT03989102|584522828|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
161858470|NCT03989102|584522829|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
161858471|NCT03989102|584522830|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
162034342|NCT00076024|585182027|FG003|Phase 1, Lead-in|Adverse Event|0|||
161858472|NCT03989102|584522828|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
161858473|NCT03989102|584522829|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
161858474|NCT03989102|584522830|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
162034343|NCT00076024|585182024|FG000|Phase 1, Lead-in|Clinical progression|1|||
162034344|NCT00076024|585182025|FG001|Phase 1, Lead-in|Clinical progression|0|||
162034345|NCT00076024|585182026|FG002|Phase 1, Lead-in|Clinical progression|0|||
162034346|NCT00076024|585182027|FG003|Phase 1, Lead-in|Clinical progression|0|||
162034347|NCT00076024|585182024|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
162034348|NCT00076024|585182025|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
162034349|NCT00076024|585182026|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
162034350|NCT00076024|585182027|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
161858475|NCT03989102|584522828|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
161858476|NCT03989102|584522829|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
161858477|NCT03989102|584522830|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
161858478|NCT03989102|584522828|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
161858479|NCT03989102|584522829|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
161858480|NCT03989102|584522830|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
161858481|NCT03989102|584522828|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
161858482|NCT03989102|584522829|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
161858483|NCT03989102|584522830|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
161858484|NCT04054765|584522831|FG000|Baseline|Withdrawal by Subject|5|||
161858485|NCT04054765|584522832|FG001|Baseline|Withdrawal by Subject|3|||
161858486|NCT04054765|584522831|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
161858487|NCT04054765|584522832|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
161858488|NCT04054765|584522831|FG000|3-month Follow up|Withdrawal by Subject|0|||
161858489|NCT04054765|584522832|FG001|3-month Follow up|Withdrawal by Subject|3|||
161858490|NCT04054765|584522831|FG000|6-month Follow up|Lost to Follow-up|32|||
161858491|NCT04054765|584522832|FG001|6-month Follow up|Lost to Follow-up|32|||
161858492|NCT01290068|584522833|FG000|Overall Study|Adverse Event|1|||
161858493|NCT01290068|584522834|FG001|Overall Study|Adverse Event|3|||
161858494|NCT01290068|584522833|FG000|Overall Study|Lost to Follow-up|3|||
161858495|NCT01290068|584522834|FG001|Overall Study|Lost to Follow-up|0|||
161858496|NCT01290068|584522833|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
162034351|NCT00076024|585182024|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
162034352|NCT00076024|585182025|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
162034353|NCT00076024|585182026|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
162034354|NCT00076024|585182027|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
162034355|NCT00076024|585182024|FG000|Phase 2, Double-blind|Adverse Event|0|||
161769924|NCT05450198|584198535|FG000|Overall Study|Lost to Follow-up|1|||
161769925|NCT05450198|584198536|FG001|Overall Study|Lost to Follow-up|0|||
161769926|NCT05450198|584198537|FG002|Overall Study|Lost to Follow-up|2|||
161769927|NCT05450198|584198538|FG003|Overall Study|Lost to Follow-up|1|||
161769928|NCT01982942|584198544|FG000|Overall Study|Adverse Event|10|||
161769929|NCT01982942|584198545|FG001|Overall Study|Adverse Event|5|||
161769930|NCT01982942|584198544|FG000|Overall Study|Lost to Follow-up|4|||
161769931|NCT01982942|584198545|FG001|Overall Study|Lost to Follow-up|3|||
161769932|NCT01982942|584198544|FG000|Overall Study|Multiple sclerosis progression|3|||
161769933|NCT01982942|584198545|FG001|Overall Study|Multiple sclerosis progression|2|||
161769934|NCT01982942|584198544|FG000|Overall Study|Wanted to try therapy not permitted|1|||
161769935|NCT01982942|584198545|FG001|Overall Study|Wanted to try therapy not permitted|0|||
161769936|NCT01982942|584198544|FG000|Overall Study|Subject declined future visits|0|||
161769937|NCT01982942|584198545|FG001|Overall Study|Subject declined future visits|1|||
161769938|NCT01982942|584198544|FG000|Overall Study|Left geographical area|2|||
161769939|NCT01982942|584198545|FG001|Overall Study|Left geographical area|0|||
161769940|NCT01982942|584198544|FG000|Overall Study|Too many pills|1|||
161769941|NCT01982942|584198545|FG001|Overall Study|Too many pills|0|||
161769942|NCT01982942|584198544|FG000|Overall Study|MS Relapse|0|||
161769943|NCT01982942|584198545|FG001|Overall Study|MS Relapse|1|||
161769944|NCT01982942|584198544|FG000|Overall Study|Chose to join a stem cell trial|0|||
161769945|NCT01982942|584198545|FG001|Overall Study|Chose to join a stem cell trial|1|||
161769946|NCT01982942|584198544|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
161769947|NCT01982942|584198545|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
161769948|NCT04511533|584198546|FG000|Treatment|Other|2|||
161769949|NCT04511533|584198546|FG000|Treatment|Withdrawal by Subject|11|||
161769950|NCT04511533|584198546|FG000|Treatment|Death|5|||
161769951|NCT04511533|584198546|FG000|Treatment|Physician Decision|1|||
161769952|NCT04511533|584198546|FG000|Treatment|Progressive Disease|61|||
161769953|NCT04511533|584198546|FG000|Follow-Up|Other|7|||
161769954|NCT04511533|584198546|FG000|Follow-Up|Withdrawal by Subject|5|||
161769955|NCT04511533|584198546|FG000|Follow-Up|Lost to Follow-up|2|||
161769956|NCT04511533|584198546|FG000|Follow-Up|Death|4|||
161769957|NCT01224171|584198547|FG000|Overall Study|Adverse Event|8|||
161769958|NCT01224171|584198548|FG001|Overall Study|Adverse Event|4|||
161769959|NCT01224171|584198547|FG000|Overall Study|Protocol Violation|0|||
161769960|NCT01224171|584198548|FG001|Overall Study|Protocol Violation|1|||
161769961|NCT01224171|584198547|FG000|Overall Study|Lack of Efficacy|5|||
161769962|NCT01224171|584198548|FG001|Overall Study|Lack of Efficacy|1|||
161769963|NCT01224171|584198547|FG000|Overall Study|Withdrawal of Consent|2|||
161769964|NCT01224171|584198548|FG001|Overall Study|Withdrawal of Consent|4|||
161769965|NCT01224171|584198547|FG000|Overall Study|Lost to Follow-up|0|||
161769966|NCT01224171|584198548|FG001|Overall Study|Lost to Follow-up|3|||
161769967|NCT01097057|584198549|FG000|Overall Study|Physician Decision|3|||
161769968|NCT01270139|584198552|FG000|Overall Study|Adverse Event|8|||
161769969|NCT01270139|584198553|FG001|Overall Study|Adverse Event|17|||
161769970|NCT01270139|584198554|FG002|Overall Study|Adverse Event|18|||
161769971|NCT01270139|584198552|FG000|Overall Study|Lost to Follow-up|10|||
161769972|NCT01270139|584198553|FG001|Overall Study|Lost to Follow-up|9|||
161769973|NCT01270139|584198554|FG002|Overall Study|Lost to Follow-up|2|||
161769974|NCT01161173|584198560|FG000|Overall Study|Protocol Violation|13|||
161769975|NCT01161173|584198560|FG000|Overall Study|Lost to Follow-up|7|||
161769976|NCT01161173|584198560|FG000|Overall Study|Progressive Disease|82|||
161769977|NCT01161173|584198560|FG000|Overall Study|Withdrawal of Consent|5|||
161769978|NCT01161173|584198560|FG000|Overall Study|Unacceptable Toxicity|21|||
161769979|NCT01161173|584198560|FG000|Overall Study|Death|194|||
161769980|NCT01161173|584198560|FG000|Overall Study|End of Study|2|||
161769981|NCT01161173|584198560|FG000|Overall Study|Reasons Not Specified|23|||
161769982|NCT01911546|584198561|FG000|Overall Study|Lost to Follow-up|1|||
161769983|NCT01911546|584198561|FG000|Overall Study|Everolimus was discontinued|5|||
161769984|NCT02213666|584198563|FG000|Overall Study|Withdrawal by Subject|1|||
161769985|NCT01319422|584198564|FG000|Overall Study|Withdrawal by Subject|1|||
161769986|NCT01319422|584198565|FG001|Overall Study|Withdrawal by Subject|0|||
161769987|NCT02918968|584198566|FG000|1st Line AAT|Progressive disease|9|||
161769988|NCT02918968|584198567|FG001|1st Line AAT|Progressive disease|4|||
161769989|NCT02918968|584198566|FG000|1st Line AAT|Adverse Event|12|||
161769990|NCT02918968|584198567|FG001|1st Line AAT|Adverse Event|3|||
161769991|NCT02918968|584198566|FG000|1st Line AAT|Physician Decision|4|||
161769992|NCT02918968|584198567|FG001|1st Line AAT|Physician Decision|2|||
161769993|NCT02918968|584198566|FG000|1st Line AAT|Withdrawal by Subject|2|||
161769994|NCT02918968|584198567|FG001|1st Line AAT|Withdrawal by Subject|1|||
161769995|NCT02918968|584198566|FG000|1st Line AAT|Lost to Follow-up|0|||
161769996|NCT02918968|584198567|FG001|1st Line AAT|Lost to Follow-up|1|||
161769997|NCT02918968|584198566|FG000|1st Line AAT|Death|1|||
161769998|NCT02918968|584198567|FG001|1st Line AAT|Death|0|||
161769999|NCT02918968|584198566|FG000|1st Line AAT|Miscellaneous|1|||
161770000|NCT02918968|584198567|FG001|1st Line AAT|Miscellaneous|0|||
161770001|NCT02918968|584198566|FG000|2nd Line AAT|Progressive disease|21|||
161770002|NCT02918968|584198567|FG001|2nd Line AAT|Progressive disease|3|||
161770003|NCT02918968|584198566|FG000|2nd Line AAT|Adverse Event|2|||
161770004|NCT02918968|584198567|FG001|2nd Line AAT|Adverse Event|5|||
161770005|NCT02918968|584198566|FG000|2nd Line AAT|Physician Decision|0|||
161770006|NCT02918968|584198567|FG001|2nd Line AAT|Physician Decision|1|||
161770007|NCT02918968|584198566|FG000|2nd Line AAT|Withdrawal by Subject|2|||
161770008|NCT02918968|584198567|FG001|2nd Line AAT|Withdrawal by Subject|2|||
161770009|NCT02918968|584198566|FG000|2nd Line AAT|Death|0|||
161770010|NCT02918968|584198567|FG001|2nd Line AAT|Death|1|||
161770011|NCT00750061|584198568|FG000|Overall Study|Adverse Event|2|||
161770012|NCT00750061|584198569|FG001|Overall Study|Adverse Event|0|||
161770013|NCT00750061|584198568|FG000|Overall Study|Withdrawal by Subject|0|||
161770014|NCT00750061|584198569|FG001|Overall Study|Withdrawal by Subject|1|||
161770015|NCT00750061|584198568|FG000|Overall Study|Physician Decision|0|||
161770016|NCT00750061|584198569|FG001|Overall Study|Physician Decision|1|||
161770017|NCT03732534|584198572|FG000|Overall Study|Study terminated by Sponsor|6|||
161770018|NCT02190604|584198573|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770019|NCT02190604|584198574|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770020|NCT02190604|584198575|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770021|NCT02190604|584198576|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770022|NCT02190604|584198577|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770023|NCT02190604|584198578|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770024|NCT02190604|584198579|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770025|NCT02190604|584198580|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770026|NCT02190604|584198581|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770027|NCT02190604|584198582|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770028|NCT02190604|584198583|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770029|NCT02190604|584198584|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770030|NCT02190604|584198585|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770031|NCT02190604|584198586|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770032|NCT02190604|584198587|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
161770033|NCT02190604|584198588|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770034|NCT02190604|584198589|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770035|NCT02190604|584198590|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161770036|NCT02190604|584198591|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161975484|NCT03697993|584958504|FG001|Overall Study|Initial Urine Culture Negative|1|||
161975485|NCT04384107|584958505|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
161975486|NCT04384107|584958506|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
161975487|NCT04384107|584958505|FG000|Overall Study|Lost to Follow-up|1|||
161975488|NCT04384107|584958506|FG001|Overall Study|Lost to Follow-up|0|||
161975489|NCT00276614|584958509|FG000|Overall Study|Progression of disease under study|3|||
161770037|NCT02190604|584198573|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770038|NCT02190604|584198574|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770039|NCT02190604|584198575|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770040|NCT02190604|584198576|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770041|NCT02190604|584198577|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770042|NCT02190604|584198578|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770043|NCT02190604|584198579|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770044|NCT02190604|584198580|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770045|NCT02190604|584198581|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770046|NCT02190604|584198582|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770047|NCT02190604|584198583|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770048|NCT02190604|584198584|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770049|NCT02190604|584198585|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770050|NCT02190604|584198586|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
161770051|NCT02190604|584198587|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770052|NCT02190604|584198588|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770053|NCT02190604|584198589|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770054|NCT02190604|584198590|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770055|NCT02190604|584198591|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161770056|NCT02797951|584198592|FG000|Overall Study|Adverse Event|4|||
161770057|NCT02797951|584198592|FG000|Overall Study|Death|1|||
161770058|NCT02797951|584198592|FG000|Overall Study|Lack of Efficacy|19|||
161770059|NCT02797951|584198592|FG000|Overall Study|Lost to Follow-up|4|||
161770060|NCT02797951|584198592|FG000|Overall Study|Physician Decision|6|||
161770061|NCT02797951|584198592|FG000|Overall Study|Withdrawal by Subject|15|||
161770062|NCT01901393|584198593|FG000|Overall Study|Adverse Event|1|||
161770063|NCT01901393|584198594|FG001|Overall Study|Adverse Event|0|||
161770064|NCT03125382|584198595|FG000|Randomization|screening failure|1|||
161770065|NCT03125382|584198596|FG001|Randomization|screening failure|4|||
161770066|NCT03125382|584198597|FG002|Randomization|screening failure|2|||
161770067|NCT03125382|584198598|FG003|Randomization|screening failure|0|||
161770068|NCT03125382|584198595|FG000|Follow-up|Death|1|||
161770069|NCT03125382|584198596|FG001|Follow-up|Death|2|||
161770070|NCT03125382|584198597|FG002|Follow-up|Death|1|||
161770071|NCT03125382|584198598|FG003|Follow-up|Death|2|||
161770072|NCT03125382|584198595|FG000|Follow-up|Lost to Follow-up|1|||
161770073|NCT03125382|584198596|FG001|Follow-up|Lost to Follow-up|4|||
161770074|NCT03125382|584198597|FG002|Follow-up|Lost to Follow-up|3|||
161770075|NCT03125382|584198598|FG003|Follow-up|Lost to Follow-up|1|||
161770076|NCT03907072|584198599|FG000|Overall Study|Study Terminated by Sponsor|2|||
161770077|NCT03907072|584198600|FG001|Overall Study|Study Terminated by Sponsor|2|||
161770078|NCT03907072|584198601|FG002|Overall Study|Study Terminated by Sponsor|2|||
161770079|NCT00612456|584198602|FG000|Overall Study|Adverse Event|1|||
161770080|NCT00612456|584198603|FG001|Overall Study|Adverse Event|0|||
161770081|NCT00612456|584198604|FG002|Overall Study|Adverse Event|0|||
161770082|NCT00612456|584198602|FG000|Overall Study|Lack of Efficacy|1|||
161770083|NCT00612456|584198603|FG001|Overall Study|Lack of Efficacy|1|||
161770084|NCT00612456|584198604|FG002|Overall Study|Lack of Efficacy|0|||
161770085|NCT00612456|584198602|FG000|Overall Study|Withdrawal by Subject|0|||
161770086|NCT00612456|584198603|FG001|Overall Study|Withdrawal by Subject|1|||
161770087|NCT00612456|584198604|FG002|Overall Study|Withdrawal by Subject|0|||
161770088|NCT00265109|584198607|FG000|Overall Study|Withdrawal by Subject|5|||
161770089|NCT00265109|584198607|FG000|Overall Study|Adverse Event|1|||
161770090|NCT02463097|584198608|FG000|Overall Study|Withdrawal by Subject|1|||
161770091|NCT00808665|584198609|FG000|Overall Study|Withdrawal by Subject|1|||
161770092|NCT00808665|584198610|FG001|Overall Study|Withdrawal by Subject|0|||
161770093|NCT00808665|584198609|FG000|Overall Study|only required minimally invasive surgery|1|||
161770094|NCT00808665|584198610|FG001|Overall Study|only required minimally invasive surgery|0|||
161770095|NCT00808665|584198609|FG000|Overall Study|surgery cancelled|1|||
161770096|NCT00808665|584198610|FG001|Overall Study|surgery cancelled|0|||
161770097|NCT00808665|584198609|FG000|Overall Study|required an additional procedure|0|||
161975490|NCT03582813|584958514|FG000|Overall Study|Lost to Follow-up|18|||
161770098|NCT00808665|584198610|FG001|Overall Study|required an additional procedure|1|||
161770099|NCT00808665|584198609|FG000|Overall Study|Physician Decision|3|||
161770100|NCT00808665|584198610|FG001|Overall Study|Physician Decision|1|||
161770101|NCT00808665|584198609|FG000|Overall Study|Medication stopped by resident|0|||
161770102|NCT00808665|584198610|FG001|Overall Study|Medication stopped by resident|1|||
161770103|NCT03831282|584198611|FG000|Overall Study|Could not place sensor|1|||
161770104|NCT00678652|584198618|FG000|Overall Study|Protocol Violation|2|||
161858497|NCT01290068|584522834|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
161858498|NCT01290068|584522833|FG000|Overall Study|Other|3|||
161858499|NCT01290068|584522834|FG001|Overall Study|Other|1|||
161858500|NCT02719184|584522837|FG000|Overall Study|Other than listed|1|||
161858501|NCT02719184|584522838|FG001|Overall Study|Other than listed|12|||
161858502|NCT02719184|584522839|FG002|Overall Study|Other than listed|13|||
161858503|NCT02719184|584522840|FG003|Overall Study|Other than listed|22|||
161858504|NCT02719184|584522841|FG004|Overall Study|Other than listed|9|||
161858505|NCT02719184|584522837|FG000|Overall Study|Withdrawal by Subject|5|||
161858506|NCT02719184|584522838|FG001|Overall Study|Withdrawal by Subject|3|||
161858507|NCT02719184|584522839|FG002|Overall Study|Withdrawal by Subject|6|||
161858508|NCT02719184|584522840|FG003|Overall Study|Withdrawal by Subject|6|||
161858509|NCT02719184|584522841|FG004|Overall Study|Withdrawal by Subject|0|||
161858510|NCT02719184|584522837|FG000|Overall Study|Lost to Follow-up|0|||
161858511|NCT02719184|584522838|FG001|Overall Study|Lost to Follow-up|4|||
161858512|NCT02719184|584522839|FG002|Overall Study|Lost to Follow-up|1|||
161858513|NCT02719184|584522840|FG003|Overall Study|Lost to Follow-up|3|||
161858514|NCT02719184|584522841|FG004|Overall Study|Lost to Follow-up|0|||
161858515|NCT02719184|584522837|FG000|Overall Study|Protocol Violation|0|||
161858516|NCT02719184|584522838|FG001|Overall Study|Protocol Violation|3|||
161858517|NCT02719184|584522839|FG002|Overall Study|Protocol Violation|0|||
161858518|NCT02719184|584522840|FG003|Overall Study|Protocol Violation|2|||
161858519|NCT02719184|584522841|FG004|Overall Study|Protocol Violation|0|||
161858520|NCT02719184|584522837|FG000|Overall Study|Adverse Event|0|||
161858521|NCT02719184|584522838|FG001|Overall Study|Adverse Event|0|||
161858522|NCT02719184|584522839|FG002|Overall Study|Adverse Event|0|||
161858523|NCT02719184|584522840|FG003|Overall Study|Adverse Event|3|||
161858524|NCT02719184|584522841|FG004|Overall Study|Adverse Event|0|||
161858525|NCT04428034|584522844|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
161858526|NCT02556801|584522847|FG000|Overall Study|Lost to Follow-up|1|||
161858527|NCT02556801|584522848|FG001|Overall Study|Lost to Follow-up|0|||
161858528|NCT02556801|584522849|FG002|Overall Study|Lost to Follow-up|2|||
161858529|NCT02556801|584522850|FG003|Overall Study|Lost to Follow-up|0|||
161858530|NCT02556801|584522847|FG000|Overall Study|Withdrawal by Subject|1|||
161858531|NCT02556801|584522848|FG001|Overall Study|Withdrawal by Subject|1|||
161858532|NCT02556801|584522849|FG002|Overall Study|Withdrawal by Subject|1|||
161858533|NCT02556801|584522850|FG003|Overall Study|Withdrawal by Subject|0|||
161858534|NCT02556801|584522847|FG000|Overall Study|Protocol Violation|0|||
161858535|NCT02556801|584522848|FG001|Overall Study|Protocol Violation|3|||
161858536|NCT02556801|584522849|FG002|Overall Study|Protocol Violation|1|||
161858537|NCT02556801|584522850|FG003|Overall Study|Protocol Violation|1|||
161858538|NCT02556801|584522847|FG000|Overall Study|Adverse Event|0|||
161858539|NCT02556801|584522848|FG001|Overall Study|Adverse Event|2|||
161858540|NCT02556801|584522849|FG002|Overall Study|Adverse Event|0|||
161858541|NCT02556801|584522850|FG003|Overall Study|Adverse Event|3|||
161858542|NCT02556801|584522847|FG000|Overall Study|Pregnancy|0|||
161858543|NCT02556801|584522848|FG001|Overall Study|Pregnancy|1|||
161858544|NCT02556801|584522849|FG002|Overall Study|Pregnancy|0|||
161858545|NCT02556801|584522850|FG003|Overall Study|Pregnancy|0|||
161858546|NCT02556801|584522847|FG000|Overall Study|Personal reasons patient|0|||
161858547|NCT02556801|584522848|FG001|Overall Study|Personal reasons patient|0|||
161858548|NCT02556801|584522849|FG002|Overall Study|Personal reasons patient|0|||
161858549|NCT02556801|584522850|FG003|Overall Study|Personal reasons patient|1|||
161858550|NCT01431079|584522860|FG000|Overall Study|Lost to Follow-up|35|||
161858551|NCT01431079|584522861|FG001|Overall Study|Lost to Follow-up|39|||
161858552|NCT01202175|584522862|FG000|Overall Study|Lost to Follow-up|2|||
161858553|NCT01202175|584522862|FG000|Overall Study|Withdrawal by Subject|1|||
162034356|NCT00076024|585182025|FG001|Phase 2, Double-blind|Adverse Event|25|||
161858554|NCT01202175|584522862|FG000|Overall Study|Adverse Event|2|||
161858555|NCT02790437|584522863|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
161858556|NCT02790437|584522864|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
161858557|NCT02790437|584522863|FG000|Overall Study|Adverse Event|1|||
161858558|NCT02790437|584522864|FG001|Overall Study|Adverse Event|0|||
161858559|NCT02790437|584522863|FG000|Overall Study|Withdrawal by Subject|1|||
161858560|NCT02790437|584522864|FG001|Overall Study|Withdrawal by Subject|0|||
161858561|NCT04747470|584522865|FG000|Overall Study|Death|0|||
161858562|NCT04747470|584522866|FG001|Overall Study|Death|3|||
161858563|NCT04747470|584522867|FG002|Overall Study|Death|2|||
161858564|NCT04747470|584522868|FG003|Overall Study|Death|2|||
161858565|NCT04747470|584522869|FG004|Overall Study|Death|2|||
161858566|NCT04747470|584522870|FG005|Overall Study|Death|0|||
161858567|NCT04747470|584522871|FG006|Overall Study|Death|0|||
161858568|NCT04747470|584522872|FG007|Overall Study|Death|0|||
161858569|NCT04747470|584522873|FG008|Overall Study|Death|0|||
161858570|NCT04747470|584522874|FG009|Overall Study|Death|0|||
161858571|NCT04747470|584522875|FG010|Overall Study|Death|0|||
161858572|NCT04747470|584522865|FG000|Overall Study|Withdrew Consent|0|||
161858573|NCT04747470|584522866|FG001|Overall Study|Withdrew Consent|0|||
161858574|NCT04747470|584522867|FG002|Overall Study|Withdrew Consent|0|||
161858575|NCT04747470|584522868|FG003|Overall Study|Withdrew Consent|1|||
161975491|NCT03582813|584958515|FG001|Overall Study|Lost to Follow-up|21|||
161975492|NCT03582813|584958514|FG000|Overall Study|Withdrawal by Subject|1|||
161975493|NCT03582813|584958515|FG001|Overall Study|Withdrawal by Subject|0|||
161975494|NCT01048866|584958516|FG000|Overall Study|Adverse Event|1|||
161975495|NCT01048866|584958517|FG001|Overall Study|Adverse Event|0|||
161975496|NCT01048866|584958516|FG000|Overall Study|Protocol Violation|1|||
161770105|NCT00678652|584198619|FG001|Overall Study|Protocol Violation|0|||
161770106|NCT00678652|584198620|FG002|Overall Study|Protocol Violation|0|||
161770107|NCT00678652|584198621|FG003|Overall Study|Protocol Violation|0|||
161770108|NCT00678652|584198618|FG000|Overall Study|Pregnancy|0|||
161770109|NCT00678652|584198619|FG001|Overall Study|Pregnancy|0|||
161770110|NCT00678652|584198620|FG002|Overall Study|Pregnancy|1|||
161770111|NCT00678652|584198621|FG003|Overall Study|Pregnancy|0|||
161770112|NCT00678652|584198618|FG000|Overall Study|Relocation|1|||
161770113|NCT00678652|584198619|FG001|Overall Study|Relocation|0|||
161770114|NCT00678652|584198620|FG002|Overall Study|Relocation|0|||
161770115|NCT00678652|584198621|FG003|Overall Study|Relocation|0|||
161770116|NCT05146999|584198622|FG000|Overall Study|Withdrew consent|6|||
161770117|NCT05146999|584198623|FG001|Overall Study|Withdrew consent|1|||
161770118|NCT05146999|584198622|FG000|Overall Study|Lost to Follow-up|3|||
161770119|NCT05146999|584198623|FG001|Overall Study|Lost to Follow-up|2|||
161770120|NCT05146999|584198622|FG000|Overall Study|Other|1|||
161770121|NCT05146999|584198623|FG001|Overall Study|Other|3|||
161770122|NCT00383292|584198626|FG000|Overall Study|Adverse Event|4|||
161770123|NCT00383292|584198627|FG001|Overall Study|Adverse Event|1|||
161770124|NCT00383292|584198628|FG002|Overall Study|Adverse Event|2|||
161770125|NCT00383292|584198626|FG000|Overall Study|Death|3|||
161770126|NCT00383292|584198627|FG001|Overall Study|Death|3|||
161770127|NCT00383292|584198628|FG002|Overall Study|Death|3|||
161770128|NCT00383292|584198626|FG000|Overall Study|Physician Decision|4|||
161770129|NCT00383292|584198627|FG001|Overall Study|Physician Decision|0|||
161770130|NCT00383292|584198628|FG002|Overall Study|Physician Decision|1|||
161770131|NCT00383292|584198626|FG000|Overall Study|Withdrawal by Subject|3|||
161770132|NCT00383292|584198627|FG001|Overall Study|Withdrawal by Subject|2|||
161770133|NCT00383292|584198628|FG002|Overall Study|Withdrawal by Subject|2|||
161770134|NCT00383292|584198626|FG000|Overall Study|Other|1|||
161770135|NCT00383292|584198627|FG001|Overall Study|Other|0|||
161770136|NCT00383292|584198628|FG002|Overall Study|Other|0|||
161770137|NCT00697255|584198629|FG000|Stage 1a|Insufficient ovarian response|1|||
161770138|NCT00697255|584198630|FG001|Stage 1a|Insufficient ovarian response|0|||
161770139|NCT00697255|584198629|FG000|Stage 1a|Multifollicular growth|1|||
161770140|NCT00697255|584198630|FG001|Stage 1a|Multifollicular growth|0|||
161770141|NCT00697255|584198629|FG000|Stage 1a|Not growing of dominant follicle|1|||
161770142|NCT00697255|584198630|FG001|Stage 1a|Not growing of dominant follicle|0|||
161770143|NCT00697255|584198629|FG000|Stage 1b|Not growing of dominant follicle|0|||
161770144|NCT00697255|584198630|FG001|Stage 1b|Not growing of dominant follicle|1|||
161770145|NCT00697255|584198629|FG000|Stage 1b|Insufficient ovarian response|0|||
161770146|NCT00697255|584198630|FG001|Stage 1b|Insufficient ovarian response|1|||
161770147|NCT05664672|584198633|FG000|Overall Study|Adverse Event|0|||
161770148|NCT05664672|584198634|FG001|Overall Study|Adverse Event|0|||
161770149|NCT05664672|584198635|FG002|Overall Study|Adverse Event|0|||
161770150|NCT05664672|584198636|FG003|Overall Study|Adverse Event|0|||
161770151|NCT05664672|584198637|FG004|Overall Study|Adverse Event|0|||
161770152|NCT05664672|584198638|FG005|Overall Study|Adverse Event|1|||
161770153|NCT05664672|584198633|FG000|Overall Study|Withdrawal by Subject|0|||
161770154|NCT05664672|584198634|FG001|Overall Study|Withdrawal by Subject|1|||
161770155|NCT05664672|584198635|FG002|Overall Study|Withdrawal by Subject|3|||
161770156|NCT05664672|584198636|FG003|Overall Study|Withdrawal by Subject|0|||
161770157|NCT05664672|584198637|FG004|Overall Study|Withdrawal by Subject|5|||
161770158|NCT05664672|584198638|FG005|Overall Study|Withdrawal by Subject|6|||
161770159|NCT05664672|584198633|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
161770160|NCT05664672|584198634|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
161770161|NCT05664672|584198635|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
161770162|NCT05664672|584198636|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
161770163|NCT05664672|584198637|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
161770164|NCT05664672|584198638|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
161770165|NCT05664672|584198633|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
161770166|NCT05664672|584198634|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161770167|NCT05664672|584198635|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161770168|NCT05664672|584198636|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161770169|NCT05664672|584198637|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161770170|NCT05664672|584198638|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161770171|NCT02815670|584198643|FG000|Overall Study|Prematurely discontinued of the trial|1|||
161975497|NCT01048866|584958517|FG001|Overall Study|Protocol Violation|0|||
161975498|NCT01048866|584958516|FG000|Overall Study|Physician Decision|1|||
161770172|NCT01815099|584198646|FG000|Overall Study|Lack of Efficacy|1|||
161770173|NCT01815099|584198646|FG000|Overall Study|unable to attend study visits|1|||
161975499|NCT01048866|584958517|FG001|Overall Study|Physician Decision|0|||
161858576|NCT04747470|584522869|FG004|Overall Study|Withdrew Consent|0|||
161858577|NCT04747470|584522870|FG005|Overall Study|Withdrew Consent|0|||
161858578|NCT04747470|584522871|FG006|Overall Study|Withdrew Consent|0|||
161858579|NCT04747470|584522872|FG007|Overall Study|Withdrew Consent|0|||
161858580|NCT04747470|584522873|FG008|Overall Study|Withdrew Consent|0|||
161858581|NCT04747470|584522874|FG009|Overall Study|Withdrew Consent|0|||
161858582|NCT04747470|584522875|FG010|Overall Study|Withdrew Consent|0|||
161858583|NCT04747470|584522865|FG000|Overall Study|Study Terminated by Sponsor|0|||
161858584|NCT04747470|584522866|FG001|Overall Study|Study Terminated by Sponsor|0|||
161858585|NCT04747470|584522867|FG002|Overall Study|Study Terminated by Sponsor|1|||
161858586|NCT04747470|584522868|FG003|Overall Study|Study Terminated by Sponsor|0|||
161858587|NCT04747470|584522869|FG004|Overall Study|Study Terminated by Sponsor|2|||
161858588|NCT04747470|584522870|FG005|Overall Study|Study Terminated by Sponsor|0|||
161858589|NCT04747470|584522871|FG006|Overall Study|Study Terminated by Sponsor|0|||
161858590|NCT04747470|584522872|FG007|Overall Study|Study Terminated by Sponsor|0|||
161858591|NCT04747470|584522873|FG008|Overall Study|Study Terminated by Sponsor|0|||
161858592|NCT04747470|584522874|FG009|Overall Study|Study Terminated by Sponsor|0|||
161858593|NCT04747470|584522875|FG010|Overall Study|Study Terminated by Sponsor|0|||
161858594|NCT01626690|584522878|FG000|Overall Study|Protocol Violation|1|||
161858595|NCT01626690|584522879|FG001|Overall Study|Protocol Violation|0|||
161858596|NCT01626690|584522878|FG000|Overall Study|Adverse Event|1|||
161858597|NCT01626690|584522879|FG001|Overall Study|Adverse Event|0|||
161858598|NCT01125189|584522880|FG000|Treatment Period|Lack of Efficacy|15|||
161858599|NCT01125189|584522881|FG001|Treatment Period|Lack of Efficacy|18|||
161858600|NCT01125189|584522882|FG002|Treatment Period|Lack of Efficacy|25|||
161858601|NCT01125189|584522880|FG000|Treatment Period|Adverse Event|7|||
161858602|NCT01125189|584522881|FG001|Treatment Period|Adverse Event|8|||
161858603|NCT01125189|584522882|FG002|Treatment Period|Adverse Event|8|||
161858604|NCT01125189|584522880|FG000|Treatment Period|Withdrawal by Subject|3|||
161858605|NCT01125189|584522881|FG001|Treatment Period|Withdrawal by Subject|1|||
161858606|NCT01125189|584522882|FG002|Treatment Period|Withdrawal by Subject|1|||
161858607|NCT01125189|584522880|FG000|Treatment Period|Death|1|||
161858608|NCT01125189|584522881|FG001|Treatment Period|Death|0|||
161858609|NCT01125189|584522882|FG002|Treatment Period|Death|0|||
161858610|NCT01125189|584522880|FG000|Treatment Period|Lost to Follow-up|1|||
161858611|NCT01125189|584522881|FG001|Treatment Period|Lost to Follow-up|2|||
161858612|NCT01125189|584522882|FG002|Treatment Period|Lost to Follow-up|1|||
161858613|NCT01125189|584522880|FG000|Treatment Period|Poor compliance/noncompliance|0|||
161858614|NCT01125189|584522881|FG001|Treatment Period|Poor compliance/noncompliance|1|||
161858615|NCT01125189|584522882|FG002|Treatment Period|Poor compliance/noncompliance|0|||
161858616|NCT01125189|584522880|FG000|Treatment Period|Participants requested to discontinue|1|||
161858617|NCT01125189|584522881|FG001|Treatment Period|Participants requested to discontinue|3|||
161858618|NCT01125189|584522882|FG002|Treatment Period|Participants requested to discontinue|4|||
161858619|NCT01125189|584522880|FG000|Treatment Period|Other reasons|1|||
161858620|NCT01125189|584522881|FG001|Treatment Period|Other reasons|1|||
161858621|NCT01125189|584522882|FG002|Treatment Period|Other reasons|0|||
161858622|NCT01125189|584522880|FG000|Treatment Period|Completed 24 week treatment period only|2|||
161858623|NCT01125189|584522881|FG001|Treatment Period|Completed 24 week treatment period only|1|||
161858624|NCT01125189|584522882|FG002|Treatment Period|Completed 24 week treatment period only|2|||
161858625|NCT01125189|584522880|FG000|Follow up Period|Withdrawal by Subject|3|||
161858626|NCT01125189|584522881|FG001|Follow up Period|Withdrawal by Subject|2|||
161858627|NCT01125189|584522882|FG002|Follow up Period|Withdrawal by Subject|5|||
161858628|NCT01125189|584522880|FG000|Follow up Period|Death|1|||
161858629|NCT01125189|584522881|FG001|Follow up Period|Death|0|||
161858630|NCT01125189|584522882|FG002|Follow up Period|Death|0|||
161858631|NCT01125189|584522880|FG000|Follow up Period|Lost to Follow-up|12|||
161858632|NCT01125189|584522881|FG001|Follow up Period|Lost to Follow-up|9|||
161858633|NCT01125189|584522882|FG002|Follow up Period|Lost to Follow-up|6|||
161858634|NCT01125189|584522880|FG000|Follow up Period|Other reasons|4|||
161858635|NCT01125189|584522881|FG001|Follow up Period|Other reasons|4|||
161858636|NCT01125189|584522882|FG002|Follow up Period|Other reasons|5|||
162034357|NCT00076024|585182026|FG002|Phase 2, Double-blind|Adverse Event|6|||
161858637|NCT00114140|584522883|FG000|Overall Study|Protocol Violation|7|||
161858638|NCT00110396|584522888|FG000|Overall Study|Adverse Event|15|||
161858639|NCT00110396|584522888|FG000|Overall Study|Lost to Follow-up|1|||
162034358|NCT00076024|585182027|FG003|Phase 2, Double-blind|Adverse Event|0|||
161858640|NCT00110396|584522888|FG000|Overall Study|Administration of plasmapheresis|1|||
161858641|NCT00110396|584522888|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
161858642|NCT00110396|584522888|FG000|Overall Study|Lack of Efficacy|1|||
161858643|NCT00110396|584522888|FG000|Overall Study|Decided not to continue treatment|1|||
161858644|NCT00110396|584522888|FG000|Overall Study|Patient non-compliance|1|||
161858645|NCT00110396|584522888|FG000|Overall Study|Patient refused to continue|1|||
162034359|NCT00076024|585182024|FG000|Phase 2, Double-blind|Un-specified|0|||
161858646|NCT00110396|584522888|FG000|Overall Study|Patient refused to participate|1|||
161858647|NCT00110396|584522888|FG000|Overall Study|Patient will|1|||
161858648|NCT00110396|584522888|FG000|Overall Study|Patient's decision|1|||
161858649|NCT00110396|584522888|FG000|Overall Study|Participation in MS vaccine study|1|||
162034360|NCT00076024|585182025|FG001|Phase 2, Double-blind|Un-specified|14|||
162034361|NCT00076024|585182026|FG002|Phase 2, Double-blind|Un-specified|6|||
162034362|NCT00076024|585182027|FG003|Phase 2, Double-blind|Un-specified|0|||
162034363|NCT00076024|585182024|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
162034364|NCT00076024|585182025|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
162034365|NCT00076024|585182026|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
162034366|NCT00076024|585182027|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
162034367|NCT00076024|585182024|FG000|Phase 2, Open-label|Adverse Event|0|||
162034368|NCT00076024|585182025|FG001|Phase 2, Open-label|Adverse Event|0|||
162034369|NCT00076024|585182026|FG002|Phase 2, Open-label|Adverse Event|0|||
162034370|NCT00076024|585182027|FG003|Phase 2, Open-label|Adverse Event|2|||
162034371|NCT00076024|585182024|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
162034372|NCT00076024|585182025|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
162034373|NCT00076024|585182026|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
161770174|NCT01475214|584198647|FG000|Overall Study|Lost to Follow-up|1|||
161770175|NCT01475214|584198648|FG001|Overall Study|Lost to Follow-up|0|||
161770176|NCT01475214|584198649|FG002|Overall Study|Lost to Follow-up|1|||
161770177|NCT01475214|584198647|FG000|Overall Study|Physician Decision|2|||
161770178|NCT01475214|584198648|FG001|Overall Study|Physician Decision|0|||
161770179|NCT01475214|584198649|FG002|Overall Study|Physician Decision|0|||
161770180|NCT01475214|584198647|FG000|Overall Study|Withdrawal by Subject|2|||
161770181|NCT01475214|584198648|FG001|Overall Study|Withdrawal by Subject|4|||
161770182|NCT01475214|584198649|FG002|Overall Study|Withdrawal by Subject|1|||
161770183|NCT00643851|584198650|FG000|Overall Study|Death|0|||
161770184|NCT00643851|584198651|FG001|Overall Study|Death|1|||
161770185|NCT00643851|584198652|FG002|Overall Study|Death|0|||
161770186|NCT00643851|584198650|FG000|Overall Study|Lack of Efficacy|0|||
161770187|NCT00643851|584198651|FG001|Overall Study|Lack of Efficacy|1|||
161770188|NCT00643851|584198652|FG002|Overall Study|Lack of Efficacy|0|||
161770189|NCT00643851|584198650|FG000|Overall Study|Adverse Event|2|||
161770190|NCT00643851|584198651|FG001|Overall Study|Adverse Event|6|||
161770191|NCT00643851|584198652|FG002|Overall Study|Adverse Event|6|||
161770192|NCT00643851|584198650|FG000|Overall Study|Lost to Follow-up|4|||
161770193|NCT00643851|584198651|FG001|Overall Study|Lost to Follow-up|6|||
161770194|NCT00643851|584198652|FG002|Overall Study|Lost to Follow-up|9|||
161770195|NCT00643851|584198650|FG000|Overall Study|Withdrawal by Subject|8|||
161770196|NCT00643851|584198651|FG001|Overall Study|Withdrawal by Subject|15|||
161770197|NCT00643851|584198652|FG002|Overall Study|Withdrawal by Subject|9|||
161770198|NCT00643851|584198650|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
161770199|NCT00643851|584198651|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
161770200|NCT00643851|584198652|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
161770201|NCT01977573|584198653|FG000|Overall Study|Adverse Event|7|||
161770202|NCT01977573|584198654|FG001|Overall Study|Adverse Event|0|||
161770203|NCT01977573|584198655|FG002|Overall Study|Adverse Event|2|||
161770204|NCT01977573|584198656|FG003|Overall Study|Adverse Event|1|||
161770205|NCT01977573|584198653|FG000|Overall Study|Lost to Follow-up|1|||
161770206|NCT01977573|584198654|FG001|Overall Study|Lost to Follow-up|0|||
161770207|NCT01977573|584198655|FG002|Overall Study|Lost to Follow-up|0|||
161770208|NCT01977573|584198656|FG003|Overall Study|Lost to Follow-up|1|||
161770209|NCT01977573|584198653|FG000|Overall Study|Physician Decision|1|||
161770210|NCT01977573|584198654|FG001|Overall Study|Physician Decision|0|||
161770211|NCT01977573|584198655|FG002|Overall Study|Physician Decision|0|||
161770212|NCT01977573|584198656|FG003|Overall Study|Physician Decision|0|||
161770213|NCT01977573|584198653|FG000|Overall Study|Protocol Violation|3|||
161770214|NCT01977573|584198654|FG001|Overall Study|Protocol Violation|1|||
161770215|NCT01977573|584198655|FG002|Overall Study|Protocol Violation|0|||
161770216|NCT01977573|584198656|FG003|Overall Study|Protocol Violation|0|||
161770217|NCT01977573|584198653|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
161770218|NCT01977573|584198654|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
161770219|NCT01977573|584198655|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
161770220|NCT01977573|584198656|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
161770221|NCT01977573|584198653|FG000|Overall Study|Withdrawal by Subject|6|||
161770222|NCT01977573|584198654|FG001|Overall Study|Withdrawal by Subject|1|||
161770223|NCT01977573|584198655|FG002|Overall Study|Withdrawal by Subject|1|||
161770224|NCT01977573|584198656|FG003|Overall Study|Withdrawal by Subject|1|||
161770225|NCT00323479|584198657|FG000|Overall Study|Adverse Event|2|||
161770226|NCT00323479|584198657|FG000|Overall Study|Withdrawal by Subject|2|||
161770227|NCT00323479|584198657|FG000|Overall Study|Protocol Violation|3|||
161770228|NCT00323479|584198657|FG000|Overall Study|house moving|1|||
161770229|NCT03044730|584198660|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
161770230|NCT03044730|584198660|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
161770231|NCT03044730|584198660|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
161770232|NCT03044730|584198660|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
161770233|NCT03044730|584198660|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
161770234|NCT03044730|584198660|FG000|Cycles 4 and Beyond|Adverse Event|1|||
162034374|NCT00076024|585182027|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
162034375|NCT00076024|585182024|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
161858650|NCT00110396|584522888|FG000|Overall Study|Pregnancy|1|||
161858651|NCT00110396|584522888|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
161858652|NCT00110396|584522888|FG000|Overall Study|Protocol Violation|2|||
161858653|NCT00110396|584522888|FG000|Overall Study|Patient refused to come back|1|||
161858654|NCT00110396|584522888|FG000|Overall Study|The patient has refused|2|||
161858655|NCT00110396|584522888|FG000|Overall Study|The patient has refused to visit site|1|||
161858656|NCT00110396|584522888|FG000|Overall Study|Patient is to be administered copaxone|1|||
161858657|NCT02414958|584522889|FG000|Overall Study|Adverse Event|6|||
161858658|NCT02414958|584522890|FG001|Overall Study|Adverse Event|6|||
161858659|NCT02414958|584522891|FG002|Overall Study|Adverse Event|3|||
161858660|NCT02414958|584522889|FG000|Overall Study|Protocol Violation|10|||
161858661|NCT02414958|584522890|FG001|Overall Study|Protocol Violation|3|||
161858662|NCT02414958|584522891|FG002|Overall Study|Protocol Violation|1|||
161858663|NCT02414958|584522889|FG000|Overall Study|Lost to Follow-up|7|||
161858664|NCT02414958|584522890|FG001|Overall Study|Lost to Follow-up|4|||
161858665|NCT02414958|584522891|FG002|Overall Study|Lost to Follow-up|0|||
161858666|NCT02414958|584522889|FG000|Overall Study|Withdrawal by Subject|5|||
161858667|NCT02414958|584522890|FG001|Overall Study|Withdrawal by Subject|3|||
161858668|NCT02414958|584522891|FG002|Overall Study|Withdrawal by Subject|5|||
161858669|NCT02414958|584522889|FG000|Overall Study|Other than specified|4|||
161858670|NCT02414958|584522890|FG001|Overall Study|Other than specified|4|||
161858671|NCT02414958|584522891|FG002|Overall Study|Other than specified|5|||
161858672|NCT01269918|584522892|FG000|Overall Study|Did not receive study drug|0|||
161858673|NCT01269918|584522893|FG001|Overall Study|Did not receive study drug|3|||
161858674|NCT04542057|584522897|FG000|Overall Study|Death|3|||
161858675|NCT04542057|584522898|FG001|Overall Study|Death|1|||
161858676|NCT04542057|584522897|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
161858677|NCT04542057|584522898|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
161858678|NCT04542057|584522897|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
161858679|NCT04542057|584522898|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
161858680|NCT04542057|584522897|FG000|Overall Study|Adverse Event|15|||
161858681|NCT04542057|584522898|FG001|Overall Study|Adverse Event|6|||
161858682|NCT04542057|584522897|FG000|Overall Study|COVID-19 adverse event|6|||
161858683|NCT04542057|584522898|FG001|Overall Study|COVID-19 adverse event|4|||
161858684|NCT04542057|584522897|FG000|Overall Study|Lack of Efficacy|2|||
161858685|NCT04542057|584522898|FG001|Overall Study|Lack of Efficacy|5|||
161858686|NCT04542057|584522897|FG000|Overall Study|Study terminated by sponsor|1|||
161858687|NCT04542057|584522898|FG001|Overall Study|Study terminated by sponsor|0|||
161858688|NCT04542057|584522897|FG000|Overall Study|Investigator discretion|2|||
161858689|NCT04542057|584522898|FG001|Overall Study|Investigator discretion|1|||
161858690|NCT04542057|584522897|FG000|Overall Study|Withdrawal by Subject|52|||
161858691|NCT04542057|584522898|FG001|Overall Study|Withdrawal by Subject|30|||
161858692|NCT04542057|584522897|FG000|Overall Study|Lost to Follow-up|8|||
161858693|NCT04542057|584522898|FG001|Overall Study|Lost to Follow-up|11|||
161858694|NCT04542057|584522897|FG000|Overall Study|Other|2|||
161858695|NCT04542057|584522898|FG001|Overall Study|Other|2|||
161858696|NCT00838526|584522899|FG000|Overall Study|Adverse Event|3|||
161858697|NCT00838526|584522900|FG001|Overall Study|Adverse Event|12|||
161858698|NCT00838526|584522899|FG000|Overall Study|Lost to Follow-up|4|||
161858699|NCT00838526|584522900|FG001|Overall Study|Lost to Follow-up|12|||
161858700|NCT00838526|584522899|FG000|Overall Study|Withdrawal by Subject|4|||
161858701|NCT00838526|584522900|FG001|Overall Study|Withdrawal by Subject|5|||
161858702|NCT00838526|584522899|FG000|Overall Study|Lack of Efficacy|2|||
161858703|NCT00838526|584522900|FG001|Overall Study|Lack of Efficacy|3|||
161858704|NCT00838526|584522899|FG000|Overall Study|Other|11|||
161858705|NCT00838526|584522900|FG001|Overall Study|Other|7|||
161858706|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
161975500|NCT01048866|584958516|FG000|Overall Study|Withdrawal by Subject|0|||
161975501|NCT01048866|584958517|FG001|Overall Study|Withdrawal by Subject|2|||
161975502|NCT01048866|584958516|FG000|Overall Study|Lost to Follow-up|0|||
161975503|NCT01048866|584958517|FG001|Overall Study|Lost to Follow-up|2|||
161858707|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
161975504|NCT01048866|584958516|FG000|Overall Study|Other|1|||
161975505|NCT01048866|584958517|FG001|Overall Study|Other|1|||
161975506|NCT02525094|584958522|FG000|Overall Study|Lost to Follow-up|2|||
161858708|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
161858709|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
161858710|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
161858711|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
161858712|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
161858713|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
161858714|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
161858715|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
161858716|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
161858717|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
161975507|NCT02525094|584958523|FG001|Overall Study|Lost to Follow-up|1|||
161975508|NCT02525094|584958522|FG000|Overall Study|Withdrawal by Subject|5|||
161975509|NCT02525094|584958523|FG001|Overall Study|Withdrawal by Subject|6|||
161975510|NCT02525094|584958522|FG000|Overall Study|Not Treated|1|||
161975511|NCT02525094|584958523|FG001|Overall Study|Not Treated|1|||
161975512|NCT01591863|584958524|FG000|Overall Study|Adverse Event|3|||
161975513|NCT01591863|584958524|FG000|Overall Study|Withdrawal by Subject|1|||
161975514|NCT01591863|584958524|FG000|Overall Study|recurrence|9|||
161975515|NCT01591863|584958524|FG000|Overall Study|Lack of Efficacy|1|||
161975516|NCT01751776|584958527|FG000|Overall Study|Adverse Event|0|||
161975517|NCT01751776|584958528|FG001|Overall Study|Adverse Event|0|||
161975518|NCT01751776|584958529|FG002|Overall Study|Adverse Event|0|||
161975519|NCT01751776|584958530|FG003|Overall Study|Adverse Event|0|||
161975520|NCT01751776|584958531|FG004|Overall Study|Adverse Event|0|||
161975521|NCT01751776|584958532|FG005|Overall Study|Adverse Event|0|||
161770235|NCT03044730|584198660|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
161770236|NCT03044730|584198660|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
161770237|NCT03044730|584198660|FG000|On Follow-up for 2 Years|Death|17|||
161770238|NCT01302366|584200168|FG000|Overall Study|patient choice or noncompliance|5|||
161770239|NCT01243762|584200171|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
161770240|NCT01243762|584200172|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
161770241|NCT01243762|584200173|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
161770242|NCT01243762|584200174|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
161770243|NCT01243762|584200175|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
161770244|NCT01243762|584200176|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
161770245|NCT01243762|584200177|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
161770246|NCT01243762|584200171|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161770247|NCT01243762|584200172|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
161770248|NCT01243762|584200173|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161770249|NCT01243762|584200174|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
161770250|NCT01243762|584200175|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161770251|NCT01243762|584200176|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161770252|NCT01243762|584200177|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161770253|NCT01243762|584200171|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
161770254|NCT01243762|584200172|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
161770255|NCT01243762|584200173|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
161770256|NCT01243762|584200174|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
161770257|NCT01243762|584200175|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
161770258|NCT01243762|584200176|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
161770259|NCT01243762|584200177|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
161770260|NCT01243762|584200171|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161770261|NCT01243762|584200172|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
161770262|NCT01243762|584200173|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161770263|NCT01243762|584200174|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161770264|NCT01243762|584200175|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161770265|NCT01243762|584200176|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161770266|NCT01243762|584200177|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161770267|NCT01243762|584200171|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161770268|NCT01243762|584200172|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
161770269|NCT01243762|584200173|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161770270|NCT01243762|584200174|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161770271|NCT01243762|584200175|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161770272|NCT01243762|584200176|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161770273|NCT01243762|584200177|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
161770274|NCT01243762|584200171|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
161770275|NCT01243762|584200172|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
161770276|NCT01243762|584200173|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
161770277|NCT01243762|584200174|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
161770278|NCT01243762|584200175|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
161770279|NCT01243762|584200176|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
161770280|NCT01243762|584200177|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
161770281|NCT01243762|584200171|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161770282|NCT01243762|584200172|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
161770283|NCT01243762|584200173|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161770284|NCT01243762|584200174|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161770285|NCT01243762|584200175|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
161975522|NCT01751776|584958533|FG006|Overall Study|Adverse Event|4|||
161975523|NCT01751776|584958534|FG007|Overall Study|Adverse Event|2|||
161975524|NCT01751776|584958527|FG000|Overall Study|Consent withdrawn|0|||
161975525|NCT01751776|584958528|FG001|Overall Study|Consent withdrawn|0|||
161975526|NCT01751776|584958529|FG002|Overall Study|Consent withdrawn|0|||
161975527|NCT01751776|584958530|FG003|Overall Study|Consent withdrawn|0|||
162034376|NCT00076024|585182025|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
162034377|NCT00076024|585182026|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
162034378|NCT00076024|585182027|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
162034379|NCT00076024|585182024|FG000|Phase 2, Open-label|Other|0|||
162034380|NCT00076024|585182025|FG001|Phase 2, Open-label|Other|0|||
162034381|NCT00076024|585182026|FG002|Phase 2, Open-label|Other|0|||
162034382|NCT00076024|585182027|FG003|Phase 2, Open-label|Other|2|||
162034383|NCT04123665|585182028|FG000|Overall Study|Withdrawal by Subject|7|||
162034384|NCT04123665|585182029|FG001|Overall Study|Withdrawal by Subject|0|||
162034385|NCT04123665|585182028|FG000|Overall Study|Lost to Follow-up|1|||
162034386|NCT04123665|585182029|FG001|Overall Study|Lost to Follow-up|0|||
162034387|NCT00478881|585182030|FG000|Overall Study|Adverse Event|31|||
162034388|NCT00478881|585182031|FG001|Overall Study|Adverse Event|12|||
162034389|NCT00478881|585182030|FG000|Overall Study|Lack of Efficacy|0|||
162034390|NCT00478881|585182031|FG001|Overall Study|Lack of Efficacy|3|||
162034391|NCT00478881|585182030|FG000|Overall Study|Lost to Follow-up|0|||
162034392|NCT00478881|585182031|FG001|Overall Study|Lost to Follow-up|1|||
162034393|NCT00478881|585182030|FG000|Overall Study|Protocol Violation|2|||
162034394|NCT00478881|585182031|FG001|Overall Study|Protocol Violation|2|||
162034395|NCT00478881|585182030|FG000|Overall Study|Withdrawal by Subject|6|||
162034396|NCT00478881|585182031|FG001|Overall Study|Withdrawal by Subject|2|||
162034397|NCT00478881|585182030|FG000|Overall Study|Non-Compliance with Study Medication|0|||
162034398|NCT00478881|585182031|FG001|Overall Study|Non-Compliance with Study Medication|2|||
162034399|NCT04950608|585182033|FG000|Overall Study|Withdrawal by Subject|2|||
162034400|NCT04950608|585182033|FG000|Overall Study|Physician Decision|3|||
162034401|NCT04104438|585182034|FG000|Overall Study|Death|2|||
162034402|NCT04104438|585182035|FG001|Overall Study|Death|1|||
162034403|NCT04104438|585182036|FG002|Overall Study|Death|2|||
162034404|NCT04104438|585182034|FG000|Overall Study|Adverse Event|0|||
162034405|NCT04104438|585182035|FG001|Overall Study|Adverse Event|3|||
162034406|NCT04104438|585182036|FG002|Overall Study|Adverse Event|0|||
162034407|NCT04104438|585182034|FG000|Overall Study|Withdrawal by Subject|0|||
162034408|NCT04104438|585182035|FG001|Overall Study|Withdrawal by Subject|1|||
162034409|NCT04104438|585182036|FG002|Overall Study|Withdrawal by Subject|0|||
162034410|NCT04104438|585182034|FG000|Overall Study|Disenrolled due to noncompliance|0|||
162034411|NCT04104438|585182035|FG001|Overall Study|Disenrolled due to noncompliance|1|||
162034412|NCT04104438|585182036|FG002|Overall Study|Disenrolled due to noncompliance|0|||
162034413|NCT04104438|585182034|FG000|Overall Study|stopped due to possible operation|0|||
162034414|NCT04104438|585182035|FG001|Overall Study|stopped due to possible operation|1|||
162034415|NCT04104438|585182036|FG002|Overall Study|stopped due to possible operation|0|||
162034416|NCT04104438|585182034|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
162034417|NCT04104438|585182035|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
162034418|NCT04104438|585182036|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
162034419|NCT00930982|585182039|FG000|Overall Study|Adverse Event|19|||
162034420|NCT00930982|585182040|FG001|Overall Study|Adverse Event|23|||
162034421|NCT00930982|585182039|FG000|Overall Study|Protocol Violation|1|||
162034422|NCT00930982|585182040|FG001|Overall Study|Protocol Violation|5|||
162034423|NCT00930982|585182039|FG000|Overall Study|Withdrawal by Subject|1|||
162034424|NCT00930982|585182040|FG001|Overall Study|Withdrawal by Subject|1|||
162034425|NCT00518973|585182041|FG000|Overall Study|Withdrawal by Subject|3|||
162034426|NCT00518973|585182042|FG001|Overall Study|Withdrawal by Subject|2|||
162034427|NCT00582816|585182043|FG000|Overall Study|Engraftment Failure|3|||
162034428|NCT01001299|585182044|FG000|Overall Study|Insufficient Therapeutic Response|20|||
162034429|NCT01001299|585182044|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
162034430|NCT01001299|585182044|FG000|Overall Study|Death|1|||
162034431|NCT01001299|585182044|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
162034432|NCT01001299|585182044|FG000|Overall Study|Withdrew Consent|1|||
162034433|NCT01565499|585182045|FG000|Overall Study|Physician Decision|1|||
162034434|NCT01565499|585182045|FG000|Overall Study|Adverse Event|5|||
162034435|NCT01565499|585182045|FG000|Overall Study|Withdrawal by Subject|2|||
162034436|NCT01923168|585182046|FG000|Overall Study|Protocol Violation|1|||
162034437|NCT01923168|585182047|FG001|Overall Study|Protocol Violation|1|||
162034438|NCT01923168|585182048|FG002|Overall Study|Protocol Violation|0|||
162034439|NCT01923168|585182046|FG000|Overall Study|Subject/guardian decision|14|||
162034440|NCT01923168|585182047|FG001|Overall Study|Subject/guardian decision|14|||
162034441|NCT01923168|585182048|FG002|Overall Study|Subject/guardian decision|4|||
162034442|NCT01923168|585182046|FG000|Overall Study|Adverse Event|12|||
162034443|NCT01923168|585182047|FG001|Overall Study|Adverse Event|12|||
162034444|NCT01923168|585182048|FG002|Overall Study|Adverse Event|0|||
162034445|NCT01923168|585182046|FG000|Overall Study|Physician Decision|6|||
162034446|NCT01923168|585182047|FG001|Overall Study|Physician Decision|9|||
162034447|NCT01923168|585182048|FG002|Overall Study|Physician Decision|5|||
162034448|NCT01923168|585182046|FG000|Overall Study|Progressive disease|4|||
162034449|NCT01923168|585182047|FG001|Overall Study|Progressive disease|3|||
162034450|NCT01923168|585182048|FG002|Overall Study|Progressive disease|7|||
162034451|NCT01923168|585182046|FG000|Overall Study|Death|0|||
162034452|NCT01923168|585182047|FG001|Overall Study|Death|0|||
162034453|NCT01923168|585182048|FG002|Overall Study|Death|1|||
161858718|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
161858719|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
161858720|NCT04338022|584522901|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
161858721|NCT04338022|584522902|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
161858722|NCT04338022|584522901|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
161858723|NCT04338022|584522902|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
161858724|NCT04338022|584522901|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
161858725|NCT04338022|584522902|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
161858726|NCT04338022|584522901|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
161858727|NCT04338022|584522902|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
161858728|NCT04338022|584522901|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
161858729|NCT04338022|584522902|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
161858730|NCT04338022|584522901|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
161858731|NCT04338022|584522902|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
161858732|NCT04338022|584522901|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
161858733|NCT04338022|584522902|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
161858734|NCT02273388|584522903|FG000|Overall Study|Adverse Event|0|||
161858735|NCT02273388|584522904|FG001|Overall Study|Adverse Event|0|||
161858736|NCT02273388|584522905|FG002|Overall Study|Adverse Event|0|||
161858737|NCT02273388|584522906|FG003|Overall Study|Adverse Event|0|||
161858738|NCT02273388|584522907|FG004|Overall Study|Adverse Event|0|||
161858739|NCT02273388|584522908|FG005|Overall Study|Adverse Event|0|||
161858740|NCT02273388|584522909|FG006|Overall Study|Adverse Event|1|||
161858741|NCT02273388|584522910|FG007|Overall Study|Adverse Event|2|||
161858742|NCT02273388|584522911|FG008|Overall Study|Adverse Event|0|||
161975528|NCT01751776|584958531|FG004|Overall Study|Consent withdrawn|0|||
161975529|NCT01751776|584958532|FG005|Overall Study|Consent withdrawn|0|||
161975530|NCT01751776|584958533|FG006|Overall Study|Consent withdrawn|0|||
161975531|NCT01751776|584958534|FG007|Overall Study|Consent withdrawn|1|||
161975532|NCT01751776|584958527|FG000|Overall Study|Other reason not specified above|0|||
161975533|NCT01751776|584958528|FG001|Overall Study|Other reason not specified above|0|||
161975534|NCT01751776|584958529|FG002|Overall Study|Other reason not specified above|0|||
161975535|NCT01751776|584958530|FG003|Overall Study|Other reason not specified above|0|||
161975536|NCT01751776|584958531|FG004|Overall Study|Other reason not specified above|0|||
161975537|NCT01751776|584958532|FG005|Overall Study|Other reason not specified above|0|||
161975538|NCT01751776|584958533|FG006|Overall Study|Other reason not specified above|0|||
161975539|NCT01751776|584958534|FG007|Overall Study|Other reason not specified above|1|||
161975540|NCT00160654|584958535|FG000|Overall Study|Adverse Event|14|||
161975541|NCT00160654|584958535|FG000|Overall Study|Lack of Efficacy|4|||
161975542|NCT00160654|584958535|FG000|Overall Study|Lost to Follow-up|2|||
161975543|NCT00160654|584958535|FG000|Overall Study|Intake of expired drug|7|||
161975544|NCT00160654|584958535|FG000|Overall Study|Psychological trauma|1|||
161975545|NCT00160654|584958535|FG000|Overall Study|Sponsor decision|1|||
161975546|NCT00160654|584958535|FG000|Overall Study|Patient met exclusion criteria|1|||
161975547|NCT00160654|584958535|FG000|Overall Study|Patient decision|1|||
161975548|NCT00160654|584958535|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
161975549|NCT00160654|584958535|FG000|Overall Study|Met exclusion criteria|1|||
161975550|NCT00831701|584958536|FG000|Overall Study|Withdrawal by Subject|2|||
161975551|NCT00831701|584958537|FG001|Overall Study|Withdrawal by Subject|0|||
161975552|NCT00831701|584958536|FG000|Overall Study|Stone expulsion before first medication|2|||
161975553|NCT00831701|584958537|FG001|Overall Study|Stone expulsion before first medication|2|||
161975554|NCT00831701|584958536|FG000|Overall Study|Lost to Follow-up|1|||
161975555|NCT00831701|584958537|FG001|Overall Study|Lost to Follow-up|3|||
161975556|NCT02366767|584958538|FG000|Overall Study|left for home after 1 day at camp|1|||
161975557|NCT02366767|584958539|FG001|Overall Study|left for home after 1 day at camp|0|||
161975558|NCT02117349|584958540|FG000|Overall Study|Withdrawal by Subject|1|||
161975559|NCT02117349|584958541|FG001|Overall Study|Withdrawal by Subject|0|||
161975560|NCT02117349|584958540|FG000|Overall Study|Lost to Follow-up|1|||
161975561|NCT02117349|584958541|FG001|Overall Study|Lost to Follow-up|1|||
161858743|NCT02273388|584522912|FG009|Overall Study|Adverse Event|0|||
161858744|NCT02273388|584522913|FG010|Overall Study|Adverse Event|0|||
161858745|NCT02273388|584522914|FG011|Overall Study|Adverse Event|0|||
161858746|NCT02273388|584522903|FG000|Overall Study|Adverse Event study disease worse|4|||
161858747|NCT02273388|584522904|FG001|Overall Study|Adverse Event study disease worse|3|||
161858748|NCT02273388|584522905|FG002|Overall Study|Adverse Event study disease worse|3|||
161858749|NCT02273388|584522906|FG003|Overall Study|Adverse Event study disease worse|2|||
161975562|NCT02117349|584958540|FG000|Overall Study|Death|1|||
161975563|NCT02117349|584958541|FG001|Overall Study|Death|0|||
161975564|NCT00664326|584960133|FG000|Overall Study|Adverse Event|14|||
161975565|NCT00664326|584960133|FG000|Overall Study|Noncompliance with study medication|3|||
161975566|NCT00664326|584960133|FG000|Overall Study|Withdrawal by Subject|1|||
161975567|NCT00664326|584960133|FG000|Overall Study|Physician Decision|1|||
161975568|NCT00664326|584960133|FG000|Overall Study|Other Reasons|3|||
161975569|NCT00664326|584960133|FG000|Overall Study|Death|2|||
161858750|NCT02273388|584522907|FG004|Overall Study|Adverse Event study disease worse|4|||
161858751|NCT02273388|584522908|FG005|Overall Study|Adverse Event study disease worse|3|||
161858752|NCT02273388|584522909|FG006|Overall Study|Adverse Event study disease worse|14|||
161858753|NCT02273388|584522910|FG007|Overall Study|Adverse Event study disease worse|6|||
161858754|NCT02273388|584522911|FG008|Overall Study|Adverse Event study disease worse|6|||
161858755|NCT02273388|584522912|FG009|Overall Study|Adverse Event study disease worse|5|||
161858756|NCT02273388|584522913|FG010|Overall Study|Adverse Event study disease worse|10|||
161858757|NCT02273388|584522914|FG011|Overall Study|Adverse Event study disease worse|1|||
161858758|NCT02273388|584522903|FG000|Overall Study|Sponsor decision|0|||
161858759|NCT02273388|584522904|FG001|Overall Study|Sponsor decision|0|||
161858760|NCT02273388|584522905|FG002|Overall Study|Sponsor decision|0|||
161858761|NCT02273388|584522906|FG003|Overall Study|Sponsor decision|0|||
161858762|NCT02273388|584522907|FG004|Overall Study|Sponsor decision|0|||
161858763|NCT02273388|584522908|FG005|Overall Study|Sponsor decision|0|||
161858764|NCT02273388|584522909|FG006|Overall Study|Sponsor decision|0|||
161858765|NCT02273388|584522910|FG007|Overall Study|Sponsor decision|0|||
161858766|NCT02273388|584522911|FG008|Overall Study|Sponsor decision|0|||
161858767|NCT02273388|584522912|FG009|Overall Study|Sponsor decision|0|||
161858768|NCT02273388|584522913|FG010|Overall Study|Sponsor decision|0|||
161858769|NCT02273388|584522914|FG011|Overall Study|Sponsor decision|1|||
161858770|NCT04331808|584522915|FG000|Overall Study|Withdrew consent|1|||
161858771|NCT04331808|584522916|FG001|Overall Study|Withdrew consent|0|||
161858772|NCT04331808|584522917|FG002|Overall Study|Withdrew consent|2|||
161858773|NCT04331808|584522918|FG003|Overall Study|Withdrew consent|3|||
161858774|NCT02445963|584522919|FG000|Overall Study|Lost to Follow-up|1|||
161858775|NCT02445963|584522920|FG001|Overall Study|Lost to Follow-up|0|||
161858776|NCT02445963|584522921|FG002|Overall Study|Lost to Follow-up|0|||
161858777|NCT02445963|584522922|FG003|Overall Study|Lost to Follow-up|0|||
161858778|NCT02445963|584522919|FG000|Overall Study|Change in employment|1|||
161858779|NCT02445963|584522920|FG001|Overall Study|Change in employment|0|||
161858780|NCT02445963|584522921|FG002|Overall Study|Change in employment|0|||
161858781|NCT02445963|584522922|FG003|Overall Study|Change in employment|0|||
161858782|NCT02445963|584522919|FG000|Overall Study|Symptoms post-vaccination|0|||
161858783|NCT02445963|584522920|FG001|Overall Study|Symptoms post-vaccination|0|||
161858784|NCT02445963|584522921|FG002|Overall Study|Symptoms post-vaccination|1|||
161858785|NCT02445963|584522922|FG003|Overall Study|Symptoms post-vaccination|0|||
161858786|NCT00952731|584522923|FG000|Overall Study|Drug supply expired|1|||
161858787|NCT00952731|584522924|FG001|Overall Study|Drug supply expired|0|||
161858788|NCT01449812|584522925|FG000|Overall Study|Migrated/moved from study area|1|||
161858789|NCT01449812|584522926|FG001|Overall Study|Migrated/moved from study area|0|||
161858790|NCT01449812|584522927|FG002|Overall Study|Migrated/moved from study area|0|||
161858791|NCT01449812|584522925|FG000|Overall Study|Withdrawal by Subject|0|||
161858792|NCT01449812|584522926|FG001|Overall Study|Withdrawal by Subject|0|||
161858793|NCT01449812|584522927|FG002|Overall Study|Withdrawal by Subject|1|||
161858794|NCT01449812|584522925|FG000|Overall Study|Lost to Follow-up|1|||
161858795|NCT01449812|584522926|FG001|Overall Study|Lost to Follow-up|0|||
161858796|NCT01449812|584522927|FG002|Overall Study|Lost to Follow-up|0|||
161858797|NCT00625872|584522928|FG000|Overall Study|Withdrawal by Subject|1|||
161858798|NCT00625872|584522929|FG001|Overall Study|Withdrawal by Subject|0|||
161858799|NCT00625872|584522928|FG000|Overall Study|Does not meet inclusion criteria|1|||
161858800|NCT00625872|584522929|FG001|Overall Study|Does not meet inclusion criteria|0|||
161858801|NCT00625872|584522928|FG000|Overall Study|Terminated by sponsor|2|||
161858802|NCT00625872|584522929|FG001|Overall Study|Terminated by sponsor|5|||
161858803|NCT00625872|584522928|FG000|Overall Study|Randomized but not treated|0|||
161858804|NCT00625872|584522929|FG001|Overall Study|Randomized but not treated|1|||
161858805|NCT01512160|584522933|FG000|Overall Study|Lost to Follow-up|1|||
161858806|NCT01512160|584522934|FG001|Overall Study|Lost to Follow-up|0|||
161858807|NCT01512160|584522935|FG002|Overall Study|Lost to Follow-up|0|||
161858808|NCT01512160|584522936|FG003|Overall Study|Lost to Follow-up|0|||
161858809|NCT01512160|584522933|FG000|Overall Study|Withdrawal by Subject|1|||
161858810|NCT01512160|584522934|FG001|Overall Study|Withdrawal by Subject|0|||
161858811|NCT01512160|584522935|FG002|Overall Study|Withdrawal by Subject|0|||
161858812|NCT01512160|584522936|FG003|Overall Study|Withdrawal by Subject|1|||
161858813|NCT02729909|584522937|FG000|Overall Study|Lost to Follow-up|0|||
161858814|NCT02729909|584522938|FG001|Overall Study|Lost to Follow-up|1|||
161858815|NCT02729909|584522937|FG000|Overall Study|Lack of Efficacy|0|||
161858816|NCT02729909|584522938|FG001|Overall Study|Lack of Efficacy|2|||
161858817|NCT02729909|584522937|FG000|Overall Study|Significant Protocol Deviation|0|||
161858818|NCT02729909|584522938|FG001|Overall Study|Significant Protocol Deviation|2|||
161858819|NCT02729909|584522937|FG000|Overall Study|Voluntary Withdrawal|1|||
161858820|NCT02729909|584522938|FG001|Overall Study|Voluntary Withdrawal|0|||
161858821|NCT01128179|584522939|FG000|Overall Study|Death|1|||
161858822|NCT01128179|584522940|FG001|Overall Study|Death|0|||
161858823|NCT01128179|584522939|FG000|Overall Study|Protocol Violation|1|||
161858824|NCT01128179|584522940|FG001|Overall Study|Protocol Violation|0|||
161858825|NCT04358081|584525178|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
161858826|NCT04358081|584525179|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
161770286|NCT01243762|584200176|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161770287|NCT01243762|584200177|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161770288|NCT01243762|584200171|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161770289|NCT01243762|584200172|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161770290|NCT01243762|584200173|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161770291|NCT01243762|584200174|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
161770292|NCT01243762|584200175|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
161770293|NCT01243762|584200176|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161770294|NCT01243762|584200177|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161770295|NCT04585906|584200178|FG000|Overall Study|Lost to Follow-up|8|||
161770296|NCT04585906|584200179|FG001|Overall Study|Lost to Follow-up|5|||
161770297|NCT04626947|584200180|FG000|Overall Study|Study terminated|14|||
161770298|NCT01428882|584200191|FG000|Overall Study|Lack of Efficacy|2|||
161770299|NCT01428882|584200192|FG001|Overall Study|Lack of Efficacy|7|||
161770300|NCT01428882|584200191|FG000|Overall Study|Protocol Violation|4|||
161770301|NCT01428882|584200192|FG001|Overall Study|Protocol Violation|3|||
161770302|NCT01694849|584200199|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
161770303|NCT01694849|584200200|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
161770304|NCT01694849|584200201|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
161770305|NCT01694849|584200199|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
161770306|NCT01694849|584200200|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
161770307|NCT01694849|584200201|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
161770308|NCT01694849|584200199|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
161770309|NCT01694849|584200200|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
161770310|NCT01694849|584200201|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
161770311|NCT01694849|584200199|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
161770312|NCT01694849|584200200|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
161770313|NCT01694849|584200201|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
161770314|NCT01694849|584200199|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
161770315|NCT01694849|584200200|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
161770316|NCT01694849|584200201|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
161770317|NCT01694849|584200199|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
161770318|NCT01694849|584200200|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
161770319|NCT01694849|584200201|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
161770320|NCT01694849|584200199|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
161770321|NCT01694849|584200200|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
161770322|NCT01694849|584200201|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
161770323|NCT01694849|584200199|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
161770324|NCT01694849|584200200|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
161770325|NCT01694849|584200201|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
161770326|NCT01326312|584200202|FG000|Overall Study|Adverse Event|11|||
161770327|NCT01326312|584200203|FG001|Overall Study|Adverse Event|11|||
161770328|NCT01326312|584200204|FG002|Overall Study|Adverse Event|1|||
161770329|NCT01326312|584200202|FG000|Overall Study|Withdrawal by Subject|1|||
161770330|NCT01326312|584200203|FG001|Overall Study|Withdrawal by Subject|2|||
161770331|NCT01326312|584200204|FG002|Overall Study|Withdrawal by Subject|1|||
161770332|NCT01326312|584200202|FG000|Overall Study|Protocol Violation|0|||
161770333|NCT01326312|584200203|FG001|Overall Study|Protocol Violation|1|||
161770334|NCT01326312|584200204|FG002|Overall Study|Protocol Violation|0|||
161770335|NCT01326312|584200202|FG000|Overall Study|Lack of Efficacy|13|||
161770336|NCT01326312|584200203|FG001|Overall Study|Lack of Efficacy|7|||
161770337|NCT01326312|584200204|FG002|Overall Study|Lack of Efficacy|1|||
161770338|NCT01326312|584200202|FG000|Overall Study|Death|1|||
161770339|NCT01326312|584200203|FG001|Overall Study|Death|0|||
161770340|NCT01326312|584200204|FG002|Overall Study|Death|1|||
161770341|NCT01326312|584200202|FG000|Overall Study|progressive disease|0|||
161770342|NCT01326312|584200203|FG001|Overall Study|progressive disease|1|||
161770343|NCT01326312|584200204|FG002|Overall Study|progressive disease|1|||
161770344|NCT01326312|584200202|FG000|Overall Study|Study terminated by Sponsor|8|||
161770345|NCT01326312|584200203|FG001|Overall Study|Study terminated by Sponsor|32|||
161770346|NCT01326312|584200204|FG002|Overall Study|Study terminated by Sponsor|46|||
161770347|NCT01326312|584200202|FG000|Overall Study|Treatment arm terminated|19|||
161770348|NCT01326312|584200203|FG001|Overall Study|Treatment arm terminated|0|||
161770349|NCT01326312|584200204|FG002|Overall Study|Treatment arm terminated|0|||
161770350|NCT01326312|584200202|FG000|Overall Study|QTc > 500|0|||
161770351|NCT01326312|584200203|FG001|Overall Study|QTc > 500|1|||
161770352|NCT01326312|584200204|FG002|Overall Study|QTc > 500|0|||
161770353|NCT02243306|584200214|FG000|Overall Study|Adverse Event|0|||
161770354|NCT02243306|584200215|FG001|Overall Study|Adverse Event|1|||
161975570|NCT00664326|584960133|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
161975571|NCT00262847|584960134|FG000|Overall Study|Disease Progression|309|||
161975572|NCT00262847|584960135|FG001|Overall Study|Disease Progression|274|||
161975573|NCT00262847|584960136|FG002|Overall Study|Disease Progression|195|||
161858827|NCT04358081|584525180|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
161858828|NCT04358081|584525178|FG000|Treatment Phase of Study|Adverse Event|1|||
161858829|NCT04358081|584525179|FG001|Treatment Phase of Study|Adverse Event|0|||
161858830|NCT04358081|584525180|FG002|Treatment Phase of Study|Adverse Event|1|||
161858831|NCT04358081|584525178|FG000|Treatment Phase of Study|Physician Decision|2|||
161858832|NCT04358081|584525179|FG001|Treatment Phase of Study|Physician Decision|0|||
161858833|NCT04358081|584525180|FG002|Treatment Phase of Study|Physician Decision|1|||
161975574|NCT00262847|584960134|FG000|Overall Study|Patient Refusal|41|||
161975575|NCT00262847|584960135|FG001|Overall Study|Patient Refusal|52|||
161975576|NCT00262847|584960136|FG002|Overall Study|Patient Refusal|47|||
161975577|NCT00262847|584960134|FG000|Overall Study|Adverse Event|74|||
161975578|NCT00262847|584960135|FG001|Overall Study|Adverse Event|88|||
161975579|NCT00262847|584960136|FG002|Overall Study|Adverse Event|108|||
161975580|NCT00262847|584960134|FG000|Overall Study|Death|8|||
161975581|NCT00262847|584960135|FG001|Overall Study|Death|8|||
161975582|NCT00262847|584960136|FG002|Overall Study|Death|11|||
161975583|NCT00262847|584960134|FG000|Overall Study|Concomitant disease|3|||
161975584|NCT00262847|584960135|FG001|Overall Study|Concomitant disease|2|||
161975585|NCT00262847|584960136|FG002|Overall Study|Concomitant disease|4|||
161975586|NCT00262847|584960134|FG000|Overall Study|Other Reasons|79|||
161858834|NCT04358081|584525178|FG000|Treatment Phase of Study|Protocol Violation|1|||
161858835|NCT04358081|584525179|FG001|Treatment Phase of Study|Protocol Violation|0|||
161858836|NCT04358081|584525180|FG002|Treatment Phase of Study|Protocol Violation|0|||
161858837|NCT04358081|584525178|FG000|Study Completion Phase|Death|0|||
161858838|NCT04358081|584525179|FG001|Study Completion Phase|Death|0|||
161858839|NCT04358081|584525180|FG002|Study Completion Phase|Death|1|||
161858840|NCT04358081|584525178|FG000|Study Completion Phase|Lost to Follow-up|1|||
161858841|NCT04358081|584525179|FG001|Study Completion Phase|Lost to Follow-up|0|||
161858842|NCT04358081|584525180|FG002|Study Completion Phase|Lost to Follow-up|1|||
161858843|NCT03283566|584525181|FG000|Overall Study|Lost to Follow-up|1|||
161858844|NCT03283566|584525182|FG001|Overall Study|Lost to Follow-up|2|||
161858845|NCT04515147|584525183|FG000|Overall Study|Withdrawal by Subject|1|||
161858846|NCT04515147|584525184|FG001|Overall Study|Withdrawal by Subject|0|||
161858847|NCT04515147|584525185|FG002|Overall Study|Withdrawal by Subject|10|||
161858848|NCT04515147|584525186|FG003|Overall Study|Withdrawal by Subject|18|||
161858849|NCT04515147|584525187|FG004|Overall Study|Withdrawal by Subject|1|||
161858850|NCT04515147|584525188|FG005|Overall Study|Withdrawal by Subject|8|||
161858851|NCT04515147|584525183|FG000|Overall Study|Lost to Follow-up|0|||
161858852|NCT04515147|584525184|FG001|Overall Study|Lost to Follow-up|1|||
161858853|NCT04515147|584525185|FG002|Overall Study|Lost to Follow-up|5|||
161858854|NCT04515147|584525186|FG003|Overall Study|Lost to Follow-up|6|||
161858855|NCT04515147|584525187|FG004|Overall Study|Lost to Follow-up|2|||
161858856|NCT04515147|584525188|FG005|Overall Study|Lost to Follow-up|1|||
161858857|NCT04515147|584525183|FG000|Overall Study|Adverse Event|0|||
161858858|NCT04515147|584525184|FG001|Overall Study|Adverse Event|0|||
161858859|NCT04515147|584525185|FG002|Overall Study|Adverse Event|0|||
161858860|NCT04515147|584525186|FG003|Overall Study|Adverse Event|2|||
161858861|NCT04515147|584525187|FG004|Overall Study|Adverse Event|0|||
161858862|NCT04515147|584525188|FG005|Overall Study|Adverse Event|0|||
161858863|NCT04515147|584525183|FG000|Overall Study|Miscellaneous|0|||
161858864|NCT04515147|584525184|FG001|Overall Study|Miscellaneous|0|||
161858865|NCT04515147|584525185|FG002|Overall Study|Miscellaneous|0|||
161858866|NCT04515147|584525186|FG003|Overall Study|Miscellaneous|1|||
161858867|NCT04515147|584525187|FG004|Overall Study|Miscellaneous|0|||
161858868|NCT04515147|584525188|FG005|Overall Study|Miscellaneous|1|||
161975587|NCT00262847|584960135|FG001|Overall Study|Other Reasons|88|||
161858869|NCT04123405|584525189|FG000|Overall Study|Adverse Event|1|||
161975588|NCT00262847|584960136|FG002|Overall Study|Other Reasons|27|||
161975589|NCT00262847|584960134|FG000|Overall Study|Did not receive study treatment|4|||
161975590|NCT00262847|584960135|FG001|Overall Study|Did not receive study treatment|1|||
161975591|NCT00262847|584960136|FG002|Overall Study|Did not receive study treatment|4|||
161975592|NCT00387647|584960137|FG000|Overall Study|Death|18|||
161858870|NCT04123405|584525190|FG001|Overall Study|Adverse Event|2|||
161858871|NCT04123405|584525191|FG002|Overall Study|Adverse Event|3|||
161858872|NCT04123405|584525192|FG003|Overall Study|Adverse Event|3|||
161858873|NCT04123405|584525189|FG000|Overall Study|Exclusion criteria met|1|||
161858874|NCT04123405|584525190|FG001|Overall Study|Exclusion criteria met|2|||
161858875|NCT04123405|584525191|FG002|Overall Study|Exclusion criteria met|0|||
161858876|NCT04123405|584525192|FG003|Overall Study|Exclusion criteria met|2|||
161858877|NCT04123405|584525189|FG000|Overall Study|Withdrawal by Subject|1|||
161975593|NCT00528996|584960138|FG000|Overall Study|Other reasons than listing|6|||
161975594|NCT00528996|584960139|FG001|Overall Study|Other reasons than listing|7|||
161975595|NCT00528996|584960140|FG002|Overall Study|Other reasons than listing|14|||
161858878|NCT04123405|584525190|FG001|Overall Study|Withdrawal by Subject|3|||
161858879|NCT04123405|584525191|FG002|Overall Study|Withdrawal by Subject|0|||
161975596|NCT00528996|584960141|FG003|Overall Study|Other reasons than listing|11|||
161975597|NCT00528996|584960142|FG004|Overall Study|Other reasons than listing|5|||
161975598|NCT00528996|584960138|FG000|Overall Study|Refused continue medication|16|||
161858880|NCT04123405|584525192|FG003|Overall Study|Withdrawal by Subject|2|||
161858881|NCT04123405|584525189|FG000|Overall Study|Contact to subject lost|0|||
161858882|NCT04123405|584525190|FG001|Overall Study|Contact to subject lost|0|||
161858883|NCT04123405|584525191|FG002|Overall Study|Contact to subject lost|0|||
161858884|NCT04123405|584525192|FG003|Overall Study|Contact to subject lost|1|||
161858885|NCT04123405|584525189|FG000|Overall Study|screening failure|1|||
161858886|NCT04123405|584525190|FG001|Overall Study|screening failure|0|||
161858887|NCT04123405|584525191|FG002|Overall Study|screening failure|0|||
161858888|NCT04123405|584525192|FG003|Overall Study|screening failure|0|||
161858889|NCT01050530|584525193|FG000|Overall Study|Adverse Event|6|||
161858890|NCT01050530|584525194|FG001|Overall Study|Adverse Event|3|||
161858891|NCT01050530|584525193|FG000|Overall Study|Lack of Efficacy|1|||
161858892|NCT01050530|584525194|FG001|Overall Study|Lack of Efficacy|4|||
161858893|NCT01050530|584525193|FG000|Overall Study|Withdrawal by Subject|0|||
161858894|NCT01050530|584525194|FG001|Overall Study|Withdrawal by Subject|3|||
161858895|NCT01050530|584525193|FG000|Overall Study|Protocol Violation|1|||
161858896|NCT01050530|584525194|FG001|Overall Study|Protocol Violation|0|||
161858897|NCT00545714|584525195|FG000|Induction Phase (6 Months)|Physician Decision|3|||
161858898|NCT00545714|584525195|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
161858899|NCT00545714|584525195|FG000|Induction Phase (6 Months)|Disease Progression|1|||
161858900|NCT00545714|584525195|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
161858901|NCT00545714|584525195|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
161858902|NCT00545714|584525195|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
161858903|NCT00545714|584525195|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
161858904|NCT00545714|584525195|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
161858905|NCT00545714|584525195|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
161858906|NCT00545714|584525195|FG000|Maintenance Phase (36 Months)|Death|2|||
161858907|NCT00116779|584525196|FG000|Overall Study|Adverse Event|4|||
161858908|NCT00116779|584525197|FG001|Overall Study|Adverse Event|2|||
161858909|NCT00116779|584525196|FG000|Overall Study|Protocol Violation|1|||
161858910|NCT00116779|584525197|FG001|Overall Study|Protocol Violation|4|||
161858911|NCT00116779|584525196|FG000|Overall Study|Withdrawal by Subject|4|||
161858912|NCT00116779|584525197|FG001|Overall Study|Withdrawal by Subject|1|||
161858913|NCT00116779|584525196|FG000|Overall Study|Inadequate testosterone suppression|7|||
161858914|NCT00116779|584525197|FG001|Overall Study|Inadequate testosterone suppression|9|||
161858915|NCT00116779|584525196|FG000|Overall Study|Physician Decision|3|||
161858916|NCT00116779|584525197|FG001|Overall Study|Physician Decision|1|||
161858917|NCT00116779|584525196|FG000|Overall Study|Elevated PSA levels|2|||
161858918|NCT00116779|584525197|FG001|Overall Study|Elevated PSA levels|2|||
161858919|NCT03934541|584525209|FG000|Overall Study|Study Terminated by Sponsor|0|||
161858920|NCT03934541|584525210|FG001|Overall Study|Study Terminated by Sponsor|1|||
161858921|NCT03934541|584525211|FG002|Overall Study|Study Terminated by Sponsor|0|||
161858922|NCT03934541|584525212|FG003|Overall Study|Study Terminated by Sponsor|0|||
161858923|NCT01928472|584525215|FG000|Overall Study|Death|0|||
161858924|NCT01928472|584525216|FG001|Overall Study|Death|0|||
161858925|NCT01928472|584525217|FG002|Overall Study|Death|1|||
161858926|NCT01928472|584525218|FG003|Overall Study|Death|0|||
161858927|NCT01928472|584525215|FG000|Overall Study|Withdrawal by Subject|4|||
161858928|NCT01928472|584525216|FG001|Overall Study|Withdrawal by Subject|4|||
161858929|NCT01928472|584525217|FG002|Overall Study|Withdrawal by Subject|1|||
161858930|NCT01928472|584525218|FG003|Overall Study|Withdrawal by Subject|2|||
161858931|NCT01928472|584525215|FG000|Overall Study|Lost to Follow-up|2|||
161858932|NCT01928472|584525216|FG001|Overall Study|Lost to Follow-up|3|||
161858933|NCT01928472|584525217|FG002|Overall Study|Lost to Follow-up|4|||
161858934|NCT01928472|584525218|FG003|Overall Study|Lost to Follow-up|0|||
161858935|NCT01928472|584525215|FG000|Overall Study|Administrative Reason|2|||
161858936|NCT01928472|584525216|FG001|Overall Study|Administrative Reason|1|||
161975599|NCT00528996|584960139|FG001|Overall Study|Refused continue medication|0|||
161975600|NCT00528996|584960140|FG002|Overall Study|Refused continue medication|3|||
161975601|NCT00528996|584960141|FG003|Overall Study|Refused continue medication|3|||
161858937|NCT01928472|584525217|FG002|Overall Study|Administrative Reason|0|||
161858938|NCT01928472|584525218|FG003|Overall Study|Administrative Reason|0|||
161858939|NCT01928472|584525215|FG000|Overall Study|Unclassified|0|||
161858940|NCT01928472|584525216|FG001|Overall Study|Unclassified|0|||
161858941|NCT01928472|584525217|FG002|Overall Study|Unclassified|1|||
161858942|NCT01928472|584525218|FG003|Overall Study|Unclassified|0|||
161858943|NCT03624192|584525220|FG000|Overall Study|Lost to Follow-up|1|||
161858944|NCT03624192|584525221|FG001|Overall Study|Lost to Follow-up|1|||
161858945|NCT01640249|584525222|FG000|Period 1|Withdrawal by Subject|1|||
161858946|NCT01640249|584525223|FG001|Period 1|Withdrawal by Subject|0|||
161858947|NCT01640249|584525224|FG002|Period 1|Withdrawal by Subject|0|||
161858948|NCT01640249|584525225|FG003|Period 1|Withdrawal by Subject|0|||
161858949|NCT01640249|584525226|FG004|Period 1|Withdrawal by Subject|0|||
161858950|NCT01640249|584525227|FG005|Period 1|Withdrawal by Subject|1|||
161858951|NCT01640249|584525228|FG006|Period 1|Withdrawal by Subject|0|||
161858952|NCT00065156|584525229|FG000|Overall Study|Adverse Event|37|||
161858953|NCT00065156|584525229|FG000|Overall Study|Lack of Efficacy|52|||
161858954|NCT00065156|584525229|FG000|Overall Study|Withdrawal by Subject|8|||
161858955|NCT00065156|584525229|FG000|Overall Study|Lost to Follow-up|1|||
161858956|NCT00065156|584525229|FG000|Overall Study|Death|11|||
161858957|NCT00065156|584525229|FG000|Overall Study|Study Closed by Sponsor|2|||
161858958|NCT00065156|584525229|FG000|Overall Study|Disease Progression|7|||
161858959|NCT00065156|584525229|FG000|Overall Study|Investigator Decision|2|||
161858960|NCT00065156|584525229|FG000|Overall Study|Non-Compliance|2|||
161858961|NCT00065156|584525229|FG000|Overall Study|Loss of Response|1|||
161858962|NCT00065156|584525229|FG000|Overall Study|Secondary Malign Disease|1|||
161858963|NCT00312338|584525230|FG000|Overall Study|Adverse Event|7|||
161858964|NCT00312338|584525231|FG001|Overall Study|Adverse Event|2|||
161858965|NCT00312338|584525230|FG000|Overall Study|Lost to Follow-up|9|||
161858966|NCT00312338|584525231|FG001|Overall Study|Lost to Follow-up|1|||
161858967|NCT00312338|584525230|FG000|Overall Study|Withdrawal by Subject|4|||
161858968|NCT00312338|584525231|FG001|Overall Study|Withdrawal by Subject|0|||
161858969|NCT00312338|584525230|FG000|Overall Study|Subsequent infection|2|||
161858970|NCT00312338|584525231|FG001|Overall Study|Subsequent infection|0|||
161858971|NCT00100828|584525232|FG000|Overall Study|Physician Decision|6|||
161858972|NCT04583735|584525233|FG000|Double-masked Treatment Period|Adverse Event|0|||
161858973|NCT04583735|584525234|FG001|Double-masked Treatment Period|Adverse Event|1|||
161858974|NCT04583735|584525233|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
161858975|NCT04583735|584525234|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
161858976|NCT04583735|584525233|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
161858977|NCT04583735|584525234|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
161858978|NCT04583735|584525233|FG000|Open-label Treatment Period|Adverse Event|1|||
161858979|NCT04583735|584525234|FG001|Open-label Treatment Period|Adverse Event|1|||
161858980|NCT04583735|584525233|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
161858981|NCT04583735|584525234|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161858982|NCT04583735|584525233|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
161858983|NCT04583735|584525234|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
161858984|NCT01176513|584525235|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
161858985|NCT01215136|584525236|FG000|Overall Study|Adverse Event|2|||
161858986|NCT01215136|584525237|FG001|Overall Study|Adverse Event|9|||
161858987|NCT01215136|584525236|FG000|Overall Study|Disease Progression|3|||
161858988|NCT01215136|584525237|FG001|Overall Study|Disease Progression|14|||
161858989|NCT01215136|584525236|FG000|Overall Study|Symptomatic Deterioration|1|||
161858990|NCT01215136|584525237|FG001|Overall Study|Symptomatic Deterioration|1|||
161858991|NCT01215136|584525236|FG000|Overall Study|Death|0|||
161858992|NCT01215136|584525237|FG001|Overall Study|Death|2|||
161858993|NCT01215136|584525236|FG000|Overall Study|Withdrawal by Subject|0|||
161858994|NCT01215136|584525237|FG001|Overall Study|Withdrawal by Subject|1|||
161858995|NCT01125917|584525242|FG000|Overall Study|Adverse Event|43|||
161858996|NCT01125917|584525242|FG000|Overall Study|Lost to Follow-up|23|||
161858997|NCT01125917|584525242|FG000|Overall Study|Withdrawal by Subject|31|||
161858998|NCT01125917|584525242|FG000|Overall Study|Administrative|223|||
161858999|NCT01125917|584525242|FG000|Overall Study|Lack of Efficacy|19|||
161859000|NCT04421131|584525244|FG000|Overall Study|Lost to Follow-up|1|||
161859001|NCT04421131|584525244|FG000|Overall Study|Protocol Violation|2|||
161859002|NCT04421131|584525244|FG000|Overall Study|App crashed|5|||
161859003|NCT02308124|584525245|FG000|Overall Study|Lost to Follow-up|6|||
161859004|NCT02308124|584525246|FG001|Overall Study|Lost to Follow-up|6|||
161859005|NCT02308124|584525247|FG002|Overall Study|Lost to Follow-up|6|||
161859006|NCT02308124|584525245|FG000|Overall Study|Adverse Event|0|||
161859007|NCT02308124|584525246|FG001|Overall Study|Adverse Event|2|||
161859008|NCT02308124|584525247|FG002|Overall Study|Adverse Event|2|||
161859009|NCT02501928|584525252|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161859010|NCT02501928|584525253|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
161859011|NCT02501928|584525254|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
161859012|NCT02501928|584525255|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
161859013|NCT02501928|584525256|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
161859014|NCT02501928|584525257|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
161859015|NCT01197911|584525258|FG000|Overall Study|Adverse Event|0|||
161859016|NCT01197911|584525259|FG001|Overall Study|Adverse Event|0|||
161859017|NCT01197911|584525260|FG002|Overall Study|Adverse Event|1|||
161859018|NCT01526057|584525264|FG000|Overall Study|Withdrawal by Subject|3|||
161859019|NCT01526057|584525265|FG001|Overall Study|Withdrawal by Subject|2|||
161859020|NCT01526057|584525266|FG002|Overall Study|Withdrawal by Subject|2|||
161859021|NCT01526057|584525264|FG000|Overall Study|Adverse Event|3|||
161859022|NCT01526057|584525265|FG001|Overall Study|Adverse Event|1|||
161859023|NCT01526057|584525266|FG002|Overall Study|Adverse Event|1|||
161859024|NCT01526057|584525264|FG000|Overall Study|Death|1|||
161859025|NCT01526057|584525265|FG001|Overall Study|Death|0|||
161859026|NCT01526057|584525266|FG002|Overall Study|Death|0|||
162034454|NCT00476047|585182049|FG000|Overall Study|Lost to Follow-up|1|||
161859027|NCT01526057|584525264|FG000|Overall Study|Lost to Follow-up|1|||
161859028|NCT01526057|584525265|FG001|Overall Study|Lost to Follow-up|0|||
161859029|NCT01526057|584525266|FG002|Overall Study|Lost to Follow-up|1|||
161859030|NCT01526057|584525264|FG000|Overall Study|Other|1|||
161859031|NCT01526057|584525265|FG001|Overall Study|Other|0|||
161859032|NCT01526057|584525266|FG002|Overall Study|Other|1|||
161859033|NCT01526057|584525264|FG000|Overall Study|Protocol Violation|0|||
161859034|NCT01526057|584525265|FG001|Overall Study|Protocol Violation|0|||
161859035|NCT01526057|584525266|FG002|Overall Study|Protocol Violation|1|||
161859036|NCT02123446|584525267|FG000|Washout Period (1 Day)|Physician Decision|1|||
161859037|NCT02123446|584525268|FG001|Washout Period (1 Day)|Physician Decision|0|||
161859038|NCT02553772|584525270|FG000|Overall Study|Adverse Event|2|||
161859039|NCT02553772|584525271|FG001|Overall Study|Adverse Event|3|||
161859040|NCT02553772|584525270|FG000|Overall Study|Lost to Follow-up|2|||
161859041|NCT02553772|584525271|FG001|Overall Study|Lost to Follow-up|1|||
161859042|NCT02553772|584525270|FG000|Overall Study|Withdrawal of Consent|1|||
161859043|NCT02553772|584525271|FG001|Overall Study|Withdrawal of Consent|1|||
161859044|NCT02553772|584525270|FG000|Overall Study|Lack of Efficacy|1|||
161859045|NCT02553772|584525271|FG001|Overall Study|Lack of Efficacy|0|||
161859046|NCT02553772|584525270|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161859047|NCT02553772|584525271|FG001|Overall Study|Other Miscellaneous Reasons|1|||
161859048|NCT02860546|584525272|FG000|Overall Study|Clinical Progression|6|||
161859049|NCT02860546|584525272|FG000|Overall Study|Radiological Progression|12|||
161859050|NCT02466321|584525273|FG000|Overall Study|Death|26|||
161859051|NCT02466321|584525273|FG000|Overall Study|Revision|6|||
161859052|NCT02466321|584525273|FG000|Overall Study|Lost to Follow-up|60|||
161859053|NCT02466321|584525273|FG000|Overall Study|Did not receive study device|1|||
161859054|NCT01184079|584525283|FG000|Overall Study|Lost to Follow-up|14|||
161859055|NCT01184079|584525284|FG001|Overall Study|Lost to Follow-up|2|||
161859056|NCT03172494|584525285|FG000|Overall Study|Adverse Event|5|||
161770355|NCT02243306|584200214|FG000|Overall Study|Other: Reached stopping criteria|0|||
161770356|NCT02243306|584200215|FG001|Overall Study|Other: Reached stopping criteria|1|||
161770357|NCT02243306|584200214|FG000|Overall Study|Physician Decision|0|||
161770358|NCT02243306|584200215|FG001|Overall Study|Physician Decision|1|||
161770359|NCT02221882|584200216|FG000|Overall Study|Withdrawal by Subject|0|||
161770360|NCT02221882|584200217|FG001|Overall Study|Withdrawal by Subject|0|||
161770361|NCT02221882|584200218|FG002|Overall Study|Withdrawal by Subject|4|||
161770362|NCT02221882|584200219|FG003|Overall Study|Withdrawal by Subject|2|||
161770363|NCT02221882|584200220|FG004|Overall Study|Withdrawal by Subject|2|||
161770364|NCT02221882|584200221|FG005|Overall Study|Withdrawal by Subject|2|||
161770365|NCT02221882|584200216|FG000|Overall Study|Death|0|||
161770366|NCT02221882|584200217|FG001|Overall Study|Death|1|||
161770367|NCT02221882|584200218|FG002|Overall Study|Death|0|||
161770368|NCT02221882|584200219|FG003|Overall Study|Death|0|||
161770369|NCT02221882|584200220|FG004|Overall Study|Death|0|||
161770370|NCT02221882|584200221|FG005|Overall Study|Death|0|||
161770371|NCT04095039|584200224|FG000|Overall Study|Withdrawal by Subject|2|||
161770372|NCT04095039|584200225|FG001|Overall Study|Withdrawal by Subject|16|||
161770373|NCT04095039|584200224|FG000|Overall Study|Transplanted|21|||
161770374|NCT04095039|584200225|FG001|Overall Study|Transplanted|24|||
161770375|NCT04095039|584200224|FG000|Overall Study|Transferred to Non-study Facility|47|||
161770376|NCT04095039|584200225|FG001|Overall Study|Transferred to Non-study Facility|44|||
161770377|NCT04095039|584200224|FG000|Overall Study|Withdrawal from internvention target|0|||
161770378|NCT04095039|584200225|FG001|Overall Study|Withdrawal from internvention target|2|||
161770379|NCT04095039|584200224|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
161770380|NCT04095039|584200225|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
161770381|NCT04095039|584200224|FG000|Overall Study|Cacliphylaxis|0|||
161770382|NCT04095039|584200225|FG001|Overall Study|Cacliphylaxis|1|||
161770383|NCT04095039|584200224|FG000|Overall Study|Pregnancy|1|||
161770384|NCT04095039|584200225|FG001|Overall Study|Pregnancy|0|||
161770385|NCT04768881|584200226|FG000|Overall Study|Completed Study Follow-up|0|||
161770386|NCT04768881|584200227|FG001|Overall Study|Completed Study Follow-up|2|||
161770387|NCT04768881|584200226|FG000|Overall Study|Death|3|||
161770388|NCT04768881|584200227|FG001|Overall Study|Death|2|||
161770389|NCT04768881|584200226|FG000|Overall Study|Study Terminated by Sponsor|2|||
161770390|NCT04768881|584200227|FG001|Overall Study|Study Terminated by Sponsor|2|||
161770391|NCT04768881|584200226|FG000|Overall Study|Withdrawal by Subject|2|||
161770392|NCT04768881|584200227|FG001|Overall Study|Withdrawal by Subject|0|||
161770393|NCT04768881|584200226|FG000|Overall Study|Other|2|||
161859057|NCT03172494|584525286|FG001|Overall Study|Adverse Event|1|||
161859058|NCT03172494|584525287|FG002|Overall Study|Adverse Event|15|||
161859059|NCT03172494|584525285|FG000|Overall Study|Protocol Violation|3|||
161859060|NCT03172494|584525286|FG001|Overall Study|Protocol Violation|2|||
161859061|NCT03172494|584525287|FG002|Overall Study|Protocol Violation|1|||
161770394|NCT04768881|584200227|FG001|Overall Study|Other|0|||
161859062|NCT03172494|584525285|FG000|Overall Study|Lack of Efficacy|0|||
161859063|NCT03172494|584525286|FG001|Overall Study|Lack of Efficacy|0|||
161859064|NCT03172494|584525287|FG002|Overall Study|Lack of Efficacy|4|||
161859065|NCT03172494|584525285|FG000|Overall Study|Pregnancy|0|||
161859066|NCT03172494|584525286|FG001|Overall Study|Pregnancy|1|||
161859067|NCT03172494|584525287|FG002|Overall Study|Pregnancy|0|||
161859068|NCT03172494|584525285|FG000|Overall Study|Withdrawal by Subject|10|||
161859069|NCT03172494|584525286|FG001|Overall Study|Withdrawal by Subject|8|||
161859070|NCT03172494|584525287|FG002|Overall Study|Withdrawal by Subject|8|||
161859071|NCT03172494|584525285|FG000|Overall Study|Severe hypoglycaemic episode|0|||
161859072|NCT03172494|584525286|FG001|Overall Study|Severe hypoglycaemic episode|0|||
161859073|NCT03172494|584525287|FG002|Overall Study|Severe hypoglycaemic episode|1|||
161859074|NCT03172494|584525285|FG000|Overall Study|Non-compliance towards treatment|2|||
161859075|NCT03172494|584525286|FG001|Overall Study|Non-compliance towards treatment|0|||
161859076|NCT03172494|584525287|FG002|Overall Study|Non-compliance towards treatment|0|||
161859077|NCT04233073|584525288|FG000|Overall Study|Death|5|||
161859078|NCT00243412|584525289|FG000|Overall Study|Death|0|||
161859079|NCT00243412|584525290|FG001|Overall Study|Death|1|||
161859080|NCT00243412|584525289|FG000|Overall Study|Adverse Event|4|||
161859081|NCT00243412|584525290|FG001|Overall Study|Adverse Event|2|||
161859082|NCT00243412|584525289|FG000|Overall Study|Lost to Follow-up|0|||
161859083|NCT00243412|584525290|FG001|Overall Study|Lost to Follow-up|1|||
161859084|NCT00243412|584525289|FG000|Overall Study|Physician Decision|1|||
161859085|NCT00243412|584525290|FG001|Overall Study|Physician Decision|1|||
161859086|NCT00243412|584525289|FG000|Overall Study|Withdrawal by Subject|4|||
161859087|NCT00243412|584525290|FG001|Overall Study|Withdrawal by Subject|5|||
161859088|NCT00243412|584525289|FG000|Overall Study|Other|1|||
161859089|NCT00243412|584525290|FG001|Overall Study|Other|1|||
161859090|NCT00143390|584525291|FG000|Overall Study|Death|2|||
161859091|NCT00143390|584525292|FG001|Overall Study|Death|0|||
161859092|NCT00143390|584525291|FG000|Overall Study|Not meeting entry criteria|2|||
161859093|NCT00143390|584525292|FG001|Overall Study|Not meeting entry criteria|5|||
161859094|NCT00143390|584525291|FG000|Overall Study|Withdrawal by Subject|4|||
161859095|NCT00143390|584525292|FG001|Overall Study|Withdrawal by Subject|4|||
161859096|NCT00143390|584525291|FG000|Overall Study|Progressive disease|119|||
161859097|NCT00143390|584525292|FG001|Overall Study|Progressive disease|115|||
161859098|NCT00143390|584525291|FG000|Overall Study|Protocol Violation|2|||
161859099|NCT00143390|584525292|FG001|Overall Study|Protocol Violation|0|||
161859100|NCT00143390|584525291|FG000|Overall Study|Study termination|10|||
161859101|NCT00143390|584525292|FG001|Overall Study|Study termination|15|||
161859102|NCT00143390|584525291|FG000|Overall Study|Adverse Event|9|||
161859103|NCT00143390|584525292|FG001|Overall Study|Adverse Event|8|||
161859104|NCT00143390|584525291|FG000|Overall Study|Other|1|||
161859105|NCT00143390|584525292|FG001|Overall Study|Other|2|||
161859106|NCT00041132|584525294|FG000|Overall Study|Adverse Event|19|||
161859107|NCT00041132|584525294|FG000|Overall Study|Death|1|||
161859108|NCT00041132|584525294|FG000|Overall Study|Not Eligible|7|||
161859109|NCT00041132|584525294|FG000|Overall Study|Withdrawal by Subject|1|||
161859110|NCT00041132|584525294|FG000|Overall Study|Physician Decision|2|||
161859111|NCT02764151|584525298|FG000|Overall Study|Subject refused further follow-up|0|||
161859112|NCT02764151|584525299|FG001|Overall Study|Subject refused further follow-up|0|||
161859113|NCT02764151|584525300|FG002|Overall Study|Subject refused further follow-up|0|||
161859114|NCT02764151|584525301|FG003|Overall Study|Subject refused further follow-up|1|||
161859115|NCT02764151|584525298|FG000|Overall Study|Other|0|||
161859116|NCT02764151|584525299|FG001|Overall Study|Other|0|||
161859117|NCT02764151|584525300|FG002|Overall Study|Other|0|||
161859118|NCT02764151|584525301|FG003|Overall Study|Other|2|||
161859119|NCT01450683|584525302|FG000|Overall Study|Adverse Event|2|||
161859120|NCT05101343|584525307|FG000|Overall Study|Withdrawal by Subject|2|||
161859121|NCT05101343|584525308|FG001|Overall Study|Withdrawal by Subject|1|||
161859122|NCT04779879|584525309|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161859123|NCT04779879|584525310|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161859124|NCT04779879|584525311|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161975602|NCT00528996|584960142|FG004|Overall Study|Refused continue medication|6|||
161859125|NCT04779879|584525312|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
161859126|NCT04779879|584525313|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161859127|NCT04779879|584525314|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161859128|NCT04779879|584525309|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
161859129|NCT04779879|584525310|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
161859130|NCT04779879|584525311|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
161859131|NCT04779879|584525312|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
161859132|NCT04779879|584525313|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
161859133|NCT04779879|584525314|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
161859134|NCT04779879|584525309|FG000|Part C: Up to Week 36|Death|0|||
161859135|NCT04779879|584525310|FG001|Part C: Up to Week 36|Death|0|||
161859136|NCT04779879|584525311|FG002|Part C: Up to Week 36|Death|0|||
161859137|NCT04779879|584525312|FG003|Part C: Up to Week 36|Death|0|||
161859138|NCT04779879|584525313|FG004|Part C: Up to Week 36|Death|0|||
161859139|NCT04779879|584525314|FG005|Part C: Up to Week 36|Death|1|||
161859140|NCT04779879|584525309|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
161859141|NCT04779879|584525310|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
161859142|NCT04779879|584525311|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
161859143|NCT04779879|584525312|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
161770395|NCT02370173|584200230|FG000|Overall Study|Protocol Violation|1|||
161770396|NCT02370173|584200231|FG001|Overall Study|Protocol Violation|1|||
161770397|NCT02370173|584200230|FG000|Overall Study|Withdrawal by Subject|2|||
161770398|NCT02370173|584200231|FG001|Overall Study|Withdrawal by Subject|2|||
161770399|NCT04236986|584200232|FG000|Overall Study|Withdrawal by Subject|3|||
161770400|NCT04236986|584200233|FG001|Overall Study|Withdrawal by Subject|1|||
161770401|NCT00307736|584200236|FG000|Overall Study|Adverse Event|0|||
161770402|NCT00307736|584200237|FG001|Overall Study|Adverse Event|0|||
161770403|NCT00307736|584200238|FG002|Overall Study|Adverse Event|1|||
161770404|NCT00307736|584200239|FG003|Overall Study|Adverse Event|3|||
161770405|NCT00307736|584200236|FG000|Overall Study|Withdrawal by Subject|0|||
161770406|NCT00307736|584200237|FG001|Overall Study|Withdrawal by Subject|0|||
161770407|NCT00307736|584200238|FG002|Overall Study|Withdrawal by Subject|2|||
161770408|NCT00307736|584200239|FG003|Overall Study|Withdrawal by Subject|0|||
161770409|NCT01365182|584200246|FG000|Overall Study|Withdrawal by Subject|10|||
161770410|NCT01365182|584200247|FG001|Overall Study|Withdrawal by Subject|13|||
161770411|NCT01365182|584200248|FG002|Overall Study|Withdrawal by Subject|12|||
161770412|NCT00736840|584200249|FG000|Overall Study|Lost to Follow-up|13|||
161770413|NCT01728194|584200252|FG000|Overall Study|Lost to Follow-up|4|||
161770414|NCT01728194|584200253|FG001|Overall Study|Lost to Follow-up|3|||
161770415|NCT01728194|584200252|FG000|Overall Study|Physician Decision|4|||
161770416|NCT01728194|584200253|FG001|Overall Study|Physician Decision|0|||
161770417|NCT01728194|584200252|FG000|Overall Study|Withdrawal by Subject|7|||
161770418|NCT01728194|584200253|FG001|Overall Study|Withdrawal by Subject|3|||
161770419|NCT01728194|584200252|FG000|Overall Study|Perceived Medication Side Effects|4|||
161770420|NCT01728194|584200253|FG001|Overall Study|Perceived Medication Side Effects|0|||
161770421|NCT01728194|584200252|FG000|Overall Study|Family Member Request|1|||
161770422|NCT01728194|584200253|FG001|Overall Study|Family Member Request|0|||
161770423|NCT02309372|584200254|FG000|Overall Study|Lost to Follow-up|3|||
161770424|NCT02309372|584200255|FG001|Overall Study|Lost to Follow-up|2|||
161770425|NCT03289676|584200260|FG000|Overall Study|Withdrawal by Subject|2|||
161770426|NCT03289676|584200261|FG001|Overall Study|Withdrawal by Subject|0|||
161770427|NCT03289676|584200260|FG000|Overall Study|Protocol Violation|2|||
161770428|NCT03289676|584200261|FG001|Overall Study|Protocol Violation|0|||
161770429|NCT03289676|584200260|FG000|Overall Study|Lost to Follow-up|0|||
161770430|NCT03289676|584200261|FG001|Overall Study|Lost to Follow-up|1|||
161770431|NCT02576652|584200264|FG000|Overall Study|Withdrawal by Subject|2|||
161770432|NCT04806334|584200265|FG000|Overall Study|Withdrawal by Subject|1|||
161770433|NCT02811640|584200266|FG000|Overall Study|Technology malfunction|2|||
161770434|NCT00553319|584200277|FG000|Overall Study|Lost to Follow-up|10|||
161770435|NCT00553319|584200278|FG001|Overall Study|Lost to Follow-up|9|||
161770436|NCT00553319|584200279|FG002|Overall Study|Lost to Follow-up|5|||
161770437|NCT00553319|584200277|FG000|Overall Study|wanted treatment elsewhere|2|||
161770438|NCT00553319|584200278|FG001|Overall Study|wanted treatment elsewhere|1|||
161770439|NCT00553319|584200279|FG002|Overall Study|wanted treatment elsewhere|1|||
161770440|NCT00553319|584200277|FG000|Overall Study|non-compliance|0|||
161770441|NCT00553319|584200278|FG001|Overall Study|non-compliance|0|||
161770442|NCT00553319|584200279|FG002|Overall Study|non-compliance|2|||
161770443|NCT00553319|584200277|FG000|Overall Study|incarceration|1|||
161770444|NCT00553319|584200278|FG001|Overall Study|incarceration|0|||
161770445|NCT00553319|584200279|FG002|Overall Study|incarceration|0|||
161770446|NCT00553319|584200277|FG000|Overall Study|moved|1|||
161770447|NCT00553319|584200278|FG001|Overall Study|moved|0|||
161770448|NCT00553319|584200279|FG002|Overall Study|moved|1|||
161770449|NCT04369742|584200284|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
161770450|NCT04369742|584200285|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
161770451|NCT04369742|584200284|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
161770452|NCT04369742|584200285|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
161770453|NCT00465894|584200286|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
161770454|NCT00465894|584200287|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
161770455|NCT00465894|584200286|FG000|Treatment For 12 Weeks|Family Issues|1|||
161770456|NCT00465894|584200287|FG001|Treatment For 12 Weeks|Family Issues|1|||
161770457|NCT00465894|584200286|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
161770458|NCT00465894|584200287|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
161770459|NCT01636076|584200288|FG000|Overall Study|Terminated by sponsor|1|||
161770460|NCT01636076|584200289|FG001|Overall Study|Terminated by sponsor|1|||
161770461|NCT01636076|584200288|FG000|Overall Study|Lack of Efficacy|0|||
161770462|NCT01636076|584200289|FG001|Overall Study|Lack of Efficacy|1|||
161770463|NCT01636076|584200288|FG000|Overall Study|Lost to Follow-up|1|||
161770464|NCT01636076|584200289|FG001|Overall Study|Lost to Follow-up|0|||
161770465|NCT01636076|584200288|FG000|Overall Study|Physician Decision|1|||
161770466|NCT01636076|584200289|FG001|Overall Study|Physician Decision|1|||
161770467|NCT01636076|584200288|FG000|Overall Study|Non-compliance with study treatment|1|||
161770468|NCT01636076|584200289|FG001|Overall Study|Non-compliance with study treatment|1|||
161770469|NCT01636076|584200288|FG000|Overall Study|Adverse Event|6|||
161770470|NCT01636076|584200289|FG001|Overall Study|Adverse Event|11|||
161770471|NCT01636076|584200288|FG000|Overall Study|Withdrawal by Subject|7|||
161770472|NCT01636076|584200289|FG001|Overall Study|Withdrawal by Subject|10|||
161859144|NCT04779879|584525313|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
161859145|NCT04779879|584525314|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
161859146|NCT02854527|584525315|FG000|Overall Study|Adverse Event|0|||
161859147|NCT02854527|584525316|FG001|Overall Study|Adverse Event|0|||
161859148|NCT02854527|584525317|FG002|Overall Study|Adverse Event|0|||
161859149|NCT02854527|584525318|FG003|Overall Study|Adverse Event|0|||
161859150|NCT02854527|584525319|FG004|Overall Study|Adverse Event|1|||
161859151|NCT02854527|584525320|FG005|Overall Study|Adverse Event|0|||
161859152|NCT02854527|584525321|FG006|Overall Study|Adverse Event|0|||
161859153|NCT02854527|584525322|FG007|Overall Study|Adverse Event|0|||
161859154|NCT02854527|584525323|FG008|Overall Study|Adverse Event|0|||
161859155|NCT02854527|584525324|FG009|Overall Study|Adverse Event|0|||
161859156|NCT02854527|584525315|FG000|Overall Study|Lost to Follow-up|0|||
161859157|NCT02854527|584525316|FG001|Overall Study|Lost to Follow-up|0|||
161859158|NCT02854527|584525317|FG002|Overall Study|Lost to Follow-up|0|||
161859159|NCT02854527|584525318|FG003|Overall Study|Lost to Follow-up|1|||
161859160|NCT02854527|584525319|FG004|Overall Study|Lost to Follow-up|0|||
161859161|NCT02854527|584525320|FG005|Overall Study|Lost to Follow-up|0|||
161859162|NCT02854527|584525321|FG006|Overall Study|Lost to Follow-up|0|||
161859163|NCT02854527|584525322|FG007|Overall Study|Lost to Follow-up|0|||
161859164|NCT02854527|584525323|FG008|Overall Study|Lost to Follow-up|0|||
161859165|NCT02854527|584525324|FG009|Overall Study|Lost to Follow-up|0|||
161859166|NCT01959295|584525325|FG000|Overall Study|Adverse Event|2|||
161859167|NCT01959295|584525326|FG001|Overall Study|Adverse Event|0|||
161859168|NCT01959295|584525325|FG000|Overall Study|Lost to Follow-up|0|||
161859169|NCT01959295|584525326|FG001|Overall Study|Lost to Follow-up|2|||
161859170|NCT01959295|584525325|FG000|Overall Study|Physician Decision|2|||
161859171|NCT01959295|584525326|FG001|Overall Study|Physician Decision|3|||
161859172|NCT01959295|584525325|FG000|Overall Study|Protocol Violation|16|||
161859173|NCT01959295|584525326|FG001|Overall Study|Protocol Violation|5|||
161859174|NCT01959295|584525325|FG000|Overall Study|Withdrawal by Subject|3|||
161859175|NCT01959295|584525326|FG001|Overall Study|Withdrawal by Subject|1|||
161859176|NCT01959295|584525325|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
161859177|NCT01959295|584525326|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
161859178|NCT01682811|584525328|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161859179|NCT01682811|584525329|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161859180|NCT01682811|584525330|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161859181|NCT01682811|584525331|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161859182|NCT01682811|584525332|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
161859183|NCT01682811|584525333|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161859184|NCT01682811|584525334|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161859185|NCT01682811|584525328|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
161859186|NCT01682811|584525329|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
161859187|NCT01682811|584525330|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
161975603|NCT00528996|584960138|FG000|Overall Study|Lost to Follow-up|2|||
161975604|NCT00528996|584960139|FG001|Overall Study|Lost to Follow-up|0|||
161975605|NCT00528996|584960140|FG002|Overall Study|Lost to Follow-up|4|||
161975606|NCT00528996|584960141|FG003|Overall Study|Lost to Follow-up|1|||
161975607|NCT00528996|584960142|FG004|Overall Study|Lost to Follow-up|3|||
161975608|NCT00528996|584960138|FG000|Overall Study|Protocol Violation|1|||
161975609|NCT00528996|584960139|FG001|Overall Study|Protocol Violation|2|||
161975610|NCT00528996|584960140|FG002|Overall Study|Protocol Violation|3|||
161975611|NCT00528996|584960141|FG003|Overall Study|Protocol Violation|3|||
161975612|NCT00528996|584960142|FG004|Overall Study|Protocol Violation|2|||
161975613|NCT00528996|584960138|FG000|Overall Study|Lack of Efficacy|7|||
161975614|NCT00528996|584960139|FG001|Overall Study|Lack of Efficacy|2|||
161975615|NCT00528996|584960140|FG002|Overall Study|Lack of Efficacy|1|||
161975616|NCT00528996|584960141|FG003|Overall Study|Lack of Efficacy|3|||
161975617|NCT00528996|584960142|FG004|Overall Study|Lack of Efficacy|3|||
161975618|NCT00528996|584960138|FG000|Overall Study|Adverse Event|32|||
161975619|NCT00528996|584960139|FG001|Overall Study|Adverse Event|13|||
161975620|NCT00528996|584960140|FG002|Overall Study|Adverse Event|18|||
161975621|NCT00528996|584960141|FG003|Overall Study|Adverse Event|29|||
161975622|NCT00528996|584960142|FG004|Overall Study|Adverse Event|18|||
161975623|NCT02831933|584960144|FG000|Overall Study|Physician Decision|11|||
161859188|NCT01682811|584525331|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
161859189|NCT01682811|584525332|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
161859190|NCT01682811|584525333|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
161975624|NCT03495102|584960145|FG000|Overall Study|Adverse Event|5|||
161859191|NCT01682811|584525334|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
161859192|NCT01682811|584525328|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
161859193|NCT01682811|584525329|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
161859194|NCT01682811|584525330|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
161859195|NCT01682811|584525331|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
161859196|NCT01682811|584525332|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
161975625|NCT03495102|584960146|FG001|Overall Study|Adverse Event|7|||
161975626|NCT03495102|584960147|FG002|Overall Study|Adverse Event|10|||
161975627|NCT03495102|584960145|FG000|Overall Study|Death|3|||
161975628|NCT03495102|584960146|FG001|Overall Study|Death|4|||
161859197|NCT01682811|584525333|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
161859198|NCT01682811|584525334|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
161859199|NCT01682811|584525328|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
161859200|NCT01682811|584525329|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
161859201|NCT01682811|584525330|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
161859202|NCT01682811|584525331|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
161859203|NCT01682811|584525332|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
161859204|NCT01682811|584525333|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
161859205|NCT01682811|584525334|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
161859206|NCT02694328|584525338|FG000|Overall Study|Adverse Event|27|||
161859207|NCT02694328|584525339|FG001|Overall Study|Adverse Event|33|||
161859208|NCT02694328|584525338|FG000|Overall Study|Withdrawal by Subject|27|||
161859209|NCT02694328|584525339|FG001|Overall Study|Withdrawal by Subject|23|||
161859210|NCT02694328|584525338|FG000|Overall Study|Lost to Follow-up|26|||
161859211|NCT02694328|584525339|FG001|Overall Study|Lost to Follow-up|22|||
161859212|NCT02694328|584525338|FG000|Overall Study|Noncompliant with study drug|11|||
161859213|NCT02694328|584525339|FG001|Overall Study|Noncompliant with study drug|8|||
161859214|NCT02694328|584525338|FG000|Overall Study|Incarceration|1|||
161859215|NCT02694328|584525339|FG001|Overall Study|Incarceration|1|||
161859216|NCT02694328|584525338|FG000|Overall Study|Lack of Efficacy|1|||
161859217|NCT02694328|584525339|FG001|Overall Study|Lack of Efficacy|2|||
161859218|NCT02694328|584525338|FG000|Overall Study|Pregnancy|1|||
161859219|NCT02694328|584525339|FG001|Overall Study|Pregnancy|1|||
161859220|NCT02694328|584525338|FG000|Overall Study|Protocol Violation|6|||
161859221|NCT02694328|584525339|FG001|Overall Study|Protocol Violation|5|||
161859222|NCT02694328|584525338|FG000|Overall Study|Abnormal Laboratory Value|0|||
161859223|NCT02694328|584525339|FG001|Overall Study|Abnormal Laboratory Value|3|||
161859224|NCT04653454|584527537|FG000|Overall Study|Withdrawal by Subject|1|||
161859225|NCT04653454|584527537|FG000|Overall Study|Physician Decision|40|||
161859226|NCT05525520|584527538|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
161859227|NCT05525520|584527539|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
161859228|NCT05525520|584527538|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
161859229|NCT05525520|584527539|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
161859230|NCT05878093|584527540|FG000|Overall Study|Withdrawal by Subject|3|||
161859231|NCT05878093|584527541|FG001|Overall Study|Withdrawal by Subject|1|||
161859232|NCT02721732|584527542|FG000|Overall Study|Adverse Event|2|||
161859233|NCT02721732|584527543|FG001|Overall Study|Adverse Event|0|||
161859234|NCT02721732|584527544|FG002|Overall Study|Adverse Event|2|||
161859235|NCT02721732|584527545|FG003|Overall Study|Adverse Event|0|||
161859236|NCT02721732|584527546|FG004|Overall Study|Adverse Event|1|||
161859237|NCT02721732|584527547|FG005|Overall Study|Adverse Event|0|||
161859238|NCT02721732|584527548|FG006|Overall Study|Adverse Event|1|||
161859239|NCT02721732|584527549|FG007|Overall Study|Adverse Event|0|||
161859240|NCT02721732|584527550|FG008|Overall Study|Adverse Event|1|||
161859241|NCT02721732|584527551|FG009|Overall Study|Adverse Event|1|||
161859242|NCT02721732|584527542|FG000|Overall Study|Death|0|||
161859243|NCT02721732|584527543|FG001|Overall Study|Death|0|||
161859244|NCT02721732|584527544|FG002|Overall Study|Death|0|||
161859245|NCT02721732|584527545|FG003|Overall Study|Death|0|||
161859246|NCT02721732|584527546|FG004|Overall Study|Death|1|||
161859247|NCT02721732|584527547|FG005|Overall Study|Death|0|||
161859248|NCT02721732|584527548|FG006|Overall Study|Death|1|||
161859249|NCT02721732|584527549|FG007|Overall Study|Death|0|||
161859250|NCT02721732|584527550|FG008|Overall Study|Death|0|||
161859251|NCT02721732|584527551|FG009|Overall Study|Death|1|||
161859252|NCT02721732|584527542|FG000|Overall Study|Lack of Efficacy|12|||
161859253|NCT02721732|584527543|FG001|Overall Study|Lack of Efficacy|11|||
161859254|NCT02721732|584527544|FG002|Overall Study|Lack of Efficacy|18|||
161859255|NCT02721732|584527545|FG003|Overall Study|Lack of Efficacy|5|||
161859256|NCT02721732|584527546|FG004|Overall Study|Lack of Efficacy|21|||
161859257|NCT02721732|584527547|FG005|Overall Study|Lack of Efficacy|2|||
161859258|NCT02721732|584527548|FG006|Overall Study|Lack of Efficacy|8|||
161859259|NCT02721732|584527549|FG007|Overall Study|Lack of Efficacy|11|||
161859260|NCT02721732|584527550|FG008|Overall Study|Lack of Efficacy|10|||
161859261|NCT02721732|584527551|FG009|Overall Study|Lack of Efficacy|20|||
161859262|NCT02721732|584527542|FG000|Overall Study|Physician Decision|0|||
161859263|NCT02721732|584527543|FG001|Overall Study|Physician Decision|0|||
161859264|NCT02721732|584527544|FG002|Overall Study|Physician Decision|1|||
161859265|NCT02721732|584527545|FG003|Overall Study|Physician Decision|0|||
161859266|NCT02721732|584527546|FG004|Overall Study|Physician Decision|0|||
161859267|NCT02721732|584527547|FG005|Overall Study|Physician Decision|0|||
161859268|NCT02721732|584527548|FG006|Overall Study|Physician Decision|0|||
161859269|NCT02721732|584527549|FG007|Overall Study|Physician Decision|0|||
161859270|NCT02721732|584527550|FG008|Overall Study|Physician Decision|0|||
161859271|NCT02721732|584527551|FG009|Overall Study|Physician Decision|0|||
161859272|NCT02721732|584527542|FG000|Overall Study|Withdrawal by Subject|1|||
161859273|NCT02721732|584527543|FG001|Overall Study|Withdrawal by Subject|0|||
161859274|NCT02721732|584527544|FG002|Overall Study|Withdrawal by Subject|0|||
161859275|NCT02721732|584527545|FG003|Overall Study|Withdrawal by Subject|0|||
161975629|NCT03495102|584960147|FG002|Overall Study|Death|4|||
161975630|NCT03495102|584960145|FG000|Overall Study|Lost to Follow-up|15|||
161975631|NCT03495102|584960146|FG001|Overall Study|Lost to Follow-up|16|||
161975632|NCT03495102|584960147|FG002|Overall Study|Lost to Follow-up|17|||
161975633|NCT03495102|584960145|FG000|Overall Study|Physician Decision|2|||
161975634|NCT03495102|584960146|FG001|Overall Study|Physician Decision|0|||
161975635|NCT03495102|584960147|FG002|Overall Study|Physician Decision|2|||
161975636|NCT03495102|584960145|FG000|Overall Study|Withdrawal by Subject|25|||
161975637|NCT03495102|584960146|FG001|Overall Study|Withdrawal by Subject|36|||
161975638|NCT03495102|584960147|FG002|Overall Study|Withdrawal by Subject|18|||
161975639|NCT03495102|584960145|FG000|Overall Study|Protocol Violation|1|||
161975640|NCT03495102|584960146|FG001|Overall Study|Protocol Violation|1|||
161975641|NCT03495102|584960147|FG002|Overall Study|Protocol Violation|0|||
161975642|NCT03495102|584960145|FG000|Overall Study|Site Closure|3|||
161975643|NCT03495102|584960146|FG001|Overall Study|Site Closure|1|||
161975644|NCT03495102|584960147|FG002|Overall Study|Site Closure|2|||
161975645|NCT03495102|584960145|FG000|Overall Study|Non-compliance|1|||
161975646|NCT03495102|584960146|FG001|Overall Study|Non-compliance|0|||
161975647|NCT03495102|584960147|FG002|Overall Study|Non-compliance|0|||
161975648|NCT03495102|584960145|FG000|Overall Study|Participant Duplicated at Another Site|0|||
161859276|NCT02721732|584527546|FG004|Overall Study|Withdrawal by Subject|3|||
161859277|NCT02721732|584527547|FG005|Overall Study|Withdrawal by Subject|0|||
161859278|NCT02721732|584527548|FG006|Overall Study|Withdrawal by Subject|1|||
161859279|NCT02721732|584527549|FG007|Overall Study|Withdrawal by Subject|1|||
161859280|NCT02721732|584527550|FG008|Overall Study|Withdrawal by Subject|0|||
161859281|NCT02721732|584527551|FG009|Overall Study|Withdrawal by Subject|1|||
161859282|NCT02721732|584527542|FG000|Overall Study|Participant Choice|1|||
161859283|NCT02721732|584527543|FG001|Overall Study|Participant Choice|0|||
161859284|NCT02721732|584527544|FG002|Overall Study|Participant Choice|0|||
161859285|NCT02721732|584527545|FG003|Overall Study|Participant Choice|0|||
161859286|NCT02721732|584527546|FG004|Overall Study|Participant Choice|0|||
161859287|NCT02721732|584527547|FG005|Overall Study|Participant Choice|0|||
161859288|NCT02721732|584527548|FG006|Overall Study|Participant Choice|0|||
161859289|NCT02721732|584527549|FG007|Overall Study|Participant Choice|0|||
161859290|NCT02721732|584527550|FG008|Overall Study|Participant Choice|0|||
161859291|NCT02721732|584527551|FG009|Overall Study|Participant Choice|1|||
161859292|NCT02721732|584527542|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859293|NCT02721732|584527543|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859294|NCT02721732|584527544|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
161859295|NCT02721732|584527545|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859296|NCT02721732|584527546|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859297|NCT02721732|584527547|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859298|NCT02721732|584527548|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859299|NCT02721732|584527549|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859300|NCT02721732|584527550|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859301|NCT02721732|584527551|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161859302|NCT02721732|584527542|FG000|Overall Study|Progression and withdrew consent|1|||
161859303|NCT02721732|584527543|FG001|Overall Study|Progression and withdrew consent|1|||
161859304|NCT02721732|584527544|FG002|Overall Study|Progression and withdrew consent|0|||
161859305|NCT02721732|584527545|FG003|Overall Study|Progression and withdrew consent|0|||
161859306|NCT02721732|584527546|FG004|Overall Study|Progression and withdrew consent|0|||
161859307|NCT02721732|584527547|FG005|Overall Study|Progression and withdrew consent|0|||
161859308|NCT02721732|584527548|FG006|Overall Study|Progression and withdrew consent|0|||
161859309|NCT02721732|584527549|FG007|Overall Study|Progression and withdrew consent|0|||
161859310|NCT02721732|584527550|FG008|Overall Study|Progression and withdrew consent|0|||
161859311|NCT02721732|584527551|FG009|Overall Study|Progression and withdrew consent|1|||
161859312|NCT02721732|584527542|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
161859313|NCT02721732|584527543|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
161975649|NCT03495102|584960146|FG001|Overall Study|Participant Duplicated at Another Site|0|||
161975650|NCT03495102|584960147|FG002|Overall Study|Participant Duplicated at Another Site|1|||
161975651|NCT03495102|584960145|FG000|Overall Study|Primary Care Physician Recommendation|0|||
161975652|NCT03495102|584960146|FG001|Overall Study|Primary Care Physician Recommendation|1|||
161975653|NCT03495102|584960147|FG002|Overall Study|Primary Care Physician Recommendation|0|||
161975654|NCT03495102|584960145|FG000|Overall Study|Relocated to Another Country|0|||
161975655|NCT03495102|584960146|FG001|Overall Study|Relocated to Another Country|1|||
161975656|NCT03495102|584960147|FG002|Overall Study|Relocated to Another Country|0|||
161975657|NCT03495102|584960145|FG000|Overall Study|Participant was in Rehabilitation|1|||
162034455|NCT02241889|585182054|FG000|Overall Study|device issues|0|||
161975658|NCT03495102|584960146|FG001|Overall Study|Participant was in Rehabilitation|0|||
161975659|NCT03495102|584960147|FG002|Overall Study|Participant was in Rehabilitation|0|||
162034456|NCT02241889|585182055|FG001|Overall Study|device issues|0|||
161859314|NCT02721732|584527544|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
161859315|NCT02721732|584527545|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
161859316|NCT02721732|584527546|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
161859317|NCT02721732|584527547|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
161859318|NCT02721732|584527548|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
161859319|NCT02721732|584527549|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
161859320|NCT02721732|584527550|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
161859321|NCT02721732|584527551|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
161859322|NCT04100018|584527552|FG000|Pre-Treatment Period|Not Reported|0|||
161859323|NCT04100018|584527553|FG001|Pre-Treatment Period|Not Reported|4|||
161859324|NCT04100018|584527552|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
161859325|NCT04100018|584527553|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
161859326|NCT04100018|584527552|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
161859327|NCT04100018|584527553|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
161859328|NCT04100018|584527552|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
161859329|NCT04100018|584527553|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
161859330|NCT04100018|584527552|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
161859331|NCT04100018|584527553|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
161859332|NCT04100018|584527552|FG000|Treatment Period|Ongoing Treatment|1|||
161859333|NCT04100018|584527553|FG001|Treatment Period|Ongoing Treatment|0|||
161859334|NCT04100018|584527552|FG000|Treatment Period|Other Reason|26|||
161859335|NCT04100018|584527553|FG001|Treatment Period|Other Reason|37|||
161859336|NCT04100018|584527552|FG000|Treatment Period|Completed treatment as per protocol|1|||
161859337|NCT04100018|584527553|FG001|Treatment Period|Completed treatment as per protocol|2|||
161859338|NCT04100018|584527552|FG000|Treatment Period|Maximum clinical benefit|3|||
161859339|NCT04100018|584527553|FG001|Treatment Period|Maximum clinical benefit|0|||
161859340|NCT04100018|584527552|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
161859341|NCT04100018|584527553|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
161859342|NCT04100018|584527552|FG000|Treatment Period|Study drug toxicity|67|||
161859343|NCT04100018|584527553|FG001|Treatment Period|Study drug toxicity|28|||
161859344|NCT04100018|584527552|FG000|Treatment Period|Disease Progression|284|||
161859345|NCT04100018|584527553|FG001|Treatment Period|Disease Progression|327|||
161859346|NCT04100018|584527552|FG000|Treatment Period|Administrative reasons by sponsor|16|||
161859347|NCT04100018|584527553|FG001|Treatment Period|Administrative reasons by sponsor|30|||
161859348|NCT04100018|584527552|FG000|Treatment Period|Poor/Non-Compliance|1|||
161859349|NCT04100018|584527553|FG001|Treatment Period|Poor/Non-Compliance|0|||
161859350|NCT04100018|584527552|FG000|Treatment Period|Lost to Follow-up|2|||
161859351|NCT04100018|584527553|FG001|Treatment Period|Lost to Follow-up|2|||
161859352|NCT04100018|584527552|FG000|Treatment Period|Death|16|||
161859353|NCT04100018|584527553|FG001|Treatment Period|Death|11|||
161859354|NCT04100018|584527552|FG000|Treatment Period|Participant withdrew consent|10|||
161859355|NCT04100018|584527553|FG001|Treatment Period|Participant withdrew consent|10|||
161859356|NCT04100018|584527552|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
161859357|NCT04100018|584527553|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
161859358|NCT04100018|584527552|FG000|Treatment Period|Adverse Event|14|||
161859359|NCT04100018|584527553|FG001|Treatment Period|Adverse Event|6|||
161859360|NCT04100018|584527552|FG000|Treatment Period|Lack of Efficacy|4|||
161859361|NCT04100018|584527553|FG001|Treatment Period|Lack of Efficacy|2|||
161859362|NCT02848001|584527554|FG000|Overall Study|other reasons|0|||
161859363|NCT02848001|584527555|FG001|Overall Study|other reasons|0|||
161859364|NCT02848001|584527556|FG002|Overall Study|other reasons|1|||
161859365|NCT02848001|584527557|FG003|Overall Study|other reasons|0|||
161859366|NCT02848001|584527558|FG004|Overall Study|other reasons|4|||
161859367|NCT02848001|584527559|FG005|Overall Study|other reasons|1|||
161859368|NCT02848001|584527560|FG006|Overall Study|other reasons|0|||
161859369|NCT02848001|584527561|FG007|Overall Study|other reasons|2|||
161859370|NCT02848001|584527562|FG008|Overall Study|other reasons|2|||
161859371|NCT02848001|584527563|FG009|Overall Study|other reasons|3|||
161859372|NCT02848001|584527564|FG010|Overall Study|other reasons|0|||
161859373|NCT02848001|584527565|FG011|Overall Study|other reasons|1|||
161859374|NCT02848001|584527566|FG012|Overall Study|other reasons|1|||
161859375|NCT02848001|584527567|FG013|Overall Study|other reasons|0|||
161859376|NCT02848001|584527568|FG014|Overall Study|other reasons|0|||
161859377|NCT02848001|584527569|FG015|Overall Study|other reasons|2|||
161859378|NCT02848001|584527570|FG016|Overall Study|other reasons|1|||
161859379|NCT02848001|584527554|FG000|Overall Study|Lack of Efficacy|0|||
161859380|NCT02848001|584527555|FG001|Overall Study|Lack of Efficacy|1|||
161859381|NCT02848001|584527556|FG002|Overall Study|Lack of Efficacy|1|||
161975660|NCT01161537|584960150|FG000|Part B|Withdrawal by Subject|2|||
161975661|NCT05160766|584960151|FG000|Overall Study|Adverse Event|0|||
161975662|NCT05160766|584960152|FG001|Overall Study|Adverse Event|1|||
161975663|NCT05160766|584960153|FG002|Overall Study|Adverse Event|0|||
161975664|NCT05160766|584960154|FG003|Overall Study|Adverse Event|0|||
161770473|NCT01130831|584200290|FG000|Overall Study|Withdrawal by Subject|7|||
161770474|NCT01130831|584200290|FG000|Overall Study|Death|4|||
161770475|NCT01130831|584200290|FG000|Overall Study|Information was missing|3|||
161770476|NCT01159665|584200291|FG000|Overall Study|Withdrawal by Subject|0|||
161770477|NCT01159665|584200292|FG001|Overall Study|Withdrawal by Subject|1|||
161770478|NCT01159665|584200293|FG002|Overall Study|Withdrawal by Subject|0|||
161770479|NCT01159665|584200294|FG003|Overall Study|Withdrawal by Subject|0|||
161770480|NCT01159665|584200295|FG004|Overall Study|Withdrawal by Subject|0|||
161770481|NCT01159665|584200296|FG005|Overall Study|Withdrawal by Subject|0|||
161770482|NCT00951912|584200297|FG000|Overall Study|Lack of Efficacy|1|||
161770483|NCT00951912|584200298|FG001|Overall Study|Lack of Efficacy|0|||
161770484|NCT00951912|584200299|FG002|Overall Study|Lack of Efficacy|0|||
161770485|NCT00951912|584200297|FG000|Overall Study|Adverse Event|0|||
161770486|NCT00951912|584200298|FG001|Overall Study|Adverse Event|1|||
161770487|NCT00951912|584200299|FG002|Overall Study|Adverse Event|1|||
161770488|NCT00951912|584200297|FG000|Overall Study|Lost to Follow-up|2|||
161770489|NCT00951912|584200298|FG001|Overall Study|Lost to Follow-up|2|||
161770490|NCT00951912|584200299|FG002|Overall Study|Lost to Follow-up|0|||
161770491|NCT00951912|584200297|FG000|Overall Study|Physician Decision|1|||
161770492|NCT00951912|584200298|FG001|Overall Study|Physician Decision|0|||
161770493|NCT00951912|584200299|FG002|Overall Study|Physician Decision|1|||
161770494|NCT00951912|584200297|FG000|Overall Study|Withdrawal by Subject|1|||
161770495|NCT00951912|584200298|FG001|Overall Study|Withdrawal by Subject|1|||
161770496|NCT00951912|584200299|FG002|Overall Study|Withdrawal by Subject|0|||
161770497|NCT00951912|584200297|FG000|Overall Study|Other:Depression|1|||
161770498|NCT00951912|584200298|FG001|Overall Study|Other:Depression|0|||
161770499|NCT00951912|584200299|FG002|Overall Study|Other:Depression|0|||
161770500|NCT00951912|584200297|FG000|Overall Study|Other: Colon cancer|1|||
161770501|NCT00951912|584200298|FG001|Overall Study|Other: Colon cancer|0|||
161770502|NCT00951912|584200299|FG002|Overall Study|Other: Colon cancer|0|||
161770503|NCT00951912|584200297|FG000|Overall Study|Other: Stroke|0|||
161770504|NCT00951912|584200298|FG001|Overall Study|Other: Stroke|1|||
161770505|NCT00951912|584200299|FG002|Overall Study|Other: Stroke|0|||
161770506|NCT02173158|584200301|FG000|Efficacy Phase|Adverse Event|1|||
161770507|NCT01377194|584200302|FG000|Overall Study|Adverse Event|3|||
161770508|NCT01377194|584200303|FG001|Overall Study|Adverse Event|12|||
161770509|NCT01377194|584200304|FG002|Overall Study|Adverse Event|19|||
161770510|NCT01377194|584200302|FG000|Overall Study|Lack of Efficacy|3|||
161770511|NCT01377194|584200303|FG001|Overall Study|Lack of Efficacy|3|||
161770512|NCT01377194|584200304|FG002|Overall Study|Lack of Efficacy|3|||
161770513|NCT01377194|584200302|FG000|Overall Study|Protocol Violation|4|||
161770514|NCT01377194|584200303|FG001|Overall Study|Protocol Violation|10|||
161770515|NCT01377194|584200304|FG002|Overall Study|Protocol Violation|6|||
161770516|NCT01377194|584200302|FG000|Overall Study|Withdrawal by Subject|8|||
161770517|NCT01377194|584200303|FG001|Overall Study|Withdrawal by Subject|10|||
161770518|NCT01377194|584200304|FG002|Overall Study|Withdrawal by Subject|7|||
161770519|NCT01377194|584200302|FG000|Overall Study|Lost to Follow-up|14|||
161770520|NCT01377194|584200303|FG001|Overall Study|Lost to Follow-up|8|||
161770521|NCT01377194|584200304|FG002|Overall Study|Lost to Follow-up|11|||
161770522|NCT01207427|584200305|FG000|Double-blind Treatment Period|Adverse Event|0|||
161770523|NCT01207427|584200306|FG001|Double-blind Treatment Period|Adverse Event|1|||
161770524|NCT01207427|584200307|FG002|Double-blind Treatment Period|Adverse Event|0|||
161770525|NCT01207427|584200305|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161770526|NCT01207427|584200306|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161770527|NCT01207427|584200307|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
161770528|NCT01207427|584200305|FG000|Double-blind Treatment Period|Protocol Violation|2|||
161770529|NCT01207427|584200306|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161770530|NCT01207427|584200307|FG002|Double-blind Treatment Period|Protocol Violation|1|||
161770531|NCT01207427|584200305|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161770532|NCT01207427|584200306|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
161770533|NCT01207427|584200307|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161770534|NCT00422227|584200308|FG000|Overall Study|Adverse Event|3|||
161770535|NCT00422227|584200309|FG001|Overall Study|Adverse Event|8|||
161770536|NCT00422227|584200308|FG000|Overall Study|Lost to Follow-up|1|||
161770537|NCT00422227|584200309|FG001|Overall Study|Lost to Follow-up|3|||
161770538|NCT00422227|584200308|FG000|Overall Study|Withdrawal by Subject|0|||
161770539|NCT00422227|584200309|FG001|Overall Study|Withdrawal by Subject|4|||
161770540|NCT00967343|584200313|FG000|Overall Study|Study termination by sponsor|12|||
161770541|NCT00967343|584200313|FG000|Overall Study|Death|24|||
161770542|NCT00967343|584200313|FG000|Overall Study|Relapse|1|||
161770543|NCT00967343|584200313|FG000|Overall Study|Lost to Follow-up|1|||
161770544|NCT03996694|584202150|FG000|First Washout (7 Days)|positive urine drug screen|0|||
161770545|NCT03996694|584202151|FG001|First Washout (7 Days)|positive urine drug screen|0|||
161770546|NCT03996694|584202152|FG002|First Washout (7 Days)|positive urine drug screen|1|||
161770547|NCT03996694|584202153|FG003|First Washout (7 Days)|positive urine drug screen|0|||
161770548|NCT03996694|584202154|FG004|First Washout (7 Days)|positive urine drug screen|0|||
161770549|NCT03996694|584202155|FG005|First Washout (7 Days)|positive urine drug screen|0|||
161859382|NCT02848001|584527557|FG003|Overall Study|Lack of Efficacy|2|||
161859383|NCT02848001|584527558|FG004|Overall Study|Lack of Efficacy|3|||
161859384|NCT02848001|584527559|FG005|Overall Study|Lack of Efficacy|0|||
161859385|NCT02848001|584527560|FG006|Overall Study|Lack of Efficacy|1|||
161859386|NCT02848001|584527561|FG007|Overall Study|Lack of Efficacy|0|||
161859387|NCT02848001|584527562|FG008|Overall Study|Lack of Efficacy|0|||
161975665|NCT05160766|584960151|FG000|Overall Study|COVID-19 infection|0|||
161975666|NCT05160766|584960152|FG001|Overall Study|COVID-19 infection|1|||
161975667|NCT05160766|584960153|FG002|Overall Study|COVID-19 infection|0|||
161975668|NCT05160766|584960154|FG003|Overall Study|COVID-19 infection|0|||
161975669|NCT05160766|584960151|FG000|Overall Study|travel time|1|||
161975670|NCT05160766|584960152|FG001|Overall Study|travel time|0|||
161975671|NCT05160766|584960153|FG002|Overall Study|travel time|0|||
161975672|NCT05160766|584960154|FG003|Overall Study|travel time|1|||
161975673|NCT05160766|584960151|FG000|Overall Study|Withdrawal by Subject|3|||
161975674|NCT05160766|584960152|FG001|Overall Study|Withdrawal by Subject|5|||
161975675|NCT05160766|584960153|FG002|Overall Study|Withdrawal by Subject|4|||
161975676|NCT05160766|584960154|FG003|Overall Study|Withdrawal by Subject|2|||
161975677|NCT05160766|584960151|FG000|Overall Study|Death|0|||
161975678|NCT05160766|584960152|FG001|Overall Study|Death|0|||
161975679|NCT05160766|584960153|FG002|Overall Study|Death|2|||
161975680|NCT05160766|584960154|FG003|Overall Study|Death|5|||
161975681|NCT05160766|584960151|FG000|Overall Study|Lost to Follow-up|0|||
161975682|NCT05160766|584960152|FG001|Overall Study|Lost to Follow-up|0|||
161975683|NCT05160766|584960153|FG002|Overall Study|Lost to Follow-up|1|||
161975684|NCT05160766|584960154|FG003|Overall Study|Lost to Follow-up|2|||
161975685|NCT05160766|584960151|FG000|Overall Study|No show|0|||
161975686|NCT05160766|584960152|FG001|Overall Study|No show|0|||
161975687|NCT05160766|584960153|FG002|Overall Study|No show|1|||
161975688|NCT05160766|584960154|FG003|Overall Study|No show|1|||
161975689|NCT05160766|584960151|FG000|Overall Study|Physician Decision|0|||
161975690|NCT05160766|584960152|FG001|Overall Study|Physician Decision|0|||
161975691|NCT05160766|584960153|FG002|Overall Study|Physician Decision|0|||
161975692|NCT05160766|584960154|FG003|Overall Study|Physician Decision|1|||
161975693|NCT05160766|584960151|FG000|Overall Study|Protocol Violation|0|||
161975694|NCT05160766|584960152|FG001|Overall Study|Protocol Violation|0|||
161975695|NCT05160766|584960153|FG002|Overall Study|Protocol Violation|1|||
162034457|NCT02241889|585182056|FG002|Overall Study|device issues|1|||
162034458|NCT02241889|585182057|FG003|Overall Study|device issues|0|||
162034459|NCT02241889|585182058|FG004|Overall Study|device issues|0|||
161859388|NCT02848001|584527563|FG009|Overall Study|Lack of Efficacy|1|||
161859389|NCT02848001|584527564|FG010|Overall Study|Lack of Efficacy|0|||
161859390|NCT02848001|584527565|FG011|Overall Study|Lack of Efficacy|2|||
161859391|NCT02848001|584527566|FG012|Overall Study|Lack of Efficacy|0|||
161859392|NCT02848001|584527567|FG013|Overall Study|Lack of Efficacy|2|||
161859393|NCT02848001|584527568|FG014|Overall Study|Lack of Efficacy|2|||
161859394|NCT02848001|584527569|FG015|Overall Study|Lack of Efficacy|0|||
161859395|NCT02848001|584527570|FG016|Overall Study|Lack of Efficacy|0|||
161859396|NCT02848001|584527554|FG000|Overall Study|Progressive Disease|2|||
161859397|NCT02848001|584527555|FG001|Overall Study|Progressive Disease|1|||
161859398|NCT02848001|584527556|FG002|Overall Study|Progressive Disease|0|||
161859399|NCT02848001|584527557|FG003|Overall Study|Progressive Disease|4|||
161859400|NCT02848001|584527558|FG004|Overall Study|Progressive Disease|3|||
161859401|NCT02848001|584527559|FG005|Overall Study|Progressive Disease|0|||
161859402|NCT02848001|584527560|FG006|Overall Study|Progressive Disease|4|||
161859403|NCT02848001|584527561|FG007|Overall Study|Progressive Disease|1|||
161859404|NCT02848001|584527562|FG008|Overall Study|Progressive Disease|0|||
161859405|NCT02848001|584527563|FG009|Overall Study|Progressive Disease|2|||
161859406|NCT02848001|584527564|FG010|Overall Study|Progressive Disease|3|||
161859407|NCT02848001|584527565|FG011|Overall Study|Progressive Disease|2|||
161859408|NCT02848001|584527566|FG012|Overall Study|Progressive Disease|1|||
161859409|NCT02848001|584527567|FG013|Overall Study|Progressive Disease|0|||
161975696|NCT05160766|584960154|FG003|Overall Study|Protocol Violation|0|||
161975697|NCT02943915|584960155|FG000|Overall Study|Withdrawal by Subject|2|||
161975698|NCT02943915|584960156|FG001|Overall Study|Withdrawal by Subject|1|||
162034460|NCT02241889|585182059|FG005|Overall Study|device issues|0|||
161859410|NCT02848001|584527568|FG014|Overall Study|Progressive Disease|2|||
161859411|NCT02848001|584527569|FG015|Overall Study|Progressive Disease|4|||
161859412|NCT02848001|584527570|FG016|Overall Study|Progressive Disease|0|||
161975699|NCT02943915|584960157|FG002|Overall Study|Withdrawal by Subject|0|||
161975700|NCT02943915|584960158|FG003|Overall Study|Withdrawal by Subject|0|||
161975701|NCT02943915|584960155|FG000|Overall Study|Lost to Follow-up|3|||
161975702|NCT02943915|584960156|FG001|Overall Study|Lost to Follow-up|1|||
161975703|NCT02943915|584960157|FG002|Overall Study|Lost to Follow-up|0|||
161859413|NCT02848001|584527554|FG000|Overall Study|Adverse Event|0|||
161975704|NCT02943915|584960158|FG003|Overall Study|Lost to Follow-up|0|||
162034461|NCT02241889|585182054|FG000|Overall Study|Withdrawal by Subject|0|||
161975705|NCT02943915|584960155|FG000|Overall Study|excluded|0|||
161975706|NCT02943915|584960156|FG001|Overall Study|excluded|1|||
161975707|NCT02943915|584960157|FG002|Overall Study|excluded|0|||
161975708|NCT02943915|584960158|FG003|Overall Study|excluded|0|||
162034462|NCT02241889|585182055|FG001|Overall Study|Withdrawal by Subject|0|||
161975709|NCT03769311|584960159|FG000|Overall Study|Withdrawal by Subject|1|||
161975710|NCT03627065|584960160|FG000|Overall Study|Study Terminated by sponsor|1|||
161975711|NCT03627065|584960160|FG000|Overall Study|Withdrawal by Subject|2|||
161975712|NCT00004445|584960161|FG000|Overall Study|Physician Decision|2|||
161975713|NCT00004445|584960161|FG000|Overall Study|Withdrawal by Subject|1|||
161975714|NCT00076336|584960162|FG000|Overall Study|Death|13|||
161975715|NCT00076336|584960163|FG001|Overall Study|Death|17|||
161975716|NCT00076336|584960162|FG000|Overall Study|Adverse Event|4|||
161770550|NCT03996694|584202150|FG000|First Washout (7 Days)|Adverse Event|0|||
161770551|NCT03996694|584202151|FG001|First Washout (7 Days)|Adverse Event|1|||
161770552|NCT03996694|584202152|FG002|First Washout (7 Days)|Adverse Event|0|||
161770553|NCT03996694|584202153|FG003|First Washout (7 Days)|Adverse Event|0|||
161770554|NCT03996694|584202154|FG004|First Washout (7 Days)|Adverse Event|0|||
161770555|NCT03996694|584202155|FG005|First Washout (7 Days)|Adverse Event|0|||
161770556|NCT03996694|584202150|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
161770557|NCT03996694|584202151|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
161770558|NCT03996694|584202152|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
161770559|NCT03996694|584202153|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
161770560|NCT03996694|584202154|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
161770561|NCT03996694|584202155|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
161770562|NCT03996694|584202150|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
161770563|NCT03996694|584202151|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
161770564|NCT03996694|584202152|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
161770565|NCT03996694|584202153|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
161770566|NCT03996694|584202154|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
161770567|NCT03996694|584202155|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
161770568|NCT03323034|584202164|FG000|Overall Study|Lack of Efficacy|5|||
161770569|NCT03323034|584202165|FG001|Overall Study|Lack of Efficacy|5|||
161770570|NCT03323034|584202166|FG002|Overall Study|Lack of Efficacy|6|||
161770571|NCT03323034|584202167|FG003|Overall Study|Lack of Efficacy|5|||
161770572|NCT03323034|584202168|FG004|Overall Study|Lack of Efficacy|5|||
161770573|NCT03323034|584202164|FG000|Overall Study|Physician Decision|0|||
161770574|NCT03323034|584202165|FG001|Overall Study|Physician Decision|0|||
161770575|NCT03323034|584202166|FG002|Overall Study|Physician Decision|0|||
161770576|NCT03323034|584202167|FG003|Overall Study|Physician Decision|0|||
161770577|NCT03323034|584202168|FG004|Overall Study|Physician Decision|1|||
161770578|NCT03323034|584202164|FG000|Overall Study|Withdrawal by Subject|1|||
161770579|NCT03323034|584202165|FG001|Overall Study|Withdrawal by Subject|1|||
161770580|NCT03323034|584202166|FG002|Overall Study|Withdrawal by Subject|0|||
161770581|NCT03323034|584202167|FG003|Overall Study|Withdrawal by Subject|1|||
161770582|NCT03323034|584202168|FG004|Overall Study|Withdrawal by Subject|0|||
161770583|NCT02646566|584202170|FG000|Overall Study|Lost to Follow-up|5|||
161770584|NCT02646566|584202171|FG001|Overall Study|Lost to Follow-up|4|||
161770585|NCT02646566|584202172|FG002|Overall Study|Lost to Follow-up|5|||
161770586|NCT02646566|584202170|FG000|Overall Study|Treatment failure|1|||
161770587|NCT02646566|584202171|FG001|Overall Study|Treatment failure|0|||
161770588|NCT02646566|584202172|FG002|Overall Study|Treatment failure|0|||
161770589|NCT04576702|584202180|FG000|Overall Study|Death|1|||
161770590|NCT04576702|584202181|FG001|Overall Study|Death|0|||
161770591|NCT04576702|584202182|FG002|Overall Study|Death|0|||
161770592|NCT04576702|584202183|FG003|Overall Study|Death|0|||
161770593|NCT04576702|584202180|FG000|Overall Study|Withdrawal by Subject|0|||
161770594|NCT04576702|584202181|FG001|Overall Study|Withdrawal by Subject|2|||
161770595|NCT04576702|584202182|FG002|Overall Study|Withdrawal by Subject|1|||
161770596|NCT04576702|584202183|FG003|Overall Study|Withdrawal by Subject|0|||
161770597|NCT04576702|584202180|FG000|Overall Study|Lost to Follow-up|3|||
161770598|NCT04576702|584202181|FG001|Overall Study|Lost to Follow-up|3|||
161770599|NCT04576702|584202182|FG002|Overall Study|Lost to Follow-up|3|||
161770600|NCT04576702|584202183|FG003|Overall Study|Lost to Follow-up|4|||
161770601|NCT01151085|584202184|FG000|Overall Study|Lost to Follow-up|31|||
161770602|NCT01151085|584202184|FG000|Overall Study|Protocol Violation|25|||
161770603|NCT00003526|584202185|FG000|Overall Study|Not evaluable|6|||
161770604|NCT02059265|584202186|FG000|Overall Study|Ineligible|4|||
161770605|NCT00998166|584202187|FG000|Overall Study|Early Study Termination|8|||
161770606|NCT02985996|584202191|FG000|Overall Study|Withdrawal by Subject|0|||
161770607|NCT02985996|584202192|FG001|Overall Study|Withdrawal by Subject|0|||
161770608|NCT02985996|584202193|FG002|Overall Study|Withdrawal by Subject|1|||
161770609|NCT02985996|584202194|FG003|Overall Study|Withdrawal by Subject|0|||
161770610|NCT02985996|584202195|FG004|Overall Study|Withdrawal by Subject|0|||
161770611|NCT02985996|584202191|FG000|Overall Study|Protocol Violation|0|||
161770612|NCT02985996|584202192|FG001|Overall Study|Protocol Violation|1|||
161770613|NCT02985996|584202193|FG002|Overall Study|Protocol Violation|0|||
161770614|NCT02985996|584202194|FG003|Overall Study|Protocol Violation|0|||
161770615|NCT02985996|584202195|FG004|Overall Study|Protocol Violation|0|||
161770616|NCT00401726|584202196|FG000|Overall Study|Adverse Event|34|||
161770617|NCT00401726|584202197|FG001|Overall Study|Adverse Event|45|||
161770618|NCT00401726|584202196|FG000|Overall Study|Death|0|||
161770619|NCT00401726|584202197|FG001|Overall Study|Death|3|||
161859414|NCT02848001|584527555|FG001|Overall Study|Adverse Event|0|||
161859415|NCT02848001|584527556|FG002|Overall Study|Adverse Event|0|||
161859416|NCT02848001|584527557|FG003|Overall Study|Adverse Event|0|||
161859417|NCT02848001|584527558|FG004|Overall Study|Adverse Event|2|||
161859418|NCT02848001|584527559|FG005|Overall Study|Adverse Event|0|||
161859419|NCT02848001|584527560|FG006|Overall Study|Adverse Event|0|||
161859420|NCT02848001|584527561|FG007|Overall Study|Adverse Event|0|||
161859421|NCT02848001|584527562|FG008|Overall Study|Adverse Event|0|||
161859422|NCT02848001|584527563|FG009|Overall Study|Adverse Event|1|||
161859423|NCT02848001|584527564|FG010|Overall Study|Adverse Event|0|||
161859424|NCT02848001|584527565|FG011|Overall Study|Adverse Event|1|||
161859425|NCT02848001|584527566|FG012|Overall Study|Adverse Event|1|||
161859426|NCT02848001|584527567|FG013|Overall Study|Adverse Event|0|||
161859427|NCT02848001|584527568|FG014|Overall Study|Adverse Event|2|||
161859428|NCT02848001|584527569|FG015|Overall Study|Adverse Event|0|||
161859429|NCT02848001|584527570|FG016|Overall Study|Adverse Event|0|||
161859430|NCT02848001|584527554|FG000|Overall Study|Death|0|||
161859431|NCT02848001|584527555|FG001|Overall Study|Death|0|||
161859432|NCT02848001|584527556|FG002|Overall Study|Death|0|||
161859433|NCT02848001|584527557|FG003|Overall Study|Death|1|||
161859434|NCT02848001|584527558|FG004|Overall Study|Death|3|||
161859435|NCT02848001|584527559|FG005|Overall Study|Death|1|||
161859436|NCT02848001|584527560|FG006|Overall Study|Death|2|||
161859437|NCT02848001|584527561|FG007|Overall Study|Death|3|||
161859438|NCT02848001|584527562|FG008|Overall Study|Death|4|||
161859439|NCT02848001|584527563|FG009|Overall Study|Death|1|||
161859440|NCT02848001|584527564|FG010|Overall Study|Death|0|||
161859441|NCT02848001|584527565|FG011|Overall Study|Death|1|||
161859442|NCT02848001|584527566|FG012|Overall Study|Death|3|||
161859443|NCT02848001|584527567|FG013|Overall Study|Death|0|||
161859444|NCT02848001|584527568|FG014|Overall Study|Death|2|||
161859445|NCT02848001|584527569|FG015|Overall Study|Death|3|||
161859446|NCT02848001|584527570|FG016|Overall Study|Death|0|||
161859447|NCT02848001|584527554|FG000|Overall Study|Physician Decision|0|||
161859448|NCT02848001|584527555|FG001|Overall Study|Physician Decision|0|||
161859449|NCT02848001|584527556|FG002|Overall Study|Physician Decision|0|||
161859450|NCT02848001|584527557|FG003|Overall Study|Physician Decision|0|||
161859451|NCT02848001|584527558|FG004|Overall Study|Physician Decision|0|||
161859452|NCT02848001|584527559|FG005|Overall Study|Physician Decision|0|||
161859453|NCT02848001|584527560|FG006|Overall Study|Physician Decision|0|||
161859454|NCT02848001|584527561|FG007|Overall Study|Physician Decision|0|||
161859455|NCT02848001|584527562|FG008|Overall Study|Physician Decision|1|||
161859456|NCT02848001|584527563|FG009|Overall Study|Physician Decision|1|||
161859457|NCT02848001|584527564|FG010|Overall Study|Physician Decision|0|||
161859458|NCT02848001|584527565|FG011|Overall Study|Physician Decision|0|||
161859459|NCT02848001|584527566|FG012|Overall Study|Physician Decision|2|||
161859460|NCT02848001|584527567|FG013|Overall Study|Physician Decision|0|||
161859461|NCT02848001|584527568|FG014|Overall Study|Physician Decision|0|||
161859462|NCT02848001|584527569|FG015|Overall Study|Physician Decision|0|||
161859463|NCT02848001|584527570|FG016|Overall Study|Physician Decision|0|||
161859464|NCT02848001|584527554|FG000|Overall Study|Withdrawal by Subject|0|||
161859465|NCT02848001|584527555|FG001|Overall Study|Withdrawal by Subject|0|||
161859466|NCT02848001|584527556|FG002|Overall Study|Withdrawal by Subject|0|||
161859467|NCT02848001|584527557|FG003|Overall Study|Withdrawal by Subject|0|||
161859468|NCT02848001|584527558|FG004|Overall Study|Withdrawal by Subject|0|||
161859469|NCT02848001|584527559|FG005|Overall Study|Withdrawal by Subject|1|||
161859470|NCT02848001|584527560|FG006|Overall Study|Withdrawal by Subject|1|||
161859471|NCT02848001|584527561|FG007|Overall Study|Withdrawal by Subject|1|||
161859472|NCT02848001|584527562|FG008|Overall Study|Withdrawal by Subject|0|||
161859473|NCT02848001|584527563|FG009|Overall Study|Withdrawal by Subject|0|||
161859474|NCT02848001|584527564|FG010|Overall Study|Withdrawal by Subject|0|||
161975717|NCT00076336|584960163|FG001|Overall Study|Adverse Event|4|||
161859475|NCT02848001|584527565|FG011|Overall Study|Withdrawal by Subject|0|||
161859476|NCT02848001|584527566|FG012|Overall Study|Withdrawal by Subject|0|||
161859477|NCT02848001|584527567|FG013|Overall Study|Withdrawal by Subject|0|||
161859478|NCT02848001|584527568|FG014|Overall Study|Withdrawal by Subject|0|||
161859479|NCT02848001|584527569|FG015|Overall Study|Withdrawal by Subject|0|||
161859480|NCT02848001|584527570|FG016|Overall Study|Withdrawal by Subject|0|||
161859481|NCT00725283|584527571|FG000|Overall Study|Missing Code|3|||
161859482|NCT00725283|584527571|FG000|Overall Study|Death|5|||
161859483|NCT00725283|584527571|FG000|Overall Study|Other|6|||
161859484|NCT00725283|584527571|FG000|Overall Study|Withdrawal by Subject|10|||
161859485|NCT03103087|584527575|FG000|Overall Study|Did not receive any study drug|1|||
161859486|NCT03103087|584527576|FG001|Overall Study|Did not receive any study drug|0|||
161859487|NCT03103087|584527577|FG002|Overall Study|Did not receive any study drug|0|||
161859488|NCT03103087|584527575|FG000|Overall Study|Protocol Violation|1|||
161975718|NCT00076336|584960162|FG000|Overall Study|Lost to Follow-up|4|||
161859489|NCT03103087|584527576|FG001|Overall Study|Protocol Violation|2|||
161859490|NCT03103087|584527577|FG002|Overall Study|Protocol Violation|1|||
161859491|NCT03103087|584527575|FG000|Overall Study|Lack of Efficacy|2|||
161859492|NCT03103087|584527576|FG001|Overall Study|Lack of Efficacy|1|||
161975719|NCT00076336|584960163|FG001|Overall Study|Lost to Follow-up|4|||
161770620|NCT00401726|584202196|FG000|Overall Study|Sponsor Request|0|||
161770621|NCT00401726|584202197|FG001|Overall Study|Sponsor Request|1|||
161770622|NCT00401726|584202196|FG000|Overall Study|Physician Decision|3|||
161770623|NCT00401726|584202197|FG001|Overall Study|Physician Decision|6|||
161770624|NCT00401726|584202196|FG000|Overall Study|Lost to Follow-up|23|||
161770625|NCT00401726|584202197|FG001|Overall Study|Lost to Follow-up|20|||
161770626|NCT00401726|584202196|FG000|Overall Study|Protocol Violation|6|||
161770627|NCT00401726|584202197|FG001|Overall Study|Protocol Violation|3|||
161770628|NCT00401726|584202196|FG000|Overall Study|Withdrawal by Subject|18|||
161770629|NCT00401726|584202197|FG001|Overall Study|Withdrawal by Subject|24|||
161770630|NCT00401726|584202196|FG000|Overall Study|Lack of Efficacy|4|||
161770631|NCT00401726|584202197|FG001|Overall Study|Lack of Efficacy|6|||
161770632|NCT00401726|584202196|FG000|Overall Study|Protocol Deviation|9|||
161770633|NCT00401726|584202197|FG001|Overall Study|Protocol Deviation|4|||
161770634|NCT00814502|584202200|FG000|Overall Study|Adverse Event|1|||
161770635|NCT00814502|584202201|FG001|Overall Study|Adverse Event|0|||
161770636|NCT00814502|584202200|FG000|Overall Study|Withdrawal by Subject|0|||
161770637|NCT00814502|584202201|FG001|Overall Study|Withdrawal by Subject|2|||
161770638|NCT03735849|584202203|FG000|Overall Study|Lost to Follow-up|1|||
161770639|NCT03735849|584202204|FG001|Overall Study|Lost to Follow-up|0|||
161770640|NCT03735849|584202205|FG002|Overall Study|Lost to Follow-up|0|||
161770641|NCT03735849|584202203|FG000|Overall Study|Participant unable to adhere to visit|1|||
161770642|NCT03735849|584202204|FG001|Overall Study|Participant unable to adhere to visit|0|||
161770643|NCT03735849|584202205|FG002|Overall Study|Participant unable to adhere to visit|0|||
161770644|NCT03735849|584202203|FG000|Overall Study|Not Randomized|0|||
161770645|NCT03735849|584202204|FG001|Overall Study|Not Randomized|0|||
161770646|NCT03735849|584202205|FG002|Overall Study|Not Randomized|4|||
161770647|NCT01050998|584202208|FG000|Overall Study|Adverse Event|1|||
161770648|NCT01050998|584202209|FG001|Overall Study|Adverse Event|0|||
161770649|NCT01050998|584202210|FG002|Overall Study|Adverse Event|1|||
161770650|NCT01050998|584202211|FG003|Overall Study|Adverse Event|0|||
161770651|NCT01050998|584202212|FG004|Overall Study|Adverse Event|2|||
161770652|NCT01050998|584202208|FG000|Overall Study|Withdrawal by Subject|0|||
161770653|NCT01050998|584202209|FG001|Overall Study|Withdrawal by Subject|0|||
161770654|NCT01050998|584202210|FG002|Overall Study|Withdrawal by Subject|0|||
161770655|NCT01050998|584202211|FG003|Overall Study|Withdrawal by Subject|1|||
161770656|NCT01050998|584202212|FG004|Overall Study|Withdrawal by Subject|3|||
161770657|NCT01050998|584202208|FG000|Overall Study|Other|3|||
161770658|NCT01050998|584202209|FG001|Overall Study|Other|2|||
161770659|NCT01050998|584202210|FG002|Overall Study|Other|1|||
161770660|NCT01050998|584202211|FG003|Overall Study|Other|1|||
161770661|NCT01050998|584202212|FG004|Overall Study|Other|5|||
161770662|NCT01050998|584202208|FG000|Overall Study|Data integrity issues|0|||
161770663|NCT01050998|584202209|FG001|Overall Study|Data integrity issues|0|||
161770664|NCT01050998|584202210|FG002|Overall Study|Data integrity issues|1|||
161770665|NCT01050998|584202211|FG003|Overall Study|Data integrity issues|1|||
161770666|NCT01050998|584202212|FG004|Overall Study|Data integrity issues|4|||
161770667|NCT04246593|584202215|FG000|Overall Study|Withdrawal by Subject|14|||
161770668|NCT04246593|584202216|FG001|Overall Study|Withdrawal by Subject|13|||
161770669|NCT04246593|584202215|FG000|Overall Study|Lost to Follow-up|124|||
161770670|NCT04246593|584202216|FG001|Overall Study|Lost to Follow-up|71|||
161770671|NCT04246593|584202215|FG000|Overall Study|Moved out of area/became ineligible|3|||
161770672|NCT04246593|584202216|FG001|Overall Study|Moved out of area/became ineligible|1|||
161770673|NCT04246593|584202215|FG000|Overall Study|Reason unknown|4|||
161770674|NCT04246593|584202216|FG001|Overall Study|Reason unknown|2|||
161770675|NCT01012765|584202219|FG000|Treatment Period 1|Adverse Event|1|||
161770676|NCT01012765|584202220|FG001|Treatment Period 1|Adverse Event|0|||
161770677|NCT01012765|584202221|FG002|Treatment Period 1|Adverse Event|1|||
161770678|NCT01012765|584202222|FG003|Treatment Period 1|Adverse Event|0|||
161770679|NCT01012765|584202223|FG004|Treatment Period 1|Adverse Event|0|||
161770680|NCT01012765|584202224|FG005|Treatment Period 1|Adverse Event|0|||
161770681|NCT01012765|584202219|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161770682|NCT01012765|584202220|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161770683|NCT01012765|584202221|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161770684|NCT01012765|584202222|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161770685|NCT01012765|584202223|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161770686|NCT01012765|584202224|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161770687|NCT01012765|584202219|FG000|Treatment Period 1|Administrative problems|0|||
161770688|NCT01012765|584202220|FG001|Treatment Period 1|Administrative problems|0|||
161770689|NCT01012765|584202221|FG002|Treatment Period 1|Administrative problems|1|||
161770690|NCT01012765|584202222|FG003|Treatment Period 1|Administrative problems|1|||
161770691|NCT01012765|584202223|FG004|Treatment Period 1|Administrative problems|1|||
161770692|NCT01012765|584202224|FG005|Treatment Period 1|Administrative problems|0|||
161770693|NCT01012765|584202219|FG000|Treatment Period 1|Protocol Violation|0|||
161975720|NCT00076336|584960162|FG000|Overall Study|Non-Compliance|2|||
161859493|NCT03103087|584527577|FG002|Overall Study|Lack of Efficacy|1|||
161859494|NCT03103087|584527575|FG000|Overall Study|Pregnancy|0|||
161859495|NCT03103087|584527576|FG001|Overall Study|Pregnancy|0|||
161859496|NCT03103087|584527577|FG002|Overall Study|Pregnancy|1|||
161859497|NCT03103087|584527575|FG000|Overall Study|Adverse Event|2|||
161859498|NCT03103087|584527576|FG001|Overall Study|Adverse Event|15|||
161859499|NCT03103087|584527577|FG002|Overall Study|Adverse Event|6|||
161859500|NCT03103087|584527575|FG000|Overall Study|Withdrawal by Subject|13|||
161859501|NCT03103087|584527576|FG001|Overall Study|Withdrawal by Subject|6|||
161859502|NCT03103087|584527577|FG002|Overall Study|Withdrawal by Subject|6|||
161859503|NCT03103087|584527575|FG000|Overall Study|Lost to Follow-up|4|||
161859504|NCT03103087|584527576|FG001|Overall Study|Lost to Follow-up|2|||
161859505|NCT03103087|584527577|FG002|Overall Study|Lost to Follow-up|7|||
161859506|NCT03103087|584527575|FG000|Overall Study|Other reason not reported|1|||
161859507|NCT03103087|584527576|FG001|Overall Study|Other reason not reported|3|||
161859508|NCT03103087|584527577|FG002|Overall Study|Other reason not reported|5|||
161859509|NCT00118157|584527578|FG000|Overall Study|Adverse Event|2|||
161859510|NCT00118157|584527578|FG000|Overall Study|Death|8|||
161859511|NCT00118157|584527578|FG000|Overall Study|Withdrawal by Subject|2|||
161859512|NCT02760004|584527579|FG000|Overall Study|Lost to Follow-up|13|||
161859513|NCT02760004|584527580|FG001|Overall Study|Lost to Follow-up|22|||
161859514|NCT01495000|584527581|FG000|Overall Study|Lost to Follow-up|2|||
161859515|NCT01495000|584527582|FG001|Overall Study|Lost to Follow-up|2|||
161859516|NCT01495000|584527581|FG000|Overall Study|Protocol Violation|1|||
161859517|NCT01495000|584527582|FG001|Overall Study|Protocol Violation|0|||
161859518|NCT01495000|584527581|FG000|Overall Study|Withdrawal by Subject|10|||
161859519|NCT01495000|584527582|FG001|Overall Study|Withdrawal by Subject|10|||
161859520|NCT02070965|584527583|FG000|Overall Study|Lost to Follow-up|0|||
161859521|NCT02070965|584527584|FG001|Overall Study|Lost to Follow-up|1|||
161859522|NCT02070965|584527585|FG002|Overall Study|Lost to Follow-up|0|||
161859523|NCT02070965|584527583|FG000|Overall Study|Withdrawal by Subject|1|||
161859524|NCT02070965|584527584|FG001|Overall Study|Withdrawal by Subject|1|||
161859525|NCT02070965|584527585|FG002|Overall Study|Withdrawal by Subject|1|||
161859526|NCT02070965|584527583|FG000|Overall Study|Subject moved|1|||
161859527|NCT02070965|584527584|FG001|Overall Study|Subject moved|0|||
161859528|NCT02070965|584527585|FG002|Overall Study|Subject moved|0|||
161859529|NCT03889886|584527587|FG000|Overall Study|Other|0|||
161859530|NCT03889886|584527588|FG001|Overall Study|Other|1|||
161859531|NCT03889886|584527589|FG002|Overall Study|Other|0|||
161859532|NCT03889886|584527590|FG003|Overall Study|Other|1|||
161859533|NCT03889886|584527587|FG000|Overall Study|Withdrawal by Subject|0|||
161859534|NCT03889886|584527588|FG001|Overall Study|Withdrawal by Subject|0|||
161859535|NCT03889886|584527589|FG002|Overall Study|Withdrawal by Subject|1|||
161859536|NCT03889886|584527590|FG003|Overall Study|Withdrawal by Subject|0|||
161859537|NCT03889886|584527587|FG000|Overall Study|Adverse Event|0|||
161859538|NCT03889886|584527588|FG001|Overall Study|Adverse Event|0|||
161859539|NCT03889886|584527589|FG002|Overall Study|Adverse Event|0|||
161859540|NCT03889886|584527590|FG003|Overall Study|Adverse Event|6|||
161859541|NCT00276484|584527591|FG000|Overall Study|Adverse Event|4|||
161859542|NCT00276484|584527592|FG001|Overall Study|Adverse Event|7|||
161859543|NCT00276484|584527591|FG000|Overall Study|Lost to Follow-up|1|||
161859544|NCT00276484|584527592|FG001|Overall Study|Lost to Follow-up|1|||
161975721|NCT00076336|584960163|FG001|Overall Study|Non-Compliance|0|||
161975722|NCT00076336|584960162|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
161975723|NCT00076336|584960163|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
161975724|NCT00076336|584960162|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
161975725|NCT00076336|584960163|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
161975726|NCT00076336|584960162|FG000|Overall Study|Liver Transplantation|3|||
161975727|NCT00076336|584960163|FG001|Overall Study|Liver Transplantation|3|||
161859545|NCT00276484|584527591|FG000|Overall Study|Protocol Violation|0|||
161859546|NCT00276484|584527592|FG001|Overall Study|Protocol Violation|1|||
161859547|NCT00276484|584527591|FG000|Overall Study|Withdrawal by Subject|4|||
161859548|NCT00276484|584527592|FG001|Overall Study|Withdrawal by Subject|3|||
161859549|NCT00276484|584527591|FG000|Overall Study|Could not take time off work|0|||
161859550|NCT00276484|584527592|FG001|Overall Study|Could not take time off work|1|||
161859551|NCT00942357|584527606|FG000|Overall Study|Ineligible|37|||
161975728|NCT00076336|584960162|FG000|Overall Study|Virologic Breakthrough|14|||
161975729|NCT00076336|584960163|FG001|Overall Study|Virologic Breakthrough|16|||
161975730|NCT00076336|584960162|FG000|Overall Study|Treatment failure|4|||
161859552|NCT00942357|584527607|FG001|Overall Study|Ineligible|40|||
161859553|NCT03347110|584527608|FG000|Overall Study|Other (Participant is incarcerated)|1|||
161859554|NCT03347110|584527608|FG000|Overall Study|Withdrawal by Subject|9|||
161859555|NCT03347110|584527608|FG000|Overall Study|Lost to Follow-up|1|||
161859556|NCT03347110|584527608|FG000|Overall Study|Lack of Efficacy|2|||
161859557|NCT03347110|584527608|FG000|Overall Study|Adverse Event, non-fatal|9|||
161859558|NCT01321879|584527609|FG000|Overall Study|Lack of Efficacy|5|||
161859559|NCT01321879|584527609|FG000|Overall Study|Adverse Event|5|||
161859560|NCT01321879|584527609|FG000|Overall Study|Death|3|||
161975731|NCT00076336|584960163|FG001|Overall Study|Treatment failure|5|||
161975732|NCT00524589|584960164|FG000|Overall Study|Withdrawal by Subject|2|||
161975733|NCT00524589|584960164|FG000|Overall Study|Disease Progression|16|||
161975734|NCT00098722|584960168|FG000|Double Blind Phase|Adverse Event|7|||
161975735|NCT00098722|584960169|FG001|Double Blind Phase|Adverse Event|7|||
161975736|NCT00098722|584960170|FG002|Double Blind Phase|Adverse Event|3|||
161975737|NCT00098722|584960171|FG003|Double Blind Phase|Adverse Event|0|||
161975738|NCT00098722|584960172|FG004|Double Blind Phase|Adverse Event|0|||
161975739|NCT00098722|584960173|FG005|Double Blind Phase|Adverse Event|0|||
161975740|NCT00098722|584960174|FG006|Double Blind Phase|Adverse Event|0|||
161975741|NCT00098722|584960168|FG000|Double Blind Phase|Death|2|||
161975742|NCT00098722|584960169|FG001|Double Blind Phase|Death|5|||
161975743|NCT00098722|584960170|FG002|Double Blind Phase|Death|0|||
161975744|NCT00098722|584960171|FG003|Double Blind Phase|Death|0|||
161975745|NCT00098722|584960172|FG004|Double Blind Phase|Death|0|||
161975746|NCT00098722|584960173|FG005|Double Blind Phase|Death|0|||
161975747|NCT00098722|584960174|FG006|Double Blind Phase|Death|0|||
161975748|NCT00098722|584960168|FG000|Double Blind Phase|Lack of Efficacy|21|||
161975749|NCT00098722|584960169|FG001|Double Blind Phase|Lack of Efficacy|23|||
161975750|NCT00098722|584960170|FG002|Double Blind Phase|Lack of Efficacy|15|||
161975751|NCT00098722|584960171|FG003|Double Blind Phase|Lack of Efficacy|0|||
161975752|NCT00098722|584960172|FG004|Double Blind Phase|Lack of Efficacy|0|||
161975753|NCT00098722|584960173|FG005|Double Blind Phase|Lack of Efficacy|0|||
161975754|NCT00098722|584960174|FG006|Double Blind Phase|Lack of Efficacy|0|||
161975755|NCT00098722|584960168|FG000|Double Blind Phase|Participant defaulted|16|||
161975756|NCT00098722|584960169|FG001|Double Blind Phase|Participant defaulted|11|||
161975757|NCT00098722|584960170|FG002|Double Blind Phase|Participant defaulted|9|||
161975758|NCT00098722|584960171|FG003|Double Blind Phase|Participant defaulted|0|||
161975759|NCT00098722|584960172|FG004|Double Blind Phase|Participant defaulted|0|||
161975760|NCT00098722|584960173|FG005|Double Blind Phase|Participant defaulted|0|||
161975761|NCT00098722|584960174|FG006|Double Blind Phase|Participant defaulted|0|||
161975762|NCT00098722|584960168|FG000|Double Blind Phase|Pregnancy|1|||
161975763|NCT00098722|584960169|FG001|Double Blind Phase|Pregnancy|0|||
161975764|NCT00098722|584960170|FG002|Double Blind Phase|Pregnancy|0|||
161975765|NCT00098722|584960171|FG003|Double Blind Phase|Pregnancy|0|||
161975766|NCT00098722|584960172|FG004|Double Blind Phase|Pregnancy|0|||
161975767|NCT00098722|584960173|FG005|Double Blind Phase|Pregnancy|0|||
161975768|NCT00098722|584960174|FG006|Double Blind Phase|Pregnancy|0|||
161975769|NCT00098722|584960168|FG000|Double Blind Phase|Randomized, not treated|4|||
161975770|NCT00098722|584960169|FG001|Double Blind Phase|Randomized, not treated|3|||
161975771|NCT00098722|584960170|FG002|Double Blind Phase|Randomized, not treated|3|||
162034463|NCT02241889|585182056|FG002|Overall Study|Withdrawal by Subject|0|||
161859561|NCT01321879|584527609|FG000|Overall Study|Withdrawal by Subject|1|||
161859562|NCT02687451|584527610|FG000|Overall Study|Withdrawal by Subject|1|||
161859563|NCT02687451|584527611|FG001|Overall Study|Withdrawal by Subject|0|||
161859564|NCT02687451|584527612|FG002|Overall Study|Withdrawal by Subject|0|||
161859565|NCT02687451|584527613|FG003|Overall Study|Withdrawal by Subject|0|||
161859566|NCT02687451|584527614|FG004|Overall Study|Withdrawal by Subject|0|||
161859567|NCT02687451|584527615|FG005|Overall Study|Withdrawal by Subject|1|||
161859568|NCT00707239|584527616|FG000|Overall Study|Adverse Event|5|||
161859569|NCT00707239|584527617|FG001|Overall Study|Adverse Event|3|||
161859570|NCT00707239|584527618|FG002|Overall Study|Adverse Event|2|||
161859571|NCT00707239|584527616|FG000|Overall Study|Death|3|||
161859572|NCT00707239|584527617|FG001|Overall Study|Death|1|||
161859573|NCT00707239|584527618|FG002|Overall Study|Death|3|||
161859574|NCT00707239|584527616|FG000|Overall Study|Physician Decision|1|||
161859575|NCT00707239|584527617|FG001|Overall Study|Physician Decision|1|||
161859576|NCT00707239|584527618|FG002|Overall Study|Physician Decision|2|||
161859577|NCT00707239|584527616|FG000|Overall Study|Protocol Violation|0|||
161859578|NCT00707239|584527617|FG001|Overall Study|Protocol Violation|0|||
161859579|NCT00707239|584527618|FG002|Overall Study|Protocol Violation|1|||
161975772|NCT00098722|584960171|FG003|Double Blind Phase|Randomized, not treated|0|||
161859580|NCT00707239|584527616|FG000|Overall Study|Lack of Efficacy|1|||
161859581|NCT00707239|584527617|FG001|Overall Study|Lack of Efficacy|2|||
161859582|NCT00707239|584527618|FG002|Overall Study|Lack of Efficacy|0|||
161975773|NCT00098722|584960172|FG004|Double Blind Phase|Randomized, not treated|0|||
161975774|NCT00098722|584960173|FG005|Double Blind Phase|Randomized, not treated|0|||
161975775|NCT00098722|584960174|FG006|Double Blind Phase|Randomized, not treated|0|||
161975776|NCT00098722|584960168|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
161975777|NCT00098722|584960169|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
161975778|NCT00098722|584960170|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
161975779|NCT00098722|584960171|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
161975780|NCT00098722|584960172|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
161975781|NCT00098722|584960173|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
161975782|NCT00098722|584960174|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
161975783|NCT00098722|584960168|FG000|Double Blind Phase|Other|7|||
161975784|NCT00098722|584960169|FG001|Double Blind Phase|Other|8|||
161975785|NCT00098722|584960170|FG002|Double Blind Phase|Other|7|||
161859583|NCT00707239|584527616|FG000|Overall Study|Randomized, but not treated|1|||
161859584|NCT00707239|584527617|FG001|Overall Study|Randomized, but not treated|1|||
161859585|NCT00707239|584527618|FG002|Overall Study|Randomized, but not treated|1|||
161859586|NCT00707239|584527616|FG000|Overall Study|Other|8|||
161859587|NCT00707239|584527617|FG001|Overall Study|Other|3|||
161859588|NCT00707239|584527618|FG002|Overall Study|Other|5|||
161859589|NCT01518322|584527619|FG000|Overall Study|FeNO measurement was missing|13|||
161859590|NCT03652051|584527620|FG000|Stage 1|Adverse Event|0|||
161859591|NCT03652051|584527621|FG001|Stage 1|Adverse Event|5|||
161859592|NCT03652051|584527622|FG002|Stage 1|Adverse Event|7|||
161859593|NCT03652051|584527623|FG003|Stage 1|Adverse Event|1|||
161859594|NCT03652051|584527620|FG000|Stage 1|Withdrawal by Subject|0|||
161859595|NCT03652051|584527621|FG001|Stage 1|Withdrawal by Subject|0|||
161859596|NCT03652051|584527622|FG002|Stage 1|Withdrawal by Subject|1|||
161859597|NCT03652051|584527623|FG003|Stage 1|Withdrawal by Subject|0|||
161859598|NCT03652051|584527620|FG000|Stage 2|Adverse Event|0|||
161859599|NCT03652051|584527621|FG001|Stage 2|Adverse Event|2|||
161859600|NCT03652051|584527622|FG002|Stage 2|Adverse Event|1|||
161859601|NCT03652051|584527623|FG003|Stage 2|Adverse Event|0|||
161859602|NCT03652051|584527620|FG000|Stage 2|Protocol Violation|0|||
161859603|NCT03652051|584527621|FG001|Stage 2|Protocol Violation|1|||
161859604|NCT03652051|584527622|FG002|Stage 2|Protocol Violation|6|||
161859605|NCT03652051|584527623|FG003|Stage 2|Protocol Violation|0|||
161859606|NCT03652051|584527620|FG000|Stage 2|Lost to Follow-up|0|||
161859607|NCT03652051|584527621|FG001|Stage 2|Lost to Follow-up|2|||
161859608|NCT03652051|584527622|FG002|Stage 2|Lost to Follow-up|0|||
161859609|NCT03652051|584527623|FG003|Stage 2|Lost to Follow-up|3|||
161859610|NCT03652051|584527620|FG000|Stage 2|Withdrawal by Subject|0|||
161859611|NCT03652051|584527621|FG001|Stage 2|Withdrawal by Subject|11|||
161859612|NCT03652051|584527622|FG002|Stage 2|Withdrawal by Subject|9|||
161859613|NCT03652051|584527623|FG003|Stage 2|Withdrawal by Subject|3|||
161859614|NCT01930162|584527624|FG000|Overall Study|Abnormal test procedure result(s)|4|||
161859615|NCT01930162|584527624|FG000|Overall Study|Death|1|||
161859616|NCT01958437|584527625|FG000|Overall Study|Incidental MRI findings|0|||
161859617|NCT01958437|584527626|FG001|Overall Study|Incidental MRI findings|0|||
161859618|NCT01958437|584527627|FG002|Overall Study|Incidental MRI findings|1|||
161859619|NCT01958437|584527628|FG003|Overall Study|Incidental MRI findings|1|||
161859620|NCT02394600|584527631|FG000|Overall Study|Adverse Event|3|||
161859621|NCT02394600|584527632|FG001|Overall Study|Adverse Event|0|||
161859622|NCT02394600|584527631|FG000|Overall Study|Lost to Follow-up|0|||
161859623|NCT02394600|584527632|FG001|Overall Study|Lost to Follow-up|1|||
161859624|NCT02394600|584527631|FG000|Overall Study|Withdrawal by Subject|0|||
161859625|NCT02394600|584527632|FG001|Overall Study|Withdrawal by Subject|1|||
161859626|NCT02394600|584527631|FG000|Overall Study|Protocol Violation|1|||
161859627|NCT02394600|584527632|FG001|Overall Study|Protocol Violation|0|||
161859628|NCT02569801|584527633|FG000|Overall Study|Withdrawal by Subject|9|||
161859629|NCT02569801|584527634|FG001|Overall Study|Withdrawal by Subject|9|||
161859630|NCT02569801|584527633|FG000|Overall Study|Sponsor Decision|13|||
161859631|NCT02569801|584527634|FG001|Overall Study|Sponsor Decision|14|||
161859632|NCT02569801|584527633|FG000|Overall Study|Progressive Disease|2|||
161859633|NCT02569801|584527634|FG001|Overall Study|Progressive Disease|7|||
161859634|NCT02569801|584527633|FG000|Overall Study|Lost to Follow-up|0|||
161859635|NCT02569801|584527634|FG001|Overall Study|Lost to Follow-up|1|||
161859636|NCT02569801|584527633|FG000|Overall Study|Death|12|||
161859637|NCT02569801|584527634|FG001|Overall Study|Death|4|||
161859638|NCT03442751|584527638|FG000|Overall Study|Withdrawal by Subject|3|||
161859639|NCT03442751|584527639|FG001|Overall Study|Withdrawal by Subject|1|||
161859640|NCT03442751|584527638|FG000|Overall Study|Lost to Follow-up|3|||
161859641|NCT03442751|584527639|FG001|Overall Study|Lost to Follow-up|0|||
161975786|NCT00098722|584960171|FG003|Double Blind Phase|Other|0|||
161975787|NCT00098722|584960172|FG004|Double Blind Phase|Other|0|||
161975788|NCT00098722|584960173|FG005|Double Blind Phase|Other|0|||
161975789|NCT00098722|584960174|FG006|Double Blind Phase|Other|0|||
161975790|NCT00098722|584960168|FG000|Open Label Phase|Adverse Event|0|||
161975791|NCT00098722|584960169|FG001|Open Label Phase|Adverse Event|0|||
161975792|NCT00098722|584960170|FG002|Open Label Phase|Adverse Event|0|||
161975793|NCT00098722|584960171|FG003|Open Label Phase|Adverse Event|5|||
161770694|NCT01012765|584202220|FG001|Treatment Period 1|Protocol Violation|0|||
161770695|NCT01012765|584202221|FG002|Treatment Period 1|Protocol Violation|0|||
161770696|NCT01012765|584202222|FG003|Treatment Period 1|Protocol Violation|2|||
161770697|NCT01012765|584202223|FG004|Treatment Period 1|Protocol Violation|1|||
161770698|NCT01012765|584202224|FG005|Treatment Period 1|Protocol Violation|0|||
161770699|NCT01012765|584202219|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161770700|NCT01012765|584202220|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161770701|NCT01012765|584202221|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161770702|NCT01012765|584202222|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161770703|NCT01012765|584202223|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
161859642|NCT02603887|584527641|FG000|Stage 1|Adverse Event|4|||
161859643|NCT02603887|584527641|FG000|Stage 1|Disease progression|1|||
161975794|NCT00098722|584960172|FG004|Open Label Phase|Adverse Event|0|||
161975795|NCT00098722|584960173|FG005|Open Label Phase|Adverse Event|0|||
161975796|NCT00098722|584960174|FG006|Open Label Phase|Adverse Event|0|||
161975797|NCT00098722|584960168|FG000|Open Label Phase|Death|0|||
161975798|NCT00098722|584960169|FG001|Open Label Phase|Death|0|||
161975799|NCT00098722|584960170|FG002|Open Label Phase|Death|0|||
161975800|NCT00098722|584960171|FG003|Open Label Phase|Death|2|||
161975801|NCT00098722|584960172|FG004|Open Label Phase|Death|0|||
161975802|NCT00098722|584960173|FG005|Open Label Phase|Death|0|||
161975803|NCT00098722|584960174|FG006|Open Label Phase|Death|0|||
161975804|NCT00098722|584960168|FG000|Open Label Phase|Lack of Efficacy|0|||
161975805|NCT00098722|584960169|FG001|Open Label Phase|Lack of Efficacy|0|||
161975806|NCT00098722|584960170|FG002|Open Label Phase|Lack of Efficacy|0|||
161975807|NCT00098722|584960171|FG003|Open Label Phase|Lack of Efficacy|8|||
161975808|NCT00098722|584960172|FG004|Open Label Phase|Lack of Efficacy|0|||
161975809|NCT00098722|584960173|FG005|Open Label Phase|Lack of Efficacy|0|||
161975810|NCT00098722|584960174|FG006|Open Label Phase|Lack of Efficacy|0|||
161975811|NCT00098722|584960168|FG000|Open Label Phase|Pregnancy|0|||
161975812|NCT00098722|584960169|FG001|Open Label Phase|Pregnancy|0|||
161975813|NCT00098722|584960170|FG002|Open Label Phase|Pregnancy|0|||
161975814|NCT00098722|584960171|FG003|Open Label Phase|Pregnancy|1|||
161975815|NCT00098722|584960172|FG004|Open Label Phase|Pregnancy|0|||
161975816|NCT00098722|584960173|FG005|Open Label Phase|Pregnancy|0|||
161975817|NCT00098722|584960174|FG006|Open Label Phase|Pregnancy|0|||
161975818|NCT00098722|584960168|FG000|Open Label Phase|Participant defaulted|0|||
161975819|NCT00098722|584960169|FG001|Open Label Phase|Participant defaulted|0|||
161975820|NCT00098722|584960170|FG002|Open Label Phase|Participant defaulted|0|||
161975821|NCT00098722|584960171|FG003|Open Label Phase|Participant defaulted|18|||
161975822|NCT00098722|584960172|FG004|Open Label Phase|Participant defaulted|0|||
161770704|NCT01012765|584202224|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161770705|NCT01012765|584202219|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161770706|NCT01012765|584202220|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161770707|NCT01012765|584202221|FG002|Treatment Period 2|Withdrawal by Subject|1|||
161770708|NCT01012765|584202222|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161770709|NCT01012765|584202223|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161770710|NCT01012765|584202224|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161770711|NCT01012765|584202219|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
161770712|NCT01012765|584202220|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
161770713|NCT01012765|584202221|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
161770714|NCT01012765|584202222|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
161770715|NCT01012765|584202223|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
161770716|NCT01012765|584202224|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
161770717|NCT01012765|584202219|FG000|Treatment Period 2|Adverse Event|0|||
161770718|NCT01012765|584202220|FG001|Treatment Period 2|Adverse Event|1|||
161770719|NCT01012765|584202221|FG002|Treatment Period 2|Adverse Event|1|||
161770720|NCT01012765|584202222|FG003|Treatment Period 2|Adverse Event|0|||
161770721|NCT01012765|584202223|FG004|Treatment Period 2|Adverse Event|0|||
161770722|NCT01012765|584202224|FG005|Treatment Period 2|Adverse Event|0|||
161770723|NCT01012765|584202219|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
161770724|NCT01012765|584202220|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
161770725|NCT01012765|584202221|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
161770726|NCT01012765|584202222|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
161770727|NCT01012765|584202223|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
161770728|NCT01012765|584202224|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
161770729|NCT04668157|584202232|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
161770730|NCT04668157|584202233|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
161770731|NCT04668157|584202232|FG000|Treatment Period (52 Weeks)|Other|0|||
161770732|NCT04668157|584202233|FG001|Treatment Period (52 Weeks)|Other|2|||
161770733|NCT02283411|584202238|FG000|Overall Study|Withdrawal by Subject|3|||
161770734|NCT02283411|584202238|FG000|Overall Study|Screen Failed|28|||
161770735|NCT05437211|584202239|FG000|Overall Study|Patient's decision|1|||
161770736|NCT05437211|584202240|FG001|Overall Study|Patient's decision|1|||
161770737|NCT03282123|584202242|FG000|Overall Study|Withdrawal by Subject|5|||
161770738|NCT03457701|584202243|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
161770739|NCT03457701|584202244|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
161770740|NCT03457701|584202243|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
161859644|NCT02603887|584527641|FG000|Stage 2|FDA guidance|1|||
161770741|NCT03457701|584202244|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
161770742|NCT03329404|584202245|FG000|Overall Study|The study was suspended.|1|||
161859645|NCT01308424|584527644|FG000|Baseline Eligibility|Screen Failures|71|||
161975823|NCT00098722|584960173|FG005|Open Label Phase|Participant defaulted|0|||
161975824|NCT00098722|584960174|FG006|Open Label Phase|Participant defaulted|0|||
161975825|NCT00098722|584960168|FG000|Open Label Phase|Ongoing at cut-off date|0|||
161975826|NCT00098722|584960169|FG001|Open Label Phase|Ongoing at cut-off date|0|||
161975827|NCT00098722|584960170|FG002|Open Label Phase|Ongoing at cut-off date|0|||
161975828|NCT00098722|584960171|FG003|Open Label Phase|Ongoing at cut-off date|220|||
161859646|NCT01308424|584527645|FG001|Baseline Eligibility|Screen Failures|0|||
161859647|NCT01308424|584527646|FG002|Baseline Eligibility|Screen Failures|0|||
161859648|NCT01308424|584527644|FG000|Randomization|Adverse Event|0|||
161859649|NCT01308424|584527645|FG001|Randomization|Adverse Event|1|||
161859650|NCT01308424|584527646|FG002|Randomization|Adverse Event|1|||
161859651|NCT01308424|584527644|FG000|Randomization|Lost to Follow-up|0|||
161859652|NCT01308424|584527645|FG001|Randomization|Lost to Follow-up|1|||
161859653|NCT01308424|584527646|FG002|Randomization|Lost to Follow-up|0|||
161859654|NCT01308424|584527644|FG000|Randomization|Physician Decision|0|||
161859655|NCT01308424|584527645|FG001|Randomization|Physician Decision|1|||
161859656|NCT01308424|584527646|FG002|Randomization|Physician Decision|1|||
161859657|NCT00948155|584527647|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
161859658|NCT00948155|584527648|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
161859659|NCT00948155|584527647|FG000|Washout 14 Days|Lost to Follow-up|1|||
161859660|NCT00948155|584527648|FG001|Washout 14 Days|Lost to Follow-up|2|||
161859661|NCT04620746|584527649|FG000|Overall Study|Adverse Event|2|||
161859662|NCT04620746|584527650|FG001|Overall Study|Adverse Event|0|||
161859663|NCT04620746|584527649|FG000|Overall Study|Uniterpretable skin test|1|||
161859664|NCT04620746|584527650|FG001|Overall Study|Uniterpretable skin test|0|||
161859665|NCT04620746|584527649|FG000|Overall Study|Withdrawal by Subject|0|||
161859666|NCT04620746|584527650|FG001|Overall Study|Withdrawal by Subject|1|||
161859667|NCT05767905|584527655|FG000|Overall Study|Adverse Event|0|||
161859668|NCT05767905|584527656|FG001|Overall Study|Adverse Event|0|||
161859669|NCT05767905|584527657|FG002|Overall Study|Adverse Event|1|||
161859670|NCT03404674|584527663|FG000|Overall Study|Inability to Attend Future Visits|0|||
161859671|NCT03404674|584527664|FG001|Overall Study|Inability to Attend Future Visits|1|||
161859672|NCT03404674|584527665|FG002|Overall Study|Inability to Attend Future Visits|1|||
161859673|NCT03404674|584527666|FG003|Overall Study|Inability to Attend Future Visits|0|||
161859674|NCT03404674|584527667|FG004|Overall Study|Inability to Attend Future Visits|0|||
161859675|NCT03404674|584527668|FG005|Overall Study|Inability to Attend Future Visits|0|||
161859676|NCT03404674|584527663|FG000|Overall Study|Behavioral Problems|0|||
161859677|NCT03404674|584527664|FG001|Overall Study|Behavioral Problems|0|||
161859678|NCT03404674|584527665|FG002|Overall Study|Behavioral Problems|1|||
161859679|NCT03404674|584527666|FG003|Overall Study|Behavioral Problems|0|||
161859680|NCT03404674|584527667|FG004|Overall Study|Behavioral Problems|0|||
161859681|NCT03404674|584527668|FG005|Overall Study|Behavioral Problems|0|||
161859682|NCT03404674|584527663|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
161859683|NCT03404674|584527664|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
161859684|NCT03404674|584527665|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
161859685|NCT03404674|584527666|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
161859686|NCT03404674|584527667|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
161859687|NCT03404674|584527668|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
161859688|NCT01841593|584527673|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
161859689|NCT01841593|584527674|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
161859690|NCT01841593|584527673|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
161859691|NCT01841593|584527674|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
161859692|NCT02635984|584527675|FG000|Overall Study|Lost to Follow-up|2|||
161859693|NCT02635984|584527676|FG001|Overall Study|Lost to Follow-up|4|||
161859694|NCT02635984|584527675|FG000|Overall Study|Study Arm Closed|1|||
161859695|NCT02635984|584527676|FG001|Overall Study|Study Arm Closed|0|||
161859696|NCT00307086|584527677|FG000|Overall Study|ineligible|5|||
161859697|NCT01487525|584527680|FG000|Overall Study|Withdrawal by Subject|0|||
161859698|NCT01487525|584527681|FG001|Overall Study|Withdrawal by Subject|1|||
161859699|NCT03518008|584527682|FG000|Period 2, Second Week of Wear|Family emergency|0|||
161859700|NCT03518008|584527683|FG001|Period 2, Second Week of Wear|Family emergency|1|||
161859701|NCT01329900|584527684|FG000|Overall Study|Elevated creatinine/renal function|1|||
161859702|NCT01855828|584527685|FG000|Overall Study|Adverse Event|1|||
161859703|NCT01855828|584527685|FG000|Overall Study|Withdrawal by Subject|1|||
161859704|NCT01866098|584527690|FG000|Overall Study|Lost to Follow-up|11|||
161859705|NCT01866098|584527691|FG001|Overall Study|Lost to Follow-up|18|||
161859706|NCT01866098|584527692|FG002|Overall Study|Lost to Follow-up|13|||
161859707|NCT01866098|584527690|FG000|Overall Study|Physician Decision|0|||
161975829|NCT00098722|584960172|FG004|Open Label Phase|Ongoing at cut-off date|50|||
161975830|NCT00098722|584960173|FG005|Open Label Phase|Ongoing at cut-off date|0|||
161975831|NCT00098722|584960174|FG006|Open Label Phase|Ongoing at cut-off date|0|||
161975832|NCT00098722|584960168|FG000|Open Label Phase|Other|0|||
161975833|NCT00098722|584960169|FG001|Open Label Phase|Other|0|||
161859708|NCT01866098|584527691|FG001|Overall Study|Physician Decision|1|||
161859709|NCT01866098|584527692|FG002|Overall Study|Physician Decision|2|||
161859710|NCT01866098|584527690|FG000|Overall Study|Adverse Event|1|||
161859711|NCT01866098|584527691|FG001|Overall Study|Adverse Event|5|||
161859712|NCT01866098|584527692|FG002|Overall Study|Adverse Event|4|||
161859713|NCT01866098|584527690|FG000|Overall Study|Protocol Violation|1|||
161859714|NCT01866098|584527691|FG001|Overall Study|Protocol Violation|0|||
161859715|NCT01866098|584527692|FG002|Overall Study|Protocol Violation|0|||
161975834|NCT00098722|584960170|FG002|Open Label Phase|Other|0|||
161859716|NCT01866098|584527690|FG000|Overall Study|Withdrawal by Subject|1|||
161859717|NCT01866098|584527691|FG001|Overall Study|Withdrawal by Subject|2|||
161859718|NCT01866098|584527692|FG002|Overall Study|Withdrawal by Subject|0|||
162034464|NCT02241889|585182057|FG003|Overall Study|Withdrawal by Subject|0|||
162034465|NCT02241889|585182058|FG004|Overall Study|Withdrawal by Subject|0|||
161859719|NCT01866098|584527690|FG000|Overall Study|Unrelated Hospitalization|2|||
161859720|NCT01866098|584527691|FG001|Overall Study|Unrelated Hospitalization|0|||
161859721|NCT01866098|584527692|FG002|Overall Study|Unrelated Hospitalization|1|||
161859722|NCT01866098|584527690|FG000|Overall Study|Non-compliance|1|||
161859723|NCT01866098|584527691|FG001|Overall Study|Non-compliance|0|||
161859724|NCT01866098|584527692|FG002|Overall Study|Non-compliance|1|||
161859725|NCT01866098|584527690|FG000|Overall Study|Pregnancy|2|||
161859726|NCT01866098|584527691|FG001|Overall Study|Pregnancy|0|||
161859727|NCT01866098|584527692|FG002|Overall Study|Pregnancy|0|||
161859728|NCT01866098|584527690|FG000|Overall Study|Death|0|||
162034466|NCT02241889|585182059|FG005|Overall Study|Withdrawal by Subject|1|||
162034467|NCT00773838|585182060|FG000|Overall Study|Adverse Event|29|||
162034468|NCT00773838|585182060|FG000|Overall Study|Lost to Follow-up|1|||
161770743|NCT03329404|584202246|FG001|Overall Study|The study was suspended.|4|||
161770744|NCT00796367|584202250|FG000|Overall Study|Adverse Event|6|||
161770745|NCT00796367|584202251|FG001|Overall Study|Adverse Event|4|||
161770746|NCT00796367|584202252|FG002|Overall Study|Adverse Event|7|||
161770747|NCT00796367|584202250|FG000|Overall Study|Lost to Follow-up|5|||
161770748|NCT00796367|584202251|FG001|Overall Study|Lost to Follow-up|4|||
161770749|NCT00796367|584202252|FG002|Overall Study|Lost to Follow-up|21|||
161770750|NCT00796367|584202250|FG000|Overall Study|Withdrawal by Subject|9|||
161770751|NCT00796367|584202251|FG001|Overall Study|Withdrawal by Subject|11|||
161770752|NCT00796367|584202252|FG002|Overall Study|Withdrawal by Subject|12|||
161770753|NCT00796367|584202250|FG000|Overall Study|Lack of Efficacy|2|||
161770754|NCT00796367|584202251|FG001|Overall Study|Lack of Efficacy|1|||
161770755|NCT00796367|584202252|FG002|Overall Study|Lack of Efficacy|0|||
161770756|NCT00796367|584202250|FG000|Overall Study|non compliance|3|||
161770757|NCT00796367|584202251|FG001|Overall Study|non compliance|1|||
161770758|NCT00796367|584202252|FG002|Overall Study|non compliance|1|||
161770759|NCT00796367|584202250|FG000|Overall Study|Pregnancy|1|||
161770760|NCT00796367|584202251|FG001|Overall Study|Pregnancy|0|||
161770761|NCT00796367|584202252|FG002|Overall Study|Pregnancy|1|||
161770762|NCT00796367|584202250|FG000|Overall Study|Requirement for restricted medication|2|||
161770763|NCT00796367|584202251|FG001|Overall Study|Requirement for restricted medication|0|||
161770764|NCT00796367|584202252|FG002|Overall Study|Requirement for restricted medication|2|||
161770765|NCT00796367|584202250|FG000|Overall Study|other|2|||
161770766|NCT00796367|584202251|FG001|Overall Study|other|4|||
161770767|NCT00796367|584202252|FG002|Overall Study|other|3|||
161770768|NCT01463631|584202253|FG000|Overall Study|Withdrawal by Subject|0|||
161770769|NCT01463631|584202254|FG001|Overall Study|Withdrawal by Subject|0|||
161770770|NCT01463631|584202255|FG002|Overall Study|Withdrawal by Subject|0|||
161770771|NCT01463631|584202256|FG003|Overall Study|Withdrawal by Subject|1|||
161770772|NCT01463631|584202253|FG000|Overall Study|Death|0|||
161770773|NCT01463631|584202254|FG001|Overall Study|Death|0|||
161770774|NCT01463631|584202255|FG002|Overall Study|Death|1|||
161770775|NCT01463631|584202256|FG003|Overall Study|Death|0|||
161770776|NCT01463631|584202253|FG000|Overall Study|Progressive Disease|0|||
161770777|NCT01463631|584202254|FG001|Overall Study|Progressive Disease|0|||
161770778|NCT01463631|584202255|FG002|Overall Study|Progressive Disease|0|||
161770779|NCT01463631|584202256|FG003|Overall Study|Progressive Disease|5|||
161770780|NCT04604015|584202265|FG000|Overall Study|Incomplete Data Collection|33|||
161770781|NCT01314261|584202266|FG000|Overall Study|Adverse Event|1|||
161770782|NCT01314261|584202267|FG001|Overall Study|Adverse Event|0|||
161770783|NCT01314261|584202268|FG002|Overall Study|Adverse Event|0|||
161770784|NCT01314261|584202269|FG003|Overall Study|Adverse Event|0|||
161770785|NCT01314261|584202266|FG000|Overall Study|Withdrawal by Subject|0|||
161770786|NCT01314261|584202267|FG001|Overall Study|Withdrawal by Subject|3|||
161770787|NCT01314261|584202268|FG002|Overall Study|Withdrawal by Subject|1|||
161770788|NCT01314261|584202269|FG003|Overall Study|Withdrawal by Subject|0|||
161770789|NCT01314261|584202266|FG000|Overall Study|Lost to Follow-up|1|||
161770790|NCT01314261|584202267|FG001|Overall Study|Lost to Follow-up|0|||
161770791|NCT01314261|584202268|FG002|Overall Study|Lost to Follow-up|2|||
161770792|NCT01314261|584202269|FG003|Overall Study|Lost to Follow-up|2|||
161770793|NCT01314261|584202266|FG000|Overall Study|Virologic Failure|0|||
161859729|NCT01866098|584527691|FG001|Overall Study|Death|1|||
161770794|NCT01314261|584202267|FG001|Overall Study|Virologic Failure|1|||
161770795|NCT01314261|584202268|FG002|Overall Study|Virologic Failure|0|||
161770796|NCT01314261|584202269|FG003|Overall Study|Virologic Failure|1|||
161770797|NCT02129192|584202270|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
161859730|NCT01866098|584527692|FG002|Overall Study|Death|0|||
161859731|NCT04239027|584527696|FG000|Overall Study|Adverse Event|4|||
161859732|NCT04239027|584527696|FG000|Overall Study|Withdrawal by Subject|9|||
161770798|NCT02129192|584202271|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
161859733|NCT04239027|584527696|FG000|Overall Study|Death|1|||
162034469|NCT00773838|585182060|FG000|Overall Study|Physician Decision|8|||
161975835|NCT00098722|584960171|FG003|Open Label Phase|Other|18|||
161975836|NCT00098722|584960172|FG004|Open Label Phase|Other|0|||
161770799|NCT01231620|584202272|FG000|Overall Study|Physician Decision|3|||
161770800|NCT01231620|584202273|FG001|Overall Study|Physician Decision|5|||
161770801|NCT01231620|584202274|FG002|Overall Study|Physician Decision|10|||
161770802|NCT01231620|584202272|FG000|Overall Study|Death|12|||
161770803|NCT01231620|584202273|FG001|Overall Study|Death|14|||
161770804|NCT01231620|584202274|FG002|Overall Study|Death|11|||
161770805|NCT01231620|584202272|FG000|Overall Study|Adverse Event|2|||
161770806|NCT01231620|584202273|FG001|Overall Study|Adverse Event|2|||
161770807|NCT01231620|584202274|FG002|Overall Study|Adverse Event|1|||
161770808|NCT01231620|584202272|FG000|Overall Study|Withdrawal by Subject|6|||
161770809|NCT01231620|584202273|FG001|Overall Study|Withdrawal by Subject|6|||
161770810|NCT01231620|584202274|FG002|Overall Study|Withdrawal by Subject|8|||
161770811|NCT01231620|584202272|FG000|Overall Study|Lost to Follow-up|3|||
161770812|NCT01231620|584202273|FG001|Overall Study|Lost to Follow-up|4|||
161770813|NCT01231620|584202274|FG002|Overall Study|Lost to Follow-up|9|||
161770814|NCT04557189|584202288|FG000|Overall Study|Adverse Event|0|||
161770815|NCT04557189|584202289|FG001|Overall Study|Adverse Event|1|||
161770816|NCT04557189|584202288|FG000|Overall Study|Lost to Follow-up|1|||
161770817|NCT04557189|584202289|FG001|Overall Study|Lost to Follow-up|1|||
161770818|NCT04557189|584202288|FG000|Overall Study|Withdrawal by Subject|2|||
161770819|NCT04557189|584202289|FG001|Overall Study|Withdrawal by Subject|1|||
161770820|NCT04557189|584202288|FG000|Overall Study|Reason not Specified|3|||
161770821|NCT04557189|584202289|FG001|Overall Study|Reason not Specified|6|||
161770822|NCT03590613|584202290|FG000|Period 2, 4 Days|Physician Decision|0|||
161770823|NCT03590613|584202291|FG001|Period 2, 4 Days|Physician Decision|0|||
161770824|NCT03590613|584202292|FG002|Period 2, 4 Days|Physician Decision|0|||
161770825|NCT03590613|584202293|FG003|Period 2, 4 Days|Physician Decision|1|||
161770826|NCT03575975|584202295|FG000|Overall Study|Lost to Follow-up|1|||
161770827|NCT03575975|584202296|FG001|Overall Study|Lost to Follow-up|0|||
161770828|NCT03575975|584202297|FG002|Overall Study|Lost to Follow-up|0|||
161770829|NCT02441517|584202298|FG000|Overall Study|Lost to Follow-up|1|||
161770830|NCT02441517|584202298|FG000|Overall Study|Withdrawal by Subject|2|||
161770831|NCT02441517|584202298|FG000|Overall Study|Study Terminated by Sponsor|1|||
161770832|NCT00129220|584202300|FG000|Study Period II|Adverse Event|9|||
161770833|NCT00129220|584202301|FG001|Study Period II|Adverse Event|5|||
161770834|NCT00129220|584202302|FG002|Study Period II|Adverse Event|7|||
161770835|NCT00129220|584202300|FG000|Study Period II|Lack of Efficacy|15|||
161770836|NCT00129220|584202301|FG001|Study Period II|Lack of Efficacy|1|||
161770837|NCT00129220|584202302|FG002|Study Period II|Lack of Efficacy|28|||
161770838|NCT00129220|584202300|FG000|Study Period II|Entry Criteria Not Met|2|||
161770839|NCT00129220|584202301|FG001|Study Period II|Entry Criteria Not Met|0|||
161770840|NCT00129220|584202302|FG002|Study Period II|Entry Criteria Not Met|2|||
161770841|NCT00129220|584202300|FG000|Study Period II|Protocol Violation|4|||
161770842|NCT00129220|584202301|FG001|Study Period II|Protocol Violation|2|||
161770843|NCT00129220|584202302|FG002|Study Period II|Protocol Violation|1|||
161770844|NCT00129220|584202300|FG000|Study Period II|Physician Decision|0|||
161770845|NCT00129220|584202301|FG001|Study Period II|Physician Decision|1|||
161770846|NCT00129220|584202302|FG002|Study Period II|Physician Decision|0|||
161770847|NCT00129220|584202300|FG000|Study Period II|Withdrawal by Subject|1|||
161770848|NCT00129220|584202301|FG001|Study Period II|Withdrawal by Subject|3|||
161770849|NCT00129220|584202302|FG002|Study Period II|Withdrawal by Subject|4|||
161770850|NCT00129220|584202300|FG000|Study Period II|Reason Not Specified|2|||
161770851|NCT00129220|584202301|FG001|Study Period II|Reason Not Specified|0|||
161770852|NCT00129220|584202302|FG002|Study Period II|Reason Not Specified|5|||
161770853|NCT00129220|584202300|FG000|Study Period III|Adverse Event|1|||
161770854|NCT00129220|584202301|FG001|Study Period III|Adverse Event|0|||
161770855|NCT00129220|584202302|FG002|Study Period III|Adverse Event|3|||
161770856|NCT00129220|584202300|FG000|Study Period III|Protocol Violation|1|||
161770857|NCT00129220|584202301|FG001|Study Period III|Protocol Violation|1|||
161770858|NCT00129220|584202302|FG002|Study Period III|Protocol Violation|2|||
161770859|NCT00129220|584202300|FG000|Study Period III|Withdrawal by Subject|1|||
161770860|NCT00129220|584202301|FG001|Study Period III|Withdrawal by Subject|0|||
161770861|NCT00129220|584202302|FG002|Study Period III|Withdrawal by Subject|3|||
161770862|NCT00129220|584202300|FG000|Study Period III|Sponsor Decision|1|||
161770863|NCT00129220|584202301|FG001|Study Period III|Sponsor Decision|0|||
161770864|NCT00129220|584202302|FG002|Study Period III|Sponsor Decision|0|||
161770865|NCT00129220|584202300|FG000|Study Period III|Reason Not Specified|9|||
161770866|NCT00129220|584202301|FG001|Study Period III|Reason Not Specified|0|||
161770867|NCT00129220|584202302|FG002|Study Period III|Reason Not Specified|2|||
161770868|NCT00686894|584202304|FG000|Overall Study|Relapse|2|||
161770869|NCT00686894|584202304|FG000|Overall Study|Protocol Violation|4|||
161770870|NCT01230489|584202305|FG000|Overall Study|Death|2|||
161770871|NCT01230489|584202305|FG000|Overall Study|Adverse Event|2|||
161770872|NCT01230489|584202305|FG000|Overall Study|Treatment modality changed|1|||
161770873|NCT00869362|584204148|FG000|Overall Study|Death|0|||
161770874|NCT00869362|584204149|FG001|Overall Study|Death|2|||
161975837|NCT00098722|584960173|FG005|Open Label Phase|Other|0|||
161975838|NCT00098722|584960174|FG006|Open Label Phase|Other|0|||
161975839|NCT00098722|584960168|FG000|Observation Phase|Death|0|||
161975840|NCT00098722|584960169|FG001|Observation Phase|Death|0|||
161975841|NCT00098722|584960170|FG002|Observation Phase|Death|0|||
161975842|NCT00098722|584960171|FG003|Observation Phase|Death|0|||
161975843|NCT00098722|584960172|FG004|Observation Phase|Death|0|||
161975844|NCT00098722|584960173|FG005|Observation Phase|Death|5|||
161975845|NCT00098722|584960174|FG006|Observation Phase|Death|3|||
161975846|NCT00098722|584960168|FG000|Observation Phase|Lack of Efficacy|0|||
161975847|NCT00098722|584960169|FG001|Observation Phase|Lack of Efficacy|0|||
161975848|NCT00098722|584960170|FG002|Observation Phase|Lack of Efficacy|0|||
161975849|NCT00098722|584960171|FG003|Observation Phase|Lack of Efficacy|0|||
161975850|NCT00098722|584960172|FG004|Observation Phase|Lack of Efficacy|0|||
161975851|NCT00098722|584960173|FG005|Observation Phase|Lack of Efficacy|2|||
161975852|NCT00098722|584960174|FG006|Observation Phase|Lack of Efficacy|0|||
161975853|NCT00098722|584960168|FG000|Observation Phase|Participant defaulted|0|||
161975854|NCT00098722|584960169|FG001|Observation Phase|Participant defaulted|0|||
161975855|NCT00098722|584960170|FG002|Observation Phase|Participant defaulted|0|||
161975856|NCT00098722|584960171|FG003|Observation Phase|Participant defaulted|0|||
161975857|NCT00098722|584960172|FG004|Observation Phase|Participant defaulted|0|||
161975858|NCT00098722|584960173|FG005|Observation Phase|Participant defaulted|17|||
161975859|NCT00098722|584960174|FG006|Observation Phase|Participant defaulted|4|||
161975860|NCT00098722|584960168|FG000|Observation Phase|Other|0|||
161975861|NCT00098722|584960169|FG001|Observation Phase|Other|0|||
161975862|NCT00098722|584960170|FG002|Observation Phase|Other|0|||
161975863|NCT00098722|584960171|FG003|Observation Phase|Other|0|||
161975864|NCT00098722|584960172|FG004|Observation Phase|Other|0|||
161975865|NCT00098722|584960173|FG005|Observation Phase|Other|21|||
161975866|NCT00098722|584960174|FG006|Observation Phase|Other|10|||
161770875|NCT00869362|584204148|FG000|Overall Study|Lost to Follow-up|1|||
161770876|NCT00869362|584204149|FG001|Overall Study|Lost to Follow-up|3|||
161770877|NCT02815540|584204152|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
161770878|NCT04887922|584204160|FG000|1st Randomization|Decided not to have surgery|0|||
161770879|NCT04887922|584204161|FG001|1st Randomization|Decided not to have surgery|1|||
161770880|NCT04887922|584204162|FG002|1st Randomization|Decided not to have surgery|0|||
161770881|NCT04887922|584204163|FG003|1st Randomization|Decided not to have surgery|0|||
161770882|NCT04887922|584204164|FG004|1st Randomization|Decided not to have surgery|0|||
161770883|NCT00953017|584204165|FG000|Overall Study|DId not show up for colonoscopy|4|||
161770884|NCT00953017|584204166|FG001|Overall Study|DId not show up for colonoscopy|4|||
161770885|NCT00953017|584204167|FG002|Overall Study|DId not show up for colonoscopy|5|||
161770886|NCT00953017|584204168|FG003|Overall Study|DId not show up for colonoscopy|4|||
161770887|NCT00953017|584204165|FG000|Overall Study|Incomplete data|1|||
161770888|NCT00953017|584204166|FG001|Overall Study|Incomplete data|1|||
161770889|NCT00953017|584204167|FG002|Overall Study|Incomplete data|0|||
161770890|NCT00953017|584204168|FG003|Overall Study|Incomplete data|0|||
161770891|NCT00953017|584204165|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
161770892|NCT00953017|584204166|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
161770893|NCT00953017|584204167|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
161770894|NCT00953017|584204168|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
161770895|NCT00953017|584204165|FG000|Overall Study|Brown stool prior to procedure|0|||
161770896|NCT00953017|584204166|FG001|Overall Study|Brown stool prior to procedure|0|||
161770897|NCT00953017|584204167|FG002|Overall Study|Brown stool prior to procedure|1|||
161770898|NCT00953017|584204168|FG003|Overall Study|Brown stool prior to procedure|0|||
161770899|NCT00798161|584204171|FG000|Overall Study|Adverse Event|3|||
161770900|NCT00798161|584204172|FG001|Overall Study|Adverse Event|4|||
161770901|NCT00798161|584204173|FG002|Overall Study|Adverse Event|6|||
161770902|NCT00798161|584204174|FG003|Overall Study|Adverse Event|6|||
161770903|NCT00798161|584204175|FG004|Overall Study|Adverse Event|5|||
161770904|NCT00798161|584204176|FG005|Overall Study|Adverse Event|2|||
161770905|NCT00798161|584204177|FG006|Overall Study|Adverse Event|4|||
161770906|NCT00798161|584204171|FG000|Overall Study|Protocol Violation|2|||
161770907|NCT00798161|584204172|FG001|Overall Study|Protocol Violation|1|||
161770908|NCT00798161|584204173|FG002|Overall Study|Protocol Violation|3|||
161770909|NCT00798161|584204174|FG003|Overall Study|Protocol Violation|3|||
161770910|NCT00798161|584204175|FG004|Overall Study|Protocol Violation|3|||
161770911|NCT00798161|584204176|FG005|Overall Study|Protocol Violation|2|||
161770912|NCT00798161|584204177|FG006|Overall Study|Protocol Violation|0|||
161770913|NCT00798161|584204171|FG000|Overall Study|Lost to Follow-up|1|||
161770914|NCT00798161|584204172|FG001|Overall Study|Lost to Follow-up|3|||
161770915|NCT00798161|584204173|FG002|Overall Study|Lost to Follow-up|4|||
161770916|NCT00798161|584204174|FG003|Overall Study|Lost to Follow-up|3|||
161770917|NCT00798161|584204175|FG004|Overall Study|Lost to Follow-up|4|||
161975867|NCT01519674|584960175|FG000|Overall Study|Adverse Event|3|||
161975868|NCT01519674|584960176|FG001|Overall Study|Adverse Event|3|||
161975869|NCT01519674|584960177|FG002|Overall Study|Adverse Event|0|||
161975870|NCT01519674|584960175|FG000|Overall Study|Lack of Efficacy|1|||
161975871|NCT01519674|584960176|FG001|Overall Study|Lack of Efficacy|1|||
161975872|NCT01519674|584960177|FG002|Overall Study|Lack of Efficacy|1|||
161975873|NCT01519674|584960175|FG000|Overall Study|Protocol Violation|0|||
161975874|NCT01519674|584960176|FG001|Overall Study|Protocol Violation|3|||
161975875|NCT01519674|584960177|FG002|Overall Study|Protocol Violation|1|||
161975876|NCT01519674|584960175|FG000|Overall Study|Withdrawal Criteria|7|||
161975877|NCT01519674|584960176|FG001|Overall Study|Withdrawal Criteria|2|||
161975878|NCT01519674|584960177|FG002|Overall Study|Withdrawal Criteria|7|||
161975879|NCT01519674|584960175|FG000|Overall Study|Unsclassified|10|||
161975880|NCT01519674|584960176|FG001|Overall Study|Unsclassified|4|||
161975881|NCT01519674|584960177|FG002|Overall Study|Unsclassified|3|||
161975882|NCT01146288|584960185|FG000|First Intervention(1 Day)|Adverse Event|0|||
161975883|NCT01146288|584960186|FG001|First Intervention(1 Day)|Adverse Event|1|||
161975884|NCT03351114|584960190|FG000|Overall Study|Withdrawal by Subject|1|||
161975885|NCT03249935|584960191|FG000|Overall Study|Discharged from facility early|36|||
161975886|NCT03249935|584960191|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
161975887|NCT03249935|584960191|FG000|Overall Study|Protocol Violation|5|||
161975888|NCT00989235|584960192|FG000|Overall Study|Death|0|||
161975889|NCT00989235|584960193|FG001|Overall Study|Death|1|||
161975890|NCT00989235|584960192|FG000|Overall Study|Adverse Event|0|||
161975891|NCT00989235|584960193|FG001|Overall Study|Adverse Event|1|||
161975892|NCT00989235|584960192|FG000|Overall Study|Lack of Efficacy|1|||
161975893|NCT00989235|584960193|FG001|Overall Study|Lack of Efficacy|0|||
161975894|NCT00989235|584960192|FG000|Overall Study|Withdrawal of Consent|1|||
161975895|NCT00989235|584960193|FG001|Overall Study|Withdrawal of Consent|1|||
161975896|NCT00989235|584960192|FG000|Overall Study|Desire to Become Pregnant|1|||
161975897|NCT00989235|584960193|FG001|Overall Study|Desire to Become Pregnant|0|||
161975898|NCT00989235|584960192|FG000|Overall Study|Randomized by Mistake|0|||
161975899|NCT00989235|584960193|FG001|Overall Study|Randomized by Mistake|2|||
161975900|NCT00989235|584960192|FG000|Overall Study|Lost to Follow-up|0|||
161975901|NCT00989235|584960193|FG001|Overall Study|Lost to Follow-up|1|||
161975902|NCT03630302|584960196|FG000|Surgery|hardware issue prevented LFP recordings|1|||
161975903|NCT03630302|584960196|FG000|3 Month Visit|Adverse Event|2|||
161975904|NCT03630302|584960196|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
161975905|NCT01135914|584960197|FG000|Overall Study|Withdrawal by Subject|1|||
161975906|NCT01135914|584960198|FG001|Overall Study|Withdrawal by Subject|3|||
161975907|NCT01135914|584960199|FG002|Overall Study|Withdrawal by Subject|6|||
161770918|NCT00798161|584204176|FG005|Overall Study|Lost to Follow-up|0|||
161770919|NCT00798161|584204177|FG006|Overall Study|Lost to Follow-up|0|||
161770920|NCT00798161|584204171|FG000|Overall Study|Withdrawal by Subject|5|||
161770921|NCT00798161|584204172|FG001|Overall Study|Withdrawal by Subject|4|||
161770922|NCT00798161|584204173|FG002|Overall Study|Withdrawal by Subject|5|||
161770923|NCT00798161|584204174|FG003|Overall Study|Withdrawal by Subject|4|||
161770924|NCT00798161|584204175|FG004|Overall Study|Withdrawal by Subject|2|||
161770925|NCT00798161|584204176|FG005|Overall Study|Withdrawal by Subject|3|||
161770926|NCT00798161|584204177|FG006|Overall Study|Withdrawal by Subject|1|||
161770927|NCT00798161|584204171|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
161770928|NCT00798161|584204172|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
161770929|NCT00798161|584204173|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
161770930|NCT00798161|584204174|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
161770931|NCT00798161|584204175|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
161770932|NCT00798161|584204176|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
161770933|NCT00798161|584204177|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
161770934|NCT00594568|584204178|FG000|Initial Treatment|Adverse Event|51|||
161770935|NCT00594568|584204179|FG001|Initial Treatment|Adverse Event|121|||
161770936|NCT00594568|584204180|FG002|Initial Treatment|Adverse Event|144|||
161770937|NCT00594568|584204178|FG000|Initial Treatment|Death|6|||
161770938|NCT00594568|584204179|FG001|Initial Treatment|Death|11|||
161770939|NCT00594568|584204180|FG002|Initial Treatment|Death|15|||
161770940|NCT00594568|584204178|FG000|Initial Treatment|Lost to Follow-up|4|||
161770941|NCT00594568|584204179|FG001|Initial Treatment|Lost to Follow-up|1|||
161770942|NCT00594568|584204180|FG002|Initial Treatment|Lost to Follow-up|4|||
161770943|NCT00594568|584204178|FG000|Initial Treatment|Physician Decision|3|||
161770944|NCT00594568|584204179|FG001|Initial Treatment|Physician Decision|2|||
161770945|NCT00594568|584204180|FG002|Initial Treatment|Physician Decision|4|||
161770946|NCT00594568|584204178|FG000|Initial Treatment|Protocol Violation|2|||
161770947|NCT00594568|584204179|FG001|Initial Treatment|Protocol Violation|2|||
161770948|NCT00594568|584204180|FG002|Initial Treatment|Protocol Violation|5|||
161770949|NCT00594568|584204178|FG000|Initial Treatment|Withdrawal by Subject|25|||
161770950|NCT00594568|584204179|FG001|Initial Treatment|Withdrawal by Subject|31|||
161770951|NCT00594568|584204180|FG002|Initial Treatment|Withdrawal by Subject|46|||
161770952|NCT00594568|584204178|FG000|Initial Treatment|Sponsor decision|193|||
161770953|NCT00594568|584204179|FG001|Initial Treatment|Sponsor decision|142|||
161770954|NCT00594568|584204180|FG002|Initial Treatment|Sponsor decision|147|||
161770955|NCT00594568|584204178|FG000|Initial Treatment|Caregiver decision|21|||
161770956|NCT00594568|584204179|FG001|Initial Treatment|Caregiver decision|36|||
162034470|NCT00773838|585182060|FG000|Overall Study|Progressive Disease|82|||
162034471|NCT00773838|585182060|FG000|Overall Study|Protocol Violation|2|||
162034472|NCT00773838|585182060|FG000|Overall Study|Withdrawal by Subject|21|||
162034473|NCT00459056|585182064|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
162034474|NCT00459056|585182065|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
162034475|NCT02522871|585182066|FG000|Overall Study|Protocol Violation|1|||
162034476|NCT02522871|585182067|FG001|Overall Study|Protocol Violation|4|||
162034477|NCT02522871|585182066|FG000|Overall Study|Treated without randomization|1|||
162034478|NCT02522871|585182067|FG001|Overall Study|Treated without randomization|0|||
162034479|NCT02522871|585182066|FG000|Overall Study|Death|9|||
162034480|NCT02522871|585182067|FG001|Overall Study|Death|9|||
162034481|NCT02522871|585182066|FG000|Overall Study|Died in operating room prior to transplant|0|||
162034482|NCT02522871|585182067|FG001|Overall Study|Died in operating room prior to transplant|1|||
162034483|NCT01658813|585182068|FG000|Overall Study|Disease progression|3|||
162034484|NCT02398227|585182069|FG000|Overall Study|Lost to Follow-up|21|||
162034485|NCT02398227|585182070|FG001|Overall Study|Lost to Follow-up|12|||
162034486|NCT02398227|585182069|FG000|Overall Study|Withdrawal by Subject|5|||
162034487|NCT02398227|585182070|FG001|Overall Study|Withdrawal by Subject|6|||
162034488|NCT02398227|585182069|FG000|Overall Study|Removed from treatment and dropped out|1|||
162034489|NCT02398227|585182070|FG001|Overall Study|Removed from treatment and dropped out|0|||
162034490|NCT01715129|585182071|FG000|Overall Study|Adverse Event, fatal|1|||
162034491|NCT01715129|585182071|FG000|Overall Study|Lack of Efficacy|3|||
162034492|NCT01715129|585182071|FG000|Overall Study|Protocol Violation|1|||
162034493|NCT01715129|585182071|FG000|Overall Study|Consent Withdrawn|2|||
162034494|NCT01715129|585182071|FG000|Overall Study|Lost to Follow-up|1|||
161859734|NCT04239027|584527696|FG000|Overall Study|Physician Decision|9|||
161859735|NCT04239027|584527696|FG000|Overall Study|Lost to Follow-up|2|||
161859736|NCT04239027|584527696|FG000|Overall Study|Lack of Efficacy|1|||
161859737|NCT01256502|584527707|FG000|Overall Study|Had scaffold removed|4|||
161859738|NCT01256502|584527707|FG000|Overall Study|Personal reasons|5|||
161859739|NCT01256502|584527707|FG000|Overall Study|Protocol deviation|1|||
161859740|NCT01523002|584527708|FG000|Period 1|Withdrawal by Subject|1|||
161859741|NCT01523002|584527709|FG001|Period 1|Withdrawal by Subject|3|||
161859742|NCT01523002|584527708|FG000|Period 1|Lost to Follow-up|1|||
162034495|NCT01715129|585182071|FG000|Overall Study|Other|1|||
162034496|NCT02793622|585182072|FG000|Overall Study|Lost to Follow-up|31|||
162034497|NCT02793622|585182073|FG001|Overall Study|Lost to Follow-up|19|||
162034498|NCT02793622|585182072|FG000|Overall Study|Withdrawal by Subject|21|||
161770957|NCT00594568|584204180|FG002|Initial Treatment|Caregiver decision|36|||
161770958|NCT00594568|584204178|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
161770959|NCT00594568|584204179|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
161770960|NCT00594568|584204180|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
161770961|NCT00594568|584204178|FG000|Initial Treatment|Entry criteria exclusion|0|||
161770962|NCT00594568|584204179|FG001|Initial Treatment|Entry criteria exclusion|1|||
161770963|NCT00594568|584204180|FG002|Initial Treatment|Entry criteria exclusion|1|||
161770964|NCT00594568|584204178|FG000|Delayed Start|Death|0|||
161770965|NCT00594568|584204179|FG001|Delayed Start|Death|0|||
161770966|NCT00594568|584204180|FG002|Delayed Start|Death|1|||
161770967|NCT00594568|584204178|FG000|Delayed Start|Adverse Event|12|||
161770968|NCT00594568|584204179|FG001|Delayed Start|Adverse Event|2|||
161770969|NCT00594568|584204180|FG002|Delayed Start|Adverse Event|2|||
161770970|NCT00594568|584204178|FG000|Delayed Start|Withdrawal by Subject|4|||
161770971|NCT00594568|584204179|FG001|Delayed Start|Withdrawal by Subject|3|||
161770972|NCT00594568|584204180|FG002|Delayed Start|Withdrawal by Subject|0|||
161770973|NCT00594568|584204178|FG000|Delayed Start|Physician Decision|0|||
161770974|NCT00594568|584204179|FG001|Delayed Start|Physician Decision|0|||
161770975|NCT00594568|584204180|FG002|Delayed Start|Physician Decision|1|||
161770976|NCT00594568|584204178|FG000|Delayed Start|Lost to Follow-up|0|||
161770977|NCT00594568|584204179|FG001|Delayed Start|Lost to Follow-up|0|||
161770978|NCT00594568|584204180|FG002|Delayed Start|Lost to Follow-up|1|||
161770979|NCT00594568|584204178|FG000|Delayed Start|Caregiver Decision|5|||
161770980|NCT00594568|584204179|FG001|Delayed Start|Caregiver Decision|6|||
161770981|NCT00594568|584204180|FG002|Delayed Start|Caregiver Decision|2|||
161770982|NCT00594568|584204178|FG000|Delayed Start|Sponsor Decision|77|||
161770983|NCT00594568|584204179|FG001|Delayed Start|Sponsor Decision|66|||
161770984|NCT00594568|584204180|FG002|Delayed Start|Sponsor Decision|59|||
161770985|NCT00594568|584204178|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
161770986|NCT00594568|584204179|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
161770987|NCT00594568|584204180|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
161770988|NCT00594568|584204178|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
161770989|NCT00594568|584204179|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
161770990|NCT00594568|584204180|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
161770991|NCT00594568|584204178|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
161770992|NCT00594568|584204179|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
161770993|NCT00594568|584204180|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
161859743|NCT01523002|584527709|FG001|Period 1|Lost to Follow-up|0|||
161859744|NCT01523002|584527708|FG000|Period 1|Adverse Event|0|||
161859745|NCT01523002|584527709|FG001|Period 1|Adverse Event|8|||
161859746|NCT01523002|584527708|FG000|Period 2|Withdrawal by Subject|4|||
161859747|NCT01523002|584527709|FG001|Period 2|Withdrawal by Subject|1|||
161859748|NCT01523002|584527708|FG000|Period 2|Adverse Event|2|||
161859749|NCT01523002|584527709|FG001|Period 2|Adverse Event|5|||
161859750|NCT01523002|584527708|FG000|Period 3|Withdrawal by Subject|1|||
161859751|NCT01523002|584527709|FG001|Period 3|Withdrawal by Subject|0|||
161859752|NCT01523002|584527708|FG000|Period 3|Adverse Event|3|||
161859753|NCT01523002|584527709|FG001|Period 3|Adverse Event|0|||
161859754|NCT03953612|584527710|FG000|Overall Study|Randomized but did not start|1|||
161859755|NCT03953612|584527711|FG001|Overall Study|Randomized but did not start|1|||
161859756|NCT03953612|584527712|FG002|Overall Study|Randomized but did not start|1|||
161859757|NCT03953612|584527710|FG000|Overall Study|Withdrawal by Subject|2|||
161859758|NCT03953612|584527711|FG001|Overall Study|Withdrawal by Subject|1|||
161859759|NCT03953612|584527712|FG002|Overall Study|Withdrawal by Subject|0|||
161859760|NCT00489255|584527713|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
161859761|NCT00489255|584527714|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
161859762|NCT00489255|584527713|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
161859763|NCT00489255|584527714|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
161859764|NCT00489255|584527713|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
161859765|NCT00489255|584527714|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
161859766|NCT00489255|584527713|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
161859767|NCT00489255|584527714|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
161859768|NCT00489255|584527713|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
161859769|NCT00489255|584527714|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
161859770|NCT00489255|584527713|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
161859771|NCT00489255|584527714|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
161859772|NCT00489255|584527713|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
161859773|NCT00489255|584527714|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
161859774|NCT00489255|584527713|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
161859775|NCT00489255|584527714|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
161859776|NCT00489255|584527713|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
161859777|NCT00489255|584527714|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
161859778|NCT00489255|584527713|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
161859779|NCT00489255|584527714|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
161859780|NCT03485352|584527715|FG000|Overall Study|Lost to Follow-up|9|||
161859781|NCT01982955|584527717|FG000|Overall Study|Randomized but not treated|0|||
161859782|NCT01982955|584527718|FG001|Overall Study|Randomized but not treated|0|||
161859783|NCT01982955|584527719|FG002|Overall Study|Randomized but not treated|0|||
161859784|NCT01982955|584527720|FG003|Overall Study|Randomized but not treated|1|||
161859785|NCT01982955|584527721|FG004|Overall Study|Randomized but not treated|0|||
161859786|NCT02548143|584527726|FG000|Overall Study|Adverse Event|1|||
161859787|NCT02548143|584527727|FG001|Overall Study|Adverse Event|0|||
161859788|NCT02548143|584527726|FG000|Overall Study|Withdrawal by Subject|0|||
161859789|NCT02548143|584527727|FG001|Overall Study|Withdrawal by Subject|1|||
161859790|NCT05655546|584529564|FG000|Overall Study|Withdrawal by Subject|2|||
161859791|NCT05655546|584529565|FG001|Overall Study|Withdrawal by Subject|4|||
161859792|NCT03493685|584529566|FG000|Overall Study|Death|4|||
161859793|NCT03493685|584529567|FG001|Overall Study|Death|3|||
161859794|NCT03493685|584529566|FG000|Overall Study|Lost to Follow-up|3|||
161859795|NCT03493685|584529567|FG001|Overall Study|Lost to Follow-up|2|||
161859796|NCT03493685|584529566|FG000|Overall Study|Physician Decision|2|||
161859797|NCT03493685|584529567|FG001|Overall Study|Physician Decision|0|||
161859798|NCT03493685|584529566|FG000|Overall Study|Withdrawal by Subject|7|||
161859799|NCT03493685|584529567|FG001|Overall Study|Withdrawal by Subject|11|||
161859800|NCT04452669|584529568|FG000|Overall Study|Death|1|||
161859801|NCT04452669|584529569|FG001|Overall Study|Death|4|||
161859802|NCT04576507|584529573|FG000|Overall Study|Adverse Event|4|||
161859803|NCT04576507|584529573|FG000|Overall Study|Withdrawal by Subject|1|||
161859804|NCT00413699|584529574|FG000|Initial Period|Death|25|||
161859805|NCT00413699|584529575|FG001|Initial Period|Death|30|||
161859806|NCT00413699|584529576|FG002|Initial Period|Death|0|||
161975908|NCT01135914|584960197|FG000|Overall Study|Lost to Follow-up|1|||
161975909|NCT01135914|584960198|FG001|Overall Study|Lost to Follow-up|0|||
161975910|NCT01135914|584960199|FG002|Overall Study|Lost to Follow-up|1|||
161859807|NCT00413699|584529574|FG000|Initial Period|Lack of Efficacy|59|||
161859808|NCT00413699|584529575|FG001|Initial Period|Lack of Efficacy|115|||
161859809|NCT00413699|584529576|FG002|Initial Period|Lack of Efficacy|0|||
161975911|NCT01135914|584960197|FG000|Overall Study|Protocol Violation|0|||
161859810|NCT00413699|584529574|FG000|Initial Period|Lost to Follow-up|31|||
161859811|NCT00413699|584529575|FG001|Initial Period|Lost to Follow-up|101|||
161859812|NCT00413699|584529576|FG002|Initial Period|Lost to Follow-up|0|||
161859813|NCT00413699|584529574|FG000|Initial Period|Protocol Violation|38|||
161859814|NCT00413699|584529575|FG001|Initial Period|Protocol Violation|89|||
161859815|NCT00413699|584529576|FG002|Initial Period|Protocol Violation|0|||
161859816|NCT00413699|584529574|FG000|Initial Period|Pregnancy|10|||
161975912|NCT01135914|584960198|FG001|Overall Study|Protocol Violation|0|||
161770994|NCT00594568|584204178|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
161770995|NCT00594568|584204179|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
161770996|NCT00594568|584204180|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
161770997|NCT00594568|584204178|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
161770998|NCT00594568|584204179|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
161770999|NCT00594568|584204180|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
161771000|NCT00594568|584204178|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
161771001|NCT00594568|584204179|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
161771002|NCT00594568|584204180|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
161771003|NCT01366846|584204184|FG000|Overall Study|Withdrawal by Subject|2|||
161771004|NCT01366846|584204185|FG001|Overall Study|Withdrawal by Subject|0|||
161771005|NCT01366846|584204186|FG002|Overall Study|Withdrawal by Subject|0|||
161771006|NCT01366846|584204187|FG003|Overall Study|Withdrawal by Subject|0|||
161771007|NCT01366846|584204184|FG000|Overall Study|Communication Difficulties|1|||
161771008|NCT01366846|584204185|FG001|Overall Study|Communication Difficulties|4|||
161771009|NCT01366846|584204186|FG002|Overall Study|Communication Difficulties|0|||
161771010|NCT01366846|584204187|FG003|Overall Study|Communication Difficulties|1|||
161771011|NCT01366846|584204184|FG000|Overall Study|Scheduling Conflicts|0|||
161771012|NCT01366846|584204185|FG001|Overall Study|Scheduling Conflicts|0|||
161771013|NCT01366846|584204186|FG002|Overall Study|Scheduling Conflicts|1|||
161771014|NCT01366846|584204187|FG003|Overall Study|Scheduling Conflicts|0|||
161771015|NCT00290511|584204188|FG000|Overall Study|Adverse Event|1|||
161771016|NCT00290511|584204188|FG000|Overall Study|Death|1|||
161771017|NCT00290511|584204188|FG000|Overall Study|Physician Decision|1|||
161771018|NCT00290511|584204188|FG000|Overall Study|Withdrawal by Subject|1|||
161771019|NCT04341727|584204193|FG000|Overall Study|Withdrawal by Subject|0|||
161771020|NCT04341727|584204194|FG001|Overall Study|Withdrawal by Subject|0|||
161771021|NCT04341727|584204195|FG002|Overall Study|Withdrawal by Subject|1|||
161771022|NCT04341727|584204196|FG003|Overall Study|Withdrawal by Subject|0|||
161771023|NCT04341727|584204193|FG000|Overall Study|Lost to Follow-up|0|||
161771024|NCT04341727|584204194|FG001|Overall Study|Lost to Follow-up|0|||
161771025|NCT04341727|584204195|FG002|Overall Study|Lost to Follow-up|0|||
161771026|NCT04341727|584204196|FG003|Overall Study|Lost to Follow-up|1|||
161771027|NCT00447265|584204197|FG000|Overall Study|Physician Decision|1|||
161771028|NCT00447265|584204198|FG001|Overall Study|Physician Decision|0|||
161771029|NCT00503035|584204199|FG000|Overall Study|Lost to Follow-up|2|||
161771030|NCT00503035|584204199|FG000|Overall Study|Physician Decision|3|||
161771031|NCT00503035|584204199|FG000|Overall Study|Ineligible|15|||
161771032|NCT04311411|584204202|FG000|Overall Study|Adverse Event|2|||
161771033|NCT04311411|584204203|FG001|Overall Study|Adverse Event|3|||
161771034|NCT04311411|584204204|FG002|Overall Study|Adverse Event|2|||
161771035|NCT04311411|584204202|FG000|Overall Study|Withdrawal by Subject|3|||
161771036|NCT04311411|584204203|FG001|Overall Study|Withdrawal by Subject|3|||
161771037|NCT04311411|584204204|FG002|Overall Study|Withdrawal by Subject|0|||
161771038|NCT01976663|584204208|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
161771039|NCT01976663|584204208|FG000|Overall Study|Personal Reasons|6|||
161771040|NCT01976663|584204208|FG000|Overall Study|Withdrawal by Subject|4|||
161771041|NCT01976663|584204208|FG000|Overall Study|Screen Failure|3|||
161771042|NCT01976663|584204208|FG000|Overall Study|Adverse Event|2|||
161771043|NCT01976663|584204208|FG000|Overall Study|Lost to Follow-up|3|||
161771044|NCT05028816|584204209|FG000|Overall Study|Lost to Follow-up|5|||
161771045|NCT05028816|584204210|FG001|Overall Study|Lost to Follow-up|3|||
161771046|NCT05028816|584204209|FG000|Overall Study|Withdrawal by Subject|4|||
161771047|NCT05028816|584204210|FG001|Overall Study|Withdrawal by Subject|1|||
161771048|NCT05028816|584204209|FG000|Overall Study|Physician Decision|1|||
161771049|NCT05028816|584204210|FG001|Overall Study|Physician Decision|0|||
161771050|NCT04780776|584204216|FG000|Titration Week 1-5|Lost to Follow-up|2|||
161771051|NCT04780776|584204217|FG001|Titration Week 1-5|Lost to Follow-up|8|||
161771052|NCT04780776|584204216|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
161771053|NCT04780776|584204217|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
161771054|NCT04780776|584204216|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
161771055|NCT04780776|584204217|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
161771056|NCT03113760|584204219|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
161771057|NCT03113760|584204220|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
161771058|NCT03113760|584204221|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
161771059|NCT03113760|584204222|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
161771060|NCT03113760|584204219|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
161771061|NCT03113760|584204220|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
161771062|NCT03113760|584204221|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
161771063|NCT03113760|584204222|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
161771064|NCT03113760|584204219|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
161771065|NCT03113760|584204220|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
161771066|NCT03113760|584204221|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
161771067|NCT03113760|584204222|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
161859817|NCT00413699|584529575|FG001|Initial Period|Pregnancy|8|||
161859818|NCT00413699|584529576|FG002|Initial Period|Pregnancy|0|||
161859819|NCT00413699|584529574|FG000|Initial Period|Did not meet entrance criteria|2|||
161859820|NCT00413699|584529575|FG001|Initial Period|Did not meet entrance criteria|2|||
161975913|NCT01135914|584960199|FG002|Overall Study|Protocol Violation|3|||
161975914|NCT01135914|584960197|FG000|Overall Study|Lack of Efficacy|2|||
161975915|NCT01135914|584960198|FG001|Overall Study|Lack of Efficacy|1|||
161975916|NCT01135914|584960199|FG002|Overall Study|Lack of Efficacy|10|||
161975917|NCT01135914|584960197|FG000|Overall Study|Adverse Event|0|||
161975918|NCT01135914|584960198|FG001|Overall Study|Adverse Event|1|||
161975919|NCT01135914|584960199|FG002|Overall Study|Adverse Event|2|||
161975920|NCT00931801|584960204|FG000|Overall Study|Adverse Event|0|||
161975921|NCT00931801|584960205|FG001|Overall Study|Adverse Event|0|||
161975922|NCT00931801|584960206|FG002|Overall Study|Adverse Event|1|||
161975923|NCT00931801|584960204|FG000|Overall Study|Lost to Follow-up|0|||
161975924|NCT00931801|584960205|FG001|Overall Study|Lost to Follow-up|1|||
161975925|NCT00931801|584960206|FG002|Overall Study|Lost to Follow-up|0|||
161975926|NCT00931801|584960204|FG000|Overall Study|Withdrawal by Subject|1|||
161975927|NCT00931801|584960205|FG001|Overall Study|Withdrawal by Subject|0|||
161975928|NCT00931801|584960206|FG002|Overall Study|Withdrawal by Subject|0|||
161975929|NCT00931801|584960204|FG000|Overall Study|Confirmed Virologic Failure|0|||
161975930|NCT00931801|584960205|FG001|Overall Study|Confirmed Virologic Failure|0|||
161975931|NCT00931801|584960206|FG002|Overall Study|Confirmed Virologic Failure|3|||
161975932|NCT00746733|584960208|FG000|Second Intervention|Adverse Event|1|||
161975933|NCT00746733|584960209|FG001|Second Intervention|Adverse Event|0|||
161975934|NCT00746733|584960208|FG000|Third Intervention|Withdrawal by Subject|1|||
161859821|NCT00413699|584529576|FG002|Initial Period|Did not meet entrance criteria|0|||
161859822|NCT00413699|584529574|FG000|Initial Period|Medication error without adverse event|0|||
161859823|NCT00413699|584529575|FG001|Initial Period|Medication error without adverse event|1|||
161859824|NCT00413699|584529576|FG002|Initial Period|Medication error without adverse event|0|||
161859825|NCT00413699|584529574|FG000|Initial Period|Study terminated by Sponsor|0|||
161859826|NCT00413699|584529575|FG001|Initial Period|Study terminated by Sponsor|1|||
161859827|NCT00413699|584529576|FG002|Initial Period|Study terminated by Sponsor|0|||
161859828|NCT00413699|584529574|FG000|Initial Period|Other|67|||
161859829|NCT00413699|584529575|FG001|Initial Period|Other|211|||
161859830|NCT00413699|584529576|FG002|Initial Period|Other|0|||
161859831|NCT00413699|584529574|FG000|Initial Period|Adverse event related to study drug|178|||
161859832|NCT00413699|584529575|FG001|Initial Period|Adverse event related to study drug|527|||
161859833|NCT00413699|584529576|FG002|Initial Period|Adverse event related to study drug|0|||
161859834|NCT00413699|584529574|FG000|Initial Period|Adverse event not related to study drug|113|||
161859835|NCT00413699|584529575|FG001|Initial Period|Adverse event not related to study drug|248|||
161859836|NCT00413699|584529576|FG002|Initial Period|Adverse event not related to study drug|0|||
161859837|NCT00413699|584529574|FG000|Initial Period|Missing end of study page|0|||
161859838|NCT00413699|584529575|FG001|Initial Period|Missing end of study page|4|||
161859839|NCT00413699|584529576|FG002|Initial Period|Missing end of study page|0|||
161859840|NCT00413699|584529574|FG000|Initial Period|No longer willing to participate|116|||
161859841|NCT00413699|584529575|FG001|Initial Period|No longer willing to participate|368|||
161859842|NCT00413699|584529576|FG002|Initial Period|No longer willing to participate|0|||
161859843|NCT00413699|584529574|FG000|Extension Period|No Longer Willing to Participate|0|||
161859844|NCT00413699|584529575|FG001|Extension Period|No Longer Willing to Participate|0|||
161859845|NCT00413699|584529576|FG002|Extension Period|No Longer Willing to Participate|2|||
161859846|NCT00413699|584529574|FG000|Extension Period|Protocol Violation|0|||
161859847|NCT00413699|584529575|FG001|Extension Period|Protocol Violation|0|||
161859848|NCT00413699|584529576|FG002|Extension Period|Protocol Violation|1|||
161859849|NCT00413699|584529574|FG000|Extension Period|Adverse Event|0|||
161859850|NCT00413699|584529575|FG001|Extension Period|Adverse Event|0|||
161859851|NCT00413699|584529576|FG002|Extension Period|Adverse Event|2|||
161859852|NCT02115269|584529578|FG000|Overall Study|Lost to Follow-up|43|||
161975935|NCT00746733|584960209|FG001|Third Intervention|Withdrawal by Subject|1|||
161975936|NCT00610441|584960210|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
161975937|NCT00610441|584960211|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
161975938|NCT00610441|584960212|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
161975939|NCT00610441|584960213|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
161975940|NCT00610441|584960210|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
161975941|NCT00610441|584960211|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
161975942|NCT00610441|584960212|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
161859853|NCT02115269|584529578|FG000|Overall Study|Did not complete patient diary|3|||
161859854|NCT02115269|584529578|FG000|Overall Study|Moved to another city|7|||
161859855|NCT02115269|584529578|FG000|Overall Study|Withdrawal by Subject|2|||
161975943|NCT00610441|584960213|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
161975944|NCT00610441|584960210|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
161975945|NCT00610441|584960211|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
161975946|NCT00610441|584960212|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
161975947|NCT00610441|584960213|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
161859856|NCT02115269|584529578|FG000|Overall Study|Didn't take study drug|2|||
161859857|NCT05989672|584529579|FG000|Overall Study|Adverse Event|3|||
161859858|NCT05989672|584529580|FG001|Overall Study|Adverse Event|0|||
161859859|NCT05989672|584529581|FG002|Overall Study|Adverse Event|0|||
161859860|NCT03511105|584529582|FG000|Overall Study|Adverse Event|1|||
161859861|NCT03511105|584529583|FG001|Overall Study|Adverse Event|0|||
161859862|NCT03511105|584529582|FG000|Overall Study|Withdrew consent|1|||
161859863|NCT03511105|584529583|FG001|Overall Study|Withdrew consent|0|||
161859864|NCT02810457|584529584|FG000|Overall Study|Randomised but no treatment received|2|||
161859865|NCT02810457|584529585|FG001|Overall Study|Randomised but no treatment received|1|||
161859866|NCT02810457|584529584|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
161859867|NCT02810457|584529585|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
161859868|NCT02810457|584529584|FG000|Overall Study|Adverse Event|37|||
161859869|NCT02810457|584529585|FG001|Overall Study|Adverse Event|43|||
161859870|NCT02810457|584529584|FG000|Overall Study|Patient decision|31|||
161859871|NCT02810457|584529585|FG001|Overall Study|Patient decision|35|||
161859872|NCT02810457|584529584|FG000|Overall Study|Patient lost to follow-up|2|||
161859873|NCT02810457|584529585|FG001|Overall Study|Patient lost to follow-up|2|||
161859874|NCT02810457|584529584|FG000|Overall Study|Death|39|||
161859875|NCT02810457|584529585|FG001|Overall Study|Death|28|||
161859876|NCT02810457|584529584|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
161859877|NCT02810457|584529585|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
161859878|NCT02810457|584529584|FG000|Overall Study|Clinical progression|15|||
161859879|NCT02810457|584529585|FG001|Overall Study|Clinical progression|16|||
161859880|NCT02810457|584529584|FG000|Overall Study|Investigator decision|3|||
161859881|NCT02810457|584529585|FG001|Overall Study|Investigator decision|2|||
161859882|NCT02810457|584529584|FG000|Overall Study|Patient ineligibility|3|||
161859883|NCT02810457|584529585|FG001|Overall Study|Patient ineligibility|0|||
161859884|NCT02810457|584529584|FG000|Overall Study|Miscalculated PD|1|||
161859885|NCT02810457|584529585|FG001|Overall Study|Miscalculated PD|0|||
161859886|NCT02810457|584529584|FG000|Overall Study|Physician Decision|0|||
161859887|NCT02810457|584529585|FG001|Overall Study|Physician Decision|1|||
161859888|NCT01962103|584529586|FG000|Phase 1|Adverse Event|4|||
161859889|NCT01962103|584529587|FG001|Phase 1|Adverse Event|0|||
161859890|NCT01962103|584529588|FG002|Phase 1|Adverse Event|2|||
161859891|NCT01962103|584529589|FG003|Phase 1|Adverse Event|1|||
161859892|NCT01962103|584529590|FG004|Phase 1|Adverse Event|2|||
161975948|NCT00610441|584960210|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
161975949|NCT00610441|584960211|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
161975950|NCT00610441|584960212|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
161975951|NCT00610441|584960213|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
161975952|NCT00610441|584960210|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
161975953|NCT00610441|584960211|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
161975954|NCT00610441|584960212|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
161975955|NCT00610441|584960213|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
161975956|NCT00610441|584960210|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
161975957|NCT00610441|584960211|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
161975958|NCT00610441|584960212|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
161975959|NCT00610441|584960213|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
161975960|NCT00610441|584960210|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
161975961|NCT00610441|584960211|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
161975962|NCT00610441|584960212|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
161859893|NCT01962103|584529591|FG005|Phase 1|Adverse Event|2|||
161859894|NCT01962103|584529592|FG006|Phase 1|Adverse Event|0|||
161859895|NCT01962103|584529593|FG007|Phase 1|Adverse Event|0|||
161859896|NCT01962103|584529594|FG008|Phase 1|Adverse Event|0|||
161859897|NCT01962103|584529586|FG000|Phase 1|Progressive Disease|8|||
161859898|NCT01962103|584529587|FG001|Phase 1|Progressive Disease|6|||
161859899|NCT01962103|584529588|FG002|Phase 1|Progressive Disease|8|||
161859900|NCT01962103|584529589|FG003|Phase 1|Progressive Disease|4|||
161859901|NCT01962103|584529590|FG004|Phase 1|Progressive Disease|5|||
161859902|NCT01962103|584529591|FG005|Phase 1|Progressive Disease|4|||
161859903|NCT01962103|584529592|FG006|Phase 1|Progressive Disease|0|||
161859904|NCT01962103|584529593|FG007|Phase 1|Progressive Disease|0|||
161859905|NCT01962103|584529594|FG008|Phase 1|Progressive Disease|0|||
161859906|NCT01962103|584529586|FG000|Phase 1|Withdrawal by Subject|0|||
161859907|NCT01962103|584529587|FG001|Phase 1|Withdrawal by Subject|0|||
161859908|NCT01962103|584529588|FG002|Phase 1|Withdrawal by Subject|0|||
161975963|NCT00610441|584960213|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
161975964|NCT00610441|584960210|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
161975965|NCT00610441|584960211|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
161975966|NCT00610441|584960212|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
161975967|NCT00610441|584960213|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
161975968|NCT00610441|584960210|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
161975969|NCT00610441|584960211|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
161975970|NCT00610441|584960212|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
161859909|NCT01962103|584529589|FG003|Phase 1|Withdrawal by Subject|2|||
161859910|NCT01962103|584529590|FG004|Phase 1|Withdrawal by Subject|0|||
161859911|NCT01962103|584529591|FG005|Phase 1|Withdrawal by Subject|0|||
161859912|NCT01962103|584529592|FG006|Phase 1|Withdrawal by Subject|0|||
161859913|NCT01962103|584529593|FG007|Phase 1|Withdrawal by Subject|0|||
161859914|NCT01962103|584529594|FG008|Phase 1|Withdrawal by Subject|0|||
161859915|NCT01962103|584529586|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
161859916|NCT01962103|584529587|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
161859917|NCT01962103|584529588|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
161859918|NCT01962103|584529589|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
161859919|NCT01962103|584529590|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
161859920|NCT01962103|584529591|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
161859921|NCT01962103|584529592|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
161859922|NCT01962103|584529593|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
161859923|NCT01962103|584529594|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
161859924|NCT01962103|584529586|FG000|Phase 1|Physician Decision|0|||
161859925|NCT01962103|584529587|FG001|Phase 1|Physician Decision|0|||
161859926|NCT01962103|584529588|FG002|Phase 1|Physician Decision|0|||
161859927|NCT01962103|584529589|FG003|Phase 1|Physician Decision|1|||
161859928|NCT01962103|584529590|FG004|Phase 1|Physician Decision|0|||
161859929|NCT01962103|584529591|FG005|Phase 1|Physician Decision|0|||
161859930|NCT01962103|584529592|FG006|Phase 1|Physician Decision|0|||
161859931|NCT01962103|584529593|FG007|Phase 1|Physician Decision|0|||
161859932|NCT01962103|584529594|FG008|Phase 1|Physician Decision|0|||
161859933|NCT01962103|584529586|FG000|Phase 1|Symptomatic Deterioration|3|||
161859934|NCT01962103|584529587|FG001|Phase 1|Symptomatic Deterioration|2|||
161859935|NCT01962103|584529588|FG002|Phase 1|Symptomatic Deterioration|2|||
161859936|NCT01962103|584529589|FG003|Phase 1|Symptomatic Deterioration|2|||
161859937|NCT01962103|584529590|FG004|Phase 1|Symptomatic Deterioration|1|||
161859938|NCT01962103|584529591|FG005|Phase 1|Symptomatic Deterioration|1|||
161859939|NCT01962103|584529592|FG006|Phase 1|Symptomatic Deterioration|0|||
161859940|NCT01962103|584529593|FG007|Phase 1|Symptomatic Deterioration|0|||
161859941|NCT01962103|584529594|FG008|Phase 1|Symptomatic Deterioration|0|||
161859942|NCT01962103|584529586|FG000|Phase 1|Miscellaneous|1|||
161859943|NCT01962103|584529587|FG001|Phase 1|Miscellaneous|0|||
161859944|NCT01962103|584529588|FG002|Phase 1|Miscellaneous|0|||
161859945|NCT01962103|584529589|FG003|Phase 1|Miscellaneous|0|||
161859946|NCT01962103|584529590|FG004|Phase 1|Miscellaneous|0|||
161859947|NCT01962103|584529591|FG005|Phase 1|Miscellaneous|0|||
161859948|NCT01962103|584529592|FG006|Phase 1|Miscellaneous|0|||
161859949|NCT01962103|584529593|FG007|Phase 1|Miscellaneous|0|||
161859950|NCT01962103|584529594|FG008|Phase 1|Miscellaneous|0|||
161859951|NCT01962103|584529586|FG000|Phase 2|Adverse Event|0|||
161859952|NCT01962103|584529587|FG001|Phase 2|Adverse Event|0|||
161859953|NCT01962103|584529588|FG002|Phase 2|Adverse Event|0|||
161859954|NCT01962103|584529589|FG003|Phase 2|Adverse Event|0|||
161859955|NCT01962103|584529590|FG004|Phase 2|Adverse Event|0|||
161859956|NCT01962103|584529591|FG005|Phase 2|Adverse Event|0|||
161859957|NCT01962103|584529592|FG006|Phase 2|Adverse Event|1|||
161859958|NCT01962103|584529593|FG007|Phase 2|Adverse Event|0|||
161859959|NCT01962103|584529594|FG008|Phase 2|Adverse Event|3|||
161859960|NCT01962103|584529586|FG000|Phase 2|Progressive Disease|0|||
161975971|NCT00610441|584960213|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
161859961|NCT01962103|584529587|FG001|Phase 2|Progressive Disease|0|||
161859962|NCT01962103|584529588|FG002|Phase 2|Progressive Disease|0|||
161859963|NCT01962103|584529589|FG003|Phase 2|Progressive Disease|0|||
161859964|NCT01962103|584529590|FG004|Phase 2|Progressive Disease|0|||
161859965|NCT01962103|584529591|FG005|Phase 2|Progressive Disease|0|||
161859966|NCT01962103|584529592|FG006|Phase 2|Progressive Disease|11|||
161859967|NCT01962103|584529593|FG007|Phase 2|Progressive Disease|12|||
161859968|NCT01962103|584529594|FG008|Phase 2|Progressive Disease|11|||
161975972|NCT00837876|584960214|FG000|Overall Study|Death|2|||
161859969|NCT01962103|584529586|FG000|Phase 2|Symptomatic Deterioration|0|||
161859970|NCT01962103|584529587|FG001|Phase 2|Symptomatic Deterioration|0|||
161859971|NCT01962103|584529588|FG002|Phase 2|Symptomatic Deterioration|0|||
161859972|NCT01962103|584529589|FG003|Phase 2|Symptomatic Deterioration|0|||
161859973|NCT01962103|584529590|FG004|Phase 2|Symptomatic Deterioration|0|||
161859974|NCT01962103|584529591|FG005|Phase 2|Symptomatic Deterioration|0|||
161859975|NCT01962103|584529592|FG006|Phase 2|Symptomatic Deterioration|2|||
161859976|NCT01962103|584529593|FG007|Phase 2|Symptomatic Deterioration|2|||
161859977|NCT01962103|584529594|FG008|Phase 2|Symptomatic Deterioration|0|||
161859978|NCT04179838|584529595|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
161859979|NCT04179838|584529596|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
161859980|NCT04179838|584529595|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
161859981|NCT04179838|584529596|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
161859982|NCT02750618|584529597|FG000|Overall Study|Withdrawal by Subject|1|||
161859983|NCT02763046|584529604|FG000|Overall Study|Adverse Event|5|||
161859984|NCT02763046|584529605|FG001|Overall Study|Adverse Event|4|||
161859985|NCT02763046|584529606|FG002|Overall Study|Adverse Event|0|||
161859986|NCT02763046|584529604|FG000|Overall Study|Lack of Efficacy|1|||
161859987|NCT02763046|584529605|FG001|Overall Study|Lack of Efficacy|1|||
161859988|NCT02763046|584529606|FG002|Overall Study|Lack of Efficacy|3|||
161859989|NCT02763046|584529604|FG000|Overall Study|Physician Decision|1|||
161859990|NCT02763046|584529605|FG001|Overall Study|Physician Decision|0|||
161859991|NCT02763046|584529606|FG002|Overall Study|Physician Decision|1|||
161859992|NCT02763046|584529604|FG000|Overall Study|Subject/guardian decision|2|||
161859993|NCT02763046|584529605|FG001|Overall Study|Subject/guardian decision|0|||
161859994|NCT02763046|584529606|FG002|Overall Study|Subject/guardian decision|4|||
161859995|NCT00818766|584529611|FG000|Overall Study|Could not be Contacted on Day 28|11|||
161859996|NCT00818766|584529612|FG001|Overall Study|Could not be Contacted on Day 28|10|||
161859997|NCT00818766|584529611|FG000|Overall Study|Death|1|||
161859998|NCT00818766|584529612|FG001|Overall Study|Death|0|||
161859999|NCT00818766|584529611|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
161860000|NCT00818766|584529612|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
161860001|NCT00086684|584529613|FG000|Overall Study|Adverse Event|12|||
161860002|NCT00086684|584529614|FG001|Overall Study|Adverse Event|17|||
161860003|NCT00086684|584529615|FG002|Overall Study|Adverse Event|14|||
161860004|NCT00086684|584529613|FG000|Overall Study|Lack of Efficacy|6|||
161860005|NCT00086684|584529614|FG001|Overall Study|Lack of Efficacy|6|||
161860006|NCT00086684|584529615|FG002|Overall Study|Lack of Efficacy|5|||
161860007|NCT00086684|584529613|FG000|Overall Study|Lost to Follow-up|15|||
161860008|NCT00086684|584529614|FG001|Overall Study|Lost to Follow-up|8|||
161860009|NCT00086684|584529615|FG002|Overall Study|Lost to Follow-up|10|||
161860010|NCT00086684|584529613|FG000|Overall Study|Protocol Violation|8|||
161860011|NCT00086684|584529614|FG001|Overall Study|Protocol Violation|3|||
161860012|NCT00086684|584529615|FG002|Overall Study|Protocol Violation|0|||
161860013|NCT00086684|584529613|FG000|Overall Study|Withdrawal by Subject|0|||
161860014|NCT00086684|584529614|FG001|Overall Study|Withdrawal by Subject|4|||
161860015|NCT00086684|584529615|FG002|Overall Study|Withdrawal by Subject|10|||
161860016|NCT00086684|584529613|FG000|Overall Study|NONCOMPLIANCE|5|||
161860017|NCT00086684|584529614|FG001|Overall Study|NONCOMPLIANCE|7|||
161860018|NCT00086684|584529615|FG002|Overall Study|NONCOMPLIANCE|6|||
161860019|NCT00086684|584529613|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161860020|NCT00086684|584529614|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
161860021|NCT00086684|584529615|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161860022|NCT00086684|584529613|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
161860023|NCT00086684|584529614|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
161860024|NCT00086684|584529615|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
161860025|NCT00086684|584529613|FG000|Overall Study|Other|4|||
161860026|NCT00086684|584529614|FG001|Overall Study|Other|2|||
161860027|NCT00086684|584529615|FG002|Overall Study|Other|3|||
161860028|NCT01103180|584529618|FG000|Overall Study|Withdrawal by Subject|8|||
161860029|NCT01103180|584529619|FG001|Overall Study|Withdrawal by Subject|13|||
161860030|NCT01103180|584529618|FG000|Overall Study|Lost to Follow-up|13|||
161860031|NCT01103180|584529619|FG001|Overall Study|Lost to Follow-up|7|||
161860032|NCT01103180|584529618|FG000|Overall Study|Physician Decision|1|||
161860033|NCT01103180|584529619|FG001|Overall Study|Physician Decision|0|||
161860034|NCT01103180|584529618|FG000|Overall Study|Protocol Violation|0|||
161860035|NCT01103180|584529619|FG001|Overall Study|Protocol Violation|1|||
161860036|NCT01067105|584529620|FG000|Overall Study|Adverse Event|14|||
161860037|NCT01067105|584529620|FG000|Overall Study|Protocol Violation|48|||
161860038|NCT01067105|584529620|FG000|Overall Study|Withdrawal by Subject|36|||
161860039|NCT01067105|584529620|FG000|Overall Study|Lost to Follow-up|6|||
161860040|NCT01067105|584529620|FG000|Overall Study|Physician Decision|6|||
161860041|NCT01067105|584529620|FG000|Overall Study|Other|31|||
161860042|NCT02439216|584529623|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
161860043|NCT02439216|584529624|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860044|NCT02439216|584529625|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860045|NCT02439216|584529626|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860046|NCT02439216|584529627|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860047|NCT02439216|584529628|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860048|NCT02439216|584529629|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860049|NCT02439216|584529630|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860050|NCT02439216|584529631|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161860051|NCT02439216|584529623|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860052|NCT02439216|584529624|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860053|NCT02439216|584529625|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161975973|NCT00837876|584960214|FG000|Overall Study|Adverse Event|7|||
161975974|NCT00837876|584960214|FG000|Overall Study|Physician Decision|1|||
161975975|NCT00837876|584960214|FG000|Overall Study|Withdrawal by Subject|3|||
161975976|NCT00837876|584960214|FG000|Overall Study|disease progression|24|||
161975977|NCT03464422|584960218|FG000|Overall Study|Lost to Follow-up|2|||
161860054|NCT02439216|584529626|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860055|NCT02439216|584529627|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860056|NCT02439216|584529628|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161975978|NCT03464422|584960218|FG000|Overall Study|Withdrawal by Subject|2|||
161771068|NCT00465101|584204223|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
161771069|NCT00465101|584204223|FG000|Overall Study|Change in health precluded follow up|4|||
161771070|NCT00465101|584204223|FG000|Overall Study|Did not meet study criteria|4|||
161771071|NCT00465101|584204223|FG000|Overall Study|Lost to Follow-up|5|||
161771072|NCT00465101|584204223|FG000|Overall Study|Other|6|||
161771073|NCT00465101|584204223|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
161771074|NCT00465101|584204223|FG000|Overall Study|Patient postponed procedure|1|||
161771075|NCT00465101|584204223|FG000|Overall Study|Site closed due to IRB expiration|1|||
161771076|NCT00465101|584204223|FG000|Overall Study|Unable to obtain IRB approval|1|||
161771077|NCT00465101|584204223|FG000|Overall Study|Death|3|||
161771078|NCT00465101|584204223|FG000|Overall Study|Withdrawal by Subject|25|||
161771079|NCT00465101|584204223|FG000|Overall Study|Physician Decision|1|||
161771080|NCT00465101|584204223|FG000|Overall Study|Withdrew consent prior to procedure|3|||
161771081|NCT00933543|584204225|FG000|Overall Study|Adverse Event|2|||
161771082|NCT00933543|584204226|FG001|Overall Study|Adverse Event|1|||
161771083|NCT00933543|584204225|FG000|Overall Study|Lost to Follow-up|0|||
161771084|NCT00933543|584204226|FG001|Overall Study|Lost to Follow-up|1|||
161771085|NCT00933543|584204225|FG000|Overall Study|Withdrawal by Subject|0|||
161771086|NCT00933543|584204226|FG001|Overall Study|Withdrawal by Subject|1|||
161771087|NCT00933543|584204225|FG000|Overall Study|Lack of Efficacy|0|||
161771088|NCT00933543|584204226|FG001|Overall Study|Lack of Efficacy|3|||
161771089|NCT00933543|584204225|FG000|Overall Study|Other|1|||
161771090|NCT00933543|584204226|FG001|Overall Study|Other|1|||
161771091|NCT04988035|584204228|FG000|Overall Study|Death|19|||
161771092|NCT04988035|584204229|FG001|Overall Study|Death|13|||
161771093|NCT04988035|584204228|FG000|Overall Study|Lost to Follow-up|12|||
161771094|NCT04988035|584204229|FG001|Overall Study|Lost to Follow-up|6|||
161771095|NCT04988035|584204228|FG000|Overall Study|Protocol Violation|0|||
161771096|NCT04988035|584204229|FG001|Overall Study|Protocol Violation|1|||
161771097|NCT04988035|584204228|FG000|Overall Study|Withdrawal by Subject|2|||
161771098|NCT04988035|584204229|FG001|Overall Study|Withdrawal by Subject|4|||
161771099|NCT04988035|584204228|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
161771100|NCT04988035|584204229|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
161771101|NCT04113746|584204232|FG000|Overall Study|Lost to Follow-up|4|||
161771102|NCT04113746|584204233|FG001|Overall Study|Lost to Follow-up|4|||
161771103|NCT00499694|584204234|FG000|Overall Study|Patient never received treatment.|1|||
161771104|NCT03958045|584204235|FG000|Overall Study|Withdrawal by Subject|1|||
161771105|NCT00674440|584204236|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
161771106|NCT00674440|584204236|FG000|Overall Study|did not have surgery, so unevaluable|7|||
161771107|NCT00674440|584204236|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
161771108|NCT04409262|584204248|FG000|Overall Study|Adverse Event|0|||
161771109|NCT04409262|584204249|FG001|Overall Study|Adverse Event|2|||
161771110|NCT04409262|584204248|FG000|Overall Study|Death|55|||
161771111|NCT04409262|584204249|FG001|Overall Study|Death|97|||
161771112|NCT04409262|584204248|FG000|Overall Study|Lost to Follow-up|12|||
161771113|NCT04409262|584204249|FG001|Overall Study|Lost to Follow-up|23|||
161771114|NCT04409262|584204248|FG000|Overall Study|Lack of Staff|0|||
161771115|NCT04409262|584204249|FG001|Overall Study|Lack of Staff|1|||
161771116|NCT04409262|584204248|FG000|Overall Study|Protocol Violation|3|||
161771117|NCT04409262|584204249|FG001|Overall Study|Protocol Violation|1|||
161771118|NCT04409262|584204248|FG000|Overall Study|Withdrawal by Subject|5|||
161771119|NCT04409262|584204249|FG001|Overall Study|Withdrawal by Subject|10|||
161771120|NCT04794491|584204253|FG000|Overall Study|Adverse Event|1|||
161771121|NCT04794491|584204253|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
161771122|NCT04794491|584204253|FG000|Overall Study|Noncompliance With Study Intervention|1|||
161771123|NCT04794491|584204253|FG000|Overall Study|Withdrawal by Subject|2|||
161771124|NCT01326481|584204254|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
161771125|NCT00948896|584204255|FG000|Randomization to 24 Months of Age|Death|1|||
161771126|NCT00948896|584204256|FG001|Randomization to 24 Months of Age|Death|0|||
161771127|NCT00948896|584204257|FG002|Randomization to 24 Months of Age|Death|0|||
161771128|NCT00948896|584204258|FG003|Randomization to 24 Months of Age|Death|0|||
161771129|NCT00948896|584204259|FG004|Randomization to 24 Months of Age|Death|2|||
161771130|NCT00948896|584204260|FG005|Randomization to 24 Months of Age|Death|1|||
161771131|NCT00948896|584204261|FG006|Randomization to 24 Months of Age|Death|2|||
161771132|NCT00948896|584204262|FG007|Randomization to 24 Months of Age|Death|1|||
161771133|NCT00948896|584204255|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
161771134|NCT00948896|584204256|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
161771135|NCT00948896|584204257|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
161771136|NCT00948896|584204258|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
161771137|NCT00948896|584204259|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
161771138|NCT00948896|584204260|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
161771139|NCT00948896|584204261|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
161771140|NCT00948896|584204262|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
161975979|NCT01628367|584960219|FG000|Overall Study|Adverse Event|1|||
161860057|NCT02439216|584529629|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860058|NCT02439216|584529630|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
161860059|NCT02439216|584529631|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161860060|NCT02439216|584529623|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860061|NCT02439216|584529624|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860062|NCT02439216|584529625|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860063|NCT02439216|584529626|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860064|NCT02439216|584529627|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860065|NCT02439216|584529628|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860066|NCT02439216|584529629|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161860067|NCT02439216|584529630|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
161860068|NCT02439216|584529631|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
161860069|NCT02439216|584529623|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860070|NCT02439216|584529624|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860071|NCT02439216|584529625|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860072|NCT02439216|584529626|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860073|NCT02439216|584529627|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860074|NCT02439216|584529628|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860075|NCT02439216|584529629|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860076|NCT02439216|584529630|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161860077|NCT02439216|584529631|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
161860078|NCT02439216|584529623|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860079|NCT02439216|584529624|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860080|NCT02439216|584529625|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860081|NCT02439216|584529626|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860082|NCT02439216|584529627|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860083|NCT02439216|584529628|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860084|NCT02439216|584529629|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161860085|NCT02439216|584529630|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
161860086|NCT02439216|584529631|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
161860087|NCT00470535|584529639|FG000|Overall Study|Disease Progression|13|||
161860088|NCT00470535|584529639|FG000|Overall Study|Withdrawal by Subject|1|||
161860089|NCT00470535|584529639|FG000|Overall Study|Adverse Event|1|||
161860090|NCT00470535|584529639|FG000|Overall Study|Death|1|||
161860091|NCT00470535|584529639|FG000|Overall Study|Other|2|||
161860092|NCT02094300|584529640|FG000|Overall Study|Death|7|||
161860093|NCT02094300|584529640|FG000|Overall Study|Lost to Follow-up|10|||
161860094|NCT02094300|584529640|FG000|Overall Study|Still be eligible for follow-up|3|||
161860095|NCT00725491|584529643|FG000|Overall Study|Adverse Event|3|||
161860096|NCT00725491|584529644|FG001|Overall Study|Adverse Event|2|||
161860097|NCT00725491|584529643|FG000|Overall Study|Pregnancy|0|||
161860098|NCT00725491|584529644|FG001|Overall Study|Pregnancy|3|||
161860099|NCT00725491|584529643|FG000|Overall Study|Risk for hyperstimulation|2|||
161860100|NCT00725491|584529644|FG001|Overall Study|Risk for hyperstimulation|9|||
161860101|NCT00725491|584529643|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
161860102|NCT00725491|584529644|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
161860103|NCT00725491|584529643|FG000|Overall Study|Fertilization failure|0|||
161860104|NCT00725491|584529644|FG001|Overall Study|Fertilization failure|1|||
161860105|NCT00725491|584529643|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
161860106|NCT00725491|584529644|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
161860107|NCT01641640|584529647|FG000|Overall Study|Enrolled but not treated|1|||
161975980|NCT01628367|584960220|FG001|Overall Study|Adverse Event|0|||
161975981|NCT04070326|584960227|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
161975982|NCT04070326|584960228|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
161975983|NCT00645528|584960229|FG000|Overall Study|Did not show up for Visit 2|7|||
161975984|NCT01886690|584960233|FG000|Overall Study|Protocol Violation|0|||
161975985|NCT01886690|584960234|FG001|Overall Study|Protocol Violation|1|||
161975986|NCT01886690|584960233|FG000|Overall Study|Personal Reasons|0|||
161975987|NCT01886690|584960234|FG001|Overall Study|Personal Reasons|1|||
161975988|NCT03077698|584960235|FG000|Progestin Monotherapy|Stable Disease|8|||
161975989|NCT03077698|584960236|FG001|Progestin Monotherapy|Stable Disease|0|||
161975990|NCT03077698|584960235|FG000|Progestin Monotherapy|Adverse Event|1|||
161975991|NCT03077698|584960236|FG001|Progestin Monotherapy|Adverse Event|0|||
161975992|NCT03077698|584960235|FG000|Progestin Monotherapy|Death|1|||
161975993|NCT03077698|584960236|FG001|Progestin Monotherapy|Death|0|||
161975994|NCT03077698|584960235|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
161975995|NCT03077698|584960236|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
162034499|NCT02793622|585182073|FG001|Overall Study|Withdrawal by Subject|17|||
162034500|NCT02793622|585182072|FG000|Overall Study|Adverse Event|0|||
161860108|NCT01641640|584529647|FG000|Overall Study|Efficacy failure|29|||
161860109|NCT01641640|584529647|FG000|Overall Study|Lost to Follow-up|3|||
161860110|NCT01641640|584529647|FG000|Overall Study|Withdrawal by Subject|2|||
161860111|NCT01641640|584529647|FG000|Overall Study|Adverse Event|1|||
161860112|NCT01778530|584529651|FG000|Overall Study|Progression on study|1|||
161860113|NCT01778530|584529651|FG000|Overall Study|Adverse event/side effect|1|||
161860114|NCT01199939|584529652|FG000|Overall Study|Adverse Event|4|||
161860115|NCT01199939|584529652|FG000|Overall Study|Protocol Violation|3|||
161860116|NCT01199939|584529652|FG000|Overall Study|Lost to Follow-up|2|||
161860117|NCT01199939|584529652|FG000|Overall Study|Reached a virologic endpoint|4|||
161860118|NCT03472014|584529653|FG000|Overall Study|Lost to Follow-up|4|||
161860119|NCT02792517|584529661|FG000|Overall Study|Withdrawal by Subject|10|||
161860120|NCT02792517|584529661|FG000|Overall Study|Decision by Sponsor|7|||
161860121|NCT02792517|584529661|FG000|Overall Study|Lost to Follow-up|3|||
161860122|NCT00882518|584529662|FG000|Overall Study|Adverse Event|9|||
161860123|NCT00882518|584529663|FG001|Overall Study|Adverse Event|18|||
161860124|NCT00882518|584529662|FG000|Overall Study|Withdrawal by Subject|9|||
161860125|NCT00882518|584529663|FG001|Overall Study|Withdrawal by Subject|13|||
161860126|NCT00882518|584529662|FG000|Overall Study|Lack of Efficacy|12|||
161860127|NCT00882518|584529663|FG001|Overall Study|Lack of Efficacy|9|||
161860128|NCT00882518|584529662|FG000|Overall Study|Severe non-compliance to protocol|3|||
161860129|NCT00882518|584529663|FG001|Overall Study|Severe non-compliance to protocol|1|||
161860130|NCT00882518|584529662|FG000|Overall Study|Incorrect enrolment|4|||
161860131|NCT00882518|584529663|FG001|Overall Study|Incorrect enrolment|2|||
161860132|NCT00882518|584529662|FG000|Overall Study|Central lab closure for National day|1|||
161860133|NCT00882518|584529663|FG001|Overall Study|Central lab closure for National day|0|||
161860134|NCT00882518|584529662|FG000|Overall Study|Allocating random number by mistake|0|||
161860135|NCT00882518|584529663|FG001|Overall Study|Allocating random number by mistake|1|||
161860136|NCT03238651|584529664|FG000|Overall Study|Other|0|||
161860137|NCT03238651|584529665|FG001|Overall Study|Other|0|||
161860138|NCT03238651|584529666|FG002|Overall Study|Other|0|||
161860139|NCT03238651|584529667|FG003|Overall Study|Other|0|||
161860140|NCT03238651|584529668|FG004|Overall Study|Other|1|||
161860141|NCT03238651|584529664|FG000|Overall Study|Progressive Disease|2|||
161860142|NCT03238651|584529665|FG001|Overall Study|Progressive Disease|2|||
161860143|NCT03238651|584529666|FG002|Overall Study|Progressive Disease|2|||
161860144|NCT03238651|584529667|FG003|Overall Study|Progressive Disease|2|||
161860145|NCT03238651|584529668|FG004|Overall Study|Progressive Disease|0|||
161860146|NCT03238651|584529664|FG000|Overall Study|Withdrawal by Subject|0|||
161860147|NCT03238651|584529665|FG001|Overall Study|Withdrawal by Subject|1|||
161860148|NCT03238651|584529666|FG002|Overall Study|Withdrawal by Subject|0|||
161860149|NCT03238651|584529667|FG003|Overall Study|Withdrawal by Subject|1|||
161860150|NCT03238651|584529668|FG004|Overall Study|Withdrawal by Subject|0|||
161860151|NCT03238651|584529664|FG000|Overall Study|Adverse Event|1|||
161860152|NCT03238651|584529665|FG001|Overall Study|Adverse Event|3|||
161860153|NCT03238651|584529666|FG002|Overall Study|Adverse Event|2|||
161860154|NCT03238651|584529667|FG003|Overall Study|Adverse Event|0|||
161860155|NCT03238651|584529668|FG004|Overall Study|Adverse Event|0|||
161860156|NCT00711087|584529669|FG000|Overall Study|Lost to Follow-up|1|||
161860157|NCT00711087|584529670|FG001|Overall Study|Lost to Follow-up|0|||
161860158|NCT03535740|584529671|FG000|Overall Study|Death|44|||
161860159|NCT03535740|584529671|FG000|Overall Study|Lost to Follow-up|1|||
161860160|NCT03535740|584529671|FG000|Overall Study|Withdrawal by Subject|13|||
161860161|NCT03535740|584529671|FG000|Overall Study|Site terminated by Sponsor|45|||
161860162|NCT01870778|584529675|FG000|Overall Study|Withdrawal by Subject|8|||
161860163|NCT01870778|584529676|FG001|Overall Study|Withdrawal by Subject|7|||
161860164|NCT01870778|584529675|FG000|Overall Study|Lost to Follow-up|0|||
161860165|NCT01870778|584529676|FG001|Overall Study|Lost to Follow-up|2|||
161860166|NCT01169350|584529683|FG000|Overall Study|Physician Decision|3|||
161860167|NCT01169350|584529683|FG000|Overall Study|Lost to Follow-up|2|||
161860168|NCT04870710|584529685|FG000|Overall Study|Lost to Follow-up|3|||
161860169|NCT01876446|584529686|FG000|Overall Study|Death|0|||
161860170|NCT01876446|584529687|FG001|Overall Study|Death|1|||
161860171|NCT01876446|584529686|FG000|Overall Study|Withdrawal by Subject|1|||
161860172|NCT01876446|584529687|FG001|Overall Study|Withdrawal by Subject|2|||
161860173|NCT01876446|584529686|FG000|Overall Study|Physician Decision|1|||
161860174|NCT01876446|584529687|FG001|Overall Study|Physician Decision|3|||
161860175|NCT02108912|584529688|FG000|Overall Study|Lost to Follow-up|1|||
161860176|NCT02108912|584529689|FG001|Overall Study|Lost to Follow-up|1|||
161860177|NCT02108912|584529688|FG000|Overall Study|lack of transportation|1|||
161860178|NCT02108912|584529689|FG001|Overall Study|lack of transportation|0|||
161860179|NCT02108912|584529688|FG000|Overall Study|high blood pressure|1|||
161860180|NCT02108912|584529689|FG001|Overall Study|high blood pressure|0|||
161860181|NCT01808573|584529690|FG000|Overall Study|Death|212|||
161860182|NCT01808573|584529691|FG001|Overall Study|Death|240|||
161860183|NCT01808573|584529690|FG000|Overall Study|Withdrawal by Subject|12|||
161860184|NCT01808573|584529691|FG001|Overall Study|Withdrawal by Subject|10|||
161860185|NCT01808573|584529690|FG000|Overall Study|Lost to Follow-up|3|||
161860186|NCT01808573|584529691|FG001|Overall Study|Lost to Follow-up|0|||
161860187|NCT01808573|584529690|FG000|Overall Study|Discontinuation of study by sponsor|79|||
161860188|NCT01808573|584529691|FG001|Overall Study|Discontinuation of study by sponsor|64|||
161860189|NCT01808573|584529690|FG000|Overall Study|Randomized in Error|1|||
161860190|NCT01808573|584529691|FG001|Overall Study|Randomized in Error|0|||
161860191|NCT00852202|584529702|FG000|Overall Study|Adverse Event|2|||
161860192|NCT00852202|584529703|FG001|Overall Study|Adverse Event|3|||
161860193|NCT00852202|584529704|FG002|Overall Study|Adverse Event|7|||
161860194|NCT00852202|584529702|FG000|Overall Study|Lack of Efficacy|4|||
161860195|NCT00852202|584529703|FG001|Overall Study|Lack of Efficacy|1|||
161860196|NCT00852202|584529704|FG002|Overall Study|Lack of Efficacy|2|||
161860197|NCT00852202|584529702|FG000|Overall Study|Protocol Violation|2|||
161860198|NCT00852202|584529703|FG001|Overall Study|Protocol Violation|2|||
161860199|NCT00852202|584529704|FG002|Overall Study|Protocol Violation|7|||
161860200|NCT00852202|584529702|FG000|Overall Study|Withdrawal by Subject|3|||
161860201|NCT00852202|584529703|FG001|Overall Study|Withdrawal by Subject|1|||
161860202|NCT00852202|584529704|FG002|Overall Study|Withdrawal by Subject|2|||
161860203|NCT00852202|584529702|FG000|Overall Study|Lost to Follow-up|5|||
161860204|NCT00852202|584529703|FG001|Overall Study|Lost to Follow-up|5|||
161860205|NCT00852202|584529704|FG002|Overall Study|Lost to Follow-up|6|||
161860206|NCT00852202|584529702|FG000|Overall Study|pregnancy,moving away and surgery|1|||
161860207|NCT00852202|584529703|FG001|Overall Study|pregnancy,moving away and surgery|0|||
161860208|NCT00852202|584529704|FG002|Overall Study|pregnancy,moving away and surgery|2|||
161860209|NCT02552121|584529710|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
161860210|NCT02552121|584529711|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860211|NCT02552121|584529712|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860212|NCT02552121|584529713|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860213|NCT02552121|584529714|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860214|NCT02552121|584529715|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860215|NCT02552121|584529716|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860216|NCT02552121|584529717|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161860217|NCT02552121|584529710|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
161860218|NCT02552121|584529711|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860219|NCT02552121|584529712|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860220|NCT02552121|584529713|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860221|NCT02552121|584529714|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860222|NCT02552121|584529715|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860223|NCT02552121|584529716|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860224|NCT02552121|584529717|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161860225|NCT02552121|584529710|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860226|NCT02552121|584529711|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
161860227|NCT02552121|584529712|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860228|NCT02552121|584529713|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860229|NCT02552121|584529714|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860230|NCT02552121|584529715|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860231|NCT02552121|584529716|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860232|NCT02552121|584529717|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161860233|NCT02552121|584529710|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860234|NCT02552121|584529711|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
161860235|NCT02552121|584529712|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860236|NCT02552121|584529713|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860237|NCT02552121|584529714|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860238|NCT02552121|584529715|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860239|NCT02552121|584529716|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161975996|NCT03077698|584960235|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
161975997|NCT03077698|584960236|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
161975998|NCT03077698|584960235|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
161975999|NCT03077698|584960236|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
161976000|NCT03077698|584960235|FG000|Safety Follow Up|Withdrawal by Subject|2|||
161976001|NCT03077698|584960236|FG001|Safety Follow Up|Withdrawal by Subject|1|||
161976002|NCT03077698|584960235|FG000|Safety Follow Up|Transfer of care to hospice|1|||
161976003|NCT03077698|584960236|FG001|Safety Follow Up|Transfer of care to hospice|0|||
161860240|NCT02552121|584529717|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161860241|NCT02552121|584529710|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161860242|NCT02552121|584529711|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
161860243|NCT02552121|584529712|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161860244|NCT02552121|584529713|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161860245|NCT02552121|584529714|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161860246|NCT02552121|584529715|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161860247|NCT02552121|584529716|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161860248|NCT02552121|584529717|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161976004|NCT03461406|584960237|FG000|Overall Study|Death|1|||
161976005|NCT03461406|584960238|FG001|Overall Study|Death|2|||
161976006|NCT03461406|584960237|FG000|Overall Study|Consent Withdrawn by Participant|0|||
161976007|NCT03461406|584960238|FG001|Overall Study|Consent Withdrawn by Participant|1|||
161976008|NCT03461406|584960237|FG000|Overall Study|Screen Failure|3|||
161976009|NCT03461406|584960238|FG001|Overall Study|Screen Failure|1|||
161976010|NCT03461406|584960237|FG000|Overall Study|Reason not Specified|1|||
161976011|NCT03461406|584960238|FG001|Overall Study|Reason not Specified|3|||
161976012|NCT03461406|584960237|FG000|Overall Study|Lost to Follow-up|3|||
161976013|NCT03461406|584960238|FG001|Overall Study|Lost to Follow-up|0|||
161976014|NCT01439074|584960239|FG000|Overall Study|Lost to Follow-up|3|||
161976015|NCT01439074|584960240|FG001|Overall Study|Lost to Follow-up|4|||
161976016|NCT01439074|584960239|FG000|Overall Study|Subject shedding|1|||
161976017|NCT01439074|584960240|FG001|Overall Study|Subject shedding|0|||
161976018|NCT01439074|584960239|FG000|Overall Study|Withdrawal by Subject|1|||
161976019|NCT01439074|584960240|FG001|Overall Study|Withdrawal by Subject|5|||
161976020|NCT01439074|584960239|FG000|Overall Study|Other|4|||
161976021|NCT01439074|584960240|FG001|Overall Study|Other|4|||
161976022|NCT01140568|584960241|FG000|Overall Study|disease progression|31|||
161976023|NCT01140568|584960241|FG000|Overall Study|Withdrawal by Subject|1|||
161976024|NCT01140568|584960241|FG000|Overall Study|Screen Fail|4|||
161976025|NCT03618628|584960242|FG000|Overall Study|Death|1|||
161976026|NCT03618628|584960242|FG000|Overall Study|Lost to Follow-up|1|||
161976027|NCT01969500|584960243|FG000|Overall Study|Death|0|||
161976028|NCT01969500|584960244|FG001|Overall Study|Death|1|||
161976029|NCT01969500|584960243|FG000|Overall Study|extended hospitalization|1|||
161976030|NCT01969500|584960244|FG001|Overall Study|extended hospitalization|1|||
161976031|NCT02193087|584960245|FG000|Overall Study|Adverse Event|2|||
161976032|NCT02193087|584960246|FG001|Overall Study|Adverse Event|0|||
161976033|NCT02193087|584960247|FG002|Overall Study|Adverse Event|0|||
161976034|NCT02193087|584960248|FG003|Overall Study|Adverse Event|11|||
161976035|NCT02193087|584960245|FG000|Overall Study|Lost to Follow-up|14|||
161976036|NCT02193087|584960246|FG001|Overall Study|Lost to Follow-up|6|||
161976037|NCT02193087|584960247|FG002|Overall Study|Lost to Follow-up|4|||
161976038|NCT02193087|584960248|FG003|Overall Study|Lost to Follow-up|37|||
161976039|NCT02193087|584960245|FG000|Overall Study|Protocol Violation|2|||
161976040|NCT02193087|584960246|FG001|Overall Study|Protocol Violation|0|||
161976041|NCT02193087|584960247|FG002|Overall Study|Protocol Violation|1|||
161976042|NCT02193087|584960248|FG003|Overall Study|Protocol Violation|2|||
161976043|NCT02193087|584960245|FG000|Overall Study|Withdrawal by Subject|10|||
161976044|NCT02193087|584960246|FG001|Overall Study|Withdrawal by Subject|3|||
161976045|NCT02193087|584960247|FG002|Overall Study|Withdrawal by Subject|1|||
161976046|NCT02193087|584960248|FG003|Overall Study|Withdrawal by Subject|19|||
161976047|NCT02193087|584960245|FG000|Overall Study|Other Reason Not Specified|7|||
161976048|NCT02193087|584960246|FG001|Overall Study|Other Reason Not Specified|2|||
161976049|NCT02193087|584960247|FG002|Overall Study|Other Reason Not Specified|1|||
161976050|NCT02193087|584960248|FG003|Overall Study|Other Reason Not Specified|9|||
161976051|NCT02193087|584960245|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
161976052|NCT02193087|584960246|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
161976053|NCT02193087|584960247|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
161976054|NCT02193087|584960248|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
161976055|NCT04096820|584960249|FG000|Overall Study|Did not return for intervention|2|||
161976056|NCT04096820|584960249|FG000|Overall Study|Death|1|||
161976057|NCT02463032|584960250|FG000|Overall Study|Lack of Efficacy|61|||
161976058|NCT02463032|584960251|FG001|Overall Study|Lack of Efficacy|50|||
161976059|NCT02463032|584960250|FG000|Overall Study|Death|8|||
161976060|NCT02463032|584960251|FG001|Overall Study|Death|8|||
161976061|NCT02463032|584960250|FG000|Overall Study|Adverse Event|2|||
161976062|NCT02463032|584960251|FG001|Overall Study|Adverse Event|6|||
161976063|NCT00612508|584960252|FG000|Overall Study|Withdrawal by Subject|3|||
161976064|NCT00612508|584960253|FG001|Overall Study|Withdrawal by Subject|4|||
161976065|NCT01636713|584960255|FG000|Overall Study|Adverse Event|16|||
161976066|NCT01636713|584960256|FG001|Overall Study|Adverse Event|16|||
162034501|NCT02793622|585182073|FG001|Overall Study|Adverse Event|1|||
162034502|NCT02793622|585182072|FG000|Overall Study|Protocol Violation|1|||
161771141|NCT00948896|584204255|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
161976067|NCT01636713|584960257|FG002|Overall Study|Adverse Event|7|||
161976068|NCT01636713|584960255|FG000|Overall Study|Lack of Efficacy|6|||
161976069|NCT01636713|584960256|FG001|Overall Study|Lack of Efficacy|6|||
161976070|NCT01636713|584960257|FG002|Overall Study|Lack of Efficacy|2|||
161976071|NCT01636713|584960255|FG000|Overall Study|Protocol Violation|3|||
161976072|NCT01636713|584960256|FG001|Overall Study|Protocol Violation|0|||
161976073|NCT01636713|584960257|FG002|Overall Study|Protocol Violation|1|||
161976074|NCT01636713|584960255|FG000|Overall Study|Lost to Follow-up|0|||
161976075|NCT01636713|584960256|FG001|Overall Study|Lost to Follow-up|0|||
161976076|NCT01636713|584960257|FG002|Overall Study|Lost to Follow-up|1|||
161976077|NCT01636713|584960255|FG000|Overall Study|Withdrawal by Subject|5|||
161976078|NCT01636713|584960256|FG001|Overall Study|Withdrawal by Subject|4|||
161976079|NCT01636713|584960257|FG002|Overall Study|Withdrawal by Subject|8|||
161976080|NCT01636713|584960255|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
161976081|NCT01636713|584960256|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
161976082|NCT01636713|584960257|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
161976083|NCT02242981|584960262|FG000|Overall Study|Withdrawal by Subject|1|||
161976084|NCT03474081|584960265|FG000|Overall Study|Adverse Event|6|||
161976085|NCT03474081|584960266|FG001|Overall Study|Adverse Event|3|||
161976086|NCT03474081|584960265|FG000|Overall Study|Lost to Follow-up|2|||
161976087|NCT03474081|584960266|FG001|Overall Study|Lost to Follow-up|1|||
161976088|NCT03474081|584960265|FG000|Overall Study|Physician Decision|3|||
161976089|NCT03474081|584960266|FG001|Overall Study|Physician Decision|2|||
161976090|NCT03474081|584960265|FG000|Overall Study|Withdrawal by Subject|5|||
161976091|NCT03474081|584960266|FG001|Overall Study|Withdrawal by Subject|7|||
161976092|NCT03474081|584960265|FG000|Overall Study|Investigator site closed|1|||
161976093|NCT03474081|584960266|FG001|Overall Study|Investigator site closed|0|||
161976094|NCT01977690|584960267|FG000|Overall Study|Withdrawal by Subject|0|||
161976095|NCT01977690|584960268|FG001|Overall Study|Withdrawal by Subject|4|||
161976096|NCT01711866|584960274|FG000|Overall Study|Noncompliant|3|||
161976097|NCT01711866|584960274|FG000|Overall Study|Withdrawal by Subject|3|||
161976098|NCT01711866|584960274|FG000|Overall Study|Adverse Event|2|||
161976099|NCT00459537|584960275|FG000|Overall Study|Adverse Event|1|||
161976100|NCT00459537|584960276|FG001|Overall Study|Adverse Event|6|||
161976101|NCT00459537|584960275|FG000|Overall Study|Lack of Efficacy|10|||
161976102|NCT00459537|584960276|FG001|Overall Study|Lack of Efficacy|11|||
161976103|NCT00459537|584960275|FG000|Overall Study|Withdrawal by Subject|20|||
161976104|NCT00459537|584960276|FG001|Overall Study|Withdrawal by Subject|26|||
161976105|NCT00459537|584960275|FG000|Overall Study|Lost to Follow-up|27|||
161976106|NCT00459537|584960276|FG001|Overall Study|Lost to Follow-up|30|||
161976107|NCT00459537|584960275|FG000|Overall Study|Administrative problems|3|||
161976108|NCT00459537|584960276|FG001|Overall Study|Administrative problems|0|||
161976109|NCT00459537|584960275|FG000|Overall Study|Protocol Violation|4|||
161976110|NCT00459537|584960276|FG001|Overall Study|Protocol Violation|3|||
161976111|NCT00459537|584960275|FG000|Overall Study|Missing|1|||
161976112|NCT00459537|584960276|FG001|Overall Study|Missing|0|||
161976113|NCT00546260|584960277|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
161976114|NCT00546260|584960278|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
161976115|NCT03780959|584960279|FG000|Part 1|Adverse Event|1|||
161976116|NCT03780959|584960280|FG001|Part 1|Adverse Event|0|||
161976117|NCT03780959|584960281|FG002|Part 1|Adverse Event|0|||
161976118|NCT03780959|584960279|FG000|Part 1|Withdrawal by Subject|1|||
161976119|NCT03780959|584960280|FG001|Part 1|Withdrawal by Subject|0|||
161976120|NCT03780959|584960281|FG002|Part 1|Withdrawal by Subject|0|||
161976121|NCT03780959|584960279|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
161976122|NCT03780959|584960280|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
161976123|NCT03780959|584960281|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
161976124|NCT03780959|584960279|FG000|Part 1|Response Status|2|||
161976125|NCT03780959|584960280|FG001|Part 1|Response Status|0|||
161976126|NCT03780959|584960281|FG002|Part 1|Response Status|0|||
161976127|NCT03780959|584960279|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
161976128|NCT03780959|584960280|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
162034503|NCT02793622|585182073|FG001|Overall Study|Protocol Violation|5|||
162034504|NCT03149848|585182074|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
162034505|NCT03149848|585182074|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
162034506|NCT04738318|585182076|FG000|Overall Study|Protocol Violation|1|||
162034507|NCT04738318|585182077|FG001|Overall Study|Protocol Violation|0|||
162034508|NCT02274038|585182078|FG000|Overall Study|Death|1|||
162034509|NCT00586664|585182083|FG000|Overall Study|Withdrawal by Subject|3|||
162034510|NCT00586664|585182084|FG001|Overall Study|Withdrawal by Subject|7|||
162034511|NCT00586664|585182085|FG002|Overall Study|Withdrawal by Subject|1|||
162034512|NCT00586664|585182083|FG000|Overall Study|Exclusion criteria met|2|||
162034513|NCT00586664|585182084|FG001|Overall Study|Exclusion criteria met|0|||
162034514|NCT00586664|585182085|FG002|Overall Study|Exclusion criteria met|0|||
162034515|NCT01602666|585182086|FG000|Induction Chemotherapy|Death|2|||
162034516|NCT01602666|585182087|FG001|Induction Chemotherapy|Death|1|||
161860249|NCT02552121|584529710|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
162034517|NCT01602666|585182086|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
162034518|NCT01602666|585182087|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
161976129|NCT03780959|584960281|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
161976130|NCT03780959|584960279|FG000|Part 2|Response Status|0|||
161976131|NCT03780959|584960280|FG001|Part 2|Response Status|18|||
161976132|NCT03780959|584960281|FG002|Part 2|Response Status|6|||
161976133|NCT03172130|584961976|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
161976134|NCT03172130|584961977|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
161976135|NCT01825941|584961981|FG000|Overall Study|Lost to Follow-up|4|||
161976136|NCT01825941|584961982|FG001|Overall Study|Lost to Follow-up|1|||
161976137|NCT00358436|584961987|FG000|Overall Study|Adverse Event|29|||
161976138|NCT00358436|584961988|FG001|Overall Study|Adverse Event|13|||
161976139|NCT00358436|584961987|FG000|Overall Study|Lack of Efficacy|34|||
161976140|NCT00358436|584961988|FG001|Overall Study|Lack of Efficacy|36|||
161976141|NCT00358436|584961987|FG000|Overall Study|Lost to Follow-up|11|||
161976142|NCT00358436|584961988|FG001|Overall Study|Lost to Follow-up|6|||
161976143|NCT00358436|584961987|FG000|Overall Study|Protocol Violation|8|||
161976144|NCT00358436|584961988|FG001|Overall Study|Protocol Violation|3|||
161976145|NCT00358436|584961987|FG000|Overall Study|Withdrawal by Subject|40|||
161976146|NCT00358436|584961988|FG001|Overall Study|Withdrawal by Subject|17|||
161976147|NCT00358436|584961987|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
161976148|NCT00358436|584961988|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
161976149|NCT00358436|584961987|FG000|Overall Study|COPD exacerbation|22|||
161976150|NCT00358436|584961988|FG001|Overall Study|COPD exacerbation|10|||
161976151|NCT00358436|584961987|FG000|Overall Study|Other|6|||
161976152|NCT00358436|584961988|FG001|Overall Study|Other|1|||
161976153|NCT05065190|584961990|FG000|Overall Study|Other than listed|2|||
161976154|NCT05065190|584961991|FG001|Overall Study|Other than listed|12|||
161976155|NCT05065190|584961990|FG000|Overall Study|Lack of Efficacy|4|||
161976156|NCT05065190|584961991|FG001|Overall Study|Lack of Efficacy|0|||
161976157|NCT05065190|584961990|FG000|Overall Study|Adverse Event|1|||
161976158|NCT05065190|584961991|FG001|Overall Study|Adverse Event|10|||
161976159|NCT03938324|584961999|FG000|Overall Study|Lost to Follow-up|42|||
161976160|NCT03938324|584962000|FG001|Overall Study|Lost to Follow-up|21|||
161976161|NCT03938324|584961999|FG000|Overall Study|Withdrawal by Subject|6|||
161976162|NCT03938324|584962000|FG001|Overall Study|Withdrawal by Subject|1|||
161976163|NCT02769962|584962001|FG000|Overall Study|Physician Decision|0|||
161976164|NCT02769962|584962002|FG001|Overall Study|Physician Decision|0|||
161976165|NCT02769962|584962003|FG002|Overall Study|Physician Decision|0|||
161976166|NCT02769962|584962004|FG003|Overall Study|Physician Decision|0|||
161976167|NCT02769962|584962005|FG004|Overall Study|Physician Decision|0|||
161976168|NCT02769962|584962006|FG005|Overall Study|Physician Decision|1|||
161976169|NCT02769962|584962007|FG006|Overall Study|Physician Decision|0|||
161976170|NCT02769962|584962008|FG007|Overall Study|Physician Decision|1|||
161976171|NCT02769962|584962001|FG000|Overall Study|Refused further treatment|0|||
161976172|NCT02769962|584962002|FG001|Overall Study|Refused further treatment|0|||
161976173|NCT02769962|584962003|FG002|Overall Study|Refused further treatment|0|||
161976174|NCT02769962|584962004|FG003|Overall Study|Refused further treatment|0|||
161976175|NCT02769962|584962005|FG004|Overall Study|Refused further treatment|0|||
161976176|NCT02769962|584962006|FG005|Overall Study|Refused further treatment|1|||
161976177|NCT02769962|584962007|FG006|Overall Study|Refused further treatment|1|||
161976178|NCT02769962|584962008|FG007|Overall Study|Refused further treatment|0|||
161976179|NCT05565937|584962009|FG000|Overall Study|Adverse Event|0|||
161976180|NCT05565937|584962010|FG001|Overall Study|Adverse Event|1|||
161976181|NCT05565937|584962009|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
161976182|NCT05565937|584962010|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
161976183|NCT05565937|584962009|FG000|Overall Study|Lost to Follow-up|2|||
161976184|NCT05565937|584962010|FG001|Overall Study|Lost to Follow-up|0|||
161976185|NCT05565937|584962009|FG000|Overall Study|Pregnancy|0|||
161976186|NCT05565937|584962010|FG001|Overall Study|Pregnancy|2|||
161976187|NCT05565937|584962009|FG000|Overall Study|Anisometropia|0|||
161976188|NCT05565937|584962010|FG001|Overall Study|Anisometropia|1|||
161860250|NCT02552121|584529711|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
161860251|NCT02552121|584529712|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860252|NCT02552121|584529713|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860253|NCT02552121|584529714|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860254|NCT02552121|584529715|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860255|NCT02552121|584529716|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860256|NCT02552121|584529717|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161860257|NCT02552121|584529710|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
161860258|NCT02552121|584529711|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
161976189|NCT04544683|584962011|FG000|Overall Study|Lost to Follow-up|2|||
161976190|NCT04544683|584962011|FG000|Overall Study|Underwent cervical spine surgery|6|||
161976191|NCT00151372|584962012|FG000|Overall Study|Death|12|||
161860259|NCT02552121|584529712|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
161860260|NCT02552121|584529713|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
161860261|NCT02552121|584529714|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
161860262|NCT02552121|584529715|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
161860263|NCT02552121|584529716|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
161976192|NCT00151372|584962013|FG001|Overall Study|Death|11|||
161976193|NCT00151372|584962012|FG000|Overall Study|Lost to Follow-up|5|||
161976194|NCT00151372|584962013|FG001|Overall Study|Lost to Follow-up|5|||
161976195|NCT00151372|584962012|FG000|Overall Study|Too sick medically to continue|5|||
161976196|NCT00151372|584962013|FG001|Overall Study|Too sick medically to continue|6|||
161976197|NCT00151372|584962012|FG000|Overall Study|Withdrawal by Subject|7|||
161976198|NCT00151372|584962013|FG001|Overall Study|Withdrawal by Subject|7|||
161976199|NCT04732949|584962014|FG000|Overall Study|Withdrawal by Subject|23|||
161976200|NCT04732949|584962015|FG001|Overall Study|Withdrawal by Subject|27|||
161976201|NCT04732949|584962014|FG000|Overall Study|Protocol Violation|0|||
161976202|NCT04732949|584962015|FG001|Overall Study|Protocol Violation|1|||
161976203|NCT04732949|584962014|FG000|Overall Study|Non-compliance|0|||
161976204|NCT04732949|584962015|FG001|Overall Study|Non-compliance|2|||
161976205|NCT04732949|584962014|FG000|Overall Study|Physician Decision|2|||
161976206|NCT04732949|584962015|FG001|Overall Study|Physician Decision|1|||
161976207|NCT04732949|584962014|FG000|Overall Study|Serious adverse event (Fatal)|16|||
161976208|NCT04732949|584962015|FG001|Overall Study|Serious adverse event (Fatal)|18|||
161976209|NCT04732949|584962014|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
161976210|NCT04732949|584962015|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
161976211|NCT04732949|584962014|FG000|Overall Study|Non-serious adverse event|1|||
161976212|NCT04732949|584962015|FG001|Overall Study|Non-serious adverse event|3|||
161976213|NCT04732949|584962014|FG000|Overall Study|Lost to Follow-up|26|||
161976214|NCT04732949|584962015|FG001|Overall Study|Lost to Follow-up|27|||
161976215|NCT04732949|584962014|FG000|Overall Study|Other|6|||
161976216|NCT04732949|584962015|FG001|Overall Study|Other|3|||
161976217|NCT01023672|584962016|FG000|Overall Study|Worsening disease|2|||
161976218|NCT01023672|584962016|FG000|Overall Study|Death|1|||
161976219|NCT01286077|584962017|FG000|Overall Study|Adverse Event|2|||
161976220|NCT01286077|584962018|FG001|Overall Study|Adverse Event|0|||
161976221|NCT01286077|584962017|FG000|Overall Study|Death|1|||
161976222|NCT01286077|584962018|FG001|Overall Study|Death|0|||
161976223|NCT01286077|584962017|FG000|Overall Study|Protocol Violation|1|||
161976224|NCT01286077|584962018|FG001|Overall Study|Protocol Violation|1|||
161976225|NCT01286077|584962017|FG000|Overall Study|Withdrawal by Subject|0|||
161976226|NCT01286077|584962018|FG001|Overall Study|Withdrawal by Subject|2|||
161976227|NCT01286077|584962017|FG000|Overall Study|Intercurrent illness|1|||
161976228|NCT01286077|584962018|FG001|Overall Study|Intercurrent illness|0|||
161976229|NCT01286077|584962017|FG000|Overall Study|Non-compliance|1|||
161976230|NCT01286077|584962018|FG001|Overall Study|Non-compliance|0|||
161976231|NCT01286077|584962017|FG000|Overall Study|The subject starts with alternative MMY|0|||
161976232|NCT01286077|584962018|FG001|Overall Study|The subject starts with alternative MMY|3|||
161976233|NCT01286077|584962017|FG000|Overall Study|Patient's decision to stop treatment|3|||
161976234|NCT01286077|584962018|FG001|Overall Study|Patient's decision to stop treatment|0|||
161976235|NCT01286077|584962017|FG000|Overall Study|Progression of disease|0|||
161976236|NCT01286077|584962018|FG001|Overall Study|Progression of disease|1|||
161976237|NCT01286077|584962017|FG000|Overall Study|refill medication not received in time|1|||
161976238|NCT01286077|584962018|FG001|Overall Study|refill medication not received in time|0|||
161976239|NCT01282294|584962019|FG000|Overall Study|Lost to Follow-up|14|||
161976240|NCT01282294|584962019|FG000|Overall Study|Screening failure|1|||
161976241|NCT01282294|584962019|FG000|Overall Study|Adverse Event|1|||
161976242|NCT01282294|584962019|FG000|Overall Study|Patient non-compliance|2|||
161976243|NCT01282294|584962019|FG000|Overall Study|Physician Decision|1|||
161976244|NCT02408523|584962020|FG000|Overall Study|Adverse Event|4|||
161976245|NCT02408523|584962021|FG001|Overall Study|Adverse Event|10|||
161976246|NCT02408523|584962020|FG000|Overall Study|Lack of Efficacy|0|||
161976247|NCT02408523|584962021|FG001|Overall Study|Lack of Efficacy|1|||
161976248|NCT02408523|584962020|FG000|Overall Study|Protocol Violation|1|||
161976249|NCT02408523|584962021|FG001|Overall Study|Protocol Violation|2|||
161976250|NCT02408523|584962020|FG000|Overall Study|Lost to Follow-up|2|||
161976251|NCT02408523|584962021|FG001|Overall Study|Lost to Follow-up|3|||
161976252|NCT02408523|584962020|FG000|Overall Study|Withdrawal by Subject|3|||
161976253|NCT02408523|584962021|FG001|Overall Study|Withdrawal by Subject|1|||
161976254|NCT02408523|584962020|FG000|Overall Study|Sponsor request|1|||
161976255|NCT02408523|584962021|FG001|Overall Study|Sponsor request|0|||
161976256|NCT02408523|584962020|FG000|Overall Study|Did not satisfy extension conditions|0|||
161976257|NCT02408523|584962021|FG001|Overall Study|Did not satisfy extension conditions|1|||
161976258|NCT00996801|584962025|FG000|Overall Study|Adverse Event|6|||
161976259|NCT00996801|584962026|FG001|Overall Study|Adverse Event|4|||
161976260|NCT00996801|584962027|FG002|Overall Study|Adverse Event|12|||
161976261|NCT00996801|584962028|FG003|Overall Study|Adverse Event|17|||
161976262|NCT00996801|584962029|FG004|Overall Study|Adverse Event|31|||
161976263|NCT00996801|584962030|FG005|Overall Study|Adverse Event|3|||
161976264|NCT00996801|584962025|FG000|Overall Study|Lack of Efficacy|3|||
161860264|NCT02552121|584529717|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
161860265|NCT02552121|584529710|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
161976265|NCT00996801|584962026|FG001|Overall Study|Lack of Efficacy|0|||
161976266|NCT00996801|584962027|FG002|Overall Study|Lack of Efficacy|1|||
161976267|NCT00996801|584962028|FG003|Overall Study|Lack of Efficacy|3|||
161976268|NCT00996801|584962029|FG004|Overall Study|Lack of Efficacy|0|||
161976269|NCT00996801|584962030|FG005|Overall Study|Lack of Efficacy|1|||
161976270|NCT00996801|584962025|FG000|Overall Study|Lost to Follow-up|0|||
161976271|NCT00996801|584962026|FG001|Overall Study|Lost to Follow-up|0|||
161976272|NCT00996801|584962027|FG002|Overall Study|Lost to Follow-up|0|||
161976273|NCT00996801|584962028|FG003|Overall Study|Lost to Follow-up|3|||
161976274|NCT00996801|584962029|FG004|Overall Study|Lost to Follow-up|3|||
161976275|NCT00996801|584962030|FG005|Overall Study|Lost to Follow-up|2|||
161976276|NCT00996801|584962025|FG000|Overall Study|Physician Decision|0|||
161976277|NCT00996801|584962026|FG001|Overall Study|Physician Decision|0|||
161976278|NCT00996801|584962027|FG002|Overall Study|Physician Decision|0|||
161976279|NCT00996801|584962028|FG003|Overall Study|Physician Decision|1|||
161860266|NCT02552121|584529711|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
161860267|NCT02552121|584529712|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
161860268|NCT02552121|584529713|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
161860269|NCT02552121|584529714|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
161860270|NCT02552121|584529715|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
161860271|NCT02552121|584529716|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
161860272|NCT02552121|584529717|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
161860273|NCT02552121|584529710|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
161860274|NCT02552121|584529711|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
161860275|NCT02552121|584529712|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
161860276|NCT02552121|584529713|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
161860277|NCT02552121|584529714|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
161860278|NCT02552121|584529715|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
161860279|NCT02552121|584529716|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
161860280|NCT02552121|584529717|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
161860281|NCT02552121|584529710|FG000|Part 2: Cohort Expansion|Death|0|||
161860282|NCT02552121|584529711|FG001|Part 2: Cohort Expansion|Death|0|||
161860283|NCT02552121|584529712|FG002|Part 2: Cohort Expansion|Death|1|||
161860284|NCT02552121|584529713|FG003|Part 2: Cohort Expansion|Death|0|||
161860285|NCT02552121|584529714|FG004|Part 2: Cohort Expansion|Death|0|||
161860286|NCT02552121|584529715|FG005|Part 2: Cohort Expansion|Death|0|||
161860287|NCT02552121|584529716|FG006|Part 2: Cohort Expansion|Death|0|||
161860288|NCT02552121|584529717|FG007|Part 2: Cohort Expansion|Death|0|||
161860289|NCT03629184|584529718|FG000|Overall Study|Withdrawal by Subject|2|||
161860290|NCT03629184|584529719|FG001|Overall Study|Withdrawal by Subject|1|||
161860291|NCT03629184|584529718|FG000|Overall Study|Physician Decision|1|||
161860292|NCT03629184|584529719|FG001|Overall Study|Physician Decision|0|||
161860293|NCT01461538|584529720|FG000|Overall Study|Death|15|||
161860294|NCT01461538|584529721|FG001|Overall Study|Death|6|||
161860295|NCT01461538|584529722|FG002|Overall Study|Death|2|||
161860296|NCT01461538|584529720|FG000|Overall Study|Study Stopped by Sponsor|2|||
161860297|NCT01461538|584529721|FG001|Overall Study|Study Stopped by Sponsor|1|||
161860298|NCT01461538|584529722|FG002|Overall Study|Study Stopped by Sponsor|0|||
161860299|NCT01461538|584529720|FG000|Overall Study|Withdrawal by Subject|1|||
161860300|NCT01461538|584529721|FG001|Overall Study|Withdrawal by Subject|1|||
161860301|NCT01461538|584529722|FG002|Overall Study|Withdrawal by Subject|0|||
161860302|NCT00141778|584529724|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
161860303|NCT00141778|584529725|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
161860304|NCT00141778|584529726|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
161860305|NCT00141778|584529724|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
161860306|NCT00141778|584529725|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
161860307|NCT00141778|584529726|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
161860308|NCT00141778|584529724|FG000|Started Study Medication|Withdrawal by Subject|0|||
161860309|NCT00141778|584529725|FG001|Started Study Medication|Withdrawal by Subject|2|||
161860310|NCT00141778|584529726|FG002|Started Study Medication|Withdrawal by Subject|0|||
161860311|NCT00141778|584529724|FG000|Started Study Medication|Difficulty Swallowing|0|||
161860312|NCT00141778|584529725|FG001|Started Study Medication|Difficulty Swallowing|1|||
161860313|NCT00141778|584529726|FG002|Started Study Medication|Difficulty Swallowing|0|||
161860314|NCT00141778|584529724|FG000|Started Study Medication|Chest Discomfort|0|||
161860315|NCT00141778|584529725|FG001|Started Study Medication|Chest Discomfort|0|||
161860316|NCT00141778|584529726|FG002|Started Study Medication|Chest Discomfort|1|||
161860317|NCT04211831|584529727|FG000|Overall Study|Withdrawal by Subject|4|||
161860318|NCT04211831|584529728|FG001|Overall Study|Withdrawal by Subject|1|||
161860319|NCT04211831|584529729|FG002|Overall Study|Withdrawal by Subject|1|||
161860320|NCT04211831|584529727|FG000|Overall Study|Protocol Violation|0|||
161860321|NCT04211831|584529728|FG001|Overall Study|Protocol Violation|0|||
161860322|NCT04211831|584529729|FG002|Overall Study|Protocol Violation|1|||
161860323|NCT04211831|584529727|FG000|Overall Study|Adverse Event|0|||
161860324|NCT04211831|584529728|FG001|Overall Study|Adverse Event|1|||
161860325|NCT04211831|584529729|FG002|Overall Study|Adverse Event|0|||
161860326|NCT04211831|584529727|FG000|Overall Study|Lack of Efficacy|0|||
161860327|NCT04211831|584529728|FG001|Overall Study|Lack of Efficacy|0|||
161860328|NCT04211831|584529729|FG002|Overall Study|Lack of Efficacy|1|||
161860329|NCT04211831|584529727|FG000|Overall Study|Lost to Follow-up|0|||
161860330|NCT04211831|584529728|FG001|Overall Study|Lost to Follow-up|0|||
161860331|NCT04211831|584529729|FG002|Overall Study|Lost to Follow-up|2|||
161860332|NCT04211831|584529727|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
161860333|NCT04211831|584529728|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
161860334|NCT04211831|584529729|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
161860335|NCT04211831|584529727|FG000|Overall Study|Other|0|||
161860336|NCT04211831|584529728|FG001|Overall Study|Other|1|||
161860337|NCT04211831|584529729|FG002|Overall Study|Other|0|||
161860338|NCT04796961|584531098|FG000|Overall Study|Lost to Follow-up|10|||
161860339|NCT04796961|584531098|FG000|Overall Study|Withdrawal by Subject|3|||
161860340|NCT04796961|584531098|FG000|Overall Study|Left Organization|10|||
161976280|NCT00996801|584962029|FG004|Overall Study|Physician Decision|0|||
161976281|NCT00996801|584962030|FG005|Overall Study|Physician Decision|0|||
161976282|NCT00996801|584962025|FG000|Overall Study|Progressive Disease|0|||
161976283|NCT00996801|584962026|FG001|Overall Study|Progressive Disease|1|||
161976284|NCT00996801|584962027|FG002|Overall Study|Progressive Disease|0|||
161976285|NCT00996801|584962028|FG003|Overall Study|Progressive Disease|0|||
161976286|NCT00996801|584962029|FG004|Overall Study|Progressive Disease|0|||
161976287|NCT00996801|584962030|FG005|Overall Study|Progressive Disease|0|||
161976288|NCT00996801|584962025|FG000|Overall Study|Protocol Violation|3|||
161976289|NCT00996801|584962026|FG001|Overall Study|Protocol Violation|4|||
161976290|NCT00996801|584962027|FG002|Overall Study|Protocol Violation|1|||
161976291|NCT00996801|584962028|FG003|Overall Study|Protocol Violation|2|||
161976292|NCT00996801|584962029|FG004|Overall Study|Protocol Violation|3|||
161976293|NCT00996801|584962030|FG005|Overall Study|Protocol Violation|4|||
161976294|NCT00996801|584962025|FG000|Overall Study|Study Terminated by Sponsor|0|||
161976295|NCT00996801|584962026|FG001|Overall Study|Study Terminated by Sponsor|1|||
161976296|NCT00996801|584962027|FG002|Overall Study|Study Terminated by Sponsor|0|||
161976297|NCT00996801|584962028|FG003|Overall Study|Study Terminated by Sponsor|0|||
161976298|NCT00996801|584962029|FG004|Overall Study|Study Terminated by Sponsor|46|||
161976299|NCT00996801|584962030|FG005|Overall Study|Study Terminated by Sponsor|0|||
161976300|NCT00996801|584962025|FG000|Overall Study|Withdrawal by Subject|8|||
161976301|NCT00996801|584962026|FG001|Overall Study|Withdrawal by Subject|6|||
161976302|NCT00996801|584962027|FG002|Overall Study|Withdrawal by Subject|9|||
161976303|NCT00996801|584962028|FG003|Overall Study|Withdrawal by Subject|5|||
161976304|NCT00996801|584962029|FG004|Overall Study|Withdrawal by Subject|5|||
161976305|NCT00996801|584962030|FG005|Overall Study|Withdrawal by Subject|9|||
161976306|NCT00289198|584962031|FG000|Overall Study|Adverse Event|0|||
161976307|NCT00289198|584962032|FG001|Overall Study|Adverse Event|2|||
161976308|NCT00289198|584962031|FG000|Overall Study|Protocol Violation|2|||
161976309|NCT00289198|584962032|FG001|Overall Study|Protocol Violation|1|||
161976310|NCT00289198|584962031|FG000|Overall Study|Withdrawal by Subject|4|||
161976311|NCT00289198|584962032|FG001|Overall Study|Withdrawal by Subject|1|||
161976312|NCT00289198|584962031|FG000|Overall Study|Lack of Efficacy|2|||
161976313|NCT00289198|584962032|FG001|Overall Study|Lack of Efficacy|0|||
161976314|NCT00289198|584962031|FG000|Overall Study|Other: Low compliance|0|||
161976315|NCT00289198|584962032|FG001|Overall Study|Other: Low compliance|1|||
161976316|NCT00289198|584962031|FG000|Overall Study|Other: Physician's decision|0|||
161976317|NCT00289198|584962032|FG001|Overall Study|Other: Physician's decision|1|||
161976318|NCT00289198|584962031|FG000|Overall Study|Other: Unable to attend on schedule|2|||
161976319|NCT00289198|584962032|FG001|Overall Study|Other: Unable to attend on schedule|1|||
161976320|NCT00289198|584962031|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
161976321|NCT00289198|584962032|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
161976322|NCT00289198|584962031|FG000|Overall Study|Other: Impossible to come on visit|0|||
161976323|NCT00289198|584962032|FG001|Overall Study|Other: Impossible to come on visit|1|||
161976324|NCT02559414|584962040|FG000|Overall Study|Lost to Follow-up|0|||
161771142|NCT00948896|584204256|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
161976325|NCT02559414|584962041|FG001|Overall Study|Lost to Follow-up|1|||
161976326|NCT02559414|584962042|FG002|Overall Study|Lost to Follow-up|0|||
161976327|NCT02559414|584962040|FG000|Overall Study|Withdrawal by Subject|1|||
161976328|NCT02559414|584962041|FG001|Overall Study|Withdrawal by Subject|0|||
161976329|NCT02559414|584962042|FG002|Overall Study|Withdrawal by Subject|1|||
161976330|NCT02559414|584962040|FG000|Overall Study|Other|0|||
161976331|NCT02559414|584962041|FG001|Overall Study|Other|1|||
161976332|NCT02559414|584962042|FG002|Overall Study|Other|1|||
161976333|NCT03369431|584962043|FG000|Overall Study|Lost to Follow-up|1|||
161976334|NCT03369431|584962044|FG001|Overall Study|Lost to Follow-up|3|||
161976335|NCT03369431|584962043|FG000|Overall Study|Withdrawal by Subject|2|||
161976336|NCT03369431|584962044|FG001|Overall Study|Withdrawal by Subject|3|||
161976337|NCT03369431|584962043|FG000|Overall Study|Protocol Violation|1|||
161976338|NCT03369431|584962044|FG001|Overall Study|Protocol Violation|1|||
161976339|NCT01062061|584962045|FG000|Overall Study|Enrolled more than once|2|||
161976340|NCT01062061|584962045|FG000|Overall Study|Investigated before study start|13|||
161976341|NCT01062061|584962045|FG000|Overall Study|Outside chief indications|10|||
161771143|NCT00948896|584204257|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
161771144|NCT00948896|584204258|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
161771145|NCT00948896|584204259|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
161771146|NCT00948896|584204260|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
161771147|NCT00948896|584204261|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
161771148|NCT00948896|584204262|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
161771149|NCT00948896|584204255|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
161771150|NCT00948896|584204256|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
161976342|NCT01062061|584962045|FG000|Overall Study|Failed to meet inclusion criteria|2|||
161976343|NCT01266317|584962046|FG000|Overall Study|Withdrawal by Subject|2|||
161976344|NCT02753127|584962049|FG000|Overall Study|Lost to Follow-up|13|||
161976345|NCT02753127|584962050|FG001|Overall Study|Lost to Follow-up|11|||
161860341|NCT01557504|584531103|FG000|Overall Study|Physician Decision|1|||
161860342|NCT01557504|584531104|FG001|Overall Study|Physician Decision|0|||
161860343|NCT01321749|584531110|FG000|Overall Study|Lost to Follow-up|4|||
161860344|NCT01321749|584531111|FG001|Overall Study|Lost to Follow-up|11|||
161860345|NCT01321749|584531110|FG000|Overall Study|Protocol Violation|4|||
161860346|NCT01321749|584531111|FG001|Overall Study|Protocol Violation|7|||
161860347|NCT01321749|584531110|FG000|Overall Study|Withdrawal by Subject|5|||
161860348|NCT01321749|584531111|FG001|Overall Study|Withdrawal by Subject|4|||
161860349|NCT01173523|584531115|FG000|Overall Study|Clinical Progression|1|||
161860350|NCT01173523|584531116|FG001|Overall Study|Clinical Progression|1|||
161860351|NCT01173523|584531115|FG000|Overall Study|Progressive Disease|10|||
161860352|NCT01173523|584531116|FG001|Overall Study|Progressive Disease|8|||
161860353|NCT01173523|584531115|FG000|Overall Study|Other|2|||
161860354|NCT01173523|584531116|FG001|Overall Study|Other|3|||
161860355|NCT00853099|584531117|FG000|Double-blind Period|Adverse Event|7|||
161860356|NCT00853099|584531118|FG001|Double-blind Period|Adverse Event|9|||
161860357|NCT00853099|584531119|FG002|Double-blind Period|Adverse Event|13|||
161860358|NCT00853099|584531120|FG003|Double-blind Period|Adverse Event|0|||
161860359|NCT00853099|584531117|FG000|Double-blind Period|Withdrawal by Subject|2|||
161860360|NCT00853099|584531118|FG001|Double-blind Period|Withdrawal by Subject|3|||
161860361|NCT00853099|584531119|FG002|Double-blind Period|Withdrawal by Subject|0|||
161860362|NCT00853099|584531120|FG003|Double-blind Period|Withdrawal by Subject|0|||
161860363|NCT00853099|584531117|FG000|Double-blind Period|Lack of Efficacy|14|||
161860364|NCT00853099|584531118|FG001|Double-blind Period|Lack of Efficacy|17|||
161860365|NCT00853099|584531119|FG002|Double-blind Period|Lack of Efficacy|16|||
161860366|NCT00853099|584531120|FG003|Double-blind Period|Lack of Efficacy|0|||
161860367|NCT00853099|584531117|FG000|Double-blind Period|Other|0|||
161860368|NCT00853099|584531118|FG001|Double-blind Period|Other|0|||
161860369|NCT00853099|584531119|FG002|Double-blind Period|Other|1|||
161860370|NCT00853099|584531120|FG003|Double-blind Period|Other|0|||
161860371|NCT00853099|584531117|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
161860372|NCT00853099|584531118|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
161860373|NCT00853099|584531119|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
161860374|NCT00853099|584531120|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
161860375|NCT00853099|584531117|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
161860376|NCT00853099|584531118|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
161860377|NCT00853099|584531119|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
161860378|NCT00853099|584531120|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
161860379|NCT00853099|584531117|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
161860380|NCT00853099|584531118|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
161860381|NCT00853099|584531119|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
161860382|NCT00853099|584531120|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
161860383|NCT00853099|584531117|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
161860384|NCT00853099|584531118|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
161860385|NCT00853099|584531119|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
161860386|NCT00853099|584531120|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
161860387|NCT00853099|584531117|FG000|Double-blind + Open-label Periods|Other|0|||
161860388|NCT00853099|584531118|FG001|Double-blind + Open-label Periods|Other|0|||
161860389|NCT00853099|584531119|FG002|Double-blind + Open-label Periods|Other|0|||
161860390|NCT00853099|584531120|FG003|Double-blind + Open-label Periods|Other|6|||
161860391|NCT00970593|584531122|FG000|Overall Study|Adverse Event|1|||
161860392|NCT00970593|584531123|FG001|Overall Study|Adverse Event|1|||
161860393|NCT00970593|584531124|FG002|Overall Study|Adverse Event|0|||
161860394|NCT00970593|584531125|FG003|Overall Study|Adverse Event|0|||
161860395|NCT00970593|584531126|FG004|Overall Study|Adverse Event|0|||
161860396|NCT00970593|584531127|FG005|Overall Study|Adverse Event|0|||
161860397|NCT00970593|584531128|FG006|Overall Study|Adverse Event|0|||
161860398|NCT00970593|584531122|FG000|Overall Study|Discontinuation of study by sponsor|0|||
161860399|NCT00970593|584531123|FG001|Overall Study|Discontinuation of study by sponsor|0|||
161976346|NCT02753127|584962049|FG000|Overall Study|Withdrawal by Subject|37|||
161976347|NCT02753127|584962050|FG001|Overall Study|Withdrawal by Subject|47|||
161976348|NCT02753127|584962049|FG000|Overall Study|Other|3|||
161976349|NCT02753127|584962050|FG001|Overall Study|Other|8|||
161976350|NCT02753127|584962049|FG000|Overall Study|Hospice|0|||
161860400|NCT00970593|584531124|FG002|Overall Study|Discontinuation of study by sponsor|5|||
161860401|NCT00970593|584531125|FG003|Overall Study|Discontinuation of study by sponsor|0|||
161860402|NCT00970593|584531126|FG004|Overall Study|Discontinuation of study by sponsor|0|||
161860403|NCT00970593|584531127|FG005|Overall Study|Discontinuation of study by sponsor|0|||
161976351|NCT02753127|584962050|FG001|Overall Study|Hospice|2|||
161976352|NCT02046070|584962059|FG000|Overall Study|Progressive Disease|18|||
161976353|NCT02046070|584962060|FG001|Overall Study|Progressive Disease|11|||
161976354|NCT02046070|584962061|FG002|Overall Study|Progressive Disease|40|||
161976355|NCT02046070|584962059|FG000|Overall Study|Adverse Event|8|||
161860404|NCT00970593|584531128|FG006|Overall Study|Discontinuation of study by sponsor|2|||
161860405|NCT00970593|584531122|FG000|Overall Study|Withdrawal by Subject|0|||
161860406|NCT00970593|584531123|FG001|Overall Study|Withdrawal by Subject|0|||
161976356|NCT02046070|584962060|FG001|Overall Study|Adverse Event|10|||
161976357|NCT02046070|584962061|FG002|Overall Study|Adverse Event|17|||
161976358|NCT02046070|584962059|FG000|Overall Study|Withdrawal by Subject|1|||
161976359|NCT02046070|584962060|FG001|Overall Study|Withdrawal by Subject|2|||
161976360|NCT02046070|584962061|FG002|Overall Study|Withdrawal by Subject|6|||
161976361|NCT02046070|584962059|FG000|Overall Study|Study Terminated by Sponsor|1|||
161976362|NCT02046070|584962060|FG001|Overall Study|Study Terminated by Sponsor|1|||
161976363|NCT02046070|584962061|FG002|Overall Study|Study Terminated by Sponsor|1|||
161976364|NCT02046070|584962059|FG000|Overall Study|Reason not Specified|4|||
161976365|NCT02046070|584962060|FG001|Overall Study|Reason not Specified|4|||
161976366|NCT02046070|584962061|FG002|Overall Study|Reason not Specified|6|||
161976367|NCT04619004|584962064|FG000|Overall Study|Death|114|||
161976368|NCT04619004|584962065|FG001|Overall Study|Death|28|||
161976369|NCT04619004|584962064|FG000|Overall Study|Lost to Follow-up|1|||
161976370|NCT04619004|584962065|FG001|Overall Study|Lost to Follow-up|1|||
161976371|NCT04619004|584962064|FG000|Overall Study|Withdrawal by Subject|24|||
161976372|NCT04619004|584962065|FG001|Overall Study|Withdrawal by Subject|7|||
161976373|NCT04619004|584962064|FG000|Overall Study|Other - Not specified|0|||
161976374|NCT04619004|584962065|FG001|Overall Study|Other - Not specified|1|||
161976375|NCT05601102|584962069|FG000|Overall Study|Death|1|||
161976376|NCT05601102|584962070|FG001|Overall Study|Death|2|||
161976377|NCT05601102|584962069|FG000|Overall Study|Withdrawal by Subject|1|||
161976378|NCT05601102|584962070|FG001|Overall Study|Withdrawal by Subject|1|||
161976379|NCT05601102|584962069|FG000|Overall Study|Lost to Follow-up|0|||
161976380|NCT05601102|584962070|FG001|Overall Study|Lost to Follow-up|2|||
161976381|NCT04284813|584962075|FG000|Overall Study|Withdrawal by Subject|1|||
161976382|NCT01145053|584962081|FG000|Overall Study|Adverse Event|22|||
161976383|NCT01145053|584962081|FG000|Overall Study|Lost to Follow-up|28|||
161976384|NCT01145053|584962081|FG000|Overall Study|Withdrawal by Subject|25|||
161976385|NCT01145053|584962081|FG000|Overall Study|Other|18|||
161976386|NCT00293709|584962082|FG000|Overall Study|Other|47|||
161976387|NCT02785458|584962083|FG000|1 Month|Withdrawal by Subject|2|||
161976388|NCT02785458|584962084|FG001|1 Month|Withdrawal by Subject|1|||
161976389|NCT02785458|584962083|FG000|1 Month|Lost to Follow-up|38|||
161976390|NCT02785458|584962084|FG001|1 Month|Lost to Follow-up|31|||
161976391|NCT02785458|584962083|FG000|1 Month|Deemed Ineligible|1|||
161976392|NCT02785458|584962084|FG001|1 Month|Deemed Ineligible|0|||
161976393|NCT02785458|584962083|FG000|1 Month|Completed Evaluation by Baseline|42|||
161976394|NCT02785458|584962084|FG001|1 Month|Completed Evaluation by Baseline|39|||
161976395|NCT02785458|584962083|FG000|1 Month|Partial Interview|0|||
161976396|NCT02785458|584962084|FG001|1 Month|Partial Interview|4|||
161976397|NCT02785458|584962083|FG000|3 Months|Withdrawal by Subject|3|||
161976398|NCT02785458|584962084|FG001|3 Months|Withdrawal by Subject|1|||
161976399|NCT02785458|584962083|FG000|3 Months|Lost to Follow-up|25|||
161976400|NCT02785458|584962084|FG001|3 Months|Lost to Follow-up|21|||
161976401|NCT02785458|584962083|FG000|3 Months|Completed Evaluation at 1 Month|100|||
161976402|NCT02785458|584962084|FG001|3 Months|Completed Evaluation at 1 Month|89|||
161976403|NCT01146652|584962085|FG000|Overall Study|Adverse Event|506|||
161976404|NCT01146652|584962086|FG001|Overall Study|Adverse Event|15|||
161860407|NCT00970593|584531124|FG002|Overall Study|Withdrawal by Subject|1|||
161860408|NCT00970593|584531125|FG003|Overall Study|Withdrawal by Subject|0|||
161860409|NCT00970593|584531126|FG004|Overall Study|Withdrawal by Subject|0|||
161976405|NCT01146652|584962085|FG000|Overall Study|Lack of Efficacy|91|||
161976406|NCT01146652|584962086|FG001|Overall Study|Lack of Efficacy|7|||
161976407|NCT01146652|584962085|FG000|Overall Study|Poor compliance to protocol|38|||
161976408|NCT01146652|584962086|FG001|Overall Study|Poor compliance to protocol|1|||
161976409|NCT01146652|584962085|FG000|Overall Study|Other unspecified reasons|314|||
161976410|NCT01146652|584962086|FG001|Overall Study|Other unspecified reasons|22|||
161976411|NCT01146652|584962085|FG000|Overall Study|Enrolled but not treated|2|||
161976412|NCT01146652|584962086|FG001|Overall Study|Enrolled but not treated|0|||
161976413|NCT02590562|584962092|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
161976414|NCT01457950|584962093|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
161976415|NCT01457950|584962094|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
161976416|NCT01457950|584962095|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
161976417|NCT01457950|584962096|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
161976418|NCT01457950|584962093|FG000|Double-Blind Phase|Protocol Violation|2|||
161976419|NCT01457950|584962094|FG001|Double-Blind Phase|Protocol Violation|1|||
161976420|NCT01457950|584962095|FG002|Double-Blind Phase|Protocol Violation|0|||
161976421|NCT01457950|584962096|FG003|Double-Blind Phase|Protocol Violation|0|||
161976422|NCT01457950|584962093|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
162034519|NCT01602666|585182086|FG000|Induction Chemotherapy|Physician Decision|12|||
161976423|NCT01457950|584962094|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
161976424|NCT01457950|584962095|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161976425|NCT01457950|584962096|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
161976426|NCT01457950|584962093|FG000|Open-Label Phase|Adverse Event|0|||
161976427|NCT01457950|584962094|FG001|Open-Label Phase|Adverse Event|0|||
161976428|NCT01457950|584962095|FG002|Open-Label Phase|Adverse Event|0|||
161976429|NCT01457950|584962096|FG003|Open-Label Phase|Adverse Event|1|||
161976430|NCT01457950|584962093|FG000|Open-Label Phase|Protocol Violation|0|||
161976431|NCT01457950|584962094|FG001|Open-Label Phase|Protocol Violation|0|||
161976432|NCT01457950|584962095|FG002|Open-Label Phase|Protocol Violation|0|||
161976433|NCT01457950|584962096|FG003|Open-Label Phase|Protocol Violation|1|||
161976434|NCT01457950|584962093|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161976435|NCT01457950|584962094|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161976436|NCT01457950|584962095|FG002|Open-Label Phase|Withdrawal by Subject|2|||
161976437|NCT01457950|584962096|FG003|Open-Label Phase|Withdrawal by Subject|0|||
161976438|NCT03684304|584962097|FG000|Overall Study|Lost to Follow-up|19|||
161976439|NCT03684304|584962098|FG001|Overall Study|Lost to Follow-up|17|||
161976440|NCT00824005|584962099|FG000|Overall Study|Death|0|||
161976441|NCT00824005|584962100|FG001|Overall Study|Death|1|||
161976442|NCT00824005|584962099|FG000|Overall Study|Lost to Follow-up|0|||
161976443|NCT00824005|584962100|FG001|Overall Study|Lost to Follow-up|1|||
161976444|NCT01510184|584962101|FG000|Overall Study|Sponsor discretion|28|||
161976445|NCT01510184|584962102|FG001|Overall Study|Sponsor discretion|28|||
161976446|NCT01510184|584962101|FG000|Overall Study|Death|1|||
161976447|NCT01510184|584962102|FG001|Overall Study|Death|2|||
161976448|NCT01510184|584962101|FG000|Overall Study|Withdrawal by Subject|1|||
161976449|NCT01510184|584962102|FG001|Overall Study|Withdrawal by Subject|4|||
161976450|NCT01510184|584962101|FG000|Overall Study|Other|0|||
161976451|NCT01510184|584962102|FG001|Overall Study|Other|1|||
161976452|NCT01143051|584962103|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
161976453|NCT01143051|584962104|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
161976454|NCT01143051|584962105|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
161976455|NCT01143051|584962106|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
161976456|NCT01143051|584962107|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
161976457|NCT01143051|584962108|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
161976458|NCT01143051|584962103|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
161976459|NCT01143051|584962104|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
161976460|NCT01143051|584962105|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
161976461|NCT01143051|584962106|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
161976462|NCT01143051|584962107|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
161976463|NCT01143051|584962108|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
161976464|NCT02677844|584962109|FG000|Period 3|Withdrawal by Subject|0|||
161976465|NCT02677844|584962110|FG001|Period 3|Withdrawal by Subject|0|||
161976466|NCT02677844|584962111|FG002|Period 3|Withdrawal by Subject|0|||
161976467|NCT02677844|584962112|FG003|Period 3|Withdrawal by Subject|1|||
161976468|NCT02677844|584962113|FG004|Period 3|Withdrawal by Subject|0|||
161976469|NCT02677844|584962114|FG005|Period 3|Withdrawal by Subject|0|||
161976470|NCT02677844|584962115|FG006|Period 3|Withdrawal by Subject|0|||
161976471|NCT03458702|584962116|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
161976472|NCT03458702|584962117|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
161976473|NCT03458702|584962116|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
161976474|NCT03458702|584962117|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
161976475|NCT00765882|584962118|FG000|Overall Study|Adverse Event|10|||
161976476|NCT00765882|584962119|FG001|Overall Study|Adverse Event|21|||
161976477|NCT00765882|584962120|FG002|Overall Study|Adverse Event|20|||
161976478|NCT00765882|584962118|FG000|Overall Study|Lack of Efficacy|4|||
161976479|NCT00765882|584962119|FG001|Overall Study|Lack of Efficacy|0|||
161976480|NCT00765882|584962120|FG002|Overall Study|Lack of Efficacy|1|||
161976481|NCT00765882|584962118|FG000|Overall Study|Protocol Violation|4|||
161976482|NCT00765882|584962119|FG001|Overall Study|Protocol Violation|3|||
161976483|NCT00765882|584962120|FG002|Overall Study|Protocol Violation|1|||
161976484|NCT00765882|584962118|FG000|Overall Study|Withdrawal by Subject|2|||
161976485|NCT00765882|584962119|FG001|Overall Study|Withdrawal by Subject|6|||
161976486|NCT00765882|584962120|FG002|Overall Study|Withdrawal by Subject|6|||
161976487|NCT00765882|584962118|FG000|Overall Study|Lost to Follow-up|1|||
161976488|NCT00765882|584962119|FG001|Overall Study|Lost to Follow-up|9|||
161976489|NCT00765882|584962120|FG002|Overall Study|Lost to Follow-up|6|||
161976490|NCT00765882|584962118|FG000|Overall Study|Other Reason|3|||
162034520|NCT01602666|585182087|FG001|Induction Chemotherapy|Physician Decision|5|||
161976491|NCT00765882|584962119|FG001|Overall Study|Other Reason|1|||
161976492|NCT00765882|584962120|FG002|Overall Study|Other Reason|2|||
161976493|NCT03532932|584962121|FG000|Overall Study|Protocol Deviation|33|||
161976494|NCT03532932|584962122|FG001|Overall Study|Protocol Deviation|31|||
161976495|NCT03532932|584962121|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
161976496|NCT03532932|584962122|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
161976497|NCT03532932|584962121|FG000|Overall Study|Withdrawal by Subject|2|||
161976498|NCT03532932|584962122|FG001|Overall Study|Withdrawal by Subject|0|||
161976499|NCT03532932|584962121|FG000|Overall Study|Lost to Follow-up|15|||
161976500|NCT03532932|584962122|FG001|Overall Study|Lost to Follow-up|9|||
161976501|NCT03532932|584962121|FG000|Overall Study|Adverse Event|4|||
161976502|NCT03532932|584962122|FG001|Overall Study|Adverse Event|3|||
161976503|NCT03532932|584962121|FG000|Overall Study|Death|0|||
161976504|NCT03532932|584962122|FG001|Overall Study|Death|2|||
161976505|NCT03532932|584962121|FG000|Overall Study|Other|11|||
161976506|NCT03532932|584962122|FG001|Overall Study|Other|16|||
161976507|NCT02255565|584962123|FG000|Overall Study|Withdrawal by Subject|0|||
161976508|NCT02255565|584962124|FG001|Overall Study|Withdrawal by Subject|1|||
161976509|NCT02255565|584962125|FG002|Overall Study|Withdrawal by Subject|0|||
161976510|NCT00810901|584962126|FG000|Overall Study|Lost to Follow-up|88|||
161976511|NCT00810901|584962127|FG001|Overall Study|Lost to Follow-up|58|||
161976512|NCT04375397|584962130|FG000|Overall Study|Death|1|||
161976513|NCT04375397|584962131|FG001|Overall Study|Death|1|||
161976514|NCT04375397|584962130|FG000|Overall Study|Withdrew consent|2|||
161976515|NCT04375397|584962131|FG001|Overall Study|Withdrew consent|0|||
161976516|NCT04375397|584962130|FG000|Overall Study|Lost to Follow-up|6|||
161976517|NCT04375397|584962131|FG001|Overall Study|Lost to Follow-up|4|||
161976518|NCT04375397|584962130|FG000|Overall Study|Other, not specified|0|||
161976519|NCT04375397|584962131|FG001|Overall Study|Other, not specified|1|||
161976520|NCT01945775|584962133|FG000|Overall Study|Death|214|||
161976521|NCT01945775|584962134|FG001|Overall Study|Death|98|||
161976522|NCT01945775|584962133|FG000|Overall Study|Lost to Follow-up|12|||
161976523|NCT01945775|584962134|FG001|Overall Study|Lost to Follow-up|7|||
161976524|NCT01945775|584962133|FG000|Overall Study|Withdrawal by Subject|11|||
161976525|NCT01945775|584962134|FG001|Overall Study|Withdrawal by Subject|21|||
161976526|NCT01945775|584962133|FG000|Overall Study|Other|50|||
161976527|NCT01945775|584962134|FG001|Overall Study|Other|18|||
161976528|NCT02876328|584962135|FG000|Overall Study|Death|2|||
161976529|NCT02876328|584962136|FG001|Overall Study|Death|1|||
161976530|NCT02876328|584962137|FG002|Overall Study|Death|3|||
161976531|NCT02876328|584962138|FG003|Overall Study|Death|0|||
161976532|NCT02876328|584962139|FG004|Overall Study|Death|0|||
161976533|NCT02876328|584962140|FG005|Overall Study|Death|0|||
161976534|NCT02876328|584962141|FG006|Overall Study|Death|1|||
161976535|NCT02876328|584962142|FG007|Overall Study|Death|3|||
161976536|NCT02876328|584962143|FG008|Overall Study|Death|0|||
161976537|NCT02876328|584962144|FG009|Overall Study|Death|1|||
161976538|NCT02876328|584962145|FG010|Overall Study|Death|1|||
161976539|NCT02876328|584962146|FG011|Overall Study|Death|0|||
161976540|NCT02876328|584962147|FG012|Overall Study|Death|0|||
161976541|NCT02876328|584962148|FG013|Overall Study|Death|0|||
161976542|NCT02876328|584962149|FG014|Overall Study|Death|0|||
162034521|NCT01602666|585182086|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
162034522|NCT01602666|585182087|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
162034523|NCT01602666|585182086|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
162034524|NCT01602666|585182087|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
162034525|NCT01602666|585182086|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
162034526|NCT01602666|585182087|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
162034527|NCT01602666|585182086|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
162034528|NCT01602666|585182087|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
162034529|NCT01602666|585182086|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
162034530|NCT01602666|585182087|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
162034531|NCT01602666|585182086|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
162034532|NCT01602666|585182087|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
162034533|NCT01602666|585182086|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
162034534|NCT01602666|585182087|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
162034535|NCT01602666|585182086|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
162034536|NCT01602666|585182087|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
162034537|NCT05458648|585182088|FG000|Overall Study|Physician Decision|1|||
162034538|NCT05458648|585182088|FG000|Overall Study|Patient presented in atrial flutter|1|||
162034539|NCT03610555|585182092|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
162034540|NCT03610555|585182093|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
162034541|NCT03610555|585182094|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
162034542|NCT03610555|585182095|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
162034543|NCT01892722|585182096|FG000|Overall Study|Protocol deviation|0|||
162034544|NCT01892722|585182097|FG001|Overall Study|Protocol deviation|1|||
162034545|NCT01892722|585182096|FG000|Overall Study|Administrative problems|0|||
162034546|NCT01892722|585182097|FG001|Overall Study|Administrative problems|1|||
162034547|NCT01892722|585182096|FG000|Overall Study|Patient/guardian decision|0|||
162034548|NCT01892722|585182097|FG001|Overall Study|Patient/guardian decision|2|||
162034549|NCT01892722|585182096|FG000|Overall Study|Physician Decision|1|||
162034550|NCT01892722|585182097|FG001|Overall Study|Physician Decision|2|||
162034551|NCT01892722|585182096|FG000|Overall Study|Adverse Event|3|||
162034552|NCT01892722|585182097|FG001|Overall Study|Adverse Event|2|||
162034553|NCT01892722|585182096|FG000|Overall Study|Lack of Efficacy|0|||
162034554|NCT01892722|585182097|FG001|Overall Study|Lack of Efficacy|7|||
162034555|NCT01892722|585182096|FG000|Overall Study|Withdrawal by Subject|3|||
161976543|NCT02876328|584962150|FG015|Overall Study|Death|0|||
161976544|NCT02876328|584962151|FG016|Overall Study|Death|1|||
161976545|NCT02876328|584962152|FG017|Overall Study|Death|1|||
161976546|NCT02876328|584962153|FG018|Overall Study|Death|0|||
161976547|NCT02876328|584962154|FG019|Overall Study|Death|0|||
161976548|NCT02876328|584962155|FG020|Overall Study|Death|0|||
161976549|NCT02876328|584962156|FG021|Overall Study|Death|1|||
161976550|NCT02876328|584962157|FG022|Overall Study|Death|0|||
161976551|NCT02876328|584962158|FG023|Overall Study|Death|0|||
161976552|NCT02876328|584962135|FG000|Overall Study|Withdrawal by Subject|0|||
161976553|NCT02876328|584962136|FG001|Overall Study|Withdrawal by Subject|2|||
161976554|NCT02876328|584962137|FG002|Overall Study|Withdrawal by Subject|3|||
161976555|NCT02876328|584962138|FG003|Overall Study|Withdrawal by Subject|3|||
161976556|NCT02876328|584962139|FG004|Overall Study|Withdrawal by Subject|0|||
161976557|NCT02876328|584962140|FG005|Overall Study|Withdrawal by Subject|1|||
161976558|NCT02876328|584962141|FG006|Overall Study|Withdrawal by Subject|0|||
161976559|NCT02876328|584962142|FG007|Overall Study|Withdrawal by Subject|1|||
161976560|NCT02876328|584962143|FG008|Overall Study|Withdrawal by Subject|1|||
161976561|NCT02876328|584962144|FG009|Overall Study|Withdrawal by Subject|2|||
161976562|NCT02876328|584962145|FG010|Overall Study|Withdrawal by Subject|0|||
161976563|NCT02876328|584962146|FG011|Overall Study|Withdrawal by Subject|0|||
161976564|NCT02876328|584962147|FG012|Overall Study|Withdrawal by Subject|0|||
161976565|NCT02876328|584962148|FG013|Overall Study|Withdrawal by Subject|0|||
161976566|NCT02876328|584962149|FG014|Overall Study|Withdrawal by Subject|0|||
161976567|NCT02876328|584962150|FG015|Overall Study|Withdrawal by Subject|0|||
161976568|NCT02876328|584962151|FG016|Overall Study|Withdrawal by Subject|1|||
161976569|NCT02876328|584962152|FG017|Overall Study|Withdrawal by Subject|3|||
161976570|NCT02876328|584962153|FG018|Overall Study|Withdrawal by Subject|0|||
161976571|NCT02876328|584962154|FG019|Overall Study|Withdrawal by Subject|0|||
161976572|NCT02876328|584962155|FG020|Overall Study|Withdrawal by Subject|1|||
161976573|NCT02876328|584962156|FG021|Overall Study|Withdrawal by Subject|0|||
161976574|NCT02876328|584962157|FG022|Overall Study|Withdrawal by Subject|0|||
161976575|NCT02876328|584962158|FG023|Overall Study|Withdrawal by Subject|0|||
161976576|NCT02876328|584962135|FG000|Overall Study|Missed 12 Month Visit|15|||
161976577|NCT02876328|584962136|FG001|Overall Study|Missed 12 Month Visit|10|||
161976578|NCT02876328|584962137|FG002|Overall Study|Missed 12 Month Visit|11|||
161976579|NCT02876328|584962138|FG003|Overall Study|Missed 12 Month Visit|6|||
161976580|NCT02876328|584962139|FG004|Overall Study|Missed 12 Month Visit|10|||
161976581|NCT02876328|584962140|FG005|Overall Study|Missed 12 Month Visit|14|||
161976582|NCT02876328|584962141|FG006|Overall Study|Missed 12 Month Visit|3|||
161976583|NCT02876328|584962142|FG007|Overall Study|Missed 12 Month Visit|8|||
161976584|NCT02876328|584962143|FG008|Overall Study|Missed 12 Month Visit|9|||
161976585|NCT02876328|584962144|FG009|Overall Study|Missed 12 Month Visit|5|||
161976586|NCT02876328|584962145|FG010|Overall Study|Missed 12 Month Visit|4|||
161976587|NCT02876328|584962146|FG011|Overall Study|Missed 12 Month Visit|1|||
161976588|NCT02876328|584962147|FG012|Overall Study|Missed 12 Month Visit|5|||
161976589|NCT02876328|584962148|FG013|Overall Study|Missed 12 Month Visit|4|||
161976590|NCT02876328|584962149|FG014|Overall Study|Missed 12 Month Visit|4|||
161976591|NCT02876328|584962150|FG015|Overall Study|Missed 12 Month Visit|4|||
161976592|NCT02876328|584962151|FG016|Overall Study|Missed 12 Month Visit|3|||
161976593|NCT02876328|584962152|FG017|Overall Study|Missed 12 Month Visit|6|||
161976594|NCT02876328|584962153|FG018|Overall Study|Missed 12 Month Visit|2|||
161976595|NCT02876328|584962154|FG019|Overall Study|Missed 12 Month Visit|2|||
161976596|NCT02876328|584962155|FG020|Overall Study|Missed 12 Month Visit|11|||
161976597|NCT02876328|584962156|FG021|Overall Study|Missed 12 Month Visit|7|||
161976598|NCT02876328|584962157|FG022|Overall Study|Missed 12 Month Visit|1|||
161976599|NCT02876328|584962158|FG023|Overall Study|Missed 12 Month Visit|0|||
161976600|NCT00456599|584962163|FG000|Overall Study|Non-compliance|1|||
161976601|NCT00456599|584962163|FG000|Overall Study|Withdrawal by Subject|2|||
161976602|NCT00260065|584962164|FG000|Overall Study|Progressive Disease|22|||
161976603|NCT00260065|584962164|FG000|Overall Study|Adverse Event|17|||
161976604|NCT00260065|584962164|FG000|Overall Study|Death|13|||
161976605|NCT00260065|584962164|FG000|Overall Study|Withdrawal by Subject|13|||
161976606|NCT00260065|584962164|FG000|Overall Study|Physician Decision|19|||
161976607|NCT00260065|584962164|FG000|Overall Study|Not otherwise specified|8|||
161976608|NCT00260065|584962164|FG000|Overall Study|Medication Noncompliance|1|||
161976609|NCT02198235|584962165|FG000|Overall Study|Lost to Follow-up|3|||
161976610|NCT02198235|584962166|FG001|Overall Study|Lost to Follow-up|2|||
161976611|NCT02198235|584962167|FG002|Overall Study|Lost to Follow-up|2|||
161976612|NCT01266590|584964362|FG000|Overall Study|Adverse Event|3|||
161976613|NCT01266590|584964362|FG000|Overall Study|Lost to Follow-up|1|||
161976614|NCT01266590|584964362|FG000|Overall Study|Withdrawal by Subject|1|||
161976615|NCT01266590|584964362|FG000|Overall Study|Physician Decision|1|||
161976616|NCT02654236|584964365|FG000|Overall Study|Withdrawal by Subject|0|||
161976617|NCT02654236|584964366|FG001|Overall Study|Withdrawal by Subject|0|||
161976618|NCT02654236|584964367|FG002|Overall Study|Withdrawal by Subject|2|||
161976619|NCT01549873|584964368|FG000|Overall Study|Physician Decision|0|||
161976620|NCT01549873|584964369|FG001|Overall Study|Physician Decision|1|||
161976621|NCT02905006|584964370|FG000|Overall Study|Adverse Event|1|||
161976622|NCT02905006|584964371|FG001|Overall Study|Adverse Event|1|||
161976623|NCT02905006|584964372|FG002|Overall Study|Adverse Event|1|||
161976624|NCT02905006|584964373|FG003|Overall Study|Adverse Event|1|||
161976625|NCT02905006|584964374|FG004|Overall Study|Adverse Event|0|||
161976626|NCT02905006|584964375|FG005|Overall Study|Adverse Event|1|||
161976627|NCT02905006|584964370|FG000|Overall Study|Lack of Efficacy|1|||
161976628|NCT02905006|584964371|FG001|Overall Study|Lack of Efficacy|0|||
161976629|NCT02905006|584964372|FG002|Overall Study|Lack of Efficacy|0|||
161976630|NCT02905006|584964373|FG003|Overall Study|Lack of Efficacy|0|||
161976631|NCT02905006|584964374|FG004|Overall Study|Lack of Efficacy|0|||
161976632|NCT02905006|584964375|FG005|Overall Study|Lack of Efficacy|0|||
161976633|NCT02905006|584964370|FG000|Overall Study|Protocol Violation|2|||
161976634|NCT02905006|584964371|FG001|Overall Study|Protocol Violation|0|||
161976635|NCT02905006|584964372|FG002|Overall Study|Protocol Violation|0|||
161976636|NCT02905006|584964373|FG003|Overall Study|Protocol Violation|0|||
161976637|NCT02905006|584964374|FG004|Overall Study|Protocol Violation|0|||
161976638|NCT02905006|584964375|FG005|Overall Study|Protocol Violation|0|||
161976639|NCT02905006|584964370|FG000|Overall Study|Lost to Follow-up|0|||
161976640|NCT02905006|584964371|FG001|Overall Study|Lost to Follow-up|0|||
161976641|NCT02905006|584964372|FG002|Overall Study|Lost to Follow-up|0|||
161976642|NCT02905006|584964373|FG003|Overall Study|Lost to Follow-up|1|||
161976643|NCT02905006|584964374|FG004|Overall Study|Lost to Follow-up|1|||
161976644|NCT02905006|584964375|FG005|Overall Study|Lost to Follow-up|0|||
161976645|NCT02905006|584964370|FG000|Overall Study|Withdrawal by Subject|0|||
161976646|NCT02905006|584964371|FG001|Overall Study|Withdrawal by Subject|0|||
161976647|NCT02905006|584964372|FG002|Overall Study|Withdrawal by Subject|1|||
161976648|NCT02905006|584964373|FG003|Overall Study|Withdrawal by Subject|1|||
161976649|NCT02905006|584964374|FG004|Overall Study|Withdrawal by Subject|0|||
161976650|NCT02905006|584964375|FG005|Overall Study|Withdrawal by Subject|1|||
161976651|NCT02905006|584964370|FG000|Overall Study|Screening exclusion criteria met|1|||
161976652|NCT02905006|584964371|FG001|Overall Study|Screening exclusion criteria met|0|||
161976653|NCT02905006|584964372|FG002|Overall Study|Screening exclusion criteria met|0|||
161976654|NCT02905006|584964373|FG003|Overall Study|Screening exclusion criteria met|0|||
161976655|NCT02905006|584964374|FG004|Overall Study|Screening exclusion criteria met|0|||
161976656|NCT02905006|584964375|FG005|Overall Study|Screening exclusion criteria met|0|||
161976657|NCT02905006|584964370|FG000|Overall Study|Lab withdrawal criterion met|0|||
161976658|NCT02905006|584964371|FG001|Overall Study|Lab withdrawal criterion met|1|||
161976659|NCT02905006|584964372|FG002|Overall Study|Lab withdrawal criterion met|2|||
161976660|NCT02905006|584964373|FG003|Overall Study|Lab withdrawal criterion met|2|||
161976661|NCT02905006|584964374|FG004|Overall Study|Lab withdrawal criterion met|2|||
161976662|NCT02905006|584964375|FG005|Overall Study|Lab withdrawal criterion met|1|||
161976663|NCT02905006|584964370|FG000|Overall Study|Positive for Tuberculosis|0|||
161976664|NCT02905006|584964371|FG001|Overall Study|Positive for Tuberculosis|1|||
161976665|NCT02905006|584964372|FG002|Overall Study|Positive for Tuberculosis|0|||
161976666|NCT02905006|584964373|FG003|Overall Study|Positive for Tuberculosis|0|||
161976667|NCT02905006|584964374|FG004|Overall Study|Positive for Tuberculosis|0|||
161976668|NCT02905006|584964375|FG005|Overall Study|Positive for Tuberculosis|0|||
161976669|NCT02905006|584964370|FG000|Overall Study|Subject positive for Hep B|0|||
161976670|NCT02905006|584964371|FG001|Overall Study|Subject positive for Hep B|0|||
161976671|NCT02905006|584964372|FG002|Overall Study|Subject positive for Hep B|1|||
161976672|NCT02905006|584964373|FG003|Overall Study|Subject positive for Hep B|0|||
161976673|NCT02905006|584964374|FG004|Overall Study|Subject positive for Hep B|0|||
161976674|NCT02905006|584964375|FG005|Overall Study|Subject positive for Hep B|0|||
161976675|NCT02905006|584964370|FG000|Overall Study|Patient moved abroad|0|||
161976676|NCT02905006|584964371|FG001|Overall Study|Patient moved abroad|0|||
161976677|NCT02905006|584964372|FG002|Overall Study|Patient moved abroad|0|||
161976678|NCT02905006|584964373|FG003|Overall Study|Patient moved abroad|1|||
161976679|NCT02905006|584964374|FG004|Overall Study|Patient moved abroad|0|||
161976680|NCT02905006|584964375|FG005|Overall Study|Patient moved abroad|0|||
161976681|NCT02905006|584964370|FG000|Overall Study|Patient randomized by mistake|0|||
161976682|NCT02905006|584964371|FG001|Overall Study|Patient randomized by mistake|0|||
161976683|NCT02905006|584964372|FG002|Overall Study|Patient randomized by mistake|0|||
161860410|NCT00970593|584531127|FG005|Overall Study|Withdrawal by Subject|0|||
161860411|NCT00970593|584531128|FG006|Overall Study|Withdrawal by Subject|0|||
161860412|NCT02203357|584531129|FG000|Overall Study|Lost to Follow-up|58|||
161860413|NCT02203357|584531130|FG001|Overall Study|Lost to Follow-up|66|||
161976684|NCT02905006|584964373|FG003|Overall Study|Patient randomized by mistake|0|||
161976685|NCT02905006|584964374|FG004|Overall Study|Patient randomized by mistake|0|||
161976686|NCT02905006|584964375|FG005|Overall Study|Patient randomized by mistake|1|||
161976687|NCT04435600|584964376|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161976688|NCT04435600|584964377|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161976689|NCT04435600|584964378|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
161976690|NCT04435600|584964379|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161860414|NCT02203357|584531131|FG002|Overall Study|Lost to Follow-up|70|||
161976691|NCT04435600|584964380|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161976692|NCT04435600|584964381|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161976693|NCT04435600|584964382|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161860415|NCT02968576|584531132|FG000|Overall Study|Pregnancy|0|||
161860416|NCT02968576|584531133|FG001|Overall Study|Pregnancy|1|||
161860417|NCT02002221|584531134|FG000|Overall Study|Adverse Event|2|||
161860418|NCT02002221|584531135|FG001|Overall Study|Adverse Event|1|||
161860419|NCT02002221|584531134|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161860420|NCT02002221|584531135|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161860421|NCT02002221|584531134|FG000|Overall Study|Patient withdrew consent|0|||
161860422|NCT02002221|584531135|FG001|Overall Study|Patient withdrew consent|1|||
161860423|NCT01998919|584531136|FG000|Overall Study|Death|2|||
161860424|NCT01998919|584531137|FG001|Overall Study|Death|2|||
161860425|NCT01998919|584531136|FG000|Overall Study|Adverse Event|0|||
161860426|NCT01998919|584531137|FG001|Overall Study|Adverse Event|5|||
161860427|NCT01998919|584531136|FG000|Overall Study|Disease progression|31|||
161860428|NCT01998919|584531137|FG001|Overall Study|Disease progression|22|||
161860429|NCT01998919|584531136|FG000|Overall Study|Withdrawal by Subject|2|||
161860430|NCT01998919|584531137|FG001|Overall Study|Withdrawal by Subject|4|||
161860431|NCT01998919|584531136|FG000|Overall Study|Lost to Follow-up|2|||
161860432|NCT01998919|584531137|FG001|Overall Study|Lost to Follow-up|0|||
161860433|NCT01998919|584531136|FG000|Overall Study|Other|5|||
161860434|NCT01998919|584531137|FG001|Overall Study|Other|2|||
161860435|NCT00897715|584531141|FG000|Overall Study|Lost to Follow-up|0|||
161860436|NCT00897715|584531142|FG001|Overall Study|Lost to Follow-up|1|||
161860437|NCT00897715|584531141|FG000|Overall Study|Physician Decision|1|||
161860438|NCT00897715|584531142|FG001|Overall Study|Physician Decision|0|||
161860439|NCT00897715|584531141|FG000|Overall Study|increased risk of infection|1|||
161860440|NCT00897715|584531142|FG001|Overall Study|increased risk of infection|0|||
161860441|NCT00927589|584531144|FG000|Overall Study|Death|1|||
161860442|NCT00927589|584531144|FG000|Overall Study|Physician Decision|1|||
161860443|NCT00927589|584531144|FG000|Overall Study|Withdrawal by Subject|3|||
161860444|NCT00927589|584531144|FG000|Overall Study|Adverse Event|2|||
161860445|NCT00927589|584531144|FG000|Overall Study|Disease Progression|8|||
161860446|NCT00927589|584531144|FG000|Overall Study|Non-compliance|1|||
161860447|NCT03875508|584531145|FG000|Overall Study|Adverse Event|1|||
161860448|NCT03875508|584531145|FG000|Overall Study|Lost to Follow-up|8|||
161860449|NCT03875508|584531145|FG000|Overall Study|Lack of Efficacy|1|||
161860450|NCT03875508|584531145|FG000|Overall Study|Other, not specified|2|||
161860451|NCT03743051|584531146|FG000|Overall Study|Adverse Event|5|||
161860452|NCT03743051|584531147|FG001|Overall Study|Adverse Event|9|||
161860453|NCT03743051|584531146|FG000|Overall Study|Death|27|||
161860454|NCT03743051|584531147|FG001|Overall Study|Death|26|||
161860455|NCT03743051|584531146|FG000|Overall Study|Lost to Follow-up|4|||
161860456|NCT03743051|584531147|FG001|Overall Study|Lost to Follow-up|8|||
161860457|NCT03743051|584531146|FG000|Overall Study|Withdrawal by Subject|32|||
161860458|NCT03743051|584531147|FG001|Overall Study|Withdrawal by Subject|19|||
161860459|NCT03743051|584531146|FG000|Overall Study|Physician Decision|10|||
161860460|NCT03743051|584531147|FG001|Overall Study|Physician Decision|15|||
161860461|NCT03743051|584531146|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
161860462|NCT03743051|584531147|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
161860463|NCT02137252|584531148|FG000|Overall Study|trial terminated early|2|||
161860464|NCT02137252|584531149|FG001|Overall Study|trial terminated early|1|||
161860465|NCT02550561|584531153|FG000|Overall Study|Lost to Follow-up|5|||
161976694|NCT04435600|584964383|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161976695|NCT04435600|584964384|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161976696|NCT04435600|584964385|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161771151|NCT00948896|584204257|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
161771152|NCT00948896|584204258|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
161771153|NCT00948896|584204259|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
161771154|NCT00948896|584204260|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
161771155|NCT00948896|584204261|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
161771156|NCT00948896|584204262|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
161771157|NCT00948896|584204255|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
161771158|NCT00948896|584204256|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
161771159|NCT00948896|584204257|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
161771160|NCT00948896|584204258|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
161771161|NCT00948896|584204259|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
161771162|NCT00948896|584204260|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
161771163|NCT00948896|584204261|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
161860466|NCT02550561|584531153|FG000|Overall Study|Withdrawal by Subject|1|||
161860467|NCT00428246|584531154|FG000|Overall Study|Withdrawal by Subject|0|||
161860468|NCT00428246|584531155|FG001|Overall Study|Withdrawal by Subject|0|||
161860469|NCT00428246|584531156|FG002|Overall Study|Withdrawal by Subject|1|||
161860470|NCT00428246|584531154|FG000|Overall Study|Adverse Event|1|||
161860471|NCT00428246|584531155|FG001|Overall Study|Adverse Event|0|||
161860472|NCT00428246|584531156|FG002|Overall Study|Adverse Event|0|||
161860473|NCT05198518|584531158|FG000|Screening Visit|Deemed unable to participate|58|||
161976697|NCT04435600|584964376|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161976698|NCT04435600|584964377|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161976699|NCT04435600|584964378|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161771164|NCT00948896|584204262|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
161771165|NCT00948896|584204255|FG000|24 Months of Age to 36 Months of Age|Death|0|||
161771166|NCT00948896|584204256|FG001|24 Months of Age to 36 Months of Age|Death|2|||
161771167|NCT00948896|584204257|FG002|24 Months of Age to 36 Months of Age|Death|2|||
161771168|NCT00948896|584204258|FG003|24 Months of Age to 36 Months of Age|Death|0|||
161771169|NCT00948896|584204259|FG004|24 Months of Age to 36 Months of Age|Death|0|||
161771170|NCT00948896|584204260|FG005|24 Months of Age to 36 Months of Age|Death|1|||
161771171|NCT00948896|584204261|FG006|24 Months of Age to 36 Months of Age|Death|0|||
161976700|NCT04435600|584964379|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161976701|NCT04435600|584964380|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161976702|NCT04435600|584964381|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161976703|NCT04435600|584964382|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161976704|NCT04435600|584964383|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161976705|NCT04435600|584964384|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
161976706|NCT04435600|584964385|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
161976707|NCT04435600|584964376|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161976708|NCT04435600|584964377|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161976709|NCT04435600|584964378|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161976710|NCT04435600|584964379|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161771172|NCT00948896|584204262|FG007|24 Months of Age to 36 Months of Age|Death|0|||
161771173|NCT00948896|584204255|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
161771174|NCT00948896|584204256|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161771175|NCT00948896|584204257|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
161771176|NCT00948896|584204258|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
161771177|NCT00948896|584204259|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161771178|NCT00948896|584204260|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161771179|NCT00948896|584204261|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161771180|NCT00948896|584204262|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161771181|NCT00948896|584204255|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
161771182|NCT00948896|584204256|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161771183|NCT00948896|584204257|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
161771184|NCT00948896|584204258|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161771185|NCT00948896|584204259|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
161771186|NCT00948896|584204260|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161771187|NCT00948896|584204261|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161771188|NCT00948896|584204262|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161771189|NCT00948896|584204255|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161771190|NCT00948896|584204256|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161771191|NCT00948896|584204257|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
161771192|NCT00948896|584204258|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161771193|NCT00948896|584204259|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161771194|NCT00948896|584204260|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
161771195|NCT00948896|584204261|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161771196|NCT00948896|584204262|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161771197|NCT00948896|584204255|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771198|NCT00948896|584204256|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771199|NCT00948896|584204257|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771200|NCT00948896|584204258|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
161771201|NCT00948896|584204259|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771202|NCT00948896|584204260|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771203|NCT00948896|584204261|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771204|NCT00948896|584204262|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161771205|NCT00945815|584204263|FG000|Overall Study|Death|3|||
161771206|NCT00945815|584204263|FG000|Overall Study|Not protocol specified|1|||
161771207|NCT00945815|584204263|FG000|Overall Study|Ineligible|3|||
161771208|NCT00945815|584204263|FG000|Overall Study|Did not begin protocol therapy|1|||
161976711|NCT04435600|584964380|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161976712|NCT04435600|584964381|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161976713|NCT04435600|584964382|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161976714|NCT04435600|584964383|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161976715|NCT04435600|584964384|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
161771209|NCT01990339|584204268|FG000|Overall Study|Data Not Available|49|||
161771210|NCT01990339|584204268|FG000|Overall Study|Voluntary Withdrawal|1402|||
161976716|NCT04435600|584964385|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
161976717|NCT04435600|584964376|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
161976718|NCT04435600|584964377|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
161976719|NCT04435600|584964378|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
161976720|NCT04435600|584964379|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
161976721|NCT04435600|584964380|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
161976722|NCT04435600|584964381|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
161976723|NCT04435600|584964382|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
161976724|NCT04435600|584964383|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
161976725|NCT04435600|584964384|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
161976726|NCT04435600|584964385|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
161976727|NCT02797184|584964390|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
161976728|NCT02797184|584964391|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
161976729|NCT05149313|584964392|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
161976730|NCT05149313|584964393|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
161976731|NCT05149313|584964394|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
161976732|NCT05149313|584964395|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
161976733|NCT05149313|584964392|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
161976734|NCT05149313|584964393|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
161976735|NCT05149313|584964394|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
161976736|NCT05149313|584964395|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
161976737|NCT05149313|584964392|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
161976738|NCT05149313|584964393|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
161976739|NCT05149313|584964394|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
161976740|NCT05149313|584964395|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
161976741|NCT05149313|584964392|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
161976742|NCT05149313|584964393|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
161976743|NCT05149313|584964394|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
161976744|NCT05149313|584964395|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
161976745|NCT05149313|584964392|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
161976746|NCT05149313|584964393|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
161976747|NCT05149313|584964394|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
161976748|NCT05149313|584964395|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
161976749|NCT05149313|584964392|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
161976750|NCT05149313|584964393|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
161976751|NCT05149313|584964394|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
161976752|NCT05149313|584964395|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
161976753|NCT05149313|584964392|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
161976754|NCT05149313|584964393|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
161976755|NCT05149313|584964394|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
161976756|NCT05149313|584964395|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
161976757|NCT05149313|584964392|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161976758|NCT05149313|584964393|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161976759|NCT05149313|584964394|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
161976760|NCT05149313|584964395|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
161976761|NCT05149313|584964392|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
161976762|NCT05149313|584964393|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
161976763|NCT05149313|584964394|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
161976764|NCT05149313|584964395|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
161976765|NCT05149313|584964392|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161976766|NCT05149313|584964393|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161976767|NCT05149313|584964394|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
161976768|NCT05149313|584964395|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161976769|NCT05149313|584964392|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
161976770|NCT05149313|584964393|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
161976771|NCT05149313|584964394|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
161976772|NCT05149313|584964395|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
161976773|NCT02212678|584964404|FG000|Overall Study|Adverse Event|1|||
161976774|NCT06250738|584964405|FG000|Overall Study|Lost to Follow-up|1|||
161976775|NCT01114360|584964406|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
161976776|NCT01114360|584964407|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
161976777|NCT03007745|584964408|FG000|Overall Study|Sleep test negative for OSA|53|||
161976778|NCT03007745|584964409|FG001|Overall Study|Sleep test negative for OSA|49|||
161976779|NCT03007745|584964408|FG000|Overall Study|Physician Decision|6|||
161976780|NCT03007745|584964409|FG001|Overall Study|Physician Decision|9|||
161976781|NCT03007745|584964408|FG000|Overall Study|Withdrawal by Subject|38|||
161976782|NCT03007745|584964409|FG001|Overall Study|Withdrawal by Subject|16|||
161976783|NCT03007745|584964408|FG000|Overall Study|Lost to Follow-up|19|||
161976784|NCT03007745|584964409|FG001|Overall Study|Lost to Follow-up|25|||
161976785|NCT03007745|584964408|FG000|Overall Study|Unable to login to website|17|||
161976786|NCT03007745|584964409|FG001|Overall Study|Unable to login to website|4|||
161976787|NCT03344172|584964412|FG000|Overall Study|Received <1 dose of treatment|1|||
161976788|NCT03344172|584964413|FG001|Overall Study|Received <1 dose of treatment|0|||
161976789|NCT04912895|584964414|FG000|Overall Study|Unable to provide specimen|2|||
161976790|NCT04912895|584964415|FG001|Overall Study|Unable to provide specimen|0|||
161976791|NCT04912895|584964416|FG002|Overall Study|Unable to provide specimen|0|||
161976792|NCT00159913|584964417|FG000|Overall Study|Adverse Event|1|||
161976793|NCT00159913|584964418|FG001|Overall Study|Adverse Event|0|||
161976794|NCT00159913|584964419|FG002|Overall Study|Adverse Event|1|||
161976795|NCT00159913|584964420|FG003|Overall Study|Adverse Event|0|||
161976796|NCT00159913|584964417|FG000|Overall Study|Withdrawal by Subject|0|||
161976797|NCT00159913|584964418|FG001|Overall Study|Withdrawal by Subject|0|||
161976798|NCT00159913|584964419|FG002|Overall Study|Withdrawal by Subject|0|||
161976799|NCT00159913|584964420|FG003|Overall Study|Withdrawal by Subject|1|||
161976800|NCT00159913|584964417|FG000|Overall Study|Lost to Follow-up|0|||
161976801|NCT00159913|584964418|FG001|Overall Study|Lost to Follow-up|0|||
161976802|NCT00159913|584964419|FG002|Overall Study|Lost to Follow-up|0|||
161976803|NCT00159913|584964420|FG003|Overall Study|Lost to Follow-up|1|||
161976804|NCT00159913|584964417|FG000|Overall Study|Protocol Violation|1|||
161976805|NCT00159913|584964418|FG001|Overall Study|Protocol Violation|0|||
161976806|NCT00159913|584964419|FG002|Overall Study|Protocol Violation|1|||
161976807|NCT00159913|584964420|FG003|Overall Study|Protocol Violation|0|||
161976808|NCT03294135|584964421|FG000|Overall Study|Serious Adverse Event|1|||
161976809|NCT03294135|584964422|FG001|Overall Study|Serious Adverse Event|0|||
161976810|NCT03294135|584964423|FG002|Overall Study|Serious Adverse Event|0|||
161976811|NCT03294135|584964421|FG000|Overall Study|Lost to Follow-up|1|||
161976812|NCT03294135|584964422|FG001|Overall Study|Lost to Follow-up|0|||
161976813|NCT03294135|584964423|FG002|Overall Study|Lost to Follow-up|1|||
161976814|NCT03294135|584964421|FG000|Overall Study|Withdrawal by Subject|0|||
161976815|NCT03294135|584964422|FG001|Overall Study|Withdrawal by Subject|0|||
161976816|NCT03294135|584964423|FG002|Overall Study|Withdrawal by Subject|1|||
161976817|NCT03294135|584964421|FG000|Overall Study|Other|2|||
161976818|NCT03294135|584964422|FG001|Overall Study|Other|0|||
161976819|NCT03294135|584964423|FG002|Overall Study|Other|0|||
161976820|NCT02763254|584964424|FG000|Overall Study|Adverse Event|1|||
161976821|NCT01390779|584964425|FG000|Overall Study|Physician Decision|1|||
161976822|NCT02231762|584964428|FG000|Combination Phase|Adverse Event|10|||
161976823|NCT02231762|584964429|FG001|Combination Phase|Adverse Event|0|||
161976824|NCT02231762|584964430|FG002|Combination Phase|Adverse Event|0|||
161976825|NCT02231762|584964431|FG003|Combination Phase|Adverse Event|0|||
161976826|NCT02231762|584964428|FG000|Combination Phase|Withdrawal by Subject|2|||
161976827|NCT02231762|584964429|FG001|Combination Phase|Withdrawal by Subject|0|||
161976828|NCT02231762|584964430|FG002|Combination Phase|Withdrawal by Subject|0|||
161976829|NCT02231762|584964431|FG003|Combination Phase|Withdrawal by Subject|0|||
161976830|NCT02231762|584964428|FG000|Combination Phase|Disease Progression|6|||
161976831|NCT02231762|584964429|FG001|Combination Phase|Disease Progression|0|||
161976832|NCT02231762|584964430|FG002|Combination Phase|Disease Progression|0|||
161976833|NCT02231762|584964431|FG003|Combination Phase|Disease Progression|0|||
161976834|NCT02231762|584964428|FG000|Combination Phase|Did not meet inclusion criteria|1|||
161976835|NCT02231762|584964429|FG001|Combination Phase|Did not meet inclusion criteria|0|||
161976836|NCT02231762|584964430|FG002|Combination Phase|Did not meet inclusion criteria|0|||
161976837|NCT02231762|584964431|FG003|Combination Phase|Did not meet inclusion criteria|0|||
161976838|NCT02231762|584964428|FG000|Combination Phase|Protocol Violation|1|||
161976839|NCT02231762|584964429|FG001|Combination Phase|Protocol Violation|0|||
161976840|NCT02231762|584964430|FG002|Combination Phase|Protocol Violation|0|||
161976841|NCT02231762|584964431|FG003|Combination Phase|Protocol Violation|0|||
161976842|NCT02231762|584964428|FG000|Maintenance Phase|Disease progression|0|||
161976843|NCT02231762|584964429|FG001|Maintenance Phase|Disease progression|3|||
161976844|NCT02231762|584964430|FG002|Maintenance Phase|Disease progression|4|||
161976845|NCT02231762|584964431|FG003|Maintenance Phase|Disease progression|3|||
161976846|NCT02231762|584964428|FG000|Maintenance Phase|Adverse Event|0|||
161976847|NCT02231762|584964429|FG001|Maintenance Phase|Adverse Event|0|||
161976848|NCT02231762|584964430|FG002|Maintenance Phase|Adverse Event|1|||
161976849|NCT02231762|584964431|FG003|Maintenance Phase|Adverse Event|2|||
161976850|NCT01697462|584964432|FG000|Overall Study|Disease Progression|1|||
161976851|NCT01697462|584964432|FG000|Overall Study|Adverse Event|6|||
161976852|NCT01697462|584964432|FG000|Overall Study|Lost to Follow-up|21|||
161976853|NCT01697462|584964432|FG000|Overall Study|Withdrawal by Subject|12|||
161976854|NCT01697462|584964432|FG000|Overall Study|Investigator Decision|21|||
161976855|NCT01697462|584964432|FG000|Overall Study|Death|1|||
161976856|NCT01697462|584964432|FG000|Overall Study|Other|10|||
161976857|NCT01697462|584964432|FG000|Overall Study|Missing|5|||
161976858|NCT00168103|584964437|FG000|Overall Study|Withdrawal by Subject|1|||
161976859|NCT00168103|584964438|FG001|Overall Study|Withdrawal by Subject|2|||
161771211|NCT01990339|584204268|FG000|Overall Study|Lost to Follow-up|861|||
161771212|NCT01038609|584204269|FG000|Overall Study|Adverse Event|0|||
161771213|NCT01038609|584204270|FG001|Overall Study|Adverse Event|0|||
161771214|NCT01038609|584204271|FG002|Overall Study|Adverse Event|1|||
161771215|NCT01038609|584204272|FG003|Overall Study|Adverse Event|0|||
161771216|NCT01038609|584204273|FG004|Overall Study|Adverse Event|0|||
161771217|NCT01038609|584204269|FG000|Overall Study|Dosing Error|0|||
161771218|NCT01038609|584204270|FG001|Overall Study|Dosing Error|0|||
161771219|NCT01038609|584204271|FG002|Overall Study|Dosing Error|0|||
161771220|NCT01038609|584204272|FG003|Overall Study|Dosing Error|1|||
161771221|NCT01038609|584204273|FG004|Overall Study|Dosing Error|1|||
161771222|NCT01038609|584204269|FG000|Overall Study|Death in the Family|1|||
161771223|NCT01038609|584204270|FG001|Overall Study|Death in the Family|0|||
161771224|NCT01038609|584204271|FG002|Overall Study|Death in the Family|0|||
161771225|NCT01038609|584204272|FG003|Overall Study|Death in the Family|0|||
161771226|NCT01038609|584204273|FG004|Overall Study|Death in the Family|0|||
161771227|NCT01038609|584204269|FG000|Overall Study|Refusal of Blood Draws|0|||
161771228|NCT01038609|584204270|FG001|Overall Study|Refusal of Blood Draws|1|||
161771229|NCT01038609|584204271|FG002|Overall Study|Refusal of Blood Draws|0|||
161771230|NCT01038609|584204272|FG003|Overall Study|Refusal of Blood Draws|0|||
161771231|NCT01038609|584204273|FG004|Overall Study|Refusal of Blood Draws|0|||
161771232|NCT00242658|584204276|FG000|Overall Study|Lost to Follow-up|22|||
161771233|NCT00242658|584204277|FG001|Overall Study|Lost to Follow-up|19|||
161771234|NCT01590810|584204278|FG000|Overall Study|Physician Decision|0|||
161771235|NCT01590810|584204279|FG001|Overall Study|Physician Decision|1|||
161771236|NCT01590810|584204280|FG002|Overall Study|Physician Decision|1|||
161771237|NCT01590810|584204281|FG003|Overall Study|Physician Decision|0|||
161771238|NCT01590810|584204282|FG004|Overall Study|Physician Decision|0|||
161771239|NCT01087944|584204283|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
161771240|NCT01087944|584204284|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
161771241|NCT01087944|584204283|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
161771242|NCT01087944|584204284|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
161771243|NCT01731600|584204285|FG000|Overall Study|Adverse Event|2|||
161771244|NCT01731600|584204286|FG001|Overall Study|Adverse Event|0|||
161771245|NCT01731600|584204285|FG000|Overall Study|Withdrawal criteria|1|||
161771246|NCT01731600|584204286|FG001|Overall Study|Withdrawal criteria|0|||
161771247|NCT01731600|584204285|FG000|Overall Study|Other reasons|3|||
161771248|NCT01731600|584204286|FG001|Overall Study|Other reasons|0|||
161771249|NCT00540228|584204287|FG000|Overall Study|Adverse Event|2|||
161771250|NCT00540228|584204288|FG001|Overall Study|Adverse Event|0|||
161771251|NCT00540228|584204289|FG002|Overall Study|Adverse Event|0|||
161771252|NCT00540228|584204290|FG003|Overall Study|Adverse Event|0|||
161771253|NCT00540228|584204291|FG004|Overall Study|Adverse Event|0|||
161771254|NCT00540228|584204287|FG000|Overall Study|Lost to Follow-up|1|||
161771255|NCT00540228|584204288|FG001|Overall Study|Lost to Follow-up|1|||
161771256|NCT00540228|584204289|FG002|Overall Study|Lost to Follow-up|0|||
161771257|NCT00540228|584204290|FG003|Overall Study|Lost to Follow-up|0|||
161771258|NCT00540228|584204291|FG004|Overall Study|Lost to Follow-up|0|||
161771259|NCT01883362|584204292|FG000|Treatment|Adverse Event|1|||
161771260|NCT01883362|584204293|FG001|Treatment|Adverse Event|8|||
161771261|NCT01883362|584204292|FG000|Treatment|Withdrawal by Subject|6|||
161771262|NCT01883362|584204293|FG001|Treatment|Withdrawal by Subject|2|||
161771263|NCT01883362|584204292|FG000|Treatment|Administrative problems|4|||
161771264|NCT01883362|584204293|FG001|Treatment|Administrative problems|1|||
161771265|NCT01883362|584204292|FG000|Treatment|Relapse|4|||
161771266|NCT01883362|584204293|FG001|Treatment|Relapse|2|||
161976860|NCT00168103|584964439|FG002|Overall Study|Withdrawal by Subject|1|||
161976861|NCT00168103|584964440|FG003|Overall Study|Withdrawal by Subject|0|||
161976862|NCT00168103|584964437|FG000|Overall Study|Lost to Follow-up|1|||
161976863|NCT00168103|584964438|FG001|Overall Study|Lost to Follow-up|3|||
161976864|NCT00168103|584964439|FG002|Overall Study|Lost to Follow-up|0|||
161976865|NCT00168103|584964440|FG003|Overall Study|Lost to Follow-up|0|||
161976866|NCT02699450|584964448|FG000|Overall Study|Death|2|||
161771267|NCT01883362|584204292|FG000|Treatment|Randomized, not treated|1|||
161976867|NCT02699450|584964449|FG001|Overall Study|Death|1|||
161976868|NCT02699450|584964450|FG002|Overall Study|Death|2|||
161771268|NCT01883362|584204293|FG001|Treatment|Randomized, not treated|1|||
161976869|NCT02699450|584964448|FG000|Overall Study|Met Criteria for Study Exit|0|||
161771269|NCT01883362|584204292|FG000|Post Treatment Follow-up|Protocol Violation|0|||
161771270|NCT01883362|584204293|FG001|Post Treatment Follow-up|Protocol Violation|1|||
161771271|NCT01883362|584204292|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
161771272|NCT01883362|584204293|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
161771273|NCT01883362|584204292|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
161771274|NCT01883362|584204293|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
161771275|NCT01883362|584204292|FG000|Post Treatment Follow-up|Administrative problems|2|||
161771276|NCT01883362|584204293|FG001|Post Treatment Follow-up|Administrative problems|0|||
161771277|NCT01883362|584204292|FG000|Post Treatment Follow-up|Death|8|||
161771278|NCT01883362|584204293|FG001|Post Treatment Follow-up|Death|4|||
161771279|NCT01883362|584204292|FG000|Post Treatment Follow-up|Relapse|1|||
161771280|NCT01883362|584204293|FG001|Post Treatment Follow-up|Relapse|2|||
161976870|NCT02699450|584964449|FG001|Overall Study|Met Criteria for Study Exit|0|||
161976871|NCT02699450|584964450|FG002|Overall Study|Met Criteria for Study Exit|1|||
161976872|NCT02699450|584964448|FG000|Overall Study|Protocol Violation|4|||
161976873|NCT02699450|584964449|FG001|Overall Study|Protocol Violation|3|||
161976874|NCT02699450|584964450|FG002|Overall Study|Protocol Violation|5|||
161976875|NCT02699450|584964448|FG000|Overall Study|Lost to Follow-up|3|||
161976876|NCT02699450|584964449|FG001|Overall Study|Lost to Follow-up|0|||
161976877|NCT02699450|584964450|FG002|Overall Study|Lost to Follow-up|5|||
161976878|NCT02699450|584964448|FG000|Overall Study|Physician Decision|2|||
161976879|NCT02699450|584964449|FG001|Overall Study|Physician Decision|0|||
161976880|NCT02699450|584964450|FG002|Overall Study|Physician Decision|0|||
161976881|NCT02699450|584964448|FG000|Overall Study|Withdrawal by Subject|3|||
161976882|NCT02699450|584964449|FG001|Overall Study|Withdrawal by Subject|1|||
161976883|NCT02699450|584964450|FG002|Overall Study|Withdrawal by Subject|2|||
161976884|NCT02699450|584964448|FG000|Overall Study|Adverse Event|1|||
161976885|NCT02699450|584964449|FG001|Overall Study|Adverse Event|0|||
161976886|NCT02699450|584964450|FG002|Overall Study|Adverse Event|0|||
161976887|NCT03689712|584964451|FG000|Overall Study|Adverse Event|1|||
161976888|NCT03689712|584964452|FG001|Overall Study|Adverse Event|0|||
161976889|NCT03689712|584964451|FG000|Overall Study|Death|20|||
161976890|NCT03689712|584964452|FG001|Overall Study|Death|10|||
161976891|NCT03689712|584964451|FG000|Overall Study|Lost to Follow-up|6|||
161976892|NCT03689712|584964452|FG001|Overall Study|Lost to Follow-up|6|||
161976893|NCT03689712|584964451|FG000|Overall Study|Other|1|||
161976894|NCT03689712|584964452|FG001|Overall Study|Other|0|||
161976895|NCT03689712|584964451|FG000|Overall Study|Patient Non-Compliance|0|||
161976896|NCT03689712|584964452|FG001|Overall Study|Patient Non-Compliance|1|||
161976897|NCT03689712|584964451|FG000|Overall Study|Withdrawal by Subject|20|||
161976898|NCT03689712|584964452|FG001|Overall Study|Withdrawal by Subject|4|||
161976899|NCT03689712|584964451|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
161976900|NCT03689712|584964452|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
161976901|NCT03689712|584964451|FG000|Overall Study|Randomized but not Treated|13|||
161976902|NCT03689712|584964452|FG001|Overall Study|Randomized but not Treated|7|||
161976903|NCT03689712|584964451|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
161976904|NCT03689712|584964452|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
161976905|NCT01133275|584964455|FG000|Overall Study|Withdrawal by Subject|1|||
161976906|NCT01133275|584964455|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
161976907|NCT01635764|584964462|FG000|Overall Study|Adverse Event|46|||
161976908|NCT01635764|584964462|FG000|Overall Study|Lack of Efficacy|76|||
161976909|NCT01635764|584964462|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
161976910|NCT01635764|584964462|FG000|Overall Study|Protocol Deviation|1|||
161976911|NCT01635764|584964462|FG000|Overall Study|Withdrew Consent|67|||
161976912|NCT01635764|584964462|FG000|Overall Study|Lost to Follow-up|53|||
161976913|NCT01635764|584964462|FG000|Overall Study|Other|28|||
161976914|NCT02266875|584964464|FG000|Overall Study|Withdrawal by Subject|9|||
161976915|NCT02266875|584964465|FG001|Overall Study|Withdrawal by Subject|0|||
161976916|NCT02266875|584964464|FG000|Overall Study|Lost to Follow-up|2|||
161976917|NCT02266875|584964465|FG001|Overall Study|Lost to Follow-up|0|||
161976918|NCT02956850|584964466|FG000|Overall Study|Withdrawal by Subject|0|||
161976919|NCT02956850|584964467|FG001|Overall Study|Withdrawal by Subject|0|||
161976920|NCT02956850|584964468|FG002|Overall Study|Withdrawal by Subject|0|||
161976921|NCT02956850|584964469|FG003|Overall Study|Withdrawal by Subject|0|||
161976922|NCT02956850|584964470|FG004|Overall Study|Withdrawal by Subject|0|||
161976923|NCT02956850|584964471|FG005|Overall Study|Withdrawal by Subject|0|||
161976924|NCT02956850|584964472|FG006|Overall Study|Withdrawal by Subject|0|||
161976925|NCT02956850|584964473|FG007|Overall Study|Withdrawal by Subject|0|||
161976926|NCT02956850|584964474|FG008|Overall Study|Withdrawal by Subject|0|||
161976927|NCT02956850|584964475|FG009|Overall Study|Withdrawal by Subject|0|||
161976928|NCT02956850|584964476|FG010|Overall Study|Withdrawal by Subject|0|||
161976929|NCT02956850|584964477|FG011|Overall Study|Withdrawal by Subject|0|||
161976930|NCT02956850|584964478|FG012|Overall Study|Withdrawal by Subject|0|||
161976931|NCT02956850|584964479|FG013|Overall Study|Withdrawal by Subject|0|||
161976932|NCT02956850|584964480|FG014|Overall Study|Withdrawal by Subject|0|||
161976933|NCT02956850|584964481|FG015|Overall Study|Withdrawal by Subject|0|||
161976934|NCT02956850|584964482|FG016|Overall Study|Withdrawal by Subject|0|||
161976935|NCT02956850|584964483|FG017|Overall Study|Withdrawal by Subject|1|||
161976936|NCT01816906|584964484|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
161976937|NCT01816906|584964485|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
161976938|NCT01816906|584964484|FG000|Six Months|Lost to Follow-up|14|||
161976939|NCT01816906|584964485|FG001|Six Months|Lost to Follow-up|16|||
161976940|NCT01816906|584964484|FG000|12 Months|Adverse Event|2|||
161976941|NCT01816906|584964485|FG001|12 Months|Adverse Event|2|||
161976942|NCT01816906|584964484|FG000|12 Months|Death|0|||
161976943|NCT01816906|584964485|FG001|12 Months|Death|2|||
161976944|NCT01816906|584964484|FG000|12 Months|Lost to Follow-up|2|||
161976945|NCT01816906|584964485|FG001|12 Months|Lost to Follow-up|1|||
161976946|NCT00086502|584964486|FG000|Overall Study|Adverse Event|11|||
161976947|NCT00086502|584964487|FG001|Overall Study|Adverse Event|2|||
161976948|NCT00086502|584964486|FG000|Overall Study|Lack of Efficacy|0|||
161976949|NCT00086502|584964487|FG001|Overall Study|Lack of Efficacy|2|||
161976950|NCT00086502|584964486|FG000|Overall Study|Lost to Follow-up|3|||
161976951|NCT00086502|584964487|FG001|Overall Study|Lost to Follow-up|1|||
161976952|NCT00086502|584964486|FG000|Overall Study|Physician Decision|1|||
161976953|NCT00086502|584964487|FG001|Overall Study|Physician Decision|1|||
161976954|NCT00086502|584964486|FG000|Overall Study|Pregnancy|0|||
161976955|NCT00086502|584964487|FG001|Overall Study|Pregnancy|1|||
161976956|NCT00086502|584964486|FG000|Overall Study|Protocol Violation|3|||
161976957|NCT00086502|584964487|FG001|Overall Study|Protocol Violation|3|||
161976958|NCT00086502|584964486|FG000|Overall Study|Withdrawal by Subject|5|||
161976959|NCT00086502|584964487|FG001|Overall Study|Withdrawal by Subject|6|||
161976960|NCT00086502|584964486|FG000|Overall Study|Patient Moved|1|||
161976961|NCT00086502|584964487|FG001|Overall Study|Patient Moved|1|||
161976962|NCT00086502|584964486|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
161976963|NCT00086502|584964487|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
161976964|NCT00086502|584964486|FG000|Overall Study|Patient Accidentally Unblinded|1|||
161976965|NCT00086502|584964487|FG001|Overall Study|Patient Accidentally Unblinded|0|||
161976966|NCT01304329|584964488|FG000|Third Intervention (3 Days)|Adverse Event|0|||
161976967|NCT01304329|584964489|FG001|Third Intervention (3 Days)|Adverse Event|1|||
161976968|NCT01304329|584964490|FG002|Third Intervention (3 Days)|Adverse Event|0|||
161976969|NCT01304329|584964491|FG003|Third Intervention (3 Days)|Adverse Event|0|||
161976970|NCT01304329|584964492|FG004|Third Intervention (3 Days)|Adverse Event|0|||
161976971|NCT01304329|584964493|FG005|Third Intervention (3 Days)|Adverse Event|0|||
161976972|NCT05545644|584964495|FG000|Overall Study|Lost to Follow-up|4|||
161976973|NCT05545644|584964496|FG001|Overall Study|Lost to Follow-up|3|||
161976974|NCT01995552|584964502|FG000|Overall Study|Protocol Violation|1|||
161976975|NCT01995552|584964502|FG000|Overall Study|Lack of Efficacy|15|||
161976976|NCT01995552|584964502|FG000|Overall Study|Death|1|||
161976977|NCT02068118|584964503|FG000|18-month Comparative Study Period|Death|90|||
161976978|NCT02068118|584964504|FG001|18-month Comparative Study Period|Death|97|||
161976979|NCT02068118|584964503|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
161976980|NCT02068118|584964504|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
161976981|NCT02068118|584964503|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
161976982|NCT02068118|584964504|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
161976983|NCT02068118|584964503|FG000|18-month Comparative Study Period|Heart transplant|9|||
161976984|NCT02068118|584964504|FG001|18-month Comparative Study Period|Heart transplant|15|||
161976985|NCT02068118|584964503|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
161976986|NCT02068118|584964504|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
161976987|NCT02068118|584964503|FG000|18-month Comparative Study Period|Hemiplegia|0|||
161976988|NCT02068118|584964504|FG001|18-month Comparative Study Period|Hemiplegia|1|||
161976989|NCT02068118|584964503|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
161976990|NCT02068118|584964504|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
161976991|NCT02068118|584964503|FG000|18-month Comparative Study Period|Move|0|||
161976992|NCT02068118|584964504|FG001|18-month Comparative Study Period|Move|1|||
161976993|NCT02068118|584964503|FG000|18-month Comparative Study Period|Hearing loss|0|||
161976994|NCT02068118|584964504|FG001|18-month Comparative Study Period|Hearing loss|1|||
161976995|NCT02068118|584964503|FG000|Extension Period|Death|0|||
161976996|NCT02068118|584964504|FG001|Extension Period|Death|2|||
161976997|NCT02068118|584964503|FG000|Extension Period|Withdrawal by Subject|1|||
161976998|NCT02068118|584964504|FG001|Extension Period|Withdrawal by Subject|0|||
161976999|NCT02068118|584964503|FG000|Extension Period|Heart transplant|1|||
161977000|NCT02068118|584964504|FG001|Extension Period|Heart transplant|0|||
161977001|NCT02068118|584964503|FG000|Extension Period|Wrong device use|0|||
161977002|NCT02068118|584964504|FG001|Extension Period|Wrong device use|1|||
161977003|NCT00353873|584964505|FG000|Overall Study|Protocol Violation|1|||
161977004|NCT00353873|584964506|FG001|Overall Study|Protocol Violation|2|||
161977005|NCT00353873|584964505|FG000|Overall Study|Exacerbation|1|||
161977006|NCT00353873|584964506|FG001|Overall Study|Exacerbation|0|||
161977007|NCT00353873|584964505|FG000|Overall Study|Adverse Event|1|||
161977008|NCT00353873|584964506|FG001|Overall Study|Adverse Event|0|||
161977009|NCT00353873|584964505|FG000|Overall Study|Physician Decision|2|||
161977010|NCT00353873|584964506|FG001|Overall Study|Physician Decision|0|||
161977011|NCT00353873|584964505|FG000|Overall Study|Withdrawal by Subject|1|||
161977012|NCT00353873|584964506|FG001|Overall Study|Withdrawal by Subject|1|||
161977013|NCT01420627|584964507|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
161977014|NCT00453973|584964508|FG000|Overall Study|Adverse Event|4|||
161977015|NCT00453973|584964509|FG001|Overall Study|Adverse Event|9|||
161977016|NCT00453973|584964508|FG000|Overall Study|Withdrawal by Subject|7|||
161977017|NCT00453973|584964509|FG001|Overall Study|Withdrawal by Subject|6|||
161977018|NCT00453973|584964508|FG000|Overall Study|PI Decision|0|||
161977019|NCT00453973|584964509|FG001|Overall Study|PI Decision|2|||
161977020|NCT00453973|584964508|FG000|Overall Study|Relocation|1|||
161977021|NCT00453973|584964509|FG001|Overall Study|Relocation|0|||
161977022|NCT00453973|584964508|FG000|Overall Study|Renal transplant|1|||
161977023|NCT00453973|584964509|FG001|Overall Study|Renal transplant|1|||
161977024|NCT00453973|584964508|FG000|Overall Study|Site closed by sponsor|3|||
161977025|NCT00453973|584964509|FG001|Overall Study|Site closed by sponsor|0|||
161977026|NCT00453973|584964508|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
161977027|NCT00453973|584964509|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
161977028|NCT03743064|584964514|FG000|Overall Study|Adverse Event|7|||
161977029|NCT03743064|584964515|FG001|Overall Study|Adverse Event|9|||
161977030|NCT03743064|584964514|FG000|Overall Study|Death|25|||
161977031|NCT03743064|584964515|FG001|Overall Study|Death|28|||
161977032|NCT03743064|584964514|FG000|Overall Study|Lost to Follow-up|3|||
161977033|NCT03743064|584964515|FG001|Overall Study|Lost to Follow-up|6|||
161977034|NCT03743064|584964514|FG000|Overall Study|Withdrawal by Subject|28|||
161977035|NCT03743064|584964515|FG001|Overall Study|Withdrawal by Subject|25|||
161977036|NCT03743064|584964514|FG000|Overall Study|Physician Decision|2|||
161977037|NCT03743064|584964515|FG001|Overall Study|Physician Decision|4|||
161977038|NCT03743064|584964514|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
161977039|NCT03743064|584964515|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
161977040|NCT02759315|584964516|FG000|Overall Study|Adverse Event|0|||
161977041|NCT02759315|584964517|FG001|Overall Study|Adverse Event|0|||
161977042|NCT02759315|584964518|FG002|Overall Study|Adverse Event|0|||
161977043|NCT02759315|584964519|FG003|Overall Study|Adverse Event|1|||
161977044|NCT02759315|584964520|FG004|Overall Study|Adverse Event|0|||
161977045|NCT02759315|584964516|FG000|Overall Study|Death|0|||
161977046|NCT02759315|584964517|FG001|Overall Study|Death|0|||
161977047|NCT02759315|584964518|FG002|Overall Study|Death|1|||
161977048|NCT02759315|584964519|FG003|Overall Study|Death|0|||
161977049|NCT02759315|584964520|FG004|Overall Study|Death|0|||
161977050|NCT02759315|584964516|FG000|Overall Study|Lost to Follow-up|2|||
161977051|NCT02759315|584964517|FG001|Overall Study|Lost to Follow-up|0|||
161977052|NCT02759315|584964518|FG002|Overall Study|Lost to Follow-up|4|||
161977053|NCT02759315|584964519|FG003|Overall Study|Lost to Follow-up|0|||
161977054|NCT02759315|584964520|FG004|Overall Study|Lost to Follow-up|0|||
161977055|NCT02759315|584964516|FG000|Overall Study|Protocol Violation|0|||
161977056|NCT02759315|584964517|FG001|Overall Study|Protocol Violation|1|||
161977057|NCT02759315|584964518|FG002|Overall Study|Protocol Violation|0|||
161977058|NCT02759315|584964519|FG003|Overall Study|Protocol Violation|0|||
161977059|NCT02759315|584964520|FG004|Overall Study|Protocol Violation|0|||
161977060|NCT02759315|584964516|FG000|Overall Study|Study terminated prior to completion|2|||
161977061|NCT02759315|584964517|FG001|Overall Study|Study terminated prior to completion|0|||
161977062|NCT02759315|584964518|FG002|Overall Study|Study terminated prior to completion|5|||
161977063|NCT02759315|584964519|FG003|Overall Study|Study terminated prior to completion|0|||
161977064|NCT02759315|584964520|FG004|Overall Study|Study terminated prior to completion|1|||
161977065|NCT00870194|584964521|FG000|Overall Study|Adverse Event|10|||
161977066|NCT00870194|584964522|FG001|Overall Study|Adverse Event|5|||
161977067|NCT00870194|584964521|FG000|Overall Study|Lack of Efficacy|0|||
161977068|NCT00870194|584964522|FG001|Overall Study|Lack of Efficacy|1|||
161977069|NCT00870194|584964521|FG000|Overall Study|Lost to Follow-up|2|||
161977070|NCT00870194|584964522|FG001|Overall Study|Lost to Follow-up|0|||
161977071|NCT00870194|584964521|FG000|Overall Study|Physician Decision|3|||
161977072|NCT00870194|584964522|FG001|Overall Study|Physician Decision|1|||
161977073|NCT00870194|584964521|FG000|Overall Study|Protocol Violation|3|||
161977074|NCT00870194|584964522|FG001|Overall Study|Protocol Violation|3|||
161977075|NCT00870194|584964521|FG000|Overall Study|Entry Criteria Not Met|1|||
161977076|NCT00870194|584964522|FG001|Overall Study|Entry Criteria Not Met|2|||
161977077|NCT00870194|584964521|FG000|Overall Study|Subject Decision|7|||
161977078|NCT00870194|584964522|FG001|Overall Study|Subject Decision|2|||
161977079|NCT00582738|584964524|FG000|Overall Study|Administrative Problems|7|||
161977080|NCT00582738|584964525|FG001|Overall Study|Administrative Problems|8|||
161977081|NCT00582738|584964524|FG000|Overall Study|Adverse Event|0|||
161977082|NCT00582738|584964525|FG001|Overall Study|Adverse Event|5|||
161977083|NCT00582738|584964524|FG000|Overall Study|Graft Lost|0|||
161977084|NCT00582738|584964525|FG001|Overall Study|Graft Lost|1|||
161977085|NCT00582738|584964524|FG000|Overall Study|Other|1|||
161977086|NCT00582738|584964525|FG001|Overall Study|Other|0|||
161977087|NCT00582738|584964524|FG000|Overall Study|Protocol Violation|1|||
161977088|NCT00582738|584964525|FG001|Overall Study|Protocol Violation|1|||
161977089|NCT00582738|584964524|FG000|Overall Study|Withdrawal by Subject|0|||
161977090|NCT00582738|584964525|FG001|Overall Study|Withdrawal by Subject|3|||
161977091|NCT01490294|584964527|FG000|Overall Study|Prematurely discontinuation|4|||
161977092|NCT01490294|584964528|FG001|Overall Study|Prematurely discontinuation|0|||
161977093|NCT01490294|584964529|FG002|Overall Study|Prematurely discontinuation|1|||
161977094|NCT01490294|584964530|FG003|Overall Study|Prematurely discontinuation|1|||
161977095|NCT01490294|584964527|FG000|Overall Study|Adverse Event|1|||
161977096|NCT01490294|584964528|FG001|Overall Study|Adverse Event|0|||
161977097|NCT01490294|584964529|FG002|Overall Study|Adverse Event|0|||
161977098|NCT01490294|584964530|FG003|Overall Study|Adverse Event|0|||
161977099|NCT02210091|584964536|FG000|Overall Study|Physician Decision|0|||
161977100|NCT02210091|584964537|FG001|Overall Study|Physician Decision|1|||
161977101|NCT02210091|584964536|FG000|Overall Study|Withdrawal by Sponsor|0|||
161977102|NCT02210091|584964537|FG001|Overall Study|Withdrawal by Sponsor|1|||
161977103|NCT01831817|584964538|FG000|Overall Study|Lost to Follow-up|1|||
161977104|NCT01831817|584964539|FG001|Overall Study|Lost to Follow-up|0|||
161977105|NCT01831817|584964540|FG002|Overall Study|Lost to Follow-up|0|||
161977106|NCT01831817|584964541|FG003|Overall Study|Lost to Follow-up|0|||
161977107|NCT01831817|584964538|FG000|Overall Study|Withdrawl of Consent|3|||
161977108|NCT01831817|584964539|FG001|Overall Study|Withdrawl of Consent|0|||
161977109|NCT01831817|584964540|FG002|Overall Study|Withdrawl of Consent|0|||
161977110|NCT01831817|584964541|FG003|Overall Study|Withdrawl of Consent|0|||
161977111|NCT00958217|584964542|FG000|Overall Study|Death|2|||
161977112|NCT00958217|584964543|FG001|Overall Study|Death|1|||
161977113|NCT00958217|584964542|FG000|Overall Study|Withdrawal by Subject|4|||
161977114|NCT00958217|584964543|FG001|Overall Study|Withdrawal by Subject|3|||
161977115|NCT00958217|584964542|FG000|Overall Study|Lost to Follow-up|17|||
161977116|NCT00958217|584964543|FG001|Overall Study|Lost to Follow-up|19|||
161977117|NCT00958217|584964542|FG000|Overall Study|Moved out of area|1|||
161977118|NCT00958217|584964543|FG001|Overall Study|Moved out of area|1|||
161977119|NCT00958217|584964542|FG000|Overall Study|Inpatient hospitalization|0|||
161977120|NCT00958217|584964543|FG001|Overall Study|Inpatient hospitalization|1|||
161977121|NCT02440789|584964544|FG000|Overall Study|Withdrawal by Subject|3|||
161977122|NCT02440789|584964544|FG000|Overall Study|Not willing to adhere to reqs|1|||
161977123|NCT01999218|584964545|FG000|Overall Study|Hyperglycemia|18|||
162034556|NCT01892722|585182097|FG001|Overall Study|Withdrawal by Subject|5|||
162034557|NCT02275910|585182098|FG000|Overall Study|Subject Choice|0|||
162034558|NCT02275910|585182099|FG001|Overall Study|Subject Choice|0|||
162034559|NCT02275910|585182100|FG002|Overall Study|Subject Choice|0|||
162034560|NCT02275910|585182101|FG003|Overall Study|Subject Choice|0|||
162034561|NCT02275910|585182102|FG004|Overall Study|Subject Choice|0|||
162034562|NCT02275910|585182103|FG005|Overall Study|Subject Choice|0|||
162034563|NCT02275910|585182104|FG006|Overall Study|Subject Choice|0|||
162034564|NCT02275910|585182105|FG007|Overall Study|Subject Choice|0|||
162034565|NCT02275910|585182106|FG008|Overall Study|Subject Choice|1|||
162034566|NCT02275910|585182107|FG009|Overall Study|Subject Choice|0|||
162034567|NCT02275910|585182108|FG010|Overall Study|Subject Choice|0|||
162034568|NCT02275910|585182109|FG011|Overall Study|Subject Choice|0|||
162034569|NCT02275910|585182098|FG000|Overall Study|Radiological Disease Progression|0|||
162034570|NCT02275910|585182099|FG001|Overall Study|Radiological Disease Progression|0|||
162034571|NCT02275910|585182100|FG002|Overall Study|Radiological Disease Progression|0|||
162034572|NCT02275910|585182101|FG003|Overall Study|Radiological Disease Progression|0|||
162034573|NCT02275910|585182102|FG004|Overall Study|Radiological Disease Progression|0|||
162034574|NCT02275910|585182103|FG005|Overall Study|Radiological Disease Progression|0|||
162034575|NCT02275910|585182104|FG006|Overall Study|Radiological Disease Progression|1|||
162034576|NCT02275910|585182105|FG007|Overall Study|Radiological Disease Progression|1|||
162034577|NCT02275910|585182106|FG008|Overall Study|Radiological Disease Progression|0|||
162034578|NCT02275910|585182107|FG009|Overall Study|Radiological Disease Progression|1|||
162034579|NCT02275910|585182108|FG010|Overall Study|Radiological Disease Progression|0|||
162034580|NCT02275910|585182109|FG011|Overall Study|Radiological Disease Progression|0|||
162034581|NCT01155219|585183465|FG000|Overall Study|Adverse Event|3|||
162034582|NCT01155219|585183466|FG001|Overall Study|Adverse Event|1|||
162034583|NCT01155219|585183465|FG000|Overall Study|non-medical reason|1|||
162034584|NCT01155219|585183466|FG001|Overall Study|non-medical reason|2|||
162034585|NCT03052764|585183467|FG000|Double-Blind Treatment Period|Adverse Event|2|||
162034586|NCT03052764|585183468|FG001|Double-Blind Treatment Period|Adverse Event|0|||
162034587|NCT03052764|585183467|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
162034588|NCT03052764|585183468|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
162034589|NCT03052764|585183467|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
162034590|NCT03052764|585183468|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
162034591|NCT03052764|585183467|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
162034592|NCT03052764|585183468|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162034593|NCT03052764|585183467|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
162034594|NCT03052764|585183468|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
162034595|NCT01314911|585183469|FG000|Overall Study|Lost to Follow-up|3|||
162034596|NCT01314911|585183470|FG001|Overall Study|Lost to Follow-up|2|||
162034597|NCT01314911|585183469|FG000|Overall Study|Withdrawal by Subject|1|||
162034598|NCT01314911|585183470|FG001|Overall Study|Withdrawal by Subject|3|||
162034599|NCT01314911|585183469|FG000|Overall Study|Received Non-randomized Study Drug|0|||
162034600|NCT01314911|585183470|FG001|Overall Study|Received Non-randomized Study Drug|1|||
162034601|NCT01314911|585183469|FG000|Overall Study|Never Started Treatment|1|||
161977124|NCT01999218|584964546|FG001|Overall Study|Hyperglycemia|17|||
161977125|NCT01999218|584964547|FG002|Overall Study|Hyperglycemia|17|||
161977126|NCT01999218|584964545|FG000|Overall Study|Lack of Efficacy|1|||
161977127|NCT01999218|584964546|FG001|Overall Study|Lack of Efficacy|0|||
161977128|NCT01999218|584964547|FG002|Overall Study|Lack of Efficacy|1|||
161977129|NCT01999218|584964545|FG000|Overall Study|Lost to Follow-up|22|||
161977130|NCT01999218|584964546|FG001|Overall Study|Lost to Follow-up|17|||
161977131|NCT01999218|584964547|FG002|Overall Study|Lost to Follow-up|18|||
161977132|NCT01999218|584964545|FG000|Overall Study|Non-Compliance With Study Drug|6|||
161977133|NCT01999218|584964546|FG001|Overall Study|Non-Compliance With Study Drug|4|||
161977134|NCT01999218|584964547|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161977135|NCT01999218|584964545|FG000|Overall Study|Physician Decision|1|||
161977136|NCT01999218|584964546|FG001|Overall Study|Physician Decision|4|||
161977137|NCT01999218|584964547|FG002|Overall Study|Physician Decision|6|||
162034602|NCT01314911|585183470|FG001|Overall Study|Never Started Treatment|0|||
162034603|NCT03150485|585183474|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
162034604|NCT03150485|585183475|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
162034605|NCT03150485|585183476|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
162034606|NCT03150485|585183477|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
162034607|NCT03150485|585183478|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
162034608|NCT03150485|585183479|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
162034609|NCT01394718|585183481|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
162034610|NCT01394718|585183482|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
162034611|NCT01695005|585183483|FG000|Overall Study|Lost to Follow-up|0|||
162034612|NCT01695005|585183484|FG001|Overall Study|Lost to Follow-up|1|||
162034613|NCT01695005|585183485|FG002|Overall Study|Lost to Follow-up|1|||
162034614|NCT01695005|585183486|FG003|Overall Study|Lost to Follow-up|0|||
162034615|NCT01695005|585183487|FG004|Overall Study|Lost to Follow-up|0|||
162034616|NCT01695005|585183488|FG005|Overall Study|Lost to Follow-up|1|||
162034617|NCT01695005|585183489|FG006|Overall Study|Lost to Follow-up|1|||
162034618|NCT01695005|585183490|FG007|Overall Study|Lost to Follow-up|1|||
162034619|NCT01695005|585183491|FG008|Overall Study|Lost to Follow-up|3|||
162034620|NCT01695005|585183492|FG009|Overall Study|Lost to Follow-up|3|||
162034621|NCT01695005|585183493|FG010|Overall Study|Lost to Follow-up|8|||
162034622|NCT01695005|585183494|FG011|Overall Study|Lost to Follow-up|5|||
162034623|NCT01695005|585183495|FG012|Overall Study|Lost to Follow-up|2|||
162034624|NCT01695005|585183496|FG013|Overall Study|Lost to Follow-up|5|||
162034625|NCT01695005|585183497|FG014|Overall Study|Lost to Follow-up|0|||
162034626|NCT01695005|585183498|FG015|Overall Study|Lost to Follow-up|4|||
162034627|NCT01695005|585183499|FG016|Overall Study|Lost to Follow-up|0|||
162034628|NCT01695005|585183500|FG017|Overall Study|Lost to Follow-up|0|||
162034629|NCT01695005|585183501|FG018|Overall Study|Lost to Follow-up|0|||
162034630|NCT01695005|585183502|FG019|Overall Study|Lost to Follow-up|1|||
162034631|NCT01695005|585183503|FG020|Overall Study|Lost to Follow-up|1|||
162034632|NCT01695005|585183504|FG021|Overall Study|Lost to Follow-up|0|||
162034633|NCT01695005|585183505|FG022|Overall Study|Lost to Follow-up|2|||
161977138|NCT01999218|584964545|FG000|Overall Study|Protocol Violation|4|||
161977139|NCT01999218|584964546|FG001|Overall Study|Protocol Violation|5|||
161977140|NCT01999218|584964547|FG002|Overall Study|Protocol Violation|4|||
161977141|NCT01999218|584964545|FG000|Overall Study|Screen failure|0|||
161977142|NCT01999218|584964546|FG001|Overall Study|Screen failure|1|||
161977143|NCT01999218|584964547|FG002|Overall Study|Screen failure|0|||
161977144|NCT01999218|584964545|FG000|Overall Study|Study Terminated By Sponsor|7|||
161977145|NCT01999218|584964546|FG001|Overall Study|Study Terminated By Sponsor|5|||
161977146|NCT01999218|584964547|FG002|Overall Study|Study Terminated By Sponsor|12|||
161977147|NCT01999218|584964545|FG000|Overall Study|Participant moves|2|||
161977148|NCT01999218|584964546|FG001|Overall Study|Participant moves|5|||
161977149|NCT01999218|584964547|FG002|Overall Study|Participant moves|3|||
161977150|NCT01999218|584964545|FG000|Overall Study|Withdrawal by Subject|28|||
161977151|NCT01999218|584964546|FG001|Overall Study|Withdrawal by Subject|29|||
161977152|NCT01999218|584964547|FG002|Overall Study|Withdrawal by Subject|34|||
161977153|NCT01999218|584964545|FG000|Overall Study|Creatinine/eGFR|0|||
161977154|NCT01999218|584964546|FG001|Overall Study|Creatinine/eGFR|0|||
161977155|NCT01999218|584964547|FG002|Overall Study|Creatinine/eGFR|1|||
161977156|NCT01999218|584964545|FG000|Overall Study|Death|7|||
161977157|NCT01999218|584964546|FG001|Overall Study|Death|1|||
161977158|NCT01999218|584964547|FG002|Overall Study|Death|2|||
161977159|NCT01999218|584964545|FG000|Overall Study|Excluded Medication|1|||
161977160|NCT01999218|584964546|FG001|Overall Study|Excluded Medication|1|||
161977161|NCT01999218|584964547|FG002|Overall Study|Excluded Medication|2|||
161977162|NCT01999218|584964545|FG000|Overall Study|Adverse Event|9|||
161977163|NCT01999218|584964546|FG001|Overall Study|Adverse Event|7|||
161977164|NCT01999218|584964547|FG002|Overall Study|Adverse Event|7|||
161977165|NCT01999218|584964545|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
161977166|NCT01999218|584964546|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
161977167|NCT01999218|584964547|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
161977168|NCT01073930|584965991|FG000|Overall Study|Withdrawal by Subject|3|||
161977169|NCT01073930|584965992|FG001|Overall Study|Withdrawal by Subject|2|||
161977170|NCT01073930|584965991|FG000|Overall Study|Lost to Follow-up|0|||
161977171|NCT01073930|584965992|FG001|Overall Study|Lost to Follow-up|1|||
161977172|NCT01073930|584965991|FG000|Overall Study|Adverse Event|0|||
162034634|NCT01695005|585183506|FG023|Overall Study|Lost to Follow-up|4|||
162034635|NCT01695005|585183507|FG024|Overall Study|Lost to Follow-up|2|||
162034636|NCT01695005|585183508|FG025|Overall Study|Lost to Follow-up|0|||
161977173|NCT01073930|584965992|FG001|Overall Study|Adverse Event|1|||
161977174|NCT01073930|584965991|FG000|Overall Study|Noncompliance with study drug|0|||
161977175|NCT01073930|584965992|FG001|Overall Study|Noncompliance with study drug|1|||
161977176|NCT01073930|584965991|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
161977177|NCT01073930|584965992|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
161771281|NCT01383317|584204294|FG000|Overall Study|Lost to Follow-up|2|||
161771282|NCT01383317|584204295|FG001|Overall Study|Lost to Follow-up|1|||
161977178|NCT00541346|584965993|FG000|Follow-up|Adverse Event|1|||
161977179|NCT02008773|584965994|FG000|Overall Study|Adverse Event|3|||
161771283|NCT01383317|584204294|FG000|Overall Study|Death|1|||
161771284|NCT01383317|584204295|FG001|Overall Study|Death|0|||
161771285|NCT01383317|584204294|FG000|Overall Study|Adverse Event|0|||
161771286|NCT01383317|584204295|FG001|Overall Study|Adverse Event|1|||
161771287|NCT01349816|584204296|FG000|Overall Study|Withdrawal by Subject|4|||
161771288|NCT01349816|584204296|FG000|Overall Study|Physician Decision|1|||
161771289|NCT01349816|584204296|FG000|Overall Study|Adverse Event|14|||
161771290|NCT01349816|584204296|FG000|Overall Study|Lost to Follow-up|2|||
161771291|NCT01349816|584204296|FG000|Overall Study|Protocol Violation|1|||
161771292|NCT01349816|584204296|FG000|Overall Study|Protocol-specified criteria|8|||
161771293|NCT02569996|584204299|FG000|Overall Study|Adverse Event|6|||
161771294|NCT02569996|584204299|FG000|Overall Study|Physician Decision|3|||
161771295|NCT02569996|584204299|FG000|Overall Study|Progression of the disease|18|||
161771296|NCT02569996|584204299|FG000|Overall Study|New anti-lymphoma treatment|1|||
161771297|NCT02569996|584204299|FG000|Overall Study|Non-compliance|9|||
161771298|NCT02569996|584204299|FG000|Overall Study|Withdrawal by Subject|5|||
161771299|NCT02569996|584204299|FG000|Overall Study|Lost to Follow-up|5|||
161771300|NCT02569996|584204299|FG000|Overall Study|Complete remission|7|||
161771301|NCT02569996|584204299|FG000|Overall Study|Unknown reason|1|||
161771302|NCT02911285|584204300|FG000|Overall Study|Lost to Follow-up|8|||
161771303|NCT02911285|584204301|FG001|Overall Study|Lost to Follow-up|5|||
161771304|NCT02911285|584204300|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
161771305|NCT02911285|584204301|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
161771306|NCT02451137|584204303|FG000|Overall Study|Randomized but not treated|19|||
161771307|NCT02451137|584204304|FG001|Overall Study|Randomized but not treated|27|||
161771308|NCT02451137|584204303|FG000|Overall Study|Adverse Event|43|||
161771309|NCT02451137|584204304|FG001|Overall Study|Adverse Event|42|||
161771310|NCT02451137|584204303|FG000|Overall Study|Lack of Efficacy|4|||
161771311|NCT02451137|584204304|FG001|Overall Study|Lack of Efficacy|9|||
161771312|NCT02451137|584204303|FG000|Overall Study|Participant decision:discontinue insulin|41|||
161771313|NCT02451137|584204304|FG001|Overall Study|Participant decision:discontinue insulin|43|||
161771314|NCT02451137|584204303|FG000|Overall Study|Hypoglycemia|2|||
161771315|NCT02451137|584204304|FG001|Overall Study|Hypoglycemia|1|||
161771316|NCT02451137|584204303|FG000|Overall Study|Investigator's decision|23|||
161771317|NCT02451137|584204304|FG001|Overall Study|Investigator's decision|19|||
161771318|NCT02451137|584204303|FG000|Overall Study|Lost to Follow-up|53|||
161771319|NCT02451137|584204304|FG001|Overall Study|Lost to Follow-up|61|||
161771320|NCT02451137|584204303|FG000|Overall Study|Physician Decision|6|||
161771321|NCT02451137|584204304|FG001|Overall Study|Physician Decision|5|||
161771322|NCT02451137|584204303|FG000|Overall Study|Sponsor decision|13|||
161771323|NCT02451137|584204304|FG001|Overall Study|Sponsor decision|25|||
161771324|NCT02451137|584204303|FG000|Overall Study|Withdrawal by Subject|40|||
161771325|NCT02451137|584204304|FG001|Overall Study|Withdrawal by Subject|63|||
161771326|NCT02451137|584204303|FG000|Overall Study|Other than specified above|2|||
161771327|NCT02451137|584204304|FG001|Overall Study|Other than specified above|3|||
161771328|NCT02842736|584206250|FG000|Overall Study|Lost to Follow-up|13|||
161771329|NCT02842736|584206250|FG000|Overall Study|Intervention for menstrual bleeding|17|||
161771330|NCT02842736|584206250|FG000|Overall Study|Withdrawal by Subject|4|||
161771331|NCT02842736|584206250|FG000|Overall Study|Pregnancy|3|||
161771332|NCT02842736|584206250|FG000|Overall Study|Hysterectomy for fibroids|2|||
161771333|NCT02842736|584206250|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
161771334|NCT02842736|584206250|FG000|Overall Study|IUD: Mirena|1|||
161771335|NCT02389621|584206252|FG000|Treatment Period|Withdrawal by Subject|1|||
161771336|NCT02389621|584206253|FG001|Treatment Period|Withdrawal by Subject|1|||
161771337|NCT02389621|584206252|FG000|Posttreatment Period|Adverse Event|3|||
161771338|NCT02389621|584206253|FG001|Posttreatment Period|Adverse Event|1|||
161771339|NCT02389621|584206252|FG000|Posttreatment Period|Withdrawal by Subject|3|||
161771340|NCT02389621|584206253|FG001|Posttreatment Period|Withdrawal by Subject|2|||
161771341|NCT02389621|584206252|FG000|Posttreatment Period|Lost to Follow-up|1|||
161771342|NCT02389621|584206253|FG001|Posttreatment Period|Lost to Follow-up|1|||
161771343|NCT02389621|584206252|FG000|Posttreatment Period|Other - Miscellaneous|2|||
161771344|NCT02389621|584206253|FG001|Posttreatment Period|Other - Miscellaneous|0|||
161860474|NCT05198518|584531159|FG001|Screening Visit|Deemed unable to participate|0|||
161860475|NCT05198518|584531160|FG002|Screening Visit|Deemed unable to participate|0|||
161771345|NCT00726882|584206258|FG000|Overall Study|Withdrawal by Subject|5|||
161771346|NCT00726882|584206258|FG000|Overall Study|Lost to Follow-up|7|||
161771347|NCT00726882|584206258|FG000|Overall Study|Other|10|||
161771348|NCT00344968|584206259|FG000|Overall Study|Adverse Event|5|||
161771349|NCT00344968|584206260|FG001|Overall Study|Adverse Event|4|||
161977180|NCT02008773|584965995|FG001|Overall Study|Adverse Event|3|||
161771350|NCT00344968|584206261|FG002|Overall Study|Adverse Event|15|||
161977181|NCT02008773|584965996|FG002|Overall Study|Adverse Event|1|||
161977182|NCT02008773|584965997|FG003|Overall Study|Adverse Event|2|||
161977183|NCT02008773|584965994|FG000|Overall Study|Medication Non-compliance|2|||
161977184|NCT02008773|584965995|FG001|Overall Study|Medication Non-compliance|1|||
161977185|NCT02008773|584965996|FG002|Overall Study|Medication Non-compliance|3|||
161977186|NCT02008773|584965997|FG003|Overall Study|Medication Non-compliance|2|||
161977187|NCT02008773|584965994|FG000|Overall Study|Withdrawal by Subject|8|||
161977188|NCT02008773|584965995|FG001|Overall Study|Withdrawal by Subject|4|||
161977189|NCT02008773|584965996|FG002|Overall Study|Withdrawal by Subject|7|||
161977190|NCT02008773|584965997|FG003|Overall Study|Withdrawal by Subject|6|||
161977191|NCT02008773|584965994|FG000|Overall Study|Lost to Follow-up|0|||
161977192|NCT02008773|584965995|FG001|Overall Study|Lost to Follow-up|1|||
161977193|NCT02008773|584965996|FG002|Overall Study|Lost to Follow-up|3|||
161977194|NCT02008773|584965997|FG003|Overall Study|Lost to Follow-up|2|||
161977195|NCT03826342|584966004|FG000|Overall Study|Withdrawal by Subject|8|||
161977196|NCT03826342|584966005|FG001|Overall Study|Withdrawal by Subject|1|||
161977197|NCT03826342|584966004|FG000|Overall Study|Lost to Follow-up|7|||
161977198|NCT03826342|584966005|FG001|Overall Study|Lost to Follow-up|7|||
161977199|NCT03826342|584966004|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
161977200|NCT03826342|584966005|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
161977201|NCT04030962|584966007|FG000|Stage 2|Adverse Event|0|||
161977202|NCT04030962|584966008|FG001|Stage 2|Adverse Event|0|||
161977203|NCT04030962|584966009|FG002|Stage 2|Adverse Event|0|||
161977204|NCT04030962|584966010|FG003|Stage 2|Adverse Event|0|||
161977205|NCT04030962|584966011|FG004|Stage 2|Adverse Event|0|||
161977206|NCT04030962|584966012|FG005|Stage 2|Adverse Event|0|||
161977207|NCT04030962|584966013|FG006|Stage 2|Adverse Event|0|||
161977208|NCT04030962|584966014|FG007|Stage 2|Adverse Event|0|||
161977209|NCT04030962|584966015|FG008|Stage 2|Adverse Event|1|||
161977210|NCT04030962|584966016|FG009|Stage 2|Adverse Event|0|||
161977211|NCT04030962|584966017|FG010|Stage 2|Adverse Event|1|||
161977212|NCT04030962|584966018|FG011|Stage 2|Adverse Event|1|||
161977213|NCT04030962|584966019|FG012|Stage 2|Adverse Event|1|||
161977214|NCT04030962|584966007|FG000|Stage 2|Withdrawal by Subject|0|||
161977215|NCT04030962|584966008|FG001|Stage 2|Withdrawal by Subject|0|||
161977216|NCT04030962|584966009|FG002|Stage 2|Withdrawal by Subject|0|||
161977217|NCT04030962|584966010|FG003|Stage 2|Withdrawal by Subject|0|||
161977218|NCT04030962|584966011|FG004|Stage 2|Withdrawal by Subject|0|||
161977219|NCT04030962|584966012|FG005|Stage 2|Withdrawal by Subject|0|||
161977220|NCT04030962|584966013|FG006|Stage 2|Withdrawal by Subject|0|||
161977221|NCT04030962|584966014|FG007|Stage 2|Withdrawal by Subject|0|||
161977222|NCT04030962|584966015|FG008|Stage 2|Withdrawal by Subject|1|||
161977223|NCT04030962|584966016|FG009|Stage 2|Withdrawal by Subject|0|||
161977224|NCT04030962|584966017|FG010|Stage 2|Withdrawal by Subject|0|||
161977225|NCT04030962|584966018|FG011|Stage 2|Withdrawal by Subject|2|||
161977226|NCT04030962|584966019|FG012|Stage 2|Withdrawal by Subject|1|||
161977227|NCT04030962|584966007|FG000|Stage 2|Lost to Follow-up|0|||
161977228|NCT04030962|584966008|FG001|Stage 2|Lost to Follow-up|0|||
161977229|NCT04030962|584966009|FG002|Stage 2|Lost to Follow-up|0|||
161977230|NCT04030962|584966010|FG003|Stage 2|Lost to Follow-up|0|||
161977231|NCT04030962|584966011|FG004|Stage 2|Lost to Follow-up|0|||
161977232|NCT04030962|584966012|FG005|Stage 2|Lost to Follow-up|0|||
161977233|NCT04030962|584966013|FG006|Stage 2|Lost to Follow-up|0|||
161977234|NCT04030962|584966014|FG007|Stage 2|Lost to Follow-up|0|||
161977235|NCT04030962|584966015|FG008|Stage 2|Lost to Follow-up|1|||
161977236|NCT04030962|584966016|FG009|Stage 2|Lost to Follow-up|0|||
161977237|NCT04030962|584966017|FG010|Stage 2|Lost to Follow-up|0|||
161977238|NCT04030962|584966018|FG011|Stage 2|Lost to Follow-up|0|||
161977239|NCT04030962|584966019|FG012|Stage 2|Lost to Follow-up|0|||
161977240|NCT04030962|584966007|FG000|Stage 2|Technical Problems|0|||
161977241|NCT04030962|584966008|FG001|Stage 2|Technical Problems|0|||
161977242|NCT04030962|584966009|FG002|Stage 2|Technical Problems|0|||
161977243|NCT04030962|584966010|FG003|Stage 2|Technical Problems|0|||
161977244|NCT04030962|584966011|FG004|Stage 2|Technical Problems|0|||
162034637|NCT01695005|585183509|FG026|Overall Study|Lost to Follow-up|0|||
162034638|NCT01695005|585183510|FG027|Overall Study|Lost to Follow-up|0|||
161977245|NCT04030962|584966012|FG005|Stage 2|Technical Problems|0|||
161977246|NCT04030962|584966013|FG006|Stage 2|Technical Problems|0|||
161977247|NCT04030962|584966014|FG007|Stage 2|Technical Problems|0|||
161977248|NCT04030962|584966015|FG008|Stage 2|Technical Problems|0|||
161977249|NCT04030962|584966016|FG009|Stage 2|Technical Problems|0|||
161977250|NCT04030962|584966017|FG010|Stage 2|Technical Problems|0|||
161977251|NCT04030962|584966018|FG011|Stage 2|Technical Problems|1|||
161977252|NCT04030962|584966019|FG012|Stage 2|Technical Problems|0|||
161977253|NCT05288166|584966022|FG000|Overall Study|Adverse Event|1|||
161977254|NCT05288166|584966023|FG001|Overall Study|Adverse Event|0|||
161977255|NCT05288166|584966022|FG000|Overall Study|Lost to Follow-up|2|||
161977256|NCT05288166|584966023|FG001|Overall Study|Lost to Follow-up|0|||
161977257|NCT05288166|584966022|FG000|Overall Study|Physician Decision|0|||
161977258|NCT05288166|584966023|FG001|Overall Study|Physician Decision|2|||
161977259|NCT05288166|584966022|FG000|Overall Study|Screen Failure|1|||
161977260|NCT05288166|584966023|FG001|Overall Study|Screen Failure|1|||
161977261|NCT05288166|584966022|FG000|Overall Study|Withdrawal by Subject|4|||
161977262|NCT05288166|584966023|FG001|Overall Study|Withdrawal by Subject|2|||
161977263|NCT05288166|584966022|FG000|Overall Study|On Study Treatment|408|||
161977264|NCT05288166|584966023|FG001|Overall Study|On Study Treatment|418|||
161977265|NCT03106415|584966024|FG000|Phase 1|Withdrawal by Subject|1|||
161977266|NCT03106415|584966025|FG001|Phase 1|Withdrawal by Subject|0|||
161977267|NCT03106415|584966026|FG002|Phase 1|Withdrawal by Subject|0|||
161977268|NCT03106415|584966024|FG000|Phase 1|Adverse Event|1|||
161977269|NCT03106415|584966025|FG001|Phase 1|Adverse Event|1|||
161977270|NCT03106415|584966026|FG002|Phase 1|Adverse Event|0|||
161977271|NCT03106415|584966024|FG000|Phase 1|Protocol Violation|0|||
161977272|NCT03106415|584966025|FG001|Phase 1|Protocol Violation|1|||
161977273|NCT03106415|584966026|FG002|Phase 1|Protocol Violation|0|||
161977274|NCT00520013|584966027|FG000|Overall Study|Withdrawal by Subject|0|||
161977275|NCT00520013|584966028|FG001|Overall Study|Withdrawal by Subject|0|||
161977276|NCT00520013|584966029|FG002|Overall Study|Withdrawal by Subject|1|||
161977277|NCT00520013|584966027|FG000|Overall Study|Adverse Event|2|||
161977278|NCT00520013|584966028|FG001|Overall Study|Adverse Event|10|||
161977279|NCT00520013|584966029|FG002|Overall Study|Adverse Event|7|||
161977280|NCT00520013|584966027|FG000|Overall Study|Progressive Disease|7|||
161977281|NCT00520013|584966028|FG001|Overall Study|Progressive Disease|3|||
161977282|NCT00520013|584966029|FG002|Overall Study|Progressive Disease|0|||
161977283|NCT00520013|584966027|FG000|Overall Study|Clinical Progression|3|||
161977284|NCT00520013|584966028|FG001|Overall Study|Clinical Progression|1|||
161977285|NCT00520013|584966029|FG002|Overall Study|Clinical Progression|0|||
161977286|NCT00520013|584966027|FG000|Overall Study|Death|0|||
161977287|NCT00520013|584966028|FG001|Overall Study|Death|1|||
161977288|NCT00520013|584966029|FG002|Overall Study|Death|0|||
161977289|NCT00520013|584966027|FG000|Overall Study|Physician Decision|0|||
161977290|NCT00520013|584966028|FG001|Overall Study|Physician Decision|0|||
161977291|NCT00520013|584966029|FG002|Overall Study|Physician Decision|3|||
161977292|NCT02981524|584966030|FG000|Overall Study|Progressive Disease|14|||
161977293|NCT02981524|584966030|FG000|Overall Study|Death (unrelated)|1|||
161977294|NCT02981524|584966030|FG000|Overall Study|Treatment Related Toxicity|1|||
161977295|NCT02981524|584966030|FG000|Overall Study|Withdrawal by Subject|1|||
161977296|NCT00431951|584966032|FG000|Overall Study|Inability to follow study procedures|1|||
161977297|NCT00431951|584966033|FG001|Overall Study|Inability to follow study procedures|0|||
161977298|NCT00431951|584966034|FG002|Overall Study|Inability to follow study procedures|1|||
161977299|NCT00431951|584966035|FG003|Overall Study|Inability to follow study procedures|2|||
161977300|NCT00431951|584966032|FG000|Overall Study|Lost to Follow-up|0|||
161977301|NCT00431951|584966033|FG001|Overall Study|Lost to Follow-up|1|||
161977302|NCT00431951|584966034|FG002|Overall Study|Lost to Follow-up|0|||
161977303|NCT00431951|584966035|FG003|Overall Study|Lost to Follow-up|0|||
161977304|NCT00431951|584966032|FG000|Overall Study|Withdrawal by Subject|0|||
161977305|NCT00431951|584966033|FG001|Overall Study|Withdrawal by Subject|1|||
161977306|NCT00431951|584966034|FG002|Overall Study|Withdrawal by Subject|0|||
161977307|NCT00431951|584966035|FG003|Overall Study|Withdrawal by Subject|0|||
161977308|NCT00431951|584966032|FG000|Overall Study|Adverse Event|0|||
161977309|NCT00431951|584966033|FG001|Overall Study|Adverse Event|0|||
161977310|NCT00431951|584966034|FG002|Overall Study|Adverse Event|1|||
161977311|NCT00431951|584966035|FG003|Overall Study|Adverse Event|0|||
161977312|NCT00385723|584966036|FG000|Overall Study|Lost to Follow-up|1|||
161977313|NCT00385723|584966037|FG001|Overall Study|Lost to Follow-up|1|||
161977314|NCT00385723|584966038|FG002|Overall Study|Lost to Follow-up|0|||
161977315|NCT00385723|584966036|FG000|Overall Study|Withdrawal by Subject|1|||
161977316|NCT00385723|584966037|FG001|Overall Study|Withdrawal by Subject|0|||
161977317|NCT00385723|584966038|FG002|Overall Study|Withdrawal by Subject|2|||
161977318|NCT03455829|584966039|FG000|Overall Study|Death|2|||
161977319|NCT03455829|584966040|FG001|Overall Study|Death|3|||
161977320|NCT03455829|584966041|FG002|Overall Study|Death|2|||
161977321|NCT03455829|584966042|FG003|Overall Study|Death|4|||
162034639|NCT01695005|585183511|FG028|Overall Study|Lost to Follow-up|1|||
162034640|NCT01695005|585183483|FG000|Overall Study|Withdrawal by Subject|0|||
161977322|NCT03455829|584966043|FG004|Overall Study|Death|2|||
161977323|NCT03455829|584966039|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
161977324|NCT03455829|584966040|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
161977325|NCT03455829|584966041|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
161977326|NCT03455829|584966042|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
161977327|NCT03455829|584966043|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
161977328|NCT03455829|584966039|FG000|Overall Study|Disease progression|0|||
161977329|NCT03455829|584966040|FG001|Overall Study|Disease progression|0|||
161977330|NCT03455829|584966041|FG002|Overall Study|Disease progression|0|||
161977331|NCT03455829|584966042|FG003|Overall Study|Disease progression|1|||
161977332|NCT03455829|584966043|FG004|Overall Study|Disease progression|1|||
161977333|NCT00689793|584966046|FG000|Overall Study|Lost to Follow-up|4|||
161977334|NCT00689793|584966047|FG001|Overall Study|Lost to Follow-up|5|||
161977335|NCT01920152|584966053|FG000|Overall Study|Withdrawal by Subject|1|||
161771351|NCT00344968|584206259|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161771352|NCT00344968|584206260|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161771353|NCT00344968|584206261|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
161771354|NCT00344968|584206259|FG000|Overall Study|Protocol Violation|2|||
161771355|NCT00344968|584206260|FG001|Overall Study|Protocol Violation|2|||
161771356|NCT00344968|584206261|FG002|Overall Study|Protocol Violation|5|||
161771357|NCT00344968|584206259|FG000|Overall Study|Withdrawal by Subject|14|||
161771358|NCT00344968|584206260|FG001|Overall Study|Withdrawal by Subject|31|||
161771359|NCT00344968|584206261|FG002|Overall Study|Withdrawal by Subject|27|||
161771360|NCT00344968|584206259|FG000|Overall Study|Lost to Follow-up|24|||
161771361|NCT00344968|584206260|FG001|Overall Study|Lost to Follow-up|37|||
161771362|NCT00344968|584206261|FG002|Overall Study|Lost to Follow-up|37|||
161771363|NCT00344968|584206259|FG000|Overall Study|Death|11|||
161771364|NCT00344968|584206260|FG001|Overall Study|Death|27|||
161771365|NCT00344968|584206261|FG002|Overall Study|Death|31|||
161771366|NCT00344968|584206259|FG000|Overall Study|Other|0|||
161771367|NCT00344968|584206260|FG001|Overall Study|Other|1|||
161771368|NCT00344968|584206261|FG002|Overall Study|Other|0|||
161771369|NCT02526017|584206262|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771370|NCT02526017|584206263|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771371|NCT02526017|584206264|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771372|NCT02526017|584206265|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771373|NCT02526017|584206266|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
161771374|NCT02526017|584206267|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771375|NCT02526017|584206268|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771376|NCT02526017|584206269|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161771377|NCT02526017|584206270|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161977336|NCT01920152|584966054|FG001|Overall Study|Withdrawal by Subject|2|||
161771378|NCT01548573|584206271|FG000|Overall Study|Death|3|||
161771379|NCT01548573|584206271|FG000|Overall Study|Withdrawal by Subject|2|||
161771380|NCT03246152|584206284|FG000|Overall Study|Lost to Follow-up|2|||
161771381|NCT03246152|584206284|FG000|Overall Study|Protocol Violation|1|||
161771382|NCT00423137|584206285|FG000|Overall Study|Lost to Follow-up|0|||
161771383|NCT00423137|584206286|FG001|Overall Study|Lost to Follow-up|0|||
161771384|NCT00423137|584206287|FG002|Overall Study|Lost to Follow-up|1|||
161771385|NCT00423137|584206288|FG003|Overall Study|Lost to Follow-up|0|||
161771386|NCT00423137|584206285|FG000|Overall Study|Protocol Violation|0|||
161771387|NCT00423137|584206286|FG001|Overall Study|Protocol Violation|0|||
161771388|NCT00423137|584206287|FG002|Overall Study|Protocol Violation|0|||
161771389|NCT00423137|584206288|FG003|Overall Study|Protocol Violation|1|||
161771390|NCT00423137|584206285|FG000|Overall Study|Adverse Event Study disease worse|1|||
161771391|NCT00423137|584206286|FG001|Overall Study|Adverse Event Study disease worse|0|||
161771392|NCT00423137|584206287|FG002|Overall Study|Adverse Event Study disease worse|3|||
161771393|NCT00423137|584206288|FG003|Overall Study|Adverse Event Study disease worse|1|||
161771394|NCT00423137|584206285|FG000|Overall Study|Adverse Event Other|0|||
161771395|NCT00423137|584206286|FG001|Overall Study|Adverse Event Other|0|||
161771396|NCT00423137|584206287|FG002|Overall Study|Adverse Event Other|2|||
161771397|NCT00423137|584206288|FG003|Overall Study|Adverse Event Other|0|||
161771398|NCT04196023|584206292|FG000|Overall Study|Withdrawal by Subject|0|||
161771399|NCT04196023|584206293|FG001|Overall Study|Withdrawal by Subject|1|||
161771400|NCT04196023|584206292|FG000|Overall Study|Adverse Event|3|||
161771401|NCT04196023|584206293|FG001|Overall Study|Adverse Event|1|||
161771402|NCT04196023|584206292|FG000|Overall Study|Lost to Follow-up|0|||
161771403|NCT04196023|584206293|FG001|Overall Study|Lost to Follow-up|1|||
161771404|NCT04359758|584206298|FG000|Overall Study|Protocol Violation|3|||
161771405|NCT04359758|584206299|FG001|Overall Study|Protocol Violation|2|||
161771406|NCT03358407|584206303|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771407|NCT03358407|584206304|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771408|NCT03358407|584206305|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
161771409|NCT03358407|584206306|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771410|NCT03358407|584206307|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161977337|NCT00708734|584966055|FG000|Overall Study|scheduling conflict|2|||
161977338|NCT00708734|584966055|FG000|Overall Study|moved|1|||
161771411|NCT03358407|584206308|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771412|NCT03358407|584206309|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771413|NCT03358407|584206310|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771414|NCT03358407|584206311|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771415|NCT03358407|584206312|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161771416|NCT03358407|584206303|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771417|NCT03358407|584206304|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771418|NCT03358407|584206305|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161977339|NCT00708734|584966055|FG000|Overall Study|leg injury|1|||
161977340|NCT00708734|584966055|FG000|Overall Study|knee replacement|1|||
161977341|NCT00708734|584966055|FG000|Overall Study|vertigo|1|||
161771419|NCT03358407|584206306|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771420|NCT03358407|584206307|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
161771421|NCT03358407|584206308|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771422|NCT03358407|584206309|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771423|NCT03358407|584206310|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771424|NCT03358407|584206311|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771425|NCT03358407|584206312|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771426|NCT03358407|584206303|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771427|NCT03358407|584206304|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771428|NCT03358407|584206305|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771429|NCT03358407|584206306|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771430|NCT03358407|584206307|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771431|NCT03358407|584206308|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
161771432|NCT03358407|584206309|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771433|NCT03358407|584206310|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
161771434|NCT03358407|584206311|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771435|NCT03358407|584206312|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161771436|NCT03358407|584206303|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771437|NCT03358407|584206304|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771438|NCT03358407|584206305|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771439|NCT03358407|584206306|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771440|NCT03358407|584206307|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771441|NCT03358407|584206308|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
161771442|NCT03358407|584206309|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771443|NCT03358407|584206310|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
161771444|NCT03358407|584206311|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771445|NCT03358407|584206312|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161771446|NCT03358407|584206303|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771447|NCT03358407|584206304|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771448|NCT03358407|584206305|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771449|NCT03358407|584206306|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771450|NCT03358407|584206307|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771451|NCT03358407|584206308|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
161771452|NCT03358407|584206309|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
161771453|NCT03358407|584206310|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771454|NCT03358407|584206311|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771455|NCT03358407|584206312|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161771456|NCT03358407|584206303|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771457|NCT03358407|584206304|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771458|NCT03358407|584206305|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771459|NCT03358407|584206306|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771460|NCT03358407|584206307|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771461|NCT03358407|584206308|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
161771462|NCT03358407|584206309|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
161771463|NCT03358407|584206310|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
161771464|NCT03358407|584206311|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771465|NCT03358407|584206312|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161771466|NCT00483574|584206313|FG000|Overall Study|Adverse Event|6|||
161771467|NCT00483574|584206314|FG001|Overall Study|Adverse Event|0|||
161771468|NCT00483574|584206313|FG000|Overall Study|Protocol Violation|28|||
161771469|NCT00483574|584206314|FG001|Overall Study|Protocol Violation|9|||
161771470|NCT00483574|584206313|FG000|Overall Study|Lost to Follow-up|16|||
161771471|NCT00483574|584206314|FG001|Overall Study|Lost to Follow-up|4|||
161771472|NCT00483574|584206313|FG000|Overall Study|Withdrawal by Subject|52|||
161771473|NCT00483574|584206314|FG001|Overall Study|Withdrawal by Subject|0|||
161771474|NCT03605758|584206315|FG000|Overall Study|Lost to Follow-up|2|||
161771475|NCT03605758|584206316|FG001|Overall Study|Lost to Follow-up|1|||
161771476|NCT03605758|584206315|FG000|Overall Study|Illness|0|||
161771477|NCT03605758|584206316|FG001|Overall Study|Illness|1|||
161771478|NCT03605758|584206315|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
161771479|NCT03605758|584206316|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
161771480|NCT04753606|584206319|FG000|Overall Study|Adverse Event|1|||
161771481|NCT04753606|584206320|FG001|Overall Study|Adverse Event|0|||
161771482|NCT04753606|584206321|FG002|Overall Study|Adverse Event|0|||
161771483|NCT00489411|584206322|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
161771484|NCT00489411|584206323|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
161977342|NCT00708734|584966055|FG000|Overall Study|leg fracture|1|||
161977343|NCT03412604|584966057|FG000|Overall Study|Withdrawal by Subject|1|||
161977344|NCT02634606|584966058|FG000|Overall Study|unable to obtain the drug at start|13|||
161977345|NCT00993499|584966066|FG000|Run-in Period (8 Days)|Adverse Event|0|||
161977346|NCT00993499|584966067|FG001|Run-in Period (8 Days)|Adverse Event|1|||
161977347|NCT00993499|584966068|FG002|Run-in Period (8 Days)|Adverse Event|0|||
161977348|NCT00993499|584966069|FG003|Run-in Period (8 Days)|Adverse Event|0|||
161977349|NCT00993499|584966070|FG004|Run-in Period (8 Days)|Adverse Event|0|||
161977350|NCT00993499|584966071|FG005|Run-in Period (8 Days)|Adverse Event|0|||
161977351|NCT00993499|584966066|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
161977352|NCT00993499|584966067|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
161977353|NCT00993499|584966068|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
161977354|NCT00993499|584966069|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
161977355|NCT00993499|584966070|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
161977356|NCT00993499|584966071|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
161977357|NCT00993499|584966066|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
161977358|NCT00993499|584966067|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
161977359|NCT00993499|584966068|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
161977360|NCT00993499|584966069|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
161977361|NCT00993499|584966070|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
161977362|NCT00993499|584966071|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
161977363|NCT00993499|584966066|FG000|Run-in Period (8 Days)|Progressive disease|0|||
161977364|NCT00993499|584966067|FG001|Run-in Period (8 Days)|Progressive disease|1|||
161977365|NCT00993499|584966068|FG002|Run-in Period (8 Days)|Progressive disease|1|||
161977366|NCT00993499|584966069|FG003|Run-in Period (8 Days)|Progressive disease|0|||
161977367|NCT00993499|584966070|FG004|Run-in Period (8 Days)|Progressive disease|0|||
161977368|NCT00993499|584966071|FG005|Run-in Period (8 Days)|Progressive disease|0|||
161977369|NCT00993499|584966066|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
161977370|NCT00993499|584966067|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
161977371|NCT00993499|584966068|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
161977372|NCT00993499|584966069|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
161977373|NCT00993499|584966070|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
161977374|NCT00993499|584966071|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
161977375|NCT00993499|584966066|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
161977376|NCT00993499|584966067|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
161977377|NCT00993499|584966068|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
161977378|NCT00993499|584966069|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
161977379|NCT00993499|584966070|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
161977380|NCT00993499|584966071|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
161977381|NCT00993499|584966066|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
161977382|NCT00993499|584966067|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
161977383|NCT00993499|584966068|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
161977384|NCT00993499|584966069|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
161977385|NCT00993499|584966070|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
161977386|NCT00993499|584966071|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
161977387|NCT00993499|584966066|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
161977388|NCT00993499|584966067|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
161977389|NCT00993499|584966068|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
161977390|NCT00993499|584966069|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
161977391|NCT00993499|584966070|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
161977392|NCT00993499|584966071|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
161977393|NCT00993499|584966066|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
161977394|NCT00993499|584966067|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
161771485|NCT00489411|584206322|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
161771486|NCT00489411|584206323|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
161771487|NCT00489411|584206322|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
161771488|NCT00489411|584206323|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
161771489|NCT00489411|584206322|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
161771490|NCT00489411|584206323|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
161977395|NCT00993499|584966068|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
161977396|NCT00993499|584966069|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
161977397|NCT00993499|584966070|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
161977398|NCT00993499|584966071|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
161977399|NCT00993499|584966066|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
161771491|NCT00489411|584206322|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
161771492|NCT00489411|584206323|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
161771493|NCT01748162|584206325|FG000|Overall Study|no additional croup episodes to evaluate|2|||
161771494|NCT01748162|584206326|FG001|Overall Study|no additional croup episodes to evaluate|2|||
161771495|NCT01748162|584206325|FG000|Overall Study|participant consented but did not begin|0|||
161771496|NCT01748162|584206326|FG001|Overall Study|participant consented but did not begin|1|||
161771497|NCT01748162|584206325|FG000|Overall Study|reasons not available|3|||
161771498|NCT01748162|584206326|FG001|Overall Study|reasons not available|2|||
161771499|NCT03219372|584206327|FG000|Overall Study|Withdrawal by Subject|1|||
161771500|NCT03219372|584206328|FG001|Overall Study|Withdrawal by Subject|0|||
161771501|NCT03841331|584206329|FG000|Overall Study|Withdrawal by Subject|4|||
161771502|NCT03841331|584206330|FG001|Overall Study|Withdrawal by Subject|9|||
161771503|NCT03841331|584206329|FG000|Overall Study|Lost to Follow-up|5|||
161771504|NCT03841331|584206330|FG001|Overall Study|Lost to Follow-up|1|||
161771505|NCT04145531|584206331|FG000|Part A|Adverse Event|2|||
161771506|NCT04145531|584206332|FG001|Part A|Adverse Event|12|||
161771507|NCT04145531|584206333|FG002|Part A|Adverse Event|6|||
161771508|NCT04145531|584206334|FG003|Part A|Adverse Event|0|||
161771509|NCT04145531|584206331|FG000|Part A|Death|1|||
161771510|NCT04145531|584206332|FG001|Part A|Death|2|||
161771511|NCT04145531|584206333|FG002|Part A|Death|0|||
161771512|NCT04145531|584206334|FG003|Part A|Death|0|||
161771513|NCT04145531|584206331|FG000|Part A|Physician Decision|2|||
161771514|NCT04145531|584206332|FG001|Part A|Physician Decision|5|||
161771515|NCT04145531|584206333|FG002|Part A|Physician Decision|2|||
161771516|NCT04145531|584206334|FG003|Part A|Physician Decision|0|||
161771517|NCT04145531|584206331|FG000|Part A|Progressive disease|0|||
161771518|NCT04145531|584206332|FG001|Part A|Progressive disease|2|||
161771519|NCT04145531|584206333|FG002|Part A|Progressive disease|1|||
161771520|NCT04145531|584206334|FG003|Part A|Progressive disease|0|||
161771521|NCT04145531|584206331|FG000|Part A|Protocol deviation|0|||
161771522|NCT04145531|584206332|FG001|Part A|Protocol deviation|0|||
161771523|NCT04145531|584206333|FG002|Part A|Protocol deviation|1|||
161771524|NCT04145531|584206334|FG003|Part A|Protocol deviation|0|||
161771525|NCT04145531|584206331|FG000|Part A|Withdrawal by parent or guardian|1|||
161771526|NCT04145531|584206332|FG001|Part A|Withdrawal by parent or guardian|0|||
161771527|NCT04145531|584206333|FG002|Part A|Withdrawal by parent or guardian|0|||
161771528|NCT04145531|584206334|FG003|Part A|Withdrawal by parent or guardian|0|||
161771529|NCT04145531|584206331|FG000|Part A|Withdrawal by participant|0|||
161771530|NCT04145531|584206332|FG001|Part A|Withdrawal by participant|0|||
161771531|NCT04145531|584206333|FG002|Part A|Withdrawal by participant|1|||
161771532|NCT04145531|584206334|FG003|Part A|Withdrawal by participant|0|||
161771533|NCT04145531|584206331|FG000|Part A|Other|0|||
161771534|NCT04145531|584206332|FG001|Part A|Other|0|||
161771535|NCT04145531|584206333|FG002|Part A|Other|1|||
161771536|NCT04145531|584206334|FG003|Part A|Other|0|||
161771537|NCT04145531|584206331|FG000|Part B|Adverse Event|0|||
161771538|NCT04145531|584206332|FG001|Part B|Adverse Event|0|||
161771539|NCT04145531|584206333|FG002|Part B|Adverse Event|0|||
161771540|NCT04145531|584206334|FG003|Part B|Adverse Event|21|||
161771541|NCT04145531|584206331|FG000|Part B|Physician Decision|0|||
161771542|NCT04145531|584206332|FG001|Part B|Physician Decision|0|||
161771543|NCT04145531|584206333|FG002|Part B|Physician Decision|0|||
161771544|NCT04145531|584206334|FG003|Part B|Physician Decision|7|||
162034641|NCT01695005|585183484|FG001|Overall Study|Withdrawal by Subject|0|||
161771545|NCT04145531|584206331|FG000|Part B|Progressive disease|0|||
161771546|NCT04145531|584206332|FG001|Part B|Progressive disease|0|||
161771547|NCT04145531|584206333|FG002|Part B|Progressive disease|0|||
161771548|NCT04145531|584206334|FG003|Part B|Progressive disease|1|||
161771549|NCT04145531|584206331|FG000|Part B|Recurrent disease|0|||
161771550|NCT04145531|584206332|FG001|Part B|Recurrent disease|0|||
161771551|NCT04145531|584206333|FG002|Part B|Recurrent disease|0|||
161771552|NCT04145531|584206334|FG003|Part B|Recurrent disease|1|||
161771553|NCT04145531|584206331|FG000|Part B|Withdrawal by parent or guardian|0|||
161771554|NCT04145531|584206332|FG001|Part B|Withdrawal by parent or guardian|0|||
161771555|NCT04145531|584206333|FG002|Part B|Withdrawal by parent or guardian|0|||
161771556|NCT04145531|584206334|FG003|Part B|Withdrawal by parent or guardian|3|||
161771557|NCT04145531|584206331|FG000|Part B|Withdrawal by participant|0|||
161771558|NCT04145531|584206332|FG001|Part B|Withdrawal by participant|0|||
161771559|NCT04145531|584206333|FG002|Part B|Withdrawal by participant|0|||
161771560|NCT04145531|584206334|FG003|Part B|Withdrawal by participant|1|||
161771561|NCT04145531|584206331|FG000|Part B|Other|0|||
161771562|NCT04145531|584206332|FG001|Part B|Other|0|||
161771563|NCT04145531|584206333|FG002|Part B|Other|0|||
161771564|NCT04145531|584206334|FG003|Part B|Other|1|||
161771565|NCT02067728|584206335|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
161771566|NCT02067728|584206336|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
161771567|NCT02067728|584206335|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
161771568|NCT02067728|584206336|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
161771569|NCT02067728|584206335|FG000|6 Month Measurements|Unable to attend|114|||
161771570|NCT02067728|584206336|FG001|6 Month Measurements|Unable to attend|97|||
161771571|NCT00442572|584206342|FG000|Overall Study|Relapse|8|||
161771572|NCT00442572|584206343|FG001|Overall Study|Relapse|1|||
161771573|NCT00442572|584206342|FG000|Overall Study|Lost to Follow-up|0|||
161771574|NCT00442572|584206343|FG001|Overall Study|Lost to Follow-up|1|||
161771575|NCT00442572|584206342|FG000|Overall Study|Withdrawal by Subject|0|||
161771576|NCT00442572|584206343|FG001|Overall Study|Withdrawal by Subject|1|||
161771577|NCT03532048|584206344|FG000|Overall Study|Lost to Follow-up|12|||
161977400|NCT00993499|584966067|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
161977401|NCT00993499|584966068|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
161977402|NCT00993499|584966069|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
161977403|NCT00993499|584966070|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
161977404|NCT00993499|584966071|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
161977405|NCT00993499|584966066|FG000|Discontinued After Starting Course 3|DLT|1|||
161977406|NCT00993499|584966067|FG001|Discontinued After Starting Course 3|DLT|0|||
161977407|NCT00993499|584966068|FG002|Discontinued After Starting Course 3|DLT|2|||
161977408|NCT00993499|584966069|FG003|Discontinued After Starting Course 3|DLT|1|||
161977409|NCT00993499|584966070|FG004|Discontinued After Starting Course 3|DLT|0|||
161977410|NCT00993499|584966071|FG005|Discontinued After Starting Course 3|DLT|0|||
161977411|NCT00993499|584966066|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
161977412|NCT00993499|584966067|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
161977413|NCT00993499|584966068|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
161977414|NCT00993499|584966069|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
161977415|NCT00993499|584966070|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
161977416|NCT00993499|584966071|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
161977417|NCT01287195|584966074|FG000|Overall Study|Withdrawal by Subject|2|||
161977418|NCT00283868|584966081|FG000|Overall Study|Lost to Follow-up|7|||
161977419|NCT00283868|584966082|FG001|Overall Study|Lost to Follow-up|8|||
161977420|NCT01515475|584966083|FG000|Overall Study|Lost to Follow-up|20|||
161977421|NCT01515475|584966084|FG001|Overall Study|Lost to Follow-up|15|||
161977422|NCT01515475|584966085|FG002|Overall Study|Lost to Follow-up|12|||
161977423|NCT01515475|584966086|FG003|Overall Study|Lost to Follow-up|12|||
161977424|NCT01996592|584966089|FG000|Overall Study|no response to text/no diary entry|32|||
161977425|NCT01996592|584966089|FG000|Overall Study|change in surgical date|4|||
161977426|NCT01996592|584966089|FG000|Overall Study|Withdrawal by Subject|5|||
161977427|NCT01996592|584966089|FG000|Overall Study|change in mode of delivery|4|||
161977428|NCT01406015|584966090|FG000|Overall Study|Withdrawal by Subject|3|||
161977429|NCT01406015|584966091|FG001|Overall Study|Withdrawal by Subject|3|||
161977430|NCT00707746|584966092|FG000|Treatment Period|Adverse Event|2|||
161977431|NCT00707746|584966093|FG001|Treatment Period|Adverse Event|4|||
161977432|NCT00707746|584966092|FG000|Treatment Period|Ineligibility|0|||
161977433|NCT00707746|584966093|FG001|Treatment Period|Ineligibility|1|||
161977434|NCT02573246|584966101|FG000|Overall Study|Lost to Follow-up|2|||
161977435|NCT02573246|584966102|FG001|Overall Study|Lost to Follow-up|0|||
161977436|NCT02573246|584966103|FG002|Overall Study|Lost to Follow-up|0|||
161977437|NCT02573246|584966104|FG003|Overall Study|Lost to Follow-up|0|||
161977438|NCT02573246|584966105|FG004|Overall Study|Lost to Follow-up|1|||
161977439|NCT02573246|584966101|FG000|Overall Study|Withdrawal by Subject|0|||
161977440|NCT02573246|584966102|FG001|Overall Study|Withdrawal by Subject|0|||
161977441|NCT02573246|584966103|FG002|Overall Study|Withdrawal by Subject|0|||
161977442|NCT02573246|584966104|FG003|Overall Study|Withdrawal by Subject|0|||
161977443|NCT02573246|584966105|FG004|Overall Study|Withdrawal by Subject|1|||
161977444|NCT02573246|584966101|FG000|Overall Study|Physician Decision|1|||
161977445|NCT02573246|584966102|FG001|Overall Study|Physician Decision|1|||
161977446|NCT02573246|584966103|FG002|Overall Study|Physician Decision|3|||
161977447|NCT02573246|584966104|FG003|Overall Study|Physician Decision|2|||
161977448|NCT02573246|584966105|FG004|Overall Study|Physician Decision|2|||
161977449|NCT01219933|584966106|FG000|Overall Study|Adverse Event|8|||
161977450|NCT01219933|584966106|FG000|Overall Study|No LDA reached|5|||
161977451|NCT01219933|584966106|FG000|Overall Study|No LDA maintained|7|||
161977452|NCT01219933|584966106|FG000|Overall Study|Lost to Follow-up|3|||
161977453|NCT01219933|584966106|FG000|Overall Study|GC free|1|||
161977454|NCT01219933|584966106|FG000|Overall Study|Withdrawal by Subject|5|||
161977455|NCT01219933|584966106|FG000|Overall Study|Protocol Violation|8|||
161977456|NCT01219933|584966106|FG000|Overall Study|Lack of Efficacy|1|||
161977457|NCT01902888|584966107|FG000|Overall Study|Study Terminated|3|||
161771578|NCT03532048|584206345|FG001|Overall Study|Lost to Follow-up|17|||
161977458|NCT02256267|584966108|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
161977459|NCT02256267|584966108|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
161977460|NCT01685983|584966109|FG000|Overall Study|Adverse Event|7|||
161977461|NCT01685983|584966109|FG000|Overall Study|Death|1|||
161977462|NCT01685983|584966109|FG000|Overall Study|Withdrawal by Subject|19|||
161977463|NCT01685983|584966109|FG000|Overall Study|Protocol Violation|2|||
161977464|NCT01685983|584966109|FG000|Overall Study|Physician Decision|13|||
161977465|NCT01685983|584966109|FG000|Overall Study|Other|7|||
161977466|NCT01685983|584966109|FG000|Overall Study|Progressive Disease|32|||
161977467|NCT01685983|584966109|FG000|Overall Study|Noncompliance with Study Drug|1|||
161977468|NCT03149003|584966110|FG000|Overall Study|Randomized but not treated|0|||
161771579|NCT03532048|584206344|FG000|Overall Study|Withdrawal by Subject|7|||
161771580|NCT03532048|584206345|FG001|Overall Study|Withdrawal by Subject|0|||
161771581|NCT04366258|584206346|FG000|Baseline Assessments|Screen Failure|21|||
161771582|NCT04366258|584206346|FG000|Baseline Assessments|Early Termination|3|||
161771583|NCT03557775|584206348|FG000|Overall Study|Withdrawal by Subject|1|||
161771584|NCT03557775|584206349|FG001|Overall Study|Withdrawal by Subject|2|||
161771585|NCT03557775|584206350|FG002|Overall Study|Withdrawal by Subject|4|||
161771586|NCT03557775|584206348|FG000|Overall Study|Physician Decision|0|||
161771587|NCT03557775|584206349|FG001|Overall Study|Physician Decision|1|||
161771588|NCT03557775|584206350|FG002|Overall Study|Physician Decision|0|||
161771589|NCT00308555|584206355|FG000|Overall Study|Withdrawal by Subject|1|||
161771590|NCT00308555|584206356|FG001|Overall Study|Withdrawal by Subject|0|||
161771591|NCT00308555|584206355|FG000|Overall Study|Physician Decision|2|||
161771592|NCT00308555|584206356|FG001|Overall Study|Physician Decision|0|||
161771593|NCT00276458|584206357|FG000|Overall Study|Adverse Event|0|||
161771594|NCT00276458|584206358|FG001|Overall Study|Adverse Event|2|||
161771595|NCT00276458|584206357|FG000|Overall Study|Lost to Follow-up|2|||
161771596|NCT00276458|584206358|FG001|Overall Study|Lost to Follow-up|2|||
161771597|NCT00276458|584206357|FG000|Overall Study|Protocol Violation|4|||
161771598|NCT00276458|584206358|FG001|Overall Study|Protocol Violation|3|||
161771599|NCT01977625|584206367|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
161771600|NCT01977625|584206368|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161771601|NCT01977625|584206367|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161771602|NCT01977625|584206368|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
161771603|NCT00429026|584206370|FG000|Overall Study|Inevaluable for response.|40|||
161771604|NCT04338685|584206375|FG000|Overall Study|Death|3|||
161771605|NCT04338685|584206376|FG001|Overall Study|Death|4|||
161771606|NCT04338685|584206377|FG002|Overall Study|Death|2|||
161771607|NCT04338685|584206378|FG003|Overall Study|Death|4|||
161771608|NCT04338685|584206379|FG004|Overall Study|Death|4|||
161771609|NCT04338685|584206380|FG005|Overall Study|Death|8|||
161771610|NCT04338685|584206381|FG006|Overall Study|Death|1|||
161771611|NCT04338685|584206382|FG007|Overall Study|Death|0|||
161771612|NCT04338685|584206383|FG008|Overall Study|Death|0|||
161771613|NCT04338685|584206375|FG000|Overall Study|Study terminated by Sponsor|0|||
161771614|NCT04338685|584206376|FG001|Overall Study|Study terminated by Sponsor|0|||
161771615|NCT04338685|584206377|FG002|Overall Study|Study terminated by Sponsor|1|||
161771616|NCT04338685|584206378|FG003|Overall Study|Study terminated by Sponsor|4|||
161771617|NCT04338685|584206379|FG004|Overall Study|Study terminated by Sponsor|0|||
161771618|NCT04338685|584206380|FG005|Overall Study|Study terminated by Sponsor|5|||
161771619|NCT04338685|584206381|FG006|Overall Study|Study terminated by Sponsor|2|||
161771620|NCT04338685|584206382|FG007|Overall Study|Study terminated by Sponsor|4|||
161771621|NCT04338685|584206383|FG008|Overall Study|Study terminated by Sponsor|1|||
161771622|NCT04338685|584206375|FG000|Overall Study|Withdrawal by Subject|1|||
161771623|NCT04338685|584206376|FG001|Overall Study|Withdrawal by Subject|2|||
161771624|NCT04338685|584206377|FG002|Overall Study|Withdrawal by Subject|0|||
161771625|NCT04338685|584206378|FG003|Overall Study|Withdrawal by Subject|2|||
161771626|NCT04338685|584206379|FG004|Overall Study|Withdrawal by Subject|0|||
161771627|NCT04338685|584206380|FG005|Overall Study|Withdrawal by Subject|5|||
161771628|NCT04338685|584206381|FG006|Overall Study|Withdrawal by Subject|1|||
161771629|NCT04338685|584206382|FG007|Overall Study|Withdrawal by Subject|1|||
161771630|NCT04338685|584206383|FG008|Overall Study|Withdrawal by Subject|0|||
161771631|NCT00234533|584206384|FG000|Overall Study|Withdrawal by Subject|6|||
161771632|NCT00234533|584206384|FG000|Overall Study|Adverse Event|2|||
161771633|NCT00234533|584206384|FG000|Overall Study|Enrolled but not treated|3|||
161771634|NCT02967055|584206385|FG000|Overall Study|Excluded|40|||
161771635|NCT02967055|584206385|FG000|Overall Study|Screen fail|3|||
161771636|NCT02967055|584206385|FG000|Overall Study|Lost to Follow-up|2|||
161771637|NCT02967055|584206385|FG000|Overall Study|Stopped due to side effects|3|||
161771638|NCT02967055|584206385|FG000|Overall Study|Stopped due to drug cost|1|||
161977469|NCT03149003|584966111|FG001|Overall Study|Randomized but not treated|1|||
161977470|NCT03149003|584966112|FG002|Overall Study|Randomized but not treated|18|||
161977471|NCT01443130|584966113|FG000|Overall Study|Lost to Follow-up|44|||
161977472|NCT01443130|584966114|FG001|Overall Study|Lost to Follow-up|42|||
161977473|NCT01443130|584966115|FG002|Overall Study|Lost to Follow-up|50|||
161771639|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
161771640|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
161771641|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
161771642|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
161771643|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
161771644|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
161771645|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
161771646|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
161771647|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
161977474|NCT01443130|584966116|FG003|Overall Study|Lost to Follow-up|23|||
161771648|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
161771649|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
161771650|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
161771651|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
161771652|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
161771653|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
161771654|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
161771655|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
161771656|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
161771657|NCT00570492|584206386|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
161771658|NCT00570492|584206387|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
161771659|NCT00570492|584206388|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
161771660|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161771661|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
161771662|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
161771663|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
161771664|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
161771665|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
161771666|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
161771667|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
161771668|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
161771669|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
161771670|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
161771671|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
161771672|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
161771673|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
161771674|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
161771675|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
161771676|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
161771677|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
161771678|NCT00570492|584206386|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
161771679|NCT00570492|584206387|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
161771680|NCT00570492|584206388|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
161771681|NCT00976989|584206389|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
161771682|NCT00976989|584206390|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
161771683|NCT00976989|584206391|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
161771684|NCT00976989|584206389|FG000|Overall Study|Death|5|||
161771685|NCT00976989|584206390|FG001|Overall Study|Death|7|||
161771686|NCT00976989|584206391|FG002|Overall Study|Death|10|||
161771687|NCT00976989|584206389|FG000|Overall Study|Refused Treatment|4|||
161771688|NCT00976989|584206390|FG001|Overall Study|Refused Treatment|3|||
161771689|NCT00976989|584206391|FG002|Overall Study|Refused Treatment|5|||
161771690|NCT00976989|584206389|FG000|Overall Study|Failure to Return|2|||
161771691|NCT00976989|584206390|FG001|Overall Study|Failure to Return|1|||
161771692|NCT00976989|584206391|FG002|Overall Study|Failure to Return|0|||
161771693|NCT00976989|584206389|FG000|Overall Study|Recurrence of Disease|0|||
161771694|NCT00976989|584206390|FG001|Overall Study|Recurrence of Disease|1|||
161771695|NCT00976989|584206391|FG002|Overall Study|Recurrence of Disease|0|||
161771696|NCT00976989|584206389|FG000|Overall Study|Other|1|||
161771697|NCT00976989|584206390|FG001|Overall Study|Other|0|||
161771698|NCT00976989|584206391|FG002|Overall Study|Other|1|||
161771699|NCT00908375|584206392|FG000|Overall Study|Withdrawal by Subject|2|||
161771700|NCT00908375|584206393|FG001|Overall Study|Withdrawal by Subject|4|||
161771701|NCT00908375|584206392|FG000|Overall Study|Lost to Follow-up|8|||
161771702|NCT00908375|584206393|FG001|Overall Study|Lost to Follow-up|6|||
161771703|NCT00903357|584206394|FG000|First Intervention|Withdrawal by Subject|5|||
161771704|NCT00903357|584206395|FG001|First Intervention|Withdrawal by Subject|3|||
161771705|NCT00903357|584206394|FG000|First Intervention|Flu|0|||
161771706|NCT00903357|584206395|FG001|First Intervention|Flu|1|||
161771707|NCT00903357|584206394|FG000|Wash Out Period of 2 Weeks|Flu|0|||
161771708|NCT00903357|584206395|FG001|Wash Out Period of 2 Weeks|Flu|1|||
161771709|NCT00903357|584206394|FG000|Second Intervention|Lost to Follow-up|1|||
161771710|NCT00903357|584206395|FG001|Second Intervention|Lost to Follow-up|0|||
161771711|NCT02279888|584206397|FG000|Overall Study|Death|326|||
161771712|NCT02279888|584206397|FG000|Overall Study|Withdrawal by Subject|38|||
161771713|NCT02279888|584206397|FG000|Overall Study|Lost to Follow-up|21|||
161771714|NCT02279888|584206397|FG000|Overall Study|Physician Decision|62|||
161860476|NCT05317312|584531167|FG000|Overall Study|Withdrawal by Subject|0|||
161860477|NCT05317312|584531168|FG001|Overall Study|Withdrawal by Subject|1|||
161977475|NCT01443130|584966117|FG004|Overall Study|Lost to Follow-up|25|||
161977476|NCT01443130|584966118|FG005|Overall Study|Lost to Follow-up|21|||
161771715|NCT02279888|584206397|FG000|Overall Study|Subject Non-compliance|43|||
161771716|NCT02279888|584206397|FG000|Overall Study|Not implanted|14|||
161771717|NCT02279888|584206397|FG000|Overall Study|Visit not performed|26|||
161771718|NCT00752206|584206398|FG000|Overall Study|Disease progression|8|||
161771719|NCT00752206|584206399|FG001|Overall Study|Disease progression|11|||
161771720|NCT00752206|584206398|FG000|Overall Study|Pregnancy|1|||
161771721|NCT00752206|584206399|FG001|Overall Study|Pregnancy|0|||
161771722|NCT01484691|584206400|FG000|Overall Study|Withdrawal by Subject|1|||
161771723|NCT01484691|584206401|FG001|Overall Study|Withdrawal by Subject|1|||
161771724|NCT01484691|584206402|FG002|Overall Study|Withdrawal by Subject|1|||
161771725|NCT01484691|584206400|FG000|Overall Study|Physician Decision|0|||
161771726|NCT01484691|584206401|FG001|Overall Study|Physician Decision|2|||
161771727|NCT01484691|584206402|FG002|Overall Study|Physician Decision|1|||
161771728|NCT03480243|584206405|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
161771729|NCT03480243|584206405|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
161771730|NCT04365387|584206406|FG000|Overall Study|Adverse Event|4|||
161771731|NCT04365387|584206407|FG001|Overall Study|Adverse Event|2|||
161771732|NCT04365387|584206406|FG000|Overall Study|Participants request|14|||
161771733|NCT04365387|584206407|FG001|Overall Study|Participants request|14|||
161771734|NCT04365387|584206406|FG000|Overall Study|Lost to Follow-up|8|||
161771735|NCT04365387|584206407|FG001|Overall Study|Lost to Follow-up|5|||
161771736|NCT04365387|584206406|FG000|Overall Study|Protocol deviation|3|||
161771737|NCT04365387|584206407|FG001|Overall Study|Protocol deviation|4|||
161771738|NCT04365387|584206406|FG000|Overall Study|Participant compliance with visit schedule|1|||
161771739|NCT04365387|584206407|FG001|Overall Study|Participant compliance with visit schedule|0|||
161771740|NCT04365387|584206406|FG000|Overall Study|Participant incarcerated|1|||
161771741|NCT04365387|584206407|FG001|Overall Study|Participant incarcerated|0|||
161771742|NCT04365387|584206406|FG000|Overall Study|Participant moved out of town (relocated)|0|||
161771743|NCT04365387|584206407|FG001|Overall Study|Participant moved out of town (relocated)|1|||
161771744|NCT04365387|584206406|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
161771745|NCT04365387|584206407|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
161771746|NCT04365387|584206406|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
161771747|NCT04365387|584206407|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
161771748|NCT01683565|584206410|FG000|Overall Study|Lost to Follow-up|2|||
161771749|NCT01683565|584206411|FG001|Overall Study|Lost to Follow-up|0|||
161771750|NCT01683565|584206410|FG000|Overall Study|Discontinued Intervention|1|||
161771751|NCT01683565|584206411|FG001|Overall Study|Discontinued Intervention|1|||
161771752|NCT00764465|584206412|FG000|Overall Study|Adverse Event|2|||
161771753|NCT00764465|584206413|FG001|Overall Study|Adverse Event|0|||
161771754|NCT00764465|584206414|FG002|Overall Study|Adverse Event|0|||
161771755|NCT00764465|584206415|FG003|Overall Study|Adverse Event|1|||
161771756|NCT00764465|584206416|FG004|Overall Study|Adverse Event|1|||
161771757|NCT00764465|584206417|FG005|Overall Study|Adverse Event|1|||
161771758|NCT00764465|584206412|FG000|Overall Study|Withdrawal by Subject|0|||
161771759|NCT00764465|584206413|FG001|Overall Study|Withdrawal by Subject|1|||
161771760|NCT00764465|584206414|FG002|Overall Study|Withdrawal by Subject|1|||
161771761|NCT00764465|584206415|FG003|Overall Study|Withdrawal by Subject|0|||
161771762|NCT00764465|584206416|FG004|Overall Study|Withdrawal by Subject|0|||
161771763|NCT00764465|584206417|FG005|Overall Study|Withdrawal by Subject|0|||
161771764|NCT01195662|584206418|FG000|Double Blind Treatment Period|Adverse Event|4|||
161771765|NCT01195662|584206419|FG001|Double Blind Treatment Period|Adverse Event|1|||
161771766|NCT01195662|584206420|FG002|Double Blind Treatment Period|Adverse Event|2|||
161771767|NCT01195662|584206418|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
161771768|NCT01195662|584206419|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
161771769|NCT01195662|584206420|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
161771770|NCT01195662|584206418|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
161771771|NCT01195662|584206419|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
161771772|NCT01195662|584206420|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
161771773|NCT01195662|584206418|FG000|Double Blind Treatment Period|Administrative reason|2|||
161771774|NCT01195662|584206419|FG001|Double Blind Treatment Period|Administrative reason|1|||
161771775|NCT01195662|584206420|FG002|Double Blind Treatment Period|Administrative reason|1|||
161860478|NCT05317312|584531169|FG002|Overall Study|Withdrawal by Subject|0|||
161860479|NCT05317312|584531170|FG003|Overall Study|Withdrawal by Subject|0|||
161860480|NCT05317312|584531167|FG000|Overall Study|Lost to Follow-up|0|||
162034642|NCT01695005|585183485|FG002|Overall Study|Withdrawal by Subject|0|||
162034643|NCT01695005|585183486|FG003|Overall Study|Withdrawal by Subject|2|||
161771776|NCT01195662|584206418|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
161771777|NCT01195662|584206419|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
161771778|NCT01195662|584206420|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
161771779|NCT01195662|584206418|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
161771780|NCT01195662|584206419|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
161771781|NCT01195662|584206420|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
161771782|NCT01195662|584206418|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
161977477|NCT01443130|584966113|FG000|Overall Study|Death|0|||
161977478|NCT01443130|584966114|FG001|Overall Study|Death|1|||
161977479|NCT01443130|584966115|FG002|Overall Study|Death|0|||
161977480|NCT01443130|584966116|FG003|Overall Study|Death|7|||
161977481|NCT01443130|584966117|FG004|Overall Study|Death|10|||
161977482|NCT01443130|584966118|FG005|Overall Study|Death|8|||
161977483|NCT01443130|584966113|FG000|Overall Study|Adverse Event|2|||
161977484|NCT01443130|584966114|FG001|Overall Study|Adverse Event|1|||
161977485|NCT01443130|584966115|FG002|Overall Study|Adverse Event|1|||
161977486|NCT01443130|584966116|FG003|Overall Study|Adverse Event|0|||
161977487|NCT01443130|584966117|FG004|Overall Study|Adverse Event|0|||
161977488|NCT01443130|584966118|FG005|Overall Study|Adverse Event|0|||
161977489|NCT01443130|584966113|FG000|Overall Study|Protocol Violation|2|||
161977490|NCT01443130|584966114|FG001|Overall Study|Protocol Violation|1|||
161977491|NCT01443130|584966115|FG002|Overall Study|Protocol Violation|3|||
161977492|NCT01443130|584966116|FG003|Overall Study|Protocol Violation|2|||
161977493|NCT01443130|584966117|FG004|Overall Study|Protocol Violation|2|||
161977494|NCT01443130|584966118|FG005|Overall Study|Protocol Violation|3|||
161977495|NCT01443130|584966113|FG000|Overall Study|Withdrawal by Subject|15|||
161977496|NCT01443130|584966114|FG001|Overall Study|Withdrawal by Subject|14|||
161977497|NCT01443130|584966115|FG002|Overall Study|Withdrawal by Subject|12|||
161977498|NCT01443130|584966116|FG003|Overall Study|Withdrawal by Subject|7|||
161977499|NCT01443130|584966117|FG004|Overall Study|Withdrawal by Subject|7|||
161977500|NCT01443130|584966118|FG005|Overall Study|Withdrawal by Subject|2|||
161977501|NCT01443130|584966113|FG000|Overall Study|Death of Subject's Infant|5|||
161977502|NCT01443130|584966114|FG001|Overall Study|Death of Subject's Infant|10|||
161977503|NCT01443130|584966115|FG002|Overall Study|Death of Subject's Infant|11|||
161977504|NCT01443130|584966116|FG003|Overall Study|Death of Subject's Infant|0|||
161977505|NCT01443130|584966117|FG004|Overall Study|Death of Subject's Infant|0|||
161977506|NCT01443130|584966118|FG005|Overall Study|Death of Subject's Infant|0|||
161977507|NCT00364533|584966122|FG000|Overall Study|Adverse Event|8|||
161977508|NCT00364533|584966123|FG001|Overall Study|Adverse Event|7|||
161771783|NCT01195662|584206419|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
161771784|NCT01195662|584206420|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
161771785|NCT01195662|584206418|FG000|Double Blind Treatment Period|Non-specified|3|||
161771786|NCT01195662|584206419|FG001|Double Blind Treatment Period|Non-specified|0|||
161771787|NCT01195662|584206420|FG002|Double Blind Treatment Period|Non-specified|0|||
161771788|NCT01195662|584206418|FG000|Double Blind Treatment Period|Missing disposition information|0|||
161771789|NCT01195662|584206419|FG001|Double Blind Treatment Period|Missing disposition information|1|||
161771790|NCT01195662|584206420|FG002|Double Blind Treatment Period|Missing disposition information|1|||
161771791|NCT01195662|584206418|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
161771792|NCT01195662|584206419|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
161771793|NCT01195662|584206420|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
161771794|NCT01195662|584206418|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
161771795|NCT01195662|584206419|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
161771796|NCT01195662|584206420|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
161771797|NCT02161380|584206421|FG000|Overall Study|Lost to Follow-up|0|||
161771798|NCT02161380|584206422|FG001|Overall Study|Lost to Follow-up|1|||
161771799|NCT02161380|584206423|FG002|Overall Study|Lost to Follow-up|0|||
161771800|NCT02161380|584206424|FG003|Overall Study|Lost to Follow-up|0|||
161771801|NCT01393444|584206435|FG000|Overall Study|Withdrawal by Subject|1|||
161771802|NCT01393444|584206435|FG000|Overall Study|Determined ineligible during screening.|2|||
161771803|NCT03039699|584206436|FG000|Overall Study|Incorrect inclusion|5|||
161771804|NCT03039699|584206437|FG001|Overall Study|Incorrect inclusion|4|||
161771805|NCT03039699|584206436|FG000|Overall Study|Lack of data to assess study endpoint|5|||
161771806|NCT03039699|584206437|FG001|Overall Study|Lack of data to assess study endpoint|3|||
161771807|NCT03039699|584206436|FG000|Overall Study|Bacterial infection|12|||
161771808|NCT03039699|584206437|FG001|Overall Study|Bacterial infection|28|||
161771809|NCT01397409|584206438|FG000|Stage 2|Adverse Event|0|||
161771810|NCT01397409|584206439|FG001|Stage 2|Adverse Event|0|||
161771811|NCT01397409|584206440|FG002|Stage 2|Adverse Event|0|||
161771812|NCT01397409|584206441|FG003|Stage 2|Adverse Event|0|||
161771813|NCT01397409|584206442|FG004|Stage 2|Adverse Event|6|||
161977509|NCT00364533|584966124|FG002|Overall Study|Adverse Event|15|||
161977510|NCT00364533|584966125|FG003|Overall Study|Adverse Event|5|||
161977511|NCT00364533|584966126|FG004|Overall Study|Adverse Event|2|||
161771814|NCT01397409|584206443|FG005|Stage 2|Adverse Event|3|||
161771815|NCT01397409|584206444|FG006|Stage 2|Adverse Event|0|||
161771816|NCT01397409|584206445|FG007|Stage 2|Adverse Event|0|||
161771817|NCT01397409|584206446|FG008|Stage 2|Adverse Event|0|||
161977512|NCT00364533|584966122|FG000|Overall Study|Withdrawal by Subject|4|||
161977513|NCT00364533|584966123|FG001|Overall Study|Withdrawal by Subject|8|||
161771818|NCT01397409|584206447|FG009|Stage 2|Adverse Event|0|||
161977514|NCT00364533|584966124|FG002|Overall Study|Withdrawal by Subject|6|||
161977515|NCT00364533|584966125|FG003|Overall Study|Withdrawal by Subject|6|||
161977516|NCT00364533|584966126|FG004|Overall Study|Withdrawal by Subject|6|||
161977517|NCT00364533|584966122|FG000|Overall Study|Lack of Efficacy|22|||
161771819|NCT01397409|584206438|FG000|Stage 2|Personal Reasons|0|||
161771820|NCT01397409|584206439|FG001|Stage 2|Personal Reasons|0|||
161771821|NCT01397409|584206440|FG002|Stage 2|Personal Reasons|0|||
161771822|NCT01397409|584206441|FG003|Stage 2|Personal Reasons|0|||
161771823|NCT01397409|584206442|FG004|Stage 2|Personal Reasons|1|||
161771824|NCT01397409|584206443|FG005|Stage 2|Personal Reasons|0|||
161771825|NCT01397409|584206444|FG006|Stage 2|Personal Reasons|0|||
161771826|NCT01397409|584206445|FG007|Stage 2|Personal Reasons|0|||
161771827|NCT01397409|584206446|FG008|Stage 2|Personal Reasons|0|||
161771828|NCT01397409|584206447|FG009|Stage 2|Personal Reasons|0|||
161771829|NCT01397409|584206438|FG000|Stage 2|Other Miscellaneous Reasons|0|||
161771830|NCT01397409|584206439|FG001|Stage 2|Other Miscellaneous Reasons|0|||
161771831|NCT01397409|584206440|FG002|Stage 2|Other Miscellaneous Reasons|0|||
161771832|NCT01397409|584206441|FG003|Stage 2|Other Miscellaneous Reasons|0|||
161771833|NCT01397409|584206442|FG004|Stage 2|Other Miscellaneous Reasons|1|||
161771834|NCT01397409|584206443|FG005|Stage 2|Other Miscellaneous Reasons|1|||
161771835|NCT01397409|584206444|FG006|Stage 2|Other Miscellaneous Reasons|0|||
161771836|NCT01397409|584206445|FG007|Stage 2|Other Miscellaneous Reasons|0|||
161771837|NCT01397409|584206446|FG008|Stage 2|Other Miscellaneous Reasons|0|||
161771838|NCT01397409|584206447|FG009|Stage 2|Other Miscellaneous Reasons|0|||
161771839|NCT01397409|584206438|FG000|Stage 3|Adverse Event|0|||
161771840|NCT01397409|584206439|FG001|Stage 3|Adverse Event|0|||
161771841|NCT01397409|584206440|FG002|Stage 3|Adverse Event|0|||
161771842|NCT01397409|584206441|FG003|Stage 3|Adverse Event|0|||
161771843|NCT01397409|584206442|FG004|Stage 3|Adverse Event|0|||
161771844|NCT01397409|584206443|FG005|Stage 3|Adverse Event|0|||
161977518|NCT00364533|584966123|FG001|Overall Study|Lack of Efficacy|22|||
161977519|NCT00364533|584966124|FG002|Overall Study|Lack of Efficacy|21|||
161977520|NCT00364533|584966125|FG003|Overall Study|Lack of Efficacy|17|||
161977521|NCT00364533|584966126|FG004|Overall Study|Lack of Efficacy|42|||
161977522|NCT00364533|584966122|FG000|Overall Study|Subject discharged from hospital|4|||
161977523|NCT00364533|584966123|FG001|Overall Study|Subject discharged from hospital|1|||
161977524|NCT00364533|584966124|FG002|Overall Study|Subject discharged from hospital|2|||
161977525|NCT00364533|584966125|FG003|Overall Study|Subject discharged from hospital|3|||
161977526|NCT00364533|584966126|FG004|Overall Study|Subject discharged from hospital|1|||
161977527|NCT00364533|584966122|FG000|Overall Study|Variations in drug compliance|2|||
161977528|NCT00364533|584966123|FG001|Overall Study|Variations in drug compliance|1|||
161977529|NCT00364533|584966124|FG002|Overall Study|Variations in drug compliance|1|||
161977530|NCT00364533|584966125|FG003|Overall Study|Variations in drug compliance|0|||
161977531|NCT00364533|584966126|FG004|Overall Study|Variations in drug compliance|0|||
161977532|NCT00364533|584966122|FG000|Overall Study|Non-compliance|1|||
161977533|NCT00364533|584966123|FG001|Overall Study|Non-compliance|0|||
161977534|NCT00364533|584966124|FG002|Overall Study|Non-compliance|0|||
161977535|NCT00364533|584966125|FG003|Overall Study|Non-compliance|0|||
161977536|NCT00364533|584966126|FG004|Overall Study|Non-compliance|0|||
161977537|NCT00364533|584966122|FG000|Overall Study|Protocol Violation|1|||
161977538|NCT00364533|584966123|FG001|Overall Study|Protocol Violation|1|||
161977539|NCT00364533|584966124|FG002|Overall Study|Protocol Violation|0|||
161977540|NCT00364533|584966125|FG003|Overall Study|Protocol Violation|0|||
161977541|NCT00364533|584966126|FG004|Overall Study|Protocol Violation|0|||
161977542|NCT02758301|584966127|FG000|Overall Study|Death|12|||
161977543|NCT02758301|584966128|FG001|Overall Study|Death|0|||
161977544|NCT02758301|584966127|FG000|Overall Study|Physician Decision|10|||
161977545|NCT02758301|584966128|FG001|Overall Study|Physician Decision|1|||
161977546|NCT02758301|584966127|FG000|Overall Study|Withdrawal by Subject|5|||
161977547|NCT02758301|584966128|FG001|Overall Study|Withdrawal by Subject|6|||
161977548|NCT02758301|584966127|FG000|Overall Study|Lost to Follow-up|7|||
161977549|NCT02758301|584966128|FG001|Overall Study|Lost to Follow-up|0|||
161977550|NCT02758301|584966127|FG000|Overall Study|Protocol Violation|0|||
161977551|NCT02758301|584966128|FG001|Overall Study|Protocol Violation|1|||
161977552|NCT01167907|584966131|FG000|Overall Study|Protocol Violation|1|||
161977553|NCT01167907|584966132|FG001|Overall Study|Protocol Violation|0|||
161977554|NCT01167907|584966131|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
161977555|NCT01167907|584966132|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
161977556|NCT00815191|584966135|FG000|Overall Study|Protocol Violation|1|||
161977557|NCT00815191|584966136|FG001|Overall Study|Protocol Violation|1|||
161977558|NCT01814670|584966141|FG000|Overall Study|Protocol Violation|12|||
161771845|NCT01397409|584206444|FG006|Stage 3|Adverse Event|0|||
161771846|NCT01397409|584206445|FG007|Stage 3|Adverse Event|1|||
161771847|NCT01397409|584206446|FG008|Stage 3|Adverse Event|0|||
161771848|NCT01397409|584206447|FG009|Stage 3|Adverse Event|0|||
161771849|NCT01397409|584206438|FG000|Stage 3|Other Miscellaneous Reasons|0|||
161771850|NCT01397409|584206439|FG001|Stage 3|Other Miscellaneous Reasons|0|||
161977559|NCT01269385|584966142|FG000|Overall Study|Adverse Event|1|||
161977560|NCT01269385|584966143|FG001|Overall Study|Adverse Event|1|||
161977561|NCT01269385|584966144|FG002|Overall Study|Adverse Event|0|||
161977562|NCT01269385|584966145|FG003|Overall Study|Adverse Event|0|||
161977563|NCT03320330|584967315|FG000|Overall Study|Lack of Efficacy|5|||
161977564|NCT03320330|584967316|FG001|Overall Study|Lack of Efficacy|5|||
161977565|NCT03320330|584967317|FG002|Overall Study|Lack of Efficacy|14|||
161771851|NCT01397409|584206440|FG002|Stage 3|Other Miscellaneous Reasons|0|||
161771852|NCT01397409|584206441|FG003|Stage 3|Other Miscellaneous Reasons|0|||
161771853|NCT01397409|584206442|FG004|Stage 3|Other Miscellaneous Reasons|0|||
161771854|NCT01397409|584206443|FG005|Stage 3|Other Miscellaneous Reasons|0|||
161771855|NCT01397409|584206444|FG006|Stage 3|Other Miscellaneous Reasons|0|||
161771856|NCT01397409|584206445|FG007|Stage 3|Other Miscellaneous Reasons|1|||
161771857|NCT01397409|584206446|FG008|Stage 3|Other Miscellaneous Reasons|0|||
161771858|NCT01397409|584206447|FG009|Stage 3|Other Miscellaneous Reasons|0|||
161771859|NCT03418727|584206448|FG000|Overall Study|Adverse Event|1|||
161771860|NCT03418727|584206449|FG001|Overall Study|Adverse Event|2|||
161771861|NCT03418727|584206450|FG002|Overall Study|Adverse Event|0|||
161771862|NCT03418727|584206448|FG000|Overall Study|Withdrawal by Subject|0|||
161771863|NCT03418727|584206449|FG001|Overall Study|Withdrawal by Subject|0|||
161771864|NCT03418727|584206450|FG002|Overall Study|Withdrawal by Subject|2|||
161771865|NCT01740297|584208188|FG000|Overall Study|Withdrawal by Subject|4|||
161771866|NCT01740297|584208189|FG001|Overall Study|Withdrawal by Subject|16|||
161771867|NCT01740297|584208190|FG002|Overall Study|Withdrawal by Subject|17|||
161771868|NCT01740297|584208188|FG000|Overall Study|Death|8|||
161771869|NCT01740297|584208189|FG001|Overall Study|Death|46|||
161771870|NCT01740297|584208190|FG002|Overall Study|Death|40|||
161771871|NCT01740297|584208188|FG000|Overall Study|Lost to Follow-up|1|||
161771872|NCT01740297|584208189|FG001|Overall Study|Lost to Follow-up|2|||
161771873|NCT01740297|584208190|FG002|Overall Study|Lost to Follow-up|4|||
161771874|NCT03280628|584208195|FG000|Overall Study|Lost to Follow-up|8|||
161771875|NCT03280628|584208196|FG001|Overall Study|Lost to Follow-up|6|||
161771876|NCT03280628|584208197|FG002|Overall Study|Lost to Follow-up|11|||
161771877|NCT00761462|584208198|FG000|Treatment|Subjects never received study medication|23|||
161771878|NCT00761462|584208199|FG001|Treatment|Subjects never received study medication|12|||
161771879|NCT00761462|584208198|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
161771880|NCT00761462|584208199|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
161771881|NCT00761462|584208198|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
161771882|NCT00761462|584208199|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
161771883|NCT00761462|584208198|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
161771884|NCT00761462|584208199|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
161771885|NCT02163759|584208206|FG000|Overall Study|Withdrawal by Subject|1|||
161771886|NCT02163759|584208207|FG001|Overall Study|Withdrawal by Subject|5|||
161771887|NCT02163759|584208208|FG002|Overall Study|Withdrawal by Subject|1|||
161771888|NCT02163759|584208206|FG000|Overall Study|Adverse Event|0|||
161771889|NCT02163759|584208207|FG001|Overall Study|Adverse Event|0|||
161771890|NCT02163759|584208208|FG002|Overall Study|Adverse Event|1|||
161771891|NCT02163759|584208206|FG000|Overall Study|Death|0|||
161771892|NCT02163759|584208207|FG001|Overall Study|Death|0|||
161771893|NCT02163759|584208208|FG002|Overall Study|Death|1|||
161771894|NCT01479777|584208214|FG000|Overall Study|Physician Decision|2|||
161771895|NCT00451191|584208218|FG000|Overall Study|withdrawal or received alternate tx|15|||
161771896|NCT00451191|584208219|FG001|Overall Study|withdrawal or received alternate tx|11|||
161771897|NCT00656669|584208227|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
161771898|NCT00656669|584208227|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
161771899|NCT00656669|584208227|FG000|AC (Cycles 6-9)|Adverse Event|1|||
161771900|NCT00656669|584208227|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
161771901|NCT03575806|584208232|FG000|Overall Study|Withdrawal by Subject|0|||
161771902|NCT03575806|584208233|FG001|Overall Study|Withdrawal by Subject|2|||
161771903|NCT03575806|584208232|FG000|Overall Study|Protocol Violation|0|||
161771904|NCT03575806|584208233|FG001|Overall Study|Protocol Violation|2|||
161771905|NCT00219349|584208234|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
161771906|NCT00219349|584208234|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
161771907|NCT00219349|584208234|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
161771908|NCT00219349|584208234|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
161771909|NCT01241591|584208236|FG000|Overall Study|Lack of Efficacy|5|||
161771910|NCT01241591|584208237|FG001|Overall Study|Lack of Efficacy|2|||
161771911|NCT01241591|584208238|FG002|Overall Study|Lack of Efficacy|2|||
161771912|NCT01241591|584208239|FG003|Overall Study|Lack of Efficacy|3|||
161771913|NCT01241591|584208236|FG000|Overall Study|Protocol Violation|5|||
161771914|NCT01241591|584208237|FG001|Overall Study|Protocol Violation|2|||
161771915|NCT01241591|584208238|FG002|Overall Study|Protocol Violation|3|||
161771916|NCT01241591|584208239|FG003|Overall Study|Protocol Violation|0|||
161771917|NCT01241591|584208236|FG000|Overall Study|Lost to Follow-up|1|||
161771918|NCT01241591|584208237|FG001|Overall Study|Lost to Follow-up|2|||
161771919|NCT01241591|584208238|FG002|Overall Study|Lost to Follow-up|2|||
161860481|NCT05317312|584531168|FG001|Overall Study|Lost to Follow-up|0|||
161860482|NCT05317312|584531169|FG002|Overall Study|Lost to Follow-up|0|||
161860483|NCT05317312|584531170|FG003|Overall Study|Lost to Follow-up|1|||
161977566|NCT03320330|584967315|FG000|Overall Study|Physician Decision|1|||
161771920|NCT01241591|584208239|FG003|Overall Study|Lost to Follow-up|2|||
161771921|NCT01241591|584208236|FG000|Overall Study|Screen Failure|3|||
161771922|NCT01241591|584208237|FG001|Overall Study|Screen Failure|2|||
161977567|NCT03320330|584967316|FG001|Overall Study|Physician Decision|0|||
161771923|NCT01241591|584208238|FG002|Overall Study|Screen Failure|1|||
161771924|NCT01241591|584208239|FG003|Overall Study|Screen Failure|0|||
161771925|NCT01241591|584208236|FG000|Overall Study|Withdrawal by Subject|6|||
161771926|NCT01241591|584208237|FG001|Overall Study|Withdrawal by Subject|4|||
161771927|NCT01241591|584208238|FG002|Overall Study|Withdrawal by Subject|2|||
161771928|NCT01241591|584208239|FG003|Overall Study|Withdrawal by Subject|2|||
161771929|NCT01241591|584208236|FG000|Overall Study|Other|0|||
161771930|NCT01241591|584208237|FG001|Overall Study|Other|1|||
161771931|NCT01241591|584208238|FG002|Overall Study|Other|0|||
161771932|NCT01241591|584208239|FG003|Overall Study|Other|1|||
161771933|NCT01241591|584208236|FG000|Overall Study|Adverse Event|3|||
161771934|NCT01241591|584208237|FG001|Overall Study|Adverse Event|11|||
161771935|NCT01241591|584208238|FG002|Overall Study|Adverse Event|12|||
161771936|NCT01241591|584208239|FG003|Overall Study|Adverse Event|4|||
161771937|NCT01945034|584208240|FG000|Overall Study|Medication Error|0|||
161771938|NCT01945034|584208241|FG001|Overall Study|Medication Error|1|||
161771939|NCT01945034|584208242|FG002|Overall Study|Medication Error|0|||
161771940|NCT01945034|584208240|FG000|Overall Study|Withdrawal by Subject|0|||
161771941|NCT01945034|584208241|FG001|Overall Study|Withdrawal by Subject|3|||
161771942|NCT01945034|584208242|FG002|Overall Study|Withdrawal by Subject|1|||
161771943|NCT01945034|584208240|FG000|Overall Study|Other|0|||
161771944|NCT01945034|584208241|FG001|Overall Study|Other|1|||
161771945|NCT01945034|584208242|FG002|Overall Study|Other|3|||
161771946|NCT01945034|584208240|FG000|Overall Study|Lost to Follow-up|0|||
161771947|NCT01945034|584208241|FG001|Overall Study|Lost to Follow-up|0|||
161771948|NCT01945034|584208242|FG002|Overall Study|Lost to Follow-up|2|||
161771949|NCT01945034|584208240|FG000|Overall Study|Protocol Violation|1|||
161771950|NCT01945034|584208241|FG001|Overall Study|Protocol Violation|0|||
161771951|NCT01945034|584208242|FG002|Overall Study|Protocol Violation|1|||
161771952|NCT00700115|584208245|FG000|Overall Study|Withdrawal by Subject|1|||
161771953|NCT00700115|584208246|FG001|Overall Study|Withdrawal by Subject|0|||
161771954|NCT00700115|584208245|FG000|Overall Study|Lost to Follow-up|0|||
161771955|NCT00700115|584208246|FG001|Overall Study|Lost to Follow-up|1|||
161771956|NCT01300741|584208252|FG000|Overall Study|Lens deposits|1|||
161771957|NCT01300741|584208252|FG000|Overall Study|Lost to Follow-up|1|||
161771958|NCT01300741|584208252|FG000|Overall Study|Discomfort|1|||
161771959|NCT04854421|584208253|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
161771960|NCT04854421|584208254|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
161771961|NCT00718809|584208256|FG000|Overall Study|Disease progression|9|||
161771962|NCT00718809|584208257|FG001|Overall Study|Disease progression|7|||
161771963|NCT00718809|584208256|FG000|Overall Study|Adverse Event|1|||
161771964|NCT00718809|584208257|FG001|Overall Study|Adverse Event|1|||
161771965|NCT00718809|584208256|FG000|Overall Study|Withdrawal by Subject|0|||
161771966|NCT00718809|584208257|FG001|Overall Study|Withdrawal by Subject|1|||
161771967|NCT00718809|584208256|FG000|Overall Study|Lost to Follow-up|1|||
161771968|NCT00718809|584208257|FG001|Overall Study|Lost to Follow-up|0|||
161771969|NCT00718809|584208256|FG000|Overall Study|Noncompliance|1|||
161771970|NCT00718809|584208257|FG001|Overall Study|Noncompliance|0|||
161771971|NCT00463385|584208258|FG000|Overall Study|Other|4|||
161771972|NCT00463385|584208259|FG001|Overall Study|Other|3|||
161771973|NCT00463385|584208260|FG002|Overall Study|Other|6|||
161771974|NCT00463385|584208261|FG003|Overall Study|Other|4|||
161771975|NCT00463385|584208258|FG000|Overall Study|Adverse Event|5|||
161771976|NCT00463385|584208259|FG001|Overall Study|Adverse Event|8|||
161771977|NCT00463385|584208260|FG002|Overall Study|Adverse Event|4|||
161771978|NCT00463385|584208261|FG003|Overall Study|Adverse Event|2|||
161771979|NCT00463385|584208258|FG000|Overall Study|Lack of Efficacy|6|||
161771980|NCT00463385|584208259|FG001|Overall Study|Lack of Efficacy|6|||
161771981|NCT00463385|584208260|FG002|Overall Study|Lack of Efficacy|7|||
161771982|NCT00463385|584208261|FG003|Overall Study|Lack of Efficacy|9|||
161771983|NCT00463385|584208258|FG000|Overall Study|Withdrawal by Subject|3|||
161771984|NCT00463385|584208259|FG001|Overall Study|Withdrawal by Subject|3|||
161771985|NCT00463385|584208260|FG002|Overall Study|Withdrawal by Subject|3|||
161771986|NCT00463385|584208261|FG003|Overall Study|Withdrawal by Subject|4|||
161771987|NCT00463385|584208258|FG000|Overall Study|Lost to Follow-up|0|||
161771988|NCT00463385|584208259|FG001|Overall Study|Lost to Follow-up|0|||
161771989|NCT00463385|584208260|FG002|Overall Study|Lost to Follow-up|0|||
161771990|NCT00463385|584208261|FG003|Overall Study|Lost to Follow-up|1|||
161771991|NCT00463385|584208258|FG000|Overall Study|Death|2|||
162034644|NCT01695005|585183487|FG004|Overall Study|Withdrawal by Subject|0|||
162034645|NCT01695005|585183488|FG005|Overall Study|Withdrawal by Subject|1|||
161771992|NCT00463385|584208259|FG001|Overall Study|Death|1|||
161771993|NCT00463385|584208260|FG002|Overall Study|Death|2|||
161771994|NCT00463385|584208261|FG003|Overall Study|Death|0|||
161771995|NCT00463385|584208258|FG000|Overall Study|Missing|2|||
161771996|NCT00463385|584208259|FG001|Overall Study|Missing|0|||
161771997|NCT00463385|584208260|FG002|Overall Study|Missing|0|||
161771998|NCT00463385|584208261|FG003|Overall Study|Missing|2|||
161771999|NCT00463385|584208258|FG000|Overall Study|1 participant received commercial drug|0|||
161772000|NCT00463385|584208259|FG001|Overall Study|1 participant received commercial drug|1|||
161772001|NCT00463385|584208260|FG002|Overall Study|1 participant received commercial drug|0|||
161772002|NCT00463385|584208261|FG003|Overall Study|1 participant received commercial drug|0|||
161772003|NCT00536991|584208263|FG000|Overall Study|Withdrawal by Subject|10|||
161772004|NCT00536991|584208263|FG000|Overall Study|Physician Decision|1|||
161772005|NCT00536991|584208263|FG000|Overall Study|patient ineligible|2|||
161772006|NCT00054639|584208264|FG000|Overall Study|Lack of Efficacy|1|||
161772007|NCT00054639|584208264|FG000|Overall Study|Physician Decision|1|||
161772008|NCT01600755|584208265|FG000|Overall Study|Withdrawal by Subject|6|||
161772009|NCT00938392|584208270|FG000|Overall Study|Adverse Event|0|||
161772010|NCT00938392|584208271|FG001|Overall Study|Adverse Event|1|||
161772011|NCT00938392|584208270|FG000|Overall Study|Withdrawal by Subject|0|||
161772012|NCT00938392|584208271|FG001|Overall Study|Withdrawal by Subject|1|||
161772013|NCT00938392|584208270|FG000|Overall Study|Lost to Follow-up|2|||
161772014|NCT00938392|584208271|FG001|Overall Study|Lost to Follow-up|2|||
161772015|NCT00122954|584208272|FG000|Overall Study|Withdrawal by Subject|2|||
161772016|NCT00122954|584208273|FG001|Overall Study|Withdrawal by Subject|2|||
161772017|NCT00122954|584208272|FG000|Overall Study|Protocol Violation|0|||
161772018|NCT00122954|584208273|FG001|Overall Study|Protocol Violation|1|||
161772019|NCT00494234|584208279|FG000|Overall Study|Withdrawal by Subject|1|||
161772020|NCT00494234|584208280|FG001|Overall Study|Withdrawal by Subject|0|||
161772021|NCT00494234|584208279|FG000|Overall Study|Disease progression|11|||
161772022|NCT00494234|584208280|FG001|Overall Study|Disease progression|8|||
161772023|NCT00494234|584208279|FG000|Overall Study|Death|2|||
161772024|NCT00494234|584208280|FG001|Overall Study|Death|1|||
161772025|NCT02743117|584208284|FG000|Overall Study|Lost to Follow-up|0|||
161772026|NCT02743117|584208285|FG001|Overall Study|Lost to Follow-up|1|||
161772027|NCT02743117|584208284|FG000|Overall Study|Other|1|||
161772028|NCT02743117|584208285|FG001|Overall Study|Other|0|||
161772029|NCT00779857|584208286|FG000|Overall Study|Death|1|||
161772030|NCT00779857|584208286|FG000|Overall Study|Withdrawal by Subject|3|||
161772031|NCT00779857|584208286|FG000|Overall Study|Missed Visit|2|||
161772032|NCT04640168|584208287|FG000|Overall Study|Withdrawal by Subject|8|||
161772033|NCT04640168|584208288|FG001|Overall Study|Withdrawal by Subject|7|||
161772034|NCT04640168|584208287|FG000|Overall Study|Lost to Follow-up|1|||
161772035|NCT04640168|584208288|FG001|Overall Study|Lost to Follow-up|0|||
161772036|NCT04640168|584208287|FG000|Overall Study|Enrolled but not treated|12|||
161772037|NCT04640168|584208288|FG001|Overall Study|Enrolled but not treated|12|||
161772038|NCT00978120|584208292|FG000|Overall Study|Death|0|||
161772039|NCT00978120|584208293|FG001|Overall Study|Death|0|||
161772040|NCT00978120|584208294|FG002|Overall Study|Death|0|||
161772041|NCT00978120|584208295|FG003|Overall Study|Death|1|||
161772042|NCT00978120|584208292|FG000|Overall Study|Lost to Follow-up|0|||
161772043|NCT00978120|584208293|FG001|Overall Study|Lost to Follow-up|0|||
161772044|NCT00978120|584208294|FG002|Overall Study|Lost to Follow-up|3|||
161772045|NCT00978120|584208295|FG003|Overall Study|Lost to Follow-up|0|||
161772046|NCT00978120|584208292|FG000|Overall Study|Withdrawal by Subject|2|||
161772047|NCT00978120|584208293|FG001|Overall Study|Withdrawal by Subject|0|||
161772048|NCT00978120|584208294|FG002|Overall Study|Withdrawal by Subject|0|||
161772049|NCT00978120|584208295|FG003|Overall Study|Withdrawal by Subject|0|||
161772050|NCT00978120|584208292|FG000|Overall Study|Moved out of state|0|||
161772051|NCT00978120|584208293|FG001|Overall Study|Moved out of state|0|||
161772052|NCT00978120|584208294|FG002|Overall Study|Moved out of state|0|||
161772053|NCT00978120|584208295|FG003|Overall Study|Moved out of state|1|||
161772054|NCT01023815|584208297|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
161772055|NCT01023815|584208298|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
161772056|NCT01023815|584208299|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
161772057|NCT01023815|584208300|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
161772058|NCT01023815|584208297|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
161772059|NCT01023815|584208298|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
161772060|NCT01023815|584208299|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
161772061|NCT01023815|584208300|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
161772062|NCT01023815|584208297|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
161772063|NCT01023815|584208298|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
161772064|NCT01023815|584208299|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
161977568|NCT03320330|584967317|FG002|Overall Study|Physician Decision|0|||
161977569|NCT03323736|584967318|FG000|Overall Study|Screen Failure|14|||
161977570|NCT03323736|584967319|FG001|Overall Study|Screen Failure|9|||
161977571|NCT03323736|584967320|FG002|Overall Study|Screen Failure|1|||
161977572|NCT03323736|584967318|FG000|Overall Study|Withdrawal Before Treatment|3|||
161977573|NCT03323736|584967319|FG001|Overall Study|Withdrawal Before Treatment|1|||
161977574|NCT03323736|584967320|FG002|Overall Study|Withdrawal Before Treatment|1|||
161977575|NCT03323736|584967318|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
161977576|NCT03323736|584967319|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
161977577|NCT03323736|584967320|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
161977578|NCT01806064|584967322|FG000|Overall Study|Randomized Not Enrolled|0|||
161772065|NCT01023815|584208300|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
161772066|NCT01023815|584208297|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
161772067|NCT01023815|584208298|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
161772068|NCT01023815|584208299|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
161772069|NCT01023815|584208300|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
161772070|NCT01023815|584208297|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
161772071|NCT01023815|584208298|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
161772072|NCT01023815|584208299|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
161772073|NCT01023815|584208300|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
161772074|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
161772075|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
161772076|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
161772077|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
161772078|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
161772079|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Death|1|||
161772080|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Death|0|||
161772081|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Death|0|||
161772082|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Death|0|||
161772083|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Death|0|||
161772084|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
161772085|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
161772086|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
161772087|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
161772088|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
161772089|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
161772090|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
161772091|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
161772092|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
161772093|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
161772094|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
161772095|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
161772096|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
161772097|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
161772098|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
161772099|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
161772100|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
161772101|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
161772102|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
161772103|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
161772104|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
161772105|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
161772106|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
161772107|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
161772108|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
161772109|NCT00634933|584208302|FG000|Part A: Baseline to Week 24|Other|1|||
161772110|NCT00634933|584208303|FG001|Part A: Baseline to Week 24|Other|8|||
161772111|NCT00634933|584208304|FG002|Part A: Baseline to Week 24|Other|5|||
161772112|NCT00634933|584208305|FG003|Part A: Baseline to Week 24|Other|0|||
161772113|NCT00634933|584208306|FG004|Part A: Baseline to Week 24|Other|0|||
161772114|NCT00634933|584208302|FG000|Between Part A and Part B|Physician Decision|0|||
161772115|NCT00634933|584208303|FG001|Between Part A and Part B|Physician Decision|1|||
161772116|NCT00634933|584208304|FG002|Between Part A and Part B|Physician Decision|0|||
161772117|NCT00634933|584208305|FG003|Between Part A and Part B|Physician Decision|0|||
161772118|NCT00634933|584208306|FG004|Between Part A and Part B|Physician Decision|0|||
161772119|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
161772120|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
161772121|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
161772122|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
161772123|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
161860484|NCT05317312|584531167|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
161860485|NCT05317312|584531168|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
161860486|NCT05317312|584531169|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
161772124|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
161772125|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
161772126|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
161772127|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
161772128|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
161772129|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
161772130|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
161772131|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
161772132|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
161772133|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
161772134|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
161772135|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
161772136|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
161772137|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
161772138|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
161772139|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
161772140|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
161772141|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
161772142|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
161772143|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
161772144|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
161772145|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
161772146|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
161772147|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
161772148|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
161772149|NCT00634933|584208302|FG000|Part B: Week 24 to Week 52|Other|0|||
161772150|NCT00634933|584208303|FG001|Part B: Week 24 to Week 52|Other|0|||
161860487|NCT05317312|584531170|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
161860488|NCT00262028|584531171|FG000|Overall Study|Withdrawal by Subject|6|||
161860489|NCT00262028|584531172|FG001|Overall Study|Withdrawal by Subject|3|||
161860490|NCT00262028|584531173|FG002|Overall Study|Withdrawal by Subject|6|||
161860491|NCT00262028|584531174|FG003|Overall Study|Withdrawal by Subject|5|||
161860492|NCT00262028|584531175|FG004|Overall Study|Withdrawal by Subject|2|||
161860493|NCT00262028|584531176|FG005|Overall Study|Withdrawal by Subject|3|||
161860494|NCT00262028|584531177|FG006|Overall Study|Withdrawal by Subject|5|||
161860495|NCT00262028|584531178|FG007|Overall Study|Withdrawal by Subject|7|||
161860496|NCT00262028|584531179|FG008|Overall Study|Withdrawal by Subject|2|||
161860497|NCT00262028|584531171|FG000|Overall Study|Lost to Follow-up|7|||
161860498|NCT00262028|584531172|FG001|Overall Study|Lost to Follow-up|7|||
161860499|NCT00262028|584531173|FG002|Overall Study|Lost to Follow-up|5|||
161860500|NCT00262028|584531174|FG003|Overall Study|Lost to Follow-up|5|||
161860501|NCT00262028|584531175|FG004|Overall Study|Lost to Follow-up|4|||
161860502|NCT00262028|584531176|FG005|Overall Study|Lost to Follow-up|3|||
161860503|NCT00262028|584531177|FG006|Overall Study|Lost to Follow-up|3|||
161860504|NCT00262028|584531178|FG007|Overall Study|Lost to Follow-up|5|||
161860505|NCT00262028|584531179|FG008|Overall Study|Lost to Follow-up|6|||
161860506|NCT00262028|584531171|FG000|Overall Study|Administrative Reason|11|||
161860507|NCT00262028|584531172|FG001|Overall Study|Administrative Reason|14|||
161860508|NCT00262028|584531173|FG002|Overall Study|Administrative Reason|9|||
161860509|NCT00262028|584531174|FG003|Overall Study|Administrative Reason|12|||
161860510|NCT00262028|584531175|FG004|Overall Study|Administrative Reason|6|||
161860511|NCT00262028|584531176|FG005|Overall Study|Administrative Reason|7|||
161860512|NCT00262028|584531177|FG006|Overall Study|Administrative Reason|4|||
161860513|NCT00262028|584531178|FG007|Overall Study|Administrative Reason|6|||
161860514|NCT00262028|584531179|FG008|Overall Study|Administrative Reason|10|||
161860515|NCT00262028|584531171|FG000|Overall Study|Protocol Violation|0|||
161860516|NCT00262028|584531172|FG001|Overall Study|Protocol Violation|0|||
161860517|NCT00262028|584531173|FG002|Overall Study|Protocol Violation|0|||
161860518|NCT00262028|584531174|FG003|Overall Study|Protocol Violation|1|||
161860519|NCT00262028|584531175|FG004|Overall Study|Protocol Violation|0|||
161860520|NCT00262028|584531176|FG005|Overall Study|Protocol Violation|0|||
161860521|NCT00262028|584531177|FG006|Overall Study|Protocol Violation|0|||
161860522|NCT00262028|584531178|FG007|Overall Study|Protocol Violation|0|||
161860523|NCT00262028|584531179|FG008|Overall Study|Protocol Violation|0|||
161860524|NCT00262028|584531171|FG000|Overall Study|Unable to classify|0|||
161860525|NCT00262028|584531172|FG001|Overall Study|Unable to classify|3|||
161860526|NCT00262028|584531173|FG002|Overall Study|Unable to classify|0|||
161860527|NCT00262028|584531174|FG003|Overall Study|Unable to classify|0|||
161860528|NCT00262028|584531175|FG004|Overall Study|Unable to classify|0|||
161860529|NCT00262028|584531176|FG005|Overall Study|Unable to classify|0|||
162034646|NCT01695005|585183489|FG006|Overall Study|Withdrawal by Subject|0|||
162034647|NCT01695005|585183490|FG007|Overall Study|Withdrawal by Subject|1|||
161772151|NCT00634933|584208304|FG002|Part B: Week 24 to Week 52|Other|5|||
161860530|NCT00262028|584531177|FG006|Overall Study|Unable to classify|0|||
161860531|NCT00262028|584531178|FG007|Overall Study|Unable to classify|0|||
161860532|NCT00262028|584531179|FG008|Overall Study|Unable to classify|1|||
161860533|NCT00124917|584531180|FG000|Overall Study|Physician Decision|3|||
161860534|NCT03164551|584531181|FG000|Overall Study|Imaging discontinued prior completion|8|||
162034648|NCT01695005|585183491|FG008|Overall Study|Withdrawal by Subject|0|||
162034649|NCT01695005|585183492|FG009|Overall Study|Withdrawal by Subject|1|||
161772152|NCT00634933|584208305|FG003|Part B: Week 24 to Week 52|Other|0|||
161772153|NCT00634933|584208306|FG004|Part B: Week 24 to Week 52|Other|1|||
161860535|NCT03164551|584531182|FG001|Overall Study|Imaging discontinued prior completion|0|||
161860536|NCT03164551|584531181|FG000|Overall Study|Participant was non-compliant|1|||
161860537|NCT03164551|584531182|FG001|Overall Study|Participant was non-compliant|0|||
161860538|NCT03164551|584531181|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
161860539|NCT03164551|584531182|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
161860540|NCT03164551|584531181|FG000|Overall Study|Other|8|||
161860541|NCT03164551|584531182|FG001|Overall Study|Other|2|||
161860542|NCT01515423|584531183|FG000|Open Label Phase|Adverse Event|57|||
161860543|NCT01515423|584531184|FG001|Open Label Phase|Adverse Event|0|||
161860544|NCT01515423|584531185|FG002|Open Label Phase|Adverse Event|0|||
161860545|NCT01515423|584531183|FG000|Open Label Phase|Death|2|||
161860546|NCT01515423|584531184|FG001|Open Label Phase|Death|0|||
161860547|NCT01515423|584531185|FG002|Open Label Phase|Death|0|||
161860548|NCT01515423|584531183|FG000|Open Label Phase|Lack of Efficacy|117|||
161860549|NCT01515423|584531184|FG001|Open Label Phase|Lack of Efficacy|0|||
161860550|NCT01515423|584531185|FG002|Open Label Phase|Lack of Efficacy|0|||
161860551|NCT01515423|584531183|FG000|Open Label Phase|Lost to Follow-up|21|||
161860552|NCT01515423|584531184|FG001|Open Label Phase|Lost to Follow-up|0|||
161860553|NCT01515423|584531185|FG002|Open Label Phase|Lost to Follow-up|0|||
161860554|NCT01515423|584531183|FG000|Open Label Phase|Withdrawal by Subject|118|||
161860555|NCT01515423|584531184|FG001|Open Label Phase|Withdrawal by Subject|0|||
161860556|NCT01515423|584531185|FG002|Open Label Phase|Withdrawal by Subject|0|||
161860557|NCT01515423|584531183|FG000|Open Label Phase|excluded from DB Phase|70|||
161860558|NCT01515423|584531184|FG001|Open Label Phase|excluded from DB Phase|0|||
161860559|NCT01515423|584531185|FG002|Open Label Phase|excluded from DB Phase|0|||
161860560|NCT01515423|584531183|FG000|Open Label Phase|Other|28|||
161860561|NCT01515423|584531184|FG001|Open Label Phase|Other|0|||
161860562|NCT01515423|584531185|FG002|Open Label Phase|Other|0|||
161860563|NCT01515423|584531183|FG000|DOUBLE BLIND|Adverse Event|0|||
161860564|NCT01515423|584531184|FG001|DOUBLE BLIND|Adverse Event|15|||
161860565|NCT01515423|584531185|FG002|DOUBLE BLIND|Adverse Event|13|||
161860566|NCT01515423|584531183|FG000|DOUBLE BLIND|Death|0|||
161860567|NCT01515423|584531184|FG001|DOUBLE BLIND|Death|1|||
161860568|NCT01515423|584531185|FG002|DOUBLE BLIND|Death|2|||
161860569|NCT01515423|584531183|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
161860570|NCT01515423|584531184|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
161860571|NCT01515423|584531185|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
161860572|NCT01515423|584531183|FG000|DOUBLE BLIND|Pregnancy|0|||
161860573|NCT01515423|584531184|FG001|DOUBLE BLIND|Pregnancy|2|||
161860574|NCT01515423|584531185|FG002|DOUBLE BLIND|Pregnancy|0|||
161860575|NCT01515423|584531183|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
161860576|NCT01515423|584531184|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
161860577|NCT01515423|584531185|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
161860578|NCT01515423|584531183|FG000|DOUBLE BLIND|Other|0|||
161860579|NCT01515423|584531184|FG001|DOUBLE BLIND|Other|6|||
161860580|NCT01515423|584531185|FG002|DOUBLE BLIND|Other|12|||
161860581|NCT01515423|584531183|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
161860582|NCT01515423|584531184|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
161860583|NCT01515423|584531185|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
161860584|NCT01422213|584531190|FG000|Overall Study|Adverse Event|8|||
161860585|NCT01422213|584531191|FG001|Overall Study|Adverse Event|7|||
161860586|NCT01422213|584531192|FG002|Overall Study|Adverse Event|11|||
161860587|NCT01422213|584531190|FG000|Overall Study|Lack of Efficacy|10|||
161860588|NCT01422213|584531191|FG001|Overall Study|Lack of Efficacy|2|||
161860589|NCT01422213|584531192|FG002|Overall Study|Lack of Efficacy|2|||
161860590|NCT01422213|584531190|FG000|Overall Study|Non-compliance with study drug|0|||
161860591|NCT01422213|584531191|FG001|Overall Study|Non-compliance with study drug|1|||
161860592|NCT01422213|584531192|FG002|Overall Study|Non-compliance with study drug|0|||
161860593|NCT01422213|584531190|FG000|Overall Study|Protocol Violation|0|||
161860594|NCT01422213|584531191|FG001|Overall Study|Protocol Violation|2|||
161860595|NCT01422213|584531192|FG002|Overall Study|Protocol Violation|4|||
161860596|NCT01422213|584531190|FG000|Overall Study|Withdrawal of Consent|7|||
161860597|NCT01422213|584531191|FG001|Overall Study|Withdrawal of Consent|3|||
161860598|NCT01422213|584531192|FG002|Overall Study|Withdrawal of Consent|5|||
161977579|NCT01806064|584967323|FG001|Overall Study|Randomized Not Enrolled|0|||
161977580|NCT01806064|584967324|FG002|Overall Study|Randomized Not Enrolled|0|||
161860599|NCT01422213|584531190|FG000|Overall Study|Lost to Follow-up|3|||
161860600|NCT01422213|584531191|FG001|Overall Study|Lost to Follow-up|3|||
161860601|NCT01422213|584531192|FG002|Overall Study|Lost to Follow-up|5|||
161860602|NCT01422213|584531190|FG000|Overall Study|Administrative or Other Reason(s)|5|||
161860603|NCT01422213|584531191|FG001|Overall Study|Administrative or Other Reason(s)|4|||
161860604|NCT01422213|584531192|FG002|Overall Study|Administrative or Other Reason(s)|2|||
161860605|NCT00613171|584531193|FG000|Overall Study|Adverse Event|7|||
161860606|NCT00613171|584531193|FG000|Overall Study|Withdrawal by Subject|3|||
161860607|NCT00613171|584531193|FG000|Overall Study|Reason not Specified|4|||
161860608|NCT00951496|584531198|FG000|Overall Study|Did not initiate study treatment|10|||
161860609|NCT00951496|584531199|FG001|Overall Study|Did not initiate study treatment|8|||
161860610|NCT00951496|584531200|FG002|Overall Study|Did not initiate study treatment|13|||
161860611|NCT01042093|584531201|FG000|Overall Study|Protocol Violation|2|||
161860612|NCT01042093|584531202|FG001|Overall Study|Protocol Violation|2|||
161977581|NCT01806064|584967325|FG003|Overall Study|Randomized Not Enrolled|1|||
161860613|NCT01042093|584531203|FG002|Overall Study|Protocol Violation|2|||
161860614|NCT01042093|584531204|FG003|Overall Study|Protocol Violation|3|||
161860615|NCT01042093|584531201|FG000|Overall Study|Withdrawal by Subject|0|||
161860616|NCT01042093|584531202|FG001|Overall Study|Withdrawal by Subject|0|||
161860617|NCT01042093|584531203|FG002|Overall Study|Withdrawal by Subject|0|||
161860618|NCT01042093|584531204|FG003|Overall Study|Withdrawal by Subject|1|||
161860619|NCT00995774|584531207|FG000|Training Period 2|Withdrawal by Subject|2|||
161860620|NCT00995774|584531208|FG001|Training Period 2|Withdrawal by Subject|0|||
161860621|NCT01998841|584531215|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
161860622|NCT01998841|584531216|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
161860623|NCT01998841|584531217|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
161860624|NCT01998841|584531218|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161860625|NCT01998841|584531219|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161860626|NCT01998841|584531215|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161860627|NCT01998841|584531216|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161860628|NCT01998841|584531217|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161860629|NCT01998841|584531218|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
161860630|NCT01998841|584531219|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
161860631|NCT00972595|584531220|FG000|Period 1|Adverse Event|1|||
161860632|NCT00972595|584531221|FG001|Period 1|Adverse Event|0|||
161860633|NCT01406574|584531223|FG000|Overall Study|Adverse Event|0|||
161860634|NCT01406574|584531224|FG001|Overall Study|Adverse Event|0|||
161860635|NCT01406574|584531225|FG002|Overall Study|Adverse Event|1|||
161860636|NCT01406574|584531226|FG003|Overall Study|Adverse Event|3|||
161860637|NCT01406574|584531223|FG000|Overall Study|Physician Decision|0|||
161860638|NCT01406574|584531224|FG001|Overall Study|Physician Decision|0|||
161860639|NCT01406574|584531225|FG002|Overall Study|Physician Decision|0|||
161860640|NCT01406574|584531226|FG003|Overall Study|Physician Decision|1|||
161860641|NCT01406574|584531223|FG000|Overall Study|Withdrawal by Subject|0|||
161860642|NCT01406574|584531224|FG001|Overall Study|Withdrawal by Subject|1|||
161860643|NCT01406574|584531225|FG002|Overall Study|Withdrawal by Subject|0|||
161860644|NCT01406574|584531226|FG003|Overall Study|Withdrawal by Subject|0|||
161860645|NCT01406574|584531223|FG000|Overall Study|Definite progression of primary disease|1|||
161860646|NCT01406574|584531224|FG001|Overall Study|Definite progression of primary disease|0|||
161860647|NCT01406574|584531225|FG002|Overall Study|Definite progression of primary disease|0|||
161860648|NCT01406574|584531226|FG003|Overall Study|Definite progression of primary disease|0|||
161860649|NCT03447743|584531227|FG000|Overall Study|Withdrawal by Subject|2|||
161860650|NCT03447743|584531227|FG000|Overall Study|Lost to Follow-up|3|||
161860651|NCT03447743|584531227|FG000|Overall Study|Adverse Event|1|||
161860652|NCT03447743|584531227|FG000|Overall Study|Did not meet criteria to continue|1|||
161860653|NCT01112059|584531228|FG000|Overall Study|Withdrawal by Subject|1|||
161860654|NCT01112059|584531229|FG001|Overall Study|Withdrawal by Subject|0|||
161860655|NCT01245283|584531230|FG000|Overall Study|Lost to Follow-up|14|||
161860656|NCT01245283|584531231|FG001|Overall Study|Lost to Follow-up|11|||
161860657|NCT01245283|584531232|FG002|Overall Study|Lost to Follow-up|11|||
161860658|NCT03567980|584531243|FG000|Overall Study|Adverse Event|1|||
161860659|NCT01610492|584531244|FG000|Overall Study|Adverse Event|1|||
161860660|NCT01610492|584531244|FG000|Overall Study|Lack of Efficacy|3|||
161860661|NCT01610492|584531244|FG000|Overall Study|Other: Reached stopping criteria|1|||
161860662|NCT01610492|584531244|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
161860663|NCT02575833|584531248|FG000|Overall Study|Withdrawal by Subject|0|||
161860664|NCT02575833|584531249|FG001|Overall Study|Withdrawal by Subject|1|||
161860665|NCT02575833|584531248|FG000|Overall Study|Lost to Follow-up|1|||
161860666|NCT02575833|584531249|FG001|Overall Study|Lost to Follow-up|0|||
161860667|NCT01757275|584531250|FG000|Overall Study|Lost to Follow-up|1|||
161860668|NCT01757275|584531251|FG001|Overall Study|Lost to Follow-up|2|||
161860669|NCT01757275|584531250|FG000|Overall Study|Adverse Event|3|||
161860670|NCT01757275|584531251|FG001|Overall Study|Adverse Event|3|||
161860671|NCT01757275|584531250|FG000|Overall Study|Withdrawal by Subject|2|||
161860672|NCT01757275|584531251|FG001|Overall Study|Withdrawal by Subject|4|||
161860673|NCT01757275|584531250|FG000|Overall Study|Not treated|3|||
161860674|NCT01757275|584531251|FG001|Overall Study|Not treated|4|||
161977582|NCT01806064|584967326|FG004|Overall Study|Randomized Not Enrolled|2|||
161977583|NCT00701805|584967327|FG000|Overall Study|Withdrawal by Subject|3|||
161860675|NCT03093259|584531252|FG000|Overall Study|Adverse Event|1|||
161860676|NCT03093259|584531253|FG001|Overall Study|Adverse Event|0|||
161860677|NCT03093259|584531252|FG000|Overall Study|Withdrawal by Subject|1|||
161860678|NCT03093259|584531253|FG001|Overall Study|Withdrawal by Subject|0|||
161860679|NCT01821807|584531254|FG000|Overall Study|Lost to Follow-up|3|||
161860680|NCT01821807|584531255|FG001|Overall Study|Lost to Follow-up|1|||
161860681|NCT00768248|584531256|FG000|Overall Study|Research coordinator didn't collect data|1|||
161860682|NCT00768248|584531257|FG001|Overall Study|Research coordinator didn't collect data|1|||
161860683|NCT00967330|584531258|FG000|Overall Study|Protocol Violation|3|||
161860684|NCT00967330|584531259|FG001|Overall Study|Protocol Violation|4|||
161977584|NCT00701805|584967328|FG001|Overall Study|Withdrawal by Subject|1|||
161977585|NCT00701805|584967329|FG002|Overall Study|Withdrawal by Subject|4|||
161772154|NCT02304484|584208307|FG000|Overall Study|Death|9|||
161772155|NCT02304484|584208307|FG000|Overall Study|Withdrawal by Subject|14|||
161772156|NCT02304484|584208307|FG000|Overall Study|Lost to Follow-up|2|||
161772157|NCT03522506|584208308|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161772158|NCT03522506|584208309|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161772159|NCT03522506|584208310|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161772160|NCT03522506|584208311|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161772161|NCT03522506|584208308|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161772162|NCT03522506|584208309|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161772163|NCT03522506|584208310|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161772164|NCT03522506|584208311|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
161772165|NCT05770401|584208312|FG000|Overall Study|Lost to Follow-up|5|||
161772166|NCT05770401|584208313|FG001|Overall Study|Lost to Follow-up|4|||
161772167|NCT01298323|584208315|FG000|Overall Study|Adverse Event|2|||
161772168|NCT01298323|584208316|FG001|Overall Study|Adverse Event|4|||
161772169|NCT01298323|584208315|FG000|Overall Study|Death|11|||
161772170|NCT01298323|584208316|FG001|Overall Study|Death|16|||
161772171|NCT01298323|584208315|FG000|Overall Study|Lost to Follow-up|1|||
161772172|NCT01298323|584208316|FG001|Overall Study|Lost to Follow-up|0|||
161772173|NCT01298323|584208315|FG000|Overall Study|Withdrawal by Subject|6|||
161772174|NCT01298323|584208316|FG001|Overall Study|Withdrawal by Subject|3|||
161772175|NCT01298323|584208315|FG000|Overall Study|Protocol Violation|1|||
161772176|NCT01298323|584208316|FG001|Overall Study|Protocol Violation|0|||
161772177|NCT01298323|584208315|FG000|Overall Study|Other|10|||
161772178|NCT01298323|584208316|FG001|Overall Study|Other|9|||
161772179|NCT01298323|584208315|FG000|Overall Study|Ongoing|55|||
161772180|NCT01298323|584208316|FG001|Overall Study|Ongoing|55|||
161772181|NCT01298323|584208315|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161772182|NCT01298323|584208316|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161772183|NCT01761565|584208317|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
161772184|NCT04524507|584208319|FG000|Overall Study|Lost to Follow-up|2|||
161772185|NCT04524507|584208320|FG001|Overall Study|Lost to Follow-up|4|||
161772186|NCT04524507|584208319|FG000|Overall Study|Withdrawal by Subject|2|||
161772187|NCT04524507|584208320|FG001|Overall Study|Withdrawal by Subject|9|||
161772188|NCT04524507|584208319|FG000|Overall Study|Death|2|||
161772189|NCT04524507|584208320|FG001|Overall Study|Death|10|||
161772190|NCT03655951|584208321|FG000|Overall Study|Lost to Follow-up|39|||
161772191|NCT03655951|584208322|FG001|Overall Study|Lost to Follow-up|20|||
161772192|NCT03655951|584208321|FG000|Overall Study|Withdrawal by Subject|0|||
161772193|NCT03655951|584208322|FG001|Overall Study|Withdrawal by Subject|1|||
161772194|NCT01078974|584208327|FG000|Overall Study|Adverse Event|3|||
161772195|NCT01791543|584208329|FG000|Overall Study|Lost to Follow-up|1|||
161772196|NCT01791543|584208329|FG000|Overall Study|Adverse Event|1|||
161772197|NCT01361308|584209726|FG000|Overall Study|Withdrawal by Subject|9|||
161772198|NCT01361308|584209727|FG001|Overall Study|Withdrawal by Subject|13|||
161772199|NCT01361308|584209726|FG000|Overall Study|Physician Decision|3|||
161772200|NCT01361308|584209727|FG001|Overall Study|Physician Decision|3|||
161772201|NCT01361308|584209726|FG000|Overall Study|Lack of Efficacy|2|||
161772202|NCT01361308|584209727|FG001|Overall Study|Lack of Efficacy|0|||
161772203|NCT01361308|584209726|FG000|Overall Study|Protocol Violation|1|||
161772204|NCT01361308|584209727|FG001|Overall Study|Protocol Violation|0|||
161772205|NCT01361308|584209726|FG000|Overall Study|Lost to Follow-up|5|||
161772206|NCT01361308|584209727|FG001|Overall Study|Lost to Follow-up|4|||
161772207|NCT01361308|584209726|FG000|Overall Study|Adverse Event|8|||
161772208|NCT01361308|584209727|FG001|Overall Study|Adverse Event|4|||
161772209|NCT01361308|584209726|FG000|Overall Study|Eligibility Criteria Not Met|2|||
161772210|NCT01361308|584209727|FG001|Overall Study|Eligibility Criteria Not Met|3|||
161772211|NCT01361308|584209726|FG000|Overall Study|Failed C-SSRS|5|||
161772212|NCT01361308|584209727|FG001|Overall Study|Failed C-SSRS|2|||
161772213|NCT01361308|584209726|FG000|Overall Study|Other|0|||
161772214|NCT01361308|584209727|FG001|Overall Study|Other|1|||
161772215|NCT03839693|584209732|FG000|Overall Study|Lost to Follow-up|0|||
161772216|NCT03839693|584209733|FG001|Overall Study|Lost to Follow-up|2|||
161772217|NCT03839693|584209734|FG002|Overall Study|Lost to Follow-up|2|||
161772218|NCT03839693|584209732|FG000|Overall Study|Withdrawal by Subject|1|||
161772219|NCT03839693|584209733|FG001|Overall Study|Withdrawal by Subject|0|||
161772220|NCT03839693|584209734|FG002|Overall Study|Withdrawal by Subject|2|||
161772221|NCT03839693|584209732|FG000|Overall Study|subject moved out of the area|1|||
161772222|NCT03839693|584209733|FG001|Overall Study|subject moved out of the area|0|||
161772223|NCT03839693|584209734|FG002|Overall Study|subject moved out of the area|0|||
161772224|NCT00270205|584209743|FG000|Overall Study|Lost to Follow-up|1|||
161772225|NCT00270205|584209744|FG001|Overall Study|Lost to Follow-up|0|||
161772226|NCT00270205|584209745|FG002|Overall Study|Lost to Follow-up|0|||
161772227|NCT00270205|584209746|FG003|Overall Study|Lost to Follow-up|1|||
161772228|NCT00066573|584209747|FG000|Overall Study|Did not received protocol treatment|28|||
161772229|NCT00066573|584209748|FG001|Overall Study|Did not received protocol treatment|28|||
161860685|NCT00967330|584531258|FG000|Overall Study|Regular|10|||
161860686|NCT00967330|584531259|FG001|Overall Study|Regular|3|||
161860687|NCT00967330|584531258|FG000|Overall Study|Withdrawal by Subject|6|||
161860688|NCT00967330|584531259|FG001|Overall Study|Withdrawal by Subject|0|||
161860689|NCT00967330|584531258|FG000|Overall Study|Lost to Follow-up|1|||
161860690|NCT00967330|584531259|FG001|Overall Study|Lost to Follow-up|1|||
161860691|NCT00967330|584531258|FG000|Overall Study|Death|102|||
161860692|NCT00967330|584531259|FG001|Overall Study|Death|51|||
161860693|NCT00967330|584531258|FG000|Overall Study|Severe protocol deviation|0|||
161860694|NCT00967330|584531259|FG001|Overall Study|Severe protocol deviation|1|||
161860695|NCT04563754|584533166|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
161860696|NCT04563754|584533167|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
161860697|NCT04563754|584533168|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
161860698|NCT04563754|584533166|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
161860699|NCT04563754|584533167|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
161860700|NCT04563754|584533168|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
161860701|NCT04563754|584533166|FG000|Follow up|Lost to Follow-up|61|||
161860702|NCT04563754|584533167|FG001|Follow up|Lost to Follow-up|23|||
161860703|NCT04563754|584533168|FG002|Follow up|Lost to Follow-up|5|||
161860704|NCT04563754|584533166|FG000|Follow up|Death|0|||
161860705|NCT04563754|584533167|FG001|Follow up|Death|2|||
161860706|NCT04563754|584533168|FG002|Follow up|Death|0|||
161860707|NCT04563754|584533166|FG000|Follow up|Ongoing|0|||
161860708|NCT04563754|584533167|FG001|Follow up|Ongoing|28|||
161860709|NCT04563754|584533168|FG002|Follow up|Ongoing|0|||
161860710|NCT00070564|584533169|FG000|Overall Study|Progression|2|||
161860711|NCT00070564|584533170|FG001|Overall Study|Progression|4|||
161860712|NCT00070564|584533171|FG002|Overall Study|Progression|7|||
161860713|NCT00070564|584533172|FG003|Overall Study|Progression|7|||
161860714|NCT00070564|584533173|FG004|Overall Study|Progression|1|||
161860715|NCT00070564|584533174|FG005|Overall Study|Progression|0|||
161860716|NCT00070564|584533169|FG000|Overall Study|Delinquent|1|||
161860717|NCT00070564|584533170|FG001|Overall Study|Delinquent|4|||
161860718|NCT00070564|584533171|FG002|Overall Study|Delinquent|2|||
161860719|NCT00070564|584533172|FG003|Overall Study|Delinquent|0|||
161860720|NCT00070564|584533173|FG004|Overall Study|Delinquent|0|||
161860721|NCT00070564|584533174|FG005|Overall Study|Delinquent|0|||
161860722|NCT00070564|584533169|FG000|Overall Study|Adverse Event|150|||
161860723|NCT00070564|584533170|FG001|Overall Study|Adverse Event|142|||
161860724|NCT00070564|584533171|FG002|Overall Study|Adverse Event|120|||
161860725|NCT00070564|584533172|FG003|Overall Study|Adverse Event|108|||
161860726|NCT00070564|584533173|FG004|Overall Study|Adverse Event|63|||
161860727|NCT00070564|584533174|FG005|Overall Study|Adverse Event|36|||
161860728|NCT00070564|584533169|FG000|Overall Study|Death|4|||
161860729|NCT00070564|584533170|FG001|Overall Study|Death|1|||
161860730|NCT00070564|584533171|FG002|Overall Study|Death|5|||
161860731|NCT00070564|584533172|FG003|Overall Study|Death|3|||
161860732|NCT00070564|584533173|FG004|Overall Study|Death|0|||
161860733|NCT00070564|584533174|FG005|Overall Study|Death|1|||
161860734|NCT00070564|584533169|FG000|Overall Study|Other, not protocol specified|17|||
161860735|NCT00070564|584533170|FG001|Overall Study|Other, not protocol specified|15|||
161860736|NCT00070564|584533171|FG002|Overall Study|Other, not protocol specified|14|||
161860737|NCT00070564|584533172|FG003|Overall Study|Other, not protocol specified|19|||
161860738|NCT00070564|584533173|FG004|Overall Study|Other, not protocol specified|6|||
161860739|NCT00070564|584533174|FG005|Overall Study|Other, not protocol specified|7|||
161860740|NCT00070564|584533169|FG000|Overall Study|Withdrawal by Subject|26|||
161860741|NCT00070564|584533170|FG001|Overall Study|Withdrawal by Subject|37|||
161860742|NCT00070564|584533171|FG002|Overall Study|Withdrawal by Subject|23|||
161860743|NCT00070564|584533172|FG003|Overall Study|Withdrawal by Subject|30|||
161860744|NCT00070564|584533173|FG004|Overall Study|Withdrawal by Subject|8|||
161860745|NCT00070564|584533174|FG005|Overall Study|Withdrawal by Subject|8|||
161860746|NCT00070564|584533169|FG000|Overall Study|Not reported|0|||
161860747|NCT00070564|584533170|FG001|Overall Study|Not reported|0|||
161860748|NCT00070564|584533171|FG002|Overall Study|Not reported|0|||
161860749|NCT00070564|584533172|FG003|Overall Study|Not reported|0|||
161860750|NCT00070564|584533173|FG004|Overall Study|Not reported|1|||
161860751|NCT00070564|584533174|FG005|Overall Study|Not reported|0|||
161860752|NCT01490086|584533177|FG000|Overall Study|Consent withdrawn|4|||
161860753|NCT01490086|584533178|FG001|Overall Study|Consent withdrawn|4|||
161860754|NCT01490086|584533179|FG002|Overall Study|Consent withdrawn|3|||
161860755|NCT01490086|584533180|FG003|Overall Study|Consent withdrawn|0|||
161860756|NCT01490086|584533181|FG004|Overall Study|Consent withdrawn|1|||
161860757|NCT01490086|584533177|FG000|Overall Study|Non-compliance|0|||
161860758|NCT01490086|584533178|FG001|Overall Study|Non-compliance|1|||
161860759|NCT01490086|584533179|FG002|Overall Study|Non-compliance|0|||
161860760|NCT01490086|584533180|FG003|Overall Study|Non-compliance|0|||
161860761|NCT01490086|584533181|FG004|Overall Study|Non-compliance|0|||
161860762|NCT01490086|584533177|FG000|Overall Study|Abnormal laboratory findings|1|||
161977586|NCT00701805|584967330|FG003|Overall Study|Withdrawal by Subject|3|||
161977587|NCT00701805|584967327|FG000|Overall Study|Adverse Event|0|||
161772230|NCT01646268|584209752|FG000|Overall Study|Adverse Event|6|||
161772231|NCT01646268|584209753|FG001|Overall Study|Adverse Event|7|||
161772232|NCT01646268|584209752|FG000|Overall Study|Lack of Efficacy|1|||
161772233|NCT01646268|584209753|FG001|Overall Study|Lack of Efficacy|3|||
161772234|NCT01646268|584209752|FG000|Overall Study|Protocol Violation|0|||
161772235|NCT01646268|584209753|FG001|Overall Study|Protocol Violation|1|||
161772236|NCT01646268|584209752|FG000|Overall Study|Withdrawal by Subject|2|||
161772237|NCT01646268|584209753|FG001|Overall Study|Withdrawal by Subject|5|||
161772238|NCT01646268|584209752|FG000|Overall Study|Other|2|||
161772239|NCT01646268|584209753|FG001|Overall Study|Other|0|||
161772240|NCT02222246|584209754|FG000|Overall Study|No Emergency Department Visits|27|||
161772241|NCT02222246|584209755|FG001|Overall Study|No Emergency Department Visits|26|||
161772242|NCT02222246|584209754|FG000|Overall Study|Physician Decision|0|||
161772243|NCT02222246|584209755|FG001|Overall Study|Physician Decision|1|||
161772244|NCT01473602|584209758|FG000|Overall Study|Adverse Event|1|||
161772245|NCT01473602|584209759|FG001|Overall Study|Adverse Event|2|||
161772246|NCT01473602|584209758|FG000|Overall Study|Death|0|||
161772247|NCT01473602|584209759|FG001|Overall Study|Death|1|||
161772248|NCT01473602|584209758|FG000|Overall Study|Lost to Follow-up|1|||
161772249|NCT01473602|584209759|FG001|Overall Study|Lost to Follow-up|1|||
161772250|NCT01473602|584209758|FG000|Overall Study|Withdrawal by Subject|5|||
161772251|NCT01473602|584209759|FG001|Overall Study|Withdrawal by Subject|4|||
161772252|NCT01473602|584209758|FG000|Overall Study|Physician Decision|1|||
161772253|NCT01473602|584209759|FG001|Overall Study|Physician Decision|0|||
161772254|NCT00449761|584209761|FG000|Overall Study|Disease progression|12|||
161772255|NCT00449761|584209761|FG000|Overall Study|Death|5|||
161772256|NCT00449761|584209761|FG000|Overall Study|New cancer therapy|1|||
161772257|NCT00560573|584209762|FG000|Overall Study|Death|4|||
161772258|NCT00560573|584209763|FG001|Overall Study|Death|1|||
161772259|NCT00560573|584209764|FG002|Overall Study|Death|4|||
161772260|NCT00560573|584209765|FG003|Overall Study|Death|5|||
161772261|NCT00560573|584209766|FG004|Overall Study|Death|1|||
161772262|NCT00560573|584209767|FG005|Overall Study|Death|10|||
161772263|NCT00560573|584209762|FG000|Overall Study|Lost to Follow-up|0|||
161772264|NCT00560573|584209763|FG001|Overall Study|Lost to Follow-up|0|||
161772265|NCT00560573|584209764|FG002|Overall Study|Lost to Follow-up|0|||
161772266|NCT00560573|584209765|FG003|Overall Study|Lost to Follow-up|1|||
161772267|NCT00560573|584209766|FG004|Overall Study|Lost to Follow-up|1|||
161772268|NCT00560573|584209767|FG005|Overall Study|Lost to Follow-up|0|||
161772269|NCT00560573|584209762|FG000|Overall Study|Withdrawal by Subject|0|||
161772270|NCT00560573|584209763|FG001|Overall Study|Withdrawal by Subject|0|||
161772271|NCT00560573|584209764|FG002|Overall Study|Withdrawal by Subject|0|||
161772272|NCT00560573|584209765|FG003|Overall Study|Withdrawal by Subject|1|||
161772273|NCT00560573|584209766|FG004|Overall Study|Withdrawal by Subject|1|||
161772274|NCT00560573|584209767|FG005|Overall Study|Withdrawal by Subject|0|||
161772275|NCT00560573|584209762|FG000|Overall Study|Other|2|||
161772276|NCT00560573|584209763|FG001|Overall Study|Other|2|||
161772277|NCT00560573|584209764|FG002|Overall Study|Other|2|||
161772278|NCT00560573|584209765|FG003|Overall Study|Other|3|||
161772279|NCT00560573|584209766|FG004|Overall Study|Other|3|||
161772280|NCT00560573|584209767|FG005|Overall Study|Other|3|||
161772281|NCT00560573|584209762|FG000|Overall Study|Enrolled, not treated|0|||
161772282|NCT00560573|584209763|FG001|Overall Study|Enrolled, not treated|0|||
161772283|NCT00560573|584209764|FG002|Overall Study|Enrolled, not treated|0|||
161772284|NCT00560573|584209765|FG003|Overall Study|Enrolled, not treated|0|||
161772285|NCT00560573|584209766|FG004|Overall Study|Enrolled, not treated|1|||
161772286|NCT00560573|584209767|FG005|Overall Study|Enrolled, not treated|0|||
161772287|NCT01422876|584209771|FG000|Week 24|Lost to Follow-up|1|||
161772288|NCT01422876|584209772|FG001|Week 24|Lost to Follow-up|1|||
161772289|NCT01422876|584209773|FG002|Week 24|Lost to Follow-up|2|||
161772290|NCT01422876|584209774|FG003|Week 24|Lost to Follow-up|4|||
161772291|NCT01422876|584209775|FG004|Week 24|Lost to Follow-up|2|||
161772292|NCT01422876|584209776|FG005|Week 24|Lost to Follow-up|0|||
161772293|NCT01422876|584209777|FG006|Week 24|Lost to Follow-up|1|||
161772294|NCT01422876|584209778|FG007|Week 24|Lost to Follow-up|3|||
161772295|NCT01422876|584209779|FG008|Week 24|Lost to Follow-up|3|||
161772296|NCT01422876|584209780|FG009|Week 24|Lost to Follow-up|4|||
161772297|NCT01422876|584209771|FG000|Week 24|Consent withdrawn|5|||
161772298|NCT01422876|584209772|FG001|Week 24|Consent withdrawn|1|||
161772299|NCT01422876|584209773|FG002|Week 24|Consent withdrawn|3|||
161977588|NCT00701805|584967328|FG001|Overall Study|Adverse Event|1|||
161772300|NCT01422876|584209774|FG003|Week 24|Consent withdrawn|4|||
161772301|NCT01422876|584209775|FG004|Week 24|Consent withdrawn|5|||
161772302|NCT01422876|584209776|FG005|Week 24|Consent withdrawn|6|||
161772303|NCT01422876|584209777|FG006|Week 24|Consent withdrawn|5|||
161772304|NCT01422876|584209778|FG007|Week 24|Consent withdrawn|4|||
161772305|NCT01422876|584209779|FG008|Week 24|Consent withdrawn|3|||
161772306|NCT01422876|584209780|FG009|Week 24|Consent withdrawn|6|||
161772307|NCT01422876|584209771|FG000|Week 24|Death|0|||
161772308|NCT01422876|584209772|FG001|Week 24|Death|1|||
161977589|NCT00701805|584967329|FG002|Overall Study|Adverse Event|1|||
161860763|NCT01490086|584533178|FG001|Overall Study|Abnormal laboratory findings|0|||
161860764|NCT01490086|584533179|FG002|Overall Study|Abnormal laboratory findings|0|||
161860765|NCT01490086|584533180|FG003|Overall Study|Abnormal laboratory findings|0|||
161860766|NCT01490086|584533181|FG004|Overall Study|Abnormal laboratory findings|0|||
161860767|NCT01490086|584533177|FG000|Overall Study|Lost to Follow-up|0|||
161860768|NCT01490086|584533178|FG001|Overall Study|Lost to Follow-up|0|||
161860769|NCT01490086|584533179|FG002|Overall Study|Lost to Follow-up|0|||
161860770|NCT01490086|584533180|FG003|Overall Study|Lost to Follow-up|0|||
161860771|NCT01490086|584533181|FG004|Overall Study|Lost to Follow-up|1|||
161860772|NCT01490086|584533177|FG000|Overall Study|Physician Decision|3|||
161860773|NCT01490086|584533178|FG001|Overall Study|Physician Decision|4|||
161860774|NCT01490086|584533179|FG002|Overall Study|Physician Decision|2|||
161860775|NCT01490086|584533180|FG003|Overall Study|Physician Decision|3|||
161860776|NCT01490086|584533181|FG004|Overall Study|Physician Decision|1|||
161860777|NCT01490086|584533177|FG000|Overall Study|Adverse Event|0|||
161860778|NCT01490086|584533178|FG001|Overall Study|Adverse Event|0|||
161860779|NCT01490086|584533179|FG002|Overall Study|Adverse Event|1|||
161860780|NCT01490086|584533180|FG003|Overall Study|Adverse Event|2|||
161860781|NCT01490086|584533181|FG004|Overall Study|Adverse Event|0|||
161860782|NCT01490086|584533177|FG000|Overall Study|Lack of Efficacy|0|||
161860783|NCT01490086|584533178|FG001|Overall Study|Lack of Efficacy|3|||
161860784|NCT01490086|584533179|FG002|Overall Study|Lack of Efficacy|1|||
161860785|NCT01490086|584533180|FG003|Overall Study|Lack of Efficacy|0|||
161860786|NCT01490086|584533181|FG004|Overall Study|Lack of Efficacy|8|||
161860787|NCT01490086|584533177|FG000|Overall Study|Worsening of symptoms|0|||
161860788|NCT01490086|584533178|FG001|Overall Study|Worsening of symptoms|1|||
161860789|NCT01490086|584533179|FG002|Overall Study|Worsening of symptoms|0|||
161860790|NCT01490086|584533180|FG003|Overall Study|Worsening of symptoms|1|||
161860791|NCT01490086|584533181|FG004|Overall Study|Worsening of symptoms|0|||
161860792|NCT01490086|584533177|FG000|Overall Study|Subject uncontrollable and abusive|0|||
161860793|NCT01490086|584533178|FG001|Overall Study|Subject uncontrollable and abusive|1|||
161860794|NCT01490086|584533179|FG002|Overall Study|Subject uncontrollable and abusive|0|||
161860795|NCT01490086|584533180|FG003|Overall Study|Subject uncontrollable and abusive|0|||
161772309|NCT01422876|584209773|FG002|Week 24|Death|0|||
161772310|NCT01422876|584209774|FG003|Week 24|Death|0|||
161772311|NCT01422876|584209775|FG004|Week 24|Death|0|||
161772312|NCT01422876|584209776|FG005|Week 24|Death|0|||
161772313|NCT01422876|584209777|FG006|Week 24|Death|0|||
161772314|NCT01422876|584209778|FG007|Week 24|Death|0|||
161772315|NCT01422876|584209779|FG008|Week 24|Death|0|||
161772316|NCT01422876|584209780|FG009|Week 24|Death|0|||
161772317|NCT01422876|584209771|FG000|Week 52|Lost to Follow-up|3|||
161772318|NCT01422876|584209772|FG001|Week 52|Lost to Follow-up|5|||
161772319|NCT01422876|584209773|FG002|Week 52|Lost to Follow-up|7|||
161772320|NCT01422876|584209774|FG003|Week 52|Lost to Follow-up|5|||
161772321|NCT01422876|584209775|FG004|Week 52|Lost to Follow-up|8|||
161772322|NCT01422876|584209776|FG005|Week 52|Lost to Follow-up|5|||
161772323|NCT01422876|584209777|FG006|Week 52|Lost to Follow-up|5|||
161772324|NCT01422876|584209778|FG007|Week 52|Lost to Follow-up|8|||
161772325|NCT01422876|584209779|FG008|Week 52|Lost to Follow-up|7|||
161772326|NCT01422876|584209780|FG009|Week 52|Lost to Follow-up|8|||
161772327|NCT01422876|584209771|FG000|Week 52|Consent withdrawn|9|||
161772328|NCT01422876|584209772|FG001|Week 52|Consent withdrawn|4|||
161772329|NCT01422876|584209773|FG002|Week 52|Consent withdrawn|6|||
161772330|NCT01422876|584209774|FG003|Week 52|Consent withdrawn|12|||
161772331|NCT01422876|584209775|FG004|Week 52|Consent withdrawn|7|||
161772332|NCT01422876|584209776|FG005|Week 52|Consent withdrawn|12|||
161772333|NCT01422876|584209777|FG006|Week 52|Consent withdrawn|10|||
161772334|NCT01422876|584209778|FG007|Week 52|Consent withdrawn|12|||
161772335|NCT01422876|584209779|FG008|Week 52|Consent withdrawn|13|||
161772336|NCT01422876|584209780|FG009|Week 52|Consent withdrawn|9|||
161772337|NCT01422876|584209771|FG000|Week 52|Death|0|||
161772338|NCT01422876|584209772|FG001|Week 52|Death|1|||
161772339|NCT01422876|584209773|FG002|Week 52|Death|0|||
161772340|NCT01422876|584209774|FG003|Week 52|Death|1|||
161772341|NCT01422876|584209775|FG004|Week 52|Death|0|||
161772342|NCT01422876|584209776|FG005|Week 52|Death|0|||
161772343|NCT01422876|584209777|FG006|Week 52|Death|1|||
161772344|NCT01422876|584209778|FG007|Week 52|Death|3|||
161772345|NCT01422876|584209779|FG008|Week 52|Death|1|||
161772346|NCT01422876|584209780|FG009|Week 52|Death|0|||
161772347|NCT00558831|584209781|FG000|Overall Study|Lost to Follow-up|1|||
161772348|NCT02204449|584209782|FG000|Overall Study|Lost to Follow-up|7|||
161772349|NCT02204449|584209783|FG001|Overall Study|Lost to Follow-up|9|||
161772350|NCT02204449|584209782|FG000|Overall Study|Death|0|||
161772351|NCT02204449|584209783|FG001|Overall Study|Death|1|||
161772352|NCT02204449|584209782|FG000|Overall Study|Withdrawal by Subject|0|||
161772353|NCT02204449|584209783|FG001|Overall Study|Withdrawal by Subject|1|||
161772354|NCT02856282|584209784|FG000|Overall Study|Withdrawal by Subject|1|||
161772355|NCT00057330|584209785|FG000|Overall Study|Adverse Event|9|||
161772356|NCT00057330|584209786|FG001|Overall Study|Adverse Event|12|||
161772357|NCT00057330|584209785|FG000|Overall Study|Death|1|||
161772358|NCT00057330|584209786|FG001|Overall Study|Death|0|||
161772359|NCT00057330|584209785|FG000|Overall Study|Protocol Violation|1|||
161860796|NCT01490086|584533181|FG004|Overall Study|Subject uncontrollable and abusive|0|||
161860797|NCT01490086|584533177|FG000|Overall Study|Subject left hospital|0|||
161860798|NCT01490086|584533178|FG001|Overall Study|Subject left hospital|1|||
161860799|NCT01490086|584533179|FG002|Overall Study|Subject left hospital|0|||
161860800|NCT01490086|584533180|FG003|Overall Study|Subject left hospital|1|||
161860801|NCT01490086|584533181|FG004|Overall Study|Subject left hospital|0|||
161860802|NCT04510090|584533184|FG000|FE-HS|Withdrawal by Subject|0|||
161860803|NCT04510090|584533185|FG001|FE-HS|Withdrawal by Subject|0|||
161860804|NCT04510090|584533186|FG002|FE-HS|Withdrawal by Subject|0|||
161860805|NCT04510090|584533187|FG003|FE-HS|Withdrawal by Subject|0|||
161860806|NCT04510090|584533188|FG004|FE-HS|Withdrawal by Subject|1|||
161860807|NCT04510090|584533189|FG005|FE-HS|Withdrawal by Subject|0|||
161860808|NCT04510090|584533190|FG006|FE-HS|Withdrawal by Subject|0|||
161860809|NCT04510090|584533191|FG007|FE-HS|Withdrawal by Subject|0|||
161860810|NCT05825404|584533192|FG000|First Intervention (Weeks 2-5)|Death|0|||
161860811|NCT05825404|584533193|FG001|First Intervention (Weeks 2-5)|Death|1|||
161860812|NCT05825404|584533192|FG000|Second Intervention (Weeks 8-11)|Death|0|||
161860813|NCT05825404|584533193|FG001|Second Intervention (Weeks 8-11)|Death|1|||
161860814|NCT01127256|584533194|FG000|Overall Study|Adverse Event|13|||
161860815|NCT01127256|584533195|FG001|Overall Study|Adverse Event|13|||
161860816|NCT01127256|584533194|FG000|Overall Study|Lack of Efficacy|4|||
161860817|NCT01127256|584533195|FG001|Overall Study|Lack of Efficacy|0|||
161860818|NCT01127256|584533194|FG000|Overall Study|Lost to Follow-up|16|||
161860819|NCT01127256|584533195|FG001|Overall Study|Lost to Follow-up|17|||
161860820|NCT01127256|584533194|FG000|Overall Study|Withdrawal by Subject|5|||
161860821|NCT01127256|584533195|FG001|Overall Study|Withdrawal by Subject|9|||
161860822|NCT01127256|584533194|FG000|Overall Study|Protocol Violation|1|||
161860823|NCT01127256|584533195|FG001|Overall Study|Protocol Violation|0|||
161860824|NCT00679211|584533196|FG000|Overall Study|Progressive disease|82|||
161860825|NCT00679211|584533196|FG000|Overall Study|Adverse Event|7|||
161860826|NCT00679211|584533196|FG000|Overall Study|Withdrawal by Subject|2|||
161860827|NCT00679211|584533196|FG000|Overall Study|Physician Decision|5|||
161860828|NCT00679211|584533196|FG000|Overall Study|Refused to undergo protocol procedures|1|||
161860829|NCT00679211|584533196|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
161860830|NCT00679211|584533196|FG000|Overall Study|Other|1|||
161860831|NCT01922037|584533197|FG000|Overall Study|Withdrawal by Subject|2|||
161860832|NCT01922037|584533198|FG001|Overall Study|Withdrawal by Subject|44|||
161860833|NCT01922037|584533197|FG000|Overall Study|Adverse Event|1|||
161860834|NCT01922037|584533198|FG001|Overall Study|Adverse Event|7|||
161860835|NCT01922037|584533197|FG000|Overall Study|Death|0|||
161860836|NCT01922037|584533198|FG001|Overall Study|Death|5|||
161860837|NCT01922037|584533197|FG000|Overall Study|Pregnancy|0|||
161860838|NCT01922037|584533198|FG001|Overall Study|Pregnancy|2|||
161860839|NCT01922037|584533197|FG000|Overall Study|Participant non-compliance|4|||
161860840|NCT01922037|584533198|FG001|Overall Study|Participant non-compliance|46|||
161860841|NCT01922037|584533197|FG000|Overall Study|Investigator/Sponsor decision|1|||
161860842|NCT01922037|584533198|FG001|Overall Study|Investigator/Sponsor decision|4|||
161860843|NCT01922037|584533197|FG000|Overall Study|Other unspecified|2|||
161860844|NCT01922037|584533198|FG001|Overall Study|Other unspecified|66|||
161860845|NCT00931528|584533199|FG000|Overall Study|Protocol Violation|9|||
161860846|NCT00931528|584533200|FG001|Overall Study|Protocol Violation|12|||
161860847|NCT00931528|584533199|FG000|Overall Study|Withdrawal by Subject|4|||
161860848|NCT00931528|584533200|FG001|Overall Study|Withdrawal by Subject|12|||
161860849|NCT00931528|584533199|FG000|Overall Study|Lost to Follow-up|6|||
161860850|NCT00931528|584533200|FG001|Overall Study|Lost to Follow-up|13|||
162034650|NCT01695005|585183493|FG010|Overall Study|Withdrawal by Subject|2|||
162034651|NCT01695005|585183494|FG011|Overall Study|Withdrawal by Subject|1|||
161860851|NCT00931528|584533199|FG000|Overall Study|Assessment outside of Time Frame|22|||
161860852|NCT00931528|584533200|FG001|Overall Study|Assessment outside of Time Frame|23|||
161860853|NCT01470248|584533201|FG000|Overall Study|Withdrawal by Subject|1|||
161860854|NCT02243605|584533204|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
161860855|NCT02243605|584533205|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
161860856|NCT02243605|584533204|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
161860857|NCT02243605|584533205|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
161860858|NCT02243605|584533204|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
161860859|NCT02243605|584533205|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
161860860|NCT02243605|584533204|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
161860861|NCT02243605|584533205|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
161860862|NCT02243605|584533204|FG000|Stage 2 - Final Analysis Population|Progression|0|||
161860863|NCT02243605|584533205|FG001|Stage 2 - Final Analysis Population|Progression|1|||
161860864|NCT05842967|584533206|FG000|Period 1: SSA|Adverse Event|1|||
162034652|NCT01695005|585183495|FG012|Overall Study|Withdrawal by Subject|1|||
162034653|NCT01695005|585183496|FG013|Overall Study|Withdrawal by Subject|0|||
161860865|NCT05842967|584533207|FG001|Period 1: SSA|Adverse Event|1|||
161860866|NCT05842967|584533208|FG002|Period 1: SSA|Adverse Event|0|||
161860867|NCT05842967|584533209|FG003|Period 1: SSA|Adverse Event|0|||
161860868|NCT05842967|584533206|FG000|Period 1: SSA|Death|1|||
161860869|NCT05842967|584533207|FG001|Period 1: SSA|Death|0|||
161860870|NCT05842967|584533208|FG002|Period 1: SSA|Death|0|||
161860871|NCT05842967|584533209|FG003|Period 1: SSA|Death|0|||
161860872|NCT05842967|584533206|FG000|Period 1: SSA|Lost to Follow-up|16|||
161860873|NCT05842967|584533207|FG001|Period 1: SSA|Lost to Follow-up|4|||
161860874|NCT05842967|584533208|FG002|Period 1: SSA|Lost to Follow-up|0|||
161860875|NCT05842967|584533209|FG003|Period 1: SSA|Lost to Follow-up|0|||
161860876|NCT05842967|584533206|FG000|Period 1: SSA|Physician Decision|1|||
161860877|NCT05842967|584533207|FG001|Period 1: SSA|Physician Decision|0|||
161860878|NCT05842967|584533208|FG002|Period 1: SSA|Physician Decision|0|||
161860879|NCT05842967|584533209|FG003|Period 1: SSA|Physician Decision|0|||
161860880|NCT05842967|584533206|FG000|Period 1: SSA|Withdrawal by Subject|2|||
161860881|NCT05842967|584533207|FG001|Period 1: SSA|Withdrawal by Subject|2|||
161860882|NCT05842967|584533208|FG002|Period 1: SSA|Withdrawal by Subject|0|||
161860883|NCT05842967|584533209|FG003|Period 1: SSA|Withdrawal by Subject|0|||
161860884|NCT05842967|584533206|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
161860885|NCT05842967|584533207|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
161860886|NCT05842967|584533208|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
161860887|NCT05842967|584533209|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
161860888|NCT05842967|584533206|FG000|Period 2: SSB|Adverse Event|0|||
161860889|NCT05842967|584533207|FG001|Period 2: SSB|Adverse Event|0|||
161860890|NCT05842967|584533208|FG002|Period 2: SSB|Adverse Event|2|||
161860891|NCT05842967|584533209|FG003|Period 2: SSB|Adverse Event|0|||
161860892|NCT05842967|584533206|FG000|Period 2: SSB|Lost to Follow-up|0|||
161860893|NCT05842967|584533207|FG001|Period 2: SSB|Lost to Follow-up|0|||
161860894|NCT05842967|584533208|FG002|Period 2: SSB|Lost to Follow-up|4|||
161860895|NCT05842967|584533209|FG003|Period 2: SSB|Lost to Follow-up|3|||
161860896|NCT05842967|584533206|FG000|Period 2: SSB|Withdrawal by Subject|0|||
161860897|NCT05842967|584533207|FG001|Period 2: SSB|Withdrawal by Subject|0|||
161860898|NCT05842967|584533208|FG002|Period 2: SSB|Withdrawal by Subject|1|||
161860899|NCT05842967|584533209|FG003|Period 2: SSB|Withdrawal by Subject|0|||
161860900|NCT05842967|584533206|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
161860901|NCT05842967|584533207|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
161860902|NCT05842967|584533208|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
161860903|NCT05842967|584533209|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
161860904|NCT05842967|584533206|FG000|Period 2: SSB|Protocol Violation|0|||
161860905|NCT05842967|584533207|FG001|Period 2: SSB|Protocol Violation|0|||
161860906|NCT05842967|584533208|FG002|Period 2: SSB|Protocol Violation|0|||
161860907|NCT05842967|584533209|FG003|Period 2: SSB|Protocol Violation|1|||
161860908|NCT01866826|584533221|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
161860909|NCT01866826|584533222|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
161860910|NCT01866826|584533221|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
161860911|NCT01866826|584533222|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
161860912|NCT01866826|584533221|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
161860913|NCT01866826|584533222|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
161860914|NCT02288312|584533223|FG000|Overall Study|Pregnancy|1|||
161860915|NCT02288312|584533224|FG001|Overall Study|Pregnancy|0|||
161860916|NCT02288312|584533225|FG002|Overall Study|Pregnancy|0|||
161860917|NCT01276041|584533226|FG000|Overall Study|Adverse Event|2|||
161860918|NCT01276041|584533226|FG000|Overall Study|Protocol Violation|1|||
161860919|NCT02058069|584533229|FG000|Overall Study|Exclusion due to implant size|5|||
161860920|NCT02058069|584533229|FG000|Overall Study|Withdrawal by Subject|6|||
161860921|NCT02222922|584533230|FG000|Overall Study|Death|0|||
161860922|NCT02222922|584533231|FG001|Overall Study|Death|0|||
161860923|NCT02222922|584533232|FG002|Overall Study|Death|0|||
161860924|NCT02222922|584533233|FG003|Overall Study|Death|0|||
161860925|NCT02222922|584533234|FG004|Overall Study|Death|13|||
161860926|NCT02222922|584533235|FG005|Overall Study|Death|0|||
161860927|NCT02222922|584533236|FG006|Overall Study|Death|0|||
161860928|NCT02222922|584533237|FG007|Overall Study|Death|0|||
161860929|NCT02222922|584533238|FG008|Overall Study|Death|2|||
161860930|NCT02222922|584533230|FG000|Overall Study|Lost to Follow-up|0|||
161860931|NCT02222922|584533231|FG001|Overall Study|Lost to Follow-up|0|||
161860932|NCT02222922|584533232|FG002|Overall Study|Lost to Follow-up|1|||
161860933|NCT02222922|584533233|FG003|Overall Study|Lost to Follow-up|0|||
161860934|NCT02222922|584533234|FG004|Overall Study|Lost to Follow-up|9|||
161860935|NCT02222922|584533235|FG005|Overall Study|Lost to Follow-up|1|||
161977590|NCT00701805|584967330|FG003|Overall Study|Adverse Event|0|||
161860936|NCT02222922|584533236|FG006|Overall Study|Lost to Follow-up|0|||
161977591|NCT00701805|584967327|FG000|Overall Study|Missed 7 consecutive doses|0|||
161860937|NCT02222922|584533237|FG007|Overall Study|Lost to Follow-up|0|||
161860938|NCT02222922|584533238|FG008|Overall Study|Lost to Follow-up|0|||
161860939|NCT02222922|584533230|FG000|Overall Study|Other|0|||
161860940|NCT02222922|584533231|FG001|Overall Study|Other|0|||
161860941|NCT02222922|584533232|FG002|Overall Study|Other|0|||
161860942|NCT02222922|584533233|FG003|Overall Study|Other|2|||
161860943|NCT02222922|584533234|FG004|Overall Study|Other|10|||
161860944|NCT02222922|584533235|FG005|Overall Study|Other|2|||
161860945|NCT02222922|584533236|FG006|Overall Study|Other|2|||
161860946|NCT02222922|584533237|FG007|Overall Study|Other|4|||
161860947|NCT02222922|584533238|FG008|Overall Study|Other|1|||
161860948|NCT02222922|584533230|FG000|Overall Study|Participant refused further follow-up|1|||
161860949|NCT02222922|584533231|FG001|Overall Study|Participant refused further follow-up|0|||
161860950|NCT02222922|584533232|FG002|Overall Study|Participant refused further follow-up|0|||
161860951|NCT02222922|584533233|FG003|Overall Study|Participant refused further follow-up|1|||
161860952|NCT02222922|584533234|FG004|Overall Study|Participant refused further follow-up|6|||
161860953|NCT02222922|584533235|FG005|Overall Study|Participant refused further follow-up|0|||
161860954|NCT02222922|584533236|FG006|Overall Study|Participant refused further follow-up|0|||
161860955|NCT02222922|584533237|FG007|Overall Study|Participant refused further follow-up|0|||
161860956|NCT02222922|584533238|FG008|Overall Study|Participant refused further follow-up|3|||
161860957|NCT01068860|584533239|FG000|Overall Study|Withdrawal by Subject|0|||
161860958|NCT01068860|584533240|FG001|Overall Study|Withdrawal by Subject|0|||
161860959|NCT01068860|584533241|FG002|Overall Study|Withdrawal by Subject|0|||
161860960|NCT01068860|584533242|FG003|Overall Study|Withdrawal by Subject|0|||
161860961|NCT01068860|584533243|FG004|Overall Study|Withdrawal by Subject|0|||
161860962|NCT01068860|584533244|FG005|Overall Study|Withdrawal by Subject|2|||
161860963|NCT01068860|584533245|FG006|Overall Study|Withdrawal by Subject|0|||
161860964|NCT01068860|584533246|FG007|Overall Study|Withdrawal by Subject|0|||
161860965|NCT01068860|584533247|FG008|Overall Study|Withdrawal by Subject|0|||
161860966|NCT01068860|584533248|FG009|Overall Study|Withdrawal by Subject|3|||
161860967|NCT01068860|584533239|FG000|Overall Study|Administrative problems; misrandomized|0|||
161860968|NCT01068860|584533240|FG001|Overall Study|Administrative problems; misrandomized|0|||
161860969|NCT01068860|584533241|FG002|Overall Study|Administrative problems; misrandomized|0|||
161860970|NCT01068860|584533242|FG003|Overall Study|Administrative problems; misrandomized|1|||
161860971|NCT01068860|584533243|FG004|Overall Study|Administrative problems; misrandomized|0|||
161860972|NCT01068860|584533244|FG005|Overall Study|Administrative problems; misrandomized|0|||
161860973|NCT01068860|584533245|FG006|Overall Study|Administrative problems; misrandomized|0|||
161860974|NCT01068860|584533246|FG007|Overall Study|Administrative problems; misrandomized|0|||
161860975|NCT01068860|584533247|FG008|Overall Study|Administrative problems; misrandomized|0|||
161860976|NCT01068860|584533248|FG009|Overall Study|Administrative problems; misrandomized|1|||
161860977|NCT01068860|584533239|FG000|Overall Study|Lost to Follow-up|0|||
161860978|NCT01068860|584533240|FG001|Overall Study|Lost to Follow-up|1|||
161860979|NCT01068860|584533241|FG002|Overall Study|Lost to Follow-up|0|||
161860980|NCT01068860|584533242|FG003|Overall Study|Lost to Follow-up|0|||
161860981|NCT01068860|584533243|FG004|Overall Study|Lost to Follow-up|0|||
161860982|NCT01068860|584533244|FG005|Overall Study|Lost to Follow-up|0|||
161860983|NCT01068860|584533245|FG006|Overall Study|Lost to Follow-up|0|||
161860984|NCT01068860|584533246|FG007|Overall Study|Lost to Follow-up|0|||
161860985|NCT01068860|584533247|FG008|Overall Study|Lost to Follow-up|0|||
161860986|NCT01068860|584533248|FG009|Overall Study|Lost to Follow-up|0|||
161860987|NCT02568072|584533249|FG000|Overall Study|Unavailable for appointment|23|||
161860988|NCT02568072|584533249|FG000|Overall Study|Unable to contact|3|||
161860989|NCT02568072|584533249|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
161860990|NCT02568072|584533249|FG000|Overall Study|Withdrawal by Subject|1|||
161860991|NCT02568072|584533249|FG000|Overall Study|Sustained injury, marathon not run|24|||
161860992|NCT05263908|584533250|FG000|Overall Study|No informed consent for publication of study results|397|||
161860993|NCT05263908|584533250|FG000|Overall Study|CRF not collected|1|||
161860994|NCT02714218|584533251|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161860995|NCT02714218|584533252|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161860996|NCT02714218|584533253|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161860997|NCT02714218|584533251|FG000|Pre-Treatment Period|Other reasons|0|||
161860998|NCT02714218|584533252|FG001|Pre-Treatment Period|Other reasons|1|||
161860999|NCT02714218|584533253|FG002|Pre-Treatment Period|Other reasons|0|||
161861000|NCT02714218|584533251|FG000|Treatment Period|Disease Progression|55|||
161861001|NCT02714218|584533252|FG001|Treatment Period|Disease Progression|52|||
161861002|NCT02714218|584533253|FG002|Treatment Period|Disease Progression|14|||
161861003|NCT02714218|584533251|FG000|Treatment Period|Study drug toxicity|46|||
161861004|NCT02714218|584533252|FG001|Treatment Period|Study drug toxicity|70|||
161861005|NCT02714218|584533253|FG002|Treatment Period|Study drug toxicity|6|||
161861006|NCT02714218|584533251|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
161861007|NCT02714218|584533252|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
162034654|NCT01695005|585183497|FG014|Overall Study|Withdrawal by Subject|0|||
162034655|NCT01695005|585183498|FG015|Overall Study|Withdrawal by Subject|0|||
162034656|NCT01695005|585183499|FG016|Overall Study|Withdrawal by Subject|0|||
162034657|NCT01695005|585183500|FG017|Overall Study|Withdrawal by Subject|0|||
161861008|NCT02714218|584533253|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
161861009|NCT02714218|584533251|FG000|Treatment Period|Request to discontinue treatment|1|||
161861010|NCT02714218|584533252|FG001|Treatment Period|Request to discontinue treatment|4|||
161861011|NCT02714218|584533253|FG002|Treatment Period|Request to discontinue treatment|1|||
161861012|NCT02714218|584533251|FG000|Treatment Period|Participant withdrew consent|2|||
161772360|NCT00057330|584209786|FG001|Overall Study|Protocol Violation|1|||
161772361|NCT00057330|584209785|FG000|Overall Study|Withdrawal by Subject|115|||
161772362|NCT00057330|584209786|FG001|Overall Study|Withdrawal by Subject|84|||
161772363|NCT00057330|584209785|FG000|Overall Study|Lost to Follow-up|745|||
161772364|NCT00057330|584209786|FG001|Overall Study|Lost to Follow-up|617|||
161772365|NCT00057330|584209785|FG000|Overall Study|Physician Decision|1|||
161772366|NCT00057330|584209786|FG001|Overall Study|Physician Decision|0|||
161772367|NCT00057330|584209785|FG000|Overall Study|Other|260|||
161772368|NCT00057330|584209786|FG001|Overall Study|Other|206|||
161772369|NCT01491737|584209787|FG000|Overall Study|Withdrawal by Subject|20|||
161772370|NCT01491737|584209788|FG001|Overall Study|Withdrawal by Subject|17|||
161772371|NCT01491737|584209787|FG000|Overall Study|Lost to Follow-up|2|||
161772372|NCT01491737|584209788|FG001|Overall Study|Lost to Follow-up|10|||
161772373|NCT01491737|584209787|FG000|Overall Study|Death|63|||
161772374|NCT01491737|584209788|FG001|Overall Study|Death|57|||
161772375|NCT01491737|584209787|FG000|Overall Study|Study Termination by Sponsor|36|||
161772376|NCT01491737|584209788|FG001|Overall Study|Study Termination by Sponsor|36|||
161772377|NCT01491737|584209787|FG000|Overall Study|Reason Not Specified|8|||
161772378|NCT01491737|584209788|FG001|Overall Study|Reason Not Specified|9|||
161772379|NCT01308476|584209789|FG000|Overall Study|Lost to Follow-up|2|||
161772380|NCT01308476|584209790|FG001|Overall Study|Lost to Follow-up|2|||
161772381|NCT01308476|584209789|FG000|Overall Study|Other|1|||
161772382|NCT01308476|584209790|FG001|Overall Study|Other|0|||
161772383|NCT03772574|584209791|FG000|Overall Study|Protocol Violation|2|||
161772384|NCT03772574|584209792|FG001|Overall Study|Protocol Violation|0|||
161772385|NCT03772574|584209793|FG002|Overall Study|Protocol Violation|0|||
161772386|NCT03772574|584209791|FG000|Overall Study|Discomfort|0|||
161772387|NCT03772574|584209792|FG001|Overall Study|Discomfort|5|||
161772388|NCT03772574|584209793|FG002|Overall Study|Discomfort|4|||
161772389|NCT02696382|584209796|FG000|Overall Study|Death|7|||
161772390|NCT02696382|584209797|FG001|Overall Study|Death|2|||
161772391|NCT02696382|584209796|FG000|Overall Study|Withdrawal by Subject|5|||
161772392|NCT02696382|584209797|FG001|Overall Study|Withdrawal by Subject|12|||
161772393|NCT02696382|584209796|FG000|Overall Study|Lost to Follow-up|4|||
161772394|NCT02696382|584209797|FG001|Overall Study|Lost to Follow-up|7|||
161772395|NCT00761969|584209798|FG000|Overall Study|Death|112|||
161772396|NCT00761969|584209799|FG001|Overall Study|Death|47|||
161772397|NCT00761969|584209798|FG000|Overall Study|Lost to Follow-up|88|||
161772398|NCT00761969|584209799|FG001|Overall Study|Lost to Follow-up|93|||
161772399|NCT01725217|584209800|FG000|Overall Study|Withdrawal by Subject|1|||
161772400|NCT01725217|584209801|FG001|Overall Study|Withdrawal by Subject|0|||
161772401|NCT01725217|584209802|FG002|Overall Study|Withdrawal by Subject|0|||
161772402|NCT00585468|584209803|FG000|First Intervention|Withdrawal by Subject|1|||
161772403|NCT00585468|584209804|FG001|First Intervention|Withdrawal by Subject|1|||
161772404|NCT02940392|584209809|FG000|Overall Study|Lost to Follow-up|3|||
161772405|NCT02940392|584209809|FG000|Overall Study|Retreatment|3|||
161772406|NCT02940392|584209809|FG000|Overall Study|Death|2|||
161772407|NCT03205046|584209810|FG000|Overall Study|Death|10|||
161772408|NCT03205046|584209811|FG001|Overall Study|Death|6|||
161772409|NCT03205046|584209810|FG000|Overall Study|Withdrawal by Subject|1|||
161772410|NCT03205046|584209811|FG001|Overall Study|Withdrawal by Subject|2|||
161772411|NCT03205046|584209810|FG000|Overall Study|Lost to Follow-up|0|||
161772412|NCT03205046|584209811|FG001|Overall Study|Lost to Follow-up|1|||
161772413|NCT03205046|584209810|FG000|Overall Study|Study terminated by sponsor|2|||
161772414|NCT03205046|584209811|FG001|Overall Study|Study terminated by sponsor|1|||
161772415|NCT00762073|584209812|FG000|Overall Study|Lack of Efficacy|1|||
161772416|NCT00762073|584209813|FG001|Overall Study|Lack of Efficacy|1|||
161772417|NCT00762073|584209814|FG002|Overall Study|Lack of Efficacy|0|||
161772418|NCT00762073|584209815|FG003|Overall Study|Lack of Efficacy|0|||
161772419|NCT00762073|584209812|FG000|Overall Study|Adverse Event|1|||
161772420|NCT00762073|584209813|FG001|Overall Study|Adverse Event|0|||
161772421|NCT00762073|584209814|FG002|Overall Study|Adverse Event|1|||
161772422|NCT00762073|584209815|FG003|Overall Study|Adverse Event|1|||
161772423|NCT00762073|584209812|FG000|Overall Study|Significant Subject Noncompliance|0|||
161772424|NCT00762073|584209813|FG001|Overall Study|Significant Subject Noncompliance|1|||
161772425|NCT00762073|584209814|FG002|Overall Study|Significant Subject Noncompliance|0|||
161772426|NCT00762073|584209815|FG003|Overall Study|Significant Subject Noncompliance|1|||
161772427|NCT00762073|584209812|FG000|Overall Study|Withdrawal by Subject|1|||
161772428|NCT00762073|584209813|FG001|Overall Study|Withdrawal by Subject|2|||
161772429|NCT00762073|584209814|FG002|Overall Study|Withdrawal by Subject|1|||
161772430|NCT00762073|584209815|FG003|Overall Study|Withdrawal by Subject|1|||
161772431|NCT00762073|584209812|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
161772432|NCT00762073|584209813|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
161772433|NCT00762073|584209814|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
161772434|NCT00762073|584209815|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
161772435|NCT01068418|584209818|FG000|Overall Study|Physician Decision|12|||
161772436|NCT02319642|584209819|FG000|Overall Study|Adverse Event|2|||
161772437|NCT02319642|584209820|FG001|Overall Study|Adverse Event|4|||
161772438|NCT02319642|584209819|FG000|Overall Study|Lack of Efficacy|1|||
161861013|NCT02714218|584533252|FG001|Treatment Period|Participant withdrew consent|2|||
161861014|NCT02714218|584533253|FG002|Treatment Period|Participant withdrew consent|0|||
161861015|NCT02714218|584533251|FG000|Treatment Period|Maximum clinical benefit|4|||
161861016|NCT02714218|584533252|FG001|Treatment Period|Maximum clinical benefit|2|||
161861017|NCT02714218|584533253|FG002|Treatment Period|Maximum clinical benefit|0|||
161861018|NCT02714218|584533251|FG000|Treatment Period|Administrative reason by sponsor|2|||
161861019|NCT02714218|584533252|FG001|Treatment Period|Administrative reason by sponsor|1|||
161861020|NCT02714218|584533253|FG002|Treatment Period|Administrative reason by sponsor|0|||
161861021|NCT02714218|584533251|FG000|Treatment Period|Other reasons|6|||
161861022|NCT02714218|584533252|FG001|Treatment Period|Other reasons|6|||
161861023|NCT02714218|584533253|FG002|Treatment Period|Other reasons|0|||
161861024|NCT02714218|584533251|FG000|Treatment Period|Completed treatment as per protocol|36|||
161861025|NCT02714218|584533252|FG001|Treatment Period|Completed treatment as per protocol|27|||
161861026|NCT02714218|584533253|FG002|Treatment Period|Completed treatment as per protocol|3|||
161861027|NCT02714218|584533251|FG000|Treatment Period|Not reported|9|||
161861028|NCT02714218|584533252|FG001|Treatment Period|Not reported|6|||
161861029|NCT02714218|584533253|FG002|Treatment Period|Not reported|0|||
161861030|NCT00840749|584533254|FG000|Overall Study|Death|1|||
161861031|NCT00840749|584533255|FG001|Overall Study|Death|2|||
161861032|NCT00840749|584533254|FG000|Overall Study|not treated on study arm|11|||
161861033|NCT00840749|584533255|FG001|Overall Study|not treated on study arm|11|||
161861034|NCT00840749|584533254|FG000|Overall Study|study closed|19|||
161861035|NCT00840749|584533255|FG001|Overall Study|study closed|14|||
161861036|NCT01113892|584533256|FG000|Overall Study|Lost to Follow-up|2|||
161861037|NCT01113892|584533257|FG001|Overall Study|Lost to Follow-up|2|||
161861038|NCT01113892|584533256|FG000|Overall Study|Withdrawal by Subject|1|||
161861039|NCT01113892|584533257|FG001|Overall Study|Withdrawal by Subject|1|||
161977592|NCT00701805|584967328|FG001|Overall Study|Missed 7 consecutive doses|1|||
161977593|NCT00701805|584967329|FG002|Overall Study|Missed 7 consecutive doses|0|||
161772439|NCT02319642|584209820|FG001|Overall Study|Lack of Efficacy|1|||
161772440|NCT02319642|584209819|FG000|Overall Study|Withdrawal by Subject|1|||
161772441|NCT02319642|584209820|FG001|Overall Study|Withdrawal by Subject|1|||
161772442|NCT01265875|584209821|FG000|Overall Study|Uncooperative/unreliable|1|||
161772443|NCT00145795|584209824|FG000|Overall Study|Adverse Event|1|||
161772444|NCT00145795|584209825|FG001|Overall Study|Adverse Event|0|||
161772445|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Adverse Event|6|||
161772446|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Adverse Event|6|||
161772447|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Death|14|||
161772448|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Death|11|||
161772449|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
161772450|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
161772451|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
161772452|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
161772453|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
161772454|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
161772455|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Disease Progression|1|||
161772456|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Disease Progression|0|||
161772457|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
161772458|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
161772459|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
161772460|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
161772461|NCT04419558|584209826|FG000|DB Period (48 Weeks)|Participant Decision|4|||
161772462|NCT04419558|584209827|FG001|DB Period (48 Weeks)|Participant Decision|3|||
161772463|NCT04419558|584209826|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
161772464|NCT04419558|584209827|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
161772465|NCT04419558|584209826|FG000|OLE Period (48 Weeks)|Death|4|||
161772466|NCT04419558|584209827|FG001|OLE Period (48 Weeks)|Death|6|||
161772467|NCT04419558|584209826|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
161861040|NCT01113892|584533256|FG000|Overall Study|Death|2|||
161861041|NCT01113892|584533257|FG001|Overall Study|Death|4|||
161861042|NCT01113892|584533256|FG000|Overall Study|Graft no longer evaluable|9|||
161861043|NCT01113892|584533257|FG001|Overall Study|Graft no longer evaluable|9|||
161861044|NCT00789854|584533264|FG000|Overall Study|Adverse Event|28|||
161861045|NCT00789854|584533265|FG001|Overall Study|Adverse Event|23|||
161861046|NCT00789854|584533266|FG002|Overall Study|Adverse Event|18|||
161861047|NCT00789854|584533264|FG000|Overall Study|Lost to Follow-up|1|||
161861048|NCT00789854|584533265|FG001|Overall Study|Lost to Follow-up|1|||
161861049|NCT00789854|584533266|FG002|Overall Study|Lost to Follow-up|4|||
161861050|NCT00789854|584533264|FG000|Overall Study|Withdrawal by Subject|9|||
161861051|NCT00789854|584533265|FG001|Overall Study|Withdrawal by Subject|6|||
161861052|NCT00789854|584533266|FG002|Overall Study|Withdrawal by Subject|17|||
161772468|NCT04419558|584209827|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
161772469|NCT04419558|584209826|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
161772470|NCT04419558|584209827|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
161772471|NCT01539512|584209828|FG000|Overall Study|Adverse Event|9|||
161772472|NCT01539512|584209829|FG001|Overall Study|Adverse Event|7|||
161772473|NCT01539512|584209828|FG000|Overall Study|Physician Decision|1|||
161772474|NCT01539512|584209829|FG001|Overall Study|Physician Decision|1|||
161772475|NCT01539512|584209828|FG000|Overall Study|Withdrawal by Subject|12|||
161772476|NCT01539512|584209829|FG001|Overall Study|Withdrawal by Subject|5|||
161772477|NCT01539512|584209828|FG000|Overall Study|Richter's Transformation|1|||
161772478|NCT01539512|584209829|FG001|Overall Study|Richter's Transformation|0|||
161772479|NCT01015118|584209830|FG000|Overall Study|Protocol Violation|5|||
161772480|NCT01015118|584209831|FG001|Overall Study|Protocol Violation|6|||
161772481|NCT01015118|584209830|FG000|Overall Study|Withdrawal by Subject|103|||
161772482|NCT01015118|584209831|FG001|Overall Study|Withdrawal by Subject|27|||
161772483|NCT01015118|584209830|FG000|Overall Study|Other Adverse Event (AE)|141|||
161772484|NCT01015118|584209831|FG001|Overall Study|Other Adverse Event (AE)|33|||
161772485|NCT01015118|584209830|FG000|Overall Study|Worsening or AE of underlying disease|5|||
161772486|NCT01015118|584209831|FG001|Overall Study|Worsening or AE of underlying disease|4|||
161772487|NCT01015118|584209830|FG000|Overall Study|Progressive disease|364|||
161772488|NCT01015118|584209831|FG001|Overall Study|Progressive disease|229|||
161772489|NCT01015118|584209830|FG000|Overall Study|Not treated|9|||
161772490|NCT01015118|584209831|FG001|Overall Study|Not treated|5|||
161772491|NCT01015118|584209830|FG000|Overall Study|Other than stated above|42|||
161772492|NCT01015118|584209831|FG001|Overall Study|Other than stated above|23|||
161772493|NCT02388906|584209832|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
161772494|NCT02388906|584209833|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
161772495|NCT02388906|584209832|FG000|Treatment Period|Disease progression|121|||
161772496|NCT02388906|584209833|FG001|Treatment Period|Disease progression|100|||
161772497|NCT02388906|584209832|FG000|Treatment Period|Study drug toxicity|41|||
161772498|NCT02388906|584209833|FG001|Treatment Period|Study drug toxicity|208|||
161772499|NCT02388906|584209832|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
161772500|NCT02388906|584209833|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
161772501|NCT02388906|584209832|FG000|Treatment Period|Participant request to stop treatment|5|||
161772502|NCT02388906|584209833|FG001|Treatment Period|Participant request to stop treatment|9|||
161772503|NCT02388906|584209832|FG000|Treatment Period|Participant withdrew consent|2|||
161772504|NCT02388906|584209833|FG001|Treatment Period|Participant withdrew consent|3|||
161772505|NCT02388906|584209832|FG000|Treatment Period|Poor/non-compliance|0|||
161772506|NCT02388906|584209833|FG001|Treatment Period|Poor/non-compliance|1|||
161772507|NCT02388906|584209832|FG000|Treatment Period|Participant no longer meets study criteria|0|||
161772508|NCT02388906|584209833|FG001|Treatment Period|Participant no longer meets study criteria|1|||
161772509|NCT02388906|584209832|FG000|Treatment Period|Other reasons|3|||
161772510|NCT02388906|584209833|FG001|Treatment Period|Other reasons|3|||
161772511|NCT01250418|584209834|FG000|Overall Study|monitor data failure|1|||
161772512|NCT01250418|584209835|FG001|Overall Study|monitor data failure|1|||
161772513|NCT02400281|584209837|FG000|Overall Study|Adverse Event|0|||
161772514|NCT02400281|584209838|FG001|Overall Study|Adverse Event|0|||
161772515|NCT02400281|584209839|FG002|Overall Study|Adverse Event|1|||
161772516|NCT02400281|584209840|FG003|Overall Study|Adverse Event|0|||
161772517|NCT02400281|584209841|FG004|Overall Study|Adverse Event|1|||
161772518|NCT02400281|584209842|FG005|Overall Study|Adverse Event|0|||
161772519|NCT02400281|584209837|FG000|Overall Study|Physician Decision|0|||
161772520|NCT02400281|584209838|FG001|Overall Study|Physician Decision|0|||
161772521|NCT02400281|584209839|FG002|Overall Study|Physician Decision|1|||
161772522|NCT02400281|584209840|FG003|Overall Study|Physician Decision|0|||
161772523|NCT02400281|584209841|FG004|Overall Study|Physician Decision|0|||
161772524|NCT02400281|584209842|FG005|Overall Study|Physician Decision|0|||
161772525|NCT00412360|584209843|FG000|Overall Study|Lost to Follow-up|0|||
161772526|NCT00412360|584209844|FG001|Overall Study|Lost to Follow-up|1|||
161772527|NCT00412360|584209843|FG000|Overall Study|Not Transplanted|1|||
161772528|NCT00412360|584209844|FG001|Overall Study|Not Transplanted|2|||
161772529|NCT03145207|584209846|FG000|Overall Study|volunteer started taking allergy shots|1|||
161772530|NCT03145207|584209846|FG000|Overall Study|baseline blood pressure high|1|||
161772531|NCT01790633|584209847|FG000|Overall Study|Protocol Violation|1|||
161772532|NCT01790633|584209848|FG001|Overall Study|Protocol Violation|2|||
161772533|NCT01790633|584209847|FG000|Overall Study|Did not have serology performed|47|||
161772534|NCT01790633|584209848|FG001|Overall Study|Did not have serology performed|0|||
161772535|NCT01790633|584209847|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
161772536|NCT01790633|584209848|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
161772537|NCT01396434|584209850|FG000|Overall Study|Lost to Follow-up|1|||
161772538|NCT01396434|584209851|FG001|Overall Study|Lost to Follow-up|0|||
161772539|NCT01396434|584209852|FG002|Overall Study|Lost to Follow-up|0|||
161772540|NCT01396434|584209850|FG000|Overall Study|Other|10|||
161772541|NCT01396434|584209851|FG001|Overall Study|Other|0|||
161772542|NCT01396434|584209852|FG002|Overall Study|Other|0|||
161772543|NCT04678557|584209853|FG000|Overall Study|Withdrawal by Subject|1|||
161772544|NCT04678557|584209854|FG001|Overall Study|Withdrawal by Subject|0|||
161772545|NCT04678557|584209853|FG000|Overall Study|Lack of Efficacy|0|||
161772546|NCT04678557|584209854|FG001|Overall Study|Lack of Efficacy|13|||
161772547|NCT04678557|584209853|FG000|Overall Study|Safety Evaluation|0|||
161772548|NCT04678557|584209854|FG001|Overall Study|Safety Evaluation|1|||
161861053|NCT00789854|584533264|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161861054|NCT00789854|584533265|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
161861055|NCT00789854|584533266|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161861056|NCT00789854|584533264|FG000|Overall Study|Severe non-compliance to the protocol|3|||
161861057|NCT00789854|584533265|FG001|Overall Study|Severe non-compliance to the protocol|0|||
161861058|NCT00789854|584533266|FG002|Overall Study|Severe non-compliance to the protocol|0|||
161861059|NCT00789854|584533264|FG000|Overall Study|Safety reasons|0|||
161861060|NCT00789854|584533265|FG001|Overall Study|Safety reasons|0|||
161861061|NCT00789854|584533266|FG002|Overall Study|Safety reasons|2|||
161861062|NCT00789854|584533264|FG000|Overall Study|Other|6|||
161861063|NCT00789854|584533265|FG001|Overall Study|Other|0|||
161861064|NCT00789854|584533266|FG002|Overall Study|Other|5|||
161861065|NCT03473925|584533267|FG000|Overall Study|Death|48|||
161861066|NCT03473925|584533268|FG001|Overall Study|Death|44|||
161861067|NCT03473925|584533267|FG000|Overall Study|Sponsor Decision|2|||
161861068|NCT03473925|584533268|FG001|Overall Study|Sponsor Decision|7|||
161861069|NCT03473925|584533267|FG000|Overall Study|Withdrawal by Subject|1|||
161861070|NCT03473925|584533268|FG001|Overall Study|Withdrawal by Subject|3|||
161861071|NCT03473925|584533267|FG000|Overall Study|Not Treated|1|||
161861072|NCT03473925|584533268|FG001|Overall Study|Not Treated|1|||
161861073|NCT03411863|584533269|FG000|Overall Study|Withdrawal by Subject|3|||
161861074|NCT03411863|584533270|FG001|Overall Study|Withdrawal by Subject|1|||
161861075|NCT03411863|584533269|FG000|Overall Study|Physician Decision|0|||
161861076|NCT03411863|584533270|FG001|Overall Study|Physician Decision|1|||
161861077|NCT02766335|584533272|FG000|Initial Registration|Adverse Event|6|||
161861078|NCT02766335|584533273|FG001|Initial Registration|Adverse Event|3|||
161861079|NCT02766335|584533274|FG002|Initial Registration|Adverse Event|0|||
161861080|NCT02766335|584533272|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
161861081|NCT02766335|584533273|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
161861082|NCT02766335|584533274|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
161861083|NCT02766335|584533272|FG000|Initial Registration|Progression/relapse|49|||
161861084|NCT02766335|584533273|FG001|Initial Registration|Progression/relapse|15|||
161861085|NCT02766335|584533274|FG002|Initial Registration|Progression/relapse|0|||
161861086|NCT02766335|584533272|FG000|Initial Registration|Death|1|||
161861087|NCT02766335|584533273|FG001|Initial Registration|Death|3|||
161861088|NCT02766335|584533274|FG002|Initial Registration|Death|0|||
161977594|NCT00701805|584967330|FG003|Overall Study|Missed 7 consecutive doses|0|||
161977595|NCT00701805|584967327|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
161977596|NCT00701805|584967328|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
161977597|NCT00701805|584967329|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
161977598|NCT00701805|584967330|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
161977599|NCT00701805|584967327|FG000|Overall Study|Physician decision, change of therapy|0|||
161977600|NCT00701805|584967328|FG001|Overall Study|Physician decision, change of therapy|0|||
161977601|NCT00701805|584967329|FG002|Overall Study|Physician decision, change of therapy|0|||
161977602|NCT00701805|584967330|FG003|Overall Study|Physician decision, change of therapy|1|||
161977603|NCT00701805|584967327|FG000|Overall Study|Difficult to travel to dialysis site|0|||
161977604|NCT00701805|584967328|FG001|Overall Study|Difficult to travel to dialysis site|0|||
161977605|NCT00701805|584967329|FG002|Overall Study|Difficult to travel to dialysis site|1|||
161977606|NCT00701805|584967330|FG003|Overall Study|Difficult to travel to dialysis site|0|||
161977607|NCT00701805|584967327|FG000|Overall Study|Resumption criteria were not met|0|||
161977608|NCT00701805|584967328|FG001|Overall Study|Resumption criteria were not met|1|||
161977609|NCT00701805|584967329|FG002|Overall Study|Resumption criteria were not met|0|||
161977610|NCT00701805|584967330|FG003|Overall Study|Resumption criteria were not met|0|||
161977611|NCT04256512|584967331|FG000|Overall Study|Withdrawal by Subject|1|||
161977612|NCT02804750|584967337|FG000|Period 1|Adverse Event|0|||
161977613|NCT02804750|584967338|FG001|Period 1|Adverse Event|2|||
161977614|NCT02804750|584967337|FG000|Period 1|Withdrawal by Subject|0|||
161977615|NCT02804750|584967338|FG001|Period 1|Withdrawal by Subject|1|||
161977616|NCT02804750|584967337|FG000|Period 2|Adverse Event|1|||
161977617|NCT02804750|584967338|FG001|Period 2|Adverse Event|0|||
161861089|NCT02766335|584533272|FG000|Initial Registration|not protocol specified|1|||
161861090|NCT02766335|584533273|FG001|Initial Registration|not protocol specified|9|||
161861091|NCT02766335|584533274|FG002|Initial Registration|not protocol specified|0|||
161861092|NCT02766335|584533272|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
161861093|NCT02766335|584533273|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
161861094|NCT02766335|584533274|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
161861095|NCT02766335|584533272|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
161861096|NCT02766335|584533273|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
161861097|NCT02766335|584533274|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
161861098|NCT02756611|584533276|FG000|Overall Study|Death|70|||
161861099|NCT02756611|584533276|FG000|Overall Study|Withdrawal by Subject|2|||
161861100|NCT02756611|584533276|FG000|Overall Study|Lost to Follow-up|3|||
161861101|NCT02756611|584533276|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
161861102|NCT02756611|584533276|FG000|Overall Study|Other|10|||
161861103|NCT03125798|584533278|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
161861104|NCT03125798|584533279|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
161861105|NCT03125798|584533278|FG000|Overall Study|Conversion to thoracotomy|7|||
161861106|NCT03125798|584533279|FG001|Overall Study|Conversion to thoracotomy|7|||
161861107|NCT00476190|584533294|FG000|Overall Study|Ineligible|1|||
161861108|NCT00476190|584533295|FG001|Overall Study|Ineligible|1|||
161861109|NCT00476190|584533294|FG000|Overall Study|Induction Death|2|||
161861110|NCT00476190|584533295|FG001|Overall Study|Induction Death|0|||
161861111|NCT00476190|584533294|FG000|Overall Study|Induction Failure|2|||
161861112|NCT00476190|584533295|FG001|Overall Study|Induction Failure|4|||
161861113|NCT00476190|584533294|FG000|Overall Study|Lost to Follow-up|1|||
161861114|NCT00476190|584533295|FG001|Overall Study|Lost to Follow-up|0|||
161861115|NCT00476190|584533294|FG000|Overall Study|Relapse/Progression|5|||
161861116|NCT00476190|584533295|FG001|Overall Study|Relapse/Progression|2|||
161861117|NCT00476190|584533294|FG000|Overall Study|Remission Death|0|||
161861118|NCT00476190|584533295|FG001|Overall Study|Remission Death|1|||
161861119|NCT00476190|584533294|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
161861120|NCT00476190|584533295|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
161861121|NCT00476190|584533294|FG000|Overall Study|Withdrawal by Subject|6|||
161861122|NCT00476190|584533295|FG001|Overall Study|Withdrawal by Subject|2|||
161861123|NCT00476190|584533294|FG000|Overall Study|Other|9|||
161861124|NCT00476190|584533295|FG001|Overall Study|Other|10|||
161861125|NCT04782076|584533296|FG000|Overall Study|Family Emergency|1|||
161861126|NCT02189837|584533300|FG000|Overall Study|Withdrawal by Subject|2|||
161861127|NCT02189837|584533301|FG001|Overall Study|Withdrawal by Subject|1|||
161861128|NCT02189837|584533302|FG002|Overall Study|Withdrawal by Subject|3|||
161861129|NCT02189837|584533303|FG003|Overall Study|Withdrawal by Subject|1|||
161861130|NCT02189837|584533300|FG000|Overall Study|Sponsor Decision|0|||
161861131|NCT02189837|584533301|FG001|Overall Study|Sponsor Decision|0|||
161861132|NCT02189837|584533302|FG002|Overall Study|Sponsor Decision|0|||
161861133|NCT02189837|584533303|FG003|Overall Study|Sponsor Decision|1|||
161861134|NCT04052620|584533304|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
161861135|NCT04052620|584533305|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
161861136|NCT04052620|584533304|FG000|Overall Study|Withdrawal by Subject|1|||
161861137|NCT04052620|584533305|FG001|Overall Study|Withdrawal by Subject|0|||
161861138|NCT04052620|584533304|FG000|Overall Study|Lost to Follow-up|1|||
161861139|NCT04052620|584533305|FG001|Overall Study|Lost to Follow-up|1|||
161861140|NCT04052620|584533304|FG000|Overall Study|Adverse Event|1|||
161861141|NCT04052620|584533305|FG001|Overall Study|Adverse Event|0|||
161861142|NCT04052620|584533304|FG000|Overall Study|Subject did not meet study Criteria|0|||
161861143|NCT04052620|584533305|FG001|Overall Study|Subject did not meet study Criteria|1|||
161861144|NCT04052620|584533304|FG000|Overall Study|Screened failure, randomized by mistake|0|||
161861145|NCT04052620|584533305|FG001|Overall Study|Screened failure, randomized by mistake|1|||
161861146|NCT04052620|584533304|FG000|Overall Study|Personal reasons|2|||
161861147|NCT04052620|584533305|FG001|Overall Study|Personal reasons|4|||
161861148|NCT04052620|584533304|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
161861149|NCT04052620|584533305|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
161861150|NCT03552380|584533307|FG000|Study Treatment|Disease Progression|3|||
161861151|NCT03552380|584533308|FG001|Study Treatment|Disease Progression|4|||
161861152|NCT03552380|584533307|FG000|Study Treatment|Adverse Event|2|||
161861153|NCT03552380|584533308|FG001|Study Treatment|Adverse Event|2|||
161861154|NCT03552380|584533307|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
161977618|NCT02804750|584967337|FG000|Period 3|Adverse Event|0|||
161977619|NCT02804750|584967338|FG001|Period 3|Adverse Event|2|||
161977620|NCT02804750|584967337|FG000|Period 4|Adverse Event|0|||
161977621|NCT02804750|584967338|FG001|Period 4|Adverse Event|5|||
161977622|NCT02337634|584967346|FG000|Overall Study|Protocol Violation|3|||
161977623|NCT02337634|584967347|FG001|Overall Study|Protocol Violation|1|||
161861155|NCT03552380|584533308|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
161861156|NCT03552380|584533307|FG000|Follow up|Death|3|||
161861157|NCT03552380|584533308|FG001|Follow up|Death|4|||
161861158|NCT03552380|584533307|FG000|Follow up|Site IRB terminated|0|||
161861159|NCT03552380|584533308|FG001|Follow up|Site IRB terminated|1|||
161861160|NCT02633787|584533311|FG000|Overall Study|Withdrawal by Subject|1|||
161861161|NCT00550459|584533312|FG000|Overall Study|Adverse Event|0|||
161861162|NCT00550459|584533313|FG001|Overall Study|Adverse Event|2|||
161861163|NCT00550459|584533312|FG000|Overall Study|Withdrawal by Subject|1|||
161861164|NCT00550459|584533313|FG001|Overall Study|Withdrawal by Subject|1|||
161861165|NCT01401452|584533314|FG000|Overall Study|Adverse reaction|9|||
161861166|NCT01401452|584533314|FG000|Overall Study|Lost to Follow-up|12|||
161861167|NCT01401452|584533314|FG000|Overall Study|Lack of Efficacy|30|||
161861168|NCT01401452|584533314|FG000|Overall Study|Participant developed breast cancer|1|||
161861169|NCT01401452|584533314|FG000|Overall Study|Tx stopped due to financial reasons|1|||
161861170|NCT01401452|584533314|FG000|Overall Study|Tx stopped by psychiatrist|1|||
161977624|NCT02337634|584967346|FG000|Overall Study|Lost to Follow-up|1|||
161977625|NCT02337634|584967347|FG001|Overall Study|Lost to Follow-up|0|||
161861171|NCT01401452|584533314|FG000|Overall Study|No more visits within the 36 wk followup|4|||
161861172|NCT01401452|584533314|FG000|Overall Study|Subject did not come to follow up visits|2|||
161861173|NCT01401452|584533314|FG000|Overall Study|Subject didn't return for routine visits|1|||
161861174|NCT01401452|584533314|FG000|Overall Study|Subject moved to another city|1|||
161861175|NCT01401452|584533314|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
161861176|NCT01401452|584533314|FG000|Overall Study|Psoriatic arthritis|1|||
161861177|NCT01401452|584533314|FG000|Overall Study|Participant stopped Tx|2|||
161861178|NCT01401452|584533314|FG000|Overall Study|Discontinuation for personal reasons|1|||
161861179|NCT01401452|584533314|FG000|Overall Study|Treatment failure|1|||
161861180|NCT01401452|584533314|FG000|Overall Study|Unsatisfactory output|1|||
161861181|NCT01401452|584533314|FG000|Overall Study|Subject withdrew because of Tx success|1|||
161861182|NCT01401452|584533314|FG000|Overall Study|Subject chose to discontinue treatment|1|||
161861183|NCT01401452|584533314|FG000|Overall Study|Participant withdrew consent|1|||
161861184|NCT00584454|584533315|FG000|Overall Study|Adverse Event|1|||
161861185|NCT00584454|584533315|FG000|Overall Study|Relocation|1|||
161861186|NCT00584454|584533315|FG000|Overall Study|Clinical Hold|2|||
161861187|NCT02404805|584533316|FG000|Overall Study|Withdrawal by Subject|1|||
161861188|NCT02404805|584533317|FG001|Overall Study|Withdrawal by Subject|0|||
161861189|NCT02404805|584533318|FG002|Overall Study|Withdrawal by Subject|0|||
161861190|NCT02404805|584533319|FG003|Overall Study|Withdrawal by Subject|0|||
161861191|NCT02404805|584533320|FG004|Overall Study|Withdrawal by Subject|0|||
161861192|NCT02404805|584533321|FG005|Overall Study|Withdrawal by Subject|0|||
161861193|NCT01742897|584533322|FG000|Overall Study|Adverse Event|3|||
161861194|NCT01742897|584533322|FG000|Overall Study|Withdrawal by Subject|1|||
161861195|NCT01742897|584533322|FG000|Overall Study|Other|1|||
161861196|NCT01459783|584533326|FG000|Baseline to 6 Months|Death|1|||
161861197|NCT01459783|584533327|FG001|Baseline to 6 Months|Death|0|||
161861198|NCT01459783|584533326|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
161861199|NCT01459783|584533327|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
161861200|NCT01459783|584533326|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
161861201|NCT01459783|584533327|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
161861202|NCT01459783|584533326|FG000|6 Months to 12 Months|Death|0|||
161861203|NCT01459783|584533327|FG001|6 Months to 12 Months|Death|1|||
161861204|NCT01459783|584533326|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
161861205|NCT01459783|584533327|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
161861206|NCT01459783|584533326|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
161861207|NCT01459783|584533327|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
161861208|NCT01459783|584533326|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
161861209|NCT01459783|584533327|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
161861210|NCT02601014|584533328|FG000|Overall Study|Adverse Event|3|||
161861211|NCT02601014|584533329|FG001|Overall Study|Adverse Event|3|||
161861212|NCT02601014|584533328|FG000|Overall Study|Death|3|||
161861213|NCT02601014|584533329|FG001|Overall Study|Death|1|||
161861214|NCT02601014|584533328|FG000|Overall Study|Disease progression|4|||
161861215|NCT02601014|584533329|FG001|Overall Study|Disease progression|8|||
161861216|NCT02698163|584533330|FG000|Overall Study|Lost to Follow-up|0|||
161861217|NCT02698163|584533331|FG001|Overall Study|Lost to Follow-up|1|||
161861218|NCT01133067|584533332|FG000|Overall Study|Death|136|||
161861219|NCT01133067|584533332|FG000|Overall Study|Lost to Follow-up|3|||
161861220|NCT00752128|584533333|FG000|Overall Study|Withdrawal by Subject|4|||
161861221|NCT00349973|584533334|FG000|Overall Study|Adverse Event|3|||
161861222|NCT00349973|584533335|FG001|Overall Study|Adverse Event|3|||
161861223|NCT00349973|584533334|FG000|Overall Study|Withdrawal by Subject|1|||
161861224|NCT00349973|584533335|FG001|Overall Study|Withdrawal by Subject|0|||
161861225|NCT04135937|584533336|FG000|Overall Study|Lost to Follow-up|2|||
161861226|NCT04135937|584533336|FG000|Overall Study|Withdrawal by Subject|1|||
161861227|NCT05620082|584533337|FG000|Overall Study|Discharged before study end|1|||
161861228|NCT05620082|584533338|FG001|Overall Study|Discharged before study end|4|||
161861229|NCT05620082|584533339|FG002|Overall Study|Discharged before study end|0|||
161861230|NCT05620082|584533337|FG000|Overall Study|Moved to a different ward|1|||
161861231|NCT05620082|584533338|FG001|Overall Study|Moved to a different ward|0|||
161861232|NCT05620082|584533339|FG002|Overall Study|Moved to a different ward|0|||
161861233|NCT05620082|584533337|FG000|Overall Study|Feeling too unwell|1|||
161861234|NCT05620082|584533338|FG001|Overall Study|Feeling too unwell|0|||
161861235|NCT05620082|584533339|FG002|Overall Study|Feeling too unwell|0|||
161861236|NCT04199104|584535882|FG000|Overall Study|Death|148|||
161977626|NCT02428205|584967349|FG000|Overall Study|Lack of Efficacy|1|||
161861237|NCT04199104|584535883|FG001|Overall Study|Death|134|||
161861238|NCT04199104|584535882|FG000|Overall Study|Lost to Follow-up|1|||
161861239|NCT04199104|584535883|FG001|Overall Study|Lost to Follow-up|1|||
161861240|NCT04199104|584535882|FG000|Overall Study|Withdrawal by Subject|4|||
161861241|NCT04199104|584535883|FG001|Overall Study|Withdrawal by Subject|4|||
161861242|NCT04199104|584535882|FG000|Overall Study|Participants Ongoing|103|||
161861243|NCT04199104|584535883|FG001|Overall Study|Participants Ongoing|116|||
161861244|NCT04023396|584535884|FG000|Overall Study|Adverse Event|16|||
161861245|NCT04023396|584535884|FG000|Overall Study|Death|1|||
161861246|NCT04023396|584535884|FG000|Overall Study|Lost to Follow-up|1|||
161861247|NCT04023396|584535884|FG000|Overall Study|Withdrawal by Subject|14|||
161861248|NCT04023396|584535884|FG000|Overall Study|Pregnancy|4|||
161861249|NCT04023396|584535884|FG000|Overall Study|Lack of Efficacy|3|||
161861250|NCT04023396|584535884|FG000|Overall Study|Physician Decision|4|||
161861251|NCT04023396|584535884|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
161861252|NCT02325973|584535887|FG000|Overall Study|Death|5|||
161861253|NCT02325973|584535887|FG000|Overall Study|Withdrawal by subject or investigator|16|||
161861254|NCT04075825|584535888|FG000|Overall Study|Withdrawal by Subject|6|||
161861255|NCT04075825|584535889|FG001|Overall Study|Withdrawal by Subject|8|||
161861256|NCT04075825|584535888|FG000|Overall Study|Physician Decision|3|||
161861257|NCT04075825|584535889|FG001|Overall Study|Physician Decision|1|||
161861258|NCT04075825|584535888|FG000|Overall Study|Lost to Follow-up|5|||
161861259|NCT04075825|584535889|FG001|Overall Study|Lost to Follow-up|1|||
161861260|NCT04075825|584535888|FG000|Overall Study|Participation in New Clinical Trial|1|||
161861261|NCT04075825|584535889|FG001|Overall Study|Participation in New Clinical Trial|1|||
161861262|NCT04075825|584535888|FG000|Overall Study|Reason Not Specified|2|||
161861263|NCT04075825|584535889|FG001|Overall Study|Reason Not Specified|2|||
161861264|NCT01168232|584535890|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
161861265|NCT01168232|584535890|FG000|Overall Study|Ineligible- Wrong cell type|6|||
161861266|NCT01168232|584535890|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
161861267|NCT03879135|584535895|FG000|Overall Study|Physician Decision|0|||
161861268|NCT03879135|584535896|FG001|Overall Study|Physician Decision|0|||
161861269|NCT03879135|584535897|FG002|Overall Study|Physician Decision|0|||
161861270|NCT03879135|584535898|FG003|Overall Study|Physician Decision|1|||
161861271|NCT03879135|584535899|FG004|Overall Study|Physician Decision|0|||
161861272|NCT03879135|584535900|FG005|Overall Study|Physician Decision|0|||
161861273|NCT03879135|584535895|FG000|Overall Study|Withdrawal by Subject|0|||
161861274|NCT03879135|584535896|FG001|Overall Study|Withdrawal by Subject|0|||
161861275|NCT03879135|584535897|FG002|Overall Study|Withdrawal by Subject|0|||
161861276|NCT03879135|584535898|FG003|Overall Study|Withdrawal by Subject|0|||
161861277|NCT03879135|584535899|FG004|Overall Study|Withdrawal by Subject|0|||
161861278|NCT03879135|584535900|FG005|Overall Study|Withdrawal by Subject|1|||
161861279|NCT03879135|584535895|FG000|Overall Study|Site Closed by Sponsor|0|||
161861280|NCT03879135|584535896|FG001|Overall Study|Site Closed by Sponsor|0|||
161861281|NCT03879135|584535897|FG002|Overall Study|Site Closed by Sponsor|0|||
161861282|NCT03879135|584535898|FG003|Overall Study|Site Closed by Sponsor|1|||
161861283|NCT03879135|584535899|FG004|Overall Study|Site Closed by Sponsor|1|||
161861284|NCT03879135|584535900|FG005|Overall Study|Site Closed by Sponsor|0|||
161861285|NCT05201794|584535901|FG000|Overall Study|Withdrawal by Subject|13|||
161861286|NCT05201794|584535902|FG001|Overall Study|Withdrawal by Subject|12|||
161861287|NCT05201794|584535903|FG002|Overall Study|Withdrawal by Subject|14|||
161861288|NCT05201794|584535904|FG003|Overall Study|Withdrawal by Subject|0|||
161861289|NCT05201794|584535901|FG000|Overall Study|Adverse Event|5|||
161861290|NCT05201794|584535902|FG001|Overall Study|Adverse Event|5|||
161861291|NCT05201794|584535903|FG002|Overall Study|Adverse Event|4|||
161861292|NCT05201794|584535904|FG003|Overall Study|Adverse Event|0|||
161861293|NCT05201794|584535901|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
161861294|NCT05201794|584535902|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161861295|NCT05201794|584535903|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
161861296|NCT05201794|584535904|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161861297|NCT05201794|584535901|FG000|Overall Study|Non-Compliance With Study Drug|2|||
161861298|NCT05201794|584535902|FG001|Overall Study|Non-Compliance With Study Drug|3|||
161861299|NCT05201794|584535903|FG002|Overall Study|Non-Compliance With Study Drug|3|||
161861300|NCT05201794|584535904|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161861301|NCT05201794|584535901|FG000|Overall Study|Physician Decision|1|||
161861302|NCT05201794|584535902|FG001|Overall Study|Physician Decision|3|||
161861303|NCT05201794|584535903|FG002|Overall Study|Physician Decision|2|||
161861304|NCT05201794|584535904|FG003|Overall Study|Physician Decision|0|||
161861305|NCT05201794|584535901|FG000|Overall Study|Lost to Follow-up|2|||
161861306|NCT05201794|584535902|FG001|Overall Study|Lost to Follow-up|2|||
161861307|NCT05201794|584535903|FG002|Overall Study|Lost to Follow-up|0|||
161861308|NCT05201794|584535904|FG003|Overall Study|Lost to Follow-up|0|||
161861309|NCT05201794|584535901|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
161861310|NCT05201794|584535902|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
161861311|NCT05201794|584535903|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
161861312|NCT05201794|584535904|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
161861313|NCT05201794|584535901|FG000|Overall Study|Protocol Violation|2|||
161977627|NCT02428205|584967350|FG001|Overall Study|Lack of Efficacy|0|||
161977628|NCT02428205|584967349|FG000|Overall Study|Lost to Follow-up|1|||
161977629|NCT02428205|584967350|FG001|Overall Study|Lost to Follow-up|1|||
161977630|NCT02428205|584967349|FG000|Overall Study|Worse behavior|0|||
161977631|NCT02428205|584967350|FG001|Overall Study|Worse behavior|1|||
161977632|NCT01818284|584967351|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
161977633|NCT01818284|584967352|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
161977634|NCT01818284|584967351|FG000|Overall Study|Death|0|||
161861314|NCT05201794|584535902|FG001|Overall Study|Protocol Violation|0|||
161861315|NCT05201794|584535903|FG002|Overall Study|Protocol Violation|1|||
161861316|NCT05201794|584535904|FG003|Overall Study|Protocol Violation|0|||
161861317|NCT05201794|584535901|FG000|Overall Study|Death|1|||
161861318|NCT05201794|584535902|FG001|Overall Study|Death|0|||
161861319|NCT05201794|584535903|FG002|Overall Study|Death|0|||
161861320|NCT05201794|584535904|FG003|Overall Study|Death|0|||
161861321|NCT05201794|584535901|FG000|Overall Study|Site Terminated By Sponsor|0|||
161861322|NCT05201794|584535902|FG001|Overall Study|Site Terminated By Sponsor|1|||
161861323|NCT05201794|584535903|FG002|Overall Study|Site Terminated By Sponsor|0|||
161861324|NCT05201794|584535904|FG003|Overall Study|Site Terminated By Sponsor|0|||
161861325|NCT05201794|584535901|FG000|Overall Study|Other|3|||
161861326|NCT05201794|584535902|FG001|Overall Study|Other|3|||
161861327|NCT05201794|584535903|FG002|Overall Study|Other|3|||
161861328|NCT05201794|584535904|FG003|Overall Study|Other|0|||
161861329|NCT05201794|584535901|FG000|Overall Study|Randomized But Not Treated|1|||
161861330|NCT05201794|584535902|FG001|Overall Study|Randomized But Not Treated|2|||
161861331|NCT05201794|584535903|FG002|Overall Study|Randomized But Not Treated|1|||
161861332|NCT05201794|584535904|FG003|Overall Study|Randomized But Not Treated|0|||
161861333|NCT03428958|584535905|FG000|Overall Study|Adverse Event|0|||
161861334|NCT03428958|584535906|FG001|Overall Study|Adverse Event|0|||
161861335|NCT03428958|584535907|FG002|Overall Study|Adverse Event|0|||
161861336|NCT03428958|584535908|FG003|Overall Study|Adverse Event|1|||
161861337|NCT03428958|584535909|FG004|Overall Study|Adverse Event|0|||
161861338|NCT03428958|584535910|FG005|Overall Study|Adverse Event|2|||
161861339|NCT03428958|584535911|FG006|Overall Study|Adverse Event|1|||
161861340|NCT03428958|584535912|FG007|Overall Study|Adverse Event|0|||
161861341|NCT03428958|584535913|FG008|Overall Study|Adverse Event|0|||
161861342|NCT03428958|584535914|FG009|Overall Study|Adverse Event|0|||
161861343|NCT03428958|584535915|FG010|Overall Study|Adverse Event|0|||
161861344|NCT03428958|584535916|FG011|Overall Study|Adverse Event|0|||
161861345|NCT03428958|584535917|FG012|Overall Study|Adverse Event|0|||
161861346|NCT03428958|584535918|FG013|Overall Study|Adverse Event|0|||
161861347|NCT03428958|584535919|FG014|Overall Study|Adverse Event|0|||
161861348|NCT03428958|584535920|FG015|Overall Study|Adverse Event|0|||
161861349|NCT03428958|584535921|FG016|Overall Study|Adverse Event|0|||
161861350|NCT03428958|584535905|FG000|Overall Study|Clinical Progression|2|||
161861351|NCT03428958|584535906|FG001|Overall Study|Clinical Progression|3|||
161861352|NCT03428958|584535907|FG002|Overall Study|Clinical Progression|2|||
161861353|NCT03428958|584535908|FG003|Overall Study|Clinical Progression|1|||
161861354|NCT03428958|584535909|FG004|Overall Study|Clinical Progression|0|||
161861355|NCT03428958|584535910|FG005|Overall Study|Clinical Progression|2|||
161861356|NCT03428958|584535911|FG006|Overall Study|Clinical Progression|0|||
161861357|NCT03428958|584535912|FG007|Overall Study|Clinical Progression|0|||
161861358|NCT03428958|584535913|FG008|Overall Study|Clinical Progression|0|||
161861359|NCT03428958|584535914|FG009|Overall Study|Clinical Progression|0|||
161861360|NCT03428958|584535915|FG010|Overall Study|Clinical Progression|0|||
161861361|NCT03428958|584535916|FG011|Overall Study|Clinical Progression|0|||
161861362|NCT03428958|584535917|FG012|Overall Study|Clinical Progression|0|||
161861363|NCT03428958|584535918|FG013|Overall Study|Clinical Progression|0|||
161861364|NCT03428958|584535919|FG014|Overall Study|Clinical Progression|0|||
161861365|NCT03428958|584535920|FG015|Overall Study|Clinical Progression|0|||
161861366|NCT03428958|584535921|FG016|Overall Study|Clinical Progression|0|||
161861367|NCT03428958|584535905|FG000|Overall Study|Progression per RECIST|6|||
161861368|NCT03428958|584535906|FG001|Overall Study|Progression per RECIST|6|||
161861369|NCT03428958|584535907|FG002|Overall Study|Progression per RECIST|7|||
161861370|NCT03428958|584535908|FG003|Overall Study|Progression per RECIST|4|||
161861371|NCT03428958|584535909|FG004|Overall Study|Progression per RECIST|0|||
161861372|NCT03428958|584535910|FG005|Overall Study|Progression per RECIST|7|||
161861373|NCT03428958|584535911|FG006|Overall Study|Progression per RECIST|8|||
161861374|NCT03428958|584535912|FG007|Overall Study|Progression per RECIST|0|||
161861375|NCT03428958|584535913|FG008|Overall Study|Progression per RECIST|0|||
161861376|NCT03428958|584535914|FG009|Overall Study|Progression per RECIST|0|||
161861377|NCT03428958|584535915|FG010|Overall Study|Progression per RECIST|0|||
161861378|NCT03428958|584535916|FG011|Overall Study|Progression per RECIST|0|||
161861379|NCT03428958|584535917|FG012|Overall Study|Progression per RECIST|1|||
161861380|NCT03428958|584535918|FG013|Overall Study|Progression per RECIST|0|||
161861381|NCT03428958|584535919|FG014|Overall Study|Progression per RECIST|0|||
161861382|NCT03428958|584535920|FG015|Overall Study|Progression per RECIST|0|||
161861383|NCT03428958|584535921|FG016|Overall Study|Progression per RECIST|0|||
161861384|NCT03428958|584535905|FG000|Overall Study|Death|2|||
161861385|NCT03428958|584535906|FG001|Overall Study|Death|2|||
161861386|NCT03428958|584535907|FG002|Overall Study|Death|0|||
161861387|NCT03428958|584535908|FG003|Overall Study|Death|0|||
161861388|NCT03428958|584535909|FG004|Overall Study|Death|0|||
161861389|NCT03428958|584535910|FG005|Overall Study|Death|7|||
161861390|NCT03428958|584535911|FG006|Overall Study|Death|9|||
161861391|NCT03428958|584535912|FG007|Overall Study|Death|6|||
161861392|NCT03428958|584535913|FG008|Overall Study|Death|0|||
161861393|NCT03428958|584535914|FG009|Overall Study|Death|0|||
161861394|NCT03428958|584535915|FG010|Overall Study|Death|3|||
161861395|NCT03428958|584535916|FG011|Overall Study|Death|0|||
161861396|NCT03428958|584535917|FG012|Overall Study|Death|4|||
161861397|NCT03428958|584535918|FG013|Overall Study|Death|0|||
161861398|NCT03428958|584535919|FG014|Overall Study|Death|0|||
161861399|NCT03428958|584535920|FG015|Overall Study|Death|0|||
161861400|NCT03428958|584535921|FG016|Overall Study|Death|0|||
161861401|NCT03428958|584535905|FG000|Overall Study|Lost to Follow-up|0|||
161861402|NCT03428958|584535906|FG001|Overall Study|Lost to Follow-up|0|||
161861403|NCT03428958|584535907|FG002|Overall Study|Lost to Follow-up|0|||
161861404|NCT03428958|584535908|FG003|Overall Study|Lost to Follow-up|0|||
161861405|NCT03428958|584535909|FG004|Overall Study|Lost to Follow-up|0|||
161861406|NCT03428958|584535910|FG005|Overall Study|Lost to Follow-up|1|||
161861407|NCT03428958|584535911|FG006|Overall Study|Lost to Follow-up|1|||
161861408|NCT03428958|584535912|FG007|Overall Study|Lost to Follow-up|0|||
161861409|NCT03428958|584535913|FG008|Overall Study|Lost to Follow-up|0|||
161861410|NCT03428958|584535914|FG009|Overall Study|Lost to Follow-up|0|||
161861411|NCT03428958|584535915|FG010|Overall Study|Lost to Follow-up|0|||
161861412|NCT03428958|584535916|FG011|Overall Study|Lost to Follow-up|0|||
161861413|NCT03428958|584535917|FG012|Overall Study|Lost to Follow-up|0|||
161861414|NCT03428958|584535918|FG013|Overall Study|Lost to Follow-up|0|||
161861415|NCT03428958|584535919|FG014|Overall Study|Lost to Follow-up|0|||
161861416|NCT03428958|584535920|FG015|Overall Study|Lost to Follow-up|0|||
161861417|NCT03428958|584535921|FG016|Overall Study|Lost to Follow-up|0|||
161861418|NCT03428958|584535905|FG000|Overall Study|Physician/Sponsor Decision|1|||
161861419|NCT03428958|584535906|FG001|Overall Study|Physician/Sponsor Decision|0|||
161861420|NCT03428958|584535907|FG002|Overall Study|Physician/Sponsor Decision|1|||
161861421|NCT03428958|584535908|FG003|Overall Study|Physician/Sponsor Decision|0|||
161861422|NCT03428958|584535909|FG004|Overall Study|Physician/Sponsor Decision|0|||
161861423|NCT03428958|584535910|FG005|Overall Study|Physician/Sponsor Decision|2|||
161861424|NCT03428958|584535911|FG006|Overall Study|Physician/Sponsor Decision|2|||
161861425|NCT03428958|584535912|FG007|Overall Study|Physician/Sponsor Decision|2|||
161861426|NCT03428958|584535913|FG008|Overall Study|Physician/Sponsor Decision|0|||
161861427|NCT03428958|584535914|FG009|Overall Study|Physician/Sponsor Decision|0|||
161861428|NCT03428958|584535915|FG010|Overall Study|Physician/Sponsor Decision|2|||
161861429|NCT03428958|584535916|FG011|Overall Study|Physician/Sponsor Decision|0|||
161861430|NCT03428958|584535917|FG012|Overall Study|Physician/Sponsor Decision|4|||
161861431|NCT03428958|584535918|FG013|Overall Study|Physician/Sponsor Decision|0|||
161861432|NCT03428958|584535919|FG014|Overall Study|Physician/Sponsor Decision|0|||
161861433|NCT03428958|584535920|FG015|Overall Study|Physician/Sponsor Decision|0|||
161861434|NCT03428958|584535921|FG016|Overall Study|Physician/Sponsor Decision|0|||
161861435|NCT03428958|584535905|FG000|Overall Study|Withdrawal by Subject|0|||
161861436|NCT03428958|584535906|FG001|Overall Study|Withdrawal by Subject|0|||
161861437|NCT03428958|584535907|FG002|Overall Study|Withdrawal by Subject|2|||
161861438|NCT03428958|584535908|FG003|Overall Study|Withdrawal by Subject|0|||
161861439|NCT03428958|584535909|FG004|Overall Study|Withdrawal by Subject|0|||
161861440|NCT03428958|584535910|FG005|Overall Study|Withdrawal by Subject|2|||
161861441|NCT03428958|584535911|FG006|Overall Study|Withdrawal by Subject|4|||
161861442|NCT03428958|584535912|FG007|Overall Study|Withdrawal by Subject|1|||
161861443|NCT03428958|584535913|FG008|Overall Study|Withdrawal by Subject|0|||
161861444|NCT03428958|584535914|FG009|Overall Study|Withdrawal by Subject|0|||
161861445|NCT03428958|584535915|FG010|Overall Study|Withdrawal by Subject|0|||
161861446|NCT03428958|584535916|FG011|Overall Study|Withdrawal by Subject|0|||
161861447|NCT03428958|584535917|FG012|Overall Study|Withdrawal by Subject|0|||
161861448|NCT03428958|584535918|FG013|Overall Study|Withdrawal by Subject|0|||
161861449|NCT03428958|584535919|FG014|Overall Study|Withdrawal by Subject|0|||
161861450|NCT03428958|584535920|FG015|Overall Study|Withdrawal by Subject|0|||
161861451|NCT03428958|584535921|FG016|Overall Study|Withdrawal by Subject|0|||
161861452|NCT03874117|584535922|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
161861453|NCT03874117|584535923|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
161861454|NCT03874117|584535922|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
161861455|NCT03874117|584535923|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
161861456|NCT03874117|584535922|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161861457|NCT03874117|584535923|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161861458|NCT03874117|584535922|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
161861459|NCT03874117|584535923|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
161861460|NCT03874117|584535922|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161861461|NCT03874117|584535923|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
161861462|NCT03657797|584535925|FG000|Overall Study|Lost to Follow-up|0|||
161861463|NCT03657797|584535926|FG001|Overall Study|Lost to Follow-up|1|||
161861464|NCT03657797|584535927|FG002|Overall Study|Lost to Follow-up|1|||
161861465|NCT03657797|584535928|FG003|Overall Study|Lost to Follow-up|0|||
162034658|NCT01695005|585183501|FG018|Overall Study|Withdrawal by Subject|2|||
161861466|NCT03657797|584535925|FG000|Overall Study|Physician Decision|0|||
161861467|NCT03657797|584535926|FG001|Overall Study|Physician Decision|1|||
161861468|NCT03657797|584535927|FG002|Overall Study|Physician Decision|0|||
161861469|NCT03657797|584535928|FG003|Overall Study|Physician Decision|0|||
161861470|NCT03657797|584535925|FG000|Overall Study|Withdrawal by Subject|0|||
161861471|NCT03657797|584535926|FG001|Overall Study|Withdrawal by Subject|1|||
161861472|NCT03657797|584535927|FG002|Overall Study|Withdrawal by Subject|2|||
161861473|NCT03657797|584535928|FG003|Overall Study|Withdrawal by Subject|0|||
161861474|NCT03657797|584535925|FG000|Overall Study|Adverse Event|0|||
161861475|NCT03657797|584535926|FG001|Overall Study|Adverse Event|0|||
161861476|NCT03657797|584535927|FG002|Overall Study|Adverse Event|2|||
161861477|NCT03657797|584535928|FG003|Overall Study|Adverse Event|0|||
161861478|NCT00711243|584535931|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
161861479|NCT00711243|584535932|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
161861480|NCT00711243|584535933|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
161861481|NCT00711243|584535934|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
161861482|NCT00711243|584535935|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
161861483|NCT00711243|584535936|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
161861484|NCT00711243|584535931|FG000|Reached First Response/4 Cycles|Death|0|||
161861485|NCT00711243|584535932|FG001|Reached First Response/4 Cycles|Death|0|||
161861486|NCT00711243|584535933|FG002|Reached First Response/4 Cycles|Death|0|||
161861487|NCT00711243|584535934|FG003|Reached First Response/4 Cycles|Death|0|||
161861488|NCT00711243|584535935|FG004|Reached First Response/4 Cycles|Death|0|||
161861489|NCT00711243|584535936|FG005|Reached First Response/4 Cycles|Death|2|||
161861490|NCT00711243|584535931|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
161861491|NCT00711243|584535932|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
161861492|NCT00711243|584535933|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
161861493|NCT00711243|584535934|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
161861494|NCT00711243|584535935|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
161861495|NCT00711243|584535936|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
161861496|NCT00711243|584535931|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
161861497|NCT00711243|584535932|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
161861498|NCT00711243|584535933|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
161861499|NCT00711243|584535934|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
161861500|NCT00711243|584535935|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
161861501|NCT00711243|584535936|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
161861502|NCT00711243|584535931|FG000|Treated Cycle 5 After First Response|Death|0|||
161861503|NCT00711243|584535932|FG001|Treated Cycle 5 After First Response|Death|0|||
161861504|NCT00711243|584535933|FG002|Treated Cycle 5 After First Response|Death|0|||
161861505|NCT00711243|584535934|FG003|Treated Cycle 5 After First Response|Death|0|||
161861506|NCT00711243|584535935|FG004|Treated Cycle 5 After First Response|Death|0|||
161861507|NCT00711243|584535936|FG005|Treated Cycle 5 After First Response|Death|2|||
161861508|NCT00711243|584535931|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
161861509|NCT00711243|584535932|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
161861510|NCT00711243|584535933|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
161861511|NCT00711243|584535934|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
161861512|NCT00711243|584535935|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
161861513|NCT00711243|584535936|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
161861514|NCT00711243|584535931|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161861515|NCT00711243|584535932|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161861516|NCT00711243|584535933|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161861517|NCT00711243|584535934|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161861518|NCT00711243|584535935|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161861519|NCT00711243|584535936|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
161861520|NCT01402570|584535939|FG000|Overall Study|Adverse Event|1|||
161861521|NCT03642262|584535940|FG000|Period 1|Withdrawal by Subject|1|||
161861522|NCT03642262|584535941|FG001|Period 1|Withdrawal by Subject|1|||
161861523|NCT03642262|584535940|FG000|Period 1|Adverse Event|0|||
161861524|NCT03642262|584535941|FG001|Period 1|Adverse Event|1|||
161861525|NCT02572570|584535942|FG000|Overall Study|Study Terminated|27|||
161861526|NCT02019472|584535943|FG000|Overall Study|Adverse Event|14|||
161861527|NCT02019472|584535944|FG001|Overall Study|Adverse Event|23|||
161861528|NCT02019472|584535945|FG002|Overall Study|Adverse Event|17|||
161861529|NCT02019472|584535943|FG000|Overall Study|Death|0|||
161861530|NCT02019472|584535944|FG001|Overall Study|Death|1|||
161861531|NCT02019472|584535945|FG002|Overall Study|Death|1|||
161861532|NCT02019472|584535943|FG000|Overall Study|Lack of Efficacy|7|||
161861533|NCT02019472|584535944|FG001|Overall Study|Lack of Efficacy|4|||
161861534|NCT02019472|584535945|FG002|Overall Study|Lack of Efficacy|4|||
161861535|NCT02019472|584535943|FG000|Overall Study|Lost to Follow-up|0|||
161861536|NCT02019472|584535944|FG001|Overall Study|Lost to Follow-up|2|||
161861537|NCT02019472|584535945|FG002|Overall Study|Lost to Follow-up|1|||
161977635|NCT01818284|584967352|FG001|Overall Study|Death|2|||
161977636|NCT02888743|584967353|FG000|Overall Study|Withdrawal by Subject|1|||
162034659|NCT01695005|585183502|FG019|Overall Study|Withdrawal by Subject|0|||
162034660|NCT01695005|585183503|FG020|Overall Study|Withdrawal by Subject|1|||
161772549|NCT00563706|584211399|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
161772550|NCT00563706|584211400|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
161772551|NCT00563706|584211401|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
161772552|NCT00563706|584211402|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
161772553|NCT00563706|584211403|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
161772554|NCT00563706|584211404|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
161772555|NCT00563706|584211405|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
161772556|NCT00563706|584211406|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
161772557|NCT00563706|584211407|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
161772558|NCT00563706|584211399|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
161772559|NCT00563706|584211400|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
161772560|NCT00563706|584211401|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
161772561|NCT00563706|584211402|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
161772562|NCT00563706|584211403|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
161772563|NCT00563706|584211404|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
161772564|NCT00563706|584211405|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
161772565|NCT00563706|584211406|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
161772566|NCT00563706|584211407|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
161772567|NCT00563706|584211399|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
161772568|NCT00563706|584211400|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
161772569|NCT00563706|584211401|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
161772570|NCT00563706|584211402|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
161772571|NCT00563706|584211403|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
161772572|NCT00563706|584211404|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
161772573|NCT00563706|584211405|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
161772574|NCT00563706|584211406|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
161772575|NCT00563706|584211407|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
161772576|NCT00563706|584211399|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
161772577|NCT00563706|584211400|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772578|NCT00563706|584211401|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772579|NCT00563706|584211402|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772580|NCT00563706|584211403|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772581|NCT00563706|584211404|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772582|NCT00563706|584211405|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772583|NCT00563706|584211406|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
161772584|NCT00563706|584211407|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161772585|NCT00563706|584211399|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772586|NCT00563706|584211400|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772587|NCT00563706|584211401|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772588|NCT00563706|584211402|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772589|NCT00563706|584211403|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772590|NCT00563706|584211404|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772591|NCT00563706|584211405|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161772592|NCT00563706|584211406|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
161772593|NCT00563706|584211407|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
161772594|NCT02985541|584211412|FG000|Overall Study|Withdrawal by Subject|33|||
161772595|NCT02985541|584211412|FG000|Overall Study|Lost to Follow-up|26|||
161772596|NCT02985541|584211412|FG000|Overall Study|Adverse Event|27|||
161772597|NCT02985541|584211412|FG000|Overall Study|Physician Decision|2|||
161772598|NCT02985541|584211412|FG000|Overall Study|Pregnancy|2|||
161772599|NCT02985541|584211412|FG000|Overall Study|Wish for pregnancy|44|||
161772600|NCT02985541|584211412|FG000|Overall Study|Other reason|5|||
161772601|NCT02985541|584211412|FG000|Overall Study|Not valid for analysis|2|||
161772602|NCT02383966|584211413|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
161772603|NCT02383966|584211414|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
161772604|NCT02383966|584211413|FG000|Overall Study|Randomized, but not treated|1|||
161772605|NCT02383966|584211414|FG001|Overall Study|Randomized, but not treated|3|||
161772606|NCT02503215|584211415|FG000|Overall Study|Unable to wear compression stockings|1|||
161772607|NCT02503215|584211415|FG000|Overall Study|Unable to use positive airway pressure|2|||
161772608|NCT02983305|584211420|FG000|Overall Study|incomplete data|2|||
161772609|NCT02983305|584211421|FG001|Overall Study|incomplete data|0|||
161772610|NCT00706901|584211422|FG000|Overall Study|Lost to Follow-up|2|||
161772611|NCT00706901|584211423|FG001|Overall Study|Lost to Follow-up|3|||
162034661|NCT01695005|585183504|FG021|Overall Study|Withdrawal by Subject|0|||
162034662|NCT01695005|585183505|FG022|Overall Study|Withdrawal by Subject|0|||
161861538|NCT02019472|584535943|FG000|Overall Study|Physician Decision|1|||
161861539|NCT02019472|584535944|FG001|Overall Study|Physician Decision|2|||
161861540|NCT02019472|584535945|FG002|Overall Study|Physician Decision|0|||
161772612|NCT00706901|584211424|FG002|Overall Study|Lost to Follow-up|2|||
161772613|NCT00706901|584211422|FG000|Overall Study|Withdrawal by Subject|4|||
161772614|NCT00706901|584211423|FG001|Overall Study|Withdrawal by Subject|2|||
161772615|NCT00706901|584211424|FG002|Overall Study|Withdrawal by Subject|5|||
161772616|NCT00706901|584211422|FG000|Overall Study|In Jail|1|||
161772617|NCT00706901|584211423|FG001|Overall Study|In Jail|0|||
161772618|NCT00706901|584211424|FG002|Overall Study|In Jail|1|||
161772619|NCT00706901|584211422|FG000|Overall Study|Death|1|||
161772620|NCT00706901|584211423|FG001|Overall Study|Death|0|||
161772621|NCT00706901|584211424|FG002|Overall Study|Death|0|||
161772622|NCT00822237|584211425|FG000|Dose 1 Vaccination|Not vaccinated|3|||
161772623|NCT00822237|584211426|FG001|Dose 1 Vaccination|Not vaccinated|0|||
161772624|NCT00822237|584211425|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
161772625|NCT00822237|584211426|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
161772626|NCT00822237|584211425|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
161772627|NCT00822237|584211426|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
161772628|NCT00822237|584211425|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
161772629|NCT00822237|584211426|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
161772630|NCT00822237|584211425|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
161772631|NCT00822237|584211426|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
161772632|NCT03433482|584211427|FG000|Overall Study|Lost to Follow-up|1|||
161772633|NCT03433482|584211428|FG001|Overall Study|Lost to Follow-up|0|||
161772634|NCT03433482|584211429|FG002|Overall Study|Lost to Follow-up|1|||
161772635|NCT03433482|584211430|FG003|Overall Study|Lost to Follow-up|1|||
161772636|NCT03433482|584211427|FG000|Overall Study|Withdrawal by Subject|0|||
161772637|NCT03433482|584211428|FG001|Overall Study|Withdrawal by Subject|0|||
161772638|NCT03433482|584211429|FG002|Overall Study|Withdrawal by Subject|1|||
161772639|NCT03433482|584211430|FG003|Overall Study|Withdrawal by Subject|0|||
161772640|NCT03433482|584211427|FG000|Overall Study|Unknown reason|0|||
161772641|NCT03433482|584211428|FG001|Overall Study|Unknown reason|0|||
161772642|NCT03433482|584211429|FG002|Overall Study|Unknown reason|2|||
161772643|NCT03433482|584211430|FG003|Overall Study|Unknown reason|0|||
161772644|NCT00437294|584211431|FG000|Overall Study|Adverse Event|5|||
161772645|NCT00437294|584211432|FG001|Overall Study|Adverse Event|4|||
161772646|NCT00437294|584211431|FG000|Overall Study|Death|5|||
161772647|NCT00437294|584211432|FG001|Overall Study|Death|2|||
161772648|NCT00437294|584211431|FG000|Overall Study|Physician Decision|0|||
161772649|NCT00437294|584211432|FG001|Overall Study|Physician Decision|3|||
161772650|NCT00437294|584211431|FG000|Overall Study|Withdrawal by Subject|5|||
161772651|NCT00437294|584211432|FG001|Overall Study|Withdrawal by Subject|0|||
161772652|NCT00437294|584211431|FG000|Overall Study|Progressive Disease|19|||
161772653|NCT00437294|584211432|FG001|Overall Study|Progressive Disease|23|||
161772654|NCT00437294|584211431|FG000|Overall Study|Sponsor Decision|8|||
161772655|NCT00437294|584211432|FG001|Overall Study|Sponsor Decision|9|||
161772656|NCT00437294|584211431|FG000|Overall Study|Protocol Violation|0|||
161772657|NCT00437294|584211432|FG001|Overall Study|Protocol Violation|1|||
161772658|NCT00437294|584211431|FG000|Overall Study|Entry criteria not met|1|||
161772659|NCT00437294|584211432|FG001|Overall Study|Entry criteria not met|1|||
161772660|NCT02064231|584211436|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
161772661|NCT02064231|584211437|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
161772662|NCT02064231|584211438|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
161772663|NCT02064231|584211439|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
161772664|NCT02064231|584211436|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
161772665|NCT02064231|584211437|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
161772666|NCT02064231|584211438|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
161772667|NCT02064231|584211439|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
161772668|NCT02064231|584211436|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
161772669|NCT02064231|584211437|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
161772670|NCT02064231|584211438|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
161772671|NCT02064231|584211439|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
161772672|NCT02064231|584211436|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
161772673|NCT02064231|584211437|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
161772674|NCT02064231|584211438|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
161772675|NCT02064231|584211439|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
161772676|NCT01339273|584211441|FG000|Overall Study|Lost to Follow-up|8|||
161772677|NCT01339273|584211442|FG001|Overall Study|Lost to Follow-up|8|||
161772678|NCT04478994|584211443|FG000|Overall Study|Withdrawal by Subject|1|||
161772679|NCT04478994|584211444|FG001|Overall Study|Withdrawal by Subject|1|||
161772680|NCT00518531|584211445|FG000|Treatment Period 1|Adverse Event|5|||
161772681|NCT00518531|584211446|FG001|Treatment Period 1|Adverse Event|0|||
161772682|NCT00518531|584211445|FG000|Treatment Period 1|Lost to Follow-up|5|||
162034663|NCT01695005|585183506|FG023|Overall Study|Withdrawal by Subject|0|||
161861541|NCT02019472|584535943|FG000|Overall Study|Pregnancy|1|||
161861542|NCT02019472|584535944|FG001|Overall Study|Pregnancy|2|||
161861543|NCT02019472|584535945|FG002|Overall Study|Pregnancy|2|||
161861544|NCT02019472|584535943|FG000|Overall Study|Withdrawal by Subject|11|||
161861545|NCT02019472|584535944|FG001|Overall Study|Withdrawal by Subject|10|||
161861546|NCT02019472|584535945|FG002|Overall Study|Withdrawal by Subject|11|||
161861547|NCT02019472|584535943|FG000|Overall Study|Other|3|||
161861548|NCT02019472|584535944|FG001|Overall Study|Other|8|||
161861549|NCT02019472|584535945|FG002|Overall Study|Other|6|||
161861550|NCT00513695|584535948|FG000|Overall Study|Discontinued therapy|2|||
161861551|NCT00513695|584535948|FG000|Overall Study|Progression prior to surgery|3|||
161861552|NCT02157935|584535949|FG000|Overall Study|Withdrawal by Subject|25|||
161861553|NCT02157935|584535950|FG001|Overall Study|Withdrawal by Subject|39|||
161861554|NCT02157935|584535949|FG000|Overall Study|Screen failure|1|||
161861555|NCT02157935|584535950|FG001|Overall Study|Screen failure|2|||
161861556|NCT02157935|584535949|FG000|Overall Study|Protocol Violation|1|||
161861557|NCT02157935|584535950|FG001|Overall Study|Protocol Violation|0|||
161861558|NCT02157935|584535949|FG000|Overall Study|Progressive disease|0|||
161861559|NCT02157935|584535950|FG001|Overall Study|Progressive disease|2|||
161861560|NCT02157935|584535949|FG000|Overall Study|Other|5|||
161861561|NCT02157935|584535950|FG001|Overall Study|Other|12|||
161861562|NCT02157935|584535949|FG000|Overall Study|Lack of Efficacy|0|||
161861563|NCT02157935|584535950|FG001|Overall Study|Lack of Efficacy|1|||
161861564|NCT02157935|584535949|FG000|Overall Study|Death|4|||
161861565|NCT02157935|584535950|FG001|Overall Study|Death|4|||
161861566|NCT02157935|584535949|FG000|Overall Study|Adverse Event|3|||
161861567|NCT02157935|584535950|FG001|Overall Study|Adverse Event|5|||
161861568|NCT01417156|584535951|FG000|Overall Study|Adverse Event|12|||
161861569|NCT01417156|584535951|FG000|Overall Study|Protocol Violation|2|||
161861570|NCT03192488|584535952|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
161861571|NCT03192488|584535953|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
161861572|NCT03192488|584535954|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
161861573|NCT03192488|584535955|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
161861574|NCT03192488|584535956|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
161861575|NCT03192488|584535957|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
161861576|NCT03192488|584535952|FG000|Third Intervention (d1)|Adverse Event|0|||
161861577|NCT03192488|584535953|FG001|Third Intervention (d1)|Adverse Event|0|||
161861578|NCT03192488|584535954|FG002|Third Intervention (d1)|Adverse Event|0|||
161861579|NCT03192488|584535955|FG003|Third Intervention (d1)|Adverse Event|0|||
161861580|NCT03192488|584535956|FG004|Third Intervention (d1)|Adverse Event|1|||
161861581|NCT03192488|584535957|FG005|Third Intervention (d1)|Adverse Event|0|||
161861582|NCT00611923|584535959|FG000|Overall Study|Withdrawal by Subject|2|||
161861583|NCT00611923|584535960|FG001|Overall Study|Withdrawal by Subject|2|||
161861584|NCT02302833|584535974|FG000|Overall Study|Lost to Follow-up|3|||
161861585|NCT04429503|584535975|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
161861586|NCT04429503|584535976|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
161861587|NCT04429503|584535977|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
161861588|NCT04429503|584535978|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
161861589|NCT04429503|584535979|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
161861590|NCT04429503|584535980|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
161861591|NCT04429503|584535975|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
161861592|NCT04429503|584535976|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
161861593|NCT04429503|584535977|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
161861594|NCT04429503|584535978|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
161861595|NCT04429503|584535979|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
161861596|NCT04429503|584535980|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
161861597|NCT04429503|584535975|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
161861598|NCT04429503|584535976|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
161861599|NCT04429503|584535977|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
161977637|NCT02888743|584967354|FG001|Overall Study|Withdrawal by Subject|2|||
161977638|NCT02888743|584967355|FG002|Overall Study|Withdrawal by Subject|2|||
161977639|NCT02888743|584967356|FG003|Overall Study|Withdrawal by Subject|0|||
161977640|NCT02888743|584967357|FG004|Overall Study|Withdrawal by Subject|1|||
161977641|NCT02888743|584967353|FG000|Overall Study|Disease progression before treatment|2|||
161861600|NCT04429503|584535978|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
161861601|NCT04429503|584535979|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
161977642|NCT02888743|584967354|FG001|Overall Study|Disease progression before treatment|0|||
161861602|NCT04429503|584535980|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
161861603|NCT04429503|584535975|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
161861604|NCT04429503|584535976|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
161861605|NCT04429503|584535977|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
161861606|NCT04429503|584535978|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
161861607|NCT04429503|584535979|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
161861608|NCT04429503|584535980|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
161861609|NCT04429503|584535975|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
161861610|NCT04429503|584535976|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
161861611|NCT04429503|584535977|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
161861612|NCT04429503|584535978|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
161861613|NCT04429503|584535979|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
161861614|NCT04429503|584535980|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
161861615|NCT04429503|584535975|FG000|Main Study (Up to Wk 96)|Death|9|||
161861616|NCT04429503|584535976|FG001|Main Study (Up to Wk 96)|Death|18|||
161861617|NCT04429503|584535977|FG002|Main Study (Up to Wk 96)|Death|5|||
161772683|NCT00518531|584211446|FG001|Treatment Period 1|Lost to Follow-up|3|||
161772684|NCT00518531|584211445|FG000|Treatment Period 1|Physician Decision|1|||
161772685|NCT00518531|584211446|FG001|Treatment Period 1|Physician Decision|0|||
161772686|NCT00518531|584211445|FG000|Treatment Period 1|Protocol Violation|2|||
161772687|NCT00518531|584211446|FG001|Treatment Period 1|Protocol Violation|0|||
161772688|NCT00518531|584211445|FG000|Treatment Period 1|Withdrawal by Subject|4|||
161772689|NCT00518531|584211446|FG001|Treatment Period 1|Withdrawal by Subject|6|||
161772690|NCT00518531|584211445|FG000|Treatment Period 1|Early crossover|1|||
161772691|NCT00518531|584211446|FG001|Treatment Period 1|Early crossover|3|||
161772692|NCT00518531|584211445|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161772693|NCT00518531|584211446|FG001|Treatment Period 2|Withdrawal by Subject|8|||
161772694|NCT00518531|584211445|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
161772695|NCT00518531|584211446|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
161772696|NCT00518531|584211445|FG000|Treatment Period 2|Adverse Event|1|||
161772697|NCT00518531|584211446|FG001|Treatment Period 2|Adverse Event|7|||
161772698|NCT00518531|584211445|FG000|Treatment Period 2|Protocol-specified criteria|0|||
161772699|NCT00518531|584211446|FG001|Treatment Period 2|Protocol-specified criteria|1|||
161772700|NCT00518531|584211445|FG000|Treatment Period 2|Non-compliance|1|||
161861618|NCT04429503|584535978|FG003|Main Study (Up to Wk 96)|Death|0|||
161861619|NCT04429503|584535979|FG004|Main Study (Up to Wk 96)|Death|0|||
161861620|NCT04429503|584535980|FG005|Main Study (Up to Wk 96)|Death|0|||
161861621|NCT04429503|584535975|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161861622|NCT04429503|584535976|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161861623|NCT04429503|584535977|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161861624|NCT04429503|584535978|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
161861625|NCT04429503|584535979|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161861626|NCT04429503|584535980|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161861627|NCT04429503|584535975|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
161861628|NCT04429503|584535976|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
161861629|NCT04429503|584535977|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
161861630|NCT04429503|584535978|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
161861631|NCT04429503|584535979|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
161861632|NCT04429503|584535980|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
161861633|NCT04429503|584535975|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
161861634|NCT04429503|584535976|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
161861635|NCT04429503|584535977|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
161861636|NCT04429503|584535978|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
161861637|NCT04429503|584535979|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
161861638|NCT04429503|584535980|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
161861639|NCT04429503|584535975|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
161861640|NCT04429503|584535976|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
161861641|NCT04429503|584535977|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
161861642|NCT04429503|584535978|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
161861643|NCT04429503|584535979|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
161861644|NCT04429503|584535980|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
161861645|NCT04429503|584535975|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
161861646|NCT04429503|584535976|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
161861647|NCT04429503|584535977|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
161861648|NCT04429503|584535978|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
162034664|NCT01695005|585183507|FG024|Overall Study|Withdrawal by Subject|1|||
162034665|NCT01695005|585183508|FG025|Overall Study|Withdrawal by Subject|0|||
162034666|NCT01695005|585183509|FG026|Overall Study|Withdrawal by Subject|0|||
161772701|NCT00518531|584211446|FG001|Treatment Period 2|Non-compliance|2|||
161861649|NCT04429503|584535979|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
161861650|NCT04429503|584535980|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
161861651|NCT04429503|584535975|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
161772702|NCT00457249|584211447|FG000|Overall Study|Lost to Follow-up|3|||
161772703|NCT00457249|584211448|FG001|Overall Study|Lost to Follow-up|0|||
161772704|NCT00457249|584211447|FG000|Overall Study|Protocol Violation|4|||
161772705|NCT00457249|584211448|FG001|Overall Study|Protocol Violation|1|||
161772706|NCT00457249|584211447|FG000|Overall Study|Withdrawal by Subject|3|||
161861652|NCT04429503|584535976|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
161861653|NCT04429503|584535977|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
161861654|NCT04429503|584535978|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
161861655|NCT04429503|584535979|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
161861656|NCT04429503|584535980|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
161861657|NCT05516108|584535981|FG000|Overall Study|Time Commitment|3|||
161861658|NCT05516108|584535982|FG001|Overall Study|Time Commitment|1|||
161861659|NCT05516108|584535981|FG000|Overall Study|Reason Unknown|2|||
161861660|NCT05516108|584535982|FG001|Overall Study|Reason Unknown|4|||
161861661|NCT03664232|584535983|FG000|Overall Study|Withdrawal by Subject|0|||
161861662|NCT03664232|584535984|FG001|Overall Study|Withdrawal by Subject|1|||
161861663|NCT03664232|584535985|FG002|Overall Study|Withdrawal by Subject|0|||
161861664|NCT03664232|584535986|FG003|Overall Study|Withdrawal by Subject|1|||
161861665|NCT03664232|584535983|FG000|Overall Study|Adverse Event|0|||
161861666|NCT03664232|584535984|FG001|Overall Study|Adverse Event|0|||
161861667|NCT03664232|584535985|FG002|Overall Study|Adverse Event|1|||
161861668|NCT03664232|584535986|FG003|Overall Study|Adverse Event|0|||
161861669|NCT03664232|584535983|FG000|Overall Study|Other-Non-compliance with study drug|0|||
161861670|NCT03664232|584535984|FG001|Overall Study|Other-Non-compliance with study drug|1|||
161861671|NCT03664232|584535985|FG002|Overall Study|Other-Non-compliance with study drug|0|||
161861672|NCT03664232|584535986|FG003|Overall Study|Other-Non-compliance with study drug|2|||
161861673|NCT03664232|584535983|FG000|Overall Study|Other-Unspecified|0|||
161861674|NCT03664232|584535984|FG001|Overall Study|Other-Unspecified|3|||
161861675|NCT03664232|584535985|FG002|Overall Study|Other-Unspecified|0|||
161861676|NCT03664232|584535986|FG003|Overall Study|Other-Unspecified|1|||
161861677|NCT03664232|584535983|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
161861678|NCT03664232|584535984|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
161861679|NCT03664232|584535985|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
161861680|NCT03664232|584535986|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
161861681|NCT02717507|584535987|FG000|Overall Study|Lost to Follow-up|5|||
161861682|NCT02717507|584535988|FG001|Overall Study|Lost to Follow-up|8|||
161861683|NCT02717507|584535987|FG000|Overall Study|Pregnancy|1|||
161861684|NCT02717507|584535988|FG001|Overall Study|Pregnancy|1|||
161861685|NCT02717507|584535987|FG000|Overall Study|Protocol Violation|2|||
161861686|NCT02717507|584535988|FG001|Overall Study|Protocol Violation|2|||
161861687|NCT02717507|584535987|FG000|Overall Study|Withdrawal by Subject|20|||
161861688|NCT02717507|584535988|FG001|Overall Study|Withdrawal by Subject|20|||
161861689|NCT02717507|584535987|FG000|Overall Study|Relapse|1|||
161861690|NCT02717507|584535988|FG001|Overall Study|Relapse|1|||
161861691|NCT02717507|584535987|FG000|Overall Study|Cardiac Event|2|||
161861692|NCT02717507|584535988|FG001|Overall Study|Cardiac Event|6|||
161861693|NCT05017246|584535989|FG000|Overall Study|Withdrawal by Subject|5|||
161861694|NCT05017246|584535990|FG001|Overall Study|Withdrawal by Subject|3|||
161861695|NCT05017246|584535989|FG000|Overall Study|Determined to be ineligible|0|||
161861696|NCT05017246|584535990|FG001|Overall Study|Determined to be ineligible|1|||
161861697|NCT05017246|584535989|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
161861698|NCT05017246|584535990|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
161861699|NCT05017246|584535989|FG000|Overall Study|Technical failure|1|||
161861700|NCT05017246|584535990|FG001|Overall Study|Technical failure|3|||
161861701|NCT02493660|584535993|FG000|Overall Study|Physician Decision|0|||
161861702|NCT02493660|584535994|FG001|Overall Study|Physician Decision|1|||
161861703|NCT02493660|584535993|FG000|Overall Study|Adverse Event|4|||
161861704|NCT02493660|584535994|FG001|Overall Study|Adverse Event|2|||
161861705|NCT02493660|584535993|FG000|Overall Study|Withdrawal by Subject|2|||
161861706|NCT02493660|584535994|FG001|Overall Study|Withdrawal by Subject|3|||
161861707|NCT02493660|584535993|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
161861708|NCT02493660|584535994|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
161861709|NCT02493660|584535993|FG000|Overall Study|Protocol Violation|0|||
161861710|NCT02493660|584535994|FG001|Overall Study|Protocol Violation|1|||
161861711|NCT02493660|584535993|FG000|Overall Study|Death|0|||
161861712|NCT02493660|584535994|FG001|Overall Study|Death|1|||
161861713|NCT02493660|584535993|FG000|Overall Study|Lost to Follow-up|2|||
161861714|NCT02493660|584535994|FG001|Overall Study|Lost to Follow-up|4|||
161861715|NCT00709995|584535995|FG000|Overall Study|Adverse Event|4|||
161861716|NCT00709995|584535996|FG001|Overall Study|Adverse Event|2|||
161861717|NCT00709995|584535995|FG000|Overall Study|Withdrawal by Subject|1|||
161861718|NCT00709995|584535996|FG001|Overall Study|Withdrawal by Subject|3|||
161861719|NCT00638508|584535997|FG000|Overall Study|Physician Decision|5|||
161861720|NCT00638508|584535998|FG001|Overall Study|Physician Decision|2|||
161861721|NCT03500198|584535999|FG000|Overall Study|Lost to Follow-up|0|||
161861722|NCT03500198|584536000|FG001|Overall Study|Lost to Follow-up|1|||
161861723|NCT00654095|584536001|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
161861724|NCT00654095|584536001|FG000|Overall Study|Elevated triglyceride level (2)|1|||
161861725|NCT00654095|584536001|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
161861726|NCT00654095|584536001|FG000|Overall Study|Adverse Event|11|||
161861727|NCT00654095|584536001|FG000|Overall Study|Withdrawal by Subject|5|||
161861728|NCT00654095|584536001|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
161861729|NCT00654095|584536001|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
161861730|NCT00654095|584536001|FG000|Overall Study|Did not meet inclusion criteria|1|||
161861731|NCT00595621|584536007|FG000|Open Label Run in|Adverse Event|1|||
161861732|NCT00595621|584536008|FG001|Open Label Run in|Adverse Event|0|||
161861733|NCT00595621|584536007|FG000|Open Label Run in|Physician Decision|1|||
161861734|NCT00595621|584536008|FG001|Open Label Run in|Physician Decision|0|||
161861735|NCT00595621|584536007|FG000|Open Label Run in|Withdrawal by Subject|1|||
161861736|NCT00595621|584536008|FG001|Open Label Run in|Withdrawal by Subject|0|||
161861737|NCT00595621|584536007|FG000|Randomization and Study|Adverse Event|2|||
161861738|NCT00595621|584536008|FG001|Randomization and Study|Adverse Event|0|||
161861739|NCT00595621|584536007|FG000|Randomization and Study|Withdrawal by Subject|0|||
161861740|NCT00595621|584536008|FG001|Randomization and Study|Withdrawal by Subject|1|||
161861741|NCT02440464|584536009|FG000|Overall Study|Withdrawal by Subject|3|||
161861742|NCT02440464|584536010|FG001|Overall Study|Withdrawal by Subject|2|||
161861743|NCT00324987|584536011|FG000|Overall Study|Adverse Event|2|||
161861744|NCT00324987|584536012|FG001|Overall Study|Adverse Event|1|||
161861745|NCT00324987|584536011|FG000|Overall Study|Withdrawal by Subject|1|||
161861746|NCT00324987|584536012|FG001|Overall Study|Withdrawal by Subject|1|||
161861747|NCT00324987|584536011|FG000|Overall Study|Progression|1|||
161861748|NCT00324987|584536012|FG001|Overall Study|Progression|1|||
161861749|NCT00324987|584536011|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
161861750|NCT00324987|584536012|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
161861751|NCT03565900|584536014|FG000|Overall Study|Disposition Unknown|4|||
161861752|NCT03565900|584536015|FG001|Overall Study|Disposition Unknown|1|||
161861753|NCT03565900|584536014|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161861754|NCT03565900|584536015|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
161861755|NCT03565900|584536014|FG000|Overall Study|Withdrawal by Subject|4|||
161861756|NCT03565900|584536015|FG001|Overall Study|Withdrawal by Subject|5|||
161861757|NCT03565900|584536014|FG000|Overall Study|Randomized By Mistake|0|||
161861758|NCT03565900|584536015|FG001|Overall Study|Randomized By Mistake|2|||
161861759|NCT03565900|584536014|FG000|Overall Study|Physician Decision|7|||
161861760|NCT03565900|584536015|FG001|Overall Study|Physician Decision|11|||
161861761|NCT03565900|584536014|FG000|Overall Study|Death|9|||
161861762|NCT03565900|584536015|FG001|Overall Study|Death|7|||
161861763|NCT01254643|584536016|FG000|Overall Study|Withdrawal by Subject|1|||
161861764|NCT03359850|584536019|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
161861765|NCT03359850|584536020|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
161861766|NCT03359850|584536019|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
161861767|NCT03359850|584536020|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
161861768|NCT03359850|584536019|FG000|Extension Phase (Up to 28 Months)|Death|2|||
161861769|NCT03359850|584536020|FG001|Extension Phase (Up to 28 Months)|Death|4|||
161861770|NCT03359850|584536019|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
161861771|NCT03359850|584536020|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
161861772|NCT03359850|584536019|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
161861773|NCT03359850|584536020|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
161861774|NCT01037218|584536034|FG000|Overall Study|Adverse Event|4|||
161861775|NCT01037218|584536035|FG001|Overall Study|Adverse Event|2|||
161861776|NCT01037218|584536036|FG002|Overall Study|Adverse Event|2|||
161861777|NCT01037218|584536037|FG003|Overall Study|Adverse Event|1|||
161861778|NCT01037218|584536034|FG000|Overall Study|Lack of Efficacy|0|||
161861779|NCT01037218|584536035|FG001|Overall Study|Lack of Efficacy|2|||
161861780|NCT01037218|584536036|FG002|Overall Study|Lack of Efficacy|1|||
161861781|NCT01037218|584536037|FG003|Overall Study|Lack of Efficacy|5|||
161861782|NCT01037218|584536034|FG000|Overall Study|Lost to Follow-up|3|||
161861783|NCT01037218|584536035|FG001|Overall Study|Lost to Follow-up|5|||
161861784|NCT01037218|584536036|FG002|Overall Study|Lost to Follow-up|4|||
161861785|NCT01037218|584536037|FG003|Overall Study|Lost to Follow-up|2|||
161861786|NCT01037218|584536034|FG000|Overall Study|Withdrawal by Subject|6|||
161861787|NCT01037218|584536035|FG001|Overall Study|Withdrawal by Subject|7|||
161861788|NCT01037218|584536036|FG002|Overall Study|Withdrawal by Subject|7|||
161861789|NCT01037218|584536037|FG003|Overall Study|Withdrawal by Subject|4|||
161861790|NCT01037218|584536034|FG000|Overall Study|Partner Withdrew Consent|0|||
161861791|NCT01037218|584536035|FG001|Overall Study|Partner Withdrew Consent|3|||
161861792|NCT01037218|584536036|FG002|Overall Study|Partner Withdrew Consent|2|||
161861793|NCT01037218|584536037|FG003|Overall Study|Partner Withdrew Consent|1|||
161861794|NCT01037218|584536034|FG000|Overall Study|Protocol Violation|0|||
161861795|NCT01037218|584536035|FG001|Overall Study|Protocol Violation|0|||
161861796|NCT01037218|584536036|FG002|Overall Study|Protocol Violation|2|||
161861797|NCT01037218|584536037|FG003|Overall Study|Protocol Violation|2|||
161861798|NCT01037218|584536034|FG000|Overall Study|Various|3|||
161861799|NCT01037218|584536035|FG001|Overall Study|Various|2|||
161861800|NCT01037218|584536036|FG002|Overall Study|Various|3|||
161861801|NCT01037218|584536037|FG003|Overall Study|Various|1|||
161861802|NCT00513240|584536039|FG000|Overall Study|Did not have intended surgery|3|||
161861803|NCT00513240|584536040|FG001|Overall Study|Did not have intended surgery|0|||
161861804|NCT00513240|584536039|FG000|Overall Study|Death|3|||
161861805|NCT00513240|584536040|FG001|Overall Study|Death|3|||
161861806|NCT00513240|584536039|FG000|Overall Study|Withdrawal by Subject|7|||
161861807|NCT00513240|584536040|FG001|Overall Study|Withdrawal by Subject|4|||
161861808|NCT00729937|584536045|FG000|Overall Study|Lost to Follow-up|49|||
161861809|NCT00729937|584536046|FG001|Overall Study|Lost to Follow-up|58|||
161861810|NCT00729937|584536047|FG002|Overall Study|Lost to Follow-up|18|||
161861811|NCT00729937|584536048|FG003|Overall Study|Lost to Follow-up|33|||
161861812|NCT00729937|584536049|FG004|Overall Study|Lost to Follow-up|18|||
161861813|NCT00729937|584536050|FG005|Overall Study|Lost to Follow-up|23|||
161861814|NCT00729937|584536045|FG000|Overall Study|Physician Decision|7|||
161861815|NCT00729937|584536046|FG001|Overall Study|Physician Decision|16|||
161861816|NCT00729937|584536047|FG002|Overall Study|Physician Decision|2|||
161861817|NCT00729937|584536048|FG003|Overall Study|Physician Decision|0|||
161861818|NCT00729937|584536049|FG004|Overall Study|Physician Decision|5|||
161861819|NCT00729937|584536050|FG005|Overall Study|Physician Decision|8|||
161861820|NCT00729937|584536045|FG000|Overall Study|Death|1|||
161861821|NCT00729937|584536046|FG001|Overall Study|Death|0|||
161861822|NCT00729937|584536047|FG002|Overall Study|Death|1|||
161861823|NCT00729937|584536048|FG003|Overall Study|Death|0|||
161861824|NCT00729937|584536049|FG004|Overall Study|Death|0|||
161861825|NCT00729937|584536050|FG005|Overall Study|Death|1|||
161861826|NCT00729937|584536045|FG000|Overall Study|Withdrawal by Subject|3|||
161861827|NCT00729937|584536046|FG001|Overall Study|Withdrawal by Subject|5|||
161861828|NCT00729937|584536047|FG002|Overall Study|Withdrawal by Subject|6|||
161861829|NCT00729937|584536048|FG003|Overall Study|Withdrawal by Subject|0|||
161861830|NCT00729937|584536049|FG004|Overall Study|Withdrawal by Subject|4|||
161861831|NCT00729937|584536050|FG005|Overall Study|Withdrawal by Subject|2|||
161861832|NCT00729937|584536045|FG000|Overall Study|Randomized but not treated|12|||
161861833|NCT00729937|584536046|FG001|Overall Study|Randomized but not treated|6|||
161861834|NCT00729937|584536047|FG002|Overall Study|Randomized but not treated|1|||
161861835|NCT00729937|584536048|FG003|Overall Study|Randomized but not treated|0|||
161861836|NCT00729937|584536049|FG004|Overall Study|Randomized but not treated|1|||
161861837|NCT00729937|584536050|FG005|Overall Study|Randomized but not treated|3|||
161861838|NCT00729937|584536045|FG000|Overall Study|Did not meet eligibility criteria|2|||
161861839|NCT00729937|584536046|FG001|Overall Study|Did not meet eligibility criteria|1|||
161861840|NCT00729937|584536047|FG002|Overall Study|Did not meet eligibility criteria|0|||
161861841|NCT00729937|584536048|FG003|Overall Study|Did not meet eligibility criteria|0|||
161861842|NCT00729937|584536049|FG004|Overall Study|Did not meet eligibility criteria|0|||
161861843|NCT00729937|584536050|FG005|Overall Study|Did not meet eligibility criteria|0|||
161861844|NCT00729937|584536045|FG000|Overall Study|Incarcerated|0|||
161861845|NCT00729937|584536046|FG001|Overall Study|Incarcerated|2|||
161861846|NCT00729937|584536047|FG002|Overall Study|Incarcerated|1|||
161861847|NCT00729937|584536048|FG003|Overall Study|Incarcerated|1|||
161861848|NCT00729937|584536049|FG004|Overall Study|Incarcerated|0|||
161861849|NCT00729937|584536050|FG005|Overall Study|Incarcerated|0|||
161861850|NCT02198963|584536054|FG000|Overall Study|Adverse Event|1|||
161861851|NCT02198963|584536054|FG000|Overall Study|Withdrawal by Subject|6|||
161861852|NCT00683657|584536055|FG000|Overall Study|Adverse Event|0|||
161861853|NCT00683657|584536056|FG001|Overall Study|Adverse Event|1|||
161861854|NCT00683657|584536055|FG000|Overall Study|Subject Withdrew Consent|1|||
161861855|NCT00683657|584536056|FG001|Overall Study|Subject Withdrew Consent|0|||
161861856|NCT02586155|584536060|FG000|Overall Study|Adverse Event|2|||
161861857|NCT02586155|584536061|FG001|Overall Study|Adverse Event|3|||
161977643|NCT02888743|584967355|FG002|Overall Study|Disease progression before treatment|2|||
161977644|NCT02888743|584967356|FG003|Overall Study|Disease progression before treatment|0|||
161977645|NCT02888743|584967357|FG004|Overall Study|Disease progression before treatment|0|||
161977646|NCT02888743|584967353|FG000|Overall Study|Patient ineligible|1|||
161977647|NCT02888743|584967354|FG001|Overall Study|Patient ineligible|2|||
161977648|NCT02888743|584967355|FG002|Overall Study|Patient ineligible|0|||
161977649|NCT02888743|584967356|FG003|Overall Study|Patient ineligible|0|||
161977650|NCT02888743|584967357|FG004|Overall Study|Patient ineligible|0|||
161977651|NCT00527319|584967358|FG000|Overall Study|Withdrawal by Subject|5|||
161977652|NCT00527319|584967359|FG001|Overall Study|Withdrawal by Subject|0|||
161861858|NCT02586155|584536060|FG000|Overall Study|Withdrawal by Subject|31|||
161861859|NCT02586155|584536061|FG001|Overall Study|Withdrawal by Subject|24|||
161861860|NCT02586155|584536060|FG000|Overall Study|Lost to Follow-up|7|||
161861861|NCT02586155|584536061|FG001|Overall Study|Lost to Follow-up|13|||
161861862|NCT02586155|584536060|FG000|Overall Study|Death|61|||
161861863|NCT02586155|584536061|FG001|Overall Study|Death|72|||
161861864|NCT02586155|584536060|FG000|Overall Study|Other reasons|26|||
161861865|NCT02586155|584536061|FG001|Overall Study|Other reasons|15|||
161861866|NCT02461160|584536062|FG000|Overall Study|Lost to Follow-up|0|||
161861867|NCT02461160|584536063|FG001|Overall Study|Lost to Follow-up|0|||
161861868|NCT02461160|584536064|FG002|Overall Study|Lost to Follow-up|0|||
161861869|NCT02461160|584536065|FG003|Overall Study|Lost to Follow-up|0|||
161861870|NCT02461160|584536066|FG004|Overall Study|Lost to Follow-up|0|||
161861871|NCT02461160|584536067|FG005|Overall Study|Lost to Follow-up|0|||
161977653|NCT00527319|584967360|FG002|Overall Study|Withdrawal by Subject|1|||
161861872|NCT02461160|584536068|FG006|Overall Study|Lost to Follow-up|0|||
161861873|NCT02461160|584536069|FG007|Overall Study|Lost to Follow-up|1|||
161861874|NCT02461160|584536070|FG008|Overall Study|Lost to Follow-up|0|||
161861875|NCT02461160|584536071|FG009|Overall Study|Lost to Follow-up|0|||
161861876|NCT02461160|584536072|FG010|Overall Study|Lost to Follow-up|0|||
161861877|NCT02461160|584536073|FG011|Overall Study|Lost to Follow-up|0|||
161861878|NCT02461160|584536074|FG012|Overall Study|Lost to Follow-up|0|||
161861879|NCT00193050|584536075|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
161861880|NCT00193050|584536075|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
161861881|NCT00193050|584536075|FG000|Neoadjuvant Treatment|Physician Decision|2|||
161861882|NCT00193050|584536075|FG000|Neoadjuvant Treatment|Adverse Event|2|||
161861883|NCT00193050|584536075|FG000|Adjuvant|Physician Decision|5|||
161861884|NCT00193050|584536075|FG000|Adjuvant|Intercurrent Hospitalization|3|||
161861885|NCT00193050|584536075|FG000|Adjuvant|Lack of Efficacy|2|||
161861886|NCT00916383|584536076|FG000|Overall Study|Adverse Event|1|||
161861887|NCT00916383|584536076|FG000|Overall Study|Death|1|||
161861888|NCT00916383|584536076|FG000|Overall Study|Protocol Violation|1|||
161861889|NCT00258960|584536077|FG000|Overall Study|Death|2|||
161861890|NCT00258960|584536077|FG000|Overall Study|Disease Progression|7|||
161861891|NCT00258960|584536077|FG000|Overall Study|Adverse Event|4|||
161861892|NCT00258960|584536077|FG000|Overall Study|Physician Decision|1|||
161861893|NCT00258960|584536077|FG000|Overall Study|Withdrawal by Subject|1|||
161861894|NCT00258960|584536077|FG000|Overall Study|Mistake|2|||
161861895|NCT02899962|584536078|FG000|Open-label Phase|Adverse Event|2|||
161861896|NCT02899962|584536079|FG001|Open-label Phase|Adverse Event|0|||
161861897|NCT02899962|584536080|FG002|Open-label Phase|Adverse Event|0|||
161861898|NCT02899962|584536078|FG000|Open-label Phase|Lost to Follow-up|9|||
161861899|NCT02899962|584536079|FG001|Open-label Phase|Lost to Follow-up|0|||
161861900|NCT02899962|584536080|FG002|Open-label Phase|Lost to Follow-up|0|||
161861901|NCT02899962|584536078|FG000|Open-label Phase|Other reasons|9|||
161861902|NCT02899962|584536079|FG001|Open-label Phase|Other reasons|0|||
161861903|NCT02899962|584536080|FG002|Open-label Phase|Other reasons|0|||
161861904|NCT02899962|584536078|FG000|Open-label Phase|Withdrawal by Subject|7|||
161861905|NCT02899962|584536079|FG001|Open-label Phase|Withdrawal by Subject|0|||
161861906|NCT02899962|584536080|FG002|Open-label Phase|Withdrawal by Subject|0|||
161861907|NCT02899962|584536078|FG000|Maintenance Phase|Adverse Event|0|||
161861908|NCT02899962|584536079|FG001|Maintenance Phase|Adverse Event|2|||
161861909|NCT02899962|584536080|FG002|Maintenance Phase|Adverse Event|1|||
161861910|NCT02899962|584536078|FG000|Maintenance Phase|Death|0|||
161861911|NCT02899962|584536079|FG001|Maintenance Phase|Death|0|||
161861912|NCT02899962|584536080|FG002|Maintenance Phase|Death|1|||
161861913|NCT02899962|584536078|FG000|Maintenance Phase|Lack of Efficacy|0|||
161861914|NCT02899962|584536079|FG001|Maintenance Phase|Lack of Efficacy|20|||
161861915|NCT02899962|584536080|FG002|Maintenance Phase|Lack of Efficacy|16|||
161861916|NCT02899962|584536078|FG000|Maintenance Phase|Lost to Follow-up|0|||
161861917|NCT02899962|584536079|FG001|Maintenance Phase|Lost to Follow-up|12|||
161861918|NCT02899962|584536080|FG002|Maintenance Phase|Lost to Follow-up|14|||
161861919|NCT02899962|584536078|FG000|Maintenance Phase|Other reasons|0|||
161861920|NCT02899962|584536079|FG001|Maintenance Phase|Other reasons|9|||
161861921|NCT02899962|584536080|FG002|Maintenance Phase|Other reasons|13|||
161861922|NCT02899962|584536078|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
161861923|NCT02899962|584536079|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
161861924|NCT02899962|584536080|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
161861925|NCT02899962|584536078|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
161861926|NCT02899962|584536079|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
161861927|NCT02899962|584536080|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
161861928|NCT02899962|584536078|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161861929|NCT02899962|584536079|FG001|Maintenance Phase|Withdrawal by Subject|30|||
161861930|NCT02899962|584536080|FG002|Maintenance Phase|Withdrawal by Subject|36|||
161861931|NCT00473590|584536081|FG000|Overall Study|Adverse Event|3|||
161861932|NCT00473590|584536082|FG001|Overall Study|Adverse Event|3|||
161861933|NCT00473590|584536081|FG000|Overall Study|Death|4|||
161861934|NCT00473590|584536082|FG001|Overall Study|Death|2|||
161861935|NCT00473590|584536081|FG000|Overall Study|Progression not resulting in death|24|||
161977654|NCT00527319|584967358|FG000|Overall Study|Lost to Follow-up|1|||
161977655|NCT00527319|584967359|FG001|Overall Study|Lost to Follow-up|0|||
161861936|NCT00473590|584536082|FG001|Overall Study|Progression not resulting in death|20|||
161861937|NCT00473590|584536081|FG000|Overall Study|Non-protocol-specified therapy|7|||
161861938|NCT00473590|584536082|FG001|Overall Study|Non-protocol-specified therapy|5|||
161861939|NCT00473590|584536081|FG000|Overall Study|Physician Decision|2|||
161861940|NCT00473590|584536082|FG001|Overall Study|Physician Decision|4|||
161861941|NCT00473590|584536081|FG000|Overall Study|Withdrawal by Subject|5|||
161861942|NCT00473590|584536082|FG001|Overall Study|Withdrawal by Subject|3|||
161861943|NCT00473590|584536081|FG000|Overall Study|Other|0|||
161861944|NCT00473590|584536082|FG001|Overall Study|Other|1|||
161861945|NCT03367819|584536086|FG000|Overall Study|Adverse Event|4|||
161861946|NCT03367819|584536087|FG001|Overall Study|Adverse Event|4|||
161977656|NCT00527319|584967360|FG002|Overall Study|Lost to Follow-up|0|||
161861947|NCT03367819|584536086|FG000|Overall Study|Progressive Disease|15|||
161861948|NCT03367819|584536087|FG001|Overall Study|Progressive Disease|13|||
161861949|NCT03367819|584536086|FG000|Overall Study|Withdrawal by Subject|1|||
161861950|NCT03367819|584536087|FG001|Overall Study|Withdrawal by Subject|0|||
161861951|NCT03367819|584536086|FG000|Overall Study|Other|4|||
161861952|NCT03367819|584536087|FG001|Overall Study|Other|2|||
161861953|NCT00445146|584536091|FG000|Overall Study|Withdrew Consent|29|||
161861954|NCT00445146|584536091|FG000|Overall Study|Lack of Efficacy|28|||
161861955|NCT00445146|584536091|FG000|Overall Study|Investigator's Discretion|22|||
161861956|NCT00445146|584536091|FG000|Overall Study|Adverse Event|13|||
161861957|NCT00445146|584536091|FG000|Overall Study|Lost to Follow-up|13|||
161861958|NCT00445146|584536091|FG000|Overall Study|Death|9|||
161861959|NCT00445146|584536091|FG000|Overall Study|Protocol Violation|4|||
161861960|NCT00445146|584536091|FG000|Overall Study|Pregnancy|1|||
161861961|NCT02623725|584536092|FG000|Overall Study|Non compliance with protocol|9|||
161861962|NCT02623725|584536093|FG001|Overall Study|Non compliance with protocol|3|||
161861963|NCT02623725|584536092|FG000|Overall Study|Serious adverse event|0|||
161861964|NCT02623725|584536093|FG001|Overall Study|Serious adverse event|2|||
161861965|NCT02623725|584536092|FG000|Overall Study|Withdrawal by Subject|7|||
161861966|NCT02623725|584536093|FG001|Overall Study|Withdrawal by Subject|1|||
161861967|NCT03918629|584536094|FG000|Overall Study|Adverse Event|19|||
161861968|NCT03918629|584536095|FG001|Overall Study|Adverse Event|20|||
161861969|NCT03918629|584536094|FG000|Overall Study|Death|14|||
161861970|NCT03918629|584536095|FG001|Overall Study|Death|7|||
161861971|NCT03918629|584536094|FG000|Overall Study|Lost to Follow-up|36|||
161861972|NCT03918629|584536095|FG001|Overall Study|Lost to Follow-up|28|||
161861973|NCT03918629|584536094|FG000|Overall Study|Physician Decision|1|||
161861974|NCT03918629|584536095|FG001|Overall Study|Physician Decision|0|||
161861975|NCT03918629|584536094|FG000|Overall Study|Protocol Violation|7|||
161861976|NCT03918629|584536095|FG001|Overall Study|Protocol Violation|4|||
161861977|NCT03918629|584536094|FG000|Overall Study|Withdrawal by Subject|47|||
161861978|NCT03918629|584536095|FG001|Overall Study|Withdrawal by Subject|47|||
161861979|NCT03918629|584536094|FG000|Overall Study|Other|7|||
161861980|NCT03918629|584536095|FG001|Overall Study|Other|11|||
161861981|NCT03918629|584536094|FG000|Overall Study|Randomized but not vaccinated|2|||
161861982|NCT03918629|584536095|FG001|Overall Study|Randomized but not vaccinated|1|||
161861983|NCT02456740|584536097|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
161861984|NCT02456740|584536098|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
161861985|NCT02456740|584536099|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
161861986|NCT02456740|584536100|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161861987|NCT02456740|584536101|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161861988|NCT02456740|584536102|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161861989|NCT02456740|584536103|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161861990|NCT02456740|584536104|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161861991|NCT02456740|584536105|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161861992|NCT02456740|584536097|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
161861993|NCT02456740|584536098|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
161861994|NCT02456740|584536099|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
161861995|NCT02456740|584536100|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161861996|NCT02456740|584536101|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161861997|NCT02456740|584536102|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161861998|NCT02456740|584536103|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161861999|NCT02456740|584536104|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161862000|NCT02456740|584536105|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161862001|NCT02456740|584536097|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
161862002|NCT02456740|584536098|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
161862003|NCT02456740|584536099|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
161862004|NCT02456740|584536100|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
162034667|NCT01695005|585183510|FG027|Overall Study|Withdrawal by Subject|1|||
161862005|NCT02456740|584536101|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161862006|NCT02456740|584536102|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161862007|NCT02456740|584536103|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161862008|NCT02456740|584536104|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161862009|NCT02456740|584536105|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161862010|NCT02456740|584536097|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161862011|NCT02456740|584536098|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161862012|NCT02456740|584536099|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161862013|NCT02456740|584536100|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
161862014|NCT02456740|584536101|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
162034668|NCT01695005|585183511|FG028|Overall Study|Withdrawal by Subject|0|||
161862015|NCT02456740|584536102|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161862016|NCT02456740|584536103|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161862017|NCT02456740|584536104|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161862018|NCT02456740|584536105|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
161862019|NCT02456740|584536097|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161862020|NCT02456740|584536098|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161862021|NCT02456740|584536099|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161862022|NCT02456740|584536100|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
161862023|NCT02456740|584536101|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
161862024|NCT02456740|584536102|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
161862025|NCT02456740|584536103|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
161862026|NCT02456740|584536104|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
161862027|NCT02456740|584536105|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
161862028|NCT02456740|584536097|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862029|NCT02456740|584536098|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862030|NCT02456740|584536099|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862031|NCT02456740|584536100|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862032|NCT02456740|584536101|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862033|NCT02456740|584536102|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862034|NCT02456740|584536103|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862035|NCT02456740|584536104|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
161862036|NCT02456740|584536105|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161862037|NCT02456740|584536097|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161862038|NCT02456740|584536098|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161862039|NCT02456740|584536099|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161862040|NCT02456740|584536100|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
161862041|NCT02456740|584536101|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
161862042|NCT02456740|584536102|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
161862043|NCT02456740|584536103|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
161862044|NCT02456740|584536104|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
161862045|NCT02456740|584536105|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
161862046|NCT01891864|584536109|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
161862047|NCT01891864|584536110|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
161862048|NCT01891864|584536111|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
161862049|NCT01891864|584536112|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
161862050|NCT01891864|584536113|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
161862051|NCT01891864|584536114|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
161862052|NCT01891864|584536109|FG000|Treatment Period 1|Physician Decision|0|||
161862053|NCT01891864|584536110|FG001|Treatment Period 1|Physician Decision|1|||
161862054|NCT01891864|584536111|FG002|Treatment Period 1|Physician Decision|0|||
161862055|NCT01891864|584536112|FG003|Treatment Period 1|Physician Decision|0|||
161862056|NCT01891864|584536113|FG004|Treatment Period 1|Physician Decision|0|||
161862057|NCT01891864|584536114|FG005|Treatment Period 1|Physician Decision|0|||
161862058|NCT01891864|584536109|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161862059|NCT01891864|584536110|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
161862060|NCT01891864|584536111|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161862061|NCT01891864|584536112|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161862062|NCT01891864|584536113|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161862063|NCT01891864|584536114|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161862064|NCT01891864|584536109|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
161862065|NCT01891864|584536110|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
161862066|NCT01891864|584536111|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
161862067|NCT01891864|584536112|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
161862068|NCT01891864|584536113|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
161862069|NCT01891864|584536114|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
161862070|NCT01891864|584536109|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161862071|NCT01891864|584536110|FG001|Treatment Period 1|Withdrawal by Subject|5|||
161862072|NCT01891864|584536111|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161862073|NCT01891864|584536112|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161862074|NCT01891864|584536113|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161862075|NCT01891864|584536114|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161862076|NCT01891864|584536109|FG000|Treatment Period 1|Lost to Follow-up|1|||
161977657|NCT00527319|584967358|FG000|Overall Study|Death|0|||
161977658|NCT00527319|584967359|FG001|Overall Study|Death|3|||
161977659|NCT00527319|584967360|FG002|Overall Study|Death|1|||
161977660|NCT00527319|584967358|FG000|Overall Study|Intercurrent Medical Illness|0|||
161977661|NCT00527319|584967359|FG001|Overall Study|Intercurrent Medical Illness|1|||
162034669|NCT04478123|585183512|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
161772707|NCT00457249|584211448|FG001|Overall Study|Withdrawal by Subject|1|||
161772708|NCT00457249|584211447|FG000|Overall Study|Serious Adverse Events|2|||
161772709|NCT00457249|584211448|FG001|Overall Study|Serious Adverse Events|0|||
161772710|NCT04621227|584211451|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
161772711|NCT04621227|584211451|FG000|Period 3 (29 Days)|Adverse Event|1|||
161772712|NCT04621227|584211451|FG000|Period 8 (2 Days)|Adverse Event|1|||
161772713|NCT02916056|584211452|FG000|Overall Study|Adverse Event|6|||
161772714|NCT02916056|584211452|FG000|Overall Study|Lost to Follow-up|1|||
161772715|NCT02916056|584211452|FG000|Overall Study|Other|12|||
161772716|NCT02916056|584211452|FG000|Overall Study|Protocol Violation|1|||
161772717|NCT02916056|584211452|FG000|Overall Study|Withdrawal by Subject|8|||
161772718|NCT02916056|584211452|FG000|Overall Study|Study Terminated by Sponsor|269|||
161772719|NCT00124709|584211453|FG000|Overall Study|Randomized but did not take medication|3|||
161772720|NCT00124709|584211454|FG001|Overall Study|Randomized but did not take medication|1|||
161772721|NCT00124709|584211453|FG000|Overall Study|Adverse Event|3|||
161772722|NCT00124709|584211454|FG001|Overall Study|Adverse Event|0|||
161772723|NCT00124709|584211453|FG000|Overall Study|Lack of Efficacy|5|||
161772724|NCT00124709|584211454|FG001|Overall Study|Lack of Efficacy|10|||
161772725|NCT00124709|584211453|FG000|Overall Study|Protocol Violation|3|||
161772726|NCT00124709|584211454|FG001|Overall Study|Protocol Violation|5|||
161772727|NCT00124709|584211453|FG000|Overall Study|Withdrawal by Subject|127|||
161772728|NCT00124709|584211454|FG001|Overall Study|Withdrawal by Subject|136|||
161772729|NCT00124709|584211453|FG000|Overall Study|Lost to Follow-up|114|||
161772730|NCT00124709|584211454|FG001|Overall Study|Lost to Follow-up|120|||
161772731|NCT01728376|584211455|FG000|Overall Study|Adverse Event|1|||
161772732|NCT01728376|584211456|FG001|Overall Study|Adverse Event|1|||
161772733|NCT01728376|584211457|FG002|Overall Study|Adverse Event|1|||
161772734|NCT01728376|584211458|FG003|Overall Study|Adverse Event|1|||
161772735|NCT01728376|584211459|FG004|Overall Study|Adverse Event|1|||
161772736|NCT01728376|584211460|FG005|Overall Study|Adverse Event|0|||
161772737|NCT01728376|584211455|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
161772738|NCT01728376|584211456|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
161772739|NCT01728376|584211457|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
161772740|NCT01728376|584211458|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
161772741|NCT01728376|584211459|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
161772742|NCT01728376|584211460|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
161772743|NCT01728376|584211455|FG000|Overall Study|No relevant bacteria|2|||
161772744|NCT01728376|584211456|FG001|Overall Study|No relevant bacteria|0|||
161772745|NCT01728376|584211457|FG002|Overall Study|No relevant bacteria|0|||
161772746|NCT01728376|584211458|FG003|Overall Study|No relevant bacteria|0|||
161772747|NCT01728376|584211459|FG004|Overall Study|No relevant bacteria|1|||
161772748|NCT01728376|584211460|FG005|Overall Study|No relevant bacteria|1|||
161772749|NCT01728376|584211455|FG000|Overall Study|Did not receive treatment|0|||
161772750|NCT01728376|584211456|FG001|Overall Study|Did not receive treatment|1|||
161772751|NCT01728376|584211457|FG002|Overall Study|Did not receive treatment|0|||
161772752|NCT01728376|584211458|FG003|Overall Study|Did not receive treatment|0|||
161772753|NCT01728376|584211459|FG004|Overall Study|Did not receive treatment|0|||
161772754|NCT01728376|584211460|FG005|Overall Study|Did not receive treatment|0|||
161772755|NCT01728376|584211455|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
161772756|NCT01728376|584211456|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
161772757|NCT01728376|584211457|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
161772758|NCT01728376|584211458|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
161772759|NCT01728376|584211459|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
161772760|NCT01728376|584211460|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
161772761|NCT02094573|584211462|FG000|Overall Study|Adverse Event|4|||
161772762|NCT02094573|584211463|FG001|Overall Study|Adverse Event|14|||
161772763|NCT02094573|584211462|FG000|Overall Study|Clinical Progressive Disease|9|||
161772764|NCT02094573|584211463|FG001|Overall Study|Clinical Progressive Disease|13|||
161772765|NCT02094573|584211462|FG000|Overall Study|Death|11|||
161772766|NCT02094573|584211463|FG001|Overall Study|Death|3|||
161772767|NCT02094573|584211462|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
161772768|NCT02094573|584211463|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
161772769|NCT02094573|584211462|FG000|Overall Study|Non-compliance with Study Drug|1|||
161772770|NCT02094573|584211463|FG001|Overall Study|Non-compliance with Study Drug|1|||
161772771|NCT02094573|584211462|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
161772772|NCT02094573|584211463|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
161772773|NCT02094573|584211462|FG000|Overall Study|Physician Decision|4|||
161772774|NCT02094573|584211463|FG001|Overall Study|Physician Decision|4|||
161772775|NCT02094573|584211462|FG000|Overall Study|Site Terminated by Sponsor|10|||
161772776|NCT02094573|584211463|FG001|Overall Study|Site Terminated by Sponsor|17|||
161772777|NCT02094573|584211462|FG000|Overall Study|Withdrawal by Subject|6|||
161772778|NCT02094573|584211463|FG001|Overall Study|Withdrawal by Subject|8|||
161772779|NCT02094573|584211462|FG000|Overall Study|Randomized but not Treated|3|||
161862077|NCT01891864|584536110|FG001|Treatment Period 1|Lost to Follow-up|0|||
161862078|NCT01891864|584536111|FG002|Treatment Period 1|Lost to Follow-up|0|||
161862079|NCT01891864|584536112|FG003|Treatment Period 1|Lost to Follow-up|0|||
161862080|NCT01891864|584536113|FG004|Treatment Period 1|Lost to Follow-up|0|||
161862081|NCT01891864|584536114|FG005|Treatment Period 1|Lost to Follow-up|0|||
161862082|NCT01891864|584536109|FG000|Treatment Period 2|Protocol Violation|0|||
161862083|NCT01891864|584536110|FG001|Treatment Period 2|Protocol Violation|0|||
161862084|NCT01891864|584536111|FG002|Treatment Period 2|Protocol Violation|0|||
161862085|NCT01891864|584536112|FG003|Treatment Period 2|Protocol Violation|1|||
161977662|NCT00527319|584967360|FG002|Overall Study|Intercurrent Medical Illness|3|||
161772780|NCT02094573|584211463|FG001|Overall Study|Randomized but not Treated|0|||
161772781|NCT02411110|584211464|FG000|Treatment Period 1|Adverse Event|4|||
161772782|NCT02411110|584211465|FG001|Treatment Period 1|Adverse Event|2|||
161772783|NCT02411110|584211464|FG000|Treatment Period 1|Lost to Follow-up|1|||
161772784|NCT02411110|584211465|FG001|Treatment Period 1|Lost to Follow-up|0|||
161772785|NCT02411110|584211464|FG000|Treatment Period 1|Personal Reasons|2|||
161772786|NCT02411110|584211465|FG001|Treatment Period 1|Personal Reasons|5|||
161772787|NCT02411110|584211464|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
161772788|NCT02411110|584211465|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
161772789|NCT02411110|584211464|FG000|Treatment Period 2|Adverse Event|1|||
161772790|NCT02411110|584211465|FG001|Treatment Period 2|Adverse Event|0|||
161772791|NCT02411110|584211464|FG000|Treatment Period 2|Lost to Follow-up|0|||
161772792|NCT02411110|584211465|FG001|Treatment Period 2|Lost to Follow-up|2|||
161772793|NCT02411110|584211464|FG000|Treatment Period 2|Personal Reasons|0|||
161772794|NCT02411110|584211465|FG001|Treatment Period 2|Personal Reasons|2|||
161772795|NCT00812968|584211466|FG000|Overall Study|Relapse after erythroid response|6|||
161772796|NCT00812968|584211466|FG000|Overall Study|Disease progression|1|||
161772797|NCT00812968|584211466|FG000|Overall Study|No further treatment required|1|||
161772798|NCT00812968|584211466|FG000|Overall Study|Study closed due to marketing approval|3|||
161772799|NCT00505765|584211472|FG000|Overall Study|Withdrawal by Subject|1|||
161772800|NCT00505765|584211473|FG001|Overall Study|Withdrawal by Subject|0|||
161772801|NCT00505765|584211474|FG002|Overall Study|Withdrawal by Subject|0|||
161772802|NCT00505765|584211472|FG000|Overall Study|Adverse Event|1|||
161772803|NCT00505765|584211473|FG001|Overall Study|Adverse Event|2|||
161772804|NCT00505765|584211474|FG002|Overall Study|Adverse Event|0|||
161772805|NCT00505765|584211472|FG000|Overall Study|Noncompliance|0|||
161772806|NCT00505765|584211473|FG001|Overall Study|Noncompliance|1|||
161772807|NCT00505765|584211474|FG002|Overall Study|Noncompliance|3|||
161772808|NCT01207219|584211476|FG000|Overall Study|changed diagnosis during study period|5|||
161772809|NCT01207219|584211477|FG001|Overall Study|changed diagnosis during study period|3|||
161772810|NCT01207219|584211478|FG002|Overall Study|changed diagnosis during study period|1|||
161772811|NCT01207219|584211476|FG000|Overall Study|Lost to Follow-up|6|||
161772812|NCT01207219|584211477|FG001|Overall Study|Lost to Follow-up|8|||
161772813|NCT01207219|584211478|FG002|Overall Study|Lost to Follow-up|6|||
161772814|NCT01012609|584211479|FG000|Overall Study|Withdrawal by Subject|1|||
161772815|NCT01012609|584211480|FG001|Overall Study|Withdrawal by Subject|1|||
161772816|NCT01453296|584211481|FG000|Treatment Period 1|Adverse Event|0|||
161772817|NCT01453296|584211482|FG001|Treatment Period 1|Adverse Event|1|||
161772818|NCT01453296|584211481|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
161772819|NCT01453296|584211482|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
161772820|NCT01453296|584211481|FG000|Treatment Period 2|Adverse Event|1|||
161772821|NCT01453296|584211482|FG001|Treatment Period 2|Adverse Event|0|||
161772822|NCT01453296|584211481|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161772823|NCT01453296|584211482|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161772824|NCT00620776|584211483|FG000|Overall Study|Did not receive treatment|3|||
161772825|NCT00620776|584211484|FG001|Overall Study|Did not receive treatment|5|||
161772826|NCT00620776|584211483|FG000|Overall Study|Adverse Event|2|||
161772827|NCT00620776|584211484|FG001|Overall Study|Adverse Event|3|||
161772828|NCT00620776|584211483|FG000|Overall Study|Lack of Efficacy|2|||
161772829|NCT00620776|584211484|FG001|Overall Study|Lack of Efficacy|1|||
161772830|NCT00620776|584211483|FG000|Overall Study|Lost to Follow-up|2|||
161772831|NCT00620776|584211484|FG001|Overall Study|Lost to Follow-up|5|||
161772832|NCT00620776|584211483|FG000|Overall Study|Withdrawal by Subject|3|||
161772833|NCT00620776|584211484|FG001|Overall Study|Withdrawal by Subject|2|||
161772834|NCT00924820|584211485|FG000|Overall Study|Death|2|||
161772835|NCT00924820|584211485|FG000|Overall Study|Ineligible, Screen Failure|5|||
161772836|NCT04983589|584211486|FG000|Overall Study|Withdrawal by Subject|0|||
161772837|NCT04983589|584211487|FG001|Overall Study|Withdrawal by Subject|3|||
161772838|NCT04983589|584211486|FG000|Overall Study|COVID-19 Infection|1|||
161772839|NCT04983589|584211487|FG001|Overall Study|COVID-19 Infection|0|||
161772840|NCT04983589|584211486|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
161772841|NCT04983589|584211487|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
161772842|NCT01049360|584211490|FG000|Period 1|Adverse Event|0|||
161772843|NCT01049360|584211491|FG001|Period 1|Adverse Event|1|||
161772844|NCT01049360|584211492|FG002|Period 1|Adverse Event|0|||
161772845|NCT01049360|584211493|FG003|Period 1|Adverse Event|1|||
161862086|NCT01891864|584536113|FG004|Treatment Period 2|Protocol Violation|0|||
161862087|NCT01891864|584536114|FG005|Treatment Period 2|Protocol Violation|0|||
161862088|NCT01891864|584536109|FG000|Treatment Period 2|Physician Decision|0|||
161862089|NCT01891864|584536110|FG001|Treatment Period 2|Physician Decision|0|||
161862090|NCT01891864|584536111|FG002|Treatment Period 2|Physician Decision|1|||
161862091|NCT01891864|584536112|FG003|Treatment Period 2|Physician Decision|0|||
161862092|NCT01891864|584536113|FG004|Treatment Period 2|Physician Decision|0|||
161862093|NCT01891864|584536114|FG005|Treatment Period 2|Physician Decision|0|||
161862094|NCT01891864|584536109|FG000|Treatment Period 2|Site Termination|0|||
161862095|NCT01891864|584536110|FG001|Treatment Period 2|Site Termination|0|||
161862096|NCT01891864|584536111|FG002|Treatment Period 2|Site Termination|1|||
161862097|NCT01891864|584536112|FG003|Treatment Period 2|Site Termination|2|||
161862098|NCT01891864|584536113|FG004|Treatment Period 2|Site Termination|0|||
161862099|NCT01891864|584536114|FG005|Treatment Period 2|Site Termination|0|||
161862100|NCT01891864|584536109|FG000|Treatment Period 2|Lack of Efficacy|0|||
161862101|NCT01891864|584536110|FG001|Treatment Period 2|Lack of Efficacy|0|||
161862102|NCT01891864|584536111|FG002|Treatment Period 2|Lack of Efficacy|1|||
161862103|NCT01891864|584536112|FG003|Treatment Period 2|Lack of Efficacy|0|||
161862104|NCT01891864|584536113|FG004|Treatment Period 2|Lack of Efficacy|1|||
161862105|NCT01891864|584536114|FG005|Treatment Period 2|Lack of Efficacy|0|||
161862106|NCT01891864|584536109|FG000|Treatment Period 2|Adverse Event|0|||
161862107|NCT01891864|584536110|FG001|Treatment Period 2|Adverse Event|0|||
161862108|NCT01891864|584536111|FG002|Treatment Period 2|Adverse Event|1|||
161862109|NCT01891864|584536112|FG003|Treatment Period 2|Adverse Event|2|||
161862110|NCT01891864|584536113|FG004|Treatment Period 2|Adverse Event|0|||
161862111|NCT01891864|584536114|FG005|Treatment Period 2|Adverse Event|4|||
161862112|NCT01891864|584536109|FG000|Treatment Period 2|Termination of Site|0|||
161862113|NCT01891864|584536110|FG001|Treatment Period 2|Termination of Site|0|||
161862114|NCT01891864|584536111|FG002|Treatment Period 2|Termination of Site|0|||
161862115|NCT01891864|584536112|FG003|Treatment Period 2|Termination of Site|0|||
161862116|NCT01891864|584536113|FG004|Treatment Period 2|Termination of Site|2|||
161862117|NCT01891864|584536114|FG005|Treatment Period 2|Termination of Site|0|||
161862118|NCT01891864|584536109|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161862119|NCT01891864|584536110|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161862120|NCT01891864|584536111|FG002|Treatment Period 2|Withdrawal by Subject|3|||
161862121|NCT01891864|584536112|FG003|Treatment Period 2|Withdrawal by Subject|4|||
161862122|NCT01891864|584536113|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161862123|NCT01891864|584536114|FG005|Treatment Period 2|Withdrawal by Subject|1|||
161862124|NCT01891864|584536109|FG000|Extension Period|Lack of Efficacy|0|||
161862125|NCT01891864|584536110|FG001|Extension Period|Lack of Efficacy|0|||
161862126|NCT01891864|584536111|FG002|Extension Period|Lack of Efficacy|0|||
161862127|NCT01891864|584536112|FG003|Extension Period|Lack of Efficacy|1|||
161862128|NCT01891864|584536113|FG004|Extension Period|Lack of Efficacy|1|||
161862129|NCT01891864|584536114|FG005|Extension Period|Lack of Efficacy|0|||
161862130|NCT01891864|584536109|FG000|Extension Period|Pregnancy|0|||
161862131|NCT01891864|584536110|FG001|Extension Period|Pregnancy|0|||
161862132|NCT01891864|584536111|FG002|Extension Period|Pregnancy|1|||
161862133|NCT01891864|584536112|FG003|Extension Period|Pregnancy|0|||
161862134|NCT01891864|584536113|FG004|Extension Period|Pregnancy|0|||
161862135|NCT01891864|584536114|FG005|Extension Period|Pregnancy|0|||
161862136|NCT01891864|584536109|FG000|Extension Period|Adverse Event|0|||
161862137|NCT01891864|584536110|FG001|Extension Period|Adverse Event|0|||
161862138|NCT01891864|584536111|FG002|Extension Period|Adverse Event|4|||
161862139|NCT01891864|584536112|FG003|Extension Period|Adverse Event|2|||
161862140|NCT01891864|584536113|FG004|Extension Period|Adverse Event|2|||
161862141|NCT01891864|584536114|FG005|Extension Period|Adverse Event|0|||
161862142|NCT01891864|584536109|FG000|Extension Period|Withdrawal by Subject|0|||
161862143|NCT01891864|584536110|FG001|Extension Period|Withdrawal by Subject|0|||
161862144|NCT01891864|584536111|FG002|Extension Period|Withdrawal by Subject|1|||
161862145|NCT01891864|584536112|FG003|Extension Period|Withdrawal by Subject|2|||
161862146|NCT01891864|584536113|FG004|Extension Period|Withdrawal by Subject|4|||
161862147|NCT01891864|584536114|FG005|Extension Period|Withdrawal by Subject|0|||
161862148|NCT01891864|584536109|FG000|Extension Period|Lost to Follow-up|0|||
161862149|NCT01891864|584536110|FG001|Extension Period|Lost to Follow-up|0|||
161862150|NCT01891864|584536111|FG002|Extension Period|Lost to Follow-up|2|||
161862151|NCT01891864|584536112|FG003|Extension Period|Lost to Follow-up|0|||
161862152|NCT01891864|584536113|FG004|Extension Period|Lost to Follow-up|0|||
161862153|NCT01891864|584536114|FG005|Extension Period|Lost to Follow-up|0|||
161862154|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
161862155|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
161862156|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
161862157|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
161862158|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
161862159|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
161862160|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
161862161|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
161862162|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
161862163|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
161862164|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
161862165|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
161862166|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
161862167|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
161862168|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
161862169|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
161862170|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
161862171|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
161862172|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
161862173|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
161862174|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
161862175|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
161862176|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
161862177|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
161862178|NCT02513160|584537936|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
161862179|NCT02513160|584537937|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
161862180|NCT02513160|584537938|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
161862181|NCT02513160|584537939|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
161862182|NCT02513160|584537936|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
161862183|NCT02513160|584537937|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
161862184|NCT02513160|584537938|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
161862185|NCT02513160|584537939|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
161862186|NCT02513160|584537936|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
161862187|NCT02513160|584537937|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
161862188|NCT02513160|584537938|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
161862189|NCT02513160|584537939|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
161862190|NCT02513160|584537936|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
161862191|NCT02513160|584537937|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
161862192|NCT02513160|584537938|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
161862193|NCT02513160|584537939|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
161862194|NCT02513160|584537936|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
161862195|NCT02513160|584537937|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
161862196|NCT02513160|584537938|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
161862197|NCT02513160|584537939|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
161862198|NCT02513160|584537936|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
161862199|NCT02513160|584537937|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
161862200|NCT02513160|584537938|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
161862201|NCT02513160|584537939|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
161862202|NCT04581824|584537941|FG000|Overall Study|Lost to Follow-up|1|||
161862203|NCT04581824|584537942|FG001|Overall Study|Lost to Follow-up|0|||
161862204|NCT04581824|584537941|FG000|Overall Study|Withdrawal by Subject|2|||
161862205|NCT04581824|584537942|FG001|Overall Study|Withdrawal by Subject|7|||
161862206|NCT04581824|584537941|FG000|Overall Study|Study terminated by sponsor|37|||
161862207|NCT04581824|584537942|FG001|Overall Study|Study terminated by sponsor|23|||
161862208|NCT05012098|584537943|FG000|Overall Study|Disease progression|5|||
161862209|NCT05012098|584537944|FG001|Overall Study|Disease progression|2|||
161862210|NCT05012098|584537943|FG000|Overall Study|Adverse Event|1|||
161862211|NCT05012098|584537944|FG001|Overall Study|Adverse Event|0|||
161862212|NCT05012098|584537943|FG000|Overall Study|Withdrawal by Subject|1|||
161862213|NCT05012098|584537944|FG001|Overall Study|Withdrawal by Subject|0|||
161862214|NCT05012098|584537943|FG000|Overall Study|Discontinuation per protocol|1|||
161862215|NCT05012098|584537944|FG001|Overall Study|Discontinuation per protocol|0|||
161862216|NCT01749826|584537947|FG000|Overall Study|Study Terminated|20|||
161862217|NCT01749826|584537948|FG001|Overall Study|Study Terminated|0|||
161862218|NCT00813150|584537949|FG000|Treatment Period|Adverse Event|16|||
161977663|NCT00527319|584967358|FG000|Overall Study|Adverse Event|0|||
161977664|NCT00527319|584967359|FG001|Overall Study|Adverse Event|0|||
161977665|NCT00527319|584967360|FG002|Overall Study|Adverse Event|1|||
161977666|NCT01804582|584967364|FG000|Overall Study|Lost to Follow-up|47|||
161977667|NCT01804582|584967365|FG001|Overall Study|Lost to Follow-up|56|||
161977668|NCT01804582|584967364|FG000|Overall Study|Physician Decision|2|||
161862219|NCT00813150|584537950|FG001|Treatment Period|Adverse Event|15|||
161862220|NCT00813150|584537949|FG000|Treatment Period|Death|2|||
161862221|NCT00813150|584537950|FG001|Treatment Period|Death|0|||
161862222|NCT00813150|584537949|FG000|Treatment Period|Progressive disease|1|||
161862223|NCT00813150|584537950|FG001|Treatment Period|Progressive disease|0|||
161977669|NCT01804582|584967365|FG001|Overall Study|Physician Decision|0|||
161862224|NCT00813150|584537949|FG000|Treatment Period|Complete response|0|||
161862225|NCT00813150|584537950|FG001|Treatment Period|Complete response|1|||
161862226|NCT00813150|584537949|FG000|Treatment Period|Stable disease|1|||
161862227|NCT00813150|584537950|FG001|Treatment Period|Stable disease|2|||
161862228|NCT00813150|584537949|FG000|Treatment Period|Protocol Violation|3|||
161862229|NCT00813150|584537950|FG001|Treatment Period|Protocol Violation|4|||
161862230|NCT00813150|584537949|FG000|Treatment Period|Withdrawal by Subject|5|||
161862231|NCT00813150|584537950|FG001|Treatment Period|Withdrawal by Subject|3|||
161862232|NCT00813150|584537949|FG000|Treatment Period|Non compliance|0|||
161862233|NCT00813150|584537950|FG001|Treatment Period|Non compliance|1|||
161862234|NCT00813150|584537949|FG000|Treatment Period|Reason not specified|3|||
161862235|NCT00813150|584537950|FG001|Treatment Period|Reason not specified|4|||
161862236|NCT00813150|584537949|FG000|Treatment Period|Data not available|1|||
161862237|NCT00813150|584537950|FG001|Treatment Period|Data not available|2|||
161862238|NCT00813150|584537949|FG000|Long Term Follow-up|Death|0|||
161862239|NCT00813150|584537950|FG001|Long Term Follow-up|Death|4|||
161862240|NCT00813150|584537949|FG000|Long Term Follow-up|Other|0|||
161862241|NCT00813150|584537950|FG001|Long Term Follow-up|Other|3|||
161862242|NCT00813150|584537949|FG000|Long Term Follow-up|Lost to Follow-up|2|||
161862243|NCT00813150|584537950|FG001|Long Term Follow-up|Lost to Follow-up|0|||
161862244|NCT00813150|584537949|FG000|Long Term Follow-up|Progression/Relapse|22|||
161862245|NCT00813150|584537950|FG001|Long Term Follow-up|Progression/Relapse|24|||
161862246|NCT05085834|584537951|FG000|Overall Study|Lost to Follow-up|9|||
161862247|NCT05085834|584537952|FG001|Overall Study|Lost to Follow-up|2|||
161862248|NCT05085834|584537951|FG000|Overall Study|Adverse Event|6|||
161862249|NCT05085834|584537952|FG001|Overall Study|Adverse Event|0|||
161862250|NCT05085834|584537951|FG000|Overall Study|Death|1|||
161862251|NCT05085834|584537952|FG001|Overall Study|Death|0|||
161862252|NCT05085834|584537951|FG000|Overall Study|Inability to swallow the pill|0|||
161862253|NCT05085834|584537952|FG001|Overall Study|Inability to swallow the pill|1|||
161862254|NCT01823328|584537957|FG000|Overall Study|Withdrawal by Subject|8|||
161862255|NCT01823328|584537958|FG001|Overall Study|Withdrawal by Subject|6|||
161862256|NCT04565145|584537959|FG000|Overall Study|Withdrawal by Subject|1|||
161862257|NCT04565145|584537960|FG001|Overall Study|Withdrawal by Subject|1|||
161862258|NCT02547428|584537961|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
161862259|NCT02547428|584537962|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
161862260|NCT02547428|584537961|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
161862261|NCT02547428|584537962|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
161862262|NCT02547428|584537961|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
161862263|NCT02547428|584537962|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
161862264|NCT02547428|584537961|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
161862265|NCT02547428|584537962|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
161862266|NCT02547428|584537961|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
161862267|NCT02547428|584537962|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
161862268|NCT02547428|584537961|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
161862269|NCT02547428|584537962|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
161977670|NCT02258529|584967369|FG000|Overall Study|Study Terminated by Sponsor|9|||
161977671|NCT02258529|584967369|FG000|Overall Study|Adverse Event|1|||
161977672|NCT00413010|584967370|FG000|Overall Study|Adverse Event|8|||
161977673|NCT00413010|584967371|FG001|Overall Study|Adverse Event|4|||
161977674|NCT00413010|584967370|FG000|Overall Study|Laboratory abnormality|0|||
161772846|NCT01049360|584211494|FG004|Period 1|Adverse Event|0|||
161772847|NCT01049360|584211495|FG005|Period 1|Adverse Event|0|||
161772848|NCT01049360|584211496|FG006|Period 1|Adverse Event|0|||
161772849|NCT01049360|584211497|FG007|Period 1|Adverse Event|1|||
161772850|NCT01049360|584211498|FG008|Period 1|Adverse Event|0|||
161772851|NCT01049360|584211499|FG009|Period 1|Adverse Event|0|||
161772852|NCT01049360|584211500|FG010|Period 1|Adverse Event|0|||
161772853|NCT01049360|584211501|FG011|Period 1|Adverse Event|0|||
161772854|NCT01049360|584211502|FG012|Period 1|Adverse Event|1|||
161772855|NCT01049360|584211503|FG013|Period 1|Adverse Event|1|||
161772856|NCT01049360|584211504|FG014|Period 1|Adverse Event|0|||
161772857|NCT01049360|584211505|FG015|Period 1|Adverse Event|0|||
161772858|NCT01049360|584211506|FG016|Period 1|Adverse Event|1|||
161772859|NCT01049360|584211507|FG017|Period 1|Adverse Event|0|||
161772860|NCT01049360|584211508|FG018|Period 1|Adverse Event|1|||
161862270|NCT02547428|584537961|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
161977675|NCT00413010|584967371|FG001|Overall Study|Laboratory abnormality|2|||
161772861|NCT01049360|584211509|FG019|Period 1|Adverse Event|0|||
161772862|NCT01049360|584211490|FG000|Period 1|Did not meet inc/exc criteria|0|||
161772863|NCT01049360|584211491|FG001|Period 1|Did not meet inc/exc criteria|0|||
161772864|NCT01049360|584211492|FG002|Period 1|Did not meet inc/exc criteria|0|||
161772865|NCT01049360|584211493|FG003|Period 1|Did not meet inc/exc criteria|0|||
161862271|NCT02547428|584537962|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
161862272|NCT02547428|584537961|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
161977676|NCT00413010|584967370|FG000|Overall Study|Lack of Efficacy|0|||
161862273|NCT02547428|584537962|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
161862274|NCT00742209|584537975|FG000|Overall Study|Adverse Event|11|||
161862275|NCT00742209|584537976|FG001|Overall Study|Adverse Event|4|||
161862276|NCT00742209|584537977|FG002|Overall Study|Adverse Event|17|||
161862277|NCT00742209|584537978|FG003|Overall Study|Adverse Event|16|||
161862278|NCT00742209|584537979|FG004|Overall Study|Adverse Event|13|||
161862279|NCT00742209|584537975|FG000|Overall Study|Participant Withdrew Consent|8|||
161862280|NCT00742209|584537976|FG001|Overall Study|Participant Withdrew Consent|4|||
161862281|NCT00742209|584537977|FG002|Overall Study|Participant Withdrew Consent|14|||
161862282|NCT00742209|584537978|FG003|Overall Study|Participant Withdrew Consent|7|||
161862283|NCT00742209|584537979|FG004|Overall Study|Participant Withdrew Consent|4|||
161862284|NCT00742209|584537975|FG000|Overall Study|Protocol Violation|6|||
161862285|NCT00742209|584537976|FG001|Overall Study|Protocol Violation|5|||
161862286|NCT00742209|584537977|FG002|Overall Study|Protocol Violation|4|||
161862287|NCT00742209|584537978|FG003|Overall Study|Protocol Violation|5|||
161862288|NCT00742209|584537979|FG004|Overall Study|Protocol Violation|3|||
161862289|NCT00742209|584537975|FG000|Overall Study|Lost to Follow-up|3|||
161862290|NCT00742209|584537976|FG001|Overall Study|Lost to Follow-up|4|||
161862291|NCT00742209|584537977|FG002|Overall Study|Lost to Follow-up|5|||
161862292|NCT00742209|584537978|FG003|Overall Study|Lost to Follow-up|5|||
161862293|NCT00742209|584537979|FG004|Overall Study|Lost to Follow-up|3|||
161862294|NCT00742209|584537975|FG000|Overall Study|Lack of Efficacy|6|||
161862295|NCT00742209|584537976|FG001|Overall Study|Lack of Efficacy|1|||
161862296|NCT00742209|584537977|FG002|Overall Study|Lack of Efficacy|1|||
161862297|NCT00742209|584537978|FG003|Overall Study|Lack of Efficacy|3|||
161862298|NCT00742209|584537979|FG004|Overall Study|Lack of Efficacy|1|||
161862299|NCT00742209|584537975|FG000|Overall Study|Investigator Discretion|0|||
161862300|NCT00742209|584537976|FG001|Overall Study|Investigator Discretion|0|||
161862301|NCT00742209|584537977|FG002|Overall Study|Investigator Discretion|5|||
161862302|NCT00742209|584537978|FG003|Overall Study|Investigator Discretion|1|||
161862303|NCT00742209|584537979|FG004|Overall Study|Investigator Discretion|1|||
161862304|NCT02003209|584537980|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
161862305|NCT02003209|584537981|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
161862306|NCT00485264|584537984|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
161862307|NCT00485264|584537985|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
161862308|NCT00485264|584537986|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
161862309|NCT00485264|584537987|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
161862310|NCT00485264|584537988|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
161862311|NCT00485264|584537989|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
161862312|NCT00485264|584537984|FG000|Overall Study|Death|1|||
161862313|NCT00485264|584537985|FG001|Overall Study|Death|0|||
161862314|NCT00485264|584537986|FG002|Overall Study|Death|0|||
161862315|NCT00485264|584537987|FG003|Overall Study|Death|0|||
161862316|NCT00485264|584537988|FG004|Overall Study|Death|1|||
161862317|NCT00485264|584537989|FG005|Overall Study|Death|0|||
161862318|NCT00485264|584537984|FG000|Overall Study|Adverse Event|1|||
161862319|NCT00485264|584537985|FG001|Overall Study|Adverse Event|0|||
161862320|NCT00485264|584537986|FG002|Overall Study|Adverse Event|2|||
161862321|NCT00485264|584537987|FG003|Overall Study|Adverse Event|3|||
161862322|NCT00485264|584537988|FG004|Overall Study|Adverse Event|1|||
161862323|NCT00485264|584537989|FG005|Overall Study|Adverse Event|3|||
161862324|NCT00485264|584537984|FG000|Overall Study|Pregnancy|4|||
161977677|NCT00413010|584967371|FG001|Overall Study|Lack of Efficacy|3|||
161977678|NCT00413010|584967370|FG000|Overall Study|Lost to Follow-up|3|||
161977679|NCT00413010|584967371|FG001|Overall Study|Lost to Follow-up|0|||
161977680|NCT00413010|584967370|FG000|Overall Study|Withdrawal by Subject|7|||
161977681|NCT00413010|584967371|FG001|Overall Study|Withdrawal by Subject|2|||
161977682|NCT00413010|584967370|FG000|Overall Study|Due to termination of the study|54|||
161977683|NCT00413010|584967371|FG001|Overall Study|Due to termination of the study|52|||
161977684|NCT01842581|584967376|FG000|Overall Study|Adverse Event|6|||
161977685|NCT01842581|584967377|FG001|Overall Study|Adverse Event|4|||
161977686|NCT01842581|584967376|FG000|Overall Study|HE breakthrough|26|||
161977687|NCT01842581|584967377|FG001|Overall Study|HE breakthrough|13|||
161862325|NCT00485264|584537985|FG001|Overall Study|Pregnancy|0|||
161862326|NCT00485264|584537986|FG002|Overall Study|Pregnancy|0|||
161862327|NCT00485264|584537987|FG003|Overall Study|Pregnancy|0|||
161862328|NCT00485264|584537988|FG004|Overall Study|Pregnancy|0|||
161862329|NCT00485264|584537989|FG005|Overall Study|Pregnancy|0|||
161862330|NCT00485264|584537984|FG000|Overall Study|Disallowed Medication|0|||
161862331|NCT00485264|584537985|FG001|Overall Study|Disallowed Medication|0|||
161862332|NCT00485264|584537986|FG002|Overall Study|Disallowed Medication|0|||
161862333|NCT00485264|584537987|FG003|Overall Study|Disallowed Medication|0|||
161862334|NCT00485264|584537988|FG004|Overall Study|Disallowed Medication|0|||
161862335|NCT00485264|584537989|FG005|Overall Study|Disallowed Medication|1|||
161862336|NCT00485264|584537984|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
161862337|NCT00485264|584537985|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
161977688|NCT01842581|584967376|FG000|Overall Study|Liver transplant|2|||
161977689|NCT01842581|584967377|FG001|Overall Study|Liver transplant|0|||
161862338|NCT00485264|584537986|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
161862339|NCT00485264|584537987|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
161862340|NCT00485264|584537988|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
161862341|NCT00485264|584537989|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
161862342|NCT00485264|584537984|FG000|Overall Study|Lack of Efficacy|0|||
161862343|NCT00485264|584537985|FG001|Overall Study|Lack of Efficacy|1|||
161862344|NCT00485264|584537986|FG002|Overall Study|Lack of Efficacy|0|||
161862345|NCT00485264|584537987|FG003|Overall Study|Lack of Efficacy|0|||
161862346|NCT00485264|584537988|FG004|Overall Study|Lack of Efficacy|0|||
161862347|NCT00485264|584537989|FG005|Overall Study|Lack of Efficacy|0|||
161862348|NCT00485264|584537984|FG000|Overall Study|Guardian Consent Withdrawn|1|||
161862349|NCT00485264|584537985|FG001|Overall Study|Guardian Consent Withdrawn|0|||
161862350|NCT00485264|584537986|FG002|Overall Study|Guardian Consent Withdrawn|0|||
161862351|NCT00485264|584537987|FG003|Overall Study|Guardian Consent Withdrawn|0|||
161862352|NCT00485264|584537988|FG004|Overall Study|Guardian Consent Withdrawn|1|||
161862353|NCT00485264|584537989|FG005|Overall Study|Guardian Consent Withdrawn|0|||
161862354|NCT00485264|584537984|FG000|Overall Study|Physician Decision|0|||
161862355|NCT00485264|584537985|FG001|Overall Study|Physician Decision|2|||
161862356|NCT00485264|584537986|FG002|Overall Study|Physician Decision|0|||
161862357|NCT00485264|584537987|FG003|Overall Study|Physician Decision|0|||
161862358|NCT00485264|584537988|FG004|Overall Study|Physician Decision|0|||
161862359|NCT00485264|584537989|FG005|Overall Study|Physician Decision|0|||
161862360|NCT00485264|584537984|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161862361|NCT00485264|584537985|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161862362|NCT00485264|584537986|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
161862363|NCT00485264|584537987|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161862364|NCT00485264|584537988|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161862365|NCT00485264|584537989|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161862366|NCT00485264|584537984|FG000|Overall Study|Not Able to Attend Clinic|5|||
161862367|NCT00485264|584537985|FG001|Overall Study|Not Able to Attend Clinic|0|||
161862368|NCT00485264|584537986|FG002|Overall Study|Not Able to Attend Clinic|0|||
161862369|NCT00485264|584537987|FG003|Overall Study|Not Able to Attend Clinic|1|||
161862370|NCT00485264|584537988|FG004|Overall Study|Not Able to Attend Clinic|1|||
161862371|NCT00485264|584537989|FG005|Overall Study|Not Able to Attend Clinic|2|||
161862372|NCT00485264|584537984|FG000|Overall Study|Non-Compliant|17|||
161862373|NCT00485264|584537985|FG001|Overall Study|Non-Compliant|2|||
161862374|NCT00485264|584537986|FG002|Overall Study|Non-Compliant|1|||
161862375|NCT00485264|584537987|FG003|Overall Study|Non-Compliant|0|||
161862376|NCT00485264|584537988|FG004|Overall Study|Non-Compliant|1|||
161862377|NCT00485264|584537989|FG005|Overall Study|Non-Compliant|0|||
161862378|NCT00485264|584537984|FG000|Overall Study|Lost to Follow-up|2|||
161862379|NCT00485264|584537985|FG001|Overall Study|Lost to Follow-up|1|||
161862380|NCT00485264|584537986|FG002|Overall Study|Lost to Follow-up|1|||
161862381|NCT00485264|584537987|FG003|Overall Study|Lost to Follow-up|0|||
161862382|NCT00485264|584537988|FG004|Overall Study|Lost to Follow-up|0|||
161862383|NCT00485264|584537989|FG005|Overall Study|Lost to Follow-up|1|||
161862384|NCT00485264|584537984|FG000|Overall Study|Other Reason|3|||
161862385|NCT00485264|584537985|FG001|Overall Study|Other Reason|0|||
161862386|NCT00485264|584537986|FG002|Overall Study|Other Reason|0|||
161862387|NCT00485264|584537987|FG003|Overall Study|Other Reason|0|||
161862388|NCT00485264|584537988|FG004|Overall Study|Other Reason|0|||
161862389|NCT00485264|584537989|FG005|Overall Study|Other Reason|0|||
161862390|NCT01514461|584537990|FG000|Overall Study|Adverse Event|2|||
161862391|NCT01514461|584537991|FG001|Overall Study|Adverse Event|1|||
161862392|NCT01514461|584537992|FG002|Overall Study|Adverse Event|3|||
161862393|NCT01514461|584537990|FG000|Overall Study|Physician Decision|1|||
161862394|NCT01514461|584537991|FG001|Overall Study|Physician Decision|1|||
161862395|NCT01514461|584537992|FG002|Overall Study|Physician Decision|0|||
161862396|NCT01514461|584537990|FG000|Overall Study|Patient/guardian decision|1|||
161862397|NCT01514461|584537991|FG001|Overall Study|Patient/guardian decision|1|||
161862398|NCT01514461|584537992|FG002|Overall Study|Patient/guardian decision|1|||
161977690|NCT01842581|584967376|FG000|Overall Study|Lost to Follow-up|2|||
161977691|NCT01842581|584967377|FG001|Overall Study|Lost to Follow-up|5|||
161977692|NCT01842581|584967376|FG000|Overall Study|Withdrawal by Subject|5|||
161977693|NCT01842581|584967377|FG001|Overall Study|Withdrawal by Subject|7|||
161977694|NCT01842581|584967376|FG000|Overall Study|Other than specified|3|||
161977695|NCT01842581|584967377|FG001|Overall Study|Other than specified|1|||
161862399|NCT01514461|584537990|FG000|Overall Study|Death|1|||
161862400|NCT01514461|584537991|FG001|Overall Study|Death|0|||
161862401|NCT01514461|584537992|FG002|Overall Study|Death|0|||
161862402|NCT02548832|584537993|FG000|Overall Study|Lost to Follow-up|2|||
161862403|NCT02548832|584537994|FG001|Overall Study|Lost to Follow-up|2|||
161862404|NCT02548832|584537995|FG002|Overall Study|Lost to Follow-up|2|||
161862405|NCT03817125|584538003|FG000|Overall Study|Adverse Event|1|||
161862406|NCT03817125|584538004|FG001|Overall Study|Adverse Event|0|||
161862407|NCT03817125|584538003|FG000|Overall Study|Physician Decision|0|||
161977696|NCT05432167|584967378|FG000|Overall Study|Adverse Event|0|||
161977697|NCT05432167|584967379|FG001|Overall Study|Adverse Event|2|||
161862408|NCT03817125|584538004|FG001|Overall Study|Physician Decision|1|||
161862409|NCT03817125|584538003|FG000|Overall Study|Lack of Efficacy|1|||
161862410|NCT03817125|584538004|FG001|Overall Study|Lack of Efficacy|5|||
161862411|NCT00942084|584538005|FG000|Overall Study|Death|2|||
161862412|NCT01062425|584538006|FG000|Overall Study|Protocol Violation|3|||
161862413|NCT01062425|584538007|FG001|Overall Study|Protocol Violation|6|||
161862414|NCT02088177|584538010|FG000|Overall Study|Lost to Follow-up|3|||
161862415|NCT01234350|584538011|FG000|Overall Study|Adverse Event|277|||
161862416|NCT01234350|584538012|FG001|Overall Study|Adverse Event|92|||
161862417|NCT01234350|584538011|FG000|Overall Study|Withdrawal by Subject|61|||
161862418|NCT01234350|584538012|FG001|Overall Study|Withdrawal by Subject|36|||
161862419|NCT01234350|584538011|FG000|Overall Study|Lost to Follow-up|115|||
161862420|NCT01234350|584538012|FG001|Overall Study|Lost to Follow-up|47|||
161862421|NCT01234350|584538011|FG000|Overall Study|Covers a diverse set of reasons|234|||
161862422|NCT01234350|584538012|FG001|Overall Study|Covers a diverse set of reasons|92|||
161862423|NCT00289848|584538013|FG000|Overall Study|Adverse Event|6|||
161862424|NCT00289848|584538014|FG001|Overall Study|Adverse Event|4|||
161862425|NCT00289848|584538013|FG000|Overall Study|Death|1|||
161862426|NCT00289848|584538014|FG001|Overall Study|Death|0|||
161862427|NCT00289848|584538013|FG000|Overall Study|Lack of Efficacy|20|||
161862428|NCT00289848|584538014|FG001|Overall Study|Lack of Efficacy|24|||
161862429|NCT00289848|584538013|FG000|Overall Study|Lost to Follow-up|3|||
161862430|NCT00289848|584538014|FG001|Overall Study|Lost to Follow-up|1|||
161862431|NCT00289848|584538013|FG000|Overall Study|Protocol Violation|5|||
161862432|NCT00289848|584538014|FG001|Overall Study|Protocol Violation|2|||
161862433|NCT00289848|584538013|FG000|Overall Study|Withdrawal by Subject|5|||
161862434|NCT00289848|584538014|FG001|Overall Study|Withdrawal by Subject|11|||
161862435|NCT00289848|584538013|FG000|Overall Study|Patient Moved|6|||
161862436|NCT00289848|584538014|FG001|Overall Study|Patient Moved|2|||
161862437|NCT00289848|584538013|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
161862438|NCT00289848|584538014|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
161862439|NCT03428152|584538021|FG000|Overall Study|Physician Decision|4|||
161862440|NCT03428152|584538022|FG001|Overall Study|Physician Decision|2|||
161862441|NCT03428152|584538021|FG000|Overall Study|Protocol Violation|3|||
161862442|NCT03428152|584538022|FG001|Overall Study|Protocol Violation|5|||
161862443|NCT03428152|584538021|FG000|Overall Study|Lack of Efficacy|0|||
161862444|NCT03428152|584538022|FG001|Overall Study|Lack of Efficacy|4|||
161862445|NCT01686373|584538023|FG000|Overall Study|Lost to Follow-up|3|||
161862446|NCT01686373|584538024|FG001|Overall Study|Lost to Follow-up|0|||
161862447|NCT01686373|584538023|FG000|Overall Study|Withdrawal by Subject|0|||
161862448|NCT01686373|584538024|FG001|Overall Study|Withdrawal by Subject|1|||
161862449|NCT01686373|584538023|FG000|Overall Study|Adverse Event|0|||
161862450|NCT01686373|584538024|FG001|Overall Study|Adverse Event|1|||
161862451|NCT05366010|584538031|FG000|Overall Study|Withdrawal by Subject|1|||
161862452|NCT05366010|584538031|FG000|Overall Study|Protocol Violation|1|||
161862453|NCT05366010|584538031|FG000|Overall Study|Lost to Follow-up|2|||
161862454|NCT05366010|584538031|FG000|Overall Study|Screen Failure|2|||
161862455|NCT02857816|584538034|FG000|Overall Study|Screen Failure|33|||
161862456|NCT02857816|584538034|FG000|Overall Study|Withdrawal by Subject|4|||
161862457|NCT02857816|584538034|FG000|Overall Study|Lost to Follow-up|1|||
161862458|NCT01949662|584538035|FG000|Overall Study|Death|9|||
161862459|NCT01949662|584538036|FG001|Overall Study|Death|7|||
161862460|NCT01949662|584538035|FG000|Overall Study|Discharged before an agitation event|8|||
161862461|NCT01949662|584538036|FG001|Overall Study|Discharged before an agitation event|3|||
161862462|NCT01949662|584538035|FG000|Overall Study|Dropped out|1|||
161862463|NCT01949662|584538036|FG001|Overall Study|Dropped out|3|||
161862464|NCT01949662|584538035|FG000|Overall Study|Ineligible|0|||
161862465|NCT01949662|584538036|FG001|Overall Study|Ineligible|1|||
161862466|NCT02291237|584538037|FG000|Overall Study|Study Terminated by Sponsor|72|||
161862467|NCT02291237|584538038|FG001|Overall Study|Study Terminated by Sponsor|67|||
161862468|NCT02291237|584538037|FG000|Overall Study|Adverse Event|1|||
161862469|NCT02291237|584538038|FG001|Overall Study|Adverse Event|3|||
161977698|NCT05432167|584967380|FG002|Overall Study|Adverse Event|1|||
161977699|NCT05432167|584967378|FG000|Overall Study|Lost to Follow-up|3|||
161862470|NCT02291237|584538037|FG000|Overall Study|Investigator's Discretion|0|||
161862471|NCT02291237|584538038|FG001|Overall Study|Investigator's Discretion|3|||
161862472|NCT02291237|584538037|FG000|Overall Study|Withdrew Consent|11|||
161862473|NCT02291237|584538038|FG001|Overall Study|Withdrew Consent|11|||
161862474|NCT02291237|584538037|FG000|Overall Study|Lost to Follow-up|0|||
161862475|NCT02291237|584538038|FG001|Overall Study|Lost to Follow-up|2|||
161862476|NCT02291237|584538037|FG000|Overall Study|Subject Required Prohibited Medication|2|||
161862477|NCT02291237|584538038|FG001|Overall Study|Subject Required Prohibited Medication|0|||
161862478|NCT00281957|584538039|FG000|Overall Study|Adverse Event|7|||
161862479|NCT00281957|584538040|FG001|Overall Study|Adverse Event|2|||
161862480|NCT00281957|584538039|FG000|Overall Study|Death|1|||
161862481|NCT00281957|584538040|FG001|Overall Study|Death|0|||
161862482|NCT00281957|584538039|FG000|Overall Study|Progression/relapse|47|||
161862483|NCT00281957|584538040|FG001|Overall Study|Progression/relapse|35|||
161862484|NCT00281957|584538039|FG000|Overall Study|Not protocol specified|8|||
161862485|NCT00281957|584538040|FG001|Overall Study|Not protocol specified|1|||
161862486|NCT00281957|584538039|FG000|Overall Study|Not eligible|1|||
161862487|NCT00281957|584538040|FG001|Overall Study|Not eligible|2|||
161862488|NCT00281957|584538039|FG000|Overall Study|Did not start treatment|3|||
161862489|NCT00281957|584538040|FG001|Overall Study|Did not start treatment|1|||
161862490|NCT00281957|584538039|FG000|Overall Study|Refusal unrelated to adverse events|0|||
161862491|NCT00281957|584538040|FG001|Overall Study|Refusal unrelated to adverse events|1|||
161862492|NCT03281876|584538049|FG000|Overall Study|Adverse Event|4|||
161862493|NCT03281876|584538050|FG001|Overall Study|Adverse Event|15|||
161862494|NCT03281876|584538049|FG000|Overall Study|Lost to Follow-up|1|||
161862495|NCT03281876|584538050|FG001|Overall Study|Lost to Follow-up|4|||
161862496|NCT03281876|584538049|FG000|Overall Study|Withdrawal by Subject|11|||
161862497|NCT03281876|584538050|FG001|Overall Study|Withdrawal by Subject|15|||
161862498|NCT03281876|584538049|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161862499|NCT03281876|584538050|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161862500|NCT03281876|584538049|FG000|Overall Study|OTHER|5|||
161862501|NCT03281876|584538050|FG001|Overall Study|OTHER|5|||
161862502|NCT02208089|584538051|FG000|Overall Study|Withdrawal by Subject|1|||
161862503|NCT02208089|584538052|FG001|Overall Study|Withdrawal by Subject|0|||
161862504|NCT02208089|584538051|FG000|Overall Study|Lost to Follow-up|6|||
161862505|NCT02208089|584538052|FG001|Overall Study|Lost to Follow-up|0|||
161862506|NCT00456300|584538053|FG000|Overall Study|Adverse Event|1|||
161862507|NCT00456300|584538054|FG001|Overall Study|Adverse Event|0|||
161862508|NCT01478373|584538056|FG000|Treatment Phase|Protocol Violation|1|||
161862509|NCT01478373|584538056|FG000|Survival Phase|Adverse Event|8|||
161862510|NCT01478373|584538056|FG000|Survival Phase|Protocol Violation|1|||
161862511|NCT01478373|584538056|FG000|Survival Phase|crossover to another study|2|||
161862512|NCT01478373|584538056|FG000|Survival Phase|Progressive Disease|27|||
162034670|NCT04478123|585183512|FG000|Overall Study|NE|1|||
162034671|NCT02395016|585183513|FG000|Overall Study|Adverse Event|4|||
162034672|NCT02395016|585183514|FG001|Overall Study|Adverse Event|3|||
162034673|NCT02395016|585183513|FG000|Overall Study|Withdrawal by Subject|9|||
162034674|NCT02395016|585183514|FG001|Overall Study|Withdrawal by Subject|6|||
162034675|NCT02395016|585183513|FG000|Overall Study|Protocol Violation|2|||
162034676|NCT02395016|585183514|FG001|Overall Study|Protocol Violation|3|||
162034677|NCT01547780|585183515|FG000|Baseline PET Scan|Physician Decision|1|||
162034678|NCT01547780|585183516|FG001|Baseline PET Scan|Physician Decision|0|||
161772866|NCT01049360|584211494|FG004|Period 1|Did not meet inc/exc criteria|0|||
161772867|NCT01049360|584211495|FG005|Period 1|Did not meet inc/exc criteria|0|||
161772868|NCT01049360|584211496|FG006|Period 1|Did not meet inc/exc criteria|0|||
161772869|NCT01049360|584211497|FG007|Period 1|Did not meet inc/exc criteria|1|||
161772870|NCT01049360|584211498|FG008|Period 1|Did not meet inc/exc criteria|1|||
161772871|NCT01049360|584211499|FG009|Period 1|Did not meet inc/exc criteria|0|||
161772872|NCT01049360|584211500|FG010|Period 1|Did not meet inc/exc criteria|0|||
161772873|NCT01049360|584211501|FG011|Period 1|Did not meet inc/exc criteria|0|||
161772874|NCT01049360|584211502|FG012|Period 1|Did not meet inc/exc criteria|0|||
161772875|NCT01049360|584211503|FG013|Period 1|Did not meet inc/exc criteria|0|||
161772876|NCT01049360|584211504|FG014|Period 1|Did not meet inc/exc criteria|0|||
161772877|NCT01049360|584211505|FG015|Period 1|Did not meet inc/exc criteria|0|||
161772878|NCT01049360|584211506|FG016|Period 1|Did not meet inc/exc criteria|0|||
161772879|NCT01049360|584211507|FG017|Period 1|Did not meet inc/exc criteria|0|||
161772880|NCT01049360|584211508|FG018|Period 1|Did not meet inc/exc criteria|0|||
161772881|NCT01049360|584211509|FG019|Period 1|Did not meet inc/exc criteria|0|||
161772882|NCT01049360|584211490|FG000|Period 1|Withdrawal by Subject|0|||
161772883|NCT01049360|584211491|FG001|Period 1|Withdrawal by Subject|0|||
161772884|NCT01049360|584211492|FG002|Period 1|Withdrawal by Subject|0|||
161772885|NCT01049360|584211493|FG003|Period 1|Withdrawal by Subject|0|||
161772886|NCT01049360|584211494|FG004|Period 1|Withdrawal by Subject|0|||
161772887|NCT01049360|584211495|FG005|Period 1|Withdrawal by Subject|0|||
161772888|NCT01049360|584211496|FG006|Period 1|Withdrawal by Subject|0|||
161772889|NCT01049360|584211497|FG007|Period 1|Withdrawal by Subject|0|||
161772890|NCT01049360|584211498|FG008|Period 1|Withdrawal by Subject|1|||
161772891|NCT01049360|584211499|FG009|Period 1|Withdrawal by Subject|0|||
161772892|NCT01049360|584211500|FG010|Period 1|Withdrawal by Subject|1|||
161772893|NCT01049360|584211501|FG011|Period 1|Withdrawal by Subject|0|||
161772894|NCT01049360|584211502|FG012|Period 1|Withdrawal by Subject|1|||
161772895|NCT01049360|584211503|FG013|Period 1|Withdrawal by Subject|0|||
161772896|NCT01049360|584211504|FG014|Period 1|Withdrawal by Subject|0|||
161772897|NCT01049360|584211505|FG015|Period 1|Withdrawal by Subject|0|||
161772898|NCT01049360|584211506|FG016|Period 1|Withdrawal by Subject|0|||
161772899|NCT01049360|584211507|FG017|Period 1|Withdrawal by Subject|0|||
161772900|NCT01049360|584211508|FG018|Period 1|Withdrawal by Subject|0|||
161772901|NCT01049360|584211509|FG019|Period 1|Withdrawal by Subject|0|||
162034679|NCT01547780|585183517|FG002|Baseline PET Scan|Physician Decision|1|||
161772902|NCT01049360|584211490|FG000|Period 2|Protocol Violation|0|||
161862513|NCT01074944|584538065|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
161862514|NCT01074944|584538066|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
162034680|NCT01547780|585183518|FG003|Baseline PET Scan|Physician Decision|0|||
161862515|NCT01074944|584538067|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
161862516|NCT01074944|584538068|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
161862517|NCT01074944|584538069|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
161862518|NCT01074944|584538065|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
161862519|NCT01074944|584538066|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
161862520|NCT01074944|584538067|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
161862521|NCT01074944|584538068|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
161862522|NCT01074944|584538069|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
161862523|NCT01074944|584538065|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
161862524|NCT01074944|584538066|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
161862525|NCT01074944|584538067|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
161862526|NCT01074944|584538068|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
161862527|NCT01074944|584538069|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
161862528|NCT01074944|584538065|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
161862529|NCT01074944|584538066|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
161862530|NCT01074944|584538067|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
161862531|NCT01074944|584538068|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
161862532|NCT01074944|584538069|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
161862533|NCT01074944|584538065|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
161862534|NCT01074944|584538066|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
161862535|NCT01074944|584538067|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
161862536|NCT01074944|584538068|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
161862537|NCT01074944|584538069|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
161862538|NCT01074944|584538065|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
161862539|NCT01074944|584538066|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
161862540|NCT01074944|584538067|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
161862541|NCT01074944|584538068|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
161862542|NCT01074944|584538069|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
161862543|NCT01074944|584538065|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
161862544|NCT01074944|584538066|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
161862545|NCT01074944|584538067|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
161862546|NCT01074944|584538068|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
161862547|NCT01074944|584538069|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
161862548|NCT01074944|584538065|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
161862549|NCT01074944|584538066|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
161862550|NCT01074944|584538067|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
161862551|NCT01074944|584538068|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
161862552|NCT01074944|584538069|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
161862553|NCT01074944|584538065|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
161862554|NCT01074944|584538066|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
161862555|NCT01074944|584538067|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
161862556|NCT01074944|584538068|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
161862557|NCT01074944|584538069|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
161862558|NCT01074944|584538065|FG000|Long Term Treatment|Adverse Event|0|||
161862559|NCT01074944|584538066|FG001|Long Term Treatment|Adverse Event|0|||
161862560|NCT01074944|584538067|FG002|Long Term Treatment|Adverse Event|0|||
161862561|NCT01074944|584538068|FG003|Long Term Treatment|Adverse Event|3|||
161862562|NCT01074944|584538069|FG004|Long Term Treatment|Adverse Event|0|||
161862563|NCT01074944|584538065|FG000|Long Term Treatment|Lost to Follow-up|0|||
161862564|NCT01074944|584538066|FG001|Long Term Treatment|Lost to Follow-up|0|||
161862565|NCT01074944|584538067|FG002|Long Term Treatment|Lost to Follow-up|0|||
161862566|NCT01074944|584538068|FG003|Long Term Treatment|Lost to Follow-up|2|||
161862567|NCT01074944|584538069|FG004|Long Term Treatment|Lost to Follow-up|0|||
161862568|NCT01074944|584538065|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
161862569|NCT01074944|584538066|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
161862570|NCT01074944|584538067|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
161862571|NCT01074944|584538068|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
161862572|NCT01074944|584538069|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
161862573|NCT01074944|584538065|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
161862574|NCT01074944|584538066|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
161862575|NCT01074944|584538067|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
161862576|NCT01074944|584538068|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
161862577|NCT01074944|584538069|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
161862578|NCT01074944|584538065|FG000|Long Term Treatment|Withdrawal by Subject|0|||
161862579|NCT01074944|584538066|FG001|Long Term Treatment|Withdrawal by Subject|0|||
161862580|NCT01074944|584538067|FG002|Long Term Treatment|Withdrawal by Subject|0|||
161862581|NCT01074944|584538068|FG003|Long Term Treatment|Withdrawal by Subject|2|||
161862582|NCT01074944|584538069|FG004|Long Term Treatment|Withdrawal by Subject|0|||
161862583|NCT01074944|584538065|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
161862584|NCT01074944|584538066|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
161862585|NCT01074944|584538067|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
161862586|NCT01074944|584538068|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
161862587|NCT01074944|584538069|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
161862588|NCT01074944|584538065|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
161862589|NCT01074944|584538066|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
161862590|NCT01074944|584538067|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
161862591|NCT01074944|584538068|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
161862592|NCT01074944|584538069|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
161862593|NCT03200717|584538075|FG000|Overall Study|Progressive disease|24|||
161862594|NCT03200717|584538076|FG001|Overall Study|Progressive disease|5|||
161862595|NCT03200717|584538075|FG000|Overall Study|Adverse Event|11|||
161862596|NCT03200717|584538076|FG001|Overall Study|Adverse Event|8|||
161862597|NCT03200717|584538075|FG000|Overall Study|Physician Decision|3|||
161862598|NCT03200717|584538076|FG001|Overall Study|Physician Decision|2|||
161862599|NCT03200717|584538075|FG000|Overall Study|Death|2|||
161862600|NCT03200717|584538076|FG001|Overall Study|Death|0|||
161862601|NCT03200717|584538075|FG000|Overall Study|Subject/Guardian Decision|1|||
161862602|NCT03200717|584538076|FG001|Overall Study|Subject/Guardian Decision|0|||
161862603|NCT01522456|584538077|FG000|Overall Study|Adverse Event|2|||
161862604|NCT01522456|584538077|FG000|Overall Study|Lost to Follow-up|2|||
161862605|NCT01522456|584538077|FG000|Overall Study|Withdrawal by Subject|2|||
161862606|NCT01522456|584538077|FG000|Overall Study|Pregnancy|1|||
161862607|NCT01522456|584538077|FG000|Overall Study|Tolerability Assessment|1|||
161862608|NCT02201784|584538078|FG000|Overall Study|Failure to achieve adequate block|2|||
161862609|NCT02201784|584538079|FG001|Overall Study|Failure to achieve adequate block|0|||
161862610|NCT02046603|584538080|FG000|Overall Study|Other|11|||
161862611|NCT02046603|584538081|FG001|Overall Study|Other|66|||
161862612|NCT02046603|584538080|FG000|Overall Study|Protocol Violation|0|||
161862613|NCT02046603|584538081|FG001|Overall Study|Protocol Violation|1|||
161862614|NCT02046603|584538080|FG000|Overall Study|Participant/legal guardian decision|1|||
161862615|NCT02046603|584538081|FG001|Overall Study|Participant/legal guardian decision|3|||
161862616|NCT02046603|584538080|FG000|Overall Study|Physician Decision|2|||
161862617|NCT02046603|584538081|FG001|Overall Study|Physician Decision|1|||
161862618|NCT02046603|584538080|FG000|Overall Study|Lost to Follow-up|1|||
161862619|NCT02046603|584538081|FG001|Overall Study|Lost to Follow-up|2|||
161862620|NCT02046603|584538080|FG000|Overall Study|Death|0|||
161862621|NCT02046603|584538081|FG001|Overall Study|Death|1|||
161862622|NCT02046603|584538080|FG000|Overall Study|Adverse Event|0|||
161862623|NCT02046603|584538081|FG001|Overall Study|Adverse Event|1|||
161862624|NCT02072980|584538082|FG000|Period 2, Second Wear|Adverse Event|0|||
161862625|NCT02072980|584538083|FG001|Period 2, Second Wear|Adverse Event|1|||
161862626|NCT02431364|584538084|FG000|Overall Study|Adverse Event|0|||
161862627|NCT02431364|584538085|FG001|Overall Study|Adverse Event|1|||
161862628|NCT02431364|584538086|FG002|Overall Study|Adverse Event|0|||
161862629|NCT02431364|584538087|FG003|Overall Study|Adverse Event|0|||
161862630|NCT02431364|584538088|FG004|Overall Study|Adverse Event|0|||
161862631|NCT02431364|584538084|FG000|Overall Study|Randomized but never treated|0|||
161862632|NCT02431364|584538085|FG001|Overall Study|Randomized but never treated|0|||
161862633|NCT02431364|584538086|FG002|Overall Study|Randomized but never treated|0|||
161862634|NCT02431364|584538087|FG003|Overall Study|Randomized but never treated|1|||
161862635|NCT02431364|584538088|FG004|Overall Study|Randomized but never treated|0|||
161862636|NCT00061932|584538089|FG000|Overall Study|Withdrawal by Subject|13|||
161862637|NCT00061932|584538090|FG001|Overall Study|Withdrawal by Subject|4|||
161862638|NCT04720105|584538093|FG000|Overall Study|Lack of Efficacy|1|||
161862639|NCT04720105|584538093|FG000|Overall Study|Lost to Follow-up|1|||
161862640|NCT04720105|584538093|FG000|Overall Study|Withdrawal by Subject|3|||
161862641|NCT00625820|584538095|FG000|Overall Study|Withdrawal by Subject|1|||
161862642|NCT02141438|584540183|FG000|Overall Study|Death|1308|||
161862643|NCT02141438|584540183|FG000|Overall Study|Lost to Follow-up|84|||
161862644|NCT02141438|584540183|FG000|Overall Study|Withdrawal by Subject|52|||
161977700|NCT05432167|584967379|FG001|Overall Study|Lost to Follow-up|3|||
161977701|NCT05432167|584967380|FG002|Overall Study|Lost to Follow-up|2|||
161977702|NCT05432167|584967378|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
161977703|NCT05432167|584967379|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
161977704|NCT05432167|584967380|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
161977705|NCT05432167|584967378|FG000|Overall Study|Physician Decision|1|||
161977706|NCT05432167|584967379|FG001|Overall Study|Physician Decision|0|||
161977707|NCT05432167|584967380|FG002|Overall Study|Physician Decision|0|||
161862645|NCT02141438|584540183|FG000|Overall Study|Physician Decision|1|||
161862646|NCT02141438|584540183|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
161862647|NCT02546986|584540186|FG000|Treatment Period|Progressive Disease|20|||
161977708|NCT05432167|584967378|FG000|Overall Study|Withdrawal by Subject|7|||
161772903|NCT01049360|584211491|FG001|Period 2|Protocol Violation|0|||
161772904|NCT01049360|584211492|FG002|Period 2|Protocol Violation|0|||
161772905|NCT01049360|584211493|FG003|Period 2|Protocol Violation|1|||
161772906|NCT01049360|584211494|FG004|Period 2|Protocol Violation|0|||
161772907|NCT01049360|584211495|FG005|Period 2|Protocol Violation|0|||
161772908|NCT01049360|584211496|FG006|Period 2|Protocol Violation|0|||
161772909|NCT01049360|584211497|FG007|Period 2|Protocol Violation|0|||
161772910|NCT01049360|584211498|FG008|Period 2|Protocol Violation|0|||
161772911|NCT01049360|584211499|FG009|Period 2|Protocol Violation|0|||
161772912|NCT01049360|584211500|FG010|Period 2|Protocol Violation|0|||
161772913|NCT01049360|584211501|FG011|Period 2|Protocol Violation|0|||
161772914|NCT01049360|584211502|FG012|Period 2|Protocol Violation|0|||
161772915|NCT01049360|584211503|FG013|Period 2|Protocol Violation|0|||
161772916|NCT01049360|584211504|FG014|Period 2|Protocol Violation|1|||
161772917|NCT01049360|584211505|FG015|Period 2|Protocol Violation|1|||
161772918|NCT01049360|584211506|FG016|Period 2|Protocol Violation|0|||
161772919|NCT01049360|584211507|FG017|Period 2|Protocol Violation|0|||
161772920|NCT01049360|584211508|FG018|Period 2|Protocol Violation|0|||
161772921|NCT01049360|584211509|FG019|Period 2|Protocol Violation|0|||
161772922|NCT01049360|584211490|FG000|Period 2|Adverse Event|0|||
161772923|NCT01049360|584211491|FG001|Period 2|Adverse Event|1|||
161772924|NCT01049360|584211492|FG002|Period 2|Adverse Event|0|||
161772925|NCT01049360|584211493|FG003|Period 2|Adverse Event|0|||
161772926|NCT01049360|584211494|FG004|Period 2|Adverse Event|0|||
161772927|NCT01049360|584211495|FG005|Period 2|Adverse Event|0|||
161772928|NCT01049360|584211496|FG006|Period 2|Adverse Event|0|||
161772929|NCT01049360|584211497|FG007|Period 2|Adverse Event|0|||
161772930|NCT01049360|584211498|FG008|Period 2|Adverse Event|1|||
161772931|NCT01049360|584211499|FG009|Period 2|Adverse Event|0|||
161772932|NCT01049360|584211500|FG010|Period 2|Adverse Event|0|||
161772933|NCT01049360|584211501|FG011|Period 2|Adverse Event|0|||
161772934|NCT01049360|584211502|FG012|Period 2|Adverse Event|0|||
161772935|NCT01049360|584211503|FG013|Period 2|Adverse Event|0|||
161772936|NCT01049360|584211504|FG014|Period 2|Adverse Event|0|||
161772937|NCT01049360|584211505|FG015|Period 2|Adverse Event|0|||
161772938|NCT01049360|584211506|FG016|Period 2|Adverse Event|0|||
161772939|NCT01049360|584211507|FG017|Period 2|Adverse Event|0|||
161772940|NCT01049360|584211508|FG018|Period 2|Adverse Event|0|||
161772941|NCT01049360|584211509|FG019|Period 2|Adverse Event|1|||
161772942|NCT01049360|584211490|FG000|Period 2|Withdrawal by Subject|0|||
161772943|NCT01049360|584211491|FG001|Period 2|Withdrawal by Subject|0|||
161772944|NCT01049360|584211492|FG002|Period 2|Withdrawal by Subject|0|||
161772945|NCT01049360|584211493|FG003|Period 2|Withdrawal by Subject|1|||
161772946|NCT01049360|584211494|FG004|Period 2|Withdrawal by Subject|0|||
161772947|NCT01049360|584211495|FG005|Period 2|Withdrawal by Subject|0|||
161772948|NCT01049360|584211496|FG006|Period 2|Withdrawal by Subject|0|||
161772949|NCT01049360|584211497|FG007|Period 2|Withdrawal by Subject|0|||
161772950|NCT01049360|584211498|FG008|Period 2|Withdrawal by Subject|0|||
161772951|NCT01049360|584211499|FG009|Period 2|Withdrawal by Subject|0|||
161772952|NCT01049360|584211500|FG010|Period 2|Withdrawal by Subject|0|||
161772953|NCT01049360|584211501|FG011|Period 2|Withdrawal by Subject|0|||
161772954|NCT01049360|584211502|FG012|Period 2|Withdrawal by Subject|0|||
161772955|NCT01049360|584211503|FG013|Period 2|Withdrawal by Subject|0|||
161772956|NCT01049360|584211504|FG014|Period 2|Withdrawal by Subject|1|||
161772957|NCT01049360|584211505|FG015|Period 2|Withdrawal by Subject|0|||
161772958|NCT01049360|584211506|FG016|Period 2|Withdrawal by Subject|0|||
161772959|NCT01049360|584211507|FG017|Period 2|Withdrawal by Subject|0|||
161772960|NCT01049360|584211508|FG018|Period 2|Withdrawal by Subject|0|||
161772961|NCT01049360|584211509|FG019|Period 2|Withdrawal by Subject|1|||
161772962|NCT01049360|584211490|FG000|Period 2|Lack of Efficacy|0|||
161772963|NCT01049360|584211491|FG001|Period 2|Lack of Efficacy|0|||
161772964|NCT01049360|584211492|FG002|Period 2|Lack of Efficacy|0|||
161772965|NCT01049360|584211493|FG003|Period 2|Lack of Efficacy|0|||
161772966|NCT01049360|584211494|FG004|Period 2|Lack of Efficacy|0|||
161772967|NCT01049360|584211495|FG005|Period 2|Lack of Efficacy|1|||
161772968|NCT01049360|584211496|FG006|Period 2|Lack of Efficacy|0|||
161772969|NCT01049360|584211497|FG007|Period 2|Lack of Efficacy|0|||
161772970|NCT01049360|584211498|FG008|Period 2|Lack of Efficacy|0|||
161772971|NCT01049360|584211499|FG009|Period 2|Lack of Efficacy|0|||
161862648|NCT02546986|584540187|FG001|Treatment Period|Progressive Disease|22|||
161862649|NCT02546986|584540186|FG000|Treatment Period|Adverse Event|14|||
161772972|NCT01049360|584211500|FG010|Period 2|Lack of Efficacy|0|||
161772973|NCT01049360|584211501|FG011|Period 2|Lack of Efficacy|0|||
161772974|NCT01049360|584211502|FG012|Period 2|Lack of Efficacy|0|||
161772975|NCT01049360|584211503|FG013|Period 2|Lack of Efficacy|0|||
161772976|NCT01049360|584211504|FG014|Period 2|Lack of Efficacy|0|||
161772977|NCT01049360|584211505|FG015|Period 2|Lack of Efficacy|0|||
161772978|NCT01049360|584211506|FG016|Period 2|Lack of Efficacy|0|||
161772979|NCT01049360|584211507|FG017|Period 2|Lack of Efficacy|0|||
161772980|NCT01049360|584211508|FG018|Period 2|Lack of Efficacy|0|||
161772981|NCT01049360|584211509|FG019|Period 2|Lack of Efficacy|0|||
161772982|NCT01049360|584211490|FG000|Period 4|Protocol Violation|0|||
161772983|NCT01049360|584211491|FG001|Period 4|Protocol Violation|0|||
161772984|NCT01049360|584211492|FG002|Period 4|Protocol Violation|0|||
161862650|NCT02546986|584540187|FG001|Treatment Period|Adverse Event|6|||
161862651|NCT02546986|584540186|FG000|Treatment Period|Symptomatic Deterioration|4|||
161862652|NCT02546986|584540187|FG001|Treatment Period|Symptomatic Deterioration|3|||
161862653|NCT02546986|584540186|FG000|Treatment Period|Death|3|||
161862654|NCT02546986|584540187|FG001|Treatment Period|Death|4|||
161862655|NCT02546986|584540186|FG000|Treatment Period|Physician Decision|1|||
161862656|NCT02546986|584540187|FG001|Treatment Period|Physician Decision|2|||
161862657|NCT02546986|584540186|FG000|Treatment Period|Protocol Violation|1|||
161862658|NCT02546986|584540187|FG001|Treatment Period|Protocol Violation|0|||
161862659|NCT02546986|584540186|FG000|Treatment Period|Withdrawal by Subject|1|||
161862660|NCT02546986|584540187|FG001|Treatment Period|Withdrawal by Subject|1|||
161862661|NCT02546986|584540186|FG000|Treatment Period|Non-compliance with Study Drug|0|||
161862662|NCT02546986|584540187|FG001|Treatment Period|Non-compliance with Study Drug|1|||
161862663|NCT02546986|584540186|FG000|Treatment Period|Study Terminated by Sponsor|0|||
161862664|NCT02546986|584540187|FG001|Treatment Period|Study Terminated by Sponsor|1|||
161862665|NCT02546986|584540186|FG000|Treatment Period|Miscellaneous|7|||
161862666|NCT02546986|584540187|FG001|Treatment Period|Miscellaneous|9|||
161862667|NCT02546986|584540186|FG000|Survival Follow-Up Phase|Missing Status|3|||
161862668|NCT02546986|584540187|FG001|Survival Follow-Up Phase|Missing Status|5|||
161862669|NCT02546986|584540186|FG000|Survival Follow-Up Phase|Death|18|||
161862670|NCT02546986|584540187|FG001|Survival Follow-Up Phase|Death|12|||
161862671|NCT02546986|584540186|FG000|Survival Follow-Up Phase|Alive|13|||
161862672|NCT02546986|584540187|FG001|Survival Follow-Up Phase|Alive|16|||
161862673|NCT02546986|584540186|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
161862674|NCT02546986|584540187|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
161862675|NCT04021914|584540190|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
161862676|NCT02844543|584540194|FG000|Overall Study|Withdrawal by Subject|4|||
161862677|NCT02844543|584540194|FG000|Overall Study|Did not meet eligibility criteria|1|||
161862678|NCT03349060|584540195|FG000|Overall Study|Adverse Event|9|||
161862679|NCT03349060|584540196|FG001|Overall Study|Adverse Event|9|||
161862680|NCT03349060|584540197|FG002|Overall Study|Adverse Event|7|||
161862681|NCT03349060|584540195|FG000|Overall Study|Lack of Efficacy|1|||
161862682|NCT03349060|584540196|FG001|Overall Study|Lack of Efficacy|0|||
161862683|NCT03349060|584540197|FG002|Overall Study|Lack of Efficacy|2|||
161862684|NCT03349060|584540195|FG000|Overall Study|Lost to Follow-up|2|||
161862685|NCT03349060|584540196|FG001|Overall Study|Lost to Follow-up|1|||
161862686|NCT03349060|584540197|FG002|Overall Study|Lost to Follow-up|1|||
161862687|NCT03349060|584540195|FG000|Overall Study|Protocol Violation|2|||
161862688|NCT03349060|584540196|FG001|Overall Study|Protocol Violation|2|||
161862689|NCT03349060|584540197|FG002|Overall Study|Protocol Violation|1|||
161862690|NCT03349060|584540195|FG000|Overall Study|Withdrawal by Subject|5|||
161862691|NCT03349060|584540196|FG001|Overall Study|Withdrawal by Subject|3|||
161862692|NCT03349060|584540197|FG002|Overall Study|Withdrawal by Subject|4|||
161862693|NCT03349060|584540195|FG000|Overall Study|Medication error,no linked adverse event|0|||
161862694|NCT03349060|584540196|FG001|Overall Study|Medication error,no linked adverse event|0|||
161862695|NCT03349060|584540197|FG002|Overall Study|Medication error,no linked adverse event|1|||
161862696|NCT03349060|584540195|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161862697|NCT03349060|584540196|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
161862698|NCT03349060|584540197|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
161862699|NCT03349060|584540195|FG000|Overall Study|Other|2|||
161862700|NCT03349060|584540196|FG001|Overall Study|Other|1|||
161862701|NCT03349060|584540197|FG002|Overall Study|Other|0|||
161862702|NCT02861586|584540198|FG000|Overall Study|Withdrawal by Subject|1|||
161862703|NCT02861586|584540199|FG001|Overall Study|Withdrawal by Subject|2|||
161862704|NCT02861586|584540200|FG002|Overall Study|Withdrawal by Subject|0|||
161862705|NCT02861586|584540201|FG003|Overall Study|Withdrawal by Subject|0|||
161862706|NCT02861586|584540202|FG004|Overall Study|Withdrawal by Subject|0|||
161862707|NCT02861586|584540203|FG005|Overall Study|Withdrawal by Subject|1|||
161862708|NCT02861586|584540204|FG006|Overall Study|Withdrawal by Subject|1|||
161862709|NCT02861586|584540205|FG007|Overall Study|Withdrawal by Subject|0|||
161862710|NCT02861586|584540198|FG000|Overall Study|Lost to Follow-up|3|||
161862711|NCT02861586|584540199|FG001|Overall Study|Lost to Follow-up|1|||
161862712|NCT02861586|584540200|FG002|Overall Study|Lost to Follow-up|1|||
161862713|NCT02861586|584540201|FG003|Overall Study|Lost to Follow-up|0|||
161862714|NCT02861586|584540202|FG004|Overall Study|Lost to Follow-up|0|||
161862715|NCT02861586|584540203|FG005|Overall Study|Lost to Follow-up|3|||
161862716|NCT02861586|584540204|FG006|Overall Study|Lost to Follow-up|0|||
161862717|NCT02861586|584540205|FG007|Overall Study|Lost to Follow-up|0|||
161862718|NCT02861586|584540198|FG000|Overall Study|Adverse Event|0|||
161862719|NCT02861586|584540199|FG001|Overall Study|Adverse Event|0|||
161862720|NCT02861586|584540200|FG002|Overall Study|Adverse Event|0|||
161862721|NCT02861586|584540201|FG003|Overall Study|Adverse Event|0|||
161862722|NCT02861586|584540202|FG004|Overall Study|Adverse Event|0|||
161862723|NCT02861586|584540203|FG005|Overall Study|Adverse Event|1|||
161862724|NCT02861586|584540204|FG006|Overall Study|Adverse Event|0|||
161862725|NCT02861586|584540205|FG007|Overall Study|Adverse Event|0|||
161862726|NCT00803790|584540206|FG000|Period 1|Adverse Event|0|||
162034681|NCT01547780|585183515|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
161772985|NCT01049360|584211493|FG003|Period 4|Protocol Violation|0|||
161772986|NCT01049360|584211494|FG004|Period 4|Protocol Violation|0|||
161772987|NCT01049360|584211495|FG005|Period 4|Protocol Violation|0|||
161772988|NCT01049360|584211496|FG006|Period 4|Protocol Violation|0|||
161772989|NCT01049360|584211497|FG007|Period 4|Protocol Violation|0|||
161772990|NCT01049360|584211498|FG008|Period 4|Protocol Violation|0|||
161772991|NCT01049360|584211499|FG009|Period 4|Protocol Violation|0|||
161772992|NCT01049360|584211500|FG010|Period 4|Protocol Violation|0|||
161772993|NCT01049360|584211501|FG011|Period 4|Protocol Violation|0|||
161772994|NCT01049360|584211502|FG012|Period 4|Protocol Violation|0|||
161772995|NCT01049360|584211503|FG013|Period 4|Protocol Violation|0|||
161772996|NCT01049360|584211504|FG014|Period 4|Protocol Violation|0|||
161772997|NCT01049360|584211505|FG015|Period 4|Protocol Violation|0|||
161772998|NCT01049360|584211506|FG016|Period 4|Protocol Violation|0|||
161772999|NCT01049360|584211507|FG017|Period 4|Protocol Violation|1|||
161773000|NCT01049360|584211508|FG018|Period 4|Protocol Violation|0|||
161773001|NCT01049360|584211509|FG019|Period 4|Protocol Violation|0|||
161773002|NCT01049360|584211490|FG000|Period 4|Withdrawal by Subject|0|||
161773003|NCT01049360|584211491|FG001|Period 4|Withdrawal by Subject|0|||
161773004|NCT01049360|584211492|FG002|Period 4|Withdrawal by Subject|0|||
161773005|NCT01049360|584211493|FG003|Period 4|Withdrawal by Subject|1|||
161773006|NCT01049360|584211494|FG004|Period 4|Withdrawal by Subject|0|||
161773007|NCT01049360|584211495|FG005|Period 4|Withdrawal by Subject|0|||
161773008|NCT01049360|584211496|FG006|Period 4|Withdrawal by Subject|0|||
161773009|NCT01049360|584211497|FG007|Period 4|Withdrawal by Subject|0|||
161773010|NCT01049360|584211498|FG008|Period 4|Withdrawal by Subject|0|||
161773011|NCT01049360|584211499|FG009|Period 4|Withdrawal by Subject|0|||
161773012|NCT01049360|584211500|FG010|Period 4|Withdrawal by Subject|0|||
161773013|NCT01049360|584211501|FG011|Period 4|Withdrawal by Subject|0|||
161773014|NCT01049360|584211502|FG012|Period 4|Withdrawal by Subject|0|||
161773015|NCT01049360|584211503|FG013|Period 4|Withdrawal by Subject|0|||
161773016|NCT01049360|584211504|FG014|Period 4|Withdrawal by Subject|0|||
161773017|NCT01049360|584211505|FG015|Period 4|Withdrawal by Subject|0|||
161773018|NCT01049360|584211506|FG016|Period 4|Withdrawal by Subject|0|||
161773019|NCT01049360|584211507|FG017|Period 4|Withdrawal by Subject|0|||
161773020|NCT01049360|584211508|FG018|Period 4|Withdrawal by Subject|0|||
161773021|NCT01049360|584211509|FG019|Period 4|Withdrawal by Subject|0|||
161773022|NCT05147311|584211512|FG000|Overall Study|Did not complete survey|2|||
161773023|NCT05147311|584211513|FG001|Overall Study|Did not complete survey|1|||
161773024|NCT05147311|584211512|FG000|Overall Study|Patient too sick|1|||
161773025|NCT05147311|584211513|FG001|Overall Study|Patient too sick|2|||
161773026|NCT05147311|584211512|FG000|Overall Study|Death|0|||
161773027|NCT05147311|584211513|FG001|Overall Study|Death|1|||
161773028|NCT05147311|584211512|FG000|Overall Study|Declined survey|1|||
161773029|NCT05147311|584211513|FG001|Overall Study|Declined survey|0|||
161773030|NCT00402298|584211529|FG000|Overall Study|Withdrawal by Subject|1|||
161773031|NCT00402298|584211530|FG001|Overall Study|Withdrawal by Subject|0|||
161773032|NCT00480077|584211531|FG000|Overall Study|Death|19|||
161773033|NCT00480077|584211532|FG001|Overall Study|Death|15|||
161773034|NCT00480077|584211531|FG000|Overall Study|early exit|12|||
161773035|NCT00480077|584211532|FG001|Overall Study|early exit|11|||
161773036|NCT00262119|584211535|FG000|Overall Study|Lost to Follow-up|38|||
161773037|NCT00262119|584211536|FG001|Overall Study|Lost to Follow-up|51|||
161773038|NCT00262119|584211537|FG002|Overall Study|Lost to Follow-up|42|||
161773039|NCT00262119|584211535|FG000|Overall Study|Death|20|||
161773040|NCT00262119|584211536|FG001|Overall Study|Death|19|||
161773041|NCT00262119|584211537|FG002|Overall Study|Death|16|||
161773042|NCT00071006|584211538|FG000|Overall Study|Lack of Efficacy|7|||
161773043|NCT00071006|584211538|FG000|Overall Study|Adverse Event|1|||
161773044|NCT00071006|584211538|FG000|Overall Study|Withdrawal by Subject|1|||
161773045|NCT00071006|584211538|FG000|Overall Study|Other|3|||
161773046|NCT00938366|584211540|FG000|Overall Study|Withdrawal by Subject|1|||
161773047|NCT00938366|584211541|FG001|Overall Study|Withdrawal by Subject|0|||
161773048|NCT01215968|584211542|FG000|Overall Study|Adverse Event|0|||
161773049|NCT01215968|584211543|FG001|Overall Study|Adverse Event|2|||
161773050|NCT01215968|584211542|FG000|Overall Study|Protocol Violation|2|||
161773051|NCT01215968|584211543|FG001|Overall Study|Protocol Violation|4|||
161773052|NCT01215968|584211542|FG000|Overall Study|Not received study drug|0|||
161773053|NCT01215968|584211543|FG001|Overall Study|Not received study drug|1|||
161773054|NCT05966129|584211544|FG000|Overall Study|Death|1|||
161773055|NCT05966129|584211545|FG001|Overall Study|Death|2|||
161773056|NCT05966129|584211544|FG000|Overall Study|Lost to Follow-up|63|||
161773057|NCT05966129|584211545|FG001|Overall Study|Lost to Follow-up|66|||
161773058|NCT05966129|584211544|FG000|Overall Study|Protocol Violation|1|||
161773059|NCT05966129|584211545|FG001|Overall Study|Protocol Violation|0|||
161773060|NCT05966129|584211544|FG000|Overall Study|Withdrawal by Subject|26|||
161773061|NCT05966129|584211545|FG001|Overall Study|Withdrawal by Subject|25|||
161773062|NCT05966129|584211544|FG000|Overall Study|Surgery not completed|63|||
161773063|NCT05966129|584211545|FG001|Overall Study|Surgery not completed|69|||
161862727|NCT00803790|584540207|FG001|Period 1|Adverse Event|1|||
161862728|NCT00803790|584540208|FG002|Period 1|Adverse Event|0|||
161862729|NCT00803790|584540209|FG003|Period 1|Adverse Event|0|||
161862730|NCT00803790|584540206|FG000|Period 1|Lost to Follow-up|1|||
161862731|NCT00803790|584540207|FG001|Period 1|Lost to Follow-up|2|||
161862732|NCT00803790|584540208|FG002|Period 1|Lost to Follow-up|0|||
161862733|NCT00803790|584540209|FG003|Period 1|Lost to Follow-up|0|||
161862734|NCT00803790|584540206|FG000|Period 1|Withdrawal by Subject|8|||
161862735|NCT00803790|584540207|FG001|Period 1|Withdrawal by Subject|6|||
161862736|NCT00803790|584540208|FG002|Period 1|Withdrawal by Subject|0|||
161862737|NCT00803790|584540209|FG003|Period 1|Withdrawal by Subject|0|||
161862738|NCT00803790|584540206|FG000|Period 1|positive drug screen or personal reasons|0|||
161862739|NCT00803790|584540207|FG001|Period 1|positive drug screen or personal reasons|3|||
161862740|NCT00803790|584540208|FG002|Period 1|positive drug screen or personal reasons|0|||
161862741|NCT00803790|584540209|FG003|Period 1|positive drug screen or personal reasons|4|||
161862742|NCT00803790|584540206|FG000|Period 1|Protocol Violation|0|||
161862743|NCT00803790|584540207|FG001|Period 1|Protocol Violation|0|||
161862744|NCT00803790|584540208|FG002|Period 1|Protocol Violation|1|||
161862745|NCT00803790|584540209|FG003|Period 1|Protocol Violation|0|||
161862746|NCT00803790|584540206|FG000|Period 2|Adverse Event|0|||
161862747|NCT00803790|584540207|FG001|Period 2|Adverse Event|0|||
161862748|NCT00803790|584540208|FG002|Period 2|Adverse Event|1|||
161862749|NCT00803790|584540209|FG003|Period 2|Adverse Event|1|||
161862750|NCT00803790|584540206|FG000|Period 2|Withdrawal by Subject|1|||
161862751|NCT00803790|584540207|FG001|Period 2|Withdrawal by Subject|0|||
161862752|NCT00803790|584540208|FG002|Period 2|Withdrawal by Subject|0|||
161862753|NCT00803790|584540209|FG003|Period 2|Withdrawal by Subject|0|||
161862754|NCT00803790|584540206|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
161862755|NCT00803790|584540207|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
161862756|NCT00803790|584540208|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
161862757|NCT00803790|584540209|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
161862758|NCT04710576|584540210|FG000|Overall Study|Participants still in the study|73|||
161862759|NCT04710576|584540211|FG001|Overall Study|Participants still in the study|70|||
161862760|NCT04710576|584540212|FG002|Overall Study|Participants still in the study|60|||
161862761|NCT04710576|584540210|FG000|Overall Study|Death|2|||
161862762|NCT04710576|584540211|FG001|Overall Study|Death|7|||
161862763|NCT04710576|584540212|FG002|Overall Study|Death|12|||
161862764|NCT04710576|584540210|FG000|Overall Study|Withdrawal by Subject|4|||
161862765|NCT04710576|584540211|FG001|Overall Study|Withdrawal by Subject|3|||
161862766|NCT04710576|584540212|FG002|Overall Study|Withdrawal by Subject|7|||
161862767|NCT04710576|584540210|FG000|Overall Study|Sponsor decision|1|||
161862768|NCT04710576|584540211|FG001|Overall Study|Sponsor decision|0|||
161862769|NCT04710576|584540212|FG002|Overall Study|Sponsor decision|0|||
161862770|NCT04796909|584540213|FG000|Overall Study|Withdrawal by Subject|1|||
161862771|NCT04796909|584540214|FG001|Overall Study|Withdrawal by Subject|1|||
161862772|NCT00437021|584540215|FG000|Overall Study|Adverse Event|0|||
161862773|NCT00437021|584540216|FG001|Overall Study|Adverse Event|0|||
161862774|NCT00437021|584540217|FG002|Overall Study|Adverse Event|0|||
161862775|NCT00437021|584540218|FG003|Overall Study|Adverse Event|0|||
161862776|NCT00437021|584540219|FG004|Overall Study|Adverse Event|0|||
161862777|NCT00437021|584540220|FG005|Overall Study|Adverse Event|0|||
161862778|NCT00437021|584540221|FG006|Overall Study|Adverse Event|1|||
161862779|NCT00437021|584540222|FG007|Overall Study|Adverse Event|0|||
161862780|NCT00437021|584540223|FG008|Overall Study|Adverse Event|0|||
161862781|NCT00437021|584540224|FG009|Overall Study|Adverse Event|0|||
161862782|NCT00437021|584540225|FG010|Overall Study|Adverse Event|0|||
161862783|NCT00437021|584540226|FG011|Overall Study|Adverse Event|0|||
161862784|NCT00437021|584540215|FG000|Overall Study|Lost to Follow-up|0|||
161862785|NCT00437021|584540216|FG001|Overall Study|Lost to Follow-up|3|||
161862786|NCT00437021|584540217|FG002|Overall Study|Lost to Follow-up|0|||
161862787|NCT00437021|584540218|FG003|Overall Study|Lost to Follow-up|0|||
161862788|NCT00437021|584540219|FG004|Overall Study|Lost to Follow-up|0|||
161862789|NCT00437021|584540220|FG005|Overall Study|Lost to Follow-up|2|||
161862790|NCT00437021|584540221|FG006|Overall Study|Lost to Follow-up|0|||
161862791|NCT00437021|584540222|FG007|Overall Study|Lost to Follow-up|1|||
161862792|NCT00437021|584540223|FG008|Overall Study|Lost to Follow-up|0|||
161862793|NCT00437021|584540224|FG009|Overall Study|Lost to Follow-up|0|||
161862794|NCT00437021|584540225|FG010|Overall Study|Lost to Follow-up|0|||
161862795|NCT00437021|584540226|FG011|Overall Study|Lost to Follow-up|0|||
161862796|NCT00437021|584540215|FG000|Overall Study|Withdrawal by Subject|2|||
161862797|NCT00437021|584540216|FG001|Overall Study|Withdrawal by Subject|1|||
161862798|NCT00437021|584540217|FG002|Overall Study|Withdrawal by Subject|0|||
161862799|NCT00437021|584540218|FG003|Overall Study|Withdrawal by Subject|0|||
161862800|NCT00437021|584540219|FG004|Overall Study|Withdrawal by Subject|0|||
161862801|NCT00437021|584540220|FG005|Overall Study|Withdrawal by Subject|0|||
161862802|NCT00437021|584540221|FG006|Overall Study|Withdrawal by Subject|0|||
161862803|NCT00437021|584540222|FG007|Overall Study|Withdrawal by Subject|0|||
161862804|NCT00437021|584540223|FG008|Overall Study|Withdrawal by Subject|0|||
161862805|NCT00437021|584540224|FG009|Overall Study|Withdrawal by Subject|0|||
161862806|NCT00437021|584540225|FG010|Overall Study|Withdrawal by Subject|0|||
161862807|NCT00437021|584540226|FG011|Overall Study|Withdrawal by Subject|0|||
161862808|NCT04162847|584540227|FG000|Overall Study|Withdrawal by Subject|7|||
161862809|NCT04162847|584540228|FG001|Overall Study|Withdrawal by Subject|1|||
161862810|NCT03985800|584540229|FG000|Overall Study|Death|1|||
161862811|NCT03985800|584540230|FG001|Overall Study|Death|2|||
161862812|NCT03985800|584540229|FG000|Overall Study|Withdrawal by Subject|3|||
161862813|NCT03985800|584540230|FG001|Overall Study|Withdrawal by Subject|6|||
161862814|NCT03985800|584540229|FG000|Overall Study|Protocol Violation|2|||
161862815|NCT03985800|584540230|FG001|Overall Study|Protocol Violation|0|||
161862816|NCT05258773|584540231|FG000|Overall Study|Screen Failure|1|||
161862817|NCT05258773|584540232|FG001|Overall Study|Screen Failure|1|||
161862818|NCT05258773|584540231|FG000|Overall Study|Adverse Event|1|||
161862819|NCT05258773|584540232|FG001|Overall Study|Adverse Event|0|||
161862820|NCT05258773|584540231|FG000|Overall Study|Withdrawal by Subject|0|||
161862821|NCT05258773|584540232|FG001|Overall Study|Withdrawal by Subject|1|||
161862822|NCT03018288|584540235|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
161862823|NCT03018288|584540236|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
161862824|NCT03018288|584540237|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
161862825|NCT03018288|584540238|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
161862826|NCT03018288|584540235|FG000|Overall Study|Participant withdrew consent.|0|||
161862827|NCT03018288|584540236|FG001|Overall Study|Participant withdrew consent.|0|||
161862828|NCT03018288|584540237|FG002|Overall Study|Participant withdrew consent.|1|||
161862829|NCT03018288|584540238|FG003|Overall Study|Participant withdrew consent.|0|||
161862830|NCT03018288|584540235|FG000|Overall Study|Switched to alternative treatment.|0|||
161862831|NCT03018288|584540236|FG001|Overall Study|Switched to alternative treatment.|0|||
161862832|NCT03018288|584540237|FG002|Overall Study|Switched to alternative treatment.|1|||
161862833|NCT03018288|584540238|FG003|Overall Study|Switched to alternative treatment.|0|||
161862834|NCT03018288|584540235|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
161862835|NCT03018288|584540236|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
161862836|NCT03018288|584540237|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
161862837|NCT03018288|584540238|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
161862838|NCT03018288|584540235|FG000|Overall Study|Screen failures|0|||
161862839|NCT03018288|584540236|FG001|Overall Study|Screen failures|0|||
161862840|NCT03018288|584540237|FG002|Overall Study|Screen failures|0|||
161862841|NCT03018288|584540238|FG003|Overall Study|Screen failures|51|||
161862842|NCT03018288|584540235|FG000|Overall Study|Chose treatment outside of UNC|0|||
161862843|NCT03018288|584540236|FG001|Overall Study|Chose treatment outside of UNC|0|||
161862844|NCT03018288|584540237|FG002|Overall Study|Chose treatment outside of UNC|0|||
161862845|NCT03018288|584540238|FG003|Overall Study|Chose treatment outside of UNC|1|||
161862846|NCT03018288|584540235|FG000|Overall Study|Unable to comply with protocol requirements|1|||
161862847|NCT03018288|584540236|FG001|Overall Study|Unable to comply with protocol requirements|1|||
161862848|NCT03018288|584540237|FG002|Overall Study|Unable to comply with protocol requirements|0|||
161862849|NCT03018288|584540238|FG003|Overall Study|Unable to comply with protocol requirements|1|||
161862850|NCT03018288|584540235|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
161862851|NCT03018288|584540236|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
161862852|NCT03018288|584540237|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
161862853|NCT03018288|584540238|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
161862854|NCT03018288|584540235|FG000|Overall Study|Physician Decision|0|||
161862855|NCT03018288|584540236|FG001|Overall Study|Physician Decision|0|||
161862856|NCT03018288|584540237|FG002|Overall Study|Physician Decision|0|||
161862857|NCT03018288|584540238|FG003|Overall Study|Physician Decision|1|||
161862858|NCT05573464|584540239|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
161862859|NCT05573464|584540240|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
161862860|NCT05573464|584540239|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
161862861|NCT05573464|584540240|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
161862862|NCT05573464|584540239|FG000|12-week Treatment Period|Protocol Violation|3|||
161862863|NCT05573464|584540240|FG001|12-week Treatment Period|Protocol Violation|1|||
161862864|NCT05573464|584540239|FG000|12-week Treatment Period|Physician Decision|1|||
161862865|NCT05573464|584540240|FG001|12-week Treatment Period|Physician Decision|2|||
161862866|NCT05573464|584540239|FG000|12-week Treatment Period|Lost to Follow-up|2|||
161862867|NCT05573464|584540240|FG001|12-week Treatment Period|Lost to Follow-up|0|||
161862868|NCT05573464|584540239|FG000|12-week Treatment Period|Adverse Event|20|||
161862869|NCT05573464|584540240|FG001|12-week Treatment Period|Adverse Event|9|||
161862870|NCT05573464|584540239|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
161977709|NCT05432167|584967379|FG001|Overall Study|Withdrawal by Subject|4|||
161977710|NCT05432167|584967380|FG002|Overall Study|Withdrawal by Subject|11|||
161862871|NCT05573464|584540240|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
161977711|NCT05432167|584967378|FG000|Overall Study|Other|0|||
161862872|NCT05573464|584540239|FG000|12-week Treatment Period|Randomised, not treated|0|||
161977712|NCT05432167|584967379|FG001|Overall Study|Other|0|||
161773064|NCT05966129|584211544|FG000|Overall Study|Surgery logistics issue|2|||
161773065|NCT05966129|584211545|FG001|Overall Study|Surgery logistics issue|1|||
161773066|NCT05182840|584211546|FG000|Run-in Period|Not treated|0|||
161773067|NCT05182840|584211547|FG001|Run-in Period|Not treated|1|||
161773068|NCT05182840|584211548|FG002|Run-in Period|Not treated|0|||
161773069|NCT05182840|584211549|FG003|Run-in Period|Not treated|0|||
161773070|NCT05182840|584211550|FG004|Run-in Period|Not treated|0|||
161773071|NCT05182840|584211551|FG005|Run-in Period|Not treated|0|||
161773072|NCT05182840|584211552|FG006|Run-in Period|Not treated|0|||
161773073|NCT05182840|584211553|FG007|Run-in Period|Not treated|0|||
161773074|NCT05182840|584211554|FG008|Run-in Period|Not treated|0|||
161773075|NCT05182840|584211555|FG009|Run-in Period|Not treated|0|||
161773076|NCT05182840|584211546|FG000|Run-in Period|Other reason but not sponsor termination|14|||
161773077|NCT05182840|584211547|FG001|Run-in Period|Other reason but not sponsor termination|18|||
161773078|NCT05182840|584211548|FG002|Run-in Period|Other reason but not sponsor termination|0|||
161773079|NCT05182840|584211549|FG003|Run-in Period|Other reason but not sponsor termination|0|||
161773080|NCT05182840|584211550|FG004|Run-in Period|Other reason but not sponsor termination|0|||
161773081|NCT05182840|584211551|FG005|Run-in Period|Other reason but not sponsor termination|0|||
161773082|NCT05182840|584211552|FG006|Run-in Period|Other reason but not sponsor termination|0|||
161773083|NCT05182840|584211553|FG007|Run-in Period|Other reason but not sponsor termination|0|||
161773084|NCT05182840|584211554|FG008|Run-in Period|Other reason but not sponsor termination|0|||
161773085|NCT05182840|584211555|FG009|Run-in Period|Other reason but not sponsor termination|0|||
161773086|NCT05182840|584211546|FG000|Run-in Period|No reason available|2|||
161773087|NCT05182840|584211547|FG001|Run-in Period|No reason available|2|||
161773088|NCT05182840|584211548|FG002|Run-in Period|No reason available|0|||
161773089|NCT05182840|584211549|FG003|Run-in Period|No reason available|0|||
161773090|NCT05182840|584211550|FG004|Run-in Period|No reason available|0|||
161773091|NCT05182840|584211551|FG005|Run-in Period|No reason available|0|||
161773092|NCT05182840|584211552|FG006|Run-in Period|No reason available|0|||
161773093|NCT05182840|584211553|FG007|Run-in Period|No reason available|0|||
161773094|NCT05182840|584211554|FG008|Run-in Period|No reason available|0|||
161773095|NCT05182840|584211555|FG009|Run-in Period|No reason available|0|||
161773096|NCT05182840|584211546|FG000|Run-in Period|Burden of study procedures|2|||
161773097|NCT05182840|584211547|FG001|Run-in Period|Burden of study procedures|2|||
161773098|NCT05182840|584211548|FG002|Run-in Period|Burden of study procedures|0|||
161773099|NCT05182840|584211549|FG003|Run-in Period|Burden of study procedures|0|||
161773100|NCT05182840|584211550|FG004|Run-in Period|Burden of study procedures|0|||
161773101|NCT05182840|584211551|FG005|Run-in Period|Burden of study procedures|0|||
161773102|NCT05182840|584211552|FG006|Run-in Period|Burden of study procedures|0|||
161773103|NCT05182840|584211553|FG007|Run-in Period|Burden of study procedures|0|||
161773104|NCT05182840|584211554|FG008|Run-in Period|Burden of study procedures|0|||
161773105|NCT05182840|584211555|FG009|Run-in Period|Burden of study procedures|0|||
161773106|NCT05182840|584211546|FG000|Run-in Period|Change of residence|1|||
161773107|NCT05182840|584211547|FG001|Run-in Period|Change of residence|0|||
161773108|NCT05182840|584211548|FG002|Run-in Period|Change of residence|0|||
161773109|NCT05182840|584211549|FG003|Run-in Period|Change of residence|0|||
161773110|NCT05182840|584211550|FG004|Run-in Period|Change of residence|0|||
161773111|NCT05182840|584211551|FG005|Run-in Period|Change of residence|0|||
161773112|NCT05182840|584211552|FG006|Run-in Period|Change of residence|0|||
161773113|NCT05182840|584211553|FG007|Run-in Period|Change of residence|0|||
161773114|NCT05182840|584211554|FG008|Run-in Period|Change of residence|0|||
161773115|NCT05182840|584211555|FG009|Run-in Period|Change of residence|0|||
161773116|NCT05182840|584211546|FG000|Run-in Period|Adverse Event|5|||
161773117|NCT05182840|584211547|FG001|Run-in Period|Adverse Event|5|||
161773118|NCT05182840|584211548|FG002|Run-in Period|Adverse Event|0|||
161773119|NCT05182840|584211549|FG003|Run-in Period|Adverse Event|0|||
161773120|NCT05182840|584211550|FG004|Run-in Period|Adverse Event|0|||
161773121|NCT05182840|584211551|FG005|Run-in Period|Adverse Event|0|||
161773122|NCT05182840|584211552|FG006|Run-in Period|Adverse Event|0|||
161773123|NCT05182840|584211553|FG007|Run-in Period|Adverse Event|0|||
161773124|NCT05182840|584211554|FG008|Run-in Period|Adverse Event|0|||
161773125|NCT05182840|584211555|FG009|Run-in Period|Adverse Event|0|||
161773126|NCT05182840|584211546|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
161773127|NCT05182840|584211547|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
161773128|NCT05182840|584211548|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773129|NCT05182840|584211549|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773130|NCT05182840|584211550|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773131|NCT05182840|584211551|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773132|NCT05182840|584211552|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773133|NCT05182840|584211553|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773134|NCT05182840|584211554|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161862873|NCT05573464|584540240|FG001|12-week Treatment Period|Randomised, not treated|1|||
161862874|NCT05573464|584540239|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
161862875|NCT05573464|584540240|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
161862876|NCT05573464|584540239|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
161862877|NCT05573464|584540240|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
161862878|NCT05573464|584540239|FG000|52-week Treatment Period|Protocol Violation|1|||
161862879|NCT05573464|584540240|FG001|52-week Treatment Period|Protocol Violation|1|||
161862880|NCT05573464|584540239|FG000|52-week Treatment Period|Physician Decision|2|||
161862881|NCT05573464|584540240|FG001|52-week Treatment Period|Physician Decision|2|||
161862882|NCT05573464|584540239|FG000|52-week Treatment Period|Lost to Follow-up|1|||
161862883|NCT05573464|584540240|FG001|52-week Treatment Period|Lost to Follow-up|1|||
161862884|NCT05573464|584540239|FG000|52-week Treatment Period|Adverse Event|11|||
161862885|NCT05573464|584540240|FG001|52-week Treatment Period|Adverse Event|8|||
161862886|NCT05573464|584540239|FG000|52-week Treatment Period|Death|1|||
161862887|NCT05573464|584540240|FG001|52-week Treatment Period|Death|1|||
161862888|NCT05734157|584540241|FG000|Overall Study|Death|3|||
161862889|NCT05734157|584540241|FG000|Overall Study|Withdrawal by Subject|2|||
161862890|NCT05734157|584540241|FG000|Overall Study|Lost to Follow-up|1|||
161862891|NCT05734157|584540241|FG000|Overall Study|Telephone call|3|||
161977713|NCT05432167|584967380|FG002|Overall Study|Other|1|||
161977714|NCT00357656|584967383|FG000|Overall Study|Other, No surgery performed|0|||
161977715|NCT00357656|584967384|FG001|Overall Study|Other, No surgery performed|3|||
161977716|NCT01873729|584967385|FG000|Overall Study|Withdrawal by Subject|1|||
161977717|NCT01741532|584967386|FG000|Overall Study|Adverse Event|4|||
161977718|NCT01741532|584967387|FG001|Overall Study|Adverse Event|0|||
161977719|NCT01741532|584967386|FG000|Overall Study|Withdrawal by Subject|1|||
161977720|NCT01741532|584967387|FG001|Overall Study|Withdrawal by Subject|1|||
161977721|NCT01741532|584967386|FG000|Overall Study|Protocol Violation|0|||
161977722|NCT01741532|584967387|FG001|Overall Study|Protocol Violation|1|||
161977723|NCT01741532|584967386|FG000|Overall Study|Worsening of the disease|3|||
161977724|NCT01741532|584967387|FG001|Overall Study|Worsening of the disease|1|||
161773135|NCT05182840|584211555|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161773136|NCT05182840|584211546|FG000|Treatment Period|Reason missing|0|||
161773137|NCT05182840|584211547|FG001|Treatment Period|Reason missing|0|||
161773138|NCT05182840|584211548|FG002|Treatment Period|Reason missing|1|||
161773139|NCT05182840|584211549|FG003|Treatment Period|Reason missing|0|||
161773140|NCT05182840|584211550|FG004|Treatment Period|Reason missing|0|||
161773141|NCT05182840|584211551|FG005|Treatment Period|Reason missing|0|||
161773142|NCT05182840|584211552|FG006|Treatment Period|Reason missing|0|||
161773143|NCT05182840|584211553|FG007|Treatment Period|Reason missing|0|||
161773144|NCT05182840|584211554|FG008|Treatment Period|Reason missing|0|||
161773145|NCT05182840|584211555|FG009|Treatment Period|Reason missing|0|||
161773146|NCT05182840|584211546|FG000|Treatment Period|Other but not sponsor termination|0|||
161773147|NCT05182840|584211547|FG001|Treatment Period|Other but not sponsor termination|0|||
161773148|NCT05182840|584211548|FG002|Treatment Period|Other but not sponsor termination|8|||
161773149|NCT05182840|584211549|FG003|Treatment Period|Other but not sponsor termination|6|||
161773150|NCT05182840|584211550|FG004|Treatment Period|Other but not sponsor termination|6|||
161773151|NCT05182840|584211551|FG005|Treatment Period|Other but not sponsor termination|7|||
161773152|NCT05182840|584211552|FG006|Treatment Period|Other but not sponsor termination|5|||
161773153|NCT05182840|584211553|FG007|Treatment Period|Other but not sponsor termination|8|||
161773154|NCT05182840|584211554|FG008|Treatment Period|Other but not sponsor termination|7|||
161773155|NCT05182840|584211555|FG009|Treatment Period|Other but not sponsor termination|2|||
161773156|NCT05182840|584211546|FG000|Treatment Period|Protocol deviation|0|||
161773157|NCT05182840|584211547|FG001|Treatment Period|Protocol deviation|0|||
161773158|NCT05182840|584211548|FG002|Treatment Period|Protocol deviation|0|||
161773159|NCT05182840|584211549|FG003|Treatment Period|Protocol deviation|0|||
161773160|NCT05182840|584211550|FG004|Treatment Period|Protocol deviation|0|||
161773161|NCT05182840|584211551|FG005|Treatment Period|Protocol deviation|0|||
161773162|NCT05182840|584211552|FG006|Treatment Period|Protocol deviation|0|||
161773163|NCT05182840|584211553|FG007|Treatment Period|Protocol deviation|0|||
161773164|NCT05182840|584211554|FG008|Treatment Period|Protocol deviation|1|||
161773165|NCT05182840|584211555|FG009|Treatment Period|Protocol deviation|0|||
161773166|NCT05182840|584211546|FG000|Treatment Period|No reason available|0|||
161773167|NCT05182840|584211547|FG001|Treatment Period|No reason available|0|||
161773168|NCT05182840|584211548|FG002|Treatment Period|No reason available|0|||
161773169|NCT05182840|584211549|FG003|Treatment Period|No reason available|1|||
161773170|NCT05182840|584211550|FG004|Treatment Period|No reason available|0|||
161862892|NCT04815083|584540242|FG000|Overall Study|Physician Decision|1|||
161862893|NCT04815083|584540242|FG000|Overall Study|Study pause|2|||
161977725|NCT01741532|584967386|FG000|Overall Study|Sponsor decision|1|||
161862894|NCT04815083|584540242|FG000|Overall Study|Screening failure|4|||
161862895|NCT06025721|584540243|FG000|Overall Study|Physician Decision|1|||
161862896|NCT06025721|584540243|FG000|Overall Study|Protocol Violation|1|||
161977726|NCT01741532|584967387|FG001|Overall Study|Sponsor decision|0|||
162034682|NCT01547780|585183516|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
162034683|NCT01547780|585183517|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
162034684|NCT01547780|585183518|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
162034685|NCT00814879|585183520|FG000|By Week 24|Cancer Diagnosis|1|||
162034686|NCT00814879|585183521|FG001|By Week 24|Cancer Diagnosis|0|||
162034687|NCT00814879|585183520|FG000|By Week 24|Incarceration|0|||
162034688|NCT00814879|585183521|FG001|By Week 24|Incarceration|1|||
162034689|NCT00814879|585183520|FG000|By Week 48|Lost to Follow-up|2|||
162034690|NCT00814879|585183521|FG001|By Week 48|Lost to Follow-up|2|||
162034691|NCT00814879|585183520|FG000|By Week 48|Death|0|||
162034692|NCT00814879|585183521|FG001|By Week 48|Death|1|||
162034693|NCT00588952|585183522|FG000|Overall Study|Adverse Event|0|||
162034694|NCT00588952|585183523|FG001|Overall Study|Adverse Event|2|||
162034695|NCT00588952|585183522|FG000|Overall Study|Withdrawal by Subject|3|||
162034696|NCT00588952|585183523|FG001|Overall Study|Withdrawal by Subject|5|||
162034697|NCT01461057|585183524|FG000|Overall Study|Death|10|||
161977727|NCT01741532|584967386|FG000|Overall Study|Medical event|1|||
161977728|NCT01741532|584967387|FG001|Overall Study|Medical event|0|||
161977729|NCT00973102|584967388|FG000|Overall Study|Protocol Violation|1|||
161977730|NCT00973102|584967389|FG001|Overall Study|Protocol Violation|0|||
161977731|NCT00973102|584967388|FG000|Overall Study|Prisoner|0|||
161977732|NCT00973102|584967389|FG001|Overall Study|Prisoner|1|||
161977733|NCT01066780|584967390|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
161977734|NCT01066780|584967391|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
161977735|NCT00613080|584967392|FG000|Overall Study|Ineligible / no protocol treatment|11|||
161977736|NCT02360293|584967393|FG000|Overall Study|Lost to Follow-up|73|||
161977737|NCT02360293|584967394|FG001|Overall Study|Lost to Follow-up|95|||
161977738|NCT02360293|584967393|FG000|Overall Study|Withdrawal by Subject|2|||
161977739|NCT02360293|584967394|FG001|Overall Study|Withdrawal by Subject|1|||
161977740|NCT02360293|584967393|FG000|Overall Study|Excluded|1|||
161977741|NCT02360293|584967394|FG001|Overall Study|Excluded|0|||
161977742|NCT02226549|584967395|FG000|Overall Study|Randomized but Never Treated|1|||
161977743|NCT02226549|584967396|FG001|Overall Study|Randomized but Never Treated|0|||
161977744|NCT02226549|584967395|FG000|Overall Study|Lost to Follow-up|0|||
161977745|NCT02226549|584967396|FG001|Overall Study|Lost to Follow-up|1|||
161977746|NCT02012686|584967398|FG000|Overall Study|muscle contraction|0|||
161977747|NCT02012686|584967399|FG001|Overall Study|muscle contraction|1|||
161977748|NCT02012686|584967398|FG000|Overall Study|electrocardiography monitoring noise|0|||
161977749|NCT02012686|584967399|FG001|Overall Study|electrocardiography monitoring noise|1|||
161977750|NCT03099148|584967400|FG000|Wash-out|scheduling conflict|0|||
161977751|NCT03099148|584967401|FG001|Wash-out|scheduling conflict|1|||
161977752|NCT03099148|584967402|FG002|Wash-out|scheduling conflict|0|||
161977753|NCT03099148|584967403|FG003|Wash-out|scheduling conflict|0|||
161977754|NCT03099148|584967400|FG000|Wash-out|Adverse Event|0|||
161977755|NCT03099148|584967401|FG001|Wash-out|Adverse Event|1|||
161977756|NCT03099148|584967402|FG002|Wash-out|Adverse Event|0|||
161977757|NCT03099148|584967403|FG003|Wash-out|Adverse Event|0|||
161977758|NCT01703065|584967406|FG000|Overall Study|Lack of Efficacy|1|||
161977759|NCT01703065|584967407|FG001|Overall Study|Lack of Efficacy|0|||
161977760|NCT00687609|584967410|FG000|Overall Study|Physician Decision|1|||
161977761|NCT00687609|584967410|FG000|Overall Study|Withdrawal by Subject|2|||
161977762|NCT02713529|584967411|FG000|Overall Study|Withdrawal by Subject|3|||
161977763|NCT02713529|584967412|FG001|Overall Study|Withdrawal by Subject|1|||
161977764|NCT02713529|584967413|FG002|Overall Study|Withdrawal by Subject|4|||
161977765|NCT02713529|584967414|FG003|Overall Study|Withdrawal by Subject|2|||
161977766|NCT02713529|584967415|FG004|Overall Study|Withdrawal by Subject|0|||
161977767|NCT02713529|584967416|FG005|Overall Study|Withdrawal by Subject|1|||
161977768|NCT02713529|584967417|FG006|Overall Study|Withdrawal by Subject|1|||
161977769|NCT02713529|584967411|FG000|Overall Study|Lost to Follow-up|1|||
161977770|NCT02713529|584967412|FG001|Overall Study|Lost to Follow-up|0|||
161977771|NCT02713529|584967413|FG002|Overall Study|Lost to Follow-up|1|||
161977772|NCT02713529|584967414|FG003|Overall Study|Lost to Follow-up|0|||
161977773|NCT02713529|584967415|FG004|Overall Study|Lost to Follow-up|0|||
161977774|NCT02713529|584967416|FG005|Overall Study|Lost to Follow-up|0|||
161977775|NCT02713529|584967417|FG006|Overall Study|Lost to Follow-up|0|||
161977776|NCT02713529|584967411|FG000|Overall Study|Death|3|||
162034698|NCT01461057|585183525|FG001|Overall Study|Death|9|||
161977777|NCT02713529|584967412|FG001|Overall Study|Death|3|||
161977778|NCT02713529|584967413|FG002|Overall Study|Death|26|||
161977779|NCT02713529|584967414|FG003|Overall Study|Death|27|||
161977780|NCT02713529|584967415|FG004|Overall Study|Death|3|||
161977781|NCT02713529|584967416|FG005|Overall Study|Death|13|||
162034699|NCT01461057|585183524|FG000|Overall Study|Withdrawal by Subject|2|||
162034700|NCT01461057|585183525|FG001|Overall Study|Withdrawal by Subject|3|||
162034701|NCT01461057|585183524|FG000|Overall Study|Physician Decision|0|||
161977782|NCT02713529|584967417|FG006|Overall Study|Death|3|||
161977783|NCT01739803|584967419|FG000|Overall Study|Lost to Follow-up|9|||
161977784|NCT01739803|584967420|FG001|Overall Study|Lost to Follow-up|6|||
161977785|NCT03759041|584967425|FG000|Overall Study|Withdrawal by Subject|4|||
162034702|NCT01461057|585183525|FG001|Overall Study|Physician Decision|2|||
161977786|NCT03759041|584967426|FG001|Overall Study|Withdrawal by Subject|10|||
161977787|NCT03759041|584967427|FG002|Overall Study|Withdrawal by Subject|10|||
161977788|NCT03759041|584967425|FG000|Overall Study|Adverse Event|1|||
161977789|NCT03759041|584967426|FG001|Overall Study|Adverse Event|3|||
161977790|NCT03759041|584967427|FG002|Overall Study|Adverse Event|4|||
161977791|NCT03759041|584967425|FG000|Overall Study|Lack of Efficacy|0|||
161977792|NCT03759041|584967426|FG001|Overall Study|Lack of Efficacy|0|||
161977793|NCT03759041|584967427|FG002|Overall Study|Lack of Efficacy|1|||
161977794|NCT03759041|584967425|FG000|Overall Study|Study Terminated by Sponsor|15|||
161977795|NCT03759041|584967426|FG001|Overall Study|Study Terminated by Sponsor|16|||
161977796|NCT03759041|584967427|FG002|Overall Study|Study Terminated by Sponsor|10|||
161977797|NCT03759041|584967425|FG000|Overall Study|Other reason for discontinuation|0|||
161977798|NCT03759041|584967426|FG001|Overall Study|Other reason for discontinuation|2|||
161977799|NCT03759041|584967427|FG002|Overall Study|Other reason for discontinuation|1|||
161977800|NCT03759041|584967425|FG000|Overall Study|Lost to Follow-up|7|||
161977801|NCT03759041|584967426|FG001|Overall Study|Lost to Follow-up|2|||
161977802|NCT03759041|584967427|FG002|Overall Study|Lost to Follow-up|2|||
161977803|NCT03759041|584967425|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
161977804|NCT03759041|584967426|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
161977805|NCT03759041|584967427|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
161977806|NCT02449018|584967428|FG000|Overall Study|Abnormal laboratory value|0|||
161977807|NCT02449018|584967429|FG001|Overall Study|Abnormal laboratory value|1|||
161977808|NCT02449018|584967428|FG000|Overall Study|Administrative problems|1|||
161977809|NCT02449018|584967429|FG001|Overall Study|Administrative problems|0|||
161977810|NCT02449018|584967428|FG000|Overall Study|Adverse Event|5|||
161977811|NCT02449018|584967429|FG001|Overall Study|Adverse Event|1|||
161977812|NCT02449018|584967428|FG000|Overall Study|Protocol deviation|4|||
161977813|NCT02449018|584967429|FG001|Overall Study|Protocol deviation|0|||
161977814|NCT02449018|584967428|FG000|Overall Study|Patient decision|2|||
161977815|NCT02449018|584967429|FG001|Overall Study|Patient decision|0|||
161977816|NCT00525824|584967435|FG000|Overall Study|Adverse Event|7|||
161977817|NCT00525824|584967436|FG001|Overall Study|Adverse Event|11|||
161977818|NCT00525824|584967437|FG002|Overall Study|Adverse Event|6|||
161977819|NCT00525824|584967438|FG003|Overall Study|Adverse Event|7|||
161977820|NCT00525824|584967435|FG000|Overall Study|Withdrawal by Subject|5|||
161977821|NCT00525824|584967436|FG001|Overall Study|Withdrawal by Subject|9|||
161977822|NCT00525824|584967437|FG002|Overall Study|Withdrawal by Subject|3|||
161977823|NCT00525824|584967438|FG003|Overall Study|Withdrawal by Subject|4|||
161977824|NCT00525824|584967435|FG000|Overall Study|Lost to Follow-up|4|||
161977825|NCT00525824|584967436|FG001|Overall Study|Lost to Follow-up|2|||
161977826|NCT00525824|584967437|FG002|Overall Study|Lost to Follow-up|4|||
161977827|NCT00525824|584967438|FG003|Overall Study|Lost to Follow-up|0|||
161977828|NCT00525824|584967435|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
161977829|NCT00525824|584967436|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
161977830|NCT00525824|584967437|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
161977831|NCT00525824|584967438|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
161977832|NCT00525824|584967435|FG000|Overall Study|Severe non-compliance|0|||
161977833|NCT00525824|584967436|FG001|Overall Study|Severe non-compliance|1|||
161977834|NCT00525824|584967437|FG002|Overall Study|Severe non-compliance|1|||
161977835|NCT00525824|584967438|FG003|Overall Study|Severe non-compliance|1|||
161977836|NCT00525824|584967435|FG000|Overall Study|Safety reasons|1|||
161977837|NCT00525824|584967436|FG001|Overall Study|Safety reasons|0|||
161977838|NCT00525824|584967437|FG002|Overall Study|Safety reasons|1|||
161977839|NCT00525824|584967438|FG003|Overall Study|Safety reasons|0|||
161977840|NCT00525824|584967435|FG000|Overall Study|Other|1|||
161977841|NCT00525824|584967436|FG001|Overall Study|Other|3|||
161977842|NCT00525824|584967437|FG002|Overall Study|Other|3|||
161977843|NCT00525824|584967438|FG003|Overall Study|Other|1|||
161977844|NCT01522404|584967442|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
161773171|NCT05182840|584211551|FG005|Treatment Period|No reason available|2|||
161773172|NCT05182840|584211552|FG006|Treatment Period|No reason available|0|||
161773173|NCT05182840|584211553|FG007|Treatment Period|No reason available|1|||
161977845|NCT01522404|584967443|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
161977846|NCT01522404|584967442|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
161977847|NCT01522404|584967443|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
161977848|NCT01522404|584967442|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
161977849|NCT01522404|584967443|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
161977850|NCT02698371|584967444|FG000|All Participants Flow|Lost to Follow-up|3|||
161977851|NCT02698371|584967444|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
161977852|NCT02698371|584967444|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
161977853|NCT02698371|584967444|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
161977854|NCT02698371|584967444|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
161977855|NCT02698371|584967444|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
161977856|NCT02698371|584967444|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
161862897|NCT06025721|584540243|FG000|Overall Study|Incarceration|1|||
161862898|NCT01730053|584540246|FG000|Overall Study|Participant moved|0|||
161862899|NCT01730053|584540247|FG001|Overall Study|Participant moved|0|||
161862900|NCT01730053|584540248|FG002|Overall Study|Participant moved|1|||
161862901|NCT01730053|584540249|FG003|Overall Study|Participant moved|0|||
161862902|NCT01730053|584540250|FG004|Overall Study|Participant moved|0|||
161862903|NCT01730053|584540251|FG005|Overall Study|Participant moved|0|||
161862904|NCT01730053|584540246|FG000|Overall Study|Physician Decision|0|||
161862905|NCT01730053|584540247|FG001|Overall Study|Physician Decision|0|||
161862906|NCT01730053|584540248|FG002|Overall Study|Physician Decision|0|||
161862907|NCT01730053|584540249|FG003|Overall Study|Physician Decision|1|||
161862908|NCT01730053|584540250|FG004|Overall Study|Physician Decision|0|||
161862909|NCT01730053|584540251|FG005|Overall Study|Physician Decision|0|||
161862910|NCT01730053|584540246|FG000|Overall Study|Adverse Event|2|||
161862911|NCT01730053|584540247|FG001|Overall Study|Adverse Event|6|||
161862912|NCT01730053|584540248|FG002|Overall Study|Adverse Event|3|||
161862913|NCT01730053|584540249|FG003|Overall Study|Adverse Event|3|||
161862914|NCT01730053|584540250|FG004|Overall Study|Adverse Event|2|||
161862915|NCT01730053|584540251|FG005|Overall Study|Adverse Event|2|||
161862916|NCT01730053|584540246|FG000|Overall Study|Poor compliance to protocol|1|||
161862917|NCT01730053|584540247|FG001|Overall Study|Poor compliance to protocol|2|||
161862918|NCT01730053|584540248|FG002|Overall Study|Poor compliance to protocol|2|||
161862919|NCT01730053|584540249|FG003|Overall Study|Poor compliance to protocol|0|||
161862920|NCT01730053|584540250|FG004|Overall Study|Poor compliance to protocol|0|||
161862921|NCT01730053|584540251|FG005|Overall Study|Poor compliance to protocol|2|||
161977857|NCT05011513|584968991|FG000|Overall Study|Death|0|||
161977858|NCT05011513|584968992|FG001|Overall Study|Death|1|||
161977859|NCT05011513|584968991|FG000|Overall Study|Lost to Follow-up|4|||
161977860|NCT05011513|584968992|FG001|Overall Study|Lost to Follow-up|0|||
161977861|NCT05011513|584968991|FG000|Overall Study|Withdrawal by Subject|18|||
161977862|NCT05011513|584968992|FG001|Overall Study|Withdrawal by Subject|17|||
161977863|NCT05011513|584968991|FG000|Overall Study|Other|4|||
161977864|NCT05011513|584968992|FG001|Overall Study|Other|2|||
161977865|NCT03667690|584968993|FG000|Overall Study|Adverse Event|0|||
161977866|NCT03667690|584968994|FG001|Overall Study|Adverse Event|3|||
161977867|NCT03667690|584968993|FG000|Overall Study|Death|22|||
161977868|NCT03667690|584968994|FG001|Overall Study|Death|21|||
161977869|NCT03667690|584968993|FG000|Overall Study|Lost to Follow-up|4|||
161977870|NCT03667690|584968994|FG001|Overall Study|Lost to Follow-up|5|||
161977871|NCT03667690|584968993|FG000|Overall Study|Withdrawal by Subject|7|||
161977872|NCT03667690|584968994|FG001|Overall Study|Withdrawal by Subject|8|||
161977873|NCT03667690|584968993|FG000|Overall Study|Subject could not return for additional investigational product|1|||
161977874|NCT03667690|584968994|FG001|Overall Study|Subject could not return for additional investigational product|0|||
161977875|NCT03667690|584968993|FG000|Overall Study|Subject discharged to hospice care|2|||
161977876|NCT03667690|584968994|FG001|Overall Study|Subject discharged to hospice care|0|||
161977877|NCT03667690|584968993|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
161977878|NCT03667690|584968994|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
161977879|NCT03667690|584968993|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
161977880|NCT03667690|584968994|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
161977881|NCT03667690|584968993|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
161977882|NCT03667690|584968994|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
161977883|NCT03667690|584968993|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
161977884|NCT03667690|584968994|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
161977885|NCT03667690|584968993|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
161977886|NCT03667690|584968994|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
161977887|NCT01192568|584969003|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
161977888|NCT01192568|584969004|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
161977889|NCT01192568|584969005|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
161977890|NCT01192568|584969006|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
161977891|NCT01192568|584969003|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
161977892|NCT01192568|584969004|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
161977893|NCT01192568|584969005|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
161977894|NCT01192568|584969006|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
161977895|NCT02593825|584969007|FG000|Intervention|Lost to Follow-up|10|||
161977896|NCT02593825|584969008|FG001|Intervention|Lost to Follow-up|12|||
161977897|NCT06359080|584969009|FG000|Overall Study|Withdrawal by Subject|3|||
161862922|NCT01730053|584540246|FG000|Overall Study|Other than specified|2|||
161862923|NCT01730053|584540247|FG001|Overall Study|Other than specified|6|||
161862924|NCT01730053|584540248|FG002|Overall Study|Other than specified|5|||
161862925|NCT01730053|584540249|FG003|Overall Study|Other than specified|4|||
161862926|NCT01730053|584540250|FG004|Overall Study|Other than specified|7|||
161862927|NCT01730053|584540251|FG005|Overall Study|Other than specified|9|||
161862928|NCT02068508|584540252|FG000|Overall Study|Case report forms uncollected|27|||
161977898|NCT00511134|584969012|FG000|Overall Study|Withdrawal by Subject|0|||
161977899|NCT00511134|584969013|FG001|Overall Study|Withdrawal by Subject|2|||
161977900|NCT01949090|584969016|FG000|Overall Study|Serious Adverse Event|0|||
161977901|NCT01949090|584969017|FG001|Overall Study|Serious Adverse Event|1|||
161977902|NCT01949090|584969018|FG002|Overall Study|Serious Adverse Event|2|||
161977903|NCT01949090|584969019|FG003|Overall Study|Serious Adverse Event|0|||
161977904|NCT01949090|584969020|FG004|Overall Study|Serious Adverse Event|1|||
161977905|NCT01949090|584969016|FG000|Overall Study|Withdrawal by Subject|2|||
161977906|NCT01949090|584969017|FG001|Overall Study|Withdrawal by Subject|0|||
161977907|NCT01949090|584969018|FG002|Overall Study|Withdrawal by Subject|0|||
161977908|NCT01949090|584969019|FG003|Overall Study|Withdrawal by Subject|0|||
161977909|NCT01949090|584969020|FG004|Overall Study|Withdrawal by Subject|1|||
161977910|NCT01949090|584969016|FG000|Overall Study|Protocol non-compliance|0|||
161977911|NCT01949090|584969017|FG001|Overall Study|Protocol non-compliance|0|||
161977912|NCT01949090|584969018|FG002|Overall Study|Protocol non-compliance|0|||
161977913|NCT01949090|584969019|FG003|Overall Study|Protocol non-compliance|0|||
161977914|NCT01949090|584969020|FG004|Overall Study|Protocol non-compliance|1|||
161977915|NCT01949090|584969016|FG000|Overall Study|Lost to Follow-up|2|||
161977916|NCT01949090|584969017|FG001|Overall Study|Lost to Follow-up|1|||
161977917|NCT01949090|584969018|FG002|Overall Study|Lost to Follow-up|0|||
161977918|NCT01949090|584969019|FG003|Overall Study|Lost to Follow-up|1|||
162034703|NCT01461057|585183524|FG000|Overall Study|Adverse Event|0|||
162034704|NCT01461057|585183525|FG001|Overall Study|Adverse Event|1|||
162034705|NCT01461057|585183524|FG000|Overall Study|Progression of Disease|1|||
162034706|NCT01461057|585183525|FG001|Overall Study|Progression of Disease|0|||
162034707|NCT01461057|585183524|FG000|Overall Study|Study Terminated by Sponsor|2|||
162034708|NCT01461057|585183525|FG001|Overall Study|Study Terminated by Sponsor|0|||
162034709|NCT01288976|585183526|FG000|Overall Study|Withdrawal by Subject|58|||
162034710|NCT01288976|585183527|FG001|Overall Study|Withdrawal by Subject|12|||
162034711|NCT01288976|585183528|FG002|Overall Study|Withdrawal by Subject|9|||
161773174|NCT05182840|584211554|FG008|Treatment Period|No reason available|0|||
161773175|NCT05182840|584211555|FG009|Treatment Period|No reason available|0|||
161773176|NCT05182840|584211546|FG000|Treatment Period|Burden of study procedures|0|||
161773177|NCT05182840|584211547|FG001|Treatment Period|Burden of study procedures|0|||
161773178|NCT05182840|584211548|FG002|Treatment Period|Burden of study procedures|0|||
161773179|NCT05182840|584211549|FG003|Treatment Period|Burden of study procedures|0|||
161773180|NCT05182840|584211550|FG004|Treatment Period|Burden of study procedures|1|||
161773181|NCT05182840|584211551|FG005|Treatment Period|Burden of study procedures|0|||
161773182|NCT05182840|584211552|FG006|Treatment Period|Burden of study procedures|0|||
161773183|NCT05182840|584211553|FG007|Treatment Period|Burden of study procedures|0|||
161773184|NCT05182840|584211554|FG008|Treatment Period|Burden of study procedures|0|||
161773185|NCT05182840|584211555|FG009|Treatment Period|Burden of study procedures|0|||
161773186|NCT05182840|584211546|FG000|Treatment Period|Change of residence|0|||
161773187|NCT05182840|584211547|FG001|Treatment Period|Change of residence|0|||
161773188|NCT05182840|584211548|FG002|Treatment Period|Change of residence|0|||
161773189|NCT05182840|584211549|FG003|Treatment Period|Change of residence|0|||
161773190|NCT05182840|584211550|FG004|Treatment Period|Change of residence|0|||
161773191|NCT05182840|584211551|FG005|Treatment Period|Change of residence|1|||
161773192|NCT05182840|584211552|FG006|Treatment Period|Change of residence|0|||
161773193|NCT05182840|584211553|FG007|Treatment Period|Change of residence|0|||
161773194|NCT05182840|584211554|FG008|Treatment Period|Change of residence|0|||
161773195|NCT05182840|584211555|FG009|Treatment Period|Change of residence|0|||
161773196|NCT05182840|584211546|FG000|Treatment Period|Adverse Event|0|||
161773197|NCT05182840|584211547|FG001|Treatment Period|Adverse Event|0|||
161773198|NCT05182840|584211548|FG002|Treatment Period|Adverse Event|4|||
161773199|NCT05182840|584211549|FG003|Treatment Period|Adverse Event|16|||
161773200|NCT05182840|584211550|FG004|Treatment Period|Adverse Event|12|||
161773201|NCT05182840|584211551|FG005|Treatment Period|Adverse Event|6|||
161773202|NCT05182840|584211552|FG006|Treatment Period|Adverse Event|4|||
161773203|NCT05182840|584211553|FG007|Treatment Period|Adverse Event|8|||
161773204|NCT05182840|584211554|FG008|Treatment Period|Adverse Event|16|||
161773205|NCT05182840|584211555|FG009|Treatment Period|Adverse Event|5|||
161862929|NCT02068508|584540252|FG000|Overall Study|Patient did not visit the study site|1|||
161862930|NCT02068508|584540252|FG000|Overall Study|Protocol Violation|4|||
161862931|NCT00075816|584540260|FG000|Overall Study|Did not undergo transplantation|14|||
161862932|NCT00075816|584540261|FG001|Overall Study|Did not undergo transplantation|11|||
161862933|NCT04173507|584540262|FG000|Overall Study|On Treatment|3|||
161977919|NCT01949090|584969020|FG004|Overall Study|Lost to Follow-up|1|||
161977920|NCT02783170|584969021|FG000|Overall Study|Randomized but not Vaccinated|1|||
161977921|NCT02783170|584969022|FG001|Overall Study|Randomized but not Vaccinated|0|||
161773206|NCT05182840|584211546|FG000|Treatment Period|Not treated with study drug|0|||
161862934|NCT04173507|584540262|FG000|Overall Study|Adverse Event|3|||
161977922|NCT04938037|584969023|FG000|Overall Study|Lost to Follow-up|4|||
161977923|NCT04938037|584969024|FG001|Overall Study|Lost to Follow-up|3|||
161977924|NCT05063539|584969030|FG000|Overall Study|Adverse Event|1|||
162034712|NCT01288976|585183526|FG000|Overall Study|Death|98|||
161862935|NCT04173507|584540262|FG000|Overall Study|Progression/Relapse|34|||
161862936|NCT04173507|584540262|FG000|Overall Study|Death|2|||
161862937|NCT02832687|584540263|FG000|Overall Study|Adverse Event|0|||
161862938|NCT02832687|584540264|FG001|Overall Study|Adverse Event|2|||
161862939|NCT04231825|584540265|FG000|Overall Study|Protocol Violation|3|||
161862940|NCT04231825|584540266|FG001|Overall Study|Protocol Violation|3|||
161862941|NCT04231825|584540265|FG000|Overall Study|Lost to Follow-up|0|||
161862942|NCT04231825|584540266|FG001|Overall Study|Lost to Follow-up|1|||
161862943|NCT01662635|584540267|FG000|Overall Study|scarce samples for evaluation|30|||
161862944|NCT01217112|584540268|FG000|Overall Study|Adverse Event|0|||
161862945|NCT01217112|584540269|FG001|Overall Study|Adverse Event|2|||
161862946|NCT01217112|584540270|FG002|Overall Study|Adverse Event|0|||
161862947|NCT01217112|584540271|FG003|Overall Study|Adverse Event|2|||
161862948|NCT01217112|584540272|FG004|Overall Study|Adverse Event|0|||
161862949|NCT01217112|584540268|FG000|Overall Study|Withdrawal by Subject|0|||
161862950|NCT01217112|584540269|FG001|Overall Study|Withdrawal by Subject|0|||
161862951|NCT01217112|584540270|FG002|Overall Study|Withdrawal by Subject|1|||
161862952|NCT01217112|584540271|FG003|Overall Study|Withdrawal by Subject|0|||
161862953|NCT01217112|584540272|FG004|Overall Study|Withdrawal by Subject|0|||
161862954|NCT01217112|584540268|FG000|Overall Study|Physician Decision|0|||
161862955|NCT01217112|584540269|FG001|Overall Study|Physician Decision|0|||
161862956|NCT01217112|584540270|FG002|Overall Study|Physician Decision|0|||
161862957|NCT01217112|584540271|FG003|Overall Study|Physician Decision|0|||
161862958|NCT01217112|584540272|FG004|Overall Study|Physician Decision|1|||
161862959|NCT01401361|584540273|FG000|Overall Study|Withdrawal by Subject|16|||
161862960|NCT01401361|584540273|FG000|Overall Study|Lack of Efficacy|6|||
161862961|NCT01401361|584540273|FG000|Overall Study|Physician Decision|1|||
161862962|NCT01401361|584540273|FG000|Overall Study|Lost to Follow-up|3|||
161862963|NCT01401361|584540273|FG000|Overall Study|Subject/family decision post procedure|2|||
161862964|NCT00595920|584540276|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
161862965|NCT00351468|584540277|FG000|Overall Study|Adverse Event|42|||
161862966|NCT00351468|584540277|FG000|Overall Study|Withdrawal by Subject|39|||
161862967|NCT00351468|584540277|FG000|Overall Study|Various -follow up w clinical team|39|||
161862968|NCT00351468|584540277|FG000|Overall Study|Lack of Efficacy|32|||
161862969|NCT00351468|584540277|FG000|Overall Study|Non-compliance|8|||
161862970|NCT00351468|584540277|FG000|Overall Study|Lost to Follow-up|4|||
161862971|NCT00351468|584540277|FG000|Overall Study|Protocol Violation|3|||
161862972|NCT03588910|584540278|FG000|Overall Study|Withdrawal by Subject|1|||
161862973|NCT03588910|584540279|FG001|Overall Study|Withdrawal by Subject|0|||
161862974|NCT03588910|584540278|FG000|Overall Study|Allergy|2|||
161862975|NCT03588910|584540279|FG001|Overall Study|Allergy|0|||
161862976|NCT03588910|584540278|FG000|Overall Study|Protocol Violation|0|||
161862977|NCT03588910|584540279|FG001|Overall Study|Protocol Violation|3|||
161862978|NCT03588910|584540278|FG000|Overall Study|Did not complete Day 1 Survey|5|||
161862979|NCT03588910|584540279|FG001|Overall Study|Did not complete Day 1 Survey|10|||
161862980|NCT03588910|584540278|FG000|Overall Study|Did not complete Day 7 Survey|5|||
161862981|NCT03588910|584540279|FG001|Overall Study|Did not complete Day 7 Survey|2|||
161862982|NCT03096314|584540280|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
161862983|NCT03096314|584540281|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
161862984|NCT00471822|584540282|FG000|Overall Study|Protocol Violation|2|||
161862985|NCT03318861|584540283|FG000|Overall Study|Death|2|||
161862986|NCT03318861|584540284|FG001|Overall Study|Death|3|||
161862987|NCT03318861|584540285|FG002|Overall Study|Death|3|||
161862988|NCT03318861|584540286|FG003|Overall Study|Death|2|||
161862989|NCT03318861|584540287|FG004|Overall Study|Death|2|||
161862990|NCT03318861|584540283|FG000|Overall Study|Enrolled But Never Treated|0|||
161862991|NCT03318861|584540284|FG001|Overall Study|Enrolled But Never Treated|1|||
161862992|NCT03318861|584540285|FG002|Overall Study|Enrolled But Never Treated|0|||
161862993|NCT03318861|584540286|FG003|Overall Study|Enrolled But Never Treated|1|||
161862994|NCT03318861|584540287|FG004|Overall Study|Enrolled But Never Treated|1|||
161862995|NCT03318861|584540283|FG000|Overall Study|Informed Consent Withdraw|0|||
161862996|NCT03318861|584540284|FG001|Overall Study|Informed Consent Withdraw|0|||
161862997|NCT03318861|584540285|FG002|Overall Study|Informed Consent Withdraw|0|||
161862998|NCT03318861|584540286|FG003|Overall Study|Informed Consent Withdraw|1|||
161862999|NCT03318861|584540287|FG004|Overall Study|Informed Consent Withdraw|0|||
161863000|NCT03318861|584540283|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
161863001|NCT03318861|584540284|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
161863002|NCT03318861|584540285|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
161863003|NCT03318861|584540286|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
161863004|NCT03318861|584540287|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
161863005|NCT02844933|584540288|FG000|Overall Study|Discontinued due to premature termination of study|3|||
162034713|NCT01288976|585183527|FG001|Overall Study|Death|6|||
161863006|NCT02844933|584540289|FG001|Overall Study|Discontinued due to premature termination of study|2|||
161863007|NCT01479465|584540290|FG000|Overall Study|Disease Progression|9|||
161863008|NCT01479465|584540291|FG001|Overall Study|Disease Progression|61|||
161863009|NCT01479465|584540292|FG002|Overall Study|Disease Progression|65|||
161863010|NCT01479465|584540293|FG003|Overall Study|Disease Progression|70|||
161863011|NCT01479465|584540290|FG000|Overall Study|Study Discontinued by Sponsor|0|||
161863012|NCT01479465|584540291|FG001|Overall Study|Study Discontinued by Sponsor|7|||
161863013|NCT01479465|584540292|FG002|Overall Study|Study Discontinued by Sponsor|5|||
161863014|NCT01479465|584540293|FG003|Overall Study|Study Discontinued by Sponsor|3|||
161863015|NCT01479465|584540290|FG000|Overall Study|Adverse Event|0|||
161863016|NCT01479465|584540291|FG001|Overall Study|Adverse Event|3|||
161863017|NCT01479465|584540292|FG002|Overall Study|Adverse Event|6|||
161863018|NCT01479465|584540293|FG003|Overall Study|Adverse Event|4|||
161863019|NCT01479465|584540290|FG000|Overall Study|Investigator Discretion|1|||
161863020|NCT01479465|584540291|FG001|Overall Study|Investigator Discretion|4|||
161863021|NCT01479465|584540292|FG002|Overall Study|Investigator Discretion|2|||
161863022|NCT01479465|584540293|FG003|Overall Study|Investigator Discretion|4|||
161863023|NCT01479465|584540290|FG000|Overall Study|Subject Request|1|||
161863024|NCT01479465|584540291|FG001|Overall Study|Subject Request|3|||
161863025|NCT01479465|584540292|FG002|Overall Study|Subject Request|4|||
161863026|NCT01479465|584540293|FG003|Overall Study|Subject Request|2|||
161863027|NCT01479465|584540290|FG000|Overall Study|Subject Withdrew Consent|0|||
161863028|NCT01479465|584540291|FG001|Overall Study|Subject Withdrew Consent|5|||
161863029|NCT01479465|584540292|FG002|Overall Study|Subject Withdrew Consent|2|||
161863030|NCT01479465|584540293|FG003|Overall Study|Subject Withdrew Consent|1|||
161863031|NCT01479465|584540290|FG000|Overall Study|Protocol Violation|0|||
161863032|NCT01479465|584540291|FG001|Overall Study|Protocol Violation|1|||
161863033|NCT01479465|584540292|FG002|Overall Study|Protocol Violation|1|||
161863034|NCT01479465|584540293|FG003|Overall Study|Protocol Violation|0|||
161863035|NCT01479465|584540290|FG000|Overall Study|Death|0|||
161863036|NCT01479465|584540291|FG001|Overall Study|Death|0|||
161863037|NCT01479465|584540292|FG002|Overall Study|Death|0|||
161863038|NCT01479465|584540293|FG003|Overall Study|Death|1|||
161863039|NCT01479465|584540290|FG000|Overall Study|Lost to Follow-up|0|||
161863040|NCT01479465|584540291|FG001|Overall Study|Lost to Follow-up|0|||
161863041|NCT01479465|584540292|FG002|Overall Study|Lost to Follow-up|1|||
161863042|NCT01479465|584540293|FG003|Overall Study|Lost to Follow-up|0|||
161863043|NCT01892501|584540294|FG000|Overall Study|Protocol Violation|2|||
161863044|NCT01892501|584540294|FG000|Overall Study|Puncture not carried out|9|||
161863045|NCT01892501|584540294|FG000|Overall Study|Radiological monitoring not carried out|5|||
161863046|NCT01892501|584540294|FG000|Overall Study|Non-contributory histological result|12|||
161863047|NCT04335123|584540298|FG000|Overall Study|Withdrawal by Subject|2|||
161863048|NCT04335123|584540299|FG001|Overall Study|Withdrawal by Subject|0|||
161863049|NCT04335123|584540298|FG000|Overall Study|Physician Decision|2|||
161863050|NCT04335123|584540299|FG001|Overall Study|Physician Decision|0|||
161863051|NCT01439802|584540300|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
161863052|NCT01439802|584540300|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
161863053|NCT01433471|584540304|FG000|Overall Study|Withdrawal by Subject|0|||
161863054|NCT01433471|584540305|FG001|Overall Study|Withdrawal by Subject|1|||
161863055|NCT00395629|584540306|FG000|Core Study|Adverse Event|0|||
161863056|NCT00395629|584540307|FG001|Core Study|Adverse Event|3|||
161863057|NCT00395629|584540308|FG002|Core Study|Adverse Event|4|||
161863058|NCT00395629|584540306|FG000|Core Study|Abnormal laboratory value(s)|0|||
161863059|NCT00395629|584540307|FG001|Core Study|Abnormal laboratory value(s)|0|||
161863060|NCT00395629|584540308|FG002|Core Study|Abnormal laboratory value(s)|1|||
161863061|NCT00395629|584540306|FG000|Core Study|Protocol Violation|1|||
161863062|NCT00395629|584540307|FG001|Core Study|Protocol Violation|0|||
161863063|NCT00395629|584540308|FG002|Core Study|Protocol Violation|0|||
161863064|NCT00395629|584540306|FG000|Core Study|Withdrawal by Subject|0|||
161863065|NCT00395629|584540307|FG001|Core Study|Withdrawal by Subject|1|||
161863066|NCT00395629|584540308|FG002|Core Study|Withdrawal by Subject|1|||
161863067|NCT00395629|584540306|FG000|Core Study|Lost to Follow-up|0|||
161863068|NCT00395629|584540307|FG001|Core Study|Lost to Follow-up|0|||
161863069|NCT00395629|584540308|FG002|Core Study|Lost to Follow-up|1|||
161863070|NCT00395629|584540306|FG000|Extension Study|Adverse Event|0|||
161863071|NCT00395629|584540307|FG001|Extension Study|Adverse Event|0|||
161863072|NCT00395629|584540308|FG002|Extension Study|Adverse Event|2|||
161863073|NCT00395629|584540306|FG000|Extension Study|Administrative problems|0|||
161863074|NCT00395629|584540307|FG001|Extension Study|Administrative problems|0|||
161863075|NCT00395629|584540308|FG002|Extension Study|Administrative problems|1|||
161863076|NCT01836471|584540309|FG000|Overall Study|Pregnancy|1|||
161863077|NCT01836471|584540310|FG001|Overall Study|Pregnancy|0|||
161863078|NCT01836471|584540311|FG002|Overall Study|Pregnancy|0|||
161863079|NCT01836471|584540312|FG003|Overall Study|Pregnancy|0|||
161863080|NCT01836471|584540313|FG004|Overall Study|Pregnancy|0|||
161863081|NCT01836471|584540309|FG000|Overall Study|Withdrawal by Subject|3|||
162034714|NCT01288976|585183528|FG002|Overall Study|Death|4|||
161863082|NCT01836471|584540310|FG001|Overall Study|Withdrawal by Subject|4|||
161863083|NCT01836471|584540311|FG002|Overall Study|Withdrawal by Subject|1|||
161863084|NCT01836471|584540312|FG003|Overall Study|Withdrawal by Subject|0|||
161863085|NCT01836471|584540313|FG004|Overall Study|Withdrawal by Subject|2|||
161863086|NCT01836471|584540309|FG000|Overall Study|Physician Decision|0|||
161863087|NCT01836471|584540310|FG001|Overall Study|Physician Decision|1|||
161863088|NCT01836471|584540311|FG002|Overall Study|Physician Decision|0|||
161863089|NCT01836471|584540312|FG003|Overall Study|Physician Decision|0|||
161863090|NCT01836471|584540313|FG004|Overall Study|Physician Decision|0|||
161863091|NCT01836471|584540309|FG000|Overall Study|Lost to Follow-up|0|||
161863092|NCT01836471|584540310|FG001|Overall Study|Lost to Follow-up|0|||
161863093|NCT01836471|584540311|FG002|Overall Study|Lost to Follow-up|0|||
161863094|NCT01836471|584540312|FG003|Overall Study|Lost to Follow-up|1|||
161863095|NCT01836471|584540313|FG004|Overall Study|Lost to Follow-up|1|||
161863096|NCT01836471|584540309|FG000|Overall Study|Adverse Event|6|||
161863097|NCT01836471|584540310|FG001|Overall Study|Adverse Event|3|||
161863098|NCT01836471|584540311|FG002|Overall Study|Adverse Event|1|||
161863099|NCT01836471|584540312|FG003|Overall Study|Adverse Event|1|||
161863100|NCT01836471|584540313|FG004|Overall Study|Adverse Event|2|||
161863101|NCT01836471|584540309|FG000|Overall Study|Non compliance with tx|1|||
161863102|NCT01836471|584540310|FG001|Overall Study|Non compliance with tx|1|||
161863103|NCT01836471|584540311|FG002|Overall Study|Non compliance with tx|0|||
161863104|NCT01836471|584540312|FG003|Overall Study|Non compliance with tx|0|||
161863105|NCT01836471|584540313|FG004|Overall Study|Non compliance with tx|0|||
161863106|NCT01960413|584540317|FG000|Overall Study|Withdrawal by Subject|1|||
161863107|NCT01960413|584540318|FG001|Overall Study|Withdrawal by Subject|1|||
161863108|NCT01960413|584540317|FG000|Overall Study|Physician Decision|1|||
161863109|NCT01960413|584540318|FG001|Overall Study|Physician Decision|0|||
161863110|NCT01960413|584540317|FG000|Overall Study|Lost to Follow-up|2|||
161863111|NCT01960413|584540318|FG001|Overall Study|Lost to Follow-up|0|||
161863112|NCT02285361|584540319|FG000|Overall Study|Protocol Violation|43|||
161863113|NCT02285361|584540319|FG000|Overall Study|Lost to Follow-up|5|||
161863114|NCT02285361|584540319|FG000|Overall Study|Not taken GIOTRIF|2|||
161863115|NCT02285361|584540319|FG000|Overall Study|Consented prior to the contract date|1|||
161863116|NCT02059135|584540320|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
161863117|NCT02059135|584540321|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
161863118|NCT02059135|584540320|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
161863119|NCT02059135|584540321|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
161863120|NCT02059135|584540320|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
161863121|NCT02059135|584540321|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
161863122|NCT02059135|584540320|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
161863123|NCT02059135|584540321|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
161863124|NCT02059135|584540320|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
161863125|NCT02059135|584540321|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
161863126|NCT02059135|584540320|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
161863127|NCT02059135|584540321|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
161863128|NCT02059135|584540320|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
161863129|NCT02059135|584540321|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
161863130|NCT02059135|584540320|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
161863131|NCT02059135|584540321|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
162034715|NCT01288976|585183526|FG000|Overall Study|Data unavailable|22|||
162034716|NCT01288976|585183527|FG001|Overall Study|Data unavailable|9|||
162034717|NCT01288976|585183528|FG002|Overall Study|Data unavailable|7|||
162034718|NCT03560739|585183530|FG000|Overall Study|Adverse Event|0|||
161773207|NCT05182840|584211547|FG001|Treatment Period|Not treated with study drug|0|||
161773208|NCT05182840|584211548|FG002|Treatment Period|Not treated with study drug|0|||
161773209|NCT05182840|584211549|FG003|Treatment Period|Not treated with study drug|1|||
161773210|NCT05182840|584211550|FG004|Treatment Period|Not treated with study drug|0|||
161773211|NCT05182840|584211551|FG005|Treatment Period|Not treated with study drug|0|||
161773212|NCT05182840|584211552|FG006|Treatment Period|Not treated with study drug|1|||
161773213|NCT05182840|584211553|FG007|Treatment Period|Not treated with study drug|1|||
161773214|NCT05182840|584211554|FG008|Treatment Period|Not treated with study drug|0|||
161773215|NCT05182840|584211555|FG009|Treatment Period|Not treated with study drug|0|||
161773216|NCT02396849|584211559|FG000|Overall Study|Lost to Follow-up|1|||
161773217|NCT02396849|584211560|FG001|Overall Study|Lost to Follow-up|1|||
161773218|NCT02396849|584211559|FG000|Overall Study|Did not tolerate intervention|1|||
161773219|NCT02396849|584211560|FG001|Overall Study|Did not tolerate intervention|1|||
161773220|NCT03328325|584211561|FG000|Overall Study|Lost to Follow-up|4|||
161773221|NCT03328325|584211561|FG000|Overall Study|Physician Decision|1|||
161773222|NCT03328325|584211561|FG000|Overall Study|Withdrawal by Subject|3|||
161773223|NCT03328325|584211561|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
161773224|NCT00157157|584211569|FG000|Overall Study|Withdrawal by Subject|6|||
161773225|NCT00157157|584211569|FG000|Overall Study|Physician Decision|1|||
161773226|NCT00157157|584211569|FG000|Overall Study|Lost to Follow-up|1|||
161773227|NCT00157157|584211569|FG000|Overall Study|Enrolled in another study|1|||
161773228|NCT00157157|584211569|FG000|Overall Study|Met exclusion criteria|1|||
161863132|NCT00191477|584540322|FG000|Overall Study|Tumor Recurrence|49|||
161863133|NCT00191477|584540323|FG001|Overall Study|Tumor Recurrence|48|||
161863134|NCT00191477|584540322|FG000|Overall Study|Death, Study Disease|1|||
161863135|NCT00191477|584540323|FG001|Overall Study|Death, Study Disease|1|||
161863136|NCT00191477|584540322|FG000|Overall Study|Death, Other Cause|3|||
161863137|NCT00191477|584540323|FG001|Overall Study|Death, Other Cause|6|||
161863138|NCT00191477|584540322|FG000|Overall Study|Lost to Follow-up|23|||
161863139|NCT00191477|584540323|FG001|Overall Study|Lost to Follow-up|21|||
161863140|NCT00191477|584540322|FG000|Overall Study|Protocol Violation|1|||
161863141|NCT00191477|584540323|FG001|Overall Study|Protocol Violation|1|||
161863142|NCT00191477|584540322|FG000|Overall Study|Treatment Change|2|||
161863143|NCT00191477|584540323|FG001|Overall Study|Treatment Change|0|||
161863144|NCT00191477|584540322|FG000|Overall Study|Withdrawal by Subject|2|||
161863145|NCT00191477|584540323|FG001|Overall Study|Withdrawal by Subject|0|||
161863146|NCT00191477|584540322|FG000|Overall Study|Other|2|||
161863147|NCT00191477|584540323|FG001|Overall Study|Other|0|||
161863148|NCT00191477|584540322|FG000|Overall Study|Not Eligible|41|||
161863149|NCT00191477|584540323|FG001|Overall Study|Not Eligible|38|||
161863150|NCT00191477|584540322|FG000|Overall Study|Pathological Specimen Lost|1|||
161863151|NCT00191477|584540323|FG001|Overall Study|Pathological Specimen Lost|0|||
161863152|NCT00191477|584540322|FG000|Overall Study|Discontinued Prior to Instillation|13|||
161863153|NCT00191477|584540323|FG001|Overall Study|Discontinued Prior to Instillation|14|||
161863154|NCT02411656|584540324|FG000|Overall Study|Adverse Event|4|||
161863155|NCT02411656|584540324|FG000|Overall Study|Clinical Progression|33|||
161863156|NCT06481709|584540325|FG000|Overall Study|Withdrawal by Subject|0|||
162034719|NCT03560739|585183531|FG001|Overall Study|Adverse Event|1|||
162034720|NCT03560739|585183532|FG002|Overall Study|Adverse Event|0|||
162034721|NCT03560739|585183533|FG003|Overall Study|Adverse Event|0|||
162034722|NCT01362595|585183534|FG000|Overall Study|Screen failure|10|||
162034723|NCT01362595|585183534|FG000|Overall Study|Withdrawal by Subject|2|||
162034724|NCT00959374|585183535|FG000|Overall Study|Withdrawal by Subject|2|||
162034725|NCT00959374|585183535|FG000|Overall Study|Lost to Follow-up|14|||
162034726|NCT00959374|585183535|FG000|Overall Study|Death|1|||
162034727|NCT00959374|585183535|FG000|Overall Study|Protocol Violation|1|||
162034728|NCT00959374|585183535|FG000|Overall Study|Implant Removed/Not Replaced|4|||
162034729|NCT00959374|585183535|FG000|Overall Study|Physician Decision|1|||
162034730|NCT02448680|585183536|FG000|Overall Study|Physician Decision|1|||
162034731|NCT02448680|585183537|FG001|Overall Study|Physician Decision|1|||
162034732|NCT02448680|585183536|FG000|Overall Study|Withdrawal by Subject|0|||
162034733|NCT02448680|585183537|FG001|Overall Study|Withdrawal by Subject|2|||
162034734|NCT01739400|585183538|FG000|Overall Study|Physician Decision|3|||
161863157|NCT06481709|584540326|FG001|Overall Study|Withdrawal by Subject|0|||
161977925|NCT05063539|584969031|FG001|Overall Study|Adverse Event|2|||
161977926|NCT05063539|584969032|FG002|Overall Study|Adverse Event|1|||
161977927|NCT05063539|584969030|FG000|Overall Study|Death|0|||
161977928|NCT05063539|584969031|FG001|Overall Study|Death|1|||
161977929|NCT05063539|584969032|FG002|Overall Study|Death|1|||
161977930|NCT05063539|584969030|FG000|Overall Study|Lost to Follow-up|0|||
161977931|NCT05063539|584969031|FG001|Overall Study|Lost to Follow-up|1|||
161977932|NCT05063539|584969032|FG002|Overall Study|Lost to Follow-up|0|||
161977933|NCT05063539|584969030|FG000|Overall Study|Physician Decision|4|||
161977934|NCT05063539|584969031|FG001|Overall Study|Physician Decision|3|||
161977935|NCT05063539|584969032|FG002|Overall Study|Physician Decision|1|||
161977936|NCT05063539|584969030|FG000|Overall Study|Progressive Disease|0|||
161977937|NCT05063539|584969031|FG001|Overall Study|Progressive Disease|2|||
161977938|NCT05063539|584969032|FG002|Overall Study|Progressive Disease|0|||
161977939|NCT05063539|584969030|FG000|Overall Study|Withdrawal by Subject|17|||
161977940|NCT05063539|584969031|FG001|Overall Study|Withdrawal by Subject|26|||
162034735|NCT01739400|585183539|FG001|Overall Study|Physician Decision|0|||
162034736|NCT01739400|585183538|FG000|Overall Study|Lost to Follow-up|2|||
162034737|NCT01739400|585183539|FG001|Overall Study|Lost to Follow-up|0|||
162034738|NCT01739400|585183538|FG000|Overall Study|Death|5|||
162034739|NCT01739400|585183539|FG001|Overall Study|Death|2|||
162034740|NCT01739400|585183538|FG000|Overall Study|Withdrawal by Subject|7|||
162034741|NCT01739400|585183539|FG001|Overall Study|Withdrawal by Subject|7|||
162034742|NCT01736657|585183540|FG000|Overall Study|insufficient vascular access|1|||
162034743|NCT03350984|585183541|FG000|Overall Study|Death|1|||
161863158|NCT06481709|584540327|FG002|Overall Study|Withdrawal by Subject|2|||
162034744|NCT03350984|585183542|FG001|Overall Study|Death|0|||
162034745|NCT03350984|585183541|FG000|Overall Study|Lost to Follow-up|5|||
162034746|NCT03350984|585183542|FG001|Overall Study|Lost to Follow-up|6|||
162034747|NCT03350984|585183541|FG000|Overall Study|Protocol Violation|1|||
161863159|NCT06481709|584540328|FG003|Overall Study|Withdrawal by Subject|0|||
161863160|NCT02224157|584540330|FG000|Overall Study|Severe non-compliance to protocol|2|||
161863161|NCT02224157|584540331|FG001|Overall Study|Severe non-compliance to protocol|2|||
161863162|NCT02224157|584540330|FG000|Overall Study|Other|13|||
161977941|NCT05063539|584969032|FG002|Overall Study|Withdrawal by Subject|14|||
161977942|NCT05063539|584969030|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
161977943|NCT05063539|584969031|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
162034748|NCT03350984|585183542|FG001|Overall Study|Protocol Violation|2|||
162034749|NCT03350984|585183541|FG000|Overall Study|Physician Decision|1|||
162034750|NCT03350984|585183542|FG001|Overall Study|Physician Decision|0|||
161977944|NCT05063539|584969032|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
161977945|NCT05063539|584969030|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
161977946|NCT05063539|584969031|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
161977947|NCT05063539|584969032|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
161977948|NCT05063539|584969030|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
161977949|NCT05063539|584969031|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
161977950|NCT05063539|584969032|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
161977951|NCT05063539|584969030|FG000|Overall Study|Discontinued due to Common Close Design|0|||
161977952|NCT05063539|584969031|FG001|Overall Study|Discontinued due to Common Close Design|1|||
161977953|NCT05063539|584969032|FG002|Overall Study|Discontinued due to Common Close Design|0|||
161977954|NCT05063539|584969030|FG000|Overall Study|Participant not co-operative|0|||
161977955|NCT05063539|584969031|FG001|Overall Study|Participant not co-operative|1|||
161977956|NCT05063539|584969032|FG002|Overall Study|Participant not co-operative|0|||
161977957|NCT05063539|584969030|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
161977958|NCT05063539|584969031|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
161977959|NCT05063539|584969032|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
161977960|NCT05063539|584969030|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
161977961|NCT05063539|584969031|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
161977962|NCT05063539|584969032|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
161977963|NCT04692077|584969033|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
161977964|NCT01751139|584969038|FG000|Overall Study|Other|135|||
161977965|NCT01751139|584969038|FG000|Overall Study|Sponsor study termination|1609|||
161977966|NCT01751139|584969038|FG000|Overall Study|Lost to Follow-up|240|||
161977967|NCT01751139|584969038|FG000|Overall Study|Withdrawal by Subject|251|||
162034751|NCT00642473|585183551|FG000|Overall Study|Withdrawal by Subject|0|||
162034752|NCT00642473|585183552|FG001|Overall Study|Withdrawal by Subject|5|||
162034753|NCT00642473|585183551|FG000|Overall Study|Progression or death|2|||
162034754|NCT00642473|585183552|FG001|Overall Study|Progression or death|4|||
162034755|NCT00642473|585183551|FG000|Overall Study|Other|2|||
162034756|NCT00642473|585183552|FG001|Overall Study|Other|2|||
162034757|NCT04533880|585183553|FG000|Overall Study|Lost to Follow-up|0|||
162034758|NCT04533880|585183554|FG001|Overall Study|Lost to Follow-up|1|||
162034759|NCT04533880|585183555|FG002|Overall Study|Lost to Follow-up|1|||
162034760|NCT02284178|585183557|FG000|Overall Study|Met exclusion criteria|49|||
162034761|NCT02284178|585183558|FG001|Overall Study|Met exclusion criteria|54|||
162034762|NCT01741012|585183559|FG000|Overall Study|Lost to Follow-up|1|||
162034763|NCT01741012|585183559|FG000|Overall Study|Withdrawal by Subject|2|||
162034764|NCT01711879|585183562|FG000|Overall Study|Death|1|||
162034765|NCT01711879|585183563|FG001|Overall Study|Death|0|||
162034766|NCT00958789|585183567|FG000|Overall Study|Death|5|||
162034767|NCT00958789|585183567|FG000|Overall Study|Lost to Follow-up|14|||
162034768|NCT00958789|585183567|FG000|Overall Study|Withdrawal by Subject|17|||
162034769|NCT00958789|585183567|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
162034770|NCT00958789|585183567|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
162034771|NCT00958789|585183567|FG000|Overall Study|Subject terminated|2|||
162034772|NCT00958789|585183567|FG000|Overall Study|Revision|7|||
162034773|NCT01466179|585183570|FG000|Overall Study|Ongoing in core study|2|||
162034774|NCT01466179|585183570|FG000|Overall Study|Physician Decision|46|||
162034775|NCT01466179|585183570|FG000|Overall Study|Progressive disease|43|||
162034776|NCT01466179|585183570|FG000|Overall Study|Adverse Event|32|||
162034777|NCT01466179|585183570|FG000|Overall Study|Disease relapse|23|||
162034778|NCT01466179|585183570|FG000|Overall Study|Lack of Efficacy|14|||
162034779|NCT01466179|585183570|FG000|Overall Study|Death|7|||
162034780|NCT01466179|585183570|FG000|Overall Study|Withdrawal by Subject|7|||
162034781|NCT01466179|585183570|FG000|Overall Study|Protocol Violation|2|||
162034782|NCT01466179|585183570|FG000|Overall Study|Other|3|||
162034783|NCT03410823|585183571|FG000|Overall Study|Death|1|||
162034784|NCT03410823|585183571|FG000|Overall Study|Withdrawal by Subject|2|||
162034785|NCT03410823|585183571|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
162034786|NCT03707184|585183574|FG000|Overall Study|Withdrawal by Subject|2|||
162034787|NCT04704154|585183575|FG000|Overall Study|Adverse Event|3|||
162034788|NCT04704154|585183576|FG001|Overall Study|Adverse Event|2|||
162034789|NCT04704154|585183577|FG002|Overall Study|Adverse Event|4|||
162034790|NCT04704154|585183578|FG003|Overall Study|Adverse Event|2|||
161773229|NCT00157157|584211569|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
161977968|NCT01751139|584969038|FG000|Overall Study|Adverse Event|1|||
161977969|NCT01751139|584969038|FG000|Overall Study|Death|31|||
162034791|NCT04704154|585183579|FG004|Overall Study|Adverse Event|3|||
162034792|NCT04704154|585183580|FG005|Overall Study|Adverse Event|0|||
162034793|NCT04704154|585183575|FG000|Overall Study|Death|3|||
162034794|NCT04704154|585183576|FG001|Overall Study|Death|0|||
161977970|NCT03199391|584969039|FG000|Overall Study|Death|1|||
161977971|NCT03199391|584969039|FG000|Overall Study|Lost to Follow-up|3|||
161977972|NCT03199391|584969039|FG000|Overall Study|Adverse Event|2|||
161977973|NCT03199391|584969039|FG000|Overall Study|Withdrawal by Subject|10|||
161977974|NCT01867086|584969040|FG000|Overall Study|Disease Progression|1|||
161977975|NCT04271475|584969045|FG000|DB Period: Day 1 up to EODBT|Death|1|||
161977976|NCT04271475|584969046|FG001|DB Period: Day 1 up to EODBT|Death|0|||
161977977|NCT04271475|584969047|FG002|DB Period: Day 1 up to EODBT|Death|0|||
161977978|NCT04271475|584969048|FG003|DB Period: Day 1 up to EODBT|Death|0|||
161977979|NCT04271475|584969045|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
161977980|NCT04271475|584969046|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
161977981|NCT04271475|584969047|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
161977982|NCT04271475|584969048|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
161977983|NCT04271475|584969045|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
161977984|NCT04271475|584969046|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
161977985|NCT04271475|584969047|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
161977986|NCT04271475|584969048|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
161977987|NCT04271475|584969045|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
161977988|NCT04271475|584969046|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
161977989|NCT04271475|584969047|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
161977990|NCT04271475|584969048|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
161977991|NCT04271475|584969045|FG000|DB Period: Day 1 up to EODBT|Other|8|||
161977992|NCT04271475|584969046|FG001|DB Period: Day 1 up to EODBT|Other|5|||
161977993|NCT04271475|584969047|FG002|DB Period: Day 1 up to EODBT|Other|0|||
161977994|NCT04271475|584969048|FG003|DB Period: Day 1 up to EODBT|Other|0|||
161977995|NCT04271475|584969045|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
161977996|NCT04271475|584969046|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
161977997|NCT04271475|584969047|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
161977998|NCT04271475|584969048|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
161977999|NCT04271475|584969045|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
161978000|NCT04271475|584969046|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
161978001|NCT04271475|584969047|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
161978002|NCT04271475|584969048|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
161978003|NCT01300351|584969052|FG000|Overall Study|Did not receive treatment|2|||
161978004|NCT01300351|584969053|FG001|Overall Study|Did not receive treatment|0|||
161978005|NCT01300351|584969052|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
161978006|NCT01300351|584969053|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
161978007|NCT01300351|584969052|FG000|Overall Study|Lost to Follow-up|0|||
161978008|NCT01300351|584969053|FG001|Overall Study|Lost to Follow-up|1|||
161978009|NCT01300351|584969052|FG000|Overall Study|Adverse Event|0|||
161978010|NCT01300351|584969053|FG001|Overall Study|Adverse Event|4|||
161978011|NCT01300351|584969052|FG000|Overall Study|Withdrawal by Subject|7|||
161978012|NCT01300351|584969053|FG001|Overall Study|Withdrawal by Subject|10|||
161978013|NCT05824936|584969058|FG000|Overall Study|Lost to Follow-up|1|||
161978014|NCT00673881|584969059|FG000|Overall Study|Withdrawal by Subject|1|||
161978015|NCT00096018|584969060|FG000|Overall Study|Became Ineligible (not treated)|0|||
161978016|NCT00096018|584969061|FG001|Overall Study|Became Ineligible (not treated)|3|||
161978017|NCT00096018|584969060|FG000|Overall Study|Miscellaneous (not treated)|0|||
161978018|NCT00096018|584969061|FG001|Overall Study|Miscellaneous (not treated)|2|||
161978019|NCT00096018|584969060|FG000|Overall Study|Adverse Event|0|||
161978020|NCT00096018|584969061|FG001|Overall Study|Adverse Event|5|||
161978021|NCT00096018|584969060|FG000|Overall Study|Death|0|||
161978022|NCT00096018|584969061|FG001|Overall Study|Death|1|||
161978023|NCT00096018|584969060|FG000|Overall Study|Withdrawal by Subject|0|||
161978024|NCT00096018|584969061|FG001|Overall Study|Withdrawal by Subject|2|||
161978025|NCT00096018|584969060|FG000|Overall Study|Miscellaneous|2|||
161978026|NCT00096018|584969061|FG001|Overall Study|Miscellaneous|1|||
161978027|NCT00483041|584969062|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
161978028|NCT00483041|584969063|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
161978029|NCT01299571|584969064|FG000|Overall Study|Protocol Violation|107|||
161978030|NCT00875056|584969069|FG000|Overall Study|Adverse Event|6|||
161978031|NCT00875056|584969070|FG001|Overall Study|Adverse Event|1|||
161978032|NCT00875056|584969071|FG002|Overall Study|Adverse Event|2|||
161978033|NCT00875056|584969069|FG000|Overall Study|Progressive Disease|14|||
161978034|NCT00875056|584969070|FG001|Overall Study|Progressive Disease|8|||
161978035|NCT00875056|584969071|FG002|Overall Study|Progressive Disease|3|||
161978036|NCT00875056|584969069|FG000|Overall Study|Withdrawal by Subject|3|||
161978037|NCT00875056|584969070|FG001|Overall Study|Withdrawal by Subject|0|||
161978038|NCT00875056|584969071|FG002|Overall Study|Withdrawal by Subject|1|||
161978039|NCT01533922|584969072|FG000|Overall Study|Adverse Event|5|||
161978040|NCT01533922|584969073|FG001|Overall Study|Adverse Event|8|||
161978041|NCT01533922|584969074|FG002|Overall Study|Adverse Event|6|||
161978042|NCT01533922|584969075|FG003|Overall Study|Adverse Event|3|||
161978043|NCT01533922|584969076|FG004|Overall Study|Adverse Event|4|||
161978044|NCT01533922|584969072|FG000|Overall Study|Lack of Efficacy|0|||
161978045|NCT01533922|584969073|FG001|Overall Study|Lack of Efficacy|0|||
161978046|NCT01533922|584969074|FG002|Overall Study|Lack of Efficacy|1|||
161978047|NCT01533922|584969075|FG003|Overall Study|Lack of Efficacy|0|||
161978048|NCT01533922|584969076|FG004|Overall Study|Lack of Efficacy|0|||
161978049|NCT01533922|584969072|FG000|Overall Study|Protocol Violation|0|||
161978050|NCT01533922|584969073|FG001|Overall Study|Protocol Violation|3|||
161978051|NCT01533922|584969074|FG002|Overall Study|Protocol Violation|0|||
161978052|NCT01533922|584969075|FG003|Overall Study|Protocol Violation|0|||
161978053|NCT01533922|584969076|FG004|Overall Study|Protocol Violation|1|||
161773230|NCT02260804|584211570|FG000|Induction Study Period|Protocol Violation|2|||
161773231|NCT02260804|584211571|FG001|Induction Study Period|Protocol Violation|0|||
161773232|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
161978054|NCT01533922|584969072|FG000|Overall Study|Withdrawal by Subject|3|||
161978055|NCT01533922|584969073|FG001|Overall Study|Withdrawal by Subject|1|||
161978056|NCT01533922|584969074|FG002|Overall Study|Withdrawal by Subject|2|||
161978057|NCT01533922|584969075|FG003|Overall Study|Withdrawal by Subject|2|||
161978058|NCT01533922|584969076|FG004|Overall Study|Withdrawal by Subject|1|||
161978059|NCT01533922|584969072|FG000|Overall Study|Other reason not defined above|2|||
161978060|NCT01533922|584969073|FG001|Overall Study|Other reason not defined above|0|||
161978061|NCT01533922|584969074|FG002|Overall Study|Other reason not defined above|1|||
161978062|NCT01533922|584969075|FG003|Overall Study|Other reason not defined above|0|||
161978063|NCT01533922|584969076|FG004|Overall Study|Other reason not defined above|0|||
161978064|NCT00286221|584969082|FG000|Overall Study|Protocol Violation|2|||
161978065|NCT00286221|584969083|FG001|Overall Study|Protocol Violation|1|||
161978066|NCT00286221|584969084|FG002|Overall Study|Protocol Violation|6|||
161978067|NCT00286221|584969085|FG003|Overall Study|Protocol Violation|4|||
161978068|NCT00286221|584969082|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
161978069|NCT00286221|584969083|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
161978070|NCT00286221|584969084|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
161978071|NCT00286221|584969085|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
161978072|NCT00286221|584969082|FG000|Overall Study|Inability to trigger PCA|2|||
161978073|NCT00286221|584969083|FG001|Overall Study|Inability to trigger PCA|0|||
161978074|NCT00286221|584969084|FG002|Overall Study|Inability to trigger PCA|0|||
161978075|NCT00286221|584969085|FG003|Overall Study|Inability to trigger PCA|0|||
161978076|NCT00286221|584969082|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
161978077|NCT00286221|584969083|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
161978078|NCT00286221|584969084|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
161978079|NCT00286221|584969085|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
161978080|NCT02553538|584969088|FG000|Overall Study|Could Not Reach by Telephone|133|||
161978081|NCT02553538|584969089|FG001|Overall Study|Could Not Reach by Telephone|0|||
161978082|NCT02553538|584969088|FG000|Overall Study|Died or Left Network|54|||
161978083|NCT02553538|584969089|FG001|Overall Study|Died or Left Network|56|||
161978084|NCT02648217|584969090|FG000|Overall Study|Adverse Event|0|||
161978085|NCT02648217|584969091|FG001|Overall Study|Adverse Event|1|||
161978086|NCT02648217|584969090|FG000|Overall Study|Lost to Follow-up|1|||
161978087|NCT02648217|584969091|FG001|Overall Study|Lost to Follow-up|1|||
161978088|NCT02648217|584969090|FG000|Overall Study|Withdrawal by Subject|4|||
161978089|NCT02648217|584969091|FG001|Overall Study|Withdrawal by Subject|3|||
161978090|NCT02648217|584969090|FG000|Overall Study|Unclassified|5|||
161978091|NCT02648217|584969091|FG001|Overall Study|Unclassified|0|||
161978092|NCT02066129|584969092|FG000|Overall Study|Lost to Follow-up|13|||
161978093|NCT02066129|584969093|FG001|Overall Study|Lost to Follow-up|12|||
161978094|NCT02066129|584969092|FG000|Overall Study|Withdrawal by Subject|7|||
161978095|NCT02066129|584969093|FG001|Overall Study|Withdrawal by Subject|10|||
161978096|NCT02066129|584969092|FG000|Overall Study|Lack of Efficacy|8|||
161978097|NCT02066129|584969093|FG001|Overall Study|Lack of Efficacy|10|||
161978098|NCT02066129|584969092|FG000|Overall Study|Physician Decision|1|||
161978099|NCT02066129|584969093|FG001|Overall Study|Physician Decision|1|||
161978100|NCT02900170|584969098|FG000|Overall Study|Lost to Follow-up|8|||
161978101|NCT02635347|584969099|FG000|Overall Study|Failed screening|20|||
161978102|NCT02635347|584969100|FG001|Overall Study|Failed screening|7|||
161978103|NCT02124772|584969101|FG000|Overall Study|Lack of Efficacy|2|||
161978104|NCT02124772|584969102|FG001|Overall Study|Lack of Efficacy|0|||
161978105|NCT02124772|584969103|FG002|Overall Study|Lack of Efficacy|0|||
161978106|NCT02124772|584969104|FG003|Overall Study|Lack of Efficacy|1|||
161978107|NCT02124772|584969105|FG004|Overall Study|Lack of Efficacy|2|||
161978108|NCT02124772|584969106|FG005|Overall Study|Lack of Efficacy|3|||
161978109|NCT02124772|584969107|FG006|Overall Study|Lack of Efficacy|0|||
161978110|NCT02124772|584969108|FG007|Overall Study|Lack of Efficacy|2|||
161978111|NCT02124772|584969109|FG008|Overall Study|Lack of Efficacy|0|||
161978112|NCT02124772|584969110|FG009|Overall Study|Lack of Efficacy|1|||
161978113|NCT02124772|584969111|FG010|Overall Study|Lack of Efficacy|0|||
161978114|NCT02124772|584969112|FG011|Overall Study|Lack of Efficacy|0|||
161978115|NCT02124772|584969113|FG012|Overall Study|Lack of Efficacy|1|||
161978116|NCT02124772|584969101|FG000|Overall Study|Adverse Event|1|||
161978117|NCT02124772|584969102|FG001|Overall Study|Adverse Event|4|||
161863163|NCT02224157|584540331|FG001|Overall Study|Other|10|||
161863164|NCT02224157|584540330|FG000|Overall Study|Subject decision|58|||
161863165|NCT02224157|584540331|FG001|Overall Study|Subject decision|50|||
161863166|NCT02224157|584540330|FG000|Overall Study|Prematurely closed site|4|||
161863167|NCT02224157|584540331|FG001|Overall Study|Prematurely closed site|2|||
161863168|NCT02224157|584540330|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
161863169|NCT02224157|584540331|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
161863170|NCT02224157|584540330|FG000|Overall Study|Lost to Follow-up|27|||
161863171|NCT02224157|584540331|FG001|Overall Study|Lost to Follow-up|35|||
161863172|NCT02224157|584540330|FG000|Overall Study|Death|1|||
161863173|NCT02224157|584540331|FG001|Overall Study|Death|1|||
161863174|NCT02224157|584540330|FG000|Overall Study|Adverse Event|1|||
161863175|NCT02224157|584540331|FG001|Overall Study|Adverse Event|3|||
161863176|NCT05906628|584540332|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
161863177|NCT05906628|584540333|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
161863178|NCT05906628|584540332|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
161863179|NCT05906628|584540333|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
161863180|NCT05906628|584540332|FG000|16-Week DBVC Period|Protocol Violation|4|||
161863181|NCT05906628|584540333|FG001|16-Week DBVC Period|Protocol Violation|2|||
161863182|NCT05906628|584540332|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
161863183|NCT05906628|584540333|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
161863184|NCT05906628|584540332|FG000|16-Week OLE Period|Death|1|||
161863185|NCT05906628|584540333|FG001|16-Week OLE Period|Death|0|||
161863186|NCT05906628|584540332|FG000|16-Week OLE Period|Lost to Follow-up|1|||
161863187|NCT05906628|584540333|FG001|16-Week OLE Period|Lost to Follow-up|1|||
161863188|NCT05906628|584540332|FG000|16-Week OLE Period|Protocol Violation|0|||
161863189|NCT05906628|584540333|FG001|16-Week OLE Period|Protocol Violation|1|||
161863190|NCT05906628|584540332|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
161863191|NCT05906628|584540333|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
161863192|NCT01108718|584540334|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
161863193|NCT01108718|584540335|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
161863194|NCT02443740|584540336|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863195|NCT02443740|584540337|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863196|NCT02443740|584540338|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863197|NCT02443740|584540339|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863198|NCT02443740|584540340|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863199|NCT02443740|584540341|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
161863200|NCT02443740|584540342|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863201|NCT02443740|584540343|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863202|NCT02443740|584540344|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863203|NCT02443740|584540345|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863204|NCT02443740|584540346|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
161863205|NCT02443740|584540336|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
161863206|NCT02443740|584540337|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863207|NCT02443740|584540338|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863208|NCT02443740|584540339|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863209|NCT02443740|584540340|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863210|NCT02443740|584540341|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863211|NCT02443740|584540342|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
161863212|NCT02443740|584540343|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863213|NCT02443740|584540344|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863214|NCT02443740|584540345|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863215|NCT02443740|584540346|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161863216|NCT02443740|584540336|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863217|NCT02443740|584540337|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863218|NCT02443740|584540338|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863219|NCT02443740|584540339|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863220|NCT02443740|584540340|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863221|NCT02443740|584540341|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
161863222|NCT02443740|584540342|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161978118|NCT02124772|584969103|FG002|Overall Study|Adverse Event|1|||
161978119|NCT02124772|584969104|FG003|Overall Study|Adverse Event|5|||
161978120|NCT02124772|584969105|FG004|Overall Study|Adverse Event|2|||
161978121|NCT02124772|584969106|FG005|Overall Study|Adverse Event|1|||
161863223|NCT02443740|584540343|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863224|NCT02443740|584540344|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863225|NCT02443740|584540345|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863226|NCT02443740|584540346|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161863227|NCT05373108|584540347|FG000|Overall Study|Withdrawal by Subject|2|||
161863228|NCT02892331|584540348|FG000|Overall Study|Withdrawal by Subject|0|||
161978122|NCT02124772|584969107|FG006|Overall Study|Adverse Event|1|||
161978123|NCT02124772|584969108|FG007|Overall Study|Adverse Event|5|||
161978124|NCT02124772|584969109|FG008|Overall Study|Adverse Event|0|||
161978125|NCT02124772|584969110|FG009|Overall Study|Adverse Event|3|||
161978126|NCT02124772|584969111|FG010|Overall Study|Adverse Event|1|||
161978127|NCT02124772|584969112|FG011|Overall Study|Adverse Event|3|||
161978128|NCT02124772|584969113|FG012|Overall Study|Adverse Event|1|||
161978129|NCT02124772|584969101|FG000|Overall Study|Withdrawal consent|0|||
161978130|NCT02124772|584969102|FG001|Overall Study|Withdrawal consent|1|||
161978131|NCT02124772|584969103|FG002|Overall Study|Withdrawal consent|1|||
161978132|NCT02124772|584969104|FG003|Overall Study|Withdrawal consent|1|||
161978133|NCT02124772|584969105|FG004|Overall Study|Withdrawal consent|0|||
161978134|NCT02124772|584969106|FG005|Overall Study|Withdrawal consent|1|||
161978135|NCT02124772|584969107|FG006|Overall Study|Withdrawal consent|1|||
161978136|NCT02124772|584969108|FG007|Overall Study|Withdrawal consent|0|||
161978137|NCT02124772|584969109|FG008|Overall Study|Withdrawal consent|0|||
161978138|NCT02124772|584969110|FG009|Overall Study|Withdrawal consent|1|||
161978139|NCT02124772|584969111|FG010|Overall Study|Withdrawal consent|0|||
161978140|NCT02124772|584969112|FG011|Overall Study|Withdrawal consent|1|||
161978141|NCT02124772|584969113|FG012|Overall Study|Withdrawal consent|0|||
161978142|NCT02124772|584969101|FG000|Overall Study|Investigator discretion|0|||
161978143|NCT02124772|584969102|FG001|Overall Study|Investigator discretion|2|||
161978144|NCT02124772|584969103|FG002|Overall Study|Investigator discretion|2|||
161978145|NCT02124772|584969104|FG003|Overall Study|Investigator discretion|1|||
161978146|NCT02124772|584969105|FG004|Overall Study|Investigator discretion|1|||
161978147|NCT02124772|584969106|FG005|Overall Study|Investigator discretion|0|||
161978148|NCT02124772|584969107|FG006|Overall Study|Investigator discretion|1|||
161978149|NCT02124772|584969108|FG007|Overall Study|Investigator discretion|0|||
161978150|NCT02124772|584969109|FG008|Overall Study|Investigator discretion|0|||
161978151|NCT02124772|584969110|FG009|Overall Study|Investigator discretion|1|||
161978152|NCT02124772|584969111|FG010|Overall Study|Investigator discretion|0|||
161978153|NCT02124772|584969112|FG011|Overall Study|Investigator discretion|1|||
161978154|NCT02124772|584969113|FG012|Overall Study|Investigator discretion|0|||
161978155|NCT02124772|584969101|FG000|Overall Study|Progressive disease|0|||
161978156|NCT02124772|584969102|FG001|Overall Study|Progressive disease|0|||
161978157|NCT02124772|584969103|FG002|Overall Study|Progressive disease|0|||
161978158|NCT02124772|584969104|FG003|Overall Study|Progressive disease|0|||
161978159|NCT02124772|584969105|FG004|Overall Study|Progressive disease|0|||
161978160|NCT02124772|584969106|FG005|Overall Study|Progressive disease|0|||
161978161|NCT02124772|584969107|FG006|Overall Study|Progressive disease|1|||
161978162|NCT02124772|584969108|FG007|Overall Study|Progressive disease|1|||
161978163|NCT02124772|584969109|FG008|Overall Study|Progressive disease|0|||
161978164|NCT02124772|584969110|FG009|Overall Study|Progressive disease|0|||
161978165|NCT02124772|584969111|FG010|Overall Study|Progressive disease|0|||
161978166|NCT02124772|584969112|FG011|Overall Study|Progressive disease|0|||
161978167|NCT02124772|584969113|FG012|Overall Study|Progressive disease|0|||
161978168|NCT02124772|584969101|FG000|Overall Study|Other|0|||
161978169|NCT02124772|584969102|FG001|Overall Study|Other|7|||
161978170|NCT02124772|584969103|FG002|Overall Study|Other|2|||
161978171|NCT02124772|584969104|FG003|Overall Study|Other|5|||
161978172|NCT02124772|584969105|FG004|Overall Study|Other|4|||
161978173|NCT02124772|584969106|FG005|Overall Study|Other|3|||
161978174|NCT02124772|584969107|FG006|Overall Study|Other|4|||
161978175|NCT02124772|584969108|FG007|Overall Study|Other|1|||
161978176|NCT02124772|584969109|FG008|Overall Study|Other|1|||
161978177|NCT02124772|584969110|FG009|Overall Study|Other|1|||
161978178|NCT02124772|584969111|FG010|Overall Study|Other|1|||
161978179|NCT02124772|584969112|FG011|Overall Study|Other|1|||
161978180|NCT02124772|584969113|FG012|Overall Study|Other|0|||
161978181|NCT01827332|584969114|FG000|Overall Study|Lost to Follow-up|2|||
161978182|NCT01827332|584969115|FG001|Overall Study|Lost to Follow-up|1|||
161978183|NCT02725593|584969116|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
161978184|NCT02725593|584969117|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
161978185|NCT02725593|584969116|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
161978186|NCT02725593|584969117|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
161978187|NCT02725593|584969116|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
161978188|NCT02725593|584969117|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
161978189|NCT02725593|584969116|FG000|Long Term Extension|Withdrawal by Subject|1|||
161978190|NCT02725593|584969117|FG001|Long Term Extension|Withdrawal by Subject|3|||
161978191|NCT01440881|584969125|FG000|Overall Study|Death|0|||
161978192|NCT01440881|584969126|FG001|Overall Study|Death|1|||
161978193|NCT02644356|584969130|FG000|Overall Study|Withdrawal by Subject|2|||
161978194|NCT02290938|584969131|FG000|Overall Study|Lost to Follow-up|14|||
161978195|NCT02290938|584969132|FG001|Overall Study|Lost to Follow-up|43|||
161978196|NCT00897390|584969133|FG000|Overall Study|Adverse Event|2|||
161978197|NCT00897390|584969133|FG000|Overall Study|No Longer Met Study Criteria|1|||
161978198|NCT00897390|584969133|FG000|Overall Study|Personal Reasons|1|||
161978199|NCT00897390|584969133|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
161978200|NCT03159104|584969134|FG000|Overall Study|Violation of inclusion criteria|1|||
161978201|NCT03159104|584969135|FG001|Overall Study|Violation of inclusion criteria|2|||
161978202|NCT01216683|584970306|FG000|Induction|Never started treatment|0|||
161978203|NCT01216683|584970307|FG001|Induction|Never started treatment|6|||
161863229|NCT02892331|584540349|FG001|Overall Study|Withdrawal by Subject|1|||
161863230|NCT02892331|584540350|FG002|Overall Study|Withdrawal by Subject|1|||
161863231|NCT02892331|584540348|FG000|Overall Study|Sick family member|0|||
161863232|NCT02892331|584540349|FG001|Overall Study|Sick family member|0|||
161863233|NCT02892331|584540350|FG002|Overall Study|Sick family member|1|||
161863234|NCT02892331|584540348|FG000|Overall Study|Corona virus pandemic|1|||
161863235|NCT02892331|584540349|FG001|Overall Study|Corona virus pandemic|0|||
161863236|NCT02892331|584540350|FG002|Overall Study|Corona virus pandemic|1|||
161863237|NCT02892331|584540348|FG000|Overall Study|Lost to Follow-up|1|||
161863238|NCT02892331|584540349|FG001|Overall Study|Lost to Follow-up|0|||
161863239|NCT02892331|584540350|FG002|Overall Study|Lost to Follow-up|1|||
161863240|NCT02892331|584540348|FG000|Overall Study|Blood pressure was too elevated|0|||
161863241|NCT02892331|584540349|FG001|Overall Study|Blood pressure was too elevated|1|||
161863242|NCT02892331|584540350|FG002|Overall Study|Blood pressure was too elevated|0|||
161863243|NCT02892331|584540348|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
161863244|NCT02892331|584540349|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
161863245|NCT02892331|584540350|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
161863246|NCT04871776|584540351|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
161863247|NCT04871776|584540352|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
161863248|NCT04871776|584540353|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
161863249|NCT04871776|584540351|FG000|Overall Study|Did not meet eligibility criteria|1|||
161863250|NCT04871776|584540352|FG001|Overall Study|Did not meet eligibility criteria|1|||
161863251|NCT04871776|584540353|FG002|Overall Study|Did not meet eligibility criteria|1|||
161863252|NCT00370552|584542177|FG000|Overall Study|Adverse Event|2|||
161863253|NCT00370552|584542178|FG001|Overall Study|Adverse Event|2|||
161863254|NCT00370552|584542179|FG002|Overall Study|Adverse Event|2|||
161863255|NCT00370552|584542177|FG000|Overall Study|Disease progression|23|||
161863256|NCT00370552|584542178|FG001|Overall Study|Disease progression|23|||
161863257|NCT00370552|584542179|FG002|Overall Study|Disease progression|15|||
161863258|NCT00370552|584542177|FG000|Overall Study|Maximum clinical benefit|3|||
161863259|NCT00370552|584542178|FG001|Overall Study|Maximum clinical benefit|5|||
161863260|NCT00370552|584542179|FG002|Overall Study|Maximum clinical benefit|5|||
161863261|NCT00370552|584542177|FG000|Overall Study|Poor or noncompliance|0|||
161863262|NCT00370552|584542178|FG001|Overall Study|Poor or noncompliance|0|||
161863263|NCT00370552|584542179|FG002|Overall Study|Poor or noncompliance|1|||
161863264|NCT00370552|584542177|FG000|Overall Study|Study drug toxicity|11|||
161863265|NCT00370552|584542178|FG001|Overall Study|Study drug toxicity|8|||
161863266|NCT00370552|584542179|FG002|Overall Study|Study drug toxicity|6|||
161863267|NCT00370552|584542177|FG000|Overall Study|Withdrawal by Subject|2|||
161863268|NCT00370552|584542178|FG001|Overall Study|Withdrawal by Subject|0|||
161863269|NCT00370552|584542179|FG002|Overall Study|Withdrawal by Subject|1|||
161863270|NCT00370552|584542177|FG000|Overall Study|Still on treatment|1|||
161863271|NCT00370552|584542178|FG001|Overall Study|Still on treatment|3|||
161863272|NCT00370552|584542179|FG002|Overall Study|Still on treatment|2|||
161863273|NCT00370552|584542177|FG000|Overall Study|Never treated|1|||
161863274|NCT00370552|584542178|FG001|Overall Study|Never treated|0|||
161863275|NCT00370552|584542179|FG002|Overall Study|Never treated|0|||
161863276|NCT00370552|584542177|FG000|Overall Study|Physician Decision|1|||
161863277|NCT00370552|584542178|FG001|Overall Study|Physician Decision|1|||
161863278|NCT00370552|584542179|FG002|Overall Study|Physician Decision|0|||
161863279|NCT00370552|584542177|FG000|Overall Study|Investigator decision|2|||
161863280|NCT00370552|584542178|FG001|Overall Study|Investigator decision|1|||
161863281|NCT00370552|584542179|FG002|Overall Study|Investigator decision|0|||
161863282|NCT00370552|584542177|FG000|Overall Study|High risk of allergic reaction|0|||
161863283|NCT00370552|584542178|FG001|Overall Study|High risk of allergic reaction|1|||
161863284|NCT00370552|584542179|FG002|Overall Study|High risk of allergic reaction|0|||
161863285|NCT00370552|584542177|FG000|Overall Study|Planned radiation for palliation|0|||
161863286|NCT00370552|584542178|FG001|Overall Study|Planned radiation for palliation|1|||
161863287|NCT00370552|584542179|FG002|Overall Study|Planned radiation for palliation|0|||
161863288|NCT03499067|584542180|FG000|First Intervention|Physician Decision|2|||
161863289|NCT03499067|584542181|FG001|First Intervention|Physician Decision|1|||
161863290|NCT03499067|584542180|FG000|First Intervention|Withdrawal by Subject|3|||
161978204|NCT01216683|584970308|FG002|Induction|Never started treatment|3|||
161978205|NCT01216683|584970306|FG000|Induction|Lack of Efficacy|4|||
161978206|NCT01216683|584970307|FG001|Induction|Lack of Efficacy|3|||
161978207|NCT01216683|584970308|FG002|Induction|Lack of Efficacy|7|||
161978208|NCT01216683|584970306|FG000|Induction|Adverse Event|0|||
161863291|NCT03499067|584542181|FG001|First Intervention|Withdrawal by Subject|6|||
161863292|NCT02392481|584542182|FG000|Overall Study|Adverse Event|0|||
161863293|NCT02392481|584542183|FG001|Overall Study|Adverse Event|0|||
161863294|NCT02392481|584542184|FG002|Overall Study|Adverse Event|1|||
161978209|NCT01216683|584970307|FG001|Induction|Adverse Event|5|||
161978210|NCT01216683|584970308|FG002|Induction|Adverse Event|5|||
161978211|NCT01216683|584970306|FG000|Induction|Death|0|||
162034795|NCT04704154|585183577|FG002|Overall Study|Death|0|||
162034796|NCT04704154|585183578|FG003|Overall Study|Death|0|||
162034797|NCT04704154|585183579|FG004|Overall Study|Death|3|||
162034798|NCT04704154|585183580|FG005|Overall Study|Death|0|||
162034799|NCT04704154|585183575|FG000|Overall Study|Physician Decision|1|||
162034800|NCT04704154|585183576|FG001|Overall Study|Physician Decision|0|||
162034801|NCT04704154|585183577|FG002|Overall Study|Physician Decision|1|||
162034802|NCT04704154|585183578|FG003|Overall Study|Physician Decision|0|||
162034803|NCT04704154|585183579|FG004|Overall Study|Physician Decision|2|||
162034804|NCT04704154|585183580|FG005|Overall Study|Physician Decision|0|||
162034805|NCT04704154|585183575|FG000|Overall Study|Participant Decision|1|||
162034806|NCT04704154|585183576|FG001|Overall Study|Participant Decision|1|||
162034807|NCT04704154|585183577|FG002|Overall Study|Participant Decision|0|||
162034808|NCT04704154|585183578|FG003|Overall Study|Participant Decision|0|||
162034809|NCT04704154|585183579|FG004|Overall Study|Participant Decision|0|||
162034810|NCT04704154|585183580|FG005|Overall Study|Participant Decision|0|||
162034811|NCT04704154|585183575|FG000|Overall Study|Progressive Disease|19|||
162034812|NCT04704154|585183576|FG001|Overall Study|Progressive Disease|17|||
162034813|NCT04704154|585183577|FG002|Overall Study|Progressive Disease|20|||
162034814|NCT04704154|585183578|FG003|Overall Study|Progressive Disease|18|||
162034815|NCT04704154|585183579|FG004|Overall Study|Progressive Disease|36|||
161773233|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
161978212|NCT01216683|584970307|FG001|Induction|Death|0|||
161978213|NCT01216683|584970308|FG002|Induction|Death|2|||
161978214|NCT01216683|584970306|FG000|Induction|Withdrawal by Subject|0|||
161978215|NCT01216683|584970307|FG001|Induction|Withdrawal by Subject|4|||
161978216|NCT01216683|584970308|FG002|Induction|Withdrawal by Subject|2|||
161978217|NCT01216683|584970306|FG000|Induction|Other disease|0|||
161978218|NCT01216683|584970307|FG001|Induction|Other disease|1|||
161978219|NCT01216683|584970308|FG002|Induction|Other disease|2|||
161978220|NCT01216683|584970306|FG000|Continuation|Lack of Efficacy|3|||
161978221|NCT01216683|584970307|FG001|Continuation|Lack of Efficacy|2|||
161978222|NCT01216683|584970308|FG002|Continuation|Lack of Efficacy|7|||
161978223|NCT01216683|584970306|FG000|Continuation|Adverse Event|5|||
161978224|NCT01216683|584970307|FG001|Continuation|Adverse Event|3|||
162034816|NCT04704154|585183580|FG005|Overall Study|Progressive Disease|30|||
162034817|NCT04704154|585183575|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
161773234|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
161773235|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
161773236|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
161773237|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
161773238|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
161773239|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
161773240|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
161773241|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
161773242|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
161773243|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
161773244|NCT02260804|584211570|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
161773245|NCT02260804|584211571|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
161773246|NCT02260804|584211570|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
161773247|NCT02260804|584211571|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
161773248|NCT02260804|584211570|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
161773249|NCT02260804|584211571|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
161773250|NCT02260804|584211570|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
161773251|NCT02260804|584211571|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
161773252|NCT00509223|584214245|FG000|Overall Study|Lost to Follow-up|1|||
161773253|NCT00509223|584214246|FG001|Overall Study|Lost to Follow-up|1|||
161773254|NCT00509223|584214245|FG000|Overall Study|Adverse Event|1|||
161773255|NCT00509223|584214246|FG001|Overall Study|Adverse Event|1|||
161773256|NCT00509223|584214245|FG000|Overall Study|Withdrawal by Subject|25|||
161773257|NCT00509223|584214246|FG001|Overall Study|Withdrawal by Subject|6|||
161773258|NCT00509223|584214245|FG000|Overall Study|Including: subject change of address|5|||
161773259|NCT00509223|584214246|FG001|Overall Study|Including: subject change of address|2|||
161773260|NCT00509223|584214245|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
161773261|NCT00509223|584214246|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
161773262|NCT04888377|584214249|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
161978225|NCT01216683|584970308|FG002|Continuation|Adverse Event|16|||
161978226|NCT01216683|584970306|FG000|Continuation|Death|1|||
162034818|NCT04704154|585183576|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
162034819|NCT04704154|585183577|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
162034820|NCT04704154|585183578|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
161978227|NCT01216683|584970307|FG001|Continuation|Death|0|||
161978228|NCT01216683|584970308|FG002|Continuation|Death|2|||
161978229|NCT01216683|584970306|FG000|Continuation|Withdrawal by Subject|4|||
161978230|NCT01216683|584970307|FG001|Continuation|Withdrawal by Subject|5|||
161978231|NCT01216683|584970308|FG002|Continuation|Withdrawal by Subject|9|||
161978232|NCT01216683|584970306|FG000|Continuation|Other diseases|0|||
161978233|NCT01216683|584970307|FG001|Continuation|Other diseases|2|||
161978234|NCT01216683|584970308|FG002|Continuation|Other diseases|1|||
161978235|NCT01216683|584970306|FG000|Continuation|Physician Decision|1|||
161978236|NCT01216683|584970307|FG001|Continuation|Physician Decision|0|||
161978237|NCT01216683|584970308|FG002|Continuation|Physician Decision|1|||
161978238|NCT01216683|584970306|FG000|Continuation|Non-compliance|1|||
161978239|NCT01216683|584970307|FG001|Continuation|Non-compliance|0|||
161978240|NCT01216683|584970308|FG002|Continuation|Non-compliance|1|||
161978241|NCT01216683|584970306|FG000|Continuation|Insurance change|0|||
161978242|NCT01216683|584970307|FG001|Continuation|Insurance change|1|||
161978243|NCT01216683|584970308|FG002|Continuation|Insurance change|0|||
161978244|NCT01216683|584970306|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
161978245|NCT01216683|584970307|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
161978246|NCT01216683|584970308|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
161978247|NCT01216683|584970306|FG000|Continuation|Not reported|0|||
161978248|NCT01216683|584970307|FG001|Continuation|Not reported|0|||
161978249|NCT01216683|584970308|FG002|Continuation|Not reported|1|||
161978250|NCT01216683|584970306|FG000|Continuation|Never started treatment|0|||
161978251|NCT01216683|584970307|FG001|Continuation|Never started treatment|1|||
161978252|NCT01216683|584970308|FG002|Continuation|Never started treatment|5|||
161978253|NCT01350115|584970309|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
161978254|NCT01350115|584970310|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
161978255|NCT01350115|584970309|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
161978256|NCT01350115|584970310|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
161978257|NCT01350115|584970309|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
161978258|NCT01350115|584970310|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
161978259|NCT04327024|584970311|FG000|Overall Study|Death|1|||
161978260|NCT04327024|584970312|FG001|Overall Study|Death|2|||
161978261|NCT04327024|584970313|FG002|Overall Study|Death|1|||
161978262|NCT04327024|584970311|FG000|Overall Study|Non-compliance with study drug|0|||
161978263|NCT04327024|584970312|FG001|Overall Study|Non-compliance with study drug|1|||
161978264|NCT04327024|584970313|FG002|Overall Study|Non-compliance with study drug|0|||
161978265|NCT04327024|584970311|FG000|Overall Study|Withdrawal by Subject|1|||
161978266|NCT04327024|584970312|FG001|Overall Study|Withdrawal by Subject|1|||
161978267|NCT04327024|584970313|FG002|Overall Study|Withdrawal by Subject|2|||
161978268|NCT00837759|584970317|FG000|Overall Study|Protocol Violation|3|||
161978269|NCT00837759|584970317|FG000|Overall Study|Lost to Follow-up|1|||
161978270|NCT01597635|584970318|FG000|Part A|Adverse Event|3|||
161978271|NCT01597635|584970319|FG001|Part A|Adverse Event|0|||
161978272|NCT01597635|584970320|FG002|Part A|Adverse Event|0|||
161978273|NCT01597635|584970318|FG000|Part B|Adverse Event|0|||
161978274|NCT01597635|584970319|FG001|Part B|Adverse Event|0|||
161978275|NCT01597635|584970320|FG002|Part B|Adverse Event|1|||
161978276|NCT01597635|584970318|FG000|Part B|Protocol Violation|0|||
161978277|NCT01597635|584970319|FG001|Part B|Protocol Violation|1|||
161978278|NCT01597635|584970320|FG002|Part B|Protocol Violation|0|||
161978279|NCT01597635|584970318|FG000|Part B|Protocol-defined stopping criteria|0|||
161978280|NCT01597635|584970319|FG001|Part B|Protocol-defined stopping criteria|4|||
161978281|NCT01597635|584970320|FG002|Part B|Protocol-defined stopping criteria|3|||
161978282|NCT01597635|584970318|FG000|Part B|Withdrawal by Subject|0|||
161978283|NCT01597635|584970319|FG001|Part B|Withdrawal by Subject|1|||
161978284|NCT01597635|584970320|FG002|Part B|Withdrawal by Subject|0|||
161863295|NCT02392481|584542185|FG003|Overall Study|Adverse Event|2|||
161863296|NCT02392481|584542182|FG000|Overall Study|Withdrawal by Subject|0|||
161978285|NCT03968159|584970321|FG000|Overall Study|Adverse Event|4|||
161978286|NCT03968159|584970322|FG001|Overall Study|Adverse Event|4|||
161978287|NCT03968159|584970321|FG000|Overall Study|Lost to Follow-up|1|||
161978288|NCT03968159|584970322|FG001|Overall Study|Lost to Follow-up|1|||
161978289|NCT03968159|584970321|FG000|Overall Study|Use of prohibited medication|0|||
161978290|NCT03968159|584970322|FG001|Overall Study|Use of prohibited medication|1|||
161978291|NCT03968159|584970321|FG000|Overall Study|Protocol Violation|2|||
161978292|NCT03968159|584970322|FG001|Overall Study|Protocol Violation|2|||
161978293|NCT03968159|584970321|FG000|Overall Study|Withdrawal by Subject|4|||
161978294|NCT03968159|584970322|FG001|Overall Study|Withdrawal by Subject|6|||
161978295|NCT03968159|584970321|FG000|Overall Study|Lack of Efficacy|0|||
161978296|NCT03968159|584970322|FG001|Overall Study|Lack of Efficacy|1|||
161978297|NCT03968159|584970321|FG000|Overall Study|Not further specified|2|||
161978298|NCT03968159|584970322|FG001|Overall Study|Not further specified|0|||
161978299|NCT00864851|584970323|FG000|Overall Study|Withdrawal by Subject|0|||
161978300|NCT00864851|584970324|FG001|Overall Study|Withdrawal by Subject|1|||
161978301|NCT00864851|584970325|FG002|Overall Study|Withdrawal by Subject|0|||
161978302|NCT00864851|584970323|FG000|Overall Study|Physician Decision|1|||
161978303|NCT00864851|584970324|FG001|Overall Study|Physician Decision|0|||
161978304|NCT00864851|584970325|FG002|Overall Study|Physician Decision|0|||
161978305|NCT00864851|584970323|FG000|Overall Study|Death|1|||
161978306|NCT00864851|584970324|FG001|Overall Study|Death|0|||
161978307|NCT00864851|584970325|FG002|Overall Study|Death|0|||
161978308|NCT00864851|584970323|FG000|Overall Study|Patient uncooperative|1|||
161978309|NCT00864851|584970324|FG001|Overall Study|Patient uncooperative|0|||
161978310|NCT00864851|584970325|FG002|Overall Study|Patient uncooperative|0|||
161978311|NCT00443781|584970326|FG000|Overall Study|Lost to Follow-up|10|||
161978312|NCT00443781|584970326|FG000|Overall Study|Physician Decision|2|||
161978313|NCT00443781|584970326|FG000|Overall Study|Protocol Violation|1|||
161978314|NCT00443781|584970326|FG000|Overall Study|Withdrawal by Subject|6|||
161978315|NCT00443781|584970326|FG000|Overall Study|Unable to comply with study follow up|2|||
161978316|NCT00443781|584970326|FG000|Overall Study|Investigator terminated participation|1|||
161978317|NCT00443781|584970326|FG000|Overall Study|Insurance not covered|2|||
161978318|NCT00443781|584970326|FG000|Overall Study|PD/FAD not done|1|||
161978319|NCT00430937|584970327|FG000|Overall Study|Adverse Event|3|||
161978320|NCT00430937|584970328|FG001|Overall Study|Adverse Event|8|||
161978321|NCT00430937|584970327|FG000|Overall Study|Death|0|||
161978322|NCT00430937|584970328|FG001|Overall Study|Death|1|||
161978323|NCT00430937|584970327|FG000|Overall Study|Lost to Follow-up|6|||
161978324|NCT00430937|584970328|FG001|Overall Study|Lost to Follow-up|6|||
161978325|NCT00430937|584970327|FG000|Overall Study|Withdrawal by Subject|5|||
161978326|NCT00430937|584970328|FG001|Overall Study|Withdrawal by Subject|2|||
161978327|NCT00430937|584970327|FG000|Overall Study|Protocol Violation|3|||
161978328|NCT00430937|584970328|FG001|Overall Study|Protocol Violation|2|||
161978329|NCT00430937|584970327|FG000|Overall Study|Lack of Efficacy|6|||
161978330|NCT00430937|584970328|FG001|Overall Study|Lack of Efficacy|5|||
161978331|NCT00430937|584970327|FG000|Overall Study|Inappropriate enrollment|2|||
161978332|NCT00430937|584970328|FG001|Overall Study|Inappropriate enrollment|1|||
161978333|NCT00430937|584970327|FG000|Overall Study|Administrative reasons|1|||
161978334|NCT00430937|584970328|FG001|Overall Study|Administrative reasons|0|||
161978335|NCT00430937|584970327|FG000|Overall Study|Protocol discontinuation criteria met|1|||
161978336|NCT00430937|584970328|FG001|Overall Study|Protocol discontinuation criteria met|2|||
161978337|NCT00430937|584970327|FG000|Overall Study|Unable to classify|0|||
161978338|NCT00430937|584970328|FG001|Overall Study|Unable to classify|1|||
161978339|NCT01267175|584970329|FG000|Overall Study|Withdrawal by Subject|1|||
161978340|NCT01267175|584970329|FG000|Overall Study|Lost to Follow-up|1|||
161978341|NCT00895661|584970331|FG000|Overall Study|Death|1|||
161978342|NCT00895661|584970331|FG000|Overall Study|reason unknown|2|||
161978343|NCT02006069|584970332|FG000|Overall Study|MPP other programming|239|||
161978344|NCT02006069|584970333|FG001|Overall Study|MPP other programming|0|||
161978345|NCT02006069|584970332|FG000|Overall Study|RV only pacing|0|||
161978346|NCT02006069|584970333|FG001|Overall Study|RV only pacing|3|||
161978347|NCT02989805|584970336|FG000|Overall Study|invalid consent|6|||
161978348|NCT02989805|584970337|FG001|Overall Study|invalid consent|4|||
161978349|NCT02776033|584970338|FG000|Overall Study|Withdrawal by Subject|0|||
161978350|NCT02776033|584970339|FG001|Overall Study|Withdrawal by Subject|0|||
161978351|NCT02776033|584970340|FG002|Overall Study|Withdrawal by Subject|2|||
161978352|NCT02776033|584970338|FG000|Overall Study|Physician Decision|2|||
161978353|NCT02776033|584970339|FG001|Overall Study|Physician Decision|0|||
161978354|NCT02776033|584970340|FG002|Overall Study|Physician Decision|0|||
161978355|NCT02776033|584970338|FG000|Overall Study|Lost to Follow-up|1|||
161978356|NCT02776033|584970339|FG001|Overall Study|Lost to Follow-up|0|||
161978357|NCT02776033|584970340|FG002|Overall Study|Lost to Follow-up|0|||
161978358|NCT02776033|584970338|FG000|Overall Study|Adverse Event|1|||
161978359|NCT02776033|584970339|FG001|Overall Study|Adverse Event|2|||
161978360|NCT02776033|584970340|FG002|Overall Study|Adverse Event|0|||
161978361|NCT00685373|584970341|FG000|Overall Study|Adverse Event|3|||
161978362|NCT00685373|584970341|FG000|Overall Study|Withdrawal by Subject|5|||
161978363|NCT00685373|584970341|FG000|Overall Study|Lack of Efficacy|3|||
161978364|NCT00685373|584970341|FG000|Overall Study|Condition no longer requires study drug|1|||
161978365|NCT00685373|584970341|FG000|Overall Study|Lost to Follow-up|2|||
162034821|NCT04704154|585183579|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
162034822|NCT04704154|585183580|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
161773263|NCT04888377|584214250|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
161978366|NCT00685373|584970341|FG000|Overall Study|Protocol Violation|1|||
161978367|NCT01302054|584970342|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
161978368|NCT01302054|584970343|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
161978369|NCT01302054|584970344|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
161978370|NCT01302054|584970342|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
161978371|NCT01302054|584970343|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
161978372|NCT01302054|584970344|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
161978373|NCT01302054|584970342|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
161978374|NCT01302054|584970343|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
161773264|NCT04888377|584214249|FG000|Overall Study|Physician Decision|6|||
161978375|NCT01302054|584970344|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
161978376|NCT01302054|584970342|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
161978377|NCT01302054|584970343|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
161978378|NCT01302054|584970344|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
161978379|NCT01302054|584970342|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
161978380|NCT01302054|584970343|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
161978381|NCT01302054|584970344|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
161978382|NCT01302054|584970342|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
161978383|NCT01302054|584970343|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
161978384|NCT01302054|584970344|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
161978385|NCT01302054|584970342|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
161978386|NCT01302054|584970343|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
161978387|NCT01302054|584970344|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
161978388|NCT01302054|584970342|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
161978389|NCT01302054|584970343|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
161978390|NCT01302054|584970344|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
161978391|NCT01302054|584970342|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161978392|NCT01302054|584970343|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
161978393|NCT01302054|584970344|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
161978394|NCT01302054|584970342|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161978395|NCT01302054|584970343|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
161978396|NCT01302054|584970344|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161978397|NCT01302054|584970342|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161978398|NCT01302054|584970343|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
161978399|NCT01302054|584970344|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
161978400|NCT01302054|584970342|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
161978401|NCT01302054|584970343|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
161978402|NCT01302054|584970344|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
161978403|NCT01302054|584970342|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161978404|NCT01302054|584970343|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
161978405|NCT01302054|584970344|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
161978406|NCT01302054|584970342|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
161978407|NCT01302054|584970343|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
161863297|NCT02392481|584542183|FG001|Overall Study|Withdrawal by Subject|0|||
161863298|NCT02392481|584542184|FG002|Overall Study|Withdrawal by Subject|1|||
161863299|NCT02392481|584542185|FG003|Overall Study|Withdrawal by Subject|0|||
161863300|NCT02502149|584542186|FG000|Intermediate|Discontinued prematurely|1|||
161863301|NCT02502149|584542187|FG001|Intermediate|Discontinued prematurely|0|||
161863302|NCT02502149|584542188|FG002|Intermediate|Discontinued prematurely|0|||
161863303|NCT02502149|584542189|FG003|Intermediate|Discontinued prematurely|0|||
161863304|NCT02502149|584542190|FG004|Intermediate|Discontinued prematurely|0|||
161863305|NCT02383017|584542207|FG000|Overall Study|Injury Sustained Outside Study|1|||
161863306|NCT02383017|584542208|FG001|Overall Study|Injury Sustained Outside Study|0|||
161863307|NCT02383017|584542207|FG000|Overall Study|Compliance|3|||
161863308|NCT02383017|584542208|FG001|Overall Study|Compliance|2|||
161863309|NCT02383017|584542207|FG000|Overall Study|Found to be Hypogonadal|1|||
161863310|NCT02383017|584542208|FG001|Overall Study|Found to be Hypogonadal|0|||
161863311|NCT03871543|584542212|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
161863312|NCT03871543|584542212|FG000|Period 1|Investigator Error|1|||
161863313|NCT03871543|584542212|FG000|Period 1|Protocol Violation|2|||
161863314|NCT03871543|584542212|FG000|Period 1|COVID-19 Related|1|||
161863315|NCT03871543|584542212|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
161863316|NCT03871543|584542212|FG000|Period 1|Withdrawal by Subject|10|||
161863317|NCT03871543|584542212|FG000|Period 2|Adverse Event|1|||
161863318|NCT03871543|584542212|FG000|Period 2|Withdrawal by Subject|1|||
161863319|NCT01894919|584542213|FG000|Overall Study|Withdrawal by Subject|1|||
161978408|NCT01302054|584970344|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
161978409|NCT01302054|584970342|FG000|Double-Blind Treatment Phase|Other|0|||
161978410|NCT01302054|584970343|FG001|Double-Blind Treatment Phase|Other|4|||
161978411|NCT01302054|584970344|FG002|Double-Blind Treatment Phase|Other|9|||
161978412|NCT00857948|584970345|FG000|Overall Study|Withdrawal by Subject|2|||
161978413|NCT00857948|584970346|FG001|Overall Study|Withdrawal by Subject|0|||
161863320|NCT01894919|584542214|FG001|Overall Study|Withdrawal by Subject|0|||
161863321|NCT01894919|584542215|FG002|Overall Study|Withdrawal by Subject|0|||
161863322|NCT01894919|584542216|FG003|Overall Study|Withdrawal by Subject|0|||
161978414|NCT00857948|584970347|FG002|Overall Study|Withdrawal by Subject|0|||
161978415|NCT00857948|584970348|FG003|Overall Study|Withdrawal by Subject|0|||
161978416|NCT00857948|584970345|FG000|Overall Study|Protocol Violation|1|||
161978417|NCT00857948|584970346|FG001|Overall Study|Protocol Violation|0|||
161863323|NCT01894919|584542217|FG004|Overall Study|Withdrawal by Subject|1|||
161863324|NCT01894919|584542218|FG005|Overall Study|Withdrawal by Subject|0|||
161863325|NCT01894919|584542219|FG006|Overall Study|Withdrawal by Subject|0|||
161863326|NCT01894919|584542220|FG007|Overall Study|Withdrawal by Subject|0|||
161863327|NCT01894919|584542221|FG008|Overall Study|Withdrawal by Subject|0|||
161863328|NCT01894919|584542222|FG009|Overall Study|Withdrawal by Subject|1|||
161863329|NCT01894919|584542223|FG010|Overall Study|Withdrawal by Subject|1|||
161863330|NCT01894919|584542224|FG011|Overall Study|Withdrawal by Subject|0|||
161863331|NCT01894919|584542225|FG012|Overall Study|Withdrawal by Subject|0|||
161863332|NCT01894919|584542213|FG000|Overall Study|Adverse Event|0|||
161863333|NCT01894919|584542214|FG001|Overall Study|Adverse Event|0|||
161863334|NCT01894919|584542215|FG002|Overall Study|Adverse Event|0|||
161863335|NCT01894919|584542216|FG003|Overall Study|Adverse Event|0|||
161863336|NCT01894919|584542217|FG004|Overall Study|Adverse Event|0|||
161863337|NCT01894919|584542218|FG005|Overall Study|Adverse Event|0|||
161863338|NCT01894919|584542219|FG006|Overall Study|Adverse Event|0|||
161863339|NCT01894919|584542220|FG007|Overall Study|Adverse Event|0|||
161863340|NCT01894919|584542221|FG008|Overall Study|Adverse Event|0|||
161863341|NCT01894919|584542222|FG009|Overall Study|Adverse Event|0|||
161863342|NCT01894919|584542223|FG010|Overall Study|Adverse Event|1|||
161863343|NCT01894919|584542224|FG011|Overall Study|Adverse Event|0|||
161863344|NCT01894919|584542225|FG012|Overall Study|Adverse Event|0|||
161863345|NCT01894919|584542213|FG000|Overall Study|Other-Unspecified|1|||
161863346|NCT01894919|584542214|FG001|Overall Study|Other-Unspecified|0|||
161863347|NCT01894919|584542215|FG002|Overall Study|Other-Unspecified|0|||
161863348|NCT01894919|584542216|FG003|Overall Study|Other-Unspecified|0|||
161863349|NCT01894919|584542217|FG004|Overall Study|Other-Unspecified|0|||
161863350|NCT01894919|584542218|FG005|Overall Study|Other-Unspecified|0|||
161863351|NCT01894919|584542219|FG006|Overall Study|Other-Unspecified|0|||
161863352|NCT01894919|584542220|FG007|Overall Study|Other-Unspecified|0|||
161863353|NCT01894919|584542221|FG008|Overall Study|Other-Unspecified|0|||
161863354|NCT01894919|584542222|FG009|Overall Study|Other-Unspecified|0|||
161863355|NCT01894919|584542223|FG010|Overall Study|Other-Unspecified|0|||
161863356|NCT01894919|584542224|FG011|Overall Study|Other-Unspecified|0|||
161863357|NCT01894919|584542225|FG012|Overall Study|Other-Unspecified|0|||
161863358|NCT01894919|584542213|FG000|Overall Study|Lost to Follow-up|0|||
161863359|NCT01894919|584542214|FG001|Overall Study|Lost to Follow-up|0|||
161863360|NCT01894919|584542215|FG002|Overall Study|Lost to Follow-up|0|||
161863361|NCT01894919|584542216|FG003|Overall Study|Lost to Follow-up|0|||
161863362|NCT01894919|584542217|FG004|Overall Study|Lost to Follow-up|2|||
161863363|NCT01894919|584542218|FG005|Overall Study|Lost to Follow-up|0|||
161863364|NCT01894919|584542219|FG006|Overall Study|Lost to Follow-up|0|||
161863365|NCT01894919|584542220|FG007|Overall Study|Lost to Follow-up|0|||
161863366|NCT01894919|584542221|FG008|Overall Study|Lost to Follow-up|0|||
161863367|NCT01894919|584542222|FG009|Overall Study|Lost to Follow-up|0|||
161863368|NCT01894919|584542223|FG010|Overall Study|Lost to Follow-up|0|||
161863369|NCT01894919|584542224|FG011|Overall Study|Lost to Follow-up|0|||
161863370|NCT01894919|584542225|FG012|Overall Study|Lost to Follow-up|0|||
161863371|NCT03711188|584542226|FG000|Overall Study|Disease progression|11|||
161863372|NCT03711188|584542226|FG000|Overall Study|Adverse Event|1|||
161863373|NCT04341363|584542229|FG000|Overall Study|Adverse Event|1|||
161863374|NCT04341363|584542229|FG000|Overall Study|Withdrawal by Subject|1|||
161863375|NCT00063934|584542230|FG000|Overall Study|Ineligible|1|||
161863376|NCT03534687|584542231|FG000|Overall Study|Lost to Follow-up|7|||
161863377|NCT03534687|584542232|FG001|Overall Study|Lost to Follow-up|2|||
161863378|NCT02570308|584542235|FG000|Overall Study|Death|1|||
161863379|NCT02570308|584542236|FG001|Overall Study|Death|5|||
161863380|NCT02570308|584542237|FG002|Overall Study|Death|4|||
161863381|NCT02570308|584542238|FG003|Overall Study|Death|4|||
161863382|NCT02570308|584542239|FG004|Overall Study|Death|69|||
161863383|NCT02570308|584542235|FG000|Overall Study|Lost to Follow-up|0|||
161863384|NCT02570308|584542236|FG001|Overall Study|Lost to Follow-up|0|||
161863385|NCT02570308|584542237|FG002|Overall Study|Lost to Follow-up|0|||
161863386|NCT02570308|584542238|FG003|Overall Study|Lost to Follow-up|0|||
161863387|NCT02570308|584542239|FG004|Overall Study|Lost to Follow-up|2|||
161863388|NCT02570308|584542235|FG000|Overall Study|Withdrawal by Subject|0|||
161863389|NCT02570308|584542236|FG001|Overall Study|Withdrawal by Subject|0|||
161863390|NCT02570308|584542237|FG002|Overall Study|Withdrawal by Subject|0|||
161863391|NCT02570308|584542238|FG003|Overall Study|Withdrawal by Subject|0|||
161863392|NCT02570308|584542239|FG004|Overall Study|Withdrawal by Subject|1|||
161978418|NCT00857948|584970347|FG002|Overall Study|Protocol Violation|1|||
161863393|NCT02570308|584542235|FG000|Overall Study|Other|0|||
161863394|NCT02570308|584542236|FG001|Overall Study|Other|0|||
161978419|NCT00857948|584970348|FG003|Overall Study|Protocol Violation|0|||
161978420|NCT02639338|584970351|FG000|Overall Study|Lost to Follow-up|2|||
161863395|NCT02570308|584542237|FG002|Overall Study|Other|0|||
161863396|NCT02570308|584542238|FG003|Overall Study|Other|0|||
161863397|NCT02570308|584542239|FG004|Overall Study|Other|2|||
161863398|NCT00314340|584542241|FG000|Overall Study|lost interest|1|||
161863399|NCT02069015|584542242|FG000|Overall Study|Lost to Follow-up|39|||
161863400|NCT02069015|584542243|FG001|Overall Study|Lost to Follow-up|32|||
161863401|NCT02069015|584542242|FG000|Overall Study|Withdrawal by Subject|1|||
161863402|NCT02069015|584542243|FG001|Overall Study|Withdrawal by Subject|1|||
161863403|NCT01283464|584542244|FG000|Overall Study|Lost to Follow-up|0|||
161863404|NCT01283464|584542245|FG001|Overall Study|Lost to Follow-up|1|||
161863405|NCT01283464|584542244|FG000|Overall Study|Withdrawal by Subject|1|||
161863406|NCT01283464|584542245|FG001|Overall Study|Withdrawal by Subject|0|||
161863407|NCT01283464|584542244|FG000|Overall Study|Physician Decision|1|||
161863408|NCT01283464|584542245|FG001|Overall Study|Physician Decision|0|||
161863409|NCT03051100|584542246|FG000|Overall Study|Withdrawal by Subject|1|||
161863410|NCT03051100|584542247|FG001|Overall Study|Withdrawal by Subject|0|||
161863411|NCT01286467|584542254|FG000|Overall Study|Death|1|||
161863412|NCT01286467|584542255|FG001|Overall Study|Death|1|||
161863413|NCT01286467|584542256|FG002|Overall Study|Death|1|||
161863414|NCT01286467|584542257|FG003|Overall Study|Death|0|||
161863415|NCT01286467|584542254|FG000|Overall Study|Lost to Follow-up|0|||
161863416|NCT01286467|584542255|FG001|Overall Study|Lost to Follow-up|0|||
161863417|NCT01286467|584542256|FG002|Overall Study|Lost to Follow-up|0|||
161863418|NCT01286467|584542257|FG003|Overall Study|Lost to Follow-up|1|||
161863419|NCT01286467|584542254|FG000|Overall Study|Withdrawal by Subject|0|||
161863420|NCT01286467|584542255|FG001|Overall Study|Withdrawal by Subject|0|||
161863421|NCT01286467|584542256|FG002|Overall Study|Withdrawal by Subject|1|||
161863422|NCT01286467|584542257|FG003|Overall Study|Withdrawal by Subject|0|||
161863423|NCT01286467|584542254|FG000|Overall Study|Physician Decision|0|||
161863424|NCT01286467|584542255|FG001|Overall Study|Physician Decision|0|||
161978421|NCT02639338|584970352|FG001|Overall Study|Lost to Follow-up|2|||
161978422|NCT02639338|584970351|FG000|Overall Study|Withdrew Consent|1|||
161978423|NCT02639338|584970352|FG001|Overall Study|Withdrew Consent|2|||
161978424|NCT02639338|584970351|FG000|Overall Study|Death|1|||
161978425|NCT02639338|584970352|FG001|Overall Study|Death|0|||
161978426|NCT02639338|584970351|FG000|Overall Study|Randomized but Not Treated|0|||
161978427|NCT02639338|584970352|FG001|Overall Study|Randomized but Not Treated|1|||
161978428|NCT04047420|584970356|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
161978429|NCT04047420|584970356|FG000|Washout Period|Refused Participation|2|||
161978430|NCT00966719|584970359|FG000|Overall Study|Lost to Follow-up|6|||
161978431|NCT00966719|584970360|FG001|Overall Study|Lost to Follow-up|11|||
161773265|NCT04888377|584214250|FG001|Overall Study|Physician Decision|6|||
161773266|NCT04888377|584214249|FG000|Overall Study|Withdrawal by Subject|7|||
161773267|NCT04888377|584214250|FG001|Overall Study|Withdrawal by Subject|3|||
161773268|NCT00526162|584214251|FG000|Overall Study|Device not implanted|3|||
161773269|NCT05279807|584214252|FG000|Overall Study|Withdrawal by Subject|1|||
161773270|NCT05279807|584214253|FG001|Overall Study|Withdrawal by Subject|0|||
161773271|NCT05279807|584214252|FG000|Overall Study|Adverse Event|0|||
161773272|NCT05279807|584214253|FG001|Overall Study|Adverse Event|1|||
161773273|NCT05279807|584214252|FG000|Overall Study|Laboratory Abnormal Results|1|||
161773274|NCT05279807|584214253|FG001|Overall Study|Laboratory Abnormal Results|0|||
161773275|NCT05299359|584214258|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
161773276|NCT05299359|584214259|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
161773277|NCT05299359|584214258|FG000|Main Part: Day 1 up to Day 366|Other|2|||
161773278|NCT05299359|584214259|FG001|Main Part: Day 1 up to Day 366|Other|0|||
161773279|NCT05299359|584214258|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
161773280|NCT05299359|584214259|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
161773281|NCT05299359|584214258|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
161773282|NCT05299359|584214259|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
161773283|NCT05299359|584214258|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
161773284|NCT05299359|584214259|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
161773285|NCT05299359|584214258|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
161773286|NCT05299359|584214259|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
161773287|NCT05299359|584214258|FG000|Extension Part: Day 1 to Day 366|Other|0|||
161773288|NCT05299359|584214259|FG001|Extension Part: Day 1 to Day 366|Other|1|||
161773289|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
161773290|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
161773291|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
161773292|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773293|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773294|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773295|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773296|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773297|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
161773298|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
161773299|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161978432|NCT00160199|584970361|FG000|Overall Study|Adverse Event|5|||
161863425|NCT01286467|584542256|FG002|Overall Study|Physician Decision|0|||
161863426|NCT01286467|584542257|FG003|Overall Study|Physician Decision|1|||
161863427|NCT01286467|584542254|FG000|Overall Study|Disease progression|3|||
161863428|NCT01286467|584542255|FG001|Overall Study|Disease progression|2|||
161863429|NCT01286467|584542256|FG002|Overall Study|Disease progression|2|||
161863430|NCT01286467|584542257|FG003|Overall Study|Disease progression|3|||
161773300|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773301|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773302|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773303|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
161773304|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
161773305|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
161773306|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773307|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773308|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773309|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773310|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
161773311|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
161773312|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
161773313|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773314|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773315|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773316|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773317|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
161773318|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161773319|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161773320|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161773321|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161773322|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161773323|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161773324|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161773325|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161773326|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
161773327|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161773328|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161773329|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161773330|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161773331|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161773332|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161773333|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
161773334|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161773335|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161773336|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161773337|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161773338|NCT04242446|584214260|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773339|NCT04242446|584214261|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
161773340|NCT04242446|584214262|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
161773341|NCT04242446|584214263|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773342|NCT04242446|584214264|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773343|NCT04242446|584214265|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773344|NCT04242446|584214266|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773345|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773346|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773347|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773348|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
161773349|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
161773350|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
161773351|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
161773352|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773353|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773354|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773355|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
161773356|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
161773357|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
161773358|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
161773359|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773360|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161863431|NCT01286467|584542254|FG000|Overall Study|Adverse Event|0|||
161863432|NCT01286467|584542255|FG001|Overall Study|Adverse Event|1|||
161863433|NCT01286467|584542256|FG002|Overall Study|Adverse Event|2|||
161863434|NCT01286467|584542257|FG003|Overall Study|Adverse Event|3|||
161863435|NCT01286467|584542254|FG000|Overall Study|Study drug stop longer than 14 days|0|||
161863436|NCT01286467|584542255|FG001|Overall Study|Study drug stop longer than 14 days|0|||
161863437|NCT01286467|584542256|FG002|Overall Study|Study drug stop longer than 14 days|1|||
161978433|NCT00160199|584970362|FG001|Overall Study|Adverse Event|14|||
161978434|NCT00160199|584970361|FG000|Overall Study|Lack of Efficacy|0|||
161978435|NCT00160199|584970362|FG001|Overall Study|Lack of Efficacy|1|||
161978436|NCT00160199|584970361|FG000|Overall Study|Lost to Follow-up|7|||
161978437|NCT00160199|584970362|FG001|Overall Study|Lost to Follow-up|7|||
161978438|NCT00160199|584970361|FG000|Overall Study|Withdrawal by Subject|4|||
161978439|NCT00160199|584970362|FG001|Overall Study|Withdrawal by Subject|6|||
161978440|NCT00160199|584970361|FG000|Overall Study|Administrative|0|||
161978441|NCT00160199|584970362|FG001|Overall Study|Administrative|1|||
161978442|NCT00160199|584970361|FG000|Overall Study|Protocol Violation|8|||
161978443|NCT00160199|584970362|FG001|Overall Study|Protocol Violation|8|||
161978444|NCT03089944|584970363|FG000|Overall Study|Lost to Follow-up|8|||
161978445|NCT03089944|584970363|FG000|Overall Study|Withdrew Consent|2|||
161978446|NCT03089944|584970363|FG000|Overall Study|Adverse Event|1|||
161978447|NCT03089944|584970363|FG000|Overall Study|Other|1|||
161978448|NCT03689244|584970364|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
161978449|NCT03689244|584970365|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
161978450|NCT03689244|584970366|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
161978451|NCT03689244|584970367|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
161978452|NCT03689244|584970364|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
161978453|NCT03689244|584970365|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
161978454|NCT03689244|584970366|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
161978455|NCT03689244|584970367|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
161978456|NCT03689244|584970364|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
161978457|NCT03689244|584970365|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
161978458|NCT03689244|584970366|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
161978459|NCT03689244|584970367|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
161978460|NCT03689244|584970364|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
161978461|NCT03689244|584970365|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
161978462|NCT03689244|584970366|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
161978463|NCT03689244|584970367|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
161978464|NCT03689244|584970364|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
161978465|NCT03689244|584970365|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
161978466|NCT03689244|584970366|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
161978467|NCT03689244|584970367|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
161978468|NCT03689244|584970364|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
161978469|NCT03689244|584970365|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
161978470|NCT03689244|584970366|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
161978471|NCT03689244|584970367|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
161978472|NCT03689244|584970364|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
161978473|NCT03689244|584970365|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
161978474|NCT03689244|584970366|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
161978475|NCT03689244|584970367|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
161978476|NCT03689244|584970364|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
161978477|NCT03689244|584970365|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
161978478|NCT03689244|584970366|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
161978479|NCT03689244|584970367|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
161978480|NCT00444067|584970398|FG000|Overall Study|Lost to Follow-up|0|||
161978481|NCT00444067|584970399|FG001|Overall Study|Lost to Follow-up|1|||
161863438|NCT01286467|584542257|FG003|Overall Study|Study drug stop longer than 14 days|0|||
161863439|NCT03335475|584542258|FG000|Overall Study|Did not wear accelerometer|4|||
161863440|NCT03335475|584542259|FG001|Overall Study|Did not wear accelerometer|0|||
161863441|NCT03335475|584542258|FG000|Overall Study|Withdrawal by Subject|0|||
161863442|NCT03335475|584542259|FG001|Overall Study|Withdrawal by Subject|1|||
161863443|NCT04886596|584542260|FG000|Overall Study|Adverse Event|442|||
161863444|NCT04886596|584542261|FG001|Overall Study|Adverse Event|441|||
161978482|NCT00267150|584970402|FG000|Overall Study|Adverse Event|1|||
161978483|NCT00969436|584970407|FG000|Overall Study|Protocol Violation|1|||
161978484|NCT00969436|584970408|FG001|Overall Study|Protocol Violation|3|||
161978485|NCT00969436|584970409|FG002|Overall Study|Protocol Violation|0|||
161978486|NCT00969436|584970407|FG000|Overall Study|Migrated/moved from study area|12|||
161863445|NCT04886596|584542260|FG000|Overall Study|Lost to Follow-up|448|||
161863446|NCT04886596|584542261|FG001|Overall Study|Lost to Follow-up|465|||
161863447|NCT04886596|584542260|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
161863448|NCT04886596|584542261|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
161863449|NCT04886596|584542260|FG000|Overall Study|Migrated/moved from the study area|201|||
161863450|NCT04886596|584542261|FG001|Overall Study|Migrated/moved from the study area|184|||
161863451|NCT04886596|584542260|FG000|Overall Study|Other|298|||
161863452|NCT04886596|584542261|FG001|Overall Study|Other|326|||
161863453|NCT03751098|584542264|FG000|Overall Study|Withdrawal by Subject|0|||
161863454|NCT03751098|584542265|FG001|Overall Study|Withdrawal by Subject|1|||
161863455|NCT05921903|584542266|FG000|Overall Study|Unsolicited non-SAE|0|||
161863456|NCT05921903|584542267|FG001|Overall Study|Unsolicited non-SAE|1|||
161863457|NCT05921903|584542268|FG002|Overall Study|Unsolicited non-SAE|0|||
161863458|NCT05921903|584542266|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
161863459|NCT05921903|584542267|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
161863460|NCT05921903|584542268|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
161863461|NCT05921903|584542266|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
161863462|NCT05921903|584542267|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
161863463|NCT05921903|584542268|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
161863464|NCT03305848|584542269|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
161863465|NCT03305848|584542269|FG000|Overall Study|Physician Decision|2|||
161863466|NCT01060072|584542273|FG000|Overall Study|Adverse Event|1|||
161863467|NCT01060072|584542274|FG001|Overall Study|Adverse Event|1|||
161863468|NCT01060072|584542273|FG000|Overall Study|Physician Decision|0|||
161863469|NCT01060072|584542274|FG001|Overall Study|Physician Decision|2|||
161863470|NCT01060072|584542273|FG000|Overall Study|Protocol Violation|0|||
161863471|NCT01060072|584542274|FG001|Overall Study|Protocol Violation|1|||
161863472|NCT01060072|584542273|FG000|Overall Study|Acute cholecystitis|1|||
161863473|NCT01060072|584542274|FG001|Overall Study|Acute cholecystitis|0|||
161863474|NCT01060072|584542273|FG000|Overall Study|Excluded Medications|0|||
161863475|NCT01060072|584542274|FG001|Overall Study|Excluded Medications|1|||
161863476|NCT02301169|584542275|FG000|Overall Study|Adverse Event|1|||
161863477|NCT02301169|584542276|FG001|Overall Study|Adverse Event|0|||
161863478|NCT03762265|584542277|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
161863479|NCT03762265|584542278|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
161863480|NCT03762265|584542277|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
161863481|NCT03762265|584542278|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
161863482|NCT03762265|584542277|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
161863483|NCT03762265|584542278|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
161863484|NCT03762265|584542277|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
161863485|NCT03762265|584542278|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
161863486|NCT03762265|584542277|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
161863487|NCT03762265|584542278|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
161863488|NCT03762265|584542277|FG000|BT Period: Weeks 1 to 37|Other|0|||
161863489|NCT03762265|584542278|FG001|BT Period: Weeks 1 to 37|Other|1|||
161863490|NCT03762265|584542277|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
161863491|NCT03762265|584542278|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
161863492|NCT03762265|584542277|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
161863493|NCT03762265|584542278|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
161863494|NCT03762265|584542277|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
161863495|NCT03762265|584542278|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
161863496|NCT03762265|584542277|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
161863497|NCT03762265|584542278|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
161863498|NCT03762265|584542277|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
161863499|NCT03762265|584542278|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
161863500|NCT03762265|584542277|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
161863501|NCT03762265|584542278|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
161863502|NCT03762265|584542277|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
161863503|NCT03762265|584542278|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
161863504|NCT03762265|584542277|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
161863505|NCT03762265|584542278|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
161863506|NCT03762265|584542277|FG000|LTE Period: Weeks 61 to 109|Other|1|||
161863507|NCT03762265|584542278|FG001|LTE Period: Weeks 61 to 109|Other|0|||
161863508|NCT00765102|584542279|FG000|Overall Study|Progressive disease|18|||
161863509|NCT00765102|584542279|FG000|Overall Study|Adverse Event|6|||
161863510|NCT00765102|584542279|FG000|Overall Study|Physician Decision|4|||
161863511|NCT00765102|584542279|FG000|Overall Study|Withdrawal by Subject|2|||
161863512|NCT00765102|584542279|FG000|Overall Study|Protocol Violation|1|||
161863513|NCT02289729|584542283|FG000|Overall Study|Lack of Efficacy|3|||
161863514|NCT02289729|584542283|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
161863515|NCT02289729|584542283|FG000|Overall Study|Withdrawal by Subject|1|||
161863516|NCT02289729|584542283|FG000|Overall Study|Death|1|||
161863517|NCT00470470|584542284|FG000|Overall Study|Adverse Event|2|||
161863518|NCT00470470|584542284|FG000|Overall Study|Death|2|||
161863519|NCT00470470|584542284|FG000|Overall Study|Not treated|1|||
161863520|NCT01149863|584542296|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
161863521|NCT03326193|584542298|FG000|Overall Study|Sponsor decision|35|||
161978487|NCT00969436|584970408|FG001|Overall Study|Migrated/moved from study area|10|||
161978488|NCT00969436|584970409|FG002|Overall Study|Migrated/moved from study area|2|||
161978489|NCT00969436|584970407|FG000|Overall Study|Father - serious health problem|0|||
161978490|NCT00969436|584970408|FG001|Overall Study|Father - serious health problem|0|||
161978491|NCT00969436|584970409|FG002|Overall Study|Father - serious health problem|1|||
161978492|NCT00969436|584970407|FG000|Overall Study|Parents personal problem|0|||
161978493|NCT00969436|584970408|FG001|Overall Study|Parents personal problem|0|||
161978494|NCT00969436|584970409|FG002|Overall Study|Parents personal problem|1|||
161978495|NCT00969436|584970407|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
161978496|NCT00969436|584970408|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
161978497|NCT00969436|584970409|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
161978498|NCT00969436|584970407|FG000|Overall Study|Withdrawal by Subject|3|||
161978499|NCT00969436|584970408|FG001|Overall Study|Withdrawal by Subject|0|||
161978500|NCT00969436|584970409|FG002|Overall Study|Withdrawal by Subject|2|||
161978501|NCT00969436|584970407|FG000|Overall Study|Lost to Follow-up|8|||
161978502|NCT00969436|584970408|FG001|Overall Study|Lost to Follow-up|8|||
161978503|NCT00969436|584970409|FG002|Overall Study|Lost to Follow-up|5|||
161978504|NCT00351273|584970410|FG000|Overall Study|Lost to Follow-up|1|||
161978505|NCT00351273|584970411|FG001|Overall Study|Lost to Follow-up|2|||
161978506|NCT00351273|584970412|FG002|Overall Study|Lost to Follow-up|5|||
161978507|NCT01672866|584970413|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
161978508|NCT01672866|584970414|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
161978509|NCT01672866|584970415|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
161978510|NCT01672866|584970413|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
161978511|NCT01672866|584970414|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
161978512|NCT01672866|584970415|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
161978513|NCT01672866|584970413|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
161978514|NCT01672866|584970414|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
162034823|NCT04704154|585183575|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
162034824|NCT04704154|585183576|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
162034825|NCT04704154|585183577|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
162034826|NCT04704154|585183578|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
162034827|NCT04704154|585183579|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
162034828|NCT04704154|585183580|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
162034829|NCT03220438|585183581|FG000|Overall Study|Lost to Follow-up|0|||
162034830|NCT03220438|585183582|FG001|Overall Study|Lost to Follow-up|0|||
162034831|NCT03220438|585183583|FG002|Overall Study|Lost to Follow-up|1|||
162034832|NCT03220438|585183584|FG003|Overall Study|Lost to Follow-up|0|||
162034833|NCT04062123|585183585|FG000|Overall Study|Withdrawal by Subject|0|||
162034834|NCT04062123|585183586|FG001|Overall Study|Withdrawal by Subject|1|||
162034835|NCT04062123|585183587|FG002|Overall Study|Withdrawal by Subject|0|||
162034836|NCT04190680|585183588|FG000|Overall Study|Not meeting criteria for data analysis|1|||
162034837|NCT04190680|585183589|FG001|Overall Study|Not meeting criteria for data analysis|15|||
162034838|NCT04190680|585183588|FG000|Overall Study|Administrative error|0|||
162034839|NCT04190680|585183589|FG001|Overall Study|Administrative error|18|||
162034840|NCT03780400|585183590|FG000|Overall Study|Lost to Follow-up|5|||
162034841|NCT03780400|585183590|FG000|Overall Study|Withdrawal by Subject|2|||
162034842|NCT01850602|585183591|FG000|Overall Study|Adverse Event|7|||
162034843|NCT01850602|585183592|FG001|Overall Study|Adverse Event|10|||
162034844|NCT01850602|585183591|FG000|Overall Study|Physician Decision|2|||
162034845|NCT01850602|585183592|FG001|Overall Study|Physician Decision|1|||
162034846|NCT01850602|585183591|FG000|Overall Study|Withdrawal by Subject|2|||
162034847|NCT01850602|585183592|FG001|Overall Study|Withdrawal by Subject|4|||
162034848|NCT01850602|585183591|FG000|Overall Study|Decrease in serum calcium|2|||
162034849|NCT01850602|585183592|FG001|Overall Study|Decrease in serum calcium|3|||
162034850|NCT01850602|585183591|FG000|Overall Study|Increase in serum ferritin|1|||
162034851|NCT01850602|585183592|FG001|Overall Study|Increase in serum ferritin|0|||
162034852|NCT00740051|585183595|FG000|Overall Study|Lack of Efficacy|2|||
162034853|NCT00740051|585183596|FG001|Overall Study|Lack of Efficacy|5|||
162034854|NCT00740051|585183595|FG000|Overall Study|Adverse Event|1|||
161773361|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773362|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
161978515|NCT01672866|584970415|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
161978516|NCT01672866|584970413|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
162034855|NCT00740051|585183596|FG001|Overall Study|Adverse Event|4|||
162034856|NCT00740051|585183595|FG000|Overall Study|Protocol Violation|2|||
162034857|NCT00740051|585183596|FG001|Overall Study|Protocol Violation|6|||
162034858|NCT00740051|585183595|FG000|Overall Study|Lost to Follow-up|3|||
162034859|NCT00740051|585183596|FG001|Overall Study|Lost to Follow-up|8|||
162034860|NCT00740051|585183595|FG000|Overall Study|Withdrawal by Subject|6|||
162034861|NCT00740051|585183596|FG001|Overall Study|Withdrawal by Subject|8|||
161978517|NCT01672866|584970414|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
162034862|NCT00740051|585183595|FG000|Overall Study|Other reason (not specified)|4|||
161978518|NCT01672866|584970415|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
161978519|NCT01672866|584970413|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
161978520|NCT01672866|584970414|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
161978521|NCT01672866|584970415|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
161978522|NCT01672866|584970413|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
161978523|NCT01672866|584970414|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
161978524|NCT01672866|584970415|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
161978525|NCT01672866|584970413|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
161978526|NCT01672866|584970414|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
161978527|NCT01672866|584970415|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
161978528|NCT01672866|584970413|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
161978529|NCT01672866|584970414|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
161978530|NCT01672866|584970415|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
161978531|NCT01672866|584970413|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
161978532|NCT01672866|584970414|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
161978533|NCT01672866|584970415|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
161978534|NCT01672866|584970413|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
161978535|NCT01672866|584970414|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
161978536|NCT01672866|584970415|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
161978537|NCT01672866|584970413|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
161978538|NCT01672866|584970414|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
161978539|NCT01672866|584970415|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
161978540|NCT01672866|584970413|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
161978541|NCT01672866|584970414|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
161978542|NCT01672866|584970415|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
161978543|NCT01672866|584970413|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
161978544|NCT01672866|584970414|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
161978545|NCT01672866|584970415|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
161978546|NCT02544373|584970418|FG000|Overall Study|Lost to Follow-up|5|||
161978547|NCT02544373|584970419|FG001|Overall Study|Lost to Follow-up|3|||
161978548|NCT02544373|584970418|FG000|Overall Study|Withdrawal by Subject|8|||
161978549|NCT02544373|584970419|FG001|Overall Study|Withdrawal by Subject|2|||
161978550|NCT04208087|584970420|FG000|Overall Study|Adverse Event|1|||
161978551|NCT04208087|584970421|FG001|Overall Study|Adverse Event|0|||
161978552|NCT04208087|584970422|FG002|Overall Study|Adverse Event|0|||
161978553|NCT04208087|584970423|FG003|Overall Study|Adverse Event|0|||
161978554|NCT04208087|584970424|FG004|Overall Study|Adverse Event|0|||
161978555|NCT04208087|584970420|FG000|Overall Study|Withdrawal by Subject|0|||
161978556|NCT04208087|584970421|FG001|Overall Study|Withdrawal by Subject|0|||
161978557|NCT04208087|584970422|FG002|Overall Study|Withdrawal by Subject|1|||
161978558|NCT04208087|584970423|FG003|Overall Study|Withdrawal by Subject|0|||
161978559|NCT04208087|584970424|FG004|Overall Study|Withdrawal by Subject|0|||
161978560|NCT04208087|584970420|FG000|Overall Study|Other|0|||
161863522|NCT00822692|584542301|FG000|Overall Study|Lost to Follow-up|17|||
161863523|NCT00822692|584542302|FG001|Overall Study|Lost to Follow-up|25|||
161863524|NCT01964976|584542303|FG000|Overall Study|Protocol Violation|31|||
161863525|NCT02452476|584542304|FG000|Overall Study|Death|4|||
161863526|NCT02452476|584542305|FG001|Overall Study|Death|7|||
161863527|NCT02452476|584542304|FG000|Overall Study|Lost to Follow-up|1|||
161863528|NCT02452476|584542305|FG001|Overall Study|Lost to Follow-up|1|||
161863529|NCT02452476|584542304|FG000|Overall Study|Physician Decision|1|||
161863530|NCT02452476|584542305|FG001|Overall Study|Physician Decision|1|||
161863531|NCT02452476|584542304|FG000|Overall Study|Not treated|5|||
161863532|NCT02452476|584542305|FG001|Overall Study|Not treated|1|||
161863533|NCT02348112|584542306|FG000|Overall Study|Withdrawal by Subject|32|||
161863534|NCT02348112|584542307|FG001|Overall Study|Withdrawal by Subject|29|||
161863535|NCT02348112|584542306|FG000|Overall Study|Lost to Follow-up|24|||
161863536|NCT02348112|584542307|FG001|Overall Study|Lost to Follow-up|20|||
161863537|NCT02348112|584542306|FG000|Overall Study|Physician Decision|17|||
161863538|NCT02348112|584542307|FG001|Overall Study|Physician Decision|15|||
161863539|NCT02348112|584542306|FG000|Overall Study|Site closed due to PI leaving|0|||
161978561|NCT04208087|584970421|FG001|Overall Study|Other|0|||
161978562|NCT04208087|584970422|FG002|Overall Study|Other|0|||
161978563|NCT04208087|584970423|FG003|Overall Study|Other|0|||
161978564|NCT04208087|584970424|FG004|Overall Study|Other|1|||
161978565|NCT01198509|584970425|FG000|Overall Study|Withdrawal by Subject|1|||
161978566|NCT01198509|584970426|FG001|Overall Study|Withdrawal by Subject|0|||
161978567|NCT01198509|584970427|FG002|Overall Study|Withdrawal by Subject|0|||
161978568|NCT01198509|584970428|FG003|Overall Study|Withdrawal by Subject|0|||
161978569|NCT01198509|584970429|FG004|Overall Study|Withdrawal by Subject|0|||
161863540|NCT02348112|584542307|FG001|Overall Study|Site closed due to PI leaving|30|||
161863541|NCT02348112|584542306|FG000|Overall Study|Sponsor withdrawal|0|||
161863542|NCT02348112|584542307|FG001|Overall Study|Sponsor withdrawal|7|||
161863543|NCT02348112|584542306|FG000|Overall Study|Death|0|||
161978570|NCT01198509|584970430|FG005|Overall Study|Withdrawal by Subject|0|||
161978571|NCT01595581|584970440|FG000|Overall Study|Withdrawal by Subject|1|||
161978572|NCT01595581|584970441|FG001|Overall Study|Withdrawal by Subject|0|||
161978573|NCT02621073|584970442|FG000|Overall Study|Lost to Follow-up|0|||
161978574|NCT02621073|584970443|FG001|Overall Study|Lost to Follow-up|1|||
161978575|NCT02621073|584970442|FG000|Overall Study|Physician Decision|3|||
161978576|NCT02621073|584970443|FG001|Overall Study|Physician Decision|2|||
161978577|NCT01969721|584970444|FG000|Overall Study|Adverse Event|3|||
161978578|NCT01969721|584970445|FG001|Overall Study|Adverse Event|8|||
161978579|NCT01969721|584970446|FG002|Overall Study|Adverse Event|3|||
161978580|NCT01969721|584970447|FG003|Overall Study|Adverse Event|2|||
161978581|NCT01969721|584970444|FG000|Overall Study|Lack of Efficacy|0|||
161978582|NCT01969721|584970445|FG001|Overall Study|Lack of Efficacy|0|||
161978583|NCT01969721|584970446|FG002|Overall Study|Lack of Efficacy|1|||
161978584|NCT01969721|584970447|FG003|Overall Study|Lack of Efficacy|0|||
161978585|NCT01969721|584970444|FG000|Overall Study|Non compliant with protocol|1|||
161978586|NCT01969721|584970445|FG001|Overall Study|Non compliant with protocol|1|||
161978587|NCT01969721|584970446|FG002|Overall Study|Non compliant with protocol|0|||
161978588|NCT01969721|584970447|FG003|Overall Study|Non compliant with protocol|2|||
161978589|NCT01969721|584970444|FG000|Overall Study|Other not defined above|0|||
161978590|NCT01969721|584970445|FG001|Overall Study|Other not defined above|2|||
161978591|NCT01969721|584970446|FG002|Overall Study|Other not defined above|0|||
161978592|NCT01969721|584970447|FG003|Overall Study|Other not defined above|0|||
161978593|NCT01969721|584970444|FG000|Overall Study|Discontinued during washout periods.|0|||
161978594|NCT01969721|584970445|FG001|Overall Study|Discontinued during washout periods.|1|||
161978595|NCT01969721|584970446|FG002|Overall Study|Discontinued during washout periods.|1|||
161978596|NCT01969721|584970447|FG003|Overall Study|Discontinued during washout periods.|2|||
161978597|NCT02920957|584970449|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
161978598|NCT02920957|584970450|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
161978599|NCT02920957|584970449|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
161978600|NCT02920957|584970450|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
161978601|NCT02920957|584970449|FG000|First Intervention : 1 Month|Adverse Event|1|||
161978602|NCT02920957|584970450|FG001|First Intervention : 1 Month|Adverse Event|0|||
161978603|NCT02920957|584970449|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
161978604|NCT02920957|584970450|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
161978605|NCT01789606|584970451|FG000|Overall Study|Participant not Purchased the Product|0|||
161978606|NCT01789606|584970452|FG001|Overall Study|Participant not Purchased the Product|20|||
161978607|NCT01789606|584970451|FG000|Overall Study|Withdrawal by Subject|0|||
161978608|NCT01789606|584970452|FG001|Overall Study|Withdrawal by Subject|1|||
161978609|NCT01789606|584970451|FG000|Overall Study|Ineligible|6|||
161978610|NCT01789606|584970452|FG001|Overall Study|Ineligible|2|||
161978611|NCT01789606|584970451|FG000|Overall Study|Administrative Reasons|17|||
161978612|NCT01789606|584970452|FG001|Overall Study|Administrative Reasons|6|||
161978613|NCT01789606|584970451|FG000|Overall Study|No Study Medication Taken|0|||
161978614|NCT01789606|584970452|FG001|Overall Study|No Study Medication Taken|1|||
161978615|NCT01789606|584970451|FG000|Overall Study|Protocol Violation|0|||
161978616|NCT01789606|584970452|FG001|Overall Study|Protocol Violation|55|||
161978617|NCT01789606|584970451|FG000|Overall Study|Adverse Event|0|||
161978618|NCT01789606|584970452|FG001|Overall Study|Adverse Event|3|||
161978619|NCT01789606|584970451|FG000|Overall Study|Lost to Follow-up|0|||
161978620|NCT01789606|584970452|FG001|Overall Study|Lost to Follow-up|14|||
161978621|NCT01789606|584970451|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
161978622|NCT01789606|584970452|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
161978623|NCT03180307|584970453|FG000|Overall Study|Lost to Follow-up|2|||
161978624|NCT03180307|584970454|FG001|Overall Study|Lost to Follow-up|0|||
161978625|NCT03180307|584970453|FG000|Overall Study|Death|1|||
161978626|NCT03180307|584970454|FG001|Overall Study|Death|0|||
161978627|NCT03180307|584970453|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
161978628|NCT03180307|584970454|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
161978629|NCT01563172|584970460|FG000|Overall Study|Adverse Event|5|||
161773363|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
161863544|NCT02348112|584542307|FG001|Overall Study|Death|1|||
161978630|NCT01563172|584970460|FG000|Overall Study|Lost to Follow-up|2|||
161978631|NCT01563172|584970460|FG000|Overall Study|Other (Protocol deviation)|5|||
161978632|NCT01563172|584970460|FG000|Overall Study|Other (Not specified)|1|||
161978633|NCT00344500|584972451|FG000|Overall Study|Adverse Event|6|||
161978634|NCT00344500|584972452|FG001|Overall Study|Adverse Event|2|||
161978635|NCT00344500|584972453|FG002|Overall Study|Adverse Event|0|||
161978636|NCT00344500|584972451|FG000|Overall Study|Lost to Follow-up|5|||
161978637|NCT00344500|584972452|FG001|Overall Study|Lost to Follow-up|13|||
161978638|NCT00344500|584972453|FG002|Overall Study|Lost to Follow-up|1|||
161978639|NCT00344500|584972451|FG000|Overall Study|Withdrawal by Subject|7|||
161978640|NCT00344500|584972452|FG001|Overall Study|Withdrawal by Subject|10|||
161978641|NCT00344500|584972453|FG002|Overall Study|Withdrawal by Subject|0|||
161978642|NCT00344500|584972451|FG000|Overall Study|Protocol Violation|4|||
161978643|NCT00344500|584972452|FG001|Overall Study|Protocol Violation|7|||
161978644|NCT00344500|584972453|FG002|Overall Study|Protocol Violation|1|||
161978645|NCT00344500|584972451|FG000|Overall Study|Not Noted|1|||
161978646|NCT00344500|584972452|FG001|Overall Study|Not Noted|3|||
161978647|NCT00344500|584972453|FG002|Overall Study|Not Noted|0|||
161978648|NCT00599755|584972454|FG000|Overall Study|Adverse Event|11|||
161978649|NCT00599755|584972454|FG000|Overall Study|Withdrawal by Subject|2|||
161978650|NCT00599755|584972454|FG000|Overall Study|Progression of Disease|3|||
161978651|NCT00599755|584972454|FG000|Overall Study|Other Reason|2|||
161978652|NCT00599755|584972454|FG000|Overall Study|No data available|1|||
161978653|NCT04037254|584972455|FG000|Overall Study|Protocol Violation|1|||
161978654|NCT04037254|584972456|FG001|Overall Study|Protocol Violation|0|||
161978655|NCT04037254|584972457|FG002|Overall Study|Protocol Violation|0|||
161978656|NCT04037254|584972458|FG003|Overall Study|Protocol Violation|0|||
161978657|NCT04037254|584972459|FG004|Overall Study|Protocol Violation|0|||
161978658|NCT04037254|584972455|FG000|Overall Study|Withdrawal by Subject|0|||
161978659|NCT04037254|584972456|FG001|Overall Study|Withdrawal by Subject|0|||
161978660|NCT04037254|584972457|FG002|Overall Study|Withdrawal by Subject|1|||
161978661|NCT04037254|584972458|FG003|Overall Study|Withdrawal by Subject|0|||
161978662|NCT04037254|584972459|FG004|Overall Study|Withdrawal by Subject|0|||
161978663|NCT04037254|584972455|FG000|Overall Study|Delayed or incomplete treatment|0|||
161978664|NCT04037254|584972456|FG001|Overall Study|Delayed or incomplete treatment|2|||
161978665|NCT04037254|584972457|FG002|Overall Study|Delayed or incomplete treatment|1|||
161978666|NCT04037254|584972458|FG003|Overall Study|Delayed or incomplete treatment|0|||
161978667|NCT04037254|584972459|FG004|Overall Study|Delayed or incomplete treatment|0|||
161978668|NCT02198794|584972460|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
161978669|NCT02198794|584972461|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
161978670|NCT02198794|584972462|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
161978671|NCT02198794|584972463|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
161978672|NCT02198794|584972460|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
161978673|NCT02198794|584972461|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
161978674|NCT02198794|584972462|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
161978675|NCT02198794|584972463|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
161978676|NCT02198794|584972460|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
161978677|NCT02198794|584972461|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
161978678|NCT02198794|584972462|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
161978679|NCT02198794|584972463|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
161978680|NCT02198794|584972460|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
161978681|NCT02198794|584972461|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
161978682|NCT02198794|584972462|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
161978683|NCT02198794|584972463|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
161978684|NCT02198794|584972460|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
161978685|NCT02198794|584972461|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
161978686|NCT02198794|584972462|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
161978687|NCT02198794|584972463|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
161978688|NCT02198794|584972460|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
161978689|NCT02198794|584972461|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
161978690|NCT02198794|584972462|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
161978691|NCT02198794|584972463|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
161978692|NCT02198794|584972460|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
161978693|NCT02198794|584972461|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
161863545|NCT01408043|584542308|FG000|Overall Study|unable to collect cells|1|||
161978694|NCT02198794|584972462|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
161978695|NCT02198794|584972463|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
161978696|NCT02198794|584972460|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
161978697|NCT02198794|584972461|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
161978698|NCT02198794|584972462|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
161978699|NCT02198794|584972463|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
161978700|NCT02198794|584972460|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
161978701|NCT02198794|584972461|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
161978702|NCT02198794|584972462|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
161978703|NCT02198794|584972463|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
161978704|NCT02198794|584972460|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
161978705|NCT02198794|584972461|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
161978706|NCT02198794|584972462|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
161978707|NCT02198794|584972463|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
161978708|NCT02198794|584972460|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
162034863|NCT00740051|585183596|FG001|Overall Study|Other reason (not specified)|1|||
161978709|NCT02198794|584972461|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
161978710|NCT02198794|584972462|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
162034864|NCT03452527|585183597|FG000|Overall Study|Withdrawal by Subject|1|||
161978711|NCT02198794|584972463|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
161978712|NCT02198794|584972460|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
161978713|NCT02198794|584972461|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
161978714|NCT02198794|584972462|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
161978715|NCT02198794|584972463|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
161978716|NCT02198794|584972460|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
161978717|NCT02198794|584972461|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
161978718|NCT02198794|584972462|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
161978719|NCT02198794|584972463|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
161978720|NCT02198794|584972460|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
161978721|NCT02198794|584972461|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
161978722|NCT02198794|584972462|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
161978723|NCT02198794|584972463|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
161978724|NCT02198794|584972460|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
161978725|NCT02198794|584972461|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
161978726|NCT02198794|584972462|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
161978727|NCT02198794|584972463|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
161978728|NCT01306656|584972464|FG000|Overall Study|Lost to Follow-up|1|||
161978729|NCT01306656|584972465|FG001|Overall Study|Lost to Follow-up|0|||
161978730|NCT02771626|584972470|FG000|Overall Study|Adverse Event|1|||
161978731|NCT02771626|584972471|FG001|Overall Study|Adverse Event|5|||
161978732|NCT02771626|584972472|FG002|Overall Study|Adverse Event|3|||
161978733|NCT02771626|584972473|FG003|Overall Study|Adverse Event|0|||
161978734|NCT02771626|584972474|FG004|Overall Study|Adverse Event|1|||
161978735|NCT02771626|584972475|FG005|Overall Study|Adverse Event|1|||
161978736|NCT02771626|584972470|FG000|Overall Study|Radiologic Disease Progression|6|||
161978737|NCT02771626|584972471|FG001|Overall Study|Radiologic Disease Progression|13|||
161978738|NCT02771626|584972472|FG002|Overall Study|Radiologic Disease Progression|10|||
161978739|NCT02771626|584972473|FG003|Overall Study|Radiologic Disease Progression|7|||
161978740|NCT02771626|584972474|FG004|Overall Study|Radiologic Disease Progression|28|||
161978741|NCT02771626|584972475|FG005|Overall Study|Radiologic Disease Progression|15|||
161978742|NCT02771626|584972470|FG000|Overall Study|Symptomatic Deterioration|0|||
161978743|NCT02771626|584972471|FG001|Overall Study|Symptomatic Deterioration|4|||
161978744|NCT02771626|584972472|FG002|Overall Study|Symptomatic Deterioration|2|||
161978745|NCT02771626|584972473|FG003|Overall Study|Symptomatic Deterioration|0|||
161978746|NCT02771626|584972474|FG004|Overall Study|Symptomatic Deterioration|5|||
161978747|NCT02771626|584972475|FG005|Overall Study|Symptomatic Deterioration|2|||
161978748|NCT02771626|584972470|FG000|Overall Study|Participant Request|0|||
161978749|NCT02771626|584972471|FG001|Overall Study|Participant Request|1|||
161978750|NCT02771626|584972472|FG002|Overall Study|Participant Request|0|||
161978751|NCT02771626|584972473|FG003|Overall Study|Participant Request|2|||
161978752|NCT02771626|584972474|FG004|Overall Study|Participant Request|0|||
161978753|NCT02771626|584972475|FG005|Overall Study|Participant Request|1|||
161978754|NCT02771626|584972470|FG000|Overall Study|Investigator Decision|0|||
161978755|NCT02771626|584972471|FG001|Overall Study|Investigator Decision|1|||
161978756|NCT02771626|584972472|FG002|Overall Study|Investigator Decision|0|||
161978757|NCT02771626|584972473|FG003|Overall Study|Investigator Decision|0|||
161978758|NCT02771626|584972474|FG004|Overall Study|Investigator Decision|1|||
161978759|NCT02771626|584972475|FG005|Overall Study|Investigator Decision|0|||
161978760|NCT02771626|584972470|FG000|Overall Study|Study Termination by Sponsor|0|||
161978761|NCT02771626|584972471|FG001|Overall Study|Study Termination by Sponsor|2|||
161978762|NCT02771626|584972472|FG002|Overall Study|Study Termination by Sponsor|1|||
161978763|NCT02771626|584972473|FG003|Overall Study|Study Termination by Sponsor|0|||
161978764|NCT02771626|584972474|FG004|Overall Study|Study Termination by Sponsor|1|||
161978765|NCT02771626|584972475|FG005|Overall Study|Study Termination by Sponsor|0|||
161978766|NCT02771626|584972470|FG000|Overall Study|Informed Consent Withdrawn|0|||
161978767|NCT02771626|584972471|FG001|Overall Study|Informed Consent Withdrawn|0|||
161978768|NCT02771626|584972472|FG002|Overall Study|Informed Consent Withdrawn|1|||
161978769|NCT02771626|584972473|FG003|Overall Study|Informed Consent Withdrawn|0|||
161978770|NCT02771626|584972474|FG004|Overall Study|Informed Consent Withdrawn|1|||
161978771|NCT02771626|584972475|FG005|Overall Study|Informed Consent Withdrawn|1|||
161978772|NCT02771626|584972470|FG000|Overall Study|Other, Not Specified|1|||
161978773|NCT02771626|584972471|FG001|Overall Study|Other, Not Specified|0|||
161978774|NCT02771626|584972472|FG002|Overall Study|Other, Not Specified|0|||
161978775|NCT02771626|584972473|FG003|Overall Study|Other, Not Specified|0|||
161978776|NCT02771626|584972474|FG004|Overall Study|Other, Not Specified|0|||
161978777|NCT02771626|584972475|FG005|Overall Study|Other, Not Specified|1|||
161978778|NCT04094584|584972476|FG000|Overall Study|No interest in study|88|||
161978779|NCT04094584|584972476|FG000|Overall Study|Unwilling to undergo screening tests|36|||
161978780|NCT04094584|584972476|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
161978781|NCT04094584|584972476|FG000|Overall Study|Opioid use|7|||
161978782|NCT04094584|584972476|FG000|Overall Study|Need for major surgery in study period|4|||
161978783|NCT04094584|584972476|FG000|Overall Study|eligible but declined enrollment|4|||
161978784|NCT04094584|584972476|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
161978785|NCT04094584|584972476|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
161978786|NCT04094584|584972476|FG000|Overall Study|Lost to Follow-up|3|||
161978787|NCT04094584|584972476|FG000|Overall Study|Withdrawal by Subject|2|||
161978788|NCT02690649|584972477|FG000|Overall Study|Withdrawal by Subject|1|||
161978789|NCT02690649|584972478|FG001|Overall Study|Withdrawal by Subject|1|||
161978790|NCT02690649|584972477|FG000|Overall Study|Protocol Violation|0|||
161978791|NCT02690649|584972478|FG001|Overall Study|Protocol Violation|3|||
161978792|NCT02276547|584972479|FG000|Overall Study|Death|2|||
161978793|NCT02276547|584972479|FG000|Overall Study|Explant|2|||
161978794|NCT02616393|584972480|FG000|Overall Study|Death|5|||
161978795|NCT02616393|584972481|FG001|Overall Study|Death|12|||
161978796|NCT02616393|584972482|FG002|Overall Study|Death|1|||
161978797|NCT02616393|584972480|FG000|Overall Study|Termination by Sponsor|4|||
161978798|NCT02616393|584972481|FG001|Overall Study|Termination by Sponsor|5|||
161978799|NCT02616393|584972482|FG002|Overall Study|Termination by Sponsor|2|||
161978800|NCT02616393|584972480|FG000|Overall Study|Other|3|||
161978801|NCT02616393|584972481|FG001|Overall Study|Other|0|||
161978802|NCT02616393|584972482|FG002|Overall Study|Other|0|||
161978803|NCT02616393|584972480|FG000|Overall Study|Withdrawal by Subject|1|||
161978804|NCT02616393|584972481|FG001|Overall Study|Withdrawal by Subject|1|||
161978805|NCT02616393|584972482|FG002|Overall Study|Withdrawal by Subject|0|||
161978806|NCT02616393|584972480|FG000|Overall Study|Lost to Follow-up|0|||
161978807|NCT02616393|584972481|FG001|Overall Study|Lost to Follow-up|2|||
161978808|NCT02616393|584972482|FG002|Overall Study|Lost to Follow-up|0|||
161978809|NCT02642965|584972483|FG000|Overall Study|Lack of Efficacy|4|||
161978810|NCT02642965|584972483|FG000|Overall Study|Physician Decision|9|||
161978811|NCT02713867|584972490|FG000|Randomization|Other Reason|2|||
161978812|NCT02713867|584972491|FG001|Randomization|Other Reason|1|||
161978813|NCT02713867|584972490|FG000|Randomization|Participant Withdrew consent|0|||
161978814|NCT02713867|584972491|FG001|Randomization|Participant Withdrew consent|2|||
161978815|NCT02713867|584972490|FG000|Treatment Period|Other Reasons|22|||
161978816|NCT02713867|584972491|FG001|Treatment Period|Other Reasons|28|||
161978817|NCT02713867|584972490|FG000|Treatment Period|Administrative reason by sponsor|21|||
161978818|NCT02713867|584972491|FG001|Treatment Period|Administrative reason by sponsor|16|||
161978819|NCT02713867|584972490|FG000|Treatment Period|No longer meets study criteria|2|||
161978820|NCT02713867|584972491|FG001|Treatment Period|No longer meets study criteria|1|||
161978821|NCT02713867|584972490|FG000|Treatment Period|Poor/Non Compliance|1|||
161978822|NCT02713867|584972491|FG001|Treatment Period|Poor/Non Compliance|0|||
161978823|NCT02713867|584972490|FG000|Treatment Period|Maximum Clinical Benefit|5|||
161978824|NCT02713867|584972491|FG001|Treatment Period|Maximum Clinical Benefit|6|||
161978825|NCT02713867|584972490|FG000|Treatment Period|Withdrew consent|3|||
161978826|NCT02713867|584972491|FG001|Treatment Period|Withdrew consent|6|||
161978827|NCT02713867|584972490|FG000|Treatment Period|Requested to Discontinue|8|||
161978828|NCT02713867|584972491|FG001|Treatment Period|Requested to Discontinue|8|||
161978829|NCT02713867|584972490|FG000|Treatment Period|AE unrelated to Study Drug|11|||
161978830|NCT02713867|584972491|FG001|Treatment Period|AE unrelated to Study Drug|10|||
161978831|NCT02713867|584972490|FG000|Treatment Period|Death|7|||
161978832|NCT02713867|584972491|FG001|Treatment Period|Death|3|||
161978833|NCT02713867|584972490|FG000|Treatment Period|Study Drug Toxicity|16|||
161978834|NCT02713867|584972491|FG001|Treatment Period|Study Drug Toxicity|19|||
161978835|NCT02713867|584972490|FG000|Treatment Period|Disease Progression|82|||
161978836|NCT02713867|584972491|FG001|Treatment Period|Disease Progression|83|||
161978837|NCT04135859|584972495|FG000|Overall Study|Withdrawal by Subject|1|||
161978838|NCT04135859|584972496|FG001|Overall Study|Withdrawal by Subject|0|||
161978839|NCT04135859|584972495|FG000|Overall Study|Withdrawal due to screening failure|1|||
161978840|NCT04135859|584972496|FG001|Overall Study|Withdrawal due to screening failure|2|||
161978841|NCT04135859|584972495|FG000|Overall Study|Did not complete stress test|3|||
161978842|NCT04135859|584972496|FG001|Overall Study|Did not complete stress test|3|||
161978843|NCT04135859|584972495|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
161978844|NCT04135859|584972496|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
161978845|NCT00493636|584972497|FG000|Overall Study|Withdrawal by Subject|1|||
161978846|NCT00493636|584972498|FG001|Overall Study|Withdrawal by Subject|0|||
162034865|NCT03452527|585183598|FG001|Overall Study|Withdrawal by Subject|1|||
162034866|NCT03452527|585183597|FG000|Overall Study|Study Terminated|2|||
161978847|NCT00493636|584972497|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
161978848|NCT00493636|584972498|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
161978849|NCT00493636|584972497|FG000|Overall Study|Mis-randomization|1|||
161978850|NCT00493636|584972498|FG001|Overall Study|Mis-randomization|1|||
161863546|NCT00946920|584542310|FG000|Overall Study|Withdrawal by Subject|28|||
161978851|NCT01600053|584972501|FG000|Overall Study|Adverse Event|2|||
161978852|NCT01600053|584972501|FG000|Overall Study|trial will not meet the interim endpoint|9|||
161978853|NCT02715726|584972504|FG000|Overall Study|Adverse Event|2|||
161978854|NCT02715726|584972505|FG001|Overall Study|Adverse Event|6|||
161978855|NCT02715726|584972504|FG000|Overall Study|Protocol Violation|1|||
161863547|NCT00946920|584542311|FG001|Overall Study|Withdrawal by Subject|15|||
161863548|NCT00946920|584542310|FG000|Overall Study|Lost to Follow-up|2|||
161863549|NCT00946920|584542311|FG001|Overall Study|Lost to Follow-up|2|||
161863550|NCT00946920|584542310|FG000|Overall Study|Physician Decision|5|||
161863551|NCT00946920|584542311|FG001|Overall Study|Physician Decision|2|||
161863552|NCT00946920|584542310|FG000|Overall Study|Adverse Event|41|||
161863553|NCT00946920|584542311|FG001|Overall Study|Adverse Event|14|||
161863554|NCT00946920|584542310|FG000|Overall Study|Protocol Violation|16|||
161863555|NCT00946920|584542311|FG001|Overall Study|Protocol Violation|8|||
161863556|NCT00946920|584542310|FG000|Overall Study|Miscellaneous reasons|18|||
161863557|NCT00946920|584542311|FG001|Overall Study|Miscellaneous reasons|3|||
161863558|NCT00397514|584542312|FG000|Overall Study|Withdrawal by Subject|1|||
161863559|NCT00397514|584542312|FG000|Overall Study|Pacing wire malfunction|1|||
161863560|NCT00397514|584542312|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
161863561|NCT00397514|584542312|FG000|Overall Study|early extubation|2|||
161863562|NCT00397514|584542312|FG000|Overall Study|poor echocardiographic windows|1|||
161863563|NCT01530464|584542313|FG000|Washout (24h)|Withdrawal by Subject|1|||
161863564|NCT01530464|584542314|FG001|Washout (24h)|Withdrawal by Subject|0|||
161863565|NCT01530464|584542313|FG000|Washout (24h)|Withdrawal by Subject|0|||
161863566|NCT01530464|584542314|FG001|Washout (24h)|Withdrawal by Subject|1|||
161863567|NCT01709500|584542315|FG000|Overall Study|Randomized but not treated|0|||
161863568|NCT01709500|584542316|FG001|Overall Study|Randomized but not treated|1|||
161863569|NCT01709500|584542315|FG000|Overall Study|Adverse Event|5|||
161863570|NCT01709500|584542316|FG001|Overall Study|Adverse Event|1|||
161863571|NCT01709500|584542315|FG000|Overall Study|Poor compliance to protocol|2|||
161863572|NCT01709500|584542316|FG001|Overall Study|Poor compliance to protocol|1|||
161863573|NCT01709500|584542315|FG000|Overall Study|Other|3|||
161863574|NCT01709500|584542316|FG001|Overall Study|Other|1|||
161863575|NCT01709500|584542315|FG000|Overall Study|Related to IMP administration|1|||
161863576|NCT01709500|584542316|FG001|Overall Study|Related to IMP administration|0|||
161863577|NCT01709500|584542315|FG000|Overall Study|Treatment ongoing|156|||
161863578|NCT01709500|584542316|FG001|Overall Study|Treatment ongoing|78|||
161863579|NCT02654054|584542321|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
161863580|NCT02654054|584542322|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
161863581|NCT02654054|584542323|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
161863582|NCT02654054|584542321|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
161863583|NCT02654054|584542322|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161863584|NCT02654054|584542323|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
161863585|NCT02654054|584542321|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
161863586|NCT02654054|584542322|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
161863587|NCT02654054|584542323|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
161863588|NCT02654054|584542321|FG000|Post-Treatment Follow-Up Period|Other|1|||
161863589|NCT02654054|584542322|FG001|Post-Treatment Follow-Up Period|Other|0|||
161863590|NCT02654054|584542323|FG002|Post-Treatment Follow-Up Period|Other|4|||
161863591|NCT02654054|584542321|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
161863592|NCT02654054|584542322|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
161863593|NCT02654054|584542323|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
161863594|NCT06389487|584542326|FG000|Overall Study|Lost to Follow-up|9|||
161863595|NCT06389487|584542327|FG001|Overall Study|Lost to Follow-up|5|||
161863596|NCT06389487|584542328|FG002|Overall Study|Lost to Follow-up|13|||
161863597|NCT06389487|584542326|FG000|Overall Study|Protocol Violation|0|||
161863598|NCT06389487|584542327|FG001|Overall Study|Protocol Violation|0|||
161863599|NCT06389487|584542328|FG002|Overall Study|Protocol Violation|2|||
161863600|NCT06389487|584542326|FG000|Overall Study|Withdrawal by Subject|2|||
161863601|NCT06389487|584542327|FG001|Overall Study|Withdrawal by Subject|2|||
161863602|NCT06389487|584542328|FG002|Overall Study|Withdrawal by Subject|1|||
161863603|NCT06389487|584542326|FG000|Overall Study|Other|1|||
161863604|NCT06389487|584542327|FG001|Overall Study|Other|0|||
161863605|NCT06389487|584542328|FG002|Overall Study|Other|1|||
161863606|NCT00955409|584544028|FG000|Overall Study|Lack of Efficacy|1|||
161863607|NCT00955409|584544029|FG001|Overall Study|Lack of Efficacy|0|||
161863608|NCT00955409|584544030|FG002|Overall Study|Lack of Efficacy|0|||
161863609|NCT00955409|584544031|FG003|Overall Study|Lack of Efficacy|0|||
161863610|NCT00955409|584544032|FG004|Overall Study|Lack of Efficacy|0|||
161863611|NCT00955409|584544033|FG005|Overall Study|Lack of Efficacy|0|||
161863612|NCT00955409|584544034|FG006|Overall Study|Lack of Efficacy|0|||
161863613|NCT00955409|584544035|FG007|Overall Study|Lack of Efficacy|0|||
161863614|NCT00955409|584544036|FG008|Overall Study|Lack of Efficacy|0|||
161863615|NCT00955409|584544037|FG009|Overall Study|Lack of Efficacy|0|||
161863616|NCT00955409|584544028|FG000|Overall Study|Withdrawal by Subject|1|||
161863617|NCT00955409|584544029|FG001|Overall Study|Withdrawal by Subject|0|||
161863618|NCT00955409|584544030|FG002|Overall Study|Withdrawal by Subject|5|||
161863619|NCT00955409|584544031|FG003|Overall Study|Withdrawal by Subject|2|||
161863620|NCT00955409|584544032|FG004|Overall Study|Withdrawal by Subject|0|||
161863621|NCT00955409|584544033|FG005|Overall Study|Withdrawal by Subject|0|||
161863622|NCT00955409|584544034|FG006|Overall Study|Withdrawal by Subject|2|||
161978856|NCT02715726|584972505|FG001|Overall Study|Protocol Violation|0|||
161978857|NCT02715726|584972504|FG000|Overall Study|Death|2|||
161978858|NCT02715726|584972505|FG001|Overall Study|Death|1|||
161978859|NCT02715726|584972504|FG000|Overall Study|Participant moved|1|||
161978860|NCT02715726|584972505|FG001|Overall Study|Participant moved|3|||
161978861|NCT02715726|584972504|FG000|Overall Study|Other than specified above|11|||
161978862|NCT02715726|584972505|FG001|Overall Study|Other than specified above|15|||
161978863|NCT02715726|584972504|FG000|Overall Study|Randomized but not treated|1|||
161978864|NCT02715726|584972505|FG001|Overall Study|Randomized but not treated|2|||
161978865|NCT02445573|584972506|FG000|Overall Study|Withdrawal by Subject|1|||
161978866|NCT02445573|584972507|FG001|Overall Study|Withdrawal by Subject|1|||
161978867|NCT02445573|584972506|FG000|Overall Study|Lost to Follow-up|0|||
161978868|NCT02445573|584972507|FG001|Overall Study|Lost to Follow-up|1|||
161978869|NCT01565941|584972508|FG000|Overall Study|Withdrawn by parent/guardian|3|||
161978870|NCT01565941|584972509|FG001|Overall Study|Withdrawn by parent/guardian|2|||
161978871|NCT01565941|584972508|FG000|Overall Study|Randomized; did not receive intevention|8|||
161978872|NCT01565941|584972509|FG001|Overall Study|Randomized; did not receive intevention|2|||
161978873|NCT03230292|584972512|FG000|Overall Study|Adverse Event|1|||
161978874|NCT03230292|584972512|FG000|Overall Study|Protocol Violation|1|||
161978875|NCT03230292|584972512|FG000|Overall Study|Lost to Follow-up|1|||
161978876|NCT03230292|584972512|FG000|Overall Study|Withdrawal by Subject|3|||
161978877|NCT02855944|584972513|FG000|Period 1: Treatment|Ongoing|14|||
161978878|NCT02855944|584972514|FG001|Period 1: Treatment|Ongoing|0|||
161978879|NCT02855944|584972513|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
161978880|NCT02855944|584972514|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
161978881|NCT02855944|584972513|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
161978882|NCT02855944|584972514|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
161978883|NCT03757130|584972515|FG000|Overall Study|Lost to Follow-up|0|||
161978884|NCT03757130|584972516|FG001|Overall Study|Lost to Follow-up|0|||
161978885|NCT03757130|584972517|FG002|Overall Study|Lost to Follow-up|0|||
161978886|NCT03757130|584972518|FG003|Overall Study|Lost to Follow-up|1|||
161978887|NCT03757130|584972519|FG004|Overall Study|Lost to Follow-up|0|||
161978888|NCT03757130|584972520|FG005|Overall Study|Lost to Follow-up|0|||
161978889|NCT03757130|584972521|FG006|Overall Study|Lost to Follow-up|0|||
161978890|NCT03757130|584972522|FG007|Overall Study|Lost to Follow-up|1|||
161978891|NCT03757130|584972515|FG000|Overall Study|Withdrawal by Subject|0|||
161978892|NCT03757130|584972516|FG001|Overall Study|Withdrawal by Subject|0|||
161978893|NCT03757130|584972517|FG002|Overall Study|Withdrawal by Subject|0|||
161978894|NCT03757130|584972518|FG003|Overall Study|Withdrawal by Subject|0|||
161978895|NCT03757130|584972519|FG004|Overall Study|Withdrawal by Subject|0|||
161978896|NCT03757130|584972520|FG005|Overall Study|Withdrawal by Subject|0|||
161978897|NCT03757130|584972521|FG006|Overall Study|Withdrawal by Subject|1|||
161978898|NCT03757130|584972522|FG007|Overall Study|Withdrawal by Subject|0|||
161978899|NCT01639755|584972523|FG000|Overall Study|Study Ongoing|15|||
161978900|NCT01639755|584972523|FG000|Overall Study|Patient had device explantation|4|||
161978901|NCT01439126|584972524|FG000|Overall Study|Adverse Event|2|||
161978902|NCT01439126|584972525|FG001|Overall Study|Adverse Event|0|||
161978903|NCT01439126|584972524|FG000|Overall Study|Withdrawal by Subject|5|||
161978904|NCT01439126|584972525|FG001|Overall Study|Withdrawal by Subject|21|||
161978905|NCT01439126|584972524|FG000|Overall Study|Protocol Violation|6|||
161978906|NCT01439126|584972525|FG001|Overall Study|Protocol Violation|4|||
161978907|NCT01439126|584972524|FG000|Overall Study|Lost to Follow-up|6|||
161978908|NCT01439126|584972525|FG001|Overall Study|Lost to Follow-up|3|||
161978909|NCT01439126|584972524|FG000|Overall Study|Other-Use of prohibited treatment|0|||
161978910|NCT01439126|584972525|FG001|Overall Study|Other-Use of prohibited treatment|2|||
161978911|NCT01439126|584972524|FG000|Overall Study|Other-Miscellaneous|12|||
161978912|NCT01439126|584972525|FG001|Overall Study|Other-Miscellaneous|12|||
161978913|NCT03242018|584972527|FG000|Overall Study|Adverse Event|7|||
161978914|NCT03242018|584972528|FG001|Overall Study|Adverse Event|7|||
161978915|NCT03242018|584972529|FG002|Overall Study|Adverse Event|6|||
161978916|NCT03242018|584972527|FG000|Overall Study|Lost to Follow-up|2|||
161773364|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
161773365|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
161773366|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161773367|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161773368|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161978917|NCT03242018|584972528|FG001|Overall Study|Lost to Follow-up|2|||
161978918|NCT03242018|584972529|FG002|Overall Study|Lost to Follow-up|2|||
161978919|NCT03242018|584972527|FG000|Overall Study|At the Participant's Own Request|5|||
161978920|NCT03242018|584972528|FG001|Overall Study|At the Participant's Own Request|1|||
161978921|NCT03242018|584972529|FG002|Overall Study|At the Participant's Own Request|4|||
161978922|NCT03242018|584972527|FG000|Overall Study|Reason Not Specified|3|||
161978923|NCT03242018|584972528|FG001|Overall Study|Reason Not Specified|4|||
161978924|NCT03242018|584972529|FG002|Overall Study|Reason Not Specified|1|||
161978925|NCT03242018|584972527|FG000|Overall Study|Study Terminated by Sponsor|1|||
162034867|NCT03452527|585183598|FG001|Overall Study|Study Terminated|3|||
161978926|NCT03242018|584972528|FG001|Overall Study|Study Terminated by Sponsor|0|||
161978927|NCT03242018|584972529|FG002|Overall Study|Study Terminated by Sponsor|1|||
161978928|NCT02365285|584972532|FG000|Overall Study|Physician Decision|0|||
161773369|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
161773370|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
161773371|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
161773372|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
161773373|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161773374|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161773375|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161773376|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
161773377|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
161773378|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
161773379|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
161773380|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161773381|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161773382|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161773383|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
161773384|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161773385|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161773386|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161773387|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161773388|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161773389|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161773390|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161773391|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
161773392|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161773393|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161773394|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161773395|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161773396|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161773397|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161773398|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
161773399|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161773400|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161773401|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161773402|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161773403|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161773404|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161773405|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
161773406|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161773407|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161773408|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161773409|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161773410|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161773411|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161773412|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
161773413|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161773414|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161773415|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161773416|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161773417|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161773418|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161773419|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
161978929|NCT02365285|584972533|FG001|Overall Study|Physician Decision|1|||
161978930|NCT02365285|584972534|FG002|Overall Study|Physician Decision|1|||
161978931|NCT02365285|584972535|FG003|Overall Study|Physician Decision|0|||
161773420|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161773421|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161773422|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161773423|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161773424|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161773425|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161773426|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161773427|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
161773428|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161773429|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161773430|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161773431|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161773432|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161773433|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161773434|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
161773435|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161773436|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161773437|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161773438|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161773439|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161773440|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161773441|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161773442|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
161773443|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161773444|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161773445|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161773446|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161773447|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161773448|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161773449|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
161773450|NCT04242446|584214260|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161773451|NCT04242446|584214261|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161773452|NCT04242446|584214262|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161773453|NCT04242446|584214263|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161773454|NCT04242446|584214264|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161773455|NCT04242446|584214265|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161773456|NCT04242446|584214266|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
161773457|NCT03587116|584214267|FG000|Overall Study|Lost to Follow-up|0|||
161773458|NCT03587116|584214268|FG001|Overall Study|Lost to Follow-up|1|||
161773459|NCT03587116|584214267|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
161773460|NCT03587116|584214268|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
161773461|NCT03587116|584214267|FG000|Overall Study|Withdrawal by Subject|4|||
161773462|NCT03587116|584214268|FG001|Overall Study|Withdrawal by Subject|0|||
161773463|NCT05993299|584214271|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
161773464|NCT05993299|584214271|FG000|Overall Study|Ongoing|4|||
161773465|NCT05644756|584214272|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
161773466|NCT05644756|584214272|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
161773467|NCT03110107|584214273|FG000|Treatment Period|Disease Progression|3|||
161773468|NCT03110107|584214274|FG001|Treatment Period|Disease Progression|9|||
161773469|NCT03110107|584214275|FG002|Treatment Period|Disease Progression|8|||
161773470|NCT03110107|584214276|FG003|Treatment Period|Disease Progression|11|||
161773471|NCT03110107|584214277|FG004|Treatment Period|Disease Progression|8|||
161773472|NCT03110107|584214278|FG005|Treatment Period|Disease Progression|4|||
161773473|NCT03110107|584214279|FG006|Treatment Period|Disease Progression|6|||
161773474|NCT03110107|584214280|FG007|Treatment Period|Disease Progression|7|||
161773475|NCT03110107|584214281|FG008|Treatment Period|Disease Progression|2|||
161773476|NCT03110107|584214282|FG009|Treatment Period|Disease Progression|10|||
161773477|NCT03110107|584214283|FG010|Treatment Period|Disease Progression|5|||
161773478|NCT03110107|584214284|FG011|Treatment Period|Disease Progression|2|||
161978932|NCT02365285|584972532|FG000|Overall Study|Adverse Event|0|||
161978933|NCT02365285|584972533|FG001|Overall Study|Adverse Event|0|||
161978934|NCT02365285|584972534|FG002|Overall Study|Adverse Event|0|||
161978935|NCT02365285|584972535|FG003|Overall Study|Adverse Event|2|||
161978936|NCT03262116|584972536|FG000|Overall Study|Physician Decision|0|||
161978937|NCT03262116|584972537|FG001|Overall Study|Physician Decision|2|||
161978938|NCT03262116|584972538|FG002|Overall Study|Physician Decision|1|||
161978939|NCT03262116|584972539|FG003|Overall Study|Physician Decision|1|||
161978940|NCT03262116|584972540|FG004|Overall Study|Physician Decision|1|||
161978941|NCT03262116|584972541|FG005|Overall Study|Physician Decision|2|||
161978942|NCT00635089|584972548|FG000|Overall Study|Adverse Event|7|||
161978943|NCT00635089|584972548|FG000|Overall Study|Lack of Efficacy|28|||
161978944|NCT00635089|584972548|FG000|Overall Study|Protocol Deviation|4|||
161978945|NCT00635089|584972548|FG000|Overall Study|Lost to Follow-up|8|||
161978946|NCT00635089|584972548|FG000|Overall Study|Other|31|||
161978947|NCT01617447|584972549|FG000|Overall Study|Adverse Event|0|||
161978948|NCT01617447|584972550|FG001|Overall Study|Adverse Event|1|||
161978949|NCT01617447|584972549|FG000|Overall Study|Physician Decision|0|||
161978950|NCT01617447|584972550|FG001|Overall Study|Physician Decision|2|||
161978951|NCT02636946|584972552|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
161978952|NCT02636946|584972553|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
161978953|NCT02636946|584972552|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
161978954|NCT02636946|584972553|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
161978955|NCT02636946|584972552|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
161978956|NCT02636946|584972553|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
161978957|NCT02636946|584972552|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
161978958|NCT02636946|584972553|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
161978959|NCT02636946|584972552|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
161978960|NCT02636946|584972553|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
161978961|NCT02636946|584972552|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
161978962|NCT02636946|584972553|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
161978963|NCT01283542|584972554|FG000|Main Phase|Acute or progressive vision loss|1|||
161978964|NCT01283542|584972554|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
161978965|NCT01283542|584972554|FG000|Main Phase|abnormal laboratory values|5|||
161978966|NCT01283542|584972554|FG000|Extension Phase|Physician Decision|1|||
161978967|NCT01283542|584972554|FG000|Extension Phase|Adverse Event|1|||
161978968|NCT01283542|584972554|FG000|Extension Phase|Administrative problems|1|||
161978969|NCT05059977|584972555|FG000|Overall Study|Withdrawal by Subject|0|||
161978970|NCT05059977|584972556|FG001|Overall Study|Withdrawal by Subject|0|||
161978971|NCT05059977|584972557|FG002|Overall Study|Withdrawal by Subject|1|||
161978972|NCT04405245|584972558|FG000|Overall Study|Adverse Event|0|||
161978973|NCT04405245|584972559|FG001|Overall Study|Adverse Event|1|||
161978974|NCT04405245|584972560|FG002|Overall Study|Adverse Event|0|||
161978975|NCT03443427|584972561|FG000|Overall Study|Adverse Event|2|||
161978976|NCT03443427|584972562|FG001|Overall Study|Adverse Event|3|||
161978977|NCT03443427|584972561|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
161978978|NCT03443427|584972562|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
161978979|NCT03443427|584972561|FG000|Overall Study|Other|4|||
161978980|NCT03443427|584972562|FG001|Overall Study|Other|6|||
161978981|NCT00576472|584972563|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
161978982|NCT00576472|584972564|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
161978983|NCT00576472|584972565|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
161773479|NCT03110107|584214285|FG012|Treatment Period|Disease Progression|0|||
161773480|NCT03110107|584214286|FG013|Treatment Period|Disease Progression|5|||
161773481|NCT03110107|584214287|FG014|Treatment Period|Disease Progression|14|||
161773482|NCT03110107|584214288|FG015|Treatment Period|Disease Progression|14|||
161773483|NCT03110107|584214289|FG016|Treatment Period|Disease Progression|4|||
161773484|NCT03110107|584214290|FG017|Treatment Period|Disease Progression|3|||
161773485|NCT03110107|584214291|FG018|Treatment Period|Disease Progression|16|||
161773486|NCT03110107|584214292|FG019|Treatment Period|Disease Progression|14|||
161773487|NCT03110107|584214293|FG020|Treatment Period|Disease Progression|12|||
161773488|NCT03110107|584214294|FG021|Treatment Period|Disease Progression|16|||
161773489|NCT03110107|584214295|FG022|Treatment Period|Disease Progression|18|||
161773490|NCT03110107|584214296|FG023|Treatment Period|Disease Progression|13|||
161773491|NCT03110107|584214297|FG024|Treatment Period|Disease Progression|16|||
161773492|NCT03110107|584214298|FG025|Treatment Period|Disease Progression|31|||
161773493|NCT03110107|584214273|FG000|Treatment Period|Study drug toxicity|1|||
161863623|NCT00955409|584544035|FG007|Overall Study|Withdrawal by Subject|0|||
161978984|NCT00576472|584972566|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
161978985|NCT00576472|584972567|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
161978986|NCT00576472|584972568|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
161978987|NCT00576472|584972569|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
161978988|NCT00576472|584972570|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
162034868|NCT01585584|585183601|FG000|Overall Study|Lack of Efficacy|1|||
161773494|NCT03110107|584214274|FG001|Treatment Period|Study drug toxicity|0|||
161773495|NCT03110107|584214275|FG002|Treatment Period|Study drug toxicity|1|||
161978989|NCT00576472|584972571|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
161978990|NCT00576472|584972572|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
161978991|NCT00576472|584972573|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
161978992|NCT00576472|584972574|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
161978993|NCT00576472|584972575|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
161978994|NCT00576472|584972576|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
161978995|NCT00576472|584972577|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
161978996|NCT00576472|584972563|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
161978997|NCT00576472|584972564|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
161978998|NCT00576472|584972565|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
161978999|NCT00576472|584972566|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
161979000|NCT00576472|584972567|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
161979001|NCT00576472|584972568|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
161979002|NCT00576472|584972569|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
161979003|NCT00576472|584972570|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
161979004|NCT00576472|584972571|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
161979005|NCT00576472|584972572|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
161979006|NCT00576472|584972573|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
161979007|NCT00576472|584972574|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
161979008|NCT00576472|584972575|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
161979009|NCT00576472|584972576|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
161979010|NCT00576472|584972577|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
161979011|NCT00576472|584972563|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979012|NCT00576472|584972564|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979013|NCT00576472|584972565|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979014|NCT00576472|584972566|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
161979015|NCT00576472|584972567|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979016|NCT00576472|584972568|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979017|NCT00576472|584972569|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979018|NCT00576472|584972570|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979019|NCT00576472|584972571|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979020|NCT00576472|584972572|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979021|NCT00576472|584972573|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979022|NCT00576472|584972574|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979023|NCT00576472|584972575|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979024|NCT00576472|584972576|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979025|NCT00576472|584972577|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
161979026|NCT00576472|584972563|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
161979027|NCT00576472|584972564|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
161979028|NCT00576472|584972565|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
161979029|NCT00576472|584972566|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
161979030|NCT00576472|584972567|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
162034869|NCT01585584|585183601|FG000|Overall Study|Withdrawal by Subject|1|||
161773496|NCT03110107|584214276|FG003|Treatment Period|Study drug toxicity|2|||
161773497|NCT03110107|584214277|FG004|Treatment Period|Study drug toxicity|0|||
161773498|NCT03110107|584214278|FG005|Treatment Period|Study drug toxicity|3|||
161773499|NCT03110107|584214279|FG006|Treatment Period|Study drug toxicity|1|||
161773500|NCT03110107|584214280|FG007|Treatment Period|Study drug toxicity|1|||
161773501|NCT03110107|584214281|FG008|Treatment Period|Study drug toxicity|3|||
161773502|NCT03110107|584214282|FG009|Treatment Period|Study drug toxicity|2|||
161773503|NCT03110107|584214283|FG010|Treatment Period|Study drug toxicity|0|||
161773504|NCT03110107|584214284|FG011|Treatment Period|Study drug toxicity|2|||
161773505|NCT03110107|584214285|FG012|Treatment Period|Study drug toxicity|0|||
161773506|NCT03110107|584214286|FG013|Treatment Period|Study drug toxicity|0|||
161773507|NCT03110107|584214287|FG014|Treatment Period|Study drug toxicity|2|||
161773508|NCT03110107|584214288|FG015|Treatment Period|Study drug toxicity|3|||
161773509|NCT03110107|584214289|FG016|Treatment Period|Study drug toxicity|3|||
161773510|NCT03110107|584214290|FG017|Treatment Period|Study drug toxicity|3|||
161773511|NCT03110107|584214291|FG018|Treatment Period|Study drug toxicity|1|||
161773512|NCT03110107|584214292|FG019|Treatment Period|Study drug toxicity|2|||
161773513|NCT03110107|584214293|FG020|Treatment Period|Study drug toxicity|2|||
161773514|NCT03110107|584214294|FG021|Treatment Period|Study drug toxicity|0|||
161773515|NCT03110107|584214295|FG022|Treatment Period|Study drug toxicity|2|||
161773516|NCT03110107|584214296|FG023|Treatment Period|Study drug toxicity|6|||
161773517|NCT03110107|584214297|FG024|Treatment Period|Study drug toxicity|7|||
161773518|NCT03110107|584214298|FG025|Treatment Period|Study drug toxicity|6|||
161773519|NCT03110107|584214273|FG000|Treatment Period|Death|0|||
161773520|NCT03110107|584214274|FG001|Treatment Period|Death|0|||
161773521|NCT03110107|584214275|FG002|Treatment Period|Death|0|||
161773522|NCT03110107|584214276|FG003|Treatment Period|Death|0|||
161773523|NCT03110107|584214277|FG004|Treatment Period|Death|0|||
161773524|NCT03110107|584214278|FG005|Treatment Period|Death|0|||
161979031|NCT00576472|584972568|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
161979032|NCT00576472|584972569|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
161979033|NCT00576472|584972570|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
161979034|NCT00576472|584972571|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
161979035|NCT00576472|584972572|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
161979036|NCT00576472|584972573|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
161979037|NCT00576472|584972574|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
161979038|NCT00576472|584972575|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
161979039|NCT00576472|584972576|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
161979040|NCT00576472|584972577|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
161979041|NCT00576472|584972563|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
161979042|NCT00576472|584972564|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
161979043|NCT00576472|584972565|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
161979044|NCT00576472|584972566|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
161979045|NCT00576472|584972567|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
161979046|NCT00576472|584972568|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
161979047|NCT00576472|584972569|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
162034870|NCT01585584|585183601|FG000|Overall Study|Physician Decision|2|||
161863624|NCT00955409|584544036|FG008|Overall Study|Withdrawal by Subject|1|||
161863625|NCT00955409|584544037|FG009|Overall Study|Withdrawal by Subject|0|||
161863626|NCT00955409|584544028|FG000|Overall Study|Caregiver Request|2|||
161863627|NCT00955409|584544029|FG001|Overall Study|Caregiver Request|0|||
161863628|NCT00955409|584544030|FG002|Overall Study|Caregiver Request|6|||
161863629|NCT00955409|584544031|FG003|Overall Study|Caregiver Request|5|||
161863630|NCT00955409|584544032|FG004|Overall Study|Caregiver Request|0|||
161863631|NCT00955409|584544033|FG005|Overall Study|Caregiver Request|2|||
161863632|NCT00955409|584544034|FG006|Overall Study|Caregiver Request|3|||
161863633|NCT00955409|584544035|FG007|Overall Study|Caregiver Request|1|||
161863634|NCT00955409|584544036|FG008|Overall Study|Caregiver Request|3|||
161863635|NCT00955409|584544037|FG009|Overall Study|Caregiver Request|0|||
161863636|NCT00955409|584544028|FG000|Overall Study|Investigator Request|0|||
161863637|NCT00955409|584544029|FG001|Overall Study|Investigator Request|0|||
161863638|NCT00955409|584544030|FG002|Overall Study|Investigator Request|1|||
161863639|NCT00955409|584544031|FG003|Overall Study|Investigator Request|0|||
161863640|NCT00955409|584544032|FG004|Overall Study|Investigator Request|0|||
161863641|NCT00955409|584544033|FG005|Overall Study|Investigator Request|0|||
161863642|NCT00955409|584544034|FG006|Overall Study|Investigator Request|0|||
161863643|NCT00955409|584544035|FG007|Overall Study|Investigator Request|0|||
161863644|NCT00955409|584544036|FG008|Overall Study|Investigator Request|0|||
161863645|NCT00955409|584544037|FG009|Overall Study|Investigator Request|0|||
161863646|NCT00955409|584544028|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
161863647|NCT00955409|584544029|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161863648|NCT00955409|584544030|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
161863649|NCT00955409|584544031|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
161863650|NCT00955409|584544032|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
161863651|NCT00955409|584544033|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
161863652|NCT00955409|584544034|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
161863653|NCT00955409|584544035|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
161863654|NCT00955409|584544036|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
161863655|NCT00955409|584544037|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
161863656|NCT00955409|584544028|FG000|Overall Study|Lost to Follow-up|0|||
161863657|NCT00955409|584544029|FG001|Overall Study|Lost to Follow-up|0|||
161863658|NCT00955409|584544030|FG002|Overall Study|Lost to Follow-up|1|||
161863659|NCT00955409|584544031|FG003|Overall Study|Lost to Follow-up|0|||
161863660|NCT00955409|584544032|FG004|Overall Study|Lost to Follow-up|0|||
161863661|NCT00955409|584544033|FG005|Overall Study|Lost to Follow-up|0|||
161863662|NCT00955409|584544034|FG006|Overall Study|Lost to Follow-up|1|||
161863663|NCT00955409|584544035|FG007|Overall Study|Lost to Follow-up|0|||
161773525|NCT03110107|584214279|FG006|Treatment Period|Death|0|||
161773526|NCT03110107|584214280|FG007|Treatment Period|Death|0|||
161773527|NCT03110107|584214281|FG008|Treatment Period|Death|0|||
161773528|NCT03110107|584214282|FG009|Treatment Period|Death|0|||
161773529|NCT03110107|584214283|FG010|Treatment Period|Death|0|||
161773530|NCT03110107|584214284|FG011|Treatment Period|Death|0|||
161773531|NCT03110107|584214285|FG012|Treatment Period|Death|1|||
161773532|NCT03110107|584214286|FG013|Treatment Period|Death|0|||
161773533|NCT03110107|584214287|FG014|Treatment Period|Death|0|||
161773534|NCT03110107|584214288|FG015|Treatment Period|Death|0|||
161773535|NCT03110107|584214289|FG016|Treatment Period|Death|0|||
161773536|NCT03110107|584214290|FG017|Treatment Period|Death|0|||
161773537|NCT03110107|584214291|FG018|Treatment Period|Death|0|||
161773538|NCT03110107|584214292|FG019|Treatment Period|Death|0|||
161773539|NCT03110107|584214293|FG020|Treatment Period|Death|0|||
161863664|NCT00955409|584544036|FG008|Overall Study|Lost to Follow-up|0|||
161863665|NCT00955409|584544037|FG009|Overall Study|Lost to Follow-up|0|||
161979048|NCT00576472|584972570|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
161773540|NCT03110107|584214294|FG021|Treatment Period|Death|0|||
161979049|NCT00576472|584972571|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
161979050|NCT00576472|584972572|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
161979051|NCT00576472|584972573|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
161979052|NCT00576472|584972574|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
161979053|NCT00576472|584972575|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
161979054|NCT00576472|584972576|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
161979055|NCT00576472|584972577|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
161979056|NCT00576472|584972563|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979057|NCT00576472|584972564|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979058|NCT00576472|584972565|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979059|NCT00576472|584972566|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979060|NCT00576472|584972567|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979061|NCT00576472|584972568|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979062|NCT00576472|584972569|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
161979063|NCT00576472|584972570|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979064|NCT00576472|584972571|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979065|NCT00576472|584972572|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979066|NCT00576472|584972573|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979067|NCT00576472|584972574|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979068|NCT00576472|584972575|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979069|NCT00576472|584972576|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979070|NCT00576472|584972577|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
161979071|NCT00576472|584972563|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
161979072|NCT00576472|584972564|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
161979073|NCT00576472|584972565|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
161979074|NCT00576472|584972566|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
161979075|NCT00576472|584972567|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
161979076|NCT00576472|584972568|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
161979077|NCT00576472|584972569|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
161979078|NCT00576472|584972570|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
161979079|NCT00576472|584972571|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
161979080|NCT00576472|584972572|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
161979081|NCT00576472|584972573|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
161979082|NCT00576472|584972574|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
161979083|NCT00576472|584972575|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
161979084|NCT00576472|584972576|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
161979085|NCT00576472|584972577|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
161979086|NCT00576472|584972563|FG000|MPH Cross Over Phase|Physician Decision|0|||
161979087|NCT00576472|584972564|FG001|MPH Cross Over Phase|Physician Decision|0|||
161979088|NCT00576472|584972565|FG002|MPH Cross Over Phase|Physician Decision|0|||
161979089|NCT00576472|584972566|FG003|MPH Cross Over Phase|Physician Decision|0|||
161979090|NCT00576472|584972567|FG004|MPH Cross Over Phase|Physician Decision|0|||
161979091|NCT00576472|584972568|FG005|MPH Cross Over Phase|Physician Decision|0|||
161979092|NCT00576472|584972569|FG006|MPH Cross Over Phase|Physician Decision|4|||
161979093|NCT00576472|584972570|FG007|MPH Cross Over Phase|Physician Decision|0|||
161979094|NCT00576472|584972571|FG008|MPH Cross Over Phase|Physician Decision|0|||
161979095|NCT00576472|584972572|FG009|MPH Cross Over Phase|Physician Decision|0|||
161979096|NCT00576472|584972573|FG010|MPH Cross Over Phase|Physician Decision|0|||
161979097|NCT00576472|584972574|FG011|MPH Cross Over Phase|Physician Decision|0|||
161979098|NCT00576472|584972575|FG012|MPH Cross Over Phase|Physician Decision|0|||
161979099|NCT00576472|584972576|FG013|MPH Cross Over Phase|Physician Decision|0|||
161979100|NCT00576472|584972577|FG014|MPH Cross Over Phase|Physician Decision|0|||
161979101|NCT00576472|584972563|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
161979102|NCT00576472|584972564|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
161979103|NCT00576472|584972565|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
161979104|NCT00576472|584972566|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
161979105|NCT00576472|584972567|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
161979106|NCT00576472|584972568|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
161979107|NCT00576472|584972569|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
161979108|NCT00576472|584972570|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
161979109|NCT00576472|584972571|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
161979110|NCT00576472|584972572|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
161979111|NCT00576472|584972573|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
161979112|NCT00576472|584972574|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
161979113|NCT00576472|584972575|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
161979114|NCT00576472|584972576|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
161979115|NCT00576472|584972577|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
161979116|NCT00576472|584972563|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979117|NCT00576472|584972564|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979118|NCT00576472|584972565|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979119|NCT00576472|584972566|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979120|NCT00576472|584972567|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979121|NCT00576472|584972568|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979122|NCT00576472|584972569|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979123|NCT00576472|584972570|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979124|NCT00576472|584972571|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979125|NCT00576472|584972572|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979126|NCT00576472|584972573|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979127|NCT00576472|584972574|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979128|NCT00576472|584972575|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979129|NCT00576472|584972576|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
161979130|NCT00576472|584972577|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161979131|NCT00576472|584972563|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
161979132|NCT00576472|584972564|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
161979133|NCT00576472|584972565|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
161979134|NCT00576472|584972566|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
161979135|NCT00576472|584972567|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
161979136|NCT00576472|584972568|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
161979137|NCT00576472|584972569|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
161979138|NCT00576472|584972570|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
161979139|NCT00576472|584972571|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
161979140|NCT00576472|584972572|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
161979141|NCT00576472|584972573|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
161979142|NCT00576472|584972574|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
161979143|NCT00576472|584972575|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
161979144|NCT00576472|584972576|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
161979145|NCT00576472|584972577|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
161979146|NCT00576472|584972563|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
161979147|NCT00576472|584972564|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
161979148|NCT00576472|584972565|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
161979149|NCT00576472|584972566|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
161979150|NCT00576472|584972567|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
161979151|NCT00576472|584972568|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
161979152|NCT00576472|584972569|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
161979153|NCT00576472|584972570|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
161979154|NCT00576472|584972571|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
161979155|NCT00576472|584972572|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
161979156|NCT00576472|584972573|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
161979157|NCT00576472|584972574|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
161979158|NCT00576472|584972575|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
161979159|NCT00576472|584972576|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
161979160|NCT00576472|584972577|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
161979161|NCT00576472|584972563|FG000|MPH Home Maintenance Phase|Side effects|0|||
161979162|NCT00576472|584972564|FG001|MPH Home Maintenance Phase|Side effects|0|||
161979163|NCT00576472|584972565|FG002|MPH Home Maintenance Phase|Side effects|0|||
161979164|NCT00576472|584972566|FG003|MPH Home Maintenance Phase|Side effects|0|||
161979165|NCT00576472|584972567|FG004|MPH Home Maintenance Phase|Side effects|0|||
161979166|NCT00576472|584972568|FG005|MPH Home Maintenance Phase|Side effects|0|||
161979167|NCT00576472|584972569|FG006|MPH Home Maintenance Phase|Side effects|0|||
161979168|NCT00576472|584972570|FG007|MPH Home Maintenance Phase|Side effects|0|||
161979169|NCT00576472|584972571|FG008|MPH Home Maintenance Phase|Side effects|0|||
161979170|NCT00576472|584972572|FG009|MPH Home Maintenance Phase|Side effects|0|||
161979171|NCT00576472|584972573|FG010|MPH Home Maintenance Phase|Side effects|0|||
161979172|NCT00576472|584972574|FG011|MPH Home Maintenance Phase|Side effects|0|||
161979173|NCT00576472|584972575|FG012|MPH Home Maintenance Phase|Side effects|0|||
161979174|NCT00576472|584972576|FG013|MPH Home Maintenance Phase|Side effects|0|||
161979175|NCT00576472|584972577|FG014|MPH Home Maintenance Phase|Side effects|8|||
161979176|NCT00576472|584972563|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979177|NCT00576472|584972564|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979178|NCT00576472|584972565|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161773541|NCT03110107|584214295|FG022|Treatment Period|Death|0|||
161773542|NCT03110107|584214296|FG023|Treatment Period|Death|0|||
161773543|NCT03110107|584214297|FG024|Treatment Period|Death|0|||
161979179|NCT00576472|584972566|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979180|NCT00576472|584972567|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979181|NCT00576472|584972568|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979182|NCT00576472|584972569|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979183|NCT00576472|584972570|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979184|NCT00576472|584972571|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979185|NCT00576472|584972572|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979186|NCT00576472|584972573|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979187|NCT00576472|584972574|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979188|NCT00576472|584972575|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979189|NCT00576472|584972576|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
161979190|NCT00576472|584972577|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
161979191|NCT00576472|584972563|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
161979192|NCT00576472|584972564|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
161979193|NCT00576472|584972565|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
161979194|NCT00576472|584972566|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
161773544|NCT03110107|584214298|FG025|Treatment Period|Death|0|||
161773545|NCT03110107|584214273|FG000|Treatment Period|Adverse Event|0|||
161773546|NCT03110107|584214274|FG001|Treatment Period|Adverse Event|0|||
161773547|NCT03110107|584214275|FG002|Treatment Period|Adverse Event|1|||
161773548|NCT03110107|584214276|FG003|Treatment Period|Adverse Event|0|||
161773549|NCT03110107|584214277|FG004|Treatment Period|Adverse Event|0|||
161773550|NCT03110107|584214278|FG005|Treatment Period|Adverse Event|2|||
161773551|NCT03110107|584214279|FG006|Treatment Period|Adverse Event|0|||
161773552|NCT03110107|584214280|FG007|Treatment Period|Adverse Event|2|||
161773553|NCT03110107|584214281|FG008|Treatment Period|Adverse Event|0|||
161773554|NCT03110107|584214282|FG009|Treatment Period|Adverse Event|1|||
161773555|NCT03110107|584214283|FG010|Treatment Period|Adverse Event|0|||
161773556|NCT03110107|584214284|FG011|Treatment Period|Adverse Event|0|||
161773557|NCT03110107|584214285|FG012|Treatment Period|Adverse Event|0|||
161773558|NCT03110107|584214286|FG013|Treatment Period|Adverse Event|0|||
161773559|NCT03110107|584214287|FG014|Treatment Period|Adverse Event|0|||
161773560|NCT03110107|584214288|FG015|Treatment Period|Adverse Event|2|||
161773561|NCT03110107|584214289|FG016|Treatment Period|Adverse Event|0|||
161773562|NCT03110107|584214290|FG017|Treatment Period|Adverse Event|1|||
161773563|NCT03110107|584214291|FG018|Treatment Period|Adverse Event|2|||
161773564|NCT03110107|584214292|FG019|Treatment Period|Adverse Event|1|||
161773565|NCT03110107|584214293|FG020|Treatment Period|Adverse Event|4|||
161773566|NCT03110107|584214294|FG021|Treatment Period|Adverse Event|2|||
161773567|NCT03110107|584214295|FG022|Treatment Period|Adverse Event|2|||
161773568|NCT03110107|584214296|FG023|Treatment Period|Adverse Event|2|||
161773569|NCT03110107|584214297|FG024|Treatment Period|Adverse Event|2|||
161773570|NCT03110107|584214298|FG025|Treatment Period|Adverse Event|4|||
161773571|NCT03110107|584214273|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
161773572|NCT03110107|584214274|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
161773573|NCT03110107|584214275|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
161773574|NCT03110107|584214276|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
161773575|NCT03110107|584214277|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
161773576|NCT03110107|584214278|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
161773577|NCT03110107|584214279|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
161773578|NCT03110107|584214280|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
161773579|NCT03110107|584214281|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
161773580|NCT03110107|584214282|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
161773581|NCT03110107|584214283|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
161773582|NCT03110107|584214284|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
161773583|NCT03110107|584214285|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
161773584|NCT03110107|584214286|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
161773585|NCT03110107|584214287|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
161773586|NCT03110107|584214288|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
161773587|NCT03110107|584214289|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
161773588|NCT03110107|584214290|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
161773589|NCT03110107|584214291|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
161773590|NCT03110107|584214292|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
161773591|NCT03110107|584214293|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
161773592|NCT03110107|584214294|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
161773593|NCT03110107|584214295|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
161773594|NCT03110107|584214296|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
161773595|NCT03110107|584214297|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
161773596|NCT03110107|584214298|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
161773597|NCT03110107|584214273|FG000|Treatment Period|Participant withdrew consent|0|||
161773598|NCT03110107|584214274|FG001|Treatment Period|Participant withdrew consent|0|||
161773599|NCT03110107|584214275|FG002|Treatment Period|Participant withdrew consent|1|||
161773600|NCT03110107|584214276|FG003|Treatment Period|Participant withdrew consent|0|||
161773601|NCT03110107|584214277|FG004|Treatment Period|Participant withdrew consent|4|||
161773602|NCT03110107|584214278|FG005|Treatment Period|Participant withdrew consent|3|||
161979195|NCT00576472|584972567|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
161979196|NCT00576472|584972568|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
161979197|NCT00576472|584972569|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
161979198|NCT00576472|584972570|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
161979199|NCT00576472|584972571|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
161979200|NCT00576472|584972572|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
161979201|NCT00576472|584972573|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
161979202|NCT00576472|584972574|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
161979203|NCT00576472|584972575|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
161979204|NCT00576472|584972576|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
161979205|NCT00576472|584972577|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
161979206|NCT00576472|584972563|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979207|NCT00576472|584972564|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979208|NCT00576472|584972565|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979209|NCT00576472|584972566|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979210|NCT00576472|584972567|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979211|NCT00576472|584972568|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979212|NCT00576472|584972569|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979213|NCT00576472|584972570|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979214|NCT00576472|584972571|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979215|NCT00576472|584972572|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979216|NCT00576472|584972573|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979217|NCT00576472|584972574|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979218|NCT00576472|584972575|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979219|NCT00576472|584972576|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161979220|NCT00576472|584972577|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
161979221|NCT00780273|584972581|FG000|Overall Study|Death|1|||
161979222|NCT00780273|584972581|FG000|Overall Study|Lost to Follow-up|1|||
161979223|NCT02576860|584972582|FG000|Overall Study|Adverse Event|6|||
161979224|NCT02576860|584972583|FG001|Overall Study|Adverse Event|6|||
161979225|NCT02576860|584972582|FG000|Overall Study|Lost to Follow-up|5|||
161979226|NCT02576860|584972583|FG001|Overall Study|Lost to Follow-up|7|||
161979227|NCT02576860|584972582|FG000|Overall Study|Physician Decision|0|||
161979228|NCT02576860|584972583|FG001|Overall Study|Physician Decision|1|||
161979229|NCT02576860|584972582|FG000|Overall Study|Protocol Violation|0|||
161979230|NCT02576860|584972583|FG001|Overall Study|Protocol Violation|2|||
161979231|NCT02576860|584972582|FG000|Overall Study|Withdrawal by Subject|13|||
161979232|NCT02576860|584972583|FG001|Overall Study|Withdrawal by Subject|8|||
161979233|NCT02576860|584972582|FG000|Overall Study|Disallowed medication|1|||
161979234|NCT02576860|584972583|FG001|Overall Study|Disallowed medication|0|||
161979235|NCT00477269|584972584|FG000|Core Study|Adverse Event|6|||
161979236|NCT00477269|584972585|FG001|Core Study|Adverse Event|4|||
161979237|NCT00477269|584972586|FG002|Core Study|Adverse Event|0|||
161979238|NCT00477269|584972584|FG000|Core Study|Death|3|||
161979239|NCT00477269|584972585|FG001|Core Study|Death|3|||
161979240|NCT00477269|584972586|FG002|Core Study|Death|0|||
161979241|NCT00477269|584972584|FG000|Core Study|Withdrawn Consent|0|||
161979242|NCT00477269|584972585|FG001|Core Study|Withdrawn Consent|1|||
161979243|NCT00477269|584972586|FG002|Core Study|Withdrawn Consent|0|||
161979244|NCT00477269|584972584|FG000|Open Label Extension|Adverse Event|0|||
161979245|NCT00477269|584972585|FG001|Open Label Extension|Adverse Event|0|||
161979246|NCT00477269|584972586|FG002|Open Label Extension|Adverse Event|4|||
161979247|NCT00477269|584972584|FG000|Open Label Extension|Abnormal laboratory values|0|||
161979248|NCT00477269|584972585|FG001|Open Label Extension|Abnormal laboratory values|0|||
161979249|NCT00477269|584972586|FG002|Open Label Extension|Abnormal laboratory values|1|||
161979250|NCT00477269|584972584|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
161979251|NCT00477269|584972585|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
161979252|NCT00477269|584972586|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
161979253|NCT00477269|584972584|FG000|Open Label Extension|Adminiatrative problems|0|||
161979254|NCT00477269|584972585|FG001|Open Label Extension|Adminiatrative problems|0|||
162034871|NCT04369053|585184787|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
162034872|NCT04369053|585184787|FG000|Overall Study|Withdrawal by Subject|773|||
161979255|NCT00477269|584972586|FG002|Open Label Extension|Adminiatrative problems|2|||
161979256|NCT00477269|584972584|FG000|Open Label Extension|Death|0|||
161979257|NCT00477269|584972585|FG001|Open Label Extension|Death|0|||
162034873|NCT04369053|585184787|FG000|Overall Study|Lost to Follow-up|182|||
162034874|NCT04369053|585184787|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
162034875|NCT00096954|585184790|FG000|Overall Study|Adverse Event|3|||
161979258|NCT00477269|584972586|FG002|Open Label Extension|Death|4|||
161979259|NCT02391961|584972587|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
161979260|NCT02391961|584972588|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
161979261|NCT02391961|584972587|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
161979262|NCT02391961|584972588|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
162034876|NCT00096954|585184791|FG001|Overall Study|Adverse Event|1|||
161979263|NCT02391961|584972587|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161979264|NCT02391961|584972588|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161979265|NCT02308488|584972591|FG000|Overall Study|Withdrawal by Subject|2|||
161979266|NCT01541917|584972592|FG000|Overall Study|Lost to Follow-up|2|||
161979267|NCT01541917|584972593|FG001|Overall Study|Lost to Follow-up|2|||
161979268|NCT01541917|584972592|FG000|Overall Study|Withdrawal by Subject|13|||
161979269|NCT01541917|584972593|FG001|Overall Study|Withdrawal by Subject|7|||
161979270|NCT00121641|584972594|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
161979271|NCT00121641|584972595|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
161979272|NCT00121641|584972596|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
161979273|NCT00121641|584972597|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
161979274|NCT00121641|584972598|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
161979275|NCT00121641|584972594|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
161979276|NCT00121641|584972595|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
161979277|NCT00121641|584972596|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
161979278|NCT00121641|584972597|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
161979279|NCT00121641|584972598|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
161979280|NCT00121641|584972594|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
161979281|NCT00121641|584972595|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
161979282|NCT00121641|584972596|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
161979283|NCT00121641|584972597|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
161979284|NCT00121641|584972598|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
161979285|NCT00121641|584972594|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
161979286|NCT00121641|584972595|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
161979287|NCT00121641|584972596|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
161979288|NCT00121641|584972597|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
161979289|NCT00121641|584972598|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
161979290|NCT00121641|584972594|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
161979291|NCT00121641|584972595|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
161979292|NCT00121641|584972596|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
161979293|NCT00121641|584972597|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
161979294|NCT00121641|584972598|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
161979295|NCT00121641|584972594|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
161979296|NCT00121641|584972595|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
161979297|NCT00121641|584972596|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
161979298|NCT00121641|584972597|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
161979299|NCT00121641|584972598|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
161979300|NCT00121641|584972594|FG000|24-week Short-term Treatment Period|Other Reason|1|||
161979301|NCT00121641|584972595|FG001|24-week Short-term Treatment Period|Other Reason|0|||
161979302|NCT00121641|584972596|FG002|24-week Short-term Treatment Period|Other Reason|0|||
161979303|NCT00121641|584972597|FG003|24-week Short-term Treatment Period|Other Reason|0|||
161979304|NCT00121641|584972598|FG004|24-week Short-term Treatment Period|Other Reason|0|||
161979305|NCT00121641|584972594|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
161979306|NCT00121641|584972595|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
161979307|NCT00121641|584972596|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
161979308|NCT00121641|584972597|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
161979309|NCT00121641|584972598|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
161979310|NCT00121641|584972594|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
161979311|NCT00121641|584972595|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
161979312|NCT00121641|584972596|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
161979313|NCT00121641|584972597|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
161979314|NCT00121641|584972598|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
161979315|NCT00121641|584972594|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
161979316|NCT00121641|584972595|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
161979317|NCT00121641|584972596|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
161979318|NCT00121641|584972597|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
161979319|NCT00121641|584972598|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
161979320|NCT00121641|584972594|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
161979321|NCT00121641|584972595|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
161979322|NCT00121641|584972596|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
161979323|NCT00121641|584972597|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
161979324|NCT00121641|584972598|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
161979325|NCT00121641|584972594|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
161979326|NCT00121641|584972595|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
161979327|NCT00121641|584972596|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
161863666|NCT00955409|584544028|FG000|Overall Study|Failed to Return|2|||
161863667|NCT00955409|584544029|FG001|Overall Study|Failed to Return|0|||
161863668|NCT00955409|584544030|FG002|Overall Study|Failed to Return|0|||
161863669|NCT00955409|584544031|FG003|Overall Study|Failed to Return|0|||
161863670|NCT00955409|584544032|FG004|Overall Study|Failed to Return|0|||
161863671|NCT00955409|584544033|FG005|Overall Study|Failed to Return|0|||
161863672|NCT00955409|584544034|FG006|Overall Study|Failed to Return|0|||
161863673|NCT00955409|584544035|FG007|Overall Study|Failed to Return|2|||
161863674|NCT00955409|584544036|FG008|Overall Study|Failed to Return|0|||
161863675|NCT00955409|584544037|FG009|Overall Study|Failed to Return|0|||
161863676|NCT00955409|584544028|FG000|Overall Study|Adverse Event (AE)|2|||
161863677|NCT00955409|584544029|FG001|Overall Study|Adverse Event (AE)|0|||
161863678|NCT00955409|584544030|FG002|Overall Study|Adverse Event (AE)|0|||
161863679|NCT00955409|584544031|FG003|Overall Study|Adverse Event (AE)|0|||
161863680|NCT00955409|584544032|FG004|Overall Study|Adverse Event (AE)|0|||
161863681|NCT00955409|584544033|FG005|Overall Study|Adverse Event (AE)|1|||
161863682|NCT00955409|584544034|FG006|Overall Study|Adverse Event (AE)|2|||
161863683|NCT00955409|584544035|FG007|Overall Study|Adverse Event (AE)|0|||
161863684|NCT00955409|584544036|FG008|Overall Study|Adverse Event (AE)|2|||
161863685|NCT00955409|584544037|FG009|Overall Study|Adverse Event (AE)|0|||
161863686|NCT00955409|584544028|FG000|Overall Study|Reason not Specified|2|||
161863687|NCT00955409|584544029|FG001|Overall Study|Reason not Specified|1|||
161863688|NCT00955409|584544030|FG002|Overall Study|Reason not Specified|13|||
161863689|NCT00955409|584544031|FG003|Overall Study|Reason not Specified|1|||
161863690|NCT00955409|584544032|FG004|Overall Study|Reason not Specified|2|||
161863691|NCT00955409|584544033|FG005|Overall Study|Reason not Specified|0|||
161863692|NCT00955409|584544034|FG006|Overall Study|Reason not Specified|16|||
161863693|NCT00955409|584544035|FG007|Overall Study|Reason not Specified|0|||
161863694|NCT00955409|584544036|FG008|Overall Study|Reason not Specified|8|||
161863695|NCT00955409|584544037|FG009|Overall Study|Reason not Specified|1|||
161863696|NCT00485732|584544038|FG000|Overall Study|Protocol Violation|1|||
161863697|NCT00485732|584544039|FG001|Overall Study|Protocol Violation|3|||
161863698|NCT00485732|584544038|FG000|Overall Study|Withdrawal by Subject|5|||
161863699|NCT00485732|584544039|FG001|Overall Study|Withdrawal by Subject|4|||
161863700|NCT00485732|584544038|FG000|Overall Study|Lost to Follow-up|2|||
161863701|NCT00485732|584544039|FG001|Overall Study|Lost to Follow-up|2|||
161863702|NCT05423093|584544041|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
161863703|NCT05423093|584544041|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
161863704|NCT05423093|584544041|FG000|Attended Intervention Session|Lost to Follow-up|3|||
161863705|NCT05423093|584544041|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
161863706|NCT05423093|584544041|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
161863707|NCT03593525|584544042|FG000|Overall Study|Withdrawal by Subject|1|||
161863708|NCT03593525|584544043|FG001|Overall Study|Withdrawal by Subject|0|||
161863709|NCT03593525|584544042|FG000|Overall Study|Lost to Follow-up|7|||
161863710|NCT03593525|584544043|FG001|Overall Study|Lost to Follow-up|5|||
161863711|NCT00210210|584544051|FG000|Overall Study|Withdrawal by Subject|3|||
161863712|NCT00210210|584544052|FG001|Overall Study|Withdrawal by Subject|2|||
161863713|NCT00210210|584544051|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
161863714|NCT00210210|584544052|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
161863715|NCT02445248|584544057|FG000|Overall Study|Death|45|||
161863716|NCT02445248|584544058|FG001|Overall Study|Death|12|||
161863717|NCT02445248|584544057|FG000|Overall Study|Progressive disease|13|||
161863718|NCT02445248|584544058|FG001|Overall Study|Progressive disease|1|||
161863719|NCT02445248|584544057|FG000|Overall Study|Subject decision|8|||
161863720|NCT02445248|584544058|FG001|Overall Study|Subject decision|0|||
161863721|NCT02445248|584544057|FG000|Overall Study|Physician Decision|5|||
161863722|NCT02445248|584544058|FG001|Overall Study|Physician Decision|0|||
161863723|NCT02445248|584544057|FG000|Overall Study|Adverse Event|1|||
161863724|NCT02445248|584544058|FG001|Overall Study|Adverse Event|0|||
161863725|NCT02445248|584544057|FG000|Overall Study|Lost to Follow-up|1|||
161863726|NCT02445248|584544058|FG001|Overall Study|Lost to Follow-up|0|||
161863727|NCT01120184|584544059|FG000|Overall Study|Adverse Event|0|||
161863728|NCT01120184|584544060|FG001|Overall Study|Adverse Event|1|||
161863729|NCT01120184|584544061|FG002|Overall Study|Adverse Event|0|||
161863730|NCT01120184|584544059|FG000|Overall Study|Lost to Follow-up|13|||
161863731|NCT01120184|584544060|FG001|Overall Study|Lost to Follow-up|13|||
161863732|NCT01120184|584544061|FG002|Overall Study|Lost to Follow-up|11|||
161863733|NCT01120184|584544059|FG000|Overall Study|Physician Decision|9|||
161863734|NCT01120184|584544060|FG001|Overall Study|Physician Decision|1|||
161863735|NCT01120184|584544061|FG002|Overall Study|Physician Decision|3|||
161863736|NCT01120184|584544059|FG000|Overall Study|Reason not Specified|8|||
161863737|NCT01120184|584544060|FG001|Overall Study|Reason not Specified|3|||
161863738|NCT01120184|584544061|FG002|Overall Study|Reason not Specified|12|||
161863739|NCT01120184|584544059|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
161863740|NCT01120184|584544060|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
161863741|NCT01120184|584544061|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
161863742|NCT01120184|584544059|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
161863743|NCT01120184|584544060|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
161979328|NCT00121641|584972597|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
161979329|NCT00121641|584972598|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
161979330|NCT00121641|584972594|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
161979331|NCT00121641|584972595|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
161979332|NCT00121641|584972596|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
161979333|NCT00121641|584972597|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
161979334|NCT00121641|584972598|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
161979335|NCT00121641|584972594|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
161979336|NCT00121641|584972595|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
161979337|NCT00121641|584972596|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
161979338|NCT00121641|584972597|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
161979339|NCT00121641|584972598|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
161979340|NCT00121641|584972594|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
161979341|NCT00121641|584972595|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
161979342|NCT00121641|584972596|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
161979343|NCT00121641|584972597|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
161979344|NCT00121641|584972598|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
161979345|NCT00121641|584972594|FG000|48-month Short Term + Long Term Period|Death|0|||
161979346|NCT00121641|584972595|FG001|48-month Short Term + Long Term Period|Death|0|||
161979347|NCT00121641|584972596|FG002|48-month Short Term + Long Term Period|Death|0|||
161979348|NCT00121641|584972597|FG003|48-month Short Term + Long Term Period|Death|1|||
161979349|NCT00121641|584972598|FG004|48-month Short Term + Long Term Period|Death|0|||
161979350|NCT00121641|584972594|FG000|48-month Short Term + Long Term Period|Missing|0|||
161979351|NCT00121641|584972595|FG001|48-month Short Term + Long Term Period|Missing|0|||
161979352|NCT00121641|584972596|FG002|48-month Short Term + Long Term Period|Missing|1|||
161979353|NCT00121641|584972597|FG003|48-month Short Term + Long Term Period|Missing|0|||
161979354|NCT00121641|584972598|FG004|48-month Short Term + Long Term Period|Missing|0|||
161979355|NCT00121641|584972594|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
161979356|NCT00121641|584972595|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
161979357|NCT00121641|584972596|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
161979358|NCT00121641|584972597|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
161979359|NCT00121641|584972598|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
161863744|NCT01120184|584544061|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
161863745|NCT01120184|584544059|FG000|Overall Study|Death|170|||
161979360|NCT03263780|584972599|FG000|Overall Study|Withdrawal by Subject|3|||
161979361|NCT03263780|584972599|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
161979362|NCT01565564|584972610|FG000|Overall Study|Lost to Follow-up|5|||
161979363|NCT01565564|584972611|FG001|Overall Study|Lost to Follow-up|1|||
161979364|NCT00249613|584972612|FG000|12 Month Follow-up|Death|1|||
161979365|NCT00249613|584972613|FG001|12 Month Follow-up|Death|1|||
161979366|NCT00249613|584972612|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
161979367|NCT00249613|584972613|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
161979368|NCT00249613|584972612|FG000|12 Month Follow-up|Lost to Follow-up|10|||
161979369|NCT00249613|584972613|FG001|12 Month Follow-up|Lost to Follow-up|8|||
161979370|NCT00806442|584972614|FG000|Overall Study|Lost to Follow-up|3|||
161979371|NCT00806442|584972615|FG001|Overall Study|Lost to Follow-up|2|||
161979372|NCT00806442|584972614|FG000|Overall Study|Withdrawal by Subject|1|||
161979373|NCT00806442|584972615|FG001|Overall Study|Withdrawal by Subject|5|||
161979374|NCT00654004|584972616|FG000|Overall Study|Lost to Follow-up|1|||
161979375|NCT00654004|584972617|FG001|Overall Study|Lost to Follow-up|0|||
161979376|NCT02528357|584972623|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979377|NCT02528357|584972624|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
161979378|NCT02528357|584972625|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979379|NCT02528357|584972626|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979380|NCT02528357|584972627|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161863746|NCT01120184|584544060|FG001|Overall Study|Death|176|||
161863747|NCT01120184|584544061|FG002|Overall Study|Death|169|||
161979381|NCT02528357|584972628|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979382|NCT02528357|584972629|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979383|NCT02528357|584972630|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979384|NCT02528357|584972631|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979385|NCT02528357|584972632|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979386|NCT02528357|584972633|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979387|NCT02528357|584972634|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979388|NCT02528357|584972635|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979389|NCT02528357|584972636|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979390|NCT02528357|584972637|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979391|NCT02528357|584972638|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979392|NCT02528357|584972639|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979393|NCT02528357|584972640|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979394|NCT02528357|584972641|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
161979395|NCT02528357|584972623|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979396|NCT02528357|584972624|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979397|NCT02528357|584972625|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979398|NCT02528357|584972626|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
161979399|NCT02528357|584972627|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979400|NCT02528357|584972628|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
161979401|NCT02528357|584972629|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979402|NCT02528357|584972630|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
161979403|NCT02528357|584972631|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979404|NCT02528357|584972632|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979405|NCT02528357|584972633|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979406|NCT02528357|584972634|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979407|NCT02528357|584972635|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979408|NCT02528357|584972636|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979409|NCT02528357|584972637|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979410|NCT02528357|584972638|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979411|NCT02528357|584972639|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979412|NCT02528357|584972640|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979413|NCT02528357|584972641|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
161979414|NCT02528357|584972623|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979415|NCT02528357|584972624|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979416|NCT02528357|584972625|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
161979417|NCT02528357|584972626|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979418|NCT02528357|584972627|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
161979419|NCT02528357|584972628|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979420|NCT02528357|584972629|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
161979421|NCT02528357|584972630|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
161979422|NCT02528357|584972631|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979423|NCT02528357|584972632|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979424|NCT02528357|584972633|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979425|NCT02528357|584972634|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979426|NCT02528357|584972635|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979427|NCT02528357|584972636|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979428|NCT02528357|584972637|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979429|NCT02528357|584972638|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979430|NCT02528357|584972639|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979431|NCT02528357|584972640|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979432|NCT02528357|584972641|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
161979433|NCT02528357|584972623|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979434|NCT02528357|584972624|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979435|NCT02528357|584972625|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979436|NCT02528357|584972626|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979437|NCT02528357|584972627|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
161979438|NCT02528357|584972628|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979439|NCT02528357|584972629|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979440|NCT02528357|584972630|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979441|NCT02528357|584972631|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979442|NCT02528357|584972632|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979443|NCT02528357|584972633|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979444|NCT02528357|584972634|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979445|NCT02528357|584972635|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979446|NCT02528357|584972636|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979447|NCT02528357|584972637|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979448|NCT02528357|584972638|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979449|NCT02528357|584972639|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979450|NCT02528357|584972640|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979451|NCT02528357|584972641|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979452|NCT02528357|584972623|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979453|NCT02528357|584972624|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979454|NCT02528357|584972625|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979455|NCT02528357|584972626|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979456|NCT02528357|584972627|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979457|NCT02528357|584972628|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979458|NCT02528357|584972629|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979459|NCT02528357|584972630|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979460|NCT02528357|584972631|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979461|NCT02528357|584972632|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979462|NCT02528357|584972633|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979463|NCT02528357|584972634|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979464|NCT02528357|584972635|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979465|NCT02528357|584972636|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
161979466|NCT02528357|584972637|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
161979467|NCT02528357|584972638|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979468|NCT02528357|584972639|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979469|NCT02528357|584972640|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979470|NCT02528357|584972641|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
161979471|NCT02528357|584972623|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979472|NCT02528357|584972624|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979473|NCT02528357|584972625|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979474|NCT02528357|584972626|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979475|NCT02528357|584972627|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979476|NCT02528357|584972628|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979477|NCT02528357|584972629|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979478|NCT02528357|584972630|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979479|NCT02528357|584972631|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979480|NCT02528357|584972632|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979481|NCT02528357|584972633|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979482|NCT02528357|584972634|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979483|NCT02528357|584972635|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979484|NCT02528357|584972636|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
161979485|NCT02528357|584972637|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979486|NCT02528357|584972638|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979487|NCT02528357|584972639|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979488|NCT02528357|584972640|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979489|NCT02528357|584972641|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161979490|NCT02528357|584972623|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979491|NCT02528357|584972624|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979492|NCT02528357|584972625|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979493|NCT02528357|584972626|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979494|NCT02528357|584972627|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979495|NCT02528357|584972628|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979496|NCT02528357|584972629|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979497|NCT02528357|584972630|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979498|NCT02528357|584972631|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979499|NCT02528357|584972632|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979500|NCT02528357|584972633|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
161979501|NCT02528357|584972634|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979502|NCT02528357|584972635|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
161979503|NCT02528357|584972636|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
161979504|NCT02528357|584972637|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
161979505|NCT02528357|584972638|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979506|NCT02528357|584972639|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979507|NCT02528357|584972640|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979508|NCT02528357|584972641|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
161979509|NCT02528357|584972623|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979510|NCT02528357|584972624|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979511|NCT02528357|584972625|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979512|NCT02528357|584972626|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979513|NCT02528357|584972627|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979514|NCT02528357|584972628|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979515|NCT02528357|584972629|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979516|NCT02528357|584972630|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979517|NCT02528357|584972631|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
161979518|NCT02528357|584972632|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
161979519|NCT02528357|584972633|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979520|NCT02528357|584972634|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
161979521|NCT02528357|584972635|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
161979522|NCT02528357|584972636|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
161979523|NCT02528357|584972637|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
161979524|NCT02528357|584972638|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979525|NCT02528357|584972639|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979526|NCT02528357|584972640|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979527|NCT02528357|584972641|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979528|NCT02528357|584972623|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979529|NCT02528357|584972624|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979530|NCT02528357|584972625|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979531|NCT02528357|584972626|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979532|NCT02528357|584972627|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979533|NCT02528357|584972628|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979534|NCT02528357|584972629|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979535|NCT02528357|584972630|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979536|NCT02528357|584972631|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979537|NCT02528357|584972632|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979538|NCT02528357|584972633|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979539|NCT02528357|584972634|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979540|NCT02528357|584972635|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979541|NCT02528357|584972636|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979542|NCT02528357|584972637|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979543|NCT02528357|584972638|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979544|NCT02528357|584972639|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
161979545|NCT02528357|584972640|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979546|NCT02528357|584972641|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
161979547|NCT02528357|584972623|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979548|NCT02528357|584972624|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979549|NCT02528357|584972625|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979550|NCT02528357|584972626|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979551|NCT02528357|584972627|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979552|NCT02528357|584972628|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979553|NCT02528357|584972629|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979554|NCT02528357|584972630|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979555|NCT02528357|584972631|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979556|NCT02528357|584972632|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979557|NCT02528357|584972633|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979558|NCT02528357|584972634|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979559|NCT02528357|584972635|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
162034877|NCT00096954|585184790|FG000|Overall Study|Withdrawal by Subject|9|||
161979560|NCT02528357|584972636|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979561|NCT02528357|584972637|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979562|NCT02528357|584972638|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
161979563|NCT02528357|584972639|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
161979564|NCT02528357|584972640|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
161979565|NCT02528357|584972641|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
161979566|NCT01455220|584972643|FG000|Overall Study|screen fail|30|||
161979567|NCT00495755|584972644|FG000|Overall Study|Adverse Event|3|||
161979568|NCT00720343|584974087|FG000|Overall Study|Lost to Follow-up|1|||
161979569|NCT00720343|584974088|FG001|Overall Study|Lost to Follow-up|0|||
161979570|NCT00720343|584974087|FG000|Overall Study|Protocol Violation|0|||
161979571|NCT00720343|584974088|FG001|Overall Study|Protocol Violation|2|||
161979572|NCT03459365|584974091|FG000|Overall Study|Withdrawal by Subject|6|||
161979573|NCT03459365|584974091|FG000|Overall Study|Protocol Violation|8|||
161979574|NCT01918332|584974094|FG000|Overall Study|Adverse Event|0|||
161979575|NCT01918332|584974095|FG001|Overall Study|Adverse Event|0|||
161979576|NCT01918332|584974096|FG002|Overall Study|Adverse Event|0|||
161979577|NCT01918332|584974097|FG003|Overall Study|Adverse Event|1|||
161979578|NCT01918332|584974094|FG000|Overall Study|Withdrawal by Subject|2|||
161979579|NCT01918332|584974095|FG001|Overall Study|Withdrawal by Subject|3|||
161979580|NCT01918332|584974096|FG002|Overall Study|Withdrawal by Subject|2|||
161979581|NCT01918332|584974097|FG003|Overall Study|Withdrawal by Subject|3|||
161979582|NCT01918332|584974094|FG000|Overall Study|Protocol Violation|6|||
161979583|NCT01918332|584974095|FG001|Overall Study|Protocol Violation|2|||
161979584|NCT01918332|584974096|FG002|Overall Study|Protocol Violation|6|||
161979585|NCT01918332|584974097|FG003|Overall Study|Protocol Violation|3|||
161979586|NCT01918332|584974094|FG000|Overall Study|lipid result by central lab did not meet|0|||
161979587|NCT01918332|584974095|FG001|Overall Study|lipid result by central lab did not meet|0|||
161979588|NCT01918332|584974096|FG002|Overall Study|lipid result by central lab did not meet|1|||
161979589|NCT01918332|584974097|FG003|Overall Study|lipid result by central lab did not meet|0|||
161979590|NCT02252965|584974100|FG000|Overall Study|Adverse Event|9|||
161979591|NCT02252965|584974101|FG001|Overall Study|Adverse Event|14|||
161979592|NCT02252965|584974100|FG000|Overall Study|Lost to Follow-up|16|||
161979593|NCT02252965|584974101|FG001|Overall Study|Lost to Follow-up|8|||
161979594|NCT02252965|584974100|FG000|Overall Study|Protocol Violation|4|||
161979595|NCT02252965|584974101|FG001|Overall Study|Protocol Violation|5|||
161979596|NCT02252965|584974100|FG000|Overall Study|Lack of Efficacy|0|||
161979597|NCT02252965|584974101|FG001|Overall Study|Lack of Efficacy|2|||
161979598|NCT02252965|584974100|FG000|Overall Study|Withdrawal by Subject|7|||
161979599|NCT02252965|584974101|FG001|Overall Study|Withdrawal by Subject|9|||
161979600|NCT02252965|584974100|FG000|Overall Study|Other|4|||
161979601|NCT02252965|584974101|FG001|Overall Study|Other|5|||
161979602|NCT04736628|584974106|FG000|Overall Study|Not treated|0|||
161979603|NCT04736628|584974107|FG001|Overall Study|Not treated|0|||
161979604|NCT04736628|584974108|FG002|Overall Study|Not treated|0|||
161979605|NCT04736628|584974109|FG003|Overall Study|Not treated|2|||
161979606|NCT04736628|584974106|FG000|Overall Study|Other reason than listed|1|||
161979607|NCT04736628|584974107|FG001|Overall Study|Other reason than listed|2|||
161979608|NCT04736628|584974108|FG002|Overall Study|Other reason than listed|2|||
161979609|NCT04736628|584974109|FG003|Overall Study|Other reason than listed|3|||
161979610|NCT04736628|584974106|FG000|Overall Study|Protocol deviation|0|||
161979611|NCT04736628|584974107|FG001|Overall Study|Protocol deviation|0|||
161979612|NCT04736628|584974108|FG002|Overall Study|Protocol deviation|0|||
161979613|NCT04736628|584974109|FG003|Overall Study|Protocol deviation|1|||
161979614|NCT04736628|584974106|FG000|Overall Study|Burden of study procedures|1|||
161979615|NCT04736628|584974107|FG001|Overall Study|Burden of study procedures|0|||
161979616|NCT04736628|584974108|FG002|Overall Study|Burden of study procedures|0|||
161979617|NCT04736628|584974109|FG003|Overall Study|Burden of study procedures|1|||
161979618|NCT04736628|584974106|FG000|Overall Study|Change of residence|0|||
161979619|NCT04736628|584974107|FG001|Overall Study|Change of residence|1|||
161979620|NCT04736628|584974108|FG002|Overall Study|Change of residence|0|||
161979621|NCT04736628|584974109|FG003|Overall Study|Change of residence|0|||
161979622|NCT04736628|584974106|FG000|Overall Study|Perceived lack of efficacy|1|||
161979623|NCT04736628|584974107|FG001|Overall Study|Perceived lack of efficacy|0|||
161863748|NCT02596971|584544064|FG000|Overall Study|Death|5|||
161863749|NCT02596971|584544065|FG001|Overall Study|Death|1|||
161979624|NCT04736628|584974108|FG002|Overall Study|Perceived lack of efficacy|0|||
161979625|NCT04736628|584974109|FG003|Overall Study|Perceived lack of efficacy|1|||
161979626|NCT04736628|584974106|FG000|Overall Study|Adverse Event|3|||
161979627|NCT04736628|584974107|FG001|Overall Study|Adverse Event|2|||
161979628|NCT04736628|584974108|FG002|Overall Study|Adverse Event|4|||
161979629|NCT04736628|584974109|FG003|Overall Study|Adverse Event|3|||
161979630|NCT04279613|584974110|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
161979631|NCT04279613|584974111|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
161979632|NCT04279613|584974112|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
161863750|NCT02596971|584544066|FG002|Overall Study|Death|5|||
161863751|NCT02596971|584544064|FG000|Overall Study|Withdrawal by Subject|5|||
161863752|NCT02596971|584544065|FG001|Overall Study|Withdrawal by Subject|1|||
161863753|NCT02596971|584544066|FG002|Overall Study|Withdrawal by Subject|4|||
161863754|NCT00824772|584544067|FG000|Overall Study|Withdrawal by Subject|8|||
161863755|NCT02764762|584544071|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
161863756|NCT02764762|584544071|FG000|Overall Study|Lost to Follow-up|4|||
161863757|NCT02764762|584544071|FG000|Overall Study|Voluntary Withdrawal|8|||
161863758|NCT02764762|584544071|FG000|Overall Study|Site Termination|1|||
161863759|NCT02764762|584544071|FG000|Overall Study|Lack of Efficacy|16|||
161863760|NCT02764762|584544071|FG000|Overall Study|Reason not Specified|1|||
161863761|NCT01002989|584544072|FG000|Overall Study|exclusion criteria, no consent|5|||
161863762|NCT02954601|584544073|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
161863763|NCT02954601|584544074|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
161863764|NCT02954601|584544075|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
161863765|NCT02954601|584544076|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
161863766|NCT00318474|584544077|FG000|Overall Study|Adverse Event|1|||
161863767|NCT00318474|584544078|FG001|Overall Study|Adverse Event|1|||
161863768|NCT00318474|584544077|FG000|Overall Study|Lost to Follow-up|0|||
161863769|NCT00318474|584544078|FG001|Overall Study|Lost to Follow-up|1|||
161863770|NCT00318474|584544077|FG000|Overall Study|Pregnancy|0|||
161863771|NCT00318474|584544078|FG001|Overall Study|Pregnancy|2|||
161863772|NCT00318474|584544077|FG000|Overall Study|Protocol Violation|1|||
161863773|NCT00318474|584544078|FG001|Overall Study|Protocol Violation|0|||
161863774|NCT00318474|584544077|FG000|Overall Study|Withdrawal by Subject|3|||
161863775|NCT00318474|584544078|FG001|Overall Study|Withdrawal by Subject|2|||
161863776|NCT00318474|584544077|FG000|Overall Study|Fall in GFR|3|||
161863777|NCT00318474|584544078|FG001|Overall Study|Fall in GFR|3|||
161863778|NCT00318474|584544077|FG000|Overall Study|Post-therapy hyperflycemia|0|||
161863779|NCT00318474|584544078|FG001|Overall Study|Post-therapy hyperflycemia|1|||
161863780|NCT00318474|584544077|FG000|Overall Study|Trial terminated|10|||
161863781|NCT00318474|584544078|FG001|Overall Study|Trial terminated|7|||
161863782|NCT00917852|584544082|FG000|Overall Study|Death|6|||
161863783|NCT00471081|584544083|FG000|Active Phase|Protocol Violation|1|||
161863784|NCT00471081|584544084|FG001|Active Phase|Protocol Violation|1|||
161863785|NCT00471081|584544083|FG000|Active Phase|Withdrawal by Subject|0|||
161863786|NCT00471081|584544084|FG001|Active Phase|Withdrawal by Subject|3|||
161863787|NCT00471081|584544083|FG000|Active Phase|Lost to Follow-up|0|||
161863788|NCT00471081|584544084|FG001|Active Phase|Lost to Follow-up|1|||
161863789|NCT00471081|584544083|FG000|Active Phase|Lost health plan/insurance|1|||
161863790|NCT00471081|584544084|FG001|Active Phase|Lost health plan/insurance|8|||
161863791|NCT00471081|584544083|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
161863792|NCT00471081|584544084|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
161863793|NCT00471081|584544083|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
161863794|NCT00471081|584544084|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
161863795|NCT00471081|584544083|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
161863796|NCT00471081|584544084|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
161863797|NCT02393950|584544089|FG000|Overall Study|Adverse Event|1|||
161863798|NCT02393950|584544090|FG001|Overall Study|Adverse Event|0|||
161863799|NCT02393950|584544089|FG000|Overall Study|Withdrawal by Subject|0|||
161863800|NCT02393950|584544090|FG001|Overall Study|Withdrawal by Subject|1|||
161863801|NCT05486091|584544091|FG000|Overall Study|Withdrawal by Subject|1|||
161979633|NCT04279613|584974113|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
161979634|NCT04279613|584974114|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
161979635|NCT04279613|584974110|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
161979636|NCT04279613|584974111|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
161979637|NCT04279613|584974112|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
161979638|NCT04279613|584974113|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
161979639|NCT04279613|584974114|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
161979640|NCT04279613|584974110|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
161979641|NCT04279613|584974111|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
161979642|NCT04279613|584974112|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
161979643|NCT04279613|584974113|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
161979644|NCT04279613|584974114|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
161979645|NCT04279613|584974110|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
161979646|NCT04279613|584974111|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
161979647|NCT04279613|584974112|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
161979648|NCT04279613|584974113|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
161979649|NCT04279613|584974114|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
161979650|NCT04279613|584974110|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
161979651|NCT04279613|584974111|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
161979652|NCT04279613|584974112|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
161863802|NCT05486091|584544091|FG000|Overall Study|Lost to Follow-up|2|||
161863803|NCT04067050|584544092|FG000|One Month|Lost to Follow-up|4|||
161863804|NCT04067050|584544093|FG001|One Month|Lost to Follow-up|0|||
161979653|NCT04279613|584974113|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
161979654|NCT04279613|584974114|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
161979655|NCT02478164|584974115|FG000|Overall Study|Lack of Efficacy|13|||
161979656|NCT02478164|584974115|FG000|Overall Study|Adverse Event|1|||
161979657|NCT02478164|584974115|FG000|Overall Study|Withdrawal by Subject|1|||
161979658|NCT04051827|584974116|FG000|Overall Study|Death|1|||
161979659|NCT04051827|584974116|FG000|Overall Study|Withdrawal by Subject|4|||
161979660|NCT04051827|584974116|FG000|Overall Study|Progressive disease|16|||
161979661|NCT04051827|584974116|FG000|Overall Study|Physician Decision|1|||
161979662|NCT04051827|584974116|FG000|Overall Study|Other|4|||
161979663|NCT05779007|584974117|FG000|Overall Study|not meeting eligibility criteria|3517|||
161979664|NCT05779007|584974118|FG001|Overall Study|not meeting eligibility criteria|2009|||
161979665|NCT01424566|584974119|FG000|Single-blind Treatment|Adverse Event|71|||
161979666|NCT01424566|584974120|FG001|Single-blind Treatment|Adverse Event|0|||
161979667|NCT01424566|584974121|FG002|Single-blind Treatment|Adverse Event|0|||
161979668|NCT01424566|584974119|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
161979669|NCT01424566|584974120|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
161979670|NCT01424566|584974121|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
161979671|NCT01424566|584974119|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
161979672|NCT01424566|584974120|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
161979673|NCT01424566|584974121|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
161979674|NCT01424566|584974119|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
161979675|NCT01424566|584974120|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
161979676|NCT01424566|584974121|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
161979677|NCT01424566|584974119|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
161979678|NCT01424566|584974120|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
161979679|NCT01424566|584974121|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
161979680|NCT01424566|584974119|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
161979681|NCT01424566|584974120|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
161979682|NCT01424566|584974121|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
161979683|NCT01424566|584974119|FG000|Double-blind Treatment|Adverse Event|0|||
161979684|NCT01424566|584974120|FG001|Double-blind Treatment|Adverse Event|21|||
161979685|NCT01424566|584974121|FG002|Double-blind Treatment|Adverse Event|13|||
161979686|NCT01424566|584974119|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
161979687|NCT01424566|584974120|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
161979688|NCT01424566|584974121|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
161979689|NCT01424566|584974119|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
161979690|NCT01424566|584974120|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
161979691|NCT01424566|584974121|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
161979692|NCT01424566|584974119|FG000|Double-blind Treatment|Lack of Efficacy|0|||
161979693|NCT01424566|584974120|FG001|Double-blind Treatment|Lack of Efficacy|1|||
161979694|NCT01424566|584974121|FG002|Double-blind Treatment|Lack of Efficacy|1|||
161979695|NCT00680368|584974124|FG000|Overall Study|not supervised, not eligible|15|||
161979696|NCT03779503|584974125|FG000|First Intervention|Adverse Event|0|||
161979697|NCT03779503|584974126|FG001|First Intervention|Adverse Event|1|||
161979698|NCT03779503|584974125|FG000|First Intervention|Withdrawal by Subject|1|||
161979699|NCT03779503|584974126|FG001|First Intervention|Withdrawal by Subject|0|||
161979700|NCT00106691|584974128|FG000|Overall Study|Adverse Event|60|||
161979701|NCT00106691|584974129|FG001|Overall Study|Adverse Event|64|||
161979702|NCT00106691|584974128|FG000|Overall Study|Lost to Follow-up|23|||
161979703|NCT00106691|584974129|FG001|Overall Study|Lost to Follow-up|18|||
161979704|NCT00106691|584974128|FG000|Overall Study|Physician Decision|18|||
161979705|NCT00106691|584974129|FG001|Overall Study|Physician Decision|21|||
161773603|NCT03110107|584214279|FG006|Treatment Period|Participant withdrew consent|0|||
161773604|NCT03110107|584214280|FG007|Treatment Period|Participant withdrew consent|0|||
161773605|NCT03110107|584214281|FG008|Treatment Period|Participant withdrew consent|0|||
161773606|NCT03110107|584214282|FG009|Treatment Period|Participant withdrew consent|1|||
161773607|NCT03110107|584214283|FG010|Treatment Period|Participant withdrew consent|0|||
161773608|NCT03110107|584214284|FG011|Treatment Period|Participant withdrew consent|0|||
161773609|NCT03110107|584214285|FG012|Treatment Period|Participant withdrew consent|0|||
161979706|NCT00106691|584974128|FG000|Overall Study|Protocol Violation|13|||
161979707|NCT00106691|584974129|FG001|Overall Study|Protocol Violation|18|||
161979708|NCT00106691|584974128|FG000|Overall Study|Withdrawal by Subject|75|||
162034878|NCT00096954|585184791|FG001|Overall Study|Withdrawal by Subject|8|||
161979709|NCT00106691|584974129|FG001|Overall Study|Withdrawal by Subject|70|||
161979710|NCT00106691|584974128|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
161979711|NCT00106691|584974129|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
161979712|NCT00106691|584974128|FG000|Overall Study|QTc>480|3|||
161979713|NCT00106691|584974129|FG001|Overall Study|QTc>480|1|||
161979714|NCT00106691|584974128|FG000|Overall Study|mililtary deployment|2|||
161979715|NCT00106691|584974129|FG001|Overall Study|mililtary deployment|0|||
161979716|NCT00106691|584974128|FG000|Overall Study|Study Site Closing/PI Moved|1|||
162034879|NCT00096954|585184790|FG000|Overall Study|Physician Decision|1|||
162034880|NCT00096954|585184791|FG001|Overall Study|Physician Decision|1|||
161863805|NCT04067050|584544092|FG000|Two Month|Lost to Follow-up|1|||
161863806|NCT04067050|584544093|FG001|Two Month|Lost to Follow-up|0|||
161863807|NCT04067050|584544092|FG000|Two Month|Adverse Event|1|||
161863808|NCT04067050|584544093|FG001|Two Month|Adverse Event|0|||
161863809|NCT00957801|584544098|FG000|Overall Study|Withdrawal by Subject|0|||
161863810|NCT00957801|584544099|FG001|Overall Study|Withdrawal by Subject|0|||
161863811|NCT00957801|584544100|FG002|Overall Study|Withdrawal by Subject|0|||
161863812|NCT00957801|584544101|FG003|Overall Study|Withdrawal by Subject|1|||
161863813|NCT02626026|584544103|FG000|Overall Study|Randomized but Never Treated|0|||
161863814|NCT02626026|584544104|FG001|Overall Study|Randomized but Never Treated|0|||
161863815|NCT02626026|584544105|FG002|Overall Study|Randomized but Never Treated|0|||
161863816|NCT02626026|584544106|FG003|Overall Study|Randomized but Never Treated|0|||
161863817|NCT02626026|584544107|FG004|Overall Study|Randomized but Never Treated|1|||
161863818|NCT02626026|584544108|FG005|Overall Study|Randomized but Never Treated|0|||
161863819|NCT01778855|584544109|FG000|Overall Study|Death|0|||
161863820|NCT01778855|584544110|FG001|Overall Study|Death|1|||
161863821|NCT00923013|584544113|FG000|Overall Study|Refused further treatment|0|||
161863822|NCT00923013|584544114|FG001|Overall Study|Refused further treatment|1|||
161863823|NCT00923013|584544115|FG002|Overall Study|Refused further treatment|2|||
161863824|NCT00923013|584544116|FG003|Overall Study|Refused further treatment|0|||
161863825|NCT00923013|584544117|FG004|Overall Study|Refused further treatment|0|||
161863826|NCT00923013|584544118|FG005|Overall Study|Refused further treatment|0|||
161863827|NCT00923013|584544113|FG000|Overall Study|Switched to alternative treatment|0|||
161863828|NCT00923013|584544114|FG001|Overall Study|Switched to alternative treatment|1|||
161863829|NCT00923013|584544115|FG002|Overall Study|Switched to alternative treatment|0|||
161863830|NCT00923013|584544116|FG003|Overall Study|Switched to alternative treatment|0|||
161863831|NCT00923013|584544117|FG004|Overall Study|Switched to alternative treatment|0|||
161863832|NCT00923013|584544118|FG005|Overall Study|Switched to alternative treatment|0|||
161863833|NCT00923013|584544113|FG000|Overall Study|Death on study|2|||
161863834|NCT00923013|584544114|FG001|Overall Study|Death on study|2|||
161863835|NCT00923013|584544115|FG002|Overall Study|Death on study|0|||
161863836|NCT00923013|584544116|FG003|Overall Study|Death on study|1|||
161863837|NCT00923013|584544117|FG004|Overall Study|Death on study|0|||
161863838|NCT00923013|584544118|FG005|Overall Study|Death on study|0|||
161863839|NCT01168427|584544119|FG000|Overall Study|Patient exited prior to implant|1|||
161863840|NCT01256879|584544120|FG000|Overall Study|Withdrawal by Subject|1|||
161863841|NCT00640315|584544121|FG000|Overall Study|Withdrawal by Subject|0|||
161863842|NCT00640315|584544122|FG001|Overall Study|Withdrawal by Subject|1|||
161863843|NCT02964247|584544123|FG000|Overall Study|Lost to Follow-up|2|||
161863844|NCT02964247|584544124|FG001|Overall Study|Lost to Follow-up|0|||
161863845|NCT02964247|584544123|FG000|Overall Study|Withdrawal by Subject|1|||
161863846|NCT02964247|584544124|FG001|Overall Study|Withdrawal by Subject|2|||
161863847|NCT00725920|584544125|FG000|Overall Study|Lack of Efficacy|3|||
161863848|NCT00725920|584544126|FG001|Overall Study|Lack of Efficacy|6|||
161863849|NCT02107131|584544127|FG000|Overall Study|Lost to Follow-up|4|||
161863850|NCT02107131|584544128|FG001|Overall Study|Lost to Follow-up|4|||
161863851|NCT02107131|584544127|FG000|Overall Study|Physician Decision|1|||
161863852|NCT02107131|584544128|FG001|Overall Study|Physician Decision|0|||
161863853|NCT02107131|584544127|FG000|Overall Study|Withdrawal by Subject|2|||
161863854|NCT02107131|584544128|FG001|Overall Study|Withdrawal by Subject|0|||
161863855|NCT02107131|584544127|FG000|Overall Study|mental instability|1|||
161863856|NCT02107131|584544128|FG001|Overall Study|mental instability|0|||
161863857|NCT02107131|584544127|FG000|Overall Study|Death|0|||
161863858|NCT02107131|584544128|FG001|Overall Study|Death|1|||
161863859|NCT02107131|584544127|FG000|Overall Study|Protocol Violation|0|||
161863860|NCT02107131|584544128|FG001|Overall Study|Protocol Violation|4|||
161979717|NCT00106691|584974129|FG001|Overall Study|Study Site Closing/PI Moved|2|||
161979718|NCT00106691|584974128|FG000|Overall Study|Cardiologist recommendation|1|||
161979719|NCT00106691|584974129|FG001|Overall Study|Cardiologist recommendation|0|||
161979720|NCT00106691|584974128|FG000|Overall Study|Pt. moved to another state|1|||
161979721|NCT00106691|584974129|FG001|Overall Study|Pt. moved to another state|0|||
161979722|NCT00106691|584974128|FG000|Overall Study|Taking exclusionary avodart|1|||
161979723|NCT00106691|584974129|FG001|Overall Study|Taking exclusionary avodart|0|||
161979724|NCT00106691|584974128|FG000|Overall Study|Not able to discontinue plavix|0|||
161979725|NCT00106691|584974129|FG001|Overall Study|Not able to discontinue plavix|1|||
161979726|NCT00530920|584974130|FG000|Overall Study|Randomized but not treated|0|||
161979727|NCT00530920|584974131|FG001|Overall Study|Randomized but not treated|2|||
161979728|NCT00530920|584974132|FG002|Overall Study|Randomized but not treated|0|||
161979729|NCT00530920|584974130|FG000|Overall Study|Adverse Event|0|||
161979730|NCT00530920|584974131|FG001|Overall Study|Adverse Event|0|||
161863861|NCT02286713|584544129|FG000|One Week Follow-Up|Death|1|||
161863862|NCT02286713|584544130|FG001|One Week Follow-Up|Death|0|||
161863863|NCT02286713|584544129|FG000|One Week Follow-Up|Lost to Follow-up|17|||
161863864|NCT02286713|584544130|FG001|One Week Follow-Up|Lost to Follow-up|21|||
161863865|NCT02286713|584544129|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
161863866|NCT02286713|584544130|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
161863867|NCT02286713|584544129|FG000|Three Month Follow-Up|Death|1|||
161773610|NCT03110107|584214286|FG013|Treatment Period|Participant withdrew consent|0|||
161773611|NCT03110107|584214287|FG014|Treatment Period|Participant withdrew consent|0|||
161979731|NCT00530920|584974132|FG002|Overall Study|Adverse Event|3|||
161979732|NCT00530920|584974130|FG000|Overall Study|Withdrawal by Subject|0|||
161979733|NCT00530920|584974131|FG001|Overall Study|Withdrawal by Subject|0|||
161979734|NCT00530920|584974132|FG002|Overall Study|Withdrawal by Subject|1|||
161979735|NCT00907296|584974133|FG000|Overall Study|Ineligibility Determined|1|||
161979736|NCT00907296|584974134|FG001|Overall Study|Ineligibility Determined|0|||
161979737|NCT00907296|584974135|FG002|Overall Study|Ineligibility Determined|0|||
161979738|NCT00907296|584974136|FG003|Overall Study|Ineligibility Determined|1|||
161979739|NCT00907296|584974137|FG004|Overall Study|Ineligibility Determined|0|||
161979740|NCT00907296|584974138|FG005|Overall Study|Ineligibility Determined|0|||
161979741|NCT00907296|584974139|FG006|Overall Study|Ineligibility Determined|0|||
161979742|NCT00907296|584974140|FG007|Overall Study|Ineligibility Determined|1|||
161979743|NCT00907296|584974141|FG008|Overall Study|Ineligibility Determined|0|||
161979744|NCT00907296|584974142|FG009|Overall Study|Ineligibility Determined|0|||
161979745|NCT00907296|584974133|FG000|Overall Study|Protocol Deviation|0|||
161979746|NCT00907296|584974134|FG001|Overall Study|Protocol Deviation|1|||
161979747|NCT00907296|584974135|FG002|Overall Study|Protocol Deviation|0|||
161979748|NCT00907296|584974136|FG003|Overall Study|Protocol Deviation|0|||
161979749|NCT00907296|584974137|FG004|Overall Study|Protocol Deviation|0|||
161979750|NCT00907296|584974138|FG005|Overall Study|Protocol Deviation|0|||
161979751|NCT00907296|584974139|FG006|Overall Study|Protocol Deviation|0|||
161979752|NCT00907296|584974140|FG007|Overall Study|Protocol Deviation|0|||
161979753|NCT00907296|584974141|FG008|Overall Study|Protocol Deviation|0|||
161979754|NCT00907296|584974142|FG009|Overall Study|Protocol Deviation|0|||
161979755|NCT00907296|584974133|FG000|Overall Study|Noncompliance|1|||
161979756|NCT00907296|584974134|FG001|Overall Study|Noncompliance|1|||
161979757|NCT00907296|584974135|FG002|Overall Study|Noncompliance|1|||
161979758|NCT00907296|584974136|FG003|Overall Study|Noncompliance|0|||
161979759|NCT00907296|584974137|FG004|Overall Study|Noncompliance|0|||
161979760|NCT00907296|584974138|FG005|Overall Study|Noncompliance|1|||
161979761|NCT00907296|584974139|FG006|Overall Study|Noncompliance|0|||
161979762|NCT00907296|584974140|FG007|Overall Study|Noncompliance|2|||
161979763|NCT00907296|584974141|FG008|Overall Study|Noncompliance|0|||
161979764|NCT00907296|584974142|FG009|Overall Study|Noncompliance|0|||
161979765|NCT00907296|584974133|FG000|Overall Study|Adverse Event|2|||
161979766|NCT00907296|584974134|FG001|Overall Study|Adverse Event|0|||
161773612|NCT03110107|584214288|FG015|Treatment Period|Participant withdrew consent|0|||
161773613|NCT03110107|584214289|FG016|Treatment Period|Participant withdrew consent|0|||
161773614|NCT03110107|584214290|FG017|Treatment Period|Participant withdrew consent|0|||
161773615|NCT03110107|584214291|FG018|Treatment Period|Participant withdrew consent|0|||
161773616|NCT03110107|584214292|FG019|Treatment Period|Participant withdrew consent|1|||
161773617|NCT03110107|584214293|FG020|Treatment Period|Participant withdrew consent|0|||
161773618|NCT03110107|584214294|FG021|Treatment Period|Participant withdrew consent|2|||
161773619|NCT03110107|584214295|FG022|Treatment Period|Participant withdrew consent|0|||
161773620|NCT03110107|584214296|FG023|Treatment Period|Participant withdrew consent|0|||
161773621|NCT03110107|584214297|FG024|Treatment Period|Participant withdrew consent|0|||
161773622|NCT03110107|584214298|FG025|Treatment Period|Participant withdrew consent|2|||
161773623|NCT03110107|584214273|FG000|Treatment Period|Participants no longer meets study criteria|0|||
161773624|NCT03110107|584214274|FG001|Treatment Period|Participants no longer meets study criteria|0|||
161773625|NCT03110107|584214275|FG002|Treatment Period|Participants no longer meets study criteria|0|||
161773626|NCT03110107|584214276|FG003|Treatment Period|Participants no longer meets study criteria|0|||
161773627|NCT03110107|584214277|FG004|Treatment Period|Participants no longer meets study criteria|0|||
161773628|NCT03110107|584214278|FG005|Treatment Period|Participants no longer meets study criteria|0|||
161773629|NCT03110107|584214279|FG006|Treatment Period|Participants no longer meets study criteria|0|||
161773630|NCT03110107|584214280|FG007|Treatment Period|Participants no longer meets study criteria|0|||
161979767|NCT00907296|584974135|FG002|Overall Study|Adverse Event|0|||
161979768|NCT00907296|584974136|FG003|Overall Study|Adverse Event|0|||
161979769|NCT00907296|584974137|FG004|Overall Study|Adverse Event|0|||
161979770|NCT00907296|584974138|FG005|Overall Study|Adverse Event|0|||
161979771|NCT00907296|584974139|FG006|Overall Study|Adverse Event|1|||
161979772|NCT00907296|584974140|FG007|Overall Study|Adverse Event|0|||
161979773|NCT00907296|584974141|FG008|Overall Study|Adverse Event|0|||
161979774|NCT00907296|584974142|FG009|Overall Study|Adverse Event|1|||
161979775|NCT00907296|584974133|FG000|Overall Study|Withdrawal by Subject|7|||
161979776|NCT00907296|584974134|FG001|Overall Study|Withdrawal by Subject|2|||
161979777|NCT00907296|584974135|FG002|Overall Study|Withdrawal by Subject|1|||
161979778|NCT00907296|584974136|FG003|Overall Study|Withdrawal by Subject|1|||
161979779|NCT00907296|584974137|FG004|Overall Study|Withdrawal by Subject|1|||
161979780|NCT00907296|584974138|FG005|Overall Study|Withdrawal by Subject|5|||
161979781|NCT00907296|584974139|FG006|Overall Study|Withdrawal by Subject|3|||
161979782|NCT00907296|584974140|FG007|Overall Study|Withdrawal by Subject|2|||
161979783|NCT00907296|584974141|FG008|Overall Study|Withdrawal by Subject|4|||
161979784|NCT00907296|584974142|FG009|Overall Study|Withdrawal by Subject|2|||
162034881|NCT00096954|585184790|FG000|Overall Study|Sponsors Decision|1|||
162034882|NCT00096954|585184791|FG001|Overall Study|Sponsors Decision|1|||
162034883|NCT00096954|585184790|FG000|Overall Study|Pregnancy|1|||
162034884|NCT00096954|585184791|FG001|Overall Study|Pregnancy|1|||
162034885|NCT00096954|585184790|FG000|Overall Study|Initiation of immunotherapy|1|||
162034886|NCT00096954|585184791|FG001|Overall Study|Initiation of immunotherapy|0|||
162034887|NCT00096954|585184790|FG000|Overall Study|Non-compliance|0|||
161773631|NCT03110107|584214281|FG008|Treatment Period|Participants no longer meets study criteria|0|||
161773632|NCT03110107|584214282|FG009|Treatment Period|Participants no longer meets study criteria|0|||
161773633|NCT03110107|584214283|FG010|Treatment Period|Participants no longer meets study criteria|0|||
161773634|NCT03110107|584214284|FG011|Treatment Period|Participants no longer meets study criteria|0|||
161773635|NCT03110107|584214285|FG012|Treatment Period|Participants no longer meets study criteria|0|||
161773636|NCT03110107|584214286|FG013|Treatment Period|Participants no longer meets study criteria|0|||
161773637|NCT03110107|584214287|FG014|Treatment Period|Participants no longer meets study criteria|0|||
161773638|NCT03110107|584214288|FG015|Treatment Period|Participants no longer meets study criteria|0|||
161773639|NCT03110107|584214289|FG016|Treatment Period|Participants no longer meets study criteria|0|||
161773640|NCT03110107|584214290|FG017|Treatment Period|Participants no longer meets study criteria|0|||
161773641|NCT03110107|584214291|FG018|Treatment Period|Participants no longer meets study criteria|0|||
161773642|NCT03110107|584214292|FG019|Treatment Period|Participants no longer meets study criteria|0|||
161773643|NCT03110107|584214293|FG020|Treatment Period|Participants no longer meets study criteria|0|||
161773644|NCT03110107|584214294|FG021|Treatment Period|Participants no longer meets study criteria|0|||
161773645|NCT03110107|584214295|FG022|Treatment Period|Participants no longer meets study criteria|0|||
161773646|NCT03110107|584214296|FG023|Treatment Period|Participants no longer meets study criteria|1|||
161773647|NCT03110107|584214297|FG024|Treatment Period|Participants no longer meets study criteria|0|||
161773648|NCT03110107|584214298|FG025|Treatment Period|Participants no longer meets study criteria|0|||
161773649|NCT03110107|584214273|FG000|Treatment Period|Other Reasons|0|||
161773650|NCT03110107|584214274|FG001|Treatment Period|Other Reasons|0|||
161773651|NCT03110107|584214275|FG002|Treatment Period|Other Reasons|1|||
161773652|NCT03110107|584214276|FG003|Treatment Period|Other Reasons|1|||
161773653|NCT03110107|584214277|FG004|Treatment Period|Other Reasons|0|||
161773654|NCT03110107|584214278|FG005|Treatment Period|Other Reasons|1|||
161773655|NCT03110107|584214279|FG006|Treatment Period|Other Reasons|0|||
161773656|NCT03110107|584214280|FG007|Treatment Period|Other Reasons|0|||
161773657|NCT03110107|584214281|FG008|Treatment Period|Other Reasons|0|||
161773658|NCT03110107|584214282|FG009|Treatment Period|Other Reasons|0|||
161773659|NCT03110107|584214283|FG010|Treatment Period|Other Reasons|0|||
161773660|NCT03110107|584214284|FG011|Treatment Period|Other Reasons|0|||
161773661|NCT03110107|584214285|FG012|Treatment Period|Other Reasons|0|||
161773662|NCT03110107|584214286|FG013|Treatment Period|Other Reasons|0|||
161773663|NCT03110107|584214287|FG014|Treatment Period|Other Reasons|0|||
161773664|NCT03110107|584214288|FG015|Treatment Period|Other Reasons|0|||
161773665|NCT03110107|584214289|FG016|Treatment Period|Other Reasons|0|||
161773666|NCT03110107|584214290|FG017|Treatment Period|Other Reasons|0|||
161773667|NCT03110107|584214291|FG018|Treatment Period|Other Reasons|0|||
161773668|NCT03110107|584214292|FG019|Treatment Period|Other Reasons|0|||
161773669|NCT03110107|584214293|FG020|Treatment Period|Other Reasons|0|||
161773670|NCT03110107|584214294|FG021|Treatment Period|Other Reasons|0|||
161773671|NCT03110107|584214295|FG022|Treatment Period|Other Reasons|0|||
161773672|NCT03110107|584214296|FG023|Treatment Period|Other Reasons|0|||
161773673|NCT03110107|584214297|FG024|Treatment Period|Other Reasons|1|||
161773674|NCT03110107|584214298|FG025|Treatment Period|Other Reasons|0|||
161773675|NCT03985982|584214302|FG000|Double-Blind Phase|Lost to Follow-up|4|||
161773676|NCT03985982|584214303|FG001|Double-Blind Phase|Lost to Follow-up|3|||
161773677|NCT03985982|584214304|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161773678|NCT03985982|584214302|FG000|Double-Blind Phase|Physician Decision|1|||
161773679|NCT03985982|584214303|FG001|Double-Blind Phase|Physician Decision|0|||
161773680|NCT03985982|584214304|FG002|Double-Blind Phase|Physician Decision|0|||
161773681|NCT03985982|584214302|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
161773682|NCT03985982|584214303|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
161773683|NCT03985982|584214304|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161773684|NCT03985982|584214302|FG000|Double-Blind Phase|COVID-19|1|||
161773685|NCT03985982|584214303|FG001|Double-Blind Phase|COVID-19|0|||
161773686|NCT03985982|584214304|FG002|Double-Blind Phase|COVID-19|0|||
161773687|NCT03985982|584214302|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
161773688|NCT03985982|584214303|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
161773689|NCT03985982|584214304|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
161773690|NCT03985982|584214302|FG000|Open-Label Phase|Lost to Follow-up|0|||
161773691|NCT03985982|584214303|FG001|Open-Label Phase|Lost to Follow-up|0|||
161773692|NCT03985982|584214304|FG002|Open-Label Phase|Lost to Follow-up|13|||
161863868|NCT02286713|584544130|FG001|Three Month Follow-Up|Death|1|||
161863869|NCT02286713|584544129|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
162034888|NCT00096954|585184791|FG001|Overall Study|Non-compliance|3|||
161979785|NCT00907296|584974133|FG000|Overall Study|Lost to Follow-up|9|||
161979786|NCT00907296|584974134|FG001|Overall Study|Lost to Follow-up|1|||
161979787|NCT00907296|584974135|FG002|Overall Study|Lost to Follow-up|0|||
161979788|NCT00907296|584974136|FG003|Overall Study|Lost to Follow-up|2|||
161979789|NCT00907296|584974137|FG004|Overall Study|Lost to Follow-up|0|||
161979790|NCT00907296|584974138|FG005|Overall Study|Lost to Follow-up|3|||
161979791|NCT00907296|584974139|FG006|Overall Study|Lost to Follow-up|2|||
161979792|NCT00907296|584974140|FG007|Overall Study|Lost to Follow-up|2|||
161979793|NCT00907296|584974141|FG008|Overall Study|Lost to Follow-up|0|||
161979794|NCT00907296|584974142|FG009|Overall Study|Lost to Follow-up|4|||
161979795|NCT02392403|584974144|FG000|Overall Study|Adverse Event|1|||
161979796|NCT02392403|584974144|FG000|Overall Study|Death|1|||
161979797|NCT02392403|584974144|FG000|Overall Study|Withdrawal by Subject|1|||
161979798|NCT00316888|584974153|FG000|Overall Study|Adverse Event|4|||
161979799|NCT00316888|584974154|FG001|Overall Study|Adverse Event|5|||
161979800|NCT00316888|584974153|FG000|Overall Study|Withdrawal by Subject|2|||
161979801|NCT00316888|584974154|FG001|Overall Study|Withdrawal by Subject|2|||
161979802|NCT00316888|584974153|FG000|Overall Study|Not start protocol therapy|0|||
161979803|NCT00316888|584974154|FG001|Overall Study|Not start protocol therapy|1|||
161979804|NCT00657371|584974155|FG000|Overall Study|Poor bowel preparation|15|||
161979805|NCT00657371|584974155|FG000|Overall Study|Unable to intubate the cecum|5|||
161979806|NCT00657371|584974155|FG000|Overall Study|Protocol Violation|2|||
161979807|NCT00657371|584974155|FG000|Overall Study|Device- related reasons|13|||
161979808|NCT00657371|584974155|FG000|Overall Study|Pre-existing medical condition|4|||
161979809|NCT00652899|584974156|FG000|Overall Study|Death|1|||
161979810|NCT00652899|584974156|FG000|Overall Study|Treating physician decision|1|||
161979811|NCT03629912|584974164|FG000|Overall Study|Lost to Follow-up|19|||
161979812|NCT03629912|584974165|FG001|Overall Study|Lost to Follow-up|7|||
161979813|NCT03629912|584974166|FG002|Overall Study|Lost to Follow-up|5|||
161979814|NCT03629912|584974167|FG003|Overall Study|Lost to Follow-up|1|||
161979815|NCT03629912|584974164|FG000|Overall Study|Withdrawal by Subject|6|||
161979816|NCT03629912|584974165|FG001|Overall Study|Withdrawal by Subject|0|||
161979817|NCT03629912|584974166|FG002|Overall Study|Withdrawal by Subject|1|||
161979818|NCT03629912|584974167|FG003|Overall Study|Withdrawal by Subject|2|||
161979819|NCT03629912|584974164|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
161979820|NCT03629912|584974165|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
161979821|NCT03629912|584974166|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
161979822|NCT03629912|584974167|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
161979823|NCT03629912|584974164|FG000|Overall Study|Death|1|||
161979824|NCT03629912|584974165|FG001|Overall Study|Death|0|||
161979825|NCT03629912|584974166|FG002|Overall Study|Death|0|||
161979826|NCT03629912|584974167|FG003|Overall Study|Death|0|||
161979827|NCT02608450|584974168|FG000|Overall Study|Lost to Follow-up|39|||
161979828|NCT02608450|584974169|FG001|Overall Study|Lost to Follow-up|32|||
161979829|NCT02608450|584974168|FG000|Overall Study|Withdrawal by Subject|21|||
161979830|NCT02608450|584974169|FG001|Overall Study|Withdrawal by Subject|15|||
161979831|NCT02608450|584974168|FG000|Overall Study|Adverse Event|3|||
161979832|NCT02608450|584974169|FG001|Overall Study|Adverse Event|6|||
161979833|NCT02608450|584974168|FG000|Overall Study|Withdrawal by parent|2|||
161979834|NCT02608450|584974169|FG001|Overall Study|Withdrawal by parent|3|||
161979835|NCT02608450|584974168|FG000|Overall Study|Lack of Efficacy|0|||
161979836|NCT02608450|584974169|FG001|Overall Study|Lack of Efficacy|3|||
161979837|NCT02608450|584974168|FG000|Overall Study|Noncompliance with study drug|0|||
161979838|NCT02608450|584974169|FG001|Overall Study|Noncompliance with study drug|2|||
161979839|NCT02608450|584974168|FG000|Overall Study|Physician Decision|0|||
161979840|NCT02608450|584974169|FG001|Overall Study|Physician Decision|1|||
161979841|NCT02608450|584974168|FG000|Overall Study|Pregnancy|0|||
161979842|NCT02608450|584974169|FG001|Overall Study|Pregnancy|1|||
161979843|NCT02608450|584974168|FG000|Overall Study|Progressive disease|1|||
161979844|NCT02608450|584974169|FG001|Overall Study|Progressive disease|0|||
161979845|NCT02608450|584974168|FG000|Overall Study|Multiple reasons|0|||
161979846|NCT02608450|584974169|FG001|Overall Study|Multiple reasons|2|||
161979847|NCT02565810|584974170|FG000|Overall Study|Withdrawal by Subject|1|||
161979848|NCT01792518|584974181|FG000|Overall Study|Adverse Event|3|||
161979849|NCT01792518|584974182|FG001|Overall Study|Adverse Event|4|||
161979850|NCT01792518|584974181|FG000|Overall Study|Protocol Violation|0|||
161979851|NCT01792518|584974182|FG001|Overall Study|Protocol Violation|1|||
161979852|NCT01792518|584974181|FG000|Overall Study|Lost to Follow-up|3|||
161979853|NCT01792518|584974182|FG001|Overall Study|Lost to Follow-up|1|||
161979854|NCT01792518|584974181|FG000|Overall Study|Withdrawal by Subject|2|||
161979855|NCT01792518|584974182|FG001|Overall Study|Withdrawal by Subject|0|||
161979856|NCT01792518|584974181|FG000|Overall Study|Other Reason|0|||
161979857|NCT01792518|584974182|FG001|Overall Study|Other Reason|1|||
161979858|NCT01504204|584974183|FG000|Overall Study|Lost to Follow-up|1|||
161979859|NCT01504204|584974184|FG001|Overall Study|Lost to Follow-up|1|||
161979860|NCT02241187|584974189|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
161979861|NCT02966015|584974190|FG000|Inclusion Visit|did not answer questionnaire|8|||
161979862|NCT02966015|584974191|FG001|Inclusion Visit|did not answer questionnaire|3|||
161863870|NCT02286713|584544130|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
161863871|NCT02286713|584544129|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
161863872|NCT02286713|584544130|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
161863873|NCT02286713|584544129|FG000|Six Month Follow-Up|Death|2|||
161863874|NCT02286713|584544130|FG001|Six Month Follow-Up|Death|0|||
161863875|NCT02286713|584544129|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
161863876|NCT02286713|584544130|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
161863877|NCT04314037|584544131|FG000|Treatment Period 2|Adverse Event|1|||
161863878|NCT04314037|584544132|FG001|Treatment Period 2|Adverse Event|0|||
161863879|NCT04314037|584544131|FG000|Treatment Period 3|Protocol Violation|1|||
161863880|NCT04314037|584544132|FG001|Treatment Period 3|Protocol Violation|0|||
161863881|NCT04314037|584544131|FG000|Treatment Period 3|Adverse Event|0|||
161863882|NCT04314037|584544132|FG001|Treatment Period 3|Adverse Event|1|||
161863883|NCT00856492|584544135|FG000|Overall Study|Ineligible or withdrew consent|1|||
161863884|NCT00856492|584544136|FG001|Overall Study|Ineligible or withdrew consent|1|||
161863885|NCT00856492|584544137|FG002|Overall Study|Ineligible or withdrew consent|2|||
161863886|NCT06018129|584544138|FG000|Overall Study|Death|1|||
161863887|NCT06018129|584544139|FG001|Overall Study|Death|1|||
161863888|NCT06018129|584544140|FG002|Overall Study|Death|2|||
161863889|NCT06018129|584544138|FG000|Overall Study|Sponsor Decision|2|||
161863890|NCT06018129|584544139|FG001|Overall Study|Sponsor Decision|2|||
161863891|NCT06018129|584544140|FG002|Overall Study|Sponsor Decision|1|||
161863892|NCT03832686|584544141|FG000|Overall Study|Lost to Follow-up|6|||
161863893|NCT03832686|584544142|FG001|Overall Study|Lost to Follow-up|9|||
161863894|NCT03832686|584544141|FG000|Overall Study|Discontinued Intervention|5|||
161863895|NCT03832686|584544142|FG001|Overall Study|Discontinued Intervention|4|||
161863896|NCT03323398|584544143|FG000|Overall Study|Other than Specified|0|||
161863897|NCT03323398|584544144|FG001|Overall Study|Other than Specified|1|||
161863898|NCT03323398|584544145|FG002|Overall Study|Other than Specified|2|||
161863899|NCT03323398|584544146|FG003|Overall Study|Other than Specified|0|||
161863900|NCT03323398|584544147|FG004|Overall Study|Other than Specified|0|||
161863901|NCT03323398|584544148|FG005|Overall Study|Other than Specified|0|||
161863902|NCT03323398|584544149|FG006|Overall Study|Other than Specified|1|||
161863903|NCT03323398|584544150|FG007|Overall Study|Other than Specified|0|||
161863904|NCT03323398|584544151|FG008|Overall Study|Other than Specified|2|||
161863905|NCT03323398|584544143|FG000|Overall Study|Lost to Follow-up|1|||
161863906|NCT03323398|584544144|FG001|Overall Study|Lost to Follow-up|2|||
161863907|NCT03323398|584544145|FG002|Overall Study|Lost to Follow-up|1|||
161863908|NCT03323398|584544146|FG003|Overall Study|Lost to Follow-up|0|||
161863909|NCT03323398|584544147|FG004|Overall Study|Lost to Follow-up|0|||
161863910|NCT03323398|584544148|FG005|Overall Study|Lost to Follow-up|0|||
161863911|NCT03323398|584544149|FG006|Overall Study|Lost to Follow-up|0|||
161863912|NCT03323398|584544150|FG007|Overall Study|Lost to Follow-up|0|||
161863913|NCT03323398|584544151|FG008|Overall Study|Lost to Follow-up|0|||
161863914|NCT03323398|584544143|FG000|Overall Study|Death|4|||
161863915|NCT03323398|584544144|FG001|Overall Study|Death|6|||
161863916|NCT03323398|584544145|FG002|Overall Study|Death|2|||
161863917|NCT03323398|584544146|FG003|Overall Study|Death|2|||
161863918|NCT03323398|584544147|FG004|Overall Study|Death|1|||
161863919|NCT03323398|584544148|FG005|Overall Study|Death|2|||
161863920|NCT03323398|584544149|FG006|Overall Study|Death|0|||
161863921|NCT03323398|584544150|FG007|Overall Study|Death|0|||
161863922|NCT03323398|584544151|FG008|Overall Study|Death|6|||
161863923|NCT03323398|584544143|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
161863924|NCT03323398|584544144|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
161863925|NCT03323398|584544145|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
161863926|NCT03323398|584544146|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
161863927|NCT03323398|584544147|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
161863928|NCT03323398|584544148|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
161863929|NCT03323398|584544149|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
161863930|NCT03323398|584544150|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
161863931|NCT03323398|584544151|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
161863932|NCT03323398|584544143|FG000|Overall Study|Withdrawal by Subject|2|||
161863933|NCT03323398|584544144|FG001|Overall Study|Withdrawal by Subject|1|||
161863934|NCT03323398|584544145|FG002|Overall Study|Withdrawal by Subject|3|||
161863935|NCT03323398|584544146|FG003|Overall Study|Withdrawal by Subject|0|||
161863936|NCT03323398|584544147|FG004|Overall Study|Withdrawal by Subject|0|||
161863937|NCT03323398|584544148|FG005|Overall Study|Withdrawal by Subject|1|||
161863938|NCT03323398|584544149|FG006|Overall Study|Withdrawal by Subject|0|||
161863939|NCT03323398|584544150|FG007|Overall Study|Withdrawal by Subject|0|||
161863940|NCT03323398|584544151|FG008|Overall Study|Withdrawal by Subject|0|||
161863941|NCT03323398|584544143|FG000|Overall Study|Participant was Put on Hospice|0|||
161863942|NCT03323398|584544144|FG001|Overall Study|Participant was Put on Hospice|0|||
161863943|NCT03323398|584544145|FG002|Overall Study|Participant was Put on Hospice|0|||
161863944|NCT03323398|584544146|FG003|Overall Study|Participant was Put on Hospice|0|||
161863945|NCT03323398|584544147|FG004|Overall Study|Participant was Put on Hospice|0|||
161979863|NCT02356887|584974192|FG000|Overall Study|poor compliance|2|||
161979864|NCT00199888|584974193|FG000|Overall Study|Lost to Follow-up|1|||
161979865|NCT02177838|584974194|FG000|Overall Study|Withdrawal by Subject|1|||
161979866|NCT02177838|584974194|FG000|Overall Study|Physician Decision|1|||
161979867|NCT02177838|584974194|FG000|Overall Study|Death|1|||
161979868|NCT01839656|584974195|FG000|Overall Study|Withdrawal by Subject|1|||
161979869|NCT01839656|584974196|FG001|Overall Study|Withdrawal by Subject|1|||
161979870|NCT01839656|584974195|FG000|Overall Study|Adverse event, serious fatal|1|||
161979871|NCT01839656|584974196|FG001|Overall Study|Adverse event, serious fatal|4|||
161979872|NCT01839656|584974195|FG000|Overall Study|Early study closure|0|||
161979873|NCT01839656|584974196|FG001|Overall Study|Early study closure|11|||
161979874|NCT01839656|584974195|FG000|Overall Study|Adverse Event|1|||
161979875|NCT01839656|584974196|FG001|Overall Study|Adverse Event|0|||
161979876|NCT02273960|584974199|FG000|Short Term Period|Lost to Follow-up|1|||
161979877|NCT02273960|584974200|FG001|Short Term Period|Lost to Follow-up|0|||
161979878|NCT02273960|584974201|FG002|Short Term Period|Lost to Follow-up|0|||
161979879|NCT02273960|584974202|FG003|Short Term Period|Lost to Follow-up|0|||
161979880|NCT02273960|584974199|FG000|Short Term Period|Lack of Efficacy|0|||
161979881|NCT02273960|584974200|FG001|Short Term Period|Lack of Efficacy|0|||
161979882|NCT02273960|584974201|FG002|Short Term Period|Lack of Efficacy|0|||
161979883|NCT02273960|584974202|FG003|Short Term Period|Lack of Efficacy|1|||
161979884|NCT02273960|584974199|FG000|Short Term Period|ST complete, not entering LTE|4|||
161979885|NCT02273960|584974200|FG001|Short Term Period|ST complete, not entering LTE|6|||
161979886|NCT02273960|584974201|FG002|Short Term Period|ST complete, not entering LTE|4|||
161979887|NCT02273960|584974202|FG003|Short Term Period|ST complete, not entering LTE|5|||
161979888|NCT02273960|584974199|FG000|Long Term Extension|Death|0|||
161979889|NCT02273960|584974200|FG001|Long Term Extension|Death|0|||
161979890|NCT02273960|584974201|FG002|Long Term Extension|Death|0|||
161979891|NCT02273960|584974202|FG003|Long Term Extension|Death|1|||
161979892|NCT00558272|584974205|FG000|Overall Study|Adverse Event|10|||
161979893|NCT00558272|584974206|FG001|Overall Study|Adverse Event|0|||
161979894|NCT00558272|584974205|FG000|Overall Study|Death|1|||
161979895|NCT00558272|584974206|FG001|Overall Study|Death|0|||
161979896|NCT00558272|584974205|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
161979897|NCT00558272|584974206|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
161979898|NCT00558272|584974205|FG000|Overall Study|AZ study team decision|0|||
161979899|NCT00558272|584974206|FG001|Overall Study|AZ study team decision|1|||
161979900|NCT00558272|584974205|FG000|Overall Study|Incorrectly enrolled|1|||
161979901|NCT00558272|584974206|FG001|Overall Study|Incorrectly enrolled|0|||
161979902|NCT00558272|584974205|FG000|Overall Study|Withdrawal by Subject|0|||
161979903|NCT00558272|584974206|FG001|Overall Study|Withdrawal by Subject|1|||
161979904|NCT03442296|584974213|FG000|3 Month Follow-up|Death|3|||
161979905|NCT03442296|584974214|FG001|3 Month Follow-up|Death|1|||
161979906|NCT03442296|584974213|FG000|3 Month Follow-up|Lost to Follow-up|1|||
161979907|NCT03442296|584974214|FG001|3 Month Follow-up|Lost to Follow-up|1|||
161979908|NCT03442296|584974213|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
161979909|NCT03442296|584974214|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
161979910|NCT03442296|584974213|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
161979911|NCT03442296|584974214|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
161979912|NCT03442296|584974213|FG000|12 Month Follow-up|Incomplete measurement|1|||
161979913|NCT03442296|584974214|FG001|12 Month Follow-up|Incomplete measurement|1|||
161979914|NCT00447122|584974215|FG000|Overall Study|worsening medical condition -came off|0|||
161979915|NCT00447122|584974216|FG001|Overall Study|worsening medical condition -came off|1|||
161979916|NCT00447122|584974217|FG002|Overall Study|worsening medical condition -came off|0|||
161979917|NCT00447122|584974218|FG003|Overall Study|worsening medical condition -came off|0|||
161979918|NCT02409342|584974219|FG000|Overall Study|Death|211|||
161979919|NCT02409342|584974220|FG001|Overall Study|Death|201|||
161979920|NCT02409342|584974219|FG000|Overall Study|Withdrawal by Subject|24|||
161979921|NCT02409342|584974220|FG001|Overall Study|Withdrawal by Subject|17|||
161979922|NCT02409342|584974219|FG000|Overall Study|Study Terminated By Sponsor|48|||
161979923|NCT02409342|584974220|FG001|Overall Study|Study Terminated By Sponsor|59|||
161979924|NCT02409342|584974219|FG000|Overall Study|Lost to Follow-up|3|||
161979925|NCT02409342|584974220|FG001|Overall Study|Lost to Follow-up|5|||
161979926|NCT02409342|584974219|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
161979927|NCT02409342|584974220|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
161979928|NCT02409342|584974219|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
161979929|NCT02409342|584974220|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
161979930|NCT02409342|584974219|FG000|Overall Study|Sponsor Decision|1|||
161979931|NCT02409342|584974220|FG001|Overall Study|Sponsor Decision|0|||
161863946|NCT03323398|584544148|FG005|Overall Study|Participant was Put on Hospice|0|||
161979932|NCT00279812|584974221|FG000|Overall Study|Protocol Violation|1|||
161863947|NCT03323398|584544149|FG006|Overall Study|Participant was Put on Hospice|1|||
161979933|NCT00279812|584974222|FG001|Overall Study|Protocol Violation|1|||
161863948|NCT03323398|584544150|FG007|Overall Study|Participant was Put on Hospice|0|||
161979934|NCT00279812|584974223|FG002|Overall Study|Protocol Violation|0|||
161979935|NCT00279812|584974224|FG003|Overall Study|Protocol Violation|0|||
161863949|NCT03323398|584544151|FG008|Overall Study|Participant was Put on Hospice|0|||
161863950|NCT03323398|584544143|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
161863951|NCT03323398|584544144|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
161863952|NCT03323398|584544145|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
161863953|NCT03323398|584544146|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
161863954|NCT03323398|584544147|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
161863955|NCT03323398|584544148|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
161863956|NCT03323398|584544149|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
161863957|NCT03323398|584544150|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
161863958|NCT03323398|584544151|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
161863959|NCT02235454|584544152|FG000|Overall Study|Withdrawal by Subject|2|||
161863960|NCT03641469|584544153|FG000|Overall Study|Ineligible|2|||
161863961|NCT03641469|584544153|FG000|Overall Study|Withdrawal by Subject|5|||
161863962|NCT03641469|584544153|FG000|Overall Study|Physician Decision|1|||
161863963|NCT03641469|584544153|FG000|Overall Study|Protocol Violation|1|||
161863964|NCT03641469|584544153|FG000|Overall Study|Lost to Follow-up|2|||
161863965|NCT01415518|584545543|FG000|Overall Study|Withdrawal by Subject|2|||
161863966|NCT01415518|584545544|FG001|Overall Study|Withdrawal by Subject|12|||
161863967|NCT01415518|584545543|FG000|Overall Study|Protocol Violation|6|||
161863968|NCT01415518|584545544|FG001|Overall Study|Protocol Violation|8|||
161863969|NCT01415518|584545543|FG000|Overall Study|Lost to Follow-up|3|||
161863970|NCT01415518|584545544|FG001|Overall Study|Lost to Follow-up|5|||
161863971|NCT01415518|584545543|FG000|Overall Study|Adverse Event|3|||
161863972|NCT01415518|584545544|FG001|Overall Study|Adverse Event|4|||
161863973|NCT01415518|584545543|FG000|Overall Study|Death|1|||
161863974|NCT01415518|584545544|FG001|Overall Study|Death|1|||
161863975|NCT01415518|584545543|FG000|Overall Study|Condition under Investigation Worsened|1|||
161863976|NCT01415518|584545544|FG001|Overall Study|Condition under Investigation Worsened|1|||
161863977|NCT05364931|584545548|FG000|Overall Study|Adverse Event|0|||
161863978|NCT05364931|584545549|FG001|Overall Study|Adverse Event|2|||
161863979|NCT05364931|584545550|FG002|Overall Study|Adverse Event|1|||
161863980|NCT05364931|584545551|FG003|Overall Study|Adverse Event|0|||
161863981|NCT05364931|584545548|FG000|Overall Study|Lost to Follow-up|1|||
161863982|NCT05364931|584545549|FG001|Overall Study|Lost to Follow-up|0|||
161863983|NCT05364931|584545550|FG002|Overall Study|Lost to Follow-up|0|||
161863984|NCT05364931|584545551|FG003|Overall Study|Lost to Follow-up|0|||
161863985|NCT05364931|584545548|FG000|Overall Study|Withdrawal by Subject|1|||
161863986|NCT05364931|584545549|FG001|Overall Study|Withdrawal by Subject|1|||
161863987|NCT05364931|584545550|FG002|Overall Study|Withdrawal by Subject|3|||
161863988|NCT05364931|584545551|FG003|Overall Study|Withdrawal by Subject|2|||
161863989|NCT05364931|584545548|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
161863990|NCT05364931|584545549|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
161863991|NCT05364931|584545550|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
161863992|NCT05364931|584545551|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
161863993|NCT05364931|584545548|FG000|Overall Study|Discontinued|1|||
161863994|NCT05364931|584545549|FG001|Overall Study|Discontinued|0|||
161863995|NCT05364931|584545550|FG002|Overall Study|Discontinued|0|||
161863996|NCT05364931|584545551|FG003|Overall Study|Discontinued|0|||
161863997|NCT03976362|584545552|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
161863998|NCT03976362|584545553|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
161863999|NCT03976362|584545554|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
161864000|NCT03976362|584545552|FG000|Induction Phase|Death|62|||
161864001|NCT03976362|584545553|FG001|Induction Phase|Death|0|||
161864002|NCT03976362|584545554|FG002|Induction Phase|Death|0|||
161864003|NCT03976362|584545552|FG000|Maintenance Phase|Participants Ongoing|0|||
161864004|NCT03976362|584545553|FG001|Maintenance Phase|Participants Ongoing|106|||
161864005|NCT03976362|584545554|FG002|Maintenance Phase|Participants Ongoing|103|||
161864006|NCT03976362|584545552|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161864007|NCT03976362|584545553|FG001|Maintenance Phase|Withdrawal by Subject|4|||
161864008|NCT03976362|584545554|FG002|Maintenance Phase|Withdrawal by Subject|4|||
161979936|NCT00279812|584974225|FG004|Overall Study|Protocol Violation|1|||
161979937|NCT00279812|584974226|FG005|Overall Study|Protocol Violation|0|||
161979938|NCT00279812|584974221|FG000|Overall Study|Withdrawal by Subject|0|||
161979939|NCT00279812|584974222|FG001|Overall Study|Withdrawal by Subject|4|||
161979940|NCT00279812|584974223|FG002|Overall Study|Withdrawal by Subject|2|||
161979941|NCT00279812|584974224|FG003|Overall Study|Withdrawal by Subject|0|||
161979942|NCT00279812|584974225|FG004|Overall Study|Withdrawal by Subject|0|||
161864009|NCT03976362|584545552|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
161864010|NCT03976362|584545553|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
161864011|NCT03976362|584545554|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
161864012|NCT03976362|584545552|FG000|Maintenance Phase|Death|0|||
161864013|NCT03976362|584545553|FG001|Maintenance Phase|Death|186|||
161979943|NCT00279812|584974226|FG005|Overall Study|Withdrawal by Subject|0|||
161979944|NCT00279812|584974221|FG000|Overall Study|Adverse Event|0|||
161979945|NCT00279812|584974222|FG001|Overall Study|Adverse Event|1|||
161979946|NCT00279812|584974223|FG002|Overall Study|Adverse Event|1|||
161979947|NCT00279812|584974224|FG003|Overall Study|Adverse Event|0|||
161979948|NCT00279812|584974225|FG004|Overall Study|Adverse Event|2|||
161979949|NCT00279812|584974226|FG005|Overall Study|Adverse Event|1|||
161979950|NCT04046250|584974234|FG000|Overall Study|Death|0|||
161979951|NCT04046250|584974235|FG001|Overall Study|Death|1|||
161979952|NCT04046250|584974234|FG000|Overall Study|Withdrawal by Subject|3|||
161979953|NCT04046250|584974235|FG001|Overall Study|Withdrawal by Subject|3|||
161979954|NCT03834220|584974240|FG000|Overall Study|Adverse Event|1|||
161979955|NCT03834220|584974241|FG001|Overall Study|Adverse Event|0|||
161979956|NCT03834220|584974242|FG002|Overall Study|Adverse Event|0|||
161979957|NCT03834220|584974240|FG000|Overall Study|Death|8|||
161979958|NCT03834220|584974241|FG001|Overall Study|Death|1|||
161979959|NCT03834220|584974242|FG002|Overall Study|Death|17|||
161979960|NCT03834220|584974240|FG000|Overall Study|Reason not Specified|9|||
161979961|NCT03834220|584974241|FG001|Overall Study|Reason not Specified|0|||
161979962|NCT03834220|584974242|FG002|Overall Study|Reason not Specified|6|||
161979963|NCT03834220|584974240|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
161979964|NCT03834220|584974241|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
161979965|NCT03834220|584974242|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
161979966|NCT03834220|584974240|FG000|Overall Study|Withdrawal of Consent|2|||
161979967|NCT03834220|584974241|FG001|Overall Study|Withdrawal of Consent|2|||
161979968|NCT03834220|584974242|FG002|Overall Study|Withdrawal of Consent|2|||
161979969|NCT00527332|584974244|FG000|Overall Study|Protocol Violation|4|||
161979970|NCT00527332|584974245|FG001|Overall Study|Protocol Violation|8|||
161979971|NCT00527332|584974244|FG000|Overall Study|Withdrew consent|5|||
161979972|NCT00527332|584974245|FG001|Overall Study|Withdrew consent|1|||
161979973|NCT03684694|584974248|FG000|Phase 1|Withdrawal by Subject|1|||
161979974|NCT03684694|584974249|FG001|Phase 1|Withdrawal by Subject|0|||
161979975|NCT03684694|584974250|FG002|Phase 1|Withdrawal by Subject|0|||
161979976|NCT03684694|584974251|FG003|Phase 1|Withdrawal by Subject|0|||
161979977|NCT03684694|584974252|FG004|Phase 1|Withdrawal by Subject|0|||
161979978|NCT03684694|584974253|FG005|Phase 1|Withdrawal by Subject|0|||
161979979|NCT03684694|584974248|FG000|Phase 1|Investigator/Sponsor Decision|12|||
161979980|NCT03684694|584974249|FG001|Phase 1|Investigator/Sponsor Decision|2|||
161979981|NCT03684694|584974250|FG002|Phase 1|Investigator/Sponsor Decision|1|||
161979982|NCT03684694|584974251|FG003|Phase 1|Investigator/Sponsor Decision|0|||
161979983|NCT03684694|584974252|FG004|Phase 1|Investigator/Sponsor Decision|0|||
161979984|NCT03684694|584974253|FG005|Phase 1|Investigator/Sponsor Decision|0|||
161979985|NCT03684694|584974248|FG000|Phase 1|Death|24|||
161979986|NCT03684694|584974249|FG001|Phase 1|Death|0|||
161979987|NCT03684694|584974250|FG002|Phase 1|Death|3|||
161979988|NCT03684694|584974251|FG003|Phase 1|Death|0|||
161979989|NCT03684694|584974252|FG004|Phase 1|Death|0|||
161979990|NCT03684694|584974253|FG005|Phase 1|Death|0|||
161979991|NCT03684694|584974248|FG000|Phase 1|Lost to Follow-up|0|||
161979992|NCT03684694|584974249|FG001|Phase 1|Lost to Follow-up|0|||
161979993|NCT03684694|584974250|FG002|Phase 1|Lost to Follow-up|1|||
161979994|NCT03684694|584974251|FG003|Phase 1|Lost to Follow-up|0|||
161979995|NCT03684694|584974252|FG004|Phase 1|Lost to Follow-up|0|||
161979996|NCT03684694|584974253|FG005|Phase 1|Lost to Follow-up|0|||
161979997|NCT03684694|584974248|FG000|Phase 1|Miscellaneous|0|||
161979998|NCT03684694|584974249|FG001|Phase 1|Miscellaneous|1|||
161979999|NCT03684694|584974250|FG002|Phase 1|Miscellaneous|0|||
161980000|NCT03684694|584974251|FG003|Phase 1|Miscellaneous|0|||
161980001|NCT03684694|584974252|FG004|Phase 1|Miscellaneous|0|||
161980002|NCT03684694|584974253|FG005|Phase 1|Miscellaneous|0|||
161980003|NCT03684694|584974248|FG000|Phase 2|Withdrawal by Subject|0|||
161980004|NCT03684694|584974249|FG001|Phase 2|Withdrawal by Subject|0|||
162034889|NCT00096954|585184790|FG000|Overall Study|Lost to Follow-up|8|||
161980005|NCT03684694|584974250|FG002|Phase 2|Withdrawal by Subject|0|||
161980006|NCT03684694|584974251|FG003|Phase 2|Withdrawal by Subject|0|||
161980007|NCT03684694|584974252|FG004|Phase 2|Withdrawal by Subject|0|||
161980008|NCT03684694|584974253|FG005|Phase 2|Withdrawal by Subject|1|||
161980009|NCT03684694|584974248|FG000|Phase 2|Investigator/Sponsor Decision|0|||
161980010|NCT03684694|584974249|FG001|Phase 2|Investigator/Sponsor Decision|0|||
161980011|NCT03684694|584974250|FG002|Phase 2|Investigator/Sponsor Decision|0|||
161980012|NCT03684694|584974251|FG003|Phase 2|Investigator/Sponsor Decision|17|||
161980013|NCT03684694|584974252|FG004|Phase 2|Investigator/Sponsor Decision|16|||
161980014|NCT03684694|584974253|FG005|Phase 2|Investigator/Sponsor Decision|6|||
161980015|NCT03684694|584974248|FG000|Phase 2|Death|0|||
161980016|NCT03684694|584974249|FG001|Phase 2|Death|0|||
161980017|NCT03684694|584974250|FG002|Phase 2|Death|0|||
161980018|NCT03684694|584974251|FG003|Phase 2|Death|28|||
161980019|NCT03684694|584974252|FG004|Phase 2|Death|14|||
161980020|NCT03684694|584974253|FG005|Phase 2|Death|3|||
161980021|NCT03684694|584974248|FG000|Phase 2|Lost to Follow-up|0|||
161980022|NCT03684694|584974249|FG001|Phase 2|Lost to Follow-up|0|||
161980023|NCT03684694|584974250|FG002|Phase 2|Lost to Follow-up|0|||
161864014|NCT03976362|584545554|FG002|Maintenance Phase|Death|187|||
161864015|NCT04846569|584545555|FG000|Overall Study|Withdrawal by Subject|3|||
161864016|NCT04846569|584545556|FG001|Overall Study|Withdrawal by Subject|1|||
161864017|NCT02525783|584545558|FG000|Overall Study|Lost to Follow-up|10|||
161864018|NCT04570670|584545561|FG000|Overall Study|Withdrawal by Subject|1|||
161864019|NCT04570670|584545562|FG001|Overall Study|Withdrawal by Subject|0|||
161864020|NCT00683618|584545563|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
161864021|NCT00683618|584545564|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
161864022|NCT00683618|584545565|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
161864023|NCT00683618|584545563|FG000|Randomised Treatment Period|Protocol Violation|0|||
161864024|NCT00683618|584545564|FG001|Randomised Treatment Period|Protocol Violation|1|||
161864025|NCT00683618|584545565|FG002|Randomised Treatment Period|Protocol Violation|0|||
161864026|NCT00683618|584545563|FG000|Randomised Treatment Period|Adverse Event|2|||
161864027|NCT00683618|584545564|FG001|Randomised Treatment Period|Adverse Event|0|||
161864028|NCT00683618|584545565|FG002|Randomised Treatment Period|Adverse Event|2|||
161864029|NCT00683618|584545563|FG000|Randomised Treatment Period|Reason not provided|0|||
161864030|NCT00683618|584545564|FG001|Randomised Treatment Period|Reason not provided|0|||
161864031|NCT00683618|584545565|FG002|Randomised Treatment Period|Reason not provided|2|||
161864032|NCT00683618|584545563|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
161864033|NCT00683618|584545564|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
161864034|NCT00683618|584545565|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
161864035|NCT00683618|584545563|FG000|Extension Treatment Period|Adverse Event|1|||
161864036|NCT00683618|584545564|FG001|Extension Treatment Period|Adverse Event|0|||
161864037|NCT00683618|584545565|FG002|Extension Treatment Period|Adverse Event|0|||
161864038|NCT00683618|584545563|FG000|Extension Treatment Period|Protocol Violation|1|||
161864039|NCT00683618|584545564|FG001|Extension Treatment Period|Protocol Violation|0|||
161864040|NCT00683618|584545565|FG002|Extension Treatment Period|Protocol Violation|0|||
161864041|NCT03776357|584545566|FG000|Overall Study|Lost to Follow-up|3|||
161864042|NCT00777296|584545568|FG000|Overall Study|Adverse Event|0|||
161864043|NCT00777296|584545569|FG001|Overall Study|Adverse Event|1|||
161864044|NCT00777296|584545570|FG002|Overall Study|Adverse Event|0|||
161864045|NCT00777296|584545571|FG003|Overall Study|Adverse Event|1|||
161864046|NCT00777296|584545568|FG000|Overall Study|Withdrawal by Subject|1|||
161864047|NCT00777296|584545569|FG001|Overall Study|Withdrawal by Subject|0|||
161864048|NCT00777296|584545570|FG002|Overall Study|Withdrawal by Subject|0|||
161864049|NCT00777296|584545571|FG003|Overall Study|Withdrawal by Subject|0|||
161864050|NCT00777296|584545568|FG000|Overall Study|CRF form not completed|0|||
161864051|NCT00777296|584545569|FG001|Overall Study|CRF form not completed|0|||
161864052|NCT00777296|584545570|FG002|Overall Study|CRF form not completed|2|||
161864053|NCT00777296|584545571|FG003|Overall Study|CRF form not completed|0|||
161864054|NCT02211209|584545572|FG000|Overall Study|Investigator judgment|0|||
161864055|NCT02211209|584545573|FG001|Overall Study|Investigator judgment|1|||
161864056|NCT02211209|584545572|FG000|Overall Study|Voluntary withdrawal|1|||
161864057|NCT02211209|584545573|FG001|Overall Study|Voluntary withdrawal|4|||
161864058|NCT02211209|584545572|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
161864059|NCT02211209|584545573|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
161864060|NCT02211209|584545572|FG000|Overall Study|Reason Not Specified|1|||
161864061|NCT02211209|584545573|FG001|Overall Study|Reason Not Specified|0|||
161864062|NCT00658723|584545577|FG000|Overall Study|Lost to Follow-up|0|||
161864063|NCT00658723|584545578|FG001|Overall Study|Lost to Follow-up|2|||
161864064|NCT00658723|584545579|FG002|Overall Study|Lost to Follow-up|2|||
161864065|NCT00658723|584545577|FG000|Overall Study|Death|2|||
161864066|NCT00658723|584545578|FG001|Overall Study|Death|1|||
161864067|NCT00658723|584545579|FG002|Overall Study|Death|4|||
161864068|NCT00658723|584545577|FG000|Overall Study|Scheduling Issue|1|||
161864069|NCT00658723|584545578|FG001|Overall Study|Scheduling Issue|1|||
161864070|NCT00658723|584545579|FG002|Overall Study|Scheduling Issue|0|||
161864071|NCT00658723|584545577|FG000|Overall Study|Withdrawal by Subject|1|||
161864072|NCT00658723|584545578|FG001|Overall Study|Withdrawal by Subject|0|||
161864073|NCT00658723|584545579|FG002|Overall Study|Withdrawal by Subject|1|||
161864074|NCT03876743|584545580|FG000|Overall Study|Lost to Follow-up|6|||
161980024|NCT03684694|584974251|FG003|Phase 2|Lost to Follow-up|1|||
161980025|NCT03684694|584974252|FG004|Phase 2|Lost to Follow-up|0|||
161980026|NCT03684694|584974253|FG005|Phase 2|Lost to Follow-up|0|||
161980027|NCT03684694|584974248|FG000|Phase 2|Miscellaneous|0|||
161980028|NCT03684694|584974249|FG001|Phase 2|Miscellaneous|0|||
161864075|NCT03876743|584545581|FG001|Overall Study|Lost to Follow-up|4|||
161864076|NCT03876743|584545582|FG002|Overall Study|Lost to Follow-up|4|||
161980029|NCT03684694|584974250|FG002|Phase 2|Miscellaneous|0|||
161980030|NCT03684694|584974251|FG003|Phase 2|Miscellaneous|3|||
161980031|NCT03684694|584974252|FG004|Phase 2|Miscellaneous|0|||
161864077|NCT03876743|584545583|FG003|Overall Study|Lost to Follow-up|7|||
161864078|NCT03889418|584545584|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
161864079|NCT03889418|584545585|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161980032|NCT03684694|584974253|FG005|Phase 2|Miscellaneous|0|||
162034890|NCT00096954|585184791|FG001|Overall Study|Lost to Follow-up|5|||
162034891|NCT01483690|585184792|FG000|Overall Study|Adverse Event|1|||
161980033|NCT02100475|584976566|FG000|Overall Study|Unclassified|1|||
161980034|NCT02100475|584976567|FG001|Overall Study|Unclassified|2|||
161980035|NCT02100475|584976566|FG000|Overall Study|Withdrawal criteria|1|||
161980036|NCT02100475|584976567|FG001|Overall Study|Withdrawal criteria|0|||
161980037|NCT03268941|584976568|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161980038|NCT03268941|584976569|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161980039|NCT03268941|584976570|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161980040|NCT03268941|584976571|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
161980041|NCT03268941|584976572|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161980042|NCT03268941|584976573|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161980043|NCT03268941|584976574|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161980044|NCT03268941|584976568|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
161980045|NCT03268941|584976569|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
161980046|NCT03268941|584976570|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
161980047|NCT03268941|584976571|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
161980048|NCT03268941|584976572|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
161980049|NCT03268941|584976573|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
161980050|NCT03268941|584976574|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
161980051|NCT03268941|584976568|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
161980052|NCT03268941|584976569|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
161980053|NCT03268941|584976570|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
161980054|NCT03268941|584976571|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
161980055|NCT03268941|584976572|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
161980056|NCT03268941|584976573|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
161980057|NCT03268941|584976574|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
161980058|NCT03268941|584976568|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
161980059|NCT03268941|584976569|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
161980060|NCT03268941|584976570|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
161980061|NCT03268941|584976571|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
161980062|NCT03268941|584976572|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
161980063|NCT03268941|584976573|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
161980064|NCT03268941|584976574|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
161980065|NCT03268941|584976568|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161980066|NCT03268941|584976569|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161980067|NCT03268941|584976570|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161980068|NCT03268941|584976571|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161980069|NCT03268941|584976572|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161980070|NCT03268941|584976573|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161980071|NCT03268941|584976574|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
161980072|NCT02720692|584976579|FG000|Overall Study|Withdrawal by Subject|3|||
161980073|NCT02720692|584976580|FG001|Overall Study|Withdrawal by Subject|0|||
161980074|NCT02720692|584976579|FG000|Overall Study|Physician Decision|1|||
161980075|NCT02720692|584976580|FG001|Overall Study|Physician Decision|0|||
161980076|NCT02720692|584976579|FG000|Overall Study|Lost to Follow-up|8|||
161980077|NCT02720692|584976580|FG001|Overall Study|Lost to Follow-up|3|||
161980078|NCT02720692|584976579|FG000|Overall Study|Subject unable to return for visit|1|||
161980079|NCT02720692|584976580|FG001|Overall Study|Subject unable to return for visit|0|||
161980080|NCT03878758|584976581|FG000|Overall Study|Withdrawal by Subject|1|||
161980081|NCT03878758|584976581|FG000|Overall Study|Protocol defined|2|||
161980082|NCT03878758|584976581|FG000|Overall Study|Improper consent documentation|1|||
161980083|NCT01769196|584976582|FG000|Overall Study|Adverse Event|24|||
161980084|NCT01769196|584976583|FG001|Overall Study|Adverse Event|20|||
161980085|NCT01769196|584976582|FG000|Overall Study|Death|21|||
161980086|NCT01769196|584976583|FG001|Overall Study|Death|26|||
161980087|NCT01769196|584976582|FG000|Overall Study|Investigator Discretion|7|||
161980088|NCT01769196|584976583|FG001|Overall Study|Investigator Discretion|3|||
161980089|NCT01769196|584976582|FG000|Overall Study|Lack of Efficacy|3|||
161980090|NCT01769196|584976583|FG001|Overall Study|Lack of Efficacy|2|||
161980091|NCT01769196|584976582|FG000|Overall Study|Progressive disease|11|||
161980092|NCT01769196|584976583|FG001|Overall Study|Progressive disease|6|||
161980093|NCT01769196|584976582|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
161980094|NCT01769196|584976583|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
161980095|NCT01769196|584976582|FG000|Overall Study|Protocol Violation|0|||
161980096|NCT01769196|584976583|FG001|Overall Study|Protocol Violation|3|||
161980097|NCT01769196|584976582|FG000|Overall Study|Study terminated by sponsor|160|||
161980098|NCT01769196|584976583|FG001|Overall Study|Study terminated by sponsor|161|||
161980099|NCT01769196|584976582|FG000|Overall Study|Participant never dosed with study drug|1|||
161980100|NCT01769196|584976583|FG001|Overall Study|Participant never dosed with study drug|0|||
161980101|NCT01769196|584976582|FG000|Overall Study|Withdrew consent|36|||
161980102|NCT01769196|584976583|FG001|Overall Study|Withdrew consent|40|||
161980103|NCT00765063|584976584|FG000|Overall Study|Lack of Efficacy|5|||
161980104|NCT00765063|584976584|FG000|Overall Study|Withdrawal by Subject|1|||
161980105|NCT00765063|584976584|FG000|Overall Study|Other|16|||
161980106|NCT00765063|584976584|FG000|Overall Study|Protocol Violation|6|||
161980107|NCT00765063|584976584|FG000|Overall Study|Adverse Event|4|||
161864080|NCT03889418|584545586|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864081|NCT03889418|584545587|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864082|NCT03889418|584545588|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161980108|NCT03614325|584976585|FG000|Overall Study|Withdrawal by Subject|0|||
161980109|NCT03614325|584976586|FG001|Overall Study|Withdrawal by Subject|2|||
161980110|NCT03614325|584976585|FG000|Overall Study|Surgery Cancelled|2|||
161980111|NCT03614325|584976586|FG001|Overall Study|Surgery Cancelled|1|||
161980112|NCT03614325|584976585|FG000|Overall Study|Lost to Follow-up|2|||
161980113|NCT03614325|584976586|FG001|Overall Study|Lost to Follow-up|1|||
161980114|NCT03614325|584976585|FG000|Overall Study|Surgery never scheduled|1|||
161980115|NCT03614325|584976586|FG001|Overall Study|Surgery never scheduled|0|||
161980116|NCT01673620|584976592|FG000|Overall Study|Adverse Event|1|||
161980117|NCT01673620|584976593|FG001|Overall Study|Adverse Event|0|||
161980118|NCT00652951|584976594|FG000|Booster Phase|Adverse event, non-fatal|0|||
161980119|NCT00652951|584976595|FG001|Booster Phase|Adverse event, non-fatal|1|||
161980120|NCT00652951|584976596|FG002|Booster Phase|Adverse event, non-fatal|0|||
161980121|NCT00652951|584976594|FG000|Booster Phase|Other|1|||
161980122|NCT00652951|584976595|FG001|Booster Phase|Other|0|||
161980123|NCT00652951|584976596|FG002|Booster Phase|Other|0|||
161980124|NCT01022424|584976597|FG000|Overall Study|Adverse Event|1|||
161980125|NCT01022424|584976597|FG000|Overall Study|Physician Decision|1|||
161980126|NCT01022424|584976597|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
161980127|NCT01206582|584976598|FG000|Overall Study|Withdrew prior to study|1|||
161980128|NCT01206582|584976599|FG001|Overall Study|Withdrew prior to study|0|||
161980129|NCT01206582|584976598|FG000|Overall Study|Discontinued intervention before week 8|1|||
161980130|NCT01206582|584976599|FG001|Overall Study|Discontinued intervention before week 8|2|||
161980131|NCT00528801|584976600|FG000|Overall Study|Withdrawal by Subject|1|||
161980132|NCT00528801|584976601|FG001|Overall Study|Withdrawal by Subject|1|||
161980133|NCT00528801|584976600|FG000|Overall Study|Protocol Violation|11|||
161980134|NCT00528801|584976601|FG001|Overall Study|Protocol Violation|5|||
161980135|NCT00528801|584976600|FG000|Overall Study|Lost to Follow-up|15|||
161980136|NCT00528801|584976601|FG001|Overall Study|Lost to Follow-up|4|||
161980137|NCT00528801|584976600|FG000|Overall Study|Administrative Reasons|0|||
161980138|NCT00528801|584976601|FG001|Overall Study|Administrative Reasons|1|||
161980139|NCT02207491|584976602|FG000|Overall Study|Adverse Event|20|||
161980140|NCT02207491|584976603|FG001|Overall Study|Adverse Event|4|||
161980141|NCT02207491|584976602|FG000|Overall Study|Withdrawal by Subject|3|||
161980142|NCT02207491|584976603|FG001|Overall Study|Withdrawal by Subject|2|||
161980143|NCT02207491|584976602|FG000|Overall Study|Non-compliant|0|||
161980144|NCT02207491|584976603|FG001|Overall Study|Non-compliant|1|||
161980145|NCT02207491|584976602|FG000|Overall Study|Lost to Follow-up|0|||
161980146|NCT02207491|584976603|FG001|Overall Study|Lost to Follow-up|1|||
161980147|NCT02207491|584976602|FG000|Overall Study|Lack of Efficacy|3|||
161980148|NCT02207491|584976603|FG001|Overall Study|Lack of Efficacy|0|||
161980149|NCT02207491|584976602|FG000|Overall Study|Physician Decision|2|||
161980150|NCT02207491|584976603|FG001|Overall Study|Physician Decision|0|||
161864083|NCT03889418|584545589|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864084|NCT03889418|584545590|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864085|NCT03889418|584545591|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864086|NCT03889418|584545592|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864087|NCT03889418|584545593|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161864088|NCT03889418|584545584|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864089|NCT03889418|584545585|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
161864090|NCT03889418|584545586|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
161864091|NCT03889418|584545587|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864092|NCT03889418|584545588|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864093|NCT03889418|584545589|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864094|NCT03889418|584545590|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864095|NCT03889418|584545591|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864096|NCT03889418|584545592|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864097|NCT03889418|584545593|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161864098|NCT03889418|584545584|FG000|October-December 2019 (Month 7-9)|Death|0|||
161864099|NCT03889418|584545585|FG001|October-December 2019 (Month 7-9)|Death|0|||
161864100|NCT03889418|584545586|FG002|October-December 2019 (Month 7-9)|Death|0|||
161864101|NCT03889418|584545587|FG003|October-December 2019 (Month 7-9)|Death|0|||
161980151|NCT02207491|584976602|FG000|Overall Study|Protocol Violation|3|||
161980152|NCT02207491|584976603|FG001|Overall Study|Protocol Violation|5|||
161980153|NCT00477152|584976606|FG000|Overall Study|Parent withdrew consent|2|||
161980154|NCT00477152|584976606|FG000|Overall Study|Adverse Event|1|||
161980155|NCT00372697|584976607|FG000|Overall Study|Protocol Violation|1|||
161980156|NCT00372697|584976608|FG001|Overall Study|Protocol Violation|1|||
161980157|NCT03221842|584976609|FG000|Period 1 (Open-label)|Adverse Event|4|||
161980158|NCT03221842|584976610|FG001|Period 1 (Open-label)|Adverse Event|0|||
161980159|NCT03221842|584976609|FG000|Period 1 (Open-label)|Physician Decision|2|||
161980160|NCT03221842|584976610|FG001|Period 1 (Open-label)|Physician Decision|0|||
161864102|NCT03889418|584545588|FG004|October-December 2019 (Month 7-9)|Death|0|||
161864103|NCT03889418|584545589|FG005|October-December 2019 (Month 7-9)|Death|0|||
161864104|NCT03889418|584545590|FG006|October-December 2019 (Month 7-9)|Death|0|||
161864105|NCT03889418|584545591|FG007|October-December 2019 (Month 7-9)|Death|0|||
161864106|NCT03889418|584545592|FG008|October-December 2019 (Month 7-9)|Death|1|||
161864107|NCT03889418|584545593|FG009|October-December 2019 (Month 7-9)|Death|0|||
161864108|NCT03889418|584545584|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864109|NCT03889418|584545585|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864110|NCT03889418|584545586|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864111|NCT03889418|584545587|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
161864112|NCT03889418|584545588|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864113|NCT03889418|584545589|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864114|NCT03889418|584545590|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864115|NCT03889418|584545591|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
161864116|NCT03889418|584545592|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864117|NCT03889418|584545593|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161864118|NCT03889418|584545584|FG000|April - June 2020 (Month 13-15)|Death|0|||
161864119|NCT03889418|584545585|FG001|April - June 2020 (Month 13-15)|Death|1|||
161864120|NCT03889418|584545586|FG002|April - June 2020 (Month 13-15)|Death|0|||
161864121|NCT03889418|584545587|FG003|April - June 2020 (Month 13-15)|Death|0|||
161864122|NCT03889418|584545588|FG004|April - June 2020 (Month 13-15)|Death|0|||
161864123|NCT03889418|584545589|FG005|April - June 2020 (Month 13-15)|Death|0|||
161864124|NCT03889418|584545590|FG006|April - June 2020 (Month 13-15)|Death|0|||
161864125|NCT03889418|584545591|FG007|April - June 2020 (Month 13-15)|Death|0|||
161864126|NCT03889418|584545592|FG008|April - June 2020 (Month 13-15)|Death|0|||
161864127|NCT03889418|584545593|FG009|April - June 2020 (Month 13-15)|Death|0|||
161864128|NCT03889418|584545584|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864129|NCT03889418|584545585|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864130|NCT03889418|584545586|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864131|NCT03889418|584545587|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
161864132|NCT03889418|584545588|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864133|NCT03889418|584545589|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864134|NCT03889418|584545590|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864135|NCT03889418|584545591|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864136|NCT03889418|584545592|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864137|NCT03889418|584545593|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161864138|NCT03889418|584545584|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
161864139|NCT03889418|584545585|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
161864140|NCT03889418|584545586|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
161864141|NCT03889418|584545587|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
161864142|NCT03889418|584545588|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
161864143|NCT03889418|584545589|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
161864144|NCT03889418|584545590|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
161864145|NCT03889418|584545591|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
161864146|NCT03889418|584545592|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
161864147|NCT03889418|584545593|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
161864148|NCT03889418|584545584|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161864149|NCT03889418|584545585|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
161864150|NCT03889418|584545586|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
161864151|NCT03889418|584545587|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
161864152|NCT03889418|584545588|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161864153|NCT03889418|584545589|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161980161|NCT03221842|584976609|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
161980162|NCT03221842|584976610|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
161980163|NCT03221842|584976609|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
161980164|NCT03221842|584976610|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
161980165|NCT03221842|584976609|FG000|Period 1 (Open-label)|Other|2|||
161980166|NCT03221842|584976610|FG001|Period 1 (Open-label)|Other|0|||
161980167|NCT03221842|584976609|FG000|Period 2 (Randomized, Blinded)|Death|0|||
161980168|NCT03221842|584976610|FG001|Period 2 (Randomized, Blinded)|Death|1|||
161980169|NCT03221842|584976609|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
161980170|NCT03221842|584976610|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
162034892|NCT01483690|585184793|FG001|Overall Study|Adverse Event|2|||
161864154|NCT03889418|584545590|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161864155|NCT03889418|584545591|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
161864156|NCT03889418|584545592|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161864157|NCT03889418|584545593|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
161864158|NCT00092118|584545595|FG000|Overall Study|Adverse Event|35|||
161864159|NCT00092118|584545596|FG001|Overall Study|Adverse Event|32|||
161980171|NCT02504580|584976611|FG000|Overall Study|Other|1|||
161864160|NCT00092118|584545595|FG000|Overall Study|Lack of Efficacy|12|||
161980172|NCT02504580|584976612|FG001|Overall Study|Other|0|||
161980173|NCT02504580|584976613|FG002|Overall Study|Other|0|||
161980174|NCT02504580|584976614|FG003|Overall Study|Other|2|||
161980175|NCT02504580|584976615|FG004|Overall Study|Other|1|||
161980176|NCT02504580|584976616|FG005|Overall Study|Other|1|||
161980177|NCT02504580|584976617|FG006|Overall Study|Other|1|||
161980178|NCT02504580|584976618|FG007|Overall Study|Other|2|||
161773693|NCT03985982|584214302|FG000|Open-Label Phase|Physician Decision|0|||
161773694|NCT03985982|584214303|FG001|Open-Label Phase|Physician Decision|0|||
161773695|NCT03985982|584214304|FG002|Open-Label Phase|Physician Decision|2|||
161773696|NCT03985982|584214302|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161773697|NCT03985982|584214303|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161773698|NCT03985982|584214304|FG002|Open-Label Phase|Withdrawal by Subject|11|||
161773699|NCT03526549|584214306|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
161773700|NCT03526549|584214307|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
161773701|NCT03526549|584214306|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
161773702|NCT03526549|584214307|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
161773703|NCT03526549|584214306|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
161773704|NCT03526549|584214307|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
161773705|NCT03526549|584214306|FG000|Open-label Phase|Adverse Event|4|||
161773706|NCT03526549|584214307|FG001|Open-label Phase|Adverse Event|0|||
161773707|NCT03526549|584214306|FG000|Open-label Phase|Withdrawal by Subject|54|||
161773708|NCT03526549|584214307|FG001|Open-label Phase|Withdrawal by Subject|0|||
161773709|NCT03526549|584214306|FG000|Open-label Phase|Lost to Follow-up|35|||
161773710|NCT03526549|584214307|FG001|Open-label Phase|Lost to Follow-up|0|||
161773711|NCT03526549|584214306|FG000|Open-label Phase|Other than Specified|5|||
161773712|NCT03526549|584214307|FG001|Open-label Phase|Other than Specified|0|||
161773713|NCT05981365|584214308|FG000|Period 1|Adverse Event|1|||
161773714|NCT05981365|584214309|FG001|Period 1|Adverse Event|0|||
161773715|NCT03927989|584214312|FG000|Overall Study|Withdrawal by Subject|0|||
161773716|NCT03927989|584214313|FG001|Overall Study|Withdrawal by Subject|1|||
161773717|NCT02593175|584214314|FG000|Overall Study|Adverse Event|5|||
161773718|NCT02593175|584214314|FG000|Overall Study|Disease progression|4|||
161773719|NCT00478933|584214318|FG000|Overall Study|Protocol Violation|22|||
161773720|NCT00478933|584214318|FG000|Overall Study|Informed consent not verified|3|||
161773721|NCT00478933|584214318|FG000|Overall Study|Inadequate data available|53|||
161773722|NCT00643006|584214320|FG000|Overall Study|Lost to Follow-up|5|||
161773723|NCT00643006|584214321|FG001|Overall Study|Lost to Follow-up|4|||
161773724|NCT02506101|584214322|FG000|Overall Study|Transportation issues|1|||
161773725|NCT02506101|584214323|FG001|Overall Study|Transportation issues|0|||
161773726|NCT02506101|584214322|FG000|Overall Study|No enrollment and staff unavailability|1|||
161773727|NCT02506101|584214323|FG001|Overall Study|No enrollment and staff unavailability|0|||
161773728|NCT01471197|584214324|FG000|Overall Study|Disease Progression|4|||
161773729|NCT01471197|584214325|FG001|Overall Study|Disease Progression|2|||
161773730|NCT01471197|584214324|FG000|Overall Study|Death|1|||
161773731|NCT01471197|584214325|FG001|Overall Study|Death|0|||
161773732|NCT01471197|584214324|FG000|Overall Study|Study Drug Toxicity|1|||
161773733|NCT01471197|584214325|FG001|Overall Study|Study Drug Toxicity|0|||
161773734|NCT01353586|584214329|FG000|Overall Study|Procedure terminated prior to ablation|3|||
161773735|NCT01353586|584214330|FG001|Overall Study|Procedure terminated prior to ablation|0|||
161773736|NCT01353586|584214329|FG000|Overall Study|Never had insertion of study catheter|4|||
161773737|NCT01353586|584214330|FG001|Overall Study|Never had insertion of study catheter|1|||
161773738|NCT01353586|584214329|FG000|Overall Study|Neurological exam not done|0|||
161773739|NCT01353586|584214330|FG001|Overall Study|Neurological exam not done|1|||
161773740|NCT03253809|584214331|FG000|Overall Study|Unable to obtain study related data|14|||
161773741|NCT03992456|584214332|FG000|Overall Study|Withdrawal by Subject|1|||
161773742|NCT03992456|584214333|FG001|Overall Study|Withdrawal by Subject|0|||
161773743|NCT03992456|584214332|FG000|Overall Study|Disease progression|4|||
161773744|NCT03992456|584214333|FG001|Overall Study|Disease progression|5|||
161773745|NCT03992456|584214332|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
161773746|NCT03992456|584214333|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
161773747|NCT03155269|584214334|FG000|Overall Study|Withdrawal by Subject|4|||
161773748|NCT03155269|584214335|FG001|Overall Study|Withdrawal by Subject|5|||
161773749|NCT03155269|584214334|FG000|Overall Study|Lost to Follow-up|1|||
161864161|NCT00092118|584545596|FG001|Overall Study|Lack of Efficacy|14|||
161864162|NCT00092118|584545595|FG000|Overall Study|Lost to Follow-up|4|||
161980179|NCT02504580|584976619|FG008|Overall Study|Other|0|||
161773750|NCT03155269|584214335|FG001|Overall Study|Lost to Follow-up|2|||
161773751|NCT00910000|584214338|FG000|Overall Study|Adverse Event|0|||
161773752|NCT00910000|584214339|FG001|Overall Study|Adverse Event|3|||
161864163|NCT00092118|584545596|FG001|Overall Study|Lost to Follow-up|3|||
161980180|NCT02504580|584976620|FG009|Overall Study|Other|0|||
161980181|NCT02504580|584976621|FG010|Overall Study|Other|0|||
161980182|NCT02504580|584976622|FG011|Overall Study|Other|2|||
161980183|NCT02504580|584976611|FG000|Overall Study|Subject refusal to continue|0|||
161980184|NCT02504580|584976612|FG001|Overall Study|Subject refusal to continue|1|||
161980185|NCT02504580|584976613|FG002|Overall Study|Subject refusal to continue|0|||
161980186|NCT02504580|584976614|FG003|Overall Study|Subject refusal to continue|0|||
161980187|NCT02504580|584976615|FG004|Overall Study|Subject refusal to continue|0|||
161980188|NCT02504580|584976616|FG005|Overall Study|Subject refusal to continue|0|||
161980189|NCT02504580|584976617|FG006|Overall Study|Subject refusal to continue|0|||
161980190|NCT02504580|584976618|FG007|Overall Study|Subject refusal to continue|0|||
161980191|NCT02504580|584976619|FG008|Overall Study|Subject refusal to continue|0|||
161980192|NCT02504580|584976620|FG009|Overall Study|Subject refusal to continue|0|||
161980193|NCT02504580|584976621|FG010|Overall Study|Subject refusal to continue|0|||
161980194|NCT02504580|584976622|FG011|Overall Study|Subject refusal to continue|0|||
161980195|NCT01939366|584976623|FG000|Overall Study|Adverse Event|8|||
161980196|NCT01939366|584976624|FG001|Overall Study|Adverse Event|17|||
161980197|NCT01939366|584976625|FG002|Overall Study|Adverse Event|30|||
161980198|NCT01939366|584976626|FG003|Overall Study|Adverse Event|8|||
161980199|NCT01939366|584976627|FG004|Overall Study|Adverse Event|5|||
161980200|NCT01939366|584976623|FG000|Overall Study|Lack of Efficacy|2|||
161980201|NCT01939366|584976624|FG001|Overall Study|Lack of Efficacy|1|||
161980202|NCT01939366|584976625|FG002|Overall Study|Lack of Efficacy|1|||
161980203|NCT01939366|584976626|FG003|Overall Study|Lack of Efficacy|1|||
161980204|NCT01939366|584976627|FG004|Overall Study|Lack of Efficacy|3|||
161980205|NCT01939366|584976623|FG000|Overall Study|Lost to Follow-up|1|||
161980206|NCT01939366|584976624|FG001|Overall Study|Lost to Follow-up|1|||
161980207|NCT01939366|584976625|FG002|Overall Study|Lost to Follow-up|0|||
161980208|NCT01939366|584976626|FG003|Overall Study|Lost to Follow-up|0|||
161980209|NCT01939366|584976627|FG004|Overall Study|Lost to Follow-up|0|||
161980210|NCT01939366|584976623|FG000|Overall Study|Withdrawal by Subject|1|||
161980211|NCT01939366|584976624|FG001|Overall Study|Withdrawal by Subject|0|||
161980212|NCT01939366|584976625|FG002|Overall Study|Withdrawal by Subject|2|||
161980213|NCT01939366|584976626|FG003|Overall Study|Withdrawal by Subject|2|||
161980214|NCT01939366|584976627|FG004|Overall Study|Withdrawal by Subject|3|||
161980215|NCT01939366|584976623|FG000|Overall Study|Inclusion criteria not met|0|||
161980216|NCT01939366|584976624|FG001|Overall Study|Inclusion criteria not met|1|||
161980217|NCT01939366|584976625|FG002|Overall Study|Inclusion criteria not met|1|||
161980218|NCT01939366|584976626|FG003|Overall Study|Inclusion criteria not met|0|||
161980219|NCT01939366|584976627|FG004|Overall Study|Inclusion criteria not met|1|||
161980220|NCT01939366|584976623|FG000|Overall Study|Other|0|||
161980221|NCT01939366|584976624|FG001|Overall Study|Other|0|||
161980222|NCT01939366|584976625|FG002|Overall Study|Other|2|||
161980223|NCT01939366|584976626|FG003|Overall Study|Other|2|||
161980224|NCT01939366|584976627|FG004|Overall Study|Other|1|||
161980225|NCT01939366|584976623|FG000|Overall Study|Protocol Violation|0|||
161980226|NCT01939366|584976624|FG001|Overall Study|Protocol Violation|0|||
161980227|NCT01939366|584976625|FG002|Overall Study|Protocol Violation|0|||
161980228|NCT01939366|584976626|FG003|Overall Study|Protocol Violation|1|||
161980229|NCT01939366|584976627|FG004|Overall Study|Protocol Violation|0|||
161980230|NCT01939366|584976623|FG000|Overall Study|Sponsor decision|0|||
161980231|NCT01939366|584976624|FG001|Overall Study|Sponsor decision|0|||
161980232|NCT01939366|584976625|FG002|Overall Study|Sponsor decision|0|||
161980233|NCT01939366|584976626|FG003|Overall Study|Sponsor decision|0|||
161980234|NCT01939366|584976627|FG004|Overall Study|Sponsor decision|2|||
161980235|NCT01939366|584976623|FG000|Overall Study|GCP non-compliance at site|2|||
161980236|NCT01939366|584976624|FG001|Overall Study|GCP non-compliance at site|3|||
161980237|NCT01939366|584976625|FG002|Overall Study|GCP non-compliance at site|2|||
161980238|NCT01939366|584976626|FG003|Overall Study|GCP non-compliance at site|3|||
161980239|NCT01939366|584976627|FG004|Overall Study|GCP non-compliance at site|3|||
161980240|NCT00231413|584976630|FG000|Overall Study|Non-serious AE|0|||
161980241|NCT00231413|584976631|FG001|Overall Study|Non-serious AE|0|||
161980242|NCT00231413|584976632|FG002|Overall Study|Non-serious AE|1|||
161980243|NCT00231413|584976633|FG003|Overall Study|Non-serious AE|0|||
161980244|NCT00231413|584976634|FG004|Overall Study|Non-serious AE|0|||
161980245|NCT00231413|584976635|FG005|Overall Study|Non-serious AE|0|||
161980246|NCT00231413|584976636|FG006|Overall Study|Non-serious AE|1|||
161980247|NCT00231413|584976630|FG000|Overall Study|Withdrawal by Subject|3|||
161980248|NCT00231413|584976631|FG001|Overall Study|Withdrawal by Subject|1|||
161980249|NCT00231413|584976632|FG002|Overall Study|Withdrawal by Subject|4|||
161980250|NCT00231413|584976633|FG003|Overall Study|Withdrawal by Subject|2|||
161980251|NCT00231413|584976634|FG004|Overall Study|Withdrawal by Subject|2|||
161980252|NCT00231413|584976635|FG005|Overall Study|Withdrawal by Subject|0|||
161980253|NCT00231413|584976636|FG006|Overall Study|Withdrawal by Subject|3|||
161980254|NCT00231413|584976630|FG000|Overall Study|Migrated/moved from study area|0|||
161980255|NCT00231413|584976631|FG001|Overall Study|Migrated/moved from study area|0|||
161980256|NCT00231413|584976632|FG002|Overall Study|Migrated/moved from study area|1|||
161980257|NCT00231413|584976633|FG003|Overall Study|Migrated/moved from study area|0|||
161980258|NCT00231413|584976634|FG004|Overall Study|Migrated/moved from study area|0|||
161980259|NCT00231413|584976635|FG005|Overall Study|Migrated/moved from study area|1|||
161980260|NCT00231413|584976636|FG006|Overall Study|Migrated/moved from study area|0|||
161980261|NCT00231413|584976630|FG000|Overall Study|Lost to Follow-up|4|||
161980262|NCT00231413|584976631|FG001|Overall Study|Lost to Follow-up|4|||
161980263|NCT00231413|584976632|FG002|Overall Study|Lost to Follow-up|1|||
161980264|NCT00231413|584976633|FG003|Overall Study|Lost to Follow-up|1|||
161980265|NCT00231413|584976634|FG004|Overall Study|Lost to Follow-up|1|||
161980266|NCT00231413|584976635|FG005|Overall Study|Lost to Follow-up|4|||
161980267|NCT00231413|584976636|FG006|Overall Study|Lost to Follow-up|0|||
161980268|NCT00231413|584976630|FG000|Overall Study|Pregnancy|1|||
161980269|NCT00231413|584976631|FG001|Overall Study|Pregnancy|0|||
161980270|NCT00231413|584976632|FG002|Overall Study|Pregnancy|0|||
161980271|NCT00231413|584976633|FG003|Overall Study|Pregnancy|0|||
161980272|NCT00231413|584976634|FG004|Overall Study|Pregnancy|0|||
161980273|NCT00231413|584976635|FG005|Overall Study|Pregnancy|0|||
161980274|NCT00231413|584976636|FG006|Overall Study|Pregnancy|0|||
161980275|NCT02708485|584976637|FG000|Overall Study|Withdrawal by Subject|3|||
161773753|NCT00910000|584214340|FG002|Overall Study|Adverse Event|2|||
161773754|NCT00910000|584214341|FG003|Overall Study|Adverse Event|2|||
161773755|NCT00910000|584214342|FG004|Overall Study|Adverse Event|0|||
161773756|NCT00910000|584214343|FG005|Overall Study|Adverse Event|1|||
161773757|NCT00910000|584214338|FG000|Overall Study|Withdrawal by Subject|0|||
161773758|NCT00910000|584214339|FG001|Overall Study|Withdrawal by Subject|0|||
161773759|NCT00910000|584214340|FG002|Overall Study|Withdrawal by Subject|1|||
161773760|NCT00910000|584214341|FG003|Overall Study|Withdrawal by Subject|0|||
161773761|NCT00910000|584214342|FG004|Overall Study|Withdrawal by Subject|1|||
161773762|NCT00910000|584214343|FG005|Overall Study|Withdrawal by Subject|0|||
161773763|NCT04637815|584214344|FG000|Overall Study|Death|1|||
161773764|NCT04637815|584214345|FG001|Overall Study|Death|0|||
161773765|NCT04637815|584214344|FG000|Overall Study|Lost to Follow-up|5|||
161773766|NCT04637815|584214345|FG001|Overall Study|Lost to Follow-up|2|||
161773767|NCT00483119|584214348|FG000|Overall Study|Adverse Event|0|||
161773768|NCT00483119|584214349|FG001|Overall Study|Adverse Event|1|||
161773769|NCT00483119|584214348|FG000|Overall Study|Physician Decision|1|||
161773770|NCT00483119|584214349|FG001|Overall Study|Physician Decision|0|||
161773771|NCT02369874|584214350|FG000|Overall Study|Lost to Follow-up|2|||
161773772|NCT02369874|584214351|FG001|Overall Study|Lost to Follow-up|2|||
161773773|NCT02369874|584214352|FG002|Overall Study|Lost to Follow-up|2|||
161773774|NCT02369874|584214350|FG000|Overall Study|Withdrawal by Subject|7|||
161773775|NCT02369874|584214351|FG001|Overall Study|Withdrawal by Subject|9|||
161773776|NCT02369874|584214352|FG002|Overall Study|Withdrawal by Subject|27|||
161773777|NCT02369874|584214350|FG000|Overall Study|Miscellaneous|1|||
161773778|NCT02369874|584214351|FG001|Overall Study|Miscellaneous|1|||
161773779|NCT02369874|584214352|FG002|Overall Study|Miscellaneous|0|||
161773780|NCT02369874|584214350|FG000|Overall Study|On Treatment/Off Study|34|||
161773781|NCT02369874|584214351|FG001|Overall Study|On Treatment/Off Study|45|||
161773782|NCT02369874|584214352|FG002|Overall Study|On Treatment/Off Study|32|||
161773783|NCT02058849|584214353|FG000|Overall Study|Hospitalization|1|||
161773784|NCT02058849|584214354|FG001|Overall Study|Hospitalization|1|||
161773785|NCT02058849|584214353|FG000|Overall Study|Death|1|||
161773786|NCT02058849|584214354|FG001|Overall Study|Death|0|||
161773787|NCT02058849|584214353|FG000|Overall Study|Lost to Follow-up|1|||
161773788|NCT02058849|584214354|FG001|Overall Study|Lost to Follow-up|0|||
161773789|NCT02058849|584214353|FG000|Overall Study|Withdrawal by Subject|4|||
161773790|NCT02058849|584214354|FG001|Overall Study|Withdrawal by Subject|0|||
161773791|NCT02331680|584214355|FG000|Overall Study|Adverse Event|3|||
161773792|NCT02331680|584214356|FG001|Overall Study|Adverse Event|0|||
161773793|NCT02331680|584214357|FG002|Overall Study|Adverse Event|2|||
161773794|NCT02331680|584214355|FG000|Overall Study|Physician Decision|1|||
161773795|NCT02331680|584214356|FG001|Overall Study|Physician Decision|1|||
161773796|NCT02331680|584214357|FG002|Overall Study|Physician Decision|2|||
161773797|NCT02331680|584214355|FG000|Overall Study|Withdrawal by Subject|0|||
161773798|NCT02331680|584214356|FG001|Overall Study|Withdrawal by Subject|1|||
161773799|NCT02331680|584214357|FG002|Overall Study|Withdrawal by Subject|2|||
161773800|NCT02331680|584214355|FG000|Overall Study|Met withdrawal criteria|2|||
161773801|NCT02331680|584214356|FG001|Overall Study|Met withdrawal criteria|2|||
161773802|NCT02331680|584214357|FG002|Overall Study|Met withdrawal criteria|5|||
161773803|NCT02331680|584214355|FG000|Overall Study|Non-compliance with study drug|0|||
161864164|NCT00092118|584545595|FG000|Overall Study|Protocol Violation|23|||
161773804|NCT02331680|584214356|FG001|Overall Study|Non-compliance with study drug|0|||
161773805|NCT02331680|584214357|FG002|Overall Study|Non-compliance with study drug|1|||
161773806|NCT02331680|584214355|FG000|Overall Study|Protocol Violation|0|||
161773807|NCT02331680|584214356|FG001|Overall Study|Protocol Violation|0|||
161773808|NCT02331680|584214357|FG002|Overall Study|Protocol Violation|3|||
161773809|NCT02219477|584214358|FG000|Overall Study|Adverse Event|0|||
161773810|NCT02219477|584214359|FG001|Overall Study|Adverse Event|1|||
161773811|NCT02219477|584214360|FG002|Overall Study|Adverse Event|1|||
161773812|NCT02219477|584214358|FG000|Overall Study|Withdrawal by Subject|0|||
161773813|NCT02219477|584214359|FG001|Overall Study|Withdrawal by Subject|1|||
161980276|NCT02708485|584976638|FG001|Overall Study|Withdrawal by Subject|2|||
161980277|NCT01100528|584976642|FG000|Overall Study|Death|1|||
161980278|NCT01100528|584976642|FG000|Overall Study|Withdrawal by Subject|2|||
161980279|NCT02066415|584976643|FG000|Overall Study|Decision by Sponsor|5|||
161773814|NCT02219477|584214360|FG002|Overall Study|Withdrawal by Subject|0|||
161773815|NCT00596466|584214361|FG000|Overall Study|Lack of Efficacy|5|||
161773816|NCT00596466|584214361|FG000|Overall Study|Adverse Event|4|||
161773817|NCT00596466|584214361|FG000|Overall Study|Withdrawal by Subject|2|||
161773818|NCT00596466|584214361|FG000|Overall Study|Protocol Violation|2|||
161773819|NCT00596466|584214361|FG000|Overall Study|Unpecified|2|||
161773820|NCT00596466|584214361|FG000|Overall Study|Enrolled, not treated|2|||
161773821|NCT04505592|584214362|FG000|Overall Study|Death|2|||
161773822|NCT04505592|584214363|FG001|Overall Study|Death|1|||
161773823|NCT01891669|584214365|FG000|Overall Study|Death|0|||
161773824|NCT01891669|584214366|FG001|Overall Study|Death|0|||
161773825|NCT01891669|584214367|FG002|Overall Study|Death|0|||
161773826|NCT01891669|584214368|FG003|Overall Study|Death|0|||
161773827|NCT01891669|584214369|FG004|Overall Study|Death|0|||
161773828|NCT01891669|584214370|FG005|Overall Study|Death|0|||
161773829|NCT01891669|584214371|FG006|Overall Study|Death|0|||
161773830|NCT01891669|584214372|FG007|Overall Study|Death|1|||
161773831|NCT01891669|584214373|FG008|Overall Study|Death|0|||
161773832|NCT01891669|584214374|FG009|Overall Study|Death|1|||
161773833|NCT01891669|584214365|FG000|Overall Study|Withdrawal by Subject|1|||
161773834|NCT01891669|584214366|FG001|Overall Study|Withdrawal by Subject|1|||
161773835|NCT01891669|584214367|FG002|Overall Study|Withdrawal by Subject|0|||
161773836|NCT01891669|584214368|FG003|Overall Study|Withdrawal by Subject|0|||
161773837|NCT01891669|584214369|FG004|Overall Study|Withdrawal by Subject|0|||
161773838|NCT01891669|584214370|FG005|Overall Study|Withdrawal by Subject|0|||
161773839|NCT01891669|584214371|FG006|Overall Study|Withdrawal by Subject|1|||
161773840|NCT01891669|584214372|FG007|Overall Study|Withdrawal by Subject|2|||
161773841|NCT01891669|584214373|FG008|Overall Study|Withdrawal by Subject|1|||
161773842|NCT01891669|584214374|FG009|Overall Study|Withdrawal by Subject|1|||
161773843|NCT01891669|584214365|FG000|Overall Study|Other|1|||
161773844|NCT01891669|584214366|FG001|Overall Study|Other|0|||
161773845|NCT01891669|584214367|FG002|Overall Study|Other|0|||
161773846|NCT01891669|584214368|FG003|Overall Study|Other|0|||
161773847|NCT01891669|584214369|FG004|Overall Study|Other|0|||
161773848|NCT01891669|584214370|FG005|Overall Study|Other|0|||
161773849|NCT01891669|584214371|FG006|Overall Study|Other|0|||
161773850|NCT01891669|584214372|FG007|Overall Study|Other|1|||
161773851|NCT01891669|584214373|FG008|Overall Study|Other|0|||
161773852|NCT01891669|584214374|FG009|Overall Study|Other|0|||
161773853|NCT04298229|584214379|FG000|Overall Study|Physician Decision|1|||
161773854|NCT04298229|584214380|FG001|Overall Study|Physician Decision|1|||
161773855|NCT04298229|584214379|FG000|Overall Study|Withdrawal by Subject|1|||
161773856|NCT04298229|584214380|FG001|Overall Study|Withdrawal by Subject|1|||
161773857|NCT04298229|584214379|FG000|Overall Study|Did not receive IV loop diuretics|2|||
161773858|NCT04298229|584214380|FG001|Overall Study|Did not receive IV loop diuretics|0|||
161773859|NCT00859313|584214381|FG000|Overall Study|Lack of Efficacy|2|||
161773860|NCT00859313|584214381|FG000|Overall Study|Adverse Event|1|||
161773861|NCT00859313|584214381|FG000|Overall Study|staff error|1|||
161773862|NCT05261126|584214386|FG000|Overall Study|Death|0|||
161773863|NCT05261126|584214387|FG001|Overall Study|Death|0|||
161773864|NCT05261126|584214388|FG002|Overall Study|Death|1|||
161773865|NCT05261126|584214389|FG003|Overall Study|Death|0|||
161773866|NCT05261126|584214390|FG004|Overall Study|Death|0|||
161773867|NCT05261126|584214386|FG000|Overall Study|Lost to Follow-up|0|||
161773868|NCT05261126|584214387|FG001|Overall Study|Lost to Follow-up|0|||
161773869|NCT05261126|584214388|FG002|Overall Study|Lost to Follow-up|0|||
161773870|NCT05261126|584214389|FG003|Overall Study|Lost to Follow-up|0|||
161773871|NCT05261126|584214390|FG004|Overall Study|Lost to Follow-up|1|||
161773872|NCT05261126|584214386|FG000|Overall Study|Physician Decision|1|||
161773873|NCT05261126|584214387|FG001|Overall Study|Physician Decision|0|||
161773874|NCT05261126|584214388|FG002|Overall Study|Physician Decision|0|||
161773875|NCT05261126|584214389|FG003|Overall Study|Physician Decision|0|||
161773876|NCT05261126|584214390|FG004|Overall Study|Physician Decision|0|||
161773877|NCT05261126|584214386|FG000|Overall Study|Screen Failure|0|||
161773878|NCT05261126|584214387|FG001|Overall Study|Screen Failure|0|||
161773879|NCT05261126|584214388|FG002|Overall Study|Screen Failure|0|||
161773880|NCT05261126|584214389|FG003|Overall Study|Screen Failure|0|||
161773881|NCT05261126|584214390|FG004|Overall Study|Screen Failure|1|||
161773882|NCT05261126|584214386|FG000|Overall Study|Withdrawal by Subject|1|||
161773883|NCT05261126|584214387|FG001|Overall Study|Withdrawal by Subject|0|||
161773884|NCT05261126|584214388|FG002|Overall Study|Withdrawal by Subject|1|||
161773885|NCT05261126|584214389|FG003|Overall Study|Withdrawal by Subject|1|||
161773886|NCT05261126|584214390|FG004|Overall Study|Withdrawal by Subject|0|||
161773887|NCT05261126|584214386|FG000|Overall Study|Not Recorded|0|||
161773888|NCT05261126|584214387|FG001|Overall Study|Not Recorded|0|||
161773889|NCT05261126|584214388|FG002|Overall Study|Not Recorded|0|||
161773890|NCT05261126|584214389|FG003|Overall Study|Not Recorded|1|||
161773891|NCT05261126|584214390|FG004|Overall Study|Not Recorded|0|||
161773892|NCT05939388|584214391|FG000|Overall Study|Lost to Follow-up|1|||
161773893|NCT03901274|584214392|FG000|Overall Study|Lost to Follow-up|120|||
161773894|NCT03901274|584214393|FG001|Overall Study|Lost to Follow-up|124|||
161773895|NCT03901274|584214392|FG000|Overall Study|Withdrawal by Subject|0|||
161980280|NCT02066415|584976644|FG001|Overall Study|Decision by Sponsor|4|||
161980281|NCT02066415|584976645|FG002|Overall Study|Decision by Sponsor|2|||
161980282|NCT02066415|584976643|FG000|Overall Study|Withdrawal by Subject|9|||
161980283|NCT02066415|584976644|FG001|Overall Study|Withdrawal by Subject|1|||
161980284|NCT02066415|584976645|FG002|Overall Study|Withdrawal by Subject|4|||
161980285|NCT02066415|584976643|FG000|Overall Study|Lost to Follow-up|7|||
161980286|NCT02066415|584976644|FG001|Overall Study|Lost to Follow-up|2|||
161980287|NCT02066415|584976645|FG002|Overall Study|Lost to Follow-up|2|||
161980288|NCT03242252|584976647|FG000|Overall Study|At the Participant's own Request|18|||
161980289|NCT03242252|584976648|FG001|Overall Study|At the Participant's own Request|10|||
161980290|NCT03242252|584976649|FG002|Overall Study|At the Participant's own Request|15|||
161980291|NCT03242252|584976647|FG000|Overall Study|Adverse Event|8|||
161980292|NCT03242252|584976648|FG001|Overall Study|Adverse Event|6|||
161980293|NCT03242252|584976649|FG002|Overall Study|Adverse Event|9|||
161980294|NCT03242252|584976647|FG000|Overall Study|Poor Compliance to Protocol|0|||
161980295|NCT03242252|584976648|FG001|Overall Study|Poor Compliance to Protocol|2|||
161980296|NCT03242252|584976649|FG002|Overall Study|Poor Compliance to Protocol|3|||
161980297|NCT03242252|584976647|FG000|Overall Study|Study Terminated by Sponsor|1|||
161980298|NCT03242252|584976648|FG001|Overall Study|Study Terminated by Sponsor|0|||
161980299|NCT03242252|584976649|FG002|Overall Study|Study Terminated by Sponsor|0|||
161980300|NCT03242252|584976647|FG000|Overall Study|Reason not Specified|4|||
161980301|NCT03242252|584976648|FG001|Overall Study|Reason not Specified|4|||
161980302|NCT03242252|584976649|FG002|Overall Study|Reason not Specified|1|||
161980303|NCT03242252|584976647|FG000|Overall Study|Lost to Follow-up|5|||
161980304|NCT03242252|584976648|FG001|Overall Study|Lost to Follow-up|1|||
161980305|NCT03242252|584976649|FG002|Overall Study|Lost to Follow-up|4|||
161980306|NCT01659255|584976650|FG000|Overall Study|Adverse Event|0|||
161980307|NCT01659255|584976651|FG001|Overall Study|Adverse Event|0|||
161980308|NCT01659255|584976652|FG002|Overall Study|Adverse Event|0|||
161980309|NCT01659255|584976653|FG003|Overall Study|Adverse Event|0|||
161980310|NCT01659255|584976654|FG004|Overall Study|Adverse Event|0|||
162034893|NCT01483690|585184792|FG000|Overall Study|clinical deterioration|1|||
162034894|NCT01483690|585184793|FG001|Overall Study|clinical deterioration|0|||
162034895|NCT01483690|585184792|FG000|Overall Study|Physician Decision|0|||
162034896|NCT01483690|585184793|FG001|Overall Study|Physician Decision|2|||
162034897|NCT01483690|585184792|FG000|Overall Study|exclusionary procedure|0|||
162034898|NCT01483690|585184793|FG001|Overall Study|exclusionary procedure|1|||
161773896|NCT03901274|584214393|FG001|Overall Study|Withdrawal by Subject|6|||
161773897|NCT05570604|584214394|FG000|Overall Study|Lost to Follow-up|1|||
161773898|NCT05570604|584214395|FG001|Overall Study|Lost to Follow-up|5|||
161773899|NCT05570604|584214394|FG000|Overall Study|Illness|2|||
161773900|NCT05570604|584214395|FG001|Overall Study|Illness|2|||
161773901|NCT04527380|584214402|FG000|Overall Study|Lack of Efficacy|0|||
161773902|NCT04527380|584214403|FG001|Overall Study|Lack of Efficacy|1|||
161773903|NCT04527380|584214402|FG000|Overall Study|Withdrawal by Subject|1|||
161773904|NCT04527380|584214403|FG001|Overall Study|Withdrawal by Subject|0|||
161773905|NCT04479358|584214404|FG000|Overall Study|Withdrawal by Subject|0|||
161773906|NCT04479358|584214405|FG001|Overall Study|Withdrawal by Subject|0|||
161773907|NCT04479358|584214406|FG002|Overall Study|Withdrawal by Subject|1|||
161773908|NCT04479358|584214407|FG003|Overall Study|Withdrawal by Subject|0|||
161773909|NCT04479358|584214408|FG004|Overall Study|Withdrawal by Subject|0|||
161773910|NCT04479358|584214409|FG005|Overall Study|Withdrawal by Subject|1|||
161773911|NCT05116241|584214424|FG000|Study|Withdrawal by Subject|5|||
161773912|NCT05116241|584214425|FG001|Study|Withdrawal by Subject|2|||
161773913|NCT05116241|584214426|FG002|Study|Withdrawal by Subject|1|||
161773914|NCT05116241|584214424|FG000|Study|Lost to Follow-up|0|||
161773915|NCT05116241|584214425|FG001|Study|Lost to Follow-up|2|||
161773916|NCT05116241|584214426|FG002|Study|Lost to Follow-up|2|||
161773917|NCT04410991|584214431|FG000|Overall Study|Poor compliance to protocol|5|||
161773918|NCT04410991|584214432|FG001|Overall Study|Poor compliance to protocol|4|||
161773919|NCT04410991|584214431|FG000|Overall Study|Withdrawal by Subject|59|||
161773920|NCT04410991|584214432|FG001|Overall Study|Withdrawal by Subject|55|||
161773921|NCT04410991|584214431|FG000|Overall Study|Other|10|||
161773922|NCT04410991|584214432|FG001|Overall Study|Other|4|||
161773923|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
161773924|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
161773925|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
161773926|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773927|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773928|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773929|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161773930|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161773931|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161773932|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
161773933|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161864165|NCT00092118|584545596|FG001|Overall Study|Protocol Violation|25|||
161980311|NCT01659255|584976655|FG005|Overall Study|Adverse Event|1|||
161980312|NCT01659255|584976656|FG006|Overall Study|Adverse Event|1|||
161980313|NCT01659255|584976657|FG007|Overall Study|Adverse Event|0|||
161980314|NCT01659255|584976658|FG008|Overall Study|Adverse Event|0|||
161980315|NCT01659255|584976659|FG009|Overall Study|Adverse Event|1|||
161980316|NCT01659255|584976660|FG010|Overall Study|Adverse Event|0|||
161980317|NCT01659255|584976661|FG011|Overall Study|Adverse Event|1|||
161980318|NCT01659255|584976662|FG012|Overall Study|Adverse Event|0|||
161980319|NCT01659255|584976663|FG013|Overall Study|Adverse Event|2|||
161980320|NCT01659255|584976664|FG014|Overall Study|Adverse Event|0|||
161980321|NCT01659255|584976665|FG015|Overall Study|Adverse Event|1|||
161980322|NCT01659255|584976666|FG016|Overall Study|Adverse Event|0|||
161980323|NCT01659255|584976650|FG000|Overall Study|Death|0|||
161980324|NCT01659255|584976651|FG001|Overall Study|Death|1|||
161980325|NCT01659255|584976652|FG002|Overall Study|Death|0|||
161980326|NCT01659255|584976653|FG003|Overall Study|Death|0|||
161980327|NCT01659255|584976654|FG004|Overall Study|Death|0|||
161980328|NCT01659255|584976655|FG005|Overall Study|Death|0|||
161980329|NCT01659255|584976656|FG006|Overall Study|Death|0|||
161980330|NCT01659255|584976657|FG007|Overall Study|Death|1|||
161980331|NCT01659255|584976658|FG008|Overall Study|Death|1|||
161980332|NCT01659255|584976659|FG009|Overall Study|Death|0|||
161980333|NCT01659255|584976660|FG010|Overall Study|Death|0|||
161980334|NCT01659255|584976661|FG011|Overall Study|Death|0|||
161980335|NCT01659255|584976662|FG012|Overall Study|Death|1|||
161980336|NCT01659255|584976663|FG013|Overall Study|Death|1|||
161980337|NCT01659255|584976664|FG014|Overall Study|Death|2|||
161980338|NCT01659255|584976665|FG015|Overall Study|Death|1|||
161980339|NCT01659255|584976666|FG016|Overall Study|Death|0|||
161980340|NCT01659255|584976650|FG000|Overall Study|Progressive Disease|2|||
161980341|NCT01659255|584976651|FG001|Overall Study|Progressive Disease|0|||
161980342|NCT01659255|584976652|FG002|Overall Study|Progressive Disease|0|||
161980343|NCT01659255|584976653|FG003|Overall Study|Progressive Disease|0|||
161980344|NCT01659255|584976654|FG004|Overall Study|Progressive Disease|0|||
161980345|NCT01659255|584976655|FG005|Overall Study|Progressive Disease|0|||
161980346|NCT01659255|584976656|FG006|Overall Study|Progressive Disease|0|||
161980347|NCT01659255|584976657|FG007|Overall Study|Progressive Disease|1|||
161980348|NCT01659255|584976658|FG008|Overall Study|Progressive Disease|0|||
161980349|NCT01659255|584976659|FG009|Overall Study|Progressive Disease|2|||
161980350|NCT01659255|584976660|FG010|Overall Study|Progressive Disease|2|||
161980351|NCT01659255|584976661|FG011|Overall Study|Progressive Disease|3|||
161980352|NCT01659255|584976662|FG012|Overall Study|Progressive Disease|5|||
161980353|NCT01659255|584976663|FG013|Overall Study|Progressive Disease|13|||
161980354|NCT01659255|584976664|FG014|Overall Study|Progressive Disease|6|||
161980355|NCT01659255|584976665|FG015|Overall Study|Progressive Disease|2|||
161980356|NCT01659255|584976666|FG016|Overall Study|Progressive Disease|3|||
161980357|NCT01659255|584976650|FG000|Overall Study|Withdrew Consent|0|||
161980358|NCT01659255|584976651|FG001|Overall Study|Withdrew Consent|0|||
161980359|NCT01659255|584976652|FG002|Overall Study|Withdrew Consent|0|||
161980360|NCT01659255|584976653|FG003|Overall Study|Withdrew Consent|0|||
161980361|NCT01659255|584976654|FG004|Overall Study|Withdrew Consent|0|||
161980362|NCT01659255|584976655|FG005|Overall Study|Withdrew Consent|0|||
161980363|NCT01659255|584976656|FG006|Overall Study|Withdrew Consent|0|||
161980364|NCT01659255|584976657|FG007|Overall Study|Withdrew Consent|0|||
161980365|NCT01659255|584976658|FG008|Overall Study|Withdrew Consent|0|||
161980366|NCT01659255|584976659|FG009|Overall Study|Withdrew Consent|0|||
161980367|NCT01659255|584976660|FG010|Overall Study|Withdrew Consent|1|||
161980368|NCT01659255|584976661|FG011|Overall Study|Withdrew Consent|0|||
161980369|NCT01659255|584976662|FG012|Overall Study|Withdrew Consent|0|||
161980370|NCT01659255|584976663|FG013|Overall Study|Withdrew Consent|1|||
162034899|NCT02239224|585184794|FG000|Overall Study|Administrative|0|||
162034900|NCT02239224|585184795|FG001|Overall Study|Administrative|0|||
162034901|NCT02239224|585184796|FG002|Overall Study|Administrative|3|||
162034902|NCT02239224|585184797|FG003|Overall Study|Administrative|1|||
162034903|NCT03183778|585184799|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
161980371|NCT01659255|584976664|FG014|Overall Study|Withdrew Consent|0|||
161980372|NCT01659255|584976665|FG015|Overall Study|Withdrew Consent|0|||
161980373|NCT01659255|584976666|FG016|Overall Study|Withdrew Consent|0|||
161980374|NCT01659255|584976650|FG000|Overall Study|Investigator Decision|0|||
161980375|NCT01659255|584976651|FG001|Overall Study|Investigator Decision|0|||
161980376|NCT01659255|584976652|FG002|Overall Study|Investigator Decision|0|||
161980377|NCT01659255|584976653|FG003|Overall Study|Investigator Decision|0|||
161980378|NCT01659255|584976654|FG004|Overall Study|Investigator Decision|0|||
161980379|NCT01659255|584976655|FG005|Overall Study|Investigator Decision|0|||
161980380|NCT01659255|584976656|FG006|Overall Study|Investigator Decision|0|||
161980381|NCT01659255|584976657|FG007|Overall Study|Investigator Decision|0|||
161980382|NCT01659255|584976658|FG008|Overall Study|Investigator Decision|0|||
162034904|NCT03228420|585184807|FG000|Overall Study|Lost to Follow-up|5|||
161980383|NCT01659255|584976659|FG009|Overall Study|Investigator Decision|0|||
161980384|NCT01659255|584976660|FG010|Overall Study|Investigator Decision|0|||
161980385|NCT01659255|584976661|FG011|Overall Study|Investigator Decision|0|||
161980386|NCT01659255|584976662|FG012|Overall Study|Investigator Decision|1|||
161980387|NCT01659255|584976663|FG013|Overall Study|Investigator Decision|1|||
161980388|NCT01659255|584976664|FG014|Overall Study|Investigator Decision|0|||
161980389|NCT01659255|584976665|FG015|Overall Study|Investigator Decision|0|||
161980390|NCT01659255|584976666|FG016|Overall Study|Investigator Decision|0|||
161980391|NCT01659255|584976650|FG000|Overall Study|Sponsor's Decision|0|||
161980392|NCT01659255|584976651|FG001|Overall Study|Sponsor's Decision|0|||
161980393|NCT01659255|584976652|FG002|Overall Study|Sponsor's Decision|0|||
161980394|NCT01659255|584976653|FG003|Overall Study|Sponsor's Decision|0|||
161980395|NCT01659255|584976654|FG004|Overall Study|Sponsor's Decision|0|||
161980396|NCT01659255|584976655|FG005|Overall Study|Sponsor's Decision|0|||
161980397|NCT01659255|584976656|FG006|Overall Study|Sponsor's Decision|1|||
161980398|NCT01659255|584976657|FG007|Overall Study|Sponsor's Decision|0|||
161980399|NCT01659255|584976658|FG008|Overall Study|Sponsor's Decision|0|||
161980400|NCT01659255|584976659|FG009|Overall Study|Sponsor's Decision|0|||
161980401|NCT01659255|584976660|FG010|Overall Study|Sponsor's Decision|0|||
161980402|NCT01659255|584976661|FG011|Overall Study|Sponsor's Decision|0|||
161980403|NCT01659255|584976662|FG012|Overall Study|Sponsor's Decision|0|||
161980404|NCT01659255|584976663|FG013|Overall Study|Sponsor's Decision|0|||
161980405|NCT01659255|584976664|FG014|Overall Study|Sponsor's Decision|0|||
161980406|NCT01659255|584976665|FG015|Overall Study|Sponsor's Decision|0|||
161980407|NCT01659255|584976666|FG016|Overall Study|Sponsor's Decision|0|||
161980408|NCT01659255|584976650|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980409|NCT01659255|584976651|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980410|NCT01659255|584976652|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980411|NCT01659255|584976653|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980412|NCT01659255|584976654|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980413|NCT01659255|584976655|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980414|NCT01659255|584976656|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980415|NCT01659255|584976657|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980416|NCT01659255|584976658|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980417|NCT01659255|584976659|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980418|NCT01659255|584976660|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980419|NCT01659255|584976661|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980420|NCT01659255|584976662|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980421|NCT01659255|584976663|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980422|NCT01659255|584976664|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980423|NCT01659255|584976665|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
161980424|NCT01659255|584976666|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161980425|NCT01659255|584976650|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
161980426|NCT01659255|584976651|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
161980427|NCT01659255|584976652|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
161980428|NCT01659255|584976653|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
161980429|NCT01659255|584976654|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
161980430|NCT01659255|584976655|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
161980431|NCT01659255|584976656|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
161980432|NCT01659255|584976657|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
161980433|NCT01659255|584976658|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
161980434|NCT01659255|584976659|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
161980435|NCT01659255|584976660|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
161980436|NCT01659255|584976661|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
161980437|NCT01659255|584976662|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
161980438|NCT01659255|584976663|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
161980439|NCT01659255|584976664|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
161980440|NCT01659255|584976665|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
161980441|NCT01659255|584976666|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
161980442|NCT01116427|584976669|FG000|Core Phase|Adverse Event|0|||
161980443|NCT01116427|584976670|FG001|Core Phase|Adverse Event|1|||
161980444|NCT01116427|584976669|FG000|Core Phase|Lost to Follow-up|1|||
161980445|NCT01116427|584976670|FG001|Core Phase|Lost to Follow-up|0|||
161980446|NCT01116427|584976669|FG000|Core Phase|Withdrawal by Subject|3|||
161980447|NCT01116427|584976670|FG001|Core Phase|Withdrawal by Subject|0|||
161980448|NCT01116427|584976669|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
161980449|NCT01116427|584976670|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
161980450|NCT01116427|584976669|FG000|Extension Phase|Adverse Event|1|||
161980451|NCT01116427|584976670|FG001|Extension Phase|Adverse Event|1|||
161980452|NCT01116427|584976669|FG000|Extension Phase|Lost to Follow-up|2|||
161980453|NCT01116427|584976670|FG001|Extension Phase|Lost to Follow-up|0|||
161980454|NCT01116427|584976669|FG000|Extension Phase|Withdrawal by Subject|5|||
161980455|NCT01116427|584976670|FG001|Extension Phase|Withdrawal by Subject|1|||
161980456|NCT01116427|584976669|FG000|Extension Phase|Not using appropriate birth control|1|||
161980457|NCT01116427|584976670|FG001|Extension Phase|Not using appropriate birth control|0|||
161980458|NCT02211313|584976671|FG000|Overall Study|Treatment Failure|5|||
161980459|NCT02211313|584976672|FG001|Overall Study|Treatment Failure|2|||
161980460|NCT02211313|584976671|FG000|Overall Study|No Follow up Questionnaires|1|||
161980461|NCT02211313|584976672|FG001|Overall Study|No Follow up Questionnaires|1|||
161980462|NCT01423916|584976673|FG000|Overall Study|Adverse Event|5|||
161980463|NCT01423916|584976674|FG001|Overall Study|Adverse Event|9|||
161980464|NCT01423916|584976675|FG002|Overall Study|Adverse Event|2|||
161980465|NCT01423916|584976673|FG000|Overall Study|Met Withdrawal Criteria|1|||
161980466|NCT01423916|584976674|FG001|Overall Study|Met Withdrawal Criteria|1|||
161980467|NCT01423916|584976675|FG002|Overall Study|Met Withdrawal Criteria|1|||
161980468|NCT01423916|584976673|FG000|Overall Study|Physician Decision|1|||
161980469|NCT01423916|584976674|FG001|Overall Study|Physician Decision|0|||
161980470|NCT01423916|584976675|FG002|Overall Study|Physician Decision|1|||
161980471|NCT01423916|584976673|FG000|Overall Study|Withdrawal by Subject|3|||
161980472|NCT01423916|584976674|FG001|Overall Study|Withdrawal by Subject|10|||
161980473|NCT01423916|584976675|FG002|Overall Study|Withdrawal by Subject|3|||
161980474|NCT01423916|584976673|FG000|Overall Study|Protocol Deviation|1|||
161980475|NCT01423916|584976674|FG001|Overall Study|Protocol Deviation|0|||
161980476|NCT01423916|584976675|FG002|Overall Study|Protocol Deviation|0|||
161980477|NCT03316950|584976676|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
161980478|NCT03316950|584976677|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
161980479|NCT03316950|584976678|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
161980480|NCT03316950|584976679|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
161980481|NCT03316950|584976676|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
161980482|NCT03316950|584976677|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
161980483|NCT03316950|584976678|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
161980484|NCT03316950|584976679|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
161980485|NCT03316950|584976676|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
161980486|NCT03316950|584976677|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
161980487|NCT03316950|584976678|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
161980488|NCT03316950|584976679|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
161980489|NCT01754194|584976680|FG000|Overall Study|Lost to Follow-up|39|||
161980490|NCT01754194|584976681|FG001|Overall Study|Lost to Follow-up|14|||
161980491|NCT01754194|584976680|FG000|Overall Study|Withdrawal by Subject|4|||
161980492|NCT01754194|584976681|FG001|Overall Study|Withdrawal by Subject|5|||
161980493|NCT01754194|584976680|FG000|Overall Study|Other|9|||
161980494|NCT01754194|584976681|FG001|Overall Study|Other|8|||
161980495|NCT00791557|584976682|FG000|Overall Study|Adverse Event|1|||
161980496|NCT01079936|584976683|FG000|Phase I: MTD|First Remission Status|2|||
161980497|NCT01079936|584976684|FG001|Phase I: MTD|First Remission Status|0|||
161980498|NCT01079936|584976685|FG002|Phase I: MTD|First Remission Status|0|||
161980499|NCT01079936|584976686|FG003|Phase I: MTD|First Remission Status|0|||
161980500|NCT01079936|584976687|FG004|Phase I: MTD|First Remission Status|0|||
161980501|NCT01079936|584976683|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
161773934|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161773935|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161773936|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161773937|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
161773938|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773939|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
161773940|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773941|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773942|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773943|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161773944|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
161773945|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773946|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
161773947|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773948|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773949|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773950|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161773951|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
161773952|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
161773953|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
161773954|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773955|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773956|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773957|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161773958|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161864166|NCT00092118|584545595|FG000|Overall Study|Withdrawal by Subject|4|||
161980502|NCT01079936|584976684|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
161980503|NCT01079936|584976685|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
161980504|NCT01079936|584976686|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
161980505|NCT01079936|584976687|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
161980506|NCT01079936|584976683|FG000|Phase II|Adverse Event|0|||
161980507|NCT01079936|584976684|FG001|Phase II|Adverse Event|0|||
161980508|NCT01079936|584976685|FG002|Phase II|Adverse Event|1|||
161980509|NCT01079936|584976686|FG003|Phase II|Adverse Event|0|||
161980510|NCT01079936|584976687|FG004|Phase II|Adverse Event|0|||
161980511|NCT01079936|584976683|FG000|Phase II|Insurance Issue|0|||
161980512|NCT01079936|584976684|FG001|Phase II|Insurance Issue|0|||
161980513|NCT01079936|584976685|FG002|Phase II|Insurance Issue|0|||
161980514|NCT01079936|584976686|FG003|Phase II|Insurance Issue|0|||
161980515|NCT01079936|584976687|FG004|Phase II|Insurance Issue|1|||
161980516|NCT02322190|584976688|FG000|Overall Study|Death on study|1|||
161980517|NCT02322190|584976689|FG001|Overall Study|Death on study|0|||
161980518|NCT03344640|584976690|FG000|Overall Study|Adverse Event|1|||
161980519|NCT03344640|584976691|FG001|Overall Study|Adverse Event|0|||
161980520|NCT03344640|584976690|FG000|Overall Study|Physician Decision|1|||
161980521|NCT03344640|584976691|FG001|Overall Study|Physician Decision|1|||
161980522|NCT03344640|584976690|FG000|Overall Study|Withdrawal by Subject|1|||
161980523|NCT03344640|584976691|FG001|Overall Study|Withdrawal by Subject|2|||
161980524|NCT03344640|584976690|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
161980525|NCT03344640|584976691|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
161980526|NCT01177969|584976697|FG000|Overall Study|Protocol Violation|2|||
161980527|NCT01177969|584976698|FG001|Overall Study|Protocol Violation|1|||
161980528|NCT01177969|584976697|FG000|Overall Study|Withdrawal by Subject|1|||
161980529|NCT01177969|584976698|FG001|Overall Study|Withdrawal by Subject|2|||
161980530|NCT01353911|584976701|FG000|Overall Study|Lost to Follow-up|2|||
161980531|NCT01353911|584976702|FG001|Overall Study|Lost to Follow-up|6|||
161980532|NCT01353911|584976703|FG002|Overall Study|Lost to Follow-up|4|||
161980533|NCT01353911|584976704|FG003|Overall Study|Lost to Follow-up|0|||
161980534|NCT01353911|584976705|FG004|Overall Study|Lost to Follow-up|4|||
161980535|NCT01353911|584976706|FG005|Overall Study|Lost to Follow-up|4|||
161980536|NCT01353911|584976707|FG006|Overall Study|Lost to Follow-up|3|||
161980537|NCT01353911|584976708|FG007|Overall Study|Lost to Follow-up|6|||
161980538|NCT01353911|584976701|FG000|Overall Study|Withdrawal by Subject|2|||
161980539|NCT01353911|584976702|FG001|Overall Study|Withdrawal by Subject|3|||
161980540|NCT01353911|584976703|FG002|Overall Study|Withdrawal by Subject|4|||
161980541|NCT01353911|584976704|FG003|Overall Study|Withdrawal by Subject|2|||
161980542|NCT01353911|584976705|FG004|Overall Study|Withdrawal by Subject|2|||
161980543|NCT01353911|584976706|FG005|Overall Study|Withdrawal by Subject|3|||
161980544|NCT01353911|584976707|FG006|Overall Study|Withdrawal by Subject|3|||
161980545|NCT01353911|584976708|FG007|Overall Study|Withdrawal by Subject|9|||
161980546|NCT01353911|584976701|FG000|Overall Study|Status Not Recorded|4|||
161980547|NCT01353911|584976702|FG001|Overall Study|Status Not Recorded|0|||
161980548|NCT01353911|584976703|FG002|Overall Study|Status Not Recorded|1|||
161980549|NCT01353911|584976704|FG003|Overall Study|Status Not Recorded|0|||
161980550|NCT01353911|584976705|FG004|Overall Study|Status Not Recorded|0|||
161980551|NCT01353911|584976706|FG005|Overall Study|Status Not Recorded|0|||
161980552|NCT01353911|584976707|FG006|Overall Study|Status Not Recorded|0|||
161980553|NCT01353911|584976708|FG007|Overall Study|Status Not Recorded|0|||
161980554|NCT02049138|584976711|FG000|Overall Study|Adverse Event|46|||
161980555|NCT02049138|584976712|FG001|Overall Study|Adverse Event|25|||
161980556|NCT02049138|584976713|FG002|Overall Study|Adverse Event|1|||
161980557|NCT02049138|584976711|FG000|Overall Study|Withdrawal by Subject|57|||
161980558|NCT02049138|584976712|FG001|Overall Study|Withdrawal by Subject|21|||
161980559|NCT02049138|584976713|FG002|Overall Study|Withdrawal by Subject|5|||
161980560|NCT02049138|584976711|FG000|Overall Study|Lost to Follow-up|18|||
161980561|NCT02049138|584976712|FG001|Overall Study|Lost to Follow-up|5|||
161980562|NCT02049138|584976713|FG002|Overall Study|Lost to Follow-up|1|||
161980563|NCT02049138|584976711|FG000|Overall Study|Lack of Efficacy|10|||
161864167|NCT00092118|584545596|FG001|Overall Study|Withdrawal by Subject|10|||
161864168|NCT00092118|584545595|FG000|Overall Study|Other|6|||
161864169|NCT00092118|584545596|FG001|Overall Study|Other|5|||
161864170|NCT01139125|584545600|FG000|Overall Study|Withdrawal by Subject|1|||
161980564|NCT02049138|584976712|FG001|Overall Study|Lack of Efficacy|26|||
161980565|NCT02049138|584976713|FG002|Overall Study|Lack of Efficacy|1|||
161980566|NCT02049138|584976711|FG000|Overall Study|Non-Compliance|15|||
161980567|NCT02049138|584976712|FG001|Overall Study|Non-Compliance|6|||
161980568|NCT02049138|584976713|FG002|Overall Study|Non-Compliance|0|||
161980569|NCT02049138|584976711|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
161980570|NCT02049138|584976712|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
161980571|NCT02049138|584976713|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
161864171|NCT00837148|584545601|FG000|Overall Study|Adverse Event|1|||
161980572|NCT02049138|584976711|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
161980573|NCT02049138|584976712|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161980574|NCT02049138|584976713|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161864172|NCT00837148|584545601|FG000|Overall Study|Death|1|||
161864173|NCT00931411|584545604|FG000|First Intervention - 42 Days|Adverse Event|2|||
161864174|NCT00931411|584545605|FG001|First Intervention - 42 Days|Adverse Event|3|||
161864175|NCT00931411|584545604|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
161864176|NCT00931411|584545605|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
161864177|NCT00931411|584545604|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
161864178|NCT00931411|584545605|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
161980575|NCT02049138|584976711|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
161980576|NCT02049138|584976712|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
161980577|NCT02049138|584976713|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
161980578|NCT02049138|584976711|FG000|Overall Study|Other|15|||
161980579|NCT02049138|584976712|FG001|Overall Study|Other|13|||
161980580|NCT02049138|584976713|FG002|Overall Study|Other|0|||
161980581|NCT02049138|584976711|FG000|Overall Study|Missing|0|||
161980582|NCT02049138|584976712|FG001|Overall Study|Missing|1|||
161980583|NCT02049138|584976713|FG002|Overall Study|Missing|0|||
161980584|NCT03995355|584976714|FG000|Overall Study|Adverse Event|1|||
161980585|NCT03995355|584976715|FG001|Overall Study|Adverse Event|0|||
161980586|NCT03995355|584976714|FG000|Overall Study|Withdrawal by Subject|1|||
161980587|NCT03995355|584976715|FG001|Overall Study|Withdrawal by Subject|0|||
161980588|NCT03995355|584976714|FG000|Overall Study|Scheduling Issues|0|||
161980589|NCT03995355|584976715|FG001|Overall Study|Scheduling Issues|1|||
161980590|NCT00094107|584976716|FG000|Overall Study|Lack of Efficacy|23|||
161980591|NCT00094107|584976716|FG000|Overall Study|Death|5|||
161980592|NCT00094107|584976716|FG000|Overall Study|Adverse Event|3|||
161980593|NCT00094107|584976716|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
161980594|NCT00587847|584976717|FG000|Overall Study|Lack of Efficacy|5|||
161980595|NCT00587847|584976717|FG000|Overall Study|Adverse Event|2|||
161980596|NCT00343382|584976719|FG000|Overall Study|Adverse Event|2|||
161980597|NCT00343382|584976720|FG001|Overall Study|Adverse Event|10|||
161980598|NCT00343382|584976721|FG002|Overall Study|Adverse Event|7|||
161980599|NCT00343382|584976719|FG000|Overall Study|Withdrawal by Subject|1|||
161980600|NCT00343382|584976720|FG001|Overall Study|Withdrawal by Subject|2|||
161980601|NCT00343382|584976721|FG002|Overall Study|Withdrawal by Subject|6|||
161980602|NCT00343382|584976719|FG000|Overall Study|Other Reason Not Specified|1|||
161980603|NCT00343382|584976720|FG001|Overall Study|Other Reason Not Specified|2|||
161980604|NCT00343382|584976721|FG002|Overall Study|Other Reason Not Specified|4|||
161980605|NCT03869333|584976726|FG000|Overall Study|Lost to Follow-up|1|||
161980606|NCT03869333|584976727|FG001|Overall Study|Lost to Follow-up|0|||
161980607|NCT03869333|584976728|FG002|Overall Study|Lost to Follow-up|0|||
161980608|NCT03869333|584976729|FG003|Overall Study|Lost to Follow-up|0|||
161980609|NCT03869333|584976726|FG000|Overall Study|Pregnancy|1|||
161980610|NCT03869333|584976727|FG001|Overall Study|Pregnancy|0|||
161980611|NCT03869333|584976728|FG002|Overall Study|Pregnancy|0|||
161980612|NCT03869333|584976729|FG003|Overall Study|Pregnancy|0|||
161980613|NCT03869333|584976726|FG000|Overall Study|Physician Decision|0|||
161980614|NCT03869333|584976727|FG001|Overall Study|Physician Decision|1|||
161980615|NCT03869333|584976728|FG002|Overall Study|Physician Decision|0|||
161980616|NCT03869333|584976729|FG003|Overall Study|Physician Decision|0|||
161980617|NCT01064687|584976732|FG000|Overall Study|Adverse Event|9|||
161980618|NCT01064687|584976733|FG001|Overall Study|Adverse Event|4|||
161980619|NCT01064687|584976734|FG002|Overall Study|Adverse Event|10|||
161980620|NCT01064687|584976735|FG003|Overall Study|Adverse Event|3|||
161980621|NCT01064687|584976732|FG000|Overall Study|Death|1|||
161980622|NCT01064687|584976733|FG001|Overall Study|Death|1|||
161980623|NCT01064687|584976734|FG002|Overall Study|Death|0|||
161980624|NCT01064687|584976735|FG003|Overall Study|Death|0|||
161980625|NCT01064687|584976732|FG000|Overall Study|Entry Criteria Not Met|3|||
161980626|NCT01064687|584976733|FG001|Overall Study|Entry Criteria Not Met|0|||
161980627|NCT01064687|584976734|FG002|Overall Study|Entry Criteria Not Met|0|||
161980628|NCT01064687|584976735|FG003|Overall Study|Entry Criteria Not Met|0|||
161980629|NCT01064687|584976732|FG000|Overall Study|Lack of Efficacy|1|||
161980630|NCT01064687|584976733|FG001|Overall Study|Lack of Efficacy|0|||
161980631|NCT01064687|584976734|FG002|Overall Study|Lack of Efficacy|2|||
161980632|NCT01064687|584976735|FG003|Overall Study|Lack of Efficacy|3|||
161980633|NCT01064687|584976732|FG000|Overall Study|Lost to Follow-up|7|||
161980634|NCT01064687|584976733|FG001|Overall Study|Lost to Follow-up|10|||
161980635|NCT01064687|584976734|FG002|Overall Study|Lost to Follow-up|13|||
161980636|NCT01064687|584976735|FG003|Overall Study|Lost to Follow-up|5|||
161980637|NCT01064687|584976732|FG000|Overall Study|Physician Decision|2|||
161980638|NCT01064687|584976733|FG001|Overall Study|Physician Decision|2|||
161980639|NCT01064687|584976734|FG002|Overall Study|Physician Decision|0|||
161980640|NCT01064687|584976735|FG003|Overall Study|Physician Decision|0|||
161980641|NCT01064687|584976732|FG000|Overall Study|Protocol Violation|1|||
161980642|NCT01064687|584976733|FG001|Overall Study|Protocol Violation|1|||
161980643|NCT01064687|584976734|FG002|Overall Study|Protocol Violation|0|||
161980644|NCT01064687|584976735|FG003|Overall Study|Protocol Violation|1|||
161980645|NCT01064687|584976732|FG000|Overall Study|Sponsor Decision|0|||
161980646|NCT01064687|584976733|FG001|Overall Study|Sponsor Decision|0|||
161980647|NCT01064687|584976734|FG002|Overall Study|Sponsor Decision|3|||
161980648|NCT01064687|584976735|FG003|Overall Study|Sponsor Decision|0|||
161980649|NCT01064687|584976732|FG000|Overall Study|Withdrawal by Subject|9|||
161980650|NCT01064687|584976733|FG001|Overall Study|Withdrawal by Subject|7|||
161980651|NCT01064687|584976734|FG002|Overall Study|Withdrawal by Subject|12|||
161980652|NCT01064687|584976735|FG003|Overall Study|Withdrawal by Subject|5|||
161980653|NCT01064687|584976732|FG000|Overall Study|Treatment Noncompliance|1|||
161980654|NCT01064687|584976733|FG001|Overall Study|Treatment Noncompliance|1|||
161980655|NCT01064687|584976734|FG002|Overall Study|Treatment Noncompliance|1|||
161980656|NCT01064687|584976735|FG003|Overall Study|Treatment Noncompliance|0|||
161980657|NCT05219669|584976740|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
161980658|NCT05219669|584976741|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
161980659|NCT05219669|584976742|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
161980660|NCT05219669|584976743|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
161980661|NCT05219669|584976744|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
161980662|NCT05219669|584976745|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
161980663|NCT02404649|584976748|FG000|Overall Study|Adverse Event|1|||
161980664|NCT02404649|584976749|FG001|Overall Study|Adverse Event|2|||
161980665|NCT02299076|584976753|FG000|Overall Study|Fraudulent Entries|20|||
161980666|NCT02299076|584976754|FG001|Overall Study|Fraudulent Entries|14|||
161980667|NCT00162266|584976755|FG000|Double-Blind Period|Adverse Event|5|||
161980668|NCT00162266|584976756|FG001|Double-Blind Period|Adverse Event|9|||
161980669|NCT00162266|584976757|FG002|Double-Blind Period|Adverse Event|11|||
161980670|NCT00162266|584976758|FG003|Double-Blind Period|Adverse Event|0|||
161980671|NCT00162266|584976755|FG000|Double-Blind Period|Death|0|||
161980672|NCT00162266|584976756|FG001|Double-Blind Period|Death|1|||
161980673|NCT00162266|584976757|FG002|Double-Blind Period|Death|0|||
161980674|NCT00162266|584976758|FG003|Double-Blind Period|Death|0|||
161980675|NCT00162266|584976755|FG000|Double-Blind Period|Lost to Follow-up|1|||
161980676|NCT00162266|584976756|FG001|Double-Blind Period|Lost to Follow-up|2|||
161980677|NCT00162266|584976757|FG002|Double-Blind Period|Lost to Follow-up|0|||
161980678|NCT00162266|584976758|FG003|Double-Blind Period|Lost to Follow-up|0|||
161980679|NCT00162266|584976755|FG000|Double-Blind Period|Other Reason|1|||
161980680|NCT00162266|584976756|FG001|Double-Blind Period|Other Reason|0|||
161980681|NCT00162266|584976757|FG002|Double-Blind Period|Other Reason|1|||
161980682|NCT00162266|584976758|FG003|Double-Blind Period|Other Reason|0|||
161980683|NCT00162266|584976755|FG000|Double-Blind Period|Lack of Efficacy|13|||
161980684|NCT00162266|584976756|FG001|Double-Blind Period|Lack of Efficacy|17|||
161980685|NCT00162266|584976757|FG002|Double-Blind Period|Lack of Efficacy|30|||
161980686|NCT00162266|584976758|FG003|Double-Blind Period|Lack of Efficacy|0|||
161980687|NCT00162266|584976755|FG000|Double-Blind Period|Withdrawal by Subject|5|||
161980688|NCT00162266|584976756|FG001|Double-Blind Period|Withdrawal by Subject|2|||
161980689|NCT00162266|584976757|FG002|Double-Blind Period|Withdrawal by Subject|6|||
161980690|NCT00162266|584976758|FG003|Double-Blind Period|Withdrawal by Subject|0|||
161980691|NCT00162266|584976755|FG000|Open-Label Period|Death|0|||
161980692|NCT00162266|584976756|FG001|Open-Label Period|Death|0|||
161980693|NCT00162266|584976757|FG002|Open-Label Period|Death|0|||
161980694|NCT00162266|584976758|FG003|Open-Label Period|Death|7|||
161980695|NCT00162266|584976755|FG000|Open-Label Period|Adverse Event|0|||
161980696|NCT00162266|584976756|FG001|Open-Label Period|Adverse Event|0|||
161980697|NCT00162266|584976757|FG002|Open-Label Period|Adverse Event|0|||
161980698|NCT00162266|584976758|FG003|Open-Label Period|Adverse Event|46|||
161980699|NCT00162266|584976755|FG000|Open-Label Period|Lack of Efficacy|0|||
161980700|NCT00162266|584976756|FG001|Open-Label Period|Lack of Efficacy|0|||
161980701|NCT00162266|584976757|FG002|Open-Label Period|Lack of Efficacy|0|||
161980702|NCT00162266|584976758|FG003|Open-Label Period|Lack of Efficacy|26|||
161980703|NCT00162266|584976755|FG000|Open-Label Period|Lost to Follow-up|0|||
161980704|NCT00162266|584976756|FG001|Open-Label Period|Lost to Follow-up|0|||
161980705|NCT00162266|584976757|FG002|Open-Label Period|Lost to Follow-up|0|||
161980706|NCT00162266|584976758|FG003|Open-Label Period|Lost to Follow-up|3|||
161980707|NCT00162266|584976755|FG000|Open-Label Period|Withdrawal by Subject|0|||
161980708|NCT00162266|584976756|FG001|Open-Label Period|Withdrawal by Subject|0|||
161980709|NCT00162266|584976757|FG002|Open-Label Period|Withdrawal by Subject|0|||
161980710|NCT00162266|584976758|FG003|Open-Label Period|Withdrawal by Subject|31|||
161980711|NCT00162266|584976755|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
161980712|NCT00162266|584976756|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
161980713|NCT00162266|584976757|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
161980714|NCT00162266|584976758|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
161980715|NCT00162266|584976755|FG000|Open-Label Period|Other Reasons|0|||
161980716|NCT00162266|584976756|FG001|Open-Label Period|Other Reasons|0|||
161980717|NCT00162266|584976757|FG002|Open-Label Period|Other Reasons|0|||
161980718|NCT00162266|584976758|FG003|Open-Label Period|Other Reasons|15|||
161980719|NCT00330668|584976759|FG000|BID Dosing Period|Adverse Event|1|||
161980720|NCT00330668|584976759|FG000|BID Dosing Period|Lost to Follow-up|7|||
161980721|NCT00330668|584976759|FG000|BID Dosing Period|Non-Compliance|5|||
161980722|NCT00330668|584976759|FG000|BID Dosing Period|Withdrawal by Subject|19|||
161980723|NCT00330668|584976759|FG000|BID Dosing Period|Sponsor's decision|1|||
161980724|NCT00330668|584976759|FG000|BID Dosing Period|Other|3|||
162034905|NCT03228420|585184808|FG001|Overall Study|Lost to Follow-up|3|||
161980725|NCT00330668|584976759|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
161980726|NCT00330668|584976759|FG000|QD Dosing Period|Other|1|||
161980727|NCT00330668|584976759|FG000|QD Dosing Period|Withdrawal by Subject|1|||
161980728|NCT00330668|584976759|FG000|QD Dosing Period|Lost to Follow-up|2|||
161980729|NCT00499746|584976765|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
161980730|NCT00499746|584976765|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
161864179|NCT01827111|584545606|FG000|Overall Study|Disease Progression|1|||
161864180|NCT03181633|584545609|FG000|Overall Study|Withdrawal by Subject|1|||
161980731|NCT00499746|584976765|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
161980732|NCT00499746|584976765|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
161980733|NCT01012323|584976766|FG000|Overall Study|Investigator Judgment|1|||
161980734|NCT00737633|584976773|FG000|Overall Study|Study terminated by sponsor|44|||
161980735|NCT00737633|584976774|FG001|Overall Study|Study terminated by sponsor|55|||
161980736|NCT00737633|584976773|FG000|Overall Study|Lost to Follow-up|0|||
161980737|NCT00737633|584976774|FG001|Overall Study|Lost to Follow-up|1|||
161980738|NCT00737633|584976773|FG000|Overall Study|protocol non-compliance|0|||
161980739|NCT00737633|584976774|FG001|Overall Study|protocol non-compliance|1|||
161980740|NCT01105377|584976778|FG000|Overall Study|Withdrawal by Subject|0|||
161980741|NCT01105377|584976779|FG001|Overall Study|Withdrawal by Subject|1|||
161980742|NCT02806960|584978572|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
161980743|NCT02806960|584978573|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
161980744|NCT02806960|584978574|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
161980745|NCT02806960|584978575|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
161980746|NCT00321464|584978576|FG000|Overall Study|Death|169|||
161980747|NCT00321464|584978577|FG001|Overall Study|Death|174|||
161980748|NCT00321464|584978576|FG000|Overall Study|Disease progression|124|||
161980749|NCT00321464|584978577|FG001|Overall Study|Disease progression|124|||
161980750|NCT00321464|584978576|FG000|Overall Study|Withdrawal by Subject|117|||
161980751|NCT00321464|584978577|FG001|Overall Study|Withdrawal by Subject|118|||
161980752|NCT00321464|584978576|FG000|Overall Study|Participant request|57|||
161980753|NCT00321464|584978577|FG001|Overall Study|Participant request|61|||
161980754|NCT00321464|584978576|FG000|Overall Study|Adverse Event|43|||
161980755|NCT00321464|584978577|FG001|Overall Study|Adverse Event|28|||
161980756|NCT00321464|584978576|FG000|Overall Study|Physician Decision|15|||
161980757|NCT00321464|584978577|FG001|Overall Study|Physician Decision|14|||
161980758|NCT00321464|584978576|FG000|Overall Study|Noncompliance|4|||
161980759|NCT00321464|584978577|FG001|Overall Study|Noncompliance|10|||
161980760|NCT00321464|584978576|FG000|Overall Study|Lost to Follow-up|7|||
161980761|NCT00321464|584978577|FG001|Overall Study|Lost to Follow-up|8|||
161980762|NCT00321464|584978576|FG000|Overall Study|Protocol deviation|0|||
161980763|NCT00321464|584978577|FG001|Overall Study|Protocol deviation|2|||
161980764|NCT00321464|584978576|FG000|Overall Study|Ineligibility determined|2|||
161980765|NCT00321464|584978577|FG001|Overall Study|Ineligibility determined|1|||
161980766|NCT00321464|584978576|FG000|Overall Study|Other|21|||
161980767|NCT00321464|584978577|FG001|Overall Study|Other|18|||
161980768|NCT02522325|584978579|FG000|Overall Study|Adverse Event|0|||
161980769|NCT02522325|584978580|FG001|Overall Study|Adverse Event|1|||
161980770|NCT02100969|584978581|FG000|Overall Study|Did not pass screening phase|1|||
161980771|NCT01629953|584978582|FG000|Overall Study|Death|3|||
161980772|NCT01629953|584978583|FG001|Overall Study|Death|1|||
162034906|NCT03228420|585184807|FG000|Overall Study|Withdrawal by Subject|10|||
161864181|NCT03181633|584545609|FG000|Overall Study|Missing follow-up visit|1|||
161864182|NCT04383327|584545616|FG000|Overall Study|Lost to Follow-up|112|||
161864183|NCT04383327|584545617|FG001|Overall Study|Lost to Follow-up|14|||
161864184|NCT04383327|584545618|FG002|Overall Study|Lost to Follow-up|78|||
161864185|NCT04383327|584545619|FG003|Overall Study|Lost to Follow-up|13|||
161864186|NCT04383327|584545620|FG004|Overall Study|Lost to Follow-up|110|||
161864187|NCT04383327|584545621|FG005|Overall Study|Lost to Follow-up|13|||
161864188|NCT04383327|584545622|FG006|Overall Study|Lost to Follow-up|74|||
161864189|NCT04383327|584545623|FG007|Overall Study|Lost to Follow-up|13|||
161864190|NCT04383327|584545624|FG008|Overall Study|Lost to Follow-up|78|||
162034907|NCT03228420|585184808|FG001|Overall Study|Withdrawal by Subject|0|||
161864191|NCT04383327|584545625|FG009|Overall Study|Lost to Follow-up|10|||
161864192|NCT04383327|584545626|FG010|Overall Study|Lost to Follow-up|160|||
161864193|NCT04383327|584545627|FG011|Overall Study|Lost to Follow-up|13|||
161864194|NCT04837196|584545628|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
161980773|NCT01629953|584978582|FG000|Overall Study|Lost to Follow-up|10|||
161980774|NCT01629953|584978583|FG001|Overall Study|Lost to Follow-up|14|||
161980775|NCT00448747|584978586|FG000|Overall Study|collapsed veins|1|||
161864195|NCT04837196|584545629|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
161980776|NCT00448747|584978587|FG001|Overall Study|collapsed veins|0|||
161980777|NCT00387725|584978588|FG000|Overall Study|Adverse Event|0|||
161980778|NCT00387725|584978589|FG001|Overall Study|Adverse Event|0|||
161980779|NCT00387725|584978590|FG002|Overall Study|Adverse Event|0|||
161980780|NCT00387725|584978591|FG003|Overall Study|Adverse Event|1|||
161980781|NCT00387725|584978588|FG000|Overall Study|Protocol Violation|0|||
161980782|NCT00387725|584978589|FG001|Overall Study|Protocol Violation|1|||
161980783|NCT00387725|584978590|FG002|Overall Study|Protocol Violation|0|||
161980784|NCT00387725|584978591|FG003|Overall Study|Protocol Violation|0|||
161980785|NCT00387725|584978588|FG000|Overall Study|Withdrawal by Subject|1|||
161980786|NCT00387725|584978589|FG001|Overall Study|Withdrawal by Subject|0|||
161980787|NCT00387725|584978590|FG002|Overall Study|Withdrawal by Subject|1|||
161980788|NCT00387725|584978591|FG003|Overall Study|Withdrawal by Subject|0|||
161980789|NCT00387725|584978588|FG000|Overall Study|Parent/legal guardian request|0|||
161980790|NCT00387725|584978589|FG001|Overall Study|Parent/legal guardian request|0|||
161980791|NCT00387725|584978590|FG002|Overall Study|Parent/legal guardian request|1|||
161980792|NCT00387725|584978591|FG003|Overall Study|Parent/legal guardian request|1|||
161980793|NCT00568126|584978592|FG000|Overall Study|Adverse Event|3|||
161980794|NCT00568126|584978593|FG001|Overall Study|Adverse Event|0|||
161980795|NCT00568126|584978592|FG000|Overall Study|Withdrawal by Subject|2|||
161980796|NCT00568126|584978593|FG001|Overall Study|Withdrawal by Subject|3|||
161980797|NCT00568126|584978592|FG000|Overall Study|Lost to Follow-up|4|||
161980798|NCT00568126|584978593|FG001|Overall Study|Lost to Follow-up|3|||
161980799|NCT00568126|584978592|FG000|Overall Study|Lack of Efficacy|0|||
161980800|NCT00568126|584978593|FG001|Overall Study|Lack of Efficacy|1|||
161980801|NCT00568126|584978592|FG000|Overall Study|Physician Decision|2|||
161980802|NCT00568126|584978593|FG001|Overall Study|Physician Decision|2|||
161980803|NCT00527982|584978595|FG000|Overall Study|Physician Decision|1|||
161980804|NCT00527982|584978596|FG001|Overall Study|Physician Decision|0|||
161980805|NCT02429791|584978602|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
161980806|NCT02429791|584978603|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
161980807|NCT02429791|584978602|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
161980808|NCT02429791|584978603|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
161980809|NCT02429791|584978602|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
161980810|NCT02429791|584978603|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
161980811|NCT02429791|584978602|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
161980812|NCT02429791|584978603|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
161980813|NCT02429791|584978602|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
161980814|NCT02429791|584978603|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
161980815|NCT02429791|584978602|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
161980816|NCT02429791|584978603|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
161980817|NCT02429791|584978602|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
161980818|NCT02429791|584978603|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
161980819|NCT02429791|584978602|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
161980820|NCT02429791|584978603|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
161980821|NCT02429791|584978602|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
161980822|NCT02429791|584978603|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
161980823|NCT02429791|584978602|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
161980824|NCT02429791|584978603|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
161980825|NCT02429791|584978602|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
161980826|NCT02429791|584978603|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
161980827|NCT02429791|584978602|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
161980828|NCT02429791|584978603|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
161980829|NCT02429791|584978602|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
161980830|NCT02429791|584978603|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
161980831|NCT02429791|584978602|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
161980832|NCT02429791|584978603|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
161980833|NCT02429791|584978602|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
161980834|NCT02429791|584978603|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
161980835|NCT02429791|584978602|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
161980836|NCT02429791|584978603|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
161980837|NCT02429791|584978602|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
161980838|NCT02429791|584978603|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
161980839|NCT02429791|584978602|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
161980840|NCT02429791|584978603|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
161980841|NCT02615691|584978604|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
161980842|NCT02615691|584978604|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
161980843|NCT02615691|584978604|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
161980844|NCT02615691|584978604|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
161980845|NCT00007020|584978605|FG000|Overall Study|Death|16|||
161980846|NCT00007020|584978605|FG000|Overall Study|Lost to Follow-up|13|||
161980847|NCT00007020|584978605|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
161980848|NCT00007020|584978605|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
161980849|NCT00007020|584978605|FG000|Overall Study|Pt cared for by outside physician|4|||
161773959|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161773960|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
161980850|NCT00007020|584978605|FG000|Overall Study|No evidence of treatment|6|||
161980851|NCT02294734|584978606|FG000|Overall Study|Adverse Event|5|||
161980852|NCT02294734|584978607|FG001|Overall Study|Adverse Event|5|||
161980853|NCT02294734|584978606|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
161980854|NCT02294734|584978607|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
161980855|NCT02294734|584978606|FG000|Overall Study|Lost to Follow-up|2|||
161980856|NCT02294734|584978607|FG001|Overall Study|Lost to Follow-up|0|||
161980857|NCT02294734|584978606|FG000|Overall Study|Physician Decision|2|||
161980858|NCT02294734|584978607|FG001|Overall Study|Physician Decision|1|||
161980859|NCT02294734|584978606|FG000|Overall Study|Withdrawal by Subject|4|||
161980860|NCT02294734|584978607|FG001|Overall Study|Withdrawal by Subject|2|||
161980861|NCT03157583|584978608|FG000|Overall Study|Other (did not meet study criteria)|1|||
161980862|NCT02809053|584978611|FG000|Overall Study|Death|0|||
161980863|NCT02809053|584978612|FG001|Overall Study|Death|1|||
161980864|NCT02809053|584978611|FG000|Overall Study|Lost to Follow-up|3|||
161980865|NCT02809053|584978612|FG001|Overall Study|Lost to Follow-up|1|||
161980866|NCT02809053|584978611|FG000|Overall Study|Withdrawal by Subject|2|||
161980867|NCT02809053|584978612|FG001|Overall Study|Withdrawal by Subject|3|||
161980868|NCT02809053|584978611|FG000|Overall Study|Disease Progression|2|||
161980869|NCT02809053|584978612|FG001|Overall Study|Disease Progression|1|||
161980870|NCT01943552|584978613|FG000|Overall Study|Adverse Event|3|||
161980871|NCT01943552|584978614|FG001|Overall Study|Adverse Event|2|||
161980872|NCT01943552|584978613|FG000|Overall Study|Withdrawal by Subject|6|||
161980873|NCT01943552|584978614|FG001|Overall Study|Withdrawal by Subject|6|||
161980874|NCT01943552|584978613|FG000|Overall Study|Other Reasons|16|||
161980875|NCT01943552|584978614|FG001|Overall Study|Other Reasons|17|||
161980876|NCT01147900|584978615|FG000|At Year 10|Lost to Follow-up|0|||
161980877|NCT01147900|584978616|FG001|At Year 10|Lost to Follow-up|1|||
161980878|NCT01147900|584978617|FG002|At Year 10|Lost to Follow-up|0|||
161980879|NCT00025155|584978618|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
161980880|NCT00025155|584978618|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
161980881|NCT05086510|584978619|FG000|Overall Study|Lost to Follow-up|0|||
161980882|NCT05086510|584978620|FG001|Overall Study|Lost to Follow-up|2|||
161980883|NCT05086510|584978619|FG000|Overall Study|Death|0|||
161980884|NCT05086510|584978620|FG001|Overall Study|Death|2|||
161980885|NCT03022981|584978621|FG000|Overall Study|Adverse Event|0|||
161980886|NCT03022981|584978622|FG001|Overall Study|Adverse Event|1|||
161980887|NCT03022981|584978623|FG002|Overall Study|Adverse Event|0|||
161980888|NCT03022981|584978621|FG000|Overall Study|Investigator's Discretion|0|||
161980889|NCT03022981|584978622|FG001|Overall Study|Investigator's Discretion|1|||
161980890|NCT03022981|584978623|FG002|Overall Study|Investigator's Discretion|2|||
161980891|NCT03022981|584978621|FG000|Overall Study|Lost to Follow-up|6|||
161980892|NCT03022981|584978622|FG001|Overall Study|Lost to Follow-up|2|||
161980893|NCT03022981|584978623|FG002|Overall Study|Lost to Follow-up|1|||
161980894|NCT03022981|584978621|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161980895|NCT03022981|584978622|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161980896|NCT03022981|584978623|FG002|Overall Study|Non-Compliance With Study Drug|2|||
161980897|NCT03022981|584978621|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
161980898|NCT03022981|584978622|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
161980899|NCT03022981|584978623|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
161980900|NCT00884832|584978625|FG000|Overall Study|Withdrawal by Subject|0|||
161980901|NCT00884832|584978626|FG001|Overall Study|Withdrawal by Subject|1|||
161980902|NCT02337725|584978627|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
161980903|NCT02337725|584978628|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
161980904|NCT02337725|584978627|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
161980905|NCT02337725|584978628|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
161980906|NCT02337725|584978627|FG000|Overall Study|Major Protocol Deviation|0|||
161980907|NCT02337725|584978628|FG001|Overall Study|Major Protocol Deviation|1|||
161980908|NCT02337725|584978627|FG000|Overall Study|Voluntary Withdrawal|14|||
161980909|NCT02337725|584978628|FG001|Overall Study|Voluntary Withdrawal|3|||
161980910|NCT02337725|584978627|FG000|Overall Study|Lack of Efficacy|4|||
161980911|NCT02337725|584978628|FG001|Overall Study|Lack of Efficacy|0|||
161980912|NCT01571453|584978629|FG000|Overall Study|Adverse Event|14|||
161980913|NCT01571453|584978630|FG001|Overall Study|Adverse Event|32|||
161980914|NCT01571453|584978629|FG000|Overall Study|Lack of Efficacy|8|||
161980915|NCT01571453|584978630|FG001|Overall Study|Lack of Efficacy|3|||
161980916|NCT01571453|584978629|FG000|Overall Study|Non-compliance|2|||
161980917|NCT01571453|584978630|FG001|Overall Study|Non-compliance|4|||
161980918|NCT01571453|584978629|FG000|Overall Study|Protocol Violation|1|||
161773961|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161773962|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161773963|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161773964|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161980919|NCT01571453|584978630|FG001|Overall Study|Protocol Violation|5|||
161980920|NCT01571453|584978629|FG000|Overall Study|Withdrawal of consent|5|||
161980921|NCT01571453|584978630|FG001|Overall Study|Withdrawal of consent|13|||
161980922|NCT01571453|584978629|FG000|Overall Study|Lost to Follow-up|4|||
161980923|NCT01571453|584978630|FG001|Overall Study|Lost to Follow-up|2|||
161980924|NCT01571453|584978629|FG000|Overall Study|Administrative or other reason(s)|4|||
161980925|NCT01571453|584978630|FG001|Overall Study|Administrative or other reason(s)|3|||
161980926|NCT00500760|584978632|FG000|Overall Study|Death|32|||
161980927|NCT00500760|584978633|FG001|Overall Study|Death|15|||
161980928|NCT00500760|584978632|FG000|Overall Study|Withdrawal by Subject|5|||
161980929|NCT00500760|584978633|FG001|Overall Study|Withdrawal by Subject|7|||
161980930|NCT00500760|584978632|FG000|Overall Study|Administrative decision|2|||
161980931|NCT00500760|584978633|FG001|Overall Study|Administrative decision|0|||
161980932|NCT00500760|584978632|FG000|Overall Study|Lost to Follow-up|3|||
161980933|NCT00500760|584978633|FG001|Overall Study|Lost to Follow-up|0|||
161980934|NCT00500760|584978632|FG000|Overall Study|Other|1|||
161980935|NCT00500760|584978633|FG001|Overall Study|Other|2|||
161980936|NCT00129961|584978634|FG000|Overall Study|Adverse Event|1|||
161980937|NCT00129961|584978635|FG001|Overall Study|Adverse Event|0|||
161980938|NCT00129961|584978634|FG000|Overall Study|Death|1|||
161980939|NCT00129961|584978635|FG001|Overall Study|Death|1|||
161980940|NCT00129961|584978634|FG000|Overall Study|Withdrawal by Sponsor|14|||
161980941|NCT00129961|584978635|FG001|Overall Study|Withdrawal by Sponsor|20|||
161980942|NCT00129961|584978634|FG000|Overall Study|Physician Decision|1|||
161980943|NCT00129961|584978635|FG001|Overall Study|Physician Decision|0|||
161980944|NCT00129961|584978634|FG000|Overall Study|Withdrawal by Subject|2|||
161980945|NCT00129961|584978635|FG001|Overall Study|Withdrawal by Subject|1|||
161980946|NCT00129961|584978634|FG000|Overall Study|Missing Record|0|||
161980947|NCT00129961|584978635|FG001|Overall Study|Missing Record|1|||
161980948|NCT01264770|584978636|FG000|Overall Study|Not reported|0|||
161980949|NCT01264770|584978637|FG001|Overall Study|Not reported|0|||
161980950|NCT01264770|584978638|FG002|Overall Study|Not reported|1|||
161980951|NCT01264770|584978639|FG003|Overall Study|Not reported|0|||
161980952|NCT01264770|584978640|FG004|Overall Study|Not reported|0|||
161980953|NCT01264770|584978641|FG005|Overall Study|Not reported|0|||
161980954|NCT01264770|584978636|FG000|Overall Study|e.g., change in circumstances|8|||
161980955|NCT01264770|584978637|FG001|Overall Study|e.g., change in circumstances|3|||
161980956|NCT01264770|584978638|FG002|Overall Study|e.g., change in circumstances|3|||
161980957|NCT01264770|584978639|FG003|Overall Study|e.g., change in circumstances|3|||
161980958|NCT01264770|584978640|FG004|Overall Study|e.g., change in circumstances|4|||
161980959|NCT01264770|584978641|FG005|Overall Study|e.g., change in circumstances|4|||
161980960|NCT01264770|584978636|FG000|Overall Study|Severe non-compliance to protocol|0|||
161980961|NCT01264770|584978637|FG001|Overall Study|Severe non-compliance to protocol|0|||
161980962|NCT01264770|584978638|FG002|Overall Study|Severe non-compliance to protocol|1|||
161980963|NCT01264770|584978639|FG003|Overall Study|Severe non-compliance to protocol|1|||
161980964|NCT01264770|584978640|FG004|Overall Study|Severe non-compliance to protocol|0|||
161980965|NCT01264770|584978641|FG005|Overall Study|Severe non-compliance to protocol|0|||
161980966|NCT01264770|584978636|FG000|Overall Study|Lack of therapeutic response|1|||
161980967|NCT01264770|584978637|FG001|Overall Study|Lack of therapeutic response|0|||
161980968|NCT01264770|584978638|FG002|Overall Study|Lack of therapeutic response|2|||
161980969|NCT01264770|584978639|FG003|Overall Study|Lack of therapeutic response|1|||
161980970|NCT01264770|584978640|FG004|Overall Study|Lack of therapeutic response|1|||
161980971|NCT01264770|584978641|FG005|Overall Study|Lack of therapeutic response|0|||
161980972|NCT01264770|584978636|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
161980973|NCT01264770|584978637|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
161980974|NCT01264770|584978638|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
161980975|NCT01264770|584978639|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
161980976|NCT01264770|584978640|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
161980977|NCT01264770|584978641|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
161980978|NCT01264770|584978636|FG000|Overall Study|Lost to Follow-up|0|||
161980979|NCT01264770|584978637|FG001|Overall Study|Lost to Follow-up|0|||
161980980|NCT01264770|584978638|FG002|Overall Study|Lost to Follow-up|1|||
161980981|NCT01264770|584978639|FG003|Overall Study|Lost to Follow-up|1|||
161980982|NCT01264770|584978640|FG004|Overall Study|Lost to Follow-up|0|||
161980983|NCT01264770|584978641|FG005|Overall Study|Lost to Follow-up|0|||
161980984|NCT01264770|584978636|FG000|Overall Study|Adverse Event|7|||
161980985|NCT01264770|584978637|FG001|Overall Study|Adverse Event|7|||
161980986|NCT01264770|584978638|FG002|Overall Study|Adverse Event|8|||
161980987|NCT01264770|584978639|FG003|Overall Study|Adverse Event|0|||
161980988|NCT01264770|584978640|FG004|Overall Study|Adverse Event|2|||
161980989|NCT01264770|584978641|FG005|Overall Study|Adverse Event|1|||
161980990|NCT00084487|584978642|FG000|Overall Study|Death|1|||
161980991|NCT03691779|584978645|FG000|Part B (24 Weeks)|Adverse Event|0|||
161980992|NCT03691779|584978646|FG001|Part B (24 Weeks)|Adverse Event|1|||
161980993|NCT03691779|584978645|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
161864196|NCT04837196|584545630|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
161980994|NCT03691779|584978646|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
161980995|NCT04881747|584978647|FG000|Period 2 Washout|Adverse Event|1|||
161980996|NCT04881747|584978648|FG001|Period 2 Washout|Adverse Event|0|||
161980997|NCT04881747|584978649|FG002|Period 2 Washout|Adverse Event|0|||
161980998|NCT04881747|584978650|FG003|Period 2 Washout|Adverse Event|0|||
161980999|NCT04881747|584978651|FG004|Period 2 Washout|Adverse Event|1|||
161981000|NCT04881747|584978652|FG005|Period 2 Washout|Adverse Event|0|||
161981001|NCT04881747|584978647|FG000|Period 2 Washout|Withdrawal by Subject|1|||
161981002|NCT04881747|584978648|FG001|Period 2 Washout|Withdrawal by Subject|0|||
161981003|NCT04881747|584978649|FG002|Period 2 Washout|Withdrawal by Subject|0|||
161981004|NCT04881747|584978650|FG003|Period 2 Washout|Withdrawal by Subject|1|||
161981005|NCT04881747|584978651|FG004|Period 2 Washout|Withdrawal by Subject|0|||
161981006|NCT04881747|584978652|FG005|Period 2 Washout|Withdrawal by Subject|0|||
161981007|NCT01927055|584978658|FG000|Open-label|Adverse Event|6|||
161981008|NCT01927055|584978659|FG001|Open-label|Adverse Event|0|||
161981009|NCT01927055|584978660|FG002|Open-label|Adverse Event|0|||
161981010|NCT01927055|584978658|FG000|Open-label|Withdrawal by Subject|1|||
161981011|NCT01927055|584978659|FG001|Open-label|Withdrawal by Subject|0|||
161981012|NCT01927055|584978660|FG002|Open-label|Withdrawal by Subject|0|||
161981013|NCT01927055|584978658|FG000|Open-label|Study Stopped|4|||
161981014|NCT01927055|584978659|FG001|Open-label|Study Stopped|0|||
161981015|NCT01927055|584978660|FG002|Open-label|Study Stopped|0|||
161981016|NCT01927055|584978658|FG000|Open-label|Supine Hypertension|4|||
161981017|NCT01927055|584978659|FG001|Open-label|Supine Hypertension|0|||
161981018|NCT01927055|584978660|FG002|Open-label|Supine Hypertension|0|||
162034908|NCT03228420|585184807|FG000|Overall Study|Adverse Event|5|||
161864197|NCT04837196|584545631|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
161864198|NCT04837196|584545632|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
161864199|NCT04837196|584545628|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
161864200|NCT04837196|584545629|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
161864201|NCT04837196|584545630|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
161864202|NCT04837196|584545631|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
161864203|NCT04837196|584545632|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
161864204|NCT04837196|584545628|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
161864205|NCT04837196|584545629|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
161864206|NCT04837196|584545630|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
161864207|NCT04837196|584545631|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
161864208|NCT04837196|584545632|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
161864209|NCT04837196|584545628|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
161864210|NCT04837196|584545629|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
161864211|NCT04837196|584545630|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
161864212|NCT04837196|584545631|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
161864213|NCT04837196|584545632|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
161864214|NCT04837196|584545628|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
161864215|NCT04837196|584545629|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
161864216|NCT04837196|584545630|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
161864217|NCT04837196|584545631|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
161864218|NCT04837196|584545632|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
161864219|NCT00991887|584545633|FG000|Overall Study|Lost to Follow-up|2|||
161864220|NCT00991887|584545634|FG001|Overall Study|Lost to Follow-up|1|||
161864221|NCT01306305|584545635|FG000|Overall Study|Lost to Follow-up|1|||
161864222|NCT01306305|584545636|FG001|Overall Study|Lost to Follow-up|0|||
161864223|NCT01306305|584545635|FG000|Overall Study|Withdrew consent|1|||
161864224|NCT01306305|584545636|FG001|Overall Study|Withdrew consent|0|||
161864225|NCT04030299|584545637|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
161864226|NCT04030299|584545637|FG000|Overall Study|Withdrawal by Subject|3|||
161864227|NCT00699998|584545638|FG000|Overall Study|Withdrawal by Subject|194|||
161864228|NCT00699998|584545639|FG001|Overall Study|Withdrawal by Subject|83|||
161864229|NCT00699998|584545640|FG002|Overall Study|Withdrawal by Subject|202|||
161864230|NCT00699998|584545641|FG003|Overall Study|Withdrawal by Subject|80|||
161864231|NCT00699998|584545638|FG000|Overall Study|Physician Decision|3|||
161864232|NCT00699998|584545639|FG001|Overall Study|Physician Decision|2|||
161864233|NCT00699998|584545640|FG002|Overall Study|Physician Decision|1|||
161864234|NCT00699998|584545641|FG003|Overall Study|Physician Decision|1|||
161981019|NCT01927055|584978658|FG000|Open-label|Difficulty attending study visits|1|||
161864235|NCT00699998|584545638|FG000|Overall Study|Lost to Follow-up|2|||
161864236|NCT00699998|584545639|FG001|Overall Study|Lost to Follow-up|1|||
161864237|NCT00699998|584545640|FG002|Overall Study|Lost to Follow-up|3|||
161864238|NCT00699998|584545641|FG003|Overall Study|Lost to Follow-up|1|||
161981020|NCT01927055|584978659|FG001|Open-label|Difficulty attending study visits|0|||
161981021|NCT01927055|584978660|FG002|Open-label|Difficulty attending study visits|0|||
161981022|NCT01927055|584978658|FG000|Double-Blind|Adverse Event|0|||
161981023|NCT01927055|584978659|FG001|Double-Blind|Adverse Event|1|||
161981024|NCT01927055|584978660|FG002|Double-Blind|Adverse Event|1|||
161981025|NCT01927055|584978658|FG000|Double-Blind|Protocol Violation|0|||
161981026|NCT01927055|584978659|FG001|Double-Blind|Protocol Violation|0|||
161981027|NCT01927055|584978660|FG002|Double-Blind|Protocol Violation|1|||
161981028|NCT01927055|584978658|FG000|Double-Blind|Withdrawal by Subject|0|||
161981029|NCT01927055|584978659|FG001|Double-Blind|Withdrawal by Subject|2|||
161981030|NCT01927055|584978660|FG002|Double-Blind|Withdrawal by Subject|3|||
161981031|NCT01927055|584978658|FG000|Double-Blind|Study Stopped|0|||
161981032|NCT01927055|584978659|FG001|Double-Blind|Study Stopped|7|||
161981033|NCT01927055|584978660|FG002|Double-Blind|Study Stopped|7|||
161981034|NCT01927055|584978658|FG000|Double-Blind|Supine Hypertension|0|||
161981035|NCT01927055|584978659|FG001|Double-Blind|Supine Hypertension|0|||
161981036|NCT01927055|584978660|FG002|Double-Blind|Supine Hypertension|1|||
161981037|NCT01927055|584978658|FG000|Double-Blind|Extended Vacation|0|||
161981038|NCT01927055|584978659|FG001|Double-Blind|Extended Vacation|1|||
161981039|NCT01927055|584978660|FG002|Double-Blind|Extended Vacation|0|||
161981040|NCT02598128|584978661|FG000|Period A: Days -7 to -1|Adverse Event|1|||
161981041|NCT02598128|584978662|FG001|Period A: Days -7 to -1|Adverse Event|0|||
161981042|NCT02598128|584978663|FG002|Period A: Days -7 to -1|Adverse Event|0|||
161981043|NCT02598128|584978664|FG003|Period A: Days -7 to -1|Adverse Event|0|||
161981044|NCT01378429|584978665|FG000|Overall Study|Noncompliance with study drug|1|||
161981045|NCT01378429|584978666|FG001|Overall Study|Noncompliance with study drug|0|||
161981046|NCT00619489|584978667|FG000|Overall Study|Adverse Event|0|||
161981047|NCT00619489|584978668|FG001|Overall Study|Adverse Event|7|||
161981048|NCT00619489|584978667|FG000|Overall Study|Withdrawal by Subject|1|||
161981049|NCT00619489|584978668|FG001|Overall Study|Withdrawal by Subject|1|||
161981050|NCT00619489|584978667|FG000|Overall Study|Lack of Efficacy|0|||
161981051|NCT00619489|584978668|FG001|Overall Study|Lack of Efficacy|11|||
161981052|NCT00619489|584978667|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
161981053|NCT00619489|584978668|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
161981054|NCT03134183|584978669|FG000|Overall Study|Withdrawal by Subject|1|||
161981055|NCT03134183|584978670|FG001|Overall Study|Withdrawal by Subject|1|||
161981056|NCT02265796|584978673|FG000|Overall Study|Death|1|||
161981057|NCT02265796|584978674|FG001|Overall Study|Death|0|||
161981058|NCT02265796|584978673|FG000|Overall Study|started on excluded medication|1|||
161981059|NCT02265796|584978674|FG001|Overall Study|started on excluded medication|0|||
161981060|NCT02265796|584978673|FG000|Overall Study|Withdrawal by Subject|1|||
161981061|NCT02265796|584978674|FG001|Overall Study|Withdrawal by Subject|1|||
161981062|NCT02477553|584978675|FG000|Overall Study|Screening up-to-date|12|||
161981063|NCT02477553|584978676|FG001|Overall Study|Screening up-to-date|13|||
161981064|NCT02477553|584978675|FG000|Overall Study|No MD visit|1|||
161981065|NCT02477553|584978676|FG001|Overall Study|No MD visit|1|||
161981066|NCT02477553|584978675|FG000|Overall Study|Workup consistent w/CRC|1|||
161981067|NCT02477553|584978676|FG001|Overall Study|Workup consistent w/CRC|1|||
161981068|NCT02477553|584978675|FG000|Overall Study|Technical issues with intervention|2|||
161981069|NCT02477553|584978676|FG001|Overall Study|Technical issues with intervention|0|||
161981070|NCT02477553|584978675|FG000|Overall Study|Elevated risk for CRC|2|||
161981071|NCT02477553|584978676|FG001|Overall Study|Elevated risk for CRC|2|||
161981072|NCT02477553|584978675|FG000|Overall Study|MD advised against screening|1|||
161981073|NCT02477553|584978676|FG001|Overall Study|MD advised against screening|3|||
161981074|NCT02477553|584978675|FG000|Overall Study|patient deceased|1|||
161981075|NCT02477553|584978676|FG001|Overall Study|patient deceased|0|||
161981076|NCT04311463|584978677|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
161981077|NCT04311463|584978678|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
161981078|NCT04311463|584978677|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
161981079|NCT04311463|584978678|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
161981080|NCT04311463|584978677|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
161981081|NCT04311463|584978678|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
161981082|NCT04023682|584978679|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
161981083|NCT00454649|584978680|FG000|Overall Study|Lack of Efficacy|2|||
161981084|NCT00454649|584978681|FG001|Overall Study|Lack of Efficacy|2|||
161981085|NCT00454649|584978682|FG002|Overall Study|Lack of Efficacy|10|||
161981086|NCT00454649|584978683|FG003|Overall Study|Lack of Efficacy|3|||
161981087|NCT00454649|584978684|FG004|Overall Study|Lack of Efficacy|0|||
161981088|NCT00454649|584978685|FG005|Overall Study|Lack of Efficacy|4|||
162034909|NCT03228420|585184808|FG001|Overall Study|Adverse Event|2|||
162034910|NCT01083173|585184809|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
162034911|NCT01083173|585184810|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
161864239|NCT04616612|584545648|FG000|Overall Study|Lost to Follow-up|6|||
161981089|NCT00454649|584978686|FG006|Overall Study|Lack of Efficacy|5|||
161981090|NCT00454649|584978687|FG007|Overall Study|Lack of Efficacy|13|||
161981091|NCT00454649|584978688|FG008|Overall Study|Lack of Efficacy|10|||
161981092|NCT00454649|584978689|FG009|Overall Study|Lack of Efficacy|2|||
161981093|NCT00454649|584978680|FG000|Overall Study|Adverse Event|0|||
161981094|NCT00454649|584978681|FG001|Overall Study|Adverse Event|1|||
161981095|NCT00454649|584978682|FG002|Overall Study|Adverse Event|3|||
161981096|NCT00454649|584978683|FG003|Overall Study|Adverse Event|0|||
161981097|NCT00454649|584978684|FG004|Overall Study|Adverse Event|1|||
161981098|NCT00454649|584978685|FG005|Overall Study|Adverse Event|2|||
161981099|NCT00454649|584978686|FG006|Overall Study|Adverse Event|3|||
161981100|NCT00454649|584978687|FG007|Overall Study|Adverse Event|4|||
161981101|NCT00454649|584978688|FG008|Overall Study|Adverse Event|6|||
161981102|NCT00454649|584978689|FG009|Overall Study|Adverse Event|2|||
161981103|NCT00454649|584978680|FG000|Overall Study|Lost to Follow-up|0|||
161981104|NCT00454649|584978681|FG001|Overall Study|Lost to Follow-up|0|||
161981105|NCT00454649|584978682|FG002|Overall Study|Lost to Follow-up|1|||
161981106|NCT00454649|584978683|FG003|Overall Study|Lost to Follow-up|0|||
161981107|NCT00454649|584978684|FG004|Overall Study|Lost to Follow-up|0|||
161981108|NCT00454649|584978685|FG005|Overall Study|Lost to Follow-up|0|||
161981109|NCT00454649|584978686|FG006|Overall Study|Lost to Follow-up|1|||
161981110|NCT00454649|584978687|FG007|Overall Study|Lost to Follow-up|0|||
161981111|NCT00454649|584978688|FG008|Overall Study|Lost to Follow-up|0|||
161981112|NCT00454649|584978689|FG009|Overall Study|Lost to Follow-up|0|||
161981113|NCT00454649|584978680|FG000|Overall Study|Other|1|||
161981114|NCT00454649|584978681|FG001|Overall Study|Other|1|||
161981115|NCT00454649|584978682|FG002|Overall Study|Other|5|||
161981116|NCT00454649|584978683|FG003|Overall Study|Other|3|||
161981117|NCT00454649|584978684|FG004|Overall Study|Other|0|||
161981118|NCT00454649|584978685|FG005|Overall Study|Other|0|||
161981119|NCT00454649|584978686|FG006|Overall Study|Other|0|||
161981120|NCT00454649|584978687|FG007|Overall Study|Other|0|||
161981121|NCT00454649|584978688|FG008|Overall Study|Other|3|||
161981122|NCT00454649|584978689|FG009|Overall Study|Other|1|||
161981123|NCT00454649|584978680|FG000|Overall Study|Withdrawal by Subject|0|||
161981124|NCT00454649|584978681|FG001|Overall Study|Withdrawal by Subject|0|||
161981125|NCT00454649|584978682|FG002|Overall Study|Withdrawal by Subject|0|||
161981126|NCT00454649|584978683|FG003|Overall Study|Withdrawal by Subject|0|||
161981127|NCT00454649|584978684|FG004|Overall Study|Withdrawal by Subject|0|||
161981128|NCT00454649|584978685|FG005|Overall Study|Withdrawal by Subject|1|||
161981129|NCT00454649|584978686|FG006|Overall Study|Withdrawal by Subject|0|||
161981130|NCT00454649|584978687|FG007|Overall Study|Withdrawal by Subject|2|||
161981131|NCT00454649|584978688|FG008|Overall Study|Withdrawal by Subject|1|||
161981132|NCT00454649|584978689|FG009|Overall Study|Withdrawal by Subject|0|||
161981133|NCT02745535|584978691|FG000|Overall Study|Death|1|||
161981134|NCT02745535|584978691|FG000|Overall Study|Adverse Event|3|||
161981135|NCT02745535|584978691|FG000|Overall Study|Lost to Follow-up|2|||
161981136|NCT01291277|584978696|FG000|Overall Study|Death|2|||
161981137|NCT01291277|584978697|FG001|Overall Study|Death|2|||
161981138|NCT01291277|584978696|FG000|Overall Study|Lost to Follow-up|3|||
161981139|NCT01291277|584978697|FG001|Overall Study|Lost to Follow-up|1|||
161981140|NCT00377364|584978698|FG000|Overall Study|Lost to Follow-up|1|||
161981141|NCT00377364|584978699|FG001|Overall Study|Lost to Follow-up|0|||
161981142|NCT00377364|584978698|FG000|Overall Study|Withdrawal by Subject|1|||
161981143|NCT00377364|584978699|FG001|Overall Study|Withdrawal by Subject|0|||
161981144|NCT03480009|584978703|FG000|Overall Study|Lost to Follow-up|4|||
161981145|NCT03480009|584978704|FG001|Overall Study|Lost to Follow-up|5|||
161981146|NCT03480009|584978705|FG002|Overall Study|Lost to Follow-up|4|||
161981147|NCT03480009|584978706|FG003|Overall Study|Lost to Follow-up|0|||
161981148|NCT01638559|584978707|FG000|Overall Study|Lost to Follow-up|1|||
161981149|NCT01638559|584978707|FG000|Overall Study|Withdrawal by Subject|1|||
161981150|NCT01638559|584978707|FG000|Overall Study|Subject declined to travel for biopsy|1|||
161981151|NCT02014584|584978708|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161981152|NCT02014584|584978709|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
161981153|NCT02014584|584978710|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161981154|NCT02014584|584978711|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161981155|NCT02014584|584978712|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161981156|NCT02014584|584978713|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161981157|NCT02014584|584978708|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
161981158|NCT02014584|584978709|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
161981159|NCT02014584|584978710|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161981160|NCT02014584|584978711|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161981161|NCT02014584|584978712|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161981162|NCT02014584|584978713|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161981163|NCT02014584|584978708|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
161981164|NCT02014584|584978709|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
161981165|NCT02014584|584978710|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
161981166|NCT02014584|584978711|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
161981167|NCT02014584|584978712|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
161981168|NCT02014584|584978713|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
161981169|NCT02014584|584978708|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
161981170|NCT02014584|584978709|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
161981171|NCT02014584|584978710|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
161981172|NCT02014584|584978711|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
161981173|NCT02014584|584978712|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
161864240|NCT04616612|584545649|FG001|Overall Study|Lost to Follow-up|3|||
161864241|NCT04740918|584545651|FG000|Overall Study|Study Terminated by Sponsor|41|||
161864242|NCT04740918|584545652|FG001|Overall Study|Study Terminated by Sponsor|32|||
161864243|NCT04740918|584545651|FG000|Overall Study|Death|3|||
161864244|NCT04740918|584545652|FG001|Overall Study|Death|6|||
161864245|NCT04740918|584545651|FG000|Overall Study|Withdrawal by Subject|5|||
161864246|NCT04740918|584545652|FG001|Overall Study|Withdrawal by Subject|4|||
161864247|NCT04740918|584545651|FG000|Overall Study|Lost to Follow-up|1|||
161864248|NCT04740918|584545652|FG001|Overall Study|Lost to Follow-up|3|||
161864249|NCT04740918|584545651|FG000|Overall Study|Progressive disease|0|||
161864250|NCT04740918|584545652|FG001|Overall Study|Progressive disease|1|||
161864251|NCT00359424|584545656|FG000|Overall Study|Death|99|||
161864252|NCT00359424|584545657|FG001|Overall Study|Death|58|||
161864253|NCT00359424|584545656|FG000|Overall Study|Lost to Follow-up|19|||
161864254|NCT00359424|584545657|FG001|Overall Study|Lost to Follow-up|7|||
161864255|NCT00359424|584545656|FG000|Overall Study|Withdrawal by Subject|10|||
161864256|NCT00359424|584545657|FG001|Overall Study|Withdrawal by Subject|2|||
161864257|NCT00359424|584545656|FG000|Overall Study|follow up not conducted|2|||
161864258|NCT00359424|584545657|FG001|Overall Study|follow up not conducted|0|||
161864259|NCT02208362|584545658|FG000|Overall Study|Participant did not complete treatment|0|||
161864260|NCT02208362|584545659|FG001|Overall Study|Participant did not complete treatment|1|||
161864261|NCT02208362|584545660|FG002|Overall Study|Participant did not complete treatment|0|||
161864262|NCT02208362|584545661|FG003|Overall Study|Participant did not complete treatment|0|||
161864263|NCT02208362|584545662|FG004|Overall Study|Participant did not complete treatment|0|||
161864264|NCT02208362|584545663|FG005|Overall Study|Participant did not complete treatment|0|||
161864265|NCT02208362|584545664|FG006|Overall Study|Participant did not complete treatment|1|||
161864266|NCT02208362|584545665|FG007|Overall Study|Participant did not complete treatment|1|||
161864267|NCT02208362|584545666|FG008|Overall Study|Participant did not complete treatment|2|||
161864268|NCT02208362|584545667|FG009|Overall Study|Participant did not complete treatment|0|||
161864269|NCT02208362|584545668|FG010|Overall Study|Participant did not complete treatment|1|||
161864270|NCT02208362|584545669|FG011|Overall Study|Participant did not complete treatment|0|||
161864271|NCT02208362|584545658|FG000|Overall Study|Participant received disallowed treatment|0|||
161864272|NCT02208362|584545659|FG001|Overall Study|Participant received disallowed treatment|0|||
161864273|NCT02208362|584545660|FG002|Overall Study|Participant received disallowed treatment|0|||
161864274|NCT02208362|584545661|FG003|Overall Study|Participant received disallowed treatment|0|||
161864275|NCT02208362|584545662|FG004|Overall Study|Participant received disallowed treatment|0|||
161864276|NCT02208362|584545663|FG005|Overall Study|Participant received disallowed treatment|0|||
161864277|NCT02208362|584545664|FG006|Overall Study|Participant received disallowed treatment|0|||
161864278|NCT02208362|584545665|FG007|Overall Study|Participant received disallowed treatment|0|||
161864279|NCT02208362|584545666|FG008|Overall Study|Participant received disallowed treatment|1|||
161864280|NCT02208362|584545667|FG009|Overall Study|Participant received disallowed treatment|0|||
161864281|NCT02208362|584545668|FG010|Overall Study|Participant received disallowed treatment|0|||
161864282|NCT02208362|584545669|FG011|Overall Study|Participant received disallowed treatment|0|||
161864283|NCT05479435|584545672|FG000|Overall Study|Withdrawal by Subject|1|||
161864284|NCT05479435|584545673|FG001|Overall Study|Withdrawal by Subject|0|||
161864285|NCT05479435|584545674|FG002|Overall Study|Withdrawal by Subject|0|||
161864286|NCT05479435|584545672|FG000|Overall Study|Covid 19|0|||
161864287|NCT05479435|584545673|FG001|Overall Study|Covid 19|0|||
161864288|NCT05479435|584545674|FG002|Overall Study|Covid 19|2|||
161864289|NCT00955617|584545679|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
161864290|NCT00955617|584545680|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
161864291|NCT00955617|584545679|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
161864292|NCT00955617|584545680|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
161864293|NCT00955617|584545679|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
161864294|NCT00955617|584545680|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
161864295|NCT00955617|584545679|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
161864296|NCT00955617|584545680|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
161864297|NCT01609790|584545681|FG000|Overall Study|Protocol Violation|1|||
161981174|NCT02014584|584978713|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
161981175|NCT02014584|584978708|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
161981176|NCT02014584|584978709|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
161981177|NCT02014584|584978710|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
161864298|NCT01609790|584545682|FG001|Overall Study|Protocol Violation|7|||
161864299|NCT01609790|584545683|FG002|Overall Study|Protocol Violation|8|||
161864300|NCT00858273|584545684|FG000|Overall Study|Protocol Violation|3|||
161864301|NCT00858273|584545685|FG001|Overall Study|Protocol Violation|5|||
161864302|NCT00982657|584545686|FG000|Overall Study|Death|1|||
161864303|NCT00982657|584545687|FG001|Overall Study|Death|0|||
161981178|NCT02014584|584978711|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
161981179|NCT02014584|584978712|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
161981180|NCT02014584|584978713|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
161981181|NCT00483002|584978714|FG000|Overall Study|Adverse Event|68|||
161981182|NCT00483002|584978714|FG000|Overall Study|Lack of Efficacy|555|||
161981183|NCT00483002|584978714|FG000|Overall Study|Lost to Follow-up|962|||
161981184|NCT00483002|584978714|FG000|Overall Study|Other|2|||
161981185|NCT00483002|584978714|FG000|Overall Study|Other|967|||
161981186|NCT02651220|584978718|FG000|Overall Study|Adverse Event|1|||
161981187|NCT02651220|584978719|FG001|Overall Study|Adverse Event|5|||
161981188|NCT02651220|584978720|FG002|Overall Study|Adverse Event|1|||
161981189|NCT02651220|584978718|FG000|Overall Study|Lost to Follow-up|8|||
161981190|NCT02651220|584978719|FG001|Overall Study|Lost to Follow-up|14|||
161981191|NCT02651220|584978720|FG002|Overall Study|Lost to Follow-up|14|||
161981192|NCT02651220|584978718|FG000|Overall Study|Non-Compliance with Study Drug|4|||
161981193|NCT02651220|584978719|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161981194|NCT02651220|584978720|FG002|Overall Study|Non-Compliance with Study Drug|1|||
161981195|NCT02651220|584978718|FG000|Overall Study|Pregnancy|1|||
161981196|NCT02651220|584978719|FG001|Overall Study|Pregnancy|0|||
161981197|NCT02651220|584978720|FG002|Overall Study|Pregnancy|1|||
161981198|NCT02651220|584978718|FG000|Overall Study|Protocol Violation|0|||
161981199|NCT02651220|584978719|FG001|Overall Study|Protocol Violation|0|||
161981200|NCT02651220|584978720|FG002|Overall Study|Protocol Violation|1|||
161981201|NCT02651220|584978718|FG000|Overall Study|Withdrawal by Subject|5|||
161981202|NCT02651220|584978719|FG001|Overall Study|Withdrawal by Subject|6|||
161981203|NCT02651220|584978720|FG002|Overall Study|Withdrawal by Subject|8|||
161981204|NCT02651220|584978718|FG000|Overall Study|Miscellaneous|4|||
161981205|NCT02651220|584978719|FG001|Overall Study|Miscellaneous|1|||
161981206|NCT02651220|584978720|FG002|Overall Study|Miscellaneous|2|||
161981207|NCT02651220|584978718|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161981208|NCT02651220|584978719|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161981209|NCT02651220|584978720|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
161981210|NCT01274429|584978722|FG000|Overall Study|Study closed do to lack of funding|5|||
161981211|NCT01439373|584978723|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
161981212|NCT01439373|584978724|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
161981213|NCT01439373|584978723|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
161981214|NCT01439373|584978724|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
161981215|NCT04576897|584978727|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
161981216|NCT02593318|584978730|FG000|Overall Study|Withdrawal by Subject|1|||
161981217|NCT02593318|584978731|FG001|Overall Study|Withdrawal by Subject|1|||
161981218|NCT03109184|584980382|FG000|Overall Study|Lost to Follow-up|6|||
161981219|NCT03109184|584980383|FG001|Overall Study|Lost to Follow-up|6|||
161981220|NCT03109184|584980382|FG000|Overall Study|Withdrawal by Subject|1|||
161981221|NCT03109184|584980383|FG001|Overall Study|Withdrawal by Subject|1|||
161981222|NCT00602420|584980384|FG000|Overall Study|Death|1|||
161981223|NCT00602420|584980385|FG001|Overall Study|Death|4|||
161981224|NCT00602420|584980384|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
161981225|NCT00602420|584980385|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
161981226|NCT00602420|584980384|FG000|Overall Study|Withdrawal by Subject|18|||
161981227|NCT00602420|584980385|FG001|Overall Study|Withdrawal by Subject|17|||
161981228|NCT00602420|584980384|FG000|Overall Study|Adverse Event|1|||
161981229|NCT00602420|584980385|FG001|Overall Study|Adverse Event|0|||
161981230|NCT01209078|584980397|FG000|Overall Study|Adverse Event|5|||
161981231|NCT01209078|584980398|FG001|Overall Study|Adverse Event|0|||
161981232|NCT01209078|584980397|FG000|Overall Study|Lost to Follow-up|4|||
161981233|NCT01209078|584980398|FG001|Overall Study|Lost to Follow-up|0|||
161981234|NCT01209078|584980397|FG000|Overall Study|Physician Decision|5|||
161981235|NCT01209078|584980398|FG001|Overall Study|Physician Decision|2|||
161981236|NCT01209078|584980397|FG000|Overall Study|Withdrawal by Subject|2|||
161981237|NCT01209078|584980398|FG001|Overall Study|Withdrawal by Subject|1|||
161981238|NCT04201093|584980399|FG000|Overall Study|Adverse Event|6|||
161981239|NCT04201093|584980400|FG001|Overall Study|Adverse Event|29|||
161981240|NCT04201093|584980401|FG002|Overall Study|Adverse Event|35|||
162034912|NCT01083173|585184809|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
162034913|NCT01083173|585184810|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
161981241|NCT04201093|584980399|FG000|Overall Study|Death|2|||
161981242|NCT04201093|584980400|FG001|Overall Study|Death|1|||
161981243|NCT04201093|584980401|FG002|Overall Study|Death|0|||
161981244|NCT04201093|584980399|FG000|Overall Study|Lack of Efficacy|5|||
161981245|NCT04201093|584980400|FG001|Overall Study|Lack of Efficacy|1|||
161981246|NCT04201093|584980401|FG002|Overall Study|Lack of Efficacy|2|||
162034914|NCT01083173|585184809|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
161864304|NCT00982657|584545688|FG002|Overall Study|Death|1|||
161981247|NCT04201093|584980399|FG000|Overall Study|Lost to Follow-up|0|||
161981248|NCT04201093|584980400|FG001|Overall Study|Lost to Follow-up|0|||
161981249|NCT04201093|584980401|FG002|Overall Study|Lost to Follow-up|1|||
161981250|NCT04201093|584980399|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
161981251|NCT04201093|584980400|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
161981252|NCT04201093|584980401|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
161864305|NCT00982657|584545689|FG003|Overall Study|Death|1|||
161864306|NCT00982657|584545686|FG000|Overall Study|Withdrawal by Subject|0|||
161864307|NCT00982657|584545687|FG001|Overall Study|Withdrawal by Subject|0|||
161864308|NCT00982657|584545688|FG002|Overall Study|Withdrawal by Subject|1|||
161864309|NCT00982657|584545689|FG003|Overall Study|Withdrawal by Subject|3|||
161864310|NCT00982657|584545686|FG000|Overall Study|Other|0|||
161864311|NCT00982657|584545687|FG001|Overall Study|Other|0|||
161864312|NCT00982657|584545688|FG002|Overall Study|Other|0|||
161864313|NCT00982657|584545689|FG003|Overall Study|Other|4|||
161864314|NCT00982657|584545686|FG000|Overall Study|On going at date of cut-off|0|||
161864315|NCT00982657|584545687|FG001|Overall Study|On going at date of cut-off|0|||
161864316|NCT00982657|584545688|FG002|Overall Study|On going at date of cut-off|0|||
161864317|NCT00982657|584545689|FG003|Overall Study|On going at date of cut-off|1|||
161864318|NCT03760744|584547674|FG000|Overall Study|Lost to Follow-up|3|||
161864319|NCT03760744|584547675|FG001|Overall Study|Lost to Follow-up|0|||
161864320|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Adverse Event|7|||
161864321|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
161864322|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Non-compliance|3|||
161864323|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Other|17|||
161864324|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Physician Decision|2|||
161864325|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Pregnancy|1|||
161864326|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
161864327|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
161864328|NCT05207865|584547676|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
161864329|NCT05207865|584547676|FG000|Follow-up Phase|Lost to Follow-up|1|||
161864330|NCT05207865|584547676|FG000|Follow-up Phase|Non-compliance|1|||
161864331|NCT05207865|584547676|FG000|Follow-up Phase|Not reported|2|||
161864332|NCT05207865|584547676|FG000|Follow-up Phase|Not collected|11|||
161864333|NCT00739882|584547681|FG000|Double-blind Period|Adverse Event|1|||
161864334|NCT00739882|584547682|FG001|Double-blind Period|Adverse Event|2|||
161864335|NCT00739882|584547681|FG000|Double-blind Period|Protocol Violation|1|||
161864336|NCT00739882|584547682|FG001|Double-blind Period|Protocol Violation|0|||
161864337|NCT00739882|584547681|FG000|Double-blind Period|Lack of Efficacy|1|||
161864338|NCT00739882|584547682|FG001|Double-blind Period|Lack of Efficacy|1|||
161864339|NCT00739882|584547681|FG000|Double-blind Period|Other|16|||
161864340|NCT00739882|584547682|FG001|Double-blind Period|Other|8|||
161864341|NCT00739882|584547681|FG000|Open-label Period|Adverse Event|1|||
161864342|NCT00739882|584547682|FG001|Open-label Period|Adverse Event|0|||
161864343|NCT00739882|584547681|FG000|Open-label Period|Other|9|||
161864344|NCT00739882|584547682|FG001|Open-label Period|Other|5|||
161864345|NCT03055338|584547685|FG000|Overall Study|Lost to Follow-up|9|||
161864346|NCT03055338|584547686|FG001|Overall Study|Lost to Follow-up|2|||
161864347|NCT03055338|584547687|FG002|Overall Study|Lost to Follow-up|3|||
161864348|NCT03055338|584547685|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
161864349|NCT03055338|584547686|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
161864350|NCT03055338|584547687|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
161864351|NCT03055338|584547685|FG000|Overall Study|Physician Decision|0|||
161864352|NCT03055338|584547686|FG001|Overall Study|Physician Decision|0|||
161864353|NCT03055338|584547687|FG002|Overall Study|Physician Decision|2|||
161864354|NCT03055338|584547685|FG000|Overall Study|Withdrawal by Subject|9|||
161864355|NCT03055338|584547686|FG001|Overall Study|Withdrawal by Subject|8|||
161864356|NCT03055338|584547687|FG002|Overall Study|Withdrawal by Subject|7|||
161864357|NCT00975611|584547688|FG000|Overall Study|Screen Fail|16|||
161864358|NCT00975611|584547688|FG000|Overall Study|Physician Decision|1|||
161864359|NCT03058705|584547689|FG000|Overall Study|Withdrawal by Subject|2|||
161864360|NCT03058705|584547689|FG000|Overall Study|Physician Decision|2|||
161981253|NCT04201093|584980399|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
161981254|NCT04201093|584980400|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
161864361|NCT01880554|584547690|FG000|Overall Study|Protocol Violation|14|||
161864362|NCT01880554|584547690|FG000|Overall Study|Simon's design requirements|2|||
161864363|NCT01102257|584547695|FG000|Overall Study|Adverse Event|1|||
161864364|NCT01102257|584547696|FG001|Overall Study|Adverse Event|0|||
161864365|NCT01102257|584547695|FG000|Overall Study|Adverse Event|1|||
161864366|NCT01102257|584547696|FG001|Overall Study|Adverse Event|0|||
161864367|NCT03752970|584547697|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
161864368|NCT03752970|584547698|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
161864369|NCT03752970|584547699|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
161981255|NCT04201093|584980401|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
161981256|NCT04201093|584980399|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
161981257|NCT04201093|584980400|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
161864370|NCT03752970|584547697|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
161864371|NCT03752970|584547698|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
161864372|NCT03752970|584547699|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
161864373|NCT03752970|584547697|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
161864374|NCT03752970|584547698|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
161981258|NCT04201093|584980401|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
161981259|NCT04201093|584980399|FG000|Overall Study|Physician Decision|1|||
161981260|NCT04201093|584980400|FG001|Overall Study|Physician Decision|0|||
161981261|NCT04201093|584980401|FG002|Overall Study|Physician Decision|0|||
161981262|NCT04201093|584980399|FG000|Overall Study|Protocol Deviation|1|||
161981263|NCT04201093|584980400|FG001|Overall Study|Protocol Deviation|0|||
161981264|NCT04201093|584980401|FG002|Overall Study|Protocol Deviation|0|||
161981265|NCT04201093|584980399|FG000|Overall Study|Site Terminated by Sponsor|5|||
161981266|NCT04201093|584980400|FG001|Overall Study|Site Terminated by Sponsor|3|||
161981267|NCT04201093|584980401|FG002|Overall Study|Site Terminated by Sponsor|1|||
161981268|NCT04201093|584980399|FG000|Overall Study|Withdrawal by Subject|7|||
161981269|NCT04201093|584980400|FG001|Overall Study|Withdrawal by Subject|8|||
161981270|NCT04201093|584980401|FG002|Overall Study|Withdrawal by Subject|15|||
161981271|NCT04201093|584980399|FG000|Overall Study|Other|0|||
161981272|NCT04201093|584980400|FG001|Overall Study|Other|1|||
161981273|NCT04201093|584980401|FG002|Overall Study|Other|2|||
161981274|NCT00881504|584980402|FG000|Overall Study|Withdrawal by Subject|1|||
161981275|NCT01276223|584980403|FG000|Overall Study|Adverse Event|7|||
161981276|NCT01276223|584980404|FG001|Overall Study|Adverse Event|4|||
161981277|NCT01276223|584980405|FG002|Overall Study|Adverse Event|1|||
161981278|NCT01276223|584980403|FG000|Overall Study|Lost to Follow-up|0|||
161981279|NCT01276223|584980404|FG001|Overall Study|Lost to Follow-up|0|||
161981280|NCT01276223|584980405|FG002|Overall Study|Lost to Follow-up|1|||
161981281|NCT01276223|584980403|FG000|Overall Study|Other|0|||
161981282|NCT01276223|584980404|FG001|Overall Study|Other|0|||
161981283|NCT01276223|584980405|FG002|Overall Study|Other|1|||
161981284|NCT01276223|584980403|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
161981285|NCT01276223|584980404|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
161981286|NCT01276223|584980405|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
161981287|NCT01276223|584980403|FG000|Overall Study|Protocol Violation|1|||
161981288|NCT01276223|584980404|FG001|Overall Study|Protocol Violation|0|||
161981289|NCT01276223|584980405|FG002|Overall Study|Protocol Violation|0|||
161981290|NCT02017522|584980406|FG000|Overall Study|Withdrawal by Subject|1|||
161981291|NCT02596230|584980407|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
161981292|NCT02596230|584980408|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
161981293|NCT02596230|584980409|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
161981294|NCT02596230|584980410|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
161981295|NCT02596230|584980411|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
161981296|NCT02596230|584980407|FG000|Objective 2, One Year|Lost to Follow-up|0|||
161981297|NCT02596230|584980408|FG001|Objective 2, One Year|Lost to Follow-up|41|||
161981298|NCT02596230|584980409|FG002|Objective 2, One Year|Lost to Follow-up|41|||
161981299|NCT02596230|584980410|FG003|Objective 2, One Year|Lost to Follow-up|32|||
161981300|NCT02596230|584980411|FG004|Objective 2, One Year|Lost to Follow-up|46|||
161981301|NCT02596230|584980407|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
161981302|NCT02596230|584980408|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
161981303|NCT02596230|584980409|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
161981304|NCT02596230|584980410|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
161981305|NCT02596230|584980411|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
161981306|NCT02596230|584980407|FG000|Objective 2, One Year|Adverse drug reaction|0|||
161981307|NCT02596230|584980408|FG001|Objective 2, One Year|Adverse drug reaction|1|||
161981308|NCT02596230|584980409|FG002|Objective 2, One Year|Adverse drug reaction|0|||
161981309|NCT02596230|584980410|FG003|Objective 2, One Year|Adverse drug reaction|0|||
161981310|NCT02596230|584980411|FG004|Objective 2, One Year|Adverse drug reaction|0|||
161981311|NCT02596230|584980407|FG000|Objective 2, One Year|Death|0|||
161981312|NCT02596230|584980408|FG001|Objective 2, One Year|Death|12|||
161981313|NCT02596230|584980409|FG002|Objective 2, One Year|Death|41|||
161981314|NCT02596230|584980410|FG003|Objective 2, One Year|Death|21|||
161981315|NCT02596230|584980411|FG004|Objective 2, One Year|Death|30|||
161981316|NCT02596230|584980407|FG000|Objective 2, One Year|Other|0|||
161981317|NCT02596230|584980408|FG001|Objective 2, One Year|Other|3|||
161981318|NCT02596230|584980409|FG002|Objective 2, One Year|Other|2|||
161981319|NCT02596230|584980410|FG003|Objective 2, One Year|Other|0|||
161981320|NCT02596230|584980411|FG004|Objective 2, One Year|Other|0|||
161981321|NCT00771615|584980412|FG000|Overall Study|Withdrawal by Subject|0|||
161981322|NCT00771615|584980413|FG001|Overall Study|Withdrawal by Subject|1|||
161981323|NCT00771615|584980414|FG002|Overall Study|Withdrawal by Subject|0|||
161981324|NCT00771615|584980415|FG003|Overall Study|Withdrawal by Subject|0|||
161981325|NCT00771615|584980416|FG004|Overall Study|Withdrawal by Subject|0|||
161981326|NCT00771615|584980417|FG005|Overall Study|Withdrawal by Subject|0|||
161981327|NCT00771615|584980418|FG006|Overall Study|Withdrawal by Subject|0|||
161981328|NCT00771615|584980419|FG007|Overall Study|Withdrawal by Subject|1|||
161981329|NCT00771615|584980420|FG008|Overall Study|Withdrawal by Subject|0|||
161981330|NCT00771615|584980412|FG000|Overall Study|Lost to Follow-up|1|||
161981331|NCT00771615|584980413|FG001|Overall Study|Lost to Follow-up|1|||
161981332|NCT00771615|584980414|FG002|Overall Study|Lost to Follow-up|1|||
161981333|NCT00771615|584980415|FG003|Overall Study|Lost to Follow-up|1|||
161981334|NCT00771615|584980416|FG004|Overall Study|Lost to Follow-up|0|||
161981335|NCT00771615|584980417|FG005|Overall Study|Lost to Follow-up|1|||
161981336|NCT00771615|584980418|FG006|Overall Study|Lost to Follow-up|1|||
161981337|NCT00771615|584980419|FG007|Overall Study|Lost to Follow-up|0|||
161981338|NCT00771615|584980420|FG008|Overall Study|Lost to Follow-up|0|||
161981339|NCT02704689|584980422|FG000|Overall Study|Physician Decision|1|||
161981340|NCT02704689|584980422|FG000|Overall Study|Study device not implanted|2|||
161981341|NCT00802893|584980423|FG000|Overall Study|study terminated|3|||
161981342|NCT00320424|584980424|FG000|Overall Study|Adverse Event|3|||
161981343|NCT00320424|584980424|FG000|Overall Study|Other|3|||
161981344|NCT02540668|584980426|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
161981345|NCT02540668|584980427|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
161981346|NCT03270891|584980428|FG000|Overall Study|Lost to Follow-up|3|||
161981347|NCT03270891|584980429|FG001|Overall Study|Lost to Follow-up|6|||
161864375|NCT03752970|584547699|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
161864376|NCT03752970|584547697|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
161864377|NCT03752970|584547698|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
161864378|NCT03752970|584547699|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
161864379|NCT03752970|584547697|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
161864380|NCT03752970|584547698|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
161864381|NCT03752970|584547699|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
161864382|NCT04767282|584547700|FG000|Overall Study|Refused or did not begin surveys|6|||
161864383|NCT04767282|584547701|FG001|Overall Study|Refused or did not begin surveys|2|||
161864384|NCT04767282|584547702|FG002|Overall Study|Refused or did not begin surveys|2|||
161864385|NCT04767282|584547700|FG000|Overall Study|Duplicate household previously enrolled|2|||
161864386|NCT04767282|584547701|FG001|Overall Study|Duplicate household previously enrolled|0|||
161864387|NCT04767282|584547702|FG002|Overall Study|Duplicate household previously enrolled|8|||
161864388|NCT04767282|584547700|FG000|Overall Study|Unable to confirm legal guardian|0|||
161864389|NCT04767282|584547701|FG001|Overall Study|Unable to confirm legal guardian|2|||
161864390|NCT04767282|584547702|FG002|Overall Study|Unable to confirm legal guardian|8|||
161864391|NCT04767282|584547700|FG000|Overall Study|Withdrawal by Subject|0|||
161864392|NCT04767282|584547701|FG001|Overall Study|Withdrawal by Subject|0|||
161864393|NCT04767282|584547702|FG002|Overall Study|Withdrawal by Subject|6|||
161864394|NCT04767282|584547700|FG000|Overall Study|Survey comprehension challenges|4|||
161864395|NCT04767282|584547701|FG001|Overall Study|Survey comprehension challenges|0|||
161864396|NCT04767282|584547702|FG002|Overall Study|Survey comprehension challenges|0|||
161864397|NCT01467713|584547704|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
161864398|NCT01467713|584547705|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
161864399|NCT01467713|584547706|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
161864400|NCT01467713|584547707|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
161864401|NCT01467713|584547704|FG000|Overall Study|Major Protocol Deviation|2|||
161864402|NCT01467713|584547705|FG001|Overall Study|Major Protocol Deviation|4|||
161864403|NCT01467713|584547706|FG002|Overall Study|Major Protocol Deviation|4|||
161864404|NCT01467713|584547707|FG003|Overall Study|Major Protocol Deviation|1|||
161864405|NCT01467713|584547704|FG000|Overall Study|Lost to Follow-up|9|||
161864406|NCT01467713|584547705|FG001|Overall Study|Lost to Follow-up|12|||
161864407|NCT01467713|584547706|FG002|Overall Study|Lost to Follow-up|6|||
161864408|NCT01467713|584547707|FG003|Overall Study|Lost to Follow-up|9|||
161864409|NCT01467713|584547704|FG000|Overall Study|Voluntary Withdrawal|18|||
161864410|NCT01467713|584547705|FG001|Overall Study|Voluntary Withdrawal|14|||
161864411|NCT01467713|584547706|FG002|Overall Study|Voluntary Withdrawal|21|||
161864412|NCT01467713|584547707|FG003|Overall Study|Voluntary Withdrawal|20|||
161864413|NCT01467713|584547704|FG000|Overall Study|Study Termination|23|||
161864414|NCT01467713|584547705|FG001|Overall Study|Study Termination|33|||
161864415|NCT01467713|584547706|FG002|Overall Study|Study Termination|28|||
161981348|NCT03270891|584980430|FG002|Overall Study|Lost to Follow-up|0|||
161981349|NCT03270891|584980428|FG000|Overall Study|Withdrawal by Subject|1|||
161981350|NCT03270891|584980429|FG001|Overall Study|Withdrawal by Subject|0|||
161981351|NCT03270891|584980430|FG002|Overall Study|Withdrawal by Subject|0|||
161864416|NCT01467713|584547707|FG003|Overall Study|Study Termination|29|||
161864417|NCT01467713|584547704|FG000|Overall Study|Pregnancy|0|||
161864418|NCT01467713|584547705|FG001|Overall Study|Pregnancy|1|||
161864419|NCT01467713|584547706|FG002|Overall Study|Pregnancy|1|||
161864420|NCT01467713|584547707|FG003|Overall Study|Pregnancy|3|||
161981352|NCT03270891|584980428|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
161981353|NCT03270891|584980429|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
161864421|NCT01467713|584547704|FG000|Overall Study|Relapse|35|||
161864422|NCT01467713|584547705|FG001|Overall Study|Relapse|25|||
161864423|NCT01467713|584547706|FG002|Overall Study|Relapse|28|||
161981354|NCT03270891|584980430|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
161864424|NCT01467713|584547707|FG003|Overall Study|Relapse|35|||
161864425|NCT01467713|584547704|FG000|Overall Study|Reason not Specified|6|||
161981355|NCT00849108|584980431|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
161981356|NCT00849108|584980432|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
161981357|NCT00849108|584980431|FG000|Cohort 2 Efficacy|Adverse Event|0|||
161981358|NCT00849108|584980432|FG001|Cohort 2 Efficacy|Adverse Event|1|||
161981359|NCT00849108|584980431|FG000|Cohort 2 Efficacy|Other|0|||
161981360|NCT00849108|584980432|FG001|Cohort 2 Efficacy|Other|9|||
161981361|NCT01475162|584980438|FG000|Overall Study|Physician Decision|1|||
161981362|NCT01475162|584980438|FG000|Overall Study|Death|10|||
161981363|NCT01475162|584980438|FG000|Overall Study|Study closed for safety|3|||
161981364|NCT00908037|584980439|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161981365|NCT00908037|584980440|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161981366|NCT00908037|584980441|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161981367|NCT00908037|584980442|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161981368|NCT00908037|584980443|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
161981369|NCT00908037|584980444|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161981370|NCT00908037|584980445|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
161981371|NCT00908037|584980446|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161981372|NCT00908037|584980447|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
161981373|NCT00908037|584980448|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161981374|NCT00908037|584980449|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161981375|NCT00908037|584980450|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
161981376|NCT00908037|584980439|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161981377|NCT00908037|584980440|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161981378|NCT00908037|584980441|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161981379|NCT00908037|584980442|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161981380|NCT00908037|584980443|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
161981381|NCT00908037|584980444|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161981382|NCT00908037|584980445|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161981383|NCT00908037|584980446|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161981384|NCT00908037|584980447|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
161981385|NCT00908037|584980448|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161981386|NCT00908037|584980449|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161981387|NCT00908037|584980450|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
161981388|NCT00908037|584980439|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161981389|NCT00908037|584980440|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161981390|NCT00908037|584980441|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161981391|NCT00908037|584980442|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
161981392|NCT00908037|584980443|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161981393|NCT00908037|584980444|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161981394|NCT00908037|584980445|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
161981395|NCT00908037|584980446|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161981396|NCT00908037|584980447|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161981397|NCT00908037|584980448|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161981398|NCT00908037|584980449|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161981399|NCT00908037|584980450|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
161981400|NCT00908037|584980439|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161981401|NCT00908037|584980440|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161981402|NCT00908037|584980441|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161981403|NCT00908037|584980442|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161981404|NCT00908037|584980443|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161981405|NCT00908037|584980444|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161981406|NCT00908037|584980445|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161981407|NCT00908037|584980446|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161981408|NCT00908037|584980447|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161981409|NCT00908037|584980448|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161981410|NCT00908037|584980449|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
161981411|NCT00908037|584980450|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
161981412|NCT00908037|584980439|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161981413|NCT00908037|584980440|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161981414|NCT00908037|584980441|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161981415|NCT00908037|584980442|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161981416|NCT00908037|584980443|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161981417|NCT00908037|584980444|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161981418|NCT00908037|584980445|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161981419|NCT00908037|584980446|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161981420|NCT00908037|584980447|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161981421|NCT00908037|584980448|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
161981422|NCT00908037|584980449|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
161981423|NCT00908037|584980450|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
161981424|NCT00908037|584980439|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161981425|NCT00908037|584980440|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161981426|NCT00908037|584980441|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161981427|NCT00908037|584980442|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161981428|NCT00908037|584980443|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161981429|NCT00908037|584980444|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161981430|NCT00908037|584980445|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161981431|NCT00908037|584980446|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161981432|NCT00908037|584980447|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161981433|NCT00908037|584980448|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
161981434|NCT00908037|584980449|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161981435|NCT00908037|584980450|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161981436|NCT00908037|584980439|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161981437|NCT00908037|584980440|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161981438|NCT00908037|584980441|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161981439|NCT00908037|584980442|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161981440|NCT00908037|584980443|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161981441|NCT00908037|584980444|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161981442|NCT00908037|584980445|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161981443|NCT00908037|584980446|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161981444|NCT00908037|584980447|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161981445|NCT00908037|584980448|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161981446|NCT00908037|584980449|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
161981447|NCT00908037|584980450|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
161981448|NCT00908037|584980439|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161981449|NCT00908037|584980440|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161981450|NCT00908037|584980441|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161981451|NCT00908037|584980442|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161981452|NCT00908037|584980443|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161981453|NCT00908037|584980444|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161981454|NCT00908037|584980445|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161981455|NCT00908037|584980446|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161981456|NCT00908037|584980447|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161981457|NCT00908037|584980448|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
161981458|NCT00908037|584980449|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161981459|NCT00908037|584980450|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161981460|NCT00908037|584980439|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161981461|NCT00908037|584980440|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161981462|NCT00908037|584980441|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161981463|NCT00908037|584980442|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161981464|NCT00908037|584980443|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161981465|NCT00908037|584980444|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161981466|NCT00908037|584980445|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161981467|NCT00908037|584980446|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161981468|NCT00908037|584980447|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161981469|NCT00908037|584980448|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161981470|NCT00908037|584980449|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
161981471|NCT00908037|584980450|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161981472|NCT00545103|584980451|FG000|Overall Study|Lack of Efficacy|48|||
161981473|NCT00545103|584980452|FG001|Overall Study|Lack of Efficacy|45|||
161981474|NCT00545103|584980453|FG002|Overall Study|Lack of Efficacy|31|||
161981475|NCT00545103|584980454|FG003|Overall Study|Lack of Efficacy|27|||
161981476|NCT00545103|584980451|FG000|Overall Study|Withdrawal by Subject|6|||
161981477|NCT00545103|584980452|FG001|Overall Study|Withdrawal by Subject|10|||
161981478|NCT00545103|584980453|FG002|Overall Study|Withdrawal by Subject|18|||
161981479|NCT00545103|584980454|FG003|Overall Study|Withdrawal by Subject|22|||
161981480|NCT00545103|584980451|FG000|Overall Study|Adverse Event|11|||
161981481|NCT00545103|584980452|FG001|Overall Study|Adverse Event|12|||
161981482|NCT00545103|584980453|FG002|Overall Study|Adverse Event|17|||
161981483|NCT00545103|584980454|FG003|Overall Study|Adverse Event|10|||
161981484|NCT00545103|584980451|FG000|Overall Study|Lost to Follow-up|4|||
161981485|NCT00545103|584980452|FG001|Overall Study|Lost to Follow-up|6|||
161981486|NCT00545103|584980453|FG002|Overall Study|Lost to Follow-up|3|||
161981487|NCT00545103|584980454|FG003|Overall Study|Lost to Follow-up|4|||
161981488|NCT00545103|584980451|FG000|Overall Study|Protocol Violation|1|||
161981489|NCT00545103|584980452|FG001|Overall Study|Protocol Violation|2|||
161981490|NCT00545103|584980453|FG002|Overall Study|Protocol Violation|3|||
161981491|NCT00545103|584980454|FG003|Overall Study|Protocol Violation|0|||
161981492|NCT00545103|584980451|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
161981493|NCT00545103|584980452|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
161981494|NCT00545103|584980453|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
161981495|NCT00545103|584980454|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
161981496|NCT00545103|584980451|FG000|Overall Study|Difficult to open package|0|||
161981497|NCT00545103|584980452|FG001|Overall Study|Difficult to open package|0|||
161981498|NCT00545103|584980453|FG002|Overall Study|Difficult to open package|0|||
161981499|NCT00545103|584980454|FG003|Overall Study|Difficult to open package|1|||
161981500|NCT00545103|584980451|FG000|Overall Study|Investigational product not taken|1|||
161981501|NCT00545103|584980452|FG001|Overall Study|Investigational product not taken|0|||
161981502|NCT00545103|584980453|FG002|Overall Study|Investigational product not taken|0|||
161981503|NCT00545103|584980454|FG003|Overall Study|Investigational product not taken|1|||
161981504|NCT00545103|584980451|FG000|Overall Study|Wish to start a family|0|||
161981505|NCT00545103|584980452|FG001|Overall Study|Wish to start a family|0|||
161981506|NCT00545103|584980453|FG002|Overall Study|Wish to start a family|0|||
161981507|NCT00545103|584980454|FG003|Overall Study|Wish to start a family|1|||
161981508|NCT00545103|584980451|FG000|Overall Study|Diverticulitis crisis|0|||
161981509|NCT00545103|584980452|FG001|Overall Study|Diverticulitis crisis|0|||
161981510|NCT00545103|584980453|FG002|Overall Study|Diverticulitis crisis|0|||
161981511|NCT00545103|584980454|FG003|Overall Study|Diverticulitis crisis|1|||
161981512|NCT00545103|584980451|FG000|Overall Study|Personal reasons|1|||
161981513|NCT00545103|584980452|FG001|Overall Study|Personal reasons|0|||
161981514|NCT00545103|584980453|FG002|Overall Study|Personal reasons|0|||
161981515|NCT00545103|584980454|FG003|Overall Study|Personal reasons|0|||
161981516|NCT00545103|584980451|FG000|Overall Study|Subject's decision|1|||
161981517|NCT00545103|584980452|FG001|Overall Study|Subject's decision|0|||
161981518|NCT00545103|584980453|FG002|Overall Study|Subject's decision|0|||
161981519|NCT00545103|584980454|FG003|Overall Study|Subject's decision|0|||
161981520|NCT00545103|584980451|FG000|Overall Study|Noncompliance|0|||
161981521|NCT00545103|584980452|FG001|Overall Study|Noncompliance|1|||
161981522|NCT00545103|584980453|FG002|Overall Study|Noncompliance|0|||
161981523|NCT00545103|584980454|FG003|Overall Study|Noncompliance|0|||
161981524|NCT00545103|584980451|FG000|Overall Study|Investigator decision|0|||
161981525|NCT00545103|584980452|FG001|Overall Study|Investigator decision|0|||
161981526|NCT00545103|584980453|FG002|Overall Study|Investigator decision|1|||
161981527|NCT00545103|584980454|FG003|Overall Study|Investigator decision|0|||
161981528|NCT00545103|584980451|FG000|Overall Study|Subject moved|0|||
161981529|NCT00545103|584980452|FG001|Overall Study|Subject moved|1|||
161981530|NCT00545103|584980453|FG002|Overall Study|Subject moved|0|||
161981531|NCT00545103|584980454|FG003|Overall Study|Subject moved|0|||
161981532|NCT00545103|584980451|FG000|Overall Study|Use of prohibited medication|0|||
161981533|NCT00545103|584980452|FG001|Overall Study|Use of prohibited medication|0|||
161981534|NCT00545103|584980453|FG002|Overall Study|Use of prohibited medication|1|||
161981535|NCT00545103|584980454|FG003|Overall Study|Use of prohibited medication|0|||
161981536|NCT00545103|584980451|FG000|Overall Study|Does not want to take study drug anymore|1|||
161981537|NCT00545103|584980452|FG001|Overall Study|Does not want to take study drug anymore|0|||
161981538|NCT00545103|584980453|FG002|Overall Study|Does not want to take study drug anymore|1|||
161981539|NCT00545103|584980454|FG003|Overall Study|Does not want to take study drug anymore|0|||
161981540|NCT00545103|584980451|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
161981541|NCT00545103|584980452|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
161981542|NCT00545103|584980453|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
161981543|NCT00545103|584980454|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
161981544|NCT00545103|584980451|FG000|Overall Study|Death|0|||
161981545|NCT00545103|584980452|FG001|Overall Study|Death|1|||
161981546|NCT00545103|584980453|FG002|Overall Study|Death|0|||
161981547|NCT00545103|584980454|FG003|Overall Study|Death|0|||
161864426|NCT01467713|584547705|FG001|Overall Study|Reason not Specified|11|||
161981548|NCT05026853|584980455|FG000|Overall Study|Cancelled appointment|1|||
161981549|NCT05026853|584980456|FG001|Overall Study|Cancelled appointment|0|||
161981550|NCT05026853|584980455|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
161981551|NCT05026853|584980456|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
161981552|NCT05026853|584980455|FG000|Overall Study|Did not complete 12-week survey|16|||
161981553|NCT05026853|584980456|FG001|Overall Study|Did not complete 12-week survey|16|||
161981554|NCT02358044|584980457|FG000|Overall Study|Adverse Event|0|||
161981555|NCT02358044|584980458|FG001|Overall Study|Adverse Event|1|||
161864427|NCT01467713|584547706|FG002|Overall Study|Reason not Specified|8|||
161864428|NCT01467713|584547707|FG003|Overall Study|Reason not Specified|7|||
161864429|NCT02512302|584547710|FG000|Period 1|Adverse Event|0|||
161864430|NCT02512302|584547711|FG001|Period 1|Adverse Event|1|||
161864431|NCT02512302|584547712|FG002|Period 1|Adverse Event|0|||
161864432|NCT02512302|584547713|FG003|Period 1|Adverse Event|0|||
161864433|NCT02512302|584547714|FG004|Period 1|Adverse Event|0|||
161864434|NCT02512302|584547715|FG005|Period 1|Adverse Event|0|||
161864435|NCT02512302|584547716|FG006|Period 1|Adverse Event|0|||
161864436|NCT02512302|584547717|FG007|Period 1|Adverse Event|0|||
161864437|NCT02512302|584547718|FG008|Period 1|Adverse Event|0|||
161864438|NCT02512302|584547719|FG009|Period 1|Adverse Event|0|||
161864439|NCT02512302|584547710|FG000|Period 2|Adverse Event|0|||
161864440|NCT02512302|584547711|FG001|Period 2|Adverse Event|0|||
161864441|NCT02512302|584547712|FG002|Period 2|Adverse Event|0|||
161864442|NCT02512302|584547713|FG003|Period 2|Adverse Event|0|||
161864443|NCT02512302|584547714|FG004|Period 2|Adverse Event|0|||
161864444|NCT02512302|584547715|FG005|Period 2|Adverse Event|0|||
161864445|NCT02512302|584547716|FG006|Period 2|Adverse Event|0|||
161864446|NCT02512302|584547717|FG007|Period 2|Adverse Event|0|||
161864447|NCT02512302|584547718|FG008|Period 2|Adverse Event|0|||
161864448|NCT02512302|584547719|FG009|Period 2|Adverse Event|1|||
161864449|NCT02512302|584547710|FG000|Period 3|Lost to Follow-up|0|||
161864450|NCT02512302|584547711|FG001|Period 3|Lost to Follow-up|0|||
161864451|NCT02512302|584547712|FG002|Period 3|Lost to Follow-up|1|||
161864452|NCT02512302|584547713|FG003|Period 3|Lost to Follow-up|0|||
161864453|NCT02512302|584547714|FG004|Period 3|Lost to Follow-up|0|||
161864454|NCT02512302|584547715|FG005|Period 3|Lost to Follow-up|0|||
161864455|NCT02512302|584547716|FG006|Period 3|Lost to Follow-up|0|||
161864456|NCT02512302|584547717|FG007|Period 3|Lost to Follow-up|0|||
161864457|NCT02512302|584547718|FG008|Period 3|Lost to Follow-up|0|||
161864458|NCT02512302|584547719|FG009|Period 3|Lost to Follow-up|0|||
161864459|NCT02512302|584547710|FG000|Period 4|Adverse Event|0|||
161864460|NCT02512302|584547711|FG001|Period 4|Adverse Event|0|||
161864461|NCT02512302|584547712|FG002|Period 4|Adverse Event|0|||
161864462|NCT02512302|584547713|FG003|Period 4|Adverse Event|0|||
161864463|NCT02512302|584547714|FG004|Period 4|Adverse Event|0|||
161864464|NCT02512302|584547715|FG005|Period 4|Adverse Event|0|||
161864465|NCT02512302|584547716|FG006|Period 4|Adverse Event|1|||
161864466|NCT02512302|584547717|FG007|Period 4|Adverse Event|0|||
161864467|NCT02512302|584547718|FG008|Period 4|Adverse Event|0|||
161864468|NCT02512302|584547719|FG009|Period 4|Adverse Event|0|||
161864469|NCT01735916|584547728|FG000|Overall Study|Subject not eligible to be randomized|11|||
161864470|NCT01735916|584547729|FG001|Overall Study|Subject not eligible to be randomized|0|||
161864471|NCT01735916|584547730|FG002|Overall Study|Subject not eligible to be randomized|0|||
161864472|NCT01735916|584547728|FG000|Overall Study|Early termination of study by sponsor|4|||
161864473|NCT01735916|584547729|FG001|Overall Study|Early termination of study by sponsor|19|||
161864474|NCT01735916|584547730|FG002|Overall Study|Early termination of study by sponsor|7|||
161864475|NCT01735916|584547728|FG000|Overall Study|Withdrawal by Subject|3|||
161864476|NCT01735916|584547729|FG001|Overall Study|Withdrawal by Subject|0|||
161864477|NCT01735916|584547730|FG002|Overall Study|Withdrawal by Subject|0|||
161864478|NCT05177484|584547736|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
161864479|NCT05177484|584547737|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
161864480|NCT05177484|584547736|FG000|Overall Study|Inadvertently withdrawn|3|||
161864481|NCT05177484|584547737|FG001|Overall Study|Inadvertently withdrawn|1|||
161864482|NCT05177484|584547736|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
161864483|NCT05177484|584547737|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
161864484|NCT01379768|584547738|FG000|Overall Study|Adverse Event|1|||
161864485|NCT01379768|584547739|FG001|Overall Study|Adverse Event|1|||
161864486|NCT01379768|584547740|FG002|Overall Study|Adverse Event|0|||
161864487|NCT01379768|584547738|FG000|Overall Study|Lost to Follow-up|2|||
161864488|NCT01379768|584547739|FG001|Overall Study|Lost to Follow-up|0|||
161864489|NCT01379768|584547740|FG002|Overall Study|Lost to Follow-up|0|||
161864490|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
161864491|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
161864492|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
161864493|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
161864494|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
161864495|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864496|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864497|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864498|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161773965|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161773966|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161773967|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
161773968|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161773969|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161773970|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161773971|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161773972|NCT04242498|584214443|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773973|NCT04242498|584214444|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
161773974|NCT04242498|584214445|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
161773975|NCT04242498|584214446|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773976|NCT04242498|584214447|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773977|NCT04242498|584214448|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773978|NCT04242498|584214449|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161773979|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773980|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773981|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773982|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161773983|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
161773984|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
161773985|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
161773986|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773987|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773988|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773989|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161773990|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
161773991|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
161773992|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
161773993|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773994|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773995|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773996|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773997|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161773998|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
161773999|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
161774000|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161774001|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161774002|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161774003|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
161774004|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
161774005|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
161774006|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
161774007|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161774008|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161774009|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161774010|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
161774011|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
161774012|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
161774013|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
161774014|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161774015|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161774016|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161774017|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161774018|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
161774019|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161774020|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161774021|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161774022|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161981556|NCT02358044|584980457|FG000|Overall Study|Lost to Follow-up|2|||
161981557|NCT02358044|584980458|FG001|Overall Study|Lost to Follow-up|1|||
161981558|NCT02358044|584980457|FG000|Overall Study|Physician Decision|0|||
161981559|NCT02358044|584980458|FG001|Overall Study|Physician Decision|1|||
161981560|NCT02358044|584980457|FG000|Overall Study|Withdrawal by Subject|0|||
161981561|NCT02358044|584980458|FG001|Overall Study|Withdrawal by Subject|4|||
161981562|NCT01732913|584980459|FG000|Overall Study|Study Terminated by Sponsor|105|||
161981563|NCT01732913|584980460|FG001|Overall Study|Study Terminated by Sponsor|55|||
161981564|NCT01732913|584980459|FG000|Overall Study|Withdrawal by Subject|27|||
161981565|NCT01732913|584980460|FG001|Overall Study|Withdrawal by Subject|4|||
161981566|NCT01732913|584980459|FG000|Overall Study|Physician Decision|14|||
161981567|NCT01732913|584980460|FG001|Overall Study|Physician Decision|7|||
161981568|NCT01732913|584980459|FG000|Overall Study|Other|7|||
161981569|NCT01732913|584980460|FG001|Overall Study|Other|1|||
161981570|NCT01732913|584980459|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
161981571|NCT01732913|584980460|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
161981572|NCT00903331|584980461|FG000|Overall Study|Death|4|||
161981573|NCT00903331|584980462|FG001|Overall Study|Death|8|||
161981574|NCT00903331|584980461|FG000|Overall Study|Withdrawal of consent|1|||
161981575|NCT00903331|584980462|FG001|Overall Study|Withdrawal of consent|8|||
161981576|NCT00903331|584980461|FG000|Overall Study|Lung transplant|0|||
161981577|NCT00903331|584980462|FG001|Overall Study|Lung transplant|2|||
161981578|NCT02723175|584980463|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
161981579|NCT02723175|584980464|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
161981580|NCT02723175|584980463|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
161981581|NCT02723175|584980464|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
161981582|NCT03233438|584980465|FG000|Overall Study|Lost to Follow-up|4|||
161981583|NCT03233438|584980466|FG001|Overall Study|Lost to Follow-up|9|||
161981584|NCT03233438|584980465|FG000|Overall Study|Withdrawal by Subject|2|||
161981585|NCT03233438|584980466|FG001|Overall Study|Withdrawal by Subject|1|||
161981586|NCT03233438|584980465|FG000|Overall Study|No recording of dalbavancin|0|||
161981587|NCT03233438|584980466|FG001|Overall Study|No recording of dalbavancin|1|||
161981588|NCT00257660|584980471|FG000|Overall Study|Lack of Efficacy|5|||
161981589|NCT00257660|584980472|FG001|Overall Study|Lack of Efficacy|23|||
161981590|NCT00257660|584980471|FG000|Overall Study|Withdrawal by Subject|2|||
161981591|NCT00257660|584980472|FG001|Overall Study|Withdrawal by Subject|0|||
161981592|NCT00257660|584980471|FG000|Overall Study|Lost to Follow-up|1|||
161981593|NCT00257660|584980472|FG001|Overall Study|Lost to Follow-up|0|||
161981594|NCT00257660|584980471|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
161981595|NCT00257660|584980472|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
161981596|NCT00257660|584980471|FG000|Overall Study|No longer wanted to do blood draws|1|||
161981597|NCT00257660|584980472|FG001|Overall Study|No longer wanted to do blood draws|0|||
161981598|NCT00491608|584980473|FG000|Overall Study|Death|2|||
161981599|NCT00491608|584980473|FG000|Overall Study|Withdrawal by Subject|1|||
161981600|NCT04109976|584980474|FG000|Overall Study|Withdrawal by Subject|1|||
161981601|NCT04109976|584980475|FG001|Overall Study|Withdrawal by Subject|0|||
161981602|NCT00413374|584980482|FG000|Overall Study|Ineligible due to screening criteria.|3|||
161981603|NCT00413374|584980483|FG001|Overall Study|Ineligible due to screening criteria.|0|||
161981604|NCT00413374|584980482|FG000|Overall Study|Adverse Event|1|||
161981605|NCT00413374|584980483|FG001|Overall Study|Adverse Event|0|||
161981606|NCT00413374|584980482|FG000|Overall Study|Lost to Follow-up|1|||
161981607|NCT00413374|584980483|FG001|Overall Study|Lost to Follow-up|0|||
161981608|NCT00413374|584980482|FG000|Overall Study|Surgery|1|||
161981609|NCT00413374|584980483|FG001|Overall Study|Surgery|0|||
161981610|NCT00552760|584980484|FG000|Overall Study|Adverse Event|3|||
161981611|NCT00552760|584980485|FG001|Overall Study|Adverse Event|5|||
161981612|NCT00552760|584980484|FG000|Overall Study|Relapsed- Depressed Event|10|||
161981613|NCT00552760|584980485|FG001|Overall Study|Relapsed- Depressed Event|16|||
161981614|NCT00552760|584980484|FG000|Overall Study|Relapse- Manic Event|3|||
161981615|NCT00552760|584980485|FG001|Overall Study|Relapse- Manic Event|3|||
161981616|NCT00552760|584980484|FG000|Overall Study|Relapsed- Mixed Event|3|||
161981617|NCT00552760|584980485|FG001|Overall Study|Relapsed- Mixed Event|5|||
161981618|NCT00552760|584980484|FG000|Overall Study|Protocol Violation|0|||
161981619|NCT00552760|584980485|FG001|Overall Study|Protocol Violation|1|||
161981620|NCT00552760|584980484|FG000|Overall Study|Lost to Follow-up|1|||
161981621|NCT00552760|584980485|FG001|Overall Study|Lost to Follow-up|1|||
161981622|NCT00552760|584980484|FG000|Overall Study|Non-compliance|1|||
161981623|NCT00552760|584980485|FG001|Overall Study|Non-compliance|1|||
161981624|NCT00552760|584980484|FG000|Overall Study|Medical Condition|1|||
161981625|NCT00552760|584980485|FG001|Overall Study|Medical Condition|1|||
161981626|NCT00552760|584980484|FG000|Overall Study|Withdrawal by Subject|3|||
161981627|NCT00552760|584980485|FG001|Overall Study|Withdrawal by Subject|0|||
161981628|NCT00552760|584980484|FG000|Overall Study|Medication Change|1|||
161981629|NCT00552760|584980485|FG001|Overall Study|Medication Change|0|||
161981630|NCT03615066|584980489|FG000|Main Study|Withdrew Consent|0|||
161981631|NCT03615066|584980490|FG001|Main Study|Withdrew Consent|1|||
161981632|NCT03615066|584980491|FG002|Main Study|Withdrew Consent|1|||
161981633|NCT03615066|584980489|FG000|Main Study|Lost to Follow-up|0|||
161981634|NCT03615066|584980490|FG001|Main Study|Lost to Follow-up|0|||
161981635|NCT03615066|584980491|FG002|Main Study|Lost to Follow-up|1|||
161981636|NCT03615066|584980489|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
161981637|NCT03615066|584980490|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
161981638|NCT03615066|584980491|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
161981639|NCT03615066|584980489|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
161981640|NCT03615066|584980490|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
161981641|NCT03615066|584980491|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
161981642|NCT03615066|584980489|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
161981643|NCT03615066|584980490|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
161981644|NCT03615066|584980491|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
161981645|NCT00494507|584980492|FG000|Double-Blind Phase|Adverse Event|2|||
161981646|NCT00494507|584980493|FG001|Double-Blind Phase|Adverse Event|0|||
161981647|NCT00494507|584980494|FG002|Double-Blind Phase|Adverse Event|1|||
161981648|NCT00494507|584980495|FG003|Double-Blind Phase|Adverse Event|0|||
161981649|NCT00494507|584980492|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
161981650|NCT00494507|584980493|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
161981651|NCT00494507|584980494|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161981652|NCT00494507|584980495|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
161981653|NCT00494507|584980492|FG000|Double-Blind Phase|Subject Non-compliance|0|||
161981654|NCT00494507|584980493|FG001|Double-Blind Phase|Subject Non-compliance|0|||
161981655|NCT00494507|584980494|FG002|Double-Blind Phase|Subject Non-compliance|1|||
161981656|NCT00494507|584980495|FG003|Double-Blind Phase|Subject Non-compliance|0|||
161981657|NCT00494507|584980492|FG000|Double-Blind Phase|Negative DNA test|0|||
162034915|NCT01083173|585184810|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
162034916|NCT01083173|585184809|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
162034917|NCT01083173|585184810|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
162034918|NCT01083173|585184809|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
162034919|NCT01083173|585184810|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
161981658|NCT00494507|584980493|FG001|Double-Blind Phase|Negative DNA test|0|||
161981659|NCT00494507|584980494|FG002|Double-Blind Phase|Negative DNA test|0|||
161981660|NCT00494507|584980495|FG003|Double-Blind Phase|Negative DNA test|1|||
161981661|NCT00494507|584980492|FG000|Open-Label Phase|Adverse Event|0|||
161981662|NCT00494507|584980493|FG001|Open-Label Phase|Adverse Event|1|||
161981663|NCT00494507|584980494|FG002|Open-Label Phase|Adverse Event|5|||
161981664|NCT00494507|584980495|FG003|Open-Label Phase|Adverse Event|3|||
161981665|NCT00494507|584980492|FG000|Open-Label Phase|Worsening Disease|0|||
161981666|NCT00494507|584980493|FG001|Open-Label Phase|Worsening Disease|0|||
161981667|NCT00494507|584980494|FG002|Open-Label Phase|Worsening Disease|0|||
161981668|NCT00494507|584980495|FG003|Open-Label Phase|Worsening Disease|2|||
161981669|NCT00924404|584980496|FG000|Overall Study|Lost to Follow-up|6|||
161981670|NCT00924404|584980497|FG001|Overall Study|Lost to Follow-up|4|||
161981671|NCT03426631|584980500|FG000|Overall Study|Lost to Follow-up|0|||
161981672|NCT03426631|584980501|FG001|Overall Study|Lost to Follow-up|1|||
162048461|NCT01781975|585233334|FG000|Overall Study|Withdrawal by Subject|1|||
161774023|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161774024|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161774025|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161774026|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
161774027|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161774028|NCT04242498|584214443|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161774029|NCT04242498|584214444|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161774030|NCT04242498|584214445|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161774031|NCT04242498|584214446|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161774032|NCT04242498|584214447|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161774033|NCT04242498|584214448|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
161774034|NCT04242498|584214449|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
161774035|NCT01958619|584214450|FG000|Overall Study|Protocol Violation|2|||
161774036|NCT01958619|584214451|FG001|Overall Study|Protocol Violation|0|||
161774037|NCT01958619|584214452|FG002|Overall Study|Protocol Violation|1|||
161774038|NCT01958619|584214453|FG003|Overall Study|Protocol Violation|0|||
161774039|NCT00931515|584214454|FG000|Overall Study|Lost to Follow-up|2|||
161774040|NCT00931515|584214455|FG001|Overall Study|Lost to Follow-up|5|||
161774041|NCT01054443|584214456|FG000|Overall Study|Withdrawal by Subject|0|||
161774042|NCT01054443|584214457|FG001|Overall Study|Withdrawal by Subject|0|||
161774043|NCT01054443|584214458|FG002|Overall Study|Withdrawal by Subject|0|||
161774044|NCT01054443|584214459|FG003|Overall Study|Withdrawal by Subject|1|||
161774045|NCT00985114|584214461|FG000|Overall Study|Adverse Event|1|||
161981673|NCT03831945|584980502|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
161981674|NCT03831945|584980503|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
161981675|NCT03831945|584980502|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
161981676|NCT03831945|584980503|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
161981677|NCT03831945|584980502|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
161981678|NCT03831945|584980503|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
161981679|NCT02437084|584980504|FG000|Overall Study|Withdrawal by Subject|2|||
161981680|NCT02437084|584980504|FG000|Overall Study|Physician Decision|1|||
161981681|NCT00454181|584980507|FG000|Overall Study|Adverse Event|1|||
161981682|NCT00454181|584980508|FG001|Overall Study|Adverse Event|1|||
161981683|NCT00454181|584980507|FG000|Overall Study|Lost to Follow-up|11|||
161864499|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864500|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161981684|NCT00454181|584980508|FG001|Overall Study|Lost to Follow-up|1|||
161981685|NCT00454181|584980507|FG000|Overall Study|Protocol Violation|1|||
161981686|NCT00454181|584980508|FG001|Overall Study|Protocol Violation|1|||
161981687|NCT00454181|584980507|FG000|Overall Study|Withdrawal by Subject|2|||
161981688|NCT00454181|584980508|FG001|Overall Study|Withdrawal by Subject|0|||
161981689|NCT02613169|584980509|FG000|Overall Study|Withdrawal by Subject|4|||
161981690|NCT02613169|584980510|FG001|Overall Study|Withdrawal by Subject|1|||
161981691|NCT02613169|584980509|FG000|Overall Study|Lost to Follow-up|0|||
161981692|NCT02613169|584980510|FG001|Overall Study|Lost to Follow-up|5|||
161981693|NCT02613169|584980509|FG000|Overall Study|HIV|0|||
161864501|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864502|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864503|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864504|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161864505|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
161864506|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
161864507|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
161864508|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
161864509|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
161864510|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864511|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864512|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864513|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864514|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864515|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864516|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864517|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864518|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864519|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161864520|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
161864521|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
161864522|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
161864523|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
161864524|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
161864525|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864526|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864527|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864528|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864529|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864530|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864531|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864532|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161981694|NCT02613169|584980510|FG001|Overall Study|HIV|2|||
161981695|NCT02613169|584980509|FG000|Overall Study|No TB infection endpoint|14|||
161981696|NCT02613169|584980510|FG001|Overall Study|No TB infection endpoint|9|||
161981697|NCT03729245|584980511|FG000|Overall Study|Lost to Follow-up|5|||
161981698|NCT03729245|584980512|FG001|Overall Study|Lost to Follow-up|6|||
161981699|NCT03729245|584980511|FG000|Overall Study|Withdrawal by Subject|16|||
161864533|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161981700|NCT03729245|584980512|FG001|Overall Study|Withdrawal by Subject|19|||
161981701|NCT03729245|584980511|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
161981702|NCT03729245|584980512|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
161981703|NCT04032080|584980513|FG000|Overall Study|Death|6|||
161981704|NCT02096263|584980514|FG000|Overall Study|Adverse Event|1|||
161981705|NCT02096263|584980515|FG001|Overall Study|Adverse Event|0|||
161981706|NCT02096263|584980516|FG002|Overall Study|Adverse Event|1|||
161981707|NCT02096263|584980514|FG000|Overall Study|Lost to Follow-up|14|||
161981708|NCT02096263|584980515|FG001|Overall Study|Lost to Follow-up|18|||
161981709|NCT02096263|584980516|FG002|Overall Study|Lost to Follow-up|15|||
161981710|NCT02096263|584980514|FG000|Overall Study|Other|7|||
161981711|NCT02096263|584980515|FG001|Overall Study|Other|9|||
161981712|NCT02096263|584980516|FG002|Overall Study|Other|6|||
161981713|NCT02096263|584980514|FG000|Overall Study|Sponsor study termination|0|||
161981714|NCT02096263|584980515|FG001|Overall Study|Sponsor study termination|0|||
161981715|NCT02096263|584980516|FG002|Overall Study|Sponsor study termination|1|||
161981716|NCT02096263|584980514|FG000|Overall Study|Protocol Violation|7|||
161981717|NCT02096263|584980515|FG001|Overall Study|Protocol Violation|2|||
161981718|NCT02096263|584980516|FG002|Overall Study|Protocol Violation|8|||
161981719|NCT02096263|584980514|FG000|Overall Study|Withdrawal by Subject|5|||
161981720|NCT02096263|584980515|FG001|Overall Study|Withdrawal by Subject|7|||
161981721|NCT02096263|584980516|FG002|Overall Study|Withdrawal by Subject|8|||
161981722|NCT01985360|584980520|FG000|Overall Study|Withdrawal by Subject|4|||
161981723|NCT01985360|584980521|FG001|Overall Study|Withdrawal by Subject|0|||
161981724|NCT01985360|584980520|FG000|Overall Study|Lost to Follow-up|5|||
161981725|NCT01985360|584980521|FG001|Overall Study|Lost to Follow-up|3|||
161981726|NCT00079677|584980522|FG000|Overall Study|Adverse Event|5|||
161981727|NCT00079677|584980523|FG001|Overall Study|Adverse Event|6|||
161981728|NCT00079677|584980522|FG000|Overall Study|Lack of Efficacy|1|||
161981729|NCT00079677|584980523|FG001|Overall Study|Lack of Efficacy|0|||
161981730|NCT00079677|584980522|FG000|Overall Study|Lost to Follow-up|2|||
161981731|NCT00079677|584980523|FG001|Overall Study|Lost to Follow-up|2|||
161981732|NCT00079677|584980522|FG000|Overall Study|Physician Decision|3|||
161981733|NCT00079677|584980523|FG001|Overall Study|Physician Decision|0|||
161981734|NCT00079677|584980522|FG000|Overall Study|Protocol Violation|2|||
161981735|NCT00079677|584980523|FG001|Overall Study|Protocol Violation|3|||
161981736|NCT00079677|584980522|FG000|Overall Study|Withdrawal by Subject|5|||
161981737|NCT00079677|584980523|FG001|Overall Study|Withdrawal by Subject|3|||
161981738|NCT00079677|584980522|FG000|Overall Study|Miscellaneous|2|||
161981739|NCT00079677|584980523|FG001|Overall Study|Miscellaneous|0|||
161981740|NCT00521222|584980526|FG000|Overall Study|Lost to Follow-up|0|||
161981741|NCT00521222|584980527|FG001|Overall Study|Lost to Follow-up|0|||
161981742|NCT00521222|584980528|FG002|Overall Study|Lost to Follow-up|1|||
161981743|NCT00521222|584980529|FG003|Overall Study|Lost to Follow-up|1|||
161981744|NCT00521222|584980526|FG000|Overall Study|Withdrawal by Subject|0|||
161981745|NCT00521222|584980527|FG001|Overall Study|Withdrawal by Subject|0|||
161981746|NCT00521222|584980528|FG002|Overall Study|Withdrawal by Subject|2|||
161981747|NCT00521222|584980529|FG003|Overall Study|Withdrawal by Subject|0|||
161981748|NCT00521222|584980526|FG000|Overall Study|Physician Decision|0|||
161981749|NCT00521222|584980527|FG001|Overall Study|Physician Decision|1|||
161981750|NCT00521222|584980528|FG002|Overall Study|Physician Decision|0|||
161981751|NCT00521222|584980529|FG003|Overall Study|Physician Decision|1|||
161981752|NCT04598269|584980530|FG000|Overall Study|Adverse Event|0|||
161981753|NCT04598269|584980531|FG001|Overall Study|Adverse Event|3|||
161981754|NCT04598269|584980530|FG000|Overall Study|Withdrawal by Subject|1|||
161981755|NCT04598269|584980531|FG001|Overall Study|Withdrawal by Subject|4|||
161981756|NCT04598269|584980530|FG000|Overall Study|Lost to Follow-up|1|||
161981757|NCT04598269|584980531|FG001|Overall Study|Lost to Follow-up|0|||
161981758|NCT04598269|584980530|FG000|Overall Study|Not Treated|2|||
161981759|NCT04598269|584980531|FG001|Overall Study|Not Treated|0|||
161981760|NCT00424190|584980532|FG000|Overall Study|Withdrew consent|3|||
161981761|NCT00424190|584980533|FG001|Overall Study|Withdrew consent|4|||
161981762|NCT00424190|584980532|FG000|Overall Study|Death|3|||
161981763|NCT00424190|584980533|FG001|Overall Study|Death|0|||
161981764|NCT00424190|584980532|FG000|Overall Study|Noncompliance|1|||
161774046|NCT00985114|584214462|FG001|Overall Study|Adverse Event|0|||
161774047|NCT00985114|584214461|FG000|Overall Study|Withdrawal by Subject|0|||
161981765|NCT00424190|584980533|FG001|Overall Study|Noncompliance|2|||
161981766|NCT00424190|584980532|FG000|Overall Study|Request of sponsor or investigator|0|||
161981767|NCT00424190|584980533|FG001|Overall Study|Request of sponsor or investigator|2|||
161981768|NCT00424190|584980532|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
161981769|NCT00424190|584980533|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
161981770|NCT00424190|584980532|FG000|Overall Study|Other|15|||
161981771|NCT00424190|584980533|FG001|Overall Study|Other|21|||
161981772|NCT00649428|584982096|FG000|Overall Study|Adverse Event|2|||
161981773|NCT00649428|584982097|FG001|Overall Study|Adverse Event|2|||
161981774|NCT00649428|584982096|FG000|Overall Study|Withdrawal by Subject|6|||
161981775|NCT00649428|584982097|FG001|Overall Study|Withdrawal by Subject|6|||
161981776|NCT00649428|584982096|FG000|Overall Study|Lost to Follow-up|1|||
161981777|NCT00649428|584982097|FG001|Overall Study|Lost to Follow-up|3|||
161981778|NCT00649428|584982096|FG000|Overall Study|Insufficient manufacturing yield|5|||
161981779|NCT00649428|584982097|FG001|Overall Study|Insufficient manufacturing yield|1|||
161981780|NCT00649428|584982096|FG000|Overall Study|Protocol Violation|6|||
161981781|NCT00649428|584982097|FG001|Overall Study|Protocol Violation|2|||
161981782|NCT00649428|584982096|FG000|Overall Study|Physician Decision|0|||
161981783|NCT00649428|584982097|FG001|Overall Study|Physician Decision|1|||
161981784|NCT02503501|584982098|FG000|Overall Study|Physician Decision|1|||
161981785|NCT02503501|584982099|FG001|Overall Study|Physician Decision|0|||
161981786|NCT02503501|584982098|FG000|Overall Study|Protocol Violation|0|||
161981787|NCT02503501|584982099|FG001|Overall Study|Protocol Violation|1|||
161981788|NCT02503501|584982098|FG000|Overall Study|Withdrawal by Subject|0|||
161981789|NCT02503501|584982099|FG001|Overall Study|Withdrawal by Subject|2|||
161981790|NCT01740401|584982100|FG000|Overall Study|Progression of disease|6|||
161981791|NCT01740401|584982100|FG000|Overall Study|Adverse Event|2|||
161981792|NCT01740401|584982100|FG000|Overall Study|Did not reach primary endpoint|2|||
161981793|NCT02315560|584982101|FG000|Overall Study|noncompliance by subjects|3|||
161981794|NCT02008227|584982102|FG000|Overall Study|Lost to Follow-up|7|||
161981795|NCT02008227|584982103|FG001|Overall Study|Lost to Follow-up|9|||
161981796|NCT02008227|584982102|FG000|Overall Study|Death|494|||
161981797|NCT02008227|584982103|FG001|Overall Study|Death|485|||
161981798|NCT02008227|584982102|FG000|Overall Study|Withdrawal by Subject|67|||
161981799|NCT02008227|584982103|FG001|Overall Study|Withdrawal by Subject|36|||
161981800|NCT02008227|584982102|FG000|Overall Study|Study Terminated By Sponsor|44|||
161981801|NCT02008227|584982103|FG001|Overall Study|Study Terminated By Sponsor|83|||
161981802|NCT04599465|584982104|FG000|Overall Study|Physician Decision|1|||
161864534|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161864535|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
161864536|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
161864537|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
161864538|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
161864539|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
161864540|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864541|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864542|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864543|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864544|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864545|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864546|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864547|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864548|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864549|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161864550|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
161864551|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864552|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
161864553|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
161864554|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
161864555|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864556|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864557|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864558|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864559|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864560|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864561|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864562|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864563|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864564|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161864565|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864566|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864567|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864568|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
161864569|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864570|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864571|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
161981803|NCT04599465|584982104|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
161864572|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
161981804|NCT04566601|584982105|FG000|Overall Study|Other than listed|13|||
161981805|NCT04566601|584982106|FG001|Overall Study|Other than listed|4|||
161981806|NCT04566601|584982107|FG002|Overall Study|Other than listed|2|||
161981807|NCT04566601|584982108|FG003|Overall Study|Other than listed|1|||
161981808|NCT04566601|584982109|FG004|Overall Study|Other than listed|4|||
161981809|NCT04566601|584982105|FG000|Overall Study|Protocol deviation|3|||
161981810|NCT04566601|584982106|FG001|Overall Study|Protocol deviation|0|||
161981811|NCT04566601|584982107|FG002|Overall Study|Protocol deviation|1|||
161981812|NCT04566601|584982108|FG003|Overall Study|Protocol deviation|1|||
161981813|NCT04566601|584982109|FG004|Overall Study|Protocol deviation|1|||
161981814|NCT04566601|584982105|FG000|Overall Study|Technical problems|0|||
161981815|NCT04566601|584982106|FG001|Overall Study|Technical problems|0|||
161981816|NCT04566601|584982107|FG002|Overall Study|Technical problems|1|||
161981817|NCT04566601|584982108|FG003|Overall Study|Technical problems|0|||
161981818|NCT04566601|584982109|FG004|Overall Study|Technical problems|0|||
161981819|NCT04566601|584982105|FG000|Overall Study|No reason available|3|||
161981820|NCT04566601|584982106|FG001|Overall Study|No reason available|2|||
161981821|NCT04566601|584982107|FG002|Overall Study|No reason available|7|||
161981822|NCT04566601|584982108|FG003|Overall Study|No reason available|1|||
161981823|NCT04566601|584982109|FG004|Overall Study|No reason available|5|||
161981824|NCT04566601|584982105|FG000|Overall Study|Burden of study procedures|3|||
161981825|NCT04566601|584982106|FG001|Overall Study|Burden of study procedures|0|||
161981826|NCT04566601|584982107|FG002|Overall Study|Burden of study procedures|0|||
161981827|NCT04566601|584982108|FG003|Overall Study|Burden of study procedures|3|||
161981828|NCT04566601|584982109|FG004|Overall Study|Burden of study procedures|1|||
161981829|NCT04566601|584982105|FG000|Overall Study|Change of residence|2|||
161981830|NCT04566601|584982106|FG001|Overall Study|Change of residence|2|||
161981831|NCT04566601|584982107|FG002|Overall Study|Change of residence|0|||
161981832|NCT04566601|584982108|FG003|Overall Study|Change of residence|1|||
161981833|NCT04566601|584982109|FG004|Overall Study|Change of residence|2|||
161981834|NCT04566601|584982105|FG000|Overall Study|Perceived lack of efficacy|2|||
161981835|NCT04566601|584982106|FG001|Overall Study|Perceived lack of efficacy|0|||
161981836|NCT04566601|584982107|FG002|Overall Study|Perceived lack of efficacy|1|||
161981837|NCT04566601|584982108|FG003|Overall Study|Perceived lack of efficacy|1|||
161981838|NCT04566601|584982109|FG004|Overall Study|Perceived lack of efficacy|2|||
161981839|NCT04566601|584982105|FG000|Overall Study|Adverse Event|7|||
161981840|NCT04566601|584982106|FG001|Overall Study|Adverse Event|4|||
161981841|NCT04566601|584982107|FG002|Overall Study|Adverse Event|6|||
161981842|NCT04566601|584982108|FG003|Overall Study|Adverse Event|5|||
161981843|NCT04566601|584982109|FG004|Overall Study|Adverse Event|12|||
161981844|NCT01272635|584982112|FG000|Overall Study|Lost to Follow-up|31|||
161981845|NCT01272635|584982113|FG001|Overall Study|Lost to Follow-up|20|||
161981846|NCT01272635|584982114|FG002|Overall Study|Lost to Follow-up|31|||
161981847|NCT01272635|584982115|FG003|Overall Study|Lost to Follow-up|23|||
161981848|NCT00306527|584982118|FG000|Overall Study|Lost to Follow-up|3|||
161981849|NCT00306527|584982119|FG001|Overall Study|Lost to Follow-up|4|||
161981850|NCT00306527|584982120|FG002|Overall Study|Lost to Follow-up|3|||
161981851|NCT00306527|584982121|FG003|Overall Study|Lost to Follow-up|0|||
161981852|NCT00306527|584982118|FG000|Overall Study|Withdrawal by Subject|2|||
161981853|NCT00306527|584982119|FG001|Overall Study|Withdrawal by Subject|3|||
161981854|NCT00306527|584982120|FG002|Overall Study|Withdrawal by Subject|0|||
161981855|NCT00306527|584982121|FG003|Overall Study|Withdrawal by Subject|3|||
161981856|NCT00306527|584982118|FG000|Overall Study|Adverse Event|0|||
161981857|NCT00306527|584982119|FG001|Overall Study|Adverse Event|0|||
161981858|NCT00306527|584982120|FG002|Overall Study|Adverse Event|1|||
161981859|NCT00306527|584982121|FG003|Overall Study|Adverse Event|1|||
161981860|NCT00306527|584982118|FG000|Overall Study|Death|1|||
161981861|NCT00306527|584982119|FG001|Overall Study|Death|0|||
161981862|NCT00306527|584982120|FG002|Overall Study|Death|1|||
161981863|NCT00306527|584982121|FG003|Overall Study|Death|2|||
161981864|NCT02702180|584982122|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161981865|NCT02702180|584982123|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
161981866|NCT02702180|584982124|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161981867|NCT02702180|584982122|FG000|Double-blind Treatment Period|Adverse Event|0|||
161981868|NCT02702180|584982123|FG001|Double-blind Treatment Period|Adverse Event|0|||
161981869|NCT02702180|584982124|FG002|Double-blind Treatment Period|Adverse Event|1|||
161981870|NCT02702180|584982122|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161981871|NCT02702180|584982123|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
161981872|NCT02702180|584982124|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
161981873|NCT02702180|584982122|FG000|Double-blind Treatment Period|Protocol Violation|0|||
161981874|NCT02702180|584982123|FG001|Double-blind Treatment Period|Protocol Violation|0|||
161981875|NCT02702180|584982124|FG002|Double-blind Treatment Period|Protocol Violation|2|||
161981876|NCT02702180|584982122|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
161981877|NCT02702180|584982123|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
161981878|NCT02702180|584982124|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
161981879|NCT02702180|584982122|FG000|Open-label Treatment Period|Withdrawn in error|0|||
161981880|NCT02702180|584982123|FG001|Open-label Treatment Period|Withdrawn in error|0|||
161981881|NCT02702180|584982124|FG002|Open-label Treatment Period|Withdrawn in error|1|||
161981882|NCT00785980|584982125|FG000|7 Day Washout Period|Protocol Violation|3|||
161981883|NCT02241343|584982138|FG000|Overall Study|Adverse Event|1|||
161981884|NCT04680975|584982139|FG000|Overall Study|Adverse Event|3|||
161981885|NCT04680975|584982139|FG000|Overall Study|Death|1|||
161981886|NCT04680975|584982139|FG000|Overall Study|Progressive Disease|1|||
161981887|NCT04680975|584982139|FG000|Overall Study|Withdrawal by Subject|1|||
161981888|NCT00753454|584982140|FG000|Overall Study|Adverse Event|4|||
161981889|NCT00753454|584982140|FG000|Overall Study|Lack of Efficacy|1|||
161981890|NCT00753454|584982140|FG000|Overall Study|Lost to Follow-up|3|||
161981891|NCT00753454|584982140|FG000|Overall Study|Withdrawal by Subject|5|||
161981892|NCT00753454|584982140|FG000|Overall Study|Investigator Decision|1|||
161981893|NCT05856227|584982143|FG000|Overall Study|Adverse Event|0|||
161981894|NCT05856227|584982144|FG001|Overall Study|Adverse Event|1|||
161981895|NCT05856227|584982143|FG000|Overall Study|Due to Investigator absence|1|||
161981896|NCT05856227|584982144|FG001|Overall Study|Due to Investigator absence|0|||
161981897|NCT05856227|584982143|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
161981898|NCT05856227|584982144|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
161981899|NCT05011058|584982145|FG000|Overall Study|Sponsor Decision|2|||
161981900|NCT05011058|584982146|FG001|Overall Study|Sponsor Decision|0|||
161981901|NCT05011058|584982147|FG002|Overall Study|Sponsor Decision|14|||
161981902|NCT05011058|584982148|FG003|Overall Study|Sponsor Decision|0|||
161981903|NCT05011058|584982149|FG004|Overall Study|Sponsor Decision|0|||
161981904|NCT05011058|584982150|FG005|Overall Study|Sponsor Decision|1|||
161981905|NCT05011058|584982151|FG006|Overall Study|Sponsor Decision|0|||
161981906|NCT05011058|584982152|FG007|Overall Study|Sponsor Decision|5|||
161981907|NCT01571232|584982153|FG000|Overall Study|Lost to Follow-up|0|||
161981908|NCT01571232|584982154|FG001|Overall Study|Lost to Follow-up|1|||
161981909|NCT01571232|584982153|FG000|Overall Study|Withdrawal by Subject|1|||
161981910|NCT01571232|584982154|FG001|Overall Study|Withdrawal by Subject|0|||
161981911|NCT01272869|584982155|FG000|Period 2 (14 Days)|Adverse Event|1|||
161981912|NCT01272869|584982156|FG001|Period 2 (14 Days)|Adverse Event|0|||
161981913|NCT02271945|584982157|FG000|Overall Study|Death|3|||
161981914|NCT02271945|584982158|FG001|Overall Study|Death|3|||
161981915|NCT02271945|584982157|FG000|Overall Study|Withdrawal by Subject|1|||
161981916|NCT02271945|584982158|FG001|Overall Study|Withdrawal by Subject|1|||
161981917|NCT02271945|584982157|FG000|Overall Study|Other|1|||
161981918|NCT02271945|584982158|FG001|Overall Study|Other|1|||
161981919|NCT02455076|584982159|FG000|Inpatient|Withdrawal by Subject|1|||
161981920|NCT02455076|584982160|FG001|Inpatient|Withdrawal by Subject|0|||
161981921|NCT02455076|584982161|FG002|Inpatient|Withdrawal by Subject|0|||
161981922|NCT02455076|584982162|FG003|Inpatient|Withdrawal by Subject|0|||
161981923|NCT02455076|584982163|FG004|Inpatient|Withdrawal by Subject|0|||
161981924|NCT02455076|584982159|FG000|Inpatient|Discharged <24 h after admission|0|||
161981925|NCT02455076|584982160|FG001|Inpatient|Discharged <24 h after admission|1|||
161981926|NCT02455076|584982161|FG002|Inpatient|Discharged <24 h after admission|0|||
161981927|NCT02455076|584982162|FG003|Inpatient|Discharged <24 h after admission|0|||
161981928|NCT02455076|584982163|FG004|Inpatient|Discharged <24 h after admission|0|||
161981929|NCT02455076|584982159|FG000|Inpatient|Adverse Event|3|||
161981930|NCT02455076|584982160|FG001|Inpatient|Adverse Event|0|||
161981931|NCT02455076|584982161|FG002|Inpatient|Adverse Event|0|||
161981932|NCT02455076|584982162|FG003|Inpatient|Adverse Event|0|||
161981933|NCT02455076|584982163|FG004|Inpatient|Adverse Event|0|||
161981934|NCT02455076|584982159|FG000|Outpatient|Adverse Event|0|||
161981935|NCT02455076|584982160|FG001|Outpatient|Adverse Event|0|||
161981936|NCT02455076|584982161|FG002|Outpatient|Adverse Event|0|||
161981937|NCT02455076|584982162|FG003|Outpatient|Adverse Event|5|||
161981938|NCT02455076|584982163|FG004|Outpatient|Adverse Event|0|||
161981939|NCT02455076|584982159|FG000|Outpatient|Lost to Follow-up|0|||
161981940|NCT02455076|584982160|FG001|Outpatient|Lost to Follow-up|0|||
161981941|NCT02455076|584982161|FG002|Outpatient|Lost to Follow-up|0|||
161981942|NCT02455076|584982162|FG003|Outpatient|Lost to Follow-up|1|||
161981943|NCT02455076|584982163|FG004|Outpatient|Lost to Follow-up|12|||
161981944|NCT00548717|584982164|FG000|Overall Study|Death|5|||
161981945|NCT00548717|584982165|FG001|Overall Study|Death|2|||
161981946|NCT00548717|584982164|FG000|Overall Study|Relapse|3|||
161981947|NCT00548717|584982165|FG001|Overall Study|Relapse|0|||
161981948|NCT00548717|584982164|FG000|Overall Study|Alternative treatment for GVHD|1|||
161981949|NCT00548717|584982165|FG001|Overall Study|Alternative treatment for GVHD|0|||
161981950|NCT00845065|584982179|FG000|Overall Study|Adverse Event|3|||
161981951|NCT00845065|584982180|FG001|Overall Study|Adverse Event|23|||
161981952|NCT00845065|584982179|FG000|Overall Study|Lack of Efficacy|43|||
161981953|NCT00845065|584982180|FG001|Overall Study|Lack of Efficacy|21|||
161981954|NCT00845065|584982179|FG000|Overall Study|Non-Medical Reasons|1|||
161981955|NCT00845065|584982180|FG001|Overall Study|Non-Medical Reasons|11|||
161981956|NCT02383433|584982181|FG000|Overall Study|Disease progression|2|||
161981957|NCT00952614|584982184|FG000|Overall Study|Death|3|||
161981958|NCT00952614|584982184|FG000|Overall Study|Lost to Follow-up|3|||
161981959|NCT00952614|584982184|FG000|Overall Study|other reason|1|||
161981960|NCT02925728|584982186|FG000|Overall Study|Death|3|||
161774048|NCT00985114|584214462|FG001|Overall Study|Withdrawal by Subject|2|||
161774049|NCT02950831|584214463|FG000|Overall Study|Lost to Follow-up|1|||
161774050|NCT02950831|584214463|FG000|Overall Study|Withdrawal by Subject|3|||
161774051|NCT02950831|584214463|FG000|Overall Study|stimulation trail failure|5|||
161774052|NCT01119118|584214464|FG000|Overall Study|Adverse Event|1|||
161981961|NCT02925728|584982187|FG001|Overall Study|Death|5|||
161981962|NCT02925728|584982186|FG000|Overall Study|Physician Decision|1|||
161981963|NCT02925728|584982187|FG001|Overall Study|Physician Decision|0|||
161864573|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864574|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864575|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864576|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864577|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864578|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864579|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
161864580|NCT03334435|584547745|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864581|NCT03334435|584547746|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
161864582|NCT03334435|584547747|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
161864583|NCT03334435|584547748|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
161864584|NCT03334435|584547749|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
161864585|NCT03334435|584547750|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864586|NCT03334435|584547751|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864587|NCT03334435|584547752|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864588|NCT03334435|584547753|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864589|NCT03334435|584547754|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864590|NCT03334435|584547755|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864591|NCT03334435|584547756|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864592|NCT03334435|584547757|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864593|NCT03334435|584547758|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864594|NCT03334435|584547759|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
161864595|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161864596|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161864597|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161864598|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161864599|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161864600|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
161864601|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
161864602|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
161864603|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
161864604|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
161864605|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
161864606|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
161864607|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
161864608|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
161864609|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
161864610|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161864611|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161864612|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161864613|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161864614|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161864615|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
161864616|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
161864617|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
161864618|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
161864619|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
161864620|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
161864621|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
161864622|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
161864623|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
161864624|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
161864625|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161864626|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161864627|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161864628|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161864629|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161864630|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
161864631|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
161864632|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
161864633|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
161864634|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
162034920|NCT01083173|585184809|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
162034921|NCT01083173|585184810|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
161981964|NCT02925728|584982186|FG000|Overall Study|Withdrawal by Subject|1|||
161981965|NCT02925728|584982187|FG001|Overall Study|Withdrawal by Subject|0|||
161981966|NCT02963701|584982188|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
161981967|NCT02963701|584982189|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
161981968|NCT01345682|584982192|FG000|Overall Study|Progressive disease per RECIST|226|||
161981969|NCT01345682|584982193|FG001|Overall Study|Progressive disease per RECIST|93|||
161981970|NCT01345682|584982192|FG000|Overall Study|Worsening of underlying cancer disease|23|||
161981971|NCT01345682|584982193|FG001|Overall Study|Worsening of underlying cancer disease|12|||
161981972|NCT01345682|584982192|FG000|Overall Study|Adverse Event|51|||
161981973|NCT01345682|584982193|FG001|Overall Study|Adverse Event|41|||
161981974|NCT01345682|584982192|FG000|Overall Study|Non-compliance with protocol|0|||
161981975|NCT01345682|584982193|FG001|Overall Study|Non-compliance with protocol|1|||
161981976|NCT01345682|584982192|FG000|Overall Study|Lost to Follow-up|0|||
161981977|NCT01345682|584982193|FG001|Overall Study|Lost to Follow-up|1|||
161981978|NCT01345682|584982192|FG000|Overall Study|Refused to continue trial medication|16|||
161981979|NCT01345682|584982193|FG001|Overall Study|Refused to continue trial medication|9|||
161981980|NCT01345682|584982192|FG000|Overall Study|Not treated|2|||
161981981|NCT01345682|584982193|FG001|Overall Study|Not treated|1|||
161981982|NCT01345682|584982192|FG000|Overall Study|Reason other than those specified above|4|||
161981983|NCT01345682|584982193|FG001|Overall Study|Reason other than those specified above|3|||
161981984|NCT00637572|584982194|FG000|Overall Study|Adverse Event|1|||
161981985|NCT00637572|584982195|FG001|Overall Study|Adverse Event|2|||
161981986|NCT00637572|584982194|FG000|Overall Study|Death|0|||
161981987|NCT00637572|584982195|FG001|Overall Study|Death|1|||
161981988|NCT00637572|584982194|FG000|Overall Study|Lost to Follow-up|0|||
161981989|NCT00637572|584982195|FG001|Overall Study|Lost to Follow-up|1|||
161981990|NCT00637572|584982194|FG000|Overall Study|Physician Decision|1|||
161981991|NCT00637572|584982195|FG001|Overall Study|Physician Decision|1|||
161981992|NCT00637572|584982194|FG000|Overall Study|Withdrawal by Subject|0|||
161981993|NCT00637572|584982195|FG001|Overall Study|Withdrawal by Subject|2|||
161774053|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
161774054|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
161774055|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
161774056|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
161774057|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
161774058|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
161774059|NCT00828009|584214465|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
161774060|NCT00828009|584214465|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
161774061|NCT00828009|584214465|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
161774062|NCT00828009|584214465|FG000|Step 2 - Maintenance Therapy|Death|1|||
161981994|NCT00637572|584982194|FG000|Overall Study|Illicit Drug Use|1|||
161981995|NCT00637572|584982195|FG001|Overall Study|Illicit Drug Use|0|||
161981996|NCT00896649|584982196|FG000|Overall Study|Physician Decision|1|||
161981997|NCT00896649|584982196|FG000|Overall Study|Pregnancy|1|||
161981998|NCT00896649|584982196|FG000|Overall Study|missing documentation|1|||
161981999|NCT00896649|584982196|FG000|Overall Study|technical difficulties|2|||
161982000|NCT01075984|584982200|FG000|Treatment Phase|Adverse Event|0|||
161982001|NCT01075984|584982201|FG001|Treatment Phase|Adverse Event|1|||
161982002|NCT01075984|584982202|FG002|Treatment Phase|Adverse Event|3|||
161982003|NCT01075984|584982203|FG003|Treatment Phase|Adverse Event|7|||
161982004|NCT01075984|584982204|FG004|Treatment Phase|Adverse Event|35|||
161982005|NCT01075984|584982200|FG000|Treatment Phase|Protocol Violation|0|||
161982006|NCT01075984|584982201|FG001|Treatment Phase|Protocol Violation|0|||
161982007|NCT01075984|584982202|FG002|Treatment Phase|Protocol Violation|1|||
161982008|NCT01075984|584982203|FG003|Treatment Phase|Protocol Violation|0|||
161982009|NCT01075984|584982204|FG004|Treatment Phase|Protocol Violation|3|||
161982010|NCT01075984|584982200|FG000|Treatment Phase|Withdrawal by Subject|0|||
161982011|NCT01075984|584982201|FG001|Treatment Phase|Withdrawal by Subject|0|||
161982012|NCT01075984|584982202|FG002|Treatment Phase|Withdrawal by Subject|2|||
161982013|NCT01075984|584982203|FG003|Treatment Phase|Withdrawal by Subject|0|||
161982014|NCT01075984|584982204|FG004|Treatment Phase|Withdrawal by Subject|15|||
161982015|NCT01075984|584982200|FG000|Treatment Phase|Treatment Failure|0|||
161982016|NCT01075984|584982201|FG001|Treatment Phase|Treatment Failure|0|||
161982017|NCT01075984|584982202|FG002|Treatment Phase|Treatment Failure|1|||
161982018|NCT01075984|584982203|FG003|Treatment Phase|Treatment Failure|0|||
161982019|NCT01075984|584982204|FG004|Treatment Phase|Treatment Failure|5|||
161982020|NCT01075984|584982200|FG000|Treatment Phase|Progression of disease|0|||
161982021|NCT01075984|584982201|FG001|Treatment Phase|Progression of disease|0|||
161982022|NCT01075984|584982202|FG002|Treatment Phase|Progression of disease|0|||
161982023|NCT01075984|584982203|FG003|Treatment Phase|Progression of disease|0|||
161982024|NCT01075984|584982204|FG004|Treatment Phase|Progression of disease|2|||
161982025|NCT01075984|584982200|FG000|Follow-up Phase|Protocol Violation|0|||
161982026|NCT01075984|584982201|FG001|Follow-up Phase|Protocol Violation|0|||
161982027|NCT01075984|584982202|FG002|Follow-up Phase|Protocol Violation|1|||
161982028|NCT01075984|584982203|FG003|Follow-up Phase|Protocol Violation|0|||
161864635|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
161864636|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
161864637|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161864638|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
161864639|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
161864640|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161864641|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161864642|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161864643|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161864644|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161864645|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
161864646|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
161864647|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
161864648|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
161864649|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
161864650|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
161864651|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
161864652|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
161864653|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
161864654|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
161864655|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864656|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864657|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864658|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864659|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864660|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864661|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
161864662|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
161864663|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
161864664|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
161864665|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
161864666|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
161864667|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161864668|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
161864669|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
161864670|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864671|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864672|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864673|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864674|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864675|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864676|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864677|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864678|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864679|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864680|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864681|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
161864682|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864683|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
161864684|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161864685|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864686|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864687|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
161982029|NCT01075984|584982204|FG004|Follow-up Phase|Protocol Violation|3|||
161982030|NCT01075984|584982200|FG000|Follow-up Phase|Adverse Event|0|||
161982031|NCT01075984|584982201|FG001|Follow-up Phase|Adverse Event|0|||
161982032|NCT01075984|584982202|FG002|Follow-up Phase|Adverse Event|0|||
161982033|NCT01075984|584982203|FG003|Follow-up Phase|Adverse Event|2|||
161982034|NCT01075984|584982204|FG004|Follow-up Phase|Adverse Event|27|||
161982035|NCT01075984|584982200|FG000|Follow-up Phase|Administrative|0|||
161982036|NCT01075984|584982201|FG001|Follow-up Phase|Administrative|0|||
161982037|NCT01075984|584982202|FG002|Follow-up Phase|Administrative|0|||
161982038|NCT01075984|584982203|FG003|Follow-up Phase|Administrative|0|||
161982039|NCT01075984|584982204|FG004|Follow-up Phase|Administrative|1|||
161982040|NCT01075984|584982200|FG000|Follow-up Phase|Withdrawal by Subject|0|||
161864688|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864689|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864690|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
161864691|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864692|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864693|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864694|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864695|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864696|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864697|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864698|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
161864699|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
161864700|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864701|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864702|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864703|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864704|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864705|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161864706|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161864707|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161864708|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161864709|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
161864710|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161864711|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161864712|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864713|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864714|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161864715|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864716|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864717|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864718|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864719|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864720|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
161864721|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
161864722|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864723|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864724|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864725|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161864726|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
161864727|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
161864728|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
161864729|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
161864730|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864731|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864732|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864733|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864734|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864735|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
161864736|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864737|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864738|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864739|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864740|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
161864741|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864742|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864743|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161864744|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
161864745|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864746|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864747|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864748|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864749|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161982041|NCT01075984|584982201|FG001|Follow-up Phase|Withdrawal by Subject|0|||
161982042|NCT01075984|584982202|FG002|Follow-up Phase|Withdrawal by Subject|0|||
161982043|NCT01075984|584982203|FG003|Follow-up Phase|Withdrawal by Subject|0|||
161982044|NCT01075984|584982204|FG004|Follow-up Phase|Withdrawal by Subject|10|||
161982045|NCT01075984|584982200|FG000|Follow-up Phase|Progression of disease|0|||
161982046|NCT01075984|584982201|FG001|Follow-up Phase|Progression of disease|0|||
161982047|NCT01075984|584982202|FG002|Follow-up Phase|Progression of disease|0|||
161982048|NCT01075984|584982203|FG003|Follow-up Phase|Progression of disease|0|||
161982049|NCT01075984|584982204|FG004|Follow-up Phase|Progression of disease|2|||
161982050|NCT01075984|584982200|FG000|Follow-up Phase|Treatment failure|0|||
161982051|NCT01075984|584982201|FG001|Follow-up Phase|Treatment failure|0|||
161982052|NCT01075984|584982202|FG002|Follow-up Phase|Treatment failure|0|||
161982053|NCT01075984|584982203|FG003|Follow-up Phase|Treatment failure|0|||
161982054|NCT01075984|584982204|FG004|Follow-up Phase|Treatment failure|4|||
161982055|NCT03652675|584982205|FG000|Overall Study|Lost to Follow-up|4|||
161982056|NCT03652675|584982206|FG001|Overall Study|Lost to Follow-up|4|||
161982057|NCT03101085|584982208|FG000|Overall Study|Lost to Follow-up|0|||
161982058|NCT03101085|584982209|FG001|Overall Study|Lost to Follow-up|1|||
161982059|NCT02986854|584982210|FG000|Overall Study|Withdrawal by Subject|0|||
161982060|NCT02986854|584982211|FG001|Overall Study|Withdrawal by Subject|1|||
161982061|NCT02986854|584982212|FG002|Overall Study|Withdrawal by Subject|1|||
161982062|NCT02986854|584982210|FG000|Overall Study|Lost to Follow-up|3|||
161982063|NCT02986854|584982211|FG001|Overall Study|Lost to Follow-up|11|||
161982064|NCT02986854|584982212|FG002|Overall Study|Lost to Follow-up|2|||
161982065|NCT00086411|584982217|FG000|Overall Study|Lost to Follow-up|11|||
161982066|NCT00086411|584982218|FG001|Overall Study|Lost to Follow-up|11|||
161982067|NCT00086411|584982219|FG002|Overall Study|Lost to Follow-up|13|||
161982068|NCT00086411|584982220|FG003|Overall Study|Lost to Follow-up|12|||
161982069|NCT00695864|584982225|FG000|Placebo|Withdrawal by Subject|1|||
161982070|NCT00695864|584982225|FG000|Placebo|Physician Decision|4|||
161982071|NCT00752726|584982226|FG000|Overall Study|Lost to Follow-up|2|||
161982072|NCT00752726|584982227|FG001|Overall Study|Lost to Follow-up|1|||
161982073|NCT00752726|584982226|FG000|Overall Study|Adverse Event|3|||
161982074|NCT00752726|584982227|FG001|Overall Study|Adverse Event|0|||
161982075|NCT00752726|584982226|FG000|Overall Study|Withdrawal by Subject|5|||
161982076|NCT00752726|584982227|FG001|Overall Study|Withdrawal by Subject|10|||
161982077|NCT00752726|584982226|FG000|Overall Study|Other Reason|1|||
161982078|NCT00752726|584982227|FG001|Overall Study|Other Reason|2|||
161982079|NCT04232215|584982228|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
161982080|NCT04232215|584982229|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
161982081|NCT01555125|584982232|FG000|Induction Period|Lost to Follow-up|0|||
161982082|NCT01555125|584982233|FG001|Induction Period|Lost to Follow-up|2|||
161982083|NCT01555125|584982234|FG002|Induction Period|Lost to Follow-up|0|||
161982084|NCT01555125|584982235|FG003|Induction Period|Lost to Follow-up|0|||
161982085|NCT01555125|584982236|FG004|Induction Period|Lost to Follow-up|0|||
161982086|NCT01555125|584982232|FG000|Induction Period|Adverse Event|0|||
161982087|NCT01555125|584982233|FG001|Induction Period|Adverse Event|1|||
161982088|NCT01555125|584982234|FG002|Induction Period|Adverse Event|0|||
161982089|NCT01555125|584982235|FG003|Induction Period|Adverse Event|0|||
161982090|NCT01555125|584982236|FG004|Induction Period|Adverse Event|1|||
161982091|NCT01555125|584982232|FG000|Induction Period|Subject / guardian decision|0|||
161982092|NCT01555125|584982233|FG001|Induction Period|Subject / guardian decision|0|||
161982093|NCT01555125|584982234|FG002|Induction Period|Subject / guardian decision|0|||
161982094|NCT01555125|584982235|FG003|Induction Period|Subject / guardian decision|0|||
161982095|NCT01555125|584982236|FG004|Induction Period|Subject / guardian decision|2|||
161982096|NCT01555125|584982232|FG000|Induction Period|Death|1|||
161982097|NCT01555125|584982233|FG001|Induction Period|Death|0|||
161982098|NCT01555125|584982234|FG002|Induction Period|Death|0|||
161982099|NCT01555125|584982235|FG003|Induction Period|Death|0|||
161982100|NCT01555125|584982236|FG004|Induction Period|Death|0|||
161982101|NCT01555125|584982232|FG000|Maintenance Period|Adverse Event|1|||
161982102|NCT01555125|584982233|FG001|Maintenance Period|Adverse Event|1|||
161982103|NCT01555125|584982234|FG002|Maintenance Period|Adverse Event|0|||
161864750|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864751|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161982104|NCT01555125|584982235|FG003|Maintenance Period|Adverse Event|0|||
161982105|NCT01555125|584982236|FG004|Maintenance Period|Adverse Event|0|||
161982106|NCT01555125|584982232|FG000|Maintenance Period|Subject / guardian decision|1|||
161982107|NCT01555125|584982233|FG001|Maintenance Period|Subject / guardian decision|2|||
161982108|NCT01555125|584982234|FG002|Maintenance Period|Subject / guardian decision|0|||
161982109|NCT01555125|584982235|FG003|Maintenance Period|Subject / guardian decision|0|||
161982110|NCT01555125|584982236|FG004|Maintenance Period|Subject / guardian decision|0|||
161982111|NCT01555125|584982232|FG000|Maintenance Period|Lost to Follow-up|2|||
161982112|NCT01555125|584982233|FG001|Maintenance Period|Lost to Follow-up|0|||
161982113|NCT01555125|584982234|FG002|Maintenance Period|Lost to Follow-up|0|||
161982114|NCT01555125|584982235|FG003|Maintenance Period|Lost to Follow-up|1|||
161982115|NCT01555125|584982236|FG004|Maintenance Period|Lost to Follow-up|0|||
161982116|NCT01555125|584982232|FG000|Maintenance Period|Lack of Efficacy|6|||
161982117|NCT01555125|584982233|FG001|Maintenance Period|Lack of Efficacy|1|||
161864752|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
161864753|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
161864754|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864755|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
161864756|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
161864757|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
161864758|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864759|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161864760|NCT03334435|584547745|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864761|NCT03334435|584547746|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864762|NCT03334435|584547747|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864763|NCT03334435|584547748|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864764|NCT03334435|584547749|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864765|NCT03334435|584547750|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864766|NCT03334435|584547751|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864767|NCT03334435|584547752|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864768|NCT03334435|584547753|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864769|NCT03334435|584547754|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864770|NCT03334435|584547755|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864771|NCT03334435|584547756|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
161864772|NCT03334435|584547757|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161864773|NCT03334435|584547758|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
161864774|NCT03334435|584547759|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
161864775|NCT03922321|584547760|FG000|Overall Study|Participant Moved|1|||
161864776|NCT03922321|584547760|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
161864777|NCT02342678|584547764|FG000|Overall Study|Lost to Follow-up|0|||
161864778|NCT02342678|584547765|FG001|Overall Study|Lost to Follow-up|1|||
161864779|NCT02342678|584547764|FG000|Overall Study|Too busy to complete study|0|||
161864780|NCT02342678|584547765|FG001|Overall Study|Too busy to complete study|2|||
161864781|NCT02342678|584547764|FG000|Overall Study|Family illness/emergency|0|||
161864782|NCT02342678|584547765|FG001|Overall Study|Family illness/emergency|1|||
161864783|NCT02342678|584547764|FG000|Overall Study|Illness/medical reason|1|||
161864784|NCT02342678|584547765|FG001|Overall Study|Illness/medical reason|1|||
161864785|NCT00460603|584547766|FG000|Phase 1|Death|1|||
161864786|NCT00460603|584547767|FG001|Phase 1|Death|0|||
161864787|NCT00460603|584547768|FG002|Phase 1|Death|0|||
161864788|NCT00460603|584547769|FG003|Phase 1|Death|2|||
161864789|NCT00460603|584547770|FG004|Phase 1|Death|0|||
161864790|NCT00460603|584547771|FG005|Phase 1|Death|0|||
161864791|NCT00460603|584547772|FG006|Phase 1|Death|0|||
161864792|NCT00460603|584547773|FG007|Phase 1|Death|0|||
161864793|NCT00460603|584547774|FG008|Phase 1|Death|1|||
161864794|NCT00460603|584547775|FG009|Phase 1|Death|0|||
161864795|NCT00460603|584547776|FG010|Phase 1|Death|0|||
161864796|NCT00460603|584547777|FG011|Phase 1|Death|0|||
161864797|NCT00460603|584547766|FG000|Phase 1|Adverse Event|3|||
161864798|NCT00460603|584547767|FG001|Phase 1|Adverse Event|1|||
161864799|NCT00460603|584547768|FG002|Phase 1|Adverse Event|1|||
161864800|NCT00460603|584547769|FG003|Phase 1|Adverse Event|2|||
161864801|NCT00460603|584547770|FG004|Phase 1|Adverse Event|0|||
161864802|NCT00460603|584547771|FG005|Phase 1|Adverse Event|0|||
161864803|NCT00460603|584547772|FG006|Phase 1|Adverse Event|3|||
161864804|NCT00460603|584547773|FG007|Phase 1|Adverse Event|0|||
161864805|NCT00460603|584547774|FG008|Phase 1|Adverse Event|4|||
161864806|NCT00460603|584547775|FG009|Phase 1|Adverse Event|0|||
161864807|NCT00460603|584547776|FG010|Phase 1|Adverse Event|0|||
161864808|NCT00460603|584547777|FG011|Phase 1|Adverse Event|0|||
161864809|NCT00460603|584547766|FG000|Phase 1|Lack of Efficacy|1|||
161864810|NCT00460603|584547767|FG001|Phase 1|Lack of Efficacy|0|||
161864811|NCT00460603|584547768|FG002|Phase 1|Lack of Efficacy|1|||
161864812|NCT00460603|584547769|FG003|Phase 1|Lack of Efficacy|2|||
161864813|NCT00460603|584547770|FG004|Phase 1|Lack of Efficacy|2|||
161864814|NCT00460603|584547771|FG005|Phase 1|Lack of Efficacy|2|||
161864815|NCT00460603|584547772|FG006|Phase 1|Lack of Efficacy|2|||
161864816|NCT00460603|584547773|FG007|Phase 1|Lack of Efficacy|2|||
161864817|NCT00460603|584547774|FG008|Phase 1|Lack of Efficacy|11|||
161864818|NCT00460603|584547775|FG009|Phase 1|Lack of Efficacy|0|||
161864819|NCT00460603|584547776|FG010|Phase 1|Lack of Efficacy|0|||
161864820|NCT00460603|584547777|FG011|Phase 1|Lack of Efficacy|0|||
161864821|NCT00460603|584547766|FG000|Phase 1|Withdrawal by Subject|1|||
161864822|NCT00460603|584547767|FG001|Phase 1|Withdrawal by Subject|2|||
161864823|NCT00460603|584547768|FG002|Phase 1|Withdrawal by Subject|1|||
161864824|NCT00460603|584547769|FG003|Phase 1|Withdrawal by Subject|1|||
161864825|NCT00460603|584547770|FG004|Phase 1|Withdrawal by Subject|3|||
161864826|NCT00460603|584547771|FG005|Phase 1|Withdrawal by Subject|0|||
161864827|NCT00460603|584547772|FG006|Phase 1|Withdrawal by Subject|1|||
161864828|NCT00460603|584547773|FG007|Phase 1|Withdrawal by Subject|0|||
161864829|NCT00460603|584547774|FG008|Phase 1|Withdrawal by Subject|2|||
161864830|NCT00460603|584547775|FG009|Phase 1|Withdrawal by Subject|0|||
161864831|NCT00460603|584547776|FG010|Phase 1|Withdrawal by Subject|0|||
161864832|NCT00460603|584547777|FG011|Phase 1|Withdrawal by Subject|0|||
161864833|NCT00460603|584547766|FG000|Phase 1|Other|0|||
161864834|NCT00460603|584547767|FG001|Phase 1|Other|3|||
161864835|NCT00460603|584547768|FG002|Phase 1|Other|1|||
161864836|NCT00460603|584547769|FG003|Phase 1|Other|1|||
161864837|NCT00460603|584547770|FG004|Phase 1|Other|1|||
161864838|NCT00460603|584547771|FG005|Phase 1|Other|2|||
161864839|NCT00460603|584547772|FG006|Phase 1|Other|0|||
161864840|NCT00460603|584547773|FG007|Phase 1|Other|1|||
161864841|NCT00460603|584547774|FG008|Phase 1|Other|0|||
161864842|NCT00460603|584547775|FG009|Phase 1|Other|0|||
161864843|NCT00460603|584547776|FG010|Phase 1|Other|0|||
161864844|NCT00460603|584547777|FG011|Phase 1|Other|0|||
161864845|NCT00460603|584547766|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864846|NCT00460603|584547767|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864847|NCT00460603|584547768|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864848|NCT00460603|584547769|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864849|NCT00460603|584547770|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864850|NCT00460603|584547771|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864851|NCT00460603|584547772|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864852|NCT00460603|584547773|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864853|NCT00460603|584547774|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864854|NCT00460603|584547775|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
161864855|NCT00460603|584547776|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864856|NCT00460603|584547777|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161864857|NCT00460603|584547766|FG000|Phase 2|Adverse Event|0|||
161864858|NCT00460603|584547767|FG001|Phase 2|Adverse Event|0|||
161864859|NCT00460603|584547768|FG002|Phase 2|Adverse Event|0|||
161864860|NCT00460603|584547769|FG003|Phase 2|Adverse Event|0|||
161864861|NCT00460603|584547770|FG004|Phase 2|Adverse Event|0|||
161864862|NCT00460603|584547771|FG005|Phase 2|Adverse Event|0|||
161864863|NCT00460603|584547772|FG006|Phase 2|Adverse Event|0|||
161864864|NCT00460603|584547773|FG007|Phase 2|Adverse Event|0|||
161864865|NCT00460603|584547774|FG008|Phase 2|Adverse Event|0|||
161864866|NCT00460603|584547775|FG009|Phase 2|Adverse Event|12|||
161864867|NCT00460603|584547776|FG010|Phase 2|Adverse Event|9|||
161864868|NCT00460603|584547777|FG011|Phase 2|Adverse Event|10|||
161864869|NCT00460603|584547766|FG000|Phase 2|Death|0|||
161864870|NCT00460603|584547767|FG001|Phase 2|Death|0|||
161864871|NCT00460603|584547768|FG002|Phase 2|Death|0|||
161864872|NCT00460603|584547769|FG003|Phase 2|Death|0|||
161864873|NCT00460603|584547770|FG004|Phase 2|Death|0|||
161864874|NCT00460603|584547771|FG005|Phase 2|Death|0|||
161864875|NCT00460603|584547772|FG006|Phase 2|Death|0|||
161864876|NCT00460603|584547773|FG007|Phase 2|Death|0|||
161864877|NCT00460603|584547774|FG008|Phase 2|Death|0|||
161864878|NCT00460603|584547775|FG009|Phase 2|Death|4|||
161864879|NCT00460603|584547776|FG010|Phase 2|Death|2|||
161864880|NCT00460603|584547777|FG011|Phase 2|Death|2|||
161864881|NCT00460603|584547766|FG000|Phase 2|Protocol Violation|0|||
161864882|NCT00460603|584547767|FG001|Phase 2|Protocol Violation|0|||
161864883|NCT00460603|584547768|FG002|Phase 2|Protocol Violation|0|||
161864884|NCT00460603|584547769|FG003|Phase 2|Protocol Violation|0|||
161864885|NCT00460603|584547770|FG004|Phase 2|Protocol Violation|0|||
161864886|NCT00460603|584547771|FG005|Phase 2|Protocol Violation|0|||
161864887|NCT00460603|584547772|FG006|Phase 2|Protocol Violation|0|||
161864888|NCT00460603|584547773|FG007|Phase 2|Protocol Violation|0|||
161864889|NCT00460603|584547774|FG008|Phase 2|Protocol Violation|0|||
161864890|NCT00460603|584547775|FG009|Phase 2|Protocol Violation|1|||
161864891|NCT00460603|584547776|FG010|Phase 2|Protocol Violation|1|||
161864892|NCT00460603|584547777|FG011|Phase 2|Protocol Violation|0|||
161864893|NCT00460603|584547766|FG000|Phase 2|Lost to Follow-up|0|||
161864894|NCT00460603|584547767|FG001|Phase 2|Lost to Follow-up|0|||
161864895|NCT00460603|584547768|FG002|Phase 2|Lost to Follow-up|0|||
161864896|NCT00460603|584547769|FG003|Phase 2|Lost to Follow-up|0|||
161864897|NCT00460603|584547770|FG004|Phase 2|Lost to Follow-up|0|||
161864898|NCT00460603|584547771|FG005|Phase 2|Lost to Follow-up|0|||
161864899|NCT00460603|584547772|FG006|Phase 2|Lost to Follow-up|0|||
161864900|NCT00460603|584547773|FG007|Phase 2|Lost to Follow-up|0|||
161864901|NCT00460603|584547774|FG008|Phase 2|Lost to Follow-up|0|||
161864902|NCT00460603|584547775|FG009|Phase 2|Lost to Follow-up|1|||
161864903|NCT00460603|584547776|FG010|Phase 2|Lost to Follow-up|0|||
161864904|NCT00460603|584547777|FG011|Phase 2|Lost to Follow-up|0|||
161864905|NCT00460603|584547766|FG000|Phase 2|Other|0|||
161864906|NCT00460603|584547767|FG001|Phase 2|Other|0|||
161864907|NCT00460603|584547768|FG002|Phase 2|Other|0|||
161864908|NCT00460603|584547769|FG003|Phase 2|Other|0|||
161864909|NCT00460603|584547770|FG004|Phase 2|Other|0|||
161864910|NCT00460603|584547771|FG005|Phase 2|Other|0|||
161864911|NCT00460603|584547772|FG006|Phase 2|Other|0|||
161864912|NCT00460603|584547773|FG007|Phase 2|Other|0|||
161864913|NCT00460603|584547774|FG008|Phase 2|Other|0|||
161864914|NCT00460603|584547775|FG009|Phase 2|Other|6|||
161864915|NCT00460603|584547776|FG010|Phase 2|Other|16|||
161864916|NCT00460603|584547777|FG011|Phase 2|Other|7|||
161864917|NCT00460603|584547766|FG000|Phase 2|Objective Progression or Relapse|0|||
161864918|NCT00460603|584547767|FG001|Phase 2|Objective Progression or Relapse|0|||
161982118|NCT01555125|584982234|FG002|Maintenance Period|Lack of Efficacy|3|||
161982119|NCT01555125|584982235|FG003|Maintenance Period|Lack of Efficacy|0|||
161982120|NCT01555125|584982236|FG004|Maintenance Period|Lack of Efficacy|0|||
161982121|NCT01555125|584982232|FG000|Maintenance Period|Physician Decision|0|||
161982122|NCT01555125|584982233|FG001|Maintenance Period|Physician Decision|0|||
161982123|NCT01555125|584982234|FG002|Maintenance Period|Physician Decision|1|||
161982124|NCT01555125|584982235|FG003|Maintenance Period|Physician Decision|0|||
161982125|NCT01555125|584982236|FG004|Maintenance Period|Physician Decision|0|||
161982126|NCT01555125|584982232|FG000|Maintenance Period|Death|0|||
161982127|NCT01555125|584982233|FG001|Maintenance Period|Death|0|||
161982128|NCT01555125|584982234|FG002|Maintenance Period|Death|0|||
161982129|NCT01555125|584982235|FG003|Maintenance Period|Death|1|||
161982130|NCT01555125|584982236|FG004|Maintenance Period|Death|0|||
161982131|NCT01555125|584982232|FG000|Extension|Adverse Event|1|||
161982132|NCT01555125|584982233|FG001|Extension|Adverse Event|2|||
161982133|NCT01555125|584982234|FG002|Extension|Adverse Event|1|||
161982134|NCT01555125|584982235|FG003|Extension|Adverse Event|1|||
161982135|NCT01555125|584982236|FG004|Extension|Adverse Event|0|||
161982136|NCT01555125|584982232|FG000|Extension|Protocol deviation|1|||
161982137|NCT01555125|584982233|FG001|Extension|Protocol deviation|0|||
161982138|NCT01555125|584982234|FG002|Extension|Protocol deviation|0|||
161982139|NCT01555125|584982235|FG003|Extension|Protocol deviation|0|||
161982140|NCT01555125|584982236|FG004|Extension|Protocol deviation|0|||
161982141|NCT01555125|584982232|FG000|Extension|Lack of Efficacy|7|||
161982142|NCT01555125|584982233|FG001|Extension|Lack of Efficacy|6|||
161982143|NCT01555125|584982234|FG002|Extension|Lack of Efficacy|3|||
161982144|NCT01555125|584982235|FG003|Extension|Lack of Efficacy|0|||
161982145|NCT01555125|584982236|FG004|Extension|Lack of Efficacy|0|||
161982146|NCT01555125|584982232|FG000|Extension|Lost to Follow-up|2|||
161982147|NCT01555125|584982233|FG001|Extension|Lost to Follow-up|1|||
161982148|NCT01555125|584982234|FG002|Extension|Lost to Follow-up|2|||
161982149|NCT01555125|584982235|FG003|Extension|Lost to Follow-up|0|||
161982150|NCT01555125|584982236|FG004|Extension|Lost to Follow-up|0|||
161982151|NCT01555125|584982232|FG000|Extension|Study terminated by sponsor|32|||
161982152|NCT01555125|584982233|FG001|Extension|Study terminated by sponsor|33|||
161982153|NCT01555125|584982234|FG002|Extension|Study terminated by sponsor|16|||
161982154|NCT01555125|584982235|FG003|Extension|Study terminated by sponsor|20|||
161982155|NCT01555125|584982236|FG004|Extension|Study terminated by sponsor|0|||
161982156|NCT01555125|584982232|FG000|Extension|Subject/guardian decision|1|||
161982157|NCT01555125|584982233|FG001|Extension|Subject/guardian decision|9|||
161864919|NCT00460603|584547768|FG002|Phase 2|Objective Progression or Relapse|0|||
161864920|NCT00460603|584547769|FG003|Phase 2|Objective Progression or Relapse|0|||
161864921|NCT00460603|584547770|FG004|Phase 2|Objective Progression or Relapse|0|||
161864922|NCT00460603|584547771|FG005|Phase 2|Objective Progression or Relapse|0|||
161864923|NCT00460603|584547772|FG006|Phase 2|Objective Progression or Relapse|0|||
161864924|NCT00460603|584547773|FG007|Phase 2|Objective Progression or Relapse|0|||
161864925|NCT00460603|584547774|FG008|Phase 2|Objective Progression or Relapse|0|||
161864926|NCT00460603|584547775|FG009|Phase 2|Objective Progression or Relapse|9|||
161864927|NCT00460603|584547776|FG010|Phase 2|Objective Progression or Relapse|10|||
161864928|NCT00460603|584547777|FG011|Phase 2|Objective Progression or Relapse|17|||
161864929|NCT00460603|584547766|FG000|Phase 2|Global Deterioration of Health Status|0|||
161864930|NCT00460603|584547767|FG001|Phase 2|Global Deterioration of Health Status|0|||
161864931|NCT00460603|584547768|FG002|Phase 2|Global Deterioration of Health Status|0|||
161864932|NCT00460603|584547769|FG003|Phase 2|Global Deterioration of Health Status|0|||
161864933|NCT00460603|584547770|FG004|Phase 2|Global Deterioration of Health Status|0|||
161864934|NCT00460603|584547771|FG005|Phase 2|Global Deterioration of Health Status|0|||
161864935|NCT00460603|584547772|FG006|Phase 2|Global Deterioration of Health Status|0|||
161864936|NCT00460603|584547773|FG007|Phase 2|Global Deterioration of Health Status|0|||
161864937|NCT00460603|584547774|FG008|Phase 2|Global Deterioration of Health Status|0|||
161864938|NCT00460603|584547775|FG009|Phase 2|Global Deterioration of Health Status|0|||
161864939|NCT00460603|584547776|FG010|Phase 2|Global Deterioration of Health Status|1|||
161864940|NCT00460603|584547777|FG011|Phase 2|Global Deterioration of Health Status|0|||
161864941|NCT00460603|584547766|FG000|Phase 2|Withdrawal by Subject|0|||
161864942|NCT00460603|584547767|FG001|Phase 2|Withdrawal by Subject|0|||
161982158|NCT01555125|584982234|FG002|Extension|Subject/guardian decision|1|||
161982159|NCT01555125|584982235|FG003|Extension|Subject/guardian decision|0|||
161982160|NCT01555125|584982236|FG004|Extension|Subject/guardian decision|0|||
161982161|NCT01555125|584982232|FG000|Extension|Technical Problems|1|||
161982162|NCT01555125|584982233|FG001|Extension|Technical Problems|0|||
161982163|NCT01555125|584982234|FG002|Extension|Technical Problems|0|||
161864943|NCT00460603|584547768|FG002|Phase 2|Withdrawal by Subject|0|||
161982164|NCT01555125|584982235|FG003|Extension|Technical Problems|1|||
161864944|NCT00460603|584547769|FG003|Phase 2|Withdrawal by Subject|0|||
161864945|NCT00460603|584547770|FG004|Phase 2|Withdrawal by Subject|0|||
161864946|NCT00460603|584547771|FG005|Phase 2|Withdrawal by Subject|0|||
161864947|NCT00460603|584547772|FG006|Phase 2|Withdrawal by Subject|0|||
161982165|NCT01555125|584982236|FG004|Extension|Technical Problems|0|||
161982166|NCT01555125|584982232|FG000|Follow-Up Period|Lost to Follow-up|1|||
161864948|NCT00460603|584547773|FG007|Phase 2|Withdrawal by Subject|0|||
161864949|NCT00460603|584547774|FG008|Phase 2|Withdrawal by Subject|0|||
161864950|NCT00460603|584547775|FG009|Phase 2|Withdrawal by Subject|5|||
161864951|NCT00460603|584547776|FG010|Phase 2|Withdrawal by Subject|4|||
161864952|NCT00460603|584547777|FG011|Phase 2|Withdrawal by Subject|5|||
161864953|NCT00460603|584547766|FG000|Phase 2|Randomized, but not treated|0|||
161864954|NCT00460603|584547767|FG001|Phase 2|Randomized, but not treated|0|||
161864955|NCT00460603|584547768|FG002|Phase 2|Randomized, but not treated|0|||
161864956|NCT00460603|584547769|FG003|Phase 2|Randomized, but not treated|0|||
161864957|NCT00460603|584547770|FG004|Phase 2|Randomized, but not treated|0|||
161864958|NCT00460603|584547771|FG005|Phase 2|Randomized, but not treated|0|||
161864959|NCT00460603|584547772|FG006|Phase 2|Randomized, but not treated|0|||
161864960|NCT00460603|584547773|FG007|Phase 2|Randomized, but not treated|0|||
161864961|NCT00460603|584547774|FG008|Phase 2|Randomized, but not treated|0|||
161864962|NCT00460603|584547775|FG009|Phase 2|Randomized, but not treated|3|||
161864963|NCT00460603|584547776|FG010|Phase 2|Randomized, but not treated|0|||
161864964|NCT00460603|584547777|FG011|Phase 2|Randomized, but not treated|0|||
161864965|NCT01651117|584547781|FG000|Overall Study|Death|2|||
161864966|NCT01651117|584547782|FG001|Overall Study|Death|3|||
161864967|NCT01651117|584547783|FG002|Overall Study|Death|2|||
161864968|NCT01651117|584547784|FG003|Overall Study|Death|2|||
161864969|NCT02075203|584547786|FG000|Overall Study|Withdrawal by Subject|1|||
161864970|NCT02075203|584547787|FG001|Overall Study|Withdrawal by Subject|0|||
161864971|NCT02075203|584547788|FG002|Overall Study|Withdrawal by Subject|1|||
161864972|NCT02075203|584547786|FG000|Overall Study|Adverse Event|1|||
161864973|NCT02075203|584547787|FG001|Overall Study|Adverse Event|0|||
161864974|NCT02075203|584547788|FG002|Overall Study|Adverse Event|0|||
161864975|NCT02075203|584547786|FG000|Overall Study|participant refused to use contraception|1|||
161864976|NCT02075203|584547787|FG001|Overall Study|participant refused to use contraception|0|||
161864977|NCT02075203|584547788|FG002|Overall Study|participant refused to use contraception|0|||
161864978|NCT00350207|584547789|FG000|Overall Study|Adverse Event|5|||
161864979|NCT00350207|584547790|FG001|Overall Study|Adverse Event|2|||
161864980|NCT00350207|584547791|FG002|Overall Study|Adverse Event|2|||
161864981|NCT00350207|584547789|FG000|Overall Study|Lack of Efficacy|1|||
161864982|NCT00350207|584547790|FG001|Overall Study|Lack of Efficacy|0|||
161864983|NCT00350207|584547791|FG002|Overall Study|Lack of Efficacy|2|||
161864984|NCT00350207|584547789|FG000|Overall Study|Lost to Follow-up|1|||
161864985|NCT00350207|584547790|FG001|Overall Study|Lost to Follow-up|0|||
161864986|NCT00350207|584547791|FG002|Overall Study|Lost to Follow-up|1|||
161864987|NCT00350207|584547789|FG000|Overall Study|Withdrawal by Subject|0|||
161864988|NCT00350207|584547790|FG001|Overall Study|Withdrawal by Subject|1|||
161864989|NCT00350207|584547791|FG002|Overall Study|Withdrawal by Subject|1|||
161864990|NCT00350207|584547789|FG000|Overall Study|Other|1|||
161864991|NCT00350207|584547790|FG001|Overall Study|Other|3|||
161864992|NCT00350207|584547791|FG002|Overall Study|Other|1|||
161864993|NCT03802825|584547792|FG000|Overall Study|Lost to follow-up for intervention|12|||
161864994|NCT03802825|584547793|FG001|Overall Study|Lost to follow-up for intervention|3|||
161864995|NCT03802825|584547792|FG000|Overall Study|Received only 1 component of intervention|0|||
161864996|NCT03802825|584547793|FG001|Overall Study|Received only 1 component of intervention|13|||
161864997|NCT00568451|584547797|FG000|Overall Study|Disease Progression|0|||
161864998|NCT00568451|584547798|FG001|Overall Study|Disease Progression|0|||
161864999|NCT00568451|584547799|FG002|Overall Study|Disease Progression|2|||
161865000|NCT00568451|584547800|FG003|Overall Study|Disease Progression|7|||
161865001|NCT01293695|584547802|FG000|Overall Study|Withdrawal by Subject|7|||
161865002|NCT01293695|584547803|FG001|Overall Study|Withdrawal by Subject|1|||
161865003|NCT01293695|584547802|FG000|Overall Study|Lost to Follow-up|8|||
161865004|NCT01293695|584547803|FG001|Overall Study|Lost to Follow-up|6|||
161865005|NCT01082328|584547807|FG000|Overall Study|Adverse Event|1|||
161865006|NCT00791778|584547808|FG000|Double-blind Treatment|Adverse Event|49|||
161865007|NCT00791778|584547809|FG001|Double-blind Treatment|Adverse Event|9|||
161865008|NCT00791778|584547808|FG000|Double-blind Treatment|Physician Decision|6|||
161865009|NCT00791778|584547809|FG001|Double-blind Treatment|Physician Decision|26|||
161865010|NCT00791778|584547808|FG000|Double-blind Treatment|Protocol Violation|0|||
161865011|NCT00791778|584547809|FG001|Double-blind Treatment|Protocol Violation|4|||
161865012|NCT00791778|584547808|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
161865013|NCT00791778|584547809|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
161865014|NCT00791778|584547808|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
161865015|NCT00791778|584547809|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
161865016|NCT00791778|584547808|FG000|Follow-up|Withdrawal by Subject|3|||
161865017|NCT00791778|584547809|FG001|Follow-up|Withdrawal by Subject|0|||
162034922|NCT01083173|585184809|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
162034923|NCT01083173|585184810|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
161865018|NCT00791778|584547808|FG000|Follow-up|Lost to Follow-up|2|||
161865019|NCT00791778|584547809|FG001|Follow-up|Lost to Follow-up|1|||
161865020|NCT00031590|584547810|FG000|Overall Study|Adverse Event|1|||
161865021|NCT00031590|584547810|FG000|Overall Study|Withdrawal by parents|2|||
161982167|NCT01555125|584982233|FG001|Follow-Up Period|Lost to Follow-up|0|||
161982168|NCT01555125|584982234|FG002|Follow-Up Period|Lost to Follow-up|0|||
161982169|NCT01555125|584982235|FG003|Follow-Up Period|Lost to Follow-up|0|||
161982170|NCT01555125|584982236|FG004|Follow-Up Period|Lost to Follow-up|0|||
161982171|NCT01555125|584982232|FG000|Follow-Up Period|Subject / guardian decision|3|||
161982172|NCT01555125|584982233|FG001|Follow-Up Period|Subject / guardian decision|1|||
161982173|NCT01555125|584982234|FG002|Follow-Up Period|Subject / guardian decision|1|||
161982174|NCT01555125|584982235|FG003|Follow-Up Period|Subject / guardian decision|1|||
161982175|NCT01555125|584982236|FG004|Follow-Up Period|Subject / guardian decision|0|||
161982176|NCT04268745|584982237|FG000|Overall Study|Lost to Follow-up|2|||
161982177|NCT04268745|584982238|FG001|Overall Study|Lost to Follow-up|3|||
161982178|NCT04268745|584982237|FG000|Overall Study|Withdrawal by Subject|4|||
161982179|NCT04268745|584982238|FG001|Overall Study|Withdrawal by Subject|2|||
161982180|NCT04268745|584982237|FG000|Overall Study|Death in the family|1|||
161982181|NCT04268745|584982238|FG001|Overall Study|Death in the family|0|||
161982182|NCT01887353|584982240|FG000|Overall Study|Study stopped early|4|||
161982183|NCT01887353|584982241|FG001|Overall Study|Study stopped early|3|||
161982184|NCT02039856|584982242|FG000|Overall Study|Death|5|||
161982185|NCT02039856|584982243|FG001|Overall Study|Death|3|||
161982186|NCT02039856|584982242|FG000|Overall Study|Partial survey completion|61|||
161982187|NCT02039856|584982243|FG001|Overall Study|Partial survey completion|26|||
161982188|NCT02039856|584982242|FG000|Overall Study|Lost to Follow-up|388|||
161982189|NCT02039856|584982243|FG001|Overall Study|Lost to Follow-up|206|||
161982190|NCT02039856|584982242|FG000|Overall Study|Withdrawal by Subject|1573|||
161982191|NCT02039856|584982243|FG001|Overall Study|Withdrawal by Subject|618|||
161982192|NCT05327361|584982257|FG000|Overall Study|Lost to Follow-up|4|||
161982193|NCT00626405|584982258|FG000|Overall Study|Deemed Ineligible|1|||
161982194|NCT00626405|584982259|FG001|Overall Study|Deemed Ineligible|0|||
161982195|NCT00626405|584982258|FG000|Overall Study|Withdrawal by Subject|0|||
161982196|NCT00626405|584982259|FG001|Overall Study|Withdrawal by Subject|1|||
161982197|NCT01174173|584982260|FG000|Overall Study|drug-drug interaction|1|||
161982198|NCT03775512|584984755|FG000|Overall Study|Death|1|||
161982199|NCT03775512|584984756|FG001|Overall Study|Death|1|||
161982200|NCT03775512|584984755|FG000|Overall Study|Withdrawal by Subject|7|||
161982201|NCT03775512|584984756|FG001|Overall Study|Withdrawal by Subject|4|||
161982202|NCT03775512|584984755|FG000|Overall Study|Lost to Follow-up|5|||
161982203|NCT03775512|584984756|FG001|Overall Study|Lost to Follow-up|5|||
161982204|NCT03775512|584984755|FG000|Overall Study|Excluded before Catheter insertion|14|||
161982205|NCT03775512|584984756|FG001|Overall Study|Excluded before Catheter insertion|5|||
161982206|NCT03775512|584984755|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
161982207|NCT03775512|584984756|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
161982208|NCT03775512|584984755|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
161982209|NCT03775512|584984756|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
161982210|NCT01610336|584984757|FG000|Overall Study|Progressive Disease|4|||
161982211|NCT01610336|584984758|FG001|Overall Study|Progressive Disease|6|||
161982212|NCT01610336|584984759|FG002|Overall Study|Progressive Disease|6|||
161982213|NCT01610336|584984760|FG003|Overall Study|Progressive Disease|5|||
161982214|NCT01610336|584984761|FG004|Overall Study|Progressive Disease|3|||
161982215|NCT01610336|584984762|FG005|Overall Study|Progressive Disease|10|||
161982216|NCT01610336|584984763|FG006|Overall Study|Progressive Disease|1|||
161982217|NCT01610336|584984764|FG007|Overall Study|Progressive Disease|6|||
161982218|NCT01610336|584984765|FG008|Overall Study|Progressive Disease|6|||
161982219|NCT01610336|584984766|FG009|Overall Study|Progressive Disease|40|||
161982220|NCT01610336|584984767|FG010|Overall Study|Progressive Disease|36|||
161982221|NCT01610336|584984757|FG000|Overall Study|Adverse Event|0|||
161982222|NCT01610336|584984758|FG001|Overall Study|Adverse Event|0|||
161982223|NCT01610336|584984759|FG002|Overall Study|Adverse Event|0|||
161982224|NCT01610336|584984760|FG003|Overall Study|Adverse Event|1|||
161982225|NCT01610336|584984761|FG004|Overall Study|Adverse Event|1|||
161982226|NCT01610336|584984762|FG005|Overall Study|Adverse Event|1|||
161982227|NCT01610336|584984763|FG006|Overall Study|Adverse Event|0|||
161982228|NCT01610336|584984764|FG007|Overall Study|Adverse Event|0|||
161982229|NCT01610336|584984765|FG008|Overall Study|Adverse Event|2|||
161982230|NCT01610336|584984766|FG009|Overall Study|Adverse Event|8|||
161982231|NCT01610336|584984767|FG010|Overall Study|Adverse Event|6|||
161982232|NCT01610336|584984757|FG000|Overall Study|Subject/Guardian decision|1|||
161982233|NCT01610336|584984758|FG001|Overall Study|Subject/Guardian decision|1|||
161982234|NCT01610336|584984759|FG002|Overall Study|Subject/Guardian decision|0|||
161982235|NCT01610336|584984760|FG003|Overall Study|Subject/Guardian decision|1|||
161982236|NCT01610336|584984761|FG004|Overall Study|Subject/Guardian decision|0|||
161982237|NCT01610336|584984762|FG005|Overall Study|Subject/Guardian decision|0|||
161982238|NCT01610336|584984763|FG006|Overall Study|Subject/Guardian decision|0|||
161982239|NCT01610336|584984764|FG007|Overall Study|Subject/Guardian decision|1|||
161982240|NCT01610336|584984765|FG008|Overall Study|Subject/Guardian decision|0|||
161982241|NCT01610336|584984766|FG009|Overall Study|Subject/Guardian decision|2|||
161982242|NCT01610336|584984767|FG010|Overall Study|Subject/Guardian decision|2|||
161982243|NCT01610336|584984757|FG000|Overall Study|Death|0|||
161982244|NCT01610336|584984758|FG001|Overall Study|Death|0|||
161982245|NCT01610336|584984759|FG002|Overall Study|Death|0|||
161982246|NCT01610336|584984760|FG003|Overall Study|Death|0|||
161982247|NCT01610336|584984761|FG004|Overall Study|Death|0|||
161982248|NCT01610336|584984762|FG005|Overall Study|Death|1|||
161982249|NCT01610336|584984763|FG006|Overall Study|Death|3|||
161982250|NCT01610336|584984764|FG007|Overall Study|Death|0|||
161982251|NCT01610336|584984765|FG008|Overall Study|Death|0|||
161982252|NCT01610336|584984766|FG009|Overall Study|Death|1|||
161982253|NCT01610336|584984767|FG010|Overall Study|Death|2|||
161982254|NCT01610336|584984757|FG000|Overall Study|Non-Compliance with study treatment|0|||
161865022|NCT05506046|584547811|FG000|Overall Study|Lost to Follow-up|89|||
161865023|NCT05506046|584547812|FG001|Overall Study|Lost to Follow-up|101|||
161865024|NCT05506046|584547813|FG002|Overall Study|Lost to Follow-up|102|||
161865025|NCT05506046|584547814|FG003|Overall Study|Lost to Follow-up|99|||
161865026|NCT03313180|584547819|FG000|Overall Study|Adverse Event|120|||
161865027|NCT03313180|584547819|FG000|Overall Study|Lost to Follow-up|3|||
161865028|NCT03313180|584547819|FG000|Overall Study|Withdrawal by Subject|39|||
161865029|NCT03313180|584547819|FG000|Overall Study|Other than listed above|15|||
161865030|NCT03313180|584547819|FG000|Overall Study|Covid-19 related|2|||
161865031|NCT01058642|584547822|FG000|Treatment Period 1|Adverse Event|0|||
161865032|NCT01058642|584547823|FG001|Treatment Period 1|Adverse Event|1|||
161865033|NCT01058642|584547824|FG002|Treatment Period 1|Adverse Event|1|||
161865034|NCT01058642|584547825|FG003|Treatment Period 1|Adverse Event|0|||
161865035|NCT01058642|584547822|FG000|Treatment Period 1|Physician Decision|0|||
161865036|NCT01058642|584547823|FG001|Treatment Period 1|Physician Decision|0|||
161865037|NCT01058642|584547824|FG002|Treatment Period 1|Physician Decision|1|||
161865038|NCT01058642|584547825|FG003|Treatment Period 1|Physician Decision|0|||
161865039|NCT01058642|584547822|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161865040|NCT01058642|584547823|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161865041|NCT01058642|584547824|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161865042|NCT01058642|584547825|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161865043|NCT01058642|584547822|FG000|Treatment Period 1|Lack of Efficacy|0|||
161865044|NCT01058642|584547823|FG001|Treatment Period 1|Lack of Efficacy|0|||
161865045|NCT01058642|584547824|FG002|Treatment Period 1|Lack of Efficacy|0|||
161865046|NCT01058642|584547825|FG003|Treatment Period 1|Lack of Efficacy|1|||
161865047|NCT01058642|584547822|FG000|Treatment Period 1|Protocol Violation|0|||
161865048|NCT01058642|584547823|FG001|Treatment Period 1|Protocol Violation|0|||
161865049|NCT01058642|584547824|FG002|Treatment Period 1|Protocol Violation|0|||
161865050|NCT01058642|584547825|FG003|Treatment Period 1|Protocol Violation|1|||
161865051|NCT01058642|584547822|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
161865052|NCT01058642|584547823|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
161865053|NCT01058642|584547824|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
161865054|NCT01058642|584547825|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
161865055|NCT03267212|584547826|FG000|First Intervention|Lost to Follow-up|0|||
161865056|NCT03267212|584547827|FG001|First Intervention|Lost to Follow-up|2|||
161865057|NCT03267212|584547826|FG000|First Intervention|Withdrawal by Subject|1|||
161865058|NCT03267212|584547827|FG001|First Intervention|Withdrawal by Subject|1|||
161865059|NCT03267212|584547826|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
161865060|NCT03267212|584547827|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
161865061|NCT03759392|584547828|FG000|Overall Study|Adverse Event|12|||
161865062|NCT03759392|584547829|FG001|Overall Study|Adverse Event|4|||
161865063|NCT03759392|584547828|FG000|Overall Study|Death|2|||
161865064|NCT03759392|584547829|FG001|Overall Study|Death|1|||
161865065|NCT03759392|584547828|FG000|Overall Study|Withdrawal by Subject|2|||
161982255|NCT01610336|584984758|FG001|Overall Study|Non-Compliance with study treatment|0|||
161865066|NCT03759392|584547829|FG001|Overall Study|Withdrawal by Subject|0|||
161865067|NCT03759392|584547828|FG000|Overall Study|Protocol Violation|2|||
161865068|NCT03759392|584547829|FG001|Overall Study|Protocol Violation|0|||
161865069|NCT03759392|584547828|FG000|Overall Study|Physician Decision|0|||
161982256|NCT01610336|584984759|FG002|Overall Study|Non-Compliance with study treatment|0|||
161982257|NCT01610336|584984760|FG003|Overall Study|Non-Compliance with study treatment|0|||
161982258|NCT01610336|584984761|FG004|Overall Study|Non-Compliance with study treatment|0|||
161982259|NCT01610336|584984762|FG005|Overall Study|Non-Compliance with study treatment|0|||
161982260|NCT01610336|584984763|FG006|Overall Study|Non-Compliance with study treatment|0|||
161982261|NCT01610336|584984764|FG007|Overall Study|Non-Compliance with study treatment|0|||
161982262|NCT01610336|584984765|FG008|Overall Study|Non-Compliance with study treatment|0|||
161982263|NCT01610336|584984766|FG009|Overall Study|Non-Compliance with study treatment|1|||
161982264|NCT01610336|584984767|FG010|Overall Study|Non-Compliance with study treatment|0|||
161982265|NCT01610336|584984757|FG000|Overall Study|Physician Decision|0|||
161865070|NCT03759392|584547829|FG001|Overall Study|Physician Decision|1|||
161865071|NCT03759392|584547828|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
161865072|NCT03759392|584547829|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
161865073|NCT03759392|584547828|FG000|Overall Study|No longer able to take medicines|1|||
161865074|NCT03759392|584547829|FG001|Overall Study|No longer able to take medicines|0|||
161865075|NCT03759392|584547828|FG000|Overall Study|Stopped taking study drug|1|||
161865076|NCT03759392|584547829|FG001|Overall Study|Stopped taking study drug|0|||
161865077|NCT01288079|584547830|FG000|Overall Study|Withdrawal by Subject|2|||
161865078|NCT01288079|584547831|FG001|Overall Study|Withdrawal by Subject|4|||
161865079|NCT01288079|584547832|FG002|Overall Study|Withdrawal by Subject|1|||
161865080|NCT01288079|584547833|FG003|Overall Study|Withdrawal by Subject|0|||
161865081|NCT01288079|584547830|FG000|Overall Study|Adverse Event|2|||
161865082|NCT01288079|584547831|FG001|Overall Study|Adverse Event|1|||
161865083|NCT01288079|584547832|FG002|Overall Study|Adverse Event|2|||
161865084|NCT01288079|584547833|FG003|Overall Study|Adverse Event|3|||
161865085|NCT01288079|584547830|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
161865086|NCT01288079|584547831|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
161865087|NCT01288079|584547832|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
161865088|NCT01288079|584547833|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
161865089|NCT01288079|584547830|FG000|Overall Study|Condition under Investigation Worsened|0|||
161865090|NCT01288079|584547831|FG001|Overall Study|Condition under Investigation Worsened|0|||
161865091|NCT01288079|584547832|FG002|Overall Study|Condition under Investigation Worsened|0|||
161865092|NCT01288079|584547833|FG003|Overall Study|Condition under Investigation Worsened|1|||
161865093|NCT01288079|584547830|FG000|Overall Study|Lack of Efficacy|2|||
161865094|NCT01288079|584547831|FG001|Overall Study|Lack of Efficacy|2|||
161865095|NCT01288079|584547832|FG002|Overall Study|Lack of Efficacy|0|||
161865096|NCT01288079|584547833|FG003|Overall Study|Lack of Efficacy|2|||
161865097|NCT01288079|584547830|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
161865098|NCT01288079|584547831|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
161865099|NCT01288079|584547832|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
161865100|NCT01288079|584547833|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
161865101|NCT01288079|584547830|FG000|Overall Study|Lost to Follow-up|1|||
161865102|NCT01288079|584547831|FG001|Overall Study|Lost to Follow-up|1|||
161865103|NCT01288079|584547832|FG002|Overall Study|Lost to Follow-up|1|||
161865104|NCT01288079|584547833|FG003|Overall Study|Lost to Follow-up|0|||
161865105|NCT01288079|584547830|FG000|Overall Study|Other or Study Termination|11|||
161865106|NCT01288079|584547831|FG001|Overall Study|Other or Study Termination|15|||
161865107|NCT01288079|584547832|FG002|Overall Study|Other or Study Termination|14|||
161865108|NCT01288079|584547833|FG003|Overall Study|Other or Study Termination|8|||
161865109|NCT02387840|584547834|FG000|Overall Study|Death|0|||
161865110|NCT02387840|584547835|FG001|Overall Study|Death|0|||
161865111|NCT02387840|584547836|FG002|Overall Study|Death|0|||
161865112|NCT02387840|584547837|FG003|Overall Study|Death|0|||
161865113|NCT02387840|584547838|FG004|Overall Study|Death|0|||
161865114|NCT02387840|584547839|FG005|Overall Study|Death|1|||
161865115|NCT03170544|584547840|FG000|Part 1|Lost to Follow-up|1|||
161865116|NCT03170544|584547841|FG001|Part 1|Lost to Follow-up|0|||
161865117|NCT03170544|584547842|FG002|Part 1|Lost to Follow-up|0|||
161865118|NCT03170544|584547843|FG003|Part 1|Lost to Follow-up|0|||
161865119|NCT03170544|584547844|FG004|Part 1|Lost to Follow-up|0|||
161865120|NCT03170544|584547845|FG005|Part 1|Lost to Follow-up|0|||
161865121|NCT03170544|584547846|FG006|Part 1|Lost to Follow-up|0|||
161865122|NCT03170544|584547847|FG007|Part 1|Lost to Follow-up|0|||
161865123|NCT03170544|584547848|FG008|Part 1|Lost to Follow-up|0|||
161865124|NCT03170544|584547849|FG009|Part 1|Lost to Follow-up|0|||
161865125|NCT03170544|584547850|FG010|Part 1|Lost to Follow-up|0|||
161865126|NCT03170544|584547851|FG011|Part 1|Lost to Follow-up|0|||
161865127|NCT03170544|584547840|FG000|Part 1|Not treated|0|||
161865128|NCT03170544|584547841|FG001|Part 1|Not treated|0|||
161865129|NCT03170544|584547842|FG002|Part 1|Not treated|0|||
161865130|NCT03170544|584547843|FG003|Part 1|Not treated|1|||
161865131|NCT03170544|584547844|FG004|Part 1|Not treated|0|||
161865132|NCT03170544|584547845|FG005|Part 1|Not treated|0|||
161865133|NCT03170544|584547846|FG006|Part 1|Not treated|0|||
161865134|NCT03170544|584547847|FG007|Part 1|Not treated|0|||
161865135|NCT03170544|584547848|FG008|Part 1|Not treated|0|||
161865136|NCT03170544|584547849|FG009|Part 1|Not treated|0|||
161865137|NCT03170544|584547850|FG010|Part 1|Not treated|0|||
161865138|NCT03170544|584547851|FG011|Part 1|Not treated|0|||
161865139|NCT01213966|584547852|FG000|Overall Study|Protocol Violation|1|||
161865140|NCT01213966|584547853|FG001|Overall Study|Protocol Violation|0|||
161865141|NCT01213966|584547854|FG002|Overall Study|Protocol Violation|3|||
161865142|NCT01213966|584547855|FG003|Overall Study|Protocol Violation|1|||
161865143|NCT05161481|584549447|FG000|Overall Study|Withdrawal of consent|0|||
161865144|NCT05161481|584549448|FG001|Overall Study|Withdrawal of consent|1|||
161865145|NCT05161481|584549449|FG002|Overall Study|Withdrawal of consent|1|||
161865146|NCT05161481|584549447|FG000|Overall Study|Study terminated by sponsor|3|||
161865147|NCT05161481|584549448|FG001|Overall Study|Study terminated by sponsor|3|||
161865148|NCT05161481|584549449|FG002|Overall Study|Study terminated by sponsor|2|||
161865149|NCT05161481|584549447|FG000|Overall Study|Adverse Event|3|||
161865150|NCT05161481|584549448|FG001|Overall Study|Adverse Event|0|||
161865151|NCT05161481|584549449|FG002|Overall Study|Adverse Event|6|||
161865152|NCT05161481|584549447|FG000|Overall Study|Randomised in error and was not treated|1|||
161865153|NCT05161481|584549448|FG001|Overall Study|Randomised in error and was not treated|0|||
161982266|NCT01610336|584984758|FG001|Overall Study|Physician Decision|0|||
161982267|NCT01610336|584984759|FG002|Overall Study|Physician Decision|0|||
161982268|NCT01610336|584984760|FG003|Overall Study|Physician Decision|0|||
161982269|NCT01610336|584984761|FG004|Overall Study|Physician Decision|0|||
161982270|NCT01610336|584984762|FG005|Overall Study|Physician Decision|0|||
161982271|NCT01610336|584984763|FG006|Overall Study|Physician Decision|1|||
161982272|NCT01610336|584984764|FG007|Overall Study|Physician Decision|0|||
161982273|NCT01610336|584984765|FG008|Overall Study|Physician Decision|0|||
161982274|NCT01610336|584984766|FG009|Overall Study|Physician Decision|0|||
161982275|NCT01610336|584984767|FG010|Overall Study|Physician Decision|0|||
161982276|NCT01610336|584984757|FG000|Overall Study|Protocol Deviation|0|||
161982277|NCT01610336|584984758|FG001|Overall Study|Protocol Deviation|0|||
161982278|NCT01610336|584984759|FG002|Overall Study|Protocol Deviation|0|||
161982279|NCT01610336|584984760|FG003|Overall Study|Protocol Deviation|0|||
161982280|NCT01610336|584984761|FG004|Overall Study|Protocol Deviation|0|||
161982281|NCT01610336|584984762|FG005|Overall Study|Protocol Deviation|0|||
161982282|NCT01610336|584984763|FG006|Overall Study|Protocol Deviation|0|||
161982283|NCT01610336|584984764|FG007|Overall Study|Protocol Deviation|0|||
161982284|NCT01610336|584984765|FG008|Overall Study|Protocol Deviation|0|||
161982285|NCT01610336|584984766|FG009|Overall Study|Protocol Deviation|1|||
161982286|NCT01610336|584984767|FG010|Overall Study|Protocol Deviation|0|||
161982287|NCT01610336|584984757|FG000|Overall Study|Transfer to another trial|0|||
161982288|NCT01610336|584984758|FG001|Overall Study|Transfer to another trial|0|||
161982289|NCT01610336|584984759|FG002|Overall Study|Transfer to another trial|0|||
161982290|NCT01610336|584984760|FG003|Overall Study|Transfer to another trial|0|||
161982291|NCT01610336|584984761|FG004|Overall Study|Transfer to another trial|0|||
161982292|NCT01610336|584984762|FG005|Overall Study|Transfer to another trial|0|||
161982293|NCT01610336|584984763|FG006|Overall Study|Transfer to another trial|0|||
161982294|NCT01610336|584984764|FG007|Overall Study|Transfer to another trial|0|||
161865154|NCT05161481|584549449|FG002|Overall Study|Randomised in error and was not treated|0|||
161865155|NCT05161481|584549447|FG000|Overall Study|Subject decision|0|||
161865156|NCT05161481|584549448|FG001|Overall Study|Subject decision|0|||
161865157|NCT05161481|584549449|FG002|Overall Study|Subject decision|1|||
161865158|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
161865159|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
161865160|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
161865161|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
161865162|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
161865163|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
161865164|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
161865165|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
161865166|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
161865167|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
161865168|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
161865169|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
161865170|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
161865171|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
161865172|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
161865173|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
161865174|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
161865175|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
161865176|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
161865177|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
161865178|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
161865179|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
161865180|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
161865181|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
161865182|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
161865183|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
161865184|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
161865185|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
161865186|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
161865187|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
161865188|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
161865189|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
161865190|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
161865191|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
161982295|NCT01610336|584984765|FG008|Overall Study|Transfer to another trial|0|||
161982296|NCT01610336|584984766|FG009|Overall Study|Transfer to another trial|0|||
161982297|NCT01610336|584984767|FG010|Overall Study|Transfer to another trial|1|||
161982298|NCT02629822|584984768|FG000|Base Study|Lost to Follow-up|2|||
161982299|NCT02629822|584984768|FG000|Base Study|Non-Compliance With Study Drug|1|||
161982300|NCT02629822|584984768|FG000|Extension Study|Adverse Event|1|||
161774063|NCT00828009|584214465|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
161774064|NCT00828009|584214465|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
161774065|NCT00828009|584214465|FG000|Step 2 - Maintenance Therapy|Other|1|||
161774066|NCT03099265|584215930|FG000|Overall Study|Adverse Event|1|||
161774067|NCT00396318|584215938|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
161774068|NCT00602927|584215939|FG000|Period 1: 13 Days|Protocol Violation|2|||
161774069|NCT00602927|584215940|FG001|Period 1: 13 Days|Protocol Violation|4|||
161774070|NCT00602927|584215939|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
161774071|NCT00602927|584215940|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
161774072|NCT00602927|584215939|FG000|Period 1: 13 Days|Time|1|||
161774073|NCT00602927|584215940|FG001|Period 1: 13 Days|Time|0|||
161774074|NCT00602927|584215939|FG000|Period 1: 13 Days|Claustrophobia|0|||
161774075|NCT00602927|584215940|FG001|Period 1: 13 Days|Claustrophobia|1|||
161774076|NCT00602927|584215939|FG000|Period 2: 14 Days|Protocol Violation|0|||
161774077|NCT00602927|584215940|FG001|Period 2: 14 Days|Protocol Violation|2|||
161774078|NCT00602927|584215939|FG000|Period 3: 13 Days|Protocol Violation|0|||
161774079|NCT00602927|584215940|FG001|Period 3: 13 Days|Protocol Violation|1|||
161774080|NCT00602927|584215939|FG000|Period 3: 13 Days|MRI data quality|2|||
161774081|NCT00602927|584215940|FG001|Period 3: 13 Days|MRI data quality|2|||
161774082|NCT01741259|584215947|FG000|Overall Study|Protocol Violation|6|||
161774083|NCT01741259|584215948|FG001|Overall Study|Protocol Violation|4|||
161774084|NCT01741259|584215947|FG000|Overall Study|Withdrawal by Subject|0|||
161774085|NCT01741259|584215948|FG001|Overall Study|Withdrawal by Subject|2|||
161774086|NCT05604521|584215954|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
161774087|NCT05604521|584215955|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
161774088|NCT05604521|584215954|FG000|Overall Study|Adverse Event|1|||
161774089|NCT05604521|584215955|FG001|Overall Study|Adverse Event|0|||
161774090|NCT02875340|584215956|FG000|Overall Study|Death|2|||
161774091|NCT02875340|584215956|FG000|Overall Study|Withdrawal by Subject|2|||
161774092|NCT02875340|584215956|FG000|Overall Study|Physician Decision|3|||
161774093|NCT02875340|584215956|FG000|Overall Study|Adverse Event|1|||
161774094|NCT01160770|584215959|FG000|Overall Study|Adverse Event|10|||
161774095|NCT01160770|584215959|FG000|Overall Study|Protocol Violation|2|||
161774096|NCT01160770|584215959|FG000|Overall Study|Subject/parent/caregiver request|33|||
161774097|NCT01160770|584215959|FG000|Overall Study|Physician Decision|1|||
161774098|NCT01160770|584215959|FG000|Overall Study|Lost to Follow-up|7|||
161774099|NCT01160770|584215959|FG000|Overall Study|Study termination or sponsor request|1|||
161774100|NCT01160770|584215959|FG000|Overall Study|Death|9|||
161774101|NCT01160770|584215959|FG000|Overall Study|Lack of Efficacy|15|||
161774102|NCT01160770|584215959|FG000|Overall Study|Other Reasons|1|||
161774103|NCT00630994|584215960|FG000|Overall Study|Adverse Event|1|||
161774104|NCT00630994|584215960|FG000|Overall Study|Disease Progression|1|||
161774105|NCT00630994|584215960|FG000|Overall Study|Lack of Efficacy|1|||
161774106|NCT00630994|584215960|FG000|Overall Study|Other|1|||
161774107|NCT03586427|584215964|FG000|Overall Study|Lost to Follow-up|0|||
161774108|NCT03586427|584215965|FG001|Overall Study|Lost to Follow-up|3|||
161774109|NCT03586427|584215966|FG002|Overall Study|Lost to Follow-up|1|||
161774110|NCT03586427|584215967|FG003|Overall Study|Lost to Follow-up|3|||
161774111|NCT03586427|584215968|FG004|Overall Study|Lost to Follow-up|3|||
161774112|NCT03586427|584215964|FG000|Overall Study|Withdrawal by Subject|0|||
161774113|NCT03586427|584215965|FG001|Overall Study|Withdrawal by Subject|1|||
161774114|NCT03586427|584215966|FG002|Overall Study|Withdrawal by Subject|2|||
161774115|NCT03586427|584215967|FG003|Overall Study|Withdrawal by Subject|1|||
161774116|NCT03586427|584215968|FG004|Overall Study|Withdrawal by Subject|1|||
161774117|NCT03586427|584215964|FG000|Overall Study|Adverse Event|0|||
161774118|NCT03586427|584215965|FG001|Overall Study|Adverse Event|0|||
161774119|NCT03586427|584215966|FG002|Overall Study|Adverse Event|1|||
161774120|NCT03586427|584215967|FG003|Overall Study|Adverse Event|0|||
161774121|NCT03586427|584215968|FG004|Overall Study|Adverse Event|0|||
161774122|NCT03586427|584215964|FG000|Overall Study|Protocol Violation|0|||
161774123|NCT03586427|584215965|FG001|Overall Study|Protocol Violation|0|||
161774124|NCT03586427|584215966|FG002|Overall Study|Protocol Violation|1|||
161774125|NCT03586427|584215967|FG003|Overall Study|Protocol Violation|0|||
161774126|NCT03586427|584215968|FG004|Overall Study|Protocol Violation|1|||
161774127|NCT03586427|584215964|FG000|Overall Study|Noncompliance with study drug|0|||
161774128|NCT03586427|584215965|FG001|Overall Study|Noncompliance with study drug|0|||
161774129|NCT03586427|584215966|FG002|Overall Study|Noncompliance with study drug|1|||
161774130|NCT03586427|584215967|FG003|Overall Study|Noncompliance with study drug|0|||
161774131|NCT03586427|584215968|FG004|Overall Study|Noncompliance with study drug|0|||
161774132|NCT03193996|584215971|FG000|Overall Study|Withdrawal by Subject|4|||
161774133|NCT03193996|584215971|FG000|Overall Study|Lost to Follow-up|4|||
161774134|NCT03193996|584215971|FG000|Overall Study|Physician Decision|2|||
161774135|NCT03193996|584215971|FG000|Overall Study|Pregnancy|1|||
161774136|NCT03193996|584215971|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
161774137|NCT03193996|584215971|FG000|Overall Study|Complicating disease|1|||
161774138|NCT00593385|584215974|FG000|Overall Study|Death|14|||
161865192|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
161865193|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
161865194|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
161865195|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
161865196|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
161865197|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
161865198|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
161865199|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
161865200|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
161865201|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
161865202|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
161865203|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
161865204|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
161865205|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
161865206|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
161865207|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
161865208|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
161865209|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
161865210|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Site closed|0|||
161865211|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Site closed|0|||
161865212|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Site closed|1|||
161865213|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Site closed|0|||
161865214|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
161865215|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
161865216|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
161865217|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
161865218|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
161865219|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
161865220|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
161865221|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
161865222|NCT00838903|584549450|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
161865223|NCT00838903|584549451|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
161865224|NCT00838903|584549452|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
161865225|NCT00838903|584549453|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
161865226|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
161865227|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
161865228|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
161865229|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
161865230|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
161865231|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
161865232|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
161865233|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
161865234|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
161865235|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
161865236|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
161865237|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
161865238|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
161865239|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
161865240|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
161865241|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
161865242|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
161865243|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
161865244|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
161865245|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
161865246|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
161865247|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
161865248|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
161865249|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
161865250|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
161865251|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
161865252|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
161865253|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
161865254|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
161865255|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
161865256|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
161865257|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
161982301|NCT02629822|584984768|FG000|Extension Study|Lost to Follow-up|1|||
161865258|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
161865259|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
161865260|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
161865261|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
161865262|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
161865263|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
161865264|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
161865265|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
161865266|NCT00838903|584549450|FG000|Follow-up Period (8 Weeks)|Missing|1|||
161865267|NCT00838903|584549451|FG001|Follow-up Period (8 Weeks)|Missing|2|||
161865268|NCT00838903|584549452|FG002|Follow-up Period (8 Weeks)|Missing|1|||
161865269|NCT00838903|584549453|FG003|Follow-up Period (8 Weeks)|Missing|1|||
161865270|NCT01894841|584549454|FG000|Overall Study|Withdrawal by Subject|9|||
161865271|NCT01894841|584549455|FG001|Overall Study|Withdrawal by Subject|4|||
161865272|NCT01894841|584549454|FG000|Overall Study|Withdrawn by investigator|2|||
161865273|NCT01894841|584549455|FG001|Overall Study|Withdrawn by investigator|2|||
161865274|NCT01894841|584549454|FG000|Overall Study|Lost to Follow-up|7|||
161865275|NCT01894841|584549455|FG001|Overall Study|Lost to Follow-up|3|||
161865276|NCT01100086|584549456|FG000|Period 1|Withdrawal by Subject|1|||
161865277|NCT01100086|584549457|FG001|Period 1|Withdrawal by Subject|0|||
161865278|NCT00495391|584549460|FG000|Overall Study|Lack of Efficacy|34|||
161865279|NCT00495391|584549461|FG001|Overall Study|Lack of Efficacy|18|||
161865280|NCT00495391|584549460|FG000|Overall Study|Withdrawal by Subject|2|||
161865281|NCT00495391|584549461|FG001|Overall Study|Withdrawal by Subject|3|||
161865282|NCT03214224|584549462|FG000|Overall Study|Protocol Violation|1|||
161865283|NCT03214224|584549462|FG000|Overall Study|Withdrawal by Subject|2|||
161865284|NCT03214224|584549462|FG000|Overall Study|Practice controls or therapists|6|||
161865285|NCT02712320|584549471|FG000|Overall Study|Lost to Follow-up|1|||
161865286|NCT02712320|584549471|FG000|Overall Study|Withdrawal by Subject|1|||
161865287|NCT02712320|584549471|FG000|Overall Study|Transferred to another facility|1|||
161865288|NCT02712320|584549471|FG000|Overall Study|Treating with the prohibited medications|2|||
161865289|NCT05266053|584549472|FG000|Overall Study|Withdrawal by Subject|8|||
161865290|NCT05266053|584549473|FG001|Overall Study|Withdrawal by Subject|4|||
161865291|NCT05344560|584549474|FG000|Period 1|Subject out of visit window|1|||
161865292|NCT05344560|584549475|FG001|Period 1|Subject out of visit window|1|||
161865293|NCT05344560|584549474|FG000|Period 2|Covid-19 Related|1|||
161865294|NCT05344560|584549475|FG001|Period 2|Covid-19 Related|0|||
161865295|NCT05344560|584549474|FG000|Period 2|Adverse Event|1|||
161865296|NCT05344560|584549475|FG001|Period 2|Adverse Event|0|||
161865297|NCT05344560|584549474|FG000|Period 2|Subject out of visit window|1|||
161865298|NCT05344560|584549475|FG001|Period 2|Subject out of visit window|1|||
161865299|NCT05344560|584549474|FG000|Period 3|Subject out of visit window|1|||
161865300|NCT05344560|584549475|FG001|Period 3|Subject out of visit window|0|||
161865301|NCT01051960|584549479|FG000|Overall Study|Adverse Event|1|||
161865302|NCT02996968|584549480|FG000|Overall Study|Withdrawal by Subject|1|||
161865303|NCT02996968|584549481|FG001|Overall Study|Withdrawal by Subject|0|||
161865304|NCT04177095|584549495|FG000|Overall Study|Withdrawal by Subject|3|||
161865305|NCT04177095|584549495|FG000|Overall Study|Screen Failure|3|||
161865306|NCT04177095|584549495|FG000|Overall Study|Problems with the Trugraf assay|1|||
161865307|NCT02275819|584549496|FG000|Overall Study|Adverse Event|0|||
161865308|NCT02275819|584549497|FG001|Overall Study|Adverse Event|1|||
161865309|NCT01346059|584549498|FG000|Overall Study|Withdrawal by Subject|1|||
161865310|NCT01346059|584549499|FG001|Overall Study|Withdrawal by Subject|0|||
161865311|NCT02556775|584549500|FG000|Overall Study|Withdrawal by Subject|1|||
162034924|NCT01083173|585184809|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
161865312|NCT02556775|584549501|FG001|Overall Study|Withdrawal by Subject|0|||
161865313|NCT02556775|584549502|FG002|Overall Study|Withdrawal by Subject|1|||
161865314|NCT02556775|584549503|FG003|Overall Study|Withdrawal by Subject|0|||
161865315|NCT02556775|584549500|FG000|Overall Study|Lost to Follow-up|1|||
161865316|NCT02556775|584549501|FG001|Overall Study|Lost to Follow-up|0|||
161865317|NCT02556775|584549502|FG002|Overall Study|Lost to Follow-up|0|||
161865318|NCT02556775|584549503|FG003|Overall Study|Lost to Follow-up|0|||
162034925|NCT01083173|585184810|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
162034926|NCT01083173|585184809|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
161865319|NCT02025725|584549504|FG000|Overall Study|Adverse Event|5|||
161865320|NCT02025725|584549505|FG001|Overall Study|Adverse Event|0|||
161865321|NCT02025725|584549504|FG000|Overall Study|Lost to Follow-up|2|||
161865322|NCT02025725|584549505|FG001|Overall Study|Lost to Follow-up|0|||
161865323|NCT02025725|584549504|FG000|Overall Study|Protocol Violation|1|||
161865324|NCT02025725|584549505|FG001|Overall Study|Protocol Violation|1|||
161865325|NCT02025725|584549504|FG000|Overall Study|Withdrawal by Subject|3|||
161865326|NCT02025725|584549505|FG001|Overall Study|Withdrawal by Subject|2|||
161865327|NCT02025725|584549504|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
161865328|NCT02025725|584549505|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
161865329|NCT01592786|584549506|FG000|Overall Study|Adverse Event|60|||
161865330|NCT01592786|584549506|FG000|Overall Study|Lack of Efficacy|19|||
161865331|NCT01592786|584549506|FG000|Overall Study|Protocol Violation|14|||
161865332|NCT01592786|584549506|FG000|Overall Study|Withdrawal by Subject|23|||
161865333|NCT01592786|584549506|FG000|Overall Study|Lost to Follow-up|19|||
161865334|NCT01592786|584549506|FG000|Overall Study|Other|3|||
161865335|NCT02172664|584549514|FG000|Overall Study|Lost to Follow-up|4|||
161865336|NCT02172664|584549515|FG001|Overall Study|Lost to Follow-up|4|||
161865337|NCT02172664|584549514|FG000|Overall Study|Death|1|||
161865338|NCT02172664|584549515|FG001|Overall Study|Death|1|||
161865339|NCT02172664|584549514|FG000|Overall Study|Moved out of area|1|||
161865340|NCT02172664|584549515|FG001|Overall Study|Moved out of area|1|||
161865341|NCT01909934|584549516|FG000|Overall Study|Withdrawal by Subject|3|||
161865342|NCT01909934|584549516|FG000|Overall Study|Lost to Follow-up|1|||
161865343|NCT01909934|584549516|FG000|Overall Study|Death|25|||
161865344|NCT01909934|584549516|FG000|Overall Study|Withdrawal of Informed Consent|1|||
161865345|NCT01909934|584549516|FG000|Overall Study|Reason Not Specified|1|||
161865346|NCT03810092|584549517|FG000|Overall Study|no ground support|17|||
161865347|NCT03810092|584549517|FG000|Overall Study|ADL not done at J0|16|||
161865348|NCT03810092|584549517|FG000|Overall Study|No hemoglobin measure at J5|27|||
161865349|NCT04578535|584549519|FG000|Overall Study|Lost to Follow-up|1|||
161865350|NCT04578535|584549520|FG001|Overall Study|Lost to Follow-up|0|||
161865351|NCT04578535|584549521|FG002|Overall Study|Lost to Follow-up|0|||
161865352|NCT04578535|584549522|FG003|Overall Study|Lost to Follow-up|1|||
161865353|NCT04578535|584549523|FG004|Overall Study|Lost to Follow-up|0|||
161865354|NCT04578535|584549524|FG005|Overall Study|Lost to Follow-up|2|||
161865355|NCT04578535|584549519|FG000|Overall Study|Pregnancy|1|||
161865356|NCT04578535|584549520|FG001|Overall Study|Pregnancy|0|||
161865357|NCT04578535|584549521|FG002|Overall Study|Pregnancy|0|||
161865358|NCT04578535|584549522|FG003|Overall Study|Pregnancy|0|||
161865359|NCT04578535|584549523|FG004|Overall Study|Pregnancy|0|||
161865360|NCT04578535|584549524|FG005|Overall Study|Pregnancy|0|||
161865361|NCT04578535|584549519|FG000|Overall Study|Withdrawal by Subject|0|||
161865362|NCT04578535|584549520|FG001|Overall Study|Withdrawal by Subject|0|||
161865363|NCT04578535|584549521|FG002|Overall Study|Withdrawal by Subject|0|||
161865364|NCT04578535|584549522|FG003|Overall Study|Withdrawal by Subject|1|||
161865365|NCT04578535|584549523|FG004|Overall Study|Withdrawal by Subject|1|||
161865366|NCT04578535|584549524|FG005|Overall Study|Withdrawal by Subject|5|||
161865367|NCT04578535|584549519|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
161865368|NCT04578535|584549520|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
161865369|NCT04578535|584549521|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
161865370|NCT04578535|584549522|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
161865371|NCT04578535|584549523|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
161865372|NCT04578535|584549524|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
161865373|NCT00235755|584549525|FG000|4-Week Titration Phase|Adverse Event|6|||
161865374|NCT00235755|584549526|FG001|4-Week Titration Phase|Adverse Event|14|||
161865375|NCT00235755|584549527|FG002|4-Week Titration Phase|Adverse Event|20|||
161865376|NCT00235755|584549525|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
161865377|NCT00235755|584549526|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
161865378|NCT00235755|584549527|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
161865379|NCT00235755|584549525|FG000|4-Week Titration Phase|Protocol Violation|2|||
161865380|NCT00235755|584549526|FG001|4-Week Titration Phase|Protocol Violation|2|||
161865381|NCT00235755|584549527|FG002|4-Week Titration Phase|Protocol Violation|1|||
161865382|NCT00235755|584549525|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
161865383|NCT00235755|584549526|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
161865384|NCT00235755|584549527|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
161865385|NCT00235755|584549525|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
161865386|NCT00235755|584549526|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
161865387|NCT00235755|584549527|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
161865388|NCT00235755|584549525|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
161865389|NCT00235755|584549526|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
161865390|NCT00235755|584549527|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
161865391|NCT00235755|584549525|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
161865392|NCT00235755|584549526|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
161865393|NCT00235755|584549527|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
161865394|NCT00235755|584549525|FG000|12-Week Maintenance Phase|Adverse Event|8|||
161865395|NCT00235755|584549526|FG001|12-Week Maintenance Phase|Adverse Event|12|||
161865396|NCT00235755|584549527|FG002|12-Week Maintenance Phase|Adverse Event|26|||
161982302|NCT00082407|584984769|FG000|Overall Study|Adverse Event|20|||
161982303|NCT00082407|584984770|FG001|Overall Study|Adverse Event|0|||
161865397|NCT00235755|584549525|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
161865398|NCT00235755|584549526|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
161865399|NCT00235755|584549527|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
161865400|NCT00235755|584549525|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
161865401|NCT00235755|584549526|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
161865402|NCT00235755|584549527|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
161865403|NCT00235755|584549525|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
161865404|NCT00235755|584549526|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
161865405|NCT00235755|584549527|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
161865406|NCT00235755|584549525|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
161865407|NCT00235755|584549526|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
161865408|NCT00235755|584549527|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
161865409|NCT00235755|584549525|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
161865410|NCT00235755|584549526|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
161865411|NCT00235755|584549527|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
161865412|NCT00806403|584549532|FG000|Overall Study|Death|4|||
161865413|NCT00806403|584549533|FG001|Overall Study|Death|3|||
161865414|NCT01320293|584549536|FG000|Overall Study|Lack of Efficacy|1|||
161865415|NCT01320293|584549536|FG000|Overall Study|Adverse Event|1|||
161865416|NCT01787292|584549539|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
161865417|NCT01787292|584549540|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
161865418|NCT01787292|584549539|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
161865419|NCT01787292|584549540|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
161865420|NCT01532934|584549541|FG000|Overall Study|Lost to Follow-up|11|||
161865421|NCT01532934|584549542|FG001|Overall Study|Lost to Follow-up|11|||
161865422|NCT01532934|584549541|FG000|Overall Study|In controlled environment|3|||
161865423|NCT01532934|584549542|FG001|Overall Study|In controlled environment|2|||
161865424|NCT01147068|584549543|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
161865425|NCT01147068|584549544|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161865426|NCT01147068|584549545|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161865427|NCT01147068|584549546|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161865428|NCT01147068|584549547|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161865429|NCT01147068|584549548|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
161865430|NCT01147068|584549549|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161865431|NCT01147068|584549543|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
161865432|NCT01147068|584549544|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
161865433|NCT01147068|584549545|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
161865434|NCT01147068|584549546|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
161865435|NCT01147068|584549547|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
161865436|NCT01147068|584549548|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
161865437|NCT01147068|584549549|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
161865438|NCT01147068|584549543|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
161865439|NCT01147068|584549544|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
161865440|NCT01147068|584549545|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
161865441|NCT01147068|584549546|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
161865442|NCT01147068|584549547|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
161865443|NCT01147068|584549548|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
161865444|NCT01147068|584549549|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
161865445|NCT01147068|584549543|FG000|Subjects That Received 2nd Dose|Other|0|||
161865446|NCT01147068|584549544|FG001|Subjects That Received 2nd Dose|Other|3|||
161865447|NCT01147068|584549545|FG002|Subjects That Received 2nd Dose|Other|3|||
161865448|NCT01147068|584549546|FG003|Subjects That Received 2nd Dose|Other|0|||
161865449|NCT01147068|584549547|FG004|Subjects That Received 2nd Dose|Other|1|||
161865450|NCT01147068|584549548|FG005|Subjects That Received 2nd Dose|Other|0|||
161865451|NCT01147068|584549549|FG006|Subjects That Received 2nd Dose|Other|0|||
161865452|NCT01147068|584549543|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
161865453|NCT01147068|584549544|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
161865454|NCT01147068|584549545|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
161865455|NCT01147068|584549546|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
161865456|NCT01147068|584549547|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
161865457|NCT01147068|584549548|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
161865458|NCT01147068|584549549|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
161865459|NCT01147068|584549543|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161865460|NCT01147068|584549544|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161865461|NCT01147068|584549545|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161865462|NCT01147068|584549546|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
162034927|NCT01083173|585184810|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
162034928|NCT01083173|585184809|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
161865463|NCT01147068|584549547|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161865464|NCT01147068|584549548|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161865465|NCT01147068|584549549|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161865466|NCT01147068|584549543|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
161865467|NCT01147068|584549544|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
161865468|NCT01147068|584549545|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
161865469|NCT01147068|584549546|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
161865470|NCT01147068|584549547|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
161865471|NCT01147068|584549548|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
161865472|NCT01147068|584549549|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
161865473|NCT02962648|584549551|FG000|Overall Study|Withdrawal by Subject|3|||
161865474|NCT02962648|584549551|FG000|Overall Study|Lost to Follow-up|3|||
161865475|NCT02962648|584549551|FG000|Overall Study|Physician Decision|1|||
161865476|NCT02962648|584549551|FG000|Overall Study|Subject had problems with transportation|2|||
161865477|NCT01597778|584549552|FG000|Overall Study|Death|7|||
161865478|NCT01597778|584549553|FG001|Overall Study|Death|10|||
161865479|NCT01597778|584549552|FG000|Overall Study|Withdrawal by Subject|3|||
161865480|NCT01597778|584549553|FG001|Overall Study|Withdrawal by Subject|4|||
161865481|NCT01597778|584549552|FG000|Overall Study|Adverse Event|1|||
161865482|NCT01597778|584549553|FG001|Overall Study|Adverse Event|1|||
161865483|NCT01597778|584549552|FG000|Overall Study|Protocol Violation|1|||
161865484|NCT01597778|584549553|FG001|Overall Study|Protocol Violation|11|||
161865485|NCT01597778|584549552|FG000|Overall Study|Transplanted off protocol|2|||
161865486|NCT01597778|584549553|FG001|Overall Study|Transplanted off protocol|3|||
161865487|NCT05691712|584549555|FG000|Overall Study|Adverse Event|0|||
161865488|NCT05691712|584549556|FG001|Overall Study|Adverse Event|1|||
161865489|NCT05691712|584549557|FG002|Overall Study|Adverse Event|2|||
161865490|NCT05691712|584549558|FG003|Overall Study|Adverse Event|1|||
161865491|NCT05691712|584549555|FG000|Overall Study|Withdrawal by Subject|2|||
161865492|NCT05691712|584549556|FG001|Overall Study|Withdrawal by Subject|3|||
161865493|NCT05691712|584549557|FG002|Overall Study|Withdrawal by Subject|3|||
161865494|NCT05691712|584549558|FG003|Overall Study|Withdrawal by Subject|1|||
161865495|NCT05691712|584549555|FG000|Overall Study|Death|1|||
161865496|NCT05691712|584549556|FG001|Overall Study|Death|0|||
161865497|NCT05691712|584549557|FG002|Overall Study|Death|0|||
161865498|NCT05691712|584549558|FG003|Overall Study|Death|0|||
161865499|NCT05691712|584549555|FG000|Overall Study|Pregnancy|0|||
161865500|NCT05691712|584549556|FG001|Overall Study|Pregnancy|1|||
161865501|NCT05691712|584549557|FG002|Overall Study|Pregnancy|0|||
161865502|NCT05691712|584549558|FG003|Overall Study|Pregnancy|0|||
161865503|NCT05691712|584549555|FG000|Overall Study|Assigned Treatment by Mistake|1|||
161865504|NCT05691712|584549556|FG001|Overall Study|Assigned Treatment by Mistake|0|||
161865505|NCT05691712|584549557|FG002|Overall Study|Assigned Treatment by Mistake|0|||
161865506|NCT05691712|584549558|FG003|Overall Study|Assigned Treatment by Mistake|1|||
161865507|NCT05303194|584549559|FG000|Overall Study|Lost to Follow-up|1|||
161865508|NCT05303194|584549560|FG001|Overall Study|Lost to Follow-up|1|||
161865509|NCT05303194|584549559|FG000|Overall Study|Withdrawal by Subject|0|||
161865510|NCT05303194|584549560|FG001|Overall Study|Withdrawal by Subject|1|||
161865511|NCT01289678|584549570|FG000|Overall Study|Physician Decision|6|||
161865512|NCT00226499|584549571|FG000|Overall Study|Adverse Event|10|||
161865513|NCT00226499|584549572|FG001|Overall Study|Adverse Event|6|||
161865514|NCT00226499|584549573|FG002|Overall Study|Adverse Event|3|||
161865515|NCT00226499|584549571|FG000|Overall Study|Others|1064|||
161865516|NCT00226499|584549572|FG001|Overall Study|Others|1066|||
161865517|NCT00226499|584549573|FG002|Overall Study|Others|356|||
161865518|NCT00468819|584549574|FG000|Overall Study|Withdrawal by Subject|4|||
161865519|NCT00468819|584549575|FG001|Overall Study|Withdrawal by Subject|0|||
161865520|NCT00468819|584549576|FG002|Overall Study|Withdrawal by Subject|1|||
161865521|NCT00468819|584549574|FG000|Overall Study|Lost to Follow-up|0|||
161865522|NCT00468819|584549575|FG001|Overall Study|Lost to Follow-up|0|||
161865523|NCT00468819|584549576|FG002|Overall Study|Lost to Follow-up|1|||
161865524|NCT00468819|584549574|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
161865525|NCT00468819|584549575|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
161865526|NCT00468819|584549576|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
161865527|NCT02723344|584549579|FG000|Overall Study|Lost to Follow-up|0|||
161865528|NCT02723344|584549580|FG001|Overall Study|Lost to Follow-up|4|||
161865529|NCT02524847|584549582|FG000|Overall Study|Adverse Event|4|||
161865530|NCT02524847|584549582|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
161865531|NCT02524847|584549582|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
161865532|NCT02524847|584549582|FG000|Overall Study|Death|1|||
161865533|NCT02524847|584549582|FG000|Overall Study|Reason not Specified|1|||
161865534|NCT04352101|584549583|FG000|Overall Study|Physician Decision|2|||
161865535|NCT04352101|584549584|FG001|Overall Study|Physician Decision|1|||
161865536|NCT03539302|584549593|FG000|Overall Study|Spontaneous cardio version|0|||
161865537|NCT03539302|584549594|FG001|Overall Study|Spontaneous cardio version|0|||
161865538|NCT03539302|584549595|FG002|Overall Study|Spontaneous cardio version|0|||
161865539|NCT03539302|584549596|FG003|Overall Study|Spontaneous cardio version|0|||
161865540|NCT03539302|584549597|FG004|Overall Study|Spontaneous cardio version|0|||
161865541|NCT03539302|584549598|FG005|Overall Study|Spontaneous cardio version|1|||
161865542|NCT03539302|584549599|FG006|Overall Study|Spontaneous cardio version|1|||
161865543|NCT04564092|584549601|FG000|Overall Study|Withdrawal by Subject|1|||
161774139|NCT00593385|584215974|FG000|Overall Study|Lost to Follow-up|17|||
161774140|NCT00593385|584215974|FG000|Overall Study|Withdrawal by Subject|9|||
161774141|NCT00924313|584215979|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
161774142|NCT01298362|584215980|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
161774143|NCT01298362|584215981|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
161774144|NCT02871921|584215986|FG000|Overall Study|Withdrawal by Subject|34|||
161774145|NCT02871921|584215987|FG001|Overall Study|Withdrawal by Subject|27|||
161774146|NCT02871921|584215988|FG002|Overall Study|Withdrawal by Subject|27|||
161774147|NCT02871921|584215989|FG003|Overall Study|Withdrawal by Subject|30|||
161774148|NCT00326625|584215994|FG000|Overall Study|Adverse Event|20|||
161774149|NCT00326625|584215995|FG001|Overall Study|Adverse Event|9|||
161774150|NCT00326625|584215994|FG000|Overall Study|Withdrawal by Subject|15|||
161774151|NCT00326625|584215995|FG001|Overall Study|Withdrawal by Subject|12|||
161774152|NCT00326625|584215994|FG000|Overall Study|Death|18|||
161774153|NCT00326625|584215995|FG001|Overall Study|Death|16|||
161774154|NCT00326625|584215994|FG000|Overall Study|Lost to Follow-up|1|||
161774155|NCT00326625|584215995|FG001|Overall Study|Lost to Follow-up|0|||
161774156|NCT00326625|584215994|FG000|Overall Study|prescheduled medical intervention|0|||
161774157|NCT00326625|584215995|FG001|Overall Study|prescheduled medical intervention|1|||
161774158|NCT02594384|584215996|FG000|Overall Study|Disease Progression|3|||
161774159|NCT02594384|584215997|FG001|Overall Study|Disease Progression|7|||
161774160|NCT02594384|584215998|FG002|Overall Study|Disease Progression|0|||
161774161|NCT02594384|584215999|FG003|Overall Study|Disease Progression|2|||
161774162|NCT02594384|584216000|FG004|Overall Study|Disease Progression|2|||
161774163|NCT02594384|584216001|FG005|Overall Study|Disease Progression|12|||
161774164|NCT02594384|584216002|FG006|Overall Study|Disease Progression|5|||
161774165|NCT02594384|584216003|FG007|Overall Study|Disease Progression|5|||
161774166|NCT02594384|584215996|FG000|Overall Study|Adverse Event|0|||
161774167|NCT02594384|584215997|FG001|Overall Study|Adverse Event|1|||
161774168|NCT02594384|584215998|FG002|Overall Study|Adverse Event|4|||
161774169|NCT02594384|584215999|FG003|Overall Study|Adverse Event|1|||
161774170|NCT02594384|584216000|FG004|Overall Study|Adverse Event|0|||
161774171|NCT02594384|584216001|FG005|Overall Study|Adverse Event|6|||
161774172|NCT02594384|584216002|FG006|Overall Study|Adverse Event|1|||
161774173|NCT02594384|584216003|FG007|Overall Study|Adverse Event|1|||
161774174|NCT02594384|584215996|FG000|Overall Study|Withdrawal by Subject|0|||
161774175|NCT02594384|584215997|FG001|Overall Study|Withdrawal by Subject|0|||
161774176|NCT02594384|584215998|FG002|Overall Study|Withdrawal by Subject|0|||
161774177|NCT02594384|584215999|FG003|Overall Study|Withdrawal by Subject|1|||
161774178|NCT02594384|584216000|FG004|Overall Study|Withdrawal by Subject|0|||
161774179|NCT02594384|584216001|FG005|Overall Study|Withdrawal by Subject|0|||
161774180|NCT02594384|584216002|FG006|Overall Study|Withdrawal by Subject|0|||
161774181|NCT02594384|584216003|FG007|Overall Study|Withdrawal by Subject|1|||
161774182|NCT02594384|584215996|FG000|Overall Study|Physician Decision|0|||
161774183|NCT02594384|584215997|FG001|Overall Study|Physician Decision|0|||
161774184|NCT02594384|584215998|FG002|Overall Study|Physician Decision|0|||
161774185|NCT02594384|584215999|FG003|Overall Study|Physician Decision|0|||
161774186|NCT02594384|584216000|FG004|Overall Study|Physician Decision|0|||
161774187|NCT02594384|584216001|FG005|Overall Study|Physician Decision|1|||
161774188|NCT02594384|584216002|FG006|Overall Study|Physician Decision|2|||
161774189|NCT02594384|584216003|FG007|Overall Study|Physician Decision|0|||
161774190|NCT02594384|584215996|FG000|Overall Study|Progressive Leukocytosis|0|||
161774191|NCT02594384|584215997|FG001|Overall Study|Progressive Leukocytosis|0|||
161774192|NCT02594384|584215998|FG002|Overall Study|Progressive Leukocytosis|1|||
161774193|NCT02594384|584215999|FG003|Overall Study|Progressive Leukocytosis|0|||
161774194|NCT02594384|584216000|FG004|Overall Study|Progressive Leukocytosis|0|||
161774195|NCT02594384|584216001|FG005|Overall Study|Progressive Leukocytosis|0|||
161774196|NCT02594384|584216002|FG006|Overall Study|Progressive Leukocytosis|0|||
161774197|NCT02594384|584216003|FG007|Overall Study|Progressive Leukocytosis|0|||
161774198|NCT02594384|584215996|FG000|Overall Study|Lack of Efficacy|0|||
161774199|NCT02594384|584215997|FG001|Overall Study|Lack of Efficacy|0|||
161774200|NCT02594384|584215998|FG002|Overall Study|Lack of Efficacy|0|||
161774201|NCT02594384|584215999|FG003|Overall Study|Lack of Efficacy|0|||
161774202|NCT02594384|584216000|FG004|Overall Study|Lack of Efficacy|1|||
161774203|NCT02594384|584216001|FG005|Overall Study|Lack of Efficacy|0|||
161774204|NCT02594384|584216002|FG006|Overall Study|Lack of Efficacy|0|||
161774205|NCT02594384|584216003|FG007|Overall Study|Lack of Efficacy|0|||
161774206|NCT02594384|584215996|FG000|Overall Study|Substantial noncompliance|0|||
161774207|NCT02594384|584215997|FG001|Overall Study|Substantial noncompliance|0|||
161774208|NCT02594384|584215998|FG002|Overall Study|Substantial noncompliance|0|||
161774209|NCT02594384|584215999|FG003|Overall Study|Substantial noncompliance|0|||
161774210|NCT02594384|584216000|FG004|Overall Study|Substantial noncompliance|0|||
161774211|NCT02594384|584216001|FG005|Overall Study|Substantial noncompliance|0|||
161774212|NCT02594384|584216002|FG006|Overall Study|Substantial noncompliance|1|||
161774213|NCT02594384|584216003|FG007|Overall Study|Substantial noncompliance|0|||
161774214|NCT03919669|584216006|FG000|Overall Study|Withdrawal by Subject|1|||
161774215|NCT03919669|584216007|FG001|Overall Study|Withdrawal by Subject|0|||
161774216|NCT03919669|584216008|FG002|Overall Study|Withdrawal by Subject|0|||
161865544|NCT00420420|584549604|FG000|Overall Study|Adverse Event|5|||
161865545|NCT00420420|584549605|FG001|Overall Study|Adverse Event|3|||
161865546|NCT00420420|584549604|FG000|Overall Study|Protocol Violation|1|||
161865547|NCT00420420|584549605|FG001|Overall Study|Protocol Violation|1|||
161865548|NCT00420420|584549604|FG000|Overall Study|Withdrawal by Subject|1|||
161865549|NCT00420420|584549605|FG001|Overall Study|Withdrawal by Subject|0|||
161865550|NCT00420420|584549604|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
161865551|NCT00420420|584549605|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
161865552|NCT00273182|584549606|FG000|Overall Study|Death|450|||
161865553|NCT00273182|584549606|FG000|Overall Study|Lost to Follow-up|88|||
161865554|NCT00273182|584549606|FG000|Overall Study|Withdrawal by Subject|257|||
161865555|NCT00273182|584549606|FG000|Overall Study|Device/System Explant|154|||
161865556|NCT00273182|584549606|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
161865557|NCT04762160|584549607|FG000|Overall Study|Study terminated early due to business reasons|5|||
161865558|NCT04146012|584549609|FG000|Overall Study|Study Terminated|30|||
161865559|NCT04146012|584549610|FG001|Overall Study|Study Terminated|15|||
161865560|NCT03817190|584549611|FG000|Overall Study|Early Termination|13|||
161865561|NCT03817190|584549612|FG001|Overall Study|Early Termination|20|||
161865562|NCT03817190|584549611|FG000|Overall Study|Adverse Event|10|||
161865563|NCT03817190|584549612|FG001|Overall Study|Adverse Event|17|||
161865564|NCT03817190|584549611|FG000|Overall Study|Withdrawal by Subject|12|||
161865565|NCT03817190|584549612|FG001|Overall Study|Withdrawal by Subject|8|||
161865566|NCT03817190|584549611|FG000|Overall Study|Lost to Follow-up|11|||
161865567|NCT03817190|584549612|FG001|Overall Study|Lost to Follow-up|7|||
161865568|NCT03817190|584549611|FG000|Overall Study|Lack of Efficacy|7|||
161865569|NCT03817190|584549612|FG001|Overall Study|Lack of Efficacy|5|||
161865570|NCT03817190|584549611|FG000|Overall Study|Investigator Decision|5|||
161865571|NCT03817190|584549612|FG001|Overall Study|Investigator Decision|1|||
161865572|NCT03817190|584549611|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
161865573|NCT03817190|584549612|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
161865574|NCT03817190|584549611|FG000|Overall Study|Lack of Contact|1|||
161865575|NCT03817190|584549612|FG001|Overall Study|Lack of Contact|0|||
161865576|NCT03817190|584549611|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
161865577|NCT03817190|584549612|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
161865578|NCT00868530|584549615|FG000|Overall Study|Adverse Event|3|||
161865579|NCT00868530|584549615|FG000|Overall Study|Lost to Follow-up|1|||
161982304|NCT00082407|584984769|FG000|Overall Study|Protocol Violation|14|||
161982305|NCT00082407|584984770|FG001|Overall Study|Protocol Violation|12|||
161982306|NCT00082407|584984769|FG000|Overall Study|Patient Decision|13|||
161982307|NCT00082407|584984770|FG001|Overall Study|Patient Decision|6|||
161982308|NCT00082407|584984769|FG000|Overall Study|Physician Decision|5|||
161982309|NCT00082407|584984770|FG001|Overall Study|Physician Decision|3|||
161982310|NCT00082407|584984769|FG000|Overall Study|Loss of Glucose Control|2|||
161982311|NCT00082407|584984770|FG001|Overall Study|Loss of Glucose Control|2|||
161982312|NCT00082407|584984769|FG000|Overall Study|Death|2|||
161982313|NCT00082407|584984770|FG001|Overall Study|Death|1|||
161982314|NCT00082407|584984769|FG000|Overall Study|Lost to Follow-up|0|||
161982315|NCT00082407|584984770|FG001|Overall Study|Lost to Follow-up|3|||
161982316|NCT03464019|584984771|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
161982317|NCT03464019|584984772|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
161982318|NCT03464019|584984773|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
161982319|NCT03464019|584984771|FG000|NODE-301 Part 1|Ablation|0|||
161982320|NCT03464019|584984772|FG001|NODE-301 Part 1|Ablation|0|||
161982321|NCT03464019|584984773|FG002|NODE-301 Part 1|Ablation|16|||
161982322|NCT03464019|584984771|FG000|NODE-301 Part 1|Test Dose Failure|0|||
161982323|NCT03464019|584984772|FG001|NODE-301 Part 1|Test Dose Failure|0|||
161982324|NCT03464019|584984773|FG002|NODE-301 Part 1|Test Dose Failure|8|||
161982325|NCT03464019|584984771|FG000|NODE-301 Part 1|Adverse Event|0|||
161982326|NCT03464019|584984772|FG001|NODE-301 Part 1|Adverse Event|0|||
162034929|NCT01083173|585184810|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
162034930|NCT01083173|585184809|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
161982327|NCT03464019|584984773|FG002|NODE-301 Part 1|Adverse Event|5|||
161982328|NCT03464019|584984771|FG000|NODE-301 Part 1|Physician Decision|0|||
161982329|NCT03464019|584984772|FG001|NODE-301 Part 1|Physician Decision|0|||
161982330|NCT03464019|584984773|FG002|NODE-301 Part 1|Physician Decision|4|||
161982331|NCT03464019|584984771|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
161982332|NCT03464019|584984772|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
161982333|NCT03464019|584984773|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
161982334|NCT03464019|584984771|FG000|NODE-301 Part 1|Protocol Violation|0|||
161982335|NCT03464019|584984772|FG001|NODE-301 Part 1|Protocol Violation|0|||
161982336|NCT03464019|584984773|FG002|NODE-301 Part 1|Protocol Violation|2|||
161982337|NCT03464019|584984771|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
161982338|NCT03464019|584984772|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
161982339|NCT03464019|584984773|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
162034931|NCT01083173|585184810|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
161865580|NCT05795153|584551613|FG000|Overall Study|Adverse Event|2|||
161865581|NCT05795153|584551613|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161865582|NCT05795153|584551613|FG000|Overall Study|Lost to Follow-up|1|||
161865583|NCT05795153|584551613|FG000|Overall Study|Subject decision|2|||
161865584|NCT03668119|584551614|FG000|Pre-treatment|Disease Progression|1|||
161865585|NCT03668119|584551615|FG001|Pre-treatment|Disease Progression|0|||
161865586|NCT03668119|584551614|FG000|Treatment|Disease Progression|76|||
161865587|NCT03668119|584551615|FG001|Treatment|Disease Progression|57|||
161865588|NCT03668119|584551614|FG000|Treatment|Study drug toxicity|19|||
161865589|NCT03668119|584551615|FG001|Treatment|Study drug toxicity|1|||
161865590|NCT03668119|584551614|FG000|Treatment|Death|3|||
161865591|NCT03668119|584551615|FG001|Treatment|Death|0|||
161865592|NCT03668119|584551614|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
161865593|NCT03668119|584551615|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
161865594|NCT03668119|584551614|FG000|Treatment|Withdrawal by Subject|1|||
161865595|NCT03668119|584551615|FG001|Treatment|Withdrawal by Subject|1|||
161865596|NCT03668119|584551614|FG000|Treatment|Participant request to discontinue study treatment|3|||
161865597|NCT03668119|584551615|FG001|Treatment|Participant request to discontinue study treatment|1|||
161865598|NCT03668119|584551614|FG000|Treatment|Maximum Clinical Benefit|0|||
161865599|NCT03668119|584551615|FG001|Treatment|Maximum Clinical Benefit|1|||
161865600|NCT03668119|584551614|FG000|Treatment|Participants completed treatment|27|||
161865601|NCT03668119|584551615|FG001|Treatment|Participants completed treatment|11|||
161865602|NCT03668119|584551614|FG000|Treatment|Other reasons|2|||
161865603|NCT03668119|584551615|FG001|Treatment|Other reasons|1|||
161865604|NCT03769168|584551616|FG000|Overall Study|Adverse Event|0|||
161865605|NCT03769168|584551617|FG001|Overall Study|Adverse Event|1|||
161865606|NCT03769168|584551616|FG000|Overall Study|Lack of Efficacy|2|||
161865607|NCT03769168|584551617|FG001|Overall Study|Lack of Efficacy|4|||
161865608|NCT03769168|584551616|FG000|Overall Study|Post study access to treatment|3|||
161865609|NCT03769168|584551617|FG001|Overall Study|Post study access to treatment|11|||
161865610|NCT03769168|584551616|FG000|Overall Study|Physician Decision|1|||
161865611|NCT03769168|584551617|FG001|Overall Study|Physician Decision|4|||
161865612|NCT03769168|584551616|FG000|Overall Study|Subject Decision|2|||
161865613|NCT03769168|584551617|FG001|Overall Study|Subject Decision|4|||
161865614|NCT03769168|584551616|FG000|Overall Study|Guardian decision|1|||
161865615|NCT03769168|584551617|FG001|Overall Study|Guardian decision|0|||
161865616|NCT05142722|584551618|FG000|Overall Study|Lost to Follow-up|16|||
161865617|NCT05142722|584551619|FG001|Overall Study|Lost to Follow-up|38|||
161865618|NCT05142722|584551618|FG000|Overall Study|Withdrawal by Subject|20|||
161865619|NCT05142722|584551619|FG001|Overall Study|Withdrawal by Subject|27|||
161865620|NCT05142722|584551618|FG000|Overall Study|Death|11|||
161865621|NCT05142722|584551619|FG001|Overall Study|Death|17|||
161865622|NCT05142722|584551618|FG000|Overall Study|Physician Decision|0|||
161865623|NCT05142722|584551619|FG001|Overall Study|Physician Decision|1|||
161865624|NCT05142722|584551618|FG000|Overall Study|Participant Moved Away|0|||
161865625|NCT05142722|584551619|FG001|Overall Study|Participant Moved Away|2|||
161865626|NCT05142722|584551618|FG000|Overall Study|Adverse Event|2|||
161865627|NCT05142722|584551619|FG001|Overall Study|Adverse Event|1|||
161865628|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
161865629|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161865630|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
161865631|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161865632|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
161865633|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161865634|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161865635|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161865636|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161865637|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161865638|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
161865639|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161865640|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161865641|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
161865642|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161865643|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161865644|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161865645|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161865646|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
161865647|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
162034932|NCT04626310|585184812|FG000|Overall Study|4-miss from treatment|6|||
161865648|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
162034933|NCT04626310|585184813|FG001|Overall Study|4-miss from treatment|5|||
162034934|NCT04626310|585184814|FG002|Overall Study|4-miss from treatment|5|||
161865649|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
161865650|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161865651|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
161865652|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
161865653|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
161865654|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
161865655|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
161865656|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
161865657|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
161865658|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
161865659|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
161865660|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865661|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865662|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
161865663|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865664|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865665|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865666|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
161865667|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865668|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161865669|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161865670|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
161865671|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161865672|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161865673|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
161865674|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161865675|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
161865676|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
161865677|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
161865678|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161865679|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161865680|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161865681|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161865682|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161865683|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161865684|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865685|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
161865686|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865687|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865688|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865689|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865690|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865691|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161865692|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865693|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865694|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865695|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865696|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
161865697|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865698|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865699|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161865700|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865701|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865702|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865703|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865704|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865705|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
161865706|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865707|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161865708|NCT03896503|584551622|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161865709|NCT03896503|584551623|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161865710|NCT03896503|584551624|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161865711|NCT03896503|584551625|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161865712|NCT03896503|584551626|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161865713|NCT03896503|584551627|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
161865714|NCT03896503|584551628|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
161865715|NCT03896503|584551629|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161865716|NCT05400655|584551630|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
161865717|NCT05400655|584551631|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
161865718|NCT05400655|584551632|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
161865719|NCT05400655|584551633|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
161865720|NCT05400655|584551634|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
161865721|NCT05400655|584551635|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
161865722|NCT05400655|584551636|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
161865723|NCT05400655|584551637|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
161865724|NCT05400655|584551638|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
161865725|NCT05400655|584551639|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
161865726|NCT05400655|584551640|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
161865727|NCT05400655|584551641|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
161865728|NCT05400655|584551642|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
161865729|NCT05400655|584551643|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
161865730|NCT05400655|584551644|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
161865731|NCT05400655|584551645|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
161865732|NCT05400655|584551646|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
161865733|NCT05400655|584551647|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
161865734|NCT05400655|584551648|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
161865735|NCT05400655|584551649|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
161865736|NCT05400655|584551650|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
161865737|NCT05400655|584551651|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
161865738|NCT05400655|584551630|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865739|NCT05400655|584551631|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865740|NCT05400655|584551632|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865741|NCT05400655|584551633|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865742|NCT05400655|584551634|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865743|NCT05400655|584551635|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865744|NCT05400655|584551636|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865745|NCT05400655|584551637|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865746|NCT05400655|584551638|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865747|NCT05400655|584551639|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865748|NCT05400655|584551640|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865749|NCT05400655|584551641|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865750|NCT05400655|584551642|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
161865751|NCT05400655|584551643|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865752|NCT05400655|584551644|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865753|NCT05400655|584551645|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865754|NCT05400655|584551646|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
161865755|NCT05400655|584551647|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865756|NCT05400655|584551648|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
161865757|NCT05400655|584551649|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
161865758|NCT05400655|584551650|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865759|NCT05400655|584551651|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161865760|NCT05400655|584551630|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865761|NCT05400655|584551631|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865762|NCT05400655|584551632|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865763|NCT05400655|584551633|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865764|NCT05400655|584551634|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865765|NCT05400655|584551635|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865766|NCT05400655|584551636|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865767|NCT05400655|584551637|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865768|NCT05400655|584551638|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865769|NCT05400655|584551639|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865770|NCT05400655|584551640|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865771|NCT05400655|584551641|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865772|NCT05400655|584551642|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865773|NCT05400655|584551643|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
161865774|NCT05400655|584551644|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865775|NCT05400655|584551645|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865776|NCT05400655|584551646|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
161865777|NCT05400655|584551647|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865778|NCT05400655|584551648|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
161865779|NCT05400655|584551649|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865780|NCT05400655|584551650|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865781|NCT05400655|584551651|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161865782|NCT05400655|584551630|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865783|NCT05400655|584551631|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865784|NCT05400655|584551632|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865785|NCT05400655|584551633|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865786|NCT05400655|584551634|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865787|NCT05400655|584551635|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865788|NCT05400655|584551636|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865789|NCT05400655|584551637|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865790|NCT05400655|584551638|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865791|NCT05400655|584551639|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865792|NCT05400655|584551640|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865793|NCT05400655|584551641|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865794|NCT05400655|584551642|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865795|NCT05400655|584551643|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865796|NCT05400655|584551644|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865797|NCT05400655|584551645|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865798|NCT05400655|584551646|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
161865799|NCT05400655|584551647|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
161865800|NCT05400655|584551648|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
161865801|NCT05400655|584551649|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161865802|NCT05400655|584551650|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
161865803|NCT05400655|584551651|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
161865804|NCT05400655|584551630|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865805|NCT05400655|584551631|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865806|NCT05400655|584551632|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865807|NCT05400655|584551633|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865808|NCT05400655|584551634|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865809|NCT05400655|584551635|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865810|NCT05400655|584551636|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865811|NCT05400655|584551637|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865812|NCT05400655|584551638|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865813|NCT05400655|584551639|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865814|NCT05400655|584551640|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865815|NCT05400655|584551641|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865816|NCT05400655|584551642|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865817|NCT05400655|584551643|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865818|NCT05400655|584551644|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865819|NCT05400655|584551645|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865820|NCT05400655|584551646|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865821|NCT05400655|584551647|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
161865822|NCT05400655|584551648|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
161865823|NCT05400655|584551649|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865824|NCT05400655|584551650|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865825|NCT05400655|584551651|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161865826|NCT05400655|584551630|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865827|NCT05400655|584551631|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865828|NCT05400655|584551632|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865829|NCT05400655|584551633|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865830|NCT05400655|584551634|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865831|NCT05400655|584551635|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865832|NCT05400655|584551636|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865833|NCT05400655|584551637|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865834|NCT05400655|584551638|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865835|NCT05400655|584551639|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865836|NCT05400655|584551640|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865837|NCT05400655|584551641|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865838|NCT05400655|584551642|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865839|NCT05400655|584551643|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161982340|NCT03464019|584984771|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
161982341|NCT03464019|584984772|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
161982342|NCT03464019|584984773|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
161865840|NCT05400655|584551644|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865841|NCT05400655|584551645|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865842|NCT05400655|584551646|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
161865843|NCT05400655|584551647|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161865844|NCT05400655|584551648|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
161865845|NCT05400655|584551649|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
161865846|NCT05400655|584551650|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
161865847|NCT05400655|584551651|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
161865848|NCT01068678|584551660|FG000|Overall Study|Lack of Efficacy|3|||
161865849|NCT01068678|584551661|FG001|Overall Study|Lack of Efficacy|2|||
161865850|NCT01068678|584551660|FG000|Overall Study|Protocol Violation|5|||
161865851|NCT01068678|584551661|FG001|Overall Study|Protocol Violation|1|||
161865852|NCT01068678|584551660|FG000|Overall Study|Withdrawal criteria|12|||
161865853|NCT01068678|584551661|FG001|Overall Study|Withdrawal criteria|6|||
161865854|NCT01068678|584551660|FG000|Overall Study|Unclassified|18|||
161865855|NCT01068678|584551661|FG001|Overall Study|Unclassified|15|||
161865856|NCT00536939|584551662|FG000|Overall Study|Withdrawal by Subject|1|||
161865857|NCT00536939|584551663|FG001|Overall Study|Withdrawal by Subject|0|||
161865858|NCT00536939|584551662|FG000|Overall Study|Other Complicating Disease|1|||
161865859|NCT00536939|584551663|FG001|Overall Study|Other Complicating Disease|0|||
161865860|NCT01611935|584551664|FG000|Overall Study|Family Declined Participation|1|||
161865861|NCT01611935|584551665|FG001|Overall Study|Family Declined Participation|0|||
161865862|NCT04227197|584551666|FG000|Randomization|Protocol Violation|1|||
161865863|NCT04227197|584551667|FG001|Randomization|Protocol Violation|0|||
161865864|NCT04227197|584551666|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
161865865|NCT04227197|584551667|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
161865866|NCT04227197|584551666|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
161865867|NCT04227197|584551667|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
161865868|NCT04227197|584551666|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
161865869|NCT04227197|584551667|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
161865870|NCT04227197|584551666|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
161865871|NCT04227197|584551667|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
161865872|NCT04227197|584551666|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
161865873|NCT04227197|584551667|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
161865874|NCT04227197|584551666|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
161865875|NCT04227197|584551667|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
161865876|NCT02549859|584551672|FG000|Long-term 60 Hz DBS|Study Closed|1|||
161865877|NCT01209949|584551680|FG000|Overall Study|Lost to Follow-up|3|||
161865878|NCT00729612|584551681|FG000|Overall Study|Non evaluable for response|10|||
161865879|NCT00708552|584551682|FG000|Overall Study|Adverse Event|10|||
161865880|NCT00708552|584551683|FG001|Overall Study|Adverse Event|3|||
161865881|NCT00708552|584551684|FG002|Overall Study|Adverse Event|4|||
161865882|NCT00708552|584551685|FG003|Overall Study|Adverse Event|6|||
161865883|NCT00708552|584551682|FG000|Overall Study|Lack of Efficacy|0|||
161865884|NCT00708552|584551683|FG001|Overall Study|Lack of Efficacy|4|||
161865885|NCT00708552|584551684|FG002|Overall Study|Lack of Efficacy|1|||
161865886|NCT00708552|584551685|FG003|Overall Study|Lack of Efficacy|0|||
161865887|NCT00708552|584551682|FG000|Overall Study|Protocol Violation|0|||
161865888|NCT00708552|584551683|FG001|Overall Study|Protocol Violation|0|||
161865889|NCT00708552|584551684|FG002|Overall Study|Protocol Violation|2|||
161865890|NCT00708552|584551685|FG003|Overall Study|Protocol Violation|4|||
161865891|NCT00708552|584551682|FG000|Overall Study|Lost to Follow-up|4|||
161865892|NCT00708552|584551683|FG001|Overall Study|Lost to Follow-up|2|||
161865893|NCT00708552|584551684|FG002|Overall Study|Lost to Follow-up|0|||
161865894|NCT00708552|584551685|FG003|Overall Study|Lost to Follow-up|1|||
161865895|NCT00708552|584551682|FG000|Overall Study|Physician Decision|1|||
161865896|NCT00708552|584551683|FG001|Overall Study|Physician Decision|2|||
161865897|NCT00708552|584551684|FG002|Overall Study|Physician Decision|0|||
161865898|NCT00708552|584551685|FG003|Overall Study|Physician Decision|0|||
161865899|NCT00708552|584551682|FG000|Overall Study|Withdrawal by Subject|12|||
161865900|NCT00708552|584551683|FG001|Overall Study|Withdrawal by Subject|7|||
161865901|NCT00708552|584551684|FG002|Overall Study|Withdrawal by Subject|8|||
161865902|NCT00708552|584551685|FG003|Overall Study|Withdrawal by Subject|10|||
161865903|NCT02309411|584551686|FG000|Overall Study|Physician Decision|1|||
161865904|NCT02309411|584551687|FG001|Overall Study|Physician Decision|0|||
161865905|NCT02309411|584551688|FG002|Overall Study|Physician Decision|0|||
161865906|NCT02309411|584551686|FG000|Overall Study|Withdrawal by Subject|1|||
161865907|NCT02309411|584551687|FG001|Overall Study|Withdrawal by Subject|1|||
161865908|NCT02309411|584551688|FG002|Overall Study|Withdrawal by Subject|0|||
161865909|NCT04878432|584551690|FG000|Overall Study|Adverse Event|1|||
161865910|NCT04878432|584551690|FG000|Overall Study|Death|2|||
161865911|NCT04878432|584551690|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161865912|NCT04878432|584551690|FG000|Overall Study|Withdrawal by Subject|6|||
161865913|NCT04878432|584551690|FG000|Overall Study|Progressive Disease|7|||
161865914|NCT04878432|584551690|FG000|Overall Study|New Therapy for Study Indication|7|||
161865915|NCT04878432|584551690|FG000|Overall Study|Physician Decision|11|||
161865916|NCT03971071|584551691|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
161865917|NCT03971071|584551692|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
161865918|NCT03971071|584551693|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
161865919|NCT03971071|584551694|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
161865920|NCT03971071|584551695|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
161865921|NCT03971071|584551691|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
161865922|NCT03971071|584551692|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
161865923|NCT03971071|584551693|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
161865924|NCT03971071|584551694|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161865925|NCT03971071|584551695|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161865926|NCT03971071|584551691|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
161865927|NCT03971071|584551692|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
161865928|NCT03971071|584551693|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
161865929|NCT03971071|584551694|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
161865930|NCT03971071|584551695|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
161865931|NCT03971071|584551691|FG000|Open-label Treatment Period|Sponsor decision|0|||
161865932|NCT03971071|584551692|FG001|Open-label Treatment Period|Sponsor decision|0|||
161865933|NCT03971071|584551693|FG002|Open-label Treatment Period|Sponsor decision|0|||
161865934|NCT03971071|584551694|FG003|Open-label Treatment Period|Sponsor decision|0|||
161865935|NCT03971071|584551695|FG004|Open-label Treatment Period|Sponsor decision|1|||
161865936|NCT03971071|584551691|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
161865937|NCT03971071|584551692|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161865938|NCT03971071|584551693|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
161865939|NCT03971071|584551694|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
161865940|NCT03971071|584551695|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
161865941|NCT03971071|584551691|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
161865942|NCT03971071|584551692|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
161865943|NCT03971071|584551693|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
161865944|NCT03971071|584551694|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
161865945|NCT03971071|584551695|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
161865946|NCT00360282|584551696|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
161865947|NCT00360282|584551697|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
161865948|NCT00360282|584551698|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
161865949|NCT00360282|584551699|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
161865950|NCT00360282|584551696|FG000|Second Intervention|Adverse Event|0|||
161865951|NCT00360282|584551697|FG001|Second Intervention|Adverse Event|1|||
161865952|NCT00360282|584551698|FG002|Second Intervention|Adverse Event|0|||
161865953|NCT00360282|584551699|FG003|Second Intervention|Adverse Event|0|||
161865954|NCT04537078|584551702|FG000|Overall Study|Protocol Violation|3|||
161865955|NCT04537078|584551703|FG001|Overall Study|Protocol Violation|2|||
161865956|NCT04537078|584551702|FG000|Overall Study|Lost to Follow-up|1|||
161865957|NCT04537078|584551703|FG001|Overall Study|Lost to Follow-up|0|||
161865958|NCT04537078|584551702|FG000|Overall Study|Withdrawal by Subject|0|||
161865959|NCT04537078|584551703|FG001|Overall Study|Withdrawal by Subject|1|||
161865960|NCT03207815|584551704|FG000|Overall Study|Protocol Violation|3|||
161865961|NCT03207815|584551705|FG001|Overall Study|Protocol Violation|1|||
161865962|NCT03207815|584551704|FG000|Overall Study|Adverse Event|1|||
161865963|NCT03207815|584551705|FG001|Overall Study|Adverse Event|2|||
161865964|NCT03207815|584551704|FG000|Overall Study|Lost to Follow-up|1|||
161865965|NCT03207815|584551705|FG001|Overall Study|Lost to Follow-up|2|||
161865966|NCT03207815|584551704|FG000|Overall Study|Investigator's Discretion|1|||
161865967|NCT03207815|584551705|FG001|Overall Study|Investigator's Discretion|1|||
161865968|NCT03207815|584551704|FG000|Overall Study|Lack of Efficacy|0|||
161865969|NCT03207815|584551705|FG001|Overall Study|Lack of Efficacy|1|||
161865970|NCT03207815|584551704|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
161865971|NCT03207815|584551705|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
161865972|NCT03207815|584551704|FG000|Overall Study|Withdrew Consent|1|||
161865973|NCT03207815|584551705|FG001|Overall Study|Withdrew Consent|0|||
161865974|NCT03817853|584551706|FG000|Induction Phase|Adverse Event|5|||
161865975|NCT03817853|584551707|FG001|Induction Phase|Adverse Event|0|||
161865976|NCT03817853|584551708|FG002|Induction Phase|Adverse Event|0|||
161865977|NCT03817853|584551706|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
161865978|NCT03817853|584551707|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
161865979|NCT03817853|584551708|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
161865980|NCT03817853|584551706|FG000|Induction Phase|Physician Decision|2|||
161865981|NCT03817853|584551707|FG001|Induction Phase|Physician Decision|0|||
161865982|NCT03817853|584551708|FG002|Induction Phase|Physician Decision|0|||
161865983|NCT03817853|584551706|FG000|Induction Phase|Progressive Disease|6|||
161865984|NCT03817853|584551707|FG001|Induction Phase|Progressive Disease|0|||
161865985|NCT03817853|584551708|FG002|Induction Phase|Progressive Disease|0|||
161865986|NCT03817853|584551706|FG000|Induction Phase|Withdrawal by Subject|4|||
161865987|NCT03817853|584551707|FG001|Induction Phase|Withdrawal by Subject|0|||
161865988|NCT03817853|584551708|FG002|Induction Phase|Withdrawal by Subject|0|||
161865989|NCT03817853|584551706|FG000|Maintenance Phase|Adverse Event|0|||
161865990|NCT03817853|584551707|FG001|Maintenance Phase|Adverse Event|8|||
161774217|NCT00625846|584216009|FG000|Overall Study|Withdrawal by Subject|2|||
161774218|NCT00625846|584216010|FG001|Overall Study|Withdrawal by Subject|0|||
161774219|NCT00625846|584216011|FG002|Overall Study|Withdrawal by Subject|1|||
161774220|NCT00625846|584216012|FG003|Overall Study|Withdrawal by Subject|2|||
161774221|NCT02686749|584216023|FG000|Overall Study|terminated for poor enrollment|2|||
161774222|NCT02686749|584216024|FG001|Overall Study|terminated for poor enrollment|2|||
161774223|NCT04409509|584216028|FG000|Overall Study|Failure to meet randomization requirement|1|||
161774224|NCT04409509|584216029|FG001|Overall Study|Failure to meet randomization requirement|0|||
161774225|NCT04409509|584216028|FG000|Overall Study|Adverse Event|0|||
161774226|NCT04409509|584216029|FG001|Overall Study|Adverse Event|1|||
161774227|NCT04409509|584216028|FG000|Overall Study|Death|11|||
161774228|NCT04409509|584216029|FG001|Overall Study|Death|10|||
161774229|NCT04409509|584216028|FG000|Overall Study|Non-compliance with study drug|0|||
161774230|NCT04409509|584216029|FG001|Overall Study|Non-compliance with study drug|1|||
161774231|NCT04409509|584216028|FG000|Overall Study|Lost to Follow-up|0|||
161774232|NCT04409509|584216029|FG001|Overall Study|Lost to Follow-up|3|||
161774233|NCT04409509|584216028|FG000|Overall Study|Withdrawal by Subject|0|||
161774234|NCT04409509|584216029|FG001|Overall Study|Withdrawal by Subject|3|||
161774235|NCT04409509|584216028|FG000|Overall Study|Randomized by mistake|0|||
161774236|NCT04409509|584216029|FG001|Overall Study|Randomized by mistake|1|||
161774237|NCT04409509|584216028|FG000|Overall Study|Other|1|||
161774238|NCT04409509|584216029|FG001|Overall Study|Other|1|||
161774239|NCT04668066|584216030|FG000|Part 1: Treatment Phase|Adverse Event|0|||
161774240|NCT04668066|584216031|FG001|Part 1: Treatment Phase|Adverse Event|0|||
161774241|NCT04668066|584216032|FG002|Part 1: Treatment Phase|Adverse Event|0|||
161774242|NCT04668066|584216033|FG003|Part 1: Treatment Phase|Adverse Event|0|||
161774243|NCT04668066|584216034|FG004|Part 1: Treatment Phase|Adverse Event|0|||
161774244|NCT04668066|584216035|FG005|Part 1: Treatment Phase|Adverse Event|0|||
161774245|NCT04668066|584216036|FG006|Part 1: Treatment Phase|Adverse Event|0|||
161774246|NCT04668066|584216037|FG007|Part 1: Treatment Phase|Adverse Event|0|||
161774247|NCT04668066|584216038|FG008|Part 1: Treatment Phase|Adverse Event|0|||
161774248|NCT04668066|584216039|FG009|Part 1: Treatment Phase|Adverse Event|0|||
161774249|NCT04668066|584216040|FG010|Part 1: Treatment Phase|Adverse Event|0|||
161774250|NCT04668066|584216041|FG011|Part 1: Treatment Phase|Adverse Event|1|||
161774251|NCT04668066|584216042|FG012|Part 1: Treatment Phase|Adverse Event|1|||
161774252|NCT04668066|584216043|FG013|Part 1: Treatment Phase|Adverse Event|0|||
161774253|NCT04668066|584216044|FG014|Part 1: Treatment Phase|Adverse Event|0|||
161774254|NCT04668066|584216045|FG015|Part 1: Treatment Phase|Adverse Event|0|||
161774255|NCT04668066|584216046|FG016|Part 1: Treatment Phase|Adverse Event|0|||
161774256|NCT04668066|584216047|FG017|Part 1: Treatment Phase|Adverse Event|0|||
161774257|NCT04668066|584216048|FG018|Part 1: Treatment Phase|Adverse Event|0|||
161774258|NCT04668066|584216030|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774259|NCT04668066|584216031|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774260|NCT04668066|584216032|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
161774261|NCT04668066|584216033|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774262|NCT04668066|584216034|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774263|NCT04668066|584216035|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774264|NCT04668066|584216036|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774265|NCT04668066|584216037|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774266|NCT04668066|584216038|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774267|NCT04668066|584216039|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774268|NCT04668066|584216040|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774269|NCT04668066|584216041|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774270|NCT04668066|584216042|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774271|NCT04668066|584216043|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774272|NCT04668066|584216044|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774273|NCT04668066|584216045|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774274|NCT04668066|584216046|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774275|NCT04668066|584216047|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774276|NCT04668066|584216048|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
161774277|NCT04668066|584216030|FG000|Part 1: Treatment Phase|Other|0|||
161774278|NCT04668066|584216031|FG001|Part 1: Treatment Phase|Other|0|||
161774279|NCT04668066|584216032|FG002|Part 1: Treatment Phase|Other|0|||
161774280|NCT04668066|584216033|FG003|Part 1: Treatment Phase|Other|0|||
161774281|NCT04668066|584216034|FG004|Part 1: Treatment Phase|Other|0|||
161774282|NCT04668066|584216035|FG005|Part 1: Treatment Phase|Other|0|||
161774283|NCT04668066|584216036|FG006|Part 1: Treatment Phase|Other|0|||
161774284|NCT04668066|584216037|FG007|Part 1: Treatment Phase|Other|0|||
161774285|NCT04668066|584216038|FG008|Part 1: Treatment Phase|Other|0|||
161774286|NCT04668066|584216039|FG009|Part 1: Treatment Phase|Other|0|||
161774287|NCT04668066|584216040|FG010|Part 1: Treatment Phase|Other|0|||
161774288|NCT04668066|584216041|FG011|Part 1: Treatment Phase|Other|1|||
161774289|NCT04668066|584216042|FG012|Part 1: Treatment Phase|Other|0|||
161774290|NCT04668066|584216043|FG013|Part 1: Treatment Phase|Other|0|||
161774291|NCT04668066|584216044|FG014|Part 1: Treatment Phase|Other|0|||
161774292|NCT04668066|584216045|FG015|Part 1: Treatment Phase|Other|0|||
161865991|NCT03817853|584551708|FG002|Maintenance Phase|Adverse Event|0|||
161865992|NCT03817853|584551706|FG000|Maintenance Phase|Death|0|||
161865993|NCT03817853|584551707|FG001|Maintenance Phase|Death|5|||
161865994|NCT03817853|584551708|FG002|Maintenance Phase|Death|0|||
161865995|NCT03817853|584551706|FG000|Maintenance Phase|Progressive Disease|0|||
161865996|NCT03817853|584551707|FG001|Maintenance Phase|Progressive Disease|7|||
161865997|NCT03817853|584551708|FG002|Maintenance Phase|Progressive Disease|0|||
161865998|NCT03817853|584551706|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161865999|NCT03817853|584551707|FG001|Maintenance Phase|Withdrawal by Subject|2|||
161866000|NCT03817853|584551708|FG002|Maintenance Phase|Withdrawal by Subject|0|||
161866001|NCT03817853|584551706|FG000|Maintenance Phase|Physician Decision|0|||
161866002|NCT03817853|584551707|FG001|Maintenance Phase|Physician Decision|1|||
161866003|NCT03817853|584551708|FG002|Maintenance Phase|Physician Decision|0|||
161866004|NCT03817853|584551706|FG000|Maintenance Phase|Various reasons|0|||
161866005|NCT03817853|584551707|FG001|Maintenance Phase|Various reasons|4|||
161866006|NCT03817853|584551708|FG002|Maintenance Phase|Various reasons|0|||
161866007|NCT03817853|584551706|FG000|Maintenance Phase|Protocol Deviation|0|||
161866008|NCT03817853|584551707|FG001|Maintenance Phase|Protocol Deviation|1|||
161866009|NCT03817853|584551708|FG002|Maintenance Phase|Protocol Deviation|0|||
161866010|NCT03817853|584551706|FG000|Follow-up Phase|Adverse Event|0|||
161866011|NCT03817853|584551707|FG001|Follow-up Phase|Adverse Event|0|||
161866012|NCT03817853|584551708|FG002|Follow-up Phase|Adverse Event|2|||
161866013|NCT03817853|584551706|FG000|Follow-up Phase|Death|0|||
161866014|NCT03817853|584551707|FG001|Follow-up Phase|Death|0|||
161866015|NCT03817853|584551708|FG002|Follow-up Phase|Death|1|||
161866016|NCT03817853|584551706|FG000|Follow-up Phase|Progressive Disease|0|||
161866017|NCT03817853|584551707|FG001|Follow-up Phase|Progressive Disease|0|||
161866018|NCT03817853|584551708|FG002|Follow-up Phase|Progressive Disease|3|||
161866019|NCT03817853|584551706|FG000|Follow-up Phase|Withdrawal by Subject|0|||
161866020|NCT03817853|584551707|FG001|Follow-up Phase|Withdrawal by Subject|0|||
161866021|NCT03817853|584551708|FG002|Follow-up Phase|Withdrawal by Subject|1|||
161866022|NCT00391768|584551709|FG000|Overall Study|Withdrawal by Subject|0|||
161866023|NCT00391768|584551710|FG001|Overall Study|Withdrawal by Subject|0|||
161866024|NCT00391768|584551711|FG002|Overall Study|Withdrawal by Subject|1|||
161866025|NCT00391768|584551712|FG003|Overall Study|Withdrawal by Subject|0|||
161866026|NCT00391768|584551713|FG004|Overall Study|Withdrawal by Subject|0|||
161866027|NCT00391768|584551714|FG005|Overall Study|Withdrawal by Subject|1|||
161866028|NCT00391768|584551715|FG006|Overall Study|Withdrawal by Subject|1|||
161866029|NCT00391768|584551709|FG000|Overall Study|Lost to Follow-up|0|||
161866030|NCT00391768|584551710|FG001|Overall Study|Lost to Follow-up|0|||
161866031|NCT00391768|584551711|FG002|Overall Study|Lost to Follow-up|0|||
161866032|NCT00391768|584551712|FG003|Overall Study|Lost to Follow-up|1|||
161866033|NCT00391768|584551713|FG004|Overall Study|Lost to Follow-up|2|||
161866034|NCT00391768|584551714|FG005|Overall Study|Lost to Follow-up|2|||
161866035|NCT00391768|584551715|FG006|Overall Study|Lost to Follow-up|3|||
161866036|NCT01620138|584551716|FG000|Overall Study|Withdrawal by Subject|3|||
161866037|NCT01620138|584551717|FG001|Overall Study|Withdrawal by Subject|0|||
161866038|NCT01620138|584551716|FG000|Overall Study|Lack of Efficacy|1|||
161866039|NCT01620138|584551717|FG001|Overall Study|Lack of Efficacy|0|||
161866040|NCT01620138|584551716|FG000|Overall Study|Adverse Event|2|||
161866041|NCT01620138|584551717|FG001|Overall Study|Adverse Event|0|||
161866042|NCT00444535|584551720|FG000|Overall Study|Withdrawal by Subject|5|||
161866043|NCT00444535|584551720|FG000|Overall Study|Physician Decision|5|||
161866044|NCT00444535|584551720|FG000|Overall Study|progressive disease|1|||
161866045|NCT00444535|584551720|FG000|Overall Study|Adverse Event|2|||
161866046|NCT01568892|584551721|FG000|Open-label Phase|Adverse Event|2|||
161866047|NCT01568892|584551722|FG001|Open-label Phase|Adverse Event|0|||
161866048|NCT01568892|584551721|FG000|Open-label Phase|Lack of Efficacy|4|||
161866049|NCT01568892|584551722|FG001|Open-label Phase|Lack of Efficacy|2|||
161866050|NCT01568892|584551721|FG000|Open-label Phase|Lost to Follow-up|0|||
161866051|NCT01568892|584551722|FG001|Open-label Phase|Lost to Follow-up|1|||
161866052|NCT01697748|584551730|FG000|Overall Study|ineligible skin incision|1|||
161866053|NCT01697748|584551731|FG001|Overall Study|ineligible skin incision|2|||
161866054|NCT01697748|584551730|FG000|Overall Study|ineligible uterine incision|4|||
161866055|NCT01697748|584551731|FG001|Overall Study|ineligible uterine incision|1|||
161866056|NCT01697748|584551730|FG000|Overall Study|Lost to Follow-up|53|||
161866057|NCT01697748|584551731|FG001|Overall Study|Lost to Follow-up|65|||
161866058|NCT01256450|584551734|FG000|Open-label Titration|Adverse Event|39|||
161866059|NCT01256450|584551735|FG001|Open-label Titration|Adverse Event|0|||
161866060|NCT01256450|584551736|FG002|Open-label Titration|Adverse Event|0|||
161866061|NCT01256450|584551734|FG000|Open-label Titration|Lost to Follow-up|7|||
161866062|NCT01256450|584551735|FG001|Open-label Titration|Lost to Follow-up|0|||
161866063|NCT01256450|584551736|FG002|Open-label Titration|Lost to Follow-up|0|||
161866064|NCT01256450|584551734|FG000|Open-label Titration|Lack of analgesic effect|30|||
161866065|NCT01256450|584551735|FG001|Open-label Titration|Lack of analgesic effect|0|||
161866066|NCT01256450|584551736|FG002|Open-label Titration|Lack of analgesic effect|0|||
161866067|NCT01256450|584551734|FG000|Open-label Titration|Non-compliance|9|||
161866068|NCT01256450|584551735|FG001|Open-label Titration|Non-compliance|0|||
161866069|NCT01256450|584551736|FG002|Open-label Titration|Non-compliance|0|||
161866070|NCT01256450|584551734|FG000|Open-label Titration|Screen failure|1|||
161866071|NCT01256450|584551735|FG001|Open-label Titration|Screen failure|0|||
161866072|NCT01256450|584551736|FG002|Open-label Titration|Screen failure|0|||
161866073|NCT01256450|584551734|FG000|Open-label Titration|Other|13|||
161866074|NCT01256450|584551735|FG001|Open-label Titration|Other|0|||
161866075|NCT01256450|584551736|FG002|Open-label Titration|Other|0|||
161866076|NCT01256450|584551734|FG000|Double-blind Treatment|Adverse Event|0|||
161866077|NCT01256450|584551735|FG001|Double-blind Treatment|Adverse Event|8|||
161866078|NCT01256450|584551736|FG002|Double-blind Treatment|Adverse Event|6|||
161866079|NCT01256450|584551734|FG000|Double-blind Treatment|Lost to Follow-up|0|||
161866080|NCT01256450|584551735|FG001|Double-blind Treatment|Lost to Follow-up|1|||
161866081|NCT01256450|584551736|FG002|Double-blind Treatment|Lost to Follow-up|7|||
161866082|NCT01256450|584551734|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
161866083|NCT01256450|584551735|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
161866084|NCT01256450|584551736|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
161866085|NCT01256450|584551734|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
161866086|NCT01256450|584551735|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
161866087|NCT01256450|584551736|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
161866088|NCT01256450|584551734|FG000|Double-blind Treatment|Non-compliance|0|||
161866089|NCT01256450|584551735|FG001|Double-blind Treatment|Non-compliance|5|||
161866090|NCT01256450|584551736|FG002|Double-blind Treatment|Non-compliance|4|||
161866091|NCT01256450|584551734|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
161866092|NCT01256450|584551735|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
161866093|NCT01256450|584551736|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
161866094|NCT01256450|584551734|FG000|Double-blind Treatment|Other|0|||
161866095|NCT01256450|584551735|FG001|Double-blind Treatment|Other|9|||
161866096|NCT01256450|584551736|FG002|Double-blind Treatment|Other|12|||
161866097|NCT01704495|584551737|FG000|Subjects Randomized|Other Reason|3|||
161866098|NCT01704495|584551738|FG001|Subjects Randomized|Other Reason|2|||
161866099|NCT01704495|584551739|FG002|Subjects Randomized|Other Reason|3|||
161866100|NCT01704495|584551740|FG003|Subjects Randomized|Other Reason|2|||
161866101|NCT01704495|584551737|FG000|Subjects Randomized|Discontinuation criteria met|4|||
161866102|NCT01704495|584551738|FG001|Subjects Randomized|Discontinuation criteria met|2|||
161866103|NCT01704495|584551739|FG002|Subjects Randomized|Discontinuation criteria met|2|||
161866104|NCT01704495|584551740|FG003|Subjects Randomized|Discontinuation criteria met|0|||
161866105|NCT01704495|584551737|FG000|Subjects Randomized|Adverse Event|8|||
161866106|NCT01704495|584551738|FG001|Subjects Randomized|Adverse Event|2|||
161866107|NCT01704495|584551739|FG002|Subjects Randomized|Adverse Event|0|||
161866108|NCT01704495|584551740|FG003|Subjects Randomized|Adverse Event|7|||
161866109|NCT01704495|584551737|FG000|Subjects Randomized|Withdrawal by Subject|5|||
161866110|NCT01704495|584551738|FG001|Subjects Randomized|Withdrawal by Subject|5|||
161866111|NCT01704495|584551739|FG002|Subjects Randomized|Withdrawal by Subject|5|||
161866112|NCT01704495|584551740|FG003|Subjects Randomized|Withdrawal by Subject|5|||
161866113|NCT01704495|584551737|FG000|Subjects Randomized|Protocol Violation|1|||
161866114|NCT01704495|584551738|FG001|Subjects Randomized|Protocol Violation|1|||
161866115|NCT01704495|584551739|FG002|Subjects Randomized|Protocol Violation|2|||
161866116|NCT01704495|584551740|FG003|Subjects Randomized|Protocol Violation|0|||
161866117|NCT01704495|584551737|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
161866118|NCT01704495|584551738|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
161866119|NCT01704495|584551739|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
161866120|NCT01704495|584551740|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
161866121|NCT01704495|584551737|FG000|Optional Safety Extension|Adverse Event|0|||
161866122|NCT01704495|584551738|FG001|Optional Safety Extension|Adverse Event|4|||
161866123|NCT01704495|584551739|FG002|Optional Safety Extension|Adverse Event|0|||
161866124|NCT01704495|584551740|FG003|Optional Safety Extension|Adverse Event|1|||
161866125|NCT01704495|584551737|FG000|Optional Safety Extension|Other reason|27|||
161866126|NCT01704495|584551738|FG001|Optional Safety Extension|Other reason|29|||
161866127|NCT01704495|584551739|FG002|Optional Safety Extension|Other reason|30|||
161866128|NCT01704495|584551740|FG003|Optional Safety Extension|Other reason|28|||
161866129|NCT01704495|584551737|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
161866130|NCT01704495|584551738|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
161866131|NCT01704495|584551739|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
161866132|NCT01704495|584551740|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
161866133|NCT02375971|584551742|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
161866134|NCT02375971|584551743|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
161866135|NCT02375971|584551744|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
161866136|NCT02375971|584551742|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
161866137|NCT02375971|584551743|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
161866138|NCT02375971|584551744|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
161866139|NCT02375971|584551742|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
161866140|NCT02375971|584551743|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
161866141|NCT02375971|584551744|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
161866142|NCT02375971|584551742|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
161866143|NCT02375971|584551743|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
161866144|NCT02375971|584551744|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
161866145|NCT02375971|584551742|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
161866146|NCT02375971|584551743|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
161866147|NCT02375971|584551744|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
161866148|NCT02375971|584551742|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
161866149|NCT02375971|584551743|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
161866150|NCT02375971|584551744|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
161866151|NCT02375971|584551742|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
161866152|NCT02375971|584551743|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
161866153|NCT02375971|584551744|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
161866154|NCT02375971|584551742|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
161866155|NCT02375971|584551743|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
161866156|NCT02375971|584551744|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
162034935|NCT04626310|585184812|FG000|Overall Study|Withdrawal by Subject|1|||
162034936|NCT04626310|585184813|FG001|Overall Study|Withdrawal by Subject|0|||
161866157|NCT00891020|584551745|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
161866158|NCT00891020|584551746|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
161866159|NCT00891020|584551747|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
161866160|NCT00891020|584551745|FG000|24 Week Treatment Period|Death|0|||
161866161|NCT00891020|584551746|FG001|24 Week Treatment Period|Death|2|||
161866162|NCT00891020|584551747|FG002|24 Week Treatment Period|Death|0|||
161866163|NCT00891020|584551745|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
161866164|NCT00891020|584551746|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
161866165|NCT00891020|584551747|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
161866166|NCT00891020|584551745|FG000|24 Week Treatment Period|Failure to return|4|||
161866167|NCT00891020|584551746|FG001|24 Week Treatment Period|Failure to return|5|||
161866168|NCT00891020|584551747|FG002|24 Week Treatment Period|Failure to return|5|||
161866169|NCT00891020|584551745|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
161866170|NCT00891020|584551746|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
161866171|NCT00891020|584551747|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
161866172|NCT00891020|584551745|FG000|24 Week Treatment Period|Other protocol violation|1|||
161866173|NCT00891020|584551746|FG001|24 Week Treatment Period|Other protocol violation|1|||
161866174|NCT00891020|584551747|FG002|24 Week Treatment Period|Other protocol violation|2|||
161866175|NCT00891020|584551745|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
161866176|NCT00891020|584551746|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
161866177|NCT00891020|584551747|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
161866178|NCT00891020|584551745|FG000|24 Week Treatment Period|Withdrew consent|6|||
161866179|NCT00891020|584551746|FG001|24 Week Treatment Period|Withdrew consent|3|||
161866180|NCT00891020|584551747|FG002|24 Week Treatment Period|Withdrew consent|15|||
161866181|NCT00891020|584551745|FG000|24 Week Treatment Period|Administrative/Other|5|||
161866182|NCT00891020|584551746|FG001|24 Week Treatment Period|Administrative/Other|6|||
161866183|NCT00891020|584551747|FG002|24 Week Treatment Period|Administrative/Other|1|||
161866184|NCT00891020|584551745|FG000|Long-term Extension Period|Adverse Event|1|||
161866185|NCT00891020|584551746|FG001|Long-term Extension Period|Adverse Event|11|||
161866186|NCT00891020|584551747|FG002|Long-term Extension Period|Adverse Event|10|||
161866187|NCT00891020|584551745|FG000|Long-term Extension Period|Death|0|||
161866188|NCT00891020|584551746|FG001|Long-term Extension Period|Death|0|||
161866189|NCT00891020|584551747|FG002|Long-term Extension Period|Death|1|||
161866190|NCT00891020|584551745|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
161866191|NCT00891020|584551746|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
161866192|NCT00891020|584551747|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
161866193|NCT00891020|584551745|FG000|Long-term Extension Period|Protocol Violation|0|||
161866194|NCT00891020|584551746|FG001|Long-term Extension Period|Protocol Violation|1|||
161866195|NCT00891020|584551747|FG002|Long-term Extension Period|Protocol Violation|1|||
161866196|NCT00891020|584551745|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
161866197|NCT00891020|584551746|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
161866198|NCT00891020|584551747|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
161866199|NCT00891020|584551745|FG000|Long-term Extension Period|Failure to return|0|||
161866200|NCT00891020|584551746|FG001|Long-term Extension Period|Failure to return|2|||
161866201|NCT00891020|584551747|FG002|Long-term Extension Period|Failure to return|3|||
161866202|NCT00891020|584551745|FG000|Long-term Extension Period|Administrative|1|||
161866203|NCT00891020|584551746|FG001|Long-term Extension Period|Administrative|2|||
161866204|NCT00891020|584551747|FG002|Long-term Extension Period|Administrative|2|||
161866205|NCT00320710|584551749|FG000|Overall Study|Disease progression|24|||
161866206|NCT00320710|584551750|FG001|Overall Study|Disease progression|19|||
161866207|NCT00320710|584551751|FG002|Overall Study|Disease progression|2|||
161866208|NCT00320710|584551749|FG000|Overall Study|Death|10|||
161866209|NCT00320710|584551750|FG001|Overall Study|Death|7|||
161866210|NCT00320710|584551751|FG002|Overall Study|Death|1|||
161866211|NCT00320710|584551749|FG000|Overall Study|Administrative problems|1|||
161866212|NCT00320710|584551750|FG001|Overall Study|Administrative problems|2|||
161866213|NCT00320710|584551751|FG002|Overall Study|Administrative problems|0|||
161866214|NCT00320710|584551749|FG000|Overall Study|Withdrawal by Subject|20|||
161866215|NCT00320710|584551750|FG001|Overall Study|Withdrawal by Subject|26|||
161866216|NCT00320710|584551751|FG002|Overall Study|Withdrawal by Subject|1|||
161866217|NCT00320710|584551749|FG000|Overall Study|Protocol Violation|6|||
161866218|NCT00320710|584551750|FG001|Overall Study|Protocol Violation|5|||
161866219|NCT00320710|584551751|FG002|Overall Study|Protocol Violation|0|||
161866220|NCT00320710|584551749|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161866221|NCT00320710|584551750|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161866222|NCT00320710|584551751|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161866223|NCT00320710|584551749|FG000|Overall Study|Abnormal laboratory value(s)|12|||
161866224|NCT00320710|584551750|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161866225|NCT00320710|584551751|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161866226|NCT00320710|584551749|FG000|Overall Study|Adverse Event|18|||
161866227|NCT00320710|584551750|FG001|Overall Study|Adverse Event|14|||
161866228|NCT00320710|584551751|FG002|Overall Study|Adverse Event|1|||
161866229|NCT00320710|584551749|FG000|Overall Study|Lost to Follow-up|1|||
161866230|NCT00320710|584551750|FG001|Overall Study|Lost to Follow-up|0|||
161866231|NCT00320710|584551751|FG002|Overall Study|Lost to Follow-up|0|||
161866232|NCT03866512|584551752|FG000|Overall Study|Lost to Follow-up|1|||
161866233|NCT03866512|584551753|FG001|Overall Study|Lost to Follow-up|2|||
161866234|NCT03866512|584551754|FG002|Overall Study|Lost to Follow-up|1|||
161866235|NCT03866512|584551752|FG000|Overall Study|Cannulation issues|0|||
161866236|NCT03866512|584551753|FG001|Overall Study|Cannulation issues|1|||
161866237|NCT03866512|584551754|FG002|Overall Study|Cannulation issues|2|||
161866238|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
161866239|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161866240|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161866241|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161866242|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
161866243|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
161866244|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
161866245|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
161866246|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
161866247|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
161866248|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
161866249|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
161866250|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
161866251|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161866252|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161866253|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161866254|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
161866255|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161866256|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161866257|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161866258|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
161866259|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161866260|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161866261|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161866262|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
161866263|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
161866264|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
161866265|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
161866266|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
161866267|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
161866268|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
161866269|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
161866270|NCT00506415|584551756|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
161866271|NCT00506415|584551757|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161866272|NCT00506415|584551758|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161866273|NCT00506415|584551759|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161866274|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
161866275|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
161866276|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
161982343|NCT03464019|584984771|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
161866277|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
161866278|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
161866279|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
161866280|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
161866281|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
161866282|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
161866283|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
161866284|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
161866285|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
161866286|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
161866287|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
161866288|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
161866289|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
161866290|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
161866291|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
161866292|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
161866293|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
161866294|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
161866295|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
161866296|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
161866297|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
161866298|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
161866299|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
161866300|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
161866301|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
161866302|NCT00506415|584551756|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
161866303|NCT00506415|584551757|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
161866304|NCT00506415|584551758|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
161866305|NCT00506415|584551759|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
161866306|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
161866307|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
161866308|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
161866309|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
161866310|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161866311|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161866312|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161866313|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
161866314|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161866315|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161866316|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161866317|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
161866318|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161866319|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161866320|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161866321|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
161866322|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161866323|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161866324|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161866325|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
161866326|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161866327|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161866328|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161866329|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
161866330|NCT00506415|584551756|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
161866331|NCT00506415|584551757|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
161866332|NCT00506415|584551758|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
161866333|NCT00506415|584551759|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
161866334|NCT00997373|584551764|FG000|Overall Study|Withdrawal by Subject|5|||
161866335|NCT00997373|584551765|FG001|Overall Study|Withdrawal by Subject|0|||
161866336|NCT00997373|584551764|FG000|Overall Study|wrong tumor type|4|||
162034937|NCT04626310|585184814|FG002|Overall Study|Withdrawal by Subject|3|||
161866337|NCT00997373|584551765|FG001|Overall Study|wrong tumor type|0|||
161866338|NCT00997373|584551764|FG000|Overall Study|could not have hysterectomy|6|||
162034938|NCT02011893|585184815|FG000|Enrollment to Randomization|Adverse Event|2|||
162034939|NCT02011893|585184816|FG001|Enrollment to Randomization|Adverse Event|0|||
161866339|NCT00997373|584551765|FG001|Overall Study|could not have hysterectomy|0|||
161866340|NCT00832455|584551766|FG000|Overall Study|Adverse Event|13|||
161866341|NCT00832455|584551766|FG000|Overall Study|Lost to Follow-up|26|||
161866342|NCT00832455|584551766|FG000|Overall Study|Protocol Violation|4|||
161866343|NCT00832455|584551766|FG000|Overall Study|Withdrawal by Subject|17|||
161866344|NCT00832455|584551766|FG000|Overall Study|Screening Failure|2|||
161866345|NCT00832455|584551766|FG000|Overall Study|Stopped Medication|4|||
161866346|NCT00832455|584551766|FG000|Overall Study|Parent misunderstood study|1|||
161866347|NCT00832455|584551766|FG000|Overall Study|Parent dissatisfied|1|||
161866348|NCT00832455|584551766|FG000|Overall Study|No improvement|3|||
161866349|NCT00832455|584551766|FG000|Overall Study|Patient moved|1|||
161866350|NCT04578457|584551767|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
161866351|NCT04578457|584551767|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
161866352|NCT04578457|584551767|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
161866353|NCT04578457|584551767|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
161866354|NCT00739661|584551769|FG000|Overall Study|Adverse Event|2|||
161866355|NCT00739661|584551770|FG001|Overall Study|Adverse Event|0|||
161866356|NCT00739661|584551769|FG000|Overall Study|Physician decision to withdraw patient|1|||
161866357|NCT00739661|584551770|FG001|Overall Study|Physician decision to withdraw patient|0|||
161866358|NCT00739661|584551769|FG000|Overall Study|Patient decision to withdraw|9|||
161866359|NCT00739661|584551770|FG001|Overall Study|Patient decision to withdraw|4|||
161866360|NCT00739661|584551769|FG000|Overall Study|Disease progression, radiographic|33|||
161866361|NCT00739661|584551770|FG001|Overall Study|Disease progression, radiographic|37|||
161866362|NCT00739661|584551769|FG000|Overall Study|Reason for discontinuation not available|1|||
161866363|NCT00739661|584551770|FG001|Overall Study|Reason for discontinuation not available|1|||
161866364|NCT02883062|584551773|FG000|Overall Study|Withdrawal by Subject|6|||
161866365|NCT02883062|584551774|FG001|Overall Study|Withdrawal by Subject|0|||
161866366|NCT03839628|584551775|FG000|Overall Study|Withdrawal by Subject|1|||
161866367|NCT00380874|584551776|FG000|Overall Study|Adverse Event|7|||
161866368|NCT00380874|584551777|FG001|Overall Study|Adverse Event|7|||
161866369|NCT00380874|584551776|FG000|Overall Study|Death|1|||
161866370|NCT00380874|584551777|FG001|Overall Study|Death|0|||
161866371|NCT00380874|584551776|FG000|Overall Study|Withdrawal by Subject|2|||
161866372|NCT00380874|584551777|FG001|Overall Study|Withdrawal by Subject|1|||
161866373|NCT00380874|584551776|FG000|Overall Study|Not related to study drug|3|||
161866374|NCT00380874|584551777|FG001|Overall Study|Not related to study drug|2|||
161866375|NCT03380429|584551778|FG000|Overall Study|Physician Decision|0|||
161866376|NCT03380429|584551779|FG001|Overall Study|Physician Decision|1|||
161866377|NCT03380429|584551780|FG002|Overall Study|Physician Decision|0|||
161866378|NCT03380429|584551781|FG003|Overall Study|Physician Decision|1|||
161866379|NCT03380429|584551782|FG004|Overall Study|Physician Decision|1|||
161866380|NCT03380429|584551778|FG000|Overall Study|Withdrawal by Subject|3|||
161866381|NCT03380429|584551779|FG001|Overall Study|Withdrawal by Subject|3|||
161866382|NCT03380429|584551780|FG002|Overall Study|Withdrawal by Subject|5|||
161866383|NCT03380429|584551781|FG003|Overall Study|Withdrawal by Subject|2|||
161866384|NCT03380429|584551782|FG004|Overall Study|Withdrawal by Subject|1|||
161866385|NCT03380429|584551778|FG000|Overall Study|Lost to Follow-up|0|||
161866386|NCT03380429|584551779|FG001|Overall Study|Lost to Follow-up|2|||
161866387|NCT03380429|584551780|FG002|Overall Study|Lost to Follow-up|4|||
161866388|NCT03380429|584551781|FG003|Overall Study|Lost to Follow-up|3|||
161866389|NCT03380429|584551782|FG004|Overall Study|Lost to Follow-up|1|||
161866390|NCT03380429|584551778|FG000|Overall Study|Protocol Violation|1|||
161866391|NCT03380429|584551779|FG001|Overall Study|Protocol Violation|0|||
161866392|NCT03380429|584551780|FG002|Overall Study|Protocol Violation|1|||
161866393|NCT03380429|584551781|FG003|Overall Study|Protocol Violation|0|||
161866394|NCT03380429|584551782|FG004|Overall Study|Protocol Violation|1|||
161866395|NCT03380429|584551778|FG000|Overall Study|Lack of Efficacy|0|||
161866396|NCT03380429|584551779|FG001|Overall Study|Lack of Efficacy|0|||
161866397|NCT03380429|584551780|FG002|Overall Study|Lack of Efficacy|0|||
161866398|NCT03380429|584551781|FG003|Overall Study|Lack of Efficacy|2|||
161866399|NCT03380429|584551782|FG004|Overall Study|Lack of Efficacy|1|||
161866400|NCT03380429|584551778|FG000|Overall Study|Adverse Event|1|||
161866401|NCT03380429|584551779|FG001|Overall Study|Adverse Event|1|||
161866402|NCT03380429|584551780|FG002|Overall Study|Adverse Event|1|||
161866403|NCT03380429|584551781|FG003|Overall Study|Adverse Event|2|||
161866404|NCT03380429|584551782|FG004|Overall Study|Adverse Event|0|||
161866405|NCT01707290|584551787|FG000|Overall Study|Adverse event (AE)|1|||
161866406|NCT01707290|584551788|FG001|Overall Study|Adverse event (AE)|0|||
161866407|NCT01707290|584551787|FG000|Overall Study|Physician Decision|1|||
161866408|NCT01707290|584551788|FG001|Overall Study|Physician Decision|0|||
161866409|NCT01707290|584551787|FG000|Overall Study|Lost to Follow-up|3|||
161866410|NCT01707290|584551788|FG001|Overall Study|Lost to Follow-up|0|||
161866411|NCT01707290|584551787|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
161866412|NCT01707290|584551788|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
161866413|NCT01707290|584551787|FG000|Overall Study|Commercial drug available|60|||
161866414|NCT01707290|584551788|FG001|Overall Study|Commercial drug available|1|||
161866415|NCT01707290|584551787|FG000|Overall Study|Other unspecified|17|||
161866416|NCT01707290|584551788|FG001|Overall Study|Other unspecified|0|||
161866417|NCT02314026|584551789|FG000|Overall Study|Protocol Violation|28|||
161866418|NCT01139775|584551790|FG000|Overall Study|Adverse Event|0|||
161866419|NCT01139775|584551791|FG001|Overall Study|Adverse Event|6|||
161866420|NCT01139775|584551792|FG002|Overall Study|Adverse Event|2|||
161866421|NCT01139775|584551790|FG000|Overall Study|Protocol Violation|0|||
161866422|NCT01139775|584551791|FG001|Overall Study|Protocol Violation|5|||
161866423|NCT01139775|584551792|FG002|Overall Study|Protocol Violation|0|||
161866424|NCT01139775|584551790|FG000|Overall Study|Withdrawal by Subject|1|||
161866425|NCT01139775|584551791|FG001|Overall Study|Withdrawal by Subject|0|||
161866426|NCT01139775|584551792|FG002|Overall Study|Withdrawal by Subject|2|||
161866427|NCT01139775|584551790|FG000|Overall Study|Physician Decision|0|||
161866428|NCT01139775|584551791|FG001|Overall Study|Physician Decision|2|||
161866429|NCT01139775|584551792|FG002|Overall Study|Physician Decision|2|||
161866430|NCT01882985|584551795|FG000|Overall Study|Lost to Follow-up|1|||
161866431|NCT01882985|584551795|FG000|Overall Study|Withdrawal by Subject|1|||
161866432|NCT03193853|584551802|FG000|Overall Study|Death|6|||
161866433|NCT04129125|584551803|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
161866434|NCT04129125|584551803|FG000|Overall Study|Study device was not used|3|||
161866435|NCT02362360|584551814|FG000|Period 1|Lack of Efficacy|1|||
161866436|NCT02362360|584551815|FG001|Period 1|Lack of Efficacy|0|||
161866437|NCT02362360|584551814|FG000|Period 1|Withdrawal by Subject|2|||
161866438|NCT02362360|584551815|FG001|Period 1|Withdrawal by Subject|1|||
161866439|NCT01546025|584551816|FG000|Overall Study|Lost to Follow-up|0|||
161866440|NCT01546025|584551817|FG001|Overall Study|Lost to Follow-up|1|||
161866441|NCT04955691|584553504|FG000|Period 2|Discontinued intervention|1|||
161866442|NCT04955691|584553505|FG001|Period 2|Discontinued intervention|2|||
161866443|NCT05336227|584553506|FG000|Overall Study|Adverse Event|1|||
161866444|NCT05336227|584553507|FG001|Overall Study|Adverse Event|0|||
161866445|NCT05336227|584553506|FG000|Overall Study|Lost to Follow-up|2|||
161866446|NCT05336227|584553507|FG001|Overall Study|Lost to Follow-up|0|||
161866447|NCT05336227|584553506|FG000|Overall Study|Withdrawal by Subject|1|||
161866448|NCT05336227|584553507|FG001|Overall Study|Withdrawal by Subject|0|||
161866449|NCT05086744|584553508|FG000|Part A|Adverse Event|0|||
161866450|NCT05086744|584553509|FG001|Part A|Adverse Event|1|||
161866451|NCT05086744|584553508|FG000|Part A|Lack of Efficacy|3|||
161866452|NCT05086744|584553509|FG001|Part A|Lack of Efficacy|0|||
161866453|NCT05086744|584553508|FG000|Part A|Protocol deviation|1|||
161866454|NCT05086744|584553509|FG001|Part A|Protocol deviation|0|||
161866455|NCT05086744|584553508|FG000|Part A|Subject decision|1|||
161866456|NCT05086744|584553509|FG001|Part A|Subject decision|0|||
161866457|NCT05086744|584553508|FG000|Part B|Adverse Event|0|||
161866458|NCT05086744|584553509|FG001|Part B|Adverse Event|1|||
161866459|NCT05086744|584553508|FG000|Part B|Lack of Efficacy|0|||
161866460|NCT05086744|584553509|FG001|Part B|Lack of Efficacy|1|||
161866461|NCT05086744|584553508|FG000|Part B|Study terminated by sponsor|1|||
161866462|NCT05086744|584553509|FG001|Part B|Study terminated by sponsor|6|||
161866463|NCT04053868|584553512|FG000|Overall Study|Withdrawal by Subject|1|||
161866464|NCT04053868|584553513|FG001|Overall Study|Withdrawal by Subject|0|||
161866465|NCT05731700|584553514|FG000|Overall Study|Death|1|||
161866466|NCT05468164|584553515|FG000|Treatment Period 4|Adverse Event|0|||
161866467|NCT05468164|584553516|FG001|Treatment Period 4|Adverse Event|0|||
161866468|NCT05468164|584553517|FG002|Treatment Period 4|Adverse Event|0|||
161866469|NCT05468164|584553518|FG003|Treatment Period 4|Adverse Event|1|||
161866470|NCT04225715|584553519|FG000|Overall Study|Reason not Specified|1|||
161866471|NCT04225715|584553520|FG001|Overall Study|Reason not Specified|0|||
161866472|NCT04225715|584553521|FG002|Overall Study|Reason not Specified|0|||
161866473|NCT04225715|584553522|FG003|Overall Study|Reason not Specified|0|||
161866474|NCT04225715|584553523|FG004|Overall Study|Reason not Specified|0|||
161866475|NCT04225715|584553524|FG005|Overall Study|Reason not Specified|0|||
161866476|NCT04225715|584553525|FG006|Overall Study|Reason not Specified|0|||
161866477|NCT04225715|584553526|FG007|Overall Study|Reason not Specified|0|||
161866478|NCT04225715|584553527|FG008|Overall Study|Reason not Specified|0|||
161866479|NCT04225715|584553519|FG000|Overall Study|Protocol Violation|1|||
161866480|NCT04225715|584553520|FG001|Overall Study|Protocol Violation|0|||
161866481|NCT04225715|584553521|FG002|Overall Study|Protocol Violation|0|||
161866482|NCT04225715|584553522|FG003|Overall Study|Protocol Violation|0|||
161866483|NCT04225715|584553523|FG004|Overall Study|Protocol Violation|0|||
161866484|NCT04225715|584553524|FG005|Overall Study|Protocol Violation|9|||
161866485|NCT04225715|584553525|FG006|Overall Study|Protocol Violation|0|||
161866486|NCT04225715|584553526|FG007|Overall Study|Protocol Violation|0|||
161866487|NCT04225715|584553527|FG008|Overall Study|Protocol Violation|0|||
161866488|NCT04225715|584553519|FG000|Overall Study|Withdrawal by Subject|4|||
161866489|NCT04225715|584553520|FG001|Overall Study|Withdrawal by Subject|1|||
161866490|NCT04225715|584553521|FG002|Overall Study|Withdrawal by Subject|1|||
161866491|NCT04225715|584553522|FG003|Overall Study|Withdrawal by Subject|0|||
161866492|NCT04225715|584553523|FG004|Overall Study|Withdrawal by Subject|3|||
161866493|NCT04225715|584553524|FG005|Overall Study|Withdrawal by Subject|1|||
161866494|NCT04225715|584553525|FG006|Overall Study|Withdrawal by Subject|1|||
161866495|NCT04225715|584553526|FG007|Overall Study|Withdrawal by Subject|1|||
161866496|NCT04225715|584553527|FG008|Overall Study|Withdrawal by Subject|0|||
161866497|NCT04225715|584553519|FG000|Overall Study|Adverse Event|0|||
161866498|NCT04225715|584553520|FG001|Overall Study|Adverse Event|0|||
161866499|NCT04225715|584553521|FG002|Overall Study|Adverse Event|0|||
161866500|NCT04225715|584553522|FG003|Overall Study|Adverse Event|0|||
161866501|NCT04225715|584553523|FG004|Overall Study|Adverse Event|0|||
161866502|NCT04225715|584553524|FG005|Overall Study|Adverse Event|0|||
161866503|NCT04225715|584553525|FG006|Overall Study|Adverse Event|0|||
161866504|NCT04225715|584553526|FG007|Overall Study|Adverse Event|0|||
161866505|NCT04225715|584553527|FG008|Overall Study|Adverse Event|1|||
161866506|NCT04225715|584553519|FG000|Overall Study|Arm Terminated By Sponsor|0|||
161866507|NCT04225715|584553520|FG001|Overall Study|Arm Terminated By Sponsor|0|||
161866508|NCT04225715|584553521|FG002|Overall Study|Arm Terminated By Sponsor|0|||
161866509|NCT04225715|584553522|FG003|Overall Study|Arm Terminated By Sponsor|0|||
161866510|NCT04225715|584553523|FG004|Overall Study|Arm Terminated By Sponsor|0|||
161866511|NCT04225715|584553524|FG005|Overall Study|Arm Terminated By Sponsor|0|||
161866512|NCT04225715|584553525|FG006|Overall Study|Arm Terminated By Sponsor|0|||
161866513|NCT04225715|584553526|FG007|Overall Study|Arm Terminated By Sponsor|17|||
161866514|NCT04225715|584553527|FG008|Overall Study|Arm Terminated By Sponsor|18|||
161866515|NCT04168112|584553528|FG000|Overall Study|Lost to Follow-up|1|||
161866516|NCT04168112|584553529|FG001|Overall Study|Lost to Follow-up|0|||
161866517|NCT04168112|584553528|FG000|Overall Study|Withdrawal by Subject|1|||
161866518|NCT04168112|584553529|FG001|Overall Study|Withdrawal by Subject|0|||
161866519|NCT02275546|584553532|FG000|Treatment Period 2|Withdrawal by Subject|2|||
161866520|NCT02275546|584553533|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161866521|NCT02275546|584553532|FG000|Treatment Period 2|Protocol Violation|0|||
161866522|NCT02275546|584553533|FG001|Treatment Period 2|Protocol Violation|1|||
161866523|NCT00570141|584553543|FG000|Overall Study|Adverse Event|1|||
161866524|NCT00570141|584553543|FG000|Overall Study|Missed visits|1|||
161866525|NCT00570141|584553543|FG000|Overall Study|Lost to Follow-up|1|||
161866526|NCT00925704|584553544|FG000|First Intervention|Withdrew consent|0|||
161866527|NCT00925704|584553545|FG001|First Intervention|Withdrew consent|0|||
161866528|NCT00925704|584553546|FG002|First Intervention|Withdrew consent|0|||
161866529|NCT00925704|584553547|FG003|First Intervention|Withdrew consent|1|||
161866530|NCT00925704|584553548|FG004|First Intervention|Withdrew consent|1|||
161866531|NCT00925704|584553549|FG005|First Intervention|Withdrew consent|0|||
161866532|NCT00925704|584553544|FG000|Second Intervention|Withdrawal by Subject|1|||
161866533|NCT00925704|584553545|FG001|Second Intervention|Withdrawal by Subject|0|||
161866534|NCT00925704|584553546|FG002|Second Intervention|Withdrawal by Subject|0|||
161866535|NCT00925704|584553547|FG003|Second Intervention|Withdrawal by Subject|0|||
161866536|NCT00925704|584553548|FG004|Second Intervention|Withdrawal by Subject|1|||
161866537|NCT00925704|584553549|FG005|Second Intervention|Withdrawal by Subject|0|||
161866538|NCT00925704|584553544|FG000|Third Intervention|Withdrew consent|0|||
161866539|NCT00925704|584553545|FG001|Third Intervention|Withdrew consent|0|||
161866540|NCT00925704|584553546|FG002|Third Intervention|Withdrew consent|0|||
161866541|NCT00925704|584553547|FG003|Third Intervention|Withdrew consent|0|||
161866542|NCT00925704|584553548|FG004|Third Intervention|Withdrew consent|0|||
161866543|NCT00925704|584553549|FG005|Third Intervention|Withdrew consent|1|||
161866544|NCT03922308|584553550|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
161866545|NCT03922308|584553551|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
161866546|NCT03922308|584553552|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
161866547|NCT03922308|584553550|FG000|Overall Study|Lost to Follow-up|1|||
161866548|NCT03922308|584553551|FG001|Overall Study|Lost to Follow-up|0|||
161866549|NCT03922308|584553552|FG002|Overall Study|Lost to Follow-up|0|||
161866550|NCT03922308|584553550|FG000|Overall Study|Reason not Specified|0|||
161866551|NCT03922308|584553551|FG001|Overall Study|Reason not Specified|2|||
161866552|NCT03922308|584553552|FG002|Overall Study|Reason not Specified|1|||
161866553|NCT05005507|584553553|FG000|Overall Study|Premature termination of study|1|||
161866554|NCT02841995|584553554|FG000|Overall Study|Disease progression|5|||
161866555|NCT02841995|584553555|FG001|Overall Study|Disease progression|11|||
161866556|NCT02841995|584553556|FG002|Overall Study|Disease progression|8|||
161866557|NCT02841995|584553554|FG000|Overall Study|Withdrawal by Subject|2|||
161866558|NCT02841995|584553555|FG001|Overall Study|Withdrawal by Subject|4|||
161866559|NCT02841995|584553556|FG002|Overall Study|Withdrawal by Subject|4|||
161866560|NCT02841995|584553554|FG000|Overall Study|Adverse Event|2|||
161866561|NCT02841995|584553555|FG001|Overall Study|Adverse Event|0|||
161866562|NCT02841995|584553556|FG002|Overall Study|Adverse Event|1|||
161866563|NCT02841995|584553554|FG000|Overall Study|Investigator decision|2|||
161866564|NCT02841995|584553555|FG001|Overall Study|Investigator decision|0|||
161866565|NCT02841995|584553556|FG002|Overall Study|Investigator decision|1|||
161866566|NCT02841995|584553554|FG000|Overall Study|Death|0|||
161866567|NCT02841995|584553555|FG001|Overall Study|Death|0|||
161866568|NCT02841995|584553556|FG002|Overall Study|Death|2|||
161866569|NCT02841995|584553554|FG000|Overall Study|Noncompliance to protocol|1|||
161866570|NCT02841995|584553555|FG001|Overall Study|Noncompliance to protocol|0|||
161866571|NCT02841995|584553556|FG002|Overall Study|Noncompliance to protocol|0|||
161866572|NCT02841995|584553554|FG000|Overall Study|Sponsor decision|1|||
161866573|NCT02841995|584553555|FG001|Overall Study|Sponsor decision|0|||
161866574|NCT02841995|584553556|FG002|Overall Study|Sponsor decision|0|||
161866575|NCT02841995|584553554|FG000|Overall Study|Other|4|||
161866576|NCT02841995|584553555|FG001|Overall Study|Other|1|||
161866577|NCT02841995|584553556|FG002|Overall Study|Other|5|||
161866578|NCT02755103|584553564|FG000|Overall Study|Lost to Follow-up|17|||
161866579|NCT02755103|584553565|FG001|Overall Study|Lost to Follow-up|15|||
161866580|NCT02755103|584553564|FG000|Overall Study|Death|0|||
161866581|NCT02755103|584553565|FG001|Overall Study|Death|1|||
161866582|NCT02755103|584553564|FG000|Overall Study|Physician Decision|0|||
161866583|NCT02755103|584553565|FG001|Overall Study|Physician Decision|1|||
161866584|NCT02755103|584553564|FG000|Overall Study|Pregnancy|0|||
161866585|NCT02755103|584553565|FG001|Overall Study|Pregnancy|1|||
161866586|NCT02755103|584553564|FG000|Overall Study|Withdrawal by Subject|3|||
161866587|NCT02755103|584553565|FG001|Overall Study|Withdrawal by Subject|0|||
161866588|NCT02198664|584553571|FG000|Overall Study|Adverse Event|2|||
161866589|NCT02198664|584553572|FG001|Overall Study|Adverse Event|0|||
161866590|NCT02198664|584553571|FG000|Overall Study|Withdrawal by Subject|11|||
161866591|NCT02198664|584553572|FG001|Overall Study|Withdrawal by Subject|8|||
161866592|NCT02198664|584553571|FG000|Overall Study|Failure to tolerate|2|||
161866593|NCT02198664|584553572|FG001|Overall Study|Failure to tolerate|0|||
161866594|NCT02198664|584553571|FG000|Overall Study|Not stated|1|||
161866595|NCT02198664|584553572|FG001|Overall Study|Not stated|0|||
161866596|NCT02632409|584553573|FG000|Randomized|AE unrelated to study Drug|0|||
161866597|NCT02632409|584553574|FG001|Randomized|AE unrelated to study Drug|1|||
161866598|NCT02632409|584553573|FG000|Randomized|Participant withdrew consent|2|||
161866599|NCT02632409|584553574|FG001|Randomized|Participant withdrew consent|1|||
161866600|NCT02632409|584553573|FG000|Randomized|No Longer meets study criteria|5|||
161866601|NCT02632409|584553574|FG001|Randomized|No Longer meets study criteria|0|||
161866602|NCT02632409|584553573|FG000|Randomized|other reasons|1|||
161866603|NCT02632409|584553574|FG001|Randomized|other reasons|0|||
161866604|NCT02632409|584553573|FG000|Treatment Period|Ongoing Treatment|20|||
162034940|NCT02011893|585184817|FG002|Enrollment to Randomization|Adverse Event|0|||
162034941|NCT02011893|585184815|FG000|Enrollment to Randomization|Physician Decision|10|||
162034942|NCT02011893|585184816|FG001|Enrollment to Randomization|Physician Decision|0|||
162034943|NCT02011893|585184817|FG002|Enrollment to Randomization|Physician Decision|0|||
162034944|NCT02011893|585184815|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
162034945|NCT02011893|585184816|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
162034946|NCT02011893|585184817|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
162034947|NCT02011893|585184815|FG000|Enrollment to Randomization|Screening Failure|29|||
162034948|NCT02011893|585184816|FG001|Enrollment to Randomization|Screening Failure|0|||
162034949|NCT02011893|585184817|FG002|Enrollment to Randomization|Screening Failure|0|||
162034950|NCT02011893|585184815|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
162034951|NCT02011893|585184816|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
162034952|NCT02011893|585184817|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
162034953|NCT02011893|585184815|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
162034954|NCT02011893|585184816|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
162034955|NCT02011893|585184817|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
162034956|NCT02011893|585184815|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
162034957|NCT02011893|585184816|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
162034958|NCT02011893|585184817|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
162034959|NCT02011893|585184815|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
162034960|NCT02011893|585184816|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
162034961|NCT02011893|585184817|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
162034962|NCT02011893|585184815|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
162034963|NCT02011893|585184816|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
162034964|NCT02011893|585184817|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
162034965|NCT03116347|585184819|FG000|Overall Study|Withdrawal by Subject|1|||
162034966|NCT03116347|585184820|FG001|Overall Study|Withdrawal by Subject|2|||
162034967|NCT01255787|585184821|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
162034968|NCT01255787|585184822|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
162034969|NCT01255787|585184823|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
161866605|NCT02632409|584553574|FG001|Treatment Period|Ongoing Treatment|21|||
161866606|NCT02632409|584553573|FG000|Treatment Period|Disease Recurrence|147|||
161866607|NCT02632409|584553574|FG001|Treatment Period|Disease Recurrence|90|||
161866608|NCT02632409|584553573|FG000|Treatment Period|Study Drug Toxicity|8|||
161866609|NCT02632409|584553574|FG001|Treatment Period|Study Drug Toxicity|49|||
161866610|NCT02632409|584553573|FG000|Treatment Period|Death|1|||
161866611|NCT02632409|584553574|FG001|Treatment Period|Death|0|||
161866612|NCT02632409|584553573|FG000|Treatment Period|AE unrelated to study drug|15|||
161866613|NCT02632409|584553574|FG001|Treatment Period|AE unrelated to study drug|16|||
161866614|NCT02632409|584553573|FG000|Treatment Period|Request to discontinue treatment|4|||
161866615|NCT02632409|584553574|FG001|Treatment Period|Request to discontinue treatment|19|||
161982344|NCT03464019|584984772|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
161982345|NCT03464019|584984773|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
161982346|NCT03464019|584984771|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
161982347|NCT03464019|584984772|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
161982348|NCT03464019|584984773|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
161982349|NCT03464019|584984771|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
161982350|NCT03464019|584984772|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
161982351|NCT03464019|584984773|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
161982352|NCT03464019|584984771|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
161982353|NCT03464019|584984772|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
161982354|NCT03464019|584984773|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
161982355|NCT03464019|584984771|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
161982356|NCT03464019|584984772|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
161982357|NCT03464019|584984773|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
161982358|NCT03464019|584984771|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
161982359|NCT03464019|584984772|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
161982360|NCT03464019|584984773|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
161982361|NCT03464019|584984771|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
161982362|NCT03464019|584984772|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
161982363|NCT03464019|584984773|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
161982364|NCT03464019|584984771|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
161982365|NCT03464019|584984772|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
161982366|NCT03464019|584984773|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
161982367|NCT03464019|584984771|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
161982368|NCT03464019|584984772|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
161982369|NCT03464019|584984773|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
161982370|NCT03464019|584984771|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
161982371|NCT03464019|584984772|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
161982372|NCT03464019|584984773|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
161982373|NCT03464019|584984771|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
161982374|NCT03464019|584984772|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
161866616|NCT02632409|584553573|FG000|Treatment Period|Participant withdrew consent|7|||
161866617|NCT02632409|584553574|FG001|Treatment Period|Participant withdrew consent|5|||
161866618|NCT02632409|584553573|FG000|Treatment Period|Lost to Follow-up|0|||
161866619|NCT02632409|584553574|FG001|Treatment Period|Lost to Follow-up|1|||
161866620|NCT02632409|584553573|FG000|Treatment Period|Maximum clinical benefit|1|||
161866621|NCT02632409|584553574|FG001|Treatment Period|Maximum clinical benefit|0|||
161866622|NCT02632409|584553573|FG000|Treatment Period|No longer meets study criteria|3|||
161866623|NCT02632409|584553574|FG001|Treatment Period|No longer meets study criteria|0|||
161866624|NCT02632409|584553573|FG000|Treatment Period|Administrative Reason by sponsor|0|||
161866625|NCT02632409|584553574|FG001|Treatment Period|Administrative Reason by sponsor|1|||
161866626|NCT02632409|584553573|FG000|Treatment Period|Other Reasons|10|||
161866627|NCT02632409|584553574|FG001|Treatment Period|Other Reasons|6|||
161866628|NCT01198470|584553575|FG000|Overall Study|Adverse Event|2|||
161866629|NCT01924689|584553576|FG000|Overall Study|Death|0|||
161866630|NCT01924689|584553577|FG001|Overall Study|Death|1|||
161866631|NCT01924689|584553578|FG002|Overall Study|Death|0|||
161866632|NCT01924689|584553579|FG003|Overall Study|Death|1|||
161866633|NCT01924689|584553580|FG004|Overall Study|Death|0|||
161866634|NCT01924689|584553581|FG005|Overall Study|Death|0|||
161866635|NCT01924689|584553576|FG000|Overall Study|Disease progression|0|||
161866636|NCT01924689|584553577|FG001|Overall Study|Disease progression|0|||
161866637|NCT01924689|584553578|FG002|Overall Study|Disease progression|2|||
161866638|NCT01924689|584553579|FG003|Overall Study|Disease progression|0|||
161866639|NCT01924689|584553580|FG004|Overall Study|Disease progression|3|||
161866640|NCT01924689|584553581|FG005|Overall Study|Disease progression|2|||
161866641|NCT01924689|584553576|FG000|Overall Study|New therapy or study|3|||
161866642|NCT01924689|584553577|FG001|Overall Study|New therapy or study|2|||
161866643|NCT01924689|584553578|FG002|Overall Study|New therapy or study|1|||
161866644|NCT01924689|584553579|FG003|Overall Study|New therapy or study|4|||
161982375|NCT03464019|584984773|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
161982376|NCT03464019|584984771|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
161982377|NCT03464019|584984772|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
161982378|NCT03464019|584984773|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
161866645|NCT01924689|584553580|FG004|Overall Study|New therapy or study|2|||
161866646|NCT01924689|584553581|FG005|Overall Study|New therapy or study|0|||
161866647|NCT01924689|584553576|FG000|Overall Study|Withdrawal of consent|0|||
161866648|NCT01924689|584553577|FG001|Overall Study|Withdrawal of consent|0|||
161866649|NCT01924689|584553578|FG002|Overall Study|Withdrawal of consent|1|||
161866650|NCT01924689|584553579|FG003|Overall Study|Withdrawal of consent|1|||
161866651|NCT01924689|584553580|FG004|Overall Study|Withdrawal of consent|0|||
161866652|NCT01924689|584553581|FG005|Overall Study|Withdrawal of consent|0|||
161866653|NCT01924689|584553576|FG000|Overall Study|Other|0|||
161866654|NCT01924689|584553577|FG001|Overall Study|Other|0|||
161866655|NCT01924689|584553578|FG002|Overall Study|Other|0|||
161866656|NCT01924689|584553579|FG003|Overall Study|Other|0|||
161866657|NCT01924689|584553580|FG004|Overall Study|Other|1|||
161866658|NCT01924689|584553581|FG005|Overall Study|Other|0|||
161866659|NCT05271175|584553583|FG000|One Week Follow up|Lost to Follow-up|10|||
161866660|NCT05271175|584553584|FG001|One Week Follow up|Lost to Follow-up|7|||
161866661|NCT05271175|584553585|FG002|One Week Follow up|Lost to Follow-up|5|||
161866662|NCT05271175|584553583|FG000|One Month Follow up|Lost to Follow-up|12|||
161866663|NCT05271175|584553584|FG001|One Month Follow up|Lost to Follow-up|7|||
161866664|NCT05271175|584553585|FG002|One Month Follow up|Lost to Follow-up|9|||
161866665|NCT05271175|584553583|FG000|Six Months Follow up|Lost to Follow-up|8|||
161866666|NCT05271175|584553584|FG001|Six Months Follow up|Lost to Follow-up|2|||
161866667|NCT05271175|584553585|FG002|Six Months Follow up|Lost to Follow-up|2|||
161866668|NCT02492867|584553586|FG000|Overall Study|Alternate therapy|1|||
161866669|NCT02492867|584553586|FG000|Overall Study|Withdrawal by Subject|2|||
161866670|NCT02492867|584553586|FG000|Overall Study|Disease progression after treatment started|1|||
161866671|NCT02492867|584553586|FG000|Overall Study|Death|1|||
161866672|NCT03296527|584553587|FG000|Overall Study|Adverse Event|15|||
161866673|NCT03296527|584553588|FG001|Overall Study|Adverse Event|33|||
161866674|NCT03296527|584553587|FG000|Overall Study|Protocol Deviation|4|||
161866675|NCT03296527|584553588|FG001|Overall Study|Protocol Deviation|0|||
161866676|NCT03296527|584553587|FG000|Overall Study|Participant withdrew consent|3|||
161866677|NCT03296527|584553588|FG001|Overall Study|Participant withdrew consent|1|||
161866678|NCT03296527|584553587|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
161866679|NCT03296527|584553588|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
161866680|NCT03296527|584553587|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
161866681|NCT03296527|584553588|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
161866682|NCT03296527|584553587|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
161866683|NCT03296527|584553588|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
161866684|NCT03296527|584553587|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
161866685|NCT03296527|584553588|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
161866686|NCT03296527|584553587|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
161866687|NCT03296527|584553588|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
161866688|NCT01597973|584553589|FG000|Overall Study|Found ineligible before study medication started|4|||
161866689|NCT01597973|584553590|FG001|Overall Study|Found ineligible before study medication started|2|||
161866690|NCT01597973|584553589|FG000|Overall Study|Eligible pathogen not confirmed|14|||
161866691|NCT01597973|584553590|FG001|Overall Study|Eligible pathogen not confirmed|15|||
161866692|NCT01597973|584553589|FG000|Overall Study|LAR not authorized to consent|0|||
161866693|NCT01597973|584553590|FG001|Overall Study|LAR not authorized to consent|1|||
161866694|NCT01597973|584553589|FG000|Overall Study|Ineligible due to early seizures|1|||
161866695|NCT01597973|584553590|FG001|Overall Study|Ineligible due to early seizures|0|||
161866696|NCT01597973|584553589|FG000|Overall Study|Ineligible due to non-target infection|1|||
161866697|NCT01597973|584553590|FG001|Overall Study|Ineligible due to non-target infection|1|||
161866698|NCT01326845|584553591|FG000|Overall Study|Administrative Problems|5|||
161866699|NCT01326845|584553592|FG001|Overall Study|Administrative Problems|2|||
161866700|NCT01326845|584553591|FG000|Overall Study|Adverse Event|1|||
161866701|NCT01326845|584553592|FG001|Overall Study|Adverse Event|0|||
161866702|NCT01326845|584553591|FG000|Overall Study|Misisng|1|||
161866703|NCT01326845|584553592|FG001|Overall Study|Misisng|3|||
161866704|NCT00740636|584553596|FG000|Overall Study|Adverse Event|0|||
161866705|NCT00740636|584553597|FG001|Overall Study|Adverse Event|2|||
161866706|NCT00740636|584553596|FG000|Overall Study|Patient Ineligible|0|||
161866707|NCT00740636|584553597|FG001|Overall Study|Patient Ineligible|1|||
161866708|NCT00740636|584553596|FG000|Overall Study|Patient Not Treated|0|||
161866709|NCT00740636|584553597|FG001|Overall Study|Patient Not Treated|1|||
161866710|NCT00740636|584553596|FG000|Overall Study|Progressive Disease|1|||
161866711|NCT00740636|584553597|FG001|Overall Study|Progressive Disease|0|||
161866712|NCT00740636|584553596|FG000|Overall Study|Death|1|||
161866713|NCT00740636|584553597|FG001|Overall Study|Death|0|||
161866714|NCT02174627|584553602|FG000|Overall Study|Missing|0|||
161866715|NCT02174627|584553603|FG001|Overall Study|Missing|1|||
161866716|NCT02174627|584553602|FG000|Overall Study|Incorrect enrolment before randomization|0|||
161866717|NCT02174627|584553603|FG001|Overall Study|Incorrect enrolment before randomization|1|||
161866718|NCT02174627|584553602|FG000|Overall Study|Participant decision|84|||
161866719|NCT02174627|584553603|FG001|Overall Study|Participant decision|128|||
161866720|NCT02166333|584553604|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
161866721|NCT02166333|584553605|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
161866722|NCT02166333|584553606|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
161866723|NCT02166333|584553607|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
161982379|NCT00767806|584984774|FG000|Overall Study|Adverse Event|30|||
161982380|NCT00767806|584984775|FG001|Overall Study|Adverse Event|11|||
161982381|NCT00767806|584984774|FG000|Overall Study|Withdrawal by Subject|8|||
161982382|NCT00767806|584984775|FG001|Overall Study|Withdrawal by Subject|13|||
161982383|NCT00767806|584984774|FG000|Overall Study|Protocol Violation|6|||
161982384|NCT00767806|584984775|FG001|Overall Study|Protocol Violation|5|||
161982385|NCT00767806|584984774|FG000|Overall Study|Lack of Efficacy|1|||
161982386|NCT00767806|584984775|FG001|Overall Study|Lack of Efficacy|9|||
161982387|NCT00767806|584984774|FG000|Overall Study|Physician Decision|4|||
161982388|NCT00767806|584984775|FG001|Overall Study|Physician Decision|3|||
161982389|NCT00767806|584984774|FG000|Overall Study|Lost to Follow-up|1|||
161982390|NCT00767806|584984775|FG001|Overall Study|Lost to Follow-up|4|||
161982391|NCT00767806|584984774|FG000|Overall Study|Entry Criteria Not Met|1|||
161982392|NCT00767806|584984775|FG001|Overall Study|Entry Criteria Not Met|1|||
161982393|NCT00767806|584984774|FG000|Overall Study|Sponsor Decision|0|||
161982394|NCT00767806|584984775|FG001|Overall Study|Sponsor Decision|1|||
161982395|NCT02489942|584984776|FG000|Overall Study|Request by patient|602|||
161982396|NCT02489942|584984776|FG000|Overall Study|Improvement/remission|157|||
161982397|NCT02489942|584984776|FG000|Overall Study|No change/Progressive disease|263|||
161982398|NCT02489942|584984776|FG000|Overall Study|Adverse Event|522|||
161982399|NCT02489942|584984776|FG000|Overall Study|Other personal reasons|1218|||
161982400|NCT02489942|584984776|FG000|Overall Study|Lost to Follow-up|456|||
161982401|NCT02489942|584984776|FG000|Overall Study|Not continuously investigated|7|||
161982402|NCT02489942|584984776|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
161982403|NCT02489942|584984776|FG000|Overall Study|Multiple registration|1|||
161982404|NCT02489942|584984776|FG000|Overall Study|No patient visit after entry|100|||
161982405|NCT02489942|584984776|FG000|Overall Study|No treatment with Jardiance|2|||
161982406|NCT02489942|584984776|FG000|Overall Study|Patient received Jardiance before registration|1|||
161982407|NCT02489942|584984776|FG000|Overall Study|No CRF collected|86|||
161982408|NCT00858208|584984777|FG000|Overall Study|Adverse Event|3|||
161982409|NCT00858208|584984777|FG000|Overall Study|Lost to Follow-up|26|||
161982410|NCT00858208|584984777|FG000|Overall Study|Participant refused|40|||
161982411|NCT00858208|584984777|FG000|Overall Study|Other|10|||
161982412|NCT01543776|584984778|FG000|Overall Study|Withdrawal by Subject|2|||
161982413|NCT01543776|584984779|FG001|Overall Study|Withdrawal by Subject|2|||
161982414|NCT00567359|584984780|FG000|Overall Study|Withdrawal by Subject|1|||
161982415|NCT02352753|584984781|FG000|6-Month Dosing Period|Decision by sponsor|2|||
161982416|NCT02352753|584984781|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
161982417|NCT02352753|584984781|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
161982418|NCT02352753|584984781|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
161982419|NCT02352753|584984781|FG000|3-Month Dosing Period|Decision by sponsor|14|||
161982420|NCT02352753|584984781|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
161982421|NCT00539305|584984782|FG000|Overall Study|Adverse Event|1|||
161982422|NCT00539305|584984783|FG001|Overall Study|Adverse Event|0|||
161982423|NCT00539305|584984782|FG000|Overall Study|Substance Use|0|||
161982424|NCT00539305|584984783|FG001|Overall Study|Substance Use|1|||
161982425|NCT00539305|584984782|FG000|Overall Study|Withdrawal by Subject|0|||
161982426|NCT00539305|584984783|FG001|Overall Study|Withdrawal by Subject|1|||
161982427|NCT00126776|584984785|FG000|Overall Study|follow up complete on all patients|0|||
161982428|NCT00126776|584984786|FG001|Overall Study|follow up complete on all patients|0|||
161982429|NCT00679172|584984790|FG000|Overall Study|Non-compliance|1|||
161982430|NCT00679172|584984791|FG001|Overall Study|Non-compliance|1|||
161982431|NCT00679172|584984792|FG002|Overall Study|Non-compliance|0|||
161982432|NCT00679172|584984793|FG003|Overall Study|Non-compliance|1|||
161982433|NCT00679172|584984794|FG004|Overall Study|Non-compliance|0|||
161982434|NCT00679172|584984790|FG000|Overall Study|Other not specified|0|||
161982435|NCT00679172|584984791|FG001|Overall Study|Other not specified|0|||
161982436|NCT00679172|584984792|FG002|Overall Study|Other not specified|1|||
161866724|NCT02166333|584553608|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
161866725|NCT02166333|584553609|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
161866726|NCT02166333|584553604|FG000|Stage 1|Death|4|||
161866727|NCT02166333|584553605|FG001|Stage 1|Death|0|||
161982437|NCT00679172|584984793|FG003|Overall Study|Other not specified|0|||
161982438|NCT00679172|584984794|FG004|Overall Study|Other not specified|0|||
161982439|NCT00417963|584984795|FG000|Overall Study|Lost to Follow-up|3|||
161982440|NCT00417963|584984795|FG000|Overall Study|Withdrawal by Subject|18|||
161982441|NCT00417963|584984795|FG000|Overall Study|Death|17|||
161982442|NCT00417963|584984795|FG000|Overall Study|Study device could not be deployed|3|||
161982443|NCT01815840|584984796|FG000|Overall Study|Missing|1|||
161982444|NCT01815840|584984797|FG001|Overall Study|Missing|0|||
161982445|NCT01815840|584984796|FG000|Overall Study|Withdrew Consent|31|||
161982446|NCT01815840|584984797|FG001|Overall Study|Withdrew Consent|30|||
161982447|NCT01815840|584984796|FG000|Overall Study|Administrative/Other|1|||
161982448|NCT01815840|584984797|FG001|Overall Study|Administrative/Other|3|||
161982449|NCT01815840|584984796|FG000|Overall Study|Adverse Event|10|||
161982450|NCT01815840|584984797|FG001|Overall Study|Adverse Event|16|||
161982451|NCT01815840|584984796|FG000|Overall Study|Death|2|||
161866728|NCT02166333|584553606|FG002|Stage 1|Death|2|||
161866729|NCT02166333|584553607|FG003|Stage 1|Death|0|||
161866730|NCT02166333|584553608|FG004|Stage 1|Death|3|||
161866731|NCT02166333|584553609|FG005|Stage 1|Death|2|||
161866732|NCT02166333|584553604|FG000|Stage 1|Lost to Follow-up|12|||
161866733|NCT02166333|584553605|FG001|Stage 1|Lost to Follow-up|0|||
161866734|NCT02166333|584553606|FG002|Stage 1|Lost to Follow-up|6|||
161866735|NCT02166333|584553607|FG003|Stage 1|Lost to Follow-up|0|||
161866736|NCT02166333|584553608|FG004|Stage 1|Lost to Follow-up|3|||
161866737|NCT02166333|584553609|FG005|Stage 1|Lost to Follow-up|3|||
161866738|NCT02166333|584553604|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
161866739|NCT02166333|584553605|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
161866740|NCT02166333|584553606|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
161866741|NCT02166333|584553607|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
161866742|NCT02166333|584553608|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
161866743|NCT02166333|584553609|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
161866744|NCT02166333|584553604|FG000|Stage 2|Death|4|||
161866745|NCT02166333|584553605|FG001|Stage 2|Death|2|||
161866746|NCT02166333|584553606|FG002|Stage 2|Death|1|||
161866747|NCT02166333|584553607|FG003|Stage 2|Death|0|||
161866748|NCT02166333|584553608|FG004|Stage 2|Death|0|||
161866749|NCT02166333|584553609|FG005|Stage 2|Death|1|||
161866750|NCT02166333|584553604|FG000|Stage 2|Lost to Follow-up|23|||
161866751|NCT02166333|584553605|FG001|Stage 2|Lost to Follow-up|4|||
161866752|NCT02166333|584553606|FG002|Stage 2|Lost to Follow-up|11|||
161866753|NCT02166333|584553607|FG003|Stage 2|Lost to Follow-up|9|||
161866754|NCT02166333|584553608|FG004|Stage 2|Lost to Follow-up|3|||
161866755|NCT02166333|584553609|FG005|Stage 2|Lost to Follow-up|6|||
161866756|NCT02269098|584553610|FG000|Overall Study|Lost to Follow-up|14|||
161866757|NCT02269098|584553611|FG001|Overall Study|Lost to Follow-up|9|||
161866758|NCT00503698|584553612|FG000|Overall Study|Protocol Violation|5|||
161866759|NCT00503698|584553613|FG001|Overall Study|Protocol Violation|6|||
161866760|NCT00503698|584553612|FG000|Overall Study|Adverse Event|52|||
161866761|NCT00503698|584553613|FG001|Overall Study|Adverse Event|41|||
161866762|NCT00503698|584553612|FG000|Overall Study|Death|1|||
161866763|NCT00503698|584553613|FG001|Overall Study|Death|0|||
161866764|NCT00503698|584553612|FG000|Overall Study|Lack of Efficacy|3|||
161866765|NCT00503698|584553613|FG001|Overall Study|Lack of Efficacy|4|||
161866766|NCT00503698|584553612|FG000|Overall Study|Trial terminated|216|||
161866767|NCT00503698|584553613|FG001|Overall Study|Trial terminated|253|||
161866768|NCT00503698|584553612|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
161866769|NCT00503698|584553613|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
161866770|NCT00503698|584553612|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
161866771|NCT00503698|584553613|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
161866772|NCT00503698|584553612|FG000|Overall Study|Any condition in exclusion criteria|4|||
161866773|NCT00503698|584553613|FG001|Overall Study|Any condition in exclusion criteria|6|||
161866774|NCT00503698|584553612|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
161866775|NCT00503698|584553613|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
161866776|NCT00503698|584553612|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
161866777|NCT00503698|584553613|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
161866778|NCT00503698|584553612|FG000|Overall Study|Critically ill|2|||
161866779|NCT00503698|584553613|FG001|Overall Study|Critically ill|0|||
161866780|NCT00503698|584553612|FG000|Overall Study|Unclassified|48|||
161866781|NCT00503698|584553613|FG001|Overall Study|Unclassified|32|||
161866782|NCT00503698|584553612|FG000|Overall Study|Not exposed to trial drug|11|||
161866783|NCT00503698|584553613|FG001|Overall Study|Not exposed to trial drug|6|||
161866784|NCT00682786|584553619|FG000|Overall Study|Withdrawal by Subject|2|||
161866785|NCT00682786|584553620|FG001|Overall Study|Withdrawal by Subject|2|||
161866786|NCT00682786|584553619|FG000|Overall Study|Did not receive irinotecan|0|||
161866787|NCT00682786|584553620|FG001|Overall Study|Did not receive irinotecan|1|||
161866788|NCT03644342|584553621|FG000|Overall Study|Adverse Event|2|||
161866789|NCT03644342|584553622|FG001|Overall Study|Adverse Event|0|||
161866790|NCT03644342|584553621|FG000|Overall Study|Protocol Violation|0|||
161866791|NCT03644342|584553622|FG001|Overall Study|Protocol Violation|1|||
161866792|NCT02462603|584553625|FG000|Overall Study|Investigator Decision|1|||
161866793|NCT02462603|584553625|FG000|Overall Study|Non-Compliance|1|||
161866794|NCT02462603|584553625|FG000|Overall Study|Withdrawal by Subject|2|||
161866795|NCT01591096|584553626|FG000|Overall Study|Adverse Event|1|||
161866796|NCT01831635|584553627|FG000|Overall Study|Withdrawal by Subject|0|||
161866797|NCT01831635|584553628|FG001|Overall Study|Withdrawal by Subject|2|||
161866798|NCT01831635|584553629|FG002|Overall Study|Withdrawal by Subject|0|||
161866799|NCT03655405|584553632|FG000|Overall Study|Death after initial data collection|4|||
161866800|NCT03655405|584553633|FG001|Overall Study|Death after initial data collection|2|||
161866801|NCT03655405|584553632|FG000|Overall Study|Died before initial data collection|1|||
161866802|NCT03655405|584553633|FG001|Overall Study|Died before initial data collection|2|||
161866803|NCT03655405|584553632|FG000|Overall Study|Protocol Violation|0|||
161866804|NCT03655405|584553633|FG001|Overall Study|Protocol Violation|1|||
161982452|NCT01815840|584984797|FG001|Overall Study|Death|2|||
161982453|NCT01815840|584984796|FG000|Overall Study|Disease progression|3|||
161982454|NCT01815840|584984797|FG001|Overall Study|Disease progression|2|||
161982455|NCT01815840|584984796|FG000|Overall Study|Investigators Decision|2|||
161982456|NCT01815840|584984797|FG001|Overall Study|Investigators Decision|3|||
161982457|NCT01815840|584984796|FG000|Overall Study|Lost to Follow-up|3|||
161982458|NCT01815840|584984797|FG001|Overall Study|Lost to Follow-up|6|||
161982459|NCT01815840|584984796|FG000|Overall Study|Refused Treatment|5|||
161982460|NCT01815840|584984797|FG001|Overall Study|Refused Treatment|1|||
161982461|NCT01815840|584984796|FG000|Overall Study|Sponsor Termination Treatment|1|||
161982462|NCT01815840|584984797|FG001|Overall Study|Sponsor Termination Treatment|0|||
161982463|NCT00434642|584984798|FG000|Blinded Treatment Phase|Adverse Event|12|||
161982464|NCT00434642|584984799|FG001|Blinded Treatment Phase|Adverse Event|58|||
161982465|NCT00434642|584984798|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
161982466|NCT00434642|584984799|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
161982467|NCT00434642|584984798|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
161982468|NCT00434642|584984799|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
161982469|NCT00434642|584984798|FG000|Blinded Treatment Phase|Physician Decision|19|||
161982470|NCT00434642|584984799|FG001|Blinded Treatment Phase|Physician Decision|27|||
161982471|NCT00434642|584984798|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
161982472|NCT00434642|584984799|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
161982473|NCT00434642|584984798|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
161982474|NCT00434642|584984799|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
161982475|NCT00434642|584984798|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
161982476|NCT00434642|584984799|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
161982477|NCT00434642|584984798|FG000|Open-label Treatment Phase|Adverse Event|0|||
161982478|NCT00434642|584984799|FG001|Open-label Treatment Phase|Adverse Event|5|||
161982479|NCT00434642|584984798|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
161982480|NCT00434642|584984799|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
161982481|NCT03908476|584984803|FG000|Overall Study|Death|3|||
161982482|NCT03908476|584984804|FG001|Overall Study|Death|0|||
161982483|NCT03908476|584984803|FG000|Overall Study|Lost to Follow-up|3|||
161982484|NCT03908476|584984804|FG001|Overall Study|Lost to Follow-up|1|||
161982485|NCT03908476|584984803|FG000|Overall Study|Withdrawal by Subject|7|||
161774293|NCT04668066|584216046|FG016|Part 1: Treatment Phase|Other|0|||
161774294|NCT04668066|584216047|FG017|Part 1: Treatment Phase|Other|0|||
161774295|NCT04668066|584216048|FG018|Part 1: Treatment Phase|Other|0|||
161774296|NCT04668066|584216030|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774297|NCT04668066|584216031|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774298|NCT04668066|584216032|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774299|NCT04668066|584216033|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774300|NCT04668066|584216034|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774301|NCT04668066|584216035|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774302|NCT04668066|584216036|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774303|NCT04668066|584216037|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774304|NCT04668066|584216038|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774305|NCT04668066|584216039|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774306|NCT04668066|584216040|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774307|NCT04668066|584216041|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774308|NCT04668066|584216042|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
161774309|NCT04668066|584216043|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774310|NCT04668066|584216044|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774311|NCT04668066|584216045|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
161774312|NCT04668066|584216046|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774313|NCT04668066|584216047|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774314|NCT04668066|584216048|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161774315|NCT04668066|584216030|FG000|Part 1: Follow-Up|Adverse Event|0|||
161774316|NCT04668066|584216031|FG001|Part 1: Follow-Up|Adverse Event|0|||
161774317|NCT04668066|584216032|FG002|Part 1: Follow-Up|Adverse Event|0|||
161774318|NCT04668066|584216033|FG003|Part 1: Follow-Up|Adverse Event|0|||
161774319|NCT04668066|584216034|FG004|Part 1: Follow-Up|Adverse Event|0|||
161774320|NCT04668066|584216035|FG005|Part 1: Follow-Up|Adverse Event|0|||
161774321|NCT04668066|584216036|FG006|Part 1: Follow-Up|Adverse Event|0|||
161774322|NCT04668066|584216037|FG007|Part 1: Follow-Up|Adverse Event|0|||
161774323|NCT04668066|584216038|FG008|Part 1: Follow-Up|Adverse Event|0|||
161774324|NCT04668066|584216039|FG009|Part 1: Follow-Up|Adverse Event|0|||
161774325|NCT04668066|584216040|FG010|Part 1: Follow-Up|Adverse Event|0|||
161774326|NCT04668066|584216041|FG011|Part 1: Follow-Up|Adverse Event|1|||
161774327|NCT04668066|584216042|FG012|Part 1: Follow-Up|Adverse Event|0|||
161774328|NCT04668066|584216043|FG013|Part 1: Follow-Up|Adverse Event|0|||
161774329|NCT04668066|584216044|FG014|Part 1: Follow-Up|Adverse Event|0|||
161774330|NCT04668066|584216045|FG015|Part 1: Follow-Up|Adverse Event|0|||
161774331|NCT04668066|584216046|FG016|Part 1: Follow-Up|Adverse Event|0|||
161774332|NCT04668066|584216047|FG017|Part 1: Follow-Up|Adverse Event|0|||
161982486|NCT03908476|584984804|FG001|Overall Study|Withdrawal by Subject|1|||
161982487|NCT03908476|584984803|FG000|Overall Study|Physician Decision|2|||
161982488|NCT03908476|584984804|FG001|Overall Study|Physician Decision|0|||
161982489|NCT03908476|584984803|FG000|Overall Study|System Explanted and not Replaced|4|||
161982490|NCT03908476|584984804|FG001|Overall Study|System Explanted and not Replaced|0|||
161982491|NCT03908476|584984803|FG000|Overall Study|Intrathecal Pump|1|||
161982492|NCT03908476|584984804|FG001|Overall Study|Intrathecal Pump|0|||
161982493|NCT03908476|584984803|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
161982494|NCT03908476|584984804|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
161982495|NCT05194267|584984805|FG000|Overall Study|Withdrawal by Subject|2|||
161982496|NCT02868229|584984806|FG000|Overall Study|Adverse Event|1|||
161982497|NCT02868229|584984807|FG001|Overall Study|Adverse Event|0|||
161982498|NCT02868229|584984808|FG002|Overall Study|Adverse Event|0|||
161982499|NCT02868229|584984809|FG003|Overall Study|Adverse Event|1|||
161982500|NCT02868229|584984806|FG000|Overall Study|Death|0|||
161982501|NCT02868229|584984807|FG001|Overall Study|Death|0|||
161982502|NCT02868229|584984808|FG002|Overall Study|Death|1|||
161982503|NCT02868229|584984809|FG003|Overall Study|Death|1|||
161982504|NCT02868229|584984806|FG000|Overall Study|Missed dose|0|||
161982505|NCT02868229|584984807|FG001|Overall Study|Missed dose|0|||
161982506|NCT02868229|584984808|FG002|Overall Study|Missed dose|0|||
161982507|NCT02868229|584984809|FG003|Overall Study|Missed dose|3|||
161982508|NCT06151288|584984810|FG000|Overall Study|Lost to Follow-up|4|||
161982509|NCT06151288|584984811|FG001|Overall Study|Lost to Follow-up|2|||
161982510|NCT06151288|584984812|FG002|Overall Study|Lost to Follow-up|4|||
161982511|NCT06151288|584984813|FG003|Overall Study|Lost to Follow-up|3|||
161982512|NCT06151288|584984810|FG000|Overall Study|Withdrawal by Subject|4|||
161982513|NCT06151288|584984811|FG001|Overall Study|Withdrawal by Subject|5|||
161982514|NCT06151288|584984812|FG002|Overall Study|Withdrawal by Subject|1|||
161982515|NCT06151288|584984813|FG003|Overall Study|Withdrawal by Subject|1|||
161982516|NCT00719680|584984817|FG000|Overall Study|Adverse Event|1|||
161982517|NCT00719680|584984817|FG000|Overall Study|Lost to Follow-up|1|||
161982518|NCT00719680|584984817|FG000|Overall Study|Withdrawal by Subject|3|||
161982519|NCT04071158|584984819|FG000|Overall Study|Lost to Follow-up|1|||
161982520|NCT04071158|584984820|FG001|Overall Study|Lost to Follow-up|2|||
161982521|NCT04071158|584984821|FG002|Overall Study|Lost to Follow-up|3|||
161982522|NCT04071158|584984822|FG003|Overall Study|Lost to Follow-up|3|||
161982523|NCT04071158|584984823|FG004|Overall Study|Lost to Follow-up|5|||
161982524|NCT04071158|584984819|FG000|Overall Study|Randomized but not treated|2|||
161982525|NCT04071158|584984820|FG001|Overall Study|Randomized but not treated|2|||
161982526|NCT04071158|584984821|FG002|Overall Study|Randomized but not treated|0|||
161982527|NCT04071158|584984822|FG003|Overall Study|Randomized but not treated|0|||
161982528|NCT04071158|584984823|FG004|Overall Study|Randomized but not treated|0|||
161982529|NCT01178099|584984824|FG000|Overall Study|Physician Decision|0|||
161982530|NCT01178099|584984825|FG001|Overall Study|Physician Decision|1|||
161982531|NCT02473367|584984826|FG000|Wait 1|Withdrawal by Subject|1|||
161982532|NCT02473367|584984826|FG000|Period 4|Lost to Follow-up|1|||
161982533|NCT04816721|584984829|FG000|Overall Study|Withdrawal by Subject|0|||
161982534|NCT04816721|584984830|FG001|Overall Study|Withdrawal by Subject|2|||
161982535|NCT04816721|584984831|FG002|Overall Study|Withdrawal by Subject|0|||
161982536|NCT04816721|584984832|FG003|Overall Study|Withdrawal by Subject|1|||
161982537|NCT04816721|584984833|FG004|Overall Study|Withdrawal by Subject|1|||
161982538|NCT04816721|584984834|FG005|Overall Study|Withdrawal by Subject|0|||
161982539|NCT04816721|584984835|FG006|Overall Study|Withdrawal by Subject|0|||
161982540|NCT04816721|584984836|FG007|Overall Study|Withdrawal by Subject|0|||
161982541|NCT04816721|584984829|FG000|Overall Study|Miscellaneous|0|||
161982542|NCT04816721|584984830|FG001|Overall Study|Miscellaneous|0|||
161982543|NCT04816721|584984831|FG002|Overall Study|Miscellaneous|0|||
161982544|NCT04816721|584984832|FG003|Overall Study|Miscellaneous|0|||
161982545|NCT04816721|584984833|FG004|Overall Study|Miscellaneous|0|||
162034970|NCT01255787|585184824|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
162034971|NCT01255787|585184821|FG000|Overall Study|Major Protocol Deviation|1|||
162034972|NCT01255787|585184822|FG001|Overall Study|Major Protocol Deviation|1|||
161982546|NCT04816721|584984834|FG005|Overall Study|Miscellaneous|1|||
161982547|NCT04816721|584984835|FG006|Overall Study|Miscellaneous|0|||
161982548|NCT04816721|584984836|FG007|Overall Study|Miscellaneous|0|||
161982549|NCT04816721|584984829|FG000|Overall Study|Lost to Follow-up|0|||
161982550|NCT04816721|584984830|FG001|Overall Study|Lost to Follow-up|0|||
161982551|NCT04816721|584984831|FG002|Overall Study|Lost to Follow-up|0|||
161982552|NCT04816721|584984832|FG003|Overall Study|Lost to Follow-up|1|||
161982553|NCT04816721|584984833|FG004|Overall Study|Lost to Follow-up|0|||
161982554|NCT04816721|584984834|FG005|Overall Study|Lost to Follow-up|0|||
161982555|NCT04816721|584984835|FG006|Overall Study|Lost to Follow-up|0|||
161982556|NCT04816721|584984836|FG007|Overall Study|Lost to Follow-up|0|||
161982557|NCT01646203|584984848|FG000|Overall Study|Adverse Event|2|||
162034973|NCT01255787|585184823|FG002|Overall Study|Major Protocol Deviation|0|||
161982558|NCT01646203|584984849|FG001|Overall Study|Adverse Event|0|||
161982559|NCT01646203|584984850|FG002|Overall Study|Adverse Event|1|||
161982560|NCT01646203|584984848|FG000|Overall Study|Withdrawal by Subject|0|||
161982561|NCT01646203|584984849|FG001|Overall Study|Withdrawal by Subject|1|||
161982562|NCT01646203|584984850|FG002|Overall Study|Withdrawal by Subject|0|||
161982563|NCT01646203|584984848|FG000|Overall Study|Physician's Decision|0|||
161982564|NCT01646203|584984849|FG001|Overall Study|Physician's Decision|1|||
161982565|NCT01646203|584984850|FG002|Overall Study|Physician's Decision|0|||
161982566|NCT04676867|584984851|FG000|Overall Study|Screen failure|0|||
161982567|NCT04676867|584984852|FG001|Overall Study|Screen failure|0|||
161982568|NCT04676867|584984853|FG002|Overall Study|Screen failure|6|||
161982569|NCT04676867|584984854|FG003|Overall Study|Screen failure|2|||
161982570|NCT04676867|584984851|FG000|Overall Study|Death|0|||
161982571|NCT04676867|584984852|FG001|Overall Study|Death|0|||
161982572|NCT04676867|584984853|FG002|Overall Study|Death|1|||
161982573|NCT04676867|584984854|FG003|Overall Study|Death|0|||
161982574|NCT04676867|584984851|FG000|Overall Study|Withdrawal by Subject|2|||
161982575|NCT04676867|584984852|FG001|Overall Study|Withdrawal by Subject|2|||
161982576|NCT04676867|584984853|FG002|Overall Study|Withdrawal by Subject|4|||
161982577|NCT04676867|584984854|FG003|Overall Study|Withdrawal by Subject|4|||
161982578|NCT04676867|584984851|FG000|Overall Study|Lost to Follow-up|1|||
161982579|NCT04676867|584984852|FG001|Overall Study|Lost to Follow-up|0|||
161982580|NCT04676867|584984853|FG002|Overall Study|Lost to Follow-up|0|||
161982581|NCT04676867|584984854|FG003|Overall Study|Lost to Follow-up|0|||
161982582|NCT02717130|584984858|FG000|Overall Study|Withdrawal by Subject|1|||
161982583|NCT02717130|584984858|FG000|Overall Study|Adverse Event|1|||
161982584|NCT02717130|584984858|FG000|Overall Study|Physician Decision|1|||
161982585|NCT02717130|584984858|FG000|Overall Study|Study Closure|4|||
161982586|NCT00551291|584984862|FG000|Overall Study|Physician Decision|1|||
161982587|NCT04268173|584984863|FG000|Overall Study|Lost to Follow-up|75|||
161982588|NCT04268173|584984864|FG001|Overall Study|Lost to Follow-up|108|||
161982589|NCT01375608|584984865|FG000|Overall Study|Withdrawal by Subject|2|||
161982590|NCT01953913|584984866|FG000|Overall Study|Disease Progression|349|||
161982591|NCT01953913|584984866|FG000|Overall Study|Worsening of underlying cancer|22|||
161982592|NCT01953913|584984866|FG000|Overall Study|Adverse Event|20|||
161982593|NCT01953913|584984866|FG000|Overall Study|Protocol Violation|6|||
161982594|NCT01953913|584984866|FG000|Overall Study|Lost to Follow-up|4|||
161982595|NCT01953913|584984866|FG000|Overall Study|Withdrawal by Subject|32|||
161982596|NCT01953913|584984866|FG000|Overall Study|Other than listed|108|||
161982597|NCT01953913|584984866|FG000|Overall Study|Not Treated|1|||
161982598|NCT02925741|584984867|FG000|Overall Study|Withdrawal by Subject|11|||
161982599|NCT02925741|584984868|FG001|Overall Study|Withdrawal by Subject|0|||
161982600|NCT00710385|584984869|FG000|Overall Study|Did not qualify|1|||
161982601|NCT00710385|584984869|FG000|Overall Study|Withdrawal by Subject|1|||
161982602|NCT00710385|584984869|FG000|Overall Study|Undisclosed back pain|1|||
161982603|NCT00710385|584984869|FG000|Overall Study|Physician Decision|1|||
161982604|NCT00710385|584984869|FG000|Overall Study|Undisclosed excessive methadone use|1|||
161982605|NCT01600092|584984870|FG000|Overall Study|Adverse Event|2|||
161982606|NCT01600092|584984871|FG001|Overall Study|Adverse Event|0|||
161982607|NCT01600092|584984870|FG000|Overall Study|Lost to Follow-up|4|||
161982608|NCT01600092|584984871|FG001|Overall Study|Lost to Follow-up|6|||
161982609|NCT01600092|584984870|FG000|Overall Study|Withdrawal by parent/guardian|8|||
161982610|NCT01600092|584984871|FG001|Overall Study|Withdrawal by parent/guardian|6|||
161982611|NCT01600092|584984870|FG000|Overall Study|Physician Decision|1|||
161982612|NCT01600092|584984871|FG001|Overall Study|Physician Decision|1|||
161982613|NCT01600092|584984870|FG000|Overall Study|Randomized but not vaccinated|3|||
161982614|NCT01600092|584984871|FG001|Overall Study|Randomized but not vaccinated|3|||
161982615|NCT02976103|584984872|FG000|Overall Study|Withdrawal by Subject|1|||
161982616|NCT02976103|584984873|FG001|Overall Study|Withdrawal by Subject|0|||
161982617|NCT02976103|584984872|FG000|Overall Study|Lost to Follow-up|12|||
161982618|NCT02976103|584984873|FG001|Overall Study|Lost to Follow-up|8|||
161982619|NCT00694304|584984874|FG000|Overall Study|Adverse Event|42|||
161982620|NCT00694304|584984874|FG000|Overall Study|Lack of Efficacy|35|||
161982621|NCT00694304|584984874|FG000|Overall Study|Non-compliance With Study Product|16|||
161982622|NCT00694304|584984874|FG000|Overall Study|Protocol Violation|6|||
162034974|NCT01255787|585184824|FG003|Overall Study|Major Protocol Deviation|4|||
162034975|NCT01255787|585184821|FG000|Overall Study|Lost to Follow-up|1|||
162034976|NCT01255787|585184822|FG001|Overall Study|Lost to Follow-up|2|||
162034977|NCT01255787|585184823|FG002|Overall Study|Lost to Follow-up|4|||
161982623|NCT00694304|584984874|FG000|Overall Study|Withdrawal of Consent|61|||
161982624|NCT00694304|584984874|FG000|Overall Study|Lost to Follow-up|15|||
161982625|NCT00694304|584984874|FG000|Overall Study|Administrative or Other Reasons|32|||
161982626|NCT01561963|584984875|FG000|Overall Study|Adverse Event|1|||
162034978|NCT01255787|585184824|FG003|Overall Study|Lost to Follow-up|2|||
162034979|NCT01255787|585184821|FG000|Overall Study|Withdrawal of Consent|3|||
161982627|NCT03040986|584984883|FG000|Overall Study|Hospice|1|||
161982628|NCT03040986|584984884|FG001|Overall Study|Hospice|0|||
161982629|NCT03040986|584984883|FG000|Overall Study|Adverse Event|2|||
161982630|NCT03040986|584984884|FG001|Overall Study|Adverse Event|1|||
161982631|NCT03040986|584984883|FG000|Overall Study|Disease progression on study|3|||
161982632|NCT03040986|584984884|FG001|Overall Study|Disease progression on study|1|||
161982633|NCT02228096|584984888|FG000|Overall Study|Study terminated by Sponsor|24|||
161982634|NCT02228096|584984888|FG000|Overall Study|Lack of Efficacy|18|||
161982635|NCT02228096|584984888|FG000|Overall Study|Death|12|||
161982636|NCT02228096|584984888|FG000|Overall Study|Physician Decision|3|||
161982637|NCT02228096|584984888|FG000|Overall Study|Subject/guardian decision|2|||
161982638|NCT02228096|584984888|FG000|Overall Study|New therapy for study indication|1|||
161982639|NCT02228096|584984888|FG000|Overall Study|Enrolled, not infused|11|||
161982640|NCT02102399|584984889|FG000|Overall Study|Withdrawal by Subject|6|||
161982641|NCT02102399|584984890|FG001|Overall Study|Withdrawal by Subject|4|||
161982642|NCT01624090|584984896|FG000|Overall Study|DLT, taken off therapy|0|||
161982643|NCT01624090|584984897|FG001|Overall Study|DLT, taken off therapy|1|||
161982644|NCT01624090|584984898|FG002|Overall Study|DLT, taken off therapy|0|||
161982645|NCT01624090|584984899|FG003|Overall Study|DLT, taken off therapy|0|||
161982646|NCT01624090|584984896|FG000|Overall Study|Withdrew prior to treatment|0|||
161982647|NCT01624090|584984897|FG001|Overall Study|Withdrew prior to treatment|1|||
161982648|NCT01624090|584984898|FG002|Overall Study|Withdrew prior to treatment|0|||
161982649|NCT01624090|584984899|FG003|Overall Study|Withdrew prior to treatment|0|||
161982650|NCT01624090|584984896|FG000|Overall Study|Died on study|0|||
161982651|NCT01624090|584984897|FG001|Overall Study|Died on study|0|||
161982652|NCT01624090|584984898|FG002|Overall Study|Died on study|2|||
161982653|NCT01624090|584984899|FG003|Overall Study|Died on study|0|||
161982654|NCT01624090|584984896|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
161982655|NCT01624090|584984897|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
161982656|NCT01624090|584984898|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
161982657|NCT01624090|584984899|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
161982658|NCT01624090|584984896|FG000|Overall Study|Dose escalated|0|||
161982659|NCT01624090|584984897|FG001|Overall Study|Dose escalated|0|||
161982660|NCT01624090|584984898|FG002|Overall Study|Dose escalated|3|||
161982661|NCT01624090|584984899|FG003|Overall Study|Dose escalated|0|||
161982662|NCT01403116|584984900|FG000|Overall Study|Adverse Event|7|||
161982663|NCT01403116|584984901|FG001|Overall Study|Adverse Event|4|||
161982664|NCT01403116|584984900|FG000|Overall Study|Lost to Follow-up|7|||
161982665|NCT01403116|584984901|FG001|Overall Study|Lost to Follow-up|5|||
161982666|NCT01403116|584984900|FG000|Overall Study|Withdrawal by Subject|12|||
161982667|NCT01403116|584984901|FG001|Overall Study|Withdrawal by Subject|15|||
161982668|NCT01403116|584984900|FG000|Overall Study|Non-compliance of study drug|3|||
161982669|NCT01403116|584984901|FG001|Overall Study|Non-compliance of study drug|0|||
161982670|NCT01403116|584984900|FG000|Overall Study|Protocol Violation|0|||
161982671|NCT01403116|584984901|FG001|Overall Study|Protocol Violation|1|||
161982672|NCT01403116|584984900|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
161982673|NCT01403116|584984901|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
161982674|NCT01403116|584984900|FG000|Overall Study|Hct >54%|2|||
161982675|NCT01403116|584984901|FG001|Overall Study|Hct >54%|0|||
161982676|NCT01403116|584984900|FG000|Overall Study|unable to keep appointments|0|||
161982677|NCT01403116|584984901|FG001|Overall Study|unable to keep appointments|2|||
161982678|NCT01895309|584984902|FG000|Overall Study|Adverse Event|13|||
161982679|NCT01895309|584984903|FG001|Overall Study|Adverse Event|17|||
161982680|NCT01895309|584984902|FG000|Overall Study|Protocol Violation|1|||
161982681|NCT01895309|584984903|FG001|Overall Study|Protocol Violation|0|||
161982682|NCT01895309|584984902|FG000|Overall Study|Lack of Efficacy|1|||
161982683|NCT01895309|584984903|FG001|Overall Study|Lack of Efficacy|3|||
161982684|NCT01895309|584984902|FG000|Overall Study|Lost to Follow-up|1|||
161982685|NCT01895309|584984903|FG001|Overall Study|Lost to Follow-up|3|||
161982686|NCT01895309|584984902|FG000|Overall Study|Physician Decision|15|||
161982687|NCT01895309|584984903|FG001|Overall Study|Physician Decision|10|||
161866805|NCT01991743|584553634|FG000|Overall Study|external cephalic version not performed|0|||
161866806|NCT01991743|584553635|FG001|Overall Study|external cephalic version not performed|0|||
161866807|NCT01991743|584553636|FG002|Overall Study|external cephalic version not performed|1|||
161866808|NCT01991743|584553637|FG003|Overall Study|external cephalic version not performed|0|||
161982688|NCT01895309|584984902|FG000|Overall Study|Withdrawal by Subject|9|||
161982689|NCT01895309|584984903|FG001|Overall Study|Withdrawal by Subject|18|||
161982690|NCT00042666|584984904|FG000|Overall Study|Adverse Event|2|||
161982691|NCT00042666|584984904|FG000|Overall Study|Death|4|||
161982692|NCT00042666|584984904|FG000|Overall Study|Protocol Violation|1|||
161982693|NCT00042666|584984904|FG000|Overall Study|Participant/Physician Perception|1|||
161982694|NCT00042666|584984904|FG000|Overall Study|Progressive Disease|41|||
161982695|NCT00042666|584984904|FG000|Overall Study|Other|1|||
161982696|NCT00042666|584984904|FG000|Overall Study|Other|4|||
161982697|NCT04667104|584984908|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
161982698|NCT04667104|584984909|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
161982699|NCT04667104|584984910|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
161982700|NCT01078168|584984911|FG000|Overall Study|Physician Decision|0|||
161982701|NCT01078168|584984912|FG001|Overall Study|Physician Decision|1|||
161982702|NCT05066165|584986898|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
161982703|NCT05066165|584986899|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
161982704|NCT05066165|584986898|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
161982705|NCT05066165|584986899|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
161982706|NCT03210961|584986900|FG000|Overall Study|Adverse Event|0|||
161982707|NCT03210961|584986901|FG001|Overall Study|Adverse Event|0|||
161982708|NCT03210961|584986902|FG002|Overall Study|Adverse Event|0|||
161982709|NCT03210961|584986903|FG003|Overall Study|Adverse Event|0|||
161982710|NCT03210961|584986904|FG004|Overall Study|Adverse Event|0|||
161982711|NCT03210961|584986905|FG005|Overall Study|Adverse Event|0|||
161982712|NCT03210961|584986906|FG006|Overall Study|Adverse Event|0|||
161982713|NCT03210961|584986907|FG007|Overall Study|Adverse Event|0|||
161982714|NCT03210961|584986908|FG008|Overall Study|Adverse Event|0|||
161982715|NCT03210961|584986909|FG009|Overall Study|Adverse Event|0|||
161982716|NCT03210961|584986910|FG010|Overall Study|Adverse Event|0|||
161982717|NCT03210961|584986911|FG011|Overall Study|Adverse Event|0|||
161982718|NCT03210961|584986912|FG012|Overall Study|Adverse Event|0|||
161982719|NCT03210961|584986913|FG013|Overall Study|Adverse Event|1|||
161982720|NCT03210961|584986914|FG014|Overall Study|Adverse Event|0|||
161982721|NCT03210961|584986900|FG000|Overall Study|Lost to Follow-up|0|||
161982722|NCT03210961|584986901|FG001|Overall Study|Lost to Follow-up|0|||
161982723|NCT03210961|584986902|FG002|Overall Study|Lost to Follow-up|0|||
161982724|NCT03210961|584986903|FG003|Overall Study|Lost to Follow-up|0|||
161982725|NCT03210961|584986904|FG004|Overall Study|Lost to Follow-up|0|||
161982726|NCT03210961|584986905|FG005|Overall Study|Lost to Follow-up|0|||
161982727|NCT03210961|584986906|FG006|Overall Study|Lost to Follow-up|0|||
161982728|NCT03210961|584986907|FG007|Overall Study|Lost to Follow-up|0|||
161982729|NCT03210961|584986908|FG008|Overall Study|Lost to Follow-up|0|||
161982730|NCT03210961|584986909|FG009|Overall Study|Lost to Follow-up|0|||
161982731|NCT03210961|584986910|FG010|Overall Study|Lost to Follow-up|0|||
161982732|NCT03210961|584986911|FG011|Overall Study|Lost to Follow-up|0|||
161982733|NCT03210961|584986912|FG012|Overall Study|Lost to Follow-up|0|||
161982734|NCT03210961|584986913|FG013|Overall Study|Lost to Follow-up|0|||
161982735|NCT03210961|584986914|FG014|Overall Study|Lost to Follow-up|1|||
161982736|NCT03210961|584986900|FG000|Overall Study|Withdrawal by Subject|0|||
161982737|NCT03210961|584986901|FG001|Overall Study|Withdrawal by Subject|0|||
161982738|NCT03210961|584986902|FG002|Overall Study|Withdrawal by Subject|0|||
161982739|NCT03210961|584986903|FG003|Overall Study|Withdrawal by Subject|0|||
161982740|NCT03210961|584986904|FG004|Overall Study|Withdrawal by Subject|0|||
161982741|NCT03210961|584986905|FG005|Overall Study|Withdrawal by Subject|0|||
161982742|NCT03210961|584986906|FG006|Overall Study|Withdrawal by Subject|0|||
161982743|NCT03210961|584986907|FG007|Overall Study|Withdrawal by Subject|0|||
161982744|NCT03210961|584986908|FG008|Overall Study|Withdrawal by Subject|0|||
161982745|NCT03210961|584986909|FG009|Overall Study|Withdrawal by Subject|0|||
161982746|NCT03210961|584986910|FG010|Overall Study|Withdrawal by Subject|0|||
161982747|NCT03210961|584986911|FG011|Overall Study|Withdrawal by Subject|0|||
161982748|NCT03210961|584986912|FG012|Overall Study|Withdrawal by Subject|0|||
161982749|NCT03210961|584986913|FG013|Overall Study|Withdrawal by Subject|0|||
161982750|NCT03210961|584986914|FG014|Overall Study|Withdrawal by Subject|1|||
161982751|NCT03210961|584986900|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982752|NCT03210961|584986901|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982753|NCT03210961|584986902|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982754|NCT03210961|584986903|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982755|NCT03210961|584986904|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982756|NCT03210961|584986905|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982757|NCT03210961|584986906|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982758|NCT03210961|584986907|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982759|NCT03210961|584986908|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982760|NCT03210961|584986909|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982761|NCT03210961|584986910|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982762|NCT03210961|584986911|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982763|NCT03210961|584986912|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982764|NCT03210961|584986913|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
161982765|NCT03210961|584986914|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
161982766|NCT03210961|584986900|FG000|Overall Study|Other|0|||
161982767|NCT03210961|584986901|FG001|Overall Study|Other|0|||
161982768|NCT03210961|584986902|FG002|Overall Study|Other|0|||
161982769|NCT03210961|584986903|FG003|Overall Study|Other|1|||
161982770|NCT03210961|584986904|FG004|Overall Study|Other|0|||
161982771|NCT03210961|584986905|FG005|Overall Study|Other|0|||
161982772|NCT03210961|584986906|FG006|Overall Study|Other|1|||
161982773|NCT03210961|584986907|FG007|Overall Study|Other|0|||
161982774|NCT03210961|584986908|FG008|Overall Study|Other|0|||
161982775|NCT03210961|584986909|FG009|Overall Study|Other|0|||
161982776|NCT03210961|584986910|FG010|Overall Study|Other|1|||
161982777|NCT03210961|584986911|FG011|Overall Study|Other|0|||
161982778|NCT03210961|584986912|FG012|Overall Study|Other|2|||
161982779|NCT03210961|584986913|FG013|Overall Study|Other|2|||
161982780|NCT03210961|584986914|FG014|Overall Study|Other|0|||
161982781|NCT02467582|584986915|FG000|Allocation|Withdrawal by Subject|1|||
161866809|NCT04050462|584555579|FG000|Overall Study|Withdrawal by Subject|1|||
161866810|NCT04050462|584555580|FG001|Overall Study|Withdrawal by Subject|0|||
161866811|NCT04050462|584555581|FG002|Overall Study|Withdrawal by Subject|0|||
161866812|NCT05151744|584555582|FG000|Overall Study|Adverse Event|6|||
161866813|NCT05151744|584555583|FG001|Overall Study|Adverse Event|2|||
161866814|NCT05151744|584555582|FG000|Overall Study|Death|1|||
161866815|NCT05151744|584555583|FG001|Overall Study|Death|2|||
161866816|NCT05151744|584555582|FG000|Overall Study|Lack of Efficacy|1|||
161866817|NCT05151744|584555583|FG001|Overall Study|Lack of Efficacy|1|||
161866818|NCT05151744|584555582|FG000|Overall Study|Lost to Follow-up|2|||
161866819|NCT05151744|584555583|FG001|Overall Study|Lost to Follow-up|2|||
161866820|NCT05151744|584555582|FG000|Overall Study|Need for Rescue Treatment|0|||
161866821|NCT05151744|584555583|FG001|Overall Study|Need for Rescue Treatment|1|||
161866822|NCT05151744|584555582|FG000|Overall Study|Non-compliance with Study Drug|0|||
161866823|NCT05151744|584555583|FG001|Overall Study|Non-compliance with Study Drug|1|||
161866824|NCT05151744|584555582|FG000|Overall Study|Reason not Specified|10|||
161866825|NCT05151744|584555583|FG001|Overall Study|Reason not Specified|0|||
161866826|NCT05151744|584555582|FG000|Overall Study|Physician Decision|2|||
161866827|NCT05151744|584555583|FG001|Overall Study|Physician Decision|1|||
161866828|NCT05151744|584555582|FG000|Overall Study|Protocol Violation|1|||
161866829|NCT05151744|584555583|FG001|Overall Study|Protocol Violation|0|||
161866830|NCT05151744|584555582|FG000|Overall Study|Withdrawal by Subject|6|||
161866831|NCT05151744|584555583|FG001|Overall Study|Withdrawal by Subject|3|||
161866832|NCT01682226|584555586|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
161866833|NCT01682226|584555586|FG000|Overall Study|Participants did not receive treatment|2|||
161866834|NCT01682226|584555586|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
161866835|NCT03771898|584555595|FG000|Overall Study|Adverse Event|1|||
161866836|NCT03771898|584555596|FG001|Overall Study|Adverse Event|0|||
161866837|NCT03771898|584555597|FG002|Overall Study|Adverse Event|0|||
161866838|NCT03771898|584555598|FG003|Overall Study|Adverse Event|0|||
161866839|NCT03771898|584555599|FG004|Overall Study|Adverse Event|0|||
161866840|NCT03771898|584555595|FG000|Overall Study|Lost to Follow-up|1|||
161866841|NCT03771898|584555596|FG001|Overall Study|Lost to Follow-up|1|||
161866842|NCT03771898|584555597|FG002|Overall Study|Lost to Follow-up|1|||
161866843|NCT03771898|584555598|FG003|Overall Study|Lost to Follow-up|0|||
161866844|NCT03771898|584555599|FG004|Overall Study|Lost to Follow-up|0|||
161866845|NCT03771898|584555595|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161866846|NCT03771898|584555596|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161866847|NCT03771898|584555597|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161866848|NCT03771898|584555598|FG003|Overall Study|Withdrawal by parent/guardian|0|||
161866849|NCT03771898|584555599|FG004|Overall Study|Withdrawal by parent/guardian|0|||
161866850|NCT03771898|584555595|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
161866851|NCT03771898|584555596|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
161866852|NCT03771898|584555597|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
161866853|NCT03771898|584555598|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
161866854|NCT03771898|584555599|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
161866855|NCT03123120|584555600|FG000|Overall Study|Lost to Follow-up|0|||
161866856|NCT03123120|584555601|FG001|Overall Study|Lost to Follow-up|1|||
161866857|NCT03123120|584555600|FG000|Overall Study|Withdrawal by Subject|0|||
161866858|NCT03123120|584555601|FG001|Overall Study|Withdrawal by Subject|1|||
161866859|NCT03135548|584555605|FG000|Overall Study|Lost to Follow-up|3|||
161866860|NCT03135548|584555606|FG001|Overall Study|Lost to Follow-up|0|||
161866861|NCT03135548|584555607|FG002|Overall Study|Lost to Follow-up|0|||
161866862|NCT03135548|584555605|FG000|Overall Study|Withdrawal by Subject|2|||
161866863|NCT03135548|584555606|FG001|Overall Study|Withdrawal by Subject|2|||
161866864|NCT03135548|584555607|FG002|Overall Study|Withdrawal by Subject|1|||
161866865|NCT03135548|584555605|FG000|Overall Study|Other than listed|0|||
161866866|NCT03135548|584555606|FG001|Overall Study|Other than listed|2|||
161866867|NCT03135548|584555607|FG002|Overall Study|Other than listed|2|||
161866868|NCT02632175|584555608|FG000|Overall Study|Withdrawal by Subject|6|||
161866869|NCT02632175|584555608|FG000|Overall Study|Lost to Follow-up|1|||
161866870|NCT02632175|584555608|FG000|Overall Study|Lack of Efficacy|18|||
161982782|NCT02467582|584986916|FG001|Allocation|Withdrawal by Subject|0|||
161866871|NCT02632175|584555608|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
161866872|NCT02632175|584555608|FG000|Overall Study|Subject noncompliance|3|||
161866873|NCT02632175|584555608|FG000|Overall Study|other|2|||
161866874|NCT02088554|584555609|FG000|Overall Study|Exited before procedure|130|||
161866875|NCT02088554|584555609|FG000|Overall Study|Attempted but not implanted|31|||
161866876|NCT02088554|584555609|FG000|Overall Study|Implant not attempted|19|||
161866877|NCT02088554|584555609|FG000|Overall Study|Pending next visit|532|||
161866878|NCT02088554|584555609|FG000|Overall Study|Death|170|||
161866879|NCT02088554|584555609|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
161866880|NCT02088554|584555609|FG000|Overall Study|Lost to Follow-up|23|||
161866881|NCT02088554|584555609|FG000|Overall Study|Explanted|32|||
161982783|NCT02467582|584986915|FG000|Follow-up|Death|5|||
161982784|NCT02467582|584986916|FG001|Follow-up|Death|4|||
161982785|NCT02467582|584986915|FG000|Follow-up|Lost to Follow-up|6|||
161982786|NCT02467582|584986916|FG001|Follow-up|Lost to Follow-up|5|||
161982787|NCT03343626|584986917|FG000|Overall Study|Lost to Follow-up|4|||
161982788|NCT03343626|584986918|FG001|Overall Study|Lost to Follow-up|3|||
161982789|NCT03343626|584986919|FG002|Overall Study|Lost to Follow-up|2|||
161982790|NCT03343626|584986920|FG003|Overall Study|Lost to Follow-up|5|||
161982791|NCT03343626|584986921|FG004|Overall Study|Lost to Follow-up|4|||
161982792|NCT03343626|584986922|FG005|Overall Study|Lost to Follow-up|4|||
161982793|NCT03343626|584986923|FG006|Overall Study|Lost to Follow-up|4|||
161982794|NCT03343626|584986924|FG007|Overall Study|Lost to Follow-up|7|||
161982795|NCT03343626|584986917|FG000|Overall Study|Withdrawal of Consent|2|||
161982796|NCT03343626|584986918|FG001|Overall Study|Withdrawal of Consent|1|||
161982797|NCT03343626|584986919|FG002|Overall Study|Withdrawal of Consent|0|||
161982798|NCT03343626|584986920|FG003|Overall Study|Withdrawal of Consent|3|||
161982799|NCT03343626|584986921|FG004|Overall Study|Withdrawal of Consent|3|||
161866882|NCT02088554|584555609|FG000|Overall Study|Any other reason not covered by previous categories|11|||
161866883|NCT04623216|584555610|FG000|Overall Study|Death|5|||
161866884|NCT04623216|584555611|FG001|Overall Study|Death|2|||
161866885|NCT04623216|584555612|FG002|Overall Study|Death|0|||
161866886|NCT04623216|584555613|FG003|Overall Study|Death|0|||
161866887|NCT04623216|584555610|FG000|Overall Study|Terminated by Sponsor|3|||
161866888|NCT04623216|584555611|FG001|Overall Study|Terminated by Sponsor|2|||
161866889|NCT04623216|584555612|FG002|Overall Study|Terminated by Sponsor|2|||
161866890|NCT04623216|584555613|FG003|Overall Study|Terminated by Sponsor|0|||
161866891|NCT04623216|584555610|FG000|Overall Study|Physician Decision|1|||
161866892|NCT04623216|584555611|FG001|Overall Study|Physician Decision|0|||
161866893|NCT04623216|584555612|FG002|Overall Study|Physician Decision|0|||
161866894|NCT04623216|584555613|FG003|Overall Study|Physician Decision|0|||
161866895|NCT03521154|584555616|FG000|Overall Study|Ongoing study at data cut-off|111|||
161866896|NCT03521154|584555617|FG001|Overall Study|Ongoing study at data cut-off|52|||
161866897|NCT04632927|584555618|FG000|Overall Study|Adverse Event|0|||
161866898|NCT04632927|584555619|FG001|Overall Study|Adverse Event|1|||
161866899|NCT04632927|584555618|FG000|Overall Study|Lack of Efficacy|0|||
161866900|NCT04632927|584555619|FG001|Overall Study|Lack of Efficacy|4|||
161866901|NCT04632927|584555618|FG000|Overall Study|Loss of efficacy|0|||
161866902|NCT04632927|584555619|FG001|Overall Study|Loss of efficacy|1|||
161866903|NCT04632927|584555618|FG000|Overall Study|Non-compliance with study drug|0|||
161866904|NCT04632927|584555619|FG001|Overall Study|Non-compliance with study drug|1|||
161866905|NCT04632927|584555618|FG000|Overall Study|Physician Decision|0|||
161866906|NCT04632927|584555619|FG001|Overall Study|Physician Decision|1|||
161866907|NCT04632927|584555618|FG000|Overall Study|Subject decision|0|||
161866908|NCT04632927|584555619|FG001|Overall Study|Subject decision|1|||
161866909|NCT04632927|584555618|FG000|Overall Study|Withdrawal by Subject|0|||
161866910|NCT04632927|584555619|FG001|Overall Study|Withdrawal by Subject|1|||
161866911|NCT03827291|584555620|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
161866912|NCT03827291|584555621|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
161866913|NCT04795466|584555622|FG000|Overall Study|Adverse Event|3|||
161866914|NCT04795466|584555623|FG001|Overall Study|Adverse Event|1|||
161866915|NCT04795466|584555622|FG000|Overall Study|Physician Decision|1|||
161866916|NCT04795466|584555623|FG001|Overall Study|Physician Decision|0|||
161866917|NCT04795466|584555622|FG000|Overall Study|Withdrawal by Subject|2|||
161866918|NCT04795466|584555623|FG001|Overall Study|Withdrawal by Subject|1|||
161866919|NCT04066244|584555635|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
161866920|NCT04066244|584555636|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
161866921|NCT04066244|584555637|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
161866922|NCT04066244|584555638|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
161866923|NCT04066244|584555639|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
161982800|NCT03343626|584986922|FG005|Overall Study|Withdrawal of Consent|1|||
161982801|NCT03343626|584986923|FG006|Overall Study|Withdrawal of Consent|1|||
161982802|NCT03343626|584986924|FG007|Overall Study|Withdrawal of Consent|2|||
162034980|NCT01255787|585184822|FG001|Overall Study|Withdrawal of Consent|9|||
161866924|NCT04066244|584555640|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
161982803|NCT03343626|584986917|FG000|Overall Study|Reason not Specified|0|||
161982804|NCT03343626|584986918|FG001|Overall Study|Reason not Specified|1|||
161982805|NCT03343626|584986919|FG002|Overall Study|Reason not Specified|0|||
161982806|NCT03343626|584986920|FG003|Overall Study|Reason not Specified|0|||
161866925|NCT04066244|584555635|FG000|Part 2 (Cohort 5)|Death|0|||
161866926|NCT04066244|584555636|FG001|Part 2 (Cohort 5)|Death|0|||
161866927|NCT04066244|584555637|FG002|Part 2 (Cohort 5)|Death|0|||
161866928|NCT04066244|584555638|FG003|Part 2 (Cohort 5)|Death|0|||
161866929|NCT04066244|584555639|FG004|Part 2 (Cohort 5)|Death|0|||
161866930|NCT04066244|584555640|FG005|Part 2 (Cohort 5)|Death|2|||
161866931|NCT04066244|584555635|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161866932|NCT04066244|584555636|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161982807|NCT03343626|584986921|FG004|Overall Study|Reason not Specified|0|||
161982808|NCT03343626|584986922|FG005|Overall Study|Reason not Specified|0|||
161982809|NCT03343626|584986923|FG006|Overall Study|Reason not Specified|0|||
161982810|NCT03343626|584986924|FG007|Overall Study|Reason not Specified|1|||
161982811|NCT03343626|584986917|FG000|Overall Study|Data Entry Error|0|||
161982812|NCT03343626|584986918|FG001|Overall Study|Data Entry Error|0|||
161982813|NCT03343626|584986919|FG002|Overall Study|Data Entry Error|0|||
161982814|NCT03343626|584986920|FG003|Overall Study|Data Entry Error|0|||
161982815|NCT03343626|584986921|FG004|Overall Study|Data Entry Error|0|||
161982816|NCT03343626|584986922|FG005|Overall Study|Data Entry Error|0|||
161982817|NCT03343626|584986923|FG006|Overall Study|Data Entry Error|0|||
161982818|NCT03343626|584986924|FG007|Overall Study|Data Entry Error|1|||
161982819|NCT00742417|584986929|FG000|Randomized|Withdrawal by legal representative|0|||
161982820|NCT00742417|584986930|FG001|Randomized|Withdrawal by legal representative|1|||
161982821|NCT00742417|584986929|FG000|Randomized|Withdrawal by Subject|1|||
161982822|NCT00742417|584986930|FG001|Randomized|Withdrawal by Subject|0|||
161982823|NCT00742417|584986929|FG000|Randomized|Physician Decision|1|||
161982824|NCT00742417|584986930|FG001|Randomized|Physician Decision|0|||
161982825|NCT00742417|584986929|FG000|Intensive Period|Withdrawal by Subject|1|||
161982826|NCT00742417|584986930|FG001|Intensive Period|Withdrawal by Subject|1|||
161982827|NCT00742417|584986929|FG000|Intensive Period|Adverse Event|2|||
161982828|NCT00742417|584986930|FG001|Intensive Period|Adverse Event|0|||
161982829|NCT00965575|584986935|FG000|Overall Study|subject unwillingness to swallow study c|1|||
161982830|NCT00965575|584986936|FG001|Overall Study|subject unwillingness to swallow study c|0|||
161982831|NCT01041287|584986939|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
161982832|NCT01041287|584986940|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
161982833|NCT01041287|584986939|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
161982834|NCT01041287|584986940|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
161982835|NCT02397057|584986941|FG000|Overall Study|Withdrawal by Subject|6|||
161982836|NCT02397057|584986942|FG001|Overall Study|Withdrawal by Subject|7|||
161982837|NCT02397057|584986941|FG000|Overall Study|Lost to Follow-up|4|||
161982838|NCT02397057|584986942|FG001|Overall Study|Lost to Follow-up|3|||
161982839|NCT02397057|584986941|FG000|Overall Study|Death|1|||
161982840|NCT02397057|584986942|FG001|Overall Study|Death|0|||
161982841|NCT02397057|584986941|FG000|Overall Study|Adverse Event|0|||
161982842|NCT02397057|584986942|FG001|Overall Study|Adverse Event|1|||
161982843|NCT02397057|584986941|FG000|Overall Study|Physician Decision|0|||
161982844|NCT02397057|584986942|FG001|Overall Study|Physician Decision|1|||
161982845|NCT02397057|584986941|FG000|Overall Study|Subject did not receive study drug|0|||
161982846|NCT02397057|584986942|FG001|Overall Study|Subject did not receive study drug|1|||
161982847|NCT00704288|584986944|FG000|Overall Treatment Period|Adverse Event|11|||
161982848|NCT00704288|584986945|FG001|Overall Treatment Period|Adverse Event|8|||
161982849|NCT00704288|584986946|FG002|Overall Treatment Period|Adverse Event|22|||
161982850|NCT00704288|584986944|FG000|Overall Treatment Period|Death|0|||
161982851|NCT00704288|584986945|FG001|Overall Treatment Period|Death|0|||
161982852|NCT00704288|584986946|FG002|Overall Treatment Period|Death|1|||
161982853|NCT00704288|584986944|FG000|Overall Treatment Period|Physician Decision|0|||
161982854|NCT00704288|584986945|FG001|Overall Treatment Period|Physician Decision|2|||
161982855|NCT00704288|584986946|FG002|Overall Treatment Period|Physician Decision|0|||
161982856|NCT00704288|584986944|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
161982857|NCT00704288|584986945|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
161982858|NCT00704288|584986946|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
161982859|NCT00704288|584986944|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
161982860|NCT00704288|584986945|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
161982861|NCT00704288|584986946|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
161982862|NCT00704288|584986944|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
161982863|NCT00704288|584986945|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
161982864|NCT00704288|584986946|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
161982865|NCT00704288|584986944|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
161982866|NCT00704288|584986945|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
161982867|NCT00704288|584986946|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
161982868|NCT00704288|584986944|FG000|Overall Treatment Period|Roll-over to another study|1|||
161982869|NCT00704288|584986945|FG001|Overall Treatment Period|Roll-over to another study|0|||
161982870|NCT00704288|584986946|FG002|Overall Treatment Period|Roll-over to another study|4|||
161982871|NCT00704288|584986944|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
161982872|NCT00704288|584986945|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
161982873|NCT00704288|584986946|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
161982874|NCT00704288|584986944|FG000|Extended Post Treatment Follow Up Period|Death|41|||
161982875|NCT00704288|584986945|FG001|Extended Post Treatment Follow Up Period|Death|50|||
161982876|NCT00704288|584986946|FG002|Extended Post Treatment Follow Up Period|Death|93|||
161982877|NCT00704288|584986944|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
161982878|NCT00704288|584986945|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
161982879|NCT00704288|584986946|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
161982880|NCT00704288|584986944|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
161982881|NCT00704288|584986945|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
161982882|NCT00704288|584986946|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
161982883|NCT00704288|584986944|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
161866933|NCT04066244|584555637|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161866934|NCT04066244|584555638|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161866935|NCT04066244|584555639|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161866936|NCT04066244|584555640|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
161866937|NCT04066244|584555635|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161866938|NCT04066244|584555636|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161866939|NCT04066244|584555637|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161866940|NCT04066244|584555638|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161866941|NCT04066244|584555639|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
161866942|NCT04066244|584555640|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161866943|NCT00866281|584555641|FG000|Overall Study|Adverse Event|1|||
161866944|NCT00866281|584555642|FG001|Overall Study|Adverse Event|0|||
161866945|NCT00866281|584555641|FG000|Overall Study|Withdrawal by participants|3|||
161866946|NCT00866281|584555642|FG001|Overall Study|Withdrawal by participants|0|||
161866947|NCT00866281|584555641|FG000|Overall Study|Disease progression|3|||
161866948|NCT00866281|584555642|FG001|Overall Study|Disease progression|11|||
161866949|NCT00866281|584555641|FG000|Overall Study|New cancer therapy|0|||
161866950|NCT00866281|584555642|FG001|Overall Study|New cancer therapy|4|||
161866951|NCT00529087|584555645|FG000|Overall Study|Adverse Event|10|||
161866952|NCT00529087|584555646|FG001|Overall Study|Adverse Event|13|||
161866953|NCT00529087|584555647|FG002|Overall Study|Adverse Event|4|||
161866954|NCT00529087|584555645|FG000|Overall Study|Lost to Follow-up|6|||
161866955|NCT00529087|584555646|FG001|Overall Study|Lost to Follow-up|4|||
161866956|NCT00529087|584555647|FG002|Overall Study|Lost to Follow-up|1|||
161866957|NCT00529087|584555645|FG000|Overall Study|Protocol Violation|8|||
161866958|NCT00529087|584555646|FG001|Overall Study|Protocol Violation|7|||
161866959|NCT00529087|584555647|FG002|Overall Study|Protocol Violation|6|||
161866960|NCT00529087|584555645|FG000|Overall Study|Withdrawal by Subject|3|||
161866961|NCT00529087|584555646|FG001|Overall Study|Withdrawal by Subject|3|||
161866962|NCT00529087|584555647|FG002|Overall Study|Withdrawal by Subject|3|||
161866963|NCT00529087|584555645|FG000|Overall Study|Protocol deviation|1|||
161866964|NCT00529087|584555646|FG001|Overall Study|Protocol deviation|1|||
161866965|NCT00529087|584555647|FG002|Overall Study|Protocol deviation|2|||
161866966|NCT02955355|584555653|FG000|Overall Study|Adverse Event|4|||
161866967|NCT02955355|584555653|FG000|Overall Study|Death|1|||
161866968|NCT02955355|584555653|FG000|Overall Study|Physician Decision|21|||
161866969|NCT02955355|584555653|FG000|Overall Study|Site Terminated by Sponsor|35|||
161866970|NCT02955355|584555653|FG000|Overall Study|Withdrawal by Subject|19|||
161866971|NCT02955355|584555653|FG000|Overall Study|Reason Not Specified|5|||
161866972|NCT02612623|584555654|FG000|Overall Study|Withdrawal by Subject|0|||
161866973|NCT02612623|584555655|FG001|Overall Study|Withdrawal by Subject|1|||
161866974|NCT02612623|584555656|FG002|Overall Study|Withdrawal by Subject|0|||
161866975|NCT02612623|584555657|FG003|Overall Study|Withdrawal by Subject|0|||
161866976|NCT02612623|584555654|FG000|Overall Study|Adverse Event|1|||
161866977|NCT02612623|584555655|FG001|Overall Study|Adverse Event|0|||
161866978|NCT02612623|584555656|FG002|Overall Study|Adverse Event|1|||
161866979|NCT02612623|584555657|FG003|Overall Study|Adverse Event|0|||
161866980|NCT03168711|584555659|FG000|Overall Study|Adverse Event|2|||
161866981|NCT03168711|584555660|FG001|Overall Study|Adverse Event|0|||
161866982|NCT03168711|584555659|FG000|Overall Study|Withdrawal by Subject|0|||
161866983|NCT03168711|584555660|FG001|Overall Study|Withdrawal by Subject|1|||
161866984|NCT03168711|584555659|FG000|Overall Study|Death|0|||
161866985|NCT03168711|584555660|FG001|Overall Study|Death|1|||
161982884|NCT00704288|584986945|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
161982885|NCT00704288|584986946|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
161982886|NCT01055314|584986947|FG000|Overall Study|Adverse Event|7|||
161866986|NCT01671007|584555665|FG000|Overall Study|Other reasons than listed|166|||
161866987|NCT01671007|584555666|FG001|Overall Study|Other reasons than listed|373|||
161866988|NCT01671007|584555667|FG002|Overall Study|Other reasons than listed|197|||
161866989|NCT01671007|584555668|FG003|Overall Study|Other reasons than listed|228|||
161866990|NCT01671007|584555669|FG004|Overall Study|Other reasons than listed|14|||
161866991|NCT01671007|584555670|FG005|Overall Study|Other reasons than listed|71|||
161866992|NCT01671007|584555671|FG006|Overall Study|Other reasons than listed|17|||
161866993|NCT01671007|584555672|FG007|Overall Study|Other reasons than listed|66|||
161866994|NCT01671007|584555673|FG008|Overall Study|Other reasons than listed|0|||
161866995|NCT01671007|584555665|FG000|Overall Study|Withdrawal by Subject|36|||
161866996|NCT01671007|584555666|FG001|Overall Study|Withdrawal by Subject|59|||
161866997|NCT01671007|584555667|FG002|Overall Study|Withdrawal by Subject|53|||
161866998|NCT01671007|584555668|FG003|Overall Study|Withdrawal by Subject|58|||
161866999|NCT01671007|584555669|FG004|Overall Study|Withdrawal by Subject|4|||
161867000|NCT01671007|584555670|FG005|Overall Study|Withdrawal by Subject|15|||
161982887|NCT01055314|584986948|FG001|Overall Study|Adverse Event|4|||
161867001|NCT01671007|584555671|FG006|Overall Study|Withdrawal by Subject|1|||
161867002|NCT01671007|584555672|FG007|Overall Study|Withdrawal by Subject|19|||
161867003|NCT01671007|584555673|FG008|Overall Study|Withdrawal by Subject|0|||
161867004|NCT01671007|584555665|FG000|Overall Study|Lost to Follow-up|93|||
161867005|NCT01671007|584555666|FG001|Overall Study|Lost to Follow-up|142|||
161867006|NCT01671007|584555667|FG002|Overall Study|Lost to Follow-up|91|||
161867007|NCT01671007|584555668|FG003|Overall Study|Lost to Follow-up|63|||
161867008|NCT01671007|584555669|FG004|Overall Study|Lost to Follow-up|7|||
161867009|NCT01671007|584555670|FG005|Overall Study|Lost to Follow-up|20|||
161867010|NCT01671007|584555671|FG006|Overall Study|Lost to Follow-up|2|||
161867011|NCT01671007|584555672|FG007|Overall Study|Lost to Follow-up|28|||
161867012|NCT01671007|584555673|FG008|Overall Study|Lost to Follow-up|0|||
161867013|NCT01671007|584555665|FG000|Overall Study|No end of study case report form|3|||
161867014|NCT01671007|584555666|FG001|Overall Study|No end of study case report form|1|||
161867015|NCT01671007|584555667|FG002|Overall Study|No end of study case report form|0|||
161867016|NCT01671007|584555668|FG003|Overall Study|No end of study case report form|2|||
161867017|NCT01671007|584555669|FG004|Overall Study|No end of study case report form|0|||
161867018|NCT01671007|584555670|FG005|Overall Study|No end of study case report form|0|||
161867019|NCT01671007|584555671|FG006|Overall Study|No end of study case report form|0|||
161867020|NCT01671007|584555672|FG007|Overall Study|No end of study case report form|0|||
161867021|NCT01671007|584555673|FG008|Overall Study|No end of study case report form|0|||
161867022|NCT01671007|584555665|FG000|Overall Study|Not eligible|23|||
161867023|NCT01671007|584555666|FG001|Overall Study|Not eligible|76|||
161867024|NCT01671007|584555667|FG002|Overall Study|Not eligible|25|||
161867025|NCT01671007|584555668|FG003|Overall Study|Not eligible|17|||
161867026|NCT01671007|584555669|FG004|Overall Study|Not eligible|0|||
161867027|NCT01671007|584555670|FG005|Overall Study|Not eligible|6|||
161867028|NCT01671007|584555671|FG006|Overall Study|Not eligible|1|||
161867029|NCT01671007|584555672|FG007|Overall Study|Not eligible|19|||
161867030|NCT01671007|584555673|FG008|Overall Study|Not eligible|0|||
161867031|NCT03877068|584555674|FG000|Overall Study|Physician Decision|9|||
161867032|NCT03877068|584555675|FG001|Overall Study|Physician Decision|3|||
161867033|NCT00449865|584555676|FG000|Overall Study|Withdrawal by Subject|110|||
161867034|NCT00449865|584555677|FG001|Overall Study|Withdrawal by Subject|110|||
161867035|NCT00449865|584555676|FG000|Overall Study|Lost to Follow-up|36|||
161867036|NCT00449865|584555677|FG001|Overall Study|Lost to Follow-up|37|||
161867037|NCT00449865|584555676|FG000|Overall Study|Physician Decision|13|||
161867038|NCT00449865|584555677|FG001|Overall Study|Physician Decision|12|||
161867039|NCT00449865|584555676|FG000|Overall Study|Death|31|||
161867040|NCT00449865|584555677|FG001|Overall Study|Death|40|||
161867041|NCT00449865|584555676|FG000|Overall Study|Protocol Violation|8|||
161867042|NCT00449865|584555677|FG001|Overall Study|Protocol Violation|7|||
161867043|NCT00449865|584555676|FG000|Overall Study|Study was stopped|324|||
161867044|NCT00449865|584555677|FG001|Overall Study|Study was stopped|328|||
161867045|NCT00406367|584555678|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
161867046|NCT00406367|584555679|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
161867047|NCT00406367|584555678|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
161867048|NCT00406367|584555679|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
161867049|NCT00406367|584555678|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
161867050|NCT00406367|584555679|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
161867051|NCT00406367|584555678|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
161867052|NCT00406367|584555679|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
161867053|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
161867054|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
161867055|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
161867056|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
161867057|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
161867058|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
161867059|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
161867060|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
161982888|NCT01055314|584986947|FG000|Overall Study|Death|2|||
161982889|NCT01055314|584986948|FG001|Overall Study|Death|1|||
161982890|NCT01055314|584986947|FG000|Overall Study|Lack of Efficacy|11|||
161867061|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
161867062|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
161867063|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
161867064|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
161867065|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
161982891|NCT01055314|584986948|FG001|Overall Study|Lack of Efficacy|19|||
161867066|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
161867067|NCT00406367|584555678|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
161867068|NCT00406367|584555679|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
161982892|NCT01055314|584986947|FG000|Overall Study|Physician Decision|10|||
161774333|NCT04668066|584216048|FG018|Part 1: Follow-Up|Adverse Event|0|||
161774334|NCT04668066|584216030|FG000|Part 1: Follow-Up|Other|0|||
161774335|NCT04668066|584216031|FG001|Part 1: Follow-Up|Other|0|||
161774336|NCT04668066|584216032|FG002|Part 1: Follow-Up|Other|0|||
161774337|NCT04668066|584216033|FG003|Part 1: Follow-Up|Other|0|||
161774338|NCT04668066|584216034|FG004|Part 1: Follow-Up|Other|0|||
161774339|NCT04668066|584216035|FG005|Part 1: Follow-Up|Other|0|||
161774340|NCT04668066|584216036|FG006|Part 1: Follow-Up|Other|0|||
161774341|NCT04668066|584216037|FG007|Part 1: Follow-Up|Other|0|||
161774342|NCT04668066|584216038|FG008|Part 1: Follow-Up|Other|0|||
161774343|NCT04668066|584216039|FG009|Part 1: Follow-Up|Other|0|||
161774344|NCT04668066|584216040|FG010|Part 1: Follow-Up|Other|0|||
161774345|NCT04668066|584216041|FG011|Part 1: Follow-Up|Other|1|||
161774346|NCT04668066|584216042|FG012|Part 1: Follow-Up|Other|1|||
161774347|NCT04668066|584216043|FG013|Part 1: Follow-Up|Other|0|||
161774348|NCT04668066|584216044|FG014|Part 1: Follow-Up|Other|0|||
161774349|NCT04668066|584216045|FG015|Part 1: Follow-Up|Other|0|||
161774350|NCT04668066|584216046|FG016|Part 1: Follow-Up|Other|0|||
161774351|NCT04668066|584216047|FG017|Part 1: Follow-Up|Other|0|||
161774352|NCT04668066|584216048|FG018|Part 1: Follow-Up|Other|0|||
161774353|NCT04668066|584216030|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774354|NCT04668066|584216031|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774355|NCT04668066|584216032|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774356|NCT04668066|584216033|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774357|NCT04668066|584216034|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774358|NCT04668066|584216035|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774359|NCT04668066|584216036|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774360|NCT04668066|584216037|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774361|NCT04668066|584216038|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774362|NCT04668066|584216039|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774363|NCT04668066|584216040|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774364|NCT04668066|584216041|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774365|NCT04668066|584216042|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
161774366|NCT04668066|584216043|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774367|NCT04668066|584216044|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774368|NCT04668066|584216045|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
161774369|NCT04668066|584216046|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774370|NCT04668066|584216047|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774371|NCT04668066|584216048|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
161774372|NCT04668066|584216030|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774373|NCT04668066|584216031|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774374|NCT04668066|584216032|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774375|NCT04668066|584216033|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774376|NCT04668066|584216034|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774377|NCT04668066|584216035|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774378|NCT04668066|584216036|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774379|NCT04668066|584216037|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774380|NCT04668066|584216038|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774381|NCT04668066|584216039|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774382|NCT04668066|584216040|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774383|NCT04668066|584216041|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774384|NCT04668066|584216042|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774385|NCT04668066|584216043|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774386|NCT04668066|584216044|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774387|NCT04668066|584216045|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774388|NCT04668066|584216046|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774389|NCT04668066|584216047|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161774390|NCT04668066|584216048|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
161774391|NCT04668066|584216030|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774392|NCT04668066|584216031|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774393|NCT04668066|584216032|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774394|NCT04668066|584216033|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774395|NCT04668066|584216034|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774396|NCT04668066|584216035|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774397|NCT04668066|584216036|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774398|NCT04668066|584216037|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774399|NCT04668066|584216038|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774400|NCT04668066|584216039|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774401|NCT04668066|584216040|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774402|NCT04668066|584216041|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774403|NCT04668066|584216042|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774404|NCT04668066|584216043|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774405|NCT04668066|584216044|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774406|NCT04668066|584216045|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774407|NCT04668066|584216046|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774408|NCT04668066|584216047|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
161774409|NCT04668066|584216048|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
161867069|NCT03252535|584555680|FG000|Overall Study|Withdrawal by Subject|1|||
161867070|NCT03252535|584555681|FG001|Overall Study|Withdrawal by Subject|0|||
161867071|NCT03252535|584555682|FG002|Overall Study|Withdrawal by Subject|0|||
161867072|NCT03252535|584555680|FG000|Overall Study|Physician Decision|0|||
161867073|NCT03252535|584555681|FG001|Overall Study|Physician Decision|1|||
161867074|NCT03252535|584555682|FG002|Overall Study|Physician Decision|0|||
161867075|NCT03252535|584555680|FG000|Overall Study|Met discontinuation criteria|0|||
161867076|NCT03252535|584555681|FG001|Overall Study|Met discontinuation criteria|1|||
161867077|NCT03252535|584555682|FG002|Overall Study|Met discontinuation criteria|0|||
161867078|NCT04426006|584555683|FG000|Inclusion|Protocol Violation|1|||
161867079|NCT04426006|584555683|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
161867080|NCT04426006|584555683|FG000|Inclusion|Blood sample at inclusion not done|1|||
161867081|NCT04426006|584555683|FG000|3 Months|Lost to Follow-up|17|||
161867082|NCT04426006|584555683|FG000|12 Months|Lost to Follow-up|38|||
161867083|NCT01262872|584555686|FG000|Step 2|Death|0|||
161867084|NCT01262872|584555687|FG001|Step 2|Death|0|||
161867085|NCT01262872|584555688|FG002|Step 2|Death|0|||
161867086|NCT01262872|584555689|FG003|Step 2|Death|1|||
161867087|NCT01262872|584555690|FG004|Step 2|Death|0|||
161867088|NCT01262872|584555691|FG005|Step 2|Death|2|||
161867089|NCT01262872|584555692|FG006|Step 2|Death|2|||
161867090|NCT01262872|584555693|FG007|Step 2|Death|1|||
161867091|NCT01262872|584555686|FG000|Step 2|Protocol Violation|0|||
161867092|NCT01262872|584555687|FG001|Step 2|Protocol Violation|0|||
161867093|NCT01262872|584555688|FG002|Step 2|Protocol Violation|1|||
161867094|NCT01262872|584555689|FG003|Step 2|Protocol Violation|0|||
161867095|NCT01262872|584555690|FG004|Step 2|Protocol Violation|0|||
161867096|NCT01262872|584555691|FG005|Step 2|Protocol Violation|0|||
161867097|NCT01262872|584555692|FG006|Step 2|Protocol Violation|3|||
161867098|NCT01262872|584555693|FG007|Step 2|Protocol Violation|1|||
161867099|NCT01262872|584555686|FG000|Step 2|Withdrawal by Subject|0|||
161867100|NCT01262872|584555687|FG001|Step 2|Withdrawal by Subject|0|||
161867101|NCT01262872|584555688|FG002|Step 2|Withdrawal by Subject|4|||
161867102|NCT01262872|584555689|FG003|Step 2|Withdrawal by Subject|6|||
161867103|NCT01262872|584555690|FG004|Step 2|Withdrawal by Subject|3|||
161867104|NCT01262872|584555691|FG005|Step 2|Withdrawal by Subject|1|||
161867105|NCT01262872|584555692|FG006|Step 2|Withdrawal by Subject|2|||
161867106|NCT01262872|584555693|FG007|Step 2|Withdrawal by Subject|1|||
161867107|NCT01262872|584555686|FG000|Step 2|Migrated/moved from study area|0|||
161867108|NCT01262872|584555687|FG001|Step 2|Migrated/moved from study area|0|||
161867109|NCT01262872|584555688|FG002|Step 2|Migrated/moved from study area|4|||
161867110|NCT01262872|584555689|FG003|Step 2|Migrated/moved from study area|3|||
161867111|NCT01262872|584555690|FG004|Step 2|Migrated/moved from study area|2|||
161867112|NCT01262872|584555691|FG005|Step 2|Migrated/moved from study area|6|||
161867113|NCT01262872|584555692|FG006|Step 2|Migrated/moved from study area|2|||
161867114|NCT01262872|584555693|FG007|Step 2|Migrated/moved from study area|3|||
161867115|NCT01000155|584555696|FG000|Overall Study|Withdrawal by Subject|1|||
161867116|NCT01000155|584555696|FG000|Overall Study|Adverse Event|1|||
161867117|NCT00720213|584555699|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
161867118|NCT00720213|584555700|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
161867119|NCT00720213|584555701|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
161867120|NCT01808066|584555705|FG000|Overall Study|Withdrawal by Subject|15|||
161867121|NCT02949973|584555710|FG000|Overall Study|Physician Decision|1|||
161867122|NCT01252095|584555711|FG000|Overall Study|Disease progression|1|||
161867123|NCT01252095|584555712|FG001|Overall Study|Disease progression|0|||
161867124|NCT01420068|584555713|FG000|Overall Study|Administrative problems|1|||
161982893|NCT01055314|584986948|FG001|Overall Study|Physician Decision|5|||
161982894|NCT01055314|584986947|FG000|Overall Study|Withdrawal by Subject|1|||
161982895|NCT01055314|584986948|FG001|Overall Study|Withdrawal by Subject|0|||
161982896|NCT01055314|584986947|FG000|Overall Study|Ineligible|3|||
161982897|NCT01055314|584986948|FG001|Overall Study|Ineligible|5|||
161982898|NCT01055314|584986947|FG000|Overall Study|Refusal of further protocol therapy|10|||
161982899|NCT01055314|584986948|FG001|Overall Study|Refusal of further protocol therapy|4|||
161867125|NCT01420068|584555714|FG001|Overall Study|Administrative problems|3|||
161867126|NCT01420068|584555713|FG000|Overall Study|Withdrawal by Subject|1|||
161867127|NCT01420068|584555714|FG001|Overall Study|Withdrawal by Subject|2|||
161867128|NCT00365794|584555715|FG000|Overall Study|Withdrawal by Subject|2|||
161867129|NCT00586703|584555716|FG000|Overall Study|Death|12|||
161982900|NCT01055314|584986947|FG000|Overall Study|No treatment|1|||
161867130|NCT04760626|584555717|FG000|Overall Study|Withdrawal by Subject|24|||
161867131|NCT04760626|584555718|FG001|Overall Study|Withdrawal by Subject|20|||
161867132|NCT04760626|584555717|FG000|Overall Study|Lost to Follow-up|14|||
161867133|NCT04760626|584555718|FG001|Overall Study|Lost to Follow-up|19|||
161867134|NCT04760626|584555717|FG000|Overall Study|Physician Decision|3|||
161867135|NCT04760626|584555718|FG001|Overall Study|Physician Decision|5|||
161867136|NCT04760626|584555717|FG000|Overall Study|Death|3|||
161867137|NCT04760626|584555718|FG001|Overall Study|Death|6|||
161867138|NCT04760626|584555717|FG000|Overall Study|Site closure|1|||
161867139|NCT04760626|584555718|FG001|Overall Study|Site closure|0|||
161982901|NCT01055314|584986948|FG001|Overall Study|No treatment|0|||
161867140|NCT02554682|584555721|FG000|Overall Study|Lost to Follow-up|11|||
161867141|NCT02554682|584555722|FG001|Overall Study|Lost to Follow-up|9|||
161867142|NCT02554682|584555723|FG002|Overall Study|Lost to Follow-up|4|||
161867143|NCT02554682|584555724|FG003|Overall Study|Lost to Follow-up|3|||
161867144|NCT02554682|584555725|FG004|Overall Study|Lost to Follow-up|2|||
161867145|NCT02554682|584555726|FG005|Overall Study|Lost to Follow-up|1|||
161867146|NCT02554682|584555727|FG006|Overall Study|Lost to Follow-up|6|||
161867147|NCT02554682|584555728|FG007|Overall Study|Lost to Follow-up|6|||
161867148|NCT02554682|584555729|FG008|Overall Study|Lost to Follow-up|2|||
161867149|NCT02554682|584555730|FG009|Overall Study|Lost to Follow-up|2|||
161867150|NCT02554682|584555721|FG000|Overall Study|Withdrawal by Subject|2|||
161867151|NCT02554682|584555722|FG001|Overall Study|Withdrawal by Subject|1|||
161867152|NCT02554682|584555723|FG002|Overall Study|Withdrawal by Subject|0|||
161867153|NCT02554682|584555724|FG003|Overall Study|Withdrawal by Subject|0|||
161867154|NCT02554682|584555725|FG004|Overall Study|Withdrawal by Subject|0|||
161867155|NCT02554682|584555726|FG005|Overall Study|Withdrawal by Subject|0|||
161867156|NCT02554682|584555727|FG006|Overall Study|Withdrawal by Subject|0|||
161867157|NCT02554682|584555728|FG007|Overall Study|Withdrawal by Subject|0|||
161867158|NCT02554682|584555729|FG008|Overall Study|Withdrawal by Subject|0|||
161867159|NCT02554682|584555730|FG009|Overall Study|Withdrawal by Subject|0|||
161867160|NCT02554682|584555721|FG000|Overall Study|Physician Decision|2|||
161867161|NCT02554682|584555722|FG001|Overall Study|Physician Decision|2|||
161867162|NCT02554682|584555723|FG002|Overall Study|Physician Decision|0|||
161867163|NCT02554682|584555724|FG003|Overall Study|Physician Decision|0|||
161867164|NCT02554682|584555725|FG004|Overall Study|Physician Decision|0|||
161867165|NCT02554682|584555726|FG005|Overall Study|Physician Decision|0|||
161867166|NCT02554682|584555727|FG006|Overall Study|Physician Decision|0|||
161867167|NCT02554682|584555728|FG007|Overall Study|Physician Decision|0|||
161867168|NCT02554682|584555729|FG008|Overall Study|Physician Decision|0|||
161867169|NCT02554682|584555730|FG009|Overall Study|Physician Decision|0|||
161867170|NCT00884117|584555733|FG000|Overall Study|Adverse Event|2|||
161867171|NCT00884117|584555733|FG000|Overall Study|Withdrawal by Subject|89|||
161867172|NCT00884117|584555733|FG000|Overall Study|Death|3|||
161867173|NCT00884117|584555733|FG000|Overall Study|Lost to Follow-up|143|||
161867174|NCT00884117|584555733|FG000|Overall Study|Other|12|||
161867175|NCT02946463|584555734|FG000|Primary Evaluation Period|Physician Decision|0|||
161867176|NCT02946463|584555735|FG001|Primary Evaluation Period|Physician Decision|1|||
161867177|NCT02946463|584555736|FG002|Primary Evaluation Period|Physician Decision|0|||
161867178|NCT02946463|584555737|FG003|Primary Evaluation Period|Physician Decision|0|||
161867179|NCT02946463|584555734|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
161867180|NCT02946463|584555735|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
161867181|NCT02946463|584555736|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
161867182|NCT02946463|584555737|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
161867183|NCT02946463|584555734|FG000|Extension Period|Death|4|||
161867184|NCT02946463|584555735|FG001|Extension Period|Death|4|||
161867185|NCT02946463|584555736|FG002|Extension Period|Death|0|||
161867186|NCT02946463|584555737|FG003|Extension Period|Death|0|||
161867187|NCT02946463|584555734|FG000|Extension Period|Withdrawal by Subject|4|||
161867188|NCT02946463|584555735|FG001|Extension Period|Withdrawal by Subject|3|||
161867189|NCT02946463|584555736|FG002|Extension Period|Withdrawal by Subject|0|||
161867190|NCT02946463|584555737|FG003|Extension Period|Withdrawal by Subject|0|||
161867191|NCT02946463|584555734|FG000|Extension Period|Other than specified|2|||
161867192|NCT02946463|584555735|FG001|Extension Period|Other than specified|3|||
161867193|NCT02946463|584555736|FG002|Extension Period|Other than specified|2|||
161867194|NCT02946463|584555737|FG003|Extension Period|Other than specified|0|||
161867195|NCT02946463|584555734|FG000|Extension Period|Physician Decision|1|||
161867196|NCT02946463|584555735|FG001|Extension Period|Physician Decision|4|||
161867197|NCT02946463|584555736|FG002|Extension Period|Physician Decision|0|||
161867198|NCT02946463|584555737|FG003|Extension Period|Physician Decision|0|||
161867199|NCT02946463|584555734|FG000|Extension Period|Pregnancy|3|||
161867200|NCT02946463|584555735|FG001|Extension Period|Pregnancy|1|||
161867201|NCT02946463|584555736|FG002|Extension Period|Pregnancy|0|||
161982902|NCT04395690|584986949|FG000|Overall Study|Lost to Follow-up|1|||
161982903|NCT04395690|584986950|FG001|Overall Study|Lost to Follow-up|1|||
161982904|NCT03927144|584986951|FG000|Core Phase|Adverse Event|9|||
161867202|NCT02946463|584555737|FG003|Extension Period|Pregnancy|0|||
161867203|NCT02946463|584555734|FG000|Extension Period|Adverse Event|1|||
161867204|NCT02946463|584555735|FG001|Extension Period|Adverse Event|2|||
161867205|NCT02946463|584555736|FG002|Extension Period|Adverse Event|0|||
161867206|NCT02946463|584555737|FG003|Extension Period|Adverse Event|0|||
161867207|NCT02946463|584555734|FG000|Extension Period|Lost to Follow-up|1|||
161867208|NCT02946463|584555735|FG001|Extension Period|Lost to Follow-up|0|||
161867209|NCT02946463|584555736|FG002|Extension Period|Lost to Follow-up|0|||
161867210|NCT02946463|584555737|FG003|Extension Period|Lost to Follow-up|0|||
161867211|NCT02022202|584555738|FG000|Overall Study|Withdrawal by Subject|2|||
161867212|NCT02022202|584555738|FG000|Overall Study|Disease Progression|3|||
161867213|NCT02022202|584555738|FG000|Overall Study|Desire go to immediately to surgery|3|||
161982905|NCT03927144|584986952|FG001|Core Phase|Adverse Event|5|||
161867214|NCT01565889|584555740|FG000|Part A|Withdrawal by Subject|1|||
161867215|NCT01565889|584555741|FG001|Part A|Withdrawal by Subject|0|||
161867216|NCT01565889|584555742|FG002|Part A|Withdrawal by Subject|0|||
161867217|NCT01565889|584555743|FG003|Part A|Withdrawal by Subject|0|||
161867218|NCT01565889|584555744|FG004|Part A|Withdrawal by Subject|0|||
161867219|NCT01565889|584555745|FG005|Part A|Withdrawal by Subject|0|||
161867220|NCT01565889|584555740|FG000|Part B|Withdrawal by Subject|0|||
161867221|NCT01565889|584555741|FG001|Part B|Withdrawal by Subject|0|||
161867222|NCT01565889|584555742|FG002|Part B|Withdrawal by Subject|0|||
161867223|NCT01565889|584555743|FG003|Part B|Withdrawal by Subject|0|||
161867224|NCT01565889|584555744|FG004|Part B|Withdrawal by Subject|0|||
161867225|NCT01565889|584555745|FG005|Part B|Withdrawal by Subject|1|||
161867226|NCT01565889|584555740|FG000|Part B|Lack of Efficacy|0|||
161867227|NCT01565889|584555741|FG001|Part B|Lack of Efficacy|0|||
161867228|NCT01565889|584555742|FG002|Part B|Lack of Efficacy|0|||
161867229|NCT01565889|584555743|FG003|Part B|Lack of Efficacy|0|||
161867230|NCT01565889|584555744|FG004|Part B|Lack of Efficacy|0|||
161867231|NCT01565889|584555745|FG005|Part B|Lack of Efficacy|2|||
161867232|NCT01565889|584555740|FG000|Part B|Lost to Follow-up|0|||
161867233|NCT01565889|584555741|FG001|Part B|Lost to Follow-up|0|||
161867234|NCT01565889|584555742|FG002|Part B|Lost to Follow-up|0|||
161867235|NCT01565889|584555743|FG003|Part B|Lost to Follow-up|0|||
161867236|NCT01565889|584555744|FG004|Part B|Lost to Follow-up|0|||
161867237|NCT01565889|584555745|FG005|Part B|Lost to Follow-up|1|||
161867238|NCT00122382|584555746|FG000|Double-Blind Study|Adverse Event|9|||
161867239|NCT00122382|584555747|FG001|Double-Blind Study|Adverse Event|11|||
161867240|NCT00122382|584555748|FG002|Double-Blind Study|Adverse Event|0|||
161867241|NCT00122382|584555746|FG000|Double-Blind Study|Death|2|||
161867242|NCT00122382|584555747|FG001|Double-Blind Study|Death|2|||
161867243|NCT00122382|584555748|FG002|Double-Blind Study|Death|0|||
161867244|NCT00122382|584555746|FG000|Double-Blind Study|Lack of Efficacy|0|||
161867245|NCT00122382|584555747|FG001|Double-Blind Study|Lack of Efficacy|8|||
161867246|NCT00122382|584555748|FG002|Double-Blind Study|Lack of Efficacy|0|||
161867247|NCT00122382|584555746|FG000|Double-Blind Study|Lost to Follow-up|2|||
161867248|NCT00122382|584555747|FG001|Double-Blind Study|Lost to Follow-up|1|||
161867249|NCT00122382|584555748|FG002|Double-Blind Study|Lost to Follow-up|0|||
161867250|NCT00122382|584555746|FG000|Double-Blind Study|Pregnancy|2|||
161867251|NCT00122382|584555747|FG001|Double-Blind Study|Pregnancy|0|||
161867252|NCT00122382|584555748|FG002|Double-Blind Study|Pregnancy|0|||
161867253|NCT00122382|584555746|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
161867254|NCT00122382|584555747|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
161867255|NCT00122382|584555748|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
161867256|NCT00122382|584555746|FG000|Double-Blind Study|Withdrawal of Consent|7|||
161867257|NCT00122382|584555747|FG001|Double-Blind Study|Withdrawal of Consent|3|||
161867258|NCT00122382|584555748|FG002|Double-Blind Study|Withdrawal of Consent|0|||
161867259|NCT00122382|584555746|FG000|Double-Blind Study|Protocol Violation|1|||
161867260|NCT00122382|584555747|FG001|Double-Blind Study|Protocol Violation|0|||
161867261|NCT00122382|584555748|FG002|Double-Blind Study|Protocol Violation|0|||
161867262|NCT00122382|584555746|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
161867263|NCT00122382|584555747|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
161867264|NCT00122382|584555748|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
161867265|NCT00122382|584555746|FG000|Double-Blind Study|Randomized but not treated|0|||
161867266|NCT00122382|584555747|FG001|Double-Blind Study|Randomized but not treated|2|||
161867267|NCT00122382|584555748|FG002|Double-Blind Study|Randomized but not treated|0|||
161867268|NCT00122382|584555746|FG000|Open-Label Study|Adverse Event|0|||
161867269|NCT00122382|584555747|FG001|Open-Label Study|Adverse Event|0|||
161867270|NCT00122382|584555748|FG002|Open-Label Study|Adverse Event|11|||
161867271|NCT00122382|584555746|FG000|Open-Label Study|Death|0|||
161867272|NCT00122382|584555747|FG001|Open-Label Study|Death|0|||
161867273|NCT00122382|584555748|FG002|Open-Label Study|Death|2|||
161867274|NCT00122382|584555746|FG000|Open-Label Study|Lack of Efficacy|0|||
161867275|NCT00122382|584555747|FG001|Open-Label Study|Lack of Efficacy|0|||
161867276|NCT00122382|584555748|FG002|Open-Label Study|Lack of Efficacy|3|||
161867277|NCT00122382|584555746|FG000|Open-Label Study|Lost to Follow-up|0|||
161982906|NCT03927144|584986951|FG000|Core Phase|Lost to Follow-up|3|||
161982907|NCT03927144|584986952|FG001|Core Phase|Lost to Follow-up|2|||
161867278|NCT00122382|584555747|FG001|Open-Label Study|Lost to Follow-up|0|||
161867279|NCT00122382|584555748|FG002|Open-Label Study|Lost to Follow-up|3|||
161867280|NCT00122382|584555746|FG000|Open-Label Study|Pregnancy|0|||
161867281|NCT00122382|584555747|FG001|Open-Label Study|Pregnancy|0|||
161867282|NCT00122382|584555748|FG002|Open-Label Study|Pregnancy|2|||
161867283|NCT00122382|584555746|FG000|Open-Label Study|Poor/Non-Compliance|0|||
161867284|NCT00122382|584555747|FG001|Open-Label Study|Poor/Non-Compliance|0|||
161867285|NCT00122382|584555748|FG002|Open-Label Study|Poor/Non-Compliance|1|||
161867286|NCT00122382|584555746|FG000|Open-Label Study|Withdrawal of Consent|0|||
161867287|NCT00122382|584555747|FG001|Open-Label Study|Withdrawal of Consent|0|||
161867288|NCT00122382|584555748|FG002|Open-Label Study|Withdrawal of Consent|4|||
161867289|NCT02040805|584555749|FG000|Overall Study|Lost to Follow-up|14|||
161867290|NCT02040805|584555750|FG001|Overall Study|Lost to Follow-up|9|||
161867291|NCT02040805|584555749|FG000|Overall Study|Withdrawal by Subject|28|||
161867292|NCT02040805|584555750|FG001|Overall Study|Withdrawal by Subject|41|||
161867293|NCT00908544|584555751|FG000|Overall Study|Withdrawal by Subject|2|||
161867294|NCT00908544|584555752|FG001|Overall Study|Withdrawal by Subject|4|||
161867295|NCT00908544|584555751|FG000|Overall Study|Lack of Efficacy|0|||
161867296|NCT00908544|584555752|FG001|Overall Study|Lack of Efficacy|1|||
161867297|NCT00908544|584555751|FG000|Overall Study|Pregnancy|1|||
161867298|NCT00908544|584555752|FG001|Overall Study|Pregnancy|0|||
161867299|NCT00908544|584555751|FG000|Overall Study|Relocation abroad|1|||
161867300|NCT00908544|584555752|FG001|Overall Study|Relocation abroad|1|||
161867301|NCT00908544|584555751|FG000|Overall Study|Unable to visit sutdy center|1|||
161867302|NCT00908544|584555752|FG001|Overall Study|Unable to visit sutdy center|0|||
161867303|NCT02259010|584555753|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
161867304|NCT01662492|584555754|FG000|Overall Study|Other miscellaneous reasons.|1|||
161867305|NCT01662492|584555755|FG001|Overall Study|Other miscellaneous reasons.|0|||
161867306|NCT01662492|584555756|FG002|Overall Study|Other miscellaneous reasons.|1|||
161867307|NCT01662492|584555754|FG000|Overall Study|Withdrawal by Subject|0|||
161867308|NCT01662492|584555755|FG001|Overall Study|Withdrawal by Subject|0|||
161867309|NCT01662492|584555756|FG002|Overall Study|Withdrawal by Subject|1|||
161867310|NCT01662492|584555754|FG000|Overall Study|Protocol Violation|1|||
161867311|NCT01662492|584555755|FG001|Overall Study|Protocol Violation|0|||
161867312|NCT01662492|584555756|FG002|Overall Study|Protocol Violation|0|||
161867313|NCT01662492|584555754|FG000|Overall Study|Lost to Follow-up|0|||
161867314|NCT01662492|584555755|FG001|Overall Study|Lost to Follow-up|0|||
161867315|NCT01662492|584555756|FG002|Overall Study|Lost to Follow-up|2|||
161867316|NCT01662492|584555754|FG000|Overall Study|Lack of Efficacy|1|||
161867317|NCT01662492|584555755|FG001|Overall Study|Lack of Efficacy|1|||
161867318|NCT01662492|584555756|FG002|Overall Study|Lack of Efficacy|2|||
161867319|NCT02859337|584555758|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
161867320|NCT02859337|584555759|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
161867321|NCT02859337|584555760|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
161867322|NCT02859337|584555758|FG000|Overall Study|Withdrawal by Subject|3|||
161982908|NCT03927144|584986951|FG000|Core Phase|New Therapy for Study Indication|0|||
161982909|NCT03927144|584986952|FG001|Core Phase|New Therapy for Study Indication|1|||
161982910|NCT03927144|584986951|FG000|Core Phase|No Longer Clinically Benefiting|4|||
161982911|NCT03927144|584986952|FG001|Core Phase|No Longer Clinically Benefiting|4|||
161982912|NCT03927144|584986951|FG000|Core Phase|Physician Decision|2|||
161982913|NCT03927144|584986952|FG001|Core Phase|Physician Decision|8|||
161982914|NCT03927144|584986951|FG000|Core Phase|Protocol Violation|2|||
161982915|NCT03927144|584986952|FG001|Core Phase|Protocol Violation|2|||
161982916|NCT03927144|584986951|FG000|Core Phase|Withdrawal by Subject|16|||
161982917|NCT03927144|584986952|FG001|Core Phase|Withdrawal by Subject|40|||
161982918|NCT03927144|584986951|FG000|Extension Phase|Adverse Event|2|||
161982919|NCT03927144|584986952|FG001|Extension Phase|Adverse Event|1|||
161982920|NCT03927144|584986951|FG000|Extension Phase|No longer clinically benefiting|4|||
161982921|NCT03927144|584986952|FG001|Extension Phase|No longer clinically benefiting|5|||
161982922|NCT03927144|584986951|FG000|Extension Phase|Pregnancy|1|||
161982923|NCT03927144|584986952|FG001|Extension Phase|Pregnancy|0|||
161982924|NCT03927144|584986951|FG000|Extension Phase|Protocol Violation|0|||
161982925|NCT03927144|584986952|FG001|Extension Phase|Protocol Violation|1|||
161982926|NCT03927144|584986951|FG000|Extension Phase|Withdrawal by Subject|8|||
161982927|NCT03927144|584986952|FG001|Extension Phase|Withdrawal by Subject|3|||
161982928|NCT03909152|584986953|FG000|Overall Study|Adverse Event|14|||
161982929|NCT03909152|584986954|FG001|Overall Study|Adverse Event|5|||
161982930|NCT03909152|584986955|FG002|Overall Study|Adverse Event|1|||
162034981|NCT01255787|585184823|FG002|Overall Study|Withdrawal of Consent|3|||
162034982|NCT01255787|585184824|FG003|Overall Study|Withdrawal of Consent|4|||
161867323|NCT02859337|584555759|FG001|Overall Study|Withdrawal by Subject|1|||
161867324|NCT02859337|584555760|FG002|Overall Study|Withdrawal by Subject|0|||
161867325|NCT02859337|584555758|FG000|Overall Study|Lost to Follow-up|1|||
161867326|NCT02859337|584555759|FG001|Overall Study|Lost to Follow-up|0|||
161867327|NCT02859337|584555760|FG002|Overall Study|Lost to Follow-up|0|||
161982931|NCT03909152|584986956|FG003|Overall Study|Adverse Event|14|||
162034983|NCT01255787|585184821|FG000|Overall Study|Pregnancy|0|||
162034984|NCT01255787|585184822|FG001|Overall Study|Pregnancy|0|||
162034985|NCT01255787|585184823|FG002|Overall Study|Pregnancy|0|||
161867328|NCT00848718|584555761|FG000|Overall Study|Adverse Event|2|||
161867329|NCT00848718|584555762|FG001|Overall Study|Adverse Event|2|||
161982932|NCT00615030|584986959|FG000|Period I|Administrative problem|0|||
161982933|NCT00615030|584986960|FG001|Period I|Administrative problem|0|||
162034986|NCT01255787|585184824|FG003|Overall Study|Pregnancy|1|||
161867330|NCT00848718|584555763|FG002|Overall Study|Adverse Event|1|||
161867331|NCT00848718|584555764|FG003|Overall Study|Adverse Event|1|||
161867332|NCT00848718|584555765|FG004|Overall Study|Adverse Event|1|||
161982934|NCT00615030|584986961|FG002|Period I|Administrative problem|0|||
161982935|NCT00615030|584986962|FG003|Period I|Administrative problem|0|||
161982936|NCT00615030|584986963|FG004|Period I|Administrative problem|1|||
161982937|NCT00615030|584986964|FG005|Period I|Administrative problem|0|||
161982938|NCT00615030|584986965|FG006|Period I|Administrative problem|0|||
161982939|NCT00615030|584986966|FG007|Period I|Administrative problem|0|||
161982940|NCT00615030|584986967|FG008|Period I|Administrative problem|0|||
161982941|NCT00615030|584986968|FG009|Period I|Administrative problem|0|||
161982942|NCT00615030|584986969|FG010|Period I|Administrative problem|0|||
161982943|NCT00615030|584986970|FG011|Period I|Administrative problem|0|||
161982944|NCT00615030|584986959|FG000|Period I|Protocol deviation|1|||
162034987|NCT01255787|585184821|FG000|Overall Study|Lack of Efficacy|2|||
161982945|NCT00615030|584986960|FG001|Period I|Protocol deviation|0|||
161982946|NCT00615030|584986961|FG002|Period I|Protocol deviation|0|||
161982947|NCT00615030|584986962|FG003|Period I|Protocol deviation|0|||
161982948|NCT00615030|584986963|FG004|Period I|Protocol deviation|0|||
162034988|NCT01255787|585184822|FG001|Overall Study|Lack of Efficacy|2|||
162034989|NCT01255787|585184823|FG002|Overall Study|Lack of Efficacy|2|||
162034990|NCT01255787|585184824|FG003|Overall Study|Lack of Efficacy|2|||
162034991|NCT01255787|585184821|FG000|Overall Study|Noncompliance with Study Drug|3|||
162034992|NCT01255787|585184822|FG001|Overall Study|Noncompliance with Study Drug|1|||
162034993|NCT01255787|585184823|FG002|Overall Study|Noncompliance with Study Drug|0|||
162034994|NCT01255787|585184824|FG003|Overall Study|Noncompliance with Study Drug|0|||
161774410|NCT04668066|584216030|FG000|Part 2: Treatment Phase|Other|0|||
161774411|NCT04668066|584216031|FG001|Part 2: Treatment Phase|Other|0|||
161774412|NCT04668066|584216032|FG002|Part 2: Treatment Phase|Other|0|||
161774413|NCT04668066|584216033|FG003|Part 2: Treatment Phase|Other|0|||
161774414|NCT04668066|584216034|FG004|Part 2: Treatment Phase|Other|0|||
161774415|NCT04668066|584216035|FG005|Part 2: Treatment Phase|Other|0|||
161774416|NCT04668066|584216036|FG006|Part 2: Treatment Phase|Other|0|||
161774417|NCT04668066|584216037|FG007|Part 2: Treatment Phase|Other|0|||
161774418|NCT04668066|584216038|FG008|Part 2: Treatment Phase|Other|0|||
161774419|NCT04668066|584216039|FG009|Part 2: Treatment Phase|Other|0|||
161774420|NCT04668066|584216040|FG010|Part 2: Treatment Phase|Other|0|||
161774421|NCT04668066|584216041|FG011|Part 2: Treatment Phase|Other|0|||
161774422|NCT04668066|584216042|FG012|Part 2: Treatment Phase|Other|0|||
161774423|NCT04668066|584216043|FG013|Part 2: Treatment Phase|Other|0|||
161774424|NCT04668066|584216044|FG014|Part 2: Treatment Phase|Other|0|||
161774425|NCT04668066|584216045|FG015|Part 2: Treatment Phase|Other|0|||
161774426|NCT04668066|584216046|FG016|Part 2: Treatment Phase|Other|0|||
161774427|NCT04668066|584216047|FG017|Part 2: Treatment Phase|Other|0|||
161774428|NCT04668066|584216048|FG018|Part 2: Treatment Phase|Other|1|||
161774429|NCT04668066|584216030|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774430|NCT04668066|584216031|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774431|NCT04668066|584216032|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774432|NCT04668066|584216033|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774433|NCT04668066|584216034|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774434|NCT04668066|584216035|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774435|NCT04668066|584216036|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774436|NCT04668066|584216037|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774437|NCT04668066|584216038|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774438|NCT04668066|584216039|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774439|NCT04668066|584216040|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774440|NCT04668066|584216041|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774441|NCT04668066|584216042|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774442|NCT04668066|584216043|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774443|NCT04668066|584216044|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774444|NCT04668066|584216045|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774445|NCT04668066|584216046|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774446|NCT04668066|584216047|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
161774447|NCT04668066|584216048|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
161774448|NCT02060188|584216049|FG000|Overall Study|Disease Progression|36|||
161774449|NCT02060188|584216050|FG001|Overall Study|Disease Progression|42|||
161774450|NCT02060188|584216051|FG002|Overall Study|Disease Progression|8|||
161774451|NCT02060188|584216052|FG003|Overall Study|Disease Progression|5|||
161774452|NCT02060188|584216053|FG004|Overall Study|Disease Progression|6|||
161774453|NCT02060188|584216054|FG005|Overall Study|Disease Progression|3|||
161774454|NCT02060188|584216055|FG006|Overall Study|Disease Progression|23|||
161774455|NCT02060188|584216056|FG007|Overall Study|Disease Progression|20|||
161774456|NCT02060188|584216057|FG008|Overall Study|Disease Progression|43|||
161774457|NCT02060188|584216049|FG000|Overall Study|Study Drug Toxicity|10|||
161774458|NCT02060188|584216050|FG001|Overall Study|Study Drug Toxicity|18|||
161774459|NCT02060188|584216051|FG002|Overall Study|Study Drug Toxicity|7|||
161774460|NCT02060188|584216052|FG003|Overall Study|Study Drug Toxicity|4|||
161774461|NCT02060188|584216053|FG004|Overall Study|Study Drug Toxicity|3|||
161774462|NCT02060188|584216054|FG005|Overall Study|Study Drug Toxicity|0|||
161774463|NCT02060188|584216055|FG006|Overall Study|Study Drug Toxicity|2|||
161774464|NCT02060188|584216056|FG007|Overall Study|Study Drug Toxicity|5|||
161774465|NCT02060188|584216057|FG008|Overall Study|Study Drug Toxicity|0|||
161774466|NCT02060188|584216049|FG000|Overall Study|Adverse event unrelated to study drug|2|||
161867333|NCT00848718|584555766|FG005|Overall Study|Adverse Event|0|||
161867334|NCT00848718|584555767|FG006|Overall Study|Adverse Event|0|||
161867335|NCT00848718|584555768|FG007|Overall Study|Adverse Event|1|||
161867336|NCT00848718|584555769|FG008|Overall Study|Adverse Event|1|||
161867337|NCT00848718|584555770|FG009|Overall Study|Adverse Event|0|||
161867338|NCT00848718|584555771|FG010|Overall Study|Adverse Event|0|||
161867339|NCT00848718|584555772|FG011|Overall Study|Adverse Event|0|||
161867340|NCT00848718|584555773|FG012|Overall Study|Adverse Event|2|||
161867341|NCT00848718|584555761|FG000|Overall Study|Lack of Efficacy|0|||
161867342|NCT00848718|584555762|FG001|Overall Study|Lack of Efficacy|0|||
161867343|NCT00848718|584555763|FG002|Overall Study|Lack of Efficacy|1|||
161867344|NCT00848718|584555764|FG003|Overall Study|Lack of Efficacy|0|||
161867345|NCT00848718|584555765|FG004|Overall Study|Lack of Efficacy|0|||
161867346|NCT00848718|584555766|FG005|Overall Study|Lack of Efficacy|0|||
161867347|NCT00848718|584555767|FG006|Overall Study|Lack of Efficacy|1|||
161867348|NCT00848718|584555768|FG007|Overall Study|Lack of Efficacy|0|||
161867349|NCT00848718|584555769|FG008|Overall Study|Lack of Efficacy|0|||
161867350|NCT00848718|584555770|FG009|Overall Study|Lack of Efficacy|0|||
161867351|NCT00848718|584555771|FG010|Overall Study|Lack of Efficacy|0|||
161867352|NCT00848718|584555772|FG011|Overall Study|Lack of Efficacy|0|||
161867353|NCT00848718|584555773|FG012|Overall Study|Lack of Efficacy|0|||
161867354|NCT00848718|584555761|FG000|Overall Study|Physician Decision|0|||
161867355|NCT00848718|584555762|FG001|Overall Study|Physician Decision|1|||
161867356|NCT00848718|584555763|FG002|Overall Study|Physician Decision|0|||
161867357|NCT00848718|584555764|FG003|Overall Study|Physician Decision|0|||
161867358|NCT00848718|584555765|FG004|Overall Study|Physician Decision|1|||
161867359|NCT00848718|584555766|FG005|Overall Study|Physician Decision|1|||
161867360|NCT00848718|584555767|FG006|Overall Study|Physician Decision|0|||
161867361|NCT00848718|584555768|FG007|Overall Study|Physician Decision|0|||
161867362|NCT00848718|584555769|FG008|Overall Study|Physician Decision|1|||
161867363|NCT00848718|584555770|FG009|Overall Study|Physician Decision|2|||
161867364|NCT00848718|584555771|FG010|Overall Study|Physician Decision|0|||
161867365|NCT00848718|584555772|FG011|Overall Study|Physician Decision|0|||
161867366|NCT00848718|584555773|FG012|Overall Study|Physician Decision|1|||
161867367|NCT00848718|584555761|FG000|Overall Study|Progressive disease before treatment|1|||
161867368|NCT00848718|584555762|FG001|Overall Study|Progressive disease before treatment|5|||
161867369|NCT00848718|584555763|FG002|Overall Study|Progressive disease before treatment|1|||
161867370|NCT00848718|584555764|FG003|Overall Study|Progressive disease before treatment|3|||
161867371|NCT00848718|584555765|FG004|Overall Study|Progressive disease before treatment|4|||
161867372|NCT00848718|584555766|FG005|Overall Study|Progressive disease before treatment|4|||
161867373|NCT00848718|584555767|FG006|Overall Study|Progressive disease before treatment|2|||
161867374|NCT00848718|584555768|FG007|Overall Study|Progressive disease before treatment|1|||
161867375|NCT00848718|584555769|FG008|Overall Study|Progressive disease before treatment|2|||
161867376|NCT00848718|584555770|FG009|Overall Study|Progressive disease before treatment|7|||
161867377|NCT00848718|584555771|FG010|Overall Study|Progressive disease before treatment|3|||
161867378|NCT00848718|584555772|FG011|Overall Study|Progressive disease before treatment|6|||
161867379|NCT00848718|584555773|FG012|Overall Study|Progressive disease before treatment|2|||
161867380|NCT00848718|584555761|FG000|Overall Study|Protocol Violation|0|||
161867381|NCT00848718|584555762|FG001|Overall Study|Protocol Violation|1|||
161867382|NCT00848718|584555763|FG002|Overall Study|Protocol Violation|0|||
161867383|NCT00848718|584555764|FG003|Overall Study|Protocol Violation|0|||
161867384|NCT00848718|584555765|FG004|Overall Study|Protocol Violation|0|||
161867385|NCT00848718|584555766|FG005|Overall Study|Protocol Violation|0|||
161867386|NCT00848718|584555767|FG006|Overall Study|Protocol Violation|0|||
161867387|NCT00848718|584555768|FG007|Overall Study|Protocol Violation|1|||
161867388|NCT00848718|584555769|FG008|Overall Study|Protocol Violation|0|||
161867389|NCT00848718|584555770|FG009|Overall Study|Protocol Violation|0|||
161867390|NCT00848718|584555771|FG010|Overall Study|Protocol Violation|0|||
161867391|NCT00848718|584555772|FG011|Overall Study|Protocol Violation|0|||
161867392|NCT00848718|584555773|FG012|Overall Study|Protocol Violation|1|||
161867393|NCT00848718|584555761|FG000|Overall Study|Withdrawal by Subject|1|||
161867394|NCT00848718|584555762|FG001|Overall Study|Withdrawal by Subject|0|||
161867395|NCT00848718|584555763|FG002|Overall Study|Withdrawal by Subject|0|||
161867396|NCT00848718|584555764|FG003|Overall Study|Withdrawal by Subject|1|||
161867397|NCT00848718|584555765|FG004|Overall Study|Withdrawal by Subject|0|||
161867398|NCT00848718|584555766|FG005|Overall Study|Withdrawal by Subject|0|||
161867399|NCT00848718|584555767|FG006|Overall Study|Withdrawal by Subject|0|||
161867400|NCT00848718|584555768|FG007|Overall Study|Withdrawal by Subject|0|||
161867401|NCT00848718|584555769|FG008|Overall Study|Withdrawal by Subject|0|||
161867402|NCT00848718|584555770|FG009|Overall Study|Withdrawal by Subject|0|||
161867403|NCT00848718|584555771|FG010|Overall Study|Withdrawal by Subject|1|||
161867404|NCT00848718|584555772|FG011|Overall Study|Withdrawal by Subject|0|||
161867405|NCT00848718|584555773|FG012|Overall Study|Withdrawal by Subject|0|||
161867406|NCT00848718|584555761|FG000|Overall Study|Progressive disease during treatment|3|||
161867407|NCT00848718|584555762|FG001|Overall Study|Progressive disease during treatment|0|||
161867408|NCT00848718|584555763|FG002|Overall Study|Progressive disease during treatment|3|||
161867409|NCT00848718|584555764|FG003|Overall Study|Progressive disease during treatment|0|||
161867410|NCT00848718|584555765|FG004|Overall Study|Progressive disease during treatment|0|||
161867411|NCT00848718|584555766|FG005|Overall Study|Progressive disease during treatment|0|||
161867412|NCT00848718|584555767|FG006|Overall Study|Progressive disease during treatment|0|||
161867413|NCT00848718|584555768|FG007|Overall Study|Progressive disease during treatment|2|||
161867414|NCT00848718|584555769|FG008|Overall Study|Progressive disease during treatment|0|||
161867415|NCT00848718|584555770|FG009|Overall Study|Progressive disease during treatment|0|||
161867416|NCT00848718|584555771|FG010|Overall Study|Progressive disease during treatment|0|||
161867417|NCT00848718|584555772|FG011|Overall Study|Progressive disease during treatment|0|||
161867418|NCT00848718|584555773|FG012|Overall Study|Progressive disease during treatment|2|||
161867419|NCT02389829|584555774|FG000|Overall Study|Lost to Follow-up|0|||
161867420|NCT02389829|584555775|FG001|Overall Study|Lost to Follow-up|1|||
161867421|NCT05271370|584557597|FG000|Overall Study|Study early termination|8|||
161867422|NCT05271370|584557598|FG001|Overall Study|Study early termination|16|||
161867423|NCT05271370|584557599|FG002|Overall Study|Study early termination|29|||
161867424|NCT02283268|584557606|FG000|Overall Study|Withdrawal by Subject|1|||
161867425|NCT00333983|584557607|FG000|Overall Study|Lost to Follow-up|2|||
161867426|NCT00333983|584557608|FG001|Overall Study|Lost to Follow-up|1|||
161867427|NCT00333983|584557609|FG002|Overall Study|Lost to Follow-up|0|||
161867428|NCT00333983|584557607|FG000|Overall Study|Adverse Event|1|||
161867429|NCT00333983|584557608|FG001|Overall Study|Adverse Event|1|||
161867430|NCT00333983|584557609|FG002|Overall Study|Adverse Event|1|||
161867431|NCT00333983|584557607|FG000|Overall Study|Withdrawal by Subject|0|||
161867432|NCT00333983|584557608|FG001|Overall Study|Withdrawal by Subject|3|||
161867433|NCT00333983|584557609|FG002|Overall Study|Withdrawal by Subject|1|||
161867434|NCT00833105|584557610|FG000|Overall Study|Withdrawal by Subject|1|||
161867435|NCT00833105|584557610|FG000|Overall Study|Adverse Event|2|||
161867436|NCT02898597|584557611|FG000|Overall Study|Protocol Violation|4|||
161867437|NCT02898597|584557612|FG001|Overall Study|Protocol Violation|2|||
161867438|NCT02898597|584557611|FG000|Overall Study|Lost to Follow-up|0|||
161867439|NCT02898597|584557612|FG001|Overall Study|Lost to Follow-up|9|||
161867440|NCT02898597|584557611|FG000|Overall Study|Death|0|||
161867441|NCT02898597|584557612|FG001|Overall Study|Death|1|||
161867442|NCT03656068|584557613|FG000|Overall Study|Withdrawal by Subject|4|||
161867443|NCT03656068|584557613|FG000|Overall Study|Adverse Event|1|||
161867444|NCT01436370|584557615|FG000|Overall Study|Lost to Follow-up|0|||
161867445|NCT01436370|584557616|FG001|Overall Study|Lost to Follow-up|0|||
161867446|NCT01436370|584557617|FG002|Overall Study|Lost to Follow-up|0|||
161867447|NCT01436370|584557618|FG003|Overall Study|Lost to Follow-up|0|||
161867448|NCT01436370|584557619|FG004|Overall Study|Lost to Follow-up|1|||
161867449|NCT01436370|584557620|FG005|Overall Study|Lost to Follow-up|0|||
161867450|NCT01436370|584557621|FG006|Overall Study|Lost to Follow-up|0|||
161867451|NCT01436370|584557622|FG007|Overall Study|Lost to Follow-up|0|||
161867452|NCT02770170|584557629|FG000|Overall Study|Withdrawal by Subject|0|||
161867453|NCT02770170|584557630|FG001|Overall Study|Withdrawal by Subject|0|||
161867454|NCT02770170|584557631|FG002|Overall Study|Withdrawal by Subject|0|||
161867455|NCT02770170|584557632|FG003|Overall Study|Withdrawal by Subject|2|||
161867456|NCT02770170|584557629|FG000|Overall Study|due to pregnancy|1|||
161867457|NCT02770170|584557630|FG001|Overall Study|due to pregnancy|0|||
161867458|NCT02770170|584557631|FG002|Overall Study|due to pregnancy|0|||
161867459|NCT02770170|584557632|FG003|Overall Study|due to pregnancy|0|||
161867460|NCT02770170|584557629|FG000|Overall Study|Lack of Efficacy|2|||
161867461|NCT02770170|584557630|FG001|Overall Study|Lack of Efficacy|0|||
161867462|NCT02770170|584557631|FG002|Overall Study|Lack of Efficacy|0|||
161867463|NCT02770170|584557632|FG003|Overall Study|Lack of Efficacy|1|||
161867464|NCT02770170|584557629|FG000|Overall Study|Adverse Event|4|||
161867465|NCT02770170|584557630|FG001|Overall Study|Adverse Event|3|||
161867466|NCT02770170|584557631|FG002|Overall Study|Adverse Event|5|||
161867467|NCT02770170|584557632|FG003|Overall Study|Adverse Event|3|||
161867468|NCT02770170|584557629|FG000|Overall Study|due to disease worsening|0|||
161867469|NCT02770170|584557630|FG001|Overall Study|due to disease worsening|0|||
161867470|NCT02770170|584557631|FG002|Overall Study|due to disease worsening|0|||
161867471|NCT02770170|584557632|FG003|Overall Study|due to disease worsening|1|||
161867472|NCT03270657|584557633|FG000|Overall Study|Withdrawal by Subject|1|||
161867473|NCT00162981|584557634|FG000|Overall Study|Adverse Event|2|||
161867474|NCT00162981|584557635|FG001|Overall Study|Adverse Event|5|||
161867475|NCT00162981|584557634|FG000|Overall Study|Withdrawal by Subject|1|||
161867476|NCT00162981|584557635|FG001|Overall Study|Withdrawal by Subject|1|||
161867477|NCT00162981|584557634|FG000|Overall Study|Physician Decision|1|||
161867478|NCT00162981|584557635|FG001|Overall Study|Physician Decision|0|||
161867479|NCT00171210|584557641|FG000|Overall Study|Adverse Event|16|||
161867480|NCT00171210|584557642|FG001|Overall Study|Adverse Event|27|||
161867481|NCT00171210|584557641|FG000|Overall Study|Abnormal laboratory value(s)|6|||
161867482|NCT00171210|584557642|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161867483|NCT00171210|584557641|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161867484|NCT00171210|584557642|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161867485|NCT00171210|584557641|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
161982949|NCT00615030|584986964|FG005|Period I|Protocol deviation|0|||
161774467|NCT02060188|584216050|FG001|Overall Study|Adverse event unrelated to study drug|5|||
161774468|NCT02060188|584216051|FG002|Overall Study|Adverse event unrelated to study drug|6|||
161774469|NCT02060188|584216052|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161774470|NCT02060188|584216053|FG004|Overall Study|Adverse event unrelated to study drug|1|||
161774471|NCT02060188|584216054|FG005|Overall Study|Adverse event unrelated to study drug|0|||
161774472|NCT02060188|584216055|FG006|Overall Study|Adverse event unrelated to study drug|4|||
161774473|NCT02060188|584216056|FG007|Overall Study|Adverse event unrelated to study drug|4|||
161774474|NCT02060188|584216057|FG008|Overall Study|Adverse event unrelated to study drug|1|||
161774475|NCT02060188|584216049|FG000|Overall Study|Participant request to discontinue study treatment|7|||
161774476|NCT02060188|584216050|FG001|Overall Study|Participant request to discontinue study treatment|7|||
161774477|NCT02060188|584216051|FG002|Overall Study|Participant request to discontinue study treatment|4|||
161774478|NCT02060188|584216052|FG003|Overall Study|Participant request to discontinue study treatment|0|||
161774479|NCT02060188|584216053|FG004|Overall Study|Participant request to discontinue study treatment|0|||
161774480|NCT02060188|584216054|FG005|Overall Study|Participant request to discontinue study treatment|0|||
161774481|NCT02060188|584216055|FG006|Overall Study|Participant request to discontinue study treatment|1|||
161774482|NCT02060188|584216056|FG007|Overall Study|Participant request to discontinue study treatment|1|||
161774483|NCT02060188|584216057|FG008|Overall Study|Participant request to discontinue study treatment|0|||
161774484|NCT02060188|584216049|FG000|Overall Study|Participant withdrew consent|3|||
161774485|NCT02060188|584216050|FG001|Overall Study|Participant withdrew consent|0|||
161774486|NCT02060188|584216051|FG002|Overall Study|Participant withdrew consent|0|||
161774487|NCT02060188|584216052|FG003|Overall Study|Participant withdrew consent|0|||
161774488|NCT02060188|584216053|FG004|Overall Study|Participant withdrew consent|0|||
161774489|NCT02060188|584216054|FG005|Overall Study|Participant withdrew consent|0|||
161774490|NCT02060188|584216055|FG006|Overall Study|Participant withdrew consent|0|||
161774491|NCT02060188|584216056|FG007|Overall Study|Participant withdrew consent|0|||
161774492|NCT02060188|584216057|FG008|Overall Study|Participant withdrew consent|0|||
161774493|NCT02060188|584216049|FG000|Overall Study|Maximum clinical benefit|13|||
161774494|NCT02060188|584216050|FG001|Overall Study|Maximum clinical benefit|38|||
161774495|NCT02060188|584216051|FG002|Overall Study|Maximum clinical benefit|19|||
161774496|NCT02060188|584216052|FG003|Overall Study|Maximum clinical benefit|0|||
161774497|NCT02060188|584216053|FG004|Overall Study|Maximum clinical benefit|0|||
161774498|NCT02060188|584216054|FG005|Overall Study|Maximum clinical benefit|0|||
161774499|NCT02060188|584216055|FG006|Overall Study|Maximum clinical benefit|0|||
161774500|NCT02060188|584216056|FG007|Overall Study|Maximum clinical benefit|10|||
161774501|NCT02060188|584216057|FG008|Overall Study|Maximum clinical benefit|0|||
161774502|NCT02060188|584216049|FG000|Overall Study|Other reason|3|||
161774503|NCT02060188|584216050|FG001|Overall Study|Other reason|7|||
161774504|NCT02060188|584216051|FG002|Overall Study|Other reason|0|||
161774505|NCT02060188|584216052|FG003|Overall Study|Other reason|1|||
161774506|NCT02060188|584216053|FG004|Overall Study|Other reason|0|||
161774507|NCT02060188|584216054|FG005|Overall Study|Other reason|0|||
161774508|NCT02060188|584216055|FG006|Overall Study|Other reason|0|||
161774509|NCT02060188|584216056|FG007|Overall Study|Other reason|9|||
161774510|NCT02060188|584216057|FG008|Overall Study|Other reason|0|||
161774511|NCT02060188|584216049|FG000|Overall Study|Death|0|||
161774512|NCT02060188|584216050|FG001|Overall Study|Death|1|||
161774513|NCT02060188|584216051|FG002|Overall Study|Death|0|||
161774514|NCT02060188|584216052|FG003|Overall Study|Death|0|||
161774515|NCT02060188|584216053|FG004|Overall Study|Death|0|||
161774516|NCT02060188|584216054|FG005|Overall Study|Death|0|||
161774517|NCT02060188|584216055|FG006|Overall Study|Death|0|||
161774518|NCT02060188|584216056|FG007|Overall Study|Death|1|||
161774519|NCT02060188|584216057|FG008|Overall Study|Death|0|||
161774520|NCT02060188|584216049|FG000|Overall Study|Administrative reasons by sponsor|0|||
161774521|NCT02060188|584216050|FG001|Overall Study|Administrative reasons by sponsor|1|||
161774522|NCT02060188|584216051|FG002|Overall Study|Administrative reasons by sponsor|0|||
161774523|NCT02060188|584216052|FG003|Overall Study|Administrative reasons by sponsor|0|||
161774524|NCT02060188|584216053|FG004|Overall Study|Administrative reasons by sponsor|0|||
161774525|NCT02060188|584216054|FG005|Overall Study|Administrative reasons by sponsor|0|||
161774526|NCT02060188|584216055|FG006|Overall Study|Administrative reasons by sponsor|0|||
161774527|NCT02060188|584216056|FG007|Overall Study|Administrative reasons by sponsor|0|||
161774528|NCT02060188|584216057|FG008|Overall Study|Administrative reasons by sponsor|0|||
161774529|NCT02060188|584216049|FG000|Overall Study|Lost to Follow-up|0|||
161774530|NCT02060188|584216050|FG001|Overall Study|Lost to Follow-up|0|||
161774531|NCT02060188|584216051|FG002|Overall Study|Lost to Follow-up|1|||
161774532|NCT02060188|584216052|FG003|Overall Study|Lost to Follow-up|0|||
161774533|NCT02060188|584216053|FG004|Overall Study|Lost to Follow-up|0|||
161774534|NCT02060188|584216054|FG005|Overall Study|Lost to Follow-up|0|||
161774535|NCT02060188|584216055|FG006|Overall Study|Lost to Follow-up|0|||
161774536|NCT02060188|584216056|FG007|Overall Study|Lost to Follow-up|0|||
161774537|NCT02060188|584216057|FG008|Overall Study|Lost to Follow-up|0|||
161774538|NCT03205605|584216068|FG000|Overall Study|Withdrawal by Subject|1|||
161867486|NCT00171210|584557642|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
161867487|NCT00171210|584557641|FG000|Overall Study|Protocol Violation|0|||
161867488|NCT00171210|584557642|FG001|Overall Study|Protocol Violation|2|||
161867489|NCT00171210|584557641|FG000|Overall Study|Withdrawal by Subject|32|||
161867490|NCT00171210|584557642|FG001|Overall Study|Withdrawal by Subject|30|||
161867491|NCT00171210|584557641|FG000|Overall Study|Lost to Follow-up|1|||
161867492|NCT00171210|584557642|FG001|Overall Study|Lost to Follow-up|0|||
161867493|NCT00171210|584557641|FG000|Overall Study|Administrative problems|1|||
161982950|NCT00615030|584986965|FG006|Period I|Protocol deviation|0|||
161982951|NCT00615030|584986966|FG007|Period I|Protocol deviation|0|||
161982952|NCT00615030|584986967|FG008|Period I|Protocol deviation|0|||
161982953|NCT00615030|584986968|FG009|Period I|Protocol deviation|0|||
161982954|NCT00615030|584986969|FG010|Period I|Protocol deviation|0|||
161982955|NCT00615030|584986970|FG011|Period I|Protocol deviation|0|||
161982956|NCT00615030|584986959|FG000|Period I|Subject withdrew consent|0|||
161982957|NCT00615030|584986960|FG001|Period I|Subject withdrew consent|0|||
161982958|NCT00615030|584986961|FG002|Period I|Subject withdrew consent|0|||
161982959|NCT00615030|584986962|FG003|Period I|Subject withdrew consent|0|||
161982960|NCT00615030|584986963|FG004|Period I|Subject withdrew consent|0|||
161982961|NCT00615030|584986964|FG005|Period I|Subject withdrew consent|0|||
161982962|NCT00615030|584986965|FG006|Period I|Subject withdrew consent|0|||
161982963|NCT00615030|584986966|FG007|Period I|Subject withdrew consent|0|||
161982964|NCT00615030|584986967|FG008|Period I|Subject withdrew consent|1|||
161982965|NCT00615030|584986968|FG009|Period I|Subject withdrew consent|0|||
161982966|NCT00615030|584986969|FG010|Period I|Subject withdrew consent|1|||
161982967|NCT00615030|584986970|FG011|Period I|Subject withdrew consent|1|||
161982968|NCT00615030|584986959|FG000|Period I|Abnormal laboratory value(s)|0|||
161867494|NCT00171210|584557642|FG001|Overall Study|Administrative problems|1|||
161867495|NCT00171210|584557641|FG000|Overall Study|Death|2|||
161867496|NCT00171210|584557642|FG001|Overall Study|Death|3|||
161867497|NCT00171210|584557641|FG000|Overall Study|Stopped at end of core|0|||
161867498|NCT00171210|584557642|FG001|Overall Study|Stopped at end of core|32|||
161867499|NCT00171210|584557641|FG000|Overall Study|Stopped at end of extension 1|0|||
161867500|NCT00171210|584557642|FG001|Overall Study|Stopped at end of extension 1|1|||
161867501|NCT03187301|584557645|FG000|Titration Period|Adverse Event|0|||
161867502|NCT03187301|584557646|FG001|Titration Period|Adverse Event|0|||
161867503|NCT03187301|584557647|FG002|Titration Period|Adverse Event|0|||
161867504|NCT03187301|584557648|FG003|Titration Period|Adverse Event|0|||
161867505|NCT03187301|584557649|FG004|Titration Period|Adverse Event|0|||
161867506|NCT03187301|584557650|FG005|Titration Period|Adverse Event|0|||
161867507|NCT03187301|584557651|FG006|Titration Period|Adverse Event|5|||
161867508|NCT03187301|584557645|FG000|Titration Period|Withdrawal by Subject|0|||
161867509|NCT03187301|584557646|FG001|Titration Period|Withdrawal by Subject|0|||
161867510|NCT03187301|584557647|FG002|Titration Period|Withdrawal by Subject|0|||
161867511|NCT03187301|584557648|FG003|Titration Period|Withdrawal by Subject|0|||
161867512|NCT03187301|584557649|FG004|Titration Period|Withdrawal by Subject|0|||
161867513|NCT03187301|584557650|FG005|Titration Period|Withdrawal by Subject|0|||
161867514|NCT03187301|584557651|FG006|Titration Period|Withdrawal by Subject|1|||
161867515|NCT03187301|584557645|FG000|Titration Period|Exclusion Criteria Met|0|||
161867516|NCT03187301|584557646|FG001|Titration Period|Exclusion Criteria Met|0|||
161867517|NCT03187301|584557647|FG002|Titration Period|Exclusion Criteria Met|0|||
161867518|NCT03187301|584557648|FG003|Titration Period|Exclusion Criteria Met|0|||
161867519|NCT03187301|584557649|FG004|Titration Period|Exclusion Criteria Met|0|||
161867520|NCT03187301|584557650|FG005|Titration Period|Exclusion Criteria Met|0|||
161867521|NCT03187301|584557651|FG006|Titration Period|Exclusion Criteria Met|1|||
161867522|NCT03187301|584557645|FG000|Pre-Intervention|Withdrawal by Subject|1|||
161867523|NCT03187301|584557646|FG001|Pre-Intervention|Withdrawal by Subject|0|||
161867524|NCT03187301|584557647|FG002|Pre-Intervention|Withdrawal by Subject|0|||
161982969|NCT00615030|584986960|FG001|Period I|Abnormal laboratory value(s)|0|||
161982970|NCT00615030|584986961|FG002|Period I|Abnormal laboratory value(s)|0|||
161982971|NCT00615030|584986962|FG003|Period I|Abnormal laboratory value(s)|0|||
161982972|NCT00615030|584986963|FG004|Period I|Abnormal laboratory value(s)|0|||
161982973|NCT00615030|584986964|FG005|Period I|Abnormal laboratory value(s)|1|||
161982974|NCT00615030|584986965|FG006|Period I|Abnormal laboratory value(s)|0|||
161867525|NCT03187301|584557648|FG003|Pre-Intervention|Withdrawal by Subject|0|||
161867526|NCT03187301|584557649|FG004|Pre-Intervention|Withdrawal by Subject|0|||
161867527|NCT03187301|584557650|FG005|Pre-Intervention|Withdrawal by Subject|0|||
161867528|NCT03187301|584557651|FG006|Pre-Intervention|Withdrawal by Subject|0|||
161867529|NCT01966120|584557657|FG000|Overall Study|Withdrawal by Subject|0|||
161867530|NCT01966120|584557658|FG001|Overall Study|Withdrawal by Subject|5|||
161867531|NCT01966120|584557657|FG000|Overall Study|Lost to Follow-up|1|||
161867532|NCT01966120|584557658|FG001|Overall Study|Lost to Follow-up|1|||
161867533|NCT00461630|584557659|FG000|Overall Study|Death|798|||
161982975|NCT00615030|584986966|FG007|Period I|Abnormal laboratory value(s)|0|||
161982976|NCT00615030|584986967|FG008|Period I|Abnormal laboratory value(s)|0|||
161982977|NCT00615030|584986968|FG009|Period I|Abnormal laboratory value(s)|0|||
161982978|NCT00615030|584986969|FG010|Period I|Abnormal laboratory value(s)|0|||
161982979|NCT00615030|584986970|FG011|Period I|Abnormal laboratory value(s)|0|||
161774539|NCT03795233|584216069|FG000|Overall Study|Withdrawal by Subject|2|||
161774540|NCT03795233|584216070|FG001|Overall Study|Withdrawal by Subject|1|||
161774541|NCT03795233|584216069|FG000|Overall Study|Lost to Follow-up|1|||
161774542|NCT03795233|584216070|FG001|Overall Study|Lost to Follow-up|0|||
161774543|NCT03795233|584216069|FG000|Overall Study|Death|1|||
161774544|NCT03795233|584216070|FG001|Overall Study|Death|0|||
161774545|NCT02756182|584216071|FG000|Overall Study|StudyTechnical Difficulties|4|||
161774546|NCT01965600|584216075|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
161774547|NCT01965600|584216076|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
161774548|NCT01965600|584216077|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
161774549|NCT01965600|584216078|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
161774550|NCT01965600|584216075|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
161774551|NCT01965600|584216076|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
161774552|NCT01965600|584216077|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
161774553|NCT01965600|584216078|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
161774554|NCT01965600|584216075|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
161774555|NCT01965600|584216076|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
161774556|NCT01965600|584216077|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
161774557|NCT01965600|584216078|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
161774558|NCT01965600|584216075|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
161774559|NCT01965600|584216076|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
161774560|NCT01965600|584216077|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
161774561|NCT01965600|584216078|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
161774562|NCT01965600|584216075|FG000|Second Intervention|Study terminated by Sponsor|0|||
161774563|NCT01965600|584216076|FG001|Second Intervention|Study terminated by Sponsor|0|||
161774564|NCT01965600|584216077|FG002|Second Intervention|Study terminated by Sponsor|2|||
161774565|NCT01965600|584216078|FG003|Second Intervention|Study terminated by Sponsor|2|||
161774566|NCT02711306|584216086|FG000|Overall Study|Withdrawal by Subject|2|||
161774567|NCT02711306|584216087|FG001|Overall Study|Withdrawal by Subject|2|||
161774568|NCT00242567|584217284|FG000|Overall Study|Adverse Event|70|||
161774569|NCT00242567|584217285|FG001|Overall Study|Adverse Event|43|||
161774570|NCT00242567|584217284|FG000|Overall Study|Disease Progression|17|||
161774571|NCT00242567|584217285|FG001|Overall Study|Disease Progression|22|||
161774572|NCT00242567|584217284|FG000|Overall Study|Symptomatic deterioration|9|||
161774573|NCT00242567|584217285|FG001|Overall Study|Symptomatic deterioration|3|||
161774574|NCT00242567|584217284|FG000|Overall Study|Lack of Efficacy|2|||
161774575|NCT00242567|584217285|FG001|Overall Study|Lack of Efficacy|2|||
161774576|NCT00242567|584217284|FG000|Overall Study|Lost to Follow-up|9|||
161774577|NCT00242567|584217285|FG001|Overall Study|Lost to Follow-up|19|||
161774578|NCT00242567|584217284|FG000|Overall Study|Withdrawal by Subject|33|||
161774579|NCT00242567|584217285|FG001|Overall Study|Withdrawal by Subject|28|||
161774580|NCT00242567|584217284|FG000|Overall Study|Protocol Violation|12|||
161774581|NCT00242567|584217285|FG001|Overall Study|Protocol Violation|12|||
161774582|NCT00242567|584217284|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
161774583|NCT00242567|584217285|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
161774584|NCT00242567|584217284|FG000|Overall Study|Other|14|||
161774585|NCT00242567|584217285|FG001|Overall Study|Other|9|||
161774586|NCT05553600|584217288|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
161774587|NCT05553600|584217289|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
161774588|NCT05553600|584217290|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
161774589|NCT05553600|584217291|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
161774590|NCT05553600|584217288|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
161774591|NCT05553600|584217289|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
161774592|NCT05553600|584217290|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
161774593|NCT05553600|584217291|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
161774594|NCT05553600|584217288|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
161774595|NCT05553600|584217289|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
161774596|NCT05553600|584217290|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
161774597|NCT05553600|584217291|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
161774598|NCT05553600|584217288|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
161774599|NCT05553600|584217289|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
161774600|NCT05553600|584217290|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
161774601|NCT05553600|584217291|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
161774602|NCT05553600|584217288|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
161774603|NCT05553600|584217289|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
161774604|NCT05553600|584217290|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
161867534|NCT00461630|584557660|FG001|Overall Study|Death|732|||
161867535|NCT00461630|584557659|FG000|Overall Study|Lost to Follow-up|108|||
161867536|NCT00461630|584557660|FG001|Overall Study|Lost to Follow-up|95|||
161867537|NCT02588612|584557664|FG000|Overall Study|Physician Decision|1|||
161867538|NCT02588612|584557664|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
161867539|NCT02588612|584557664|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
161867540|NCT02588612|584557664|FG000|Overall Study|Death prior to T-cell infusion|1|||
161867541|NCT03809663|584557665|FG000|Overall Study|Decision by sponsor|24|||
161867542|NCT03809663|584557666|FG001|Overall Study|Decision by sponsor|18|||
161867543|NCT03809663|584557667|FG002|Overall Study|Decision by sponsor|20|||
161867544|NCT03809663|584557668|FG003|Overall Study|Decision by sponsor|20|||
161867545|NCT03809663|584557669|FG004|Overall Study|Decision by sponsor|0|||
161867546|NCT03809663|584557670|FG005|Overall Study|Decision by sponsor|0|||
161867547|NCT03809663|584557665|FG000|Overall Study|Withdrawal by Subject|26|||
161867548|NCT03809663|584557666|FG001|Overall Study|Withdrawal by Subject|22|||
161867549|NCT03809663|584557667|FG002|Overall Study|Withdrawal by Subject|27|||
161867550|NCT03809663|584557668|FG003|Overall Study|Withdrawal by Subject|26|||
161867551|NCT03809663|584557669|FG004|Overall Study|Withdrawal by Subject|0|||
161867552|NCT03809663|584557670|FG005|Overall Study|Withdrawal by Subject|0|||
161867553|NCT03809663|584557665|FG000|Overall Study|Lost to Follow-up|1|||
161867554|NCT03809663|584557666|FG001|Overall Study|Lost to Follow-up|4|||
161867555|NCT03809663|584557667|FG002|Overall Study|Lost to Follow-up|1|||
161867556|NCT03809663|584557668|FG003|Overall Study|Lost to Follow-up|1|||
161867557|NCT03809663|584557669|FG004|Overall Study|Lost to Follow-up|0|||
161867558|NCT03809663|584557670|FG005|Overall Study|Lost to Follow-up|0|||
161867559|NCT03376789|584557671|FG000|Overall Study|Withdrawal by Subject|3|||
161867560|NCT03376789|584557672|FG001|Overall Study|Withdrawal by Subject|5|||
161867561|NCT03376789|584557671|FG000|Overall Study|Protocol Violation|0|||
161867562|NCT03376789|584557672|FG001|Overall Study|Protocol Violation|1|||
161867563|NCT03376789|584557671|FG000|Overall Study|Adverse Event|0|||
161867564|NCT03376789|584557672|FG001|Overall Study|Adverse Event|1|||
161867565|NCT03376789|584557671|FG000|Overall Study|Lost to Follow-up|1|||
161867566|NCT03376789|584557672|FG001|Overall Study|Lost to Follow-up|1|||
161867567|NCT03376789|584557671|FG000|Overall Study|Per sponsor due to noncompliance|1|||
161867568|NCT03376789|584557672|FG001|Overall Study|Per sponsor due to noncompliance|0|||
161867569|NCT03376789|584557671|FG000|Overall Study|Subject off study medication|0|||
161867570|NCT03376789|584557672|FG001|Overall Study|Subject off study medication|1|||
161867571|NCT01703260|584557673|FG000|Overall Study|Adverse Event|1|||
161867572|NCT01703260|584557674|FG001|Overall Study|Adverse Event|2|||
161867573|NCT01703260|584557675|FG002|Overall Study|Adverse Event|2|||
161867574|NCT01703260|584557673|FG000|Overall Study|Lost to Follow-up|1|||
161867575|NCT01703260|584557674|FG001|Overall Study|Lost to Follow-up|0|||
161867576|NCT01703260|584557675|FG002|Overall Study|Lost to Follow-up|0|||
161867577|NCT01703260|584557673|FG000|Overall Study|Withdrawal by Subject|0|||
161867578|NCT01703260|584557674|FG001|Overall Study|Withdrawal by Subject|0|||
161867579|NCT01703260|584557675|FG002|Overall Study|Withdrawal by Subject|1|||
161867580|NCT01703260|584557673|FG000|Overall Study|Study Termination|1|||
161867581|NCT01703260|584557674|FG001|Overall Study|Study Termination|2|||
161867582|NCT01703260|584557675|FG002|Overall Study|Study Termination|0|||
161867583|NCT02042014|584557676|FG000|Overall Study|Adverse Event|1|||
161867584|NCT02042014|584557676|FG000|Overall Study|Physician Decision|7|||
161867585|NCT02792062|584557680|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
161867586|NCT02792062|584557681|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161867587|NCT02792062|584557682|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161867588|NCT02792062|584557683|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161867589|NCT02792062|584557684|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161867590|NCT02792062|584557685|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161867591|NCT03309943|584557688|FG000|Overall Study|Withdrawal by Subject|0|||
161867592|NCT03309943|584557689|FG001|Overall Study|Withdrawal by Subject|1|||
161867593|NCT03309943|584557688|FG000|Overall Study|Inappropriate behavior towards staff|0|||
161867594|NCT03309943|584557689|FG001|Overall Study|Inappropriate behavior towards staff|1|||
161867595|NCT03123393|584557690|FG000|Overall Study|Study Terminated by Sponsor|6|||
161867596|NCT03123393|584557691|FG001|Overall Study|Study Terminated by Sponsor|9|||
161867597|NCT03123393|584557690|FG000|Overall Study|Withdrawal by Subject|2|||
161867598|NCT03123393|584557691|FG001|Overall Study|Withdrawal by Subject|1|||
161867599|NCT03123393|584557690|FG000|Overall Study|Reason not Specified|13|||
161867600|NCT03123393|584557691|FG001|Overall Study|Reason not Specified|13|||
161867601|NCT02230904|584557693|FG000|Overall Study|Safety follow up could not take place|0|||
161867602|NCT02230904|584557694|FG001|Overall Study|Safety follow up could not take place|1|||
161867603|NCT01464424|584557695|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
161867604|NCT01464424|584557696|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
161867605|NCT05047211|584557700|FG000|Overall Study|Lost to Follow-up|8|||
161867606|NCT05047211|584557701|FG001|Overall Study|Lost to Follow-up|5|||
161867607|NCT00561392|584557702|FG000|Overall Study|Adverse Event|38|||
161867608|NCT00561392|584557702|FG000|Overall Study|Lack of Efficacy|2|||
161867609|NCT00561392|584557702|FG000|Overall Study|Protocol Violation|1|||
161867610|NCT00561392|584557702|FG000|Overall Study|Withdrawal by Subject|8|||
161867611|NCT00561392|584557702|FG000|Overall Study|Administrative problems|4|||
161867612|NCT03822468|584557703|FG000|Treatment Period|Progressive disease|98|||
161867613|NCT03822468|584557704|FG001|Treatment Period|Progressive disease|94|||
161867614|NCT03822468|584557703|FG000|Treatment Period|Adverse Event|21|||
161867615|NCT03822468|584557704|FG001|Treatment Period|Adverse Event|24|||
161867616|NCT03822468|584557703|FG000|Treatment Period|Withdrawal by Subject|9|||
161867617|NCT03822468|584557704|FG001|Treatment Period|Withdrawal by Subject|5|||
161867618|NCT03822468|584557703|FG000|Treatment Period|Physician Decision|9|||
161867619|NCT03822468|584557704|FG001|Treatment Period|Physician Decision|7|||
161867620|NCT03822468|584557703|FG000|Treatment Period|Protocol Violation|2|||
161867621|NCT03822468|584557704|FG001|Treatment Period|Protocol Violation|1|||
161867622|NCT03822468|584557703|FG000|Treatment Period|Death|2|||
161867623|NCT03822468|584557704|FG001|Treatment Period|Death|3|||
161867624|NCT03822468|584557703|FG000|Treatment Period|Lost to Follow-up|1|||
161867625|NCT03822468|584557704|FG001|Treatment Period|Lost to Follow-up|1|||
161867626|NCT03822468|584557703|FG000|Treatment Period|Sponsor decision|46|||
161867627|NCT03822468|584557704|FG001|Treatment Period|Sponsor decision|53|||
161867628|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
161867629|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
161867630|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
161867631|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
161867632|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Death|1|||
161867633|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Death|0|||
161867634|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161867635|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
161867636|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
161867637|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161867638|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
161867639|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161867640|NCT03822468|584557703|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
161867641|NCT03822468|584557704|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
161867642|NCT03331796|584557705|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
161867643|NCT03331796|584557706|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
161867644|NCT03331796|584557707|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
161867645|NCT03331796|584557705|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
161867646|NCT03331796|584557706|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
161867647|NCT03331796|584557707|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
161867648|NCT03331796|584557705|FG000|Extended Follow-up|Adverse Event|1|||
161867649|NCT03331796|584557706|FG001|Extended Follow-up|Adverse Event|0|||
161867650|NCT03331796|584557707|FG002|Extended Follow-up|Adverse Event|1|||
161867651|NCT03331796|584557705|FG000|Extended Follow-up|Lost to Follow-up|0|||
161867652|NCT03331796|584557706|FG001|Extended Follow-up|Lost to Follow-up|0|||
161867653|NCT03331796|584557707|FG002|Extended Follow-up|Lost to Follow-up|1|||
161867654|NCT03331796|584557705|FG000|Extended Follow-up|Withdrawal by Subject|1|||
161867655|NCT03331796|584557706|FG001|Extended Follow-up|Withdrawal by Subject|0|||
161867656|NCT03331796|584557707|FG002|Extended Follow-up|Withdrawal by Subject|0|||
161867657|NCT03331796|584557705|FG000|Extended Follow-up|Termination of Funding|0|||
161867658|NCT03331796|584557706|FG001|Extended Follow-up|Termination of Funding|1|||
161867659|NCT03331796|584557707|FG002|Extended Follow-up|Termination of Funding|0|||
161867660|NCT01786993|584557709|FG000|Overall Study|Death|6|||
161867661|NCT01786993|584557710|FG001|Overall Study|Death|7|||
161867662|NCT01786993|584557709|FG000|Overall Study|Withdrawal by Subject|3|||
161867663|NCT01786993|584557710|FG001|Overall Study|Withdrawal by Subject|2|||
161867664|NCT01786993|584557709|FG000|Overall Study|Lost to Follow-up|0|||
161867665|NCT01786993|584557710|FG001|Overall Study|Lost to Follow-up|1|||
161867666|NCT01786993|584557709|FG000|Overall Study|Subject Non-Compliance|1|||
161867667|NCT01786993|584557710|FG001|Overall Study|Subject Non-Compliance|0|||
161867668|NCT01786993|584557709|FG000|Overall Study|System Explant|1|||
161867669|NCT01786993|584557710|FG001|Overall Study|System Explant|0|||
161867670|NCT01786993|584557709|FG000|Overall Study|Hospice Admission|1|||
161867671|NCT01786993|584557710|FG001|Overall Study|Hospice Admission|0|||
161867672|NCT00450437|584557711|FG000|Overall Study|Withdrawal by Subject|10|||
161867673|NCT00450437|584557712|FG001|Overall Study|Withdrawal by Subject|2|||
161867674|NCT00450437|584557713|FG002|Overall Study|Withdrawal by Subject|0|||
161867675|NCT00450437|584557714|FG003|Overall Study|Withdrawal by Subject|1|||
161867676|NCT00450437|584557711|FG000|Overall Study|Lost to Follow-up|31|||
161867677|NCT00450437|584557712|FG001|Overall Study|Lost to Follow-up|12|||
161867678|NCT00450437|584557713|FG002|Overall Study|Lost to Follow-up|19|||
161867679|NCT00450437|584557714|FG003|Overall Study|Lost to Follow-up|9|||
161867680|NCT00450437|584557711|FG000|Overall Study|Protocol Violation|0|||
161867681|NCT00450437|584557712|FG001|Overall Study|Protocol Violation|1|||
161867682|NCT00450437|584557713|FG002|Overall Study|Protocol Violation|0|||
161867683|NCT00450437|584557714|FG003|Overall Study|Protocol Violation|1|||
161867684|NCT00450437|584557711|FG000|Overall Study|Inappropriate enrollment|4|||
161867685|NCT00450437|584557712|FG001|Overall Study|Inappropriate enrollment|1|||
161867686|NCT00450437|584557713|FG002|Overall Study|Inappropriate enrollment|3|||
161867687|NCT00450437|584557714|FG003|Overall Study|Inappropriate enrollment|0|||
161867688|NCT00450437|584557711|FG000|Overall Study|Administrative reason|0|||
161867689|NCT00450437|584557712|FG001|Overall Study|Administrative reason|0|||
161867690|NCT00450437|584557713|FG002|Overall Study|Administrative reason|1|||
161867691|NCT00450437|584557714|FG003|Overall Study|Administrative reason|0|||
161867692|NCT00450437|584557711|FG000|Overall Study|Unable to Classify|1|||
161867693|NCT00450437|584557712|FG001|Overall Study|Unable to Classify|0|||
161867694|NCT00450437|584557713|FG002|Overall Study|Unable to Classify|1|||
161867695|NCT00450437|584557714|FG003|Overall Study|Unable to Classify|0|||
161867696|NCT01890122|584557715|FG000|Overall Study|Adverse Event|1|||
161867697|NCT01890122|584557716|FG001|Overall Study|Adverse Event|1|||
161867698|NCT01890122|584557717|FG002|Overall Study|Adverse Event|1|||
161867699|NCT01890122|584557718|FG003|Overall Study|Adverse Event|2|||
161867700|NCT01890122|584557715|FG000|Overall Study|Major Protocol Deviation|3|||
161867701|NCT01890122|584557716|FG001|Overall Study|Major Protocol Deviation|1|||
161867702|NCT01890122|584557717|FG002|Overall Study|Major Protocol Deviation|0|||
161867703|NCT01890122|584557718|FG003|Overall Study|Major Protocol Deviation|1|||
161867704|NCT01890122|584557715|FG000|Overall Study|Lost to Follow-up|0|||
161867705|NCT01890122|584557716|FG001|Overall Study|Lost to Follow-up|1|||
161867706|NCT01890122|584557717|FG002|Overall Study|Lost to Follow-up|2|||
161867707|NCT01890122|584557718|FG003|Overall Study|Lost to Follow-up|2|||
161867708|NCT01890122|584557715|FG000|Overall Study|Voluntary Withdrawal|8|||
161867709|NCT01890122|584557716|FG001|Overall Study|Voluntary Withdrawal|8|||
161867710|NCT01890122|584557717|FG002|Overall Study|Voluntary Withdrawal|2|||
161867711|NCT01890122|584557718|FG003|Overall Study|Voluntary Withdrawal|11|||
161867712|NCT01890122|584557715|FG000|Overall Study|Lack of Efficacy|14|||
161867713|NCT01890122|584557716|FG001|Overall Study|Lack of Efficacy|24|||
161867714|NCT01890122|584557717|FG002|Overall Study|Lack of Efficacy|7|||
161867715|NCT01890122|584557718|FG003|Overall Study|Lack of Efficacy|41|||
161867716|NCT01890122|584557715|FG000|Overall Study|Reason not Specified|0|||
161867717|NCT01890122|584557716|FG001|Overall Study|Reason not Specified|1|||
161867718|NCT01890122|584557717|FG002|Overall Study|Reason not Specified|1|||
161867719|NCT01890122|584557718|FG003|Overall Study|Reason not Specified|2|||
161867720|NCT01890122|584557715|FG000|Overall Study|Randomized but not Treated|1|||
161867721|NCT01890122|584557716|FG001|Overall Study|Randomized but not Treated|1|||
161867722|NCT01890122|584557717|FG002|Overall Study|Randomized but not Treated|0|||
161867723|NCT01890122|584557718|FG003|Overall Study|Randomized but not Treated|0|||
161867724|NCT04025879|584557719|FG000|Randomization|Participant withdrew consent|0|||
161867725|NCT04025879|584557720|FG001|Randomization|Participant withdrew consent|1|||
161867726|NCT04025879|584557719|FG000|Randomization|Participant no longer met study criteria|1|||
161867727|NCT04025879|584557720|FG001|Randomization|Participant no longer met study criteria|1|||
161867728|NCT04025879|584557719|FG000|Treatment|Ongoing treatment|10|||
161867729|NCT04025879|584557720|FG001|Treatment|Ongoing treatment|8|||
161867730|NCT04025879|584557719|FG000|Treatment|Disease progression/recurrence|36|||
161867731|NCT04025879|584557720|FG001|Treatment|Disease progression/recurrence|72|||
161867732|NCT04025879|584557719|FG000|Treatment|Study drug toxicity|36|||
161867733|NCT04025879|584557720|FG001|Treatment|Study drug toxicity|13|||
161867734|NCT04025879|584557719|FG000|Treatment|Death|2|||
161867735|NCT04025879|584557720|FG001|Treatment|Death|0|||
161867736|NCT04025879|584557719|FG000|Treatment|Adverse event unrelated to study drug|21|||
161867737|NCT04025879|584557720|FG001|Treatment|Adverse event unrelated to study drug|14|||
161867738|NCT04025879|584557719|FG000|Treatment|Participant request to discontinue study treatment|16|||
161867739|NCT04025879|584557720|FG001|Treatment|Participant request to discontinue study treatment|8|||
161867740|NCT04025879|584557719|FG000|Treatment|Participant withdrew consent|1|||
161867741|NCT04025879|584557720|FG001|Treatment|Participant withdrew consent|3|||
161867742|NCT04025879|584557719|FG000|Treatment|Participant no longer meets study criteria|3|||
161867743|NCT04025879|584557720|FG001|Treatment|Participant no longer meets study criteria|2|||
161867744|NCT04025879|584557719|FG000|Treatment|Lost to Follow-up|1|||
161867745|NCT04025879|584557720|FG001|Treatment|Lost to Follow-up|0|||
161867746|NCT04025879|584557719|FG000|Treatment|Other reasons|15|||
161867747|NCT04025879|584557720|FG001|Treatment|Other reasons|17|||
161867748|NCT04025879|584557719|FG000|Treatment|Administrative reason by sponsor|0|||
161867749|NCT04025879|584557720|FG001|Treatment|Administrative reason by sponsor|1|||
161867750|NCT04025879|584557719|FG000|Treatment|Not reported|2|||
161867751|NCT04025879|584557720|FG001|Treatment|Not reported|0|||
161867752|NCT00071110|584557725|FG000|Overall Study|Protocol Violation|0|||
161867753|NCT00071110|584557726|FG001|Overall Study|Protocol Violation|4|||
161867754|NCT02640664|584557733|FG000|Epoch 1|Withdrawal of informed consent|1|||
161867755|NCT02640664|584557734|FG001|Epoch 1|Withdrawal of informed consent|0|||
161867756|NCT02640664|584557735|FG002|Epoch 1|Withdrawal of informed consent|0|||
161867757|NCT02640664|584557733|FG000|Epoch 1|Death|0|||
161867758|NCT02640664|584557734|FG001|Epoch 1|Death|0|||
161867759|NCT02640664|584557735|FG002|Epoch 1|Death|1|||
161867760|NCT02640664|584557733|FG000|Epoch 2|Withdrawal of informed consent|3|||
161867761|NCT02640664|584557734|FG001|Epoch 2|Withdrawal of informed consent|4|||
161867762|NCT02640664|584557735|FG002|Epoch 2|Withdrawal of informed consent|2|||
161867763|NCT02640664|584557733|FG000|Epoch 2|Subject/guardian decision|0|||
161867764|NCT02640664|584557734|FG001|Epoch 2|Subject/guardian decision|2|||
161867765|NCT02640664|584557735|FG002|Epoch 2|Subject/guardian decision|2|||
161867766|NCT02640664|584557733|FG000|Epoch 2|Lost to Follow-up|3|||
161867767|NCT02640664|584557734|FG001|Epoch 2|Lost to Follow-up|4|||
161867768|NCT02640664|584557735|FG002|Epoch 2|Lost to Follow-up|1|||
161867769|NCT02640664|584557733|FG000|Epoch 2|Death|0|||
161867770|NCT02640664|584557734|FG001|Epoch 2|Death|0|||
161867771|NCT02640664|584557735|FG002|Epoch 2|Death|1|||
161867772|NCT05514873|584557740|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
161867773|NCT05514873|584557740|FG000|Main Treatment Period|Adverse Event|2|||
161867774|NCT05514873|584557740|FG000|Extension Treatment Period|Lost to Follow-up|3|||
161867775|NCT02729025|584557741|FG000|Overall Study|Sponsor Decision|0|||
161867776|NCT02729025|584557742|FG001|Overall Study|Sponsor Decision|1|||
161867777|NCT03525678|584557743|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
161867778|NCT03525678|584557744|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
161867779|NCT03525678|584557745|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
161867780|NCT03525678|584557746|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
161867781|NCT03525678|584557747|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
161867782|NCT03525678|584557743|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
161867783|NCT03525678|584557744|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
161867784|NCT03525678|584557745|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
161867785|NCT03525678|584557746|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
161867786|NCT03525678|584557747|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
161867787|NCT03525678|584557743|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
161867788|NCT03525678|584557744|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
161867789|NCT03525678|584557745|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
161867790|NCT03525678|584557746|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
161867791|NCT03525678|584557747|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
161867792|NCT03525678|584557743|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
161867793|NCT03525678|584557744|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
161867794|NCT03525678|584557745|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
161867795|NCT03525678|584557746|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
161867796|NCT03525678|584557747|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
161982980|NCT00615030|584986959|FG000|Period II|Adverse Event|0|||
161982981|NCT00615030|584986960|FG001|Period II|Adverse Event|0|||
161982982|NCT00615030|584986961|FG002|Period II|Adverse Event|1|||
161982983|NCT00615030|584986962|FG003|Period II|Adverse Event|0|||
161982984|NCT00615030|584986963|FG004|Period II|Adverse Event|0|||
161982985|NCT00615030|584986964|FG005|Period II|Adverse Event|0|||
161982986|NCT00615030|584986965|FG006|Period II|Adverse Event|0|||
161982987|NCT00615030|584986966|FG007|Period II|Adverse Event|0|||
161982988|NCT00615030|584986967|FG008|Period II|Adverse Event|1|||
161982989|NCT00615030|584986968|FG009|Period II|Adverse Event|0|||
161982990|NCT00615030|584986969|FG010|Period II|Adverse Event|0|||
161867797|NCT03525678|584557743|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
161867798|NCT03525678|584557744|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
161867799|NCT03525678|584557745|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
161867800|NCT03525678|584557746|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
161867801|NCT03525678|584557747|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
161867802|NCT03525678|584557743|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
161982991|NCT00615030|584986970|FG011|Period II|Adverse Event|0|||
161982992|NCT00615030|584986959|FG000|Period II|Subject withdrew consent|0|||
161982993|NCT00615030|584986960|FG001|Period II|Subject withdrew consent|0|||
161982994|NCT00615030|584986961|FG002|Period II|Subject withdrew consent|0|||
161982995|NCT00615030|584986962|FG003|Period II|Subject withdrew consent|1|||
161982996|NCT00615030|584986963|FG004|Period II|Subject withdrew consent|0|||
161982997|NCT00615030|584986964|FG005|Period II|Subject withdrew consent|0|||
161982998|NCT00615030|584986965|FG006|Period II|Subject withdrew consent|1|||
161982999|NCT00615030|584986966|FG007|Period II|Subject withdrew consent|0|||
161983000|NCT00615030|584986967|FG008|Period II|Subject withdrew consent|0|||
161983001|NCT00615030|584986968|FG009|Period II|Subject withdrew consent|0|||
161983002|NCT00615030|584986969|FG010|Period II|Subject withdrew consent|0|||
161983003|NCT00615030|584986970|FG011|Period II|Subject withdrew consent|0|||
161983004|NCT00615030|584986959|FG000|Period III|Administrative problems|1|||
161983005|NCT00615030|584986960|FG001|Period III|Administrative problems|0|||
161983006|NCT00615030|584986961|FG002|Period III|Administrative problems|0|||
161983007|NCT00615030|584986962|FG003|Period III|Administrative problems|1|||
161983008|NCT00615030|584986963|FG004|Period III|Administrative problems|0|||
161983009|NCT00615030|584986964|FG005|Period III|Administrative problems|0|||
161983010|NCT00615030|584986965|FG006|Period III|Administrative problems|0|||
161983011|NCT00615030|584986966|FG007|Period III|Administrative problems|0|||
161983012|NCT00615030|584986967|FG008|Period III|Administrative problems|0|||
161983013|NCT00615030|584986968|FG009|Period III|Administrative problems|0|||
161983014|NCT00615030|584986969|FG010|Period III|Administrative problems|0|||
161983015|NCT00615030|584986970|FG011|Period III|Administrative problems|0|||
161867803|NCT03525678|584557744|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
161867804|NCT03525678|584557745|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
161867805|NCT03525678|584557746|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
161867806|NCT03525678|584557747|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
161867807|NCT05343000|584558985|FG000|Overall Study|Physician Decision|2|||
161867808|NCT04432831|584558986|FG000|Overall Study|Withdrawal by Subject|24|||
161867809|NCT04432831|584558987|FG001|Overall Study|Withdrawal by Subject|28|||
161867810|NCT04432831|584558988|FG002|Overall Study|Withdrawal by Subject|21|||
161867811|NCT04432831|584558986|FG000|Overall Study|Death|23|||
161867812|NCT04432831|584558987|FG001|Overall Study|Death|23|||
161867813|NCT04432831|584558988|FG002|Overall Study|Death|17|||
161867814|NCT04432831|584558986|FG000|Overall Study|Lost to Follow-up|15|||
161867815|NCT04432831|584558987|FG001|Overall Study|Lost to Follow-up|15|||
161867816|NCT04432831|584558988|FG002|Overall Study|Lost to Follow-up|12|||
161867817|NCT04432831|584558986|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
161867818|NCT04432831|584558987|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
161867819|NCT04432831|584558988|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
161867820|NCT04432831|584558986|FG000|Overall Study|Reason Not Specified|7|||
161867821|NCT04432831|584558987|FG001|Overall Study|Reason Not Specified|11|||
161867822|NCT04432831|584558988|FG002|Overall Study|Reason Not Specified|9|||
161867823|NCT04432831|584558986|FG000|Overall Study|Adverse Event|7|||
161867824|NCT04432831|584558987|FG001|Overall Study|Adverse Event|7|||
161867825|NCT04432831|584558988|FG002|Overall Study|Adverse Event|7|||
161867826|NCT04432831|584558986|FG000|Overall Study|Physician Decision|1|||
161867827|NCT04432831|584558987|FG001|Overall Study|Physician Decision|3|||
161867828|NCT04432831|584558988|FG002|Overall Study|Physician Decision|6|||
161867829|NCT04432831|584558986|FG000|Overall Study|Protocol Violation|1|||
161867830|NCT04432831|584558987|FG001|Overall Study|Protocol Violation|0|||
161867831|NCT04432831|584558988|FG002|Overall Study|Protocol Violation|2|||
161867832|NCT04432831|584558986|FG000|Overall Study|Pregnancy|0|||
161867833|NCT04432831|584558987|FG001|Overall Study|Pregnancy|1|||
161867834|NCT04432831|584558988|FG002|Overall Study|Pregnancy|0|||
161867835|NCT04432831|584558986|FG000|Overall Study|Lack of Efficacy|0|||
161867836|NCT04432831|584558987|FG001|Overall Study|Lack of Efficacy|0|||
161867837|NCT04432831|584558988|FG002|Overall Study|Lack of Efficacy|2|||
161867838|NCT03782792|584558989|FG000|Overall Study|Patient left the country|0|||
161983016|NCT03002311|584986983|FG000|Overall Study|Lost to Follow-up|13|||
161983017|NCT03002311|584986984|FG001|Overall Study|Lost to Follow-up|26|||
161983018|NCT03002311|584986983|FG000|Overall Study|Referral provider called to schedule app|3|||
161983019|NCT03002311|584986984|FG001|Overall Study|Referral provider called to schedule app|3|||
161983020|NCT03002311|584986983|FG000|Overall Study|Physician Decision|3|||
161983021|NCT03002311|584986984|FG001|Overall Study|Physician Decision|1|||
161983022|NCT00308074|584986985|FG000|Overall Study|Withdrawal by Subject|1|||
161983023|NCT01329939|584986989|FG000|Overall Study|Lost to Follow-up|3|||
161983024|NCT01329939|584986990|FG001|Overall Study|Lost to Follow-up|0|||
161983025|NCT01329939|584986991|FG002|Overall Study|Lost to Follow-up|1|||
161983026|NCT01329939|584986992|FG003|Overall Study|Lost to Follow-up|2|||
161983027|NCT01329939|584986989|FG000|Overall Study|Withdrawal by Subject|0|||
161983028|NCT01329939|584986990|FG001|Overall Study|Withdrawal by Subject|1|||
161983029|NCT01329939|584986991|FG002|Overall Study|Withdrawal by Subject|0|||
161983030|NCT01329939|584986992|FG003|Overall Study|Withdrawal by Subject|0|||
161983031|NCT01329939|584986989|FG000|Overall Study|Adverse Event|0|||
161983032|NCT01329939|584986990|FG001|Overall Study|Adverse Event|0|||
161983033|NCT01329939|584986991|FG002|Overall Study|Adverse Event|0|||
161983034|NCT01329939|584986992|FG003|Overall Study|Adverse Event|3|||
161983035|NCT03722524|584986993|FG000|Overall Study|Protocol Violation|86|||
161983036|NCT03722524|584986993|FG000|Overall Study|Adverse Event|7|||
161983037|NCT03722524|584986993|FG000|Overall Study|Lost to Follow-up|1|||
161983038|NCT03722524|584986993|FG000|Overall Study|Reason is not stated|1|||
161983039|NCT03722524|584986993|FG000|Overall Study|Physician Decision|1|||
161983040|NCT03722524|584986993|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
161983041|NCT04369950|584986995|FG000|Overall Study|Protocol Violation|2|||
161983042|NCT04369950|584986996|FG001|Overall Study|Protocol Violation|2|||
161983043|NCT00989963|584986997|FG000|Overall Study|Adverse Event|1|||
161983044|NCT00989963|584986998|FG001|Overall Study|Adverse Event|1|||
161983045|NCT00989963|584986999|FG002|Overall Study|Adverse Event|1|||
161983046|NCT01240200|584987007|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
161983047|NCT01240200|584987008|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
161983048|NCT03194438|584987013|FG000|Overall Study|Withdrawal by Subject|2|||
161983049|NCT01286740|584987014|FG000|Overall Study|Enrolled but not treated|1|||
161983050|NCT01286740|584987014|FG000|Overall Study|Protocol Violation|1|||
161983051|NCT02335424|584987017|FG000|Overall Study|Withdrawal by Subject|19|||
161983052|NCT02335424|584987017|FG000|Overall Study|Adverse Event|25|||
161983053|NCT02335424|584987017|FG000|Overall Study|Death|273|||
161983054|NCT02335424|584987017|FG000|Overall Study|Lost to Follow-up|3|||
161983055|NCT02335424|584987017|FG000|Overall Study|Physician Decision|13|||
161867839|NCT03782792|584558990|FG001|Overall Study|Patient left the country|1|||
161867840|NCT03782792|584558989|FG000|Overall Study|Withdrawal by Subject|1|||
161867841|NCT03782792|584558990|FG001|Overall Study|Withdrawal by Subject|2|||
161867842|NCT00617890|584558991|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
161867843|NCT00617890|584558992|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
161867844|NCT00617890|584558993|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
161867845|NCT00617890|584558994|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
161867846|NCT00617890|584558991|FG000|Overall Study|Lack of Efficacy|23|||
161867847|NCT00617890|584558992|FG001|Overall Study|Lack of Efficacy|26|||
161867848|NCT00617890|584558993|FG002|Overall Study|Lack of Efficacy|30|||
161867849|NCT00617890|584558994|FG003|Overall Study|Lack of Efficacy|97|||
161867850|NCT00617890|584558991|FG000|Overall Study|Lost to Follow-up|0|||
161867851|NCT00617890|584558992|FG001|Overall Study|Lost to Follow-up|0|||
161867852|NCT00617890|584558993|FG002|Overall Study|Lost to Follow-up|1|||
161867853|NCT00617890|584558994|FG003|Overall Study|Lost to Follow-up|2|||
161867854|NCT00617890|584558991|FG000|Overall Study|Withdrawal by Subject|4|||
161867855|NCT00617890|584558992|FG001|Overall Study|Withdrawal by Subject|1|||
161867856|NCT00617890|584558993|FG002|Overall Study|Withdrawal by Subject|0|||
161867857|NCT00617890|584558994|FG003|Overall Study|Withdrawal by Subject|2|||
161867858|NCT00617890|584558991|FG000|Overall Study|Protocol Violation|2|||
161867859|NCT00617890|584558992|FG001|Overall Study|Protocol Violation|1|||
161867860|NCT00617890|584558993|FG002|Overall Study|Protocol Violation|0|||
161867861|NCT00617890|584558994|FG003|Overall Study|Protocol Violation|0|||
161867862|NCT00617890|584558991|FG000|Overall Study|Adverse Event|1|||
161867863|NCT00617890|584558992|FG001|Overall Study|Adverse Event|0|||
161867864|NCT00617890|584558993|FG002|Overall Study|Adverse Event|3|||
161867865|NCT00617890|584558994|FG003|Overall Study|Adverse Event|8|||
161867866|NCT00617890|584558991|FG000|Overall Study|Not treated|1|||
161867867|NCT00617890|584558992|FG001|Overall Study|Not treated|0|||
161983056|NCT02335424|584987017|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
161983057|NCT02335424|584987017|FG000|Overall Study|Protocol Violation|1|||
161983058|NCT02335424|584987017|FG000|Overall Study|Screen failure|1|||
161983059|NCT01141478|584987018|FG000|Overall Study|Withdrawal by Subject|1|||
161983060|NCT01141478|584987019|FG001|Overall Study|Withdrawal by Subject|1|||
161983061|NCT01581619|584987022|FG000|Overall Study|Withdrawal by Subject|1|||
161983062|NCT01581619|584987022|FG000|Overall Study|Lost to Follow-up|1|||
161983063|NCT00290498|584987023|FG000|Overall Study|Death|2|||
161983064|NCT00290498|584987024|FG001|Overall Study|Death|0|||
161983065|NCT00290498|584987023|FG000|Overall Study|Physician Decision|1|||
161983066|NCT00290498|584987024|FG001|Overall Study|Physician Decision|0|||
161983067|NCT00290498|584987023|FG000|Overall Study|Withdrawal by Subject|1|||
161983068|NCT00290498|584987024|FG001|Overall Study|Withdrawal by Subject|0|||
161983069|NCT00290498|584987023|FG000|Overall Study|Ineligible|3|||
161983070|NCT00290498|584987024|FG001|Overall Study|Ineligible|0|||
161983071|NCT00290498|584987023|FG000|Overall Study|Non-Compliance|1|||
161983072|NCT00290498|584987024|FG001|Overall Study|Non-Compliance|0|||
161983073|NCT03847909|584987027|FG000|Overall Study|Withdrawal by Subject|1|||
161983074|NCT03847909|584987028|FG001|Overall Study|Withdrawal by Subject|1|||
161983075|NCT00599638|584987029|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
161983076|NCT00599638|584987030|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
161983077|NCT00599638|584987031|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
161983078|NCT00599638|584987032|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
161983079|NCT00599638|584987029|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
161983080|NCT00599638|584987030|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
161983081|NCT00599638|584987031|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
161983082|NCT00599638|584987032|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
161983083|NCT00599638|584987029|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
161983084|NCT00599638|584987030|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
161983085|NCT00599638|584987031|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
161983086|NCT00599638|584987032|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
161983087|NCT00599638|584987029|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
161983088|NCT00599638|584987030|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
161983089|NCT00599638|584987031|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
161983090|NCT00599638|584987032|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
161983091|NCT00599638|584987029|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
161983092|NCT00599638|584987030|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
161983093|NCT00599638|584987031|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
161983094|NCT00599638|584987032|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
161983095|NCT00599638|584987029|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
161983096|NCT00599638|584987030|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
161983097|NCT00599638|584987031|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
161983098|NCT00599638|584987032|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
161983099|NCT00599638|584987029|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
161983100|NCT00599638|584987030|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
161983101|NCT00599638|584987031|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
161867868|NCT00617890|584558993|FG002|Overall Study|Not treated|1|||
161867869|NCT00617890|584558994|FG003|Overall Study|Not treated|1|||
161867870|NCT00154284|584558998|FG000|Overall Study|Adverse Event|6|||
161867871|NCT00154284|584558999|FG001|Overall Study|Adverse Event|9|||
161867872|NCT00154284|584558998|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161867873|NCT00154284|584558999|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161867874|NCT00154284|584558998|FG000|Overall Study|Lack of Efficacy|1|||
161867875|NCT00154284|584558999|FG001|Overall Study|Lack of Efficacy|2|||
161867876|NCT00154284|584558998|FG000|Overall Study|Protocol Violation|0|||
161867877|NCT00154284|584558999|FG001|Overall Study|Protocol Violation|1|||
161867878|NCT00427648|584559003|FG000|Overall Study|Protocol Violation|1|||
161867879|NCT00427648|584559004|FG001|Overall Study|Protocol Violation|2|||
161867880|NCT00427648|584559003|FG000|Overall Study|Adverse Event|0|||
161867881|NCT00427648|584559004|FG001|Overall Study|Adverse Event|1|||
161867882|NCT01609296|584559005|FG000|Overall Study|Death|253|||
161867883|NCT01609296|584559005|FG000|Overall Study|Withdrawal by Subject|151|||
161867884|NCT01609296|584559005|FG000|Overall Study|Lost to Follow-up|21|||
161867885|NCT01609296|584559005|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
161867886|NCT01609296|584559005|FG000|Overall Study|missed visit but known to be alive|28|||
161867887|NCT01681212|584559008|FG000|Overall Study|No longer met study criteria|5|||
161867888|NCT01681212|584559008|FG000|Overall Study|Administrative reason by sponsor|1|||
161867889|NCT01464333|584559009|FG000|Overall Study|Adverse Event|34|||
161867890|NCT01464333|584559009|FG000|Overall Study|Lack of Efficacy|72|||
161867891|NCT01464333|584559009|FG000|Overall Study|Withdrawal by Subject|11|||
161867892|NCT01464333|584559009|FG000|Overall Study|Other|4|||
161867893|NCT01464333|584559009|FG000|Overall Study|No Hospital Visit|42|||
161867894|NCT03321968|584559013|FG000|Overall Study|Withdrawal by Subject|1|||
161867895|NCT03321968|584559014|FG001|Overall Study|Withdrawal by Subject|2|||
161867896|NCT03321968|584559015|FG002|Overall Study|Withdrawal by Subject|1|||
161867897|NCT03321968|584559013|FG000|Overall Study|Lost to Follow-up|2|||
161867898|NCT03321968|584559014|FG001|Overall Study|Lost to Follow-up|0|||
161867899|NCT03321968|584559015|FG002|Overall Study|Lost to Follow-up|1|||
161867900|NCT03321968|584559013|FG000|Overall Study|Other than specified|0|||
161867901|NCT03321968|584559014|FG001|Overall Study|Other than specified|0|||
161867902|NCT03321968|584559015|FG002|Overall Study|Other than specified|1|||
161867903|NCT02282813|584559018|FG000|Overall Study|Withdrawal by Subject|4|||
161867904|NCT02282813|584559019|FG001|Overall Study|Withdrawal by Subject|5|||
161867905|NCT02282813|584559020|FG002|Overall Study|Withdrawal by Subject|0|||
161867906|NCT02282813|584559018|FG000|Overall Study|Adverse Event|3|||
161867907|NCT02282813|584559019|FG001|Overall Study|Adverse Event|10|||
161867908|NCT02282813|584559020|FG002|Overall Study|Adverse Event|1|||
161867909|NCT02282813|584559018|FG000|Overall Study|Subject non-compliance|1|||
161867910|NCT02282813|584559019|FG001|Overall Study|Subject non-compliance|4|||
161867911|NCT02282813|584559020|FG002|Overall Study|Subject non-compliance|0|||
161867912|NCT02282813|584559018|FG000|Overall Study|Physician Decision|0|||
161867913|NCT02282813|584559019|FG001|Overall Study|Physician Decision|3|||
161867914|NCT02282813|584559020|FG002|Overall Study|Physician Decision|1|||
161867915|NCT02282813|584559018|FG000|Overall Study|Lost to Follow-up|2|||
161867916|NCT02282813|584559019|FG001|Overall Study|Lost to Follow-up|0|||
161867917|NCT02282813|584559020|FG002|Overall Study|Lost to Follow-up|1|||
161867918|NCT02282813|584559018|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
161867919|NCT02282813|584559019|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
161867920|NCT02282813|584559020|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
161867921|NCT02282813|584559018|FG000|Overall Study|Lack of Efficacy|1|||
161867922|NCT02282813|584559019|FG001|Overall Study|Lack of Efficacy|0|||
161867923|NCT02282813|584559020|FG002|Overall Study|Lack of Efficacy|0|||
161867924|NCT02282813|584559018|FG000|Overall Study|Administrative reasons|0|||
161867925|NCT02282813|584559019|FG001|Overall Study|Administrative reasons|1|||
161867926|NCT02282813|584559020|FG002|Overall Study|Administrative reasons|0|||
161867927|NCT00529308|584559021|FG000|Overall Study|Withdrawal by Subject|1|||
161867928|NCT00529308|584559022|FG001|Overall Study|Withdrawal by Subject|1|||
161867929|NCT06509438|584559023|FG000|Overall Study|Adverse Event|1|||
161867930|NCT06509438|584559023|FG000|Overall Study|Lost to Follow-up|3|||
161867931|NCT00745901|584559025|FG000|Overall Study|Adverse Event|3|||
161867932|NCT00745901|584559026|FG001|Overall Study|Adverse Event|4|||
161867933|NCT00745901|584559025|FG000|Overall Study|Protocol Violation|0|||
161867934|NCT00745901|584559026|FG001|Overall Study|Protocol Violation|1|||
161867935|NCT00745901|584559025|FG000|Overall Study|Withdrawal by Subject|1|||
161867936|NCT00745901|584559026|FG001|Overall Study|Withdrawal by Subject|0|||
161867937|NCT00745901|584559025|FG000|Overall Study|Lost to Follow-up|7|||
161867938|NCT00745901|584559026|FG001|Overall Study|Lost to Follow-up|4|||
161867939|NCT00745901|584559025|FG000|Overall Study|Pregnancy|2|||
161867940|NCT00745901|584559026|FG001|Overall Study|Pregnancy|4|||
161867941|NCT00745901|584559025|FG000|Overall Study|Lack of compliance|2|||
161867942|NCT00745901|584559026|FG001|Overall Study|Lack of compliance|2|||
161867943|NCT00745901|584559025|FG000|Overall Study|Patient's next menses did not start with|1|||
161867944|NCT00745901|584559026|FG001|Overall Study|Patient's next menses did not start with|0|||
161867945|NCT00745901|584559025|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
162034995|NCT04966741|585184825|FG000|Overall Study|Lost to Follow-up|1|||
161867946|NCT00745901|584559026|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
161867947|NCT00745901|584559025|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
161867948|NCT00745901|584559026|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
161867949|NCT00745901|584559025|FG000|Overall Study|Patient didn't take any study medication|7|||
161867950|NCT00745901|584559026|FG001|Overall Study|Patient didn't take any study medication|3|||
161867951|NCT01753310|584559028|FG000|Overall Study|Entered into open label extension study|25|||
161867952|NCT01753310|584559029|FG001|Overall Study|Entered into open label extension study|22|||
161867953|NCT01753310|584559028|FG000|Overall Study|Adverse Event|1|||
161867954|NCT01753310|584559029|FG001|Overall Study|Adverse Event|0|||
161867955|NCT01753310|584559028|FG000|Overall Study|Lost to Follow-up|2|||
161867956|NCT01753310|584559029|FG001|Overall Study|Lost to Follow-up|0|||
161867957|NCT01753310|584559028|FG000|Overall Study|Subject decision|2|||
161867958|NCT01753310|584559029|FG001|Overall Study|Subject decision|2|||
161867959|NCT01753310|584559028|FG000|Overall Study|Sponsor decision|1|||
161867960|NCT01753310|584559029|FG001|Overall Study|Sponsor decision|0|||
161867961|NCT01753310|584559028|FG000|Overall Study|Withdrawal by Subject|1|||
161867962|NCT01753310|584559029|FG001|Overall Study|Withdrawal by Subject|0|||
161867963|NCT05581641|584559030|FG000|Overall Study|Withdrawal by Subject|0|||
161867964|NCT05581641|584559031|FG001|Overall Study|Withdrawal by Subject|1|||
161867965|NCT05581641|584559032|FG002|Overall Study|Withdrawal by Subject|3|||
161867966|NCT05581641|584559033|FG003|Overall Study|Withdrawal by Subject|1|||
161867967|NCT05581641|584559030|FG000|Overall Study|Lost to Follow-up|0|||
161867968|NCT05581641|584559031|FG001|Overall Study|Lost to Follow-up|1|||
161867969|NCT05581641|584559032|FG002|Overall Study|Lost to Follow-up|0|||
161867970|NCT05581641|584559033|FG003|Overall Study|Lost to Follow-up|1|||
161867971|NCT05581641|584559030|FG000|Overall Study|Protocol Violation|1|||
161867972|NCT05581641|584559031|FG001|Overall Study|Protocol Violation|0|||
161867973|NCT05581641|584559032|FG002|Overall Study|Protocol Violation|0|||
161867974|NCT05581641|584559033|FG003|Overall Study|Protocol Violation|0|||
161867975|NCT05581641|584559030|FG000|Overall Study|Other|1|||
161867976|NCT05581641|584559031|FG001|Overall Study|Other|0|||
161867977|NCT05581641|584559032|FG002|Overall Study|Other|2|||
161867978|NCT05581641|584559033|FG003|Overall Study|Other|1|||
161867979|NCT04390763|584559034|FG000|Safety run-in Part|Adverse Event|4|||
161867980|NCT04390763|584559035|FG001|Safety run-in Part|Adverse Event|0|||
161867981|NCT04390763|584559036|FG002|Safety run-in Part|Adverse Event|0|||
161867982|NCT04390763|584559037|FG003|Safety run-in Part|Adverse Event|0|||
161867983|NCT04390763|584559034|FG000|Safety run-in Part|Physician Decision|1|||
161867984|NCT04390763|584559035|FG001|Safety run-in Part|Physician Decision|0|||
161867985|NCT04390763|584559036|FG002|Safety run-in Part|Physician Decision|0|||
161867986|NCT04390763|584559037|FG003|Safety run-in Part|Physician Decision|0|||
161867987|NCT04390763|584559034|FG000|Safety run-in Part|Progressive Disease|6|||
161867988|NCT04390763|584559035|FG001|Safety run-in Part|Progressive Disease|0|||
161867989|NCT04390763|584559036|FG002|Safety run-in Part|Progressive Disease|0|||
161867990|NCT04390763|584559037|FG003|Safety run-in Part|Progressive Disease|0|||
161867991|NCT04390763|584559034|FG000|Randomized Part|Adverse Event|0|||
161867992|NCT04390763|584559035|FG001|Randomized Part|Adverse Event|11|||
161867993|NCT04390763|584559036|FG002|Randomized Part|Adverse Event|5|||
161867994|NCT04390763|584559037|FG003|Randomized Part|Adverse Event|5|||
161867995|NCT04390763|584559034|FG000|Randomized Part|Death|0|||
161867996|NCT04390763|584559035|FG001|Randomized Part|Death|3|||
161867997|NCT04390763|584559036|FG002|Randomized Part|Death|4|||
161867998|NCT04390763|584559037|FG003|Randomized Part|Death|2|||
161867999|NCT04390763|584559034|FG000|Randomized Part|Physician Decision|0|||
161868000|NCT04390763|584559035|FG001|Randomized Part|Physician Decision|2|||
161983102|NCT00599638|584987032|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
161868001|NCT04390763|584559036|FG002|Randomized Part|Physician Decision|2|||
161868002|NCT04390763|584559037|FG003|Randomized Part|Physician Decision|9|||
161868003|NCT04390763|584559034|FG000|Randomized Part|Progressive Disease|0|||
161983103|NCT00599638|584987029|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
161983104|NCT00599638|584987030|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
161868004|NCT04390763|584559035|FG001|Randomized Part|Progressive Disease|24|||
161868005|NCT04390763|584559036|FG002|Randomized Part|Progressive Disease|31|||
161868006|NCT04390763|584559037|FG003|Randomized Part|Progressive Disease|23|||
161983105|NCT00599638|584987031|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
161983106|NCT00599638|584987032|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
161868007|NCT04390763|584559034|FG000|Randomized Part|Study terminated by sponsor|0|||
161868008|NCT04390763|584559035|FG001|Randomized Part|Study terminated by sponsor|1|||
161868009|NCT04390763|584559036|FG002|Randomized Part|Study terminated by sponsor|0|||
161868010|NCT04390763|584559037|FG003|Randomized Part|Study terminated by sponsor|0|||
161868011|NCT04390763|584559034|FG000|Randomized Part|Participant Decision|0|||
161868012|NCT04390763|584559035|FG001|Randomized Part|Participant Decision|5|||
161868013|NCT04390763|584559036|FG002|Randomized Part|Participant Decision|7|||
161868014|NCT04390763|584559037|FG003|Randomized Part|Participant Decision|6|||
161868015|NCT04390763|584559034|FG000|Randomized Part|Not treated|0|||
161868016|NCT04390763|584559035|FG001|Randomized Part|Not treated|4|||
161868017|NCT04390763|584559036|FG002|Randomized Part|Not treated|2|||
161868018|NCT04390763|584559037|FG003|Randomized Part|Not treated|7|||
161868019|NCT01956773|584559042|FG000|Overall Study|Lost to Follow-up|628|||
161868020|NCT01956773|584559043|FG001|Overall Study|Lost to Follow-up|1|||
161868021|NCT01383174|584559046|FG000|3 Month Assessment|Death|0|||
161868022|NCT01383174|584559047|FG001|3 Month Assessment|Death|1|||
161868023|NCT01383174|584559046|FG000|3 Month Assessment|Lost to Follow-up|2|||
161868024|NCT01383174|584559047|FG001|3 Month Assessment|Lost to Follow-up|0|||
161868025|NCT01383174|584559046|FG000|3 Month Assessment|Refused to complete|4|||
161868026|NCT01383174|584559047|FG001|3 Month Assessment|Refused to complete|0|||
161868027|NCT01383174|584559046|FG000|6 Month Assessment|Lost to Follow-up|1|||
161868028|NCT01383174|584559047|FG001|6 Month Assessment|Lost to Follow-up|1|||
161868029|NCT01383174|584559046|FG000|6 Month Assessment|Refused to complete|4|||
161868030|NCT01383174|584559047|FG001|6 Month Assessment|Refused to complete|0|||
161868031|NCT01153815|584559048|FG000|Overall Study|Adverse Event|3|||
161868032|NCT01153815|584559049|FG001|Overall Study|Adverse Event|1|||
161868033|NCT01153815|584559048|FG000|Overall Study|Withdrawal by Subject|6|||
161868034|NCT01153815|584559049|FG001|Overall Study|Withdrawal by Subject|4|||
161868035|NCT02169271|584559052|FG000|Overall Study|Protocol Violation|1|||
161868036|NCT02169271|584559053|FG001|Overall Study|Protocol Violation|2|||
161868037|NCT03591874|584559054|FG000|Overall Study|Adverse Event|4|||
161868038|NCT03591874|584559055|FG001|Overall Study|Adverse Event|0|||
161868039|NCT03591874|584559054|FG000|Overall Study|Withdrawal by Subject|2|||
161868040|NCT03591874|584559055|FG001|Overall Study|Withdrawal by Subject|1|||
161868041|NCT03591874|584559054|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
161868042|NCT03591874|584559055|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
161868043|NCT03591874|584559054|FG000|Overall Study|On Study at Time of Study Termination|12|||
161868044|NCT03591874|584559055|FG001|Overall Study|On Study at Time of Study Termination|6|||
161868045|NCT03194542|584559058|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
161868046|NCT03194542|584559059|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
161868047|NCT03194542|584559060|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
161868048|NCT03194542|584559061|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
161868049|NCT03194542|584559058|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
161868050|NCT03194542|584559059|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
161868051|NCT03194542|584559060|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
161868052|NCT03194542|584559061|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
161868053|NCT03194542|584559058|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
161868054|NCT03194542|584559059|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
161868055|NCT03194542|584559060|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
161868056|NCT03194542|584559061|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
161868057|NCT03194542|584559058|FG000|Overall Study|Loss of Response|4|||
161868058|NCT03194542|584559059|FG001|Overall Study|Loss of Response|2|||
161868059|NCT03194542|584559060|FG002|Overall Study|Loss of Response|3|||
161868060|NCT03194542|584559061|FG003|Overall Study|Loss of Response|4|||
161868061|NCT03194542|584559058|FG000|Overall Study|Physician Decision|0|||
161868062|NCT03194542|584559059|FG001|Overall Study|Physician Decision|1|||
161868063|NCT03194542|584559060|FG002|Overall Study|Physician Decision|0|||
161868064|NCT03194542|584559061|FG003|Overall Study|Physician Decision|0|||
161868065|NCT03194542|584559058|FG000|Overall Study|Lack of Efficacy|2|||
161868066|NCT03194542|584559059|FG001|Overall Study|Lack of Efficacy|2|||
161868067|NCT03194542|584559060|FG002|Overall Study|Lack of Efficacy|2|||
161868068|NCT03194542|584559061|FG003|Overall Study|Lack of Efficacy|6|||
161868069|NCT03194542|584559058|FG000|Overall Study|Withdrawal by Subject|2|||
161868070|NCT03194542|584559059|FG001|Overall Study|Withdrawal by Subject|1|||
161868071|NCT03194542|584559060|FG002|Overall Study|Withdrawal by Subject|5|||
161868072|NCT03194542|584559061|FG003|Overall Study|Withdrawal by Subject|4|||
161868073|NCT03194542|584559058|FG000|Overall Study|Progressive Disease|1|||
161868074|NCT03194542|584559059|FG001|Overall Study|Progressive Disease|0|||
161868075|NCT03194542|584559060|FG002|Overall Study|Progressive Disease|1|||
161868076|NCT03194542|584559061|FG003|Overall Study|Progressive Disease|1|||
161868077|NCT03194542|584559058|FG000|Overall Study|Adverse Event|1|||
161868078|NCT03194542|584559059|FG001|Overall Study|Adverse Event|2|||
161868079|NCT03194542|584559060|FG002|Overall Study|Adverse Event|0|||
161868080|NCT03194542|584559061|FG003|Overall Study|Adverse Event|5|||
161868081|NCT03194542|584559058|FG000|Overall Study|Death|1|||
161868082|NCT03194542|584559059|FG001|Overall Study|Death|2|||
161868083|NCT03194542|584559060|FG002|Overall Study|Death|0|||
161983107|NCT00599638|584987029|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
161868084|NCT03194542|584559061|FG003|Overall Study|Death|5|||
161868085|NCT03194542|584559058|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
161868086|NCT03194542|584559059|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
161868087|NCT03194542|584559060|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
161868088|NCT03194542|584559061|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
161868089|NCT03859427|584559065|FG000|Overall Study|Withdrawal by Subject|4|||
161868090|NCT03859427|584559066|FG001|Overall Study|Withdrawal by Subject|7|||
161868091|NCT03859427|584559065|FG000|Overall Study|Decision by sponsor|0|||
161868092|NCT03859427|584559066|FG001|Overall Study|Decision by sponsor|3|||
161868093|NCT03859427|584559065|FG000|Overall Study|Lost to Follow-up|3|||
161868094|NCT03859427|584559066|FG001|Overall Study|Lost to Follow-up|2|||
161868095|NCT03859427|584559065|FG000|Overall Study|Death|22|||
161868096|NCT03859427|584559066|FG001|Overall Study|Death|25|||
161868097|NCT00722137|584559067|FG000|Overall Study|Overt Disease Progression|5|||
161868098|NCT00722137|584559068|FG001|Overall Study|Overt Disease Progression|4|||
161868099|NCT00722137|584559067|FG000|Overall Study|Adverse Event|17|||
161868100|NCT00722137|584559068|FG001|Overall Study|Adverse Event|21|||
161868101|NCT00722137|584559067|FG000|Overall Study|Death|12|||
161868102|NCT00722137|584559068|FG001|Overall Study|Death|7|||
161868103|NCT00722137|584559067|FG000|Overall Study|Withdrawal by Subject|6|||
161868104|NCT00722137|584559068|FG001|Overall Study|Withdrawal by Subject|9|||
161868105|NCT00722137|584559067|FG000|Overall Study|Other Reason Unknown|3|||
161868106|NCT00722137|584559068|FG001|Overall Study|Other Reason Unknown|4|||
161868107|NCT00722137|584559067|FG000|Overall Study|Randomized But Not Treated|2|||
161868108|NCT00722137|584559068|FG001|Overall Study|Randomized But Not Treated|3|||
161868109|NCT01295671|584560614|FG000|Overall Study|Lost to Follow-up|4|||
161868110|NCT01295671|584560615|FG001|Overall Study|Lost to Follow-up|6|||
161868111|NCT01295671|584560616|FG002|Overall Study|Lost to Follow-up|3|||
161868112|NCT01295671|584560614|FG000|Overall Study|Withdrawal by Subject|3|||
161868113|NCT01295671|584560615|FG001|Overall Study|Withdrawal by Subject|1|||
161868114|NCT01295671|584560616|FG002|Overall Study|Withdrawal by Subject|0|||
161868115|NCT02395848|584560619|FG000|Overall Study|Lost to Follow-up|2|||
161868116|NCT02276560|584560620|FG000|Overall Study|Adverse Event|1|||
161868117|NCT02276560|584560621|FG001|Overall Study|Adverse Event|0|||
161868118|NCT02276560|584560622|FG002|Overall Study|Adverse Event|0|||
161868119|NCT02058537|584560623|FG000|Overall Study|Withdrawal by Subject|1|||
161868120|NCT02126579|584560624|FG000|Overall Study|disease progression|0|||
161868121|NCT02126579|584560625|FG001|Overall Study|disease progression|0|||
161868122|NCT02126579|584560626|FG002|Overall Study|disease progression|0|||
161868123|NCT02126579|584560627|FG003|Overall Study|disease progression|1|||
161868124|NCT02126579|584560628|FG004|Overall Study|disease progression|0|||
161868125|NCT02126579|584560629|FG005|Overall Study|disease progression|0|||
161868126|NCT02126579|584560630|FG006|Overall Study|disease progression|1|||
161868127|NCT01780038|584560633|FG000|Overall Study|Lost to Follow-up|4|||
161868128|NCT01780038|584560634|FG001|Overall Study|Lost to Follow-up|1|||
161868129|NCT01609010|584560637|FG000|Overall Study|Stable disease (SD)|22|||
161868130|NCT01609010|584560638|FG001|Overall Study|Stable disease (SD)|16|||
161868131|NCT01609010|584560637|FG000|Overall Study|Progressive disease (PD)|8|||
161868132|NCT01609010|584560638|FG001|Overall Study|Progressive disease (PD)|10|||
161868133|NCT01609010|584560637|FG000|Overall Study|Adverse Event|3|||
161868134|NCT01609010|584560638|FG001|Overall Study|Adverse Event|6|||
161868135|NCT01609010|584560637|FG000|Overall Study|Withdrawal by Subject|2|||
161868136|NCT01609010|584560638|FG001|Overall Study|Withdrawal by Subject|2|||
161868137|NCT01609010|584560637|FG000|Overall Study|Other|2|||
161868138|NCT01609010|584560638|FG001|Overall Study|Other|0|||
161868139|NCT01609010|584560637|FG000|Overall Study|Other malignancy|1|||
161868140|NCT01609010|584560638|FG001|Overall Study|Other malignancy|0|||
161868141|NCT01609010|584560637|FG000|Overall Study|Pathology review|2|||
161868142|NCT01609010|584560638|FG001|Overall Study|Pathology review|1|||
161868143|NCT01609010|584560637|FG000|Overall Study|Protocol Violation|1|||
161868144|NCT01609010|584560638|FG001|Overall Study|Protocol Violation|1|||
161868145|NCT01609010|584560637|FG000|Overall Study|New cancer|1|||
161868146|NCT01609010|584560638|FG001|Overall Study|New cancer|0|||
161868147|NCT01609010|584560637|FG000|Overall Study|Lost to Follow-up|1|||
161868148|NCT01609010|584560638|FG001|Overall Study|Lost to Follow-up|1|||
161868149|NCT01134107|584560639|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
161868150|NCT01134107|584560640|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
161868151|NCT01134107|584560639|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
161868152|NCT01134107|584560640|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
161868153|NCT01134107|584560639|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
162034996|NCT04966741|585184826|FG001|Overall Study|Lost to Follow-up|0|||
162034997|NCT05101317|585184827|FG000|Week1-13|Adverse Event|0|||
161868154|NCT01134107|584560640|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
161868155|NCT01134107|584560639|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
161868156|NCT01134107|584560640|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
161868157|NCT01134107|584560639|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
161868158|NCT01134107|584560640|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
161868159|NCT01134107|584560639|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
161868160|NCT01134107|584560640|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
161868161|NCT01134107|584560639|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
162034998|NCT05101317|585184828|FG001|Week1-13|Adverse Event|1|||
161868162|NCT01134107|584560640|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
161868163|NCT04541589|584560646|FG000|Treatment Period|Adverse Event|8|||
162034999|NCT05101317|585184829|FG002|Week1-13|Adverse Event|0|||
161868164|NCT04541589|584560647|FG001|Treatment Period|Adverse Event|2|||
161868165|NCT04541589|584560646|FG000|Treatment Period|Physician Decision|3|||
161868166|NCT04541589|584560647|FG001|Treatment Period|Physician Decision|1|||
161868167|NCT04541589|584560646|FG000|Treatment Period|Subject decision|7|||
161868168|NCT04541589|584560647|FG001|Treatment Period|Subject decision|4|||
161868169|NCT04541589|584560646|FG000|Treatment Period|Withdrawal by Subject|1|||
161868170|NCT04541589|584560647|FG001|Treatment Period|Withdrawal by Subject|0|||
161868171|NCT04541589|584560646|FG000|Safety Follow-up Period|Adverse Event|2|||
161868172|NCT04541589|584560647|FG001|Safety Follow-up Period|Adverse Event|1|||
161868173|NCT04541589|584560646|FG000|Safety Follow-up Period|Physician Decision|1|||
161868174|NCT04541589|584560647|FG001|Safety Follow-up Period|Physician Decision|0|||
161868175|NCT04541589|584560646|FG000|Safety Follow-up Period|Subject decision|5|||
161868176|NCT04541589|584560647|FG001|Safety Follow-up Period|Subject decision|3|||
161868177|NCT04541589|584560646|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
161868178|NCT04541589|584560647|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
161868179|NCT03581123|584560650|FG000|2-month Follow-up|Withdrawal by Subject|5|||
161868180|NCT03581123|584560651|FG001|2-month Follow-up|Withdrawal by Subject|4|||
161868181|NCT03581123|584560652|FG002|2-month Follow-up|Withdrawal by Subject|6|||
161868182|NCT03581123|584560653|FG003|2-month Follow-up|Withdrawal by Subject|4|||
161868183|NCT03581123|584560650|FG000|2-month Follow-up|Lost to Follow-up|8|||
161868184|NCT03581123|584560651|FG001|2-month Follow-up|Lost to Follow-up|1|||
161868185|NCT03581123|584560652|FG002|2-month Follow-up|Lost to Follow-up|2|||
161868186|NCT03581123|584560653|FG003|2-month Follow-up|Lost to Follow-up|2|||
161868187|NCT03581123|584560650|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
161868188|NCT03581123|584560651|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
161868189|NCT03581123|584560652|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
161868190|NCT03581123|584560653|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
161868191|NCT03581123|584560650|FG000|6-Month Follow-up|Lost to Follow-up|3|||
161868192|NCT03581123|584560651|FG001|6-Month Follow-up|Lost to Follow-up|3|||
161868193|NCT03581123|584560652|FG002|6-Month Follow-up|Lost to Follow-up|1|||
161868194|NCT03581123|584560653|FG003|6-Month Follow-up|Lost to Follow-up|1|||
161868195|NCT03581123|584560650|FG000|12-Month Follow-up|Lost to Follow-up|4|||
161868196|NCT03581123|584560651|FG001|12-Month Follow-up|Lost to Follow-up|3|||
161868197|NCT03581123|584560652|FG002|12-Month Follow-up|Lost to Follow-up|4|||
161868198|NCT03581123|584560653|FG003|12-Month Follow-up|Lost to Follow-up|5|||
161868199|NCT04195685|584560654|FG000|Overall Study|Withdrawal by Subject|6|||
161868200|NCT04195685|584560655|FG001|Overall Study|Withdrawal by Subject|2|||
161868201|NCT04195685|584560654|FG000|Overall Study|Lost to Follow-up|1|||
161868202|NCT04195685|584560655|FG001|Overall Study|Lost to Follow-up|4|||
161868203|NCT00455403|584560657|FG000|Overall Study|Lost to Follow-up|2|||
161868204|NCT00455403|584560658|FG001|Overall Study|Lost to Follow-up|1|||
161868205|NCT00455403|584560657|FG000|Overall Study|Withdrawal by Subject|1|||
161868206|NCT00455403|584560658|FG001|Overall Study|Withdrawal by Subject|3|||
161868207|NCT00455403|584560657|FG000|Overall Study|Protocol Violation|0|||
161868208|NCT00455403|584560658|FG001|Overall Study|Protocol Violation|2|||
161868209|NCT01812109|584560659|FG000|Overall Study|research personnel delay|16|||
161868210|NCT01812109|584560659|FG000|Overall Study|NIRS Unattainable|17|||
161868211|NCT04630002|584560660|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
161868212|NCT04630002|584560661|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
161868213|NCT04630002|584560662|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
161868214|NCT04630002|584560660|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
161868215|NCT04630002|584560661|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
161868216|NCT04630002|584560662|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
161868217|NCT04630002|584560660|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
161868218|NCT04630002|584560661|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
161868219|NCT04630002|584560662|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
161868220|NCT04630002|584560660|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
161868221|NCT04630002|584560661|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
161868222|NCT04630002|584560662|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
161868223|NCT04630002|584560660|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
161868224|NCT04630002|584560661|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
161868225|NCT04630002|584560662|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
161868226|NCT04630002|584560660|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
161868227|NCT04630002|584560661|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
161868228|NCT04630002|584560662|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
161868229|NCT04630002|584560660|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
161983108|NCT00599638|584987030|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
161868230|NCT04630002|584560661|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
161868231|NCT04630002|584560662|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
161868232|NCT04630002|584560660|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
161868233|NCT04630002|584560661|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
161868234|NCT04630002|584560662|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
161868235|NCT00442897|584560663|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
161868236|NCT00442897|584560664|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
161868237|NCT00442897|584560663|FG000|Base Study (12 Week Follow-up)|Death|0|||
161868238|NCT00442897|584560664|FG001|Base Study (12 Week Follow-up)|Death|1|||
161868239|NCT00442897|584560663|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
161868240|NCT00442897|584560664|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
161868241|NCT00442897|584560663|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
161868242|NCT00442897|584560664|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
161868243|NCT00442897|584560663|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
161868244|NCT00442897|584560664|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
161868245|NCT00442897|584560663|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
161868246|NCT00442897|584560664|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
161868247|NCT00442897|584560663|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
161868248|NCT00442897|584560664|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
161868249|NCT00442897|584560663|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
161868250|NCT00442897|584560664|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
161868251|NCT04498182|584560666|FG000|Overall Study|Adverse Event|2|||
161868252|NCT04498182|584560667|FG001|Overall Study|Adverse Event|3|||
161868253|NCT04498182|584560668|FG002|Overall Study|Adverse Event|2|||
161868254|NCT04498182|584560666|FG000|Overall Study|Withdrawal of Consent|3|||
161868255|NCT04498182|584560667|FG001|Overall Study|Withdrawal of Consent|4|||
161868256|NCT04498182|584560668|FG002|Overall Study|Withdrawal of Consent|3|||
161868257|NCT04498182|584560666|FG000|Overall Study|Non-Compliant|1|||
161868258|NCT04498182|584560667|FG001|Overall Study|Non-Compliant|0|||
161868259|NCT04498182|584560668|FG002|Overall Study|Non-Compliant|1|||
161868260|NCT04498182|584560666|FG000|Overall Study|Lost to Follow-up|0|||
161868261|NCT04498182|584560667|FG001|Overall Study|Lost to Follow-up|0|||
161868262|NCT04498182|584560668|FG002|Overall Study|Lost to Follow-up|1|||
161868263|NCT04498182|584560666|FG000|Overall Study|Investigator Decision|0|||
161868264|NCT04498182|584560667|FG001|Overall Study|Investigator Decision|0|||
161868265|NCT04498182|584560668|FG002|Overall Study|Investigator Decision|1|||
161868266|NCT04498182|584560666|FG000|Overall Study|Protocol Violation|1|||
161868267|NCT04498182|584560667|FG001|Overall Study|Protocol Violation|0|||
161868268|NCT04498182|584560668|FG002|Overall Study|Protocol Violation|2|||
161868269|NCT01372618|584560678|FG000|Overall Study|PI Died. Study Terminated|9|||
161868270|NCT03448419|584560679|FG000|Overall Study|Adverse Event|10|||
161868271|NCT03448419|584560680|FG001|Overall Study|Adverse Event|9|||
161868272|NCT03448419|584560679|FG000|Overall Study|Lost to Follow-up|0|||
161868273|NCT03448419|584560680|FG001|Overall Study|Lost to Follow-up|2|||
161868274|NCT03448419|584560679|FG000|Overall Study|Withdrawal by Subject|3|||
161868275|NCT03448419|584560680|FG001|Overall Study|Withdrawal by Subject|1|||
161868276|NCT03448419|584560679|FG000|Overall Study|Not treated|0|||
161868277|NCT03448419|584560680|FG001|Overall Study|Not treated|1|||
161868278|NCT03448419|584560679|FG000|Overall Study|Patient did not attend all visits|0|||
161868279|NCT03448419|584560680|FG001|Overall Study|Patient did not attend all visits|2|||
161868280|NCT03448419|584560679|FG000|Overall Study|Withdrawn by Sponsor|0|||
161868281|NCT03448419|584560680|FG001|Overall Study|Withdrawn by Sponsor|1|||
161868282|NCT04548193|584560691|FG000|Overall Study|Lost to Follow-up|0|||
161868283|NCT04548193|584560692|FG001|Overall Study|Lost to Follow-up|1|||
161868284|NCT04548193|584560691|FG000|Overall Study|Death|0|||
161868285|NCT04548193|584560692|FG001|Overall Study|Death|1|||
161868286|NCT04548193|584560691|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
161868287|NCT04548193|584560692|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
161868288|NCT04548193|584560691|FG000|Overall Study|Withdrawal by Subject|2|||
161868289|NCT04548193|584560692|FG001|Overall Study|Withdrawal by Subject|2|||
161868290|NCT00630825|584560693|FG000|Overall Study|Adverse Event|4|||
161983109|NCT00599638|584987031|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
161983110|NCT00599638|584987032|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
161983111|NCT03006887|584987036|FG000|Overall Study|Adverse Event|1|||
161983112|NCT03836677|584987037|FG000|Period 1|Adverse Event|0|||
161983113|NCT03836677|584987038|FG001|Period 1|Adverse Event|1|||
161983114|NCT03836677|584987037|FG000|Period 2|Severe non-compliance to protocol|1|||
161868291|NCT00630825|584560694|FG001|Overall Study|Adverse Event|4|||
161868292|NCT00630825|584560695|FG002|Overall Study|Adverse Event|3|||
161868293|NCT00630825|584560696|FG003|Overall Study|Adverse Event|1|||
161983115|NCT03836677|584987038|FG001|Period 2|Severe non-compliance to protocol|0|||
161868294|NCT00630825|584560693|FG000|Overall Study|Entry Criteria Not Met|1|||
161868295|NCT00630825|584560694|FG001|Overall Study|Entry Criteria Not Met|0|||
161868296|NCT00630825|584560695|FG002|Overall Study|Entry Criteria Not Met|2|||
161868297|NCT00630825|584560696|FG003|Overall Study|Entry Criteria Not Met|1|||
161868298|NCT00630825|584560693|FG000|Overall Study|Lost to Follow-up|1|||
161868299|NCT00630825|584560694|FG001|Overall Study|Lost to Follow-up|1|||
161868300|NCT00630825|584560695|FG002|Overall Study|Lost to Follow-up|1|||
161868301|NCT00630825|584560696|FG003|Overall Study|Lost to Follow-up|1|||
161983116|NCT02895945|584987039|FG000|Overall Study|Physician Decision|2|||
161983117|NCT02895945|584987040|FG001|Overall Study|Physician Decision|1|||
161983118|NCT00462748|584987041|FG000|Overall Study|Adverse Event|7|||
161983119|NCT00462748|584987042|FG001|Overall Study|Adverse Event|5|||
161983120|NCT00462748|584987043|FG002|Overall Study|Adverse Event|9|||
161983121|NCT00462748|584987041|FG000|Overall Study|Protocol Violation|0|||
161983122|NCT00462748|584987042|FG001|Overall Study|Protocol Violation|2|||
161983123|NCT00462748|584987043|FG002|Overall Study|Protocol Violation|1|||
161983124|NCT00462748|584987041|FG000|Overall Study|Withdrew consent|3|||
161983125|NCT00462748|584987042|FG001|Overall Study|Withdrew consent|3|||
161983126|NCT00462748|584987043|FG002|Overall Study|Withdrew consent|0|||
161983127|NCT00462748|584987041|FG000|Overall Study|Lost to Follow-up|1|||
161983128|NCT00462748|584987042|FG001|Overall Study|Lost to Follow-up|1|||
161983129|NCT00462748|584987043|FG002|Overall Study|Lost to Follow-up|1|||
161983130|NCT00462748|584987041|FG000|Overall Study|Discontinued after 41 days Rx|1|||
161983131|NCT00462748|584987042|FG001|Overall Study|Discontinued after 41 days Rx|0|||
161983132|NCT00462748|584987043|FG002|Overall Study|Discontinued after 41 days Rx|0|||
161983133|NCT03429543|584987044|FG000|Overall Study|Adverse Event|1|||
161983134|NCT03429543|584987045|FG001|Overall Study|Adverse Event|1|||
161983135|NCT03429543|584987046|FG002|Overall Study|Adverse Event|0|||
161983136|NCT03429543|584987047|FG003|Overall Study|Adverse Event|0|||
161983137|NCT03429543|584987048|FG004|Overall Study|Adverse Event|0|||
161983138|NCT03429543|584987049|FG005|Overall Study|Adverse Event|2|||
161983139|NCT03429543|584987050|FG006|Overall Study|Adverse Event|0|||
161983140|NCT03429543|584987044|FG000|Overall Study|Lost to Follow-up|1|||
161983141|NCT03429543|584987045|FG001|Overall Study|Lost to Follow-up|0|||
161983142|NCT03429543|584987046|FG002|Overall Study|Lost to Follow-up|0|||
161983143|NCT03429543|584987047|FG003|Overall Study|Lost to Follow-up|0|||
161983144|NCT03429543|584987048|FG004|Overall Study|Lost to Follow-up|1|||
161983145|NCT03429543|584987049|FG005|Overall Study|Lost to Follow-up|0|||
161983146|NCT03429543|584987050|FG006|Overall Study|Lost to Follow-up|0|||
161983147|NCT03429543|584987044|FG000|Overall Study|Withdrawal by Subject|5|||
161983148|NCT03429543|584987045|FG001|Overall Study|Withdrawal by Subject|0|||
161983149|NCT03429543|584987046|FG002|Overall Study|Withdrawal by Subject|1|||
161983150|NCT03429543|584987047|FG003|Overall Study|Withdrawal by Subject|2|||
161983151|NCT03429543|584987048|FG004|Overall Study|Withdrawal by Subject|6|||
161983152|NCT03429543|584987049|FG005|Overall Study|Withdrawal by Subject|3|||
161983153|NCT03429543|584987050|FG006|Overall Study|Withdrawal by Subject|1|||
161983154|NCT03429543|584987044|FG000|Overall Study|Other reason than listed|0|||
161983155|NCT03429543|584987045|FG001|Overall Study|Other reason than listed|1|||
161774605|NCT05553600|584217291|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
161774606|NCT05553600|584217288|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
161774607|NCT05553600|584217289|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
161774608|NCT05553600|584217290|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
161774609|NCT05553600|584217291|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
161774610|NCT05553600|584217288|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
161774611|NCT05553600|584217289|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
161774612|NCT05553600|584217290|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
161774613|NCT05553600|584217291|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
161774614|NCT05553600|584217288|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
161774615|NCT05553600|584217289|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
161774616|NCT05553600|584217290|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
161774617|NCT05553600|584217291|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
161774618|NCT05553600|584217288|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
161774619|NCT05553600|584217289|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
161774620|NCT05553600|584217290|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
161774621|NCT05553600|584217291|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
161774622|NCT05553600|584217288|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
161774623|NCT05553600|584217289|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
161774624|NCT05553600|584217290|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
161774625|NCT05553600|584217291|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
161774626|NCT05553600|584217288|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
161774627|NCT05553600|584217289|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
161774628|NCT05553600|584217290|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
161774629|NCT05553600|584217291|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
161983156|NCT03429543|584987046|FG002|Overall Study|Other reason than listed|0|||
161983157|NCT03429543|584987047|FG003|Overall Study|Other reason than listed|0|||
161983158|NCT03429543|584987048|FG004|Overall Study|Other reason than listed|4|||
161983159|NCT03429543|584987049|FG005|Overall Study|Other reason than listed|4|||
161983160|NCT03429543|584987050|FG006|Overall Study|Other reason than listed|0|||
161983161|NCT03429543|584987044|FG000|Overall Study|Not treated|0|||
161983162|NCT03429543|584987045|FG001|Overall Study|Not treated|0|||
161868302|NCT00630825|584560693|FG000|Overall Study|Physician Decision|1|||
161868303|NCT00630825|584560694|FG001|Overall Study|Physician Decision|0|||
161868304|NCT00630825|584560695|FG002|Overall Study|Physician Decision|0|||
161868305|NCT00630825|584560696|FG003|Overall Study|Physician Decision|0|||
161868306|NCT00630825|584560693|FG000|Overall Study|Withdrawal by Subject|2|||
161868307|NCT00630825|584560694|FG001|Overall Study|Withdrawal by Subject|2|||
161868308|NCT00630825|584560695|FG002|Overall Study|Withdrawal by Subject|2|||
161868309|NCT00630825|584560696|FG003|Overall Study|Withdrawal by Subject|3|||
161868310|NCT01081769|584560699|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
161868311|NCT01081769|584560700|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
161868312|NCT01081769|584560699|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
161868313|NCT01081769|584560700|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
161868314|NCT01081769|584560699|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
161868315|NCT01081769|584560700|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
161868316|NCT01081769|584560699|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
161868317|NCT01081769|584560700|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
161868318|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Adverse Event|14|||
161868319|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Adverse Event|11|||
161868320|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Death|1|||
161868321|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Death|1|||
161868322|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
161868323|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
161868324|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
161868325|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
161868326|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Pregnancy|1|||
161868327|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Pregnancy|0|||
161868328|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
161868329|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
161868330|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
161868331|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
161868332|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Other|0|||
161868333|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Other|1|||
161868334|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Ineligibility|3|||
161868335|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Ineligibility|4|||
161868336|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
161868337|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
161868338|NCT01081769|584560699|FG000|CORE Intent-To-Treat|Patient Moved|2|||
161868339|NCT01081769|584560700|FG001|CORE Intent-To-Treat|Patient Moved|2|||
161868340|NCT00558701|584560701|FG000|Overall Study|Protocol Deviations|1|||
161868341|NCT00558701|584560702|FG001|Overall Study|Protocol Deviations|4|||
161868342|NCT02187198|584560703|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
161868343|NCT02187198|584560704|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
161868344|NCT02187198|584560703|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
161868345|NCT02187198|584560704|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
161868346|NCT00546377|584560705|FG000|Overall Study|Deemed ineligible|1|||
161868347|NCT00546377|584560705|FG000|Overall Study|Adverse Event|6|||
161868348|NCT01532518|584560706|FG000|Overall Study|Withdrawal by Subject|0|||
161868349|NCT01532518|584560707|FG001|Overall Study|Withdrawal by Subject|0|||
161868350|NCT01532518|584560708|FG002|Overall Study|Withdrawal by Subject|1|||
161868351|NCT01575834|584560709|FG000|Overall Study|Withdrawal by Subject|352|||
161868352|NCT01575834|584560710|FG001|Overall Study|Withdrawal by Subject|390|||
161868353|NCT01575834|584560709|FG000|Overall Study|Death|81|||
161868354|NCT01575834|584560710|FG001|Overall Study|Death|74|||
161868355|NCT01575834|584560709|FG000|Overall Study|Other|70|||
161868356|NCT01575834|584560710|FG001|Overall Study|Other|70|||
161868357|NCT01575834|584560709|FG000|Overall Study|Adverse Event|63|||
161868358|NCT01575834|584560710|FG001|Overall Study|Adverse Event|61|||
161868359|NCT01575834|584560709|FG000|Overall Study|Lost to Follow-up|55|||
161868360|NCT01575834|584560710|FG001|Overall Study|Lost to Follow-up|68|||
161983163|NCT03429543|584987046|FG002|Overall Study|Not treated|0|||
161983164|NCT03429543|584987047|FG003|Overall Study|Not treated|0|||
161983165|NCT03429543|584987048|FG004|Overall Study|Not treated|1|||
161868361|NCT01575834|584560709|FG000|Overall Study|Noncompliance|52|||
161868362|NCT01575834|584560710|FG001|Overall Study|Noncompliance|27|||
161868363|NCT01575834|584560709|FG000|Overall Study|Administrative decision|15|||
161868364|NCT01575834|584560710|FG001|Overall Study|Administrative decision|33|||
161868365|NCT01575834|584560709|FG000|Overall Study|Ineligibility Determined|5|||
161868366|NCT01575834|584560710|FG001|Overall Study|Ineligibility Determined|8|||
161868367|NCT01575834|584560709|FG000|Overall Study|Protocol Deviation|4|||
161868368|NCT01575834|584560710|FG001|Overall Study|Protocol Deviation|3|||
161868369|NCT01575834|584560709|FG000|Overall Study|Requirement for Alternative Therapy|2|||
161868370|NCT01575834|584560710|FG001|Overall Study|Requirement for Alternative Therapy|4|||
161868371|NCT00488644|584560712|FG000|Overall Study|Not Eligible|1|||
161983166|NCT03429543|584987049|FG005|Overall Study|Not treated|0|||
161983167|NCT03429543|584987050|FG006|Overall Study|Not treated|0|||
161983168|NCT00082381|584987051|FG000|Overall Study|Adverse Event|27|||
161983169|NCT00082381|584987052|FG001|Overall Study|Adverse Event|2|||
161983170|NCT00082381|584987051|FG000|Overall Study|Lost to Follow-up|5|||
161983171|NCT00082381|584987052|FG001|Overall Study|Lost to Follow-up|7|||
161983172|NCT00082381|584987051|FG000|Overall Study|Patient Decision|8|||
161983173|NCT00082381|584987052|FG001|Overall Study|Patient Decision|4|||
161983174|NCT00082381|584987051|FG000|Overall Study|Physician Decision|1|||
161983175|NCT00082381|584987052|FG001|Overall Study|Physician Decision|2|||
161983176|NCT00082381|584987051|FG000|Overall Study|Protocol Violation|10|||
161983177|NCT00082381|584987052|FG001|Overall Study|Protocol Violation|11|||
161983178|NCT00082381|584987051|FG000|Overall Study|Loss of Glucose Control|4|||
161983179|NCT00082381|584987052|FG001|Overall Study|Loss of Glucose Control|0|||
161983180|NCT01729208|584987053|FG000|Baseline|Physician Decision|5|||
161983181|NCT01729208|584987054|FG001|Baseline|Physician Decision|4|||
161983182|NCT01729208|584987053|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
161983183|NCT01729208|584987054|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
161983184|NCT01729208|584987053|FG000|12 Months Follow-up|Lost to Follow-up|3|||
161774630|NCT05553600|584217288|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
161774631|NCT05553600|584217289|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
161774632|NCT05553600|584217290|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
161774633|NCT05553600|584217291|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
161774634|NCT05027958|584217293|FG000|Overall Study|Lost to Follow-up|1|||
161774635|NCT05027958|584217294|FG001|Overall Study|Lost to Follow-up|1|||
161774636|NCT05027958|584217293|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
161774637|NCT05027958|584217294|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
161774638|NCT05027958|584217293|FG000|Overall Study|Physician Decision|1|||
161774639|NCT05027958|584217294|FG001|Overall Study|Physician Decision|4|||
161774640|NCT05027958|584217293|FG000|Overall Study|Adverse Event|0|||
161774641|NCT05027958|584217294|FG001|Overall Study|Adverse Event|1|||
161774642|NCT00890409|584217298|FG000|Overall Study|Lost to Follow-up|20|||
161774643|NCT00890409|584217299|FG001|Overall Study|Lost to Follow-up|21|||
161774644|NCT00455923|584217300|FG000|Overall Study|Pregnancy|0|||
161774645|NCT00455923|584217301|FG001|Overall Study|Pregnancy|2|||
161774646|NCT00455923|584217300|FG000|Overall Study|Other|3|||
161774647|NCT00455923|584217301|FG001|Overall Study|Other|1|||
161774648|NCT02353572|584217302|FG000|Overall Study|Withdrawal by Subject|1|||
161774649|NCT02353572|584217302|FG000|Overall Study|Study terminated|2|||
161774650|NCT01244516|584217303|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
161774651|NCT01244516|584217304|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
161774652|NCT01244516|584217305|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
161774653|NCT01244516|584217303|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
161774654|NCT01244516|584217304|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
161774655|NCT01244516|584217305|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
161774656|NCT01244516|584217303|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
161774657|NCT01244516|584217304|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
161774658|NCT01244516|584217305|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
161774659|NCT01244516|584217303|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
161774660|NCT01244516|584217304|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
161774661|NCT01244516|584217305|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
161774662|NCT01244516|584217303|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
161774663|NCT01244516|584217304|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
161774664|NCT01244516|584217305|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
161774665|NCT01244516|584217303|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
161774666|NCT01244516|584217304|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
161774667|NCT01244516|584217305|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
161774668|NCT01244516|584217303|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
161774669|NCT01244516|584217304|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
161774670|NCT01244516|584217305|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
161774671|NCT04456998|584217310|FG000|Overall Study|Adverse Event|0|||
161774672|NCT04456998|584217311|FG001|Overall Study|Adverse Event|4|||
161774673|NCT04456998|584217310|FG000|Overall Study|Protocol Deviation|0|||
161774674|NCT04456998|584217311|FG001|Overall Study|Protocol Deviation|1|||
161774675|NCT04456998|584217310|FG000|Overall Study|Withdrawal by Subject|0|||
161774676|NCT04456998|584217311|FG001|Overall Study|Withdrawal by Subject|1|||
161774677|NCT03707145|584217315|FG000|Overall Study|Lost to Follow-up|0|||
161774678|NCT03707145|584217316|FG001|Overall Study|Lost to Follow-up|1|||
161774679|NCT03707145|584217317|FG002|Overall Study|Lost to Follow-up|1|||
161774680|NCT03707145|584217318|FG003|Overall Study|Lost to Follow-up|0|||
161774681|NCT04221477|584217319|FG000|Overall Study|Adverse Event|1|||
161774682|NCT04221477|584217320|FG001|Overall Study|Adverse Event|1|||
161774683|NCT04221477|584217319|FG000|Overall Study|Death|5|||
161774684|NCT04221477|584217320|FG001|Overall Study|Death|4|||
161983185|NCT01729208|584987054|FG001|12 Months Follow-up|Lost to Follow-up|3|||
161983186|NCT01729208|584987053|FG000|24 Months Follow-up|Lost to Follow-up|3|||
161983187|NCT01729208|584987054|FG001|24 Months Follow-up|Lost to Follow-up|0|||
161868372|NCT00488644|584560712|FG000|Overall Study|Not Evaluable|1|||
161868373|NCT02503540|584560717|FG000|Overall Study|Death|2|||
161868374|NCT02503540|584560717|FG000|Overall Study|Withdrawal by Subject|1|||
161868375|NCT00564850|584560718|FG000|Overall Study|Protocol Violation|2|||
161868376|NCT00979654|584560719|FG000|Overall Study|Lost to Follow-up|1|||
161868377|NCT00979654|584560719|FG000|Overall Study|Withdrawal by Subject|22|||
161868378|NCT00979654|584560719|FG000|Overall Study|Death|1|||
161868379|NCT00979654|584560719|FG000|Overall Study|Lack of Efficacy|6|||
161868380|NCT00979654|584560719|FG000|Overall Study|Adverse Event|1|||
161868381|NCT00979654|584560719|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
161868382|NCT00979654|584560719|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
161868383|NCT00979654|584560719|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
161868384|NCT00979654|584560719|FG000|Overall Study|Serious Adverse Event|1|||
161868385|NCT00979654|584560719|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
161868386|NCT01804946|584560722|FG000|Overall Study|Protocol Violation|1|||
161868387|NCT01804946|584560723|FG001|Overall Study|Protocol Violation|0|||
161868388|NCT01804946|584560722|FG000|Overall Study|Adverse Event|0|||
161868389|NCT01804946|584560723|FG001|Overall Study|Adverse Event|1|||
161868390|NCT01804946|584560722|FG000|Overall Study|Insufficient data available|0|||
161868391|NCT01804946|584560723|FG001|Overall Study|Insufficient data available|1|||
161868392|NCT01804946|584560722|FG000|Overall Study|Do not meet inclusion criteria|1|||
161868393|NCT01804946|584560723|FG001|Overall Study|Do not meet inclusion criteria|2|||
161868394|NCT03830333|584560726|FG000|Overall Study|Death|0|||
161868395|NCT03830333|584560727|FG001|Overall Study|Death|1|||
161983188|NCT01729208|584987053|FG000|36 Months Follow-up|Physician Decision|1|||
161983189|NCT01729208|584987054|FG001|36 Months Follow-up|Physician Decision|0|||
161983190|NCT01729208|584987053|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
161983191|NCT01729208|584987054|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
161983192|NCT02428413|584987055|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
161983193|NCT02428413|584987056|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
161983194|NCT02428413|584987055|FG000|Overall Study|Protocol Violation|1|||
161983195|NCT02428413|584987056|FG001|Overall Study|Protocol Violation|2|||
161983196|NCT02428413|584987055|FG000|Overall Study|Case Cancelled|2|||
161983197|NCT02428413|584987056|FG001|Overall Study|Case Cancelled|0|||
161983198|NCT02428413|584987055|FG000|Overall Study|Missed Cases|1|||
161983199|NCT02428413|584987056|FG001|Overall Study|Missed Cases|2|||
161983200|NCT02428413|584987055|FG000|Overall Study|Nurse Refusal|1|||
161983201|NCT02428413|584987056|FG001|Overall Study|Nurse Refusal|0|||
161983202|NCT03689855|584987064|FG000|Overall Study|Adverse Event|3|||
161983203|NCT03689855|584987064|FG000|Overall Study|Withdrawal by Subject|1|||
161983204|NCT01300455|584987066|FG000|Washout|Withdrawal by Subject|1|||
161983205|NCT01300455|584987067|FG001|Washout|Withdrawal by Subject|0|||
161983206|NCT03332160|584987075|FG000|Overall Study|Withdrawal by Subject|1|||
161983207|NCT03332160|584987076|FG001|Overall Study|Withdrawal by Subject|1|||
161983208|NCT03332160|584987075|FG000|Overall Study|Adverse Event|0|||
161983209|NCT03332160|584987076|FG001|Overall Study|Adverse Event|1|||
161983210|NCT03332160|584987075|FG000|Overall Study|Developed Exclusion Criteria|0|||
161983211|NCT03332160|584987076|FG001|Overall Study|Developed Exclusion Criteria|1|||
161983212|NCT03332160|584987075|FG000|Overall Study|Non-adherence to treatment|0|||
161983213|NCT03332160|584987076|FG001|Overall Study|Non-adherence to treatment|2|||
161983214|NCT00772109|584987079|FG000|Overall Study|Serious adverse event|1|||
161983215|NCT00772109|584987080|FG001|Overall Study|Serious adverse event|0|||
161983216|NCT00772109|584987081|FG002|Overall Study|Serious adverse event|1|||
161983217|NCT00772109|584987082|FG003|Overall Study|Serious adverse event|0|||
161983218|NCT00772109|584987079|FG000|Overall Study|Protocol Violation|5|||
161983219|NCT00772109|584987080|FG001|Overall Study|Protocol Violation|8|||
161983220|NCT00772109|584987081|FG002|Overall Study|Protocol Violation|7|||
161983221|NCT00772109|584987082|FG003|Overall Study|Protocol Violation|6|||
161983222|NCT00772109|584987079|FG000|Overall Study|Lost to Follow-up|7|||
161983223|NCT00772109|584987080|FG001|Overall Study|Lost to Follow-up|3|||
161983224|NCT00772109|584987081|FG002|Overall Study|Lost to Follow-up|5|||
161983225|NCT00772109|584987082|FG003|Overall Study|Lost to Follow-up|9|||
161983226|NCT00772109|584987079|FG000|Overall Study|Withdrawal by Subject|8|||
161983227|NCT00772109|584987080|FG001|Overall Study|Withdrawal by Subject|8|||
161983228|NCT00772109|584987081|FG002|Overall Study|Withdrawal by Subject|6|||
161983229|NCT00772109|584987082|FG003|Overall Study|Withdrawal by Subject|16|||
161983230|NCT00410605|584987083|FG000|Overall Study|Adverse Event|12|||
161983231|NCT00410605|584987083|FG000|Overall Study|Physician Decision|3|||
161983232|NCT00410605|584987083|FG000|Overall Study|Withdrawal by Subject|5|||
161983233|NCT00410605|584987083|FG000|Overall Study|Started Non-Protocol Therapy|3|||
161868396|NCT03830333|584560726|FG000|Overall Study|Withdrawal by Subject|5|||
161868397|NCT03830333|584560727|FG001|Overall Study|Withdrawal by Subject|1|||
161983234|NCT00410605|584987083|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
161983235|NCT00410605|584987083|FG000|Overall Study|Transferred to another Institution|1|||
161868398|NCT03830333|584560726|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
161868399|NCT03830333|584560727|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
162035000|NCT05101317|585184830|FG003|Week1-13|Adverse Event|0|||
162035001|NCT05101317|585184827|FG000|Week1-13|Withdrawal by Subject|0|||
162035002|NCT05101317|585184828|FG001|Week1-13|Withdrawal by Subject|2|||
161774685|NCT04221477|584217319|FG000|Overall Study|Lack of Efficacy|1|||
161983236|NCT03592368|584988653|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
161983237|NCT03592368|584988654|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
161983238|NCT03592368|584988655|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
161983239|NCT03592368|584988656|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
161983240|NCT03592368|584988653|FG000|Overall Study|Adverse Event|0|||
161983241|NCT03592368|584988654|FG001|Overall Study|Adverse Event|0|||
161983242|NCT03592368|584988655|FG002|Overall Study|Adverse Event|0|||
161983243|NCT03592368|584988656|FG003|Overall Study|Adverse Event|1|||
161983244|NCT03592368|584988653|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
161983245|NCT03592368|584988654|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
161983246|NCT03592368|584988655|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
161983247|NCT03592368|584988656|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
161983248|NCT03047031|584988659|FG000|Overall Study|Other than listed|1|||
161983249|NCT03047031|584988660|FG001|Overall Study|Other than listed|0|||
161983250|NCT03047031|584988661|FG002|Overall Study|Other than listed|0|||
161983251|NCT03047031|584988659|FG000|Overall Study|Lost to Follow-up|4|||
161983252|NCT03047031|584988660|FG001|Overall Study|Lost to Follow-up|0|||
161983253|NCT03047031|584988661|FG002|Overall Study|Lost to Follow-up|0|||
161983254|NCT03047031|584988659|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
161983255|NCT03047031|584988660|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
161983256|NCT03047031|584988661|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
161983257|NCT03047031|584988659|FG000|Overall Study|Adverse Event|1|||
161983258|NCT03047031|584988660|FG001|Overall Study|Adverse Event|0|||
161983259|NCT03047031|584988661|FG002|Overall Study|Adverse Event|0|||
161983260|NCT03047031|584988659|FG000|Overall Study|Withdrawal by Subject|2|||
161983261|NCT03047031|584988660|FG001|Overall Study|Withdrawal by Subject|0|||
161983262|NCT03047031|584988661|FG002|Overall Study|Withdrawal by Subject|0|||
161983263|NCT03047031|584988659|FG000|Overall Study|Change to other medication|2|||
161983264|NCT03047031|584988660|FG001|Overall Study|Change to other medication|0|||
161983265|NCT03047031|584988661|FG002|Overall Study|Change to other medication|0|||
161983266|NCT03047031|584988659|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
161983267|NCT03047031|584988660|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
161983268|NCT03047031|584988661|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
161983269|NCT02814175|584988662|FG000|Part 1|Adverse Event|2|||
161983270|NCT02814175|584988663|FG001|Part 1|Adverse Event|3|||
161983271|NCT02814175|584988664|FG002|Part 1|Adverse Event|0|||
161983272|NCT02814175|584988665|FG003|Part 1|Adverse Event|0|||
161983273|NCT02814175|584988666|FG004|Part 1|Adverse Event|0|||
161983274|NCT02814175|584988667|FG005|Part 1|Adverse Event|0|||
161983275|NCT02814175|584988662|FG000|Part 1|Withdrawal Consent|8|||
161983276|NCT02814175|584988663|FG001|Part 1|Withdrawal Consent|1|||
161983277|NCT02814175|584988664|FG002|Part 1|Withdrawal Consent|0|||
161983278|NCT02814175|584988665|FG003|Part 1|Withdrawal Consent|0|||
161983279|NCT02814175|584988666|FG004|Part 1|Withdrawal Consent|0|||
161983280|NCT02814175|584988667|FG005|Part 1|Withdrawal Consent|0|||
161983281|NCT02814175|584988662|FG000|Part 1|Lost to Follow-up|1|||
162035003|NCT05101317|585184829|FG002|Week1-13|Withdrawal by Subject|0|||
161774686|NCT04221477|584217320|FG001|Overall Study|Lack of Efficacy|2|||
161774687|NCT04221477|584217319|FG000|Overall Study|Lost to Follow-up|1|||
161774688|NCT04221477|584217320|FG001|Overall Study|Lost to Follow-up|2|||
161774689|NCT04221477|584217319|FG000|Overall Study|Non-compliance with Study Drug|1|||
161774690|NCT04221477|584217320|FG001|Overall Study|Non-compliance with Study Drug|0|||
161774691|NCT04221477|584217319|FG000|Overall Study|Reason not Specified|0|||
161774692|NCT04221477|584217320|FG001|Overall Study|Reason not Specified|5|||
161774693|NCT04221477|584217319|FG000|Overall Study|Physician Decision|0|||
161774694|NCT04221477|584217320|FG001|Overall Study|Physician Decision|6|||
161774695|NCT04221477|584217319|FG000|Overall Study|Withdrawal by Subject|10|||
161774696|NCT04221477|584217320|FG001|Overall Study|Withdrawal by Subject|14|||
161774697|NCT04221477|584217319|FG000|Overall Study|Ongoing in the Study|116|||
161774698|NCT04221477|584217320|FG001|Overall Study|Ongoing in the Study|102|||
161774699|NCT02242942|584217321|FG000|Overall Study|Death|17|||
161774700|NCT02242942|584217322|FG001|Overall Study|Death|20|||
161774701|NCT02242942|584217323|FG002|Overall Study|Death|2|||
161774702|NCT02242942|584217321|FG000|Overall Study|Physician Decision|1|||
161774703|NCT02242942|584217322|FG001|Overall Study|Physician Decision|0|||
161774704|NCT02242942|584217323|FG002|Overall Study|Physician Decision|0|||
161774705|NCT02242942|584217321|FG000|Overall Study|Withdrawal by Subject|8|||
161774706|NCT02242942|584217322|FG001|Overall Study|Withdrawal by Subject|10|||
161774707|NCT02242942|584217323|FG002|Overall Study|Withdrawal by Subject|0|||
161983282|NCT02814175|584988663|FG001|Part 1|Lost to Follow-up|0|||
161983283|NCT02814175|584988664|FG002|Part 1|Lost to Follow-up|0|||
161983284|NCT02814175|584988665|FG003|Part 1|Lost to Follow-up|0|||
161983285|NCT02814175|584988666|FG004|Part 1|Lost to Follow-up|0|||
161983286|NCT02814175|584988667|FG005|Part 1|Lost to Follow-up|0|||
161983287|NCT02814175|584988662|FG000|Part 1|Lack of Efficacy|1|||
161983288|NCT02814175|584988663|FG001|Part 1|Lack of Efficacy|2|||
161983289|NCT02814175|584988664|FG002|Part 1|Lack of Efficacy|0|||
161983290|NCT02814175|584988665|FG003|Part 1|Lack of Efficacy|0|||
161983291|NCT02814175|584988666|FG004|Part 1|Lack of Efficacy|0|||
161983292|NCT02814175|584988667|FG005|Part 1|Lack of Efficacy|0|||
162035004|NCT05101317|585184830|FG003|Week1-13|Withdrawal by Subject|0|||
162035005|NCT05101317|585184827|FG000|Week1-13|Early Withdrawl|0|||
162035006|NCT05101317|585184828|FG001|Week1-13|Early Withdrawl|0|||
161774708|NCT02242942|584217321|FG000|Overall Study|On-going in Study|190|||
161774709|NCT02242942|584217322|FG001|Overall Study|On-going in Study|186|||
161774710|NCT02242942|584217323|FG002|Overall Study|On-going in Study|11|||
161774711|NCT04784455|584217324|FG000|Overall Study|Death|4|||
161774712|NCT04882085|584217325|FG000|Overall Study|Death|6|||
161774713|NCT04882085|584217326|FG001|Overall Study|Death|9|||
161774714|NCT04882085|584217325|FG000|Overall Study|Withdrawal by Subject|0|||
161774715|NCT04882085|584217326|FG001|Overall Study|Withdrawal by Subject|3|||
161774716|NCT04882085|584217325|FG000|Overall Study|Randomized not treated|1|||
161774717|NCT04882085|584217326|FG001|Overall Study|Randomized not treated|0|||
161774718|NCT04455620|584217330|FG000|Overall Study|Withdrawal by Subject|0|||
161774719|NCT04455620|584217331|FG001|Overall Study|Withdrawal by Subject|0|||
161774720|NCT04455620|584217332|FG002|Overall Study|Withdrawal by Subject|2|||
161774721|NCT04455620|584217333|FG003|Overall Study|Withdrawal by Subject|0|||
161774722|NCT04455620|584217334|FG004|Overall Study|Withdrawal by Subject|1|||
161774723|NCT04455620|584217330|FG000|Overall Study|Lost to Follow-up|0|||
161774724|NCT04455620|584217331|FG001|Overall Study|Lost to Follow-up|0|||
161774725|NCT04455620|584217332|FG002|Overall Study|Lost to Follow-up|1|||
161774726|NCT04455620|584217333|FG003|Overall Study|Lost to Follow-up|1|||
161774727|NCT04455620|584217334|FG004|Overall Study|Lost to Follow-up|0|||
161774728|NCT04455620|584217330|FG000|Overall Study|Death|1|||
161774729|NCT04455620|584217331|FG001|Overall Study|Death|6|||
161774730|NCT04455620|584217332|FG002|Overall Study|Death|20|||
161774731|NCT04455620|584217333|FG003|Overall Study|Death|1|||
161774732|NCT04455620|584217334|FG004|Overall Study|Death|7|||
161774733|NCT04455620|584217330|FG000|Overall Study|Study Termination|0|||
161774734|NCT04455620|584217331|FG001|Overall Study|Study Termination|2|||
161774735|NCT04455620|584217332|FG002|Overall Study|Study Termination|1|||
161774736|NCT04455620|584217333|FG003|Overall Study|Study Termination|0|||
161774737|NCT04455620|584217334|FG004|Overall Study|Study Termination|6|||
161774738|NCT00965562|584217335|FG000|Overall Study|Lost to Follow-up|1|||
161774739|NCT00965562|584217336|FG001|Overall Study|Lost to Follow-up|2|||
161774740|NCT00965562|584217337|FG002|Overall Study|Lost to Follow-up|3|||
161774741|NCT00965562|584217335|FG000|Overall Study|Withdrawal by Subject|2|||
161774742|NCT00965562|584217336|FG001|Overall Study|Withdrawal by Subject|2|||
161774743|NCT00965562|584217337|FG002|Overall Study|Withdrawal by Subject|0|||
161774744|NCT05681715|584217338|FG000|Training Period (6-weeks)|Adverse Event|3|||
161774745|NCT05681715|584217339|FG001|Training Period (6-weeks)|Adverse Event|0|||
161774746|NCT05681715|584217340|FG002|Training Period (6-weeks)|Adverse Event|0|||
161774747|NCT05681715|584217338|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
161774748|NCT05681715|584217339|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
161774749|NCT05681715|584217340|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
161774750|NCT05681715|584217338|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
161774751|NCT05681715|584217339|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
161774752|NCT05681715|584217340|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
161774753|NCT05681715|584217338|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
161774754|NCT05681715|584217339|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
161774755|NCT05681715|584217340|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
161774756|NCT05681715|584217338|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
161774757|NCT05681715|584217339|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
161774758|NCT05681715|584217340|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
161774759|NCT05681715|584217338|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
161774760|NCT05681715|584217339|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
161983293|NCT02814175|584988662|FG000|Part 2|Adverse Event|0|||
161774761|NCT05681715|584217340|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
161774762|NCT05681715|584217338|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
161774763|NCT05681715|584217339|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
161774764|NCT05681715|584217340|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
161983294|NCT02814175|584988663|FG001|Part 2|Adverse Event|0|||
161983295|NCT02814175|584988664|FG002|Part 2|Adverse Event|0|||
161868400|NCT01129557|584560728|FG000|Overall Study|Adverse Event|1|||
161868401|NCT01129557|584560729|FG001|Overall Study|Adverse Event|2|||
161868402|NCT01129557|584560730|FG002|Overall Study|Adverse Event|2|||
161868403|NCT01129557|584560728|FG000|Overall Study|Novartis terminated study early|3|||
162035007|NCT05101317|585184829|FG002|Week1-13|Early Withdrawl|0|||
162035008|NCT05101317|585184830|FG003|Week1-13|Early Withdrawl|1|||
162035009|NCT05101317|585184827|FG000|Week 13-25|Lost to Follow-up|0|||
162035010|NCT05101317|585184828|FG001|Week 13-25|Lost to Follow-up|0|||
162035011|NCT05101317|585184829|FG002|Week 13-25|Lost to Follow-up|1|||
162035012|NCT05101317|585184830|FG003|Week 13-25|Lost to Follow-up|0|||
162035013|NCT05101317|585184827|FG000|Week 13-25|Withdrawal by Subject|1|||
162035014|NCT05101317|585184828|FG001|Week 13-25|Withdrawal by Subject|1|||
162035015|NCT05101317|585184829|FG002|Week 13-25|Withdrawal by Subject|0|||
161868404|NCT01129557|584560729|FG001|Overall Study|Novartis terminated study early|3|||
161868405|NCT01129557|584560730|FG002|Overall Study|Novartis terminated study early|2|||
161868406|NCT01486446|584560731|FG000|Overall Study|Adverse Event|1|||
161868407|NCT01486446|584560732|FG001|Overall Study|Adverse Event|0|||
161868408|NCT04390113|584560733|FG000|Overall Study|Not Treated|0|||
161868409|NCT04390113|584560734|FG001|Overall Study|Not Treated|1|||
161868410|NCT04390113|584560733|FG000|Overall Study|Adverse Event|1|||
161868411|NCT04390113|584560734|FG001|Overall Study|Adverse Event|0|||
161868412|NCT04390113|584560733|FG000|Overall Study|Death|2|||
161868413|NCT04390113|584560734|FG001|Overall Study|Death|1|||
161868414|NCT04390113|584560733|FG000|Overall Study|Physician Decision|1|||
161868415|NCT04390113|584560734|FG001|Overall Study|Physician Decision|3|||
161868416|NCT04390113|584560733|FG000|Overall Study|Study Terminated by Sponsor|5|||
161868417|NCT04390113|584560734|FG001|Overall Study|Study Terminated by Sponsor|3|||
161868418|NCT04390113|584560733|FG000|Overall Study|Withdrawal by Subject|10|||
161868419|NCT04390113|584560734|FG001|Overall Study|Withdrawal by Subject|5|||
161868420|NCT04390113|584560733|FG000|Overall Study|Other|1|||
161868421|NCT04390113|584560734|FG001|Overall Study|Other|0|||
161868422|NCT04390113|584560733|FG000|Overall Study|Missing|0|||
161868423|NCT04390113|584560734|FG001|Overall Study|Missing|1|||
161868424|NCT04031846|584560738|FG000|Overall Study|Lost to Follow-up|4|||
161868425|NCT04031846|584560739|FG001|Overall Study|Lost to Follow-up|4|||
161868426|NCT04031846|584560738|FG000|Overall Study|Physician Decision|0|||
161868427|NCT04031846|584560739|FG001|Overall Study|Physician Decision|1|||
161868428|NCT04031846|584560738|FG000|Overall Study|Protocol Violation|1|||
161868429|NCT04031846|584560739|FG001|Overall Study|Protocol Violation|1|||
161868430|NCT04031846|584560738|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
161868431|NCT04031846|584560739|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
161868432|NCT02431676|584560740|FG000|Overall Study|no lab obtained|0|||
161868433|NCT02431676|584560741|FG001|Overall Study|no lab obtained|1|||
161868434|NCT02431676|584560742|FG002|Overall Study|no lab obtained|2|||
161868435|NCT00571727|584560743|FG000|Overall Study|Did not enter in this study|1|||
161868436|NCT00571727|584560743|FG000|Overall Study|Non-compliance|4|||
161983296|NCT02814175|584988665|FG003|Part 2|Adverse Event|1|||
161983297|NCT02814175|584988666|FG004|Part 2|Adverse Event|1|||
161983298|NCT02814175|584988667|FG005|Part 2|Adverse Event|2|||
161983299|NCT02814175|584988662|FG000|Part 2|Withdrawal Consent|0|||
161983300|NCT02814175|584988663|FG001|Part 2|Withdrawal Consent|0|||
161983301|NCT02814175|584988664|FG002|Part 2|Withdrawal Consent|0|||
161983302|NCT02814175|584988665|FG003|Part 2|Withdrawal Consent|2|||
161983303|NCT02814175|584988666|FG004|Part 2|Withdrawal Consent|1|||
161983304|NCT02814175|584988667|FG005|Part 2|Withdrawal Consent|1|||
161983305|NCT02814175|584988662|FG000|Part 2|Lost to Follow-up|0|||
161983306|NCT02814175|584988663|FG001|Part 2|Lost to Follow-up|0|||
161983307|NCT02814175|584988664|FG002|Part 2|Lost to Follow-up|0|||
161983308|NCT02814175|584988665|FG003|Part 2|Lost to Follow-up|1|||
161983309|NCT02814175|584988666|FG004|Part 2|Lost to Follow-up|0|||
161983310|NCT02814175|584988667|FG005|Part 2|Lost to Follow-up|0|||
161983311|NCT02814175|584988662|FG000|Part 2|Lack of Efficacy|0|||
161983312|NCT02814175|584988663|FG001|Part 2|Lack of Efficacy|0|||
161983313|NCT02814175|584988664|FG002|Part 2|Lack of Efficacy|0|||
161983314|NCT02814175|584988665|FG003|Part 2|Lack of Efficacy|0|||
161868437|NCT00571727|584560743|FG000|Overall Study|Lost to Follow-up|30|||
161868438|NCT00571727|584560743|FG000|Overall Study|Poor growth|1|||
161868439|NCT00571727|584560743|FG000|Overall Study|Parent/patient decision|2|||
161983315|NCT02814175|584988666|FG004|Part 2|Lack of Efficacy|0|||
162035016|NCT05101317|585184830|FG003|Week 13-25|Withdrawal by Subject|0|||
162035017|NCT05101317|585184827|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
162035018|NCT05101317|585184828|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
161868440|NCT00571727|584560743|FG000|Overall Study|Participant transferred to commercial drug|14|||
162035019|NCT05101317|585184829|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
161868441|NCT00571727|584560743|FG000|Overall Study|Unable to provide study drug|6|||
161868442|NCT00571727|584560743|FG000|Overall Study|On-treatment at end of study|8|||
161983316|NCT02814175|584988667|FG005|Part 2|Lack of Efficacy|3|||
161983317|NCT04207749|584988680|FG000|Overall Study|Lost to Follow-up|0|||
161983318|NCT04207749|584988681|FG001|Overall Study|Lost to Follow-up|2|||
161983319|NCT04207749|584988680|FG000|Overall Study|Protocol Violation|0|||
161983320|NCT04207749|584988681|FG001|Overall Study|Protocol Violation|1|||
161868443|NCT01622673|584560744|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161868444|NCT01622673|584560745|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161868445|NCT01622673|584560746|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161868446|NCT01622673|584560747|FG003|Treatment Period 1|Withdrawal by Subject|1|||
161868447|NCT01622673|584560748|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161868448|NCT01622673|584560749|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161868449|NCT01622673|584560744|FG000|Treatment Period 1|Protocol Violation|0|||
161868450|NCT01622673|584560745|FG001|Treatment Period 1|Protocol Violation|1|||
161868451|NCT01622673|584560746|FG002|Treatment Period 1|Protocol Violation|0|||
161868452|NCT01622673|584560747|FG003|Treatment Period 1|Protocol Violation|0|||
161868453|NCT01622673|584560748|FG004|Treatment Period 1|Protocol Violation|0|||
161868454|NCT01622673|584560749|FG005|Treatment Period 1|Protocol Violation|0|||
161868455|NCT01622673|584560744|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161868456|NCT01622673|584560745|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161868457|NCT01622673|584560746|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161868458|NCT01622673|584560747|FG003|Treatment Period 2|Withdrawal by Subject|1|||
161868459|NCT01622673|584560748|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161868460|NCT01622673|584560749|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161868461|NCT01622673|584560744|FG000|Treatment Period 3|Protocol Violation|0|||
161868462|NCT01622673|584560745|FG001|Treatment Period 3|Protocol Violation|1|||
161868463|NCT01622673|584560746|FG002|Treatment Period 3|Protocol Violation|0|||
161983321|NCT04207749|584988680|FG000|Overall Study|Withdrawal by Subject|3|||
161983322|NCT04207749|584988681|FG001|Overall Study|Withdrawal by Subject|0|||
161983323|NCT04207749|584988680|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
161983324|NCT04207749|584988681|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
161983325|NCT03416127|584988682|FG000|Overall Study|Withdrawal by Subject|0|||
161983326|NCT03416127|584988683|FG001|Overall Study|Withdrawal by Subject|1|||
161983327|NCT03416127|584988684|FG002|Overall Study|Withdrawal by Subject|1|||
161983328|NCT01971008|584988685|FG000|Overall Study|Protocol Violation|2|||
161983329|NCT01971008|584988686|FG001|Overall Study|Protocol Violation|1|||
161983330|NCT00924508|584988687|FG000|Overall Study|Withdrawal by Subject|3|||
161983331|NCT00495625|584988688|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
161983332|NCT03679624|584988689|FG000|Overall Study|Adverse Event|1|||
161983333|NCT03679624|584988690|FG001|Overall Study|Adverse Event|0|||
161983334|NCT01912339|584988691|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
161983335|NCT01912339|584988692|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
161983336|NCT01912339|584988693|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
161983337|NCT01912339|584988691|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
161983338|NCT01912339|584988692|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
161983339|NCT01912339|584988693|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
161983340|NCT01912339|584988691|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
161983341|NCT01912339|584988692|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
161983342|NCT01912339|584988693|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
161983343|NCT01912339|584988691|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
161983344|NCT01912339|584988692|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
161983345|NCT01912339|584988693|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
161983346|NCT01912339|584988691|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
161983347|NCT01912339|584988692|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
161983348|NCT01912339|584988693|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
161983349|NCT01912339|584988691|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
161983350|NCT01912339|584988692|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
161983351|NCT01912339|584988693|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
161983352|NCT01912339|584988691|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
161983353|NCT01912339|584988692|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
161983354|NCT01912339|584988693|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
161983355|NCT01912339|584988691|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
161983356|NCT01912339|584988692|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
161983357|NCT01912339|584988693|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
161983358|NCT01912339|584988691|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
161983359|NCT01912339|584988692|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
161983360|NCT01912339|584988693|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
161983361|NCT01912339|584988691|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
161983362|NCT01912339|584988692|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
161983363|NCT01912339|584988693|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
161983364|NCT01912339|584988691|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
161983365|NCT01912339|584988692|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
161983366|NCT01912339|584988693|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
161868464|NCT01622673|584560747|FG003|Treatment Period 3|Protocol Violation|0|||
161868465|NCT01622673|584560748|FG004|Treatment Period 3|Protocol Violation|0|||
161868466|NCT01622673|584560749|FG005|Treatment Period 3|Protocol Violation|0|||
161868467|NCT01540487|584563007|FG000|Overall Study|Protocol Violation|1|||
161868468|NCT01540487|584563008|FG001|Overall Study|Protocol Violation|0|||
161868469|NCT03503370|584563009|FG000|Overall Study|Death|3|||
161868470|NCT03503370|584563010|FG001|Overall Study|Death|1|||
161868471|NCT03483961|584563011|FG000|Overall Study|Lost to Follow-up|7|||
161868472|NCT03483961|584563012|FG001|Overall Study|Lost to Follow-up|6|||
161868473|NCT03483961|584563013|FG002|Overall Study|Lost to Follow-up|6|||
161868474|NCT03483961|584563014|FG003|Overall Study|Lost to Follow-up|6|||
161868475|NCT03483961|584563015|FG004|Overall Study|Lost to Follow-up|6|||
161868476|NCT03483961|584563016|FG005|Overall Study|Lost to Follow-up|4|||
161868477|NCT03483961|584563017|FG006|Overall Study|Lost to Follow-up|4|||
161868478|NCT03483961|584563018|FG007|Overall Study|Lost to Follow-up|11|||
161868479|NCT03483961|584563019|FG008|Overall Study|Lost to Follow-up|1|||
161868480|NCT03483961|584563020|FG009|Overall Study|Lost to Follow-up|0|||
161868481|NCT03483961|584563011|FG000|Overall Study|Withdrawal by Subject|3|||
161868482|NCT03483961|584563012|FG001|Overall Study|Withdrawal by Subject|4|||
161868483|NCT03483961|584563013|FG002|Overall Study|Withdrawal by Subject|5|||
161868484|NCT03483961|584563014|FG003|Overall Study|Withdrawal by Subject|3|||
161868485|NCT03483961|584563015|FG004|Overall Study|Withdrawal by Subject|4|||
161868486|NCT03483961|584563016|FG005|Overall Study|Withdrawal by Subject|2|||
161868487|NCT03483961|584563017|FG006|Overall Study|Withdrawal by Subject|1|||
161868488|NCT03483961|584563018|FG007|Overall Study|Withdrawal by Subject|2|||
161868489|NCT03483961|584563019|FG008|Overall Study|Withdrawal by Subject|1|||
161868490|NCT03483961|584563020|FG009|Overall Study|Withdrawal by Subject|0|||
161868491|NCT03483961|584563011|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
161868492|NCT03483961|584563012|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868493|NCT03483961|584563013|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868494|NCT03483961|584563014|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868495|NCT03483961|584563015|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868496|NCT03483961|584563016|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868497|NCT03483961|584563017|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868498|NCT03483961|584563018|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868499|NCT03483961|584563019|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868500|NCT03483961|584563020|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161868501|NCT03483961|584563011|FG000|Overall Study|Adverse Event|0|||
161868502|NCT03483961|584563012|FG001|Overall Study|Adverse Event|0|||
161868503|NCT03483961|584563013|FG002|Overall Study|Adverse Event|1|||
161868504|NCT03483961|584563014|FG003|Overall Study|Adverse Event|0|||
161868505|NCT03483961|584563015|FG004|Overall Study|Adverse Event|0|||
161868506|NCT03483961|584563016|FG005|Overall Study|Adverse Event|0|||
161868507|NCT03483961|584563017|FG006|Overall Study|Adverse Event|0|||
161868508|NCT03483961|584563018|FG007|Overall Study|Adverse Event|0|||
161868509|NCT03483961|584563019|FG008|Overall Study|Adverse Event|0|||
161774765|NCT05681715|584217338|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
161774766|NCT05681715|584217339|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
161774767|NCT05681715|584217340|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
161774768|NCT05455684|584217341|FG000|Overall Study|Withdrawal by Subject|7|||
161774769|NCT05455684|584217342|FG001|Overall Study|Withdrawal by Subject|4|||
161774770|NCT05455684|584217341|FG000|Overall Study|Lost to Follow-up|3|||
161774771|NCT05455684|584217342|FG001|Overall Study|Lost to Follow-up|3|||
161774772|NCT05455684|584217341|FG000|Overall Study|Adverse Event|2|||
161774773|NCT05455684|584217342|FG001|Overall Study|Adverse Event|3|||
161774774|NCT05455684|584217341|FG000|Overall Study|Protocol Violation|1|||
161774775|NCT05455684|584217342|FG001|Overall Study|Protocol Violation|1|||
161774776|NCT05455684|584217341|FG000|Overall Study|Non-Compliant with study drug|0|||
161774777|NCT05455684|584217342|FG001|Overall Study|Non-Compliant with study drug|1|||
161774778|NCT05455684|584217341|FG000|Overall Study|Other|1|||
161774779|NCT05455684|584217342|FG001|Overall Study|Other|2|||
161774780|NCT05455684|584217341|FG000|Overall Study|Randomized but not treated|1|||
161774781|NCT05455684|584217342|FG001|Overall Study|Randomized but not treated|0|||
161774782|NCT05204563|584217343|FG000|Overall Study|Other than Specified|2|||
161774783|NCT05204563|584217344|FG001|Overall Study|Other than Specified|1|||
161774784|NCT05204563|584217343|FG000|Overall Study|Death|18|||
161774785|NCT05204563|584217344|FG001|Overall Study|Death|4|||
161774786|NCT05204563|584217343|FG000|Overall Study|Lost to Follow-up|6|||
161774787|NCT05204563|584217344|FG001|Overall Study|Lost to Follow-up|3|||
161774788|NCT05204563|584217343|FG000|Overall Study|Withdrawal by Subject|12|||
161774789|NCT05204563|584217344|FG001|Overall Study|Withdrawal by Subject|3|||
161774790|NCT05204563|584217343|FG000|Overall Study|Enrolled, Not Treated|1|||
161868510|NCT03483961|584563020|FG009|Overall Study|Adverse Event|0|||
161868511|NCT02366637|584563026|FG000|First Intervention Period|Adverse Event|0|||
161868512|NCT02366637|584563027|FG001|First Intervention Period|Adverse Event|1|||
161868513|NCT02366637|584563026|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
161868514|NCT02366637|584563027|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
161868515|NCT02366637|584563026|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
161868516|NCT02366637|584563027|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
161868517|NCT02609607|584563033|FG000|Overall Study|Lost to Follow-up|0|||
161868518|NCT02609607|584563034|FG001|Overall Study|Lost to Follow-up|1|||
161868519|NCT03691207|584563035|FG000|Overall Study|Death|41|||
161868520|NCT03691207|584563036|FG001|Overall Study|Death|26|||
161868521|NCT03691207|584563035|FG000|Overall Study|Lost to Follow-up|1|||
161868522|NCT03691207|584563036|FG001|Overall Study|Lost to Follow-up|1|||
161868523|NCT03691207|584563035|FG000|Overall Study|Withdrawal by Subject|2|||
161868524|NCT03691207|584563036|FG001|Overall Study|Withdrawal by Subject|8|||
161868525|NCT03691207|584563035|FG000|Overall Study|Sponsor decision|1|||
161868526|NCT03691207|584563036|FG001|Overall Study|Sponsor decision|7|||
161868527|NCT00651261|584563037|FG000|Overall Study|Adverse Event|32|||
161868528|NCT00651261|584563038|FG001|Overall Study|Adverse Event|22|||
161868529|NCT00651261|584563037|FG000|Overall Study|Death|18|||
161868530|NCT00651261|584563038|FG001|Overall Study|Death|18|||
161868531|NCT00651261|584563037|FG000|Overall Study|Withdrawal by Subject|22|||
161868532|NCT00651261|584563038|FG001|Overall Study|Withdrawal by Subject|40|||
161868533|NCT00651261|584563037|FG000|Overall Study|Induction failure|24|||
161868534|NCT00651261|584563038|FG001|Overall Study|Induction failure|35|||
161868535|NCT00651261|584563037|FG000|Overall Study|Disease progression|58|||
161868536|NCT00651261|584563038|FG001|Overall Study|Disease progression|58|||
161868537|NCT00651261|584563037|FG000|Overall Study|Alternative therapy|109|||
161868538|NCT00651261|584563038|FG001|Overall Study|Alternative therapy|107|||
161868539|NCT00651261|584563037|FG000|Overall Study|Other disease or participant decisions|23|||
161868540|NCT00651261|584563038|FG001|Overall Study|Other disease or participant decisions|23|||
161868541|NCT00651261|584563037|FG000|Overall Study|Never treated|5|||
161868542|NCT00651261|584563038|FG001|Overall Study|Never treated|3|||
161868543|NCT04509076|584563044|FG000|Overall Study|Withdrawal by Subject|1|||
161868544|NCT04509076|584563045|FG001|Overall Study|Withdrawal by Subject|2|||
161868545|NCT04509076|584563044|FG000|Overall Study|Lost to Follow-up|1|||
161868546|NCT04509076|584563045|FG001|Overall Study|Lost to Follow-up|2|||
161868547|NCT03351608|584563046|FG000|Overall Study|Lost to Follow-up|0|||
161868548|NCT03351608|584563047|FG001|Overall Study|Lost to Follow-up|1|||
161868549|NCT03351608|584563048|FG002|Overall Study|Lost to Follow-up|1|||
161868550|NCT03351608|584563049|FG003|Overall Study|Lost to Follow-up|1|||
161868551|NCT03351608|584563050|FG004|Overall Study|Lost to Follow-up|1|||
161868552|NCT03351608|584563046|FG000|Overall Study|Physician Decision|1|||
161868553|NCT03351608|584563047|FG001|Overall Study|Physician Decision|0|||
161868554|NCT03351608|584563048|FG002|Overall Study|Physician Decision|0|||
161868555|NCT03351608|584563049|FG003|Overall Study|Physician Decision|2|||
161868556|NCT03351608|584563050|FG004|Overall Study|Physician Decision|1|||
161868557|NCT03351608|584563046|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
161868558|NCT03351608|584563047|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
161868559|NCT03351608|584563048|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
161868560|NCT03351608|584563049|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
161868561|NCT03351608|584563050|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
161868562|NCT03351608|584563046|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161868563|NCT03351608|584563047|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161868564|NCT03351608|584563048|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161868565|NCT03351608|584563049|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161868566|NCT03351608|584563050|FG004|Overall Study|Withdrawal by parent/guardian|0|||
161868567|NCT03351608|584563046|FG000|Overall Study|Other|0|||
161868568|NCT03351608|584563047|FG001|Overall Study|Other|1|||
161868569|NCT03351608|584563048|FG002|Overall Study|Other|1|||
161868570|NCT03351608|584563049|FG003|Overall Study|Other|3|||
161868571|NCT03351608|584563050|FG004|Overall Study|Other|0|||
161868572|NCT02877004|584563051|FG000|Overall Study|Pregnancy|0|||
161868573|NCT02877004|584563052|FG001|Overall Study|Pregnancy|0|||
161868574|NCT02877004|584563053|FG002|Overall Study|Pregnancy|1|||
161868575|NCT02727478|584563054|FG000|Overall Study|Withdrawal by Subject|8|||
161868576|NCT02727478|584563055|FG001|Overall Study|Withdrawal by Subject|10|||
161868577|NCT02633293|584563056|FG000|Overall Study|Death|56|||
161868578|NCT02633293|584563056|FG000|Overall Study|Progressive Disease|12|||
161868579|NCT02633293|584563056|FG000|Overall Study|Adverse Event|29|||
161868580|NCT02633293|584563056|FG000|Overall Study|Withdrawal by Subject|41|||
161868581|NCT02633293|584563056|FG000|Overall Study|Protocol Violation|1|||
161868582|NCT02633293|584563056|FG000|Overall Study|Lost to Follow-up|1|||
161868583|NCT02633293|584563056|FG000|Overall Study|Study Terminated by Sponsor|24|||
161868584|NCT02633293|584563056|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
161868585|NCT02633293|584563056|FG000|Overall Study|Lung Transplant|5|||
161868586|NCT02633293|584563056|FG000|Overall Study|Lack of Efficacy|2|||
161868587|NCT02633293|584563056|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
161868588|NCT01343043|584563057|FG000|Overall Study|Disease progression before treatment|1|||
161868589|NCT01343043|584563058|FG001|Overall Study|Disease progression before treatment|0|||
161868590|NCT01343043|584563059|FG002|Overall Study|Disease progression before treatment|0|||
161868591|NCT01343043|584563060|FG003|Overall Study|Disease progression before treatment|0|||
161868592|NCT01343043|584563057|FG000|Overall Study|Withdrawal by Subject|1|||
161868593|NCT01343043|584563058|FG001|Overall Study|Withdrawal by Subject|0|||
161868594|NCT01343043|584563059|FG002|Overall Study|Withdrawal by Subject|0|||
161868595|NCT01343043|584563060|FG003|Overall Study|Withdrawal by Subject|0|||
161868596|NCT01343043|584563057|FG000|Overall Study|Death|1|||
161868597|NCT01343043|584563058|FG001|Overall Study|Death|1|||
161868598|NCT01343043|584563059|FG002|Overall Study|Death|0|||
161868599|NCT01343043|584563060|FG003|Overall Study|Death|1|||
161868600|NCT00502242|584563063|FG000|Overall Study|Lack of Efficacy|1|||
161868601|NCT00502242|584563064|FG001|Overall Study|Lack of Efficacy|11|||
161868602|NCT00502242|584563063|FG000|Overall Study|Adverse Event|31|||
161868603|NCT00502242|584563064|FG001|Overall Study|Adverse Event|20|||
161868604|NCT00502242|584563063|FG000|Overall Study|Physician Decision|2|||
161868605|NCT00502242|584563064|FG001|Overall Study|Physician Decision|3|||
161868606|NCT00502242|584563063|FG000|Overall Study|Other - Unspecified|8|||
161868607|NCT00502242|584563064|FG001|Overall Study|Other - Unspecified|14|||
161868608|NCT00502242|584563063|FG000|Overall Study|Protocol Violation|3|||
161868609|NCT00502242|584563064|FG001|Overall Study|Protocol Violation|1|||
161868610|NCT00502242|584563063|FG000|Overall Study|Withdrawal by Subject|6|||
161868611|NCT00502242|584563064|FG001|Overall Study|Withdrawal by Subject|7|||
161868612|NCT00778817|584563065|FG000|Overall Study|Adverse Event|2|||
161868613|NCT00778817|584563065|FG000|Overall Study|Withdrawal by Subject|2|||
161868614|NCT02509507|584563066|FG000|Overall Study|Death|21|||
161868615|NCT02509507|584563067|FG001|Overall Study|Death|3|||
161868616|NCT02509507|584563068|FG002|Overall Study|Death|22|||
161868617|NCT02509507|584563069|FG003|Overall Study|Death|14|||
161868618|NCT02509507|584563070|FG004|Overall Study|Death|8|||
161868619|NCT02509507|584563071|FG005|Overall Study|Death|12|||
161868620|NCT02509507|584563072|FG006|Overall Study|Death|5|||
161868621|NCT02509507|584563073|FG007|Overall Study|Death|4|||
161868622|NCT02509507|584563074|FG008|Overall Study|Death|8|||
161868623|NCT02509507|584563066|FG000|Overall Study|Lost to Follow-up|0|||
161868624|NCT02509507|584563067|FG001|Overall Study|Lost to Follow-up|1|||
161868625|NCT02509507|584563068|FG002|Overall Study|Lost to Follow-up|0|||
161868626|NCT02509507|584563069|FG003|Overall Study|Lost to Follow-up|0|||
161868627|NCT02509507|584563070|FG004|Overall Study|Lost to Follow-up|0|||
161868628|NCT02509507|584563071|FG005|Overall Study|Lost to Follow-up|2|||
161868629|NCT02509507|584563072|FG006|Overall Study|Lost to Follow-up|0|||
161868630|NCT02509507|584563073|FG007|Overall Study|Lost to Follow-up|0|||
161868631|NCT02509507|584563074|FG008|Overall Study|Lost to Follow-up|0|||
161868632|NCT02509507|584563066|FG000|Overall Study|Withdrawal by Subject|2|||
161868633|NCT02509507|584563067|FG001|Overall Study|Withdrawal by Subject|0|||
161868634|NCT02509507|584563068|FG002|Overall Study|Withdrawal by Subject|1|||
161868635|NCT02509507|584563069|FG003|Overall Study|Withdrawal by Subject|4|||
161868636|NCT02509507|584563070|FG004|Overall Study|Withdrawal by Subject|1|||
161868637|NCT02509507|584563071|FG005|Overall Study|Withdrawal by Subject|3|||
161868638|NCT02509507|584563072|FG006|Overall Study|Withdrawal by Subject|4|||
161868639|NCT02509507|584563073|FG007|Overall Study|Withdrawal by Subject|0|||
161868640|NCT02509507|584563074|FG008|Overall Study|Withdrawal by Subject|1|||
161868641|NCT02356588|584563075|FG000|Overall Study|Lack of Efficacy|4|||
161868642|NCT02356588|584563076|FG001|Overall Study|Lack of Efficacy|10|||
161868643|NCT02356588|584563075|FG000|Overall Study|Adverse Event|0|||
161868644|NCT02356588|584563076|FG001|Overall Study|Adverse Event|2|||
161983367|NCT01912339|584988691|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
161868645|NCT02356588|584563075|FG000|Overall Study|Withdrawal by Subject|1|||
161868646|NCT02356588|584563076|FG001|Overall Study|Withdrawal by Subject|0|||
161868647|NCT02356588|584563075|FG000|Overall Study|Protocol Violation|0|||
161868648|NCT02356588|584563076|FG001|Overall Study|Protocol Violation|1|||
161868649|NCT01418378|584563077|FG000|Overall Study|Death|1|||
161868650|NCT01418378|584563078|FG001|Overall Study|Death|2|||
161868651|NCT01418378|584563077|FG000|Overall Study|Physician Decision|0|||
161868652|NCT01418378|584563078|FG001|Overall Study|Physician Decision|1|||
161868653|NCT01418378|584563077|FG000|Overall Study|ligament imbalance|0|||
161868654|NCT01418378|584563078|FG001|Overall Study|ligament imbalance|1|||
161868655|NCT01418378|584563077|FG000|Overall Study|developed chronic myopathy|0|||
161868656|NCT01418378|584563078|FG001|Overall Study|developed chronic myopathy|1|||
161868657|NCT01346696|584563083|FG000|Overall Study|Death|1|||
161868658|NCT02182843|584563084|FG000|Overall Study|Withdrawal by Subject|7|||
161868659|NCT02182843|584563084|FG000|Overall Study|Lost to Follow-up|2|||
161868660|NCT02182843|584563084|FG000|Overall Study|Adverse Event|1|||
161868661|NCT01051791|584563092|FG000|Overall Study|Failed screening|3|||
161868662|NCT01051791|584563092|FG000|Overall Study|Withdrawal by Subject|1|||
161868663|NCT00288626|584563095|FG000|Overall Study|Death|3|||
161868664|NCT00288626|584563095|FG000|Overall Study|Withdrawal by Subject|4|||
161868665|NCT04610346|584563096|FG000|Overall Study|Withdrawal by Subject|1|||
161868666|NCT04610346|584563097|FG001|Overall Study|Withdrawal by Subject|1|||
161868667|NCT04610346|584563096|FG000|Overall Study|did not complete shelter onboarding|2|||
161868668|NCT04610346|584563097|FG001|Overall Study|did not complete shelter onboarding|1|||
161868669|NCT00558467|584563098|FG000|Overall Study|Adverse Event|1|||
161868670|NCT00558467|584563099|FG001|Overall Study|Adverse Event|2|||
161868671|NCT00558467|584563098|FG000|Overall Study|Lack of Efficacy|0|||
161868672|NCT00558467|584563099|FG001|Overall Study|Lack of Efficacy|1|||
161868673|NCT00558467|584563098|FG000|Overall Study|Patient moving out of state|0|||
161983368|NCT01912339|584988692|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
161983369|NCT01912339|584988693|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
161983370|NCT01912339|584988691|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
161983371|NCT01912339|584988692|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
161983372|NCT01912339|584988693|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
161983373|NCT00741013|584988694|FG000|Overall Study|Adverse Event|1|||
161983374|NCT00741013|584988695|FG001|Overall Study|Adverse Event|0|||
161983375|NCT00741013|584988696|FG002|Overall Study|Adverse Event|0|||
161983376|NCT00741013|584988694|FG000|Overall Study|Withdrawal by Subject|0|||
161983377|NCT00741013|584988695|FG001|Overall Study|Withdrawal by Subject|0|||
161983378|NCT00741013|584988696|FG002|Overall Study|Withdrawal by Subject|1|||
161983379|NCT00741013|584988694|FG000|Overall Study|Discovered failed screen after enrolled|0|||
161983380|NCT00741013|584988695|FG001|Overall Study|Discovered failed screen after enrolled|2|||
161983381|NCT00741013|584988696|FG002|Overall Study|Discovered failed screen after enrolled|0|||
161983382|NCT01754493|584988698|FG000|Overall Study|Adverse Event|1|||
161983383|NCT01754493|584988698|FG000|Overall Study|Lost to Follow-up|3|||
161983384|NCT01754493|584988698|FG000|Overall Study|Withdrawal by Subject|1|||
161983385|NCT01754493|584988698|FG000|Overall Study|Moved out of town|1|||
161983386|NCT01754493|584988698|FG000|Overall Study|Scheduling conflict|1|||
161983387|NCT02702414|584988701|FG000|Overall Study|Death|96|||
161983388|NCT02702414|584988702|FG001|Overall Study|Death|42|||
161983389|NCT02702414|584988701|FG000|Overall Study|Lost to Follow-up|0|||
161983390|NCT02702414|584988702|FG001|Overall Study|Lost to Follow-up|1|||
161983391|NCT02702414|584988701|FG000|Overall Study|Withdrawal by Subject|0|||
161983392|NCT02702414|584988702|FG001|Overall Study|Withdrawal by Subject|1|||
161983393|NCT02702414|584988701|FG000|Overall Study|Protocol Violation|1|||
161983394|NCT02702414|584988702|FG001|Overall Study|Protocol Violation|0|||
161983395|NCT02702414|584988701|FG000|Overall Study|Sponsor Decision|8|||
161983396|NCT02702414|584988702|FG001|Overall Study|Sponsor Decision|7|||
161983397|NCT04541628|584988703|FG000|Overall Study|Study Terminated|1|||
161983398|NCT04541628|584988704|FG001|Overall Study|Study Terminated|1|||
161983399|NCT04541628|584988705|FG002|Overall Study|Study Terminated|1|||
161983400|NCT01452919|584988709|FG000|Open-Label Treatment|Adverse Event|5|||
161983401|NCT01452919|584988710|FG001|Open-Label Treatment|Adverse Event|0|||
161983402|NCT01452919|584988711|FG002|Open-Label Treatment|Adverse Event|0|||
161983403|NCT01452919|584988709|FG000|Open-Label Treatment|Lost to Follow-up|4|||
161983404|NCT01452919|584988710|FG001|Open-Label Treatment|Lost to Follow-up|0|||
161983405|NCT01452919|584988711|FG002|Open-Label Treatment|Lost to Follow-up|0|||
161983406|NCT01452919|584988709|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
161983407|NCT01452919|584988710|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
161983408|NCT01452919|584988711|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
161983409|NCT01452919|584988709|FG000|Open-Label Treatment|Protocol Violation|4|||
161983410|NCT01452919|584988710|FG001|Open-Label Treatment|Protocol Violation|0|||
161983411|NCT01452919|584988711|FG002|Open-Label Treatment|Protocol Violation|0|||
161983412|NCT01452919|584988709|FG000|Open-Label Treatment|Sponsor Decision|1|||
161983413|NCT01452919|584988710|FG001|Open-Label Treatment|Sponsor Decision|0|||
161983414|NCT01452919|584988711|FG002|Open-Label Treatment|Sponsor Decision|0|||
161983415|NCT01452919|584988709|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
161983416|NCT01452919|584988710|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
161983417|NCT01452919|584988711|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
161983418|NCT01452919|584988709|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
161983419|NCT01452919|584988710|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
161983420|NCT01452919|584988711|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
161983421|NCT01452919|584988709|FG000|Randomization Treatment|Adverse Event|0|||
161983422|NCT01452919|584988710|FG001|Randomization Treatment|Adverse Event|0|||
161983423|NCT01452919|584988711|FG002|Randomization Treatment|Adverse Event|2|||
162035020|NCT05101317|585184830|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
162035021|NCT01853618|585184831|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
162035022|NCT01853618|585184832|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
161983424|NCT01452919|584988709|FG000|Randomization Treatment|Sponsor Decision|0|||
161983425|NCT01452919|584988710|FG001|Randomization Treatment|Sponsor Decision|1|||
161983426|NCT01452919|584988711|FG002|Randomization Treatment|Sponsor Decision|0|||
161983427|NCT01452919|584988709|FG000|Randomization Treatment|Withdrawal by Subject|0|||
161983428|NCT01452919|584988710|FG001|Randomization Treatment|Withdrawal by Subject|1|||
161868674|NCT00558467|584563099|FG001|Overall Study|Patient moving out of state|1|||
161868675|NCT00931255|584563100|FG000|Overall Study|Follow up biopsy not done|2|||
161868676|NCT00931255|584563101|FG001|Overall Study|Follow up biopsy not done|3|||
161868677|NCT02019264|584563102|FG000|Overall Study|Not treated|6|||
161868678|NCT02019264|584563103|FG001|Overall Study|Not treated|4|||
161868679|NCT02019264|584563102|FG000|Overall Study|Lost to Follow-up|50|||
161868680|NCT02019264|584563103|FG001|Overall Study|Lost to Follow-up|47|||
161868681|NCT02019264|584563102|FG000|Overall Study|Withdrawal by Subject|142|||
161868682|NCT02019264|584563103|FG001|Overall Study|Withdrawal by Subject|117|||
161868683|NCT02019264|584563102|FG000|Overall Study|Administrative reason|36|||
161868684|NCT02019264|584563103|FG001|Overall Study|Administrative reason|28|||
161868685|NCT02019264|584563102|FG000|Overall Study|Missing|14|||
161868686|NCT02019264|584563103|FG001|Overall Study|Missing|11|||
161868687|NCT00869999|584563115|FG000|Overall Study|Withdrawal by Subject|1|||
161868688|NCT00869999|584563115|FG000|Overall Study|removed prior to starting therapy|1|||
161868689|NCT03674112|584563119|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
161868690|NCT03674112|584563120|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
161868691|NCT03674112|584563119|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
161868692|NCT03674112|584563120|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
161868693|NCT03674112|584563119|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
161868694|NCT03674112|584563120|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
161868695|NCT03674112|584563119|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
161868696|NCT03674112|584563120|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
161868697|NCT03674112|584563119|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
161868698|NCT03674112|584563120|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
161868699|NCT03674112|584563119|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
161868700|NCT03674112|584563120|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
161868701|NCT03674112|584563119|FG000|Follow-Up Period (≥3 Years)|Death|2|||
161868702|NCT03674112|584563120|FG001|Follow-Up Period (≥3 Years)|Death|0|||
161868703|NCT03674112|584563119|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
161868704|NCT03674112|584563120|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
161868705|NCT04157348|584563121|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
161868706|NCT04157348|584563122|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
161868707|NCT04157348|584563121|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
161868708|NCT04157348|584563122|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
161868709|NCT04157348|584563121|FG000|Double-blind Treatment Period|Adverse Event|0|||
161868710|NCT04157348|584563122|FG001|Double-blind Treatment Period|Adverse Event|1|||
161868711|NCT04157348|584563121|FG000|Open-label Extension Period|Adverse Event|1|||
161868712|NCT04157348|584563122|FG001|Open-label Extension Period|Adverse Event|1|||
161868713|NCT04157348|584563121|FG000|Open-label Extension Period|Death|0|||
161868714|NCT04157348|584563122|FG001|Open-label Extension Period|Death|1|||
161868715|NCT04157348|584563121|FG000|Open-label Extension Period|Lack of Efficacy|2|||
161868716|NCT04157348|584563122|FG001|Open-label Extension Period|Lack of Efficacy|2|||
161868717|NCT04157348|584563121|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
161868718|NCT04157348|584563122|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
161868719|NCT04157348|584563121|FG000|Open-label Extension Period|Ongoing|60|||
161868720|NCT04157348|584563122|FG001|Open-label Extension Period|Ongoing|57|||
161868721|NCT04157348|584563121|FG000|Open-label Extension Period|other reasons|1|||
161868722|NCT04157348|584563122|FG001|Open-label Extension Period|other reasons|1|||
161868723|NCT02220764|584563125|FG000|Overall Study|Lost to Follow-up|3|||
161868724|NCT02220764|584563126|FG001|Overall Study|Lost to Follow-up|1|||
161868725|NCT02220764|584563125|FG000|Overall Study|Death|1|||
161868726|NCT02220764|584563126|FG001|Overall Study|Death|0|||
161868727|NCT04526288|584563130|FG000|Overall Study|Disease Progression|1|||
161868728|NCT04526288|584563131|FG001|Overall Study|Disease Progression|0|||
161868729|NCT00952068|584563132|FG000|Overall Study|Adverse Event|3|||
161868730|NCT00952068|584563132|FG000|Overall Study|Withdrawal by Subject|4|||
161868731|NCT04926831|584563133|FG000|Overall Study|Withdrawal by Subject|2|||
161868732|NCT04926831|584563133|FG000|Overall Study|Adverse Event|2|||
161868733|NCT02712554|584563134|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
161868734|NCT02712554|584563135|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
161868735|NCT02712554|584563134|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
161868736|NCT02712554|584563135|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
161868737|NCT02712554|584563134|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
161868738|NCT02712554|584563135|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
161868739|NCT02712554|584563134|FG000|Part B: Qualification Phase|Adverse Event|0|||
161868740|NCT02712554|584563135|FG001|Part B: Qualification Phase|Adverse Event|1|||
161868741|NCT02712554|584563134|FG000|Part B: Treatment Phase|Adverse Event|0|||
161868742|NCT02712554|584563135|FG001|Part B: Treatment Phase|Adverse Event|1|||
161868743|NCT02712554|584563134|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
161868744|NCT02712554|584563135|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
161868745|NCT02712554|584563134|FG000|Part B: Treatment Phase|Other|0|||
161868746|NCT02712554|584563135|FG001|Part B: Treatment Phase|Other|1|||
161868747|NCT01445730|584563136|FG000|Overall Study|Adverse Event|1|||
161983429|NCT01452919|584988711|FG002|Randomization Treatment|Withdrawal by Subject|0|||
161983430|NCT01452919|584988709|FG000|Randomization Treatment|Subject is moving or has moved|0|||
161983431|NCT01452919|584988710|FG001|Randomization Treatment|Subject is moving or has moved|1|||
161983432|NCT01452919|584988711|FG002|Randomization Treatment|Subject is moving or has moved|0|||
161983433|NCT00859937|584988712|FG000|Overall Study|Protocol Violation|1|||
161983434|NCT00859937|584988713|FG001|Overall Study|Protocol Violation|0|||
161983435|NCT00151476|584988714|FG000|FAP Identified Subjects|Protocol Violation|0|||
161983436|NCT00151476|584988715|FG001|FAP Identified Subjects|Protocol Violation|1|||
161983437|NCT00151476|584988714|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
161983438|NCT00151476|584988715|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
161983439|NCT00151476|584988714|FG000|FAP Analyzed Subjects|Other study participation|0|||
161983440|NCT00151476|584988715|FG001|FAP Analyzed Subjects|Other study participation|1|||
161983441|NCT03446456|584988716|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
161983442|NCT03446456|584988717|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
161983443|NCT03446456|584988716|FG000|Overall Study|Lost to Follow-up|1|||
161983444|NCT03446456|584988717|FG001|Overall Study|Lost to Follow-up|3|||
161983445|NCT03446456|584988716|FG000|Overall Study|Participant failed the toxicology test|1|||
161983446|NCT03446456|584988717|FG001|Overall Study|Participant failed the toxicology test|0|||
161983447|NCT03446456|584988716|FG000|Overall Study|Break down of the experimental equipment|1|||
161983448|NCT03446456|584988717|FG001|Overall Study|Break down of the experimental equipment|0|||
161983449|NCT00658814|584988720|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
161983450|NCT00658814|584988721|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
161983451|NCT00658814|584988720|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
161983452|NCT00658814|584988721|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
161983453|NCT00658814|584988720|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
161983454|NCT00658814|584988721|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
161983455|NCT00658814|584988720|FG000|Remission Induction Chemotherapy|Death|1|||
161983456|NCT00658814|584988721|FG001|Remission Induction Chemotherapy|Death|4|||
161983457|NCT00658814|584988720|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
161983458|NCT00658814|584988721|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
161983459|NCT00658814|584988720|FG000|Remission Induction Chemotherapy|Not eligible|1|||
161983460|NCT00658814|584988721|FG001|Remission Induction Chemotherapy|Not eligible|2|||
161983461|NCT00658814|584988720|FG000|Consolidation Therapy|Not protocol specified|0|||
161983462|NCT00658814|584988721|FG001|Consolidation Therapy|Not protocol specified|1|||
161983463|NCT00658814|584988720|FG000|Consolidation Therapy|Not eligible|2|||
161983464|NCT00658814|584988721|FG001|Consolidation Therapy|Not eligible|2|||
161983465|NCT00658814|584988720|FG000|Maintenance Therapy|Adverse Event|1|||
161983466|NCT00658814|584988721|FG001|Maintenance Therapy|Adverse Event|1|||
161983467|NCT00658814|584988720|FG000|Maintenance Therapy|Not protocol specified|1|||
161983468|NCT00658814|584988721|FG001|Maintenance Therapy|Not protocol specified|0|||
161983469|NCT00658814|584988720|FG000|Maintenance Therapy|Not eligible|1|||
161983470|NCT00658814|584988721|FG001|Maintenance Therapy|Not eligible|0|||
161983471|NCT00455143|584988724|FG000|Overall Study|Physician Decision|1|||
161983472|NCT00455143|584988724|FG000|Overall Study|Withdrawal by Subject|1|||
161983473|NCT00455143|584988724|FG000|Overall Study|Staff was not avail to follow patient|2|||
161983474|NCT00455143|584988724|FG000|Overall Study|No longer met Inclusion Criteria|1|||
161983475|NCT00455143|584988724|FG000|Overall Study|Surgical time, staff not available|1|||
161983476|NCT00549770|584988727|FG000|Overall Study|Protocol deviation|1|||
161983477|NCT00549770|584988728|FG001|Overall Study|Protocol deviation|1|||
161983478|NCT00549770|584988729|FG002|Overall Study|Protocol deviation|1|||
161983479|NCT00549770|584988730|FG003|Overall Study|Protocol deviation|2|||
161983480|NCT00549770|584988731|FG004|Overall Study|Protocol deviation|2|||
161983481|NCT00549770|584988732|FG005|Overall Study|Protocol deviation|2|||
161983482|NCT00549770|584988733|FG006|Overall Study|Protocol deviation|1|||
161983483|NCT00549770|584988734|FG007|Overall Study|Protocol deviation|2|||
161983484|NCT00549770|584988727|FG000|Overall Study|Administrative problems|0|||
161983485|NCT00549770|584988728|FG001|Overall Study|Administrative problems|1|||
161983486|NCT00549770|584988729|FG002|Overall Study|Administrative problems|0|||
161983487|NCT00549770|584988730|FG003|Overall Study|Administrative problems|0|||
161983488|NCT00549770|584988731|FG004|Overall Study|Administrative problems|0|||
161983489|NCT00549770|584988732|FG005|Overall Study|Administrative problems|0|||
161983490|NCT00549770|584988733|FG006|Overall Study|Administrative problems|0|||
161983491|NCT00549770|584988734|FG007|Overall Study|Administrative problems|1|||
161983492|NCT00549770|584988727|FG000|Overall Study|Lost to Follow-up|0|||
161983493|NCT00549770|584988728|FG001|Overall Study|Lost to Follow-up|0|||
161983494|NCT00549770|584988729|FG002|Overall Study|Lost to Follow-up|2|||
161983495|NCT00549770|584988730|FG003|Overall Study|Lost to Follow-up|2|||
161983496|NCT00549770|584988731|FG004|Overall Study|Lost to Follow-up|3|||
161983497|NCT00549770|584988732|FG005|Overall Study|Lost to Follow-up|2|||
162035023|NCT01853618|585184833|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
161983498|NCT00549770|584988733|FG006|Overall Study|Lost to Follow-up|0|||
162035024|NCT01853618|585184834|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
162035025|NCT01853618|585184835|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
161983499|NCT00549770|584988734|FG007|Overall Study|Lost to Follow-up|0|||
161983500|NCT00549770|584988727|FG000|Overall Study|Withdrawal by Subject|4|||
161983501|NCT00549770|584988728|FG001|Overall Study|Withdrawal by Subject|6|||
162035026|NCT01853618|585184831|FG000|Overall Study|Progressive disease|1|||
162035027|NCT01853618|585184832|FG001|Overall Study|Progressive disease|1|||
162035028|NCT01853618|585184833|FG002|Overall Study|Progressive disease|1|||
162035029|NCT01853618|585184834|FG003|Overall Study|Progressive disease|1|||
162035030|NCT01853618|585184835|FG004|Overall Study|Progressive disease|2|||
162035031|NCT01853618|585184831|FG000|Overall Study|Physician Decision|0|||
162035032|NCT01853618|585184832|FG001|Overall Study|Physician Decision|1|||
161983502|NCT00549770|584988729|FG002|Overall Study|Withdrawal by Subject|4|||
161983503|NCT00549770|584988730|FG003|Overall Study|Withdrawal by Subject|5|||
161983504|NCT00549770|584988731|FG004|Overall Study|Withdrawal by Subject|6|||
161983505|NCT00549770|584988732|FG005|Overall Study|Withdrawal by Subject|6|||
161983506|NCT00549770|584988733|FG006|Overall Study|Withdrawal by Subject|4|||
161983507|NCT00549770|584988734|FG007|Overall Study|Withdrawal by Subject|9|||
161983508|NCT00549770|584988727|FG000|Overall Study|Lack of Efficacy|1|||
161983509|NCT00549770|584988728|FG001|Overall Study|Lack of Efficacy|0|||
162035033|NCT01853618|585184833|FG002|Overall Study|Physician Decision|1|||
162035034|NCT01853618|585184834|FG003|Overall Study|Physician Decision|0|||
162035035|NCT01853618|585184835|FG004|Overall Study|Physician Decision|0|||
161774791|NCT05204563|584217344|FG001|Overall Study|Enrolled, Not Treated|0|||
161774792|NCT05643573|584217345|FG000|Overall Study|Adverse Event|117|||
161774793|NCT05643573|584217346|FG001|Overall Study|Adverse Event|90|||
161774794|NCT05643573|584217345|FG000|Overall Study|Death|53|||
161774795|NCT05643573|584217346|FG001|Overall Study|Death|57|||
161774796|NCT05643573|584217345|FG000|Overall Study|Lost to Follow-up|6|||
161774797|NCT05643573|584217346|FG001|Overall Study|Lost to Follow-up|3|||
161774798|NCT05643573|584217345|FG000|Overall Study|Other|18|||
161774799|NCT05643573|584217346|FG001|Overall Study|Other|15|||
161774800|NCT05643573|584217345|FG000|Overall Study|Outcome event|64|||
161774801|NCT05643573|584217346|FG001|Overall Study|Outcome event|36|||
161774802|NCT05643573|584217345|FG000|Overall Study|Physician Decision|33|||
161774803|NCT05643573|584217346|FG001|Overall Study|Physician Decision|19|||
161774804|NCT05643573|584217345|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
161774805|NCT05643573|584217346|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
161774806|NCT05643573|584217345|FG000|Overall Study|Site terminated by sponsor|10|||
161774807|NCT05643573|584217346|FG001|Overall Study|Site terminated by sponsor|10|||
161774808|NCT05643573|584217345|FG000|Overall Study|Study terminated by sponsor|1|||
161774809|NCT05643573|584217346|FG001|Overall Study|Study terminated by sponsor|0|||
161774810|NCT05643573|584217345|FG000|Overall Study|Withdrawal by Subject|178|||
161774811|NCT05643573|584217346|FG001|Overall Study|Withdrawal by Subject|130|||
161774812|NCT02268214|584217350|FG000|Overall Study|Subject no longer meets study criteria|0|||
161774813|NCT02268214|584217351|FG001|Overall Study|Subject no longer meets study criteria|2|||
161774814|NCT02268214|584217352|FG002|Overall Study|Subject no longer meets study criteria|0|||
161774815|NCT02268214|584217350|FG000|Overall Study|Pregnancy|2|||
161774816|NCT02268214|584217351|FG001|Overall Study|Pregnancy|2|||
161774817|NCT02268214|584217352|FG002|Overall Study|Pregnancy|1|||
161774818|NCT02268214|584217350|FG000|Overall Study|Lost to Follow-up|3|||
161774819|NCT02268214|584217351|FG001|Overall Study|Lost to Follow-up|3|||
161774820|NCT02268214|584217352|FG002|Overall Study|Lost to Follow-up|4|||
161774821|NCT02268214|584217350|FG000|Overall Study|Lack of Efficacy|1|||
161774822|NCT02268214|584217351|FG001|Overall Study|Lack of Efficacy|0|||
161774823|NCT02268214|584217352|FG002|Overall Study|Lack of Efficacy|2|||
161774824|NCT02268214|584217350|FG000|Overall Study|Adverse Event|11|||
161774825|NCT02268214|584217351|FG001|Overall Study|Adverse Event|14|||
161774826|NCT02268214|584217352|FG002|Overall Study|Adverse Event|9|||
161774827|NCT02268214|584217350|FG000|Overall Study|Withdrawal by Subject|4|||
161868748|NCT01445730|584563136|FG000|Overall Study|For the advice of a dentist|1|||
161983510|NCT00549770|584988729|FG002|Overall Study|Lack of Efficacy|2|||
161983511|NCT00549770|584988730|FG003|Overall Study|Lack of Efficacy|3|||
161983512|NCT00549770|584988731|FG004|Overall Study|Lack of Efficacy|5|||
161983513|NCT00549770|584988732|FG005|Overall Study|Lack of Efficacy|1|||
162035036|NCT01853618|585184831|FG000|Overall Study|Refused further treatment|0|||
162035037|NCT01853618|585184832|FG001|Overall Study|Refused further treatment|0|||
162035038|NCT01853618|585184833|FG002|Overall Study|Refused further treatment|0|||
162035039|NCT01853618|585184834|FG003|Overall Study|Refused further treatment|0|||
161774828|NCT02268214|584217351|FG001|Overall Study|Withdrawal by Subject|5|||
161774829|NCT02268214|584217352|FG002|Overall Study|Withdrawal by Subject|10|||
161774830|NCT02268214|584217350|FG000|Overall Study|Subject request to discontinue treatment|10|||
161774831|NCT02268214|584217351|FG001|Overall Study|Subject request to discontinue treatment|8|||
161774832|NCT02268214|584217352|FG002|Overall Study|Subject request to discontinue treatment|6|||
161774833|NCT02268214|584217350|FG000|Overall Study|Poor/non-compliance|2|||
161774834|NCT02268214|584217351|FG001|Overall Study|Poor/non-compliance|1|||
161983514|NCT00549770|584988733|FG006|Overall Study|Lack of Efficacy|3|||
161868749|NCT01445730|584563136|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
161868750|NCT01367886|584563137|FG000|Overall Study|Lost to Follow-up|4|||
161868751|NCT01367886|584563137|FG000|Overall Study|Lack of Efficacy|2|||
161868752|NCT01367886|584563137|FG000|Overall Study|Death|1|||
161868753|NCT01167140|584563142|FG000|Overall Study|Withdrawal by Subject|1|||
161868754|NCT00985504|584563147|FG000|Acute Treatment Period|Adverse Event|3|||
161868755|NCT00985504|584563148|FG001|Acute Treatment Period|Adverse Event|4|||
161868756|NCT00985504|584563147|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
161868757|NCT00985504|584563148|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
161868758|NCT00985504|584563147|FG000|Acute Treatment Period|Protocol Violation|2|||
161868759|NCT00985504|584563148|FG001|Acute Treatment Period|Protocol Violation|0|||
161868760|NCT00985504|584563147|FG000|Acute Treatment Period|Sponsor Decision|0|||
161868761|NCT00985504|584563148|FG001|Acute Treatment Period|Sponsor Decision|1|||
161868762|NCT00985504|584563147|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
161868763|NCT00985504|584563148|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
161868764|NCT00985504|584563147|FG000|Optimization Period|Adverse Event|7|||
161868765|NCT00985504|584563148|FG001|Optimization Period|Adverse Event|9|||
161868766|NCT00985504|584563147|FG000|Optimization Period|Death|0|||
161868767|NCT00985504|584563148|FG001|Optimization Period|Death|1|||
161868768|NCT00985504|584563147|FG000|Optimization Period|Lack of Efficacy|5|||
161868769|NCT00985504|584563148|FG001|Optimization Period|Lack of Efficacy|3|||
161868770|NCT00985504|584563147|FG000|Optimization Period|Lost to Follow-up|0|||
161868771|NCT00985504|584563148|FG001|Optimization Period|Lost to Follow-up|1|||
161868772|NCT00985504|584563147|FG000|Optimization Period|Physician Decision|1|||
161868773|NCT00985504|584563148|FG001|Optimization Period|Physician Decision|0|||
161868774|NCT00985504|584563147|FG000|Optimization Period|Protocol Violation|3|||
161868775|NCT00985504|584563148|FG001|Optimization Period|Protocol Violation|1|||
161868776|NCT00985504|584563147|FG000|Optimization Period|Withdrawal by Subject|10|||
161868777|NCT00985504|584563148|FG001|Optimization Period|Withdrawal by Subject|8|||
161868778|NCT03805412|584563149|FG000|Overall Study|Lost to Follow-up|0|||
161868779|NCT03805412|584563150|FG001|Overall Study|Lost to Follow-up|1|||
161868780|NCT03711786|584563151|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
161868781|NCT03711786|584563152|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
161868782|NCT03711786|584563151|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
161868783|NCT03711786|584563152|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
161868784|NCT03711786|584563151|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
161868785|NCT03711786|584563152|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
161868786|NCT03711786|584563151|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
161868787|NCT03711786|584563152|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
161868788|NCT03711786|584563151|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
161868789|NCT03711786|584563152|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
161868790|NCT03711786|584563151|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
161868791|NCT03711786|584563152|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
161868792|NCT00669669|584563159|FG000|Overall Study|To late to start treatment|1|||
161868793|NCT01611883|584563160|FG000|Overall Study|Adverse Event|1|||
161868794|NCT01611883|584563161|FG001|Overall Study|Adverse Event|1|||
161868795|NCT03379727|584563163|FG000|Overall Study|Lack of Efficacy|73|||
161868796|NCT03379727|584563163|FG000|Overall Study|Adverse Event|32|||
161868797|NCT03379727|584563163|FG000|Overall Study|Death|18|||
161868798|NCT03379727|584563163|FG000|Overall Study|Patient/guardian decision|17|||
161868799|NCT03379727|584563163|FG000|Overall Study|Physician Decision|104|||
161868800|NCT03379727|584563163|FG000|Overall Study|Protocol Violation|4|||
161868801|NCT03379727|584563163|FG000|Overall Study|Lost to Follow-up|1|||
161868802|NCT00030901|584563166|FG000|Initial Registration|Ineligible|167|||
161868803|NCT00030901|584563167|FG001|Initial Registration|Ineligible|0|||
161868804|NCT00030901|584563168|FG002|Initial Registration|Ineligible|0|||
161868805|NCT00030901|584563166|FG000|Randomization|Adverse Event|0|||
161868806|NCT00030901|584563167|FG001|Randomization|Adverse Event|11|||
161868807|NCT00030901|584563168|FG002|Randomization|Adverse Event|7|||
161868808|NCT00030901|584563166|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
161868809|NCT00030901|584563167|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
161868810|NCT00030901|584563168|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
161868811|NCT00030901|584563166|FG000|Randomization|Progression/Relapse|0|||
161868812|NCT00030901|584563167|FG001|Randomization|Progression/Relapse|22|||
161868813|NCT00030901|584563168|FG002|Randomization|Progression/Relapse|21|||
161868814|NCT00030901|584563166|FG000|Randomization|Death|0|||
161868815|NCT00030901|584563167|FG001|Randomization|Death|1|||
161868816|NCT00030901|584563168|FG002|Randomization|Death|3|||
161868817|NCT00030901|584563166|FG000|Randomization|Other|0|||
161868818|NCT00030901|584563167|FG001|Randomization|Other|36|||
161868819|NCT00030901|584563168|FG002|Randomization|Other|33|||
161868820|NCT00030901|584563166|FG000|Randomization|Ineligible|0|||
161868821|NCT00030901|584563167|FG001|Randomization|Ineligible|15|||
161868822|NCT00030901|584563168|FG002|Randomization|Ineligible|14|||
161868823|NCT02576847|584563169|FG000|Overall Study|Adverse Event|27|||
161868824|NCT02576847|584563169|FG000|Overall Study|Lost to Follow-up|22|||
161868825|NCT02576847|584563169|FG000|Overall Study|Physician Decision|1|||
161868826|NCT02576847|584563169|FG000|Overall Study|Pregnancy|1|||
161868827|NCT02576847|584563169|FG000|Overall Study|Protocol Violation|3|||
161868828|NCT02576847|584563169|FG000|Overall Study|Withdrawal by Subject|78|||
161868829|NCT02576847|584563169|FG000|Overall Study|Other|5|||
161868830|NCT01806051|584563170|FG000|Overall Study|Withdrawal by Subject|6|||
161868831|NCT01205776|584563173|FG000|Overall Study|Lost to Follow-up|53|||
161868832|NCT01205776|584563174|FG001|Overall Study|Lost to Follow-up|61|||
161868833|NCT01205776|584563173|FG000|Overall Study|Withdrawal by Subject|11|||
161868834|NCT01205776|584563174|FG001|Overall Study|Withdrawal by Subject|34|||
161868835|NCT02418182|584563175|FG000|Overall Study|Unable to re-consent|18|||
161868836|NCT02418182|584563176|FG001|Overall Study|Unable to re-consent|15|||
161868837|NCT02418182|584563175|FG000|Overall Study|Lost to Follow-up|0|||
161868838|NCT02418182|584563176|FG001|Overall Study|Lost to Follow-up|2|||
161868839|NCT00734994|584563177|FG000|Overall Study|Withdrawal by Subject|1|||
161868840|NCT02747108|584563183|FG000|Overall Study|Death|2|||
161868841|NCT02747108|584563184|FG001|Overall Study|Death|2|||
161868842|NCT02747108|584563183|FG000|Overall Study|Withdrawal by Subject|1|||
161868843|NCT02747108|584563184|FG001|Overall Study|Withdrawal by Subject|0|||
161868844|NCT02747108|584563183|FG000|Overall Study|Protocol Violation|2|||
161868845|NCT02747108|584563184|FG001|Overall Study|Protocol Violation|0|||
161868846|NCT03103152|584563185|FG000|Overall Study|Physician Decision|5|||
161868847|NCT03103152|584563186|FG001|Overall Study|Physician Decision|2|||
161868848|NCT03103152|584563187|FG002|Overall Study|Physician Decision|6|||
161868849|NCT03103152|584563188|FG003|Overall Study|Physician Decision|3|||
161868850|NCT03103152|584563189|FG004|Overall Study|Physician Decision|3|||
161868851|NCT03103152|584563190|FG005|Overall Study|Physician Decision|1|||
161868852|NCT03103152|584563185|FG000|Overall Study|Protocol Violation|2|||
161868853|NCT03103152|584563186|FG001|Overall Study|Protocol Violation|2|||
161868854|NCT03103152|584563187|FG002|Overall Study|Protocol Violation|1|||
161868855|NCT03103152|584563188|FG003|Overall Study|Protocol Violation|2|||
161868856|NCT03103152|584563189|FG004|Overall Study|Protocol Violation|1|||
161868857|NCT03103152|584563190|FG005|Overall Study|Protocol Violation|1|||
161868858|NCT03103152|584563185|FG000|Overall Study|Inter-current illness|0|||
161868859|NCT03103152|584563186|FG001|Overall Study|Inter-current illness|0|||
161868860|NCT03103152|584563187|FG002|Overall Study|Inter-current illness|1|||
161868861|NCT03103152|584563188|FG003|Overall Study|Inter-current illness|0|||
161868862|NCT03103152|584563189|FG004|Overall Study|Inter-current illness|0|||
161868863|NCT03103152|584563190|FG005|Overall Study|Inter-current illness|0|||
161868864|NCT03103152|584563185|FG000|Overall Study|Death|0|||
161868865|NCT03103152|584563186|FG001|Overall Study|Death|1|||
161868866|NCT03103152|584563187|FG002|Overall Study|Death|0|||
161868867|NCT03103152|584563188|FG003|Overall Study|Death|0|||
161868868|NCT03103152|584563189|FG004|Overall Study|Death|0|||
161868869|NCT03103152|584563190|FG005|Overall Study|Death|0|||
161868870|NCT03103152|584563185|FG000|Overall Study|Adverse Event|0|||
161868871|NCT03103152|584563186|FG001|Overall Study|Adverse Event|0|||
161868872|NCT03103152|584563187|FG002|Overall Study|Adverse Event|1|||
161868873|NCT03103152|584563188|FG003|Overall Study|Adverse Event|0|||
161868874|NCT03103152|584563189|FG004|Overall Study|Adverse Event|0|||
161868875|NCT03103152|584563190|FG005|Overall Study|Adverse Event|1|||
161868876|NCT03103152|584563185|FG000|Overall Study|Withdrawal by Subject|1|||
161868877|NCT03103152|584563186|FG001|Overall Study|Withdrawal by Subject|0|||
161868878|NCT03103152|584563187|FG002|Overall Study|Withdrawal by Subject|1|||
161868879|NCT03103152|584563188|FG003|Overall Study|Withdrawal by Subject|1|||
161868880|NCT03103152|584563189|FG004|Overall Study|Withdrawal by Subject|1|||
161868881|NCT03103152|584563190|FG005|Overall Study|Withdrawal by Subject|1|||
161983515|NCT00549770|584988734|FG007|Overall Study|Lack of Efficacy|8|||
161868882|NCT03103152|584563185|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
161868883|NCT03103152|584563186|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
161868884|NCT03103152|584563187|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
161868885|NCT03103152|584563188|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
161868886|NCT03103152|584563189|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
161868887|NCT03103152|584563190|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
161868888|NCT03103152|584563185|FG000|Overall Study|Unacceptable side effects|0|||
161868889|NCT03103152|584563186|FG001|Overall Study|Unacceptable side effects|0|||
161868890|NCT03103152|584563187|FG002|Overall Study|Unacceptable side effects|0|||
161868891|NCT03103152|584563188|FG003|Overall Study|Unacceptable side effects|0|||
161983516|NCT00549770|584988727|FG000|Overall Study|Abnormal test procedure results|0|||
161983517|NCT00549770|584988728|FG001|Overall Study|Abnormal test procedure results|0|||
161868892|NCT03103152|584563189|FG004|Overall Study|Unacceptable side effects|0|||
161868893|NCT03103152|584563190|FG005|Overall Study|Unacceptable side effects|1|||
161868894|NCT03103152|584563185|FG000|Overall Study|Lost to Follow-up|0|||
161868895|NCT03103152|584563186|FG001|Overall Study|Lost to Follow-up|1|||
161868896|NCT03103152|584563187|FG002|Overall Study|Lost to Follow-up|0|||
161868897|NCT03103152|584563188|FG003|Overall Study|Lost to Follow-up|1|||
161868898|NCT03103152|584563189|FG004|Overall Study|Lost to Follow-up|0|||
161868899|NCT03103152|584563190|FG005|Overall Study|Lost to Follow-up|1|||
161868900|NCT03103152|584563185|FG000|Overall Study|Testicular pain|0|||
161868901|NCT03103152|584563186|FG001|Overall Study|Testicular pain|0|||
161868902|NCT03103152|584563187|FG002|Overall Study|Testicular pain|0|||
161868903|NCT03103152|584563188|FG003|Overall Study|Testicular pain|1|||
161868904|NCT03103152|584563189|FG004|Overall Study|Testicular pain|0|||
161868905|NCT03103152|584563190|FG005|Overall Study|Testicular pain|0|||
161868906|NCT05966584|584563191|FG000|Overall Study|Lost to Follow-up|1|||
161868907|NCT06360588|584564910|FG000|Overall Study|Adverse Event|3|||
161868908|NCT06360588|584564910|FG000|Overall Study|Death|2|||
161868909|NCT06360588|584564910|FG000|Overall Study|Disease Progression|14|||
161868910|NCT06360588|584564910|FG000|Overall Study|Withdrawal by Subject|1|||
161868911|NCT06360588|584564910|FG000|Overall Study|Lack of Efficacy|1|||
161868912|NCT06360588|584564910|FG000|Overall Study|Ineligible|1|||
161868913|NCT04010240|584564911|FG000|Overall Study|IHC not performed|2299|||
161868914|NCT01481766|584564912|FG000|4 months|Lost to Follow-up|3|||
161868915|NCT01481766|584564913|FG001|4 months|Lost to Follow-up|2|||
161868916|NCT01481766|584564914|FG002|4 months|Lost to Follow-up|1|||
161868917|NCT01481766|584564915|FG003|4 months|Lost to Follow-up|5|||
161868918|NCT01481766|584564912|FG000|12 months|Lost to Follow-up|7|||
161868919|NCT01481766|584564913|FG001|12 months|Lost to Follow-up|8|||
161868920|NCT01481766|584564914|FG002|12 months|Lost to Follow-up|5|||
161868921|NCT01481766|584564915|FG003|12 months|Lost to Follow-up|3|||
161868922|NCT00347958|584564916|FG000|Overall Study|Adverse Event|1|||
161868923|NCT00347958|584564916|FG000|Overall Study|Protocol Violation|2|||
161868924|NCT00347958|584564916|FG000|Overall Study|Withdrawal by Subject|1|||
161868925|NCT00754234|584564917|FG000|Overall Study|Withdrawal by Subject|3|||
161868926|NCT00570687|584564918|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868927|NCT00570687|584564919|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868928|NCT00570687|584564920|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868929|NCT00570687|584564921|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868930|NCT00570687|584564922|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
161868931|NCT00570687|584564923|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
161868932|NCT00570687|584564924|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
161868933|NCT00570687|584564925|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
161868934|NCT00570687|584564926|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
161868935|NCT00570687|584564927|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
161868936|NCT00570687|584564918|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868937|NCT00570687|584564919|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868938|NCT00570687|584564920|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868939|NCT00570687|584564921|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868940|NCT00570687|584564922|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868941|NCT00570687|584564923|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868942|NCT00570687|584564924|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868943|NCT00570687|584564925|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868944|NCT00570687|584564926|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
161868945|NCT00570687|584564927|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868946|NCT00570687|584564918|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868947|NCT00570687|584564919|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868948|NCT00570687|584564920|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868949|NCT00570687|584564921|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868950|NCT00570687|584564922|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868951|NCT00570687|584564923|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868952|NCT00570687|584564924|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
161868953|NCT00570687|584564925|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868954|NCT00570687|584564926|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868955|NCT00570687|584564927|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161868956|NCT03263936|584564928|FG000|Overall Study|Adverse Event|0|||
161868957|NCT03263936|584564929|FG001|Overall Study|Adverse Event|1|||
161868958|NCT03263936|584564930|FG002|Overall Study|Adverse Event|0|||
161868959|NCT03263936|584564928|FG000|Overall Study|Death|0|||
161868960|NCT03263936|584564929|FG001|Overall Study|Death|1|||
161868961|NCT03263936|584564930|FG002|Overall Study|Death|0|||
161868962|NCT00298272|584564932|FG000|Double-blind Phase|Adverse Event|2|||
161868963|NCT00298272|584564933|FG001|Double-blind Phase|Adverse Event|0|||
161868964|NCT00298272|584564932|FG000|Double-blind Phase|Failure to Return|2|||
161868965|NCT00298272|584564933|FG001|Double-blind Phase|Failure to Return|0|||
161868966|NCT00298272|584564932|FG000|Double-blind Phase|Protocol Violation|2|||
161868967|NCT00298272|584564933|FG001|Double-blind Phase|Protocol Violation|0|||
161868968|NCT00298272|584564932|FG000|Double-blind Phase|Withdrawal by Subject|2|||
161868969|NCT00298272|584564933|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161868970|NCT00298272|584564932|FG000|Open Label Retreatment Phase|Adverse Event|1|||
161868971|NCT00298272|584564933|FG001|Open Label Retreatment Phase|Adverse Event|2|||
161983518|NCT00549770|584988729|FG002|Overall Study|Abnormal test procedure results|0|||
161983519|NCT00549770|584988730|FG003|Overall Study|Abnormal test procedure results|2|||
161983520|NCT00549770|584988731|FG004|Overall Study|Abnormal test procedure results|0|||
161983521|NCT00549770|584988732|FG005|Overall Study|Abnormal test procedure results|1|||
161983522|NCT00549770|584988733|FG006|Overall Study|Abnormal test procedure results|1|||
161983523|NCT00549770|584988734|FG007|Overall Study|Abnormal test procedure results|1|||
161983524|NCT00549770|584988727|FG000|Overall Study|Abnormal laboratory values|0|||
161983525|NCT00549770|584988728|FG001|Overall Study|Abnormal laboratory values|0|||
161983526|NCT00549770|584988729|FG002|Overall Study|Abnormal laboratory values|0|||
161983527|NCT00549770|584988730|FG003|Overall Study|Abnormal laboratory values|0|||
161983528|NCT00549770|584988731|FG004|Overall Study|Abnormal laboratory values|0|||
161983529|NCT00549770|584988732|FG005|Overall Study|Abnormal laboratory values|1|||
161983530|NCT00549770|584988733|FG006|Overall Study|Abnormal laboratory values|0|||
161983531|NCT00549770|584988734|FG007|Overall Study|Abnormal laboratory values|0|||
161983532|NCT00549770|584988727|FG000|Overall Study|Adverse Event|1|||
161983533|NCT00549770|584988728|FG001|Overall Study|Adverse Event|3|||
161983534|NCT00549770|584988729|FG002|Overall Study|Adverse Event|1|||
161983535|NCT00549770|584988730|FG003|Overall Study|Adverse Event|2|||
161983536|NCT00549770|584988731|FG004|Overall Study|Adverse Event|1|||
161983537|NCT00549770|584988732|FG005|Overall Study|Adverse Event|0|||
161983538|NCT00549770|584988733|FG006|Overall Study|Adverse Event|5|||
161983539|NCT00549770|584988734|FG007|Overall Study|Adverse Event|4|||
161983540|NCT04856904|584988737|FG000|Overall Study|Physician Decision|1|||
161983541|NCT04856904|584988738|FG001|Overall Study|Physician Decision|1|||
161983542|NCT04856904|584988737|FG000|Overall Study|Withdrawal by Subject|13|||
161983543|NCT04856904|584988738|FG001|Overall Study|Withdrawal by Subject|13|||
161983544|NCT04856904|584988737|FG000|Overall Study|Adverse Event|1|||
161983545|NCT04856904|584988738|FG001|Overall Study|Adverse Event|1|||
161983546|NCT04856904|584988737|FG000|Overall Study|Non-compliance with study drug|1|||
161983547|NCT04856904|584988738|FG001|Overall Study|Non-compliance with study drug|1|||
161983548|NCT04856904|584988737|FG000|Overall Study|Lost to Follow-up|4|||
161983549|NCT04856904|584988738|FG001|Overall Study|Lost to Follow-up|4|||
161983550|NCT04856904|584988737|FG000|Overall Study|Withdrawal by Subject|1|||
161983551|NCT04856904|584988738|FG001|Overall Study|Withdrawal by Subject|1|||
161983552|NCT04856904|584988737|FG000|Overall Study|Protocol Violation|1|||
161983553|NCT04856904|584988738|FG001|Overall Study|Protocol Violation|1|||
161983554|NCT02712424|584988739|FG000|Overall Study|Lost to Follow-up|34|||
161983555|NCT02712424|584988740|FG001|Overall Study|Lost to Follow-up|32|||
161983556|NCT00847015|584988741|FG000|Overall Study|Withdrawal by Subject|1|||
161983557|NCT00847015|584988741|FG000|Overall Study|declined any surgery|1|||
161983558|NCT00847015|584988741|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
161983559|NCT01641822|584988744|FG000|Run-in Phase|Noncompliance with study drug|1|||
161983560|NCT01641822|584988745|FG001|Run-in Phase|Noncompliance with study drug|0|||
161983561|NCT01641822|584988746|FG002|Run-in Phase|Noncompliance with study drug|0|||
161983562|NCT01641822|584988744|FG000|Run-in Phase|Adverse Event|3|||
161983563|NCT01641822|584988745|FG001|Run-in Phase|Adverse Event|0|||
161983564|NCT01641822|584988746|FG002|Run-in Phase|Adverse Event|0|||
161983565|NCT01641822|584988744|FG000|Run-in Phase|Withdrew consent|1|||
161983566|NCT01641822|584988745|FG001|Run-in Phase|Withdrew consent|0|||
161983567|NCT01641822|584988746|FG002|Run-in Phase|Withdrew consent|0|||
161983568|NCT01641822|584988744|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
161983569|NCT01641822|584988745|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
161983570|NCT01641822|584988746|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
161983571|NCT01641822|584988744|FG000|Comparative Phase|Noncompliance with study drug|0|||
161983572|NCT01641822|584988745|FG001|Comparative Phase|Noncompliance with study drug|1|||
161983573|NCT01641822|584988746|FG002|Comparative Phase|Noncompliance with study drug|0|||
161983574|NCT01641822|584988744|FG000|Comparative Phase|Investigator's discretion|0|||
161983575|NCT01641822|584988745|FG001|Comparative Phase|Investigator's discretion|0|||
161983576|NCT01641822|584988746|FG002|Comparative Phase|Investigator's discretion|1|||
161983577|NCT01641822|584988744|FG000|Comparative Phase|Pregnancy|0|||
161983578|NCT01641822|584988745|FG001|Comparative Phase|Pregnancy|0|||
161983579|NCT01641822|584988746|FG002|Comparative Phase|Pregnancy|1|||
161983580|NCT01641822|584988744|FG000|Comparative Phase|Adverse event, serious fatal|0|||
161983581|NCT01641822|584988745|FG001|Comparative Phase|Adverse event, serious fatal|1|||
161983582|NCT01641822|584988746|FG002|Comparative Phase|Adverse event, serious fatal|0|||
161983583|NCT01641822|584988744|FG000|Comparative Phase|Withdrew consent|0|||
161983584|NCT01641822|584988745|FG001|Comparative Phase|Withdrew consent|3|||
161983585|NCT01641822|584988746|FG002|Comparative Phase|Withdrew consent|7|||
161983586|NCT01641822|584988744|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
161983587|NCT01641822|584988745|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
161983588|NCT01641822|584988746|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
161983589|NCT00454584|584988747|FG000|Controlled Period|Adverse Event|5|||
161983590|NCT00454584|584988748|FG001|Controlled Period|Adverse Event|2|||
161983591|NCT00454584|584988749|FG002|Controlled Period|Adverse Event|1|||
161983592|NCT00454584|584988750|FG003|Controlled Period|Adverse Event|0|||
161868972|NCT00298272|584564932|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
161868973|NCT00298272|584564933|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
161868974|NCT00298272|584564932|FG000|Open Label Retreatment Phase|Failure to Return|1|||
161868975|NCT00298272|584564933|FG001|Open Label Retreatment Phase|Failure to Return|0|||
161868976|NCT00298272|584564932|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
161868977|NCT00298272|584564933|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
161868978|NCT00298272|584564932|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
161868979|NCT00298272|584564933|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
161868980|NCT00298272|584564932|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
161868981|NCT00298272|584564933|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
161868982|NCT00298272|584564932|FG000|Safety Follow-up Phase|Failure to Return|1|||
161868983|NCT00298272|584564933|FG001|Safety Follow-up Phase|Failure to Return|1|||
161868984|NCT00298272|584564932|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
161868985|NCT00298272|584564933|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
161868986|NCT00298272|584564932|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
161868987|NCT00298272|584564933|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
161868988|NCT00326716|584564934|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
161868989|NCT00326716|584564935|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
161868990|NCT00326716|584564936|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
161868991|NCT00326716|584564937|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
161868992|NCT00684411|584564938|FG000|Overall Study|New Primary Cancer|1|||
161868993|NCT00684411|584564938|FG000|Overall Study|Disease Progression|10|||
161868994|NCT00684411|584564938|FG000|Overall Study|Adverse Event|1|||
161868995|NCT00734162|584564939|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
161868996|NCT00734162|584564940|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
161868997|NCT00734162|584564941|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
161868998|NCT00734162|584564942|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
161868999|NCT00734162|584564939|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
161869000|NCT00734162|584564940|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
161869001|NCT00734162|584564941|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
161869002|NCT00734162|584564942|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
161869003|NCT00734162|584564939|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
161869004|NCT00734162|584564940|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
161869005|NCT00734162|584564941|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
161869006|NCT00734162|584564942|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
161869007|NCT00734162|584564939|FG000|Open-Label Phase|Withdrew Consent|1|||
161869008|NCT00734162|584564940|FG001|Open-Label Phase|Withdrew Consent|0|||
161869009|NCT00734162|584564941|FG002|Open-Label Phase|Withdrew Consent|1|||
161869010|NCT00734162|584564942|FG003|Open-Label Phase|Withdrew Consent|1|||
161869011|NCT00734162|584564939|FG000|Open-Label Phase|Lost to Follow-up|1|||
161869012|NCT00734162|584564940|FG001|Open-Label Phase|Lost to Follow-up|2|||
161869013|NCT00734162|584564941|FG002|Open-Label Phase|Lost to Follow-up|0|||
161869014|NCT00734162|584564942|FG003|Open-Label Phase|Lost to Follow-up|1|||
161869015|NCT00734162|584564939|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161869016|NCT00734162|584564940|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161869017|NCT00734162|584564941|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161869018|NCT00734162|584564942|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
161869019|NCT05253573|584564943|FG000|Overall Study|Death|1|||
161869020|NCT05253573|584564944|FG001|Overall Study|Death|0|||
161869021|NCT01344824|584564945|FG000|Overall Study|Adverse Event|15|||
161869022|NCT01344824|584564945|FG000|Overall Study|Withdrawal by Subject|6|||
161869023|NCT01344824|584564945|FG000|Overall Study|Other complicating disease|1|||
161869024|NCT01344824|584564945|FG000|Overall Study|Progression|15|||
161869025|NCT00566020|584564946|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
161869026|NCT00566020|584564947|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
161869027|NCT00566020|584564946|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
161869028|NCT00566020|584564947|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
161869029|NCT00566020|584564946|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
161869030|NCT00566020|584564947|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
161869031|NCT00566020|584564946|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
161869032|NCT00566020|584564947|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
161869033|NCT00566020|584564946|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
161869034|NCT00566020|584564947|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
161869035|NCT00566020|584564946|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
161869036|NCT00566020|584564947|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
161869037|NCT01754129|584564948|FG000|Overall Study|Death|13|||
161869038|NCT01754129|584564948|FG000|Overall Study|Duodopa discontinuation|9|||
161869039|NCT01754129|584564948|FG000|Overall Study|Lost to Follow-up|7|||
161869040|NCT01754129|584564948|FG000|Overall Study|Withdrew consent|1|||
161869041|NCT01754129|584564948|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
161983593|NCT00454584|584988751|FG004|Controlled Period|Adverse Event|0|||
161983594|NCT00454584|584988752|FG005|Controlled Period|Adverse Event|0|||
161983595|NCT00454584|584988747|FG000|Controlled Period|Lost to Follow-up|1|||
161983596|NCT00454584|584988748|FG001|Controlled Period|Lost to Follow-up|2|||
161983597|NCT00454584|584988749|FG002|Controlled Period|Lost to Follow-up|2|||
161983598|NCT00454584|584988750|FG003|Controlled Period|Lost to Follow-up|0|||
161983599|NCT00454584|584988751|FG004|Controlled Period|Lost to Follow-up|0|||
161983600|NCT00454584|584988752|FG005|Controlled Period|Lost to Follow-up|0|||
161983601|NCT00454584|584988747|FG000|Controlled Period|Other|5|||
161983602|NCT00454584|584988748|FG001|Controlled Period|Other|4|||
161983603|NCT00454584|584988749|FG002|Controlled Period|Other|2|||
161983604|NCT00454584|584988750|FG003|Controlled Period|Other|0|||
161983605|NCT00454584|584988751|FG004|Controlled Period|Other|0|||
161983606|NCT00454584|584988752|FG005|Controlled Period|Other|0|||
161983607|NCT00454584|584988747|FG000|After Controlled Period|Adverse Event|0|||
161983608|NCT00454584|584988748|FG001|After Controlled Period|Adverse Event|0|||
161983609|NCT00454584|584988749|FG002|After Controlled Period|Adverse Event|0|||
161983610|NCT00454584|584988750|FG003|After Controlled Period|Adverse Event|9|||
161983611|NCT00454584|584988751|FG004|After Controlled Period|Adverse Event|3|||
161983612|NCT00454584|584988752|FG005|After Controlled Period|Adverse Event|9|||
161983613|NCT00454584|584988747|FG000|After Controlled Period|Lack of Efficacy|0|||
161983614|NCT00454584|584988748|FG001|After Controlled Period|Lack of Efficacy|0|||
161983615|NCT00454584|584988749|FG002|After Controlled Period|Lack of Efficacy|0|||
161983616|NCT00454584|584988750|FG003|After Controlled Period|Lack of Efficacy|1|||
161983617|NCT00454584|584988751|FG004|After Controlled Period|Lack of Efficacy|0|||
161983618|NCT00454584|584988752|FG005|After Controlled Period|Lack of Efficacy|0|||
161983619|NCT00454584|584988747|FG000|After Controlled Period|Lost to Follow-up|0|||
161983620|NCT00454584|584988748|FG001|After Controlled Period|Lost to Follow-up|0|||
161983621|NCT00454584|584988749|FG002|After Controlled Period|Lost to Follow-up|0|||
161983622|NCT00454584|584988750|FG003|After Controlled Period|Lost to Follow-up|2|||
161983623|NCT00454584|584988751|FG004|After Controlled Period|Lost to Follow-up|4|||
161983624|NCT00454584|584988752|FG005|After Controlled Period|Lost to Follow-up|6|||
161983625|NCT00454584|584988747|FG000|After Controlled Period|Other|0|||
161983626|NCT00454584|584988748|FG001|After Controlled Period|Other|0|||
161983627|NCT00454584|584988749|FG002|After Controlled Period|Other|0|||
161983628|NCT00454584|584988750|FG003|After Controlled Period|Other|1|||
161983629|NCT00454584|584988751|FG004|After Controlled Period|Other|0|||
161983630|NCT00454584|584988752|FG005|After Controlled Period|Other|0|||
161983631|NCT00454584|584988747|FG000|After Controlled Period|Other|0|||
161983632|NCT00454584|584988748|FG001|After Controlled Period|Other|0|||
161983633|NCT00454584|584988749|FG002|After Controlled Period|Other|0|||
161983634|NCT00454584|584988750|FG003|After Controlled Period|Other|13|||
161983635|NCT00454584|584988751|FG004|After Controlled Period|Other|5|||
161983636|NCT00454584|584988752|FG005|After Controlled Period|Other|17|||
161983637|NCT02760810|584988753|FG000|Overall Study|Protocol Violation|1|||
161983638|NCT02421601|584988754|FG000|Overall Study|Adverse Event|4|||
161983639|NCT02421601|584988754|FG000|Overall Study|Lack of Efficacy|5|||
161983640|NCT02421601|584988754|FG000|Overall Study|Physician Decision|1|||
161983641|NCT02421601|584988754|FG000|Overall Study|Withdrawal by Subject|31|||
161983642|NCT02421601|584988754|FG000|Overall Study|Others|41|||
161983643|NCT02250664|584988757|FG000|Overall Study|Lost to Follow-up|18|||
161983644|NCT02250664|584988758|FG001|Overall Study|Lost to Follow-up|28|||
161983645|NCT02250664|584988759|FG002|Overall Study|Lost to Follow-up|33|||
161983646|NCT02250664|584988757|FG000|Overall Study|Personal Reasons|7|||
161983647|NCT02250664|584988758|FG001|Overall Study|Personal Reasons|8|||
161983648|NCT02250664|584988759|FG002|Overall Study|Personal Reasons|14|||
161774835|NCT02268214|584217352|FG002|Overall Study|Poor/non-compliance|2|||
161774836|NCT02268214|584217350|FG000|Overall Study|Other reasons|7|||
161774837|NCT02268214|584217351|FG001|Overall Study|Other reasons|3|||
161774838|NCT02268214|584217352|FG002|Overall Study|Other reasons|3|||
161774839|NCT02268214|584217350|FG000|Overall Study|Not entering long-term period|2|||
161774840|NCT02268214|584217351|FG001|Overall Study|Not entering long-term period|3|||
161774841|NCT02268214|584217352|FG002|Overall Study|Not entering long-term period|5|||
161983649|NCT02250664|584988757|FG000|Overall Study|Adverse Event|6|||
162035040|NCT01853618|585184835|FG004|Overall Study|Refused further treatment|1|||
161774842|NCT02951130|584217353|FG000|Overall Study|Protocol Violation|1|||
161774843|NCT02951130|584217354|FG001|Overall Study|Protocol Violation|1|||
161774844|NCT04584294|584217355|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
161983650|NCT02250664|584988758|FG001|Overall Study|Adverse Event|3|||
161983651|NCT02250664|584988759|FG002|Overall Study|Adverse Event|8|||
161983652|NCT02250664|584988757|FG000|Overall Study|Incarcerated|2|||
161983653|NCT02250664|584988758|FG001|Overall Study|Incarcerated|1|||
161983654|NCT02250664|584988759|FG002|Overall Study|Incarcerated|2|||
161983655|NCT02250664|584988757|FG000|Overall Study|Withdrawal by Subject|0|||
161983656|NCT02250664|584988758|FG001|Overall Study|Withdrawal by Subject|1|||
161983657|NCT02250664|584988759|FG002|Overall Study|Withdrawal by Subject|2|||
161983658|NCT02250664|584988757|FG000|Overall Study|Death|0|||
161983659|NCT02250664|584988758|FG001|Overall Study|Death|1|||
161983660|NCT02250664|584988759|FG002|Overall Study|Death|1|||
161983661|NCT02250664|584988757|FG000|Overall Study|Physician Decision|1|||
161983662|NCT02250664|584988758|FG001|Overall Study|Physician Decision|3|||
161983663|NCT02250664|584988759|FG002|Overall Study|Physician Decision|1|||
161983664|NCT02250664|584988757|FG000|Overall Study|Protocol Violation|1|||
161983665|NCT02250664|584988758|FG001|Overall Study|Protocol Violation|0|||
161983666|NCT02250664|584988759|FG002|Overall Study|Protocol Violation|1|||
161983667|NCT02250664|584988757|FG000|Overall Study|Reason unknown|1|||
161983668|NCT02250664|584988758|FG001|Overall Study|Reason unknown|0|||
161983669|NCT02250664|584988759|FG002|Overall Study|Reason unknown|0|||
161983670|NCT00490022|584988761|FG000|Overall Study|Adverse Event|0|||
161983671|NCT00490022|584988762|FG001|Overall Study|Adverse Event|2|||
161983672|NCT00490022|584988761|FG000|Overall Study|Withdrawal by Subject|1|||
161983673|NCT00490022|584988762|FG001|Overall Study|Withdrawal by Subject|0|||
161983674|NCT00490022|584988761|FG000|Overall Study|Subject failed to disclose concommitant|0|||
161983675|NCT00490022|584988762|FG001|Overall Study|Subject failed to disclose concommitant|1|||
161983676|NCT00869401|584988763|FG000|Overall Study|Withdrawal by Subject|0|||
161983677|NCT00869401|584988764|FG001|Overall Study|Withdrawal by Subject|0|||
161983678|NCT00869401|584988765|FG002|Overall Study|Withdrawal by Subject|0|||
161983679|NCT00869401|584988766|FG003|Overall Study|Withdrawal by Subject|5|||
161983680|NCT00869401|584988767|FG004|Overall Study|Withdrawal by Subject|3|||
161983681|NCT00975143|584988770|FG000|Overall Study|Adverse Event|19|||
161983682|NCT00975143|584988771|FG001|Overall Study|Adverse Event|15|||
161983683|NCT00975143|584988770|FG000|Overall Study|Withdrawal by Subject|15|||
161983684|NCT00975143|584988771|FG001|Overall Study|Withdrawal by Subject|15|||
161983685|NCT00975143|584988770|FG000|Overall Study|Lost to Follow-up|20|||
161983686|NCT00975143|584988771|FG001|Overall Study|Lost to Follow-up|16|||
161983687|NCT00975143|584988770|FG000|Overall Study|Non-compliance|5|||
161983688|NCT00975143|584988771|FG001|Overall Study|Non-compliance|8|||
161983689|NCT00975143|584988770|FG000|Overall Study|Physician Decision|1|||
161983690|NCT00975143|584988771|FG001|Overall Study|Physician Decision|2|||
161983691|NCT00975143|584988770|FG000|Overall Study|Details not available|10|||
161983692|NCT00975143|584988771|FG001|Overall Study|Details not available|4|||
161983693|NCT01753401|584988772|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
161983694|NCT01753401|584988773|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
161983695|NCT01753401|584988774|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
161983696|NCT01753401|584988775|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
161983697|NCT01753401|584988772|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
161983698|NCT01753401|584988773|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
161983699|NCT01753401|584988774|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161983700|NCT01753401|584988775|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161983701|NCT01753401|584988772|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
161983702|NCT01753401|584988773|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
161983703|NCT01753401|584988774|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
161983704|NCT01753401|584988775|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
161774845|NCT04584294|584217356|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
161774846|NCT04584294|584217355|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
161774847|NCT04584294|584217356|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
161774848|NCT04584294|584217355|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
161774849|NCT04584294|584217356|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
161774850|NCT04584294|584217355|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
161774851|NCT04584294|584217356|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
161774852|NCT04584294|584217355|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
161774853|NCT04584294|584217356|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
161983705|NCT01753401|584988772|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
161983706|NCT01753401|584988773|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
161983707|NCT01753401|584988774|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
161983708|NCT01753401|584988775|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
161774854|NCT04584294|584217355|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
161774855|NCT04584294|584217356|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
161774856|NCT02500732|584217358|FG000|Overall Study|Physician Decision|0|||
161774857|NCT02500732|584217359|FG001|Overall Study|Physician Decision|1|||
161774858|NCT01233284|584217369|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
161774859|NCT01233284|584217370|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161774860|NCT01233284|584217371|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161774861|NCT01233284|584217372|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161774862|NCT01233284|584217373|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161774863|NCT01233284|584217369|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161774864|NCT01233284|584217370|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
161774865|NCT01233284|584217371|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161774866|NCT01233284|584217372|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161774867|NCT01233284|584217373|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161774868|NCT01233284|584217369|FG000|Period 1 (4 Weeks)|Other|0|||
161774869|NCT01233284|584217370|FG001|Period 1 (4 Weeks)|Other|0|||
161869042|NCT01085630|584564949|FG000|Overall Study|Insufficient data|1|||
161869043|NCT01085630|584564950|FG001|Overall Study|Insufficient data|0|||
161869044|NCT01085630|584564949|FG000|Overall Study|Ineligible|3|||
161983709|NCT01753401|584988772|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
161983710|NCT01753401|584988773|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
161983711|NCT01753401|584988774|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
161983712|NCT01753401|584988775|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
161869045|NCT01085630|584564950|FG001|Overall Study|Ineligible|0|||
161869046|NCT02027545|584564951|FG000|Overall Study|Failed to sign HIPAA|0|||
161869047|NCT02027545|584564952|FG001|Overall Study|Failed to sign HIPAA|2|||
161869048|NCT02027545|584564951|FG000|Overall Study|Failed to attend study visit|2|||
161869049|NCT02027545|584564952|FG001|Overall Study|Failed to attend study visit|0|||
161869050|NCT02027545|584564951|FG000|Overall Study|Protocol Violation|1|||
161869051|NCT02027545|584564952|FG001|Overall Study|Protocol Violation|0|||
161869052|NCT01017874|584564953|FG000|Overall Study|Withdrawal by Subject|23|||
161869053|NCT01017874|584564954|FG001|Overall Study|Withdrawal by Subject|20|||
161869054|NCT01017874|584564953|FG000|Overall Study|Sponsor decision|3|||
161869055|NCT01017874|584564954|FG001|Overall Study|Sponsor decision|1|||
161869056|NCT01017874|584564953|FG000|Overall Study|Lost to Follow-up|3|||
161869057|NCT01017874|584564954|FG001|Overall Study|Lost to Follow-up|2|||
161869058|NCT01017874|584564953|FG000|Overall Study|Physician Decision|1|||
161869059|NCT01017874|584564954|FG001|Overall Study|Physician Decision|3|||
161869060|NCT01790984|584564959|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
161869061|NCT01790984|584564960|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
161869062|NCT01790984|584564961|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
161869063|NCT01790984|584564962|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
161869064|NCT01163851|584564970|FG000|Overall Study|Site Closure|0|||
161869065|NCT01163851|584564971|FG001|Overall Study|Site Closure|1|||
161869066|NCT01163851|584564970|FG000|Overall Study|Enrolled but not treated|1|||
161869067|NCT01163851|584564971|FG001|Overall Study|Enrolled but not treated|0|||
161869068|NCT00789373|584564975|FG000|Induction|Adverse Event|64|||
161869069|NCT00789373|584564976|FG001|Induction|Adverse Event|0|||
161869070|NCT00789373|584564977|FG002|Induction|Adverse Event|0|||
161869071|NCT00789373|584564975|FG000|Induction|Death Due to study disease|24|||
161869072|NCT00789373|584564976|FG001|Induction|Death Due to study disease|0|||
161869073|NCT00789373|584564977|FG002|Induction|Death Due to study disease|0|||
161869074|NCT00789373|584564975|FG000|Induction|Death due to adverse event|19|||
161869075|NCT00789373|584564976|FG001|Induction|Death due to adverse event|0|||
161869076|NCT00789373|584564977|FG002|Induction|Death due to adverse event|0|||
161869077|NCT00789373|584564975|FG000|Induction|Death due to toxicity|11|||
161869078|NCT00789373|584564976|FG001|Induction|Death due to toxicity|0|||
161869079|NCT00789373|584564977|FG002|Induction|Death due to toxicity|0|||
161869080|NCT00789373|584564975|FG000|Induction|Death due to procedure|1|||
161869081|NCT00789373|584564976|FG001|Induction|Death due to procedure|0|||
161869082|NCT00789373|584564977|FG002|Induction|Death due to procedure|0|||
161869083|NCT00789373|584564975|FG000|Induction|Investigator decision|7|||
161869084|NCT00789373|584564976|FG001|Induction|Investigator decision|0|||
161869085|NCT00789373|584564977|FG002|Induction|Investigator decision|0|||
161869086|NCT00789373|584564975|FG000|Induction|Protocol entry criteria not met|9|||
161869087|NCT00789373|584564976|FG001|Induction|Protocol entry criteria not met|0|||
161869088|NCT00789373|584564977|FG002|Induction|Protocol entry criteria not met|0|||
161869089|NCT00789373|584564975|FG000|Induction|Lost to Follow-up|6|||
161869090|NCT00789373|584564976|FG001|Induction|Lost to Follow-up|0|||
161869091|NCT00789373|584564977|FG002|Induction|Lost to Follow-up|0|||
161869092|NCT00789373|584564975|FG000|Induction|Protocol Violation|1|||
161869093|NCT00789373|584564976|FG001|Induction|Protocol Violation|0|||
161869094|NCT00789373|584564977|FG002|Induction|Protocol Violation|0|||
161869095|NCT00789373|584564975|FG000|Induction|Progressive Disease|220|||
161983713|NCT01753401|584988772|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
161983714|NCT01753401|584988773|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
161983715|NCT01753401|584988774|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
161869096|NCT00789373|584564976|FG001|Induction|Progressive Disease|0|||
161869097|NCT00789373|584564977|FG002|Induction|Progressive Disease|0|||
161869098|NCT00789373|584564975|FG000|Induction|Withdrawal by Subject|37|||
161983716|NCT01753401|584988775|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
161983717|NCT01753401|584988772|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
161983718|NCT01753401|584988773|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
161983719|NCT01753401|584988774|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
162035041|NCT01092832|585184840|FG000|Overall Study|Other|1|||
161869099|NCT00789373|584564976|FG001|Induction|Withdrawal by Subject|0|||
161869100|NCT00789373|584564977|FG002|Induction|Withdrawal by Subject|0|||
161869101|NCT00789373|584564975|FG000|Maintenance|Adverse Event|0|||
161869102|NCT00789373|584564976|FG001|Maintenance|Adverse Event|65|||
161869103|NCT00789373|584564977|FG002|Maintenance|Adverse Event|12|||
161869104|NCT00789373|584564975|FG000|Maintenance|Death due to study disease|0|||
161869105|NCT00789373|584564976|FG001|Maintenance|Death due to study disease|3|||
161869106|NCT00789373|584564977|FG002|Maintenance|Death due to study disease|1|||
161869107|NCT00789373|584564975|FG000|Maintenance|Death due to adverse event|0|||
161869108|NCT00789373|584564976|FG001|Maintenance|Death due to adverse event|4|||
161869109|NCT00789373|584564977|FG002|Maintenance|Death due to adverse event|1|||
161869110|NCT00789373|584564975|FG000|Maintenance|Death due to toxicity|0|||
161869111|NCT00789373|584564976|FG001|Maintenance|Death due to toxicity|1|||
161869112|NCT00789373|584564977|FG002|Maintenance|Death due to toxicity|2|||
161869113|NCT00789373|584564975|FG000|Maintenance|Investigator Decision|0|||
161869114|NCT00789373|584564976|FG001|Maintenance|Investigator Decision|4|||
161869115|NCT00789373|584564977|FG002|Maintenance|Investigator Decision|2|||
161869116|NCT00789373|584564975|FG000|Maintenance|Protocol entry criteria not met|0|||
161869117|NCT00789373|584564976|FG001|Maintenance|Protocol entry criteria not met|2|||
161869118|NCT00789373|584564977|FG002|Maintenance|Protocol entry criteria not met|0|||
161869119|NCT00789373|584564975|FG000|Maintenance|Lost to Follow-up|0|||
161869120|NCT00789373|584564976|FG001|Maintenance|Lost to Follow-up|2|||
161869121|NCT00789373|584564977|FG002|Maintenance|Lost to Follow-up|0|||
161869122|NCT00789373|584564975|FG000|Maintenance|Progressive Disease|0|||
161869123|NCT00789373|584564976|FG001|Maintenance|Progressive Disease|253|||
161869124|NCT00789373|584564977|FG002|Maintenance|Progressive Disease|152|||
161869125|NCT00789373|584564975|FG000|Maintenance|Withdrawal by Subject|0|||
161869126|NCT00789373|584564976|FG001|Maintenance|Withdrawal by Subject|21|||
161869127|NCT00789373|584564977|FG002|Maintenance|Withdrawal by Subject|8|||
161869128|NCT00789373|584564975|FG000|Maintenance|Sponsor Decision|0|||
161869129|NCT00789373|584564976|FG001|Maintenance|Sponsor Decision|0|||
161869130|NCT00789373|584564977|FG002|Maintenance|Sponsor Decision|2|||
161869131|NCT00789373|584564975|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
161869132|NCT00789373|584564976|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
161869133|NCT00789373|584564977|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
161869134|NCT01684423|584564987|FG000|Overall Study|Withdrawal by Subject|0|||
161869135|NCT01684423|584564988|FG001|Overall Study|Withdrawal by Subject|0|||
161869136|NCT01684423|584564989|FG002|Overall Study|Withdrawal by Subject|1|||
161869137|NCT01684423|584564990|FG003|Overall Study|Withdrawal by Subject|0|||
161869138|NCT01684423|584564991|FG004|Overall Study|Withdrawal by Subject|0|||
161869139|NCT02155283|584564992|FG000|Overall Study|Lost to Follow-up|3|||
161869140|NCT02155283|584564992|FG000|Overall Study|Withdrawal by Subject|1|||
161869141|NCT02155283|584564992|FG000|Overall Study|Protocol Violation|3|||
161869142|NCT01741688|584564996|FG000|Overall Study|Lack of insurance coverage|2|||
161869143|NCT01741688|584564996|FG000|Overall Study|Withdrawal by Subject|1|||
161869144|NCT03850496|584565001|FG000|Overall Study|Withdrawal by Subject|1|||
161869145|NCT03850496|584565002|FG001|Overall Study|Withdrawal by Subject|0|||
161869146|NCT03850496|584565003|FG002|Overall Study|Withdrawal by Subject|0|||
161869147|NCT03850496|584565001|FG000|Overall Study|Lost to Follow-up|0|||
161869148|NCT03850496|584565002|FG001|Overall Study|Lost to Follow-up|1|||
161869149|NCT03850496|584565003|FG002|Overall Study|Lost to Follow-up|4|||
161869150|NCT03020992|584565004|FG000|Overall Study|Adverse Event|5|||
161869151|NCT03020992|584565004|FG000|Overall Study|Withdrawal by Subject|1|||
161869152|NCT05000164|584565005|FG000|Overall Study|Adverse Event|1|||
161869153|NCT05000164|584565005|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
161869154|NCT05000164|584565005|FG000|Overall Study|Lens Discomfort|3|||
161869155|NCT05000164|584565005|FG000|Overall Study|Withdrew Consent during Study|2|||
161869156|NCT05000164|584565005|FG000|Overall Study|Subject Withdrawn by PI|2|||
161869157|NCT05000164|584565005|FG000|Overall Study|Other Fractured Test Article|1|||
161869158|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
161869159|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
161869160|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
161869161|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
161869162|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Pregnancy|0|||
161869163|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Pregnancy|1|||
161869164|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
161869165|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
161869166|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
161869167|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
161869168|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
161869169|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
162035042|NCT01092832|585184841|FG001|Overall Study|Other|0|||
162035043|NCT04777331|585184842|FG000|DBT Period|Death|2|||
161869170|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Other|3|||
161869171|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Other|0|||
161869172|NCT01006122|584565006|FG000|First Double-blind Intervention Period|Adverse Event|0|||
161869173|NCT01006122|584565007|FG001|First Double-blind Intervention Period|Adverse Event|4|||
161869174|NCT01006122|584565006|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
161869175|NCT01006122|584565007|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
161869176|NCT01006122|584565006|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
161869177|NCT01006122|584565007|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
162035044|NCT04777331|585184843|FG001|DBT Period|Death|1|||
161869178|NCT01006122|584565006|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
161869179|NCT01006122|584565007|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
161869180|NCT01006122|584565006|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
161869181|NCT01006122|584565007|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
161869182|NCT01006122|584565006|FG000|Second Double-blind Intervention Period|Death|0|||
161869183|NCT01006122|584565007|FG001|Second Double-blind Intervention Period|Death|1|||
161869184|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
161869185|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
161869186|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
161869187|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
161869188|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
161869189|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
161869190|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
161869191|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
161869192|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
161869193|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
161869194|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
161869195|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
161869196|NCT03493854|584565008|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
161869197|NCT03493854|584565009|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
161869198|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
161869199|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
161869200|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
161869201|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
161869202|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
161869203|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
161869204|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
161869205|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
161869206|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
161869207|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
161869208|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
161869209|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
161869210|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
161869211|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
161869212|NCT03493854|584565008|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
161869213|NCT03493854|584565009|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
161869214|NCT03493854|584565008|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
161869215|NCT03493854|584565009|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
161869216|NCT03493854|584565008|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
161869217|NCT03493854|584565009|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
161869218|NCT03493854|584565008|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
161869219|NCT03493854|584565009|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
161869220|NCT00410813|584565012|FG000|Overall Study|Adverse Event|6|||
161869221|NCT00410813|584565013|FG001|Overall Study|Adverse Event|11|||
161869222|NCT00410813|584565012|FG000|Overall Study|Progression|32|||
161869223|NCT00410813|584565013|FG001|Overall Study|Progression|21|||
161869224|NCT00410813|584565012|FG000|Overall Study|Not protocol specified|3|||
161869225|NCT00410813|584565013|FG001|Overall Study|Not protocol specified|4|||
161869226|NCT00410813|584565012|FG000|Overall Study|Ineligible|2|||
161869227|NCT00410813|584565013|FG001|Overall Study|Ineligible|4|||
161869228|NCT00410813|584565012|FG000|Overall Study|Death|0|||
161869229|NCT00410813|584565013|FG001|Overall Study|Death|2|||
161869230|NCT02268916|584565025|FG000|Overall Study|Lost to Follow-up|1|||
161869231|NCT02268916|584565026|FG001|Overall Study|Lost to Follow-up|1|||
161869232|NCT02268916|584565025|FG000|Overall Study|Withdrawal by Subject|6|||
161869233|NCT02268916|584565026|FG001|Overall Study|Withdrawal by Subject|5|||
161869234|NCT02268916|584565025|FG000|Overall Study|Participant did not have diabetes|1|||
161869235|NCT02268916|584565026|FG001|Overall Study|Participant did not have diabetes|0|||
161869236|NCT02268916|584565025|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
161869237|NCT02268916|584565026|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
161869238|NCT00594165|584565029|FG000|Overall Study|Major protocol violation|1|||
161869239|NCT00594165|584565029|FG000|Overall Study|Lack of Efficacy|12|||
161983720|NCT01753401|584988775|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
161983721|NCT00581360|584988776|FG000|Overall Study|Withdrawal by Subject|1|||
161983722|NCT03129360|584988777|FG000|Overall Study|Did not meet entry criteria|0|||
161983723|NCT03129360|584988778|FG001|Overall Study|Did not meet entry criteria|2|||
161869240|NCT00594165|584565029|FG000|Overall Study|Adverse Event|52|||
161869241|NCT00594165|584565029|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
161869242|NCT00594165|584565029|FG000|Overall Study|Subject withdrew consent|27|||
161983724|NCT03129360|584988779|FG002|Overall Study|Did not meet entry criteria|1|||
161983725|NCT03129360|584988777|FG000|Overall Study|Excluded due to motion in scanner|1|||
161983726|NCT03129360|584988778|FG001|Overall Study|Excluded due to motion in scanner|0|||
161983727|NCT03129360|584988779|FG002|Overall Study|Excluded due to motion in scanner|0|||
161983728|NCT02345330|584988782|FG000|Overall Study|Death|1|||
161983729|NCT02345330|584988782|FG000|Overall Study|Progressive Disease|2|||
161983730|NCT00295932|584988783|FG000|Overall Study|Not Treated|0|||
161983731|NCT00295932|584988784|FG001|Overall Study|Not Treated|0|||
161983732|NCT00295932|584988785|FG002|Overall Study|Not Treated|0|||
161983733|NCT00295932|584988786|FG003|Overall Study|Not Treated|0|||
161983734|NCT00295932|584988787|FG004|Overall Study|Not Treated|0|||
161774870|NCT01233284|584217371|FG002|Period 1 (4 Weeks)|Other|1|||
161774871|NCT01233284|584217372|FG003|Period 1 (4 Weeks)|Other|0|||
161774872|NCT01233284|584217373|FG004|Period 1 (4 Weeks)|Other|0|||
161774873|NCT01233284|584217369|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161774874|NCT01233284|584217370|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161774875|NCT01233284|584217371|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
161774876|NCT01233284|584217372|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161774877|NCT01233284|584217373|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161774878|NCT01233284|584217369|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161774879|NCT01233284|584217370|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161774880|NCT01233284|584217371|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
161774881|NCT01233284|584217372|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161774882|NCT01233284|584217373|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161774883|NCT01233284|584217369|FG000|Period 3 (4 Weeks)|Other|0|||
161774884|NCT01233284|584217370|FG001|Period 3 (4 Weeks)|Other|0|||
161774885|NCT01233284|584217371|FG002|Period 3 (4 Weeks)|Other|0|||
161774886|NCT01233284|584217372|FG003|Period 3 (4 Weeks)|Other|1|||
161774887|NCT01233284|584217373|FG004|Period 3 (4 Weeks)|Other|0|||
161774888|NCT01233284|584217369|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
161774889|NCT01233284|584217370|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
161774890|NCT01233284|584217371|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
161774891|NCT01233284|584217372|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
161774892|NCT01233284|584217373|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
161774893|NCT01233284|584217369|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
161774894|NCT01233284|584217370|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
161774895|NCT01233284|584217371|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
161774896|NCT01233284|584217372|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
161774897|NCT01233284|584217373|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
161774898|NCT03759340|584217374|FG000|Overall Study|Adverse Event|2|||
161774899|NCT03759340|584217374|FG000|Overall Study|Lost to Follow-up|1|||
161774900|NCT03759340|584217374|FG000|Overall Study|Withdrawal by Subject|15|||
161774901|NCT03759340|584217374|FG000|Overall Study|Study Terminated by Sponsor|38|||
161774902|NCT04814654|584217375|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
161774903|NCT04814654|584217376|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
161774904|NCT04814654|584217377|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
161774905|NCT00157820|584217383|FG000|Randomized|Physician Decision|4|||
161774906|NCT00157820|584217384|FG001|Randomized|Physician Decision|2|||
161774907|NCT00157820|584217385|FG002|Randomized|Physician Decision|3|||
161774908|NCT00157820|584217383|FG000|Randomized|Withdrawal by Subject|1|||
161774909|NCT00157820|584217384|FG001|Randomized|Withdrawal by Subject|2|||
161774910|NCT00157820|584217385|FG002|Randomized|Withdrawal by Subject|3|||
161774911|NCT00157820|584217383|FG000|Randomized|Protocol Violation|2|||
161774912|NCT00157820|584217384|FG001|Randomized|Protocol Violation|1|||
161774913|NCT00157820|584217385|FG002|Randomized|Protocol Violation|2|||
161774914|NCT00157820|584217383|FG000|1st 8 Month|Death|7|||
161774915|NCT00157820|584217384|FG001|1st 8 Month|Death|8|||
161774916|NCT00157820|584217385|FG002|1st 8 Month|Death|3|||
161774917|NCT00157820|584217383|FG000|1st 8 Month|Lost to Follow-up|1|||
161774918|NCT00157820|584217384|FG001|1st 8 Month|Lost to Follow-up|2|||
161774919|NCT00157820|584217385|FG002|1st 8 Month|Lost to Follow-up|1|||
161774920|NCT00157820|584217383|FG000|1st 8 Month|Premature cross-over|0|||
161774921|NCT00157820|584217384|FG001|1st 8 Month|Premature cross-over|2|||
161774922|NCT00157820|584217385|FG002|1st 8 Month|Premature cross-over|2|||
161774923|NCT00157820|584217383|FG000|2nd 8 Months|Death|3|||
161774924|NCT00157820|584217384|FG001|2nd 8 Months|Death|1|||
161774925|NCT00157820|584217385|FG002|2nd 8 Months|Death|3|||
161774926|NCT00157820|584217383|FG000|2nd 8 Months|Lost to Follow-up|1|||
161774927|NCT00157820|584217384|FG001|2nd 8 Months|Lost to Follow-up|5|||
161983735|NCT00295932|584988788|FG005|Overall Study|Not Treated|0|||
161983736|NCT00295932|584988789|FG006|Overall Study|Not Treated|0|||
161983737|NCT00295932|584988790|FG007|Overall Study|Not Treated|0|||
161774928|NCT00157820|584217385|FG002|2nd 8 Months|Lost to Follow-up|2|||
161774929|NCT00157820|584217383|FG000|2nd 8 Months|Premature cross-over|1|||
161983738|NCT00295932|584988791|FG008|Overall Study|Not Treated|0|||
161774930|NCT00157820|584217384|FG001|2nd 8 Months|Premature cross-over|7|||
161774931|NCT00157820|584217385|FG002|2nd 8 Months|Premature cross-over|9|||
161774932|NCT01676818|584217386|FG000|Overall Study|Physician Decision|1|||
161774933|NCT01676818|584217386|FG000|Overall Study|Withdrawal by Subject|1|||
161869243|NCT00594165|584565029|FG000|Overall Study|Study ended per sponsor|102|||
161869244|NCT00594165|584565029|FG000|Overall Study|Lost to Follow-up|4|||
161869245|NCT00594165|584565029|FG000|Overall Study|Other: PI discretion|5|||
161869246|NCT00594165|584565029|FG000|Overall Study|Other: Subject moving|3|||
161869247|NCT00594165|584565029|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
161869248|NCT00594165|584565029|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
161869249|NCT00594165|584565029|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
161869250|NCT00594165|584565029|FG000|Overall Study|Other: Site terminated participation|2|||
161869251|NCT04830969|584565030|FG000|Overall Study|Withdrawal by Subject|6|||
161869252|NCT04830969|584565031|FG001|Overall Study|Withdrawal by Subject|2|||
161869253|NCT04830969|584565030|FG000|Overall Study|Protocol Violation|3|||
161869254|NCT04830969|584565031|FG001|Overall Study|Protocol Violation|9|||
161869255|NCT04830969|584565030|FG000|Overall Study|Lost to Follow-up|4|||
161869256|NCT04830969|584565031|FG001|Overall Study|Lost to Follow-up|4|||
161869257|NCT00996125|584565032|FG000|Overall Study|Adverse Event|0|||
161869258|NCT00996125|584565033|FG001|Overall Study|Adverse Event|2|||
161869259|NCT00996125|584565032|FG000|Overall Study|Lost to Follow-up|1|||
161869260|NCT00996125|584565033|FG001|Overall Study|Lost to Follow-up|6|||
161869261|NCT00996125|584565032|FG000|Overall Study|Withdrawal by Subject|4|||
161869262|NCT00996125|584565033|FG001|Overall Study|Withdrawal by Subject|3|||
161869263|NCT05236764|584565034|FG000|Overall Study|In follow up (ongoing)|1|||
161869264|NCT05236764|584565034|FG000|Overall Study|Taken off study - secondary graft failure|1|||
161869265|NCT05236764|584565034|FG000|Overall Study|Death|1|||
161869266|NCT02062450|584565043|FG000|Overall Study|No follow-up visit|124|||
161869267|NCT04495829|584565044|FG000|Overall Study|Lost to Follow-up|2|||
161869268|NCT04495829|584565044|FG000|Overall Study|Inclusion criterion not met|3|||
161869269|NCT01205269|584565053|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161869270|NCT01205269|584565054|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161869271|NCT01205269|584565055|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161869272|NCT01205269|584565056|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
161869273|NCT01205269|584565057|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161869274|NCT01205269|584565058|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161869275|NCT00987337|584565059|FG000|Overall Study|Adverse Event|10|||
161869276|NCT00987337|584565060|FG001|Overall Study|Adverse Event|9|||
161869277|NCT00987337|584565061|FG002|Overall Study|Adverse Event|8|||
161869278|NCT00987337|584565059|FG000|Overall Study|Insufficient Virologic Response|10|||
161869279|NCT00987337|584565060|FG001|Overall Study|Insufficient Virologic Response|7|||
161869280|NCT00987337|584565061|FG002|Overall Study|Insufficient Virologic Response|12|||
161869281|NCT00987337|584565059|FG000|Overall Study|Virologic Breakthrough|2|||
161869282|NCT00987337|584565060|FG001|Overall Study|Virologic Breakthrough|2|||
161869283|NCT00987337|584565061|FG002|Overall Study|Virologic Breakthrough|8|||
161869284|NCT00987337|584565059|FG000|Overall Study|Lost to Follow-up|10|||
161869285|NCT00987337|584565060|FG001|Overall Study|Lost to Follow-up|6|||
161869286|NCT00987337|584565061|FG002|Overall Study|Lost to Follow-up|2|||
161869287|NCT00987337|584565059|FG000|Overall Study|Withdrawal by Subject|6|||
161869288|NCT00987337|584565060|FG001|Overall Study|Withdrawal by Subject|9|||
161869289|NCT00987337|584565061|FG002|Overall Study|Withdrawal by Subject|9|||
161869290|NCT00987337|584565059|FG000|Overall Study|Other|0|||
161869291|NCT00987337|584565060|FG001|Overall Study|Other|2|||
161869292|NCT00987337|584565061|FG002|Overall Study|Other|5|||
161869293|NCT00987337|584565059|FG000|Overall Study|Protocol Violation|1|||
161869294|NCT00987337|584565060|FG001|Overall Study|Protocol Violation|0|||
161869295|NCT00987337|584565061|FG002|Overall Study|Protocol Violation|2|||
161869296|NCT00987337|584565059|FG000|Overall Study|Participant Relapsed|18|||
161869297|NCT00987337|584565060|FG001|Overall Study|Participant Relapsed|20|||
161869298|NCT00987337|584565061|FG002|Overall Study|Participant Relapsed|5|||
161869299|NCT03100903|584566685|FG000|Overall Study|Withdrawal by Subject|0|||
161869300|NCT03100903|584566686|FG001|Overall Study|Withdrawal by Subject|0|||
161869301|NCT03100903|584566687|FG002|Overall Study|Withdrawal by Subject|1|||
161869302|NCT04659993|584566688|FG000|Overall Study|Withdrawal by Subject|2|||
161869303|NCT04659993|584566688|FG000|Overall Study|Lost to Follow-up|2|||
161869304|NCT03868930|584566692|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
161869305|NCT03868930|584566693|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
161983739|NCT00295932|584988792|FG009|Overall Study|Not Treated|0|||
161983740|NCT00295932|584988793|FG010|Overall Study|Not Treated|1|||
161983741|NCT00109577|584988794|FG000|Overall Study|Withdrawal by Subject|3|||
161869306|NCT03868930|584566692|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
161869307|NCT03868930|584566693|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
161869308|NCT03868930|584566692|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
161869309|NCT03868930|584566693|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
161869310|NCT03868930|584566692|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
161983742|NCT00109577|584988795|FG001|Overall Study|Withdrawal by Subject|3|||
161869311|NCT03868930|584566693|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
161869312|NCT03868930|584566692|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
161869313|NCT03868930|584566693|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
161869314|NCT02151851|584566696|FG000|Overall Study|Lack of Efficacy|67|||
161869315|NCT02151851|584566697|FG001|Overall Study|Lack of Efficacy|94|||
161869316|NCT02151851|584566696|FG000|Overall Study|Protocol Violation|0|||
161869317|NCT02151851|584566697|FG001|Overall Study|Protocol Violation|1|||
161869318|NCT02151851|584566696|FG000|Overall Study|Withdrawal by Subject|2|||
161869319|NCT02151851|584566697|FG001|Overall Study|Withdrawal by Subject|5|||
161869320|NCT02151851|584566696|FG000|Overall Study|Medical impairment|1|||
161869321|NCT02151851|584566697|FG001|Overall Study|Medical impairment|0|||
161869322|NCT02151851|584566696|FG000|Overall Study|Low compliance to study visits|0|||
161869323|NCT02151851|584566697|FG001|Overall Study|Low compliance to study visits|1|||
161869324|NCT02151851|584566696|FG000|Overall Study|Subject entered into study in error|0|||
161869325|NCT02151851|584566697|FG001|Overall Study|Subject entered into study in error|1|||
161869326|NCT02151851|584566696|FG000|Overall Study|Adverse Event|6|||
161869327|NCT02151851|584566697|FG001|Overall Study|Adverse Event|28|||
161869328|NCT02159053|584566698|FG000|Overall Study|Death|2|||
161869329|NCT02159053|584566699|FG001|Overall Study|Death|0|||
161869330|NCT02159053|584566700|FG002|Overall Study|Death|1|||
161869331|NCT02159053|584566698|FG000|Overall Study|Physician Decision|0|||
161869332|NCT02159053|584566699|FG001|Overall Study|Physician Decision|1|||
161869333|NCT02159053|584566700|FG002|Overall Study|Physician Decision|1|||
161869334|NCT02159053|584566698|FG000|Overall Study|Lack of Efficacy|3|||
161869335|NCT02159053|584566699|FG001|Overall Study|Lack of Efficacy|4|||
161869336|NCT02159053|584566700|FG002|Overall Study|Lack of Efficacy|7|||
161869337|NCT02159053|584566698|FG000|Overall Study|Adverse Event|7|||
161869338|NCT02159053|584566699|FG001|Overall Study|Adverse Event|6|||
161869339|NCT02159053|584566700|FG002|Overall Study|Adverse Event|5|||
161869340|NCT02159053|584566698|FG000|Overall Study|Participants/guardian decision|8|||
161869341|NCT02159053|584566699|FG001|Overall Study|Participants/guardian decision|10|||
161869342|NCT02159053|584566700|FG002|Overall Study|Participants/guardian decision|6|||
161869343|NCT02640950|584566701|FG000|Overall Study|Adverse Event|1|||
161869344|NCT02640950|584566701|FG000|Overall Study|Withdrawal by Subject|1|||
161869345|NCT04545489|584566702|FG000|Overall Study|Withdrawal by Subject|12|||
161869346|NCT04545489|584566703|FG001|Overall Study|Withdrawal by Subject|4|||
161869347|NCT04545489|584566702|FG000|Overall Study|Lost to Follow-up|17|||
161869348|NCT04545489|584566703|FG001|Overall Study|Lost to Follow-up|18|||
161869349|NCT04545489|584566702|FG000|Overall Study|12month BP not collected|4|||
161869350|NCT04545489|584566703|FG001|Overall Study|12month BP not collected|4|||
161869351|NCT00652626|584566704|FG000|Initial Treatment Phase|Adverse Event|0|||
161869352|NCT00652626|584566705|FG001|Initial Treatment Phase|Adverse Event|0|||
161869353|NCT00652626|584566706|FG002|Initial Treatment Phase|Adverse Event|0|||
161869354|NCT00652626|584566707|FG003|Initial Treatment Phase|Adverse Event|0|||
161869355|NCT00652626|584566708|FG004|Initial Treatment Phase|Adverse Event|1|||
161869356|NCT00652626|584566709|FG005|Initial Treatment Phase|Adverse Event|0|||
161869357|NCT00652626|584566710|FG006|Initial Treatment Phase|Adverse Event|0|||
161869358|NCT00652626|584566704|FG000|Initial Treatment Phase|Protocol Violation|0|||
161869359|NCT00652626|584566705|FG001|Initial Treatment Phase|Protocol Violation|0|||
161869360|NCT00652626|584566706|FG002|Initial Treatment Phase|Protocol Violation|0|||
161869361|NCT00652626|584566707|FG003|Initial Treatment Phase|Protocol Violation|1|||
161869362|NCT00652626|584566708|FG004|Initial Treatment Phase|Protocol Violation|0|||
161869363|NCT00652626|584566709|FG005|Initial Treatment Phase|Protocol Violation|0|||
161869364|NCT00652626|584566710|FG006|Initial Treatment Phase|Protocol Violation|0|||
161869365|NCT00652626|584566704|FG000|Initial Treatment Phase|Physician Decision|0|||
161869366|NCT00652626|584566705|FG001|Initial Treatment Phase|Physician Decision|0|||
161869367|NCT00652626|584566706|FG002|Initial Treatment Phase|Physician Decision|0|||
161869368|NCT00652626|584566707|FG003|Initial Treatment Phase|Physician Decision|0|||
161869369|NCT00652626|584566708|FG004|Initial Treatment Phase|Physician Decision|1|||
161869370|NCT00652626|584566709|FG005|Initial Treatment Phase|Physician Decision|0|||
161869371|NCT00652626|584566710|FG006|Initial Treatment Phase|Physician Decision|0|||
161869372|NCT00652626|584566704|FG000|Initial Treatment Phase|Sponsor Request|0|||
161869373|NCT00652626|584566705|FG001|Initial Treatment Phase|Sponsor Request|0|||
161869374|NCT00652626|584566706|FG002|Initial Treatment Phase|Sponsor Request|1|||
161869375|NCT00652626|584566707|FG003|Initial Treatment Phase|Sponsor Request|0|||
161869376|NCT00652626|584566708|FG004|Initial Treatment Phase|Sponsor Request|0|||
161869377|NCT00652626|584566709|FG005|Initial Treatment Phase|Sponsor Request|0|||
161869378|NCT00652626|584566710|FG006|Initial Treatment Phase|Sponsor Request|0|||
161869379|NCT00652626|584566704|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
161869380|NCT00652626|584566705|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
161869381|NCT00652626|584566706|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
161869382|NCT00652626|584566707|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
161869383|NCT00652626|584566708|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
161869384|NCT00652626|584566709|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
161869385|NCT00652626|584566710|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
161869386|NCT00652626|584566704|FG000|Extension Phase|Withdrawal by Subject|0|||
161869387|NCT00652626|584566705|FG001|Extension Phase|Withdrawal by Subject|0|||
161869388|NCT00652626|584566706|FG002|Extension Phase|Withdrawal by Subject|0|||
161869389|NCT00652626|584566707|FG003|Extension Phase|Withdrawal by Subject|0|||
161869390|NCT00652626|584566708|FG004|Extension Phase|Withdrawal by Subject|0|||
161869391|NCT00652626|584566709|FG005|Extension Phase|Withdrawal by Subject|2|||
161869392|NCT00652626|584566710|FG006|Extension Phase|Withdrawal by Subject|0|||
161869393|NCT00652626|584566704|FG000|Extension Phase|Adverse Event|0|||
161869394|NCT00652626|584566705|FG001|Extension Phase|Adverse Event|0|||
161869395|NCT00652626|584566706|FG002|Extension Phase|Adverse Event|0|||
161869396|NCT00652626|584566707|FG003|Extension Phase|Adverse Event|0|||
161869397|NCT00652626|584566708|FG004|Extension Phase|Adverse Event|0|||
161869398|NCT00652626|584566709|FG005|Extension Phase|Adverse Event|2|||
161869399|NCT00652626|584566710|FG006|Extension Phase|Adverse Event|1|||
161869400|NCT00652626|584566704|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161869401|NCT00652626|584566705|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161869402|NCT00652626|584566706|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161869403|NCT00652626|584566707|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161869404|NCT00652626|584566708|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161869405|NCT00652626|584566709|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
161869406|NCT00652626|584566710|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161869407|NCT00652626|584566704|FG000|Extension Phase|Physician Decision|0|||
161869408|NCT00652626|584566705|FG001|Extension Phase|Physician Decision|0|||
161869409|NCT00652626|584566706|FG002|Extension Phase|Physician Decision|0|||
161869410|NCT00652626|584566707|FG003|Extension Phase|Physician Decision|0|||
161869411|NCT00652626|584566708|FG004|Extension Phase|Physician Decision|0|||
161869412|NCT00652626|584566709|FG005|Extension Phase|Physician Decision|1|||
161869413|NCT00652626|584566710|FG006|Extension Phase|Physician Decision|1|||
161869414|NCT00652626|584566704|FG000|Extension Phase|Death|0|||
161869415|NCT00652626|584566705|FG001|Extension Phase|Death|0|||
161869416|NCT00652626|584566706|FG002|Extension Phase|Death|0|||
161869417|NCT00652626|584566707|FG003|Extension Phase|Death|0|||
161869418|NCT00652626|584566708|FG004|Extension Phase|Death|0|||
161869419|NCT00652626|584566709|FG005|Extension Phase|Death|1|||
161869420|NCT00652626|584566710|FG006|Extension Phase|Death|1|||
161869421|NCT04003636|584566711|FG000|Overall Study|Death|409|||
161869422|NCT04003636|584566712|FG001|Overall Study|Death|443|||
161869423|NCT04003636|584566711|FG000|Overall Study|Lost to Follow-up|0|||
161869424|NCT04003636|584566712|FG001|Overall Study|Lost to Follow-up|1|||
161869425|NCT04003636|584566711|FG000|Overall Study|Withdrawal by Subject|5|||
161869426|NCT04003636|584566712|FG001|Overall Study|Withdrawal by Subject|2|||
161869427|NCT04003636|584566711|FG000|Overall Study|Participant On-going|119|||
161869428|NCT04003636|584566712|FG001|Overall Study|Participant On-going|90|||
161869429|NCT03048747|584566713|FG000|Overall Study|Adverse Event|2|||
161869430|NCT03048747|584566713|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
161869431|NCT03048747|584566713|FG000|Overall Study|Physician Decision|1|||
161869432|NCT00915018|584566716|FG000|Overall Study|Death|75|||
161869433|NCT00915018|584566717|FG001|Overall Study|Death|70|||
161869434|NCT00915018|584566716|FG000|Overall Study|Lost to Follow-up|10|||
161869435|NCT00915018|584566717|FG001|Overall Study|Lost to Follow-up|5|||
161869436|NCT00915018|584566716|FG000|Overall Study|Withdrawal by Subject|38|||
161869437|NCT00915018|584566717|FG001|Overall Study|Withdrawal by Subject|27|||
161869438|NCT00915018|584566716|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
161869439|NCT00915018|584566717|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
161869440|NCT00457002|584566718|FG000|Overall Study|Death|40|||
161869441|NCT00457002|584566719|FG001|Overall Study|Death|47|||
161869442|NCT00457002|584566718|FG000|Overall Study|Adverse Event|284|||
161869443|NCT00457002|584566719|FG001|Overall Study|Adverse Event|260|||
161869444|NCT00457002|584566718|FG000|Overall Study|Withdrawal by Subject|299|||
161869445|NCT00457002|584566719|FG001|Overall Study|Withdrawal by Subject|271|||
161983743|NCT03322423|584988796|FG000|Period 1|Subject no longer eligible|0|||
161983744|NCT03322423|584988797|FG001|Period 1|Subject no longer eligible|1|||
161983745|NCT03322423|584988796|FG000|Period 1|Withdrawal by Subject|0|||
161983746|NCT03322423|584988797|FG001|Period 1|Withdrawal by Subject|1|||
161983747|NCT03322423|584988796|FG000|Period 1|Incorrect Lens Dispensed|1|||
161983748|NCT03322423|584988797|FG001|Period 1|Incorrect Lens Dispensed|0|||
161983749|NCT03322423|584988796|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
161869446|NCT00457002|584566718|FG000|Overall Study|Lost to Follow-up|72|||
161869447|NCT00457002|584566719|FG001|Overall Study|Lost to Follow-up|71|||
161869448|NCT00457002|584566718|FG000|Overall Study|Poor/Non-compliance|46|||
161983750|NCT03322423|584988797|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
161983751|NCT03322423|584988796|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
161869449|NCT00457002|584566719|FG001|Overall Study|Poor/Non-compliance|33|||
161869450|NCT00457002|584566718|FG000|Overall Study|No longer met criteria|41|||
161869451|NCT00457002|584566719|FG001|Overall Study|No longer met criteria|37|||
161869452|NCT00457002|584566718|FG000|Overall Study|Administrative reason by Sponsor|1|||
161869453|NCT00457002|584566719|FG001|Overall Study|Administrative reason by Sponsor|0|||
161869454|NCT00457002|584566718|FG000|Overall Study|non-specified|29|||
161869455|NCT00457002|584566719|FG001|Overall Study|non-specified|38|||
161869456|NCT00457002|584566718|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
161869457|NCT00457002|584566719|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
161869458|NCT01623310|584566720|FG000|Overall Study|Adverse Event|21|||
161869459|NCT01623310|584566720|FG000|Overall Study|Lost to Follow-up|18|||
161869460|NCT01623310|584566720|FG000|Overall Study|Lack of Efficacy|6|||
161869461|NCT01623310|584566720|FG000|Overall Study|Protocol Violation|6|||
161869462|NCT01623310|584566720|FG000|Overall Study|Withdrawal by Subject|25|||
161869463|NCT01623310|584566720|FG000|Overall Study|Became potentially child-bearing|1|||
161869464|NCT01623310|584566720|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
161869465|NCT01623310|584566720|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
161869466|NCT00454246|584566721|FG000|Overall Study|Adverse Event|2|||
161869467|NCT00454246|584566722|FG001|Overall Study|Adverse Event|2|||
161869468|NCT00454246|584566723|FG002|Overall Study|Adverse Event|0|||
161869469|NCT00454246|584566721|FG000|Overall Study|Violation of selection criteria at entry|6|||
161869470|NCT00454246|584566722|FG001|Overall Study|Violation of selection criteria at entry|0|||
161869471|NCT00454246|584566723|FG002|Overall Study|Violation of selection criteria at entry|0|||
161869472|NCT00454246|584566721|FG000|Overall Study|Protocol Violation|1|||
161869473|NCT00454246|584566722|FG001|Overall Study|Protocol Violation|0|||
161869474|NCT00454246|584566723|FG002|Overall Study|Protocol Violation|0|||
161869475|NCT00454246|584566721|FG000|Overall Study|Refused Treatment|1|||
161869476|NCT00454246|584566722|FG001|Overall Study|Refused Treatment|1|||
161869477|NCT00454246|584566723|FG002|Overall Study|Refused Treatment|0|||
161869478|NCT00454246|584566721|FG000|Overall Study|Failure to return|1|||
161869479|NCT00454246|584566722|FG001|Overall Study|Failure to return|0|||
161869480|NCT00454246|584566723|FG002|Overall Study|Failure to return|0|||
161869481|NCT00454246|584566721|FG000|Overall Study|Early termination of study|62|||
161869482|NCT00454246|584566722|FG001|Overall Study|Early termination of study|26|||
161869483|NCT00454246|584566723|FG002|Overall Study|Early termination of study|9|||
161869484|NCT00356603|584566724|FG000|Overall Study|Other|6|||
161869485|NCT00356603|584566725|FG001|Overall Study|Other|3|||
161869486|NCT05326529|584566726|FG000|Overall Study|Lack of Efficacy|0|||
161869487|NCT05326529|584566727|FG001|Overall Study|Lack of Efficacy|1|||
161869488|NCT05326529|584566728|FG002|Overall Study|Lack of Efficacy|0|||
161869489|NCT05326529|584566726|FG000|Overall Study|Physician Decision|0|||
161869490|NCT05326529|584566727|FG001|Overall Study|Physician Decision|0|||
161869491|NCT05326529|584566728|FG002|Overall Study|Physician Decision|2|||
161869492|NCT01262287|584566730|FG000|Overall Study|Lost to Follow-up|2|||
161869493|NCT01262287|584566731|FG001|Overall Study|Lost to Follow-up|1|||
161869494|NCT00932373|584566732|FG000|Overall Study|Progressive disease|3|||
161869495|NCT00932373|584566733|FG001|Overall Study|Progressive disease|1|||
161869496|NCT00932373|584566734|FG002|Overall Study|Progressive disease|0|||
161869497|NCT00932373|584566735|FG003|Overall Study|Progressive disease|0|||
161869498|NCT00932373|584566736|FG004|Overall Study|Progressive disease|10|||
161869499|NCT00932373|584566737|FG005|Overall Study|Progressive disease|1|||
161869500|NCT00932373|584566738|FG006|Overall Study|Progressive disease|0|||
161869501|NCT00932373|584566739|FG007|Overall Study|Progressive disease|2|||
161869502|NCT00932373|584566740|FG008|Overall Study|Progressive disease|1|||
161869503|NCT00932373|584566741|FG009|Overall Study|Progressive disease|9|||
161869504|NCT00932373|584566742|FG010|Overall Study|Progressive disease|2|||
161869505|NCT00932373|584566732|FG000|Overall Study|Adverse Event|0|||
161869506|NCT00932373|584566733|FG001|Overall Study|Adverse Event|0|||
161869507|NCT00932373|584566734|FG002|Overall Study|Adverse Event|0|||
161869508|NCT00932373|584566735|FG003|Overall Study|Adverse Event|0|||
161869509|NCT00932373|584566736|FG004|Overall Study|Adverse Event|2|||
162035045|NCT04777331|585184844|FG002|DBT Period|Death|0|||
162035046|NCT04777331|585184842|FG000|DBT Period|Reason not Specified|1|||
162035047|NCT04777331|585184843|FG001|DBT Period|Reason not Specified|1|||
162035048|NCT04777331|585184844|FG002|DBT Period|Reason not Specified|0|||
162035049|NCT04777331|585184842|FG000|DBT Period|Physician Decision|4|||
161869510|NCT00932373|584566737|FG005|Overall Study|Adverse Event|1|||
161869511|NCT00932373|584566738|FG006|Overall Study|Adverse Event|0|||
161869512|NCT00932373|584566739|FG007|Overall Study|Adverse Event|1|||
161869513|NCT00932373|584566740|FG008|Overall Study|Adverse Event|0|||
161869514|NCT00932373|584566741|FG009|Overall Study|Adverse Event|2|||
162035050|NCT04777331|585184843|FG001|DBT Period|Physician Decision|0|||
161869515|NCT00932373|584566742|FG010|Overall Study|Adverse Event|1|||
161869516|NCT00932373|584566732|FG000|Overall Study|Physician Decision|0|||
161869517|NCT00932373|584566733|FG001|Overall Study|Physician Decision|0|||
161869518|NCT00932373|584566734|FG002|Overall Study|Physician Decision|1|||
161869519|NCT00932373|584566735|FG003|Overall Study|Physician Decision|0|||
161869520|NCT00932373|584566736|FG004|Overall Study|Physician Decision|2|||
161869521|NCT00932373|584566737|FG005|Overall Study|Physician Decision|0|||
161869522|NCT00932373|584566738|FG006|Overall Study|Physician Decision|0|||
161869523|NCT00932373|584566739|FG007|Overall Study|Physician Decision|0|||
161869524|NCT00932373|584566740|FG008|Overall Study|Physician Decision|0|||
161869525|NCT00932373|584566741|FG009|Overall Study|Physician Decision|1|||
161869526|NCT00932373|584566742|FG010|Overall Study|Physician Decision|0|||
161869527|NCT00932373|584566732|FG000|Overall Study|Dose limiting toxicity|0|||
161869528|NCT00932373|584566733|FG001|Overall Study|Dose limiting toxicity|0|||
161869529|NCT00932373|584566734|FG002|Overall Study|Dose limiting toxicity|0|||
161983752|NCT03322423|584988797|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
161983753|NCT03322423|584988796|FG000|Period 2|Protocol Violation|1|||
161983754|NCT03322423|584988797|FG001|Period 2|Protocol Violation|0|||
161983755|NCT03322423|584988796|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
161983756|NCT03322423|584988797|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
161983757|NCT04891107|584988798|FG000|Overall Study|Physician Decision|1|||
161983758|NCT04891107|584988798|FG000|Overall Study|Withdrawal by Subject|1|||
161983759|NCT04891107|584988798|FG000|Overall Study|Screen failure after consent|1|||
161983760|NCT02453555|584988799|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
161983761|NCT02453555|584988800|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
161983762|NCT02453555|584988801|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
161774934|NCT02207413|584217394|FG000|Overall Study|Withdrawal by Subject|1|||
161774935|NCT02207413|584217395|FG001|Overall Study|Withdrawal by Subject|0|||
161774936|NCT02207413|584217396|FG002|Overall Study|Withdrawal by Subject|0|||
161774937|NCT02207413|584217397|FG003|Overall Study|Withdrawal by Subject|0|||
161774938|NCT02207413|584217398|FG004|Overall Study|Withdrawal by Subject|3|||
161774939|NCT02207413|584217399|FG005|Overall Study|Withdrawal by Subject|7|||
161774940|NCT02207413|584217394|FG000|Overall Study|Lost to Follow-up|0|||
161774941|NCT02207413|584217395|FG001|Overall Study|Lost to Follow-up|0|||
161774942|NCT02207413|584217396|FG002|Overall Study|Lost to Follow-up|0|||
161774943|NCT02207413|584217397|FG003|Overall Study|Lost to Follow-up|1|||
161774944|NCT02207413|584217398|FG004|Overall Study|Lost to Follow-up|1|||
161774945|NCT02207413|584217399|FG005|Overall Study|Lost to Follow-up|5|||
161774946|NCT02207413|584217394|FG000|Overall Study|Adverse Event|0|||
161774947|NCT02207413|584217395|FG001|Overall Study|Adverse Event|0|||
161774948|NCT02207413|584217396|FG002|Overall Study|Adverse Event|0|||
161774949|NCT02207413|584217397|FG003|Overall Study|Adverse Event|0|||
161774950|NCT02207413|584217398|FG004|Overall Study|Adverse Event|2|||
161774951|NCT02207413|584217399|FG005|Overall Study|Adverse Event|1|||
161774952|NCT02207413|584217394|FG000|Overall Study|Migrated/moved from study area|0|||
161774953|NCT02207413|584217395|FG001|Overall Study|Migrated/moved from study area|0|||
161774954|NCT02207413|584217396|FG002|Overall Study|Migrated/moved from study area|0|||
161774955|NCT02207413|584217397|FG003|Overall Study|Migrated/moved from study area|0|||
161774956|NCT02207413|584217398|FG004|Overall Study|Migrated/moved from study area|1|||
161774957|NCT02207413|584217399|FG005|Overall Study|Migrated/moved from study area|0|||
161774958|NCT01100073|584219331|FG000|Overall Study|Lack of Efficacy|4|||
161774959|NCT01100073|584219331|FG000|Overall Study|Insufficient Tolerability|21|||
161774960|NCT01100073|584219331|FG000|Overall Study|Withdrawal by Subject|13|||
161774961|NCT01100073|584219331|FG000|Overall Study|Lost to Follow-up|39|||
161774962|NCT01100073|584219331|FG000|Overall Study|Lack of effect + patient's wish|2|||
161774963|NCT01100073|584219331|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
161774964|NCT01100073|584219331|FG000|Overall Study|Other|8|||
161774965|NCT01100073|584219331|FG000|Overall Study|Missing|5|||
161774966|NCT00299546|584219332|FG000|Overall Study|Death|3|||
161774967|NCT00299546|584219333|FG001|Overall Study|Death|2|||
161774968|NCT00299546|584219334|FG002|Overall Study|Death|0|||
161774969|NCT00299546|584219332|FG000|Overall Study|Lost to Follow-up|2|||
161774970|NCT00299546|584219333|FG001|Overall Study|Lost to Follow-up|2|||
161774971|NCT00299546|584219334|FG002|Overall Study|Lost to Follow-up|5|||
161774972|NCT00299546|584219332|FG000|Overall Study|Adverse Event|37|||
161774973|NCT00299546|584219333|FG001|Overall Study|Adverse Event|22|||
161774974|NCT00299546|584219334|FG002|Overall Study|Adverse Event|27|||
161774975|NCT00299546|584219332|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
161774976|NCT00299546|584219333|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
161774977|NCT00299546|584219334|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
161983763|NCT02453555|584988802|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
161983764|NCT02453555|584988803|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
161983765|NCT02453555|584988804|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
161774978|NCT00299546|584219332|FG000|Overall Study|Other|24|||
161774979|NCT00299546|584219333|FG001|Overall Study|Other|26|||
161774980|NCT00299546|584219334|FG002|Overall Study|Other|19|||
161774981|NCT00299546|584219332|FG000|Overall Study|Not treated|0|||
161774982|NCT00299546|584219333|FG001|Overall Study|Not treated|1|||
161774983|NCT00299546|584219334|FG002|Overall Study|Not treated|1|||
161774984|NCT01656850|584219335|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
161774985|NCT01656850|584219336|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
161774986|NCT00968539|584219337|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
161774987|NCT00968539|584219338|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
161774988|NCT00326118|584219339|FG000|Active Phase|Withdrawal by Subject|4|||
161774989|NCT00326118|584219340|FG001|Active Phase|Withdrawal by Subject|1|||
161774990|NCT02525627|584219347|FG000|Overall Study|Revision|1|||
161774991|NCT02525627|584219348|FG001|Overall Study|Revision|1|||
161774992|NCT02525627|584219347|FG000|Overall Study|Withdrawal by Subject|1|||
161774993|NCT02525627|584219348|FG001|Overall Study|Withdrawal by Subject|2|||
162035051|NCT04777331|585184844|FG002|DBT Period|Physician Decision|0|||
161774994|NCT02525627|584219347|FG000|Overall Study|Death|1|||
161774995|NCT02525627|584219348|FG001|Overall Study|Death|0|||
161774996|NCT02525627|584219347|FG000|Overall Study|Site terminated|11|||
161774997|NCT02525627|584219348|FG001|Overall Study|Site terminated|10|||
161774998|NCT03710824|584219351|FG000|Overall Study|Withdrawal by Subject|1|||
161774999|NCT03710824|584219351|FG000|Overall Study|Lost to Follow-up|3|||
161775000|NCT03710824|584219351|FG000|Overall Study|Adverse Event|25|||
161775001|NCT03710824|584219351|FG000|Overall Study|Treatment discontinuation|2|||
161775002|NCT02329834|584219352|FG000|Overall Study|Physician Decision|1|||
161775003|NCT02329834|584219353|FG001|Overall Study|Physician Decision|0|||
161775004|NCT00578448|584219354|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
161775005|NCT00578448|584219354|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
161775006|NCT00578448|584219354|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
161775007|NCT00578448|584219354|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
161775008|NCT01301625|584219367|FG000|Overall Study|Death|5|||
161775009|NCT01301625|584219367|FG000|Overall Study|Not Due|21|||
161775010|NCT01301625|584219367|FG000|Overall Study|Expected|8|||
161775011|NCT01301625|584219367|FG000|Overall Study|Lost to Follow-up|1|||
161775012|NCT05102162|584219373|FG000|Overall Study|Withdrawal by Subject|3|||
161775013|NCT05102162|584219374|FG001|Overall Study|Withdrawal by Subject|0|||
161775014|NCT05102162|584219373|FG000|Overall Study|Baseline cultures negative|4|||
161775015|NCT05102162|584219374|FG001|Overall Study|Baseline cultures negative|2|||
161775016|NCT05102162|584219373|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
161775017|NCT05102162|584219374|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
161775018|NCT05102162|584219373|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
161775019|NCT05102162|584219374|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
161775020|NCT02181673|584219377|FG000|Up to Week 24|Adverse Event|2|||
161775021|NCT02181673|584219378|FG001|Up to Week 24|Adverse Event|0|||
161775022|NCT02181673|584219379|FG002|Up to Week 24|Adverse Event|3|||
161775023|NCT02181673|584219377|FG000|Up to Week 24|Death|1|||
161775024|NCT02181673|584219378|FG001|Up to Week 24|Death|0|||
161775025|NCT02181673|584219379|FG002|Up to Week 24|Death|0|||
161775026|NCT02181673|584219377|FG000|Up to Week 24|Lack of Efficacy|1|||
161775027|NCT02181673|584219378|FG001|Up to Week 24|Lack of Efficacy|0|||
161775028|NCT02181673|584219379|FG002|Up to Week 24|Lack of Efficacy|0|||
161775029|NCT02181673|584219377|FG000|Up to Week 24|Lost to Follow-up|1|||
161775030|NCT02181673|584219378|FG001|Up to Week 24|Lost to Follow-up|0|||
161775031|NCT02181673|584219379|FG002|Up to Week 24|Lost to Follow-up|0|||
161775032|NCT02181673|584219377|FG000|Up to Week 24|Physician Decision|0|||
161775033|NCT02181673|584219378|FG001|Up to Week 24|Physician Decision|0|||
161775034|NCT02181673|584219379|FG002|Up to Week 24|Physician Decision|3|||
161775035|NCT02181673|584219377|FG000|Up to Week 24|Withdrawal by Subject|10|||
161775036|NCT02181673|584219378|FG001|Up to Week 24|Withdrawal by Subject|0|||
161775037|NCT02181673|584219379|FG002|Up to Week 24|Withdrawal by Subject|1|||
161775038|NCT02181673|584219377|FG000|Up to Week 24|Other|2|||
161775039|NCT02181673|584219378|FG001|Up to Week 24|Other|0|||
161775040|NCT02181673|584219379|FG002|Up to Week 24|Other|3|||
161775041|NCT02181673|584219377|FG000|Up to Week 24|Randomized not Treated|0|||
161775042|NCT02181673|584219378|FG001|Up to Week 24|Randomized not Treated|0|||
161775043|NCT02181673|584219379|FG002|Up to Week 24|Randomized not Treated|1|||
161775044|NCT02181673|584219377|FG000|Week 24-Week 60|Adverse Event|0|||
161775045|NCT02181673|584219378|FG001|Week 24-Week 60|Adverse Event|4|||
161775046|NCT02181673|584219379|FG002|Week 24-Week 60|Adverse Event|10|||
161775047|NCT02181673|584219377|FG000|Week 24-Week 60|Other|0|||
161775048|NCT02181673|584219378|FG001|Week 24-Week 60|Other|2|||
161775049|NCT02181673|584219379|FG002|Week 24-Week 60|Other|1|||
161775050|NCT02181673|584219377|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
161775051|NCT02181673|584219378|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
161775052|NCT02181673|584219379|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
161775053|NCT02181673|584219377|FG000|Week 24-Week 60|Pregnancy|0|||
161775054|NCT02181673|584219378|FG001|Week 24-Week 60|Pregnancy|0|||
161775055|NCT02181673|584219379|FG002|Week 24-Week 60|Pregnancy|1|||
161775056|NCT02181673|584219377|FG000|Week 24-Week 60|Lack of Efficacy|0|||
161775057|NCT02181673|584219378|FG001|Week 24-Week 60|Lack of Efficacy|0|||
161775058|NCT02181673|584219379|FG002|Week 24-Week 60|Lack of Efficacy|1|||
161775059|NCT02181673|584219377|FG000|Week 24-Week 60|Lost to Follow-up|0|||
161775060|NCT02181673|584219378|FG001|Week 24-Week 60|Lost to Follow-up|0|||
161775061|NCT02181673|584219379|FG002|Week 24-Week 60|Lost to Follow-up|1|||
161775062|NCT02181673|584219377|FG000|Week 24-Week 60|Physician Decision|0|||
161775063|NCT02181673|584219378|FG001|Week 24-Week 60|Physician Decision|0|||
161775064|NCT02181673|584219379|FG002|Week 24-Week 60|Physician Decision|1|||
161775065|NCT00433771|584219380|FG000|Overall Study|screen fail|14|||
161775066|NCT00433771|584219380|FG000|Overall Study|Treated and later found to be ineligible|2|||
161775067|NCT00433771|584219380|FG000|Overall Study|Death|2|||
161775068|NCT00433771|584219380|FG000|Overall Study|Failure to deploy stent|1|||
161775069|NCT00138658|584219381|FG000|Overall Study|Adverse Event|23|||
161775070|NCT00138658|584219381|FG000|Overall Study|Death|1|||
162035052|NCT04777331|585184842|FG000|DBT Period|Withdrawal by Subject|12|||
161775071|NCT00138658|584219381|FG000|Overall Study|Disease Progression|21|||
161775072|NCT00138658|584219381|FG000|Overall Study|Physician Decision|11|||
161869530|NCT00932373|584566735|FG003|Overall Study|Dose limiting toxicity|0|||
161869531|NCT00932373|584566736|FG004|Overall Study|Dose limiting toxicity|0|||
161869532|NCT00932373|584566737|FG005|Overall Study|Dose limiting toxicity|1|||
161869533|NCT00932373|584566738|FG006|Overall Study|Dose limiting toxicity|0|||
161869534|NCT00932373|584566739|FG007|Overall Study|Dose limiting toxicity|0|||
161869535|NCT00932373|584566740|FG008|Overall Study|Dose limiting toxicity|0|||
161869536|NCT00932373|584566741|FG009|Overall Study|Dose limiting toxicity|0|||
161869537|NCT00932373|584566742|FG010|Overall Study|Dose limiting toxicity|0|||
161869538|NCT00932373|584566732|FG000|Overall Study|Withdrawal by Subject|0|||
161869539|NCT00932373|584566733|FG001|Overall Study|Withdrawal by Subject|0|||
161869540|NCT00932373|584566734|FG002|Overall Study|Withdrawal by Subject|0|||
161869541|NCT00932373|584566735|FG003|Overall Study|Withdrawal by Subject|0|||
161869542|NCT00932373|584566736|FG004|Overall Study|Withdrawal by Subject|0|||
161869543|NCT00932373|584566737|FG005|Overall Study|Withdrawal by Subject|0|||
161869544|NCT00932373|584566738|FG006|Overall Study|Withdrawal by Subject|0|||
161869545|NCT00932373|584566739|FG007|Overall Study|Withdrawal by Subject|0|||
161869546|NCT00932373|584566740|FG008|Overall Study|Withdrawal by Subject|1|||
161869547|NCT00932373|584566741|FG009|Overall Study|Withdrawal by Subject|0|||
161869548|NCT00932373|584566742|FG010|Overall Study|Withdrawal by Subject|0|||
161869549|NCT00932373|584566732|FG000|Overall Study|Clinical progression|0|||
161869550|NCT00932373|584566733|FG001|Overall Study|Clinical progression|0|||
161869551|NCT00932373|584566734|FG002|Overall Study|Clinical progression|0|||
161869552|NCT00932373|584566735|FG003|Overall Study|Clinical progression|0|||
161869553|NCT00932373|584566736|FG004|Overall Study|Clinical progression|0|||
161869554|NCT00932373|584566737|FG005|Overall Study|Clinical progression|0|||
161869555|NCT00932373|584566738|FG006|Overall Study|Clinical progression|1|||
161869556|NCT00932373|584566739|FG007|Overall Study|Clinical progression|0|||
161869557|NCT00932373|584566740|FG008|Overall Study|Clinical progression|0|||
161869558|NCT00932373|584566741|FG009|Overall Study|Clinical progression|0|||
161869559|NCT00932373|584566742|FG010|Overall Study|Clinical progression|0|||
161869560|NCT00932373|584566732|FG000|Overall Study|Lack of Efficacy|0|||
161869561|NCT00932373|584566733|FG001|Overall Study|Lack of Efficacy|0|||
161869562|NCT00932373|584566734|FG002|Overall Study|Lack of Efficacy|0|||
161869563|NCT00932373|584566735|FG003|Overall Study|Lack of Efficacy|0|||
161869564|NCT00932373|584566736|FG004|Overall Study|Lack of Efficacy|0|||
161869565|NCT00932373|584566737|FG005|Overall Study|Lack of Efficacy|0|||
161869566|NCT00932373|584566738|FG006|Overall Study|Lack of Efficacy|0|||
161869567|NCT00932373|584566739|FG007|Overall Study|Lack of Efficacy|0|||
161869568|NCT00932373|584566740|FG008|Overall Study|Lack of Efficacy|0|||
161869569|NCT00932373|584566741|FG009|Overall Study|Lack of Efficacy|1|||
161869570|NCT00932373|584566742|FG010|Overall Study|Lack of Efficacy|0|||
161869571|NCT04134767|584566745|FG000|Overall Study|Death|0|||
161869572|NCT04134767|584566746|FG001|Overall Study|Death|1|||
161869573|NCT04134767|584566745|FG000|Overall Study|Removed for harassing staff|0|||
161869574|NCT04134767|584566746|FG001|Overall Study|Removed for harassing staff|1|||
161869575|NCT04134767|584566745|FG000|Overall Study|Lost to Follow-up|44|||
161869576|NCT04134767|584566746|FG001|Overall Study|Lost to Follow-up|40|||
161869577|NCT02582242|584566747|FG000|Overall Study|Adverse Event|4|||
161869578|NCT02582242|584566748|FG001|Overall Study|Adverse Event|3|||
161869579|NCT02582242|584566747|FG000|Overall Study|Protocol Violation|3|||
161869580|NCT02582242|584566748|FG001|Overall Study|Protocol Violation|1|||
161869581|NCT02582242|584566747|FG000|Overall Study|Lost to Follow-up|0|||
161869582|NCT02582242|584566748|FG001|Overall Study|Lost to Follow-up|1|||
161869583|NCT02582242|584566747|FG000|Overall Study|Withdrawal by Subject|11|||
161869584|NCT02582242|584566748|FG001|Overall Study|Withdrawal by Subject|11|||
161869585|NCT02582242|584566747|FG000|Overall Study|Unclassified|2|||
161869586|NCT02582242|584566748|FG001|Overall Study|Unclassified|1|||
161869587|NCT02101736|584566749|FG000|Overall Study|Protocol Violation|3|||
161869588|NCT02101736|584566750|FG001|Overall Study|Protocol Violation|0|||
161869589|NCT02101736|584566749|FG000|Overall Study|Withdrawal by Subject|1|||
161869590|NCT02101736|584566750|FG001|Overall Study|Withdrawal by Subject|1|||
161869591|NCT03150719|584566755|FG000|Overall Study|Adverse Event|0|||
162035053|NCT04777331|585184843|FG001|DBT Period|Withdrawal by Subject|11|||
162035054|NCT04777331|585184844|FG002|DBT Period|Withdrawal by Subject|0|||
162035055|NCT04777331|585184842|FG000|DBT Period|Randomized but not Treated|1|||
162035056|NCT04777331|585184843|FG001|DBT Period|Randomized but not Treated|3|||
161869592|NCT03150719|584566756|FG001|Overall Study|Adverse Event|1|||
162035057|NCT04777331|585184844|FG002|DBT Period|Randomized but not Treated|0|||
162035058|NCT04777331|585184842|FG000|OLE Period|Ongoing in OLE|0|||
161869593|NCT03150719|584566755|FG000|Overall Study|Death|0|||
161869594|NCT03150719|584566756|FG001|Overall Study|Death|1|||
161869595|NCT03150719|584566755|FG000|Overall Study|Other|1|||
161869596|NCT03150719|584566756|FG001|Overall Study|Other|0|||
161869597|NCT04938180|584566757|FG000|Overall Study|Adverse Event|1|||
161869598|NCT01964222|584566758|FG000|Overall Study|Lost to Follow-up|7|||
161869599|NCT01964222|584566759|FG001|Overall Study|Lost to Follow-up|5|||
161869600|NCT01964222|584566758|FG000|Overall Study|Withdrawal by Subject|6|||
161869601|NCT01964222|584566759|FG001|Overall Study|Withdrawal by Subject|6|||
162035059|NCT04777331|585184843|FG001|OLE Period|Ongoing in OLE|0|||
161869602|NCT01964222|584566758|FG000|Overall Study|Screening Failure|2|||
161869603|NCT01964222|584566759|FG001|Overall Study|Screening Failure|0|||
161869604|NCT01019694|584566764|FG000|Overall Study|Adverse Event|12|||
161869605|NCT01019694|584566765|FG001|Overall Study|Adverse Event|16|||
161869606|NCT01019694|584566766|FG002|Overall Study|Adverse Event|19|||
161869607|NCT01019694|584566764|FG000|Overall Study|Protocol Violation|2|||
161869608|NCT01019694|584566765|FG001|Overall Study|Protocol Violation|6|||
161869609|NCT01019694|584566766|FG002|Overall Study|Protocol Violation|4|||
161869610|NCT01019694|584566764|FG000|Overall Study|Lost to Follow-up|5|||
161869611|NCT01019694|584566765|FG001|Overall Study|Lost to Follow-up|3|||
161869612|NCT01019694|584566766|FG002|Overall Study|Lost to Follow-up|3|||
161869613|NCT01019694|584566764|FG000|Overall Study|Withdrawal by Subject|4|||
161869614|NCT01019694|584566765|FG001|Overall Study|Withdrawal by Subject|6|||
161869615|NCT01019694|584566766|FG002|Overall Study|Withdrawal by Subject|12|||
161869616|NCT01019694|584566764|FG000|Overall Study|Not treated|0|||
161869617|NCT01019694|584566765|FG001|Overall Study|Not treated|2|||
161869618|NCT01019694|584566766|FG002|Overall Study|Not treated|3|||
161869619|NCT01019694|584566764|FG000|Overall Study|Other reason (not specified)|1|||
161869620|NCT01019694|584566765|FG001|Overall Study|Other reason (not specified)|5|||
161869621|NCT01019694|584566766|FG002|Overall Study|Other reason (not specified)|6|||
161869622|NCT00441129|584566769|FG000|Overall Study|Withdrawal by Subject|6|||
161869623|NCT00441129|584566770|FG001|Overall Study|Withdrawal by Subject|14|||
161869624|NCT04278417|584566780|FG000|Overall Study|Withdrawal by Subject|20|||
161869625|NCT04278417|584566781|FG001|Overall Study|Withdrawal by Subject|20|||
161869626|NCT04278417|584566780|FG000|Overall Study|Progressive disease|0|||
161869627|NCT04278417|584566781|FG001|Overall Study|Progressive disease|2|||
161869628|NCT04278417|584566780|FG000|Overall Study|Physician Decision|4|||
161869629|NCT04278417|584566781|FG001|Overall Study|Physician Decision|6|||
161869630|NCT04278417|584566780|FG000|Overall Study|Lost to Follow-up|11|||
161869631|NCT04278417|584566781|FG001|Overall Study|Lost to Follow-up|13|||
161869632|NCT04278417|584566780|FG000|Overall Study|Death|8|||
161869633|NCT04278417|584566781|FG001|Overall Study|Death|9|||
161869634|NCT04278417|584566780|FG000|Overall Study|Adverse Event|3|||
161869635|NCT04278417|584566781|FG001|Overall Study|Adverse Event|5|||
161869636|NCT02097745|584566787|FG000|Overall Study|Adverse Event|25|||
161869637|NCT02097745|584566787|FG000|Overall Study|Death|16|||
161869638|NCT02097745|584566787|FG000|Overall Study|Failure to Return|14|||
161869639|NCT02097745|584566787|FG000|Overall Study|Administrative/Other|27|||
161869640|NCT02097745|584566787|FG000|Overall Study|Reason Not Specified|96|||
161869641|NCT02748356|584566788|FG000|Overall Study|Withdrawal by Subject|1|||
161869642|NCT00425750|584566789|FG000|Overall Study|Death|1|||
161869643|NCT00425750|584566789|FG000|Overall Study|Withdrawal by Subject|3|||
161869644|NCT00425750|584566789|FG000|Overall Study|Adverse Event|3|||
161869645|NCT00425750|584566789|FG000|Overall Study|Progression of disease|18|||
161869646|NCT04331067|584566790|FG000|Overall Study|Adverse Event|1|||
161869647|NCT04331067|584566791|FG001|Overall Study|Adverse Event|3|||
161869648|NCT04331067|584566792|FG002|Overall Study|Adverse Event|1|||
161869649|NCT04331067|584566790|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
161869650|NCT04331067|584566791|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
161869651|NCT04331067|584566792|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
161869652|NCT00347009|584566793|FG000|Overall Study|Death|1|||
161869653|NCT00347009|584566793|FG000|Overall Study|Adverse Event|6|||
161983766|NCT02453555|584988799|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
161983767|NCT02453555|584988800|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
161983768|NCT02453555|584988801|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
161983769|NCT02453555|584988802|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
161983770|NCT02453555|584988803|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
161983771|NCT02453555|584988804|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
161869654|NCT00347009|584566793|FG000|Overall Study|Withdrawal by Subject|3|||
161983772|NCT02453555|584988799|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
161983773|NCT02453555|584988800|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
161983774|NCT02453555|584988801|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161983775|NCT02453555|584988802|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161869655|NCT00347009|584566793|FG000|Overall Study|Physician Decision|5|||
161869656|NCT00347009|584566793|FG000|Overall Study|Lost to Follow-up|4|||
161869657|NCT00347009|584566793|FG000|Overall Study|Protocol Violation|2|||
161869658|NCT00347009|584566793|FG000|Overall Study|Adverse Laboratory Experience|1|||
161869659|NCT00347009|584566793|FG000|Overall Study|Insufficient Viral Suppression|3|||
161869660|NCT00347009|584566793|FG000|Overall Study|Increased ALT/HBV DNA|1|||
161869661|NCT00347009|584566793|FG000|Overall Study|Serious Adverse Event|1|||
161869662|NCT02907177|584566794|FG000|Overall Study|Death|0|||
161869663|NCT02907177|584566795|FG001|Overall Study|Death|1|||
161869664|NCT02907177|584566794|FG000|Overall Study|Physician Decision|3|||
161869665|NCT02907177|584566795|FG001|Overall Study|Physician Decision|3|||
161869666|NCT02907177|584566794|FG000|Overall Study|Withdrawal by Subject|15|||
161869667|NCT02907177|584566795|FG001|Overall Study|Withdrawal by Subject|7|||
161869668|NCT02907177|584566794|FG000|Overall Study|Sponsor's Decision|50|||
161869669|NCT02907177|584566795|FG001|Overall Study|Sponsor's Decision|57|||
161869670|NCT01796392|584566796|FG000|Overall Study|Withdrawal by Subject|2|||
161869671|NCT01796392|584566797|FG001|Overall Study|Withdrawal by Subject|0|||
161869672|NCT01796392|584566796|FG000|Overall Study|Death|5|||
161869673|NCT01796392|584566797|FG001|Overall Study|Death|1|||
161869674|NCT01796392|584566796|FG000|Overall Study|Excluded for medical reasons|1|||
161869675|NCT01796392|584566797|FG001|Overall Study|Excluded for medical reasons|2|||
161869676|NCT01796392|584566796|FG000|Overall Study|Lost to Follow-up|1|||
161869677|NCT01796392|584566797|FG001|Overall Study|Lost to Follow-up|0|||
161869678|NCT03482635|584566798|FG000|Overall Study|Lack of Efficacy|0|||
161869679|NCT03482635|584566799|FG001|Overall Study|Lack of Efficacy|0|||
161869680|NCT03482635|584566800|FG002|Overall Study|Lack of Efficacy|1|||
161869681|NCT03482635|584566801|FG003|Overall Study|Lack of Efficacy|3|||
161869682|NCT03482635|584566798|FG000|Overall Study|Adverse Event|2|||
161869683|NCT03482635|584566799|FG001|Overall Study|Adverse Event|2|||
161869684|NCT03482635|584566800|FG002|Overall Study|Adverse Event|0|||
161869685|NCT03482635|584566801|FG003|Overall Study|Adverse Event|3|||
161869686|NCT03482635|584566798|FG000|Overall Study|Withdrawal by Subject|2|||
161869687|NCT03482635|584566799|FG001|Overall Study|Withdrawal by Subject|1|||
161869688|NCT03482635|584566800|FG002|Overall Study|Withdrawal by Subject|0|||
161869689|NCT03482635|584566801|FG003|Overall Study|Withdrawal by Subject|1|||
161869690|NCT03482635|584566798|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
161869691|NCT03482635|584566799|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
161869692|NCT03482635|584566800|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
161869693|NCT03482635|584566801|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
161869694|NCT03482635|584566798|FG000|Overall Study|Not treated|0|||
161869695|NCT03482635|584566799|FG001|Overall Study|Not treated|0|||
161869696|NCT03482635|584566800|FG002|Overall Study|Not treated|0|||
161869697|NCT03482635|584566801|FG003|Overall Study|Not treated|1|||
161869698|NCT04639219|584566802|FG000|Overall Study|Withdrawal by Subject|8|||
161869699|NCT04639219|584566802|FG000|Overall Study|Lost to Follow-up|6|||
161869700|NCT04639219|584566802|FG000|Overall Study|Death|55|||
161869701|NCT04681066|584566803|FG000|Overall Study|Lost to Follow-up|3|||
161869702|NCT04681066|584566804|FG001|Overall Study|Lost to Follow-up|1|||
161869703|NCT04681066|584566805|FG002|Overall Study|Lost to Follow-up|2|||
161869704|NCT04681066|584566806|FG003|Overall Study|Lost to Follow-up|1|||
161869705|NCT04681066|584566803|FG000|Overall Study|Withdrawal by Subject|2|||
161869706|NCT04681066|584566804|FG001|Overall Study|Withdrawal by Subject|1|||
161869707|NCT04681066|584566805|FG002|Overall Study|Withdrawal by Subject|0|||
161869708|NCT04681066|584566806|FG003|Overall Study|Withdrawal by Subject|3|||
161869709|NCT04681066|584566803|FG000|Overall Study|Death|0|||
161869710|NCT04681066|584566804|FG001|Overall Study|Death|1|||
161869711|NCT04681066|584566805|FG002|Overall Study|Death|0|||
161869712|NCT04681066|584566806|FG003|Overall Study|Death|0|||
161869713|NCT03474965|584566807|FG000|Overall Study|Pregnancy|1|||
161869714|NCT03474965|584566808|FG001|Overall Study|Pregnancy|0|||
161869715|NCT03474965|584566809|FG002|Overall Study|Pregnancy|0|||
161869716|NCT03474965|584566810|FG003|Overall Study|Pregnancy|0|||
161869717|NCT03474965|584566807|FG000|Overall Study|Lost to Follow-up|0|||
161983776|NCT02453555|584988803|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161983777|NCT02453555|584988804|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161983778|NCT02453555|584988799|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
161869718|NCT03474965|584566808|FG001|Overall Study|Lost to Follow-up|0|||
161869719|NCT03474965|584566809|FG002|Overall Study|Lost to Follow-up|1|||
161869720|NCT03474965|584566810|FG003|Overall Study|Lost to Follow-up|0|||
161869721|NCT03474965|584566807|FG000|Overall Study|Death|1|||
161869722|NCT03474965|584566808|FG001|Overall Study|Death|0|||
161869723|NCT03474965|584566809|FG002|Overall Study|Death|0|||
161869724|NCT03474965|584566810|FG003|Overall Study|Death|0|||
161869725|NCT03474965|584566807|FG000|Overall Study|Adverse Event|1|||
161869726|NCT03474965|584566808|FG001|Overall Study|Adverse Event|0|||
161869727|NCT03474965|584566809|FG002|Overall Study|Adverse Event|0|||
161869728|NCT03474965|584566810|FG003|Overall Study|Adverse Event|1|||
161869729|NCT03474965|584566807|FG000|Overall Study|Physician Decision|3|||
161869730|NCT03474965|584566808|FG001|Overall Study|Physician Decision|1|||
161869731|NCT03474965|584566809|FG002|Overall Study|Physician Decision|2|||
161869732|NCT03474965|584566810|FG003|Overall Study|Physician Decision|0|||
161869733|NCT03474965|584566807|FG000|Overall Study|Participant Decision|7|||
161869734|NCT03474965|584566808|FG001|Overall Study|Participant Decision|0|||
161869735|NCT03474965|584566809|FG002|Overall Study|Participant Decision|1|||
161869736|NCT03474965|584566810|FG003|Overall Study|Participant Decision|0|||
161869737|NCT03474965|584566807|FG000|Overall Study|Guardian Decision|4|||
161869738|NCT03474965|584566808|FG001|Overall Study|Guardian Decision|2|||
161869739|NCT03474965|584566809|FG002|Overall Study|Guardian Decision|7|||
161869740|NCT03474965|584566810|FG003|Overall Study|Guardian Decision|2|||
161869741|NCT00300885|584568412|FG000|Treatment|Adverse Event|134|||
161869742|NCT00300885|584568413|FG001|Treatment|Adverse Event|82|||
161869743|NCT00300885|584568412|FG000|Treatment|Death|20|||
161869744|NCT00300885|584568413|FG001|Treatment|Death|7|||
162035060|NCT04777331|585184844|FG002|OLE Period|Ongoing in OLE|534|||
162035061|NCT01401959|585184845|FG000|Enrolled|Withdrawal by Subject|1|||
162035062|NCT01401959|585184846|FG001|Enrolled|Withdrawal by Subject|0|||
162035063|NCT01401959|585184847|FG002|Enrolled|Withdrawal by Subject|0|||
162035064|NCT01401959|585184845|FG000|Treated|Disease Progression|2|||
162035065|NCT01401959|585184846|FG001|Treated|Disease Progression|2|||
162035066|NCT01401959|585184847|FG002|Treated|Disease Progression|1|||
162035067|NCT01401959|585184845|FG000|Treated|Adverse Event|4|||
162035068|NCT01401959|585184846|FG001|Treated|Adverse Event|3|||
162035069|NCT01401959|585184847|FG002|Treated|Adverse Event|2|||
162035070|NCT01401959|585184845|FG000|Treated|Withdrawal by Subject|1|||
162035071|NCT01401959|585184846|FG001|Treated|Withdrawal by Subject|2|||
162035072|NCT01401959|585184847|FG002|Treated|Withdrawal by Subject|2|||
162035073|NCT01401959|585184845|FG000|Treated|Protocol Violation|0|||
162035074|NCT01401959|585184846|FG001|Treated|Protocol Violation|1|||
162035075|NCT01401959|585184847|FG002|Treated|Protocol Violation|0|||
162035076|NCT00400153|585184848|FG000|Overall Study|AE due to study disease worsening|14|||
162035077|NCT00400153|585184849|FG001|Overall Study|AE due to study disease worsening|19|||
162035078|NCT00400153|585184850|FG002|Overall Study|AE due to study disease worsening|20|||
162035079|NCT00400153|585184848|FG000|Overall Study|AE due to other disease worsening|2|||
162035080|NCT00400153|585184849|FG001|Overall Study|AE due to other disease worsening|1|||
162035081|NCT00400153|585184850|FG002|Overall Study|AE due to other disease worsening|0|||
162035082|NCT00400153|585184848|FG000|Overall Study|AE due to other condition|3|||
162035083|NCT00400153|585184849|FG001|Overall Study|AE due to other condition|14|||
162035084|NCT00400153|585184850|FG002|Overall Study|AE due to other condition|15|||
162035085|NCT00400153|585184848|FG000|Overall Study|Protocol Violation|7|||
161983779|NCT02453555|584988800|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
161983780|NCT02453555|584988801|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
161983781|NCT02453555|584988802|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
161983782|NCT02453555|584988803|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
161983783|NCT02453555|584988804|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
161983784|NCT02453555|584988799|FG000|Extension Period|Adverse Event|0|||
161983785|NCT02453555|584988800|FG001|Extension Period|Adverse Event|0|||
161983786|NCT02453555|584988801|FG002|Extension Period|Adverse Event|1|||
161983787|NCT02453555|584988802|FG003|Extension Period|Adverse Event|2|||
161983788|NCT02453555|584988803|FG004|Extension Period|Adverse Event|1|||
161983789|NCT02453555|584988804|FG005|Extension Period|Adverse Event|1|||
161983790|NCT02453555|584988799|FG000|Extension Period|Protocol Violation|0|||
161983791|NCT02453555|584988800|FG001|Extension Period|Protocol Violation|0|||
161983792|NCT02453555|584988801|FG002|Extension Period|Protocol Violation|1|||
161983793|NCT02453555|584988802|FG003|Extension Period|Protocol Violation|0|||
161983794|NCT02453555|584988803|FG004|Extension Period|Protocol Violation|0|||
161983795|NCT02453555|584988804|FG005|Extension Period|Protocol Violation|0|||
161983796|NCT02453555|584988799|FG000|Extension Period|Withdrawal by Subject|0|||
161983797|NCT02453555|584988800|FG001|Extension Period|Withdrawal by Subject|0|||
161983798|NCT02453555|584988801|FG002|Extension Period|Withdrawal by Subject|1|||
161983799|NCT02453555|584988802|FG003|Extension Period|Withdrawal by Subject|0|||
161983800|NCT02453555|584988803|FG004|Extension Period|Withdrawal by Subject|0|||
161983801|NCT02453555|584988804|FG005|Extension Period|Withdrawal by Subject|0|||
161983802|NCT03178669|584988808|FG000|Overall Study|Adverse Event|4|||
161983803|NCT03178669|584988809|FG001|Overall Study|Adverse Event|1|||
161983804|NCT03178669|584988810|FG002|Overall Study|Adverse Event|4|||
161983805|NCT03178669|584988811|FG003|Overall Study|Adverse Event|2|||
161983806|NCT03178669|584988812|FG004|Overall Study|Adverse Event|2|||
161983807|NCT03178669|584988808|FG000|Overall Study|Lack of Efficacy|0|||
161983808|NCT03178669|584988809|FG001|Overall Study|Lack of Efficacy|0|||
161983809|NCT03178669|584988810|FG002|Overall Study|Lack of Efficacy|2|||
161983810|NCT03178669|584988811|FG003|Overall Study|Lack of Efficacy|0|||
161983811|NCT03178669|584988812|FG004|Overall Study|Lack of Efficacy|1|||
161983812|NCT03178669|584988808|FG000|Overall Study|Physician Decision|0|||
161983813|NCT03178669|584988809|FG001|Overall Study|Physician Decision|0|||
161983814|NCT03178669|584988810|FG002|Overall Study|Physician Decision|0|||
162035086|NCT00400153|585184849|FG001|Overall Study|Protocol Violation|4|||
161983815|NCT03178669|584988811|FG003|Overall Study|Physician Decision|0|||
162035087|NCT00400153|585184850|FG002|Overall Study|Protocol Violation|9|||
162035088|NCT00400153|585184848|FG000|Overall Study|Lost to Follow-up|2|||
162035089|NCT00400153|585184849|FG001|Overall Study|Lost to Follow-up|1|||
161983816|NCT03178669|584988812|FG004|Overall Study|Physician Decision|1|||
161983817|NCT03178669|584988808|FG000|Overall Study|Withdrawal by Subject|1|||
161983818|NCT03178669|584988809|FG001|Overall Study|Withdrawal by Subject|0|||
161983819|NCT03178669|584988810|FG002|Overall Study|Withdrawal by Subject|1|||
161983820|NCT03178669|584988811|FG003|Overall Study|Withdrawal by Subject|1|||
161983821|NCT03178669|584988812|FG004|Overall Study|Withdrawal by Subject|0|||
162035090|NCT00400153|585184850|FG002|Overall Study|Lost to Follow-up|4|||
162035091|NCT00400153|585184848|FG000|Overall Study|Withdrawal by Subject|12|||
162035092|NCT00400153|585184849|FG001|Overall Study|Withdrawal by Subject|11|||
162035093|NCT00400153|585184850|FG002|Overall Study|Withdrawal by Subject|10|||
162035094|NCT00400153|585184848|FG000|Overall Study|Other reasons - not mentioned above|8|||
162035095|NCT00400153|585184849|FG001|Overall Study|Other reasons - not mentioned above|5|||
162035096|NCT00400153|585184850|FG002|Overall Study|Other reasons - not mentioned above|3|||
162035097|NCT01423604|585184851|FG000|Safety Run-In|Adverse Event|3|||
161869745|NCT00300885|584568412|FG000|Treatment|Lack of Efficacy|1|||
161869746|NCT00300885|584568413|FG001|Treatment|Lack of Efficacy|1|||
161869747|NCT00300885|584568412|FG000|Treatment|Lost to Follow-up|3|||
161869748|NCT00300885|584568413|FG001|Treatment|Lost to Follow-up|2|||
161869749|NCT00300885|584568412|FG000|Treatment|Physician Decision|4|||
161869750|NCT00300885|584568413|FG001|Treatment|Physician Decision|5|||
161869751|NCT00300885|584568412|FG000|Treatment|Protocol Violation|11|||
161869752|NCT00300885|584568413|FG001|Treatment|Protocol Violation|11|||
161869753|NCT00300885|584568412|FG000|Treatment|Withdrawal by Subject|26|||
161869754|NCT00300885|584568413|FG001|Treatment|Withdrawal by Subject|23|||
161869755|NCT00300885|584568412|FG000|Treatment|Disease progression|171|||
161869756|NCT00300885|584568413|FG001|Treatment|Disease progression|238|||
161869757|NCT00300885|584568412|FG000|Treatment|Random code broken (subject died)|0|||
161869758|NCT00300885|584568413|FG001|Treatment|Random code broken (subject died)|1|||
161869759|NCT00300885|584568412|FG000|Treatment|Non-compliant with study medication|3|||
161869760|NCT00300885|584568413|FG001|Treatment|Non-compliant with study medication|4|||
161869761|NCT00300885|584568412|FG000|Follow-up|Death|141|||
161869762|NCT00300885|584568413|FG001|Follow-up|Death|163|||
161869763|NCT00300885|584568412|FG000|Follow-up|Lost to Follow-up|11|||
161869764|NCT00300885|584568413|FG001|Follow-up|Lost to Follow-up|7|||
161869765|NCT00300885|584568412|FG000|Follow-up|Withdrawal by Subject|26|||
161869766|NCT00300885|584568413|FG001|Follow-up|Withdrawal by Subject|25|||
161869767|NCT01637922|584568414|FG000|Overall Study|Adverse Event|0|||
161869768|NCT01637922|584568415|FG001|Overall Study|Adverse Event|1|||
161869769|NCT01637922|584568414|FG000|Overall Study|Protocol Violation|0|||
161869770|NCT01637922|584568415|FG001|Overall Study|Protocol Violation|1|||
161869771|NCT01637922|584568414|FG000|Overall Study|Withdrawal by Subject|0|||
161869772|NCT01637922|584568415|FG001|Overall Study|Withdrawal by Subject|3|||
161869773|NCT01637922|584568414|FG000|Overall Study|Lost to Follow-up|2|||
161869774|NCT01637922|584568415|FG001|Overall Study|Lost to Follow-up|0|||
161869775|NCT00638404|584568416|FG000|Overall Study|Physician Decision|8|||
161869776|NCT00638404|584568417|FG001|Overall Study|Physician Decision|0|||
161869777|NCT02492984|584568421|FG000|Overall Study|Adverse Event|1|||
161869778|NCT02492984|584568422|FG001|Overall Study|Adverse Event|0|||
161869779|NCT02492984|584568421|FG000|Overall Study|Protocol Violation|1|||
161869780|NCT02492984|584568422|FG001|Overall Study|Protocol Violation|0|||
161869781|NCT02492984|584568421|FG000|Overall Study|Withdrawal by Subject|1|||
161869782|NCT02492984|584568422|FG001|Overall Study|Withdrawal by Subject|0|||
161869783|NCT02282631|584568423|FG000|Overall Study|Lost to Follow-up|2|||
161869784|NCT02282631|584568424|FG001|Overall Study|Lost to Follow-up|0|||
161869785|NCT00459290|584568425|FG000|Overall Study|Adverse Event|3|||
161869786|NCT00459290|584568425|FG000|Overall Study|Ineligible|2|||
161869787|NCT00687271|584568426|FG000|Overall Study|Adverse Event|1|||
161869788|NCT00687271|584568427|FG001|Overall Study|Adverse Event|3|||
161869789|NCT00687271|584568428|FG002|Overall Study|Adverse Event|1|||
161869790|NCT00687271|584568429|FG003|Overall Study|Adverse Event|0|||
161869791|NCT00687271|584568426|FG000|Overall Study|Lost to Follow-up|0|||
161869792|NCT00687271|584568427|FG001|Overall Study|Lost to Follow-up|1|||
161869793|NCT00687271|584568428|FG002|Overall Study|Lost to Follow-up|0|||
161869794|NCT00687271|584568429|FG003|Overall Study|Lost to Follow-up|0|||
161869795|NCT00687271|584568426|FG000|Overall Study|Protocol Violation|2|||
161869796|NCT00687271|584568427|FG001|Overall Study|Protocol Violation|1|||
161869797|NCT00687271|584568428|FG002|Overall Study|Protocol Violation|1|||
161869798|NCT00687271|584568429|FG003|Overall Study|Protocol Violation|0|||
161869799|NCT00687271|584568426|FG000|Overall Study|Withdrawal by Subject|0|||
161869800|NCT00687271|584568427|FG001|Overall Study|Withdrawal by Subject|1|||
161869801|NCT00687271|584568428|FG002|Overall Study|Withdrawal by Subject|3|||
161869802|NCT00687271|584568429|FG003|Overall Study|Withdrawal by Subject|0|||
162035098|NCT01423604|585184852|FG001|Safety Run-In|Adverse Event|0|||
161869803|NCT02453334|584568430|FG000|Overall Study|Death|15|||
161869804|NCT02453334|584568431|FG001|Overall Study|Death|13|||
161869805|NCT02453334|584568430|FG000|Overall Study|Adverse Event|2|||
161869806|NCT02453334|584568431|FG001|Overall Study|Adverse Event|1|||
161869807|NCT02453334|584568430|FG000|Overall Study|Lost to Follow-up|5|||
161869808|NCT02453334|584568431|FG001|Overall Study|Lost to Follow-up|9|||
161869809|NCT02453334|584568430|FG000|Overall Study|Physician Decision|1|||
161869810|NCT02453334|584568431|FG001|Overall Study|Physician Decision|0|||
161869811|NCT02453334|584568430|FG000|Overall Study|Withdrawal by Subject|17|||
161869812|NCT02453334|584568431|FG001|Overall Study|Withdrawal by Subject|13|||
161869813|NCT02453334|584568430|FG000|Overall Study|Other reason|1|||
161869814|NCT02453334|584568431|FG001|Overall Study|Other reason|4|||
161869815|NCT01841762|584568432|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
161869816|NCT01841762|584568432|FG000|Treatment Period|Adverse Event|16|||
161869817|NCT01841762|584568432|FG000|Treatment Period|Death|1|||
161869818|NCT01841762|584568432|FG000|Treatment Period|Withdrawal by Subject|7|||
162035099|NCT01423604|585184851|FG000|Safety Run-In|Death|1|||
161983822|NCT03178669|584988808|FG000|Overall Study|Lost to Follow-up|0|||
161983823|NCT03178669|584988809|FG001|Overall Study|Lost to Follow-up|0|||
161983824|NCT03178669|584988810|FG002|Overall Study|Lost to Follow-up|0|||
161983825|NCT03178669|584988811|FG003|Overall Study|Lost to Follow-up|1|||
161983826|NCT03178669|584988812|FG004|Overall Study|Lost to Follow-up|0|||
161983827|NCT02914561|584988813|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
161983828|NCT02914561|584988814|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
161983829|NCT02914561|584988815|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
161983830|NCT02914561|584988816|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
161983831|NCT02914561|584988817|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
161983832|NCT02914561|584988818|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
161983833|NCT02914561|584988819|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
161983834|NCT02914561|584988820|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
161983835|NCT02914561|584988821|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
161983836|NCT02914561|584988822|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
161983837|NCT02914561|584988823|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
161869819|NCT01841762|584568432|FG000|Treatment Period|Lost to Follow-up|1|||
161869820|NCT01841762|584568432|FG000|Treatment Period|Physician Decision|2|||
161869821|NCT01841762|584568432|FG000|Treatment Period|Other, including non-compliance|5|||
161869822|NCT01841762|584568432|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
161869823|NCT01841762|584568432|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
161869824|NCT01841762|584568432|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
161869825|NCT01841762|584568432|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
161869826|NCT05483686|584568436|FG000|Overall Study|Lost to Follow-up|5|||
161869827|NCT05483686|584568437|FG001|Overall Study|Lost to Follow-up|7|||
161869828|NCT03981900|584568438|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
161869829|NCT03981900|584568438|FG000|Overall Study|Adverse Event|5|||
161869830|NCT03981900|584568438|FG000|Overall Study|Protocol Violation|1|||
161869831|NCT03981900|584568438|FG000|Overall Study|Withdrawal by Subject|7|||
161869832|NCT03981900|584568438|FG000|Overall Study|Lost to Follow-up|46|||
161869833|NCT03981900|584568438|FG000|Overall Study|Decision of the researcher|3|||
161869834|NCT03981900|584568438|FG000|Overall Study|Death|3|||
161869835|NCT03981900|584568438|FG000|Overall Study|Other|5|||
161869836|NCT02693106|584568440|FG000|Overall Study|No time|3|||
161869837|NCT06152224|584568447|FG000|Overall Study|Withdrawal by Subject|1|||
161869838|NCT06152224|584568448|FG001|Overall Study|Withdrawal by Subject|0|||
161869839|NCT06152224|584568447|FG000|Overall Study|Lost to Follow-up|0|||
161869840|NCT06152224|584568448|FG001|Overall Study|Lost to Follow-up|1|||
161869841|NCT06152224|584568447|FG000|Overall Study|On Follow Up|18|||
161869842|NCT06152224|584568448|FG001|Overall Study|On Follow Up|18|||
161869843|NCT05780983|584568449|FG000|Overall Study|Withdrawal by Subject|1|||
161869844|NCT06028438|584568453|FG000|Overall Study|Adverse Event|3|||
161869845|NCT06028438|584568454|FG001|Overall Study|Adverse Event|9|||
161869846|NCT06028438|584568453|FG000|Overall Study|Lack of Efficacy|1|||
161869847|NCT06028438|584568454|FG001|Overall Study|Lack of Efficacy|1|||
161869848|NCT06028438|584568453|FG000|Overall Study|Lost to Follow-up|1|||
161869849|NCT06028438|584568454|FG001|Overall Study|Lost to Follow-up|0|||
161869850|NCT06028438|584568453|FG000|Overall Study|Withdrawal by Subject|1|||
161869851|NCT06028438|584568454|FG001|Overall Study|Withdrawal by Subject|0|||
161869852|NCT06028438|584568453|FG000|Overall Study|Other|3|||
161869853|NCT06028438|584568454|FG001|Overall Study|Other|3|||
161869854|NCT05625802|584568455|FG000|Overall Study|Lost to Follow-up|1|||
161869855|NCT05625802|584568456|FG001|Overall Study|Lost to Follow-up|0|||
161869856|NCT00808210|584568458|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
161869857|NCT00808210|584568459|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
161869858|NCT00808210|584568458|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
161869859|NCT00808210|584568459|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
161869860|NCT00808210|584568458|FG000|Double-Blind TX Period|Adverse Event|0|||
161869861|NCT00808210|584568459|FG001|Double-Blind TX Period|Adverse Event|1|||
161869862|NCT00808210|584568458|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
161983838|NCT02914561|584988813|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
161869863|NCT00808210|584568459|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
161983839|NCT02914561|584988814|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
161869864|NCT00808210|584568458|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
161869865|NCT00808210|584568459|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
161983840|NCT02914561|584988815|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
161983841|NCT02914561|584988816|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
161983842|NCT02914561|584988817|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
161983843|NCT02914561|584988818|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
161869866|NCT00808210|584568458|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
161869867|NCT00808210|584568459|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
161869868|NCT02044302|584568460|FG000|Overall Study|study terminated|2|||
161869869|NCT02044302|584568461|FG001|Overall Study|study terminated|0|||
161869870|NCT01954056|584568463|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
161869871|NCT01954056|584568464|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
161869872|NCT03337113|584568476|FG000|Overall Study|Adverse Event|1|||
161869873|NCT03337113|584568477|FG001|Overall Study|Adverse Event|1|||
161869874|NCT03337113|584568478|FG002|Overall Study|Adverse Event|0|||
161869875|NCT03337113|584568479|FG003|Overall Study|Adverse Event|1|||
161869876|NCT03337113|584568476|FG000|Overall Study|Physician Decision|0|||
161869877|NCT03337113|584568477|FG001|Overall Study|Physician Decision|2|||
161869878|NCT03337113|584568478|FG002|Overall Study|Physician Decision|0|||
161869879|NCT03337113|584568479|FG003|Overall Study|Physician Decision|1|||
161869880|NCT03337113|584568476|FG000|Overall Study|Withdrawal by Subject|0|||
161869881|NCT03337113|584568477|FG001|Overall Study|Withdrawal by Subject|0|||
161869882|NCT03337113|584568478|FG002|Overall Study|Withdrawal by Subject|1|||
161869883|NCT03337113|584568479|FG003|Overall Study|Withdrawal by Subject|0|||
161869884|NCT01164579|584568480|FG000|Overall Study|Lack of Efficacy|0|||
161869885|NCT01164579|584568481|FG001|Overall Study|Lack of Efficacy|0|||
161869886|NCT01164579|584568482|FG002|Overall Study|Lack of Efficacy|6|||
161869887|NCT01164579|584568480|FG000|Overall Study|Lost to Follow-up|1|||
161869888|NCT01164579|584568481|FG001|Overall Study|Lost to Follow-up|1|||
161869889|NCT01164579|584568482|FG002|Overall Study|Lost to Follow-up|0|||
161869890|NCT01164579|584568480|FG000|Overall Study|Withdrawal by Subject|2|||
161869891|NCT01164579|584568481|FG001|Overall Study|Withdrawal by Subject|5|||
161869892|NCT01164579|584568482|FG002|Overall Study|Withdrawal by Subject|3|||
161869893|NCT01164579|584568480|FG000|Overall Study|Protocol Violation|0|||
161869894|NCT01164579|584568481|FG001|Overall Study|Protocol Violation|1|||
161869895|NCT01164579|584568482|FG002|Overall Study|Protocol Violation|2|||
161869896|NCT01164579|584568480|FG000|Overall Study|Adverse Event|4|||
161869897|NCT01164579|584568481|FG001|Overall Study|Adverse Event|2|||
161869898|NCT01164579|584568482|FG002|Overall Study|Adverse Event|5|||
161869899|NCT01164579|584568480|FG000|Overall Study|Reason not specified|1|||
161869900|NCT01164579|584568481|FG001|Overall Study|Reason not specified|0|||
161869901|NCT01164579|584568482|FG002|Overall Study|Reason not specified|0|||
161869902|NCT01372995|584568491|FG000|Overall Study|Spouse withdrew participant from study|0|||
161869903|NCT01372995|584568492|FG001|Overall Study|Spouse withdrew participant from study|1|||
161869904|NCT01372995|584568493|FG002|Overall Study|Spouse withdrew participant from study|0|||
161869905|NCT01372995|584568491|FG000|Overall Study|Physician Decision|0|||
161869906|NCT01372995|584568492|FG001|Overall Study|Physician Decision|0|||
161869907|NCT01372995|584568493|FG002|Overall Study|Physician Decision|1|||
161869908|NCT01297517|584568498|FG000|Overall Study|Adverse Event|21|||
161869909|NCT01297517|584568499|FG001|Overall Study|Adverse Event|7|||
161869910|NCT01297517|584568500|FG002|Overall Study|Adverse Event|16|||
161869911|NCT01297517|584568498|FG000|Overall Study|Lost to Follow-up|1|||
161869912|NCT01297517|584568499|FG001|Overall Study|Lost to Follow-up|0|||
161869913|NCT01297517|584568500|FG002|Overall Study|Lost to Follow-up|1|||
161869914|NCT01297517|584568498|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
161869915|NCT01297517|584568499|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
161869916|NCT01297517|584568500|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
161869917|NCT01297517|584568498|FG000|Overall Study|Noncompliance|1|||
161869918|NCT01297517|584568499|FG001|Overall Study|Noncompliance|0|||
161869919|NCT01297517|584568500|FG002|Overall Study|Noncompliance|0|||
161869920|NCT01297517|584568498|FG000|Overall Study|Protocol Violation|1|||
161869921|NCT01297517|584568499|FG001|Overall Study|Protocol Violation|1|||
161869922|NCT01297517|584568500|FG002|Overall Study|Protocol Violation|1|||
161869923|NCT01297517|584568498|FG000|Overall Study|Inadequate Control of IOP|1|||
161869924|NCT01297517|584568499|FG001|Overall Study|Inadequate Control of IOP|1|||
161869925|NCT01297517|584568500|FG002|Overall Study|Inadequate Control of IOP|2|||
161869926|NCT02914613|584568501|FG000|Overall Study|Withdrawal by Subject|1|||
161869927|NCT02914613|584568502|FG001|Overall Study|Withdrawal by Subject|2|||
161869928|NCT02914613|584568501|FG000|Overall Study|Adverse Event|1|||
161869929|NCT02914613|584568502|FG001|Overall Study|Adverse Event|0|||
161869930|NCT01737710|584568503|FG000|Overall Study|Lost to Follow-up|0|||
161869931|NCT01737710|584568504|FG001|Overall Study|Lost to Follow-up|2|||
161869932|NCT01737710|584568505|FG002|Overall Study|Lost to Follow-up|2|||
161869933|NCT01737710|584568506|FG003|Overall Study|Lost to Follow-up|0|||
161869934|NCT01737710|584568507|FG004|Overall Study|Lost to Follow-up|0|||
162035100|NCT01423604|585184852|FG001|Safety Run-In|Death|0|||
161869935|NCT01737710|584568503|FG000|Overall Study|Withdrawal by Subject|1|||
161869936|NCT01737710|584568504|FG001|Overall Study|Withdrawal by Subject|1|||
161869937|NCT01737710|584568505|FG002|Overall Study|Withdrawal by Subject|1|||
161869938|NCT01737710|584568506|FG003|Overall Study|Withdrawal by Subject|0|||
161869939|NCT01737710|584568507|FG004|Overall Study|Withdrawal by Subject|0|||
161869940|NCT01737710|584568503|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
161869941|NCT01737710|584568504|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
161869942|NCT01737710|584568505|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
161869943|NCT01737710|584568506|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
161869944|NCT01737710|584568507|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
161983844|NCT02914561|584988819|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
161983845|NCT02914561|584988820|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
161983846|NCT02914561|584988821|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
161983847|NCT02914561|584988822|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
161983848|NCT02914561|584988823|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
161983849|NCT02914561|584988813|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
161983850|NCT02914561|584988814|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
161983851|NCT02914561|584988815|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
161983852|NCT02914561|584988816|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
161983853|NCT02914561|584988817|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
161983854|NCT02914561|584988818|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
161983855|NCT02914561|584988819|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
161983856|NCT02914561|584988820|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
161983857|NCT02914561|584988821|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
161983858|NCT02914561|584988822|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
161983859|NCT02914561|584988823|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
161983860|NCT02914561|584988813|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
161983861|NCT02914561|584988814|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
161983862|NCT02914561|584988815|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
161983863|NCT02914561|584988816|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
161983864|NCT02914561|584988817|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
161983865|NCT02914561|584988818|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
161983866|NCT02914561|584988819|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
161983867|NCT02914561|584988820|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
161983868|NCT02914561|584988821|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
161983869|NCT02914561|584988822|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
161983870|NCT02914561|584988823|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
161983871|NCT02914561|584988813|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161983872|NCT02914561|584988814|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161983873|NCT02914561|584988815|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
161983874|NCT02914561|584988816|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161983875|NCT02914561|584988817|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161983876|NCT02914561|584988818|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
161983877|NCT02914561|584988819|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161983878|NCT02914561|584988820|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161983879|NCT02914561|584988821|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161983880|NCT02914561|584988822|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161983881|NCT02914561|584988823|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
161983882|NCT02914561|584988813|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
161983883|NCT02914561|584988814|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161983884|NCT02914561|584988815|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161983885|NCT02914561|584988816|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161983886|NCT02914561|584988817|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161983887|NCT02914561|584988818|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161983888|NCT02914561|584988819|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161983889|NCT02914561|584988820|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161983890|NCT02914561|584988821|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161983891|NCT02914561|584988822|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161983892|NCT02914561|584988823|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
161983893|NCT02914561|584988813|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161983894|NCT02914561|584988814|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161983895|NCT02914561|584988815|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
161983896|NCT02914561|584988816|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161983897|NCT02914561|584988817|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161983898|NCT02914561|584988818|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161983899|NCT02914561|584988819|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161983900|NCT02914561|584988820|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161983901|NCT02914561|584988821|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161983902|NCT02914561|584988822|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161983903|NCT02914561|584988823|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
161983904|NCT02914561|584988813|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
161983905|NCT02914561|584988814|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
161983906|NCT02914561|584988815|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
161983907|NCT02914561|584988816|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
161983908|NCT02914561|584988817|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
161869945|NCT00758485|584568513|FG000|Overall Study|Lost to Follow-up|0|||
161869946|NCT00758485|584568514|FG001|Overall Study|Lost to Follow-up|1|||
161869947|NCT00758485|584568513|FG000|Overall Study|Not Treated|1|||
161869948|NCT00758485|584568514|FG001|Overall Study|Not Treated|2|||
161869949|NCT00921557|584568515|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
161869950|NCT00921557|584568516|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
161869951|NCT00921557|584568517|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
161869952|NCT00921557|584568515|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
161869953|NCT00921557|584568516|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
161869954|NCT00921557|584568517|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
161869955|NCT00921557|584568515|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
161869956|NCT00921557|584568516|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
161869957|NCT00921557|584568517|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
161869958|NCT00921557|584568515|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
161869959|NCT00921557|584568516|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
161869960|NCT00921557|584568517|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
161869961|NCT00921557|584568515|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
161869962|NCT00921557|584568516|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
161869963|NCT00921557|584568517|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
161869964|NCT03259425|584568518|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
161869965|NCT00463047|584568519|FG000|Titration Period 1|Adverse Event|10|||
161869966|NCT00463047|584568520|FG001|Titration Period 1|Adverse Event|8|||
161869967|NCT00463047|584568519|FG000|Titration Period 1|Lack of Efficacy|10|||
161869968|NCT00463047|584568520|FG001|Titration Period 1|Lack of Efficacy|4|||
161869969|NCT00463047|584568519|FG000|Titration Period 1|Lost to Follow-up|2|||
161869970|NCT00463047|584568520|FG001|Titration Period 1|Lost to Follow-up|0|||
161869971|NCT00463047|584568519|FG000|Titration Period 1|Non-compliance with study medication|3|||
161869972|NCT00463047|584568520|FG001|Titration Period 1|Non-compliance with study medication|5|||
161869973|NCT00463047|584568519|FG000|Titration Period 1|Protocol Violation|5|||
161869974|NCT00463047|584568520|FG001|Titration Period 1|Protocol Violation|5|||
161869975|NCT00463047|584568519|FG000|Titration Period 1|Withdrawal by Subject|3|||
161869976|NCT00463047|584568520|FG001|Titration Period 1|Withdrawal by Subject|5|||
161869977|NCT00463047|584568519|FG000|Titration Period 1|Non-compliance procedures|4|||
161869978|NCT00463047|584568520|FG001|Titration Period 1|Non-compliance procedures|10|||
161869979|NCT00463047|584568519|FG000|Titration Period 1|Other|0|||
161869980|NCT00463047|584568520|FG001|Titration Period 1|Other|2|||
161869981|NCT00463047|584568519|FG000|Titration Period 2|Adverse Event|9|||
161869982|NCT00463047|584568520|FG001|Titration Period 2|Adverse Event|9|||
161869983|NCT00463047|584568519|FG000|Titration Period 2|Lack of Efficacy|6|||
161869984|NCT00463047|584568520|FG001|Titration Period 2|Lack of Efficacy|4|||
161869985|NCT00463047|584568519|FG000|Titration Period 2|Withdrawal by Subject|1|||
161869986|NCT00463047|584568520|FG001|Titration Period 2|Withdrawal by Subject|0|||
161869987|NCT00463047|584568519|FG000|Titration Period 2|Protocol Violation|2|||
161869988|NCT00463047|584568520|FG001|Titration Period 2|Protocol Violation|3|||
161869989|NCT00463047|584568519|FG000|Titration Period 2|Lost to Follow-up|1|||
161869990|NCT00463047|584568520|FG001|Titration Period 2|Lost to Follow-up|2|||
161869991|NCT00463047|584568519|FG000|Titration Period 2|Non-compliance study medication|4|||
161869992|NCT00463047|584568520|FG001|Titration Period 2|Non-compliance study medication|2|||
161869993|NCT00463047|584568519|FG000|Titration Period 2|Non-compliance procedures|4|||
161869994|NCT00463047|584568520|FG001|Titration Period 2|Non-compliance procedures|1|||
161869995|NCT00463047|584568519|FG000|Titration Period 2|Other|3|||
161869996|NCT00463047|584568520|FG001|Titration Period 2|Other|2|||
161869997|NCT00463047|584568519|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
161869998|NCT00463047|584568520|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
161869999|NCT00463047|584568519|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
161870000|NCT00463047|584568520|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
161870001|NCT00463047|584568519|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
161870002|NCT00463047|584568520|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
161870003|NCT00463047|584568519|FG000|Double-Blind Treatment Period 1|Other|1|||
161870004|NCT00463047|584568520|FG001|Double-Blind Treatment Period 1|Other|0|||
161870005|NCT00463047|584568519|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
161870006|NCT00463047|584568520|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
161870007|NCT00463047|584568519|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
161870008|NCT00463047|584568520|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
161870009|NCT00463047|584568519|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
161870010|NCT00463047|584568520|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
161870011|NCT01732458|584568526|FG000|Overall Study|Lost to Follow-up|0|||
161870012|NCT01732458|584568527|FG001|Overall Study|Lost to Follow-up|2|||
161870013|NCT01732458|584568528|FG002|Overall Study|Lost to Follow-up|0|||
161983909|NCT02914561|584988818|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
161983910|NCT02914561|584988819|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
161870014|NCT01732458|584568529|FG003|Overall Study|Lost to Follow-up|0|||
161870015|NCT01732458|584568526|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161870016|NCT01732458|584568527|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161870017|NCT01732458|584568528|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161870018|NCT01732458|584568529|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161870019|NCT01732458|584568526|FG000|Overall Study|Physician Decision|1|||
161870020|NCT01732458|584568527|FG001|Overall Study|Physician Decision|2|||
161870021|NCT01732458|584568528|FG002|Overall Study|Physician Decision|2|||
161870022|NCT01732458|584568529|FG003|Overall Study|Physician Decision|0|||
161870023|NCT01732458|584568526|FG000|Overall Study|Protocol Violation|2|||
161870024|NCT01732458|584568527|FG001|Overall Study|Protocol Violation|0|||
161870025|NCT01732458|584568528|FG002|Overall Study|Protocol Violation|0|||
161870026|NCT01732458|584568529|FG003|Overall Study|Protocol Violation|2|||
161870027|NCT01732458|584568526|FG000|Overall Study|Screen Failure|0|||
161870028|NCT01732458|584568527|FG001|Overall Study|Screen Failure|1|||
161870029|NCT01732458|584568528|FG002|Overall Study|Screen Failure|0|||
161870030|NCT01732458|584568529|FG003|Overall Study|Screen Failure|0|||
161870031|NCT05870371|584568530|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
161870032|NCT05870371|584568531|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
161870033|NCT02203721|584568532|FG000|Overall Study|Lost to Follow-up|1|||
161870034|NCT02203721|584568533|FG001|Overall Study|Lost to Follow-up|0|||
161870035|NCT02203721|584568532|FG000|Overall Study|Death|0|||
161870036|NCT02203721|584568533|FG001|Overall Study|Death|2|||
161870037|NCT02203721|584568532|FG000|Overall Study|Illness|0|||
161870038|NCT02203721|584568533|FG001|Overall Study|Illness|1|||
161870039|NCT00703157|584568534|FG000|Overall Study|Lost to Follow-up|0|||
161870040|NCT00703157|584568535|FG001|Overall Study|Lost to Follow-up|1|||
161870041|NCT00703157|584568534|FG000|Overall Study|source data permanently lost/ other|4|||
161870042|NCT00703157|584568535|FG001|Overall Study|source data permanently lost/ other|1|||
161870043|NCT02522884|584568538|FG000|Overall Study|Withdrawal by Subject|6|||
161870044|NCT02522884|584568538|FG000|Overall Study|Death|3|||
161870045|NCT02522884|584568538|FG000|Overall Study|Missed 12-month Follow-up|9|||
161870046|NCT04495751|584568539|FG000|Overall Study|Withdrawal by Subject|1|||
161870047|NCT04495751|584568540|FG001|Overall Study|Withdrawal by Subject|0|||
161870048|NCT04495751|584568539|FG000|Overall Study|Lost to Follow-up|1|||
161870049|NCT04495751|584568540|FG001|Overall Study|Lost to Follow-up|0|||
161870050|NCT03289754|584568541|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
161870051|NCT04873934|584568542|FG000|Overall Study|Adverse Event|0|||
161870052|NCT04873934|584568543|FG001|Overall Study|Adverse Event|1|||
161870053|NCT04873934|584568542|FG000|Overall Study|Death|0|||
161870054|NCT04873934|584568543|FG001|Overall Study|Death|2|||
161870055|NCT04873934|584568542|FG000|Overall Study|Lost to Follow-up|13|||
161870056|NCT04873934|584568543|FG001|Overall Study|Lost to Follow-up|9|||
161870057|NCT04873934|584568542|FG000|Overall Study|Physician Decision|1|||
161870058|NCT04873934|584568543|FG001|Overall Study|Physician Decision|1|||
161870059|NCT04873934|584568542|FG000|Overall Study|Protocol deviation|2|||
161870060|NCT04873934|584568543|FG001|Overall Study|Protocol deviation|1|||
161870061|NCT04873934|584568542|FG000|Overall Study|Subject decision|1|||
161870062|NCT04873934|584568543|FG001|Overall Study|Subject decision|8|||
161870063|NCT04873934|584568542|FG000|Overall Study|Withdrew consent|0|||
161870064|NCT04873934|584568543|FG001|Overall Study|Withdrew consent|4|||
161870065|NCT04873934|584568542|FG000|Overall Study|Missing|1|||
161870066|NCT04873934|584568543|FG001|Overall Study|Missing|0|||
161870067|NCT00708461|584568544|FG000|Overall Study|Lost to Follow-up|18|||
161870068|NCT00708461|584568545|FG001|Overall Study|Lost to Follow-up|11|||
161870069|NCT00708461|584568544|FG000|Overall Study|Withdrawal by Subject|8|||
161870070|NCT00708461|584568545|FG001|Overall Study|Withdrawal by Subject|9|||
161870071|NCT00708461|584568544|FG000|Overall Study|left workforce|115|||
161870072|NCT00708461|584568545|FG001|Overall Study|left workforce|180|||
161870073|NCT03584854|584568547|FG000|Overall Study|Primary outcome not measured|1|||
161870074|NCT03584854|584568548|FG001|Overall Study|Primary outcome not measured|2|||
161870075|NCT02968173|584568549|FG000|Overall Study|Withdrawal by Subject|1|||
161870076|NCT00314327|584568553|FG000|Overall Study|Withdrawal by Subject|1|||
161870077|NCT01207687|584568554|FG000|Overall Study|Adverse Event|1|||
161870078|NCT01207687|584568554|FG000|Overall Study|Withdrawal by Subject|1|||
161983911|NCT02914561|584988820|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
161870079|NCT01801865|584568555|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
161870080|NCT01801865|584568555|FG000|Overall Study|Physician Decision|7|||
161870081|NCT01500382|584568556|FG000|Washout Period|Study site went out of business|0|||
161983912|NCT02914561|584988821|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
161983913|NCT02914561|584988822|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
161870082|NCT01500382|584568557|FG001|Washout Period|Study site went out of business|0|||
161870083|NCT01500382|584568558|FG002|Washout Period|Study site went out of business|1|||
161870084|NCT01500382|584568559|FG003|Washout Period|Study site went out of business|0|||
161870085|NCT02134015|584568560|FG000|Overall Study|Protocol Violation|0|||
161870086|NCT02134015|584568561|FG001|Overall Study|Protocol Violation|1|||
161870087|NCT02134015|584568560|FG000|Overall Study|Death|2|||
161870088|NCT02134015|584568561|FG001|Overall Study|Death|1|||
161870089|NCT02134015|584568560|FG000|Overall Study|Reason not provided|1|||
161870090|NCT02134015|584568561|FG001|Overall Study|Reason not provided|2|||
161870091|NCT02134015|584568560|FG000|Overall Study|Clinical progression|14|||
161870092|NCT02134015|584568561|FG001|Overall Study|Clinical progression|7|||
161870093|NCT02134015|584568560|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
161870094|NCT02134015|584568561|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
161870095|NCT02134015|584568560|FG000|Overall Study|Study terminated by sponsor|2|||
161870096|NCT02134015|584568561|FG001|Overall Study|Study terminated by sponsor|3|||
161870097|NCT02134015|584568560|FG000|Overall Study|Adverse Event|9|||
161870098|NCT02134015|584568561|FG001|Overall Study|Adverse Event|10|||
161870099|NCT02134015|584568560|FG000|Overall Study|Withdrawal by Subject|3|||
161870100|NCT02134015|584568561|FG001|Overall Study|Withdrawal by Subject|7|||
161870101|NCT01515865|584570093|FG000|Part A (Open-label)|Other|3|||
161870102|NCT01515865|584570094|FG001|Part A (Open-label)|Other|0|||
161870103|NCT01515865|584570095|FG002|Part A (Open-label)|Other|0|||
161870104|NCT01515865|584570093|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
161870105|NCT01515865|584570094|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
161870106|NCT01515865|584570095|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
161870107|NCT01515865|584570093|FG000|Part B (Open-label)|Other|1|||
161870108|NCT01515865|584570094|FG001|Part B (Open-label)|Other|0|||
161870109|NCT01515865|584570095|FG002|Part B (Open-label)|Other|0|||
161870110|NCT02510664|584570100|FG000|Overall Study|Transferred Care|9|||
161870111|NCT02510664|584570101|FG001|Overall Study|Transferred Care|9|||
161870112|NCT02510664|584570102|FG002|Overall Study|Transferred Care|0|||
161870113|NCT02510664|584570100|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
161870114|NCT02510664|584570101|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
161870115|NCT02510664|584570102|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
161870116|NCT02510664|584570100|FG000|Overall Study|Time Constraints|1|||
161870117|NCT02510664|584570101|FG001|Overall Study|Time Constraints|1|||
161870118|NCT02510664|584570102|FG002|Overall Study|Time Constraints|0|||
161870119|NCT04090060|584570104|FG000|Overall Study|Lost to Follow-up|76|||
161870120|NCT04090060|584570105|FG001|Overall Study|Lost to Follow-up|77|||
161870121|NCT00507455|584570109|FG000|Overall Study|Adverse Event|3|||
161870122|NCT00507455|584570110|FG001|Overall Study|Adverse Event|3|||
161870123|NCT00507455|584570111|FG002|Overall Study|Adverse Event|6|||
161870124|NCT00507455|584570109|FG000|Overall Study|Withdrawal by Subject|2|||
161870125|NCT00507455|584570110|FG001|Overall Study|Withdrawal by Subject|1|||
161870126|NCT00507455|584570111|FG002|Overall Study|Withdrawal by Subject|2|||
161870127|NCT00507455|584570109|FG000|Overall Study|Protocol Violation|4|||
161870128|NCT00507455|584570110|FG001|Overall Study|Protocol Violation|1|||
161870129|NCT00507455|584570111|FG002|Overall Study|Protocol Violation|1|||
161870130|NCT00507455|584570109|FG000|Overall Study|Lost to Follow-up|2|||
161870131|NCT00507455|584570110|FG001|Overall Study|Lost to Follow-up|0|||
161870132|NCT00507455|584570111|FG002|Overall Study|Lost to Follow-up|2|||
161870133|NCT00507455|584570109|FG000|Overall Study|Lack of Efficacy|0|||
161870134|NCT00507455|584570110|FG001|Overall Study|Lack of Efficacy|1|||
161870135|NCT00507455|584570111|FG002|Overall Study|Lack of Efficacy|0|||
161870136|NCT00507455|584570109|FG000|Overall Study|Other - miscellaneous reason|1|||
161870137|NCT00507455|584570110|FG001|Overall Study|Other - miscellaneous reason|0|||
161870138|NCT00507455|584570111|FG002|Overall Study|Other - miscellaneous reason|1|||
161870139|NCT02176655|584570112|FG000|Overall Study|Subjects did not treat|6|||
161870140|NCT06110494|584570118|FG000|Overall Study|Protocol Violation|2|||
161870141|NCT06110494|584570119|FG001|Overall Study|Protocol Violation|0|||
161870142|NCT06110494|584570120|FG002|Overall Study|Protocol Violation|1|||
161870143|NCT06110494|584570118|FG000|Overall Study|Dixon's test for outlier analysis|1|||
161870144|NCT06110494|584570119|FG001|Overall Study|Dixon's test for outlier analysis|1|||
161870145|NCT06110494|584570120|FG002|Overall Study|Dixon's test for outlier analysis|0|||
161870146|NCT00105079|584570121|FG000|Overall Study|Adverse Event|5|||
161870147|NCT00105079|584570122|FG001|Overall Study|Adverse Event|12|||
161870148|NCT00105079|584570121|FG000|Overall Study|Death|3|||
161870149|NCT00105079|584570122|FG001|Overall Study|Death|1|||
161870150|NCT00105079|584570121|FG000|Overall Study|Lost to Follow-up|12|||
161983914|NCT02914561|584988823|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
161983915|NCT02914561|584988813|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
161983916|NCT02914561|584988814|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
161983917|NCT02914561|584988815|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
162035101|NCT01423604|585184851|FG000|Safety Run-In|Physician Decision|1|||
161870151|NCT00105079|584570122|FG001|Overall Study|Lost to Follow-up|12|||
161870152|NCT00105079|584570121|FG000|Overall Study|Lack of Efficacy|9|||
161870153|NCT00105079|584570122|FG001|Overall Study|Lack of Efficacy|3|||
161870154|NCT00105079|584570121|FG000|Overall Study|Refused treatment|6|||
161870155|NCT00105079|584570122|FG001|Overall Study|Refused treatment|4|||
161870156|NCT00105079|584570121|FG000|Overall Study|Violation of selection criteria at entry|0|||
161870157|NCT00105079|584570122|FG001|Overall Study|Violation of selection criteria at entry|2|||
161870158|NCT00105079|584570121|FG000|Overall Study|Protocol Violation|1|||
161870159|NCT00105079|584570122|FG001|Overall Study|Protocol Violation|0|||
161870160|NCT00105079|584570121|FG000|Overall Study|Other|3|||
161983918|NCT02914561|584988816|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
161983919|NCT02914561|584988817|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
161983920|NCT02914561|584988818|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
161983921|NCT02914561|584988819|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
161983922|NCT02914561|584988820|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
161983923|NCT02914561|584988821|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
161983924|NCT02914561|584988822|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
161983925|NCT02914561|584988823|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
161983926|NCT02914561|584988813|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
161983927|NCT02914561|584988814|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
161983928|NCT02914561|584988815|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
161983929|NCT02914561|584988816|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
161983930|NCT02914561|584988817|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
161983931|NCT02914561|584988818|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
161983932|NCT02914561|584988819|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
161983933|NCT02914561|584988820|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
161983934|NCT02914561|584988821|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
161983935|NCT02914561|584988822|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
161983936|NCT02914561|584988823|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
161983937|NCT02914561|584988813|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
161983938|NCT02914561|584988814|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
161983939|NCT02914561|584988815|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
161983940|NCT02914561|584988816|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
161983941|NCT02914561|584988817|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
161983942|NCT02914561|584988818|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
161983943|NCT02914561|584988819|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
161983944|NCT02914561|584988820|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
161983945|NCT02914561|584988821|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
161983946|NCT02914561|584988822|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
161983947|NCT02914561|584988823|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
161983948|NCT02914561|584988813|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161983949|NCT02914561|584988814|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161983950|NCT02914561|584988815|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161983951|NCT02914561|584988816|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161983952|NCT02914561|584988817|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161983953|NCT02914561|584988818|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161983954|NCT02914561|584988819|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
161983955|NCT02914561|584988820|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161983956|NCT02914561|584988821|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
161983957|NCT02914561|584988822|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161983958|NCT02914561|584988823|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
161983959|NCT02914561|584988813|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161983960|NCT02914561|584988814|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161983961|NCT02914561|584988815|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161983962|NCT02914561|584988816|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161983963|NCT02914561|584988817|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161983964|NCT02914561|584988818|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161983965|NCT02914561|584988819|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
161983966|NCT02914561|584988820|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
161983967|NCT02914561|584988821|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
161983968|NCT02914561|584988822|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
161983969|NCT02914561|584988823|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
161983970|NCT02914561|584988813|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161983971|NCT02914561|584988814|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161983972|NCT02914561|584988815|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161983973|NCT02914561|584988816|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161983974|NCT02914561|584988817|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161983975|NCT02914561|584988818|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161983976|NCT02914561|584988819|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
161983977|NCT02914561|584988820|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161983978|NCT02914561|584988821|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
161983979|NCT02914561|584988822|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161983980|NCT02914561|584988823|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
161983981|NCT02914561|584988813|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161983982|NCT02914561|584988814|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
162035102|NCT01423604|585184852|FG001|Safety Run-In|Physician Decision|0|||
162035103|NCT01423604|585184851|FG000|Safety Run-In|Disease progression|3|||
162035104|NCT01423604|585184852|FG001|Safety Run-In|Disease progression|0|||
162035105|NCT01423604|585184851|FG000|Safety Run-In|Patient decision|1|||
162035106|NCT01423604|585184852|FG001|Safety Run-In|Patient decision|0|||
162035107|NCT01423604|585184851|FG000|Randomized|Adverse Event|4|||
161775073|NCT00138658|584219381|FG000|Overall Study|Withdrawal by Subject|5|||
161775074|NCT00320801|584219386|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
161775075|NCT00320801|584219387|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
161775076|NCT00320801|584219388|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
161775077|NCT00320801|584219389|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
161775078|NCT00320801|584219386|FG000|Open-label Run-in Period|Adverse Event|33|||
161775079|NCT00320801|584219387|FG001|Open-label Run-in Period|Adverse Event|0|||
161775080|NCT00320801|584219388|FG002|Open-label Run-in Period|Adverse Event|0|||
161775081|NCT00320801|584219389|FG003|Open-label Run-in Period|Adverse Event|0|||
161775082|NCT00320801|584219386|FG000|Open-label Run-in Period|Administrative|10|||
161775083|NCT00320801|584219387|FG001|Open-label Run-in Period|Administrative|0|||
161775084|NCT00320801|584219388|FG002|Open-label Run-in Period|Administrative|0|||
161775085|NCT00320801|584219389|FG003|Open-label Run-in Period|Administrative|0|||
161775086|NCT00320801|584219386|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
161775087|NCT00320801|584219387|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
161775088|NCT00320801|584219388|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
161775089|NCT00320801|584219389|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
161775090|NCT00320801|584219386|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
161775091|NCT00320801|584219387|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
161775092|NCT00320801|584219388|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
161775093|NCT00320801|584219389|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
161775094|NCT00320801|584219386|FG000|Open-label Run-in Period|Did not qualify|1|||
161775095|NCT00320801|584219387|FG001|Open-label Run-in Period|Did not qualify|0|||
161775096|NCT00320801|584219388|FG002|Open-label Run-in Period|Did not qualify|0|||
161775097|NCT00320801|584219389|FG003|Open-label Run-in Period|Did not qualify|0|||
161775098|NCT00320801|584219386|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161775099|NCT00320801|584219387|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161775100|NCT00320801|584219388|FG002|Double-blind Phase|Withdrawal by Subject|1|||
161775101|NCT00320801|584219389|FG003|Double-blind Phase|Withdrawal by Subject|0|||
161775102|NCT00320801|584219386|FG000|Double-blind Phase|Adverse Event|0|||
161775103|NCT00320801|584219387|FG001|Double-blind Phase|Adverse Event|2|||
161775104|NCT00320801|584219388|FG002|Double-blind Phase|Adverse Event|8|||
161775105|NCT00320801|584219389|FG003|Double-blind Phase|Adverse Event|0|||
161775106|NCT00320801|584219386|FG000|Double-blind Phase|Administrative|0|||
161775107|NCT00320801|584219387|FG001|Double-blind Phase|Administrative|0|||
161775108|NCT00320801|584219388|FG002|Double-blind Phase|Administrative|4|||
161775109|NCT00320801|584219389|FG003|Double-blind Phase|Administrative|0|||
161775110|NCT00320801|584219386|FG000|Double-blind Phase|Lack of Efficacy|0|||
161775111|NCT00320801|584219387|FG001|Double-blind Phase|Lack of Efficacy|9|||
161775112|NCT00320801|584219388|FG002|Double-blind Phase|Lack of Efficacy|1|||
161775113|NCT00320801|584219389|FG003|Double-blind Phase|Lack of Efficacy|0|||
161775114|NCT00320801|584219386|FG000|Extension Phase|Withdrawal by Subject|0|||
161775115|NCT00320801|584219387|FG001|Extension Phase|Withdrawal by Subject|0|||
161775116|NCT00320801|584219388|FG002|Extension Phase|Withdrawal by Subject|0|||
161775117|NCT00320801|584219389|FG003|Extension Phase|Withdrawal by Subject|6|||
161775118|NCT00320801|584219386|FG000|Extension Phase|Adverse Event|0|||
161775119|NCT00320801|584219387|FG001|Extension Phase|Adverse Event|0|||
161775120|NCT00320801|584219388|FG002|Extension Phase|Adverse Event|0|||
161775121|NCT00320801|584219389|FG003|Extension Phase|Adverse Event|8|||
161775122|NCT00320801|584219386|FG000|Extension Phase|Administrative|0|||
161775123|NCT00320801|584219387|FG001|Extension Phase|Administrative|0|||
161775124|NCT00320801|584219388|FG002|Extension Phase|Administrative|0|||
161775125|NCT00320801|584219389|FG003|Extension Phase|Administrative|29|||
161775126|NCT00320801|584219386|FG000|Extension Phase|Lack of Efficacy|0|||
161775127|NCT00320801|584219387|FG001|Extension Phase|Lack of Efficacy|0|||
161775128|NCT00320801|584219388|FG002|Extension Phase|Lack of Efficacy|0|||
161775129|NCT00320801|584219389|FG003|Extension Phase|Lack of Efficacy|2|||
161775130|NCT00320801|584219386|FG000|Extension Phase|Lost to Follow-up|0|||
161775131|NCT00320801|584219387|FG001|Extension Phase|Lost to Follow-up|0|||
161775132|NCT00320801|584219388|FG002|Extension Phase|Lost to Follow-up|0|||
161775133|NCT00320801|584219389|FG003|Extension Phase|Lost to Follow-up|3|||
161775134|NCT00337727|584219390|FG000|Overall Study|Adverse Event|5|||
161775135|NCT00337727|584219391|FG001|Overall Study|Adverse Event|3|||
161775136|NCT00337727|584219390|FG000|Overall Study|Lost to Follow-up|5|||
161775137|NCT00337727|584219391|FG001|Overall Study|Lost to Follow-up|4|||
161775138|NCT00337727|584219390|FG000|Overall Study|Physician Decision|1|||
161775139|NCT00337727|584219391|FG001|Overall Study|Physician Decision|0|||
161775140|NCT00337727|584219390|FG000|Overall Study|Protocol Violation|4|||
161775141|NCT00337727|584219391|FG001|Overall Study|Protocol Violation|0|||
161775142|NCT00337727|584219390|FG000|Overall Study|Withdrawal by Subject|3|||
162035108|NCT01423604|585184852|FG001|Randomized|Adverse Event|10|||
162035109|NCT01423604|585184851|FG000|Randomized|Death|1|||
161870161|NCT00105079|584570122|FG001|Overall Study|Other|1|||
161870162|NCT01464593|584570123|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
161870163|NCT02490371|584570126|FG000|Overall Study|Lost to Follow-up|1|||
161870164|NCT02490371|584570127|FG001|Overall Study|Lost to Follow-up|1|||
161870165|NCT00656292|584570130|FG000|Overall Study|Withdrawal by Subject|2|||
161870166|NCT00656292|584570131|FG001|Overall Study|Withdrawal by Subject|3|||
161870167|NCT00656292|584570130|FG000|Overall Study|Screen failure|1|||
161870168|NCT00656292|584570131|FG001|Overall Study|Screen failure|2|||
161870169|NCT03363776|584570132|FG000|Overall Study|Progressive disease|2|||
161870170|NCT03363776|584570133|FG001|Overall Study|Progressive disease|3|||
161870171|NCT03363776|584570134|FG002|Overall Study|Progressive disease|1|||
161870172|NCT03363776|584570132|FG000|Overall Study|Study drug toxicity|0|||
161870173|NCT03363776|584570133|FG001|Overall Study|Study drug toxicity|0|||
161870174|NCT03363776|584570134|FG002|Overall Study|Study drug toxicity|1|||
161870175|NCT03363776|584570132|FG000|Overall Study|Death|1|||
161870176|NCT03363776|584570133|FG001|Overall Study|Death|0|||
161870177|NCT03363776|584570134|FG002|Overall Study|Death|0|||
161870178|NCT02993250|584570142|FG000|Overall Study|Lost to Follow-up|0|||
161870179|NCT02993250|584570143|FG001|Overall Study|Lost to Follow-up|1|||
161870180|NCT02527434|584570145|FG000|Overall Study|Lost to Follow-up|2|||
161870181|NCT02527434|584570146|FG001|Overall Study|Lost to Follow-up|2|||
161870182|NCT02527434|584570147|FG002|Overall Study|Lost to Follow-up|0|||
161870183|NCT02527434|584570145|FG000|Overall Study|Death|19|||
161870184|NCT02527434|584570146|FG001|Overall Study|Death|6|||
161870185|NCT02527434|584570147|FG002|Overall Study|Death|17|||
161870186|NCT02527434|584570145|FG000|Overall Study|Withdrawal by Subject|5|||
161870187|NCT02527434|584570146|FG001|Overall Study|Withdrawal by Subject|3|||
161870188|NCT02527434|584570147|FG002|Overall Study|Withdrawal by Subject|3|||
161870189|NCT02527434|584570145|FG000|Overall Study|Reason Not Specified|1|||
161870190|NCT02527434|584570146|FG001|Overall Study|Reason Not Specified|0|||
161870191|NCT02527434|584570147|FG002|Overall Study|Reason Not Specified|0|||
161870192|NCT02527434|584570145|FG000|Overall Study|Site closure|1|||
161870193|NCT02527434|584570146|FG001|Overall Study|Site closure|0|||
161870194|NCT02527434|584570147|FG002|Overall Study|Site closure|0|||
161870195|NCT02861807|584570148|FG000|Overall Study|Lost to Follow-up|7|||
161870196|NCT02861807|584570149|FG001|Overall Study|Lost to Follow-up|6|||
161870197|NCT02861807|584570148|FG000|Overall Study|Withdrawal by Subject|5|||
161870198|NCT02861807|584570149|FG001|Overall Study|Withdrawal by Subject|8|||
161870199|NCT00568061|584570154|FG000|Overall Study|Inclusion / exclusion criteria|5|||
161870200|NCT00568061|584570155|FG001|Overall Study|Inclusion / exclusion criteria|1|||
161870201|NCT00568061|584570154|FG000|Overall Study|Adverse Event|0|||
161870202|NCT00568061|584570155|FG001|Overall Study|Adverse Event|1|||
161870203|NCT05027451|584570156|FG000|Overall Study|Lost to Follow-up|1|||
161870204|NCT05027451|584570157|FG001|Overall Study|Lost to Follow-up|1|||
161870205|NCT00356148|584570158|FG000|Overall Study|Reoperation within 30 days|2|||
161870206|NCT00356148|584570159|FG001|Overall Study|Reoperation within 30 days|1|||
161870207|NCT02693002|584570161|FG000|Overall Study|Withdrawal by Subject|1|||
161870208|NCT02693002|584570162|FG001|Overall Study|Withdrawal by Subject|0|||
161870209|NCT00812981|584570163|FG000|Overall Study|Other|0|||
161870210|NCT00812981|584570164|FG001|Overall Study|Other|1|||
161870211|NCT04666259|584570166|FG000|Treatment Phase|Physician Decision|9|||
161870212|NCT04666259|584570167|FG001|Treatment Phase|Physician Decision|3|||
161870213|NCT04666259|584570168|FG002|Treatment Phase|Physician Decision|3|||
161870214|NCT04666259|584570166|FG000|Treatment Phase|Adverse Event|3|||
161870215|NCT04666259|584570167|FG001|Treatment Phase|Adverse Event|1|||
161870216|NCT04666259|584570168|FG002|Treatment Phase|Adverse Event|0|||
161870217|NCT04666259|584570166|FG000|Treatment Phase|Subject decision|1|||
161870218|NCT04666259|584570167|FG001|Treatment Phase|Subject decision|2|||
161870219|NCT04666259|584570168|FG002|Treatment Phase|Subject decision|0|||
161870220|NCT04666259|584570166|FG000|Treatment Phase|Progressive disease|0|||
161870221|NCT04666259|584570167|FG001|Treatment Phase|Progressive disease|1|||
161870222|NCT04666259|584570168|FG002|Treatment Phase|Progressive disease|0|||
161870223|NCT04666259|584570166|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
161870224|NCT04666259|584570167|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
161870225|NCT04666259|584570168|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
161870226|NCT04666259|584570166|FG000|Safety Follow-up Phase|Physician Decision|2|||
161870227|NCT04666259|584570167|FG001|Safety Follow-up Phase|Physician Decision|0|||
161870228|NCT04666259|584570168|FG002|Safety Follow-up Phase|Physician Decision|0|||
161870229|NCT04666259|584570166|FG000|Safety Follow-up Phase|Subject decision|1|||
161870230|NCT04666259|584570167|FG001|Safety Follow-up Phase|Subject decision|0|||
161870231|NCT04666259|584570168|FG002|Safety Follow-up Phase|Subject decision|0|||
161870232|NCT04666259|584570166|FG000|Safety Follow-up Phase|Death|0|||
161870233|NCT04666259|584570167|FG001|Safety Follow-up Phase|Death|1|||
161870234|NCT04666259|584570168|FG002|Safety Follow-up Phase|Death|0|||
161870235|NCT04178122|584570169|FG000|Overall Study|Withdrawal by Subject|1|||
161870236|NCT04178122|584570170|FG001|Overall Study|Withdrawal by Subject|1|||
161870237|NCT04178122|584570169|FG000|Overall Study|Death|2|||
161870238|NCT04178122|584570170|FG001|Overall Study|Death|0|||
161983983|NCT02914561|584988815|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161983984|NCT02914561|584988816|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161983985|NCT02914561|584988817|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161983986|NCT02914561|584988818|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161983987|NCT02914561|584988819|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161983988|NCT02914561|584988820|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161983989|NCT02914561|584988821|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
161983990|NCT02914561|584988822|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161983991|NCT02914561|584988823|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
161983992|NCT02914561|584988813|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161983993|NCT02914561|584988814|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161983994|NCT02914561|584988815|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161983995|NCT02914561|584988816|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161983996|NCT02914561|584988817|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161983997|NCT02914561|584988818|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161983998|NCT02914561|584988819|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
161983999|NCT02914561|584988820|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161984000|NCT02914561|584988821|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161984001|NCT02914561|584988822|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161984002|NCT02914561|584988823|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
161984003|NCT02914561|584988813|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161984004|NCT02914561|584988814|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161984005|NCT02914561|584988815|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161984006|NCT02914561|584988816|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161984007|NCT02914561|584988817|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161984008|NCT02914561|584988818|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161984009|NCT02914561|584988819|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161984010|NCT02914561|584988820|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
161984011|NCT02914561|584988821|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
161984012|NCT02914561|584988822|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
161984013|NCT02914561|584988823|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
161984014|NCT00565136|584988824|FG000|Overall Study|Lost to Follow-up|1|||
161984015|NCT00565136|584988824|FG000|Overall Study|Withdrawal by Subject|1|||
161984016|NCT00565136|584988824|FG000|Overall Study|Protocol Violation|1|||
161984017|NCT00778895|584988828|FG000|Active Phase|Adverse Event|3|||
161984018|NCT00778895|584988829|FG001|Active Phase|Adverse Event|1|||
161984019|NCT00778895|584988830|FG002|Active Phase|Adverse Event|0|||
161984020|NCT00778895|584988828|FG000|Active Phase|Withdrawal by Subject|1|||
161984021|NCT00778895|584988829|FG001|Active Phase|Withdrawal by Subject|4|||
161984022|NCT00778895|584988830|FG002|Active Phase|Withdrawal by Subject|0|||
161984023|NCT00778895|584988828|FG000|Active Phase|Lost to Follow-up|1|||
161984024|NCT00778895|584988829|FG001|Active Phase|Lost to Follow-up|1|||
161984025|NCT00778895|584988830|FG002|Active Phase|Lost to Follow-up|0|||
161984026|NCT00778895|584988828|FG000|Active Phase|Other|2|||
161984027|NCT00778895|584988829|FG001|Active Phase|Other|0|||
161984028|NCT00778895|584988830|FG002|Active Phase|Other|0|||
161984029|NCT00778895|584988828|FG000|ESFU Phase|Adverse Event|2|||
161984030|NCT00778895|584988829|FG001|ESFU Phase|Adverse Event|1|||
161984031|NCT00778895|584988830|FG002|ESFU Phase|Adverse Event|0|||
161984032|NCT00778895|584988828|FG000|ESFU Phase|Withdrawal by Subject|1|||
161984033|NCT00778895|584988829|FG001|ESFU Phase|Withdrawal by Subject|4|||
161984034|NCT00778895|584988830|FG002|ESFU Phase|Withdrawal by Subject|0|||
161984035|NCT00778895|584988828|FG000|ESFU Phase|Lost to Follow-up|6|||
161984036|NCT00778895|584988829|FG001|ESFU Phase|Lost to Follow-up|7|||
161984037|NCT00778895|584988830|FG002|ESFU Phase|Lost to Follow-up|2|||
161984038|NCT00778895|584988828|FG000|ESFU Phase|Other|2|||
161984039|NCT00778895|584988829|FG001|ESFU Phase|Other|0|||
161984040|NCT00778895|584988830|FG002|ESFU Phase|Other|0|||
161984041|NCT01459913|584988834|FG000|Overall Study|Adverse Event|0|||
161870239|NCT04178122|584570169|FG000|Overall Study|Did not complete testing|3|||
161870240|NCT04178122|584570170|FG001|Overall Study|Did not complete testing|13|||
161984042|NCT01459913|584988835|FG001|Overall Study|Adverse Event|0|||
161984043|NCT01459913|584988836|FG002|Overall Study|Adverse Event|0|||
161984044|NCT01459913|584988837|FG003|Overall Study|Adverse Event|3|||
161870241|NCT03124407|584570175|FG000|Overall Study|Lost to Follow-up|1|||
161984045|NCT01459913|584988834|FG000|Overall Study|Withdrawal by Subject|4|||
161984046|NCT01459913|584988835|FG001|Overall Study|Withdrawal by Subject|0|||
161984047|NCT01459913|584988836|FG002|Overall Study|Withdrawal by Subject|0|||
161870242|NCT03124407|584570176|FG001|Overall Study|Lost to Follow-up|0|||
161984048|NCT01459913|584988837|FG003|Overall Study|Withdrawal by Subject|5|||
161984049|NCT01459913|584988834|FG000|Overall Study|Lost to Follow-up|7|||
161984050|NCT01459913|584988835|FG001|Overall Study|Lost to Follow-up|4|||
161870243|NCT03124407|584570177|FG002|Overall Study|Lost to Follow-up|0|||
161984051|NCT01459913|584988836|FG002|Overall Study|Lost to Follow-up|1|||
161984052|NCT01459913|584988837|FG003|Overall Study|Lost to Follow-up|8|||
161984053|NCT01459913|584988834|FG000|Overall Study|Death|0|||
161984054|NCT01459913|584988835|FG001|Overall Study|Death|0|||
161984055|NCT01459913|584988836|FG002|Overall Study|Death|0|||
161984056|NCT01459913|584988837|FG003|Overall Study|Death|1|||
161984057|NCT01459913|584988834|FG000|Overall Study|Non- Compliance|0|||
161984058|NCT01459913|584988835|FG001|Overall Study|Non- Compliance|0|||
161984059|NCT01459913|584988836|FG002|Overall Study|Non- Compliance|0|||
161984060|NCT01459913|584988837|FG003|Overall Study|Non- Compliance|3|||
161984061|NCT01459913|584988834|FG000|Overall Study|Physician Decision|0|||
161984062|NCT01459913|584988835|FG001|Overall Study|Physician Decision|1|||
161984063|NCT01459913|584988836|FG002|Overall Study|Physician Decision|0|||
161984064|NCT01459913|584988837|FG003|Overall Study|Physician Decision|0|||
161984065|NCT01459913|584988834|FG000|Overall Study|Study Terminated by Sponsor|30|||
161984066|NCT01459913|584988835|FG001|Overall Study|Study Terminated by Sponsor|15|||
161984067|NCT01459913|584988836|FG002|Overall Study|Study Terminated by Sponsor|9|||
161984068|NCT01459913|584988837|FG003|Overall Study|Study Terminated by Sponsor|11|||
161984069|NCT01459913|584988834|FG000|Overall Study|Other|0|||
161984070|NCT01459913|584988835|FG001|Overall Study|Other|0|||
161984071|NCT01459913|584988836|FG002|Overall Study|Other|3|||
161984072|NCT01459913|584988837|FG003|Overall Study|Other|1|||
161984073|NCT01459913|584988834|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
161984074|NCT01459913|584988835|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
161984075|NCT01459913|584988836|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
161984076|NCT01459913|584988837|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
161984077|NCT05096312|584988838|FG000|Overall Study|Lost to Follow-up|2|||
161984078|NCT05096312|584988839|FG001|Overall Study|Lost to Follow-up|4|||
161984079|NCT05096312|584988838|FG000|Overall Study|Adverse Event|1|||
161984080|NCT05096312|584988839|FG001|Overall Study|Adverse Event|0|||
161984081|NCT00576576|584988840|FG000|Overall Study|Lost to Follow-up|6|||
161984082|NCT00576576|584988840|FG000|Overall Study|Protocol Violation|1|||
161775143|NCT00337727|584219391|FG001|Overall Study|Withdrawal by Subject|5|||
161775144|NCT00491322|584219393|FG000|Overall Study|Protocol Violation|1|||
161775145|NCT00491322|584219394|FG001|Overall Study|Protocol Violation|0|||
161775146|NCT00491322|584219393|FG000|Overall Study|Pregnancy|0|||
161775147|NCT00491322|584219394|FG001|Overall Study|Pregnancy|1|||
161775148|NCT06067191|584219400|FG000|Overall Study|Withdrawal by Subject|0|||
161775149|NCT06067191|584219401|FG001|Overall Study|Withdrawal by Subject|1|||
161775150|NCT01870921|584219404|FG000|Overall Study|Subject decision|80|||
161775151|NCT01870921|584219404|FG000|Overall Study|Severe non-compliance to protocol|7|||
161775152|NCT01870921|584219404|FG000|Overall Study|Subject Lost to Follow up|2|||
161775153|NCT01870921|584219404|FG000|Overall Study|Other|1|||
161775154|NCT00806416|584219405|FG000|Period 1 - Part I|Adverse Event|0|||
161775155|NCT00806416|584219406|FG001|Period 1 - Part I|Adverse Event|1|||
161775156|NCT00806416|584219407|FG002|Period 1 - Part I|Adverse Event|0|||
161775157|NCT00806416|584219408|FG003|Period 1 - Part I|Adverse Event|0|||
161775158|NCT00806416|584219405|FG000|Period 1 - Part I|Lost to Follow-up|0|||
161775159|NCT00806416|584219406|FG001|Period 1 - Part I|Lost to Follow-up|2|||
161775160|NCT00806416|584219407|FG002|Period 1 - Part I|Lost to Follow-up|0|||
161775161|NCT00806416|584219408|FG003|Period 1 - Part I|Lost to Follow-up|0|||
161775162|NCT00806416|584219405|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
161775163|NCT00806416|584219406|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
161775164|NCT00806416|584219407|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
161775165|NCT00806416|584219408|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
161984083|NCT03135210|584988841|FG000|Overall Study|Death|0|||
161775166|NCT00806416|584219405|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
161775167|NCT00806416|584219406|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
161775168|NCT00806416|584219407|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
161775169|NCT00806416|584219408|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
161775170|NCT01102972|584219414|FG000|Overall Study|Adverse Event|8|||
161775171|NCT01102972|584219415|FG001|Overall Study|Adverse Event|2|||
161775172|NCT01102972|584219414|FG000|Overall Study|Lack of Efficacy|2|||
161775173|NCT01102972|584219415|FG001|Overall Study|Lack of Efficacy|1|||
161775174|NCT01102972|584219414|FG000|Overall Study|Protocol Violation|1|||
161775175|NCT01102972|584219415|FG001|Overall Study|Protocol Violation|0|||
161775176|NCT01102972|584219414|FG000|Overall Study|Lost to Follow-up|10|||
161775177|NCT01102972|584219415|FG001|Overall Study|Lost to Follow-up|5|||
161775178|NCT01102972|584219414|FG000|Overall Study|Investigator Discretion|2|||
161775179|NCT01102972|584219415|FG001|Overall Study|Investigator Discretion|0|||
161775180|NCT01102972|584219414|FG000|Overall Study|Withdrawal by Subject|6|||
161775181|NCT01102972|584219415|FG001|Overall Study|Withdrawal by Subject|6|||
161775182|NCT03664024|584219419|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
161775183|NCT03664024|584219419|FG000|Overall Study|Lost to Follow-up|2|||
161775184|NCT03664024|584219419|FG000|Overall Study|Withdrawal by Subject|2|||
161984084|NCT03135210|584988842|FG001|Overall Study|Death|1|||
161984085|NCT03517566|584988845|FG000|Overall Study|Adverse Event|5|||
161984086|NCT03517566|584988846|FG001|Overall Study|Adverse Event|2|||
161984087|NCT03517566|584988847|FG002|Overall Study|Adverse Event|2|||
161775185|NCT03664024|584219419|FG000|Overall Study|Death|80|||
161984088|NCT03517566|584988848|FG003|Overall Study|Adverse Event|8|||
161984089|NCT03517566|584988849|FG004|Overall Study|Adverse Event|7|||
161984090|NCT03517566|584988845|FG000|Overall Study|Lack of Efficacy|3|||
161984091|NCT03517566|584988846|FG001|Overall Study|Lack of Efficacy|2|||
161984092|NCT03517566|584988847|FG002|Overall Study|Lack of Efficacy|1|||
161984093|NCT03517566|584988848|FG003|Overall Study|Lack of Efficacy|1|||
161984094|NCT03517566|584988849|FG004|Overall Study|Lack of Efficacy|4|||
161984095|NCT03517566|584988845|FG000|Overall Study|Lost to Follow-up|3|||
161984096|NCT03517566|584988846|FG001|Overall Study|Lost to Follow-up|1|||
161984097|NCT03517566|584988847|FG002|Overall Study|Lost to Follow-up|1|||
161984098|NCT03517566|584988848|FG003|Overall Study|Lost to Follow-up|1|||
161984099|NCT03517566|584988849|FG004|Overall Study|Lost to Follow-up|0|||
161984100|NCT03517566|584988845|FG000|Overall Study|Physician Decision|1|||
161984101|NCT03517566|584988846|FG001|Overall Study|Physician Decision|1|||
161984102|NCT03517566|584988847|FG002|Overall Study|Physician Decision|0|||
161984103|NCT03517566|584988848|FG003|Overall Study|Physician Decision|1|||
161984104|NCT03517566|584988849|FG004|Overall Study|Physician Decision|0|||
161984105|NCT03517566|584988845|FG000|Overall Study|Pregnancy|0|||
161984106|NCT03517566|584988846|FG001|Overall Study|Pregnancy|1|||
161984107|NCT03517566|584988847|FG002|Overall Study|Pregnancy|0|||
161984108|NCT03517566|584988848|FG003|Overall Study|Pregnancy|0|||
161984109|NCT03517566|584988849|FG004|Overall Study|Pregnancy|0|||
161984110|NCT03517566|584988845|FG000|Overall Study|Protocol Deviation|0|||
161984111|NCT03517566|584988846|FG001|Overall Study|Protocol Deviation|1|||
161984112|NCT03517566|584988847|FG002|Overall Study|Protocol Deviation|0|||
161984113|NCT03517566|584988848|FG003|Overall Study|Protocol Deviation|1|||
161984114|NCT03517566|584988849|FG004|Overall Study|Protocol Deviation|1|||
161984115|NCT03517566|584988845|FG000|Overall Study|Study terminated by Sponsor|11|||
161984116|NCT03517566|584988846|FG001|Overall Study|Study terminated by Sponsor|5|||
161984117|NCT03517566|584988847|FG002|Overall Study|Study terminated by Sponsor|6|||
161984118|NCT03517566|584988848|FG003|Overall Study|Study terminated by Sponsor|14|||
161984119|NCT03517566|584988849|FG004|Overall Study|Study terminated by Sponsor|12|||
161984120|NCT03517566|584988845|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
161984121|NCT03517566|584988846|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
161984122|NCT03517566|584988847|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
161984123|NCT03517566|584988848|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
161984124|NCT03517566|584988849|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
161984125|NCT00671437|584988850|FG000|Overall Study|Progressive disease before C1 week 8|8|||
161984126|NCT00671437|584988850|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
161984127|NCT00671437|584988850|FG000|Overall Study|Adverse Event|3|||
161984128|NCT00671437|584988850|FG000|Overall Study|Ineligible post-hoc|1|||
161984129|NCT01704456|584988857|FG000|Overall Study|Lost to Follow-up|8|||
161984130|NCT01704456|584988858|FG001|Overall Study|Lost to Follow-up|14|||
161984131|NCT00718770|584988859|FG000|Overall Study|Adverse Event|1|||
161984132|NCT00718770|584988859|FG000|Overall Study|Lack of Efficacy|1|||
161984133|NCT00718770|584988859|FG000|Overall Study|Lack of Efficacy|1|||
161984134|NCT00718770|584988859|FG000|Overall Study|Adverse Event|1|||
161984135|NCT00718770|584988859|FG000|Overall Study|Lack of Efficacy|1|||
161984136|NCT00718770|584988859|FG000|Overall Study|Adverse Event|1|||
161984137|NCT00718770|584988859|FG000|Overall Study|Lack of Efficacy|1|||
161984138|NCT00718770|584988859|FG000|Overall Study|Adverse Event|1|||
161984139|NCT04583956|584988860|FG000|Overall Study|Death|9|||
161984140|NCT04583956|584988861|FG001|Overall Study|Death|11|||
161984141|NCT04583956|584988860|FG000|Overall Study|Lost to Follow-up|7|||
161984142|NCT04583956|584988861|FG001|Overall Study|Lost to Follow-up|9|||
161984143|NCT04583956|584988860|FG000|Overall Study|Protocol Violation|2|||
161984144|NCT04583956|584988861|FG001|Overall Study|Protocol Violation|0|||
161984145|NCT04583956|584988860|FG000|Overall Study|Withdrawal by Subject|0|||
161984146|NCT04583956|584988861|FG001|Overall Study|Withdrawal by Subject|2|||
161984147|NCT04583956|584988860|FG000|Overall Study|Randomized but not dosed|2|||
161984148|NCT04583956|584988861|FG001|Overall Study|Randomized but not dosed|3|||
161984149|NCT04583956|584988860|FG000|Overall Study|Withdrawal of consent before product administration|1|||
161984150|NCT04583956|584988861|FG001|Overall Study|Withdrawal of consent before product administration|0|||
161984151|NCT01370265|584990181|FG000|First Intervention|Adverse Event|1|||
161984152|NCT01370265|584990182|FG001|First Intervention|Adverse Event|1|||
161984153|NCT00703924|584990183|FG000|Overall Study|Withdrawal by Subject|1|||
161984154|NCT00703924|584990184|FG001|Overall Study|Withdrawal by Subject|1|||
161984155|NCT01031979|584990185|FG000|Overall Study|Lost to Follow-up|5|||
161984156|NCT01031979|584990186|FG001|Overall Study|Lost to Follow-up|4|||
161775186|NCT01157065|584219420|FG000|Overall Study|Death|0|||
161984157|NCT03831100|584990187|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
161984158|NCT03831100|584990188|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
161984159|NCT02454478|584990196|FG000|Overall Study|Incomplete DLT Evaluation|1|||
161984160|NCT01732770|584990200|FG000|Overall Study|Lost to Follow-up|2|||
161984161|NCT01732770|584990201|FG001|Overall Study|Lost to Follow-up|3|||
161984162|NCT01732770|584990200|FG000|Overall Study|Withdrawal by Subject|5|||
161984163|NCT01732770|584990201|FG001|Overall Study|Withdrawal by Subject|3|||
161984164|NCT01732770|584990200|FG000|Overall Study|Decision by Sponsor|2|||
161984165|NCT01732770|584990201|FG001|Overall Study|Decision by Sponsor|2|||
161984166|NCT01732770|584990200|FG000|Overall Study|Death|1|||
161984167|NCT01732770|584990201|FG001|Overall Study|Death|0|||
161984168|NCT01900054|584990205|FG000|Overall Study|Physician Decision|1|||
161984169|NCT01900054|584990205|FG000|Overall Study|Withdrawal by Subject|1|||
161984170|NCT01959841|584990208|FG000|Overall Study|Adverse Event|1|||
161984171|NCT01959841|584990209|FG001|Overall Study|Adverse Event|3|||
161984172|NCT01959841|584990210|FG002|Overall Study|Adverse Event|2|||
161984173|NCT01959841|584990208|FG000|Overall Study|Lack of Efficacy|5|||
161984174|NCT01959841|584990209|FG001|Overall Study|Lack of Efficacy|0|||
161984175|NCT01959841|584990210|FG002|Overall Study|Lack of Efficacy|0|||
161984176|NCT01959841|584990208|FG000|Overall Study|Lost to Follow-up|1|||
161984177|NCT01959841|584990209|FG001|Overall Study|Lost to Follow-up|1|||
161984178|NCT01959841|584990210|FG002|Overall Study|Lost to Follow-up|0|||
161984179|NCT01959841|584990208|FG000|Overall Study|Physician Decision|0|||
161984180|NCT01959841|584990209|FG001|Overall Study|Physician Decision|2|||
161984181|NCT01959841|584990210|FG002|Overall Study|Physician Decision|3|||
161984182|NCT01959841|584990208|FG000|Overall Study|Protocol Violation|16|||
161984183|NCT01959841|584990209|FG001|Overall Study|Protocol Violation|23|||
161984184|NCT01959841|584990210|FG002|Overall Study|Protocol Violation|16|||
161984185|NCT01959841|584990208|FG000|Overall Study|Withdrawal by Subject|7|||
161984186|NCT01959841|584990209|FG001|Overall Study|Withdrawal by Subject|7|||
161984187|NCT01959841|584990210|FG002|Overall Study|Withdrawal by Subject|5|||
161984188|NCT01959841|584990208|FG000|Overall Study|Clinical laboratory value|2|||
161984189|NCT01959841|584990209|FG001|Overall Study|Clinical laboratory value|6|||
161984190|NCT01959841|584990210|FG002|Overall Study|Clinical laboratory value|6|||
161984191|NCT01959841|584990208|FG000|Overall Study|Platelet count below on day1 or 4|11|||
161984192|NCT01959841|584990209|FG001|Overall Study|Platelet count below on day1 or 4|15|||
161984193|NCT01959841|584990210|FG002|Overall Study|Platelet count below on day1 or 4|11|||
161984194|NCT01450098|584990212|FG000|Period 3|Protocol Violation|0|||
161984195|NCT01450098|584990213|FG001|Period 3|Protocol Violation|1|||
161984196|NCT01450098|584990212|FG000|Period 3|Withdrawal by Subject|0|||
161984197|NCT01450098|584990213|FG001|Period 3|Withdrawal by Subject|2|||
161984198|NCT03229109|584990222|FG000|Overall Study|Withdrawal by Subject|0|||
161984199|NCT03229109|584990223|FG001|Overall Study|Withdrawal by Subject|0|||
161984200|NCT03229109|584990224|FG002|Overall Study|Withdrawal by Subject|0|||
161984201|NCT03229109|584990225|FG003|Overall Study|Withdrawal by Subject|1|||
161984202|NCT00655629|584990228|FG000|Overall Study|Adverse Event|4|||
161984203|NCT00655629|584990229|FG001|Overall Study|Adverse Event|1|||
161984204|NCT00655629|584990228|FG000|Overall Study|Lack of Efficacy|2|||
161984205|NCT00655629|584990229|FG001|Overall Study|Lack of Efficacy|12|||
161984206|NCT00655629|584990228|FG000|Overall Study|Lost to Follow-up|4|||
161984207|NCT00655629|584990229|FG001|Overall Study|Lost to Follow-up|3|||
161984208|NCT00655629|584990228|FG000|Overall Study|Protocol Violation|5|||
161984209|NCT00655629|584990229|FG001|Overall Study|Protocol Violation|3|||
161984210|NCT00655629|584990228|FG000|Overall Study|consent withdrawn|6|||
161984211|NCT00655629|584990229|FG001|Overall Study|consent withdrawn|4|||
161984212|NCT01835223|584990232|FG000|Overall Study|Adverse Event|1|||
161984213|NCT01835223|584990233|FG001|Overall Study|Adverse Event|0|||
161984214|NCT01835223|584990232|FG000|Overall Study|Withdrawal by Subject|2|||
161984215|NCT01835223|584990233|FG001|Overall Study|Withdrawal by Subject|0|||
161984216|NCT01835223|584990232|FG000|Overall Study|Disease progression|2|||
161984217|NCT01835223|584990233|FG001|Overall Study|Disease progression|1|||
161984218|NCT01835223|584990232|FG000|Overall Study|Became Inelligible|4|||
161984219|NCT01835223|584990233|FG001|Overall Study|Became Inelligible|0|||
161984220|NCT04097379|584990237|FG000|Overall Study|Adverse Event|1|||
161984221|NCT04097379|584990238|FG001|Overall Study|Adverse Event|0|||
161984222|NCT04097379|584990239|FG002|Overall Study|Adverse Event|0|||
161984223|NCT04097379|584990240|FG003|Overall Study|Adverse Event|0|||
161984224|NCT04097379|584990237|FG000|Overall Study|Physician Decision|0|||
161984225|NCT04097379|584990238|FG001|Overall Study|Physician Decision|1|||
161984226|NCT04097379|584990239|FG002|Overall Study|Physician Decision|0|||
161984227|NCT04097379|584990240|FG003|Overall Study|Physician Decision|0|||
161984228|NCT03387020|584990241|FG000|Overall Study|Adverse Event|0|||
161984229|NCT03387020|584990242|FG001|Overall Study|Adverse Event|2|||
161984230|NCT03387020|584990243|FG002|Overall Study|Adverse Event|0|||
161984231|NCT03387020|584990241|FG000|Overall Study|Withdrawal by Subject|2|||
161984232|NCT03387020|584990242|FG001|Overall Study|Withdrawal by Subject|0|||
161984233|NCT03387020|584990243|FG002|Overall Study|Withdrawal by Subject|0|||
161984234|NCT01425632|584990244|FG000|Overall Study|Adverse Event|0|||
161984235|NCT01425632|584990245|FG001|Overall Study|Adverse Event|1|||
161984236|NCT01425632|584990246|FG002|Overall Study|Adverse Event|1|||
161984237|NCT01425632|584990244|FG000|Overall Study|Physician Decision|1|||
161984238|NCT01425632|584990245|FG001|Overall Study|Physician Decision|0|||
161984239|NCT01425632|584990246|FG002|Overall Study|Physician Decision|0|||
161984240|NCT01425632|584990244|FG000|Overall Study|Protocol Violation|0|||
161984241|NCT01425632|584990245|FG001|Overall Study|Protocol Violation|0|||
161984242|NCT01425632|584990246|FG002|Overall Study|Protocol Violation|2|||
161984243|NCT01425632|584990244|FG000|Overall Study|Withdrawal by Subject|0|||
161870244|NCT03124407|584570178|FG003|Overall Study|Lost to Follow-up|0|||
161870245|NCT03124407|584570175|FG000|Overall Study|Adverse Event|0|||
161870246|NCT03124407|584570176|FG001|Overall Study|Adverse Event|0|||
161870247|NCT03124407|584570177|FG002|Overall Study|Adverse Event|1|||
161870248|NCT03124407|584570178|FG003|Overall Study|Adverse Event|0|||
161870249|NCT05343364|584570179|FG000|Overall Study|Miscellaneous|0|||
161870250|NCT05343364|584570180|FG001|Overall Study|Miscellaneous|1|||
161870251|NCT01791894|584570181|FG000|Overall Study|Adverse Event|1|||
161870252|NCT00984542|584570184|FG000|Overall Study|disease progression|19|||
161870253|NCT00984542|584570184|FG000|Overall Study|toxicity|7|||
161870254|NCT00984542|584570184|FG000|Overall Study|Death|7|||
161870255|NCT00984542|584570184|FG000|Overall Study|complicating disease|3|||
161870256|NCT00984542|584570184|FG000|Overall Study|Withdrawal by Subject|3|||
161870257|NCT00984542|584570184|FG000|Overall Study|clinical deterioration|2|||
161870258|NCT01422889|584570185|FG000|Overall Study|No Data Entered for Study Stent|9|||
161870259|NCT01276756|584570194|FG000|Overall Study|Lost to Follow-up|2|||
161870260|NCT01276756|584570195|FG001|Overall Study|Lost to Follow-up|0|||
161870261|NCT01276756|584570194|FG000|Overall Study|Adverse Event|3|||
161870262|NCT01276756|584570195|FG001|Overall Study|Adverse Event|2|||
161870263|NCT02589639|584570196|FG000|Overall Study|Lost to Follow-up|1|||
161870264|NCT02589639|584570197|FG001|Overall Study|Lost to Follow-up|0|||
161870265|NCT02589639|584570198|FG002|Overall Study|Lost to Follow-up|0|||
161870266|NCT02589639|584570196|FG000|Overall Study|Protocol Violation|1|||
161870267|NCT02589639|584570197|FG001|Overall Study|Protocol Violation|0|||
161870268|NCT02589639|584570198|FG002|Overall Study|Protocol Violation|0|||
161870269|NCT02589639|584570196|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
161870270|NCT02589639|584570197|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
161870271|NCT02589639|584570198|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
161870272|NCT02589639|584570196|FG000|Overall Study|Adverse Event|4|||
161870273|NCT02589639|584570197|FG001|Overall Study|Adverse Event|5|||
161870274|NCT02589639|584570198|FG002|Overall Study|Adverse Event|3|||
161870275|NCT02589639|584570196|FG000|Overall Study|Other reason than specified above|1|||
161870276|NCT02589639|584570197|FG001|Overall Study|Other reason than specified above|2|||
161870277|NCT02589639|584570198|FG002|Overall Study|Other reason than specified above|1|||
161870278|NCT02589639|584570196|FG000|Overall Study|Not Treated|0|||
161870279|NCT02589639|584570197|FG001|Overall Study|Not Treated|3|||
161870280|NCT02589639|584570198|FG002|Overall Study|Not Treated|0|||
161870281|NCT02630251|584570201|FG000|Overall Study|Physician Decision|0|||
161870282|NCT02630251|584570202|FG001|Overall Study|Physician Decision|0|||
161870283|NCT02630251|584570203|FG002|Overall Study|Physician Decision|1|||
161870284|NCT02630251|584570204|FG003|Overall Study|Physician Decision|0|||
161870285|NCT00153179|584570210|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
161870286|NCT00153179|584570211|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
161870287|NCT00153179|584570212|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
161870288|NCT00153179|584570213|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
161870289|NCT03517540|584570214|FG000|Overall Study|Protocol Violation|2|||
161870290|NCT03517540|584570215|FG001|Overall Study|Protocol Violation|0|||
161870291|NCT03517540|584570216|FG002|Overall Study|Protocol Violation|0|||
161870292|NCT03517540|584570217|FG003|Overall Study|Protocol Violation|1|||
161870293|NCT03517540|584570214|FG000|Overall Study|Adverse Event|9|||
161870294|NCT03517540|584570215|FG001|Overall Study|Adverse Event|3|||
161870295|NCT03517540|584570216|FG002|Overall Study|Adverse Event|8|||
161870296|NCT03517540|584570217|FG003|Overall Study|Adverse Event|1|||
161870297|NCT03517540|584570214|FG000|Overall Study|Withdrawal by Subject|3|||
161870298|NCT03517540|584570215|FG001|Overall Study|Withdrawal by Subject|4|||
161870299|NCT03517540|584570216|FG002|Overall Study|Withdrawal by Subject|1|||
161870300|NCT03517540|584570217|FG003|Overall Study|Withdrawal by Subject|3|||
161870301|NCT05763875|584570226|FG000|Overall Study|Subject decision|5|||
161870302|NCT05763875|584570227|FG001|Overall Study|Subject decision|2|||
161870303|NCT05763875|584570228|FG002|Overall Study|Subject decision|1|||
161870304|NCT05763875|584570226|FG000|Overall Study|Lost to Follow-up|4|||
161870305|NCT05763875|584570227|FG001|Overall Study|Lost to Follow-up|1|||
161870306|NCT05763875|584570228|FG002|Overall Study|Lost to Follow-up|2|||
161870307|NCT05763875|584570226|FG000|Overall Study|Adverse Event|1|||
161870308|NCT05763875|584570227|FG001|Overall Study|Adverse Event|0|||
161870309|NCT05763875|584570228|FG002|Overall Study|Adverse Event|0|||
161870310|NCT01777282|584570229|FG000|Overall Study|Persistent Hyperglycemia|0|||
161870311|NCT01777282|584570230|FG001|Overall Study|Persistent Hyperglycemia|0|||
161870312|NCT01777282|584570231|FG002|Overall Study|Persistent Hyperglycemia|1|||
161870313|NCT01777282|584570232|FG003|Overall Study|Persistent Hyperglycemia|0|||
161870314|NCT01777282|584570233|FG004|Overall Study|Persistent Hyperglycemia|0|||
161870315|NCT01777282|584570229|FG000|Overall Study|New Antidiabetic Medication|0|||
161870316|NCT01777282|584570230|FG001|Overall Study|New Antidiabetic Medication|0|||
161870317|NCT01777282|584570231|FG002|Overall Study|New Antidiabetic Medication|1|||
161870318|NCT01777282|584570232|FG003|Overall Study|New Antidiabetic Medication|0|||
161870319|NCT01777282|584570233|FG004|Overall Study|New Antidiabetic Medication|0|||
161870320|NCT01777282|584570229|FG000|Overall Study|Adverse Event|4|||
161870321|NCT01777282|584570230|FG001|Overall Study|Adverse Event|4|||
161870322|NCT01777282|584570231|FG002|Overall Study|Adverse Event|2|||
161870323|NCT01777282|584570232|FG003|Overall Study|Adverse Event|1|||
161870324|NCT01777282|584570233|FG004|Overall Study|Adverse Event|3|||
161870325|NCT01777282|584570229|FG000|Overall Study|Withdrawal by Subject|4|||
161870326|NCT01777282|584570230|FG001|Overall Study|Withdrawal by Subject|0|||
161870327|NCT01777282|584570231|FG002|Overall Study|Withdrawal by Subject|0|||
161870328|NCT01777282|584570232|FG003|Overall Study|Withdrawal by Subject|1|||
161870329|NCT01777282|584570233|FG004|Overall Study|Withdrawal by Subject|2|||
161870330|NCT01777282|584570229|FG000|Overall Study|Protocol Violation|2|||
161870331|NCT01777282|584570230|FG001|Overall Study|Protocol Violation|0|||
161870332|NCT01777282|584570231|FG002|Overall Study|Protocol Violation|1|||
161870333|NCT01777282|584570232|FG003|Overall Study|Protocol Violation|0|||
161870334|NCT01777282|584570233|FG004|Overall Study|Protocol Violation|2|||
161870335|NCT01777282|584570229|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
161870336|NCT01777282|584570230|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
161870337|NCT01777282|584570231|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
161870338|NCT01777282|584570232|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
161870339|NCT01777282|584570233|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
161870340|NCT04015518|584570234|FG000|Overall Study|Adverse Event|6|||
161870341|NCT04015518|584570235|FG001|Overall Study|Adverse Event|1|||
161870342|NCT04015518|584570236|FG002|Overall Study|Adverse Event|1|||
161870343|NCT04015518|584570237|FG003|Overall Study|Adverse Event|3|||
161870344|NCT04015518|584570238|FG004|Overall Study|Adverse Event|3|||
161870345|NCT04015518|584570234|FG000|Overall Study|Lack of Efficacy|1|||
161870346|NCT04015518|584570235|FG001|Overall Study|Lack of Efficacy|0|||
161870347|NCT04015518|584570236|FG002|Overall Study|Lack of Efficacy|1|||
161870348|NCT04015518|584570237|FG003|Overall Study|Lack of Efficacy|0|||
161870349|NCT04015518|584570238|FG004|Overall Study|Lack of Efficacy|4|||
161870350|NCT04015518|584570234|FG000|Overall Study|Lost to Follow-up|0|||
161870351|NCT04015518|584570235|FG001|Overall Study|Lost to Follow-up|0|||
161870352|NCT04015518|584570236|FG002|Overall Study|Lost to Follow-up|0|||
161870353|NCT04015518|584570237|FG003|Overall Study|Lost to Follow-up|0|||
161870354|NCT04015518|584570238|FG004|Overall Study|Lost to Follow-up|1|||
161870355|NCT04015518|584570234|FG000|Overall Study|Withdrawal by Subject|0|||
161870356|NCT04015518|584570235|FG001|Overall Study|Withdrawal by Subject|1|||
161870357|NCT04015518|584570236|FG002|Overall Study|Withdrawal by Subject|0|||
161870358|NCT04015518|584570237|FG003|Overall Study|Withdrawal by Subject|1|||
161870359|NCT04015518|584570238|FG004|Overall Study|Withdrawal by Subject|1|||
161870360|NCT04015518|584570234|FG000|Overall Study|Patient did not come for consecutive visits|0|||
161870361|NCT04015518|584570235|FG001|Overall Study|Patient did not come for consecutive visits|1|||
161870362|NCT04015518|584570236|FG002|Overall Study|Patient did not come for consecutive visits|0|||
161870363|NCT04015518|584570237|FG003|Overall Study|Patient did not come for consecutive visits|0|||
161870364|NCT04015518|584570238|FG004|Overall Study|Patient did not come for consecutive visits|0|||
161870365|NCT04015518|584570234|FG000|Overall Study|not willing to travel due to Covid-19|0|||
161870366|NCT04015518|584570235|FG001|Overall Study|not willing to travel due to Covid-19|0|||
161870367|NCT04015518|584570236|FG002|Overall Study|not willing to travel due to Covid-19|1|||
161870368|NCT04015518|584570237|FG003|Overall Study|not willing to travel due to Covid-19|0|||
161870369|NCT04015518|584570238|FG004|Overall Study|not willing to travel due to Covid-19|0|||
161870370|NCT04015518|584570234|FG000|Overall Study|Patient wants to discontinue treatment|0|||
161870371|NCT04015518|584570235|FG001|Overall Study|Patient wants to discontinue treatment|0|||
161870372|NCT04015518|584570236|FG002|Overall Study|Patient wants to discontinue treatment|0|||
161870373|NCT04015518|584570237|FG003|Overall Study|Patient wants to discontinue treatment|1|||
161870374|NCT04015518|584570238|FG004|Overall Study|Patient wants to discontinue treatment|0|||
161870375|NCT04015518|584570234|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
161870376|NCT04015518|584570235|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
161870377|NCT04015518|584570236|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
161870378|NCT04015518|584570237|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
161870379|NCT04015518|584570238|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
161870380|NCT04015518|584570234|FG000|Overall Study|Pregnancy|0|||
161870381|NCT04015518|584570235|FG001|Overall Study|Pregnancy|0|||
161870382|NCT04015518|584570236|FG002|Overall Study|Pregnancy|0|||
161870383|NCT04015518|584570237|FG003|Overall Study|Pregnancy|0|||
161870384|NCT04015518|584570238|FG004|Overall Study|Pregnancy|1|||
161870385|NCT04015518|584570234|FG000|Overall Study|Personal reasons|1|||
161870386|NCT04015518|584570235|FG001|Overall Study|Personal reasons|0|||
161870387|NCT04015518|584570236|FG002|Overall Study|Personal reasons|0|||
161870388|NCT04015518|584570237|FG003|Overall Study|Personal reasons|0|||
161870389|NCT04015518|584570238|FG004|Overall Study|Personal reasons|1|||
161870390|NCT04015518|584570234|FG000|Overall Study|Withdrew consent|1|||
161870391|NCT04015518|584570235|FG001|Overall Study|Withdrew consent|0|||
161870392|NCT04015518|584570236|FG002|Overall Study|Withdrew consent|0|||
161870393|NCT04015518|584570237|FG003|Overall Study|Withdrew consent|0|||
161870394|NCT04015518|584570238|FG004|Overall Study|Withdrew consent|0|||
161870395|NCT04015518|584570234|FG000|Overall Study|Prostate carcinoma|1|||
161984244|NCT01425632|584990245|FG001|Overall Study|Withdrawal by Subject|0|||
161775187|NCT01157065|584219421|FG001|Overall Study|Death|1|||
161775188|NCT03426995|584219424|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775189|NCT03426995|584219425|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775190|NCT03426995|584219426|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
161775191|NCT03426995|584219427|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775192|NCT03426995|584219428|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775193|NCT03426995|584219429|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775194|NCT03426995|584219430|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775195|NCT03426995|584219431|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775196|NCT03426995|584219432|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775197|NCT03426995|584219433|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775198|NCT03426995|584219434|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775199|NCT03426995|584219435|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775200|NCT03426995|584219436|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775201|NCT03426995|584219437|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775202|NCT03426995|584219438|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775203|NCT03426995|584219439|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775204|NCT03426995|584219440|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775205|NCT03426995|584219441|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775206|NCT03426995|584219442|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161775207|NCT03426995|584219424|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775208|NCT03426995|584219425|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775209|NCT03426995|584219426|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775210|NCT03426995|584219427|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775211|NCT03426995|584219428|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775212|NCT03426995|584219429|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
161775213|NCT03426995|584219430|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775214|NCT03426995|584219431|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775215|NCT03426995|584219432|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775216|NCT03426995|584219433|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775217|NCT03426995|584219434|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775218|NCT03426995|584219435|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775219|NCT03426995|584219436|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775220|NCT03426995|584219437|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775221|NCT03426995|584219438|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775222|NCT03426995|584219439|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775223|NCT03426995|584219440|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775224|NCT03426995|584219441|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775225|NCT03426995|584219442|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161775226|NCT03426995|584219424|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775227|NCT03426995|584219425|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775228|NCT03426995|584219426|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775229|NCT03426995|584219427|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775230|NCT03426995|584219428|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
161775231|NCT03426995|584219429|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
161775232|NCT03426995|584219430|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775233|NCT03426995|584219431|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775234|NCT03426995|584219432|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775235|NCT03426995|584219433|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775236|NCT03426995|584219434|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775237|NCT03426995|584219435|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775238|NCT03426995|584219436|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775239|NCT03426995|584219437|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775240|NCT03426995|584219438|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775241|NCT03426995|584219439|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775242|NCT03426995|584219440|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775243|NCT03426995|584219441|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775244|NCT03426995|584219442|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161775245|NCT03426995|584219424|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775246|NCT03426995|584219425|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775247|NCT03426995|584219426|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775248|NCT03426995|584219427|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775249|NCT03426995|584219428|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775250|NCT03426995|584219429|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161870396|NCT04015518|584570235|FG001|Overall Study|Prostate carcinoma|0|||
161775251|NCT03426995|584219430|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775252|NCT03426995|584219431|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775253|NCT03426995|584219432|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775254|NCT03426995|584219433|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775255|NCT03426995|584219434|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
161775256|NCT03426995|584219435|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775257|NCT03426995|584219436|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775258|NCT03426995|584219437|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775259|NCT03426995|584219438|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775260|NCT03426995|584219439|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775261|NCT03426995|584219440|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775262|NCT03426995|584219441|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775263|NCT03426995|584219442|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161775264|NCT03426995|584219424|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775265|NCT03426995|584219425|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775266|NCT03426995|584219426|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775267|NCT03426995|584219427|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775268|NCT03426995|584219428|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775269|NCT03426995|584219429|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775270|NCT03426995|584219430|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775271|NCT03426995|584219431|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
161775272|NCT03426995|584219432|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775273|NCT03426995|584219433|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775274|NCT03426995|584219434|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775275|NCT03426995|584219435|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775276|NCT03426995|584219436|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775277|NCT03426995|584219437|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775278|NCT03426995|584219438|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775279|NCT03426995|584219439|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775280|NCT03426995|584219440|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775281|NCT03426995|584219441|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775282|NCT03426995|584219442|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161775283|NCT03426995|584219424|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775284|NCT03426995|584219425|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775285|NCT03426995|584219426|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775286|NCT03426995|584219427|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775287|NCT03426995|584219428|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775288|NCT03426995|584219429|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775289|NCT03426995|584219430|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775290|NCT03426995|584219431|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775291|NCT03426995|584219432|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775292|NCT03426995|584219433|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775293|NCT03426995|584219434|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775294|NCT03426995|584219435|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775295|NCT03426995|584219436|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775296|NCT03426995|584219437|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775297|NCT03426995|584219438|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
161775298|NCT03426995|584219439|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
161775299|NCT03426995|584219440|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775300|NCT03426995|584219441|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775301|NCT03426995|584219442|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161775302|NCT03426995|584219424|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775303|NCT03426995|584219425|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775304|NCT03426995|584219426|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775305|NCT03426995|584219427|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775306|NCT03426995|584219428|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775307|NCT03426995|584219429|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775308|NCT03426995|584219430|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775309|NCT03426995|584219431|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775310|NCT03426995|584219432|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775311|NCT03426995|584219433|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775312|NCT03426995|584219434|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775313|NCT03426995|584219435|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775314|NCT03426995|584219436|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775315|NCT03426995|584219437|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161870397|NCT04015518|584570236|FG002|Overall Study|Prostate carcinoma|0|||
161984245|NCT01425632|584990246|FG002|Overall Study|Withdrawal by Subject|1|||
161984246|NCT04512976|584990249|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
161984247|NCT04512976|584990250|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
161984248|NCT04512976|584990251|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
161984249|NCT04512976|584990252|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
161984250|NCT04512976|584990253|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
161984251|NCT04512976|584990254|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
161984252|NCT05249569|584990258|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
161984253|NCT03461146|584990259|FG000|Overall Study|Adverse Event|2|||
161984254|NCT03461146|584990259|FG000|Overall Study|Physician Decision|1|||
161984255|NCT02140047|584990260|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161984256|NCT02140047|584990261|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161984257|NCT02140047|584990262|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161984258|NCT04617496|584990263|FG000|Overall Study|Death|2|||
161984259|NCT04617496|584990264|FG001|Overall Study|Death|1|||
161984260|NCT04617496|584990263|FG000|Overall Study|Lost to Follow-up|3|||
161984261|NCT04617496|584990264|FG001|Overall Study|Lost to Follow-up|3|||
161984262|NCT00200356|584990269|FG000|Overall Study|Lack of Efficacy|3|||
161984263|NCT00200356|584990270|FG001|Overall Study|Lack of Efficacy|3|||
161984264|NCT00200356|584990269|FG000|Overall Study|Protocol Violation|4|||
161984265|NCT00200356|584990270|FG001|Overall Study|Protocol Violation|4|||
161984266|NCT00200356|584990269|FG000|Overall Study|Nontreatment|1|||
161984267|NCT00200356|584990270|FG001|Overall Study|Nontreatment|0|||
161984268|NCT04530552|584990273|FG000|Overall Study|Physician Decision|0|||
161984269|NCT04530552|584990274|FG001|Overall Study|Physician Decision|1|||
161984270|NCT04530552|584990273|FG000|Overall Study|Withdrawal by Subject|0|||
161984271|NCT04530552|584990274|FG001|Overall Study|Withdrawal by Subject|1|||
161984272|NCT04530552|584990273|FG000|Overall Study|Adverse Event|0|||
161984273|NCT04530552|584990274|FG001|Overall Study|Adverse Event|1|||
161984274|NCT04530552|584990273|FG000|Overall Study|No surgery|0|||
161984275|NCT04530552|584990274|FG001|Overall Study|No surgery|1|||
161984276|NCT02409719|584990283|FG000|Overall Study|Lost to Follow-up|3|||
161984277|NCT02409719|584990284|FG001|Overall Study|Lost to Follow-up|3|||
161984278|NCT01026220|584990285|FG000|Induction|Death|1|||
161984279|NCT01026220|584990286|FG001|Induction|Death|0|||
161984280|NCT01026220|584990287|FG002|Induction|Death|0|||
161984281|NCT01026220|584990285|FG000|Induction|Lack of Efficacy|2|||
161984282|NCT01026220|584990286|FG001|Induction|Lack of Efficacy|0|||
161984283|NCT01026220|584990287|FG002|Induction|Lack of Efficacy|0|||
161984284|NCT01026220|584990285|FG000|Induction|Physician Decision|12|||
161984285|NCT01026220|584990286|FG001|Induction|Physician Decision|0|||
161984286|NCT01026220|584990287|FG002|Induction|Physician Decision|0|||
161984287|NCT01026220|584990285|FG000|Induction|Withdrawal by Subject|9|||
161984288|NCT01026220|584990286|FG001|Induction|Withdrawal by Subject|0|||
161984289|NCT01026220|584990287|FG002|Induction|Withdrawal by Subject|0|||
161984290|NCT01026220|584990285|FG000|Induction|Ineligible|1|||
161984291|NCT01026220|584990286|FG001|Induction|Ineligible|0|||
161984292|NCT01026220|584990287|FG002|Induction|Ineligible|0|||
161984293|NCT01026220|584990285|FG000|Consolidation Maintenance|Death|0|||
161984294|NCT01026220|584990286|FG001|Consolidation Maintenance|Death|1|||
161984295|NCT01026220|584990287|FG002|Consolidation Maintenance|Death|0|||
161984296|NCT01026220|584990285|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
161984297|NCT01026220|584990286|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
161984298|NCT01026220|584990287|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
161984299|NCT01026220|584990285|FG000|Consolidation Maintenance|Physician Decision|0|||
161984300|NCT01026220|584990286|FG001|Consolidation Maintenance|Physician Decision|2|||
161984301|NCT01026220|584990287|FG002|Consolidation Maintenance|Physician Decision|7|||
161984302|NCT01026220|584990285|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
161984303|NCT01026220|584990286|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
161984304|NCT01026220|584990287|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
161984305|NCT04349033|584990290|FG000|Overall Study|Lost to Follow-up|3|||
161984306|NCT04349033|584990291|FG001|Overall Study|Lost to Follow-up|1|||
161984307|NCT04349033|584990292|FG002|Overall Study|Lost to Follow-up|1|||
161984308|NCT00915551|584990299|FG000|Overall Study|Withdrawal by Subject|0|||
161984309|NCT00915551|584990300|FG001|Overall Study|Withdrawal by Subject|1|||
161984310|NCT04390841|584990301|FG000|Overall Study|Withdrawal by Subject|2|||
161984311|NCT02540291|584990302|FG000|Overall Study|Death|7|||
161984312|NCT02540291|584990303|FG001|Overall Study|Death|7|||
161984313|NCT02540291|584990304|FG002|Overall Study|Death|5|||
161984314|NCT02540291|584990305|FG003|Overall Study|Death|7|||
161984315|NCT02540291|584990302|FG000|Overall Study|Lost to Follow-up|0|||
161984316|NCT02540291|584990303|FG001|Overall Study|Lost to Follow-up|0|||
161984317|NCT02540291|584990304|FG002|Overall Study|Lost to Follow-up|1|||
161984318|NCT02540291|584990305|FG003|Overall Study|Lost to Follow-up|0|||
161984319|NCT02540291|584990302|FG000|Overall Study|Withdrawal Of Consent|0|||
161984320|NCT02540291|584990303|FG001|Overall Study|Withdrawal Of Consent|1|||
161984321|NCT02540291|584990304|FG002|Overall Study|Withdrawal Of Consent|0|||
161984322|NCT02540291|584990305|FG003|Overall Study|Withdrawal Of Consent|0|||
161984323|NCT02540291|584990302|FG000|Overall Study|Study Terminated By Sponsor|1|||
161984324|NCT02540291|584990303|FG001|Overall Study|Study Terminated By Sponsor|0|||
161984325|NCT02540291|584990304|FG002|Overall Study|Study Terminated By Sponsor|0|||
161984326|NCT02540291|584990305|FG003|Overall Study|Study Terminated By Sponsor|0|||
161984327|NCT02540291|584990302|FG000|Overall Study|Other|0|||
161984328|NCT02540291|584990303|FG001|Overall Study|Other|0|||
161984329|NCT02540291|584990304|FG002|Overall Study|Other|1|||
161984330|NCT02540291|584990305|FG003|Overall Study|Other|0|||
161984331|NCT01879072|584990307|FG000|Overall Study|Withdrawal by Subject|121|||
161984332|NCT01879072|584990307|FG000|Overall Study|Not Transplanted|30|||
161984333|NCT02666105|584990322|FG000|Overall Study|Death|1|||
161984334|NCT00411632|584990323|FG000|Overall Study|Death|1|||
161984335|NCT01264419|584990324|FG000|Overall Study|Lost to Follow-up|3|||
161984336|NCT00659230|584990325|FG000|Overall Study|Lost to Follow-up|2|||
161984337|NCT00659230|584990326|FG001|Overall Study|Lost to Follow-up|5|||
161984338|NCT00659230|584990325|FG000|Overall Study|Lost source documentation|5|||
161984339|NCT00659230|584990326|FG001|Overall Study|Lost source documentation|4|||
161984340|NCT00659230|584990325|FG000|Overall Study|Did not return post-randomization|2|||
161984341|NCT00659230|584990326|FG001|Overall Study|Did not return post-randomization|3|||
161984342|NCT03329196|584991824|FG000|Overall Study|Adverse Event|10|||
161984343|NCT03329196|584991825|FG001|Overall Study|Adverse Event|5|||
161984344|NCT03329196|584991824|FG000|Overall Study|Physician Decision|2|||
161984345|NCT03329196|584991825|FG001|Overall Study|Physician Decision|2|||
161984346|NCT03329196|584991824|FG000|Overall Study|Withdrawal by Subject|11|||
161984347|NCT03329196|584991825|FG001|Overall Study|Withdrawal by Subject|3|||
161984348|NCT03329196|584991824|FG000|Overall Study|Hepatic function abnormalities|0|||
161984349|NCT03329196|584991825|FG001|Overall Study|Hepatic function abnormalities|1|||
161984350|NCT03329196|584991824|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
161984351|NCT03329196|584991825|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
161984352|NCT03329196|584991824|FG000|Overall Study|Difficult to control Hb|2|||
161984353|NCT03329196|584991825|FG001|Overall Study|Difficult to control Hb|3|||
161984354|NCT03329196|584991824|FG000|Overall Study|Dialysis or renal transplant|13|||
161984355|NCT03329196|584991825|FG001|Overall Study|Dialysis or renal transplant|15|||
161984356|NCT04481750|584991829|FG000|Period 1 (Fasted)|Adverse Event|0|||
161984357|NCT04481750|584991830|FG001|Period 1 (Fasted)|Adverse Event|0|||
161984358|NCT04481750|584991831|FG002|Period 1 (Fasted)|Adverse Event|1|||
161984359|NCT04481750|584991832|FG003|Period 1 (Fasted)|Adverse Event|0|||
161984360|NCT04481750|584991833|FG004|Period 1 (Fasted)|Adverse Event|0|||
161984361|NCT04481750|584991834|FG005|Period 1 (Fasted)|Adverse Event|0|||
161984362|NCT04481750|584991835|FG006|Period 1 (Fasted)|Adverse Event|0|||
161984363|NCT04481750|584991836|FG007|Period 1 (Fasted)|Adverse Event|0|||
161984364|NCT04481750|584991837|FG008|Period 1 (Fasted)|Adverse Event|0|||
161984365|NCT04481750|584991838|FG009|Period 1 (Fasted)|Adverse Event|0|||
161984366|NCT04481750|584991839|FG010|Period 1 (Fasted)|Adverse Event|0|||
161984367|NCT03176771|584991840|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
161984368|NCT03176771|584991841|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
161984369|NCT03176771|584991842|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
161984370|NCT03176771|584991843|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
161984371|NCT03176771|584991844|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
161984372|NCT03176771|584991840|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
161984373|NCT03176771|584991841|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
161984374|NCT03176771|584991842|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
161984375|NCT03176771|584991843|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
161984376|NCT03176771|584991844|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
161984377|NCT03176771|584991840|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
161984378|NCT03176771|584991841|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
162035110|NCT01423604|585184852|FG001|Randomized|Death|0|||
162035111|NCT01423604|585184851|FG000|Randomized|Physician Decision|16|||
162035112|NCT01423604|585184852|FG001|Randomized|Physician Decision|13|||
162035113|NCT01423604|585184851|FG000|Randomized|Other - unspecified|37|||
162035114|NCT01423604|585184852|FG001|Randomized|Other - unspecified|31|||
162035115|NCT01423604|585184851|FG000|Randomized|Patient decision|5|||
161775316|NCT03426995|584219438|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
161984379|NCT03176771|584991842|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
161984380|NCT03176771|584991843|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
161984381|NCT03176771|584991844|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
161984382|NCT03176771|584991840|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
161984383|NCT03176771|584991841|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
161984384|NCT03176771|584991842|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
161984385|NCT03176771|584991843|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
161984386|NCT03176771|584991844|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
162035116|NCT01423604|585184852|FG001|Randomized|Patient decision|9|||
161984387|NCT03176771|584991840|FG000|Double-Blind Extension Period|Adverse Event|0|||
161984388|NCT03176771|584991841|FG001|Double-Blind Extension Period|Adverse Event|0|||
161984389|NCT03176771|584991842|FG002|Double-Blind Extension Period|Adverse Event|0|||
161984390|NCT03176771|584991843|FG003|Double-Blind Extension Period|Adverse Event|15|||
161984391|NCT03176771|584991844|FG004|Double-Blind Extension Period|Adverse Event|18|||
161984392|NCT03176771|584991840|FG000|Double-Blind Extension Period|Death|0|||
161984393|NCT03176771|584991841|FG001|Double-Blind Extension Period|Death|0|||
161984394|NCT03176771|584991842|FG002|Double-Blind Extension Period|Death|0|||
161984395|NCT03176771|584991843|FG003|Double-Blind Extension Period|Death|3|||
161984396|NCT03176771|584991844|FG004|Double-Blind Extension Period|Death|4|||
161984397|NCT03176771|584991840|FG000|Double-Blind Extension Period|Physician Decision|0|||
161984398|NCT03176771|584991841|FG001|Double-Blind Extension Period|Physician Decision|0|||
161984399|NCT03176771|584991842|FG002|Double-Blind Extension Period|Physician Decision|0|||
161984400|NCT03176771|584991843|FG003|Double-Blind Extension Period|Physician Decision|3|||
161984401|NCT03176771|584991844|FG004|Double-Blind Extension Period|Physician Decision|1|||
161984402|NCT03176771|584991840|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
161984403|NCT03176771|584991841|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
161984404|NCT03176771|584991842|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
161984405|NCT03176771|584991843|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
161984406|NCT03176771|584991844|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
161984407|NCT03439137|584991845|FG000|Overall Study|Adverse Event|16|||
161984408|NCT03439137|584991846|FG001|Overall Study|Adverse Event|12|||
161984409|NCT03439137|584991845|FG000|Overall Study|Physician Decision|0|||
161984410|NCT03439137|584991846|FG001|Overall Study|Physician Decision|5|||
161984411|NCT03439137|584991845|FG000|Overall Study|Withdrawal by Subject|14|||
161984412|NCT03439137|584991846|FG001|Overall Study|Withdrawal by Subject|4|||
161984413|NCT03439137|584991845|FG000|Overall Study|Conducting rescue therapy|2|||
161984414|NCT03439137|584991846|FG001|Overall Study|Conducting rescue therapy|1|||
161984415|NCT03439137|584991845|FG000|Overall Study|Difficult to control Hb|10|||
161984416|NCT03439137|584991846|FG001|Overall Study|Difficult to control Hb|2|||
161984417|NCT03439137|584991845|FG000|Overall Study|Initiation of a renal transplant|0|||
161984418|NCT03439137|584991846|FG001|Overall Study|Initiation of a renal transplant|2|||
161984419|NCT00691028|584991847|FG000|Open-label Period|Adverse Event|0|||
161984420|NCT00691028|584991848|FG001|Open-label Period|Adverse Event|0|||
161984421|NCT00691028|584991849|FG002|Open-label Period|Adverse Event|0|||
161984422|NCT00691028|584991850|FG003|Open-label Period|Adverse Event|16|||
161984423|NCT00691028|584991847|FG000|Open-label Period|Withdrawal by Subject|0|||
161984424|NCT00691028|584991848|FG001|Open-label Period|Withdrawal by Subject|0|||
161984425|NCT00691028|584991849|FG002|Open-label Period|Withdrawal by Subject|0|||
161984426|NCT00691028|584991850|FG003|Open-label Period|Withdrawal by Subject|3|||
161984427|NCT00691028|584991847|FG000|Open-label Period|not come to a hospital|0|||
161984428|NCT00691028|584991848|FG001|Open-label Period|not come to a hospital|0|||
161984429|NCT00691028|584991849|FG002|Open-label Period|not come to a hospital|0|||
161984430|NCT00691028|584991850|FG003|Open-label Period|not come to a hospital|1|||
161984431|NCT00691028|584991847|FG000|Double-blind Period|Adverse Event|8|||
161984432|NCT00691028|584991848|FG001|Double-blind Period|Adverse Event|9|||
161984433|NCT00691028|584991849|FG002|Double-blind Period|Adverse Event|6|||
161984434|NCT00691028|584991850|FG003|Double-blind Period|Adverse Event|0|||
161984435|NCT00691028|584991847|FG000|Double-blind Period|Lack of Efficacy|4|||
161984436|NCT00691028|584991848|FG001|Double-blind Period|Lack of Efficacy|3|||
161984437|NCT00691028|584991849|FG002|Double-blind Period|Lack of Efficacy|2|||
161984438|NCT00691028|584991850|FG003|Double-blind Period|Lack of Efficacy|0|||
161984439|NCT00691028|584991847|FG000|Double-blind Period|Withdrawal by Subject|1|||
161984440|NCT00691028|584991848|FG001|Double-blind Period|Withdrawal by Subject|0|||
161984441|NCT00691028|584991849|FG002|Double-blind Period|Withdrawal by Subject|1|||
161984442|NCT00691028|584991850|FG003|Double-blind Period|Withdrawal by Subject|0|||
161870398|NCT04015518|584570237|FG003|Overall Study|Prostate carcinoma|0|||
161870399|NCT04015518|584570238|FG004|Overall Study|Prostate carcinoma|0|||
161870400|NCT04015518|584570234|FG000|Overall Study|Could not keep appointments due to work|1|||
161870401|NCT04015518|584570235|FG001|Overall Study|Could not keep appointments due to work|0|||
161870402|NCT04015518|584570236|FG002|Overall Study|Could not keep appointments due to work|0|||
161870403|NCT04015518|584570237|FG003|Overall Study|Could not keep appointments due to work|0|||
161870404|NCT04015518|584570238|FG004|Overall Study|Could not keep appointments due to work|0|||
161870405|NCT00550745|584570239|FG000|Overall Study|Death|20|||
161984443|NCT00691028|584991847|FG000|Double-blind Period|not come to a hospital.|0|||
161984444|NCT00691028|584991848|FG001|Double-blind Period|not come to a hospital.|1|||
161984445|NCT00691028|584991849|FG002|Double-blind Period|not come to a hospital.|0|||
161984446|NCT00691028|584991850|FG003|Double-blind Period|not come to a hospital.|0|||
161984447|NCT03703856|584991853|FG000|Enrolled in study|Withdrawal by Subject|23|||
161984448|NCT03703856|584991853|FG000|Titrated to full dose|Withdrawal by Subject|5|||
161984449|NCT03703856|584991853|FG000|16 week assessment|Withdrawal by Subject|1|||
161984450|NCT03703856|584991853|FG000|24 week assessment|Withdrawal by Subject|1|||
161984451|NCT01596335|584991854|FG000|Overall Study|exacerbation of primary disease|5|||
161984452|NCT01596335|584991855|FG001|Overall Study|exacerbation of primary disease|9|||
161984453|NCT03402386|584991856|FG000|Overall Study|Adverse Event|3|||
161984454|NCT03402386|584991856|FG000|Overall Study|Physician Decision|1|||
161984455|NCT03402386|584991856|FG000|Overall Study|Difficult to control Hb|2|||
161984456|NCT01532570|584991860|FG000|Overall Study|Lack of Efficacy|1|||
161984457|NCT01532570|584991861|FG001|Overall Study|Lack of Efficacy|0|||
161984458|NCT01532570|584991862|FG002|Overall Study|Lack of Efficacy|0|||
161984459|NCT01532570|584991863|FG003|Overall Study|Lack of Efficacy|0|||
161984460|NCT01532570|584991860|FG000|Overall Study|Withdrawal by Subject|0|||
161984461|NCT01532570|584991861|FG001|Overall Study|Withdrawal by Subject|1|||
161984462|NCT01532570|584991862|FG002|Overall Study|Withdrawal by Subject|0|||
161984463|NCT01532570|584991863|FG003|Overall Study|Withdrawal by Subject|0|||
161984464|NCT01585155|584991864|FG000|Overall Study|Adverse Event|1|||
161984465|NCT01585155|584991864|FG000|Overall Study|Lack of Efficacy|2|||
161984466|NCT01585155|584991864|FG000|Overall Study|Worsening ulcerative colitis|2|||
161984467|NCT01192412|584991866|FG000|Overall Study|Lost to Follow-up|2|||
161984468|NCT01192412|584991867|FG001|Overall Study|Lost to Follow-up|1|||
161984469|NCT01192412|584991866|FG000|Overall Study|Withdrawal by Subject|2|||
161984470|NCT01192412|584991867|FG001|Overall Study|Withdrawal by Subject|1|||
161984471|NCT02421588|584991868|FG000|Overall Study|Non-treatment-related AE|8|||
161870406|NCT00550745|584570240|FG001|Overall Study|Death|16|||
161870407|NCT00550745|584570239|FG000|Overall Study|Lost to Follow-up|45|||
161870408|NCT00550745|584570240|FG001|Overall Study|Lost to Follow-up|30|||
161870409|NCT00550745|584570239|FG000|Overall Study|Physician Decision|0|||
161870410|NCT00550745|584570240|FG001|Overall Study|Physician Decision|2|||
161870411|NCT00550745|584570239|FG000|Overall Study|Protocol Violation|4|||
161870412|NCT00550745|584570240|FG001|Overall Study|Protocol Violation|2|||
161870413|NCT00550745|584570239|FG000|Overall Study|Withdrawal by Subject|17|||
161870414|NCT00550745|584570240|FG001|Overall Study|Withdrawal by Subject|10|||
161870415|NCT00550745|584570239|FG000|Overall Study|Screen failure|1|||
161870416|NCT00550745|584570240|FG001|Overall Study|Screen failure|0|||
161870417|NCT00764660|584570241|FG000|Overall Study|Adverse Event|6|||
161870418|NCT00764660|584570242|FG001|Overall Study|Adverse Event|3|||
161870419|NCT00764660|584570241|FG000|Overall Study|Lost to Follow-up|3|||
161870420|NCT00764660|584570242|FG001|Overall Study|Lost to Follow-up|4|||
161870421|NCT00764660|584570241|FG000|Overall Study|Withdrawal by Subject|7|||
161870422|NCT00764660|584570242|FG001|Overall Study|Withdrawal by Subject|3|||
161870423|NCT00764660|584570241|FG000|Overall Study|Noncompliance With Protocol|5|||
161870424|NCT00764660|584570242|FG001|Overall Study|Noncompliance With Protocol|1|||
161870425|NCT00764660|584570241|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
161870426|NCT00764660|584570242|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
161870427|NCT01131455|584570243|FG000|Overall Study|Death of PI|6|||
161870428|NCT01131455|584570244|FG001|Overall Study|Death of PI|4|||
161870429|NCT01131455|584570245|FG002|Overall Study|Death of PI|0|||
161870430|NCT02186873|584571635|FG000|Overall Study|Adverse Event|1|||
161870431|NCT02186873|584571636|FG001|Overall Study|Adverse Event|3|||
161870432|NCT02186873|584571635|FG000|Overall Study|Lack of Efficacy|0|||
161870433|NCT02186873|584571636|FG001|Overall Study|Lack of Efficacy|1|||
161870434|NCT02186873|584571635|FG000|Overall Study|Lost to Follow-up|1|||
161870435|NCT02186873|584571636|FG001|Overall Study|Lost to Follow-up|2|||
161870436|NCT02186873|584571635|FG000|Overall Study|Withdrawal by Subject|7|||
161870437|NCT02186873|584571636|FG001|Overall Study|Withdrawal by Subject|2|||
161870438|NCT03694002|584571637|FG000|Overall Study|Progression|4|||
161870439|NCT03694002|584571638|FG001|Overall Study|Progression|2|||
161870440|NCT03694002|584571637|FG000|Overall Study|Adverse Event|2|||
161870441|NCT03694002|584571638|FG001|Overall Study|Adverse Event|0|||
161870442|NCT03694002|584571637|FG000|Overall Study|Other not protocol specified|1|||
161870443|NCT03694002|584571638|FG001|Overall Study|Other not protocol specified|0|||
161870444|NCT03694002|584571637|FG000|Overall Study|Ineligible|0|||
161870445|NCT03694002|584571638|FG001|Overall Study|Ineligible|1|||
161984472|NCT02421588|584991869|FG001|Overall Study|Non-treatment-related AE|8|||
161984473|NCT02421588|584991868|FG000|Overall Study|Progressive disease|152|||
161984474|NCT02421588|584991869|FG001|Overall Study|Progressive disease|135|||
161870446|NCT03694002|584571637|FG000|Overall Study|Withdrew consent before starting treatment|0|||
161870447|NCT03694002|584571638|FG001|Overall Study|Withdrew consent before starting treatment|3|||
161870448|NCT01760655|584571639|FG000|Overall Study|Death|18|||
161870449|NCT01760655|584571639|FG000|Overall Study|Physician Decision|1|||
161870450|NCT00068393|584571644|FG000|Overall Study|Adverse Event|2|||
161870451|NCT00068393|584571644|FG000|Overall Study|Death|3|||
161870452|NCT00068393|584571644|FG000|Overall Study|Withdrawal by Subject|3|||
161984475|NCT02421588|584991868|FG000|Overall Study|Death|11|||
161984476|NCT02421588|584991869|FG001|Overall Study|Death|3|||
161870453|NCT00068393|584571644|FG000|Overall Study|Alternative treatment|1|||
161870454|NCT00068393|584571644|FG000|Overall Study|Quality of life worsening|1|||
161870455|NCT01399047|584571645|FG000|Overall Study|Withdrawal by Subject|0|||
161984477|NCT02421588|584991868|FG000|Overall Study|Physician Decision|8|||
161870456|NCT01399047|584571646|FG001|Overall Study|Withdrawal by Subject|1|||
161984478|NCT02421588|584991869|FG001|Overall Study|Physician Decision|17|||
161984479|NCT02421588|584991868|FG000|Overall Study|Other reason not specified|3|||
161870457|NCT03300505|584571652|FG000|Overall Study|Death|0|||
161870458|NCT03300505|584571653|FG001|Overall Study|Death|1|||
161870459|NCT03300505|584571654|FG002|Overall Study|Death|0|||
161870460|NCT03300505|584571652|FG000|Overall Study|Withdrawal by Subject|0|||
161870461|NCT03300505|584571653|FG001|Overall Study|Withdrawal by Subject|1|||
161870462|NCT03300505|584571654|FG002|Overall Study|Withdrawal by Subject|1|||
161870463|NCT03300505|584571652|FG000|Overall Study|Sponsor Termination|0|||
161870464|NCT03300505|584571653|FG001|Overall Study|Sponsor Termination|1|||
161870465|NCT03300505|584571654|FG002|Overall Study|Sponsor Termination|0|||
161870466|NCT03300505|584571652|FG000|Overall Study|Adverse Event|0|||
161870467|NCT03300505|584571653|FG001|Overall Study|Adverse Event|0|||
161870468|NCT03300505|584571654|FG002|Overall Study|Adverse Event|2|||
161870469|NCT01108341|584571658|FG000|Overall Study|Death|2|||
161870470|NCT01108341|584571658|FG000|Overall Study|Withdrawal by Subject|1|||
161870471|NCT01108341|584571658|FG000|Overall Study|Lost to Follow-up|1|||
161870472|NCT01108341|584571658|FG000|Overall Study|Other|1|||
161870473|NCT00386360|584571659|FG000|Overall Study|Adverse Event|4|||
161870474|NCT00386360|584571660|FG001|Overall Study|Adverse Event|2|||
161870475|NCT00386360|584571659|FG000|Overall Study|Physician Decision|2|||
161870476|NCT00386360|584571660|FG001|Overall Study|Physician Decision|2|||
161870477|NCT00386360|584571659|FG000|Overall Study|Lost to Follow-up|0|||
161870478|NCT00386360|584571660|FG001|Overall Study|Lost to Follow-up|2|||
161870479|NCT00386360|584571659|FG000|Overall Study|Protocol Violation|0|||
161870480|NCT00386360|584571660|FG001|Overall Study|Protocol Violation|3|||
161870481|NCT00386360|584571659|FG000|Overall Study|Withdrawal by Subject|3|||
161870482|NCT00386360|584571660|FG001|Overall Study|Withdrawal by Subject|6|||
161870483|NCT00386360|584571659|FG000|Overall Study|Did not take any study medication|0|||
161870484|NCT00386360|584571660|FG001|Overall Study|Did not take any study medication|2|||
161870485|NCT01073605|584571665|FG000|Overall Study|Ongoing at Cutoff Date|1|||
161870486|NCT01073605|584571666|FG001|Overall Study|Ongoing at Cutoff Date|1|||
161870487|NCT01073605|584571667|FG002|Overall Study|Ongoing at Cutoff Date|0|||
161870488|NCT01073605|584571665|FG000|Overall Study|Adverse Event|2|||
161870489|NCT01073605|584571666|FG001|Overall Study|Adverse Event|1|||
161870490|NCT01073605|584571667|FG002|Overall Study|Adverse Event|0|||
161870491|NCT01073605|584571665|FG000|Overall Study|Lost to Follow-up|3|||
161870492|NCT01073605|584571666|FG001|Overall Study|Lost to Follow-up|4|||
161870493|NCT01073605|584571667|FG002|Overall Study|Lost to Follow-up|9|||
161870494|NCT01073605|584571665|FG000|Overall Study|Other|25|||
161870495|NCT01073605|584571666|FG001|Overall Study|Other|21|||
161870496|NCT01073605|584571667|FG002|Overall Study|Other|29|||
161870497|NCT01073605|584571665|FG000|Overall Study|Withdrawal by Subject|31|||
161870498|NCT01073605|584571666|FG001|Overall Study|Withdrawal by Subject|39|||
161870499|NCT01073605|584571667|FG002|Overall Study|Withdrawal by Subject|22|||
161870500|NCT01073605|584571665|FG000|Overall Study|Randomized But Not Treated|0|||
161870501|NCT01073605|584571666|FG001|Overall Study|Randomized But Not Treated|1|||
161870502|NCT01073605|584571667|FG002|Overall Study|Randomized But Not Treated|1|||
161870503|NCT03491462|584571668|FG000|Overall Study|Lost to Follow-up|2|||
161870504|NCT03491462|584571669|FG001|Overall Study|Lost to Follow-up|0|||
161870505|NCT03491462|584571668|FG000|Overall Study|Adverse Event|11|||
161870506|NCT03491462|584571669|FG001|Overall Study|Adverse Event|1|||
161870507|NCT03491462|584571668|FG000|Overall Study|Physician Decision|3|||
161870508|NCT03491462|584571669|FG001|Overall Study|Physician Decision|0|||
161870509|NCT03491462|584571668|FG000|Overall Study|Withdrawal by Subject|22|||
161870510|NCT03491462|584571669|FG001|Overall Study|Withdrawal by Subject|15|||
161870511|NCT03018080|584571670|FG000|Overall Study|Death|12|||
161870512|NCT03018080|584571671|FG001|Overall Study|Death|19|||
161870513|NCT00740792|584571672|FG000|Overall Study|Adverse Event|3|||
161870514|NCT00740792|584571673|FG001|Overall Study|Adverse Event|1|||
161870515|NCT00740792|584571674|FG002|Overall Study|Adverse Event|1|||
161870516|NCT00740792|584571675|FG003|Overall Study|Adverse Event|3|||
161870517|NCT00740792|584571672|FG000|Overall Study|Lack of Efficacy|1|||
161870518|NCT00740792|584571673|FG001|Overall Study|Lack of Efficacy|1|||
161870519|NCT00740792|584571674|FG002|Overall Study|Lack of Efficacy|0|||
161870520|NCT00740792|584571675|FG003|Overall Study|Lack of Efficacy|3|||
161870521|NCT00740792|584571672|FG000|Overall Study|Lost to Follow-up|2|||
161870522|NCT00740792|584571673|FG001|Overall Study|Lost to Follow-up|1|||
161870523|NCT00740792|584571674|FG002|Overall Study|Lost to Follow-up|0|||
161870524|NCT00740792|584571675|FG003|Overall Study|Lost to Follow-up|0|||
161870525|NCT00740792|584571672|FG000|Overall Study|Protocol Violation|0|||
161870526|NCT00740792|584571673|FG001|Overall Study|Protocol Violation|1|||
161870527|NCT00740792|584571674|FG002|Overall Study|Protocol Violation|0|||
161870528|NCT00740792|584571675|FG003|Overall Study|Protocol Violation|2|||
161870529|NCT00740792|584571672|FG000|Overall Study|Withdrawal by Subject|1|||
161870530|NCT00740792|584571673|FG001|Overall Study|Withdrawal by Subject|1|||
161870531|NCT00740792|584571674|FG002|Overall Study|Withdrawal by Subject|0|||
161870532|NCT00740792|584571675|FG003|Overall Study|Withdrawal by Subject|0|||
161870533|NCT00740792|584571672|FG000|Overall Study|administrative|3|||
161870534|NCT00740792|584571673|FG001|Overall Study|administrative|3|||
161870535|NCT00740792|584571674|FG002|Overall Study|administrative|8|||
161870536|NCT00740792|584571675|FG003|Overall Study|administrative|2|||
161984480|NCT02421588|584991869|FG001|Overall Study|Other reason not specified|1|||
161984481|NCT02421588|584991868|FG000|Overall Study|Symptomatic deterioration|13|||
161984482|NCT02421588|584991869|FG001|Overall Study|Symptomatic deterioration|19|||
161984483|NCT02421588|584991868|FG000|Overall Study|Treatment-related AE|10|||
161984484|NCT02421588|584991869|FG001|Overall Study|Treatment-related AE|14|||
161984485|NCT02421588|584991868|FG000|Overall Study|Withdrawal by Subject|14|||
161984486|NCT02421588|584991869|FG001|Overall Study|Withdrawal by Subject|16|||
161984487|NCT02421588|584991868|FG000|Overall Study|Not treated|2|||
161984488|NCT02421588|584991869|FG001|Overall Study|Not treated|8|||
161984489|NCT04254913|584991872|FG000|Overall Study|Adverse Event|1|||
161984490|NCT01004952|584991873|FG000|Overall Study|Lost to Follow-up|0|||
161984491|NCT01004952|584991874|FG001|Overall Study|Lost to Follow-up|11|||
161984492|NCT01004952|584991873|FG000|Overall Study|Withdrawal by Subject|0|||
161984493|NCT01004952|584991874|FG001|Overall Study|Withdrawal by Subject|5|||
161984494|NCT01359943|584991875|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
161984495|NCT01359943|584991876|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
161984496|NCT01359943|584991877|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
161984497|NCT01359943|584991875|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
161984498|NCT01359943|584991876|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
161984499|NCT01359943|584991877|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
161984500|NCT01359943|584991875|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
161984501|NCT01359943|584991876|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
161984502|NCT01359943|584991877|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
161984503|NCT01359943|584991875|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
161984504|NCT01359943|584991876|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
161984505|NCT01359943|584991877|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
161984506|NCT01359943|584991875|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
161984507|NCT01359943|584991876|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
161984508|NCT01359943|584991877|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
161984509|NCT01359943|584991875|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
161984510|NCT01359943|584991876|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
161984511|NCT01359943|584991877|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
161984512|NCT01359943|584991875|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
161984513|NCT01359943|584991876|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
161984514|NCT01359943|584991877|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
161984515|NCT01359943|584991875|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
161870537|NCT00026494|584571678|FG000|Overall Study|Withdrawal by Subject|1|||
161870538|NCT00026494|584571679|FG001|Overall Study|Withdrawal by Subject|0|||
161870539|NCT00026494|584571680|FG002|Overall Study|Withdrawal by Subject|1|||
161870540|NCT00026494|584571681|FG003|Overall Study|Withdrawal by Subject|0|||
161870541|NCT00026494|584571678|FG000|Overall Study|Patient non-compliance|1|||
161870542|NCT00026494|584571679|FG001|Overall Study|Patient non-compliance|0|||
161870543|NCT00026494|584571680|FG002|Overall Study|Patient non-compliance|0|||
161870544|NCT00026494|584571681|FG003|Overall Study|Patient non-compliance|0|||
161870545|NCT00026494|584571678|FG000|Overall Study|Patient not treated|0|||
161870546|NCT00026494|584571679|FG001|Overall Study|Patient not treated|0|||
161870547|NCT00026494|584571680|FG002|Overall Study|Patient not treated|2|||
161870548|NCT00026494|584571681|FG003|Overall Study|Patient not treated|0|||
161870549|NCT00026494|584571678|FG000|Overall Study|Clinical progression|0|||
161870550|NCT00026494|584571679|FG001|Overall Study|Clinical progression|0|||
161870551|NCT00026494|584571680|FG002|Overall Study|Clinical progression|3|||
161870552|NCT00026494|584571681|FG003|Overall Study|Clinical progression|0|||
161870553|NCT01455597|584571682|FG000|Overall Study|Adverse Event|7|||
161870554|NCT01455597|584571683|FG001|Overall Study|Adverse Event|0|||
161870555|NCT01455597|584571684|FG002|Overall Study|Adverse Event|5|||
161870556|NCT01455597|584571685|FG003|Overall Study|Adverse Event|1|||
161870557|NCT01455597|584571682|FG000|Overall Study|Lack of Efficacy|0|||
161870558|NCT01455597|584571683|FG001|Overall Study|Lack of Efficacy|1|||
161870559|NCT01455597|584571684|FG002|Overall Study|Lack of Efficacy|2|||
161870560|NCT01455597|584571685|FG003|Overall Study|Lack of Efficacy|0|||
161870561|NCT01455597|584571682|FG000|Overall Study|Lost to Follow-up|3|||
161870562|NCT01455597|584571683|FG001|Overall Study|Lost to Follow-up|0|||
161870563|NCT01455597|584571684|FG002|Overall Study|Lost to Follow-up|2|||
161870564|NCT01455597|584571685|FG003|Overall Study|Lost to Follow-up|1|||
161870565|NCT01455597|584571682|FG000|Overall Study|Withdrew Consent|6|||
161870566|NCT01455597|584571683|FG001|Overall Study|Withdrew Consent|5|||
161870567|NCT01455597|584571684|FG002|Overall Study|Withdrew Consent|8|||
161870568|NCT01455597|584571685|FG003|Overall Study|Withdrew Consent|5|||
161870569|NCT01455597|584571682|FG000|Overall Study|Reason not Specified|1|||
161870570|NCT01455597|584571683|FG001|Overall Study|Reason not Specified|2|||
161870571|NCT01455597|584571684|FG002|Overall Study|Reason not Specified|3|||
161870572|NCT01455597|584571685|FG003|Overall Study|Reason not Specified|3|||
161984516|NCT01359943|584991876|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
161984517|NCT01359943|584991877|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
161870573|NCT03412734|584571689|FG000|Overall Study|Incorrect labeling of samples|2|||
161870574|NCT03412734|584571690|FG001|Overall Study|Incorrect labeling of samples|0|||
161870575|NCT03412734|584571689|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
161870576|NCT03412734|584571690|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
161870577|NCT00423332|584571691|FG000|Overall Study|Adverse Event|6|||
161870578|NCT00423332|584571692|FG001|Overall Study|Adverse Event|2|||
161870579|NCT00423332|584571691|FG000|Overall Study|Withdrawal by Subject|1|||
161870580|NCT00423332|584571692|FG001|Overall Study|Withdrawal by Subject|0|||
161870581|NCT00423332|584571691|FG000|Overall Study|Condition under investigation worsened|1|||
161870582|NCT00423332|584571692|FG001|Overall Study|Condition under investigation worsened|1|||
161870583|NCT00423332|584571691|FG000|Overall Study|Progressive at Week 6|0|||
161870584|NCT00423332|584571692|FG001|Overall Study|Progressive at Week 6|1|||
161870585|NCT00423332|584571691|FG000|Overall Study|Unblinded before 12 weeks|1|||
161870586|NCT00423332|584571692|FG001|Overall Study|Unblinded before 12 weeks|3|||
161870587|NCT00179660|584571701|FG000|Overall Study|Adverse Event|7|||
161870588|NCT00179660|584571701|FG000|Overall Study|Lack of therapeutic effect|28|||
161870589|NCT00179660|584571701|FG000|Overall Study|Withdrawal by Subject|2|||
161870590|NCT00179660|584571701|FG000|Overall Study|Lost to Follow-up|1|||
161870591|NCT00179660|584571701|FG000|Overall Study|Death|3|||
161870592|NCT00179660|584571701|FG000|Overall Study|Other - Unspecified|9|||
161870593|NCT03777436|584571702|FG000|Placebo-controlled Phase|Adverse Event|8|||
161870594|NCT03777436|584571703|FG001|Placebo-controlled Phase|Adverse Event|10|||
161870595|NCT03777436|584571704|FG002|Placebo-controlled Phase|Adverse Event|0|||
161870596|NCT03777436|584571702|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
161870597|NCT03777436|584571703|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
161870598|NCT03777436|584571704|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
161870599|NCT03777436|584571702|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
161870600|NCT03777436|584571703|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
161870601|NCT03777436|584571704|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
161870602|NCT03777436|584571702|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
161870603|NCT03777436|584571703|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
161870604|NCT03777436|584571704|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
161870605|NCT03777436|584571702|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
161870606|NCT03777436|584571703|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
161870607|NCT03777436|584571704|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
161870608|NCT03777436|584571702|FG000|Placebo-controlled Phase|Physician Decision|0|||
161870609|NCT03777436|584571703|FG001|Placebo-controlled Phase|Physician Decision|1|||
161870610|NCT03777436|584571704|FG002|Placebo-controlled Phase|Physician Decision|0|||
161870611|NCT03777436|584571702|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
161870612|NCT03777436|584571703|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
161870613|NCT03777436|584571704|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
161870614|NCT03777436|584571702|FG000|Apremilast Extension Phase|Adverse Event|0|||
161870615|NCT03777436|584571703|FG001|Apremilast Extension Phase|Adverse Event|0|||
161870616|NCT03777436|584571704|FG002|Apremilast Extension Phase|Adverse Event|6|||
161870617|NCT03777436|584571702|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
161870618|NCT03777436|584571703|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
161870619|NCT03777436|584571704|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
161870620|NCT03777436|584571702|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
161870621|NCT03777436|584571703|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
161870622|NCT03777436|584571704|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
161870623|NCT03777436|584571702|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
161870624|NCT03777436|584571703|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
161870625|NCT03777436|584571704|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
161870626|NCT03777436|584571702|FG000|Apremilast Extension Phase|Miscellaneous|0|||
161870627|NCT03777436|584571703|FG001|Apremilast Extension Phase|Miscellaneous|0|||
161870628|NCT03777436|584571704|FG002|Apremilast Extension Phase|Miscellaneous|1|||
161870629|NCT02035202|584571705|FG000|Overall Study|Lost to Follow-up|8|||
161870630|NCT02035202|584571706|FG001|Overall Study|Lost to Follow-up|16|||
161870631|NCT02035202|584571707|FG002|Overall Study|Lost to Follow-up|2|||
161870632|NCT00685399|584571709|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161870633|NCT00685399|584571710|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161870634|NCT00685399|584571711|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161984518|NCT01359943|584991875|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
161984519|NCT01359943|584991876|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
161870635|NCT00685399|584571712|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161870636|NCT00685399|584571713|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161870637|NCT00685399|584571714|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161870638|NCT00685399|584571715|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161870639|NCT00685399|584571716|FG007|Treatment Period 1|Withdrawal by Subject|0|||
161870640|NCT00685399|584571709|FG000|Treatment Period 1|Protocol Violation|1|||
161870641|NCT00685399|584571710|FG001|Treatment Period 1|Protocol Violation|0|||
161984520|NCT01359943|584991877|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
161984521|NCT01359943|584991875|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
161984522|NCT01359943|584991876|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
161984523|NCT01359943|584991877|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
161984524|NCT01359943|584991875|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
161984525|NCT01359943|584991876|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
161984526|NCT01359943|584991877|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
161984527|NCT01359943|584991875|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
161984528|NCT01359943|584991876|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
161984529|NCT01359943|584991877|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
161984530|NCT01359943|584991875|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
161984531|NCT01359943|584991876|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
161984532|NCT01359943|584991877|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
161984533|NCT01359943|584991875|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
161984534|NCT01359943|584991876|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
161984535|NCT01359943|584991877|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
161984536|NCT01359943|584991875|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
161984537|NCT01359943|584991876|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
161984538|NCT01359943|584991877|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
161984539|NCT01529034|584991878|FG000|Overall Study|Discontinued prior to study treatment|14|||
161984540|NCT01529034|584991878|FG000|Overall Study|Site closure|62|||
161984541|NCT01529034|584991878|FG000|Overall Study|Study termination|29|||
161984542|NCT01529034|584991878|FG000|Overall Study|Withdrawal by Subject|25|||
161984543|NCT01529034|584991878|FG000|Overall Study|No treated SCs within protocol window|13|||
161984544|NCT01529034|584991878|FG000|Overall Study|Noncompliance|8|||
161984545|NCT01529034|584991878|FG000|Overall Study|Caregiver no longer available|7|||
161984546|NCT01529034|584991878|FG000|Overall Study|Adverse Event|4|||
161984547|NCT01529034|584991878|FG000|Overall Study|Protocol Violation|4|||
161984548|NCT01529034|584991878|FG000|Overall Study|Lack of Efficacy|4|||
161984549|NCT01529034|584991878|FG000|Overall Study|Investigator no longer available|2|||
161984550|NCT01529034|584991878|FG000|Overall Study|Study drug not available|2|||
161984551|NCT02911142|584991881|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
161984552|NCT02911142|584991881|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
161984553|NCT02911142|584991881|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
161984554|NCT02911142|584991881|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
161984555|NCT03436693|584991882|FG000|Overall Study|Adverse Event|22|||
161984556|NCT03436693|584991883|FG001|Overall Study|Adverse Event|10|||
161984557|NCT03436693|584991882|FG000|Overall Study|Physician Decision|3|||
161984558|NCT03436693|584991883|FG001|Overall Study|Physician Decision|3|||
161984559|NCT03436693|584991882|FG000|Overall Study|Withdrawal by Subject|4|||
161984560|NCT03436693|584991883|FG001|Overall Study|Withdrawal by Subject|13|||
161984561|NCT03436693|584991882|FG000|Overall Study|Progressive Disease|1|||
161984562|NCT03436693|584991883|FG001|Overall Study|Progressive Disease|1|||
161984563|NCT04481789|584991884|FG000|Period 1|Withdrawal by Subject|1|||
161984564|NCT04481789|584991885|FG001|Period 1|Withdrawal by Subject|0|||
161984565|NCT04481789|584991886|FG002|Period 1|Withdrawal by Subject|0|||
161984566|NCT04481789|584991887|FG003|Period 1|Withdrawal by Subject|0|||
161984567|NCT04481789|584991888|FG004|Period 1|Withdrawal by Subject|0|||
161984568|NCT04481789|584991889|FG005|Period 1|Withdrawal by Subject|0|||
161984569|NCT05216224|584991890|FG000|Overall Study|Adverse Event|6|||
161984570|NCT05216224|584991891|FG001|Overall Study|Adverse Event|3|||
161984571|NCT05216224|584991890|FG000|Overall Study|Lack of Efficacy|1|||
161984572|NCT05216224|584991891|FG001|Overall Study|Lack of Efficacy|0|||
161984573|NCT05216224|584991890|FG000|Overall Study|Lost to Follow-up|8|||
161984574|NCT05216224|584991891|FG001|Overall Study|Lost to Follow-up|6|||
161984575|NCT05216224|584991890|FG000|Overall Study|Protocol Violation|1|||
161984576|NCT05216224|584991891|FG001|Overall Study|Protocol Violation|1|||
161984577|NCT05216224|584991890|FG000|Overall Study|Withdrawal by Subject|6|||
161984578|NCT05216224|584991891|FG001|Overall Study|Withdrawal by Subject|5|||
161984579|NCT05216224|584991890|FG000|Overall Study|Other than specified|1|||
161984580|NCT05216224|584991891|FG001|Overall Study|Other than specified|0|||
161984581|NCT03245008|584991892|FG000|Overall Study|Adverse Event|15|||
161984582|NCT03245008|584991893|FG001|Overall Study|Adverse Event|18|||
161984583|NCT03245008|584991894|FG002|Overall Study|Adverse Event|15|||
161984584|NCT03245008|584991895|FG003|Overall Study|Adverse Event|0|||
161984585|NCT03245008|584991896|FG004|Overall Study|Adverse Event|1|||
161984586|NCT03245008|584991892|FG000|Overall Study|Lack of Efficacy|0|||
161984587|NCT03245008|584991893|FG001|Overall Study|Lack of Efficacy|1|||
161984588|NCT03245008|584991894|FG002|Overall Study|Lack of Efficacy|0|||
161984589|NCT03245008|584991895|FG003|Overall Study|Lack of Efficacy|0|||
161984590|NCT03245008|584991896|FG004|Overall Study|Lack of Efficacy|0|||
161984591|NCT03245008|584991892|FG000|Overall Study|Lost to Follow-up|4|||
161984592|NCT03245008|584991893|FG001|Overall Study|Lost to Follow-up|1|||
161984593|NCT03245008|584991894|FG002|Overall Study|Lost to Follow-up|0|||
161984594|NCT03245008|584991895|FG003|Overall Study|Lost to Follow-up|0|||
161984595|NCT03245008|584991896|FG004|Overall Study|Lost to Follow-up|1|||
161984596|NCT03245008|584991892|FG000|Overall Study|Physician Decision|1|||
161870642|NCT00685399|584571711|FG002|Treatment Period 1|Protocol Violation|0|||
161870643|NCT00685399|584571712|FG003|Treatment Period 1|Protocol Violation|0|||
161870644|NCT00685399|584571713|FG004|Treatment Period 1|Protocol Violation|0|||
161870645|NCT00685399|584571714|FG005|Treatment Period 1|Protocol Violation|0|||
161870646|NCT00685399|584571715|FG006|Treatment Period 1|Protocol Violation|0|||
161870647|NCT00685399|584571716|FG007|Treatment Period 1|Protocol Violation|0|||
161870648|NCT00685399|584571709|FG000|Treatment Period 1|Administrative|2|||
161870649|NCT00685399|584571710|FG001|Treatment Period 1|Administrative|0|||
161870650|NCT00685399|584571711|FG002|Treatment Period 1|Administrative|0|||
161870651|NCT00685399|584571712|FG003|Treatment Period 1|Administrative|0|||
161870652|NCT00685399|584571713|FG004|Treatment Period 1|Administrative|0|||
161870653|NCT00685399|584571714|FG005|Treatment Period 1|Administrative|0|||
161870654|NCT00685399|584571715|FG006|Treatment Period 1|Administrative|0|||
161870655|NCT00685399|584571716|FG007|Treatment Period 1|Administrative|0|||
161870656|NCT00685399|584571709|FG000|Treatment Period 1|Lack of Efficacy|1|||
161870657|NCT00685399|584571710|FG001|Treatment Period 1|Lack of Efficacy|0|||
161870658|NCT00685399|584571711|FG002|Treatment Period 1|Lack of Efficacy|0|||
161870659|NCT00685399|584571712|FG003|Treatment Period 1|Lack of Efficacy|0|||
161870660|NCT00685399|584571713|FG004|Treatment Period 1|Lack of Efficacy|0|||
161870661|NCT00685399|584571714|FG005|Treatment Period 1|Lack of Efficacy|0|||
161870662|NCT00685399|584571715|FG006|Treatment Period 1|Lack of Efficacy|0|||
161870663|NCT00685399|584571716|FG007|Treatment Period 1|Lack of Efficacy|0|||
161870664|NCT00685399|584571709|FG000|Treatment Period 2|Administrative Problems|0|||
161870665|NCT00685399|584571710|FG001|Treatment Period 2|Administrative Problems|2|||
161870666|NCT00685399|584571711|FG002|Treatment Period 2|Administrative Problems|1|||
161870667|NCT00685399|584571712|FG003|Treatment Period 2|Administrative Problems|0|||
161870668|NCT00685399|584571713|FG004|Treatment Period 2|Administrative Problems|0|||
161870669|NCT00685399|584571714|FG005|Treatment Period 2|Administrative Problems|0|||
161870670|NCT00685399|584571715|FG006|Treatment Period 2|Administrative Problems|0|||
161870671|NCT00685399|584571716|FG007|Treatment Period 2|Administrative Problems|0|||
161870672|NCT00685399|584571709|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161870673|NCT00685399|584571710|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161870674|NCT00685399|584571711|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161870675|NCT00685399|584571712|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161870676|NCT00685399|584571713|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161870677|NCT00685399|584571714|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161870678|NCT00685399|584571715|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161870679|NCT00685399|584571716|FG007|Treatment Period 2|Withdrawal by Subject|2|||
161870680|NCT00685399|584571709|FG000|Treatment Period 2|Adverse Event|0|||
161870681|NCT00685399|584571710|FG001|Treatment Period 2|Adverse Event|0|||
161870682|NCT00685399|584571711|FG002|Treatment Period 2|Adverse Event|0|||
161870683|NCT00685399|584571712|FG003|Treatment Period 2|Adverse Event|0|||
161870684|NCT00685399|584571713|FG004|Treatment Period 2|Adverse Event|0|||
161870685|NCT00685399|584571714|FG005|Treatment Period 2|Adverse Event|1|||
161870686|NCT00685399|584571715|FG006|Treatment Period 2|Adverse Event|0|||
161870687|NCT00685399|584571716|FG007|Treatment Period 2|Adverse Event|0|||
161870688|NCT00685399|584571709|FG000|Treatment Period 2|Lack of Efficacy|0|||
161870689|NCT00685399|584571710|FG001|Treatment Period 2|Lack of Efficacy|10|||
161870690|NCT00685399|584571711|FG002|Treatment Period 2|Lack of Efficacy|2|||
161870691|NCT00685399|584571712|FG003|Treatment Period 2|Lack of Efficacy|0|||
161870692|NCT00685399|584571713|FG004|Treatment Period 2|Lack of Efficacy|0|||
161870693|NCT00685399|584571714|FG005|Treatment Period 2|Lack of Efficacy|1|||
161870694|NCT00685399|584571715|FG006|Treatment Period 2|Lack of Efficacy|0|||
161870695|NCT00685399|584571716|FG007|Treatment Period 2|Lack of Efficacy|0|||
161870696|NCT00685399|584571709|FG000|Extension|Administrative Issues|0|||
161870697|NCT00685399|584571710|FG001|Extension|Administrative Issues|0|||
161870698|NCT00685399|584571711|FG002|Extension|Administrative Issues|0|||
161870699|NCT00685399|584571712|FG003|Extension|Administrative Issues|1|||
161870700|NCT00685399|584571713|FG004|Extension|Administrative Issues|0|||
161870701|NCT00685399|584571714|FG005|Extension|Administrative Issues|0|||
161870702|NCT00685399|584571715|FG006|Extension|Administrative Issues|0|||
161870703|NCT00685399|584571716|FG007|Extension|Administrative Issues|0|||
161870704|NCT00685399|584571709|FG000|Extension|Withdrawal by Subject|0|||
161870705|NCT00685399|584571710|FG001|Extension|Withdrawal by Subject|0|||
161870706|NCT00685399|584571711|FG002|Extension|Withdrawal by Subject|0|||
161870707|NCT00685399|584571712|FG003|Extension|Withdrawal by Subject|1|||
161870708|NCT00685399|584571713|FG004|Extension|Withdrawal by Subject|0|||
161870709|NCT00685399|584571714|FG005|Extension|Withdrawal by Subject|0|||
161870710|NCT00685399|584571715|FG006|Extension|Withdrawal by Subject|0|||
161870711|NCT00685399|584571716|FG007|Extension|Withdrawal by Subject|0|||
161870712|NCT00685399|584571709|FG000|Extension|Protocol Violation|0|||
161870713|NCT00685399|584571710|FG001|Extension|Protocol Violation|0|||
161870714|NCT00685399|584571711|FG002|Extension|Protocol Violation|0|||
161870715|NCT00685399|584571712|FG003|Extension|Protocol Violation|1|||
161870716|NCT00685399|584571713|FG004|Extension|Protocol Violation|0|||
161870717|NCT00685399|584571714|FG005|Extension|Protocol Violation|0|||
161870718|NCT00685399|584571715|FG006|Extension|Protocol Violation|0|||
161870719|NCT00685399|584571716|FG007|Extension|Protocol Violation|0|||
161984597|NCT03245008|584991893|FG001|Overall Study|Physician Decision|3|||
161984598|NCT03245008|584991894|FG002|Overall Study|Physician Decision|4|||
161984599|NCT03245008|584991895|FG003|Overall Study|Physician Decision|0|||
161984600|NCT03245008|584991896|FG004|Overall Study|Physician Decision|0|||
161984601|NCT03245008|584991892|FG000|Overall Study|Protocol Violation|0|||
161984602|NCT03245008|584991893|FG001|Overall Study|Protocol Violation|1|||
161984603|NCT03245008|584991894|FG002|Overall Study|Protocol Violation|0|||
161984604|NCT03245008|584991895|FG003|Overall Study|Protocol Violation|0|||
161984605|NCT03245008|584991896|FG004|Overall Study|Protocol Violation|0|||
161984606|NCT03245008|584991892|FG000|Overall Study|Withdrawal by Subject|20|||
161984607|NCT03245008|584991893|FG001|Overall Study|Withdrawal by Subject|19|||
161984608|NCT03245008|584991894|FG002|Overall Study|Withdrawal by Subject|11|||
161984609|NCT03245008|584991895|FG003|Overall Study|Withdrawal by Subject|0|||
161984610|NCT03245008|584991896|FG004|Overall Study|Withdrawal by Subject|0|||
161984611|NCT03245008|584991892|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
161984612|NCT03245008|584991893|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
161984613|NCT03245008|584991894|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
161984614|NCT03245008|584991895|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
161984615|NCT03245008|584991896|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
161984616|NCT03245008|584991892|FG000|Overall Study|Failure to meet randomization criteria|0|||
161984617|NCT03245008|584991893|FG001|Overall Study|Failure to meet randomization criteria|1|||
161984618|NCT03245008|584991894|FG002|Overall Study|Failure to meet randomization criteria|0|||
161984619|NCT03245008|584991895|FG003|Overall Study|Failure to meet randomization criteria|1|||
161984620|NCT03245008|584991896|FG004|Overall Study|Failure to meet randomization criteria|0|||
161984621|NCT04655144|584991902|FG000|Overall Study|Consumed THC|1|||
161984622|NCT04655144|584991903|FG001|Overall Study|Consumed THC|0|||
161984623|NCT04655144|584991902|FG000|Overall Study|Unilateral embolization|0|||
161984624|NCT04655144|584991903|FG001|Overall Study|Unilateral embolization|1|||
161984625|NCT04317742|584991904|FG000|Overall Study|Lost to Follow-up|57|||
161984626|NCT04317742|584991905|FG001|Overall Study|Lost to Follow-up|59|||
161984627|NCT04317742|584991904|FG000|Overall Study|Pregnancy|1|||
161984628|NCT04317742|584991905|FG001|Overall Study|Pregnancy|1|||
161984629|NCT04317742|584991904|FG000|Overall Study|Withdrawal by Subject|46|||
161984630|NCT04317742|584991905|FG001|Overall Study|Withdrawal by Subject|24|||
161984631|NCT03645863|584991906|FG000|Overall Study|Withdrawal by Subject|1|||
161984632|NCT03645863|584991907|FG001|Overall Study|Withdrawal by Subject|0|||
161984633|NCT03645863|584991908|FG002|Overall Study|Withdrawal by Subject|0|||
161984634|NCT01580670|584991909|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
161984635|NCT01580670|584991909|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
161984636|NCT02220907|584991910|FG000|Overall Study|Adverse Event|7|||
161984637|NCT02220907|584991910|FG000|Overall Study|Physician Decision|1|||
161984638|NCT02220907|584991910|FG000|Overall Study|Withdrawal by Subject|2|||
162048462|NCT01781975|585233335|FG001|Overall Study|Withdrawal by Subject|1|||
161870720|NCT00685399|584571709|FG000|Extension|Lack of Efficacy|0|||
161870721|NCT00685399|584571710|FG001|Extension|Lack of Efficacy|0|||
161870722|NCT00685399|584571711|FG002|Extension|Lack of Efficacy|0|||
161870723|NCT00685399|584571712|FG003|Extension|Lack of Efficacy|2|||
161870724|NCT00685399|584571713|FG004|Extension|Lack of Efficacy|0|||
161870725|NCT00685399|584571714|FG005|Extension|Lack of Efficacy|0|||
161870726|NCT00685399|584571715|FG006|Extension|Lack of Efficacy|0|||
161870727|NCT00685399|584571716|FG007|Extension|Lack of Efficacy|0|||
161870728|NCT00685399|584571709|FG000|Extension|Adverse Event|0|||
161870729|NCT00685399|584571710|FG001|Extension|Adverse Event|0|||
161870730|NCT00685399|584571711|FG002|Extension|Adverse Event|0|||
161870731|NCT00685399|584571712|FG003|Extension|Adverse Event|2|||
161870732|NCT00685399|584571713|FG004|Extension|Adverse Event|0|||
161870733|NCT00685399|584571714|FG005|Extension|Adverse Event|0|||
161870734|NCT00685399|584571715|FG006|Extension|Adverse Event|0|||
161870735|NCT00685399|584571716|FG007|Extension|Adverse Event|0|||
161870736|NCT04478695|584571717|FG000|Overall Study|Death|1|||
161870737|NCT04478695|584571718|FG001|Overall Study|Death|0|||
161870738|NCT00644917|584571719|FG000|Overall Study|Withdrawal by Subject|2|||
161870739|NCT01136356|584571720|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
161984639|NCT02220907|584991910|FG000|Overall Study|Conflict with the stopping criteria|1|||
161984640|NCT00542815|584991911|FG000|Overall Study|Adverse Event|19|||
161984641|NCT00542815|584991912|FG001|Overall Study|Adverse Event|6|||
161984642|NCT00542815|584991913|FG002|Overall Study|Adverse Event|9|||
161984643|NCT00542815|584991911|FG000|Overall Study|Death|10|||
161984644|NCT00542815|584991912|FG001|Overall Study|Death|7|||
161870740|NCT01136356|584571721|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
161870741|NCT01136356|584571720|FG000|First 18-day Withdrawal|Physician Decision|1|||
161870742|NCT01136356|584571721|FG001|First 18-day Withdrawal|Physician Decision|0|||
161870743|NCT01136356|584571720|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
161984645|NCT00542815|584991913|FG002|Overall Study|Death|3|||
161984646|NCT00542815|584991911|FG000|Overall Study|Lack of Efficacy|9|||
161870744|NCT01136356|584571721|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
161870745|NCT00402688|584571722|FG000|Overall Study|Adverse Event|12|||
161984647|NCT00542815|584991912|FG001|Overall Study|Lack of Efficacy|2|||
161984648|NCT00542815|584991913|FG002|Overall Study|Lack of Efficacy|0|||
161984649|NCT00542815|584991911|FG000|Overall Study|Physician Decision|2|||
161984650|NCT00542815|584991912|FG001|Overall Study|Physician Decision|1|||
161984651|NCT00542815|584991913|FG002|Overall Study|Physician Decision|0|||
161984652|NCT00542815|584991911|FG000|Overall Study|Protocol Violation|1|||
161984653|NCT00542815|584991912|FG001|Overall Study|Protocol Violation|1|||
161984654|NCT00542815|584991913|FG002|Overall Study|Protocol Violation|2|||
161984655|NCT00542815|584991911|FG000|Overall Study|Withdrawal by Subject|41|||
161984656|NCT00542815|584991912|FG001|Overall Study|Withdrawal by Subject|5|||
161984657|NCT00542815|584991913|FG002|Overall Study|Withdrawal by Subject|8|||
161984658|NCT00542815|584991911|FG000|Overall Study|Other reasons|24|||
161984659|NCT00542815|584991912|FG001|Overall Study|Other reasons|10|||
161984660|NCT00542815|584991913|FG002|Overall Study|Other reasons|10|||
161984661|NCT02678923|584991914|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
161984662|NCT02678923|584991915|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
161984663|NCT02678923|584991914|FG000|Overall Study|Withdrawal by Subject|3|||
161984664|NCT02678923|584991915|FG001|Overall Study|Withdrawal by Subject|2|||
161984665|NCT02678923|584991914|FG000|Overall Study|Lost to Follow-up|1|||
161984666|NCT02678923|584991915|FG001|Overall Study|Lost to Follow-up|0|||
161984667|NCT02678923|584991914|FG000|Overall Study|Did Not Return for Study Visits|1|||
161984668|NCT02678923|584991915|FG001|Overall Study|Did Not Return for Study Visits|0|||
161984669|NCT03266172|584991916|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
161984670|NCT03266172|584991917|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
161984671|NCT03266172|584991918|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
161984672|NCT03266172|584991916|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
161984673|NCT03266172|584991917|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
161984674|NCT03266172|584991918|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
161984675|NCT03266172|584991916|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
161984676|NCT03266172|584991917|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
161984677|NCT03266172|584991918|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
161984678|NCT03266172|584991916|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
161984679|NCT03266172|584991917|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
161984680|NCT03266172|584991918|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
161984681|NCT03266172|584991916|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
161984682|NCT03266172|584991917|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
161984683|NCT03266172|584991918|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
161984684|NCT03266172|584991916|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
161984685|NCT03266172|584991917|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
161984686|NCT03266172|584991918|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
161984687|NCT01554514|584991919|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
161984688|NCT01554514|584991919|FG000|Overall Study|Physician Decision|1|||
161984689|NCT01374178|584991922|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
161984690|NCT01374178|584991923|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
161870746|NCT00402688|584571723|FG001|Overall Study|Adverse Event|9|||
161870747|NCT00402688|584571724|FG002|Overall Study|Adverse Event|3|||
161870748|NCT00402688|584571722|FG000|Overall Study|Withdrawal by Subject|3|||
161870749|NCT00402688|584571723|FG001|Overall Study|Withdrawal by Subject|1|||
161870750|NCT00402688|584571724|FG002|Overall Study|Withdrawal by Subject|1|||
161870751|NCT00402688|584571722|FG000|Overall Study|Physician Decision|0|||
161870752|NCT00402688|584571723|FG001|Overall Study|Physician Decision|0|||
161870753|NCT00402688|584571724|FG002|Overall Study|Physician Decision|1|||
161870754|NCT00402688|584571722|FG000|Overall Study|Lack of Efficacy|4|||
161984691|NCT01374178|584991922|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
161984692|NCT01374178|584991923|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
161984693|NCT01422824|584991924|FG000|Overall Study|Case record form not evaluated|1|||
161984694|NCT01422824|584991924|FG000|Overall Study|Lost to Follow-up|37|||
161984695|NCT01716104|584991925|FG000|Overall Study|Do not meet inclusion criteria|6|||
161984696|NCT01716104|584991926|FG001|Overall Study|Do not meet inclusion criteria|7|||
161984697|NCT00117793|584991927|FG000|Overall Study|Withdrawal by Subject|12|||
161984698|NCT00470418|584991928|FG000|Overall Study|Withdrawal by Subject|1|||
161984699|NCT00470418|584991929|FG001|Overall Study|Withdrawal by Subject|0|||
161984700|NCT01818492|584991930|FG000|Overall Study|Adverse Event|2|||
161984701|NCT01818492|584991930|FG000|Overall Study|Death|3|||
161984702|NCT01818492|584991930|FG000|Overall Study|Withdrawal by Subject|1|||
161984703|NCT01818492|584991930|FG000|Overall Study|Additional therapy when not allowed PP|4|||
161984704|NCT02438813|584991931|FG000|Overall Study|Patient Decision|59|||
161984705|NCT02438813|584991931|FG000|Overall Study|Patient Lost to Follow-Up|137|||
161984706|NCT02438813|584991931|FG000|Overall Study|Study Ended by Sponsor|80|||
161984707|NCT02438813|584991931|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
161870755|NCT00402688|584571723|FG001|Overall Study|Lack of Efficacy|4|||
161870756|NCT00402688|584571724|FG002|Overall Study|Lack of Efficacy|5|||
161870757|NCT00402688|584571722|FG000|Overall Study|Protocol Violation|1|||
161870758|NCT00402688|584571723|FG001|Overall Study|Protocol Violation|1|||
161870759|NCT00402688|584571724|FG002|Overall Study|Protocol Violation|1|||
161870760|NCT00402688|584571722|FG000|Overall Study|Lost to Follow-up|1|||
161870761|NCT00402688|584571723|FG001|Overall Study|Lost to Follow-up|0|||
161870762|NCT00402688|584571724|FG002|Overall Study|Lost to Follow-up|2|||
161870763|NCT00402688|584571722|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
161870764|NCT00402688|584571723|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
161870765|NCT00402688|584571724|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
161870766|NCT00402688|584571722|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
161870767|NCT00402688|584571723|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
161870768|NCT00402688|584571724|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
161870769|NCT00402688|584571722|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
161870770|NCT00402688|584571723|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
161870771|NCT00402688|584571724|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
161870772|NCT00178685|584571725|FG000|Overall Study|Death|3|||
161870773|NCT00178685|584571726|FG001|Overall Study|Death|3|||
161870774|NCT00178685|584571727|FG002|Overall Study|Death|6|||
161870775|NCT00178685|584571725|FG000|Overall Study|Lost to Follow-up|100|||
161870776|NCT00178685|584571726|FG001|Overall Study|Lost to Follow-up|187|||
161870777|NCT00178685|584571727|FG002|Overall Study|Lost to Follow-up|183|||
161870778|NCT00178685|584571725|FG000|Overall Study|Withdrawal by Subject|8|||
161870779|NCT00178685|584571726|FG001|Overall Study|Withdrawal by Subject|14|||
161870780|NCT00178685|584571727|FG002|Overall Study|Withdrawal by Subject|7|||
161870781|NCT00927862|584571728|FG000|Overall Study|Missing data needed for endpt analyses|27|||
161870782|NCT00927862|584571729|FG001|Overall Study|Missing data needed for endpt analyses|45|||
161870783|NCT00820248|584571730|FG000|Overall Study|No treated|4|||
161870784|NCT00820248|584571731|FG001|Overall Study|No treated|1|||
161870785|NCT04157296|584571741|FG000|Overall Study|Withdrawal by Subject|0|||
161870786|NCT04157296|584571742|FG001|Overall Study|Withdrawal by Subject|1|||
161870787|NCT04157296|584571741|FG000|Overall Study|Did not obtain second fMRI.|0|||
161870788|NCT04157296|584571742|FG001|Overall Study|Did not obtain second fMRI.|1|||
161870789|NCT04157296|584571741|FG000|Overall Study|MRI failed/no second fMRI|0|||
161870790|NCT04157296|584571742|FG001|Overall Study|MRI failed/no second fMRI|1|||
161870791|NCT02088905|584571749|FG000|Overall Study|Withdrawal by Subject|5|||
161870792|NCT02088905|584571750|FG001|Overall Study|Withdrawal by Subject|1|||
161870793|NCT01562782|584571756|FG000|Overall Study|Withdrawal by Subject|3|||
161870794|NCT01562782|584571757|FG001|Overall Study|Withdrawal by Subject|3|||
161870795|NCT01562782|584571756|FG000|Overall Study|screen failure|1|||
161870796|NCT01562782|584571757|FG001|Overall Study|screen failure|2|||
161870797|NCT02308540|584571758|FG000|Overall Study|Lost to Follow-up|0|||
161870798|NCT02308540|584571759|FG001|Overall Study|Lost to Follow-up|0|||
161870799|NCT02308540|584571760|FG002|Overall Study|Lost to Follow-up|0|||
161870800|NCT02308540|584571761|FG003|Overall Study|Lost to Follow-up|0|||
161870801|NCT02308540|584571762|FG004|Overall Study|Lost to Follow-up|0|||
161870802|NCT02308540|584571763|FG005|Overall Study|Lost to Follow-up|1|||
161870803|NCT04109391|584571764|FG000|Overall Study|Adverse Event|2|||
161870804|NCT04109391|584571765|FG001|Overall Study|Adverse Event|2|||
161870805|NCT04109391|584571766|FG002|Overall Study|Adverse Event|0|||
161870806|NCT04109391|584571764|FG000|Overall Study|Withdrawal by Subject|2|||
161870807|NCT04109391|584571765|FG001|Overall Study|Withdrawal by Subject|0|||
161870808|NCT04109391|584571766|FG002|Overall Study|Withdrawal by Subject|0|||
161870809|NCT04109391|584571764|FG000|Overall Study|Pregnancy|1|||
161870810|NCT04109391|584571765|FG001|Overall Study|Pregnancy|0|||
161870811|NCT04109391|584571766|FG002|Overall Study|Pregnancy|0|||
161870812|NCT04109391|584571764|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
161870813|NCT04109391|584571765|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
161870814|NCT04109391|584571766|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
161870815|NCT04109391|584571764|FG000|Overall Study|Lost to Follow-up|0|||
161870816|NCT04109391|584571765|FG001|Overall Study|Lost to Follow-up|0|||
161870817|NCT04109391|584571766|FG002|Overall Study|Lost to Follow-up|1|||
161870818|NCT04109391|584571764|FG000|Overall Study|Lack of Efficacy|2|||
161870819|NCT04109391|584571765|FG001|Overall Study|Lack of Efficacy|2|||
161870820|NCT04109391|584571766|FG002|Overall Study|Lack of Efficacy|3|||
161870821|NCT02649439|584571767|FG000|Overall Study|Switched to alternative treatment|6|||
161870822|NCT02649439|584571768|FG001|Overall Study|Switched to alternative treatment|4|||
161870823|NCT02649439|584571767|FG000|Overall Study|Patient decision|1|||
161870824|NCT02649439|584571768|FG001|Overall Study|Patient decision|0|||
161870825|NCT02649439|584571767|FG000|Overall Study|Patient going out of country|1|||
161870826|NCT02649439|584571768|FG001|Overall Study|Patient going out of country|0|||
161870827|NCT02649439|584571767|FG000|Overall Study|To start finasteride|1|||
161870828|NCT02649439|584571768|FG001|Overall Study|To start finasteride|0|||
161870829|NCT02649439|584571767|FG000|Overall Study|Physician Decision|1|||
161870830|NCT02649439|584571768|FG001|Overall Study|Physician Decision|0|||
161870831|NCT02649439|584571767|FG000|Overall Study|Disease progression on study|12|||
161870832|NCT02649439|584571768|FG001|Overall Study|Disease progression on study|13|||
161870833|NCT02649439|584571767|FG000|Overall Study|Refused further treatment|1|||
161984708|NCT02879578|584991935|FG000|Overall Study|Adverse Event|1|||
161984709|NCT02879578|584991936|FG001|Overall Study|Adverse Event|2|||
161984710|NCT02879578|584991937|FG002|Overall Study|Adverse Event|14|||
161984711|NCT02879578|584991935|FG000|Overall Study|Protocol Violation|0|||
161984712|NCT02879578|584991936|FG001|Overall Study|Protocol Violation|1|||
161984713|NCT02879578|584991937|FG002|Overall Study|Protocol Violation|1|||
161984714|NCT02879578|584991935|FG000|Overall Study|Withdrawal by Subject|8|||
161984715|NCT02879578|584991936|FG001|Overall Study|Withdrawal by Subject|6|||
161984716|NCT02879578|584991937|FG002|Overall Study|Withdrawal by Subject|9|||
161984717|NCT02879578|584991935|FG000|Overall Study|Lost to Follow-up|1|||
161984718|NCT02879578|584991936|FG001|Overall Study|Lost to Follow-up|0|||
161984719|NCT02879578|584991937|FG002|Overall Study|Lost to Follow-up|4|||
161984720|NCT02879578|584991935|FG000|Overall Study|Physician Decision|0|||
161984721|NCT02879578|584991936|FG001|Overall Study|Physician Decision|0|||
161984722|NCT02879578|584991937|FG002|Overall Study|Physician Decision|4|||
161984723|NCT05138419|584992841|FG000|Overall Study|Study terminated before participant completed.|0|||
161984724|NCT05138419|584992842|FG001|Overall Study|Study terminated before participant completed.|0|||
161984725|NCT05138419|584992843|FG002|Overall Study|Study terminated before participant completed.|1|||
161984726|NCT01048853|584992844|FG000|Overall Study|Death|1|||
161984727|NCT01048853|584992845|FG001|Overall Study|Death|0|||
161984728|NCT01048853|584992846|FG002|Overall Study|Death|0|||
161984729|NCT01048853|584992844|FG000|Overall Study|Lost to Follow-up|1|||
161984730|NCT01048853|584992845|FG001|Overall Study|Lost to Follow-up|4|||
161984731|NCT01048853|584992846|FG002|Overall Study|Lost to Follow-up|0|||
161984732|NCT00805766|584992851|FG000|Screening Period|Adverse Event|1|||
161984733|NCT00805766|584992851|FG000|Screening Period|Lack of Efficacy|2|||
161984734|NCT00805766|584992851|FG000|Screening Period|Pregnancy|1|||
161984735|NCT00805766|584992851|FG000|Screening Period|Responder|2|||
161984736|NCT00805766|584992851|FG000|Increased Dose Period|Adverse Event|4|||
161984737|NCT00805766|584992851|FG000|Increased Dose Period|Lack of Efficacy|7|||
161984738|NCT00805766|584992851|FG000|Increased Dose Period|Pregnancy|1|||
161984739|NCT00805766|584992851|FG000|Increased Dose Period|Withdrawal by Subject|1|||
161984740|NCT00971243|584992852|FG000|Double Blind Period|Adverse Event|2|||
161984741|NCT00971243|584992853|FG001|Double Blind Period|Adverse Event|3|||
161984742|NCT00971243|584992854|FG002|Double Blind Period|Adverse Event|2|||
161984743|NCT00971243|584992855|FG003|Double Blind Period|Adverse Event|2|||
161984744|NCT00971243|584992856|FG004|Double Blind Period|Adverse Event|3|||
161984745|NCT00971243|584992852|FG000|Double Blind Period|Lost to Follow-up|0|||
161984746|NCT00971243|584992853|FG001|Double Blind Period|Lost to Follow-up|1|||
161984747|NCT00971243|584992854|FG002|Double Blind Period|Lost to Follow-up|1|||
161984748|NCT00971243|584992855|FG003|Double Blind Period|Lost to Follow-up|0|||
161984749|NCT00971243|584992856|FG004|Double Blind Period|Lost to Follow-up|1|||
161984750|NCT00971243|584992852|FG000|Double Blind Period|Physician Decision|10|||
161984751|NCT00971243|584992853|FG001|Double Blind Period|Physician Decision|6|||
161984752|NCT00971243|584992854|FG002|Double Blind Period|Physician Decision|7|||
161984753|NCT00971243|584992855|FG003|Double Blind Period|Physician Decision|6|||
161984754|NCT00971243|584992856|FG004|Double Blind Period|Physician Decision|7|||
161984755|NCT00971243|584992852|FG000|Double Blind Period|Protocol Violation|2|||
161984756|NCT00971243|584992853|FG001|Double Blind Period|Protocol Violation|0|||
161984757|NCT00971243|584992854|FG002|Double Blind Period|Protocol Violation|3|||
161984758|NCT00971243|584992855|FG003|Double Blind Period|Protocol Violation|2|||
161984759|NCT00971243|584992856|FG004|Double Blind Period|Protocol Violation|2|||
161984760|NCT00971243|584992852|FG000|Double Blind Period|Withdrawal by Subject|4|||
161984761|NCT00971243|584992853|FG001|Double Blind Period|Withdrawal by Subject|1|||
161984762|NCT00971243|584992854|FG002|Double Blind Period|Withdrawal by Subject|4|||
161984763|NCT00971243|584992855|FG003|Double Blind Period|Withdrawal by Subject|4|||
161984764|NCT00971243|584992856|FG004|Double Blind Period|Withdrawal by Subject|4|||
161984765|NCT00971243|584992852|FG000|Double Blind Period|Other reasons|1|||
161984766|NCT00971243|584992853|FG001|Double Blind Period|Other reasons|0|||
161984767|NCT00971243|584992854|FG002|Double Blind Period|Other reasons|2|||
161984768|NCT00971243|584992855|FG003|Double Blind Period|Other reasons|0|||
161984769|NCT00971243|584992856|FG004|Double Blind Period|Other reasons|1|||
161984770|NCT00971243|584992852|FG000|Open-label Period|Adverse Event|1|||
161984771|NCT00971243|584992853|FG001|Open-label Period|Adverse Event|0|||
161984772|NCT00971243|584992854|FG002|Open-label Period|Adverse Event|1|||
161984773|NCT00971243|584992855|FG003|Open-label Period|Adverse Event|1|||
161984774|NCT00971243|584992856|FG004|Open-label Period|Adverse Event|0|||
161984775|NCT00971243|584992852|FG000|Open-label Period|Physician Decision|5|||
161984776|NCT00971243|584992853|FG001|Open-label Period|Physician Decision|9|||
161984777|NCT00971243|584992854|FG002|Open-label Period|Physician Decision|3|||
161984778|NCT00971243|584992855|FG003|Open-label Period|Physician Decision|7|||
161984779|NCT00971243|584992856|FG004|Open-label Period|Physician Decision|2|||
161984780|NCT00971243|584992852|FG000|Open-label Period|Protocol Violation|1|||
161984781|NCT00971243|584992853|FG001|Open-label Period|Protocol Violation|1|||
161984782|NCT00971243|584992854|FG002|Open-label Period|Protocol Violation|1|||
161984783|NCT00971243|584992855|FG003|Open-label Period|Protocol Violation|0|||
161984784|NCT00971243|584992856|FG004|Open-label Period|Protocol Violation|1|||
162048463|NCT01622231|585233336|FG000|Overall Study|Physician Decision|1|||
161984785|NCT00971243|584992852|FG000|Open-label Period|Withdrawal by Subject|1|||
161984786|NCT00971243|584992853|FG001|Open-label Period|Withdrawal by Subject|0|||
161984787|NCT00971243|584992854|FG002|Open-label Period|Withdrawal by Subject|0|||
161984788|NCT00971243|584992855|FG003|Open-label Period|Withdrawal by Subject|2|||
161984789|NCT00971243|584992856|FG004|Open-label Period|Withdrawal by Subject|1|||
161984790|NCT00971243|584992852|FG000|Open-label Period|Other reason|0|||
161984791|NCT00971243|584992853|FG001|Open-label Period|Other reason|0|||
161984792|NCT00971243|584992854|FG002|Open-label Period|Other reason|0|||
161984793|NCT00971243|584992855|FG003|Open-label Period|Other reason|0|||
161984794|NCT00971243|584992856|FG004|Open-label Period|Other reason|2|||
161984795|NCT02354222|584992860|FG000|Overall Study|Adverse Event|0|||
161984796|NCT02354222|584992861|FG001|Overall Study|Adverse Event|3|||
161984797|NCT02354222|584992860|FG000|Overall Study|Physician Decision|1|||
161984798|NCT02354222|584992861|FG001|Overall Study|Physician Decision|1|||
161984799|NCT02354222|584992860|FG000|Overall Study|Pregnancy|1|||
161984800|NCT02354222|584992861|FG001|Overall Study|Pregnancy|0|||
161984801|NCT02354222|584992860|FG000|Overall Study|Withdrawal by Subject|2|||
161984802|NCT02354222|584992861|FG001|Overall Study|Withdrawal by Subject|3|||
161984803|NCT02354222|584992860|FG000|Overall Study|Conflict with the stopping criteria|0|||
161984804|NCT02354222|584992861|FG001|Overall Study|Conflict with the stopping criteria|4|||
161984805|NCT04300218|584992862|FG000|Overall Study|Lost to Follow-up|6|||
161984806|NCT04300218|584992863|FG001|Overall Study|Lost to Follow-up|8|||
161984807|NCT04099511|584992864|FG000|Overall Study|Lost to Follow-up|2|||
161984808|NCT04099511|584992865|FG001|Overall Study|Lost to Follow-up|2|||
161984809|NCT04099511|584992864|FG000|Overall Study|Withdrawal by Subject|8|||
161984810|NCT04099511|584992865|FG001|Overall Study|Withdrawal by Subject|4|||
161984811|NCT06581094|584992868|FG000|Overall Study|Lost to Follow-up|1|||
161984812|NCT06581094|584992869|FG001|Overall Study|Lost to Follow-up|1|||
161984813|NCT05740618|584992870|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|1|||
161984814|NCT05740618|584992870|FG000|Overall Study|Physician Decision|1|||
161984815|NCT04588389|584992871|FG000|Overall Study|Issues with anesthesia during surgery|2|||
161984816|NCT04588389|584992872|FG001|Overall Study|Issues with anesthesia during surgery|0|||
161984817|NCT04588389|584992873|FG002|Overall Study|Issues with anesthesia during surgery|0|||
161984818|NCT02354235|584992877|FG000|Overall Study|Adverse Event|2|||
161984819|NCT02354235|584992878|FG001|Overall Study|Adverse Event|2|||
161984820|NCT02354235|584992877|FG000|Overall Study|Physician Decision|0|||
161984821|NCT02354235|584992878|FG001|Overall Study|Physician Decision|1|||
161984822|NCT02354235|584992877|FG000|Overall Study|Withdrawal by Subject|1|||
161984823|NCT02354235|584992878|FG001|Overall Study|Withdrawal by Subject|3|||
161984824|NCT02354235|584992877|FG000|Overall Study|Conflict with the stopping criteria|0|||
161984825|NCT02354235|584992878|FG001|Overall Study|Conflict with the stopping criteria|1|||
161984826|NCT05451940|584992879|FG000|Treatment Period|Physician Decision|1|||
161984827|NCT06045507|584992883|FG000|Overall Study|Death|0|||
161984828|NCT06045507|584992884|FG001|Overall Study|Death|0|||
161984829|NCT06045507|584992885|FG002|Overall Study|Death|1|||
161984830|NCT06045507|584992886|FG003|Overall Study|Death|0|||
161984831|NCT06045507|584992883|FG000|Overall Study|Lost to Follow-up|3|||
161984832|NCT06045507|584992884|FG001|Overall Study|Lost to Follow-up|3|||
161984833|NCT06045507|584992885|FG002|Overall Study|Lost to Follow-up|0|||
161984834|NCT06045507|584992886|FG003|Overall Study|Lost to Follow-up|0|||
161984835|NCT06045507|584992883|FG000|Overall Study|Randomized by mistake (no study treatment given)|0|||
161984836|NCT06045507|584992884|FG001|Overall Study|Randomized by mistake (no study treatment given)|1|||
161984837|NCT06045507|584992885|FG002|Overall Study|Randomized by mistake (no study treatment given)|1|||
161984838|NCT06045507|584992886|FG003|Overall Study|Randomized by mistake (no study treatment given)|0|||
161984839|NCT06045507|584992883|FG000|Overall Study|Withdrawal by Subject|4|||
161984840|NCT06045507|584992884|FG001|Overall Study|Withdrawal by Subject|1|||
161984841|NCT06045507|584992885|FG002|Overall Study|Withdrawal by Subject|0|||
161984842|NCT06045507|584992886|FG003|Overall Study|Withdrawal by Subject|2|||
161984843|NCT06045507|584992883|FG000|Overall Study|Miscellaneous|2|||
161984844|NCT06045507|584992884|FG001|Overall Study|Miscellaneous|0|||
161984845|NCT06045507|584992885|FG002|Overall Study|Miscellaneous|0|||
161984846|NCT06045507|584992886|FG003|Overall Study|Miscellaneous|1|||
161984847|NCT01966445|584992890|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
161984848|NCT01966445|584992891|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
161984849|NCT01966445|584992892|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
161984850|NCT01966445|584992893|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
161984851|NCT01966445|584992894|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
161984852|NCT01966445|584992895|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
161984853|NCT01966445|584992896|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
161984854|NCT01966445|584992890|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
161984855|NCT01966445|584992891|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
161984856|NCT01966445|584992892|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
161984857|NCT01966445|584992893|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
161984858|NCT01966445|584992894|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
161870834|NCT02649439|584571768|FG001|Overall Study|Refused further treatment|0|||
161870835|NCT02649439|584571767|FG000|Overall Study|Refused further follow up|2|||
161870836|NCT02649439|584571768|FG001|Overall Study|Refused further follow up|7|||
161870837|NCT02649439|584571767|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
161870838|NCT02649439|584571768|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
161870839|NCT02649439|584571767|FG000|Overall Study|No treatment, per protocol|1|||
161870840|NCT02649439|584571768|FG001|Overall Study|No treatment, per protocol|0|||
161870841|NCT02649439|584571767|FG000|Overall Study|PSA DT makes ineligible|0|||
161870842|NCT02649439|584571768|FG001|Overall Study|PSA DT makes ineligible|1|||
161870843|NCT02649439|584571767|FG000|Overall Study|Rising PSA No Mets|0|||
161870844|NCT02649439|584571768|FG001|Overall Study|Rising PSA No Mets|1|||
161870845|NCT02649439|584571767|FG000|Overall Study|Rising PSA|0|||
161870846|NCT02649439|584571768|FG001|Overall Study|Rising PSA|1|||
161870847|NCT02649439|584571767|FG000|Overall Study|Signed follow up protocol|0|||
161870848|NCT02649439|584571768|FG001|Overall Study|Signed follow up protocol|1|||
161870849|NCT02097238|584571769|FG000|Overall Study|Death|1|||
161870850|NCT02097238|584571769|FG000|Overall Study|Physician Decision|1|||
161870851|NCT02097238|584571769|FG000|Overall Study|Progressive Disease|17|||
161870852|NCT01282372|584571780|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
161870853|NCT01282372|584571780|FG000|Overall Study|Lost to Follow-up|23|||
161870854|NCT01282372|584571780|FG000|Overall Study|Withdrawal by Subject|11|||
161870855|NCT01282372|584571780|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
161870856|NCT01282372|584571780|FG000|Overall Study|Death|1|||
161870857|NCT01282372|584571780|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
161870858|NCT01282372|584571780|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
161870859|NCT01282372|584571780|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
161870860|NCT01282372|584571780|FG000|Overall Study|Adverse Event|12|||
161870861|NCT02737930|584571781|FG000|Overall Study|Withdrawal by Subject|0|||
161870862|NCT02737930|584571782|FG001|Overall Study|Withdrawal by Subject|1|||
161870863|NCT04468347|584571787|FG000|Overall Study|Withdrawal by Subject|0|||
161870864|NCT04468347|584571788|FG001|Overall Study|Withdrawal by Subject|1|||
161870865|NCT04468347|584571789|FG002|Overall Study|Withdrawal by Subject|3|||
161870866|NCT04468347|584571790|FG003|Overall Study|Withdrawal by Subject|3|||
161870867|NCT04468347|584571787|FG000|Overall Study|Lost to Follow-up|0|||
161870868|NCT04468347|584571788|FG001|Overall Study|Lost to Follow-up|0|||
161870869|NCT04468347|584571789|FG002|Overall Study|Lost to Follow-up|1|||
161870870|NCT04468347|584571790|FG003|Overall Study|Lost to Follow-up|1|||
161870871|NCT04468347|584571787|FG000|Overall Study|Physician Decision|1|||
161870872|NCT04468347|584571788|FG001|Overall Study|Physician Decision|0|||
161870873|NCT04468347|584571789|FG002|Overall Study|Physician Decision|2|||
161870874|NCT04468347|584571790|FG003|Overall Study|Physician Decision|0|||
161870875|NCT04468347|584571787|FG000|Overall Study|Protocol Violation|1|||
161870876|NCT04468347|584571788|FG001|Overall Study|Protocol Violation|0|||
161870877|NCT04468347|584571789|FG002|Overall Study|Protocol Violation|0|||
161870878|NCT04468347|584571790|FG003|Overall Study|Protocol Violation|0|||
161870879|NCT00994461|584571792|FG000|Overall Study|Adverse Event|2|||
161870880|NCT00994461|584571793|FG001|Overall Study|Adverse Event|1|||
161870881|NCT00994461|584571794|FG002|Overall Study|Adverse Event|0|||
161870882|NCT04339062|584571795|FG000|Overall Study|Death|0|||
161870883|NCT04339062|584571796|FG001|Overall Study|Death|1|||
161870884|NCT05868577|584571797|FG000|Overall Study|Lost to Follow-up|5|||
161870885|NCT05868577|584571798|FG001|Overall Study|Lost to Follow-up|5|||
161870886|NCT02505217|584571799|FG000|Overall Study|Withdrawal by Subject|1|||
161870887|NCT02505217|584571800|FG001|Overall Study|Withdrawal by Subject|2|||
161870888|NCT00615550|584571805|FG000|Overall Study|Lost to Follow-up|6|||
161870889|NCT00615550|584571806|FG001|Overall Study|Lost to Follow-up|1|||
161870890|NCT01408303|584571807|FG000|Overall Study|Adverse Event|3|||
161870891|NCT01408303|584571808|FG001|Overall Study|Adverse Event|7|||
161984859|NCT01966445|584992895|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
161984860|NCT01966445|584992896|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
161984861|NCT01966445|584992890|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
161984862|NCT01966445|584992891|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
161870892|NCT01408303|584571809|FG002|Overall Study|Adverse Event|2|||
161870893|NCT01408303|584571807|FG000|Overall Study|Lost to Follow-up|0|||
161870894|NCT01408303|584571808|FG001|Overall Study|Lost to Follow-up|1|||
161870895|NCT01408303|584571809|FG002|Overall Study|Lost to Follow-up|2|||
161870896|NCT01408303|584571807|FG000|Overall Study|Withdrawal by Subject|2|||
161870897|NCT01408303|584571808|FG001|Overall Study|Withdrawal by Subject|3|||
161870898|NCT01408303|584571809|FG002|Overall Study|Withdrawal by Subject|1|||
161870899|NCT01408303|584571807|FG000|Overall Study|Protocol Violation|0|||
161870900|NCT01408303|584571808|FG001|Overall Study|Protocol Violation|1|||
161984863|NCT01966445|584992892|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
161870901|NCT01408303|584571809|FG002|Overall Study|Protocol Violation|0|||
161870902|NCT01408303|584571807|FG000|Overall Study|Noncompliance|1|||
161870903|NCT01408303|584571808|FG001|Overall Study|Noncompliance|0|||
161870904|NCT01408303|584571809|FG002|Overall Study|Noncompliance|1|||
161984864|NCT01966445|584992893|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
161984865|NCT01966445|584992894|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
161984866|NCT01966445|584992895|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
161984867|NCT01966445|584992896|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
161984868|NCT01966445|584992890|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161984869|NCT01966445|584992891|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161984870|NCT01966445|584992892|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161984871|NCT01966445|584992893|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161984872|NCT01966445|584992894|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161984873|NCT01966445|584992895|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161984874|NCT01966445|584992896|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
161984875|NCT01966445|584992890|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
161984876|NCT01966445|584992891|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
161984877|NCT01966445|584992892|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
161984878|NCT01966445|584992893|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
161984879|NCT01966445|584992894|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
161984880|NCT01966445|584992895|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
161984881|NCT01966445|584992896|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
161984882|NCT00885482|584992901|FG000|Overall Study|Pregnancy|1|||
161984883|NCT00885482|584992901|FG000|Overall Study|Lack of Efficacy|1|||
161984884|NCT00885482|584992901|FG000|Overall Study|Death|1|||
161984885|NCT00885482|584992901|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
161984886|NCT02772978|584992902|FG000|Overall Study|Withdrawal by Subject|1|||
161984887|NCT02772978|584992903|FG001|Overall Study|Withdrawal by Subject|1|||
161984888|NCT00409344|584992904|FG000|Overall Study|no enrollment|0|||
161984889|NCT00409344|584992905|FG001|Overall Study|no enrollment|0|||
161984890|NCT01069705|584992908|FG000|Overall Study|Adverse Event|1|||
161984891|NCT01069705|584992908|FG000|Overall Study|Withdrawal by Subject|2|||
161984892|NCT03624127|584992909|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
161984893|NCT03624127|584992910|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
161984894|NCT03624127|584992911|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
161984895|NCT03624127|584992909|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
161984896|NCT03624127|584992910|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
161984897|NCT03624127|584992911|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
161984898|NCT03624127|584992909|FG000|Treatment Week 0 - Week 16|Death|0|||
161984899|NCT03624127|584992910|FG001|Treatment Week 0 - Week 16|Death|1|||
161984900|NCT03624127|584992911|FG002|Treatment Week 0 - Week 16|Death|0|||
161984901|NCT03624127|584992909|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
161984902|NCT03624127|584992910|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
161984903|NCT03624127|584992911|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
161984904|NCT03624127|584992909|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
161984905|NCT03624127|584992910|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
161984906|NCT03624127|584992911|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
161984907|NCT03624127|584992909|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
161984908|NCT03624127|584992910|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
161984909|NCT03624127|584992911|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
161984910|NCT03624127|584992909|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
161984911|NCT03624127|584992910|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
161984912|NCT03624127|584992911|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
161984913|NCT03624127|584992909|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
161984914|NCT03624127|584992910|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
161984915|NCT03624127|584992911|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
161984916|NCT03624127|584992909|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
161984917|NCT03624127|584992910|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
161984918|NCT03624127|584992911|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
161984919|NCT03624127|584992909|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
161984920|NCT03624127|584992910|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
161984921|NCT03624127|584992911|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
161984922|NCT03624127|584992909|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
161984923|NCT03624127|584992910|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
161984924|NCT03624127|584992911|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
161984925|NCT03624127|584992909|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
161984926|NCT03624127|584992910|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
161984927|NCT03624127|584992911|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
161984928|NCT03624127|584992909|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
161984929|NCT03624127|584992910|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
161984930|NCT03624127|584992911|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
161984931|NCT03624127|584992909|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
161984932|NCT03624127|584992910|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
161870905|NCT02644668|584571810|FG000|Overall Study|Adverse Event|2|||
161870906|NCT02644668|584571811|FG001|Overall Study|Adverse Event|0|||
161870907|NCT02644668|584571812|FG002|Overall Study|Adverse Event|1|||
161870908|NCT02644668|584571810|FG000|Overall Study|Protocol Violation|0|||
161870909|NCT02644668|584571811|FG001|Overall Study|Protocol Violation|0|||
161870910|NCT02644668|584571812|FG002|Overall Study|Protocol Violation|1|||
161870911|NCT02644668|584571810|FG000|Overall Study|Withdrawal by Subject|0|||
161870912|NCT02644668|584571811|FG001|Overall Study|Withdrawal by Subject|0|||
161870913|NCT02644668|584571812|FG002|Overall Study|Withdrawal by Subject|1|||
161870914|NCT05119595|584573606|FG000|Overall Study|Death|1|||
161870915|NCT05119595|584573606|FG000|Overall Study|Lost to Follow-up|7|||
161870916|NCT01806961|584573607|FG000|Overall Study|sponsor decision|16|||
161870917|NCT03056638|584573614|FG000|Overall Study|Death|1|||
161870918|NCT03056638|584573615|FG001|Overall Study|Death|0|||
161870919|NCT02530125|584573616|FG000|Completed Treatment|Early termination of study|1|||
161870920|NCT02530125|584573616|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
161870921|NCT00468481|584573617|FG000|Overall Study|Adverse Event|13|||
161870922|NCT00468481|584573618|FG001|Overall Study|Adverse Event|3|||
161870923|NCT00468481|584573617|FG000|Overall Study|Lost to Follow-up|25|||
161870924|NCT00468481|584573618|FG001|Overall Study|Lost to Follow-up|8|||
161870925|NCT00468481|584573617|FG000|Overall Study|Pregnancy|2|||
161870926|NCT00468481|584573618|FG001|Overall Study|Pregnancy|0|||
161870927|NCT00468481|584573617|FG000|Overall Study|Protocol Violation|18|||
161870928|NCT00468481|584573618|FG001|Overall Study|Protocol Violation|8|||
161870929|NCT00468481|584573617|FG000|Overall Study|Withdrawal by Subject|12|||
161870930|NCT00468481|584573618|FG001|Overall Study|Withdrawal by Subject|3|||
161870931|NCT00468481|584573617|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
161870932|NCT00468481|584573618|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
161870933|NCT00468481|584573617|FG000|Overall Study|Prohibited Medication|1|||
161870934|NCT00468481|584573618|FG001|Overall Study|Prohibited Medication|1|||
161870935|NCT00468481|584573617|FG000|Overall Study|Egg Donor|1|||
161870936|NCT00468481|584573618|FG001|Overall Study|Egg Donor|0|||
161870937|NCT00468481|584573617|FG000|Overall Study|Moved out of area|4|||
161870938|NCT00468481|584573618|FG001|Overall Study|Moved out of area|1|||
161870939|NCT00468481|584573617|FG000|Overall Study|Non-Compliance|5|||
161870940|NCT00468481|584573618|FG001|Overall Study|Non-Compliance|0|||
161870941|NCT00468481|584573617|FG000|Overall Study|Other|6|||
161870942|NCT00468481|584573618|FG001|Overall Study|Other|0|||
161870943|NCT01568034|584573619|FG000|Overall Study|Withdrawal by Subject|1|||
161870944|NCT01568034|584573620|FG001|Overall Study|Withdrawal by Subject|0|||
161870945|NCT01568034|584573621|FG002|Overall Study|Withdrawal by Subject|0|||
161870946|NCT01568034|584573622|FG003|Overall Study|Withdrawal by Subject|0|||
161870947|NCT00728468|584573623|FG000|Overall Study|Enrolled but not treated|1|||
161870948|NCT00728468|584573623|FG000|Overall Study|Death|1|||
161870949|NCT00728468|584573623|FG000|Overall Study|Protocol Violation|4|||
161870950|NCT00728468|584573623|FG000|Overall Study|Objective progression or relapse|9|||
161870951|NCT00728468|584573623|FG000|Overall Study|Study terminated by sponsor|1|||
161870952|NCT00596687|584573624|FG000|Overall Study|< 24 hours of insulin treatment|8|||
161984933|NCT03624127|584992911|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
161984934|NCT03624127|584992909|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
161984935|NCT03624127|584992910|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
161984936|NCT03624127|584992911|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
161984937|NCT03624127|584992909|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
161984938|NCT03624127|584992910|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
161984939|NCT03624127|584992911|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
161984940|NCT03624127|584992909|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
161984941|NCT03624127|584992910|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
161984942|NCT03624127|584992911|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
161984943|NCT03624127|584992909|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
161984944|NCT03624127|584992910|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
161984945|NCT03624127|584992911|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
161984946|NCT03624127|584992909|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
161984947|NCT03624127|584992910|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
161984948|NCT03624127|584992911|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
161984949|NCT03624127|584992909|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
161984950|NCT03624127|584992910|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
161984951|NCT03624127|584992911|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
161984952|NCT03624127|584992909|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
161984953|NCT03624127|584992910|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
161984954|NCT03624127|584992911|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
161870953|NCT00596687|584573625|FG001|Overall Study|< 24 hours of insulin treatment|6|||
161870954|NCT00596687|584573624|FG000|Overall Study|continuous insulin infusion during TPN|2|||
161870955|NCT00596687|584573625|FG001|Overall Study|continuous insulin infusion during TPN|1|||
161870956|NCT00596687|584573624|FG000|Overall Study|Withdrawal by Subject|3|||
161870957|NCT00596687|584573625|FG001|Overall Study|Withdrawal by Subject|1|||
161870958|NCT00596687|584573624|FG000|Overall Study|cancelled surgery|1|||
161870959|NCT00596687|584573625|FG001|Overall Study|cancelled surgery|1|||
161870960|NCT03831113|584573626|FG000|Overall Study|Withdrawal by Subject|0|||
161984955|NCT00666224|584994487|FG000|Double-Blind|Adverse Event|15|||
161984956|NCT00666224|584994488|FG001|Double-Blind|Adverse Event|5|||
161984957|NCT00666224|584994487|FG000|Double-Blind|Lost to Follow-up|2|||
161984958|NCT00666224|584994488|FG001|Double-Blind|Lost to Follow-up|2|||
161984959|NCT00666224|584994487|FG000|Double-Blind|Withdrawal by Subject|18|||
161984960|NCT00666224|584994488|FG001|Double-Blind|Withdrawal by Subject|14|||
161984961|NCT00666224|584994487|FG000|Double-Blind|Physician Decision|0|||
161984962|NCT00666224|584994488|FG001|Double-Blind|Physician Decision|3|||
161984963|NCT00666224|584994487|FG000|Double-Blind|Sponsor decision|1|||
161984964|NCT00666224|584994488|FG001|Double-Blind|Sponsor decision|0|||
161984965|NCT00666224|584994487|FG000|Double-Blind|Pregnancy|3|||
161984966|NCT00666224|584994488|FG001|Double-Blind|Pregnancy|2|||
161984967|NCT00666224|584994487|FG000|Double-Blind|Noncompliance|1|||
161984968|NCT00666224|584994488|FG001|Double-Blind|Noncompliance|0|||
161984969|NCT00666224|584994487|FG000|Double-Blind|Death|1|||
161984970|NCT00666224|584994488|FG001|Double-Blind|Death|0|||
161984971|NCT00666224|584994487|FG000|Double-Blind|Undefined/Unknown|4|||
161984972|NCT00666224|584994488|FG001|Double-Blind|Undefined/Unknown|1|||
161984973|NCT00666224|584994487|FG000|Open-Label|Adverse Event|8|||
161984974|NCT00666224|584994488|FG001|Open-Label|Adverse Event|43|||
161984975|NCT00666224|584994487|FG000|Open-Label|Lost to Follow-up|4|||
161984976|NCT00666224|584994488|FG001|Open-Label|Lost to Follow-up|5|||
161984977|NCT00666224|584994487|FG000|Open-Label|Withdrawal by Subject|12|||
161984978|NCT00666224|584994488|FG001|Open-Label|Withdrawal by Subject|25|||
161984979|NCT00666224|584994487|FG000|Open-Label|Physician Decision|7|||
161984980|NCT00666224|584994488|FG001|Open-Label|Physician Decision|5|||
161984981|NCT00666224|584994487|FG000|Open-Label|Pregnancy|1|||
161984982|NCT00666224|584994488|FG001|Open-Label|Pregnancy|5|||
161984983|NCT00666224|584994487|FG000|Open-Label|Noncompliance|2|||
161984984|NCT00666224|584994488|FG001|Open-Label|Noncompliance|1|||
161984985|NCT00666224|584994487|FG000|Open-Label|Undefined/Unknown|1|||
161984986|NCT00666224|584994488|FG001|Open-Label|Undefined/Unknown|1|||
161984987|NCT03521141|584994489|FG000|Overall Study|Death|1|||
161984988|NCT03521141|584994490|FG001|Overall Study|Death|0|||
161984989|NCT03521141|584994491|FG002|Overall Study|Death|1|||
161984990|NCT03828617|584994493|FG000|Overall Study|Lost to Follow-up|22|||
161984991|NCT03828617|584994494|FG001|Overall Study|Lost to Follow-up|12|||
161984992|NCT03828617|584994495|FG002|Overall Study|Lost to Follow-up|23|||
161984993|NCT03828617|584994496|FG003|Overall Study|Lost to Follow-up|7|||
161984994|NCT03828617|584994493|FG000|Overall Study|No longer met eligibility criteria|0|||
161984995|NCT03828617|584994494|FG001|Overall Study|No longer met eligibility criteria|1|||
161984996|NCT03828617|584994495|FG002|Overall Study|No longer met eligibility criteria|1|||
161984997|NCT03828617|584994496|FG003|Overall Study|No longer met eligibility criteria|3|||
161984998|NCT03828617|584994493|FG000|Overall Study|Protocol Violation|0|||
161984999|NCT03828617|584994494|FG001|Overall Study|Protocol Violation|2|||
161985000|NCT03828617|584994495|FG002|Overall Study|Protocol Violation|0|||
161985001|NCT03828617|584994496|FG003|Overall Study|Protocol Violation|0|||
161985002|NCT03828617|584994493|FG000|Overall Study|Withdrawal by Subject|2|||
161985003|NCT03828617|584994494|FG001|Overall Study|Withdrawal by Subject|0|||
161985004|NCT03828617|584994495|FG002|Overall Study|Withdrawal by Subject|2|||
161985005|NCT03828617|584994496|FG003|Overall Study|Withdrawal by Subject|0|||
161985006|NCT03354273|584994497|FG000|Overall Study|Adverse Event|5|||
161985007|NCT03354273|584994497|FG000|Overall Study|Screen Failure|21|||
161985008|NCT03354273|584994497|FG000|Overall Study|Withdrawal by Subject|34|||
161985009|NCT03354273|584994497|FG000|Overall Study|Technical Problems|30|||
161985010|NCT03354273|584994497|FG000|Overall Study|Lost to Follow-up|4|||
161985011|NCT03354273|584994497|FG000|Overall Study|Investigator Decision|3|||
161985012|NCT03354273|584994497|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
161985013|NCT03354273|584994497|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
161985014|NCT03354273|584994497|FG000|Overall Study|COVID-19 Restrictions|9|||
161985015|NCT03354273|584994497|FG000|Overall Study|Other|5|||
161985016|NCT00303485|584994498|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
161985017|NCT00303485|584994499|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
161870961|NCT03831113|584573627|FG001|Overall Study|Withdrawal by Subject|2|||
161985018|NCT00303485|584994498|FG000|Overall Study|Failure to return|0|||
161985019|NCT00303485|584994499|FG001|Overall Study|Failure to return|1|||
161985020|NCT00303485|584994498|FG000|Overall Study|Withdrawal by Subject|1|||
161985021|NCT00303485|584994499|FG001|Overall Study|Withdrawal by Subject|0|||
161985022|NCT03688100|584994501|FG000|Overall Study|Lost to Follow-up|21|||
161985023|NCT03688100|584994502|FG001|Overall Study|Lost to Follow-up|15|||
161985024|NCT03688100|584994503|FG002|Overall Study|Lost to Follow-up|15|||
161985025|NCT03688100|584994504|FG003|Overall Study|Lost to Follow-up|18|||
161985026|NCT03688100|584994501|FG000|Overall Study|Withdrawal by Subject|19|||
161985027|NCT03688100|584994502|FG001|Overall Study|Withdrawal by Subject|16|||
161985028|NCT03688100|584994503|FG002|Overall Study|Withdrawal by Subject|0|||
161985029|NCT03688100|584994504|FG003|Overall Study|Withdrawal by Subject|0|||
161985030|NCT03688100|584994501|FG000|Overall Study|Death|36|||
161870962|NCT03831113|584573626|FG000|Overall Study|Protocol Violation|0|||
161870963|NCT03831113|584573627|FG001|Overall Study|Protocol Violation|9|||
161870964|NCT01068730|584573628|FG000|Period 3|Personal reason|1|||
161870965|NCT01068730|584573629|FG001|Period 3|Personal reason|0|||
161870966|NCT01068730|584573630|FG002|Period 3|Personal reason|0|||
161870967|NCT01068730|584573631|FG003|Period 3|Personal reason|0|||
161870968|NCT01068730|584573628|FG000|Period 4|Family emergency|0|||
161870969|NCT01068730|584573629|FG001|Period 4|Family emergency|1|||
161870970|NCT01068730|584573630|FG002|Period 4|Family emergency|0|||
161870971|NCT01068730|584573631|FG003|Period 4|Family emergency|0|||
161870972|NCT03508726|584573632|FG000|Overall Study|Withdrawal by Subject|0|||
161870973|NCT03508726|584573633|FG001|Overall Study|Withdrawal by Subject|1|||
161870974|NCT02498444|584573637|FG000|Overall Study|Withdrawal by Subject|3|||
161870975|NCT02498444|584573638|FG001|Overall Study|Withdrawal by Subject|0|||
161870976|NCT02498444|584573637|FG000|Overall Study|Physician Decision|1|||
161870977|NCT02498444|584573638|FG001|Overall Study|Physician Decision|0|||
161870978|NCT03656692|584573639|FG000|Overall Study|Worsening of disease activity|2|||
161870979|NCT03656692|584573639|FG000|Overall Study|Physician Decision|1|||
161870980|NCT03233529|584573640|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
161870981|NCT03233529|584573640|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
161870982|NCT01177293|584573641|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
161870983|NCT01177293|584573642|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
161870984|NCT00594100|584573643|FG000|Procedure|Technical Failure|9|||
161870985|NCT00594100|584573643|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
161870986|NCT00594100|584573643|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
161870987|NCT00594100|584573643|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
161870988|NCT02448537|584573644|FG000|Overall Study|Withdrawal by Subject|1|||
161870989|NCT02448537|584573645|FG001|Overall Study|Withdrawal by Subject|1|||
161870990|NCT02448537|584573646|FG002|Overall Study|Withdrawal by Subject|1|||
161775317|NCT03426995|584219439|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
161775318|NCT03426995|584219440|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775319|NCT03426995|584219441|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775320|NCT03426995|584219442|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161775321|NCT01886105|584219443|FG000|Overall Study|Lack of Efficacy|3|||
161775322|NCT01360021|584219446|FG000|Overall Study|Eligibility criteria + other|2|||
161775323|NCT01360021|584219447|FG001|Overall Study|Eligibility criteria + other|1|||
161775324|NCT01360021|584219448|FG002|Overall Study|Eligibility criteria + other|1|||
161775325|NCT01360021|584219446|FG000|Overall Study|Protocol Violation|0|||
161775326|NCT01360021|584219447|FG001|Overall Study|Protocol Violation|0|||
161775327|NCT01360021|584219448|FG002|Overall Study|Protocol Violation|1|||
161775328|NCT01360021|584219446|FG000|Overall Study|Withdrawal by Subject|4|||
161775329|NCT01360021|584219447|FG001|Overall Study|Withdrawal by Subject|0|||
161775330|NCT01360021|584219448|FG002|Overall Study|Withdrawal by Subject|2|||
161775331|NCT01360021|584219446|FG000|Overall Study|Adverse Event|2|||
161775332|NCT01360021|584219447|FG001|Overall Study|Adverse Event|3|||
161775333|NCT01360021|584219448|FG002|Overall Study|Adverse Event|3|||
161775334|NCT03075826|584219451|FG000|Overall Study|Withdrawal by Subject|1|||
161775335|NCT03075826|584219451|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
161775336|NCT00650806|584219453|FG000|Overall Study|Adverse Event|0|||
161775337|NCT00650806|584219454|FG001|Overall Study|Adverse Event|5|||
161775338|NCT00650806|584219455|FG002|Overall Study|Adverse Event|3|||
161775339|NCT00650806|584219456|FG003|Overall Study|Adverse Event|4|||
161775340|NCT00650806|584219453|FG000|Overall Study|Lost to Follow-up|7|||
161775341|NCT00650806|584219454|FG001|Overall Study|Lost to Follow-up|6|||
161775342|NCT00650806|584219455|FG002|Overall Study|Lost to Follow-up|11|||
161775343|NCT00650806|584219456|FG003|Overall Study|Lost to Follow-up|10|||
161775344|NCT00650806|584219453|FG000|Overall Study|Protocol Violation|0|||
161775345|NCT00650806|584219454|FG001|Overall Study|Protocol Violation|0|||
161775346|NCT00650806|584219455|FG002|Overall Study|Protocol Violation|0|||
161775347|NCT00650806|584219456|FG003|Overall Study|Protocol Violation|1|||
161775348|NCT00650806|584219453|FG000|Overall Study|Pregnancy|0|||
161775349|NCT00650806|584219454|FG001|Overall Study|Pregnancy|0|||
161775350|NCT00650806|584219455|FG002|Overall Study|Pregnancy|0|||
161775351|NCT00650806|584219456|FG003|Overall Study|Pregnancy|1|||
161775352|NCT00650806|584219453|FG000|Overall Study|Withdrawal by Subject|7|||
161775353|NCT00650806|584219454|FG001|Overall Study|Withdrawal by Subject|5|||
161775354|NCT00650806|584219455|FG002|Overall Study|Withdrawal by Subject|8|||
161775355|NCT00650806|584219456|FG003|Overall Study|Withdrawal by Subject|6|||
161775356|NCT00650806|584219453|FG000|Overall Study|Noncompliance with study drug regimen|1|||
161870991|NCT01106911|584573659|FG000|Overall Study|Physician Decision|2|||
161870992|NCT01106911|584573659|FG000|Overall Study|deemed ineligible after screening|3|||
161870993|NCT01814696|584573661|FG000|Overall Study|Withdrawal by Subject|1|||
161870994|NCT01814696|584573662|FG001|Overall Study|Withdrawal by Subject|0|||
161870995|NCT01814696|584573661|FG000|Overall Study|Randomized to wrong group|1|||
161870996|NCT01814696|584573662|FG001|Overall Study|Randomized to wrong group|0|||
161870997|NCT05708976|584573673|FG000|Overall Study|Withdrawal by Subject|0|||
161985031|NCT03688100|584994502|FG001|Overall Study|Death|27|||
161985032|NCT03688100|584994503|FG002|Overall Study|Death|0|||
161985033|NCT03688100|584994504|FG003|Overall Study|Death|0|||
161985034|NCT02479139|584994510|FG000|Overall Study|Lost to Follow-up|2|||
161985035|NCT02479139|584994511|FG001|Overall Study|Lost to Follow-up|4|||
161985036|NCT02479139|584994512|FG002|Overall Study|Lost to Follow-up|4|||
161985037|NCT02479139|584994513|FG003|Overall Study|Lost to Follow-up|2|||
161985038|NCT02479139|584994514|FG004|Overall Study|Lost to Follow-up|3|||
161985039|NCT02479139|584994515|FG005|Overall Study|Lost to Follow-up|5|||
161985040|NCT02479139|584994510|FG000|Overall Study|Withdrew Consent|5|||
161985041|NCT02479139|584994511|FG001|Overall Study|Withdrew Consent|6|||
161985042|NCT02479139|584994512|FG002|Overall Study|Withdrew Consent|1|||
161985043|NCT02479139|584994513|FG003|Overall Study|Withdrew Consent|4|||
161985044|NCT02479139|584994514|FG004|Overall Study|Withdrew Consent|1|||
161985045|NCT02479139|584994515|FG005|Overall Study|Withdrew Consent|1|||
161985046|NCT02479139|584994510|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
161985047|NCT02479139|584994511|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
161985048|NCT02479139|584994512|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
161985049|NCT02479139|584994513|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
161985050|NCT02479139|584994514|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
161985051|NCT02479139|584994515|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
161985052|NCT02479139|584994510|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161985053|NCT02479139|584994511|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161985054|NCT02479139|584994512|FG002|Overall Study|Other Miscellaneous Reasons|1|||
161985055|NCT02479139|584994513|FG003|Overall Study|Other Miscellaneous Reasons|1|||
161985056|NCT02479139|584994514|FG004|Overall Study|Other Miscellaneous Reasons|1|||
161985057|NCT02479139|584994515|FG005|Overall Study|Other Miscellaneous Reasons|0|||
161985058|NCT00084656|584994516|FG000|Overall Study|Other reasons|0|||
161985059|NCT00084656|584994517|FG001|Overall Study|Other reasons|12|||
161985060|NCT00084656|584994518|FG002|Overall Study|Other reasons|11|||
161985061|NCT00084656|584994516|FG000|Overall Study|Withdrawal by Subject|15|||
161985062|NCT00084656|584994517|FG001|Overall Study|Withdrawal by Subject|4|||
161985063|NCT00084656|584994518|FG002|Overall Study|Withdrawal by Subject|4|||
161985064|NCT00084656|584994516|FG000|Overall Study|Disease relapse|0|||
161985065|NCT00084656|584994517|FG001|Overall Study|Disease relapse|9|||
161985066|NCT00084656|584994518|FG002|Overall Study|Disease relapse|10|||
161985067|NCT00084656|584994516|FG000|Overall Study|Disease progression|9|||
161985068|NCT00084656|584994517|FG001|Overall Study|Disease progression|0|||
161985069|NCT00084656|584994518|FG002|Overall Study|Disease progression|0|||
161985070|NCT00084656|584994516|FG000|Overall Study|Lost to Follow-up|1|||
161985071|NCT00084656|584994517|FG001|Overall Study|Lost to Follow-up|0|||
161985072|NCT00084656|584994518|FG002|Overall Study|Lost to Follow-up|1|||
161985073|NCT00989781|584994519|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
161985074|NCT00989781|584994520|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
161985075|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
161985076|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
161985077|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
161985078|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
161985079|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
161985080|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
161985081|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
161985082|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
161985083|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
161985084|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
161985085|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
161985086|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
161985087|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
161985088|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
161985089|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
161985090|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
161985091|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
161985092|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
161985093|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
161985094|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
161985095|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
161985096|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
161985097|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
161985098|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
161985099|NCT01532869|584994521|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
161985100|NCT01532869|584994522|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
161985101|NCT01532869|584994521|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
161985102|NCT01532869|584994522|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
161985103|NCT01532869|584994521|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
161985104|NCT01532869|584994522|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
161985105|NCT01532869|584994521|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
161985106|NCT01532869|584994522|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
161985107|NCT01532869|584994521|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
161985108|NCT01532869|584994522|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
161985109|NCT01389323|584994523|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
161985110|NCT01389323|584994523|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
161985111|NCT01389323|584994523|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
161985112|NCT01389323|584994523|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
161985113|NCT01389323|584994523|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
161985114|NCT01389323|584994523|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
161985115|NCT01389323|584994523|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
161985116|NCT01389323|584994523|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
161985117|NCT01389323|584994523|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
161985118|NCT01389323|584994523|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
161985119|NCT01389323|584994523|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
161985120|NCT03203291|584994526|FG000|Overall Study|Withdrawal by Subject|1|||
161985121|NCT01300260|584994527|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
161985122|NCT01300260|584994528|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
161985123|NCT01300260|584994527|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
161985124|NCT01300260|584994528|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
161985125|NCT01300260|584994527|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
161985126|NCT01300260|584994528|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
161985127|NCT05098509|584994534|FG000|Overall Study|Withdrawal by Subject|0|||
161985128|NCT05098509|584994535|FG001|Overall Study|Withdrawal by Subject|0|||
161985129|NCT05098509|584994536|FG002|Overall Study|Withdrawal by Subject|1|||
161985130|NCT05098509|584994537|FG003|Overall Study|Withdrawal by Subject|0|||
161985131|NCT05098509|584994534|FG000|Overall Study|Early study termination|1|||
161985132|NCT05098509|584994535|FG001|Overall Study|Early study termination|1|||
161985133|NCT05098509|584994536|FG002|Overall Study|Early study termination|1|||
161985134|NCT05098509|584994537|FG003|Overall Study|Early study termination|0|||
161985135|NCT01147848|584994538|FG000|Run-in Period|Screen Failure|623|||
161985136|NCT01147848|584994539|FG001|Run-in Period|Screen Failure|0|||
161985137|NCT01147848|584994540|FG002|Run-in Period|Screen Failure|0|||
161985138|NCT01147848|584994538|FG000|Run-in Period|Run-in Failure|135|||
161985139|NCT01147848|584994539|FG001|Run-in Period|Run-in Failure|0|||
161985140|NCT01147848|584994540|FG002|Run-in Period|Run-in Failure|0|||
161985141|NCT01147848|584994538|FG000|Randomized Phase|Adverse Event|0|||
161985142|NCT01147848|584994539|FG001|Randomized Phase|Adverse Event|6|||
161985143|NCT01147848|584994540|FG002|Randomized Phase|Adverse Event|8|||
161985144|NCT01147848|584994538|FG000|Randomized Phase|Lack of Efficacy|0|||
161985145|NCT01147848|584994539|FG001|Randomized Phase|Lack of Efficacy|20|||
161870998|NCT05708976|584573674|FG001|Overall Study|Withdrawal by Subject|1|||
161870999|NCT05310071|584573675|FG000|Overall Study|Death|0|||
161871000|NCT05310071|584573676|FG001|Overall Study|Death|3|||
161871001|NCT05310071|584573675|FG000|Overall Study|Adverse Event|4|||
161871002|NCT05310071|584573676|FG001|Overall Study|Adverse Event|31|||
161871003|NCT05310071|584573675|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
161871004|NCT05310071|584573676|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
161871005|NCT05310071|584573675|FG000|Overall Study|Protocol Deviation|2|||
161871006|NCT05310071|584573676|FG001|Overall Study|Protocol Deviation|0|||
161871007|NCT05310071|584573675|FG000|Overall Study|Randomized by Mistake|0|||
161871008|NCT05310071|584573676|FG001|Overall Study|Randomized by Mistake|1|||
161871009|NCT05310071|584573675|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
161871010|NCT05310071|584573676|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
161871011|NCT05310071|584573675|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
161871012|NCT05310071|584573676|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
161871013|NCT05310071|584573675|FG000|Overall Study|Site Terminated by Sponsor|0|||
161871014|NCT05310071|584573676|FG001|Overall Study|Site Terminated by Sponsor|2|||
161871015|NCT05310071|584573675|FG000|Overall Study|Study Terminated by Sponsor|282|||
161871016|NCT05310071|584573676|FG001|Overall Study|Study Terminated by Sponsor|559|||
161871017|NCT05310071|584573675|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
161871018|NCT05310071|584573676|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
161871019|NCT05310071|584573675|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
161871020|NCT05310071|584573676|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
161871021|NCT05310071|584573675|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
161871022|NCT05310071|584573676|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
161985146|NCT01147848|584994540|FG002|Randomized Phase|Lack of Efficacy|11|||
161985147|NCT01147848|584994538|FG000|Randomized Phase|Protocol Violation|0|||
161985148|NCT01147848|584994539|FG001|Randomized Phase|Protocol Violation|7|||
161985149|NCT01147848|584994540|FG002|Randomized Phase|Protocol Violation|10|||
161985150|NCT01147848|584994538|FG000|Randomized Phase|Lost to Follow-up|0|||
161985151|NCT01147848|584994539|FG001|Randomized Phase|Lost to Follow-up|5|||
161985152|NCT01147848|584994540|FG002|Randomized Phase|Lost to Follow-up|7|||
161985153|NCT01147848|584994538|FG000|Randomized Phase|Physician Decision|0|||
161871023|NCT05310071|584573675|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
161871024|NCT05310071|584573676|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
161871025|NCT05310071|584573675|FG000|Overall Study|Withdrawal by Participant - Other|25|||
161871026|NCT05310071|584573676|FG001|Overall Study|Withdrawal by Participant - Other|30|||
161871027|NCT05310071|584573675|FG000|Overall Study|Lost to Follow-up|2|||
161871028|NCT05310071|584573676|FG001|Overall Study|Lost to Follow-up|4|||
161871029|NCT05310071|584573675|FG000|Overall Study|Reason Not Specified|1|||
161871030|NCT05310071|584573676|FG001|Overall Study|Reason Not Specified|3|||
161871031|NCT02105987|584573677|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
161871032|NCT02105987|584573678|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161871033|NCT02105987|584573679|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161871034|NCT02105987|584573680|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161871035|NCT02105987|584573681|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161871036|NCT02105987|584573682|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161871037|NCT02105987|584573677|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
161871038|NCT02105987|584573678|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
161871039|NCT02105987|584573679|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
161871040|NCT02105987|584573680|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
161871041|NCT02105987|584573681|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
161871042|NCT02105987|584573682|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
161871043|NCT02105987|584573677|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
161871044|NCT02105987|584573678|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
161871045|NCT02105987|584573679|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871046|NCT02105987|584573680|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871047|NCT02105987|584573681|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871048|NCT02105987|584573682|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871049|NCT02105987|584573677|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
161871050|NCT02105987|584573678|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
161871051|NCT02105987|584573679|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871052|NCT02105987|584573680|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871053|NCT02105987|584573681|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871054|NCT02105987|584573682|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871055|NCT02105987|584573677|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
161871056|NCT02105987|584573678|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
161871057|NCT02105987|584573679|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
161871058|NCT02105987|584573680|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
161871059|NCT02105987|584573681|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
161871060|NCT02105987|584573682|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
161871061|NCT02105987|584573677|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161871062|NCT02105987|584573678|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
161871063|NCT02105987|584573679|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161871064|NCT02105987|584573680|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161871065|NCT02105987|584573681|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161871066|NCT02105987|584573682|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161871067|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
161871068|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
161871069|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
161871070|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
161871071|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
161871072|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
161871073|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
161871074|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
161871075|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
161871076|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
161871077|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
161871078|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
161871079|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871080|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871081|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
161871082|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
161985154|NCT01147848|584994539|FG001|Randomized Phase|Physician Decision|0|||
161871083|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161985155|NCT01147848|584994540|FG002|Randomized Phase|Physician Decision|1|||
161985156|NCT01147848|584994538|FG000|Randomized Phase|Withdrawal by Subject|0|||
161985157|NCT01147848|584994539|FG001|Randomized Phase|Withdrawal by Subject|7|||
161985158|NCT01147848|584994540|FG002|Randomized Phase|Withdrawal by Subject|9|||
161985159|NCT04033068|584994541|FG000|Overall Study|Withdrawal by Subject|0|||
161985160|NCT04033068|584994542|FG001|Overall Study|Withdrawal by Subject|0|||
161985161|NCT04033068|584994543|FG002|Overall Study|Withdrawal by Subject|1|||
161985162|NCT04033068|584994544|FG003|Overall Study|Withdrawal by Subject|0|||
161985163|NCT04033068|584994541|FG000|Overall Study|Lost to Follow-up|0|||
161985164|NCT04033068|584994542|FG001|Overall Study|Lost to Follow-up|1|||
161985165|NCT04033068|584994543|FG002|Overall Study|Lost to Follow-up|0|||
161985166|NCT04033068|584994544|FG003|Overall Study|Lost to Follow-up|0|||
161985167|NCT04033068|584994541|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
161985168|NCT04033068|584994542|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
161985169|NCT04033068|584994543|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
161985170|NCT04033068|584994544|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
161985171|NCT03157037|584994547|FG000|Overall Study|Death|1|||
161985172|NCT03596450|584994548|FG000|Overall Study|Death|9|||
161985173|NCT03596450|584994549|FG001|Overall Study|Death|9|||
161985174|NCT03596450|584994548|FG000|Overall Study|Protocol Violation|18|||
161985175|NCT03596450|584994549|FG001|Overall Study|Protocol Violation|26|||
161985176|NCT03596450|584994548|FG000|Overall Study|Lost to Follow-up|50|||
161985177|NCT03596450|584994549|FG001|Overall Study|Lost to Follow-up|56|||
161985178|NCT03596450|584994548|FG000|Overall Study|Adverse Event|14|||
161985179|NCT03596450|584994549|FG001|Overall Study|Adverse Event|7|||
161985180|NCT03596450|584994548|FG000|Overall Study|Withdrawal by Subject|38|||
161985181|NCT03596450|584994549|FG001|Overall Study|Withdrawal by Subject|36|||
161985182|NCT03596450|584994548|FG000|Overall Study|Accidentally Randomized|2|||
161985183|NCT03596450|584994549|FG001|Overall Study|Accidentally Randomized|0|||
161985184|NCT03596450|584994548|FG000|Overall Study|Other reasons|48|||
161985185|NCT03596450|584994549|FG001|Overall Study|Other reasons|53|||
161985186|NCT03596450|584994548|FG000|Overall Study|Pregnancy|2|||
161985187|NCT03596450|584994549|FG001|Overall Study|Pregnancy|0|||
161985188|NCT01817959|584994552|FG000|Overall Study|Graft loss|1|||
161985189|NCT01817959|584994553|FG001|Overall Study|Graft loss|1|||
161985190|NCT01817959|584994552|FG000|Overall Study|forbidden medication|1|||
161985191|NCT01817959|584994553|FG001|Overall Study|forbidden medication|1|||
161985192|NCT01817959|584994552|FG000|Overall Study|Adverse Event|1|||
161985193|NCT01817959|584994553|FG001|Overall Study|Adverse Event|0|||
161985194|NCT01817959|584994552|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
161985195|NCT01817959|584994553|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
161985196|NCT03235089|584994554|FG000|Overall Study|Lost to Follow-up|1|||
161985197|NCT03235089|584994555|FG001|Overall Study|Lost to Follow-up|1|||
161985198|NCT03235089|584994554|FG000|Overall Study|Physician Decision|2|||
161985199|NCT03235089|584994555|FG001|Overall Study|Physician Decision|2|||
161985200|NCT03238924|584994560|FG000|Overall Study|Withdrawal by Subject|2|||
161985201|NCT03238924|584994561|FG001|Overall Study|Withdrawal by Subject|2|||
161985202|NCT03576716|584994562|FG000|Overall Study|Withdrawal by Subject|0|||
161985203|NCT03576716|584994563|FG001|Overall Study|Withdrawal by Subject|1|||
161985204|NCT00559988|584994564|FG000|Overall Study|Death|147|||
161985205|NCT00559988|584994565|FG001|Overall Study|Death|140|||
161985206|NCT00559988|584994564|FG000|Overall Study|Withdrawal by Subject|152|||
161985207|NCT00559988|584994565|FG001|Overall Study|Withdrawal by Subject|139|||
161985208|NCT00559988|584994564|FG000|Overall Study|Lost to Follow-up|42|||
161985209|NCT00559988|584994565|FG001|Overall Study|Lost to Follow-up|56|||
161985210|NCT00559988|584994564|FG000|Overall Study|ICD device explanted|10|||
161985211|NCT00559988|584994565|FG001|Overall Study|ICD device explanted|17|||
161985212|NCT02891382|584994566|FG000|Overall Study|Lost to Follow-up|3|||
161985213|NCT02891382|584994567|FG001|Overall Study|Lost to Follow-up|4|||
161985214|NCT02891382|584994568|FG002|Overall Study|Lost to Follow-up|5|||
161985215|NCT02891382|584994569|FG003|Overall Study|Lost to Follow-up|3|||
161985216|NCT02891382|584994570|FG004|Overall Study|Lost to Follow-up|4|||
161985217|NCT02516228|584994571|FG000|Overall Study|Lost to Follow-up|1|||
161985218|NCT02516228|584994571|FG000|Overall Study|Withdrawal by Subject|1|||
161985219|NCT02516228|584994571|FG000|Overall Study|Physician Decision|1|||
162035117|NCT06785857|585184862|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
162035118|NCT06785857|585184863|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
162035119|NCT05952401|585184871|FG000|Overall Study|Lost to Follow-up|4|||
161775357|NCT00650806|584219454|FG001|Overall Study|Noncompliance with study drug regimen|1|||
161775358|NCT00650806|584219455|FG002|Overall Study|Noncompliance with study drug regimen|0|||
161775359|NCT00650806|584219456|FG003|Overall Study|Noncompliance with study drug regimen|0|||
161985220|NCT03916484|584994572|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161985221|NCT03916484|584994573|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
161985222|NCT03916484|584994574|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161985223|NCT03916484|584994575|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161985224|NCT03916484|584994572|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
161871084|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161871085|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871086|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871087|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
161871088|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
161871089|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871090|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161871091|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161871092|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161871093|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
161871094|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161871095|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161871096|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161871097|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161871098|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161871099|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161871100|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
161871101|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161871102|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161871103|NCT02105987|584573677|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161871104|NCT02105987|584573678|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161871105|NCT02105987|584573679|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
161871106|NCT02105987|584573680|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161871107|NCT02105987|584573681|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161871108|NCT02105987|584573682|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161871109|NCT02105987|584573677|FG000|Continuation Phase|Protocol Violation|0|||
161871110|NCT02105987|584573678|FG001|Continuation Phase|Protocol Violation|0|||
161871111|NCT02105987|584573679|FG002|Continuation Phase|Protocol Violation|0|||
161871112|NCT02105987|584573680|FG003|Continuation Phase|Protocol Violation|0|||
161871113|NCT02105987|584573681|FG004|Continuation Phase|Protocol Violation|1|||
161871114|NCT02105987|584573682|FG005|Continuation Phase|Protocol Violation|0|||
161871115|NCT02418949|584573689|FG000|Overall Study|Withdrawal by Subject|1|||
161871116|NCT02418949|584573690|FG001|Overall Study|Withdrawal by Subject|0|||
161871117|NCT02418949|584573691|FG002|Overall Study|Withdrawal by Subject|1|||
161871118|NCT02418949|584573692|FG003|Overall Study|Withdrawal by Subject|1|||
161871119|NCT02418949|584573689|FG000|Overall Study|Lost to Follow-up|1|||
161871120|NCT02418949|584573690|FG001|Overall Study|Lost to Follow-up|0|||
161871121|NCT02418949|584573691|FG002|Overall Study|Lost to Follow-up|1|||
161871122|NCT02418949|584573692|FG003|Overall Study|Lost to Follow-up|0|||
161871123|NCT02418949|584573689|FG000|Overall Study|Physician Decision|1|||
161871124|NCT02418949|584573690|FG001|Overall Study|Physician Decision|1|||
161871125|NCT02418949|584573691|FG002|Overall Study|Physician Decision|1|||
161871126|NCT02418949|584573692|FG003|Overall Study|Physician Decision|0|||
161871127|NCT00396656|584573698|FG000|First Treatment Period|Withdrawal by Subject|0|||
161871128|NCT00396656|584573699|FG001|First Treatment Period|Withdrawal by Subject|2|||
161871129|NCT00396656|584573698|FG000|Second Treatment Period|Adverse Event|0|||
161871130|NCT00396656|584573699|FG001|Second Treatment Period|Adverse Event|1|||
161871131|NCT02343939|584573700|FG000|Overall Study|Death|0|||
161871132|NCT02343939|584573701|FG001|Overall Study|Death|15|||
161871133|NCT02343939|584573702|FG002|Overall Study|Death|4|||
161871134|NCT02343939|584573703|FG003|Overall Study|Death|2|||
161871135|NCT02343939|584573704|FG004|Overall Study|Death|5|||
161871136|NCT02343939|584573705|FG005|Overall Study|Death|11|||
161871137|NCT02343939|584573706|FG006|Overall Study|Death|8|||
161871138|NCT02343939|584573707|FG007|Overall Study|Death|22|||
161871139|NCT02343939|584573708|FG008|Overall Study|Death|1|||
161871140|NCT02343939|584573700|FG000|Overall Study|Study terminated by sponsor|0|||
161871141|NCT02343939|584573701|FG001|Overall Study|Study terminated by sponsor|27|||
161871142|NCT02343939|584573702|FG002|Overall Study|Study terminated by sponsor|0|||
161871143|NCT02343939|584573703|FG003|Overall Study|Study terminated by sponsor|1|||
161871144|NCT02343939|584573704|FG004|Overall Study|Study terminated by sponsor|1|||
161985225|NCT03916484|584994573|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
161985226|NCT03916484|584994574|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
161871145|NCT02343939|584573705|FG005|Overall Study|Study terminated by sponsor|5|||
161871146|NCT02343939|584573706|FG006|Overall Study|Study terminated by sponsor|3|||
161871147|NCT02343939|584573707|FG007|Overall Study|Study terminated by sponsor|4|||
161871148|NCT02343939|584573708|FG008|Overall Study|Study terminated by sponsor|0|||
161871149|NCT02343939|584573700|FG000|Overall Study|Withdrew consent|3|||
161871150|NCT02343939|584573701|FG001|Overall Study|Withdrew consent|6|||
161871151|NCT02343939|584573702|FG002|Overall Study|Withdrew consent|1|||
161871152|NCT02343939|584573703|FG003|Overall Study|Withdrew consent|2|||
161871153|NCT02343939|584573704|FG004|Overall Study|Withdrew consent|2|||
161871154|NCT02343939|584573705|FG005|Overall Study|Withdrew consent|0|||
161871155|NCT02343939|584573706|FG006|Overall Study|Withdrew consent|0|||
161985227|NCT03916484|584994575|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
161985228|NCT01123707|584994577|FG000|Overall Study|Lost to Follow-up|3|||
161985229|NCT01123707|584994578|FG001|Overall Study|Lost to Follow-up|1|||
161985230|NCT01123707|584994579|FG002|Overall Study|Lost to Follow-up|3|||
161985231|NCT01123707|584994580|FG003|Overall Study|Lost to Follow-up|2|||
161985232|NCT01123707|584994577|FG000|Overall Study|Adverse Event|5|||
161985233|NCT01123707|584994578|FG001|Overall Study|Adverse Event|7|||
161985234|NCT01123707|584994579|FG002|Overall Study|Adverse Event|5|||
161985235|NCT01123707|584994580|FG003|Overall Study|Adverse Event|3|||
161985236|NCT01123707|584994577|FG000|Overall Study|Sponsor Discontinued Study|30|||
161985237|NCT01123707|584994578|FG001|Overall Study|Sponsor Discontinued Study|24|||
161985238|NCT01123707|584994579|FG002|Overall Study|Sponsor Discontinued Study|25|||
161985239|NCT01123707|584994580|FG003|Overall Study|Sponsor Discontinued Study|40|||
161985240|NCT01123707|584994577|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
161985241|NCT01123707|584994578|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
161985242|NCT01123707|584994579|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
161985243|NCT01123707|584994580|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
161985244|NCT01123707|584994577|FG000|Overall Study|Investigator Withdrew Participant|0|||
161985245|NCT01123707|584994578|FG001|Overall Study|Investigator Withdrew Participant|1|||
161985246|NCT01123707|584994579|FG002|Overall Study|Investigator Withdrew Participant|1|||
161985247|NCT01123707|584994580|FG003|Overall Study|Investigator Withdrew Participant|1|||
161985248|NCT01123707|584994577|FG000|Overall Study|Subject Withdrew Consent|4|||
161985249|NCT01123707|584994578|FG001|Overall Study|Subject Withdrew Consent|5|||
161985250|NCT01123707|584994579|FG002|Overall Study|Subject Withdrew Consent|1|||
161985251|NCT01123707|584994580|FG003|Overall Study|Subject Withdrew Consent|2|||
161985252|NCT01123707|584994577|FG000|Overall Study|Lack of Efficacy|1|||
161985253|NCT01123707|584994578|FG001|Overall Study|Lack of Efficacy|2|||
161985254|NCT01123707|584994579|FG002|Overall Study|Lack of Efficacy|1|||
161985255|NCT01123707|584994580|FG003|Overall Study|Lack of Efficacy|0|||
161985256|NCT01123707|584994577|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
161985257|NCT01123707|584994578|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
161985258|NCT01123707|584994579|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
161985259|NCT01123707|584994580|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
161985260|NCT03281304|584994583|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
161985261|NCT03281304|584994584|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
161985262|NCT03281304|584994583|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
161985263|NCT03281304|584994584|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
161985264|NCT03281304|584994583|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
161985265|NCT03281304|584994584|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
161985266|NCT03281304|584994583|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
161985267|NCT03281304|584994584|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
161985268|NCT03281304|584994583|FG000|Treatment Phase (up to 42 Months)|Death|0|||
161985269|NCT03281304|584994584|FG001|Treatment Phase (up to 42 Months)|Death|1|||
161985270|NCT03281304|584994583|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
161985271|NCT03281304|584994584|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
161985272|NCT03281304|584994583|FG000|Treatment Phase (up to 42 Months)|Other|0|||
161985273|NCT03281304|584994584|FG001|Treatment Phase (up to 42 Months)|Other|2|||
161985274|NCT03281304|584994583|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
161985275|NCT03281304|584994584|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
161985276|NCT00858637|584994585|FG000|Active Comparison Phase|Adverse Event|14|||
161985277|NCT00858637|584994586|FG001|Active Comparison Phase|Adverse Event|0|||
161985278|NCT00858637|584994587|FG002|Active Comparison Phase|Adverse Event|0|||
161985279|NCT00858637|584994588|FG003|Active Comparison Phase|Adverse Event|9|||
161985280|NCT00858637|584994589|FG004|Active Comparison Phase|Adverse Event|0|||
161985281|NCT00858637|584994590|FG005|Active Comparison Phase|Adverse Event|0|||
161985282|NCT00858637|584994585|FG000|Active Comparison Phase|Death|1|||
161985283|NCT00858637|584994586|FG001|Active Comparison Phase|Death|0|||
161985284|NCT00858637|584994587|FG002|Active Comparison Phase|Death|0|||
161985285|NCT00858637|584994588|FG003|Active Comparison Phase|Death|1|||
161985286|NCT00858637|584994589|FG004|Active Comparison Phase|Death|0|||
161985287|NCT00858637|584994590|FG005|Active Comparison Phase|Death|0|||
161985288|NCT00858637|584994585|FG000|Active Comparison Phase|Physician Decision|1|||
161985289|NCT00858637|584994586|FG001|Active Comparison Phase|Physician Decision|0|||
161985290|NCT00858637|584994587|FG002|Active Comparison Phase|Physician Decision|0|||
161985291|NCT00858637|584994588|FG003|Active Comparison Phase|Physician Decision|1|||
161985292|NCT00858637|584994589|FG004|Active Comparison Phase|Physician Decision|0|||
161985293|NCT00858637|584994590|FG005|Active Comparison Phase|Physician Decision|0|||
161985294|NCT00858637|584994585|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
161985295|NCT00858637|584994586|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
161871156|NCT02343939|584573707|FG007|Overall Study|Withdrew consent|8|||
161985296|NCT00858637|584994587|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
161871157|NCT02343939|584573708|FG008|Overall Study|Withdrew consent|6|||
161871158|NCT02343939|584573700|FG000|Overall Study|Treatment failure|0|||
161871159|NCT02343939|584573701|FG001|Overall Study|Treatment failure|0|||
161985297|NCT00858637|584994588|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
161985298|NCT00858637|584994589|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
161985299|NCT00858637|584994590|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
161985300|NCT00858637|584994585|FG000|Active Comparison Phase|Other Reasons|1|||
161985301|NCT00858637|584994586|FG001|Active Comparison Phase|Other Reasons|0|||
161985302|NCT00858637|584994587|FG002|Active Comparison Phase|Other Reasons|0|||
161985303|NCT00858637|584994588|FG003|Active Comparison Phase|Other Reasons|1|||
161985304|NCT00858637|584994589|FG004|Active Comparison Phase|Other Reasons|0|||
161985305|NCT00858637|584994590|FG005|Active Comparison Phase|Other Reasons|0|||
161985306|NCT00858637|584994585|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
161985307|NCT00858637|584994586|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
161985308|NCT00858637|584994587|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
161985309|NCT00858637|584994588|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
161985310|NCT00858637|584994589|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
161985311|NCT00858637|584994590|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
161985312|NCT00858637|584994585|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
161985313|NCT00858637|584994586|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
161985314|NCT00858637|584994587|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
161985315|NCT00858637|584994588|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
161985316|NCT00858637|584994589|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
161985317|NCT00858637|584994590|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
161985318|NCT02292706|584994591|FG000|Overall Study|Lost to Follow-up|20|||
161985319|NCT02292706|584994592|FG001|Overall Study|Lost to Follow-up|44|||
161985320|NCT02292706|584994593|FG002|Overall Study|Lost to Follow-up|24|||
161985321|NCT02292706|584994594|FG003|Overall Study|Lost to Follow-up|61|||
161985322|NCT02292706|584994595|FG004|Overall Study|Lost to Follow-up|21|||
161985323|NCT02292706|584994596|FG005|Overall Study|Lost to Follow-up|52|||
161985324|NCT02292706|584994597|FG006|Overall Study|Lost to Follow-up|25|||
161985325|NCT02292706|584994598|FG007|Overall Study|Lost to Follow-up|0|||
161985326|NCT02292706|584994591|FG000|Overall Study|Withdrew consent|15|||
161985327|NCT02292706|584994592|FG001|Overall Study|Withdrew consent|56|||
161985328|NCT02292706|584994593|FG002|Overall Study|Withdrew consent|43|||
161985329|NCT02292706|584994594|FG003|Overall Study|Withdrew consent|36|||
161985330|NCT02292706|584994595|FG004|Overall Study|Withdrew consent|13|||
161985331|NCT02292706|584994596|FG005|Overall Study|Withdrew consent|51|||
161985332|NCT02292706|584994597|FG006|Overall Study|Withdrew consent|20|||
161985333|NCT02292706|584994598|FG007|Overall Study|Withdrew consent|0|||
161985334|NCT02292706|584994591|FG000|Overall Study|Death|3|||
161985335|NCT02292706|584994592|FG001|Overall Study|Death|11|||
161985336|NCT02292706|584994593|FG002|Overall Study|Death|16|||
161985337|NCT02292706|584994594|FG003|Overall Study|Death|22|||
161985338|NCT02292706|584994595|FG004|Overall Study|Death|8|||
161985339|NCT02292706|584994596|FG005|Overall Study|Death|17|||
161985340|NCT02292706|584994597|FG006|Overall Study|Death|3|||
161985341|NCT02292706|584994598|FG007|Overall Study|Death|0|||
161985342|NCT02292706|584994591|FG000|Overall Study|Study terminated by sponsor|0|||
161985343|NCT02292706|584994592|FG001|Overall Study|Study terminated by sponsor|9|||
161985344|NCT02292706|584994593|FG002|Overall Study|Study terminated by sponsor|4|||
161985345|NCT02292706|584994594|FG003|Overall Study|Study terminated by sponsor|21|||
161985346|NCT02292706|584994595|FG004|Overall Study|Study terminated by sponsor|11|||
161985347|NCT02292706|584994596|FG005|Overall Study|Study terminated by sponsor|13|||
161985348|NCT02292706|584994597|FG006|Overall Study|Study terminated by sponsor|3|||
161985349|NCT02292706|584994598|FG007|Overall Study|Study terminated by sponsor|0|||
161985350|NCT02292706|584994591|FG000|Overall Study|Investigator's discretion|4|||
161985351|NCT02292706|584994592|FG001|Overall Study|Investigator's discretion|9|||
161985352|NCT02292706|584994593|FG002|Overall Study|Investigator's discretion|7|||
161985353|NCT02292706|584994594|FG003|Overall Study|Investigator's discretion|11|||
161985354|NCT02292706|584994595|FG004|Overall Study|Investigator's discretion|4|||
161985355|NCT02292706|584994596|FG005|Overall Study|Investigator's discretion|10|||
161985356|NCT02292706|584994597|FG006|Overall Study|Investigator's discretion|1|||
161985357|NCT02292706|584994598|FG007|Overall Study|Investigator's discretion|0|||
161985358|NCT02292706|584994591|FG000|Overall Study|Liver transplant|1|||
161985359|NCT02292706|584994592|FG001|Overall Study|Liver transplant|1|||
161985360|NCT02292706|584994593|FG002|Overall Study|Liver transplant|11|||
161985361|NCT02292706|584994594|FG003|Overall Study|Liver transplant|16|||
161985362|NCT02292706|584994595|FG004|Overall Study|Liver transplant|5|||
161985363|NCT02292706|584994596|FG005|Overall Study|Liver transplant|6|||
161985364|NCT02292706|584994597|FG006|Overall Study|Liver transplant|5|||
161985365|NCT02292706|584994598|FG007|Overall Study|Liver transplant|0|||
161985366|NCT02292706|584994591|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
161985367|NCT02292706|584994592|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
161985368|NCT02292706|584994593|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
161985369|NCT02292706|584994594|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
161985370|NCT02292706|584994595|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
161985371|NCT02292706|584994596|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
161985372|NCT02292706|584994597|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
161985373|NCT02292706|584994598|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
161985374|NCT02292706|584994591|FG000|Overall Study|Subject terminated by sponsor|1|||
161985375|NCT02292706|584994592|FG001|Overall Study|Subject terminated by sponsor|0|||
161985376|NCT02292706|584994593|FG002|Overall Study|Subject terminated by sponsor|0|||
161985377|NCT02292706|584994594|FG003|Overall Study|Subject terminated by sponsor|2|||
161985378|NCT02292706|584994595|FG004|Overall Study|Subject terminated by sponsor|1|||
161985379|NCT02292706|584994596|FG005|Overall Study|Subject terminated by sponsor|0|||
161985380|NCT02292706|584994597|FG006|Overall Study|Subject terminated by sponsor|0|||
161985381|NCT02292706|584994598|FG007|Overall Study|Subject terminated by sponsor|0|||
161985382|NCT02292706|584994591|FG000|Overall Study|Missing|0|||
161985383|NCT02292706|584994592|FG001|Overall Study|Missing|0|||
161985384|NCT02292706|584994593|FG002|Overall Study|Missing|1|||
161985385|NCT02292706|584994594|FG003|Overall Study|Missing|1|||
161985386|NCT02292706|584994595|FG004|Overall Study|Missing|0|||
161985387|NCT02292706|584994596|FG005|Overall Study|Missing|1|||
161985388|NCT02292706|584994597|FG006|Overall Study|Missing|0|||
161985389|NCT02292706|584994598|FG007|Overall Study|Missing|0|||
161985390|NCT02292706|584994591|FG000|Overall Study|Virologic relapse or reinfection|1|||
161985391|NCT02292706|584994592|FG001|Overall Study|Virologic relapse or reinfection|0|||
161985392|NCT02292706|584994593|FG002|Overall Study|Virologic relapse or reinfection|0|||
161985393|NCT02292706|584994594|FG003|Overall Study|Virologic relapse or reinfection|1|||
161985394|NCT02292706|584994595|FG004|Overall Study|Virologic relapse or reinfection|0|||
161985395|NCT02292706|584994596|FG005|Overall Study|Virologic relapse or reinfection|1|||
161985396|NCT02292706|584994597|FG006|Overall Study|Virologic relapse or reinfection|0|||
161985397|NCT02292706|584994598|FG007|Overall Study|Virologic relapse or reinfection|0|||
161985398|NCT01990612|584994603|FG000|Overall Study|Lost to Follow-up|2|||
161985399|NCT01990612|584994604|FG001|Overall Study|Lost to Follow-up|1|||
161985400|NCT01990612|584994603|FG000|Overall Study|Withdrawal by Subject|5|||
161985401|NCT01990612|584994604|FG001|Overall Study|Withdrawal by Subject|2|||
161985402|NCT02725866|584994605|FG000|Overall Study|Failure to return|6|||
161985403|NCT02725866|584994605|FG000|Overall Study|Withdrew consent|3|||
161985404|NCT02725866|584994605|FG000|Overall Study|Insufficient virological response|1|||
161985405|NCT02725866|584994605|FG000|Overall Study|Other, not specified|4|||
161985406|NCT02188849|584994608|FG000|Overall Study|Lost to Follow-up|3|||
161985407|NCT02188849|584994609|FG001|Overall Study|Lost to Follow-up|8|||
161985408|NCT02980133|584994611|FG000|Overall Study|Other than specified|1|||
161985409|NCT02980133|584994612|FG001|Overall Study|Other than specified|1|||
161985410|NCT02980133|584994613|FG002|Overall Study|Other than specified|2|||
161985411|NCT02980133|584994614|FG003|Overall Study|Other than specified|2|||
161985412|NCT02980133|584994611|FG000|Overall Study|Lost to Follow-up|0|||
161985413|NCT02980133|584994612|FG001|Overall Study|Lost to Follow-up|0|||
161985414|NCT02980133|584994613|FG002|Overall Study|Lost to Follow-up|1|||
161985415|NCT02980133|584994614|FG003|Overall Study|Lost to Follow-up|3|||
161985416|NCT02980133|584994611|FG000|Overall Study|Protocol Violation|0|||
161985417|NCT02980133|584994612|FG001|Overall Study|Protocol Violation|1|||
161985418|NCT02980133|584994613|FG002|Overall Study|Protocol Violation|0|||
161985419|NCT02980133|584994614|FG003|Overall Study|Protocol Violation|0|||
161985420|NCT02980133|584994611|FG000|Overall Study|Withdrawal by parent/guardian|6|||
161985421|NCT02980133|584994612|FG001|Overall Study|Withdrawal by parent/guardian|3|||
161985422|NCT02980133|584994613|FG002|Overall Study|Withdrawal by parent/guardian|3|||
161985423|NCT02980133|584994614|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161985424|NCT02980133|584994611|FG000|Overall Study|Withdrawal by Subject|0|||
161985425|NCT02980133|584994612|FG001|Overall Study|Withdrawal by Subject|0|||
161985426|NCT02980133|584994613|FG002|Overall Study|Withdrawal by Subject|1|||
161985427|NCT02980133|584994614|FG003|Overall Study|Withdrawal by Subject|0|||
161985428|NCT03208088|584994621|FG000|Period 2|Withdrawal by Subject|0|||
161985429|NCT03208088|584994622|FG001|Period 2|Withdrawal by Subject|0|||
161985430|NCT03208088|584994623|FG002|Period 2|Withdrawal by Subject|0|||
161985431|NCT03208088|584994624|FG003|Period 2|Withdrawal by Subject|0|||
161985432|NCT03208088|584994625|FG004|Period 2|Withdrawal by Subject|0|||
162035120|NCT05952401|585184872|FG001|Overall Study|Lost to Follow-up|1|||
161985433|NCT03208088|584994626|FG005|Period 2|Withdrawal by Subject|0|||
161985434|NCT03208088|584994627|FG006|Period 2|Withdrawal by Subject|0|||
161985435|NCT03208088|584994628|FG007|Period 2|Withdrawal by Subject|0|||
161985436|NCT03208088|584994629|FG008|Period 2|Withdrawal by Subject|1|||
161985437|NCT03208088|584994630|FG009|Period 2|Withdrawal by Subject|0|||
161985438|NCT03208088|584994621|FG000|Period 3|Unsatisfactory Test Article|0|||
161985439|NCT03208088|584994622|FG001|Period 3|Unsatisfactory Test Article|0|||
161985440|NCT03208088|584994623|FG002|Period 3|Unsatisfactory Test Article|0|||
161985441|NCT03208088|584994624|FG003|Period 3|Unsatisfactory Test Article|1|||
161985442|NCT03208088|584994625|FG004|Period 3|Unsatisfactory Test Article|0|||
162035121|NCT03954041|585185839|FG000|Overall Study|Lost to Follow-up|3|||
161871160|NCT02343939|584573702|FG002|Overall Study|Treatment failure|0|||
161985443|NCT03208088|584994626|FG005|Period 3|Unsatisfactory Test Article|0|||
161985444|NCT03208088|584994627|FG006|Period 3|Unsatisfactory Test Article|0|||
161985445|NCT03208088|584994628|FG007|Period 3|Unsatisfactory Test Article|0|||
162035122|NCT03954041|585185840|FG001|Overall Study|Lost to Follow-up|3|||
161985446|NCT03208088|584994629|FG008|Period 3|Unsatisfactory Test Article|0|||
161985447|NCT03208088|584994630|FG009|Period 3|Unsatisfactory Test Article|0|||
161985448|NCT03208088|584994621|FG000|Period 4|Unsatisfactory Test Article|0|||
161985449|NCT03208088|584994622|FG001|Period 4|Unsatisfactory Test Article|0|||
161985450|NCT03208088|584994623|FG002|Period 4|Unsatisfactory Test Article|0|||
161985451|NCT03208088|584994624|FG003|Period 4|Unsatisfactory Test Article|1|||
161871161|NCT02343939|584573703|FG003|Overall Study|Treatment failure|0|||
161871162|NCT02343939|584573704|FG004|Overall Study|Treatment failure|0|||
161871163|NCT02343939|584573705|FG005|Overall Study|Treatment failure|0|||
161871164|NCT02343939|584573706|FG006|Overall Study|Treatment failure|2|||
161871165|NCT02343939|584573707|FG007|Overall Study|Treatment failure|1|||
161871166|NCT02343939|584573708|FG008|Overall Study|Treatment failure|0|||
161871167|NCT02343939|584573700|FG000|Overall Study|Investigator's discretion|0|||
161871168|NCT02343939|584573701|FG001|Overall Study|Investigator's discretion|0|||
161871169|NCT02343939|584573702|FG002|Overall Study|Investigator's discretion|0|||
161871170|NCT02343939|584573703|FG003|Overall Study|Investigator's discretion|1|||
161871171|NCT02343939|584573704|FG004|Overall Study|Investigator's discretion|0|||
161871172|NCT02343939|584573705|FG005|Overall Study|Investigator's discretion|0|||
161871173|NCT02343939|584573706|FG006|Overall Study|Investigator's discretion|1|||
161871174|NCT02343939|584573707|FG007|Overall Study|Investigator's discretion|0|||
161871175|NCT02343939|584573708|FG008|Overall Study|Investigator's discretion|0|||
161871176|NCT02343939|584573700|FG000|Overall Study|Adverse Event|0|||
161871177|NCT02343939|584573701|FG001|Overall Study|Adverse Event|0|||
161871178|NCT02343939|584573702|FG002|Overall Study|Adverse Event|0|||
161871179|NCT02343939|584573703|FG003|Overall Study|Adverse Event|0|||
161871180|NCT02343939|584573704|FG004|Overall Study|Adverse Event|0|||
161871181|NCT02343939|584573705|FG005|Overall Study|Adverse Event|1|||
161871182|NCT02343939|584573706|FG006|Overall Study|Adverse Event|0|||
161871183|NCT02343939|584573707|FG007|Overall Study|Adverse Event|0|||
161871184|NCT02343939|584573708|FG008|Overall Study|Adverse Event|0|||
161871185|NCT02343939|584573700|FG000|Overall Study|Never Treated With ENTO|0|||
161871186|NCT02343939|584573701|FG001|Overall Study|Never Treated With ENTO|0|||
161871187|NCT02343939|584573702|FG002|Overall Study|Never Treated With ENTO|0|||
161871188|NCT02343939|584573703|FG003|Overall Study|Never Treated With ENTO|0|||
161871189|NCT02343939|584573704|FG004|Overall Study|Never Treated With ENTO|0|||
161871190|NCT02343939|584573705|FG005|Overall Study|Never Treated With ENTO|0|||
161871191|NCT02343939|584573706|FG006|Overall Study|Never Treated With ENTO|1|||
161871192|NCT02343939|584573707|FG007|Overall Study|Never Treated With ENTO|2|||
161871193|NCT02343939|584573708|FG008|Overall Study|Never Treated With ENTO|0|||
161871194|NCT01303172|584573709|FG000|Overall Study|Physician Decision|9|||
161871195|NCT01303172|584573710|FG001|Overall Study|Physician Decision|6|||
161871196|NCT01303172|584573709|FG000|Overall Study|Adverse Event|5|||
161871197|NCT01303172|584573710|FG001|Overall Study|Adverse Event|2|||
161871198|NCT01303172|584573709|FG000|Overall Study|Withdrawal by Subject|4|||
161871199|NCT01303172|584573710|FG001|Overall Study|Withdrawal by Subject|2|||
161871200|NCT01303172|584573709|FG000|Overall Study|Death|20|||
161871201|NCT01303172|584573710|FG001|Overall Study|Death|7|||
161871202|NCT01303172|584573709|FG000|Overall Study|Lack of Efficacy|25|||
161871203|NCT01303172|584573710|FG001|Overall Study|Lack of Efficacy|17|||
161871204|NCT02684097|584573711|FG000|Overall Study|Lack of Efficacy|13|||
161871205|NCT02684097|584573712|FG001|Overall Study|Lack of Efficacy|6|||
161871206|NCT00462709|584573713|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
161871207|NCT00462709|584573713|FG000|Overall Study|Lost to Follow-up|10|||
161871208|NCT00462709|584573713|FG000|Overall Study|Withdrawal by Subject|8|||
161871209|NCT00462709|584573713|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
161871210|NCT00462709|584573713|FG000|Overall Study|Death|2|||
161871211|NCT00462709|584573713|FG000|Overall Study|Logistical reasons|2|||
161985452|NCT03208088|584994625|FG004|Period 4|Unsatisfactory Test Article|0|||
161985453|NCT03208088|584994626|FG005|Period 4|Unsatisfactory Test Article|0|||
161985454|NCT03208088|584994627|FG006|Period 4|Unsatisfactory Test Article|0|||
161985455|NCT03208088|584994628|FG007|Period 4|Unsatisfactory Test Article|0|||
161871212|NCT00462709|584573713|FG000|Overall Study|Physician Decision|1|||
161871213|NCT00462709|584573713|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
161871214|NCT02099110|584573718|FG000|Overall Study|Protocol Violation|2|||
161985456|NCT03208088|584994629|FG008|Period 4|Unsatisfactory Test Article|0|||
161985457|NCT03208088|584994630|FG009|Period 4|Unsatisfactory Test Article|0|||
161985458|NCT00605345|584994636|FG000|Overall Study|Withdrawal by Subject|1|||
162035123|NCT03954041|585185841|FG002|Overall Study|Lost to Follow-up|6|||
161871215|NCT02099110|584573719|FG001|Overall Study|Protocol Violation|1|||
161871216|NCT02099110|584573720|FG002|Overall Study|Protocol Violation|0|||
161871217|NCT02099110|584573721|FG003|Overall Study|Protocol Violation|3|||
161871218|NCT02099110|584573722|FG004|Overall Study|Protocol Violation|1|||
161871219|NCT02099110|584573718|FG000|Overall Study|Participant moved|1|||
161871220|NCT02099110|584573719|FG001|Overall Study|Participant moved|1|||
161871221|NCT02099110|584573720|FG002|Overall Study|Participant moved|1|||
161871222|NCT02099110|584573721|FG003|Overall Study|Participant moved|0|||
161871223|NCT02099110|584573722|FG004|Overall Study|Participant moved|2|||
161871224|NCT02099110|584573718|FG000|Overall Study|Withdrawal by Subject|7|||
161985459|NCT00605345|584994637|FG001|Overall Study|Withdrawal by Subject|0|||
161985460|NCT00605345|584994636|FG000|Overall Study|Adverse Event|0|||
161985461|NCT00605345|584994637|FG001|Overall Study|Adverse Event|1|||
161985462|NCT00605345|584994636|FG000|Overall Study|Protocol Violation|0|||
161985463|NCT00605345|584994637|FG001|Overall Study|Protocol Violation|2|||
161985464|NCT02577016|584994638|FG000|Overall Study|Adverse Event|2|||
161985465|NCT02577016|584994639|FG001|Overall Study|Adverse Event|1|||
161985466|NCT02577016|584994638|FG000|Overall Study|Physician Decision|0|||
161985467|NCT02577016|584994639|FG001|Overall Study|Physician Decision|1|||
161985468|NCT02126839|584994640|FG000|Overall Study|Adverse Event|0|||
161985469|NCT02126839|584994641|FG001|Overall Study|Adverse Event|1|||
161985470|NCT02126839|584994640|FG000|Overall Study|Withdrawal by Subject|1|||
161985471|NCT02126839|584994641|FG001|Overall Study|Withdrawal by Subject|0|||
161985472|NCT02126839|584994640|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161985473|NCT02126839|584994641|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161985474|NCT02126839|584994640|FG000|Overall Study|Protocol Violation|2|||
161985475|NCT02126839|584994641|FG001|Overall Study|Protocol Violation|3|||
161985476|NCT02126839|584994640|FG000|Overall Study|Sponsor request|0|||
161985477|NCT02126839|584994641|FG001|Overall Study|Sponsor request|1|||
161985478|NCT02126839|584994640|FG000|Overall Study|Lost to Follow-up|1|||
161985479|NCT02126839|584994641|FG001|Overall Study|Lost to Follow-up|4|||
161985480|NCT02126839|584994640|FG000|Overall Study|Other|5|||
161985481|NCT02126839|584994641|FG001|Overall Study|Other|5|||
161985482|NCT01108523|584994642|FG000|Overall Study|Protocol Violation|4|||
161985483|NCT00687531|584994643|FG000|Overall Study|Did not meet protocol eligibility|104|||
161985484|NCT00687531|584994643|FG000|Overall Study|Adverse Event|5|||
161985485|NCT00687531|584994643|FG000|Overall Study|Lost to Follow-up|26|||
161985486|NCT00547521|584994646|FG000|Short Term Study (4 Months)|Adverse Event|1|||
161985487|NCT00547521|584994647|FG001|Short Term Study (4 Months)|Adverse Event|0|||
161985488|NCT00547521|584994646|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
161985489|NCT00547521|584994647|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
161985490|NCT00547521|584994646|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
161985491|NCT00547521|584994647|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
161985492|NCT00547521|584994646|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
161985493|NCT00547521|584994647|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
161985494|NCT00547521|584994646|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
161985495|NCT00547521|584994647|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
161985496|NCT00547521|584994646|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
161985497|NCT00547521|584994647|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
161985498|NCT00547521|584994646|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
161985499|NCT00547521|584994647|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
161985500|NCT00547521|584994646|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
161985501|NCT00547521|584994647|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
161985502|NCT00547521|584994646|FG000|Long Term Extension (LTE) Study|Other|0|||
161985503|NCT00547521|584994647|FG001|Long Term Extension (LTE) Study|Other|2|||
161985504|NCT00547521|584994646|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
161985505|NCT00547521|584994647|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
161985506|NCT00239928|584996180|FG000|Overall Study|Lack of Efficacy|1|||
161985507|NCT00239928|584996180|FG000|Overall Study|Adverse Event|4|||
161985508|NCT00239928|584996180|FG000|Overall Study|Not need to continue study|3|||
161985509|NCT00239928|584996180|FG000|Overall Study|Withdrawal by Subject|2|||
161985510|NCT02942485|584996181|FG000|Overall Study|Lost to Follow-up|1|||
161985511|NCT02942485|584996182|FG001|Overall Study|Lost to Follow-up|0|||
161985512|NCT00902174|584996190|FG000|Overall Study|Adverse Event|27|||
161985513|NCT00902174|584996191|FG001|Overall Study|Adverse Event|7|||
161985514|NCT00902174|584996190|FG000|Overall Study|Lack of Efficacy|1|||
161985515|NCT00902174|584996191|FG001|Overall Study|Lack of Efficacy|5|||
161985516|NCT00902174|584996190|FG000|Overall Study|Death|2|||
161985517|NCT00902174|584996191|FG001|Overall Study|Death|2|||
161985518|NCT00902174|584996190|FG000|Overall Study|Withdrawal by Subject|2|||
162035124|NCT03954041|585185839|FG000|Overall Study|Death|4|||
161871225|NCT02099110|584573719|FG001|Overall Study|Withdrawal by Subject|11|||
161871226|NCT02099110|584573720|FG002|Overall Study|Withdrawal by Subject|13|||
161871227|NCT02099110|584573721|FG003|Overall Study|Withdrawal by Subject|9|||
161871228|NCT02099110|584573722|FG004|Overall Study|Withdrawal by Subject|13|||
161871229|NCT02099110|584573718|FG000|Overall Study|Adverse Event|3|||
161985519|NCT00902174|584996191|FG001|Overall Study|Withdrawal by Subject|1|||
161985520|NCT00902174|584996190|FG000|Overall Study|Abnormal labs|1|||
161985521|NCT00902174|584996191|FG001|Overall Study|Abnormal labs|1|||
161985522|NCT00902174|584996190|FG000|Overall Study|Protocol Violation|1|||
161985523|NCT00902174|584996191|FG001|Overall Study|Protocol Violation|1|||
161985524|NCT00902174|584996190|FG000|Overall Study|Administration problem|0|||
161985525|NCT00902174|584996191|FG001|Overall Study|Administration problem|1|||
161985526|NCT00764673|584996193|FG000|Overall Study|Death|1|||
161985527|NCT00764673|584996193|FG000|Overall Study|Lost to Follow-up|3|||
161871230|NCT02099110|584573719|FG001|Overall Study|Adverse Event|5|||
161871231|NCT02099110|584573720|FG002|Overall Study|Adverse Event|2|||
161871232|NCT02099110|584573721|FG003|Overall Study|Adverse Event|3|||
161871233|NCT02099110|584573722|FG004|Overall Study|Adverse Event|2|||
161871234|NCT02099110|584573718|FG000|Overall Study|Lost to Follow-up|6|||
161871235|NCT02099110|584573719|FG001|Overall Study|Lost to Follow-up|12|||
161871236|NCT02099110|584573720|FG002|Overall Study|Lost to Follow-up|11|||
161871237|NCT02099110|584573721|FG003|Overall Study|Lost to Follow-up|5|||
161871238|NCT02099110|584573722|FG004|Overall Study|Lost to Follow-up|6|||
161871239|NCT02099110|584573718|FG000|Overall Study|Death|0|||
161871240|NCT02099110|584573719|FG001|Overall Study|Death|1|||
161871241|NCT02099110|584573720|FG002|Overall Study|Death|0|||
161871242|NCT02099110|584573721|FG003|Overall Study|Death|0|||
161871243|NCT02099110|584573722|FG004|Overall Study|Death|0|||
161871244|NCT02099110|584573718|FG000|Overall Study|Screen failure|0|||
161871245|NCT02099110|584573719|FG001|Overall Study|Screen failure|0|||
161871246|NCT02099110|584573720|FG002|Overall Study|Screen failure|0|||
161871247|NCT02099110|584573721|FG003|Overall Study|Screen failure|0|||
161871248|NCT02099110|584573722|FG004|Overall Study|Screen failure|1|||
161871249|NCT02099110|584573718|FG000|Overall Study|Non-compliance with study drug|2|||
161871250|NCT02099110|584573719|FG001|Overall Study|Non-compliance with study drug|0|||
161871251|NCT02099110|584573720|FG002|Overall Study|Non-compliance with study drug|0|||
161871252|NCT02099110|584573721|FG003|Overall Study|Non-compliance with study drug|0|||
161871253|NCT02099110|584573722|FG004|Overall Study|Non-compliance with study drug|1|||
161871254|NCT02099110|584573718|FG000|Overall Study|Physician Decision|3|||
161871255|NCT02099110|584573719|FG001|Overall Study|Physician Decision|0|||
161871256|NCT02099110|584573720|FG002|Overall Study|Physician Decision|1|||
161871257|NCT02099110|584573721|FG003|Overall Study|Physician Decision|2|||
161871258|NCT02099110|584573722|FG004|Overall Study|Physician Decision|1|||
161871259|NCT02064816|584573723|FG000|Overall Study|Adverse Event|3|||
161871260|NCT02064816|584573724|FG001|Overall Study|Adverse Event|2|||
161871261|NCT02064816|584573723|FG000|Overall Study|Withdrawal by Subject|2|||
161871262|NCT02064816|584573724|FG001|Overall Study|Withdrawal by Subject|1|||
161871263|NCT02064816|584573723|FG000|Overall Study|Lost to Follow-up|2|||
161871264|NCT02064816|584573724|FG001|Overall Study|Lost to Follow-up|1|||
161871265|NCT02064816|584573723|FG000|Overall Study|Therapeutic failure|0|||
161871266|NCT02064816|584573724|FG001|Overall Study|Therapeutic failure|1|||
161871267|NCT02064816|584573723|FG000|Overall Study|Other|1|||
161871268|NCT02064816|584573724|FG001|Overall Study|Other|3|||
161871269|NCT01757184|584573731|FG000|Double-blind Period|Adverse Event|1|||
161871270|NCT01757184|584573732|FG001|Double-blind Period|Adverse Event|0|||
161871271|NCT01757184|584573733|FG002|Double-blind Period|Adverse Event|0|||
161871272|NCT01757184|584573734|FG003|Double-blind Period|Adverse Event|0|||
161871273|NCT01757184|584573731|FG000|Open-label Period|Lost to Follow-up|0|||
161871274|NCT01757184|584573732|FG001|Open-label Period|Lost to Follow-up|0|||
161871275|NCT01757184|584573733|FG002|Open-label Period|Lost to Follow-up|2|||
161871276|NCT01757184|584573734|FG003|Open-label Period|Lost to Follow-up|0|||
161871277|NCT01757184|584573731|FG000|Open-label Period|Withdrawal by Subject|0|||
161871278|NCT01757184|584573732|FG001|Open-label Period|Withdrawal by Subject|0|||
161871279|NCT01757184|584573733|FG002|Open-label Period|Withdrawal by Subject|1|||
161871280|NCT01757184|584573734|FG003|Open-label Period|Withdrawal by Subject|1|||
161871281|NCT01757184|584573731|FG000|Open-label Period|Discontinued by Sponsor|0|||
161871282|NCT01757184|584573732|FG001|Open-label Period|Discontinued by Sponsor|0|||
161871283|NCT01757184|584573733|FG002|Open-label Period|Discontinued by Sponsor|1|||
161871284|NCT01757184|584573734|FG003|Open-label Period|Discontinued by Sponsor|2|||
161871285|NCT00237458|584573735|FG000|Overall Study|Lack of Efficacy|1|||
161871286|NCT00237458|584573735|FG000|Overall Study|Adverse Event|1|||
161871287|NCT00237458|584573735|FG000|Overall Study|Withdrawal by Subject|1|||
161871288|NCT05107492|584573736|FG000|Overall Study|Lost to Follow-up|1|||
161871289|NCT05107492|584573737|FG001|Overall Study|Lost to Follow-up|0|||
161871290|NCT03218826|584573738|FG000|Overall Study|Non-compliance with protocol|1|||
161871291|NCT03218826|584573739|FG001|Overall Study|Non-compliance with protocol|0|||
161871292|NCT03218826|584573740|FG002|Overall Study|Non-compliance with protocol|2|||
161871293|NCT03218826|584573741|FG003|Overall Study|Non-compliance with protocol|1|||
161871294|NCT03218826|584573742|FG004|Overall Study|Non-compliance with protocol|1|||
161871295|NCT04586244|584573749|FG000|Overall Study|Lost to Follow-up|1|||
161871296|NCT04586244|584573750|FG001|Overall Study|Lost to Follow-up|0|||
161871297|NCT04586244|584573751|FG002|Overall Study|Lost to Follow-up|0|||
161871298|NCT04586244|584573752|FG003|Overall Study|Lost to Follow-up|1|||
161871299|NCT04586244|584573753|FG004|Overall Study|Lost to Follow-up|0|||
161871300|NCT04586244|584573749|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
161871301|NCT04586244|584573750|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
161871302|NCT04586244|584573751|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
161871303|NCT04586244|584573752|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
161871304|NCT04586244|584573753|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
161871305|NCT03564119|584573754|FG000|Overall Study|Adverse Event|4|||
161871306|NCT03564119|584573755|FG001|Overall Study|Adverse Event|0|||
161985528|NCT00764673|584996193|FG000|Overall Study|Withdrawal by Subject|6|||
161985529|NCT00764673|584996193|FG000|Overall Study|Revision of Device|2|||
161985530|NCT01331291|584996196|FG000|Overall Study|Lack of Efficacy|2|||
161985531|NCT01331291|584996197|FG001|Overall Study|Lack of Efficacy|8|||
161985532|NCT01331291|584996196|FG000|Overall Study|Death|0|||
161985533|NCT01331291|584996197|FG001|Overall Study|Death|1|||
161985534|NCT01805037|584996204|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
161985535|NCT01805037|584996205|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
161985536|NCT01805037|584996204|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
161985537|NCT01805037|584996205|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
161985538|NCT01805037|584996204|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
161985539|NCT01805037|584996205|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
161985540|NCT01805037|584996204|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
161985541|NCT01805037|584996205|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
161985542|NCT01805037|584996204|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
161985543|NCT01805037|584996205|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
161985544|NCT01805037|584996204|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
161985545|NCT01805037|584996205|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
161985546|NCT01805037|584996204|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
161985547|NCT01805037|584996205|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
161985548|NCT01805037|584996204|FG000|Follow Up (up to 3 Years)|Death|0|||
161985549|NCT01805037|584996205|FG001|Follow Up (up to 3 Years)|Death|2|||
161985550|NCT01805037|584996204|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
161985551|NCT01805037|584996205|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
161985552|NCT01805037|584996204|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
161985553|NCT01805037|584996205|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
161985554|NCT01270256|584996206|FG000|Overall Study|Withdrawal by Subject|1|||
161985555|NCT01270256|584996207|FG001|Overall Study|Withdrawal by Subject|0|||
161985556|NCT04566692|584996211|FG000|Overall Study|Adverse Event|2|||
161985557|NCT04566692|584996212|FG001|Overall Study|Adverse Event|0|||
161985558|NCT04566692|584996211|FG000|Overall Study|Withdrawal by Subject|1|||
161985559|NCT04566692|584996212|FG001|Overall Study|Withdrawal by Subject|1|||
161985560|NCT01183468|584996213|FG000|Overall Study|Lost to Follow-up|2|||
161985561|NCT01183468|584996214|FG001|Overall Study|Lost to Follow-up|1|||
161985562|NCT01183468|584996215|FG002|Overall Study|Lost to Follow-up|0|||
161985563|NCT01183468|584996216|FG003|Overall Study|Lost to Follow-up|0|||
161985564|NCT01183468|584996213|FG000|Overall Study|Physician Decision|1|||
161985565|NCT01183468|584996214|FG001|Overall Study|Physician Decision|0|||
161985566|NCT01183468|584996215|FG002|Overall Study|Physician Decision|0|||
161985567|NCT01183468|584996216|FG003|Overall Study|Physician Decision|0|||
161985568|NCT01183468|584996213|FG000|Overall Study|Withdrawal by Subject|0|||
161985569|NCT01183468|584996214|FG001|Overall Study|Withdrawal by Subject|1|||
161985570|NCT01183468|584996215|FG002|Overall Study|Withdrawal by Subject|0|||
161985571|NCT01183468|584996216|FG003|Overall Study|Withdrawal by Subject|0|||
161985572|NCT00590577|584996217|FG000|Overall Study|Lack of Efficacy|31|||
161985573|NCT00590577|584996218|FG001|Overall Study|Lack of Efficacy|28|||
161985574|NCT00590577|584996219|FG002|Overall Study|Lack of Efficacy|23|||
161985575|NCT00590577|584996220|FG003|Overall Study|Lack of Efficacy|45|||
161985576|NCT00590577|584996217|FG000|Overall Study|Withdrawal by Subject|23|||
161985577|NCT00590577|584996218|FG001|Overall Study|Withdrawal by Subject|28|||
161985578|NCT00590577|584996219|FG002|Overall Study|Withdrawal by Subject|30|||
161985579|NCT00590577|584996220|FG003|Overall Study|Withdrawal by Subject|26|||
161985580|NCT00590577|584996217|FG000|Overall Study|Adverse Event|10|||
161985581|NCT00590577|584996218|FG001|Overall Study|Adverse Event|10|||
161985582|NCT00590577|584996219|FG002|Overall Study|Adverse Event|13|||
161985583|NCT00590577|584996220|FG003|Overall Study|Adverse Event|11|||
161985584|NCT00590577|584996217|FG000|Overall Study|Lost to Follow-up|12|||
161985585|NCT00590577|584996218|FG001|Overall Study|Lost to Follow-up|6|||
161985586|NCT00590577|584996219|FG002|Overall Study|Lost to Follow-up|6|||
161985587|NCT00590577|584996220|FG003|Overall Study|Lost to Follow-up|9|||
161985588|NCT00590577|584996217|FG000|Overall Study|Pregnancy|0|||
161985589|NCT00590577|584996218|FG001|Overall Study|Pregnancy|1|||
161985590|NCT00590577|584996219|FG002|Overall Study|Pregnancy|0|||
161775360|NCT00650806|584219453|FG000|Overall Study|Study terminated by sponsor|2|||
161775361|NCT00650806|584219454|FG001|Overall Study|Study terminated by sponsor|3|||
161775362|NCT00650806|584219455|FG002|Overall Study|Study terminated by sponsor|5|||
161985591|NCT00590577|584996220|FG003|Overall Study|Pregnancy|0|||
161985592|NCT00590577|584996217|FG000|Overall Study|Various reasons|1|||
161985593|NCT00590577|584996218|FG001|Overall Study|Various reasons|3|||
161985594|NCT00590577|584996219|FG002|Overall Study|Various reasons|1|||
161985595|NCT00590577|584996220|FG003|Overall Study|Various reasons|2|||
161985596|NCT03927404|584996222|FG000|Overall Study|Withdrawal by Subject|1|||
161985597|NCT01229449|584996223|FG000|Overall Study|Withdrawal by Subject|0|||
161775363|NCT00650806|584219456|FG003|Overall Study|Study terminated by sponsor|4|||
161775364|NCT00650806|584219453|FG000|Overall Study|Other|1|||
161985598|NCT01229449|584996224|FG001|Overall Study|Withdrawal by Subject|3|||
161985599|NCT01229449|584996225|FG002|Overall Study|Withdrawal by Subject|0|||
161871307|NCT03564119|584573754|FG000|Overall Study|Lost to Follow-up|1|||
161871308|NCT03564119|584573755|FG001|Overall Study|Lost to Follow-up|4|||
161871309|NCT03564119|584573754|FG000|Overall Study|Protocol Violation|1|||
161871310|NCT03564119|584573755|FG001|Overall Study|Protocol Violation|0|||
161871311|NCT03564119|584573754|FG000|Overall Study|Withdrawal by Subject|9|||
161871312|NCT03564119|584573755|FG001|Overall Study|Withdrawal by Subject|4|||
161871313|NCT03564119|584573754|FG000|Overall Study|Other Than Specified|0|||
161871314|NCT03564119|584573755|FG001|Overall Study|Other Than Specified|1|||
161871315|NCT00634036|584573756|FG000|Overall Study|Lost to Follow-up|1|||
161871316|NCT00634036|584573757|FG001|Overall Study|Lost to Follow-up|1|||
161871317|NCT00634036|584573756|FG000|Overall Study|Withdrawal by Subject|1|||
161775365|NCT00650806|584219454|FG001|Overall Study|Other|1|||
161775366|NCT00650806|584219455|FG002|Overall Study|Other|2|||
161775367|NCT00650806|584219456|FG003|Overall Study|Other|0|||
161775368|NCT04228107|584219457|FG000|Overall Study|Protocol Violation|1|||
161775369|NCT04228107|584219458|FG001|Overall Study|Protocol Violation|0|||
161775370|NCT04228107|584219457|FG000|Overall Study|Withdrawal by Subject|6|||
161775371|NCT04228107|584219458|FG001|Overall Study|Withdrawal by Subject|0|||
161775372|NCT04228107|584219457|FG000|Overall Study|Lost to Follow-up|18|||
161775373|NCT04228107|584219458|FG001|Overall Study|Lost to Follow-up|0|||
161775374|NCT04228107|584219457|FG000|Overall Study|No controller use data|1|||
161775375|NCT04228107|584219458|FG001|Overall Study|No controller use data|0|||
161775376|NCT04228107|584219457|FG000|Overall Study|No medication data collected|1|||
161775377|NCT04228107|584219458|FG001|Overall Study|No medication data collected|0|||
161775378|NCT03792633|584219459|FG000|Overall Study|Alternative Treatment|17|||
161775379|NCT03792633|584219460|FG001|Overall Study|Alternative Treatment|19|||
161775380|NCT03792633|584219459|FG000|Overall Study|Death|2|||
161775381|NCT03792633|584219460|FG001|Overall Study|Death|0|||
161775382|NCT03792633|584219459|FG000|Overall Study|Disease progression|8|||
161775383|NCT03792633|584219460|FG001|Overall Study|Disease progression|9|||
161775384|NCT03792633|584219459|FG000|Overall Study|Lost to Follow-up|1|||
161775385|NCT03792633|584219460|FG001|Overall Study|Lost to Follow-up|1|||
161775386|NCT03792633|584219459|FG000|Overall Study|Screen fail|1|||
161775387|NCT03792633|584219460|FG001|Overall Study|Screen fail|0|||
161775388|NCT03792633|584219459|FG000|Overall Study|Second malignancy|0|||
161775389|NCT03792633|584219460|FG001|Overall Study|Second malignancy|1|||
161775390|NCT00145119|584219461|FG000|Overall Study|Death|45|||
161775391|NCT04411641|584219462|FG000|DB Period|Other|7|||
161775392|NCT04411641|584219463|FG001|DB Period|Other|27|||
161775393|NCT04411641|584219464|FG002|DB Period|Other|0|||
161775394|NCT04411641|584219465|FG003|DB Period|Other|0|||
161775395|NCT04411641|584219462|FG000|DB Period|Withdrawal by Subject|67|||
161775396|NCT04411641|584219463|FG001|DB Period|Withdrawal by Subject|122|||
161775397|NCT04411641|584219464|FG002|DB Period|Withdrawal by Subject|0|||
161775398|NCT04411641|584219465|FG003|DB Period|Withdrawal by Subject|0|||
161775399|NCT04411641|584219462|FG000|DB Period|Progressive disease|76|||
161775400|NCT04411641|584219463|FG001|DB Period|Progressive disease|116|||
161775401|NCT04411641|584219464|FG002|DB Period|Progressive disease|0|||
161775402|NCT04411641|584219465|FG003|DB Period|Progressive disease|0|||
161775403|NCT04411641|584219462|FG000|DB Period|Poor compliance to protocol|1|||
161775404|NCT04411641|584219463|FG001|DB Period|Poor compliance to protocol|5|||
161775405|NCT04411641|584219464|FG002|DB Period|Poor compliance to protocol|0|||
161775406|NCT04411641|584219465|FG003|DB Period|Poor compliance to protocol|0|||
161775407|NCT04411641|584219462|FG000|DB Period|Lack of Efficacy|19|||
161775408|NCT04411641|584219463|FG001|DB Period|Lack of Efficacy|19|||
161775409|NCT04411641|584219464|FG002|DB Period|Lack of Efficacy|0|||
161775410|NCT04411641|584219465|FG003|DB Period|Lack of Efficacy|0|||
161775411|NCT04411641|584219462|FG000|DB Period|Adverse Event|13|||
161775412|NCT04411641|584219463|FG001|DB Period|Adverse Event|29|||
161775413|NCT04411641|584219464|FG002|DB Period|Adverse Event|0|||
161775414|NCT04411641|584219465|FG003|DB Period|Adverse Event|0|||
161775415|NCT04411641|584219462|FG000|DB Period|Randomized and not treated|2|||
161775416|NCT04411641|584219463|FG001|DB Period|Randomized and not treated|2|||
161775417|NCT04411641|584219464|FG002|DB Period|Randomized and not treated|0|||
161775418|NCT04411641|584219465|FG003|DB Period|Randomized and not treated|0|||
161775419|NCT04411641|584219462|FG000|OL|Withdrawal by Subject|0|||
161775420|NCT04411641|584219463|FG001|OL|Withdrawal by Subject|0|||
161775421|NCT04411641|584219464|FG002|OL|Withdrawal by Subject|6|||
161775422|NCT04411641|584219465|FG003|OL|Withdrawal by Subject|17|||
161775423|NCT04411641|584219462|FG000|OL|Progressive disease|0|||
161775424|NCT04411641|584219463|FG001|OL|Progressive disease|0|||
161775425|NCT04411641|584219464|FG002|OL|Progressive disease|1|||
161775426|NCT04411641|584219465|FG003|OL|Progressive disease|2|||
161775427|NCT04411641|584219462|FG000|OL|Poor compliance to protocol|0|||
161775428|NCT04411641|584219463|FG001|OL|Poor compliance to protocol|0|||
161775429|NCT04411641|584219464|FG002|OL|Poor compliance to protocol|1|||
161775430|NCT04411641|584219465|FG003|OL|Poor compliance to protocol|0|||
161775431|NCT04411641|584219462|FG000|OL|Adverse Event|0|||
161775432|NCT04411641|584219463|FG001|OL|Adverse Event|0|||
161985600|NCT01229449|584996226|FG003|Overall Study|Withdrawal by Subject|1|||
161985601|NCT01229449|584996227|FG004|Overall Study|Withdrawal by Subject|1|||
161985602|NCT01229449|584996223|FG000|Overall Study|Lost to Follow-up|1|||
161985603|NCT01229449|584996224|FG001|Overall Study|Lost to Follow-up|1|||
161985604|NCT01229449|584996225|FG002|Overall Study|Lost to Follow-up|1|||
161985605|NCT01229449|584996226|FG003|Overall Study|Lost to Follow-up|0|||
161985606|NCT01229449|584996227|FG004|Overall Study|Lost to Follow-up|0|||
161985607|NCT01229449|584996223|FG000|Overall Study|Physician Decision|0|||
161985608|NCT01229449|584996224|FG001|Overall Study|Physician Decision|0|||
161985609|NCT01229449|584996225|FG002|Overall Study|Physician Decision|1|||
161985610|NCT01229449|584996226|FG003|Overall Study|Physician Decision|0|||
161985611|NCT01229449|584996227|FG004|Overall Study|Physician Decision|0|||
161985612|NCT02540265|584996230|FG000|Overall Study|Lost to Follow-up|0|||
161985613|NCT02540265|584996231|FG001|Overall Study|Lost to Follow-up|0|||
161985614|NCT02540265|584996232|FG002|Overall Study|Lost to Follow-up|1|||
161985615|NCT00324233|584996233|FG000|First Period|unable to insert catheter|1|||
161985616|NCT00324233|584996234|FG001|First Period|unable to insert catheter|0|||
161985617|NCT00324233|584996233|FG000|Second Period|unable to insert catheter|1|||
161985618|NCT00324233|584996234|FG001|Second Period|unable to insert catheter|1|||
161985619|NCT00324233|584996233|FG000|Second Period|Protocol Violation|4|||
161985620|NCT00324233|584996234|FG001|Second Period|Protocol Violation|6|||
161985621|NCT01972789|584996235|FG000|Overall Study|Adverse Event|11|||
161985622|NCT01972789|584996236|FG001|Overall Study|Adverse Event|4|||
161985623|NCT01972789|584996235|FG000|Overall Study|Subject withdrew consent|14|||
161985624|NCT01972789|584996236|FG001|Overall Study|Subject withdrew consent|12|||
161985625|NCT01972789|584996235|FG000|Overall Study|Lost to Follow-up|4|||
161985626|NCT01972789|584996236|FG001|Overall Study|Lost to Follow-up|7|||
161985627|NCT01972789|584996235|FG000|Overall Study|Death|7|||
161985628|NCT01972789|584996236|FG001|Overall Study|Death|5|||
161985629|NCT01972789|584996235|FG000|Overall Study|Protocol deviation|1|||
161985630|NCT01972789|584996236|FG001|Overall Study|Protocol deviation|0|||
161985631|NCT01972789|584996235|FG000|Overall Study|Physician Decision|3|||
161985632|NCT01972789|584996236|FG001|Overall Study|Physician Decision|2|||
161985633|NCT00666965|584996241|FG000|Overall Study|Adverse Event|0|||
161985634|NCT00666965|584996242|FG001|Overall Study|Adverse Event|2|||
161985635|NCT00666965|584996243|FG002|Overall Study|Adverse Event|1|||
161985636|NCT00666965|584996244|FG003|Overall Study|Adverse Event|9|||
161985637|NCT00666965|584996241|FG000|Overall Study|Lack of Efficacy|1|||
161985638|NCT00666965|584996242|FG001|Overall Study|Lack of Efficacy|1|||
161985639|NCT00666965|584996243|FG002|Overall Study|Lack of Efficacy|0|||
161985640|NCT00666965|584996244|FG003|Overall Study|Lack of Efficacy|0|||
161985641|NCT00666965|584996241|FG000|Overall Study|Protocol Violation|0|||
161985642|NCT00666965|584996242|FG001|Overall Study|Protocol Violation|0|||
161985643|NCT00666965|584996243|FG002|Overall Study|Protocol Violation|0|||
161985644|NCT00666965|584996244|FG003|Overall Study|Protocol Violation|2|||
161985645|NCT00666965|584996241|FG000|Overall Study|Discontinuation criteria|2|||
161985646|NCT00666965|584996242|FG001|Overall Study|Discontinuation criteria|1|||
161985647|NCT00666965|584996243|FG002|Overall Study|Discontinuation criteria|1|||
161985648|NCT00666965|584996244|FG003|Overall Study|Discontinuation criteria|2|||
161985649|NCT00666965|584996241|FG000|Overall Study|Withdrawal by Subject|0|||
161985650|NCT00666965|584996242|FG001|Overall Study|Withdrawal by Subject|0|||
161985651|NCT00666965|584996243|FG002|Overall Study|Withdrawal by Subject|0|||
161871318|NCT00634036|584573757|FG001|Overall Study|Withdrawal by Subject|1|||
161871319|NCT03896022|584573758|FG000|Overall Study|Withdrawal by Subject|1|||
161871320|NCT03896022|584573759|FG001|Overall Study|Withdrawal by Subject|0|||
161871321|NCT03896022|584573760|FG002|Overall Study|Withdrawal by Subject|0|||
161871322|NCT03896022|584573758|FG000|Overall Study|Did not have procedure|3|||
161871323|NCT03896022|584573759|FG001|Overall Study|Did not have procedure|0|||
161871324|NCT03896022|584573760|FG002|Overall Study|Did not have procedure|0|||
161871325|NCT02741076|584573761|FG000|Overall Study|Adverse Event|0|||
161871326|NCT02741076|584573762|FG001|Overall Study|Adverse Event|1|||
161871327|NCT02741076|584573763|FG002|Overall Study|Adverse Event|1|||
161871328|NCT02741076|584573764|FG003|Overall Study|Adverse Event|0|||
161871329|NCT02741076|584573761|FG000|Overall Study|Lack of Efficacy|1|||
161871330|NCT02741076|584573762|FG001|Overall Study|Lack of Efficacy|0|||
161985652|NCT00666965|584996244|FG003|Overall Study|Withdrawal by Subject|2|||
161985653|NCT00498355|584996248|FG000|Overall Study|Lost to Follow-up|1|||
161985654|NCT03262441|584996257|FG000|Overall Study|Withdrawal by Subject|1|||
161985655|NCT02607228|584996258|FG000|Overall Study|Progressive Disease|4|||
161985656|NCT02607228|584996259|FG001|Overall Study|Progressive Disease|3|||
161985657|NCT02607228|584996260|FG002|Overall Study|Progressive Disease|1|||
161985658|NCT02607228|584996261|FG003|Overall Study|Progressive Disease|5|||
161985659|NCT02607228|584996262|FG004|Overall Study|Progressive Disease|4|||
161985660|NCT02607228|584996263|FG005|Overall Study|Progressive Disease|3|||
161985661|NCT02607228|584996264|FG006|Overall Study|Progressive Disease|1|||
161985662|NCT02607228|584996258|FG000|Overall Study|Adverse Event|1|||
161985663|NCT02607228|584996259|FG001|Overall Study|Adverse Event|0|||
161985664|NCT02607228|584996260|FG002|Overall Study|Adverse Event|1|||
161985665|NCT02607228|584996261|FG003|Overall Study|Adverse Event|0|||
161985666|NCT02607228|584996262|FG004|Overall Study|Adverse Event|1|||
161985667|NCT02607228|584996263|FG005|Overall Study|Adverse Event|1|||
161985668|NCT02607228|584996264|FG006|Overall Study|Adverse Event|1|||
161985669|NCT02607228|584996258|FG000|Overall Study|Investigator's Discretion|0|||
161985670|NCT02607228|584996259|FG001|Overall Study|Investigator's Discretion|0|||
161985671|NCT02607228|584996260|FG002|Overall Study|Investigator's Discretion|1|||
161985672|NCT02607228|584996261|FG003|Overall Study|Investigator's Discretion|0|||
161985673|NCT02607228|584996262|FG004|Overall Study|Investigator's Discretion|0|||
161985674|NCT02607228|584996263|FG005|Overall Study|Investigator's Discretion|1|||
161985675|NCT02607228|584996264|FG006|Overall Study|Investigator's Discretion|0|||
161985676|NCT02607228|584996258|FG000|Overall Study|Withdrew Consent|0|||
161985677|NCT02607228|584996259|FG001|Overall Study|Withdrew Consent|1|||
161985678|NCT02607228|584996260|FG002|Overall Study|Withdrew Consent|0|||
161985679|NCT02607228|584996261|FG003|Overall Study|Withdrew Consent|0|||
161985680|NCT02607228|584996262|FG004|Overall Study|Withdrew Consent|0|||
161985681|NCT02607228|584996263|FG005|Overall Study|Withdrew Consent|1|||
161985682|NCT02607228|584996264|FG006|Overall Study|Withdrew Consent|0|||
161985683|NCT02607228|584996258|FG000|Overall Study|Study Terminated by Sponsor|0|||
161985684|NCT02607228|584996259|FG001|Overall Study|Study Terminated by Sponsor|0|||
161985685|NCT02607228|584996260|FG002|Overall Study|Study Terminated by Sponsor|0|||
161985686|NCT02607228|584996261|FG003|Overall Study|Study Terminated by Sponsor|1|||
161985687|NCT02607228|584996262|FG004|Overall Study|Study Terminated by Sponsor|0|||
161985688|NCT02607228|584996263|FG005|Overall Study|Study Terminated by Sponsor|0|||
161985689|NCT02607228|584996264|FG006|Overall Study|Study Terminated by Sponsor|0|||
161985690|NCT01455194|584996272|FG000|Overall Study|Screen Failure|20|||
161985691|NCT01455194|584996273|FG001|Overall Study|Screen Failure|0|||
161985692|NCT01455194|584996274|FG002|Overall Study|Screen Failure|0|||
161985693|NCT01455194|584996275|FG003|Overall Study|Screen Failure|0|||
161985694|NCT01455194|584996272|FG000|Overall Study|Randomisation Failure|90|||
161985695|NCT01455194|584996273|FG001|Overall Study|Randomisation Failure|0|||
161985696|NCT01455194|584996274|FG002|Overall Study|Randomisation Failure|0|||
161985697|NCT01455194|584996275|FG003|Overall Study|Randomisation Failure|0|||
161985698|NCT01455194|584996272|FG000|Overall Study|Deterioration in asthma|12|||
161985699|NCT01455194|584996273|FG001|Overall Study|Deterioration in asthma|6|||
161985700|NCT01455194|584996274|FG002|Overall Study|Deterioration in asthma|14|||
161985701|NCT01455194|584996275|FG003|Overall Study|Deterioration in asthma|9|||
161985702|NCT01455194|584996272|FG000|Overall Study|Adverse Event|1|||
161985703|NCT01455194|584996273|FG001|Overall Study|Adverse Event|1|||
161985704|NCT01455194|584996274|FG002|Overall Study|Adverse Event|1|||
161985705|NCT01455194|584996275|FG003|Overall Study|Adverse Event|3|||
161985706|NCT01455194|584996272|FG000|Overall Study|Withdrawal by Subject|21|||
161985707|NCT01455194|584996273|FG001|Overall Study|Withdrawal by Subject|16|||
161985708|NCT01455194|584996274|FG002|Overall Study|Withdrawal by Subject|12|||
161985709|NCT01455194|584996275|FG003|Overall Study|Withdrawal by Subject|9|||
161985710|NCT01455194|584996272|FG000|Overall Study|Lost to Follow-up|2|||
161985711|NCT01455194|584996273|FG001|Overall Study|Lost to Follow-up|0|||
161985712|NCT01455194|584996274|FG002|Overall Study|Lost to Follow-up|1|||
161985713|NCT01455194|584996275|FG003|Overall Study|Lost to Follow-up|1|||
161985714|NCT01455194|584996272|FG000|Overall Study|Pregnancy|0|||
161985715|NCT01455194|584996273|FG001|Overall Study|Pregnancy|1|||
161985716|NCT01455194|584996274|FG002|Overall Study|Pregnancy|1|||
161985717|NCT01455194|584996275|FG003|Overall Study|Pregnancy|0|||
161985718|NCT01455194|584996272|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
161985719|NCT01455194|584996273|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
161985720|NCT01455194|584996274|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
161985721|NCT01455194|584996275|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
161985722|NCT01455194|584996272|FG000|Overall Study|Miscellaneous|4|||
161985723|NCT01455194|584996273|FG001|Overall Study|Miscellaneous|5|||
161985724|NCT01455194|584996274|FG002|Overall Study|Miscellaneous|1|||
161985725|NCT01455194|584996275|FG003|Overall Study|Miscellaneous|4|||
161985726|NCT05090852|584996276|FG000|Overall Study|Physician Decision|5|||
161985727|NCT00504894|584996277|FG000|Overall Study|fMRI technical problems|1|||
161985728|NCT00504894|584996278|FG001|Overall Study|fMRI technical problems|1|||
161985729|NCT00504894|584996279|FG002|Overall Study|fMRI technical problems|0|||
161985730|NCT00504894|584996277|FG000|Overall Study|Withdrawal by Subject|0|||
161985731|NCT00504894|584996278|FG001|Overall Study|Withdrawal by Subject|1|||
161985732|NCT00504894|584996279|FG002|Overall Study|Withdrawal by Subject|0|||
161985733|NCT00504894|584996277|FG000|Overall Study|Infusion technical problems|0|||
161985734|NCT00504894|584996278|FG001|Overall Study|Infusion technical problems|1|||
161985735|NCT00504894|584996279|FG002|Overall Study|Infusion technical problems|0|||
161985736|NCT00504894|584996277|FG000|Overall Study|poor subject data|2|||
161985737|NCT00504894|584996278|FG001|Overall Study|poor subject data|0|||
161985738|NCT00504894|584996279|FG002|Overall Study|poor subject data|0|||
161985739|NCT01196416|584996280|FG000|Overall Study|Withdrawal by Subject|2|||
161985740|NCT00148941|584996281|FG000|Overall Study|Lost to Follow-up|17|||
161985741|NCT00148941|584996282|FG001|Overall Study|Lost to Follow-up|24|||
161985742|NCT00148941|584996283|FG002|Overall Study|Lost to Follow-up|18|||
161985743|NCT00148941|584996284|FG003|Overall Study|Lost to Follow-up|22|||
161985744|NCT00148941|584996281|FG000|Overall Study|Withdrawal by Subject|1|||
161985745|NCT00148941|584996282|FG001|Overall Study|Withdrawal by Subject|0|||
161985746|NCT00148941|584996283|FG002|Overall Study|Withdrawal by Subject|1|||
161985747|NCT00148941|584996284|FG003|Overall Study|Withdrawal by Subject|0|||
161985748|NCT00148941|584996281|FG000|Overall Study|Other|0|||
161985749|NCT00148941|584996282|FG001|Overall Study|Other|0|||
161985750|NCT00148941|584996283|FG002|Overall Study|Other|1|||
161985751|NCT00148941|584996284|FG003|Overall Study|Other|2|||
161985752|NCT02673684|584996287|FG000|Overall Study|Study not completed d/t loss of funding|9|||
161985753|NCT02673684|584996288|FG001|Overall Study|Study not completed d/t loss of funding|8|||
161985754|NCT01092663|584996289|FG000|Overall Study|Withdrawal by Subject|3|||
161985755|NCT01092663|584996290|FG001|Overall Study|Withdrawal by Subject|2|||
161985756|NCT01092663|584996289|FG000|Overall Study|Glucose >300mg/dL|1|||
161985757|NCT01092663|584996290|FG001|Overall Study|Glucose >300mg/dL|0|||
161985758|NCT01092663|584996289|FG000|Overall Study|High fasting triglyceride|2|||
161985759|NCT01092663|584996290|FG001|Overall Study|High fasting triglyceride|0|||
161985760|NCT01092663|584996289|FG000|Overall Study|Adverse Event|1|||
161985761|NCT01092663|584996290|FG001|Overall Study|Adverse Event|1|||
161985762|NCT01092663|584996289|FG000|Overall Study|Protocol Violation|0|||
161985763|NCT01092663|584996290|FG001|Overall Study|Protocol Violation|1|||
161985764|NCT00788710|584996291|FG000|Overall Study|Adverse Event|1|||
161985765|NCT00788710|584996292|FG001|Overall Study|Adverse Event|3|||
161985766|NCT00788710|584996293|FG002|Overall Study|Adverse Event|4|||
161985767|NCT00788710|584996291|FG000|Overall Study|Lack of Efficacy|0|||
161985768|NCT00788710|584996292|FG001|Overall Study|Lack of Efficacy|0|||
161985769|NCT00788710|584996293|FG002|Overall Study|Lack of Efficacy|1|||
161985770|NCT00788710|584996291|FG000|Overall Study|Lost to Follow-up|0|||
161985771|NCT00788710|584996292|FG001|Overall Study|Lost to Follow-up|1|||
161985772|NCT00788710|584996293|FG002|Overall Study|Lost to Follow-up|0|||
161985773|NCT00788710|584996291|FG000|Overall Study|Physician Decision|2|||
161985774|NCT00788710|584996292|FG001|Overall Study|Physician Decision|1|||
161985775|NCT00788710|584996293|FG002|Overall Study|Physician Decision|0|||
161985776|NCT00788710|584996291|FG000|Overall Study|Protocol Violation|0|||
161985777|NCT00788710|584996292|FG001|Overall Study|Protocol Violation|1|||
161985778|NCT00788710|584996293|FG002|Overall Study|Protocol Violation|1|||
161985779|NCT00788710|584996291|FG000|Overall Study|Withdrawal by Subject|2|||
161985780|NCT00788710|584996292|FG001|Overall Study|Withdrawal by Subject|2|||
161985781|NCT00788710|584996293|FG002|Overall Study|Withdrawal by Subject|0|||
161985782|NCT01008904|584996294|FG000|Overall Study|Lost to Follow-up|1|||
161985783|NCT01008904|584996294|FG000|Overall Study|Adverse Event|2|||
161985784|NCT01008904|584996294|FG000|Overall Study|unexpected unrelated surgery|1|||
161985785|NCT03908970|584996295|FG000|Overall Study|Adverse Event|7|||
161985786|NCT03908970|584996296|FG001|Overall Study|Adverse Event|21|||
161775433|NCT04411641|584219464|FG002|OL|Adverse Event|1|||
161775434|NCT04411641|584219465|FG003|OL|Adverse Event|0|||
161775435|NCT04411641|584219462|FG000|OL|Other|0|||
161775436|NCT04411641|584219463|FG001|OL|Other|0|||
161775437|NCT04411641|584219464|FG002|OL|Other|0|||
161775438|NCT04411641|584219465|FG003|OL|Other|6|||
161775439|NCT04342390|584219466|FG000|Overall Study|Lost to Follow-up|3|||
161775440|NCT04342390|584219467|FG001|Overall Study|Lost to Follow-up|0|||
161775441|NCT01003691|584219472|FG000|Overall Study|Adverse Event|0|||
161775442|NCT01003691|584219473|FG001|Overall Study|Adverse Event|0|||
161775443|NCT01003691|584219474|FG002|Overall Study|Adverse Event|0|||
161775444|NCT01003691|584219475|FG003|Overall Study|Adverse Event|1|||
161775445|NCT01869959|584219479|FG000|Randomization Period|Physician Decision|0|||
161775446|NCT01869959|584219480|FG001|Randomization Period|Physician Decision|0|||
161775447|NCT01869959|584219481|FG002|Randomization Period|Physician Decision|0|||
161775448|NCT01869959|584219482|FG003|Randomization Period|Physician Decision|0|||
161775449|NCT01869959|584219483|FG004|Randomization Period|Physician Decision|1|||
161775450|NCT01869959|584219479|FG000|Treatment Period|Adverse Event|1|||
161775451|NCT01869959|584219480|FG001|Treatment Period|Adverse Event|0|||
161775452|NCT01869959|584219481|FG002|Treatment Period|Adverse Event|3|||
161775453|NCT01869959|584219482|FG003|Treatment Period|Adverse Event|1|||
161775454|NCT01869959|584219483|FG004|Treatment Period|Adverse Event|0|||
161775455|NCT01869959|584219479|FG000|Treatment Period|Sponsor decision|0|||
161775456|NCT01869959|584219480|FG001|Treatment Period|Sponsor decision|1|||
161775457|NCT01869959|584219481|FG002|Treatment Period|Sponsor decision|0|||
161775458|NCT01869959|584219482|FG003|Treatment Period|Sponsor decision|1|||
161775459|NCT01869959|584219483|FG004|Treatment Period|Sponsor decision|0|||
161775460|NCT01869959|584219479|FG000|Treatment Period|Withdrawal by Subject|0|||
161775461|NCT01869959|584219480|FG001|Treatment Period|Withdrawal by Subject|1|||
161775462|NCT01869959|584219481|FG002|Treatment Period|Withdrawal by Subject|0|||
161775463|NCT01869959|584219482|FG003|Treatment Period|Withdrawal by Subject|0|||
161775464|NCT01869959|584219483|FG004|Treatment Period|Withdrawal by Subject|0|||
161775465|NCT04075656|584219488|FG000|Overall Study|Withdrawal by Subject|5|||
161775466|NCT04075656|584219489|FG001|Overall Study|Withdrawal by Subject|5|||
161775467|NCT01519635|584221183|FG000|Overall Study|Withdrawal by Subject|0|||
161775468|NCT01519635|584221184|FG001|Overall Study|Withdrawal by Subject|1|||
161985787|NCT03908970|584996295|FG000|Overall Study|Physician Decision|1|||
161775469|NCT01519635|584221183|FG000|Overall Study|No possibility to put a catheter|1|||
161775470|NCT01519635|584221184|FG001|Overall Study|No possibility to put a catheter|2|||
161775471|NCT00347776|584221185|FG000|1.5 Month Follow-up|Death|2|||
161775472|NCT00347776|584221186|FG001|1.5 Month Follow-up|Death|0|||
161775473|NCT00347776|584221187|FG002|1.5 Month Follow-up|Death|0|||
161775474|NCT00347776|584221185|FG000|1.5 Month Follow-up|reached the endpoint|12|||
161775475|NCT00347776|584221186|FG001|1.5 Month Follow-up|reached the endpoint|8|||
161775476|NCT00347776|584221187|FG002|1.5 Month Follow-up|reached the endpoint|12|||
161775477|NCT00347776|584221185|FG000|6 Month Follow-up|Death|2|||
161985788|NCT03908970|584996296|FG001|Overall Study|Physician Decision|4|||
161985789|NCT03908970|584996295|FG000|Overall Study|Withdrawal by Subject|9|||
161985790|NCT03908970|584996296|FG001|Overall Study|Withdrawal by Subject|22|||
161985791|NCT04407234|584996297|FG000|Overall Study|Adverse Event|3|||
161985792|NCT04407234|584996298|FG001|Overall Study|Adverse Event|3|||
161985793|NCT00727558|584996299|FG000|Overall Study|Lens issue|0|||
161985794|NCT00727558|584996300|FG001|Overall Study|Lens issue|1|||
161985795|NCT00727558|584996299|FG000|Overall Study|Adverse Event|0|||
161985796|NCT00727558|584996300|FG001|Overall Study|Adverse Event|1|||
161985797|NCT00727558|584996299|FG000|Overall Study|Subject unable to return for follow-up|1|||
161985798|NCT00727558|584996300|FG001|Overall Study|Subject unable to return for follow-up|1|||
161985799|NCT00727558|584996299|FG000|Overall Study|Lost to Follow-up|1|||
161985800|NCT00727558|584996300|FG001|Overall Study|Lost to Follow-up|0|||
161985801|NCT02262754|584996308|FG000|Overall Study|Adverse Event|3|||
161985802|NCT02262754|584996309|FG001|Overall Study|Adverse Event|4|||
161985803|NCT02262754|584996310|FG002|Overall Study|Adverse Event|0|||
161985804|NCT02262754|584996308|FG000|Overall Study|Lack of Efficacy|2|||
161985805|NCT02262754|584996309|FG001|Overall Study|Lack of Efficacy|0|||
161985806|NCT02262754|584996310|FG002|Overall Study|Lack of Efficacy|1|||
161985807|NCT02262754|584996308|FG000|Overall Study|Lost to Follow-up|0|||
161985808|NCT02262754|584996309|FG001|Overall Study|Lost to Follow-up|0|||
161985809|NCT02262754|584996310|FG002|Overall Study|Lost to Follow-up|1|||
161985810|NCT02262754|584996308|FG000|Overall Study|No longer meets eligibility criteria|0|||
161985811|NCT02262754|584996309|FG001|Overall Study|No longer meets eligibility criteria|1|||
161985812|NCT02262754|584996310|FG002|Overall Study|No longer meets eligibility criteria|0|||
161985813|NCT02262754|584996308|FG000|Overall Study|Study terminated by sponsor|5|||
161985814|NCT02262754|584996309|FG001|Overall Study|Study terminated by sponsor|4|||
161985815|NCT02262754|584996310|FG002|Overall Study|Study terminated by sponsor|4|||
161985816|NCT02262754|584996308|FG000|Overall Study|Protocol Violation|1|||
161985817|NCT02262754|584996309|FG001|Overall Study|Protocol Violation|0|||
161985818|NCT02262754|584996310|FG002|Overall Study|Protocol Violation|0|||
161985819|NCT02262754|584996308|FG000|Overall Study|Withdrawal by Subject|1|||
161985820|NCT02262754|584996309|FG001|Overall Study|Withdrawal by Subject|0|||
161985821|NCT02262754|584996310|FG002|Overall Study|Withdrawal by Subject|1|||
161985822|NCT02262754|584996308|FG000|Overall Study|Other|4|||
161985823|NCT02262754|584996309|FG001|Overall Study|Other|0|||
161985824|NCT02262754|584996310|FG002|Overall Study|Other|2|||
161985825|NCT04079114|584996318|FG000|Overall Study|Study prematuely terminated.|166|||
161985826|NCT00629798|584996319|FG000|Overall Study|Not Treated|4|||
161985827|NCT00422383|584996321|FG000|Overall Study|Adverse Event|5|||
161985828|NCT00422383|584996322|FG001|Overall Study|Adverse Event|3|||
161985829|NCT00422383|584996323|FG002|Overall Study|Adverse Event|1|||
161985830|NCT00422383|584996324|FG003|Overall Study|Adverse Event|1|||
161985831|NCT00422383|584996325|FG004|Overall Study|Adverse Event|0|||
161985832|NCT00422383|584996321|FG000|Overall Study|Lack of Efficacy|4|||
161985833|NCT00422383|584996322|FG001|Overall Study|Lack of Efficacy|4|||
161985834|NCT00422383|584996323|FG002|Overall Study|Lack of Efficacy|2|||
161985835|NCT00422383|584996324|FG003|Overall Study|Lack of Efficacy|1|||
161985836|NCT00422383|584996325|FG004|Overall Study|Lack of Efficacy|1|||
161985837|NCT00422383|584996321|FG000|Overall Study|Lost to Follow-up|0|||
161985838|NCT00422383|584996322|FG001|Overall Study|Lost to Follow-up|1|||
161985839|NCT00422383|584996323|FG002|Overall Study|Lost to Follow-up|0|||
161985840|NCT00422383|584996324|FG003|Overall Study|Lost to Follow-up|0|||
161985841|NCT00422383|584996325|FG004|Overall Study|Lost to Follow-up|1|||
161985842|NCT00422383|584996321|FG000|Overall Study|Protocol Violation|1|||
161985843|NCT00422383|584996322|FG001|Overall Study|Protocol Violation|1|||
161985844|NCT00422383|584996323|FG002|Overall Study|Protocol Violation|1|||
161985845|NCT00422383|584996324|FG003|Overall Study|Protocol Violation|0|||
161985846|NCT00422383|584996325|FG004|Overall Study|Protocol Violation|0|||
161985847|NCT00422383|584996321|FG000|Overall Study|Withdrawal by Subject|5|||
161985848|NCT00422383|584996322|FG001|Overall Study|Withdrawal by Subject|5|||
161985849|NCT00422383|584996323|FG002|Overall Study|Withdrawal by Subject|0|||
161985850|NCT00422383|584996324|FG003|Overall Study|Withdrawal by Subject|0|||
161985851|NCT00422383|584996325|FG004|Overall Study|Withdrawal by Subject|1|||
161985852|NCT00566254|584996326|FG000|Overall Study|Adverse Event|3|||
161985853|NCT00566254|584996327|FG001|Overall Study|Adverse Event|1|||
161775478|NCT00347776|584221186|FG001|6 Month Follow-up|Death|1|||
161775479|NCT00347776|584221187|FG002|6 Month Follow-up|Death|3|||
161985854|NCT00566254|584996326|FG000|Overall Study|Protocol Violation|1|||
161985855|NCT00566254|584996327|FG001|Overall Study|Protocol Violation|3|||
161985856|NCT00566254|584996326|FG000|Overall Study|Withdrawal by Subject|1|||
161985857|NCT00566254|584996327|FG001|Overall Study|Withdrawal by Subject|2|||
161985858|NCT00566254|584996326|FG000|Overall Study|Lack of Efficacy|5|||
161985859|NCT00566254|584996327|FG001|Overall Study|Lack of Efficacy|6|||
161985860|NCT00566254|584996326|FG000|Overall Study|Other|0|||
161985861|NCT00566254|584996327|FG001|Overall Study|Other|2|||
161985862|NCT00238238|584996328|FG000|Overall Study|Withdrawal by Subject|0|||
161985863|NCT00238238|584996329|FG001|Overall Study|Withdrawal by Subject|3|||
161985864|NCT00238238|584996330|FG002|Overall Study|Withdrawal by Subject|0|||
161985865|NCT01007838|584996334|FG000|Overall Study|Withdrawal by Subject|1|||
161985866|NCT01007838|584996335|FG001|Overall Study|Withdrawal by Subject|0|||
161985867|NCT01007838|584996336|FG002|Overall Study|Withdrawal by Subject|0|||
161985868|NCT01007838|584996337|FG003|Overall Study|Withdrawal by Subject|0|||
161985869|NCT01007838|584996334|FG000|Overall Study|Physician Decision|1|||
161985870|NCT01007838|584996335|FG001|Overall Study|Physician Decision|0|||
161985871|NCT01007838|584996336|FG002|Overall Study|Physician Decision|0|||
161985872|NCT01007838|584996337|FG003|Overall Study|Physician Decision|0|||
161985873|NCT01007838|584996334|FG000|Overall Study|Started home haemodialysis|1|||
161985874|NCT01007838|584996335|FG001|Overall Study|Started home haemodialysis|0|||
161985875|NCT01007838|584996336|FG002|Overall Study|Started home haemodialysis|0|||
161985876|NCT01007838|584996337|FG003|Overall Study|Started home haemodialysis|0|||
161985877|NCT02277119|584996338|FG000|Overall Study|Lack of Efficacy|1|||
161985878|NCT02277119|584996339|FG001|Overall Study|Lack of Efficacy|1|||
161985879|NCT02277119|584996340|FG002|Overall Study|Lack of Efficacy|1|||
161985880|NCT02277119|584996338|FG000|Overall Study|Protocol Violation|2|||
161985881|NCT02277119|584996339|FG001|Overall Study|Protocol Violation|3|||
161985882|NCT02277119|584996340|FG002|Overall Study|Protocol Violation|7|||
161985883|NCT01345669|584996341|FG000|Overall Study|Primary tumour recurrence|53|||
161985884|NCT01345669|584996342|FG001|Overall Study|Primary tumour recurrence|32|||
161985885|NCT01345669|584996341|FG000|Overall Study|Second primary tumour|4|||
161985886|NCT01345669|584996342|FG001|Overall Study|Second primary tumour|3|||
161985887|NCT01345669|584996341|FG000|Overall Study|Adverse Event|63|||
161985888|NCT01345669|584996342|FG001|Overall Study|Adverse Event|9|||
161985889|NCT01345669|584996341|FG000|Overall Study|Protocol Violation|3|||
161985890|NCT01345669|584996342|FG001|Overall Study|Protocol Violation|1|||
161871331|NCT02741076|584573763|FG002|Overall Study|Lack of Efficacy|0|||
161871332|NCT02741076|584573764|FG003|Overall Study|Lack of Efficacy|0|||
161871333|NCT02741076|584573761|FG000|Overall Study|Withdrawal by Subject|0|||
161871334|NCT02741076|584573762|FG001|Overall Study|Withdrawal by Subject|1|||
161871335|NCT02741076|584573763|FG002|Overall Study|Withdrawal by Subject|0|||
161871336|NCT02741076|584573764|FG003|Overall Study|Withdrawal by Subject|0|||
161871337|NCT02741076|584573761|FG000|Overall Study|Sponsor Request|2|||
161871338|NCT02741076|584573762|FG001|Overall Study|Sponsor Request|3|||
161871339|NCT02741076|584573763|FG002|Overall Study|Sponsor Request|0|||
161871340|NCT02741076|584573764|FG003|Overall Study|Sponsor Request|1|||
161871341|NCT02741076|584573761|FG000|Overall Study|No additional information available|0|||
161871342|NCT02741076|584573762|FG001|Overall Study|No additional information available|0|||
161871343|NCT02741076|584573763|FG002|Overall Study|No additional information available|1|||
161871344|NCT02741076|584573764|FG003|Overall Study|No additional information available|1|||
161871345|NCT01779440|584573765|FG000|Overall Study|Withdrawal by Subject|3|||
161871346|NCT01779440|584573766|FG001|Overall Study|Withdrawal by Subject|5|||
161871347|NCT01190410|584575111|FG000|Overall Study|Adverse Event|0|||
161871348|NCT01190410|584575112|FG001|Overall Study|Adverse Event|3|||
161871349|NCT01190410|584575111|FG000|Overall Study|Lack of Efficacy|0|||
161871350|NCT01190410|584575112|FG001|Overall Study|Lack of Efficacy|2|||
161871351|NCT01190410|584575111|FG000|Overall Study|Withdrawal by Subject|0|||
161871352|NCT01190410|584575112|FG001|Overall Study|Withdrawal by Subject|2|||
161871353|NCT01190410|584575111|FG000|Overall Study|Administrative decision|1|||
161871354|NCT01190410|584575112|FG001|Overall Study|Administrative decision|0|||
161871355|NCT01190410|584575111|FG000|Overall Study|PI discretion|0|||
161871356|NCT01190410|584575112|FG001|Overall Study|PI discretion|2|||
161871357|NCT01283334|584575114|FG000|Overall Study|Withdrawal by Subject|1|||
161871358|NCT01283334|584575114|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
161871359|NCT01283334|584575114|FG000|Overall Study|Adverse Event|4|||
161985891|NCT01345669|584996341|FG000|Overall Study|Lost to Follow-up|1|||
161985892|NCT01345669|584996342|FG001|Overall Study|Lost to Follow-up|1|||
161871360|NCT01283334|584575114|FG000|Overall Study|Physician Decision|1|||
161871361|NCT03467217|584575115|FG000|Overall Study|Trial stopped early|5|||
161985893|NCT01345669|584996341|FG000|Overall Study|Withdrawal by Subject|52|||
161985894|NCT01345669|584996342|FG001|Overall Study|Withdrawal by Subject|13|||
161871362|NCT03467217|584575116|FG001|Overall Study|Trial stopped early|2|||
161985895|NCT01345669|584996341|FG000|Overall Study|Other Reasons|111|||
161985896|NCT01345669|584996342|FG001|Overall Study|Other Reasons|60|||
161985897|NCT01793883|584996343|FG000|Overall Study|Withdrawal by Subject|3|||
161985898|NCT01793883|584996344|FG001|Overall Study|Withdrawal by Subject|7|||
161985899|NCT01793883|584996345|FG002|Overall Study|Withdrawal by Subject|3|||
161985900|NCT01793883|584996343|FG000|Overall Study|Subject noncompliance|0|||
161985901|NCT01793883|584996344|FG001|Overall Study|Subject noncompliance|1|||
161985902|NCT01793883|584996345|FG002|Overall Study|Subject noncompliance|1|||
161985903|NCT01793883|584996343|FG000|Overall Study|Lost to Follow-up|5|||
161985904|NCT01793883|584996344|FG001|Overall Study|Lost to Follow-up|1|||
161985905|NCT01793883|584996345|FG002|Overall Study|Lost to Follow-up|3|||
161985906|NCT01793883|584996343|FG000|Overall Study|Randomized in error|1|||
161985907|NCT01793883|584996344|FG001|Overall Study|Randomized in error|0|||
161985908|NCT01793883|584996345|FG002|Overall Study|Randomized in error|0|||
161985909|NCT01793883|584996343|FG000|Overall Study|Unable to complete spriometry|1|||
161985910|NCT01793883|584996344|FG001|Overall Study|Unable to complete spriometry|0|||
161985911|NCT01793883|584996345|FG002|Overall Study|Unable to complete spriometry|0|||
161985912|NCT01793883|584996343|FG000|Overall Study|Unable to complete measurements|1|||
161985913|NCT01793883|584996344|FG001|Overall Study|Unable to complete measurements|0|||
161985914|NCT01793883|584996345|FG002|Overall Study|Unable to complete measurements|0|||
161985915|NCT01793883|584996343|FG000|Overall Study|Met exclusion criteria|1|||
161985916|NCT01793883|584996344|FG001|Overall Study|Met exclusion criteria|0|||
161985917|NCT01793883|584996345|FG002|Overall Study|Met exclusion criteria|0|||
161985918|NCT01793883|584996343|FG000|Overall Study|Dosing error|0|||
161985919|NCT01793883|584996344|FG001|Overall Study|Dosing error|1|||
161985920|NCT01793883|584996345|FG002|Overall Study|Dosing error|0|||
161985921|NCT01793883|584996343|FG000|Overall Study|Respiratory distress during spirometry|0|||
161985922|NCT01793883|584996344|FG001|Overall Study|Respiratory distress during spirometry|0|||
161985923|NCT01793883|584996345|FG002|Overall Study|Respiratory distress during spirometry|1|||
161985924|NCT00761527|584996346|FG000|Overall Study|Adverse Event|3|||
161985925|NCT00761527|584996346|FG000|Overall Study|Poor Compliance|8|||
161985926|NCT00761527|584996346|FG000|Overall Study|Lost to Follow-up|9|||
161985927|NCT00761527|584996346|FG000|Overall Study|Unknown reason|2|||
161871363|NCT03467217|584575115|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
161871364|NCT03467217|584575116|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
161871365|NCT03467217|584575115|FG000|Overall Study|Lost to Follow-up|0|||
161871366|NCT03467217|584575116|FG001|Overall Study|Lost to Follow-up|2|||
161871367|NCT00769067|584575117|FG000|Overall Study|Death|89|||
161985928|NCT02353728|584996347|FG000|Overall Study|Subject non-compliance|1|||
161985929|NCT02301624|584996348|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
161985930|NCT02301624|584996349|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
161985931|NCT02301624|584996348|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
161985932|NCT02301624|584996349|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
161985933|NCT02301624|584996348|FG000|Open-label Maintenance Phase|Adverse Event|2|||
161985934|NCT02301624|584996349|FG001|Open-label Maintenance Phase|Adverse Event|5|||
161985935|NCT02301624|584996348|FG000|Open-label Maintenance Phase|Physician Decision|3|||
161985936|NCT02301624|584996349|FG001|Open-label Maintenance Phase|Physician Decision|3|||
161985937|NCT02301624|584996348|FG000|Open-label Maintenance Phase|Death|2|||
161985938|NCT02301624|584996349|FG001|Open-label Maintenance Phase|Death|1|||
161985939|NCT02301624|584996348|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
161871368|NCT00769067|584575118|FG001|Overall Study|Death|86|||
161871369|NCT00769067|584575117|FG000|Overall Study|Lost to Follow-up|3|||
161871370|NCT00769067|584575118|FG001|Overall Study|Lost to Follow-up|1|||
161871371|NCT00769067|584575117|FG000|Overall Study|Study terminated by sponsor|1|||
161871372|NCT00769067|584575118|FG001|Overall Study|Study terminated by sponsor|3|||
161871373|NCT00769067|584575117|FG000|Overall Study|Other|1|||
161985940|NCT02301624|584996349|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
161985941|NCT00895310|584996350|FG000|Overall Study|Withdrawal by Subject|1|||
161985942|NCT03077919|584998268|FG000|Overall Study|Lost to Follow-up|4|||
161985943|NCT03077919|584998269|FG001|Overall Study|Lost to Follow-up|1|||
161985944|NCT00826618|584998270|FG000|Overall Study|Withdrawal by Subject|1|||
161985945|NCT01487265|584998273|FG000|Overall Study|Adverse Event|8|||
161985946|NCT01487265|584998273|FG000|Overall Study|Withdrawal by Subject|5|||
161985947|NCT01487265|584998273|FG000|Overall Study|Disease Progression|21|||
161985948|NCT01487265|584998273|FG000|Overall Study|Death|2|||
162035125|NCT03954041|585185840|FG001|Overall Study|Death|0|||
162035126|NCT03954041|585185841|FG002|Overall Study|Death|1|||
162035127|NCT03954041|585185839|FG000|Overall Study|Death by neurologic criteria|0|||
162035128|NCT03954041|585185840|FG001|Overall Study|Death by neurologic criteria|0|||
161871374|NCT00769067|584575118|FG001|Overall Study|Other|3|||
161871375|NCT00769067|584575117|FG000|Overall Study|Withdrawal by Subject|0|||
161871376|NCT00769067|584575118|FG001|Overall Study|Withdrawal by Subject|1|||
161985949|NCT01487265|584998273|FG000|Overall Study|Still on Treatment|1|||
162035129|NCT03954041|585185841|FG002|Overall Study|Death by neurologic criteria|1|||
162035130|NCT03954041|585185839|FG000|Overall Study|Reason not specified|7|||
161871377|NCT04981470|584575121|FG000|Overall Study|Device failure in all 4 patients|4|||
161871378|NCT04402138|584575122|FG000|Overall Study|Progressive Disease|2|||
161985950|NCT01271725|584998278|FG000|Part A|Progressive disease according to RECIST|8|||
161985951|NCT01271725|584998279|FG001|Part A|Progressive disease according to RECIST|0|||
161985952|NCT01271725|584998278|FG000|Part A|Clinical signs/symptoms of progression|2|||
161985953|NCT01271725|584998279|FG001|Part A|Clinical signs/symptoms of progression|0|||
161985954|NCT01271725|584998278|FG000|Part A|Other Adverse Event|8|||
161871379|NCT04402138|584575122|FG000|Overall Study|Adverse Event|1|||
161871380|NCT00784238|584575123|FG000|Overall Study|Adverse Event|14|||
161871381|NCT00784238|584575123|FG000|Overall Study|Death|2|||
161871382|NCT00784238|584575123|FG000|Overall Study|Lack of Efficacy|33|||
161871383|NCT00784238|584575123|FG000|Overall Study|Lost to Follow-up|29|||
161871384|NCT00784238|584575123|FG000|Overall Study|Pregnancy|1|||
161871385|NCT00784238|584575123|FG000|Overall Study|Withdrawal by Subject|26|||
161871386|NCT00784238|584575123|FG000|Overall Study|Other|14|||
161871387|NCT04390503|584575125|FG000|Overall Study|Physician Decision|2|||
161871388|NCT04390503|584575126|FG001|Overall Study|Physician Decision|1|||
161871389|NCT04390503|584575125|FG000|Overall Study|Adverse Event|1|||
161871390|NCT04390503|584575126|FG001|Overall Study|Adverse Event|0|||
161871391|NCT00078767|584575127|FG000|Overall Study|Withdrawal by Subject|1|||
161871392|NCT00078767|584575128|FG001|Overall Study|Withdrawal by Subject|1|||
161871393|NCT06098339|584575129|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
161871394|NCT06098339|584575130|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
161871395|NCT06098339|584575129|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
161871396|NCT06098339|584575130|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
161871397|NCT03528369|584575133|FG000|Overall Study|Withdrawal by Subject|2|||
161871398|NCT03528369|584575134|FG001|Overall Study|Withdrawal by Subject|0|||
161871399|NCT03528369|584575135|FG002|Overall Study|Withdrawal by Subject|0|||
161871400|NCT03528369|584575133|FG000|Overall Study|Lost to Follow-up|1|||
161871401|NCT03528369|584575134|FG001|Overall Study|Lost to Follow-up|0|||
161871402|NCT03528369|584575135|FG002|Overall Study|Lost to Follow-up|0|||
161871403|NCT03528369|584575133|FG000|Overall Study|Adverse Event|0|||
161871404|NCT03528369|584575134|FG001|Overall Study|Adverse Event|1|||
161871405|NCT03528369|584575135|FG002|Overall Study|Adverse Event|0|||
161871406|NCT04725812|584575136|FG000|Overall Study|Withdrawal by Subject|1|||
161871407|NCT05656534|584575138|FG000|Overall Study|Withdrawal by Subject|1|||
161871408|NCT05656534|584575139|FG001|Overall Study|Withdrawal by Subject|1|||
161871409|NCT05656534|584575140|FG002|Overall Study|Withdrawal by Subject|0|||
161871410|NCT05656534|584575141|FG003|Overall Study|Withdrawal by Subject|0|||
161871411|NCT05656534|584575138|FG000|Overall Study|Physician Decision|1|||
161871412|NCT05656534|584575139|FG001|Overall Study|Physician Decision|1|||
161871413|NCT05656534|584575140|FG002|Overall Study|Physician Decision|0|||
161871414|NCT05656534|584575141|FG003|Overall Study|Physician Decision|0|||
161871415|NCT00839800|584575146|FG000|Overall Study|Adverse Event|8|||
161871416|NCT00839800|584575147|FG001|Overall Study|Adverse Event|12|||
161871417|NCT00839800|584575146|FG000|Overall Study|Lost to Follow-up|31|||
161871418|NCT00839800|584575147|FG001|Overall Study|Lost to Follow-up|26|||
161871419|NCT00839800|584575146|FG000|Overall Study|Withdrawal by Subject|28|||
161871420|NCT00839800|584575147|FG001|Overall Study|Withdrawal by Subject|34|||
161871421|NCT00839800|584575146|FG000|Overall Study|Incorrect Enrolment|3|||
161871422|NCT00839800|584575147|FG001|Overall Study|Incorrect Enrolment|3|||
161871423|NCT00839800|584575146|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
161871424|NCT00839800|584575147|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
161871425|NCT00839800|584575146|FG000|Overall Study|Safety Reasons|2|||
161871426|NCT00839800|584575147|FG001|Overall Study|Safety Reasons|1|||
161871427|NCT00839800|584575146|FG000|Overall Study|Other|8|||
161871428|NCT00839800|584575147|FG001|Overall Study|Other|14|||
161871429|NCT00839800|584575146|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
161871430|NCT00839800|584575147|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
161871431|NCT02801617|584575148|FG000|Overall Study|Protocol Violation|2|||
161871432|NCT02801617|584575149|FG001|Overall Study|Protocol Violation|6|||
161871433|NCT00302328|584575150|FG000|Overall Study|Physician Decision|0|||
161871434|NCT00302328|584575151|FG001|Overall Study|Physician Decision|1|||
161871435|NCT00302328|584575152|FG002|Overall Study|Physician Decision|0|||
161871436|NCT01718535|584575155|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
161871437|NCT01718535|584575156|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
161871438|NCT01718535|584575157|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
161871439|NCT01718535|584575158|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
161871440|NCT01718535|584575159|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
161871441|NCT01718535|584575160|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
161871442|NCT01718535|584575161|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
161871443|NCT01718535|584575162|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
161871444|NCT01718535|584575163|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
161871445|NCT01718535|584575164|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
161871446|NCT02476578|584575165|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
161871447|NCT02476578|584575166|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
161871448|NCT02476578|584575165|FG000|Overall Study|Lost to Follow-up|6|||
161871449|NCT02476578|584575166|FG001|Overall Study|Lost to Follow-up|13|||
161871450|NCT00912743|584575173|FG000|Overall Study|Adverse Event|3|||
161871451|NCT00912743|584575174|FG001|Overall Study|Adverse Event|1|||
161871452|NCT00912743|584575173|FG000|Overall Study|Lack of Efficacy|9|||
161985955|NCT01271725|584998279|FG001|Part A|Other Adverse Event|0|||
161985956|NCT01271725|584998278|FG000|Part A|Lost to Follow-up|1|||
161985957|NCT01271725|584998279|FG001|Part A|Lost to Follow-up|0|||
161985958|NCT01271725|584998278|FG000|Part A|Withdrawal by Subject|12|||
161985959|NCT01271725|584998279|FG001|Part A|Withdrawal by Subject|0|||
161985960|NCT01271725|584998278|FG000|Part A|Other than specified|3|||
161985961|NCT01271725|584998279|FG001|Part A|Other than specified|0|||
161985962|NCT01271725|584998278|FG000|Part A|Protocol Violation|1|||
161985963|NCT01271725|584998279|FG001|Part A|Protocol Violation|0|||
161985964|NCT01271725|584998278|FG000|Part B|Other than specified|0|||
161985965|NCT01271725|584998279|FG001|Part B|Other than specified|2|||
161985966|NCT01271725|584998278|FG000|Part B|Clinical signs/symptoms of progression|0|||
161985967|NCT01271725|584998279|FG001|Part B|Clinical signs/symptoms of progression|2|||
161985968|NCT01271725|584998278|FG000|Part B|Other Adverse Event|0|||
161985969|NCT01271725|584998279|FG001|Part B|Other Adverse Event|1|||
161985970|NCT01271725|584998278|FG000|Part B|Protocol Violation|0|||
161985971|NCT01271725|584998279|FG001|Part B|Protocol Violation|1|||
161985972|NCT01271725|584998278|FG000|Part B|Withdrawal by Subject|0|||
161985973|NCT01271725|584998279|FG001|Part B|Withdrawal by Subject|6|||
161985974|NCT02950480|584998282|FG000|Overall Study|Withdrawal by Subject|1|||
161985975|NCT02950480|584998283|FG001|Overall Study|Withdrawal by Subject|0|||
161985976|NCT01363661|584998284|FG000|Overall Study|Adverse Event|9|||
161985977|NCT01363661|584998285|FG001|Overall Study|Adverse Event|2|||
161985978|NCT01363661|584998284|FG000|Overall Study|Withdrawal by Subject|1|||
161985979|NCT01363661|584998285|FG001|Overall Study|Withdrawal by Subject|1|||
161985980|NCT01363661|584998284|FG000|Overall Study|Protocol Violation|1|||
161985981|NCT01363661|584998285|FG001|Overall Study|Protocol Violation|0|||
161985982|NCT01363661|584998284|FG000|Overall Study|Lost to Follow-up|3|||
161985983|NCT01363661|584998285|FG001|Overall Study|Lost to Follow-up|1|||
161985984|NCT00705367|584998286|FG000|Long-term Extension Period|Adverse Event|2|||
161985985|NCT00705367|584998287|FG001|Long-term Extension Period|Adverse Event|0|||
161985986|NCT00705367|584998286|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
161985987|NCT00705367|584998287|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
161985988|NCT00705367|584998286|FG000|Long-term Extension Period|Lack of Efficacy|1|||
161985989|NCT00705367|584998287|FG001|Long-term Extension Period|Lack of Efficacy|0|||
161985990|NCT00705367|584998286|FG000|Long-term Extension Period|No longer met study criteria|1|||
161985991|NCT00705367|584998287|FG001|Long-term Extension Period|No longer met study criteria|0|||
161985992|NCT00705367|584998286|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
161985993|NCT00705367|584998287|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
161985994|NCT01959139|584998290|FG000|Phase II|Disease progression|0|||
161985995|NCT01959139|584998291|FG001|Phase II|Disease progression|0|||
161985996|NCT01959139|584998292|FG002|Phase II|Disease progression|26|||
161985997|NCT01959139|584998293|FG003|Phase II|Disease progression|34|||
161985998|NCT01959139|584998290|FG000|Phase II|Adverse Event|0|||
161985999|NCT01959139|584998291|FG001|Phase II|Adverse Event|0|||
161986000|NCT01959139|584998292|FG002|Phase II|Adverse Event|10|||
161986001|NCT01959139|584998293|FG003|Phase II|Adverse Event|11|||
161986002|NCT01959139|584998290|FG000|Phase II|Patient Refusal|0|||
161986003|NCT01959139|584998291|FG001|Phase II|Patient Refusal|0|||
161986004|NCT01959139|584998292|FG002|Phase II|Patient Refusal|5|||
161986005|NCT01959139|584998293|FG003|Phase II|Patient Refusal|4|||
161986006|NCT01959139|584998290|FG000|Phase II|Death|0|||
161986007|NCT01959139|584998291|FG001|Phase II|Death|0|||
161986008|NCT01959139|584998292|FG002|Phase II|Death|3|||
161986009|NCT01959139|584998293|FG003|Phase II|Death|1|||
161986010|NCT01959139|584998290|FG000|Phase II|Other/Unknown|0|||
161986011|NCT01959139|584998291|FG001|Phase II|Other/Unknown|0|||
161986012|NCT01959139|584998292|FG002|Phase II|Other/Unknown|8|||
161986013|NCT01959139|584998293|FG003|Phase II|Other/Unknown|5|||
161986014|NCT01959139|584998290|FG000|Phase II|On treatment|0|||
161986015|NCT01959139|584998291|FG001|Phase II|On treatment|0|||
161986016|NCT01959139|584998292|FG002|Phase II|On treatment|4|||
161986017|NCT01959139|584998293|FG003|Phase II|On treatment|0|||
161775480|NCT00347776|584221185|FG000|6 Month Follow-up|reached endpont|20|||
161986018|NCT01378325|584998299|FG000|Overall Study|Protocol Violation|0|||
161986019|NCT01378325|584998300|FG001|Overall Study|Protocol Violation|1|||
161986020|NCT01559675|584998301|FG000|Overall Study|Protocol Violation|1|||
161986021|NCT01559675|584998302|FG001|Overall Study|Protocol Violation|2|||
161986022|NCT01559675|584998301|FG000|Overall Study|2nd operation on same patient excluded|14|||
161986023|NCT01559675|584998302|FG001|Overall Study|2nd operation on same patient excluded|12|||
161986024|NCT01496469|584998303|FG000|Overall Study|Adverse Event|1|||
161775481|NCT00347776|584221186|FG001|6 Month Follow-up|reached endpont|12|||
161775482|NCT00347776|584221187|FG002|6 Month Follow-up|reached endpont|15|||
161775483|NCT00347776|584221185|FG000|12 Month Follow-up|Lost to Follow-up|7|||
161986025|NCT01496469|584998304|FG001|Overall Study|Adverse Event|0|||
161986026|NCT01496469|584998303|FG000|Overall Study|Protocol Violation|2|||
161986027|NCT01496469|584998304|FG001|Overall Study|Protocol Violation|0|||
161986028|NCT01496469|584998303|FG000|Overall Study|Lost to Follow-up|1|||
161986029|NCT01496469|584998304|FG001|Overall Study|Lost to Follow-up|1|||
161986030|NCT01496469|584998303|FG000|Overall Study|Withdrawal by Subject|4|||
161775484|NCT00347776|584221186|FG001|12 Month Follow-up|Lost to Follow-up|6|||
161775485|NCT00347776|584221187|FG002|12 Month Follow-up|Lost to Follow-up|6|||
161775486|NCT00347776|584221185|FG000|12 Month Follow-up|Death|3|||
161775487|NCT00347776|584221186|FG001|12 Month Follow-up|Death|4|||
161775488|NCT00347776|584221187|FG002|12 Month Follow-up|Death|4|||
161775489|NCT00347776|584221185|FG000|12 Month Follow-up|Reached endpoint|13|||
161775490|NCT00347776|584221186|FG001|12 Month Follow-up|Reached endpoint|6|||
161775491|NCT00347776|584221187|FG002|12 Month Follow-up|Reached endpoint|9|||
161775492|NCT02074982|584221188|FG000|Overall Study|Adverse Event|15|||
161775493|NCT02074982|584221189|FG001|Overall Study|Adverse Event|7|||
161775494|NCT02074982|584221188|FG000|Overall Study|Lack of Efficacy|6|||
161775495|NCT02074982|584221189|FG001|Overall Study|Lack of Efficacy|1|||
161775496|NCT02074982|584221188|FG000|Overall Study|Lost to Follow-up|9|||
161775497|NCT02074982|584221189|FG001|Overall Study|Lost to Follow-up|10|||
161775498|NCT02074982|584221188|FG000|Overall Study|Non-compliance with study treatment|0|||
161775499|NCT02074982|584221189|FG001|Overall Study|Non-compliance with study treatment|2|||
161775500|NCT02074982|584221188|FG000|Overall Study|Physician Decision|1|||
161775501|NCT02074982|584221189|FG001|Overall Study|Physician Decision|1|||
161775502|NCT02074982|584221188|FG000|Overall Study|Pregnancy|1|||
161775503|NCT02074982|584221189|FG001|Overall Study|Pregnancy|2|||
161775504|NCT02074982|584221188|FG000|Overall Study|Protocol deviation|4|||
161775505|NCT02074982|584221189|FG001|Overall Study|Protocol deviation|3|||
161775506|NCT02074982|584221188|FG000|Overall Study|Technical problems|0|||
161775507|NCT02074982|584221189|FG001|Overall Study|Technical problems|2|||
161775508|NCT02074982|584221188|FG000|Overall Study|Subject/guardian decision|15|||
161775509|NCT02074982|584221189|FG001|Overall Study|Subject/guardian decision|24|||
161775510|NCT02074982|584221188|FG000|Overall Study|Death|0|||
161775511|NCT02074982|584221189|FG001|Overall Study|Death|2|||
161775512|NCT02116309|584221206|FG000|Overall Study|Lost to Follow-up|0|||
161775513|NCT02116309|584221207|FG001|Overall Study|Lost to Follow-up|1|||
161775514|NCT03292731|584221208|FG000|Overall Study|Protocol Violation|4|||
161775515|NCT03292731|584221209|FG001|Overall Study|Protocol Violation|11|||
161775516|NCT03292731|584221210|FG002|Overall Study|Protocol Violation|1|||
161775517|NCT00471237|584221211|FG000|Overall Study|Adverse Event|6|||
161775518|NCT00471237|584221212|FG001|Overall Study|Adverse Event|5|||
161775519|NCT00471237|584221213|FG002|Overall Study|Adverse Event|4|||
161775520|NCT00471237|584221214|FG003|Overall Study|Adverse Event|8|||
161775521|NCT00471237|584221215|FG004|Overall Study|Adverse Event|7|||
161775522|NCT00471237|584221216|FG005|Overall Study|Adverse Event|5|||
161775523|NCT00471237|584221217|FG006|Overall Study|Adverse Event|0|||
161775524|NCT00471237|584221211|FG000|Overall Study|Lost to Follow-up|1|||
161775525|NCT00471237|584221212|FG001|Overall Study|Lost to Follow-up|1|||
161775526|NCT00471237|584221213|FG002|Overall Study|Lost to Follow-up|0|||
161775527|NCT00471237|584221214|FG003|Overall Study|Lost to Follow-up|2|||
161775528|NCT00471237|584221215|FG004|Overall Study|Lost to Follow-up|3|||
161775529|NCT00471237|584221216|FG005|Overall Study|Lost to Follow-up|0|||
161775530|NCT00471237|584221217|FG006|Overall Study|Lost to Follow-up|0|||
161775531|NCT00471237|584221211|FG000|Overall Study|Protocol Violation|3|||
161775532|NCT00471237|584221212|FG001|Overall Study|Protocol Violation|6|||
161775533|NCT00471237|584221213|FG002|Overall Study|Protocol Violation|3|||
161775534|NCT00471237|584221214|FG003|Overall Study|Protocol Violation|2|||
161775535|NCT00471237|584221215|FG004|Overall Study|Protocol Violation|2|||
161775536|NCT00471237|584221216|FG005|Overall Study|Protocol Violation|4|||
161775537|NCT00471237|584221217|FG006|Overall Study|Protocol Violation|1|||
161775538|NCT00471237|584221211|FG000|Overall Study|Withdrawal by Subject|8|||
161775539|NCT00471237|584221212|FG001|Overall Study|Withdrawal by Subject|6|||
161775540|NCT00471237|584221213|FG002|Overall Study|Withdrawal by Subject|5|||
161775541|NCT00471237|584221214|FG003|Overall Study|Withdrawal by Subject|8|||
161775542|NCT00471237|584221215|FG004|Overall Study|Withdrawal by Subject|7|||
161775543|NCT00471237|584221216|FG005|Overall Study|Withdrawal by Subject|4|||
161775544|NCT00471237|584221217|FG006|Overall Study|Withdrawal by Subject|2|||
161775545|NCT00471237|584221211|FG000|Overall Study|Sponsor terminated study|20|||
161775546|NCT00471237|584221212|FG001|Overall Study|Sponsor terminated study|23|||
161775547|NCT00471237|584221213|FG002|Overall Study|Sponsor terminated study|19|||
161775548|NCT00471237|584221214|FG003|Overall Study|Sponsor terminated study|22|||
161775549|NCT00471237|584221215|FG004|Overall Study|Sponsor terminated study|18|||
161775550|NCT00471237|584221216|FG005|Overall Study|Sponsor terminated study|24|||
161775551|NCT00471237|584221217|FG006|Overall Study|Sponsor terminated study|0|||
161775552|NCT00471237|584221211|FG000|Overall Study|Non-compliance|0|||
161775553|NCT00471237|584221212|FG001|Overall Study|Non-compliance|1|||
161775554|NCT00471237|584221213|FG002|Overall Study|Non-compliance|0|||
161775555|NCT00471237|584221214|FG003|Overall Study|Non-compliance|1|||
161775556|NCT00471237|584221215|FG004|Overall Study|Non-compliance|0|||
161775557|NCT00471237|584221216|FG005|Overall Study|Non-compliance|0|||
161775558|NCT00471237|584221217|FG006|Overall Study|Non-compliance|0|||
161775559|NCT00471237|584221211|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
161775560|NCT00471237|584221212|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
161775561|NCT00471237|584221213|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
161775562|NCT00471237|584221214|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
161871453|NCT00912743|584575174|FG001|Overall Study|Lack of Efficacy|18|||
161871454|NCT00912743|584575173|FG000|Overall Study|Toxicity|0|||
161871455|NCT00912743|584575174|FG001|Overall Study|Toxicity|1|||
161871456|NCT00912743|584575173|FG000|Overall Study|End of treatment form was not collected|1|||
161871457|NCT00912743|584575174|FG001|Overall Study|End of treatment form was not collected|0|||
161871458|NCT04747886|584575175|FG000|Overall Study|Withdrawal by Subject|1|||
161871459|NCT04747886|584575176|FG001|Overall Study|Withdrawal by Subject|4|||
161871460|NCT02237196|584575177|FG000|Overall Study|Adverse Event|0|||
161871461|NCT02237196|584575178|FG001|Overall Study|Adverse Event|1|||
161871462|NCT02237196|584575179|FG002|Overall Study|Adverse Event|1|||
161871463|NCT02237196|584575180|FG003|Overall Study|Adverse Event|0|||
161871464|NCT02237196|584575177|FG000|Overall Study|Lost to Follow-up|4|||
161871465|NCT02237196|584575178|FG001|Overall Study|Lost to Follow-up|2|||
161871466|NCT02237196|584575179|FG002|Overall Study|Lost to Follow-up|4|||
161871467|NCT02237196|584575180|FG003|Overall Study|Lost to Follow-up|6|||
161871468|NCT02237196|584575177|FG000|Overall Study|Physician Decision|2|||
161871469|NCT02237196|584575178|FG001|Overall Study|Physician Decision|0|||
161871470|NCT02237196|584575179|FG002|Overall Study|Physician Decision|0|||
161871471|NCT02237196|584575180|FG003|Overall Study|Physician Decision|1|||
161871472|NCT02237196|584575177|FG000|Overall Study|Pregnancy|0|||
161871473|NCT02237196|584575178|FG001|Overall Study|Pregnancy|0|||
161871474|NCT02237196|584575179|FG002|Overall Study|Pregnancy|1|||
161871475|NCT02237196|584575180|FG003|Overall Study|Pregnancy|1|||
161871476|NCT02237196|584575177|FG000|Overall Study|Withdrawal by Subject|1|||
161871477|NCT02237196|584575178|FG001|Overall Study|Withdrawal by Subject|1|||
161871478|NCT02237196|584575179|FG002|Overall Study|Withdrawal by Subject|4|||
161871479|NCT02237196|584575180|FG003|Overall Study|Withdrawal by Subject|1|||
161871480|NCT02237196|584575177|FG000|Overall Study|Site Error|1|||
161871481|NCT02237196|584575178|FG001|Overall Study|Site Error|2|||
161871482|NCT02237196|584575179|FG002|Overall Study|Site Error|0|||
161871483|NCT02237196|584575180|FG003|Overall Study|Site Error|2|||
161871484|NCT01057810|584575181|FG000|Overall Study|Disease progression|156|||
161871485|NCT01057810|584575182|FG001|Overall Study|Disease progression|197|||
161871486|NCT01057810|584575181|FG000|Overall Study|Study drug toxicity|5|||
161871487|NCT01057810|584575182|FG001|Overall Study|Study drug toxicity|114|||
161871488|NCT01057810|584575181|FG000|Overall Study|Adverse event unrelated to study drug|13|||
161871489|NCT01057810|584575182|FG001|Overall Study|Adverse event unrelated to study drug|29|||
161871490|NCT01057810|584575181|FG000|Overall Study|Withdrawal by Subject|10|||
161871491|NCT01057810|584575182|FG001|Overall Study|Withdrawal by Subject|25|||
161871492|NCT01057810|584575181|FG000|Overall Study|Death|2|||
161871493|NCT01057810|584575182|FG001|Overall Study|Death|12|||
161871494|NCT01057810|584575181|FG000|Overall Study|Maximum clinical benefit|5|||
161871495|NCT01057810|584575182|FG001|Overall Study|Maximum clinical benefit|5|||
161871496|NCT01057810|584575181|FG000|Overall Study|Poor/non-compliance|0|||
161871497|NCT01057810|584575182|FG001|Overall Study|Poor/non-compliance|1|||
161871498|NCT01057810|584575181|FG000|Overall Study|No longer met study criteria|0|||
161871499|NCT01057810|584575182|FG001|Overall Study|No longer met study criteria|1|||
161871500|NCT01057810|584575181|FG000|Overall Study|Other|7|||
161871501|NCT01057810|584575182|FG001|Overall Study|Other|14|||
161871502|NCT00267969|584575183|FG000|Controlled Period|Adverse Event|6|||
161871503|NCT00267969|584575184|FG001|Controlled Period|Adverse Event|0|||
161871504|NCT00267969|584575185|FG002|Controlled Period|Adverse Event|2|||
161871505|NCT00267969|584575186|FG003|Controlled Period|Adverse Event|0|||
161871506|NCT00267969|584575187|FG004|Controlled Period|Adverse Event|0|||
161871507|NCT00267969|584575188|FG005|Controlled Period|Adverse Event|0|||
162035131|NCT03954041|585185840|FG001|Overall Study|Reason not specified|4|||
162035132|NCT03954041|585185841|FG002|Overall Study|Reason not specified|2|||
161871508|NCT00267969|584575189|FG006|Controlled Period|Adverse Event|0|||
161871509|NCT00267969|584575183|FG000|Controlled Period|Lack of Efficacy|3|||
161871510|NCT00267969|584575184|FG001|Controlled Period|Lack of Efficacy|0|||
161871511|NCT00267969|584575185|FG002|Controlled Period|Lack of Efficacy|1|||
161871512|NCT00267969|584575186|FG003|Controlled Period|Lack of Efficacy|0|||
161871513|NCT00267969|584575187|FG004|Controlled Period|Lack of Efficacy|0|||
161871514|NCT00267969|584575188|FG005|Controlled Period|Lack of Efficacy|0|||
161871515|NCT00267969|584575189|FG006|Controlled Period|Lack of Efficacy|0|||
162035133|NCT03954041|585185839|FG000|Overall Study|Withdrew prior to dosing|4|||
161871516|NCT00267969|584575183|FG000|Controlled Period|Lost to Follow-up|1|||
161871517|NCT00267969|584575184|FG001|Controlled Period|Lost to Follow-up|0|||
161871518|NCT00267969|584575185|FG002|Controlled Period|Lost to Follow-up|1|||
161871519|NCT00267969|584575186|FG003|Controlled Period|Lost to Follow-up|0|||
161871520|NCT00267969|584575187|FG004|Controlled Period|Lost to Follow-up|0|||
161871521|NCT00267969|584575188|FG005|Controlled Period|Lost to Follow-up|0|||
161871522|NCT00267969|584575189|FG006|Controlled Period|Lost to Follow-up|0|||
161871523|NCT00267969|584575183|FG000|Controlled Period|Randomized but not treated|0|||
161871524|NCT00267969|584575184|FG001|Controlled Period|Randomized but not treated|0|||
161871525|NCT00267969|584575185|FG002|Controlled Period|Randomized but not treated|1|||
161871526|NCT00267969|584575186|FG003|Controlled Period|Randomized but not treated|0|||
161871527|NCT00267969|584575187|FG004|Controlled Period|Randomized but not treated|0|||
161986031|NCT01496469|584998304|FG001|Overall Study|Withdrawal by Subject|4|||
161986032|NCT01496469|584998303|FG000|Overall Study|BP exceeds protocol limits|1|||
161986033|NCT01496469|584998304|FG001|Overall Study|BP exceeds protocol limits|2|||
161986034|NCT01496469|584998303|FG000|Overall Study|Other|1|||
161986035|NCT01496469|584998304|FG001|Overall Study|Other|1|||
161986036|NCT00193180|584998308|FG000|Overall Study|Lack of Efficacy|1|||
161986037|NCT00193180|584998308|FG000|Overall Study|Adverse Event|8|||
161986038|NCT00193180|584998308|FG000|Overall Study|Protocol Violation|1|||
161986039|NCT02219334|584998309|FG000|Overall Study|Withdrawal by Subject|1|||
161986040|NCT02219334|584998310|FG001|Overall Study|Withdrawal by Subject|0|||
161986041|NCT02219334|584998309|FG000|Overall Study|Protocol Violation|7|||
161986042|NCT02219334|584998310|FG001|Overall Study|Protocol Violation|3|||
161986043|NCT00891228|584998312|FG000|Overall Study|Adverse Event|0|||
161986044|NCT00891228|584998313|FG001|Overall Study|Adverse Event|2|||
161986045|NCT00891228|584998314|FG002|Overall Study|Adverse Event|3|||
161986046|NCT00891228|584998312|FG000|Overall Study|Withdrawal by Subject|2|||
161986047|NCT00891228|584998313|FG001|Overall Study|Withdrawal by Subject|4|||
161986048|NCT00891228|584998314|FG002|Overall Study|Withdrawal by Subject|5|||
161986049|NCT00891228|584998312|FG000|Overall Study|Protocol Violation|3|||
161986050|NCT00891228|584998313|FG001|Overall Study|Protocol Violation|1|||
161986051|NCT00891228|584998314|FG002|Overall Study|Protocol Violation|2|||
161986052|NCT00891228|584998312|FG000|Overall Study|Physician Decision|2|||
161986053|NCT00891228|584998313|FG001|Overall Study|Physician Decision|1|||
161986054|NCT00891228|584998314|FG002|Overall Study|Physician Decision|0|||
161986055|NCT00891228|584998312|FG000|Overall Study|Lost to Follow-up|4|||
161986056|NCT00891228|584998313|FG001|Overall Study|Lost to Follow-up|4|||
161986057|NCT00891228|584998314|FG002|Overall Study|Lost to Follow-up|5|||
161986058|NCT00891228|584998312|FG000|Overall Study|Pregnancy|0|||
161986059|NCT00891228|584998313|FG001|Overall Study|Pregnancy|1|||
161986060|NCT00891228|584998314|FG002|Overall Study|Pregnancy|0|||
161986061|NCT02688985|584998323|FG000|Overall Study|Adverse Event|1|||
161986062|NCT02688985|584998324|FG001|Overall Study|Adverse Event|2|||
161986063|NCT02688985|584998325|FG002|Overall Study|Adverse Event|2|||
161986064|NCT02688985|584998326|FG003|Overall Study|Adverse Event|0|||
161986065|NCT02688985|584998327|FG004|Overall Study|Adverse Event|0|||
161986066|NCT02688985|584998323|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
161986067|NCT02688985|584998324|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
161986068|NCT02688985|584998325|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
161986069|NCT02688985|584998326|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
161986070|NCT02688985|584998327|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
161986071|NCT02688985|584998323|FG000|Overall Study|Death|0|||
161986072|NCT02688985|584998324|FG001|Overall Study|Death|0|||
161986073|NCT02688985|584998325|FG002|Overall Study|Death|0|||
161986074|NCT02688985|584998326|FG003|Overall Study|Death|0|||
161986075|NCT02688985|584998327|FG004|Overall Study|Death|1|||
161986076|NCT02688985|584998323|FG000|Overall Study|Lack of Efficacy|0|||
161986077|NCT02688985|584998324|FG001|Overall Study|Lack of Efficacy|0|||
161986078|NCT02688985|584998325|FG002|Overall Study|Lack of Efficacy|0|||
161986079|NCT02688985|584998326|FG003|Overall Study|Lack of Efficacy|0|||
161986080|NCT02688985|584998327|FG004|Overall Study|Lack of Efficacy|1|||
161986081|NCT02688985|584998323|FG000|Overall Study|Lost to Follow-up|2|||
161986082|NCT02688985|584998324|FG001|Overall Study|Lost to Follow-up|0|||
161986083|NCT02688985|584998325|FG002|Overall Study|Lost to Follow-up|1|||
161986084|NCT02688985|584998326|FG003|Overall Study|Lost to Follow-up|1|||
161986085|NCT02688985|584998327|FG004|Overall Study|Lost to Follow-up|1|||
161986086|NCT02688985|584998323|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161986087|NCT02688985|584998324|FG001|Overall Study|Non-Compliance With Study Drug|3|||
161986088|NCT02688985|584998325|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161986089|NCT02688985|584998326|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161986090|NCT02688985|584998327|FG004|Overall Study|Non-Compliance With Study Drug|1|||
161986091|NCT02688985|584998323|FG000|Overall Study|Other|3|||
161986092|NCT02688985|584998324|FG001|Overall Study|Other|4|||
161986093|NCT02688985|584998325|FG002|Overall Study|Other|1|||
161986094|NCT02688985|584998326|FG003|Overall Study|Other|0|||
161986095|NCT02688985|584998327|FG004|Overall Study|Other|0|||
161986096|NCT02688985|584998323|FG000|Overall Study|Physician Decision|2|||
161986097|NCT02688985|584998324|FG001|Overall Study|Physician Decision|2|||
161986098|NCT02688985|584998325|FG002|Overall Study|Physician Decision|0|||
161986099|NCT02688985|584998326|FG003|Overall Study|Physician Decision|0|||
161986100|NCT02688985|584998327|FG004|Overall Study|Physician Decision|1|||
161986101|NCT02688985|584998323|FG000|Overall Study|Pregnancy|0|||
162035134|NCT03954041|585185840|FG001|Overall Study|Withdrew prior to dosing|2|||
162035135|NCT03954041|585185841|FG002|Overall Study|Withdrew prior to dosing|0|||
161986102|NCT02688985|584998324|FG001|Overall Study|Pregnancy|0|||
161986103|NCT02688985|584998325|FG002|Overall Study|Pregnancy|2|||
161986104|NCT02688985|584998326|FG003|Overall Study|Pregnancy|1|||
161986105|NCT02688985|584998327|FG004|Overall Study|Pregnancy|0|||
161986106|NCT02688985|584998323|FG000|Overall Study|Study Terminated By Sponsor|0|||
161986107|NCT02688985|584998324|FG001|Overall Study|Study Terminated By Sponsor|0|||
161986108|NCT02688985|584998325|FG002|Overall Study|Study Terminated By Sponsor|0|||
161986109|NCT02688985|584998326|FG003|Overall Study|Study Terminated By Sponsor|1|||
161986110|NCT02688985|584998327|FG004|Overall Study|Study Terminated By Sponsor|0|||
161986111|NCT02688985|584998323|FG000|Overall Study|Withdrawal by Subject|2|||
161986112|NCT02688985|584998324|FG001|Overall Study|Withdrawal by Subject|8|||
161986113|NCT02688985|584998325|FG002|Overall Study|Withdrawal by Subject|7|||
161986114|NCT02688985|584998326|FG003|Overall Study|Withdrawal by Subject|1|||
161986115|NCT02688985|584998327|FG004|Overall Study|Withdrawal by Subject|4|||
161986116|NCT00930553|584998330|FG000|Overall Study|Adverse Event|1|||
161986117|NCT00930553|584998330|FG000|Overall Study|Lack of Efficacy|7|||
161986118|NCT00930553|584998330|FG000|Overall Study|Physician Decision|39|||
161986119|NCT00930553|584998330|FG000|Overall Study|Protocol Violation|1|||
161986120|NCT00930553|584998330|FG000|Overall Study|Pregnancy|1|||
161986121|NCT00930553|584998330|FG000|Overall Study|Withdrawal by Subject|88|||
161986122|NCT00930553|584998330|FG000|Overall Study|Lost to Follow-up|25|||
161986123|NCT00930553|584998330|FG000|Overall Study|Death|9|||
161986124|NCT00930553|584998330|FG000|Overall Study|Study terminated by sponsor|24|||
161986125|NCT00930553|584998330|FG000|Overall Study|Other than specified above|28|||
161986126|NCT01964963|584998331|FG000|Overall Study|Case Report Forms Uncollected|888|||
161986127|NCT01964963|584998331|FG000|Overall Study|Protocol Deviation|50|||
161986128|NCT01964963|584998331|FG000|Overall Study|Data Reliability was not Assured|5|||
161986129|NCT01726582|584998332|FG000|Overall Study|Physician Decision|99|||
161986130|NCT01726582|584998332|FG000|Overall Study|Death|85|||
161986131|NCT01235234|584998333|FG000|Overall Study|Adverse Event|2|||
161986132|NCT01235234|584998334|FG001|Overall Study|Adverse Event|2|||
161986133|NCT01235234|584998335|FG002|Overall Study|Adverse Event|1|||
161986134|NCT02630472|584998336|FG000|Overall Study|Physician Decision|10|||
161986135|NCT02630472|584998337|FG001|Overall Study|Physician Decision|0|||
161986136|NCT03704688|584998342|FG000|Overall Study|Adverse Event|0|||
161986137|NCT03704688|584998343|FG001|Overall Study|Adverse Event|0|||
161986138|NCT03704688|584998344|FG002|Overall Study|Adverse Event|0|||
161986139|NCT03704688|584998345|FG003|Overall Study|Adverse Event|4|||
161986140|NCT03704688|584998346|FG004|Overall Study|Adverse Event|1|||
161986141|NCT03704688|584998347|FG005|Overall Study|Adverse Event|0|||
161986142|NCT03704688|584998342|FG000|Overall Study|Disease Progression|0|||
161986143|NCT03704688|584998343|FG001|Overall Study|Disease Progression|0|||
161986144|NCT03704688|584998344|FG002|Overall Study|Disease Progression|0|||
161986145|NCT03704688|584998345|FG003|Overall Study|Disease Progression|3|||
161986146|NCT03704688|584998346|FG004|Overall Study|Disease Progression|1|||
161986147|NCT03704688|584998347|FG005|Overall Study|Disease Progression|0|||
161986148|NCT03704688|584998342|FG000|Overall Study|Death|0|||
161986149|NCT03704688|584998343|FG001|Overall Study|Death|0|||
161986150|NCT03704688|584998344|FG002|Overall Study|Death|0|||
161986151|NCT03704688|584998345|FG003|Overall Study|Death|0|||
161986152|NCT03704688|584998346|FG004|Overall Study|Death|3|||
161986153|NCT03704688|584998347|FG005|Overall Study|Death|0|||
161986154|NCT01832155|584998348|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
161986155|NCT01832155|584998349|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
161986156|NCT01832155|584998348|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
161986157|NCT01832155|584998349|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
161986158|NCT00787189|584998350|FG000|Overall Study|Lost to Follow-up|2|||
161986159|NCT00787189|584998351|FG001|Overall Study|Lost to Follow-up|2|||
161986160|NCT01279616|584998352|FG000|Overall Study|donor could not be located|5|||
161986161|NCT01279616|584998352|FG000|Overall Study|no signs of sickle cell disease|2|||
161986162|NCT00842543|584998355|FG000|Overall Study|Withdrawal by Subject|2|||
161986163|NCT00842543|584998356|FG001|Overall Study|Withdrawal by Subject|0|||
161986164|NCT00842543|584998357|FG002|Overall Study|Withdrawal by Subject|3|||
161986165|NCT00842543|584998358|FG003|Overall Study|Withdrawal by Subject|4|||
162035136|NCT04565236|585185844|FG000|Overall Study|Patient/Guardian Decision|0|||
162035137|NCT04565236|585185845|FG001|Overall Study|Patient/Guardian Decision|0|||
162035138|NCT04565236|585185846|FG002|Overall Study|Patient/Guardian Decision|1|||
162035139|NCT04565236|585185847|FG003|Overall Study|Patient/Guardian Decision|0|||
162035140|NCT00740246|585185850|FG000|Overall Study|Received Blood Transfusion|0|||
162035141|NCT00740246|585185851|FG001|Overall Study|Received Blood Transfusion|1|||
161986166|NCT01483183|584998363|FG000|Overall Study|Physician Decision|0|||
161986167|NCT01483183|584998364|FG001|Overall Study|Physician Decision|0|||
161986168|NCT01483183|584998365|FG002|Overall Study|Physician Decision|0|||
161986169|NCT01483183|584998366|FG003|Overall Study|Physician Decision|0|||
161871528|NCT00267969|584575188|FG005|Controlled Period|Randomized but not treated|0|||
161986170|NCT01483183|584998367|FG004|Overall Study|Physician Decision|0|||
161986171|NCT01483183|584998368|FG005|Overall Study|Physician Decision|0|||
162035142|NCT00740246|585185850|FG000|Overall Study|Adverse Event|1|||
162035143|NCT00740246|585185851|FG001|Overall Study|Adverse Event|2|||
161871529|NCT00267969|584575189|FG006|Controlled Period|Randomized but not treated|0|||
161986172|NCT01483183|584998369|FG006|Overall Study|Physician Decision|2|||
161986173|NCT01483183|584998370|FG007|Overall Study|Physician Decision|0|||
161986174|NCT01483183|584998371|FG008|Overall Study|Physician Decision|0|||
162035144|NCT00740246|585185850|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
161986175|NCT01483183|584998372|FG009|Overall Study|Physician Decision|0|||
161986176|NCT01483183|584998363|FG000|Overall Study|Withdrawal by Subject|0|||
161986177|NCT01483183|584998364|FG001|Overall Study|Withdrawal by Subject|0|||
161986178|NCT01483183|584998365|FG002|Overall Study|Withdrawal by Subject|0|||
161986179|NCT01483183|584998366|FG003|Overall Study|Withdrawal by Subject|0|||
161986180|NCT01483183|584998367|FG004|Overall Study|Withdrawal by Subject|0|||
161986181|NCT01483183|584998368|FG005|Overall Study|Withdrawal by Subject|0|||
161986182|NCT01483183|584998369|FG006|Overall Study|Withdrawal by Subject|0|||
161986183|NCT01483183|584998370|FG007|Overall Study|Withdrawal by Subject|0|||
161986184|NCT01483183|584998371|FG008|Overall Study|Withdrawal by Subject|0|||
161986185|NCT01483183|584998372|FG009|Overall Study|Withdrawal by Subject|1|||
161986186|NCT04302545|584998378|FG000|Overall Study|Lost to Follow-up|3|||
161986187|NCT04302545|584998379|FG001|Overall Study|Lost to Follow-up|4|||
161986188|NCT02516592|584998380|FG000|Overall Study|Patient withdrew consent|5|||
161986189|NCT02516592|584998381|FG001|Overall Study|Patient withdrew consent|2|||
161986190|NCT02516592|584998380|FG000|Overall Study|Protocol deviation|4|||
161986191|NCT02516592|584998381|FG001|Overall Study|Protocol deviation|4|||
161986192|NCT02516592|584998380|FG000|Overall Study|Lost to Follow-up|2|||
161986193|NCT02516592|584998381|FG001|Overall Study|Lost to Follow-up|3|||
161986194|NCT02516592|584998380|FG000|Overall Study|Patient/guardian decision|2|||
161986195|NCT02516592|584998381|FG001|Overall Study|Patient/guardian decision|1|||
161986196|NCT02516592|584998380|FG000|Overall Study|Adverse Event|1|||
161986197|NCT02516592|584998381|FG001|Overall Study|Adverse Event|2|||
161986198|NCT02516592|584998380|FG000|Overall Study|Abnormal test procedure result|1|||
161986199|NCT02516592|584998381|FG001|Overall Study|Abnormal test procedure result|0|||
161986200|NCT02516592|584998380|FG000|Overall Study|Death|1|||
161986201|NCT02516592|584998381|FG001|Overall Study|Death|1|||
161986202|NCT00300365|584998383|FG000|Overall Study|Lost to Follow-up|1|||
161986203|NCT00300365|584998384|FG001|Overall Study|Lost to Follow-up|0|||
161986204|NCT00300365|584998383|FG000|Overall Study|Physician Decision|2|||
161986205|NCT00300365|584998384|FG001|Overall Study|Physician Decision|0|||
161986206|NCT00300365|584998383|FG000|Overall Study|Withdrawal by Subject|1|||
161986207|NCT00300365|584998384|FG001|Overall Study|Withdrawal by Subject|0|||
161986208|NCT00300365|584998383|FG000|Overall Study|Adverse Event|0|||
161986209|NCT00300365|584998384|FG001|Overall Study|Adverse Event|2|||
161986210|NCT01438177|584998385|FG000|Overall Study|Withdrawal by Subject|1|||
161986211|NCT01438177|584998385|FG000|Overall Study|Initiation of new therapy|1|||
161986212|NCT01727336|584998386|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
161986213|NCT01727336|584998387|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
161986214|NCT01727336|584998388|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
161986215|NCT01727336|584998389|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
161986216|NCT01727336|584998390|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
161986217|NCT01727336|584998391|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
161986218|NCT01727336|584998386|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
161986219|NCT01727336|584998387|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
161986220|NCT01727336|584998388|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
161986221|NCT01727336|584998389|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
161986222|NCT01727336|584998390|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
161986223|NCT01727336|584998391|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
162035145|NCT00740246|585185851|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
162035146|NCT00740246|585185850|FG000|Overall Study|Lost to Follow-up|2|||
161986224|NCT01727336|584998386|FG000|Part 2 Blinded|Death|0|||
161986225|NCT01727336|584998387|FG001|Part 2 Blinded|Death|0|||
161986226|NCT01727336|584998388|FG002|Part 2 Blinded|Death|0|||
161775563|NCT00471237|584221215|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
161775564|NCT00471237|584221216|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
161775565|NCT00471237|584221217|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
161775566|NCT00471237|584221211|FG000|Overall Study|Early stopping due to non-efficacy|1|||
161775567|NCT00471237|584221212|FG001|Overall Study|Early stopping due to non-efficacy|0|||
161775568|NCT00471237|584221213|FG002|Overall Study|Early stopping due to non-efficacy|0|||
161775569|NCT00471237|584221214|FG003|Overall Study|Early stopping due to non-efficacy|0|||
161775570|NCT00471237|584221215|FG004|Overall Study|Early stopping due to non-efficacy|1|||
161775571|NCT00471237|584221216|FG005|Overall Study|Early stopping due to non-efficacy|0|||
161775572|NCT00471237|584221217|FG006|Overall Study|Early stopping due to non-efficacy|0|||
161775573|NCT00471237|584221211|FG000|Overall Study|Participant planned to travel to abraod|1|||
161775574|NCT00471237|584221212|FG001|Overall Study|Participant planned to travel to abraod|0|||
161986227|NCT01727336|584998389|FG003|Part 2 Blinded|Death|0|||
161986228|NCT01727336|584998390|FG004|Part 2 Blinded|Death|20|||
161986229|NCT01727336|584998391|FG005|Part 2 Blinded|Death|16|||
161775575|NCT00471237|584221213|FG002|Overall Study|Participant planned to travel to abraod|0|||
161986230|NCT01727336|584998386|FG000|Part 2 Blinded|Lack of Efficacy|0|||
161986231|NCT01727336|584998387|FG001|Part 2 Blinded|Lack of Efficacy|0|||
161986232|NCT01727336|584998388|FG002|Part 2 Blinded|Lack of Efficacy|0|||
161986233|NCT01727336|584998389|FG003|Part 2 Blinded|Lack of Efficacy|0|||
162035147|NCT00740246|585185851|FG001|Overall Study|Lost to Follow-up|2|||
161871530|NCT00267969|584575183|FG000|Controlled Period|Other|2|||
161871531|NCT00267969|584575184|FG001|Controlled Period|Other|1|||
161871532|NCT00267969|584575185|FG002|Controlled Period|Other|6|||
161986234|NCT01727336|584998390|FG004|Part 2 Blinded|Lack of Efficacy|42|||
161986235|NCT01727336|584998391|FG005|Part 2 Blinded|Lack of Efficacy|44|||
161986236|NCT01727336|584998386|FG000|Part 2 Blinded|Lost to Follow-up|0|||
161986237|NCT01727336|584998387|FG001|Part 2 Blinded|Lost to Follow-up|0|||
161986238|NCT01727336|584998388|FG002|Part 2 Blinded|Lost to Follow-up|0|||
161986239|NCT01727336|584998389|FG003|Part 2 Blinded|Lost to Follow-up|0|||
161986240|NCT01727336|584998390|FG004|Part 2 Blinded|Lost to Follow-up|0|||
161986241|NCT01727336|584998391|FG005|Part 2 Blinded|Lost to Follow-up|1|||
161986242|NCT01727336|584998386|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
161986243|NCT01727336|584998387|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
161986244|NCT01727336|584998388|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
161986245|NCT01727336|584998389|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
161986246|NCT01727336|584998390|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
161986247|NCT01727336|584998391|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
161986248|NCT01727336|584998386|FG000|Part 2 Blinded|use of prohibited medications|0|||
161986249|NCT01727336|584998387|FG001|Part 2 Blinded|use of prohibited medications|0|||
161986250|NCT01727336|584998388|FG002|Part 2 Blinded|use of prohibited medications|0|||
161986251|NCT01727336|584998389|FG003|Part 2 Blinded|use of prohibited medications|0|||
161986252|NCT01727336|584998390|FG004|Part 2 Blinded|use of prohibited medications|1|||
161986253|NCT01727336|584998391|FG005|Part 2 Blinded|use of prohibited medications|3|||
161986254|NCT00619099|584998392|FG000|Overall Study|Progressive Disease|7|||
161986255|NCT00619099|584998393|FG001|Overall Study|Progressive Disease|5|||
161986256|NCT00619099|584998392|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
161986257|NCT00619099|584998393|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
161986258|NCT00619099|584998392|FG000|Overall Study|Adverse Event|4|||
161986259|NCT00619099|584998393|FG001|Overall Study|Adverse Event|3|||
161986260|NCT00619099|584998392|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
161986261|NCT00619099|584998393|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
161986262|NCT00619099|584998392|FG000|Overall Study|Withdrawal by Subject|10|||
161986263|NCT00619099|584998393|FG001|Overall Study|Withdrawal by Subject|2|||
161986264|NCT00619099|584998392|FG000|Overall Study|Physician Decision|9|||
161986265|NCT00619099|584998393|FG001|Overall Study|Physician Decision|6|||
161986266|NCT04058886|584998396|FG000|Overall Study|Withdrawal by Subject|4|||
161986267|NCT04058886|584998396|FG000|Overall Study|Inadequate deafness interpreter service|1|||
161986268|NCT00699335|584998402|FG000|Overall Study|Combination of multiple reasons|176|||
161986269|NCT00699335|584998402|FG000|Overall Study|Missing data|52|||
161986270|NCT01717326|584998408|FG000|Overall Study|Death|0|||
161986271|NCT01717326|584998409|FG001|Overall Study|Death|0|||
161986272|NCT01717326|584998410|FG002|Overall Study|Death|0|||
161986273|NCT01717326|584998411|FG003|Overall Study|Death|0|||
161986274|NCT01717326|584998412|FG004|Overall Study|Death|0|||
161986275|NCT01717326|584998413|FG005|Overall Study|Death|0|||
161986276|NCT01717326|584998414|FG006|Overall Study|Death|0|||
161986277|NCT01717326|584998415|FG007|Overall Study|Death|0|||
161986278|NCT01717326|584998416|FG008|Overall Study|Death|0|||
161871533|NCT00267969|584575186|FG003|Controlled Period|Other|0|||
161871534|NCT00267969|584575187|FG004|Controlled Period|Other|0|||
161871535|NCT00267969|584575188|FG005|Controlled Period|Other|0|||
161871536|NCT00267969|584575189|FG006|Controlled Period|Other|0|||
161871537|NCT00267969|584575183|FG000|After Controlled Period|Adverse Event|0|||
161871538|NCT00267969|584575184|FG001|After Controlled Period|Adverse Event|0|||
161871539|NCT00267969|584575185|FG002|After Controlled Period|Adverse Event|0|||
161871540|NCT00267969|584575186|FG003|After Controlled Period|Adverse Event|7|||
161871541|NCT00267969|584575187|FG004|After Controlled Period|Adverse Event|8|||
161871542|NCT00267969|584575188|FG005|After Controlled Period|Adverse Event|23|||
161871543|NCT00267969|584575189|FG006|After Controlled Period|Adverse Event|21|||
161871544|NCT00267969|584575183|FG000|After Controlled Period|Death|0|||
161871545|NCT00267969|584575184|FG001|After Controlled Period|Death|0|||
161871546|NCT00267969|584575185|FG002|After Controlled Period|Death|0|||
161871547|NCT00267969|584575186|FG003|After Controlled Period|Death|1|||
161871548|NCT00267969|584575187|FG004|After Controlled Period|Death|2|||
161986279|NCT01717326|584998417|FG009|Overall Study|Death|0|||
161986280|NCT01717326|584998418|FG010|Overall Study|Death|1|||
161986281|NCT01717326|584998419|FG011|Overall Study|Death|0|||
161986282|NCT01717326|584998420|FG012|Overall Study|Death|0|||
161871549|NCT00267969|584575188|FG005|After Controlled Period|Death|0|||
161871550|NCT00267969|584575189|FG006|After Controlled Period|Death|1|||
161871551|NCT00267969|584575183|FG000|After Controlled Period|Lack of Efficacy|0|||
161871552|NCT00267969|584575184|FG001|After Controlled Period|Lack of Efficacy|0|||
161871553|NCT00267969|584575185|FG002|After Controlled Period|Lack of Efficacy|0|||
161871554|NCT00267969|584575186|FG003|After Controlled Period|Lack of Efficacy|10|||
161986283|NCT01717326|584998421|FG013|Overall Study|Death|0|||
161986284|NCT01717326|584998422|FG014|Overall Study|Death|0|||
161986285|NCT01717326|584998423|FG015|Overall Study|Death|0|||
161986286|NCT01717326|584998424|FG016|Overall Study|Death|0|||
161986287|NCT01717326|584998425|FG017|Overall Study|Death|0|||
161986288|NCT01717326|584998426|FG018|Overall Study|Death|0|||
161986289|NCT01717326|584998427|FG019|Overall Study|Death|0|||
161986290|NCT01717326|584998408|FG000|Overall Study|Lost to Follow-up|3|||
161986291|NCT01717326|584998409|FG001|Overall Study|Lost to Follow-up|0|||
161986292|NCT01717326|584998410|FG002|Overall Study|Lost to Follow-up|0|||
161986293|NCT01717326|584998411|FG003|Overall Study|Lost to Follow-up|2|||
161986294|NCT01717326|584998412|FG004|Overall Study|Lost to Follow-up|1|||
161986295|NCT01717326|584998413|FG005|Overall Study|Lost to Follow-up|0|||
161986296|NCT01717326|584998414|FG006|Overall Study|Lost to Follow-up|1|||
161986297|NCT01717326|584998415|FG007|Overall Study|Lost to Follow-up|0|||
161986298|NCT01717326|584998416|FG008|Overall Study|Lost to Follow-up|0|||
161986299|NCT01717326|584998417|FG009|Overall Study|Lost to Follow-up|0|||
161986300|NCT01717326|584998418|FG010|Overall Study|Lost to Follow-up|1|||
161986301|NCT01717326|584998419|FG011|Overall Study|Lost to Follow-up|0|||
161986302|NCT01717326|584998420|FG012|Overall Study|Lost to Follow-up|0|||
161986303|NCT01717326|584998421|FG013|Overall Study|Lost to Follow-up|0|||
161986304|NCT01717326|584998422|FG014|Overall Study|Lost to Follow-up|0|||
161986305|NCT01717326|584998423|FG015|Overall Study|Lost to Follow-up|2|||
161871555|NCT00267969|584575187|FG004|After Controlled Period|Lack of Efficacy|6|||
161871556|NCT00267969|584575188|FG005|After Controlled Period|Lack of Efficacy|28|||
161871557|NCT00267969|584575189|FG006|After Controlled Period|Lack of Efficacy|15|||
161871558|NCT00267969|584575183|FG000|After Controlled Period|Lost to Follow-up|0|||
161871559|NCT00267969|584575184|FG001|After Controlled Period|Lost to Follow-up|0|||
161871560|NCT00267969|584575185|FG002|After Controlled Period|Lost to Follow-up|0|||
161871561|NCT00267969|584575186|FG003|After Controlled Period|Lost to Follow-up|5|||
161871562|NCT00267969|584575187|FG004|After Controlled Period|Lost to Follow-up|8|||
161871563|NCT00267969|584575188|FG005|After Controlled Period|Lost to Follow-up|9|||
161871564|NCT00267969|584575189|FG006|After Controlled Period|Lost to Follow-up|10|||
161871565|NCT00267969|584575183|FG000|After Controlled Period|Other|0|||
161871566|NCT00267969|584575184|FG001|After Controlled Period|Other|0|||
161871567|NCT00267969|584575185|FG002|After Controlled Period|Other|0|||
161871568|NCT00267969|584575186|FG003|After Controlled Period|Other|13|||
161871569|NCT00267969|584575187|FG004|After Controlled Period|Other|11|||
161871570|NCT00267969|584575188|FG005|After Controlled Period|Other|22|||
161871571|NCT00267969|584575189|FG006|After Controlled Period|Other|25|||
161871572|NCT00862823|584575190|FG000|First Intervention|Withdrawal by Subject|1|||
161871573|NCT00862823|584575191|FG001|First Intervention|Withdrawal by Subject|1|||
161871574|NCT00887315|584575192|FG000|Overall Study|Study termination|7|||
161871575|NCT00887315|584575193|FG001|Overall Study|Study termination|4|||
161871576|NCT00619892|584575195|FG000|Overall Study|Adverse Event|3|||
161871577|NCT00619892|584575196|FG001|Overall Study|Adverse Event|0|||
161871578|NCT00619892|584575195|FG000|Overall Study|Lost to Follow-up|0|||
161871579|NCT00619892|584575196|FG001|Overall Study|Lost to Follow-up|1|||
161871580|NCT00619892|584575195|FG000|Overall Study|Intercurrent illness|0|||
161871581|NCT00619892|584575196|FG001|Overall Study|Intercurrent illness|1|||
161871582|NCT00857896|584575205|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
161986306|NCT01717326|584998424|FG016|Overall Study|Lost to Follow-up|1|||
161986307|NCT01717326|584998425|FG017|Overall Study|Lost to Follow-up|0|||
161871583|NCT01091662|584575207|FG000|Overall Study|Adverse Event|1|||
161871584|NCT01091662|584575208|FG001|Overall Study|Adverse Event|9|||
161871585|NCT01091662|584575207|FG000|Overall Study|Physician Decision|1|||
161871586|NCT01091662|584575208|FG001|Overall Study|Physician Decision|1|||
161871587|NCT01091662|584575207|FG000|Overall Study|Withdrawal by Subject|7|||
161871588|NCT01091662|584575208|FG001|Overall Study|Withdrawal by Subject|6|||
161871589|NCT01091662|584575207|FG000|Overall Study|met exit criteria|7|||
161871590|NCT01091662|584575208|FG001|Overall Study|met exit criteria|13|||
161871591|NCT01091662|584575207|FG000|Overall Study|met exclusion criteria|1|||
161871592|NCT01091662|584575208|FG001|Overall Study|met exclusion criteria|0|||
161871593|NCT01091662|584575207|FG000|Overall Study|Lost to Follow-up|0|||
161871594|NCT01091662|584575208|FG001|Overall Study|Lost to Follow-up|1|||
161871595|NCT01091662|584575207|FG000|Overall Study|Pregnancy|0|||
161871596|NCT01091662|584575208|FG001|Overall Study|Pregnancy|1|||
161871597|NCT01091662|584575207|FG000|Overall Study|Protocol Violation|0|||
161871598|NCT01091662|584575208|FG001|Overall Study|Protocol Violation|2|||
161871599|NCT01091662|584575207|FG000|Overall Study|unable to swallow capsule|0|||
161871600|NCT01091662|584575208|FG001|Overall Study|unable to swallow capsule|1|||
161871601|NCT02285166|584575209|FG000|Overall Study|Case Report Forms Uncollected|564|||
161871602|NCT02285166|584575209|FG000|Overall Study|Protocol Deviation|402|||
161986308|NCT01717326|584998426|FG018|Overall Study|Lost to Follow-up|2|||
161986309|NCT01717326|584998427|FG019|Overall Study|Lost to Follow-up|3|||
161871603|NCT00443079|584575214|FG000|Overall Study|Lost to Follow-up|0|||
161871604|NCT00443079|584575215|FG001|Overall Study|Lost to Follow-up|1|||
161871605|NCT01421225|584575216|FG000|Overall Study|Withdrawal by Subject|0|||
161871606|NCT01421225|584575217|FG001|Overall Study|Withdrawal by Subject|1|||
161986310|NCT01717326|584998408|FG000|Overall Study|Physician Decision|0|||
161986311|NCT01717326|584998409|FG001|Overall Study|Physician Decision|0|||
161986312|NCT01717326|584998410|FG002|Overall Study|Physician Decision|0|||
161986313|NCT01717326|584998411|FG003|Overall Study|Physician Decision|0|||
161986314|NCT01717326|584998412|FG004|Overall Study|Physician Decision|0|||
161986315|NCT01717326|584998413|FG005|Overall Study|Physician Decision|0|||
161871607|NCT02049814|584575218|FG000|Overall Study|Reason not Specified|4|||
161871608|NCT02049814|584575219|FG001|Overall Study|Reason not Specified|3|||
161871609|NCT02049814|584575218|FG000|Overall Study|Pregnancy|1|||
161871610|NCT02049814|584575219|FG001|Overall Study|Pregnancy|0|||
161871611|NCT02049814|584575218|FG000|Overall Study|Lost to Follow-up|2|||
161871612|NCT02049814|584575219|FG001|Overall Study|Lost to Follow-up|3|||
161871613|NCT02049814|584575218|FG000|Overall Study|Serious Protocol Violation|5|||
161871614|NCT02049814|584575219|FG001|Overall Study|Serious Protocol Violation|7|||
161871615|NCT02049814|584575218|FG000|Overall Study|Study Termination|0|||
161871616|NCT02049814|584575219|FG001|Overall Study|Study Termination|1|||
161871617|NCT02049814|584575218|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
161871618|NCT02049814|584575219|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
161871619|NCT02049814|584575218|FG000|Overall Study|Voluntary withdrawal|9|||
161871620|NCT02049814|584575219|FG001|Overall Study|Voluntary withdrawal|8|||
161871621|NCT02714595|584575220|FG000|Overall Study|Lost to Follow-up|1|||
161871622|NCT02714595|584575221|FG001|Overall Study|Lost to Follow-up|0|||
161871623|NCT02714595|584575220|FG000|Overall Study|Withdrawal by Subject|1|||
161871624|NCT02714595|584575221|FG001|Overall Study|Withdrawal by Subject|2|||
161871625|NCT02714595|584575220|FG000|Overall Study|Lack of Efficacy|0|||
161871626|NCT02714595|584575221|FG001|Overall Study|Lack of Efficacy|1|||
161871627|NCT02714595|584575220|FG000|Overall Study|Death|30|||
161871628|NCT02714595|584575221|FG001|Overall Study|Death|9|||
161871629|NCT02714595|584575220|FG000|Overall Study|Other-Miscellaneous|0|||
161871630|NCT02714595|584575221|FG001|Overall Study|Other-Miscellaneous|1|||
161871631|NCT00713258|584575222|FG000|Overall Study|Adverse Event|2|||
161871632|NCT00713258|584575223|FG001|Overall Study|Adverse Event|4|||
161871633|NCT00713258|584575222|FG000|Overall Study|Non-Compliance|2|||
161871634|NCT00713258|584575223|FG001|Overall Study|Non-Compliance|1|||
161871635|NCT00713258|584575222|FG000|Overall Study|Other|1|||
161871636|NCT00713258|584575223|FG001|Overall Study|Other|1|||
161871637|NCT03515811|584575236|FG000|Overall Study|Lost to Follow-up|2|||
161871638|NCT03515811|584575237|FG001|Overall Study|Lost to Follow-up|1|||
161871639|NCT03515811|584575236|FG000|Overall Study|Protocol Violation|1|||
161871640|NCT03515811|584575237|FG001|Overall Study|Protocol Violation|1|||
161871641|NCT03515811|584575236|FG000|Overall Study|Death|1|||
161871642|NCT03515811|584575237|FG001|Overall Study|Death|1|||
161871643|NCT03515811|584575236|FG000|Overall Study|Withdrawal by Subject|0|||
161871644|NCT03515811|584575237|FG001|Overall Study|Withdrawal by Subject|2|||
161871645|NCT03515811|584575236|FG000|Overall Study|Technical Problems|1|||
161871646|NCT03515811|584575237|FG001|Overall Study|Technical Problems|0|||
161871647|NCT03515811|584575236|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
161871648|NCT03515811|584575237|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
161871649|NCT03515811|584575236|FG000|Overall Study|COVID-19|0|||
161871650|NCT03515811|584575237|FG001|Overall Study|COVID-19|1|||
161871651|NCT01197534|584575238|FG000|Overall Study|Not reported|16|||
161871652|NCT01197534|584575239|FG001|Overall Study|Not reported|10|||
161871653|NCT01197534|584575240|FG002|Overall Study|Not reported|16|||
161871654|NCT01197534|584575238|FG000|Overall Study|Enrolment in long term extension|57|||
161871655|NCT01197534|584575239|FG001|Overall Study|Enrolment in long term extension|66|||
161871656|NCT01197534|584575240|FG002|Overall Study|Enrolment in long term extension|119|||
161871657|NCT01197534|584575238|FG000|Overall Study|Severe non-compliance to protocol|3|||
161871658|NCT01197534|584575239|FG001|Overall Study|Severe non-compliance to protocol|4|||
161871659|NCT01197534|584575240|FG002|Overall Study|Severe non-compliance to protocol|1|||
161986316|NCT01717326|584998414|FG006|Overall Study|Physician Decision|0|||
161986317|NCT01717326|584998415|FG007|Overall Study|Physician Decision|0|||
161986318|NCT01717326|584998416|FG008|Overall Study|Physician Decision|0|||
161986319|NCT01717326|584998417|FG009|Overall Study|Physician Decision|1|||
161986320|NCT01717326|584998418|FG010|Overall Study|Physician Decision|0|||
161986321|NCT01717326|584998419|FG011|Overall Study|Physician Decision|0|||
161986322|NCT01717326|584998420|FG012|Overall Study|Physician Decision|0|||
161986323|NCT01717326|584998421|FG013|Overall Study|Physician Decision|0|||
161986324|NCT01717326|584998422|FG014|Overall Study|Physician Decision|0|||
161986325|NCT01717326|584998423|FG015|Overall Study|Physician Decision|0|||
161871660|NCT01197534|584575238|FG000|Overall Study|Lack of therapeutic response|9|||
161871661|NCT01197534|584575239|FG001|Overall Study|Lack of therapeutic response|4|||
161871662|NCT01197534|584575240|FG002|Overall Study|Lack of therapeutic response|9|||
161871663|NCT01197534|584575238|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
161871664|NCT01197534|584575239|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
161871665|NCT01197534|584575240|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
161871666|NCT01197534|584575238|FG000|Overall Study|Lost to Follow-up|1|||
161871667|NCT01197534|584575239|FG001|Overall Study|Lost to Follow-up|4|||
161871668|NCT01197534|584575240|FG002|Overall Study|Lost to Follow-up|2|||
161871669|NCT01197534|584575238|FG000|Overall Study|Adverse Event|35|||
161871670|NCT01197534|584575239|FG001|Overall Study|Adverse Event|36|||
161871671|NCT01197534|584575240|FG002|Overall Study|Adverse Event|24|||
161871672|NCT02593097|584575241|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
161871673|NCT02593097|584575242|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
161986326|NCT01717326|584998424|FG016|Overall Study|Physician Decision|0|||
161986327|NCT01717326|584998425|FG017|Overall Study|Physician Decision|0|||
161871674|NCT02593097|584575241|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161871675|NCT02593097|584575242|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
161986328|NCT01717326|584998426|FG018|Overall Study|Physician Decision|0|||
161986329|NCT01717326|584998427|FG019|Overall Study|Physician Decision|0|||
161986330|NCT01717326|584998408|FG000|Overall Study|Protocol Violation|0|||
161986331|NCT01717326|584998409|FG001|Overall Study|Protocol Violation|0|||
161986332|NCT01717326|584998410|FG002|Overall Study|Protocol Violation|0|||
161986333|NCT01717326|584998411|FG003|Overall Study|Protocol Violation|0|||
161986334|NCT01717326|584998412|FG004|Overall Study|Protocol Violation|1|||
161986335|NCT01717326|584998413|FG005|Overall Study|Protocol Violation|0|||
161986336|NCT01717326|584998414|FG006|Overall Study|Protocol Violation|0|||
161986337|NCT01717326|584998415|FG007|Overall Study|Protocol Violation|0|||
161986338|NCT01717326|584998416|FG008|Overall Study|Protocol Violation|0|||
161986339|NCT01717326|584998417|FG009|Overall Study|Protocol Violation|0|||
161986340|NCT01717326|584998418|FG010|Overall Study|Protocol Violation|0|||
161986341|NCT01717326|584998419|FG011|Overall Study|Protocol Violation|0|||
161986342|NCT01717326|584998420|FG012|Overall Study|Protocol Violation|0|||
161986343|NCT01717326|584998421|FG013|Overall Study|Protocol Violation|0|||
161986344|NCT01717326|584998422|FG014|Overall Study|Protocol Violation|0|||
161986345|NCT01717326|584998423|FG015|Overall Study|Protocol Violation|0|||
161986346|NCT01717326|584998424|FG016|Overall Study|Protocol Violation|0|||
161986347|NCT01717326|584998425|FG017|Overall Study|Protocol Violation|0|||
161986348|NCT01717326|584998426|FG018|Overall Study|Protocol Violation|0|||
161986349|NCT01717326|584998427|FG019|Overall Study|Protocol Violation|0|||
161986350|NCT01717326|584998408|FG000|Overall Study|Withdrawal by Subject|0|||
161986351|NCT01717326|584998409|FG001|Overall Study|Withdrawal by Subject|1|||
161986352|NCT01717326|584998410|FG002|Overall Study|Withdrawal by Subject|0|||
161986353|NCT01717326|584998411|FG003|Overall Study|Withdrawal by Subject|0|||
161986354|NCT01717326|584998412|FG004|Overall Study|Withdrawal by Subject|0|||
161986355|NCT01717326|584998413|FG005|Overall Study|Withdrawal by Subject|0|||
161986356|NCT01717326|584998414|FG006|Overall Study|Withdrawal by Subject|0|||
161986357|NCT01717326|584998415|FG007|Overall Study|Withdrawal by Subject|0|||
161986358|NCT01717326|584998416|FG008|Overall Study|Withdrawal by Subject|0|||
161986359|NCT01717326|584998417|FG009|Overall Study|Withdrawal by Subject|1|||
161986360|NCT01717326|584998418|FG010|Overall Study|Withdrawal by Subject|0|||
161986361|NCT01717326|584998419|FG011|Overall Study|Withdrawal by Subject|0|||
161986362|NCT01717326|584998420|FG012|Overall Study|Withdrawal by Subject|1|||
161986363|NCT01717326|584998421|FG013|Overall Study|Withdrawal by Subject|0|||
161986364|NCT01717326|584998422|FG014|Overall Study|Withdrawal by Subject|0|||
161986365|NCT01717326|584998423|FG015|Overall Study|Withdrawal by Subject|1|||
161986366|NCT01717326|584998424|FG016|Overall Study|Withdrawal by Subject|0|||
161986367|NCT01717326|584998425|FG017|Overall Study|Withdrawal by Subject|0|||
161986368|NCT01717326|584998426|FG018|Overall Study|Withdrawal by Subject|2|||
161986369|NCT01717326|584998427|FG019|Overall Study|Withdrawal by Subject|3|||
161986370|NCT01299116|584998428|FG000|Overall Study|Lost to Follow-up|65|||
161986371|NCT01299116|584998429|FG001|Overall Study|Lost to Follow-up|9|||
161986372|NCT01299116|584998430|FG002|Overall Study|Lost to Follow-up|11|||
161986373|NCT01114438|584998433|FG000|Overall Study|Adverse Event|10|||
161986374|NCT01114438|584998433|FG000|Overall Study|concomitant medication|1|||
161986375|NCT01114438|584998433|FG000|Overall Study|Physician Decision|1|||
161986376|NCT01114438|584998433|FG000|Overall Study|Withdrawal by Subject|2|||
161986377|NCT00428844|584998436|FG000|Completed Study Drug Treatment|Adverse Event|2|||
161986378|NCT00428844|584998437|FG001|Completed Study Drug Treatment|Adverse Event|4|||
161986379|NCT00428844|584998438|FG002|Completed Study Drug Treatment|Adverse Event|4|||
161986380|NCT00428844|584998436|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
161986381|NCT00428844|584998437|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
161986382|NCT00428844|584998438|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
161986383|NCT00428844|584998436|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
161986384|NCT00428844|584998437|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
161986385|NCT00428844|584998438|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
161986386|NCT00428844|584998436|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
161871676|NCT02593097|584575241|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
161871677|NCT02593097|584575242|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
161986387|NCT00428844|584998437|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
161986388|NCT00428844|584998438|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
161986389|NCT00428844|584998436|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
161986390|NCT00428844|584998437|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
161986391|NCT00428844|584998438|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
161986392|NCT00428844|584998436|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
161986393|NCT00428844|584998437|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
161986394|NCT00428844|584998438|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
161986395|NCT00428844|584998436|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
161986396|NCT00428844|584998437|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
161871678|NCT02593097|584575241|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
162035148|NCT00740246|585185850|FG000|Overall Study|Withdrawal by Subject|4|||
161871679|NCT02593097|584575242|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
161871680|NCT02593097|584575241|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
161871681|NCT02593097|584575242|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
161871682|NCT02858583|584575243|FG000|Overall Study|Declined consent|1|||
161871683|NCT02858583|584575244|FG001|Overall Study|Declined consent|1|||
161871684|NCT03627546|584575249|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
161871685|NCT03627546|584575250|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
161871686|NCT03627546|584575251|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
161871687|NCT03627546|584575249|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
161871688|NCT03627546|584575250|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
161871689|NCT03627546|584575251|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
161871690|NCT00961350|584575254|FG000|Overall Study|Adverse Event|18|||
161871691|NCT00961350|584575255|FG001|Overall Study|Adverse Event|33|||
161871692|NCT00961350|584575254|FG000|Overall Study|Withdrawal by Subject|10|||
161871693|NCT00961350|584575255|FG001|Overall Study|Withdrawal by Subject|10|||
161871694|NCT00961350|584575254|FG000|Overall Study|Lost to Follow-up|3|||
161871695|NCT00961350|584575255|FG001|Overall Study|Lost to Follow-up|3|||
161871696|NCT00961350|584575254|FG000|Overall Study|Misc|16|||
161871697|NCT00961350|584575255|FG001|Overall Study|Misc|21|||
161871698|NCT03291431|584575257|FG000|Overall Study|Protocol Violation|2|||
161871699|NCT03291431|584575258|FG001|Overall Study|Protocol Violation|1|||
161871700|NCT03291431|584575257|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
161871701|NCT03291431|584575258|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
161871702|NCT03291431|584575257|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
161871703|NCT03291431|584575258|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
161871704|NCT06868654|584575259|FG000|Overall Study|Death|4|||
161871705|NCT06868654|584575260|FG001|Overall Study|Death|14|||
161871706|NCT06868654|584575259|FG000|Overall Study|Lost to Follow-up|0|||
161871707|NCT06868654|584575260|FG001|Overall Study|Lost to Follow-up|1|||
161871708|NCT06868654|584575259|FG000|Overall Study|Withdrawal by Subject|5|||
161871709|NCT06868654|584575260|FG001|Overall Study|Withdrawal by Subject|3|||
161871710|NCT06868654|584575259|FG000|Overall Study|Physician Decision|0|||
161871711|NCT06868654|584575260|FG001|Overall Study|Physician Decision|1|||
161871712|NCT06868654|584575259|FG000|Overall Study|Ongoing|23|||
161871713|NCT06868654|584575260|FG001|Overall Study|Ongoing|21|||
161871714|NCT03867201|584575261|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
161871715|NCT03867201|584575262|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
161871716|NCT03867201|584575261|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
161871717|NCT03867201|584575262|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
161871718|NCT03867201|584575261|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
161871719|NCT03867201|584575262|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
161871720|NCT03867201|584575261|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
161871721|NCT03867201|584575262|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
161871722|NCT03867201|584575261|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
161871723|NCT03867201|584575262|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
161871724|NCT03867201|584575261|FG000|Open-Label Period From Week 12|Adverse Event|5|||
161871725|NCT03867201|584575262|FG001|Open-Label Period From Week 12|Adverse Event|11|||
161871726|NCT03867201|584575261|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
161871727|NCT03867201|584575262|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
161871728|NCT03867201|584575261|FG000|Open-Label Period From Week 12|Physician Decision|6|||
161871729|NCT03867201|584575262|FG001|Open-Label Period From Week 12|Physician Decision|3|||
161871730|NCT03867201|584575261|FG000|Open-Label Period From Week 12|Pregnancy|2|||
161871731|NCT03867201|584575262|FG001|Open-Label Period From Week 12|Pregnancy|2|||
161871732|NCT03867201|584575261|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
161871733|NCT03867201|584575262|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
161871734|NCT03867201|584575261|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
161871735|NCT03867201|584575262|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
161871736|NCT03867201|584575261|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
161871737|NCT03867201|584575262|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
161871738|NCT03867201|584575261|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
161871739|NCT03867201|584575262|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
161871740|NCT03260244|584576950|FG000|Overall Study|Death|19|||
161871741|NCT03260244|584576950|FG000|Overall Study|Lost to Follow-up|60|||
161871742|NCT03260244|584576950|FG000|Overall Study|Withdrawal by Subject|48|||
161871743|NCT03260244|584576950|FG000|Overall Study|Procedure Not Performed|21|||
161871744|NCT03260244|584576950|FG000|Overall Study|Enrollment Criteria Not Met|31|||
161871745|NCT03260244|584576950|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
161871746|NCT03260244|584576950|FG000|Overall Study|Subject Noncompliance|6|||
161986397|NCT00428844|584998438|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
161986398|NCT00428844|584998436|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
161986399|NCT00428844|584998437|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
161986400|NCT00428844|584998438|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
161986401|NCT00428844|584998436|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
161986402|NCT00428844|584998437|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
161986403|NCT00428844|584998438|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
161986404|NCT00488826|584998441|FG000|Overall Study|Withdrawal by Subject|40|||
161986405|NCT00488826|584998442|FG001|Overall Study|Withdrawal by Subject|35|||
161986406|NCT00488826|584998443|FG002|Overall Study|Withdrawal by Subject|19|||
161986407|NCT00488826|584998441|FG000|Overall Study|Protocol Violation|0|||
161986408|NCT00488826|584998442|FG001|Overall Study|Protocol Violation|0|||
161986409|NCT00488826|584998443|FG002|Overall Study|Protocol Violation|2|||
161986410|NCT00488826|584998441|FG000|Overall Study|Adverse Event|9|||
161986411|NCT00488826|584998442|FG001|Overall Study|Adverse Event|15|||
161986412|NCT00488826|584998443|FG002|Overall Study|Adverse Event|4|||
161986413|NCT00488826|584998441|FG000|Overall Study|Lost to Follow-up|5|||
161986414|NCT00488826|584998442|FG001|Overall Study|Lost to Follow-up|1|||
161986415|NCT00488826|584998443|FG002|Overall Study|Lost to Follow-up|0|||
161986416|NCT00488826|584998441|FG000|Overall Study|Protocol Deviations|2|||
161986417|NCT00488826|584998442|FG001|Overall Study|Protocol Deviations|1|||
161986418|NCT00488826|584998443|FG002|Overall Study|Protocol Deviations|1|||
161986419|NCT03043651|584998447|FG000|Overall Study|Death|1|||
161986420|NCT03043651|584998447|FG000|Overall Study|Progressive Disease|2|||
161986421|NCT03043651|584998447|FG000|Overall Study|Adverse Event|2|||
161986422|NCT03043651|584998447|FG000|Overall Study|Withdrawal by Subject|4|||
161986423|NCT03043651|584998447|FG000|Overall Study|Study Terminated by Sponsor|39|||
161986424|NCT02974842|584998448|FG000|Overall Study|Withdrawal by Subject|4|||
161986425|NCT02974842|584998448|FG000|Overall Study|Screen failures|4|||
161986426|NCT01959243|584998449|FG000|Overall Study|Investigator Decision|3|||
161986427|NCT01959243|584998450|FG001|Overall Study|Investigator Decision|0|||
161986428|NCT01959243|584998449|FG000|Overall Study|Adverse Event|5|||
161986429|NCT01959243|584998450|FG001|Overall Study|Adverse Event|2|||
161986430|NCT01959243|584998449|FG000|Overall Study|Administrative reasons|2|||
161986431|NCT01959243|584998450|FG001|Overall Study|Administrative reasons|1|||
161986432|NCT01959243|584998449|FG000|Overall Study|Lost to Follow-up|3|||
161986433|NCT01959243|584998450|FG001|Overall Study|Lost to Follow-up|1|||
161986434|NCT00812565|584998451|FG000|Overall Study|Did Not Receive Study Medication|1|||
161986435|NCT00812565|584998452|FG001|Overall Study|Did Not Receive Study Medication|1|||
161986436|NCT00812565|584998453|FG002|Overall Study|Did Not Receive Study Medication|0|||
161986437|NCT00812565|584998454|FG003|Overall Study|Did Not Receive Study Medication|0|||
161986438|NCT00812565|584998455|FG004|Overall Study|Did Not Receive Study Medication|0|||
161986439|NCT00812565|584998456|FG005|Overall Study|Did Not Receive Study Medication|0|||
161986440|NCT00812565|584998457|FG006|Overall Study|Did Not Receive Study Medication|0|||
161986441|NCT00812565|584998458|FG007|Overall Study|Did Not Receive Study Medication|0|||
161986442|NCT00812565|584998451|FG000|Overall Study|Adverse Event|0|||
161986443|NCT00812565|584998452|FG001|Overall Study|Adverse Event|0|||
161986444|NCT00812565|584998453|FG002|Overall Study|Adverse Event|0|||
161986445|NCT00812565|584998454|FG003|Overall Study|Adverse Event|2|||
161986446|NCT00812565|584998455|FG004|Overall Study|Adverse Event|0|||
161986447|NCT00812565|584998456|FG005|Overall Study|Adverse Event|0|||
161986448|NCT00812565|584998457|FG006|Overall Study|Adverse Event|0|||
161986449|NCT00812565|584998458|FG007|Overall Study|Adverse Event|1|||
161986450|NCT00812565|584998451|FG000|Overall Study|Did Not Come to Study Visit|1|||
161986451|NCT00812565|584998452|FG001|Overall Study|Did Not Come to Study Visit|0|||
161986452|NCT00812565|584998453|FG002|Overall Study|Did Not Come to Study Visit|0|||
161986453|NCT00812565|584998454|FG003|Overall Study|Did Not Come to Study Visit|0|||
161986454|NCT00812565|584998455|FG004|Overall Study|Did Not Come to Study Visit|0|||
161986455|NCT00812565|584998456|FG005|Overall Study|Did Not Come to Study Visit|0|||
161986456|NCT00812565|584998457|FG006|Overall Study|Did Not Come to Study Visit|0|||
161986457|NCT00812565|584998458|FG007|Overall Study|Did Not Come to Study Visit|0|||
161986458|NCT00812565|584998451|FG000|Overall Study|Withdrawal of Consent|1|||
161986459|NCT00812565|584998452|FG001|Overall Study|Withdrawal of Consent|0|||
161986460|NCT00812565|584998453|FG002|Overall Study|Withdrawal of Consent|0|||
161986461|NCT00812565|584998454|FG003|Overall Study|Withdrawal of Consent|0|||
161986462|NCT00812565|584998455|FG004|Overall Study|Withdrawal of Consent|1|||
161986463|NCT00812565|584998456|FG005|Overall Study|Withdrawal of Consent|0|||
161986464|NCT00812565|584998457|FG006|Overall Study|Withdrawal of Consent|0|||
161986465|NCT00812565|584998458|FG007|Overall Study|Withdrawal of Consent|0|||
161986466|NCT00812565|584998451|FG000|Overall Study|Reason Not Specified|0|||
161986467|NCT00812565|584998452|FG001|Overall Study|Reason Not Specified|0|||
161986468|NCT00812565|584998453|FG002|Overall Study|Reason Not Specified|0|||
161986469|NCT00812565|584998454|FG003|Overall Study|Reason Not Specified|0|||
161986470|NCT00812565|584998455|FG004|Overall Study|Reason Not Specified|0|||
161986471|NCT00812565|584998456|FG005|Overall Study|Reason Not Specified|1|||
161986472|NCT00812565|584998457|FG006|Overall Study|Reason Not Specified|0|||
161986473|NCT00812565|584998458|FG007|Overall Study|Reason Not Specified|0|||
161986474|NCT02596945|584998461|FG000|Overall Study|No documentation of study drug dosing|3|||
161986475|NCT02596945|584998461|FG000|Overall Study|Other|32|||
161986476|NCT02596945|584998461|FG000|Overall Study|Change to hemodialysis|15|||
161986477|NCT02596945|584998461|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
161986478|NCT02596945|584998461|FG000|Overall Study|Withdrawal by Subject|1|||
161986479|NCT02596945|584998461|FG000|Overall Study|Missing|1|||
161986480|NCT04699461|584998462|FG000|Overall Study|Withdrawal by Subject|1|||
161986481|NCT04699461|584998463|FG001|Overall Study|Withdrawal by Subject|0|||
161986482|NCT04699461|584998462|FG000|Overall Study|Study termination by sponsor|2|||
161986483|NCT04699461|584998463|FG001|Overall Study|Study termination by sponsor|1|||
161986484|NCT04699461|584998462|FG000|Overall Study|Death|1|||
161986485|NCT04699461|584998463|FG001|Overall Study|Death|0|||
161986486|NCT04699461|584998462|FG000|Overall Study|Radiographic progression|0|||
161986487|NCT04699461|584998463|FG001|Overall Study|Radiographic progression|1|||
161986488|NCT02611817|585000895|FG000|Open-label Induction Phase|Reason not Specified|9|||
161986489|NCT02611817|585000896|FG001|Open-label Induction Phase|Reason not Specified|0|||
161986490|NCT02611817|585000897|FG002|Open-label Induction Phase|Reason not Specified|0|||
161986491|NCT02611817|585000895|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
161986492|NCT02611817|585000896|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
161986493|NCT02611817|585000897|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
161986494|NCT02611817|585000895|FG000|Open-label Induction Phase|Pregnancy|1|||
161986495|NCT02611817|585000896|FG001|Open-label Induction Phase|Pregnancy|0|||
161986496|NCT02611817|585000897|FG002|Open-label Induction Phase|Pregnancy|0|||
161986497|NCT02611817|585000895|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
161986498|NCT02611817|585000896|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
161986499|NCT02611817|585000897|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
161986500|NCT02611817|585000895|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
161986501|NCT02611817|585000896|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
161986502|NCT02611817|585000897|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
161986503|NCT02611817|585000895|FG000|Open-label Induction Phase|Protocol Violation|5|||
161986504|NCT02611817|585000896|FG001|Open-label Induction Phase|Protocol Violation|0|||
161986505|NCT02611817|585000897|FG002|Open-label Induction Phase|Protocol Violation|0|||
161986506|NCT02611817|585000895|FG000|Open-label Induction Phase|Adverse Event|16|||
161986507|NCT02611817|585000896|FG001|Open-label Induction Phase|Adverse Event|0|||
161986508|NCT02611817|585000897|FG002|Open-label Induction Phase|Adverse Event|0|||
161986509|NCT02611817|585000895|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
161986510|NCT02611817|585000896|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
161986511|NCT02611817|585000897|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
161986512|NCT02611817|585000895|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
161986513|NCT02611817|585000896|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
161986514|NCT02611817|585000897|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
161986515|NCT02611817|585000895|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
161986516|NCT02611817|585000896|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
161986517|NCT02611817|585000897|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
161986518|NCT02611817|585000895|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
161986519|NCT02611817|585000896|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
161986520|NCT02611817|585000897|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
161986521|NCT02611817|585000895|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
161986522|NCT02611817|585000896|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
161986523|NCT02611817|585000897|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
161986524|NCT02611817|585000895|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
162035149|NCT00740246|585185851|FG001|Overall Study|Withdrawal by Subject|3|||
161775576|NCT00471237|584221214|FG003|Overall Study|Participant planned to travel to abraod|0|||
161775577|NCT00471237|584221215|FG004|Overall Study|Participant planned to travel to abraod|0|||
161775578|NCT00471237|584221216|FG005|Overall Study|Participant planned to travel to abraod|1|||
161775579|NCT00471237|584221217|FG006|Overall Study|Participant planned to travel to abraod|0|||
161775580|NCT00471237|584221211|FG000|Overall Study|High parathyroid hormone|0|||
161775581|NCT00471237|584221212|FG001|Overall Study|High parathyroid hormone|0|||
161775582|NCT00471237|584221213|FG002|Overall Study|High parathyroid hormone|1|||
161775583|NCT00471237|584221214|FG003|Overall Study|High parathyroid hormone|0|||
161775584|NCT00471237|584221215|FG004|Overall Study|High parathyroid hormone|0|||
161775585|NCT00471237|584221216|FG005|Overall Study|High parathyroid hormone|0|||
161775586|NCT00471237|584221217|FG006|Overall Study|High parathyroid hormone|0|||
161775587|NCT00471237|584221211|FG000|Overall Study|Participant lost medication|0|||
161775588|NCT00471237|584221212|FG001|Overall Study|Participant lost medication|0|||
161775589|NCT00471237|584221213|FG002|Overall Study|Participant lost medication|0|||
161775590|NCT00471237|584221214|FG003|Overall Study|Participant lost medication|0|||
161775591|NCT00471237|584221215|FG004|Overall Study|Participant lost medication|1|||
161775592|NCT00471237|584221216|FG005|Overall Study|Participant lost medication|0|||
161775593|NCT00471237|584221217|FG006|Overall Study|Participant lost medication|0|||
161775594|NCT00471237|584221211|FG000|Overall Study|Administration of prohibited medicine|0|||
161871747|NCT03260244|584576950|FG000|Overall Study|No inducible Arrhythmia|2|||
161871748|NCT03260244|584576950|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
161871749|NCT03260244|584576950|FG000|Overall Study|Screen Failure|2|||
161871750|NCT03260244|584576950|FG000|Overall Study|Treated Off Label|69|||
161871751|NCT03260244|584576950|FG000|Overall Study|No Radiofrequency Ablation|14|||
161871752|NCT01288937|584576954|FG000|Overall Study|Adverse Event|1|||
161871753|NCT01288937|584576955|FG001|Overall Study|Adverse Event|0|||
161871754|NCT01750697|584576961|FG000|Overall Study|Transferred Back to Local Hospital|1|||
161871755|NCT01750697|584576961|FG000|Overall Study|Physician and Family Decision|1|||
161871756|NCT01750697|584576961|FG000|Overall Study|Transferred to Adult Services|5|||
161871757|NCT01750697|584576961|FG000|Overall Study|Physician Decision|1|||
161871758|NCT01750697|584576961|FG000|Overall Study|Withdrawal by Subject|1|||
161871759|NCT00384839|584576966|FG000|Overall Study|Adverse Event|4|||
161871760|NCT00384839|584576966|FG000|Overall Study|Investigator Request|1|||
161871761|NCT00384839|584576966|FG000|Overall Study|Patient Request|1|||
161871762|NCT00384839|584576966|FG000|Overall Study|Ineligible|2|||
161871763|NCT01431716|584576969|FG000|Overall Study|Withdrawal of consent|1|||
161871764|NCT02484456|584576972|FG000|Washout Period|Withdrawal by Subject|0|||
161871765|NCT02484456|584576973|FG001|Washout Period|Withdrawal by Subject|1|||
161871766|NCT02484456|584576972|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
161871767|NCT02484456|584576973|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
161871768|NCT02484456|584576972|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
161871769|NCT02484456|584576973|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
161871770|NCT02484456|584576972|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
161871771|NCT02484456|584576973|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
161871772|NCT00708214|584576974|FG000|Overall Study|Other Adverse Event|3|||
161871773|NCT00708214|584576975|FG001|Overall Study|Other Adverse Event|6|||
161871774|NCT00708214|584576976|FG002|Overall Study|Other Adverse Event|2|||
161871775|NCT00708214|584576974|FG000|Overall Study|Other|0|||
161871776|NCT00708214|584576975|FG001|Overall Study|Other|1|||
161871777|NCT00708214|584576976|FG002|Overall Study|Other|1|||
161871778|NCT00708214|584576974|FG000|Overall Study|Progressive Disease|4|||
161871779|NCT00708214|584576975|FG001|Overall Study|Progressive Disease|6|||
161871780|NCT00708214|584576976|FG002|Overall Study|Progressive Disease|5|||
161871781|NCT02199795|584576977|FG000|Overall Study|no longer met inclusion criteria|1|||
161871782|NCT02199795|584576978|FG001|Overall Study|no longer met inclusion criteria|0|||
161871783|NCT02199795|584576977|FG000|Overall Study|withdrew due to shoulder pain|1|||
161871784|NCT02199795|584576978|FG001|Overall Study|withdrew due to shoulder pain|0|||
161871785|NCT01908829|584576982|FG000|Overall Study|Adverse Event|13|||
161871786|NCT01908829|584576983|FG001|Overall Study|Adverse Event|11|||
161871787|NCT01908829|584576984|FG002|Overall Study|Adverse Event|13|||
161871788|NCT01908829|584576982|FG000|Overall Study|Lost to Follow-up|4|||
161871789|NCT01908829|584576983|FG001|Overall Study|Lost to Follow-up|2|||
161871790|NCT01908829|584576984|FG002|Overall Study|Lost to Follow-up|1|||
161871791|NCT01908829|584576982|FG000|Overall Study|Randomized no double-blind drug received|1|||
161871792|NCT01908829|584576983|FG001|Overall Study|Randomized no double-blind drug received|0|||
161871793|NCT01908829|584576984|FG002|Overall Study|Randomized no double-blind drug received|1|||
161871794|NCT01908829|584576982|FG000|Overall Study|Discontinued (no EoT page)|2|||
161871795|NCT01908829|584576983|FG001|Overall Study|Discontinued (no EoT page)|0|||
161871796|NCT01908829|584576984|FG002|Overall Study|Discontinued (no EoT page)|0|||
161871797|NCT01908829|584576982|FG000|Overall Study|Miscellaneous|0|||
161871798|NCT01908829|584576983|FG001|Overall Study|Miscellaneous|2|||
161871799|NCT01908829|584576984|FG002|Overall Study|Miscellaneous|0|||
161871800|NCT01908829|584576982|FG000|Overall Study|Protocol Violation|2|||
161871801|NCT01908829|584576983|FG001|Overall Study|Protocol Violation|2|||
161871802|NCT01908829|584576984|FG002|Overall Study|Protocol Violation|0|||
161871803|NCT01908829|584576982|FG000|Overall Study|Lack of Efficacy|1|||
161871804|NCT01908829|584576983|FG001|Overall Study|Lack of Efficacy|3|||
161871805|NCT01908829|584576984|FG002|Overall Study|Lack of Efficacy|2|||
161871806|NCT01908829|584576982|FG000|Overall Study|Withdrawal by Subject|26|||
161871807|NCT01908829|584576983|FG001|Overall Study|Withdrawal by Subject|29|||
161871808|NCT01908829|584576984|FG002|Overall Study|Withdrawal by Subject|22|||
161871809|NCT02792192|584576985|FG000|Overall Study|Death|1|||
161871810|NCT02792192|584576986|FG001|Overall Study|Death|0|||
161871811|NCT02792192|584576987|FG002|Overall Study|Death|0|||
161871812|NCT02792192|584576988|FG003|Overall Study|Death|0|||
161871813|NCT02792192|584576985|FG000|Overall Study|Informed Consent Withdrawn|4|||
161871814|NCT02792192|584576986|FG001|Overall Study|Informed Consent Withdrawn|0|||
161871815|NCT02792192|584576987|FG002|Overall Study|Informed Consent Withdrawn|0|||
161871816|NCT02792192|584576988|FG003|Overall Study|Informed Consent Withdrawn|0|||
161871817|NCT02792192|584576985|FG000|Overall Study|Physician Decision|1|||
161871818|NCT02792192|584576986|FG001|Overall Study|Physician Decision|0|||
161871819|NCT02792192|584576987|FG002|Overall Study|Physician Decision|0|||
161871820|NCT02792192|584576988|FG003|Overall Study|Physician Decision|0|||
161871821|NCT02792192|584576985|FG000|Overall Study|Progressive Disease|0|||
161871822|NCT02792192|584576986|FG001|Overall Study|Progressive Disease|1|||
161871823|NCT02792192|584576987|FG002|Overall Study|Progressive Disease|0|||
161986525|NCT02611817|585000896|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
161986526|NCT02611817|585000897|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
161986527|NCT02611817|585000895|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
161986528|NCT02611817|585000896|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
161986529|NCT02611817|585000897|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
161986530|NCT03738618|585000898|FG000|Overall Study|Protocol deviation|23|||
161986531|NCT03738618|585000899|FG001|Overall Study|Protocol deviation|0|||
161986532|NCT03738618|585000898|FG000|Overall Study|Adverse Event|4|||
161986533|NCT03738618|585000899|FG001|Overall Study|Adverse Event|0|||
161986534|NCT03738618|585000898|FG000|Overall Study|Lost to Follow-up|2|||
161986535|NCT03738618|585000899|FG001|Overall Study|Lost to Follow-up|0|||
161986536|NCT03738618|585000898|FG000|Overall Study|Randomization failure|1|||
161986537|NCT03738618|585000899|FG001|Overall Study|Randomization failure|0|||
161986538|NCT03738618|585000898|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
161986539|NCT03738618|585000899|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
161986540|NCT03738618|585000898|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
161986541|NCT03738618|585000899|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
161986542|NCT01016600|585000902|FG000|Overall Study|Did not start treatment|1|||
161986543|NCT01016600|585000903|FG001|Overall Study|Did not start treatment|0|||
161986544|NCT01016600|585000904|FG002|Overall Study|Did not start treatment|0|||
161986545|NCT01016600|585000905|FG003|Overall Study|Did not start treatment|0|||
161986546|NCT00801229|585000908|FG000|Signed Consent|Withdrawal by Subject|2|||
161986547|NCT00801229|585000909|FG001|Signed Consent|Withdrawal by Subject|2|||
161986548|NCT00801229|585000908|FG000|Signed Consent|Found Ineligible|1|||
161986549|NCT00801229|585000909|FG001|Signed Consent|Found Ineligible|1|||
161986550|NCT00801229|585000908|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
161986551|NCT00801229|585000909|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
161986552|NCT00801229|585000908|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
161986553|NCT00801229|585000909|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
161986554|NCT00801229|585000908|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
161986555|NCT00801229|585000909|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
161986556|NCT00801229|585000908|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
161986557|NCT00801229|585000909|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
161986558|NCT00801229|585000908|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
161986559|NCT00801229|585000909|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
161986560|NCT00801229|585000908|FG000|Received Study Drug/Placebo|Adverse Event|1|||
161986561|NCT00801229|585000909|FG001|Received Study Drug/Placebo|Adverse Event|1|||
161986562|NCT03826186|585000910|FG000|Overall Study|Protocol Violation|2|||
161986563|NCT03826186|585000911|FG001|Overall Study|Protocol Violation|0|||
161986564|NCT03826186|585000910|FG000|Overall Study|Withdrawal by Subject|1|||
161986565|NCT03826186|585000911|FG001|Overall Study|Withdrawal by Subject|0|||
161986566|NCT02737475|585000912|FG000|Overall Study|Other reasons|0|||
161986567|NCT02737475|585000913|FG001|Overall Study|Other reasons|0|||
161986568|NCT02737475|585000914|FG002|Overall Study|Other reasons|0|||
161986569|NCT02737475|585000915|FG003|Overall Study|Other reasons|0|||
161986570|NCT02737475|585000916|FG004|Overall Study|Other reasons|1|||
161986571|NCT02737475|585000917|FG005|Overall Study|Other reasons|1|||
161986572|NCT02737475|585000918|FG006|Overall Study|Other reasons|0|||
161986573|NCT02737475|585000919|FG007|Overall Study|Other reasons|0|||
161986574|NCT02737475|585000920|FG008|Overall Study|Other reasons|1|||
161986575|NCT02737475|585000921|FG009|Overall Study|Other reasons|0|||
161986576|NCT02737475|585000922|FG010|Overall Study|Other reasons|1|||
161986577|NCT02737475|585000923|FG011|Overall Study|Other reasons|0|||
161986578|NCT02737475|585000924|FG012|Overall Study|Other reasons|0|||
161986579|NCT02737475|585000925|FG013|Overall Study|Other reasons|0|||
161986580|NCT02737475|585000926|FG014|Overall Study|Other reasons|0|||
161986581|NCT02737475|585000927|FG015|Overall Study|Other reasons|0|||
161986582|NCT02737475|585000928|FG016|Overall Study|Other reasons|0|||
161986583|NCT02737475|585000929|FG017|Overall Study|Other reasons|0|||
161986584|NCT02737475|585000930|FG018|Overall Study|Other reasons|0|||
161986585|NCT02737475|585000931|FG019|Overall Study|Other reasons|0|||
161986586|NCT02737475|585000932|FG020|Overall Study|Other reasons|0|||
161986587|NCT02737475|585000933|FG021|Overall Study|Other reasons|1|||
161986588|NCT02737475|585000934|FG022|Overall Study|Other reasons|0|||
161986589|NCT02737475|585000935|FG023|Overall Study|Other reasons|1|||
161986590|NCT02737475|585000936|FG024|Overall Study|Other reasons|1|||
161986591|NCT02737475|585000937|FG025|Overall Study|Other reasons|1|||
161986592|NCT02737475|585000938|FG026|Overall Study|Other reasons|0|||
161986593|NCT02737475|585000912|FG000|Overall Study|Death|1|||
161986594|NCT02737475|585000913|FG001|Overall Study|Death|0|||
161986595|NCT02737475|585000914|FG002|Overall Study|Death|0|||
161986596|NCT02737475|585000915|FG003|Overall Study|Death|1|||
161986597|NCT02737475|585000916|FG004|Overall Study|Death|0|||
161986598|NCT02737475|585000917|FG005|Overall Study|Death|0|||
161986599|NCT02737475|585000918|FG006|Overall Study|Death|0|||
161986600|NCT02737475|585000919|FG007|Overall Study|Death|2|||
161986601|NCT02737475|585000920|FG008|Overall Study|Death|0|||
161986602|NCT02737475|585000921|FG009|Overall Study|Death|0|||
161986603|NCT02737475|585000922|FG010|Overall Study|Death|0|||
161986604|NCT02737475|585000923|FG011|Overall Study|Death|4|||
161986605|NCT02737475|585000924|FG012|Overall Study|Death|2|||
161986606|NCT02737475|585000925|FG013|Overall Study|Death|2|||
161986607|NCT02737475|585000926|FG014|Overall Study|Death|0|||
161986608|NCT02737475|585000927|FG015|Overall Study|Death|2|||
161986609|NCT02737475|585000928|FG016|Overall Study|Death|2|||
161986610|NCT02737475|585000929|FG017|Overall Study|Death|2|||
161986611|NCT02737475|585000930|FG018|Overall Study|Death|1|||
161986612|NCT02737475|585000931|FG019|Overall Study|Death|0|||
161986613|NCT02737475|585000932|FG020|Overall Study|Death|0|||
161986614|NCT02737475|585000933|FG021|Overall Study|Death|0|||
161986615|NCT02737475|585000934|FG022|Overall Study|Death|0|||
161986616|NCT02737475|585000935|FG023|Overall Study|Death|0|||
161986617|NCT02737475|585000936|FG024|Overall Study|Death|0|||
161986618|NCT02737475|585000937|FG025|Overall Study|Death|0|||
161986619|NCT02737475|585000938|FG026|Overall Study|Death|0|||
161986620|NCT02737475|585000912|FG000|Overall Study|Participant withdrew consent|0|||
161986621|NCT02737475|585000913|FG001|Overall Study|Participant withdrew consent|0|||
161986622|NCT02737475|585000914|FG002|Overall Study|Participant withdrew consent|0|||
161986623|NCT02737475|585000915|FG003|Overall Study|Participant withdrew consent|0|||
161986624|NCT02737475|585000916|FG004|Overall Study|Participant withdrew consent|0|||
161986625|NCT02737475|585000917|FG005|Overall Study|Participant withdrew consent|2|||
161986626|NCT02737475|585000918|FG006|Overall Study|Participant withdrew consent|0|||
161986627|NCT02737475|585000919|FG007|Overall Study|Participant withdrew consent|0|||
161986628|NCT02737475|585000920|FG008|Overall Study|Participant withdrew consent|0|||
161986629|NCT02737475|585000921|FG009|Overall Study|Participant withdrew consent|0|||
161986630|NCT02737475|585000922|FG010|Overall Study|Participant withdrew consent|0|||
161986631|NCT02737475|585000923|FG011|Overall Study|Participant withdrew consent|0|||
161986632|NCT02737475|585000924|FG012|Overall Study|Participant withdrew consent|0|||
161986633|NCT02737475|585000925|FG013|Overall Study|Participant withdrew consent|0|||
161986634|NCT02737475|585000926|FG014|Overall Study|Participant withdrew consent|1|||
161986635|NCT02737475|585000927|FG015|Overall Study|Participant withdrew consent|0|||
161986636|NCT02737475|585000928|FG016|Overall Study|Participant withdrew consent|0|||
161986637|NCT02737475|585000929|FG017|Overall Study|Participant withdrew consent|2|||
161986638|NCT02737475|585000930|FG018|Overall Study|Participant withdrew consent|1|||
161986639|NCT02737475|585000931|FG019|Overall Study|Participant withdrew consent|0|||
161986640|NCT02737475|585000932|FG020|Overall Study|Participant withdrew consent|2|||
161986641|NCT02737475|585000933|FG021|Overall Study|Participant withdrew consent|0|||
161986642|NCT02737475|585000934|FG022|Overall Study|Participant withdrew consent|0|||
161986643|NCT02737475|585000935|FG023|Overall Study|Participant withdrew consent|0|||
161986644|NCT02737475|585000936|FG024|Overall Study|Participant withdrew consent|0|||
161986645|NCT02737475|585000937|FG025|Overall Study|Participant withdrew consent|0|||
161986646|NCT02737475|585000938|FG026|Overall Study|Participant withdrew consent|0|||
161986647|NCT02737475|585000912|FG000|Overall Study|Lost to Follow-up|0|||
161986648|NCT02737475|585000913|FG001|Overall Study|Lost to Follow-up|0|||
161986649|NCT02737475|585000914|FG002|Overall Study|Lost to Follow-up|0|||
161986650|NCT02737475|585000915|FG003|Overall Study|Lost to Follow-up|0|||
161986651|NCT02737475|585000916|FG004|Overall Study|Lost to Follow-up|0|||
161986652|NCT02737475|585000917|FG005|Overall Study|Lost to Follow-up|0|||
161986653|NCT02737475|585000918|FG006|Overall Study|Lost to Follow-up|0|||
161986654|NCT02737475|585000919|FG007|Overall Study|Lost to Follow-up|0|||
161986655|NCT02737475|585000920|FG008|Overall Study|Lost to Follow-up|0|||
161986656|NCT02737475|585000921|FG009|Overall Study|Lost to Follow-up|0|||
161986657|NCT02737475|585000922|FG010|Overall Study|Lost to Follow-up|0|||
161986658|NCT02737475|585000923|FG011|Overall Study|Lost to Follow-up|0|||
161986659|NCT02737475|585000924|FG012|Overall Study|Lost to Follow-up|0|||
161986660|NCT02737475|585000925|FG013|Overall Study|Lost to Follow-up|0|||
161986661|NCT02737475|585000926|FG014|Overall Study|Lost to Follow-up|0|||
161986662|NCT02737475|585000927|FG015|Overall Study|Lost to Follow-up|1|||
161986663|NCT02737475|585000928|FG016|Overall Study|Lost to Follow-up|0|||
161986664|NCT02737475|585000929|FG017|Overall Study|Lost to Follow-up|0|||
161986665|NCT02737475|585000930|FG018|Overall Study|Lost to Follow-up|0|||
161986666|NCT02737475|585000931|FG019|Overall Study|Lost to Follow-up|0|||
162035150|NCT00740246|585185850|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
162035151|NCT00740246|585185851|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
162035152|NCT00740246|585185850|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
162035153|NCT00740246|585185851|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
161986667|NCT02737475|585000932|FG020|Overall Study|Lost to Follow-up|0|||
161986668|NCT02737475|585000933|FG021|Overall Study|Lost to Follow-up|0|||
161986669|NCT02737475|585000934|FG022|Overall Study|Lost to Follow-up|0|||
161986670|NCT02737475|585000935|FG023|Overall Study|Lost to Follow-up|0|||
161986671|NCT02737475|585000936|FG024|Overall Study|Lost to Follow-up|0|||
161986672|NCT02737475|585000937|FG025|Overall Study|Lost to Follow-up|0|||
161986673|NCT02737475|585000938|FG026|Overall Study|Lost to Follow-up|0|||
161871824|NCT02792192|584576988|FG003|Overall Study|Progressive Disease|0|||
161986674|NCT02737475|585000912|FG000|Overall Study|Disease Progression|0|||
161986675|NCT02737475|585000913|FG001|Overall Study|Disease Progression|0|||
161986676|NCT02737475|585000914|FG002|Overall Study|Disease Progression|0|||
161986677|NCT02737475|585000915|FG003|Overall Study|Disease Progression|0|||
161986678|NCT02737475|585000916|FG004|Overall Study|Disease Progression|0|||
161986679|NCT02737475|585000917|FG005|Overall Study|Disease Progression|0|||
161986680|NCT02737475|585000918|FG006|Overall Study|Disease Progression|0|||
161986681|NCT02737475|585000919|FG007|Overall Study|Disease Progression|0|||
161986682|NCT02737475|585000920|FG008|Overall Study|Disease Progression|0|||
161986683|NCT02737475|585000921|FG009|Overall Study|Disease Progression|0|||
161986684|NCT02737475|585000922|FG010|Overall Study|Disease Progression|0|||
161986685|NCT02737475|585000923|FG011|Overall Study|Disease Progression|0|||
161986686|NCT02737475|585000924|FG012|Overall Study|Disease Progression|0|||
161986687|NCT02737475|585000925|FG013|Overall Study|Disease Progression|0|||
161986688|NCT02737475|585000926|FG014|Overall Study|Disease Progression|0|||
161986689|NCT02737475|585000927|FG015|Overall Study|Disease Progression|0|||
161986690|NCT02737475|585000928|FG016|Overall Study|Disease Progression|0|||
161986691|NCT02737475|585000929|FG017|Overall Study|Disease Progression|0|||
161986692|NCT02737475|585000930|FG018|Overall Study|Disease Progression|0|||
161986693|NCT02737475|585000931|FG019|Overall Study|Disease Progression|0|||
161986694|NCT02737475|585000932|FG020|Overall Study|Disease Progression|0|||
161986695|NCT02737475|585000933|FG021|Overall Study|Disease Progression|0|||
161986696|NCT02737475|585000934|FG022|Overall Study|Disease Progression|0|||
161986697|NCT02737475|585000935|FG023|Overall Study|Disease Progression|0|||
161986698|NCT02737475|585000936|FG024|Overall Study|Disease Progression|0|||
161986699|NCT02737475|585000937|FG025|Overall Study|Disease Progression|0|||
161986700|NCT02737475|585000938|FG026|Overall Study|Disease Progression|1|||
161986701|NCT02255461|585000949|FG000|Overall Study|Adverse Event|0|||
161986702|NCT02255461|585000950|FG001|Overall Study|Adverse Event|1|||
161871825|NCT02792192|584576985|FG000|Overall Study|Study Terminated By Sponsor|6|||
161871826|NCT02792192|584576986|FG001|Overall Study|Study Terminated By Sponsor|10|||
161871827|NCT02792192|584576987|FG002|Overall Study|Study Terminated By Sponsor|0|||
161871828|NCT02792192|584576988|FG003|Overall Study|Study Terminated By Sponsor|0|||
161871829|NCT01339923|584576989|FG000|Overall Study|Adverse Event|1|||
161871830|NCT01339923|584576990|FG001|Overall Study|Adverse Event|1|||
161871831|NCT01339923|584576991|FG002|Overall Study|Adverse Event|1|||
161871832|NCT01339923|584576992|FG003|Overall Study|Adverse Event|0|||
161871833|NCT01339923|584576993|FG004|Overall Study|Adverse Event|0|||
161871834|NCT01339923|584576994|FG005|Overall Study|Adverse Event|0|||
161871835|NCT01339923|584576995|FG006|Overall Study|Adverse Event|1|||
161871836|NCT01339923|584576989|FG000|Overall Study|Inappropriate Enrollment|1|||
161871837|NCT01339923|584576990|FG001|Overall Study|Inappropriate Enrollment|0|||
161871838|NCT01339923|584576991|FG002|Overall Study|Inappropriate Enrollment|0|||
161871839|NCT01339923|584576992|FG003|Overall Study|Inappropriate Enrollment|0|||
161871840|NCT01339923|584576993|FG004|Overall Study|Inappropriate Enrollment|0|||
161871841|NCT01339923|584576994|FG005|Overall Study|Inappropriate Enrollment|1|||
161871842|NCT01339923|584576995|FG006|Overall Study|Inappropriate Enrollment|0|||
161871843|NCT01339923|584576989|FG000|Overall Study|Lost to Follow-up|4|||
161871844|NCT01339923|584576990|FG001|Overall Study|Lost to Follow-up|4|||
161871845|NCT01339923|584576991|FG002|Overall Study|Lost to Follow-up|0|||
161871846|NCT01339923|584576992|FG003|Overall Study|Lost to Follow-up|3|||
161871847|NCT01339923|584576993|FG004|Overall Study|Lost to Follow-up|1|||
161871848|NCT01339923|584576994|FG005|Overall Study|Lost to Follow-up|1|||
161871849|NCT01339923|584576995|FG006|Overall Study|Lost to Follow-up|5|||
161871850|NCT01339923|584576989|FG000|Overall Study|Protocol Violation|0|||
161871851|NCT01339923|584576990|FG001|Overall Study|Protocol Violation|0|||
161871852|NCT01339923|584576991|FG002|Overall Study|Protocol Violation|0|||
161871853|NCT01339923|584576992|FG003|Overall Study|Protocol Violation|0|||
161871854|NCT01339923|584576993|FG004|Overall Study|Protocol Violation|0|||
161871855|NCT01339923|584576994|FG005|Overall Study|Protocol Violation|3|||
161871856|NCT01339923|584576995|FG006|Overall Study|Protocol Violation|1|||
161871857|NCT01339923|584576989|FG000|Overall Study|Unable to Classify|1|||
161986703|NCT02255461|585000951|FG002|Overall Study|Adverse Event|0|||
161986704|NCT02255461|585000952|FG003|Overall Study|Adverse Event|0|||
161986705|NCT02255461|585000953|FG004|Overall Study|Adverse Event|1|||
161986706|NCT02255461|585000949|FG000|Overall Study|Withdrawal by Subject|0|||
161986707|NCT02255461|585000950|FG001|Overall Study|Withdrawal by Subject|0|||
161986708|NCT02255461|585000951|FG002|Overall Study|Withdrawal by Subject|1|||
161986709|NCT02255461|585000952|FG003|Overall Study|Withdrawal by Subject|0|||
161986710|NCT02255461|585000953|FG004|Overall Study|Withdrawal by Subject|1|||
161986711|NCT02255461|585000949|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
161871858|NCT01339923|584576990|FG001|Overall Study|Unable to Classify|0|||
161871859|NCT01339923|584576991|FG002|Overall Study|Unable to Classify|1|||
161871860|NCT01339923|584576992|FG003|Overall Study|Unable to Classify|0|||
161871861|NCT01339923|584576993|FG004|Overall Study|Unable to Classify|0|||
161871862|NCT01339923|584576994|FG005|Overall Study|Unable to Classify|1|||
161871863|NCT01339923|584576995|FG006|Overall Study|Unable to Classify|5|||
161871864|NCT01339923|584576989|FG000|Overall Study|Withdrawal by Subject|7|||
161871865|NCT01339923|584576990|FG001|Overall Study|Withdrawal by Subject|11|||
161871866|NCT01339923|584576991|FG002|Overall Study|Withdrawal by Subject|6|||
161871867|NCT01339923|584576992|FG003|Overall Study|Withdrawal by Subject|1|||
161871868|NCT01339923|584576993|FG004|Overall Study|Withdrawal by Subject|4|||
161871869|NCT01339923|584576994|FG005|Overall Study|Withdrawal by Subject|3|||
161871870|NCT01339923|584576995|FG006|Overall Study|Withdrawal by Subject|2|||
161871871|NCT01430403|584576998|FG000|Overall Study|Lost to Follow-up|5|||
161871872|NCT01430403|584576999|FG001|Overall Study|Lost to Follow-up|5|||
161871873|NCT01430403|584577000|FG002|Overall Study|Lost to Follow-up|3|||
161871874|NCT01430403|584576998|FG000|Overall Study|Physician Decision|1|||
161871875|NCT01430403|584576999|FG001|Overall Study|Physician Decision|0|||
161871876|NCT01430403|584577000|FG002|Overall Study|Physician Decision|0|||
161871877|NCT01430403|584576998|FG000|Overall Study|Protocol Violation|2|||
161871878|NCT01430403|584576999|FG001|Overall Study|Protocol Violation|3|||
161871879|NCT01430403|584577000|FG002|Overall Study|Protocol Violation|2|||
161871880|NCT01430403|584576998|FG000|Overall Study|Withdrawal by Subject|9|||
161871881|NCT01430403|584576999|FG001|Overall Study|Withdrawal by Subject|1|||
161871882|NCT01430403|584577000|FG002|Overall Study|Withdrawal by Subject|3|||
161871883|NCT02677922|584577001|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
161871884|NCT02677922|584577002|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
161871885|NCT02677922|584577003|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
161871886|NCT02677922|584577004|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
161871887|NCT02677922|584577005|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
161871888|NCT02677922|584577006|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
161871889|NCT02677922|584577001|FG000|Treatment Period|Adverse Event|0|||
161871890|NCT02677922|584577002|FG001|Treatment Period|Adverse Event|0|||
161871891|NCT02677922|584577003|FG002|Treatment Period|Adverse Event|1|||
161871892|NCT02677922|584577004|FG003|Treatment Period|Adverse Event|3|||
161871893|NCT02677922|584577005|FG004|Treatment Period|Adverse Event|5|||
161871894|NCT02677922|584577006|FG005|Treatment Period|Adverse Event|2|||
161871895|NCT02677922|584577001|FG000|Treatment Period|Progressive Disease|1|||
161871896|NCT02677922|584577002|FG001|Treatment Period|Progressive Disease|1|||
161871897|NCT02677922|584577003|FG002|Treatment Period|Progressive Disease|0|||
161871898|NCT02677922|584577004|FG003|Treatment Period|Progressive Disease|0|||
161871899|NCT02677922|584577005|FG004|Treatment Period|Progressive Disease|8|||
161871900|NCT02677922|584577006|FG005|Treatment Period|Progressive Disease|7|||
161871901|NCT02677922|584577001|FG000|Treatment Period|Lack of Efficacy|0|||
161871902|NCT02677922|584577002|FG001|Treatment Period|Lack of Efficacy|0|||
161871903|NCT02677922|584577003|FG002|Treatment Period|Lack of Efficacy|0|||
161871904|NCT02677922|584577004|FG003|Treatment Period|Lack of Efficacy|1|||
161871905|NCT02677922|584577005|FG004|Treatment Period|Lack of Efficacy|1|||
161871906|NCT02677922|584577006|FG005|Treatment Period|Lack of Efficacy|6|||
161871907|NCT02677922|584577001|FG000|Treatment Period|Withdrawal by Subject|0|||
161871908|NCT02677922|584577002|FG001|Treatment Period|Withdrawal by Subject|0|||
161871909|NCT02677922|584577003|FG002|Treatment Period|Withdrawal by Subject|1|||
161871910|NCT02677922|584577004|FG003|Treatment Period|Withdrawal by Subject|3|||
161871911|NCT02677922|584577005|FG004|Treatment Period|Withdrawal by Subject|5|||
161871912|NCT02677922|584577006|FG005|Treatment Period|Withdrawal by Subject|5|||
161871913|NCT02677922|584577001|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
161871914|NCT02677922|584577002|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
161871915|NCT02677922|584577003|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
161871916|NCT02677922|584577004|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
161871917|NCT02677922|584577005|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
161871918|NCT02677922|584577006|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
161871919|NCT02677922|584577001|FG000|Treatment Period|Disease Relapse|0|||
161871920|NCT02677922|584577002|FG001|Treatment Period|Disease Relapse|0|||
161871921|NCT02677922|584577003|FG002|Treatment Period|Disease Relapse|0|||
161871922|NCT02677922|584577004|FG003|Treatment Period|Disease Relapse|3|||
161871923|NCT02677922|584577005|FG004|Treatment Period|Disease Relapse|6|||
161871924|NCT02677922|584577006|FG005|Treatment Period|Disease Relapse|1|||
161871925|NCT02677922|584577001|FG000|Treatment Period|Allogeneic HSCT|1|||
161871926|NCT02677922|584577002|FG001|Treatment Period|Allogeneic HSCT|0|||
161871927|NCT02677922|584577003|FG002|Treatment Period|Allogeneic HSCT|0|||
161871928|NCT02677922|584577004|FG003|Treatment Period|Allogeneic HSCT|1|||
161871929|NCT02677922|584577005|FG004|Treatment Period|Allogeneic HSCT|4|||
161871930|NCT02677922|584577006|FG005|Treatment Period|Allogeneic HSCT|1|||
161871931|NCT02677922|584577001|FG000|Treatment Period|Other Reasons|0|||
161871932|NCT02677922|584577002|FG001|Treatment Period|Other Reasons|0|||
161871933|NCT02677922|584577003|FG002|Treatment Period|Other Reasons|0|||
161871934|NCT02677922|584577004|FG003|Treatment Period|Other Reasons|1|||
161871935|NCT02677922|584577005|FG004|Treatment Period|Other Reasons|3|||
161871936|NCT02677922|584577006|FG005|Treatment Period|Other Reasons|5|||
161871937|NCT02677922|584577001|FG000|Treatment Period|Death|0|||
161871938|NCT02677922|584577002|FG001|Treatment Period|Death|0|||
161871939|NCT02677922|584577003|FG002|Treatment Period|Death|0|||
161871940|NCT02677922|584577004|FG003|Treatment Period|Death|0|||
161871941|NCT02677922|584577005|FG004|Treatment Period|Death|12|||
161871942|NCT02677922|584577006|FG005|Treatment Period|Death|1|||
161871943|NCT02677922|584577001|FG000|Treatment Period|Non-compliance with Study Drug|0|||
161871944|NCT02677922|584577002|FG001|Treatment Period|Non-compliance with Study Drug|0|||
161871945|NCT02677922|584577003|FG002|Treatment Period|Non-compliance with Study Drug|0|||
161871946|NCT02677922|584577004|FG003|Treatment Period|Non-compliance with Study Drug|0|||
161871947|NCT02677922|584577005|FG004|Treatment Period|Non-compliance with Study Drug|1|||
161871948|NCT02677922|584577006|FG005|Treatment Period|Non-compliance with Study Drug|0|||
161871949|NCT02677922|584577001|FG000|Treatment Period|Physician Decision|0|||
161871950|NCT02677922|584577002|FG001|Treatment Period|Physician Decision|0|||
161871951|NCT02677922|584577003|FG002|Treatment Period|Physician Decision|0|||
161871952|NCT02677922|584577004|FG003|Treatment Period|Physician Decision|0|||
161871953|NCT02677922|584577005|FG004|Treatment Period|Physician Decision|0|||
161871954|NCT02677922|584577006|FG005|Treatment Period|Physician Decision|1|||
161871955|NCT02677922|584577001|FG000|Treatment Period|Symptomatic Deterioration|0|||
161871956|NCT02677922|584577002|FG001|Treatment Period|Symptomatic Deterioration|0|||
161871957|NCT02677922|584577003|FG002|Treatment Period|Symptomatic Deterioration|0|||
161871958|NCT02677922|584577004|FG003|Treatment Period|Symptomatic Deterioration|0|||
161871959|NCT02677922|584577005|FG004|Treatment Period|Symptomatic Deterioration|1|||
161871960|NCT02677922|584577006|FG005|Treatment Period|Symptomatic Deterioration|0|||
161775595|NCT00471237|584221212|FG001|Overall Study|Administration of prohibited medicine|0|||
161775596|NCT00471237|584221213|FG002|Overall Study|Administration of prohibited medicine|0|||
161775597|NCT00471237|584221214|FG003|Overall Study|Administration of prohibited medicine|0|||
161871961|NCT00637000|584577007|FG000|Overall Study|Withdrawal by Subject|4|||
161871962|NCT00637000|584577008|FG001|Overall Study|Withdrawal by Subject|3|||
161871963|NCT00183885|584577031|FG000|Overall Study|Adverse Event|11|||
161871964|NCT00183885|584577031|FG000|Overall Study|Death|1|||
161871965|NCT00183885|584577031|FG000|Overall Study|Lost to Follow-up|3|||
161871966|NCT00183885|584577031|FG000|Overall Study|Physician Decision|6|||
161871967|NCT00183885|584577031|FG000|Overall Study|Withdrawal by Subject|5|||
161871968|NCT00183885|584577031|FG000|Overall Study|Switched to alternative treatment|8|||
161986712|NCT02255461|585000950|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
161986713|NCT02255461|585000951|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
161986714|NCT02255461|585000952|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
161986715|NCT02255461|585000953|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
161775598|NCT00471237|584221215|FG004|Overall Study|Administration of prohibited medicine|1|||
161775599|NCT00471237|584221216|FG005|Overall Study|Administration of prohibited medicine|0|||
161775600|NCT00471237|584221217|FG006|Overall Study|Administration of prohibited medicine|0|||
161775601|NCT00471237|584221211|FG000|Overall Study|Participant shifted residence|0|||
161775602|NCT00471237|584221212|FG001|Overall Study|Participant shifted residence|0|||
161775603|NCT00471237|584221213|FG002|Overall Study|Participant shifted residence|0|||
161775604|NCT00471237|584221214|FG003|Overall Study|Participant shifted residence|0|||
161775605|NCT00471237|584221215|FG004|Overall Study|Participant shifted residence|1|||
161775606|NCT00471237|584221216|FG005|Overall Study|Participant shifted residence|0|||
161775607|NCT00471237|584221217|FG006|Overall Study|Participant shifted residence|0|||
161775608|NCT00471237|584221211|FG000|Overall Study|Participant's decision|0|||
161775609|NCT00471237|584221212|FG001|Overall Study|Participant's decision|0|||
161775610|NCT00471237|584221213|FG002|Overall Study|Participant's decision|0|||
161775611|NCT00471237|584221214|FG003|Overall Study|Participant's decision|0|||
161775612|NCT00471237|584221215|FG004|Overall Study|Participant's decision|0|||
161775613|NCT00471237|584221216|FG005|Overall Study|Participant's decision|1|||
161775614|NCT00471237|584221217|FG006|Overall Study|Participant's decision|0|||
161775615|NCT00848965|584221218|FG000|Overall Study|Adverse Event|1|||
161775616|NCT00848965|584221218|FG000|Overall Study|Withdrawal by Subject|1|||
161775617|NCT00348348|584221219|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
161775618|NCT00348348|584221220|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
161775619|NCT00348348|584221219|FG000|Overall Study|Lack of Efficacy|1|||
161775620|NCT00348348|584221220|FG001|Overall Study|Lack of Efficacy|1|||
161775621|NCT00348348|584221219|FG000|Overall Study|Lost to Follow-up|8|||
161775622|NCT00348348|584221220|FG001|Overall Study|Lost to Follow-up|10|||
161775623|NCT00348348|584221219|FG000|Overall Study|Withdrawal by Subject|4|||
161775624|NCT00348348|584221220|FG001|Overall Study|Withdrawal by Subject|1|||
161775625|NCT00348348|584221219|FG000|Overall Study|Other|7|||
161775626|NCT00348348|584221220|FG001|Overall Study|Other|4|||
161775627|NCT00348348|584221219|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
161775628|NCT00348348|584221220|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
161775629|NCT00348348|584221219|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
161775630|NCT00348348|584221220|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
161775631|NCT00348348|584221219|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
161775632|NCT00348348|584221220|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
161775633|NCT00348348|584221219|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
161775634|NCT00348348|584221220|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
161986716|NCT01357551|585000956|FG000|Overall Study|Withdrawal by Subject|6|||
161986717|NCT01357551|585000957|FG001|Overall Study|Withdrawal by Subject|4|||
161986718|NCT01357551|585000956|FG000|Overall Study|Death|0|||
161986719|NCT01357551|585000957|FG001|Overall Study|Death|1|||
161986720|NCT01357551|585000956|FG000|Overall Study|Lost to Follow-up|16|||
161986721|NCT01357551|585000957|FG001|Overall Study|Lost to Follow-up|6|||
161986722|NCT00847886|585000970|FG000|Overall Study|Adverse Event|0|||
161986723|NCT00847886|585000971|FG001|Overall Study|Adverse Event|1|||
161986724|NCT00413036|585000972|FG000|Overall Study|Adverse Event|44|||
161986725|NCT00413036|585000972|FG000|Overall Study|Lack of Efficacy|129|||
161986726|NCT00413036|585000972|FG000|Overall Study|Withdrawal by Subject|7|||
161986727|NCT00413036|585000972|FG000|Overall Study|Death|9|||
161986728|NCT00413036|585000972|FG000|Overall Study|Other|26|||
161986729|NCT00413036|585000972|FG000|Overall Study|Missing|2|||
161986730|NCT00183625|585000973|FG000|Overall Study|Withdrawal by Subject|18|||
161986731|NCT00183625|585000974|FG001|Overall Study|Withdrawal by Subject|18|||
161986732|NCT00183625|585000975|FG002|Overall Study|Withdrawal by Subject|19|||
161986733|NCT00183625|585000976|FG003|Overall Study|Withdrawal by Subject|14|||
161986734|NCT01369641|585000977|FG000|Overall Study|Withdrawal by Subject|1|||
161986735|NCT02524158|585000978|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
161986736|NCT02524158|585000979|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
161986737|NCT02524158|585000978|FG000|12-weeks Assessment|Lost to Follow-up|18|||
161986738|NCT02524158|585000979|FG001|12-weeks Assessment|Lost to Follow-up|12|||
161986739|NCT02524158|585000978|FG000|6-month Assessment|Withdrawal by Subject|1|||
161986740|NCT02524158|585000979|FG001|6-month Assessment|Withdrawal by Subject|1|||
161986741|NCT02524158|585000978|FG000|6-month Assessment|Lost to Follow-up|21|||
161986742|NCT02524158|585000979|FG001|6-month Assessment|Lost to Follow-up|20|||
161986743|NCT01835158|585000980|FG000|Overall Study|Withdrawal by Subject|1|||
161986744|NCT01835158|585000981|FG001|Overall Study|Withdrawal by Subject|6|||
161986745|NCT00596830|585000982|FG000|Overall Study|Death|258|||
161986746|NCT00596830|585000983|FG001|Overall Study|Death|247|||
161986747|NCT00596830|585000982|FG000|Overall Study|Lost to Follow-up|7|||
161986748|NCT00596830|585000983|FG001|Overall Study|Lost to Follow-up|11|||
161986749|NCT00596830|585000982|FG000|Overall Study|Withdrawal by Subject|22|||
161986750|NCT00596830|585000983|FG001|Overall Study|Withdrawal by Subject|12|||
161986751|NCT00596830|585000982|FG000|Overall Study|Study terminated by sponsor|51|||
161986752|NCT00596830|585000983|FG001|Overall Study|Study terminated by sponsor|62|||
161986753|NCT00596830|585000982|FG000|Overall Study|Follow-up was discontinued|1|||
161986754|NCT00596830|585000983|FG001|Overall Study|Follow-up was discontinued|0|||
161986755|NCT00596830|585000982|FG000|Overall Study|Randomized but not treated|3|||
161986756|NCT00596830|585000983|FG001|Overall Study|Randomized but not treated|7|||
161986757|NCT00887926|585000984|FG000|Overall Study|Withdrawal by Subject|0|||
161986758|NCT00887926|585000985|FG001|Overall Study|Withdrawal by Subject|1|||
161986759|NCT00887926|585000986|FG002|Overall Study|Withdrawal by Subject|0|||
161986760|NCT00887926|585000987|FG003|Overall Study|Withdrawal by Subject|0|||
161986761|NCT04427072|585000990|FG000|Randomized Treatment Phase|Progressive disease|9|||
161986762|NCT04427072|585000991|FG001|Randomized Treatment Phase|Progressive disease|4|||
161986763|NCT04427072|585000990|FG000|Randomized Treatment Phase|Adverse Event|3|||
161986764|NCT04427072|585000991|FG001|Randomized Treatment Phase|Adverse Event|1|||
161986765|NCT04427072|585000990|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
161986766|NCT04427072|585000991|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
161986767|NCT04427072|585000990|FG000|Randomized Treatment Phase|Death|0|||
161986768|NCT04427072|585000991|FG001|Randomized Treatment Phase|Death|1|||
161986769|NCT04427072|585000990|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
161986770|NCT04427072|585000991|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
161986771|NCT04427072|585000990|FG000|Extension Treatment Phase|Progressive disease|0|||
161986772|NCT04427072|585000991|FG001|Extension Treatment Phase|Progressive disease|5|||
161986773|NCT01110382|585000996|FG000|Overall Study|Withdrawal by Subject|0|||
161986774|NCT01110382|585000997|FG001|Overall Study|Withdrawal by Subject|1|||
161986775|NCT01110382|585000996|FG000|Overall Study|Protocol Violation|0|||
161986776|NCT01110382|585000997|FG001|Overall Study|Protocol Violation|1|||
161986777|NCT00098306|585000998|FG000|Double Blind|Randomized, not treated|9|||
161871969|NCT00183885|584577031|FG000|Overall Study|Treatment delayed too long|4|||
161986778|NCT00098306|585000999|FG001|Double Blind|Randomized, not treated|5|||
161986779|NCT00098306|585001000|FG002|Double Blind|Randomized, not treated|2|||
161986780|NCT00098306|585001001|FG003|Double Blind|Randomized, not treated|0|||
161871970|NCT00183885|584577031|FG000|Overall Study|Developed second malignancy|1|||
161986781|NCT00098306|585001002|FG004|Double Blind|Randomized, not treated|0|||
161986782|NCT00098306|585001003|FG005|Double Blind|Randomized, not treated|0|||
161986783|NCT00098306|585001004|FG006|Double Blind|Randomized, not treated|0|||
161986784|NCT00098306|585000998|FG000|Double Blind|Ongoing at cut-off date|151|||
161986785|NCT00098306|585000999|FG001|Double Blind|Ongoing at cut-off date|166|||
161986786|NCT00098306|585001000|FG002|Double Blind|Ongoing at cut-off date|72|||
161986787|NCT00098306|585001001|FG003|Double Blind|Ongoing at cut-off date|0|||
161986788|NCT00098306|585001002|FG004|Double Blind|Ongoing at cut-off date|0|||
161986789|NCT00098306|585001003|FG005|Double Blind|Ongoing at cut-off date|0|||
161986790|NCT00098306|585001004|FG006|Double Blind|Ongoing at cut-off date|0|||
161986791|NCT00098306|585000998|FG000|Double Blind|Adverse Event|11|||
161986792|NCT00098306|585000999|FG001|Double Blind|Adverse Event|10|||
161986793|NCT00098306|585001000|FG002|Double Blind|Adverse Event|6|||
161986794|NCT00098306|585001001|FG003|Double Blind|Adverse Event|0|||
161986795|NCT00098306|585001002|FG004|Double Blind|Adverse Event|0|||
161986796|NCT00098306|585001003|FG005|Double Blind|Adverse Event|0|||
161986797|NCT00098306|585001004|FG006|Double Blind|Adverse Event|0|||
161986798|NCT00098306|585000998|FG000|Double Blind|Lack of Efficacy|43|||
161986799|NCT00098306|585000999|FG001|Double Blind|Lack of Efficacy|34|||
161986800|NCT00098306|585001000|FG002|Double Blind|Lack of Efficacy|17|||
161986801|NCT00098306|585001001|FG003|Double Blind|Lack of Efficacy|0|||
161986802|NCT00098306|585001002|FG004|Double Blind|Lack of Efficacy|0|||
161986803|NCT00098306|585001003|FG005|Double Blind|Lack of Efficacy|0|||
161986804|NCT00098306|585001004|FG006|Double Blind|Lack of Efficacy|0|||
161986805|NCT00098306|585000998|FG000|Double Blind|Death|1|||
161986806|NCT00098306|585000999|FG001|Double Blind|Death|4|||
161986807|NCT00098306|585001000|FG002|Double Blind|Death|1|||
161986808|NCT00098306|585001001|FG003|Double Blind|Death|0|||
161986809|NCT00098306|585001002|FG004|Double Blind|Death|0|||
161986810|NCT00098306|585001003|FG005|Double Blind|Death|0|||
161986811|NCT00098306|585001004|FG006|Double Blind|Death|0|||
161986812|NCT00098306|585000998|FG000|Double Blind|Participant defaulted|19|||
161986813|NCT00098306|585000999|FG001|Double Blind|Participant defaulted|18|||
161986814|NCT00098306|585001000|FG002|Double Blind|Participant defaulted|11|||
161986815|NCT00098306|585001001|FG003|Double Blind|Participant defaulted|0|||
161986816|NCT00098306|585001002|FG004|Double Blind|Participant defaulted|0|||
161986817|NCT00098306|585001003|FG005|Double Blind|Participant defaulted|0|||
161986818|NCT00098306|585001004|FG006|Double Blind|Participant defaulted|0|||
161986819|NCT00098306|585000998|FG000|Double Blind|Un-specified|7|||
161986820|NCT00098306|585000999|FG001|Double Blind|Un-specified|3|||
161986821|NCT00098306|585001000|FG002|Double Blind|Un-specified|11|||
161986822|NCT00098306|585001001|FG003|Double Blind|Un-specified|0|||
161986823|NCT00098306|585001002|FG004|Double Blind|Un-specified|0|||
161986824|NCT00098306|585001003|FG005|Double Blind|Un-specified|0|||
161986825|NCT00098306|585001004|FG006|Double Blind|Un-specified|0|||
161986826|NCT00098306|585000998|FG000|Open Label|Lack of Efficacy|0|||
161986827|NCT00098306|585000999|FG001|Open Label|Lack of Efficacy|0|||
161986828|NCT00098306|585001000|FG002|Open Label|Lack of Efficacy|0|||
161986829|NCT00098306|585001001|FG003|Open Label|Lack of Efficacy|13|||
161986830|NCT00098306|585001002|FG004|Open Label|Lack of Efficacy|0|||
161986831|NCT00098306|585001003|FG005|Open Label|Lack of Efficacy|0|||
161986832|NCT00098306|585001004|FG006|Open Label|Lack of Efficacy|0|||
161986833|NCT00098306|585000998|FG000|Open Label|Adverse Event|0|||
161986834|NCT00098306|585000999|FG001|Open Label|Adverse Event|0|||
161986835|NCT00098306|585001000|FG002|Open Label|Adverse Event|0|||
161986836|NCT00098306|585001001|FG003|Open Label|Adverse Event|2|||
161986837|NCT00098306|585001002|FG004|Open Label|Adverse Event|0|||
161986838|NCT00098306|585001003|FG005|Open Label|Adverse Event|0|||
161986839|NCT00098306|585001004|FG006|Open Label|Adverse Event|0|||
161986840|NCT00098306|585000998|FG000|Open Label|Death|0|||
161986841|NCT00098306|585000999|FG001|Open Label|Death|0|||
161986842|NCT00098306|585001000|FG002|Open Label|Death|0|||
161986843|NCT00098306|585001001|FG003|Open Label|Death|4|||
161986844|NCT00098306|585001002|FG004|Open Label|Death|0|||
161986845|NCT00098306|585001003|FG005|Open Label|Death|0|||
161986846|NCT00098306|585001004|FG006|Open Label|Death|0|||
161986847|NCT00098306|585000998|FG000|Open Label|Participant defaulted|0|||
161986848|NCT00098306|585000999|FG001|Open Label|Participant defaulted|0|||
161986849|NCT00098306|585001000|FG002|Open Label|Participant defaulted|0|||
161986850|NCT00098306|585001001|FG003|Open Label|Participant defaulted|24|||
161986851|NCT00098306|585001002|FG004|Open Label|Participant defaulted|0|||
161986852|NCT00098306|585001003|FG005|Open Label|Participant defaulted|0|||
161986853|NCT00098306|585001004|FG006|Open Label|Participant defaulted|0|||
161986854|NCT00098306|585000998|FG000|Open Label|Un-specified|0|||
161986855|NCT00098306|585000999|FG001|Open Label|Un-specified|0|||
161986856|NCT00098306|585001000|FG002|Open Label|Un-specified|0|||
161986857|NCT00098306|585001001|FG003|Open Label|Un-specified|15|||
161986858|NCT00098306|585001002|FG004|Open Label|Un-specified|0|||
161986859|NCT00098306|585001003|FG005|Open Label|Un-specified|0|||
161986860|NCT00098306|585001004|FG006|Open Label|Un-specified|0|||
161986861|NCT00098306|585000998|FG000|Open Label|Ongoing at cut-off date|0|||
161986862|NCT00098306|585000999|FG001|Open Label|Ongoing at cut-off date|0|||
161986863|NCT00098306|585001000|FG002|Open Label|Ongoing at cut-off date|0|||
161986864|NCT00098306|585001001|FG003|Open Label|Ongoing at cut-off date|269|||
161986865|NCT00098306|585001002|FG004|Open Label|Ongoing at cut-off date|62|||
161986866|NCT00098306|585001003|FG005|Open Label|Ongoing at cut-off date|0|||
161986867|NCT00098306|585001004|FG006|Open Label|Ongoing at cut-off date|0|||
161986868|NCT00098306|585000998|FG000|Observational Phase|Death|0|||
161986869|NCT00098306|585000999|FG001|Observational Phase|Death|0|||
161986870|NCT00098306|585001000|FG002|Observational Phase|Death|0|||
161986871|NCT00098306|585001001|FG003|Observational Phase|Death|0|||
161986872|NCT00098306|585001002|FG004|Observational Phase|Death|0|||
161986873|NCT00098306|585001003|FG005|Observational Phase|Death|5|||
161871971|NCT00014495|584577034|FG000|Overall Study|Death|0|||
161871972|NCT00014495|584577035|FG001|Overall Study|Death|0|||
161871973|NCT00014495|584577036|FG002|Overall Study|Death|1|||
161871974|NCT00014495|584577037|FG003|Overall Study|Death|0|||
161871975|NCT00014495|584577034|FG000|Overall Study|Clinical deterioration|0|||
161871976|NCT00014495|584577035|FG001|Overall Study|Clinical deterioration|0|||
161871977|NCT00014495|584577036|FG002|Overall Study|Clinical deterioration|0|||
161871978|NCT00014495|584577037|FG003|Overall Study|Clinical deterioration|1|||
161871979|NCT00828568|584577038|FG000|Randomized|Withdrawal by Subject|1|||
161871980|NCT00828568|584577039|FG001|Randomized|Withdrawal by Subject|0|||
161871981|NCT00828568|584577040|FG002|Randomized|Withdrawal by Subject|2|||
161871982|NCT00828568|584577038|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
161871983|NCT00828568|584577039|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
161871984|NCT00828568|584577040|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
161871985|NCT00828568|584577038|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
161871986|NCT00828568|584577039|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
161871987|NCT00828568|584577040|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
161871988|NCT00828568|584577038|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
161871989|NCT00828568|584577039|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
161871990|NCT00828568|584577040|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
161871991|NCT00828568|584577038|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
161871992|NCT00828568|584577039|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
161871993|NCT00828568|584577040|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
161871994|NCT00460811|584577042|FG000|Overall Study|Adverse Event|4|||
161871995|NCT00460811|584577043|FG001|Overall Study|Adverse Event|6|||
161871996|NCT00460811|584577044|FG002|Overall Study|Adverse Event|3|||
161871997|NCT00460811|584577045|FG003|Overall Study|Adverse Event|10|||
161871998|NCT00460811|584577046|FG004|Overall Study|Adverse Event|2|||
161871999|NCT00460811|584577042|FG000|Overall Study|Noncompliance|1|||
161872000|NCT00460811|584577043|FG001|Overall Study|Noncompliance|0|||
161872001|NCT00460811|584577044|FG002|Overall Study|Noncompliance|0|||
161872002|NCT00460811|584577045|FG003|Overall Study|Noncompliance|2|||
161872003|NCT00460811|584577046|FG004|Overall Study|Noncompliance|1|||
161872004|NCT00460811|584577042|FG000|Overall Study|Withdrawal by Subject|7|||
161872005|NCT00460811|584577043|FG001|Overall Study|Withdrawal by Subject|7|||
161872006|NCT00460811|584577044|FG002|Overall Study|Withdrawal by Subject|6|||
161872007|NCT00460811|584577045|FG003|Overall Study|Withdrawal by Subject|3|||
161872008|NCT00460811|584577046|FG004|Overall Study|Withdrawal by Subject|11|||
161872009|NCT00460811|584577042|FG000|Overall Study|Physician Decision|1|||
161872010|NCT00460811|584577043|FG001|Overall Study|Physician Decision|0|||
161872011|NCT00460811|584577044|FG002|Overall Study|Physician Decision|0|||
161872012|NCT00460811|584577045|FG003|Overall Study|Physician Decision|0|||
161872013|NCT00460811|584577046|FG004|Overall Study|Physician Decision|0|||
161872014|NCT00460811|584577042|FG000|Overall Study|Lost to Follow-up|3|||
161872015|NCT00460811|584577043|FG001|Overall Study|Lost to Follow-up|2|||
161872016|NCT00460811|584577044|FG002|Overall Study|Lost to Follow-up|5|||
161872017|NCT00460811|584577045|FG003|Overall Study|Lost to Follow-up|3|||
161872018|NCT00460811|584577046|FG004|Overall Study|Lost to Follow-up|6|||
161872019|NCT02821754|584577047|FG000|Overall Study|Procedure not required prior to amendment change|13|||
161872020|NCT02821754|584577048|FG001|Overall Study|Procedure not required prior to amendment change|11|||
161872021|NCT02821754|584577049|FG002|Overall Study|Procedure not required prior to amendment change|0|||
161872022|NCT02821754|584577047|FG000|Overall Study|Participant's Clinical status|2|||
161872023|NCT02821754|584577048|FG001|Overall Study|Participant's Clinical status|0|||
161872024|NCT02821754|584577049|FG002|Overall Study|Participant's Clinical status|0|||
161872025|NCT02821754|584577047|FG000|Overall Study|Participant removed for noncompliance|1|||
161872026|NCT02821754|584577048|FG001|Overall Study|Participant removed for noncompliance|0|||
161872027|NCT02821754|584577049|FG002|Overall Study|Participant removed for noncompliance|0|||
161872028|NCT02821754|584577047|FG000|Overall Study|Drug not available.|0|||
161872029|NCT02821754|584577048|FG001|Overall Study|Drug not available.|0|||
161872030|NCT02821754|584577049|FG002|Overall Study|Drug not available.|1|||
161872031|NCT02821754|584577047|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
161872032|NCT02821754|584577048|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
161872033|NCT02821754|584577049|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
161872034|NCT01355575|584577050|FG000|Overall Study|Withdrawal by Subject|2|||
161872035|NCT01166438|584577051|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
161872036|NCT01166438|584577052|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
161872037|NCT01166438|584577051|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
161872038|NCT01166438|584577052|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
161872039|NCT01166438|584577051|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
161872040|NCT01166438|584577052|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
161872041|NCT01166438|584577051|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
161872042|NCT01166438|584577052|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
161986874|NCT00098306|585001004|FG006|Observational Phase|Death|4|||
161986875|NCT00098306|585000998|FG000|Observational Phase|Participant defaulted|0|||
161986876|NCT00098306|585000999|FG001|Observational Phase|Participant defaulted|0|||
161986877|NCT00098306|585001000|FG002|Observational Phase|Participant defaulted|0|||
161986878|NCT00098306|585001001|FG003|Observational Phase|Participant defaulted|0|||
161986879|NCT00098306|585001002|FG004|Observational Phase|Participant defaulted|0|||
161986880|NCT00098306|585001003|FG005|Observational Phase|Participant defaulted|34|||
161986881|NCT00098306|585001004|FG006|Observational Phase|Participant defaulted|18|||
161986882|NCT00098306|585000998|FG000|Observational Phase|Un-specified|0|||
161986883|NCT00098306|585000999|FG001|Observational Phase|Un-specified|0|||
161986884|NCT00098306|585001000|FG002|Observational Phase|Un-specified|0|||
161986885|NCT00098306|585001001|FG003|Observational Phase|Un-specified|0|||
161986886|NCT00098306|585001002|FG004|Observational Phase|Un-specified|0|||
161986887|NCT00098306|585001003|FG005|Observational Phase|Un-specified|7|||
161986888|NCT00098306|585001004|FG006|Observational Phase|Un-specified|4|||
161986889|NCT00077649|585001005|FG000|Overall Study|Adverse Event|5|||
161986890|NCT00077649|585001006|FG001|Overall Study|Adverse Event|1|||
161986891|NCT00077649|585001007|FG002|Overall Study|Adverse Event|7|||
161986892|NCT00077649|585001008|FG003|Overall Study|Adverse Event|9|||
161986893|NCT00077649|585001005|FG000|Overall Study|Lack of Efficacy|5|||
161986894|NCT00077649|585001006|FG001|Overall Study|Lack of Efficacy|3|||
161986895|NCT00077649|585001007|FG002|Overall Study|Lack of Efficacy|3|||
161986896|NCT00077649|585001008|FG003|Overall Study|Lack of Efficacy|2|||
161986897|NCT00077649|585001005|FG000|Overall Study|Withdrawal by Subject|0|||
161986898|NCT00077649|585001006|FG001|Overall Study|Withdrawal by Subject|1|||
161986899|NCT00077649|585001007|FG002|Overall Study|Withdrawal by Subject|1|||
161986900|NCT00077649|585001008|FG003|Overall Study|Withdrawal by Subject|2|||
161986901|NCT00077649|585001005|FG000|Overall Study|Lost to Follow-up|2|||
161986902|NCT00077649|585001006|FG001|Overall Study|Lost to Follow-up|2|||
161986903|NCT00077649|585001007|FG002|Overall Study|Lost to Follow-up|3|||
161986904|NCT00077649|585001008|FG003|Overall Study|Lost to Follow-up|2|||
161986905|NCT00077649|585001005|FG000|Overall Study|Abnormality of Laboratory Test|1|||
161986906|NCT00077649|585001006|FG001|Overall Study|Abnormality of Laboratory Test|2|||
161986907|NCT00077649|585001007|FG002|Overall Study|Abnormality of Laboratory Test|1|||
161986908|NCT00077649|585001008|FG003|Overall Study|Abnormality of Laboratory Test|2|||
161986909|NCT00077649|585001005|FG000|Overall Study|Randomized but never dosed|1|||
161986910|NCT00077649|585001006|FG001|Overall Study|Randomized but never dosed|0|||
161986911|NCT00077649|585001007|FG002|Overall Study|Randomized but never dosed|0|||
161986912|NCT00077649|585001008|FG003|Overall Study|Randomized but never dosed|0|||
161986913|NCT03550404|585001011|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
161986914|NCT03550404|585001012|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
161986915|NCT03550404|585001013|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
161986916|NCT03550404|585001011|FG000|Phase 2|Vacated position|1|||
161986917|NCT03550404|585001012|FG001|Phase 2|Vacated position|0|||
161986918|NCT03550404|585001013|FG002|Phase 2|Vacated position|0|||
161986919|NCT00820222|585001015|FG000|Overall Study|Lost to Follow-up|10|||
161986920|NCT00820222|585001016|FG001|Overall Study|Lost to Follow-up|9|||
161986921|NCT00820222|585001015|FG000|Overall Study|Withdrawal by Subject|19|||
161986922|NCT00820222|585001016|FG001|Overall Study|Withdrawal by Subject|21|||
161986923|NCT00820222|585001015|FG000|Overall Study|Physician Decision|93|||
161986924|NCT00820222|585001016|FG001|Overall Study|Physician Decision|88|||
161986925|NCT00820222|585001015|FG000|Overall Study|Sponsor Terminated Study|43|||
161986926|NCT00820222|585001016|FG001|Overall Study|Sponsor Terminated Study|65|||
161986927|NCT00820222|585001015|FG000|Overall Study|Unkown|11|||
161986928|NCT00820222|585001016|FG001|Overall Study|Unkown|7|||
161986929|NCT02690714|585001017|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
161986930|NCT02690714|585001017|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
161986931|NCT00293020|585001018|FG000|Overall Study|Withdrawal by Subject|34|||
161986932|NCT00293020|585001018|FG000|Overall Study|Adverse Event|30|||
161986933|NCT00293020|585001018|FG000|Overall Study|Death|32|||
161986934|NCT00293020|585001018|FG000|Overall Study|Lack of Efficacy|12|||
161986935|NCT00293020|585001018|FG000|Overall Study|Lost to Follow-up|4|||
161986936|NCT00293020|585001018|FG000|Overall Study|Protocol Violation|6|||
161986937|NCT00293020|585001018|FG000|Overall Study|Physician Decision|21|||
161986938|NCT00293020|585001018|FG000|Overall Study|Other Reason|22|||
161986939|NCT00293020|585001018|FG000|Overall Study|No dose taken|1|||
162048464|NCT01622231|585233336|FG000|Overall Study|Withdrawal by Subject|1|||
161986940|NCT01336023|585001019|FG000|Week 0 to Week 26|Adverse Event|8|||
161986941|NCT01336023|585001020|FG001|Week 0 to Week 26|Adverse Event|10|||
161986942|NCT01336023|585001021|FG002|Week 0 to Week 26|Adverse Event|24|||
161986943|NCT01336023|585001019|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
161986944|NCT01336023|585001020|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
161986945|NCT01336023|585001021|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
161986946|NCT01336023|585001019|FG000|Week 0 to Week 26|Protocol Violation|1|||
161872043|NCT01166438|584577051|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
161986947|NCT01336023|585001020|FG001|Week 0 to Week 26|Protocol Violation|2|||
161986948|NCT01336023|585001021|FG002|Week 0 to Week 26|Protocol Violation|0|||
161986949|NCT01336023|585001019|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
161986950|NCT01336023|585001020|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
161986951|NCT01336023|585001021|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
161986952|NCT01336023|585001019|FG000|Week 0 to Week 26|Unclassified|5|||
161986953|NCT01336023|585001020|FG001|Week 0 to Week 26|Unclassified|16|||
161986954|NCT01336023|585001021|FG002|Week 0 to Week 26|Unclassified|9|||
161986955|NCT01336023|585001019|FG000|Week 27 to 52|Adverse Event|1|||
161986956|NCT01336023|585001020|FG001|Week 27 to 52|Adverse Event|5|||
161986957|NCT01336023|585001021|FG002|Week 27 to 52|Adverse Event|2|||
161986958|NCT01336023|585001019|FG000|Week 27 to 52|Protocol Violation|0|||
161986959|NCT01336023|585001020|FG001|Week 27 to 52|Protocol Violation|2|||
161986960|NCT01336023|585001021|FG002|Week 27 to 52|Protocol Violation|1|||
161986961|NCT01336023|585001019|FG000|Week 27 to 52|Withdrawal Criteria|14|||
161986962|NCT01336023|585001020|FG001|Week 27 to 52|Withdrawal Criteria|19|||
161986963|NCT01336023|585001021|FG002|Week 27 to 52|Withdrawal Criteria|16|||
161986964|NCT01336023|585001019|FG000|Week 27 to 52|Unclassified|13|||
161986965|NCT01336023|585001020|FG001|Week 27 to 52|Unclassified|18|||
161986966|NCT01336023|585001021|FG002|Week 27 to 52|Unclassified|9|||
161986967|NCT01894022|585001024|FG000|Overall Study|Death|1|||
161986968|NCT01894022|585001025|FG001|Overall Study|Death|0|||
161986969|NCT01894022|585001024|FG000|Overall Study|Adverse Event, non-fatal|1|||
161986970|NCT01894022|585001025|FG001|Overall Study|Adverse Event, non-fatal|0|||
161986971|NCT01894022|585001024|FG000|Overall Study|Study Closed/terminated|7|||
161986972|NCT01894022|585001025|FG001|Overall Study|Study Closed/terminated|10|||
161986973|NCT04496453|585001026|FG000|Overall Study|Lost to Follow-up|6|||
161986974|NCT00767819|585001027|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
161986975|NCT00767819|585001028|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
161872044|NCT01166438|584577052|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
161872045|NCT01166438|584577051|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
161872046|NCT01166438|584577052|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
161986976|NCT00767819|585001029|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161986977|NCT00767819|585001027|FG000|Overall Study|Withdrawal by Subject|1|||
161986978|NCT00767819|585001028|FG001|Overall Study|Withdrawal by Subject|1|||
161986979|NCT00767819|585001029|FG002|Overall Study|Withdrawal by Subject|0|||
161986980|NCT00767819|585001027|FG000|Overall Study|Administrative problems|0|||
161986981|NCT00767819|585001028|FG001|Overall Study|Administrative problems|1|||
161986982|NCT00767819|585001029|FG002|Overall Study|Administrative problems|0|||
161986983|NCT00767819|585001027|FG000|Overall Study|Death|2|||
161986984|NCT00767819|585001028|FG001|Overall Study|Death|3|||
161986985|NCT00767819|585001029|FG002|Overall Study|Death|0|||
161986986|NCT00767819|585001027|FG000|Overall Study|Adverse Event|2|||
161986987|NCT00767819|585001028|FG001|Overall Study|Adverse Event|0|||
161986988|NCT00767819|585001029|FG002|Overall Study|Adverse Event|0|||
161986989|NCT00767819|585001027|FG000|Overall Study|Abnormal lab values|1|||
161986990|NCT00767819|585001028|FG001|Overall Study|Abnormal lab values|0|||
161986991|NCT00767819|585001029|FG002|Overall Study|Abnormal lab values|0|||
161986992|NCT00767819|585001027|FG000|Overall Study|Lost to Follow-up|1|||
161986993|NCT00767819|585001028|FG001|Overall Study|Lost to Follow-up|0|||
161986994|NCT00767819|585001029|FG002|Overall Study|Lost to Follow-up|0|||
161986995|NCT03916081|585001030|FG000|Overall Study|Adverse Event|1|||
161986996|NCT03916081|585001031|FG001|Overall Study|Adverse Event|0|||
161986997|NCT03916081|585001032|FG002|Overall Study|Adverse Event|0|||
161986998|NCT03916081|585001030|FG000|Overall Study|Physician Decision|0|||
161986999|NCT03916081|585001031|FG001|Overall Study|Physician Decision|0|||
161987000|NCT03916081|585001032|FG002|Overall Study|Physician Decision|1|||
161872047|NCT03759587|584577063|FG000|Overall Study|Adverse Event|5|||
161872048|NCT03759587|584577063|FG000|Overall Study|Progressive Disease|10|||
161872049|NCT03759587|584577063|FG000|Overall Study|Site Terminated by Sponsor|3|||
161872050|NCT03759587|584577063|FG000|Overall Study|Withdrawal by Subject|1|||
161872051|NCT00591565|584577064|FG000|Overall Study|lost follow up, withdrawn|5|||
161872052|NCT00454363|584577065|FG000|Overall Study|Adverse Event|1|||
161872053|NCT00454363|584577066|FG001|Overall Study|Adverse Event|2|||
161872054|NCT00454363|584577065|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
161872055|NCT00454363|584577066|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
161987001|NCT03916081|585001030|FG000|Overall Study|Lost to Follow-up|0|||
161987002|NCT03916081|585001031|FG001|Overall Study|Lost to Follow-up|1|||
161987003|NCT03916081|585001032|FG002|Overall Study|Lost to Follow-up|0|||
161987004|NCT03916081|585001030|FG000|Overall Study|Withdrawal by Subject|3|||
161872056|NCT01554527|584577068|FG000|Overall Study|Withdrawal by Subject|1|||
161872057|NCT01554527|584577069|FG001|Overall Study|Withdrawal by Subject|0|||
161987005|NCT03916081|585001031|FG001|Overall Study|Withdrawal by Subject|0|||
161987006|NCT03916081|585001032|FG002|Overall Study|Withdrawal by Subject|1|||
161987007|NCT03916081|585001030|FG000|Overall Study|Worsening of AD|0|||
161987008|NCT03916081|585001031|FG001|Overall Study|Worsening of AD|0|||
161987009|NCT03916081|585001032|FG002|Overall Study|Worsening of AD|1|||
161987010|NCT00235716|585001033|FG000|Overall Study|Death|26|||
161987011|NCT00235716|585001034|FG001|Overall Study|Death|39|||
161987012|NCT00235716|585001035|FG002|Overall Study|Death|32|||
161987013|NCT00235716|585001036|FG003|Overall Study|Death|31|||
161987014|NCT00235716|585001033|FG000|Overall Study|Withdrawal by Subject|23|||
161987015|NCT00235716|585001034|FG001|Overall Study|Withdrawal by Subject|19|||
161987016|NCT00235716|585001035|FG002|Overall Study|Withdrawal by Subject|17|||
161987017|NCT00235716|585001036|FG003|Overall Study|Withdrawal by Subject|18|||
161987018|NCT00235716|585001033|FG000|Overall Study|Lost to Follow-up|12|||
161987019|NCT00235716|585001034|FG001|Overall Study|Lost to Follow-up|7|||
161987020|NCT00235716|585001035|FG002|Overall Study|Lost to Follow-up|14|||
161987021|NCT00235716|585001036|FG003|Overall Study|Lost to Follow-up|10|||
161987022|NCT00235716|585001033|FG000|Overall Study|Adverse Event|1|||
161987023|NCT00235716|585001034|FG001|Overall Study|Adverse Event|1|||
161987024|NCT00235716|585001035|FG002|Overall Study|Adverse Event|1|||
161987025|NCT00235716|585001036|FG003|Overall Study|Adverse Event|0|||
161987026|NCT00235716|585001033|FG000|Overall Study|Physician Decision|0|||
161987027|NCT00235716|585001034|FG001|Overall Study|Physician Decision|1|||
161987028|NCT00235716|585001035|FG002|Overall Study|Physician Decision|1|||
161987029|NCT00235716|585001036|FG003|Overall Study|Physician Decision|3|||
161987030|NCT01545050|585001037|FG000|Overall Study|Lack of Efficacy|0|||
161987031|NCT01545050|585001038|FG001|Overall Study|Lack of Efficacy|0|||
161987032|NCT01545050|585001039|FG002|Overall Study|Lack of Efficacy|0|||
161987033|NCT01545050|585001040|FG003|Overall Study|Lack of Efficacy|3|||
161987034|NCT01545050|585001041|FG004|Overall Study|Lack of Efficacy|2|||
161987035|NCT01545050|585001037|FG000|Overall Study|Adverse Event|1|||
161987036|NCT01545050|585001038|FG001|Overall Study|Adverse Event|1|||
161987037|NCT01545050|585001039|FG002|Overall Study|Adverse Event|2|||
161987038|NCT01545050|585001040|FG003|Overall Study|Adverse Event|2|||
161987039|NCT01545050|585001041|FG004|Overall Study|Adverse Event|0|||
161987040|NCT01545050|585001037|FG000|Overall Study|Discontinued study treatment|1|||
161987041|NCT01545050|585001038|FG001|Overall Study|Discontinued study treatment|0|||
161987042|NCT01545050|585001039|FG002|Overall Study|Discontinued study treatment|0|||
161987043|NCT01545050|585001040|FG003|Overall Study|Discontinued study treatment|0|||
161987044|NCT01545050|585001041|FG004|Overall Study|Discontinued study treatment|0|||
161987045|NCT01545050|585001037|FG000|Overall Study|Withdrawal by Subject|1|||
161987046|NCT01545050|585001038|FG001|Overall Study|Withdrawal by Subject|0|||
161987047|NCT01545050|585001039|FG002|Overall Study|Withdrawal by Subject|0|||
161987048|NCT01545050|585001040|FG003|Overall Study|Withdrawal by Subject|2|||
161987049|NCT01545050|585001041|FG004|Overall Study|Withdrawal by Subject|1|||
161987050|NCT01545050|585001037|FG000|Overall Study|Participant no longer meets study criteria|0|||
161987051|NCT01545050|585001038|FG001|Overall Study|Participant no longer meets study criteria|2|||
161987052|NCT01545050|585001039|FG002|Overall Study|Participant no longer meets study criteria|0|||
161987053|NCT01545050|585001040|FG003|Overall Study|Participant no longer meets study criteria|0|||
161987054|NCT01545050|585001041|FG004|Overall Study|Participant no longer meets study criteria|1|||
161987055|NCT01545050|585001037|FG000|Overall Study|Administrative reason by sponsor|4|||
161987056|NCT01545050|585001038|FG001|Overall Study|Administrative reason by sponsor|2|||
161987057|NCT01545050|585001039|FG002|Overall Study|Administrative reason by sponsor|3|||
161987058|NCT01545050|585001040|FG003|Overall Study|Administrative reason by sponsor|5|||
161987059|NCT01545050|585001041|FG004|Overall Study|Administrative reason by sponsor|5|||
161987060|NCT02249182|585001042|FG000|Treatment Phase|Lost to Follow-up|4|||
161987061|NCT02249182|585001043|FG001|Treatment Phase|Lost to Follow-up|0|||
161987062|NCT02249182|585001044|FG002|Treatment Phase|Lost to Follow-up|0|||
161987063|NCT02249182|585001045|FG003|Treatment Phase|Lost to Follow-up|0|||
161987064|NCT02249182|585001046|FG004|Treatment Phase|Lost to Follow-up|0|||
161987065|NCT03244826|585001053|FG000|Overall Study|Withdrawal by Subject|2|||
161987066|NCT03244826|585001054|FG001|Overall Study|Withdrawal by Subject|0|||
161987067|NCT03244826|585001053|FG000|Overall Study|Transplant delayed or withdrawn|12|||
161987068|NCT03244826|585001054|FG001|Overall Study|Transplant delayed or withdrawn|10|||
161987069|NCT04356040|585001055|FG000|Overall Study|Death|2|||
161987070|NCT04356040|585001056|FG001|Overall Study|Death|0|||
161987071|NCT04356040|585001055|FG000|Overall Study|Lost to Follow-up|1|||
161987072|NCT04356040|585001056|FG001|Overall Study|Lost to Follow-up|0|||
161987073|NCT04356040|585001055|FG000|Overall Study|Physician Decision|0|||
161987074|NCT04356040|585001056|FG001|Overall Study|Physician Decision|1|||
161987075|NCT04356040|585001055|FG000|Overall Study|Withdrawal by Subject|13|||
161987076|NCT04356040|585001056|FG001|Overall Study|Withdrawal by Subject|1|||
161987077|NCT04356040|585001055|FG000|Overall Study|Enrollment Pause|10|||
161987078|NCT04356040|585001056|FG001|Overall Study|Enrollment Pause|0|||
161987079|NCT04356040|585001055|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
161987080|NCT04356040|585001056|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
161987081|NCT04356040|585001055|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
161987082|NCT04356040|585001056|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
161987083|NCT04356040|585001055|FG000|Overall Study|PI left institution|3|||
161987084|NCT04356040|585001056|FG001|Overall Study|PI left institution|0|||
161987085|NCT00416455|585001057|FG000|Overall Study|PET / CT not done|3|||
161987086|NCT00416455|585001058|FG001|Overall Study|PET / CT not done|5|||
161987087|NCT00416455|585001057|FG000|Overall Study|PET / CT poor quality|2|||
161987088|NCT00416455|585001058|FG001|Overall Study|PET / CT poor quality|1|||
161987089|NCT00416455|585001057|FG000|Overall Study|Inadequate pathology|11|||
161872058|NCT01554527|584577070|FG002|Overall Study|Withdrawal by Subject|3|||
161872059|NCT01554527|584577068|FG000|Overall Study|Lost to Follow-up|0|||
161872060|NCT01554527|584577069|FG001|Overall Study|Lost to Follow-up|0|||
161872061|NCT01554527|584577070|FG002|Overall Study|Lost to Follow-up|4|||
161872062|NCT01554527|584577068|FG000|Overall Study|Physician Decision|0|||
161872063|NCT01554527|584577069|FG001|Overall Study|Physician Decision|0|||
161872064|NCT01554527|584577070|FG002|Overall Study|Physician Decision|1|||
161872065|NCT01863667|584577077|FG000|Overall Study|Adverse Event|1|||
161872066|NCT01863667|584577078|FG001|Overall Study|Adverse Event|0|||
161872067|NCT01863667|584577077|FG000|Overall Study|Study terminated by Sponsor|30|||
161872068|NCT01863667|584577078|FG001|Overall Study|Study terminated by Sponsor|30|||
161872069|NCT01863667|584577077|FG000|Overall Study|Withdrawal by Subject|2|||
161872070|NCT01863667|584577078|FG001|Overall Study|Withdrawal by Subject|2|||
161872071|NCT01537042|584577082|FG000|Overall Study|Adverse Event|0|||
161872072|NCT01537042|584577083|FG001|Overall Study|Adverse Event|2|||
161872073|NCT01537042|584577082|FG000|Overall Study|Lack of Efficacy|0|||
161872074|NCT01537042|584577083|FG001|Overall Study|Lack of Efficacy|1|||
161872075|NCT01537042|584577082|FG000|Overall Study|Protocol Violation|0|||
161872076|NCT01537042|584577083|FG001|Overall Study|Protocol Violation|1|||
161987090|NCT00416455|585001058|FG001|Overall Study|Inadequate pathology|2|||
161872077|NCT01537042|584577082|FG000|Overall Study|Other|0|||
161872078|NCT01537042|584577083|FG001|Overall Study|Other|1|||
161987091|NCT02456857|585001059|FG000|Overall Study|Disease Progression|4|||
161987092|NCT00781859|585001060|FG000|Overall Study|Adverse Event|2|||
161987093|NCT00781859|585001061|FG001|Overall Study|Adverse Event|2|||
161987094|NCT00781859|585001060|FG000|Overall Study|Withdrawal by Subject|8|||
161987095|NCT00781859|585001061|FG001|Overall Study|Withdrawal by Subject|4|||
161987096|NCT00781859|585001060|FG000|Overall Study|Lost to Follow-up|6|||
161987097|NCT00781859|585001061|FG001|Overall Study|Lost to Follow-up|3|||
161987098|NCT00781859|585001060|FG000|Overall Study|Death|3|||
161775635|NCT00348348|584221219|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
161775636|NCT00348348|584221220|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
161775637|NCT00348348|584221219|FG000|Overall Study|Adverse event probably related to study|1|||
161775638|NCT00348348|584221220|FG001|Overall Study|Adverse event probably related to study|0|||
161775639|NCT01605370|584221223|FG000|Overall Study|Adverse Event|1|||
161775640|NCT01605370|584221224|FG001|Overall Study|Adverse Event|0|||
161775641|NCT01976104|584221225|FG000|Overall Study|Adverse Event|0|||
161775642|NCT01976104|584221226|FG001|Overall Study|Adverse Event|0|||
161775643|NCT01976104|584221227|FG002|Overall Study|Adverse Event|1|||
161775644|NCT01976104|584221228|FG003|Overall Study|Adverse Event|0|||
161775645|NCT01976104|584221225|FG000|Overall Study|Lost to Follow-up|3|||
161775646|NCT01976104|584221226|FG001|Overall Study|Lost to Follow-up|0|||
161775647|NCT01976104|584221227|FG002|Overall Study|Lost to Follow-up|1|||
161775648|NCT01976104|584221228|FG003|Overall Study|Lost to Follow-up|1|||
161775649|NCT01976104|584221225|FG000|Overall Study|Subject Choice|0|||
161775650|NCT01976104|584221226|FG001|Overall Study|Subject Choice|1|||
161872079|NCT02837731|584577084|FG000|Allocation|Admitted to General Floor|3|||
161872080|NCT02837731|584577085|FG001|Allocation|Admitted to General Floor|4|||
161872081|NCT02837731|584577084|FG000|Allocation|Immediate surgery/withdrew|2|||
161872082|NCT02837731|584577085|FG001|Allocation|Immediate surgery/withdrew|0|||
161872083|NCT02837731|584577084|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
161872084|NCT02837731|584577085|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
161872085|NCT02837731|584577084|FG000|Allocation|Withdrawal by Subject|2|||
161872086|NCT02837731|584577085|FG001|Allocation|Withdrawal by Subject|0|||
161775651|NCT01976104|584221227|FG002|Overall Study|Subject Choice|0|||
161872087|NCT02837731|584577084|FG000|Allocation|Device not available|1|||
161872088|NCT02837731|584577085|FG001|Allocation|Device not available|0|||
161872089|NCT02837731|584577084|FG000|Allocation|Protocol not implemented|7|||
161872090|NCT02837731|584577085|FG001|Allocation|Protocol not implemented|0|||
161872091|NCT02837731|584577084|FG000|Allocation|Moribund/Do not resuscitate|2|||
161872092|NCT02837731|584577085|FG001|Allocation|Moribund/Do not resuscitate|0|||
161775652|NCT01976104|584221228|FG003|Overall Study|Subject Choice|1|||
161775653|NCT01976104|584221225|FG000|Overall Study|Withdrawal by Subject|3|||
161775654|NCT01976104|584221226|FG001|Overall Study|Withdrawal by Subject|0|||
161775655|NCT01976104|584221227|FG002|Overall Study|Withdrawal by Subject|0|||
161775656|NCT01976104|584221228|FG003|Overall Study|Withdrawal by Subject|1|||
161775657|NCT01976104|584221225|FG000|Overall Study|Other|0|||
161987099|NCT00781859|585001061|FG001|Overall Study|Death|0|||
161987100|NCT01138501|585001062|FG000|Overall Study|Protocol Violation|2|||
161775658|NCT01976104|584221226|FG001|Overall Study|Other|1|||
161872093|NCT02837731|584577084|FG000|Allocation|Did not meet sepsis criteria|1|||
161775659|NCT01976104|584221227|FG002|Overall Study|Other|0|||
161775660|NCT01976104|584221228|FG003|Overall Study|Other|0|||
161775661|NCT01317199|584221229|FG000|Dose-escalation Phase 1|Physician Decision|5|||
161775662|NCT01317199|584221230|FG001|Dose-escalation Phase 1|Physician Decision|0|||
161775663|NCT01317199|584221231|FG002|Dose-escalation Phase 1|Physician Decision|0|||
161872094|NCT02837731|584577085|FG001|Allocation|Did not meet sepsis criteria|2|||
161872095|NCT02837731|584577084|FG000|Allocation|Known aortic abnormalities|0|||
162035154|NCT00740246|585185850|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
162035155|NCT00740246|585185851|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
162035156|NCT00740246|585185850|FG000|Overall Study|Unable To Comply With Study Visits|2|||
162035157|NCT00740246|585185851|FG001|Overall Study|Unable To Comply With Study Visits|0|||
162035158|NCT00740246|585185850|FG000|Overall Study|Unable to Access Vein|0|||
162035159|NCT00740246|585185851|FG001|Overall Study|Unable to Access Vein|2|||
162035160|NCT00740246|585185850|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
162035161|NCT00740246|585185851|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
162035162|NCT01041495|585185852|FG000|Overall Study|Withdrawal by Subject|2|||
162035163|NCT01041495|585185853|FG001|Overall Study|Withdrawal by Subject|5|||
162035164|NCT01041495|585185852|FG000|Overall Study|Adverse Event|2|||
162035165|NCT01041495|585185853|FG001|Overall Study|Adverse Event|1|||
162035166|NCT01041495|585185852|FG000|Overall Study|Lost to Follow-up|0|||
162035167|NCT01041495|585185853|FG001|Overall Study|Lost to Follow-up|1|||
162035168|NCT03584373|585185854|FG000|Overall Study|Lost to Follow-up|7|||
162035169|NCT03584373|585185855|FG001|Overall Study|Lost to Follow-up|8|||
162035170|NCT00662532|585185857|FG000|Overall Study|Adverse Event|0|||
162035171|NCT00662532|585185858|FG001|Overall Study|Adverse Event|1|||
162035172|NCT00662532|585185857|FG000|Overall Study|Lost to Follow-up|0|||
162035173|NCT00662532|585185858|FG001|Overall Study|Lost to Follow-up|1|||
162035174|NCT00366340|585185859|FG000|Infant Series|Protocol Violation|3|||
162035175|NCT00366340|585185860|FG001|Infant Series|Protocol Violation|4|||
162035176|NCT00366340|585185859|FG000|Infant Series|Withdrawal by Subject|3|||
162035177|NCT00366340|585185860|FG001|Infant Series|Withdrawal by Subject|3|||
162035178|NCT00366340|585185859|FG000|Infant Series|Adverse Event|0|||
162035179|NCT00366340|585185860|FG001|Infant Series|Adverse Event|2|||
162035180|NCT00366340|585185859|FG000|Infant Series|Lost to Follow-up|1|||
162035181|NCT00366340|585185860|FG001|Infant Series|Lost to Follow-up|1|||
162035182|NCT00366340|585185859|FG000|Infant Series|Failure to return|1|||
162035183|NCT00366340|585185860|FG001|Infant Series|Failure to return|0|||
162035184|NCT00366340|585185859|FG000|After the Infant Series|Parent/legal guardian request|1|||
162035185|NCT00366340|585185860|FG001|After the Infant Series|Parent/legal guardian request|1|||
162035186|NCT00366340|585185859|FG000|After the Infant Series|Failed to return|0|||
162035187|NCT00366340|585185860|FG001|After the Infant Series|Failed to return|1|||
162035188|NCT00366340|585185859|FG000|After the Infant Series|Protocol Violation|2|||
162035189|NCT00366340|585185860|FG001|After the Infant Series|Protocol Violation|2|||
162035190|NCT00366340|585185859|FG000|After the Infant Series|Adverse Event|0|||
162035191|NCT00366340|585185860|FG001|After the Infant Series|Adverse Event|1|||
162035192|NCT00366340|585185859|FG000|After the Infant Series|Lost to Follow-up|0|||
162035193|NCT00366340|585185860|FG001|After the Infant Series|Lost to Follow-up|1|||
162035194|NCT00366340|585185859|FG000|Toddler Dose|Failed to return|1|||
162035195|NCT00366340|585185860|FG001|Toddler Dose|Failed to return|0|||
162035196|NCT00366340|585185859|FG000|Toddler Dose|Parent/legal guardian request|0|||
162035197|NCT00366340|585185860|FG001|Toddler Dose|Parent/legal guardian request|1|||
162035198|NCT00367770|585185861|FG000|Overall Study|Adverse Event|1|||
162035199|NCT00367770|585185861|FG000|Overall Study|Withdrawal by Subject|1|||
162035200|NCT03282565|585185866|FG000|Overall Study|COVID-19 Research Shutdown|0|||
162035201|NCT03282565|585185867|FG001|Overall Study|COVID-19 Research Shutdown|2|||
162035202|NCT03282565|585185868|FG002|Overall Study|COVID-19 Research Shutdown|2|||
162035203|NCT00991952|585185870|FG000|Overall Study|Adverse Event|0|||
162035204|NCT00991952|585185871|FG001|Overall Study|Adverse Event|1|||
162035205|NCT05764265|585185874|FG000|Overall Study|Adverse Event|1|||
162035206|NCT05764265|585185875|FG001|Overall Study|Adverse Event|0|||
162035207|NCT05764265|585185874|FG000|Overall Study|Physician Decision|1|||
162035208|NCT05764265|585185875|FG001|Overall Study|Physician Decision|8|||
161987101|NCT01138501|585001062|FG000|Overall Study|Withdrawal by Subject|3|||
161987102|NCT00360568|585001063|FG000|Overall Study|Adverse Event|1|||
161987103|NCT00360568|585001064|FG001|Overall Study|Adverse Event|2|||
161987104|NCT00360568|585001063|FG000|Overall Study|Lack of Efficacy|1|||
161987105|NCT00360568|585001064|FG001|Overall Study|Lack of Efficacy|0|||
161987106|NCT00360568|585001063|FG000|Overall Study|Withdrawal by Subject|0|||
161987107|NCT00360568|585001064|FG001|Overall Study|Withdrawal by Subject|3|||
161987108|NCT01008449|585001065|FG000|Overall Study|Lost to Follow-up|29|||
161987109|NCT01008449|585001066|FG001|Overall Study|Lost to Follow-up|19|||
162035209|NCT05764265|585185874|FG000|Overall Study|Study Terminated By Sponsor|20|||
162035210|NCT05764265|585185875|FG001|Overall Study|Study Terminated By Sponsor|0|||
162035211|NCT05764265|585185874|FG000|Overall Study|Participant Decision|1|||
162035212|NCT05764265|585185875|FG001|Overall Study|Participant Decision|0|||
162035213|NCT00509262|585185876|FG000|Overall Study|Adverse Event|16|||
162035214|NCT00509262|585185877|FG001|Overall Study|Adverse Event|18|||
161987110|NCT01220180|585001067|FG000|Overall Study|Lost to Follow-up|76|||
162035215|NCT00509262|585185876|FG000|Overall Study|Other|2|||
162035216|NCT00509262|585185877|FG001|Overall Study|Other|2|||
162035217|NCT00509262|585185876|FG000|Overall Study|Lack of Efficacy|1|||
162035218|NCT00509262|585185877|FG001|Overall Study|Lack of Efficacy|0|||
162035219|NCT00509262|585185876|FG000|Overall Study|Lost to Follow-up|1|||
161987111|NCT01220180|585001067|FG000|Overall Study|Other|72|||
161987112|NCT01220180|585001067|FG000|Overall Study|Adverse Event|35|||
161987113|NCT01220180|585001067|FG000|Overall Study|Lack of Efficacy|22|||
161987114|NCT01220180|585001067|FG000|Overall Study|Death|1|||
161987115|NCT01220180|585001067|FG000|Overall Study|Randomized but not treated|1|||
161987116|NCT01364389|585001070|FG000|Overall Study|Withdrawal by Subject|0|||
161987117|NCT01364389|585001071|FG001|Overall Study|Withdrawal by Subject|1|||
161987118|NCT01364389|585001072|FG002|Overall Study|Withdrawal by Subject|0|||
161987119|NCT01364389|585001070|FG000|Overall Study|Protocol deviation|0|||
161987120|NCT01364389|585001071|FG001|Overall Study|Protocol deviation|0|||
161987121|NCT01364389|585001072|FG002|Overall Study|Protocol deviation|1|||
161987122|NCT01364389|585001070|FG000|Overall Study|Administrative problems|1|||
161987123|NCT01364389|585001071|FG001|Overall Study|Administrative problems|0|||
161987124|NCT01364389|585001072|FG002|Overall Study|Administrative problems|0|||
161987125|NCT01364389|585001070|FG000|Overall Study|Adverse Event|1|||
161987126|NCT01364389|585001071|FG001|Overall Study|Adverse Event|0|||
161987127|NCT01364389|585001072|FG002|Overall Study|Adverse Event|0|||
161987128|NCT02478255|585001074|FG000|Overall Study|Physician Decision|6|||
161987129|NCT02478255|585001075|FG001|Overall Study|Physician Decision|0|||
161987130|NCT02478255|585001074|FG000|Overall Study|Withdrawal by Subject|2|||
161987131|NCT02478255|585001075|FG001|Overall Study|Withdrawal by Subject|0|||
161987132|NCT03068767|585001081|FG000|Overall Study|Lost to Follow-up|7|||
161987133|NCT03068767|585001082|FG001|Overall Study|Lost to Follow-up|3|||
161987134|NCT03068767|585001081|FG000|Overall Study|Protocol Violation|3|||
161987135|NCT03068767|585001082|FG001|Overall Study|Protocol Violation|0|||
161987136|NCT00061633|585001083|FG000|Overall Study|Adverse Event|1|||
161987137|NCT00061633|585001084|FG001|Overall Study|Adverse Event|2|||
161987138|NCT00061633|585001083|FG000|Overall Study|Withdrawal by Subject|2|||
161987139|NCT00061633|585001084|FG001|Overall Study|Withdrawal by Subject|2|||
161987140|NCT00061633|585001083|FG000|Overall Study|Lost to Follow-up|1|||
161987141|NCT00061633|585001084|FG001|Overall Study|Lost to Follow-up|4|||
161987142|NCT00061633|585001083|FG000|Overall Study|Other|1|||
161987143|NCT00061633|585001084|FG001|Overall Study|Other|1|||
161987144|NCT00061633|585001083|FG000|Overall Study|Never received study treatment|0|||
161987145|NCT00061633|585001084|FG001|Overall Study|Never received study treatment|2|||
161987146|NCT01431963|585001085|FG000|Overall Study|Adverse Event|18|||
161987147|NCT01431963|585001085|FG000|Overall Study|Lack of Efficacy|7|||
161987148|NCT01431963|585001085|FG000|Overall Study|Protocol Violation|1|||
161987149|NCT01431963|585001085|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
161987150|NCT01431963|585001085|FG000|Overall Study|Physician Decision|4|||
161987151|NCT01431963|585001085|FG000|Overall Study|Withdrawal by Subject|3|||
161987152|NCT02475278|585003592|FG000|Overall Study|Lost to Follow-up|1|||
161987153|NCT02475278|585003592|FG000|Overall Study|Reason Not Specified|1|||
161987154|NCT01946152|585003593|FG000|Overall Study|Adverse Event|1|||
161987155|NCT01946152|585003594|FG001|Overall Study|Adverse Event|0|||
161987156|NCT01946152|585003595|FG002|Overall Study|Adverse Event|0|||
161987157|NCT01946152|585003596|FG003|Overall Study|Adverse Event|0|||
161987158|NCT01946152|585003593|FG000|Overall Study|Withdrawal by Subject|0|||
161987159|NCT01946152|585003594|FG001|Overall Study|Withdrawal by Subject|2|||
161987160|NCT01946152|585003595|FG002|Overall Study|Withdrawal by Subject|0|||
161987161|NCT01946152|585003596|FG003|Overall Study|Withdrawal by Subject|0|||
161987162|NCT01946152|585003593|FG000|Overall Study|Progression|0|||
161987163|NCT01946152|585003594|FG001|Overall Study|Progression|1|||
161987164|NCT01946152|585003595|FG002|Overall Study|Progression|4|||
161987165|NCT01946152|585003596|FG003|Overall Study|Progression|7|||
161987166|NCT01946152|585003593|FG000|Overall Study|Physician Decision|0|||
161987167|NCT01946152|585003594|FG001|Overall Study|Physician Decision|0|||
161987168|NCT01946152|585003595|FG002|Overall Study|Physician Decision|1|||
161987169|NCT01946152|585003596|FG003|Overall Study|Physician Decision|0|||
161987170|NCT01946152|585003593|FG000|Overall Study|Second malignancy|0|||
161987171|NCT01946152|585003594|FG001|Overall Study|Second malignancy|0|||
161987172|NCT01946152|585003595|FG002|Overall Study|Second malignancy|1|||
161987173|NCT01946152|585003596|FG003|Overall Study|Second malignancy|0|||
161987174|NCT01946152|585003593|FG000|Overall Study|Adverse Event|0|||
161987175|NCT01946152|585003594|FG001|Overall Study|Adverse Event|0|||
161987176|NCT01946152|585003595|FG002|Overall Study|Adverse Event|0|||
161987177|NCT01946152|585003596|FG003|Overall Study|Adverse Event|1|||
161987178|NCT03712787|585003597|FG000|Overall Study|Adverse Event|2|||
161987179|NCT03712787|585003598|FG001|Overall Study|Adverse Event|3|||
161987180|NCT03712787|585003599|FG002|Overall Study|Adverse Event|0|||
161987181|NCT03712787|585003600|FG003|Overall Study|Adverse Event|4|||
161987182|NCT03712787|585003597|FG000|Overall Study|Withdrawal by Subject|4|||
161987183|NCT03712787|585003598|FG001|Overall Study|Withdrawal by Subject|14|||
161775664|NCT01317199|584221232|FG003|Dose-escalation Phase 1|Physician Decision|0|||
161987184|NCT03712787|585003599|FG002|Overall Study|Withdrawal by Subject|12|||
161987185|NCT03712787|585003600|FG003|Overall Study|Withdrawal by Subject|8|||
161987186|NCT03712787|585003597|FG000|Overall Study|Lost to Follow-up|1|||
161987187|NCT03712787|585003598|FG001|Overall Study|Lost to Follow-up|1|||
161987188|NCT03712787|585003599|FG002|Overall Study|Lost to Follow-up|2|||
161987189|NCT03712787|585003600|FG003|Overall Study|Lost to Follow-up|1|||
161987190|NCT03712787|585003597|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
161987191|NCT03712787|585003598|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
161987192|NCT03712787|585003599|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
161987193|NCT03712787|585003600|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
161987194|NCT03712787|585003597|FG000|Overall Study|COVID-19 Infection|0|||
161987195|NCT03712787|585003598|FG001|Overall Study|COVID-19 Infection|1|||
161987196|NCT03712787|585003599|FG002|Overall Study|COVID-19 Infection|0|||
161987197|NCT03712787|585003600|FG003|Overall Study|COVID-19 Infection|0|||
161987198|NCT03712787|585003597|FG000|Overall Study|Other, Not Specified|79|||
161987199|NCT03712787|585003598|FG001|Overall Study|Other, Not Specified|77|||
161987200|NCT03712787|585003599|FG002|Overall Study|Other, Not Specified|74|||
161987201|NCT03712787|585003600|FG003|Overall Study|Other, Not Specified|78|||
161987202|NCT01865448|585003601|FG000|Overall Study|Adverse Event|1|||
161987203|NCT01865448|585003602|FG001|Overall Study|Adverse Event|1|||
161987204|NCT01865448|585003601|FG000|Overall Study|Pregnancy|0|||
161987205|NCT01865448|585003602|FG001|Overall Study|Pregnancy|1|||
161987206|NCT01865448|585003601|FG000|Overall Study|dropout unrelated to study|1|||
161987207|NCT01865448|585003602|FG001|Overall Study|dropout unrelated to study|1|||
161987208|NCT04794270|585003603|FG000|Period 1|Non Compliance|1|||
161987209|NCT04794270|585003604|FG001|Period 1|Non Compliance|0|||
161987210|NCT04794270|585003603|FG000|Period 1|Adverse Event|1|||
161987211|NCT04794270|585003604|FG001|Period 1|Adverse Event|0|||
161987212|NCT04794270|585003603|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
161987213|NCT04794270|585003604|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
161987214|NCT00265317|585003608|FG000|Lead-In|Objective progression or relapse|6|||
161987215|NCT00265317|585003609|FG001|Lead-In|Objective progression or relapse|11|||
161987216|NCT00265317|585003610|FG002|Lead-In|Objective progression or relapse|0|||
161987217|NCT00265317|585003611|FG003|Lead-In|Objective progression or relapse|0|||
161987218|NCT00265317|585003608|FG000|Lead-In|Adverse Event|2|||
161987219|NCT00265317|585003609|FG001|Lead-In|Adverse Event|1|||
161987220|NCT00265317|585003610|FG002|Lead-In|Adverse Event|0|||
161987221|NCT00265317|585003611|FG003|Lead-In|Adverse Event|0|||
161987222|NCT00265317|585003608|FG000|Lead-In|Death|3|||
161987223|NCT00265317|585003609|FG001|Lead-In|Death|5|||
161987224|NCT00265317|585003610|FG002|Lead-In|Death|0|||
161987225|NCT00265317|585003611|FG003|Lead-In|Death|0|||
161987226|NCT00265317|585003608|FG000|Lead-In|Withdrawal/other than adverse event|1|||
161987227|NCT00265317|585003609|FG001|Lead-In|Withdrawal/other than adverse event|0|||
161987228|NCT00265317|585003610|FG002|Lead-In|Withdrawal/other than adverse event|0|||
161987229|NCT00265317|585003611|FG003|Lead-In|Withdrawal/other than adverse event|0|||
161987230|NCT00265317|585003608|FG000|Phase 2|Objective progression or relapse|0|||
161987231|NCT00265317|585003609|FG001|Phase 2|Objective progression or relapse|0|||
161987232|NCT00265317|585003610|FG002|Phase 2|Objective progression or relapse|37|||
161987233|NCT00265317|585003611|FG003|Phase 2|Objective progression or relapse|38|||
161987234|NCT00265317|585003608|FG000|Phase 2|Global deterioration of health status|0|||
161987235|NCT00265317|585003609|FG001|Phase 2|Global deterioration of health status|0|||
161987236|NCT00265317|585003610|FG002|Phase 2|Global deterioration of health status|3|||
161987237|NCT00265317|585003611|FG003|Phase 2|Global deterioration of health status|0|||
161987238|NCT00265317|585003608|FG000|Phase 2|Adverse Event|0|||
161987239|NCT00265317|585003609|FG001|Phase 2|Adverse Event|0|||
161987240|NCT00265317|585003610|FG002|Phase 2|Adverse Event|7|||
161987241|NCT00265317|585003611|FG003|Phase 2|Adverse Event|5|||
161987242|NCT00265317|585003608|FG000|Phase 2|Death|0|||
161987243|NCT00265317|585003609|FG001|Phase 2|Death|0|||
161987244|NCT00265317|585003610|FG002|Phase 2|Death|12|||
161987245|NCT00265317|585003611|FG003|Phase 2|Death|15|||
161987246|NCT00265317|585003608|FG000|Phase 2|Protocol Violation|0|||
161987247|NCT00265317|585003609|FG001|Phase 2|Protocol Violation|0|||
161987248|NCT00265317|585003610|FG002|Phase 2|Protocol Violation|1|||
161987249|NCT00265317|585003611|FG003|Phase 2|Protocol Violation|4|||
161987250|NCT00265317|585003608|FG000|Phase 2|Lost to Follow-up|0|||
161987251|NCT00265317|585003609|FG001|Phase 2|Lost to Follow-up|0|||
161872096|NCT02837731|584577085|FG001|Allocation|Known aortic abnormalities|1|||
161872097|NCT02965573|584577087|FG000|Overall Study|Lack of Efficacy|1|||
161872098|NCT02965573|584577088|FG001|Overall Study|Lack of Efficacy|0|||
161987252|NCT00265317|585003610|FG002|Phase 2|Lost to Follow-up|0|||
161872099|NCT00315458|584577089|FG000|Overall Study|Administrative|0|||
161987253|NCT00265317|585003611|FG003|Phase 2|Lost to Follow-up|1|||
161987254|NCT00265317|585003608|FG000|Phase 2|Withdrawal/other than adverse event|0|||
161987255|NCT00265317|585003609|FG001|Phase 2|Withdrawal/other than adverse event|0|||
161987256|NCT00265317|585003610|FG002|Phase 2|Withdrawal/other than adverse event|2|||
161987257|NCT00265317|585003611|FG003|Phase 2|Withdrawal/other than adverse event|1|||
161987258|NCT00265317|585003608|FG000|Phase 2|Study terminated by sponsor|0|||
161987259|NCT00265317|585003609|FG001|Phase 2|Study terminated by sponsor|0|||
161987260|NCT00265317|585003610|FG002|Phase 2|Study terminated by sponsor|1|||
161987261|NCT00265317|585003611|FG003|Phase 2|Study terminated by sponsor|0|||
161987262|NCT00265317|585003608|FG000|Phase 2|Other|0|||
161987263|NCT00265317|585003609|FG001|Phase 2|Other|0|||
161987264|NCT00265317|585003610|FG002|Phase 2|Other|1|||
161987265|NCT00265317|585003611|FG003|Phase 2|Other|1|||
161987266|NCT00732875|585003614|FG000|Overall Study|Adverse Event|16|||
161987267|NCT00732875|585003614|FG000|Overall Study|Withdrawal by Subject|6|||
161987268|NCT00732875|585003614|FG000|Overall Study|Lack of Efficacy|13|||
161987269|NCT02300259|585003615|FG000|Period 1|Adverse Event|0|||
161987270|NCT02300259|585003616|FG001|Period 1|Adverse Event|0|||
161987271|NCT02300259|585003617|FG002|Period 1|Adverse Event|1|||
161987272|NCT02300259|585003615|FG000|Period 1|Withdrawal by Subject|0|||
161987273|NCT02300259|585003616|FG001|Period 1|Withdrawal by Subject|0|||
161987274|NCT02300259|585003617|FG002|Period 1|Withdrawal by Subject|1|||
161987275|NCT02300259|585003615|FG000|Period 2|Adverse Event|1|||
161987276|NCT02300259|585003616|FG001|Period 2|Adverse Event|0|||
161987277|NCT02300259|585003617|FG002|Period 2|Adverse Event|0|||
161987278|NCT02300259|585003615|FG000|Period 2|Withdrawal by Subject|0|||
161987279|NCT02300259|585003616|FG001|Period 2|Withdrawal by Subject|0|||
161987280|NCT02300259|585003617|FG002|Period 2|Withdrawal by Subject|1|||
161987281|NCT02510001|585003618|FG000|Overall Study|Early disease progression|0|||
161987282|NCT02510001|585003619|FG001|Overall Study|Early disease progression|0|||
161987283|NCT02510001|585003620|FG002|Overall Study|Early disease progression|0|||
161987284|NCT02510001|585003621|FG003|Overall Study|Early disease progression|1|||
161987285|NCT02510001|585003622|FG004|Overall Study|Early disease progression|1|||
161987286|NCT02510001|585003623|FG005|Overall Study|Early disease progression|1|||
161987287|NCT02510001|585003624|FG006|Overall Study|Early disease progression|0|||
161987288|NCT02510001|585003625|FG007|Overall Study|Early disease progression|0|||
161987289|NCT02510001|585003618|FG000|Overall Study|Adverse Event|0|||
161987290|NCT02510001|585003619|FG001|Overall Study|Adverse Event|0|||
161987291|NCT02510001|585003620|FG002|Overall Study|Adverse Event|0|||
161987292|NCT02510001|585003621|FG003|Overall Study|Adverse Event|1|||
161987293|NCT02510001|585003622|FG004|Overall Study|Adverse Event|2|||
161987294|NCT02510001|585003623|FG005|Overall Study|Adverse Event|1|||
161987295|NCT02510001|585003624|FG006|Overall Study|Adverse Event|2|||
161987296|NCT02510001|585003625|FG007|Overall Study|Adverse Event|5|||
161987297|NCT02510001|585003618|FG000|Overall Study|Physician Decision|0|||
161987298|NCT02510001|585003619|FG001|Overall Study|Physician Decision|0|||
161987299|NCT02510001|585003620|FG002|Overall Study|Physician Decision|0|||
161987300|NCT02510001|585003621|FG003|Overall Study|Physician Decision|0|||
161987301|NCT02510001|585003622|FG004|Overall Study|Physician Decision|1|||
161987302|NCT02510001|585003623|FG005|Overall Study|Physician Decision|0|||
161987303|NCT02510001|585003624|FG006|Overall Study|Physician Decision|0|||
161987304|NCT02510001|585003625|FG007|Overall Study|Physician Decision|0|||
161987305|NCT02510001|585003618|FG000|Overall Study|Withdrawal by Subject|0|||
161987306|NCT02510001|585003619|FG001|Overall Study|Withdrawal by Subject|0|||
161987307|NCT02510001|585003620|FG002|Overall Study|Withdrawal by Subject|0|||
161987308|NCT02510001|585003621|FG003|Overall Study|Withdrawal by Subject|0|||
161987309|NCT02510001|585003622|FG004|Overall Study|Withdrawal by Subject|0|||
161987310|NCT02510001|585003623|FG005|Overall Study|Withdrawal by Subject|0|||
161987311|NCT02510001|585003624|FG006|Overall Study|Withdrawal by Subject|0|||
161987312|NCT02510001|585003625|FG007|Overall Study|Withdrawal by Subject|2|||
161987313|NCT05362058|585003629|FG000|Treatment Period|Adverse Event|3|||
161987314|NCT05362058|585003630|FG001|Treatment Period|Adverse Event|3|||
161987315|NCT05362058|585003629|FG000|Treatment Period|Assigned treatment by mistake|3|||
161987316|NCT05362058|585003630|FG001|Treatment Period|Assigned treatment by mistake|4|||
161987317|NCT05362058|585003629|FG000|Treatment Period|Death|1|||
161987318|NCT05362058|585003630|FG001|Treatment Period|Death|1|||
161987319|NCT05362058|585003629|FG000|Treatment Period|Lost to Follow-up|6|||
161987320|NCT05362058|585003630|FG001|Treatment Period|Lost to Follow-up|3|||
161987321|NCT05362058|585003629|FG000|Treatment Period|Non-compliance with study drug|0|||
161987322|NCT05362058|585003630|FG001|Treatment Period|Non-compliance with study drug|1|||
161987323|NCT05362058|585003629|FG000|Treatment Period|Physician Decision|1|||
161987324|NCT05362058|585003630|FG001|Treatment Period|Physician Decision|0|||
161987325|NCT05362058|585003629|FG000|Treatment Period|Protocol deviation|1|||
161987326|NCT05362058|585003630|FG001|Treatment Period|Protocol deviation|0|||
161987327|NCT05362058|585003629|FG000|Treatment Period|Withdrawal by Subject|10|||
161987328|NCT05362058|585003630|FG001|Treatment Period|Withdrawal by Subject|11|||
161987329|NCT05362058|585003629|FG000|Follow-Up Period|Death|1|||
161987330|NCT05362058|585003630|FG001|Follow-Up Period|Death|0|||
161987331|NCT05362058|585003629|FG000|Follow-Up Period|Lost to Follow-up|2|||
161987332|NCT05362058|585003630|FG001|Follow-Up Period|Lost to Follow-up|1|||
161987333|NCT05362058|585003629|FG000|Follow-Up Period|Protocol deviation|1|||
161987334|NCT05362058|585003630|FG001|Follow-Up Period|Protocol deviation|1|||
161987335|NCT05362058|585003629|FG000|Follow-Up Period|Withdrawal by Subject|0|||
161987336|NCT05362058|585003630|FG001|Follow-Up Period|Withdrawal by Subject|3|||
161987337|NCT00711971|585003637|FG000|Overall Study|Lost to Follow-up|3|||
161987338|NCT00711971|585003638|FG001|Overall Study|Lost to Follow-up|4|||
161987339|NCT00711971|585003639|FG002|Overall Study|Lost to Follow-up|1|||
161987340|NCT00887549|585003642|FG000|Induction Therapy|Adverse Event|8|||
161987341|NCT00887549|585003642|FG000|Induction Therapy|Physician Decision|1|||
161987342|NCT00887549|585003642|FG000|Induction Therapy|Progressive Disease|13|||
161987343|NCT00887549|585003642|FG000|Induction Therapy|Death due to Study Disease|4|||
162035220|NCT00509262|585185877|FG001|Overall Study|Lost to Follow-up|6|||
161872100|NCT00315458|584577090|FG001|Overall Study|Administrative|3|||
161872101|NCT00315458|584577091|FG002|Overall Study|Administrative|8|||
161872102|NCT00315458|584577092|FG003|Overall Study|Administrative|21|||
161872103|NCT00315458|584577089|FG000|Overall Study|Adverse Event|2|||
161872104|NCT00315458|584577090|FG001|Overall Study|Adverse Event|4|||
161872105|NCT00315458|584577091|FG002|Overall Study|Adverse Event|23|||
161872106|NCT00315458|584577092|FG003|Overall Study|Adverse Event|3|||
161872107|NCT00315458|584577089|FG000|Overall Study|Lost to Follow-up|1|||
161872108|NCT00315458|584577090|FG001|Overall Study|Lost to Follow-up|2|||
161872109|NCT00315458|584577091|FG002|Overall Study|Lost to Follow-up|0|||
161872110|NCT00315458|584577092|FG003|Overall Study|Lost to Follow-up|2|||
161872111|NCT00315458|584577089|FG000|Overall Study|Withdrawal by Subject|0|||
161872112|NCT00315458|584577090|FG001|Overall Study|Withdrawal by Subject|3|||
161872113|NCT00315458|584577091|FG002|Overall Study|Withdrawal by Subject|0|||
161872114|NCT00315458|584577092|FG003|Overall Study|Withdrawal by Subject|2|||
161872115|NCT00315458|584577089|FG000|Overall Study|Lack of Efficacy|0|||
161872116|NCT00315458|584577090|FG001|Overall Study|Lack of Efficacy|0|||
161872117|NCT00315458|584577091|FG002|Overall Study|Lack of Efficacy|20|||
161872118|NCT00315458|584577092|FG003|Overall Study|Lack of Efficacy|1|||
161872119|NCT00315458|584577089|FG000|Overall Study|Did not qualify|0|||
161872120|NCT00315458|584577090|FG001|Overall Study|Did not qualify|0|||
161872121|NCT00315458|584577091|FG002|Overall Study|Did not qualify|1|||
161872122|NCT00315458|584577092|FG003|Overall Study|Did not qualify|0|||
161872123|NCT00523848|584577094|FG000|Overall Study|Adverse Event|11|||
161872124|NCT00523848|584577094|FG000|Overall Study|Withdrawal by Subject|2|||
161872125|NCT00523848|584577094|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
161872126|NCT00523848|584577094|FG000|Overall Study|Disease Progression|5|||
161872127|NCT00523848|584577094|FG000|Overall Study|Other, unspecified|4|||
161872128|NCT00086619|584577096|FG000|Overall Study|Withdrawal by Subject|6|||
161872129|NCT00086619|584577097|FG001|Overall Study|Withdrawal by Subject|6|||
161872130|NCT00086619|584577096|FG000|Overall Study|Adverse Event|8|||
161872131|NCT00086619|584577097|FG001|Overall Study|Adverse Event|10|||
161872132|NCT00086619|584577096|FG000|Overall Study|Protocol Violation|1|||
161872133|NCT00086619|584577097|FG001|Overall Study|Protocol Violation|1|||
161872134|NCT00489918|584577098|FG000|Overall Study|Withdrawal by Subject|2|||
161872135|NCT00489918|584577099|FG001|Overall Study|Withdrawal by Subject|1|||
161872136|NCT00489918|584577100|FG002|Overall Study|Withdrawal by Subject|1|||
161872137|NCT00489918|584577101|FG003|Overall Study|Withdrawal by Subject|0|||
161872138|NCT00489918|584577102|FG004|Overall Study|Withdrawal by Subject|1|||
161872139|NCT00489918|584577098|FG000|Overall Study|Adverse Event|0|||
161872140|NCT00489918|584577099|FG001|Overall Study|Adverse Event|1|||
161872141|NCT00489918|584577100|FG002|Overall Study|Adverse Event|1|||
161872142|NCT00489918|584577101|FG003|Overall Study|Adverse Event|0|||
161872143|NCT00489918|584577102|FG004|Overall Study|Adverse Event|0|||
161872144|NCT00489918|584577098|FG000|Overall Study|Lost to Follow-up|0|||
161872145|NCT00489918|584577099|FG001|Overall Study|Lost to Follow-up|0|||
161872146|NCT00489918|584577100|FG002|Overall Study|Lost to Follow-up|1|||
161872147|NCT00489918|584577101|FG003|Overall Study|Lost to Follow-up|1|||
161872148|NCT00489918|584577102|FG004|Overall Study|Lost to Follow-up|0|||
161872149|NCT00489918|584577098|FG000|Overall Study|Physician Decision|0|||
161872150|NCT00489918|584577099|FG001|Overall Study|Physician Decision|0|||
161872151|NCT00489918|584577100|FG002|Overall Study|Physician Decision|1|||
161872152|NCT00489918|584577101|FG003|Overall Study|Physician Decision|0|||
161872153|NCT00489918|584577102|FG004|Overall Study|Physician Decision|0|||
161872154|NCT02748213|584577103|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
161872155|NCT02748213|584577104|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
161872156|NCT02748213|584577103|FG000|Overall Study|Abnormal Laboratory Test|1|||
161872157|NCT02748213|584577104|FG001|Overall Study|Abnormal Laboratory Test|0|||
161872158|NCT02748213|584577103|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
161872159|NCT02748213|584577104|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
161872160|NCT02748213|584577103|FG000|Overall Study|Death|5|||
161872161|NCT02748213|584577104|FG001|Overall Study|Death|3|||
161872162|NCT02748213|584577103|FG000|Overall Study|Insufficient Therapeutic Response|56|||
161872163|NCT02748213|584577104|FG001|Overall Study|Insufficient Therapeutic Response|57|||
161872164|NCT02748213|584577103|FG000|Overall Study|Violation of Selection Criteria|2|||
162035221|NCT00509262|585185876|FG000|Overall Study|Physician Decision|1|||
161872165|NCT02748213|584577104|FG001|Overall Study|Violation of Selection Criteria|0|||
161872166|NCT02748213|584577103|FG000|Overall Study|Protocol Violation|6|||
161872167|NCT02748213|584577104|FG001|Overall Study|Protocol Violation|4|||
161872168|NCT02748213|584577103|FG000|Overall Study|Refused Treatment*|6|||
161872169|NCT02748213|584577104|FG001|Overall Study|Refused Treatment*|6|||
161872170|NCT02748213|584577103|FG000|Overall Study|Failure to Return|1|||
161872171|NCT02748213|584577104|FG001|Overall Study|Failure to Return|0|||
161872172|NCT02748213|584577103|FG000|Overall Study|Other|30|||
161872173|NCT02748213|584577104|FG001|Overall Study|Other|29|||
161872174|NCT01209520|584577108|FG000|Overall Study|Withdrawal by Subject|3|||
161872175|NCT03850483|584577109|FG000|Treatment for Stage 1|Adverse Event|1|||
161872176|NCT03850483|584577110|FG001|Treatment for Stage 1|Adverse Event|1|||
162035222|NCT00509262|585185877|FG001|Overall Study|Physician Decision|3|||
161872177|NCT03850483|584577111|FG002|Treatment for Stage 1|Adverse Event|3|||
161872178|NCT03850483|584577112|FG003|Treatment for Stage 1|Adverse Event|0|||
161872179|NCT03850483|584577113|FG004|Treatment for Stage 1|Adverse Event|2|||
161872180|NCT03850483|584577114|FG005|Treatment for Stage 1|Adverse Event|0|||
161987344|NCT00887549|585003642|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
161987345|NCT00887549|585003642|FG000|Maintenance Therapy|Adverse Event|16|||
161987346|NCT00887549|585003642|FG000|Maintenance Therapy|Physician Decision|1|||
161987347|NCT00887549|585003642|FG000|Maintenance Therapy|Progressive Disease|25|||
161987348|NCT00887549|585003642|FG000|Maintenance Therapy|Death due to adverse event|1|||
161987349|NCT01858740|585003644|FG000|Overall Study|Death|4|||
161987350|NCT03100058|585003646|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161987351|NCT03100058|585003647|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161987352|NCT03100058|585003648|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
161987353|NCT03100058|585003649|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
161987354|NCT03100058|585003650|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
161987355|NCT03100058|585003651|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161987356|NCT03100058|585003652|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
161987357|NCT03100058|585003653|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
161987358|NCT03100058|585003654|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
161987359|NCT03100058|585003655|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161987360|NCT03100058|585003656|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161987361|NCT03100058|585003657|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161987362|NCT03100058|585003658|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
161987363|NCT03100058|585003646|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
161987364|NCT03100058|585003647|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
161987365|NCT03100058|585003648|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
161987366|NCT03100058|585003649|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
161987367|NCT03100058|585003650|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
161987368|NCT03100058|585003651|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
161987369|NCT03100058|585003652|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
161987370|NCT03100058|585003653|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
161987371|NCT03100058|585003654|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
161987372|NCT03100058|585003655|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
161987373|NCT03100058|585003656|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
161987374|NCT03100058|585003657|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
161987375|NCT03100058|585003658|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
161987376|NCT03100058|585003646|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161987377|NCT03100058|585003647|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
161987378|NCT03100058|585003648|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
161987379|NCT03100058|585003649|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161987380|NCT03100058|585003650|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161987381|NCT03100058|585003651|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
161987382|NCT03100058|585003652|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
161987383|NCT03100058|585003653|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161987384|NCT03100058|585003654|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161987385|NCT03100058|585003655|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161987386|NCT03100058|585003656|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161987387|NCT03100058|585003657|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161987388|NCT03100058|585003658|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
161987389|NCT03100058|585003646|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161987390|NCT03100058|585003647|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
161987391|NCT03100058|585003648|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
161987392|NCT03100058|585003649|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161987393|NCT03100058|585003650|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161987394|NCT03100058|585003651|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161987395|NCT03100058|585003652|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
161987396|NCT03100058|585003653|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161987397|NCT03100058|585003654|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
161987398|NCT03100058|585003655|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161872181|NCT03850483|584577115|FG006|Treatment for Stage 1|Adverse Event|2|||
161872182|NCT03850483|584577116|FG007|Treatment for Stage 1|Adverse Event|2|||
161987399|NCT03100058|585003656|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161872183|NCT03850483|584577117|FG008|Treatment for Stage 1|Adverse Event|0|||
161872184|NCT03850483|584577118|FG009|Treatment for Stage 1|Adverse Event|0|||
161872185|NCT03850483|584577109|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
161872186|NCT03850483|584577110|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
161872187|NCT03850483|584577111|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
161987400|NCT03100058|585003657|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161987401|NCT03100058|585003658|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
161987402|NCT03100058|585003646|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161987403|NCT03100058|585003647|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161987404|NCT03100058|585003648|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161987405|NCT03100058|585003649|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
161987406|NCT03100058|585003650|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161987407|NCT03100058|585003651|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161987408|NCT03100058|585003652|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161987409|NCT03100058|585003653|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
161987410|NCT03100058|585003654|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161987411|NCT03100058|585003655|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161987412|NCT03100058|585003656|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161987413|NCT03100058|585003657|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161987414|NCT03100058|585003658|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
161987415|NCT03100058|585003646|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161987416|NCT03100058|585003647|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161987417|NCT03100058|585003648|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161987418|NCT03100058|585003649|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
161987419|NCT03100058|585003650|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161987420|NCT03100058|585003651|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161987421|NCT03100058|585003652|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
161987422|NCT03100058|585003653|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161987423|NCT03100058|585003654|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161987424|NCT03100058|585003655|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161987425|NCT03100058|585003656|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161987426|NCT03100058|585003657|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161987427|NCT03100058|585003658|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161987428|NCT03100058|585003646|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161987429|NCT03100058|585003647|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
161987430|NCT03100058|585003648|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161987431|NCT03100058|585003649|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161987432|NCT03100058|585003650|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161987433|NCT03100058|585003651|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161987434|NCT03100058|585003652|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161987435|NCT03100058|585003653|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161987436|NCT03100058|585003654|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161987437|NCT03100058|585003655|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161987438|NCT03100058|585003656|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161987439|NCT03100058|585003657|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161987440|NCT03100058|585003658|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161987441|NCT03100058|585003646|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
161987442|NCT03100058|585003647|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161987443|NCT03100058|585003648|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161987444|NCT03100058|585003649|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161987445|NCT03100058|585003650|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161987446|NCT03100058|585003651|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161987447|NCT03100058|585003652|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161987448|NCT03100058|585003653|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161987449|NCT03100058|585003654|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161987450|NCT03100058|585003655|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161987451|NCT03100058|585003656|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161987452|NCT03100058|585003657|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161987453|NCT03100058|585003658|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161987454|NCT03100058|585003646|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161987455|NCT03100058|585003647|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161987456|NCT03100058|585003648|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161987457|NCT03100058|585003649|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161987458|NCT03100058|585003650|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161987459|NCT03100058|585003651|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161987460|NCT03100058|585003652|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
161987461|NCT03100058|585003653|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
162035223|NCT00509262|585185876|FG000|Overall Study|Protocol Violation|2|||
162035224|NCT00509262|585185877|FG001|Overall Study|Protocol Violation|2|||
161987462|NCT03100058|585003654|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161987463|NCT03100058|585003655|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161987464|NCT03100058|585003656|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161987465|NCT03100058|585003657|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161987466|NCT03100058|585003658|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161987467|NCT03100058|585003646|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161987468|NCT03100058|585003647|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161987469|NCT03100058|585003648|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161987470|NCT03100058|585003649|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161987471|NCT03100058|585003650|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161987472|NCT03100058|585003651|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161987473|NCT03100058|585003652|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161987474|NCT03100058|585003653|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161987475|NCT03100058|585003654|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161987476|NCT03100058|585003655|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161987477|NCT03100058|585003656|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
161987478|NCT03100058|585003657|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
161987479|NCT03100058|585003658|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
161987480|NCT03100058|585003646|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161987481|NCT03100058|585003647|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161987482|NCT03100058|585003648|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161987483|NCT03100058|585003649|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161987484|NCT03100058|585003650|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161987485|NCT03100058|585003651|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161987486|NCT03100058|585003652|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161987487|NCT03100058|585003653|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161987488|NCT03100058|585003654|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161987489|NCT03100058|585003655|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161987490|NCT03100058|585003656|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
161987491|NCT03100058|585003657|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
161987492|NCT03100058|585003658|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
161987493|NCT03100058|585003646|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161987494|NCT03100058|585003647|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161987495|NCT03100058|585003648|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161987496|NCT03100058|585003649|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161987497|NCT03100058|585003650|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161987498|NCT03100058|585003651|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161987499|NCT03100058|585003652|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161987500|NCT03100058|585003653|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161987501|NCT03100058|585003654|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161987502|NCT03100058|585003655|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
161987503|NCT03100058|585003656|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
161987504|NCT03100058|585003657|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161987505|NCT03100058|585003658|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
161987506|NCT03100058|585003646|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161987507|NCT03100058|585003647|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161987508|NCT03100058|585003648|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161987509|NCT03100058|585003649|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161987510|NCT03100058|585003650|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161987511|NCT03100058|585003651|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161987512|NCT03100058|585003652|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161987513|NCT03100058|585003653|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161987514|NCT03100058|585003654|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161987515|NCT03100058|585003655|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161987516|NCT03100058|585003656|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
161987517|NCT03100058|585003657|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161987518|NCT03100058|585003658|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
161987519|NCT03100058|585003646|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161987520|NCT03100058|585003647|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161987521|NCT03100058|585003648|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161987522|NCT03100058|585003649|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161987523|NCT03100058|585003650|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161987524|NCT03100058|585003651|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161987525|NCT03100058|585003652|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161987526|NCT03100058|585003653|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161987527|NCT03100058|585003654|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161987528|NCT03100058|585003655|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161987529|NCT03100058|585003656|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161987530|NCT03100058|585003657|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
161987531|NCT03100058|585003658|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
161987532|NCT03100058|585003646|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
162035225|NCT00509262|585185876|FG000|Overall Study|Withdrawal by Subject|24|||
161872188|NCT03850483|584577112|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
161872189|NCT03850483|584577113|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
161872190|NCT03850483|584577114|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
161872191|NCT03850483|584577115|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
161872192|NCT03850483|584577116|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
161872193|NCT03850483|584577117|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
161872194|NCT03850483|584577118|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
161872195|NCT03850483|584577109|FG000|Treatment for Stage 1|Protocol Violation|1|||
161872196|NCT03850483|584577110|FG001|Treatment for Stage 1|Protocol Violation|0|||
161872197|NCT03850483|584577111|FG002|Treatment for Stage 1|Protocol Violation|0|||
161872198|NCT03850483|584577112|FG003|Treatment for Stage 1|Protocol Violation|0|||
161872199|NCT03850483|584577113|FG004|Treatment for Stage 1|Protocol Violation|0|||
161872200|NCT03850483|584577114|FG005|Treatment for Stage 1|Protocol Violation|0|||
161872201|NCT03850483|584577115|FG006|Treatment for Stage 1|Protocol Violation|1|||
161872202|NCT03850483|584577116|FG007|Treatment for Stage 1|Protocol Violation|0|||
161872203|NCT03850483|584577117|FG008|Treatment for Stage 1|Protocol Violation|0|||
161872204|NCT03850483|584577118|FG009|Treatment for Stage 1|Protocol Violation|0|||
161872205|NCT03850483|584577109|FG000|Treatment for Stage 1|Physician Decision|0|||
161872206|NCT03850483|584577110|FG001|Treatment for Stage 1|Physician Decision|0|||
161872207|NCT03850483|584577111|FG002|Treatment for Stage 1|Physician Decision|0|||
161872208|NCT03850483|584577112|FG003|Treatment for Stage 1|Physician Decision|0|||
161872209|NCT03850483|584577113|FG004|Treatment for Stage 1|Physician Decision|0|||
161872210|NCT03850483|584577114|FG005|Treatment for Stage 1|Physician Decision|1|||
161872211|NCT03850483|584577115|FG006|Treatment for Stage 1|Physician Decision|0|||
161872212|NCT03850483|584577116|FG007|Treatment for Stage 1|Physician Decision|0|||
161872213|NCT03850483|584577117|FG008|Treatment for Stage 1|Physician Decision|0|||
161872214|NCT03850483|584577118|FG009|Treatment for Stage 1|Physician Decision|0|||
161872215|NCT03850483|584577109|FG000|Treatment for Stage 1|Other|0|||
161872216|NCT03850483|584577110|FG001|Treatment for Stage 1|Other|0|||
161872217|NCT03850483|584577111|FG002|Treatment for Stage 1|Other|0|||
161872218|NCT03850483|584577112|FG003|Treatment for Stage 1|Other|0|||
161872219|NCT03850483|584577113|FG004|Treatment for Stage 1|Other|2|||
161872220|NCT03850483|584577114|FG005|Treatment for Stage 1|Other|1|||
161872221|NCT03850483|584577115|FG006|Treatment for Stage 1|Other|0|||
161872222|NCT03850483|584577116|FG007|Treatment for Stage 1|Other|0|||
161872223|NCT03850483|584577117|FG008|Treatment for Stage 1|Other|0|||
161872224|NCT03850483|584577118|FG009|Treatment for Stage 1|Other|0|||
161872225|NCT03850483|584577109|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872226|NCT03850483|584577110|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872227|NCT03850483|584577111|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
161872228|NCT03850483|584577112|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872229|NCT03850483|584577113|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872230|NCT03850483|584577114|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872231|NCT03850483|584577115|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872232|NCT03850483|584577116|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872233|NCT03850483|584577117|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872234|NCT03850483|584577118|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161872235|NCT03850483|584577109|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872236|NCT03850483|584577110|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872237|NCT03850483|584577111|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872238|NCT03850483|584577112|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872239|NCT03850483|584577113|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872240|NCT03850483|584577114|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
161872241|NCT03850483|584577115|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872242|NCT03850483|584577116|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872243|NCT03850483|584577117|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872244|NCT03850483|584577118|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161872245|NCT03850483|584577109|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
161872246|NCT03850483|584577110|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
161872247|NCT03850483|584577111|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
161872248|NCT03850483|584577112|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
161987533|NCT03100058|585003647|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161987534|NCT03100058|585003648|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
162035226|NCT00509262|585185877|FG001|Overall Study|Withdrawal by Subject|11|||
161872249|NCT03850483|584577113|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
161872250|NCT03850483|584577114|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
161872251|NCT03850483|584577115|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
161872252|NCT03850483|584577116|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
161872253|NCT03850483|584577117|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
161872254|NCT03850483|584577118|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
161872255|NCT03850483|584577109|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
161872256|NCT03850483|584577110|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
161987535|NCT03100058|585003649|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161987536|NCT03100058|585003650|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161987537|NCT03100058|585003651|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161987538|NCT03100058|585003652|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161987539|NCT03100058|585003653|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161987540|NCT03100058|585003654|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161987541|NCT03100058|585003655|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
161987542|NCT03100058|585003656|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161987543|NCT03100058|585003657|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161987544|NCT03100058|585003658|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
161987545|NCT03671304|585003661|FG000|Overall Study|study terminated|7|||
161987546|NCT01067144|585003662|FG000|Treatment|Did not receive allocated intervention|4|||
161987547|NCT01067144|585003663|FG001|Treatment|Did not receive allocated intervention|7|||
161987548|NCT01067144|585003662|FG000|Follow-up|Lost to Follow-up|22|||
161987549|NCT01067144|585003663|FG001|Follow-up|Lost to Follow-up|12|||
161987550|NCT01067144|585003662|FG000|Follow-up|Censored owing to second surgery|19|||
161987551|NCT01067144|585003663|FG001|Follow-up|Censored owing to second surgery|28|||
161987552|NCT01067144|585003662|FG000|Follow-up|Withdrawal by Subject|18|||
161987553|NCT01067144|585003663|FG001|Follow-up|Withdrawal by Subject|14|||
161987554|NCT01067144|585003662|FG000|Follow-up|Surgery cancelled|0|||
161987555|NCT01067144|585003663|FG001|Follow-up|Surgery cancelled|1|||
161987556|NCT01067144|585003662|FG000|Follow-up|Death|0|||
161987557|NCT01067144|585003663|FG001|Follow-up|Death|1|||
161987558|NCT02718716|585003665|FG000|Overall Study|Lack of Efficacy|1|||
161987559|NCT02718716|585003666|FG001|Overall Study|Lack of Efficacy|0|||
161987560|NCT02718716|585003667|FG002|Overall Study|Lack of Efficacy|0|||
161987561|NCT02718716|585003668|FG003|Overall Study|Lack of Efficacy|0|||
161987562|NCT02718716|585003669|FG004|Overall Study|Lack of Efficacy|0|||
161987563|NCT02097030|585003676|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
161987564|NCT02097030|585003677|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
161987565|NCT02097030|585003676|FG000|First Intervention (3 Days)|Visual Acuity|0|||
161987566|NCT02097030|585003677|FG001|First Intervention (3 Days)|Visual Acuity|1|||
161987567|NCT01919801|585003678|FG000|Overall Study|Withdrawal by Subject|1|||
161987568|NCT01919801|585003679|FG001|Overall Study|Withdrawal by Subject|0|||
161987569|NCT01919801|585003678|FG000|Overall Study|Physician Decision|0|||
161987570|NCT01919801|585003679|FG001|Overall Study|Physician Decision|1|||
161987571|NCT01919801|585003678|FG000|Overall Study|Lost to Follow-up|0|||
161987572|NCT01919801|585003679|FG001|Overall Study|Lost to Follow-up|1|||
161987573|NCT01919801|585003678|FG000|Overall Study|Other|0|||
161987574|NCT01919801|585003679|FG001|Overall Study|Other|1|||
161987575|NCT01677858|585003684|FG000|Overall Study|Adverse Event|0|||
161987576|NCT01677858|585003685|FG001|Overall Study|Adverse Event|0|||
161987577|NCT01677858|585003686|FG002|Overall Study|Adverse Event|2|||
161987578|NCT01677858|585003687|FG003|Overall Study|Adverse Event|3|||
161987579|NCT01677858|585003688|FG004|Overall Study|Adverse Event|13|||
161987580|NCT01677858|585003684|FG000|Overall Study|Death|0|||
161987581|NCT01677858|585003685|FG001|Overall Study|Death|0|||
161987582|NCT01677858|585003686|FG002|Overall Study|Death|0|||
161987583|NCT01677858|585003687|FG003|Overall Study|Death|0|||
161987584|NCT01677858|585003688|FG004|Overall Study|Death|1|||
161987585|NCT01677858|585003684|FG000|Overall Study|Physician Decision|1|||
161987586|NCT01677858|585003685|FG001|Overall Study|Physician Decision|0|||
161987587|NCT01677858|585003686|FG002|Overall Study|Physician Decision|2|||
161987588|NCT01677858|585003687|FG003|Overall Study|Physician Decision|0|||
161987589|NCT01677858|585003688|FG004|Overall Study|Physician Decision|12|||
161987590|NCT01677858|585003684|FG000|Overall Study|Progressive Disease|2|||
161987591|NCT01677858|585003685|FG001|Overall Study|Progressive Disease|1|||
161987592|NCT01677858|585003686|FG002|Overall Study|Progressive Disease|9|||
161987593|NCT01677858|585003687|FG003|Overall Study|Progressive Disease|3|||
161987594|NCT01677858|585003688|FG004|Overall Study|Progressive Disease|43|||
161987595|NCT01677858|585003684|FG000|Overall Study|Withdrawal by Subject|0|||
161987596|NCT01677858|585003685|FG001|Overall Study|Withdrawal by Subject|1|||
161987597|NCT01677858|585003686|FG002|Overall Study|Withdrawal by Subject|1|||
161987598|NCT01677858|585003687|FG003|Overall Study|Withdrawal by Subject|0|||
161987599|NCT01677858|585003688|FG004|Overall Study|Withdrawal by Subject|15|||
162035227|NCT00725842|585185878|FG000|Overall Study|Lost to Follow-up|19|||
162035228|NCT00725842|585185878|FG000|Overall Study|Death|1|||
162035229|NCT00725842|585185878|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
161987600|NCT01677858|585003684|FG000|Overall Study|Lost to Follow-up|0|||
161987601|NCT01677858|585003685|FG001|Overall Study|Lost to Follow-up|0|||
161987602|NCT01677858|585003686|FG002|Overall Study|Lost to Follow-up|0|||
161987603|NCT01677858|585003687|FG003|Overall Study|Lost to Follow-up|0|||
161987604|NCT01677858|585003688|FG004|Overall Study|Lost to Follow-up|1|||
161987605|NCT00988091|585003689|FG000|Double-blind Period|Withdrawal by Subject|15|||
161987606|NCT00988091|585003690|FG001|Double-blind Period|Withdrawal by Subject|13|||
162035230|NCT00725842|585185878|FG000|Overall Study|Consent date prior to study start date|5|||
161872257|NCT03850483|584577111|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
161872258|NCT03850483|584577112|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
161872259|NCT03850483|584577113|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
161872260|NCT03850483|584577114|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
161872261|NCT03850483|584577115|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
161872262|NCT03850483|584577116|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
161872263|NCT03850483|584577117|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
161872264|NCT03850483|584577118|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
161872265|NCT03850483|584577109|FG000|Treatment for Stage 1|Death|0|||
161872266|NCT03850483|584577110|FG001|Treatment for Stage 1|Death|0|||
161872267|NCT03850483|584577111|FG002|Treatment for Stage 1|Death|0|||
161872268|NCT03850483|584577112|FG003|Treatment for Stage 1|Death|0|||
161872269|NCT03850483|584577113|FG004|Treatment for Stage 1|Death|0|||
161872270|NCT03850483|584577114|FG005|Treatment for Stage 1|Death|1|||
161872271|NCT03850483|584577115|FG006|Treatment for Stage 1|Death|0|||
162035231|NCT00725842|585185878|FG000|Overall Study|Inclusion criterion not met|1|||
162035232|NCT00725842|585185878|FG000|Overall Study|No Visit 1 data|1|||
162035233|NCT02009384|585185882|FG000|Overall Study|Death|2|||
162035234|NCT01075191|585185883|FG000|Overall Study|Death|1|||
162035235|NCT01075191|585185883|FG000|Overall Study|Intensification|3|||
162035236|NCT01075191|585185883|FG000|Overall Study|Co-morbidities|1|||
162035237|NCT01075191|585185883|FG000|Overall Study|Adverse Event|4|||
162035238|NCT01075191|585185883|FG000|Overall Study|Noncompliance|3|||
162035239|NCT01075191|585185883|FG000|Overall Study|Therapy Break|3|||
162035240|NCT01075191|585185883|FG000|Overall Study|Patient's Wish|2|||
162035241|NCT01075191|585185883|FG000|Overall Study|Unknown Reasons|1|||
162035242|NCT01244490|585185888|FG000|Overall Study|Lack of Efficacy|14|||
162035243|NCT01244490|585185889|FG001|Overall Study|Lack of Efficacy|5|||
162035244|NCT01244490|585185890|FG002|Overall Study|Lack of Efficacy|5|||
162035245|NCT01244490|585185888|FG000|Overall Study|Withdrawal by Subject|4|||
161872272|NCT03850483|584577116|FG007|Treatment for Stage 1|Death|0|||
161872273|NCT03850483|584577117|FG008|Treatment for Stage 1|Death|0|||
161872274|NCT03850483|584577118|FG009|Treatment for Stage 1|Death|0|||
161987607|NCT00988091|585003689|FG000|Double-blind Period|Lost to Follow-up|12|||
161987608|NCT00988091|585003690|FG001|Double-blind Period|Lost to Follow-up|14|||
161987609|NCT00988091|585003689|FG000|Double-blind Period|Other|8|||
161987610|NCT00988091|585003690|FG001|Double-blind Period|Other|8|||
161987611|NCT00988091|585003689|FG000|Double-blind Period|Adverse Event|6|||
161987612|NCT00988091|585003690|FG001|Double-blind Period|Adverse Event|9|||
161987613|NCT00988091|585003689|FG000|Double-blind Period|Use of exclusionary medication|2|||
161987614|NCT00988091|585003690|FG001|Double-blind Period|Use of exclusionary medication|3|||
161987615|NCT00988091|585003689|FG000|Open-label Period|Adverse Event|4|||
161987616|NCT00988091|585003690|FG001|Open-label Period|Adverse Event|7|||
161987617|NCT00988091|585003689|FG000|Open-label Period|Use of exclusionary medication|1|||
161987618|NCT00988091|585003690|FG001|Open-label Period|Use of exclusionary medication|1|||
161987619|NCT00988091|585003689|FG000|Open-label Period|Protocol Violation|1|||
161987620|NCT00988091|585003690|FG001|Open-label Period|Protocol Violation|1|||
161987621|NCT00988091|585003689|FG000|Open-label Period|Withdrawal by Subject|10|||
161987622|NCT00988091|585003690|FG001|Open-label Period|Withdrawal by Subject|16|||
161987623|NCT00988091|585003689|FG000|Open-label Period|Lost to Follow-up|3|||
161987624|NCT00988091|585003690|FG001|Open-label Period|Lost to Follow-up|5|||
161987625|NCT00988091|585003689|FG000|Open-label Period|Other|2|||
161987626|NCT00988091|585003690|FG001|Open-label Period|Other|3|||
161987627|NCT03078855|585003694|FG000|Overall Study|Lack of Efficacy|62|||
161987628|NCT03078855|585003695|FG001|Overall Study|Lack of Efficacy|31|||
161987629|NCT03078855|585003694|FG000|Overall Study|Death|1|||
161987630|NCT03078855|585003695|FG001|Overall Study|Death|0|||
161987631|NCT03078855|585003694|FG000|Overall Study|Withdrawal by Subject|12|||
161987632|NCT03078855|585003695|FG001|Overall Study|Withdrawal by Subject|6|||
161987633|NCT03078855|585003694|FG000|Overall Study|Physician Decision|3|||
161987634|NCT03078855|585003695|FG001|Overall Study|Physician Decision|2|||
161987635|NCT03078855|585003694|FG000|Overall Study|Second Malignancy|4|||
161987636|NCT03078855|585003695|FG001|Overall Study|Second Malignancy|0|||
161987637|NCT03078855|585003694|FG000|Overall Study|Ineligible|2|||
161872275|NCT03850483|584577109|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
161872276|NCT03850483|584577110|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
161987638|NCT03078855|585003695|FG001|Overall Study|Ineligible|0|||
161987639|NCT03078855|585003694|FG000|Overall Study|Withdrew before day 1 treatment|2|||
161987640|NCT03078855|585003695|FG001|Overall Study|Withdrew before day 1 treatment|1|||
161987641|NCT00391027|585003696|FG000|Overall Study|Adverse Event|8|||
161987642|NCT00391027|585003697|FG001|Overall Study|Adverse Event|8|||
161872277|NCT03850483|584577111|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
161872278|NCT03850483|584577112|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
161872279|NCT03850483|584577113|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
161872280|NCT03850483|584577114|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
161987643|NCT00391027|585003696|FG000|Overall Study|Lack of Efficacy|3|||
162035246|NCT01244490|585185889|FG001|Overall Study|Withdrawal by Subject|4|||
162035247|NCT01244490|585185890|FG002|Overall Study|Withdrawal by Subject|9|||
161987644|NCT00391027|585003697|FG001|Overall Study|Lack of Efficacy|0|||
161987645|NCT00391027|585003696|FG000|Overall Study|Withdrawal by Subject|10|||
161987646|NCT00391027|585003697|FG001|Overall Study|Withdrawal by Subject|1|||
161987647|NCT00391027|585003696|FG000|Overall Study|Other|4|||
161987648|NCT00391027|585003697|FG001|Overall Study|Other|3|||
161987649|NCT03194646|585003698|FG000|Overall Study|Adverse Event|24|||
161987650|NCT03194646|585003699|FG001|Overall Study|Adverse Event|25|||
161987651|NCT03194646|585003700|FG002|Overall Study|Adverse Event|14|||
161987652|NCT03194646|585003701|FG003|Overall Study|Adverse Event|17|||
161987653|NCT03194646|585003698|FG000|Overall Study|Lack of Efficacy|4|||
161987654|NCT03194646|585003699|FG001|Overall Study|Lack of Efficacy|2|||
161987655|NCT03194646|585003700|FG002|Overall Study|Lack of Efficacy|2|||
161987656|NCT03194646|585003701|FG003|Overall Study|Lack of Efficacy|12|||
161987657|NCT03194646|585003698|FG000|Overall Study|Lost to Follow-up|30|||
161987658|NCT03194646|585003699|FG001|Overall Study|Lost to Follow-up|22|||
161987659|NCT03194646|585003700|FG002|Overall Study|Lost to Follow-up|12|||
161987660|NCT03194646|585003701|FG003|Overall Study|Lost to Follow-up|35|||
161987661|NCT03194646|585003698|FG000|Overall Study|Non-compliance with study drug|4|||
161987662|NCT03194646|585003699|FG001|Overall Study|Non-compliance with study drug|0|||
161987663|NCT03194646|585003700|FG002|Overall Study|Non-compliance with study drug|1|||
161987664|NCT03194646|585003701|FG003|Overall Study|Non-compliance with study drug|1|||
161987665|NCT03194646|585003698|FG000|Overall Study|Other|89|||
161987666|NCT03194646|585003699|FG001|Overall Study|Other|68|||
161987667|NCT03194646|585003700|FG002|Overall Study|Other|34|||
161987668|NCT03194646|585003701|FG003|Overall Study|Other|31|||
161987669|NCT03194646|585003698|FG000|Overall Study|Physician Decision|7|||
161987670|NCT03194646|585003699|FG001|Overall Study|Physician Decision|9|||
161987671|NCT03194646|585003700|FG002|Overall Study|Physician Decision|5|||
161987672|NCT03194646|585003701|FG003|Overall Study|Physician Decision|4|||
161987673|NCT03194646|585003698|FG000|Overall Study|Pregnancy|4|||
161987674|NCT03194646|585003699|FG001|Overall Study|Pregnancy|5|||
161987675|NCT03194646|585003700|FG002|Overall Study|Pregnancy|1|||
161987676|NCT03194646|585003701|FG003|Overall Study|Pregnancy|2|||
161987677|NCT03194646|585003698|FG000|Overall Study|Protocol Violation|4|||
161987678|NCT03194646|585003699|FG001|Overall Study|Protocol Violation|2|||
161987679|NCT03194646|585003700|FG002|Overall Study|Protocol Violation|1|||
161987680|NCT03194646|585003701|FG003|Overall Study|Protocol Violation|1|||
161987681|NCT03194646|585003698|FG000|Overall Study|Site terminated by sponsor|0|||
161987682|NCT03194646|585003699|FG001|Overall Study|Site terminated by sponsor|0|||
161987683|NCT03194646|585003700|FG002|Overall Study|Site terminated by sponsor|2|||
161987684|NCT03194646|585003701|FG003|Overall Study|Site terminated by sponsor|0|||
161987685|NCT03194646|585003698|FG000|Overall Study|Study terminated by sponsor|62|||
161987686|NCT03194646|585003699|FG001|Overall Study|Study terminated by sponsor|61|||
161987687|NCT03194646|585003700|FG002|Overall Study|Study terminated by sponsor|30|||
161987688|NCT03194646|585003701|FG003|Overall Study|Study terminated by sponsor|34|||
161987689|NCT03194646|585003698|FG000|Overall Study|Withdrawal by Subject|75|||
161987690|NCT03194646|585003699|FG001|Overall Study|Withdrawal by Subject|74|||
161987691|NCT03194646|585003700|FG002|Overall Study|Withdrawal by Subject|36|||
161987692|NCT03194646|585003701|FG003|Overall Study|Withdrawal by Subject|131|||
161987693|NCT03194646|585003698|FG000|Overall Study|Missing|1|||
161987694|NCT03194646|585003699|FG001|Overall Study|Missing|0|||
161987695|NCT03194646|585003700|FG002|Overall Study|Missing|1|||
161987696|NCT03194646|585003701|FG003|Overall Study|Missing|12|||
161987697|NCT04869358|585003702|FG000|Overall Study|Wish to have children.|1|||
161987698|NCT04869358|585003703|FG001|Overall Study|Wish to have children.|0|||
161987699|NCT04869358|585003704|FG002|Overall Study|Wish to have children.|0|||
161987700|NCT04869358|585003705|FG003|Overall Study|Wish to have children.|0|||
161987701|NCT05232864|585003706|FG000|Overall Study|Adverse Event|0|||
161987702|NCT05232864|585003707|FG001|Overall Study|Adverse Event|1|||
161987703|NCT05232864|585003706|FG000|Overall Study|Study terminated by sponsor|16|||
161987704|NCT05232864|585003707|FG001|Overall Study|Study terminated by sponsor|14|||
161987705|NCT04765202|585003711|FG000|Overall Study|Lost to Follow-up|1|||
161987706|NCT04765202|585003712|FG001|Overall Study|Lost to Follow-up|1|||
161987707|NCT04765202|585003713|FG002|Overall Study|Lost to Follow-up|2|||
161987708|NCT04765202|585003714|FG003|Overall Study|Lost to Follow-up|2|||
161987709|NCT04765202|585003711|FG000|Overall Study|Physician Decision|0|||
161987710|NCT04765202|585003712|FG001|Overall Study|Physician Decision|0|||
162035248|NCT01244490|585185888|FG000|Overall Study|Adverse Event|1|||
161987711|NCT04765202|585003713|FG002|Overall Study|Physician Decision|1|||
161987712|NCT04765202|585003714|FG003|Overall Study|Physician Decision|1|||
161987713|NCT04929249|585003715|FG000|Overall Study|Adverse Event|2|||
161987714|NCT04929249|585003716|FG001|Overall Study|Adverse Event|1|||
161987715|NCT04929249|585003715|FG000|Overall Study|Death|2|||
161987716|NCT04929249|585003716|FG001|Overall Study|Death|1|||
161987717|NCT04929249|585003715|FG000|Overall Study|Lost to Follow-up|3|||
161987718|NCT04929249|585003716|FG001|Overall Study|Lost to Follow-up|11|||
161987719|NCT04929249|585003715|FG000|Overall Study|Technical problems|0|||
161987720|NCT04929249|585003716|FG001|Overall Study|Technical problems|1|||
161987721|NCT04929249|585003715|FG000|Overall Study|Subject decision|6|||
161987722|NCT04929249|585003716|FG001|Overall Study|Subject decision|8|||
161987723|NCT04929249|585003715|FG000|Overall Study|Withdrew consent|0|||
161987724|NCT04929249|585003716|FG001|Overall Study|Withdrew consent|8|||
161987725|NCT03068754|585003717|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
161987726|NCT03068754|585003718|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
161987727|NCT03068754|585003719|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
161987728|NCT03068754|585003720|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
161987729|NCT03068754|585003717|FG000|Randomized Treatment Period (RTP)|Death|2|||
161987730|NCT03068754|585003718|FG001|Randomized Treatment Period (RTP)|Death|2|||
161987731|NCT03068754|585003719|FG002|Randomized Treatment Period (RTP)|Death|0|||
161987732|NCT03068754|585003720|FG003|Randomized Treatment Period (RTP)|Death|0|||
161987733|NCT03068754|585003717|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
161987734|NCT03068754|585003718|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
161987735|NCT03068754|585003719|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
161987736|NCT03068754|585003720|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
161987737|NCT03068754|585003717|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
161987738|NCT03068754|585003718|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
161987739|NCT03068754|585003719|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
161987740|NCT03068754|585003720|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
161987741|NCT03068754|585003717|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
161987742|NCT03068754|585003718|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
161987743|NCT03068754|585003719|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
161987744|NCT03068754|585003720|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
161987745|NCT03068754|585003717|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
161987746|NCT03068754|585003718|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
161987747|NCT03068754|585003719|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
161987748|NCT03068754|585003720|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
161987749|NCT03068754|585003717|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
161987750|NCT03068754|585003718|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
161987751|NCT03068754|585003719|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
161987752|NCT03068754|585003720|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
161987753|NCT03068754|585003717|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
161987754|NCT03068754|585003718|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
161987755|NCT03068754|585003719|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
161987756|NCT03068754|585003720|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
161987757|NCT03068754|585003717|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
161987758|NCT03068754|585003718|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
161987759|NCT03068754|585003719|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
161987760|NCT03068754|585003720|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
161987761|NCT03068754|585003717|FG000|Open Label Extension Period (OLE)|Death|0|||
161987762|NCT03068754|585003718|FG001|Open Label Extension Period (OLE)|Death|0|||
161987763|NCT03068754|585003719|FG002|Open Label Extension Period (OLE)|Death|0|||
161987764|NCT03068754|585003720|FG003|Open Label Extension Period (OLE)|Death|1|||
161987765|NCT03068754|585003717|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
161987766|NCT03068754|585003718|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
161987767|NCT03068754|585003719|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
161987768|NCT03068754|585003720|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
161987769|NCT03068754|585003717|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
161987770|NCT03068754|585003718|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
161987771|NCT03068754|585003719|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
161987772|NCT03068754|585003720|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
161987773|NCT03068754|585003717|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
161987774|NCT03068754|585003718|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
161987775|NCT03068754|585003719|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
161987776|NCT03068754|585003720|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
161987777|NCT03068754|585003717|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
161987778|NCT03068754|585003718|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
161987779|NCT03068754|585003719|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
161987780|NCT03068754|585003720|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
161987781|NCT00129467|585003721|FG000|Received Intervention|Death|1|||
161987782|NCT00129467|585003722|FG001|Received Intervention|Death|1|||
161987783|NCT00129467|585003721|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
161987784|NCT00129467|585003722|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
161987785|NCT00129467|585003721|FG000|Received Intervention|Delirium|2|||
161987786|NCT00129467|585003722|FG001|Received Intervention|Delirium|0|||
161987787|NCT00129467|585003721|FG000|Received Intervention|Withdrawal by Subject|1|||
161987788|NCT00129467|585003722|FG001|Received Intervention|Withdrawal by Subject|0|||
161987789|NCT00129467|585003721|FG000|Received Intervention|Nausea|1|||
161872281|NCT03850483|584577115|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
161872282|NCT03850483|584577116|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
161872283|NCT03850483|584577117|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
161872284|NCT03850483|584577118|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
161872285|NCT03850483|584577109|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
161872286|NCT03850483|584577110|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
161872287|NCT03850483|584577111|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
161872288|NCT03850483|584577112|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
161872289|NCT03850483|584577113|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
161872290|NCT03850483|584577114|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
161872291|NCT03850483|584577115|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
161872292|NCT03850483|584577116|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
161872293|NCT03850483|584577117|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
161872294|NCT03850483|584577118|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
161872295|NCT03850483|584577109|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872296|NCT03850483|584577110|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872297|NCT03850483|584577111|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872298|NCT03850483|584577112|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872299|NCT03850483|584577113|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872300|NCT03850483|584577114|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872301|NCT03850483|584577115|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
161872302|NCT03850483|584577116|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
161872303|NCT03850483|584577117|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872304|NCT03850483|584577118|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
161872305|NCT03850483|584577109|FG000|Follow-up for Stage 1|Physician Decision|0|||
161872306|NCT03850483|584577110|FG001|Follow-up for Stage 1|Physician Decision|0|||
161872307|NCT03850483|584577111|FG002|Follow-up for Stage 1|Physician Decision|0|||
161872308|NCT03850483|584577112|FG003|Follow-up for Stage 1|Physician Decision|0|||
161872309|NCT03850483|584577113|FG004|Follow-up for Stage 1|Physician Decision|1|||
161872310|NCT03850483|584577114|FG005|Follow-up for Stage 1|Physician Decision|0|||
161872311|NCT03850483|584577115|FG006|Follow-up for Stage 1|Physician Decision|1|||
161872312|NCT03850483|584577116|FG007|Follow-up for Stage 1|Physician Decision|0|||
161872313|NCT03850483|584577117|FG008|Follow-up for Stage 1|Physician Decision|0|||
161872314|NCT03850483|584577118|FG009|Follow-up for Stage 1|Physician Decision|0|||
161872315|NCT03850483|584577109|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
161872316|NCT03850483|584577110|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
161872317|NCT03850483|584577111|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
161872318|NCT03850483|584577112|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
161872319|NCT03850483|584577113|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
161872320|NCT03850483|584577114|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
161872321|NCT03850483|584577115|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
161872322|NCT03850483|584577116|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
161872323|NCT03850483|584577117|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
161872324|NCT03850483|584577118|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
161872325|NCT03850483|584577109|FG000|Follow-up for Stage 1|Adverse Event|0|||
161872326|NCT03850483|584577110|FG001|Follow-up for Stage 1|Adverse Event|0|||
161872327|NCT03850483|584577111|FG002|Follow-up for Stage 1|Adverse Event|1|||
161872328|NCT03850483|584577112|FG003|Follow-up for Stage 1|Adverse Event|0|||
161872329|NCT03850483|584577113|FG004|Follow-up for Stage 1|Adverse Event|0|||
161872330|NCT03850483|584577114|FG005|Follow-up for Stage 1|Adverse Event|1|||
161872331|NCT03850483|584577115|FG006|Follow-up for Stage 1|Adverse Event|0|||
161872332|NCT03850483|584577116|FG007|Follow-up for Stage 1|Adverse Event|0|||
161872333|NCT03850483|584577117|FG008|Follow-up for Stage 1|Adverse Event|0|||
161872334|NCT03850483|584577118|FG009|Follow-up for Stage 1|Adverse Event|0|||
161872335|NCT03850483|584577109|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872336|NCT03850483|584577110|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
161872337|NCT03850483|584577111|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872338|NCT03850483|584577112|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872339|NCT03850483|584577113|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
161872340|NCT03850483|584577114|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
161872341|NCT03850483|584577115|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872342|NCT03850483|584577116|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872343|NCT03850483|584577117|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872344|NCT03850483|584577118|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161872345|NCT03850483|584577109|FG000|Follow-up for Stage 1|Other|0|||
161872346|NCT03850483|584577110|FG001|Follow-up for Stage 1|Other|2|||
161987790|NCT00129467|585003722|FG001|Received Intervention|Nausea|0|||
161987791|NCT00129467|585003721|FG000|Received Intervention|Intolerance to citalopram|0|||
161987792|NCT00129467|585003722|FG001|Received Intervention|Intolerance to citalopram|1|||
161872347|NCT03850483|584577111|FG002|Follow-up for Stage 1|Other|0|||
161872348|NCT03850483|584577112|FG003|Follow-up for Stage 1|Other|2|||
161872349|NCT03850483|584577113|FG004|Follow-up for Stage 1|Other|0|||
161872350|NCT03850483|584577114|FG005|Follow-up for Stage 1|Other|1|||
161872351|NCT03850483|584577115|FG006|Follow-up for Stage 1|Other|0|||
161872352|NCT03850483|584577116|FG007|Follow-up for Stage 1|Other|0|||
161872353|NCT03850483|584577117|FG008|Follow-up for Stage 1|Other|0|||
161872354|NCT03850483|584577118|FG009|Follow-up for Stage 1|Other|0|||
161872355|NCT03850483|584577109|FG000|Treatment for Stage 2|Adverse Event|0|||
161872356|NCT03850483|584577110|FG001|Treatment for Stage 2|Adverse Event|0|||
161872357|NCT03850483|584577111|FG002|Treatment for Stage 2|Adverse Event|0|||
161872358|NCT03850483|584577112|FG003|Treatment for Stage 2|Adverse Event|0|||
161872359|NCT03850483|584577113|FG004|Treatment for Stage 2|Adverse Event|0|||
161872360|NCT03850483|584577114|FG005|Treatment for Stage 2|Adverse Event|0|||
161872361|NCT03850483|584577115|FG006|Treatment for Stage 2|Adverse Event|0|||
161872362|NCT03850483|584577116|FG007|Treatment for Stage 2|Adverse Event|0|||
161872363|NCT03850483|584577117|FG008|Treatment for Stage 2|Adverse Event|0|||
161872364|NCT03850483|584577118|FG009|Treatment for Stage 2|Adverse Event|1|||
161872365|NCT03850483|584577109|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
161872366|NCT03850483|584577110|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
161872367|NCT03850483|584577111|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
161872368|NCT03850483|584577112|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
161872369|NCT03850483|584577113|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
161872370|NCT03850483|584577114|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
161872371|NCT03850483|584577115|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
161872372|NCT03850483|584577116|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
161872373|NCT03850483|584577117|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
161872374|NCT03850483|584577118|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
161872375|NCT03850483|584577109|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
161872376|NCT03850483|584577110|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
161872377|NCT03850483|584577111|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
161872378|NCT03850483|584577112|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
161872379|NCT03850483|584577113|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
161872380|NCT03850483|584577114|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
161872381|NCT03850483|584577115|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
161872382|NCT03850483|584577116|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
161872383|NCT03850483|584577117|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
161872384|NCT03850483|584577118|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
161872385|NCT03850483|584577109|FG000|Treatment for Stage 2|Physician Decision|0|||
161872386|NCT03850483|584577110|FG001|Treatment for Stage 2|Physician Decision|0|||
161872387|NCT03850483|584577111|FG002|Treatment for Stage 2|Physician Decision|0|||
161872388|NCT03850483|584577112|FG003|Treatment for Stage 2|Physician Decision|0|||
161872389|NCT03850483|584577113|FG004|Treatment for Stage 2|Physician Decision|0|||
161872390|NCT03850483|584577114|FG005|Treatment for Stage 2|Physician Decision|0|||
161872391|NCT03850483|584577115|FG006|Treatment for Stage 2|Physician Decision|0|||
161872392|NCT03850483|584577116|FG007|Treatment for Stage 2|Physician Decision|0|||
161872393|NCT03850483|584577117|FG008|Treatment for Stage 2|Physician Decision|0|||
161872394|NCT03850483|584577118|FG009|Treatment for Stage 2|Physician Decision|1|||
161872395|NCT03850483|584577109|FG000|Treatment for Stage 2|Protocol Violation|0|||
161872396|NCT03850483|584577110|FG001|Treatment for Stage 2|Protocol Violation|0|||
161872397|NCT03850483|584577111|FG002|Treatment for Stage 2|Protocol Violation|0|||
161872398|NCT03850483|584577112|FG003|Treatment for Stage 2|Protocol Violation|0|||
161872399|NCT03850483|584577113|FG004|Treatment for Stage 2|Protocol Violation|0|||
161872400|NCT03850483|584577114|FG005|Treatment for Stage 2|Protocol Violation|0|||
161872401|NCT03850483|584577115|FG006|Treatment for Stage 2|Protocol Violation|0|||
161872402|NCT03850483|584577116|FG007|Treatment for Stage 2|Protocol Violation|0|||
161872403|NCT03850483|584577117|FG008|Treatment for Stage 2|Protocol Violation|1|||
161872404|NCT03850483|584577118|FG009|Treatment for Stage 2|Protocol Violation|0|||
161872405|NCT03850483|584577109|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
161872406|NCT03850483|584577110|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
161872407|NCT03850483|584577111|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
161987793|NCT00129467|585003721|FG000|Received Intervention|Dizzyness, fatigue|0|||
161987794|NCT00129467|585003722|FG001|Received Intervention|Dizzyness, fatigue|1|||
161987795|NCT00129467|585003721|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
161987796|NCT00129467|585003722|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
161987797|NCT00129467|585003721|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
161987798|NCT00129467|585003722|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
161872408|NCT03850483|584577112|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
161872409|NCT03850483|584577113|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
161872410|NCT03850483|584577114|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
161872411|NCT03850483|584577115|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
161987799|NCT01009086|585003723|FG000|Overall Study|Lack of Efficacy|16|||
161872412|NCT03850483|584577116|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
161872413|NCT03850483|584577117|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
161872414|NCT03850483|584577118|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
161872415|NCT03850483|584577109|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872416|NCT03850483|584577110|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161987800|NCT01009086|585003724|FG001|Overall Study|Lack of Efficacy|15|||
161987801|NCT01009086|585003725|FG002|Overall Study|Lack of Efficacy|9|||
161987802|NCT01009086|585003723|FG000|Overall Study|Lost to Follow-up|4|||
161987803|NCT01009086|585003724|FG001|Overall Study|Lost to Follow-up|5|||
161987804|NCT01009086|585003725|FG002|Overall Study|Lost to Follow-up|3|||
161987805|NCT01009086|585003723|FG000|Overall Study|Adverse Event|12|||
161987806|NCT01009086|585003724|FG001|Overall Study|Adverse Event|11|||
161987807|NCT01009086|585003725|FG002|Overall Study|Adverse Event|8|||
161987808|NCT01009086|585003723|FG000|Overall Study|Withdrawal by Subject|9|||
161987809|NCT01009086|585003724|FG001|Overall Study|Withdrawal by Subject|11|||
161987810|NCT01009086|585003725|FG002|Overall Study|Withdrawal by Subject|13|||
161987811|NCT01009086|585003723|FG000|Overall Study|Other|3|||
161987812|NCT01009086|585003724|FG001|Overall Study|Other|5|||
161987813|NCT01009086|585003725|FG002|Overall Study|Other|1|||
161987814|NCT02202538|585003738|FG000|Overall Study|Withdrawal by Subject|5|||
161987815|NCT02202538|585003738|FG000|Overall Study|Did not meet all inclusion criteria|2|||
161987816|NCT02202538|585003738|FG000|Overall Study|Investigator Decision|1|||
161987817|NCT01846741|585003739|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
161987818|NCT01853878|585003740|FG000|Overall Study|Recurrence|2|||
161987819|NCT01853878|585003741|FG001|Overall Study|Recurrence|0|||
161987820|NCT01853878|585003740|FG000|Overall Study|Adverse Event|2|||
161987821|NCT01853878|585003741|FG001|Overall Study|Adverse Event|0|||
161987822|NCT01853878|585003740|FG000|Overall Study|Withdrawal by Subject|3|||
161987823|NCT01853878|585003741|FG001|Overall Study|Withdrawal by Subject|1|||
161987824|NCT01853878|585003740|FG000|Overall Study|Migrated/moved from the study area|1|||
161987825|NCT01853878|585003741|FG001|Overall Study|Migrated/moved from the study area|0|||
161987826|NCT01853878|585003740|FG000|Overall Study|Other|55|||
161987827|NCT01853878|585003741|FG001|Overall Study|Other|43|||
161987828|NCT01361178|585003742|FG000|Overall Study|Death|13|||
161987829|NCT01361178|585003743|FG001|Overall Study|Death|0|||
161987830|NCT04294147|585003746|FG000|Overall Study|Protocol Violation|2|||
161987831|NCT04294147|585003747|FG001|Overall Study|Protocol Violation|0|||
161987832|NCT01371305|585003755|FG000|Overall Study|Adverse Event|0|||
161987833|NCT01371305|585003756|FG001|Overall Study|Adverse Event|0|||
161987834|NCT01371305|585003757|FG002|Overall Study|Adverse Event|0|||
161987835|NCT01371305|585003758|FG003|Overall Study|Adverse Event|2|||
161987836|NCT01371305|585003759|FG004|Overall Study|Adverse Event|1|||
161987837|NCT01371305|585003760|FG005|Overall Study|Adverse Event|0|||
161987838|NCT01371305|585003755|FG000|Overall Study|Study terminated by sponsor|0|||
161987839|NCT01371305|585003756|FG001|Overall Study|Study terminated by sponsor|0|||
161987840|NCT01371305|585003757|FG002|Overall Study|Study terminated by sponsor|0|||
161987841|NCT01371305|585003758|FG003|Overall Study|Study terminated by sponsor|0|||
161987842|NCT01371305|585003759|FG004|Overall Study|Study terminated by sponsor|3|||
161987843|NCT01371305|585003760|FG005|Overall Study|Study terminated by sponsor|1|||
161987844|NCT01371305|585003755|FG000|Overall Study|Subject request|0|||
161987845|NCT01371305|585003756|FG001|Overall Study|Subject request|0|||
161987846|NCT01371305|585003757|FG002|Overall Study|Subject request|0|||
161987847|NCT01371305|585003758|FG003|Overall Study|Subject request|0|||
161987848|NCT01371305|585003759|FG004|Overall Study|Subject request|0|||
161987849|NCT01371305|585003760|FG005|Overall Study|Subject request|1|||
161987850|NCT04038567|585003761|FG000|Overall Study|Lost to Follow-up|6|||
161987851|NCT04038567|585003762|FG001|Overall Study|Lost to Follow-up|4|||
161987852|NCT04038567|585003763|FG002|Overall Study|Lost to Follow-up|5|||
161987853|NCT04038567|585003764|FG003|Overall Study|Lost to Follow-up|4|||
161987854|NCT04038567|585003765|FG004|Overall Study|Lost to Follow-up|6|||
161987855|NCT04038567|585003766|FG005|Overall Study|Lost to Follow-up|4|||
161987856|NCT04038567|585003767|FG006|Overall Study|Lost to Follow-up|4|||
161987857|NCT04038567|585003768|FG007|Overall Study|Lost to Follow-up|1|||
161987858|NCT04038567|585003761|FG000|Overall Study|Withdrawal by Subject|2|||
161987859|NCT04038567|585003762|FG001|Overall Study|Withdrawal by Subject|1|||
161987860|NCT04038567|585003763|FG002|Overall Study|Withdrawal by Subject|1|||
161987861|NCT04038567|585003764|FG003|Overall Study|Withdrawal by Subject|1|||
161987862|NCT04038567|585003765|FG004|Overall Study|Withdrawal by Subject|4|||
161987863|NCT04038567|585003766|FG005|Overall Study|Withdrawal by Subject|1|||
161987864|NCT04038567|585003767|FG006|Overall Study|Withdrawal by Subject|1|||
161987865|NCT04038567|585003768|FG007|Overall Study|Withdrawal by Subject|1|||
161987866|NCT04038567|585003761|FG000|Overall Study|missed survey window|1|||
161987867|NCT04038567|585003762|FG001|Overall Study|missed survey window|2|||
161987868|NCT04038567|585003763|FG002|Overall Study|missed survey window|0|||
161987869|NCT04038567|585003764|FG003|Overall Study|missed survey window|0|||
161987870|NCT04038567|585003765|FG004|Overall Study|missed survey window|1|||
161987871|NCT04038567|585003766|FG005|Overall Study|missed survey window|1|||
161987872|NCT04038567|585003767|FG006|Overall Study|missed survey window|2|||
161987873|NCT04038567|585003768|FG007|Overall Study|missed survey window|2|||
161987874|NCT04038567|585003761|FG000|Overall Study|technical issues|0|||
161987875|NCT04038567|585003762|FG001|Overall Study|technical issues|0|||
161987876|NCT04038567|585003763|FG002|Overall Study|technical issues|0|||
161987877|NCT04038567|585003764|FG003|Overall Study|technical issues|0|||
161987878|NCT04038567|585003765|FG004|Overall Study|technical issues|0|||
161987879|NCT04038567|585003766|FG005|Overall Study|technical issues|0|||
161987880|NCT04038567|585003767|FG006|Overall Study|technical issues|1|||
161987881|NCT04038567|585003768|FG007|Overall Study|technical issues|0|||
161987882|NCT04038567|585003761|FG000|Overall Study|Medical issues (i.e., illness)|0|||
161987883|NCT04038567|585003762|FG001|Overall Study|Medical issues (i.e., illness)|1|||
161987884|NCT04038567|585003763|FG002|Overall Study|Medical issues (i.e., illness)|2|||
161987885|NCT04038567|585003764|FG003|Overall Study|Medical issues (i.e., illness)|1|||
161987886|NCT04038567|585003765|FG004|Overall Study|Medical issues (i.e., illness)|1|||
161987887|NCT04038567|585003766|FG005|Overall Study|Medical issues (i.e., illness)|1|||
161987888|NCT04038567|585003767|FG006|Overall Study|Medical issues (i.e., illness)|0|||
161987889|NCT04038567|585003768|FG007|Overall Study|Medical issues (i.e., illness)|0|||
161987890|NCT04038567|585003761|FG000|Overall Study|Death|0|||
161987891|NCT04038567|585003762|FG001|Overall Study|Death|0|||
161987892|NCT04038567|585003763|FG002|Overall Study|Death|0|||
161987893|NCT04038567|585003764|FG003|Overall Study|Death|1|||
161987894|NCT04038567|585003765|FG004|Overall Study|Death|1|||
161987895|NCT04038567|585003766|FG005|Overall Study|Death|0|||
161987896|NCT04038567|585003767|FG006|Overall Study|Death|0|||
161987897|NCT04038567|585003768|FG007|Overall Study|Death|1|||
161987898|NCT02726022|585003769|FG000|Overall Study|Adverse Event|14|||
161987899|NCT02726022|585003769|FG000|Overall Study|Treatment Failure|8|||
161987900|NCT02726022|585003769|FG000|Overall Study|Poor Compliance|13|||
161987901|NCT02726022|585003769|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
161987902|NCT02999633|585003770|FG000|Overall Study|Adverse Event|2|||
161987903|NCT02999633|585003770|FG000|Overall Study|Progressive disease|12|||
161987904|NCT01990859|585003776|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
161987905|NCT01990859|585003776|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
161987906|NCT00348309|585003777|FG000|Overall Study|Adverse Event|56|||
161987907|NCT00348309|585003778|FG001|Overall Study|Adverse Event|28|||
161987908|NCT00348309|585003779|FG002|Overall Study|Adverse Event|63|||
161987909|NCT00348309|585003777|FG000|Overall Study|Lost to Follow-up|6|||
161987910|NCT00348309|585003778|FG001|Overall Study|Lost to Follow-up|7|||
161987911|NCT00348309|585003779|FG002|Overall Study|Lost to Follow-up|4|||
161987912|NCT00348309|585003777|FG000|Overall Study|Protocol Violation|7|||
161987913|NCT00348309|585003778|FG001|Overall Study|Protocol Violation|12|||
161987914|NCT00348309|585003779|FG002|Overall Study|Protocol Violation|7|||
161987915|NCT00348309|585003777|FG000|Overall Study|Withdrawal by Subject|33|||
161987916|NCT00348309|585003778|FG001|Overall Study|Withdrawal by Subject|37|||
161987917|NCT00348309|585003779|FG002|Overall Study|Withdrawal by Subject|40|||
161987918|NCT00348309|585003777|FG000|Overall Study|Non-compliance|8|||
161987919|NCT00348309|585003778|FG001|Overall Study|Non-compliance|6|||
161987920|NCT00348309|585003779|FG002|Overall Study|Non-compliance|8|||
161987921|NCT00348309|585003777|FG000|Overall Study|Death of caregiver|1|||
161987922|NCT00348309|585003778|FG001|Overall Study|Death of caregiver|0|||
161987923|NCT00348309|585003779|FG002|Overall Study|Death of caregiver|1|||
161987924|NCT00348309|585003777|FG000|Overall Study|Lack of insight, dementia|1|||
161987925|NCT00348309|585003778|FG001|Overall Study|Lack of insight, dementia|0|||
161987926|NCT00348309|585003779|FG002|Overall Study|Lack of insight, dementia|0|||
161987927|NCT00348309|585003777|FG000|Overall Study|Wrong bottle allocated|1|||
161987928|NCT00348309|585003778|FG001|Overall Study|Wrong bottle allocated|0|||
161987929|NCT00348309|585003779|FG002|Overall Study|Wrong bottle allocated|0|||
162035249|NCT01244490|585185889|FG001|Overall Study|Adverse Event|9|||
162035250|NCT01244490|585185890|FG002|Overall Study|Adverse Event|5|||
162035251|NCT01244490|585185888|FG000|Overall Study|Lost to Follow-up|0|||
162035252|NCT01244490|585185889|FG001|Overall Study|Lost to Follow-up|6|||
161872417|NCT03850483|584577111|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872418|NCT03850483|584577112|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872419|NCT03850483|584577113|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872420|NCT03850483|584577114|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872421|NCT03850483|584577115|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161987930|NCT00348309|585003777|FG000|Overall Study|Caregiver sick|1|||
161987931|NCT00348309|585003778|FG001|Overall Study|Caregiver sick|0|||
161987932|NCT00348309|585003779|FG002|Overall Study|Caregiver sick|0|||
161987933|NCT00348309|585003777|FG000|Overall Study|Use of prohibited medication|5|||
161987934|NCT00348309|585003778|FG001|Overall Study|Use of prohibited medication|2|||
161987935|NCT00348309|585003779|FG002|Overall Study|Use of prohibited medication|2|||
161987936|NCT00348309|585003777|FG000|Overall Study|Caregiver withdrawal|3|||
161987937|NCT00348309|585003778|FG001|Overall Study|Caregiver withdrawal|0|||
161987938|NCT00348309|585003779|FG002|Overall Study|Caregiver withdrawal|7|||
161987939|NCT00348309|585003777|FG000|Overall Study|Unable to complete ET visit|1|||
161987940|NCT00348309|585003778|FG001|Overall Study|Unable to complete ET visit|0|||
161987941|NCT00348309|585003779|FG002|Overall Study|Unable to complete ET visit|0|||
161987942|NCT00348309|585003777|FG000|Overall Study|PI closing medical practice|1|||
161987943|NCT00348309|585003778|FG001|Overall Study|PI closing medical practice|0|||
161987944|NCT00348309|585003779|FG002|Overall Study|PI closing medical practice|0|||
161987945|NCT00348309|585003777|FG000|Overall Study|Principal investigator's decision|1|||
161872422|NCT03850483|584577116|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872423|NCT03850483|584577117|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161872424|NCT03850483|584577118|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
161872425|NCT03850483|584577109|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
161872426|NCT03850483|584577110|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
161872427|NCT03850483|584577111|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
161872428|NCT03850483|584577112|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
161872429|NCT03850483|584577113|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
161872430|NCT03850483|584577114|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
161872431|NCT03850483|584577115|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
161872432|NCT03850483|584577116|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
161872433|NCT03850483|584577117|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
161872434|NCT03850483|584577118|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
161872435|NCT03850483|584577109|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
161872436|NCT03850483|584577110|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
161872437|NCT03850483|584577111|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
161872438|NCT03850483|584577112|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
161872439|NCT03850483|584577113|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
161872440|NCT03850483|584577114|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
161872441|NCT03850483|584577115|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
161872442|NCT03850483|584577116|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
161872443|NCT03850483|584577117|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
161872444|NCT03850483|584577118|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
161872445|NCT03850483|584577109|FG000|Follow-up For Stage 2|Other|0|||
161872446|NCT03850483|584577110|FG001|Follow-up For Stage 2|Other|0|||
161872447|NCT03850483|584577111|FG002|Follow-up For Stage 2|Other|0|||
161872448|NCT03850483|584577112|FG003|Follow-up For Stage 2|Other|0|||
161872449|NCT03850483|584577113|FG004|Follow-up For Stage 2|Other|0|||
161872450|NCT03850483|584577114|FG005|Follow-up For Stage 2|Other|0|||
161872451|NCT03850483|584577115|FG006|Follow-up For Stage 2|Other|0|||
161872452|NCT03850483|584577116|FG007|Follow-up For Stage 2|Other|0|||
161872453|NCT03850483|584577117|FG008|Follow-up For Stage 2|Other|0|||
161872454|NCT03850483|584577118|FG009|Follow-up For Stage 2|Other|1|||
161872455|NCT03232931|584578537|FG000|Overall Study|Physician Decision|1|||
161872456|NCT03232931|584578538|FG001|Overall Study|Physician Decision|1|||
161872457|NCT03232931|584578537|FG000|Overall Study|Withdrawal by Subject|6|||
161872458|NCT03232931|584578538|FG001|Overall Study|Withdrawal by Subject|0|||
161872459|NCT03232931|584578537|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
161872460|NCT03232931|584578538|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
161872461|NCT03232931|584578537|FG000|Overall Study|Parent did not record voice|1|||
161872462|NCT03232931|584578538|FG001|Overall Study|Parent did not record voice|2|||
161872463|NCT03232931|584578537|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
161872464|NCT03232931|584578538|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
161872465|NCT04925557|584578539|FG000|Overall Study|Study closed|5|||
161872466|NCT04925557|584578540|FG001|Overall Study|Study closed|3|||
161872467|NCT01270464|584578544|FG000|Overall Study|Protocol Violation|4|||
161872468|NCT01270464|584578545|FG001|Overall Study|Protocol Violation|3|||
161872469|NCT01270464|584578546|FG002|Overall Study|Protocol Violation|2|||
161872470|NCT01270464|584578544|FG000|Overall Study|Lack of Efficacy|2|||
161872471|NCT01270464|584578545|FG001|Overall Study|Lack of Efficacy|3|||
161872472|NCT01270464|584578546|FG002|Overall Study|Lack of Efficacy|1|||
161872473|NCT01270464|584578544|FG000|Overall Study|Adverse Event|9|||
161872474|NCT01270464|584578545|FG001|Overall Study|Adverse Event|1|||
161872475|NCT01270464|584578546|FG002|Overall Study|Adverse Event|7|||
161987946|NCT00348309|585003778|FG001|Overall Study|Principal investigator's decision|0|||
161987947|NCT00348309|585003779|FG002|Overall Study|Principal investigator's decision|0|||
161987948|NCT00348309|585003777|FG000|Overall Study|No disponibility of medication|1|||
161987949|NCT00348309|585003778|FG001|Overall Study|No disponibility of medication|0|||
161987950|NCT00348309|585003779|FG002|Overall Study|No disponibility of medication|0|||
161987951|NCT00348309|585003777|FG000|Overall Study|Worsened neurodegenerative disease|1|||
161872476|NCT01270464|584578544|FG000|Overall Study|Withdrawal by Subject|2|||
161872477|NCT01270464|584578545|FG001|Overall Study|Withdrawal by Subject|1|||
161872478|NCT01270464|584578546|FG002|Overall Study|Withdrawal by Subject|4|||
161872479|NCT01270464|584578544|FG000|Overall Study|Lost to Follow-up|2|||
161872480|NCT01270464|584578545|FG001|Overall Study|Lost to Follow-up|3|||
161872481|NCT01270464|584578546|FG002|Overall Study|Lost to Follow-up|1|||
161872482|NCT01270464|584578544|FG000|Overall Study|Other|1|||
161872483|NCT01270464|584578545|FG001|Overall Study|Other|1|||
161872484|NCT01270464|584578546|FG002|Overall Study|Other|3|||
161872485|NCT00076752|584578547|FG000|Overall Study|Death|2|||
161987952|NCT00348309|585003778|FG001|Overall Study|Worsened neurodegenerative disease|0|||
161987953|NCT00348309|585003779|FG002|Overall Study|Worsened neurodegenerative disease|0|||
161987954|NCT00348309|585003777|FG000|Overall Study|Cognitive and behaviour worsening|2|||
161987955|NCT00348309|585003778|FG001|Overall Study|Cognitive and behaviour worsening|0|||
161872486|NCT00076752|584578547|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
161872487|NCT00892151|584578548|FG000|Overall Study|Protocol Violation|1|||
161872488|NCT01222520|584578553|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
161872489|NCT01222520|584578554|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
161872490|NCT01222520|584578553|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
161872491|NCT01222520|584578554|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
161872492|NCT01222520|584578553|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
161872493|NCT01222520|584578554|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
161872494|NCT01222520|584578553|FG000|Double-blind Period|Adverse Event|0|||
161872495|NCT01222520|584578554|FG001|Double-blind Period|Adverse Event|1|||
161872496|NCT01222520|584578553|FG000|Double-blind Period|Lack of Efficacy|0|||
161872497|NCT01222520|584578554|FG001|Double-blind Period|Lack of Efficacy|1|||
161872498|NCT01222520|584578553|FG000|Double-blind Period|Study medication stolen|1|||
161872499|NCT01222520|584578554|FG001|Double-blind Period|Study medication stolen|0|||
161872500|NCT01322490|584578557|FG000|Treatment Period|Adverse Event|12|||
161872501|NCT01322490|584578558|FG001|Treatment Period|Adverse Event|18|||
161872502|NCT01322490|584578559|FG002|Treatment Period|Adverse Event|15|||
161872503|NCT01322490|584578557|FG000|Treatment Period|Death|5|||
161872504|NCT01322490|584578558|FG001|Treatment Period|Death|7|||
161872505|NCT01322490|584578559|FG002|Treatment Period|Death|3|||
161872506|NCT01322490|584578557|FG000|Treatment Period|Lack of Efficacy|89|||
161872507|NCT01322490|584578558|FG001|Treatment Period|Lack of Efficacy|100|||
161872508|NCT01322490|584578559|FG002|Treatment Period|Lack of Efficacy|112|||
161872509|NCT01322490|584578557|FG000|Treatment Period|Physician Decision|0|||
161872510|NCT01322490|584578558|FG001|Treatment Period|Physician Decision|2|||
161872511|NCT01322490|584578559|FG002|Treatment Period|Physician Decision|1|||
161872512|NCT01322490|584578557|FG000|Treatment Period|Protocol Violation|7|||
161872513|NCT01322490|584578558|FG001|Treatment Period|Protocol Violation|5|||
161872514|NCT01322490|584578559|FG002|Treatment Period|Protocol Violation|4|||
161872515|NCT01322490|584578557|FG000|Treatment Period|Withdrawal by Subject|14|||
161872516|NCT01322490|584578558|FG001|Treatment Period|Withdrawal by Subject|16|||
161872517|NCT01322490|584578559|FG002|Treatment Period|Withdrawal by Subject|11|||
161872518|NCT01322490|584578557|FG000|Treatment Period|Non-compliance with study drug|0|||
161872519|NCT01322490|584578558|FG001|Treatment Period|Non-compliance with study drug|0|||
161872520|NCT01322490|584578559|FG002|Treatment Period|Non-compliance with study drug|1|||
161872521|NCT01322490|584578557|FG000|Treatment Period|Other per report|2|||
161872522|NCT01322490|584578558|FG001|Treatment Period|Other per report|2|||
161872523|NCT01322490|584578559|FG002|Treatment Period|Other per report|1|||
161872524|NCT01322490|584578557|FG000|Treatment Period|Randomized but Not Treated|3|||
161872525|NCT01322490|584578558|FG001|Treatment Period|Randomized but Not Treated|3|||
161872526|NCT01322490|584578559|FG002|Treatment Period|Randomized but Not Treated|5|||
161872527|NCT01322490|584578557|FG000|Long Term Follow-up Period|Death|235|||
161872528|NCT01322490|584578558|FG001|Long Term Follow-up Period|Death|239|||
161872529|NCT01322490|584578559|FG002|Long Term Follow-up Period|Death|236|||
161872530|NCT01322490|584578557|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
161872531|NCT01322490|584578558|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
161872532|NCT01322490|584578559|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
161872533|NCT01322490|584578557|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
161872534|NCT01322490|584578558|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
161872535|NCT01322490|584578559|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
161872536|NCT01322490|584578557|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
161872537|NCT01322490|584578558|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
161872538|NCT01322490|584578559|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
161872539|NCT01322490|584578557|FG000|Long Term Follow-up Period|Other per report|3|||
161872540|NCT01322490|584578558|FG001|Long Term Follow-up Period|Other per report|2|||
161872541|NCT01322490|584578559|FG002|Long Term Follow-up Period|Other per report|2|||
161872542|NCT01322490|584578557|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
161872543|NCT01322490|584578558|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
161872544|NCT01322490|584578559|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
161987956|NCT00348309|585003779|FG002|Overall Study|Cognitive and behaviour worsening|0|||
161987957|NCT00348309|585003777|FG000|Overall Study|Worsening of alzheimer|1|||
161872545|NCT02257489|584578562|FG000|Overall Study|Withdrawal by Subject|0|||
161872546|NCT02257489|584578563|FG001|Overall Study|Withdrawal by Subject|0|||
161872547|NCT02257489|584578564|FG002|Overall Study|Withdrawal by Subject|0|||
161872548|NCT02257489|584578565|FG003|Overall Study|Withdrawal by Subject|1|||
161872549|NCT02257489|584578566|FG004|Overall Study|Withdrawal by Subject|0|||
161872550|NCT02257489|584578567|FG005|Overall Study|Withdrawal by Subject|0|||
161872551|NCT02257489|584578568|FG006|Overall Study|Withdrawal by Subject|0|||
161987958|NCT00348309|585003778|FG001|Overall Study|Worsening of alzheimer|0|||
161872552|NCT02257489|584578569|FG007|Overall Study|Withdrawal by Subject|0|||
161872553|NCT02257489|584578570|FG008|Overall Study|Withdrawal by Subject|0|||
161872554|NCT04606394|584578571|FG000|Overall Study|Withdrawal by Subject|3|||
161872555|NCT04606394|584578571|FG000|Overall Study|Exclusion criteria screen failure|12|||
161872556|NCT01896128|584578572|FG000|Overall Study|Withdrawal by Subject|3|||
161872557|NCT01896128|584578573|FG001|Overall Study|Withdrawal by Subject|3|||
161872558|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
161775665|NCT01317199|584221229|FG000|Dose-escalation Phase 1|Disease progression|1|||
161775666|NCT01317199|584221230|FG001|Dose-escalation Phase 1|Disease progression|0|||
161775667|NCT01317199|584221231|FG002|Dose-escalation Phase 1|Disease progression|0|||
161775668|NCT01317199|584221232|FG003|Dose-escalation Phase 1|Disease progression|0|||
161775669|NCT01317199|584221229|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
161775670|NCT01317199|584221230|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
161775671|NCT01317199|584221231|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
161775672|NCT01317199|584221232|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
161775673|NCT01317199|584221229|FG000|Randomized Phase 2|Disease progression|0|||
161775674|NCT01317199|584221230|FG001|Randomized Phase 2|Disease progression|3|||
161775675|NCT01317199|584221231|FG002|Randomized Phase 2|Disease progression|7|||
161775676|NCT01317199|584221232|FG003|Randomized Phase 2|Disease progression|5|||
161775677|NCT01317199|584221229|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
161775678|NCT01317199|584221230|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
161775679|NCT01317199|584221231|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
161775680|NCT01317199|584221232|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
161775681|NCT01317199|584221229|FG000|Randomized Phase 2|Adverse Event|0|||
161775682|NCT01317199|584221230|FG001|Randomized Phase 2|Adverse Event|0|||
161775683|NCT01317199|584221231|FG002|Randomized Phase 2|Adverse Event|0|||
161775684|NCT01317199|584221232|FG003|Randomized Phase 2|Adverse Event|1|||
161775685|NCT01317199|584221229|FG000|Randomized Phase 2|Comorbidities|0|||
161775686|NCT01317199|584221230|FG001|Randomized Phase 2|Comorbidities|2|||
161775687|NCT01317199|584221231|FG002|Randomized Phase 2|Comorbidities|2|||
161775688|NCT01317199|584221232|FG003|Randomized Phase 2|Comorbidities|2|||
161775689|NCT01317199|584221229|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
161775690|NCT01317199|584221230|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
161775691|NCT01317199|584221231|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
161775692|NCT01317199|584221232|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
161775693|NCT01317199|584221229|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
161775694|NCT01317199|584221230|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
161775695|NCT01317199|584221231|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
161775696|NCT01317199|584221232|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
161775697|NCT01317199|584221229|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
161775698|NCT01317199|584221230|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
161775699|NCT01317199|584221231|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
161775700|NCT01317199|584221232|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
161775701|NCT01317199|584221229|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
161775702|NCT01317199|584221230|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
161775703|NCT01317199|584221231|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
161775704|NCT01317199|584221232|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
161775705|NCT01353209|584221233|FG000|Overall Study|Adverse Event|1|||
161775706|NCT01353209|584221234|FG001|Overall Study|Adverse Event|1|||
161775707|NCT01283009|584221235|FG000|Overall Study|Death|83|||
161775708|NCT01283009|584221236|FG001|Overall Study|Death|78|||
161775709|NCT01283009|584221235|FG000|Overall Study|Study ended early|23|||
161775710|NCT01283009|584221236|FG001|Overall Study|Study ended early|26|||
161775711|NCT01283009|584221235|FG000|Overall Study|Withdrawal by Subject|10|||
161775712|NCT01283009|584221236|FG001|Overall Study|Withdrawal by Subject|8|||
161775713|NCT01283009|584221235|FG000|Overall Study|Physician Decision|1|||
161775714|NCT01283009|584221236|FG001|Overall Study|Physician Decision|1|||
161775715|NCT01283009|584221235|FG000|Overall Study|Lost to Follow-up|1|||
161775716|NCT01283009|584221236|FG001|Overall Study|Lost to Follow-up|0|||
161775717|NCT01283009|584221235|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
161775718|NCT01283009|584221236|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
161775719|NCT03237325|584221240|FG000|Overall Study|Lost to Follow-up|3|||
161775720|NCT03237325|584221241|FG001|Overall Study|Lost to Follow-up|5|||
161775721|NCT03237325|584221240|FG000|Overall Study|Physician Decision|2|||
161775722|NCT03237325|584221241|FG001|Overall Study|Physician Decision|4|||
161775723|NCT03237325|584221240|FG000|Overall Study|Withdrawal by Subject|9|||
161775724|NCT03237325|584221241|FG001|Overall Study|Withdrawal by Subject|12|||
161775725|NCT03237325|584221240|FG000|Overall Study|Noncompliance with Study Procedures|1|||
161775726|NCT03237325|584221241|FG001|Overall Study|Noncompliance with Study Procedures|1|||
161775727|NCT03237325|584221240|FG000|Overall Study|Termination by Sponsor|0|||
161775728|NCT03237325|584221241|FG001|Overall Study|Termination by Sponsor|1|||
161775729|NCT03237325|584221240|FG000|Overall Study|Reason other than described|0|||
161775730|NCT03237325|584221241|FG001|Overall Study|Reason other than described|2|||
161775731|NCT02684370|584221242|FG000|Part A|Adverse Event|2|||
161775732|NCT02684370|584221243|FG001|Part A|Adverse Event|0|||
161775733|NCT02684370|584221244|FG002|Part A|Adverse Event|1|||
161775734|NCT02684370|584221245|FG003|Part A|Adverse Event|0|||
161775735|NCT02684370|584221246|FG004|Part A|Adverse Event|0|||
161775736|NCT02684370|584221247|FG005|Part A|Adverse Event|0|||
161775737|NCT02684370|584221242|FG000|Part A|Lost to Follow-up|1|||
161987959|NCT00348309|585003779|FG002|Overall Study|Worsening of alzheimer|1|||
161987960|NCT00348309|585003777|FG000|Overall Study|Did not appear in time for Visit 3|1|||
161987961|NCT00348309|585003778|FG001|Overall Study|Did not appear in time for Visit 3|0|||
161987962|NCT00348309|585003779|FG002|Overall Study|Did not appear in time for Visit 3|0|||
161987963|NCT00348309|585003777|FG000|Overall Study|Participant died|2|||
161987964|NCT00348309|585003778|FG001|Overall Study|Participant died|1|||
161987965|NCT00348309|585003779|FG002|Overall Study|Participant died|1|||
161987966|NCT00348309|585003777|FG000|Overall Study|Decision of sponsor|1|||
161987967|NCT00348309|585003778|FG001|Overall Study|Decision of sponsor|0|||
161987968|NCT00348309|585003779|FG002|Overall Study|Decision of sponsor|0|||
161987969|NCT00348309|585003777|FG000|Overall Study|Ineffectiveness of treatment|0|||
161987970|NCT00348309|585003778|FG001|Overall Study|Ineffectiveness of treatment|1|||
161987971|NCT00348309|585003779|FG002|Overall Study|Ineffectiveness of treatment|0|||
161987972|NCT00348309|585003777|FG000|Overall Study|A foul of exclusion criteria|0|||
161987973|NCT00348309|585003778|FG001|Overall Study|A foul of exclusion criteria|1|||
161987974|NCT00348309|585003779|FG002|Overall Study|A foul of exclusion criteria|0|||
161987975|NCT00348309|585003777|FG000|Overall Study|Participant was hospitalized|0|||
161987976|NCT00348309|585003778|FG001|Overall Study|Participant was hospitalized|1|||
161987977|NCT00348309|585003779|FG002|Overall Study|Participant was hospitalized|0|||
161987978|NCT00348309|585003777|FG000|Overall Study|Sponsor refuseal|0|||
161987979|NCT00348309|585003778|FG001|Overall Study|Sponsor refuseal|1|||
161987980|NCT00348309|585003779|FG002|Overall Study|Sponsor refuseal|1|||
161987981|NCT00348309|585003777|FG000|Overall Study|Forgot often medication|0|||
161987982|NCT00348309|585003778|FG001|Overall Study|Forgot often medication|1|||
161987983|NCT00348309|585003779|FG002|Overall Study|Forgot often medication|0|||
161987984|NCT00348309|585003777|FG000|Overall Study|Medical Monitor decision|0|||
161987985|NCT00348309|585003778|FG001|Overall Study|Medical Monitor decision|0|||
161987986|NCT00348309|585003779|FG002|Overall Study|Medical Monitor decision|1|||
161987987|NCT00348309|585003777|FG000|Overall Study|Increased dose of Aricept|0|||
161987988|NCT00348309|585003778|FG001|Overall Study|Increased dose of Aricept|0|||
161987989|NCT00348309|585003779|FG002|Overall Study|Increased dose of Aricept|1|||
161987990|NCT00348309|585003777|FG000|Overall Study|Site closure|0|||
161987991|NCT00348309|585003778|FG001|Overall Study|Site closure|0|||
161987992|NCT00348309|585003779|FG002|Overall Study|Site closure|1|||
161987993|NCT00348309|585003777|FG000|Overall Study|Adverse event not attended|0|||
161987994|NCT00348309|585003778|FG001|Overall Study|Adverse event not attended|0|||
161775738|NCT02684370|584221243|FG001|Part A|Lost to Follow-up|1|||
161775739|NCT02684370|584221244|FG002|Part A|Lost to Follow-up|0|||
161775740|NCT02684370|584221245|FG003|Part A|Lost to Follow-up|0|||
161775741|NCT02684370|584221246|FG004|Part A|Lost to Follow-up|0|||
161775742|NCT02684370|584221247|FG005|Part A|Lost to Follow-up|0|||
161775743|NCT02684370|584221242|FG000|Part A|Subject Withdrawal|1|||
161775744|NCT02684370|584221243|FG001|Part A|Subject Withdrawal|0|||
161775745|NCT02684370|584221244|FG002|Part A|Subject Withdrawal|3|||
161775746|NCT02684370|584221245|FG003|Part A|Subject Withdrawal|0|||
161775747|NCT02684370|584221246|FG004|Part A|Subject Withdrawal|0|||
161775748|NCT02684370|584221247|FG005|Part A|Subject Withdrawal|0|||
161775749|NCT02684370|584221242|FG000|Part A|Other|0|||
161775750|NCT02684370|584221243|FG001|Part A|Other|0|||
161775751|NCT02684370|584221244|FG002|Part A|Other|1|||
161775752|NCT02684370|584221245|FG003|Part A|Other|0|||
161775753|NCT02684370|584221246|FG004|Part A|Other|0|||
161775754|NCT02684370|584221247|FG005|Part A|Other|0|||
161775755|NCT02684370|584221242|FG000|Part B|Adverse Event|0|||
161775756|NCT02684370|584221243|FG001|Part B|Adverse Event|0|||
161775757|NCT02684370|584221244|FG002|Part B|Adverse Event|0|||
161775758|NCT02684370|584221245|FG003|Part B|Adverse Event|0|||
161775759|NCT02684370|584221246|FG004|Part B|Adverse Event|2|||
161775760|NCT02684370|584221247|FG005|Part B|Adverse Event|1|||
161775761|NCT02684370|584221242|FG000|Part B|Lost to Follow-up|0|||
161775762|NCT02684370|584221243|FG001|Part B|Lost to Follow-up|0|||
161775763|NCT02684370|584221244|FG002|Part B|Lost to Follow-up|0|||
161775764|NCT02684370|584221245|FG003|Part B|Lost to Follow-up|1|||
161775765|NCT02684370|584221246|FG004|Part B|Lost to Follow-up|2|||
161775766|NCT02684370|584221247|FG005|Part B|Lost to Follow-up|5|||
161775767|NCT02684370|584221242|FG000|Part B|Subject Withdrawal|0|||
161775768|NCT02684370|584221243|FG001|Part B|Subject Withdrawal|0|||
161775769|NCT02684370|584221244|FG002|Part B|Subject Withdrawal|0|||
161775770|NCT02684370|584221245|FG003|Part B|Subject Withdrawal|1|||
161775771|NCT02684370|584221246|FG004|Part B|Subject Withdrawal|1|||
161775772|NCT02684370|584221247|FG005|Part B|Subject Withdrawal|2|||
161775773|NCT00627094|584221249|FG000|Overall Study|Adverse Event|8|||
161775774|NCT00627094|584221250|FG001|Overall Study|Adverse Event|7|||
161775775|NCT00627094|584221249|FG000|Overall Study|Lost to Follow-up|1|||
161775776|NCT00627094|584221250|FG001|Overall Study|Lost to Follow-up|0|||
161775777|NCT00627094|584221249|FG000|Overall Study|Withdrawal by Subject|1|||
161775778|NCT00627094|584221250|FG001|Overall Study|Withdrawal by Subject|1|||
161775779|NCT00627094|584221249|FG000|Overall Study|ulcer healed|1|||
161775780|NCT00627094|584221250|FG001|Overall Study|ulcer healed|7|||
161775781|NCT00627094|584221249|FG000|Overall Study|Other reason|1|||
161775782|NCT00627094|584221250|FG001|Overall Study|Other reason|0|||
161987995|NCT00348309|585003779|FG002|Overall Study|Adverse event not attended|1|||
161987996|NCT00348309|585003777|FG000|Overall Study|ECG abnormal|0|||
161987997|NCT00348309|585003778|FG001|Overall Study|ECG abnormal|0|||
161987998|NCT00348309|585003779|FG002|Overall Study|ECG abnormal|2|||
161987999|NCT00348309|585003777|FG000|Overall Study|Cardiologist recommendations|0|||
161988000|NCT00348309|585003778|FG001|Overall Study|Cardiologist recommendations|0|||
161988001|NCT00348309|585003779|FG002|Overall Study|Cardiologist recommendations|1|||
161988002|NCT00348309|585003777|FG000|Overall Study|HCV career|0|||
161988003|NCT00348309|585003778|FG001|Overall Study|HCV career|0|||
161988004|NCT00348309|585003779|FG002|Overall Study|HCV career|1|||
161988005|NCT00622388|585003780|FG000|Overall Study|Disease Progression|47|||
161988006|NCT00622388|585003780|FG000|Overall Study|Adverse Event|6|||
161988007|NCT00622388|585003780|FG000|Overall Study|Protocol Violation|3|||
161988008|NCT00622388|585003780|FG000|Overall Study|Participant Refusal|1|||
161988009|NCT00622388|585003780|FG000|Overall Study|Death|3|||
161988010|NCT00622388|585003780|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
161988011|NCT00622388|585003780|FG000|Overall Study|Took Prohibited Medication|2|||
161988012|NCT00622388|585003780|FG000|Overall Study|Withdrew Consent|1|||
161988013|NCT00622388|585003780|FG000|Overall Study|Insurance Expired|1|||
161988014|NCT01534195|585003781|FG000|Overall Study|Withdrawal by Subject|1|||
161988015|NCT01534195|585003782|FG001|Overall Study|Withdrawal by Subject|1|||
161988016|NCT02554981|585003783|FG000|Overall Study|Adverse Event|1|||
161988017|NCT02554981|585003783|FG000|Overall Study|Administrative Reasons|1|||
161988018|NCT02554981|585003783|FG000|Overall Study|Other Miscellaneous Reasons|3|||
161988019|NCT01630889|585003784|FG000|Overall Study|Death|2|||
161988020|NCT01630889|585003784|FG000|Overall Study|Withdrawal by Subject|1|||
161988021|NCT01630889|585003784|FG000|Overall Study|Other than Specified|2|||
161988022|NCT01630889|585003784|FG000|Overall Study|Lost to Follow-up|4|||
161988023|NCT01630889|585003784|FG000|Overall Study|Other|1|||
161988024|NCT01068158|585003785|FG000|Overall Study|Withdrawal by Subject|1|||
161988025|NCT01068158|585003786|FG001|Overall Study|Withdrawal by Subject|2|||
161988026|NCT01068158|585003785|FG000|Overall Study|Lost to Follow-up|7|||
161988027|NCT01068158|585003786|FG001|Overall Study|Lost to Follow-up|0|||
161988028|NCT01068158|585003785|FG000|Overall Study|Protocol Violation|0|||
161988029|NCT01068158|585003786|FG001|Overall Study|Protocol Violation|2|||
161988030|NCT03499314|585006407|FG000|Overall Study|Time Commitment|1|||
161988031|NCT03499314|585006408|FG001|Overall Study|Time Commitment|2|||
161988032|NCT03499314|585006407|FG000|Overall Study|Medical issue unrelated to research study|1|||
161988033|NCT03499314|585006408|FG001|Overall Study|Medical issue unrelated to research study|1|||
161988034|NCT01618695|585006409|FG000|Core Phase|Adverse Event|4|||
161988035|NCT01618695|585006410|FG001|Core Phase|Adverse Event|5|||
161988036|NCT01618695|585006411|FG002|Core Phase|Adverse Event|15|||
161988037|NCT01618695|585006412|FG003|Core Phase|Adverse Event|20|||
161988038|NCT01618695|585006409|FG000|Core Phase|Lost to Follow-up|0|||
161988039|NCT01618695|585006410|FG001|Core Phase|Lost to Follow-up|0|||
161988040|NCT01618695|585006411|FG002|Core Phase|Lost to Follow-up|1|||
161988041|NCT01618695|585006412|FG003|Core Phase|Lost to Follow-up|0|||
161988042|NCT01618695|585006409|FG000|Core Phase|Withdrawal by Subject|16|||
161988043|NCT01618695|585006410|FG001|Core Phase|Withdrawal by Subject|11|||
161988044|NCT01618695|585006411|FG002|Core Phase|Withdrawal by Subject|9|||
161988045|NCT01618695|585006412|FG003|Core Phase|Withdrawal by Subject|13|||
161988046|NCT01618695|585006409|FG000|Core Phase|Pregnancy|2|||
161988047|NCT01618695|585006410|FG001|Core Phase|Pregnancy|0|||
161988048|NCT01618695|585006411|FG002|Core Phase|Pregnancy|0|||
161988049|NCT01618695|585006412|FG003|Core Phase|Pregnancy|0|||
161988050|NCT01618695|585006409|FG000|Core Phase|Lack of Efficacy|1|||
161988051|NCT01618695|585006410|FG001|Core Phase|Lack of Efficacy|2|||
161988052|NCT01618695|585006411|FG002|Core Phase|Lack of Efficacy|1|||
161988053|NCT01618695|585006412|FG003|Core Phase|Lack of Efficacy|1|||
161988054|NCT01618695|585006409|FG000|Core Phase|Other than specified|1|||
161988055|NCT01618695|585006410|FG001|Core Phase|Other than specified|2|||
161988056|NCT01618695|585006411|FG002|Core Phase|Other than specified|2|||
161988057|NCT01618695|585006412|FG003|Core Phase|Other than specified|2|||
161988058|NCT01618695|585006409|FG000|Core Phase|Not treated|1|||
161988059|NCT01618695|585006410|FG001|Core Phase|Not treated|0|||
161988060|NCT01618695|585006411|FG002|Core Phase|Not treated|2|||
161872559|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
161872560|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
161988061|NCT01618695|585006412|FG003|Core Phase|Not treated|0|||
161988062|NCT01618695|585006409|FG000|Extension Phase|Lack of Efficacy|17|||
161988063|NCT01618695|585006410|FG001|Extension Phase|Lack of Efficacy|33|||
161988064|NCT01618695|585006411|FG002|Extension Phase|Lack of Efficacy|26|||
161988065|NCT01618695|585006412|FG003|Extension Phase|Lack of Efficacy|24|||
161872561|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
161988066|NCT01618695|585006409|FG000|Extension Phase|Pregnancy|2|||
161988067|NCT01618695|585006410|FG001|Extension Phase|Pregnancy|0|||
161988068|NCT01618695|585006411|FG002|Extension Phase|Pregnancy|1|||
161988069|NCT01618695|585006412|FG003|Extension Phase|Pregnancy|1|||
161988070|NCT01618695|585006409|FG000|Extension Phase|Withdrawal by Subject|43|||
161988071|NCT01618695|585006410|FG001|Extension Phase|Withdrawal by Subject|48|||
162035253|NCT01244490|585185890|FG002|Overall Study|Lost to Follow-up|3|||
161988072|NCT01618695|585006411|FG002|Extension Phase|Withdrawal by Subject|42|||
161988073|NCT01618695|585006412|FG003|Extension Phase|Withdrawal by Subject|33|||
161988074|NCT01618695|585006409|FG000|Extension Phase|Adverse Event|18|||
161988075|NCT01618695|585006410|FG001|Extension Phase|Adverse Event|16|||
161988076|NCT01618695|585006411|FG002|Extension Phase|Adverse Event|9|||
161988077|NCT01618695|585006412|FG003|Extension Phase|Adverse Event|20|||
161988078|NCT01618695|585006409|FG000|Extension Phase|Lost to Follow-up|2|||
161988079|NCT01618695|585006410|FG001|Extension Phase|Lost to Follow-up|1|||
161988080|NCT01618695|585006411|FG002|Extension Phase|Lost to Follow-up|1|||
161988081|NCT01618695|585006412|FG003|Extension Phase|Lost to Follow-up|1|||
161988082|NCT01618695|585006409|FG000|Extension Phase|Other than specified|13|||
161988083|NCT01618695|585006410|FG001|Extension Phase|Other than specified|18|||
161988084|NCT01618695|585006411|FG002|Extension Phase|Other than specified|13|||
161988085|NCT01618695|585006412|FG003|Extension Phase|Other than specified|18|||
161988086|NCT02291419|585006416|FG000|Overall Study|Early study termination|1|||
161988087|NCT02291419|585006417|FG001|Overall Study|Early study termination|5|||
161988088|NCT00931606|585006418|FG000|Overall Study|Death|1|||
161988089|NCT00931606|585006419|FG001|Overall Study|Death|3|||
161988090|NCT00931606|585006420|FG002|Overall Study|Death|2|||
161988091|NCT00931606|585006421|FG003|Overall Study|Death|0|||
161988092|NCT00931606|585006418|FG000|Overall Study|Lost to Follow-up|0|||
161988093|NCT00931606|585006419|FG001|Overall Study|Lost to Follow-up|1|||
161988094|NCT00931606|585006420|FG002|Overall Study|Lost to Follow-up|0|||
161988095|NCT00931606|585006421|FG003|Overall Study|Lost to Follow-up|0|||
161988096|NCT00931606|585006418|FG000|Overall Study|Physician Decision|0|||
161988097|NCT00931606|585006419|FG001|Overall Study|Physician Decision|0|||
161988098|NCT00931606|585006420|FG002|Overall Study|Physician Decision|3|||
161988099|NCT00931606|585006421|FG003|Overall Study|Physician Decision|0|||
161988100|NCT00931606|585006418|FG000|Overall Study|Sponsor Decision|1|||
161988101|NCT00931606|585006419|FG001|Overall Study|Sponsor Decision|4|||
161988102|NCT00931606|585006420|FG002|Overall Study|Sponsor Decision|0|||
161988103|NCT00931606|585006421|FG003|Overall Study|Sponsor Decision|2|||
161988104|NCT00931606|585006418|FG000|Overall Study|Withdrawal by Subject|3|||
161988105|NCT00931606|585006419|FG001|Overall Study|Withdrawal by Subject|1|||
161988106|NCT00931606|585006420|FG002|Overall Study|Withdrawal by Subject|1|||
161988107|NCT00931606|585006421|FG003|Overall Study|Withdrawal by Subject|1|||
161988108|NCT00871338|585006422|FG000|Prior to Booster|Withdrawal by Subject|1|||
161988109|NCT00871338|585006423|FG001|Prior to Booster|Withdrawal by Subject|3|||
161988110|NCT00871338|585006422|FG000|Prior to Booster|Lost to Follow-up|1|||
161988111|NCT00871338|585006423|FG001|Prior to Booster|Lost to Follow-up|0|||
161988112|NCT02391363|585006424|FG000|Overall Study|Lost to Follow-up|5|||
161988113|NCT02391363|585006425|FG001|Overall Study|Lost to Follow-up|5|||
161988114|NCT02391363|585006424|FG000|Overall Study|Withdrawal by Subject|6|||
161988115|NCT02391363|585006425|FG001|Overall Study|Withdrawal by Subject|3|||
161988116|NCT00799266|585006426|FG000|Overall Study|Adverse Event|0|||
161988117|NCT00799266|585006427|FG001|Overall Study|Adverse Event|1|||
161988118|NCT00799266|585006426|FG000|Overall Study|Subject withdrew consent|3|||
161988119|NCT00799266|585006427|FG001|Overall Study|Subject withdrew consent|0|||
161988120|NCT00872599|585006428|FG000|Second Washout Period|Adverse Event|1|||
161988121|NCT00872599|585006429|FG001|Second Washout Period|Adverse Event|1|||
161988122|NCT01504841|585006436|FG000|Overall Study|Withdrawal by Subject|1|||
161988123|NCT01504841|585006437|FG001|Overall Study|Withdrawal by Subject|1|||
161988124|NCT01504841|585006438|FG002|Overall Study|Withdrawal by Subject|0|||
161988125|NCT03149055|585006445|FG000|Overall Study|Not treated|4|||
161988126|NCT04440813|585006446|FG000|Overall Study|Lost to Follow-up|5|||
161988127|NCT04440813|585006447|FG001|Overall Study|Lost to Follow-up|5|||
161988128|NCT00660179|585006448|FG000|Overall Study|Death|44|||
161988129|NCT00660179|585006449|FG001|Overall Study|Death|47|||
161988130|NCT00660179|585006450|FG002|Overall Study|Death|34|||
161988131|NCT00660179|585006448|FG000|Overall Study|Withdrawal of consent|4|||
161988132|NCT00660179|585006449|FG001|Overall Study|Withdrawal of consent|6|||
161988133|NCT00660179|585006450|FG002|Overall Study|Withdrawal of consent|4|||
161988134|NCT00660179|585006448|FG000|Overall Study|Lost to Follow-up|7|||
161988135|NCT00660179|585006449|FG001|Overall Study|Lost to Follow-up|5|||
161988136|NCT00660179|585006450|FG002|Overall Study|Lost to Follow-up|2|||
161988137|NCT00660179|585006448|FG000|Overall Study|Administrative reason|0|||
161988138|NCT00660179|585006449|FG001|Overall Study|Administrative reason|0|||
161988139|NCT00660179|585006450|FG002|Overall Study|Administrative reason|1|||
161988140|NCT00660179|585006448|FG000|Overall Study|Incorrect randomization|1|||
161988141|NCT00660179|585006449|FG001|Overall Study|Incorrect randomization|0|||
161988142|NCT00660179|585006450|FG002|Overall Study|Incorrect randomization|0|||
161988143|NCT00291018|585006457|FG000|Overall Study|Not Consented or Declined PAS|12|||
161988144|NCT00291018|585006458|FG001|Overall Study|Not Consented or Declined PAS|15|||
161988145|NCT00291018|585006459|FG002|Overall Study|Not Consented or Declined PAS|15|||
161988146|NCT00291018|585006457|FG000|Overall Study|Death|3|||
161988147|NCT00291018|585006458|FG001|Overall Study|Death|3|||
161988148|NCT00291018|585006459|FG002|Overall Study|Death|4|||
161988149|NCT00291018|585006457|FG000|Overall Study|Withdrawal by Subject|2|||
161988150|NCT00291018|585006458|FG001|Overall Study|Withdrawal by Subject|8|||
161988151|NCT00291018|585006459|FG002|Overall Study|Withdrawal by Subject|1|||
161988152|NCT00291018|585006457|FG000|Overall Study|Failures|5|||
161988153|NCT00291018|585006458|FG001|Overall Study|Failures|12|||
161988154|NCT00291018|585006459|FG002|Overall Study|Failures|5|||
161988155|NCT00291018|585006457|FG000|Overall Study|Lost to Follow-up|3|||
161988156|NCT00291018|585006458|FG001|Overall Study|Lost to Follow-up|4|||
161988157|NCT00291018|585006459|FG002|Overall Study|Lost to Follow-up|18|||
161988158|NCT01504412|585006460|FG000|Overall Study|Adverse Event|1|||
161988159|NCT01504412|585006461|FG001|Overall Study|Adverse Event|8|||
161988160|NCT01504412|585006462|FG002|Overall Study|Adverse Event|1|||
161988161|NCT01504412|585006463|FG003|Overall Study|Adverse Event|7|||
161988162|NCT01504412|585006464|FG004|Overall Study|Adverse Event|10|||
161988163|NCT01504412|585006460|FG000|Overall Study|Withdrawal by Subject|2|||
161988164|NCT01504412|585006461|FG001|Overall Study|Withdrawal by Subject|1|||
161988165|NCT01504412|585006462|FG002|Overall Study|Withdrawal by Subject|1|||
161988166|NCT01504412|585006463|FG003|Overall Study|Withdrawal by Subject|5|||
161988167|NCT01504412|585006464|FG004|Overall Study|Withdrawal by Subject|1|||
161988168|NCT01504412|585006460|FG000|Overall Study|Other|2|||
161988169|NCT01504412|585006461|FG001|Overall Study|Other|1|||
161988170|NCT01504412|585006462|FG002|Overall Study|Other|1|||
161988171|NCT01504412|585006463|FG003|Overall Study|Other|6|||
161988172|NCT01504412|585006464|FG004|Overall Study|Other|1|||
161988173|NCT01504412|585006460|FG000|Overall Study|Lost to Follow-up|0|||
161988174|NCT01504412|585006461|FG001|Overall Study|Lost to Follow-up|2|||
161988175|NCT01504412|585006462|FG002|Overall Study|Lost to Follow-up|0|||
161988176|NCT01504412|585006463|FG003|Overall Study|Lost to Follow-up|0|||
161988177|NCT01504412|585006464|FG004|Overall Study|Lost to Follow-up|0|||
161988178|NCT01504412|585006460|FG000|Overall Study|Lack of Efficacy|0|||
161988179|NCT01504412|585006461|FG001|Overall Study|Lack of Efficacy|0|||
161988180|NCT01504412|585006462|FG002|Overall Study|Lack of Efficacy|1|||
161988181|NCT01504412|585006463|FG003|Overall Study|Lack of Efficacy|0|||
161988182|NCT01504412|585006464|FG004|Overall Study|Lack of Efficacy|1|||
161988183|NCT01504412|585006460|FG000|Overall Study|Death|0|||
161988184|NCT01504412|585006461|FG001|Overall Study|Death|0|||
161988185|NCT01504412|585006462|FG002|Overall Study|Death|0|||
161988186|NCT01504412|585006463|FG003|Overall Study|Death|1|||
161988187|NCT01504412|585006464|FG004|Overall Study|Death|0|||
161988188|NCT00630344|585006465|FG000|Overall Study|Adverse Event|5|||
161988189|NCT00630344|585006465|FG000|Overall Study|Progressive Disease|19|||
161988190|NCT00630344|585006465|FG000|Overall Study|Physician Decision|9|||
161988191|NCT00630344|585006465|FG000|Overall Study|Withdrawal by Subject|1|||
161988192|NCT00630344|585006465|FG000|Overall Study|Intercurrent Illness|1|||
161988193|NCT00630344|585006465|FG000|Overall Study|Other|1|||
161988194|NCT04774926|585006467|FG000|Overall Study|Adverse Event|15|||
161988195|NCT04774926|585006467|FG000|Overall Study|Lost to Follow-up|3|||
161988196|NCT04774926|585006467|FG000|Overall Study|Physician Decision|6|||
161988197|NCT04774926|585006467|FG000|Overall Study|Withdrawal by Subject|3|||
161988198|NCT04774926|585006467|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
161988199|NCT01393639|585006468|FG000|Overall Study|Protocol Violation|0|||
161988200|NCT01393639|585006469|FG001|Overall Study|Protocol Violation|0|||
161988201|NCT01393639|585006470|FG002|Overall Study|Protocol Violation|0|||
161988202|NCT01393639|585006471|FG003|Overall Study|Protocol Violation|1|||
161988203|NCT01393639|585006472|FG004|Overall Study|Protocol Violation|0|||
161988204|NCT01393639|585006473|FG005|Overall Study|Protocol Violation|0|||
161988205|NCT01393639|585006474|FG006|Overall Study|Protocol Violation|0|||
161988206|NCT01393639|585006468|FG000|Overall Study|Other|0|||
161988207|NCT01393639|585006469|FG001|Overall Study|Other|2|||
161988208|NCT01393639|585006470|FG002|Overall Study|Other|0|||
161988209|NCT01393639|585006471|FG003|Overall Study|Other|2|||
161988210|NCT01393639|585006472|FG004|Overall Study|Other|1|||
161988211|NCT01393639|585006473|FG005|Overall Study|Other|0|||
161988212|NCT01393639|585006474|FG006|Overall Study|Other|1|||
161988213|NCT01393639|585006468|FG000|Overall Study|Withdrawal by Subject|1|||
161988214|NCT01393639|585006469|FG001|Overall Study|Withdrawal by Subject|1|||
161988215|NCT01393639|585006470|FG002|Overall Study|Withdrawal by Subject|0|||
161988216|NCT01393639|585006471|FG003|Overall Study|Withdrawal by Subject|0|||
161988217|NCT01393639|585006472|FG004|Overall Study|Withdrawal by Subject|0|||
161988218|NCT01393639|585006473|FG005|Overall Study|Withdrawal by Subject|0|||
161988219|NCT01393639|585006474|FG006|Overall Study|Withdrawal by Subject|1|||
161988220|NCT01393639|585006468|FG000|Overall Study|Medication error without associated AE|0|||
161988221|NCT01393639|585006469|FG001|Overall Study|Medication error without associated AE|0|||
161988222|NCT01393639|585006470|FG002|Overall Study|Medication error without associated AE|0|||
161988223|NCT01393639|585006471|FG003|Overall Study|Medication error without associated AE|0|||
161988224|NCT01393639|585006472|FG004|Overall Study|Medication error without associated AE|0|||
161988225|NCT01393639|585006473|FG005|Overall Study|Medication error without associated AE|0|||
161988226|NCT01393639|585006474|FG006|Overall Study|Medication error without associated AE|1|||
161988227|NCT01393639|585006468|FG000|Overall Study|Lost to Follow-up|0|||
161988228|NCT01393639|585006469|FG001|Overall Study|Lost to Follow-up|1|||
161988229|NCT01393639|585006470|FG002|Overall Study|Lost to Follow-up|0|||
161872562|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
161872563|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
161872564|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
161872565|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
161872566|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
161872567|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
161872568|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
161872569|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
161872570|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
161872571|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
161988230|NCT01393639|585006471|FG003|Overall Study|Lost to Follow-up|0|||
161988231|NCT01393639|585006472|FG004|Overall Study|Lost to Follow-up|0|||
161988232|NCT01393639|585006473|FG005|Overall Study|Lost to Follow-up|0|||
161988233|NCT01393639|585006474|FG006|Overall Study|Lost to Follow-up|1|||
161872572|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
161872573|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
161872574|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
161872575|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
161872576|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
161872577|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
161872578|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
161872579|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
161872580|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
161872581|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
161872582|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
161872583|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
161872584|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
161872585|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
161872586|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
161872587|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
161872588|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
161872589|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
161872590|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
161872591|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
161872592|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
161872593|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
161872594|NCT02016105|584578574|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
161872595|NCT02016105|584578575|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
161872596|NCT02016105|584578576|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
161872597|NCT02016105|584578577|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
161872598|NCT02016105|584578578|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
161872599|NCT02016105|584578579|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
161872600|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
161872601|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
161872602|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
161872603|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
161872604|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
161872605|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
161872606|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
161872607|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
161872608|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
161872609|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
161872610|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
161872611|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
161872612|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
161872613|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
161872614|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
161872615|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
161872616|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
161872617|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
161872618|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Death|0|||
161872619|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Death|0|||
161872620|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Death|0|||
161872621|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Death|0|||
161988234|NCT01393639|585006468|FG000|Overall Study|Lack of Efficacy|0|||
161872622|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Death|0|||
161988235|NCT01393639|585006469|FG001|Overall Study|Lack of Efficacy|0|||
161988236|NCT01393639|585006470|FG002|Overall Study|Lack of Efficacy|0|||
161872623|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Death|1|||
161872624|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
161872625|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
161872626|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
161872627|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
161872628|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
161872629|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
161872630|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
161872631|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
161988237|NCT01393639|585006471|FG003|Overall Study|Lack of Efficacy|0|||
161988238|NCT01393639|585006472|FG004|Overall Study|Lack of Efficacy|0|||
161988239|NCT01393639|585006473|FG005|Overall Study|Lack of Efficacy|0|||
161988240|NCT01393639|585006474|FG006|Overall Study|Lack of Efficacy|1|||
161988241|NCT01393639|585006468|FG000|Overall Study|Adverse Event|2|||
161988242|NCT01393639|585006469|FG001|Overall Study|Adverse Event|3|||
161988243|NCT01393639|585006470|FG002|Overall Study|Adverse Event|1|||
161988244|NCT01393639|585006471|FG003|Overall Study|Adverse Event|2|||
161988245|NCT01393639|585006472|FG004|Overall Study|Adverse Event|0|||
161988246|NCT01393639|585006473|FG005|Overall Study|Adverse Event|2|||
161988247|NCT01393639|585006474|FG006|Overall Study|Adverse Event|3|||
161988248|NCT03626545|585006475|FG000|Overall Study|Progressive disease|3|||
161988249|NCT03626545|585006476|FG001|Overall Study|Progressive disease|82|||
161988250|NCT03626545|585006477|FG002|Overall Study|Progressive disease|85|||
161988251|NCT03626545|585006475|FG000|Overall Study|Adverse Event|3|||
161988252|NCT03626545|585006476|FG001|Overall Study|Adverse Event|13|||
161988253|NCT03626545|585006477|FG002|Overall Study|Adverse Event|10|||
161988254|NCT03626545|585006475|FG000|Overall Study|Physician Decision|1|||
161988255|NCT03626545|585006476|FG001|Overall Study|Physician Decision|18|||
161988256|NCT03626545|585006477|FG002|Overall Study|Physician Decision|14|||
161988257|NCT03626545|585006475|FG000|Overall Study|Subject Decision|0|||
161988258|NCT03626545|585006476|FG001|Overall Study|Subject Decision|5|||
161988259|NCT03626545|585006477|FG002|Overall Study|Subject Decision|5|||
161988260|NCT03626545|585006475|FG000|Overall Study|Death|1|||
161988261|NCT03626545|585006476|FG001|Overall Study|Death|1|||
161988262|NCT03626545|585006477|FG002|Overall Study|Death|1|||
161988263|NCT03626545|585006475|FG000|Overall Study|Protocol Deviation|0|||
161988264|NCT03626545|585006476|FG001|Overall Study|Protocol Deviation|1|||
161988265|NCT03626545|585006477|FG002|Overall Study|Protocol Deviation|1|||
161988266|NCT03626545|585006475|FG000|Overall Study|Guardian Decision|0|||
161988267|NCT03626545|585006476|FG001|Overall Study|Guardian Decision|0|||
161988268|NCT03626545|585006477|FG002|Overall Study|Guardian Decision|1|||
161988269|NCT00793325|585006479|FG000|Overall Study|Protocol Violation|18|||
161988270|NCT00793325|585006479|FG000|Overall Study|Lost to Follow-up|1|||
161988271|NCT01440816|585006480|FG000|Overall Study|Disease Progression|0|||
161988272|NCT01440816|585006481|FG001|Overall Study|Disease Progression|9|||
161988273|NCT01440816|585006480|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
161988274|NCT01440816|585006481|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
161988275|NCT02462720|585006485|FG000|Part 2|Withdrawal by Subject|1|||
161988276|NCT02462720|585006486|FG001|Part 2|Withdrawal by Subject|0|||
161988277|NCT02462720|585006485|FG000|Part 2|Protocol Violation|0|||
161988278|NCT02462720|585006486|FG001|Part 2|Protocol Violation|1|||
161988279|NCT03250182|585006491|FG000|Overall Study|Withdrawal by Subject|1|||
161988280|NCT05173012|585006494|FG000|Overall Study|Adverse Event|2|||
161988281|NCT05173012|585006495|FG001|Overall Study|Adverse Event|3|||
161988282|NCT05173012|585006496|FG002|Overall Study|Adverse Event|4|||
161988283|NCT05173012|585006497|FG003|Overall Study|Adverse Event|13|||
161988284|NCT05173012|585006498|FG004|Overall Study|Adverse Event|0|||
161988285|NCT05173012|585006499|FG005|Overall Study|Adverse Event|0|||
161988286|NCT05173012|585006500|FG006|Overall Study|Adverse Event|2|||
161988287|NCT05173012|585006501|FG007|Overall Study|Adverse Event|4|||
161988288|NCT05173012|585006494|FG000|Overall Study|Lost to Follow-up|0|||
161988289|NCT05173012|585006495|FG001|Overall Study|Lost to Follow-up|0|||
161988290|NCT05173012|585006496|FG002|Overall Study|Lost to Follow-up|0|||
161988291|NCT05173012|585006497|FG003|Overall Study|Lost to Follow-up|1|||
161988292|NCT05173012|585006498|FG004|Overall Study|Lost to Follow-up|0|||
161988293|NCT05173012|585006499|FG005|Overall Study|Lost to Follow-up|0|||
161988294|NCT05173012|585006500|FG006|Overall Study|Lost to Follow-up|0|||
161988295|NCT05173012|585006501|FG007|Overall Study|Lost to Follow-up|0|||
161988296|NCT05173012|585006494|FG000|Overall Study|Withdrawal by Subject|1|||
161988297|NCT05173012|585006495|FG001|Overall Study|Withdrawal by Subject|0|||
161988298|NCT05173012|585006496|FG002|Overall Study|Withdrawal by Subject|1|||
161988299|NCT05173012|585006497|FG003|Overall Study|Withdrawal by Subject|3|||
161988300|NCT05173012|585006498|FG004|Overall Study|Withdrawal by Subject|1|||
161988301|NCT05173012|585006499|FG005|Overall Study|Withdrawal by Subject|0|||
161988302|NCT05173012|585006500|FG006|Overall Study|Withdrawal by Subject|1|||
161988303|NCT05173012|585006501|FG007|Overall Study|Withdrawal by Subject|0|||
161988304|NCT05173012|585006494|FG000|Overall Study|Protocol Deviation|0|||
161988305|NCT05173012|585006495|FG001|Overall Study|Protocol Deviation|0|||
161988306|NCT05173012|585006496|FG002|Overall Study|Protocol Deviation|0|||
161988307|NCT05173012|585006497|FG003|Overall Study|Protocol Deviation|1|||
161988308|NCT05173012|585006498|FG004|Overall Study|Protocol Deviation|0|||
161988309|NCT05173012|585006499|FG005|Overall Study|Protocol Deviation|0|||
161988310|NCT05173012|585006500|FG006|Overall Study|Protocol Deviation|0|||
161988311|NCT05173012|585006501|FG007|Overall Study|Protocol Deviation|0|||
161988312|NCT05173012|585006494|FG000|Overall Study|Other|0|||
161988313|NCT05173012|585006495|FG001|Overall Study|Other|0|||
161988314|NCT05173012|585006496|FG002|Overall Study|Other|0|||
161988315|NCT05173012|585006497|FG003|Overall Study|Other|2|||
161988316|NCT05173012|585006498|FG004|Overall Study|Other|0|||
161988317|NCT05173012|585006499|FG005|Overall Study|Other|0|||
161988318|NCT05173012|585006500|FG006|Overall Study|Other|0|||
161988319|NCT05173012|585006501|FG007|Overall Study|Other|0|||
161988320|NCT03472950|585006502|FG000|Overall Study|Lost to Follow-up|0|||
161988321|NCT03472950|585006503|FG001|Overall Study|Lost to Follow-up|1|||
161988322|NCT03472950|585006502|FG000|Overall Study|Adverse Event|0|||
161988323|NCT03472950|585006503|FG001|Overall Study|Adverse Event|3|||
161988324|NCT03668613|585006504|FG000|Overall Study|Adverse Event|1|||
161988325|NCT03668613|585006505|FG001|Overall Study|Adverse Event|2|||
161988326|NCT03668613|585006504|FG000|Overall Study|Lack of Efficacy|5|||
161988327|NCT03668613|585006505|FG001|Overall Study|Lack of Efficacy|1|||
161988328|NCT03668613|585006504|FG000|Overall Study|Pregnancy|0|||
161988329|NCT03668613|585006505|FG001|Overall Study|Pregnancy|2|||
161988330|NCT03668613|585006504|FG000|Overall Study|Protocol Violation|1|||
161988331|NCT03668613|585006505|FG001|Overall Study|Protocol Violation|0|||
161988332|NCT03668613|585006504|FG000|Overall Study|Physician Decision|1|||
161988333|NCT03668613|585006505|FG001|Overall Study|Physician Decision|0|||
161988334|NCT03668613|585006504|FG000|Overall Study|Withdrawal by Subject|2|||
161988335|NCT03668613|585006505|FG001|Overall Study|Withdrawal by Subject|1|||
161988336|NCT03668613|585006504|FG000|Overall Study|Guardian decision|1|||
161988337|NCT03668613|585006505|FG001|Overall Study|Guardian decision|0|||
161988338|NCT03386487|585006508|FG000|Overall Study|Lost to Follow-up|5|||
161988339|NCT03386487|585006509|FG001|Overall Study|Lost to Follow-up|6|||
161988340|NCT03386487|585006508|FG000|Overall Study|Withdrawal by Subject|11|||
161988341|NCT03386487|585006509|FG001|Overall Study|Withdrawal by Subject|7|||
161988342|NCT03386487|585006508|FG000|Overall Study|Physician Decision|11|||
161988343|NCT03386487|585006509|FG001|Overall Study|Physician Decision|8|||
161988344|NCT01068769|585006510|FG000|Overall Study|Ineligible|1|||
161988345|NCT00894361|585006515|FG000|Overall Study|deaths and less than 2 years followup|24|||
161988346|NCT00894361|585006516|FG001|Overall Study|deaths and less than 2 years followup|64|||
161988347|NCT00286494|585006517|FG000|Overall Study|Hyperglycemic rescue|12|||
161988348|NCT00286494|585006518|FG001|Overall Study|Hyperglycemic rescue|19|||
161988349|NCT00286494|585006519|FG002|Overall Study|Hyperglycemic rescue|18|||
161988350|NCT00286494|585006517|FG000|Overall Study|Withdrawal by Subject|2|||
161988351|NCT00286494|585006518|FG001|Overall Study|Withdrawal by Subject|10|||
161988352|NCT00286494|585006519|FG002|Overall Study|Withdrawal by Subject|9|||
161988353|NCT00286494|585006517|FG000|Overall Study|Adverse Event|3|||
161988354|NCT00286494|585006518|FG001|Overall Study|Adverse Event|8|||
161988355|NCT00286494|585006519|FG002|Overall Study|Adverse Event|6|||
161988356|NCT00286494|585006517|FG000|Overall Study|Physician Decision|5|||
161988357|NCT00286494|585006518|FG001|Overall Study|Physician Decision|5|||
161988358|NCT00286494|585006519|FG002|Overall Study|Physician Decision|1|||
161988359|NCT00286494|585006517|FG000|Overall Study|Lost to Follow-up|3|||
161988360|NCT00286494|585006518|FG001|Overall Study|Lost to Follow-up|1|||
161988361|NCT00286494|585006519|FG002|Overall Study|Lost to Follow-up|3|||
161988362|NCT00286494|585006517|FG000|Overall Study|Protocol Violation|1|||
161988363|NCT00286494|585006518|FG001|Overall Study|Protocol Violation|1|||
161988364|NCT00286494|585006519|FG002|Overall Study|Protocol Violation|2|||
161988365|NCT04776317|585006520|FG000|Overall Study|Physician Decision|0|||
161988366|NCT04776317|585006521|FG001|Overall Study|Physician Decision|1|||
161988367|NCT04776317|585006522|FG002|Overall Study|Physician Decision|0|||
161988368|NCT04776317|585006523|FG003|Overall Study|Physician Decision|0|||
161988369|NCT04776317|585006524|FG004|Overall Study|Physician Decision|0|||
161988370|NCT04776317|585006525|FG005|Overall Study|Physician Decision|0|||
161988371|NCT04776317|585006526|FG006|Overall Study|Physician Decision|0|||
161988372|NCT04776317|585006527|FG007|Overall Study|Physician Decision|0|||
161988373|NCT04776317|585006528|FG008|Overall Study|Physician Decision|0|||
161988374|NCT04776317|585006529|FG009|Overall Study|Physician Decision|0|||
161988375|NCT04776317|585006530|FG010|Overall Study|Physician Decision|0|||
161988376|NCT04776317|585006531|FG011|Overall Study|Physician Decision|0|||
161988377|NCT04776317|585006532|FG012|Overall Study|Physician Decision|0|||
161988378|NCT04776317|585006533|FG013|Overall Study|Physician Decision|0|||
161988379|NCT04776317|585006534|FG014|Overall Study|Physician Decision|0|||
161988380|NCT04776317|585006520|FG000|Overall Study|Protocol Violation|0|||
161988381|NCT04776317|585006521|FG001|Overall Study|Protocol Violation|0|||
161988382|NCT04776317|585006522|FG002|Overall Study|Protocol Violation|1|||
161988383|NCT04776317|585006523|FG003|Overall Study|Protocol Violation|0|||
161988384|NCT04776317|585006524|FG004|Overall Study|Protocol Violation|0|||
161988385|NCT04776317|585006525|FG005|Overall Study|Protocol Violation|0|||
161988386|NCT04776317|585006526|FG006|Overall Study|Protocol Violation|0|||
161988387|NCT04776317|585006527|FG007|Overall Study|Protocol Violation|0|||
161988388|NCT04776317|585006528|FG008|Overall Study|Protocol Violation|0|||
161988389|NCT04776317|585006529|FG009|Overall Study|Protocol Violation|0|||
161988390|NCT04776317|585006530|FG010|Overall Study|Protocol Violation|0|||
161988391|NCT04776317|585006531|FG011|Overall Study|Protocol Violation|0|||
162035254|NCT01244490|585185888|FG000|Overall Study|Other|0|||
161988392|NCT04776317|585006532|FG012|Overall Study|Protocol Violation|0|||
161988393|NCT04776317|585006533|FG013|Overall Study|Protocol Violation|0|||
161988394|NCT04776317|585006534|FG014|Overall Study|Protocol Violation|0|||
161988395|NCT04776317|585006520|FG000|Overall Study|Withdrawal by Subject|0|||
161988396|NCT04776317|585006521|FG001|Overall Study|Withdrawal by Subject|0|||
161988397|NCT04776317|585006522|FG002|Overall Study|Withdrawal by Subject|0|||
161988398|NCT04776317|585006523|FG003|Overall Study|Withdrawal by Subject|0|||
161988399|NCT04776317|585006524|FG004|Overall Study|Withdrawal by Subject|1|||
161988400|NCT04776317|585006525|FG005|Overall Study|Withdrawal by Subject|0|||
161988401|NCT04776317|585006526|FG006|Overall Study|Withdrawal by Subject|0|||
161988402|NCT04776317|585006527|FG007|Overall Study|Withdrawal by Subject|0|||
161988403|NCT04776317|585006528|FG008|Overall Study|Withdrawal by Subject|0|||
161988404|NCT04776317|585006529|FG009|Overall Study|Withdrawal by Subject|0|||
161988405|NCT04776317|585006530|FG010|Overall Study|Withdrawal by Subject|0|||
161988406|NCT04776317|585006531|FG011|Overall Study|Withdrawal by Subject|0|||
161988407|NCT04776317|585006532|FG012|Overall Study|Withdrawal by Subject|0|||
161988408|NCT04776317|585006533|FG013|Overall Study|Withdrawal by Subject|0|||
161988409|NCT04776317|585006534|FG014|Overall Study|Withdrawal by Subject|0|||
161988410|NCT04207060|585006535|FG000|Overall Study|Lost to Follow-up|2|||
161988411|NCT04207060|585006536|FG001|Overall Study|Lost to Follow-up|0|||
161988412|NCT00774800|585006537|FG000|Intervention 4|Withdrawal by Subject|1|||
161988413|NCT00532298|585006538|FG000|Overall Study|Adverse Event|1|||
161988414|NCT00532298|585006539|FG001|Overall Study|Adverse Event|0|||
161988415|NCT00532298|585006540|FG002|Overall Study|Adverse Event|0|||
161988416|NCT00532298|585006541|FG003|Overall Study|Adverse Event|0|||
161988417|NCT00532298|585006542|FG004|Overall Study|Adverse Event|1|||
161988418|NCT00532298|585006543|FG005|Overall Study|Adverse Event|1|||
161988419|NCT00532298|585006538|FG000|Overall Study|Lost to Follow-up|1|||
161988420|NCT00532298|585006539|FG001|Overall Study|Lost to Follow-up|1|||
161988421|NCT00532298|585006540|FG002|Overall Study|Lost to Follow-up|1|||
161988422|NCT00532298|585006541|FG003|Overall Study|Lost to Follow-up|0|||
161988423|NCT00532298|585006542|FG004|Overall Study|Lost to Follow-up|0|||
161988424|NCT00532298|585006543|FG005|Overall Study|Lost to Follow-up|1|||
161988425|NCT00479856|585006544|FG000|Overall Study|Adverse Event|1|||
161988426|NCT00479856|585006544|FG000|Overall Study|Withdrawal by Subject|1|||
161988427|NCT00479856|585006544|FG000|Overall Study|Physician Decision|1|||
161988428|NCT04164732|585006549|FG000|Treatment run-in Period|Adverse Event|4|||
161988429|NCT04164732|585006550|FG001|Treatment run-in Period|Adverse Event|0|||
161988430|NCT04164732|585006551|FG002|Treatment run-in Period|Adverse Event|0|||
161988431|NCT04164732|585006549|FG000|Treatment run-in Period|Physician Decision|1|||
161988432|NCT04164732|585006550|FG001|Treatment run-in Period|Physician Decision|0|||
161988433|NCT04164732|585006551|FG002|Treatment run-in Period|Physician Decision|0|||
161988434|NCT04164732|585006549|FG000|Treatment run-in Period|Screen Failure|1|||
161988435|NCT04164732|585006550|FG001|Treatment run-in Period|Screen Failure|0|||
161988436|NCT04164732|585006551|FG002|Treatment run-in Period|Screen Failure|0|||
161988437|NCT04164732|585006549|FG000|Randomized Treatment Period|Adverse Event|0|||
161988438|NCT04164732|585006550|FG001|Randomized Treatment Period|Adverse Event|1|||
161988439|NCT04164732|585006551|FG002|Randomized Treatment Period|Adverse Event|0|||
161988440|NCT04164732|585006549|FG000|Randomized Treatment Period|Protocol Deviation|0|||
161988441|NCT04164732|585006550|FG001|Randomized Treatment Period|Protocol Deviation|1|||
161988442|NCT04164732|585006551|FG002|Randomized Treatment Period|Protocol Deviation|1|||
161988443|NCT04164732|585006549|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
161988444|NCT04164732|585006550|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
161988445|NCT04164732|585006551|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
161988446|NCT02141360|585006552|FG000|Overall Study|Withdrawal by Subject|6|||
161988447|NCT02141360|585006553|FG001|Overall Study|Withdrawal by Subject|0|||
161988448|NCT02141360|585006554|FG002|Overall Study|Withdrawal by Subject|0|||
161988449|NCT02141360|585006552|FG000|Overall Study|Study Terminated before Visit|1|||
161988450|NCT02141360|585006553|FG001|Overall Study|Study Terminated before Visit|0|||
161988451|NCT02141360|585006554|FG002|Overall Study|Study Terminated before Visit|0|||
161988452|NCT00646399|585006555|FG000|Overall Study|Death|63|||
161988453|NCT00646399|585006556|FG001|Overall Study|Death|53|||
161988454|NCT00646399|585006555|FG000|Overall Study|Withdrawal by Subject|9|||
161988455|NCT00646399|585006556|FG001|Overall Study|Withdrawal by Subject|10|||
161988456|NCT00646399|585006555|FG000|Overall Study|Other Reason|11|||
161988457|NCT00646399|585006556|FG001|Overall Study|Other Reason|11|||
161988458|NCT00661622|585006557|FG000|Overall Study|Protocol Violation|1|||
161988459|NCT00661622|585006558|FG001|Overall Study|Protocol Violation|0|||
161988460|NCT02332291|585006563|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
161988461|NCT02332291|585006564|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
161988462|NCT02332291|585006563|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
161988463|NCT02332291|585006564|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
161988464|NCT02332291|585006563|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
161988465|NCT02332291|585006564|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
161988466|NCT02332291|585006563|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
161988467|NCT02332291|585006564|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
162035255|NCT01244490|585185889|FG001|Overall Study|Other|0|||
161988468|NCT02332291|585006563|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
161988469|NCT02332291|585006564|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
161988470|NCT02332291|585006563|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
162035256|NCT01244490|585185890|FG002|Overall Study|Other|1|||
161872632|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
161872633|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
161872634|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
161872635|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
161872636|NCT02016105|584578574|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
161872637|NCT02016105|584578575|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
161872638|NCT02016105|584578576|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
161872639|NCT02016105|584578577|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
161872640|NCT02016105|584578578|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
161872641|NCT02016105|584578579|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
161872642|NCT02016105|584578574|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
161872643|NCT02016105|584578575|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
161872644|NCT02016105|584578576|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
161872645|NCT02016105|584578577|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
161872646|NCT02016105|584578578|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
161872647|NCT02016105|584578579|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
161872648|NCT02016105|584578574|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
161872649|NCT02016105|584578575|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
161872650|NCT02016105|584578576|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
161872651|NCT02016105|584578577|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
161872652|NCT02016105|584578578|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
161872653|NCT02016105|584578579|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
161872654|NCT02016105|584578574|FG000|EXTENSION PERIOD|Adverse Event|0|||
161872655|NCT02016105|584578575|FG001|EXTENSION PERIOD|Adverse Event|0|||
161872656|NCT02016105|584578576|FG002|EXTENSION PERIOD|Adverse Event|2|||
161872657|NCT02016105|584578577|FG003|EXTENSION PERIOD|Adverse Event|0|||
161872658|NCT02016105|584578578|FG004|EXTENSION PERIOD|Adverse Event|1|||
161872659|NCT02016105|584578579|FG005|EXTENSION PERIOD|Adverse Event|0|||
161872660|NCT02016105|584578574|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
161872661|NCT02016105|584578575|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
161872662|NCT02016105|584578576|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
161872663|NCT02016105|584578577|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
161872664|NCT02016105|584578578|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
161872665|NCT02016105|584578579|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
161872666|NCT02016105|584578574|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
161872667|NCT02016105|584578575|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
161872668|NCT02016105|584578576|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
161872669|NCT02016105|584578577|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
161872670|NCT02016105|584578578|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
161872671|NCT02016105|584578579|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
161872672|NCT02016105|584578574|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
161872673|NCT02016105|584578575|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
161872674|NCT02016105|584578576|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
161872675|NCT02016105|584578577|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
161872676|NCT02016105|584578578|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
161872677|NCT02016105|584578579|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
161872678|NCT00090493|584578580|FG000|Overall Study|Physician Decision|2|||
161872679|NCT02865499|584578581|FG000|Baseline|Adverse Event|1|||
161872680|NCT02865499|584578581|FG000|Baseline|Withdrawal by Subject|1|||
161872681|NCT02320058|584578582|FG000|Overall Study|Death|25|||
161872682|NCT02320058|584578583|FG001|Overall Study|Death|10|||
161872683|NCT02320058|584578582|FG000|Overall Study|Lost to Follow-up|4|||
161872684|NCT02320058|584578583|FG001|Overall Study|Lost to Follow-up|0|||
161872685|NCT02320058|584578582|FG000|Overall Study|Other reasons|4|||
161872686|NCT02320058|584578583|FG001|Overall Study|Other reasons|1|||
161872687|NCT02320058|584578582|FG000|Overall Study|Withdrawal by Subject|8|||
161872688|NCT02320058|584578583|FG001|Overall Study|Withdrawal by Subject|2|||
161872689|NCT02320058|584578582|FG000|Overall Study|Not reported|1|||
161988471|NCT02332291|585006564|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
161988472|NCT00395850|585006571|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
161988473|NCT00395850|585006572|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
161988474|NCT00395850|585006573|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
161988475|NCT00395850|585006574|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
161872690|NCT02320058|584578583|FG001|Overall Study|Not reported|0|||
161872691|NCT00661609|584578584|FG000|Overall Study|Adverse Event|4|||
161872692|NCT00661609|584578584|FG000|Overall Study|Death|20|||
161872693|NCT00661609|584578584|FG000|Overall Study|Withdrawal by Subject|2|||
161872694|NCT00661609|584578584|FG000|Overall Study|PI Decision|1|||
161988476|NCT00395850|585006571|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
161872695|NCT00661609|584578584|FG000|Overall Study|Survival follow up stage discontinued|11|||
161872696|NCT00661609|584578584|FG000|Overall Study|Disease progression|3|||
161872697|NCT01769508|584578585|FG000|Overall Study|Death|3|||
161872698|NCT01769508|584578585|FG000|Overall Study|Withdrawal by Subject|1|||
161872699|NCT01769508|584578585|FG000|Overall Study|Adverse Event|1|||
161872700|NCT01769508|584578585|FG000|Overall Study|Lost to Follow-up|1|||
161988477|NCT00395850|585006572|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
161988478|NCT00395850|585006573|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
161988479|NCT00395850|585006574|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
161988480|NCT00395850|585006571|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
161988481|NCT00395850|585006572|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
161988482|NCT00395850|585006573|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
161988483|NCT00395850|585006574|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
161988484|NCT00395850|585006571|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
161988485|NCT00395850|585006572|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
161988486|NCT00395850|585006573|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
161988487|NCT00395850|585006574|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
161988488|NCT00395850|585006571|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
161988489|NCT00395850|585006572|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
161988490|NCT00395850|585006573|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
161988491|NCT00395850|585006574|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
161988492|NCT00395850|585006571|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
161988493|NCT00395850|585006572|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
161988494|NCT00395850|585006573|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
161988495|NCT00395850|585006574|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
161988496|NCT00395850|585006571|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
161988497|NCT00395850|585006572|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
161988498|NCT00395850|585006573|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
161988499|NCT00395850|585006574|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
161988500|NCT01424228|585006577|FG000|Overall Study|Withdrawal by Subject|27|||
161988501|NCT01424228|585006578|FG001|Overall Study|Withdrawal by Subject|11|||
161988502|NCT01424228|585006577|FG000|Overall Study|Adverse Event|10|||
161988503|NCT01424228|585006578|FG001|Overall Study|Adverse Event|14|||
161988504|NCT01424228|585006577|FG000|Overall Study|Sponsor's decision|9|||
161988505|NCT01424228|585006578|FG001|Overall Study|Sponsor's decision|12|||
161988506|NCT01424228|585006577|FG000|Overall Study|Lack of Efficacy|5|||
161988507|NCT01424228|585006578|FG001|Overall Study|Lack of Efficacy|7|||
161988508|NCT01424228|585006577|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
161988509|NCT01424228|585006578|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
161988510|NCT01424228|585006577|FG000|Overall Study|Non-compliance|2|||
161988511|NCT01424228|585006578|FG001|Overall Study|Non-compliance|0|||
161988512|NCT01424228|585006577|FG000|Overall Study|Worsening of symptoms|1|||
161988513|NCT01424228|585006578|FG001|Overall Study|Worsening of symptoms|0|||
161872701|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
161872702|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
161872703|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
161872704|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
161872705|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
161872706|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
161872707|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
161988514|NCT01424228|585006577|FG000|Overall Study|Unplanned journey|0|||
161988515|NCT01424228|585006578|FG001|Overall Study|Unplanned journey|1|||
161988516|NCT00844558|585006579|FG000|Overall Study|Withdrawal by Subject|9|||
161988517|NCT00844558|585006580|FG001|Overall Study|Withdrawal by Subject|2|||
161988518|NCT00844558|585006579|FG000|Overall Study|Death|1|||
161988519|NCT00844558|585006580|FG001|Overall Study|Death|0|||
161988520|NCT00844558|585006579|FG000|Overall Study|Protocol Violation|1|||
161988521|NCT00844558|585006580|FG001|Overall Study|Protocol Violation|1|||
161988522|NCT00844558|585006579|FG000|Overall Study|Lost to Follow-up|0|||
161988523|NCT00844558|585006580|FG001|Overall Study|Lost to Follow-up|1|||
161988524|NCT00844558|585006579|FG000|Overall Study|Physician Decision|1|||
161988525|NCT00844558|585006580|FG001|Overall Study|Physician Decision|0|||
161988526|NCT00588094|585006581|FG000|Overall Study|Adverse Event|3|||
161988527|NCT00588094|585006581|FG000|Overall Study|Progression of Disease|2|||
161988528|NCT02951429|585006588|FG000|Overall Study|Adverse Event|3|||
161988529|NCT02951429|585006589|FG001|Overall Study|Adverse Event|7|||
161988530|NCT02951429|585006588|FG000|Overall Study|Death|28|||
161988531|NCT02951429|585006589|FG001|Overall Study|Death|36|||
161988532|NCT02951429|585006588|FG000|Overall Study|Lack of Efficacy|0|||
161988533|NCT02951429|585006589|FG001|Overall Study|Lack of Efficacy|1|||
161988534|NCT02951429|585006588|FG000|Overall Study|Lost to Follow-up|0|||
161988535|NCT02951429|585006589|FG001|Overall Study|Lost to Follow-up|1|||
161988536|NCT02951429|585006588|FG000|Overall Study|Lung Transplantation|9|||
161988537|NCT02951429|585006589|FG001|Overall Study|Lung Transplantation|6|||
161988538|NCT02951429|585006588|FG000|Overall Study|Other|1|||
161988539|NCT02951429|585006589|FG001|Overall Study|Other|3|||
161988540|NCT02951429|585006588|FG000|Overall Study|Progressive Disease|1|||
161988541|NCT02951429|585006589|FG001|Overall Study|Progressive Disease|1|||
161988542|NCT02951429|585006588|FG000|Overall Study|Withdrawal by Subject|7|||
161988543|NCT02951429|585006589|FG001|Overall Study|Withdrawal by Subject|11|||
161988544|NCT02951429|585006588|FG000|Overall Study|Participant ongoing in the study|23|||
161988545|NCT02951429|585006589|FG001|Overall Study|Participant ongoing in the study|17|||
161988546|NCT01300572|585006596|FG000|Overall Study|HAMA + post dosimetry|1|||
161988547|NCT01368081|585006597|FG000|Overall Study|Adverse Event|4|||
161988548|NCT01368081|585006598|FG001|Overall Study|Adverse Event|4|||
161988549|NCT01368081|585006599|FG002|Overall Study|Adverse Event|3|||
161988550|NCT01368081|585006600|FG003|Overall Study|Adverse Event|2|||
161988551|NCT01368081|585006601|FG004|Overall Study|Adverse Event|2|||
161988552|NCT01368081|585006602|FG005|Overall Study|Adverse Event|5|||
161988553|NCT01368081|585006603|FG006|Overall Study|Adverse Event|6|||
161988554|NCT01368081|585006604|FG007|Overall Study|Adverse Event|2|||
161988555|NCT01368081|585006605|FG008|Overall Study|Adverse Event|3|||
161988556|NCT01368081|585006606|FG009|Overall Study|Adverse Event|5|||
161988557|NCT01368081|585006607|FG010|Overall Study|Adverse Event|6|||
161988558|NCT01368081|585006608|FG011|Overall Study|Adverse Event|1|||
161988559|NCT01368081|585006609|FG012|Overall Study|Adverse Event|3|||
161988560|NCT01368081|585006597|FG000|Overall Study|Lack of Efficacy|0|||
161988561|NCT01368081|585006598|FG001|Overall Study|Lack of Efficacy|1|||
161988562|NCT01368081|585006599|FG002|Overall Study|Lack of Efficacy|0|||
161988563|NCT01368081|585006600|FG003|Overall Study|Lack of Efficacy|1|||
161988564|NCT01368081|585006601|FG004|Overall Study|Lack of Efficacy|0|||
161988565|NCT01368081|585006602|FG005|Overall Study|Lack of Efficacy|0|||
161988566|NCT01368081|585006603|FG006|Overall Study|Lack of Efficacy|0|||
161988567|NCT01368081|585006604|FG007|Overall Study|Lack of Efficacy|2|||
161988568|NCT01368081|585006605|FG008|Overall Study|Lack of Efficacy|0|||
161988569|NCT01368081|585006606|FG009|Overall Study|Lack of Efficacy|0|||
161988570|NCT01368081|585006607|FG010|Overall Study|Lack of Efficacy|0|||
161988571|NCT01368081|585006608|FG011|Overall Study|Lack of Efficacy|0|||
161988572|NCT01368081|585006609|FG012|Overall Study|Lack of Efficacy|0|||
161988573|NCT01368081|585006597|FG000|Overall Study|Protocol Violation|0|||
161988574|NCT01368081|585006598|FG001|Overall Study|Protocol Violation|0|||
161988575|NCT01368081|585006599|FG002|Overall Study|Protocol Violation|0|||
161988576|NCT01368081|585006600|FG003|Overall Study|Protocol Violation|0|||
161988577|NCT01368081|585006601|FG004|Overall Study|Protocol Violation|0|||
161988578|NCT01368081|585006602|FG005|Overall Study|Protocol Violation|1|||
161988579|NCT01368081|585006603|FG006|Overall Study|Protocol Violation|0|||
161988580|NCT01368081|585006604|FG007|Overall Study|Protocol Violation|1|||
161988581|NCT01368081|585006605|FG008|Overall Study|Protocol Violation|0|||
161988582|NCT01368081|585006606|FG009|Overall Study|Protocol Violation|0|||
161988583|NCT01368081|585006607|FG010|Overall Study|Protocol Violation|0|||
161988584|NCT01368081|585006608|FG011|Overall Study|Protocol Violation|0|||
161988585|NCT01368081|585006609|FG012|Overall Study|Protocol Violation|0|||
161988586|NCT01368081|585006597|FG000|Overall Study|Lost to Follow-up|0|||
161988587|NCT01368081|585006598|FG001|Overall Study|Lost to Follow-up|0|||
161988588|NCT01368081|585006599|FG002|Overall Study|Lost to Follow-up|0|||
161988589|NCT01368081|585006600|FG003|Overall Study|Lost to Follow-up|0|||
161988590|NCT01368081|585006601|FG004|Overall Study|Lost to Follow-up|0|||
161988591|NCT01368081|585006602|FG005|Overall Study|Lost to Follow-up|0|||
161988592|NCT01368081|585006603|FG006|Overall Study|Lost to Follow-up|0|||
161988593|NCT01368081|585006604|FG007|Overall Study|Lost to Follow-up|0|||
161988594|NCT01368081|585006605|FG008|Overall Study|Lost to Follow-up|0|||
161988595|NCT01368081|585006606|FG009|Overall Study|Lost to Follow-up|0|||
161988596|NCT01368081|585006607|FG010|Overall Study|Lost to Follow-up|0|||
161988597|NCT01368081|585006608|FG011|Overall Study|Lost to Follow-up|0|||
161988598|NCT01368081|585006609|FG012|Overall Study|Lost to Follow-up|1|||
161988599|NCT01368081|585006597|FG000|Overall Study|Withdrawal by Subject|4|||
161988600|NCT01368081|585006598|FG001|Overall Study|Withdrawal by Subject|4|||
161988601|NCT01368081|585006599|FG002|Overall Study|Withdrawal by Subject|1|||
161988602|NCT01368081|585006600|FG003|Overall Study|Withdrawal by Subject|1|||
162035257|NCT02414139|585185895|FG000|Treatment Period|Adverse Event|11|||
162035258|NCT02414139|585185896|FG001|Treatment Period|Adverse Event|6|||
162035259|NCT02414139|585185897|FG002|Treatment Period|Adverse Event|8|||
161988603|NCT01368081|585006601|FG004|Overall Study|Withdrawal by Subject|0|||
161988604|NCT01368081|585006602|FG005|Overall Study|Withdrawal by Subject|3|||
161988605|NCT01368081|585006603|FG006|Overall Study|Withdrawal by Subject|4|||
161988606|NCT01368081|585006604|FG007|Overall Study|Withdrawal by Subject|2|||
161988607|NCT01368081|585006605|FG008|Overall Study|Withdrawal by Subject|5|||
161988608|NCT01368081|585006606|FG009|Overall Study|Withdrawal by Subject|4|||
161988609|NCT01368081|585006607|FG010|Overall Study|Withdrawal by Subject|3|||
161988610|NCT01368081|585006608|FG011|Overall Study|Withdrawal by Subject|2|||
161988611|NCT01368081|585006609|FG012|Overall Study|Withdrawal by Subject|0|||
161988612|NCT01368081|585006597|FG000|Overall Study|Other reason not defined above|2|||
161988613|NCT01368081|585006598|FG001|Overall Study|Other reason not defined above|0|||
161988614|NCT01368081|585006599|FG002|Overall Study|Other reason not defined above|0|||
161988615|NCT01368081|585006600|FG003|Overall Study|Other reason not defined above|1|||
161988616|NCT01368081|585006601|FG004|Overall Study|Other reason not defined above|0|||
161988617|NCT01368081|585006602|FG005|Overall Study|Other reason not defined above|1|||
161988618|NCT01368081|585006603|FG006|Overall Study|Other reason not defined above|2|||
161988619|NCT01368081|585006604|FG007|Overall Study|Other reason not defined above|0|||
161988620|NCT01368081|585006605|FG008|Overall Study|Other reason not defined above|0|||
161988621|NCT01368081|585006606|FG009|Overall Study|Other reason not defined above|1|||
161988622|NCT01368081|585006607|FG010|Overall Study|Other reason not defined above|0|||
161988623|NCT01368081|585006608|FG011|Overall Study|Other reason not defined above|0|||
161988624|NCT01368081|585006609|FG012|Overall Study|Other reason not defined above|3|||
162035260|NCT02414139|585185898|FG003|Treatment Period|Adverse Event|5|||
161988625|NCT02813889|585008090|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
161988626|NCT02813889|585008091|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
161988627|NCT02974257|585008095|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
161988628|NCT02974257|585008096|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
161988629|NCT02974257|585008095|FG000|Overall Study|Clinical indication for thiamine|1|||
161988630|NCT02974257|585008096|FG001|Overall Study|Clinical indication for thiamine|0|||
161988631|NCT02974257|585008095|FG000|Overall Study|Already on thiamine|1|||
161988632|NCT02974257|585008096|FG001|Overall Study|Already on thiamine|0|||
161988633|NCT02974257|585008095|FG000|Overall Study|Extubated prior to study drug|0|||
161988634|NCT02974257|585008096|FG001|Overall Study|Extubated prior to study drug|1|||
161988635|NCT02974257|585008095|FG000|Overall Study|Death|0|||
161988636|NCT02974257|585008096|FG001|Overall Study|Death|1|||
161988637|NCT00398567|585008097|FG000|Overall Study|Disease Progression|3|||
161988638|NCT00398567|585008098|FG001|Overall Study|Disease Progression|4|||
161988639|NCT00398567|585008099|FG002|Overall Study|Disease Progression|27|||
161988640|NCT00398567|585008097|FG000|Overall Study|Withdrawal by Subject|1|||
161988641|NCT00398567|585008098|FG001|Overall Study|Withdrawal by Subject|0|||
161988642|NCT00398567|585008099|FG002|Overall Study|Withdrawal by Subject|4|||
161988643|NCT00398567|585008097|FG000|Overall Study|Adverse Event|0|||
161988644|NCT00398567|585008098|FG001|Overall Study|Adverse Event|0|||
161988645|NCT00398567|585008099|FG002|Overall Study|Adverse Event|2|||
161988646|NCT00398567|585008097|FG000|Overall Study|Protocol Violation|0|||
161988647|NCT00398567|585008098|FG001|Overall Study|Protocol Violation|0|||
161988648|NCT00398567|585008099|FG002|Overall Study|Protocol Violation|1|||
161988649|NCT00517361|585008105|FG000|Overall Study|Death|6|||
161988650|NCT00517361|585008105|FG000|Overall Study|The study was terminated|5|||
161988651|NCT01858766|585008106|FG000|Overall Study|Randomized but Never Treated|0|||
161988652|NCT01858766|585008107|FG001|Overall Study|Randomized but Never Treated|0|||
161988653|NCT01858766|585008108|FG002|Overall Study|Randomized but Never Treated|0|||
161988654|NCT01858766|585008109|FG003|Overall Study|Randomized but Never Treated|0|||
161988655|NCT01858766|585008110|FG004|Overall Study|Randomized but Never Treated|0|||
161988656|NCT01858766|585008111|FG005|Overall Study|Randomized but Never Treated|1|||
161988657|NCT01858766|585008112|FG006|Overall Study|Randomized but Never Treated|0|||
161988658|NCT01858766|585008113|FG007|Overall Study|Randomized but Never Treated|0|||
161988659|NCT01858766|585008114|FG008|Overall Study|Randomized but Never Treated|0|||
161988660|NCT01858766|585008115|FG009|Overall Study|Randomized but Never Treated|0|||
161988661|NCT01858766|585008116|FG010|Overall Study|Randomized but Never Treated|0|||
161988662|NCT01858766|585008117|FG011|Overall Study|Randomized but Never Treated|0|||
161988663|NCT01858766|585008118|FG012|Overall Study|Randomized but Never Treated|0|||
161988664|NCT01858766|585008119|FG013|Overall Study|Randomized but Never Treated|0|||
161988665|NCT01858766|585008120|FG014|Overall Study|Randomized but Never Treated|0|||
161988666|NCT01858766|585008121|FG015|Overall Study|Randomized but Never Treated|0|||
161988667|NCT01858766|585008122|FG016|Overall Study|Randomized but Never Treated|0|||
161988668|NCT01858766|585008123|FG017|Overall Study|Randomized but Never Treated|1|||
161988669|NCT01858766|585008124|FG018|Overall Study|Randomized but Never Treated|0|||
161988670|NCT01858766|585008106|FG000|Overall Study|Death|0|||
161988671|NCT01858766|585008107|FG001|Overall Study|Death|0|||
161988672|NCT01858766|585008108|FG002|Overall Study|Death|1|||
161988673|NCT01858766|585008109|FG003|Overall Study|Death|0|||
161988674|NCT01858766|585008110|FG004|Overall Study|Death|0|||
161988675|NCT01858766|585008111|FG005|Overall Study|Death|0|||
161988676|NCT01858766|585008112|FG006|Overall Study|Death|0|||
161988677|NCT01858766|585008113|FG007|Overall Study|Death|0|||
161988678|NCT01858766|585008114|FG008|Overall Study|Death|0|||
161988679|NCT01858766|585008115|FG009|Overall Study|Death|0|||
161988680|NCT01858766|585008116|FG010|Overall Study|Death|0|||
161988681|NCT01858766|585008117|FG011|Overall Study|Death|0|||
161988682|NCT01858766|585008118|FG012|Overall Study|Death|0|||
161988683|NCT01858766|585008119|FG013|Overall Study|Death|0|||
161988684|NCT01858766|585008120|FG014|Overall Study|Death|0|||
161988685|NCT01858766|585008121|FG015|Overall Study|Death|0|||
161988686|NCT01858766|585008122|FG016|Overall Study|Death|0|||
161988687|NCT01858766|585008123|FG017|Overall Study|Death|0|||
161988688|NCT01858766|585008124|FG018|Overall Study|Death|0|||
161988689|NCT01858766|585008106|FG000|Overall Study|Lack of Efficacy|1|||
161988690|NCT01858766|585008107|FG001|Overall Study|Lack of Efficacy|0|||
161988691|NCT01858766|585008108|FG002|Overall Study|Lack of Efficacy|0|||
161988692|NCT01858766|585008109|FG003|Overall Study|Lack of Efficacy|0|||
161988693|NCT01858766|585008110|FG004|Overall Study|Lack of Efficacy|1|||
161988694|NCT01858766|585008111|FG005|Overall Study|Lack of Efficacy|2|||
161988695|NCT01858766|585008112|FG006|Overall Study|Lack of Efficacy|0|||
161988696|NCT01858766|585008113|FG007|Overall Study|Lack of Efficacy|0|||
161988697|NCT01858766|585008114|FG008|Overall Study|Lack of Efficacy|0|||
161988698|NCT01858766|585008115|FG009|Overall Study|Lack of Efficacy|0|||
161988699|NCT01858766|585008116|FG010|Overall Study|Lack of Efficacy|0|||
161988700|NCT01858766|585008117|FG011|Overall Study|Lack of Efficacy|3|||
161988701|NCT01858766|585008118|FG012|Overall Study|Lack of Efficacy|5|||
161988702|NCT01858766|585008119|FG013|Overall Study|Lack of Efficacy|3|||
161988703|NCT01858766|585008120|FG014|Overall Study|Lack of Efficacy|5|||
161988704|NCT01858766|585008121|FG015|Overall Study|Lack of Efficacy|5|||
161988705|NCT01858766|585008122|FG016|Overall Study|Lack of Efficacy|2|||
161988706|NCT01858766|585008123|FG017|Overall Study|Lack of Efficacy|3|||
161988707|NCT01858766|585008124|FG018|Overall Study|Lack of Efficacy|3|||
161988708|NCT01858766|585008106|FG000|Overall Study|Lost to Follow-up|0|||
161988709|NCT01858766|585008107|FG001|Overall Study|Lost to Follow-up|0|||
161988710|NCT01858766|585008108|FG002|Overall Study|Lost to Follow-up|0|||
161988711|NCT01858766|585008109|FG003|Overall Study|Lost to Follow-up|0|||
161988712|NCT01858766|585008110|FG004|Overall Study|Lost to Follow-up|0|||
161988713|NCT01858766|585008111|FG005|Overall Study|Lost to Follow-up|1|||
161988714|NCT01858766|585008112|FG006|Overall Study|Lost to Follow-up|0|||
161988715|NCT01858766|585008113|FG007|Overall Study|Lost to Follow-up|2|||
161988716|NCT01858766|585008114|FG008|Overall Study|Lost to Follow-up|0|||
161988717|NCT01858766|585008115|FG009|Overall Study|Lost to Follow-up|0|||
161988718|NCT01858766|585008116|FG010|Overall Study|Lost to Follow-up|0|||
161988719|NCT01858766|585008117|FG011|Overall Study|Lost to Follow-up|1|||
161988720|NCT01858766|585008118|FG012|Overall Study|Lost to Follow-up|0|||
161988721|NCT01858766|585008119|FG013|Overall Study|Lost to Follow-up|0|||
161988722|NCT01858766|585008120|FG014|Overall Study|Lost to Follow-up|3|||
161988723|NCT01858766|585008121|FG015|Overall Study|Lost to Follow-up|1|||
161988724|NCT01858766|585008122|FG016|Overall Study|Lost to Follow-up|1|||
161988725|NCT01858766|585008123|FG017|Overall Study|Lost to Follow-up|0|||
161988726|NCT01858766|585008124|FG018|Overall Study|Lost to Follow-up|1|||
161988727|NCT01858766|585008106|FG000|Overall Study|Withdrew Consent|0|||
161988728|NCT01858766|585008107|FG001|Overall Study|Withdrew Consent|0|||
161988729|NCT01858766|585008108|FG002|Overall Study|Withdrew Consent|0|||
161988730|NCT01858766|585008109|FG003|Overall Study|Withdrew Consent|0|||
161988731|NCT01858766|585008110|FG004|Overall Study|Withdrew Consent|0|||
161988732|NCT01858766|585008111|FG005|Overall Study|Withdrew Consent|0|||
161988733|NCT01858766|585008112|FG006|Overall Study|Withdrew Consent|0|||
161988734|NCT01858766|585008113|FG007|Overall Study|Withdrew Consent|0|||
161988735|NCT01858766|585008114|FG008|Overall Study|Withdrew Consent|0|||
161988736|NCT01858766|585008115|FG009|Overall Study|Withdrew Consent|0|||
161988737|NCT01858766|585008116|FG010|Overall Study|Withdrew Consent|0|||
161988738|NCT01858766|585008117|FG011|Overall Study|Withdrew Consent|1|||
161988739|NCT01858766|585008118|FG012|Overall Study|Withdrew Consent|0|||
161988740|NCT01858766|585008119|FG013|Overall Study|Withdrew Consent|0|||
161988741|NCT01858766|585008120|FG014|Overall Study|Withdrew Consent|0|||
161988742|NCT01858766|585008121|FG015|Overall Study|Withdrew Consent|0|||
161988743|NCT01858766|585008122|FG016|Overall Study|Withdrew Consent|0|||
161988744|NCT01858766|585008123|FG017|Overall Study|Withdrew Consent|0|||
161988745|NCT01858766|585008124|FG018|Overall Study|Withdrew Consent|0|||
161988746|NCT05438576|585008139|FG000|Overall Study|Death|1|||
161988747|NCT05438576|585008140|FG001|Overall Study|Death|1|||
161988748|NCT05438576|585008139|FG000|Overall Study|Withdrawal by Subject|4|||
161988749|NCT05438576|585008140|FG001|Overall Study|Withdrawal by Subject|2|||
161988750|NCT05438576|585008139|FG000|Overall Study|Not Eligible|2|||
161988751|NCT05438576|585008140|FG001|Overall Study|Not Eligible|1|||
162035261|NCT02414139|585185899|FG004|Treatment Period|Adverse Event|14|||
162035262|NCT02414139|585185900|FG005|Treatment Period|Adverse Event|3|||
161988752|NCT05438576|585008139|FG000|Overall Study|Did not complete baseline testing|22|||
161988753|NCT05438576|585008140|FG001|Overall Study|Did not complete baseline testing|4|||
161988754|NCT02881762|585008143|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161988755|NCT02881762|585008144|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161988756|NCT00245037|585008145|FG000|Overall Study|Death|17|||
161988757|NCT00296140|585008147|FG000|Overall Study|Lost to Follow-up|1|||
161988758|NCT00296140|585008148|FG001|Overall Study|Lost to Follow-up|0|||
161988759|NCT00296140|585008147|FG000|Overall Study|Withdrawal by Subject|1|||
161988760|NCT00296140|585008148|FG001|Overall Study|Withdrawal by Subject|0|||
161988761|NCT00296140|585008147|FG000|Overall Study|Discharge to Nursing Home|1|||
161988762|NCT00296140|585008148|FG001|Overall Study|Discharge to Nursing Home|0|||
161988763|NCT00880191|585008155|FG000|Overall Study|Refused further treatment|4|||
161988764|NCT00880191|585008156|FG001|Overall Study|Refused further treatment|1|||
161988765|NCT00880191|585008155|FG000|Overall Study|Adverse Event|8|||
161988766|NCT00880191|585008156|FG001|Overall Study|Adverse Event|6|||
161988767|NCT00880191|585008155|FG000|Overall Study|Hospitalization/efficacy|1|||
161775783|NCT00183170|584221252|FG000|First Intervention|Did not complete study|1|||
161775784|NCT00183170|584221253|FG001|First Intervention|Did not complete study|0|||
161775785|NCT00183170|584221252|FG000|First Intervention|Did not meet targeted BrAC|1|||
161775786|NCT00183170|584221253|FG001|First Intervention|Did not meet targeted BrAC|0|||
161775787|NCT00183170|584221252|FG000|Washout 1 Week|Did not complete study|6|||
161775788|NCT00183170|584221253|FG001|Washout 1 Week|Did not complete study|8|||
161775789|NCT00183170|584221252|FG000|Second Intervention|Did not complete study|1|||
161775790|NCT00183170|584221253|FG001|Second Intervention|Did not complete study|0|||
161775791|NCT00183170|584221252|FG000|Second Intervention|Did not meet targeted BrAC|0|||
161775792|NCT00183170|584221253|FG001|Second Intervention|Did not meet targeted BrAC|2|||
161775793|NCT01165424|584221254|FG000|Overall Study|Clinical adverse experiences|1|||
161775794|NCT01165424|584221254|FG000|Overall Study|Laboratory adverse experiences|1|||
161775795|NCT01165424|584221254|FG000|Overall Study|Did not meet entry criteria|1|||
161775796|NCT01165424|584221254|FG000|Overall Study|Participant moved (relocated)|1|||
161775797|NCT02050373|584221260|FG000|Overall Study|Adverse Event|4|||
161775798|NCT02050373|584221261|FG001|Overall Study|Adverse Event|7|||
161775799|NCT02050373|584221260|FG000|Overall Study|Death|3|||
161775800|NCT02050373|584221261|FG001|Overall Study|Death|3|||
161775801|NCT00807040|584221265|FG000|Overall Study|Death|24|||
161775802|NCT00807040|584221266|FG001|Overall Study|Death|29|||
161775803|NCT00807040|584221265|FG000|Overall Study|Withdrawal by Subject|8|||
161775804|NCT00807040|584221266|FG001|Overall Study|Withdrawal by Subject|6|||
161775805|NCT00807040|584221265|FG000|Overall Study|Lost to Follow-up|4|||
161775806|NCT00807040|584221266|FG001|Overall Study|Lost to Follow-up|6|||
161775807|NCT01067339|584221267|FG000|Overall Study|Withdrawal by Subject|6|||
161775808|NCT01067339|584221268|FG001|Overall Study|Withdrawal by Subject|5|||
161775809|NCT01179191|584221269|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
161775810|NCT01179191|584221269|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
161775811|NCT01179191|584221269|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
161775812|NCT01179191|584221269|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
161775813|NCT01179191|584221269|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
161775814|NCT01179191|584221269|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
161775815|NCT01179191|584221269|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
161775816|NCT01179191|584221269|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
161775817|NCT01179191|584221269|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
161775818|NCT01179191|584221269|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
161775819|NCT01179191|584221269|FG000|Maintenance Phase (8 Weeks)|Other|66|||
161775820|NCT00572910|584221274|FG000|Overall Study|Adverse Event|1|||
161775821|NCT00572910|584221275|FG001|Overall Study|Adverse Event|2|||
161775822|NCT00572910|584221276|FG002|Overall Study|Adverse Event|0|||
161775823|NCT00572910|584221277|FG003|Overall Study|Adverse Event|2|||
161775824|NCT00572910|584221278|FG004|Overall Study|Adverse Event|0|||
161775825|NCT00572910|584221279|FG005|Overall Study|Adverse Event|0|||
161775826|NCT00572910|584221280|FG006|Overall Study|Adverse Event|4|||
161775827|NCT00572910|584221281|FG007|Overall Study|Adverse Event|2|||
161775828|NCT00572910|584221282|FG008|Overall Study|Adverse Event|1|||
161775829|NCT00572910|584221283|FG009|Overall Study|Adverse Event|3|||
161775830|NCT00572910|584221284|FG010|Overall Study|Adverse Event|2|||
161775831|NCT00572910|584221274|FG000|Overall Study|Lost to Follow-up|0|||
161775832|NCT00572910|584221275|FG001|Overall Study|Lost to Follow-up|1|||
161775833|NCT00572910|584221276|FG002|Overall Study|Lost to Follow-up|1|||
161775834|NCT00572910|584221277|FG003|Overall Study|Lost to Follow-up|2|||
161775835|NCT00572910|584221278|FG004|Overall Study|Lost to Follow-up|1|||
161775836|NCT00572910|584221279|FG005|Overall Study|Lost to Follow-up|0|||
161775837|NCT00572910|584221280|FG006|Overall Study|Lost to Follow-up|0|||
161775838|NCT00572910|584221281|FG007|Overall Study|Lost to Follow-up|0|||
161775839|NCT00572910|584221282|FG008|Overall Study|Lost to Follow-up|0|||
161775840|NCT00572910|584221283|FG009|Overall Study|Lost to Follow-up|1|||
161775841|NCT00572910|584221284|FG010|Overall Study|Lost to Follow-up|0|||
161775842|NCT00572910|584221274|FG000|Overall Study|Withdrawal by Subject|3|||
161775843|NCT00572910|584221275|FG001|Overall Study|Withdrawal by Subject|0|||
161775844|NCT00572910|584221276|FG002|Overall Study|Withdrawal by Subject|1|||
161775845|NCT00572910|584221277|FG003|Overall Study|Withdrawal by Subject|0|||
161775846|NCT00572910|584221278|FG004|Overall Study|Withdrawal by Subject|1|||
161775847|NCT00572910|584221279|FG005|Overall Study|Withdrawal by Subject|3|||
161775848|NCT00572910|584221280|FG006|Overall Study|Withdrawal by Subject|0|||
161775849|NCT00572910|584221281|FG007|Overall Study|Withdrawal by Subject|2|||
161775850|NCT00572910|584221282|FG008|Overall Study|Withdrawal by Subject|2|||
161775851|NCT00572910|584221283|FG009|Overall Study|Withdrawal by Subject|2|||
161775852|NCT00572910|584221284|FG010|Overall Study|Withdrawal by Subject|1|||
161775853|NCT01833897|584221290|FG000|Overall Study|Lack of Efficacy|1|||
161775854|NCT05275673|584221291|FG000|Overall Study|Study Termination by Sponsor|2|||
161775855|NCT05275673|584221292|FG001|Overall Study|Study Termination by Sponsor|3|||
161775856|NCT05275673|584221291|FG000|Overall Study|Death|1|||
161775857|NCT05275673|584221292|FG001|Overall Study|Death|0|||
161775858|NCT05275673|584221291|FG000|Overall Study|Withdrawal by Subject|1|||
161872708|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
161872709|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
161872710|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
161872711|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
161872712|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
161872713|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
161872714|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
161872715|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
161872716|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
161872717|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
161872718|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
161872719|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
161872720|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
161872721|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
161872722|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
161872723|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
161872724|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
161872725|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
161872726|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
161872727|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
161872728|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
161872729|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
161872730|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
161872731|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
161872732|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
161872733|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
161872734|NCT00839527|584578586|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
161872735|NCT00839527|584578587|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
161872736|NCT00839527|584578588|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
161872737|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
161872738|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
161872739|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
161872740|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
161872741|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
161872742|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
161872743|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
161872744|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
161872745|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
161872746|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
161872747|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
161872748|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
161872749|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
161872750|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
161872751|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
161872752|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
161872753|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
161872754|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
161872755|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
161872756|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
161872757|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
161872758|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
161872759|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
161872760|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
161872761|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
161872762|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
161872763|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
161872764|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
161872765|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
161872766|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
161872767|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
161872768|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
161872769|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
162035263|NCT02414139|585185901|FG006|Treatment Period|Adverse Event|6|||
162035264|NCT02414139|585185902|FG007|Treatment Period|Adverse Event|1|||
162035265|NCT02414139|585185903|FG008|Treatment Period|Adverse Event|6|||
161988768|NCT00880191|585008156|FG001|Overall Study|Hospitalization/efficacy|1|||
161988769|NCT01843062|585008158|FG000|Overall Study|Protocol Violation|1|||
161988770|NCT01843062|585008159|FG001|Overall Study|Protocol Violation|0|||
161988771|NCT01843062|585008158|FG000|Overall Study|New treatment following progression|2|||
161988772|NCT01843062|585008159|FG001|Overall Study|New treatment following progression|0|||
161988773|NCT01843062|585008158|FG000|Overall Study|Pregnancy|1|||
161988774|NCT01843062|585008159|FG001|Overall Study|Pregnancy|0|||
161988775|NCT01843062|585008158|FG000|Overall Study|Adverse Event|2|||
161988776|NCT01843062|585008159|FG001|Overall Study|Adverse Event|0|||
161988777|NCT01843062|585008158|FG000|Overall Study|Incorrect randomisation|1|||
161988778|NCT01843062|585008159|FG001|Overall Study|Incorrect randomisation|0|||
161988779|NCT01843062|585008158|FG000|Overall Study|Withdrawal by Subject|12|||
161988780|NCT01843062|585008159|FG001|Overall Study|Withdrawal by Subject|3|||
161988781|NCT01843062|585008158|FG000|Overall Study|Death|1|||
161988782|NCT01843062|585008159|FG001|Overall Study|Death|2|||
161988783|NCT01843062|585008158|FG000|Overall Study|Lost to Follow-up|2|||
161988784|NCT01843062|585008159|FG001|Overall Study|Lost to Follow-up|4|||
161988785|NCT00994422|585008163|FG000|Overall Study|Lost to Follow-up|7|||
161988786|NCT00994422|585008164|FG001|Overall Study|Lost to Follow-up|1|||
161988787|NCT02669212|585008165|FG000|Overall Study|Lost to Follow-up|1|||
161988788|NCT02669212|585008166|FG001|Overall Study|Lost to Follow-up|0|||
161988789|NCT02669212|585008165|FG000|Overall Study|Medical Condition|3|||
161988790|NCT02669212|585008166|FG001|Overall Study|Medical Condition|4|||
161988791|NCT02669212|585008165|FG000|Overall Study|Withdrawal by Subject|0|||
161988792|NCT02669212|585008166|FG001|Overall Study|Withdrawal by Subject|2|||
161988793|NCT02669212|585008165|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
161988794|NCT02669212|585008166|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
161988795|NCT03549104|585008169|FG000|Overall Study|Withdrawal by Subject|5|||
161988796|NCT03549104|585008170|FG001|Overall Study|Withdrawal by Subject|2|||
161988797|NCT03549104|585008169|FG000|Overall Study|Covid shelter in place|1|||
161988798|NCT03549104|585008170|FG001|Overall Study|Covid shelter in place|2|||
161988799|NCT04124705|585008171|FG000|Titration Period|Adverse Event|9|||
161988800|NCT04124705|585008172|FG001|Titration Period|Adverse Event|5|||
161988801|NCT04124705|585008171|FG000|Titration Period|Withdrawal by Subject|6|||
161988802|NCT04124705|585008172|FG001|Titration Period|Withdrawal by Subject|3|||
161988803|NCT04124705|585008171|FG000|Titration Period|Lost to Follow-up|0|||
161988804|NCT04124705|585008172|FG001|Titration Period|Lost to Follow-up|1|||
161988805|NCT04124705|585008171|FG000|Titration Period|Death|1|||
161988806|NCT04124705|585008172|FG001|Titration Period|Death|1|||
161988807|NCT04124705|585008171|FG000|Titration Period|Lack of Efficacy|2|||
161988808|NCT04124705|585008172|FG001|Titration Period|Lack of Efficacy|0|||
161988809|NCT04124705|585008171|FG000|Titration Period|Physician Decision|2|||
161988810|NCT04124705|585008172|FG001|Titration Period|Physician Decision|0|||
161988811|NCT04124705|585008171|FG000|Titration Period|Non-compliance with Study Drug|2|||
161988812|NCT04124705|585008172|FG001|Titration Period|Non-compliance with Study Drug|0|||
161988813|NCT04124705|585008171|FG000|Titration Period|Other|4|||
161988814|NCT04124705|585008172|FG001|Titration Period|Other|9|||
161988815|NCT04124705|585008171|FG000|Stabilization Period|Adverse Event|4|||
161988816|NCT04124705|585008172|FG001|Stabilization Period|Adverse Event|2|||
161988817|NCT04124705|585008171|FG000|Stabilization Period|Withdrawal by Subject|1|||
161988818|NCT04124705|585008172|FG001|Stabilization Period|Withdrawal by Subject|1|||
161988819|NCT04124705|585008171|FG000|Stabilization Period|Lost to Follow-up|0|||
161988820|NCT04124705|585008172|FG001|Stabilization Period|Lost to Follow-up|1|||
161988821|NCT04124705|585008171|FG000|Stabilization Period|Lack of Efficacy|4|||
161988822|NCT04124705|585008172|FG001|Stabilization Period|Lack of Efficacy|2|||
161988823|NCT04124705|585008171|FG000|Stabilization Period|Protocol Deviation|0|||
161988824|NCT04124705|585008172|FG001|Stabilization Period|Protocol Deviation|2|||
161988825|NCT04124705|585008171|FG000|Stabilization Period|Other|2|||
161988826|NCT04124705|585008172|FG001|Stabilization Period|Other|2|||
161988827|NCT03422536|585008173|FG000|Randomized|Physician Decision|1|||
161988828|NCT03422536|585008174|FG001|Randomized|Physician Decision|1|||
161988829|NCT03422536|585008173|FG000|Allocation - Received Intervention|Disease progression|19|||
161775859|NCT05275673|584221292|FG001|Overall Study|Withdrawal by Subject|0|||
161988830|NCT03422536|585008174|FG001|Allocation - Received Intervention|Disease progression|25|||
161988831|NCT03422536|585008173|FG000|Allocation - Received Intervention|Death|1|||
161988832|NCT03422536|585008174|FG001|Allocation - Received Intervention|Death|3|||
161988833|NCT03422536|585008173|FG000|Allocation - Received Intervention|Adverse Event|1|||
161988834|NCT03422536|585008174|FG001|Allocation - Received Intervention|Adverse Event|0|||
161988835|NCT03422536|585008173|FG000|Allocation - Received Intervention|Physician Decision|1|||
161988836|NCT03422536|585008174|FG001|Allocation - Received Intervention|Physician Decision|1|||
161988837|NCT03422536|585008173|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
161988838|NCT03422536|585008174|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
161988839|NCT03422536|585008173|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
161988840|NCT03422536|585008174|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
161775860|NCT02325739|584221293|FG000|Phase I Part|Adverse Event|1|||
161775861|NCT02325739|584221294|FG001|Phase I Part|Adverse Event|0|||
161872770|NCT00839527|584578586|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
161872771|NCT00839527|584578587|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
161872772|NCT00839527|584578588|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
161872773|NCT02751450|584578589|FG000|Overall Study|Adverse Event|1|||
161872774|NCT02751450|584578590|FG001|Overall Study|Adverse Event|0|||
161872775|NCT02587598|584578591|FG000|Overall Study|Death|4|||
161988841|NCT01973998|585008175|FG000|Overall Study|Death|2|||
161988842|NCT01973998|585008176|FG001|Overall Study|Death|2|||
161988843|NCT02540993|585008183|FG000|Overall Study|Lost to Follow-up|5|||
161988844|NCT02540993|585008184|FG001|Overall Study|Lost to Follow-up|3|||
161988845|NCT02540993|585008183|FG000|Overall Study|Withdrawal by Subject|4|||
161988846|NCT02540993|585008184|FG001|Overall Study|Withdrawal by Subject|6|||
161988847|NCT02540993|585008183|FG000|Overall Study|GCP violations|33|||
161988848|NCT02540993|585008184|FG001|Overall Study|GCP violations|27|||
161988849|NCT00932165|585008187|FG000|Overall Study|Lost to Follow-up|1|||
161988850|NCT01620528|585008188|FG000|Treatment Period|Did Not Receive Study Drug|0|||
161988851|NCT01620528|585008189|FG001|Treatment Period|Did Not Receive Study Drug|0|||
161988852|NCT01620528|585008190|FG002|Treatment Period|Did Not Receive Study Drug|1|||
161988853|NCT01620528|585008188|FG000|Treatment Period|Withdrawal by Subject|35|||
161988854|NCT01620528|585008189|FG001|Treatment Period|Withdrawal by Subject|21|||
161988855|NCT01620528|585008190|FG002|Treatment Period|Withdrawal by Subject|16|||
161988856|NCT01620528|585008188|FG000|Treatment Period|Adverse Event|17|||
161988857|NCT01620528|585008189|FG001|Treatment Period|Adverse Event|13|||
161988858|NCT01620528|585008190|FG002|Treatment Period|Adverse Event|21|||
161988859|NCT01620528|585008188|FG000|Treatment Period|Lost to Follow-up|16|||
161988860|NCT01620528|585008189|FG001|Treatment Period|Lost to Follow-up|8|||
161988861|NCT01620528|585008190|FG002|Treatment Period|Lost to Follow-up|14|||
161988862|NCT01620528|585008188|FG000|Treatment Period|Other|9|||
161988863|NCT01620528|585008189|FG001|Treatment Period|Other|5|||
161988864|NCT01620528|585008190|FG002|Treatment Period|Other|7|||
161988865|NCT01620528|585008188|FG000|Treatment Period|Subject Noncompliant|11|||
161988866|NCT01620528|585008189|FG001|Treatment Period|Subject Noncompliant|2|||
161988867|NCT01620528|585008190|FG002|Treatment Period|Subject Noncompliant|2|||
161988868|NCT01620528|585008188|FG000|Treatment Period|Pregnancy|7|||
161988869|NCT01620528|585008189|FG001|Treatment Period|Pregnancy|2|||
161988870|NCT01620528|585008190|FG002|Treatment Period|Pregnancy|2|||
161988871|NCT01620528|585008188|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
161988872|NCT01620528|585008189|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
161988873|NCT01620528|585008190|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
161988874|NCT01620528|585008188|FG000|Treatment Period|Exclusionary Medication Received|0|||
161988875|NCT01620528|585008189|FG001|Treatment Period|Exclusionary Medication Received|1|||
161988876|NCT01620528|585008190|FG002|Treatment Period|Exclusionary Medication Received|0|||
161988877|NCT01620528|585008188|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
161988878|NCT01620528|585008189|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
161988879|NCT01620528|585008190|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
161988880|NCT01620528|585008188|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
161988881|NCT01620528|585008189|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
161988882|NCT01620528|585008190|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
161988883|NCT01620528|585008188|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
161988884|NCT01620528|585008189|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
161988885|NCT01620528|585008190|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
161988886|NCT01620528|585008188|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
161988887|NCT01620528|585008189|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
161988888|NCT01620528|585008190|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
161988889|NCT01620528|585008188|FG000|Post-Treatment Follow-Up Period|Other|6|||
161988890|NCT01620528|585008189|FG001|Post-Treatment Follow-Up Period|Other|4|||
161988891|NCT01620528|585008190|FG002|Post-Treatment Follow-Up Period|Other|2|||
161988892|NCT03997825|585008199|FG000|Overall Study|Death|3|||
161988893|NCT03997825|585008199|FG000|Overall Study|Lost to Follow-up|10|||
161988894|NCT03997825|585008199|FG000|Overall Study|Withdrawal by Subject|3|||
161988895|NCT03997825|585008199|FG000|Overall Study|Refused participation|1|||
161988896|NCT01153698|585008200|FG000|Overall Study|Adverse Event|12|||
161988897|NCT01153698|585008200|FG000|Overall Study|Lost to Follow-up|4|||
161988898|NCT01153698|585008200|FG000|Overall Study|Withdrawal by Subject|2|||
161988899|NCT01153698|585008200|FG000|Overall Study|Switch to other anticoagulants|4|||
161988900|NCT01153698|585008200|FG000|Overall Study|Other|2|||
161872776|NCT02587598|584578592|FG001|Overall Study|Death|8|||
161988901|NCT01153698|585008200|FG000|Overall Study|Not treated with Pradaxa|5|||
161988902|NCT00465647|585008202|FG000|Overall Study|Administrative|2|||
161988903|NCT00465647|585008203|FG001|Overall Study|Administrative|2|||
161988904|NCT00465647|585008204|FG002|Overall Study|Administrative|3|||
161988905|NCT00465647|585008205|FG003|Overall Study|Administrative|2|||
161988906|NCT00465647|585008202|FG000|Overall Study|Adverse Event|2|||
161988907|NCT00465647|585008203|FG001|Overall Study|Adverse Event|0|||
161988908|NCT00465647|585008204|FG002|Overall Study|Adverse Event|3|||
161872777|NCT02587598|584578593|FG002|Overall Study|Death|4|||
161872778|NCT02587598|584578594|FG003|Overall Study|Death|16|||
161872779|NCT02587598|584578595|FG004|Overall Study|Death|9|||
161872780|NCT02587598|584578596|FG005|Overall Study|Death|4|||
161872781|NCT02587598|584578597|FG006|Overall Study|Death|6|||
161872782|NCT02587598|584578598|FG007|Overall Study|Death|7|||
161872783|NCT02587598|584578599|FG008|Overall Study|Death|9|||
161872784|NCT02587598|584578600|FG009|Overall Study|Death|1|||
161872785|NCT02587598|584578601|FG010|Overall Study|Death|3|||
161872786|NCT02587598|584578591|FG000|Overall Study|Study Terminated by the Sponsor|0|||
161872787|NCT02587598|584578592|FG001|Overall Study|Study Terminated by the Sponsor|1|||
161872788|NCT02587598|584578593|FG002|Overall Study|Study Terminated by the Sponsor|0|||
161872789|NCT02587598|584578594|FG003|Overall Study|Study Terminated by the Sponsor|3|||
161872790|NCT02587598|584578595|FG004|Overall Study|Study Terminated by the Sponsor|0|||
161872791|NCT02587598|584578596|FG005|Overall Study|Study Terminated by the Sponsor|1|||
161872792|NCT02587598|584578597|FG006|Overall Study|Study Terminated by the Sponsor|0|||
161872793|NCT02587598|584578598|FG007|Overall Study|Study Terminated by the Sponsor|0|||
161872794|NCT02587598|584578599|FG008|Overall Study|Study Terminated by the Sponsor|0|||
161872795|NCT02587598|584578600|FG009|Overall Study|Study Terminated by the Sponsor|1|||
161872796|NCT02587598|584578601|FG010|Overall Study|Study Terminated by the Sponsor|6|||
161872797|NCT02587598|584578591|FG000|Overall Study|Reason for study withdrawal not specified|0|||
161872798|NCT02587598|584578592|FG001|Overall Study|Reason for study withdrawal not specified|1|||
161872799|NCT02587598|584578593|FG002|Overall Study|Reason for study withdrawal not specified|0|||
161872800|NCT02587598|584578594|FG003|Overall Study|Reason for study withdrawal not specified|0|||
161872801|NCT02587598|584578595|FG004|Overall Study|Reason for study withdrawal not specified|0|||
161872802|NCT02587598|584578596|FG005|Overall Study|Reason for study withdrawal not specified|0|||
161872803|NCT02587598|584578597|FG006|Overall Study|Reason for study withdrawal not specified|0|||
161872804|NCT02587598|584578598|FG007|Overall Study|Reason for study withdrawal not specified|0|||
161872805|NCT02587598|584578599|FG008|Overall Study|Reason for study withdrawal not specified|0|||
161872806|NCT02587598|584578600|FG009|Overall Study|Reason for study withdrawal not specified|0|||
161872807|NCT02587598|584578601|FG010|Overall Study|Reason for study withdrawal not specified|0|||
161872808|NCT02587598|584578591|FG000|Overall Study|Withdrawal by Subject|0|||
161872809|NCT02587598|584578592|FG001|Overall Study|Withdrawal by Subject|1|||
161872810|NCT02587598|584578593|FG002|Overall Study|Withdrawal by Subject|0|||
161872811|NCT02587598|584578594|FG003|Overall Study|Withdrawal by Subject|2|||
161872812|NCT02587598|584578595|FG004|Overall Study|Withdrawal by Subject|3|||
161872813|NCT02587598|584578596|FG005|Overall Study|Withdrawal by Subject|1|||
161872814|NCT02587598|584578597|FG006|Overall Study|Withdrawal by Subject|0|||
161872815|NCT02587598|584578598|FG007|Overall Study|Withdrawal by Subject|0|||
161872816|NCT02587598|584578599|FG008|Overall Study|Withdrawal by Subject|0|||
161872817|NCT02587598|584578600|FG009|Overall Study|Withdrawal by Subject|1|||
161872818|NCT02587598|584578601|FG010|Overall Study|Withdrawal by Subject|2|||
161872819|NCT02587598|584578591|FG000|Overall Study|Physician Decision|0|||
161872820|NCT02587598|584578592|FG001|Overall Study|Physician Decision|0|||
161872821|NCT02587598|584578593|FG002|Overall Study|Physician Decision|0|||
161872822|NCT02587598|584578594|FG003|Overall Study|Physician Decision|0|||
161872823|NCT02587598|584578595|FG004|Overall Study|Physician Decision|0|||
161872824|NCT02587598|584578596|FG005|Overall Study|Physician Decision|0|||
161872825|NCT02587598|584578597|FG006|Overall Study|Physician Decision|0|||
161872826|NCT02587598|584578598|FG007|Overall Study|Physician Decision|0|||
161872827|NCT02587598|584578599|FG008|Overall Study|Physician Decision|0|||
161872828|NCT02587598|584578600|FG009|Overall Study|Physician Decision|0|||
161988909|NCT00465647|585008205|FG003|Overall Study|Adverse Event|2|||
161988910|NCT00465647|585008202|FG000|Overall Study|Withdrawal by Subject|1|||
161988911|NCT00465647|585008203|FG001|Overall Study|Withdrawal by Subject|2|||
161988912|NCT00465647|585008204|FG002|Overall Study|Withdrawal by Subject|2|||
161988913|NCT00465647|585008205|FG003|Overall Study|Withdrawal by Subject|7|||
161988914|NCT00465647|585008202|FG000|Overall Study|"The other reasons included loss of IV"|8|||
161988915|NCT00465647|585008203|FG001|Overall Study|"The other reasons included loss of IV"|4|||
161988916|NCT00465647|585008204|FG002|Overall Study|"The other reasons included loss of IV"|3|||
161988917|NCT00465647|585008205|FG003|Overall Study|"The other reasons included loss of IV"|2|||
161988918|NCT01240135|585008206|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
161988919|NCT01240135|585008207|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
161988920|NCT01240135|585008206|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
161988921|NCT01240135|585008207|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
161988922|NCT02220712|585008208|FG000|Overall Study|Adverse Event|1|||
161988923|NCT02220712|585008208|FG000|Overall Study|Withdrawal by Subject|2|||
161872829|NCT02587598|584578601|FG010|Overall Study|Physician Decision|3|||
161872830|NCT00679289|584578602|FG000|Overall Study|Progressive disease|4|||
161872831|NCT00679289|584578603|FG001|Overall Study|Progressive disease|5|||
161872832|NCT00679289|584578604|FG002|Overall Study|Progressive disease|18|||
161872833|NCT00679289|584578602|FG000|Overall Study|Withdrawal by Subject|0|||
161872834|NCT00679289|584578603|FG001|Overall Study|Withdrawal by Subject|1|||
161872835|NCT00679289|584578604|FG002|Overall Study|Withdrawal by Subject|1|||
162035266|NCT02414139|585185904|FG009|Treatment Period|Adverse Event|8|||
161988924|NCT02220712|585008208|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
161988925|NCT00760838|585008209|FG000|Overall Study|Adverse Event|1|||
161988926|NCT00760838|585008210|FG001|Overall Study|Adverse Event|1|||
161988927|NCT00760838|585008209|FG000|Overall Study|Lack of Efficacy|1|||
161988928|NCT00760838|585008210|FG001|Overall Study|Lack of Efficacy|0|||
161988929|NCT00760838|585008209|FG000|Overall Study|Lost to Follow-up|2|||
161988930|NCT00760838|585008210|FG001|Overall Study|Lost to Follow-up|0|||
161988931|NCT00760838|585008209|FG000|Overall Study|Withdrawal by Subject|1|||
161988932|NCT00760838|585008210|FG001|Overall Study|Withdrawal by Subject|1|||
161988933|NCT01628965|585008211|FG000|Overall Study|Adverse Event|30|||
161988934|NCT01628965|585008211|FG000|Overall Study|Lack of Efficacy|7|||
161988935|NCT01628965|585008211|FG000|Overall Study|Withdrawal by Subject|3|||
161988936|NCT01628965|585008211|FG000|Overall Study|Lost to Follow-up|1|||
161988937|NCT01628965|585008211|FG000|Overall Study|Discontinuation criteria|8|||
161988938|NCT04356352|585008216|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
161988939|NCT04356352|585008217|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
161988940|NCT04356352|585008218|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
161988941|NCT04356352|585008216|FG000|Overall Study|Protocol Violation|0|||
161988942|NCT04356352|585008217|FG001|Overall Study|Protocol Violation|3|||
161988943|NCT04356352|585008218|FG002|Overall Study|Protocol Violation|1|||
161988944|NCT01983774|585008224|FG000|Overall Study|Lung Transplant|0|||
161988945|NCT01983774|585008225|FG001|Overall Study|Lung Transplant|1|||
161988946|NCT01983774|585008224|FG000|Overall Study|Lost to Follow-up|1|||
161988947|NCT01983774|585008225|FG001|Overall Study|Lost to Follow-up|0|||
161988948|NCT01339897|585008226|FG000|Overall Study|Adverse Event|1|||
161988949|NCT01339897|585008227|FG001|Overall Study|Adverse Event|0|||
161988950|NCT01339897|585008228|FG002|Overall Study|Adverse Event|0|||
161988951|NCT01339897|585008229|FG003|Overall Study|Adverse Event|1|||
161988952|NCT00847197|585008230|FG000|Overall Study|Adverse Event|21|||
161988953|NCT00847197|585008231|FG001|Overall Study|Adverse Event|3|||
161988954|NCT00847197|585008230|FG000|Overall Study|Protocol Violation|0|||
161988955|NCT00847197|585008231|FG001|Overall Study|Protocol Violation|1|||
161988956|NCT00847197|585008230|FG000|Overall Study|Withdrawal by Subject|3|||
161988957|NCT00847197|585008231|FG001|Overall Study|Withdrawal by Subject|1|||
161988958|NCT01743040|585008234|FG000|Overall Study|Death|1|||
161988959|NCT01743040|585008234|FG000|Overall Study|Lost to Follow-up|66|||
161988960|NCT01743040|585008234|FG000|Overall Study|Physician Decision|40|||
161988961|NCT01743040|585008234|FG000|Overall Study|Protocol Violation|1|||
161988962|NCT01743040|585008234|FG000|Overall Study|Withdrawal by Subject|121|||
161988963|NCT00830180|585008235|FG000|Overall Study|Adverse Event|6|||
161988964|NCT00830180|585008235|FG000|Overall Study|Death|11|||
161988965|NCT00830180|585008235|FG000|Overall Study|Insufficient clinical response|1|||
161988966|NCT00830180|585008235|FG000|Overall Study|Withdrawal by Subject|5|||
161988967|NCT00830180|585008235|FG000|Overall Study|Progressive disease|2|||
161988968|NCT00830180|585008235|FG000|Overall Study|Other - Unspecified|1|||
161988969|NCT01832532|585008236|FG000|Overall Study|Withdrawal by Subject|5|||
161988970|NCT01832532|585008237|FG001|Overall Study|Withdrawal by Subject|2|||
161988971|NCT03824587|585008238|FG000|Run-in Period|Screen Failure|0|||
161988972|NCT03824587|585008239|FG001|Run-in Period|Screen Failure|275|||
161988973|NCT03824587|585008238|FG000|Treatment Period|Adverse Event|4|||
161988974|NCT03824587|585008239|FG001|Treatment Period|Adverse Event|1|||
161988975|NCT03824587|585008238|FG000|Treatment Period|Withdrawal by Subject|0|||
161988976|NCT03824587|585008239|FG001|Treatment Period|Withdrawal by Subject|1|||
161988977|NCT03824587|585008238|FG000|Treatment Period|Kidney Transplant|1|||
161988978|NCT03824587|585008239|FG001|Treatment Period|Kidney Transplant|1|||
161988979|NCT02461745|585008240|FG000|Overall Study|Lack of Efficacy|9|||
161988980|NCT02461745|585008241|FG001|Overall Study|Lack of Efficacy|1|||
161988981|NCT02461745|585008240|FG000|Overall Study|Lost to Follow-up|2|||
161988982|NCT02461745|585008241|FG001|Overall Study|Lost to Follow-up|2|||
161988983|NCT02461745|585008240|FG000|Overall Study|Withdrawal by Subject|3|||
161988984|NCT02461745|585008241|FG001|Overall Study|Withdrawal by Subject|1|||
161988985|NCT02921087|585008242|FG000|Overall Study|Withdrawal by Subject|0|||
161988986|NCT02921087|585008243|FG001|Overall Study|Withdrawal by Subject|1|||
161988987|NCT05128578|585009993|FG000|Overall Study|Withdrawal by Subject|9|||
161988988|NCT05128578|585009993|FG000|Overall Study|Lost to Follow-up|5|||
161988989|NCT01128244|585009994|FG000|Overall Study|Adverse Event|1|||
161988990|NCT01128244|585009994|FG000|Overall Study|Scheduling conflict|2|||
161988991|NCT02837029|585009995|FG000|Screening|Failed to meet screening requirements.|7|||
161988992|NCT02837029|585009996|FG001|Screening|Failed to meet screening requirements.|3|||
161988993|NCT02837029|585009997|FG002|Screening|Failed to meet screening requirements.|0|||
161988994|NCT02837029|585009995|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
161988995|NCT02837029|585009996|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
161988996|NCT02837029|585009997|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
161988997|NCT02837029|585009995|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
161988998|NCT02837029|585009996|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
161988999|NCT02837029|585009997|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
162035267|NCT02414139|585185895|FG000|Treatment Period|Death|0|||
162035268|NCT02414139|585185896|FG001|Treatment Period|Death|0|||
162035269|NCT02414139|585185897|FG002|Treatment Period|Death|1|||
162035270|NCT02414139|585185898|FG003|Treatment Period|Death|1|||
162035271|NCT02414139|585185899|FG004|Treatment Period|Death|0|||
162035272|NCT02414139|585185900|FG005|Treatment Period|Death|0|||
162035273|NCT02414139|585185901|FG006|Treatment Period|Death|0|||
162035274|NCT02414139|585185902|FG007|Treatment Period|Death|0|||
162035275|NCT02414139|585185903|FG008|Treatment Period|Death|0|||
162035276|NCT02414139|585185904|FG009|Treatment Period|Death|1|||
162035277|NCT02414139|585185895|FG000|Treatment Period|Physician Decision|5|||
162035278|NCT02414139|585185896|FG001|Treatment Period|Physician Decision|4|||
162035279|NCT02414139|585185897|FG002|Treatment Period|Physician Decision|6|||
162035280|NCT02414139|585185898|FG003|Treatment Period|Physician Decision|1|||
162035281|NCT02414139|585185899|FG004|Treatment Period|Physician Decision|4|||
162035282|NCT02414139|585185900|FG005|Treatment Period|Physician Decision|0|||
162035283|NCT02414139|585185901|FG006|Treatment Period|Physician Decision|2|||
161872836|NCT00679289|584578602|FG000|Overall Study|Adverse Event|0|||
161872837|NCT00679289|584578603|FG001|Overall Study|Adverse Event|0|||
161872838|NCT00679289|584578604|FG002|Overall Study|Adverse Event|3|||
161872839|NCT00679289|584578602|FG000|Overall Study|Physician Decision|1|||
161872840|NCT00679289|584578603|FG001|Overall Study|Physician Decision|0|||
161872841|NCT00679289|584578604|FG002|Overall Study|Physician Decision|1|||
161872842|NCT00937040|584578605|FG000|Overall Study|Adverse Event|5|||
161872843|NCT00937040|584578606|FG001|Overall Study|Adverse Event|8|||
161872844|NCT00937040|584578605|FG000|Overall Study|Lost to Follow-up|12|||
161872845|NCT00937040|584578606|FG001|Overall Study|Lost to Follow-up|12|||
161872846|NCT00937040|584578605|FG000|Overall Study|Protocol Violation|3|||
161872847|NCT00937040|584578606|FG001|Overall Study|Protocol Violation|0|||
161872848|NCT00937040|584578605|FG000|Overall Study|Withdrawal by Subject|13|||
161872849|NCT00937040|584578606|FG001|Overall Study|Withdrawal by Subject|7|||
161872850|NCT00937040|584578605|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
161872851|NCT00937040|584578606|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
161872852|NCT00937040|584578605|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
161872853|NCT00937040|584578606|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
161872854|NCT02477826|584578607|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
161872855|NCT02477826|584578608|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
161872856|NCT02477826|584578609|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
161872857|NCT02477826|584578610|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
161872858|NCT02477826|584578611|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
161872859|NCT02477826|584578612|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
161872860|NCT02477826|584578613|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
161989000|NCT02837029|585009995|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
161989001|NCT02837029|585009996|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
161989002|NCT02837029|585009997|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
161989003|NCT02837029|585009995|FG000|Cycle 2 and Beyond|Adverse Event|1|||
161989004|NCT02837029|585009996|FG001|Cycle 2 and Beyond|Adverse Event|0|||
161989005|NCT02837029|585009997|FG002|Cycle 2 and Beyond|Adverse Event|0|||
161989006|NCT02837029|585009995|FG000|2 Year Follow-up|Death|6|||
161989007|NCT02837029|585009996|FG001|2 Year Follow-up|Death|7|||
161989008|NCT02837029|585009997|FG002|2 Year Follow-up|Death|0|||
161989009|NCT01363908|585009998|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
161989010|NCT01363908|585009999|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
161989011|NCT01363908|585009998|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
161989012|NCT01363908|585009999|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
161989013|NCT01363908|585009998|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
161989014|NCT01363908|585009999|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
161989015|NCT01363908|585009998|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
161989016|NCT01363908|585009999|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
161989017|NCT05258149|585010000|FG000|Period 1|Protocol Deviation|1|||
161989018|NCT05258149|585010001|FG001|Period 1|Protocol Deviation|0|||
161989019|NCT05258149|585010000|FG000|Period 1|Adverse Event|0|||
161989020|NCT05258149|585010001|FG001|Period 1|Adverse Event|1|||
161989021|NCT05258149|585010000|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
161989022|NCT05258149|585010001|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
161989023|NCT05258149|585010000|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
161989024|NCT05258149|585010001|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
161989025|NCT05258149|585010000|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
162035284|NCT02414139|585185902|FG007|Treatment Period|Physician Decision|0|||
162035285|NCT02414139|585185903|FG008|Treatment Period|Physician Decision|1|||
162035286|NCT02414139|585185904|FG009|Treatment Period|Physician Decision|4|||
161872861|NCT02477826|584578614|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
162035287|NCT02414139|585185895|FG000|Treatment Period|Progressive disease|48|||
161989026|NCT05258149|585010001|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
162035288|NCT02414139|585185896|FG001|Treatment Period|Progressive disease|31|||
161989027|NCT03437577|585010004|FG000|Pre-Randomization|Withdrawal by Subject|0|||
161989028|NCT03437577|585010005|FG001|Pre-Randomization|Withdrawal by Subject|0|||
161989029|NCT03437577|585010006|FG002|Pre-Randomization|Withdrawal by Subject|10|||
161989030|NCT03437577|585010004|FG000|Post-Randomization|Physician Decision|0|||
161989031|NCT03437577|585010005|FG001|Post-Randomization|Physician Decision|2|||
161989032|NCT03437577|585010006|FG002|Post-Randomization|Physician Decision|0|||
161989033|NCT04273893|585010014|FG000|Overall Study|Withdrawal by Subject|0|||
161989034|NCT04273893|585010015|FG001|Overall Study|Withdrawal by Subject|2|||
161989035|NCT04273893|585010014|FG000|Overall Study|Treatment of Disease Progression|0|||
161989036|NCT04273893|585010015|FG001|Overall Study|Treatment of Disease Progression|2|||
161989037|NCT04273893|585010014|FG000|Overall Study|Death|1|||
161989038|NCT04273893|585010015|FG001|Overall Study|Death|2|||
161989039|NCT04273893|585010014|FG000|Overall Study|Lost to Follow-up|0|||
161989040|NCT04273893|585010015|FG001|Overall Study|Lost to Follow-up|2|||
161989041|NCT04273893|585010014|FG000|Overall Study|Physician Decision|1|||
161989042|NCT04273893|585010015|FG001|Overall Study|Physician Decision|0|||
161989043|NCT00100789|585010020|FG000|Overall Study|Adverse Event|10|||
161989044|NCT00100789|585010020|FG000|Overall Study|Withdrawal by Subject|1|||
161989045|NCT00100789|585010020|FG000|Overall Study|Progression/relapse|42|||
161989046|NCT00100789|585010020|FG000|Overall Study|Death|2|||
161989047|NCT00100789|585010020|FG000|Overall Study|Not protocol specified|5|||
161989048|NCT00100789|585010020|FG000|Overall Study|Ineligible|3|||
161989049|NCT00100789|585010020|FG000|Overall Study|Never received treatment|1|||
161989050|NCT02936843|585010021|FG000|Overall Study|Lost to Follow-up|3|||
161989051|NCT02936843|585010022|FG001|Overall Study|Lost to Follow-up|1|||
161989052|NCT02936843|585010021|FG000|Overall Study|Withdrawal by Subject|1|||
161989053|NCT02936843|585010022|FG001|Overall Study|Withdrawal by Subject|1|||
161989054|NCT01393821|585010023|FG000|Overall Study|Cancel|1|||
161989055|NCT01393821|585010024|FG001|Overall Study|Cancel|1|||
161989056|NCT01393821|585010023|FG000|Overall Study|not evaluable for primary endpoint|4|||
161989057|NCT01393821|585010024|FG001|Overall Study|not evaluable for primary endpoint|2|||
161989058|NCT01948063|585010036|FG000|Overall Study|Boston MCI halted research protocol|0|||
161989059|NCT01948063|585010037|FG001|Overall Study|Boston MCI halted research protocol|1|||
161989060|NCT01948063|585010036|FG000|Overall Study|Discovered an enrollment in other study|0|||
161989061|NCT01948063|585010037|FG001|Overall Study|Discovered an enrollment in other study|1|||
161989062|NCT01948063|585010036|FG000|Overall Study|Blood samples were accidentally thawed|1|||
161989063|NCT01948063|585010037|FG001|Overall Study|Blood samples were accidentally thawed|0|||
161989064|NCT00773747|585010039|FG000|Overall Study|Lack of Efficacy|112|||
161989065|NCT00773747|585010040|FG001|Overall Study|Lack of Efficacy|144|||
161989066|NCT00773747|585010039|FG000|Overall Study|Physician Decision|26|||
161989067|NCT00773747|585010040|FG001|Overall Study|Physician Decision|18|||
161989068|NCT00773747|585010039|FG000|Overall Study|Lost to Follow-up|0|||
161989069|NCT00773747|585010040|FG001|Overall Study|Lost to Follow-up|1|||
161989070|NCT00773747|585010039|FG000|Overall Study|Protocol Violation|2|||
161989071|NCT00773747|585010040|FG001|Overall Study|Protocol Violation|2|||
161989072|NCT00773747|585010039|FG000|Overall Study|Withdrawal by Subject|89|||
161989073|NCT00773747|585010040|FG001|Overall Study|Withdrawal by Subject|61|||
161989074|NCT00773747|585010039|FG000|Overall Study|Adverse Event|61|||
161989075|NCT00773747|585010040|FG001|Overall Study|Adverse Event|62|||
161989076|NCT00773747|585010039|FG000|Overall Study|Death|5|||
161989077|NCT00773747|585010040|FG001|Overall Study|Death|8|||
161989078|NCT00773747|585010039|FG000|Overall Study|Not Treated|2|||
161989079|NCT00773747|585010040|FG001|Overall Study|Not Treated|0|||
161989080|NCT00836186|585010041|FG000|Overall Study|Blood could not be drawn|1|||
161989081|NCT04079816|585010042|FG000|Overall Study|Request of Subject|2|||
161989082|NCT04079816|585010042|FG000|Overall Study|Unable to draw samples|1|||
161989083|NCT01636986|585010043|FG000|Overall Study|Withdrawal by Subject|0|||
161989084|NCT01636986|585010044|FG001|Overall Study|Withdrawal by Subject|1|||
161989085|NCT01636986|585010043|FG000|Overall Study|Corneal Staining|0|||
161989086|NCT01636986|585010044|FG001|Overall Study|Corneal Staining|1|||
161989087|NCT02160145|585010047|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
161989088|NCT02160145|585010048|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
161989089|NCT02160145|585010049|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
161989090|NCT02160145|585010047|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
161989091|NCT02160145|585010048|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
161989092|NCT02160145|585010049|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
161989093|NCT02160145|585010047|FG000|Randomized Double-blind Period|Subject decision|0|||
161989094|NCT02160145|585010048|FG001|Randomized Double-blind Period|Subject decision|21|||
161989095|NCT02160145|585010049|FG002|Randomized Double-blind Period|Subject decision|20|||
161989096|NCT02160145|585010047|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
161989097|NCT02160145|585010048|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
161989098|NCT02160145|585010049|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
161989099|NCT02160145|585010047|FG000|Randomized Double-blind Period|Physician Decision|0|||
161989100|NCT02160145|585010048|FG001|Randomized Double-blind Period|Physician Decision|7|||
161989101|NCT02160145|585010049|FG002|Randomized Double-blind Period|Physician Decision|5|||
162035289|NCT02414139|585185897|FG002|Treatment Period|Progressive disease|37|||
162035290|NCT02414139|585185898|FG003|Treatment Period|Progressive disease|21|||
162035291|NCT02414139|585185899|FG004|Treatment Period|Progressive disease|43|||
162035292|NCT02414139|585185900|FG005|Treatment Period|Progressive disease|12|||
162035293|NCT02414139|585185901|FG006|Treatment Period|Progressive disease|16|||
162035294|NCT02414139|585185902|FG007|Treatment Period|Progressive disease|2|||
162035295|NCT02414139|585185903|FG008|Treatment Period|Progressive disease|20|||
162035296|NCT02414139|585185904|FG009|Treatment Period|Progressive disease|14|||
162035297|NCT02414139|585185895|FG000|Treatment Period|Protocol deviation|0|||
162035298|NCT02414139|585185896|FG001|Treatment Period|Protocol deviation|0|||
162035299|NCT02414139|585185897|FG002|Treatment Period|Protocol deviation|1|||
162035300|NCT02414139|585185898|FG003|Treatment Period|Protocol deviation|0|||
162035301|NCT02414139|585185899|FG004|Treatment Period|Protocol deviation|0|||
162035302|NCT02414139|585185900|FG005|Treatment Period|Protocol deviation|0|||
162035303|NCT02414139|585185901|FG006|Treatment Period|Protocol deviation|0|||
162035304|NCT02414139|585185902|FG007|Treatment Period|Protocol deviation|0|||
162035305|NCT02414139|585185903|FG008|Treatment Period|Protocol deviation|0|||
162035306|NCT02414139|585185904|FG009|Treatment Period|Protocol deviation|0|||
162035307|NCT02414139|585185895|FG000|Treatment Period|Subject/Guardian decision|5|||
162035308|NCT02414139|585185896|FG001|Treatment Period|Subject/Guardian decision|1|||
162035309|NCT02414139|585185897|FG002|Treatment Period|Subject/Guardian decision|1|||
162035310|NCT02414139|585185898|FG003|Treatment Period|Subject/Guardian decision|2|||
162035311|NCT02414139|585185899|FG004|Treatment Period|Subject/Guardian decision|5|||
162035312|NCT02414139|585185900|FG005|Treatment Period|Subject/Guardian decision|0|||
162035313|NCT02414139|585185901|FG006|Treatment Period|Subject/Guardian decision|2|||
162035314|NCT02414139|585185902|FG007|Treatment Period|Subject/Guardian decision|0|||
162035315|NCT02414139|585185903|FG008|Treatment Period|Subject/Guardian decision|1|||
162035316|NCT02414139|585185904|FG009|Treatment Period|Subject/Guardian decision|1|||
162035317|NCT02414139|585185895|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
162035318|NCT02414139|585185896|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
162035319|NCT02414139|585185897|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
162035320|NCT02414139|585185898|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
162035321|NCT02414139|585185899|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
162035322|NCT02414139|585185900|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
162035323|NCT02414139|585185901|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
162035324|NCT02414139|585185902|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
162035325|NCT02414139|585185903|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
162035326|NCT02414139|585185904|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
161872862|NCT02477826|584578615|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
161989102|NCT00705146|585010051|FG000|Overall Study|Lost to Follow-up|1|||
161989103|NCT00705146|585010052|FG001|Overall Study|Lost to Follow-up|1|||
161989104|NCT01457846|585010053|FG000|Overall Study|Death before treatment|1|||
161989105|NCT01457846|585010054|FG001|Overall Study|Death before treatment|2|||
161989106|NCT01457846|585010053|FG000|Overall Study|Did not receive treatment|0|||
161989107|NCT01457846|585010054|FG001|Overall Study|Did not receive treatment|1|||
161989108|NCT01457846|585010053|FG000|Overall Study|Death|27|||
161989109|NCT01457846|585010054|FG001|Overall Study|Death|16|||
161989110|NCT01457846|585010053|FG000|Overall Study|Unclassified reason for not completed|11|||
161989111|NCT01457846|585010054|FG001|Overall Study|Unclassified reason for not completed|10|||
161989112|NCT01457846|585010053|FG000|Overall Study|Withdrawal by Subject|1|||
161989113|NCT01457846|585010054|FG001|Overall Study|Withdrawal by Subject|1|||
161989114|NCT01457846|585010053|FG000|Overall Study|Lost to Follow-up|1|||
161989115|NCT01457846|585010054|FG001|Overall Study|Lost to Follow-up|0|||
161989116|NCT00383162|585010055|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
161989117|NCT00383162|585010056|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
161989118|NCT00383162|585010055|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
161989119|NCT00383162|585010056|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
161989120|NCT00383162|585010055|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
161989121|NCT00383162|585010056|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
161989122|NCT00383162|585010055|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
161989123|NCT00383162|585010056|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
161989124|NCT00383162|585010055|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
161989125|NCT00383162|585010056|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
161989126|NCT00383162|585010055|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
161989127|NCT00383162|585010056|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
161989128|NCT00383162|585010055|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
162035327|NCT02414139|585185895|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
162035328|NCT02414139|585185896|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162035329|NCT02414139|585185897|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162035330|NCT02414139|585185898|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161989129|NCT00383162|585010056|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
161989130|NCT00383162|585010055|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
161989131|NCT00383162|585010056|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
161989132|NCT00383162|585010055|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
161989133|NCT00383162|585010056|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
161989134|NCT05392803|585010059|FG000|Overall Study|Lost to Follow-up|0|||
161989135|NCT05392803|585010060|FG001|Overall Study|Lost to Follow-up|2|||
161989136|NCT00923845|585010064|FG000|Induction Therapy|Poor performance status|0|||
161989137|NCT00923845|585010065|FG001|Induction Therapy|Poor performance status|2|||
161989138|NCT03688620|585010070|FG000|Overall Study|Other|0|||
161989139|NCT03688620|585010071|FG001|Overall Study|Other|0|||
161989140|NCT03688620|585010072|FG002|Overall Study|Other|1|||
161989141|NCT03688620|585010070|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
161989142|NCT03688620|585010071|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
161989143|NCT03688620|585010072|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
161989144|NCT03688620|585010070|FG000|Overall Study|Lost to Follow-up|16|||
161989145|NCT03688620|585010071|FG001|Overall Study|Lost to Follow-up|0|||
161989146|NCT03688620|585010072|FG002|Overall Study|Lost to Follow-up|1|||
161989147|NCT03688620|585010070|FG000|Overall Study|Withdrawal by Subject|0|||
161989148|NCT03688620|585010071|FG001|Overall Study|Withdrawal by Subject|0|||
161989149|NCT03688620|585010072|FG002|Overall Study|Withdrawal by Subject|6|||
161989150|NCT02828020|585010073|FG000|Treatment Period|Adverse Event|3|||
161989151|NCT02828020|585010074|FG001|Treatment Period|Adverse Event|1|||
161989152|NCT02828020|585010075|FG002|Treatment Period|Adverse Event|1|||
161989153|NCT02828020|585010073|FG000|Treatment Period|Withdrawal of Consent|10|||
161989154|NCT02828020|585010074|FG001|Treatment Period|Withdrawal of Consent|14|||
161989155|NCT02828020|585010075|FG002|Treatment Period|Withdrawal of Consent|9|||
161989156|NCT02828020|585010073|FG000|Treatment Period|Lost to Follow-up|21|||
161989157|NCT02828020|585010074|FG001|Treatment Period|Lost to Follow-up|24|||
161989158|NCT02828020|585010075|FG002|Treatment Period|Lost to Follow-up|18|||
161989159|NCT02828020|585010073|FG000|Treatment Period|Lack of Qualifying Event|44|||
161989160|NCT02828020|585010074|FG001|Treatment Period|Lack of Qualifying Event|53|||
161989161|NCT02828020|585010075|FG002|Treatment Period|Lack of Qualifying Event|43|||
161989162|NCT02828020|585010073|FG000|Treatment Period|Pregnancy|0|||
161989163|NCT02828020|585010074|FG001|Treatment Period|Pregnancy|2|||
161989164|NCT02828020|585010075|FG002|Treatment Period|Pregnancy|0|||
161989165|NCT02828020|585010073|FG000|Treatment Period|Protocol Violation|2|||
161989166|NCT02828020|585010074|FG001|Treatment Period|Protocol Violation|4|||
161989167|NCT02828020|585010075|FG002|Treatment Period|Protocol Violation|7|||
161989168|NCT02828020|585010073|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
161989169|NCT02828020|585010074|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
161989170|NCT02828020|585010075|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
161989171|NCT02828020|585010073|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
161989172|NCT02828020|585010074|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
161989173|NCT02828020|585010075|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
161989174|NCT02828020|585010073|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
161989175|NCT02828020|585010074|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
161989176|NCT02828020|585010075|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
161989177|NCT02828020|585010073|FG000|Safety Follow-up Period|Protocol Violation|0|||
161989178|NCT02828020|585010074|FG001|Safety Follow-up Period|Protocol Violation|2|||
161989179|NCT02828020|585010075|FG002|Safety Follow-up Period|Protocol Violation|1|||
161989180|NCT02828020|585010073|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
161989181|NCT02828020|585010074|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
161989182|NCT02828020|585010075|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
161989183|NCT01183065|585010077|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
161989184|NCT02578186|585010078|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
161989185|NCT02578186|585010079|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
161989186|NCT02578186|585010078|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
161989187|NCT02578186|585010079|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
161989188|NCT03657095|585010080|FG000|Overall Study|Withdrawal by Subject|1|||
161989189|NCT03657095|585010081|FG001|Overall Study|Withdrawal by Subject|1|||
161989190|NCT03657095|585010080|FG000|Overall Study|Adverse Event|0|||
161989191|NCT03657095|585010081|FG001|Overall Study|Adverse Event|3|||
161989192|NCT03657095|585010080|FG000|Overall Study|Study Terminated by Sponsor|58|||
161989193|NCT03657095|585010081|FG001|Overall Study|Study Terminated by Sponsor|49|||
161989194|NCT01894243|585010082|FG000|Overall Study|Adverse Event|0|||
162035331|NCT02414139|585185899|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
162035332|NCT02414139|585185900|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161989195|NCT01894243|585010083|FG001|Overall Study|Adverse Event|1|||
161989196|NCT01894243|585010084|FG002|Overall Study|Adverse Event|2|||
161989197|NCT01894243|585010082|FG000|Overall Study|Death|0|||
161989198|NCT01894243|585010083|FG001|Overall Study|Death|0|||
161989199|NCT01894243|585010084|FG002|Overall Study|Death|3|||
162035333|NCT02414139|585185901|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161989200|NCT01894243|585010082|FG000|Overall Study|Lack of Efficacy|3|||
161989201|NCT01894243|585010083|FG001|Overall Study|Lack of Efficacy|3|||
161989202|NCT01894243|585010084|FG002|Overall Study|Lack of Efficacy|1|||
161989203|NCT01894243|585010082|FG000|Overall Study|Condition under investigation worsened|8|||
161989204|NCT01894243|585010083|FG001|Overall Study|Condition under investigation worsened|6|||
161989205|NCT01894243|585010084|FG002|Overall Study|Condition under investigation worsened|2|||
161989206|NCT01894243|585010082|FG000|Overall Study|Subject decision|1|||
161989207|NCT01894243|585010083|FG001|Overall Study|Subject decision|0|||
161989208|NCT01894243|585010084|FG002|Overall Study|Subject decision|0|||
161989209|NCT01894243|585010082|FG000|Overall Study|Other|1|||
161989210|NCT01894243|585010083|FG001|Overall Study|Other|0|||
161989211|NCT01894243|585010084|FG002|Overall Study|Other|0|||
161989212|NCT00828750|585010087|FG000|Overall Study|Lack of Efficacy|3|||
161989213|NCT00828750|585010087|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
161989214|NCT04006392|585010088|FG000|Overall Study|Lost to Follow-up|0|||
161989215|NCT04006392|585010089|FG001|Overall Study|Lost to Follow-up|1|||
161989216|NCT01067469|585010090|FG000|Overall Study|Withdrawal by Subject|0|||
161989217|NCT01067469|585010091|FG001|Overall Study|Withdrawal by Subject|1|||
161989218|NCT01067469|585010090|FG000|Overall Study|Disease Progression|0|||
161989219|NCT01067469|585010091|FG001|Overall Study|Disease Progression|1|||
161989220|NCT01620944|585010092|FG000|Overall Study|Early termination of Study|2|||
161989221|NCT01620944|585010093|FG001|Overall Study|Early termination of Study|1|||
161989222|NCT04378114|585010094|FG000|Overall Study|Withdrawal by Subject|5|||
161989223|NCT00392990|585010096|FG000|Treatment on Study|Adverse Event|3|||
161989224|NCT00392990|585010097|FG001|Treatment on Study|Adverse Event|1|||
161989225|NCT00392990|585010096|FG000|Follow up for 2 Years|Death|4|||
161989226|NCT00392990|585010097|FG001|Follow up for 2 Years|Death|0|||
161989227|NCT00825812|585010101|FG000|Overall Study|Never entered follow up|0|||
161989228|NCT00825812|585010102|FG001|Overall Study|Never entered follow up|0|||
161989229|NCT00825812|585010103|FG002|Overall Study|Never entered follow up|0|||
161989230|NCT00825812|585010104|FG003|Overall Study|Never entered follow up|1|||
161989231|NCT00825812|585010101|FG000|Overall Study|Adverse Event|0|||
161989232|NCT00825812|585010102|FG001|Overall Study|Adverse Event|0|||
161989233|NCT00825812|585010103|FG002|Overall Study|Adverse Event|0|||
161989234|NCT00825812|585010104|FG003|Overall Study|Adverse Event|1|||
161989235|NCT00825812|585010101|FG000|Overall Study|Subject withdrew consent|0|||
161989236|NCT00825812|585010102|FG001|Overall Study|Subject withdrew consent|0|||
161989237|NCT00825812|585010103|FG002|Overall Study|Subject withdrew consent|3|||
161989238|NCT00825812|585010104|FG003|Overall Study|Subject withdrew consent|2|||
161989239|NCT00825812|585010101|FG000|Overall Study|Non-compliance with protocol|0|||
161989240|NCT00825812|585010102|FG001|Overall Study|Non-compliance with protocol|0|||
161989241|NCT00825812|585010103|FG002|Overall Study|Non-compliance with protocol|0|||
161989242|NCT00825812|585010104|FG003|Overall Study|Non-compliance with protocol|1|||
161989243|NCT00825812|585010101|FG000|Overall Study|Administrative|0|||
161989244|NCT00825812|585010102|FG001|Overall Study|Administrative|1|||
161989245|NCT00825812|585010103|FG002|Overall Study|Administrative|3|||
161989246|NCT00825812|585010104|FG003|Overall Study|Administrative|5|||
161989247|NCT00991406|585010106|FG000|Overall Study|One participant did not respond to FES.|1|||
161989248|NCT00986362|585010107|FG000|Overall Study|Death|2|||
161989249|NCT00986362|585010108|FG001|Overall Study|Death|0|||
161989250|NCT00986362|585010107|FG000|Overall Study|Lost to Follow-up|0|||
161989251|NCT00986362|585010108|FG001|Overall Study|Lost to Follow-up|1|||
161989252|NCT03597061|585010109|FG000|Overall Study|Lost to Follow-up|1|||
161989253|NCT03597061|585010110|FG001|Overall Study|Lost to Follow-up|0|||
161989254|NCT03597061|585010109|FG000|Overall Study|Protocol Violation|0|||
161989255|NCT03597061|585010110|FG001|Overall Study|Protocol Violation|1|||
161989256|NCT03755661|585010115|FG000|Overall Study|Lost to Follow-up|1|||
161989257|NCT03755661|585010116|FG001|Overall Study|Lost to Follow-up|0|||
161989258|NCT02038075|585010117|FG000|Overall Study|Withdrawal by Subject|3|||
161989259|NCT02038075|585010118|FG001|Overall Study|Withdrawal by Subject|0|||
161989260|NCT04000581|585010119|FG000|Overall Study|Withdrawal by Subject|0|||
161989261|NCT04000581|585010120|FG001|Overall Study|Withdrawal by Subject|1|||
162035334|NCT02414139|585185902|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162035335|NCT02414139|585185903|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161989262|NCT00895453|585010124|FG000|Overall Study|Lost to Follow-up|25|||
161989263|NCT00895453|585010125|FG001|Overall Study|Lost to Follow-up|25|||
161989264|NCT00895453|585010126|FG002|Overall Study|Lost to Follow-up|23|||
161989265|NCT02519595|585010127|FG000|Overall Study|Protocol Violation|8|||
161989266|NCT02519595|585010128|FG001|Overall Study|Protocol Violation|22|||
162035336|NCT02414139|585185904|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
162035337|NCT02414139|585185895|FG000|Post-treatment Efficacy Follow-up|Death|0|||
161989267|NCT02519595|585010129|FG002|Overall Study|Protocol Violation|16|||
161989268|NCT03188510|585010132|FG000|Overall Study|Inappropriate behavior with site staff|0|||
161989269|NCT03188510|585010133|FG001|Overall Study|Inappropriate behavior with site staff|1|||
161989270|NCT03188510|585010134|FG002|Overall Study|Inappropriate behavior with site staff|0|||
161989271|NCT01736618|585010137|FG000|Overall Study|Death|294|||
161989272|NCT01736618|585010137|FG000|Overall Study|Lost to Follow-up|193|||
161872863|NCT02477826|584578616|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
161872864|NCT02477826|584578607|FG000|Pre-Treatment|Other reasons|4|||
161872865|NCT02477826|584578608|FG001|Pre-Treatment|Other reasons|1|||
161872866|NCT02477826|584578609|FG002|Pre-Treatment|Other reasons|4|||
161872867|NCT02477826|584578610|FG003|Pre-Treatment|Other reasons|1|||
161872868|NCT02477826|584578611|FG004|Pre-Treatment|Other reasons|4|||
161872869|NCT02477826|584578612|FG005|Pre-Treatment|Other reasons|2|||
161872870|NCT02477826|584578613|FG006|Pre-Treatment|Other reasons|0|||
161872871|NCT02477826|584578614|FG007|Pre-Treatment|Other reasons|0|||
161872872|NCT02477826|584578615|FG008|Pre-Treatment|Other reasons|0|||
161872873|NCT02477826|584578616|FG009|Pre-Treatment|Other reasons|0|||
161872874|NCT02477826|584578607|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
161872875|NCT02477826|584578608|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
161872876|NCT02477826|584578609|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
161872877|NCT02477826|584578610|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
161872878|NCT02477826|584578611|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
161872879|NCT02477826|584578612|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
161872880|NCT02477826|584578613|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
161872881|NCT02477826|584578614|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
161872882|NCT02477826|584578615|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
161872883|NCT02477826|584578616|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
161872884|NCT02477826|584578607|FG000|Pre-Treatment|Subject withdrew consent|0|||
161872885|NCT02477826|584578608|FG001|Pre-Treatment|Subject withdrew consent|0|||
161872886|NCT02477826|584578609|FG002|Pre-Treatment|Subject withdrew consent|3|||
161872887|NCT02477826|584578610|FG003|Pre-Treatment|Subject withdrew consent|0|||
161872888|NCT02477826|584578611|FG004|Pre-Treatment|Subject withdrew consent|0|||
161872889|NCT02477826|584578612|FG005|Pre-Treatment|Subject withdrew consent|1|||
161872890|NCT02477826|584578613|FG006|Pre-Treatment|Subject withdrew consent|0|||
161872891|NCT02477826|584578614|FG007|Pre-Treatment|Subject withdrew consent|1|||
161872892|NCT02477826|584578615|FG008|Pre-Treatment|Subject withdrew consent|0|||
161872893|NCT02477826|584578616|FG009|Pre-Treatment|Subject withdrew consent|3|||
161872894|NCT02477826|584578607|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872895|NCT02477826|584578608|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
161872896|NCT02477826|584578609|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872897|NCT02477826|584578610|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872898|NCT02477826|584578611|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872899|NCT02477826|584578612|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872900|NCT02477826|584578613|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872901|NCT02477826|584578614|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872902|NCT02477826|584578615|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
161872903|NCT02477826|584578616|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
161872904|NCT02477826|584578607|FG000|Pre-Treatment|Death|0|||
161872905|NCT02477826|584578608|FG001|Pre-Treatment|Death|0|||
161872906|NCT02477826|584578609|FG002|Pre-Treatment|Death|0|||
161872907|NCT02477826|584578610|FG003|Pre-Treatment|Death|0|||
161872908|NCT02477826|584578611|FG004|Pre-Treatment|Death|0|||
161872909|NCT02477826|584578612|FG005|Pre-Treatment|Death|0|||
161872910|NCT02477826|584578613|FG006|Pre-Treatment|Death|1|||
161872911|NCT02477826|584578614|FG007|Pre-Treatment|Death|0|||
161872912|NCT02477826|584578615|FG008|Pre-Treatment|Death|0|||
161872913|NCT02477826|584578616|FG009|Pre-Treatment|Death|0|||
161872914|NCT02477826|584578607|FG000|Treatment Period|Not reported|8|||
161872915|NCT02477826|584578608|FG001|Treatment Period|Not reported|6|||
161872916|NCT02477826|584578609|FG002|Treatment Period|Not reported|4|||
161989273|NCT01736618|585010137|FG000|Overall Study|Withdrawal by Subject|54|||
161989274|NCT01736618|585010137|FG000|Overall Study|Subject unable to be followed at study location|223|||
161989275|NCT01736618|585010137|FG000|Overall Study|Physician Decision|33|||
161989276|NCT01736618|585010137|FG000|Overall Study|Transplant or removal of target organ|19|||
161872917|NCT02477826|584578610|FG003|Treatment Period|Not reported|4|||
161872918|NCT02477826|584578611|FG004|Treatment Period|Not reported|2|||
161872919|NCT02477826|584578612|FG005|Treatment Period|Not reported|1|||
161872920|NCT02477826|584578613|FG006|Treatment Period|Not reported|14|||
161872921|NCT02477826|584578614|FG007|Treatment Period|Not reported|8|||
161872922|NCT02477826|584578615|FG008|Treatment Period|Not reported|5|||
161872923|NCT02477826|584578616|FG009|Treatment Period|Not reported|2|||
161872924|NCT02477826|584578607|FG000|Treatment Period|Other reasons|5|||
161872925|NCT02477826|584578608|FG001|Treatment Period|Other reasons|6|||
161872926|NCT02477826|584578609|FG002|Treatment Period|Other reasons|12|||
161872927|NCT02477826|584578610|FG003|Treatment Period|Other reasons|7|||
161872928|NCT02477826|584578611|FG004|Treatment Period|Other reasons|5|||
161872929|NCT02477826|584578612|FG005|Treatment Period|Other reasons|1|||
161989277|NCT01736618|585010137|FG000|Overall Study|Change in indication or condition|78|||
161872930|NCT02477826|584578613|FG006|Treatment Period|Other reasons|8|||
161872931|NCT02477826|584578614|FG007|Treatment Period|Other reasons|8|||
161989278|NCT01736618|585010137|FG000|Overall Study|Study device explant|103|||
161989279|NCT01736618|585010137|FG000|Overall Study|Unable to complete implant|2|||
161989280|NCT04167137|585010138|FG000|Overall Study|Disease progression|1|||
161989281|NCT04167137|585010139|FG001|Overall Study|Disease progression|1|||
161989282|NCT04167137|585010140|FG002|Overall Study|Disease progression|3|||
161989283|NCT04167137|585010141|FG003|Overall Study|Disease progression|3|||
161989284|NCT04167137|585010142|FG004|Overall Study|Disease progression|2|||
161989285|NCT04167137|585010143|FG005|Overall Study|Disease progression|3|||
161989286|NCT04167137|585010144|FG006|Overall Study|Disease progression|2|||
161989287|NCT04167137|585010145|FG007|Overall Study|Disease progression|2|||
161989288|NCT04167137|585010138|FG000|Overall Study|Withdrawal by Subject|1|||
161989289|NCT04167137|585010139|FG001|Overall Study|Withdrawal by Subject|0|||
161989290|NCT04167137|585010140|FG002|Overall Study|Withdrawal by Subject|0|||
161989291|NCT04167137|585010141|FG003|Overall Study|Withdrawal by Subject|1|||
161989292|NCT04167137|585010142|FG004|Overall Study|Withdrawal by Subject|0|||
161989293|NCT04167137|585010143|FG005|Overall Study|Withdrawal by Subject|2|||
161989294|NCT04167137|585010144|FG006|Overall Study|Withdrawal by Subject|1|||
161989295|NCT04167137|585010145|FG007|Overall Study|Withdrawal by Subject|0|||
161989296|NCT04167137|585010138|FG000|Overall Study|Adverse Event|0|||
161989297|NCT04167137|585010139|FG001|Overall Study|Adverse Event|0|||
161989298|NCT04167137|585010140|FG002|Overall Study|Adverse Event|0|||
161989299|NCT04167137|585010141|FG003|Overall Study|Adverse Event|0|||
161989300|NCT04167137|585010142|FG004|Overall Study|Adverse Event|0|||
161989301|NCT04167137|585010143|FG005|Overall Study|Adverse Event|1|||
161989302|NCT04167137|585010144|FG006|Overall Study|Adverse Event|0|||
161989303|NCT04167137|585010145|FG007|Overall Study|Adverse Event|1|||
161989304|NCT04167137|585010138|FG000|Overall Study|Physician Decision|0|||
161989305|NCT04167137|585010139|FG001|Overall Study|Physician Decision|0|||
161989306|NCT04167137|585010140|FG002|Overall Study|Physician Decision|0|||
161989307|NCT04167137|585010141|FG003|Overall Study|Physician Decision|1|||
161989308|NCT04167137|585010142|FG004|Overall Study|Physician Decision|0|||
161989309|NCT04167137|585010143|FG005|Overall Study|Physician Decision|0|||
161989310|NCT04167137|585010144|FG006|Overall Study|Physician Decision|1|||
161989311|NCT04167137|585010145|FG007|Overall Study|Physician Decision|0|||
161989312|NCT04167137|585010138|FG000|Overall Study|Death|0|||
161989313|NCT04167137|585010139|FG001|Overall Study|Death|1|||
161989314|NCT04167137|585010140|FG002|Overall Study|Death|0|||
161989315|NCT04167137|585010141|FG003|Overall Study|Death|0|||
161989316|NCT04167137|585010142|FG004|Overall Study|Death|0|||
161989317|NCT04167137|585010143|FG005|Overall Study|Death|0|||
161989318|NCT04167137|585010144|FG006|Overall Study|Death|0|||
161989319|NCT04167137|585010145|FG007|Overall Study|Death|0|||
161989320|NCT04167137|585010138|FG000|Overall Study|Study terminated by Sponsor|0|||
161989321|NCT04167137|585010139|FG001|Overall Study|Study terminated by Sponsor|0|||
161989322|NCT04167137|585010140|FG002|Overall Study|Study terminated by Sponsor|0|||
161989323|NCT04167137|585010141|FG003|Overall Study|Study terminated by Sponsor|0|||
161989324|NCT04167137|585010142|FG004|Overall Study|Study terminated by Sponsor|0|||
161989325|NCT04167137|585010143|FG005|Overall Study|Study terminated by Sponsor|0|||
161989326|NCT04167137|585010144|FG006|Overall Study|Study terminated by Sponsor|0|||
161989327|NCT04167137|585010145|FG007|Overall Study|Study terminated by Sponsor|1|||
161989328|NCT01748825|585010149|FG000|Dose Escalation|Refused further treatment|2|||
161989329|NCT01748825|585010150|FG001|Dose Escalation|Refused further treatment|2|||
161989330|NCT01748825|585010151|FG002|Dose Escalation|Refused further treatment|0|||
161989331|NCT01748825|585010152|FG003|Dose Escalation|Refused further treatment|0|||
161989332|NCT01748825|585010153|FG004|Dose Escalation|Refused further treatment|1|||
161989333|NCT01748825|585010154|FG005|Dose Escalation|Refused further treatment|2|||
161989334|NCT01748825|585010155|FG006|Dose Escalation|Refused further treatment|0|||
161989335|NCT01748825|585010156|FG007|Dose Escalation|Refused further treatment|0|||
161989336|NCT01748825|585010157|FG008|Dose Escalation|Refused further treatment|0|||
161989337|NCT01748825|585010158|FG009|Dose Escalation|Refused further treatment|0|||
161989338|NCT01748825|585010149|FG000|Dose Escalation|Switched to alternative treatment|0|||
161989339|NCT01748825|585010150|FG001|Dose Escalation|Switched to alternative treatment|0|||
161989340|NCT01748825|585010151|FG002|Dose Escalation|Switched to alternative treatment|0|||
161989341|NCT01748825|585010152|FG003|Dose Escalation|Switched to alternative treatment|1|||
161989342|NCT01748825|585010153|FG004|Dose Escalation|Switched to alternative treatment|0|||
161989343|NCT01748825|585010154|FG005|Dose Escalation|Switched to alternative treatment|0|||
161989344|NCT01748825|585010155|FG006|Dose Escalation|Switched to alternative treatment|0|||
161989345|NCT01748825|585010156|FG007|Dose Escalation|Switched to alternative treatment|0|||
161989346|NCT01748825|585010157|FG008|Dose Escalation|Switched to alternative treatment|0|||
161989347|NCT01748825|585010158|FG009|Dose Escalation|Switched to alternative treatment|0|||
161989348|NCT01748825|585010149|FG000|Dose Escalation|Adverse Event|0|||
161989349|NCT01748825|585010150|FG001|Dose Escalation|Adverse Event|0|||
161989350|NCT01748825|585010151|FG002|Dose Escalation|Adverse Event|0|||
161989351|NCT01748825|585010152|FG003|Dose Escalation|Adverse Event|0|||
161989352|NCT01748825|585010153|FG004|Dose Escalation|Adverse Event|0|||
161989353|NCT01748825|585010154|FG005|Dose Escalation|Adverse Event|0|||
161989354|NCT01748825|585010155|FG006|Dose Escalation|Adverse Event|1|||
161989355|NCT01748825|585010156|FG007|Dose Escalation|Adverse Event|0|||
162035338|NCT02414139|585185896|FG001|Post-treatment Efficacy Follow-up|Death|1|||
162035339|NCT02414139|585185897|FG002|Post-treatment Efficacy Follow-up|Death|0|||
162035340|NCT02414139|585185898|FG003|Post-treatment Efficacy Follow-up|Death|0|||
162035341|NCT02414139|585185899|FG004|Post-treatment Efficacy Follow-up|Death|1|||
162035342|NCT02414139|585185900|FG005|Post-treatment Efficacy Follow-up|Death|0|||
162035343|NCT02414139|585185901|FG006|Post-treatment Efficacy Follow-up|Death|0|||
162035344|NCT02414139|585185902|FG007|Post-treatment Efficacy Follow-up|Death|0|||
162035345|NCT02414139|585185903|FG008|Post-treatment Efficacy Follow-up|Death|0|||
162035346|NCT02414139|585185904|FG009|Post-treatment Efficacy Follow-up|Death|1|||
162035347|NCT02414139|585185895|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
162035348|NCT02414139|585185896|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162035349|NCT02414139|585185897|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162035350|NCT02414139|585185898|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162035351|NCT02414139|585185899|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162035352|NCT02414139|585185900|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162035353|NCT02414139|585185901|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162035354|NCT02414139|585185902|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162035355|NCT02414139|585185903|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162035356|NCT02414139|585185904|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
162035357|NCT02414139|585185895|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
162035358|NCT02414139|585185896|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
162035359|NCT02414139|585185897|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
162035360|NCT02414139|585185898|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
162035361|NCT02414139|585185899|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
162035362|NCT02414139|585185900|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
162035363|NCT02414139|585185901|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
162035364|NCT02414139|585185902|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
162035365|NCT02414139|585185903|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
162035366|NCT02414139|585185904|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
162035367|NCT02414139|585185895|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
162035368|NCT02414139|585185896|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
162035369|NCT02414139|585185897|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
162035370|NCT02414139|585185898|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
162035371|NCT02414139|585185899|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
162035372|NCT02414139|585185900|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
162035373|NCT02414139|585185901|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
162035374|NCT02414139|585185902|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
162035375|NCT02414139|585185903|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
162035376|NCT02414139|585185904|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
162035377|NCT02414139|585185895|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162035378|NCT02414139|585185896|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
162035379|NCT02414139|585185897|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162035380|NCT02414139|585185898|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162035381|NCT02414139|585185899|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162035382|NCT02414139|585185900|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162035383|NCT02414139|585185901|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162035384|NCT02414139|585185902|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162035385|NCT02414139|585185903|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
162035386|NCT02414139|585185904|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
162035387|NCT02414139|585185895|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
162035388|NCT02414139|585185896|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
162035389|NCT02414139|585185897|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
162035390|NCT02414139|585185898|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
162035391|NCT02414139|585185899|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
162035392|NCT02414139|585185900|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
162035393|NCT02414139|585185901|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
162035394|NCT02414139|585185902|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
162035395|NCT02414139|585185903|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
161775862|NCT02325739|584221295|FG002|Phase I Part|Adverse Event|1|||
161775863|NCT02325739|584221296|FG003|Phase I Part|Adverse Event|2|||
161775864|NCT02325739|584221297|FG004|Phase I Part|Adverse Event|3|||
161775865|NCT02325739|584221298|FG005|Phase I Part|Adverse Event|1|||
161775866|NCT02325739|584221299|FG006|Phase I Part|Adverse Event|0|||
161775867|NCT02325739|584221300|FG007|Phase I Part|Adverse Event|2|||
161775868|NCT02325739|584221301|FG008|Phase I Part|Adverse Event|0|||
161775869|NCT02325739|584221302|FG009|Phase I Part|Adverse Event|0|||
161775870|NCT02325739|584221303|FG010|Phase I Part|Adverse Event|0|||
161989356|NCT01748825|585010157|FG008|Dose Escalation|Adverse Event|0|||
161989357|NCT01748825|585010158|FG009|Dose Escalation|Adverse Event|0|||
161989358|NCT01748825|585010149|FG000|Dose Expansion|Refused further treatment|0|||
161989359|NCT01748825|585010150|FG001|Dose Expansion|Refused further treatment|0|||
161989360|NCT01748825|585010151|FG002|Dose Expansion|Refused further treatment|0|||
161989361|NCT01748825|585010152|FG003|Dose Expansion|Refused further treatment|0|||
161989362|NCT01748825|585010153|FG004|Dose Expansion|Refused further treatment|0|||
161989363|NCT01748825|585010154|FG005|Dose Expansion|Refused further treatment|0|||
161989364|NCT01748825|585010155|FG006|Dose Expansion|Refused further treatment|0|||
161989365|NCT01748825|585010156|FG007|Dose Expansion|Refused further treatment|0|||
161989366|NCT01748825|585010157|FG008|Dose Expansion|Refused further treatment|1|||
161989367|NCT01748825|585010158|FG009|Dose Expansion|Refused further treatment|1|||
161989368|NCT01748825|585010149|FG000|Dose Expansion|Switched to alternative treatment|0|||
161989369|NCT01748825|585010150|FG001|Dose Expansion|Switched to alternative treatment|0|||
161989370|NCT01748825|585010151|FG002|Dose Expansion|Switched to alternative treatment|0|||
161989371|NCT01748825|585010152|FG003|Dose Expansion|Switched to alternative treatment|0|||
161989372|NCT01748825|585010153|FG004|Dose Expansion|Switched to alternative treatment|0|||
161989373|NCT01748825|585010154|FG005|Dose Expansion|Switched to alternative treatment|0|||
161989374|NCT01748825|585010155|FG006|Dose Expansion|Switched to alternative treatment|0|||
161989375|NCT01748825|585010156|FG007|Dose Expansion|Switched to alternative treatment|0|||
161989376|NCT01748825|585010157|FG008|Dose Expansion|Switched to alternative treatment|0|||
161989377|NCT01748825|585010158|FG009|Dose Expansion|Switched to alternative treatment|1|||
161989378|NCT01748825|585010149|FG000|Dose Expansion|Adverse Event|0|||
161989379|NCT01748825|585010150|FG001|Dose Expansion|Adverse Event|0|||
161989380|NCT01748825|585010151|FG002|Dose Expansion|Adverse Event|0|||
161989381|NCT01748825|585010152|FG003|Dose Expansion|Adverse Event|0|||
161989382|NCT01748825|585010153|FG004|Dose Expansion|Adverse Event|0|||
161989383|NCT01748825|585010154|FG005|Dose Expansion|Adverse Event|0|||
161989384|NCT01748825|585010155|FG006|Dose Expansion|Adverse Event|0|||
161989385|NCT01748825|585010156|FG007|Dose Expansion|Adverse Event|0|||
161989386|NCT01748825|585010157|FG008|Dose Expansion|Adverse Event|0|||
161989387|NCT01748825|585010158|FG009|Dose Expansion|Adverse Event|3|||
161989388|NCT01748825|585010149|FG000|Dose Expansion|Physician Decision|0|||
161989389|NCT01748825|585010150|FG001|Dose Expansion|Physician Decision|0|||
161989390|NCT01748825|585010151|FG002|Dose Expansion|Physician Decision|0|||
161989391|NCT01748825|585010152|FG003|Dose Expansion|Physician Decision|0|||
161989392|NCT01748825|585010153|FG004|Dose Expansion|Physician Decision|0|||
161989393|NCT01748825|585010154|FG005|Dose Expansion|Physician Decision|0|||
161989394|NCT01748825|585010155|FG006|Dose Expansion|Physician Decision|0|||
161989395|NCT01748825|585010156|FG007|Dose Expansion|Physician Decision|0|||
161989396|NCT01748825|585010157|FG008|Dose Expansion|Physician Decision|1|||
161989397|NCT01748825|585010158|FG009|Dose Expansion|Physician Decision|0|||
161989398|NCT01730586|585010162|FG000|Overall Study|Progressive Disease|2|||
161989399|NCT01730586|585010162|FG000|Overall Study|Inadequate Trial|8|||
161989400|NCT01730586|585010162|FG000|Overall Study|Adverse Event|2|||
161989401|NCT01730586|585010162|FG000|Overall Study|Hospice|1|||
161989402|NCT00211887|585010163|FG000|Overall Study|Adverse Event|8|||
161989403|NCT00211887|585010164|FG001|Overall Study|Adverse Event|4|||
161989404|NCT00211887|585010165|FG002|Overall Study|Adverse Event|6|||
161989405|NCT00211887|585010163|FG000|Overall Study|Death|1|||
161989406|NCT00211887|585010164|FG001|Overall Study|Death|1|||
161989407|NCT00211887|585010165|FG002|Overall Study|Death|1|||
161989408|NCT00211887|585010163|FG000|Overall Study|Lost to Follow-up|28|||
161989409|NCT00211887|585010164|FG001|Overall Study|Lost to Follow-up|13|||
161989410|NCT00211887|585010165|FG002|Overall Study|Lost to Follow-up|9|||
161989411|NCT00211887|585010163|FG000|Overall Study|Non-medical reason|31|||
161989412|NCT00211887|585010164|FG001|Overall Study|Non-medical reason|14|||
161989413|NCT00211887|585010165|FG002|Overall Study|Non-medical reason|8|||
161989414|NCT00211887|585010163|FG000|Overall Study|Other medical reason|15|||
161989415|NCT00211887|585010164|FG001|Overall Study|Other medical reason|11|||
161989416|NCT00211887|585010165|FG002|Overall Study|Other medical reason|7|||
161989417|NCT00211887|585010163|FG000|Overall Study|Side effects|19|||
161989418|NCT00211887|585010164|FG001|Overall Study|Side effects|13|||
161989419|NCT00211887|585010165|FG002|Overall Study|Side effects|5|||
161989420|NCT03058692|585012098|FG000|Overall Study|Lost to Follow-up|2|||
161989421|NCT03058692|585012099|FG001|Overall Study|Lost to Follow-up|1|||
161989422|NCT03058692|585012098|FG000|Overall Study|Withdrawal by Subject|1|||
161989423|NCT03058692|585012099|FG001|Overall Study|Withdrawal by Subject|1|||
161989424|NCT05111249|585012104|FG000|Overall Study|Lost to Follow-up|0|||
161989425|NCT05111249|585012105|FG001|Overall Study|Lost to Follow-up|2|||
161989426|NCT05111249|585012104|FG000|Overall Study|Physician Decision|0|||
161989427|NCT05111249|585012105|FG001|Overall Study|Physician Decision|1|||
161989428|NCT05111249|585012104|FG000|Overall Study|Participant decision|1|||
161989429|NCT05111249|585012105|FG001|Overall Study|Participant decision|5|||
161989430|NCT01702025|585012113|FG000|Overall Study|Equipment failure|1|||
161989431|NCT01702025|585012114|FG001|Overall Study|Equipment failure|0|||
161989432|NCT01702025|585012115|FG002|Overall Study|Equipment failure|0|||
161989433|NCT01702025|585012116|FG003|Overall Study|Equipment failure|0|||
161989434|NCT01702025|585012113|FG000|Overall Study|Adverse Event|1|||
161989435|NCT01702025|585012114|FG001|Overall Study|Adverse Event|1|||
161989436|NCT01702025|585012115|FG002|Overall Study|Adverse Event|1|||
161989437|NCT01702025|585012116|FG003|Overall Study|Adverse Event|0|||
161989438|NCT02679755|585012117|FG000|Overall Study|Death|0|||
161989439|NCT02679755|585012118|FG001|Overall Study|Death|3|||
161989440|NCT02679755|585012117|FG000|Overall Study|Global deterioration of health status|1|||
161989441|NCT02679755|585012118|FG001|Overall Study|Global deterioration of health status|8|||
161989442|NCT02679755|585012117|FG000|Overall Study|Lost to Follow-up|1|||
161989443|NCT02679755|585012118|FG001|Overall Study|Lost to Follow-up|0|||
161989444|NCT02679755|585012117|FG000|Overall Study|Objective progression or relapse|24|||
161989445|NCT02679755|585012118|FG001|Overall Study|Objective progression or relapse|83|||
161989446|NCT02679755|585012117|FG000|Overall Study|Not defined|0|||
161989447|NCT02679755|585012118|FG001|Overall Study|Not defined|2|||
161989448|NCT02679755|585012117|FG000|Overall Study|Withdrawal by participant|6|||
161989449|NCT02679755|585012118|FG001|Overall Study|Withdrawal by participant|3|||
161989450|NCT02679755|585012117|FG000|Overall Study|Adverse Event|1|||
161989451|NCT02679755|585012118|FG001|Overall Study|Adverse Event|4|||
161989452|NCT02679755|585012117|FG000|Overall Study|Adverse events not related to study drug|1|||
161989453|NCT02679755|585012118|FG001|Overall Study|Adverse events not related to study drug|2|||
161989454|NCT01061359|585012119|FG000|Overall Study|Death|32|||
161989455|NCT01061359|585012119|FG000|Overall Study|Lost to Follow-up|1072|||
161989456|NCT01061359|585012119|FG000|Overall Study|Relapse|187|||
161989457|NCT01061359|585012119|FG000|Overall Study|Secondary neoplasm|11|||
161989458|NCT03038126|585012121|FG000|Overall Study|Death|1|||
161989459|NCT03038126|585012122|FG001|Overall Study|Death|1|||
161989460|NCT03038126|585012121|FG000|Overall Study|Withdrawal by Subject|5|||
161989461|NCT03038126|585012122|FG001|Overall Study|Withdrawal by Subject|0|||
161989462|NCT03038126|585012121|FG000|Overall Study|Lost to Follow-up|0|||
161989463|NCT03038126|585012122|FG001|Overall Study|Lost to Follow-up|1|||
161989464|NCT03038126|585012121|FG000|Overall Study|Long Term Hospitalization|2|||
161989465|NCT03038126|585012122|FG001|Overall Study|Long Term Hospitalization|0|||
161989466|NCT03038126|585012121|FG000|Overall Study|Too Ill to Participate|1|||
161989467|NCT03038126|585012122|FG001|Overall Study|Too Ill to Participate|2|||
161989468|NCT02610777|585012123|FG000|Overall Study|Lost to Follow-up|1|||
161989469|NCT02610777|585012124|FG001|Overall Study|Lost to Follow-up|0|||
161989470|NCT02610777|585012123|FG000|Overall Study|Site Terminated by Sponsor|9|||
161989471|NCT02610777|585012124|FG001|Overall Study|Site Terminated by Sponsor|8|||
161989472|NCT02610777|585012123|FG000|Overall Study|Withdrawal by Subject|2|||
161989473|NCT02610777|585012124|FG001|Overall Study|Withdrawal by Subject|2|||
161989474|NCT02610777|585012123|FG000|Overall Study|Reason not Specified|0|||
161989475|NCT02610777|585012124|FG001|Overall Study|Reason not Specified|1|||
161989476|NCT02610777|585012123|FG000|Overall Study|Death|50|||
161989477|NCT02610777|585012124|FG001|Overall Study|Death|47|||
161989478|NCT01724866|585012125|FG000|Overall Study|Adverse Event|0|||
161989479|NCT01724866|585012126|FG001|Overall Study|Adverse Event|0|||
161989480|NCT01724866|585012127|FG002|Overall Study|Adverse Event|1|||
161989481|NCT01724866|585012128|FG003|Overall Study|Adverse Event|1|||
161989482|NCT01724866|585012125|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
161989483|NCT01724866|585012126|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
161989484|NCT01724866|585012127|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
161989485|NCT01724866|585012128|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
161989486|NCT01724866|585012125|FG000|Overall Study|Investigator's Discretion|0|||
161989487|NCT01724866|585012126|FG001|Overall Study|Investigator's Discretion|1|||
161989488|NCT01724866|585012127|FG002|Overall Study|Investigator's Discretion|1|||
161989489|NCT01724866|585012128|FG003|Overall Study|Investigator's Discretion|0|||
161989490|NCT01724866|585012125|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
161989491|NCT01724866|585012126|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
161989492|NCT01724866|585012127|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
161989493|NCT01724866|585012128|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
161989494|NCT01724866|585012125|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
161989495|NCT01724866|585012126|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
161989496|NCT01724866|585012127|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
161989497|NCT01724866|585012128|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
161989498|NCT00411671|585012133|FG000|Overall Study|Adverse Event|15|||
161989499|NCT00411671|585012133|FG000|Overall Study|Death|2|||
161989500|NCT00411671|585012133|FG000|Overall Study|Lost to Follow-up|3|||
161989501|NCT01173601|585012134|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
161989502|NCT01173601|585012135|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161775871|NCT02325739|584221293|FG000|Phase I Part|Progressive disease|9|||
161775872|NCT02325739|584221294|FG001|Phase I Part|Progressive disease|6|||
161775873|NCT02325739|584221295|FG002|Phase I Part|Progressive disease|3|||
161989503|NCT01173601|585012136|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161989504|NCT01173601|585012137|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161989505|NCT01173601|585012138|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161989506|NCT01173601|585012134|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
161989507|NCT01173601|585012135|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161989508|NCT01173601|585012136|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161989509|NCT01173601|585012137|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161989510|NCT01173601|585012138|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161989511|NCT01173601|585012134|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
161989512|NCT01173601|585012135|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161989513|NCT01173601|585012136|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161989514|NCT01173601|585012137|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161989515|NCT01173601|585012138|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161989516|NCT01173601|585012134|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
161989517|NCT01173601|585012135|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161989518|NCT01173601|585012136|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161989519|NCT01173601|585012137|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161989520|NCT01173601|585012138|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161989521|NCT01173601|585012134|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
161989522|NCT01173601|585012135|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161989523|NCT01173601|585012136|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161989524|NCT01173601|585012137|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161989525|NCT01173601|585012138|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161989526|NCT01173601|585012134|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
161989527|NCT01173601|585012135|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161989528|NCT01173601|585012136|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161989529|NCT01173601|585012137|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161989530|NCT01173601|585012138|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161989531|NCT01173601|585012134|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
161989532|NCT01173601|585012135|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161989533|NCT01173601|585012136|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161989534|NCT01173601|585012137|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161989535|NCT01173601|585012138|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161989536|NCT01173601|585012134|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
161989537|NCT01173601|585012135|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
161989538|NCT01173601|585012136|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
161989539|NCT01173601|585012137|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
161989540|NCT01173601|585012138|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
161989541|NCT01173601|585012134|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
161989542|NCT01173601|585012135|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
161989543|NCT01173601|585012136|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
161989544|NCT01173601|585012137|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
161989545|NCT01173601|585012138|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
161989546|NCT01173601|585012134|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
161989547|NCT01173601|585012135|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
161989548|NCT01173601|585012136|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
161989549|NCT01173601|585012137|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
161989550|NCT01173601|585012138|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
161989551|NCT01173601|585012134|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161989552|NCT01173601|585012135|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
161989553|NCT01173601|585012136|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161989554|NCT01173601|585012137|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
161989555|NCT01173601|585012138|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
161989556|NCT01173601|585012134|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
161989557|NCT01173601|585012135|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
161989558|NCT01173601|585012136|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
161989559|NCT01173601|585012137|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
161989560|NCT01173601|585012138|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
161989561|NCT01173601|585012134|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
161989562|NCT01173601|585012135|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
161989563|NCT01173601|585012136|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
161989564|NCT01173601|585012137|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
161775874|NCT02325739|584221296|FG003|Phase I Part|Progressive disease|23|||
161775875|NCT02325739|584221297|FG004|Phase I Part|Progressive disease|14|||
161775876|NCT02325739|584221298|FG005|Phase I Part|Progressive disease|6|||
161872932|NCT02477826|584578615|FG008|Treatment Period|Other reasons|21|||
161989565|NCT01173601|585012138|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
161989566|NCT01173601|585012134|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
161989567|NCT01173601|585012135|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
161989568|NCT01173601|585012136|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
161989569|NCT01173601|585012137|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
161989570|NCT01173601|585012138|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
161989571|NCT04737278|585012139|FG000|Overall Study|Lost to Follow-up|1|||
161989572|NCT04737278|585012140|FG001|Overall Study|Lost to Follow-up|1|||
161989573|NCT04737278|585012139|FG000|Overall Study|Withdrawal by Subject|1|||
161989574|NCT04737278|585012140|FG001|Overall Study|Withdrawal by Subject|0|||
161989575|NCT04737278|585012139|FG000|Overall Study|Protocol Violation|1|||
161989576|NCT04737278|585012140|FG001|Overall Study|Protocol Violation|1|||
161989577|NCT04737278|585012139|FG000|Overall Study|failure to complete questionnaire|1|||
161989578|NCT04737278|585012140|FG001|Overall Study|failure to complete questionnaire|1|||
161989579|NCT00546000|585012145|FG000|Overall Study|Adverse Event|1|||
161989580|NCT00546000|585012145|FG000|Overall Study|Lost to Follow-up|1|||
161989581|NCT00546000|585012145|FG000|Overall Study|Baseline HPA Axis Supression|2|||
161989582|NCT03688074|585012150|FG000|Overall Study|Adverse Event|0|||
161989583|NCT03688074|585012151|FG001|Overall Study|Adverse Event|1|||
161989584|NCT03688074|585012150|FG000|Overall Study|Other|1|||
161989585|NCT03688074|585012151|FG001|Overall Study|Other|0|||
161989586|NCT01362608|585012154|FG000|Overall Study|Protocol Violation|0|||
161989587|NCT01362608|585012155|FG001|Overall Study|Protocol Violation|1|||
161989588|NCT01362608|585012154|FG000|Overall Study|Lost to Follow-up|3|||
161989589|NCT01362608|585012155|FG001|Overall Study|Lost to Follow-up|1|||
161989590|NCT01362608|585012154|FG000|Overall Study|Withdrawal by Subject|1|||
161989591|NCT01362608|585012155|FG001|Overall Study|Withdrawal by Subject|2|||
161989592|NCT01362608|585012154|FG000|Overall Study|Lack of Efficacy|0|||
161989593|NCT01362608|585012155|FG001|Overall Study|Lack of Efficacy|2|||
161989594|NCT01362608|585012154|FG000|Overall Study|Adverse Event|0|||
161989595|NCT01362608|585012155|FG001|Overall Study|Adverse Event|2|||
161989596|NCT03056339|585012162|FG000|Overall Study|Failed Requirements|0|||
161989597|NCT03056339|585012163|FG001|Overall Study|Failed Requirements|2|||
161989598|NCT03056339|585012164|FG002|Overall Study|Failed Requirements|7|||
161989599|NCT03056339|585012165|FG003|Overall Study|Failed Requirements|1|||
161989600|NCT04171219|585012170|FG000|Overall Study|Adverse Event|1|||
161989601|NCT04171219|585012171|FG001|Overall Study|Adverse Event|0|||
161989602|NCT04171219|585012170|FG000|Overall Study|Death|0|||
161989603|NCT04171219|585012171|FG001|Overall Study|Death|1|||
161989604|NCT04171219|585012170|FG000|Overall Study|Lack of Efficacy|9|||
161989605|NCT04171219|585012171|FG001|Overall Study|Lack of Efficacy|13|||
161989606|NCT04171219|585012170|FG000|Overall Study|Withdrawal by Subject|1|||
161989607|NCT04171219|585012171|FG001|Overall Study|Withdrawal by Subject|2|||
161989608|NCT04171219|585012170|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
161989609|NCT04171219|585012171|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
161989610|NCT04171219|585012170|FG000|Overall Study|Clinical PD/Patient choice|1|||
161989611|NCT04171219|585012171|FG001|Overall Study|Clinical PD/Patient choice|0|||
161989612|NCT04171219|585012170|FG000|Overall Study|Toxicity/ Patient choice|1|||
161989613|NCT04171219|585012171|FG001|Overall Study|Toxicity/ Patient choice|0|||
161989614|NCT04809285|585012172|FG000|Phase 1|Lost to Follow-up|6|||
161989615|NCT04809285|585012172|FG000|Phase 1|Protocol Violation|2|||
161989616|NCT04809285|585012172|FG000|Phase 1|Physician Decision|3|||
161989617|NCT04809285|585012172|FG000|Phase 1|Withdrawal by Subject|29|||
161989618|NCT04809285|585012172|FG000|Phase 2|Protocol Violation|3|||
161989619|NCT04809285|585012172|FG000|Phase 2|Withdrawal by Subject|4|||
161989620|NCT03350815|585012174|FG000|Period 1|Adverse Event|10|||
161989621|NCT03350815|585012175|FG001|Period 1|Adverse Event|0|||
161989622|NCT03350815|585012176|FG002|Period 1|Adverse Event|0|||
161989623|NCT03350815|585012177|FG003|Period 1|Adverse Event|0|||
161872933|NCT02477826|584578616|FG009|Treatment Period|Other reasons|1|||
161872934|NCT02477826|584578607|FG000|Treatment Period|Administrative reason by sponsor|0|||
161989624|NCT03350815|585012174|FG000|Period 1|Technical problems|1|||
161989625|NCT03350815|585012175|FG001|Period 1|Technical problems|0|||
161989626|NCT03350815|585012176|FG002|Period 1|Technical problems|0|||
161989627|NCT03350815|585012177|FG003|Period 1|Technical problems|0|||
161989628|NCT03350815|585012174|FG000|Period 1|Lost to Follow-up|3|||
161989629|NCT03350815|585012175|FG001|Period 1|Lost to Follow-up|0|||
161989630|NCT03350815|585012176|FG002|Period 1|Lost to Follow-up|0|||
161989631|NCT03350815|585012177|FG003|Period 1|Lost to Follow-up|0|||
161989632|NCT03350815|585012174|FG000|Period 1|Physician Decision|1|||
161989633|NCT03350815|585012175|FG001|Period 1|Physician Decision|0|||
161989634|NCT03350815|585012176|FG002|Period 1|Physician Decision|0|||
161989635|NCT03350815|585012177|FG003|Period 1|Physician Decision|0|||
161989636|NCT03350815|585012174|FG000|Period 1|Withdrawal by Subject|8|||
161989637|NCT03350815|585012175|FG001|Period 1|Withdrawal by Subject|0|||
161989638|NCT03350815|585012176|FG002|Period 1|Withdrawal by Subject|0|||
161989639|NCT03350815|585012177|FG003|Period 1|Withdrawal by Subject|0|||
161989640|NCT03350815|585012174|FG000|Period 1|Lack of Efficacy|15|||
161989641|NCT03350815|585012175|FG001|Period 1|Lack of Efficacy|0|||
161989642|NCT03350815|585012176|FG002|Period 1|Lack of Efficacy|0|||
161989643|NCT03350815|585012177|FG003|Period 1|Lack of Efficacy|0|||
161989644|NCT03350815|585012174|FG000|Period 1|Non-compliance with study treatment|2|||
161989645|NCT03350815|585012175|FG001|Period 1|Non-compliance with study treatment|0|||
161989646|NCT03350815|585012176|FG002|Period 1|Non-compliance with study treatment|0|||
161989647|NCT03350815|585012177|FG003|Period 1|Non-compliance with study treatment|0|||
161989648|NCT03350815|585012174|FG000|Period 1|Protocol Violation|3|||
161989649|NCT03350815|585012175|FG001|Period 1|Protocol Violation|0|||
161989650|NCT03350815|585012176|FG002|Period 1|Protocol Violation|0|||
161989651|NCT03350815|585012177|FG003|Period 1|Protocol Violation|0|||
161989652|NCT03350815|585012174|FG000|Period 2|Adverse Event|0|||
161989653|NCT03350815|585012175|FG001|Period 2|Adverse Event|3|||
161989654|NCT03350815|585012176|FG002|Period 2|Adverse Event|5|||
161989655|NCT03350815|585012177|FG003|Period 2|Adverse Event|0|||
161989656|NCT03350815|585012174|FG000|Period 2|Technical problem|0|||
161989657|NCT03350815|585012175|FG001|Period 2|Technical problem|1|||
161989658|NCT03350815|585012176|FG002|Period 2|Technical problem|0|||
161989659|NCT03350815|585012177|FG003|Period 2|Technical problem|0|||
161989660|NCT03350815|585012174|FG000|Period 2|Lost to Follow-up|0|||
161989661|NCT03350815|585012175|FG001|Period 2|Lost to Follow-up|3|||
161989662|NCT03350815|585012176|FG002|Period 2|Lost to Follow-up|3|||
161989663|NCT03350815|585012177|FG003|Period 2|Lost to Follow-up|0|||
161989664|NCT03350815|585012174|FG000|Period 2|Physician Decision|0|||
161989665|NCT03350815|585012175|FG001|Period 2|Physician Decision|0|||
161989666|NCT03350815|585012176|FG002|Period 2|Physician Decision|1|||
161989667|NCT03350815|585012177|FG003|Period 2|Physician Decision|0|||
161989668|NCT03350815|585012174|FG000|Period 2|Withdrawal by Subject|0|||
161989669|NCT03350815|585012175|FG001|Period 2|Withdrawal by Subject|3|||
161989670|NCT03350815|585012176|FG002|Period 2|Withdrawal by Subject|4|||
161989671|NCT03350815|585012177|FG003|Period 2|Withdrawal by Subject|0|||
161989672|NCT03350815|585012174|FG000|Period 2|Lack of Efficacy|0|||
161989673|NCT03350815|585012175|FG001|Period 2|Lack of Efficacy|6|||
161989674|NCT03350815|585012176|FG002|Period 2|Lack of Efficacy|2|||
161989675|NCT03350815|585012177|FG003|Period 2|Lack of Efficacy|0|||
161989676|NCT03350815|585012174|FG000|Period 2|Protocol Violation|0|||
161989677|NCT03350815|585012175|FG001|Period 2|Protocol Violation|0|||
161989678|NCT03350815|585012176|FG002|Period 2|Protocol Violation|1|||
161989679|NCT03350815|585012177|FG003|Period 2|Protocol Violation|0|||
161989680|NCT03350815|585012174|FG000|Period 2|New therapy for study indication|0|||
161989681|NCT03350815|585012175|FG001|Period 2|New therapy for study indication|0|||
161989682|NCT03350815|585012176|FG002|Period 2|New therapy for study indication|1|||
161989683|NCT03350815|585012177|FG003|Period 2|New therapy for study indication|0|||
161989684|NCT03526146|585012178|FG000|Overall Study|Lost to Follow-up|5|||
161989685|NCT03526146|585012178|FG000|Overall Study|Withdrawal by Subject|6|||
161989686|NCT03526146|585012178|FG000|Overall Study|class canceled due to COVID-19|4|||
161989687|NCT02828436|585012181|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
161989688|NCT02828436|585012182|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
161989689|NCT02828436|585012181|FG000|Period 1|Lost to Follow-up|0|||
161989690|NCT02828436|585012182|FG001|Period 1|Lost to Follow-up|1|||
161989691|NCT02828436|585012181|FG000|Period 2|Withdrawal by Subject|4|||
161989692|NCT02828436|585012182|FG001|Period 2|Withdrawal by Subject|0|||
161989693|NCT02828436|585012181|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
161989694|NCT02828436|585012182|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
161989695|NCT02828436|585012181|FG000|Period 2|Lost to Follow-up|1|||
161989696|NCT02828436|585012182|FG001|Period 2|Lost to Follow-up|0|||
161989697|NCT02644343|585012183|FG000|Overall Study|Withdrawal by Subject|1|||
161989698|NCT00536471|585012184|FG000|Overall Study|Lost to Follow-up|48|||
161989699|NCT00536471|585012185|FG001|Overall Study|Lost to Follow-up|23|||
161989700|NCT00536471|585012186|FG002|Overall Study|Lost to Follow-up|48|||
161989701|NCT00536471|585012187|FG003|Overall Study|Lost to Follow-up|22|||
161989702|NCT00536471|585012184|FG000|Overall Study|Adverse Event|32|||
161989703|NCT00536471|585012185|FG001|Overall Study|Adverse Event|16|||
161989704|NCT00536471|585012186|FG002|Overall Study|Adverse Event|28|||
161989705|NCT00536471|585012187|FG003|Overall Study|Adverse Event|13|||
161989706|NCT00536471|585012184|FG000|Overall Study|Withdrawal by Subject|40|||
161989707|NCT00536471|585012185|FG001|Overall Study|Withdrawal by Subject|24|||
161989708|NCT00536471|585012186|FG002|Overall Study|Withdrawal by Subject|43|||
161989709|NCT00536471|585012187|FG003|Overall Study|Withdrawal by Subject|21|||
161989710|NCT00536471|585012184|FG000|Overall Study|Lack of Efficacy|17|||
161989711|NCT00536471|585012185|FG001|Overall Study|Lack of Efficacy|18|||
161989712|NCT00536471|585012186|FG002|Overall Study|Lack of Efficacy|11|||
161989713|NCT00536471|585012187|FG003|Overall Study|Lack of Efficacy|9|||
161989714|NCT00536471|585012184|FG000|Overall Study|Protocol Violation|8|||
161989715|NCT00536471|585012185|FG001|Overall Study|Protocol Violation|1|||
161989716|NCT00536471|585012186|FG002|Overall Study|Protocol Violation|2|||
161989717|NCT00536471|585012187|FG003|Overall Study|Protocol Violation|3|||
161989718|NCT00536471|585012184|FG000|Overall Study|Physician Decision|11|||
161989719|NCT00536471|585012185|FG001|Overall Study|Physician Decision|1|||
162035396|NCT02414139|585185904|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
162035397|NCT01226121|585185905|FG000|Overall Study|Lost to Follow-up|2|||
162035398|NCT01226121|585185906|FG001|Overall Study|Lost to Follow-up|0|||
162035399|NCT01226121|585185907|FG002|Overall Study|Lost to Follow-up|1|||
162035400|NCT03324581|585185908|FG000|Overall Study|Adverse Event|18|||
162035401|NCT03324581|585185909|FG001|Overall Study|Adverse Event|11|||
162035402|NCT03324581|585185910|FG002|Overall Study|Adverse Event|7|||
162035403|NCT03324581|585185908|FG000|Overall Study|Lack of Efficacy|0|||
162035404|NCT03324581|585185909|FG001|Overall Study|Lack of Efficacy|1|||
162035405|NCT03324581|585185910|FG002|Overall Study|Lack of Efficacy|0|||
162035406|NCT03324581|585185908|FG000|Overall Study|Lost to Follow-up|5|||
162035407|NCT03324581|585185909|FG001|Overall Study|Lost to Follow-up|3|||
162035408|NCT03324581|585185910|FG002|Overall Study|Lost to Follow-up|6|||
162035409|NCT03324581|585185908|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
162035410|NCT03324581|585185909|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
162035411|NCT03324581|585185910|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
162035412|NCT03324581|585185908|FG000|Overall Study|Physician Decision|0|||
162035413|NCT03324581|585185909|FG001|Overall Study|Physician Decision|1|||
162035414|NCT03324581|585185910|FG002|Overall Study|Physician Decision|2|||
162035415|NCT03324581|585185908|FG000|Overall Study|Protocol Deviation|8|||
162035416|NCT03324581|585185909|FG001|Overall Study|Protocol Deviation|9|||
162035417|NCT03324581|585185910|FG002|Overall Study|Protocol Deviation|4|||
162035418|NCT03324581|585185908|FG000|Overall Study|Withdrawal by Subject|6|||
162035419|NCT03324581|585185909|FG001|Overall Study|Withdrawal by Subject|8|||
162035420|NCT03324581|585185910|FG002|Overall Study|Withdrawal by Subject|6|||
161989720|NCT00536471|585012186|FG002|Overall Study|Physician Decision|3|||
161989721|NCT00536471|585012187|FG003|Overall Study|Physician Decision|2|||
161989722|NCT00536471|585012184|FG000|Overall Study|Death|0|||
161989723|NCT00536471|585012185|FG001|Overall Study|Death|0|||
161989724|NCT00536471|585012186|FG002|Overall Study|Death|1|||
161989725|NCT00536471|585012187|FG003|Overall Study|Death|2|||
161989726|NCT00536471|585012184|FG000|Overall Study|Sponsor Decision|0|||
161989727|NCT00536471|585012185|FG001|Overall Study|Sponsor Decision|1|||
161989728|NCT00536471|585012186|FG002|Overall Study|Sponsor Decision|3|||
161989729|NCT00536471|585012187|FG003|Overall Study|Sponsor Decision|2|||
161989730|NCT01442714|585012188|FG000|Overall Study|Death|11|||
161989731|NCT01442714|585012188|FG000|Overall Study|Withdrawal by Subject|1|||
161989732|NCT01979952|585012199|FG000|Overall Study|Adverse Event|4|||
161989733|NCT01979952|585012200|FG001|Overall Study|Adverse Event|5|||
161989734|NCT01979952|585012199|FG000|Overall Study|Protocol Violation|1|||
161989735|NCT01979952|585012200|FG001|Overall Study|Protocol Violation|0|||
161989736|NCT01979952|585012199|FG000|Overall Study|Withdrawal by Subject|2|||
161989737|NCT01979952|585012200|FG001|Overall Study|Withdrawal by Subject|1|||
161989738|NCT01979952|585012199|FG000|Overall Study|Other than specified above|1|||
161989739|NCT01979952|585012200|FG001|Overall Study|Other than specified above|0|||
161989740|NCT00203424|585012202|FG000|Treatment Period|Withdrawal by Subject|4|||
161989741|NCT00203424|585012202|FG000|Treatment Period|Adverse Event|5|||
161989742|NCT00203424|585012202|FG000|Treatment Period|progressive disease|2|||
161989743|NCT00203424|585012202|FG000|Follow-up Period|Withdrawal by Subject|1|||
161989744|NCT00203424|585012202|FG000|Follow-up Period|progressive disease|4|||
161989745|NCT00203424|585012202|FG000|Follow-up Period|Lost to Follow-up|1|||
161989746|NCT01053988|585012203|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
161989747|NCT01053988|585012204|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161989748|NCT01053988|585012205|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161989749|NCT01053988|585012206|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162035421|NCT03324581|585185908|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
162035422|NCT03324581|585185909|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
162035423|NCT03324581|585185910|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
162035424|NCT04473482|585185911|FG000|Overall Study|Death|0|||
161989750|NCT01053988|585012207|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161989751|NCT01053988|585012208|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161989752|NCT01053988|585012203|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
161989753|NCT01053988|585012204|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161989754|NCT01053988|585012205|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
162035425|NCT04473482|585185912|FG001|Overall Study|Death|3|||
162035426|NCT04473482|585185911|FG000|Overall Study|Lost to Follow-up|9|||
162035427|NCT04473482|585185912|FG001|Overall Study|Lost to Follow-up|7|||
162035428|NCT04473482|585185911|FG000|Overall Study|Withdrawal by Subject|2|||
162035429|NCT04473482|585185912|FG001|Overall Study|Withdrawal by Subject|1|||
161775877|NCT02325739|584221299|FG006|Phase I Part|Progressive disease|6|||
161989755|NCT01053988|585012206|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161989756|NCT01053988|585012207|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
161989757|NCT01053988|585012208|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
162035430|NCT00266864|585185914|FG000|Overall Study|Lost to Follow-up|4|||
161989758|NCT01053988|585012203|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
161989759|NCT01053988|585012204|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161989760|NCT01053988|585012205|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161989761|NCT01053988|585012206|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161989762|NCT01053988|585012207|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161989763|NCT01053988|585012208|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161989764|NCT01053988|585012203|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
161989765|NCT01053988|585012204|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
161989766|NCT01053988|585012205|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
161989767|NCT01053988|585012206|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
161989768|NCT01053988|585012207|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
161989769|NCT01053988|585012208|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
161989770|NCT01053988|585012203|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
161989771|NCT01053988|585012204|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
161989772|NCT01053988|585012205|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
161989773|NCT01053988|585012206|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
161989774|NCT01053988|585012207|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
161989775|NCT01053988|585012208|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
161989776|NCT01053988|585012203|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
161989777|NCT01053988|585012204|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161989778|NCT01053988|585012205|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161989779|NCT01053988|585012206|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161989780|NCT01053988|585012207|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161989781|NCT01053988|585012208|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161989782|NCT01053988|585012203|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
161989783|NCT01053988|585012204|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
161989784|NCT01053988|585012205|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
161989785|NCT01053988|585012206|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
161989786|NCT01053988|585012207|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
161989787|NCT01053988|585012208|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
161989788|NCT01053988|585012203|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161989789|NCT01053988|585012204|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
161989790|NCT01053988|585012205|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
161989791|NCT01053988|585012206|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
161989792|NCT01053988|585012207|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
161989793|NCT01053988|585012208|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161989794|NCT01053988|585012203|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
161989795|NCT01053988|585012204|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
161989796|NCT01053988|585012205|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
161989797|NCT01053988|585012206|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
161989798|NCT01053988|585012207|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
161989799|NCT01053988|585012208|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
161989800|NCT01053988|585012203|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
161989801|NCT01053988|585012204|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
161989802|NCT01053988|585012205|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
161989803|NCT01053988|585012206|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
161989804|NCT01053988|585012207|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
161989805|NCT01053988|585012208|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
161989806|NCT01053988|585012203|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161989807|NCT01053988|585012204|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
161989808|NCT01053988|585012205|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
161989809|NCT01053988|585012206|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
161989810|NCT01053988|585012207|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
161989811|NCT01053988|585012208|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
161989812|NCT01053988|585012203|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162035431|NCT00266864|585185915|FG001|Overall Study|Lost to Follow-up|1|||
161989813|NCT01053988|585012204|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
161989814|NCT01053988|585012205|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161989815|NCT01053988|585012206|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
161989816|NCT01053988|585012207|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
162035432|NCT00266864|585185914|FG000|Overall Study|Withdrawal by Subject|1|||
162035433|NCT00266864|585185915|FG001|Overall Study|Withdrawal by Subject|1|||
162035434|NCT00727532|585185916|FG000|Overall Study|Adverse Event|1|||
161989817|NCT01053988|585012208|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
161989818|NCT01053988|585012203|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
161989819|NCT01053988|585012204|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
161989820|NCT01053988|585012205|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
161989821|NCT01053988|585012206|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
161989822|NCT01053988|585012207|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
161989823|NCT01053988|585012208|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
161989824|NCT01053988|585012203|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161989825|NCT01053988|585012204|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
161989826|NCT01053988|585012205|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
161989827|NCT01053988|585012206|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
161989828|NCT01053988|585012207|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
161989829|NCT01053988|585012208|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
161989830|NCT01922271|585012210|FG000|WASHOUT Period|Withdrawal by Subject|1|||
161989831|NCT01922271|585012211|FG001|WASHOUT Period|Withdrawal by Subject|0|||
161989832|NCT00719355|585012212|FG000|Overall Study|Death|0|||
161989833|NCT00719355|585012213|FG001|Overall Study|Death|1|||
161989834|NCT00719355|585012212|FG000|Overall Study|Medical|14|||
161989835|NCT00719355|585012213|FG001|Overall Study|Medical|5|||
161989836|NCT00719355|585012212|FG000|Overall Study|Compliance|4|||
161989837|NCT00719355|585012213|FG001|Overall Study|Compliance|6|||
161989838|NCT00719355|585012212|FG000|Overall Study|Moved|0|||
161989839|NCT00719355|585012213|FG001|Overall Study|Moved|1|||
161989840|NCT01856582|585012214|FG000|Overall Study|Died prior to Boost infusion|1|||
161989841|NCT01824355|585012215|FG000|Overall Study|Adverse Event|2|||
161989842|NCT01824355|585012215|FG000|Overall Study|unevaluable reference method results per|1|||
161989843|NCT01331109|585012216|FG000|Overall Study|Adverse Event|6|||
161989844|NCT01331109|585012216|FG000|Overall Study|Lack of Efficacy|2|||
161989845|NCT01331109|585012216|FG000|Overall Study|Protocol Violation|3|||
161989846|NCT01331109|585012216|FG000|Overall Study|Withdrawal by Subject|7|||
161989847|NCT01331109|585012216|FG000|Overall Study|Lost to Follow-up|1|||
161989848|NCT01331109|585012216|FG000|Overall Study|Study Terminated by Sponsor|38|||
161989849|NCT01620762|585012224|FG000|Overall Study|Protocol Violation|1|||
161989850|NCT01620762|585012225|FG001|Overall Study|Protocol Violation|1|||
161989851|NCT01620762|585012226|FG002|Overall Study|Protocol Violation|1|||
161989852|NCT01620762|585012224|FG000|Overall Study|Adverse Event|9|||
161989853|NCT01620762|585012225|FG001|Overall Study|Adverse Event|5|||
161989854|NCT01620762|585012226|FG002|Overall Study|Adverse Event|2|||
161989855|NCT01620762|585012224|FG000|Overall Study|Withdrawal by Subject|23|||
161989856|NCT01620762|585012225|FG001|Overall Study|Withdrawal by Subject|26|||
161989857|NCT01620762|585012226|FG002|Overall Study|Withdrawal by Subject|27|||
161989858|NCT01620762|585012224|FG000|Overall Study|Lost to Follow-up|11|||
161989859|NCT01620762|585012225|FG001|Overall Study|Lost to Follow-up|17|||
161989860|NCT01620762|585012226|FG002|Overall Study|Lost to Follow-up|10|||
161989861|NCT01620762|585012224|FG000|Overall Study|Protocol deviation|1|||
161989862|NCT01620762|585012225|FG001|Overall Study|Protocol deviation|1|||
161989863|NCT01620762|585012226|FG002|Overall Study|Protocol deviation|6|||
161989864|NCT01620762|585012224|FG000|Overall Study|Subject deterioration|0|||
161989865|NCT01620762|585012225|FG001|Overall Study|Subject deterioration|1|||
161989866|NCT01620762|585012226|FG002|Overall Study|Subject deterioration|1|||
161989867|NCT01620762|585012224|FG000|Overall Study|Non-specified|3|||
161989868|NCT01620762|585012225|FG001|Overall Study|Non-specified|6|||
161989869|NCT01620762|585012226|FG002|Overall Study|Non-specified|5|||
161989870|NCT01620762|585012224|FG000|Overall Study|Use of prohibted therapies|0|||
161989871|NCT01620762|585012225|FG001|Overall Study|Use of prohibted therapies|1|||
161989872|NCT01620762|585012226|FG002|Overall Study|Use of prohibted therapies|1|||
161989873|NCT03664765|585012231|FG000|Overall Study|Withdrawal by Subject|4|||
161989874|NCT03664765|585012232|FG001|Overall Study|Withdrawal by Subject|1|||
161989875|NCT03664765|585012231|FG000|Overall Study|Lost to Follow-up|0|||
161989876|NCT03664765|585012232|FG001|Overall Study|Lost to Follow-up|1|||
161989877|NCT01496846|585012233|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
161989878|NCT01496846|585012234|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
161989879|NCT01496846|585012235|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
161775878|NCT02325739|584221300|FG007|Phase I Part|Progressive disease|3|||
161775879|NCT02325739|584221301|FG008|Phase I Part|Progressive disease|0|||
161775880|NCT02325739|584221302|FG009|Phase I Part|Progressive disease|0|||
161775881|NCT02325739|584221303|FG010|Phase I Part|Progressive disease|0|||
161775882|NCT02325739|584221293|FG000|Phase I Part|Subject/guardian decision|1|||
161775883|NCT02325739|584221294|FG001|Phase I Part|Subject/guardian decision|0|||
161775884|NCT02325739|584221295|FG002|Phase I Part|Subject/guardian decision|1|||
161775885|NCT02325739|584221296|FG003|Phase I Part|Subject/guardian decision|1|||
161775886|NCT02325739|584221297|FG004|Phase I Part|Subject/guardian decision|0|||
161775887|NCT02325739|584221298|FG005|Phase I Part|Subject/guardian decision|0|||
161775888|NCT02325739|584221299|FG006|Phase I Part|Subject/guardian decision|0|||
161775889|NCT02325739|584221300|FG007|Phase I Part|Subject/guardian decision|1|||
161989880|NCT01496846|585012236|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
161989881|NCT01496846|585012237|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
161989882|NCT01496846|585012238|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
161989883|NCT01772576|585012239|FG000|Overall Study|Death|15|||
161989884|NCT01772576|585012239|FG000|Overall Study|Protocol Violation|1|||
161989885|NCT01772576|585012239|FG000|Overall Study|Lost to Follow-up|3|||
161989886|NCT01772576|585012239|FG000|Overall Study|Study device not used|3|||
161989887|NCT01772576|585012239|FG000|Overall Study|Adverse Event|6|||
161989888|NCT01772576|585012239|FG000|Overall Study|Withdrawal by Subject|6|||
161989889|NCT00527904|585012243|FG000|Overall Study|Adverse Event|45|||
161989890|NCT00527904|585012243|FG000|Overall Study|Withdrawal by Subject|21|||
161989891|NCT00527904|585012243|FG000|Overall Study|Lost to Follow-up|8|||
161989892|NCT00527904|585012243|FG000|Overall Study|misc|22|||
161989893|NCT02873338|585012247|FG000|Overall Study|Adverse Event|0|||
161989894|NCT02873338|585012248|FG001|Overall Study|Adverse Event|2|||
161989895|NCT02873338|585012249|FG002|Overall Study|Adverse Event|1|||
161989896|NCT02873338|585012247|FG000|Overall Study|Death|2|||
161989897|NCT02873338|585012248|FG001|Overall Study|Death|1|||
161989898|NCT02873338|585012249|FG002|Overall Study|Death|1|||
161989899|NCT02873338|585012247|FG000|Overall Study|Withdrawal by Subject|2|||
161989900|NCT02873338|585012248|FG001|Overall Study|Withdrawal by Subject|1|||
161989901|NCT02873338|585012249|FG002|Overall Study|Withdrawal by Subject|3|||
161989902|NCT02873338|585012247|FG000|Overall Study|Lack of Efficacy|0|||
161989903|NCT02873338|585012248|FG001|Overall Study|Lack of Efficacy|2|||
161989904|NCT02873338|585012249|FG002|Overall Study|Lack of Efficacy|0|||
161989905|NCT02873338|585012247|FG000|Overall Study|Other or Missing|14|||
161989906|NCT02873338|585012248|FG001|Overall Study|Other or Missing|15|||
161989907|NCT02873338|585012249|FG002|Overall Study|Other or Missing|13|||
161989908|NCT03477838|585012259|FG000|Overall Study|Lost to Follow-up|14|||
161989909|NCT00850538|585012260|FG000|Overall Study|unable/unwilling to complete MRI|13|||
161989910|NCT00850538|585012260|FG000|Overall Study|specimen missed due to scheduling error|14|||
161989911|NCT00850538|585012260|FG000|Overall Study|specimen unusable|7|||
161989912|NCT00850538|585012260|FG000|Overall Study|Withdrawal by Subject|3|||
161989913|NCT00850538|585012260|FG000|Overall Study|radiology error|2|||
161989914|NCT00850538|585012260|FG000|Overall Study|Protocol Violation|2|||
161989915|NCT03777059|585014123|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
161989916|NCT03777059|585014124|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
161989917|NCT03777059|585014125|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
161989918|NCT03777059|585014126|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
161989919|NCT03777059|585014123|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
161989920|NCT03777059|585014124|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
161989921|NCT03777059|585014125|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
161989922|NCT03777059|585014126|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
161989923|NCT03777059|585014123|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
161989924|NCT03777059|585014124|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
161989925|NCT03777059|585014125|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
161989926|NCT03777059|585014126|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
161989927|NCT03777059|585014123|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
161989928|NCT03777059|585014124|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
161989929|NCT03777059|585014125|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
161989930|NCT03777059|585014126|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
161989931|NCT03777059|585014123|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
161989932|NCT03777059|585014124|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
161989933|NCT03777059|585014125|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
161989934|NCT03777059|585014126|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
161989935|NCT03777059|585014123|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
161989936|NCT03777059|585014124|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
161989937|NCT03777059|585014125|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
161989938|NCT03777059|585014126|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
161989939|NCT03777059|585014123|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
161989940|NCT03777059|585014124|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
161989941|NCT03777059|585014125|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
161989942|NCT03777059|585014126|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
161989943|NCT03777059|585014123|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
161989944|NCT03777059|585014124|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
161989945|NCT03777059|585014125|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
161989946|NCT03777059|585014126|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
161989947|NCT03777059|585014123|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
161989948|NCT03777059|585014124|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
161989949|NCT03777059|585014125|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
161989950|NCT03777059|585014126|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
161989951|NCT03777059|585014123|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
161989952|NCT03777059|585014124|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
161989953|NCT03777059|585014125|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
161989954|NCT03777059|585014126|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
161989955|NCT03777059|585014123|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
161989956|NCT03777059|585014124|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
161989957|NCT03777059|585014125|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
161989958|NCT03777059|585014126|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
161989959|NCT04506502|585014127|FG000|Overall Study|Withdrawal by Subject|1|||
161989960|NCT04506502|585014127|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
161989961|NCT01449006|585014128|FG000|Overall Study|Lost to Follow-up|1|||
161989962|NCT01449006|585014129|FG001|Overall Study|Lost to Follow-up|0|||
161989963|NCT01449006|585014128|FG000|Overall Study|Withdrawal by Subject|1|||
161989964|NCT01449006|585014129|FG001|Overall Study|Withdrawal by Subject|0|||
161989965|NCT01449006|585014128|FG000|Overall Study|Protocol Violation|1|||
161989966|NCT01449006|585014129|FG001|Overall Study|Protocol Violation|0|||
161989967|NCT02517541|585014132|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
161989968|NCT02517541|585014132|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
161989969|NCT02517541|585014132|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
161989970|NCT02517541|585014132|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
161989971|NCT02517541|585014132|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
161989972|NCT02517541|585014132|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
161989973|NCT00699608|585014133|FG000|First Intervention|Withdrawal by Subject|0|||
161989974|NCT00699608|585014134|FG001|First Intervention|Withdrawal by Subject|0|||
161989975|NCT00699608|585014135|FG002|First Intervention|Withdrawal by Subject|1|||
161989976|NCT00699608|585014136|FG003|First Intervention|Withdrawal by Subject|0|||
161989977|NCT00699608|585014137|FG004|First Intervention|Withdrawal by Subject|0|||
161989978|NCT00699608|585014138|FG005|First Intervention|Withdrawal by Subject|0|||
161989979|NCT00699608|585014133|FG000|First Intervention|Protocol Violation|0|||
161989980|NCT00699608|585014134|FG001|First Intervention|Protocol Violation|0|||
161989981|NCT00699608|585014135|FG002|First Intervention|Protocol Violation|0|||
161989982|NCT00699608|585014136|FG003|First Intervention|Protocol Violation|0|||
161989983|NCT00699608|585014137|FG004|First Intervention|Protocol Violation|1|||
161989984|NCT00699608|585014138|FG005|First Intervention|Protocol Violation|0|||
161989985|NCT00699608|585014133|FG000|Second Intervention|Adverse Event|0|||
161989986|NCT00699608|585014134|FG001|Second Intervention|Adverse Event|0|||
161989987|NCT00699608|585014135|FG002|Second Intervention|Adverse Event|1|||
161989988|NCT00699608|585014136|FG003|Second Intervention|Adverse Event|0|||
161989989|NCT00699608|585014137|FG004|Second Intervention|Adverse Event|0|||
161989990|NCT00699608|585014138|FG005|Second Intervention|Adverse Event|0|||
161989991|NCT00699608|585014133|FG000|Second Intervention|Withdrawal by Subject|0|||
161989992|NCT00699608|585014134|FG001|Second Intervention|Withdrawal by Subject|0|||
161989993|NCT00699608|585014135|FG002|Second Intervention|Withdrawal by Subject|0|||
161989994|NCT00699608|585014136|FG003|Second Intervention|Withdrawal by Subject|1|||
161989995|NCT00699608|585014137|FG004|Second Intervention|Withdrawal by Subject|0|||
161989996|NCT00699608|585014138|FG005|Second Intervention|Withdrawal by Subject|0|||
161989997|NCT02034877|585014140|FG000|Overall Study|Lost to Follow-up|0|||
161989998|NCT02034877|585014141|FG001|Overall Study|Lost to Follow-up|3|||
161989999|NCT02034877|585014140|FG000|Overall Study|No Longer Willing to Participate|0|||
161990000|NCT02034877|585014141|FG001|Overall Study|No Longer Willing to Participate|3|||
161990001|NCT03574779|585014144|FG000|Overall Study|Screening failure|13|||
161990002|NCT03574779|585014145|FG001|Overall Study|Screening failure|83|||
161990003|NCT01036321|585014149|FG000|Overall Study|Ineligible after randomization|0|||
161990004|NCT01036321|585014150|FG001|Overall Study|Ineligible after randomization|1|||
161990005|NCT01036321|585014149|FG000|Overall Study|Withdrawal by Subject|3|||
161990006|NCT01036321|585014150|FG001|Overall Study|Withdrawal by Subject|2|||
161990007|NCT01036321|585014149|FG000|Overall Study|Adverse Event|2|||
161990008|NCT01036321|585014150|FG001|Overall Study|Adverse Event|1|||
161990009|NCT03755882|585014151|FG000|Period 1|Protocol Violation|1|||
161990010|NCT03755882|585014152|FG001|Period 1|Protocol Violation|0|||
161990011|NCT03755882|585014151|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
161990012|NCT03755882|585014152|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
161990013|NCT00381693|585014153|FG000|Overall Study|Death|1|||
161990014|NCT00381693|585014153|FG000|Overall Study|Adverse Event|4|||
161990015|NCT00381693|585014153|FG000|Overall Study|Patient Choice|1|||
161990016|NCT00381693|585014153|FG000|Overall Study|Progression|2|||
161990017|NCT02598297|585014154|FG000|Overall Study|Study terminated by Sponsor|21|||
161990018|NCT02598297|585014155|FG001|Overall Study|Study terminated by Sponsor|23|||
161990019|NCT02598297|585014154|FG000|Overall Study|Adverse Event|1|||
161990020|NCT02598297|585014155|FG001|Overall Study|Adverse Event|1|||
161990021|NCT02598297|585014154|FG000|Overall Study|Physician Decision|1|||
161990022|NCT02598297|585014155|FG001|Overall Study|Physician Decision|0|||
161990023|NCT02598297|585014154|FG000|Overall Study|Subject/guardian decision|1|||
161990024|NCT02598297|585014155|FG001|Overall Study|Subject/guardian decision|0|||
161872935|NCT02477826|584578608|FG001|Treatment Period|Administrative reason by sponsor|3|||
161872936|NCT02477826|584578609|FG002|Treatment Period|Administrative reason by sponsor|0|||
161872937|NCT02477826|584578610|FG003|Treatment Period|Administrative reason by sponsor|0|||
161872938|NCT02477826|584578611|FG004|Treatment Period|Administrative reason by sponsor|0|||
161872939|NCT02477826|584578612|FG005|Treatment Period|Administrative reason by sponsor|0|||
161872940|NCT02477826|584578613|FG006|Treatment Period|Administrative reason by sponsor|0|||
161872941|NCT02477826|584578614|FG007|Treatment Period|Administrative reason by sponsor|0|||
161872942|NCT02477826|584578615|FG008|Treatment Period|Administrative reason by sponsor|0|||
161872943|NCT02477826|584578616|FG009|Treatment Period|Administrative reason by sponsor|0|||
161872944|NCT02477826|584578607|FG000|Treatment Period|Participant meet no longer study criteria|1|||
161872945|NCT02477826|584578608|FG001|Treatment Period|Participant meet no longer study criteria|1|||
161872946|NCT02477826|584578609|FG002|Treatment Period|Participant meet no longer study criteria|0|||
161872947|NCT02477826|584578610|FG003|Treatment Period|Participant meet no longer study criteria|0|||
161872948|NCT02477826|584578611|FG004|Treatment Period|Participant meet no longer study criteria|1|||
161872949|NCT02477826|584578612|FG005|Treatment Period|Participant meet no longer study criteria|1|||
161872950|NCT02477826|584578613|FG006|Treatment Period|Participant meet no longer study criteria|0|||
161872951|NCT02477826|584578614|FG007|Treatment Period|Participant meet no longer study criteria|1|||
161872952|NCT02477826|584578615|FG008|Treatment Period|Participant meet no longer study criteria|0|||
161872953|NCT02477826|584578616|FG009|Treatment Period|Participant meet no longer study criteria|0|||
161872954|NCT02477826|584578607|FG000|Treatment Period|Poor/Non Compliance|1|||
161872955|NCT02477826|584578608|FG001|Treatment Period|Poor/Non Compliance|0|||
161872956|NCT02477826|584578609|FG002|Treatment Period|Poor/Non Compliance|2|||
161872957|NCT02477826|584578610|FG003|Treatment Period|Poor/Non Compliance|0|||
161872958|NCT02477826|584578611|FG004|Treatment Period|Poor/Non Compliance|0|||
161872959|NCT02477826|584578612|FG005|Treatment Period|Poor/Non Compliance|1|||
161872960|NCT02477826|584578613|FG006|Treatment Period|Poor/Non Compliance|1|||
161872961|NCT02477826|584578614|FG007|Treatment Period|Poor/Non Compliance|0|||
161872962|NCT02477826|584578615|FG008|Treatment Period|Poor/Non Compliance|0|||
161872963|NCT02477826|584578616|FG009|Treatment Period|Poor/Non Compliance|1|||
161872964|NCT02477826|584578607|FG000|Treatment Period|Maximum Clinical Benefit|3|||
161872965|NCT02477826|584578608|FG001|Treatment Period|Maximum Clinical Benefit|3|||
161872966|NCT02477826|584578609|FG002|Treatment Period|Maximum Clinical Benefit|1|||
161872967|NCT02477826|584578610|FG003|Treatment Period|Maximum Clinical Benefit|1|||
161872968|NCT02477826|584578611|FG004|Treatment Period|Maximum Clinical Benefit|3|||
161872969|NCT02477826|584578612|FG005|Treatment Period|Maximum Clinical Benefit|0|||
161872970|NCT02477826|584578613|FG006|Treatment Period|Maximum Clinical Benefit|3|||
161872971|NCT02477826|584578614|FG007|Treatment Period|Maximum Clinical Benefit|2|||
161872972|NCT02477826|584578615|FG008|Treatment Period|Maximum Clinical Benefit|2|||
161872973|NCT02477826|584578616|FG009|Treatment Period|Maximum Clinical Benefit|2|||
161872974|NCT02477826|584578607|FG000|Treatment Period|Lost to Follow-up|0|||
161872975|NCT02477826|584578608|FG001|Treatment Period|Lost to Follow-up|0|||
161872976|NCT02477826|584578609|FG002|Treatment Period|Lost to Follow-up|1|||
161872977|NCT02477826|584578610|FG003|Treatment Period|Lost to Follow-up|1|||
161872978|NCT02477826|584578611|FG004|Treatment Period|Lost to Follow-up|0|||
161872979|NCT02477826|584578612|FG005|Treatment Period|Lost to Follow-up|0|||
161872980|NCT02477826|584578613|FG006|Treatment Period|Lost to Follow-up|2|||
161872981|NCT02477826|584578614|FG007|Treatment Period|Lost to Follow-up|2|||
161872982|NCT02477826|584578615|FG008|Treatment Period|Lost to Follow-up|0|||
161872983|NCT02477826|584578616|FG009|Treatment Period|Lost to Follow-up|0|||
161872984|NCT02477826|584578607|FG000|Treatment Period|Participant withdrew Consent|5|||
161872985|NCT02477826|584578608|FG001|Treatment Period|Participant withdrew Consent|5|||
161872986|NCT02477826|584578609|FG002|Treatment Period|Participant withdrew Consent|3|||
161872987|NCT02477826|584578610|FG003|Treatment Period|Participant withdrew Consent|3|||
161872988|NCT02477826|584578611|FG004|Treatment Period|Participant withdrew Consent|1|||
161872989|NCT02477826|584578612|FG005|Treatment Period|Participant withdrew Consent|3|||
161872990|NCT02477826|584578613|FG006|Treatment Period|Participant withdrew Consent|3|||
161872991|NCT02477826|584578614|FG007|Treatment Period|Participant withdrew Consent|3|||
161872992|NCT02477826|584578615|FG008|Treatment Period|Participant withdrew Consent|2|||
161872993|NCT02477826|584578616|FG009|Treatment Period|Participant withdrew Consent|3|||
161872994|NCT02477826|584578607|FG000|Treatment Period|Participant request to discontinue treatment|5|||
161872995|NCT02477826|584578608|FG001|Treatment Period|Participant request to discontinue treatment|3|||
161872996|NCT02477826|584578609|FG002|Treatment Period|Participant request to discontinue treatment|15|||
161872997|NCT02477826|584578610|FG003|Treatment Period|Participant request to discontinue treatment|5|||
161872998|NCT02477826|584578611|FG004|Treatment Period|Participant request to discontinue treatment|3|||
161872999|NCT02477826|584578612|FG005|Treatment Period|Participant request to discontinue treatment|6|||
161873000|NCT02477826|584578613|FG006|Treatment Period|Participant request to discontinue treatment|13|||
161873001|NCT02477826|584578614|FG007|Treatment Period|Participant request to discontinue treatment|15|||
162035435|NCT00727532|585185916|FG000|Overall Study|Withdrawal by Subject|1|||
162035436|NCT00829933|585185917|FG000|Overall Study|Adverse Event|2|||
162035437|NCT00829933|585185918|FG001|Overall Study|Adverse Event|3|||
161990025|NCT02598297|585014154|FG000|Overall Study|Followed for survival|1|||
161990026|NCT02598297|585014155|FG001|Overall Study|Followed for survival|0|||
161990027|NCT02003534|585014161|FG000|Overall Study|Lost to Follow-up|47|||
161990028|NCT04112303|585014162|FG000|Overall Study|Death|1|||
161990029|NCT01685697|585014163|FG000|Overall Study|Protocol Violation|3|||
161990030|NCT01685697|585014164|FG001|Overall Study|Protocol Violation|3|||
161990031|NCT02703324|585014165|FG000|Period Two|Withdrawal by Subject|0|||
161990032|NCT02703324|585014166|FG001|Period Two|Withdrawal by Subject|0|||
161990033|NCT02703324|585014167|FG002|Period Two|Withdrawal by Subject|1|||
161990034|NCT02703324|585014168|FG003|Period Two|Withdrawal by Subject|0|||
161990035|NCT02703324|585014169|FG004|Period Two|Withdrawal by Subject|0|||
161990036|NCT02703324|585014170|FG005|Period Two|Withdrawal by Subject|0|||
161990037|NCT04303572|585014173|FG000|Overall Study|Study closed due to poor enrollment|1|||
161990038|NCT06312592|585014174|FG000|Overall Study|Lost to Follow-up|29|||
161990039|NCT06312592|585014175|FG001|Overall Study|Lost to Follow-up|13|||
161990040|NCT03517228|585014178|FG000|Overall Study|Withdrawal by Subject|2|||
161990041|NCT03517228|585014178|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
161990042|NCT03517228|585014178|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
161990043|NCT03517228|585014178|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
161990044|NCT03517228|585014178|FG000|Overall Study|Canceled due to device being updated|1|||
161990045|NCT03517228|585014178|FG000|Overall Study|No V Cares in stock|1|||
161990046|NCT03517228|585014178|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
161990047|NCT03781414|585014183|FG000|Overall Study|Study terminated by sponsor|39|||
161990048|NCT03781414|585014184|FG001|Overall Study|Study terminated by sponsor|34|||
161990049|NCT03781414|585014185|FG002|Overall Study|Study terminated by sponsor|25|||
161990050|NCT03781414|585014183|FG000|Overall Study|Adverse Event|3|||
161990051|NCT03781414|585014184|FG001|Overall Study|Adverse Event|6|||
161990052|NCT03781414|585014185|FG002|Overall Study|Adverse Event|3|||
161990053|NCT03781414|585014183|FG000|Overall Study|Physician Decision|2|||
161990054|NCT03781414|585014184|FG001|Overall Study|Physician Decision|0|||
161990055|NCT03781414|585014185|FG002|Overall Study|Physician Decision|1|||
161990056|NCT03781414|585014183|FG000|Overall Study|Withdrawal by Subject|2|||
161990057|NCT03781414|585014184|FG001|Overall Study|Withdrawal by Subject|3|||
161990058|NCT03781414|585014185|FG002|Overall Study|Withdrawal by Subject|3|||
161990059|NCT03781414|585014183|FG000|Overall Study|Death|1|||
161990060|NCT03781414|585014184|FG001|Overall Study|Death|4|||
161990061|NCT03781414|585014185|FG002|Overall Study|Death|0|||
161990062|NCT03781414|585014183|FG000|Overall Study|Lost to Follow-up|1|||
161990063|NCT03781414|585014184|FG001|Overall Study|Lost to Follow-up|1|||
161990064|NCT03781414|585014185|FG002|Overall Study|Lost to Follow-up|0|||
161990065|NCT01147055|585014186|FG000|First Intervention Period|Lost to Follow-up|1|||
161990066|NCT01147055|585014187|FG001|First Intervention Period|Lost to Follow-up|0|||
161990067|NCT00095173|585014220|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
161990068|NCT00095173|585014221|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
161990069|NCT00095173|585014222|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
161990070|NCT00095173|585014223|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
161990071|NCT00095173|585014224|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
161990072|NCT00095173|585014225|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
161990073|NCT00095173|585014220|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
161990074|NCT00095173|585014221|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
161990075|NCT00095173|585014222|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
161990076|NCT00095173|585014223|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
161990077|NCT00095173|585014224|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
161990078|NCT00095173|585014225|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
161990079|NCT00095173|585014220|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
161990080|NCT00095173|585014221|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
161990081|NCT00095173|585014222|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
161990082|NCT00095173|585014223|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
161990083|NCT00095173|585014224|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
161775890|NCT02325739|584221301|FG008|Phase I Part|Subject/guardian decision|0|||
161775891|NCT02325739|584221302|FG009|Phase I Part|Subject/guardian decision|0|||
161775892|NCT02325739|584221303|FG010|Phase I Part|Subject/guardian decision|0|||
161775893|NCT02325739|584221293|FG000|Phase I Part|Death|0|||
161775894|NCT02325739|584221294|FG001|Phase I Part|Death|0|||
161775895|NCT02325739|584221295|FG002|Phase I Part|Death|0|||
161775896|NCT02325739|584221296|FG003|Phase I Part|Death|0|||
161775897|NCT02325739|584221297|FG004|Phase I Part|Death|2|||
161775898|NCT02325739|584221298|FG005|Phase I Part|Death|0|||
161775899|NCT02325739|584221299|FG006|Phase I Part|Death|0|||
161775900|NCT02325739|584221300|FG007|Phase I Part|Death|0|||
161775901|NCT02325739|584221301|FG008|Phase I Part|Death|0|||
161775902|NCT02325739|584221302|FG009|Phase I Part|Death|0|||
161990084|NCT00095173|585014225|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
161775903|NCT02325739|584221303|FG010|Phase I Part|Death|0|||
161990085|NCT00095173|585014220|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
162035438|NCT00829933|585185919|FG002|Overall Study|Adverse Event|2|||
162035439|NCT00829933|585185920|FG003|Overall Study|Adverse Event|1|||
162035440|NCT00829933|585185917|FG000|Overall Study|Death|0|||
162035441|NCT00829933|585185918|FG001|Overall Study|Death|0|||
162035442|NCT00829933|585185919|FG002|Overall Study|Death|1|||
162035443|NCT00829933|585185920|FG003|Overall Study|Death|1|||
162035444|NCT00829933|585185917|FG000|Overall Study|Lack of Efficacy|0|||
162035445|NCT00829933|585185918|FG001|Overall Study|Lack of Efficacy|1|||
162035446|NCT00829933|585185919|FG002|Overall Study|Lack of Efficacy|0|||
162035447|NCT00829933|585185920|FG003|Overall Study|Lack of Efficacy|0|||
162035448|NCT00829933|585185917|FG000|Overall Study|Physician Decision|5|||
162035449|NCT00829933|585185918|FG001|Overall Study|Physician Decision|7|||
161873002|NCT02477826|584578615|FG008|Treatment Period|Participant request to discontinue treatment|4|||
161990086|NCT00095173|585014221|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
161990087|NCT00095173|585014222|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
161990088|NCT00095173|585014223|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
161990089|NCT00095173|585014224|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
161990090|NCT00095173|585014225|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
161990091|NCT00095173|585014220|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
161990092|NCT00095173|585014221|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
161990093|NCT00095173|585014222|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
161990094|NCT00095173|585014223|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
161990095|NCT00095173|585014224|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
161990096|NCT00095173|585014225|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
161990097|NCT00095173|585014220|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
161990098|NCT00095173|585014221|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
161990099|NCT00095173|585014222|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
161990100|NCT00095173|585014223|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
161990101|NCT00095173|585014224|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
161990102|NCT00095173|585014225|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
161990103|NCT00095173|585014220|FG000|Open-Label Extension Phase (Period C)|Death|0|||
161990104|NCT00095173|585014221|FG001|Open-Label Extension Phase (Period C)|Death|0|||
161990105|NCT00095173|585014222|FG002|Open-Label Extension Phase (Period C)|Death|0|||
161990106|NCT00095173|585014223|FG003|Open-Label Extension Phase (Period C)|Death|0|||
161990107|NCT00095173|585014224|FG004|Open-Label Extension Phase (Period C)|Death|0|||
161990108|NCT00095173|585014225|FG005|Open-Label Extension Phase (Period C)|Death|1|||
161990109|NCT00095173|585014220|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
161990110|NCT00095173|585014221|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
161990111|NCT00095173|585014222|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
161990112|NCT00095173|585014223|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
161990113|NCT00095173|585014224|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
161990114|NCT00095173|585014225|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
161990115|NCT00095173|585014220|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
161990116|NCT00095173|585014221|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
161990117|NCT00095173|585014222|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
161990118|NCT00095173|585014223|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
161990119|NCT00095173|585014224|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
161990120|NCT00095173|585014225|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
161990121|NCT00095173|585014220|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
161990122|NCT00095173|585014221|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
161990123|NCT00095173|585014222|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
161990124|NCT00095173|585014223|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
161990125|NCT00095173|585014224|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
161990126|NCT00095173|585014225|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
161990127|NCT00095173|585014220|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
161990128|NCT00095173|585014221|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
161990129|NCT00095173|585014222|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
161990130|NCT00095173|585014223|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
161990131|NCT00095173|585014224|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
161990132|NCT00095173|585014225|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
161990133|NCT00095173|585014220|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
161990134|NCT00095173|585014221|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
161990135|NCT00095173|585014222|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
161990136|NCT00095173|585014223|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
161990137|NCT00095173|585014224|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
162035450|NCT00829933|585185919|FG002|Overall Study|Physician Decision|8|||
162035451|NCT00829933|585185920|FG003|Overall Study|Physician Decision|1|||
162035452|NCT00829933|585185917|FG000|Overall Study|Pregnancy|0|||
162035453|NCT00829933|585185918|FG001|Overall Study|Pregnancy|0|||
162035454|NCT00829933|585185919|FG002|Overall Study|Pregnancy|0|||
162035455|NCT00829933|585185920|FG003|Overall Study|Pregnancy|2|||
162035456|NCT00829933|585185917|FG000|Overall Study|Protocol Violation|2|||
162035457|NCT00829933|585185918|FG001|Overall Study|Protocol Violation|1|||
162035458|NCT00829933|585185919|FG002|Overall Study|Protocol Violation|0|||
162035459|NCT00829933|585185920|FG003|Overall Study|Protocol Violation|0|||
162035460|NCT00829933|585185917|FG000|Overall Study|withdrew before treatment started|5|||
162035461|NCT00829933|585185918|FG001|Overall Study|withdrew before treatment started|1|||
162035462|NCT00829933|585185919|FG002|Overall Study|withdrew before treatment started|2|||
162035463|NCT00829933|585185920|FG003|Overall Study|withdrew before treatment started|9|||
162035464|NCT03687970|585185924|FG000|Overall Study|visit scheduling conflicts|2|||
162035465|NCT03687970|585185925|FG001|Overall Study|visit scheduling conflicts|0|||
162035466|NCT00686998|585185926|FG000|Overall Study|Adverse Event|3|||
162035467|NCT00686998|585185927|FG001|Overall Study|Adverse Event|2|||
162035468|NCT00686998|585185928|FG002|Overall Study|Adverse Event|1|||
162035469|NCT00686998|585185926|FG000|Overall Study|Withdrawal by Subject|2|||
162035470|NCT00686998|585185927|FG001|Overall Study|Withdrawal by Subject|1|||
162035471|NCT00686998|585185928|FG002|Overall Study|Withdrawal by Subject|2|||
162035472|NCT00686998|585185926|FG000|Overall Study|Lack of Efficacy|7|||
162035473|NCT00686998|585185927|FG001|Overall Study|Lack of Efficacy|5|||
162035474|NCT00686998|585185928|FG002|Overall Study|Lack of Efficacy|0|||
162035475|NCT00686998|585185926|FG000|Overall Study|Other|0|||
162035476|NCT00686998|585185927|FG001|Overall Study|Other|0|||
162035477|NCT00686998|585185928|FG002|Overall Study|Other|1|||
162035478|NCT00686998|585185926|FG000|Overall Study|Safety Reasons|1|||
162035479|NCT00686998|585185927|FG001|Overall Study|Safety Reasons|0|||
162035480|NCT00686998|585185928|FG002|Overall Study|Safety Reasons|0|||
162035481|NCT06374394|585185932|FG000|Overall Study|Adverse Event|0|||
162035482|NCT06374394|585185933|FG001|Overall Study|Adverse Event|2|||
162035483|NCT06374394|585185932|FG000|Overall Study|Lost to Follow-up|6|||
162035484|NCT06374394|585185933|FG001|Overall Study|Lost to Follow-up|9|||
162035485|NCT06374394|585185932|FG000|Overall Study|Withdrawal by Subject|1|||
162035486|NCT06374394|585185933|FG001|Overall Study|Withdrawal by Subject|7|||
162035487|NCT06374394|585185932|FG000|Overall Study|Other|1|||
162035488|NCT06374394|585185933|FG001|Overall Study|Other|0|||
162035489|NCT00356122|585185934|FG000|TREATMENT|Lack of Efficacy|26|||
162035490|NCT00356122|585185934|FG000|TREATMENT|Adverse Event|10|||
162035491|NCT00356122|585185934|FG000|TREATMENT|Subject's request|4|||
162035492|NCT00356122|585185934|FG000|TREATMENT|Other|4|||
162035493|NCT00356122|585185934|FG000|TREATMENT|Did not receive study medication|1|||
162035494|NCT00356122|585185934|FG000|FOLLOW-UP|Death|37|||
162035495|NCT00356122|585185934|FG000|FOLLOW-UP|Lost to Follow-up|2|||
162035496|NCT00356122|585185934|FG000|FOLLOW-UP|Other|2|||
162035497|NCT02483429|585185935|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
162035498|NCT02483429|585185936|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
162035499|NCT03576274|585185937|FG000|Overall Study|Lost to Follow-up|3|||
162035500|NCT03576274|585185938|FG001|Overall Study|Lost to Follow-up|2|||
162035501|NCT03576274|585185939|FG002|Overall Study|Lost to Follow-up|3|||
162035502|NCT03576274|585185940|FG003|Overall Study|Lost to Follow-up|1|||
162035503|NCT03576274|585185941|FG004|Overall Study|Lost to Follow-up|3|||
162035504|NCT03576274|585185937|FG000|Overall Study|Withdrawal by Subject|5|||
162035505|NCT03576274|585185938|FG001|Overall Study|Withdrawal by Subject|3|||
162035506|NCT03576274|585185939|FG002|Overall Study|Withdrawal by Subject|2|||
162035507|NCT03576274|585185940|FG003|Overall Study|Withdrawal by Subject|8|||
162035508|NCT03576274|585185941|FG004|Overall Study|Withdrawal by Subject|6|||
162035509|NCT00543855|585187044|FG000|Overall Study|Adverse Event|3|||
162035510|NCT00543855|585187045|FG001|Overall Study|Adverse Event|1|||
162035511|NCT00543855|585187046|FG002|Overall Study|Adverse Event|3|||
162035512|NCT00543855|585187047|FG003|Overall Study|Adverse Event|4|||
162035513|NCT00543855|585187044|FG000|Overall Study|Lost to Follow-up|0|||
162035514|NCT00543855|585187045|FG001|Overall Study|Lost to Follow-up|0|||
162035515|NCT00543855|585187046|FG002|Overall Study|Lost to Follow-up|1|||
162035516|NCT00543855|585187047|FG003|Overall Study|Lost to Follow-up|0|||
161775904|NCT02325739|584221293|FG000|Phase II Part|Adverse Event|0|||
161775905|NCT02325739|584221294|FG001|Phase II Part|Adverse Event|0|||
162035517|NCT00543855|585187044|FG000|Overall Study|Withdrawal by Subject|0|||
162035518|NCT00543855|585187045|FG001|Overall Study|Withdrawal by Subject|1|||
162035519|NCT00543855|585187046|FG002|Overall Study|Withdrawal by Subject|2|||
162035520|NCT00543855|585187047|FG003|Overall Study|Withdrawal by Subject|0|||
162035521|NCT00543855|585187044|FG000|Overall Study|Protocol Violation|1|||
162035522|NCT00543855|585187045|FG001|Overall Study|Protocol Violation|0|||
162035523|NCT00543855|585187046|FG002|Overall Study|Protocol Violation|0|||
162035524|NCT00543855|585187047|FG003|Overall Study|Protocol Violation|0|||
162035525|NCT01994590|585187051|FG000|Overall Study|Adverse Event|1|||
162035526|NCT01994590|585187051|FG000|Overall Study|Trial Terminated|1|||
162035527|NCT00719264|585187053|FG000|Overall Study|Adverse Event|41|||
162035528|NCT00719264|585187054|FG001|Overall Study|Adverse Event|49|||
162035529|NCT00719264|585187053|FG000|Overall Study|Death|13|||
162035530|NCT00719264|585187054|FG001|Overall Study|Death|10|||
161990138|NCT00095173|585014225|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
161990139|NCT00095173|585014220|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
161990140|NCT00095173|585014221|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
161990141|NCT00095173|585014222|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
161990142|NCT00095173|585014223|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
161990143|NCT00095173|585014224|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
161990144|NCT00095173|585014225|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
161990145|NCT00095173|585014220|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
161990146|NCT00095173|585014221|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
161990147|NCT00095173|585014222|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
161990148|NCT00095173|585014223|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
161990149|NCT00095173|585014224|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
161990150|NCT00095173|585014225|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
161990151|NCT00095173|585014220|FG000|Open-Label Extension Phase (Period C)|Other|0|||
161990152|NCT00095173|585014221|FG001|Open-Label Extension Phase (Period C)|Other|0|||
161990153|NCT00095173|585014222|FG002|Open-Label Extension Phase (Period C)|Other|0|||
161990154|NCT00095173|585014223|FG003|Open-Label Extension Phase (Period C)|Other|4|||
161990155|NCT00095173|585014224|FG004|Open-Label Extension Phase (Period C)|Other|6|||
161990156|NCT00095173|585014225|FG005|Open-Label Extension Phase (Period C)|Other|8|||
161990157|NCT02161757|585014232|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
161990158|NCT02161757|585014233|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
161990159|NCT02161757|585014234|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
161990160|NCT02161757|585014232|FG000|Treatment Through Study Completion|Adverse Event|1|||
161990161|NCT02161757|585014233|FG001|Treatment Through Study Completion|Adverse Event|1|||
161990162|NCT02161757|585014234|FG002|Treatment Through Study Completion|Adverse Event|0|||
161990163|NCT02161757|585014232|FG000|Treatment Through Study Completion|Protocol Violation|0|||
161990164|NCT02161757|585014233|FG001|Treatment Through Study Completion|Protocol Violation|1|||
161990165|NCT02161757|585014234|FG002|Treatment Through Study Completion|Protocol Violation|2|||
161990166|NCT02161757|585014232|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
161990167|NCT02161757|585014233|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
161990168|NCT02161757|585014234|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
161990169|NCT02161757|585014232|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
161990170|NCT02161757|585014233|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
161990171|NCT02161757|585014234|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
161990172|NCT02161757|585014232|FG000|Treatment Through Study Completion|Other|20|||
161990173|NCT02161757|585014233|FG001|Treatment Through Study Completion|Other|19|||
161990174|NCT02161757|585014234|FG002|Treatment Through Study Completion|Other|12|||
161990175|NCT02161757|585014232|FG000|Treatment Through Study Completion|Death|2|||
161990176|NCT02161757|585014233|FG001|Treatment Through Study Completion|Death|1|||
161990177|NCT02161757|585014234|FG002|Treatment Through Study Completion|Death|1|||
161990178|NCT00391625|585014235|FG000|Month 14|Withdrawal by Subject|1|||
161990179|NCT00391625|585014235|FG000|Month 50|Physician Decision|1|||
161990180|NCT02106403|585014242|FG000|Follow-Up Visit 3|Other Reason|0|||
161990181|NCT02106403|585014243|FG001|Follow-Up Visit 3|Other Reason|0|||
161990182|NCT02106403|585014244|FG002|Follow-Up Visit 3|Other Reason|0|||
161990183|NCT02106403|585014245|FG003|Follow-Up Visit 3|Other Reason|0|||
161990184|NCT02106403|585014246|FG004|Follow-Up Visit 3|Other Reason|0|||
161990185|NCT02106403|585014247|FG005|Follow-Up Visit 3|Other Reason|1|||
161990186|NCT01128946|585014258|FG000|Period I|Protocol Violation|0|||
161990187|NCT01128946|585014259|FG001|Period I|Protocol Violation|1|||
161990188|NCT01128946|585014260|FG002|Period I|Protocol Violation|0|||
161990189|NCT01128946|585014261|FG003|Period I|Protocol Violation|0|||
161990190|NCT01128946|585014258|FG000|Period I|Withdrawal by Subject|0|||
161990191|NCT01128946|585014259|FG001|Period I|Withdrawal by Subject|0|||
161990192|NCT01128946|585014260|FG002|Period I|Withdrawal by Subject|1|||
161990193|NCT01128946|585014261|FG003|Period I|Withdrawal by Subject|1|||
161990194|NCT01128946|585014258|FG000|Period II|Protocol Violation|0|||
161990195|NCT01128946|585014259|FG001|Period II|Protocol Violation|1|||
161990196|NCT01128946|585014260|FG002|Period II|Protocol Violation|0|||
161990197|NCT01128946|585014261|FG003|Period II|Protocol Violation|0|||
161990198|NCT01128946|585014258|FG000|Period II|Withdrawal by Subject|0|||
161990199|NCT01128946|585014259|FG001|Period II|Withdrawal by Subject|0|||
161990200|NCT01128946|585014260|FG002|Period II|Withdrawal by Subject|0|||
161990201|NCT01128946|585014261|FG003|Period II|Withdrawal by Subject|1|||
161990202|NCT01128946|585014258|FG000|Period III|Protocol Violation|1|||
161990203|NCT01128946|585014259|FG001|Period III|Protocol Violation|0|||
161990204|NCT01128946|585014260|FG002|Period III|Protocol Violation|0|||
161990205|NCT01128946|585014261|FG003|Period III|Protocol Violation|0|||
161990206|NCT04698993|585014262|FG000|Overall Study|PCR results not accessible|2|||
161990207|NCT04698993|585014263|FG001|Overall Study|PCR results not accessible|7|||
162035531|NCT00719264|585187053|FG000|Overall Study|Administrative Problems|6|||
161990208|NCT04698993|585014262|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
162035532|NCT00719264|585187054|FG001|Overall Study|Administrative Problems|4|||
161873003|NCT02477826|584578616|FG009|Treatment Period|Participant request to discontinue treatment|18|||
161873004|NCT02477826|584578607|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
161873005|NCT02477826|584578608|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
161873006|NCT02477826|584578609|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
161873007|NCT02477826|584578610|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
161873008|NCT02477826|584578611|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
161873009|NCT02477826|584578612|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
161873010|NCT02477826|584578613|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
161873011|NCT02477826|584578614|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
161873012|NCT02477826|584578615|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
161873013|NCT02477826|584578616|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
161873014|NCT02477826|584578607|FG000|Treatment Period|Death|4|||
161873015|NCT02477826|584578608|FG001|Treatment Period|Death|7|||
161873016|NCT02477826|584578609|FG002|Treatment Period|Death|0|||
161873017|NCT02477826|584578610|FG003|Treatment Period|Death|0|||
161873018|NCT02477826|584578611|FG004|Treatment Period|Death|1|||
161873019|NCT02477826|584578612|FG005|Treatment Period|Death|2|||
161873020|NCT02477826|584578613|FG006|Treatment Period|Death|6|||
161873021|NCT02477826|584578614|FG007|Treatment Period|Death|5|||
161873022|NCT02477826|584578615|FG008|Treatment Period|Death|9|||
161873023|NCT02477826|584578616|FG009|Treatment Period|Death|0|||
161873024|NCT02477826|584578607|FG000|Treatment Period|Study Drug Toxicity|79|||
161873025|NCT02477826|584578608|FG001|Treatment Period|Study Drug Toxicity|51|||
161873026|NCT02477826|584578609|FG002|Treatment Period|Study Drug Toxicity|31|||
161873027|NCT02477826|584578610|FG003|Treatment Period|Study Drug Toxicity|39|||
161873028|NCT02477826|584578611|FG004|Treatment Period|Study Drug Toxicity|12|||
161873029|NCT02477826|584578612|FG005|Treatment Period|Study Drug Toxicity|25|||
161873030|NCT02477826|584578613|FG006|Treatment Period|Study Drug Toxicity|52|||
161873031|NCT02477826|584578614|FG007|Treatment Period|Study Drug Toxicity|30|||
161873032|NCT02477826|584578615|FG008|Treatment Period|Study Drug Toxicity|20|||
161873033|NCT02477826|584578616|FG009|Treatment Period|Study Drug Toxicity|9|||
161873034|NCT02477826|584578607|FG000|Treatment Period|Disease progression|212|||
161873035|NCT02477826|584578608|FG001|Treatment Period|Disease progression|240|||
161873036|NCT02477826|584578609|FG002|Treatment Period|Disease progression|202|||
161873037|NCT02477826|584578610|FG003|Treatment Period|Disease progression|93|||
161873038|NCT02477826|584578611|FG004|Treatment Period|Disease progression|113|||
161873039|NCT02477826|584578612|FG005|Treatment Period|Disease progression|96|||
161873040|NCT02477826|584578613|FG006|Treatment Period|Disease progression|208|||
161873041|NCT02477826|584578614|FG007|Treatment Period|Disease progression|195|||
161873042|NCT02477826|584578615|FG008|Treatment Period|Disease progression|59|||
161873043|NCT02477826|584578616|FG009|Treatment Period|Disease progression|46|||
161873044|NCT02477826|584578607|FG000|Treatment Period|Pregnancy|0|||
161873045|NCT02477826|584578608|FG001|Treatment Period|Pregnancy|0|||
161873046|NCT02477826|584578609|FG002|Treatment Period|Pregnancy|0|||
161873047|NCT02477826|584578610|FG003|Treatment Period|Pregnancy|0|||
161873048|NCT02477826|584578611|FG004|Treatment Period|Pregnancy|0|||
161873049|NCT02477826|584578612|FG005|Treatment Period|Pregnancy|0|||
161873050|NCT02477826|584578613|FG006|Treatment Period|Pregnancy|0|||
161873051|NCT02477826|584578614|FG007|Treatment Period|Pregnancy|0|||
161873052|NCT02477826|584578615|FG008|Treatment Period|Pregnancy|0|||
161873053|NCT02477826|584578616|FG009|Treatment Period|Pregnancy|1|||
161873054|NCT02477826|584578607|FG000|Treatment Period|Other|0|||
161873055|NCT02477826|584578608|FG001|Treatment Period|Other|0|||
161873056|NCT02477826|584578609|FG002|Treatment Period|Other|0|||
161873057|NCT02477826|584578610|FG003|Treatment Period|Other|0|||
161873058|NCT02477826|584578611|FG004|Treatment Period|Other|0|||
161873059|NCT02477826|584578612|FG005|Treatment Period|Other|0|||
161873060|NCT02477826|584578613|FG006|Treatment Period|Other|0|||
161873061|NCT02477826|584578614|FG007|Treatment Period|Other|0|||
161873062|NCT02477826|584578615|FG008|Treatment Period|Other|0|||
161873063|NCT02477826|584578616|FG009|Treatment Period|Other|1|||
161873064|NCT00403481|584578650|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
161873065|NCT00403481|584578650|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
161873066|NCT00403481|584578650|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
161873067|NCT00403481|584578650|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
161873068|NCT00403481|584578650|FG000|Olm 40 mg|Adverse Event|2|||
161873069|NCT00403481|584578650|FG000|Olm 40 mg|Protocol Violation|1|||
161873070|NCT00403481|584578650|FG000|Olm 40 mg|Withdrawal by Subject|1|||
161873071|NCT00403481|584578650|FG000|Olm 40 mg|Other|1|||
161873072|NCT00403481|584578650|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
161873073|NCT00403481|584578650|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
161873074|NCT00403481|584578650|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
161873075|NCT00403481|584578650|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
161873076|NCT00403481|584578650|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
161873077|NCT00403481|584578650|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
161873078|NCT02929589|584578652|FG000|Overall Study|Withdrawal by Subject|1|||
162035533|NCT00719264|585187053|FG000|Overall Study|Lost to Follow-up|1|||
162035534|NCT00719264|585187054|FG001|Overall Study|Lost to Follow-up|1|||
162035535|NCT00719264|585187053|FG000|Overall Study|Withdrawal by Subject|12|||
162035536|NCT00719264|585187054|FG001|Overall Study|Withdrawal by Subject|7|||
162035537|NCT00719264|585187053|FG000|Overall Study|Protocol Deviation|1|||
162035538|NCT00719264|585187054|FG001|Overall Study|Protocol Deviation|3|||
162035539|NCT00719264|585187053|FG000|Overall Study|New Cancer Therapy|4|||
162035540|NCT00719264|585187054|FG001|Overall Study|New Cancer Therapy|2|||
162035541|NCT00719264|585187053|FG000|Overall Study|Disease Progression|104|||
162035542|NCT00719264|585187054|FG001|Overall Study|Disease Progression|107|||
162035543|NCT01277042|585187055|FG000|Overall Study|Adverse Event|4|||
162035544|NCT01277042|585187056|FG001|Overall Study|Adverse Event|3|||
162035545|NCT01277042|585187055|FG000|Overall Study|Lost to Follow-up|2|||
162035546|NCT01277042|585187056|FG001|Overall Study|Lost to Follow-up|2|||
162035547|NCT01277042|585187055|FG000|Overall Study|Withdrawal by Subject|2|||
162035548|NCT01277042|585187056|FG001|Overall Study|Withdrawal by Subject|0|||
162035549|NCT03581786|585187063|FG000|Overall Study|Death|67|||
162035550|NCT03581786|585187064|FG001|Overall Study|Death|47|||
162035551|NCT03581786|585187063|FG000|Overall Study|Withdrawal by Subject|2|||
162035552|NCT03581786|585187064|FG001|Overall Study|Withdrawal by Subject|5|||
162035553|NCT03581786|585187063|FG000|Overall Study|Lost to Follow-up|7|||
162035554|NCT03581786|585187064|FG001|Overall Study|Lost to Follow-up|4|||
162035555|NCT03581786|585187063|FG000|Overall Study|reason other than specified above|0|||
162035556|NCT03581786|585187064|FG001|Overall Study|reason other than specified above|1|||
162035557|NCT02469038|585187065|FG000|Overall Study|Physician Decision|4|||
162035558|NCT02469038|585187066|FG001|Overall Study|Physician Decision|5|||
162035559|NCT03435640|585187067|FG000|Overall Study|Withdrawal by Subject|0|||
162035560|NCT03435640|585187068|FG001|Overall Study|Withdrawal by Subject|1|||
162035561|NCT03435640|585187069|FG002|Overall Study|Withdrawal by Subject|0|||
162035562|NCT03435640|585187070|FG003|Overall Study|Withdrawal by Subject|2|||
162035563|NCT03435640|585187071|FG004|Overall Study|Withdrawal by Subject|0|||
162035564|NCT03435640|585187072|FG005|Overall Study|Withdrawal by Subject|0|||
161775906|NCT02325739|584221295|FG002|Phase II Part|Adverse Event|0|||
161775907|NCT02325739|584221296|FG003|Phase II Part|Adverse Event|0|||
161775908|NCT02325739|584221297|FG004|Phase II Part|Adverse Event|0|||
161775909|NCT02325739|584221298|FG005|Phase II Part|Adverse Event|0|||
161775910|NCT02325739|584221299|FG006|Phase II Part|Adverse Event|0|||
161775911|NCT02325739|584221300|FG007|Phase II Part|Adverse Event|0|||
162035565|NCT03435640|585187073|FG006|Overall Study|Withdrawal by Subject|3|||
162035566|NCT03435640|585187074|FG007|Overall Study|Withdrawal by Subject|0|||
162035567|NCT03435640|585187075|FG008|Overall Study|Withdrawal by Subject|0|||
162035568|NCT03435640|585187076|FG009|Overall Study|Withdrawal by Subject|2|||
162035569|NCT03435640|585187077|FG010|Overall Study|Withdrawal by Subject|3|||
162035570|NCT03435640|585187067|FG000|Overall Study|Lost to Follow-up|0|||
162035571|NCT03435640|585187068|FG001|Overall Study|Lost to Follow-up|0|||
162035572|NCT03435640|585187069|FG002|Overall Study|Lost to Follow-up|1|||
162035573|NCT03435640|585187070|FG003|Overall Study|Lost to Follow-up|0|||
162035574|NCT03435640|585187071|FG004|Overall Study|Lost to Follow-up|0|||
162035575|NCT03435640|585187072|FG005|Overall Study|Lost to Follow-up|0|||
162035576|NCT03435640|585187073|FG006|Overall Study|Lost to Follow-up|0|||
162035577|NCT03435640|585187074|FG007|Overall Study|Lost to Follow-up|0|||
162035578|NCT03435640|585187075|FG008|Overall Study|Lost to Follow-up|0|||
162035579|NCT03435640|585187076|FG009|Overall Study|Lost to Follow-up|0|||
162035580|NCT03435640|585187077|FG010|Overall Study|Lost to Follow-up|0|||
162035581|NCT01347307|585187078|FG000|Overall Study|Death|0|||
162035582|NCT01347307|585187079|FG001|Overall Study|Death|4|||
162035583|NCT01347307|585187078|FG000|Overall Study|Physician Decision|0|||
162035584|NCT01347307|585187079|FG001|Overall Study|Physician Decision|1|||
162035585|NCT00442468|585187093|FG000|Overall Study|Adverse Event|4|||
162035586|NCT00442468|585187093|FG000|Overall Study|Withdrawal by Subject|91|||
162035587|NCT00442468|585187093|FG000|Overall Study|Did not complete all study procedures|88|||
162035588|NCT00589784|585187094|FG000|Overall Study|Withdrawal by Subject|0|||
162035589|NCT00589784|585187095|FG001|Overall Study|Withdrawal by Subject|6|||
162035590|NCT00589784|585187094|FG000|Overall Study|Patient inevaluable|1|||
162035591|NCT00589784|585187095|FG001|Overall Study|Patient inevaluable|0|||
162035592|NCT00589784|585187094|FG000|Overall Study|Adverse Event|0|||
162035593|NCT00589784|585187095|FG001|Overall Study|Adverse Event|4|||
162035594|NCT00287079|585187097|FG000|Overall Study|Qualifying relapse|12|||
162035595|NCT00287079|585187098|FG001|Overall Study|Qualifying relapse|1|||
162035596|NCT00287079|585187097|FG000|Overall Study|Non-qualifying relapse|1|||
162035597|NCT00287079|585187098|FG001|Overall Study|Non-qualifying relapse|0|||
162035598|NCT00287079|585187097|FG000|Overall Study|Adverse Event|5|||
162035599|NCT00287079|585187098|FG001|Overall Study|Adverse Event|0|||
162035600|NCT00287079|585187097|FG000|Overall Study|Protocol Violation|1|||
162035601|NCT00287079|585187098|FG001|Overall Study|Protocol Violation|0|||
162035602|NCT00287079|585187097|FG000|Overall Study|Other|3|||
162035603|NCT00287079|585187098|FG001|Overall Study|Other|0|||
162035604|NCT00174291|585187103|FG000|Overall Study|Lost to Follow-up|1|||
162035605|NCT00174291|585187104|FG001|Overall Study|Lost to Follow-up|1|||
161873079|NCT02929589|584578653|FG001|Overall Study|Withdrawal by Subject|0|||
161873080|NCT02929589|584578654|FG002|Overall Study|Withdrawal by Subject|0|||
161873081|NCT02929589|584578655|FG003|Overall Study|Withdrawal by Subject|0|||
161873082|NCT02929589|584578652|FG000|Overall Study|Physician Decision|2|||
161873083|NCT02929589|584578653|FG001|Overall Study|Physician Decision|0|||
161873084|NCT02929589|584578654|FG002|Overall Study|Physician Decision|0|||
161873085|NCT02929589|584578655|FG003|Overall Study|Physician Decision|0|||
161873086|NCT02091089|584578656|FG000|Overall Study|Lost to Follow-up|2|||
161873087|NCT00766636|584578667|FG000|Overall Study|Withdrawal by Subject|1|||
161873088|NCT00766636|584578668|FG001|Overall Study|Withdrawal by Subject|1|||
161873089|NCT00766636|584578667|FG000|Overall Study|Incomplete Treatment|0|||
161873090|NCT00766636|584578668|FG001|Overall Study|Incomplete Treatment|1|||
161873091|NCT00766636|584578667|FG000|Overall Study|Adverse Event|1|||
161873092|NCT00766636|584578668|FG001|Overall Study|Adverse Event|0|||
161873093|NCT00766636|584578667|FG000|Overall Study|Disease Progression|1|||
161873094|NCT00766636|584578668|FG001|Overall Study|Disease Progression|0|||
161873095|NCT02477332|584578671|FG000|Overall Study|Adverse Event|0|||
161873096|NCT02477332|584578672|FG001|Overall Study|Adverse Event|1|||
161873097|NCT02477332|584578673|FG002|Overall Study|Adverse Event|1|||
161873098|NCT02477332|584578674|FG003|Overall Study|Adverse Event|2|||
161873099|NCT02477332|584578675|FG004|Overall Study|Adverse Event|1|||
161873100|NCT02477332|584578676|FG005|Overall Study|Adverse Event|2|||
161873101|NCT02477332|584578671|FG000|Overall Study|Lack of Efficacy|1|||
161873102|NCT02477332|584578672|FG001|Overall Study|Lack of Efficacy|2|||
161873103|NCT02477332|584578673|FG002|Overall Study|Lack of Efficacy|1|||
161873104|NCT02477332|584578674|FG003|Overall Study|Lack of Efficacy|2|||
161873105|NCT02477332|584578675|FG004|Overall Study|Lack of Efficacy|1|||
161873106|NCT02477332|584578676|FG005|Overall Study|Lack of Efficacy|1|||
161873107|NCT02477332|584578671|FG000|Overall Study|Non-compliance with study treatment|0|||
161873108|NCT02477332|584578672|FG001|Overall Study|Non-compliance with study treatment|1|||
161873109|NCT02477332|584578673|FG002|Overall Study|Non-compliance with study treatment|2|||
161873110|NCT02477332|584578674|FG003|Overall Study|Non-compliance with study treatment|0|||
161873111|NCT02477332|584578675|FG004|Overall Study|Non-compliance with study treatment|0|||
161873112|NCT02477332|584578676|FG005|Overall Study|Non-compliance with study treatment|0|||
161873113|NCT02477332|584578671|FG000|Overall Study|Pregnancy|0|||
161873114|NCT02477332|584578672|FG001|Overall Study|Pregnancy|0|||
161873115|NCT02477332|584578673|FG002|Overall Study|Pregnancy|0|||
161873116|NCT02477332|584578674|FG003|Overall Study|Pregnancy|1|||
161873117|NCT02477332|584578675|FG004|Overall Study|Pregnancy|0|||
161873118|NCT02477332|584578676|FG005|Overall Study|Pregnancy|0|||
161873119|NCT02477332|584578671|FG000|Overall Study|Protocol Violation|2|||
161873120|NCT02477332|584578672|FG001|Overall Study|Protocol Violation|0|||
161873121|NCT02477332|584578673|FG002|Overall Study|Protocol Violation|3|||
161873122|NCT02477332|584578674|FG003|Overall Study|Protocol Violation|3|||
161873123|NCT02477332|584578675|FG004|Overall Study|Protocol Violation|1|||
161873124|NCT02477332|584578676|FG005|Overall Study|Protocol Violation|1|||
161873125|NCT02477332|584578671|FG000|Overall Study|Technical problems|0|||
161873126|NCT02477332|584578672|FG001|Overall Study|Technical problems|0|||
161873127|NCT02477332|584578673|FG002|Overall Study|Technical problems|1|||
161873128|NCT02477332|584578674|FG003|Overall Study|Technical problems|0|||
161873129|NCT02477332|584578675|FG004|Overall Study|Technical problems|0|||
161873130|NCT02477332|584578676|FG005|Overall Study|Technical problems|0|||
161873131|NCT02477332|584578671|FG000|Overall Study|Lost to Follow-up|0|||
161873132|NCT02477332|584578672|FG001|Overall Study|Lost to Follow-up|0|||
161873133|NCT02477332|584578673|FG002|Overall Study|Lost to Follow-up|2|||
161873134|NCT02477332|584578674|FG003|Overall Study|Lost to Follow-up|0|||
162035606|NCT00174291|585187103|FG000|Overall Study|Protocol Violation|0|||
162035607|NCT00174291|585187104|FG001|Overall Study|Protocol Violation|2|||
162035608|NCT00174291|585187103|FG000|Overall Study|Study terminated by sponsor|1|||
162035609|NCT00174291|585187104|FG001|Overall Study|Study terminated by sponsor|0|||
161873135|NCT02477332|584578675|FG004|Overall Study|Lost to Follow-up|0|||
161873136|NCT02477332|584578676|FG005|Overall Study|Lost to Follow-up|0|||
161873137|NCT02477332|584578671|FG000|Overall Study|Physician Decision|0|||
161873138|NCT02477332|584578672|FG001|Overall Study|Physician Decision|0|||
161873139|NCT02477332|584578673|FG002|Overall Study|Physician Decision|1|||
161873140|NCT02477332|584578674|FG003|Overall Study|Physician Decision|3|||
161873141|NCT02477332|584578675|FG004|Overall Study|Physician Decision|0|||
161873142|NCT02477332|584578676|FG005|Overall Study|Physician Decision|1|||
161873143|NCT02477332|584578671|FG000|Overall Study|Withdrawal by Subject|0|||
161873144|NCT02477332|584578672|FG001|Overall Study|Withdrawal by Subject|3|||
161873145|NCT02477332|584578673|FG002|Overall Study|Withdrawal by Subject|1|||
161873146|NCT02477332|584578674|FG003|Overall Study|Withdrawal by Subject|2|||
161873147|NCT02477332|584578675|FG004|Overall Study|Withdrawal by Subject|1|||
161873148|NCT02477332|584578676|FG005|Overall Study|Withdrawal by Subject|0|||
161873149|NCT04657198|584578677|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
161873150|NCT04657198|584578678|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
161873151|NCT04657198|584578679|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
161873152|NCT02977572|584578682|FG000|Overall Study|Exclusion criterion|2|||
161873153|NCT02977572|584578683|FG001|Overall Study|Exclusion criterion|2|||
161873154|NCT01075256|584578686|FG000|Overall Study|Withdrawal by Subject|1|||
161873155|NCT01075256|584578687|FG001|Overall Study|Withdrawal by Subject|0|||
161873156|NCT01075256|584578688|FG002|Overall Study|Withdrawal by Subject|0|||
161873157|NCT03502070|584578689|FG000|Overall Study|Withdrawal by Subject|1|||
161873158|NCT03502070|584578689|FG000|Overall Study|Screen Failure|1|||
161873159|NCT01218087|584578701|FG000|Overall Study|Death|2|||
161873160|NCT01218087|584578702|FG001|Overall Study|Death|1|||
161873161|NCT01218087|584578701|FG000|Overall Study|Withdrawal by Subject|5|||
161873162|NCT01218087|584578702|FG001|Overall Study|Withdrawal by Subject|0|||
161873163|NCT01218087|584578701|FG000|Overall Study|Transferred|8|||
161873164|NCT01218087|584578702|FG001|Overall Study|Transferred|5|||
161873165|NCT03170362|584578703|FG000|Overall Study|Death|2|||
161873166|NCT03170362|584578704|FG001|Overall Study|Death|2|||
161873167|NCT03170362|584578703|FG000|Overall Study|Withdrawal by Subject|23|||
161873168|NCT03170362|584578704|FG001|Overall Study|Withdrawal by Subject|22|||
161873169|NCT03170362|584578703|FG000|Overall Study|Lost to Follow-up|187|||
161873170|NCT03170362|584578704|FG001|Overall Study|Lost to Follow-up|167|||
161873171|NCT00552396|584578705|FG000|Overall Study|protocol withdrawal criteria|3|||
161873172|NCT00552396|584578706|FG001|Overall Study|protocol withdrawal criteria|3|||
161873173|NCT00552396|584578707|FG002|Overall Study|protocol withdrawal criteria|3|||
161873174|NCT00552396|584578708|FG003|Overall Study|protocol withdrawal criteria|6|||
161873175|NCT00552396|584578709|FG004|Overall Study|protocol withdrawal criteria|3|||
161873176|NCT00552396|584578710|FG005|Overall Study|protocol withdrawal criteria|3|||
161873177|NCT00552396|584578711|FG006|Overall Study|protocol withdrawal criteria|9|||
161873178|NCT03340454|584578712|FG000|Overall Study|Lost to Follow-up|0|||
161873179|NCT03340454|584578713|FG001|Overall Study|Lost to Follow-up|4|||
161873180|NCT03307252|584578719|FG000|Part 2, Period 1|Treatment not received|0|||
161873181|NCT03307252|584578720|FG001|Part 2, Period 1|Treatment not received|0|||
161873182|NCT03307252|584578721|FG002|Part 2, Period 1|Treatment not received|0|||
161873183|NCT03307252|584578722|FG003|Part 2, Period 1|Treatment not received|0|||
161873184|NCT03307252|584578723|FG004|Part 2, Period 1|Treatment not received|0|||
161873185|NCT03307252|584578724|FG005|Part 2, Period 1|Treatment not received|1|||
161873186|NCT03307252|584578725|FG006|Part 2, Period 1|Treatment not received|0|||
161873187|NCT03307252|584578726|FG007|Part 2, Period 1|Treatment not received|0|||
161873188|NCT03307252|584578727|FG008|Part 2, Period 1|Treatment not received|0|||
161873189|NCT03307252|584578728|FG009|Part 2, Period 1|Treatment not received|0|||
161873190|NCT03307252|584578729|FG010|Part 2, Period 1|Treatment not received|0|||
161873191|NCT03307252|584578719|FG000|Part 2, Period 3|Other than listed|0|||
161873192|NCT03307252|584578720|FG001|Part 2, Period 3|Other than listed|0|||
161873193|NCT03307252|584578721|FG002|Part 2, Period 3|Other than listed|0|||
161873194|NCT03307252|584578722|FG003|Part 2, Period 3|Other than listed|0|||
161873195|NCT03307252|584578723|FG004|Part 2, Period 3|Other than listed|1|||
161873196|NCT03307252|584578724|FG005|Part 2, Period 3|Other than listed|0|||
161873197|NCT03307252|584578725|FG006|Part 2, Period 3|Other than listed|0|||
161873198|NCT03307252|584578726|FG007|Part 2, Period 3|Other than listed|0|||
161873199|NCT03307252|584578727|FG008|Part 2, Period 3|Other than listed|0|||
161873200|NCT03307252|584578728|FG009|Part 2, Period 3|Other than listed|0|||
161873201|NCT03307252|584578729|FG010|Part 2, Period 3|Other than listed|0|||
161873202|NCT03307252|584578719|FG000|Part 2, Period 4|Other than listed|0|||
161873203|NCT03307252|584578720|FG001|Part 2, Period 4|Other than listed|0|||
161873204|NCT03307252|584578721|FG002|Part 2, Period 4|Other than listed|0|||
161873205|NCT03307252|584578722|FG003|Part 2, Period 4|Other than listed|0|||
161873206|NCT03307252|584578723|FG004|Part 2, Period 4|Other than listed|0|||
161873207|NCT03307252|584578724|FG005|Part 2, Period 4|Other than listed|0|||
161873208|NCT03307252|584578725|FG006|Part 2, Period 4|Other than listed|1|||
161873209|NCT03307252|584578726|FG007|Part 2, Period 4|Other than listed|0|||
161873210|NCT03307252|584578727|FG008|Part 2, Period 4|Other than listed|0|||
161873211|NCT03307252|584578728|FG009|Part 2, Period 4|Other than listed|0|||
161873212|NCT03307252|584578729|FG010|Part 2, Period 4|Other than listed|0|||
161873213|NCT03307252|584578719|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873214|NCT03307252|584578720|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873215|NCT03307252|584578721|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161990209|NCT04698993|585014263|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
161873216|NCT03307252|584578722|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873217|NCT03307252|584578723|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873218|NCT03307252|584578724|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873219|NCT03307252|584578725|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873220|NCT03307252|584578726|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873221|NCT03307252|584578727|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873222|NCT03307252|584578728|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161873223|NCT03307252|584578729|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
161873224|NCT01052480|584578730|FG000|Overall Study|Lost to Follow-up|3|||
161873225|NCT01052480|584578731|FG001|Overall Study|Lost to Follow-up|3|||
161873226|NCT01052480|584578730|FG000|Overall Study|Protocol Violation|1|||
161873227|NCT01052480|584578731|FG001|Overall Study|Protocol Violation|0|||
161873228|NCT01052480|584578730|FG000|Overall Study|Withdrawal by Subject|3|||
161873229|NCT01052480|584578731|FG001|Overall Study|Withdrawal by Subject|7|||
161873230|NCT01052480|584578730|FG000|Overall Study|Physician Decision|0|||
161873231|NCT01052480|584578731|FG001|Overall Study|Physician Decision|2|||
161873232|NCT01052480|584578730|FG000|Overall Study|Death|1|||
161873233|NCT01052480|584578731|FG001|Overall Study|Death|5|||
161873234|NCT04185220|584578736|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
161873235|NCT04185220|584578737|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
161873236|NCT04185220|584578736|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
161873237|NCT04185220|584578737|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
161873238|NCT03225105|584578744|FG000|Overall Study|Withdrawal by Subject|1|||
161873239|NCT03225105|584578745|FG001|Overall Study|Withdrawal by Subject|0|||
161873240|NCT03225105|584578746|FG002|Overall Study|Withdrawal by Subject|0|||
161873241|NCT03225105|584578747|FG003|Overall Study|Withdrawal by Subject|0|||
161873242|NCT03225105|584578744|FG000|Overall Study|Death|0|||
161873243|NCT03225105|584578745|FG001|Overall Study|Death|4|||
161873244|NCT03225105|584578746|FG002|Overall Study|Death|2|||
161873245|NCT03225105|584578747|FG003|Overall Study|Death|0|||
161873246|NCT03225105|584578744|FG000|Overall Study|Study termination per Sponsor Decision|2|||
161873247|NCT03225105|584578745|FG001|Overall Study|Study termination per Sponsor Decision|0|||
161873248|NCT03225105|584578746|FG002|Overall Study|Study termination per Sponsor Decision|3|||
161873249|NCT03225105|584578747|FG003|Overall Study|Study termination per Sponsor Decision|3|||
161873250|NCT05488470|584580523|FG000|Overall Study|Physician Decision|2|||
161873251|NCT05488470|584580523|FG000|Overall Study|Withdrawal by Subject|1|||
161873252|NCT05488470|584580523|FG000|Overall Study|Death|1|||
161873253|NCT01736397|584580524|FG000|Overall Study|Lack of Efficacy|1|||
161990210|NCT00379912|585014264|FG000|Overall Study|Lack of Efficacy|1|||
161990211|NCT00379912|585014265|FG001|Overall Study|Lack of Efficacy|0|||
161990212|NCT00766051|585014267|FG000|Overall Study|Withdrawal by Subject|2|||
161990213|NCT00766051|585014268|FG001|Overall Study|Withdrawal by Subject|0|||
161990214|NCT02669121|585014269|FG000|Overall Study|Adverse Event|4|||
161990215|NCT02669121|585014270|FG001|Overall Study|Adverse Event|5|||
161990216|NCT02669121|585014269|FG000|Overall Study|Lost to Follow-up|15|||
161990217|NCT02669121|585014270|FG001|Overall Study|Lost to Follow-up|27|||
161990218|NCT02669121|585014269|FG000|Overall Study|Withdrawal by Subject|132|||
161990219|NCT02669121|585014270|FG001|Overall Study|Withdrawal by Subject|140|||
161990220|NCT02669121|585014269|FG000|Overall Study|Pregnancy|0|||
161990221|NCT02669121|585014270|FG001|Overall Study|Pregnancy|1|||
161990222|NCT02669121|585014269|FG000|Overall Study|Discharged from US Military Active Service|117|||
161990223|NCT02669121|585014270|FG001|Overall Study|Discharged from US Military Active Service|91|||
161990224|NCT02669121|585014269|FG000|Overall Study|Reason not Specified|22|||
161990225|NCT02669121|585014270|FG001|Overall Study|Reason not Specified|18|||
161990226|NCT00635882|585014271|FG000|Overall Study|Protocol Violation|1|||
161990227|NCT00635882|585014272|FG001|Overall Study|Protocol Violation|0|||
161990228|NCT00635882|585014273|FG002|Overall Study|Protocol Violation|0|||
161990229|NCT00635882|585014274|FG003|Overall Study|Protocol Violation|0|||
161990230|NCT00635882|585014275|FG004|Overall Study|Protocol Violation|0|||
161990231|NCT00635882|585014276|FG005|Overall Study|Protocol Violation|0|||
161990232|NCT01320202|585014277|FG000|Overall Study|Adverse Event|5|||
161990233|NCT01320202|585014278|FG001|Overall Study|Adverse Event|5|||
161990234|NCT01320202|585014277|FG000|Overall Study|Death|5|||
161990235|NCT01320202|585014278|FG001|Overall Study|Death|3|||
161990236|NCT01320202|585014277|FG000|Overall Study|Lost to Follow-up|1|||
161990237|NCT01320202|585014278|FG001|Overall Study|Lost to Follow-up|0|||
161990238|NCT01320202|585014277|FG000|Overall Study|Physician Decision|3|||
161990239|NCT01320202|585014278|FG001|Overall Study|Physician Decision|1|||
161990240|NCT01320202|585014277|FG000|Overall Study|Protocol Violation|2|||
161990241|NCT01320202|585014278|FG001|Overall Study|Protocol Violation|1|||
161990242|NCT01320202|585014277|FG000|Overall Study|Withdrawal by Subject|10|||
161990243|NCT01320202|585014278|FG001|Overall Study|Withdrawal by Subject|3|||
162035610|NCT00174291|585187103|FG000|Overall Study|Withdrawal by Subject|3|||
162035611|NCT00174291|585187104|FG001|Overall Study|Withdrawal by Subject|3|||
162035612|NCT03882008|585187105|FG000|Overall Study|Withdrawal by Subject|1|||
161990244|NCT01320202|585014277|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
162035613|NCT03882008|585187105|FG000|Overall Study|Lost to Follow-up|1|||
162035614|NCT02953509|585187106|FG000|Overall Study|Death|1|||
161990245|NCT01320202|585014278|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
161990246|NCT01320202|585014277|FG000|Overall Study|kidney transplant|1|||
161990247|NCT01320202|585014278|FG001|Overall Study|kidney transplant|2|||
161990248|NCT01320202|585014277|FG000|Overall Study|blood transfusion|1|||
161990249|NCT01320202|585014278|FG001|Overall Study|blood transfusion|7|||
162035615|NCT02953509|585187107|FG001|Overall Study|Death|3|||
161873254|NCT01736397|584580525|FG001|Overall Study|Lack of Efficacy|11|||
161873255|NCT01736397|584580524|FG000|Overall Study|Withdrawal by Subject|6|||
161873256|NCT01736397|584580525|FG001|Overall Study|Withdrawal by Subject|5|||
161873257|NCT01736397|584580524|FG000|Overall Study|Lost to Follow-up|0|||
161873258|NCT01736397|584580525|FG001|Overall Study|Lost to Follow-up|1|||
161873259|NCT01736397|584580524|FG000|Overall Study|Adverse Event|6|||
161873260|NCT01736397|584580525|FG001|Overall Study|Adverse Event|3|||
161873261|NCT01736397|584580524|FG000|Overall Study|Not stated|1|||
161873262|NCT01736397|584580525|FG001|Overall Study|Not stated|4|||
161873263|NCT01868438|584580526|FG000|First Intervention|Withdrawal by Subject|5|||
161873264|NCT01868438|584580527|FG001|First Intervention|Withdrawal by Subject|1|||
161873265|NCT01868438|584580526|FG000|First Intervention|Lost to Follow-up|2|||
161873266|NCT01868438|584580527|FG001|First Intervention|Lost to Follow-up|3|||
161873267|NCT01868438|584580526|FG000|First Intervention|Meeting the non-redosing criteria|0|||
161873268|NCT01868438|584580527|FG001|First Intervention|Meeting the non-redosing criteria|1|||
161873269|NCT01868438|584580526|FG000|Second Intervention|Adverse Event|3|||
161873270|NCT01868438|584580527|FG001|Second Intervention|Adverse Event|3|||
161873271|NCT02028767|584580528|FG000|Treatment Period 2|Non compliant with protocol|1|||
161873272|NCT02028767|584580529|FG001|Treatment Period 2|Non compliant with protocol|0|||
161873273|NCT02028767|584580528|FG000|Treatment Period 2|Reason other than those specified above|1|||
161873274|NCT02028767|584580529|FG001|Treatment Period 2|Reason other than those specified above|0|||
161873275|NCT01284348|584580530|FG000|Overall Study|Death|1|||
161873276|NCT01284348|584580531|FG001|Overall Study|Death|1|||
161873277|NCT01284348|584580530|FG000|Overall Study|Withdrew consent|0|||
161873278|NCT01284348|584580531|FG001|Overall Study|Withdrew consent|1|||
161873279|NCT01284348|584580530|FG000|Overall Study|Status not recorded|9|||
161873280|NCT01284348|584580531|FG001|Overall Study|Status not recorded|10|||
161873281|NCT02875613|584580534|FG000|Overall Study|Withdrawal by Subject|1|||
161873282|NCT02875613|584580534|FG000|Overall Study|Screen Failure|1|||
161873283|NCT02347774|584580535|FG000|Study Participation|Lost to Follow-up|3|||
161873284|NCT02347774|584580536|FG001|Study Participation|Lost to Follow-up|6|||
161873285|NCT02347774|584580537|FG002|Study Participation|Lost to Follow-up|2|||
161873286|NCT02347774|584580535|FG000|Study Participation|Withdrawal by Subject|8|||
161873287|NCT02347774|584580536|FG001|Study Participation|Withdrawal by Subject|9|||
161873288|NCT02347774|584580537|FG002|Study Participation|Withdrawal by Subject|15|||
161873289|NCT02347774|584580535|FG000|Study Participation|Adverse Event|1|||
161873290|NCT02347774|584580536|FG001|Study Participation|Adverse Event|4|||
161873291|NCT02347774|584580537|FG002|Study Participation|Adverse Event|6|||
161873292|NCT02347774|584580535|FG000|Study Participation|withdrew consent|1|||
161873293|NCT02347774|584580536|FG001|Study Participation|withdrew consent|1|||
161873294|NCT02347774|584580537|FG002|Study Participation|withdrew consent|1|||
161873295|NCT02347774|584580535|FG000|Study Participation|Met Prolonged QT criteria|1|||
161873296|NCT02347774|584580536|FG001|Study Participation|Met Prolonged QT criteria|0|||
161873297|NCT02347774|584580537|FG002|Study Participation|Met Prolonged QT criteria|0|||
161873298|NCT02347774|584580535|FG000|Study Participation|non-compliance with study drug|0|||
161873299|NCT02347774|584580536|FG001|Study Participation|non-compliance with study drug|1|||
161873300|NCT02347774|584580537|FG002|Study Participation|non-compliance with study drug|0|||
161873301|NCT02347774|584580535|FG000|Study Participation|incarceration|1|||
161873302|NCT02347774|584580536|FG001|Study Participation|incarceration|0|||
161873303|NCT02347774|584580537|FG002|Study Participation|incarceration|0|||
161873304|NCT02347774|584580535|FG000|Study Participation|randomized in error|0|||
161873305|NCT02347774|584580536|FG001|Study Participation|randomized in error|0|||
161873306|NCT02347774|584580537|FG002|Study Participation|randomized in error|1|||
161873307|NCT02347774|584580535|FG000|On Study Treatment|Adverse Event|9|||
161873308|NCT02347774|584580536|FG001|On Study Treatment|Adverse Event|15|||
161873309|NCT02347774|584580537|FG002|On Study Treatment|Adverse Event|19|||
161873310|NCT02347774|584580535|FG000|On Study Treatment|Lack of Efficacy|3|||
161873311|NCT02347774|584580536|FG001|On Study Treatment|Lack of Efficacy|0|||
161873312|NCT02347774|584580537|FG002|On Study Treatment|Lack of Efficacy|2|||
161873313|NCT02347774|584580535|FG000|On Study Treatment|non-complicance with study medication|0|||
161873314|NCT02347774|584580536|FG001|On Study Treatment|non-complicance with study medication|2|||
161873315|NCT02347774|584580537|FG002|On Study Treatment|non-complicance with study medication|0|||
161873316|NCT02347774|584580535|FG000|On Study Treatment|Protocol Violation|0|||
161873317|NCT02347774|584580536|FG001|On Study Treatment|Protocol Violation|0|||
161873318|NCT02347774|584580537|FG002|On Study Treatment|Protocol Violation|1|||
161873319|NCT02347774|584580535|FG000|On Study Treatment|withdrew consent|9|||
161873320|NCT02347774|584580536|FG001|On Study Treatment|withdrew consent|8|||
161873321|NCT02347774|584580537|FG002|On Study Treatment|withdrew consent|12|||
161873322|NCT02347774|584580535|FG000|On Study Treatment|Lost to Follow-up|2|||
161873323|NCT02347774|584580536|FG001|On Study Treatment|Lost to Follow-up|6|||
161873324|NCT02347774|584580537|FG002|On Study Treatment|Lost to Follow-up|1|||
161873325|NCT02347774|584580535|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
161873326|NCT02347774|584580536|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
161873327|NCT02347774|584580537|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
161873328|NCT02347774|584580535|FG000|On Study Treatment|ranomized in error|0|||
161873329|NCT02347774|584580536|FG001|On Study Treatment|ranomized in error|0|||
161873330|NCT02347774|584580537|FG002|On Study Treatment|ranomized in error|1|||
162035616|NCT02953509|585187108|FG002|Overall Study|Death|3|||
162035617|NCT02953509|585187109|FG003|Overall Study|Death|4|||
162035618|NCT02953509|585187110|FG004|Overall Study|Death|12|||
162035619|NCT02953509|585187111|FG005|Overall Study|Death|3|||
162035620|NCT02953509|585187112|FG006|Overall Study|Death|25|||
162035621|NCT02953509|585187113|FG007|Overall Study|Death|10|||
162035622|NCT02953509|585187114|FG008|Overall Study|Death|21|||
162035623|NCT02953509|585187115|FG009|Overall Study|Death|20|||
162035624|NCT02953509|585187106|FG000|Overall Study|Reason Not Specified|0|||
162035625|NCT02953509|585187107|FG001|Overall Study|Reason Not Specified|2|||
162035626|NCT02953509|585187108|FG002|Overall Study|Reason Not Specified|8|||
162035627|NCT02953509|585187109|FG003|Overall Study|Reason Not Specified|2|||
162035628|NCT02953509|585187110|FG004|Overall Study|Reason Not Specified|11|||
162035629|NCT02953509|585187111|FG005|Overall Study|Reason Not Specified|4|||
162035630|NCT02953509|585187112|FG006|Overall Study|Reason Not Specified|12|||
162035631|NCT02953509|585187113|FG007|Overall Study|Reason Not Specified|2|||
162035632|NCT02953509|585187114|FG008|Overall Study|Reason Not Specified|7|||
162035633|NCT02953509|585187115|FG009|Overall Study|Reason Not Specified|2|||
162035634|NCT02953509|585187106|FG000|Overall Study|Consent Withdrawn|1|||
161873331|NCT04112043|584580539|FG000|Overall Study|Withdrawal by Subject|1|||
161873332|NCT04112043|584580540|FG001|Overall Study|Withdrawal by Subject|1|||
161873333|NCT04112043|584580541|FG002|Overall Study|Withdrawal by Subject|1|||
161873334|NCT04112043|584580539|FG000|Overall Study|Taking NR supplement|1|||
161873335|NCT04112043|584580540|FG001|Overall Study|Taking NR supplement|0|||
161873336|NCT04112043|584580541|FG002|Overall Study|Taking NR supplement|0|||
161873337|NCT04112043|584580539|FG000|Overall Study|Adverse Event|0|||
161873338|NCT04112043|584580540|FG001|Overall Study|Adverse Event|1|||
161873339|NCT04112043|584580541|FG002|Overall Study|Adverse Event|0|||
161873340|NCT00954941|584580544|FG000|Overall Study|Received treatment at home|1|||
161873341|NCT00954941|584580545|FG001|Overall Study|Received treatment at home|0|||
161873342|NCT00954941|584580544|FG000|Overall Study|Withdrawal by Subject|1|||
161873343|NCT00954941|584580545|FG001|Overall Study|Withdrawal by Subject|0|||
161873344|NCT00954941|584580544|FG000|Overall Study|Insurance Denial|2|||
162035635|NCT02953509|585187107|FG001|Overall Study|Consent Withdrawn|1|||
162035636|NCT02953509|585187108|FG002|Overall Study|Consent Withdrawn|2|||
162035637|NCT02953509|585187109|FG003|Overall Study|Consent Withdrawn|1|||
162035638|NCT02953509|585187110|FG004|Overall Study|Consent Withdrawn|3|||
162035639|NCT02953509|585187111|FG005|Overall Study|Consent Withdrawn|0|||
162035640|NCT02953509|585187112|FG006|Overall Study|Consent Withdrawn|4|||
162035641|NCT02953509|585187113|FG007|Overall Study|Consent Withdrawn|1|||
162035642|NCT02953509|585187114|FG008|Overall Study|Consent Withdrawn|1|||
162035643|NCT02953509|585187115|FG009|Overall Study|Consent Withdrawn|4|||
162035644|NCT02953509|585187106|FG000|Overall Study|Lost to Follow-up|0|||
162035645|NCT02953509|585187107|FG001|Overall Study|Lost to Follow-up|0|||
162035646|NCT02953509|585187108|FG002|Overall Study|Lost to Follow-up|0|||
162035647|NCT02953509|585187109|FG003|Overall Study|Lost to Follow-up|0|||
162035648|NCT02953509|585187110|FG004|Overall Study|Lost to Follow-up|0|||
162035649|NCT02953509|585187111|FG005|Overall Study|Lost to Follow-up|0|||
162035650|NCT02953509|585187112|FG006|Overall Study|Lost to Follow-up|1|||
162035651|NCT02953509|585187113|FG007|Overall Study|Lost to Follow-up|1|||
162035652|NCT02953509|585187114|FG008|Overall Study|Lost to Follow-up|1|||
161775912|NCT02325739|584221301|FG008|Phase II Part|Adverse Event|4|||
161775913|NCT02325739|584221302|FG009|Phase II Part|Adverse Event|5|||
161775914|NCT02325739|584221303|FG010|Phase II Part|Adverse Event|1|||
161775915|NCT02325739|584221293|FG000|Phase II Part|Physician Decision|0|||
161775916|NCT02325739|584221294|FG001|Phase II Part|Physician Decision|0|||
161775917|NCT02325739|584221295|FG002|Phase II Part|Physician Decision|0|||
161775918|NCT02325739|584221296|FG003|Phase II Part|Physician Decision|0|||
161775919|NCT02325739|584221297|FG004|Phase II Part|Physician Decision|0|||
161775920|NCT02325739|584221298|FG005|Phase II Part|Physician Decision|0|||
161775921|NCT02325739|584221299|FG006|Phase II Part|Physician Decision|0|||
161775922|NCT02325739|584221300|FG007|Phase II Part|Physician Decision|0|||
161775923|NCT02325739|584221301|FG008|Phase II Part|Physician Decision|0|||
161775924|NCT02325739|584221302|FG009|Phase II Part|Physician Decision|1|||
161775925|NCT02325739|584221303|FG010|Phase II Part|Physician Decision|0|||
161775926|NCT02325739|584221293|FG000|Phase II Part|Progressive disease|0|||
161775927|NCT02325739|584221294|FG001|Phase II Part|Progressive disease|0|||
161775928|NCT02325739|584221295|FG002|Phase II Part|Progressive disease|0|||
161775929|NCT02325739|584221296|FG003|Phase II Part|Progressive disease|0|||
161775930|NCT02325739|584221297|FG004|Phase II Part|Progressive disease|0|||
161775931|NCT02325739|584221298|FG005|Phase II Part|Progressive disease|0|||
161775932|NCT02325739|584221299|FG006|Phase II Part|Progressive disease|0|||
161775933|NCT02325739|584221300|FG007|Phase II Part|Progressive disease|0|||
161775934|NCT02325739|584221301|FG008|Phase II Part|Progressive disease|22|||
161775935|NCT02325739|584221302|FG009|Phase II Part|Progressive disease|29|||
161775936|NCT02325739|584221303|FG010|Phase II Part|Progressive disease|18|||
161775937|NCT02325739|584221293|FG000|Phase II Part|Subject/guardian decision|0|||
162035653|NCT02953509|585187115|FG009|Overall Study|Lost to Follow-up|1|||
161990250|NCT01320202|585014277|FG000|Overall Study|moved/changed dialysis|5|||
161990251|NCT01320202|585014278|FG001|Overall Study|moved/changed dialysis|2|||
161775938|NCT02325739|584221294|FG001|Phase II Part|Subject/guardian decision|0|||
161775939|NCT02325739|584221295|FG002|Phase II Part|Subject/guardian decision|0|||
161775940|NCT02325739|584221296|FG003|Phase II Part|Subject/guardian decision|0|||
161775941|NCT02325739|584221297|FG004|Phase II Part|Subject/guardian decision|0|||
161775942|NCT02325739|584221298|FG005|Phase II Part|Subject/guardian decision|0|||
161775943|NCT02325739|584221299|FG006|Phase II Part|Subject/guardian decision|0|||
161775944|NCT02325739|584221300|FG007|Phase II Part|Subject/guardian decision|0|||
161775945|NCT02325739|584221301|FG008|Phase II Part|Subject/guardian decision|4|||
161775946|NCT02325739|584221302|FG009|Phase II Part|Subject/guardian decision|1|||
161775947|NCT02325739|584221303|FG010|Phase II Part|Subject/guardian decision|1|||
161775948|NCT00227591|584221304|FG000|Overall Study|Withdrawal by Subject|1|||
161775949|NCT02335411|584221305|FG000|Overall Study|Death|223|||
161775950|NCT02335411|584221306|FG001|Overall Study|Death|22|||
161775951|NCT02335411|584221307|FG002|Overall Study|Death|26|||
161775952|NCT02335411|584221305|FG000|Overall Study|Physician Decision|3|||
161775953|NCT02335411|584221306|FG001|Overall Study|Physician Decision|0|||
161775954|NCT02335411|584221307|FG002|Overall Study|Physician Decision|0|||
161775955|NCT02335411|584221305|FG000|Overall Study|Protocol Violation|1|||
161775956|NCT02335411|584221306|FG001|Overall Study|Protocol Violation|0|||
161775957|NCT02335411|584221307|FG002|Overall Study|Protocol Violation|0|||
161775958|NCT02335411|584221305|FG000|Overall Study|Withdrawal by Subject|11|||
161775959|NCT02335411|584221306|FG001|Overall Study|Withdrawal by Subject|0|||
161775960|NCT02335411|584221307|FG002|Overall Study|Withdrawal by Subject|3|||
161775961|NCT02335411|584221305|FG000|Overall Study|Sponsor Decision|12|||
161775962|NCT02335411|584221306|FG001|Overall Study|Sponsor Decision|3|||
161775963|NCT02335411|584221307|FG002|Overall Study|Sponsor Decision|2|||
161775964|NCT02335411|584221305|FG000|Overall Study|Adverse Event|9|||
161775965|NCT02335411|584221306|FG001|Overall Study|Adverse Event|0|||
161775966|NCT02335411|584221307|FG002|Overall Study|Adverse Event|0|||
161775967|NCT02596009|584221310|FG000|Overall Study|Administrative problems|0|||
161775968|NCT02596009|584221311|FG001|Overall Study|Administrative problems|1|||
161775969|NCT02596009|584221312|FG002|Overall Study|Administrative problems|0|||
161775970|NCT02596009|584221313|FG003|Overall Study|Administrative problems|0|||
161775971|NCT02596009|584221314|FG004|Overall Study|Administrative problems|0|||
161775972|NCT02596009|584221315|FG005|Overall Study|Administrative problems|0|||
161775973|NCT04755283|584221319|FG000|Overall Study|Withdrawal by Subject|14|||
161775974|NCT04755283|584221320|FG001|Overall Study|Withdrawal by Subject|3|||
161775975|NCT04755283|584221321|FG002|Overall Study|Withdrawal by Subject|6|||
161775976|NCT04755283|584221319|FG000|Overall Study|Lost to Follow-up|0|||
161775977|NCT04755283|584221320|FG001|Overall Study|Lost to Follow-up|0|||
161775978|NCT04755283|584221321|FG002|Overall Study|Lost to Follow-up|1|||
161775979|NCT04755283|584221319|FG000|Overall Study|Death|31|||
161775980|NCT04755283|584221320|FG001|Overall Study|Death|36|||
161775981|NCT04755283|584221321|FG002|Overall Study|Death|34|||
161775982|NCT04410978|584221330|FG000|Overall Study|Poor compliance to protocol|2|||
161775983|NCT04410978|584221331|FG001|Overall Study|Poor compliance to protocol|4|||
161775984|NCT04410978|584221330|FG000|Overall Study|Withdrawal by Subject|64|||
161775985|NCT04410978|584221331|FG001|Overall Study|Withdrawal by Subject|66|||
161775986|NCT04410978|584221330|FG000|Overall Study|Other|6|||
161775987|NCT04410978|584221331|FG001|Overall Study|Other|7|||
161775988|NCT04410978|584221330|FG000|Overall Study|Missing study status|1|||
161775989|NCT04410978|584221331|FG001|Overall Study|Missing study status|0|||
161775990|NCT05153629|584221332|FG000|Overall Study|Withdrawal by Subject|0|||
161775991|NCT05153629|584221333|FG001|Overall Study|Withdrawal by Subject|2|||
161775992|NCT04089566|584221336|FG000|Overall Study|Death|0|||
161775993|NCT04089566|584221337|FG001|Overall Study|Death|6|||
161775994|NCT04089566|584221338|FG002|Overall Study|Death|10|||
161775995|NCT04089566|584221339|FG003|Overall Study|Death|0|||
161775996|NCT04089566|584221340|FG004|Overall Study|Death|0|||
161775997|NCT04089566|584221341|FG005|Overall Study|Death|0|||
161775998|NCT04089566|584221336|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
161775999|NCT04089566|584221337|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
161776000|NCT04089566|584221338|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
161776001|NCT04089566|584221339|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
161776002|NCT04089566|584221340|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
161776003|NCT04089566|584221341|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
161776004|NCT04089566|584221336|FG000|Overall Study|Reason not Specified|0|||
161776005|NCT04089566|584221337|FG001|Overall Study|Reason not Specified|4|||
161776006|NCT04089566|584221338|FG002|Overall Study|Reason not Specified|4|||
161776007|NCT04089566|584221339|FG003|Overall Study|Reason not Specified|1|||
161776008|NCT04089566|584221340|FG004|Overall Study|Reason not Specified|0|||
161776009|NCT04089566|584221341|FG005|Overall Study|Reason not Specified|0|||
161776010|NCT01083121|584221342|FG000|Overall Study|Use of Humira outside the approved label|81|||
161776011|NCT05403502|584221344|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
161776012|NCT05403502|584221344|FG000|Humalog Lead-In Period|Physician Decision|2|||
161776013|NCT05403502|584221344|FG000|Humalog Lead-In Period|Protocol Violation|1|||
162035654|NCT02953509|585187106|FG000|Overall Study|Study terminated by sponsor|1|||
162035655|NCT02953509|585187107|FG001|Overall Study|Study terminated by sponsor|0|||
162035656|NCT02953509|585187108|FG002|Overall Study|Study terminated by sponsor|0|||
162035657|NCT02953509|585187109|FG003|Overall Study|Study terminated by sponsor|0|||
161873345|NCT00954941|584580545|FG001|Overall Study|Insurance Denial|2|||
161873346|NCT00954941|584580544|FG000|Overall Study|Physician Decision|2|||
161873347|NCT00954941|584580545|FG001|Overall Study|Physician Decision|2|||
161873348|NCT00954941|584580544|FG000|Overall Study|Ineligible|2|||
161873349|NCT00954941|584580545|FG001|Overall Study|Ineligible|2|||
161873350|NCT00954941|584580544|FG000|Overall Study|Adverse Event|0|||
161873351|NCT00954941|584580545|FG001|Overall Study|Adverse Event|1|||
161873352|NCT00955955|584580546|FG000|Overall Study|Lost to Follow-up|2|||
161873353|NCT00955955|584580547|FG001|Overall Study|Lost to Follow-up|0|||
161873354|NCT00955955|584580548|FG002|Overall Study|Lost to Follow-up|0|||
161873355|NCT01996254|584580552|FG000|Overall Study|Change in Eligibility|0|||
161873356|NCT01996254|584580553|FG001|Overall Study|Change in Eligibility|2|||
161873357|NCT01996254|584580554|FG002|Overall Study|Change in Eligibility|0|||
161873358|NCT01996254|584580552|FG000|Overall Study|Withdrawal by Subject|0|||
161873359|NCT01996254|584580553|FG001|Overall Study|Withdrawal by Subject|3|||
161873360|NCT01996254|584580554|FG002|Overall Study|Withdrawal by Subject|4|||
161873361|NCT01996254|584580552|FG000|Overall Study|Lost to Follow-up|1|||
161873362|NCT01996254|584580553|FG001|Overall Study|Lost to Follow-up|0|||
161873363|NCT01996254|584580554|FG002|Overall Study|Lost to Follow-up|4|||
161873364|NCT02920008|584580555|FG000|Overall Study|Death|117|||
161873365|NCT02920008|584580556|FG001|Overall Study|Death|127|||
161873366|NCT02920008|584580555|FG000|Overall Study|Withdrawal by Subject|3|||
161873367|NCT02920008|584580556|FG001|Overall Study|Withdrawal by Subject|6|||
161873368|NCT02920008|584580555|FG000|Overall Study|Lost to Follow-up|0|||
161873369|NCT02920008|584580556|FG001|Overall Study|Lost to Follow-up|1|||
161873370|NCT01053663|584580557|FG000|Overall Study|Death|2|||
161873371|NCT01053663|584580557|FG000|Overall Study|Lost to Follow-up|1|||
161873372|NCT01053663|584580557|FG000|Overall Study|Poor IV Access|1|||
161873373|NCT01053663|584580557|FG000|Overall Study|Transferred to Another Hospital|1|||
161873374|NCT01053663|584580557|FG000|Overall Study|Negative Influenza Diagnosis|1|||
161873375|NCT03533114|584580560|FG000|Overall|Adverse Event|16|||
161873376|NCT03533114|584580561|FG001|Overall|Adverse Event|11|||
161873377|NCT03533114|584580560|FG000|Overall|Consent Withdrawal by Participant|7|||
161873378|NCT03533114|584580561|FG001|Overall|Consent Withdrawal by Participant|6|||
161873379|NCT03533114|584580560|FG000|Overall|Lack of Efficacy|5|||
161873380|NCT03533114|584580561|FG001|Overall|Lack of Efficacy|3|||
161873381|NCT03533114|584580560|FG000|Overall|Lost to Follow-up|1|||
161873382|NCT03533114|584580561|FG001|Overall|Lost to Follow-up|1|||
161873383|NCT03533114|584580560|FG000|Overall|Physician Decision|0|||
161873384|NCT03533114|584580561|FG001|Overall|Physician Decision|2|||
161873385|NCT03533114|584580560|FG000|Overall|Protocol deviation|1|||
161873386|NCT03533114|584580561|FG001|Overall|Protocol deviation|1|||
161873387|NCT03533114|584580560|FG000|Overall|Failure to meet randomization criteria|1|||
161873388|NCT03533114|584580561|FG001|Overall|Failure to meet randomization criteria|2|||
161873389|NCT03533114|584580560|FG000|Overall|Non-Compliance with study drug|0|||
161873390|NCT03533114|584580561|FG001|Overall|Non-Compliance with study drug|1|||
161873391|NCT03533114|584580560|FG000|Overall|Other|0|||
161873392|NCT03533114|584580561|FG001|Overall|Other|1|||
161873393|NCT03533114|584580560|FG000|Open Label Titration and Optimization|Adverse Event|11|||
161873394|NCT03533114|584580561|FG001|Open Label Titration and Optimization|Adverse Event|8|||
161873395|NCT03533114|584580560|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
161873396|NCT03533114|584580561|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
161873397|NCT03533114|584580560|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
161873398|NCT03533114|584580561|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
161873399|NCT03533114|584580560|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
161873400|NCT03533114|584580561|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
161873401|NCT03533114|584580560|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
161873402|NCT03533114|584580561|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
161873403|NCT03533114|584580560|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
162035658|NCT02953509|585187110|FG004|Overall Study|Study terminated by sponsor|0|||
162035659|NCT02953509|585187111|FG005|Overall Study|Study terminated by sponsor|0|||
162035660|NCT02953509|585187112|FG006|Overall Study|Study terminated by sponsor|1|||
161873404|NCT03533114|584580561|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
161873405|NCT03533114|584580560|FG000|Stable Dose|Adverse Event|0|||
161873406|NCT03533114|584580561|FG001|Stable Dose|Adverse Event|2|||
161873407|NCT03533114|584580560|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
161873408|NCT03533114|584580561|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
161873409|NCT03533114|584580560|FG000|Stable Dose|Lack of Efficacy|1|||
161873410|NCT03533114|584580561|FG001|Stable Dose|Lack of Efficacy|0|||
161873411|NCT03533114|584580560|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
161873412|NCT03533114|584580561|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
161873413|NCT03533114|584580560|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
161873414|NCT03533114|584580561|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
161873415|NCT03533114|584580560|FG000|Open-Label Safety Extension|Adverse Event|3|||
161873416|NCT03533114|584580561|FG001|Open-Label Safety Extension|Adverse Event|0|||
161873417|NCT03533114|584580560|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
161873418|NCT03533114|584580561|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
161873419|NCT03533114|584580560|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
161873420|NCT03533114|584580561|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
161873421|NCT03533114|584580560|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
161873422|NCT03533114|584580561|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
161873423|NCT03533114|584580560|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
161873424|NCT03533114|584580561|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
161873425|NCT03852264|584580562|FG000|Third Research Visit|Lost to Follow-up|1|||
161873426|NCT03852264|584580563|FG001|Third Research Visit|Lost to Follow-up|0|||
161873427|NCT01862250|584580564|FG000|Overall Study|Adverse Event|4|||
161873428|NCT02411396|584580568|FG000|Overall Study|Lost to Follow-up|31|||
161873429|NCT02411396|584580568|FG000|Overall Study|Death|10|||
161873430|NCT03575793|584580577|FG000|Overall Study|Withdrawal by Subject|0|||
161873431|NCT03575793|584580578|FG001|Overall Study|Withdrawal by Subject|1|||
161873432|NCT03575793|584580577|FG000|Overall Study|Never Treated|0|||
161873433|NCT03575793|584580578|FG001|Overall Study|Never Treated|2|||
161873434|NCT03521115|584580581|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
161873435|NCT03521115|584580582|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
161873436|NCT03521115|584580581|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
161873437|NCT03521115|584580582|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
161873438|NCT02295020|584580592|FG000|Overall Study|Adverse Event|0|||
161873439|NCT02295020|584580593|FG001|Overall Study|Adverse Event|1|||
161873440|NCT02295020|584580592|FG000|Overall Study|Withdrawal by Subject|3|||
161873441|NCT02295020|584580593|FG001|Overall Study|Withdrawal by Subject|2|||
161873442|NCT00562302|584580594|FG000|Overall Study|Lost to Follow-up|3|||
161873443|NCT00562302|584580595|FG001|Overall Study|Lost to Follow-up|3|||
161873444|NCT00562302|584580594|FG000|Overall Study|Adverse Event|0|||
161873445|NCT00562302|584580595|FG001|Overall Study|Adverse Event|6|||
161873446|NCT00562302|584580594|FG000|Overall Study|Non-compliance|1|||
161873447|NCT00562302|584580595|FG001|Overall Study|Non-compliance|2|||
161873448|NCT00562302|584580594|FG000|Overall Study|Withdrawal by Subject|7|||
161873449|NCT00562302|584580595|FG001|Overall Study|Withdrawal by Subject|8|||
161873450|NCT00562302|584580594|FG000|Overall Study|Death|1|||
161873451|NCT00562302|584580595|FG001|Overall Study|Death|2|||
161873452|NCT00562302|584580594|FG000|Overall Study|Lung resection prior to study completion|7|||
161873453|NCT00562302|584580595|FG001|Overall Study|Lung resection prior to study completion|7|||
161873454|NCT00562302|584580594|FG000|Overall Study|Not stated|1|||
161873455|NCT00562302|584580595|FG001|Overall Study|Not stated|4|||
161873456|NCT01855243|584580596|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
161873457|NCT01855243|584580597|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
161873458|NCT01855243|584580598|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
161873459|NCT03615144|584580599|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
161873460|NCT03615144|584580600|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
161873461|NCT04791319|584580603|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
161873462|NCT04791319|584580604|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
161873463|NCT04791319|584580605|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
161873464|NCT04791319|584580606|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
161873465|NCT04791319|584580607|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873466|NCT04791319|584580608|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873467|NCT04791319|584580609|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873468|NCT04791319|584580610|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873469|NCT04791319|584580611|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873470|NCT04791319|584580612|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873471|NCT04791319|584580613|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161873472|NCT04791319|584580603|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
161873473|NCT04791319|584580604|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161990252|NCT01320202|585014277|FG000|Overall Study|sponsor request|2|||
161990253|NCT01320202|585014278|FG001|Overall Study|sponsor request|0|||
161990254|NCT01320202|585014277|FG000|Overall Study|ineligible|3|||
161873474|NCT04791319|584580605|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
161990255|NCT01320202|585014278|FG001|Overall Study|ineligible|0|||
161990256|NCT01320202|585014277|FG000|Overall Study|regained renal function|1|||
161990257|NCT01320202|585014278|FG001|Overall Study|regained renal function|0|||
161990258|NCT02006979|585014280|FG000|Overall Study|Withdrawal by Subject|1|||
161873475|NCT04791319|584580606|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
161990259|NCT02006979|585014281|FG001|Overall Study|Withdrawal by Subject|1|||
161990260|NCT02006979|585014280|FG000|Overall Study|Protocol Violation|0|||
161990261|NCT02006979|585014281|FG001|Overall Study|Protocol Violation|1|||
161873476|NCT04791319|584580607|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873477|NCT04791319|584580608|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873478|NCT04791319|584580609|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873479|NCT04791319|584580610|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873480|NCT04791319|584580611|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873481|NCT04791319|584580612|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873482|NCT04791319|584580613|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161873483|NCT04791319|584580603|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
161873484|NCT04791319|584580604|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
161873485|NCT04791319|584580605|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
161873486|NCT04791319|584580606|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
161873487|NCT04791319|584580607|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873488|NCT04791319|584580608|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873489|NCT04791319|584580609|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873490|NCT04791319|584580610|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873491|NCT04791319|584580611|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873492|NCT04791319|584580612|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873493|NCT04791319|584580613|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161873494|NCT04791319|584580603|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
161873495|NCT04791319|584580604|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
161873496|NCT04791319|584580605|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
161873497|NCT04791319|584580606|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
161873498|NCT04791319|584580607|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873499|NCT04791319|584580608|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873500|NCT04791319|584580609|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873501|NCT04791319|584580610|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873502|NCT04791319|584580611|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873503|NCT04791319|584580612|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873504|NCT04791319|584580613|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161873505|NCT04791319|584580603|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873506|NCT04791319|584580604|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873507|NCT04791319|584580605|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873508|NCT04791319|584580606|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
161873509|NCT04791319|584580607|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873510|NCT04791319|584580608|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873511|NCT04791319|584580609|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873512|NCT04791319|584580610|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873513|NCT04791319|584580611|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873514|NCT04791319|584580612|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873515|NCT04791319|584580613|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161873516|NCT04791319|584580603|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873517|NCT04791319|584580604|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873518|NCT04791319|584580605|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873519|NCT04791319|584580606|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873520|NCT04791319|584580607|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
161873521|NCT04791319|584580608|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
161873522|NCT04791319|584580609|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
161873523|NCT04791319|584580610|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873524|NCT04791319|584580611|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873525|NCT04791319|584580612|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161873526|NCT04791319|584580613|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
161873527|NCT04791319|584580603|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873528|NCT04791319|584580604|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873529|NCT04791319|584580605|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873530|NCT04791319|584580606|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873531|NCT04791319|584580607|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873532|NCT04791319|584580608|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873533|NCT04791319|584580609|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873534|NCT04791319|584580610|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161990262|NCT01088399|585014293|FG000|Overall Study|Adverse Event|211|||
161990263|NCT01088399|585014294|FG001|Overall Study|Adverse Event|16|||
161990264|NCT01088399|585014295|FG002|Overall Study|Adverse Event|0|||
161990265|NCT01088399|585014293|FG000|Overall Study|Death|204|||
161990266|NCT01088399|585014294|FG001|Overall Study|Death|45|||
162035661|NCT02953509|585187113|FG007|Overall Study|Study terminated by sponsor|0|||
162035662|NCT02953509|585187114|FG008|Overall Study|Study terminated by sponsor|1|||
162035663|NCT02953509|585187115|FG009|Overall Study|Study terminated by sponsor|1|||
162035664|NCT00484185|585187116|FG000|Overall Study|Lost to Follow-up|44|||
162035665|NCT00484185|585187116|FG000|Overall Study|Other|20|||
162035666|NCT00484185|585187116|FG000|Overall Study|Randomized but not treated|5|||
162035667|NCT00484185|585187116|FG000|Overall Study|Death|2|||
162035668|NCT01222403|585187119|FG000|Overall Study|Inappropriate enrollment|0|||
162035669|NCT01222403|585187120|FG001|Overall Study|Inappropriate enrollment|2|||
162035670|NCT02325791|585187121|FG000|Overall Study|Adverse Event|0|||
162035671|NCT02325791|585187122|FG001|Overall Study|Adverse Event|1|||
162035672|NCT02325791|585187123|FG002|Overall Study|Adverse Event|1|||
162035673|NCT02325791|585187124|FG003|Overall Study|Adverse Event|0|||
162035674|NCT02325791|585187121|FG000|Overall Study|Death|0|||
162035675|NCT02325791|585187122|FG001|Overall Study|Death|3|||
162035676|NCT02325791|585187123|FG002|Overall Study|Death|0|||
162035677|NCT02325791|585187124|FG003|Overall Study|Death|1|||
162035678|NCT02325791|585187121|FG000|Overall Study|Lost to Follow-up|0|||
162035679|NCT02325791|585187122|FG001|Overall Study|Lost to Follow-up|15|||
162035680|NCT02325791|585187123|FG002|Overall Study|Lost to Follow-up|14|||
162035681|NCT02325791|585187124|FG003|Overall Study|Lost to Follow-up|9|||
162035682|NCT02325791|585187121|FG000|Overall Study|Physician Decision|0|||
162035683|NCT02325791|585187122|FG001|Overall Study|Physician Decision|1|||
162035684|NCT02325791|585187123|FG002|Overall Study|Physician Decision|1|||
162035685|NCT02325791|585187124|FG003|Overall Study|Physician Decision|0|||
162035686|NCT02325791|585187121|FG000|Overall Study|Protocol Violation|0|||
162035687|NCT02325791|585187122|FG001|Overall Study|Protocol Violation|0|||
162035688|NCT02325791|585187123|FG002|Overall Study|Protocol Violation|1|||
162035689|NCT02325791|585187124|FG003|Overall Study|Protocol Violation|0|||
162035690|NCT02325791|585187121|FG000|Overall Study|Withdrawal by Subject|0|||
162035691|NCT02325791|585187122|FG001|Overall Study|Withdrawal by Subject|5|||
162035692|NCT02325791|585187123|FG002|Overall Study|Withdrawal by Subject|8|||
162035693|NCT02325791|585187124|FG003|Overall Study|Withdrawal by Subject|16|||
162035694|NCT00722371|585187126|FG000|Overall Study|Adverse Event|6|||
162035695|NCT00722371|585187127|FG001|Overall Study|Adverse Event|13|||
162035696|NCT00722371|585187128|FG002|Overall Study|Adverse Event|9|||
162035697|NCT00722371|585187129|FG003|Overall Study|Adverse Event|10|||
162035698|NCT00722371|585187130|FG004|Overall Study|Adverse Event|6|||
162035699|NCT00722371|585187131|FG005|Overall Study|Adverse Event|8|||
162035700|NCT00722371|585187132|FG006|Overall Study|Adverse Event|4|||
162035701|NCT00722371|585187126|FG000|Overall Study|Contraindication|0|||
162035702|NCT00722371|585187127|FG001|Overall Study|Contraindication|0|||
162035703|NCT00722371|585187128|FG002|Overall Study|Contraindication|1|||
162035704|NCT00722371|585187129|FG003|Overall Study|Contraindication|0|||
162035705|NCT00722371|585187130|FG004|Overall Study|Contraindication|0|||
162035706|NCT00722371|585187131|FG005|Overall Study|Contraindication|0|||
161776014|NCT05403502|584221344|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
161776015|NCT05403502|584221344|FG000|Lyumjev Treatment Period|Physician Decision|2|||
161776016|NCT01593761|584221345|FG000|Overall Study|Lost to Follow-up|1|||
161776017|NCT01593761|584221345|FG000|Overall Study|culture negative for MRSA at baseline|5|||
161776018|NCT01593761|584221345|FG000|Overall Study|positive for hepatitis C virus|1|||
161776019|NCT01593761|584221345|FG000|Overall Study|secondary cellulitis|1|||
161776020|NCT02576951|584221346|FG000|Overall Study|Lost to Follow-up|0|||
161776021|NCT02576951|584221347|FG001|Overall Study|Lost to Follow-up|0|||
161776022|NCT02576951|584221348|FG002|Overall Study|Lost to Follow-up|2|||
161776023|NCT02576951|584221349|FG003|Overall Study|Lost to Follow-up|2|||
161776024|NCT02576951|584221346|FG000|Overall Study|Withdrawal by Subject|1|||
161776025|NCT02576951|584221347|FG001|Overall Study|Withdrawal by Subject|0|||
161776026|NCT02576951|584221348|FG002|Overall Study|Withdrawal by Subject|0|||
161776027|NCT02576951|584221349|FG003|Overall Study|Withdrawal by Subject|2|||
161776028|NCT02576951|584221346|FG000|Overall Study|Protocol Violation|0|||
161776029|NCT02576951|584221347|FG001|Overall Study|Protocol Violation|0|||
161776030|NCT02576951|584221348|FG002|Overall Study|Protocol Violation|0|||
161776031|NCT02576951|584221349|FG003|Overall Study|Protocol Violation|1|||
161776032|NCT00223990|584221350|FG000|Overall Study|Moved from area|2|||
161776033|NCT00223990|584221351|FG001|Overall Study|Moved from area|1|||
161776034|NCT00223990|584221350|FG000|Overall Study|Withdrawal by Subject|4|||
161776035|NCT00223990|584221351|FG001|Overall Study|Withdrawal by Subject|8|||
162035707|NCT00722371|585187132|FG006|Overall Study|Contraindication|0|||
162035708|NCT00722371|585187126|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
162035709|NCT00722371|585187127|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
162035710|NCT00722371|585187128|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
161776036|NCT00223990|584221350|FG000|Overall Study|Lost to Follow-up|1|||
162035711|NCT00722371|585187129|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
162035712|NCT00722371|585187130|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
162035713|NCT00722371|585187131|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
162035714|NCT00722371|585187132|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
162035715|NCT00722371|585187126|FG000|Overall Study|Excluded medication|0|||
161873535|NCT04791319|584580611|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873536|NCT04791319|584580612|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
161873537|NCT04791319|584580613|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161873538|NCT04791319|584580603|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161873539|NCT04791319|584580604|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161873540|NCT04791319|584580605|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161873541|NCT04791319|584580606|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161873542|NCT04791319|584580607|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
161873543|NCT04791319|584580608|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
161873544|NCT04791319|584580609|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
161873545|NCT04791319|584580610|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161873546|NCT04791319|584580611|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
161873547|NCT04791319|584580612|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
161873548|NCT04791319|584580613|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
161873549|NCT04791319|584580603|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
161873550|NCT04791319|584580604|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
161873551|NCT04791319|584580605|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
161873552|NCT04791319|584580606|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
161873553|NCT04791319|584580607|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
161873554|NCT04791319|584580608|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
161873555|NCT04791319|584580609|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
161873556|NCT04791319|584580610|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
161873557|NCT04791319|584580611|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
161873558|NCT04791319|584580612|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
161873559|NCT04791319|584580613|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
161873560|NCT01704651|584580616|FG000|Overall Study|Pre-op withdrawal by subject|1|||
161873561|NCT01704651|584580617|FG001|Overall Study|Pre-op withdrawal by subject|1|||
161873562|NCT01704651|584580616|FG000|Overall Study|Pre-op change in treatment plan|1|||
161873563|NCT01704651|584580617|FG001|Overall Study|Pre-op change in treatment plan|4|||
161873564|NCT01704651|584580616|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
161873565|NCT01704651|584580617|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
161873566|NCT01704651|584580616|FG000|Overall Study|Post-op did not have laparotomy|2|||
161873567|NCT01704651|584580617|FG001|Overall Study|Post-op did not have laparotomy|1|||
161873568|NCT01860040|584580618|FG000|Overall Study|Withdrawal by Subject|1|||
161873569|NCT01860040|584580619|FG001|Overall Study|Withdrawal by Subject|0|||
161873570|NCT01931995|584580620|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
161873571|NCT01931995|584580621|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
161873572|NCT01931995|584580620|FG000|First Intervention (1 Day)|Physician Decision|1|||
161873573|NCT01931995|584580621|FG001|First Intervention (1 Day)|Physician Decision|1|||
161873574|NCT01931995|584580620|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
161873575|NCT01931995|584580621|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
161873576|NCT00791661|584580622|FG000|7 Day Wash-out|Adverse Event|0|||
161873577|NCT00791661|584580623|FG001|7 Day Wash-out|Adverse Event|0|||
161873578|NCT00791661|584580624|FG002|7 Day Wash-out|Adverse Event|1|||
161873579|NCT00791661|584580622|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
161873580|NCT00791661|584580623|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
161873581|NCT00791661|584580624|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
161873582|NCT00364923|584580627|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
161873583|NCT00364923|584580627|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
161873584|NCT00427921|584580633|FG000|Overall Study|Adverse Event|26|||
161873585|NCT00427921|584580633|FG000|Overall Study|Withdrawal by Subject|4|||
161873586|NCT00427921|584580633|FG000|Overall Study|Lost to Follow-up|2|||
161873587|NCT00427921|584580633|FG000|Overall Study|Other reason not specified|10|||
161873588|NCT00427921|584580633|FG000|Overall Study|Adverse Event + Hospitalization|1|||
161873589|NCT00427921|584580633|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
161873590|NCT00427921|584580633|FG000|Overall Study|Adverse Event + No Response|1|||
161873591|NCT00427921|584580633|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
161873592|NCT00427921|584580633|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
161873593|NCT00427921|584580633|FG000|Overall Study|Adverse Event + Lost Response|1|||
161873594|NCT00427921|584580633|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
161990267|NCT01088399|585014295|FG002|Overall Study|Death|0|||
161990268|NCT01088399|585014293|FG000|Overall Study|Lack of Efficacy|298|||
161990269|NCT01088399|585014294|FG001|Overall Study|Lack of Efficacy|7|||
161873595|NCT00427921|584580633|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
161990270|NCT01088399|585014295|FG002|Overall Study|Lack of Efficacy|5|||
161873596|NCT00520533|584580636|FG000|Overall Study|Death|1|||
161873597|NCT00520533|584580636|FG000|Overall Study|Suspension of the study for safety reasons|1|||
161873598|NCT00520533|584580636|FG000|Overall Study|Withdrawal by Subject|1|||
161873599|NCT00520533|584580636|FG000|Overall Study|Physician Decision|1|||
161873600|NCT01972438|584580642|FG000|Baseline-Month 3 Crossover Period|Death|1|||
161873601|NCT01972438|584580643|FG001|Baseline-Month 3 Crossover Period|Death|0|||
161873602|NCT01972438|584580642|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
161873603|NCT01972438|584580643|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
161873604|NCT01972438|584580642|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
161873605|NCT01972438|584580643|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
161873606|NCT01972438|584580642|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
161873607|NCT01972438|584580643|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
161873608|NCT01972438|584580642|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
161873609|NCT01972438|584580643|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
161873610|NCT01972438|584580642|FG000|Months 6-12 Study Period|Death|1|||
161873611|NCT01972438|584580643|FG001|Months 6-12 Study Period|Death|0|||
161873612|NCT01972438|584580642|FG000|Months 6-12 Study Period|Early Study Closure|2|||
161873613|NCT01972438|584580643|FG001|Months 6-12 Study Period|Early Study Closure|2|||
161873614|NCT01972438|584580642|FG000|Post Month 12 Study Period|Early Study Closure|3|||
161873615|NCT01972438|584580643|FG001|Post Month 12 Study Period|Early Study Closure|4|||
161873616|NCT00697463|584580644|FG000|Overall Study|Withdrawal by Subject|1|||
161873617|NCT02568189|584580645|FG000|Overall Study|Protocol Violation|0|||
161873618|NCT02568189|584580646|FG001|Overall Study|Protocol Violation|0|||
161873619|NCT02568189|584580647|FG002|Overall Study|Protocol Violation|19|||
161873620|NCT02568189|584580648|FG003|Overall Study|Protocol Violation|18|||
161873621|NCT00529373|584580649|FG000|Base Study|Adverse Event|525|||
161990271|NCT01088399|585014293|FG000|Overall Study|Lost to Follow-up|1070|||
161990272|NCT01088399|585014294|FG001|Overall Study|Lost to Follow-up|278|||
161990273|NCT01088399|585014295|FG002|Overall Study|Lost to Follow-up|58|||
161990274|NCT01088399|585014293|FG000|Overall Study|Physician Decision|531|||
161990275|NCT01088399|585014294|FG001|Overall Study|Physician Decision|88|||
161990276|NCT01088399|585014295|FG002|Overall Study|Physician Decision|16|||
161990277|NCT01088399|585014293|FG000|Overall Study|Withdrawal by Subject|544|||
161990278|NCT01088399|585014294|FG001|Overall Study|Withdrawal by Subject|195|||
161990279|NCT01088399|585014295|FG002|Overall Study|Withdrawal by Subject|33|||
161990280|NCT01088399|585014293|FG000|Overall Study|Change to or start of somatropin therapy|234|||
161990281|NCT01088399|585014294|FG001|Overall Study|Change to or start of somatropin therapy|17|||
161990282|NCT01088399|585014295|FG002|Overall Study|Change to or start of somatropin therapy|12|||
161990283|NCT01088399|585014293|FG000|Overall Study|Sponsor decision|1573|||
161990284|NCT01088399|585014294|FG001|Overall Study|Sponsor decision|298|||
161990285|NCT01088399|585014295|FG002|Overall Study|Sponsor decision|7|||
161990286|NCT01088399|585014293|FG000|Overall Study|Protocol Violation|10|||
161990287|NCT01088399|585014294|FG001|Overall Study|Protocol Violation|1|||
161990288|NCT01088399|585014295|FG002|Overall Study|Protocol Violation|0|||
161990289|NCT01088399|585014293|FG000|Overall Study|Enrollment criteria not met|48|||
161990290|NCT01088399|585014294|FG001|Overall Study|Enrollment criteria not met|119|||
161990291|NCT01088399|585014295|FG002|Overall Study|Enrollment criteria not met|70|||
161990292|NCT01088399|585014293|FG000|Overall Study|Study summary visit not completed|2398|||
161990293|NCT01088399|585014294|FG001|Overall Study|Study summary visit not completed|283|||
161990294|NCT01088399|585014295|FG002|Overall Study|Study summary visit not completed|80|||
161990295|NCT03193736|585014296|FG000|Overall Study|Death|2|||
161990296|NCT03193736|585014296|FG000|Overall Study|Withdrawal by Subject|1|||
161990297|NCT03193736|585014296|FG000|Overall Study|Lost to Follow-up|1|||
161990298|NCT03193736|585014296|FG000|Overall Study|implant not received|1|||
161990299|NCT00852241|585014297|FG000|Overall Study|Physician Decision|18|||
161990300|NCT03848949|585014298|FG000|Overall Study|Lost to Follow-up|5|||
161990301|NCT03848949|585014299|FG001|Overall Study|Lost to Follow-up|7|||
161990302|NCT02697435|585014300|FG000|Overall Study|Withdrawal by Subject|1|||
161990303|NCT02697435|585014301|FG001|Overall Study|Withdrawal by Subject|0|||
161990304|NCT02697435|585014300|FG000|Overall Study|Physician Decision|0|||
161990305|NCT02697435|585014301|FG001|Overall Study|Physician Decision|4|||
161990306|NCT04230213|585014306|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
161873622|NCT00529373|584580650|FG001|Base Study|Adverse Event|470|||
161873623|NCT00529373|584580649|FG000|Base Study|Lack of Efficacy|16|||
161873624|NCT00529373|584580650|FG001|Base Study|Lack of Efficacy|75|||
161873625|NCT00529373|584580649|FG000|Base Study|Lost to Follow-up|221|||
161873626|NCT00529373|584580650|FG001|Base Study|Lost to Follow-up|208|||
161873627|NCT00529373|584580649|FG000|Base Study|Other Protocol Specified Criteria|19|||
161990307|NCT04230213|585014307|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
161990308|NCT04230213|585014308|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
161990309|NCT04230213|585014306|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
161990310|NCT04230213|585014307|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
161990311|NCT04230213|585014308|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
161990312|NCT04230213|585014306|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
162035716|NCT00722371|585187127|FG001|Overall Study|Excluded medication|1|||
161873628|NCT00529373|584580650|FG001|Base Study|Other Protocol Specified Criteria|20|||
161873629|NCT00529373|584580649|FG000|Base Study|Physician Decision|60|||
161873630|NCT00529373|584580650|FG001|Base Study|Physician Decision|52|||
161873631|NCT00529373|584580649|FG000|Base Study|Protocol Violation|48|||
161873632|NCT00529373|584580650|FG001|Base Study|Protocol Violation|38|||
161873633|NCT00529373|584580649|FG000|Base Study|Withdrawal by Subject|1062|||
161873634|NCT00529373|584580650|FG001|Base Study|Withdrawal by Subject|967|||
161873635|NCT00529373|584580649|FG000|Base Study|Did not continue into Extension|1795|||
161873636|NCT00529373|584580650|FG001|Base Study|Did not continue into Extension|2238|||
161873637|NCT00529373|584580649|FG000|First Extension Study|Adverse Event|162|||
161873638|NCT00529373|584580650|FG001|First Extension Study|Adverse Event|142|||
161873639|NCT00529373|584580649|FG000|First Extension Study|Lack of Efficacy|65|||
161873640|NCT00529373|584580650|FG001|First Extension Study|Lack of Efficacy|427|||
161873641|NCT00529373|584580649|FG000|First Extension Study|Lost to Follow-up|41|||
161873642|NCT00529373|584580650|FG001|First Extension Study|Lost to Follow-up|37|||
161873643|NCT00529373|584580649|FG000|First Extension Study|Other|27|||
161873644|NCT00529373|584580650|FG001|First Extension Study|Other|47|||
161873645|NCT00529373|584580649|FG000|First Extension Study|Physician Decision|50|||
161873646|NCT00529373|584580650|FG001|First Extension Study|Physician Decision|45|||
161873647|NCT00529373|584580649|FG000|First Extension Study|Protocol Violation|16|||
161873648|NCT00529373|584580650|FG001|First Extension Study|Protocol Violation|13|||
161873649|NCT00529373|584580649|FG000|First Extension Study|Withdrawal by Subject|296|||
161873650|NCT00529373|584580650|FG001|First Extension Study|Withdrawal by Subject|287|||
161873651|NCT00529373|584580649|FG000|First Extension Study|Disposition record non-existing|0|||
161873652|NCT00529373|584580650|FG001|First Extension Study|Disposition record non-existing|1|||
161873653|NCT00529373|584580649|FG000|First Extension Study|Discontinued after 5 years completion|208|||
161873654|NCT00529373|584580650|FG001|First Extension Study|Discontinued after 5 years completion|346|||
161873655|NCT00529373|584580649|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
161873656|NCT00529373|584580650|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
161873657|NCT00529373|584580649|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
161873658|NCT00529373|584580650|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
161873659|NCT00529373|584580649|FG000|Second Extension Study|Adverse Event|101|||
161873660|NCT00529373|584580650|FG001|Second Extension Study|Adverse Event|51|||
161873661|NCT00529373|584580649|FG000|Second Extension Study|Lack of Efficacy|7|||
161873662|NCT00529373|584580650|FG001|Second Extension Study|Lack of Efficacy|15|||
161873663|NCT00529373|584580649|FG000|Second Extension Study|Lost to Follow-up|18|||
161873664|NCT00529373|584580650|FG001|Second Extension Study|Lost to Follow-up|12|||
161873665|NCT00529373|584580649|FG000|Second Extension Study|Other|7|||
161873666|NCT00529373|584580650|FG001|Second Extension Study|Other|12|||
161873667|NCT00529373|584580649|FG000|Second Extension Study|Physician Decision|63|||
161873668|NCT00529373|584580650|FG001|Second Extension Study|Physician Decision|26|||
161873669|NCT00529373|584580649|FG000|Second Extension Study|Protocol Violation|2|||
161873670|NCT00529373|584580650|FG001|Second Extension Study|Protocol Violation|1|||
161873671|NCT00529373|584580649|FG000|Second Extension Study|Withdrawal by Subject|97|||
161873672|NCT00529373|584580650|FG001|Second Extension Study|Withdrawal by Subject|75|||
161873673|NCT00529373|584580649|FG000|Second Extension Study|Status Missing|5|||
161873674|NCT00529373|584580650|FG001|Second Extension Study|Status Missing|5|||
161873675|NCT01074268|584580651|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
161873676|NCT01074268|584580652|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
161873677|NCT01074268|584580651|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
161873678|NCT01074268|584580652|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
161873679|NCT01074268|584580651|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
161873680|NCT01074268|584580652|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
161873681|NCT01074268|584580651|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
161873682|NCT01074268|584580652|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
161873683|NCT01074268|584580651|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
161873684|NCT01074268|584580652|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
161873685|NCT01074268|584580651|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
161873686|NCT01074268|584580652|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
161873687|NCT01074268|584580651|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
161873688|NCT01074268|584580652|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
161873689|NCT01074268|584580651|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
161873690|NCT01074268|584580652|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
161873691|NCT01074268|584580651|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
161873692|NCT01074268|584580652|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
161873693|NCT01119859|584580655|FG000|Overall Study|Adverse Event|9|||
161873694|NCT01119859|584580656|FG001|Overall Study|Adverse Event|10|||
161873695|NCT01119859|584580655|FG000|Overall Study|Death|2|||
161873696|NCT01119859|584580656|FG001|Overall Study|Death|0|||
161873697|NCT01119859|584580655|FG000|Overall Study|Insufficient therapeutic response|7|||
161873698|NCT01119859|584580656|FG001|Overall Study|Insufficient therapeutic response|14|||
161873699|NCT01119859|584580655|FG000|Overall Study|Refused treatment|3|||
161990313|NCT04230213|585014307|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
161990314|NCT04230213|585014308|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
161990315|NCT04230213|585014306|FG000|TP2: Week 10 to Week 16|Other|0|||
161990316|NCT04230213|585014307|FG001|TP2: Week 10 to Week 16|Other|2|||
161990317|NCT04230213|585014308|FG002|TP2: Week 10 to Week 16|Other|1|||
161990318|NCT04230213|585014306|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
161990319|NCT04230213|585014307|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
161990320|NCT04230213|585014308|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
161990321|NCT04230213|585014306|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
161990322|NCT04230213|585014307|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
161990323|NCT04230213|585014308|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
161990324|NCT04230213|585014306|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
161990325|NCT04230213|585014307|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
161990326|NCT04230213|585014308|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
161990327|NCT04230213|585014306|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
161990328|NCT04230213|585014307|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
161990329|NCT04230213|585014308|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
161990330|NCT04230213|585014306|FG000|TP3: Week 16 to Week 22|Other|0|||
161990331|NCT04230213|585014307|FG001|TP3: Week 16 to Week 22|Other|1|||
161990332|NCT04230213|585014308|FG002|TP3: Week 16 to Week 22|Other|3|||
161990333|NCT04230213|585014306|FG000|TP4: Week 22 to Week 32|Other|0|||
161990334|NCT04230213|585014307|FG001|TP4: Week 22 to Week 32|Other|5|||
161990335|NCT04230213|585014308|FG002|TP4: Week 22 to Week 32|Other|5|||
161990336|NCT04230213|585014306|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
161990337|NCT04230213|585014307|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
161990338|NCT04230213|585014308|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
161990339|NCT04230213|585014306|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
161990340|NCT04230213|585014307|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
161990341|NCT04230213|585014308|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
161990342|NCT04230213|585014306|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
161990343|NCT04230213|585014307|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
161990344|NCT04230213|585014308|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
161990345|NCT04230213|585014306|FG000|Follow up: Week 32 to Week 36|Other|0|||
161990346|NCT04230213|585014307|FG001|Follow up: Week 32 to Week 36|Other|1|||
161990347|NCT04230213|585014308|FG002|Follow up: Week 32 to Week 36|Other|1|||
161990348|NCT00619307|585014320|FG000|Overall Study|Adverse Event|0|||
161990349|NCT00619307|585014321|FG001|Overall Study|Adverse Event|1|||
161990350|NCT00619307|585014320|FG000|Overall Study|Lost to Follow-up|0|||
161990351|NCT00619307|585014321|FG001|Overall Study|Lost to Follow-up|1|||
161990352|NCT00619307|585014320|FG000|Overall Study|Protocol Violation|3|||
161990353|NCT00619307|585014321|FG001|Overall Study|Protocol Violation|0|||
161990354|NCT00619307|585014320|FG000|Overall Study|Withdrew consent|1|||
161990355|NCT00619307|585014321|FG001|Overall Study|Withdrew consent|0|||
161990356|NCT00619307|585014320|FG000|Overall Study|Severe migraine|0|||
161990357|NCT00619307|585014321|FG001|Overall Study|Severe migraine|1|||
161990358|NCT00619307|585014320|FG000|Overall Study|MS attack plus steroids|0|||
161990359|NCT00619307|585014321|FG001|Overall Study|MS attack plus steroids|1|||
161990360|NCT00118430|585014330|FG000|Overall Study|Withdrawal by Subject|6|||
161990361|NCT00118430|585014331|FG001|Overall Study|Withdrawal by Subject|2|||
161990362|NCT00118430|585014332|FG002|Overall Study|Withdrawal by Subject|0|||
161990363|NCT00118430|585014330|FG000|Overall Study|Lost to Follow-up|15|||
161990364|NCT00118430|585014331|FG001|Overall Study|Lost to Follow-up|22|||
161990365|NCT00118430|585014332|FG002|Overall Study|Lost to Follow-up|28|||
161990366|NCT00534976|585014333|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
161990367|NCT00534976|585014334|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
162035717|NCT00722371|585187128|FG002|Overall Study|Excluded medication|1|||
161776037|NCT00223990|584221351|FG001|Overall Study|Lost to Follow-up|0|||
161776038|NCT03505606|584223067|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
161776039|NCT03505606|584223068|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
161776040|NCT03505606|584223069|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
161776041|NCT03505606|584223067|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
161776042|NCT03505606|584223068|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
161776043|NCT03505606|584223069|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
161776044|NCT03505606|584223067|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
161776045|NCT03505606|584223068|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
161776046|NCT03505606|584223069|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
161776047|NCT03505606|584223067|FG000|Overall Study|Poor compliance with refractive correction|0|||
161776048|NCT03505606|584223068|FG001|Overall Study|Poor compliance with refractive correction|0|||
161776049|NCT03505606|584223069|FG002|Overall Study|Poor compliance with refractive correction|1|||
161776050|NCT03505606|584223067|FG000|Overall Study|Insufficient anisometropia|0|||
161776051|NCT03505606|584223068|FG001|Overall Study|Insufficient anisometropia|0|||
161776052|NCT03505606|584223069|FG002|Overall Study|Insufficient anisometropia|2|||
161873700|NCT01119859|584580656|FG001|Overall Study|Refused treatment|6|||
162035718|NCT00722371|585187129|FG003|Overall Study|Excluded medication|0|||
162035719|NCT00722371|585187130|FG004|Overall Study|Excluded medication|0|||
161873701|NCT01119859|584580655|FG000|Overall Study|Failure to return|3|||
161873702|NCT01119859|584580656|FG001|Overall Study|Failure to return|0|||
161873703|NCT00603473|584580657|FG000|Overall Study|Adverse Event|4|||
161873704|NCT00603473|584580657|FG000|Overall Study|Lack of Efficacy|4|||
161873705|NCT00603473|584580657|FG000|Overall Study|Protocol Violation|1|||
161873706|NCT01134939|584580661|FG000|Overall Study|Adverse Event|9|||
161873707|NCT01134939|584580662|FG001|Overall Study|Adverse Event|3|||
161873708|NCT01134939|584580663|FG002|Overall Study|Adverse Event|4|||
161873709|NCT01134939|584580664|FG003|Overall Study|Adverse Event|5|||
161873710|NCT01134939|584580665|FG004|Overall Study|Adverse Event|5|||
161873711|NCT01134939|584580666|FG005|Overall Study|Adverse Event|5|||
161873712|NCT01134939|584580667|FG006|Overall Study|Adverse Event|1|||
161873713|NCT01134939|584580668|FG007|Overall Study|Adverse Event|0|||
161873714|NCT01134939|584580661|FG000|Overall Study|Lack of Efficacy|2|||
161873715|NCT01134939|584580662|FG001|Overall Study|Lack of Efficacy|5|||
161873716|NCT01134939|584580663|FG002|Overall Study|Lack of Efficacy|1|||
161873717|NCT01134939|584580664|FG003|Overall Study|Lack of Efficacy|0|||
161873718|NCT01134939|584580665|FG004|Overall Study|Lack of Efficacy|3|||
161873719|NCT01134939|584580666|FG005|Overall Study|Lack of Efficacy|0|||
161873720|NCT01134939|584580667|FG006|Overall Study|Lack of Efficacy|1|||
161873721|NCT01134939|584580668|FG007|Overall Study|Lack of Efficacy|0|||
161873722|NCT01134939|584580661|FG000|Overall Study|Lost to Follow-up|2|||
161873723|NCT01134939|584580662|FG001|Overall Study|Lost to Follow-up|3|||
161873724|NCT01134939|584580663|FG002|Overall Study|Lost to Follow-up|0|||
161873725|NCT01134939|584580664|FG003|Overall Study|Lost to Follow-up|1|||
161873726|NCT01134939|584580665|FG004|Overall Study|Lost to Follow-up|2|||
161873727|NCT01134939|584580666|FG005|Overall Study|Lost to Follow-up|1|||
161873728|NCT01134939|584580667|FG006|Overall Study|Lost to Follow-up|0|||
161873729|NCT01134939|584580668|FG007|Overall Study|Lost to Follow-up|0|||
161873730|NCT01134939|584580661|FG000|Overall Study|Death|0|||
161873731|NCT01134939|584580662|FG001|Overall Study|Death|1|||
161873732|NCT01134939|584580663|FG002|Overall Study|Death|0|||
161873733|NCT01134939|584580664|FG003|Overall Study|Death|0|||
161873734|NCT01134939|584580665|FG004|Overall Study|Death|0|||
161873735|NCT01134939|584580666|FG005|Overall Study|Death|0|||
161873736|NCT01134939|584580667|FG006|Overall Study|Death|0|||
161873737|NCT01134939|584580668|FG007|Overall Study|Death|0|||
161873738|NCT01134939|584580661|FG000|Overall Study|Termination page not available|4|||
161873739|NCT01134939|584580662|FG001|Overall Study|Termination page not available|6|||
161873740|NCT01134939|584580663|FG002|Overall Study|Termination page not available|5|||
161873741|NCT01134939|584580664|FG003|Overall Study|Termination page not available|8|||
161873742|NCT01134939|584580665|FG004|Overall Study|Termination page not available|0|||
162035720|NCT00722371|585187131|FG005|Overall Study|Excluded medication|0|||
162035721|NCT00722371|585187132|FG006|Overall Study|Excluded medication|1|||
162035722|NCT00722371|585187126|FG000|Overall Study|Hyperglycemia|2|||
162035723|NCT00722371|585187127|FG001|Overall Study|Hyperglycemia|6|||
162035724|NCT00722371|585187128|FG002|Overall Study|Hyperglycemia|4|||
162035725|NCT00722371|585187129|FG003|Overall Study|Hyperglycemia|2|||
162035726|NCT00722371|585187130|FG004|Overall Study|Hyperglycemia|5|||
162035727|NCT00722371|585187131|FG005|Overall Study|Hyperglycemia|1|||
162035728|NCT00722371|585187132|FG006|Overall Study|Hyperglycemia|1|||
162035729|NCT00722371|585187126|FG000|Overall Study|Hypoglycemia|1|||
162035730|NCT00722371|585187127|FG001|Overall Study|Hypoglycemia|0|||
161873743|NCT01134939|584580666|FG005|Overall Study|Termination page not available|3|||
161873744|NCT01134939|584580667|FG006|Overall Study|Termination page not available|7|||
161873745|NCT01134939|584580668|FG007|Overall Study|Termination page not available|0|||
161873746|NCT00733421|584580669|FG000|Overall Study|Withdrawal by Subject|1|||
162035731|NCT00722371|585187128|FG002|Overall Study|Hypoglycemia|0|||
162035732|NCT00722371|585187129|FG003|Overall Study|Hypoglycemia|0|||
162035733|NCT00722371|585187130|FG004|Overall Study|Hypoglycemia|0|||
162035734|NCT00722371|585187131|FG005|Overall Study|Hypoglycemia|0|||
162035735|NCT00722371|585187132|FG006|Overall Study|Hypoglycemia|0|||
162035736|NCT00722371|585187126|FG000|Overall Study|Lack of Efficacy|4|||
161873747|NCT00733421|584580670|FG001|Overall Study|Withdrawal by Subject|1|||
161873748|NCT03652636|584582192|FG000|Overall Study|Withdrawal by Subject|7|||
162035737|NCT00722371|585187127|FG001|Overall Study|Lack of Efficacy|6|||
161873749|NCT00679029|584582195|FG000|Overall Study|Adverse Event|3|||
161873750|NCT00679029|584582195|FG000|Overall Study|Withdrawal by Subject|1|||
161873751|NCT00679029|584582195|FG000|Overall Study|Lost to Follow-up|1|||
162035738|NCT00722371|585187128|FG002|Overall Study|Lack of Efficacy|6|||
162035739|NCT00722371|585187129|FG003|Overall Study|Lack of Efficacy|6|||
161873752|NCT04075682|584582196|FG000|Overall Study|Lost to Follow-up|5|||
161873753|NCT04075682|584582197|FG001|Overall Study|Lost to Follow-up|5|||
161873754|NCT04075682|584582198|FG002|Overall Study|Lost to Follow-up|2|||
161873755|NCT04075682|584582199|FG003|Overall Study|Lost to Follow-up|2|||
162035740|NCT00722371|585187130|FG004|Overall Study|Lack of Efficacy|2|||
162035741|NCT00722371|585187131|FG005|Overall Study|Lack of Efficacy|3|||
161873756|NCT04075682|584582196|FG000|Overall Study|Withdrawal by Subject|1|||
161873757|NCT04075682|584582197|FG001|Overall Study|Withdrawal by Subject|0|||
161873758|NCT04075682|584582198|FG002|Overall Study|Withdrawal by Subject|1|||
161873759|NCT04075682|584582199|FG003|Overall Study|Withdrawal by Subject|0|||
161873760|NCT04075682|584582196|FG000|Overall Study|Protocol Violation|0|||
161873761|NCT04075682|584582197|FG001|Overall Study|Protocol Violation|1|||
161873762|NCT04075682|584582198|FG002|Overall Study|Protocol Violation|1|||
161873763|NCT04075682|584582199|FG003|Overall Study|Protocol Violation|0|||
161873764|NCT04075682|584582196|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
161873765|NCT04075682|584582197|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
161873766|NCT04075682|584582198|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
161873767|NCT04075682|584582199|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
161873768|NCT04075682|584582196|FG000|Overall Study|Lost study phone the first day of study participation|0|||
161873769|NCT04075682|584582197|FG001|Overall Study|Lost study phone the first day of study participation|1|||
161873770|NCT04075682|584582198|FG002|Overall Study|Lost study phone the first day of study participation|0|||
161873771|NCT04075682|584582199|FG003|Overall Study|Lost study phone the first day of study participation|0|||
161873772|NCT03423173|584582200|FG000|Overall Study|Randomized but not vaccinated|1|||
161873773|NCT03423173|584582201|FG001|Overall Study|Randomized but not vaccinated|0|||
161873774|NCT03423173|584582202|FG002|Overall Study|Randomized but not vaccinated|2|||
161873775|NCT03423173|584582203|FG003|Overall Study|Randomized but not vaccinated|1|||
161873776|NCT03423173|584582200|FG000|Overall Study|Adverse Event|1|||
161873777|NCT03423173|584582201|FG001|Overall Study|Adverse Event|1|||
161873778|NCT03423173|584582202|FG002|Overall Study|Adverse Event|1|||
161873779|NCT03423173|584582203|FG003|Overall Study|Adverse Event|1|||
161873780|NCT03423173|584582200|FG000|Overall Study|Lost to Follow-up|10|||
161873781|NCT03423173|584582201|FG001|Overall Study|Lost to Follow-up|19|||
161873782|NCT03423173|584582202|FG002|Overall Study|Lost to Follow-up|17|||
161873783|NCT03423173|584582203|FG003|Overall Study|Lost to Follow-up|22|||
161873784|NCT03423173|584582200|FG000|Overall Study|Withdrawal of consent|4|||
161873785|NCT03423173|584582201|FG001|Overall Study|Withdrawal of consent|10|||
161873786|NCT03423173|584582202|FG002|Overall Study|Withdrawal of consent|4|||
161873787|NCT03423173|584582203|FG003|Overall Study|Withdrawal of consent|5|||
161873788|NCT03423173|584582200|FG000|Overall Study|Death|1|||
161873789|NCT03423173|584582201|FG001|Overall Study|Death|0|||
161873790|NCT03423173|584582202|FG002|Overall Study|Death|0|||
161873791|NCT03423173|584582203|FG003|Overall Study|Death|0|||
161873792|NCT03423173|584582200|FG000|Overall Study|Reason not Specified|2|||
161873793|NCT03423173|584582201|FG001|Overall Study|Reason not Specified|5|||
161873794|NCT03423173|584582202|FG002|Overall Study|Reason not Specified|3|||
161873795|NCT03423173|584582203|FG003|Overall Study|Reason not Specified|1|||
161873796|NCT05338502|584582204|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
161873797|NCT05338502|584582205|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
161873798|NCT05338502|584582206|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
161873799|NCT05338502|584582204|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
161873800|NCT05338502|584582205|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
161873801|NCT05338502|584582206|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
161873802|NCT02071706|584582207|FG000|Overall Study|Adverse Event|1|||
161873803|NCT02071706|584582207|FG000|Overall Study|Withdrawal by Subject|2|||
161873804|NCT02247440|584582208|FG000|Overall Study|Withdrawal by Subject|1|||
161873805|NCT02247440|584582208|FG000|Overall Study|Lack of Efficacy|3|||
161873806|NCT00729157|584582209|FG000|Overall Study|Withdrawal by Subject|1|||
161873807|NCT01062113|584582210|FG000|Overall Study|Adverse Event|1|||
161873808|NCT01062113|584582211|FG001|Overall Study|Adverse Event|0|||
161873809|NCT01062113|584582212|FG002|Overall Study|Adverse Event|0|||
161873810|NCT01062113|584582210|FG000|Overall Study|Lack of Efficacy|38|||
161873811|NCT01062113|584582211|FG001|Overall Study|Lack of Efficacy|22|||
161873812|NCT01062113|584582212|FG002|Overall Study|Lack of Efficacy|31|||
161873813|NCT01062113|584582210|FG000|Overall Study|Withdrawal by Subject|1|||
161990368|NCT00534976|585014333|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
161990369|NCT00534976|585014334|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
161990370|NCT00534976|585014333|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
161990371|NCT00534976|585014334|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
161990372|NCT02147288|585014335|FG000|Overall Study|post-operative hematoma|1|||
161990373|NCT02147288|585014336|FG001|Overall Study|post-operative hematoma|1|||
161873814|NCT01062113|584582211|FG001|Overall Study|Withdrawal by Subject|0|||
161873815|NCT01062113|584582212|FG002|Overall Study|Withdrawal by Subject|0|||
161873816|NCT03499899|584582213|FG000|Overall Study|Adverse Event|2|||
161873817|NCT03499899|584582214|FG001|Overall Study|Adverse Event|3|||
161873818|NCT03499899|584582215|FG002|Overall Study|Adverse Event|3|||
161873819|NCT03499899|584582213|FG000|Overall Study|Death|0|||
161873820|NCT03499899|584582214|FG001|Overall Study|Death|0|||
161873821|NCT03499899|584582215|FG002|Overall Study|Death|1|||
161873822|NCT03499899|584582213|FG000|Overall Study|Physician Decision|3|||
161873823|NCT03499899|584582214|FG001|Overall Study|Physician Decision|6|||
161873824|NCT03499899|584582215|FG002|Overall Study|Physician Decision|6|||
161873825|NCT03499899|584582213|FG000|Overall Study|Progressive disease|15|||
161873826|NCT03499899|584582214|FG001|Overall Study|Progressive disease|23|||
161873827|NCT03499899|584582215|FG002|Overall Study|Progressive disease|23|||
161873828|NCT03499899|584582213|FG000|Overall Study|Patient decision|0|||
161873829|NCT03499899|584582214|FG001|Overall Study|Patient decision|1|||
161873830|NCT03499899|584582215|FG002|Overall Study|Patient decision|1|||
161873831|NCT03499899|584582213|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
161873832|NCT03499899|584582214|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
161873833|NCT03499899|584582215|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
161873834|NCT03655470|584582216|FG000|Overall Study|Lost to Follow-up|6|||
161873835|NCT03655470|584582217|FG001|Overall Study|Lost to Follow-up|7|||
161873836|NCT03063086|584582218|FG000|Overall Study|technical problems|1|||
161873837|NCT03063086|584582219|FG001|Overall Study|technical problems|0|||
161873838|NCT03063086|584582220|FG002|Overall Study|technical problems|0|||
161873839|NCT03063086|584582221|FG003|Overall Study|technical problems|0|||
161873840|NCT03063086|584582222|FG004|Overall Study|technical problems|0|||
161873841|NCT03063086|584582223|FG005|Overall Study|technical problems|0|||
161873842|NCT03063086|584582218|FG000|Overall Study|Adverse Event|1|||
161873843|NCT03063086|584582219|FG001|Overall Study|Adverse Event|1|||
161873844|NCT03063086|584582220|FG002|Overall Study|Adverse Event|1|||
161873845|NCT03063086|584582221|FG003|Overall Study|Adverse Event|1|||
161873846|NCT03063086|584582222|FG004|Overall Study|Adverse Event|0|||
161873847|NCT03063086|584582223|FG005|Overall Study|Adverse Event|0|||
161873848|NCT03063086|584582218|FG000|Overall Study|subject/guardian decision|1|||
161873849|NCT03063086|584582219|FG001|Overall Study|subject/guardian decision|0|||
161873850|NCT03063086|584582220|FG002|Overall Study|subject/guardian decision|0|||
161873851|NCT03063086|584582221|FG003|Overall Study|subject/guardian decision|0|||
161873852|NCT03063086|584582222|FG004|Overall Study|subject/guardian decision|0|||
161873853|NCT03063086|584582223|FG005|Overall Study|subject/guardian decision|0|||
161873854|NCT03063086|584582218|FG000|Overall Study|Non-compliance with study treatment|0|||
161873855|NCT03063086|584582219|FG001|Overall Study|Non-compliance with study treatment|0|||
161873856|NCT03063086|584582220|FG002|Overall Study|Non-compliance with study treatment|0|||
161873857|NCT03063086|584582221|FG003|Overall Study|Non-compliance with study treatment|1|||
161873858|NCT03063086|584582222|FG004|Overall Study|Non-compliance with study treatment|0|||
161873859|NCT03063086|584582223|FG005|Overall Study|Non-compliance with study treatment|1|||
161873860|NCT03063086|584582218|FG000|Overall Study|Physician Decision|0|||
161873861|NCT03063086|584582219|FG001|Overall Study|Physician Decision|0|||
161873862|NCT03063086|584582220|FG002|Overall Study|Physician Decision|0|||
161873863|NCT03063086|584582221|FG003|Overall Study|Physician Decision|1|||
161873864|NCT03063086|584582222|FG004|Overall Study|Physician Decision|0|||
161873865|NCT03063086|584582223|FG005|Overall Study|Physician Decision|0|||
161873866|NCT02244463|584582226|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
161873867|NCT02244463|584582227|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161873868|NCT02244463|584582228|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161873869|NCT02244463|584582229|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161873870|NCT02244463|584582230|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161873871|NCT02244463|584582231|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161873872|NCT02244463|584582226|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
161873873|NCT02244463|584582227|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
161873874|NCT02244463|584582228|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
161873875|NCT02244463|584582229|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
161873876|NCT02244463|584582230|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
161873877|NCT02244463|584582231|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
161873878|NCT02244463|584582226|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161873879|NCT02244463|584582227|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
161873880|NCT02244463|584582228|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161873881|NCT02244463|584582229|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161873882|NCT02244463|584582230|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161873883|NCT02244463|584582231|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161873884|NCT02244463|584582226|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161873885|NCT02244463|584582227|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161873886|NCT02244463|584582228|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
161873887|NCT02244463|584582229|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161873888|NCT02244463|584582230|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161873889|NCT02244463|584582231|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161873890|NCT02244463|584582226|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161873891|NCT02244463|584582227|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161873892|NCT02244463|584582228|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161873893|NCT02244463|584582229|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
161873894|NCT02244463|584582230|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161873895|NCT02244463|584582231|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161873896|NCT02244463|584582226|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161873897|NCT02244463|584582227|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161873898|NCT02244463|584582228|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161873899|NCT02244463|584582229|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
161873900|NCT02244463|584582230|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161873901|NCT02244463|584582231|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161873902|NCT02244463|584582226|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161873903|NCT02244463|584582227|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161873904|NCT02244463|584582228|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161873905|NCT02244463|584582229|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
161873906|NCT02244463|584582230|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161873907|NCT02244463|584582231|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161873908|NCT02244463|584582226|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161873909|NCT02244463|584582227|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161873910|NCT02244463|584582228|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161873911|NCT02244463|584582229|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
161873912|NCT02244463|584582230|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161873913|NCT02244463|584582231|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161873914|NCT02244463|584582226|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161873915|NCT02244463|584582227|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161873916|NCT02244463|584582228|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161873917|NCT02244463|584582229|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
161873918|NCT02244463|584582230|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161873919|NCT02244463|584582231|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161873920|NCT02244463|584582226|FG000|Period 5: Phase II|Disease Progression|0|||
161873921|NCT02244463|584582227|FG001|Period 5: Phase II|Disease Progression|0|||
161873922|NCT02244463|584582228|FG002|Period 5: Phase II|Disease Progression|0|||
161873923|NCT02244463|584582229|FG003|Period 5: Phase II|Disease Progression|0|||
161873924|NCT02244463|584582230|FG004|Period 5: Phase II|Disease Progression|10|||
161873925|NCT02244463|584582231|FG005|Period 5: Phase II|Disease Progression|11|||
161873926|NCT02244463|584582226|FG000|Period 5: Phase II|Physician Decision|0|||
161873927|NCT02244463|584582227|FG001|Period 5: Phase II|Physician Decision|0|||
161873928|NCT02244463|584582228|FG002|Period 5: Phase II|Physician Decision|0|||
161873929|NCT02244463|584582229|FG003|Period 5: Phase II|Physician Decision|0|||
161873930|NCT02244463|584582230|FG004|Period 5: Phase II|Physician Decision|3|||
161873931|NCT02244463|584582231|FG005|Period 5: Phase II|Physician Decision|2|||
161873932|NCT02244463|584582226|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
161873933|NCT02244463|584582227|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
161873934|NCT02244463|584582228|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
161873935|NCT02244463|584582229|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
161873936|NCT02244463|584582230|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
161873937|NCT02244463|584582231|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
161873938|NCT02244463|584582226|FG000|Period 5: Phase II|Intercurrent Illness|0|||
161990374|NCT02147288|585014337|FG002|Overall Study|post-operative hematoma|0|||
161990375|NCT02147288|585014338|FG003|Overall Study|post-operative hematoma|0|||
161990376|NCT02147288|585014339|FG004|Overall Study|post-operative hematoma|0|||
161990377|NCT02147288|585014340|FG005|Overall Study|post-operative hematoma|0|||
161990378|NCT02147288|585014341|FG006|Overall Study|post-operative hematoma|0|||
161990379|NCT02147288|585014342|FG007|Overall Study|post-operative hematoma|0|||
161990380|NCT02147288|585014343|FG008|Overall Study|post-operative hematoma|0|||
161990381|NCT02147288|585014344|FG009|Overall Study|post-operative hematoma|0|||
161990382|NCT02147288|585014335|FG000|Overall Study|complications from concurrent hernia rep|0|||
161990383|NCT02147288|585014336|FG001|Overall Study|complications from concurrent hernia rep|1|||
161990384|NCT02147288|585014337|FG002|Overall Study|complications from concurrent hernia rep|0|||
161990385|NCT02147288|585014338|FG003|Overall Study|complications from concurrent hernia rep|0|||
161990386|NCT02147288|585014339|FG004|Overall Study|complications from concurrent hernia rep|0|||
161990387|NCT02147288|585014340|FG005|Overall Study|complications from concurrent hernia rep|0|||
161990388|NCT02147288|585014341|FG006|Overall Study|complications from concurrent hernia rep|0|||
161990389|NCT02147288|585014342|FG007|Overall Study|complications from concurrent hernia rep|0|||
161990390|NCT02147288|585014343|FG008|Overall Study|complications from concurrent hernia rep|0|||
161990391|NCT02147288|585014344|FG009|Overall Study|complications from concurrent hernia rep|0|||
161990392|NCT00861471|585014345|FG000|Overall Study|Withdrawal by Subject|1|||
161990393|NCT00861471|585014345|FG000|Overall Study|Adverse Event|2|||
161990394|NCT00861471|585014345|FG000|Overall Study|Lack of Efficacy|3|||
161990395|NCT00861471|585014345|FG000|Overall Study|treatment for lumbar laminectomy|1|||
161990396|NCT00861471|585014345|FG000|Overall Study|Physician Decision|2|||
161990397|NCT02069392|585014348|FG000|Overall Study|Withdrawal by Subject|4|||
161990398|NCT02069392|585014349|FG001|Overall Study|Withdrawal by Subject|2|||
161873939|NCT02244463|584582227|FG001|Period 5: Phase II|Intercurrent Illness|0|||
161873940|NCT02244463|584582228|FG002|Period 5: Phase II|Intercurrent Illness|0|||
161873941|NCT02244463|584582229|FG003|Period 5: Phase II|Intercurrent Illness|0|||
161873942|NCT02244463|584582230|FG004|Period 5: Phase II|Intercurrent Illness|2|||
161873943|NCT02244463|584582231|FG005|Period 5: Phase II|Intercurrent Illness|0|||
161873944|NCT02244463|584582226|FG000|Period 5: Phase II|Adverse Event|0|||
161873945|NCT02244463|584582227|FG001|Period 5: Phase II|Adverse Event|0|||
161873946|NCT02244463|584582228|FG002|Period 5: Phase II|Adverse Event|0|||
161873947|NCT02244463|584582229|FG003|Period 5: Phase II|Adverse Event|0|||
161873948|NCT02244463|584582230|FG004|Period 5: Phase II|Adverse Event|0|||
161873949|NCT02244463|584582231|FG005|Period 5: Phase II|Adverse Event|2|||
161873950|NCT02244463|584582226|FG000|Period 5: Phase II|Still On treatment|0|||
161873951|NCT02244463|584582227|FG001|Period 5: Phase II|Still On treatment|0|||
161873952|NCT02244463|584582228|FG002|Period 5: Phase II|Still On treatment|0|||
161873953|NCT02244463|584582229|FG003|Period 5: Phase II|Still On treatment|0|||
161873954|NCT02244463|584582230|FG004|Period 5: Phase II|Still On treatment|0|||
161873955|NCT02244463|584582231|FG005|Period 5: Phase II|Still On treatment|3|||
161873956|NCT05481125|584582232|FG000|Overall Study|Adverse Event|1|||
161873957|NCT05481125|584582233|FG001|Overall Study|Adverse Event|0|||
161873958|NCT05481125|584582232|FG000|Overall Study|Lost to Follow-up|0|||
161873959|NCT05481125|584582233|FG001|Overall Study|Lost to Follow-up|1|||
161873960|NCT05481125|584582232|FG000|Overall Study|Withdrawal by Subject|0|||
161873961|NCT05481125|584582233|FG001|Overall Study|Withdrawal by Subject|1|||
161873962|NCT03702010|584582238|FG000|Follow-up (30days)|Lack of Efficacy|2|||
161873963|NCT03702010|584582239|FG001|Follow-up (30days)|Lack of Efficacy|2|||
161873964|NCT03474731|584582247|FG000|Overall Study|Withdrawal by Subject|36|||
161873965|NCT03474731|584582248|FG001|Overall Study|Withdrawal by Subject|29|||
161873966|NCT03474731|584582249|FG002|Overall Study|Withdrawal by Subject|11|||
161873967|NCT03474731|584582250|FG003|Overall Study|Withdrawal by Subject|27|||
161873968|NCT03474731|584582247|FG000|Overall Study|COVID|0|||
161873969|NCT03474731|584582248|FG001|Overall Study|COVID|23|||
161873970|NCT03474731|584582249|FG002|Overall Study|COVID|0|||
161873971|NCT03474731|584582250|FG003|Overall Study|COVID|0|||
161873972|NCT03474731|584582247|FG000|Overall Study|Participant moved from area|1|||
161873973|NCT03474731|584582248|FG001|Overall Study|Participant moved from area|0|||
161873974|NCT03474731|584582249|FG002|Overall Study|Participant moved from area|0|||
161873975|NCT03474731|584582250|FG003|Overall Study|Participant moved from area|0|||
161873976|NCT03474731|584582247|FG000|Overall Study|Lost to Follow-up|11|||
161873977|NCT03474731|584582248|FG001|Overall Study|Lost to Follow-up|3|||
161873978|NCT03474731|584582249|FG002|Overall Study|Lost to Follow-up|18|||
161873979|NCT03474731|584582250|FG003|Overall Study|Lost to Follow-up|17|||
161873980|NCT03474731|584582247|FG000|Overall Study|Death|0|||
161873981|NCT03474731|584582248|FG001|Overall Study|Death|1|||
161873982|NCT03474731|584582249|FG002|Overall Study|Death|0|||
161873983|NCT03474731|584582250|FG003|Overall Study|Death|0|||
161873984|NCT03474731|584582247|FG000|Overall Study|Participant Removed|0|||
161873985|NCT03474731|584582248|FG001|Overall Study|Participant Removed|0|||
161873986|NCT03474731|584582249|FG002|Overall Study|Participant Removed|0|||
161873987|NCT03474731|584582250|FG003|Overall Study|Participant Removed|1|||
161873988|NCT00554515|584582253|FG000|Overall Study|Withdrawal by Subject|3|||
161873989|NCT00554515|584582253|FG000|Overall Study|Disease progression|52|||
161873990|NCT00554515|584582253|FG000|Overall Study|Physician Decision|18|||
161873991|NCT00554515|584582253|FG000|Overall Study|Withdrawal by Subject|11|||
161873992|NCT00554515|584582253|FG000|Overall Study|Adverse Event|9|||
161873993|NCT00554515|584582253|FG000|Overall Study|Death|2|||
161873994|NCT00554515|584582253|FG000|Overall Study|Achieved Stable Disease|7|||
161873995|NCT00554515|584582253|FG000|Overall Study|Other|1|||
161873996|NCT00554515|584582253|FG000|Overall Study|Misc|15|||
161873997|NCT02549287|584582261|FG000|Overall Study|Lost to Follow-up|65|||
161873998|NCT02549287|584582262|FG001|Overall Study|Lost to Follow-up|26|||
161873999|NCT02549287|584582261|FG000|Overall Study|Withdrawal by Subject|15|||
161874000|NCT02549287|584582262|FG001|Overall Study|Withdrawal by Subject|6|||
161874001|NCT03793842|584582263|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
161874002|NCT03793842|584582264|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
161874003|NCT03793842|584582263|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
161874004|NCT03793842|584582264|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
161874005|NCT04087720|584582265|FG000|Overall Study|Withdrawal by Subject|2|||
161874006|NCT04087720|584582265|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
161874007|NCT00900159|584582268|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
161874008|NCT00900159|584582269|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
161874009|NCT00765336|584582270|FG000|Overall Study|Protocol Violation|4|||
161874010|NCT00765336|584582271|FG001|Overall Study|Protocol Violation|2|||
161874011|NCT00765336|584582270|FG000|Overall Study|Withdrawal by Subject|6|||
161874012|NCT00765336|584582271|FG001|Overall Study|Withdrawal by Subject|4|||
161874013|NCT00765336|584582270|FG000|Overall Study|Lost to Follow-up|7|||
161874014|NCT00765336|584582271|FG001|Overall Study|Lost to Follow-up|9|||
161874015|NCT00765336|584582270|FG000|Overall Study|Adverse Event|2|||
161874016|NCT00765336|584582271|FG001|Overall Study|Adverse Event|1|||
161874017|NCT01377922|584582272|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
161874018|NCT01377922|584582273|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
161874019|NCT04615403|584582274|FG000|Overall Study|Death|1|||
162035742|NCT00722371|585187132|FG006|Overall Study|Lack of Efficacy|0|||
161776053|NCT03505606|584223067|FG000|Overall Study|Ectopia Lentis|0|||
161776054|NCT03505606|584223068|FG001|Overall Study|Ectopia Lentis|0|||
161776055|NCT03505606|584223069|FG002|Overall Study|Ectopia Lentis|1|||
161776056|NCT03505606|584223067|FG000|Overall Study|alternation of amblyopic eye|0|||
161776057|NCT03505606|584223068|FG001|Overall Study|alternation of amblyopic eye|1|||
161776058|NCT03505606|584223069|FG002|Overall Study|alternation of amblyopic eye|0|||
161776059|NCT02087865|584223072|FG000|Overall Study|Withdrawal by Subject|6|||
161776060|NCT02087865|584223073|FG001|Overall Study|Withdrawal by Subject|0|||
161776061|NCT02087865|584223074|FG002|Overall Study|Withdrawal by Subject|1|||
161776062|NCT02087865|584223072|FG000|Overall Study|Lost to Follow-up|0|||
161776063|NCT02087865|584223073|FG001|Overall Study|Lost to Follow-up|0|||
161776064|NCT02087865|584223074|FG002|Overall Study|Lost to Follow-up|1|||
161776065|NCT02087865|584223072|FG000|Overall Study|Drug Non-compliance|0|||
161776066|NCT02087865|584223073|FG001|Overall Study|Drug Non-compliance|2|||
161776067|NCT02087865|584223074|FG002|Overall Study|Drug Non-compliance|0|||
161776068|NCT02087865|584223072|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
161776069|NCT02087865|584223073|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
161776070|NCT02087865|584223074|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
161776071|NCT01392469|584223075|FG000|Overall Study|Adverse Event|2|||
161776072|NCT01392469|584223075|FG000|Overall Study|Withdrawal by Subject|1|||
161776073|NCT01392469|584223075|FG000|Overall Study|Protocol Violation|1|||
161776074|NCT03443973|584223078|FG000|Double-blind Treatment Period|Adverse Event|5|||
161776075|NCT03443973|584223079|FG001|Double-blind Treatment Period|Adverse Event|19|||
161776076|NCT03443973|584223080|FG002|Double-blind Treatment Period|Adverse Event|0|||
161776077|NCT03443973|584223081|FG003|Double-blind Treatment Period|Adverse Event|0|||
161776078|NCT03443973|584223078|FG000|Double-blind Treatment Period|Death|5|||
161776079|NCT03443973|584223079|FG001|Double-blind Treatment Period|Death|7|||
161776080|NCT03443973|584223080|FG002|Double-blind Treatment Period|Death|0|||
161776081|NCT03443973|584223081|FG003|Double-blind Treatment Period|Death|0|||
161776082|NCT03443973|584223078|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
161776083|NCT03443973|584223079|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
161776084|NCT03443973|584223080|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
161776085|NCT03443973|584223081|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
161776086|NCT03443973|584223078|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161776087|NCT03443973|584223079|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
161776088|NCT03443973|584223080|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
161776089|NCT03443973|584223081|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
161776090|NCT03443973|584223078|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
161776091|NCT03443973|584223079|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
161776092|NCT03443973|584223080|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
161776093|NCT03443973|584223081|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
161776094|NCT03443973|584223078|FG000|Double-blind Treatment Period|Physician Decision|5|||
161776095|NCT03443973|584223079|FG001|Double-blind Treatment Period|Physician Decision|6|||
161776096|NCT03443973|584223080|FG002|Double-blind Treatment Period|Physician Decision|0|||
161776097|NCT03443973|584223081|FG003|Double-blind Treatment Period|Physician Decision|0|||
161776098|NCT03443973|584223078|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
161776099|NCT03443973|584223079|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
161776100|NCT03443973|584223080|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
161776101|NCT03443973|584223081|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
161776102|NCT03443973|584223078|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
161776103|NCT03443973|584223079|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
161776104|NCT03443973|584223080|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161776105|NCT03443973|584223081|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
161776106|NCT03443973|584223078|FG000|Open-label Extension Period|Reason Not Specified|0|||
161776107|NCT03443973|584223079|FG001|Open-label Extension Period|Reason Not Specified|0|||
161776108|NCT03443973|584223080|FG002|Open-label Extension Period|Reason Not Specified|3|||
161776109|NCT03443973|584223081|FG003|Open-label Extension Period|Reason Not Specified|0|||
161776110|NCT03443973|584223078|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
161776111|NCT03443973|584223079|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
161776112|NCT03443973|584223080|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
161776113|NCT03443973|584223081|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
161776114|NCT04930536|584223082|FG000|Overall Study|Adverse Event|1|||
161776115|NCT04930536|584223083|FG001|Overall Study|Adverse Event|0|||
161776116|NCT04930536|584223082|FG000|Overall Study|Disease Progression|2|||
161776117|NCT04930536|584223083|FG001|Overall Study|Disease Progression|0|||
161776118|NCT04930536|584223082|FG000|Overall Study|Patient Decision|4|||
161776119|NCT04930536|584223083|FG001|Overall Study|Patient Decision|2|||
161776120|NCT04930536|584223082|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
161874020|NCT00665431|584582275|FG000|Overall Study|Adverse Event|16|||
161874021|NCT00665431|584582276|FG001|Overall Study|Adverse Event|22|||
161874022|NCT00665431|584582277|FG002|Overall Study|Adverse Event|6|||
161874023|NCT00665431|584582275|FG000|Overall Study|Withdrawal by Subject|17|||
161874024|NCT00665431|584582276|FG001|Overall Study|Withdrawal by Subject|25|||
161874025|NCT00665431|584582277|FG002|Overall Study|Withdrawal by Subject|15|||
161874026|NCT00665431|584582275|FG000|Overall Study|Lost to Follow-up|3|||
161874027|NCT00665431|584582276|FG001|Overall Study|Lost to Follow-up|3|||
161874028|NCT00665431|584582277|FG002|Overall Study|Lost to Follow-up|1|||
161874029|NCT00665431|584582275|FG000|Overall Study|Other|4|||
161874030|NCT00665431|584582276|FG001|Overall Study|Other|7|||
161874031|NCT00665431|584582277|FG002|Overall Study|Other|2|||
161874032|NCT01464164|584582281|FG000|Overall Study|Screen failure|0|||
161874033|NCT01464164|584582282|FG001|Overall Study|Screen failure|1|||
161874034|NCT01464164|584582283|FG002|Overall Study|Screen failure|2|||
161874035|NCT01464164|584582284|FG003|Overall Study|Screen failure|0|||
161874036|NCT01464164|584582285|FG004|Overall Study|Screen failure|0|||
161874037|NCT01464164|584582286|FG005|Overall Study|Screen failure|0|||
161874038|NCT01464164|584582287|FG006|Overall Study|Screen failure|0|||
161874039|NCT01464164|584582281|FG000|Overall Study|Physician Decision|0|||
161874040|NCT01464164|584582282|FG001|Overall Study|Physician Decision|1|||
161874041|NCT01464164|584582283|FG002|Overall Study|Physician Decision|0|||
161874042|NCT01464164|584582284|FG003|Overall Study|Physician Decision|0|||
161874043|NCT01464164|584582285|FG004|Overall Study|Physician Decision|0|||
161874044|NCT01464164|584582286|FG005|Overall Study|Physician Decision|0|||
161874045|NCT01464164|584582287|FG006|Overall Study|Physician Decision|2|||
161874046|NCT01578239|584582288|FG000|Treatment Period|Progressive Disease|19|||
161874047|NCT01578239|584582289|FG001|Treatment Period|Progressive Disease|64|||
161874048|NCT01578239|584582288|FG000|Treatment Period|Physician Decision|17|||
161874049|NCT01578239|584582289|FG001|Treatment Period|Physician Decision|17|||
161874050|NCT01578239|584582288|FG000|Treatment Period|Adverse Event|13|||
161874051|NCT01578239|584582289|FG001|Treatment Period|Adverse Event|10|||
161874052|NCT01578239|584582288|FG000|Treatment Period|Non-compliance|2|||
161874053|NCT01578239|584582289|FG001|Treatment Period|Non-compliance|0|||
161874054|NCT01578239|584582288|FG000|Treatment Period|Withdrawal by Subject|10|||
161874055|NCT01578239|584582289|FG001|Treatment Period|Withdrawal by Subject|9|||
161874056|NCT01578239|584582288|FG000|Treatment Period|Other|6|||
161874057|NCT01578239|584582289|FG001|Treatment Period|Other|1|||
161874058|NCT01578239|584582288|FG000|Long-term Follow-Up Period|Death|69|||
161874059|NCT01578239|584582289|FG001|Long-term Follow-Up Period|Death|64|||
161874060|NCT01578239|584582288|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
161874061|NCT01578239|584582289|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
161874062|NCT01578239|584582288|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
161874063|NCT01578239|584582289|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
161874064|NCT01578239|584582288|FG000|Long-term Follow-Up Period|Other|2|||
161874065|NCT01578239|584582289|FG001|Long-term Follow-Up Period|Other|2|||
161874066|NCT02347813|584582292|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
161874067|NCT02347813|584582293|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
161874068|NCT02347813|584582292|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
161874069|NCT02347813|584582293|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
161874070|NCT02547220|584582297|FG000|Overall Study|Withdrawal by Subject|1|||
161874071|NCT02547220|584582298|FG001|Overall Study|Withdrawal by Subject|0|||
161874072|NCT02547220|584582297|FG000|Overall Study|Study terminated by sponsor|18|||
161874073|NCT02547220|584582298|FG001|Overall Study|Study terminated by sponsor|20|||
161874074|NCT03817229|584582299|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
161874075|NCT03817229|584582300|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
161874076|NCT03817229|584582301|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
161874077|NCT03817229|584582302|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
161874078|NCT03817229|584582299|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
161874079|NCT03817229|584582300|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
161874080|NCT03817229|584582301|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
161874081|NCT03817229|584582302|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
162035743|NCT00722371|585187126|FG000|Overall Study|Lost to Follow-up|11|||
162035744|NCT00722371|585187127|FG001|Overall Study|Lost to Follow-up|14|||
161874082|NCT03817229|584582299|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
161874083|NCT03817229|584582300|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
161874084|NCT03817229|584582301|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
161874085|NCT03817229|584582302|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
161874086|NCT03817229|584582299|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
161874087|NCT03817229|584582300|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
162035745|NCT00722371|585187128|FG002|Overall Study|Lost to Follow-up|21|||
161874088|NCT03817229|584582301|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
161874089|NCT03817229|584582302|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
161874090|NCT03817229|584582299|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
161874091|NCT03817229|584582300|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
161874092|NCT03817229|584582301|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
161874093|NCT03817229|584582302|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
161874094|NCT03817229|584582299|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
161874095|NCT03817229|584582300|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
161874096|NCT03817229|584582301|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
161874097|NCT03817229|584582302|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
161874098|NCT03817229|584582299|FG000|Post-Intervention|Withdrawal by Subject|6|||
161874099|NCT03817229|584582300|FG001|Post-Intervention|Withdrawal by Subject|0|||
161874100|NCT03817229|584582301|FG002|Post-Intervention|Withdrawal by Subject|2|||
161874101|NCT03817229|584582302|FG003|Post-Intervention|Withdrawal by Subject|2|||
161874102|NCT03817229|584582299|FG000|Post-Intervention|Withdrawal by Study Team|3|||
161874103|NCT03817229|584582300|FG001|Post-Intervention|Withdrawal by Study Team|1|||
161874104|NCT03817229|584582301|FG002|Post-Intervention|Withdrawal by Study Team|1|||
161874105|NCT03817229|584582302|FG003|Post-Intervention|Withdrawal by Study Team|4|||
161874106|NCT03817229|584582299|FG000|Post-Intervention|Weaned from medication|3|||
161874107|NCT03817229|584582300|FG001|Post-Intervention|Weaned from medication|0|||
161874108|NCT03817229|584582301|FG002|Post-Intervention|Weaned from medication|2|||
161874109|NCT03817229|584582302|FG003|Post-Intervention|Weaned from medication|1|||
161874110|NCT03817229|584582299|FG000|Post-Intervention|Transferred care to another institution|1|||
161874111|NCT03817229|584582300|FG001|Post-Intervention|Transferred care to another institution|0|||
161874112|NCT03817229|584582301|FG002|Post-Intervention|Transferred care to another institution|0|||
161874113|NCT03817229|584582302|FG003|Post-Intervention|Transferred care to another institution|0|||
161874114|NCT03817229|584582299|FG000|Post-Intervention|Change in parental guardianship|0|||
161874115|NCT03817229|584582300|FG001|Post-Intervention|Change in parental guardianship|0|||
161874116|NCT03817229|584582301|FG002|Post-Intervention|Change in parental guardianship|1|||
161874117|NCT03817229|584582302|FG003|Post-Intervention|Change in parental guardianship|0|||
161874118|NCT03817229|584582299|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
161874119|NCT03817229|584582300|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
161874120|NCT03817229|584582301|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
161874121|NCT03817229|584582302|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
161874122|NCT03817229|584582299|FG000|Follow-up 1|Withdrawal by Subject|1|||
161874123|NCT03817229|584582300|FG001|Follow-up 1|Withdrawal by Subject|2|||
161874124|NCT03817229|584582301|FG002|Follow-up 1|Withdrawal by Subject|0|||
161874125|NCT03817229|584582302|FG003|Follow-up 1|Withdrawal by Subject|0|||
161874126|NCT03817229|584582299|FG000|Follow-up 1|Withdrawal by Study Team|3|||
161874127|NCT03817229|584582300|FG001|Follow-up 1|Withdrawal by Study Team|1|||
161874128|NCT03817229|584582301|FG002|Follow-up 1|Withdrawal by Study Team|0|||
161874129|NCT03817229|584582302|FG003|Follow-up 1|Withdrawal by Study Team|0|||
161874130|NCT03817229|584582299|FG000|Follow-up 1|Wean from medication|3|||
161874131|NCT03817229|584582300|FG001|Follow-up 1|Wean from medication|4|||
161874132|NCT03817229|584582301|FG002|Follow-up 1|Wean from medication|0|||
161874133|NCT03817229|584582302|FG003|Follow-up 1|Wean from medication|1|||
161874134|NCT03817229|584582299|FG000|Follow-up 1|Transferred care to another hospital|1|||
161874135|NCT03817229|584582300|FG001|Follow-up 1|Transferred care to another hospital|0|||
161874136|NCT03817229|584582301|FG002|Follow-up 1|Transferred care to another hospital|0|||
161874137|NCT03817229|584582302|FG003|Follow-up 1|Transferred care to another hospital|0|||
161874138|NCT03817229|584582299|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
161874139|NCT03817229|584582300|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
161874140|NCT03817229|584582301|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
161874141|NCT03817229|584582302|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
161874142|NCT03817229|584582299|FG000|Follow-up 2|Withdrawal by Subject|2|||
161874143|NCT03817229|584582300|FG001|Follow-up 2|Withdrawal by Subject|0|||
161874144|NCT03817229|584582301|FG002|Follow-up 2|Withdrawal by Subject|1|||
161874145|NCT03817229|584582302|FG003|Follow-up 2|Withdrawal by Subject|1|||
161990399|NCT00269633|585014350|FG000|Overall Study|Withdrawal by Subject|1|||
161990400|NCT00269633|585014351|FG001|Overall Study|Withdrawal by Subject|0|||
161990401|NCT01574651|585014352|FG000|Overall Study|Lost to Follow-up|2|||
161990402|NCT01574651|585014353|FG001|Overall Study|Lost to Follow-up|4|||
161990403|NCT01574651|585014352|FG000|Overall Study|Administrative problems|0|||
161990404|NCT01574651|585014353|FG001|Overall Study|Administrative problems|1|||
161990405|NCT01574651|585014352|FG000|Overall Study|Death|3|||
161990406|NCT01574651|585014353|FG001|Overall Study|Death|3|||
161990407|NCT01574651|585014352|FG000|Overall Study|Patient's inability to use the device|0|||
162035746|NCT00722371|585187129|FG003|Overall Study|Lost to Follow-up|13|||
161874146|NCT03817229|584582299|FG000|Follow-up 2|Withdrawal by Study Team|2|||
161874147|NCT03817229|584582300|FG001|Follow-up 2|Withdrawal by Study Team|0|||
161874148|NCT03817229|584582301|FG002|Follow-up 2|Withdrawal by Study Team|1|||
161874149|NCT03817229|584582302|FG003|Follow-up 2|Withdrawal by Study Team|0|||
161874150|NCT03817229|584582299|FG000|Follow-up 2|Wean from medication|1|||
161874151|NCT03817229|584582300|FG001|Follow-up 2|Wean from medication|0|||
161874152|NCT03817229|584582301|FG002|Follow-up 2|Wean from medication|0|||
161990408|NCT01574651|585014353|FG001|Overall Study|Patient's inability to use the device|1|||
161874153|NCT03817229|584582302|FG003|Follow-up 2|Wean from medication|0|||
161874154|NCT03817229|584582299|FG000|Follow-up 2|Transferred care|0|||
161874155|NCT03817229|584582300|FG001|Follow-up 2|Transferred care|0|||
161874156|NCT03817229|584582301|FG002|Follow-up 2|Transferred care|1|||
161874157|NCT03817229|584582302|FG003|Follow-up 2|Transferred care|0|||
161874158|NCT02887183|584582304|FG000|Overall Study|Adverse Event|44|||
161874159|NCT02887183|584582304|FG000|Overall Study|Death|30|||
161874160|NCT02887183|584582304|FG000|Overall Study|Pregnancy|1|||
161874161|NCT02887183|584582304|FG000|Overall Study|Protocol Violation|6|||
161874162|NCT02887183|584582304|FG000|Overall Study|Technical Problems|2|||
161874163|NCT02887183|584582304|FG000|Overall Study|Lost to Follow-up|13|||
161874164|NCT02887183|584582304|FG000|Overall Study|Physician Decision|10|||
161874165|NCT02887183|584582304|FG000|Overall Study|Withdrawal by Subject|35|||
161874166|NCT01029782|584582305|FG000|Overall Study|Lost to Follow-up|2|||
161874167|NCT01029782|584582306|FG001|Overall Study|Lost to Follow-up|2|||
161874168|NCT01029782|584582305|FG000|Overall Study|Diagnosis changed|1|||
161874169|NCT01029782|584582306|FG001|Overall Study|Diagnosis changed|1|||
161874170|NCT01029782|584582305|FG000|Overall Study|Adverse Event|0|||
161874171|NCT01029782|584582306|FG001|Overall Study|Adverse Event|1|||
161874172|NCT01029782|584582305|FG000|Overall Study|Physician Decision|0|||
161874173|NCT01029782|584582306|FG001|Overall Study|Physician Decision|1|||
161874174|NCT01029782|584582305|FG000|Overall Study|Protocol Violation|0|||
161874175|NCT01029782|584582306|FG001|Overall Study|Protocol Violation|2|||
161874176|NCT01029782|584582305|FG000|Overall Study|Withdrawal by Subject|0|||
161874177|NCT01029782|584582306|FG001|Overall Study|Withdrawal by Subject|1|||
161874178|NCT02195869|584582308|FG000|Overall Study|cGVHD Progression|5|||
161874179|NCT02195869|584582308|FG000|Overall Study|Malignancy Progression/relapse|2|||
161874180|NCT02195869|584582308|FG000|Overall Study|Adverse Event|15|||
161874181|NCT02195869|584582308|FG000|Overall Study|Withdrawal by Subject|7|||
161874182|NCT02195869|584582308|FG000|Overall Study|Physician Decision|4|||
161874183|NCT02195869|584582308|FG000|Overall Study|Study Terminated by Sponsor|7|||
161874184|NCT02195869|584582308|FG000|Overall Study|Noncompliance with study drug|2|||
161874185|NCT00757042|584582312|FG000|Overall Study|Lost to Follow-up|0|||
161874186|NCT00757042|584582313|FG001|Overall Study|Lost to Follow-up|0|||
161874187|NCT00757042|584582314|FG002|Overall Study|Lost to Follow-up|0|||
161874188|NCT00757042|584582315|FG003|Overall Study|Lost to Follow-up|0|||
161874189|NCT00757042|584582316|FG004|Overall Study|Lost to Follow-up|0|||
161874190|NCT00757042|584582317|FG005|Overall Study|Lost to Follow-up|0|||
161874191|NCT00757042|584582318|FG006|Overall Study|Lost to Follow-up|0|||
161874192|NCT00757042|584582319|FG007|Overall Study|Lost to Follow-up|0|||
161874193|NCT00757042|584582320|FG008|Overall Study|Lost to Follow-up|1|||
161874194|NCT00757042|584582321|FG009|Overall Study|Lost to Follow-up|0|||
161874195|NCT00757042|584582322|FG010|Overall Study|Lost to Follow-up|0|||
161874196|NCT00757042|584582312|FG000|Overall Study|Ineligibility Determined|0|||
161874197|NCT00757042|584582313|FG001|Overall Study|Ineligibility Determined|0|||
161874198|NCT00757042|584582314|FG002|Overall Study|Ineligibility Determined|0|||
161874199|NCT00757042|584582315|FG003|Overall Study|Ineligibility Determined|0|||
161874200|NCT00757042|584582316|FG004|Overall Study|Ineligibility Determined|0|||
161874201|NCT00757042|584582317|FG005|Overall Study|Ineligibility Determined|0|||
161874202|NCT00757042|584582318|FG006|Overall Study|Ineligibility Determined|0|||
161874203|NCT00757042|584582319|FG007|Overall Study|Ineligibility Determined|0|||
161874204|NCT00757042|584582320|FG008|Overall Study|Ineligibility Determined|0|||
161874205|NCT00757042|584582321|FG009|Overall Study|Ineligibility Determined|0|||
161874206|NCT00757042|584582322|FG010|Overall Study|Ineligibility Determined|1|||
161874207|NCT00757042|584582312|FG000|Overall Study|Withdrawal by Subject|0|||
161874208|NCT00757042|584582313|FG001|Overall Study|Withdrawal by Subject|0|||
161874209|NCT00757042|584582314|FG002|Overall Study|Withdrawal by Subject|0|||
161874210|NCT00757042|584582315|FG003|Overall Study|Withdrawal by Subject|0|||
161874211|NCT00757042|584582316|FG004|Overall Study|Withdrawal by Subject|0|||
161874212|NCT00757042|584582317|FG005|Overall Study|Withdrawal by Subject|0|||
161874213|NCT00757042|584582318|FG006|Overall Study|Withdrawal by Subject|0|||
161874214|NCT00757042|584582319|FG007|Overall Study|Withdrawal by Subject|0|||
161874215|NCT00757042|584582320|FG008|Overall Study|Withdrawal by Subject|0|||
161874216|NCT00757042|584582321|FG009|Overall Study|Withdrawal by Subject|1|||
161874217|NCT00757042|584582322|FG010|Overall Study|Withdrawal by Subject|0|||
161874218|NCT02654977|584582323|FG000|Overall Study|Death|1|||
161874219|NCT02654977|584582323|FG000|Overall Study|Lost to Follow-up|1|||
161874220|NCT02654977|584582323|FG000|Overall Study|Adverse Event|1|||
161874221|NCT02654977|584582323|FG000|Overall Study|Withdrawal by Subject|1|||
161874222|NCT02654977|584582323|FG000|Overall Study|Lack of Efficacy|3|||
161874223|NCT01266291|584582324|FG000|Overall Study|Adverse Event|1|||
161874224|NCT02702388|584582328|FG000|Overall Study|Disease Progression|18|||
161874225|NCT02702388|584582329|FG001|Overall Study|Disease Progression|25|||
161874226|NCT02702388|584582328|FG000|Overall Study|Withdrawal by Subject|9|||
161874227|NCT02702388|584582329|FG001|Overall Study|Withdrawal by Subject|7|||
161874228|NCT02702388|584582328|FG000|Overall Study|Adverse Event|11|||
161874229|NCT02702388|584582329|FG001|Overall Study|Adverse Event|15|||
161874230|NCT02702388|584582328|FG000|Overall Study|Other|2|||
161874231|NCT02702388|584582329|FG001|Overall Study|Other|4|||
161874232|NCT02729051|584582330|FG000|Overall Study|Adverse Event|21|||
161874233|NCT02729051|584582331|FG001|Overall Study|Adverse Event|11|||
161874234|NCT02729051|584582330|FG000|Overall Study|Lack of Efficacy|1|||
161874235|NCT02729051|584582331|FG001|Overall Study|Lack of Efficacy|1|||
161874236|NCT02729051|584582330|FG000|Overall Study|Lost to Follow-up|1|||
161874237|NCT02729051|584582331|FG001|Overall Study|Lost to Follow-up|2|||
161874238|NCT02729051|584582330|FG000|Overall Study|Physician Decision|1|||
161874239|NCT02729051|584582331|FG001|Overall Study|Physician Decision|1|||
161874240|NCT02729051|584582330|FG000|Overall Study|Withdrawal by Subject|6|||
161874241|NCT02729051|584582331|FG001|Overall Study|Withdrawal by Subject|17|||
161874242|NCT02981082|584582332|FG000|Overall Study|Withdrawal by Subject|2|||
161874243|NCT02981082|584582333|FG001|Overall Study|Withdrawal by Subject|0|||
161874244|NCT02981082|584582332|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
161874245|NCT02981082|584582333|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
161874246|NCT02981082|584582332|FG000|Overall Study|Adverse Event|0|||
161874247|NCT02981082|584582333|FG001|Overall Study|Adverse Event|1|||
161874248|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
161874249|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
161874250|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
161874251|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
161874252|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Death|0|||
161874253|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Death|0|||
161874254|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Death|1|||
161874255|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Death|0|||
161874256|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
161874257|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
161874258|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
161874259|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
161874260|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
161874261|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
161874262|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
161874263|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
161874264|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
161874265|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
161874266|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
161874267|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
161874268|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
161874269|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
161874270|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
161874271|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
161874272|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
161874273|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
161874274|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
161874275|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
161874276|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
161990409|NCT01574651|585014352|FG000|Overall Study|Adverse Event|36|||
161990410|NCT01574651|585014353|FG001|Overall Study|Adverse Event|27|||
161990411|NCT01574651|585014352|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161990412|NCT01574651|585014353|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161990413|NCT01574651|585014352|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161990414|NCT01574651|585014353|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161990415|NCT01574651|585014352|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
161990416|NCT01574651|585014353|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161990417|NCT01574651|585014352|FG000|Overall Study|Protocol Violation|3|||
161990418|NCT01574651|585014353|FG001|Overall Study|Protocol Violation|5|||
161990419|NCT01574651|585014352|FG000|Overall Study|Withdrawal by Subject|9|||
161990420|NCT01574651|585014353|FG001|Overall Study|Withdrawal by Subject|10|||
161990421|NCT00965419|585014354|FG000|Open Label Treatment for Responders|Adverse Event|33|||
161990422|NCT00965419|585014354|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
161990423|NCT00965419|585014354|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
161990424|NCT00965419|585014354|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
161990425|NCT00965419|585014354|FG000|Open Label Treatment for Responders|Physician Decision|6|||
161990426|NCT00965419|585014354|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
161990427|NCT00965419|585014354|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
161990428|NCT00965419|585014354|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
161990429|NCT00965419|585014354|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
161874277|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
161990430|NCT00965419|585014354|FG000|Follow-up Phase|Adverse Event|9|||
161990431|NCT00965419|585014354|FG000|Follow-up Phase|Protocol Violation|4|||
161990432|NCT00965419|585014354|FG000|Follow-up Phase|Withdrawal by Subject|8|||
161874278|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
161874279|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
161874280|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161874281|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
161874282|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161874283|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161874284|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
161874285|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
161874286|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
161874287|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
161874288|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
161874289|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
161874290|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
161874291|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
161874292|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Other|8|||
161874293|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Other|14|||
161874294|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Other|8|||
161874295|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Other|23|||
161874296|NCT01106677|584583885|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
161874297|NCT01106677|584583886|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
161874298|NCT01106677|584583887|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
161874299|NCT01106677|584583888|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
161874300|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161874301|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161874302|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
161874303|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
161874304|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Death|0|||
161874305|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Death|0|||
161874306|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Death|0|||
161874307|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Death|1|||
161874308|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
161874309|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
161874310|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
161874311|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
161874312|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161874313|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
161874314|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
161874315|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
161874316|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
161874317|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
161874318|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
161874319|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
161874320|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161874321|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161874322|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161874323|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161874324|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161874325|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
161874326|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
161874327|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161874328|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
161874329|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
161874330|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
161874331|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
161874332|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161874333|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161874334|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161874335|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
161874336|NCT01106677|584583885|FG000|Extension Period: Week 26 to Week 52|Other|6|||
161874337|NCT01106677|584583886|FG001|Extension Period: Week 26 to Week 52|Other|5|||
161874338|NCT01106677|584583887|FG002|Extension Period: Week 26 to Week 52|Other|8|||
161874339|NCT01106677|584583888|FG003|Extension Period: Week 26 to Week 52|Other|5|||
161874340|NCT00972816|584583889|FG000|Overall Study|Adverse Event|0|||
161874341|NCT00972816|584583890|FG001|Overall Study|Adverse Event|0|||
161874342|NCT00972816|584583891|FG002|Overall Study|Adverse Event|1|||
161874343|NCT00972816|584583892|FG003|Overall Study|Adverse Event|0|||
161874344|NCT00972816|584583893|FG004|Overall Study|Adverse Event|0|||
161874345|NCT00972816|584583894|FG005|Overall Study|Adverse Event|0|||
161874346|NCT00972816|584583895|FG006|Overall Study|Adverse Event|0|||
161874347|NCT00972816|584583896|FG007|Overall Study|Adverse Event|0|||
161874348|NCT00972816|584583889|FG000|Overall Study|Withdrawal by Subject|4|||
161874349|NCT00972816|584583890|FG001|Overall Study|Withdrawal by Subject|2|||
161874350|NCT00972816|584583891|FG002|Overall Study|Withdrawal by Subject|1|||
161874351|NCT00972816|584583892|FG003|Overall Study|Withdrawal by Subject|3|||
161874352|NCT00972816|584583893|FG004|Overall Study|Withdrawal by Subject|0|||
161874353|NCT00972816|584583894|FG005|Overall Study|Withdrawal by Subject|1|||
161874354|NCT00972816|584583895|FG006|Overall Study|Withdrawal by Subject|1|||
161874355|NCT00972816|584583896|FG007|Overall Study|Withdrawal by Subject|2|||
161874356|NCT00972816|584583889|FG000|Overall Study|Lost to Follow-up|11|||
161874357|NCT00972816|584583890|FG001|Overall Study|Lost to Follow-up|9|||
161874358|NCT00972816|584583891|FG002|Overall Study|Lost to Follow-up|7|||
161874359|NCT00972816|584583892|FG003|Overall Study|Lost to Follow-up|5|||
161874360|NCT00972816|584583893|FG004|Overall Study|Lost to Follow-up|11|||
161874361|NCT00972816|584583894|FG005|Overall Study|Lost to Follow-up|10|||
161874362|NCT00972816|584583895|FG006|Overall Study|Lost to Follow-up|7|||
161874363|NCT00972816|584583896|FG007|Overall Study|Lost to Follow-up|7|||
161874364|NCT00972816|584583889|FG000|Overall Study|Inappropriate enrolment|0|||
161874365|NCT00972816|584583890|FG001|Overall Study|Inappropriate enrolment|0|||
161874366|NCT00972816|584583891|FG002|Overall Study|Inappropriate enrolment|0|||
161874367|NCT00972816|584583892|FG003|Overall Study|Inappropriate enrolment|0|||
161874368|NCT00972816|584583893|FG004|Overall Study|Inappropriate enrolment|0|||
161874369|NCT00972816|584583894|FG005|Overall Study|Inappropriate enrolment|0|||
161874370|NCT00972816|584583895|FG006|Overall Study|Inappropriate enrolment|2|||
161874371|NCT00972816|584583896|FG007|Overall Study|Inappropriate enrolment|0|||
161874372|NCT00972816|584583889|FG000|Overall Study|Unable to classify|2|||
161874373|NCT00972816|584583890|FG001|Overall Study|Unable to classify|0|||
161874374|NCT00972816|584583891|FG002|Overall Study|Unable to classify|0|||
161874375|NCT00972816|584583892|FG003|Overall Study|Unable to classify|0|||
161874376|NCT00972816|584583893|FG004|Overall Study|Unable to classify|1|||
161874377|NCT00972816|584583894|FG005|Overall Study|Unable to classify|0|||
161874378|NCT00972816|584583895|FG006|Overall Study|Unable to classify|0|||
161874379|NCT00972816|584583896|FG007|Overall Study|Unable to classify|0|||
161874380|NCT03806933|584583897|FG000|Main Period|Physician Decision|0|||
161874381|NCT03806933|584583898|FG001|Main Period|Physician Decision|0|||
161874382|NCT03806933|584583899|FG002|Main Period|Physician Decision|0|||
161874383|NCT03806933|584583900|FG003|Main Period|Physician Decision|1|||
161874384|NCT03806933|584583897|FG000|Main Period|Pregnancy|0|||
161874385|NCT03806933|584583898|FG001|Main Period|Pregnancy|0|||
161874386|NCT03806933|584583899|FG002|Main Period|Pregnancy|1|||
161874387|NCT03806933|584583900|FG003|Main Period|Pregnancy|0|||
161874388|NCT03806933|584583897|FG000|Main Period|Withdrawal by Subject|2|||
161874389|NCT03806933|584583898|FG001|Main Period|Withdrawal by Subject|1|||
161874390|NCT03806933|584583899|FG002|Main Period|Withdrawal by Subject|1|||
161874391|NCT03806933|584583900|FG003|Main Period|Withdrawal by Subject|2|||
161874392|NCT03806933|584583897|FG000|Main Period|Lost to Follow-up|2|||
161874393|NCT03806933|584583898|FG001|Main Period|Lost to Follow-up|2|||
161874394|NCT03806933|584583899|FG002|Main Period|Lost to Follow-up|0|||
161874395|NCT03806933|584583900|FG003|Main Period|Lost to Follow-up|0|||
161874396|NCT03806933|584583897|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
161874397|NCT03806933|584583898|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
161874398|NCT03806933|584583899|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
161874399|NCT03806933|584583900|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
161990433|NCT00965419|585014354|FG000|Follow-up Phase|Physician Decision|4|||
161990434|NCT00965419|585014354|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
161990435|NCT00965419|585014354|FG000|Follow-up Phase|Lack of Efficacy|28|||
161990436|NCT04412707|585014355|FG000|Cycle 1|Death|0|||
161990437|NCT04412707|585014356|FG001|Cycle 1|Death|3|||
161990438|NCT04412707|585014355|FG000|Cycle 1|Disease progression|1|||
161874400|NCT05088603|584583901|FG000|Overall Study|Protocol Violation|6|||
161874401|NCT05088603|584583902|FG001|Overall Study|Protocol Violation|1|||
161990439|NCT04412707|585014356|FG001|Cycle 1|Disease progression|2|||
161990440|NCT04412707|585014355|FG000|Cycle 2|Death|0|||
161874402|NCT00956592|584583907|FG000|Overall Study|Protocol Violation|1|||
161874403|NCT00956592|584583908|FG001|Overall Study|Protocol Violation|3|||
161874404|NCT02162719|584583909|FG000|Overall Study|Death|41|||
161874405|NCT02162719|584583910|FG001|Overall Study|Death|46|||
161874406|NCT02162719|584583909|FG000|Overall Study|Lost to Follow-up|1|||
161990441|NCT04412707|585014356|FG001|Cycle 2|Death|1|||
161874407|NCT02162719|584583910|FG001|Overall Study|Lost to Follow-up|3|||
161874408|NCT02162719|584583909|FG000|Overall Study|Disease Progression|2|||
161874409|NCT02162719|584583910|FG001|Overall Study|Disease Progression|1|||
161874410|NCT02162719|584583909|FG000|Overall Study|Withdrawal by Subject|8|||
161874411|NCT02162719|584583910|FG001|Overall Study|Withdrawal by Subject|2|||
161990442|NCT04412707|585014355|FG000|Cycle 2|Disease progression|3|||
161990443|NCT04412707|585014356|FG001|Cycle 2|Disease progression|0|||
161990444|NCT04412707|585014355|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
161990445|NCT04412707|585014356|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
161990446|NCT04412707|585014355|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
161990447|NCT04412707|585014356|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
161990448|NCT04412707|585014355|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
161990449|NCT04412707|585014356|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
161990450|NCT04412707|585014355|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
161990451|NCT04412707|585014356|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
161990452|NCT00264537|585014357|FG000|Overall Study|Death|0|||
161990453|NCT00264537|585014358|FG001|Overall Study|Death|3|||
161990454|NCT00264537|585014359|FG002|Overall Study|Death|3|||
161990455|NCT00264537|585014360|FG003|Overall Study|Death|2|||
161990456|NCT00264537|585014357|FG000|Overall Study|Lost to Follow-up|3|||
161990457|NCT00264537|585014358|FG001|Overall Study|Lost to Follow-up|4|||
161990458|NCT00264537|585014359|FG002|Overall Study|Lost to Follow-up|7|||
161990459|NCT00264537|585014360|FG003|Overall Study|Lost to Follow-up|6|||
161990460|NCT00264537|585014357|FG000|Overall Study|Adverse Event|21|||
161990461|NCT00264537|585014358|FG001|Overall Study|Adverse Event|32|||
161990462|NCT00264537|585014359|FG002|Overall Study|Adverse Event|24|||
161990463|NCT00264537|585014360|FG003|Overall Study|Adverse Event|34|||
161776121|NCT04930536|584223083|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
161776122|NCT01432600|584223084|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
161776123|NCT01432600|584223085|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
161776124|NCT01432600|584223086|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
161776125|NCT00398632|584223087|FG000|Overall Study|Withdrawal by Subject|1|||
161776126|NCT00398632|584223087|FG000|Overall Study|Lack of Efficacy|1|||
161776127|NCT00267020|584223088|FG000|Overall Study|Adverse Event|22|||
161776128|NCT00267020|584223089|FG001|Overall Study|Adverse Event|5|||
161776129|NCT00267020|584223088|FG000|Overall Study|Death|2|||
161776130|NCT00267020|584223089|FG001|Overall Study|Death|1|||
161776131|NCT00267020|584223088|FG000|Overall Study|Withdrawal by Subject|17|||
161776132|NCT00267020|584223089|FG001|Overall Study|Withdrawal by Subject|7|||
161776133|NCT00267020|584223088|FG000|Overall Study|Physician Decision|3|||
161776134|NCT00267020|584223089|FG001|Overall Study|Physician Decision|2|||
161776135|NCT00267020|584223088|FG000|Overall Study|Disease Progression|39|||
161776136|NCT00267020|584223089|FG001|Overall Study|Disease Progression|25|||
161776137|NCT00267020|584223088|FG000|Overall Study|Unrelated Complication|1|||
161776138|NCT00267020|584223089|FG001|Overall Study|Unrelated Complication|1|||
161776139|NCT00267020|584223088|FG000|Overall Study|Sponsor Request|1|||
161776140|NCT00267020|584223089|FG001|Overall Study|Sponsor Request|0|||
161776141|NCT00267020|584223088|FG000|Overall Study|Other|1|||
161776142|NCT00267020|584223089|FG001|Overall Study|Other|2|||
161776143|NCT04292171|584223093|FG000|Overall Study|Pharmacy error|2|||
161776144|NCT04292171|584223094|FG001|Overall Study|Pharmacy error|0|||
161776145|NCT04292171|584223093|FG000|Overall Study|Delivered prior to procedure|0|||
161776146|NCT04292171|584223094|FG001|Overall Study|Delivered prior to procedure|1|||
161776147|NCT04465916|584223095|FG000|Overall Study|Withdrawal by Subject|0|||
161776148|NCT04465916|584223096|FG001|Overall Study|Withdrawal by Subject|1|||
161776149|NCT04633434|584223100|FG000|Overall Study|Lost to Follow-up|32|||
161776150|NCT04633434|584223101|FG001|Overall Study|Lost to Follow-up|32|||
161776151|NCT00297882|584223105|FG000|Day 14|Lack of Efficacy|12|||
161776152|NCT00297882|584223106|FG001|Day 14|Lack of Efficacy|49|||
161776153|NCT00297882|584223105|FG000|Day 28|Lost to Follow-up|13|||
161776154|NCT00297882|584223106|FG001|Day 28|Lost to Follow-up|23|||
161776155|NCT00297882|584223105|FG000|Day 28|Lack of Efficacy|3|||
161776156|NCT00297882|584223106|FG001|Day 28|Lack of Efficacy|0|||
161776157|NCT04242264|584223107|FG000|Overall Study|Lost to Follow-up|2|||
161776158|NCT04242264|584223108|FG001|Overall Study|Lost to Follow-up|2|||
161776159|NCT04242264|584223109|FG002|Overall Study|Lost to Follow-up|1|||
161776160|NCT04242264|584223110|FG003|Overall Study|Lost to Follow-up|1|||
161776161|NCT04242264|584223107|FG000|Overall Study|Withdrawal by Subject|1|||
161776162|NCT04242264|584223108|FG001|Overall Study|Withdrawal by Subject|0|||
161776163|NCT04242264|584223109|FG002|Overall Study|Withdrawal by Subject|0|||
161776164|NCT04242264|584223110|FG003|Overall Study|Withdrawal by Subject|0|||
161776165|NCT04221373|584223111|FG000|Overall Study|Physician Decision|4|||
161776166|NCT04221373|584223112|FG001|Overall Study|Physician Decision|0|||
161776167|NCT04139642|584223122|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
161776168|NCT04139642|584223123|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
161776169|NCT00577031|584223129|FG000|Overall Study|Adverse Event|52|||
161776170|NCT00577031|584223129|FG000|Overall Study|Progression of disease|93|||
161776171|NCT00577031|584223129|FG000|Overall Study|Protocol Violation|5|||
161776172|NCT00577031|584223129|FG000|Overall Study|Participant withdrew consent|13|||
161776173|NCT00577031|584223129|FG000|Overall Study|Participant non-compliance|5|||
161776174|NCT00577031|584223129|FG000|Overall Study|Need for surgery|17|||
161776175|NCT00577031|584223129|FG000|Overall Study|Medical decision|14|||
161990464|NCT00264537|585014357|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
161874412|NCT02162719|584583909|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
161874413|NCT02162719|584583910|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
161874414|NCT03555565|584583912|FG000|Overall Study|Case Report Forms Uncollected|2|||
161874415|NCT03555565|584583912|FG000|Overall Study|Protocol Deviation|13|||
161874416|NCT03854370|584583915|FG000|Overall Study|samples not collected|1|||
161874417|NCT03854370|584583916|FG001|Overall Study|samples not collected|1|||
161874418|NCT03854370|584583917|FG002|Overall Study|samples not collected|1|||
161874419|NCT03854370|584583918|FG003|Overall Study|samples not collected|1|||
161874420|NCT02656290|584583921|FG000|Overall Study|Lost to Follow-up|1|||
161874421|NCT02656290|584583921|FG000|Overall Study|Reintervention|3|||
161874422|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
161874423|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
161874424|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
161874425|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
161874426|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
161874427|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
161874428|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
161874429|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
161874430|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Death|0|||
161874431|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Death|1|||
161874432|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
161874433|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
161874434|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
161874435|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
161874436|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
161874437|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
161874438|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
161874439|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
161874440|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
161874441|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
161874442|NCT00394836|584583922|FG000|Teatment or Follow-up Phase|Non compliance|0|||
161874443|NCT00394836|584583923|FG001|Teatment or Follow-up Phase|Non compliance|1|||
161874444|NCT00394836|584583922|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
161874445|NCT00394836|584583923|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
161874446|NCT00394836|584583922|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
161874447|NCT00394836|584583923|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
161874448|NCT00394836|584583922|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
161874449|NCT00394836|584583923|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
161874450|NCT00394836|584583922|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
161874451|NCT00394836|584583923|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
161874452|NCT03692325|584583924|FG000|Overall Study|Adverse Event|2|||
161874453|NCT03692325|584583924|FG000|Overall Study|Progression/Recurrence|2|||
161874454|NCT02817516|584583925|FG000|Overall Study|Other|0|||
161874455|NCT02817516|584583926|FG001|Overall Study|Other|0|||
161874456|NCT02817516|584583927|FG002|Overall Study|Other|1|||
161874457|NCT02817516|584583928|FG003|Overall Study|Other|0|||
161874458|NCT00610155|584583932|FG000|Period 1|Withdrawal by Subject|0|||
161874459|NCT00610155|584583933|FG001|Period 1|Withdrawal by Subject|0|||
161874460|NCT00610155|584583934|FG002|Period 1|Withdrawal by Subject|1|||
161874461|NCT00610155|584583935|FG003|Period 1|Withdrawal by Subject|0|||
161874462|NCT00610155|584583936|FG004|Period 1|Withdrawal by Subject|0|||
161874463|NCT00610155|584583937|FG005|Period 1|Withdrawal by Subject|0|||
161874464|NCT00610155|584583932|FG000|Period 3|Adverse Event|1|||
161874465|NCT00610155|584583933|FG001|Period 3|Adverse Event|0|||
161874466|NCT00610155|584583934|FG002|Period 3|Adverse Event|0|||
161874467|NCT00610155|584583935|FG003|Period 3|Adverse Event|0|||
161874468|NCT00610155|584583936|FG004|Period 3|Adverse Event|0|||
161874469|NCT00610155|584583937|FG005|Period 3|Adverse Event|0|||
161874470|NCT01560234|584583938|FG000|Overall Study|Lost to Follow-up|3|||
161874471|NCT01560234|584583939|FG001|Overall Study|Lost to Follow-up|0|||
161874472|NCT01560234|584583940|FG002|Overall Study|Lost to Follow-up|1|||
161874473|NCT01560234|584583941|FG003|Overall Study|Lost to Follow-up|0|||
161874474|NCT01560234|584583942|FG004|Overall Study|Lost to Follow-up|0|||
161874475|NCT01560234|584583943|FG005|Overall Study|Lost to Follow-up|2|||
161874476|NCT01560234|584583944|FG006|Overall Study|Lost to Follow-up|0|||
161874477|NCT01560234|584583945|FG007|Overall Study|Lost to Follow-up|2|||
161874478|NCT00083759|584583949|FG000|Overall Study|Adverse Event|5|||
161874479|NCT00083759|584583950|FG001|Overall Study|Adverse Event|3|||
161874480|NCT00083759|584583949|FG000|Overall Study|Lost to Follow-up|1|||
161990465|NCT00264537|585014358|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
161990466|NCT00264537|585014359|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
161874481|NCT00083759|584583950|FG001|Overall Study|Lost to Follow-up|0|||
161874482|NCT00083759|584583949|FG000|Overall Study|Death|1|||
161874483|NCT00083759|584583950|FG001|Overall Study|Death|1|||
161874484|NCT00083759|584583949|FG000|Overall Study|Inadequate Therapeutic Response|32|||
161874485|NCT00083759|584583950|FG001|Overall Study|Inadequate Therapeutic Response|35|||
161874486|NCT00083759|584583949|FG000|Overall Study|Subject Withdrew Consent|2|||
161874487|NCT00083759|584583950|FG001|Overall Study|Subject Withdrew Consent|2|||
161874488|NCT00083759|584583949|FG000|Overall Study|Non-Compliance|1|||
161874489|NCT00083759|584583950|FG001|Overall Study|Non-Compliance|0|||
161874490|NCT00083759|584583949|FG000|Overall Study|Sponsor's Discretion|28|||
161874491|NCT00083759|584583950|FG001|Overall Study|Sponsor's Discretion|29|||
161874492|NCT00083759|584583949|FG000|Overall Study|Other|14|||
161874493|NCT00083759|584583950|FG001|Overall Study|Other|13|||
161874494|NCT04292912|584583955|FG000|Overall Study|Physician Decision|1|||
161874495|NCT04292912|584583955|FG000|Overall Study|Protocol Violation|6|||
161874496|NCT03348930|584583956|FG000|Washout (1 Week)|Lost to Follow-up|1|||
161874497|NCT03348930|584583957|FG001|Washout (1 Week)|Lost to Follow-up|1|||
161874498|NCT01290679|584583965|FG000|Overall Study|Adverse Event|2|||
161874499|NCT01290679|584583966|FG001|Overall Study|Adverse Event|0|||
161874500|NCT01290679|584583965|FG000|Overall Study|Lost to Follow-up|8|||
161874501|NCT01290679|584583966|FG001|Overall Study|Lost to Follow-up|10|||
161874502|NCT01290679|584583965|FG000|Overall Study|Protocol Violation|0|||
161874503|NCT01290679|584583966|FG001|Overall Study|Protocol Violation|1|||
161874504|NCT01290679|584583965|FG000|Overall Study|Withdrawal by Subject|6|||
161874505|NCT01290679|584583966|FG001|Overall Study|Withdrawal by Subject|5|||
161874506|NCT01290679|584583965|FG000|Overall Study|Subject Entered Another Trial|0|||
161874507|NCT01290679|584583966|FG001|Overall Study|Subject Entered Another Trial|5|||
161874508|NCT01598090|584583967|FG000|Treatment Period|Poor/non-compliance|0|||
161874509|NCT01598090|584583968|FG001|Treatment Period|Poor/non-compliance|2|||
161874510|NCT01598090|584583969|FG002|Treatment Period|Poor/non-compliance|0|||
161874511|NCT01598090|584583967|FG000|Treatment Period|No longer meet study criteria|0|||
161874512|NCT01598090|584583968|FG001|Treatment Period|No longer meet study criteria|1|||
161874513|NCT01598090|584583969|FG002|Treatment Period|No longer meet study criteria|0|||
161874514|NCT01598090|584583967|FG000|Treatment Period|Lack of Efficacy|5|||
161874515|NCT01598090|584583968|FG001|Treatment Period|Lack of Efficacy|14|||
161874516|NCT01598090|584583969|FG002|Treatment Period|Lack of Efficacy|6|||
161874517|NCT01598090|584583967|FG000|Treatment Period|Adverse Event|2|||
161874518|NCT01598090|584583968|FG001|Treatment Period|Adverse Event|33|||
161874519|NCT01598090|584583969|FG002|Treatment Period|Adverse Event|17|||
161874520|NCT01598090|584583967|FG000|Treatment Period|Other reasons|0|||
161874521|NCT01598090|584583968|FG001|Treatment Period|Other reasons|4|||
161874522|NCT01598090|584583969|FG002|Treatment Period|Other reasons|1|||
161874523|NCT01598090|584583967|FG000|Treatment Period|Withdrawal by Subject|3|||
161874524|NCT01598090|584583968|FG001|Treatment Period|Withdrawal by Subject|13|||
161874525|NCT01598090|584583969|FG002|Treatment Period|Withdrawal by Subject|10|||
161874526|NCT01598090|584583967|FG000|Treatment Period|Lost to Follow-up|1|||
161874527|NCT01598090|584583968|FG001|Treatment Period|Lost to Follow-up|5|||
161874528|NCT01598090|584583969|FG002|Treatment Period|Lost to Follow-up|1|||
161874529|NCT01598090|584583967|FG000|Follow-up Period|Death|0|||
161874530|NCT01598090|584583968|FG001|Follow-up Period|Death|1|||
161874531|NCT01598090|584583969|FG002|Follow-up Period|Death|0|||
161874532|NCT01598090|584583967|FG000|Follow-up Period|No longer required per protocol|1|||
161874533|NCT01598090|584583968|FG001|Follow-up Period|No longer required per protocol|3|||
161874534|NCT01598090|584583969|FG002|Follow-up Period|No longer required per protocol|2|||
161874535|NCT01598090|584583967|FG000|Follow-up Period|Not reported|0|||
161874536|NCT01598090|584583968|FG001|Follow-up Period|Not reported|10|||
161874537|NCT01598090|584583969|FG002|Follow-up Period|Not reported|4|||
161874538|NCT01598090|584583967|FG000|Follow-up Period|Withdrawal by Subject|0|||
161874539|NCT01598090|584583968|FG001|Follow-up Period|Withdrawal by Subject|3|||
161874540|NCT01598090|584583969|FG002|Follow-up Period|Withdrawal by Subject|2|||
161874541|NCT01598090|584583967|FG000|Follow-up Period|Other reasons|2|||
161874542|NCT01598090|584583968|FG001|Follow-up Period|Other reasons|8|||
161874543|NCT01598090|584583969|FG002|Follow-up Period|Other reasons|8|||
161874544|NCT01598090|584583967|FG000|Follow-up Period|Lost to Follow-up|2|||
161874545|NCT01598090|584583968|FG001|Follow-up Period|Lost to Follow-up|10|||
161874546|NCT01598090|584583969|FG002|Follow-up Period|Lost to Follow-up|12|||
161874547|NCT00355147|584583974|FG000|Overall Study|Lost to Follow-up|10|||
161874548|NCT00355147|584583975|FG001|Overall Study|Lost to Follow-up|8|||
161874549|NCT00355147|584583974|FG000|Overall Study|Withdrawal by Subject|8|||
161874550|NCT00355147|584583975|FG001|Overall Study|Withdrawal by Subject|12|||
161874551|NCT03557931|584583982|FG000|Overall Study|Adverse Event|4|||
161874552|NCT03557931|584583983|FG001|Overall Study|Adverse Event|6|||
161874553|NCT03557931|584583984|FG002|Overall Study|Adverse Event|1|||
161874554|NCT03557931|584583982|FG000|Overall Study|Lost to Follow-up|4|||
161874555|NCT03557931|584583983|FG001|Overall Study|Lost to Follow-up|4|||
161874556|NCT03557931|584583984|FG002|Overall Study|Lost to Follow-up|1|||
161874557|NCT03557931|584583982|FG000|Overall Study|Protocol Violation|1|||
161874558|NCT03557931|584583983|FG001|Overall Study|Protocol Violation|4|||
161874559|NCT03557931|584583984|FG002|Overall Study|Protocol Violation|1|||
161874560|NCT03557931|584583982|FG000|Overall Study|Withdrawal by Subject|14|||
161874561|NCT03557931|584583983|FG001|Overall Study|Withdrawal by Subject|0|||
161990467|NCT00264537|585014360|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
161990468|NCT00264537|585014357|FG000|Overall Study|Other|21|||
161990469|NCT00264537|585014358|FG001|Overall Study|Other|11|||
161990470|NCT00264537|585014359|FG002|Overall Study|Other|10|||
161990471|NCT00264537|585014360|FG003|Overall Study|Other|11|||
161990472|NCT00264537|585014357|FG000|Overall Study|Not treated|0|||
161874562|NCT03557931|584583984|FG002|Overall Study|Withdrawal by Subject|7|||
161874563|NCT03557931|584583982|FG000|Overall Study|Miscellaneous|8|||
161874564|NCT03557931|584583983|FG001|Overall Study|Miscellaneous|5|||
161874565|NCT03557931|584583984|FG002|Overall Study|Miscellaneous|3|||
161874566|NCT02394340|584583987|FG000|Overall Study|Failed drug screen test|1|||
161874567|NCT02394340|584583987|FG000|Overall Study|Adverse Event|1|||
161874568|NCT03605862|584583988|FG000|Overall Study|Withdrawal by Subject|12|||
161874569|NCT03605862|584583989|FG001|Overall Study|Withdrawal by Subject|9|||
161874570|NCT03605862|584583988|FG000|Overall Study|Adverse Event|2|||
161874571|NCT03605862|584583989|FG001|Overall Study|Adverse Event|1|||
161874572|NCT03605862|584583988|FG000|Overall Study|Physician Decision|3|||
161874573|NCT03605862|584583989|FG001|Overall Study|Physician Decision|1|||
161874574|NCT03605862|584583988|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
161874575|NCT03605862|584583989|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
161874576|NCT00675428|584583992|FG000|Overall Study|Disease Progression|2|||
161874577|NCT00675428|584583993|FG001|Overall Study|Disease Progression|2|||
161874578|NCT00675428|584583992|FG000|Overall Study|No Disease Response After Cycle 6|0|||
161874579|NCT00675428|584583993|FG001|Overall Study|No Disease Response After Cycle 6|1|||
161874580|NCT00675428|584583992|FG000|Overall Study|Physician Decision|1|||
161874581|NCT00675428|584583993|FG001|Overall Study|Physician Decision|0|||
161874582|NCT00886743|584583995|FG000|Overall Study|Adverse Event|3|||
161874583|NCT00886743|584583995|FG000|Overall Study|Other|1|||
161874584|NCT00478777|584583996|FG000|Overall Study|Adverse Event|29|||
161874585|NCT00478777|584583996|FG000|Overall Study|Lack of Efficacy|23|||
161874586|NCT00478777|584583996|FG000|Overall Study|Withdrawal by Subject|4|||
161874587|NCT00478777|584583996|FG000|Overall Study|Death|3|||
161874588|NCT00478777|584583996|FG000|Overall Study|Protocol Violation|3|||
161874589|NCT00478777|584583996|FG000|Overall Study|Lost to Follow-up|3|||
161874590|NCT00478777|584583996|FG000|Overall Study|Physician Decision|1|||
161874591|NCT00478777|584583996|FG000|Overall Study|Intolerance of therapy|1|||
161874592|NCT00478777|584583996|FG000|Overall Study|Lack of compliance|1|||
161874593|NCT00478777|584583996|FG000|Overall Study|Lymphocytes infusion|1|||
161874594|NCT00478777|584583996|FG000|Overall Study|End of therapy|2|||
161874595|NCT00478777|584583996|FG000|Overall Study|Not treated with lenalidomide|6|||
161874596|NCT01582178|584583999|FG000|Overall Study|Physician Decision|6|||
161874597|NCT01582178|584584000|FG001|Overall Study|Physician Decision|5|||
161874598|NCT01323387|584584001|FG000|Overall Study|Withdrawal by Subject|41|||
161874599|NCT01323387|584584001|FG000|Overall Study|Radiographic Data Unavailable|1|||
161874600|NCT01323387|584584001|FG000|Overall Study|Revision|14|||
161874601|NCT01323387|584584001|FG000|Overall Study|Protocol Violation|12|||
161874602|NCT01323387|584584001|FG000|Overall Study|Randomized but Never Treated|16|||
161874603|NCT01726270|584584002|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
161874604|NCT01726270|584584002|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
161874605|NCT01726270|584584002|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
161874606|NCT01726270|584584002|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
161874607|NCT01726270|584584002|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
161874608|NCT01726270|584584002|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
161874609|NCT02157376|584584005|FG000|Overall Study|Death|10|||
161874610|NCT02157376|584584006|FG001|Overall Study|Death|4|||
161874611|NCT02157376|584584005|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161874612|NCT02157376|584584006|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161874613|NCT02157376|584584005|FG000|Overall Study|Withdrawal by Subject|3|||
161990473|NCT00264537|585014358|FG001|Overall Study|Not treated|2|||
161776176|NCT00577031|584223129|FG000|Overall Study|Death|6|||
161776177|NCT00557830|584223130|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
161776178|NCT00557830|584223131|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
161776179|NCT00557830|584223132|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
161776180|NCT00557830|584223130|FG000|Screening Treatment Phase|Adverse Event|2|||
161776181|NCT00557830|584223131|FG001|Screening Treatment Phase|Adverse Event|0|||
161776182|NCT00557830|584223132|FG002|Screening Treatment Phase|Adverse Event|0|||
161776183|NCT00557830|584223130|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
161776184|NCT00557830|584223131|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
161776185|NCT00557830|584223132|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
161776186|NCT00538473|584223134|FG000|Overall Study|Adverse Event|1|||
161776187|NCT00538473|584223135|FG001|Overall Study|Adverse Event|0|||
161776188|NCT01569074|584223136|FG000|Overall Study|Study stopped|6|||
161776189|NCT01569074|584223137|FG001|Overall Study|Study stopped|6|||
161776190|NCT01569074|584223138|FG002|Overall Study|Study stopped|8|||
161776191|NCT01569074|584223139|FG003|Overall Study|Study stopped|7|||
161874614|NCT02157376|584584006|FG001|Overall Study|Withdrawal by Subject|8|||
161874615|NCT02157376|584584005|FG000|Overall Study|Not treated|8|||
161874616|NCT02157376|584584006|FG001|Overall Study|Not treated|3|||
161874617|NCT02157376|584584005|FG000|Overall Study|Investigator's misjudgement|1|||
161874618|NCT02157376|584584006|FG001|Overall Study|Investigator's misjudgement|2|||
161874619|NCT04200651|584584007|FG000|Overall Study|Moved to another country during follow-up|2|||
161874620|NCT04200651|584584008|FG001|Overall Study|Moved to another country during follow-up|2|||
161874621|NCT04200651|584584007|FG000|Overall Study|Lost to Follow-up|1|||
161874622|NCT04200651|584584008|FG001|Overall Study|Lost to Follow-up|3|||
161874623|NCT01031680|584584009|FG000|Overall Study|Adverse Event|8|||
161874624|NCT01031680|584584010|FG001|Overall Study|Adverse Event|3|||
161874625|NCT01031680|584584009|FG000|Overall Study|Lost to Follow-up|2|||
161874626|NCT01031680|584584010|FG001|Overall Study|Lost to Follow-up|10|||
161874627|NCT01031680|584584009|FG000|Overall Study|Withdrawal by Subject|12|||
161874628|NCT01031680|584584010|FG001|Overall Study|Withdrawal by Subject|16|||
161874629|NCT01031680|584584009|FG000|Overall Study|Death|2|||
161874630|NCT01031680|584584010|FG001|Overall Study|Death|1|||
161874631|NCT01031680|584584009|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
161874632|NCT01031680|584584010|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
161874633|NCT01031680|584584009|FG000|Overall Study|Poor/Non-compliance|5|||
161874634|NCT01031680|584584010|FG001|Overall Study|Poor/Non-compliance|6|||
161874635|NCT01031680|584584009|FG000|Overall Study|Safety|1|||
161874636|NCT01031680|584584010|FG001|Overall Study|Safety|0|||
161874637|NCT01031680|584584009|FG000|Overall Study|Incorrect Enrolment|1|||
161874638|NCT01031680|584584010|FG001|Overall Study|Incorrect Enrolment|2|||
161874639|NCT01031680|584584009|FG000|Overall Study|Administrative Reason by Sponsor|0|||
161874640|NCT01031680|584584010|FG001|Overall Study|Administrative Reason by Sponsor|1|||
161874641|NCT01031680|584584009|FG000|Overall Study|Various|0|||
161874642|NCT01031680|584584010|FG001|Overall Study|Various|2|||
161874643|NCT01186692|584584017|FG000|Overall Study|Not Catheterized|11|||
161874644|NCT01186692|584584017|FG000|Overall Study|Futher testing contraindicated implant|19|||
161874645|NCT01186692|584584017|FG000|Overall Study|Adverse Event|2|||
161874646|NCT03319732|584584018|FG000|Overall Study|Adverse Event|40|||
161874647|NCT03319732|584584018|FG000|Overall Study|Withdrawal by Subject|50|||
161874648|NCT03319732|584584018|FG000|Overall Study|MS relapse|10|||
161874649|NCT03319732|584584018|FG000|Overall Study|reason not specified|5|||
161874650|NCT01921101|584584020|FG000|Overall Study|Death|16|||
161874651|NCT01921101|584584021|FG001|Overall Study|Death|6|||
161874652|NCT00596817|584584023|FG000|Open-label Period|Adverse Event|0|||
161874653|NCT00596817|584584024|FG001|Open-label Period|Adverse Event|49|||
161874654|NCT00596817|584584023|FG000|Open-label Period|Lack of Efficacy|0|||
161874655|NCT00596817|584584024|FG001|Open-label Period|Lack of Efficacy|33|||
161874656|NCT00596817|584584023|FG000|Open-label Period|Other Reasons|0|||
161874657|NCT00596817|584584024|FG001|Open-label Period|Other Reasons|65|||
161874658|NCT00596817|584584023|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
161874659|NCT00596817|584584024|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
161874660|NCT00596817|584584023|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
161874661|NCT00596817|584584024|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
161874662|NCT00596817|584584023|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
161874663|NCT00596817|584584024|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
161874664|NCT00596817|584584023|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
161874665|NCT00596817|584584024|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
161874666|NCT00596817|584584023|FG000|Double-blind Period|Adverse Event|5|||
161874667|NCT00596817|584584024|FG001|Double-blind Period|Adverse Event|16|||
161874668|NCT00596817|584584023|FG000|Double-blind Period|Lack of Efficacy|52|||
161874669|NCT00596817|584584024|FG001|Double-blind Period|Lack of Efficacy|28|||
161874670|NCT00596817|584584023|FG000|Double-blind Period|Non-compliance With Study Product|3|||
161874671|NCT00596817|584584024|FG001|Double-blind Period|Non-compliance With Study Product|4|||
161874672|NCT00596817|584584023|FG000|Double-blind Period|Protocol Violation|11|||
161874673|NCT00596817|584584024|FG001|Double-blind Period|Protocol Violation|8|||
161874674|NCT00596817|584584023|FG000|Double-blind Period|Withdrawal of Consent|7|||
161874675|NCT00596817|584584024|FG001|Double-blind Period|Withdrawal of Consent|3|||
161874676|NCT00596817|584584023|FG000|Double-blind Period|Lost to Follow-up|0|||
161874677|NCT00596817|584584024|FG001|Double-blind Period|Lost to Follow-up|2|||
161874678|NCT00596817|584584023|FG000|Double-blind Period|Other Reasons|10|||
161874679|NCT00596817|584584024|FG001|Double-blind Period|Other Reasons|18|||
161874680|NCT01314872|584584030|FG000|Treatment Period 1|Protocol Violation|2|||
161874681|NCT01314872|584584031|FG001|Treatment Period 1|Protocol Violation|1|||
161874682|NCT01314872|584584032|FG002|Treatment Period 1|Protocol Violation|1|||
161874683|NCT01314872|584584033|FG003|Treatment Period 1|Protocol Violation|0|||
161874684|NCT01314872|584584034|FG004|Treatment Period 1|Protocol Violation|1|||
161990474|NCT00264537|585014359|FG002|Overall Study|Not treated|1|||
161874685|NCT01314872|584584035|FG005|Treatment Period 1|Protocol Violation|0|||
161874686|NCT01314872|584584036|FG006|Treatment Period 1|Protocol Violation|0|||
161874687|NCT01314872|584584037|FG007|Treatment Period 1|Protocol Violation|0|||
161874688|NCT01314872|584584038|FG008|Treatment Period 1|Protocol Violation|0|||
161874689|NCT01314872|584584039|FG009|Treatment Period 1|Protocol Violation|1|||
161874690|NCT01314872|584584040|FG010|Treatment Period 1|Protocol Violation|1|||
161874691|NCT01314872|584584041|FG011|Treatment Period 1|Protocol Violation|0|||
161874692|NCT01314872|584584042|FG012|Treatment Period 1|Protocol Violation|0|||
161874693|NCT01314872|584584043|FG013|Treatment Period 1|Protocol Violation|0|||
161874694|NCT01314872|584584044|FG014|Treatment Period 1|Protocol Violation|0|||
161874695|NCT01314872|584584030|FG000|Treatment Period 1|Physician Decision|0|||
161874696|NCT01314872|584584031|FG001|Treatment Period 1|Physician Decision|1|||
161874697|NCT01314872|584584032|FG002|Treatment Period 1|Physician Decision|0|||
161874698|NCT01314872|584584033|FG003|Treatment Period 1|Physician Decision|1|||
161874699|NCT01314872|584584034|FG004|Treatment Period 1|Physician Decision|0|||
161874700|NCT01314872|584584035|FG005|Treatment Period 1|Physician Decision|0|||
161874701|NCT01314872|584584036|FG006|Treatment Period 1|Physician Decision|0|||
161874702|NCT01314872|584584037|FG007|Treatment Period 1|Physician Decision|0|||
161874703|NCT01314872|584584038|FG008|Treatment Period 1|Physician Decision|0|||
161874704|NCT01314872|584584039|FG009|Treatment Period 1|Physician Decision|1|||
161874705|NCT01314872|584584040|FG010|Treatment Period 1|Physician Decision|0|||
161874706|NCT01314872|584584041|FG011|Treatment Period 1|Physician Decision|0|||
161874707|NCT01314872|584584042|FG012|Treatment Period 1|Physician Decision|0|||
161874708|NCT01314872|584584043|FG013|Treatment Period 1|Physician Decision|0|||
161874709|NCT01314872|584584044|FG014|Treatment Period 1|Physician Decision|0|||
161874710|NCT01314872|584584030|FG000|Treatment Period 1|Lack of Efficacy|1|||
161874711|NCT01314872|584584031|FG001|Treatment Period 1|Lack of Efficacy|0|||
161874712|NCT01314872|584584032|FG002|Treatment Period 1|Lack of Efficacy|0|||
161874713|NCT01314872|584584033|FG003|Treatment Period 1|Lack of Efficacy|0|||
161874714|NCT01314872|584584034|FG004|Treatment Period 1|Lack of Efficacy|0|||
161874715|NCT01314872|584584035|FG005|Treatment Period 1|Lack of Efficacy|1|||
161874716|NCT01314872|584584036|FG006|Treatment Period 1|Lack of Efficacy|0|||
161874717|NCT01314872|584584037|FG007|Treatment Period 1|Lack of Efficacy|2|||
161874718|NCT01314872|584584038|FG008|Treatment Period 1|Lack of Efficacy|0|||
161874719|NCT01314872|584584039|FG009|Treatment Period 1|Lack of Efficacy|0|||
161874720|NCT01314872|584584040|FG010|Treatment Period 1|Lack of Efficacy|0|||
161874721|NCT01314872|584584041|FG011|Treatment Period 1|Lack of Efficacy|0|||
161874722|NCT01314872|584584042|FG012|Treatment Period 1|Lack of Efficacy|0|||
161874723|NCT01314872|584584043|FG013|Treatment Period 1|Lack of Efficacy|0|||
161874724|NCT01314872|584584044|FG014|Treatment Period 1|Lack of Efficacy|0|||
161874725|NCT01314872|584584030|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
161874726|NCT01314872|584584031|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
161874727|NCT01314872|584584032|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
161874728|NCT01314872|584584033|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
161874729|NCT01314872|584584034|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
161874730|NCT01314872|584584035|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
161874731|NCT01314872|584584036|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
161874732|NCT01314872|584584037|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
161874733|NCT01314872|584584038|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
161874734|NCT01314872|584584039|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
161874735|NCT01314872|584584040|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
161874736|NCT01314872|584584041|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
161874737|NCT01314872|584584042|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
161874738|NCT01314872|584584043|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
161874739|NCT01314872|584584044|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
161874740|NCT01314872|584584030|FG000|Treatment Period 1|Withdrawal by Subject|3|||
161874741|NCT01314872|584584031|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161874742|NCT01314872|584584032|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161874743|NCT01314872|584584033|FG003|Treatment Period 1|Withdrawal by Subject|2|||
161874744|NCT01314872|584584034|FG004|Treatment Period 1|Withdrawal by Subject|3|||
161874745|NCT01314872|584584035|FG005|Treatment Period 1|Withdrawal by Subject|1|||
161874746|NCT01314872|584584036|FG006|Treatment Period 1|Withdrawal by Subject|3|||
161874747|NCT01314872|584584037|FG007|Treatment Period 1|Withdrawal by Subject|2|||
161874748|NCT01314872|584584038|FG008|Treatment Period 1|Withdrawal by Subject|2|||
161874749|NCT01314872|584584039|FG009|Treatment Period 1|Withdrawal by Subject|2|||
161874750|NCT01314872|584584040|FG010|Treatment Period 1|Withdrawal by Subject|1|||
161874751|NCT01314872|584584041|FG011|Treatment Period 1|Withdrawal by Subject|0|||
161874752|NCT01314872|584584042|FG012|Treatment Period 1|Withdrawal by Subject|0|||
161874753|NCT01314872|584584043|FG013|Treatment Period 1|Withdrawal by Subject|0|||
161874754|NCT01314872|584584044|FG014|Treatment Period 1|Withdrawal by Subject|0|||
161874755|NCT01314872|584584030|FG000|Treatment Period 1|Lost to Follow-up|0|||
161874756|NCT01314872|584584031|FG001|Treatment Period 1|Lost to Follow-up|1|||
161874757|NCT01314872|584584032|FG002|Treatment Period 1|Lost to Follow-up|2|||
161874758|NCT01314872|584584033|FG003|Treatment Period 1|Lost to Follow-up|2|||
161874759|NCT01314872|584584034|FG004|Treatment Period 1|Lost to Follow-up|1|||
161874760|NCT01314872|584584035|FG005|Treatment Period 1|Lost to Follow-up|1|||
161874761|NCT01314872|584584036|FG006|Treatment Period 1|Lost to Follow-up|1|||
161990475|NCT00264537|585014360|FG003|Overall Study|Not treated|0|||
161874762|NCT01314872|584584037|FG007|Treatment Period 1|Lost to Follow-up|1|||
161874763|NCT01314872|584584038|FG008|Treatment Period 1|Lost to Follow-up|1|||
161874764|NCT01314872|584584039|FG009|Treatment Period 1|Lost to Follow-up|0|||
161874765|NCT01314872|584584040|FG010|Treatment Period 1|Lost to Follow-up|0|||
161874766|NCT01314872|584584041|FG011|Treatment Period 1|Lost to Follow-up|0|||
161874767|NCT01314872|584584042|FG012|Treatment Period 1|Lost to Follow-up|0|||
161874768|NCT01314872|584584043|FG013|Treatment Period 1|Lost to Follow-up|0|||
161874769|NCT01314872|584584044|FG014|Treatment Period 1|Lost to Follow-up|0|||
161874770|NCT01314872|584584030|FG000|Period 2|Protocol Violation|0|||
161874771|NCT01314872|584584031|FG001|Period 2|Protocol Violation|0|||
161874772|NCT01314872|584584032|FG002|Period 2|Protocol Violation|0|||
161874773|NCT01314872|584584033|FG003|Period 2|Protocol Violation|0|||
161874774|NCT01314872|584584034|FG004|Period 2|Protocol Violation|0|||
161874775|NCT01314872|584584035|FG005|Period 2|Protocol Violation|0|||
161874776|NCT01314872|584584036|FG006|Period 2|Protocol Violation|0|||
161874777|NCT01314872|584584037|FG007|Period 2|Protocol Violation|0|||
161874778|NCT01314872|584584038|FG008|Period 2|Protocol Violation|0|||
161874779|NCT01314872|584584039|FG009|Period 2|Protocol Violation|0|||
161874780|NCT01314872|584584040|FG010|Period 2|Protocol Violation|0|||
161874781|NCT01314872|584584041|FG011|Period 2|Protocol Violation|3|||
161874782|NCT01314872|584584042|FG012|Period 2|Protocol Violation|3|||
161874783|NCT01314872|584584043|FG013|Period 2|Protocol Violation|2|||
161874784|NCT01314872|584584044|FG014|Period 2|Protocol Violation|0|||
161874785|NCT01314872|584584030|FG000|Period 2|Non-compliance with study drug|0|||
161874786|NCT01314872|584584031|FG001|Period 2|Non-compliance with study drug|0|||
161874787|NCT01314872|584584032|FG002|Period 2|Non-compliance with study drug|0|||
161874788|NCT01314872|584584033|FG003|Period 2|Non-compliance with study drug|0|||
161874789|NCT01314872|584584034|FG004|Period 2|Non-compliance with study drug|0|||
161874790|NCT01314872|584584035|FG005|Period 2|Non-compliance with study drug|0|||
161874791|NCT01314872|584584036|FG006|Period 2|Non-compliance with study drug|0|||
161874792|NCT01314872|584584037|FG007|Period 2|Non-compliance with study drug|0|||
161874793|NCT01314872|584584038|FG008|Period 2|Non-compliance with study drug|0|||
161874794|NCT01314872|584584039|FG009|Period 2|Non-compliance with study drug|0|||
161874795|NCT01314872|584584040|FG010|Period 2|Non-compliance with study drug|0|||
161874796|NCT01314872|584584041|FG011|Period 2|Non-compliance with study drug|3|||
161874797|NCT01314872|584584042|FG012|Period 2|Non-compliance with study drug|3|||
161874798|NCT01314872|584584043|FG013|Period 2|Non-compliance with study drug|1|||
161874799|NCT01314872|584584044|FG014|Period 2|Non-compliance with study drug|2|||
161874800|NCT01314872|584584030|FG000|Period 2|Lack of Efficacy|0|||
161874801|NCT01314872|584584031|FG001|Period 2|Lack of Efficacy|0|||
161874802|NCT01314872|584584032|FG002|Period 2|Lack of Efficacy|0|||
161874803|NCT01314872|584584033|FG003|Period 2|Lack of Efficacy|0|||
161874804|NCT01314872|584584034|FG004|Period 2|Lack of Efficacy|0|||
161874805|NCT01314872|584584035|FG005|Period 2|Lack of Efficacy|0|||
161874806|NCT01314872|584584036|FG006|Period 2|Lack of Efficacy|0|||
161874807|NCT01314872|584584037|FG007|Period 2|Lack of Efficacy|0|||
161874808|NCT01314872|584584038|FG008|Period 2|Lack of Efficacy|0|||
161874809|NCT01314872|584584039|FG009|Period 2|Lack of Efficacy|0|||
161874810|NCT01314872|584584040|FG010|Period 2|Lack of Efficacy|0|||
161874811|NCT01314872|584584041|FG011|Period 2|Lack of Efficacy|7|||
161874812|NCT01314872|584584042|FG012|Period 2|Lack of Efficacy|12|||
161874813|NCT01314872|584584043|FG013|Period 2|Lack of Efficacy|9|||
161874814|NCT01314872|584584044|FG014|Period 2|Lack of Efficacy|2|||
161874815|NCT01314872|584584030|FG000|Period 2|Pregnancy|0|||
161874816|NCT01314872|584584031|FG001|Period 2|Pregnancy|0|||
161874817|NCT01314872|584584032|FG002|Period 2|Pregnancy|0|||
161874818|NCT01314872|584584033|FG003|Period 2|Pregnancy|0|||
161874819|NCT01314872|584584034|FG004|Period 2|Pregnancy|0|||
161874820|NCT01314872|584584035|FG005|Period 2|Pregnancy|0|||
161874821|NCT01314872|584584036|FG006|Period 2|Pregnancy|0|||
161874822|NCT01314872|584584037|FG007|Period 2|Pregnancy|0|||
161990476|NCT04306510|585016285|FG000|Overall Study|Voluntarily withdrawal|1|||
161990477|NCT04306510|585016285|FG000|Overall Study|Enrolled but Not Treated|1|||
161990478|NCT04720417|585016286|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
161874823|NCT01314872|584584038|FG008|Period 2|Pregnancy|0|||
161874824|NCT01314872|584584039|FG009|Period 2|Pregnancy|0|||
161874825|NCT01314872|584584040|FG010|Period 2|Pregnancy|0|||
161874826|NCT01314872|584584041|FG011|Period 2|Pregnancy|0|||
161874827|NCT01314872|584584042|FG012|Period 2|Pregnancy|0|||
161874828|NCT01314872|584584043|FG013|Period 2|Pregnancy|0|||
161874829|NCT01314872|584584044|FG014|Period 2|Pregnancy|1|||
161874830|NCT01314872|584584030|FG000|Period 2|Study terminated by Sponsor|0|||
161874831|NCT01314872|584584031|FG001|Period 2|Study terminated by Sponsor|0|||
161874832|NCT01314872|584584032|FG002|Period 2|Study terminated by Sponsor|0|||
161874833|NCT01314872|584584033|FG003|Period 2|Study terminated by Sponsor|0|||
161874834|NCT01314872|584584034|FG004|Period 2|Study terminated by Sponsor|0|||
161874835|NCT01314872|584584035|FG005|Period 2|Study terminated by Sponsor|0|||
161874836|NCT01314872|584584036|FG006|Period 2|Study terminated by Sponsor|0|||
161874837|NCT01314872|584584037|FG007|Period 2|Study terminated by Sponsor|0|||
161874838|NCT01314872|584584038|FG008|Period 2|Study terminated by Sponsor|0|||
162035747|NCT00722371|585187130|FG004|Overall Study|Lost to Follow-up|8|||
162035748|NCT00722371|585187131|FG005|Overall Study|Lost to Follow-up|16|||
162035749|NCT00722371|585187132|FG006|Overall Study|Lost to Follow-up|13|||
162035750|NCT00722371|585187126|FG000|Overall Study|Physician Decision|5|||
162035751|NCT00722371|585187127|FG001|Overall Study|Physician Decision|2|||
162035752|NCT00722371|585187128|FG002|Overall Study|Physician Decision|2|||
162035753|NCT00722371|585187129|FG003|Overall Study|Physician Decision|5|||
162035754|NCT00722371|585187130|FG004|Overall Study|Physician Decision|2|||
162035755|NCT00722371|585187131|FG005|Overall Study|Physician Decision|3|||
162035756|NCT00722371|585187132|FG006|Overall Study|Physician Decision|4|||
162035757|NCT00722371|585187126|FG000|Overall Study|Pregnancy|1|||
162035758|NCT00722371|585187127|FG001|Overall Study|Pregnancy|1|||
162035759|NCT00722371|585187128|FG002|Overall Study|Pregnancy|0|||
162035760|NCT00722371|585187129|FG003|Overall Study|Pregnancy|0|||
162035761|NCT00722371|585187130|FG004|Overall Study|Pregnancy|0|||
162035762|NCT00722371|585187131|FG005|Overall Study|Pregnancy|1|||
162035763|NCT00722371|585187132|FG006|Overall Study|Pregnancy|0|||
162035764|NCT00722371|585187126|FG000|Overall Study|Protocol Violation|6|||
162035765|NCT00722371|585187127|FG001|Overall Study|Protocol Violation|1|||
162035766|NCT00722371|585187128|FG002|Overall Study|Protocol Violation|0|||
162035767|NCT00722371|585187129|FG003|Overall Study|Protocol Violation|1|||
162035768|NCT00722371|585187130|FG004|Overall Study|Protocol Violation|4|||
162035769|NCT00722371|585187131|FG005|Overall Study|Protocol Violation|2|||
162035770|NCT00722371|585187132|FG006|Overall Study|Protocol Violation|1|||
161776192|NCT01569074|584223140|FG004|Overall Study|Study stopped|7|||
161776193|NCT01569074|584223136|FG000|Overall Study|Study-specific discontinuation criteria|0|||
161776194|NCT01569074|584223137|FG001|Overall Study|Study-specific discontinuation criteria|1|||
161776195|NCT01569074|584223138|FG002|Overall Study|Study-specific discontinuation criteria|0|||
161776196|NCT01569074|584223139|FG003|Overall Study|Study-specific discontinuation criteria|0|||
161776197|NCT01569074|584223140|FG004|Overall Study|Study-specific discontinuation criteria|0|||
161776198|NCT01569074|584223136|FG000|Overall Study|Severe non-compliance to protocol|0|||
162035771|NCT00722371|585187126|FG000|Overall Study|Withdrawal by Subject|18|||
162035772|NCT00722371|585187127|FG001|Overall Study|Withdrawal by Subject|27|||
162035773|NCT00722371|585187128|FG002|Overall Study|Withdrawal by Subject|19|||
162035774|NCT00722371|585187129|FG003|Overall Study|Withdrawal by Subject|23|||
162035775|NCT00722371|585187130|FG004|Overall Study|Withdrawal by Subject|19|||
162035776|NCT00722371|585187131|FG005|Overall Study|Withdrawal by Subject|18|||
162035777|NCT00722371|585187132|FG006|Overall Study|Withdrawal by Subject|26|||
162035778|NCT00718237|585187133|FG000|Overall Study|Adverse Event|1|||
162035779|NCT00718237|585187134|FG001|Overall Study|Adverse Event|3|||
162035780|NCT00718237|585187133|FG000|Overall Study|Lost to Follow-up|2|||
162035781|NCT00718237|585187134|FG001|Overall Study|Lost to Follow-up|2|||
162035782|NCT00718237|585187133|FG000|Overall Study|Physician Decision|1|||
162035783|NCT00718237|585187134|FG001|Overall Study|Physician Decision|0|||
162035784|NCT00718237|585187133|FG000|Overall Study|Withdrawal by Subject|9|||
162035785|NCT00718237|585187134|FG001|Overall Study|Withdrawal by Subject|10|||
162035786|NCT02068768|585187135|FG000|Overall Study|Lost to Follow-up|5|||
162035787|NCT02068768|585187135|FG000|Overall Study|Early Termination by Sponsor|2|||
162035788|NCT01185834|585187136|FG000|Overall Study|Lost to Follow-up|2|||
162035789|NCT01185834|585187136|FG000|Overall Study|Discomfort|4|||
162035790|NCT01185834|585187136|FG000|Overall Study|Biomicroscopy|4|||
162035791|NCT01185834|585187136|FG000|Overall Study|Time/Job Conflict|2|||
162035792|NCT01185834|585187136|FG000|Overall Study|Early exit - Site error|2|||
162035793|NCT00913692|585187138|FG000|Screening (4 Months)|Physician Decision|3|||
162035794|NCT00913692|585187138|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
162035795|NCT00913692|585187138|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
162035796|NCT02694718|585187139|FG000|Overall Study|Death|1|||
162035797|NCT02694718|585187139|FG000|Overall Study|Withdrawal by Subject|1|||
162035798|NCT00322153|585187141|FG000|Overall Study|Adverse Event|21|||
162035799|NCT00322153|585187142|FG001|Overall Study|Adverse Event|34|||
162035800|NCT00322153|585187141|FG000|Overall Study|Protocol Violation|6|||
162035801|NCT00322153|585187142|FG001|Overall Study|Protocol Violation|14|||
162035802|NCT00322153|585187141|FG000|Overall Study|Withdrawal by Subject|18|||
162035803|NCT00322153|585187142|FG001|Overall Study|Withdrawal by Subject|10|||
162035804|NCT00322153|585187141|FG000|Overall Study|Lack of Efficacy|8|||
162035805|NCT00322153|585187142|FG001|Overall Study|Lack of Efficacy|3|||
162035806|NCT00322153|585187141|FG000|Overall Study|Lost to Follow-up|5|||
162035807|NCT00322153|585187142|FG001|Overall Study|Lost to Follow-up|4|||
162035808|NCT00322153|585187141|FG000|Overall Study|Withdrawn for other reasons|5|||
161776199|NCT01569074|584223137|FG001|Overall Study|Severe non-compliance to protocol|0|||
162035809|NCT00322153|585187142|FG001|Overall Study|Withdrawn for other reasons|4|||
162035810|NCT02290431|585187144|FG000|Overall Study|Adverse Event|20|||
162035811|NCT02290431|585187144|FG000|Overall Study|Progressive disease|4|||
162035812|NCT02290431|585187144|FG000|Overall Study|Study terminated by Sponsor|1|||
162035813|NCT02290431|585187144|FG000|Overall Study|Physician Decision|2|||
162035814|NCT00321893|585187146|FG000|Overall Study|Non-Compliance/Refusal|16|||
162035815|NCT00321893|585187147|FG001|Overall Study|Non-Compliance/Refusal|10|||
162035816|NCT00321893|585187146|FG000|Overall Study|Lost to Follow-up|2|||
161874839|NCT01314872|584584039|FG009|Period 2|Study terminated by Sponsor|0|||
161874840|NCT01314872|584584040|FG010|Period 2|Study terminated by Sponsor|0|||
161874841|NCT01314872|584584041|FG011|Period 2|Study terminated by Sponsor|2|||
161874842|NCT01314872|584584042|FG012|Period 2|Study terminated by Sponsor|2|||
161874843|NCT01314872|584584043|FG013|Period 2|Study terminated by Sponsor|3|||
161874844|NCT01314872|584584044|FG014|Period 2|Study terminated by Sponsor|0|||
161874845|NCT01314872|584584030|FG000|Period 2|Adverse event, non-fatal|0|||
161874846|NCT01314872|584584031|FG001|Period 2|Adverse event, non-fatal|0|||
161874847|NCT01314872|584584032|FG002|Period 2|Adverse event, non-fatal|0|||
161874848|NCT01314872|584584033|FG003|Period 2|Adverse event, non-fatal|0|||
161874849|NCT01314872|584584034|FG004|Period 2|Adverse event, non-fatal|0|||
161874850|NCT01314872|584584035|FG005|Period 2|Adverse event, non-fatal|0|||
161874851|NCT01314872|584584036|FG006|Period 2|Adverse event, non-fatal|0|||
161874852|NCT01314872|584584037|FG007|Period 2|Adverse event, non-fatal|0|||
161874853|NCT01314872|584584038|FG008|Period 2|Adverse event, non-fatal|0|||
161874854|NCT01314872|584584039|FG009|Period 2|Adverse event, non-fatal|0|||
161874855|NCT01314872|584584040|FG010|Period 2|Adverse event, non-fatal|0|||
161874856|NCT01314872|584584041|FG011|Period 2|Adverse event, non-fatal|13|||
161874857|NCT01314872|584584042|FG012|Period 2|Adverse event, non-fatal|16|||
161874858|NCT01314872|584584043|FG013|Period 2|Adverse event, non-fatal|24|||
161874859|NCT01314872|584584044|FG014|Period 2|Adverse event, non-fatal|9|||
161874860|NCT01314872|584584030|FG000|Period 2|Withdrawal by Subject|0|||
161874861|NCT01314872|584584031|FG001|Period 2|Withdrawal by Subject|0|||
161874862|NCT01314872|584584032|FG002|Period 2|Withdrawal by Subject|0|||
161874863|NCT01314872|584584033|FG003|Period 2|Withdrawal by Subject|0|||
161874864|NCT01314872|584584034|FG004|Period 2|Withdrawal by Subject|0|||
161874865|NCT01314872|584584035|FG005|Period 2|Withdrawal by Subject|0|||
161874866|NCT01314872|584584036|FG006|Period 2|Withdrawal by Subject|0|||
161874867|NCT01314872|584584037|FG007|Period 2|Withdrawal by Subject|0|||
161874868|NCT01314872|584584038|FG008|Period 2|Withdrawal by Subject|0|||
161874869|NCT01314872|584584039|FG009|Period 2|Withdrawal by Subject|0|||
161874870|NCT01314872|584584040|FG010|Period 2|Withdrawal by Subject|0|||
161874871|NCT01314872|584584041|FG011|Period 2|Withdrawal by Subject|14|||
161874872|NCT01314872|584584042|FG012|Period 2|Withdrawal by Subject|17|||
161874873|NCT01314872|584584043|FG013|Period 2|Withdrawal by Subject|12|||
161874874|NCT01314872|584584044|FG014|Period 2|Withdrawal by Subject|4|||
161874875|NCT01314872|584584030|FG000|Period 2|Lost to Follow-up|0|||
161874876|NCT01314872|584584031|FG001|Period 2|Lost to Follow-up|0|||
161874877|NCT01314872|584584032|FG002|Period 2|Lost to Follow-up|0|||
161874878|NCT01314872|584584033|FG003|Period 2|Lost to Follow-up|0|||
161874879|NCT01314872|584584034|FG004|Period 2|Lost to Follow-up|0|||
161874880|NCT01314872|584584035|FG005|Period 2|Lost to Follow-up|0|||
161874881|NCT01314872|584584036|FG006|Period 2|Lost to Follow-up|0|||
161874882|NCT01314872|584584037|FG007|Period 2|Lost to Follow-up|0|||
161874883|NCT01314872|584584038|FG008|Period 2|Lost to Follow-up|0|||
161874884|NCT01314872|584584039|FG009|Period 2|Lost to Follow-up|0|||
161874885|NCT01314872|584584040|FG010|Period 2|Lost to Follow-up|0|||
161874886|NCT01314872|584584041|FG011|Period 2|Lost to Follow-up|6|||
161874887|NCT01314872|584584042|FG012|Period 2|Lost to Follow-up|7|||
161874888|NCT01314872|584584043|FG013|Period 2|Lost to Follow-up|2|||
161874889|NCT01314872|584584044|FG014|Period 2|Lost to Follow-up|6|||
161874890|NCT03634033|584585344|FG000|Overall Study|Did not have a post-assessment|384|||
161874891|NCT03634033|584585345|FG001|Overall Study|Did not have a post-assessment|291|||
161874892|NCT03634033|584585346|FG002|Overall Study|Did not have a post-assessment|114|||
161874893|NCT03634033|584585347|FG003|Overall Study|Did not have a post-assessment|161|||
161874894|NCT03634033|584585348|FG004|Overall Study|Did not have a post-assessment|5|||
161874895|NCT03634033|584585349|FG005|Overall Study|Did not have a post-assessment|0|||
161874896|NCT03634033|584585350|FG006|Overall Study|Did not have a post-assessment|0|||
161874897|NCT03634033|584585344|FG000|Overall Study|Death|0|||
161874898|NCT03634033|584585345|FG001|Overall Study|Death|0|||
161874899|NCT03634033|584585346|FG002|Overall Study|Death|0|||
161874900|NCT03634033|584585347|FG003|Overall Study|Death|0|||
161874901|NCT03634033|584585348|FG004|Overall Study|Death|0|||
161874902|NCT03634033|584585349|FG005|Overall Study|Death|7|||
161874903|NCT03634033|584585350|FG006|Overall Study|Death|7|||
161990479|NCT03329092|585016287|FG000|Overall Study|Other|2|||
161990480|NCT03329092|585016288|FG001|Overall Study|Other|2|||
161990481|NCT03329092|585016287|FG000|Overall Study|Withdrawal by Subject|16|||
161990482|NCT03329092|585016288|FG001|Overall Study|Withdrawal by Subject|3|||
161874904|NCT03634033|584585344|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161874905|NCT03634033|584585345|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161874906|NCT03634033|584585346|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161874907|NCT03634033|584585347|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161874908|NCT03634033|584585348|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161874909|NCT03634033|584585349|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
161874910|NCT03634033|584585350|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
161874911|NCT03634033|584585344|FG000|Overall Study|Lost to Follow-up|0|||
161874912|NCT03634033|584585345|FG001|Overall Study|Lost to Follow-up|0|||
162035817|NCT00321893|585187147|FG001|Overall Study|Lost to Follow-up|1|||
162035818|NCT00321893|585187146|FG000|Overall Study|Adverse Event|6|||
162035819|NCT00321893|585187147|FG001|Overall Study|Adverse Event|3|||
162035820|NCT03455764|585187148|FG000|Overall Study|Adverse Event|1|||
162035821|NCT03455764|585187149|FG001|Overall Study|Adverse Event|0|||
162035822|NCT03455764|585187150|FG002|Overall Study|Adverse Event|0|||
162035823|NCT03455764|585187151|FG003|Overall Study|Adverse Event|0|||
162035824|NCT03455764|585187152|FG004|Overall Study|Adverse Event|0|||
162035825|NCT03455764|585187148|FG000|Overall Study|Disease Progression|4|||
162035826|NCT03455764|585187149|FG001|Overall Study|Disease Progression|0|||
162035827|NCT03455764|585187150|FG002|Overall Study|Disease Progression|0|||
162035828|NCT03455764|585187151|FG003|Overall Study|Disease Progression|0|||
162035829|NCT03455764|585187152|FG004|Overall Study|Disease Progression|0|||
162035830|NCT03455764|585187148|FG000|Overall Study|On Treatment|1|||
162035831|NCT03455764|585187149|FG001|Overall Study|On Treatment|0|||
162035832|NCT03455764|585187150|FG002|Overall Study|On Treatment|0|||
162035833|NCT03455764|585187151|FG003|Overall Study|On Treatment|0|||
162035834|NCT03455764|585187152|FG004|Overall Study|On Treatment|0|||
162035835|NCT03523000|585187153|FG000|Overall Study|Withdrawal by Subject|3|||
162035836|NCT03523000|585187154|FG001|Overall Study|Withdrawal by Subject|0|||
162035837|NCT03523000|585187153|FG000|Overall Study|Unsuccessful trial|2|||
162035838|NCT03523000|585187154|FG001|Overall Study|Unsuccessful trial|0|||
162035839|NCT00772070|585187155|FG000|Overall Study|Lost to Follow-up|0|||
162035840|NCT00772070|585187156|FG001|Overall Study|Lost to Follow-up|8|||
162035841|NCT00772070|585187155|FG000|Overall Study|Withdrawal by Subject|0|||
162035842|NCT00772070|585187156|FG001|Overall Study|Withdrawal by Subject|2|||
162035843|NCT00772070|585187155|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
162035844|NCT00772070|585187156|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
162035845|NCT03993379|585187161|FG000|Overall Study|The study was terminated early due to business decision.|0|||
162035846|NCT03993379|585187162|FG001|Overall Study|The study was terminated early due to business decision.|2|||
162035847|NCT03993379|585187163|FG002|Overall Study|The study was terminated early due to business decision.|0|||
162035848|NCT03993379|585187164|FG003|Overall Study|The study was terminated early due to business decision.|0|||
162035849|NCT03993379|585187161|FG000|Overall Study|Withdrawal by Subject|0|||
162035850|NCT03993379|585187162|FG001|Overall Study|Withdrawal by Subject|1|||
162035851|NCT03993379|585187163|FG002|Overall Study|Withdrawal by Subject|0|||
162035852|NCT03993379|585187164|FG003|Overall Study|Withdrawal by Subject|0|||
162035853|NCT02380690|585187165|FG000|Overall Study|Lost to Follow-up|14|||
161874913|NCT03634033|584585346|FG002|Overall Study|Lost to Follow-up|0|||
161874914|NCT03634033|584585347|FG003|Overall Study|Lost to Follow-up|0|||
161874915|NCT03634033|584585348|FG004|Overall Study|Lost to Follow-up|0|||
161874916|NCT03634033|584585349|FG005|Overall Study|Lost to Follow-up|1|||
161874917|NCT03634033|584585350|FG006|Overall Study|Lost to Follow-up|2|||
161874918|NCT03634033|584585344|FG000|Overall Study|Withdrawal by Subject|0|||
161874919|NCT03634033|584585345|FG001|Overall Study|Withdrawal by Subject|0|||
161874920|NCT03634033|584585346|FG002|Overall Study|Withdrawal by Subject|0|||
161874921|NCT03634033|584585347|FG003|Overall Study|Withdrawal by Subject|0|||
161874922|NCT03634033|584585348|FG004|Overall Study|Withdrawal by Subject|0|||
161874923|NCT03634033|584585349|FG005|Overall Study|Withdrawal by Subject|0|||
161874924|NCT03634033|584585350|FG006|Overall Study|Withdrawal by Subject|1|||
161874925|NCT06366087|584585351|FG000|Overall Study|Withdrawal by Subject|0|||
161874926|NCT06366087|584585352|FG001|Overall Study|Withdrawal by Subject|1|||
161874927|NCT00199797|584585353|FG000|Overall Study|Progressive Disease|1|||
161874928|NCT00199797|584585353|FG000|Overall Study|Adverse Event|1|||
161874929|NCT00199797|584585353|FG000|Overall Study|Physician Decision|1|||
161874930|NCT00504725|584585361|FG000|Overall Study|Protocol Violation|1|||
161874931|NCT00504725|584585362|FG001|Overall Study|Protocol Violation|0|||
161874932|NCT01435018|584585363|FG000|Overall Study|Death|37|||
161874933|NCT01435018|584585364|FG001|Overall Study|Death|18|||
161874934|NCT01435018|584585365|FG002|Overall Study|Death|25|||
161874935|NCT01435018|584585363|FG000|Overall Study|Site is closing|4|||
161874936|NCT01435018|584585364|FG001|Overall Study|Site is closing|9|||
161874937|NCT01435018|584585365|FG002|Overall Study|Site is closing|7|||
162035854|NCT02380690|585187166|FG001|Overall Study|Lost to Follow-up|4|||
162035855|NCT02380690|585187165|FG000|Overall Study|Withdrawal by Subject|20|||
162035856|NCT02380690|585187166|FG001|Overall Study|Withdrawal by Subject|8|||
162035857|NCT02361346|585187167|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
162035858|NCT02361346|585187168|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
162035859|NCT02361346|585187169|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
162035860|NCT02361346|585187170|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
161874938|NCT01435018|584585363|FG000|Overall Study|Withdrew consent|0|||
161874939|NCT01435018|584585364|FG001|Overall Study|Withdrew consent|3|||
161874940|NCT01435018|584585365|FG002|Overall Study|Withdrew consent|1|||
161874941|NCT01435018|584585363|FG000|Overall Study|Not willing to adhere to requirements|0|||
161874942|NCT01435018|584585364|FG001|Overall Study|Not willing to adhere to requirements|2|||
161874943|NCT01435018|584585365|FG002|Overall Study|Not willing to adhere to requirements|3|||
161874944|NCT01435018|584585363|FG000|Overall Study|Not able to get to clinic|2|||
161874945|NCT01435018|584585364|FG001|Overall Study|Not able to get to clinic|0|||
161874946|NCT01435018|584585365|FG002|Overall Study|Not able to get to clinic|2|||
161874947|NCT01435018|584585363|FG000|Overall Study|Severe debilitation, unable to continue|0|||
161874948|NCT01435018|584585364|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161874949|NCT01435018|584585365|FG002|Overall Study|Severe debilitation, unable to continue|1|||
161874950|NCT01435018|584585363|FG000|Overall Study|Unable to contact participant/parent|1|||
161874951|NCT01435018|584585364|FG001|Overall Study|Unable to contact participant/parent|1|||
161874952|NCT01435018|584585365|FG002|Overall Study|Unable to contact participant/parent|1|||
161874953|NCT01435018|584585363|FG000|Overall Study|Enrollment Violation|0|||
161874954|NCT01435018|584585364|FG001|Overall Study|Enrollment Violation|1|||
161874955|NCT01435018|584585365|FG002|Overall Study|Enrollment Violation|0|||
161874956|NCT01435018|584585363|FG000|Overall Study|Never started chemotherapy|3|||
161874957|NCT01435018|584585364|FG001|Overall Study|Never started chemotherapy|0|||
161874958|NCT01435018|584585365|FG002|Overall Study|Never started chemotherapy|1|||
161874959|NCT03937908|584585366|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
161874960|NCT03937908|584585367|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
161874961|NCT03875092|584585368|FG000|Overall Study|Adverse Event|2|||
161874962|NCT03875092|584585369|FG001|Overall Study|Adverse Event|5|||
161874963|NCT03875092|584585368|FG000|Overall Study|Death|44|||
161874964|NCT03875092|584585369|FG001|Overall Study|Death|51|||
161874965|NCT03875092|584585368|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
161874966|NCT03875092|584585369|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
161874967|NCT03205761|584585370|FG000|Overall Study|Withdrawal by Subject|1|||
161874968|NCT03205761|584585370|FG000|Overall Study|Progressive Disease|10|||
161874969|NCT00636194|584585371|FG000|Overall Study|Study related symptoms and complaints|1|||
161874970|NCT00636194|584585372|FG001|Overall Study|Study related symptoms and complaints|0|||
161874971|NCT00636194|584585371|FG000|Overall Study|Protocol Violation|2|||
161874972|NCT00636194|584585372|FG001|Overall Study|Protocol Violation|0|||
161874973|NCT04114357|584585374|FG000|Baseline-Randomization|Adverse Event|2|||
161874974|NCT04114357|584585375|FG001|Baseline-Randomization|Adverse Event|1|||
161874975|NCT04114357|584585374|FG000|Baseline-Randomization|Lost to Follow-up|1|||
161874976|NCT04114357|584585375|FG001|Baseline-Randomization|Lost to Follow-up|1|||
161874977|NCT04114357|584585374|FG000|Cross-over|Adverse Event|0|||
161874978|NCT04114357|584585375|FG001|Cross-over|Adverse Event|1|||
161874979|NCT02163226|584585376|FG000|Overall Study|Death|2|||
161874980|NCT02163226|584585377|FG001|Overall Study|Death|1|||
161874981|NCT02163226|584585376|FG000|Overall Study|Withdrawal by Subject|5|||
161874982|NCT02163226|584585377|FG001|Overall Study|Withdrawal by Subject|2|||
161874983|NCT02163226|584585376|FG000|Overall Study|Returned home, local radiotherapy|3|||
161874984|NCT02163226|584585377|FG001|Overall Study|Returned home, local radiotherapy|0|||
161874985|NCT02163226|584585376|FG000|Overall Study|Repeat imaging showed no disease|2|||
161874986|NCT02163226|584585377|FG001|Overall Study|Repeat imaging showed no disease|0|||
161874987|NCT02163226|584585376|FG000|Overall Study|Incomplete radiotherapy|3|||
161874988|NCT02163226|584585377|FG001|Overall Study|Incomplete radiotherapy|0|||
161874989|NCT02163226|584585376|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
161874990|NCT02163226|584585377|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
161874991|NCT02163226|584585376|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
161874992|NCT02163226|584585377|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
161874993|NCT02163226|584585376|FG000|Overall Study|ineligible|0|||
161874994|NCT02163226|584585377|FG001|Overall Study|ineligible|3|||
161874995|NCT03625466|584585381|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
161874996|NCT03625466|584585382|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
161990483|NCT03329092|585016287|FG000|Overall Study|Physician Decision|1|||
161990484|NCT03329092|585016288|FG001|Overall Study|Physician Decision|0|||
161990485|NCT03329092|585016287|FG000|Overall Study|Death|17|||
161874997|NCT03625466|584585383|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
161874998|NCT03625466|584585381|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
161874999|NCT03625466|584585382|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
161875000|NCT03625466|584585383|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
161875001|NCT03625466|584585381|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
161875002|NCT03625466|584585382|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
161875003|NCT03625466|584585383|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
161875004|NCT00809471|584585386|FG000|Overall Study|Protocol non-compliance|15|||
161875005|NCT00809471|584585387|FG001|Overall Study|Protocol non-compliance|15|||
161875006|NCT00809471|584585388|FG002|Overall Study|Protocol non-compliance|6|||
161875007|NCT00809471|584585386|FG000|Overall Study|Lost to Follow-up|4|||
161875008|NCT00809471|584585387|FG001|Overall Study|Lost to Follow-up|2|||
161875009|NCT00809471|584585388|FG002|Overall Study|Lost to Follow-up|9|||
161875010|NCT00809471|584585386|FG000|Overall Study|Adverse Event|0|||
161875011|NCT00809471|584585387|FG001|Overall Study|Adverse Event|2|||
161990486|NCT03329092|585016288|FG001|Overall Study|Death|11|||
161990487|NCT03329092|585016287|FG000|Overall Study|Adverse Event|3|||
161990488|NCT03329092|585016288|FG001|Overall Study|Adverse Event|1|||
161875012|NCT00809471|584585388|FG002|Overall Study|Adverse Event|2|||
161875013|NCT00809471|584585386|FG000|Overall Study|Requirement for restricted medication|1|||
161875014|NCT00809471|584585387|FG001|Overall Study|Requirement for restricted medication|1|||
161875015|NCT00809471|584585388|FG002|Overall Study|Requirement for restricted medication|0|||
161875016|NCT00831311|584585389|FG000|Overall Study|Definitive Contraindication|3|||
161875017|NCT00831311|584585390|FG001|Overall Study|Definitive Contraindication|3|||
161875018|NCT00831311|584585389|FG000|Overall Study|Lost to Follow-up|3|||
161875019|NCT00831311|584585390|FG001|Overall Study|Lost to Follow-up|0|||
161875020|NCT00831311|584585389|FG000|Overall Study|Physician Decision|0|||
161875021|NCT00831311|584585390|FG001|Overall Study|Physician Decision|1|||
161875022|NCT00831311|584585389|FG000|Overall Study|Withdrawal by Subject|6|||
161875023|NCT00831311|584585390|FG001|Overall Study|Withdrawal by Subject|4|||
161875024|NCT05318092|584585394|FG000|Overall Study|Lost to Follow-up|3|||
161875025|NCT05318092|584585394|FG000|Overall Study|Withdrawal by Subject|1|||
161875026|NCT00160706|584585396|FG000|Overall Study|Adverse Event|53|||
161875027|NCT00160706|584585396|FG000|Overall Study|Adverse Event and Other Reason|105|||
161875028|NCT00160706|584585396|FG000|Overall Study|Protocol Violation|3|||
161875029|NCT00160706|584585396|FG000|Overall Study|Withdrawal by Subject|41|||
161875030|NCT00160706|584585396|FG000|Overall Study|Withdrawal by Subject and Other|12|||
161875031|NCT00160706|584585396|FG000|Overall Study|Physician Decision|10|||
161875032|NCT00160706|584585396|FG000|Overall Study|Physician Decision and Other|3|||
161875033|NCT00160706|584585396|FG000|Overall Study|Lost to Follow-up|4|||
161875034|NCT00160706|584585396|FG000|Overall Study|Lost to Follow-up and Other|1|||
161875035|NCT00160706|584585396|FG000|Overall Study|Lack of Efficacy|42|||
161875036|NCT00160706|584585396|FG000|Overall Study|Lack of Efficacy and Other|1|||
161875037|NCT00160706|584585396|FG000|Overall Study|Other Reason|11|||
161875038|NCT03214380|584585397|FG000|Lead-in|Adverse Event|3|||
161875039|NCT03214380|584585398|FG001|Lead-in|Adverse Event|0|||
161875040|NCT03214380|584585399|FG002|Lead-in|Adverse Event|0|||
161875041|NCT03214380|584585400|FG003|Lead-in|Adverse Event|1|||
161875042|NCT03214380|584585401|FG004|Lead-in|Adverse Event|0|||
161875043|NCT03214380|584585402|FG005|Lead-in|Adverse Event|0|||
161875044|NCT03214380|584585397|FG000|Lead-in|Lost to Follow-up|4|||
161875045|NCT03214380|584585398|FG001|Lead-in|Lost to Follow-up|0|||
161875046|NCT03214380|584585399|FG002|Lead-in|Lost to Follow-up|0|||
161875047|NCT03214380|584585400|FG003|Lead-in|Lost to Follow-up|1|||
161875048|NCT03214380|584585401|FG004|Lead-in|Lost to Follow-up|0|||
161875049|NCT03214380|584585402|FG005|Lead-in|Lost to Follow-up|0|||
161875050|NCT03214380|584585397|FG000|Lead-in|Eligibility Criteria|3|||
161875051|NCT03214380|584585398|FG001|Lead-in|Eligibility Criteria|0|||
161875052|NCT03214380|584585399|FG002|Lead-in|Eligibility Criteria|0|||
161875053|NCT03214380|584585400|FG003|Lead-in|Eligibility Criteria|0|||
161875054|NCT03214380|584585401|FG004|Lead-in|Eligibility Criteria|0|||
161875055|NCT03214380|584585402|FG005|Lead-in|Eligibility Criteria|0|||
161875056|NCT03214380|584585397|FG000|Lead-in|Physician Decision|6|||
161875057|NCT03214380|584585398|FG001|Lead-in|Physician Decision|0|||
161875058|NCT03214380|584585399|FG002|Lead-in|Physician Decision|0|||
161875059|NCT03214380|584585400|FG003|Lead-in|Physician Decision|0|||
161875060|NCT03214380|584585401|FG004|Lead-in|Physician Decision|0|||
161875061|NCT03214380|584585402|FG005|Lead-in|Physician Decision|0|||
161875062|NCT03214380|584585397|FG000|Lead-in|Protocol Deviation|7|||
161875063|NCT03214380|584585398|FG001|Lead-in|Protocol Deviation|0|||
161875064|NCT03214380|584585399|FG002|Lead-in|Protocol Deviation|0|||
161875065|NCT03214380|584585400|FG003|Lead-in|Protocol Deviation|3|||
161875066|NCT03214380|584585401|FG004|Lead-in|Protocol Deviation|0|||
161875067|NCT03214380|584585402|FG005|Lead-in|Protocol Deviation|0|||
161875068|NCT03214380|584585397|FG000|Lead-in|Withdrawal by Subject|41|||
161875069|NCT03214380|584585398|FG001|Lead-in|Withdrawal by Subject|0|||
161875070|NCT03214380|584585399|FG002|Lead-in|Withdrawal by Subject|0|||
161875071|NCT03214380|584585400|FG003|Lead-in|Withdrawal by Subject|14|||
161875072|NCT03214380|584585401|FG004|Lead-in|Withdrawal by Subject|0|||
161875073|NCT03214380|584585402|FG005|Lead-in|Withdrawal by Subject|0|||
161875074|NCT03214380|584585397|FG000|Lead-in|Family Emergency|1|||
161875075|NCT03214380|584585398|FG001|Lead-in|Family Emergency|0|||
161875076|NCT03214380|584585399|FG002|Lead-in|Family Emergency|0|||
161875077|NCT03214380|584585400|FG003|Lead-in|Family Emergency|0|||
161875078|NCT03214380|584585401|FG004|Lead-in|Family Emergency|0|||
161875079|NCT03214380|584585402|FG005|Lead-in|Family Emergency|0|||
161875080|NCT03214380|584585397|FG000|Lead-in|Natural Disaster|9|||
161875081|NCT03214380|584585398|FG001|Lead-in|Natural Disaster|0|||
161875082|NCT03214380|584585399|FG002|Lead-in|Natural Disaster|0|||
161875083|NCT03214380|584585400|FG003|Lead-in|Natural Disaster|0|||
161875084|NCT03214380|584585401|FG004|Lead-in|Natural Disaster|0|||
161875085|NCT03214380|584585402|FG005|Lead-in|Natural Disaster|0|||
161875086|NCT03214380|584585397|FG000|Lead-in|Non Compliance|1|||
161875087|NCT03214380|584585398|FG001|Lead-in|Non Compliance|0|||
161875088|NCT03214380|584585399|FG002|Lead-in|Non Compliance|0|||
161875089|NCT03214380|584585400|FG003|Lead-in|Non Compliance|0|||
161875090|NCT03214380|584585401|FG004|Lead-in|Non Compliance|0|||
161875091|NCT03214380|584585402|FG005|Lead-in|Non Compliance|0|||
161875092|NCT03214380|584585397|FG000|Lead-in|Participant Schedule|2|||
161875093|NCT03214380|584585398|FG001|Lead-in|Participant Schedule|0|||
161875094|NCT03214380|584585399|FG002|Lead-in|Participant Schedule|0|||
161875095|NCT03214380|584585400|FG003|Lead-in|Participant Schedule|0|||
161875096|NCT03214380|584585401|FG004|Lead-in|Participant Schedule|0|||
161875097|NCT03214380|584585402|FG005|Lead-in|Participant Schedule|0|||
161875098|NCT03214380|584585397|FG000|Treatment Period|Adverse Event|0|||
161875099|NCT03214380|584585398|FG001|Treatment Period|Adverse Event|1|||
161875100|NCT03214380|584585399|FG002|Treatment Period|Adverse Event|1|||
161875101|NCT03214380|584585400|FG003|Treatment Period|Adverse Event|0|||
161875102|NCT03214380|584585401|FG004|Treatment Period|Adverse Event|1|||
161875103|NCT03214380|584585402|FG005|Treatment Period|Adverse Event|0|||
161875104|NCT03214380|584585397|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
161875105|NCT03214380|584585398|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
161875106|NCT03214380|584585399|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
161875107|NCT03214380|584585400|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
161875108|NCT03214380|584585401|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
161875109|NCT03214380|584585402|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
161875110|NCT03214380|584585397|FG000|Treatment Period|Withdrawal by Subject|0|||
161875111|NCT03214380|584585398|FG001|Treatment Period|Withdrawal by Subject|10|||
161875112|NCT03214380|584585399|FG002|Treatment Period|Withdrawal by Subject|8|||
161875113|NCT03214380|584585400|FG003|Treatment Period|Withdrawal by Subject|0|||
161875114|NCT03214380|584585401|FG004|Treatment Period|Withdrawal by Subject|7|||
161875115|NCT03214380|584585402|FG005|Treatment Period|Withdrawal by Subject|11|||
161875116|NCT03214380|584585397|FG000|Treatment Period|Death|0|||
161875117|NCT03214380|584585398|FG001|Treatment Period|Death|1|||
161875118|NCT03214380|584585399|FG002|Treatment Period|Death|2|||
161875119|NCT03214380|584585400|FG003|Treatment Period|Death|0|||
161875120|NCT03214380|584585401|FG004|Treatment Period|Death|0|||
161875121|NCT03214380|584585402|FG005|Treatment Period|Death|0|||
161875122|NCT03214380|584585397|FG000|Treatment Period|Lost to Follow-up|0|||
161875123|NCT03214380|584585398|FG001|Treatment Period|Lost to Follow-up|6|||
161875124|NCT03214380|584585399|FG002|Treatment Period|Lost to Follow-up|3|||
161875125|NCT03214380|584585400|FG003|Treatment Period|Lost to Follow-up|0|||
161875126|NCT03214380|584585401|FG004|Treatment Period|Lost to Follow-up|0|||
161875127|NCT03214380|584585402|FG005|Treatment Period|Lost to Follow-up|0|||
161875128|NCT03214380|584585397|FG000|Treatment Period|Participant schedule|0|||
161875129|NCT03214380|584585398|FG001|Treatment Period|Participant schedule|0|||
161875130|NCT03214380|584585399|FG002|Treatment Period|Participant schedule|1|||
161875131|NCT03214380|584585400|FG003|Treatment Period|Participant schedule|0|||
161875132|NCT03214380|584585401|FG004|Treatment Period|Participant schedule|0|||
161875133|NCT03214380|584585402|FG005|Treatment Period|Participant schedule|0|||
161875134|NCT03214380|584585397|FG000|Treatment Period|Treatment Interruption|0|||
161875135|NCT03214380|584585398|FG001|Treatment Period|Treatment Interruption|0|||
161875136|NCT03214380|584585399|FG002|Treatment Period|Treatment Interruption|1|||
161875137|NCT03214380|584585400|FG003|Treatment Period|Treatment Interruption|0|||
161875138|NCT03214380|584585401|FG004|Treatment Period|Treatment Interruption|0|||
161875139|NCT03214380|584585402|FG005|Treatment Period|Treatment Interruption|0|||
161875140|NCT00723255|584585408|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
161875141|NCT00723255|584585408|FG000|Overall Study|Ineligible: Second primary|1|||
161875142|NCT00723255|584585408|FG000|Overall Study|Ineligible: Wrong Primary|2|||
161875143|NCT00614523|584585409|FG000|Overall Study|Adverse Event|4|||
161875144|NCT00614523|584585410|FG001|Overall Study|Adverse Event|20|||
161875145|NCT00614523|584585409|FG000|Overall Study|Death|5|||
161875146|NCT00614523|584585410|FG001|Overall Study|Death|8|||
161875147|NCT00614523|584585409|FG000|Overall Study|Lack of Efficacy|9|||
161875148|NCT00614523|584585410|FG001|Overall Study|Lack of Efficacy|11|||
161875149|NCT00614523|584585409|FG000|Overall Study|Lost to Follow-up|0|||
161875150|NCT00614523|584585410|FG001|Overall Study|Lost to Follow-up|1|||
161875151|NCT00614523|584585409|FG000|Overall Study|Protocol Violation|3|||
161875152|NCT00614523|584585410|FG001|Overall Study|Protocol Violation|2|||
161875153|NCT00614523|584585409|FG000|Overall Study|Withdrawal by Subject|12|||
161875154|NCT00614523|584585410|FG001|Overall Study|Withdrawal by Subject|22|||
161875155|NCT00614523|584585409|FG000|Overall Study|Other|6|||
161875156|NCT00614523|584585410|FG001|Overall Study|Other|11|||
161875157|NCT00614523|584585409|FG000|Overall Study|Ineligibility Determined|1|||
161875158|NCT00614523|584585410|FG001|Overall Study|Ineligibility Determined|2|||
161875159|NCT00614523|584585409|FG000|Overall Study|Disease Progression|0|||
161875160|NCT00614523|584585410|FG001|Overall Study|Disease Progression|8|||
161875161|NCT00614523|584585409|FG000|Overall Study|Administrative Decision|23|||
161875162|NCT00614523|584585410|FG001|Overall Study|Administrative Decision|46|||
161875163|NCT00452673|584585417|FG000|Dose Escalation Period|Disease Progression|6|||
161875164|NCT00452673|584585418|FG001|Dose Escalation Period|Disease Progression|6|||
161875165|NCT00452673|584585419|FG002|Dose Escalation Period|Disease Progression|2|||
161875166|NCT00452673|584585420|FG003|Dose Escalation Period|Disease Progression|6|||
161875167|NCT00452673|584585421|FG004|Dose Escalation Period|Disease Progression|0|||
161875168|NCT00452673|584585417|FG000|Dose Escalation Period|study drug toxicity|1|||
161875169|NCT00452673|584585418|FG001|Dose Escalation Period|study drug toxicity|3|||
161875170|NCT00452673|584585419|FG002|Dose Escalation Period|study drug toxicity|3|||
161875171|NCT00452673|584585420|FG003|Dose Escalation Period|study drug toxicity|1|||
161875172|NCT00452673|584585421|FG004|Dose Escalation Period|study drug toxicity|0|||
161875173|NCT00452673|584585417|FG000|Dose Escalation Period|Other|0|||
161875174|NCT00452673|584585418|FG001|Dose Escalation Period|Other|0|||
161875175|NCT00452673|584585419|FG002|Dose Escalation Period|Other|1|||
161875176|NCT00452673|584585420|FG003|Dose Escalation Period|Other|0|||
161875177|NCT00452673|584585421|FG004|Dose Escalation Period|Other|0|||
161875178|NCT00452673|584585417|FG000|Dose Escalation Period|Adverse Event|0|||
161875179|NCT00452673|584585418|FG001|Dose Escalation Period|Adverse Event|0|||
161875180|NCT00452673|584585419|FG002|Dose Escalation Period|Adverse Event|0|||
161875181|NCT00452673|584585420|FG003|Dose Escalation Period|Adverse Event|1|||
161875182|NCT00452673|584585421|FG004|Dose Escalation Period|Adverse Event|0|||
161875183|NCT00452673|584585417|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
161875184|NCT00452673|584585418|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
161875185|NCT00452673|584585419|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
161875186|NCT00452673|584585420|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
161875187|NCT00452673|584585421|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
161875188|NCT00452673|584585417|FG000|Dose Expansion Period|Disease Progression|0|||
161875189|NCT00452673|584585418|FG001|Dose Expansion Period|Disease Progression|0|||
161875190|NCT00452673|584585419|FG002|Dose Expansion Period|Disease Progression|0|||
161875191|NCT00452673|584585420|FG003|Dose Expansion Period|Disease Progression|0|||
161875192|NCT00452673|584585421|FG004|Dose Expansion Period|Disease Progression|19|||
161875193|NCT00452673|584585417|FG000|Dose Expansion Period|Other|0|||
161875194|NCT00452673|584585418|FG001|Dose Expansion Period|Other|0|||
161875195|NCT00452673|584585419|FG002|Dose Expansion Period|Other|0|||
161875196|NCT00452673|584585420|FG003|Dose Expansion Period|Other|0|||
161875197|NCT00452673|584585421|FG004|Dose Expansion Period|Other|2|||
161875198|NCT00748189|584585424|FG000|Overall Study|Death|99|||
161875199|NCT00748189|584585425|FG001|Overall Study|Death|84|||
161875200|NCT00748189|584585424|FG000|Overall Study|Withdrawal by Subject|23|||
161875201|NCT00748189|584585425|FG001|Overall Study|Withdrawal by Subject|29|||
161875202|NCT00748189|584585424|FG000|Overall Study|Physician Decision|16|||
161875203|NCT00748189|584585425|FG001|Overall Study|Physician Decision|5|||
161875204|NCT00748189|584585424|FG000|Overall Study|Lost to Follow-up|8|||
161875205|NCT00748189|584585425|FG001|Overall Study|Lost to Follow-up|15|||
161875206|NCT00748189|584585424|FG000|Overall Study|Study terminated by Sponsor|70|||
161875207|NCT00748189|584585425|FG001|Overall Study|Study terminated by Sponsor|79|||
161875208|NCT04481191|584585432|FG000|Overall Study|Withdrawn by parent/guardian|15|||
161875209|NCT04481191|584585433|FG001|Overall Study|Withdrawn by parent/guardian|10|||
161875210|NCT00546117|584585438|FG000|Overall Study|Withdrawal by Subject|3|||
161875211|NCT00546117|584585439|FG001|Overall Study|Withdrawal by Subject|0|||
161875212|NCT00546117|584585438|FG000|Overall Study|Inability to schedule follow-up visit|1|||
161875213|NCT00546117|584585439|FG001|Overall Study|Inability to schedule follow-up visit|0|||
161875214|NCT04984278|584585444|FG000|Period 1|Withdrawal by Subject|1|||
161875215|NCT04984278|584585445|FG001|Period 1|Withdrawal by Subject|0|||
161875216|NCT04984278|584585444|FG000|Period 1|Other|0|||
161875217|NCT04984278|584585445|FG001|Period 1|Other|1|||
161875218|NCT04984278|584585444|FG000|Period 2|Adverse Event|1|||
161875219|NCT04984278|584585445|FG001|Period 2|Adverse Event|0|||
161875220|NCT04984278|584585444|FG000|Period 2|Other|0|||
161875221|NCT04984278|584585445|FG001|Period 2|Other|1|||
161875222|NCT04696055|584585446|FG000|Overall Study|Adverse Event|10|||
161875223|NCT04696055|584585447|FG001|Overall Study|Adverse Event|2|||
161875224|NCT04696055|584585446|FG000|Overall Study|Death|4|||
161875225|NCT04696055|584585447|FG001|Overall Study|Death|0|||
161875226|NCT04696055|584585446|FG000|Overall Study|Other|7|||
161875227|NCT04696055|584585447|FG001|Overall Study|Other|2|||
161875228|NCT04696055|584585446|FG000|Overall Study|Physician Decision|3|||
161875229|NCT04696055|584585447|FG001|Overall Study|Physician Decision|0|||
161875230|NCT04696055|584585446|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
161875231|NCT04696055|584585447|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
161875232|NCT04696055|584585446|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
161990489|NCT03329092|585016287|FG000|Overall Study|Lost to Follow-up|1|||
161990490|NCT03329092|585016288|FG001|Overall Study|Lost to Follow-up|1|||
161875233|NCT04696055|584585447|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
161875234|NCT04696055|584585446|FG000|Overall Study|Subject Decision|1|||
161875235|NCT04696055|584585447|FG001|Overall Study|Subject Decision|2|||
161875236|NCT03969901|584585448|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161875237|NCT03969901|584585449|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161875238|NCT03969901|584585450|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161875239|NCT03969901|584585451|FG003|Overall Study|Withdrawal by parent/guardian|0|||
161875240|NCT03969901|584585452|FG004|Overall Study|Withdrawal by parent/guardian|1|||
161875241|NCT03969901|584585453|FG005|Overall Study|Withdrawal by parent/guardian|0|||
161875242|NCT03969901|584585454|FG006|Overall Study|Withdrawal by parent/guardian|0|||
161875243|NCT03969901|584585455|FG007|Overall Study|Withdrawal by parent/guardian|1|||
161990491|NCT04878211|585016289|FG000|Overall Study|Lost to Follow-up|0|||
161875244|NCT03969901|584585456|FG008|Overall Study|Withdrawal by parent/guardian|1|||
161875245|NCT03969901|584585457|FG009|Overall Study|Withdrawal by parent/guardian|0|||
161875246|NCT00348595|584585458|FG000|Overall Study|Adverse Event|5|||
161875247|NCT00348595|584585459|FG001|Overall Study|Adverse Event|8|||
161875248|NCT01920958|584585460|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
161875249|NCT03192306|584585465|FG000|Overall Study|Did not treat cold sore during study|149|||
161875250|NCT03192306|584585466|FG001|Overall Study|Did not treat cold sore during study|143|||
161875251|NCT03192306|584585465|FG000|Overall Study|Withdrawal by Subject|1|||
161875252|NCT03192306|584585466|FG001|Overall Study|Withdrawal by Subject|1|||
161875253|NCT03192306|584585465|FG000|Overall Study|Lost to Follow-up|1|||
161875254|NCT03192306|584585466|FG001|Overall Study|Lost to Follow-up|0|||
161875255|NCT03192306|584585465|FG000|Overall Study|Protocol Violation|1|||
161875256|NCT03192306|584585466|FG001|Overall Study|Protocol Violation|1|||
161875257|NCT02589626|584585471|FG000|Overall Study|Other than the reason specified|1|||
161875258|NCT02589626|584585472|FG001|Overall Study|Other than the reason specified|0|||
161875259|NCT02589626|584585471|FG000|Overall Study|Withdrawal by Subject|1|||
161875260|NCT02589626|584585472|FG001|Overall Study|Withdrawal by Subject|1|||
161875261|NCT02589626|584585471|FG000|Overall Study|Adverse Event|1|||
161875262|NCT02589626|584585472|FG001|Overall Study|Adverse Event|1|||
161875263|NCT00379080|584585473|FG000|Overall Study|Withdrawal by Subject|0|||
161875264|NCT00379080|584585474|FG001|Overall Study|Withdrawal by Subject|4|||
161875265|NCT00379080|584585475|FG002|Overall Study|Withdrawal by Subject|0|||
161875266|NCT01089608|584585476|FG000|Overall Study|Adverse Event|0|||
161875267|NCT01089608|584585477|FG001|Overall Study|Adverse Event|4|||
161875268|NCT01089608|584585476|FG000|Overall Study|Lost to Follow-up|0|||
161875269|NCT01089608|584585477|FG001|Overall Study|Lost to Follow-up|2|||
161875270|NCT02429778|584585479|FG000|Overall Study|Lost to Follow-up|2|||
161875271|NCT02429778|584585480|FG001|Overall Study|Lost to Follow-up|0|||
161875272|NCT02429778|584585479|FG000|Overall Study|Withdrawal by Subject|5|||
161875273|NCT02429778|584585480|FG001|Overall Study|Withdrawal by Subject|0|||
161875274|NCT01893281|584585481|FG000|Overall Study|Adverse Event|1|||
161875275|NCT01893281|584585481|FG000|Overall Study|Protocol Violation|1|||
161875276|NCT01893281|584585481|FG000|Overall Study|Withdrawal by Subject|1|||
161875277|NCT00789698|584585485|FG000|Overall Study|Lack of Efficacy|10|||
161875278|NCT00789698|584585486|FG001|Overall Study|Lack of Efficacy|4|||
161875279|NCT00789698|584585487|FG002|Overall Study|Lack of Efficacy|5|||
161875280|NCT00789698|584585488|FG003|Overall Study|Lack of Efficacy|18|||
161875281|NCT00789698|584585485|FG000|Overall Study|Adverse Event|5|||
161875282|NCT00789698|584585486|FG001|Overall Study|Adverse Event|5|||
161875283|NCT00789698|584585487|FG002|Overall Study|Adverse Event|3|||
161875284|NCT00789698|584585488|FG003|Overall Study|Adverse Event|4|||
161875285|NCT00789698|584585485|FG000|Overall Study|Lost to Follow-up|5|||
161875286|NCT00789698|584585486|FG001|Overall Study|Lost to Follow-up|5|||
161875287|NCT00789698|584585487|FG002|Overall Study|Lost to Follow-up|2|||
161875288|NCT00789698|584585488|FG003|Overall Study|Lost to Follow-up|9|||
161875289|NCT00789698|584585485|FG000|Overall Study|Protocol Violation|6|||
161875290|NCT00789698|584585486|FG001|Overall Study|Protocol Violation|1|||
161875291|NCT00789698|584585487|FG002|Overall Study|Protocol Violation|2|||
161875292|NCT00789698|584585488|FG003|Overall Study|Protocol Violation|1|||
161875293|NCT00789698|584585485|FG000|Overall Study|Withdrawal by Subject|14|||
161875294|NCT00789698|584585486|FG001|Overall Study|Withdrawal by Subject|15|||
161875295|NCT00789698|584585487|FG002|Overall Study|Withdrawal by Subject|12|||
161875296|NCT00789698|584585488|FG003|Overall Study|Withdrawal by Subject|19|||
161875297|NCT00789698|584585485|FG000|Overall Study|Administrative|0|||
161875298|NCT00789698|584585486|FG001|Overall Study|Administrative|3|||
161875299|NCT00789698|584585487|FG002|Overall Study|Administrative|3|||
161875300|NCT00789698|584585488|FG003|Overall Study|Administrative|1|||
162035861|NCT02361346|585187171|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
162035862|NCT02361346|585187172|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
162035863|NCT02361346|585187173|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
162035864|NCT02361346|585187174|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
162035865|NCT02361346|585187175|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
162035866|NCT02361346|585187167|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161875301|NCT01397786|584587026|FG000|Phase A|Lost to Follow-up|0|||
161875302|NCT01397786|584587027|FG001|Phase A|Lost to Follow-up|0|||
162035867|NCT02361346|585187168|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161875303|NCT01397786|584587028|FG002|Phase A|Lost to Follow-up|6|||
161875304|NCT01397786|584587026|FG000|Phase A|Adverse Event|0|||
161875305|NCT01397786|584587027|FG001|Phase A|Adverse Event|0|||
161875306|NCT01397786|584587028|FG002|Phase A|Adverse Event|8|||
161875307|NCT01397786|584587026|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
161875308|NCT01397786|584587027|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
161875309|NCT01397786|584587028|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
161875310|NCT01397786|584587026|FG000|Phase A|Physician Decision|0|||
161875311|NCT01397786|584587027|FG001|Phase A|Physician Decision|0|||
161875312|NCT01397786|584587028|FG002|Phase A|Physician Decision|1|||
161875313|NCT01397786|584587026|FG000|Phase A|Withdrawal by Subject|0|||
161875314|NCT01397786|584587027|FG001|Phase A|Withdrawal by Subject|0|||
161875315|NCT01397786|584587028|FG002|Phase A|Withdrawal by Subject|5|||
161875316|NCT01397786|584587026|FG000|Phase A|Lack of Efficacy|0|||
161875317|NCT01397786|584587027|FG001|Phase A|Lack of Efficacy|0|||
161875318|NCT01397786|584587028|FG002|Phase A|Lack of Efficacy|1|||
161875319|NCT01397786|584587026|FG000|Phase B|Lost to Follow-up|22|||
161875320|NCT01397786|584587027|FG001|Phase B|Lost to Follow-up|12|||
161875321|NCT01397786|584587028|FG002|Phase B|Lost to Follow-up|22|||
161875322|NCT01397786|584587026|FG000|Phase B|Adverse Event|109|||
161875323|NCT01397786|584587027|FG001|Phase B|Adverse Event|23|||
161875324|NCT01397786|584587028|FG002|Phase B|Adverse Event|27|||
161875325|NCT01397786|584587026|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
161875326|NCT01397786|584587027|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
161875327|NCT01397786|584587028|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
161875328|NCT01397786|584587026|FG000|Phase B|Physician Decision|9|||
161875329|NCT01397786|584587027|FG001|Phase B|Physician Decision|1|||
161875330|NCT01397786|584587028|FG002|Phase B|Physician Decision|3|||
161875331|NCT01397786|584587026|FG000|Phase B|Withdrawal by Subject|102|||
161875332|NCT01397786|584587027|FG001|Phase B|Withdrawal by Subject|45|||
161875333|NCT01397786|584587028|FG002|Phase B|Withdrawal by Subject|30|||
161875334|NCT01397786|584587026|FG000|Phase B|Protocol Deviation|1|||
161875335|NCT01397786|584587027|FG001|Phase B|Protocol Deviation|2|||
161875336|NCT01397786|584587028|FG002|Phase B|Protocol Deviation|4|||
161875337|NCT01397786|584587026|FG000|Phase B|Lack of Efficacy|22|||
161875338|NCT01397786|584587027|FG001|Phase B|Lack of Efficacy|7|||
161875339|NCT01397786|584587028|FG002|Phase B|Lack of Efficacy|14|||
161875340|NCT04250350|584587032|FG000|Overall Study|Withdrawal by Subject|13|||
161875341|NCT04250350|584587032|FG000|Overall Study|Lost to Follow-up|8|||
161875342|NCT04250350|584587032|FG000|Overall Study|Adverse Event|5|||
161875343|NCT04250350|584587032|FG000|Overall Study|Lack of Efficacy|4|||
161875344|NCT04250350|584587032|FG000|Overall Study|Physician Decision|1|||
161875345|NCT04250350|584587032|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
161875346|NCT00860249|584587033|FG000|Overall Study|trial was terminated prior to completion|21|||
161875347|NCT00860249|584587034|FG001|Overall Study|trial was terminated prior to completion|18|||
161875348|NCT00860249|584587035|FG002|Overall Study|trial was terminated prior to completion|21|||
161875349|NCT00743288|584587036|FG000|Overall Study|Adverse Event|1|||
161875350|NCT00743288|584587037|FG001|Overall Study|Adverse Event|1|||
161875351|NCT00743288|584587038|FG002|Overall Study|Adverse Event|2|||
161875352|NCT00743288|584587039|FG003|Overall Study|Adverse Event|2|||
161875353|NCT00743288|584587040|FG004|Overall Study|Adverse Event|1|||
161875354|NCT00743288|584587041|FG005|Overall Study|Adverse Event|1|||
161875355|NCT00743288|584587042|FG006|Overall Study|Adverse Event|2|||
161875356|NCT00743288|584587036|FG000|Overall Study|Withdrawal by Subject|0|||
161875357|NCT00743288|584587037|FG001|Overall Study|Withdrawal by Subject|0|||
161875358|NCT00743288|584587038|FG002|Overall Study|Withdrawal by Subject|1|||
161875359|NCT00743288|584587039|FG003|Overall Study|Withdrawal by Subject|0|||
161875360|NCT00743288|584587040|FG004|Overall Study|Withdrawal by Subject|0|||
161875361|NCT00743288|584587041|FG005|Overall Study|Withdrawal by Subject|1|||
161875362|NCT00743288|584587042|FG006|Overall Study|Withdrawal by Subject|1|||
161875363|NCT00743288|584587036|FG000|Overall Study|Progressive disease (PD)|2|||
161875364|NCT00743288|584587037|FG001|Overall Study|Progressive disease (PD)|0|||
161875365|NCT00743288|584587038|FG002|Overall Study|Progressive disease (PD)|1|||
161875366|NCT00743288|584587039|FG003|Overall Study|Progressive disease (PD)|4|||
161990492|NCT04878211|585016290|FG001|Overall Study|Lost to Follow-up|0|||
161990493|NCT04878211|585016291|FG002|Overall Study|Lost to Follow-up|0|||
161990494|NCT04878211|585016292|FG003|Overall Study|Lost to Follow-up|1|||
161990495|NCT04878211|585016293|FG004|Overall Study|Lost to Follow-up|0|||
161990496|NCT04878211|585016294|FG005|Overall Study|Lost to Follow-up|1|||
161990497|NCT04878211|585016289|FG000|Overall Study|Protocol deviation|1|||
161990498|NCT04878211|585016290|FG001|Overall Study|Protocol deviation|0|||
161990499|NCT04878211|585016291|FG002|Overall Study|Protocol deviation|0|||
161990500|NCT04878211|585016292|FG003|Overall Study|Protocol deviation|0|||
161990501|NCT04878211|585016293|FG004|Overall Study|Protocol deviation|0|||
161990502|NCT04878211|585016294|FG005|Overall Study|Protocol deviation|0|||
162035868|NCT02361346|585187169|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161875367|NCT00743288|584587040|FG004|Overall Study|Progressive disease (PD)|5|||
161875368|NCT00743288|584587041|FG005|Overall Study|Progressive disease (PD)|3|||
161875369|NCT00743288|584587042|FG006|Overall Study|Progressive disease (PD)|6|||
161875370|NCT00743288|584587036|FG000|Overall Study|Worsening of condition (Not PD)|0|||
161875371|NCT00743288|584587037|FG001|Overall Study|Worsening of condition (Not PD)|2|||
161875372|NCT00743288|584587038|FG002|Overall Study|Worsening of condition (Not PD)|1|||
161875373|NCT00743288|584587039|FG003|Overall Study|Worsening of condition (Not PD)|1|||
161875374|NCT00743288|584587040|FG004|Overall Study|Worsening of condition (Not PD)|0|||
161875375|NCT00743288|584587041|FG005|Overall Study|Worsening of condition (Not PD)|0|||
161875376|NCT00743288|584587042|FG006|Overall Study|Worsening of condition (Not PD)|0|||
161875377|NCT02836236|584587047|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
161875378|NCT02836236|584587048|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
161990503|NCT04878211|585016289|FG000|Overall Study|Study terminated by sponsor|0|||
161990504|NCT04878211|585016290|FG001|Overall Study|Study terminated by sponsor|0|||
161875379|NCT02836236|584587049|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
161875380|NCT02836236|584587050|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
161875381|NCT02836236|584587047|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
161875382|NCT02836236|584587048|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
161875383|NCT02836236|584587049|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
161875384|NCT02836236|584587050|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
161875385|NCT02836236|584587047|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161875386|NCT02836236|584587048|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
161875387|NCT02836236|584587049|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
161875388|NCT02836236|584587050|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161875389|NCT02836236|584587047|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
161875390|NCT02836236|584587048|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161875391|NCT02836236|584587049|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161875392|NCT02836236|584587050|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161875393|NCT02836236|584587047|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
161875394|NCT02836236|584587048|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
161875395|NCT02836236|584587049|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
161875396|NCT02836236|584587050|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
161875397|NCT02836236|584587047|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
161875398|NCT02836236|584587048|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
161875399|NCT02836236|584587049|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
161875400|NCT02836236|584587050|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
161875401|NCT02836236|584587047|FG000|Open-Label TAF Treatment Phase|Death|0|||
161875402|NCT02836236|584587048|FG001|Open-Label TAF Treatment Phase|Death|0|||
161875403|NCT02836236|584587049|FG002|Open-Label TAF Treatment Phase|Death|1|||
161875404|NCT02836236|584587050|FG003|Open-Label TAF Treatment Phase|Death|1|||
161875405|NCT02836236|584587047|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
161875406|NCT02836236|584587048|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
161875407|NCT02836236|584587049|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
161875408|NCT02836236|584587050|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
161875409|NCT00378508|584587051|FG000|Overall Study|Withdrawal by Subject|1|||
161875410|NCT00378508|584587052|FG001|Overall Study|Withdrawal by Subject|3|||
161875411|NCT00378508|584587051|FG000|Overall Study|Lost to Follow-up|1|||
161875412|NCT00378508|584587052|FG001|Overall Study|Lost to Follow-up|0|||
161875413|NCT00593684|584587053|FG000|Overall Study|Death|2|||
161875414|NCT00593684|584587054|FG001|Overall Study|Death|1|||
161875415|NCT01669174|584587061|FG000|Overall Study|Subject withdrew consent|2|||
161875416|NCT01669174|584587062|FG001|Overall Study|Subject withdrew consent|2|||
161875417|NCT01669174|584587061|FG000|Overall Study|Lost to Follow-up|1|||
161875418|NCT01669174|584587062|FG001|Overall Study|Lost to Follow-up|0|||
161875419|NCT01669174|584587061|FG000|Overall Study|Adverse Event|2|||
161875420|NCT01669174|584587062|FG001|Overall Study|Adverse Event|2|||
161875421|NCT01669174|584587061|FG000|Overall Study|Administrative problems|1|||
161875422|NCT01669174|584587062|FG001|Overall Study|Administrative problems|2|||
161875423|NCT01953601|584587066|FG000|Part 1 (Base Study)|Adverse Event|24|||
161875424|NCT01953601|584587067|FG001|Part 1 (Base Study)|Adverse Event|37|||
161875425|NCT01953601|584587068|FG002|Part 1 (Base Study)|Adverse Event|15|||
161875426|NCT01953601|584587066|FG000|Part 1 (Base Study)|Death|2|||
161875427|NCT01953601|584587067|FG001|Part 1 (Base Study)|Death|0|||
161875428|NCT01953601|584587068|FG002|Part 1 (Base Study)|Death|3|||
161875429|NCT01953601|584587066|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
161875430|NCT01953601|584587067|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
161875431|NCT01953601|584587068|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
161875432|NCT01953601|584587066|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
161875433|NCT01953601|584587067|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
161875434|NCT01953601|584587068|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
161875435|NCT01953601|584587066|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
161875436|NCT01953601|584587067|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
161875437|NCT01953601|584587068|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
161875438|NCT01953601|584587066|FG000|Part 1 (Base Study)|Physician Decision|3|||
161875439|NCT01953601|584587067|FG001|Part 1 (Base Study)|Physician Decision|7|||
161990505|NCT04878211|585016291|FG002|Overall Study|Study terminated by sponsor|0|||
161990506|NCT04878211|585016292|FG003|Overall Study|Study terminated by sponsor|0|||
161990507|NCT04878211|585016293|FG004|Overall Study|Study terminated by sponsor|9|||
161990508|NCT04878211|585016294|FG005|Overall Study|Study terminated by sponsor|4|||
161875440|NCT01953601|584587068|FG002|Part 1 (Base Study)|Physician Decision|4|||
161875441|NCT01953601|584587066|FG000|Part 1 (Base Study)|Screen failure|1|||
161875442|NCT01953601|584587067|FG001|Part 1 (Base Study)|Screen failure|0|||
161875443|NCT01953601|584587068|FG002|Part 1 (Base Study)|Screen failure|1|||
161875444|NCT01953601|584587066|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
161875445|NCT01953601|584587067|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
161875446|NCT01953601|584587068|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
161990509|NCT04878211|585016289|FG000|Overall Study|Subject decision|0|||
161875447|NCT01953601|584587066|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
161875448|NCT01953601|584587067|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
161875449|NCT01953601|584587068|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
161875450|NCT01953601|584587066|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
161875451|NCT01953601|584587067|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
161875452|NCT01953601|584587068|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
161875453|NCT01953601|584587066|FG000|Part 1 (Base Study)|Subject moved|2|||
161875454|NCT01953601|584587067|FG001|Part 1 (Base Study)|Subject moved|2|||
161875455|NCT01953601|584587068|FG002|Part 1 (Base Study)|Subject moved|1|||
161875456|NCT01953601|584587066|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
161875457|NCT01953601|584587067|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
161875458|NCT01953601|584587068|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
161875459|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Adverse Event|1|||
161875460|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Adverse Event|1|||
161875461|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Adverse Event|10|||
161875462|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Death|0|||
161875463|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Death|3|||
161875464|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Death|0|||
161875465|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
161875466|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
161875467|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
161875468|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
161875469|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
161875470|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
161875471|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Physician Decision|2|||
161875472|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Physician Decision|0|||
161875473|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Physician Decision|2|||
161875474|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
161875475|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
161875476|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
161875477|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
161875478|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
161875479|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
161875480|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
161875481|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
161875482|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
161875483|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Subject moved|0|||
161875484|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Subject moved|0|||
161875485|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Subject moved|1|||
161875486|NCT01953601|584587066|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
161875487|NCT01953601|584587067|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
161875488|NCT01953601|584587068|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
161875489|NCT01905553|584587075|FG000|Period 2|Adverse Event|1|||
161875490|NCT01905553|584587076|FG001|Period 2|Adverse Event|0|||
161875491|NCT04310397|584587077|FG000|Overall Study|Lack of Efficacy|3|||
161875492|NCT04310397|584587077|FG000|Overall Study|Withdrawal by Subject|1|||
161875493|NCT03645395|584587086|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
161875494|NCT03645395|584587087|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
161875495|NCT03645395|584587088|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
161875496|NCT03645395|584587089|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
161875497|NCT03645395|584587086|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
161875498|NCT03645395|584587087|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
161875499|NCT03645395|584587088|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
161990510|NCT04878211|585016290|FG001|Overall Study|Subject decision|0|||
161990511|NCT04878211|585016291|FG002|Overall Study|Subject decision|0|||
161990512|NCT04878211|585016292|FG003|Overall Study|Subject decision|0|||
161990513|NCT04878211|585016293|FG004|Overall Study|Subject decision|1|||
161990514|NCT04878211|585016294|FG005|Overall Study|Subject decision|0|||
161990515|NCT01687101|585016297|FG000|Overall Study|Lost to Follow-up|7|||
161875500|NCT03645395|584587089|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
161875501|NCT03645395|584587086|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
161875502|NCT03645395|584587087|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
161875503|NCT03645395|584587088|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
161990516|NCT03040674|585016299|FG000|Overall Study|Lost to Follow-up|225|||
161990517|NCT03040674|585016299|FG000|Overall Study|Death|23|||
161875504|NCT03645395|584587089|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
161875505|NCT03645395|584587086|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
161875506|NCT03645395|584587087|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
161875507|NCT03645395|584587088|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
161990518|NCT02206035|585016301|FG000|Overall Study|Physician Decision|10|||
161990519|NCT02206035|585016302|FG001|Overall Study|Physician Decision|0|||
161990520|NCT02206035|585016303|FG002|Overall Study|Physician Decision|175|||
161875508|NCT03645395|584587089|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
161875509|NCT01289639|584587091|FG000|Overall Study|Lost to Follow-up|1|||
161875510|NCT01289639|584587092|FG001|Overall Study|Lost to Follow-up|0|||
161875511|NCT01289639|584587093|FG002|Overall Study|Lost to Follow-up|0|||
161875512|NCT02780713|584587094|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
161875513|NCT02780713|584587095|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
161875514|NCT02780713|584587096|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
161875515|NCT02780713|584587097|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
161875516|NCT02780713|584587098|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
161875517|NCT01931475|584587101|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
161875518|NCT01931475|584587102|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
161875519|NCT01931475|584587101|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
161875520|NCT01931475|584587102|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
161875521|NCT01931475|584587101|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
161875522|NCT01931475|584587102|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
161875523|NCT01931475|584587101|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
161875524|NCT01931475|584587102|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
161875525|NCT01931475|584587101|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
161875526|NCT01931475|584587102|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
161875527|NCT01931475|584587101|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
161875528|NCT01931475|584587102|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
161875529|NCT01931475|584587101|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
161875530|NCT01931475|584587102|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
161875531|NCT01931475|584587101|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
161875532|NCT01931475|584587102|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
161875533|NCT01931475|584587101|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
161875534|NCT01931475|584587102|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
161875535|NCT01931475|584587101|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
161875536|NCT01931475|584587102|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
161875537|NCT01931475|584587101|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
161875538|NCT01931475|584587102|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
161875539|NCT00280397|584587103|FG000|Overall Study|Adverse Event|1|||
161875540|NCT01028014|584587113|FG000|Overall Study|Lost to Follow-up|1|||
161875541|NCT01028014|584587114|FG001|Overall Study|Lost to Follow-up|2|||
161875542|NCT01028014|584587115|FG002|Overall Study|Lost to Follow-up|0|||
161875543|NCT01028014|584587116|FG003|Overall Study|Lost to Follow-up|1|||
161875544|NCT01028014|584587117|FG004|Overall Study|Lost to Follow-up|1|||
161875545|NCT01028014|584587118|FG005|Overall Study|Lost to Follow-up|2|||
161875546|NCT01127451|584587119|FG000|Overall Study|Other|2|||
161875547|NCT01127451|584587120|FG001|Overall Study|Other|1|||
161875548|NCT01127451|584587119|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
161875549|NCT01127451|584587120|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
161875550|NCT01127451|584587119|FG000|Overall Study|Death|22|||
161875551|NCT01127451|584587120|FG001|Overall Study|Death|17|||
161875552|NCT01127451|584587119|FG000|Overall Study|Lost to Follow-up|3|||
161875553|NCT01127451|584587120|FG001|Overall Study|Lost to Follow-up|0|||
161875554|NCT01127451|584587119|FG000|Overall Study|Administrative Reason by Sponsor|2|||
161875555|NCT01127451|584587120|FG001|Overall Study|Administrative Reason by Sponsor|2|||
161875556|NCT00425061|584587121|FG000|Overall Study|Adverse Event|1|||
161875557|NCT00425061|584587122|FG001|Overall Study|Adverse Event|0|||
161875558|NCT00425061|584587123|FG002|Overall Study|Adverse Event|0|||
161875559|NCT00425061|584587124|FG003|Overall Study|Adverse Event|2|||
161875560|NCT00425061|584587125|FG004|Overall Study|Adverse Event|2|||
161875561|NCT00425061|584587126|FG005|Overall Study|Adverse Event|0|||
161875562|NCT00425061|584587127|FG006|Overall Study|Adverse Event|0|||
161875563|NCT00425061|584587121|FG000|Overall Study|Lost to Follow-up|0|||
161875564|NCT00425061|584587122|FG001|Overall Study|Lost to Follow-up|1|||
161875565|NCT00425061|584587123|FG002|Overall Study|Lost to Follow-up|0|||
161875566|NCT00425061|584587124|FG003|Overall Study|Lost to Follow-up|0|||
161875567|NCT00425061|584587125|FG004|Overall Study|Lost to Follow-up|0|||
161875568|NCT00425061|584587126|FG005|Overall Study|Lost to Follow-up|0|||
161875569|NCT00425061|584587127|FG006|Overall Study|Lost to Follow-up|0|||
161875570|NCT00425061|584587121|FG000|Overall Study|Protocol Violation|1|||
161875571|NCT00425061|584587122|FG001|Overall Study|Protocol Violation|0|||
161875572|NCT00425061|584587123|FG002|Overall Study|Protocol Violation|0|||
161875573|NCT00425061|584587124|FG003|Overall Study|Protocol Violation|0|||
161875574|NCT00425061|584587125|FG004|Overall Study|Protocol Violation|0|||
161875575|NCT00425061|584587126|FG005|Overall Study|Protocol Violation|0|||
161875576|NCT00425061|584587127|FG006|Overall Study|Protocol Violation|0|||
161875577|NCT00425061|584587121|FG000|Overall Study|Withdrawal by Subject|0|||
161875578|NCT00425061|584587122|FG001|Overall Study|Withdrawal by Subject|1|||
161875579|NCT00425061|584587123|FG002|Overall Study|Withdrawal by Subject|0|||
161990521|NCT01934010|585016304|FG000|Overall Study|Adverse Event|1|||
161990522|NCT01934010|585016305|FG001|Overall Study|Adverse Event|1|||
161875580|NCT00425061|584587124|FG003|Overall Study|Withdrawal by Subject|0|||
161875581|NCT00425061|584587125|FG004|Overall Study|Withdrawal by Subject|1|||
161875582|NCT00425061|584587126|FG005|Overall Study|Withdrawal by Subject|0|||
161875583|NCT00425061|584587127|FG006|Overall Study|Withdrawal by Subject|3|||
161875584|NCT00425061|584587121|FG000|Overall Study|Sponsor's request|0|||
161875585|NCT00425061|584587122|FG001|Overall Study|Sponsor's request|0|||
161875586|NCT00425061|584587123|FG002|Overall Study|Sponsor's request|0|||
161875587|NCT00425061|584587124|FG003|Overall Study|Sponsor's request|0|||
161875588|NCT00425061|584587125|FG004|Overall Study|Sponsor's request|19|||
161875589|NCT00425061|584587126|FG005|Overall Study|Sponsor's request|4|||
161875590|NCT00425061|584587127|FG006|Overall Study|Sponsor's request|15|||
161875591|NCT00425061|584587121|FG000|Overall Study|Physician Decision|0|||
161875592|NCT00425061|584587122|FG001|Overall Study|Physician Decision|0|||
161875593|NCT00425061|584587123|FG002|Overall Study|Physician Decision|0|||
161875594|NCT00425061|584587124|FG003|Overall Study|Physician Decision|0|||
161875595|NCT00425061|584587125|FG004|Overall Study|Physician Decision|1|||
161875596|NCT00425061|584587126|FG005|Overall Study|Physician Decision|0|||
161875597|NCT00425061|584587127|FG006|Overall Study|Physician Decision|0|||
161875598|NCT00425061|584587121|FG000|Overall Study|Other|0|||
161875599|NCT00425061|584587122|FG001|Overall Study|Other|0|||
161875600|NCT00425061|584587123|FG002|Overall Study|Other|0|||
161875601|NCT00425061|584587124|FG003|Overall Study|Other|0|||
161875602|NCT00425061|584587125|FG004|Overall Study|Other|3|||
161875603|NCT00425061|584587126|FG005|Overall Study|Other|0|||
161875604|NCT00425061|584587127|FG006|Overall Study|Other|1|||
161875605|NCT02111577|584587128|FG000|Overall Study|Protocol Violation|2|||
161875606|NCT02111577|584587129|FG001|Overall Study|Protocol Violation|0|||
161875607|NCT02111577|584587128|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
161875608|NCT02111577|584587129|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
161875609|NCT02111577|584587128|FG000|Overall Study|Failure to produce study treatment|6|||
161875610|NCT02111577|584587129|FG001|Overall Study|Failure to produce study treatment|0|||
161875611|NCT02111577|584587128|FG000|Overall Study|Death|518|||
161875612|NCT02111577|584587129|FG001|Overall Study|Death|254|||
161875613|NCT02111577|584587128|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
161875614|NCT02111577|584587129|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
161875615|NCT02111577|584587128|FG000|Overall Study|Adverse Event|1|||
161875616|NCT02111577|584587129|FG001|Overall Study|Adverse Event|1|||
161875617|NCT02111577|584587128|FG000|Overall Study|Withdrawal by Subject|51|||
161875618|NCT02111577|584587129|FG001|Overall Study|Withdrawal by Subject|23|||
161875619|NCT02111577|584587128|FG000|Overall Study|Disease progression|0|||
161875620|NCT02111577|584587129|FG001|Overall Study|Disease progression|1|||
161875621|NCT02111577|584587128|FG000|Overall Study|Lost to Follow-up|19|||
161875622|NCT02111577|584587129|FG001|Overall Study|Lost to Follow-up|10|||
161875623|NCT04590586|584587136|FG000|Overall Study|Death|7|||
161875624|NCT04590586|584587137|FG001|Overall Study|Death|1|||
161875625|NCT04590586|584587138|FG002|Overall Study|Death|37|||
161875626|NCT04590586|584587139|FG003|Overall Study|Death|34|||
161875627|NCT04590586|584587140|FG004|Overall Study|Death|19|||
161875628|NCT04590586|584587141|FG005|Overall Study|Death|3|||
161875629|NCT04590586|584587136|FG000|Overall Study|Lost to Follow-up|3|||
161875630|NCT04590586|584587137|FG001|Overall Study|Lost to Follow-up|0|||
161875631|NCT04590586|584587138|FG002|Overall Study|Lost to Follow-up|11|||
161875632|NCT04590586|584587139|FG003|Overall Study|Lost to Follow-up|11|||
161875633|NCT04590586|584587140|FG004|Overall Study|Lost to Follow-up|6|||
161875634|NCT04590586|584587141|FG005|Overall Study|Lost to Follow-up|0|||
161875635|NCT04590586|584587136|FG000|Overall Study|Withdrawal by Subject|0|||
161875636|NCT04590586|584587137|FG001|Overall Study|Withdrawal by Subject|0|||
161875637|NCT04590586|584587138|FG002|Overall Study|Withdrawal by Subject|6|||
161875638|NCT04590586|584587139|FG003|Overall Study|Withdrawal by Subject|0|||
161875639|NCT04590586|584587140|FG004|Overall Study|Withdrawal by Subject|3|||
161875640|NCT04590586|584587141|FG005|Overall Study|Withdrawal by Subject|0|||
161875641|NCT04590586|584587136|FG000|Overall Study|Other|3|||
161875642|NCT04590586|584587137|FG001|Overall Study|Other|0|||
161875643|NCT04590586|584587138|FG002|Overall Study|Other|1|||
161875644|NCT04590586|584587139|FG003|Overall Study|Other|1|||
161990523|NCT01934010|585016306|FG002|Overall Study|Adverse Event|0|||
161990524|NCT01934010|585016304|FG000|Overall Study|Withdrawal by Subject|15|||
161990525|NCT01934010|585016305|FG001|Overall Study|Withdrawal by Subject|6|||
161990526|NCT01934010|585016306|FG002|Overall Study|Withdrawal by Subject|2|||
161990527|NCT01934010|585016304|FG000|Overall Study|Lost to Follow-up|7|||
161990528|NCT01934010|585016305|FG001|Overall Study|Lost to Follow-up|4|||
161875645|NCT04590586|584587140|FG004|Overall Study|Other|2|||
161875646|NCT04590586|584587141|FG005|Overall Study|Other|1|||
161875647|NCT01609543|584587142|FG000|Overall Study|Disease Progression|28|||
161875648|NCT01609543|584587142|FG000|Overall Study|Adverse Event|5|||
161875649|NCT01609543|584587142|FG000|Overall Study|Withdrawal by Subject|1|||
161875650|NCT01609543|584587142|FG000|Overall Study|Protocol Violation|1|||
161875651|NCT01609543|584587142|FG000|Overall Study|Death|7|||
161990529|NCT01934010|585016306|FG002|Overall Study|Lost to Follow-up|0|||
161875652|NCT01254318|584587143|FG000|Overall Study|Lost to Follow-up|5|||
161875653|NCT01254318|584587143|FG000|Overall Study|Death|47|||
161875654|NCT01137110|584587144|FG000|Overall Study|Protocol Violation|1|||
161875655|NCT01137110|584587145|FG001|Overall Study|Protocol Violation|0|||
161875656|NCT02828124|584587148|FG000|Overall Study|Disease Progression|1|||
161875657|NCT02828124|584587149|FG001|Overall Study|Disease Progression|2|||
161875658|NCT02828124|584587150|FG002|Overall Study|Disease Progression|1|||
161875659|NCT02828124|584587151|FG003|Overall Study|Disease Progression|4|||
161875660|NCT02828124|584587148|FG000|Overall Study|AE Unrelated to Study Drug|0|||
161875661|NCT02828124|584587149|FG001|Overall Study|AE Unrelated to Study Drug|0|||
161875662|NCT02828124|584587150|FG002|Overall Study|AE Unrelated to Study Drug|0|||
161875663|NCT02828124|584587151|FG003|Overall Study|AE Unrelated to Study Drug|1|||
161875664|NCT02828124|584587148|FG000|Overall Study|Subject Withdrew Consent|0|||
161875665|NCT02828124|584587149|FG001|Overall Study|Subject Withdrew Consent|0|||
161875666|NCT02828124|584587150|FG002|Overall Study|Subject Withdrew Consent|0|||
161875667|NCT02828124|584587151|FG003|Overall Study|Subject Withdrew Consent|1|||
161875668|NCT03990571|584587152|FG000|Overall Study|Withdrawal by Subject|1|||
161875669|NCT03990571|584587152|FG000|Overall Study|Insurance Issues|3|||
161875670|NCT03990571|584587152|FG000|Overall Study|Covid Restrictions|2|||
161875671|NCT00634803|584587153|FG000|Overall Study|Lost to Follow-up|6|||
161875672|NCT00634803|584587154|FG001|Overall Study|Lost to Follow-up|7|||
161875673|NCT00634803|584587155|FG002|Overall Study|Lost to Follow-up|7|||
161875674|NCT04105218|584587157|FG000|Overall Study|Withdrawal by Subject|3|||
161875675|NCT04105218|584587158|FG001|Overall Study|Withdrawal by Subject|2|||
161875676|NCT04105218|584587157|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
161875677|NCT04105218|584587158|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
161875678|NCT04105218|584587157|FG000|Overall Study|Failed screening tests|2|||
161875679|NCT04105218|584587158|FG001|Overall Study|Failed screening tests|1|||
161875680|NCT02553499|584587165|FG000|Overall Study|Adverse Event|0|||
161875681|NCT02553499|584587166|FG001|Overall Study|Adverse Event|0|||
161875682|NCT02553499|584587167|FG002|Overall Study|Adverse Event|0|||
161875683|NCT02553499|584587168|FG003|Overall Study|Adverse Event|0|||
161875684|NCT02553499|584587169|FG004|Overall Study|Adverse Event|0|||
161875685|NCT02553499|584587170|FG005|Overall Study|Adverse Event|0|||
161875686|NCT02553499|584587171|FG006|Overall Study|Adverse Event|1|||
161875687|NCT02553499|584587172|FG007|Overall Study|Adverse Event|1|||
161875688|NCT02553499|584587173|FG008|Overall Study|Adverse Event|0|||
161875689|NCT02553499|584587174|FG009|Overall Study|Adverse Event|0|||
161875690|NCT02553499|584587175|FG010|Overall Study|Adverse Event|0|||
161875691|NCT02553499|584587176|FG011|Overall Study|Adverse Event|0|||
161875692|NCT02553499|584587177|FG012|Overall Study|Adverse Event|0|||
161875693|NCT02553499|584587178|FG013|Overall Study|Adverse Event|1|||
161875694|NCT02553499|584587165|FG000|Overall Study|Death|0|||
161875695|NCT02553499|584587166|FG001|Overall Study|Death|1|||
161875696|NCT02553499|584587167|FG002|Overall Study|Death|1|||
161875697|NCT02553499|584587168|FG003|Overall Study|Death|0|||
161875698|NCT02553499|584587169|FG004|Overall Study|Death|1|||
161875699|NCT02553499|584587170|FG005|Overall Study|Death|2|||
161875700|NCT02553499|584587171|FG006|Overall Study|Death|0|||
161875701|NCT02553499|584587172|FG007|Overall Study|Death|0|||
161875702|NCT02553499|584587173|FG008|Overall Study|Death|0|||
161875703|NCT02553499|584587174|FG009|Overall Study|Death|0|||
161875704|NCT02553499|584587175|FG010|Overall Study|Death|1|||
161875705|NCT02553499|584587176|FG011|Overall Study|Death|0|||
161875706|NCT02553499|584587177|FG012|Overall Study|Death|0|||
161875707|NCT02553499|584587178|FG013|Overall Study|Death|0|||
161875708|NCT02553499|584587165|FG000|Overall Study|Lost to Follow-up|0|||
161875709|NCT02553499|584587166|FG001|Overall Study|Lost to Follow-up|0|||
161875710|NCT02553499|584587167|FG002|Overall Study|Lost to Follow-up|0|||
161875711|NCT02553499|584587168|FG003|Overall Study|Lost to Follow-up|0|||
161875712|NCT02553499|584587169|FG004|Overall Study|Lost to Follow-up|0|||
161875713|NCT02553499|584587170|FG005|Overall Study|Lost to Follow-up|0|||
161875714|NCT02553499|584587171|FG006|Overall Study|Lost to Follow-up|1|||
161875715|NCT02553499|584587172|FG007|Overall Study|Lost to Follow-up|0|||
161875716|NCT02553499|584587173|FG008|Overall Study|Lost to Follow-up|0|||
161875717|NCT02553499|584587174|FG009|Overall Study|Lost to Follow-up|0|||
161990530|NCT01746368|585016308|FG000|Overall Study|Lost to Follow-up|2|||
161990531|NCT01746368|585016309|FG001|Overall Study|Lost to Follow-up|0|||
161990532|NCT01746368|585016308|FG000|Overall Study|Withdrawal by Subject|0|||
161875718|NCT02553499|584587175|FG010|Overall Study|Lost to Follow-up|0|||
161875719|NCT02553499|584587176|FG011|Overall Study|Lost to Follow-up|0|||
161875720|NCT02553499|584587177|FG012|Overall Study|Lost to Follow-up|0|||
161875721|NCT02553499|584587178|FG013|Overall Study|Lost to Follow-up|0|||
161875722|NCT02553499|584587165|FG000|Overall Study|Physician Decision|0|||
161875723|NCT02553499|584587166|FG001|Overall Study|Physician Decision|1|||
161875724|NCT02553499|584587167|FG002|Overall Study|Physician Decision|1|||
161875725|NCT02553499|584587168|FG003|Overall Study|Physician Decision|0|||
161875726|NCT02553499|584587169|FG004|Overall Study|Physician Decision|1|||
161875727|NCT02553499|584587170|FG005|Overall Study|Physician Decision|0|||
161875728|NCT02553499|584587171|FG006|Overall Study|Physician Decision|0|||
161875729|NCT02553499|584587172|FG007|Overall Study|Physician Decision|1|||
161875730|NCT02553499|584587173|FG008|Overall Study|Physician Decision|1|||
161875731|NCT02553499|584587174|FG009|Overall Study|Physician Decision|2|||
161875732|NCT02553499|584587175|FG010|Overall Study|Physician Decision|1|||
161875733|NCT02553499|584587176|FG011|Overall Study|Physician Decision|3|||
161875734|NCT02553499|584587177|FG012|Overall Study|Physician Decision|1|||
161875735|NCT02553499|584587178|FG013|Overall Study|Physician Decision|0|||
161875736|NCT02553499|584587165|FG000|Overall Study|Progressive Disease|0|||
161875737|NCT02553499|584587166|FG001|Overall Study|Progressive Disease|0|||
161875738|NCT02553499|584587167|FG002|Overall Study|Progressive Disease|0|||
161875739|NCT02553499|584587168|FG003|Overall Study|Progressive Disease|2|||
161875740|NCT02553499|584587169|FG004|Overall Study|Progressive Disease|1|||
161875741|NCT02553499|584587170|FG005|Overall Study|Progressive Disease|1|||
161875742|NCT02553499|584587171|FG006|Overall Study|Progressive Disease|1|||
161875743|NCT02553499|584587172|FG007|Overall Study|Progressive Disease|0|||
161875744|NCT02553499|584587173|FG008|Overall Study|Progressive Disease|0|||
161875745|NCT02553499|584587174|FG009|Overall Study|Progressive Disease|1|||
161875746|NCT02553499|584587175|FG010|Overall Study|Progressive Disease|0|||
161875747|NCT02553499|584587176|FG011|Overall Study|Progressive Disease|0|||
161875748|NCT02553499|584587177|FG012|Overall Study|Progressive Disease|2|||
161875749|NCT02553499|584587178|FG013|Overall Study|Progressive Disease|1|||
161875750|NCT02553499|584587165|FG000|Overall Study|Study Terminated by Sponsor|0|||
161875751|NCT02553499|584587166|FG001|Overall Study|Study Terminated by Sponsor|0|||
161875752|NCT02553499|584587167|FG002|Overall Study|Study Terminated by Sponsor|0|||
161875753|NCT02553499|584587168|FG003|Overall Study|Study Terminated by Sponsor|0|||
161875754|NCT02553499|584587169|FG004|Overall Study|Study Terminated by Sponsor|0|||
161875755|NCT02553499|584587170|FG005|Overall Study|Study Terminated by Sponsor|0|||
161875756|NCT02553499|584587171|FG006|Overall Study|Study Terminated by Sponsor|0|||
161875757|NCT02553499|584587172|FG007|Overall Study|Study Terminated by Sponsor|0|||
161875758|NCT02553499|584587173|FG008|Overall Study|Study Terminated by Sponsor|1|||
161875759|NCT02553499|584587174|FG009|Overall Study|Study Terminated by Sponsor|0|||
161875760|NCT02553499|584587175|FG010|Overall Study|Study Terminated by Sponsor|0|||
161875761|NCT02553499|584587176|FG011|Overall Study|Study Terminated by Sponsor|0|||
161875762|NCT02553499|584587177|FG012|Overall Study|Study Terminated by Sponsor|0|||
161875763|NCT02553499|584587178|FG013|Overall Study|Study Terminated by Sponsor|0|||
161875764|NCT02553499|584587165|FG000|Overall Study|Withdrawal by Subject|2|||
161875765|NCT02553499|584587166|FG001|Overall Study|Withdrawal by Subject|0|||
161875766|NCT02553499|584587167|FG002|Overall Study|Withdrawal by Subject|0|||
161875767|NCT02553499|584587168|FG003|Overall Study|Withdrawal by Subject|0|||
161875768|NCT02553499|584587169|FG004|Overall Study|Withdrawal by Subject|0|||
161875769|NCT02553499|584587170|FG005|Overall Study|Withdrawal by Subject|0|||
161875770|NCT02553499|584587171|FG006|Overall Study|Withdrawal by Subject|0|||
161875771|NCT02553499|584587172|FG007|Overall Study|Withdrawal by Subject|1|||
161875772|NCT02553499|584587173|FG008|Overall Study|Withdrawal by Subject|1|||
161875773|NCT02553499|584587174|FG009|Overall Study|Withdrawal by Subject|0|||
162035869|NCT02361346|585187170|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
162035870|NCT02361346|585187171|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
162035871|NCT02361346|585187172|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
162035872|NCT02361346|585187173|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161776200|NCT01569074|584223138|FG002|Overall Study|Severe non-compliance to protocol|1|||
161776201|NCT01569074|584223139|FG003|Overall Study|Severe non-compliance to protocol|0|||
161776202|NCT01569074|584223140|FG004|Overall Study|Severe non-compliance to protocol|0|||
161776203|NCT01569074|584223136|FG000|Overall Study|eg change in circumstances|0|||
161776204|NCT01569074|584223137|FG001|Overall Study|eg change in circumstances|2|||
161776205|NCT01569074|584223138|FG002|Overall Study|eg change in circumstances|0|||
161776206|NCT01569074|584223139|FG003|Overall Study|eg change in circumstances|1|||
161776207|NCT01569074|584223140|FG004|Overall Study|eg change in circumstances|1|||
161776208|NCT01569074|584223136|FG000|Overall Study|Adverse Event|1|||
161776209|NCT01569074|584223137|FG001|Overall Study|Adverse Event|0|||
161776210|NCT01569074|584223138|FG002|Overall Study|Adverse Event|3|||
161776211|NCT01569074|584223139|FG003|Overall Study|Adverse Event|0|||
161776212|NCT01569074|584223140|FG004|Overall Study|Adverse Event|0|||
161875774|NCT02553499|584587175|FG010|Overall Study|Withdrawal by Subject|1|||
161875775|NCT02553499|584587176|FG011|Overall Study|Withdrawal by Subject|0|||
161875776|NCT02553499|584587177|FG012|Overall Study|Withdrawal by Subject|0|||
161875777|NCT02553499|584587178|FG013|Overall Study|Withdrawal by Subject|0|||
161875778|NCT00570063|584587179|FG000|Overall Study|Adverse Event|4|||
161875779|NCT00570063|584587180|FG001|Overall Study|Adverse Event|1|||
161875780|NCT00570063|584587179|FG000|Overall Study|Lack of Efficacy|0|||
161875781|NCT00570063|584587180|FG001|Overall Study|Lack of Efficacy|1|||
161875782|NCT00570063|584587179|FG000|Overall Study|Withdrawal by Subject|4|||
161875783|NCT00570063|584587180|FG001|Overall Study|Withdrawal by Subject|3|||
161875784|NCT00570063|584587179|FG000|Overall Study|Sponsor's Decision|7|||
161776213|NCT00669110|584223141|FG000|Overall Study|Adverse Event|4|||
161776214|NCT00669110|584223142|FG001|Overall Study|Adverse Event|3|||
161776215|NCT00669110|584223141|FG000|Overall Study|Caregiver request|3|||
161776216|NCT00669110|584223142|FG001|Overall Study|Caregiver request|2|||
161875785|NCT00570063|584587180|FG001|Overall Study|Sponsor's Decision|3|||
161875786|NCT00550043|584587184|FG000|Overall Study|Adverse Event|0|||
161875787|NCT00550043|584587185|FG001|Overall Study|Adverse Event|0|||
161875788|NCT00550043|584587186|FG002|Overall Study|Adverse Event|0|||
161875789|NCT00550043|584587187|FG003|Overall Study|Adverse Event|1|||
161875790|NCT00550043|584587188|FG004|Overall Study|Adverse Event|1|||
161990533|NCT01746368|585016309|FG001|Overall Study|Withdrawal by Subject|1|||
161776217|NCT00669110|584223141|FG000|Overall Study|Physician Decision|0|||
161776218|NCT00669110|584223142|FG001|Overall Study|Physician Decision|1|||
161776219|NCT00669110|584223141|FG000|Overall Study|Lost to Follow-up|1|||
161776220|NCT00669110|584223142|FG001|Overall Study|Lost to Follow-up|0|||
161776221|NCT00669110|584223141|FG000|Overall Study|Protocol Violation|0|||
161776222|NCT00669110|584223142|FG001|Overall Study|Protocol Violation|5|||
161776223|NCT00669110|584223141|FG000|Overall Study|Withdrawal by Subject|0|||
161776224|NCT00669110|584223142|FG001|Overall Study|Withdrawal by Subject|2|||
161776225|NCT05168657|584223145|FG000|Overall Study|Adverse Event|0|||
161776226|NCT05168657|584223146|FG001|Overall Study|Adverse Event|0|||
161776227|NCT05168657|584223147|FG002|Overall Study|Adverse Event|1|||
161776228|NCT05168657|584223148|FG003|Overall Study|Adverse Event|0|||
161776229|NCT05168657|584223149|FG004|Overall Study|Adverse Event|0|||
161776230|NCT05168657|584223150|FG005|Overall Study|Adverse Event|0|||
161776231|NCT05168657|584223151|FG006|Overall Study|Adverse Event|0|||
161776232|NCT05168657|584223152|FG007|Overall Study|Adverse Event|0|||
161776233|NCT00962013|584223153|FG000|Overall Study|Did not have surgery|1|||
161776234|NCT00962013|584223153|FG000|Overall Study|Death|8|||
161776235|NCT00962013|584223153|FG000|Overall Study|Lost to Follow-up|12|||
161776236|NCT00962013|584223153|FG000|Overall Study|Unable/Unwilling to return|6|||
161776237|NCT00962013|584223153|FG000|Overall Study|Withdrawal by Subject|8|||
161776238|NCT00962013|584223153|FG000|Overall Study|Removal of study device|3|||
161776239|NCT00962013|584223153|FG000|Overall Study|Site Termination|24|||
161776240|NCT00962013|584223153|FG000|Overall Study|No 5 year evaluation|6|||
161776241|NCT03843775|584223156|FG000|Overall Study|Adverse Event|1|||
161776242|NCT03843775|584223157|FG001|Overall Study|Adverse Event|1|||
161776243|NCT03843775|584223156|FG000|Overall Study|Lack of Efficacy|2|||
161776244|NCT03843775|584223157|FG001|Overall Study|Lack of Efficacy|6|||
161776245|NCT03843775|584223156|FG000|Overall Study|Withdrawal by Subject|0|||
161776246|NCT03843775|584223157|FG001|Overall Study|Withdrawal by Subject|1|||
161776247|NCT00530621|584223160|FG000|Overall Study|Adverse Event|11|||
161776248|NCT00530621|584223161|FG001|Overall Study|Adverse Event|8|||
161776249|NCT00530621|584223160|FG000|Overall Study|Physician Decision|2|||
161776250|NCT00530621|584223161|FG001|Overall Study|Physician Decision|4|||
161776251|NCT00530621|584223160|FG000|Overall Study|Progressive Disease (PD)|47|||
161776252|NCT00530621|584223161|FG001|Overall Study|Progressive Disease (PD)|40|||
161776253|NCT00530621|584223160|FG000|Overall Study|Sponsor Decision|12|||
161776254|NCT00530621|584223161|FG001|Overall Study|Sponsor Decision|15|||
161776255|NCT00530621|584223160|FG000|Overall Study|Subject Decision|4|||
161776256|NCT00530621|584223161|FG001|Overall Study|Subject Decision|7|||
161776257|NCT00530621|584223160|FG000|Overall Study|Death|3|||
161776258|NCT00530621|584223161|FG001|Overall Study|Death|6|||
161776259|NCT00530621|584223160|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
161776260|NCT00530621|584223161|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
161776261|NCT04611152|584223164|FG000|Overall Study|Adverse Event|9|||
161776262|NCT04611152|584223165|FG001|Overall Study|Adverse Event|8|||
161776263|NCT04611152|584223164|FG000|Overall Study|Non-compliance with study schedule|1|||
161776264|NCT04611152|584223165|FG001|Overall Study|Non-compliance with study schedule|3|||
161776265|NCT04611152|584223164|FG000|Overall Study|Withdrawal by Subject|5|||
161776266|NCT04611152|584223165|FG001|Overall Study|Withdrawal by Subject|6|||
161776267|NCT04611152|584223164|FG000|Overall Study|Lost to Follow-up|11|||
161776268|NCT04611152|584223165|FG001|Overall Study|Lost to Follow-up|2|||
161776269|NCT03917654|584223172|FG000|Year 1|Withdrawal by Subject|1|||
161776270|NCT03917654|584223173|FG001|Year 1|Withdrawal by Subject|0|||
161776271|NCT03917654|584223174|FG002|Year 1|Withdrawal by Subject|0|||
161776272|NCT03917654|584223175|FG003|Year 1|Withdrawal by Subject|0|||
161776273|NCT03917654|584223176|FG004|Year 1|Withdrawal by Subject|0|||
161776274|NCT03917654|584223177|FG005|Year 1|Withdrawal by Subject|1|||
161776275|NCT03917654|584223178|FG006|Year 1|Withdrawal by Subject|6|||
161776276|NCT03917654|584223179|FG007|Year 1|Withdrawal by Subject|2|||
161776277|NCT03917654|584223180|FG008|Year 1|Withdrawal by Subject|5|||
161776278|NCT03917654|584223181|FG009|Year 1|Withdrawal by Subject|3|||
161776279|NCT03917654|584223182|FG010|Year 1|Withdrawal by Subject|1|||
161776280|NCT03917654|584223183|FG011|Year 1|Withdrawal by Subject|0|||
161776281|NCT03917654|584223172|FG000|Year 1|Travel|0|||
161776282|NCT03917654|584223173|FG001|Year 1|Travel|1|||
161776283|NCT03917654|584223174|FG002|Year 1|Travel|1|||
161776284|NCT03917654|584223175|FG003|Year 1|Travel|0|||
161776285|NCT03917654|584223176|FG004|Year 1|Travel|4|||
161776286|NCT03917654|584223177|FG005|Year 1|Travel|4|||
161776287|NCT03917654|584223178|FG006|Year 1|Travel|10|||
161776288|NCT03917654|584223179|FG007|Year 1|Travel|8|||
161875791|NCT00550043|584587184|FG000|Overall Study|Subject Withdrew Consent|0|||
161875792|NCT00550043|584587185|FG001|Overall Study|Subject Withdrew Consent|2|||
161875793|NCT00550043|584587186|FG002|Overall Study|Subject Withdrew Consent|1|||
161875794|NCT00550043|584587187|FG003|Overall Study|Subject Withdrew Consent|0|||
161875795|NCT00550043|584587188|FG004|Overall Study|Subject Withdrew Consent|0|||
161875796|NCT00550043|584587184|FG000|Overall Study|Other Reasons- Unspecified|0|||
161875797|NCT00550043|584587185|FG001|Overall Study|Other Reasons- Unspecified|1|||
161875798|NCT00550043|584587186|FG002|Overall Study|Other Reasons- Unspecified|0|||
161875799|NCT00550043|584587187|FG003|Overall Study|Other Reasons- Unspecified|1|||
161875800|NCT00550043|584587188|FG004|Overall Study|Other Reasons- Unspecified|0|||
161875801|NCT00519428|584589555|FG000|Overall Study|Adverse Event|5|||
161875802|NCT00519428|584589556|FG001|Overall Study|Adverse Event|2|||
161875803|NCT00519428|584589557|FG002|Overall Study|Adverse Event|10|||
161875804|NCT00519428|584589555|FG000|Overall Study|Lost to Follow-up|7|||
161875805|NCT00519428|584589556|FG001|Overall Study|Lost to Follow-up|7|||
161875806|NCT00519428|584589557|FG002|Overall Study|Lost to Follow-up|6|||
161875807|NCT00519428|584589555|FG000|Overall Study|Withdrawal by Subject|8|||
161875808|NCT00519428|584589556|FG001|Overall Study|Withdrawal by Subject|3|||
161875809|NCT00519428|584589557|FG002|Overall Study|Withdrawal by Subject|7|||
161875810|NCT00519428|584589555|FG000|Overall Study|unstated|1|||
161875811|NCT00519428|584589556|FG001|Overall Study|unstated|3|||
161875812|NCT00519428|584589557|FG002|Overall Study|unstated|2|||
161875813|NCT00688701|584589558|FG000|Overall Study|Adverse Event|1|||
161875814|NCT00688701|584589559|FG001|Overall Study|Adverse Event|0|||
161875815|NCT00688701|584589560|FG002|Overall Study|Adverse Event|5|||
161875816|NCT00688701|584589561|FG003|Overall Study|Adverse Event|3|||
161875817|NCT00688701|584589558|FG000|Overall Study|Lack of Efficacy|0|||
161875818|NCT00688701|584589559|FG001|Overall Study|Lack of Efficacy|1|||
161875819|NCT00688701|584589560|FG002|Overall Study|Lack of Efficacy|0|||
161875820|NCT00688701|584589561|FG003|Overall Study|Lack of Efficacy|0|||
161875821|NCT00688701|584589558|FG000|Overall Study|Withdrawal by Subject|3|||
161875822|NCT00688701|584589559|FG001|Overall Study|Withdrawal by Subject|3|||
161875823|NCT00688701|584589560|FG002|Overall Study|Withdrawal by Subject|4|||
161875824|NCT00688701|584589561|FG003|Overall Study|Withdrawal by Subject|8|||
161875825|NCT00688701|584589558|FG000|Overall Study|Poor compliance to protocol|0|||
161875826|NCT00688701|584589559|FG001|Overall Study|Poor compliance to protocol|1|||
161875827|NCT00688701|584589560|FG002|Overall Study|Poor compliance to protocol|1|||
161875828|NCT00688701|584589561|FG003|Overall Study|Poor compliance to protocol|0|||
161875829|NCT01275755|584589571|FG000|Double-blind Treatment Period|Adverse Event|0|||
161875830|NCT01275755|584589572|FG001|Double-blind Treatment Period|Adverse Event|2|||
161875831|NCT01275755|584589571|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
161875832|NCT01275755|584589572|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
161875833|NCT01275755|584589571|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161875834|NCT01275755|584589572|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
161875835|NCT01275755|584589571|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
161875836|NCT01275755|584589572|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
161875837|NCT04420585|584589575|FG000|Overall Study|Adverse Event|1|||
161875838|NCT04420585|584589575|FG000|Overall Study|Never initiated medication|2|||
161875839|NCT03693612|584589578|FG000|Overall Study|Lost to Follow-up|0|||
161875840|NCT03693612|584589579|FG001|Overall Study|Lost to Follow-up|0|||
161875841|NCT03693612|584589580|FG002|Overall Study|Lost to Follow-up|0|||
161875842|NCT03693612|584589581|FG003|Overall Study|Lost to Follow-up|0|||
161875843|NCT03693612|584589582|FG004|Overall Study|Lost to Follow-up|1|||
161875844|NCT03693612|584589583|FG005|Overall Study|Lost to Follow-up|0|||
161875845|NCT03693612|584589584|FG006|Overall Study|Lost to Follow-up|0|||
161875846|NCT03693612|584589578|FG000|Overall Study|Withdrawal by Subject|0|||
161875847|NCT03693612|584589579|FG001|Overall Study|Withdrawal by Subject|0|||
161875848|NCT03693612|584589580|FG002|Overall Study|Withdrawal by Subject|1|||
161875849|NCT03693612|584589581|FG003|Overall Study|Withdrawal by Subject|0|||
161875850|NCT03693612|584589582|FG004|Overall Study|Withdrawal by Subject|2|||
161875851|NCT03693612|584589583|FG005|Overall Study|Withdrawal by Subject|0|||
161875852|NCT03693612|584589584|FG006|Overall Study|Withdrawal by Subject|0|||
161990534|NCT00377858|585016310|FG000|Overall Study|Withdrawal by Subject|12|||
161990535|NCT00377858|585016311|FG001|Overall Study|Withdrawal by Subject|11|||
161875853|NCT03693612|584589578|FG000|Overall Study|Study Terminated by Sponsor|0|||
161875854|NCT03693612|584589579|FG001|Overall Study|Study Terminated by Sponsor|1|||
161875855|NCT03693612|584589580|FG002|Overall Study|Study Terminated by Sponsor|0|||
161875856|NCT03693612|584589581|FG003|Overall Study|Study Terminated by Sponsor|0|||
161875857|NCT03693612|584589582|FG004|Overall Study|Study Terminated by Sponsor|3|||
161875858|NCT03693612|584589583|FG005|Overall Study|Study Terminated by Sponsor|0|||
161875859|NCT03693612|584589584|FG006|Overall Study|Study Terminated by Sponsor|0|||
161990536|NCT00377858|585016310|FG000|Overall Study|Lost to Follow-up|6|||
161875860|NCT03962790|584589585|FG000|Period 1|Adverse Event|0|||
161875861|NCT03962790|584589586|FG001|Period 1|Adverse Event|1|||
161875862|NCT03962790|584589585|FG000|Period 1|Failed to meet all eligibility criteria|1|||
161875863|NCT03962790|584589586|FG001|Period 1|Failed to meet all eligibility criteria|1|||
161990537|NCT00377858|585016311|FG001|Overall Study|Lost to Follow-up|1|||
161875864|NCT03962790|584589585|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
161875865|NCT03962790|584589586|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
161875866|NCT03962790|584589585|FG000|Period 1|Withdrawal by Subject|1|||
161875867|NCT03962790|584589586|FG001|Period 1|Withdrawal by Subject|0|||
161875868|NCT01608087|584589592|FG000|Overall Study|Lost to Follow-up|0|||
161875869|NCT01608087|584589593|FG001|Overall Study|Lost to Follow-up|1|||
161875870|NCT01608087|584589594|FG002|Overall Study|Lost to Follow-up|0|||
161875871|NCT01608087|584589592|FG000|Overall Study|Other Reason|0|||
161875872|NCT01608087|584589593|FG001|Overall Study|Other Reason|1|||
161875873|NCT01608087|584589594|FG002|Overall Study|Other Reason|0|||
161875874|NCT00664859|584589604|FG000|Overall Study|Adverse Event|2|||
161875875|NCT00664859|584589605|FG001|Overall Study|Adverse Event|1|||
161875876|NCT00664859|584589606|FG002|Overall Study|Adverse Event|3|||
161875877|NCT00664859|584589604|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
161875878|NCT00664859|584589605|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
161875879|NCT00664859|584589606|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
161875880|NCT00664859|584589604|FG000|Overall Study|Noncompliance with protocol|1|||
161875881|NCT00664859|584589605|FG001|Overall Study|Noncompliance with protocol|0|||
161875882|NCT00664859|584589606|FG002|Overall Study|Noncompliance with protocol|4|||
161875883|NCT00664859|584589604|FG000|Overall Study|Laboratory abnormality|2|||
161875884|NCT00664859|584589605|FG001|Overall Study|Laboratory abnormality|1|||
161875885|NCT00664859|584589606|FG002|Overall Study|Laboratory abnormality|4|||
161875886|NCT00664859|584589604|FG000|Overall Study|Withdrawal by Subject|4|||
161875887|NCT00664859|584589605|FG001|Overall Study|Withdrawal by Subject|1|||
161875888|NCT00664859|584589606|FG002|Overall Study|Withdrawal by Subject|3|||
161875889|NCT00664859|584589604|FG000|Overall Study|Lost to Follow-up|2|||
161875890|NCT00664859|584589605|FG001|Overall Study|Lost to Follow-up|2|||
161875891|NCT00664859|584589606|FG002|Overall Study|Lost to Follow-up|1|||
161875892|NCT00664859|584589604|FG000|Overall Study|Other|0|||
161875893|NCT00664859|584589605|FG001|Overall Study|Other|1|||
161875894|NCT00664859|584589606|FG002|Overall Study|Other|2|||
161875895|NCT01943851|584589607|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875896|NCT01943851|584589608|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875897|NCT01943851|584589609|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875898|NCT01943851|584589610|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
161875899|NCT01943851|584589611|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875900|NCT01943851|584589612|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875901|NCT01943851|584589613|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
161875902|NCT01943851|584589614|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
161875903|NCT01943851|584589615|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
161875904|NCT01943851|584589616|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875905|NCT01943851|584589617|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875906|NCT01943851|584589618|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875907|NCT01943851|584589619|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875908|NCT01943851|584589620|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875909|NCT01943851|584589621|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875910|NCT01943851|584589622|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875911|NCT01943851|584589623|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875912|NCT01943851|584589624|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161875913|NCT01943851|584589607|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875914|NCT01943851|584589608|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875915|NCT01943851|584589609|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875916|NCT01943851|584589610|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875917|NCT01943851|584589611|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
161875918|NCT01943851|584589612|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875919|NCT01943851|584589613|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875920|NCT01943851|584589614|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
161875921|NCT01943851|584589615|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875922|NCT01943851|584589616|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875923|NCT01943851|584589617|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875924|NCT01943851|584589618|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875925|NCT01943851|584589619|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875926|NCT01943851|584589620|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875927|NCT01943851|584589621|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875928|NCT01943851|584589622|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875929|NCT01943851|584589623|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875930|NCT01943851|584589624|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161875931|NCT01943851|584589607|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875932|NCT01943851|584589608|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875933|NCT01943851|584589609|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875934|NCT01943851|584589610|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875935|NCT01943851|584589611|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875936|NCT01943851|584589612|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875937|NCT01943851|584589613|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875938|NCT01943851|584589614|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875939|NCT01943851|584589615|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875940|NCT01943851|584589616|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875941|NCT01943851|584589617|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875942|NCT01943851|584589618|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875943|NCT01943851|584589619|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875944|NCT01943851|584589620|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
161875945|NCT01943851|584589621|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875946|NCT01943851|584589622|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875947|NCT01943851|584589623|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875948|NCT01943851|584589624|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161875949|NCT01943851|584589607|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875950|NCT01943851|584589608|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875951|NCT01943851|584589609|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875952|NCT01943851|584589610|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875953|NCT01943851|584589611|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875954|NCT01943851|584589612|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875955|NCT01943851|584589613|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875956|NCT01943851|584589614|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875957|NCT01943851|584589615|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875958|NCT01943851|584589616|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875959|NCT01943851|584589617|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875960|NCT01943851|584589618|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875961|NCT01943851|584589619|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875962|NCT01943851|584589620|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875963|NCT01943851|584589621|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875964|NCT01943851|584589622|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
161776289|NCT03917654|584223180|FG008|Year 1|Travel|2|||
161776290|NCT03917654|584223181|FG009|Year 1|Travel|5|||
161776291|NCT03917654|584223182|FG010|Year 1|Travel|3|||
161776292|NCT03917654|584223183|FG011|Year 1|Travel|3|||
161776293|NCT03917654|584223172|FG000|Year 1|Subject moved away from site|0|||
161776294|NCT03917654|584223173|FG001|Year 1|Subject moved away from site|1|||
161776295|NCT03917654|584223174|FG002|Year 1|Subject moved away from site|0|||
161776296|NCT03917654|584223175|FG003|Year 1|Subject moved away from site|0|||
161776297|NCT03917654|584223176|FG004|Year 1|Subject moved away from site|0|||
161776298|NCT03917654|584223177|FG005|Year 1|Subject moved away from site|0|||
161776299|NCT03917654|584223178|FG006|Year 1|Subject moved away from site|1|||
161776300|NCT03917654|584223179|FG007|Year 1|Subject moved away from site|2|||
161776301|NCT03917654|584223180|FG008|Year 1|Subject moved away from site|1|||
161776302|NCT03917654|584223181|FG009|Year 1|Subject moved away from site|0|||
161776303|NCT03917654|584223182|FG010|Year 1|Subject moved away from site|0|||
161776304|NCT03917654|584223183|FG011|Year 1|Subject moved away from site|3|||
161776305|NCT03917654|584223172|FG000|Year 1|Spouse/Family member request|0|||
161776306|NCT03917654|584223173|FG001|Year 1|Spouse/Family member request|0|||
161776307|NCT03917654|584223174|FG002|Year 1|Spouse/Family member request|1|||
161776308|NCT03917654|584223175|FG003|Year 1|Spouse/Family member request|0|||
161776309|NCT03917654|584223176|FG004|Year 1|Spouse/Family member request|1|||
161776310|NCT03917654|584223177|FG005|Year 1|Spouse/Family member request|0|||
161776311|NCT03917654|584223178|FG006|Year 1|Spouse/Family member request|0|||
161776312|NCT03917654|584223179|FG007|Year 1|Spouse/Family member request|2|||
161776313|NCT03917654|584223180|FG008|Year 1|Spouse/Family member request|0|||
161776314|NCT03917654|584223181|FG009|Year 1|Spouse/Family member request|0|||
161776315|NCT03917654|584223182|FG010|Year 1|Spouse/Family member request|0|||
161776316|NCT03917654|584223183|FG011|Year 1|Spouse/Family member request|1|||
161776317|NCT03917654|584223172|FG000|Year 1|Death|0|||
161776318|NCT03917654|584223173|FG001|Year 1|Death|0|||
161776319|NCT03917654|584223174|FG002|Year 1|Death|0|||
161776320|NCT03917654|584223175|FG003|Year 1|Death|0|||
161776321|NCT03917654|584223176|FG004|Year 1|Death|0|||
161776322|NCT03917654|584223177|FG005|Year 1|Death|0|||
161776323|NCT03917654|584223178|FG006|Year 1|Death|0|||
161776324|NCT03917654|584223179|FG007|Year 1|Death|0|||
161776325|NCT03917654|584223180|FG008|Year 1|Death|1|||
161776326|NCT03917654|584223181|FG009|Year 1|Death|1|||
161776327|NCT03917654|584223182|FG010|Year 1|Death|0|||
161875965|NCT01943851|584589623|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875966|NCT01943851|584589624|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161875967|NCT01943851|584589607|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161776328|NCT03917654|584223183|FG011|Year 1|Death|0|||
161776329|NCT03917654|584223172|FG000|Year 1|Lost to Follow-up|0|||
161776330|NCT03917654|584223173|FG001|Year 1|Lost to Follow-up|0|||
161776331|NCT03917654|584223174|FG002|Year 1|Lost to Follow-up|0|||
161776332|NCT03917654|584223175|FG003|Year 1|Lost to Follow-up|0|||
161875968|NCT01943851|584589608|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875969|NCT01943851|584589609|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161990538|NCT00377858|585016310|FG000|Overall Study|Physician Decision|5|||
161990539|NCT00377858|585016311|FG001|Overall Study|Physician Decision|5|||
161990540|NCT00377858|585016310|FG000|Overall Study|Protocol Violation|3|||
161875970|NCT01943851|584589610|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875971|NCT01943851|584589611|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875972|NCT01943851|584589612|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875973|NCT01943851|584589613|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875974|NCT01943851|584589614|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875975|NCT01943851|584589615|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875976|NCT01943851|584589616|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875977|NCT01943851|584589617|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875978|NCT01943851|584589618|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875979|NCT01943851|584589619|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875980|NCT01943851|584589620|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875981|NCT01943851|584589621|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161875982|NCT01943851|584589622|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
161875983|NCT01943851|584589623|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
161875984|NCT01943851|584589624|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
161875985|NCT00401544|584589627|FG000|Overall Study|Adverse Event|5|||
161875986|NCT00401544|584589628|FG001|Overall Study|Adverse Event|1|||
161875987|NCT00401544|584589629|FG002|Overall Study|Adverse Event|1|||
161875988|NCT00401544|584589630|FG003|Overall Study|Adverse Event|1|||
161875989|NCT00401544|584589627|FG000|Overall Study|Death|3|||
161875990|NCT00401544|584589628|FG001|Overall Study|Death|6|||
161875991|NCT00401544|584589629|FG002|Overall Study|Death|2|||
161875992|NCT00401544|584589630|FG003|Overall Study|Death|5|||
161875993|NCT00401544|584589627|FG000|Overall Study|Lost to Follow-up|2|||
161875994|NCT00401544|584589628|FG001|Overall Study|Lost to Follow-up|0|||
161875995|NCT00401544|584589629|FG002|Overall Study|Lost to Follow-up|1|||
161875996|NCT00401544|584589630|FG003|Overall Study|Lost to Follow-up|1|||
161875997|NCT00401544|584589627|FG000|Overall Study|Withdrawal by Subject|7|||
161875998|NCT00401544|584589628|FG001|Overall Study|Withdrawal by Subject|6|||
161875999|NCT00401544|584589629|FG002|Overall Study|Withdrawal by Subject|6|||
161876000|NCT00401544|584589630|FG003|Overall Study|Withdrawal by Subject|5|||
161876001|NCT00401544|584589627|FG000|Overall Study|Physician Decision|1|||
161876002|NCT00401544|584589628|FG001|Overall Study|Physician Decision|3|||
161876003|NCT00401544|584589629|FG002|Overall Study|Physician Decision|0|||
161876004|NCT00401544|584589630|FG003|Overall Study|Physician Decision|0|||
161876005|NCT00401544|584589627|FG000|Overall Study|Ineligibility determined|0|||
161876006|NCT00401544|584589628|FG001|Overall Study|Ineligibility determined|1|||
161876007|NCT00401544|584589629|FG002|Overall Study|Ineligibility determined|0|||
161876008|NCT00401544|584589630|FG003|Overall Study|Ineligibility determined|2|||
161876009|NCT00401544|584589627|FG000|Overall Study|Disease progression|0|||
161876010|NCT00401544|584589628|FG001|Overall Study|Disease progression|1|||
161876011|NCT00401544|584589629|FG002|Overall Study|Disease progression|0|||
161876012|NCT00401544|584589630|FG003|Overall Study|Disease progression|0|||
161876013|NCT00401544|584589627|FG000|Overall Study|Other|0|||
161876014|NCT00401544|584589628|FG001|Overall Study|Other|0|||
161876015|NCT00401544|584589629|FG002|Overall Study|Other|2|||
161876016|NCT00401544|584589630|FG003|Overall Study|Other|2|||
161876017|NCT01250873|584589631|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
161876018|NCT01250873|584589631|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
161876019|NCT04429555|584589632|FG000|Overall Study|Death|0|||
161876020|NCT04429555|584589633|FG001|Overall Study|Death|2|||
161876021|NCT04429555|584589632|FG000|Overall Study|Other|2|||
161876022|NCT04429555|584589633|FG001|Overall Study|Other|0|||
161876023|NCT00930774|584589634|FG000|Overall Study|Withdrawal by Subject|1|||
161876024|NCT00930774|584589635|FG001|Overall Study|Withdrawal by Subject|9|||
161876025|NCT00930774|584589636|FG002|Overall Study|Withdrawal by Subject|2|||
161876026|NCT00930774|584589637|FG003|Overall Study|Withdrawal by Subject|0|||
161876027|NCT03200704|584589638|FG000|Overall Study|Withdrawal by Subject|1|||
161876028|NCT04967885|584589639|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
161876029|NCT04967885|584589640|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
161876030|NCT04967885|584589639|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
161876031|NCT04967885|584589640|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
161876032|NCT04967885|584589639|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
161876033|NCT04967885|584589640|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
161876034|NCT04967885|584589639|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
161876035|NCT04967885|584589640|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
161876036|NCT04967885|584589639|FG000|EMI-II Intervention|Lost to Follow-up|14|||
161876037|NCT04967885|584589640|FG001|EMI-II Intervention|Lost to Follow-up|10|||
161876038|NCT01011465|584589641|FG000|Overall Study|Withdrawal by Subject|2|||
161876039|NCT01011465|584589642|FG001|Overall Study|Withdrawal by Subject|1|||
161876040|NCT01011465|584589643|FG002|Overall Study|Withdrawal by Subject|0|||
161876041|NCT01011465|584589644|FG003|Overall Study|Withdrawal by Subject|0|||
161876042|NCT01011465|584589645|FG004|Overall Study|Withdrawal by Subject|1|||
161990541|NCT00377858|585016311|FG001|Overall Study|Protocol Violation|4|||
161876043|NCT01011465|584589646|FG005|Overall Study|Withdrawal by Subject|0|||
161876044|NCT01011465|584589647|FG006|Overall Study|Withdrawal by Subject|1|||
161876045|NCT01011465|584589648|FG007|Overall Study|Withdrawal by Subject|0|||
161876046|NCT02042950|584589651|FG000|Overall Study|Progressive Disease|4|||
161876047|NCT02217410|584589655|FG000|Overall Study|Graft Loss|0|||
161876048|NCT02217410|584589656|FG001|Overall Study|Graft Loss|0|||
161876049|NCT02217410|584589657|FG002|Overall Study|Graft Loss|2|||
161876050|NCT02217410|584589655|FG000|Overall Study|Withdrawal by Subject|0|||
161876051|NCT02217410|584589656|FG001|Overall Study|Withdrawal by Subject|0|||
161876052|NCT02217410|584589657|FG002|Overall Study|Withdrawal by Subject|2|||
161876053|NCT02217410|584589655|FG000|Overall Study|Lost to Follow-up|0|||
161876054|NCT02217410|584589656|FG001|Overall Study|Lost to Follow-up|0|||
161876055|NCT02217410|584589657|FG002|Overall Study|Lost to Follow-up|1|||
161876056|NCT02217410|584589655|FG000|Overall Study|Lack of Efficacy|0|||
161876057|NCT02217410|584589656|FG001|Overall Study|Lack of Efficacy|1|||
161876058|NCT02217410|584589657|FG002|Overall Study|Lack of Efficacy|0|||
161876059|NCT02217410|584589655|FG000|Overall Study|Physician Decision|1|||
161876060|NCT02217410|584589656|FG001|Overall Study|Physician Decision|3|||
161876061|NCT02217410|584589657|FG002|Overall Study|Physician Decision|0|||
161876062|NCT00626821|584589658|FG000|Overall Study|Adverse Event|44|||
161876063|NCT00626821|584589658|FG000|Overall Study|Protocol Violation|33|||
161876064|NCT00626821|584589658|FG000|Overall Study|Withdrawal by Subject|10|||
161876065|NCT00626821|584589658|FG000|Overall Study|Physician Decision|9|||
161876066|NCT00626821|584589658|FG000|Overall Study|Product dysfunction|21|||
161876067|NCT00626821|584589658|FG000|Overall Study|other/unknown reason|104|||
161876068|NCT01940887|584589659|FG000|Year 1|Protocol Violation|0|||
161876069|NCT01940887|584589660|FG001|Year 1|Protocol Violation|1|||
161876070|NCT01940887|584589659|FG000|Year 1|Physician Decision|7|||
161876071|NCT01940887|584589660|FG001|Year 1|Physician Decision|3|||
161876072|NCT01940887|584589659|FG000|Year 1|Death|5|||
161876073|NCT01940887|584589660|FG001|Year 1|Death|3|||
161876074|NCT01940887|584589659|FG000|Year 1|Adverse Event|7|||
161876075|NCT01940887|584589660|FG001|Year 1|Adverse Event|6|||
161876076|NCT01940887|584589659|FG000|Year 1|Withdrawal by Subject|18|||
161876077|NCT01940887|584589660|FG001|Year 1|Withdrawal by Subject|9|||
161876078|NCT01940887|584589659|FG000|Year 1|Lost to Follow-up|2|||
161876079|NCT01940887|584589660|FG001|Year 1|Lost to Follow-up|1|||
161876080|NCT01940887|584589659|FG000|Year 2|Physician Decision|8|||
161876081|NCT01940887|584589660|FG001|Year 2|Physician Decision|1|||
161876082|NCT01940887|584589659|FG000|Year 2|Death|0|||
161876083|NCT01940887|584589660|FG001|Year 2|Death|2|||
161876084|NCT01940887|584589659|FG000|Year 2|Sponsor Decision, early termination|192|||
161876085|NCT01940887|584589660|FG001|Year 2|Sponsor Decision, early termination|203|||
161876086|NCT01940887|584589659|FG000|Year 2|Adverse Event|8|||
161876087|NCT01940887|584589660|FG001|Year 2|Adverse Event|2|||
161876088|NCT01940887|584589659|FG000|Year 2|Withdrawal by Subject|8|||
161876089|NCT01940887|584589660|FG001|Year 2|Withdrawal by Subject|8|||
161876090|NCT01940887|584589659|FG000|Year 2|Lost to Follow-up|1|||
161876091|NCT01940887|584589660|FG001|Year 2|Lost to Follow-up|6|||
161876092|NCT02475265|584589661|FG000|Overall Study|Physician Decision|1|||
161876093|NCT02475265|584589661|FG000|Overall Study|Withdrawal by Subject|2|||
161876094|NCT06586788|584589675|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
161876095|NCT03514485|584589676|FG000|Overall Study|Lost to Follow-up|5|||
161876096|NCT03514485|584589677|FG001|Overall Study|Lost to Follow-up|3|||
161876097|NCT03514485|584589678|FG002|Overall Study|Lost to Follow-up|2|||
161876098|NCT03514485|584589679|FG003|Overall Study|Lost to Follow-up|0|||
161876099|NCT03514485|584589680|FG004|Overall Study|Lost to Follow-up|1|||
161876100|NCT03514485|584589681|FG005|Overall Study|Lost to Follow-up|4|||
161876101|NCT03514485|584589676|FG000|Overall Study|Withdrawal by Subject|0|||
161876102|NCT03514485|584589677|FG001|Overall Study|Withdrawal by Subject|1|||
161876103|NCT03514485|584589678|FG002|Overall Study|Withdrawal by Subject|3|||
161876104|NCT03514485|584589679|FG003|Overall Study|Withdrawal by Subject|1|||
161876105|NCT03514485|584589680|FG004|Overall Study|Withdrawal by Subject|2|||
161876106|NCT03514485|584589681|FG005|Overall Study|Withdrawal by Subject|1|||
161876107|NCT03075891|584589682|FG000|Overall Study|Withdrawal by Subject|3|||
161876108|NCT03075891|584589683|FG001|Overall Study|Withdrawal by Subject|6|||
161876109|NCT03075891|584589682|FG000|Overall Study|Lost to Follow-up|1|||
161876110|NCT03075891|584589683|FG001|Overall Study|Lost to Follow-up|0|||
161876111|NCT03075891|584589682|FG000|Overall Study|Pregnancy|3|||
161876112|NCT03075891|584589683|FG001|Overall Study|Pregnancy|1|||
161876113|NCT03075891|584589682|FG000|Overall Study|visits not performed (no time)|1|||
161876114|NCT03075891|584589683|FG001|Overall Study|visits not performed (no time)|0|||
161876115|NCT03075891|584589682|FG000|Overall Study|Drug abuse relapse issue|0|||
161876116|NCT03075891|584589683|FG001|Overall Study|Drug abuse relapse issue|1|||
161876117|NCT03075891|584589682|FG000|Overall Study|Participant requiring study withdrawal|0|||
161876118|NCT03075891|584589683|FG001|Overall Study|Participant requiring study withdrawal|1|||
161876119|NCT03075891|584589682|FG000|Overall Study|Adverse event, non-fatal|1|||
161876120|NCT03075891|584589683|FG001|Overall Study|Adverse event, non-fatal|4|||
161876121|NCT00582608|584589699|FG000|Overall Study|Not Treated|7|||
161876122|NCT00582608|584589699|FG000|Overall Study|Patient Ineligible|1|||
161990542|NCT00377858|585016310|FG000|Overall Study|Adverse Event|2|||
161990543|NCT00377858|585016311|FG001|Overall Study|Adverse Event|1|||
161990544|NCT00377858|585016310|FG000|Overall Study|Entry Criteria Not Met|2|||
161990545|NCT00377858|585016311|FG001|Overall Study|Entry Criteria Not Met|0|||
161990546|NCT00377858|585016310|FG000|Overall Study|Sponsor Decision|1|||
161990547|NCT00377858|585016311|FG001|Overall Study|Sponsor Decision|2|||
161990548|NCT00377858|585016310|FG000|Overall Study|Death|0|||
161990549|NCT00377858|585016311|FG001|Overall Study|Death|3|||
161990550|NCT03534141|585016312|FG000|Overall Study|Enrolled in other clinical trial|1|||
161990551|NCT03534141|585016313|FG001|Overall Study|Enrolled in other clinical trial|0|||
161990552|NCT03534141|585016312|FG000|Overall Study|Liver transplant aborted after randomization|0|||
161990553|NCT03534141|585016313|FG001|Overall Study|Liver transplant aborted after randomization|2|||
161990554|NCT03534141|585016312|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
161990555|NCT03534141|585016313|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
161776333|NCT03917654|584223176|FG004|Year 1|Lost to Follow-up|0|||
161776334|NCT03917654|584223177|FG005|Year 1|Lost to Follow-up|0|||
161776335|NCT03917654|584223178|FG006|Year 1|Lost to Follow-up|2|||
161776336|NCT03917654|584223179|FG007|Year 1|Lost to Follow-up|0|||
161776337|NCT03917654|584223180|FG008|Year 1|Lost to Follow-up|0|||
161776338|NCT03917654|584223181|FG009|Year 1|Lost to Follow-up|0|||
161776339|NCT03917654|584223182|FG010|Year 1|Lost to Follow-up|0|||
161776340|NCT03917654|584223183|FG011|Year 1|Lost to Follow-up|0|||
161776341|NCT03917654|584223172|FG000|Year 1|Missed visits|0|||
161776342|NCT03917654|584223173|FG001|Year 1|Missed visits|0|||
161776343|NCT03917654|584223174|FG002|Year 1|Missed visits|0|||
161776344|NCT03917654|584223175|FG003|Year 1|Missed visits|0|||
161776345|NCT03917654|584223176|FG004|Year 1|Missed visits|0|||
161776346|NCT03917654|584223177|FG005|Year 1|Missed visits|0|||
161776347|NCT03917654|584223178|FG006|Year 1|Missed visits|0|||
161776348|NCT03917654|584223179|FG007|Year 1|Missed visits|0|||
161776349|NCT03917654|584223180|FG008|Year 1|Missed visits|0|||
161776350|NCT03917654|584223181|FG009|Year 1|Missed visits|0|||
161776351|NCT03917654|584223182|FG010|Year 1|Missed visits|1|||
161776352|NCT03917654|584223183|FG011|Year 1|Missed visits|1|||
161776353|NCT03917654|584223172|FG000|Year 1|Pregnancy|0|||
161776354|NCT03917654|584223173|FG001|Year 1|Pregnancy|0|||
161776355|NCT03917654|584223174|FG002|Year 1|Pregnancy|0|||
161776356|NCT03917654|584223175|FG003|Year 1|Pregnancy|0|||
161776357|NCT03917654|584223176|FG004|Year 1|Pregnancy|0|||
161776358|NCT03917654|584223177|FG005|Year 1|Pregnancy|0|||
161776359|NCT03917654|584223178|FG006|Year 1|Pregnancy|0|||
161776360|NCT03917654|584223179|FG007|Year 1|Pregnancy|1|||
161776361|NCT03917654|584223180|FG008|Year 1|Pregnancy|0|||
161776362|NCT03917654|584223181|FG009|Year 1|Pregnancy|1|||
161776363|NCT03917654|584223182|FG010|Year 1|Pregnancy|0|||
161776364|NCT03917654|584223183|FG011|Year 1|Pregnancy|0|||
161776365|NCT03917654|584223172|FG000|Year 2|Travel|1|||
161776366|NCT03917654|584223173|FG001|Year 2|Travel|0|||
161776367|NCT03917654|584223174|FG002|Year 2|Travel|0|||
161776368|NCT03917654|584223175|FG003|Year 2|Travel|0|||
161776369|NCT03917654|584223176|FG004|Year 2|Travel|1|||
161776370|NCT03917654|584223177|FG005|Year 2|Travel|1|||
161776371|NCT03917654|584223178|FG006|Year 2|Travel|2|||
161776372|NCT03917654|584223179|FG007|Year 2|Travel|1|||
161776373|NCT03917654|584223180|FG008|Year 2|Travel|0|||
161776374|NCT03917654|584223181|FG009|Year 2|Travel|1|||
161776375|NCT03917654|584223182|FG010|Year 2|Travel|0|||
161776376|NCT03917654|584223183|FG011|Year 2|Travel|1|||
161776377|NCT03917654|584223172|FG000|Year 2|Married|1|||
161776378|NCT03917654|584223173|FG001|Year 2|Married|0|||
161776379|NCT03917654|584223174|FG002|Year 2|Married|0|||
161776380|NCT03917654|584223175|FG003|Year 2|Married|0|||
161776381|NCT03917654|584223176|FG004|Year 2|Married|0|||
161776382|NCT03917654|584223177|FG005|Year 2|Married|0|||
161776383|NCT03917654|584223178|FG006|Year 2|Married|1|||
161776384|NCT03917654|584223179|FG007|Year 2|Married|1|||
161776385|NCT03917654|584223180|FG008|Year 2|Married|0|||
161776386|NCT03917654|584223181|FG009|Year 2|Married|0|||
161776387|NCT03917654|584223182|FG010|Year 2|Married|0|||
161776388|NCT03917654|584223183|FG011|Year 2|Married|0|||
161776389|NCT03917654|584223172|FG000|Year 2|Subject moved away from site|1|||
161776390|NCT03917654|584223173|FG001|Year 2|Subject moved away from site|0|||
161776391|NCT03917654|584223174|FG002|Year 2|Subject moved away from site|0|||
161776392|NCT03917654|584223175|FG003|Year 2|Subject moved away from site|0|||
161776393|NCT03917654|584223176|FG004|Year 2|Subject moved away from site|1|||
161876123|NCT00582608|584589699|FG000|Overall Study|Lack of accrual|4|||
161776394|NCT03917654|584223177|FG005|Year 2|Subject moved away from site|0|||
161776395|NCT03917654|584223178|FG006|Year 2|Subject moved away from site|2|||
161776396|NCT03917654|584223179|FG007|Year 2|Subject moved away from site|3|||
161776397|NCT03917654|584223180|FG008|Year 2|Subject moved away from site|0|||
161776398|NCT03917654|584223181|FG009|Year 2|Subject moved away from site|2|||
161776399|NCT03917654|584223182|FG010|Year 2|Subject moved away from site|0|||
161990556|NCT02506192|585016314|FG000|Overall Study|Withdrawal by Subject|1|||
161990557|NCT02506192|585016315|FG001|Overall Study|Withdrawal by Subject|1|||
161990558|NCT04042909|585016316|FG000|Overall Study|Withdrawal by Subject|1|||
161990559|NCT04042909|585016317|FG001|Overall Study|Withdrawal by Subject|0|||
161876124|NCT03482453|584589700|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161990560|NCT04042909|585016318|FG002|Overall Study|Withdrawal by Subject|0|||
161990561|NCT04042909|585016316|FG000|Overall Study|duplicate cases|2|||
161776400|NCT03917654|584223183|FG011|Year 2|Subject moved away from site|1|||
161776401|NCT03917654|584223172|FG000|Year 2|Year 2 Screening failure|0|||
161776402|NCT03917654|584223173|FG001|Year 2|Year 2 Screening failure|1|||
161776403|NCT03917654|584223174|FG002|Year 2|Year 2 Screening failure|0|||
161776404|NCT03917654|584223175|FG003|Year 2|Year 2 Screening failure|0|||
161776405|NCT03917654|584223176|FG004|Year 2|Year 2 Screening failure|2|||
161776406|NCT03917654|584223177|FG005|Year 2|Year 2 Screening failure|0|||
161776407|NCT03917654|584223178|FG006|Year 2|Year 2 Screening failure|4|||
161776408|NCT03917654|584223179|FG007|Year 2|Year 2 Screening failure|3|||
161776409|NCT03917654|584223180|FG008|Year 2|Year 2 Screening failure|10|||
161776410|NCT03917654|584223181|FG009|Year 2|Year 2 Screening failure|2|||
161776411|NCT03917654|584223182|FG010|Year 2|Year 2 Screening failure|1|||
161776412|NCT03917654|584223183|FG011|Year 2|Year 2 Screening failure|1|||
161776413|NCT03917654|584223172|FG000|Year 2|Death|0|||
161776414|NCT03917654|584223173|FG001|Year 2|Death|0|||
161776415|NCT03917654|584223174|FG002|Year 2|Death|0|||
161776416|NCT03917654|584223175|FG003|Year 2|Death|0|||
161776417|NCT03917654|584223176|FG004|Year 2|Death|0|||
161776418|NCT03917654|584223177|FG005|Year 2|Death|1|||
161776419|NCT03917654|584223178|FG006|Year 2|Death|0|||
161776420|NCT03917654|584223179|FG007|Year 2|Death|0|||
161776421|NCT03917654|584223180|FG008|Year 2|Death|1|||
161776422|NCT03917654|584223181|FG009|Year 2|Death|1|||
161776423|NCT03917654|584223182|FG010|Year 2|Death|0|||
161776424|NCT03917654|584223183|FG011|Year 2|Death|0|||
161776425|NCT03917654|584223172|FG000|Year 2|Withdrawal by Subject|0|||
161776426|NCT03917654|584223173|FG001|Year 2|Withdrawal by Subject|0|||
161776427|NCT03917654|584223174|FG002|Year 2|Withdrawal by Subject|0|||
161776428|NCT03917654|584223175|FG003|Year 2|Withdrawal by Subject|0|||
161776429|NCT03917654|584223176|FG004|Year 2|Withdrawal by Subject|0|||
161776430|NCT03917654|584223177|FG005|Year 2|Withdrawal by Subject|0|||
161776431|NCT03917654|584223178|FG006|Year 2|Withdrawal by Subject|3|||
161776432|NCT03917654|584223179|FG007|Year 2|Withdrawal by Subject|0|||
161776433|NCT03917654|584223180|FG008|Year 2|Withdrawal by Subject|2|||
161776434|NCT03917654|584223181|FG009|Year 2|Withdrawal by Subject|5|||
161776435|NCT03917654|584223182|FG010|Year 2|Withdrawal by Subject|0|||
161776436|NCT03917654|584223183|FG011|Year 2|Withdrawal by Subject|0|||
161776437|NCT03917654|584223172|FG000|Year 2|Spouse/family member request|0|||
161776438|NCT03917654|584223173|FG001|Year 2|Spouse/family member request|0|||
161776439|NCT03917654|584223174|FG002|Year 2|Spouse/family member request|0|||
161776440|NCT03917654|584223175|FG003|Year 2|Spouse/family member request|0|||
161776441|NCT03917654|584223176|FG004|Year 2|Spouse/family member request|0|||
161776442|NCT03917654|584223177|FG005|Year 2|Spouse/family member request|0|||
161776443|NCT03917654|584223178|FG006|Year 2|Spouse/family member request|1|||
161776444|NCT03917654|584223179|FG007|Year 2|Spouse/family member request|0|||
161776445|NCT03917654|584223180|FG008|Year 2|Spouse/family member request|0|||
161776446|NCT03917654|584223181|FG009|Year 2|Spouse/family member request|0|||
161990562|NCT04042909|585016317|FG001|Overall Study|duplicate cases|0|||
161990563|NCT04042909|585016318|FG002|Overall Study|duplicate cases|0|||
161990564|NCT04042909|585016316|FG000|Overall Study|technical problem|0|||
161990565|NCT04042909|585016317|FG001|Overall Study|technical problem|1|||
161990566|NCT04042909|585016318|FG002|Overall Study|technical problem|0|||
161990567|NCT03785405|585016320|FG000|Overall Study|Adverse Event|16|||
161990568|NCT03785405|585016321|FG001|Overall Study|Adverse Event|1|||
161990569|NCT03785405|585016320|FG000|Overall Study|Death|6|||
161990570|NCT03785405|585016321|FG001|Overall Study|Death|4|||
161990571|NCT03785405|585016320|FG000|Overall Study|Guardian decision|4|||
161990572|NCT03785405|585016321|FG001|Overall Study|Guardian decision|1|||
161990573|NCT03785405|585016320|FG000|Overall Study|Lost to Follow-up|1|||
161990574|NCT03785405|585016321|FG001|Overall Study|Lost to Follow-up|0|||
161990575|NCT03785405|585016320|FG000|Overall Study|Physician Decision|8|||
161990576|NCT03785405|585016321|FG001|Overall Study|Physician Decision|5|||
161990577|NCT03785405|585016320|FG000|Overall Study|Participant decision|2|||
161990578|NCT03785405|585016321|FG001|Overall Study|Participant decision|0|||
161990579|NCT03785405|585016320|FG000|Overall Study|Other|1|||
161990580|NCT03785405|585016321|FG001|Overall Study|Other|0|||
161990581|NCT03785405|585016320|FG000|Overall Study|No treatment was received|0|||
161990582|NCT03785405|585016321|FG001|Overall Study|No treatment was received|1|||
161990583|NCT03705559|585016322|FG000|Overall Study|COVID Shut down|1|||
161990584|NCT06041919|585016328|FG000|Overall Study|Lost to Follow-up|1|||
161990585|NCT06041919|585016329|FG001|Overall Study|Lost to Follow-up|0|||
161990586|NCT06041919|585016330|FG002|Overall Study|Lost to Follow-up|0|||
161776447|NCT03917654|584223182|FG010|Year 2|Spouse/family member request|0|||
161776448|NCT03917654|584223183|FG011|Year 2|Spouse/family member request|0|||
161990587|NCT06041919|585016331|FG003|Overall Study|Lost to Follow-up|0|||
161776449|NCT03917654|584223172|FG000|Year 2|Lost to Follow-up|0|||
161776450|NCT03917654|584223173|FG001|Year 2|Lost to Follow-up|0|||
161776451|NCT03917654|584223174|FG002|Year 2|Lost to Follow-up|0|||
161776452|NCT03917654|584223175|FG003|Year 2|Lost to Follow-up|0|||
161876125|NCT03482453|584589701|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876126|NCT03482453|584589702|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876127|NCT03482453|584589703|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876128|NCT03482453|584589704|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876129|NCT03482453|584589705|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876130|NCT03482453|584589706|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876131|NCT03482453|584589707|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876132|NCT03482453|584589708|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876133|NCT03482453|584589709|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876134|NCT03482453|584589710|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
161876135|NCT03482453|584589711|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161876136|NCT03478644|584589712|FG000|Phase 2|Withdrawal by Subject|2|||
161876137|NCT03478644|584589713|FG001|Phase 2|Withdrawal by Subject|1|||
161876138|NCT03478644|584589712|FG000|Phase 2|Lost to Follow-up|1|||
161876139|NCT03478644|584589713|FG001|Phase 2|Lost to Follow-up|0|||
161876140|NCT02073929|584589714|FG000|Overall Study|Lost to Follow-up|2|||
161876141|NCT02073929|584589715|FG001|Overall Study|Lost to Follow-up|1|||
161876142|NCT02073929|584589714|FG000|Overall Study|Adverse Event|2|||
161876143|NCT02073929|584589715|FG001|Overall Study|Adverse Event|1|||
161876144|NCT02073929|584589714|FG000|Overall Study|Withdrawal by Subject|0|||
161876145|NCT02073929|584589715|FG001|Overall Study|Withdrawal by Subject|1|||
161876146|NCT01870973|584589716|FG000|Overall Study|Lost to Follow-up|10|||
161876147|NCT01870973|584589717|FG001|Overall Study|Lost to Follow-up|3|||
161876148|NCT02504827|584589720|FG000|Overall Study|Could not produce sputum|1|||
161876149|NCT00686829|584589721|FG000|Overall Study|Adverse Event|5|||
161876150|NCT00686829|584589721|FG000|Overall Study|Lack of Efficacy|6|||
161876151|NCT00686829|584589721|FG000|Overall Study|Lost to Follow-up|4|||
161876152|NCT00686829|584589721|FG000|Overall Study|Withdrawal by Subject|14|||
161876153|NCT00686829|584589721|FG000|Overall Study|Protocol Violation|3|||
161876154|NCT00686829|584589721|FG000|Overall Study|Sponsor discontinued VCV|47|||
161876155|NCT00712543|584589722|FG000|Day 8-14|Lost to Follow-up|0|||
161876156|NCT00712543|584589723|FG001|Day 8-14|Lost to Follow-up|2|||
161876157|NCT04740827|584589724|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
161876158|NCT04740827|584589725|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
161876159|NCT04740827|584589724|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
161876160|NCT04740827|584589725|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
161876161|NCT04740827|584589724|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
161876162|NCT04740827|584589725|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
161876163|NCT04740827|584589724|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
161876164|NCT04740827|584589725|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
161876165|NCT04740827|584589724|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
161876166|NCT04740827|584589725|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
161876167|NCT04740827|584589724|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
161876168|NCT04740827|584589725|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
161876169|NCT00940823|584589726|FG000|Overall Study|Death|8|||
161876170|NCT00940823|584589727|FG001|Overall Study|Death|12|||
161876171|NCT00940823|584589726|FG000|Overall Study|Lost to Follow-up|27|||
161876172|NCT00940823|584589727|FG001|Overall Study|Lost to Follow-up|20|||
161876173|NCT00477750|584592475|FG000|Overall Study|Currently Receiving Treatment|11|||
161876174|NCT01300338|584592477|FG000|Overall Study|Lost to Follow-up|5|||
161876175|NCT01300338|584592478|FG001|Overall Study|Lost to Follow-up|0|||
161876176|NCT02461524|584592479|FG000|Overall Study|Death|16|||
161876177|NCT02461524|584592479|FG000|Overall Study|Withdrawal by Subject|4|||
161876178|NCT02461524|584592479|FG000|Overall Study|Device Explanted|5|||
161876179|NCT02461524|584592479|FG000|Overall Study|Missed Visit|6|||
161876180|NCT00381238|584592483|FG000|Overall Study|Adverse Event|3|||
161876181|NCT00381238|584592483|FG000|Overall Study|Protocol Violation|1|||
161876182|NCT00381238|584592483|FG000|Overall Study|Withdrawal by Subject|4|||
161876183|NCT00381238|584592483|FG000|Overall Study|Lack of Efficacy|2|||
161876184|NCT00381238|584592483|FG000|Overall Study|Withdrew by physician|1|||
161876185|NCT00381238|584592483|FG000|Overall Study|Disease progression|1|||
161876186|NCT00843037|584592486|FG000|Overall Study|Lost to Follow-up|1|||
161876187|NCT02564900|584592487|FG000|Dose Escalation|Progressive disease per RECIST|2|||
161876188|NCT02564900|584592488|FG001|Dose Escalation|Progressive disease per RECIST|3|||
161876189|NCT02564900|584592489|FG002|Dose Escalation|Progressive disease per RECIST|3|||
161876190|NCT02564900|584592490|FG003|Dose Escalation|Progressive disease per RECIST|3|||
161876191|NCT02564900|584592491|FG004|Dose Escalation|Progressive disease per RECIST|3|||
161876192|NCT02564900|584592492|FG005|Dose Escalation|Progressive disease per RECIST|1|||
161876193|NCT02564900|584592493|FG006|Dose Escalation|Progressive disease per RECIST|0|||
161876194|NCT02564900|584592494|FG007|Dose Escalation|Progressive disease per RECIST|0|||
161876195|NCT02564900|584592495|FG008|Dose Escalation|Progressive disease per RECIST|0|||
161876196|NCT02564900|584592496|FG009|Dose Escalation|Progressive disease per RECIST|0|||
161990588|NCT06041919|585016332|FG004|Overall Study|Lost to Follow-up|0|||
161776453|NCT03917654|584223176|FG004|Year 2|Lost to Follow-up|0|||
161776454|NCT03917654|584223177|FG005|Year 2|Lost to Follow-up|0|||
161776455|NCT03917654|584223178|FG006|Year 2|Lost to Follow-up|1|||
161776456|NCT03917654|584223179|FG007|Year 2|Lost to Follow-up|0|||
161776457|NCT03917654|584223180|FG008|Year 2|Lost to Follow-up|1|||
161776458|NCT03917654|584223181|FG009|Year 2|Lost to Follow-up|0|||
161776459|NCT03917654|584223182|FG010|Year 2|Lost to Follow-up|0|||
161776460|NCT03917654|584223183|FG011|Year 2|Lost to Follow-up|1|||
161876197|NCT02564900|584592497|FG010|Dose Escalation|Progressive disease per RECIST|0|||
161876198|NCT02564900|584592498|FG011|Dose Escalation|Progressive disease per RECIST|0|||
161876199|NCT02564900|584592499|FG012|Dose Escalation|Progressive disease per RECIST|0|||
161876200|NCT02564900|584592500|FG013|Dose Escalation|Progressive disease per RECIST|0|||
161876201|NCT02564900|584592501|FG014|Dose Escalation|Progressive disease per RECIST|0|||
161876202|NCT02564900|584592487|FG000|Dose Escalation|Ongoing|1|||
161876203|NCT02564900|584592488|FG001|Dose Escalation|Ongoing|0|||
161876204|NCT02564900|584592489|FG002|Dose Escalation|Ongoing|0|||
161876205|NCT02564900|584592490|FG003|Dose Escalation|Ongoing|2|||
161876206|NCT02564900|584592491|FG004|Dose Escalation|Ongoing|2|||
161876207|NCT02564900|584592492|FG005|Dose Escalation|Ongoing|2|||
161876208|NCT02564900|584592493|FG006|Dose Escalation|Ongoing|0|||
161876209|NCT02564900|584592494|FG007|Dose Escalation|Ongoing|0|||
161876210|NCT02564900|584592495|FG008|Dose Escalation|Ongoing|0|||
161876211|NCT02564900|584592496|FG009|Dose Escalation|Ongoing|0|||
161876212|NCT02564900|584592497|FG010|Dose Escalation|Ongoing|0|||
161876213|NCT02564900|584592498|FG011|Dose Escalation|Ongoing|0|||
161876214|NCT02564900|584592499|FG012|Dose Escalation|Ongoing|0|||
161876215|NCT02564900|584592500|FG013|Dose Escalation|Ongoing|0|||
161876216|NCT02564900|584592501|FG014|Dose Escalation|Ongoing|0|||
161876217|NCT02564900|584592487|FG000|Dose Escalation|Adverse Event|0|||
161876218|NCT02564900|584592488|FG001|Dose Escalation|Adverse Event|0|||
161876219|NCT02564900|584592489|FG002|Dose Escalation|Adverse Event|0|||
161876220|NCT02564900|584592490|FG003|Dose Escalation|Adverse Event|1|||
161876221|NCT02564900|584592491|FG004|Dose Escalation|Adverse Event|1|||
161876222|NCT02564900|584592492|FG005|Dose Escalation|Adverse Event|3|||
161876223|NCT02564900|584592493|FG006|Dose Escalation|Adverse Event|0|||
161876224|NCT02564900|584592494|FG007|Dose Escalation|Adverse Event|0|||
161876225|NCT02564900|584592495|FG008|Dose Escalation|Adverse Event|0|||
161876226|NCT02564900|584592496|FG009|Dose Escalation|Adverse Event|0|||
161876227|NCT02564900|584592497|FG010|Dose Escalation|Adverse Event|0|||
161876228|NCT02564900|584592498|FG011|Dose Escalation|Adverse Event|0|||
161876229|NCT02564900|584592499|FG012|Dose Escalation|Adverse Event|0|||
161876230|NCT02564900|584592500|FG013|Dose Escalation|Adverse Event|0|||
161876231|NCT02564900|584592501|FG014|Dose Escalation|Adverse Event|0|||
161876232|NCT02564900|584592487|FG000|Dose Expansion|Progressive disease per RECIST|0|||
161876233|NCT02564900|584592488|FG001|Dose Expansion|Progressive disease per RECIST|0|||
161876234|NCT02564900|584592489|FG002|Dose Expansion|Progressive disease per RECIST|0|||
161876235|NCT02564900|584592490|FG003|Dose Expansion|Progressive disease per RECIST|0|||
161876236|NCT02564900|584592491|FG004|Dose Expansion|Progressive disease per RECIST|0|||
161876237|NCT02564900|584592492|FG005|Dose Expansion|Progressive disease per RECIST|0|||
161876238|NCT02564900|584592493|FG006|Dose Expansion|Progressive disease per RECIST|19|||
161876239|NCT02564900|584592494|FG007|Dose Expansion|Progressive disease per RECIST|17|||
161876240|NCT02564900|584592495|FG008|Dose Expansion|Progressive disease per RECIST|8|||
161876241|NCT02564900|584592496|FG009|Dose Expansion|Progressive disease per RECIST|16|||
161876242|NCT02564900|584592497|FG010|Dose Expansion|Progressive disease per RECIST|13|||
161876243|NCT02564900|584592498|FG011|Dose Expansion|Progressive disease per RECIST|19|||
161876244|NCT02564900|584592499|FG012|Dose Expansion|Progressive disease per RECIST|10|||
161876245|NCT02564900|584592500|FG013|Dose Expansion|Progressive disease per RECIST|13|||
161876246|NCT02564900|584592501|FG014|Dose Expansion|Progressive disease per RECIST|11|||
161876247|NCT02564900|584592487|FG000|Dose Expansion|Clinical progression|0|||
161876248|NCT02564900|584592488|FG001|Dose Expansion|Clinical progression|0|||
161876249|NCT02564900|584592489|FG002|Dose Expansion|Clinical progression|0|||
161876250|NCT02564900|584592490|FG003|Dose Expansion|Clinical progression|0|||
161876251|NCT02564900|584592491|FG004|Dose Expansion|Clinical progression|0|||
161876252|NCT02564900|584592492|FG005|Dose Expansion|Clinical progression|0|||
161876253|NCT02564900|584592493|FG006|Dose Expansion|Clinical progression|5|||
161876254|NCT02564900|584592494|FG007|Dose Expansion|Clinical progression|12|||
161776461|NCT03917654|584223172|FG000|Year 2|Adverse Event|0|||
161776462|NCT03917654|584223173|FG001|Year 2|Adverse Event|0|||
161876255|NCT02564900|584592495|FG008|Dose Expansion|Clinical progression|0|||
161876256|NCT02564900|584592496|FG009|Dose Expansion|Clinical progression|3|||
161876257|NCT02564900|584592497|FG010|Dose Expansion|Clinical progression|2|||
161876258|NCT02564900|584592498|FG011|Dose Expansion|Clinical progression|0|||
161876259|NCT02564900|584592499|FG012|Dose Expansion|Clinical progression|1|||
161876260|NCT02564900|584592500|FG013|Dose Expansion|Clinical progression|3|||
161876261|NCT02564900|584592501|FG014|Dose Expansion|Clinical progression|1|||
161876262|NCT02564900|584592487|FG000|Dose Expansion|Adverse Event|0|||
161876263|NCT02564900|584592488|FG001|Dose Expansion|Adverse Event|0|||
161776463|NCT03917654|584223174|FG002|Year 2|Adverse Event|0|||
161776464|NCT03917654|584223175|FG003|Year 2|Adverse Event|0|||
161876264|NCT02564900|584592489|FG002|Dose Expansion|Adverse Event|0|||
161876265|NCT02564900|584592490|FG003|Dose Expansion|Adverse Event|0|||
161876266|NCT02564900|584592491|FG004|Dose Expansion|Adverse Event|0|||
161876267|NCT02564900|584592492|FG005|Dose Expansion|Adverse Event|0|||
161876268|NCT02564900|584592493|FG006|Dose Expansion|Adverse Event|9|||
161876269|NCT02564900|584592494|FG007|Dose Expansion|Adverse Event|22|||
161876270|NCT02564900|584592495|FG008|Dose Expansion|Adverse Event|0|||
161876271|NCT02564900|584592496|FG009|Dose Expansion|Adverse Event|11|||
161876272|NCT02564900|584592497|FG010|Dose Expansion|Adverse Event|0|||
161876273|NCT02564900|584592498|FG011|Dose Expansion|Adverse Event|5|||
161876274|NCT02564900|584592499|FG012|Dose Expansion|Adverse Event|2|||
161876275|NCT02564900|584592500|FG013|Dose Expansion|Adverse Event|2|||
161876276|NCT02564900|584592501|FG014|Dose Expansion|Adverse Event|1|||
161776465|NCT03917654|584223176|FG004|Year 2|Adverse Event|0|||
161776466|NCT03917654|584223177|FG005|Year 2|Adverse Event|0|||
161776467|NCT03917654|584223178|FG006|Year 2|Adverse Event|0|||
161776468|NCT03917654|584223179|FG007|Year 2|Adverse Event|0|||
161776469|NCT03917654|584223180|FG008|Year 2|Adverse Event|0|||
161776470|NCT03917654|584223181|FG009|Year 2|Adverse Event|1|||
161776471|NCT03917654|584223182|FG010|Year 2|Adverse Event|0|||
161776472|NCT03917654|584223183|FG011|Year 2|Adverse Event|0|||
161776473|NCT05012943|584223184|FG000|Overall Study|Adverse Event|2|||
161776474|NCT05012943|584223185|FG001|Overall Study|Adverse Event|1|||
161776475|NCT05012943|584223186|FG002|Overall Study|Adverse Event|0|||
161876277|NCT02564900|584592487|FG000|Dose Expansion|Ongoing|0|||
161876278|NCT02564900|584592488|FG001|Dose Expansion|Ongoing|0|||
161876279|NCT02564900|584592489|FG002|Dose Expansion|Ongoing|0|||
161876280|NCT02564900|584592490|FG003|Dose Expansion|Ongoing|0|||
161876281|NCT02564900|584592491|FG004|Dose Expansion|Ongoing|0|||
161876282|NCT02564900|584592492|FG005|Dose Expansion|Ongoing|0|||
161876283|NCT02564900|584592493|FG006|Dose Expansion|Ongoing|9|||
161876284|NCT02564900|584592494|FG007|Dose Expansion|Ongoing|10|||
161876285|NCT02564900|584592495|FG008|Dose Expansion|Ongoing|11|||
161876286|NCT02564900|584592496|FG009|Dose Expansion|Ongoing|3|||
161876287|NCT02564900|584592497|FG010|Dose Expansion|Ongoing|0|||
161876288|NCT02564900|584592498|FG011|Dose Expansion|Ongoing|0|||
161876289|NCT02564900|584592499|FG012|Dose Expansion|Ongoing|4|||
161876290|NCT02564900|584592500|FG013|Dose Expansion|Ongoing|0|||
161876291|NCT02564900|584592501|FG014|Dose Expansion|Ongoing|6|||
161876292|NCT02564900|584592487|FG000|Dose Expansion|Death|0|||
161876293|NCT02564900|584592488|FG001|Dose Expansion|Death|0|||
161876294|NCT02564900|584592489|FG002|Dose Expansion|Death|0|||
161876295|NCT02564900|584592490|FG003|Dose Expansion|Death|0|||
161876296|NCT02564900|584592491|FG004|Dose Expansion|Death|0|||
161876297|NCT02564900|584592492|FG005|Dose Expansion|Death|0|||
161876298|NCT02564900|584592493|FG006|Dose Expansion|Death|1|||
161876299|NCT02564900|584592494|FG007|Dose Expansion|Death|0|||
161876300|NCT02564900|584592495|FG008|Dose Expansion|Death|0|||
161876301|NCT02564900|584592496|FG009|Dose Expansion|Death|0|||
161876302|NCT02564900|584592497|FG010|Dose Expansion|Death|1|||
161876303|NCT02564900|584592498|FG011|Dose Expansion|Death|0|||
161876304|NCT02564900|584592499|FG012|Dose Expansion|Death|1|||
161876305|NCT02564900|584592500|FG013|Dose Expansion|Death|1|||
161876306|NCT02564900|584592501|FG014|Dose Expansion|Death|0|||
161876307|NCT02564900|584592487|FG000|Dose Expansion|Withdrawal by Subject|0|||
161876308|NCT02564900|584592488|FG001|Dose Expansion|Withdrawal by Subject|0|||
161876309|NCT02564900|584592489|FG002|Dose Expansion|Withdrawal by Subject|0|||
161876310|NCT02564900|584592490|FG003|Dose Expansion|Withdrawal by Subject|0|||
161876311|NCT02564900|584592491|FG004|Dose Expansion|Withdrawal by Subject|0|||
161876312|NCT02564900|584592492|FG005|Dose Expansion|Withdrawal by Subject|0|||
161876313|NCT02564900|584592493|FG006|Dose Expansion|Withdrawal by Subject|4|||
161876314|NCT02564900|584592494|FG007|Dose Expansion|Withdrawal by Subject|0|||
161876315|NCT02564900|584592495|FG008|Dose Expansion|Withdrawal by Subject|0|||
161876316|NCT02564900|584592496|FG009|Dose Expansion|Withdrawal by Subject|0|||
161876317|NCT02564900|584592497|FG010|Dose Expansion|Withdrawal by Subject|1|||
161876318|NCT02564900|584592498|FG011|Dose Expansion|Withdrawal by Subject|0|||
161876319|NCT02564900|584592499|FG012|Dose Expansion|Withdrawal by Subject|0|||
161876320|NCT02564900|584592500|FG013|Dose Expansion|Withdrawal by Subject|1|||
161876321|NCT02564900|584592501|FG014|Dose Expansion|Withdrawal by Subject|1|||
161876322|NCT02564900|584592487|FG000|Dose Expansion|Other|0|||
161876323|NCT02564900|584592488|FG001|Dose Expansion|Other|0|||
161876324|NCT02564900|584592489|FG002|Dose Expansion|Other|0|||
161876325|NCT02564900|584592490|FG003|Dose Expansion|Other|0|||
161876326|NCT02564900|584592491|FG004|Dose Expansion|Other|0|||
161876327|NCT02564900|584592492|FG005|Dose Expansion|Other|0|||
161876328|NCT02564900|584592493|FG006|Dose Expansion|Other|1|||
161876329|NCT02564900|584592494|FG007|Dose Expansion|Other|0|||
161876330|NCT02564900|584592495|FG008|Dose Expansion|Other|1|||
161776476|NCT05012943|584223184|FG000|Overall Study|Withdrawal by Subject|1052|||
161876331|NCT02564900|584592496|FG009|Dose Expansion|Other|0|||
161876332|NCT02564900|584592497|FG010|Dose Expansion|Other|0|||
161876333|NCT02564900|584592498|FG011|Dose Expansion|Other|0|||
161876334|NCT02564900|584592499|FG012|Dose Expansion|Other|0|||
161876335|NCT02564900|584592500|FG013|Dose Expansion|Other|0|||
161876336|NCT02564900|584592501|FG014|Dose Expansion|Other|1|||
161876337|NCT02564900|584592487|FG000|Dose Expansion|Did not receive treatment|0|||
161876338|NCT02564900|584592488|FG001|Dose Expansion|Did not receive treatment|0|||
161876339|NCT02564900|584592489|FG002|Dose Expansion|Did not receive treatment|0|||
161876340|NCT02564900|584592490|FG003|Dose Expansion|Did not receive treatment|0|||
161876341|NCT02564900|584592491|FG004|Dose Expansion|Did not receive treatment|0|||
161876342|NCT02564900|584592492|FG005|Dose Expansion|Did not receive treatment|0|||
161876343|NCT02564900|584592493|FG006|Dose Expansion|Did not receive treatment|1|||
161876344|NCT02564900|584592494|FG007|Dose Expansion|Did not receive treatment|1|||
161876345|NCT02564900|584592495|FG008|Dose Expansion|Did not receive treatment|0|||
161876346|NCT02564900|584592496|FG009|Dose Expansion|Did not receive treatment|0|||
161876347|NCT02564900|584592497|FG010|Dose Expansion|Did not receive treatment|0|||
161876348|NCT02564900|584592498|FG011|Dose Expansion|Did not receive treatment|0|||
161876349|NCT02564900|584592499|FG012|Dose Expansion|Did not receive treatment|0|||
161876350|NCT02564900|584592500|FG013|Dose Expansion|Did not receive treatment|0|||
161990589|NCT06041919|585016328|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
161990590|NCT06041919|585016329|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
161990591|NCT06041919|585016330|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
161990592|NCT06041919|585016331|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
161990593|NCT06041919|585016332|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
161990594|NCT02576795|585016333|FG000|Overall Study|Lost to Follow-up|0|||
161990595|NCT02576795|585016334|FG001|Overall Study|Lost to Follow-up|0|||
161990596|NCT02576795|585016335|FG002|Overall Study|Lost to Follow-up|1|||
161990597|NCT02576795|585016336|FG003|Overall Study|Lost to Follow-up|0|||
161990598|NCT03724890|585016337|FG000|Overall Study|Death|2|||
161990599|NCT03724890|585016338|FG001|Overall Study|Death|6|||
161990600|NCT03724890|585016339|FG002|Overall Study|Death|3|||
161990601|NCT03724890|585016340|FG003|Overall Study|Death|5|||
161990602|NCT03724890|585016341|FG004|Overall Study|Death|2|||
161990603|NCT03724890|585016342|FG005|Overall Study|Death|0|||
161990604|NCT03724890|585016343|FG006|Overall Study|Death|2|||
161990605|NCT03724890|585016344|FG007|Overall Study|Death|3|||
161990606|NCT03724890|585016345|FG008|Overall Study|Death|4|||
161990607|NCT03724890|585016346|FG009|Overall Study|Death|2|||
161990608|NCT03724890|585016347|FG010|Overall Study|Death|2|||
161990609|NCT03724890|585016337|FG000|Overall Study|Lost to Follow-up|0|||
161990610|NCT03724890|585016338|FG001|Overall Study|Lost to Follow-up|3|||
161990611|NCT03724890|585016339|FG002|Overall Study|Lost to Follow-up|0|||
161990612|NCT03724890|585016340|FG003|Overall Study|Lost to Follow-up|1|||
161990613|NCT03724890|585016341|FG004|Overall Study|Lost to Follow-up|2|||
161990614|NCT03724890|585016342|FG005|Overall Study|Lost to Follow-up|2|||
161990615|NCT03724890|585016343|FG006|Overall Study|Lost to Follow-up|1|||
161990616|NCT03724890|585016344|FG007|Overall Study|Lost to Follow-up|0|||
161990617|NCT03724890|585016345|FG008|Overall Study|Lost to Follow-up|2|||
161990618|NCT03724890|585016346|FG009|Overall Study|Lost to Follow-up|0|||
161990619|NCT03724890|585016347|FG010|Overall Study|Lost to Follow-up|0|||
161990620|NCT03724890|585016337|FG000|Overall Study|Withdrawal by Subject|1|||
161990621|NCT03724890|585016338|FG001|Overall Study|Withdrawal by Subject|2|||
161990622|NCT03724890|585016339|FG002|Overall Study|Withdrawal by Subject|1|||
161990623|NCT03724890|585016340|FG003|Overall Study|Withdrawal by Subject|0|||
161990624|NCT03724890|585016341|FG004|Overall Study|Withdrawal by Subject|0|||
161990625|NCT03724890|585016342|FG005|Overall Study|Withdrawal by Subject|1|||
161990626|NCT03724890|585016343|FG006|Overall Study|Withdrawal by Subject|0|||
161990627|NCT03724890|585016344|FG007|Overall Study|Withdrawal by Subject|0|||
161990628|NCT03724890|585016345|FG008|Overall Study|Withdrawal by Subject|2|||
161990629|NCT03724890|585016346|FG009|Overall Study|Withdrawal by Subject|2|||
161990630|NCT03724890|585016347|FG010|Overall Study|Withdrawal by Subject|1|||
161990631|NCT03724890|585016337|FG000|Overall Study|Other|1|||
161990632|NCT03724890|585016338|FG001|Overall Study|Other|0|||
161990633|NCT03724890|585016339|FG002|Overall Study|Other|0|||
161990634|NCT03724890|585016340|FG003|Overall Study|Other|0|||
161990635|NCT03724890|585016341|FG004|Overall Study|Other|0|||
161990636|NCT03724890|585016342|FG005|Overall Study|Other|0|||
161990637|NCT03724890|585016343|FG006|Overall Study|Other|0|||
161990638|NCT03724890|585016344|FG007|Overall Study|Other|1|||
161990639|NCT03724890|585016345|FG008|Overall Study|Other|1|||
161990640|NCT03724890|585016346|FG009|Overall Study|Other|0|||
161990641|NCT03724890|585016347|FG010|Overall Study|Other|2|||
161990642|NCT02362464|585016349|FG000|Overall Study|Switched to alternative therapy|1|||
161990643|NCT02362464|585016349|FG000|Overall Study|Refused further treatment|1|||
161990644|NCT02362464|585016349|FG000|Overall Study|Physician Decision|4|||
161990645|NCT02123823|585016350|FG000|Overall Study|Lack of Efficacy|0|||
161990646|NCT02123823|585016351|FG001|Overall Study|Lack of Efficacy|2|||
161990647|NCT02123823|585016352|FG002|Overall Study|Lack of Efficacy|8|||
161990648|NCT02123823|585016353|FG003|Overall Study|Lack of Efficacy|10|||
161990649|NCT02123823|585016350|FG000|Overall Study|Progressive disease|3|||
161876351|NCT02564900|584592501|FG014|Dose Expansion|Did not receive treatment|1|||
161876352|NCT03991299|584592502|FG000|Overall Study|Study closed, sponsor decision|3|||
161876353|NCT03991299|584592502|FG000|Overall Study|Withdrawal by Subject|1|||
161876354|NCT02278939|584592507|FG000|Overall Study|lack of time|1|||
161876355|NCT02278939|584592508|FG001|Overall Study|lack of time|0|||
161876356|NCT02278939|584592507|FG000|Overall Study|Lost to Follow-up|1|||
161876357|NCT02278939|584592508|FG001|Overall Study|Lost to Follow-up|1|||
161876358|NCT02278939|584592507|FG000|Overall Study|death in family|1|||
161876359|NCT02278939|584592508|FG001|Overall Study|death in family|0|||
161876360|NCT02278939|584592507|FG000|Overall Study|family emergency unable to commit|2|||
161876361|NCT02278939|584592508|FG001|Overall Study|family emergency unable to commit|0|||
161876362|NCT02423343|584592511|FG000|Overall Study|Withdrawal by Subject|0|||
161876363|NCT02423343|584592512|FG001|Overall Study|Withdrawal by Subject|1|||
161876364|NCT02423343|584592513|FG002|Overall Study|Withdrawal by Subject|0|||
161876365|NCT02423343|584592514|FG003|Overall Study|Withdrawal by Subject|0|||
161876366|NCT02423343|584592515|FG004|Overall Study|Withdrawal by Subject|0|||
161876367|NCT02423343|584592516|FG005|Overall Study|Withdrawal by Subject|0|||
161876368|NCT02423343|584592511|FG000|Overall Study|Progressive Disease|0|||
161876369|NCT02423343|584592512|FG001|Overall Study|Progressive Disease|0|||
161876370|NCT02423343|584592513|FG002|Overall Study|Progressive Disease|0|||
161876371|NCT02423343|584592514|FG003|Overall Study|Progressive Disease|0|||
161876372|NCT02423343|584592515|FG004|Overall Study|Progressive Disease|2|||
161876373|NCT02423343|584592516|FG005|Overall Study|Progressive Disease|0|||
161876374|NCT02423343|584592511|FG000|Overall Study|Adverse Event|0|||
161876375|NCT02423343|584592512|FG001|Overall Study|Adverse Event|0|||
161876376|NCT02423343|584592513|FG002|Overall Study|Adverse Event|0|||
161876377|NCT02423343|584592514|FG003|Overall Study|Adverse Event|0|||
161876378|NCT02423343|584592515|FG004|Overall Study|Adverse Event|2|||
161876379|NCT02423343|584592516|FG005|Overall Study|Adverse Event|0|||
161876380|NCT02423343|584592511|FG000|Overall Study|Death|0|||
161876381|NCT02423343|584592512|FG001|Overall Study|Death|0|||
161876382|NCT02423343|584592513|FG002|Overall Study|Death|0|||
161876383|NCT02423343|584592514|FG003|Overall Study|Death|0|||
161876384|NCT02423343|584592515|FG004|Overall Study|Death|1|||
161876385|NCT02423343|584592516|FG005|Overall Study|Death|0|||
161876386|NCT02703272|584592524|FG000|Overall Study|Death|4|||
161876387|NCT02703272|584592525|FG001|Overall Study|Death|9|||
161876388|NCT02703272|584592526|FG002|Overall Study|Death|19|||
161876389|NCT02703272|584592527|FG003|Overall Study|Death|10|||
161990650|NCT02123823|585016351|FG001|Overall Study|Progressive disease|19|||
161990651|NCT02123823|585016352|FG002|Overall Study|Progressive disease|52|||
161990652|NCT02123823|585016353|FG003|Overall Study|Progressive disease|53|||
161990653|NCT02123823|585016350|FG000|Overall Study|Withdrawal by Subject|0|||
161990654|NCT02123823|585016351|FG001|Overall Study|Withdrawal by Subject|0|||
161990655|NCT02123823|585016352|FG002|Overall Study|Withdrawal by Subject|7|||
161990656|NCT02123823|585016353|FG003|Overall Study|Withdrawal by Subject|2|||
161990657|NCT02123823|585016350|FG000|Overall Study|Adverse Event|0|||
161990658|NCT02123823|585016351|FG001|Overall Study|Adverse Event|0|||
161990659|NCT02123823|585016352|FG002|Overall Study|Adverse Event|3|||
161990660|NCT02123823|585016353|FG003|Overall Study|Adverse Event|5|||
161990661|NCT01635855|585016356|FG000|Overall Study|Withdrawal by Subject|4|||
161990662|NCT02104947|585016359|FG000|Overall Study|Withdrawal by Subject|10|||
161990663|NCT02104947|585016360|FG001|Overall Study|Withdrawal by Subject|3|||
161990664|NCT02104947|585016359|FG000|Overall Study|Lost to Follow-up|4|||
161990665|NCT02104947|585016360|FG001|Overall Study|Lost to Follow-up|4|||
161990666|NCT02104947|585016359|FG000|Overall Study|Protocol Violation|6|||
161990667|NCT02104947|585016360|FG001|Overall Study|Protocol Violation|8|||
161990668|NCT02104947|585016359|FG000|Overall Study|Adverse Event|57|||
161990669|NCT02104947|585016360|FG001|Overall Study|Adverse Event|38|||
161990670|NCT02104947|585016359|FG000|Overall Study|Other than stated above|2|||
161990671|NCT02104947|585016360|FG001|Overall Study|Other than stated above|3|||
161990672|NCT01844778|585016361|FG000|Overall Study|Protocol deviation|0|||
161990673|NCT01844778|585016362|FG001|Overall Study|Protocol deviation|1|||
161990674|NCT01844778|585016363|FG002|Overall Study|Protocol deviation|2|||
161990675|NCT01844778|585016361|FG000|Overall Study|Withdrawal by Subject|2|||
161990676|NCT01844778|585016362|FG001|Overall Study|Withdrawal by Subject|0|||
161876390|NCT02703272|584592524|FG000|Overall Study|Withdrawal by Subject|0|||
161876391|NCT02703272|584592525|FG001|Overall Study|Withdrawal by Subject|0|||
161876392|NCT02703272|584592526|FG002|Overall Study|Withdrawal by Subject|4|||
161876393|NCT02703272|584592527|FG003|Overall Study|Withdrawal by Subject|2|||
161876394|NCT02703272|584592524|FG000|Overall Study|Study Terminated by Sponsor|6|||
161876395|NCT02703272|584592525|FG001|Overall Study|Study Terminated by Sponsor|1|||
161876396|NCT02703272|584592526|FG002|Overall Study|Study Terminated by Sponsor|12|||
161876397|NCT02703272|584592527|FG003|Overall Study|Study Terminated by Sponsor|4|||
161876398|NCT02703272|584592524|FG000|Overall Study|Other|1|||
161876399|NCT02703272|584592525|FG001|Overall Study|Other|0|||
161876400|NCT02703272|584592526|FG002|Overall Study|Other|0|||
161876401|NCT02703272|584592527|FG003|Overall Study|Other|0|||
161876402|NCT00712881|584592528|FG000|Overall Study|Adverse Event|3|||
161876403|NCT00712881|584592529|FG001|Overall Study|Adverse Event|3|||
161990677|NCT01844778|585016363|FG002|Overall Study|Withdrawal by Subject|0|||
161876404|NCT00712881|584592528|FG000|Overall Study|Withdrawal by Subject|1|||
161990678|NCT01844778|585016361|FG000|Overall Study|Adverse Event|0|||
161876405|NCT00712881|584592529|FG001|Overall Study|Withdrawal by Subject|1|||
161876406|NCT00712881|584592528|FG000|Overall Study|Disease Progression|2|||
161876407|NCT00712881|584592529|FG001|Overall Study|Disease Progression|1|||
161876408|NCT00712881|584592528|FG000|Overall Study|Lost to Follow-up|1|||
161876409|NCT00712881|584592529|FG001|Overall Study|Lost to Follow-up|1|||
161876410|NCT00712881|584592528|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
161876411|NCT00712881|584592529|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
161876412|NCT00712881|584592528|FG000|Overall Study|Protocol Violation|1|||
161876413|NCT00712881|584592529|FG001|Overall Study|Protocol Violation|1|||
161876414|NCT00712881|584592528|FG000|Overall Study|Randomized but not treated|1|||
161876415|NCT00712881|584592529|FG001|Overall Study|Randomized but not treated|0|||
161876416|NCT01680861|584592530|FG000|Early Post-transplant Period|Protocol Violation|1|||
161876417|NCT01680861|584592531|FG001|Early Post-transplant Period|Protocol Violation|1|||
161876418|NCT00654875|584592532|FG000|Overall Study|Adverse Event|5|||
161876419|NCT00654875|584592533|FG001|Overall Study|Adverse Event|5|||
161876420|NCT00654875|584592532|FG000|Overall Study|Withdrawal by Subject|4|||
161876421|NCT00654875|584592533|FG001|Overall Study|Withdrawal by Subject|4|||
161876422|NCT00654875|584592532|FG000|Overall Study|Protocol Violation|3|||
161876423|NCT00654875|584592533|FG001|Overall Study|Protocol Violation|3|||
161876424|NCT00654875|584592532|FG000|Overall Study|Lack of Efficacy|2|||
161876425|NCT00654875|584592533|FG001|Overall Study|Lack of Efficacy|2|||
161876426|NCT00654875|584592532|FG000|Overall Study|Lost to Follow-up|1|||
161876427|NCT00654875|584592533|FG001|Overall Study|Lost to Follow-up|3|||
161876428|NCT00654875|584592532|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
161876429|NCT00654875|584592533|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
161876430|NCT00654875|584592532|FG000|Overall Study|Administrative Problems|1|||
161876431|NCT00654875|584592533|FG001|Overall Study|Administrative Problems|0|||
161876432|NCT00723008|584592534|FG000|Enrollment|Lost to Follow-up|1|||
161876433|NCT00723008|584592535|FG001|Enrollment|Lost to Follow-up|0|||
161876434|NCT00723008|584592534|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
161876435|NCT00723008|584592535|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
161876436|NCT00723008|584592534|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
161876437|NCT00723008|584592535|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
161876438|NCT00723008|584592534|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
161876439|NCT00723008|584592535|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
161876440|NCT00723008|584592534|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
161876441|NCT00723008|584592535|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
161876442|NCT00723008|584592534|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
161876443|NCT00723008|584592535|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
161876444|NCT01014988|584592536|FG000|Overall Study|Adverse Event|20|||
161876445|NCT01014988|584592537|FG001|Overall Study|Adverse Event|0|||
161876446|NCT01014988|584592538|FG002|Overall Study|Adverse Event|1|||
161876447|NCT01014988|584592539|FG003|Overall Study|Adverse Event|0|||
161876448|NCT01014988|584592540|FG004|Overall Study|Adverse Event|1|||
161876449|NCT01014988|584592541|FG005|Overall Study|Adverse Event|3|||
161876450|NCT01014988|584592536|FG000|Overall Study|Lost to Follow-up|1|||
161876451|NCT01014988|584592537|FG001|Overall Study|Lost to Follow-up|0|||
161876452|NCT01014988|584592538|FG002|Overall Study|Lost to Follow-up|1|||
161876453|NCT01014988|584592539|FG003|Overall Study|Lost to Follow-up|0|||
161876454|NCT01014988|584592540|FG004|Overall Study|Lost to Follow-up|0|||
161876455|NCT01014988|584592541|FG005|Overall Study|Lost to Follow-up|0|||
161876456|NCT01014988|584592536|FG000|Overall Study|Physician Decision|1|||
161876457|NCT01014988|584592537|FG001|Overall Study|Physician Decision|0|||
161876458|NCT01014988|584592538|FG002|Overall Study|Physician Decision|0|||
161876459|NCT01014988|584592539|FG003|Overall Study|Physician Decision|0|||
161876460|NCT01014988|584592540|FG004|Overall Study|Physician Decision|0|||
161876461|NCT01014988|584592541|FG005|Overall Study|Physician Decision|0|||
161876462|NCT01014988|584592536|FG000|Overall Study|Withdrawal by Subject|1|||
161876463|NCT01014988|584592537|FG001|Overall Study|Withdrawal by Subject|0|||
161876464|NCT01014988|584592538|FG002|Overall Study|Withdrawal by Subject|0|||
161876465|NCT01014988|584592539|FG003|Overall Study|Withdrawal by Subject|0|||
161876466|NCT01014988|584592540|FG004|Overall Study|Withdrawal by Subject|0|||
161876467|NCT01014988|584592541|FG005|Overall Study|Withdrawal by Subject|0|||
161876468|NCT05835011|584592543|FG000|Overall Study|Study Terminated by the Sponsor|1|||
161876469|NCT05835011|584592543|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
161876470|NCT01683266|584592544|FG000|Overall Study|Adverse Event|5|||
161876471|NCT01683266|584592545|FG001|Overall Study|Adverse Event|4|||
161876472|NCT01683266|584592544|FG000|Overall Study|Lack of Efficacy|5|||
161876473|NCT01683266|584592545|FG001|Overall Study|Lack of Efficacy|2|||
161876474|NCT01683266|584592544|FG000|Overall Study|Protocol Violation|13|||
161876475|NCT01683266|584592545|FG001|Overall Study|Protocol Violation|6|||
161876476|NCT01683266|584592544|FG000|Overall Study|Personal Reason|17|||
161876477|NCT01683266|584592545|FG001|Overall Study|Personal Reason|25|||
161876478|NCT01683266|584592544|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
161876479|NCT01683266|584592545|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
161876480|NCT01683266|584592544|FG000|Overall Study|Lost to Follow-up|5|||
161876481|NCT01683266|584592545|FG001|Overall Study|Lost to Follow-up|0|||
161876482|NCT01683266|584592544|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
161876483|NCT01683266|584592545|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
161876484|NCT01683266|584592544|FG000|Overall Study|Nonserious Hypoglycemia|0|||
161876485|NCT01683266|584592545|FG001|Overall Study|Nonserious Hypoglycemia|3|||
161876486|NCT01683266|584592544|FG000|Overall Study|Perceived Lack of Efficacy|1|||
161876487|NCT01683266|584592545|FG001|Overall Study|Perceived Lack of Efficacy|1|||
161876488|NCT01683266|584592544|FG000|Overall Study|Possibly Hypoglycemia|1|||
161876489|NCT01683266|584592545|FG001|Overall Study|Possibly Hypoglycemia|0|||
161876490|NCT01683266|584592544|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
161876491|NCT01683266|584592545|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
161876492|NCT02222545|584592550|FG000|Overall Study|Adverse Event|1|||
161876493|NCT02222545|584592551|FG001|Overall Study|Adverse Event|0|||
161876494|NCT02222545|584592552|FG002|Overall Study|Adverse Event|2|||
161876495|NCT02222545|584592550|FG000|Overall Study|Death|0|||
161876496|NCT02222545|584592551|FG001|Overall Study|Death|0|||
161876497|NCT02222545|584592552|FG002|Overall Study|Death|9|||
161876498|NCT02222545|584592550|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
161876499|NCT02222545|584592551|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
161876500|NCT02222545|584592552|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
161876501|NCT02222545|584592550|FG000|Overall Study|Withdrawal by Subject|0|||
161876502|NCT02222545|584592551|FG001|Overall Study|Withdrawal by Subject|0|||
161876503|NCT02222545|584592552|FG002|Overall Study|Withdrawal by Subject|3|||
161876504|NCT02222545|584592550|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
161876505|NCT02222545|584592551|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
161876506|NCT02222545|584592552|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
161876507|NCT00090220|584592553|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
161876508|NCT00090220|584592554|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
161876509|NCT00090220|584592555|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161876510|NCT00090220|584592556|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161876511|NCT00090220|584592557|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161876512|NCT00090220|584592558|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161876513|NCT00090220|584592553|FG000|Base Study Vaccination Period|Adverse Event|6|||
161876514|NCT00090220|584592554|FG001|Base Study Vaccination Period|Adverse Event|1|||
161876515|NCT00090220|584592555|FG002|Base Study Vaccination Period|Adverse Event|0|||
161876516|NCT00090220|584592556|FG003|Base Study Vaccination Period|Adverse Event|0|||
161876517|NCT00090220|584592557|FG004|Base Study Vaccination Period|Adverse Event|0|||
161876518|NCT00090220|584592558|FG005|Base Study Vaccination Period|Adverse Event|0|||
161876519|NCT00090220|584592553|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
161876520|NCT00090220|584592554|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
161776477|NCT05012943|584223185|FG001|Overall Study|Withdrawal by Subject|1006|||
161776478|NCT05012943|584223186|FG002|Overall Study|Withdrawal by Subject|20|||
161776479|NCT05012943|584223184|FG000|Overall Study|Death|25|||
161776480|NCT05012943|584223185|FG001|Overall Study|Death|17|||
161776481|NCT05012943|584223186|FG002|Overall Study|Death|4|||
161776482|NCT05012943|584223184|FG000|Overall Study|Lost to Follow-up|11|||
161776483|NCT05012943|584223185|FG001|Overall Study|Lost to Follow-up|24|||
161776484|NCT05012943|584223186|FG002|Overall Study|Lost to Follow-up|3|||
161776485|NCT05012943|584223184|FG000|Overall Study|Physician Decision|1|||
161776486|NCT05012943|584223185|FG001|Overall Study|Physician Decision|1|||
161776487|NCT05012943|584223186|FG002|Overall Study|Physician Decision|0|||
161776488|NCT05012943|584223184|FG000|Overall Study|Other than Specified|2|||
161776489|NCT05012943|584223185|FG001|Overall Study|Other than Specified|1|||
161776490|NCT05012943|584223186|FG002|Overall Study|Other than Specified|0|||
161776491|NCT00400985|584223188|FG000|Overall Study|Withdrawal by Subject|5|||
161776492|NCT00400985|584223188|FG000|Overall Study|system modification|8|||
161776493|NCT00400985|584223188|FG000|Overall Study|Death|30|||
161776494|NCT00400985|584223188|FG000|Overall Study|Lost to Follow-up|9|||
161776495|NCT05048875|584223190|FG000|Overall Study|Withdrawal by Subject|1|||
161776496|NCT05048875|584223191|FG001|Overall Study|Withdrawal by Subject|0|||
161776497|NCT05048875|584223192|FG002|Overall Study|Withdrawal by Subject|0|||
161776498|NCT05048875|584223193|FG003|Overall Study|Withdrawal by Subject|0|||
161776499|NCT05048875|584223194|FG004|Overall Study|Withdrawal by Subject|0|||
161776500|NCT05048875|584223195|FG005|Overall Study|Withdrawal by Subject|0|||
161776501|NCT05048875|584223196|FG006|Overall Study|Withdrawal by Subject|0|||
161776502|NCT05048875|584223197|FG007|Overall Study|Withdrawal by Subject|0|||
161776503|NCT05048875|584223190|FG000|Overall Study|Adverse Event|0|||
161776504|NCT05048875|584223191|FG001|Overall Study|Adverse Event|0|||
161776505|NCT05048875|584223192|FG002|Overall Study|Adverse Event|0|||
161776506|NCT05048875|584223193|FG003|Overall Study|Adverse Event|1|||
161776507|NCT05048875|584223194|FG004|Overall Study|Adverse Event|0|||
161776508|NCT05048875|584223195|FG005|Overall Study|Adverse Event|0|||
161776509|NCT05048875|584223196|FG006|Overall Study|Adverse Event|0|||
161776510|NCT05048875|584223197|FG007|Overall Study|Adverse Event|0|||
161876521|NCT00090220|584592555|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
161876522|NCT00090220|584592556|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
161876523|NCT00090220|584592557|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
161876524|NCT00090220|584592558|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
161876525|NCT00090220|584592553|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
161876526|NCT00090220|584592554|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
161876527|NCT00090220|584592555|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
161876528|NCT00090220|584592556|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
161876529|NCT00090220|584592557|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
161876530|NCT00090220|584592558|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
161876531|NCT00090220|584592553|FG000|Base Study Vaccination Period|Patient Moved|6|||
161876532|NCT00090220|584592554|FG001|Base Study Vaccination Period|Patient Moved|2|||
161876533|NCT00090220|584592555|FG002|Base Study Vaccination Period|Patient Moved|0|||
161876534|NCT00090220|584592556|FG003|Base Study Vaccination Period|Patient Moved|0|||
161876535|NCT00090220|584592557|FG004|Base Study Vaccination Period|Patient Moved|0|||
161876536|NCT00090220|584592558|FG005|Base Study Vaccination Period|Patient Moved|0|||
161876537|NCT00090220|584592553|FG000|Base Study Vaccination Period|Other|4|||
161876538|NCT00090220|584592554|FG001|Base Study Vaccination Period|Other|4|||
161876539|NCT00090220|584592555|FG002|Base Study Vaccination Period|Other|0|||
161876540|NCT00090220|584592556|FG003|Base Study Vaccination Period|Other|0|||
161876541|NCT00090220|584592557|FG004|Base Study Vaccination Period|Other|0|||
161876542|NCT00090220|584592558|FG005|Base Study Vaccination Period|Other|0|||
161876543|NCT00090220|584592553|FG000|Base Study Follow-up Period|Adverse Event|6|||
161876544|NCT00090220|584592554|FG001|Base Study Follow-up Period|Adverse Event|1|||
161876545|NCT00090220|584592555|FG002|Base Study Follow-up Period|Adverse Event|0|||
161876546|NCT00090220|584592556|FG003|Base Study Follow-up Period|Adverse Event|0|||
161876547|NCT00090220|584592557|FG004|Base Study Follow-up Period|Adverse Event|0|||
161876548|NCT00090220|584592558|FG005|Base Study Follow-up Period|Adverse Event|0|||
161876549|NCT00090220|584592553|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
161876550|NCT00090220|584592554|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
161876551|NCT00090220|584592555|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
161876552|NCT00090220|584592556|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
161876553|NCT00090220|584592557|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
161876554|NCT00090220|584592558|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
161876555|NCT00090220|584592553|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
161876556|NCT00090220|584592554|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
161876557|NCT00090220|584592555|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
161876558|NCT00090220|584592556|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
161876559|NCT00090220|584592557|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
161876560|NCT00090220|584592558|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
161876561|NCT00090220|584592553|FG000|Base Study Follow-up Period|Patient Moved|20|||
161876562|NCT00090220|584592554|FG001|Base Study Follow-up Period|Patient Moved|28|||
161876563|NCT00090220|584592555|FG002|Base Study Follow-up Period|Patient Moved|0|||
161876564|NCT00090220|584592556|FG003|Base Study Follow-up Period|Patient Moved|0|||
161876565|NCT00090220|584592557|FG004|Base Study Follow-up Period|Patient Moved|0|||
161876566|NCT00090220|584592558|FG005|Base Study Follow-up Period|Patient Moved|0|||
161876567|NCT00090220|584592553|FG000|Base Study Follow-up Period|Other|19|||
161876568|NCT00090220|584592554|FG001|Base Study Follow-up Period|Other|21|||
161876569|NCT00090220|584592555|FG002|Base Study Follow-up Period|Other|0|||
161876570|NCT00090220|584592556|FG003|Base Study Follow-up Period|Other|0|||
161876571|NCT00090220|584592557|FG004|Base Study Follow-up Period|Other|0|||
161876572|NCT00090220|584592558|FG005|Base Study Follow-up Period|Other|0|||
161876573|NCT00090220|584592553|FG000|Extension 1 (EXT1)|Adverse Event|0|||
161876574|NCT00090220|584592554|FG001|Extension 1 (EXT1)|Adverse Event|0|||
161876575|NCT00090220|584592555|FG002|Extension 1 (EXT1)|Adverse Event|4|||
161876576|NCT00090220|584592556|FG003|Extension 1 (EXT1)|Adverse Event|0|||
161876577|NCT00090220|584592557|FG004|Extension 1 (EXT1)|Adverse Event|0|||
161876578|NCT00090220|584592558|FG005|Extension 1 (EXT1)|Adverse Event|0|||
161876579|NCT00090220|584592553|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
161876580|NCT00090220|584592554|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
161876581|NCT00090220|584592555|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
161876582|NCT00090220|584592556|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
161876583|NCT00090220|584592557|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
161876584|NCT00090220|584592558|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
161876585|NCT00090220|584592553|FG000|Extension 1 (EXT1)|Moved|0|||
161876586|NCT00090220|584592554|FG001|Extension 1 (EXT1)|Moved|0|||
161876587|NCT00090220|584592555|FG002|Extension 1 (EXT1)|Moved|2|||
161876588|NCT00090220|584592556|FG003|Extension 1 (EXT1)|Moved|1|||
161876589|NCT00090220|584592557|FG004|Extension 1 (EXT1)|Moved|0|||
161876590|NCT00090220|584592558|FG005|Extension 1 (EXT1)|Moved|0|||
161876591|NCT00090220|584592553|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161876592|NCT00090220|584592554|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161876593|NCT00090220|584592555|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
161876594|NCT00090220|584592556|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161876595|NCT00090220|584592557|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161876596|NCT00090220|584592558|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161876597|NCT00090220|584592553|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
161876598|NCT00090220|584592554|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
161876599|NCT00090220|584592555|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
161876600|NCT00090220|584592556|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
161876601|NCT00090220|584592557|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
161876602|NCT00090220|584592558|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
161876603|NCT00090220|584592553|FG000|Extension 1 (EXT1)|Other reason|0|||
161876604|NCT00090220|584592554|FG001|Extension 1 (EXT1)|Other reason|0|||
161876605|NCT00090220|584592555|FG002|Extension 1 (EXT1)|Other reason|2|||
161876606|NCT00090220|584592556|FG003|Extension 1 (EXT1)|Other reason|0|||
161876607|NCT00090220|584592557|FG004|Extension 1 (EXT1)|Other reason|0|||
161876608|NCT00090220|584592558|FG005|Extension 1 (EXT1)|Other reason|0|||
161876609|NCT00090220|584592553|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161876610|NCT00090220|584592554|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161876611|NCT00090220|584592555|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161876612|NCT00090220|584592556|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161876613|NCT00090220|584592557|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
161876614|NCT00090220|584592558|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
161876615|NCT00090220|584592553|FG000|Long-term Follow-up (EXT2)|Death|0|||
161876616|NCT00090220|584592554|FG001|Long-term Follow-up (EXT2)|Death|0|||
161876617|NCT00090220|584592555|FG002|Long-term Follow-up (EXT2)|Death|0|||
161876618|NCT00090220|584592556|FG003|Long-term Follow-up (EXT2)|Death|0|||
161876619|NCT00090220|584592557|FG004|Long-term Follow-up (EXT2)|Death|1|||
161876620|NCT00090220|584592558|FG005|Long-term Follow-up (EXT2)|Death|1|||
161876621|NCT00090220|584592553|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161876622|NCT00090220|584592554|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161876623|NCT00090220|584592555|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161876624|NCT00090220|584592556|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161876625|NCT00090220|584592557|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
161876626|NCT00090220|584592558|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
161876627|NCT00090220|584592553|FG000|Long-term Follow-up (EXT2)|Other|0|||
161876628|NCT00090220|584592554|FG001|Long-term Follow-up (EXT2)|Other|0|||
161876629|NCT00090220|584592555|FG002|Long-term Follow-up (EXT2)|Other|0|||
161876630|NCT00090220|584592556|FG003|Long-term Follow-up (EXT2)|Other|0|||
161876631|NCT00090220|584592557|FG004|Long-term Follow-up (EXT2)|Other|1|||
161876632|NCT00090220|584592558|FG005|Long-term Follow-up (EXT2)|Other|0|||
161876633|NCT00941863|584592559|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
161876634|NCT00941863|584592560|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
161876635|NCT00941863|584592561|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
161876636|NCT00941863|584592562|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
161876637|NCT00941863|584592563|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
161876638|NCT00941863|584592559|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
161876639|NCT00941863|584592560|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
161876640|NCT00941863|584592561|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
161876641|NCT00941863|584592562|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
161876642|NCT00941863|584592563|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
161876643|NCT00941863|584592559|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
161876644|NCT00941863|584592560|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
161876645|NCT00941863|584592561|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
161876646|NCT00941863|584592562|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
161876647|NCT00941863|584592563|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
161876648|NCT00941863|584592559|FG000|Until Primary Completion Date (PCD)|Death|0|||
161876649|NCT00941863|584592560|FG001|Until Primary Completion Date (PCD)|Death|0|||
161876650|NCT00941863|584592561|FG002|Until Primary Completion Date (PCD)|Death|1|||
161876651|NCT00941863|584592562|FG003|Until Primary Completion Date (PCD)|Death|2|||
161876652|NCT00941863|584592563|FG004|Until Primary Completion Date (PCD)|Death|7|||
161876653|NCT00941863|584592559|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
161990679|NCT01844778|585016362|FG001|Overall Study|Adverse Event|2|||
161990680|NCT01844778|585016363|FG002|Overall Study|Adverse Event|2|||
161990681|NCT02343406|585016364|FG000|Overall Study|Progressive disease|72|||
161990682|NCT02343406|585016365|FG001|Overall Study|Progressive disease|70|||
161876654|NCT00941863|584592560|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
161876655|NCT00941863|584592561|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
161876656|NCT00941863|584592562|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
161876657|NCT00941863|584592563|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
161876658|NCT00941863|584592559|FG000|Continued After PCD|Withdrawal by Subject|0|||
161876659|NCT00941863|584592560|FG001|Continued After PCD|Withdrawal by Subject|0|||
161876660|NCT00941863|584592561|FG002|Continued After PCD|Withdrawal by Subject|0|||
161876661|NCT00941863|584592562|FG003|Continued After PCD|Withdrawal by Subject|0|||
161876662|NCT00941863|584592563|FG004|Continued After PCD|Withdrawal by Subject|1|||
161990683|NCT02343406|585016366|FG002|Overall Study|Progressive disease|43|||
161876663|NCT00941863|584592559|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
161876664|NCT00941863|584592560|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
161876665|NCT00941863|584592561|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
161876666|NCT00941863|584592562|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
161876667|NCT00941863|584592563|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
161876668|NCT01471340|584592564|FG000|Overall Study|Death|5|||
161876669|NCT01471340|584592565|FG001|Overall Study|Death|4|||
161876670|NCT01471340|584592564|FG000|Overall Study|Lost to Follow-up|0|||
161876671|NCT01471340|584592565|FG001|Overall Study|Lost to Follow-up|1|||
161876672|NCT01471340|584592564|FG000|Overall Study|Investigational site closure|0|||
161876673|NCT01471340|584592565|FG001|Overall Study|Investigational site closure|1|||
161876674|NCT01471340|584592564|FG000|Overall Study|Invalid informed consent|1|||
161876675|NCT01471340|584592565|FG001|Overall Study|Invalid informed consent|0|||
161876676|NCT03452488|584592566|FG000|Overall Study|Adverse Event|4|||
161876677|NCT03452488|584592567|FG001|Overall Study|Adverse Event|6|||
161876678|NCT03452488|584592568|FG002|Overall Study|Adverse Event|1|||
161876679|NCT03452488|584592566|FG000|Overall Study|Death|0|||
161876680|NCT03452488|584592567|FG001|Overall Study|Death|0|||
161876681|NCT03452488|584592568|FG002|Overall Study|Death|1|||
161876682|NCT03452488|584592566|FG000|Overall Study|Lost to Follow-up|1|||
161876683|NCT03452488|584592567|FG001|Overall Study|Lost to Follow-up|2|||
161876684|NCT03452488|584592568|FG002|Overall Study|Lost to Follow-up|0|||
161876685|NCT03452488|584592566|FG000|Overall Study|PI Decision|1|||
161876686|NCT03452488|584592567|FG001|Overall Study|PI Decision|0|||
161876687|NCT03452488|584592568|FG002|Overall Study|PI Decision|0|||
161876688|NCT03452488|584592566|FG000|Overall Study|Withdrew consent|4|||
161876689|NCT03452488|584592567|FG001|Overall Study|Withdrew consent|2|||
161876690|NCT03452488|584592568|FG002|Overall Study|Withdrew consent|2|||
161876691|NCT03452488|584592566|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
161876692|NCT03452488|584592567|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
161876693|NCT03452488|584592568|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
161876694|NCT03452488|584592566|FG000|Overall Study|Other|0|||
161876695|NCT03452488|584592567|FG001|Overall Study|Other|2|||
161876696|NCT03452488|584592568|FG002|Overall Study|Other|2|||
161876697|NCT03315286|584592569|FG000|Overall Study|Lost to Follow-up|0|||
161876698|NCT03315286|584592570|FG001|Overall Study|Lost to Follow-up|3|||
161876699|NCT03315286|584592569|FG000|Overall Study|Withdrawal by Subject|1|||
161876700|NCT03315286|584592570|FG001|Overall Study|Withdrawal by Subject|0|||
161876701|NCT03315286|584592569|FG000|Overall Study|Protocol Violation|0|||
161876702|NCT03315286|584592570|FG001|Overall Study|Protocol Violation|1|||
161876703|NCT00747474|584592571|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876704|NCT00747474|584592572|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876705|NCT00747474|584592573|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876706|NCT00747474|584592574|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876707|NCT00747474|584592575|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876708|NCT00747474|584592576|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876709|NCT00747474|584592577|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876710|NCT00747474|584592578|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
161876711|NCT00747474|584592579|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876712|NCT00747474|584592580|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876713|NCT00747474|584592581|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876714|NCT00747474|584592582|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161876715|NCT02829723|584592584|FG000|Overall Study|Adverse Event|0|||
161876716|NCT02829723|584592585|FG001|Overall Study|Adverse Event|0|||
161876717|NCT02829723|584592586|FG002|Overall Study|Adverse Event|1|||
161876718|NCT02829723|584592587|FG003|Overall Study|Adverse Event|1|||
161876719|NCT02829723|584592588|FG004|Overall Study|Adverse Event|0|||
161876720|NCT02829723|584592589|FG005|Overall Study|Adverse Event|0|||
161876721|NCT02829723|584592590|FG006|Overall Study|Adverse Event|0|||
161876722|NCT02829723|584592591|FG007|Overall Study|Adverse Event|1|||
161876723|NCT02829723|584592592|FG008|Overall Study|Adverse Event|0|||
161990684|NCT02343406|585016367|FG003|Overall Study|Progressive disease|15|||
161876724|NCT02829723|584592593|FG009|Overall Study|Adverse Event|0|||
161876725|NCT02829723|584592594|FG010|Overall Study|Adverse Event|0|||
161876726|NCT02829723|584592595|FG011|Overall Study|Adverse Event|0|||
161990685|NCT02343406|585016368|FG004|Overall Study|Progressive disease|5|||
161990686|NCT02343406|585016364|FG000|Overall Study|Adverse Event|6|||
161876727|NCT02829723|584592596|FG012|Overall Study|Adverse Event|0|||
161876728|NCT02829723|584592597|FG013|Overall Study|Adverse Event|0|||
161876729|NCT02829723|584592598|FG014|Overall Study|Adverse Event|1|||
161876730|NCT02829723|584592599|FG015|Overall Study|Adverse Event|1|||
161876731|NCT02829723|584592600|FG016|Overall Study|Adverse Event|1|||
161876732|NCT02829723|584592601|FG017|Overall Study|Adverse Event|2|||
161876733|NCT02829723|584592602|FG018|Overall Study|Adverse Event|1|||
161876734|NCT02829723|584592603|FG019|Overall Study|Adverse Event|1|||
161876735|NCT02829723|584592604|FG020|Overall Study|Adverse Event|3|||
161876736|NCT02829723|584592605|FG021|Overall Study|Adverse Event|0|||
161876737|NCT02829723|584592606|FG022|Overall Study|Adverse Event|0|||
161876738|NCT02829723|584592607|FG023|Overall Study|Adverse Event|1|||
161876739|NCT02829723|584592608|FG024|Overall Study|Adverse Event|1|||
161876740|NCT02829723|584592609|FG025|Overall Study|Adverse Event|3|||
161876741|NCT02829723|584592610|FG026|Overall Study|Adverse Event|5|||
161876742|NCT02829723|584592584|FG000|Overall Study|Death|1|||
161876743|NCT02829723|584592585|FG001|Overall Study|Death|0|||
161876744|NCT02829723|584592586|FG002|Overall Study|Death|1|||
161876745|NCT02829723|584592587|FG003|Overall Study|Death|1|||
161876746|NCT02829723|584592588|FG004|Overall Study|Death|0|||
161876747|NCT02829723|584592589|FG005|Overall Study|Death|0|||
161876748|NCT02829723|584592590|FG006|Overall Study|Death|2|||
161876749|NCT02829723|584592591|FG007|Overall Study|Death|0|||
161876750|NCT02829723|584592592|FG008|Overall Study|Death|1|||
161876751|NCT02829723|584592593|FG009|Overall Study|Death|0|||
161876752|NCT02829723|584592594|FG010|Overall Study|Death|0|||
161876753|NCT02829723|584592595|FG011|Overall Study|Death|0|||
161876754|NCT02829723|584592596|FG012|Overall Study|Death|2|||
161876755|NCT02829723|584592597|FG013|Overall Study|Death|1|||
161876756|NCT02829723|584592598|FG014|Overall Study|Death|0|||
161876757|NCT02829723|584592599|FG015|Overall Study|Death|0|||
161876758|NCT02829723|584592600|FG016|Overall Study|Death|0|||
161876759|NCT02829723|584592601|FG017|Overall Study|Death|0|||
161876760|NCT02829723|584592602|FG018|Overall Study|Death|0|||
161876761|NCT02829723|584592603|FG019|Overall Study|Death|0|||
161876762|NCT02829723|584592604|FG020|Overall Study|Death|0|||
161876763|NCT02829723|584592605|FG021|Overall Study|Death|2|||
161876764|NCT02829723|584592606|FG022|Overall Study|Death|0|||
161876765|NCT02829723|584592607|FG023|Overall Study|Death|0|||
161876766|NCT02829723|584592608|FG024|Overall Study|Death|0|||
161876767|NCT02829723|584592609|FG025|Overall Study|Death|1|||
161876768|NCT02829723|584592610|FG026|Overall Study|Death|2|||
161876769|NCT02829723|584592584|FG000|Overall Study|Physician Decision|0|||
161876770|NCT02829723|584592585|FG001|Overall Study|Physician Decision|0|||
161876771|NCT02829723|584592586|FG002|Overall Study|Physician Decision|0|||
161876772|NCT02829723|584592587|FG003|Overall Study|Physician Decision|0|||
161876773|NCT02829723|584592588|FG004|Overall Study|Physician Decision|0|||
161876774|NCT02829723|584592589|FG005|Overall Study|Physician Decision|0|||
161876775|NCT02829723|584592590|FG006|Overall Study|Physician Decision|0|||
161876776|NCT02829723|584592591|FG007|Overall Study|Physician Decision|0|||
161876777|NCT02829723|584592592|FG008|Overall Study|Physician Decision|0|||
161876778|NCT02829723|584592593|FG009|Overall Study|Physician Decision|1|||
161876779|NCT02829723|584592594|FG010|Overall Study|Physician Decision|1|||
161876780|NCT02829723|584592595|FG011|Overall Study|Physician Decision|0|||
161876781|NCT02829723|584592596|FG012|Overall Study|Physician Decision|0|||
161876782|NCT02829723|584592597|FG013|Overall Study|Physician Decision|1|||
161876783|NCT02829723|584592598|FG014|Overall Study|Physician Decision|0|||
161876784|NCT02829723|584592599|FG015|Overall Study|Physician Decision|0|||
161876785|NCT02829723|584592600|FG016|Overall Study|Physician Decision|2|||
161876786|NCT02829723|584592601|FG017|Overall Study|Physician Decision|0|||
161876787|NCT02829723|584592602|FG018|Overall Study|Physician Decision|0|||
161876788|NCT02829723|584592603|FG019|Overall Study|Physician Decision|0|||
161876789|NCT02829723|584592604|FG020|Overall Study|Physician Decision|0|||
161876790|NCT02829723|584592605|FG021|Overall Study|Physician Decision|0|||
161876791|NCT02829723|584592606|FG022|Overall Study|Physician Decision|1|||
161876792|NCT02829723|584592607|FG023|Overall Study|Physician Decision|1|||
161876793|NCT02829723|584592608|FG024|Overall Study|Physician Decision|1|||
161876794|NCT02829723|584592609|FG025|Overall Study|Physician Decision|1|||
161876795|NCT02829723|584592610|FG026|Overall Study|Physician Decision|3|||
161876796|NCT02829723|584592584|FG000|Overall Study|Progressive disease|4|||
161876797|NCT02829723|584592585|FG001|Overall Study|Progressive disease|6|||
161876798|NCT02829723|584592586|FG002|Overall Study|Progressive disease|3|||
161876799|NCT02829723|584592587|FG003|Overall Study|Progressive disease|3|||
161990687|NCT02343406|585016365|FG001|Overall Study|Adverse Event|8|||
161990688|NCT02343406|585016366|FG002|Overall Study|Adverse Event|6|||
161876800|NCT02829723|584592588|FG004|Overall Study|Progressive disease|3|||
161990689|NCT02343406|585016367|FG003|Overall Study|Adverse Event|3|||
161990690|NCT02343406|585016368|FG004|Overall Study|Adverse Event|0|||
161876801|NCT02829723|584592589|FG005|Overall Study|Progressive disease|5|||
161876802|NCT02829723|584592590|FG006|Overall Study|Progressive disease|4|||
161876803|NCT02829723|584592591|FG007|Overall Study|Progressive disease|6|||
161876804|NCT02829723|584592592|FG008|Overall Study|Progressive disease|8|||
161990691|NCT02343406|585016364|FG000|Overall Study|Withdrawal by Subject|6|||
161990692|NCT02343406|585016365|FG001|Overall Study|Withdrawal by Subject|4|||
161876805|NCT02829723|584592593|FG009|Overall Study|Progressive disease|4|||
161876806|NCT02829723|584592594|FG010|Overall Study|Progressive disease|9|||
161876807|NCT02829723|584592595|FG011|Overall Study|Progressive disease|0|||
161876808|NCT02829723|584592596|FG012|Overall Study|Progressive disease|3|||
161876809|NCT02829723|584592597|FG013|Overall Study|Progressive disease|4|||
161876810|NCT02829723|584592598|FG014|Overall Study|Progressive disease|2|||
161876811|NCT02829723|584592599|FG015|Overall Study|Progressive disease|4|||
161876812|NCT02829723|584592600|FG016|Overall Study|Progressive disease|5|||
161876813|NCT02829723|584592601|FG017|Overall Study|Progressive disease|3|||
161876814|NCT02829723|584592602|FG018|Overall Study|Progressive disease|4|||
161876815|NCT02829723|584592603|FG019|Overall Study|Progressive disease|4|||
161876816|NCT02829723|584592604|FG020|Overall Study|Progressive disease|7|||
161876817|NCT02829723|584592605|FG021|Overall Study|Progressive disease|6|||
161876818|NCT02829723|584592606|FG022|Overall Study|Progressive disease|3|||
161876819|NCT02829723|584592607|FG023|Overall Study|Progressive disease|3|||
161876820|NCT02829723|584592608|FG024|Overall Study|Progressive disease|3|||
161876821|NCT02829723|584592609|FG025|Overall Study|Progressive disease|16|||
161876822|NCT02829723|584592610|FG026|Overall Study|Progressive disease|10|||
161876823|NCT02829723|584592584|FG000|Overall Study|Subject/guardian decision|0|||
161876824|NCT02829723|584592585|FG001|Overall Study|Subject/guardian decision|1|||
161876825|NCT02829723|584592586|FG002|Overall Study|Subject/guardian decision|0|||
161876826|NCT02829723|584592587|FG003|Overall Study|Subject/guardian decision|1|||
161876827|NCT02829723|584592588|FG004|Overall Study|Subject/guardian decision|0|||
161876828|NCT02829723|584592589|FG005|Overall Study|Subject/guardian decision|0|||
161876829|NCT02829723|584592590|FG006|Overall Study|Subject/guardian decision|0|||
161876830|NCT02829723|584592591|FG007|Overall Study|Subject/guardian decision|1|||
161876831|NCT02829723|584592592|FG008|Overall Study|Subject/guardian decision|0|||
161876832|NCT02829723|584592593|FG009|Overall Study|Subject/guardian decision|0|||
161876833|NCT02829723|584592594|FG010|Overall Study|Subject/guardian decision|0|||
161876834|NCT02829723|584592595|FG011|Overall Study|Subject/guardian decision|0|||
161876835|NCT02829723|584592596|FG012|Overall Study|Subject/guardian decision|0|||
161876836|NCT02829723|584592597|FG013|Overall Study|Subject/guardian decision|0|||
161876837|NCT02829723|584592598|FG014|Overall Study|Subject/guardian decision|1|||
161876838|NCT02829723|584592599|FG015|Overall Study|Subject/guardian decision|0|||
161876839|NCT02829723|584592600|FG016|Overall Study|Subject/guardian decision|1|||
161876840|NCT02829723|584592601|FG017|Overall Study|Subject/guardian decision|0|||
161876841|NCT02829723|584592602|FG018|Overall Study|Subject/guardian decision|1|||
161876842|NCT02829723|584592603|FG019|Overall Study|Subject/guardian decision|0|||
161876843|NCT02829723|584592604|FG020|Overall Study|Subject/guardian decision|1|||
161876844|NCT02829723|584592605|FG021|Overall Study|Subject/guardian decision|0|||
161876845|NCT02829723|584592606|FG022|Overall Study|Subject/guardian decision|0|||
161876846|NCT02829723|584592607|FG023|Overall Study|Subject/guardian decision|1|||
161876847|NCT02829723|584592608|FG024|Overall Study|Subject/guardian decision|0|||
161876848|NCT02829723|584592609|FG025|Overall Study|Subject/guardian decision|1|||
161876849|NCT02829723|584592610|FG026|Overall Study|Subject/guardian decision|1|||
161876850|NCT02829723|584592584|FG000|Overall Study|Study terminated by sponsor|0|||
161876851|NCT02829723|584592585|FG001|Overall Study|Study terminated by sponsor|0|||
161876852|NCT02829723|584592586|FG002|Overall Study|Study terminated by sponsor|0|||
161876853|NCT02829723|584592587|FG003|Overall Study|Study terminated by sponsor|0|||
161876854|NCT02829723|584592588|FG004|Overall Study|Study terminated by sponsor|0|||
161876855|NCT02829723|584592589|FG005|Overall Study|Study terminated by sponsor|0|||
161876856|NCT02829723|584592590|FG006|Overall Study|Study terminated by sponsor|0|||
161876857|NCT02829723|584592591|FG007|Overall Study|Study terminated by sponsor|0|||
161876858|NCT02829723|584592592|FG008|Overall Study|Study terminated by sponsor|0|||
161876859|NCT02829723|584592593|FG009|Overall Study|Study terminated by sponsor|0|||
161876860|NCT02829723|584592594|FG010|Overall Study|Study terminated by sponsor|0|||
161876861|NCT02829723|584592595|FG011|Overall Study|Study terminated by sponsor|0|||
161876862|NCT02829723|584592596|FG012|Overall Study|Study terminated by sponsor|0|||
161876863|NCT02829723|584592597|FG013|Overall Study|Study terminated by sponsor|0|||
161876864|NCT02829723|584592598|FG014|Overall Study|Study terminated by sponsor|0|||
161876865|NCT02829723|584592599|FG015|Overall Study|Study terminated by sponsor|0|||
161876866|NCT02829723|584592600|FG016|Overall Study|Study terminated by sponsor|0|||
161876867|NCT02829723|584592601|FG017|Overall Study|Study terminated by sponsor|0|||
161876868|NCT02829723|584592602|FG018|Overall Study|Study terminated by sponsor|0|||
161876869|NCT02829723|584592603|FG019|Overall Study|Study terminated by sponsor|0|||
161876870|NCT02829723|584592604|FG020|Overall Study|Study terminated by sponsor|0|||
161876871|NCT02829723|584592605|FG021|Overall Study|Study terminated by sponsor|1|||
161876872|NCT02829723|584592606|FG022|Overall Study|Study terminated by sponsor|0|||
161876873|NCT02829723|584592607|FG023|Overall Study|Study terminated by sponsor|0|||
161876874|NCT02829723|584592608|FG024|Overall Study|Study terminated by sponsor|0|||
161876875|NCT02829723|584592609|FG025|Overall Study|Study terminated by sponsor|0|||
161876876|NCT02829723|584592610|FG026|Overall Study|Study terminated by sponsor|0|||
161876877|NCT02989649|584592611|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
161876878|NCT02989649|584592611|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
161876879|NCT02989649|584592611|FG000|Overall Study|Lost For Observation During Study|3|||
161876880|NCT02989649|584592611|FG000|Overall Study|Reason Not Specified|13|||
161876881|NCT00330343|584592612|FG000|Overall Study|Lost to Follow-up|5|||
161876882|NCT00256854|584592613|FG000|Overall Study|Withdrawal by Subject|2|||
161876883|NCT00256854|584592614|FG001|Overall Study|Withdrawal by Subject|3|||
161876884|NCT00256854|584592615|FG002|Overall Study|Withdrawal by Subject|0|||
161876885|NCT00256854|584592616|FG003|Overall Study|Withdrawal by Subject|0|||
161876886|NCT00256854|584592617|FG004|Overall Study|Withdrawal by Subject|0|||
161876887|NCT00256854|584592618|FG005|Overall Study|Withdrawal by Subject|0|||
161876888|NCT00256854|584592613|FG000|Overall Study|Lack of Efficacy|1|||
161876889|NCT00256854|584592614|FG001|Overall Study|Lack of Efficacy|0|||
161876890|NCT00256854|584592615|FG002|Overall Study|Lack of Efficacy|0|||
161876891|NCT00256854|584592616|FG003|Overall Study|Lack of Efficacy|0|||
161876892|NCT00256854|584592617|FG004|Overall Study|Lack of Efficacy|0|||
161876893|NCT00256854|584592618|FG005|Overall Study|Lack of Efficacy|0|||
161876894|NCT00256854|584592613|FG000|Overall Study|Protocol Violation|0|||
161876895|NCT00256854|584592614|FG001|Overall Study|Protocol Violation|1|||
161876896|NCT00256854|584592615|FG002|Overall Study|Protocol Violation|1|||
161876897|NCT00256854|584592616|FG003|Overall Study|Protocol Violation|1|||
161876898|NCT00256854|584592617|FG004|Overall Study|Protocol Violation|0|||
161876899|NCT00256854|584592618|FG005|Overall Study|Protocol Violation|0|||
161876900|NCT00256854|584592613|FG000|Overall Study|Adverse Event|0|||
161876901|NCT00256854|584592614|FG001|Overall Study|Adverse Event|0|||
161876902|NCT00256854|584592615|FG002|Overall Study|Adverse Event|2|||
161876903|NCT00256854|584592616|FG003|Overall Study|Adverse Event|2|||
161876904|NCT00256854|584592617|FG004|Overall Study|Adverse Event|0|||
161876905|NCT00256854|584592618|FG005|Overall Study|Adverse Event|1|||
161876906|NCT00256854|584592613|FG000|Overall Study|Not compliant with the study drug|0|||
161876907|NCT00256854|584592614|FG001|Overall Study|Not compliant with the study drug|0|||
161876908|NCT00256854|584592615|FG002|Overall Study|Not compliant with the study drug|0|||
161876909|NCT00256854|584592616|FG003|Overall Study|Not compliant with the study drug|0|||
161876910|NCT00256854|584592617|FG004|Overall Study|Not compliant with the study drug|1|||
161876911|NCT00256854|584592618|FG005|Overall Study|Not compliant with the study drug|0|||
161876912|NCT00281632|584592619|FG000|Overall Study|Adverse Event|7|||
161876913|NCT00281632|584592619|FG000|Overall Study|Withdrawal by Subject|2|||
161876914|NCT00281632|584592619|FG000|Overall Study|Disease Progression|22|||
161876915|NCT00281632|584592619|FG000|Overall Study|Death|1|||
161876916|NCT00281632|584592619|FG000|Overall Study|Physician Decision|1|||
161876917|NCT00281632|584592619|FG000|Overall Study|Ongoing|3|||
161876918|NCT03047720|584592625|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
161876919|NCT03047720|584592626|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
161876920|NCT01475851|584592637|FG000|Overall Study|Protocol defined stopping criteria|1|||
161876921|NCT01475851|584592638|FG001|Overall Study|Protocol defined stopping criteria|0|||
161876922|NCT04603482|584592639|FG000|Overall Study|Lost to Follow-up|15|||
161876923|NCT04603482|584592640|FG001|Overall Study|Lost to Follow-up|15|||
161876924|NCT04603482|584592641|FG002|Overall Study|Lost to Follow-up|15|||
161876925|NCT00732758|584592642|FG000|Overall Study|Lost to Follow-up|8|||
161876926|NCT00732758|584592643|FG001|Overall Study|Lost to Follow-up|16|||
161876927|NCT00373958|584592644|FG000|Infant Series|Withdrawal by Subject|13|||
161876928|NCT00373958|584592645|FG001|Infant Series|Withdrawal by Subject|15|||
161876929|NCT00373958|584592644|FG000|Infant Series|Failed to return|8|||
161876930|NCT00373958|584592645|FG001|Infant Series|Failed to return|13|||
161876931|NCT00373958|584592644|FG000|Infant Series|Lost to Follow-up|6|||
161876932|NCT00373958|584592645|FG001|Infant Series|Lost to Follow-up|5|||
161876933|NCT00373958|584592644|FG000|Infant Series|Protocol Violation|3|||
161876934|NCT00373958|584592645|FG001|Infant Series|Protocol Violation|7|||
161876935|NCT00373958|584592644|FG000|Infant Series|Lost Kaiser coverage|4|||
161876936|NCT00373958|584592645|FG001|Infant Series|Lost Kaiser coverage|0|||
161876937|NCT00373958|584592644|FG000|Infant Series|Child relocated|1|||
161876938|NCT00373958|584592645|FG001|Infant Series|Child relocated|0|||
161876939|NCT00373958|584592644|FG000|Infant Series|Consent was not received|1|||
161876940|NCT00373958|584592645|FG001|Infant Series|Consent was not received|0|||
161876941|NCT00373958|584592644|FG000|Infant Series|Adverse Event|3|||
161876942|NCT00373958|584592645|FG001|Infant Series|Adverse Event|1|||
161876943|NCT00373958|584592644|FG000|Infant Series|Physician Decision|1|||
161876944|NCT00373958|584592645|FG001|Infant Series|Physician Decision|1|||
161876945|NCT00373958|584592644|FG000|Toddler Dose|Lost to Follow-up|5|||
161876946|NCT00373958|584592645|FG001|Toddler Dose|Lost to Follow-up|8|||
161876947|NCT00373958|584592644|FG000|Toddler Dose|Withdrawal by Subject|2|||
161876948|NCT00373958|584592645|FG001|Toddler Dose|Withdrawal by Subject|2|||
161990693|NCT02343406|585016366|FG002|Overall Study|Withdrawal by Subject|8|||
161990694|NCT02343406|585016367|FG003|Overall Study|Withdrawal by Subject|3|||
161990695|NCT02343406|585016368|FG004|Overall Study|Withdrawal by Subject|0|||
161990696|NCT02343406|585016364|FG000|Overall Study|Death|2|||
161876949|NCT00373958|584592644|FG000|Toddler Dose|Failed to return|1|||
161876950|NCT00373958|584592645|FG001|Toddler Dose|Failed to return|2|||
161876951|NCT00373958|584592644|FG000|Toddler Dose|Protocol Violation|0|||
161876952|NCT00373958|584592645|FG001|Toddler Dose|Protocol Violation|1|||
161876953|NCT00373958|584592644|FG000|Toddler Dose|Withdrawn after infant series|22|||
161876954|NCT00373958|584592645|FG001|Toddler Dose|Withdrawn after infant series|25|||
161876955|NCT01552915|584592646|FG000|Overall Study|Adverse Event|3|||
161876956|NCT01552915|584592647|FG001|Overall Study|Adverse Event|14|||
161990697|NCT02343406|585016365|FG001|Overall Study|Death|1|||
161876957|NCT01552915|584592648|FG002|Overall Study|Adverse Event|3|||
161876958|NCT01552915|584592646|FG000|Overall Study|Lost to Follow-up|4|||
161876959|NCT01552915|584592647|FG001|Overall Study|Lost to Follow-up|6|||
161990698|NCT02343406|585016366|FG002|Overall Study|Death|0|||
161876960|NCT01552915|584592648|FG002|Overall Study|Lost to Follow-up|5|||
161876961|NCT01552915|584592646|FG000|Overall Study|Withdrawal by Subject|6|||
161876962|NCT01552915|584592647|FG001|Overall Study|Withdrawal by Subject|4|||
161876963|NCT01552915|584592648|FG002|Overall Study|Withdrawal by Subject|5|||
161876964|NCT01552915|584592646|FG000|Overall Study|Protocol Violation|0|||
161876965|NCT01552915|584592647|FG001|Overall Study|Protocol Violation|4|||
161876966|NCT01552915|584592648|FG002|Overall Study|Protocol Violation|4|||
161876967|NCT01552915|584592646|FG000|Overall Study|Lack of Efficacy|8|||
161876968|NCT01552915|584592647|FG001|Overall Study|Lack of Efficacy|1|||
161876969|NCT01552915|584592648|FG002|Overall Study|Lack of Efficacy|4|||
161876970|NCT01552915|584592646|FG000|Overall Study|Other|2|||
161876971|NCT01552915|584592647|FG001|Overall Study|Other|0|||
161876972|NCT01552915|584592648|FG002|Overall Study|Other|6|||
161876973|NCT00179673|584592651|FG000|Overall Study|Adverse Event|7|||
161876974|NCT00179673|584592651|FG000|Overall Study|Lack of Efficacy|15|||
161876975|NCT00179673|584592651|FG000|Overall Study|Withdrawal by Subject|3|||
161876976|NCT00179673|584592651|FG000|Overall Study|Death|4|||
161876977|NCT00179673|584592651|FG000|Overall Study|Other Observations and options|14|||
161876978|NCT00492648|584592652|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
161876979|NCT00492648|584592653|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
161876980|NCT00282113|584592654|FG000|Overall Study|Removed at parents request|1|||
161876981|NCT00282113|584592655|FG001|Overall Study|Removed at parents request|0|||
161876982|NCT00282113|584592656|FG002|Overall Study|Removed at parents request|0|||
161876983|NCT03382834|584592657|FG000|Step 1|Lost to Follow-up|0|||
161876984|NCT03382834|584592658|FG001|Step 1|Lost to Follow-up|1|||
161876985|NCT03382834|584592657|FG000|Step 2|Death|1|||
161876986|NCT03382834|584592658|FG001|Step 2|Death|0|||
161876987|NCT03382834|584592657|FG000|Step 2|Lost to Follow-up|2|||
161876988|NCT03382834|584592658|FG001|Step 2|Lost to Follow-up|2|||
161876989|NCT03382834|584592657|FG000|Step 2|Site Terminated by Sponsor|1|||
161876990|NCT03382834|584592658|FG001|Step 2|Site Terminated by Sponsor|0|||
161990699|NCT02343406|585016367|FG003|Overall Study|Death|0|||
161990700|NCT02343406|585016368|FG004|Overall Study|Death|0|||
161990701|NCT02343406|585016364|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
161990702|NCT02343406|585016365|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
161990703|NCT02343406|585016366|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
161990704|NCT02343406|585016367|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
161990705|NCT02343406|585016368|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
161990706|NCT02343406|585016364|FG000|Overall Study|Other primary malignancy|0|||
161990707|NCT02343406|585016365|FG001|Overall Study|Other primary malignancy|1|||
161990708|NCT02343406|585016366|FG002|Overall Study|Other primary malignancy|0|||
161990709|NCT02343406|585016367|FG003|Overall Study|Other primary malignancy|0|||
161990710|NCT02343406|585016368|FG004|Overall Study|Other primary malignancy|0|||
161990711|NCT02343406|585016364|FG000|Overall Study|Other, not specified|2|||
161990712|NCT02343406|585016365|FG001|Overall Study|Other, not specified|1|||
161990713|NCT02343406|585016366|FG002|Overall Study|Other, not specified|1|||
161990714|NCT02343406|585016367|FG003|Overall Study|Other, not specified|4|||
161990715|NCT02343406|585016368|FG004|Overall Study|Other, not specified|0|||
161990716|NCT00548145|585016369|FG000|Overall Study|Death|0|||
161990717|NCT00548145|585016370|FG001|Overall Study|Death|1|||
161990718|NCT00548145|585016369|FG000|Overall Study|Withdrawal by Subject|0|||
161990719|NCT00548145|585016370|FG001|Overall Study|Withdrawal by Subject|2|||
161990720|NCT00548145|585016369|FG000|Overall Study|Physician Decision|1|||
161990721|NCT00548145|585016370|FG001|Overall Study|Physician Decision|1|||
161990722|NCT00874848|585016371|FG000|Overall Study|Adverse Event|13|||
161990723|NCT00874848|585016372|FG001|Overall Study|Adverse Event|2|||
161990724|NCT00874848|585016371|FG000|Overall Study|Progressive neoplastic disease|38|||
161990725|NCT00874848|585016372|FG001|Overall Study|Progressive neoplastic disease|18|||
161990726|NCT00874848|585016371|FG000|Overall Study|Withdrawal by Subject|7|||
161990727|NCT00874848|585016372|FG001|Overall Study|Withdrawal by Subject|4|||
161990728|NCT00874848|585016371|FG000|Overall Study|Noncompliance|1|||
161990729|NCT00874848|585016372|FG001|Overall Study|Noncompliance|1|||
161990730|NCT00874848|585016371|FG000|Overall Study|Failure to comply with protocol|0|||
161990731|NCT00874848|585016372|FG001|Overall Study|Failure to comply with protocol|1|||
161990732|NCT00874848|585016371|FG000|Overall Study|Physician Decision|0|||
161876991|NCT02387957|584592659|FG000|Overall Study|The study was discontinued|21|||
161876992|NCT02387957|584592660|FG001|Overall Study|The study was discontinued|21|||
161876993|NCT02387957|584592661|FG002|Overall Study|The study was discontinued|20|||
161876994|NCT02887248|584592662|FG000|Overall Study|Withdrawal by Subject|1|||
161876995|NCT02887248|584592662|FG000|Overall Study|Adverse Event|1|||
161876996|NCT02887248|584592662|FG000|Overall Study|Progressive Disease|1|||
161876997|NCT02294396|584592663|FG000|Overall Study|Adverse Event|26|||
161876998|NCT02294396|584592664|FG001|Overall Study|Adverse Event|25|||
161876999|NCT02294396|584592665|FG002|Overall Study|Adverse Event|21|||
161877000|NCT02294396|584592666|FG003|Overall Study|Adverse Event|24|||
161990733|NCT00874848|585016372|FG001|Overall Study|Physician Decision|2|||
161990734|NCT03301350|585016381|FG000|Overall Study|Withdrawal by Subject|4|||
161990735|NCT03301350|585016381|FG000|Overall Study|Adverse Event|1|||
161877001|NCT02294396|584592663|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
161877002|NCT02294396|584592664|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
161877003|NCT02294396|584592665|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
161877004|NCT02294396|584592666|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
161877005|NCT02294396|584592663|FG000|Overall Study|Withdrawal by Subject|8|||
161877006|NCT02294396|584592664|FG001|Overall Study|Withdrawal by Subject|6|||
161877007|NCT02294396|584592665|FG002|Overall Study|Withdrawal by Subject|6|||
161877008|NCT02294396|584592666|FG003|Overall Study|Withdrawal by Subject|8|||
161877009|NCT02294396|584592663|FG000|Overall Study|Lost to Follow-up|0|||
161877010|NCT02294396|584592664|FG001|Overall Study|Lost to Follow-up|0|||
161877011|NCT02294396|584592665|FG002|Overall Study|Lost to Follow-up|1|||
161877012|NCT02294396|584592666|FG003|Overall Study|Lost to Follow-up|1|||
161877013|NCT02294396|584592663|FG000|Overall Study|Protocol Deviation|3|||
161877014|NCT02294396|584592664|FG001|Overall Study|Protocol Deviation|2|||
161877015|NCT02294396|584592665|FG002|Overall Study|Protocol Deviation|2|||
161877016|NCT02294396|584592666|FG003|Overall Study|Protocol Deviation|1|||
161877017|NCT02294396|584592663|FG000|Overall Study|Miscellaneous|2|||
161877018|NCT02294396|584592664|FG001|Overall Study|Miscellaneous|0|||
161877019|NCT02294396|584592665|FG002|Overall Study|Miscellaneous|5|||
161877020|NCT02294396|584592666|FG003|Overall Study|Miscellaneous|2|||
161877021|NCT02120833|584592667|FG000|Overall Study|Adverse Event|1|||
161877022|NCT02120833|584592668|FG001|Overall Study|Adverse Event|0|||
161877023|NCT02120833|584592667|FG000|Overall Study|Withdrawal by Subject|2|||
161877024|NCT02120833|584592668|FG001|Overall Study|Withdrawal by Subject|0|||
161877025|NCT02120833|584592667|FG000|Overall Study|Lost to Follow-up|1|||
161877026|NCT02120833|584592668|FG001|Overall Study|Lost to Follow-up|1|||
161877027|NCT02438826|584592669|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
161877028|NCT02438826|584592670|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
161877029|NCT02438826|584592671|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
161877030|NCT02438826|584592672|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161877031|NCT02438826|584592669|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
161877032|NCT02438826|584592670|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161877033|NCT02438826|584592671|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161877034|NCT02438826|584592672|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161877035|NCT02438826|584592669|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
161877036|NCT02438826|584592670|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
161877037|NCT02438826|584592671|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161877038|NCT02438826|584592672|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161877039|NCT02438826|584592669|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
161877040|NCT02438826|584592670|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
161877041|NCT02438826|584592671|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
161877042|NCT02438826|584592672|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
161877043|NCT02438826|584592669|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
161877044|NCT02438826|584592670|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
161877045|NCT02438826|584592671|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
161877046|NCT02438826|584592672|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
161877047|NCT02438826|584592669|FG000|Open-Label Treatment Phase|Adverse Event|11|||
161877048|NCT02438826|584592670|FG001|Open-Label Treatment Phase|Adverse Event|6|||
161877049|NCT02438826|584592671|FG002|Open-Label Treatment Phase|Adverse Event|0|||
161877050|NCT02438826|584592672|FG003|Open-Label Treatment Phase|Adverse Event|0|||
161877051|NCT02438826|584592669|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
161877052|NCT02438826|584592670|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
161877053|NCT02438826|584592671|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
161877054|NCT02438826|584592672|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
161877055|NCT02438826|584592669|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
161877056|NCT02438826|584592670|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
161877057|NCT02438826|584592671|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
161877058|NCT02438826|584592672|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
161877059|NCT02438826|584592669|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
161877060|NCT02438826|584592670|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
161877061|NCT02438826|584592671|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
161877062|NCT02438826|584592672|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
161877063|NCT02438826|584592669|FG000|Post-Treatment Phase|Adverse Event|3|||
161877064|NCT02438826|584592670|FG001|Post-Treatment Phase|Adverse Event|0|||
161877065|NCT02438826|584592671|FG002|Post-Treatment Phase|Adverse Event|0|||
161877066|NCT02438826|584592672|FG003|Post-Treatment Phase|Adverse Event|0|||
161877067|NCT02438826|584592669|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
161990736|NCT03301350|585016381|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
161877068|NCT02438826|584592670|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
161877069|NCT02438826|584592671|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
161990737|NCT03301350|585016381|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
161990738|NCT03301350|585016381|FG000|Overall Study|no detail provided|1|||
161990739|NCT01371734|585016382|FG000|Overall Study|Other|2|||
161877070|NCT02438826|584592672|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
161877071|NCT02438826|584592669|FG000|Post-Treatment Phase|Physician Decision|1|||
161877072|NCT02438826|584592670|FG001|Post-Treatment Phase|Physician Decision|0|||
161877073|NCT02438826|584592671|FG002|Post-Treatment Phase|Physician Decision|0|||
161877074|NCT02438826|584592672|FG003|Post-Treatment Phase|Physician Decision|0|||
161877075|NCT02438826|584592669|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
161877076|NCT02438826|584592670|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
161877077|NCT02438826|584592671|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
161877078|NCT02438826|584592672|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
161877079|NCT03429244|584592676|FG000|Overall Study|Withdrawal by Subject|2|||
161877080|NCT03429244|584592677|FG001|Overall Study|Withdrawal by Subject|1|||
161877081|NCT03429244|584592678|FG002|Overall Study|Withdrawal by Subject|1|||
161877082|NCT01500187|584592679|FG000|Overall Study|Lost to Follow-up|6|||
161877083|NCT01500187|584592680|FG001|Overall Study|Lost to Follow-up|0|||
161877084|NCT00784550|584594188|FG000|Overall Study|Adverse Event|12|||
161877085|NCT00784550|584594189|FG001|Overall Study|Adverse Event|10|||
161877086|NCT00784550|584594188|FG000|Overall Study|Lack of Efficacy|0|||
161877087|NCT00784550|584594189|FG001|Overall Study|Lack of Efficacy|1|||
161877088|NCT00784550|584594188|FG000|Overall Study|Protocol Violation|10|||
161877089|NCT00784550|584594189|FG001|Overall Study|Protocol Violation|10|||
161877090|NCT00784550|584594188|FG000|Overall Study|Lost to Follow-up|8|||
161877091|NCT00784550|584594189|FG001|Overall Study|Lost to Follow-up|5|||
161877092|NCT00784550|584594188|FG000|Overall Study|Physician Decision|2|||
161877093|NCT00784550|584594189|FG001|Overall Study|Physician Decision|3|||
161877094|NCT00784550|584594188|FG000|Overall Study|Withdrawal by Subject|4|||
161877095|NCT00784550|584594189|FG001|Overall Study|Withdrawal by Subject|13|||
161877096|NCT03558152|584594191|FG000|Overall Study|Adverse Event|0|||
161877097|NCT03558152|584594192|FG001|Overall Study|Adverse Event|0|||
161877098|NCT03558152|584594193|FG002|Overall Study|Adverse Event|1|||
161877099|NCT03558152|584594194|FG003|Overall Study|Adverse Event|1|||
161877100|NCT03558152|584594195|FG004|Overall Study|Adverse Event|2|||
161877101|NCT03558152|584594196|FG005|Overall Study|Adverse Event|1|||
161877102|NCT03558152|584594197|FG006|Overall Study|Adverse Event|1|||
161877103|NCT03558152|584594198|FG007|Overall Study|Adverse Event|0|||
161877104|NCT03558152|584594191|FG000|Overall Study|Death|0|||
161877105|NCT03558152|584594192|FG001|Overall Study|Death|0|||
161877106|NCT03558152|584594193|FG002|Overall Study|Death|0|||
161877107|NCT03558152|584594194|FG003|Overall Study|Death|0|||
161877108|NCT03558152|584594195|FG004|Overall Study|Death|1|||
161877109|NCT03558152|584594196|FG005|Overall Study|Death|0|||
161877110|NCT03558152|584594197|FG006|Overall Study|Death|0|||
161877111|NCT03558152|584594198|FG007|Overall Study|Death|0|||
161877112|NCT03558152|584594191|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
161877113|NCT03558152|584594192|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877114|NCT03558152|584594193|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877115|NCT03558152|584594194|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877116|NCT03558152|584594195|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877117|NCT03558152|584594196|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877118|NCT03558152|584594197|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877119|NCT03558152|584594198|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161877120|NCT03558152|584594191|FG000|Overall Study|Miscalculation in mmcs|0|||
161877121|NCT03558152|584594192|FG001|Overall Study|Miscalculation in mmcs|0|||
161877122|NCT03558152|584594193|FG002|Overall Study|Miscalculation in mmcs|0|||
161877123|NCT03558152|584594194|FG003|Overall Study|Miscalculation in mmcs|0|||
161877124|NCT03558152|584594195|FG004|Overall Study|Miscalculation in mmcs|0|||
161877125|NCT03558152|584594196|FG005|Overall Study|Miscalculation in mmcs|0|||
161877126|NCT03558152|584594197|FG006|Overall Study|Miscalculation in mmcs|1|||
161877127|NCT03558152|584594198|FG007|Overall Study|Miscalculation in mmcs|0|||
161877128|NCT03558152|584594191|FG000|Overall Study|Mistake in calculation|0|||
161877129|NCT03558152|584594192|FG001|Overall Study|Mistake in calculation|0|||
161877130|NCT03558152|584594193|FG002|Overall Study|Mistake in calculation|0|||
161877131|NCT03558152|584594194|FG003|Overall Study|Mistake in calculation|1|||
161877132|NCT03558152|584594195|FG004|Overall Study|Mistake in calculation|0|||
161877133|NCT03558152|584594196|FG005|Overall Study|Mistake in calculation|0|||
161877134|NCT03558152|584594197|FG006|Overall Study|Mistake in calculation|0|||
161877135|NCT03558152|584594198|FG007|Overall Study|Mistake in calculation|0|||
161877136|NCT03558152|584594191|FG000|Overall Study|Mistake in evaluation of disease status|0|||
161877137|NCT03558152|584594192|FG001|Overall Study|Mistake in evaluation of disease status|0|||
161877138|NCT03558152|584594193|FG002|Overall Study|Mistake in evaluation of disease status|0|||
161877139|NCT03558152|584594194|FG003|Overall Study|Mistake in evaluation of disease status|0|||
161877140|NCT03558152|584594195|FG004|Overall Study|Mistake in evaluation of disease status|0|||
161877141|NCT03558152|584594196|FG005|Overall Study|Mistake in evaluation of disease status|0|||
161877142|NCT03558152|584594197|FG006|Overall Study|Mistake in evaluation of disease status|0|||
161877143|NCT03558152|584594198|FG007|Overall Study|Mistake in evaluation of disease status|1|||
161877144|NCT03558152|584594191|FG000|Overall Study|Physician Decision|0|||
161877145|NCT03558152|584594192|FG001|Overall Study|Physician Decision|0|||
161877146|NCT03558152|584594193|FG002|Overall Study|Physician Decision|0|||
161877147|NCT03558152|584594194|FG003|Overall Study|Physician Decision|0|||
161877148|NCT03558152|584594195|FG004|Overall Study|Physician Decision|0|||
161877149|NCT03558152|584594196|FG005|Overall Study|Physician Decision|0|||
161877150|NCT03558152|584594197|FG006|Overall Study|Physician Decision|1|||
161877151|NCT03558152|584594198|FG007|Overall Study|Physician Decision|0|||
161877152|NCT03558152|584594191|FG000|Overall Study|Withdrawal by Subject|2|||
161877153|NCT03558152|584594192|FG001|Overall Study|Withdrawal by Subject|3|||
161877154|NCT03558152|584594193|FG002|Overall Study|Withdrawal by Subject|2|||
161877155|NCT03558152|584594194|FG003|Overall Study|Withdrawal by Subject|1|||
161877156|NCT03558152|584594195|FG004|Overall Study|Withdrawal by Subject|1|||
161877157|NCT03558152|584594196|FG005|Overall Study|Withdrawal by Subject|1|||
161877158|NCT03558152|584594197|FG006|Overall Study|Withdrawal by Subject|3|||
161877159|NCT03558152|584594198|FG007|Overall Study|Withdrawal by Subject|2|||
161877160|NCT03558152|584594191|FG000|Overall Study|Lack of Efficacy|11|||
161877161|NCT03558152|584594192|FG001|Overall Study|Lack of Efficacy|11|||
161877162|NCT03558152|584594193|FG002|Overall Study|Lack of Efficacy|10|||
161877163|NCT03558152|584594194|FG003|Overall Study|Lack of Efficacy|11|||
161877164|NCT03558152|584594195|FG004|Overall Study|Lack of Efficacy|14|||
161877165|NCT03558152|584594196|FG005|Overall Study|Lack of Efficacy|12|||
161877166|NCT03558152|584594197|FG006|Overall Study|Lack of Efficacy|14|||
161877167|NCT03558152|584594198|FG007|Overall Study|Lack of Efficacy|13|||
161877168|NCT03558152|584594191|FG000|Overall Study|Protocol Violation|1|||
161877169|NCT03558152|584594192|FG001|Overall Study|Protocol Violation|1|||
161877170|NCT03558152|584594193|FG002|Overall Study|Protocol Violation|0|||
161877171|NCT03558152|584594194|FG003|Overall Study|Protocol Violation|1|||
161877172|NCT03558152|584594195|FG004|Overall Study|Protocol Violation|1|||
161877173|NCT03558152|584594196|FG005|Overall Study|Protocol Violation|0|||
161877174|NCT03558152|584594197|FG006|Overall Study|Protocol Violation|2|||
161877175|NCT03558152|584594198|FG007|Overall Study|Protocol Violation|0|||
161877176|NCT04166591|584594199|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
161877177|NCT04166591|584594200|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
161877178|NCT04166591|584594201|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161877179|NCT04166591|584594202|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161877180|NCT04166591|584594199|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
161877181|NCT04166591|584594200|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
161877182|NCT04166591|584594201|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161877183|NCT04166591|584594202|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161877186|NCT03960021|584594205|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
161877187|NCT00601172|584594206|FG000|Overall Study|Adverse Event|43|||
161877188|NCT00601172|584594207|FG001|Overall Study|Adverse Event|32|||
161877189|NCT00601172|584594206|FG000|Overall Study|Lack of Efficacy|11|||
161877190|NCT00601172|584594207|FG001|Overall Study|Lack of Efficacy|12|||
161877191|NCT00601172|584594206|FG000|Overall Study|Protocol Violation|2|||
161877192|NCT00601172|584594207|FG001|Overall Study|Protocol Violation|5|||
161877193|NCT00601172|584594206|FG000|Overall Study|Lost to Follow-up|4|||
161877194|NCT00601172|584594207|FG001|Overall Study|Lost to Follow-up|3|||
161877195|NCT00601172|584594206|FG000|Overall Study|Physician Decision|27|||
161990740|NCT01371734|585016383|FG001|Overall Study|Other|1|||
161990741|NCT01371734|585016384|FG002|Overall Study|Other|2|||
161877196|NCT00601172|584594207|FG001|Overall Study|Physician Decision|28|||
161877197|NCT00601172|584594206|FG000|Overall Study|Withdrawal by Subject|35|||
161877198|NCT00601172|584594207|FG001|Overall Study|Withdrawal by Subject|27|||
161877199|NCT00601172|584594206|FG000|Overall Study|Did not meet continuation criteria|19|||
161877200|NCT00601172|584594207|FG001|Overall Study|Did not meet continuation criteria|20|||
161877201|NCT04434469|584594211|FG000|Overall Study|Death|2|||
161877202|NCT04434469|584594212|FG001|Overall Study|Death|3|||
161877203|NCT04434469|584594213|FG002|Overall Study|Death|2|||
161877204|NCT04434469|584594214|FG003|Overall Study|Death|2|||
161877205|NCT04434469|584594215|FG004|Overall Study|Death|2|||
161877206|NCT04434469|584594216|FG005|Overall Study|Death|0|||
161877207|NCT04434469|584594211|FG000|Overall Study|Lost to Follow-up|0|||
161877208|NCT04434469|584594212|FG001|Overall Study|Lost to Follow-up|0|||
161877209|NCT04434469|584594213|FG002|Overall Study|Lost to Follow-up|0|||
161877210|NCT04434469|584594214|FG003|Overall Study|Lost to Follow-up|1|||
161877211|NCT04434469|584594215|FG004|Overall Study|Lost to Follow-up|1|||
161877212|NCT04434469|584594216|FG005|Overall Study|Lost to Follow-up|0|||
161877213|NCT04434469|584594211|FG000|Overall Study|Study terminated by sponsor|1|||
161877214|NCT04434469|584594212|FG001|Overall Study|Study terminated by sponsor|1|||
161877215|NCT04434469|584594213|FG002|Overall Study|Study terminated by sponsor|1|||
161877216|NCT04434469|584594214|FG003|Overall Study|Study terminated by sponsor|2|||
161877217|NCT04434469|584594215|FG004|Overall Study|Study terminated by sponsor|3|||
161877218|NCT04434469|584594216|FG005|Overall Study|Study terminated by sponsor|3|||
161877219|NCT04434469|584594211|FG000|Overall Study|Withdrawal by Subject|0|||
161877220|NCT04434469|584594212|FG001|Overall Study|Withdrawal by Subject|0|||
161990742|NCT01371734|585016382|FG000|Overall Study|Withdrawal by Subject|3|||
161990743|NCT01371734|585016383|FG001|Overall Study|Withdrawal by Subject|4|||
161877221|NCT04434469|584594213|FG002|Overall Study|Withdrawal by Subject|1|||
161877222|NCT04434469|584594214|FG003|Overall Study|Withdrawal by Subject|0|||
161877223|NCT04434469|584594215|FG004|Overall Study|Withdrawal by Subject|0|||
161877224|NCT04434469|584594216|FG005|Overall Study|Withdrawal by Subject|0|||
161877225|NCT01936181|584594220|FG000|Randomised, Double-blind|Adverse Event|27|||
161877226|NCT01936181|584594221|FG001|Randomised, Double-blind|Adverse Event|21|||
161877227|NCT01936181|584594222|FG002|Randomised, Double-blind|Adverse Event|0|||
161877228|NCT01936181|584594223|FG003|Randomised, Double-blind|Adverse Event|0|||
161877229|NCT01936181|584594220|FG000|Randomised, Double-blind|Protocol Violation|1|||
161877230|NCT01936181|584594221|FG001|Randomised, Double-blind|Protocol Violation|5|||
161877231|NCT01936181|584594222|FG002|Randomised, Double-blind|Protocol Violation|0|||
161877232|NCT01936181|584594223|FG003|Randomised, Double-blind|Protocol Violation|0|||
161877233|NCT01936181|584594220|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
161877234|NCT01936181|584594221|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
161877235|NCT01936181|584594222|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
161877236|NCT01936181|584594223|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
161877237|NCT01936181|584594220|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
161877238|NCT01936181|584594221|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
161877239|NCT01936181|584594222|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
161877240|NCT01936181|584594223|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
161877241|NCT01936181|584594220|FG000|Randomised, Double-blind|Pregnancy|0|||
161877242|NCT01936181|584594221|FG001|Randomised, Double-blind|Pregnancy|1|||
161877243|NCT01936181|584594222|FG002|Randomised, Double-blind|Pregnancy|0|||
161877244|NCT01936181|584594223|FG003|Randomised, Double-blind|Pregnancy|0|||
161877245|NCT01936181|584594220|FG000|Randomised, Double-blind|Physician Decision|4|||
161877246|NCT01936181|584594221|FG001|Randomised, Double-blind|Physician Decision|4|||
161877247|NCT01936181|584594222|FG002|Randomised, Double-blind|Physician Decision|0|||
161877248|NCT01936181|584594223|FG003|Randomised, Double-blind|Physician Decision|0|||
161877249|NCT01936181|584594220|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
161877250|NCT01936181|584594221|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
161877251|NCT01936181|584594222|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
161877252|NCT01936181|584594223|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
161877253|NCT01936181|584594220|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
161877254|NCT01936181|584594221|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
161877255|NCT01936181|584594222|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
161877256|NCT01936181|584594223|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
161877257|NCT01936181|584594220|FG000|Transition-extension|Adverse Event|3|||
161877258|NCT01936181|584594221|FG001|Transition-extension|Adverse Event|0|||
161877259|NCT01936181|584594222|FG002|Transition-extension|Adverse Event|3|||
161877260|NCT01936181|584594223|FG003|Transition-extension|Adverse Event|1|||
161877261|NCT01936181|584594220|FG000|Transition-extension|Lost to Follow-up|3|||
161877262|NCT01936181|584594221|FG001|Transition-extension|Lost to Follow-up|0|||
161877263|NCT01936181|584594222|FG002|Transition-extension|Lost to Follow-up|1|||
161877264|NCT01936181|584594223|FG003|Transition-extension|Lost to Follow-up|2|||
161877265|NCT01936181|584594220|FG000|Transition-extension|Physician Decision|2|||
161877266|NCT01936181|584594221|FG001|Transition-extension|Physician Decision|0|||
161877267|NCT01936181|584594222|FG002|Transition-extension|Physician Decision|0|||
161877268|NCT01936181|584594223|FG003|Transition-extension|Physician Decision|1|||
161776511|NCT02255422|584223199|FG000|Overall Study|Withdrawal by Subject|0|||
161776512|NCT02255422|584223200|FG001|Overall Study|Withdrawal by Subject|0|||
161776513|NCT02255422|584223201|FG002|Overall Study|Withdrawal by Subject|0|||
161776514|NCT02255422|584223202|FG003|Overall Study|Withdrawal by Subject|0|||
161776515|NCT02255422|584223203|FG004|Overall Study|Withdrawal by Subject|0|||
161776516|NCT02255422|584223204|FG005|Overall Study|Withdrawal by Subject|0|||
161776517|NCT02255422|584223205|FG006|Overall Study|Withdrawal by Subject|2|||
161776518|NCT02255422|584223199|FG000|Overall Study|Lost to Follow-up|0|||
161877269|NCT01936181|584594220|FG000|Transition-extension|Withdrawal by Subject|7|||
161877270|NCT01936181|584594221|FG001|Transition-extension|Withdrawal by Subject|0|||
161877271|NCT01936181|584594222|FG002|Transition-extension|Withdrawal by Subject|2|||
161877272|NCT01936181|584594223|FG003|Transition-extension|Withdrawal by Subject|1|||
161877273|NCT01346189|584594224|FG000|Overall Study|Withdrawal by Subject|7|||
161877274|NCT01346189|584594225|FG001|Overall Study|Withdrawal by Subject|5|||
161877275|NCT01346189|584594226|FG002|Overall Study|Withdrawal by Subject|3|||
161877276|NCT01346189|584594227|FG003|Overall Study|Withdrawal by Subject|5|||
161776519|NCT02255422|584223200|FG001|Overall Study|Lost to Follow-up|0|||
161776520|NCT02255422|584223201|FG002|Overall Study|Lost to Follow-up|1|||
161776521|NCT02255422|584223202|FG003|Overall Study|Lost to Follow-up|0|||
161877277|NCT01346189|584594224|FG000|Overall Study|Physician Decision|4|||
161877278|NCT01346189|584594225|FG001|Overall Study|Physician Decision|0|||
161776522|NCT02255422|584223203|FG004|Overall Study|Lost to Follow-up|0|||
161776523|NCT02255422|584223204|FG005|Overall Study|Lost to Follow-up|0|||
161776524|NCT02255422|584223205|FG006|Overall Study|Lost to Follow-up|0|||
161776525|NCT03179462|584223213|FG000|Overall Study|screening failure|1|||
161877279|NCT01346189|584594226|FG002|Overall Study|Physician Decision|0|||
161877280|NCT01346189|584594227|FG003|Overall Study|Physician Decision|0|||
161877281|NCT01346189|584594224|FG000|Overall Study|Moved|3|||
161877282|NCT01346189|584594225|FG001|Overall Study|Moved|0|||
161877283|NCT01346189|584594226|FG002|Overall Study|Moved|4|||
161877284|NCT01346189|584594227|FG003|Overall Study|Moved|0|||
161877285|NCT01346189|584594224|FG000|Overall Study|Other|2|||
161877286|NCT01346189|584594225|FG001|Overall Study|Other|4|||
161877287|NCT01346189|584594226|FG002|Overall Study|Other|7|||
161877288|NCT01346189|584594227|FG003|Overall Study|Other|3|||
161877289|NCT01346189|584594224|FG000|Overall Study|Death|0|||
161877290|NCT01346189|584594225|FG001|Overall Study|Death|3|||
161877291|NCT01346189|584594226|FG002|Overall Study|Death|0|||
161877292|NCT01346189|584594227|FG003|Overall Study|Death|0|||
161877293|NCT01346189|584594224|FG000|Overall Study|Non-health system primary care physician|0|||
161877294|NCT01346189|584594225|FG001|Overall Study|Non-health system primary care physician|5|||
161877295|NCT01346189|584594226|FG002|Overall Study|Non-health system primary care physician|0|||
161877296|NCT01346189|584594227|FG003|Overall Study|Non-health system primary care physician|0|||
161990744|NCT01371734|585016384|FG002|Overall Study|Withdrawal by Subject|9|||
161990745|NCT01371734|585016382|FG000|Overall Study|Lost to Follow-up|5|||
161990746|NCT01371734|585016383|FG001|Overall Study|Lost to Follow-up|3|||
161990747|NCT01371734|585016384|FG002|Overall Study|Lost to Follow-up|1|||
161990748|NCT01371734|585016382|FG000|Overall Study|Protocol Violation|3|||
161990749|NCT01371734|585016383|FG001|Overall Study|Protocol Violation|1|||
161990750|NCT01371734|585016384|FG002|Overall Study|Protocol Violation|2|||
161990751|NCT01371734|585016382|FG000|Overall Study|Adverse Event|8|||
161990752|NCT01371734|585016383|FG001|Overall Study|Adverse Event|8|||
161990753|NCT01371734|585016384|FG002|Overall Study|Adverse Event|3|||
161990754|NCT01371734|585016382|FG000|Overall Study|Lack of Efficacy|2|||
161990755|NCT01371734|585016383|FG001|Overall Study|Lack of Efficacy|2|||
161990756|NCT01371734|585016384|FG002|Overall Study|Lack of Efficacy|0|||
161990757|NCT00621140|585016385|FG000|Overall Study|Adverse Event|4|||
161990758|NCT00621140|585016386|FG001|Overall Study|Adverse Event|5|||
161990759|NCT00621140|585016385|FG000|Overall Study|Lost to Follow-up|1|||
161990760|NCT00621140|585016386|FG001|Overall Study|Lost to Follow-up|2|||
161990761|NCT00621140|585016385|FG000|Overall Study|Withdrawal by Subject|4|||
161990762|NCT00621140|585016386|FG001|Overall Study|Withdrawal by Subject|6|||
161990763|NCT00621140|585016385|FG000|Overall Study|Other incl. lack of efficacy|6|||
161990764|NCT00621140|585016386|FG001|Overall Study|Other incl. lack of efficacy|5|||
161990765|NCT00958165|585016387|FG000|Overall Study|Lost to Follow-up|5|||
161990766|NCT00958165|585016387|FG000|Overall Study|Not eligible|9|||
161990767|NCT00206440|585016388|FG000|Overall Study|Protocol Violation|1|||
161990768|NCT00206440|585016389|FG001|Overall Study|Protocol Violation|2|||
161990769|NCT00206440|585016388|FG000|Overall Study|Adverse Event|4|||
161990770|NCT00206440|585016389|FG001|Overall Study|Adverse Event|2|||
161990771|NCT00145574|585016390|FG000|Double Blind|Adverse Event|0|||
161990772|NCT00145574|585016391|FG001|Double Blind|Adverse Event|3|||
161990773|NCT00145574|585016392|FG002|Double Blind|Adverse Event|1|||
161990774|NCT00145574|585016390|FG000|Double Blind|Withdrawal by Subject|1|||
161990775|NCT00145574|585016391|FG001|Double Blind|Withdrawal by Subject|1|||
161990776|NCT00145574|585016392|FG002|Double Blind|Withdrawal by Subject|1|||
161990777|NCT00145574|585016390|FG000|Double Blind|required restricted medicine|0|||
161990778|NCT00145574|585016391|FG001|Double Blind|required restricted medicine|1|||
161990779|NCT00145574|585016392|FG002|Double Blind|required restricted medicine|0|||
161990780|NCT00145574|585016390|FG000|Open Label Long-term Extension|Adverse Event|0|||
161990781|NCT00145574|585016391|FG001|Open Label Long-term Extension|Adverse Event|0|||
161990782|NCT00145574|585016392|FG002|Open Label Long-term Extension|Adverse Event|5|||
161990783|NCT00145574|585016390|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
161990784|NCT00145574|585016391|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
161990785|NCT00145574|585016392|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
161990786|NCT00145574|585016390|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
161990787|NCT00145574|585016391|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
161990788|NCT00145574|585016392|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
161990789|NCT00145574|585016390|FG000|Open Label Long-term Extension|required restricted medicine|0|||
161990790|NCT00145574|585016391|FG001|Open Label Long-term Extension|required restricted medicine|0|||
161877297|NCT01346189|584594224|FG000|Overall Study|Travel|0|||
161877298|NCT01346189|584594225|FG001|Overall Study|Travel|0|||
161990791|NCT00145574|585016392|FG002|Open Label Long-term Extension|required restricted medicine|1|||
161990792|NCT01298765|585016394|FG000|Titration Period|Adverse Event|26|||
161877299|NCT01346189|584594226|FG002|Overall Study|Travel|0|||
161990793|NCT01298765|585016394|FG000|Titration Period|Death|1|||
161990794|NCT01298765|585016394|FG000|Titration Period|Lack of Efficacy|21|||
161990795|NCT01298765|585016394|FG000|Titration Period|Lost to Follow-up|9|||
161990796|NCT01298765|585016394|FG000|Titration Period|Physician Decision|1|||
161990797|NCT01298765|585016394|FG000|Titration Period|Withdrawal by Subject|10|||
161990798|NCT01298765|585016394|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
161877300|NCT01346189|584594227|FG003|Overall Study|Travel|3|||
161877301|NCT00900757|584594228|FG000|Overall Study|screen failure|19|||
161877302|NCT03535194|584594231|FG000|Induction Period|Adverse Event|2|||
161877303|NCT03535194|584594232|FG001|Induction Period|Adverse Event|2|||
161877304|NCT03535194|584594233|FG002|Induction Period|Adverse Event|1|||
161877305|NCT03535194|584594234|FG003|Induction Period|Adverse Event|3|||
161877306|NCT03535194|584594235|FG004|Induction Period|Adverse Event|0|||
161877307|NCT03535194|584594231|FG000|Induction Period|Death|0|||
161877308|NCT03535194|584594232|FG001|Induction Period|Death|1|||
161877309|NCT03535194|584594233|FG002|Induction Period|Death|0|||
161877310|NCT03535194|584594234|FG003|Induction Period|Death|0|||
161877311|NCT03535194|584594235|FG004|Induction Period|Death|0|||
161877312|NCT03535194|584594231|FG000|Induction Period|Lack of Efficacy|1|||
161877313|NCT03535194|584594232|FG001|Induction Period|Lack of Efficacy|3|||
161877314|NCT03535194|584594233|FG002|Induction Period|Lack of Efficacy|2|||
161877315|NCT03535194|584594234|FG003|Induction Period|Lack of Efficacy|2|||
161877316|NCT03535194|584594235|FG004|Induction Period|Lack of Efficacy|0|||
161877317|NCT03535194|584594231|FG000|Induction Period|Lost to Follow-up|3|||
161877318|NCT03535194|584594232|FG001|Induction Period|Lost to Follow-up|5|||
161877319|NCT03535194|584594233|FG002|Induction Period|Lost to Follow-up|2|||
161877320|NCT03535194|584594234|FG003|Induction Period|Lost to Follow-up|3|||
161877321|NCT03535194|584594235|FG004|Induction Period|Lost to Follow-up|0|||
161877322|NCT03535194|584594231|FG000|Induction Period|Physician Decision|1|||
161877323|NCT03535194|584594232|FG001|Induction Period|Physician Decision|1|||
161877324|NCT03535194|584594233|FG002|Induction Period|Physician Decision|0|||
161877325|NCT03535194|584594234|FG003|Induction Period|Physician Decision|0|||
161877326|NCT03535194|584594235|FG004|Induction Period|Physician Decision|0|||
161877327|NCT03535194|584594231|FG000|Induction Period|Protocol Violation|1|||
161877328|NCT03535194|584594232|FG001|Induction Period|Protocol Violation|0|||
161877329|NCT03535194|584594233|FG002|Induction Period|Protocol Violation|0|||
161877330|NCT03535194|584594234|FG003|Induction Period|Protocol Violation|1|||
161877331|NCT03535194|584594235|FG004|Induction Period|Protocol Violation|0|||
161877332|NCT03535194|584594231|FG000|Induction Period|Screen Failure|0|||
161877333|NCT03535194|584594232|FG001|Induction Period|Screen Failure|1|||
161877334|NCT03535194|584594233|FG002|Induction Period|Screen Failure|0|||
161877335|NCT03535194|584594234|FG003|Induction Period|Screen Failure|0|||
161877336|NCT03535194|584594235|FG004|Induction Period|Screen Failure|0|||
161877337|NCT03535194|584594231|FG000|Induction Period|Withdrawal by Subject|3|||
161877338|NCT03535194|584594232|FG001|Induction Period|Withdrawal by Subject|4|||
161877339|NCT03535194|584594233|FG002|Induction Period|Withdrawal by Subject|3|||
161877340|NCT03535194|584594234|FG003|Induction Period|Withdrawal by Subject|2|||
161877341|NCT03535194|584594235|FG004|Induction Period|Withdrawal by Subject|0|||
161877342|NCT03535194|584594231|FG000|Maintenance Period|Adverse Event|6|||
161877343|NCT03535194|584594232|FG001|Maintenance Period|Adverse Event|5|||
161877344|NCT03535194|584594233|FG002|Maintenance Period|Adverse Event|1|||
161877345|NCT03535194|584594234|FG003|Maintenance Period|Adverse Event|11|||
161877346|NCT03535194|584594235|FG004|Maintenance Period|Adverse Event|4|||
161877347|NCT03535194|584594231|FG000|Maintenance Period|Lack of Efficacy|3|||
161877348|NCT03535194|584594232|FG001|Maintenance Period|Lack of Efficacy|2|||
161877349|NCT03535194|584594233|FG002|Maintenance Period|Lack of Efficacy|5|||
161877350|NCT03535194|584594234|FG003|Maintenance Period|Lack of Efficacy|9|||
161877351|NCT03535194|584594235|FG004|Maintenance Period|Lack of Efficacy|0|||
161877352|NCT03535194|584594231|FG000|Maintenance Period|Lost to Follow-up|4|||
161877353|NCT03535194|584594232|FG001|Maintenance Period|Lost to Follow-up|2|||
161877354|NCT03535194|584594233|FG002|Maintenance Period|Lost to Follow-up|1|||
161877355|NCT03535194|584594234|FG003|Maintenance Period|Lost to Follow-up|5|||
161877356|NCT03535194|584594235|FG004|Maintenance Period|Lost to Follow-up|2|||
161877357|NCT03535194|584594231|FG000|Maintenance Period|Other|1|||
161877358|NCT03535194|584594232|FG001|Maintenance Period|Other|2|||
161877359|NCT03535194|584594233|FG002|Maintenance Period|Other|0|||
161877360|NCT03535194|584594234|FG003|Maintenance Period|Other|0|||
161990799|NCT01298765|585016394|FG000|Long-Term Treatment Period|Adverse Event|19|||
161990800|NCT01298765|585016394|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
161990801|NCT01298765|585016394|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
161877361|NCT03535194|584594235|FG004|Maintenance Period|Other|0|||
161877362|NCT03535194|584594231|FG000|Maintenance Period|Physician Decision|1|||
161990802|NCT01298765|585016394|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
161877363|NCT03535194|584594232|FG001|Maintenance Period|Physician Decision|2|||
161877364|NCT03535194|584594233|FG002|Maintenance Period|Physician Decision|0|||
161877365|NCT03535194|584594234|FG003|Maintenance Period|Physician Decision|2|||
161877366|NCT03535194|584594235|FG004|Maintenance Period|Physician Decision|0|||
161877367|NCT03535194|584594231|FG000|Maintenance Period|Pregnancy|0|||
161877368|NCT03535194|584594232|FG001|Maintenance Period|Pregnancy|0|||
161877369|NCT03535194|584594233|FG002|Maintenance Period|Pregnancy|0|||
161877370|NCT03535194|584594234|FG003|Maintenance Period|Pregnancy|2|||
161877371|NCT03535194|584594235|FG004|Maintenance Period|Pregnancy|0|||
161877372|NCT03535194|584594231|FG000|Maintenance Period|Protocol Violation|0|||
161877373|NCT03535194|584594232|FG001|Maintenance Period|Protocol Violation|1|||
161877374|NCT03535194|584594233|FG002|Maintenance Period|Protocol Violation|0|||
161877375|NCT03535194|584594234|FG003|Maintenance Period|Protocol Violation|0|||
161877376|NCT03535194|584594235|FG004|Maintenance Period|Protocol Violation|0|||
161877377|NCT03535194|584594231|FG000|Maintenance Period|Withdrawal by Subject|7|||
161877378|NCT03535194|584594232|FG001|Maintenance Period|Withdrawal by Subject|2|||
161877379|NCT03535194|584594233|FG002|Maintenance Period|Withdrawal by Subject|1|||
161877380|NCT03535194|584594234|FG003|Maintenance Period|Withdrawal by Subject|8|||
161877381|NCT03535194|584594235|FG004|Maintenance Period|Withdrawal by Subject|0|||
161877382|NCT03535194|584594231|FG000|Post-Treatment Followup Period|Adverse Event|4|||
161877383|NCT03535194|584594232|FG001|Post-Treatment Followup Period|Adverse Event|5|||
161877384|NCT03535194|584594233|FG002|Post-Treatment Followup Period|Adverse Event|1|||
161877385|NCT03535194|584594234|FG003|Post-Treatment Followup Period|Adverse Event|8|||
161877386|NCT03535194|584594235|FG004|Post-Treatment Followup Period|Adverse Event|0|||
161877387|NCT03535194|584594231|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
161877388|NCT03535194|584594232|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
161877389|NCT03535194|584594233|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
161877390|NCT03535194|584594234|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
161877391|NCT03535194|584594235|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
161877392|NCT03535194|584594231|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
161877393|NCT03535194|584594232|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
161877394|NCT03535194|584594233|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
161877395|NCT03535194|584594234|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
161877396|NCT03535194|584594235|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
161877397|NCT03535194|584594231|FG000|Post-Treatment Followup Period|Other|1|||
161877398|NCT03535194|584594232|FG001|Post-Treatment Followup Period|Other|0|||
161877399|NCT03535194|584594233|FG002|Post-Treatment Followup Period|Other|0|||
161877400|NCT03535194|584594234|FG003|Post-Treatment Followup Period|Other|5|||
161877401|NCT03535194|584594235|FG004|Post-Treatment Followup Period|Other|0|||
161877402|NCT03535194|584594231|FG000|Post-Treatment Followup Period|Physician Decision|0|||
161877403|NCT03535194|584594232|FG001|Post-Treatment Followup Period|Physician Decision|2|||
161877404|NCT03535194|584594233|FG002|Post-Treatment Followup Period|Physician Decision|1|||
161877405|NCT03535194|584594234|FG003|Post-Treatment Followup Period|Physician Decision|1|||
161877406|NCT03535194|584594235|FG004|Post-Treatment Followup Period|Physician Decision|0|||
161877407|NCT03535194|584594231|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
161877408|NCT03535194|584594232|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
161877409|NCT03535194|584594233|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
161877410|NCT03535194|584594234|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
161877411|NCT03535194|584594235|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161877412|NCT04411810|584594236|FG000|Overall Study|Screen failure|1|||
161877413|NCT04411810|584594236|FG000|Overall Study|Withdrawal by Subject|1|||
161877414|NCT04304235|584594240|FG000|Overall Study|incomplete triage data|0|||
161877415|NCT04304235|584594241|FG001|Overall Study|incomplete triage data|69|||
161877416|NCT04304235|584594242|FG002|Overall Study|incomplete triage data|0|||
161877417|NCT04304235|584594243|FG003|Overall Study|incomplete triage data|0|||
161877418|NCT04304235|584594244|FG004|Overall Study|incomplete triage data|289|||
161877419|NCT04304235|584594245|FG005|Overall Study|incomplete triage data|123|||
161877420|NCT04304235|584594246|FG006|Overall Study|incomplete triage data|65|||
161877421|NCT04470544|584594247|FG000|Overall Study|Withdrawal by Subject|4|||
161877422|NCT04470544|584594248|FG001|Overall Study|Withdrawal by Subject|6|||
161877423|NCT05113979|584594252|FG000|Overall Study|Death|2|||
161877424|NCT05113979|584594252|FG000|Overall Study|Lost to Follow-up|1|||
161877425|NCT00526669|584594253|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
161877426|NCT00526669|584594254|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
161877427|NCT00526669|584594253|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
161877428|NCT00526669|584594254|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
161877429|NCT00526669|584594253|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
161877430|NCT00526669|584594254|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
161877431|NCT00526669|584594253|FG000|Combined Treatment Phase|Death|0|||
161877432|NCT00526669|584594254|FG001|Combined Treatment Phase|Death|2|||
161877433|NCT02218736|584594258|FG000|Overall Study|Withdrawal by Subject|10|||
161877434|NCT02218736|584594259|FG001|Overall Study|Withdrawal by Subject|9|||
161877435|NCT02218736|584594258|FG000|Overall Study|Protocol Violation|2|||
161877436|NCT02218736|584594259|FG001|Overall Study|Protocol Violation|0|||
161877437|NCT04016779|584594262|FG000|Overall Study|Adverse Event|9|||
161990803|NCT01298765|585016394|FG000|Long-Term Treatment Period|Physician Decision|1|||
161990804|NCT01298765|585016394|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
161877438|NCT04016779|584594263|FG001|Overall Study|Adverse Event|17|||
161877439|NCT04016779|584594262|FG000|Overall Study|Lack of Efficacy|4|||
161877440|NCT04016779|584594263|FG001|Overall Study|Lack of Efficacy|1|||
161877441|NCT04016779|584594262|FG000|Overall Study|Lost to Follow-up|5|||
161877442|NCT04016779|584594263|FG001|Overall Study|Lost to Follow-up|14|||
161877443|NCT04016779|584594262|FG000|Overall Study|Physician Decision|1|||
161877444|NCT04016779|584594263|FG001|Overall Study|Physician Decision|3|||
161877445|NCT04016779|584594262|FG000|Overall Study|Withdrawal by Subject|6|||
161877446|NCT04016779|584594263|FG001|Overall Study|Withdrawal by Subject|8|||
161990805|NCT03565237|585016395|FG000|Overall Study|Non-compliance of Investigational Product|1|||
161990806|NCT03565237|585016395|FG000|Overall Study|Physician Decision|1|||
161990807|NCT01140061|585016398|FG000|Part I|Adverse Event|1|||
161990808|NCT01140061|585016399|FG001|Part I|Adverse Event|0|||
161990809|NCT01140061|585016400|FG002|Part I|Adverse Event|0|||
161990810|NCT01140061|585016401|FG003|Part I|Adverse Event|0|||
161990811|NCT01140061|585016402|FG004|Part I|Adverse Event|0|||
161990812|NCT01140061|585016403|FG005|Part I|Adverse Event|0|||
161990813|NCT01140061|585016404|FG006|Part I|Adverse Event|0|||
161990814|NCT01140061|585016405|FG007|Part I|Adverse Event|0|||
161990815|NCT01140061|585016406|FG008|Part I|Adverse Event|0|||
161990816|NCT01140061|585016407|FG009|Part I|Adverse Event|0|||
161990817|NCT01140061|585016398|FG000|Extension|Laboratory Adverse Event|0|||
161990818|NCT01140061|585016399|FG001|Extension|Laboratory Adverse Event|0|||
161990819|NCT01140061|585016400|FG002|Extension|Laboratory Adverse Event|0|||
161990820|NCT01140061|585016401|FG003|Extension|Laboratory Adverse Event|0|||
161990821|NCT01140061|585016402|FG004|Extension|Laboratory Adverse Event|0|||
161990822|NCT01140061|585016403|FG005|Extension|Laboratory Adverse Event|0|||
161990823|NCT01140061|585016404|FG006|Extension|Laboratory Adverse Event|0|||
161990824|NCT01140061|585016405|FG007|Extension|Laboratory Adverse Event|0|||
161990825|NCT01140061|585016406|FG008|Extension|Laboratory Adverse Event|0|||
161990826|NCT01140061|585016407|FG009|Extension|Laboratory Adverse Event|1|||
161990827|NCT00428389|585016408|FG000|Core Phase|Adverse Event|6|||
161990828|NCT00428389|585016409|FG001|Core Phase|Adverse Event|4|||
161990829|NCT00428389|585016408|FG000|Core Phase|Lack of Efficacy|2|||
161990830|NCT00428389|585016409|FG001|Core Phase|Lack of Efficacy|0|||
161990831|NCT00428389|585016408|FG000|Core Phase|Abnormal test procedure result(s)|0|||
161990832|NCT00428389|585016409|FG001|Core Phase|Abnormal test procedure result(s)|1|||
161990833|NCT00428389|585016408|FG000|Core Phase|Withdrawal by Subject|3|||
161990834|NCT00428389|585016409|FG001|Core Phase|Withdrawal by Subject|4|||
161990835|NCT00428389|585016408|FG000|Core Phase|Protocol deviation|0|||
161990836|NCT00428389|585016409|FG001|Core Phase|Protocol deviation|2|||
161990837|NCT00428389|585016408|FG000|Extension Phase|Adverse Event|17|||
161990838|NCT00428389|585016409|FG001|Extension Phase|Adverse Event|11|||
161990839|NCT00428389|585016408|FG000|Extension Phase|Lack of Efficacy|4|||
161990840|NCT00428389|585016409|FG001|Extension Phase|Lack of Efficacy|3|||
161990841|NCT00428389|585016408|FG000|Extension Phase|Withdrawal by Subject|6|||
161990842|NCT00428389|585016409|FG001|Extension Phase|Withdrawal by Subject|6|||
161990843|NCT00428389|585016408|FG000|Extension Phase|Lost to Follow-up|0|||
161990844|NCT00428389|585016409|FG001|Extension Phase|Lost to Follow-up|3|||
161990845|NCT00428389|585016408|FG000|Extension Phase|Death|1|||
161990846|NCT00428389|585016409|FG001|Extension Phase|Death|0|||
161990847|NCT00428389|585016408|FG000|Extension Phase|Protocol Violation|3|||
161990848|NCT00428389|585016409|FG001|Extension Phase|Protocol Violation|2|||
161990849|NCT00428389|585016408|FG000|Extension Phase|Administrative problems|1|||
161990850|NCT00428389|585016409|FG001|Extension Phase|Administrative problems|1|||
161990851|NCT02708355|585016410|FG000|Overall Study|Adverse Event|1|||
161990852|NCT02708355|585016411|FG001|Overall Study|Adverse Event|0|||
161990853|NCT02708355|585016412|FG002|Overall Study|Adverse Event|0|||
161990854|NCT03216746|585016413|FG000|Overall Study|Lost to Follow-up|6|||
161990855|NCT03216746|585016414|FG001|Overall Study|Lost to Follow-up|8|||
161990856|NCT03216746|585016415|FG002|Overall Study|Lost to Follow-up|5|||
161990857|NCT03216746|585016416|FG003|Overall Study|Lost to Follow-up|6|||
161990858|NCT04384523|585016417|FG000|Overall Study|Lost to Follow-up|0|||
161990859|NCT04384523|585016418|FG001|Overall Study|Lost to Follow-up|0|||
161990860|NCT04384523|585016419|FG002|Overall Study|Lost to Follow-up|0|||
161990861|NCT04384523|585016420|FG003|Overall Study|Lost to Follow-up|0|||
161990862|NCT04384523|585016421|FG004|Overall Study|Lost to Follow-up|0|||
161990863|NCT04384523|585016422|FG005|Overall Study|Lost to Follow-up|1|||
161990864|NCT04384523|585016417|FG000|Overall Study|Protocol Violation|0|||
161990865|NCT04384523|585016418|FG001|Overall Study|Protocol Violation|1|||
161990866|NCT04384523|585016419|FG002|Overall Study|Protocol Violation|0|||
161990867|NCT04384523|585016420|FG003|Overall Study|Protocol Violation|0|||
161990868|NCT04384523|585016421|FG004|Overall Study|Protocol Violation|0|||
161990869|NCT04384523|585016422|FG005|Overall Study|Protocol Violation|0|||
161990870|NCT04384523|585016417|FG000|Overall Study|Withdrawal by Subject|1|||
161990871|NCT04384523|585016418|FG001|Overall Study|Withdrawal by Subject|0|||
161990872|NCT04384523|585016419|FG002|Overall Study|Withdrawal by Subject|0|||
161990873|NCT04384523|585016420|FG003|Overall Study|Withdrawal by Subject|0|||
161990874|NCT04384523|585016421|FG004|Overall Study|Withdrawal by Subject|0|||
161990875|NCT04384523|585016422|FG005|Overall Study|Withdrawal by Subject|0|||
161990876|NCT04090242|585016423|FG000|Overall Study|Withdrawal by Subject|1|||
161990877|NCT04090242|585016424|FG001|Overall Study|Withdrawal by Subject|0|||
161990878|NCT02687581|585016425|FG000|Overall Study|Withdrawal by Subject|1|||
161990879|NCT02687581|585016426|FG001|Overall Study|Withdrawal by Subject|0|||
161990880|NCT02687581|585016427|FG002|Overall Study|Withdrawal by Subject|0|||
161990881|NCT02687581|585016428|FG003|Overall Study|Withdrawal by Subject|1|||
161990882|NCT02687581|585016425|FG000|Overall Study|Lost to Follow-up|2|||
161990883|NCT02687581|585016426|FG001|Overall Study|Lost to Follow-up|2|||
161990884|NCT02687581|585016427|FG002|Overall Study|Lost to Follow-up|0|||
161877447|NCT04016779|584594262|FG000|Overall Study|Non-compliance with Study Drug|2|||
161877448|NCT04016779|584594263|FG001|Overall Study|Non-compliance with Study Drug|3|||
161877449|NCT04016779|584594262|FG000|Overall Study|Other, Multiple categories|17|||
161877450|NCT04016779|584594263|FG001|Overall Study|Other, Multiple categories|17|||
161877451|NCT00623935|584594264|FG000|Overall Study|Death|1|||
161877452|NCT00623935|584594264|FG000|Overall Study|Patient Declined Transplant|1|||
161877453|NCT01878084|584594265|FG000|Overall Study|Physician Decision|2|||
161877454|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
161877455|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
161877456|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
161877457|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
161877458|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
161877459|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
161877460|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
161877461|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
161877462|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
161877463|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
161877464|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Death|1|||
161877465|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Death|0|||
161877466|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
161877467|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
161877468|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
161877469|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
161877470|NCT01876784|584594266|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
161877471|NCT01876784|584594267|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
161877472|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
161877473|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
161877474|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Adverse Event|2|||
161877475|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Adverse Event|6|||
161877476|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
161877477|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
161877478|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Progressive disease|4|||
161877479|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Progressive disease|35|||
161877480|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
161877481|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
161877482|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
161877483|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
161877484|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Death|0|||
161877485|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Death|1|||
161877486|NCT01876784|584594266|FG000|Open-label Period (31 Months)|Other than specified above|9|||
161877487|NCT01876784|584594267|FG001|Open-label Period (31 Months)|Other than specified above|18|||
161877488|NCT00638443|584594268|FG000|First Intervention|Adverse Event|2|||
161877489|NCT00638443|584594269|FG001|First Intervention|Adverse Event|1|||
161877490|NCT01044290|584594270|FG000|Follow-up 1|Death|3|||
161877491|NCT01044290|584594271|FG001|Follow-up 1|Death|3|||
161877492|NCT01044290|584594272|FG002|Follow-up 1|Death|1|||
161877493|NCT01044290|584594270|FG000|Follow-up 1|Withdrawal by Subject|2|||
161877494|NCT01044290|584594271|FG001|Follow-up 1|Withdrawal by Subject|2|||
161877495|NCT01044290|584594272|FG002|Follow-up 1|Withdrawal by Subject|0|||
161877496|NCT01044290|584594270|FG000|Follow-Up 2|Death|0|||
161877497|NCT01044290|584594271|FG001|Follow-Up 2|Death|1|||
161877498|NCT01044290|584594272|FG002|Follow-Up 2|Death|1|||
161877499|NCT01044290|584594270|FG000|Follow-Up 2|Withdrawal by Subject|0|||
161877500|NCT01044290|584594271|FG001|Follow-Up 2|Withdrawal by Subject|1|||
161877501|NCT01044290|584594272|FG002|Follow-Up 2|Withdrawal by Subject|1|||
161877502|NCT01967706|584594275|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
161877503|NCT01967706|584594276|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
161877504|NCT01967706|584594277|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
161877505|NCT01967706|584594278|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
161990885|NCT02687581|585016428|FG003|Overall Study|Lost to Follow-up|0|||
161990886|NCT02687581|585016425|FG000|Overall Study|the device is too small for the patient.|1|||
161990887|NCT02687581|585016426|FG001|Overall Study|the device is too small for the patient.|0|||
161877506|NCT04152837|584594291|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
161990888|NCT02687581|585016427|FG002|Overall Study|the device is too small for the patient.|0|||
161990889|NCT02687581|585016428|FG003|Overall Study|the device is too small for the patient.|0|||
161990890|NCT00835341|585016429|FG000|Overall Study|Lost to Follow-up|3|||
161877507|NCT04152837|584594291|FG000|Maintenance Period|Adverse Event|1|||
161877508|NCT04152837|584594291|FG000|Maintenance Period|Withdrawal by Subject|1|||
161877509|NCT04152837|584594291|FG000|Maintenance Period|Sponsor Termination of Study|2|||
161990891|NCT00835341|585016430|FG001|Overall Study|Lost to Follow-up|12|||
161877510|NCT00586820|584594292|FG000|Overall Study|Unsuccessful PCI|1|||
161877511|NCT00586820|584594293|FG001|Overall Study|Unsuccessful PCI|0|||
161877512|NCT00430573|584594294|FG000|Overall Study|Withdrawal by Subject|5|||
161877513|NCT01483027|584594299|FG000|Overall Study|Administrative Reasons|2|||
161877514|NCT01483027|584594300|FG001|Overall Study|Administrative Reasons|1|||
161877515|NCT01483027|584594299|FG000|Overall Study|Withdrawal by Subject|21|||
161877516|NCT01483027|584594300|FG001|Overall Study|Withdrawal by Subject|32|||
161877517|NCT01483027|584594299|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
161776526|NCT03179462|584223214|FG001|Overall Study|screening failure|2|||
161776527|NCT03179462|584223215|FG002|Overall Study|screening failure|0|||
161776528|NCT02851069|584223216|FG000|Overall Study|Failure to Return|3|||
161776529|NCT02851069|584223216|FG000|Overall Study|Other|3|||
161776530|NCT02684162|584223217|FG000|Overall Study|Physician Decision|0|||
161776531|NCT02684162|584223218|FG001|Overall Study|Physician Decision|1|||
161776532|NCT02684162|584223219|FG002|Overall Study|Physician Decision|0|||
161776533|NCT03743571|584223222|FG000|Overall Study|Withdrawal by Subject|1|||
161776534|NCT03743571|584223223|FG001|Overall Study|Withdrawal by Subject|1|||
161776535|NCT03743571|584223222|FG000|Overall Study|Lost to Follow-up|1|||
161776536|NCT03743571|584223223|FG001|Overall Study|Lost to Follow-up|2|||
161776537|NCT01489865|584223224|FG000|Overall Study|Progression of Disease|4|||
161776538|NCT01489865|584223225|FG001|Overall Study|Progression of Disease|2|||
161776539|NCT01489865|584223226|FG002|Overall Study|Progression of Disease|2|||
161776540|NCT01489865|584223227|FG003|Overall Study|Progression of Disease|3|||
161776541|NCT01489865|584223228|FG004|Overall Study|Progression of Disease|1|||
161776542|NCT01489865|584223229|FG005|Overall Study|Progression of Disease|6|||
161776543|NCT01489865|584223230|FG006|Overall Study|Progression of Disease|3|||
161776544|NCT01489865|584223231|FG007|Overall Study|Progression of Disease|0|||
161776545|NCT01489865|584223232|FG008|Overall Study|Progression of Disease|23|||
161776546|NCT01489865|584223224|FG000|Overall Study|Adverse Event|2|||
161776547|NCT01489865|584223225|FG001|Overall Study|Adverse Event|0|||
161776548|NCT01489865|584223226|FG002|Overall Study|Adverse Event|0|||
161776549|NCT01489865|584223227|FG003|Overall Study|Adverse Event|0|||
161776550|NCT01489865|584223228|FG004|Overall Study|Adverse Event|1|||
161776551|NCT01489865|584223229|FG005|Overall Study|Adverse Event|0|||
161776552|NCT01489865|584223230|FG006|Overall Study|Adverse Event|2|||
161776553|NCT01489865|584223231|FG007|Overall Study|Adverse Event|0|||
161776554|NCT01489865|584223232|FG008|Overall Study|Adverse Event|5|||
161776555|NCT01489865|584223224|FG000|Overall Study|Death|0|||
161776556|NCT01489865|584223225|FG001|Overall Study|Death|1|||
161776557|NCT01489865|584223226|FG002|Overall Study|Death|0|||
161776558|NCT01489865|584223227|FG003|Overall Study|Death|0|||
161776559|NCT01489865|584223228|FG004|Overall Study|Death|1|||
161776560|NCT01489865|584223229|FG005|Overall Study|Death|0|||
161776561|NCT01489865|584223230|FG006|Overall Study|Death|0|||
161776562|NCT01489865|584223231|FG007|Overall Study|Death|0|||
161776563|NCT01489865|584223232|FG008|Overall Study|Death|2|||
161776564|NCT01489865|584223224|FG000|Overall Study|Withdrawal by Subject|0|||
161776565|NCT01489865|584223225|FG001|Overall Study|Withdrawal by Subject|0|||
161776566|NCT01489865|584223226|FG002|Overall Study|Withdrawal by Subject|0|||
161776567|NCT01489865|584223227|FG003|Overall Study|Withdrawal by Subject|0|||
161776568|NCT01489865|584223228|FG004|Overall Study|Withdrawal by Subject|0|||
161776569|NCT01489865|584223229|FG005|Overall Study|Withdrawal by Subject|1|||
161776570|NCT01489865|584223230|FG006|Overall Study|Withdrawal by Subject|1|||
161776571|NCT01489865|584223231|FG007|Overall Study|Withdrawal by Subject|0|||
161776572|NCT01489865|584223232|FG008|Overall Study|Withdrawal by Subject|2|||
161776573|NCT01489865|584223224|FG000|Overall Study|Shifted|0|||
161776574|NCT01489865|584223225|FG001|Overall Study|Shifted|0|||
161776575|NCT01489865|584223226|FG002|Overall Study|Shifted|1|||
161776576|NCT01489865|584223227|FG003|Overall Study|Shifted|0|||
161776577|NCT01489865|584223228|FG004|Overall Study|Shifted|0|||
161776578|NCT01489865|584223229|FG005|Overall Study|Shifted|0|||
161776579|NCT01489865|584223230|FG006|Overall Study|Shifted|0|||
161776580|NCT01489865|584223231|FG007|Overall Study|Shifted|0|||
161776581|NCT01489865|584223232|FG008|Overall Study|Shifted|0|||
161776582|NCT04115488|584223233|FG000|Overall Study|Adverse Event|8|||
161776583|NCT04115488|584223234|FG001|Overall Study|Adverse Event|4|||
161877518|NCT01483027|584594300|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
161776584|NCT04115488|584223233|FG000|Overall Study|Withdrawal by Subject|3|||
161776585|NCT04115488|584223234|FG001|Overall Study|Withdrawal by Subject|6|||
161776586|NCT04115488|584223233|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
161776587|NCT04115488|584223234|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
161776588|NCT04115488|584223233|FG000|Overall Study|Patient 's location change|1|||
161776589|NCT04115488|584223234|FG001|Overall Study|Patient 's location change|0|||
161776590|NCT04115488|584223233|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
161776591|NCT04115488|584223234|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
161776592|NCT00885677|584223235|FG000|Overall Study|Death|40|||
161776593|NCT00885677|584223236|FG001|Overall Study|Death|34|||
161877519|NCT01483027|584594299|FG000|Overall Study|Lost to Follow-up|1|||
161776594|NCT00885677|584223235|FG000|Overall Study|Lost to Follow-up|15|||
161990892|NCT04405076|585016431|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
161990893|NCT04405076|585016432|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
161990894|NCT04405076|585016433|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
161990895|NCT04405076|585016434|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
161990896|NCT04405076|585016435|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
161990897|NCT04405076|585016436|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
161990898|NCT04405076|585016437|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
161990899|NCT04405076|585016438|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
161990900|NCT04405076|585016439|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
161776595|NCT00885677|584223236|FG001|Overall Study|Lost to Follow-up|13|||
161776596|NCT00885677|584223235|FG000|Overall Study|Protocol Violation|54|||
161776597|NCT00885677|584223236|FG001|Overall Study|Protocol Violation|54|||
161776598|NCT00885677|584223235|FG000|Overall Study|premature study closure|41|||
161776599|NCT00885677|584223236|FG001|Overall Study|premature study closure|44|||
161776600|NCT00885677|584223235|FG000|Overall Study|device/lead revision or replacement|7|||
161776601|NCT00885677|584223236|FG001|Overall Study|device/lead revision or replacement|6|||
161776602|NCT00885677|584223235|FG000|Overall Study|Heart transplantation|1|||
161776603|NCT00885677|584223236|FG001|Overall Study|Heart transplantation|0|||
161776604|NCT00885677|584223235|FG000|Overall Study|Inclusion/exclusion not met|25|||
161776605|NCT00885677|584223236|FG001|Overall Study|Inclusion/exclusion not met|27|||
161776606|NCT00972309|584223237|FG000|Overall Study|Switched to alternative treatment|0|||
161776607|NCT00972309|584223238|FG001|Overall Study|Switched to alternative treatment|2|||
161776608|NCT00972309|584223237|FG000|Overall Study|Refused further treatment|0|||
161776609|NCT00972309|584223238|FG001|Overall Study|Refused further treatment|1|||
161776610|NCT00972309|584223237|FG000|Overall Study|Late determination of ineligibility|0|||
161776611|NCT00972309|584223238|FG001|Overall Study|Late determination of ineligibility|1|||
161776612|NCT00972309|584223237|FG000|Overall Study|Second malignancy|1|||
161776613|NCT00972309|584223238|FG001|Overall Study|Second malignancy|1|||
161776614|NCT00972309|584223237|FG000|Overall Study|Visa issues|0|||
161776615|NCT00972309|584223238|FG001|Overall Study|Visa issues|1|||
161776616|NCT00972309|584223237|FG000|Overall Study|Secondary cancer (SCC)|0|||
161776617|NCT00972309|584223238|FG001|Overall Study|Secondary cancer (SCC)|1|||
161776618|NCT00972309|584223237|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
161776619|NCT00972309|584223238|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
161776620|NCT00972309|584223237|FG000|Overall Study|Lost to Follow-up|1|||
161776621|NCT00972309|584223238|FG001|Overall Study|Lost to Follow-up|1|||
161776622|NCT00972309|584223237|FG000|Overall Study|Disease progression on study|10|||
161776623|NCT00972309|584223238|FG001|Overall Study|Disease progression on study|4|||
161776624|NCT01058707|584223250|FG000|Overall Study|Disease Progression|15|||
161776625|NCT01058707|584223251|FG001|Overall Study|Disease Progression|20|||
161776626|NCT01058707|584223252|FG002|Overall Study|Disease Progression|20|||
161776627|NCT01058707|584223253|FG003|Overall Study|Disease Progression|15|||
161776628|NCT01058707|584223254|FG004|Overall Study|Disease Progression|23|||
161776629|NCT01058707|584223255|FG005|Overall Study|Disease Progression|10|||
161776630|NCT01058707|584223256|FG006|Overall Study|Disease Progression|12|||
161776631|NCT01058707|584223250|FG000|Overall Study|Adverse Event|11|||
161776632|NCT01058707|584223251|FG001|Overall Study|Adverse Event|4|||
161776633|NCT01058707|584223252|FG002|Overall Study|Adverse Event|7|||
161776634|NCT01058707|584223253|FG003|Overall Study|Adverse Event|6|||
161776635|NCT01058707|584223254|FG004|Overall Study|Adverse Event|7|||
161776636|NCT01058707|584223255|FG005|Overall Study|Adverse Event|3|||
161776637|NCT01058707|584223256|FG006|Overall Study|Adverse Event|1|||
161776638|NCT01058707|584223250|FG000|Overall Study|Subject Decision|5|||
161776639|NCT01058707|584223251|FG001|Overall Study|Subject Decision|3|||
161776640|NCT01058707|584223252|FG002|Overall Study|Subject Decision|3|||
161776641|NCT01058707|584223253|FG003|Overall Study|Subject Decision|1|||
161776642|NCT01058707|584223254|FG004|Overall Study|Subject Decision|2|||
161776643|NCT01058707|584223255|FG005|Overall Study|Subject Decision|3|||
161776644|NCT01058707|584223256|FG006|Overall Study|Subject Decision|6|||
161776645|NCT01058707|584223250|FG000|Overall Study|Lost to Follow-up|0|||
161776646|NCT01058707|584223251|FG001|Overall Study|Lost to Follow-up|0|||
161776647|NCT01058707|584223252|FG002|Overall Study|Lost to Follow-up|1|||
161776648|NCT01058707|584223253|FG003|Overall Study|Lost to Follow-up|0|||
161776649|NCT01058707|584223254|FG004|Overall Study|Lost to Follow-up|0|||
161776650|NCT01058707|584223255|FG005|Overall Study|Lost to Follow-up|0|||
161776651|NCT01058707|584223256|FG006|Overall Study|Lost to Follow-up|0|||
161776652|NCT01058707|584223250|FG000|Overall Study|Reason Not Specified|0|||
161776653|NCT01058707|584223251|FG001|Overall Study|Reason Not Specified|3|||
161776654|NCT01058707|584223252|FG002|Overall Study|Reason Not Specified|2|||
161776655|NCT01058707|584223253|FG003|Overall Study|Reason Not Specified|0|||
161776656|NCT01058707|584223254|FG004|Overall Study|Reason Not Specified|7|||
161776657|NCT01058707|584223255|FG005|Overall Study|Reason Not Specified|1|||
161776658|NCT01058707|584223256|FG006|Overall Study|Reason Not Specified|7|||
161776659|NCT00167414|584223259|FG000|Overall Study|Death|10|||
161776660|NCT00795886|584223264|FG000|Overall Study|Death|10|||
161877520|NCT01483027|584594300|FG001|Overall Study|Lost to Follow-up|1|||
161877521|NCT01483027|584594299|FG000|Overall Study|Adverse Event|0|||
161877522|NCT01483027|584594300|FG001|Overall Study|Adverse Event|1|||
161877523|NCT01483027|584594299|FG000|Overall Study|Withdrawal by Subject|0|||
161877524|NCT01483027|584594300|FG001|Overall Study|Withdrawal by Subject|1|||
161877525|NCT04463251|584594303|FG000|Overall Study|Death|1|||
161877526|NCT04463251|584594304|FG001|Overall Study|Death|0|||
161877527|NCT04463251|584594305|FG002|Overall Study|Death|1|||
161877528|NCT04463251|584594303|FG000|Overall Study|Adverse Event|0|||
161877529|NCT04463251|584594304|FG001|Overall Study|Adverse Event|1|||
161877530|NCT04463251|584594305|FG002|Overall Study|Adverse Event|0|||
161877531|NCT04463251|584594303|FG000|Overall Study|Lost to Follow-up|0|||
161877532|NCT04463251|584594304|FG001|Overall Study|Lost to Follow-up|1|||
161877533|NCT04463251|584594305|FG002|Overall Study|Lost to Follow-up|0|||
161877534|NCT04463251|584594303|FG000|Overall Study|Withdrawal by Subject|0|||
161877535|NCT04463251|584594304|FG001|Overall Study|Withdrawal by Subject|2|||
161877536|NCT04463251|584594305|FG002|Overall Study|Withdrawal by Subject|2|||
161877537|NCT05020665|584594306|FG000|Overall Study|Study terminated by Sponsor|5|||
161877538|NCT05020665|584594307|FG001|Overall Study|Study terminated by Sponsor|4|||
161877539|NCT05020665|584594306|FG000|Overall Study|Death|2|||
161877540|NCT05020665|584594307|FG001|Overall Study|Death|1|||
161877541|NCT05020665|584594306|FG000|Overall Study|Physician Decision|0|||
161877542|NCT05020665|584594307|FG001|Overall Study|Physician Decision|1|||
161877543|NCT05020665|584594306|FG000|Overall Study|Withdrawal by Subject|0|||
161877544|NCT05020665|584594307|FG001|Overall Study|Withdrawal by Subject|1|||
161877545|NCT05020665|584594306|FG000|Overall Study|Reason not specified|1|||
161877546|NCT05020665|584594307|FG001|Overall Study|Reason not specified|0|||
161877547|NCT01743560|584594312|FG000|Overall Study|Disease progression|26|||
161877548|NCT01743560|584594312|FG000|Overall Study|Adverse Event|8|||
161877549|NCT01743560|584594312|FG000|Overall Study|Death|3|||
161877550|NCT01743560|584594312|FG000|Overall Study|Withdrawal by Subject|2|||
161877551|NCT01743560|584594312|FG000|Overall Study|Protocol Violation|1|||
161877552|NCT01743560|584594312|FG000|Overall Study|>1 dose of study drug|3|||
161877553|NCT01732640|584594318|FG000|Overall Study|Adverse Event|0|||
161877554|NCT01732640|584594319|FG001|Overall Study|Adverse Event|1|||
161877555|NCT01732640|584594318|FG000|Overall Study|Death|0|||
161877556|NCT01732640|584594319|FG001|Overall Study|Death|1|||
161877557|NCT00877487|584594322|FG000|Open-label Treatment Phase|Adverse Event|1|||
161990901|NCT04405076|585016431|FG000|Part A (Blinded Phase)|Physician Decision|1|||
161990902|NCT04405076|585016432|FG001|Part A (Blinded Phase)|Physician Decision|2|||
161990903|NCT04405076|585016433|FG002|Part A (Blinded Phase)|Physician Decision|0|||
161990904|NCT04405076|585016434|FG003|Part A (Blinded Phase)|Physician Decision|0|||
161990905|NCT04405076|585016435|FG004|Part A (Blinded Phase)|Physician Decision|0|||
161990906|NCT04405076|585016436|FG005|Part A (Blinded Phase)|Physician Decision|0|||
161990907|NCT04405076|585016437|FG006|Part A (Blinded Phase)|Physician Decision|0|||
161990908|NCT04405076|585016438|FG007|Part A (Blinded Phase)|Physician Decision|0|||
161990909|NCT04405076|585016439|FG008|Part A (Blinded Phase)|Physician Decision|0|||
161990910|NCT04405076|585016431|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
161990911|NCT04405076|585016432|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
161990912|NCT04405076|585016433|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
161990913|NCT04405076|585016434|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
161990914|NCT04405076|585016435|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
161990915|NCT04405076|585016436|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
161990916|NCT04405076|585016437|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
161990917|NCT04405076|585016438|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
161990918|NCT04405076|585016439|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
161990919|NCT04405076|585016431|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
161990920|NCT04405076|585016432|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161990921|NCT04405076|585016433|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161990922|NCT04405076|585016434|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161990923|NCT04405076|585016435|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161990924|NCT04405076|585016436|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161990925|NCT04405076|585016437|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161990926|NCT04405076|585016438|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161990927|NCT04405076|585016439|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
161877558|NCT00877487|584594323|FG001|Open-label Treatment Phase|Adverse Event|0|||
161877559|NCT00877487|584594322|FG000|Open-label Treatment Phase|Protocol Violation|3|||
161877560|NCT00877487|584594323|FG001|Open-label Treatment Phase|Protocol Violation|0|||
161877561|NCT00877487|584594322|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
161877562|NCT00877487|584594323|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
161877563|NCT00877487|584594322|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
161877564|NCT00877487|584594323|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
161877565|NCT00877487|584594322|FG000|Open-label Treatment Phase|Out of country for business|1|||
161877566|NCT00877487|584594323|FG001|Open-label Treatment Phase|Out of country for business|0|||
161877567|NCT00877487|584594322|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
161877568|NCT00877487|584594323|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
161877569|NCT00877487|584594322|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
161877570|NCT00877487|584594323|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
161877571|NCT00877487|584594322|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
161877572|NCT00877487|584594323|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
161877573|NCT00877487|584594322|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
161877574|NCT00877487|584594323|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
161877575|NCT03070002|584594324|FG000|Follow up for 2 Years|Death|1|||
161877576|NCT03425396|584594336|FG000|Overall Study|Lost to Follow-up|2|||
161877577|NCT03425396|584594337|FG001|Overall Study|Lost to Follow-up|5|||
161877578|NCT03425396|584594338|FG002|Overall Study|Lost to Follow-up|2|||
161877579|NCT03425396|584594339|FG003|Overall Study|Lost to Follow-up|0|||
161877580|NCT03425396|584594340|FG004|Overall Study|Lost to Follow-up|0|||
161877581|NCT03425396|584594336|FG000|Overall Study|Withdrawal by Subject|0|||
161877582|NCT03425396|584594337|FG001|Overall Study|Withdrawal by Subject|1|||
161877583|NCT03425396|584594338|FG002|Overall Study|Withdrawal by Subject|0|||
161877584|NCT03425396|584594339|FG003|Overall Study|Withdrawal by Subject|1|||
161877585|NCT03425396|584594340|FG004|Overall Study|Withdrawal by Subject|0|||
161877586|NCT03425396|584594336|FG000|Overall Study|Other|0|||
161877587|NCT03425396|584594337|FG001|Overall Study|Other|1|||
161877588|NCT03425396|584594338|FG002|Overall Study|Other|1|||
161877589|NCT03425396|584594339|FG003|Overall Study|Other|0|||
161877590|NCT03425396|584594340|FG004|Overall Study|Other|1|||
161877591|NCT01082211|584594343|FG000|Overall Study|Protocol Violation|4|||
161877592|NCT01082211|584594343|FG000|Overall Study|No protocol treatment received|3|||
161877593|NCT04999163|584594344|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
161877594|NCT04999163|584594345|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
161877595|NCT04999163|584594344|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
161877596|NCT04999163|584594345|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
161877597|NCT04999163|584594344|FG000|Overall Study|Withdrawal by Subject|1|||
161877598|NCT04999163|584594345|FG001|Overall Study|Withdrawal by Subject|0|||
161877599|NCT03917472|584596548|FG000|Overall Study|Physician Decision|4|||
161877600|NCT03917472|584596549|FG001|Overall Study|Physician Decision|0|||
161877601|NCT03917472|584596548|FG000|Overall Study|Adverse Event|3|||
161877602|NCT03917472|584596549|FG001|Overall Study|Adverse Event|1|||
161877603|NCT03917472|584596548|FG000|Overall Study|Death|7|||
161877604|NCT03917472|584596549|FG001|Overall Study|Death|5|||
161877605|NCT03917472|584596548|FG000|Overall Study|Withdrawal by Subject|11|||
161877606|NCT03917472|584596549|FG001|Overall Study|Withdrawal by Subject|4|||
161877607|NCT03917472|584596548|FG000|Overall Study|Lost to Follow-up|10|||
161877608|NCT03917472|584596549|FG001|Overall Study|Lost to Follow-up|5|||
161877609|NCT01154296|584596550|FG000|Randomization and Intervention|Decided to decline|1|||
161877610|NCT01154296|584596551|FG001|Randomization and Intervention|Decided to decline|1|||
161877611|NCT01154296|584596550|FG000|Randomization and Intervention|Declined by staff|1|||
161877612|NCT01154296|584596551|FG001|Randomization and Intervention|Declined by staff|0|||
161877613|NCT01154296|584596550|FG000|Randomization and Intervention|Did not return|1|||
161877614|NCT01154296|584596551|FG001|Randomization and Intervention|Did not return|0|||
161877615|NCT01154296|584596550|FG000|Randomization and Intervention|Left before test|0|||
161877616|NCT01154296|584596551|FG001|Randomization and Intervention|Left before test|1|||
161877617|NCT01154296|584596550|FG000|Randomization and Intervention|Left clinic early|2|||
161877618|NCT01154296|584596551|FG001|Randomization and Intervention|Left clinic early|0|||
161877619|NCT01154296|584596550|FG000|6-month Follow-up|Lost contact|269|||
161877620|NCT01154296|584596551|FG001|6-month Follow-up|Lost contact|275|||
161877621|NCT01154296|584596550|FG000|6-month Follow-up|Incarcerated|37|||
161877622|NCT01154296|584596551|FG001|6-month Follow-up|Incarcerated|32|||
161877623|NCT01154296|584596550|FG000|6-month Follow-up|Withdrew consent|14|||
161877624|NCT01154296|584596551|FG001|6-month Follow-up|Withdrew consent|15|||
161877625|NCT01154296|584596550|FG000|6-month Follow-up|Death|3|||
161990928|NCT04405076|585016431|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
161877626|NCT01154296|584596551|FG001|6-month Follow-up|Death|2|||
161877627|NCT01154296|584596550|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
161877628|NCT01154296|584596551|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
161877629|NCT02203851|584596552|FG000|Overall Study|Lost to Follow-up|4|||
161990929|NCT04405076|585016432|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
161877630|NCT02203851|584596552|FG000|Overall Study|Withdrawal by Subject|6|||
161877631|NCT02203851|584596552|FG000|Overall Study|Other|1|||
161877632|NCT02005692|584596555|FG000|Overall Study|Protocol Violation|1|||
161877633|NCT02005692|584596555|FG000|Overall Study|Withdrawal by Subject|1|||
161877634|NCT02005692|584596555|FG000|Overall Study|Discharged earlier than anticipated|5|||
161877635|NCT05896527|584596557|FG000|Overall Study|Withdrawal by Subject|11|||
161877636|NCT05896527|584596558|FG001|Overall Study|Withdrawal by Subject|10|||
161877637|NCT05896527|584596559|FG002|Overall Study|Withdrawal by Subject|4|||
161877638|NCT05896527|584596560|FG003|Overall Study|Withdrawal by Subject|3|||
161877639|NCT05896527|584596561|FG004|Overall Study|Withdrawal by Subject|2|||
161877640|NCT05896527|584596557|FG000|Overall Study|Lost to Follow-up|0|||
161877641|NCT05896527|584596558|FG001|Overall Study|Lost to Follow-up|2|||
161877642|NCT05896527|584596559|FG002|Overall Study|Lost to Follow-up|2|||
161877643|NCT05896527|584596560|FG003|Overall Study|Lost to Follow-up|2|||
161877644|NCT05896527|584596561|FG004|Overall Study|Lost to Follow-up|1|||
161877645|NCT05896527|584596557|FG000|Overall Study|Significant protocol noncompliance|0|||
161877646|NCT05896527|584596558|FG001|Overall Study|Significant protocol noncompliance|1|||
161877647|NCT05896527|584596559|FG002|Overall Study|Significant protocol noncompliance|0|||
161877648|NCT05896527|584596560|FG003|Overall Study|Significant protocol noncompliance|0|||
161877649|NCT05896527|584596561|FG004|Overall Study|Significant protocol noncompliance|0|||
161877650|NCT05896527|584596557|FG000|Overall Study|Eligibility criteria not met|1|||
161877651|NCT05896527|584596558|FG001|Overall Study|Eligibility criteria not met|0|||
161877652|NCT05896527|584596559|FG002|Overall Study|Eligibility criteria not met|0|||
161877653|NCT05896527|584596560|FG003|Overall Study|Eligibility criteria not met|0|||
161877654|NCT05896527|584596561|FG004|Overall Study|Eligibility criteria not met|0|||
161877655|NCT05896527|584596557|FG000|Overall Study|Sponsor's decision|0|||
161877656|NCT05896527|584596558|FG001|Overall Study|Sponsor's decision|0|||
161877657|NCT05896527|584596559|FG002|Overall Study|Sponsor's decision|0|||
161877658|NCT05896527|584596560|FG003|Overall Study|Sponsor's decision|1|||
161877659|NCT05896527|584596561|FG004|Overall Study|Sponsor's decision|0|||
161877660|NCT05896527|584596557|FG000|Overall Study|Investigator's decision|0|||
161877661|NCT05896527|584596558|FG001|Overall Study|Investigator's decision|1|||
161877662|NCT05896527|584596559|FG002|Overall Study|Investigator's decision|0|||
161877663|NCT05896527|584596560|FG003|Overall Study|Investigator's decision|0|||
161877664|NCT05896527|584596561|FG004|Overall Study|Investigator's decision|0|||
161877665|NCT05896527|584596557|FG000|Overall Study|Pregnancy of his partner|0|||
161877666|NCT05896527|584596558|FG001|Overall Study|Pregnancy of his partner|0|||
161877667|NCT05896527|584596559|FG002|Overall Study|Pregnancy of his partner|0|||
161877668|NCT05896527|584596560|FG003|Overall Study|Pregnancy of his partner|1|||
161877669|NCT05896527|584596561|FG004|Overall Study|Pregnancy of his partner|0|||
161877670|NCT01279070|584596562|FG000|Overall Study|Withdrawal by Subject|2|||
161877671|NCT01279070|584596563|FG001|Overall Study|Withdrawal by Subject|3|||
161877672|NCT01279070|584596562|FG000|Overall Study|Acute exacerbation|3|||
161877673|NCT01279070|584596563|FG001|Overall Study|Acute exacerbation|1|||
161877674|NCT02651155|584596564|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161877675|NCT02651155|584596565|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
161877676|NCT02651155|584596564|FG000|Overall Study|Voluntary Withdrawal|5|||
161877677|NCT02651155|584596565|FG001|Overall Study|Voluntary Withdrawal|0|||
161877678|NCT01867710|584596568|FG000|Overall Study|Death|25|||
161877679|NCT01867710|584596569|FG001|Overall Study|Death|15|||
161877680|NCT01867710|584596570|FG002|Overall Study|Death|27|||
161877681|NCT01867710|584596571|FG003|Overall Study|Death|20|||
161877682|NCT01867710|584596568|FG000|Overall Study|Lost to Follow-up|3|||
161877683|NCT01867710|584596569|FG001|Overall Study|Lost to Follow-up|4|||
161877684|NCT01867710|584596570|FG002|Overall Study|Lost to Follow-up|3|||
161877685|NCT01867710|584596571|FG003|Overall Study|Lost to Follow-up|2|||
161877686|NCT01867710|584596568|FG000|Overall Study|Withdrawal of consent|2|||
161877687|NCT01867710|584596569|FG001|Overall Study|Withdrawal of consent|5|||
161877688|NCT01867710|584596570|FG002|Overall Study|Withdrawal of consent|1|||
161877689|NCT01867710|584596571|FG003|Overall Study|Withdrawal of consent|2|||
161877690|NCT01867710|584596568|FG000|Overall Study|Study Terminated by Sponsor|9|||
161877691|NCT01867710|584596569|FG001|Overall Study|Study Terminated by Sponsor|13|||
161877692|NCT01867710|584596570|FG002|Overall Study|Study Terminated by Sponsor|8|||
161877693|NCT01867710|584596571|FG003|Overall Study|Study Terminated by Sponsor|16|||
161877694|NCT01867710|584596568|FG000|Overall Study|Biochemical progression|0|||
161877695|NCT01867710|584596569|FG001|Overall Study|Biochemical progression|1|||
161877696|NCT01867710|584596570|FG002|Overall Study|Biochemical progression|0|||
161877697|NCT01867710|584596571|FG003|Overall Study|Biochemical progression|0|||
161877698|NCT01867710|584596568|FG000|Overall Study|Clinical progression|0|||
161877699|NCT01867710|584596569|FG001|Overall Study|Clinical progression|0|||
161877700|NCT01867710|584596570|FG002|Overall Study|Clinical progression|1|||
161877701|NCT01867710|584596571|FG003|Overall Study|Clinical progression|0|||
161877702|NCT01867710|584596568|FG000|Overall Study|Disease progression|1|||
161877703|NCT01867710|584596569|FG001|Overall Study|Disease progression|0|||
161877704|NCT01867710|584596570|FG002|Overall Study|Disease progression|0|||
161877705|NCT01867710|584596571|FG003|Overall Study|Disease progression|0|||
161877706|NCT01867710|584596568|FG000|Overall Study|Patient decision|0|||
161877707|NCT01867710|584596569|FG001|Overall Study|Patient decision|0|||
161877708|NCT01867710|584596570|FG002|Overall Study|Patient decision|0|||
161877709|NCT01867710|584596571|FG003|Overall Study|Patient decision|1|||
161877710|NCT01867710|584596568|FG000|Overall Study|Patient to follow subsequent treatment|0|||
161877711|NCT01867710|584596569|FG001|Overall Study|Patient to follow subsequent treatment|1|||
161990930|NCT04405076|585016433|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161877712|NCT01867710|584596570|FG002|Overall Study|Patient to follow subsequent treatment|0|||
161877713|NCT01867710|584596571|FG003|Overall Study|Patient to follow subsequent treatment|0|||
161877714|NCT01867710|584596568|FG000|Overall Study|Progressive disease|1|||
161877715|NCT01867710|584596569|FG001|Overall Study|Progressive disease|0|||
161877716|NCT01867710|584596570|FG002|Overall Study|Progressive disease|0|||
161877717|NCT01867710|584596571|FG003|Overall Study|Progressive disease|0|||
161877718|NCT01867710|584596568|FG000|Overall Study|Protocol Violation|0|||
161877719|NCT01867710|584596569|FG001|Overall Study|Protocol Violation|0|||
161877720|NCT01867710|584596570|FG002|Overall Study|Protocol Violation|0|||
161877721|NCT01867710|584596571|FG003|Overall Study|Protocol Violation|1|||
161877722|NCT01867710|584596568|FG000|Overall Study|PSA-progression|0|||
161877723|NCT01867710|584596569|FG001|Overall Study|PSA-progression|1|||
161877724|NCT01867710|584596570|FG002|Overall Study|PSA-progression|0|||
161877725|NCT01867710|584596571|FG003|Overall Study|PSA-progression|0|||
161877726|NCT01867710|584596568|FG000|Overall Study|Study medication no longer effective|0|||
161877727|NCT01867710|584596569|FG001|Overall Study|Study medication no longer effective|1|||
161877728|NCT01867710|584596570|FG002|Overall Study|Study medication no longer effective|0|||
161877729|NCT01867710|584596571|FG003|Overall Study|Study medication no longer effective|0|||
161877730|NCT00976820|584596572|FG000|Overall Study|Lost to Follow-up|5|||
161877731|NCT00976820|584596573|FG001|Overall Study|Lost to Follow-up|16|||
161877732|NCT00976820|584596574|FG002|Overall Study|Lost to Follow-up|2|||
161877733|NCT00976820|584596575|FG003|Overall Study|Lost to Follow-up|3|||
161877734|NCT00976820|584596572|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
161877735|NCT00976820|584596573|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
161877736|NCT00976820|584596574|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
161877737|NCT00976820|584596575|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
161877738|NCT00976820|584596572|FG000|Overall Study|Withdrawal by Subject|2|||
161877739|NCT00976820|584596573|FG001|Overall Study|Withdrawal by Subject|4|||
161877740|NCT00976820|584596574|FG002|Overall Study|Withdrawal by Subject|1|||
161877741|NCT00976820|584596575|FG003|Overall Study|Withdrawal by Subject|4|||
161877742|NCT02048826|584596576|FG000|Overall Study|Withdrawal by Subject|1|||
161877743|NCT02048826|584596577|FG001|Overall Study|Withdrawal by Subject|0|||
161877744|NCT00968981|584596578|FG000|Overall Study|Adverse Event|2|||
161877745|NCT00968981|584596579|FG001|Overall Study|Adverse Event|0|||
161877746|NCT00968981|584596580|FG002|Overall Study|Adverse Event|0|||
161877747|NCT00968981|584596578|FG000|Overall Study|Disease Progression|14|||
161877748|NCT00968981|584596579|FG001|Overall Study|Disease Progression|16|||
161877749|NCT00968981|584596580|FG002|Overall Study|Disease Progression|13|||
161877750|NCT00968981|584596578|FG000|Overall Study|Lost to Follow-up|0|||
161877751|NCT00968981|584596579|FG001|Overall Study|Lost to Follow-up|0|||
161877752|NCT00968981|584596580|FG002|Overall Study|Lost to Follow-up|1|||
161877753|NCT00968981|584596578|FG000|Overall Study|Physician Decision|5|||
161877754|NCT00968981|584596579|FG001|Overall Study|Physician Decision|3|||
161877755|NCT00968981|584596580|FG002|Overall Study|Physician Decision|5|||
161877756|NCT00968981|584596578|FG000|Overall Study|Withdrawal by Subject|1|||
161877757|NCT00968981|584596579|FG001|Overall Study|Withdrawal by Subject|3|||
161877758|NCT00968981|584596580|FG002|Overall Study|Withdrawal by Subject|3|||
161877759|NCT01981954|584596591|FG000|Titration Period|Protocol Deviation|1|||
161877760|NCT01981954|584596591|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
161877761|NCT01489254|584596592|FG000|Double-blind Part|Adverse Event|7|||
161877762|NCT01489254|584596593|FG001|Double-blind Part|Adverse Event|2|||
161877763|NCT01489254|584596594|FG002|Double-blind Part|Adverse Event|2|||
161877764|NCT01489254|584596595|FG003|Double-blind Part|Adverse Event|0|||
161877765|NCT01489254|584596592|FG000|Double-blind Part|Pregnancy|1|||
161877766|NCT01489254|584596593|FG001|Double-blind Part|Pregnancy|3|||
161877767|NCT01489254|584596594|FG002|Double-blind Part|Pregnancy|0|||
161877768|NCT01489254|584596595|FG003|Double-blind Part|Pregnancy|0|||
161877769|NCT01489254|584596592|FG000|Double-blind Part|Withdrawal by Subject|12|||
161990931|NCT04405076|585016434|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161990932|NCT04405076|585016435|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161990933|NCT04405076|585016436|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161990934|NCT04405076|585016437|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161990935|NCT04405076|585016438|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161990936|NCT04405076|585016439|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
161877770|NCT01489254|584596593|FG001|Double-blind Part|Withdrawal by Subject|20|||
161877771|NCT01489254|584596594|FG002|Double-blind Part|Withdrawal by Subject|1|||
161877772|NCT01489254|584596595|FG003|Double-blind Part|Withdrawal by Subject|0|||
161877773|NCT01489254|584596592|FG000|Double-blind Part|Lost to Follow-up|1|||
161877774|NCT01489254|584596593|FG001|Double-blind Part|Lost to Follow-up|2|||
161877775|NCT01489254|584596594|FG002|Double-blind Part|Lost to Follow-up|0|||
161877776|NCT01489254|584596595|FG003|Double-blind Part|Lost to Follow-up|0|||
161877777|NCT01489254|584596592|FG000|Double-blind Part|Other reasons for not completing study|4|||
161877778|NCT01489254|584596593|FG001|Double-blind Part|Other reasons for not completing study|6|||
161877779|NCT01489254|584596594|FG002|Double-blind Part|Other reasons for not completing study|0|||
161990937|NCT04405076|585016431|FG000|Part A (Blinded Phase)|Other than Specified|0|||
161990938|NCT04405076|585016432|FG001|Part A (Blinded Phase)|Other than Specified|0|||
161877780|NCT01489254|584596595|FG003|Double-blind Part|Other reasons for not completing study|0|||
161877781|NCT01489254|584596592|FG000|Open-label Extension Part|Adverse Event|0|||
161877782|NCT01489254|584596593|FG001|Open-label Extension Part|Adverse Event|0|||
161877783|NCT01489254|584596594|FG002|Open-label Extension Part|Adverse Event|0|||
161877784|NCT01489254|584596595|FG003|Open-label Extension Part|Adverse Event|10|||
161877785|NCT01489254|584596592|FG000|Open-label Extension Part|Pregnancy|0|||
161877786|NCT01489254|584596593|FG001|Open-label Extension Part|Pregnancy|0|||
161877787|NCT01489254|584596594|FG002|Open-label Extension Part|Pregnancy|0|||
161877788|NCT01489254|584596595|FG003|Open-label Extension Part|Pregnancy|3|||
161877789|NCT01489254|584596592|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
161877790|NCT01489254|584596593|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
161877791|NCT01489254|584596594|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
161877792|NCT01489254|584596595|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
161877793|NCT01489254|584596592|FG000|Open-label Extension Part|Protocol Violation|0|||
161877794|NCT01489254|584596593|FG001|Open-label Extension Part|Protocol Violation|0|||
161877795|NCT01489254|584596594|FG002|Open-label Extension Part|Protocol Violation|0|||
161877796|NCT01489254|584596595|FG003|Open-label Extension Part|Protocol Violation|1|||
161877797|NCT01489254|584596592|FG000|Open-label Extension Part|Lost to Follow-up|0|||
161877798|NCT01489254|584596593|FG001|Open-label Extension Part|Lost to Follow-up|0|||
161877799|NCT01489254|584596594|FG002|Open-label Extension Part|Lost to Follow-up|0|||
161877800|NCT01489254|584596595|FG003|Open-label Extension Part|Lost to Follow-up|9|||
161877801|NCT01489254|584596592|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
161877802|NCT01489254|584596593|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
161877803|NCT01489254|584596594|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
161877804|NCT01489254|584596595|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
161877805|NCT00890084|584596609|FG000|Overall Study|Adverse Event|16|||
161877806|NCT00890084|584596609|FG000|Overall Study|Lost to Follow-up|126|||
161877807|NCT02738879|584596610|FG000|Overall Study|Adverse Event|1|||
161877808|NCT02738879|584596611|FG001|Overall Study|Adverse Event|1|||
161877809|NCT02738879|584596610|FG000|Overall Study|Death|0|||
161877810|NCT02738879|584596611|FG001|Overall Study|Death|2|||
161877811|NCT02738879|584596610|FG000|Overall Study|Lost to Follow-up|1|||
161877812|NCT02738879|584596611|FG001|Overall Study|Lost to Follow-up|5|||
161877813|NCT02738879|584596610|FG000|Overall Study|Protocol Violation|1|||
161877814|NCT02738879|584596611|FG001|Overall Study|Protocol Violation|3|||
161877815|NCT02738879|584596610|FG000|Overall Study|Physician Decision|3|||
161877816|NCT02738879|584596611|FG001|Overall Study|Physician Decision|4|||
161877817|NCT02738879|584596610|FG000|Overall Study|Pregnancy|0|||
161877818|NCT02738879|584596611|FG001|Overall Study|Pregnancy|1|||
161877819|NCT02738879|584596610|FG000|Overall Study|Screen Failure|1|||
161877820|NCT02738879|584596611|FG001|Overall Study|Screen Failure|2|||
161877821|NCT02738879|584596610|FG000|Overall Study|Site Discontinued Study Participation|1|||
161877822|NCT02738879|584596611|FG001|Overall Study|Site Discontinued Study Participation|0|||
161877823|NCT02738879|584596610|FG000|Overall Study|Withdrawal by Subject|5|||
161877824|NCT02738879|584596611|FG001|Overall Study|Withdrawal by Subject|7|||
161877825|NCT01647516|584596616|FG000|Induction Period (IP)|Physician Decision|2|||
161877826|NCT01647516|584596617|FG001|Induction Period (IP)|Physician Decision|0|||
161877827|NCT01647516|584596618|FG002|Induction Period (IP)|Physician Decision|0|||
161877828|NCT01647516|584596619|FG003|Induction Period (IP)|Physician Decision|0|||
161877829|NCT01647516|584596620|FG004|Induction Period (IP)|Physician Decision|0|||
161877830|NCT01647516|584596621|FG005|Induction Period (IP)|Physician Decision|0|||
161877831|NCT01647516|584596616|FG000|Induction Period (IP)|Adverse Event|1|||
161877832|NCT01647516|584596617|FG001|Induction Period (IP)|Adverse Event|2|||
161877833|NCT01647516|584596618|FG002|Induction Period (IP)|Adverse Event|0|||
161990939|NCT04405076|585016433|FG002|Part A (Blinded Phase)|Other than Specified|3|||
161990940|NCT04405076|585016434|FG003|Part A (Blinded Phase)|Other than Specified|0|||
161990941|NCT04405076|585016435|FG004|Part A (Blinded Phase)|Other than Specified|0|||
161990942|NCT04405076|585016436|FG005|Part A (Blinded Phase)|Other than Specified|0|||
161990943|NCT04405076|585016437|FG006|Part A (Blinded Phase)|Other than Specified|0|||
161990944|NCT04405076|585016438|FG007|Part A (Blinded Phase)|Other than Specified|0|||
161990945|NCT04405076|585016439|FG008|Part A (Blinded Phase)|Other than Specified|0|||
161877834|NCT01647516|584596619|FG003|Induction Period (IP)|Adverse Event|0|||
161877835|NCT01647516|584596620|FG004|Induction Period (IP)|Adverse Event|0|||
161877836|NCT01647516|584596621|FG005|Induction Period (IP)|Adverse Event|0|||
161877837|NCT01647516|584596616|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
161877838|NCT01647516|584596617|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
161877839|NCT01647516|584596618|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
161877840|NCT01647516|584596619|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
161877841|NCT01647516|584596620|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
161877842|NCT01647516|584596621|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
161877843|NCT01647516|584596616|FG000|Induction Period (IP)|Participant Choice|0|||
161877844|NCT01647516|584596617|FG001|Induction Period (IP)|Participant Choice|0|||
161877845|NCT01647516|584596618|FG002|Induction Period (IP)|Participant Choice|1|||
161877846|NCT01647516|584596619|FG003|Induction Period (IP)|Participant Choice|0|||
161877847|NCT01647516|584596620|FG004|Induction Period (IP)|Participant Choice|0|||
161877848|NCT01647516|584596621|FG005|Induction Period (IP)|Participant Choice|0|||
161877849|NCT01647516|584596616|FG000|Induction Period (IP)|Lack of Efficacy|1|||
161877850|NCT01647516|584596617|FG001|Induction Period (IP)|Lack of Efficacy|0|||
161877851|NCT01647516|584596618|FG002|Induction Period (IP)|Lack of Efficacy|0|||
161877852|NCT01647516|584596619|FG003|Induction Period (IP)|Lack of Efficacy|0|||
161877853|NCT01647516|584596620|FG004|Induction Period (IP)|Lack of Efficacy|0|||
161877854|NCT01647516|584596621|FG005|Induction Period (IP)|Lack of Efficacy|0|||
161877855|NCT01647516|584596616|FG000|Induction Period (IP)|No study drug received|1|||
161877856|NCT01647516|584596617|FG001|Induction Period (IP)|No study drug received|1|||
161877857|NCT01647516|584596618|FG002|Induction Period (IP)|No study drug received|0|||
161877858|NCT01647516|584596619|FG003|Induction Period (IP)|No study drug received|0|||
161877859|NCT01647516|584596620|FG004|Induction Period (IP)|No study drug received|0|||
161877860|NCT01647516|584596621|FG005|Induction Period (IP)|No study drug received|0|||
161877861|NCT01647516|584596616|FG000|Maintenance Period (MP)|Adverse Event|2|||
161877862|NCT01647516|584596617|FG001|Maintenance Period (MP)|Adverse Event|1|||
161877863|NCT01647516|584596618|FG002|Maintenance Period (MP)|Adverse Event|0|||
161877864|NCT01647516|584596619|FG003|Maintenance Period (MP)|Adverse Event|0|||
161877865|NCT01647516|584596620|FG004|Maintenance Period (MP)|Adverse Event|0|||
161877866|NCT01647516|584596621|FG005|Maintenance Period (MP)|Adverse Event|0|||
161877867|NCT01647516|584596616|FG000|Maintenance Period (MP)|Non-compliance|1|||
161877868|NCT01647516|584596617|FG001|Maintenance Period (MP)|Non-compliance|0|||
161877869|NCT01647516|584596618|FG002|Maintenance Period (MP)|Non-compliance|0|||
161877870|NCT01647516|584596619|FG003|Maintenance Period (MP)|Non-compliance|0|||
161877871|NCT01647516|584596620|FG004|Maintenance Period (MP)|Non-compliance|0|||
161877872|NCT01647516|584596621|FG005|Maintenance Period (MP)|Non-compliance|0|||
161877873|NCT01647516|584596616|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
161877874|NCT01647516|584596617|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
161776661|NCT05554471|584223265|FG000|Overall Study|Physician Decision|2|||
161776662|NCT05554471|584223266|FG001|Overall Study|Physician Decision|1|||
161776663|NCT05554471|584223265|FG000|Overall Study|Lost to Follow-up|2|||
161776664|NCT05554471|584223266|FG001|Overall Study|Lost to Follow-up|1|||
161776665|NCT05554471|584223265|FG000|Overall Study|Death|0|||
161776666|NCT05554471|584223266|FG001|Overall Study|Death|1|||
161776667|NCT01319994|584225372|FG000|Overall Study|Protocol Violation|7|||
161776668|NCT01319994|584225373|FG001|Overall Study|Protocol Violation|6|||
161776669|NCT01340794|584225374|FG000|Overall Study|Withdrawal by Subject|0|||
161776670|NCT01340794|584225375|FG001|Overall Study|Withdrawal by Subject|1|||
161776671|NCT02674568|584225384|FG000|Overall Study|Withdrawal by Subject|5|||
161776672|NCT02674568|584225384|FG000|Overall Study|Death|303|||
161776673|NCT02674568|584225384|FG000|Overall Study|Physician Decision|2|||
161776674|NCT02674568|584225384|FG000|Overall Study|Lost to Follow-up|9|||
161776675|NCT02674568|584225384|FG000|Overall Study|Other, Not Specified|20|||
161776676|NCT01808508|584225387|FG000|Overall Study|Lost to Follow-up|1|||
161776677|NCT01808508|584225388|FG001|Overall Study|Lost to Follow-up|0|||
161776678|NCT01808508|584225389|FG002|Overall Study|Lost to Follow-up|0|||
161776679|NCT01118949|584225390|FG000|Overall Study|Adverse Event|5|||
161776680|NCT01118949|584225390|FG000|Overall Study|Withdrawal by Subject|4|||
161776681|NCT00648739|584225391|FG000|Overall Study|Adverse Event|1|||
161776682|NCT00648739|584225392|FG001|Overall Study|Adverse Event|0|||
161776683|NCT00648739|584225393|FG002|Overall Study|Adverse Event|1|||
161776684|NCT00648739|584225394|FG003|Overall Study|Adverse Event|2|||
161776685|NCT00648739|584225395|FG004|Overall Study|Adverse Event|1|||
161776686|NCT00648739|584225396|FG005|Overall Study|Adverse Event|0|||
161776687|NCT00648739|584225397|FG006|Overall Study|Adverse Event|0|||
161877875|NCT01647516|584596618|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
161877876|NCT01647516|584596619|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
161877877|NCT01647516|584596620|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
161877878|NCT01647516|584596621|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
161877879|NCT01647516|584596616|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
161877880|NCT01647516|584596617|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
161877881|NCT01647516|584596618|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
161877882|NCT01647516|584596619|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
161877883|NCT01647516|584596620|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
161877884|NCT01647516|584596621|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
161776688|NCT00648739|584225391|FG000|Overall Study|Withdrawal by Subject|1|||
161776689|NCT00648739|584225392|FG001|Overall Study|Withdrawal by Subject|0|||
161776690|NCT00648739|584225393|FG002|Overall Study|Withdrawal by Subject|1|||
161776691|NCT00648739|584225394|FG003|Overall Study|Withdrawal by Subject|0|||
161776692|NCT00648739|584225395|FG004|Overall Study|Withdrawal by Subject|0|||
161776693|NCT00648739|584225396|FG005|Overall Study|Withdrawal by Subject|2|||
161776694|NCT00648739|584225397|FG006|Overall Study|Withdrawal by Subject|0|||
161776695|NCT00648739|584225391|FG000|Overall Study|Lack of Efficacy|0|||
161776696|NCT00648739|584225392|FG001|Overall Study|Lack of Efficacy|0|||
161776697|NCT00648739|584225393|FG002|Overall Study|Lack of Efficacy|0|||
161877885|NCT01647516|584596616|FG000|Open-Label Period|Adverse Event|0|||
161877886|NCT01647516|584596617|FG001|Open-Label Period|Adverse Event|0|||
161877887|NCT01647516|584596618|FG002|Open-Label Period|Adverse Event|0|||
161877888|NCT01647516|584596619|FG003|Open-Label Period|Adverse Event|5|||
161877889|NCT01647516|584596620|FG004|Open-Label Period|Adverse Event|6|||
161877890|NCT01647516|584596621|FG005|Open-Label Period|Adverse Event|3|||
161877891|NCT01647516|584596616|FG000|Open-Label Period|Pregnancy|0|||
161877892|NCT01647516|584596617|FG001|Open-Label Period|Pregnancy|0|||
161877893|NCT01647516|584596618|FG002|Open-Label Period|Pregnancy|0|||
161877894|NCT01647516|584596619|FG003|Open-Label Period|Pregnancy|0|||
161877895|NCT01647516|584596620|FG004|Open-Label Period|Pregnancy|0|||
161877896|NCT01647516|584596621|FG005|Open-Label Period|Pregnancy|1|||
161877897|NCT01647516|584596616|FG000|Open-Label Period|Non-compliance|0|||
161877898|NCT01647516|584596617|FG001|Open-Label Period|Non-compliance|0|||
161877899|NCT01647516|584596618|FG002|Open-Label Period|Non-compliance|0|||
161877900|NCT01647516|584596619|FG003|Open-Label Period|Non-compliance|1|||
161877901|NCT01647516|584596620|FG004|Open-Label Period|Non-compliance|0|||
161877902|NCT01647516|584596621|FG005|Open-Label Period|Non-compliance|1|||
161877903|NCT01647516|584596616|FG000|Open-Label Period|Physician Decision|0|||
161877904|NCT01647516|584596617|FG001|Open-Label Period|Physician Decision|0|||
161877905|NCT01647516|584596618|FG002|Open-Label Period|Physician Decision|0|||
161877906|NCT01647516|584596619|FG003|Open-Label Period|Physician Decision|1|||
161877907|NCT01647516|584596620|FG004|Open-Label Period|Physician Decision|1|||
161877908|NCT01647516|584596621|FG005|Open-Label Period|Physician Decision|0|||
161877909|NCT01647516|584596616|FG000|Open-Label Period|Withdrawal by Subject|0|||
161877910|NCT01647516|584596617|FG001|Open-Label Period|Withdrawal by Subject|0|||
161877911|NCT01647516|584596618|FG002|Open-Label Period|Withdrawal by Subject|0|||
161877912|NCT01647516|584596619|FG003|Open-Label Period|Withdrawal by Subject|9|||
161877913|NCT01647516|584596620|FG004|Open-Label Period|Withdrawal by Subject|11|||
161877914|NCT01647516|584596621|FG005|Open-Label Period|Withdrawal by Subject|6|||
161877915|NCT01647516|584596616|FG000|Open-Label Period|Lost to Follow-up|0|||
161877916|NCT01647516|584596617|FG001|Open-Label Period|Lost to Follow-up|0|||
161877917|NCT01647516|584596618|FG002|Open-Label Period|Lost to Follow-up|0|||
161877918|NCT01647516|584596619|FG003|Open-Label Period|Lost to Follow-up|1|||
161877919|NCT01647516|584596620|FG004|Open-Label Period|Lost to Follow-up|0|||
161877920|NCT01647516|584596621|FG005|Open-Label Period|Lost to Follow-up|1|||
161877921|NCT01647516|584596616|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
161877922|NCT01647516|584596617|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
161877923|NCT01647516|584596618|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
161877924|NCT01647516|584596619|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
161877925|NCT01647516|584596620|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
161877926|NCT01647516|584596621|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
161877927|NCT01647516|584596616|FG000|Open-Label Period|Lack of Efficacy|0|||
161877928|NCT01647516|584596617|FG001|Open-Label Period|Lack of Efficacy|0|||
161877929|NCT01647516|584596618|FG002|Open-Label Period|Lack of Efficacy|0|||
161877930|NCT01647516|584596619|FG003|Open-Label Period|Lack of Efficacy|7|||
161877931|NCT01647516|584596620|FG004|Open-Label Period|Lack of Efficacy|9|||
161877932|NCT01647516|584596621|FG005|Open-Label Period|Lack of Efficacy|10|||
161877933|NCT01647516|584596616|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
161877934|NCT01647516|584596617|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
161877935|NCT01647516|584596618|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
161877936|NCT01647516|584596619|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
161877937|NCT01647516|584596620|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
161877938|NCT01647516|584596621|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
161877939|NCT01647516|584596616|FG000|Open-Label Period|No completion / discontinuation visit|0|||
161776698|NCT00648739|584225394|FG003|Overall Study|Lack of Efficacy|0|||
161776699|NCT00648739|584225395|FG004|Overall Study|Lack of Efficacy|1|||
161776700|NCT00648739|584225396|FG005|Overall Study|Lack of Efficacy|2|||
161776701|NCT00648739|584225397|FG006|Overall Study|Lack of Efficacy|0|||
161776702|NCT00648739|584225391|FG000|Overall Study|Investigator Considered it Advisable|0|||
161776703|NCT00648739|584225392|FG001|Overall Study|Investigator Considered it Advisable|0|||
161776704|NCT00648739|584225393|FG002|Overall Study|Investigator Considered it Advisable|0|||
161877940|NCT01647516|584596617|FG001|Open-Label Period|No completion / discontinuation visit|0|||
161877941|NCT01647516|584596618|FG002|Open-Label Period|No completion / discontinuation visit|0|||
161877942|NCT01647516|584596619|FG003|Open-Label Period|No completion / discontinuation visit|0|||
161877943|NCT01647516|584596620|FG004|Open-Label Period|No completion / discontinuation visit|2|||
161877944|NCT01647516|584596621|FG005|Open-Label Period|No completion / discontinuation visit|1|||
161877945|NCT02980341|584596622|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
161877946|NCT02980341|584596623|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
161877947|NCT02980341|584596624|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
161877948|NCT02980341|584596625|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
161877949|NCT02980341|584596626|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
161776705|NCT00648739|584225394|FG003|Overall Study|Investigator Considered it Advisable|0|||
161776706|NCT00648739|584225395|FG004|Overall Study|Investigator Considered it Advisable|0|||
161776707|NCT00648739|584225396|FG005|Overall Study|Investigator Considered it Advisable|1|||
161776708|NCT00648739|584225397|FG006|Overall Study|Investigator Considered it Advisable|1|||
161776709|NCT00648739|584225391|FG000|Overall Study|Death|0|||
161776710|NCT00648739|584225392|FG001|Overall Study|Death|1|||
161776711|NCT00648739|584225393|FG002|Overall Study|Death|0|||
161776712|NCT00648739|584225394|FG003|Overall Study|Death|0|||
161776713|NCT00648739|584225395|FG004|Overall Study|Death|0|||
161776714|NCT00648739|584225396|FG005|Overall Study|Death|0|||
161776715|NCT00648739|584225397|FG006|Overall Study|Death|0|||
161776716|NCT00648739|584225391|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
161776717|NCT00648739|584225392|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
161776718|NCT00648739|584225393|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
161776719|NCT00648739|584225394|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
161776720|NCT00648739|584225395|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
161776721|NCT00648739|584225396|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
161776722|NCT00648739|584225397|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
161776723|NCT00648739|584225391|FG000|Overall Study|Follow-up Visits Not Completed|0|||
161776724|NCT00648739|584225392|FG001|Overall Study|Follow-up Visits Not Completed|1|||
161776725|NCT00648739|584225393|FG002|Overall Study|Follow-up Visits Not Completed|0|||
161776726|NCT00648739|584225394|FG003|Overall Study|Follow-up Visits Not Completed|0|||
161776727|NCT00648739|584225395|FG004|Overall Study|Follow-up Visits Not Completed|0|||
161776728|NCT00648739|584225396|FG005|Overall Study|Follow-up Visits Not Completed|0|||
161776729|NCT00648739|584225397|FG006|Overall Study|Follow-up Visits Not Completed|0|||
161776730|NCT03387423|584225402|FG000|Overall Study|Lost to Follow-up|16|||
161776731|NCT03387423|584225403|FG001|Overall Study|Lost to Follow-up|12|||
161776732|NCT03387423|584225404|FG002|Overall Study|Lost to Follow-up|1|||
161776733|NCT03387423|584225405|FG003|Overall Study|Lost to Follow-up|0|||
161776734|NCT03387423|584225402|FG000|Overall Study|Other|0|||
161776735|NCT03387423|584225403|FG001|Overall Study|Other|3|||
161776736|NCT03387423|584225404|FG002|Overall Study|Other|0|||
161776737|NCT03387423|584225405|FG003|Overall Study|Other|0|||
161776738|NCT03387423|584225402|FG000|Overall Study|Administrative Reason|166|||
161776739|NCT03387423|584225403|FG001|Overall Study|Administrative Reason|89|||
161776740|NCT03387423|584225404|FG002|Overall Study|Administrative Reason|17|||
161776741|NCT03387423|584225405|FG003|Overall Study|Administrative Reason|19|||
161776742|NCT03387423|584225402|FG000|Overall Study|Revocation Consent|76|||
161776743|NCT03387423|584225403|FG001|Overall Study|Revocation Consent|32|||
161776744|NCT03387423|584225404|FG002|Overall Study|Revocation Consent|3|||
161776745|NCT03387423|584225405|FG003|Overall Study|Revocation Consent|5|||
161776746|NCT04362761|584225412|FG000|Part A (48 Weeks)|Adverse Event|2|||
161776747|NCT04362761|584225412|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
161776748|NCT04362761|584225412|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
161776749|NCT04362761|584225412|FG000|Part A (48 Weeks)|Other|5|||
161776750|NCT04362761|584225412|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
161776751|NCT04362761|584225412|FG000|Part B (86 Weeks)|Other|4|||
161776752|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
161776753|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
161776754|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
161776755|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
161776756|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
161776757|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
161776758|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
161776759|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
161776760|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
161776761|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
161776762|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
161776763|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
161776764|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
161776765|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
161776766|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
161776767|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
161776768|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
161776769|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
161776770|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
161877950|NCT02980341|584596627|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161776771|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
161776772|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
161776773|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
161776774|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
161776775|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
161776776|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
161877951|NCT02980341|584596628|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161877952|NCT02980341|584596629|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161877953|NCT02980341|584596630|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161877954|NCT02980341|584596631|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161877955|NCT02980341|584596632|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161877956|NCT02980341|584596622|FG000|Dose Escalation|Clinical progression|0|||
161877957|NCT02980341|584596623|FG001|Dose Escalation|Clinical progression|0|||
161877958|NCT02980341|584596624|FG002|Dose Escalation|Clinical progression|2|||
161877959|NCT02980341|584596625|FG003|Dose Escalation|Clinical progression|1|||
161877960|NCT02980341|584596626|FG004|Dose Escalation|Clinical progression|0|||
161877961|NCT02980341|584596627|FG005|Dose Escalation|Clinical progression|0|||
161877962|NCT02980341|584596628|FG006|Dose Escalation|Clinical progression|0|||
161877963|NCT02980341|584596629|FG007|Dose Escalation|Clinical progression|0|||
161877964|NCT02980341|584596630|FG008|Dose Escalation|Clinical progression|0|||
161877965|NCT02980341|584596631|FG009|Dose Escalation|Clinical progression|0|||
161877966|NCT02980341|584596632|FG010|Dose Escalation|Clinical progression|0|||
161877967|NCT02980341|584596622|FG000|Dose Escalation|Adverse Event|0|||
161877968|NCT02980341|584596623|FG001|Dose Escalation|Adverse Event|0|||
161877969|NCT02980341|584596624|FG002|Dose Escalation|Adverse Event|1|||
161877970|NCT02980341|584596625|FG003|Dose Escalation|Adverse Event|2|||
161877971|NCT02980341|584596626|FG004|Dose Escalation|Adverse Event|2|||
161877972|NCT02980341|584596627|FG005|Dose Escalation|Adverse Event|0|||
161877973|NCT02980341|584596628|FG006|Dose Escalation|Adverse Event|0|||
161776777|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
161776778|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
161776779|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
161776780|NCT01299272|584225422|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
161776781|NCT01299272|584225423|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
161776782|NCT01299272|584225424|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
161776783|NCT01299272|584225425|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
161776784|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
161776785|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
161776786|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
161776787|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
161776788|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
161776789|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
161776790|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
161776791|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
161776792|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
161776793|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
161776794|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
161776795|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
161776796|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
161776797|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
161776798|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
161776799|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
161776800|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
161776801|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
161776802|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
161776803|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
161776804|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
161776805|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
161776806|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
161776807|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
161776808|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
161776809|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
161776810|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
161776811|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
161776812|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
161877974|NCT02980341|584596629|FG007|Dose Escalation|Adverse Event|0|||
161877975|NCT02980341|584596630|FG008|Dose Escalation|Adverse Event|0|||
161877976|NCT02980341|584596631|FG009|Dose Escalation|Adverse Event|0|||
161877977|NCT02980341|584596632|FG010|Dose Escalation|Adverse Event|0|||
161877978|NCT02980341|584596622|FG000|Dose Escalation|Withdrawal by Subject|0|||
161877979|NCT02980341|584596623|FG001|Dose Escalation|Withdrawal by Subject|0|||
161877980|NCT02980341|584596624|FG002|Dose Escalation|Withdrawal by Subject|1|||
161877981|NCT02980341|584596625|FG003|Dose Escalation|Withdrawal by Subject|0|||
161877982|NCT02980341|584596626|FG004|Dose Escalation|Withdrawal by Subject|0|||
161877983|NCT02980341|584596627|FG005|Dose Escalation|Withdrawal by Subject|0|||
161776813|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
161776814|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
161776815|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
161776816|NCT01299272|584225422|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
161776817|NCT01299272|584225423|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
161776818|NCT01299272|584225424|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
161776819|NCT01299272|584225425|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
161776820|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
161776821|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
161776822|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
161776823|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
161776824|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
161776825|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
161776826|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
161776827|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
161776828|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
161776829|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
161776830|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
161776831|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
161776832|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
161776833|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
161776834|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
161776835|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
161776836|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
161776837|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
161776838|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
161776839|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
161776840|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
161776841|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
161776842|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
161776843|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
161776844|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
161776845|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
161776846|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
161776847|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
161776848|NCT01299272|584225422|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
161776849|NCT01299272|584225423|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
161776850|NCT01299272|584225424|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
161776851|NCT01299272|584225425|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
161776852|NCT00464308|584225426|FG000|Overall Study|Adverse Event|22|||
161776853|NCT00464308|584225427|FG001|Overall Study|Adverse Event|27|||
161776854|NCT00464308|584225428|FG002|Overall Study|Adverse Event|16|||
161776855|NCT00464308|584225426|FG000|Overall Study|Lost to Follow-up|29|||
161776856|NCT00464308|584225427|FG001|Overall Study|Lost to Follow-up|19|||
161776857|NCT00464308|584225428|FG002|Overall Study|Lost to Follow-up|20|||
161776858|NCT00464308|584225426|FG000|Overall Study|Patient discontinued and other reasons|17|||
161776859|NCT00464308|584225427|FG001|Overall Study|Patient discontinued and other reasons|17|||
161776860|NCT00464308|584225428|FG002|Overall Study|Patient discontinued and other reasons|23|||
161776861|NCT00464308|584225426|FG000|Overall Study|Physician Decision|1|||
161776862|NCT00464308|584225427|FG001|Overall Study|Physician Decision|0|||
161776863|NCT00464308|584225428|FG002|Overall Study|Physician Decision|0|||
161776864|NCT01721200|584225429|FG000|Overall Study|Lost to Follow-up|3|||
161776865|NCT01721200|584225430|FG001|Overall Study|Lost to Follow-up|5|||
161776866|NCT01513759|584225431|FG000|Overall Study|Protocol Violation|4|||
161776867|NCT01513759|584225431|FG000|Overall Study|Death during catheter placement|1|||
161776868|NCT03606109|584225432|FG000|Overall Study|Lost to Follow-up|2|||
161776869|NCT03606109|584225433|FG001|Overall Study|Lost to Follow-up|1|||
161776870|NCT03926728|584225434|FG000|Overall Study|Withdrawal by Subject|0|||
161776871|NCT03926728|584225435|FG001|Overall Study|Withdrawal by Subject|1|||
161776872|NCT03926728|584225436|FG002|Overall Study|Withdrawal by Subject|1|||
161776873|NCT03926728|584225437|FG003|Overall Study|Withdrawal by Subject|0|||
161776874|NCT03926728|584225438|FG004|Overall Study|Withdrawal by Subject|0|||
161776875|NCT03926728|584225439|FG005|Overall Study|Withdrawal by Subject|1|||
161776876|NCT03926728|584225440|FG006|Overall Study|Withdrawal by Subject|1|||
161776877|NCT03926728|584225441|FG007|Overall Study|Withdrawal by Subject|0|||
161776878|NCT03926728|584225442|FG008|Overall Study|Withdrawal by Subject|0|||
161776879|NCT03926728|584225443|FG009|Overall Study|Withdrawal by Subject|1|||
161776880|NCT03926728|584225444|FG010|Overall Study|Withdrawal by Subject|0|||
161776881|NCT03926728|584225445|FG011|Overall Study|Withdrawal by Subject|0|||
161990946|NCT04405076|585016431|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
161990947|NCT04405076|585016432|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
161990948|NCT04405076|585016433|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
161990949|NCT04405076|585016434|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
161990950|NCT04405076|585016435|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
161990951|NCT04405076|585016436|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
161990952|NCT04405076|585016437|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
161990953|NCT04405076|585016438|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
161990954|NCT04405076|585016439|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
161990955|NCT04405076|585016431|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161990956|NCT04405076|585016432|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161990957|NCT04405076|585016433|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161990958|NCT04405076|585016434|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161990959|NCT04405076|585016435|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
161990960|NCT04405076|585016436|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161990961|NCT04405076|585016437|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161990962|NCT04405076|585016438|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161990963|NCT04405076|585016439|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
161990964|NCT04405076|585016431|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
161990965|NCT04405076|585016432|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
161990966|NCT04405076|585016433|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
161990967|NCT04405076|585016434|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
161990968|NCT04405076|585016435|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
161990969|NCT04405076|585016436|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
161990970|NCT04405076|585016437|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
161990971|NCT04405076|585016438|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
161990972|NCT04405076|585016439|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
161990973|NCT04405076|585016431|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161990974|NCT04405076|585016432|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161990975|NCT04405076|585016433|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161990976|NCT04405076|585016434|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161990977|NCT04405076|585016435|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161990978|NCT04405076|585016436|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161990979|NCT04405076|585016437|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
161990980|NCT04405076|585016438|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
161990981|NCT04405076|585016439|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
161990982|NCT04405076|585016431|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161990983|NCT04405076|585016432|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161990984|NCT04405076|585016433|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161990985|NCT04405076|585016434|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161990986|NCT04405076|585016435|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161990987|NCT04405076|585016436|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161990988|NCT04405076|585016437|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
161990989|NCT04405076|585016438|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161990990|NCT04405076|585016439|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161990991|NCT02513472|585016440|FG000|Overall Study|Radiological Disease Progression|45|||
161990992|NCT02513472|585016441|FG001|Overall Study|Radiological Disease Progression|57|||
161990993|NCT02513472|585016440|FG000|Overall Study|Clinical Disease Progression|5|||
161990994|NCT02513472|585016441|FG001|Overall Study|Clinical Disease Progression|13|||
161990995|NCT02513472|585016440|FG000|Overall Study|Adverse Event|8|||
161990996|NCT02513472|585016441|FG001|Overall Study|Adverse Event|11|||
161990997|NCT02513472|585016440|FG000|Overall Study|Withdrawal by Subject|0|||
161990998|NCT02513472|585016441|FG001|Overall Study|Withdrawal by Subject|4|||
161990999|NCT02513472|585016440|FG000|Overall Study|Subject Choice|2|||
161991000|NCT02513472|585016441|FG001|Overall Study|Subject Choice|7|||
161991001|NCT02513472|585016440|FG000|Overall Study|Treatment Completed as per Protocol|3|||
161991002|NCT02513472|585016441|FG001|Overall Study|Treatment Completed as per Protocol|3|||
161991003|NCT02513472|585016440|FG000|Overall Study|Other|3|||
161991004|NCT02513472|585016441|FG001|Overall Study|Other|6|||
161991005|NCT00195663|585016442|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
161991006|NCT00195663|585016443|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
161991007|NCT00195663|585016444|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
161991008|NCT00195663|585016442|FG000|2-year Double-blind Treatment Period|Death|0|||
161991009|NCT00195663|585016443|FG001|2-year Double-blind Treatment Period|Death|2|||
161991010|NCT00195663|585016444|FG002|2-year Double-blind Treatment Period|Death|0|||
161877984|NCT02980341|584596628|FG006|Dose Escalation|Withdrawal by Subject|0|||
161877985|NCT02980341|584596629|FG007|Dose Escalation|Withdrawal by Subject|0|||
161877986|NCT02980341|584596630|FG008|Dose Escalation|Withdrawal by Subject|0|||
161877987|NCT02980341|584596631|FG009|Dose Escalation|Withdrawal by Subject|0|||
161877988|NCT02980341|584596632|FG010|Dose Escalation|Withdrawal by Subject|0|||
161877989|NCT02980341|584596622|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877990|NCT02980341|584596623|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877991|NCT02980341|584596624|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877992|NCT02980341|584596625|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
161877993|NCT02980341|584596626|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877994|NCT02980341|584596627|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877995|NCT02980341|584596628|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877996|NCT02980341|584596629|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877997|NCT02980341|584596630|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877998|NCT02980341|584596631|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
161877999|NCT02980341|584596632|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
161878000|NCT02980341|584596622|FG000|Dose Escalation|Due to investigator's decision|0|||
161878001|NCT02980341|584596623|FG001|Dose Escalation|Due to investigator's decision|0|||
161878002|NCT02980341|584596624|FG002|Dose Escalation|Due to investigator's decision|0|||
161878003|NCT02980341|584596625|FG003|Dose Escalation|Due to investigator's decision|0|||
161878004|NCT02980341|584596626|FG004|Dose Escalation|Due to investigator's decision|1|||
161878005|NCT02980341|584596627|FG005|Dose Escalation|Due to investigator's decision|0|||
161878006|NCT02980341|584596628|FG006|Dose Escalation|Due to investigator's decision|0|||
161878007|NCT02980341|584596629|FG007|Dose Escalation|Due to investigator's decision|0|||
161878008|NCT02980341|584596630|FG008|Dose Escalation|Due to investigator's decision|0|||
161878009|NCT02980341|584596631|FG009|Dose Escalation|Due to investigator's decision|0|||
161878010|NCT02980341|584596632|FG010|Dose Escalation|Due to investigator's decision|0|||
161991011|NCT00195663|585016442|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
161991012|NCT00195663|585016443|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
161991013|NCT00195663|585016444|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
161991014|NCT00195663|585016442|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
161991015|NCT00195663|585016443|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
161991016|NCT00195663|585016444|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
161991017|NCT00195663|585016442|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
161991018|NCT00195663|585016443|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
161991019|NCT00195663|585016444|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
161991020|NCT00195663|585016442|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
161991021|NCT00195663|585016443|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
161991022|NCT00195663|585016444|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
161991023|NCT00195663|585016442|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
161991024|NCT00195663|585016443|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
161991025|NCT00195663|585016444|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
161991026|NCT00195663|585016442|FG000|2-year Double-blind Treatment Period|Recovery|1|||
161991027|NCT00195663|585016443|FG001|2-year Double-blind Treatment Period|Recovery|0|||
161991028|NCT00195663|585016444|FG002|2-year Double-blind Treatment Period|Recovery|1|||
161991029|NCT00195663|585016442|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
161991030|NCT00195663|585016443|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
161991031|NCT00195663|585016444|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
161991032|NCT00195663|585016442|FG000|Open-Label Extension Period|Adverse Event|21|||
161991033|NCT00195663|585016443|FG001|Open-Label Extension Period|Adverse Event|32|||
161991034|NCT00195663|585016444|FG002|Open-Label Extension Period|Adverse Event|36|||
161991035|NCT00195663|585016442|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
161991036|NCT00195663|585016443|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
161991037|NCT00195663|585016444|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
161991038|NCT00195663|585016442|FG000|Open-Label Extension Period|Recovery|0|||
161991039|NCT00195663|585016443|FG001|Open-Label Extension Period|Recovery|2|||
161991040|NCT00195663|585016444|FG002|Open-Label Extension Period|Recovery|2|||
161991041|NCT00195663|585016442|FG000|Open-Label Extension Period|Protocol Violation|3|||
161991042|NCT00195663|585016443|FG001|Open-Label Extension Period|Protocol Violation|4|||
161991043|NCT00195663|585016444|FG002|Open-Label Extension Period|Protocol Violation|4|||
161991044|NCT00195663|585016442|FG000|Open-Label Extension Period|Death|2|||
161991045|NCT00195663|585016443|FG001|Open-Label Extension Period|Death|2|||
161991046|NCT00195663|585016444|FG002|Open-Label Extension Period|Death|2|||
161991047|NCT00195663|585016442|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
161991048|NCT00195663|585016443|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
161878011|NCT02980341|584596622|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878012|NCT02980341|584596623|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
161991049|NCT00195663|585016444|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
161776882|NCT03669640|584225450|FG000|Overall Study|Study Terminated by Sponsor|0|||
161776883|NCT03669640|584225451|FG001|Overall Study|Study Terminated by Sponsor|0|||
161776884|NCT03669640|584225452|FG002|Overall Study|Study Terminated by Sponsor|0|||
161776885|NCT03669640|584225453|FG003|Overall Study|Study Terminated by Sponsor|0|||
161776886|NCT03669640|584225454|FG004|Overall Study|Study Terminated by Sponsor|1|||
161776887|NCT03669640|584225455|FG005|Overall Study|Study Terminated by Sponsor|0|||
161776888|NCT03669640|584225450|FG000|Overall Study|Lost to Follow-up|0|||
161776889|NCT03669640|584225451|FG001|Overall Study|Lost to Follow-up|0|||
161776890|NCT03669640|584225452|FG002|Overall Study|Lost to Follow-up|2|||
161776891|NCT03669640|584225453|FG003|Overall Study|Lost to Follow-up|0|||
161776892|NCT03669640|584225454|FG004|Overall Study|Lost to Follow-up|0|||
161776893|NCT03669640|584225455|FG005|Overall Study|Lost to Follow-up|0|||
161776894|NCT03669640|584225450|FG000|Overall Study|Death|0|||
161776895|NCT03669640|584225451|FG001|Overall Study|Death|0|||
161776896|NCT03669640|584225452|FG002|Overall Study|Death|1|||
161776897|NCT03669640|584225453|FG003|Overall Study|Death|0|||
161776898|NCT03669640|584225454|FG004|Overall Study|Death|0|||
161776899|NCT03669640|584225455|FG005|Overall Study|Death|0|||
161776900|NCT03669640|584225450|FG000|Overall Study|Withdrawal by Subject|1|||
161878013|NCT02980341|584596624|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878014|NCT02980341|584596625|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878015|NCT02980341|584596626|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878016|NCT02980341|584596627|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
161878017|NCT02980341|584596628|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
161878018|NCT02980341|584596629|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878019|NCT02980341|584596630|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878020|NCT02980341|584596631|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878021|NCT02980341|584596632|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
161878022|NCT02980341|584596622|FG000|Dose Finding|Adverse Event|0|||
161878023|NCT02980341|584596623|FG001|Dose Finding|Adverse Event|0|||
161878024|NCT02980341|584596624|FG002|Dose Finding|Adverse Event|0|||
161878025|NCT02980341|584596625|FG003|Dose Finding|Adverse Event|0|||
161878026|NCT02980341|584596626|FG004|Dose Finding|Adverse Event|0|||
161878027|NCT02980341|584596627|FG005|Dose Finding|Adverse Event|3|||
161878028|NCT02980341|584596628|FG006|Dose Finding|Adverse Event|0|||
161776901|NCT03669640|584225451|FG001|Overall Study|Withdrawal by Subject|2|||
161776902|NCT03669640|584225452|FG002|Overall Study|Withdrawal by Subject|1|||
161776903|NCT03669640|584225453|FG003|Overall Study|Withdrawal by Subject|0|||
161776904|NCT03669640|584225454|FG004|Overall Study|Withdrawal by Subject|1|||
161776905|NCT03669640|584225455|FG005|Overall Study|Withdrawal by Subject|3|||
161776906|NCT03669640|584225450|FG000|Overall Study|Protocol Violation|1|||
161878029|NCT02980341|584596629|FG007|Dose Finding|Adverse Event|0|||
161878030|NCT02980341|584596630|FG008|Dose Finding|Adverse Event|0|||
161878031|NCT02980341|584596631|FG009|Dose Finding|Adverse Event|0|||
161878032|NCT02980341|584596632|FG010|Dose Finding|Adverse Event|0|||
161878033|NCT02980341|584596622|FG000|Dose Finding|Withdrawal by Subject|0|||
161878034|NCT02980341|584596623|FG001|Dose Finding|Withdrawal by Subject|0|||
161878035|NCT02980341|584596624|FG002|Dose Finding|Withdrawal by Subject|0|||
161878036|NCT02980341|584596625|FG003|Dose Finding|Withdrawal by Subject|0|||
161878037|NCT02980341|584596626|FG004|Dose Finding|Withdrawal by Subject|0|||
161878038|NCT02980341|584596627|FG005|Dose Finding|Withdrawal by Subject|1|||
161878039|NCT02980341|584596628|FG006|Dose Finding|Withdrawal by Subject|1|||
161878040|NCT02980341|584596629|FG007|Dose Finding|Withdrawal by Subject|0|||
161878041|NCT02980341|584596630|FG008|Dose Finding|Withdrawal by Subject|0|||
161776907|NCT03669640|584225451|FG001|Overall Study|Protocol Violation|0|||
161776908|NCT03669640|584225452|FG002|Overall Study|Protocol Violation|0|||
161776909|NCT03669640|584225453|FG003|Overall Study|Protocol Violation|0|||
161776910|NCT03669640|584225454|FG004|Overall Study|Protocol Violation|0|||
161776911|NCT03669640|584225455|FG005|Overall Study|Protocol Violation|0|||
161776912|NCT03669640|584225450|FG000|Overall Study|Physician Decision|0|||
161776913|NCT03669640|584225451|FG001|Overall Study|Physician Decision|2|||
161878042|NCT02980341|584596631|FG009|Dose Finding|Withdrawal by Subject|0|||
161878043|NCT02980341|584596632|FG010|Dose Finding|Withdrawal by Subject|0|||
161878044|NCT02980341|584596622|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161878045|NCT02980341|584596623|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161776914|NCT03669640|584225452|FG002|Overall Study|Physician Decision|0|||
161776915|NCT03669640|584225453|FG003|Overall Study|Physician Decision|0|||
161776916|NCT03669640|584225454|FG004|Overall Study|Physician Decision|0|||
161776917|NCT03669640|584225455|FG005|Overall Study|Physician Decision|0|||
161776918|NCT03669640|584225450|FG000|Overall Study|Disease Relapse|1|||
161776919|NCT03669640|584225451|FG001|Overall Study|Disease Relapse|0|||
161776920|NCT03669640|584225452|FG002|Overall Study|Disease Relapse|0|||
161776921|NCT03669640|584225453|FG003|Overall Study|Disease Relapse|0|||
161776922|NCT03669640|584225454|FG004|Overall Study|Disease Relapse|0|||
161878046|NCT02980341|584596624|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161878047|NCT02980341|584596625|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161776923|NCT03669640|584225455|FG005|Overall Study|Disease Relapse|0|||
161776924|NCT03669640|584225450|FG000|Overall Study|Adverse Event|2|||
161776925|NCT03669640|584225451|FG001|Overall Study|Adverse Event|1|||
161776926|NCT03669640|584225452|FG002|Overall Study|Adverse Event|0|||
161776927|NCT03669640|584225453|FG003|Overall Study|Adverse Event|0|||
161776928|NCT03669640|584225454|FG004|Overall Study|Adverse Event|1|||
161776929|NCT03669640|584225455|FG005|Overall Study|Adverse Event|0|||
161776930|NCT03722849|584225458|FG000|Overall Study|Withdrawal by Subject|1|||
161776931|NCT03722849|584225459|FG001|Overall Study|Withdrawal by Subject|1|||
161776932|NCT03993288|584225460|FG000|Overall Study|Lost to Follow-up|2|||
161776933|NCT03993288|584225461|FG001|Overall Study|Lost to Follow-up|1|||
161776934|NCT03993288|584225460|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
161776935|NCT03993288|584225461|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
161776936|NCT03993288|584225460|FG000|Overall Study|wrong randomization|0|||
161776937|NCT03993288|584225461|FG001|Overall Study|wrong randomization|1|||
161878048|NCT02980341|584596626|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161878049|NCT02980341|584596627|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161878050|NCT02980341|584596628|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161878051|NCT02980341|584596629|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
161878052|NCT02980341|584596630|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
161878053|NCT02980341|584596631|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
161878054|NCT02980341|584596632|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
161878055|NCT02980341|584596622|FG000|Dose Expansion|Clinical progression|0|||
161878056|NCT02980341|584596623|FG001|Dose Expansion|Clinical progression|0|||
161878057|NCT02980341|584596624|FG002|Dose Expansion|Clinical progression|0|||
161878058|NCT02980341|584596625|FG003|Dose Expansion|Clinical progression|0|||
161776938|NCT03993288|584225460|FG000|Overall Study|improper enrollment|0|||
161776939|NCT03993288|584225461|FG001|Overall Study|improper enrollment|1|||
161776940|NCT03993288|584225460|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
161776941|NCT03993288|584225461|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
161776942|NCT03993288|584225460|FG000|Overall Study|developed SAE|2|||
161776943|NCT03993288|584225461|FG001|Overall Study|developed SAE|0|||
161776944|NCT03993288|584225460|FG000|Overall Study|consent withdrawal|1|||
161776945|NCT03993288|584225461|FG001|Overall Study|consent withdrawal|0|||
161776946|NCT03993288|584225460|FG000|Overall Study|did not follow the treatment schedule|1|||
161776947|NCT03993288|584225461|FG001|Overall Study|did not follow the treatment schedule|0|||
161878059|NCT02980341|584596626|FG004|Dose Expansion|Clinical progression|0|||
161878060|NCT02980341|584596627|FG005|Dose Expansion|Clinical progression|0|||
161878061|NCT02980341|584596628|FG006|Dose Expansion|Clinical progression|0|||
161878062|NCT02980341|584596629|FG007|Dose Expansion|Clinical progression|4|||
161878063|NCT02980341|584596630|FG008|Dose Expansion|Clinical progression|3|||
161878064|NCT02980341|584596631|FG009|Dose Expansion|Clinical progression|1|||
161878065|NCT02980341|584596632|FG010|Dose Expansion|Clinical progression|4|||
161878066|NCT02980341|584596622|FG000|Dose Expansion|Adverse Event|0|||
161878067|NCT02980341|584596623|FG001|Dose Expansion|Adverse Event|0|||
161878068|NCT02980341|584596624|FG002|Dose Expansion|Adverse Event|0|||
161878069|NCT02980341|584596625|FG003|Dose Expansion|Adverse Event|0|||
161878070|NCT02980341|584596626|FG004|Dose Expansion|Adverse Event|0|||
161878071|NCT02980341|584596627|FG005|Dose Expansion|Adverse Event|0|||
161878072|NCT02980341|584596628|FG006|Dose Expansion|Adverse Event|0|||
161878073|NCT02980341|584596629|FG007|Dose Expansion|Adverse Event|3|||
161878074|NCT02980341|584596630|FG008|Dose Expansion|Adverse Event|0|||
161878075|NCT02980341|584596631|FG009|Dose Expansion|Adverse Event|1|||
161878076|NCT02980341|584596632|FG010|Dose Expansion|Adverse Event|3|||
161878077|NCT02980341|584596622|FG000|Dose Expansion|Death|0|||
161878078|NCT02980341|584596623|FG001|Dose Expansion|Death|0|||
161878079|NCT02980341|584596624|FG002|Dose Expansion|Death|0|||
161878080|NCT02980341|584596625|FG003|Dose Expansion|Death|0|||
161878081|NCT02980341|584596626|FG004|Dose Expansion|Death|0|||
161878082|NCT02980341|584596627|FG005|Dose Expansion|Death|0|||
161878083|NCT02980341|584596628|FG006|Dose Expansion|Death|0|||
161878084|NCT02980341|584596629|FG007|Dose Expansion|Death|0|||
161878085|NCT02980341|584596630|FG008|Dose Expansion|Death|2|||
161878086|NCT02980341|584596631|FG009|Dose Expansion|Death|1|||
161878087|NCT02980341|584596632|FG010|Dose Expansion|Death|0|||
161878088|NCT02980341|584596622|FG000|Dose Expansion|Withdrawal by Subject|0|||
161776948|NCT03993288|584225460|FG000|Overall Study|did not follow the treatment regimen|1|||
161776949|NCT03993288|584225461|FG001|Overall Study|did not follow the treatment regimen|0|||
161878089|NCT02980341|584596623|FG001|Dose Expansion|Withdrawal by Subject|0|||
161878090|NCT02980341|584596624|FG002|Dose Expansion|Withdrawal by Subject|0|||
161878091|NCT02980341|584596625|FG003|Dose Expansion|Withdrawal by Subject|0|||
161878092|NCT02980341|584596626|FG004|Dose Expansion|Withdrawal by Subject|0|||
161878093|NCT02980341|584596627|FG005|Dose Expansion|Withdrawal by Subject|0|||
161878094|NCT02980341|584596628|FG006|Dose Expansion|Withdrawal by Subject|0|||
161776950|NCT03993288|584225460|FG000|Overall Study|Adverse Event|1|||
161776951|NCT03993288|584225461|FG001|Overall Study|Adverse Event|0|||
161776952|NCT03993288|584225460|FG000|Overall Study|Withdrawal by Subject|1|||
161878095|NCT02980341|584596629|FG007|Dose Expansion|Withdrawal by Subject|2|||
161878096|NCT02980341|584596630|FG008|Dose Expansion|Withdrawal by Subject|0|||
161878097|NCT02980341|584596631|FG009|Dose Expansion|Withdrawal by Subject|1|||
161878098|NCT02980341|584596632|FG010|Dose Expansion|Withdrawal by Subject|0|||
161878099|NCT02980341|584596622|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878100|NCT02980341|584596623|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878101|NCT02980341|584596624|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878102|NCT02980341|584596625|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878103|NCT02980341|584596626|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878104|NCT02980341|584596627|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878105|NCT02980341|584596628|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878106|NCT02980341|584596629|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
161878107|NCT02980341|584596630|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878108|NCT02980341|584596631|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878109|NCT02980341|584596632|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161878110|NCT02980341|584596622|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878111|NCT02980341|584596623|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878112|NCT02980341|584596624|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878113|NCT02980341|584596625|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878114|NCT02980341|584596626|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161776953|NCT03993288|584225461|FG001|Overall Study|Withdrawal by Subject|1|||
161776954|NCT02729545|584225462|FG000|Overall Study|Pregnancy|1|||
161776955|NCT02729545|584225463|FG001|Overall Study|Pregnancy|1|||
161776956|NCT02729545|584225462|FG000|Overall Study|Lost to Follow-up|0|||
161776957|NCT02729545|584225463|FG001|Overall Study|Lost to Follow-up|1|||
161776958|NCT02729545|584225462|FG000|Overall Study|Withdrawal by Subject|2|||
161776959|NCT02729545|584225463|FG001|Overall Study|Withdrawal by Subject|3|||
161776960|NCT03533608|584225464|FG000|Overall Study|Withdrawal by Subject|3|||
161776961|NCT03533608|584225464|FG000|Overall Study|Physician Decision|2|||
161776962|NCT00915473|584225465|FG000|Screening|Withdrawal by Subject|1|||
161776963|NCT00915473|584225466|FG001|Screening|Withdrawal by Subject|0|||
161776964|NCT00915473|584225465|FG000|4-week Follow Up|Lost to Follow-up|1|||
161776965|NCT00915473|584225466|FG001|4-week Follow Up|Lost to Follow-up|5|||
161776966|NCT01389024|584225467|FG000|Overall Study|Withdrawal by Subject|0|||
161776967|NCT01389024|584225468|FG001|Overall Study|Withdrawal by Subject|1|||
161776968|NCT01389024|584225467|FG000|Overall Study|Lost to Follow-up|1|||
161776969|NCT01389024|584225468|FG001|Overall Study|Lost to Follow-up|0|||
161776970|NCT00640614|584225470|FG000|Overall Study|Lost to Follow-up|1|||
161776971|NCT00640614|584225471|FG001|Overall Study|Lost to Follow-up|0|||
161776972|NCT00529802|584225472|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
161776973|NCT00529802|584225472|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
161776974|NCT00529802|584225472|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
161776975|NCT00529802|584225472|FG000|Evaluable for Primary Endpoint|Death|1|||
161776976|NCT00529802|584225472|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
161776977|NCT00529802|584225472|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
161776978|NCT00529802|584225472|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
161776979|NCT02209454|584225476|FG000|Second Period|Adverse Event|1|||
161776980|NCT02209454|584225477|FG001|Second Period|Adverse Event|0|||
161776981|NCT00366678|584225478|FG000|Infant Series|Withdrawal by Subject|8|||
161776982|NCT00366678|584225479|FG001|Infant Series|Withdrawal by Subject|6|||
161776983|NCT00366678|584225480|FG002|Infant Series|Withdrawal by Subject|0|||
161776984|NCT00366678|584225478|FG000|Infant Series|Protocol Violation|4|||
161776985|NCT00366678|584225479|FG001|Infant Series|Protocol Violation|3|||
161776986|NCT00366678|584225480|FG002|Infant Series|Protocol Violation|0|||
161776987|NCT00366678|584225478|FG000|Infant Series|Failed to return|1|||
161776988|NCT00366678|584225479|FG001|Infant Series|Failed to return|1|||
161776989|NCT00366678|584225480|FG002|Infant Series|Failed to return|0|||
161776990|NCT00366678|584225478|FG000|Infant Series|Adverse Event|1|||
161776991|NCT00366678|584225479|FG001|Infant Series|Adverse Event|0|||
161776992|NCT00366678|584225480|FG002|Infant Series|Adverse Event|0|||
161776993|NCT00366678|584225478|FG000|After Infant|Withdrawal by Subject|8|||
161776994|NCT00366678|584225479|FG001|After Infant|Withdrawal by Subject|4|||
161776995|NCT00366678|584225480|FG002|After Infant|Withdrawal by Subject|0|||
161776996|NCT00366678|584225478|FG000|After Infant|Lost to Follow-up|2|||
161776997|NCT00366678|584225479|FG001|After Infant|Lost to Follow-up|1|||
161776998|NCT00366678|584225480|FG002|After Infant|Lost to Follow-up|0|||
161776999|NCT00366678|584225478|FG000|After Infant|Failed to return|5|||
161777000|NCT00366678|584225479|FG001|After Infant|Failed to return|5|||
161777001|NCT00366678|584225480|FG002|After Infant|Failed to return|0|||
161777002|NCT00366678|584225478|FG000|After Infant|Adverse Event|1|||
161991050|NCT00195663|585016442|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
161991051|NCT00195663|585016443|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
161991052|NCT00195663|585016444|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
161991053|NCT00195663|585016442|FG000|Open-Label Extension Period|Administrative reasons|11|||
161991054|NCT00195663|585016443|FG001|Open-Label Extension Period|Administrative reasons|11|||
161991055|NCT00195663|585016444|FG002|Open-Label Extension Period|Administrative reasons|13|||
161991056|NCT01380834|585016445|FG000|Overall Study|Physician Decision|1|||
161991057|NCT01380834|585016446|FG001|Overall Study|Physician Decision|0|||
161991058|NCT03214406|585016447|FG000|Overall Study|did not meet enrollment criteria|9|||
161991059|NCT03214406|585016448|FG001|Overall Study|did not meet enrollment criteria|13|||
161991060|NCT03214406|585016447|FG000|Overall Study|Withdrawal by Subject|1|||
161991061|NCT03214406|585016448|FG001|Overall Study|Withdrawal by Subject|0|||
161991062|NCT03214406|585016447|FG000|Overall Study|Lost to Follow-up|0|||
161991063|NCT03214406|585016448|FG001|Overall Study|Lost to Follow-up|2|||
161991064|NCT01098305|585016450|FG000|Overall Study|Lost to Follow-up|31|||
161991065|NCT01098305|585016451|FG001|Overall Study|Lost to Follow-up|33|||
161991066|NCT03170193|585016457|FG000|Overall Study|Withdrawal by Subject|0|||
161991067|NCT03170193|585016458|FG001|Overall Study|Withdrawal by Subject|0|||
161991068|NCT03170193|585016459|FG002|Overall Study|Withdrawal by Subject|0|||
161991069|NCT03170193|585016460|FG003|Overall Study|Withdrawal by Subject|1|||
161991070|NCT03170193|585016461|FG004|Overall Study|Withdrawal by Subject|0|||
161991071|NCT03170193|585016462|FG005|Overall Study|Withdrawal by Subject|0|||
161991072|NCT03170193|585016463|FG006|Overall Study|Withdrawal by Subject|0|||
161991073|NCT03170193|585016457|FG000|Overall Study|Lost to Follow-up|1|||
161991074|NCT03170193|585016458|FG001|Overall Study|Lost to Follow-up|1|||
161991075|NCT03170193|585016459|FG002|Overall Study|Lost to Follow-up|0|||
161991076|NCT03170193|585016460|FG003|Overall Study|Lost to Follow-up|0|||
161991077|NCT03170193|585016461|FG004|Overall Study|Lost to Follow-up|0|||
161991078|NCT03170193|585016462|FG005|Overall Study|Lost to Follow-up|0|||
161991079|NCT03170193|585016463|FG006|Overall Study|Lost to Follow-up|0|||
161991080|NCT02560012|585016464|FG000|Overall Study|Study Terminated|2|||
161991081|NCT03052816|585016465|FG000|Overall Study|Withdrawal by Subject|1|||
161991082|NCT03052816|585016466|FG001|Overall Study|Withdrawal by Subject|0|||
161991083|NCT03052816|585016465|FG000|Overall Study|Desired opioids|2|||
161991084|NCT03052816|585016466|FG001|Overall Study|Desired opioids|0|||
161991085|NCT00042991|585016467|FG000|Overall Study|Adverse Event|1|||
161991086|NCT00042991|585016468|FG001|Overall Study|Adverse Event|4|||
161991087|NCT00042991|585016469|FG002|Overall Study|Adverse Event|2|||
161991088|NCT00042991|585016470|FG003|Overall Study|Adverse Event|0|||
161991089|NCT00042991|585016471|FG004|Overall Study|Adverse Event|0|||
161991090|NCT00042991|585016472|FG005|Overall Study|Adverse Event|1|||
161991091|NCT00042991|585016473|FG006|Overall Study|Adverse Event|0|||
161991092|NCT00042991|585016467|FG000|Overall Study|Withdrawal by Subject|0|||
161991093|NCT00042991|585016468|FG001|Overall Study|Withdrawal by Subject|7|||
161991094|NCT00042991|585016469|FG002|Overall Study|Withdrawal by Subject|2|||
161991095|NCT00042991|585016470|FG003|Overall Study|Withdrawal by Subject|0|||
161991096|NCT00042991|585016471|FG004|Overall Study|Withdrawal by Subject|1|||
161991097|NCT00042991|585016472|FG005|Overall Study|Withdrawal by Subject|0|||
161991098|NCT00042991|585016473|FG006|Overall Study|Withdrawal by Subject|0|||
161991099|NCT00042991|585016467|FG000|Overall Study|Disease Progression|5|||
161991100|NCT00042991|585016468|FG001|Overall Study|Disease Progression|29|||
161991101|NCT00042991|585016469|FG002|Overall Study|Disease Progression|2|||
161991102|NCT00042991|585016470|FG003|Overall Study|Disease Progression|2|||
161991103|NCT00042991|585016471|FG004|Overall Study|Disease Progression|1|||
161991104|NCT00042991|585016472|FG005|Overall Study|Disease Progression|4|||
161991105|NCT00042991|585016473|FG006|Overall Study|Disease Progression|2|||
161991106|NCT00042991|585016467|FG000|Overall Study|Alternative Therapy|0|||
161991107|NCT00042991|585016468|FG001|Overall Study|Alternative Therapy|0|||
161991108|NCT00042991|585016469|FG002|Overall Study|Alternative Therapy|0|||
161991109|NCT00042991|585016470|FG003|Overall Study|Alternative Therapy|0|||
161991110|NCT00042991|585016471|FG004|Overall Study|Alternative Therapy|1|||
161991111|NCT00042991|585016472|FG005|Overall Study|Alternative Therapy|0|||
161991112|NCT00042991|585016473|FG006|Overall Study|Alternative Therapy|0|||
161991113|NCT03369236|585016474|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
161991114|NCT03369236|585016475|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
161991115|NCT03369236|585016474|FG000|Open-label Extension Period|Lack of Efficacy|2|||
161991116|NCT03369236|585016475|FG001|Open-label Extension Period|Lack of Efficacy|1|||
161991117|NCT03369236|585016474|FG000|Open-label Extension Period|Adverse Event|0|||
161991118|NCT03369236|585016475|FG001|Open-label Extension Period|Adverse Event|1|||
161991119|NCT03369236|585016474|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
161991120|NCT03369236|585016475|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
161991121|NCT02508428|585016483|FG000|Overall Study|Death|32|||
161991122|NCT02508428|585016484|FG001|Overall Study|Death|33|||
161991123|NCT02508428|585016483|FG000|Overall Study|Liner revised|3|||
161991124|NCT02508428|585016484|FG001|Overall Study|Liner revised|19|||
161991125|NCT02508428|585016483|FG000|Overall Study|Incomplete follow-up|17|||
161991126|NCT02508428|585016484|FG001|Overall Study|Incomplete follow-up|15|||
161878115|NCT02980341|584596627|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878116|NCT02980341|584596628|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878117|NCT02980341|584596629|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878118|NCT02980341|584596630|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
161878119|NCT02980341|584596631|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161991127|NCT00615017|585018389|FG000|Overall Study|Adverse Event|0|||
161991128|NCT00615017|585018390|FG001|Overall Study|Adverse Event|1|||
161991129|NCT00615017|585018391|FG002|Overall Study|Adverse Event|2|||
161991130|NCT00615017|585018392|FG003|Overall Study|Adverse Event|0|||
161991131|NCT00615017|585018393|FG004|Overall Study|Adverse Event|0|||
161991132|NCT00615017|585018394|FG005|Overall Study|Adverse Event|1|||
161991133|NCT00615017|585018389|FG000|Overall Study|Death|0|||
161991134|NCT00615017|585018390|FG001|Overall Study|Death|0|||
161991135|NCT00615017|585018391|FG002|Overall Study|Death|2|||
161991136|NCT00615017|585018392|FG003|Overall Study|Death|0|||
161991137|NCT00615017|585018393|FG004|Overall Study|Death|1|||
161991138|NCT00615017|585018394|FG005|Overall Study|Death|1|||
161991139|NCT00615017|585018389|FG000|Overall Study|Sepsis resolved|0|||
161991140|NCT00615017|585018390|FG001|Overall Study|Sepsis resolved|0|||
161991141|NCT00615017|585018391|FG002|Overall Study|Sepsis resolved|1|||
161777003|NCT00366678|584225479|FG001|After Infant|Adverse Event|0|||
161991142|NCT00615017|585018392|FG003|Overall Study|Sepsis resolved|0|||
161991143|NCT00615017|585018393|FG004|Overall Study|Sepsis resolved|0|||
161777004|NCT00366678|584225480|FG002|After Infant|Adverse Event|0|||
161777005|NCT00366678|584225478|FG000|After Infant|Protocol Violation|1|||
161777006|NCT00366678|584225479|FG001|After Infant|Protocol Violation|0|||
161777007|NCT00366678|584225480|FG002|After Infant|Protocol Violation|0|||
161777008|NCT00366678|584225478|FG000|Toddler Dose|Protocol Violation|2|||
161777009|NCT00366678|584225479|FG001|Toddler Dose|Protocol Violation|1|||
161777010|NCT00366678|584225480|FG002|Toddler Dose|Protocol Violation|0|||
161777011|NCT00366678|584225478|FG000|Toddler Dose|Failed to return|1|||
161777012|NCT00366678|584225479|FG001|Toddler Dose|Failed to return|0|||
161777013|NCT00366678|584225480|FG002|Toddler Dose|Failed to return|0|||
161777014|NCT00366678|584225478|FG000|Toddler Dose|Withdrawal by Subject|1|||
161777015|NCT00366678|584225479|FG001|Toddler Dose|Withdrawal by Subject|0|||
161777016|NCT00366678|584225480|FG002|Toddler Dose|Withdrawal by Subject|0|||
161777017|NCT00366678|584225478|FG000|Toddler Dose|protocol deviation|1|||
161777018|NCT00366678|584225479|FG001|Toddler Dose|protocol deviation|0|||
161777019|NCT00366678|584225480|FG002|Toddler Dose|protocol deviation|0|||
161777020|NCT00740480|584225484|FG000|Overall Study|Adverse Event|1|||
161777021|NCT00740480|584225484|FG000|Overall Study|Physician Decision|1|||
161777022|NCT03079869|584225485|FG000|Overall Study|Adverse Event|6|||
161777023|NCT03079869|584225486|FG001|Overall Study|Adverse Event|8|||
161777024|NCT03079869|584225485|FG000|Overall Study|Withdrawal by Subject|4|||
161777025|NCT03079869|584225486|FG001|Overall Study|Withdrawal by Subject|1|||
161777026|NCT03079869|584225485|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
161777027|NCT03079869|584225486|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
161777028|NCT01325701|584225487|FG000|Overall Study|Adverse Event|12|||
161777029|NCT01325701|584225488|FG001|Overall Study|Adverse Event|0|||
161777030|NCT01325701|584225487|FG000|Overall Study|Protocol Violation|1|||
161777031|NCT01325701|584225488|FG001|Overall Study|Protocol Violation|0|||
161777032|NCT01325701|584225487|FG000|Overall Study|Physician Decision|2|||
161777033|NCT01325701|584225488|FG001|Overall Study|Physician Decision|2|||
161777034|NCT01325701|584225487|FG000|Overall Study|Withdrawal by Subject|2|||
161777035|NCT01325701|584225488|FG001|Overall Study|Withdrawal by Subject|1|||
161777036|NCT01325701|584225487|FG000|Overall Study|Rollerover Extension Study|4|||
161777037|NCT01325701|584225488|FG001|Overall Study|Rollerover Extension Study|0|||
161777038|NCT01005680|584225494|FG000|Overall Study|Lost to Follow-up|4|||
161777039|NCT01005680|584225495|FG001|Overall Study|Lost to Follow-up|6|||
161777040|NCT01005680|584225494|FG000|Overall Study|Withdrawal by Subject|1|||
161777041|NCT01005680|584225495|FG001|Overall Study|Withdrawal by Subject|4|||
161777042|NCT01005680|584225494|FG000|Overall Study|Physician Decision|1|||
161777043|NCT01005680|584225495|FG001|Overall Study|Physician Decision|1|||
161777044|NCT04484805|584225500|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
161777045|NCT04484805|584225501|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
161777046|NCT04484805|584225500|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
161777047|NCT04484805|584225501|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
161777048|NCT02118896|584225502|FG000|Overall Study|Death|4|||
161777049|NCT02118896|584225503|FG001|Overall Study|Death|0|||
161777050|NCT02118896|584225504|FG002|Overall Study|Death|4|||
161777051|NCT02118896|584225505|FG003|Overall Study|Death|6|||
161777052|NCT02118896|584225506|FG004|Overall Study|Death|3|||
161777053|NCT02118896|584225507|FG005|Overall Study|Death|1|||
161991144|NCT00615017|585018394|FG005|Overall Study|Sepsis resolved|0|||
161991145|NCT00615017|585018389|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
161878120|NCT02980341|584596632|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161878121|NCT02980341|584596622|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878122|NCT02980341|584596623|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878123|NCT02980341|584596624|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878124|NCT02980341|584596625|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878125|NCT02980341|584596626|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878126|NCT02980341|584596627|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878127|NCT02980341|584596628|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878128|NCT02980341|584596629|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878129|NCT02980341|584596630|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
161878130|NCT02980341|584596631|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878131|NCT02980341|584596632|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161878132|NCT02980341|584596622|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878133|NCT02980341|584596623|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878134|NCT02980341|584596624|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878135|NCT02980341|584596625|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878136|NCT02980341|584596626|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878137|NCT02980341|584596627|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878138|NCT02980341|584596628|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878139|NCT02980341|584596629|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878140|NCT02980341|584596630|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878141|NCT02980341|584596631|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161878142|NCT02980341|584596632|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
161878143|NCT04964544|584596639|FG000|Overall Study|Screen failure or other uncategorised|10|||
161878144|NCT04964544|584596639|FG000|Overall Study|Physician Decision|4|||
161878145|NCT04964544|584596639|FG000|Overall Study|Lost to Follow-up|9|||
161878146|NCT04964544|584596639|FG000|Overall Study|Withdrawal by Subject|18|||
161878147|NCT04964544|584596639|FG000|Overall Study|Death|1|||
161878148|NCT04143594|584596643|FG000|Overall Study|Withdrew consent|3|||
161878149|NCT04143594|584596644|FG001|Overall Study|Withdrew consent|10|||
161878150|NCT04143594|584596645|FG002|Overall Study|Withdrew consent|3|||
161878151|NCT04143594|584596646|FG003|Overall Study|Withdrew consent|1|||
161878152|NCT04143594|584596643|FG000|Overall Study|Lost to Follow-up|3|||
161878153|NCT04143594|584596644|FG001|Overall Study|Lost to Follow-up|5|||
161878154|NCT04143594|584596645|FG002|Overall Study|Lost to Follow-up|11|||
161878155|NCT04143594|584596646|FG003|Overall Study|Lost to Follow-up|0|||
161878156|NCT04143594|584596643|FG000|Overall Study|Investigator's discretion|2|||
161878157|NCT04143594|584596644|FG001|Overall Study|Investigator's discretion|2|||
161878158|NCT04143594|584596645|FG002|Overall Study|Investigator's discretion|0|||
161878159|NCT04143594|584596646|FG003|Overall Study|Investigator's discretion|0|||
161878160|NCT04143594|584596643|FG000|Overall Study|Randomized but never treated|0|||
161878161|NCT04143594|584596644|FG001|Overall Study|Randomized but never treated|0|||
161878162|NCT04143594|584596645|FG002|Overall Study|Randomized but never treated|0|||
161878163|NCT04143594|584596646|FG003|Overall Study|Randomized but never treated|1|||
161878164|NCT04143594|584596643|FG000|Overall Study|Death|1|||
161878165|NCT04143594|584596644|FG001|Overall Study|Death|0|||
161878166|NCT04143594|584596645|FG002|Overall Study|Death|1|||
161878167|NCT04143594|584596646|FG003|Overall Study|Death|0|||
161878168|NCT04143594|584596643|FG000|Overall Study|Adverse Event|1|||
161878169|NCT04143594|584596644|FG001|Overall Study|Adverse Event|0|||
161878170|NCT04143594|584596645|FG002|Overall Study|Adverse Event|0|||
161878171|NCT04143594|584596646|FG003|Overall Study|Adverse Event|0|||
161878172|NCT04143594|584596643|FG000|Overall Study|Pregnancy|0|||
161878173|NCT04143594|584596644|FG001|Overall Study|Pregnancy|0|||
161878174|NCT04143594|584596645|FG002|Overall Study|Pregnancy|1|||
161878175|NCT04143594|584596646|FG003|Overall Study|Pregnancy|0|||
161878176|NCT04143594|584596643|FG000|Overall Study|Lack of Efficacy|1|||
161878177|NCT04143594|584596644|FG001|Overall Study|Lack of Efficacy|1|||
161878178|NCT04143594|584596645|FG002|Overall Study|Lack of Efficacy|0|||
161878179|NCT04143594|584596646|FG003|Overall Study|Lack of Efficacy|0|||
161878180|NCT01023256|584596647|FG000|Overall Study|Protocol Violation|2|||
161878181|NCT01023256|584596648|FG001|Overall Study|Protocol Violation|3|||
161878182|NCT01023256|584596649|FG002|Overall Study|Protocol Violation|0|||
161878183|NCT01023256|584596650|FG003|Overall Study|Protocol Violation|0|||
161878184|NCT01023256|584596647|FG000|Overall Study|Randomized but not treated|1|||
161878185|NCT01023256|584596648|FG001|Overall Study|Randomized but not treated|0|||
161878186|NCT01023256|584596649|FG002|Overall Study|Randomized but not treated|1|||
161878187|NCT01023256|584596650|FG003|Overall Study|Randomized but not treated|0|||
161878188|NCT01023256|584596647|FG000|Overall Study|Other|1|||
161777054|NCT02118896|584225508|FG006|Overall Study|Death|0|||
161777055|NCT02118896|584225509|FG007|Overall Study|Death|0|||
161777056|NCT02118896|584225510|FG008|Overall Study|Death|0|||
161777057|NCT02118896|584225511|FG009|Overall Study|Death|0|||
161777058|NCT02118896|584225502|FG000|Overall Study|Adverse Event|5|||
161777059|NCT02118896|584225503|FG001|Overall Study|Adverse Event|4|||
161777060|NCT02118896|584225504|FG002|Overall Study|Adverse Event|4|||
161777061|NCT02118896|584225505|FG003|Overall Study|Adverse Event|5|||
161777062|NCT02118896|584225506|FG004|Overall Study|Adverse Event|5|||
161777063|NCT02118896|584225507|FG005|Overall Study|Adverse Event|9|||
161777064|NCT02118896|584225508|FG006|Overall Study|Adverse Event|1|||
161777065|NCT02118896|584225509|FG007|Overall Study|Adverse Event|1|||
161777066|NCT02118896|584225510|FG008|Overall Study|Adverse Event|4|||
161777067|NCT02118896|584225511|FG009|Overall Study|Adverse Event|0|||
161777068|NCT02118896|584225502|FG000|Overall Study|Consent withdrawn|2|||
161777069|NCT02118896|584225503|FG001|Overall Study|Consent withdrawn|0|||
161777070|NCT02118896|584225504|FG002|Overall Study|Consent withdrawn|3|||
161777071|NCT02118896|584225505|FG003|Overall Study|Consent withdrawn|4|||
161777072|NCT02118896|584225506|FG004|Overall Study|Consent withdrawn|1|||
161777073|NCT02118896|584225507|FG005|Overall Study|Consent withdrawn|4|||
161777074|NCT02118896|584225508|FG006|Overall Study|Consent withdrawn|0|||
161777075|NCT02118896|584225509|FG007|Overall Study|Consent withdrawn|0|||
161777076|NCT02118896|584225510|FG008|Overall Study|Consent withdrawn|0|||
161777077|NCT02118896|584225511|FG009|Overall Study|Consent withdrawn|0|||
161777078|NCT02118896|584225502|FG000|Overall Study|Non-compliance|2|||
161777079|NCT02118896|584225503|FG001|Overall Study|Non-compliance|1|||
161777080|NCT02118896|584225504|FG002|Overall Study|Non-compliance|1|||
161777081|NCT02118896|584225505|FG003|Overall Study|Non-compliance|5|||
161777082|NCT02118896|584225506|FG004|Overall Study|Non-compliance|0|||
161777083|NCT02118896|584225507|FG005|Overall Study|Non-compliance|1|||
161777084|NCT02118896|584225508|FG006|Overall Study|Non-compliance|0|||
161777085|NCT02118896|584225509|FG007|Overall Study|Non-compliance|1|||
161777086|NCT02118896|584225510|FG008|Overall Study|Non-compliance|0|||
161777087|NCT02118896|584225511|FG009|Overall Study|Non-compliance|0|||
161777088|NCT02118896|584225502|FG000|Overall Study|Pregnancy|1|||
161777089|NCT02118896|584225503|FG001|Overall Study|Pregnancy|1|||
161777090|NCT02118896|584225504|FG002|Overall Study|Pregnancy|0|||
161777091|NCT02118896|584225505|FG003|Overall Study|Pregnancy|0|||
161777092|NCT02118896|584225506|FG004|Overall Study|Pregnancy|1|||
161777093|NCT02118896|584225507|FG005|Overall Study|Pregnancy|3|||
161777094|NCT02118896|584225508|FG006|Overall Study|Pregnancy|1|||
161777095|NCT02118896|584225509|FG007|Overall Study|Pregnancy|0|||
161777096|NCT02118896|584225510|FG008|Overall Study|Pregnancy|0|||
161777097|NCT02118896|584225511|FG009|Overall Study|Pregnancy|0|||
161777098|NCT02118896|584225502|FG000|Overall Study|Lost to Follow-up|1|||
161777099|NCT02118896|584225503|FG001|Overall Study|Lost to Follow-up|2|||
161777100|NCT02118896|584225504|FG002|Overall Study|Lost to Follow-up|1|||
161777101|NCT02118896|584225505|FG003|Overall Study|Lost to Follow-up|0|||
161777102|NCT02118896|584225506|FG004|Overall Study|Lost to Follow-up|2|||
161777103|NCT02118896|584225507|FG005|Overall Study|Lost to Follow-up|1|||
161777104|NCT02118896|584225508|FG006|Overall Study|Lost to Follow-up|0|||
161777105|NCT02118896|584225509|FG007|Overall Study|Lost to Follow-up|0|||
161777106|NCT02118896|584225510|FG008|Overall Study|Lost to Follow-up|0|||
161777107|NCT02118896|584225511|FG009|Overall Study|Lost to Follow-up|0|||
161777108|NCT02118896|584225502|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
161777109|NCT02118896|584225503|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
161777110|NCT02118896|584225504|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
161777111|NCT02118896|584225505|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
161777112|NCT02118896|584225506|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
161777113|NCT02118896|584225507|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
161777114|NCT02118896|584225508|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
161878189|NCT01023256|584596648|FG001|Overall Study|Other|0|||
161878190|NCT01023256|584596649|FG002|Overall Study|Other|0|||
161777115|NCT02118896|584225509|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
161777116|NCT02118896|584225510|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
161777117|NCT02118896|584225511|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
161777118|NCT02118896|584225502|FG000|Overall Study|Prohibited medication|0|||
161777119|NCT02118896|584225503|FG001|Overall Study|Prohibited medication|0|||
161777120|NCT02118896|584225504|FG002|Overall Study|Prohibited medication|0|||
161777121|NCT02118896|584225505|FG003|Overall Study|Prohibited medication|0|||
161777122|NCT02118896|584225506|FG004|Overall Study|Prohibited medication|1|||
161777123|NCT02118896|584225507|FG005|Overall Study|Prohibited medication|3|||
161777124|NCT02118896|584225508|FG006|Overall Study|Prohibited medication|0|||
161777125|NCT02118896|584225509|FG007|Overall Study|Prohibited medication|0|||
161777126|NCT02118896|584225510|FG008|Overall Study|Prohibited medication|0|||
161777127|NCT02118896|584225511|FG009|Overall Study|Prohibited medication|0|||
161777128|NCT02118896|584225502|FG000|Overall Study|Miscellaneous|1|||
161777129|NCT02118896|584225503|FG001|Overall Study|Miscellaneous|2|||
161777130|NCT02118896|584225504|FG002|Overall Study|Miscellaneous|0|||
161777131|NCT02118896|584225505|FG003|Overall Study|Miscellaneous|2|||
161991146|NCT00615017|585018390|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
161991147|NCT00615017|585018391|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
161991148|NCT00615017|585018392|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
161991149|NCT00615017|585018393|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
161991150|NCT00615017|585018394|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
161991151|NCT00615017|585018389|FG000|Overall Study|Physician discontinued drug|0|||
161991152|NCT00615017|585018390|FG001|Overall Study|Physician discontinued drug|0|||
161991153|NCT00615017|585018391|FG002|Overall Study|Physician discontinued drug|0|||
161991154|NCT00615017|585018392|FG003|Overall Study|Physician discontinued drug|0|||
161991155|NCT00615017|585018393|FG004|Overall Study|Physician discontinued drug|0|||
161991156|NCT00615017|585018394|FG005|Overall Study|Physician discontinued drug|1|||
161991157|NCT00806988|585018395|FG000|Overall Study|Death|15|||
161991158|NCT00806988|585018396|FG001|Overall Study|Death|16|||
161991159|NCT00806988|585018395|FG000|Overall Study|Withdrawal by Subject|8|||
161991160|NCT00806988|585018396|FG001|Overall Study|Withdrawal by Subject|8|||
161991161|NCT00806988|585018395|FG000|Overall Study|Lost to Follow-up|4|||
161991162|NCT00806988|585018396|FG001|Overall Study|Lost to Follow-up|19|||
161991163|NCT04775953|585018398|FG000|Overall Study|Lost to Follow-up|6|||
161991164|NCT04775953|585018399|FG001|Overall Study|Lost to Follow-up|11|||
161991165|NCT04775953|585018398|FG000|Overall Study|Death|5|||
161991166|NCT04775953|585018399|FG001|Overall Study|Death|4|||
161991167|NCT04775953|585018398|FG000|Overall Study|Withdrawal by Subject|3|||
161991168|NCT04775953|585018399|FG001|Overall Study|Withdrawal by Subject|3|||
161991169|NCT04775953|585018398|FG000|Overall Study|Protocol Violation|2|||
161991170|NCT04775953|585018399|FG001|Overall Study|Protocol Violation|0|||
161991171|NCT04775953|585018398|FG000|Overall Study|Participant non-compliance|0|||
161991172|NCT04775953|585018399|FG001|Overall Study|Participant non-compliance|1|||
161991173|NCT01698814|585018400|FG000|Overall Study|Adverse Event|0|||
161991174|NCT01698814|585018401|FG001|Overall Study|Adverse Event|2|||
161991175|NCT01698814|585018400|FG000|Overall Study|Lost to Follow-up|0|||
161991176|NCT01698814|585018401|FG001|Overall Study|Lost to Follow-up|1|||
161991177|NCT01698814|585018400|FG000|Overall Study|Pregnancy|1|||
161991178|NCT01698814|585018401|FG001|Overall Study|Pregnancy|0|||
161991179|NCT01698814|585018400|FG000|Overall Study|Randomized in error|1|||
161991180|NCT01698814|585018401|FG001|Overall Study|Randomized in error|0|||
161991181|NCT00855959|585018402|FG000|Overall Study|Adverse Event|2|||
161991182|NCT00855959|585018402|FG000|Overall Study|Lost to Follow-up|2|||
161991183|NCT00855959|585018402|FG000|Overall Study|Withdrawal by Subject|3|||
161991184|NCT00855959|585018402|FG000|Overall Study|Pregnancy|1|||
161991185|NCT00855959|585018402|FG000|Overall Study|Incorrect enrolment|1|||
161991186|NCT04014062|585018403|FG000|Period I: Dosing|Medical Grounds|4|||
161991187|NCT04014062|585018404|FG001|Period I: Dosing|Medical Grounds|5|||
161991188|NCT04014062|585018403|FG000|Period I: Dosing|Withdrawal by Subject|3|||
161991189|NCT04014062|585018404|FG001|Period I: Dosing|Withdrawal by Subject|1|||
161991190|NCT01424501|585018405|FG000|Overall Study|Withdrawal by Subject|1|||
161991191|NCT01424501|585018406|FG001|Overall Study|Withdrawal by Subject|0|||
161991192|NCT01424501|585018407|FG002|Overall Study|Withdrawal by Subject|1|||
161991193|NCT01424501|585018408|FG003|Overall Study|Withdrawal by Subject|0|||
161991194|NCT01424501|585018409|FG004|Overall Study|Withdrawal by Subject|0|||
161991195|NCT01424501|585018410|FG005|Overall Study|Withdrawal by Subject|0|||
161991196|NCT01424501|585018405|FG000|Overall Study|Lost to Follow-up|0|||
161991197|NCT01424501|585018406|FG001|Overall Study|Lost to Follow-up|1|||
161991198|NCT01424501|585018407|FG002|Overall Study|Lost to Follow-up|1|||
161991199|NCT01424501|585018408|FG003|Overall Study|Lost to Follow-up|0|||
161991200|NCT01424501|585018409|FG004|Overall Study|Lost to Follow-up|0|||
161991201|NCT01424501|585018410|FG005|Overall Study|Lost to Follow-up|0|||
161991202|NCT01980095|585018411|FG000|Overall Study|Lost to Follow-up|6|||
161991203|NCT01980095|585018412|FG001|Overall Study|Lost to Follow-up|7|||
161991204|NCT01980095|585018411|FG000|Overall Study|Withdrawal by Subject|2|||
161991205|NCT01980095|585018412|FG001|Overall Study|Withdrawal by Subject|3|||
161991206|NCT01980095|585018411|FG000|Overall Study|Poor compliance|5|||
161991207|NCT01980095|585018412|FG001|Overall Study|Poor compliance|0|||
161991208|NCT01980095|585018411|FG000|Overall Study|Safety issue|0|||
161991209|NCT01980095|585018412|FG001|Overall Study|Safety issue|1|||
161991210|NCT01980095|585018411|FG000|Overall Study|Study drug discontinued|1|||
161991211|NCT01980095|585018412|FG001|Overall Study|Study drug discontinued|0|||
161991212|NCT01980095|585018411|FG000|Overall Study|Randomized by mistake|1|||
161991213|NCT01980095|585018412|FG001|Overall Study|Randomized by mistake|0|||
161991214|NCT02783599|585018419|FG000|Overall Study|Progressive disease|23|||
161991215|NCT02783599|585018419|FG000|Overall Study|Surgical Resection|10|||
161991216|NCT02783599|585018419|FG000|Overall Study|Adverse Event|4|||
161991217|NCT02783599|585018419|FG000|Overall Study|Physician Decision|2|||
161991218|NCT02783599|585018419|FG000|Overall Study|Death|1|||
161991219|NCT00856544|585018420|FG000|Overall Study|Randomized but not treated|3|||
161991220|NCT00856544|585018421|FG001|Overall Study|Randomized but not treated|0|||
161991221|NCT00856544|585018422|FG002|Overall Study|Randomized but not treated|0|||
161991222|NCT00856544|585018423|FG003|Overall Study|Randomized but not treated|0|||
161991223|NCT00856544|585018420|FG000|Overall Study|Death|0|||
161777132|NCT02118896|584225506|FG004|Overall Study|Miscellaneous|0|||
161777133|NCT02118896|584225507|FG005|Overall Study|Miscellaneous|4|||
161777134|NCT02118896|584225508|FG006|Overall Study|Miscellaneous|0|||
161777135|NCT02118896|584225509|FG007|Overall Study|Miscellaneous|0|||
161777136|NCT02118896|584225510|FG008|Overall Study|Miscellaneous|0|||
161777137|NCT02118896|584225511|FG009|Overall Study|Miscellaneous|0|||
161777138|NCT00539006|584225515|FG000|Pre-treatment|Other|0|||
161777139|NCT00539006|584225516|FG001|Pre-treatment|Other|1|||
161777140|NCT00539006|584225517|FG002|Pre-treatment|Other|0|||
161777141|NCT00539006|584225518|FG003|Pre-treatment|Other|0|||
161777142|NCT00539006|584225515|FG000|Treatment Period 1|Lost to Follow-up|0|||
161777143|NCT00539006|584225516|FG001|Treatment Period 1|Lost to Follow-up|0|||
161777144|NCT00539006|584225517|FG002|Treatment Period 1|Lost to Follow-up|1|||
161777145|NCT00539006|584225518|FG003|Treatment Period 1|Lost to Follow-up|0|||
161777146|NCT00539006|584225515|FG000|Treatment Period 1|Protocol Violation|0|||
161777147|NCT00539006|584225516|FG001|Treatment Period 1|Protocol Violation|0|||
161777148|NCT00539006|584225517|FG002|Treatment Period 1|Protocol Violation|1|||
161777149|NCT00539006|584225518|FG003|Treatment Period 1|Protocol Violation|0|||
161777150|NCT00539006|584225515|FG000|Treatment Period 1|Lack of Efficacy|0|||
161777151|NCT00539006|584225516|FG001|Treatment Period 1|Lack of Efficacy|0|||
161777152|NCT00539006|584225517|FG002|Treatment Period 1|Lack of Efficacy|0|||
161777153|NCT00539006|584225518|FG003|Treatment Period 1|Lack of Efficacy|1|||
161777154|NCT00539006|584225515|FG000|Washout|Adverse Event|2|||
161777155|NCT00539006|584225516|FG001|Washout|Adverse Event|1|||
161777156|NCT00539006|584225517|FG002|Washout|Adverse Event|0|||
161777157|NCT00539006|584225518|FG003|Washout|Adverse Event|0|||
161777158|NCT00539006|584225515|FG000|Washout|Protocol Violation|1|||
161777159|NCT00539006|584225516|FG001|Washout|Protocol Violation|1|||
161777160|NCT00539006|584225517|FG002|Washout|Protocol Violation|0|||
161777161|NCT00539006|584225518|FG003|Washout|Protocol Violation|0|||
161777162|NCT00539006|584225515|FG000|Washout|Withdrawal by Subject|0|||
161777163|NCT00539006|584225516|FG001|Washout|Withdrawal by Subject|2|||
161777164|NCT00539006|584225517|FG002|Washout|Withdrawal by Subject|0|||
161777165|NCT00539006|584225518|FG003|Washout|Withdrawal by Subject|0|||
161777166|NCT00539006|584225515|FG000|Washout|Failed to meet continuation criteria|16|||
161777167|NCT00539006|584225516|FG001|Washout|Failed to meet continuation criteria|5|||
161777168|NCT00539006|584225517|FG002|Washout|Failed to meet continuation criteria|14|||
161777169|NCT00539006|584225518|FG003|Washout|Failed to meet continuation criteria|6|||
161777170|NCT00539006|584225515|FG000|Washout|Other|1|||
161777171|NCT00539006|584225516|FG001|Washout|Other|1|||
161777172|NCT00539006|584225517|FG002|Washout|Other|2|||
161777173|NCT00539006|584225518|FG003|Washout|Other|3|||
161777174|NCT00539006|584225515|FG000|Treatment Period 2|Protocol Violation|1|||
161777175|NCT00539006|584225516|FG001|Treatment Period 2|Protocol Violation|0|||
161777176|NCT00539006|584225517|FG002|Treatment Period 2|Protocol Violation|0|||
161777177|NCT00539006|584225518|FG003|Treatment Period 2|Protocol Violation|0|||
161777178|NCT00539006|584225515|FG000|Treatment Period 2|Other|0|||
161777179|NCT00539006|584225516|FG001|Treatment Period 2|Other|1|||
161777180|NCT00539006|584225517|FG002|Treatment Period 2|Other|0|||
161777181|NCT00539006|584225518|FG003|Treatment Period 2|Other|0|||
161777182|NCT03733301|584225519|FG000|Overall Study|Screen Fail|1|||
161777183|NCT03733301|584225520|FG001|Overall Study|Screen Fail|0|||
161777184|NCT03733301|584225521|FG002|Overall Study|Screen Fail|0|||
161777185|NCT03733301|584225519|FG000|Overall Study|Non-compliance|1|||
161878191|NCT01023256|584596650|FG003|Overall Study|Other|2|||
161878192|NCT01023256|584596647|FG000|Overall Study|Adverse Event|0|||
161991224|NCT00856544|585018421|FG001|Overall Study|Death|2|||
161991225|NCT00856544|585018422|FG002|Overall Study|Death|0|||
161991226|NCT00856544|585018423|FG003|Overall Study|Death|0|||
161991227|NCT00856544|585018420|FG000|Overall Study|Adverse Event|20|||
161991228|NCT00856544|585018421|FG001|Overall Study|Adverse Event|29|||
161991229|NCT00856544|585018422|FG002|Overall Study|Adverse Event|2|||
161991230|NCT00856544|585018423|FG003|Overall Study|Adverse Event|3|||
161991231|NCT00856544|585018420|FG000|Overall Study|Lack of Efficacy|16|||
161991232|NCT00856544|585018421|FG001|Overall Study|Lack of Efficacy|12|||
161991233|NCT00856544|585018422|FG002|Overall Study|Lack of Efficacy|3|||
161991234|NCT00856544|585018423|FG003|Overall Study|Lack of Efficacy|3|||
161991235|NCT00856544|585018420|FG000|Overall Study|Other|9|||
161991236|NCT00856544|585018421|FG001|Overall Study|Other|16|||
161991237|NCT00856544|585018422|FG002|Overall Study|Other|1|||
161991238|NCT00856544|585018423|FG003|Overall Study|Other|6|||
161991239|NCT00856544|585018420|FG000|Overall Study|Lost to Follow-up|1|||
161991240|NCT00856544|585018421|FG001|Overall Study|Lost to Follow-up|2|||
161991241|NCT00856544|585018422|FG002|Overall Study|Lost to Follow-up|2|||
161991242|NCT00856544|585018423|FG003|Overall Study|Lost to Follow-up|0|||
161991243|NCT00856544|585018420|FG000|Overall Study|Withdrawal by Subject|8|||
161991244|NCT00856544|585018421|FG001|Overall Study|Withdrawal by Subject|5|||
161777186|NCT03733301|584225520|FG001|Overall Study|Non-compliance|0|||
161777187|NCT03733301|584225521|FG002|Overall Study|Non-compliance|0|||
161777188|NCT03733301|584225519|FG000|Overall Study|Lack of Efficacy|2|||
161777189|NCT03733301|584225520|FG001|Overall Study|Lack of Efficacy|3|||
161777190|NCT03733301|584225521|FG002|Overall Study|Lack of Efficacy|0|||
161777191|NCT03733301|584225519|FG000|Overall Study|Adverse Event|0|||
161777192|NCT03733301|584225520|FG001|Overall Study|Adverse Event|1|||
161777193|NCT03733301|584225521|FG002|Overall Study|Adverse Event|3|||
161777194|NCT03733301|584225519|FG000|Overall Study|Withdrawal by Subject|3|||
161777195|NCT03733301|584225520|FG001|Overall Study|Withdrawal by Subject|5|||
161777196|NCT03733301|584225521|FG002|Overall Study|Withdrawal by Subject|1|||
161777197|NCT01965431|584225522|FG000|Overall Study|Adverse Event|0|||
161777198|NCT01965431|584225523|FG001|Overall Study|Adverse Event|1|||
161777199|NCT01965431|584225524|FG002|Overall Study|Adverse Event|0|||
161777200|NCT01965431|584225525|FG003|Overall Study|Adverse Event|0|||
161777201|NCT01965431|584225526|FG004|Overall Study|Adverse Event|0|||
161777202|NCT01965431|584225527|FG005|Overall Study|Adverse Event|0|||
161777203|NCT01965431|584225522|FG000|Overall Study|Other than stated above|6|||
161777204|NCT01965431|584225523|FG001|Overall Study|Other than stated above|5|||
161777205|NCT01965431|584225524|FG002|Overall Study|Other than stated above|6|||
161777206|NCT01965431|584225525|FG003|Overall Study|Other than stated above|6|||
161777207|NCT01965431|584225526|FG004|Overall Study|Other than stated above|6|||
161777208|NCT01965431|584225527|FG005|Overall Study|Other than stated above|6|||
161777209|NCT04635631|584225528|FG000|Overall Study|Adverse Event|1|||
161777210|NCT04635631|584225528|FG000|Overall Study|Progressive disease|13|||
161777211|NCT04635631|584225528|FG000|Overall Study|Withdrawal by Subject|1|||
161777212|NCT00943826|584225529|FG000|Concurrent Phase|Adverse Event|50|||
161777213|NCT00943826|584225530|FG001|Concurrent Phase|Adverse Event|27|||
161777214|NCT00943826|584225529|FG000|Concurrent Phase|Withdrew consent|3|||
161777215|NCT00943826|584225530|FG001|Concurrent Phase|Withdrew consent|7|||
161777216|NCT00943826|584225529|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
161777217|NCT00943826|584225530|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
161777218|NCT00943826|584225529|FG000|Concurrent Phase|Administrative reasons|2|||
161777219|NCT00943826|584225530|FG001|Concurrent Phase|Administrative reasons|1|||
161777220|NCT00943826|584225529|FG000|Concurrent Phase|Protocol Violation|1|||
161777221|NCT00943826|584225530|FG001|Concurrent Phase|Protocol Violation|0|||
161777222|NCT00943826|584225529|FG000|Maintenance Phase|Adverse Event|31|||
161777223|NCT00943826|584225530|FG001|Maintenance Phase|Adverse Event|30|||
161777224|NCT00943826|584225529|FG000|Maintenance Phase|Withdrew consent|2|||
161777225|NCT00943826|584225530|FG001|Maintenance Phase|Withdrew consent|4|||
161777226|NCT00943826|584225529|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
161777227|NCT00943826|584225530|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
161777228|NCT00943826|584225529|FG000|Maintenance Phase|Administrative reasons|4|||
161777229|NCT00943826|584225530|FG001|Maintenance Phase|Administrative reasons|1|||
161777230|NCT00943826|584225529|FG000|Maintenance Phase|Failure to return|0|||
161777231|NCT00943826|584225530|FG001|Maintenance Phase|Failure to return|1|||
161777232|NCT00943826|584225529|FG000|Monotherapy Phase|Adverse Event|42|||
161777233|NCT00943826|584225530|FG001|Monotherapy Phase|Adverse Event|5|||
161777234|NCT00943826|584225529|FG000|Monotherapy Phase|Administrative reasons|11|||
161878193|NCT01023256|584596648|FG001|Overall Study|Adverse Event|0|||
161878194|NCT01023256|584596649|FG002|Overall Study|Adverse Event|0|||
161878195|NCT01023256|584596650|FG003|Overall Study|Adverse Event|1|||
161878196|NCT01023256|584596647|FG000|Overall Study|Withdrawal by Subject|0|||
161878197|NCT01023256|584596648|FG001|Overall Study|Withdrawal by Subject|0|||
161878198|NCT01023256|584596649|FG002|Overall Study|Withdrawal by Subject|0|||
161878199|NCT01023256|584596650|FG003|Overall Study|Withdrawal by Subject|2|||
161878200|NCT03089697|584596651|FG000|Overall Study|Adverse Event|1|||
161878201|NCT03089697|584596652|FG001|Overall Study|Adverse Event|2|||
161878202|NCT03089697|584596651|FG000|Overall Study|Withdrawal by Subject|1|||
161878203|NCT03089697|584596652|FG001|Overall Study|Withdrawal by Subject|0|||
161878204|NCT00308087|584596653|FG000|Overall Study|Progressive Disease|19|||
161878205|NCT00308087|584596654|FG001|Overall Study|Progressive Disease|21|||
161878206|NCT00308087|584596653|FG000|Overall Study|Study Closure|11|||
161878207|NCT00308087|584596654|FG001|Overall Study|Study Closure|12|||
161878208|NCT00308087|584596653|FG000|Overall Study|Withdrawal by Subject|2|||
161878209|NCT00308087|584596654|FG001|Overall Study|Withdrawal by Subject|1|||
161878210|NCT00308087|584596653|FG000|Overall Study|Other|4|||
161878211|NCT00308087|584596654|FG001|Overall Study|Other|3|||
161878212|NCT02949843|584596658|FG000|Overall Study|Withdrawal by Subject|0|||
161878213|NCT02949843|584596659|FG001|Overall Study|Withdrawal by Subject|1|||
161878214|NCT02949843|584596660|FG002|Overall Study|Withdrawal by Subject|1|||
161878215|NCT03613649|584596661|FG000|Second Treatment|Lost to Follow-up|0|||
161878216|NCT03613649|584596662|FG001|Second Treatment|Lost to Follow-up|0|||
161878217|NCT03613649|584596663|FG002|Second Treatment|Lost to Follow-up|1|||
161878218|NCT03613649|584596664|FG003|Second Treatment|Lost to Follow-up|0|||
161777235|NCT00943826|584225530|FG001|Monotherapy Phase|Administrative reasons|5|||
161777236|NCT00943826|584225529|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
161878219|NCT03613649|584596665|FG004|Second Treatment|Lost to Follow-up|0|||
161777237|NCT00943826|584225530|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
161777238|NCT00943826|584225529|FG000|Monotherapy Phase|Withdrew Consent|2|||
161878220|NCT03613649|584596666|FG005|Second Treatment|Lost to Follow-up|0|||
161878221|NCT03613649|584596667|FG006|Second Treatment|Lost to Follow-up|0|||
161991245|NCT00856544|585018422|FG002|Overall Study|Withdrawal by Subject|0|||
161991246|NCT00856544|585018423|FG003|Overall Study|Withdrawal by Subject|1|||
161991247|NCT01564732|585018424|FG000|Overall Study|Early termination by the study sponsor|6|||
161991248|NCT01564732|585018425|FG001|Overall Study|Early termination by the study sponsor|5|||
161991249|NCT00394706|585018431|FG000|Overall Study|Withdrawal by Subject|2|||
161991250|NCT00394706|585018432|FG001|Overall Study|Withdrawal by Subject|0|||
161991251|NCT00394706|585018433|FG002|Overall Study|Withdrawal by Subject|1|||
161991252|NCT00394706|585018434|FG003|Overall Study|Withdrawal by Subject|0|||
161991253|NCT00394706|585018435|FG004|Overall Study|Withdrawal by Subject|0|||
161991254|NCT00394706|585018436|FG005|Overall Study|Withdrawal by Subject|2|||
161991255|NCT00394706|585018437|FG006|Overall Study|Withdrawal by Subject|1|||
161991256|NCT00394706|585018438|FG007|Overall Study|Withdrawal by Subject|0|||
161991257|NCT00394706|585018431|FG000|Overall Study|Lost to Follow-up|2|||
161991258|NCT00394706|585018432|FG001|Overall Study|Lost to Follow-up|2|||
161991259|NCT00394706|585018433|FG002|Overall Study|Lost to Follow-up|8|||
161991260|NCT00394706|585018434|FG003|Overall Study|Lost to Follow-up|1|||
161991261|NCT00394706|585018435|FG004|Overall Study|Lost to Follow-up|2|||
161991262|NCT00394706|585018436|FG005|Overall Study|Lost to Follow-up|5|||
161991263|NCT00394706|585018437|FG006|Overall Study|Lost to Follow-up|2|||
161991264|NCT00394706|585018438|FG007|Overall Study|Lost to Follow-up|0|||
161991265|NCT03920254|585018439|FG000|Overall Study|Adverse Event|1|||
161991266|NCT03920254|585018440|FG001|Overall Study|Adverse Event|0|||
161991267|NCT03920254|585018441|FG002|Overall Study|Adverse Event|0|||
161991268|NCT03920254|585018439|FG000|Overall Study|Physician Decision|0|||
161991269|NCT03920254|585018440|FG001|Overall Study|Physician Decision|1|||
161991270|NCT03920254|585018441|FG002|Overall Study|Physician Decision|2|||
161991271|NCT03920254|585018439|FG000|Overall Study|Study Terminated By Sponsor|12|||
161991272|NCT03920254|585018440|FG001|Overall Study|Study Terminated By Sponsor|17|||
161991273|NCT03920254|585018441|FG002|Overall Study|Study Terminated By Sponsor|12|||
161991274|NCT03920254|585018439|FG000|Overall Study|Withdrawal by Subject|0|||
161991275|NCT03920254|585018440|FG001|Overall Study|Withdrawal by Subject|0|||
161991276|NCT03920254|585018441|FG002|Overall Study|Withdrawal by Subject|1|||
161991277|NCT05274269|585018442|FG000|Overall Study|Adverse Event|0|||
161991278|NCT05274269|585018443|FG001|Overall Study|Adverse Event|3|||
161991279|NCT05274269|585018442|FG000|Overall Study|Death|0|||
161991280|NCT05274269|585018443|FG001|Overall Study|Death|1|||
161991281|NCT05274269|585018442|FG000|Overall Study|Other|0|||
161991282|NCT05274269|585018443|FG001|Overall Study|Other|2|||
161991283|NCT05274269|585018442|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
161991284|NCT05274269|585018443|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
161991285|NCT05636852|585018444|FG000|Overall Study|Withdrawal by Subject|1|||
161991286|NCT05636852|585018444|FG000|Overall Study|Other than specified|1|||
161991287|NCT00709618|585018445|FG000|Overall Study|Withdrawal by Subject|4|||
161991288|NCT00709618|585018445|FG000|Overall Study|Lost to Follow-up|1|||
161991289|NCT00709618|585018445|FG000|Overall Study|Study Closed/Terminated|25|||
161991290|NCT01415401|585018453|FG000|Overall Study|Adverse Event|5|||
161991291|NCT01415401|585018453|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
161991292|NCT01415401|585018453|FG000|Overall Study|Terminated by Sponsor|1|||
161991293|NCT01746225|585018455|FG000|Overall Study|Death|1|||
161991294|NCT01746225|585018456|FG001|Overall Study|Death|0|||
161991295|NCT01746225|585018457|FG002|Overall Study|Death|1|||
161991296|NCT01746225|585018455|FG000|Overall Study|Withdrawal by Subject|5|||
161991297|NCT01746225|585018456|FG001|Overall Study|Withdrawal by Subject|15|||
161991298|NCT01746225|585018457|FG002|Overall Study|Withdrawal by Subject|19|||
161991299|NCT01746225|585018455|FG000|Overall Study|Physician Decision|14|||
161991300|NCT01746225|585018456|FG001|Overall Study|Physician Decision|11|||
161991301|NCT01746225|585018457|FG002|Overall Study|Physician Decision|3|||
161991302|NCT01746225|585018455|FG000|Overall Study|Adverse Event|15|||
161991303|NCT01746225|585018456|FG001|Overall Study|Adverse Event|12|||
161991304|NCT01746225|585018457|FG002|Overall Study|Adverse Event|17|||
161991305|NCT01746225|585018455|FG000|Overall Study|Continuing Treatment|5|||
161991306|NCT01746225|585018456|FG001|Overall Study|Continuing Treatment|8|||
161991307|NCT01746225|585018457|FG002|Overall Study|Continuing Treatment|3|||
161991308|NCT00595478|585018458|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
161991309|NCT00595478|585018459|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
161991310|NCT00595478|585018458|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
161991311|NCT00595478|585018459|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
161991312|NCT02713828|585018462|FG000|Overall Study|Death|2|||
161991313|NCT02713828|585018463|FG001|Overall Study|Death|0|||
161991314|NCT02713828|585018462|FG000|Overall Study|Withdrawal by Subject|1|||
161991315|NCT02713828|585018463|FG001|Overall Study|Withdrawal by Subject|0|||
161991316|NCT02713828|585018462|FG000|Overall Study|study terminated but patient allowed to|2|||
161991317|NCT02713828|585018463|FG001|Overall Study|study terminated but patient allowed to|0|||
161991318|NCT03302247|585018464|FG000|Overall Study|the study has closed prematurely|2|||
161991319|NCT03302247|585018464|FG000|Overall Study|Death|1|||
161991320|NCT01019369|585018465|FG000|Overall Study|Lost to Follow-up|10|||
161991321|NCT01019369|585018466|FG001|Overall Study|Lost to Follow-up|6|||
161878222|NCT03613649|584596668|FG007|Second Treatment|Lost to Follow-up|0|||
161878223|NCT03613649|584596669|FG008|Second Treatment|Lost to Follow-up|0|||
161878224|NCT03613649|584596670|FG009|Second Treatment|Lost to Follow-up|0|||
161878225|NCT03613649|584596671|FG010|Second Treatment|Lost to Follow-up|0|||
161878226|NCT03613649|584596672|FG011|Second Treatment|Lost to Follow-up|0|||
161878227|NCT03613649|584596661|FG000|Second Treatment|Withdrawal by Subject|0|||
161878228|NCT03613649|584596662|FG001|Second Treatment|Withdrawal by Subject|0|||
161878229|NCT03613649|584596663|FG002|Second Treatment|Withdrawal by Subject|0|||
161878230|NCT03613649|584596664|FG003|Second Treatment|Withdrawal by Subject|0|||
161878231|NCT03613649|584596665|FG004|Second Treatment|Withdrawal by Subject|1|||
161878232|NCT03613649|584596666|FG005|Second Treatment|Withdrawal by Subject|0|||
161878233|NCT03613649|584596667|FG006|Second Treatment|Withdrawal by Subject|0|||
161878234|NCT03613649|584596668|FG007|Second Treatment|Withdrawal by Subject|0|||
161878235|NCT03613649|584596669|FG008|Second Treatment|Withdrawal by Subject|0|||
161878236|NCT03613649|584596670|FG009|Second Treatment|Withdrawal by Subject|0|||
161878237|NCT03613649|584596671|FG010|Second Treatment|Withdrawal by Subject|0|||
161878238|NCT03613649|584596672|FG011|Second Treatment|Withdrawal by Subject|0|||
161878239|NCT03613649|584596661|FG000|Third Treatment|Lost to Follow-up|0|||
161878240|NCT03613649|584596662|FG001|Third Treatment|Lost to Follow-up|0|||
161878241|NCT03613649|584596663|FG002|Third Treatment|Lost to Follow-up|0|||
161878242|NCT03613649|584596664|FG003|Third Treatment|Lost to Follow-up|0|||
161878243|NCT03613649|584596665|FG004|Third Treatment|Lost to Follow-up|1|||
161878244|NCT03613649|584596666|FG005|Third Treatment|Lost to Follow-up|0|||
161878245|NCT03613649|584596667|FG006|Third Treatment|Lost to Follow-up|0|||
161878246|NCT03613649|584596668|FG007|Third Treatment|Lost to Follow-up|0|||
161878247|NCT03613649|584596669|FG008|Third Treatment|Lost to Follow-up|0|||
161878248|NCT03613649|584596670|FG009|Third Treatment|Lost to Follow-up|0|||
161878249|NCT03613649|584596671|FG010|Third Treatment|Lost to Follow-up|0|||
161878250|NCT03613649|584596672|FG011|Third Treatment|Lost to Follow-up|1|||
161878251|NCT03613649|584596661|FG000|Third Treatment|Protocol Violation|0|||
161878252|NCT03613649|584596662|FG001|Third Treatment|Protocol Violation|0|||
161878253|NCT03613649|584596663|FG002|Third Treatment|Protocol Violation|0|||
161878254|NCT03613649|584596664|FG003|Third Treatment|Protocol Violation|0|||
161878255|NCT03613649|584596665|FG004|Third Treatment|Protocol Violation|0|||
161878256|NCT03613649|584596666|FG005|Third Treatment|Protocol Violation|0|||
161878257|NCT03613649|584596667|FG006|Third Treatment|Protocol Violation|1|||
161878258|NCT03613649|584596668|FG007|Third Treatment|Protocol Violation|0|||
161878259|NCT03613649|584596669|FG008|Third Treatment|Protocol Violation|0|||
161878260|NCT03613649|584596670|FG009|Third Treatment|Protocol Violation|0|||
161878261|NCT03613649|584596671|FG010|Third Treatment|Protocol Violation|0|||
161878262|NCT03613649|584596672|FG011|Third Treatment|Protocol Violation|1|||
161878263|NCT03613649|584596661|FG000|Fourth Treatment|Protocol Violation|1|||
161878264|NCT03613649|584596662|FG001|Fourth Treatment|Protocol Violation|0|||
161878265|NCT03613649|584596663|FG002|Fourth Treatment|Protocol Violation|0|||
161878266|NCT03613649|584596664|FG003|Fourth Treatment|Protocol Violation|0|||
161878267|NCT03613649|584596665|FG004|Fourth Treatment|Protocol Violation|1|||
161878268|NCT03613649|584596666|FG005|Fourth Treatment|Protocol Violation|0|||
161878269|NCT03613649|584596667|FG006|Fourth Treatment|Protocol Violation|0|||
161878270|NCT03613649|584596668|FG007|Fourth Treatment|Protocol Violation|0|||
161878271|NCT03613649|584596669|FG008|Fourth Treatment|Protocol Violation|0|||
161878272|NCT03613649|584596670|FG009|Fourth Treatment|Protocol Violation|0|||
161878273|NCT03613649|584596671|FG010|Fourth Treatment|Protocol Violation|0|||
161878274|NCT03613649|584596672|FG011|Fourth Treatment|Protocol Violation|0|||
161878275|NCT03613649|584596661|FG000|Fourth Treatment|Physician Decision|0|||
161878276|NCT03613649|584596662|FG001|Fourth Treatment|Physician Decision|0|||
161878277|NCT03613649|584596663|FG002|Fourth Treatment|Physician Decision|0|||
161878278|NCT03613649|584596664|FG003|Fourth Treatment|Physician Decision|0|||
161878279|NCT03613649|584596665|FG004|Fourth Treatment|Physician Decision|0|||
161878280|NCT03613649|584596666|FG005|Fourth Treatment|Physician Decision|0|||
161878281|NCT03613649|584596667|FG006|Fourth Treatment|Physician Decision|1|||
161878282|NCT03613649|584596668|FG007|Fourth Treatment|Physician Decision|0|||
161991322|NCT01019369|585018465|FG000|Overall Study|Withdrawal by Subject|0|||
161991323|NCT01019369|585018466|FG001|Overall Study|Withdrawal by Subject|1|||
161991324|NCT00604695|585018467|FG000|Overall Study|Did not receive first bolus.|0|||
161878283|NCT03613649|584596669|FG008|Fourth Treatment|Physician Decision|0|||
161878284|NCT03613649|584596670|FG009|Fourth Treatment|Physician Decision|0|||
161878285|NCT03613649|584596671|FG010|Fourth Treatment|Physician Decision|0|||
161878286|NCT03613649|584596672|FG011|Fourth Treatment|Physician Decision|0|||
161878287|NCT02783729|584596673|FG000|Overall Study|Lack of Efficacy|1|||
161878288|NCT02783729|584596674|FG001|Overall Study|Lack of Efficacy|0|||
161878289|NCT02783729|584596675|FG002|Overall Study|Lack of Efficacy|0|||
161878290|NCT02783729|584596676|FG003|Overall Study|Lack of Efficacy|0|||
161878291|NCT02783729|584596673|FG000|Overall Study|Adverse Event|2|||
161878292|NCT02783729|584596674|FG001|Overall Study|Adverse Event|6|||
161878293|NCT02783729|584596675|FG002|Overall Study|Adverse Event|2|||
161878294|NCT02783729|584596676|FG003|Overall Study|Adverse Event|3|||
161878295|NCT02783729|584596673|FG000|Overall Study|Other|1|||
161878296|NCT02783729|584596674|FG001|Overall Study|Other|6|||
161878297|NCT02783729|584596675|FG002|Overall Study|Other|2|||
161878298|NCT02783729|584596676|FG003|Overall Study|Other|3|||
161878299|NCT02783729|584596673|FG000|Overall Study|Withdrawal by Subject|2|||
161878300|NCT02783729|584596674|FG001|Overall Study|Withdrawal by Subject|3|||
161878301|NCT02783729|584596675|FG002|Overall Study|Withdrawal by Subject|1|||
161878302|NCT02783729|584596676|FG003|Overall Study|Withdrawal by Subject|2|||
161878303|NCT02783729|584596673|FG000|Overall Study|Participant's choice|2|||
161878304|NCT02783729|584596674|FG001|Overall Study|Participant's choice|1|||
161878305|NCT02783729|584596675|FG002|Overall Study|Participant's choice|2|||
161878306|NCT02783729|584596676|FG003|Overall Study|Participant's choice|1|||
161878307|NCT02783729|584596673|FG000|Overall Study|Lost to Follow-up|2|||
161878308|NCT02783729|584596674|FG001|Overall Study|Lost to Follow-up|1|||
161878309|NCT02783729|584596675|FG002|Overall Study|Lost to Follow-up|1|||
161878310|NCT02783729|584596676|FG003|Overall Study|Lost to Follow-up|0|||
161878311|NCT02693171|584596677|FG000|Overall Study|Adverse Event|1|||
161878312|NCT02693171|584596677|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
161878313|NCT00319592|584596679|FG000|Overall Study|Protocol Violation|1|||
161878314|NCT00319592|584596680|FG001|Overall Study|Protocol Violation|0|||
161878315|NCT00319592|584596679|FG000|Overall Study|Physician Decision|0|||
161878316|NCT00319592|584596680|FG001|Overall Study|Physician Decision|1|||
161878317|NCT00750139|584596689|FG000|Overall Study|Adverse Event|1|||
161878318|NCT00750139|584596690|FG001|Overall Study|Adverse Event|2|||
161878319|NCT00750139|584596691|FG002|Overall Study|Adverse Event|0|||
161878320|NCT00750139|584596692|FG003|Overall Study|Adverse Event|1|||
161878321|NCT00750139|584596689|FG000|Overall Study|Lost to Follow-up|17|||
161878322|NCT00750139|584596690|FG001|Overall Study|Lost to Follow-up|12|||
161878323|NCT00750139|584596691|FG002|Overall Study|Lost to Follow-up|15|||
161878324|NCT00750139|584596692|FG003|Overall Study|Lost to Follow-up|6|||
161878325|NCT00750139|584596689|FG000|Overall Study|Withdrawal by Subject|3|||
161878326|NCT00750139|584596690|FG001|Overall Study|Withdrawal by Subject|2|||
161878327|NCT00750139|584596691|FG002|Overall Study|Withdrawal by Subject|6|||
161878328|NCT00750139|584596692|FG003|Overall Study|Withdrawal by Subject|2|||
161878329|NCT00750139|584596689|FG000|Overall Study|Physician Decision|1|||
161878330|NCT00750139|584596690|FG001|Overall Study|Physician Decision|1|||
161878331|NCT00750139|584596691|FG002|Overall Study|Physician Decision|0|||
161878332|NCT00750139|584596692|FG003|Overall Study|Physician Decision|0|||
161878333|NCT00750139|584596689|FG000|Overall Study|Non-compliance|1|||
161878334|NCT00750139|584596690|FG001|Overall Study|Non-compliance|0|||
161878335|NCT00750139|584596691|FG002|Overall Study|Non-compliance|1|||
161878336|NCT00750139|584596692|FG003|Overall Study|Non-compliance|3|||
161878337|NCT00750139|584596689|FG000|Overall Study|Termination by sponsor|4|||
161878338|NCT00750139|584596690|FG001|Overall Study|Termination by sponsor|0|||
161878339|NCT00750139|584596691|FG002|Overall Study|Termination by sponsor|0|||
161878340|NCT00750139|584596692|FG003|Overall Study|Termination by sponsor|1|||
161878341|NCT00750139|584596689|FG000|Overall Study|Non-specific|62|||
161878342|NCT00750139|584596690|FG001|Overall Study|Non-specific|42|||
161878343|NCT00750139|584596691|FG002|Overall Study|Non-specific|79|||
161878344|NCT00750139|584596692|FG003|Overall Study|Non-specific|33|||
161878345|NCT00658775|584596693|FG000|Overall Study|Adverse Event|4|||
161878346|NCT00658775|584596694|FG001|Overall Study|Adverse Event|6|||
161878347|NCT00658775|584596693|FG000|Overall Study|Lost to Follow-up|17|||
161878348|NCT00658775|584596694|FG001|Overall Study|Lost to Follow-up|18|||
161878349|NCT00658775|584596693|FG000|Overall Study|Withdrawal by Subject|6|||
161878350|NCT00658775|584596694|FG001|Overall Study|Withdrawal by Subject|4|||
161878351|NCT00658775|584596693|FG000|Overall Study|Withdrawal of consent|8|||
161878352|NCT00658775|584596694|FG001|Overall Study|Withdrawal of consent|7|||
161878353|NCT00658775|584596693|FG000|Overall Study|Other|7|||
161878354|NCT00658775|584596694|FG001|Overall Study|Other|8|||
161878355|NCT03085238|584596695|FG000|Overall Study|Adverse Event|2|||
161878356|NCT03085238|584596695|FG000|Overall Study|Death|2|||
161878357|NCT03887442|584596700|FG000|Overall Study|Adverse Event|1|||
161878358|NCT03887442|584596701|FG001|Overall Study|Adverse Event|0|||
161878359|NCT00767455|584596702|FG000|Overall Study|Investigator error|19|||
161878360|NCT00746564|584596705|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
161878361|NCT01628198|584596706|FG000|Overall Study|Lost to Follow-up|7|||
161878362|NCT01628198|584596706|FG000|Overall Study|Withdrawal by Subject|10|||
161878363|NCT01628198|584596706|FG000|Overall Study|Screen failure|1|||
161878364|NCT03386994|584596707|FG000|Overall Study|Lung transplant|1|||
161878365|NCT03386994|584596707|FG000|Overall Study|Adverse Event|14|||
161878366|NCT03386994|584596707|FG000|Overall Study|Lost to Follow-up|4|||
161878367|NCT03386994|584596707|FG000|Overall Study|Withdrawal by Subject|3|||
161878368|NCT03386994|584596707|FG000|Overall Study|Death|16|||
161878369|NCT01827267|584596708|FG000|Overall Study|Did not receive study drug|1|||
161878370|NCT01827267|584596709|FG001|Overall Study|Did not receive study drug|1|||
161878371|NCT01827267|584596708|FG000|Overall Study|Physician Decision|1|||
161878372|NCT01827267|584596709|FG001|Overall Study|Physician Decision|0|||
161878373|NCT01827267|584596708|FG000|Overall Study|Disease Progression|1|||
161878374|NCT01827267|584596709|FG001|Overall Study|Disease Progression|1|||
161878375|NCT01827267|584596708|FG000|Overall Study|Sponsor Discontinued Study|2|||
161878376|NCT01827267|584596709|FG001|Overall Study|Sponsor Discontinued Study|8|||
161878377|NCT01827267|584596708|FG000|Overall Study|Still on study|0|||
161878378|NCT01827267|584596709|FG001|Overall Study|Still on study|2|||
161878379|NCT02147158|584596713|FG000|Treatment Course 1|Adverse Event|1|||
161878380|NCT02147158|584596714|FG001|Treatment Course 1|Adverse Event|4|||
161878381|NCT02147158|584596715|FG002|Treatment Course 1|Adverse Event|3|||
161878382|NCT02147158|584596716|FG003|Treatment Course 1|Adverse Event|4|||
161878383|NCT02147158|584596717|FG004|Treatment Course 1|Adverse Event|1|||
161878384|NCT02147158|584596718|FG005|Treatment Course 1|Adverse Event|2|||
161878385|NCT02147158|584596713|FG000|Treatment Course 1|Lost to Follow-up|2|||
161878386|NCT02147158|584596714|FG001|Treatment Course 1|Lost to Follow-up|4|||
161878387|NCT02147158|584596715|FG002|Treatment Course 1|Lost to Follow-up|3|||
161878388|NCT02147158|584596716|FG003|Treatment Course 1|Lost to Follow-up|3|||
161878389|NCT02147158|584596717|FG004|Treatment Course 1|Lost to Follow-up|2|||
161878390|NCT02147158|584596718|FG005|Treatment Course 1|Lost to Follow-up|4|||
161878391|NCT02147158|584596713|FG000|Treatment Course 1|Protocol Violation|0|||
161878392|NCT02147158|584596714|FG001|Treatment Course 1|Protocol Violation|0|||
161878393|NCT02147158|584596715|FG002|Treatment Course 1|Protocol Violation|1|||
161878394|NCT02147158|584596716|FG003|Treatment Course 1|Protocol Violation|1|||
161878395|NCT02147158|584596717|FG004|Treatment Course 1|Protocol Violation|0|||
161878396|NCT02147158|584596718|FG005|Treatment Course 1|Protocol Violation|0|||
161878397|NCT02147158|584596713|FG000|Treatment Course 1|Withdrawal of Consent|1|||
161878398|NCT02147158|584596714|FG001|Treatment Course 1|Withdrawal of Consent|1|||
161878399|NCT02147158|584596715|FG002|Treatment Course 1|Withdrawal of Consent|1|||
161878400|NCT02147158|584596716|FG003|Treatment Course 1|Withdrawal of Consent|5|||
161878401|NCT02147158|584596717|FG004|Treatment Course 1|Withdrawal of Consent|3|||
161878402|NCT02147158|584596718|FG005|Treatment Course 1|Withdrawal of Consent|2|||
161878403|NCT02147158|584596713|FG000|Off-Treatment Interval 1|Adverse Event|1|||
161878404|NCT02147158|584596714|FG001|Off-Treatment Interval 1|Adverse Event|0|||
161878405|NCT02147158|584596715|FG002|Off-Treatment Interval 1|Adverse Event|0|||
161878406|NCT02147158|584596716|FG003|Off-Treatment Interval 1|Adverse Event|1|||
161878407|NCT02147158|584596717|FG004|Off-Treatment Interval 1|Adverse Event|0|||
161878408|NCT02147158|584596718|FG005|Off-Treatment Interval 1|Adverse Event|0|||
161878409|NCT02147158|584596713|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
161878410|NCT02147158|584596714|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
161878411|NCT02147158|584596715|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
161878412|NCT02147158|584596716|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
161878413|NCT02147158|584596717|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
161878414|NCT02147158|584596718|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
161878415|NCT02147158|584596713|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
161878416|NCT02147158|584596714|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
161878417|NCT02147158|584596715|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
161878418|NCT02147158|584596716|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
161878419|NCT02147158|584596717|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
161878420|NCT02147158|584596718|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
161878421|NCT02147158|584596713|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
161878422|NCT02147158|584596714|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
161878423|NCT02147158|584596715|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
161878424|NCT02147158|584596716|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
161878425|NCT02147158|584596717|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
161878426|NCT02147158|584596718|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
161878427|NCT02147158|584596713|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
161878428|NCT02147158|584596714|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
161878429|NCT02147158|584596715|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
161878430|NCT02147158|584596716|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
161878431|NCT02147158|584596717|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
161878432|NCT02147158|584596718|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
161878433|NCT02147158|584596713|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
161878434|NCT02147158|584596714|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
161878435|NCT02147158|584596715|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
161878436|NCT02147158|584596716|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
161878437|NCT02147158|584596717|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
161878438|NCT02147158|584596718|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
161878439|NCT02147158|584596713|FG000|Treatment Course 2|Adverse Event|0|||
161878440|NCT02147158|584596714|FG001|Treatment Course 2|Adverse Event|4|||
161878441|NCT02147158|584596715|FG002|Treatment Course 2|Adverse Event|2|||
161878442|NCT02147158|584596716|FG003|Treatment Course 2|Adverse Event|1|||
161878443|NCT02147158|584596717|FG004|Treatment Course 2|Adverse Event|0|||
161878444|NCT02147158|584596718|FG005|Treatment Course 2|Adverse Event|1|||
161878445|NCT02147158|584596713|FG000|Treatment Course 2|Withdrawal of Consent|0|||
161878446|NCT02147158|584596714|FG001|Treatment Course 2|Withdrawal of Consent|1|||
161878447|NCT02147158|584596715|FG002|Treatment Course 2|Withdrawal of Consent|2|||
161878448|NCT02147158|584596716|FG003|Treatment Course 2|Withdrawal of Consent|3|||
161878449|NCT02147158|584596717|FG004|Treatment Course 2|Withdrawal of Consent|0|||
161878450|NCT02147158|584596718|FG005|Treatment Course 2|Withdrawal of Consent|0|||
161878451|NCT02147158|584596713|FG000|Treatment Course 2|Lost to Follow-up|1|||
161878452|NCT02147158|584596714|FG001|Treatment Course 2|Lost to Follow-up|0|||
161878453|NCT02147158|584596715|FG002|Treatment Course 2|Lost to Follow-up|1|||
161878454|NCT02147158|584596716|FG003|Treatment Course 2|Lost to Follow-up|1|||
161878455|NCT02147158|584596717|FG004|Treatment Course 2|Lost to Follow-up|0|||
161878456|NCT02147158|584596718|FG005|Treatment Course 2|Lost to Follow-up|1|||
161878457|NCT02147158|584596713|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
161878458|NCT02147158|584596714|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
161878459|NCT02147158|584596715|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
161878460|NCT02147158|584596716|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
161878461|NCT02147158|584596717|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
161878462|NCT02147158|584596718|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
161878463|NCT02147158|584596713|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
161878464|NCT02147158|584596714|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
161878465|NCT02147158|584596715|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
161878466|NCT02147158|584596716|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
161878467|NCT02147158|584596717|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
161878468|NCT02147158|584596718|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
161878469|NCT02147158|584596713|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
161878470|NCT02147158|584596714|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
161878471|NCT02147158|584596715|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
161878472|NCT02147158|584596716|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
161878473|NCT02147158|584596717|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
161878474|NCT02147158|584596718|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
161878475|NCT02147158|584596713|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
161878476|NCT02147158|584596714|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
161878477|NCT02147158|584596715|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
161878478|NCT02147158|584596716|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
161878479|NCT02147158|584596717|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
161878480|NCT02147158|584596718|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
161878481|NCT02147158|584596713|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
161878482|NCT02147158|584596714|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
161878483|NCT02147158|584596715|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
161878484|NCT02147158|584596716|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
161878485|NCT02147158|584596717|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
161878486|NCT02147158|584596718|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
161878487|NCT04520997|584596719|FG000|Overall Study|Lost to Follow-up|1|||
161878488|NCT04520997|584596720|FG001|Overall Study|Lost to Follow-up|1|||
161878489|NCT04520997|584596719|FG000|Overall Study|Withdrawal by Subject|1|||
161878490|NCT04520997|584596720|FG001|Overall Study|Withdrawal by Subject|0|||
161878491|NCT04520997|584596719|FG000|Overall Study|Not Treated|0|||
161878492|NCT04520997|584596720|FG001|Overall Study|Not Treated|1|||
161878493|NCT03689374|584596721|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
161878494|NCT03689374|584596722|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
161878495|NCT03689374|584596723|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
161878496|NCT03689374|584596721|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
161878497|NCT03689374|584596722|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
161878498|NCT03689374|584596723|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
161878499|NCT03689374|584596721|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
161878500|NCT03689374|584596722|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
161878501|NCT03689374|584596723|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
161878502|NCT03689374|584596721|FG000|Treatment Period (Week 0 to 52)|Death|0|||
161878503|NCT03689374|584596722|FG001|Treatment Period (Week 0 to 52)|Death|11|||
161878504|NCT03689374|584596723|FG002|Treatment Period (Week 0 to 52)|Death|1|||
161878505|NCT05367973|584596724|FG000|Overall Study|Adverse Event|0|||
161878506|NCT05367973|584596725|FG001|Overall Study|Adverse Event|2|||
161878507|NCT00986921|584596726|FG000|Overall Study|Physician Decision|1|||
161878508|NCT00986921|584596727|FG001|Overall Study|Physician Decision|0|||
161878509|NCT01758731|584596728|FG000|Overall Study|Physician Decision|1|||
161878510|NCT04445714|584596729|FG000|Overall Study|Discontinuation of the study|14|||
161878511|NCT04445714|584596729|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
161878512|NCT04445714|584596729|FG000|Overall Study|Withdrawal of Informed Consent|8|||
161878513|NCT02396420|584596734|FG000|Overall Study|Death|1|||
161878514|NCT01273623|584596735|FG000|Overall Study|did not meet IVUS criteria|29|||
161878515|NCT02122887|584596743|FG000|Overall Study|Withdrawal by Subject|20|||
161878516|NCT02122887|584596744|FG001|Overall Study|Withdrawal by Subject|2|||
161878517|NCT05903924|584598688|FG000|Overall Study|Lost to Follow-up|1|||
161878518|NCT05903924|584598689|FG001|Overall Study|Lost to Follow-up|0|||
161878519|NCT05903924|584598690|FG002|Overall Study|Lost to Follow-up|0|||
161878520|NCT04338269|584598691|FG000|Overall Study|Death|86|||
161878521|NCT04338269|584598692|FG001|Overall Study|Death|89|||
161878522|NCT04338269|584598691|FG000|Overall Study|Lost to Follow-up|1|||
161878523|NCT04338269|584598692|FG001|Overall Study|Lost to Follow-up|2|||
161878524|NCT04338269|584598691|FG000|Overall Study|Physician Decision|1|||
161878525|NCT04338269|584598692|FG001|Overall Study|Physician Decision|0|||
161878526|NCT04338269|584598691|FG000|Overall Study|Withdrawal by Subject|14|||
161878527|NCT04338269|584598692|FG001|Overall Study|Withdrawal by Subject|11|||
161878528|NCT00174967|584598693|FG000|Overall Study|Adverse Event|1|||
161878529|NCT00174967|584598694|FG001|Overall Study|Adverse Event|2|||
161878530|NCT00174967|584598695|FG002|Overall Study|Adverse Event|2|||
161878531|NCT00174967|584598696|FG003|Overall Study|Adverse Event|1|||
161878532|NCT00174967|584598693|FG000|Overall Study|Gout Flare|0|||
161878533|NCT00174967|584598694|FG001|Overall Study|Gout Flare|0|||
161878534|NCT00174967|584598695|FG002|Overall Study|Gout Flare|0|||
161878535|NCT00174967|584598696|FG003|Overall Study|Gout Flare|1|||
161878536|NCT00174967|584598693|FG000|Overall Study|Other|0|||
161878537|NCT00174967|584598694|FG001|Overall Study|Other|1|||
161878538|NCT00174967|584598695|FG002|Overall Study|Other|0|||
161878539|NCT00174967|584598696|FG003|Overall Study|Other|0|||
161878540|NCT03030989|584598697|FG000|Overall Study|Fever|2|||
161878541|NCT03030989|584598698|FG001|Overall Study|Fever|2|||
161878542|NCT03030989|584598697|FG000|Overall Study|Rash|2|||
161878543|NCT03030989|584598698|FG001|Overall Study|Rash|1|||
161878544|NCT03030989|584598697|FG000|Overall Study|Fatigue/Overwhelmed|1|||
161878545|NCT03030989|584598698|FG001|Overall Study|Fatigue/Overwhelmed|5|||
161878546|NCT03030989|584598697|FG000|Overall Study|Positive Blood Cultures|2|||
161878547|NCT03030989|584598698|FG001|Overall Study|Positive Blood Cultures|1|||
161878548|NCT03030989|584598697|FG000|Overall Study|Line Removed|0|||
161878549|NCT03030989|584598698|FG001|Overall Study|Line Removed|2|||
161878550|NCT03030989|584598697|FG000|Overall Study|No longer interested|5|||
161878551|NCT03030989|584598698|FG001|Overall Study|No longer interested|3|||
161878552|NCT02730377|584598699|FG000|Overall Study|Other|5|||
161878553|NCT02730377|584598700|FG001|Overall Study|Other|4|||
161878554|NCT02730377|584598699|FG000|Overall Study|Death|1|||
161878555|NCT02730377|584598700|FG001|Overall Study|Death|8|||
161878556|NCT02730377|584598699|FG000|Overall Study|Inadequate glycaemic control|368|||
161878557|NCT02730377|584598700|FG001|Overall Study|Inadequate glycaemic control|473|||
161878558|NCT02730377|584598699|FG000|Overall Study|Adverse Event|79|||
161878559|NCT02730377|584598700|FG001|Overall Study|Adverse Event|41|||
161878560|NCT02730377|584598699|FG000|Overall Study|Protocol Violation|23|||
161878561|NCT02730377|584598700|FG001|Overall Study|Protocol Violation|30|||
161878562|NCT02730377|584598699|FG000|Overall Study|Lack of Efficacy|4|||
161878563|NCT02730377|584598700|FG001|Overall Study|Lack of Efficacy|13|||
161878564|NCT02730377|584598699|FG000|Overall Study|Pregnancy|0|||
161878565|NCT02730377|584598700|FG001|Overall Study|Pregnancy|1|||
161878566|NCT02730377|584598699|FG000|Overall Study|Withdrawal by Subject|45|||
161878567|NCT02730377|584598700|FG001|Overall Study|Withdrawal by Subject|42|||
161878568|NCT02730377|584598699|FG000|Overall Study|Lost to Follow-up|25|||
161878569|NCT02730377|584598700|FG001|Overall Study|Lost to Follow-up|21|||
161878570|NCT02706886|584598701|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
161878571|NCT02706886|584598702|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
161878572|NCT02706886|584598703|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
161878573|NCT02706886|584598704|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
161878574|NCT02706886|584598705|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
161878575|NCT02706886|584598706|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
161878576|NCT02706886|584598707|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
161878577|NCT02706886|584598708|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
161878578|NCT02706886|584598709|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
161878579|NCT04934189|584598710|FG000|Overall Study|Lost to Follow-up|4|||
161878580|NCT04934189|584598710|FG000|Overall Study|Withdrawal by Subject|17|||
161878581|NCT03320850|584598711|FG000|Overall Study|Lost to Follow-up|0|||
161878582|NCT03320850|584598712|FG001|Overall Study|Lost to Follow-up|0|||
161878583|NCT03320850|584598713|FG002|Overall Study|Lost to Follow-up|0|||
161878584|NCT03320850|584598714|FG003|Overall Study|Lost to Follow-up|0|||
161878585|NCT03320850|584598715|FG004|Overall Study|Lost to Follow-up|1|||
161878586|NCT03320850|584598716|FG005|Overall Study|Lost to Follow-up|2|||
161878587|NCT03320850|584598717|FG006|Overall Study|Lost to Follow-up|2|||
161878588|NCT03320850|584598718|FG007|Overall Study|Lost to Follow-up|0|||
161878589|NCT03320850|584598719|FG008|Overall Study|Lost to Follow-up|6|||
161878590|NCT03320850|584598720|FG009|Overall Study|Lost to Follow-up|4|||
161878591|NCT03320850|584598711|FG000|Overall Study|Withdrawal by Subject|0|||
161878592|NCT03320850|584598712|FG001|Overall Study|Withdrawal by Subject|0|||
161878593|NCT03320850|584598713|FG002|Overall Study|Withdrawal by Subject|0|||
161878594|NCT03320850|584598714|FG003|Overall Study|Withdrawal by Subject|0|||
161878595|NCT03320850|584598715|FG004|Overall Study|Withdrawal by Subject|1|||
161878596|NCT03320850|584598716|FG005|Overall Study|Withdrawal by Subject|2|||
161878597|NCT03320850|584598717|FG006|Overall Study|Withdrawal by Subject|4|||
161878598|NCT03320850|584598718|FG007|Overall Study|Withdrawal by Subject|5|||
161878599|NCT03320850|584598719|FG008|Overall Study|Withdrawal by Subject|2|||
161878600|NCT03320850|584598720|FG009|Overall Study|Withdrawal by Subject|1|||
161878601|NCT03320850|584598711|FG000|Overall Study|Lack of Efficacy|0|||
161878602|NCT03320850|584598712|FG001|Overall Study|Lack of Efficacy|0|||
161878603|NCT03320850|584598713|FG002|Overall Study|Lack of Efficacy|0|||
161878604|NCT03320850|584598714|FG003|Overall Study|Lack of Efficacy|1|||
161878605|NCT03320850|584598715|FG004|Overall Study|Lack of Efficacy|0|||
161878606|NCT03320850|584598716|FG005|Overall Study|Lack of Efficacy|1|||
161878607|NCT03320850|584598717|FG006|Overall Study|Lack of Efficacy|0|||
161878608|NCT03320850|584598718|FG007|Overall Study|Lack of Efficacy|2|||
161878609|NCT03320850|584598719|FG008|Overall Study|Lack of Efficacy|0|||
161878610|NCT03320850|584598720|FG009|Overall Study|Lack of Efficacy|3|||
161878611|NCT03320850|584598711|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
161878612|NCT03320850|584598712|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
161878613|NCT03320850|584598713|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
161878614|NCT03320850|584598714|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
161878615|NCT03320850|584598715|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
161878616|NCT03320850|584598716|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
161878617|NCT03320850|584598717|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
161878618|NCT03320850|584598718|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
161878619|NCT03320850|584598719|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
161878620|NCT03320850|584598720|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
161878621|NCT03320850|584598711|FG000|Overall Study|Adverse Event|0|||
161878622|NCT03320850|584598712|FG001|Overall Study|Adverse Event|0|||
161878623|NCT03320850|584598713|FG002|Overall Study|Adverse Event|0|||
161878624|NCT03320850|584598714|FG003|Overall Study|Adverse Event|0|||
161878625|NCT03320850|584598715|FG004|Overall Study|Adverse Event|0|||
161878626|NCT03320850|584598716|FG005|Overall Study|Adverse Event|2|||
161878627|NCT03320850|584598717|FG006|Overall Study|Adverse Event|1|||
161878628|NCT03320850|584598718|FG007|Overall Study|Adverse Event|0|||
161878629|NCT03320850|584598719|FG008|Overall Study|Adverse Event|2|||
161878630|NCT03320850|584598720|FG009|Overall Study|Adverse Event|0|||
161878631|NCT03320850|584598711|FG000|Overall Study|Reason Not Specified|0|||
161878632|NCT03320850|584598712|FG001|Overall Study|Reason Not Specified|0|||
161878633|NCT03320850|584598713|FG002|Overall Study|Reason Not Specified|0|||
161878634|NCT03320850|584598714|FG003|Overall Study|Reason Not Specified|0|||
161878635|NCT03320850|584598715|FG004|Overall Study|Reason Not Specified|0|||
161878636|NCT03320850|584598716|FG005|Overall Study|Reason Not Specified|1|||
161878637|NCT03320850|584598717|FG006|Overall Study|Reason Not Specified|0|||
161878638|NCT03320850|584598718|FG007|Overall Study|Reason Not Specified|0|||
161878639|NCT03320850|584598719|FG008|Overall Study|Reason Not Specified|0|||
161878640|NCT03320850|584598720|FG009|Overall Study|Reason Not Specified|1|||
161878641|NCT02002533|584598723|FG000|Overall Study|Withdrawal by Subject|6|||
161878642|NCT02002533|584598724|FG001|Overall Study|Withdrawal by Subject|13|||
161878643|NCT02002533|584598723|FG000|Overall Study|Protocol Violation|0|||
161878644|NCT02002533|584598724|FG001|Overall Study|Protocol Violation|1|||
161878645|NCT02002533|584598723|FG000|Overall Study|Adverse Event|0|||
161878646|NCT02002533|584598724|FG001|Overall Study|Adverse Event|3|||
161878647|NCT02002533|584598723|FG000|Overall Study|Lost to Follow-up|0|||
161878648|NCT02002533|584598724|FG001|Overall Study|Lost to Follow-up|1|||
161878649|NCT02086448|584598730|FG000|Overall Study|Withdrawal by Subject|1|||
161878650|NCT02086448|584598731|FG001|Overall Study|Withdrawal by Subject|0|||
161878651|NCT02086448|584598732|FG002|Overall Study|Withdrawal by Subject|0|||
161878652|NCT02086448|584598733|FG003|Overall Study|Withdrawal by Subject|2|||
161878653|NCT02031640|584598744|FG000|Screening Period|Adverse Event|1|||
161878654|NCT02031640|584598745|FG001|Screening Period|Adverse Event|0|||
161878655|NCT02031640|584598746|FG002|Screening Period|Adverse Event|0|||
161878656|NCT02031640|584598747|FG003|Screening Period|Adverse Event|0|||
161878657|NCT02031640|584598748|FG004|Screening Period|Adverse Event|0|||
161878658|NCT02031640|584598749|FG005|Screening Period|Adverse Event|0|||
161878659|NCT02031640|584598744|FG000|Screening Period|Withdrawal by Subject|29|||
161878660|NCT02031640|584598745|FG001|Screening Period|Withdrawal by Subject|0|||
161878661|NCT02031640|584598746|FG002|Screening Period|Withdrawal by Subject|0|||
161878662|NCT02031640|584598747|FG003|Screening Period|Withdrawal by Subject|0|||
161878663|NCT02031640|584598748|FG004|Screening Period|Withdrawal by Subject|0|||
161878664|NCT02031640|584598749|FG005|Screening Period|Withdrawal by Subject|0|||
161878665|NCT02031640|584598744|FG000|Screening Period|Inclusion criteria not met|312|||
161878666|NCT02031640|584598745|FG001|Screening Period|Inclusion criteria not met|0|||
161878667|NCT02031640|584598746|FG002|Screening Period|Inclusion criteria not met|0|||
161878668|NCT02031640|584598747|FG003|Screening Period|Inclusion criteria not met|0|||
161878669|NCT02031640|584598748|FG004|Screening Period|Inclusion criteria not met|0|||
161878670|NCT02031640|584598749|FG005|Screening Period|Inclusion criteria not met|0|||
161878671|NCT02031640|584598744|FG000|Screening Period|Exclusion criteria met|30|||
161878672|NCT02031640|584598745|FG001|Screening Period|Exclusion criteria met|0|||
161878673|NCT02031640|584598746|FG002|Screening Period|Exclusion criteria met|0|||
161878674|NCT02031640|584598747|FG003|Screening Period|Exclusion criteria met|0|||
161878675|NCT02031640|584598748|FG004|Screening Period|Exclusion criteria met|0|||
161878676|NCT02031640|584598749|FG005|Screening Period|Exclusion criteria met|0|||
161878677|NCT02031640|584598744|FG000|Screening Period|Lost to Follow-up|14|||
161878678|NCT02031640|584598745|FG001|Screening Period|Lost to Follow-up|0|||
161878679|NCT02031640|584598746|FG002|Screening Period|Lost to Follow-up|0|||
161878680|NCT02031640|584598747|FG003|Screening Period|Lost to Follow-up|0|||
161878681|NCT02031640|584598748|FG004|Screening Period|Lost to Follow-up|0|||
161878682|NCT02031640|584598749|FG005|Screening Period|Lost to Follow-up|0|||
161878683|NCT02031640|584598744|FG000|Screening Period|Enrollment closed|26|||
161878684|NCT02031640|584598745|FG001|Screening Period|Enrollment closed|0|||
161878685|NCT02031640|584598746|FG002|Screening Period|Enrollment closed|0|||
161878686|NCT02031640|584598747|FG003|Screening Period|Enrollment closed|0|||
161878687|NCT02031640|584598748|FG004|Screening Period|Enrollment closed|0|||
161878688|NCT02031640|584598749|FG005|Screening Period|Enrollment closed|0|||
161878689|NCT02031640|584598744|FG000|Run-In Period|Adverse Event|4|||
161878690|NCT02031640|584598745|FG001|Run-In Period|Adverse Event|0|||
161878691|NCT02031640|584598746|FG002|Run-In Period|Adverse Event|0|||
161878692|NCT02031640|584598747|FG003|Run-In Period|Adverse Event|0|||
161878693|NCT02031640|584598748|FG004|Run-In Period|Adverse Event|0|||
161878694|NCT02031640|584598749|FG005|Run-In Period|Adverse Event|0|||
161878695|NCT02031640|584598744|FG000|Run-In Period|Withdrawal by Subject|17|||
161878696|NCT02031640|584598745|FG001|Run-In Period|Withdrawal by Subject|0|||
161878697|NCT02031640|584598746|FG002|Run-In Period|Withdrawal by Subject|0|||
161878698|NCT02031640|584598747|FG003|Run-In Period|Withdrawal by Subject|0|||
161878699|NCT02031640|584598748|FG004|Run-In Period|Withdrawal by Subject|0|||
161878700|NCT02031640|584598749|FG005|Run-In Period|Withdrawal by Subject|0|||
161878701|NCT02031640|584598744|FG000|Run-In Period|Inclusion criteria not met|38|||
161878702|NCT02031640|584598745|FG001|Run-In Period|Inclusion criteria not met|0|||
161878703|NCT02031640|584598746|FG002|Run-In Period|Inclusion criteria not met|0|||
161878704|NCT02031640|584598747|FG003|Run-In Period|Inclusion criteria not met|0|||
161878705|NCT02031640|584598748|FG004|Run-In Period|Inclusion criteria not met|0|||
161878706|NCT02031640|584598749|FG005|Run-In Period|Inclusion criteria not met|0|||
161878707|NCT02031640|584598744|FG000|Run-In Period|Exclusion criteria met|8|||
161878708|NCT02031640|584598745|FG001|Run-In Period|Exclusion criteria met|0|||
161878709|NCT02031640|584598746|FG002|Run-In Period|Exclusion criteria met|0|||
161878710|NCT02031640|584598747|FG003|Run-In Period|Exclusion criteria met|0|||
161878711|NCT02031640|584598748|FG004|Run-In Period|Exclusion criteria met|0|||
161878712|NCT02031640|584598749|FG005|Run-In Period|Exclusion criteria met|0|||
161878713|NCT02031640|584598744|FG000|Run-In Period|Randomization criteria not met|85|||
161878714|NCT02031640|584598745|FG001|Run-In Period|Randomization criteria not met|0|||
161878715|NCT02031640|584598746|FG002|Run-In Period|Randomization criteria not met|0|||
161878716|NCT02031640|584598747|FG003|Run-In Period|Randomization criteria not met|0|||
161878717|NCT02031640|584598748|FG004|Run-In Period|Randomization criteria not met|0|||
161878718|NCT02031640|584598749|FG005|Run-In Period|Randomization criteria not met|0|||
161878719|NCT02031640|584598744|FG000|Run-In Period|Various administrative reasons|17|||
161878720|NCT02031640|584598745|FG001|Run-In Period|Various administrative reasons|0|||
161878721|NCT02031640|584598746|FG002|Run-In Period|Various administrative reasons|0|||
161878722|NCT02031640|584598747|FG003|Run-In Period|Various administrative reasons|0|||
161878723|NCT02031640|584598748|FG004|Run-In Period|Various administrative reasons|0|||
161878724|NCT02031640|584598749|FG005|Run-In Period|Various administrative reasons|0|||
161878725|NCT02031640|584598744|FG000|Double-blind Treatment Period|Protocol deviation|0|||
161878726|NCT02031640|584598745|FG001|Double-blind Treatment Period|Protocol deviation|2|||
161878727|NCT02031640|584598746|FG002|Double-blind Treatment Period|Protocol deviation|0|||
161878728|NCT02031640|584598747|FG003|Double-blind Treatment Period|Protocol deviation|1|||
161878729|NCT02031640|584598748|FG004|Double-blind Treatment Period|Protocol deviation|3|||
161878730|NCT02031640|584598749|FG005|Double-blind Treatment Period|Protocol deviation|1|||
161878731|NCT02031640|584598744|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161878732|NCT02031640|584598745|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
161878733|NCT02031640|584598746|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
161878734|NCT02031640|584598747|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
161878735|NCT02031640|584598748|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
161878736|NCT02031640|584598749|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
161878737|NCT02031640|584598744|FG000|Double-blind Treatment Period|Non-compliance|0|||
161878738|NCT02031640|584598745|FG001|Double-blind Treatment Period|Non-compliance|1|||
161878739|NCT02031640|584598746|FG002|Double-blind Treatment Period|Non-compliance|0|||
161878740|NCT02031640|584598747|FG003|Double-blind Treatment Period|Non-compliance|1|||
161878741|NCT02031640|584598748|FG004|Double-blind Treatment Period|Non-compliance|1|||
161991325|NCT00604695|585018468|FG001|Overall Study|Did not receive first bolus.|4|||
161991326|NCT04310566|585018471|FG000|Period 1|Study Termination due to COVID-19|15|||
161991327|NCT04310566|585018472|FG001|Period 1|Study Termination due to COVID-19|17|||
161991328|NCT04310566|585018471|FG000|Period 1|Protocol Violation|0|||
161878742|NCT02031640|584598749|FG005|Double-blind Treatment Period|Non-compliance|0|||
161878743|NCT02031640|584598744|FG000|Double-blind Treatment Period|Adverse Event|0|||
161878744|NCT02031640|584598745|FG001|Double-blind Treatment Period|Adverse Event|0|||
161878745|NCT02031640|584598746|FG002|Double-blind Treatment Period|Adverse Event|0|||
161878746|NCT02031640|584598747|FG003|Double-blind Treatment Period|Adverse Event|2|||
161878747|NCT02031640|584598748|FG004|Double-blind Treatment Period|Adverse Event|0|||
161878748|NCT02031640|584598749|FG005|Double-blind Treatment Period|Adverse Event|0|||
161878749|NCT02031640|584598744|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
161878750|NCT02031640|584598745|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161878751|NCT02031640|584598746|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
161878752|NCT02031640|584598747|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
161878753|NCT02031640|584598748|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
161878754|NCT02031640|584598749|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
161878755|NCT02031640|584598744|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161878756|NCT02031640|584598745|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
161878757|NCT02031640|584598746|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
161878758|NCT02031640|584598747|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
161878759|NCT02031640|584598748|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
161878760|NCT02031640|584598749|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
161878761|NCT01194999|584598752|FG000|Overall Study|Lost to Follow-up|17|||
161878762|NCT01895270|584598753|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
161878763|NCT01895270|584598754|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
161878764|NCT01895270|584598753|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
161878765|NCT01895270|584598754|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
161878766|NCT01895270|584598753|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
161878767|NCT01895270|584598754|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
161878768|NCT01895270|584598753|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
161878769|NCT01895270|584598754|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
161878770|NCT01895270|584598753|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
161878771|NCT01895270|584598754|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
161878772|NCT01895270|584598753|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
161878773|NCT01895270|584598754|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
161878774|NCT01895270|584598753|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
161878775|NCT01895270|584598754|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
161878776|NCT02091375|584598757|FG000|Overall Study|Adverse Event|8|||
161878777|NCT02091375|584598758|FG001|Overall Study|Adverse Event|1|||
161878778|NCT02091375|584598757|FG000|Overall Study|Lost to Follow-up|0|||
161878779|NCT02091375|584598758|FG001|Overall Study|Lost to Follow-up|1|||
161878780|NCT02091375|584598757|FG000|Overall Study|Withdrawal by Subject|0|||
161878781|NCT02091375|584598758|FG001|Overall Study|Withdrawal by Subject|1|||
161878782|NCT02091375|584598757|FG000|Overall Study|Withdrawn by the investigator|1|||
161878783|NCT02091375|584598758|FG001|Overall Study|Withdrawn by the investigator|0|||
161878784|NCT03781583|584598762|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
161878785|NCT03781583|584598763|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
161878786|NCT03781583|584598764|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
161878787|NCT03781583|584598765|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
161878788|NCT03781583|584598762|FG000|Overall Study|Technology did not work for that person in that environment|1|||
161878789|NCT03781583|584598763|FG001|Overall Study|Technology did not work for that person in that environment|0|||
161878790|NCT03781583|584598764|FG002|Overall Study|Technology did not work for that person in that environment|0|||
161878791|NCT03781583|584598765|FG003|Overall Study|Technology did not work for that person in that environment|0|||
161878792|NCT03781583|584598762|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
161878793|NCT03781583|584598763|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
161878794|NCT03781583|584598764|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
161878795|NCT03781583|584598765|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
161878796|NCT03781583|584598762|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
161878797|NCT03781583|584598763|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
161878798|NCT03781583|584598764|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
161878799|NCT03781583|584598765|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
161878800|NCT01938430|584598767|FG000|Overall Study|Randomized but Not Treated|0|||
161878801|NCT01938430|584598768|FG001|Overall Study|Randomized but Not Treated|0|||
161878802|NCT01938430|584598769|FG002|Overall Study|Randomized but Not Treated|0|||
161878803|NCT01938430|584598770|FG003|Overall Study|Randomized but Not Treated|0|||
161878804|NCT01938430|584598771|FG004|Overall Study|Randomized but Not Treated|0|||
161878805|NCT01938430|584598772|FG005|Overall Study|Randomized but Not Treated|0|||
161878806|NCT01938430|584598773|FG006|Overall Study|Randomized but Not Treated|0|||
161878807|NCT01938430|584598774|FG007|Overall Study|Randomized but Not Treated|0|||
161991329|NCT04310566|585018472|FG001|Period 1|Protocol Violation|1|||
161991330|NCT04310566|585018471|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
161991331|NCT04310566|585018472|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
161991332|NCT04310566|585018471|FG000|Period 1|Lost to Follow-up|1|||
161991333|NCT04310566|585018472|FG001|Period 1|Lost to Follow-up|0|||
161991334|NCT04310566|585018471|FG000|Period 1|Withdrawal by Subject|0|||
161991335|NCT04310566|585018472|FG001|Period 1|Withdrawal by Subject|1|||
161991336|NCT04310566|585018471|FG000|Period 2|Study Termination|7|||
161991337|NCT04310566|585018472|FG001|Period 2|Study Termination|5|||
161991338|NCT04677504|585018474|FG000|Overall Study|Death|51|||
161991339|NCT04677504|585018475|FG001|Overall Study|Death|49|||
161991340|NCT04677504|585018474|FG000|Overall Study|Progressive Disease|1|||
161991341|NCT04677504|585018475|FG001|Overall Study|Progressive Disease|0|||
161991342|NCT04677504|585018474|FG000|Overall Study|Symptomatic Deterioration|1|||
161991343|NCT04677504|585018475|FG001|Overall Study|Symptomatic Deterioration|0|||
161991344|NCT04677504|585018474|FG000|Overall Study|Withdrawal by Subject|2|||
161991345|NCT04677504|585018475|FG001|Overall Study|Withdrawal by Subject|5|||
161991346|NCT04677504|585018474|FG000|Overall Study|Study Terminated By Sponsor|28|||
161991347|NCT04677504|585018475|FG001|Overall Study|Study Terminated By Sponsor|24|||
161991348|NCT04677504|585018474|FG000|Overall Study|Adverse Event|0|||
161991349|NCT04677504|585018475|FG001|Overall Study|Adverse Event|1|||
161991350|NCT03182907|585018476|FG000|Overall Study|Death|3|||
161991351|NCT03182907|585018477|FG001|Overall Study|Death|0|||
161991352|NCT03182907|585018476|FG000|Overall Study|Protocol Violation|4|||
161991353|NCT03182907|585018477|FG001|Overall Study|Protocol Violation|0|||
161991354|NCT03182907|585018476|FG000|Overall Study|Lost to Follow-up|1|||
161991355|NCT03182907|585018477|FG001|Overall Study|Lost to Follow-up|0|||
161991356|NCT03182907|585018476|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161991357|NCT03182907|585018477|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161991358|NCT01711645|585018480|FG000|Overall Study|Withdrawal by Subject|8|||
161991359|NCT01711645|585018480|FG000|Overall Study|Lost to Follow-up|6|||
161991360|NCT01711645|585018480|FG000|Overall Study|Physician Decision|5|||
161991361|NCT01746173|585018485|FG000|Overall Study|Disease Progression|2|||
161991362|NCT00172042|585018487|FG000|Overall Study|Adverse Event|27|||
161991363|NCT00172042|585018488|FG001|Overall Study|Adverse Event|13|||
161991364|NCT00172042|585018487|FG000|Overall Study|Abnormal laboratory value(s)|5|||
161777239|NCT00943826|584225530|FG001|Monotherapy Phase|Withdrew Consent|3|||
161777240|NCT00943826|584225529|FG000|Monotherapy Phase|Failure to return|2|||
161777241|NCT00943826|584225530|FG001|Monotherapy Phase|Failure to return|1|||
161777242|NCT00943826|584225529|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
161777243|NCT00943826|584225530|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
161777244|NCT00943826|584225529|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
161777245|NCT00943826|584225530|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
161777246|NCT00943826|584225529|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
161777247|NCT00943826|584225530|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
161777248|NCT00943826|584225529|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
161777249|NCT00943826|584225530|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
161777250|NCT04764669|584225531|FG000|Overall Study|Adverse Event|1|||
161777251|NCT04764669|584225532|FG001|Overall Study|Adverse Event|0|||
161777252|NCT04764669|584225533|FG002|Overall Study|Adverse Event|1|||
161777253|NCT04764669|584225534|FG003|Overall Study|Adverse Event|0|||
161777254|NCT04764669|584225531|FG000|Overall Study|Subject Choice|0|||
161777255|NCT04764669|584225532|FG001|Overall Study|Subject Choice|0|||
161777256|NCT04764669|584225533|FG002|Overall Study|Subject Choice|1|||
161777257|NCT04764669|584225534|FG003|Overall Study|Subject Choice|0|||
161777258|NCT04764669|584225531|FG000|Overall Study|Withdrawal by Subject|2|||
161777259|NCT04764669|584225532|FG001|Overall Study|Withdrawal by Subject|0|||
161777260|NCT04764669|584225533|FG002|Overall Study|Withdrawal by Subject|0|||
161777261|NCT04764669|584225534|FG003|Overall Study|Withdrawal by Subject|0|||
161777262|NCT00592007|584225536|FG000|Overall Study|Withdrawal by Subject|1|||
161777263|NCT00592007|584225536|FG000|Overall Study|patient ineligible (out of lab range)|1|||
161777264|NCT01275170|584225538|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
161777265|NCT01275170|584225539|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777266|NCT01275170|584225540|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777267|NCT01275170|584225541|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777268|NCT01275170|584225542|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777269|NCT01275170|584225543|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777270|NCT01275170|584225544|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777271|NCT01275170|584225545|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
161777272|NCT00605839|584225546|FG000|Overall Study|Protocol Violation|1|||
161777273|NCT00605839|584225547|FG001|Overall Study|Protocol Violation|0|||
161777274|NCT00605839|584225548|FG002|Overall Study|Protocol Violation|0|||
161777275|NCT04636437|584225552|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
161777276|NCT04636437|584225553|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
161777277|NCT04636437|584225554|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
161777278|NCT04636437|584225552|FG000|Overall Study|Started weight loss drug/program|2|||
161878808|NCT01938430|584598775|FG008|Overall Study|Randomized but Not Treated|0|||
161878809|NCT01938430|584598776|FG009|Overall Study|Randomized but Not Treated|0|||
161878810|NCT01938430|584598777|FG010|Overall Study|Randomized but Not Treated|1|||
161878811|NCT01938430|584598778|FG011|Overall Study|Randomized but Not Treated|0|||
161878812|NCT01938430|584598779|FG012|Overall Study|Randomized but Not Treated|0|||
161878813|NCT01938430|584598780|FG013|Overall Study|Randomized but Not Treated|1|||
161878814|NCT01938430|584598767|FG000|Overall Study|Adverse Event|0|||
161878815|NCT01938430|584598768|FG001|Overall Study|Adverse Event|0|||
161878816|NCT01938430|584598769|FG002|Overall Study|Adverse Event|0|||
161878817|NCT01938430|584598770|FG003|Overall Study|Adverse Event|0|||
161878818|NCT01938430|584598771|FG004|Overall Study|Adverse Event|0|||
161878819|NCT01938430|584598772|FG005|Overall Study|Adverse Event|0|||
161878820|NCT01938430|584598773|FG006|Overall Study|Adverse Event|1|||
161878821|NCT01938430|584598774|FG007|Overall Study|Adverse Event|0|||
161878822|NCT01938430|584598775|FG008|Overall Study|Adverse Event|0|||
161878823|NCT01938430|584598776|FG009|Overall Study|Adverse Event|0|||
161878824|NCT01938430|584598777|FG010|Overall Study|Adverse Event|0|||
161878825|NCT01938430|584598778|FG011|Overall Study|Adverse Event|0|||
161878826|NCT01938430|584598779|FG012|Overall Study|Adverse Event|0|||
161878827|NCT01938430|584598780|FG013|Overall Study|Adverse Event|0|||
161878828|NCT01938430|584598767|FG000|Overall Study|Death|1|||
161878829|NCT01938430|584598768|FG001|Overall Study|Death|2|||
161878830|NCT01938430|584598769|FG002|Overall Study|Death|2|||
161878831|NCT01938430|584598770|FG003|Overall Study|Death|1|||
161878832|NCT01938430|584598771|FG004|Overall Study|Death|0|||
161878833|NCT01938430|584598772|FG005|Overall Study|Death|0|||
161878834|NCT01938430|584598773|FG006|Overall Study|Death|1|||
161878835|NCT01938430|584598774|FG007|Overall Study|Death|1|||
161878836|NCT01938430|584598775|FG008|Overall Study|Death|2|||
161878837|NCT01938430|584598776|FG009|Overall Study|Death|3|||
161878838|NCT01938430|584598777|FG010|Overall Study|Death|0|||
161878839|NCT01938430|584598778|FG011|Overall Study|Death|0|||
161878840|NCT01938430|584598779|FG012|Overall Study|Death|0|||
161878841|NCT01938430|584598780|FG013|Overall Study|Death|0|||
161878842|NCT01938430|584598767|FG000|Overall Study|Investigator's Discretion|0|||
161878843|NCT01938430|584598768|FG001|Overall Study|Investigator's Discretion|0|||
161878844|NCT01938430|584598769|FG002|Overall Study|Investigator's Discretion|1|||
161878845|NCT01938430|584598770|FG003|Overall Study|Investigator's Discretion|0|||
161878846|NCT01938430|584598771|FG004|Overall Study|Investigator's Discretion|0|||
161878847|NCT01938430|584598772|FG005|Overall Study|Investigator's Discretion|0|||
161878848|NCT01938430|584598773|FG006|Overall Study|Investigator's Discretion|0|||
161878849|NCT01938430|584598774|FG007|Overall Study|Investigator's Discretion|0|||
161878850|NCT01938430|584598775|FG008|Overall Study|Investigator's Discretion|0|||
161878851|NCT01938430|584598776|FG009|Overall Study|Investigator's Discretion|0|||
161878852|NCT01938430|584598777|FG010|Overall Study|Investigator's Discretion|0|||
161878853|NCT01938430|584598778|FG011|Overall Study|Investigator's Discretion|0|||
161878854|NCT01938430|584598779|FG012|Overall Study|Investigator's Discretion|0|||
161878855|NCT01938430|584598780|FG013|Overall Study|Investigator's Discretion|0|||
161878856|NCT01938430|584598767|FG000|Overall Study|Lack of Efficacy|3|||
161878857|NCT01938430|584598768|FG001|Overall Study|Lack of Efficacy|1|||
161878858|NCT01938430|584598769|FG002|Overall Study|Lack of Efficacy|1|||
161878859|NCT01938430|584598770|FG003|Overall Study|Lack of Efficacy|1|||
161878860|NCT01938430|584598771|FG004|Overall Study|Lack of Efficacy|0|||
161878861|NCT01938430|584598772|FG005|Overall Study|Lack of Efficacy|0|||
161878862|NCT01938430|584598773|FG006|Overall Study|Lack of Efficacy|0|||
161878863|NCT01938430|584598774|FG007|Overall Study|Lack of Efficacy|0|||
161991365|NCT00172042|585018488|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161991366|NCT00172042|585018487|FG000|Overall Study|Abnormal test procedure(s)|0|||
161991367|NCT00172042|585018488|FG001|Overall Study|Abnormal test procedure(s)|3|||
161991368|NCT00172042|585018487|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
161991369|NCT00172042|585018488|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
161991370|NCT00172042|585018487|FG000|Overall Study|Patient no longer requires study drug|10|||
161991371|NCT00172042|585018488|FG001|Overall Study|Patient no longer requires study drug|8|||
161991372|NCT00172042|585018487|FG000|Overall Study|Protocol Violation|8|||
161991373|NCT00172042|585018488|FG001|Overall Study|Protocol Violation|7|||
161878864|NCT01938430|584598775|FG008|Overall Study|Lack of Efficacy|1|||
161878865|NCT01938430|584598776|FG009|Overall Study|Lack of Efficacy|0|||
161991374|NCT00172042|585018487|FG000|Overall Study|Withdrawal by Subject|37|||
161878866|NCT01938430|584598777|FG010|Overall Study|Lack of Efficacy|2|||
161878867|NCT01938430|584598778|FG011|Overall Study|Lack of Efficacy|1|||
161878868|NCT01938430|584598779|FG012|Overall Study|Lack of Efficacy|0|||
161878869|NCT01938430|584598780|FG013|Overall Study|Lack of Efficacy|0|||
161878870|NCT01938430|584598767|FG000|Overall Study|Lost to Follow-up|0|||
161878871|NCT01938430|584598768|FG001|Overall Study|Lost to Follow-up|0|||
161878872|NCT01938430|584598769|FG002|Overall Study|Lost to Follow-up|1|||
161878873|NCT01938430|584598770|FG003|Overall Study|Lost to Follow-up|0|||
161878874|NCT01938430|584598771|FG004|Overall Study|Lost to Follow-up|0|||
161878875|NCT01938430|584598772|FG005|Overall Study|Lost to Follow-up|1|||
161878876|NCT01938430|584598773|FG006|Overall Study|Lost to Follow-up|0|||
161878877|NCT01938430|584598774|FG007|Overall Study|Lost to Follow-up|0|||
161878878|NCT01938430|584598775|FG008|Overall Study|Lost to Follow-up|0|||
161878879|NCT01938430|584598776|FG009|Overall Study|Lost to Follow-up|0|||
161878880|NCT01938430|584598777|FG010|Overall Study|Lost to Follow-up|0|||
161878881|NCT01938430|584598778|FG011|Overall Study|Lost to Follow-up|0|||
161878882|NCT01938430|584598779|FG012|Overall Study|Lost to Follow-up|0|||
161878883|NCT01938430|584598780|FG013|Overall Study|Lost to Follow-up|0|||
161878884|NCT01938430|584598767|FG000|Overall Study|Withdrew Consent|0|||
161878885|NCT01938430|584598768|FG001|Overall Study|Withdrew Consent|0|||
161878886|NCT01938430|584598769|FG002|Overall Study|Withdrew Consent|0|||
161878887|NCT01938430|584598770|FG003|Overall Study|Withdrew Consent|0|||
161878888|NCT01938430|584598771|FG004|Overall Study|Withdrew Consent|0|||
161878889|NCT01938430|584598772|FG005|Overall Study|Withdrew Consent|0|||
161878890|NCT01938430|584598773|FG006|Overall Study|Withdrew Consent|0|||
161878891|NCT01938430|584598774|FG007|Overall Study|Withdrew Consent|0|||
161878892|NCT01938430|584598775|FG008|Overall Study|Withdrew Consent|1|||
161878893|NCT01938430|584598776|FG009|Overall Study|Withdrew Consent|0|||
161878894|NCT01938430|584598777|FG010|Overall Study|Withdrew Consent|0|||
161878895|NCT01938430|584598778|FG011|Overall Study|Withdrew Consent|0|||
161878896|NCT01938430|584598779|FG012|Overall Study|Withdrew Consent|0|||
161878897|NCT01938430|584598780|FG013|Overall Study|Withdrew Consent|0|||
161878898|NCT01613222|584598783|FG000|Overall Study|Physician Decision|1|||
161878899|NCT01613222|584598783|FG000|Overall Study|Unable to place arterial line|1|||
161878900|NCT01613222|584598783|FG000|Overall Study|Reused disposable sensors|10|||
161878901|NCT01895608|584598785|FG000|Overall Study|change in health status|0|||
161878902|NCT01895608|584598786|FG001|Overall Study|change in health status|1|||
161878903|NCT01895608|584598787|FG002|Overall Study|change in health status|1|||
161878904|NCT01895608|584598788|FG003|Overall Study|change in health status|0|||
161878905|NCT01895608|584598785|FG000|Overall Study|Withdrawal by Subject|0|||
161878906|NCT01895608|584598786|FG001|Overall Study|Withdrawal by Subject|0|||
161878907|NCT01895608|584598787|FG002|Overall Study|Withdrawal by Subject|2|||
161878908|NCT01895608|584598788|FG003|Overall Study|Withdrawal by Subject|0|||
161878909|NCT02691936|584598791|FG000|Overall Study|Withdrawal by Subject|2|||
161878910|NCT02691936|584598792|FG001|Overall Study|Withdrawal by Subject|5|||
161878911|NCT00749684|584598793|FG000|Overall Study|Death|1|||
161878912|NCT00749684|584598793|FG000|Overall Study|Adverse Event|27|||
161878913|NCT00749684|584598793|FG000|Overall Study|Participant's Wish|10|||
161878914|NCT00749684|584598793|FG000|Overall Study|Not Documented|1|||
161878915|NCT00749684|584598793|FG000|Overall Study|Progressive Desease|31|||
161878916|NCT00749684|584598793|FG000|Overall Study|Therapy according to protocol + AE|2|||
161878917|NCT00749684|584598793|FG000|Overall Study|AE+discontinuation on participants wish|1|||
161878918|NCT00749684|584598793|FG000|Overall Study|Missing|9|||
161878919|NCT03696108|584598794|FG000|Overall Study|Physician Decision|1|||
161878920|NCT03696108|584598795|FG001|Overall Study|Physician Decision|0|||
161878921|NCT03696108|584598794|FG000|Overall Study|Withdrawal by Subject|3|||
161878922|NCT03696108|584598795|FG001|Overall Study|Withdrawal by Subject|6|||
161878923|NCT03505593|584598797|FG000|Overall Study|Withdrawal by Subject|1|||
161878924|NCT03505593|584598797|FG000|Overall Study|Died before procedure|1|||
161878925|NCT03505593|584598797|FG000|Overall Study|Anatomical abnormality|1|||
161878926|NCT03505593|584598797|FG000|Overall Study|Unable to pass through esophagus|1|||
161878927|NCT03505593|584598797|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
161878928|NCT01194531|584598798|FG000|Overall Study|Withdrawal by Subject|1|||
161878929|NCT01194531|584598799|FG001|Overall Study|Withdrawal by Subject|0|||
161991375|NCT00172042|585018488|FG001|Overall Study|Withdrawal by Subject|25|||
161991376|NCT00172042|585018487|FG000|Overall Study|Lost to Follow-up|3|||
161991377|NCT00172042|585018488|FG001|Overall Study|Lost to Follow-up|5|||
161991378|NCT00172042|585018487|FG000|Overall Study|Administrative problems|13|||
161991379|NCT00172042|585018488|FG001|Overall Study|Administrative problems|10|||
161991380|NCT00172042|585018487|FG000|Overall Study|Death|42|||
161991381|NCT00172042|585018488|FG001|Overall Study|Death|42|||
161991382|NCT00384332|585018489|FG000|Overall Study|Lost to Follow-up|4|||
161991383|NCT00384332|585018490|FG001|Overall Study|Lost to Follow-up|0|||
161991384|NCT00375518|585018491|FG000|Overall Study|Withdrawal by Subject|2|||
161991385|NCT00375518|585018492|FG001|Overall Study|Withdrawal by Subject|10|||
161991386|NCT00375518|585018491|FG000|Overall Study|Patient Not Treated|6|||
161991387|NCT00375518|585018492|FG001|Overall Study|Patient Not Treated|6|||
161991388|NCT00375518|585018491|FG000|Overall Study|Death|0|||
161991389|NCT00375518|585018492|FG001|Overall Study|Death|1|||
161991390|NCT01771250|585018493|FG000|Period 1|Met exclusion criteria|1|||
161991391|NCT01771250|585018494|FG001|Period 1|Met exclusion criteria|0|||
161878930|NCT01194531|584598798|FG000|Overall Study|Protocol Violation|4|||
161878931|NCT01194531|584598799|FG001|Overall Study|Protocol Violation|1|||
161878932|NCT01194531|584598798|FG000|Overall Study|Physician Decision|0|||
161878933|NCT01194531|584598799|FG001|Overall Study|Physician Decision|2|||
161878934|NCT03891862|584598800|FG000|Open-label Period|Adverse Event|2|||
161878935|NCT03891862|584598801|FG001|Open-label Period|Adverse Event|0|||
161878936|NCT03891862|584598802|FG002|Open-label Period|Adverse Event|0|||
161878937|NCT03891862|584598800|FG000|Open-label Period|Protocol Violation|5|||
161991392|NCT02058563|585018495|FG000|Overall Study|Lost to Follow-up|26|||
161878938|NCT03891862|584598801|FG001|Open-label Period|Protocol Violation|0|||
161878939|NCT03891862|584598802|FG002|Open-label Period|Protocol Violation|0|||
161878940|NCT03891862|584598800|FG000|Open-label Period|Withdrawal by Subject|6|||
161878941|NCT03891862|584598801|FG001|Open-label Period|Withdrawal by Subject|0|||
161878942|NCT03891862|584598802|FG002|Open-label Period|Withdrawal by Subject|0|||
161878943|NCT03891862|584598800|FG000|Open-label Period|Death|1|||
161878944|NCT03891862|584598801|FG001|Open-label Period|Death|0|||
161878945|NCT03891862|584598802|FG002|Open-label Period|Death|0|||
161878946|NCT03891862|584598800|FG000|Open-label Period|Lost to Follow-up|2|||
161878947|NCT03891862|584598801|FG001|Open-label Period|Lost to Follow-up|0|||
161878948|NCT03891862|584598802|FG002|Open-label Period|Lost to Follow-up|0|||
161878949|NCT03891862|584598800|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
161878950|NCT03891862|584598801|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
161878951|NCT03891862|584598802|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
161878952|NCT03891862|584598800|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
161878953|NCT03891862|584598801|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
161878954|NCT03891862|584598802|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
161878955|NCT03891862|584598800|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
161878956|NCT03891862|584598801|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
161878957|NCT03891862|584598802|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
161878958|NCT03891862|584598800|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
161878959|NCT03891862|584598801|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
161878960|NCT03891862|584598802|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
161878961|NCT01053962|584598803|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
161878962|NCT01053962|584598804|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
161878963|NCT01053962|584598805|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
161878964|NCT01053962|584598806|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
161878965|NCT01053962|584598807|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
161878966|NCT01053962|584598803|FG000|Pretreatment Period|Venipuncture Failure|0|||
161878967|NCT01053962|584598804|FG001|Pretreatment Period|Venipuncture Failure|0|||
161878968|NCT01053962|584598805|FG002|Pretreatment Period|Venipuncture Failure|1|||
161878969|NCT01053962|584598806|FG003|Pretreatment Period|Venipuncture Failure|0|||
161878970|NCT01053962|584598807|FG004|Pretreatment Period|Venipuncture Failure|0|||
161878971|NCT01053962|584598803|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
161878972|NCT01053962|584598804|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
161878973|NCT01053962|584598805|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
161878974|NCT01053962|584598806|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
161878975|NCT01053962|584598807|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
161878976|NCT01053962|584598803|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
161878977|NCT01053962|584598804|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
161878978|NCT01053962|584598805|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
161878979|NCT01053962|584598806|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
161878980|NCT01053962|584598807|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
161878981|NCT01053962|584598803|FG000|Treatment Period|Lack of Efficacy|0|||
161878982|NCT01053962|584598804|FG001|Treatment Period|Lack of Efficacy|0|||
161878983|NCT01053962|584598805|FG002|Treatment Period|Lack of Efficacy|0|||
161878984|NCT01053962|584598806|FG003|Treatment Period|Lack of Efficacy|0|||
161878985|NCT01053962|584598807|FG004|Treatment Period|Lack of Efficacy|1|||
161878986|NCT01053962|584598803|FG000|Treatment Period|Adverse Event|0|||
161878987|NCT01053962|584598804|FG001|Treatment Period|Adverse Event|0|||
161878988|NCT01053962|584598805|FG002|Treatment Period|Adverse Event|0|||
161878989|NCT01053962|584598806|FG003|Treatment Period|Adverse Event|0|||
161878990|NCT01053962|584598807|FG004|Treatment Period|Adverse Event|1|||
161878991|NCT01053962|584598803|FG000|Treatment Period|Withdrawal by Subject|0|||
161878992|NCT01053962|584598804|FG001|Treatment Period|Withdrawal by Subject|0|||
161878993|NCT01053962|584598805|FG002|Treatment Period|Withdrawal by Subject|0|||
161878994|NCT01053962|584598806|FG003|Treatment Period|Withdrawal by Subject|0|||
161878995|NCT01053962|584598807|FG004|Treatment Period|Withdrawal by Subject|1|||
161878996|NCT01053962|584598803|FG000|Treatment Period|Noncompliance with protocol|1|||
161878997|NCT01053962|584598804|FG001|Treatment Period|Noncompliance with protocol|0|||
161878998|NCT01053962|584598805|FG002|Treatment Period|Noncompliance with protocol|0|||
161878999|NCT01053962|584598806|FG003|Treatment Period|Noncompliance with protocol|0|||
161879000|NCT01053962|584598807|FG004|Treatment Period|Noncompliance with protocol|0|||
161879001|NCT01154088|584598813|FG000|Overall Study|Lost to Follow-up|4|||
161879002|NCT01154088|584598814|FG001|Overall Study|Lost to Follow-up|6|||
161879003|NCT01154088|584598815|FG002|Overall Study|Lost to Follow-up|7|||
161991393|NCT02058563|585018496|FG001|Overall Study|Lost to Follow-up|22|||
161991394|NCT02058563|585018495|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
161991395|NCT02058563|585018496|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
161879004|NCT05129137|584598816|FG000|Second Period|Adverse Event|1|||
161879005|NCT05129137|584598817|FG001|Second Period|Adverse Event|0|||
161879006|NCT05129137|584598818|FG002|Second Period|Adverse Event|0|||
161991396|NCT02058563|585018495|FG000|Overall Study|Consent Withdrawal|1|||
161879007|NCT05129137|584598819|FG003|Second Period|Adverse Event|0|||
161879008|NCT05129137|584598816|FG000|Second Period|Protocol Violation|0|||
161879009|NCT05129137|584598817|FG001|Second Period|Protocol Violation|0|||
161879010|NCT05129137|584598818|FG002|Second Period|Protocol Violation|0|||
161879011|NCT05129137|584598819|FG003|Second Period|Protocol Violation|1|||
161879012|NCT05129137|584598816|FG000|Third Period|Protocol Violation|0|||
161879013|NCT05129137|584598817|FG001|Third Period|Protocol Violation|0|||
161879014|NCT05129137|584598818|FG002|Third Period|Protocol Violation|0|||
161879015|NCT05129137|584598819|FG003|Third Period|Protocol Violation|1|||
161879016|NCT05129137|584598816|FG000|Forth Period|Protocol Violation|0|||
161879017|NCT05129137|584598817|FG001|Forth Period|Protocol Violation|1|||
161879018|NCT05129137|584598818|FG002|Forth Period|Protocol Violation|0|||
161879019|NCT05129137|584598819|FG003|Forth Period|Protocol Violation|0|||
161879020|NCT05129137|584598816|FG000|Forth Period|Withdrawal by Subject|0|||
161879021|NCT05129137|584598817|FG001|Forth Period|Withdrawal by Subject|0|||
161879022|NCT05129137|584598818|FG002|Forth Period|Withdrawal by Subject|1|||
161879023|NCT05129137|584598819|FG003|Forth Period|Withdrawal by Subject|0|||
161879024|NCT01992653|584598823|FG000|Overall Study|Death|0|||
161879025|NCT01992653|584598824|FG001|Overall Study|Death|0|||
161879026|NCT01992653|584598825|FG002|Overall Study|Death|1|||
161879027|NCT01992653|584598826|FG003|Overall Study|Death|0|||
161879028|NCT01992653|584598827|FG004|Overall Study|Death|1|||
161879029|NCT01992653|584598828|FG005|Overall Study|Death|0|||
161879030|NCT01992653|584598829|FG006|Overall Study|Death|4|||
161879031|NCT01992653|584598830|FG007|Overall Study|Death|2|||
161879032|NCT01992653|584598823|FG000|Overall Study|Lost to Follow-up|0|||
161879033|NCT01992653|584598824|FG001|Overall Study|Lost to Follow-up|0|||
161879034|NCT01992653|584598825|FG002|Overall Study|Lost to Follow-up|0|||
161879035|NCT01992653|584598826|FG003|Overall Study|Lost to Follow-up|0|||
161879036|NCT01992653|584598827|FG004|Overall Study|Lost to Follow-up|0|||
161879037|NCT01992653|584598828|FG005|Overall Study|Lost to Follow-up|0|||
161879038|NCT01992653|584598829|FG006|Overall Study|Lost to Follow-up|0|||
161879039|NCT01992653|584598830|FG007|Overall Study|Lost to Follow-up|1|||
161879040|NCT01992653|584598823|FG000|Overall Study|Study Completed|0|||
161879041|NCT01992653|584598824|FG001|Overall Study|Study Completed|0|||
161879042|NCT01992653|584598825|FG002|Overall Study|Study Completed|0|||
161777279|NCT04636437|584225553|FG001|Overall Study|Started weight loss drug/program|1|||
161777280|NCT04636437|584225554|FG002|Overall Study|Started weight loss drug/program|1|||
161777281|NCT04636437|584225552|FG000|Overall Study|Lost to Follow-up|3|||
161777282|NCT04636437|584225553|FG001|Overall Study|Lost to Follow-up|1|||
161777283|NCT04636437|584225554|FG002|Overall Study|Lost to Follow-up|4|||
161777284|NCT04636437|584225552|FG000|Overall Study|Participant or physician decision|3|||
161777285|NCT04636437|584225553|FG001|Overall Study|Participant or physician decision|1|||
161777286|NCT04636437|584225554|FG002|Overall Study|Participant or physician decision|1|||
161777287|NCT00816166|584225555|FG000|Overall Study|Lost to Follow-up|6|||
161777288|NCT00816166|584225556|FG001|Overall Study|Lost to Follow-up|10|||
161777289|NCT00816166|584225555|FG000|Overall Study|Death|4|||
161777290|NCT00816166|584225556|FG001|Overall Study|Death|2|||
161777291|NCT01071278|584225557|FG000|Overall Study|Premature Discontinuation|254|||
161777292|NCT01071278|584225557|FG000|Overall Study|Completion Status Unknown|459|||
161777293|NCT00352664|584225558|FG000|Overall Study|Withdrawal by Subject|7|||
161777294|NCT00352664|584225559|FG001|Overall Study|Withdrawal by Subject|0|||
161777295|NCT01821391|584225565|FG000|Overall Study|Adverse Event|1|||
161777296|NCT01821391|584225566|FG001|Overall Study|Adverse Event|0|||
161777297|NCT01875731|584225568|FG000|Overall Study|Fail to obtain lab sample|1|||
161777298|NCT01875731|584225569|FG001|Overall Study|Fail to obtain lab sample|0|||
161777299|NCT03417102|584225570|FG000|Overall Study|Adverse Event|0|||
161777300|NCT03417102|584225571|FG001|Overall Study|Adverse Event|1|||
161777301|NCT03417102|584225570|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
161777302|NCT03417102|584225571|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
161777303|NCT03417102|584225570|FG000|Overall Study|Other|0|||
161777304|NCT03417102|584225571|FG001|Overall Study|Other|1|||
161777305|NCT02062385|584225575|FG000|Overall Study|Adverse Event|19|||
161777306|NCT02062385|584225576|FG001|Overall Study|Adverse Event|13|||
161777307|NCT02062385|584225577|FG002|Overall Study|Adverse Event|1|||
161777308|NCT02062385|584225578|FG003|Overall Study|Adverse Event|0|||
161777309|NCT02062385|584225575|FG000|Overall Study|Protocol Violation|1|||
161777310|NCT02062385|584225576|FG001|Overall Study|Protocol Violation|0|||
161777311|NCT02062385|584225577|FG002|Overall Study|Protocol Violation|0|||
161777312|NCT02062385|584225578|FG003|Overall Study|Protocol Violation|0|||
161777313|NCT02062385|584225575|FG000|Overall Study|Incomplete EPI by database lock|2|||
161777314|NCT02062385|584225576|FG001|Overall Study|Incomplete EPI by database lock|0|||
161777315|NCT02062385|584225577|FG002|Overall Study|Incomplete EPI by database lock|0|||
161777316|NCT02062385|584225578|FG003|Overall Study|Incomplete EPI by database lock|0|||
161777317|NCT02062385|584225575|FG000|Overall Study|Moved|10|||
161777318|NCT02062385|584225576|FG001|Overall Study|Moved|11|||
161777319|NCT02062385|584225577|FG002|Overall Study|Moved|1|||
161777320|NCT02062385|584225578|FG003|Overall Study|Moved|0|||
161879043|NCT01992653|584598826|FG003|Overall Study|Study Completed|0|||
161879044|NCT01992653|584598827|FG004|Overall Study|Study Completed|0|||
161879045|NCT01992653|584598828|FG005|Overall Study|Study Completed|0|||
161879046|NCT01992653|584598829|FG006|Overall Study|Study Completed|0|||
161879047|NCT01992653|584598830|FG007|Overall Study|Study Completed|1|||
161879048|NCT01992653|584598823|FG000|Overall Study|Disease Progression|0|||
161879049|NCT01992653|584598824|FG001|Overall Study|Disease Progression|0|||
161879050|NCT01992653|584598825|FG002|Overall Study|Disease Progression|0|||
161879051|NCT01992653|584598826|FG003|Overall Study|Disease Progression|0|||
161879052|NCT01992653|584598827|FG004|Overall Study|Disease Progression|0|||
161879053|NCT01992653|584598828|FG005|Overall Study|Disease Progression|0|||
161879054|NCT01992653|584598829|FG006|Overall Study|Disease Progression|4|||
161879055|NCT01992653|584598830|FG007|Overall Study|Disease Progression|0|||
161879056|NCT01435460|584598831|FG000|Overall Study|Adverse Event|2|||
161879057|NCT01435460|584598832|FG001|Overall Study|Adverse Event|1|||
161879058|NCT01435460|584598831|FG000|Overall Study|Lost to Follow-up|6|||
161879059|NCT01435460|584598832|FG001|Overall Study|Lost to Follow-up|1|||
161879060|NCT01435460|584598831|FG000|Overall Study|Withdrawal by Subject|1|||
161879061|NCT01435460|584598832|FG001|Overall Study|Withdrawal by Subject|3|||
161879062|NCT01435460|584598831|FG000|Overall Study|Protocol Violation|0|||
161879063|NCT01435460|584598832|FG001|Overall Study|Protocol Violation|1|||
161879064|NCT01435460|584598831|FG000|Overall Study|Did not meet eligibility criteria|2|||
161879065|NCT01435460|584598832|FG001|Overall Study|Did not meet eligibility criteria|0|||
161879066|NCT01706939|584598833|FG000|Pre Randomization|Screen Failure|1|||
161879067|NCT01706939|584598834|FG001|Pre Randomization|Screen Failure|0|||
161879068|NCT01706939|584598835|FG002|Pre Randomization|Screen Failure|0|||
161879069|NCT01706939|584598833|FG000|Pre Randomization|Ineligible for Randomization|1|||
161879070|NCT01706939|584598834|FG001|Pre Randomization|Ineligible for Randomization|0|||
161879071|NCT01706939|584598835|FG002|Pre Randomization|Ineligible for Randomization|0|||
161879072|NCT01706939|584598833|FG000|Pre Randomization|Withdrawal by Subject|1|||
161879073|NCT01706939|584598834|FG001|Pre Randomization|Withdrawal by Subject|0|||
161879074|NCT01706939|584598835|FG002|Pre Randomization|Withdrawal by Subject|0|||
161879075|NCT01706939|584598833|FG000|Randomization|Insufficient QoL survey compliance|0|||
161879076|NCT01706939|584598834|FG001|Randomization|Insufficient QoL survey compliance|1|||
161879077|NCT01706939|584598835|FG002|Randomization|Insufficient QoL survey compliance|1|||
161879078|NCT01706939|584598833|FG000|Randomization|Progression of disease|0|||
161879079|NCT01706939|584598834|FG001|Randomization|Progression of disease|2|||
161879080|NCT01706939|584598835|FG002|Randomization|Progression of disease|1|||
161879081|NCT01046903|584598836|FG000|Overall Study|Lost to Follow-up|16|||
161879082|NCT01046903|584598836|FG000|Overall Study|Adverse Event|4|||
161879083|NCT01046903|584598836|FG000|Overall Study|Withdrawal by Subject|3|||
161879084|NCT01046903|584598836|FG000|Overall Study|Other|5|||
161879085|NCT00977314|584598837|FG000|Overall Study|Withdrawal by Subject|1|||
161879086|NCT00977314|584598838|FG001|Overall Study|Withdrawal by Subject|0|||
161879087|NCT00977314|584598837|FG000|Overall Study|Physician Decision|1|||
161879088|NCT00977314|584598838|FG001|Overall Study|Physician Decision|0|||
161879089|NCT01343277|584598839|FG000|Overall Study|Other|3|||
161879090|NCT01343277|584598840|FG001|Overall Study|Other|3|||
161879091|NCT01343277|584598839|FG000|Overall Study|Withdrawal by Subject|18|||
161879092|NCT01343277|584598840|FG001|Overall Study|Withdrawal by Subject|13|||
161879093|NCT01343277|584598839|FG000|Overall Study|Physician Decision|1|||
161879094|NCT01343277|584598840|FG001|Overall Study|Physician Decision|2|||
161879095|NCT01343277|584598839|FG000|Overall Study|Death|10|||
161879096|NCT01343277|584598840|FG001|Overall Study|Death|1|||
161879097|NCT01343277|584598839|FG000|Overall Study|Adverse Event|67|||
161879098|NCT01343277|584598840|FG001|Overall Study|Adverse Event|13|||
161879099|NCT01343277|584598839|FG000|Overall Study|Disease progression|270|||
161879100|NCT01343277|584598840|FG001|Overall Study|Disease progression|138|||
161879101|NCT01343277|584598839|FG000|Overall Study|Randomized not treated|6|||
161879102|NCT01343277|584598840|FG001|Overall Study|Randomized not treated|21|||
161879103|NCT01343277|584598839|FG000|Overall Study|Treatment ongoing|8|||
161879104|NCT01343277|584598840|FG001|Overall Study|Treatment ongoing|2|||
161879105|NCT01343277|584598839|FG000|Overall Study|Subsequent anticancer therapy|1|||
161879106|NCT01343277|584598840|FG001|Overall Study|Subsequent anticancer therapy|0|||
161879107|NCT01894100|584598843|FG000|Overall Study|Lost to Follow-up|0|||
161879108|NCT01894100|584598844|FG001|Overall Study|Lost to Follow-up|1|||
161879109|NCT01894100|584598843|FG000|Overall Study|Withdrawal by Subject|3|||
161879110|NCT01894100|584598844|FG001|Overall Study|Withdrawal by Subject|0|||
161879111|NCT01094301|584598847|FG000|Trial Stage|Withdrawal by Subject|1|||
161879112|NCT01094301|584598847|FG000|Implant Stage|Adverse Event|1|||
161879113|NCT01094301|584598847|FG000|Implant Stage|Protocol Violation|1|||
161879114|NCT01094301|584598847|FG000|Implant Stage|Withdrawal by Subject|2|||
161879115|NCT01094301|584598847|FG000|Implant Stage|No return of pain|4|||
161879116|NCT00135512|584598848|FG000|Overall Study|Adverse Event|56|||
161879117|NCT00135512|584598848|FG000|Overall Study|Lack of Efficacy|25|||
161879118|NCT00135512|584598848|FG000|Overall Study|Other|42|||
161879119|NCT04439214|584598852|FG000|Overall Study|Adverse Event|13|||
161879120|NCT04439214|584598852|FG000|Overall Study|Disease progression|16|||
161879121|NCT04439214|584598852|FG000|Overall Study|Death|1|||
161879122|NCT04439214|584598852|FG000|Overall Study|Withdrawal by Subject|2|||
161879123|NCT04439214|584598852|FG000|Overall Study|Declining health|1|||
161879124|NCT04439214|584598852|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
161879125|NCT04439214|584598852|FG000|Overall Study|Ineligible|5|||
161879126|NCT02964208|584598853|FG000|Overall Study|Death|103|||
161879127|NCT02964208|584598853|FG000|Overall Study|Withdrawal by Subject|6|||
161879128|NCT02964208|584598853|FG000|Overall Study|Lost to Follow-up|6|||
161879129|NCT02964208|584598853|FG000|Overall Study|Unsuccessful Procedure|5|||
161879130|NCT02964208|584598853|FG000|Overall Study|Device Explant|1|||
161879131|NCT02964208|584598853|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
161879132|NCT00556933|584598857|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
161879133|NCT00556933|584598858|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
161879134|NCT00556933|584598859|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
161879135|NCT00556933|584598860|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
161879136|NCT00556933|584598857|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
161879137|NCT00556933|584598858|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
161879138|NCT00556933|584598859|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
161879139|NCT00556933|584598860|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
161879140|NCT00556933|584598857|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
161879141|NCT00556933|584598858|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
161879142|NCT00556933|584598859|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
161879143|NCT00556933|584598860|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
161879144|NCT00556933|584598857|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
161879145|NCT00556933|584598858|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
161879146|NCT00556933|584598859|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
161879147|NCT00556933|584598860|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
161879148|NCT00556933|584598857|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
161879149|NCT00556933|584598858|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
161879150|NCT00556933|584598859|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
161879151|NCT00556933|584598860|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
161879152|NCT00556933|584598857|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
161879153|NCT00556933|584598858|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
161879154|NCT00556933|584598859|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
161879155|NCT00556933|584598860|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
161879156|NCT00556933|584598857|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
161879157|NCT00556933|584598858|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
161879158|NCT00556933|584598859|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
161879159|NCT00556933|584598860|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
161879160|NCT00556933|584598857|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
161879161|NCT00556933|584598858|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
161879162|NCT00556933|584598859|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
161879163|NCT00556933|584598860|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
161879164|NCT00556933|584598857|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
161879165|NCT00556933|584598858|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
161879166|NCT00556933|584598859|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
161879167|NCT00556933|584598860|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
161879168|NCT00556933|584598857|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
161879169|NCT00556933|584598858|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
161879170|NCT00556933|584598859|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
161879171|NCT00556933|584598860|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
161879172|NCT00556933|584598857|FG000|CNI Withdrawal vs. Minimization|Death|0|||
161879173|NCT00556933|584598858|FG001|CNI Withdrawal vs. Minimization|Death|0|||
161879174|NCT00556933|584598859|FG002|CNI Withdrawal vs. Minimization|Death|0|||
161879175|NCT00556933|584598860|FG003|CNI Withdrawal vs. Minimization|Death|1|||
161879176|NCT01493284|584598872|FG000|Overall Study|Death|29|||
161879177|NCT01493284|584598872|FG000|Overall Study|Withdrawal by Subject|32|||
161879178|NCT01871402|584600380|FG000|Overall Study|Lost to Follow-up|1|||
161879179|NCT01871402|584600381|FG001|Overall Study|Lost to Follow-up|0|||
161879180|NCT01871402|584600380|FG000|Overall Study|Withdrawal by Subject|0|||
161879181|NCT01871402|584600381|FG001|Overall Study|Withdrawal by Subject|2|||
161879182|NCT01871402|584600380|FG000|Overall Study|Non-compliance|0|||
161879183|NCT01871402|584600381|FG001|Overall Study|Non-compliance|1|||
161991397|NCT02058563|585018496|FG001|Overall Study|Consent Withdrawal|1|||
161991398|NCT02058563|585018495|FG000|Overall Study|Other (patient incarcerated)|0|||
161991399|NCT02058563|585018496|FG001|Overall Study|Other (patient incarcerated)|1|||
161879184|NCT04594941|584600382|FG000|Overall Study|Other|0|||
161879185|NCT04594941|584600383|FG001|Overall Study|Other|3|||
161879186|NCT04594941|584600384|FG002|Overall Study|Other|1|||
161879187|NCT04594941|584600385|FG003|Overall Study|Other|0|||
161991400|NCT01180296|585018497|FG000|Overall Study|Protocol Violation|1|||
161879188|NCT03408444|584600386|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
161879189|NCT03408444|584600387|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
161879190|NCT03408444|584600388|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
161879191|NCT03408444|584600389|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
161879192|NCT03408444|584600386|FG000|Overall Study|Lens Discomfort|0|||
161879193|NCT03408444|584600387|FG001|Overall Study|Lens Discomfort|1|||
161879194|NCT03408444|584600388|FG002|Overall Study|Lens Discomfort|0|||
161879195|NCT03408444|584600389|FG003|Overall Study|Lens Discomfort|0|||
161879196|NCT03408444|584600386|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
161879197|NCT03408444|584600387|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
161879198|NCT03408444|584600388|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
161879199|NCT03408444|584600389|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
161879200|NCT03408444|584600386|FG000|Overall Study|Withdrawal by Subject|0|||
161879201|NCT03408444|584600387|FG001|Overall Study|Withdrawal by Subject|2|||
161879202|NCT03408444|584600388|FG002|Overall Study|Withdrawal by Subject|3|||
161879203|NCT03408444|584600389|FG003|Overall Study|Withdrawal by Subject|0|||
161879204|NCT03408444|584600386|FG000|Overall Study|Lost to Follow-up|0|||
161879205|NCT03408444|584600387|FG001|Overall Study|Lost to Follow-up|0|||
161879206|NCT03408444|584600388|FG002|Overall Study|Lost to Follow-up|1|||
161879207|NCT03408444|584600389|FG003|Overall Study|Lost to Follow-up|0|||
161879208|NCT03408444|584600386|FG000|Overall Study|Adverse Event|0|||
161879209|NCT03408444|584600387|FG001|Overall Study|Adverse Event|0|||
161879210|NCT03408444|584600388|FG002|Overall Study|Adverse Event|0|||
161879211|NCT03408444|584600389|FG003|Overall Study|Adverse Event|1|||
161879212|NCT03408444|584600386|FG000|Overall Study|Lens Handling Difficulties|0|||
161879213|NCT03408444|584600387|FG001|Overall Study|Lens Handling Difficulties|0|||
161879214|NCT03408444|584600388|FG002|Overall Study|Lens Handling Difficulties|1|||
161879215|NCT03408444|584600389|FG003|Overall Study|Lens Handling Difficulties|0|||
161879216|NCT03408444|584600386|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
161879217|NCT03408444|584600387|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
161879218|NCT03408444|584600388|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
161879219|NCT03408444|584600389|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
161879220|NCT00231114|584600390|FG000|Randomized|Withdrawal by Subject|6|||
161879221|NCT00231114|584600391|FG001|Randomized|Withdrawal by Subject|3|||
161879222|NCT00231114|584600390|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
161879223|NCT00231114|584600391|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
161879224|NCT00231114|584600390|FG000|Post-Treatment Period|Lost to Follow-up|6|||
161879225|NCT00231114|584600391|FG001|Post-Treatment Period|Lost to Follow-up|1|||
161879226|NCT00231114|584600390|FG000|Post-Treatment Period|Physician Decision|1|||
161879227|NCT00231114|584600391|FG001|Post-Treatment Period|Physician Decision|0|||
161879228|NCT00231114|584600390|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
161879229|NCT00231114|584600391|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
161879230|NCT04720911|584600393|FG000|Overall Study|Withdrawal by Subject|0|||
161879231|NCT04720911|584600394|FG001|Overall Study|Withdrawal by Subject|1|||
161879232|NCT04720911|584600395|FG002|Overall Study|Withdrawal by Subject|0|||
161879233|NCT00537316|584600396|FG000|Part 1|Adverse Event|7|||
161879234|NCT00537316|584600397|FG001|Part 1|Adverse Event|11|||
161879235|NCT00537316|584600398|FG002|Part 1|Adverse Event|8|||
161879236|NCT00537316|584600399|FG003|Part 1|Adverse Event|0|||
161879237|NCT00537316|584600400|FG004|Part 1|Adverse Event|0|||
161879238|NCT00537316|584600401|FG005|Part 1|Adverse Event|0|||
161879239|NCT00537316|584600402|FG006|Part 1|Adverse Event|0|||
161879240|NCT00537316|584600396|FG000|Part 1|Protocol defined clinical event|1|||
161879241|NCT00537316|584600397|FG001|Part 1|Protocol defined clinical event|0|||
161879242|NCT00537316|584600398|FG002|Part 1|Protocol defined clinical event|0|||
161879243|NCT00537316|584600399|FG003|Part 1|Protocol defined clinical event|0|||
161879244|NCT00537316|584600400|FG004|Part 1|Protocol defined clinical event|0|||
161879245|NCT00537316|584600401|FG005|Part 1|Protocol defined clinical event|0|||
161879246|NCT00537316|584600402|FG006|Part 1|Protocol defined clinical event|0|||
161879247|NCT00537316|584600396|FG000|Part 1|Lost to Follow-up|1|||
161879248|NCT00537316|584600397|FG001|Part 1|Lost to Follow-up|0|||
161879249|NCT00537316|584600398|FG002|Part 1|Lost to Follow-up|0|||
161991401|NCT01180296|585018498|FG001|Overall Study|Protocol Violation|2|||
161879250|NCT00537316|584600399|FG003|Part 1|Lost to Follow-up|0|||
161879251|NCT00537316|584600400|FG004|Part 1|Lost to Follow-up|0|||
161879252|NCT00537316|584600401|FG005|Part 1|Lost to Follow-up|0|||
161879253|NCT00537316|584600402|FG006|Part 1|Lost to Follow-up|0|||
161879254|NCT00537316|584600396|FG000|Part 1|Withdrawal by Subject|3|||
161879255|NCT00537316|584600397|FG001|Part 1|Withdrawal by Subject|8|||
161879256|NCT00537316|584600398|FG002|Part 1|Withdrawal by Subject|4|||
161879257|NCT00537316|584600399|FG003|Part 1|Withdrawal by Subject|0|||
161879258|NCT00537316|584600400|FG004|Part 1|Withdrawal by Subject|0|||
161879259|NCT00537316|584600401|FG005|Part 1|Withdrawal by Subject|0|||
161879260|NCT00537316|584600402|FG006|Part 1|Withdrawal by Subject|0|||
161879261|NCT00537316|584600396|FG000|Part 1|Protocol Violation|1|||
161879262|NCT00537316|584600397|FG001|Part 1|Protocol Violation|5|||
161879263|NCT00537316|584600398|FG002|Part 1|Protocol Violation|1|||
161777321|NCT02062385|584225575|FG000|Overall Study|Withdrawn by parent/guardian|46|||
161777322|NCT02062385|584225576|FG001|Overall Study|Withdrawn by parent/guardian|41|||
161777323|NCT02062385|584225577|FG002|Overall Study|Withdrawn by parent/guardian|9|||
161777324|NCT02062385|584225578|FG003|Overall Study|Withdrawn by parent/guardian|8|||
161777325|NCT02062385|584225575|FG000|Overall Study|Death|0|||
161879264|NCT00537316|584600399|FG003|Part 1|Protocol Violation|0|||
161879265|NCT00537316|584600400|FG004|Part 1|Protocol Violation|0|||
161879266|NCT00537316|584600401|FG005|Part 1|Protocol Violation|0|||
161879267|NCT00537316|584600402|FG006|Part 1|Protocol Violation|0|||
161879268|NCT00537316|584600396|FG000|Part 1|Did not meet protocol eligibility|1|||
161879269|NCT00537316|584600397|FG001|Part 1|Did not meet protocol eligibility|3|||
161777326|NCT02062385|584225576|FG001|Overall Study|Death|0|||
161777327|NCT02062385|584225577|FG002|Overall Study|Death|0|||
161777328|NCT02062385|584225578|FG003|Overall Study|Death|1|||
161777329|NCT02062385|584225575|FG000|Overall Study|Lost to Follow-up|0|||
161777330|NCT02062385|584225576|FG001|Overall Study|Lost to Follow-up|0|||
161777331|NCT02062385|584225577|FG002|Overall Study|Lost to Follow-up|1|||
161879270|NCT00537316|584600398|FG002|Part 1|Did not meet protocol eligibility|2|||
161879271|NCT00537316|584600399|FG003|Part 1|Did not meet protocol eligibility|0|||
161879272|NCT00537316|584600400|FG004|Part 1|Did not meet protocol eligibility|0|||
161879273|NCT00537316|584600401|FG005|Part 1|Did not meet protocol eligibility|0|||
161879274|NCT00537316|584600402|FG006|Part 1|Did not meet protocol eligibility|0|||
161879275|NCT00537316|584600396|FG000|Part 1|Administrative|0|||
161879276|NCT00537316|584600397|FG001|Part 1|Administrative|0|||
161879277|NCT00537316|584600398|FG002|Part 1|Administrative|2|||
161879278|NCT00537316|584600399|FG003|Part 1|Administrative|0|||
161879279|NCT00537316|584600400|FG004|Part 1|Administrative|0|||
161879280|NCT00537316|584600401|FG005|Part 1|Administrative|0|||
161879281|NCT00537316|584600402|FG006|Part 1|Administrative|0|||
161879282|NCT00537316|584600396|FG000|Part 2|Never entered follow-up|0|||
161879283|NCT00537316|584600397|FG001|Part 2|Never entered follow-up|0|||
161879284|NCT00537316|584600398|FG002|Part 2|Never entered follow-up|0|||
161879285|NCT00537316|584600399|FG003|Part 2|Never entered follow-up|0|||
161879286|NCT00537316|584600400|FG004|Part 2|Never entered follow-up|0|||
161879287|NCT00537316|584600401|FG005|Part 2|Never entered follow-up|0|||
161879288|NCT00537316|584600402|FG006|Part 2|Never entered follow-up|1|||
161879289|NCT00537316|584600396|FG000|Part 2|Adverse Event|4|||
161879290|NCT00537316|584600397|FG001|Part 2|Adverse Event|0|||
161879291|NCT00537316|584600398|FG002|Part 2|Adverse Event|2|||
161879292|NCT00537316|584600399|FG003|Part 2|Adverse Event|0|||
161879293|NCT00537316|584600400|FG004|Part 2|Adverse Event|0|||
161879294|NCT00537316|584600401|FG005|Part 2|Adverse Event|0|||
161879295|NCT00537316|584600402|FG006|Part 2|Adverse Event|0|||
161879296|NCT00537316|584600396|FG000|Part 2|Lost to Follow-up|1|||
161879297|NCT00537316|584600397|FG001|Part 2|Lost to Follow-up|0|||
161879298|NCT00537316|584600398|FG002|Part 2|Lost to Follow-up|2|||
161879299|NCT00537316|584600399|FG003|Part 2|Lost to Follow-up|0|||
161879300|NCT00537316|584600400|FG004|Part 2|Lost to Follow-up|0|||
161879301|NCT00537316|584600401|FG005|Part 2|Lost to Follow-up|0|||
161879302|NCT00537316|584600402|FG006|Part 2|Lost to Follow-up|0|||
161879303|NCT00537316|584600396|FG000|Part 2|Withdrawal by Subject|5|||
161879304|NCT00537316|584600397|FG001|Part 2|Withdrawal by Subject|1|||
161879305|NCT00537316|584600398|FG002|Part 2|Withdrawal by Subject|4|||
161879306|NCT00537316|584600399|FG003|Part 2|Withdrawal by Subject|0|||
161879307|NCT00537316|584600400|FG004|Part 2|Withdrawal by Subject|0|||
161879308|NCT00537316|584600401|FG005|Part 2|Withdrawal by Subject|0|||
161879309|NCT00537316|584600402|FG006|Part 2|Withdrawal by Subject|0|||
161879310|NCT00537316|584600396|FG000|Part 2|Administrative|16|||
161879311|NCT00537316|584600397|FG001|Part 2|Administrative|8|||
161879312|NCT00537316|584600398|FG002|Part 2|Administrative|24|||
161879313|NCT00537316|584600399|FG003|Part 2|Administrative|3|||
161879314|NCT00537316|584600400|FG004|Part 2|Administrative|1|||
161879315|NCT00537316|584600401|FG005|Part 2|Administrative|4|||
161879316|NCT00537316|584600402|FG006|Part 2|Administrative|1|||
161879317|NCT04533412|584600404|FG000|Overall Study|Withdrawal by Subject|1|||
161777332|NCT02062385|584225578|FG003|Overall Study|Lost to Follow-up|0|||
161879318|NCT04533412|584600405|FG001|Overall Study|Withdrawal by Subject|1|||
161879319|NCT04533412|584600404|FG000|Overall Study|Lost to Follow-up|1|||
161879320|NCT04533412|584600405|FG001|Overall Study|Lost to Follow-up|4|||
161879321|NCT03261674|584600406|FG000|Overall Study|Lost to Follow-up|6|||
161879322|NCT03261674|584600407|FG001|Overall Study|Lost to Follow-up|7|||
161879323|NCT03261674|584600406|FG000|Overall Study|Protocol Violation|1|||
161879324|NCT03261674|584600407|FG001|Overall Study|Protocol Violation|4|||
161879325|NCT03261674|584600406|FG000|Overall Study|Withdrawal by Subject|1|||
161879326|NCT03261674|584600407|FG001|Overall Study|Withdrawal by Subject|4|||
161879327|NCT03261674|584600406|FG000|Overall Study|Physician Decision|1|||
161879328|NCT03261674|584600407|FG001|Overall Study|Physician Decision|0|||
161879329|NCT00782184|584600408|FG000|Overall Study|Adverse Event|1|||
161879330|NCT00782184|584600409|FG001|Overall Study|Adverse Event|2|||
161879331|NCT00782184|584600408|FG000|Overall Study|Protocol Violation|0|||
161879332|NCT00782184|584600409|FG001|Overall Study|Protocol Violation|1|||
161879333|NCT00782184|584600408|FG000|Overall Study|Withdrawal by Subject|3|||
161879334|NCT00782184|584600409|FG001|Overall Study|Withdrawal by Subject|2|||
161879335|NCT01438294|584600410|FG000|Overall Study|Lost to Follow-up|3|||
161879336|NCT01438294|584600411|FG001|Overall Study|Lost to Follow-up|7|||
161879337|NCT01730534|584600416|FG000|Overall Study|Withdrawal by Subject|97|||
161879338|NCT01730534|584600417|FG001|Overall Study|Withdrawal by Subject|127|||
161879339|NCT01730534|584600416|FG000|Overall Study|Lost to Follow-up|12|||
161879340|NCT01730534|584600417|FG001|Overall Study|Lost to Follow-up|18|||
161879341|NCT01676896|584600418|FG000|Overall Study|Withdrawal by Subject|12|||
161879342|NCT01676896|584600419|FG001|Overall Study|Withdrawal by Subject|7|||
161879343|NCT01676896|584600420|FG002|Overall Study|Withdrawal by Subject|19|||
161879344|NCT03614078|584600421|FG000|Overall Study|Withdrawal by Subject|2|||
161879345|NCT03614078|584600422|FG001|Overall Study|Withdrawal by Subject|2|||
161879346|NCT03614078|584600423|FG002|Overall Study|Withdrawal by Subject|3|||
161879347|NCT03614078|584600421|FG000|Overall Study|Participant Did Not Return for Visit|0|||
161879348|NCT03614078|584600422|FG001|Overall Study|Participant Did Not Return for Visit|1|||
161879349|NCT03614078|584600423|FG002|Overall Study|Participant Did Not Return for Visit|0|||
161879350|NCT03614078|584600421|FG000|Overall Study|High Neutrophils|0|||
161879351|NCT03614078|584600422|FG001|Overall Study|High Neutrophils|0|||
161879352|NCT03614078|584600423|FG002|Overall Study|High Neutrophils|2|||
161879353|NCT03614078|584600421|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
161879354|NCT03614078|584600422|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
161879355|NCT03614078|584600423|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
161879356|NCT03614078|584600421|FG000|Overall Study|Exacerbation of Psoriasis|0|||
161879357|NCT03614078|584600422|FG001|Overall Study|Exacerbation of Psoriasis|1|||
161879358|NCT03614078|584600423|FG002|Overall Study|Exacerbation of Psoriasis|0|||
161879359|NCT03614078|584600421|FG000|Overall Study|Adverse Event|0|||
161879360|NCT03614078|584600422|FG001|Overall Study|Adverse Event|2|||
161879361|NCT03614078|584600423|FG002|Overall Study|Adverse Event|0|||
161879362|NCT03614078|584600421|FG000|Overall Study|Dizziness and Rash|0|||
161879363|NCT03614078|584600422|FG001|Overall Study|Dizziness and Rash|1|||
161879364|NCT03614078|584600423|FG002|Overall Study|Dizziness and Rash|0|||
161879365|NCT02833844|584600424|FG000|Double-Blind Period|Withdrawal by Subject|2|||
161879366|NCT02833844|584600425|FG001|Double-Blind Period|Withdrawal by Subject|3|||
161991402|NCT00166439|585018499|FG000|Overall Study|Ineligible|5|||
161991403|NCT00483938|585018500|FG000|Overall Study|Protocol Violation|0|||
161991404|NCT00483938|585018501|FG001|Overall Study|Protocol Violation|0|||
161991405|NCT00483938|585018502|FG002|Overall Study|Protocol Violation|0|||
161991406|NCT00483938|585018503|FG003|Overall Study|Protocol Violation|0|||
161991407|NCT00483938|585018504|FG004|Overall Study|Protocol Violation|0|||
161991408|NCT00483938|585018505|FG005|Overall Study|Protocol Violation|0|||
161991409|NCT00483938|585018506|FG006|Overall Study|Protocol Violation|3|||
161991410|NCT00483938|585018500|FG000|Overall Study|Withdrawal by Subject|1|||
161777333|NCT03188991|584225579|FG000|Overall Study|Withdrawal by Subject|0|||
161777334|NCT03188991|584225580|FG001|Overall Study|Withdrawal by Subject|0|||
161777335|NCT03188991|584225581|FG002|Overall Study|Withdrawal by Subject|0|||
161777336|NCT03188991|584225582|FG003|Overall Study|Withdrawal by Subject|1|||
161777337|NCT03255226|584226985|FG000|Overall Study|Adverse Event|2|||
161777338|NCT03255226|584226985|FG000|Overall Study|Physician Decision|3|||
161777339|NCT03255226|584226985|FG000|Overall Study|Withdrawal by Subject|1|||
161777340|NCT03255226|584226985|FG000|Overall Study|Serum or blood sodium increased|4|||
161777341|NCT03255226|584226985|FG000|Overall Study|Serum or blood potassium increased|4|||
161777342|NCT01017731|584226986|FG000|Overall Study|Lost to Follow-up|2|||
161777343|NCT01017731|584226986|FG000|Overall Study|Withdrawal by Subject|3|||
161777344|NCT01017731|584226986|FG000|Overall Study|Physician Decision|2|||
161777345|NCT01017731|584226986|FG000|Overall Study|Adverse Event|1|||
161777346|NCT01035229|584226987|FG000|Overall Study|Adverse Event|61|||
161777347|NCT01035229|584226988|FG001|Overall Study|Adverse Event|14|||
161777348|NCT01035229|584226987|FG000|Overall Study|Withdrawal by Subject|20|||
161777349|NCT01035229|584226988|FG001|Overall Study|Withdrawal by Subject|7|||
161777350|NCT01035229|584226987|FG000|Overall Study|Lost to Follow-up|1|||
161777351|NCT01035229|584226988|FG001|Overall Study|Lost to Follow-up|0|||
161777352|NCT01035229|584226987|FG000|Overall Study|Administrative problems|1|||
161777353|NCT01035229|584226988|FG001|Overall Study|Administrative problems|1|||
161777354|NCT01035229|584226987|FG000|Overall Study|Death|13|||
161777355|NCT01035229|584226988|FG001|Overall Study|Death|5|||
161777356|NCT01035229|584226987|FG000|Overall Study|New cancer therapy|2|||
161777357|NCT01035229|584226988|FG001|Overall Study|New cancer therapy|0|||
161777358|NCT01035229|584226987|FG000|Overall Study|Protocol Violation|0|||
161879367|NCT02833844|584600424|FG000|Double-Blind Period|Protocol Violation|0|||
161879368|NCT02833844|584600425|FG001|Double-Blind Period|Protocol Violation|4|||
161879369|NCT02833844|584600424|FG000|Open-Label Period|Death|0|||
161879370|NCT02833844|584600425|FG001|Open-Label Period|Death|2|||
161879371|NCT02833844|584600424|FG000|Open-Label Period|Lost to Follow-up|1|||
161879372|NCT02833844|584600425|FG001|Open-Label Period|Lost to Follow-up|0|||
161879373|NCT02833844|584600424|FG000|Open-Label Period|Withdrawal by Subject|1|||
161879374|NCT02833844|584600425|FG001|Open-Label Period|Withdrawal by Subject|0|||
161879375|NCT04323306|584600426|FG000|Overall Study|Physician Decision|1|||
161991411|NCT00483938|585018501|FG001|Overall Study|Withdrawal by Subject|6|||
161879376|NCT04323306|584600427|FG001|Overall Study|Physician Decision|0|||
161879377|NCT04323306|584600428|FG002|Overall Study|Physician Decision|0|||
161879378|NCT04323306|584600429|FG003|Overall Study|Physician Decision|0|||
161879379|NCT04323306|584600430|FG004|Overall Study|Physician Decision|0|||
161879380|NCT04323306|584600431|FG005|Overall Study|Physician Decision|0|||
161879381|NCT04323306|584600432|FG006|Overall Study|Physician Decision|0|||
161879382|NCT04323306|584600433|FG007|Overall Study|Physician Decision|0|||
161879383|NCT04323306|584600434|FG008|Overall Study|Physician Decision|0|||
161879384|NCT04323306|584600426|FG000|Overall Study|Withdrawal by Subject|0|||
161879385|NCT04323306|584600427|FG001|Overall Study|Withdrawal by Subject|0|||
161879386|NCT04323306|584600428|FG002|Overall Study|Withdrawal by Subject|0|||
161879387|NCT04323306|584600429|FG003|Overall Study|Withdrawal by Subject|0|||
161879388|NCT04323306|584600430|FG004|Overall Study|Withdrawal by Subject|0|||
161879389|NCT04323306|584600431|FG005|Overall Study|Withdrawal by Subject|1|||
161879390|NCT04323306|584600432|FG006|Overall Study|Withdrawal by Subject|3|||
161879391|NCT04323306|584600433|FG007|Overall Study|Withdrawal by Subject|0|||
161879392|NCT04323306|584600434|FG008|Overall Study|Withdrawal by Subject|1|||
161879393|NCT00089778|584600435|FG000|Overall Study|Protocol Violation|0|||
161879394|NCT00089778|584600436|FG001|Overall Study|Protocol Violation|0|||
161879395|NCT00089778|584600437|FG002|Overall Study|Protocol Violation|1|||
161879396|NCT04712019|584600438|FG000|Overall Study|Withdrawal by Subject|2|||
161879397|NCT04712019|584600439|FG001|Overall Study|Withdrawal by Subject|2|||
161879398|NCT04712019|584600438|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
161879399|NCT04712019|584600439|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
161879400|NCT01646021|584600440|FG000|Overall Study|Death|77|||
161879401|NCT01646021|584600441|FG001|Overall Study|Death|83|||
161879402|NCT01646021|584600440|FG000|Overall Study|Study Terminated by Sponsor|50|||
161879403|NCT01646021|584600441|FG001|Overall Study|Study Terminated by Sponsor|41|||
161879404|NCT01646021|584600440|FG000|Overall Study|Lost to Follow-up|2|||
161879405|NCT01646021|584600441|FG001|Overall Study|Lost to Follow-up|2|||
161879406|NCT01646021|584600440|FG000|Overall Study|Withdrawal by Subject|10|||
161879407|NCT01646021|584600441|FG001|Overall Study|Withdrawal by Subject|15|||
161879408|NCT02347891|584600449|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
161879409|NCT02347891|584600450|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
161879410|NCT02347891|584600449|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
161879411|NCT02347891|584600450|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
161879412|NCT00725608|584600454|FG000|Overall Study|Lost to Follow-up|60|||
161879413|NCT00725608|584600454|FG000|Overall Study|Adverse Event|14|||
161879414|NCT00725608|584600454|FG000|Overall Study|Individual reasons|86|||
161879415|NCT00725608|584600454|FG000|Overall Study|Other|7|||
161879416|NCT00614120|584600458|FG000|Overall Study|Adverse Event|9|||
161879417|NCT00614120|584600459|FG001|Overall Study|Adverse Event|22|||
161879418|NCT00614120|584600460|FG002|Overall Study|Adverse Event|30|||
161879419|NCT00614120|584600461|FG003|Overall Study|Adverse Event|3|||
161879420|NCT00614120|584600458|FG000|Overall Study|Lack of Efficacy|3|||
161879421|NCT00614120|584600459|FG001|Overall Study|Lack of Efficacy|3|||
161879422|NCT00614120|584600460|FG002|Overall Study|Lack of Efficacy|2|||
161879423|NCT00614120|584600461|FG003|Overall Study|Lack of Efficacy|2|||
161879424|NCT00614120|584600458|FG000|Overall Study|Protocol Violation|2|||
161879425|NCT00614120|584600459|FG001|Overall Study|Protocol Violation|5|||
161879426|NCT00614120|584600460|FG002|Overall Study|Protocol Violation|3|||
161879427|NCT00614120|584600461|FG003|Overall Study|Protocol Violation|1|||
161879428|NCT00614120|584600458|FG000|Overall Study|Withdrawal criteria|1|||
161879429|NCT00614120|584600459|FG001|Overall Study|Withdrawal criteria|0|||
161879430|NCT00614120|584600460|FG002|Overall Study|Withdrawal criteria|0|||
161879431|NCT00614120|584600461|FG003|Overall Study|Withdrawal criteria|0|||
161879432|NCT00614120|584600458|FG000|Overall Study|Withdrawal by Subject|9|||
161879433|NCT00614120|584600459|FG001|Overall Study|Withdrawal by Subject|10|||
161879434|NCT00614120|584600460|FG002|Overall Study|Withdrawal by Subject|16|||
161879435|NCT00614120|584600461|FG003|Overall Study|Withdrawal by Subject|3|||
161879436|NCT00614120|584600458|FG000|Overall Study|Did not meet trial criteria|0|||
161879437|NCT00614120|584600459|FG001|Overall Study|Did not meet trial criteria|1|||
161879438|NCT00614120|584600460|FG002|Overall Study|Did not meet trial criteria|1|||
161879439|NCT00614120|584600461|FG003|Overall Study|Did not meet trial criteria|1|||
161991412|NCT00483938|585018502|FG002|Overall Study|Withdrawal by Subject|0|||
161991413|NCT00483938|585018503|FG003|Overall Study|Withdrawal by Subject|0|||
161879440|NCT00614120|584600458|FG000|Overall Study|hCG positive (not pregnant)|0|||
161879441|NCT00614120|584600459|FG001|Overall Study|hCG positive (not pregnant)|0|||
161879442|NCT00614120|584600460|FG002|Overall Study|hCG positive (not pregnant)|1|||
161879443|NCT00614120|584600461|FG003|Overall Study|hCG positive (not pregnant)|0|||
161879444|NCT00614120|584600458|FG000|Overall Study|Hypoglycaemia|0|||
161879445|NCT00614120|584600459|FG001|Overall Study|Hypoglycaemia|0|||
161879446|NCT00614120|584600460|FG002|Overall Study|Hypoglycaemia|0|||
161879447|NCT00614120|584600461|FG003|Overall Study|Hypoglycaemia|1|||
161879448|NCT00614120|584600458|FG000|Overall Study|Lack of trial product|3|||
161879449|NCT00614120|584600459|FG001|Overall Study|Lack of trial product|3|||
161879450|NCT00614120|584600460|FG002|Overall Study|Lack of trial product|2|||
161777359|NCT01035229|584226988|FG001|Overall Study|Protocol Violation|2|||
161777360|NCT01035229|584226987|FG000|Overall Study|Sponsor's decision to end study|3|||
161777361|NCT01035229|584226988|FG001|Overall Study|Sponsor's decision to end study|3|||
161879451|NCT00614120|584600461|FG003|Overall Study|Lack of trial product|0|||
161879452|NCT00614120|584600458|FG000|Overall Study|Late syphilis, latent|1|||
161879453|NCT00614120|584600459|FG001|Overall Study|Late syphilis, latent|0|||
161879454|NCT00614120|584600460|FG002|Overall Study|Late syphilis, latent|0|||
161879455|NCT00614120|584600461|FG003|Overall Study|Late syphilis, latent|0|||
161777362|NCT01035229|584226987|FG000|Overall Study|Disease Progression|261|||
161777363|NCT01035229|584226988|FG001|Overall Study|Disease Progression|152|||
161777364|NCT00685763|584226990|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
161777365|NCT00685763|584226990|FG000|Overall Study|Protocol Violation|1|||
161777366|NCT00698009|584226994|FG000|Overall Study|Withdrawal by Subject|1|||
161777367|NCT00564486|584226998|FG000|Overall Study|Adverse Event|0|||
161777368|NCT00564486|584226999|FG001|Overall Study|Adverse Event|1|||
161777369|NCT00564486|584227000|FG002|Overall Study|Adverse Event|0|||
161777370|NCT00564486|584227001|FG003|Overall Study|Adverse Event|0|||
161777371|NCT00564486|584226998|FG000|Overall Study|Withdrawal by Subject|4|||
161777372|NCT00564486|584226999|FG001|Overall Study|Withdrawal by Subject|0|||
161777373|NCT00564486|584227000|FG002|Overall Study|Withdrawal by Subject|0|||
161777374|NCT00564486|584227001|FG003|Overall Study|Withdrawal by Subject|5|||
161777375|NCT00564486|584226998|FG000|Overall Study|Subject refused to have blood drawn|0|||
161879456|NCT00614120|584600458|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
161879457|NCT00614120|584600459|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
161879458|NCT00614120|584600460|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
161879459|NCT00614120|584600461|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
161879460|NCT00614120|584600458|FG000|Overall Study|Lost to Follow-up|1|||
161879461|NCT00614120|584600459|FG001|Overall Study|Lost to Follow-up|2|||
161879462|NCT00614120|584600460|FG002|Overall Study|Lost to Follow-up|3|||
161879463|NCT00614120|584600461|FG003|Overall Study|Lost to Follow-up|4|||
161879464|NCT01084668|584600462|FG000|Overall Study|Lack of Efficacy|5|||
161879465|NCT01084668|584600462|FG000|Overall Study|Withdrawal by Subject|2|||
161879466|NCT01084668|584600462|FG000|Overall Study|Pregnancy|1|||
161879467|NCT01084668|584600462|FG000|Overall Study|Non-compliance|1|||
161879468|NCT02447497|584600463|FG000|Overall Study|Did not meet treatment day baseline.|6|||
161879469|NCT02447497|584600464|FG001|Overall Study|Did not meet treatment day baseline.|5|||
161879470|NCT02447497|584600465|FG002|Overall Study|Did not meet treatment day baseline.|2|||
161879471|NCT02447497|584600466|FG003|Overall Study|Did not meet treatment day baseline.|2|||
161879472|NCT02447497|584600463|FG000|Overall Study|Dressing was compromised|0|||
161879473|NCT02447497|584600464|FG001|Overall Study|Dressing was compromised|1|||
161879474|NCT02447497|584600465|FG002|Overall Study|Dressing was compromised|0|||
161879475|NCT02447497|584600466|FG003|Overall Study|Dressing was compromised|0|||
161879476|NCT02017912|584600467|FG000|Overall Study|Withdrawal by Subject|2|||
161879477|NCT02017912|584600468|FG001|Overall Study|Withdrawal by Subject|1|||
161879478|NCT02017912|584600467|FG000|Overall Study|miscellaneous|1|||
161879479|NCT02017912|584600468|FG001|Overall Study|miscellaneous|1|||
161879480|NCT04569968|584600469|FG000|Overall Study|Lost to Follow-up|2|||
161879481|NCT04569968|584600470|FG001|Overall Study|Lost to Follow-up|5|||
161879482|NCT04569968|584600469|FG000|Overall Study|Story of head and/or neck surgery|2|||
161879483|NCT04569968|584600470|FG001|Overall Study|Story of head and/or neck surgery|2|||
161879484|NCT04569968|584600469|FG000|Overall Study|Time of stroke onset|8|||
161879485|NCT04569968|584600470|FG001|Overall Study|Time of stroke onset|7|||
161879486|NCT04569968|584600469|FG000|Overall Study|Type of strokr|12|||
161879487|NCT04569968|584600470|FG001|Overall Study|Type of strokr|8|||
161879488|NCT04569968|584600469|FG000|Overall Study|Cooperation|8|||
161879489|NCT04569968|584600470|FG001|Overall Study|Cooperation|8|||
161879490|NCT04569968|584600469|FG000|Overall Study|Age interval|17|||
161879491|NCT04569968|584600470|FG001|Overall Study|Age interval|6|||
161879492|NCT04569968|584600469|FG000|Overall Study|Denial of participation to the study|0|||
161879493|NCT04569968|584600470|FG001|Overall Study|Denial of participation to the study|3|||
161879494|NCT04569968|584600469|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
161879495|NCT04569968|584600470|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
161879496|NCT04569968|584600469|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
161879497|NCT04569968|584600470|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
161879498|NCT04569968|584600469|FG000|Overall Study|Quarantine|1|||
161879499|NCT04569968|584600470|FG001|Overall Study|Quarantine|0|||
161879500|NCT04569968|584600469|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
161879501|NCT04569968|584600470|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
161879502|NCT04569968|584600469|FG000|Overall Study|Repetitive stroke|8|||
161879503|NCT04569968|584600470|FG001|Overall Study|Repetitive stroke|0|||
161777376|NCT00564486|584226999|FG001|Overall Study|Subject refused to have blood drawn|0|||
161777377|NCT00564486|584227000|FG002|Overall Study|Subject refused to have blood drawn|1|||
161879504|NCT04569968|584600469|FG000|Overall Study|Insufficient mastication|1|||
161777378|NCT00564486|584227001|FG003|Overall Study|Subject refused to have blood drawn|0|||
161777379|NCT00564486|584226998|FG000|Overall Study|Lost to Follow-up|3|||
161777380|NCT00564486|584226999|FG001|Overall Study|Lost to Follow-up|0|||
161777381|NCT00564486|584227000|FG002|Overall Study|Lost to Follow-up|2|||
161777382|NCT00564486|584227001|FG003|Overall Study|Lost to Follow-up|2|||
161777383|NCT03862807|584227002|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
161777384|NCT00798707|584227003|FG000|Overall Study|Adverse Event|6|||
161777385|NCT00798707|584227004|FG001|Overall Study|Adverse Event|8|||
161777386|NCT00798707|584227005|FG002|Overall Study|Adverse Event|8|||
161777387|NCT00798707|584227003|FG000|Overall Study|Failed to return|2|||
161777388|NCT00798707|584227004|FG001|Overall Study|Failed to return|2|||
161777389|NCT00798707|584227005|FG002|Overall Study|Failed to return|0|||
161777390|NCT00798707|584227003|FG000|Overall Study|Investigator|0|||
161777391|NCT00798707|584227004|FG001|Overall Study|Investigator|1|||
161777392|NCT00798707|584227005|FG002|Overall Study|Investigator|2|||
161777393|NCT00798707|584227003|FG000|Overall Study|Lack of Efficacy|2|||
161879505|NCT04569968|584600470|FG001|Overall Study|Insufficient mastication|0|||
161879506|NCT04569968|584600469|FG000|Overall Study|Infection|1|||
161777394|NCT00798707|584227004|FG001|Overall Study|Lack of Efficacy|2|||
161777395|NCT00798707|584227005|FG002|Overall Study|Lack of Efficacy|1|||
161777396|NCT00798707|584227003|FG000|Overall Study|Lost to Follow-up|5|||
161879507|NCT04569968|584600470|FG001|Overall Study|Infection|0|||
161879508|NCT00727844|584600471|FG000|Initial Randomization|Physician Decision|2|||
161879509|NCT00727844|584600472|FG001|Initial Randomization|Physician Decision|0|||
161879510|NCT00727844|584600473|FG002|Initial Randomization|Physician Decision|0|||
161777397|NCT00798707|584227004|FG001|Overall Study|Lost to Follow-up|6|||
161777398|NCT00798707|584227005|FG002|Overall Study|Lost to Follow-up|6|||
161777399|NCT00798707|584227003|FG000|Overall Study|Other|0|||
161777400|NCT00798707|584227004|FG001|Overall Study|Other|1|||
161777401|NCT00798707|584227005|FG002|Overall Study|Other|0|||
161777402|NCT00798707|584227003|FG000|Overall Study|Protocol Violation|4|||
161777403|NCT00798707|584227004|FG001|Overall Study|Protocol Violation|0|||
161777404|NCT00798707|584227005|FG002|Overall Study|Protocol Violation|2|||
161879511|NCT00727844|584600474|FG003|Initial Randomization|Physician Decision|0|||
161879512|NCT00985959|584600479|FG000|Overall Study|Adverse Event|0|||
161879513|NCT00985959|584600480|FG001|Overall Study|Adverse Event|0|||
161879514|NCT00985959|584600481|FG002|Overall Study|Adverse Event|19|||
161879515|NCT00985959|584600479|FG000|Overall Study|Withdrawal by Subject|0|||
161879516|NCT00985959|584600480|FG001|Overall Study|Withdrawal by Subject|0|||
161879517|NCT00985959|584600481|FG002|Overall Study|Withdrawal by Subject|8|||
161879518|NCT00985959|584600479|FG000|Overall Study|Progressive disease|1|||
161879519|NCT00985959|584600480|FG001|Overall Study|Progressive disease|2|||
161879520|NCT00985959|584600481|FG002|Overall Study|Progressive disease|8|||
161879521|NCT00985959|584600479|FG000|Overall Study|Unrecovered toxicity|0|||
161879522|NCT00985959|584600480|FG001|Overall Study|Unrecovered toxicity|0|||
161879523|NCT00985959|584600481|FG002|Overall Study|Unrecovered toxicity|7|||
161879524|NCT00985959|584600479|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
161879525|NCT00985959|584600480|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
161879526|NCT00985959|584600481|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
161879527|NCT00985959|584600479|FG000|Overall Study|Complete response observed over 2 cycles|0|||
161879528|NCT00985959|584600480|FG001|Overall Study|Complete response observed over 2 cycles|1|||
161879529|NCT00985959|584600481|FG002|Overall Study|Complete response observed over 2 cycles|4|||
161879530|NCT00985959|584600479|FG000|Overall Study|Other|0|||
161879531|NCT00985959|584600480|FG001|Overall Study|Other|0|||
161879532|NCT00985959|584600481|FG002|Overall Study|Other|11|||
161879533|NCT00979420|584600482|FG000|Overall Study|Adverse Event|1|||
161879534|NCT00979420|584600483|FG001|Overall Study|Adverse Event|0|||
161879535|NCT00979420|584600484|FG002|Overall Study|Adverse Event|0|||
161879536|NCT00979420|584600485|FG003|Overall Study|Adverse Event|0|||
161879537|NCT00979420|584600482|FG000|Overall Study|Lack of Efficacy|3|||
161879538|NCT00979420|584600483|FG001|Overall Study|Lack of Efficacy|0|||
161879539|NCT00979420|584600484|FG002|Overall Study|Lack of Efficacy|1|||
161879540|NCT00979420|584600485|FG003|Overall Study|Lack of Efficacy|1|||
161879541|NCT00979420|584600482|FG000|Overall Study|Other reasons not related to Viramune|3|||
161879542|NCT00979420|584600483|FG001|Overall Study|Other reasons not related to Viramune|0|||
161879543|NCT00979420|584600484|FG002|Overall Study|Other reasons not related to Viramune|0|||
161777405|NCT00798707|584227003|FG000|Overall Study|Withdrawal by Subject|3|||
161777406|NCT00798707|584227004|FG001|Overall Study|Withdrawal by Subject|8|||
161777407|NCT00798707|584227005|FG002|Overall Study|Withdrawal by Subject|2|||
161777408|NCT00798707|584227003|FG000|Overall Study|Randomized not treated|4|||
161777409|NCT00798707|584227004|FG001|Overall Study|Randomized not treated|5|||
161777410|NCT00798707|584227005|FG002|Overall Study|Randomized not treated|1|||
161777411|NCT01473589|584227006|FG000|Overall Study|Adverse Event|1|||
161879544|NCT00979420|584600485|FG003|Overall Study|Other reasons not related to Viramune|1|||
161879545|NCT02107859|584600487|FG000|Overall Study|Withdrawal by Subject|14|||
161879546|NCT02107859|584600487|FG000|Overall Study|Adverse Event|3|||
161879547|NCT02107859|584600487|FG000|Overall Study|Study closure|41|||
161879548|NCT02107859|584600487|FG000|Overall Study|Other than specified|3|||
161777412|NCT01473589|584227007|FG001|Overall Study|Adverse Event|1|||
161879549|NCT02235077|584600488|FG000|Overall Study|Death|5|||
161879550|NCT02235077|584600489|FG001|Overall Study|Death|7|||
161879551|NCT02235077|584600488|FG000|Overall Study|Lost to Follow-up|5|||
161879552|NCT02235077|584600489|FG001|Overall Study|Lost to Follow-up|6|||
161879553|NCT02235077|584600488|FG000|Overall Study|Withdrawal by Subject|8|||
161879554|NCT02235077|584600489|FG001|Overall Study|Withdrawal by Subject|5|||
161879555|NCT02235077|584600488|FG000|Overall Study|Physician Decision|0|||
161879556|NCT02235077|584600489|FG001|Overall Study|Physician Decision|1|||
161879557|NCT03852628|584600490|FG000|Overall Study|Lost to Follow-up|7|||
161879558|NCT03852628|584600491|FG001|Overall Study|Lost to Follow-up|6|||
161879559|NCT03852628|584600490|FG000|Overall Study|Lack of Efficacy|6|||
161879560|NCT03852628|584600491|FG001|Overall Study|Lack of Efficacy|6|||
161879561|NCT04013672|584600496|FG000|Overall Study|Withdrawal by Subject|3|||
161879562|NCT04013672|584600497|FG001|Overall Study|Withdrawal by Subject|0|||
161879563|NCT04013672|584600496|FG000|Overall Study|Death|1|||
161879564|NCT04013672|584600497|FG001|Overall Study|Death|0|||
161879565|NCT04013672|584600496|FG000|Overall Study|Physician Decision|5|||
161879566|NCT04013672|584600497|FG001|Overall Study|Physician Decision|0|||
161879567|NCT02847494|584600502|FG000|Overall Study|Lost to Follow-up|8|||
161879568|NCT02847494|584600503|FG001|Overall Study|Lost to Follow-up|5|||
161879569|NCT00022698|584600506|FG000|Overall Study|Adverse Event|5|||
161879570|NCT00022698|584600507|FG001|Overall Study|Adverse Event|9|||
161879571|NCT00022698|584600506|FG000|Overall Study|Death|0|||
161879572|NCT00022698|584600507|FG001|Overall Study|Death|2|||
161879573|NCT00022698|584600506|FG000|Overall Study|Failure to return|0|||
161879574|NCT00022698|584600507|FG001|Overall Study|Failure to return|1|||
161879575|NCT00022698|584600506|FG000|Overall Study|Refused treatment|0|||
161879576|NCT00022698|584600507|FG001|Overall Study|Refused treatment|2|||
161879577|NCT00022698|584600506|FG000|Overall Study|Insufficient therapeutic response|2|||
161879578|NCT00022698|584600507|FG001|Overall Study|Insufficient therapeutic response|14|||
161879579|NCT00022698|584600506|FG000|Overall Study|Administrative /other|1|||
161879580|NCT00022698|584600507|FG001|Overall Study|Administrative /other|7|||
161879581|NCT04553471|584600508|FG000|Overall Study|Did not start treatment on protocol|3|||
161879582|NCT04553471|584600508|FG000|Overall Study|Death|1|||
161879583|NCT01441765|584600509|FG000|Overall Study|Death|1|||
161879584|NCT01441765|584600510|FG001|Overall Study|Death|0|||
161879585|NCT00813813|584600511|FG000|Overall Study|Withdrawal by Subject|1|||
161879586|NCT00813813|584600512|FG001|Overall Study|Withdrawal by Subject|1|||
161879587|NCT00813813|584600511|FG000|Overall Study|Lost to Follow-up|2|||
161879588|NCT00813813|584600512|FG001|Overall Study|Lost to Follow-up|7|||
161879589|NCT00813813|584600511|FG000|Overall Study|Other|0|||
161879590|NCT00813813|584600512|FG001|Overall Study|Other|1|||
161879591|NCT01684943|584600514|FG000|Overall Study|Inadequate Venous Access|3|||
161879592|NCT01684943|584600515|FG001|Overall Study|Inadequate Venous Access|0|||
161879593|NCT01684943|584600516|FG002|Overall Study|Inadequate Venous Access|0|||
161879594|NCT01684943|584600514|FG000|Overall Study|Principal Investigator Determination|1|||
161879595|NCT01684943|584600515|FG001|Overall Study|Principal Investigator Determination|0|||
161879596|NCT01684943|584600516|FG002|Overall Study|Principal Investigator Determination|0|||
161879597|NCT01684943|584600514|FG000|Overall Study|Excluded from Analysis|1|||
161879598|NCT01684943|584600515|FG001|Overall Study|Excluded from Analysis|1|||
161879599|NCT01684943|584600516|FG002|Overall Study|Excluded from Analysis|1|||
161879600|NCT01684943|584600514|FG000|Overall Study|Lost to Follow-up|3|||
161879601|NCT01684943|584600515|FG001|Overall Study|Lost to Follow-up|0|||
161879602|NCT01684943|584600516|FG002|Overall Study|Lost to Follow-up|0|||
161879603|NCT01684943|584600514|FG000|Overall Study|Planning Pregnancy|1|||
161879604|NCT01684943|584600515|FG001|Overall Study|Planning Pregnancy|0|||
161879605|NCT01684943|584600516|FG002|Overall Study|Planning Pregnancy|0|||
161879606|NCT00325156|584600517|FG000|Overall Study|Protocol Violation|8|||
161879607|NCT00325156|584600517|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
161879608|NCT00325156|584600517|FG000|Overall Study|Migrated/moved from study area|12|||
161879609|NCT00325156|584600517|FG000|Overall Study|Adverse event, non-fatal|3|||
161879610|NCT00325156|584600517|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
161879611|NCT00325156|584600517|FG000|Overall Study|Other|1|||
161879612|NCT00325156|584600517|FG000|Overall Study|Withdrawal by Subject|31|||
161879613|NCT04064411|584600518|FG000|Overall Study|Adverse Event|29|||
161879614|NCT04064411|584600519|FG001|Overall Study|Adverse Event|19|||
161879615|NCT04064411|584600518|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
161879616|NCT04064411|584600519|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
161879617|NCT04064411|584600518|FG000|Overall Study|Protocol Deviation|0|||
161879618|NCT04064411|584600519|FG001|Overall Study|Protocol Deviation|2|||
161879619|NCT04064411|584600518|FG000|Overall Study|Withdrawal by Subject|25|||
161879620|NCT04064411|584600519|FG001|Overall Study|Withdrawal by Subject|29|||
161879621|NCT04064411|584600518|FG000|Overall Study|Lost to Follow-up|5|||
161879622|NCT04064411|584600519|FG001|Overall Study|Lost to Follow-up|2|||
161879623|NCT04064411|584600518|FG000|Overall Study|Other than Specified|4|||
161879624|NCT04064411|584600519|FG001|Overall Study|Other than Specified|1|||
161879625|NCT04064411|584600518|FG000|Overall Study|Death|1|||
161879626|NCT04064411|584600519|FG001|Overall Study|Death|0|||
161879627|NCT03395184|584600520|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
161879628|NCT03395184|584600521|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
161879629|NCT03395184|584600522|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
161879630|NCT03395184|584600523|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
161879631|NCT03395184|584600524|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
161879632|NCT03395184|584600525|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
161879633|NCT03395184|584600526|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
161879634|NCT03395184|584600520|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161879635|NCT03395184|584600521|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
161879636|NCT03395184|584600522|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
161879637|NCT03395184|584600523|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161879638|NCT03395184|584600524|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161879639|NCT03395184|584600525|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161879640|NCT03395184|584600526|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161879641|NCT03395184|584600520|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
161879642|NCT03395184|584600521|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
161879643|NCT03395184|584600522|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161879644|NCT03395184|584600523|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161879645|NCT03395184|584600524|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161879646|NCT03395184|584600525|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161879647|NCT03395184|584600526|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161879648|NCT03395184|584600520|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161879649|NCT03395184|584600521|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
161879650|NCT03395184|584600522|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161879651|NCT03395184|584600523|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161879652|NCT03395184|584600524|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161879653|NCT03395184|584600525|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161879654|NCT03395184|584600526|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161879655|NCT03395184|584600520|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
161879656|NCT03395184|584600521|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161879657|NCT03395184|584600522|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
161879658|NCT03395184|584600523|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161879659|NCT03395184|584600524|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161879660|NCT03395184|584600525|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161879661|NCT03395184|584600526|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161879662|NCT03395184|584600520|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
161879663|NCT03395184|584600521|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
161879664|NCT03395184|584600522|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
161879665|NCT03395184|584600523|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
161879666|NCT03395184|584600524|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
161879667|NCT03395184|584600525|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
161879668|NCT03395184|584600526|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
161879669|NCT03395184|584600520|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
161879670|NCT03395184|584600521|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
161879671|NCT03395184|584600522|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
161879672|NCT03395184|584600523|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
161879673|NCT03395184|584600524|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
161879674|NCT03395184|584600525|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
161879675|NCT03395184|584600526|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
161879676|NCT03395184|584600520|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
161879677|NCT03395184|584600521|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
161879678|NCT03395184|584600522|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
161879679|NCT03395184|584600523|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
161879680|NCT03395184|584600524|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
161879681|NCT03395184|584600525|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
161879682|NCT03395184|584600526|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
161879683|NCT03395184|584600520|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161879684|NCT03395184|584600521|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161879685|NCT03395184|584600522|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161879686|NCT03395184|584600523|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161879687|NCT03395184|584600524|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
161879688|NCT03395184|584600525|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161879689|NCT03395184|584600526|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161879690|NCT03395184|584600520|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
161879691|NCT03395184|584600521|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
161879692|NCT03395184|584600522|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
161879693|NCT03395184|584600523|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
161879694|NCT03395184|584600524|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
161879695|NCT03395184|584600525|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
161879696|NCT03395184|584600526|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
161879697|NCT03395184|584600520|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161879698|NCT03395184|584600521|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161879699|NCT03395184|584600522|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161879700|NCT03395184|584600523|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
161879701|NCT03395184|584600524|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161879702|NCT03395184|584600525|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
161879703|NCT03395184|584600526|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161879704|NCT03395184|584600520|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
161879705|NCT03395184|584600521|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
161879706|NCT03395184|584600522|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
161879707|NCT03395184|584600523|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
161879708|NCT03395184|584600524|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
161879709|NCT03395184|584600525|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
161879710|NCT03395184|584600526|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
161879711|NCT03512210|584600530|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
161879712|NCT03512210|584600530|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
161879713|NCT03512210|584600530|FG000|Step 2:Post-MINMON|Death|2|||
161879714|NCT03512210|584600530|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
161879715|NCT03512210|584600530|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
161879716|NCT01672710|584600531|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
161879717|NCT01672710|584600532|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
161879718|NCT01672710|584600531|FG000|3 Month Follow up|Lost to Follow-up|2|||
161879719|NCT01672710|584600532|FG001|3 Month Follow up|Lost to Follow-up|3|||
161879720|NCT01672710|584600531|FG000|3 Month Follow up|follow up due after termination date|4|||
161879721|NCT01672710|584600532|FG001|3 Month Follow up|follow up due after termination date|1|||
161879722|NCT05033262|584600533|FG000|Overall Study|Lost to Follow-up|1|||
161879723|NCT05033262|584600534|FG001|Overall Study|Lost to Follow-up|0|||
161879724|NCT05033262|584600535|FG002|Overall Study|Lost to Follow-up|0|||
161879725|NCT05033262|584600536|FG003|Overall Study|Lost to Follow-up|1|||
161879726|NCT03725761|584600537|FG000|Overall Study|still on study|1|||
161879727|NCT03197467|584602747|FG000|Overall Study|Withdrawal by Subject|1|||
161879728|NCT03666533|584602748|FG000|Overall Study|Lost to Follow-up|2|||
161879729|NCT03666533|584602749|FG001|Overall Study|Lost to Follow-up|2|||
161879730|NCT02017717|584602750|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879731|NCT02017717|584602751|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879732|NCT02017717|584602752|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879733|NCT02017717|584602753|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879734|NCT02017717|584602754|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879735|NCT02017717|584602755|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879736|NCT02017717|584602756|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879737|NCT02017717|584602757|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
161879738|NCT02017717|584602758|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161879739|NCT02017717|584602750|FG000|Before Treatment Period|Participant request to stop therapy|0|||
161879740|NCT02017717|584602751|FG001|Before Treatment Period|Participant request to stop therapy|0|||
161879741|NCT02017717|584602752|FG002|Before Treatment Period|Participant request to stop therapy|0|||
161879742|NCT02017717|584602753|FG003|Before Treatment Period|Participant request to stop therapy|0|||
161879743|NCT02017717|584602754|FG004|Before Treatment Period|Participant request to stop therapy|0|||
161879744|NCT02017717|584602755|FG005|Before Treatment Period|Participant request to stop therapy|0|||
161879745|NCT02017717|584602756|FG006|Before Treatment Period|Participant request to stop therapy|0|||
161879746|NCT02017717|584602757|FG007|Before Treatment Period|Participant request to stop therapy|0|||
161879747|NCT02017717|584602758|FG008|Before Treatment Period|Participant request to stop therapy|5|||
161879748|NCT02017717|584602750|FG000|Before Treatment Period|Participant withdrew consent|0|||
161879749|NCT02017717|584602751|FG001|Before Treatment Period|Participant withdrew consent|0|||
161879750|NCT02017717|584602752|FG002|Before Treatment Period|Participant withdrew consent|0|||
161879751|NCT02017717|584602753|FG003|Before Treatment Period|Participant withdrew consent|0|||
161879752|NCT02017717|584602754|FG004|Before Treatment Period|Participant withdrew consent|0|||
161879753|NCT02017717|584602755|FG005|Before Treatment Period|Participant withdrew consent|0|||
161879754|NCT02017717|584602756|FG006|Before Treatment Period|Participant withdrew consent|2|||
161879755|NCT02017717|584602757|FG007|Before Treatment Period|Participant withdrew consent|0|||
161879756|NCT02017717|584602758|FG008|Before Treatment Period|Participant withdrew consent|11|||
161879757|NCT02017717|584602750|FG000|Before Treatment Period|Lost to Follow-up|0|||
161879758|NCT02017717|584602751|FG001|Before Treatment Period|Lost to Follow-up|0|||
161879759|NCT02017717|584602752|FG002|Before Treatment Period|Lost to Follow-up|0|||
161879760|NCT02017717|584602753|FG003|Before Treatment Period|Lost to Follow-up|0|||
161879761|NCT02017717|584602754|FG004|Before Treatment Period|Lost to Follow-up|0|||
161879762|NCT02017717|584602755|FG005|Before Treatment Period|Lost to Follow-up|0|||
161879763|NCT02017717|584602756|FG006|Before Treatment Period|Lost to Follow-up|0|||
161879764|NCT02017717|584602757|FG007|Before Treatment Period|Lost to Follow-up|0|||
161879765|NCT02017717|584602758|FG008|Before Treatment Period|Lost to Follow-up|1|||
161879766|NCT02017717|584602750|FG000|Before Treatment Period|Participant no longer met criteria|0|||
161879767|NCT02017717|584602751|FG001|Before Treatment Period|Participant no longer met criteria|0|||
161879768|NCT02017717|584602752|FG002|Before Treatment Period|Participant no longer met criteria|0|||
161777413|NCT01473589|584227006|FG000|Overall Study|Death|2|||
161777414|NCT01473589|584227007|FG001|Overall Study|Death|0|||
161777415|NCT01473589|584227006|FG000|Overall Study|Lost to Follow-up|2|||
161777416|NCT01473589|584227007|FG001|Overall Study|Lost to Follow-up|2|||
161777417|NCT01473589|584227006|FG000|Overall Study|Protocol Violation|1|||
161777418|NCT01473589|584227007|FG001|Overall Study|Protocol Violation|0|||
161777419|NCT01473589|584227006|FG000|Overall Study|Withdrawal by Subject|5|||
161777420|NCT01473589|584227007|FG001|Overall Study|Withdrawal by Subject|11|||
161777421|NCT01473589|584227006|FG000|Overall Study|Physician Decision|0|||
161777422|NCT01473589|584227007|FG001|Overall Study|Physician Decision|1|||
161777423|NCT01473589|584227006|FG000|Overall Study|Entry criteria not met|0|||
161879769|NCT02017717|584602753|FG003|Before Treatment Period|Participant no longer met criteria|0|||
161879770|NCT02017717|584602754|FG004|Before Treatment Period|Participant no longer met criteria|0|||
161879771|NCT02017717|584602755|FG005|Before Treatment Period|Participant no longer met criteria|1|||
161879772|NCT02017717|584602756|FG006|Before Treatment Period|Participant no longer met criteria|0|||
161879773|NCT02017717|584602757|FG007|Before Treatment Period|Participant no longer met criteria|1|||
161879774|NCT02017717|584602758|FG008|Before Treatment Period|Participant no longer met criteria|2|||
161879775|NCT02017717|584602750|FG000|Before Treatment Period|other reason|0|||
161879776|NCT02017717|584602751|FG001|Before Treatment Period|other reason|0|||
161879777|NCT02017717|584602752|FG002|Before Treatment Period|other reason|0|||
161879778|NCT02017717|584602753|FG003|Before Treatment Period|other reason|0|||
161879779|NCT02017717|584602754|FG004|Before Treatment Period|other reason|0|||
161879780|NCT02017717|584602755|FG005|Before Treatment Period|other reason|0|||
161879781|NCT02017717|584602756|FG006|Before Treatment Period|other reason|0|||
161777424|NCT01473589|584227007|FG001|Overall Study|Entry criteria not met|1|||
161777425|NCT03286426|584227011|FG000|Overall Study|Physician Decision|3|||
161879782|NCT02017717|584602757|FG007|Before Treatment Period|other reason|0|||
161777426|NCT01817764|584227012|FG000|Overall Study|Adverse Event|7|||
161777427|NCT01817764|584227013|FG001|Overall Study|Adverse Event|10|||
161777428|NCT01817764|584227012|FG000|Overall Study|Lack of Efficacy|9|||
161777429|NCT01817764|584227013|FG001|Overall Study|Lack of Efficacy|7|||
161777430|NCT01817764|584227012|FG000|Overall Study|Protocol Violation|7|||
161777431|NCT01817764|584227013|FG001|Overall Study|Protocol Violation|5|||
161777432|NCT01817764|584227012|FG000|Overall Study|Lost to Follow-up|1|||
161777433|NCT01817764|584227013|FG001|Overall Study|Lost to Follow-up|4|||
161777434|NCT01817764|584227012|FG000|Overall Study|Withdrawal by Subject|10|||
161777435|NCT01817764|584227013|FG001|Overall Study|Withdrawal by Subject|12|||
161777436|NCT01956123|584227014|FG000|COS Cycle 2|Protocol Violation|8|||
161777437|NCT01956123|584227015|FG001|COS Cycle 2|Protocol Violation|3|||
161777438|NCT01956123|584227016|FG002|COS Cycle 2|Protocol Violation|0|||
161777439|NCT01956123|584227017|FG003|COS Cycle 2|Protocol Violation|0|||
161777440|NCT01956123|584227014|FG000|COS Cycle 2|Adverse Event|3|||
161777441|NCT01956123|584227015|FG001|COS Cycle 2|Adverse Event|4|||
161777442|NCT01956123|584227016|FG002|COS Cycle 2|Adverse Event|0|||
161777443|NCT01956123|584227017|FG003|COS Cycle 2|Adverse Event|0|||
161777444|NCT01956123|584227014|FG000|COS Cycle 2|Personal Reasons|2|||
161777445|NCT01956123|584227015|FG001|COS Cycle 2|Personal Reasons|0|||
161777446|NCT01956123|584227016|FG002|COS Cycle 2|Personal Reasons|0|||
161777447|NCT01956123|584227017|FG003|COS Cycle 2|Personal Reasons|0|||
161777448|NCT01956123|584227014|FG000|COS Cycle 2|Withdrawal by Subject|1|||
161777449|NCT01956123|584227015|FG001|COS Cycle 2|Withdrawal by Subject|0|||
161777450|NCT01956123|584227016|FG002|COS Cycle 2|Withdrawal by Subject|0|||
161777451|NCT01956123|584227017|FG003|COS Cycle 2|Withdrawal by Subject|0|||
161777452|NCT01956123|584227014|FG000|COS Cycle 3|Protocol Violation|0|||
161777453|NCT01956123|584227015|FG001|COS Cycle 3|Protocol Violation|0|||
161777454|NCT01956123|584227016|FG002|COS Cycle 3|Protocol Violation|2|||
161777455|NCT01956123|584227017|FG003|COS Cycle 3|Protocol Violation|1|||
161777456|NCT01956123|584227014|FG000|COS Cycle 3|Adverse Event|0|||
161777457|NCT01956123|584227015|FG001|COS Cycle 3|Adverse Event|0|||
161777458|NCT01956123|584227016|FG002|COS Cycle 3|Adverse Event|3|||
161777459|NCT01956123|584227017|FG003|COS Cycle 3|Adverse Event|0|||
161777460|NCT01956123|584227014|FG000|COS Cycle 3|Personal Reasons|0|||
161777461|NCT01956123|584227015|FG001|COS Cycle 3|Personal Reasons|0|||
161777462|NCT01956123|584227016|FG002|COS Cycle 3|Personal Reasons|1|||
161777463|NCT01956123|584227017|FG003|COS Cycle 3|Personal Reasons|0|||
161777464|NCT01956123|584227014|FG000|COS Cycle 3|Withdrawal by Subject|0|||
161777465|NCT01956123|584227015|FG001|COS Cycle 3|Withdrawal by Subject|0|||
161777466|NCT01956123|584227016|FG002|COS Cycle 3|Withdrawal by Subject|0|||
161777467|NCT01956123|584227017|FG003|COS Cycle 3|Withdrawal by Subject|1|||
161777468|NCT00826176|584227030|FG000|Overall Study|Lost to Follow-up|1|||
161777469|NCT00826176|584227031|FG001|Overall Study|Lost to Follow-up|0|||
161777470|NCT00826176|584227030|FG000|Overall Study|Subject Withdrew Consent|3|||
161879783|NCT02017717|584602758|FG008|Before Treatment Period|other reason|1|||
161777471|NCT00826176|584227031|FG001|Overall Study|Subject Withdrew Consent|0|||
161777472|NCT00826176|584227030|FG000|Overall Study|Administrative|9|||
161879784|NCT02017717|584602750|FG000|Treatment Period|Disease progression|7|||
161879785|NCT02017717|584602751|FG001|Treatment Period|Disease progression|9|||
161879786|NCT02017717|584602752|FG002|Treatment Period|Disease progression|12|||
161879787|NCT02017717|584602753|FG003|Treatment Period|Disease progression|20|||
161879788|NCT02017717|584602754|FG004|Treatment Period|Disease progression|26|||
161879789|NCT02017717|584602755|FG005|Treatment Period|Disease progression|16|||
161879790|NCT02017717|584602756|FG006|Treatment Period|Disease progression|22|||
161879791|NCT02017717|584602757|FG007|Treatment Period|Disease progression|165|||
161879792|NCT02017717|584602758|FG008|Treatment Period|Disease progression|135|||
161879793|NCT02017717|584602750|FG000|Treatment Period|Study drug toxicity|3|||
161879794|NCT02017717|584602751|FG001|Treatment Period|Study drug toxicity|0|||
161879795|NCT02017717|584602752|FG002|Treatment Period|Study drug toxicity|1|||
161879796|NCT02017717|584602753|FG003|Treatment Period|Study drug toxicity|4|||
161879797|NCT02017717|584602754|FG004|Treatment Period|Study drug toxicity|4|||
161879798|NCT02017717|584602755|FG005|Treatment Period|Study drug toxicity|5|||
161879799|NCT02017717|584602756|FG006|Treatment Period|Study drug toxicity|3|||
161879800|NCT02017717|584602757|FG007|Treatment Period|Study drug toxicity|7|||
161879801|NCT02017717|584602758|FG008|Treatment Period|Study drug toxicity|11|||
161879802|NCT02017717|584602750|FG000|Treatment Period|Death|0|||
161879803|NCT02017717|584602751|FG001|Treatment Period|Death|0|||
161879804|NCT02017717|584602752|FG002|Treatment Period|Death|1|||
161879805|NCT02017717|584602753|FG003|Treatment Period|Death|0|||
161879806|NCT02017717|584602754|FG004|Treatment Period|Death|0|||
161879807|NCT02017717|584602755|FG005|Treatment Period|Death|2|||
161879808|NCT02017717|584602756|FG006|Treatment Period|Death|0|||
161777473|NCT00826176|584227031|FG001|Overall Study|Administrative|0|||
161777474|NCT00568776|584227034|FG000|Overall Study|Adverse Event|8|||
161777475|NCT00568776|584227035|FG001|Overall Study|Adverse Event|8|||
161777476|NCT00568776|584227036|FG002|Overall Study|Adverse Event|10|||
161777477|NCT00568776|584227037|FG003|Overall Study|Adverse Event|8|||
161777478|NCT00568776|584227034|FG000|Overall Study|Death|0|||
161777479|NCT00568776|584227035|FG001|Overall Study|Death|1|||
161879809|NCT02017717|584602757|FG007|Treatment Period|Death|0|||
161879810|NCT02017717|584602758|FG008|Treatment Period|Death|0|||
161879811|NCT02017717|584602750|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
161879812|NCT02017717|584602751|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
161879813|NCT02017717|584602752|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
161879814|NCT02017717|584602753|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
161879815|NCT02017717|584602754|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
161777480|NCT00568776|584227036|FG002|Overall Study|Death|4|||
161777481|NCT00568776|584227037|FG003|Overall Study|Death|3|||
161879816|NCT02017717|584602755|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
161879817|NCT02017717|584602756|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
161777482|NCT00568776|584227034|FG000|Overall Study|Physician Decision|0|||
161777483|NCT00568776|584227035|FG001|Overall Study|Physician Decision|2|||
161777484|NCT00568776|584227036|FG002|Overall Study|Physician Decision|0|||
161777485|NCT00568776|584227037|FG003|Overall Study|Physician Decision|0|||
161777486|NCT00568776|584227034|FG000|Overall Study|Lack of Efficacy|2|||
161777487|NCT00568776|584227035|FG001|Overall Study|Lack of Efficacy|2|||
161879818|NCT02017717|584602757|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
161879819|NCT02017717|584602758|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
161879820|NCT02017717|584602750|FG000|Treatment Period|Participant request to stop therapy|0|||
161879821|NCT02017717|584602751|FG001|Treatment Period|Participant request to stop therapy|0|||
161879822|NCT02017717|584602752|FG002|Treatment Period|Participant request to stop therapy|3|||
161777488|NCT00568776|584227036|FG002|Overall Study|Lack of Efficacy|2|||
161777489|NCT00568776|584227037|FG003|Overall Study|Lack of Efficacy|4|||
161777490|NCT00568776|584227034|FG000|Overall Study|Lost to Follow-up|1|||
161777491|NCT00568776|584227035|FG001|Overall Study|Lost to Follow-up|1|||
161777492|NCT00568776|584227036|FG002|Overall Study|Lost to Follow-up|1|||
161777493|NCT00568776|584227037|FG003|Overall Study|Lost to Follow-up|1|||
161777494|NCT00568776|584227034|FG000|Overall Study|Protocol Violation|1|||
161777495|NCT00568776|584227035|FG001|Overall Study|Protocol Violation|0|||
161777496|NCT00568776|584227036|FG002|Overall Study|Protocol Violation|1|||
161777497|NCT00568776|584227037|FG003|Overall Study|Protocol Violation|1|||
161777498|NCT00568776|584227034|FG000|Overall Study|Withdrawal by Subject|13|||
161777499|NCT00568776|584227035|FG001|Overall Study|Withdrawal by Subject|15|||
161777500|NCT00568776|584227036|FG002|Overall Study|Withdrawal by Subject|13|||
161777501|NCT00568776|584227037|FG003|Overall Study|Withdrawal by Subject|7|||
161777502|NCT00568776|584227034|FG000|Overall Study|Loss of Caregiver|0|||
161879823|NCT02017717|584602753|FG003|Treatment Period|Participant request to stop therapy|6|||
161879824|NCT02017717|584602754|FG004|Treatment Period|Participant request to stop therapy|0|||
161879825|NCT02017717|584602755|FG005|Treatment Period|Participant request to stop therapy|2|||
161777503|NCT00568776|584227035|FG001|Overall Study|Loss of Caregiver|2|||
161777504|NCT00568776|584227036|FG002|Overall Study|Loss of Caregiver|1|||
161777505|NCT00568776|584227037|FG003|Overall Study|Loss of Caregiver|2|||
161777506|NCT00568776|584227034|FG000|Overall Study|Sponsor Decision|2|||
161777507|NCT00568776|584227035|FG001|Overall Study|Sponsor Decision|2|||
161777508|NCT00568776|584227036|FG002|Overall Study|Sponsor Decision|41|||
161777509|NCT00568776|584227037|FG003|Overall Study|Sponsor Decision|42|||
161777510|NCT00568776|584227034|FG000|Overall Study|Miscellaeneous|3|||
161777511|NCT00568776|584227035|FG001|Overall Study|Miscellaeneous|3|||
161777512|NCT00568776|584227036|FG002|Overall Study|Miscellaeneous|1|||
161777513|NCT00568776|584227037|FG003|Overall Study|Miscellaeneous|4|||
161777514|NCT03576131|584227038|FG000|Overall Study|Investigator decision|0|||
161777515|NCT03576131|584227039|FG001|Overall Study|Investigator decision|0|||
161777516|NCT03576131|584227040|FG002|Overall Study|Investigator decision|0|||
161777517|NCT03576131|584227041|FG003|Overall Study|Investigator decision|1|||
161777518|NCT03576131|584227042|FG004|Overall Study|Investigator decision|0|||
161777519|NCT03576131|584227043|FG005|Overall Study|Investigator decision|1|||
161777520|NCT03576131|584227044|FG006|Overall Study|Investigator decision|0|||
161777521|NCT03576131|584227045|FG007|Overall Study|Investigator decision|0|||
161777522|NCT03576131|584227038|FG000|Overall Study|Withdrawal by Subject|1|||
161777523|NCT03576131|584227039|FG001|Overall Study|Withdrawal by Subject|1|||
161777524|NCT03576131|584227040|FG002|Overall Study|Withdrawal by Subject|0|||
161777525|NCT03576131|584227041|FG003|Overall Study|Withdrawal by Subject|1|||
161777526|NCT03576131|584227042|FG004|Overall Study|Withdrawal by Subject|2|||
161777527|NCT03576131|584227043|FG005|Overall Study|Withdrawal by Subject|3|||
161777528|NCT03576131|584227044|FG006|Overall Study|Withdrawal by Subject|1|||
161777529|NCT03576131|584227045|FG007|Overall Study|Withdrawal by Subject|0|||
161777530|NCT03576131|584227038|FG000|Overall Study|Death|3|||
161777531|NCT03576131|584227039|FG001|Overall Study|Death|3|||
161777532|NCT03576131|584227040|FG002|Overall Study|Death|1|||
161777533|NCT03576131|584227041|FG003|Overall Study|Death|5|||
161777534|NCT03576131|584227042|FG004|Overall Study|Death|4|||
161777535|NCT03576131|584227043|FG005|Overall Study|Death|1|||
161777536|NCT03576131|584227044|FG006|Overall Study|Death|0|||
161777537|NCT03576131|584227045|FG007|Overall Study|Death|1|||
161777538|NCT03576131|584227038|FG000|Overall Study|New anti-cancer treatment|5|||
161777539|NCT03576131|584227039|FG001|Overall Study|New anti-cancer treatment|1|||
161777540|NCT03576131|584227040|FG002|Overall Study|New anti-cancer treatment|2|||
161777541|NCT03576131|584227041|FG003|Overall Study|New anti-cancer treatment|3|||
161777542|NCT03576131|584227042|FG004|Overall Study|New anti-cancer treatment|0|||
161777543|NCT03576131|584227043|FG005|Overall Study|New anti-cancer treatment|0|||
161777544|NCT03576131|584227044|FG006|Overall Study|New anti-cancer treatment|0|||
161777545|NCT03576131|584227045|FG007|Overall Study|New anti-cancer treatment|0|||
161777546|NCT03576131|584227038|FG000|Overall Study|Unspecified reason|0|||
161777547|NCT03576131|584227039|FG001|Overall Study|Unspecified reason|0|||
161777548|NCT03576131|584227040|FG002|Overall Study|Unspecified reason|1|||
161777549|NCT03576131|584227041|FG003|Overall Study|Unspecified reason|1|||
161777550|NCT03576131|584227042|FG004|Overall Study|Unspecified reason|1|||
161777551|NCT03576131|584227043|FG005|Overall Study|Unspecified reason|1|||
161777552|NCT03576131|584227044|FG006|Overall Study|Unspecified reason|0|||
161777553|NCT03576131|584227045|FG007|Overall Study|Unspecified reason|0|||
161777554|NCT03576131|584227038|FG000|Overall Study|Subject non-compliance|0|||
161777555|NCT03576131|584227039|FG001|Overall Study|Subject non-compliance|0|||
161777556|NCT03576131|584227040|FG002|Overall Study|Subject non-compliance|0|||
161777557|NCT03576131|584227041|FG003|Overall Study|Subject non-compliance|0|||
161777558|NCT03576131|584227042|FG004|Overall Study|Subject non-compliance|0|||
161879826|NCT02017717|584602756|FG006|Treatment Period|Participant request to stop therapy|1|||
161879827|NCT02017717|584602757|FG007|Treatment Period|Participant request to stop therapy|4|||
161879828|NCT02017717|584602758|FG008|Treatment Period|Participant request to stop therapy|7|||
161777559|NCT03576131|584227043|FG005|Overall Study|Subject non-compliance|1|||
161777560|NCT03576131|584227044|FG006|Overall Study|Subject non-compliance|0|||
161777561|NCT03576131|584227045|FG007|Overall Study|Subject non-compliance|0|||
161777562|NCT01569594|584227050|FG000|Overall Study|Physician Decision|4|||
161777563|NCT01569594|584227050|FG000|Overall Study|Death|13|||
161777564|NCT01569594|584227050|FG000|Overall Study|Lost to Follow-up|22|||
161777565|NCT01569594|584227050|FG000|Overall Study|Adverse Event|2|||
161777566|NCT01569594|584227050|FG000|Overall Study|Withdrawal by Subject|13|||
161777567|NCT01569594|584227050|FG000|Overall Study|Other|4|||
161777568|NCT01569594|584227050|FG000|Overall Study|No ECM used|9|||
161777569|NCT00877799|584227051|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
161777570|NCT00877799|584227052|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
161777571|NCT00877799|584227053|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
161777572|NCT00877799|584227054|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
161777573|NCT00877799|584227055|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
161879829|NCT02017717|584602750|FG000|Treatment Period|Participant withdrew consent|0|||
161879830|NCT02017717|584602751|FG001|Treatment Period|Participant withdrew consent|0|||
161777574|NCT00877799|584227051|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
161777575|NCT00877799|584227052|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
161777576|NCT00877799|584227053|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
161777577|NCT00877799|584227054|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
161777578|NCT00877799|584227055|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
161777579|NCT00877799|584227051|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
161777580|NCT00877799|584227052|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
161777581|NCT00877799|584227053|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
161777582|NCT00877799|584227054|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
161777583|NCT00877799|584227055|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
161777584|NCT00877799|584227051|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
161777585|NCT00877799|584227052|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
161777586|NCT00877799|584227053|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
161777587|NCT00877799|584227054|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
161777588|NCT00877799|584227055|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
161777589|NCT00877799|584227051|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
161777590|NCT00877799|584227052|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
161777591|NCT00877799|584227053|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
161777592|NCT00877799|584227054|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
161777593|NCT00877799|584227055|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
161777594|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
161777595|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
161777596|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
161777597|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
161777598|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
161777599|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
161777600|NCT00566631|584227056|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
161777601|NCT00566631|584227056|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
161777602|NCT00566631|584227056|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
161777603|NCT00566631|584227056|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
161777604|NCT00566631|584227056|FG000|Part 2: Extension Phase|Adverse Event|11|||
161777605|NCT00566631|584227056|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
161777606|NCT00566631|584227056|FG000|Part 2: Extension Phase|Death|1|||
161777607|NCT00566631|584227056|FG000|Part 2: Extension Phase|Other|5|||
161777608|NCT04054011|584227057|FG000|Overall Study|COVID|3|||
161777609|NCT01785472|584227058|FG000|Overall Study|Adverse Event|5|||
161777610|NCT01785472|584227059|FG001|Overall Study|Adverse Event|4|||
161777611|NCT01785472|584227060|FG002|Overall Study|Adverse Event|6|||
161777612|NCT01785472|584227058|FG000|Overall Study|Lack of Efficacy|2|||
161777613|NCT01785472|584227059|FG001|Overall Study|Lack of Efficacy|0|||
161777614|NCT01785472|584227060|FG002|Overall Study|Lack of Efficacy|1|||
161777615|NCT01785472|584227058|FG000|Overall Study|Lost to Follow-up|1|||
161777616|NCT01785472|584227059|FG001|Overall Study|Lost to Follow-up|2|||
161777617|NCT01785472|584227060|FG002|Overall Study|Lost to Follow-up|0|||
161777618|NCT01785472|584227058|FG000|Overall Study|Physician Decision|1|||
161777619|NCT01785472|584227059|FG001|Overall Study|Physician Decision|1|||
161777620|NCT01785472|584227060|FG002|Overall Study|Physician Decision|1|||
161777621|NCT01785472|584227058|FG000|Overall Study|Protocol deviation|0|||
161777622|NCT01785472|584227059|FG001|Overall Study|Protocol deviation|2|||
161777623|NCT01785472|584227060|FG002|Overall Study|Protocol deviation|2|||
161777624|NCT01785472|584227058|FG000|Overall Study|Subject/guardian decision|15|||
161777625|NCT01785472|584227059|FG001|Overall Study|Subject/guardian decision|10|||
161777626|NCT01785472|584227060|FG002|Overall Study|Subject/guardian decision|11|||
161777627|NCT01785472|584227058|FG000|Overall Study|Technical problems|0|||
161777628|NCT01785472|584227059|FG001|Overall Study|Technical problems|0|||
161777629|NCT01785472|584227060|FG002|Overall Study|Technical problems|1|||
161777630|NCT00595127|584227061|FG000|Overall Study|Death|6|||
161777631|NCT00595127|584227061|FG000|Overall Study|Relapsed|3|||
161777632|NCT00595127|584227061|FG000|Overall Study|joined another trial|1|||
161777633|NCT01803464|584227063|FG000|Overall Study|Incomplete data|0|||
161777634|NCT01803464|584227064|FG001|Overall Study|Incomplete data|0|||
161777635|NCT01803464|584227065|FG002|Overall Study|Incomplete data|4|||
161777636|NCT01803464|584227066|FG003|Overall Study|Incomplete data|0|||
161777637|NCT01803464|584227063|FG000|Overall Study|Withdrawal by Subject|1|||
161777638|NCT01803464|584227064|FG001|Overall Study|Withdrawal by Subject|0|||
161777639|NCT01803464|584227065|FG002|Overall Study|Withdrawal by Subject|0|||
161777640|NCT01803464|584227066|FG003|Overall Study|Withdrawal by Subject|0|||
161777641|NCT02860039|584227072|FG000|Overall Study|Death|4|||
161777642|NCT02860039|584227073|FG001|Overall Study|Death|0|||
161777643|NCT02860039|584227072|FG000|Overall Study|Lost to Follow-up|2|||
161777644|NCT02860039|584227073|FG001|Overall Study|Lost to Follow-up|2|||
161777645|NCT02860039|584227072|FG000|Overall Study|Protocol Violation|3|||
161777646|NCT02860039|584227073|FG001|Overall Study|Protocol Violation|1|||
161777647|NCT02860039|584227072|FG000|Overall Study|Withdrawal by Subject|1|||
161777648|NCT02860039|584227073|FG001|Overall Study|Withdrawal by Subject|0|||
161879831|NCT02017717|584602752|FG002|Treatment Period|Participant withdrew consent|1|||
161879832|NCT02017717|584602753|FG003|Treatment Period|Participant withdrew consent|0|||
161879833|NCT02017717|584602754|FG004|Treatment Period|Participant withdrew consent|0|||
161879834|NCT02017717|584602755|FG005|Treatment Period|Participant withdrew consent|2|||
161879835|NCT02017717|584602756|FG006|Treatment Period|Participant withdrew consent|0|||
161879836|NCT02017717|584602757|FG007|Treatment Period|Participant withdrew consent|1|||
161879837|NCT02017717|584602758|FG008|Treatment Period|Participant withdrew consent|4|||
161879838|NCT02017717|584602750|FG000|Treatment Period|Participant no longer met criteria|0|||
161879839|NCT02017717|584602751|FG001|Treatment Period|Participant no longer met criteria|0|||
161879840|NCT02017717|584602752|FG002|Treatment Period|Participant no longer met criteria|0|||
161879841|NCT02017717|584602753|FG003|Treatment Period|Participant no longer met criteria|0|||
161879842|NCT02017717|584602754|FG004|Treatment Period|Participant no longer met criteria|0|||
161879843|NCT02017717|584602755|FG005|Treatment Period|Participant no longer met criteria|0|||
161879844|NCT02017717|584602756|FG006|Treatment Period|Participant no longer met criteria|0|||
161879845|NCT02017717|584602757|FG007|Treatment Period|Participant no longer met criteria|0|||
161879846|NCT02017717|584602758|FG008|Treatment Period|Participant no longer met criteria|1|||
161879847|NCT02017717|584602750|FG000|Treatment Period|Other reasons|0|||
161879848|NCT02017717|584602751|FG001|Treatment Period|Other reasons|0|||
161879849|NCT02017717|584602752|FG002|Treatment Period|Other reasons|0|||
161879850|NCT02017717|584602753|FG003|Treatment Period|Other reasons|1|||
161879851|NCT02017717|584602754|FG004|Treatment Period|Other reasons|0|||
161879852|NCT02017717|584602755|FG005|Treatment Period|Other reasons|1|||
161879853|NCT02017717|584602756|FG006|Treatment Period|Other reasons|1|||
161879854|NCT02017717|584602757|FG007|Treatment Period|Other reasons|1|||
161879855|NCT02017717|584602758|FG008|Treatment Period|Other reasons|1|||
161879856|NCT02017717|584602750|FG000|Treatment Period|Maximum clinical benefit|0|||
161879857|NCT02017717|584602751|FG001|Treatment Period|Maximum clinical benefit|0|||
161991414|NCT00483938|585018504|FG004|Overall Study|Withdrawal by Subject|1|||
161991415|NCT00483938|585018505|FG005|Overall Study|Withdrawal by Subject|3|||
161991416|NCT00483938|585018506|FG006|Overall Study|Withdrawal by Subject|2|||
161991417|NCT00483938|585018500|FG000|Overall Study|Lost to Follow-up|1|||
161991418|NCT00483938|585018501|FG001|Overall Study|Lost to Follow-up|2|||
161991419|NCT00483938|585018502|FG002|Overall Study|Lost to Follow-up|0|||
161991420|NCT00483938|585018503|FG003|Overall Study|Lost to Follow-up|2|||
161991421|NCT00483938|585018504|FG004|Overall Study|Lost to Follow-up|1|||
161991422|NCT00483938|585018505|FG005|Overall Study|Lost to Follow-up|1|||
161991423|NCT00483938|585018506|FG006|Overall Study|Lost to Follow-up|3|||
161991424|NCT00483938|585018500|FG000|Overall Study|Death|0|||
161991425|NCT00483938|585018501|FG001|Overall Study|Death|2|||
161991426|NCT00483938|585018502|FG002|Overall Study|Death|0|||
161991427|NCT00483938|585018503|FG003|Overall Study|Death|0|||
161991428|NCT00483938|585018504|FG004|Overall Study|Death|0|||
161991429|NCT00483938|585018505|FG005|Overall Study|Death|0|||
161991430|NCT00483938|585018506|FG006|Overall Study|Death|0|||
161991431|NCT00483938|585018500|FG000|Overall Study|Other|3|||
161991432|NCT00483938|585018501|FG001|Overall Study|Other|9|||
161991433|NCT00483938|585018502|FG002|Overall Study|Other|0|||
161991434|NCT00483938|585018503|FG003|Overall Study|Other|4|||
161991435|NCT00483938|585018504|FG004|Overall Study|Other|0|||
161991436|NCT00483938|585018505|FG005|Overall Study|Other|4|||
161991437|NCT00483938|585018506|FG006|Overall Study|Other|32|||
161991438|NCT02218008|585018509|FG000|Stage 1 (S1)|Adverse Event|6|||
161991439|NCT02218008|585018510|FG001|Stage 1 (S1)|Adverse Event|5|||
161991440|NCT02218008|585018511|FG002|Stage 1 (S1)|Adverse Event|11|||
161991441|NCT02218008|585018512|FG003|Stage 1 (S1)|Adverse Event|0|||
161991442|NCT02218008|585018513|FG004|Stage 1 (S1)|Adverse Event|0|||
161991443|NCT02218008|585018514|FG005|Stage 1 (S1)|Adverse Event|0|||
161991444|NCT02218008|585018509|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
161991445|NCT02218008|585018510|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
161991446|NCT02218008|585018511|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
161991447|NCT02218008|585018512|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
161991448|NCT02218008|585018513|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
161991449|NCT02218008|585018514|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
161991450|NCT02218008|585018509|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
161991451|NCT02218008|585018510|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
161991452|NCT02218008|585018511|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
161991453|NCT02218008|585018512|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
161777649|NCT02860039|584227072|FG000|Overall Study|Not otherwise eligible|1|||
161777650|NCT02860039|584227073|FG001|Overall Study|Not otherwise eligible|1|||
161991454|NCT02218008|585018513|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
161991455|NCT02218008|585018514|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
161777651|NCT02723786|584227076|FG000|Overall Study|Lost to Follow-up|1|||
161777652|NCT03170271|584227077|FG000|Overall Study|Adverse Event|7|||
161777653|NCT03170271|584227078|FG001|Overall Study|Adverse Event|2|||
161777654|NCT03170271|584227077|FG000|Overall Study|Lost to Follow-up|0|||
161777655|NCT03170271|584227078|FG001|Overall Study|Lost to Follow-up|1|||
161777656|NCT03170271|584227077|FG000|Overall Study|Physician Decision|1|||
161777657|NCT03170271|584227078|FG001|Overall Study|Physician Decision|0|||
161879858|NCT02017717|584602752|FG002|Treatment Period|Maximum clinical benefit|0|||
161879859|NCT02017717|584602753|FG003|Treatment Period|Maximum clinical benefit|0|||
161879860|NCT02017717|584602754|FG004|Treatment Period|Maximum clinical benefit|0|||
161879861|NCT02017717|584602755|FG005|Treatment Period|Maximum clinical benefit|0|||
161879862|NCT02017717|584602756|FG006|Treatment Period|Maximum clinical benefit|0|||
161879863|NCT02017717|584602757|FG007|Treatment Period|Maximum clinical benefit|0|||
161879864|NCT02017717|584602758|FG008|Treatment Period|Maximum clinical benefit|1|||
161879865|NCT02017717|584602750|FG000|Treatment Period|Not reported|0|||
161879866|NCT02017717|584602751|FG001|Treatment Period|Not reported|1|||
161879867|NCT02017717|584602752|FG002|Treatment Period|Not reported|0|||
161879868|NCT02017717|584602753|FG003|Treatment Period|Not reported|0|||
161879869|NCT02017717|584602754|FG004|Treatment Period|Not reported|0|||
161879870|NCT02017717|584602755|FG005|Treatment Period|Not reported|0|||
161879871|NCT02017717|584602756|FG006|Treatment Period|Not reported|0|||
161879872|NCT02017717|584602757|FG007|Treatment Period|Not reported|0|||
161879873|NCT02017717|584602758|FG008|Treatment Period|Not reported|0|||
161879874|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
161879875|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
161879876|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
161879877|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
161879878|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
161879879|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
161879880|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
161879881|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
161879882|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
161879883|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
161879884|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
161879885|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
161879886|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
161879887|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
161879888|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
161879889|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
161879890|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
161879891|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
161879892|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
161879893|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
161879894|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
161879895|NCT04488419|584602760|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
161879896|NCT04488419|584602761|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
161879897|NCT04488419|584602762|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
161879898|NCT04488419|584602760|FG000|Primary Analysis Population|Adverse Event|6|||
161879899|NCT04488419|584602761|FG001|Primary Analysis Population|Adverse Event|9|||
161879900|NCT04488419|584602762|FG002|Primary Analysis Population|Adverse Event|0|||
161879901|NCT04488419|584602760|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
161879902|NCT04488419|584602761|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
161879903|NCT04488419|584602762|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
161879904|NCT04488419|584602760|FG000|Primary Analysis Population|Protocol Violation|1|||
161879905|NCT04488419|584602761|FG001|Primary Analysis Population|Protocol Violation|1|||
161879906|NCT04488419|584602762|FG002|Primary Analysis Population|Protocol Violation|0|||
161879907|NCT04488419|584602760|FG000|Primary Analysis Population|Undetermined|7|||
161879908|NCT04488419|584602761|FG001|Primary Analysis Population|Undetermined|3|||
161879909|NCT04488419|584602762|FG002|Primary Analysis Population|Undetermined|0|||
161879910|NCT04488419|584602760|FG000|Primary Analysis Population|>1 Reason|2|||
161879911|NCT04488419|584602761|FG001|Primary Analysis Population|>1 Reason|4|||
161879912|NCT04488419|584602762|FG002|Primary Analysis Population|>1 Reason|0|||
161879913|NCT00970632|584602768|FG000|Overall Study|Adverse Event|2|||
161879914|NCT00970632|584602769|FG001|Overall Study|Adverse Event|2|||
161879915|NCT00970632|584602770|FG002|Overall Study|Adverse Event|1|||
161777658|NCT03170271|584227077|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
161777659|NCT03170271|584227078|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
161777660|NCT03170271|584227077|FG000|Overall Study|Withdrawal by Subject|17|||
161777661|NCT03170271|584227078|FG001|Overall Study|Withdrawal by Subject|5|||
161777662|NCT03170271|584227077|FG000|Overall Study|Other|2|||
161777663|NCT03170271|584227078|FG001|Overall Study|Other|2|||
161777664|NCT03170271|584227077|FG000|Overall Study|Randomized in error|4|||
161777665|NCT03170271|584227078|FG001|Overall Study|Randomized in error|0|||
161777666|NCT01125358|584227081|FG000|Overall Study|Adverse Event|3|||
161777667|NCT01125358|584227082|FG001|Overall Study|Adverse Event|0|||
161777668|NCT01125358|584227083|FG002|Overall Study|Adverse Event|0|||
161777669|NCT01125358|584227084|FG003|Overall Study|Adverse Event|2|||
161777670|NCT01125358|584227081|FG000|Overall Study|Perceived Lack of Efficacy|6|||
161879916|NCT00970632|584602768|FG000|Overall Study|Lack of Efficacy|3|||
161879917|NCT00970632|584602769|FG001|Overall Study|Lack of Efficacy|0|||
161879918|NCT00970632|584602770|FG002|Overall Study|Lack of Efficacy|0|||
161879919|NCT00970632|584602768|FG000|Overall Study|Lost to Follow-up|3|||
161879920|NCT00970632|584602769|FG001|Overall Study|Lost to Follow-up|0|||
161879921|NCT00970632|584602770|FG002|Overall Study|Lost to Follow-up|2|||
161879922|NCT00970632|584602768|FG000|Overall Study|Protocol Violation|8|||
161879923|NCT00970632|584602769|FG001|Overall Study|Protocol Violation|5|||
161879924|NCT00970632|584602770|FG002|Overall Study|Protocol Violation|8|||
161879925|NCT00970632|584602768|FG000|Overall Study|Withdrawal by Subject|7|||
161879926|NCT00970632|584602769|FG001|Overall Study|Withdrawal by Subject|6|||
161879927|NCT00970632|584602770|FG002|Overall Study|Withdrawal by Subject|4|||
161879928|NCT00970632|584602768|FG000|Overall Study|Entry criteria not met|0|||
161879929|NCT00970632|584602769|FG001|Overall Study|Entry criteria not met|2|||
161879930|NCT00970632|584602770|FG002|Overall Study|Entry criteria not met|2|||
161879931|NCT00970632|584602768|FG000|Overall Study|Sponsor decision|1|||
161879932|NCT00970632|584602769|FG001|Overall Study|Sponsor decision|0|||
161879933|NCT00970632|584602770|FG002|Overall Study|Sponsor decision|1|||
161879934|NCT01286168|584602777|FG000|Overall Study|Withdrawal by Subject|1|||
161879935|NCT01286168|584602777|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
161879936|NCT02487771|584602778|FG000|Overall Study|Lost to Follow-up|2|||
161879937|NCT02487771|584602779|FG001|Overall Study|Lost to Follow-up|3|||
161879938|NCT02487771|584602778|FG000|Overall Study|Moved out of area|5|||
161879939|NCT02487771|584602779|FG001|Overall Study|Moved out of area|6|||
161879940|NCT02487771|584602778|FG000|Overall Study|Withdrawal by Subject|3|||
161879941|NCT02487771|584602779|FG001|Overall Study|Withdrawal by Subject|5|||
161879942|NCT01482065|584602782|FG000|Overall Study|Withdrawal by Subject|0|||
161879943|NCT01482065|584602783|FG001|Overall Study|Withdrawal by Subject|1|||
161879944|NCT03728426|584602784|FG000|Overall Study|Death|3|||
161879945|NCT02682823|584602785|FG000|Overall Study|Withdrawal by Subject|0|||
161879946|NCT02682823|584602786|FG001|Overall Study|Withdrawal by Subject|0|||
161879947|NCT02682823|584602787|FG002|Overall Study|Withdrawal by Subject|1|||
161879948|NCT02682823|584602788|FG003|Overall Study|Withdrawal by Subject|0|||
161879949|NCT02682823|584602789|FG004|Overall Study|Withdrawal by Subject|1|||
161879950|NCT02682823|584602785|FG000|Overall Study|Protocol Deviation|0|||
161879951|NCT02682823|584602786|FG001|Overall Study|Protocol Deviation|1|||
161879952|NCT02682823|584602787|FG002|Overall Study|Protocol Deviation|0|||
161879953|NCT02682823|584602788|FG003|Overall Study|Protocol Deviation|0|||
161879954|NCT02682823|584602789|FG004|Overall Study|Protocol Deviation|0|||
161879955|NCT02682823|584602785|FG000|Overall Study|Adverse Event|0|||
161879956|NCT02682823|584602786|FG001|Overall Study|Adverse Event|0|||
161879957|NCT02682823|584602787|FG002|Overall Study|Adverse Event|0|||
161879958|NCT02682823|584602788|FG003|Overall Study|Adverse Event|1|||
161879959|NCT02682823|584602789|FG004|Overall Study|Adverse Event|0|||
161879960|NCT01741792|584602790|FG000|Overall Study|Death|6|||
161879961|NCT01741792|584602791|FG001|Overall Study|Death|1|||
161879962|NCT01741792|584602792|FG002|Overall Study|Death|12|||
161879963|NCT01995175|584602793|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
161879964|NCT01995175|584602793|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
161879965|NCT01995175|584602793|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
161879966|NCT01995175|584602793|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
161879967|NCT01995175|584602793|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
161879968|NCT01995175|584602793|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
161879969|NCT01995175|584602793|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
161879970|NCT01995175|584602793|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
161879971|NCT01995175|584602793|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
161879972|NCT02045862|584602794|FG000|Overall Study|Death|0|||
161879973|NCT02045862|584602795|FG001|Overall Study|Death|0|||
161879974|NCT02045862|584602796|FG002|Overall Study|Death|1|||
161879975|NCT02045862|584602794|FG000|Overall Study|Miscellaneous|5|||
161879976|NCT02045862|584602795|FG001|Overall Study|Miscellaneous|0|||
161879977|NCT02045862|584602796|FG002|Overall Study|Miscellaneous|8|||
161879978|NCT02045862|584602794|FG000|Overall Study|Withdrawal by Patient|18|||
161879979|NCT02045862|584602795|FG001|Overall Study|Withdrawal by Patient|27|||
161879980|NCT02045862|584602796|FG002|Overall Study|Withdrawal by Patient|57|||
161879981|NCT02045862|584602794|FG000|Overall Study|Protocol Violation|0|||
161879982|NCT02045862|584602795|FG001|Overall Study|Protocol Violation|0|||
161879983|NCT02045862|584602796|FG002|Overall Study|Protocol Violation|6|||
161879984|NCT02045862|584602794|FG000|Overall Study|Lack of Efficacy|8|||
161879985|NCT02045862|584602795|FG001|Overall Study|Lack of Efficacy|4|||
161879986|NCT02045862|584602796|FG002|Overall Study|Lack of Efficacy|13|||
161879987|NCT02045862|584602794|FG000|Overall Study|Randomized but not Received Study Drug|0|||
161879988|NCT02045862|584602795|FG001|Overall Study|Randomized but not Received Study Drug|2|||
161879989|NCT02045862|584602796|FG002|Overall Study|Randomized but not Received Study Drug|8|||
161879990|NCT02045862|584602794|FG000|Overall Study|Adverse Event|7|||
161879991|NCT02045862|584602795|FG001|Overall Study|Adverse Event|5|||
161879992|NCT02045862|584602796|FG002|Overall Study|Adverse Event|27|||
161879993|NCT02045862|584602794|FG000|Overall Study|Lost to Follow-up|1|||
161879994|NCT02045862|584602795|FG001|Overall Study|Lost to Follow-up|2|||
161879995|NCT02045862|584602796|FG002|Overall Study|Lost to Follow-up|6|||
161879996|NCT02353442|584602801|FG000|Overall Study|Withdrawal by Subject|3|||
161879997|NCT02353442|584602802|FG001|Overall Study|Withdrawal by Subject|4|||
161879998|NCT01075646|584602805|FG000|Overall Study|Lost to Follow-up|4|||
161879999|NCT01075646|584602806|FG001|Overall Study|Lost to Follow-up|3|||
161880000|NCT01075646|584602807|FG002|Overall Study|Lost to Follow-up|1|||
161880001|NCT01075646|584602808|FG003|Overall Study|Lost to Follow-up|2|||
161880002|NCT02004886|584602812|FG000|Overall Study|Adverse Event|0|||
161880003|NCT02004886|584602813|FG001|Overall Study|Adverse Event|1|||
161880004|NCT02004886|584602814|FG002|Overall Study|Adverse Event|0|||
161880005|NCT02004886|584602815|FG003|Overall Study|Adverse Event|0|||
161880006|NCT02004886|584602812|FG000|Overall Study|Unable to attend future visits|1|||
161880007|NCT02004886|584602813|FG001|Overall Study|Unable to attend future visits|0|||
161880008|NCT02004886|584602814|FG002|Overall Study|Unable to attend future visits|0|||
161880009|NCT02004886|584602815|FG003|Overall Study|Unable to attend future visits|0|||
161880010|NCT05239494|584602817|FG000|Overall Study|Lost to Follow-up|1|||
161880011|NCT02822573|584602818|FG000|Overall Study|Lost to Follow-up|5|||
161880012|NCT02822573|584602819|FG001|Overall Study|Lost to Follow-up|3|||
161880013|NCT02822573|584602818|FG000|Overall Study|Physician Decision|1|||
161880014|NCT02822573|584602819|FG001|Overall Study|Physician Decision|1|||
161880015|NCT02822573|584602818|FG000|Overall Study|Withdrawal by Subject|9|||
161880016|NCT02822573|584602819|FG001|Overall Study|Withdrawal by Subject|5|||
161880017|NCT02822573|584602818|FG000|Overall Study|Protocol Violation|6|||
161880018|NCT02822573|584602819|FG001|Overall Study|Protocol Violation|4|||
161880019|NCT02822573|584602818|FG000|Overall Study|Too sick or ill|2|||
161880020|NCT02822573|584602819|FG001|Overall Study|Too sick or ill|1|||
161880021|NCT02822573|584602818|FG000|Overall Study|Disease Progression|1|||
161880022|NCT02822573|584602819|FG001|Overall Study|Disease Progression|1|||
161880023|NCT02822573|584602818|FG000|Overall Study|No reason given|6|||
161880024|NCT02822573|584602819|FG001|Overall Study|No reason given|4|||
161880025|NCT02892422|584602820|FG000|Overall Study|Enrolled not treated|4|||
161880026|NCT02892422|584602820|FG000|Overall Study|Adverse Event|38|||
161880027|NCT02892422|584602820|FG000|Overall Study|Lack of Efficacy|32|||
161880028|NCT02892422|584602820|FG000|Overall Study|Non-compliance with study drug|11|||
161880029|NCT02892422|584602820|FG000|Overall Study|Protocol Violation|4|||
161880030|NCT02892422|584602820|FG000|Overall Study|Withdrawal by Subject|56|||
161880031|NCT02892422|584602820|FG000|Overall Study|Lost to Follow-up|5|||
161880032|NCT02892422|584602820|FG000|Overall Study|sponsor information 16159A results|21|||
161880033|NCT02892422|584602820|FG000|Overall Study|withdrawal of consent|13|||
161880034|NCT02892422|584602820|FG000|Overall Study|exclusion criteria met|3|||
161880035|NCT02892422|584602820|FG000|Overall Study|moving elsewhere|4|||
161880036|NCT02892422|584602820|FG000|Overall Study|non-compliance|10|||
161880037|NCT02892422|584602820|FG000|Overall Study|patient legally incapable|1|||
161880038|NCT02892422|584602820|FG000|Overall Study|patient decision|7|||
161880039|NCT02892422|584602820|FG000|Overall Study|Investigator decision|1|||
161880040|NCT02855359|584602821|FG000|Overall Study|Death|2|||
161880041|NCT02855359|584602822|FG001|Overall Study|Death|2|||
161880042|NCT02855359|584602823|FG002|Overall Study|Death|0|||
161880043|NCT02855359|584602824|FG003|Overall Study|Death|0|||
161880044|NCT02855359|584602821|FG000|Overall Study|Study Termination by Sponsor|9|||
161880045|NCT02855359|584602822|FG001|Overall Study|Study Termination by Sponsor|11|||
161880046|NCT02855359|584602823|FG002|Overall Study|Study Termination by Sponsor|0|||
161880047|NCT02855359|584602824|FG003|Overall Study|Study Termination by Sponsor|0|||
161880048|NCT03155178|584602825|FG000|Overall Study|Did not meet treatment day baseline|7|||
161880049|NCT03155178|584602826|FG001|Overall Study|Did not meet treatment day baseline|7|||
161880050|NCT03155178|584602827|FG002|Overall Study|Did not meet treatment day baseline|7|||
161880051|NCT03155178|584602828|FG003|Overall Study|Did not meet treatment day baseline|7|||
161880052|NCT00759785|584602829|FG000|Overall Study|Participant sample not evaluable|11|||
161880053|NCT00759785|584602830|FG001|Overall Study|Participant sample not evaluable|2|||
161880054|NCT00759785|584602829|FG000|Overall Study|Participant sample lost|0|||
161880055|NCT00759785|584602830|FG001|Overall Study|Participant sample lost|1|||
161880056|NCT00759785|584602829|FG000|Overall Study|Protocol Violation|1|||
161880057|NCT00759785|584602830|FG001|Overall Study|Protocol Violation|0|||
161880058|NCT00759785|584602829|FG000|Overall Study|Physician Decision|0|||
161880059|NCT00759785|584602830|FG001|Overall Study|Physician Decision|1|||
161880060|NCT00759785|584602829|FG000|Overall Study|Withdrawal by Subject|0|||
161880061|NCT00759785|584602830|FG001|Overall Study|Withdrawal by Subject|1|||
161880062|NCT03729570|584602834|FG000|Overall Study|Lost to Follow-up|16|||
161991456|NCT02218008|585018509|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
161880063|NCT03729570|584602835|FG001|Overall Study|Lost to Follow-up|20|||
161880064|NCT03729570|584602834|FG000|Overall Study|Seroconversion|5|||
161880065|NCT03729570|584602835|FG001|Overall Study|Seroconversion|0|||
161880066|NCT03729570|584602834|FG000|Overall Study|Moved out of the city|1|||
161880067|NCT03729570|584602835|FG001|Overall Study|Moved out of the city|0|||
161880068|NCT03729570|584602834|FG000|Overall Study|Time Conflict|1|||
161880069|NCT03729570|584602835|FG001|Overall Study|Time Conflict|0|||
161880070|NCT03729570|584602834|FG000|Overall Study|Time Commitment|2|||
161880071|NCT03729570|584602835|FG001|Overall Study|Time Commitment|0|||
161880072|NCT03729570|584602834|FG000|Overall Study|Bad Experience|0|||
161880073|NCT03729570|584602835|FG001|Overall Study|Bad Experience|1|||
161880074|NCT03729570|584602834|FG000|Overall Study|No reason provided|2|||
161880075|NCT03729570|584602835|FG001|Overall Study|No reason provided|1|||
161880076|NCT03729570|584602834|FG000|Overall Study|Family Conflict|0|||
161880077|NCT03729570|584602835|FG001|Overall Study|Family Conflict|1|||
161880078|NCT03729570|584602834|FG000|Overall Study|Did not want to continue taking medications|0|||
161880079|NCT03729570|584602835|FG001|Overall Study|Did not want to continue taking medications|1|||
161880080|NCT03729570|584602834|FG000|Overall Study|Found another PrEP provider|1|||
161880081|NCT03729570|584602835|FG001|Overall Study|Found another PrEP provider|0|||
161880082|NCT03729570|584602834|FG000|Overall Study|Did not enjoy being in the control group|0|||
161880083|NCT03729570|584602835|FG001|Overall Study|Did not enjoy being in the control group|1|||
161880084|NCT00631410|584602836|FG000|Overall Study|Adverse Event|1|||
161880085|NCT00631410|584602837|FG001|Overall Study|Adverse Event|3|||
161880086|NCT00631410|584602836|FG000|Overall Study|Objective Progression or Relapse|4|||
161880087|NCT00631410|584602837|FG001|Overall Study|Objective Progression or Relapse|3|||
161880088|NCT00631410|584602836|FG000|Overall Study|Surgery|1|||
161880089|NCT00631410|584602837|FG001|Overall Study|Surgery|0|||
161880090|NCT02858180|584602838|FG000|Overall Study|Lost to Follow-up|0|||
161880091|NCT02858180|584602839|FG001|Overall Study|Lost to Follow-up|2|||
161880092|NCT01054196|584602840|FG000|Overall Study|Physician Decision|0|||
161880093|NCT01054196|584602841|FG001|Overall Study|Physician Decision|0|||
161880094|NCT01054196|584602842|FG002|Overall Study|Physician Decision|0|||
161880095|NCT01054196|584602843|FG003|Overall Study|Physician Decision|1|||
161880096|NCT01054196|584602844|FG004|Overall Study|Physician Decision|0|||
161880097|NCT01054196|584602845|FG005|Overall Study|Physician Decision|0|||
161880098|NCT01054196|584602846|FG006|Overall Study|Physician Decision|1|||
161880099|NCT03843632|584602851|FG000|Overall Study|Withdrawal by Subject|1|||
161880100|NCT03843632|584602852|FG001|Overall Study|Withdrawal by Subject|0|||
161880101|NCT03843632|584602853|FG002|Overall Study|Withdrawal by Subject|0|||
161880102|NCT03843632|584602854|FG003|Overall Study|Withdrawal by Subject|0|||
161880103|NCT01820572|584602855|FG000|Randomization|Not Treated|2|||
161880104|NCT01820572|584602856|FG001|Randomization|Not Treated|1|||
161880105|NCT01820572|584602855|FG000|Treatment Period|Adverse Event|12|||
161880106|NCT01820572|584602856|FG001|Treatment Period|Adverse Event|7|||
161880107|NCT01820572|584602855|FG000|Treatment Period|Death|3|||
161880108|NCT01820572|584602856|FG001|Treatment Period|Death|3|||
161880109|NCT01820572|584602855|FG000|Treatment Period|Lack of Efficacy|1|||
161880110|NCT01820572|584602856|FG001|Treatment Period|Lack of Efficacy|0|||
161880111|NCT01820572|584602855|FG000|Treatment Period|poor/non compliance|0|||
161880112|NCT01820572|584602856|FG001|Treatment Period|poor/non compliance|3|||
161880113|NCT01820572|584602855|FG000|Treatment Period|request to discontinue|6|||
161880114|NCT01820572|584602856|FG001|Treatment Period|request to discontinue|11|||
161880115|NCT01820572|584602855|FG000|Treatment Period|No longer meets study criteria|3|||
161880116|NCT01820572|584602856|FG001|Treatment Period|No longer meets study criteria|10|||
161880117|NCT01820572|584602855|FG000|Treatment Period|withdrew consent|1|||
161880118|NCT01820572|584602856|FG001|Treatment Period|withdrew consent|2|||
161880119|NCT00595517|584602857|FG000|Overall Study|Adverse Event|6|||
161880120|NCT00595517|584602857|FG000|Overall Study|Withdrawal by Subject|4|||
161880121|NCT00595517|584602857|FG000|Overall Study|Protocol Violation|2|||
161880122|NCT00595517|584602857|FG000|Overall Study|Recurrence of ulcer|5|||
161880123|NCT00595517|584602857|FG000|Overall Study|usage of prohibited treatment|1|||
161880124|NCT00595517|584602857|FG000|Overall Study|No intention to attend regularly|1|||
161880125|NCT00387010|584602860|FG000|Dose Titration Period|Adverse Event|12|||
161880126|NCT00387010|584602860|FG000|Dose Titration Period|Lack of Efficacy|5|||
161880127|NCT00387010|584602860|FG000|Dose Titration Period|Withdrawal by Subject|3|||
161880128|NCT00387010|584602860|FG000|Dose Titration Period|Protocol Violation|1|||
161880129|NCT00387010|584602860|FG000|Dose Titration Period|Lost to Follow-up|2|||
161880130|NCT00387010|584602860|FG000|Dose Titration Period|Noncompliance with study medication|8|||
161880131|NCT00387010|584602860|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
161880132|NCT00387010|584602860|FG000|Treatment Period|Adverse Event|4|||
161880133|NCT00387010|584602860|FG000|Treatment Period|Withdrawal by Subject|1|||
161880134|NCT00387010|584602860|FG000|Treatment Period|Noncompliance with study medication|2|||
161880135|NCT00387010|584602860|FG000|Treatment Period|Noncompliance with study procedures|3|||
161991457|NCT02218008|585018510|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
161991458|NCT02218008|585018511|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
161991459|NCT02218008|585018512|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
161991460|NCT02218008|585018513|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
161991461|NCT02218008|585018514|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
161880136|NCT00387010|584602860|FG000|Treatment Period|Participant reported study drug stolen|1|||
161880137|NCT01167881|584602863|FG000|Overall Study|Adverse Event|47|||
161880138|NCT01167881|584602864|FG001|Overall Study|Adverse Event|51|||
161880139|NCT01167881|584602863|FG000|Overall Study|Lack of Efficacy|4|||
161991462|NCT02218008|585018509|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
161880140|NCT01167881|584602864|FG001|Overall Study|Lack of Efficacy|7|||
161880141|NCT01167881|584602863|FG000|Overall Study|Non compliant with protocol|9|||
161880142|NCT01167881|584602864|FG001|Overall Study|Non compliant with protocol|18|||
161880143|NCT01167881|584602863|FG000|Overall Study|Lost to Follow-up|19|||
161880144|NCT01167881|584602864|FG001|Overall Study|Lost to Follow-up|20|||
161880145|NCT01167881|584602863|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
161880146|NCT01167881|584602864|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
161880147|NCT01167881|584602863|FG000|Overall Study|Not treated|4|||
161880148|NCT01167881|584602864|FG001|Overall Study|Not treated|0|||
161880149|NCT01167881|584602863|FG000|Overall Study|Other not defined above|31|||
161880150|NCT01167881|584602864|FG001|Overall Study|Other not defined above|55|||
161880151|NCT01668173|584602869|FG000|Overall Study|Adverse Event|3|||
161880152|NCT01668173|584602869|FG000|Overall Study|Trial suspension|4|||
161880153|NCT01295827|584602870|FG000|Overall Study|Adverse Event|1|||
161880154|NCT01295827|584602871|FG001|Overall Study|Adverse Event|2|||
161880155|NCT01295827|584602872|FG002|Overall Study|Adverse Event|2|||
161880156|NCT01295827|584602873|FG003|Overall Study|Adverse Event|1|||
161880157|NCT01295827|584602874|FG004|Overall Study|Adverse Event|1|||
161880158|NCT01295827|584602875|FG005|Overall Study|Adverse Event|4|||
161880159|NCT01295827|584602876|FG006|Overall Study|Adverse Event|15|||
161880160|NCT01295827|584602877|FG007|Overall Study|Adverse Event|49|||
161880161|NCT01295827|584602878|FG008|Overall Study|Adverse Event|22|||
161880162|NCT01295827|584602879|FG009|Overall Study|Adverse Event|7|||
161880163|NCT01295827|584602880|FG010|Overall Study|Adverse Event|50|||
161880164|NCT01295827|584602881|FG011|Overall Study|Adverse Event|21|||
161880165|NCT01295827|584602882|FG012|Overall Study|Adverse Event|0|||
161880166|NCT01295827|584602883|FG013|Overall Study|Adverse Event|0|||
161880167|NCT01295827|584602884|FG014|Overall Study|Adverse Event|0|||
161880168|NCT01295827|584602870|FG000|Overall Study|Lost to Follow-up|0|||
161880169|NCT01295827|584602871|FG001|Overall Study|Lost to Follow-up|0|||
161880170|NCT01295827|584602872|FG002|Overall Study|Lost to Follow-up|3|||
161880171|NCT01295827|584602873|FG003|Overall Study|Lost to Follow-up|0|||
161880172|NCT01295827|584602874|FG004|Overall Study|Lost to Follow-up|1|||
161880173|NCT01295827|584602875|FG005|Overall Study|Lost to Follow-up|0|||
161880174|NCT01295827|584602876|FG006|Overall Study|Lost to Follow-up|4|||
161880175|NCT01295827|584602877|FG007|Overall Study|Lost to Follow-up|8|||
161880176|NCT01295827|584602878|FG008|Overall Study|Lost to Follow-up|7|||
161880177|NCT01295827|584602879|FG009|Overall Study|Lost to Follow-up|4|||
161880178|NCT01295827|584602880|FG010|Overall Study|Lost to Follow-up|7|||
161880179|NCT01295827|584602881|FG011|Overall Study|Lost to Follow-up|3|||
161880180|NCT01295827|584602882|FG012|Overall Study|Lost to Follow-up|0|||
161880181|NCT01295827|584602883|FG013|Overall Study|Lost to Follow-up|0|||
161880182|NCT01295827|584602884|FG014|Overall Study|Lost to Follow-up|0|||
161880183|NCT01295827|584602870|FG000|Overall Study|Not Reported|0|||
161880184|NCT01295827|584602871|FG001|Overall Study|Not Reported|0|||
161880185|NCT01295827|584602872|FG002|Overall Study|Not Reported|0|||
161880186|NCT01295827|584602873|FG003|Overall Study|Not Reported|1|||
161880187|NCT01295827|584602874|FG004|Overall Study|Not Reported|0|||
161880188|NCT01295827|584602875|FG005|Overall Study|Not Reported|0|||
161880189|NCT01295827|584602876|FG006|Overall Study|Not Reported|24|||
161880190|NCT01295827|584602877|FG007|Overall Study|Not Reported|58|||
161880191|NCT01295827|584602878|FG008|Overall Study|Not Reported|41|||
161880192|NCT01295827|584602879|FG009|Overall Study|Not Reported|2|||
161880193|NCT01295827|584602880|FG010|Overall Study|Not Reported|23|||
161880194|NCT01295827|584602881|FG011|Overall Study|Not Reported|13|||
161880195|NCT01295827|584602882|FG012|Overall Study|Not Reported|0|||
161880196|NCT01295827|584602883|FG013|Overall Study|Not Reported|0|||
161880197|NCT01295827|584602884|FG014|Overall Study|Not Reported|0|||
161880198|NCT01295827|584602870|FG000|Overall Study|Progressive Disease|2|||
161880199|NCT01295827|584602871|FG001|Overall Study|Progressive Disease|1|||
161880200|NCT01295827|584602872|FG002|Overall Study|Progressive Disease|5|||
161880201|NCT01295827|584602873|FG003|Overall Study|Progressive Disease|2|||
161880202|NCT01295827|584602874|FG004|Overall Study|Progressive Disease|0|||
161880203|NCT01295827|584602875|FG005|Overall Study|Progressive Disease|1|||
161880204|NCT01295827|584602876|FG006|Overall Study|Progressive Disease|87|||
161880205|NCT01295827|584602877|FG007|Overall Study|Progressive Disease|144|||
161880206|NCT01295827|584602878|FG008|Overall Study|Progressive Disease|85|||
161880207|NCT01295827|584602879|FG009|Overall Study|Progressive Disease|40|||
161880208|NCT01295827|584602880|FG010|Overall Study|Progressive Disease|175|||
161880209|NCT01295827|584602881|FG011|Overall Study|Progressive Disease|136|||
161880210|NCT01295827|584602882|FG012|Overall Study|Progressive Disease|0|||
161880211|NCT01295827|584602883|FG013|Overall Study|Progressive Disease|0|||
161880212|NCT01295827|584602884|FG014|Overall Study|Progressive Disease|0|||
161880213|NCT01295827|584602870|FG000|Overall Study|Screen Failure|0|||
161880214|NCT01295827|584602871|FG001|Overall Study|Screen Failure|0|||
161880215|NCT01295827|584602872|FG002|Overall Study|Screen Failure|0|||
161880216|NCT01295827|584602873|FG003|Overall Study|Screen Failure|0|||
161880217|NCT01295827|584602874|FG004|Overall Study|Screen Failure|0|||
161880218|NCT01295827|584602875|FG005|Overall Study|Screen Failure|0|||
161880219|NCT01295827|584602876|FG006|Overall Study|Screen Failure|2|||
161880220|NCT01295827|584602877|FG007|Overall Study|Screen Failure|2|||
161777671|NCT01125358|584227082|FG001|Overall Study|Perceived Lack of Efficacy|3|||
161777672|NCT01125358|584227083|FG002|Overall Study|Perceived Lack of Efficacy|7|||
161777673|NCT01125358|584227084|FG003|Overall Study|Perceived Lack of Efficacy|4|||
161777674|NCT01125358|584227081|FG000|Overall Study|Protocol Violation|1|||
161777675|NCT01125358|584227082|FG001|Overall Study|Protocol Violation|0|||
161777676|NCT01125358|584227083|FG002|Overall Study|Protocol Violation|0|||
161777677|NCT01125358|584227084|FG003|Overall Study|Protocol Violation|0|||
161777678|NCT01125358|584227081|FG000|Overall Study|Sponsor Decision|0|||
161777679|NCT01125358|584227082|FG001|Overall Study|Sponsor Decision|0|||
161777680|NCT01125358|584227083|FG002|Overall Study|Sponsor Decision|1|||
161777681|NCT01125358|584227084|FG003|Overall Study|Sponsor Decision|1|||
161777682|NCT01125358|584227081|FG000|Overall Study|Withdrawal by Subject|2|||
161777683|NCT01125358|584227082|FG001|Overall Study|Withdrawal by Subject|1|||
161777684|NCT01125358|584227083|FG002|Overall Study|Withdrawal by Subject|1|||
161777685|NCT01125358|584227084|FG003|Overall Study|Withdrawal by Subject|1|||
161777686|NCT01060007|584227085|FG000|Overall Study|Withdrawal by Subject|1|||
161777687|NCT01060007|584227085|FG000|Overall Study|Inevaluable for response at surgery|3|||
161777688|NCT04935931|584227091|FG000|Overall Study|Withdrawal by Subject|1|||
161777689|NCT02628418|584227094|FG000|Overall Study|Lost to Follow-up|1|||
161777690|NCT02628418|584227095|FG001|Overall Study|Lost to Follow-up|2|||
161777691|NCT03159611|584227099|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
161777692|NCT03159611|584227100|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
161777693|NCT03159611|584227099|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
161777694|NCT03159611|584227100|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
161777695|NCT03159611|584227099|FG000|Overall Study|Protocol Violation|7|||
161777696|NCT03159611|584227100|FG001|Overall Study|Protocol Violation|4|||
161777697|NCT03159611|584227099|FG000|Overall Study|Adverse Event|1|||
161777698|NCT03159611|584227100|FG001|Overall Study|Adverse Event|0|||
161777699|NCT03159611|584227099|FG000|Overall Study|Withdrawal by Subject|1|||
161777700|NCT03159611|584227100|FG001|Overall Study|Withdrawal by Subject|1|||
161777701|NCT03159611|584227099|FG000|Overall Study|Non-compliance with protocol requirement|3|||
161777702|NCT03159611|584227100|FG001|Overall Study|Non-compliance with protocol requirement|2|||
161777703|NCT03159611|584227099|FG000|Overall Study|Inability to perform procedures|1|||
161777704|NCT03159611|584227100|FG001|Overall Study|Inability to perform procedures|0|||
161777705|NCT01984229|584227101|FG000|Safety Follow-up Period|Adverse Event|1|||
161777706|NCT01984229|584227102|FG001|Safety Follow-up Period|Adverse Event|1|||
161777707|NCT01984229|584227101|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
161777708|NCT01984229|584227102|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
161777709|NCT02072174|584227103|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
161777710|NCT02072174|584227104|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
161777711|NCT02072174|584227103|FG000|Overall Study|Protocol Violation|16|||
161777712|NCT02072174|584227104|FG001|Overall Study|Protocol Violation|23|||
161777713|NCT02072174|584227103|FG000|Overall Study|Physician Decision|0|||
161777714|NCT02072174|584227104|FG001|Overall Study|Physician Decision|1|||
161777715|NCT02072174|584227103|FG000|Overall Study|Non-compliance with protocol requirement|2|||
161777716|NCT02072174|584227104|FG001|Overall Study|Non-compliance with protocol requirement|0|||
161777717|NCT01608321|584227109|FG000|Overall Study|Withdrawal by Subject|1|||
161777718|NCT01608321|584227110|FG001|Overall Study|Withdrawal by Subject|0|||
161777719|NCT03222856|584227111|FG000|Overall Study|Adverse Event|6|||
161777720|NCT03222856|584227111|FG000|Overall Study|Death|1|||
161777721|NCT03457727|584228778|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
161777722|NCT03457727|584228779|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
161777723|NCT03457727|584228780|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
161777724|NCT03457727|584228781|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
161777725|NCT00929201|584228782|FG000|Period 1|Withdrawal by Subject|0|||
161777726|NCT00929201|584228783|FG001|Period 1|Withdrawal by Subject|1|||
161777727|NCT00388674|584228789|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
161777728|NCT00388674|584228790|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
161777729|NCT00388674|584228789|FG000|Initial Treatment|Adverse Event|22|||
161777730|NCT00388674|584228790|FG001|Initial Treatment|Adverse Event|87|||
161777731|NCT00388674|584228789|FG000|Initial Treatment|Death|215|||
161777732|NCT00388674|584228790|FG001|Initial Treatment|Death|216|||
161777733|NCT00388674|584228789|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
161777734|NCT00388674|584228790|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
161777735|NCT00388674|584228789|FG000|Initial Treatment|HCC|12|||
161777736|NCT00388674|584228790|FG001|Initial Treatment|HCC|20|||
161777737|NCT00388674|584228789|FG000|Initial Treatment|Lost to Follow-up|526|||
161777738|NCT00388674|584228790|FG001|Initial Treatment|Lost to Follow-up|624|||
161777739|NCT00388674|584228789|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
161777740|NCT00388674|584228790|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
161777741|NCT00388674|584228789|FG000|Initial Treatment|Never Treated with Study Medication|1|||
161777742|NCT00388674|584228790|FG001|Initial Treatment|Never Treated with Study Medication|7|||
161777743|NCT00388674|584228789|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
161777744|NCT00388674|584228790|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
161777745|NCT00388674|584228789|FG000|Initial Treatment|Not Defined|125|||
161880221|NCT01295827|584602878|FG008|Overall Study|Screen Failure|2|||
161880222|NCT01295827|584602879|FG009|Overall Study|Screen Failure|0|||
161880223|NCT01295827|584602880|FG010|Overall Study|Screen Failure|1|||
161880224|NCT01295827|584602881|FG011|Overall Study|Screen Failure|0|||
161880225|NCT01295827|584602882|FG012|Overall Study|Screen Failure|0|||
161880226|NCT01295827|584602883|FG013|Overall Study|Screen Failure|0|||
161880227|NCT01295827|584602884|FG014|Overall Study|Screen Failure|0|||
161880228|NCT01295827|584602870|FG000|Overall Study|Withdrawal by Subject|1|||
161880229|NCT01295827|584602871|FG001|Overall Study|Withdrawal by Subject|0|||
161777746|NCT00388674|584228790|FG001|Initial Treatment|Not Defined|172|||
161777747|NCT00388674|584228789|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
161777748|NCT00388674|584228790|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
161777749|NCT00388674|584228789|FG000|Initial Treatment|Pregnancy|26|||
161777750|NCT00388674|584228790|FG001|Initial Treatment|Pregnancy|16|||
161777751|NCT00388674|584228789|FG000|Initial Treatment|Study Drug Toxicity|5|||
161777752|NCT00388674|584228790|FG001|Initial Treatment|Study Drug Toxicity|92|||
161777753|NCT00388674|584228789|FG000|Initial Treatment|Participant Request|501|||
161777754|NCT00388674|584228790|FG001|Initial Treatment|Participant Request|673|||
161777755|NCT00388674|584228789|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
161880230|NCT01295827|584602872|FG002|Overall Study|Withdrawal by Subject|2|||
161880231|NCT01295827|584602873|FG003|Overall Study|Withdrawal by Subject|0|||
161880232|NCT01295827|584602874|FG004|Overall Study|Withdrawal by Subject|0|||
161880233|NCT01295827|584602875|FG005|Overall Study|Withdrawal by Subject|1|||
161880234|NCT01295827|584602876|FG006|Overall Study|Withdrawal by Subject|13|||
161880235|NCT01295827|584602877|FG007|Overall Study|Withdrawal by Subject|35|||
161777756|NCT00388674|584228790|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
161777757|NCT00388674|584228789|FG000|Initial Treatment|Not Reported|10|||
161777758|NCT00388674|584228790|FG001|Initial Treatment|Not Reported|12|||
161777759|NCT00388674|584228789|FG000|End of Study|Administrative Reason By Sponsor|299|||
161777760|NCT00388674|584228790|FG001|End of Study|Administrative Reason By Sponsor|253|||
161777761|NCT00388674|584228789|FG000|End of Study|Death|239|||
161777762|NCT00388674|584228790|FG001|End of Study|Death|262|||
161777763|NCT00388674|584228789|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
161777764|NCT00388674|584228790|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
161777765|NCT00388674|584228789|FG000|End of Study|HCC|8|||
161777766|NCT00388674|584228790|FG001|End of Study|HCC|7|||
161777767|NCT00388674|584228789|FG000|End of Study|Lost to Follow-up|587|||
161777768|NCT00388674|584228790|FG001|End of Study|Lost to Follow-up|715|||
161777769|NCT00388674|584228789|FG000|End of Study|Malignancy (Non-HCC)|1|||
161777770|NCT00388674|584228790|FG001|End of Study|Malignancy (Non-HCC)|1|||
161880236|NCT01295827|584602878|FG008|Overall Study|Withdrawal by Subject|11|||
161880237|NCT01295827|584602879|FG009|Overall Study|Withdrawal by Subject|2|||
161880238|NCT01295827|584602880|FG010|Overall Study|Withdrawal by Subject|18|||
161880239|NCT01295827|584602881|FG011|Overall Study|Withdrawal by Subject|13|||
161880240|NCT01295827|584602882|FG012|Overall Study|Withdrawal by Subject|0|||
161880241|NCT01295827|584602883|FG013|Overall Study|Withdrawal by Subject|0|||
161777771|NCT00388674|584228789|FG000|End of Study|Non-Study Related Comorbidities|3|||
161777772|NCT00388674|584228790|FG001|End of Study|Non-Study Related Comorbidities|4|||
161777773|NCT00388674|584228789|FG000|End of Study|Not Defined|135|||
161777774|NCT00388674|584228790|FG001|End of Study|Not Defined|214|||
161777775|NCT00388674|584228789|FG000|End of Study|Participant Withdrew Consent|437|||
161777776|NCT00388674|584228790|FG001|End of Study|Participant Withdrew Consent|673|||
161777777|NCT00388674|584228789|FG000|End of Study|No Off-Treatment Status Data|22|||
161777778|NCT00388674|584228790|FG001|End of Study|No Off-Treatment Status Data|30|||
161777779|NCT00388674|584228789|FG000|End of Study|Not Reported|0|||
161777780|NCT00388674|584228790|FG001|End of Study|Not Reported|1|||
161880242|NCT01295827|584602884|FG014|Overall Study|Withdrawal by Subject|0|||
161880243|NCT01295827|584602870|FG000|Overall Study|Other|0|||
161880244|NCT01295827|584602871|FG001|Overall Study|Other|0|||
161880245|NCT01295827|584602872|FG002|Overall Study|Other|0|||
161880246|NCT01295827|584602873|FG003|Overall Study|Other|0|||
161880247|NCT01295827|584602874|FG004|Overall Study|Other|0|||
161880248|NCT01295827|584602875|FG005|Overall Study|Other|0|||
161880249|NCT01295827|584602876|FG006|Overall Study|Other|1|||
161880250|NCT01295827|584602877|FG007|Overall Study|Other|1|||
161880251|NCT01295827|584602878|FG008|Overall Study|Other|1|||
161777781|NCT01563029|584228797|FG000|Overall Study|Adverse Event|1|||
161777782|NCT01563029|584228798|FG001|Overall Study|Adverse Event|0|||
161777783|NCT01563029|584228799|FG002|Overall Study|Adverse Event|1|||
161777784|NCT01563029|584228800|FG003|Overall Study|Adverse Event|2|||
161777785|NCT01563029|584228801|FG004|Overall Study|Adverse Event|1|||
161777786|NCT01563029|584228797|FG000|Overall Study|Lack of Efficacy|42|||
161777787|NCT01563029|584228798|FG001|Overall Study|Lack of Efficacy|16|||
161777788|NCT01563029|584228799|FG002|Overall Study|Lack of Efficacy|23|||
161777789|NCT01563029|584228800|FG003|Overall Study|Lack of Efficacy|21|||
161777790|NCT01563029|584228801|FG004|Overall Study|Lack of Efficacy|19|||
161880252|NCT01295827|584602879|FG009|Overall Study|Other|0|||
161777791|NCT01563029|584228797|FG000|Overall Study|Protocol Violation|1|||
161880253|NCT01295827|584602880|FG010|Overall Study|Other|2|||
161880254|NCT01295827|584602881|FG011|Overall Study|Other|0|||
161880255|NCT01295827|584602882|FG012|Overall Study|Other|0|||
161880256|NCT01295827|584602883|FG013|Overall Study|Other|0|||
161880257|NCT01295827|584602884|FG014|Overall Study|Other|0|||
161880258|NCT00101166|584602885|FG000|Overall Study|progressive disease|10|||
161880259|NCT01868022|584602886|FG000|Overall Study|Withdrawal by Subject|0|||
161880260|NCT01868022|584602887|FG001|Overall Study|Withdrawal by Subject|0|||
161880261|NCT01868022|584602888|FG002|Overall Study|Withdrawal by Subject|1|||
161880262|NCT01868022|584602889|FG003|Overall Study|Withdrawal by Subject|1|||
161880263|NCT01868022|584602890|FG004|Overall Study|Withdrawal by Subject|0|||
161880264|NCT01868022|584602891|FG005|Overall Study|Withdrawal by Subject|0|||
161880265|NCT01868022|584602892|FG006|Overall Study|Withdrawal by Subject|0|||
161880266|NCT01868022|584602893|FG007|Overall Study|Withdrawal by Subject|1|||
161880267|NCT01868022|584602894|FG008|Overall Study|Withdrawal by Subject|0|||
161880268|NCT01868022|584602886|FG000|Overall Study|Adverse Event|0|||
161880269|NCT01868022|584602887|FG001|Overall Study|Adverse Event|0|||
161880270|NCT01868022|584602888|FG002|Overall Study|Adverse Event|0|||
161880271|NCT01868022|584602889|FG003|Overall Study|Adverse Event|0|||
161880272|NCT01868022|584602890|FG004|Overall Study|Adverse Event|2|||
161880273|NCT01868022|584602891|FG005|Overall Study|Adverse Event|0|||
161880274|NCT01868022|584602892|FG006|Overall Study|Adverse Event|0|||
161880275|NCT01868022|584602893|FG007|Overall Study|Adverse Event|2|||
161880276|NCT01868022|584602894|FG008|Overall Study|Adverse Event|2|||
161880277|NCT01868022|584602886|FG000|Overall Study|Physician Decision|0|||
161880278|NCT01868022|584602887|FG001|Overall Study|Physician Decision|0|||
161880279|NCT01868022|584602888|FG002|Overall Study|Physician Decision|0|||
161880280|NCT01868022|584602889|FG003|Overall Study|Physician Decision|0|||
161880281|NCT01868022|584602890|FG004|Overall Study|Physician Decision|0|||
161880282|NCT01868022|584602891|FG005|Overall Study|Physician Decision|1|||
161880283|NCT01868022|584602892|FG006|Overall Study|Physician Decision|0|||
161880284|NCT01868022|584602893|FG007|Overall Study|Physician Decision|2|||
161880285|NCT01868022|584602894|FG008|Overall Study|Physician Decision|0|||
161880286|NCT01868022|584602886|FG000|Overall Study|Study closed/terminated|0|||
161880287|NCT01868022|584602887|FG001|Overall Study|Study closed/terminated|0|||
161880288|NCT01868022|584602888|FG002|Overall Study|Study closed/terminated|0|||
161880289|NCT01868022|584602889|FG003|Overall Study|Study closed/terminated|0|||
161880290|NCT01868022|584602890|FG004|Overall Study|Study closed/terminated|0|||
161880291|NCT01868022|584602891|FG005|Overall Study|Study closed/terminated|0|||
161880292|NCT01868022|584602892|FG006|Overall Study|Study closed/terminated|0|||
161880293|NCT01868022|584602893|FG007|Overall Study|Study closed/terminated|1|||
161880294|NCT01868022|584602894|FG008|Overall Study|Study closed/terminated|0|||
161880295|NCT01868022|584602886|FG000|Overall Study|Ongoing|0|||
161880296|NCT01868022|584602887|FG001|Overall Study|Ongoing|0|||
161880297|NCT01868022|584602888|FG002|Overall Study|Ongoing|0|||
161880298|NCT01868022|584602889|FG003|Overall Study|Ongoing|0|||
161880299|NCT01868022|584602890|FG004|Overall Study|Ongoing|0|||
161880300|NCT01868022|584602891|FG005|Overall Study|Ongoing|0|||
161880301|NCT01868022|584602892|FG006|Overall Study|Ongoing|0|||
161880302|NCT01868022|584602893|FG007|Overall Study|Ongoing|3|||
161880303|NCT01868022|584602894|FG008|Overall Study|Ongoing|0|||
161880304|NCT03226769|584602897|FG000|Overall Study|Withdrawal by Subject|0|||
161880305|NCT03226769|584602898|FG001|Overall Study|Withdrawal by Subject|1|||
161880306|NCT02640677|584602899|FG000|Overall Study|Lost to Follow-up|1|||
161880307|NCT02640677|584602899|FG000|Overall Study|Withdrawal by Subject|1|||
161880308|NCT01516008|584602906|FG000|Overall Study|Adverse Event|0|||
161880309|NCT01516008|584602907|FG001|Overall Study|Adverse Event|2|||
161880310|NCT01516008|584602908|FG002|Overall Study|Adverse Event|7|||
161880311|NCT01516008|584602906|FG000|Overall Study|Lack of Efficacy|44|||
161880312|NCT01516008|584602907|FG001|Overall Study|Lack of Efficacy|14|||
161880313|NCT01516008|584602908|FG002|Overall Study|Lack of Efficacy|10|||
161880314|NCT01516008|584602906|FG000|Overall Study|Protocol Violation|1|||
161880315|NCT01516008|584602907|FG001|Overall Study|Protocol Violation|0|||
161880316|NCT01516008|584602908|FG002|Overall Study|Protocol Violation|0|||
161880317|NCT01516008|584602906|FG000|Overall Study|Reason not specified|0|||
161880318|NCT01516008|584602907|FG001|Overall Study|Reason not specified|0|||
161880319|NCT01516008|584602908|FG002|Overall Study|Reason not specified|1|||
161880320|NCT01217476|584602909|FG000|Overall Study|Adverse Event|6|||
161880321|NCT01217476|584602910|FG001|Overall Study|Adverse Event|1|||
161880322|NCT01217476|584602909|FG000|Overall Study|Physician Decision|0|||
161880323|NCT01217476|584602910|FG001|Overall Study|Physician Decision|1|||
161880324|NCT01217476|584602909|FG000|Overall Study|Withdrawal by Subject|3|||
161880325|NCT01217476|584602910|FG001|Overall Study|Withdrawal by Subject|3|||
161880326|NCT01217476|584602909|FG000|Overall Study|Surgery on the Target Limb|0|||
161880327|NCT01217476|584602910|FG001|Overall Study|Surgery on the Target Limb|2|||
161880328|NCT01217476|584602909|FG000|Overall Study|Protocol Deviation|1|||
161991463|NCT02218008|585018510|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
161991464|NCT02218008|585018511|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
161991465|NCT02218008|585018512|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
161991466|NCT02218008|585018513|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
161880329|NCT01217476|584602910|FG001|Overall Study|Protocol Deviation|0|||
161777792|NCT01563029|584228798|FG001|Overall Study|Protocol Violation|2|||
161777793|NCT01563029|584228799|FG002|Overall Study|Protocol Violation|3|||
161777794|NCT01563029|584228800|FG003|Overall Study|Protocol Violation|1|||
161777795|NCT01563029|584228801|FG004|Overall Study|Protocol Violation|3|||
161777796|NCT01563029|584228797|FG000|Overall Study|Protocol defined stopping criteria|1|||
161777797|NCT01563029|584228798|FG001|Overall Study|Protocol defined stopping criteria|0|||
161880330|NCT01217476|584602909|FG000|Overall Study|Other|2|||
161880331|NCT01217476|584602910|FG001|Overall Study|Other|0|||
161777798|NCT01563029|584228799|FG002|Overall Study|Protocol defined stopping criteria|0|||
161777799|NCT01563029|584228800|FG003|Overall Study|Protocol defined stopping criteria|0|||
161777800|NCT01563029|584228801|FG004|Overall Study|Protocol defined stopping criteria|0|||
161777801|NCT01563029|584228797|FG000|Overall Study|Lost to Follow-up|1|||
161880332|NCT03033602|584602911|FG000|Overall Study|Withdrawal by Subject|11|||
161880333|NCT03033602|584602912|FG001|Overall Study|Withdrawal by Subject|21|||
161880334|NCT03033602|584602911|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
161880335|NCT03033602|584602912|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
161880336|NCT02778074|584602914|FG000|Overall Study|Lost to Follow-up|7|||
161880337|NCT02778074|584602915|FG001|Overall Study|Lost to Follow-up|10|||
161880338|NCT03489707|584602918|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
161880339|NCT03489707|584602919|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
161880340|NCT03489707|584602918|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
161880341|NCT03489707|584602919|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
161880342|NCT03617770|584602920|FG000|Overall Study|Lost to Follow-up|1|||
161880343|NCT03617770|584602921|FG001|Overall Study|Lost to Follow-up|0|||
161880344|NCT00356135|584602922|FG000|Overall Study|Protocol Violation|1|||
161880345|NCT00356135|584602923|FG001|Overall Study|Protocol Violation|0|||
161880346|NCT00356135|584602924|FG002|Overall Study|Protocol Violation|0|||
161880347|NCT00356135|584602922|FG000|Overall Study|Adverse Event|1|||
161880348|NCT00356135|584602923|FG001|Overall Study|Adverse Event|0|||
161880349|NCT00356135|584602924|FG002|Overall Study|Adverse Event|0|||
161880350|NCT00356135|584602922|FG000|Overall Study|Lost to Follow-up|0|||
161880351|NCT00356135|584602923|FG001|Overall Study|Lost to Follow-up|0|||
161880352|NCT00356135|584602924|FG002|Overall Study|Lost to Follow-up|1|||
161880353|NCT00356135|584602922|FG000|Overall Study|Physician Decision|1|||
161880354|NCT00356135|584602923|FG001|Overall Study|Physician Decision|1|||
161880355|NCT00356135|584602924|FG002|Overall Study|Physician Decision|1|||
161880356|NCT00356135|584602922|FG000|Overall Study|Subject non-compliance|1|||
161880357|NCT00356135|584602923|FG001|Overall Study|Subject non-compliance|1|||
161880358|NCT00356135|584602924|FG002|Overall Study|Subject non-compliance|3|||
161880359|NCT03963232|584602925|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161880360|NCT03963232|584602926|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
161880361|NCT03963232|584602925|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
161880362|NCT03963232|584602926|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
161777802|NCT01563029|584228798|FG001|Overall Study|Lost to Follow-up|0|||
161777803|NCT01563029|584228799|FG002|Overall Study|Lost to Follow-up|1|||
161777804|NCT01563029|584228800|FG003|Overall Study|Lost to Follow-up|1|||
161777805|NCT01563029|584228801|FG004|Overall Study|Lost to Follow-up|1|||
161880363|NCT03963232|584602925|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
161880364|NCT03963232|584602926|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
161880365|NCT03963232|584602925|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
161880366|NCT03963232|584602926|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
161880367|NCT03963232|584602925|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
161880368|NCT03963232|584602926|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
161880369|NCT03963232|584602925|FG000|Open-Label Treatment Phase|Adverse Event|1|||
161880370|NCT03963232|584602926|FG001|Open-Label Treatment Phase|Adverse Event|2|||
161880371|NCT03963232|584602925|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
161880372|NCT03963232|584602926|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
161777806|NCT01563029|584228797|FG000|Overall Study|Physician Decision|3|||
161777807|NCT01563029|584228798|FG001|Overall Study|Physician Decision|5|||
161880373|NCT03963232|584602925|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
161880374|NCT03963232|584602926|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
161880375|NCT03963232|584602925|FG000|Open-Label Treatment Phase|Pregnancy|1|||
161880376|NCT03963232|584602926|FG001|Open-Label Treatment Phase|Pregnancy|0|||
161880377|NCT03963232|584602925|FG000|Follow-up Phase|Withdrawal by Subject|7|||
161880378|NCT03963232|584602926|FG001|Follow-up Phase|Withdrawal by Subject|5|||
161880379|NCT03963232|584602925|FG000|Follow-up Phase|Protocol Violation|0|||
161880380|NCT03963232|584602926|FG001|Follow-up Phase|Protocol Violation|2|||
161777808|NCT01563029|584228799|FG002|Overall Study|Physician Decision|2|||
161880381|NCT03963232|584602925|FG000|Follow-up Phase|Adverse Event|0|||
161777809|NCT01563029|584228800|FG003|Overall Study|Physician Decision|4|||
161777810|NCT01563029|584228801|FG004|Overall Study|Physician Decision|2|||
161880382|NCT03963232|584602926|FG001|Follow-up Phase|Adverse Event|1|||
161880383|NCT03963232|584602925|FG000|Follow-up Phase|Lost to Follow-up|0|||
161880384|NCT03963232|584602926|FG001|Follow-up Phase|Lost to Follow-up|1|||
161880385|NCT05270395|584602932|FG000|Overall Study|Lost to Follow-up|2|||
161880386|NCT05270395|584602933|FG001|Overall Study|Lost to Follow-up|2|||
161880387|NCT05270395|584602932|FG000|Overall Study|Death|1|||
161880388|NCT05270395|584602933|FG001|Overall Study|Death|2|||
161880389|NCT05270395|584602932|FG000|Overall Study|Study Team Withdrew|1|||
161880390|NCT05270395|584602933|FG001|Overall Study|Study Team Withdrew|0|||
161880391|NCT03055494|584604962|FG000|Overall Study|Lost to Follow-up|6|||
161880392|NCT03055494|584604963|FG001|Overall Study|Lost to Follow-up|0|||
161880393|NCT03055494|584604962|FG000|Overall Study|Physician Decision|2|||
161880394|NCT03055494|584604963|FG001|Overall Study|Physician Decision|0|||
161880395|NCT03055494|584604962|FG000|Overall Study|Withdrawal by Subject|1|||
161880396|NCT03055494|584604963|FG001|Overall Study|Withdrawal by Subject|0|||
161880397|NCT03055494|584604962|FG000|Overall Study|Adverse Event|0|||
161880398|NCT03055494|584604963|FG001|Overall Study|Adverse Event|1|||
161880399|NCT03055494|584604962|FG000|Overall Study|Non-compliance with study treatment|1|||
161880400|NCT03055494|584604963|FG001|Overall Study|Non-compliance with study treatment|0|||
161880401|NCT04743804|584604966|FG000|Overall Study|Other|1|||
161880402|NCT04743804|584604967|FG001|Overall Study|Other|0|||
161880403|NCT04743804|584604966|FG000|Overall Study|Withdrawal by Subject|0|||
161880404|NCT04743804|584604967|FG001|Overall Study|Withdrawal by Subject|1|||
161880405|NCT04743804|584604966|FG000|Overall Study|Study Terminated by Sponsor|1|||
161880406|NCT04743804|584604967|FG001|Overall Study|Study Terminated by Sponsor|4|||
161880407|NCT04743804|584604966|FG000|Overall Study|Physician Decision|0|||
161880408|NCT04743804|584604967|FG001|Overall Study|Physician Decision|1|||
161880409|NCT04743804|584604966|FG000|Overall Study|Death|3|||
161880410|NCT04743804|584604967|FG001|Overall Study|Death|0|||
161880411|NCT01942486|584604968|FG000|Overall Study|Lost to Follow-up|27|||
161880412|NCT02424630|584604971|FG000|Overall Study|No rotator cuff tear|1|||
161880413|NCT02424630|584604972|FG001|Overall Study|No rotator cuff tear|2|||
161880414|NCT02424630|584604971|FG000|Overall Study|Open procedure|0|||
161880415|NCT02424630|584604972|FG001|Overall Study|Open procedure|1|||
161880416|NCT02691013|584604973|FG000|Overall Study|Withdrawal by Subject|3|||
161880417|NCT02691013|584604974|FG001|Overall Study|Withdrawal by Subject|0|||
161880418|NCT02111785|584604975|FG000|Overall Study|Death|0|||
161880419|NCT02111785|584604976|FG001|Overall Study|Death|1|||
161880420|NCT02111785|584604977|FG002|Overall Study|Death|0|||
161880421|NCT02111785|584604978|FG003|Overall Study|Death|0|||
161880422|NCT04507256|584604979|FG000|Overall Study|Withdrawal by Subject|1|||
161880423|NCT04507256|584604980|FG001|Overall Study|Withdrawal by Subject|0|||
161880424|NCT04507256|584604981|FG002|Overall Study|Withdrawal by Subject|0|||
161880425|NCT04507256|584604982|FG003|Overall Study|Withdrawal by Subject|1|||
161880426|NCT04507256|584604983|FG004|Overall Study|Withdrawal by Subject|0|||
161880427|NCT04507256|584604984|FG005|Overall Study|Withdrawal by Subject|0|||
161880428|NCT02677038|584604989|FG000|Overall Study|Physician Decision|1|||
161880429|NCT02677038|584604989|FG000|Overall Study|Withdrawal by Subject|1|||
161880430|NCT02777970|584604994|FG000|Overall Study|Lost to Follow-up|0|||
161880431|NCT02777970|584604995|FG001|Overall Study|Lost to Follow-up|1|||
161880432|NCT02777970|584604996|FG002|Overall Study|Lost to Follow-up|0|||
161880433|NCT02777970|584604994|FG000|Overall Study|Protocol Violation|1|||
161880434|NCT02777970|584604995|FG001|Overall Study|Protocol Violation|0|||
161880435|NCT02777970|584604996|FG002|Overall Study|Protocol Violation|0|||
161880436|NCT02541669|584605001|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
161880437|NCT02541669|584605002|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
161880438|NCT02541669|584605003|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
161880439|NCT02541669|584605004|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
161880440|NCT02541669|584605005|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
161880441|NCT00834639|584605006|FG000|Second Intervention|Physician Decision|0|||
161880442|NCT00834639|584605007|FG001|Second Intervention|Physician Decision|2|||
161880443|NCT04739722|584605008|FG000|Overall Study|Lost to Follow-up|5301|||
161880444|NCT04739722|584605008|FG000|Overall Study|Withdrawal by Subject|42|||
161880445|NCT04739722|584605008|FG000|Overall Study|Non Average-risk|1157|||
161991467|NCT02218008|585018514|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
161991468|NCT02218008|585018509|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
161991469|NCT02218008|585018510|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
161991470|NCT02218008|585018511|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
161991471|NCT02218008|585018512|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
161991472|NCT02218008|585018513|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
161991473|NCT02218008|585018514|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
161880446|NCT01968707|584605012|FG000|Overall Study|Did not meet treatment day baseline|49|||
161880447|NCT01968707|584605013|FG001|Overall Study|Did not meet treatment day baseline|12|||
161880448|NCT01968707|584605014|FG002|Overall Study|Did not meet treatment day baseline|41|||
161880449|NCT01968707|584605015|FG003|Overall Study|Did not meet treatment day baseline|44|||
161880450|NCT01968707|584605016|FG004|Overall Study|Did not meet treatment day baseline|36|||
161880451|NCT01968707|584605017|FG005|Overall Study|Did not meet treatment day baseline|11|||
161880452|NCT01968707|584605018|FG006|Overall Study|Did not meet treatment day baseline|34|||
161880453|NCT01968707|584605019|FG007|Overall Study|Did not meet treatment day baseline|35|||
161991474|NCT02218008|585018509|FG000|Stage 1 (S1)|Pregnancy|0|||
161880454|NCT02083185|584605027|FG000|Overall Study|Lost to Follow-up|0|||
161880455|NCT02083185|584605028|FG001|Overall Study|Lost to Follow-up|3|||
161880456|NCT02083185|584605029|FG002|Overall Study|Lost to Follow-up|0|||
161880457|NCT02083185|584605027|FG000|Overall Study|Withdrawal by Subject|9|||
161880458|NCT02083185|584605028|FG001|Overall Study|Withdrawal by Subject|15|||
161880459|NCT02083185|584605029|FG002|Overall Study|Withdrawal by Subject|1|||
161880460|NCT02083185|584605027|FG000|Overall Study|Death|2|||
161880461|NCT02083185|584605028|FG001|Overall Study|Death|2|||
161880462|NCT02083185|584605029|FG002|Overall Study|Death|1|||
161880463|NCT02083185|584605027|FG000|Overall Study|Reason not Specified|9|||
161880464|NCT02083185|584605028|FG001|Overall Study|Reason not Specified|6|||
161880465|NCT02083185|584605029|FG002|Overall Study|Reason not Specified|5|||
161880466|NCT02083185|584605027|FG000|Overall Study|Study Terminated by Sponsor|0|||
161880467|NCT02083185|584605028|FG001|Overall Study|Study Terminated by Sponsor|1|||
161880468|NCT02083185|584605029|FG002|Overall Study|Study Terminated by Sponsor|0|||
161880469|NCT02083185|584605027|FG000|Overall Study|Did not Receive Study Drug|0|||
161880470|NCT02083185|584605028|FG001|Overall Study|Did not Receive Study Drug|2|||
161880471|NCT02083185|584605029|FG002|Overall Study|Did not Receive Study Drug|0|||
161880472|NCT03419598|584605030|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
161880473|NCT02474589|584605031|FG000|Overall Study|Adverse Event|6|||
161880474|NCT02474589|584605032|FG001|Overall Study|Adverse Event|2|||
161880475|NCT02474589|584605031|FG000|Overall Study|Lost to Follow-up|6|||
161880476|NCT02474589|584605032|FG001|Overall Study|Lost to Follow-up|1|||
161880477|NCT02474589|584605031|FG000|Overall Study|Protocol Violation|4|||
161880478|NCT02474589|584605032|FG001|Overall Study|Protocol Violation|1|||
161880479|NCT02474589|584605031|FG000|Overall Study|Withdrawal by Subject|4|||
161880480|NCT02474589|584605032|FG001|Overall Study|Withdrawal by Subject|0|||
161880481|NCT02474589|584605031|FG000|Overall Study|Inability to complete study procedures|5|||
161880482|NCT02474589|584605032|FG001|Overall Study|Inability to complete study procedures|1|||
161880483|NCT00380081|584605035|FG000|Overall Study|Withdrawal by Subject|0|||
161880484|NCT00380081|584605036|FG001|Overall Study|Withdrawal by Subject|0|||
161880485|NCT00380081|584605037|FG002|Overall Study|Withdrawal by Subject|0|||
161880486|NCT00380081|584605038|FG003|Overall Study|Withdrawal by Subject|0|||
161880487|NCT00380081|584605039|FG004|Overall Study|Withdrawal by Subject|1|||
161880488|NCT00380081|584605040|FG005|Overall Study|Withdrawal by Subject|0|||
161880489|NCT00380081|584605035|FG000|Overall Study|Family Emergency|0|||
161880490|NCT00380081|584605036|FG001|Overall Study|Family Emergency|0|||
161880491|NCT00380081|584605037|FG002|Overall Study|Family Emergency|0|||
161880492|NCT00380081|584605038|FG003|Overall Study|Family Emergency|0|||
161880493|NCT00380081|584605039|FG004|Overall Study|Family Emergency|0|||
161880494|NCT00380081|584605040|FG005|Overall Study|Family Emergency|1|||
161880495|NCT02231879|584605041|FG000|Overall Study|Adverse Event|2|||
161880496|NCT02231879|584605042|FG001|Overall Study|Adverse Event|1|||
161880497|NCT02231879|584605041|FG000|Overall Study|Lack of Efficacy|0|||
161880498|NCT02231879|584605042|FG001|Overall Study|Lack of Efficacy|1|||
161880499|NCT00459706|584605043|FG000|Overall Study|Adverse Event|19|||
161880500|NCT00459706|584605044|FG001|Overall Study|Adverse Event|13|||
161880501|NCT00459706|584605043|FG000|Overall Study|Withdrawal by Subject|1|||
161880502|NCT00459706|584605044|FG001|Overall Study|Withdrawal by Subject|6|||
161880503|NCT00459706|584605043|FG000|Overall Study|Physician Decision|2|||
161880504|NCT00459706|584605044|FG001|Overall Study|Physician Decision|0|||
161880505|NCT00459706|584605043|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
161880506|NCT00459706|584605044|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161880507|NCT00459706|584605043|FG000|Overall Study|Protocol Violation|2|||
161880508|NCT00459706|584605044|FG001|Overall Study|Protocol Violation|1|||
161880509|NCT00459706|584605043|FG000|Overall Study|Failed to Return|1|||
161880510|NCT00459706|584605044|FG001|Overall Study|Failed to Return|0|||
161880511|NCT00459706|584605043|FG000|Overall Study|Other|0|||
161880512|NCT00459706|584605044|FG001|Overall Study|Other|1|||
161880513|NCT00189306|584605045|FG000|Treatment Period|Withdrawal by Subject|2|||
161880514|NCT00189306|584605045|FG000|Treatment Period|Adverse Event|2|||
161880515|NCT00189306|584605045|FG000|Treatment Period|Protocol Violation|1|||
161880516|NCT00189306|584605045|FG000|Posttreatment Period|Death|1|||
161880517|NCT00189306|584605045|FG000|Posttreatment Period|Withdrawal by Subject|2|||
161880518|NCT00189306|584605045|FG000|Posttreatment Period|Noncompliance|1|||
161880519|NCT00189306|584605045|FG000|Posttreatment Period|Target lesion excised|1|||
161880520|NCT00189306|584605045|FG000|Posttreatment Period|Protocol Violation|1|||
161880521|NCT00189306|584605045|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
161880522|NCT00189306|584605045|FG000|Posttreatment Period|Local skin reaction/sign|1|||
161880523|NCT00189306|584605045|FG000|Long-Term Follow-up|Adverse Event|2|||
161880524|NCT00189306|584605045|FG000|Long-Term Follow-up|Death|4|||
161880525|NCT00189306|584605045|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
161880526|NCT00189306|584605045|FG000|Long-Term Follow-up|Intercurrent disease|2|||
161880527|NCT00189306|584605045|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
161880528|NCT00189306|584605045|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
161880529|NCT03640481|584605046|FG000|Overall Study|Death|14|||
161880530|NCT03640481|584605047|FG001|Overall Study|Death|14|||
161880531|NCT03640481|584605048|FG002|Overall Study|Death|0|||
161880532|NCT03640481|584605049|FG003|Overall Study|Death|0|||
161880533|NCT03640481|584605046|FG000|Overall Study|Lost to Follow-up|2|||
161880534|NCT03640481|584605047|FG001|Overall Study|Lost to Follow-up|0|||
161880535|NCT03640481|584605048|FG002|Overall Study|Lost to Follow-up|0|||
161777811|NCT01563029|584228797|FG000|Overall Study|Withdrawal by Subject|4|||
161777812|NCT01563029|584228798|FG001|Overall Study|Withdrawal by Subject|1|||
161777813|NCT01563029|584228799|FG002|Overall Study|Withdrawal by Subject|3|||
161777814|NCT01563029|584228800|FG003|Overall Study|Withdrawal by Subject|4|||
161777815|NCT01563029|584228801|FG004|Overall Study|Withdrawal by Subject|3|||
161777816|NCT03069365|584228802|FG000|Overall Study|Adverse Event|1|||
161777817|NCT02780115|584228803|FG000|Overall Study|Withdrawal by Subject|0|||
161777818|NCT02780115|584228804|FG001|Overall Study|Withdrawal by Subject|1|||
161777819|NCT02780115|584228805|FG002|Overall Study|Withdrawal by Subject|1|||
161777820|NCT02780115|584228806|FG003|Overall Study|Withdrawal by Subject|0|||
161777821|NCT02780115|584228807|FG004|Overall Study|Withdrawal by Subject|0|||
161777822|NCT02780115|584228803|FG000|Overall Study|Adverse Event|0|||
161777823|NCT02780115|584228804|FG001|Overall Study|Adverse Event|0|||
161777824|NCT02780115|584228805|FG002|Overall Study|Adverse Event|0|||
161777825|NCT02780115|584228806|FG003|Overall Study|Adverse Event|1|||
161777826|NCT02780115|584228807|FG004|Overall Study|Adverse Event|1|||
161777827|NCT00769132|584228808|FG000|Period 1|Adverse Event|1|||
161777828|NCT00769132|584228809|FG001|Period 1|Adverse Event|0|||
161777829|NCT00769132|584228810|FG002|Period 1|Adverse Event|0|||
161777830|NCT00769132|584228811|FG003|Period 1|Adverse Event|1|||
161777831|NCT00769132|584228808|FG000|Period 2|Withdrawal by Subject|0|||
161777832|NCT00769132|584228809|FG001|Period 2|Withdrawal by Subject|0|||
161777833|NCT00769132|584228810|FG002|Period 2|Withdrawal by Subject|0|||
161777834|NCT00769132|584228811|FG003|Period 2|Withdrawal by Subject|1|||
161777835|NCT00769132|584228808|FG000|Period 3|Withdrawal by Subject|1|||
161777836|NCT00769132|584228809|FG001|Period 3|Withdrawal by Subject|0|||
161777837|NCT00769132|584228810|FG002|Period 3|Withdrawal by Subject|0|||
161777838|NCT00769132|584228811|FG003|Period 3|Withdrawal by Subject|0|||
161777839|NCT00769132|584228808|FG000|Period 4|Withdrawal by Subject|0|||
161777840|NCT00769132|584228809|FG001|Period 4|Withdrawal by Subject|1|||
161777841|NCT00769132|584228810|FG002|Period 4|Withdrawal by Subject|0|||
161777842|NCT00769132|584228811|FG003|Period 4|Withdrawal by Subject|0|||
161777843|NCT01257737|584228812|FG000|Overall Study|Lost to Follow-up|1|||
161777844|NCT01257737|584228813|FG001|Overall Study|Lost to Follow-up|2|||
161777845|NCT01257737|584228812|FG000|Overall Study|Liver transplant|1|||
161777846|NCT01257737|584228813|FG001|Overall Study|Liver transplant|0|||
161777847|NCT01257737|584228812|FG000|Overall Study|Relocation out of the country|0|||
161777848|NCT01257737|584228813|FG001|Overall Study|Relocation out of the country|1|||
161777849|NCT01257737|584228812|FG000|Overall Study|Withdrew from study|0|||
161777850|NCT01257737|584228813|FG001|Overall Study|Withdrew from study|1|||
161777851|NCT00127192|584228816|FG000|Overall Study|Adverse Event|0|||
161777852|NCT00127192|584228817|FG001|Overall Study|Adverse Event|1|||
161777853|NCT00127192|584228818|FG002|Overall Study|Adverse Event|1|||
161777854|NCT00127192|584228819|FG003|Overall Study|Adverse Event|1|||
161777855|NCT00127192|584228820|FG004|Overall Study|Adverse Event|0|||
161777856|NCT00127192|584228816|FG000|Overall Study|Lack of Efficacy|2|||
161777857|NCT00127192|584228817|FG001|Overall Study|Lack of Efficacy|0|||
161777858|NCT00127192|584228818|FG002|Overall Study|Lack of Efficacy|0|||
161777859|NCT00127192|584228819|FG003|Overall Study|Lack of Efficacy|0|||
161777860|NCT00127192|584228820|FG004|Overall Study|Lack of Efficacy|2|||
161777861|NCT00127192|584228816|FG000|Overall Study|Withdrawal by Subject|0|||
161777862|NCT00127192|584228817|FG001|Overall Study|Withdrawal by Subject|0|||
161777863|NCT00127192|584228818|FG002|Overall Study|Withdrawal by Subject|1|||
161777864|NCT00127192|584228819|FG003|Overall Study|Withdrawal by Subject|0|||
161777865|NCT00127192|584228820|FG004|Overall Study|Withdrawal by Subject|3|||
161777866|NCT00127192|584228816|FG000|Overall Study|Adverse event in pre-treatment period|1|||
161777867|NCT00127192|584228817|FG001|Overall Study|Adverse event in pre-treatment period|0|||
161777868|NCT00127192|584228818|FG002|Overall Study|Adverse event in pre-treatment period|0|||
161880536|NCT03640481|584605049|FG003|Overall Study|Lost to Follow-up|0|||
161880537|NCT03640481|584605046|FG000|Overall Study|Site terminated by sponsor|1|||
161880538|NCT03640481|584605047|FG001|Overall Study|Site terminated by sponsor|3|||
161880539|NCT03640481|584605048|FG002|Overall Study|Site terminated by sponsor|0|||
161880540|NCT03640481|584605049|FG003|Overall Study|Site terminated by sponsor|0|||
161880541|NCT03640481|584605046|FG000|Overall Study|Study terminated by sponsor|29|||
161777869|NCT00127192|584228819|FG003|Overall Study|Adverse event in pre-treatment period|0|||
161777870|NCT00127192|584228820|FG004|Overall Study|Adverse event in pre-treatment period|0|||
161777871|NCT01036594|584228835|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
161777872|NCT01036594|584228836|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
161777873|NCT01036594|584228835|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
161777874|NCT01036594|584228836|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
161777875|NCT01036594|584228835|FG000|Week 12 Evaluation|Adverse Event|5|||
161777876|NCT01036594|584228836|FG001|Week 12 Evaluation|Adverse Event|0|||
161777877|NCT01036594|584228835|FG000|Week 12 Evaluation|Physician Decision|1|||
161777878|NCT01036594|584228836|FG001|Week 12 Evaluation|Physician Decision|0|||
161777879|NCT01036594|584228835|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
161777880|NCT01036594|584228836|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
161991475|NCT02218008|585018510|FG001|Stage 1 (S1)|Pregnancy|0|||
161991476|NCT02218008|585018511|FG002|Stage 1 (S1)|Pregnancy|1|||
161991477|NCT02218008|585018512|FG003|Stage 1 (S1)|Pregnancy|0|||
161991478|NCT02218008|585018513|FG004|Stage 1 (S1)|Pregnancy|0|||
161991479|NCT02218008|585018514|FG005|Stage 1 (S1)|Pregnancy|0|||
161991480|NCT02218008|585018509|FG000|Stage 1 (S1)|Protocol Violation|0|||
161991481|NCT02218008|585018510|FG001|Stage 1 (S1)|Protocol Violation|0|||
161991482|NCT02218008|585018511|FG002|Stage 1 (S1)|Protocol Violation|1|||
161991483|NCT02218008|585018512|FG003|Stage 1 (S1)|Protocol Violation|0|||
161991484|NCT02218008|585018513|FG004|Stage 1 (S1)|Protocol Violation|0|||
161991485|NCT02218008|585018514|FG005|Stage 1 (S1)|Protocol Violation|0|||
161991486|NCT02218008|585018509|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
161991487|NCT02218008|585018510|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
161991488|NCT02218008|585018511|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
161991489|NCT02218008|585018512|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
161991490|NCT02218008|585018513|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
161991491|NCT02218008|585018514|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
161991492|NCT02218008|585018509|FG000|Stage 2 (S2)|Adverse Event|0|||
161991493|NCT02218008|585018510|FG001|Stage 2 (S2)|Adverse Event|0|||
161991494|NCT02218008|585018511|FG002|Stage 2 (S2)|Adverse Event|0|||
161991495|NCT02218008|585018512|FG003|Stage 2 (S2)|Adverse Event|2|||
161991496|NCT02218008|585018513|FG004|Stage 2 (S2)|Adverse Event|3|||
161991497|NCT02218008|585018514|FG005|Stage 2 (S2)|Adverse Event|3|||
161991498|NCT02218008|585018509|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
161991499|NCT02218008|585018510|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
161991500|NCT02218008|585018511|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
161991501|NCT02218008|585018512|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
161991502|NCT02218008|585018513|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
161991503|NCT02218008|585018514|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
161991504|NCT02218008|585018509|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
161991505|NCT02218008|585018510|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
161991506|NCT02218008|585018511|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
161991507|NCT02218008|585018512|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
161991508|NCT02218008|585018513|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
161991509|NCT02218008|585018514|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
161991510|NCT02218008|585018509|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
161991511|NCT02218008|585018510|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
161991512|NCT02218008|585018511|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
161991513|NCT02218008|585018512|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
161991514|NCT02218008|585018513|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
161991515|NCT02218008|585018514|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
161991516|NCT02218008|585018509|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
161991517|NCT02218008|585018510|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
161991518|NCT02218008|585018511|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
161991519|NCT02218008|585018512|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
161991520|NCT02218008|585018513|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
161991521|NCT02218008|585018514|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
161991522|NCT00408434|585018519|FG000|Overall Study|Adverse Event|0|||
161991523|NCT00408434|585018520|FG001|Overall Study|Adverse Event|0|||
161991524|NCT00408434|585018521|FG002|Overall Study|Adverse Event|1|||
161777881|NCT01036594|584228835|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
161777882|NCT01036594|584228836|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
161777883|NCT01036594|584228835|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
161777884|NCT01036594|584228836|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
161777885|NCT01036594|584228835|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
161777886|NCT01036594|584228836|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
161777887|NCT01036594|584228835|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
161777888|NCT01036594|584228836|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
161777889|NCT01612780|584228839|FG000|Overall Study|Treatment not completed|1|||
161777890|NCT01612780|584228839|FG000|Overall Study|Withdrawal by Subject|5|||
161777891|NCT03466060|584228840|FG000|Period 1|Test Lens Damage|0|||
161777892|NCT03466060|584228841|FG001|Period 1|Test Lens Damage|2|||
161777893|NCT03466060|584228842|FG002|Period 1|Test Lens Damage|0|||
161777894|NCT03466060|584228843|FG003|Period 1|Test Lens Damage|0|||
161777895|NCT03466060|584228844|FG004|Period 1|Test Lens Damage|0|||
161777896|NCT03466060|584228845|FG005|Period 1|Test Lens Damage|0|||
161777897|NCT03466060|584228840|FG000|Period 1|Withdrawal by Subject|0|||
161777898|NCT03466060|584228841|FG001|Period 1|Withdrawal by Subject|0|||
161777899|NCT03466060|584228842|FG002|Period 1|Withdrawal by Subject|2|||
161777900|NCT03466060|584228843|FG003|Period 1|Withdrawal by Subject|0|||
161777901|NCT03466060|584228844|FG004|Period 1|Withdrawal by Subject|0|||
161777902|NCT03466060|584228845|FG005|Period 1|Withdrawal by Subject|0|||
161777903|NCT03466060|584228840|FG000|Period 1|Lost to Follow-up|0|||
161880542|NCT03640481|584605047|FG001|Overall Study|Study terminated by sponsor|42|||
161880543|NCT03640481|584605048|FG002|Overall Study|Study terminated by sponsor|1|||
161880544|NCT03640481|584605049|FG003|Overall Study|Study terminated by sponsor|0|||
161880545|NCT03640481|584605046|FG000|Overall Study|Withdrawal by Subject|5|||
161880546|NCT03640481|584605047|FG001|Overall Study|Withdrawal by Subject|4|||
161880547|NCT03640481|584605048|FG002|Overall Study|Withdrawal by Subject|0|||
161880548|NCT03640481|584605049|FG003|Overall Study|Withdrawal by Subject|1|||
161880549|NCT03640481|584605046|FG000|Overall Study|Other|26|||
161880550|NCT03640481|584605047|FG001|Overall Study|Other|12|||
161880551|NCT03640481|584605048|FG002|Overall Study|Other|1|||
161880552|NCT03640481|584605049|FG003|Overall Study|Other|0|||
161880553|NCT03640481|584605046|FG000|Overall Study|Randomized, but not treated|1|||
161880554|NCT03640481|584605047|FG001|Overall Study|Randomized, but not treated|3|||
161880555|NCT03640481|584605048|FG002|Overall Study|Randomized, but not treated|0|||
161880556|NCT03640481|584605049|FG003|Overall Study|Randomized, but not treated|0|||
161880557|NCT01322035|584605050|FG000|Overall Study|Lost to Follow-up|8|||
161880558|NCT01322035|584605051|FG001|Overall Study|Lost to Follow-up|3|||
161880559|NCT00535847|584605052|FG000|Overall Study|Adverse Event|5|||
161880560|NCT00535847|584605053|FG001|Overall Study|Adverse Event|3|||
161880561|NCT00535847|584605054|FG002|Overall Study|Adverse Event|2|||
161880562|NCT00535847|584605052|FG000|Overall Study|Non compliance|1|||
161880563|NCT00535847|584605053|FG001|Overall Study|Non compliance|1|||
161880564|NCT00535847|584605054|FG002|Overall Study|Non compliance|0|||
161880565|NCT00535847|584605052|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
161880566|NCT00535847|584605053|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
161880567|NCT00535847|584605054|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
161880568|NCT01546168|584605057|FG000|Overall Study|Lost to Follow-up|1|||
161880569|NCT01546168|584605058|FG001|Overall Study|Lost to Follow-up|0|||
161880570|NCT01546168|584605057|FG000|Overall Study|Withdrawal by Subject|1|||
161880571|NCT01546168|584605058|FG001|Overall Study|Withdrawal by Subject|0|||
161880572|NCT01546168|584605057|FG000|Overall Study|ineligible after signing consent|2|||
161880573|NCT01546168|584605058|FG001|Overall Study|ineligible after signing consent|0|||
161880574|NCT02850016|584605061|FG000|Overall Study|Withdrawal by Subject|1|||
161880575|NCT02850016|584605062|FG001|Overall Study|Withdrawal by Subject|2|||
161880576|NCT00070018|584605065|FG000|Overall Study|Adverse Event|2|||
161880577|NCT00070018|584605065|FG000|Overall Study|Lack of Efficacy|1|||
161880578|NCT00070018|584605065|FG000|Overall Study|Withdrawal by Subject|1|||
161880579|NCT02939716|584605066|FG000|Overall Study|scanner failure|0|||
161880580|NCT02939716|584605067|FG001|Overall Study|scanner failure|0|||
161880581|NCT02939716|584605068|FG002|Overall Study|scanner failure|0|||
161880582|NCT02939716|584605069|FG003|Overall Study|scanner failure|1|||
161880583|NCT02939716|584605070|FG004|Overall Study|scanner failure|1|||
161880584|NCT02939716|584605071|FG005|Overall Study|scanner failure|1|||
161880585|NCT04240457|584605077|FG000|Overall Study|Lost to Follow-up|5|||
161880586|NCT04240457|584605078|FG001|Overall Study|Lost to Follow-up|1|||
161880587|NCT00844480|584605083|FG000|Overall Study|Withdrawal by Subject|2|||
161880588|NCT00844480|584605084|FG001|Overall Study|Withdrawal by Subject|3|||
161880589|NCT03197870|584605089|FG000|Overall Study|Adverse Event|9|||
161880590|NCT03197870|584605090|FG001|Overall Study|Adverse Event|4|||
161880591|NCT03197870|584605091|FG002|Overall Study|Adverse Event|6|||
161880592|NCT03197870|584605089|FG000|Overall Study|Withdrawal by Subject|2|||
161880593|NCT03197870|584605090|FG001|Overall Study|Withdrawal by Subject|3|||
161880594|NCT03197870|584605091|FG002|Overall Study|Withdrawal by Subject|0|||
161880595|NCT03197870|584605089|FG000|Overall Study|Lost to Follow-up|2|||
161880596|NCT03197870|584605090|FG001|Overall Study|Lost to Follow-up|2|||
161880597|NCT03197870|584605091|FG002|Overall Study|Lost to Follow-up|0|||
161880598|NCT03197870|584605089|FG000|Overall Study|data not available|1|||
161880599|NCT03197870|584605090|FG001|Overall Study|data not available|1|||
161880600|NCT03197870|584605091|FG002|Overall Study|data not available|0|||
161880601|NCT01618019|584605093|FG000|Overall Study|Withdrawal by Subject|14|||
161880602|NCT01618019|584605094|FG001|Overall Study|Withdrawal by Subject|14|||
161880603|NCT01508130|584605098|FG000|Overall Study|Adverse Event|81|||
161880604|NCT01508130|584605099|FG001|Overall Study|Adverse Event|28|||
161880605|NCT01508130|584605098|FG000|Overall Study|Death|3|||
161880606|NCT01508130|584605099|FG001|Overall Study|Death|1|||
161880607|NCT01508130|584605098|FG000|Overall Study|Protocol Violation|2|||
161880608|NCT01508130|584605099|FG001|Overall Study|Protocol Violation|0|||
161880609|NCT01508130|584605098|FG000|Overall Study|Lost to Follow-up|25|||
161880610|NCT01508130|584605099|FG001|Overall Study|Lost to Follow-up|2|||
161880611|NCT01508130|584605098|FG000|Overall Study|Withdrawal by Subject|3|||
161880612|NCT01508130|584605099|FG001|Overall Study|Withdrawal by Subject|3|||
161880613|NCT01508130|584605098|FG000|Overall Study|Subject's substantial non-compliance|25|||
161880614|NCT01508130|584605099|FG001|Overall Study|Subject's substantial non-compliance|9|||
161880615|NCT01508130|584605098|FG000|Overall Study|Insufficient therapeutic response|74|||
161880616|NCT01508130|584605099|FG001|Overall Study|Insufficient therapeutic response|23|||
161880617|NCT01508130|584605098|FG000|Overall Study|Administrative|14|||
161880618|NCT01508130|584605099|FG001|Overall Study|Administrative|3|||
161880619|NCT02288091|584605102|FG000|Overall Study|Lost to Follow-up|1|||
161880620|NCT02288091|584605102|FG000|Overall Study|Screen fail|7|||
161880621|NCT03403751|584605107|FG000|Overall Study|Death|5|||
161880622|NCT03403751|584605108|FG001|Overall Study|Death|6|||
161880623|NCT03403751|584605107|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
161880624|NCT03403751|584605108|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
161880625|NCT00520481|584605115|FG000|Overall Study|Adverse Event|4|||
161880626|NCT00520481|584605116|FG001|Overall Study|Adverse Event|1|||
161880627|NCT00520481|584605115|FG000|Overall Study|Withdrawal by Subject|3|||
161880628|NCT00520481|584605116|FG001|Overall Study|Withdrawal by Subject|0|||
161880629|NCT04442269|584605119|FG000|Overall Study|Adverse Event|1|||
161880630|NCT04442269|584605120|FG001|Overall Study|Adverse Event|0|||
161880631|NCT04442269|584605119|FG000|Overall Study|Death|0|||
161880632|NCT04442269|584605120|FG001|Overall Study|Death|1|||
161880633|NCT04442269|584605119|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
161880634|NCT04442269|584605120|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
161880635|NCT04442269|584605119|FG000|Overall Study|Lost to Follow-up|1|||
161880636|NCT04442269|584605120|FG001|Overall Study|Lost to Follow-up|0|||
161880637|NCT04442269|584605119|FG000|Overall Study|Withdrawal by Subject|3|||
161880638|NCT04442269|584605120|FG001|Overall Study|Withdrawal by Subject|2|||
161880639|NCT04442269|584605119|FG000|Overall Study|Protocol Deviation|0|||
161880640|NCT04442269|584605120|FG001|Overall Study|Protocol Deviation|1|||
161880641|NCT04442269|584605119|FG000|Overall Study|Travel Limitations|1|||
161880642|NCT04442269|584605120|FG001|Overall Study|Travel Limitations|1|||
161880643|NCT03802565|584605124|FG000|Overall Study|Adverse Event|0|||
161880644|NCT03802565|584605125|FG001|Overall Study|Adverse Event|1|||
161880645|NCT03802565|584605126|FG002|Overall Study|Adverse Event|2|||
161880646|NCT03802565|584605127|FG003|Overall Study|Adverse Event|1|||
161880647|NCT03802565|584605128|FG004|Overall Study|Adverse Event|1|||
161880648|NCT03802565|584605124|FG000|Overall Study|Withdrawal by Subject|2|||
161880649|NCT03802565|584605125|FG001|Overall Study|Withdrawal by Subject|2|||
161880650|NCT03802565|584605126|FG002|Overall Study|Withdrawal by Subject|2|||
161880651|NCT03802565|584605127|FG003|Overall Study|Withdrawal by Subject|0|||
161880652|NCT03802565|584605128|FG004|Overall Study|Withdrawal by Subject|1|||
161880653|NCT03802565|584605124|FG000|Overall Study|Protocol Violation|2|||
161880654|NCT03802565|584605125|FG001|Overall Study|Protocol Violation|1|||
161880655|NCT03802565|584605126|FG002|Overall Study|Protocol Violation|4|||
161880656|NCT03802565|584605127|FG003|Overall Study|Protocol Violation|5|||
161880657|NCT03802565|584605128|FG004|Overall Study|Protocol Violation|1|||
161880658|NCT03802565|584605124|FG000|Overall Study|Lost to Follow-up|0|||
161880659|NCT03802565|584605125|FG001|Overall Study|Lost to Follow-up|0|||
161880660|NCT03802565|584605126|FG002|Overall Study|Lost to Follow-up|1|||
161880661|NCT03802565|584605127|FG003|Overall Study|Lost to Follow-up|0|||
161880662|NCT03802565|584605128|FG004|Overall Study|Lost to Follow-up|0|||
161880663|NCT03802565|584605124|FG000|Overall Study|Subjects Related to Each Other|1|||
161880664|NCT03802565|584605125|FG001|Overall Study|Subjects Related to Each Other|0|||
161880665|NCT03802565|584605126|FG002|Overall Study|Subjects Related to Each Other|0|||
161880666|NCT03802565|584605127|FG003|Overall Study|Subjects Related to Each Other|2|||
161880667|NCT03802565|584605128|FG004|Overall Study|Subjects Related to Each Other|1|||
161880668|NCT03802565|584605124|FG000|Overall Study|Elevated Enzymes|0|||
161880669|NCT03802565|584605125|FG001|Overall Study|Elevated Enzymes|0|||
161880670|NCT03802565|584605126|FG002|Overall Study|Elevated Enzymes|0|||
161880671|NCT03802565|584605127|FG003|Overall Study|Elevated Enzymes|0|||
161880672|NCT03802565|584605128|FG004|Overall Study|Elevated Enzymes|2|||
161880673|NCT00430352|584605129|FG000|Overall Study|Disease progression|58|||
161880674|NCT00430352|584605129|FG000|Overall Study|Withdrawal by Subject|11|||
161880675|NCT00430352|584605129|FG000|Overall Study|Adverse Event|16|||
161880676|NCT00430352|584605129|FG000|Overall Study|Death|5|||
161880677|NCT00430352|584605129|FG000|Overall Study|Other|48|||
161880678|NCT03099694|584605130|FG000|Overall Study|Withdrawal by Subject|11|||
161880679|NCT03099694|584605131|FG001|Overall Study|Withdrawal by Subject|13|||
161880680|NCT03099694|584605130|FG000|Overall Study|Lost to Follow-up|9|||
161880681|NCT03099694|584605131|FG001|Overall Study|Lost to Follow-up|5|||
161880682|NCT04326439|584605132|FG000|Overall Study|Withdrawal by Subject|1|||
161880683|NCT04326439|584605133|FG001|Overall Study|Withdrawal by Subject|0|||
161880684|NCT04326439|584605132|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
161880685|NCT04326439|584605133|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
161880686|NCT04326439|584605132|FG000|Overall Study|Relapse after Induction 2|0|||
161880687|NCT04326439|584605133|FG001|Overall Study|Relapse after Induction 2|1|||
161880688|NCT04326439|584605132|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
161880689|NCT04326439|584605133|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
161880690|NCT01931956|584605137|FG000|Overall Study|Death|42|||
161880691|NCT01931956|584605138|FG001|Overall Study|Death|7|||
161880692|NCT01931956|584605139|FG002|Overall Study|Death|379|||
161880693|NCT01931956|584605140|FG003|Overall Study|Death|96|||
161880694|NCT01931956|584605137|FG000|Overall Study|Withdrawal by Subject|5|||
161880695|NCT01931956|584605138|FG001|Overall Study|Withdrawal by Subject|0|||
161880696|NCT01931956|584605139|FG002|Overall Study|Withdrawal by Subject|70|||
161880697|NCT01931956|584605140|FG003|Overall Study|Withdrawal by Subject|30|||
161880698|NCT01931956|584605137|FG000|Overall Study|Lost to Follow-up|2|||
161880699|NCT01931956|584605138|FG001|Overall Study|Lost to Follow-up|0|||
161880700|NCT01931956|584605139|FG002|Overall Study|Lost to Follow-up|11|||
161880701|NCT01931956|584605140|FG003|Overall Study|Lost to Follow-up|7|||
161880702|NCT01931956|584605137|FG000|Overall Study|Expected|2|||
161880703|NCT01931956|584605138|FG001|Overall Study|Expected|0|||
161880704|NCT01931956|584605139|FG002|Overall Study|Expected|6|||
161880705|NCT01931956|584605140|FG003|Overall Study|Expected|0|||
161880706|NCT01931956|584605137|FG000|Overall Study|Not due|0|||
161880707|NCT01931956|584605138|FG001|Overall Study|Not due|0|||
161777904|NCT03466060|584228841|FG001|Period 1|Lost to Follow-up|0|||
161777905|NCT03466060|584228842|FG002|Period 1|Lost to Follow-up|0|||
161880708|NCT01931956|584605139|FG002|Overall Study|Not due|21|||
161777906|NCT03466060|584228843|FG003|Period 1|Lost to Follow-up|1|||
161777907|NCT03466060|584228844|FG004|Period 1|Lost to Follow-up|0|||
161777908|NCT03466060|584228845|FG005|Period 1|Lost to Follow-up|0|||
161777909|NCT03466060|584228840|FG000|Period 1|Grade 2 Conjunctivitis|0|||
161777910|NCT03466060|584228841|FG001|Period 1|Grade 2 Conjunctivitis|0|||
161777911|NCT03466060|584228842|FG002|Period 1|Grade 2 Conjunctivitis|1|||
161777912|NCT03466060|584228843|FG003|Period 1|Grade 2 Conjunctivitis|0|||
161777913|NCT03466060|584228844|FG004|Period 1|Grade 2 Conjunctivitis|0|||
161777914|NCT03466060|584228845|FG005|Period 1|Grade 2 Conjunctivitis|0|||
161777915|NCT03466060|584228840|FG000|Period 2|Lens Handling Difficulties|0|||
161777916|NCT03466060|584228841|FG001|Period 2|Lens Handling Difficulties|0|||
161777917|NCT03466060|584228842|FG002|Period 2|Lens Handling Difficulties|1|||
161777918|NCT03466060|584228843|FG003|Period 2|Lens Handling Difficulties|0|||
161777919|NCT03466060|584228844|FG004|Period 2|Lens Handling Difficulties|0|||
161777920|NCT03466060|584228845|FG005|Period 2|Lens Handling Difficulties|0|||
161777921|NCT03345485|584228848|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
161777922|NCT03345485|584228849|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
161777923|NCT03345485|584228850|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
161777924|NCT03345485|584228851|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
161777925|NCT03345485|584228852|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
161777926|NCT03345485|584228853|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
161777927|NCT03345485|584228854|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
161777928|NCT03345485|584228855|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
161777929|NCT03345485|584228856|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
161777930|NCT03345485|584228857|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
161777931|NCT03345485|584228858|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
161777932|NCT03345485|584228859|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
161777933|NCT03345485|584228860|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
161777934|NCT02985515|584228861|FG000|Olfaction Testing|Lost to Follow-up|0|||
161880709|NCT01931956|584605140|FG003|Overall Study|Not due|0|||
161880710|NCT02294175|584605141|FG000|Overall Study|Withdrawal by Subject|1|||
161880711|NCT02294175|584605142|FG001|Overall Study|Withdrawal by Subject|2|||
161880712|NCT02294175|584605141|FG000|Overall Study|pt taking excluded medication|3|||
161880713|NCT02294175|584605142|FG001|Overall Study|pt taking excluded medication|1|||
161880714|NCT02294175|584605141|FG000|Overall Study|Protocol Violation|1|||
161880715|NCT02294175|584605142|FG001|Overall Study|Protocol Violation|0|||
161880716|NCT02294175|584605141|FG000|Overall Study|Lost to Follow-up|0|||
161880717|NCT02294175|584605142|FG001|Overall Study|Lost to Follow-up|1|||
161880718|NCT02294175|584605141|FG000|Overall Study|wound healed|0|||
161880719|NCT02294175|584605142|FG001|Overall Study|wound healed|2|||
161880720|NCT01901653|584605143|FG000|Overall Study|Death|2|||
161880721|NCT01901653|584605144|FG001|Overall Study|Death|1|||
161880722|NCT01901653|584605145|FG002|Overall Study|Death|8|||
161880723|NCT01901653|584605146|FG003|Overall Study|Death|3|||
161880724|NCT01901653|584605147|FG004|Overall Study|Death|2|||
161880725|NCT01901653|584605148|FG005|Overall Study|Death|2|||
161880726|NCT01901653|584605149|FG006|Overall Study|Death|6|||
161880727|NCT01901653|584605150|FG007|Overall Study|Death|9|||
161880728|NCT01901653|584605151|FG008|Overall Study|Death|1|||
161880729|NCT01901653|584605152|FG009|Overall Study|Death|16|||
161880730|NCT01901653|584605153|FG010|Overall Study|Death|2|||
161880731|NCT01901653|584605154|FG011|Overall Study|Death|15|||
161777935|NCT02985515|584228862|FG001|Olfaction Testing|Lost to Follow-up|5|||
161777936|NCT02985515|584228861|FG000|Olfaction Testing|Protocol Violation|0|||
161880732|NCT01901653|584605155|FG012|Overall Study|Death|4|||
161880733|NCT01901653|584605143|FG000|Overall Study|Lost to Follow-up|1|||
161880734|NCT01901653|584605144|FG001|Overall Study|Lost to Follow-up|0|||
161880735|NCT01901653|584605145|FG002|Overall Study|Lost to Follow-up|2|||
161880736|NCT01901653|584605146|FG003|Overall Study|Lost to Follow-up|0|||
161880737|NCT01901653|584605147|FG004|Overall Study|Lost to Follow-up|0|||
161880738|NCT01901653|584605148|FG005|Overall Study|Lost to Follow-up|1|||
161880739|NCT01901653|584605149|FG006|Overall Study|Lost to Follow-up|0|||
161880740|NCT01901653|584605150|FG007|Overall Study|Lost to Follow-up|1|||
161880741|NCT01901653|584605151|FG008|Overall Study|Lost to Follow-up|0|||
161880742|NCT01901653|584605152|FG009|Overall Study|Lost to Follow-up|0|||
161880743|NCT01901653|584605153|FG010|Overall Study|Lost to Follow-up|0|||
161880744|NCT01901653|584605154|FG011|Overall Study|Lost to Follow-up|0|||
161880745|NCT01901653|584605155|FG012|Overall Study|Lost to Follow-up|0|||
161880746|NCT01901653|584605143|FG000|Overall Study|Withdrawal by Subject|0|||
161880747|NCT01901653|584605144|FG001|Overall Study|Withdrawal by Subject|0|||
161880748|NCT01901653|584605145|FG002|Overall Study|Withdrawal by Subject|0|||
161880749|NCT01901653|584605146|FG003|Overall Study|Withdrawal by Subject|0|||
161880750|NCT01901653|584605147|FG004|Overall Study|Withdrawal by Subject|0|||
161880751|NCT01901653|584605148|FG005|Overall Study|Withdrawal by Subject|0|||
161880752|NCT01901653|584605149|FG006|Overall Study|Withdrawal by Subject|1|||
161880753|NCT01901653|584605150|FG007|Overall Study|Withdrawal by Subject|0|||
161880754|NCT01901653|584605151|FG008|Overall Study|Withdrawal by Subject|0|||
161880755|NCT01901653|584605152|FG009|Overall Study|Withdrawal by Subject|0|||
161880756|NCT01901653|584605153|FG010|Overall Study|Withdrawal by Subject|0|||
161880757|NCT01901653|584605154|FG011|Overall Study|Withdrawal by Subject|0|||
161880758|NCT01901653|584605155|FG012|Overall Study|Withdrawal by Subject|0|||
161880759|NCT01901653|584605143|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
161880760|NCT01901653|584605144|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
161880761|NCT01901653|584605145|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
161880762|NCT01901653|584605146|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
161880763|NCT01901653|584605147|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
161880764|NCT01901653|584605148|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
161880765|NCT01901653|584605149|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
161880766|NCT01901653|584605150|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
161880767|NCT01901653|584605151|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
161880768|NCT01901653|584605152|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
161880769|NCT01901653|584605153|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
161880770|NCT01901653|584605154|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
161880771|NCT01901653|584605155|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
161880772|NCT02548351|584605156|FG000|Overall Study|Withdrawal by Subject|149|||
161880773|NCT02548351|584605157|FG001|Overall Study|Withdrawal by Subject|154|||
161880774|NCT02548351|584605158|FG002|Overall Study|Withdrawal by Subject|152|||
161880775|NCT02548351|584605156|FG000|Overall Study|Death|11|||
161880776|NCT02548351|584605157|FG001|Overall Study|Death|15|||
161880777|NCT02548351|584605158|FG002|Overall Study|Death|12|||
161880778|NCT02548351|584605156|FG000|Overall Study|Adverse Event|22|||
161880779|NCT02548351|584605157|FG001|Overall Study|Adverse Event|56|||
161880780|NCT02548351|584605158|FG002|Overall Study|Adverse Event|36|||
161880781|NCT02548351|584605156|FG000|Overall Study|Study Terminated by Sponsor|549|||
161880782|NCT02548351|584605157|FG001|Overall Study|Study Terminated by Sponsor|509|||
161880783|NCT02548351|584605158|FG002|Overall Study|Study Terminated by Sponsor|528|||
161880784|NCT02548351|584605156|FG000|Overall Study|Site Closure|14|||
161880785|NCT02548351|584605157|FG001|Overall Study|Site Closure|5|||
161880786|NCT02548351|584605158|FG002|Overall Study|Site Closure|7|||
161880787|NCT02548351|584605156|FG000|Overall Study|Non-compliance with Study Drug|4|||
161880788|NCT02548351|584605157|FG001|Overall Study|Non-compliance with Study Drug|2|||
161880789|NCT02548351|584605158|FG002|Overall Study|Non-compliance with Study Drug|0|||
161880790|NCT02548351|584605156|FG000|Overall Study|Protocol Violation|2|||
161880791|NCT02548351|584605157|FG001|Overall Study|Protocol Violation|1|||
161880792|NCT02548351|584605158|FG002|Overall Study|Protocol Violation|2|||
161880793|NCT02548351|584605156|FG000|Overall Study|Physician Decision|11|||
161880794|NCT02548351|584605157|FG001|Overall Study|Physician Decision|18|||
161880795|NCT02548351|584605158|FG002|Overall Study|Physician Decision|11|||
161880796|NCT02548351|584605156|FG000|Overall Study|Lost to Follow-up|43|||
161880797|NCT02548351|584605157|FG001|Overall Study|Lost to Follow-up|50|||
161880798|NCT02548351|584605158|FG002|Overall Study|Lost to Follow-up|57|||
161880799|NCT02548351|584605156|FG000|Overall Study|Other|19|||
161880800|NCT02548351|584605157|FG001|Overall Study|Other|16|||
161880801|NCT02548351|584605158|FG002|Overall Study|Other|20|||
161880802|NCT02548351|584605156|FG000|Overall Study|Missing|1|||
161880803|NCT02548351|584605157|FG001|Overall Study|Missing|1|||
161880804|NCT02548351|584605158|FG002|Overall Study|Missing|0|||
161991525|NCT00408434|585018522|FG003|Overall Study|Adverse Event|0|||
161991526|NCT00408434|585018523|FG004|Overall Study|Adverse Event|0|||
161880805|NCT02805660|584605159|FG000|Overall Study|Death|5|||
161880806|NCT02805660|584605160|FG001|Overall Study|Death|2|||
161880807|NCT02805660|584605161|FG002|Overall Study|Death|9|||
161880808|NCT02805660|584605162|FG003|Overall Study|Death|5|||
161880809|NCT02805660|584605163|FG004|Overall Study|Death|0|||
161880810|NCT02805660|584605164|FG005|Overall Study|Death|14|||
161880811|NCT02805660|584605165|FG006|Overall Study|Death|12|||
161880812|NCT02805660|584605159|FG000|Overall Study|Lost to Follow-up|0|||
161880813|NCT02805660|584605160|FG001|Overall Study|Lost to Follow-up|1|||
161880814|NCT02805660|584605161|FG002|Overall Study|Lost to Follow-up|1|||
161880815|NCT02805660|584605162|FG003|Overall Study|Lost to Follow-up|2|||
161880816|NCT02805660|584605163|FG004|Overall Study|Lost to Follow-up|0|||
161880817|NCT02805660|584605164|FG005|Overall Study|Lost to Follow-up|0|||
161880818|NCT02805660|584605165|FG006|Overall Study|Lost to Follow-up|0|||
161880819|NCT02805660|584605159|FG000|Overall Study|Withdrawal by Subject|0|||
161880820|NCT02805660|584605160|FG001|Overall Study|Withdrawal by Subject|0|||
161880821|NCT02805660|584605161|FG002|Overall Study|Withdrawal by Subject|0|||
161880822|NCT02805660|584605162|FG003|Overall Study|Withdrawal by Subject|3|||
161880823|NCT02805660|584605163|FG004|Overall Study|Withdrawal by Subject|1|||
161880824|NCT02805660|584605164|FG005|Overall Study|Withdrawal by Subject|0|||
161880825|NCT02805660|584605165|FG006|Overall Study|Withdrawal by Subject|2|||
161880826|NCT02805660|584605159|FG000|Overall Study|Study terminated by Sponsor|0|||
161880827|NCT02805660|584605160|FG001|Overall Study|Study terminated by Sponsor|0|||
161880828|NCT02805660|584605161|FG002|Overall Study|Study terminated by Sponsor|1|||
161880829|NCT02805660|584605162|FG003|Overall Study|Study terminated by Sponsor|4|||
161880830|NCT02805660|584605163|FG004|Overall Study|Study terminated by Sponsor|2|||
161880831|NCT02805660|584605164|FG005|Overall Study|Study terminated by Sponsor|3|||
161880832|NCT02805660|584605165|FG006|Overall Study|Study terminated by Sponsor|1|||
161880833|NCT02805660|584605159|FG000|Overall Study|Miscellaneous|0|||
161880834|NCT02805660|584605160|FG001|Overall Study|Miscellaneous|1|||
161880835|NCT02805660|584605161|FG002|Overall Study|Miscellaneous|0|||
161880836|NCT02805660|584605162|FG003|Overall Study|Miscellaneous|4|||
161880837|NCT02805660|584605163|FG004|Overall Study|Miscellaneous|0|||
161880838|NCT02805660|584605164|FG005|Overall Study|Miscellaneous|6|||
161880839|NCT02805660|584605165|FG006|Overall Study|Miscellaneous|4|||
161880840|NCT02572076|584605166|FG000|Overall Study|Protocol Violation|1|||
161880841|NCT00197002|584607092|FG000|Overall Study|Adverse Event|0|||
161880842|NCT00197002|584607093|FG001|Overall Study|Adverse Event|1|||
161880843|NCT00197002|584607094|FG002|Overall Study|Adverse Event|0|||
161880844|NCT00197002|584607092|FG000|Overall Study|Protocol Violation|1|||
161880845|NCT00197002|584607093|FG001|Overall Study|Protocol Violation|0|||
161880846|NCT00197002|584607094|FG002|Overall Study|Protocol Violation|2|||
161880847|NCT00197002|584607092|FG000|Overall Study|Withdrawal by Subject|9|||
161880848|NCT00197002|584607093|FG001|Overall Study|Withdrawal by Subject|5|||
161880849|NCT00197002|584607094|FG002|Overall Study|Withdrawal by Subject|7|||
161880850|NCT00197002|584607092|FG000|Overall Study|Migrated/moved from study area|3|||
161880851|NCT00197002|584607093|FG001|Overall Study|Migrated/moved from study area|5|||
161880852|NCT00197002|584607094|FG002|Overall Study|Migrated/moved from study area|1|||
161880853|NCT00197002|584607092|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
161880854|NCT00197002|584607093|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
161880855|NCT00197002|584607094|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
161880856|NCT00197002|584607092|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
161880857|NCT00197002|584607093|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
161880858|NCT00197002|584607094|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
161880859|NCT00197002|584607092|FG000|Overall Study|Others|3|||
161880860|NCT00197002|584607093|FG001|Overall Study|Others|1|||
161880861|NCT00197002|584607094|FG002|Overall Study|Others|1|||
161880862|NCT02759055|584607100|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
161880863|NCT02759055|584607101|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
161880864|NCT02515994|584607102|FG000|Overall Study|Protocol Violation|3|||
161880865|NCT02515994|584607103|FG001|Overall Study|Protocol Violation|5|||
161880866|NCT02515994|584607102|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
161880867|NCT02515994|584607103|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
161880868|NCT02515994|584607102|FG000|Overall Study|Adverse Event|3|||
161880869|NCT02515994|584607103|FG001|Overall Study|Adverse Event|1|||
161880870|NCT02515994|584607102|FG000|Overall Study|Withdrawal by Subject|2|||
161880871|NCT02515994|584607103|FG001|Overall Study|Withdrawal by Subject|0|||
161880872|NCT01424514|584607105|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
161880873|NCT01424514|584607106|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
161880874|NCT01424514|584607105|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
161880875|NCT01424514|584607106|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
161991527|NCT00408434|585018524|FG005|Overall Study|Adverse Event|0|||
161991528|NCT00408434|585018525|FG006|Overall Study|Adverse Event|0|||
161991529|NCT00408434|585018519|FG000|Overall Study|Progressive disease|6|||
161991530|NCT00408434|585018520|FG001|Overall Study|Progressive disease|3|||
161991531|NCT00408434|585018521|FG002|Overall Study|Progressive disease|4|||
161991532|NCT00408434|585018522|FG003|Overall Study|Progressive disease|3|||
161991533|NCT00408434|585018523|FG004|Overall Study|Progressive disease|3|||
161880876|NCT02653170|584607107|FG000|Overall Study|Withdrawal by Subject|3|||
161880877|NCT02653170|584607108|FG001|Overall Study|Withdrawal by Subject|8|||
161991534|NCT00408434|585018524|FG005|Overall Study|Progressive disease|1|||
161991535|NCT00408434|585018525|FG006|Overall Study|Progressive disease|4|||
161991536|NCT00408434|585018519|FG000|Overall Study|Other|0|||
161880878|NCT02653170|584607109|FG002|Overall Study|Withdrawal by Subject|3|||
161880879|NCT02653170|584607107|FG000|Overall Study|withdrawn by study team|2|||
161880880|NCT02653170|584607108|FG001|Overall Study|withdrawn by study team|4|||
161880881|NCT02653170|584607109|FG002|Overall Study|withdrawn by study team|5|||
161991537|NCT00408434|585018520|FG001|Overall Study|Other|0|||
161991538|NCT00408434|585018521|FG002|Overall Study|Other|1|||
161880882|NCT02653170|584607107|FG000|Overall Study|Lost to Follow-up|12|||
161880883|NCT02653170|584607108|FG001|Overall Study|Lost to Follow-up|4|||
161880884|NCT02653170|584607109|FG002|Overall Study|Lost to Follow-up|10|||
161880885|NCT04598451|584607110|FG000|Overall Study|Adverse Event|3|||
161880886|NCT04598451|584607111|FG001|Overall Study|Adverse Event|2|||
161880887|NCT04598451|584607110|FG000|Overall Study|Withdrawal by Subject|3|||
161880888|NCT04598451|584607111|FG001|Overall Study|Withdrawal by Subject|7|||
161880889|NCT04598451|584607110|FG000|Overall Study|Lost to Follow-up|2|||
161880890|NCT04598451|584607111|FG001|Overall Study|Lost to Follow-up|0|||
161880891|NCT04598451|584607110|FG000|Overall Study|Physician Decision|4|||
161880892|NCT04598451|584607111|FG001|Overall Study|Physician Decision|1|||
161880893|NCT04598451|584607110|FG000|Overall Study|Requires Prohibited Medication|1|||
161880894|NCT04598451|584607111|FG001|Overall Study|Requires Prohibited Medication|0|||
161880895|NCT04598451|584607110|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
161880896|NCT04598451|584607111|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
161880897|NCT01632150|584607112|FG000|Overall Study|Disease progression|27|||
161880898|NCT01632150|584607112|FG000|Overall Study|Study drug toxicity|1|||
161880899|NCT01632150|584607112|FG000|Overall Study|Unrelated adverse event|7|||
161880900|NCT01632150|584607112|FG000|Overall Study|Withdrawal by Subject|2|||
161880901|NCT01632150|584607112|FG000|Overall Study|Patient underwent autologous transplant|1|||
161880902|NCT01632150|584607112|FG000|Overall Study|Moved to compassionate program|2|||
161880903|NCT02879994|584607115|FG000|Overall Study|off treatment early|7|||
161880904|NCT02879994|584607115|FG000|Overall Study|Adverse Event|2|||
161880905|NCT02879994|584607115|FG000|Overall Study|Death|2|||
161880906|NCT02143791|584607116|FG000|Enrolled|Withdrawal by Subject|4|||
161880907|NCT02143791|584607116|FG000|Trial Stimulation|Lack of Efficacy|21|||
161880908|NCT02143791|584607116|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
161880909|NCT02143791|584607116|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
161880910|NCT02143791|584607116|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
161880911|NCT02143791|584607116|FG000|Any Programming (3-6 Months)|Missing Data|1|||
161880912|NCT02143791|584607116|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
161880913|NCT04984681|584607121|FG000|Overall Study|Lost to Follow-up|3|||
161880914|NCT04984681|584607122|FG001|Overall Study|Lost to Follow-up|1|||
161880915|NCT04327661|584607123|FG000|Overall Study|Withdrawal by Subject|1|||
161880916|NCT04327661|584607124|FG001|Overall Study|Withdrawal by Subject|0|||
161880917|NCT04327661|584607125|FG002|Overall Study|Withdrawal by Subject|0|||
161880918|NCT01473394|584607126|FG000|Overall Study|Adverse Event|13|||
161880919|NCT01473394|584607127|FG001|Overall Study|Adverse Event|16|||
161880920|NCT01473394|584607126|FG000|Overall Study|Insufficient Therapeutic Response|4|||
161880921|NCT01473394|584607127|FG001|Overall Study|Insufficient Therapeutic Response|1|||
161880922|NCT01473394|584607126|FG000|Overall Study|Protocol Violation|7|||
161880923|NCT01473394|584607127|FG001|Overall Study|Protocol Violation|5|||
161880924|NCT01473394|584607126|FG000|Overall Study|Withdrew Consent|12|||
161880925|NCT01473394|584607127|FG001|Overall Study|Withdrew Consent|10|||
161880926|NCT01473394|584607126|FG000|Overall Study|Lost to Follow-up|9|||
161880927|NCT01473394|584607127|FG001|Overall Study|Lost to Follow-up|11|||
161880928|NCT03391232|584607128|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
161880929|NCT03391232|584607129|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
161880930|NCT03391232|584607128|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
161880931|NCT03391232|584607129|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
161880932|NCT02091960|584607130|FG000|Overall Study|Death|7|||
161880933|NCT02091960|584607130|FG000|Overall Study|Withdrawal by Subject|1|||
161880934|NCT02091960|584607130|FG000|Overall Study|Miscellaneous Reasons|37|||
161880935|NCT02637895|584607141|FG000|Overall Study|Lost to Follow-up|4|||
161880936|NCT02637895|584607142|FG001|Overall Study|Lost to Follow-up|0|||
161880937|NCT02637895|584607141|FG000|Overall Study|Protocol Violation|0|||
161880938|NCT02637895|584607142|FG001|Overall Study|Protocol Violation|1|||
161880939|NCT02637895|584607141|FG000|Overall Study|Lack of Efficacy|1|||
161880940|NCT02637895|584607142|FG001|Overall Study|Lack of Efficacy|0|||
161880941|NCT02637895|584607141|FG000|Overall Study|Withdrawal by Subject|1|||
161880942|NCT02637895|584607142|FG001|Overall Study|Withdrawal by Subject|1|||
161880943|NCT02637895|584607141|FG000|Overall Study|Abnormal baseline lab|0|||
161880944|NCT02637895|584607142|FG001|Overall Study|Abnormal baseline lab|1|||
161880945|NCT00984061|584607145|FG000|Clarithromycin Alone|Protocol Violation|1|||
161880946|NCT05139303|584607146|FG000|Overall Study|Lost to Follow-up|3|||
161880947|NCT05139303|584607147|FG001|Overall Study|Lost to Follow-up|0|||
161880948|NCT05139303|584607146|FG000|Overall Study|Adverse Event|1|||
161880949|NCT05139303|584607147|FG001|Overall Study|Adverse Event|0|||
161880950|NCT00761280|584607148|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
161880951|NCT00761280|584607149|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
161880952|NCT00761280|584607148|FG000|Randomization to First Dose|Sponsor decision|1|||
161880953|NCT00761280|584607149|FG001|Randomization to First Dose|Sponsor decision|0|||
161880954|NCT00761280|584607148|FG000|Randomization to First Dose|Other|1|||
161880955|NCT00761280|584607149|FG001|Randomization to First Dose|Other|0|||
161880956|NCT00761280|584607148|FG000|First Dose to End of Study|End of trial|5|||
161880957|NCT00761280|584607149|FG001|First Dose to End of Study|End of trial|5|||
161880958|NCT00761280|584607148|FG000|First Dose to End of Study|Progressive disease|5|||
161880959|NCT00761280|584607149|FG001|First Dose to End of Study|Progressive disease|3|||
161880960|NCT00761280|584607148|FG000|First Dose to End of Study|Sponsor decision|1|||
161880961|NCT00761280|584607149|FG001|First Dose to End of Study|Sponsor decision|2|||
161880962|NCT00761280|584607148|FG000|First Dose to End of Study|Death|1|||
161880963|NCT00761280|584607149|FG001|First Dose to End of Study|Death|0|||
161880964|NCT00761280|584607148|FG000|First Dose to End of Study|Lost to Follow-up|0|||
161880965|NCT00761280|584607149|FG001|First Dose to End of Study|Lost to Follow-up|1|||
161880966|NCT03875482|584607153|FG000|Overall Study|Adverse Event|0|||
161880967|NCT03875482|584607154|FG001|Overall Study|Adverse Event|1|||
161880968|NCT03875482|584607153|FG000|Overall Study|Withdrew consent|5|||
161880969|NCT03875482|584607154|FG001|Overall Study|Withdrew consent|6|||
161880970|NCT03875482|584607153|FG000|Overall Study|Lost to Follow-up|8|||
161880971|NCT03875482|584607154|FG001|Overall Study|Lost to Follow-up|2|||
161880972|NCT03875482|584607153|FG000|Overall Study|Lack of Efficacy|0|||
161880973|NCT03875482|584607154|FG001|Overall Study|Lack of Efficacy|11|||
161880974|NCT04777201|584607155|FG000|Main Study|Withdrawal by Subject|19|||
161880975|NCT04777201|584607156|FG001|Main Study|Withdrawal by Subject|27|||
161880976|NCT04777201|584607157|FG002|Main Study|Withdrawal by Subject|0|||
161880977|NCT04777201|584607155|FG000|Main Study|Death|13|||
161880978|NCT04777201|584607156|FG001|Main Study|Death|27|||
161880979|NCT04777201|584607157|FG002|Main Study|Death|0|||
161880980|NCT04777201|584607155|FG000|Main Study|Subject missed the safety follow-up visit|9|||
161880981|NCT04777201|584607156|FG001|Main Study|Subject missed the safety follow-up visit|10|||
161880982|NCT04777201|584607157|FG002|Main Study|Subject missed the safety follow-up visit|0|||
161880983|NCT04777201|584607155|FG000|Main Study|Physician Decision|8|||
161880984|NCT04777201|584607156|FG001|Main Study|Physician Decision|10|||
161880985|NCT04777201|584607157|FG002|Main Study|Physician Decision|0|||
161880986|NCT04777201|584607155|FG000|Main Study|Adverse Event|8|||
161880987|NCT04777201|584607156|FG001|Main Study|Adverse Event|8|||
161880988|NCT04777201|584607157|FG002|Main Study|Adverse Event|0|||
161880989|NCT04777201|584607155|FG000|Main Study|Lost to Follow-up|9|||
161880990|NCT04777201|584607156|FG001|Main Study|Lost to Follow-up|4|||
161880991|NCT04777201|584607157|FG002|Main Study|Lost to Follow-up|0|||
161880992|NCT04777201|584607155|FG000|Main Study|Reason not specified|3|||
161880993|NCT04777201|584607156|FG001|Main Study|Reason not specified|3|||
161880994|NCT04777201|584607157|FG002|Main Study|Reason not specified|0|||
161880995|NCT04777201|584607155|FG000|Main Study|Lack of Efficacy|1|||
161880996|NCT04777201|584607156|FG001|Main Study|Lack of Efficacy|1|||
161880997|NCT04777201|584607157|FG002|Main Study|Lack of Efficacy|0|||
161880998|NCT04777201|584607155|FG000|Main Study|Protocol Violation|1|||
161880999|NCT04777201|584607156|FG001|Main Study|Protocol Violation|0|||
161881000|NCT04777201|584607157|FG002|Main Study|Protocol Violation|0|||
161881001|NCT04777201|584607155|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
161881002|NCT04777201|584607156|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
161881003|NCT04777201|584607157|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
161881004|NCT04777201|584607155|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
161881005|NCT04777201|584607156|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
161881006|NCT04777201|584607157|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
161881007|NCT04777201|584607155|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
161881008|NCT04777201|584607156|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
161881009|NCT04777201|584607157|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
161881010|NCT04777201|584607155|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
161881011|NCT04777201|584607156|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
161881012|NCT04777201|584607157|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
161881013|NCT04777201|584607155|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
161881014|NCT04777201|584607156|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
161881015|NCT04777201|584607157|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
161881016|NCT04777201|584607155|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
161881017|NCT04777201|584607156|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
161881018|NCT04777201|584607157|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
161881019|NCT00507819|584607160|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
161881020|NCT00507819|584607161|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
161881021|NCT02256982|584607167|FG000|Overall Study|Disease Progression|0|||
161881022|NCT02256982|584607168|FG001|Overall Study|Disease Progression|1|||
161881023|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Adverse Event|6|||
161881024|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Adverse Event|14|||
161881025|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Death|3|||
161881026|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Death|1|||
161881027|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
161881028|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
161881029|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
161881030|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
161881031|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
161881032|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
161881033|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
161881034|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
161881035|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
161881036|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
161881037|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Physician Decision|2|||
161881038|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Physician Decision|4|||
161881039|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Pregnancy|2|||
161881040|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Pregnancy|1|||
161881041|NCT02275780|584607169|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
161881042|NCT02275780|584607170|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
161881043|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
161881044|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
161881045|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
161881046|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
161881047|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
161881048|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
161881049|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
161881050|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
161881051|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
161881052|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
161881053|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
161881054|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
161881055|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
161881056|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
161881057|NCT02275780|584607169|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
161881058|NCT02275780|584607170|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
161881059|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
161881060|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
161881061|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
161881062|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
161881063|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
161881064|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
161881065|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
161881066|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
161881067|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
161881068|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
161881069|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
161881070|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
161881071|NCT02275780|584607169|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
161881072|NCT02275780|584607170|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
161881073|NCT02275780|584607169|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
161881074|NCT02275780|584607170|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
161881075|NCT02275780|584607169|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
161881076|NCT02275780|584607170|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
161881077|NCT02275780|584607169|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
161881078|NCT02275780|584607170|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
161881079|NCT02275780|584607169|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
161881080|NCT02275780|584607170|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
161881081|NCT02275780|584607169|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
161881082|NCT02275780|584607170|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
161881083|NCT02275780|584607169|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
161881084|NCT02275780|584607170|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
161881085|NCT01054300|584607177|FG000|Period 1|Adverse Event|1|||
161881086|NCT01054300|584607178|FG001|Period 1|Adverse Event|0|||
161881087|NCT01054300|584607179|FG002|Period 1|Adverse Event|0|||
161881088|NCT01054300|584607180|FG003|Period 1|Adverse Event|0|||
161881089|NCT01054300|584607177|FG000|Period 2|Withdrawal by Subject|0|||
161881090|NCT01054300|584607178|FG001|Period 2|Withdrawal by Subject|0|||
161881091|NCT01054300|584607179|FG002|Period 2|Withdrawal by Subject|1|||
161991539|NCT00408434|585018522|FG003|Overall Study|Other|0|||
161991540|NCT00408434|585018523|FG004|Overall Study|Other|2|||
161991541|NCT00408434|585018524|FG005|Overall Study|Other|1|||
161991542|NCT00408434|585018525|FG006|Overall Study|Other|0|||
161991543|NCT00408434|585018519|FG000|Overall Study|Terminated by Investigator|0|||
161991544|NCT00408434|585018520|FG001|Overall Study|Terminated by Investigator|0|||
161991545|NCT00408434|585018521|FG002|Overall Study|Terminated by Investigator|0|||
161881092|NCT01054300|584607180|FG003|Period 2|Withdrawal by Subject|0|||
161881093|NCT01899742|584607183|FG000|Overall Study|Adverse Event|5|||
161881094|NCT01899742|584607184|FG001|Overall Study|Adverse Event|4|||
161881095|NCT01899742|584607183|FG000|Overall Study|Lack of Efficacy|1|||
161881096|NCT01899742|584607184|FG001|Overall Study|Lack of Efficacy|5|||
161881097|NCT01899742|584607183|FG000|Overall Study|Protocol Violation|2|||
161881098|NCT01899742|584607184|FG001|Overall Study|Protocol Violation|2|||
161881099|NCT01899742|584607183|FG000|Overall Study|Withdrawal by Subject|9|||
161881100|NCT01899742|584607184|FG001|Overall Study|Withdrawal by Subject|5|||
161881101|NCT00738881|584607188|FG000|Overall Study|Withdrawal by Subject|0|||
161881102|NCT00738881|584607189|FG001|Overall Study|Withdrawal by Subject|2|||
161881103|NCT02662764|584607190|FG000|Overall Study|Adverse Event|6|||
161881104|NCT02662764|584607190|FG000|Overall Study|Lack of Efficacy|8|||
161881105|NCT02662764|584607190|FG000|Overall Study|Protocol Violation|1|||
161881106|NCT02662764|584607190|FG000|Overall Study|Withdrawal by Subject|5|||
161881107|NCT02662764|584607190|FG000|Overall Study|Device failure|4|||
161881108|NCT02662764|584607190|FG000|Overall Study|Patient changed treatment|1|||
161881109|NCT02662764|584607190|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
161881110|NCT00177307|584607194|FG000|Overall Study|Withdrawal by Subject|1|||
161881111|NCT01282164|584607195|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
161881112|NCT01282164|584607196|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
161881113|NCT03671564|584607197|FG000|Overall Study|Progressive Disease|3|||
161881114|NCT03671564|584607198|FG001|Overall Study|Progressive Disease|5|||
161881115|NCT03671564|584607199|FG002|Overall Study|Progressive Disease|3|||
161881116|NCT03671564|584607197|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
161881117|NCT03671564|584607198|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
161881118|NCT03671564|584607199|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
161881119|NCT03671564|584607197|FG000|Overall Study|Withdrawal by Subject|1|||
161881120|NCT03671564|584607198|FG001|Overall Study|Withdrawal by Subject|1|||
161881121|NCT03671564|584607199|FG002|Overall Study|Withdrawal by Subject|0|||
161881122|NCT04521621|584607200|FG000|Overall Study|Death|17|||
161881123|NCT04521621|584607201|FG001|Overall Study|Death|8|||
161777937|NCT02985515|584228862|FG001|Olfaction Testing|Protocol Violation|3|||
161777938|NCT01610284|584228863|FG000|Randomization Phase|Adverse Event|1|||
161777939|NCT01610284|584228864|FG001|Randomization Phase|Adverse Event|0|||
161777940|NCT01610284|584228863|FG000|Randomization Phase|Physician Decision|1|||
161777941|NCT01610284|584228864|FG001|Randomization Phase|Physician Decision|1|||
161777942|NCT01610284|584228863|FG000|Randomization Phase|Death|0|||
161777943|NCT01610284|584228864|FG001|Randomization Phase|Death|1|||
161777944|NCT01610284|584228863|FG000|Treatment Phase|Adverse Event|80|||
161777945|NCT01610284|584228864|FG001|Treatment Phase|Adverse Event|12|||
161777946|NCT01610284|584228863|FG000|Treatment Phase|Lost to Follow-up|1|||
161777947|NCT01610284|584228864|FG001|Treatment Phase|Lost to Follow-up|0|||
161777948|NCT01610284|584228863|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
161777949|NCT01610284|584228864|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
161777950|NCT01610284|584228863|FG000|Treatment Phase|Physician Decision|27|||
161777951|NCT01610284|584228864|FG001|Treatment Phase|Physician Decision|24|||
161777952|NCT01610284|584228863|FG000|Treatment Phase|Progressive Disease|377|||
161777953|NCT01610284|584228864|FG001|Treatment Phase|Progressive Disease|486|||
161777954|NCT01610284|584228863|FG000|Treatment Phase|Protocol Deviation|2|||
161777955|NCT01610284|584228864|FG001|Treatment Phase|Protocol Deviation|3|||
161777956|NCT01610284|584228863|FG000|Treatment Phase|Study terminated by Sponsor|18|||
161777957|NCT01610284|584228864|FG001|Treatment Phase|Study terminated by Sponsor|15|||
161777958|NCT01610284|584228863|FG000|Treatment Phase|Subject/Guardian Decision|55|||
161777959|NCT01610284|584228864|FG001|Treatment Phase|Subject/Guardian Decision|23|||
161777960|NCT01610284|584228863|FG000|Treatment Phase|Death|6|||
161777961|NCT01610284|584228864|FG001|Treatment Phase|Death|5|||
161777962|NCT01610284|584228863|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
161777963|NCT01610284|584228864|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161777964|NCT01610284|584228863|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
161777965|NCT01610284|584228864|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
161777966|NCT01610284|584228863|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
161777967|NCT01610284|584228864|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
161777968|NCT01610284|584228863|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
161777969|NCT01610284|584228864|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
161777970|NCT01610284|584228863|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
161777971|NCT01610284|584228864|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
161777972|NCT01610284|584228863|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
161777973|NCT01610284|584228864|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
161777974|NCT03020966|584228865|FG000|Overall Study|Withdrawal by Subject|2|||
161777975|NCT03020966|584228866|FG001|Overall Study|Withdrawal by Subject|0|||
161777976|NCT01856257|584228867|FG000|Overall Study|Death|2|||
161777977|NCT01856257|584228868|FG001|Overall Study|Death|0|||
161881124|NCT04521621|584607202|FG002|Overall Study|Death|8|||
161881125|NCT04521621|584607203|FG003|Overall Study|Death|5|||
161881126|NCT04521621|584607204|FG004|Overall Study|Death|2|||
161881127|NCT04521621|584607205|FG005|Overall Study|Death|7|||
161881128|NCT04521621|584607206|FG006|Overall Study|Death|0|||
161881129|NCT04521621|584607207|FG007|Overall Study|Death|0|||
161881130|NCT04521621|584607200|FG000|Overall Study|Study Terminated by Sponsor|4|||
161881131|NCT04521621|584607201|FG001|Overall Study|Study Terminated by Sponsor|6|||
161881132|NCT04521621|584607202|FG002|Overall Study|Study Terminated by Sponsor|8|||
161881133|NCT04521621|584607203|FG003|Overall Study|Study Terminated by Sponsor|0|||
161881134|NCT04521621|584607204|FG004|Overall Study|Study Terminated by Sponsor|1|||
161881135|NCT04521621|584607205|FG005|Overall Study|Study Terminated by Sponsor|7|||
161881136|NCT04521621|584607206|FG006|Overall Study|Study Terminated by Sponsor|0|||
161881137|NCT04521621|584607207|FG007|Overall Study|Study Terminated by Sponsor|0|||
161881138|NCT04521621|584607200|FG000|Overall Study|Withdrawal by Subject|0|||
161881139|NCT04521621|584607201|FG001|Overall Study|Withdrawal by Subject|0|||
161881140|NCT04521621|584607202|FG002|Overall Study|Withdrawal by Subject|1|||
161881141|NCT04521621|584607203|FG003|Overall Study|Withdrawal by Subject|1|||
161881142|NCT04521621|584607204|FG004|Overall Study|Withdrawal by Subject|0|||
161881143|NCT04521621|584607205|FG005|Overall Study|Withdrawal by Subject|0|||
161881144|NCT04521621|584607206|FG006|Overall Study|Withdrawal by Subject|0|||
161881145|NCT04521621|584607207|FG007|Overall Study|Withdrawal by Subject|0|||
161881146|NCT04521621|584607200|FG000|Overall Study|Allocated in error without study intervention|1|||
161881147|NCT04521621|584607201|FG001|Overall Study|Allocated in error without study intervention|0|||
161881148|NCT04521621|584607202|FG002|Overall Study|Allocated in error without study intervention|0|||
161881149|NCT04521621|584607203|FG003|Overall Study|Allocated in error without study intervention|0|||
161881150|NCT04521621|584607204|FG004|Overall Study|Allocated in error without study intervention|0|||
161881151|NCT04521621|584607205|FG005|Overall Study|Allocated in error without study intervention|0|||
161881152|NCT04521621|584607206|FG006|Overall Study|Allocated in error without study intervention|0|||
161881153|NCT04521621|584607207|FG007|Overall Study|Allocated in error without study intervention|0|||
161881154|NCT01740128|584607212|FG000|Overall Study|Pregnancy|0|||
161881155|NCT01740128|584607213|FG001|Overall Study|Pregnancy|1|||
161881156|NCT01740128|584607212|FG000|Overall Study|Protocol Violation|1|||
161881157|NCT01740128|584607213|FG001|Overall Study|Protocol Violation|2|||
161881158|NCT01740128|584607212|FG000|Overall Study|Lost to Follow-up|2|||
161881159|NCT01740128|584607213|FG001|Overall Study|Lost to Follow-up|2|||
161881160|NCT01740128|584607212|FG000|Overall Study|Withdrawal by Subject|1|||
161881161|NCT01740128|584607213|FG001|Overall Study|Withdrawal by Subject|0|||
161881162|NCT01740128|584607212|FG000|Overall Study|Insufficient protocol compliance|2|||
161881163|NCT01740128|584607213|FG001|Overall Study|Insufficient protocol compliance|2|||
161881164|NCT01041976|584607214|FG000|Overall Study|Withdrawal by Subject|3|||
161881165|NCT01041976|584607215|FG001|Overall Study|Withdrawal by Subject|0|||
161881166|NCT01041976|584607214|FG000|Overall Study|Incarceration|2|||
161881167|NCT01041976|584607215|FG001|Overall Study|Incarceration|0|||
161881168|NCT01041976|584607214|FG000|Overall Study|Death|0|||
161881169|NCT01041976|584607215|FG001|Overall Study|Death|4|||
161881170|NCT02658734|584607216|FG000|Overall Study|Adverse Event|2|||
161881171|NCT02658734|584607216|FG000|Overall Study|Death|4|||
161881172|NCT02658734|584607216|FG000|Overall Study|Lost to Follow-up|7|||
161881173|NCT02658734|584607216|FG000|Overall Study|Withdrawal of Consent|16|||
161881174|NCT02658734|584607216|FG000|Overall Study|Disease Progression|28|||
161881175|NCT00574249|584607217|FG000|Overall Study|Adverse Event|6|||
161881176|NCT00574249|584607218|FG001|Overall Study|Adverse Event|18|||
161881177|NCT00574249|584607217|FG000|Overall Study|Lack of Efficacy|5|||
161881178|NCT00574249|584607218|FG001|Overall Study|Lack of Efficacy|3|||
161881179|NCT00574249|584607217|FG000|Overall Study|Lost to Follow-up|4|||
161881180|NCT00574249|584607218|FG001|Overall Study|Lost to Follow-up|3|||
161881181|NCT00574249|584607217|FG000|Overall Study|Protocol Violation|5|||
161881182|NCT00574249|584607218|FG001|Overall Study|Protocol Violation|2|||
161881183|NCT00574249|584607217|FG000|Overall Study|History of carcinoma|1|||
161881184|NCT00574249|584607218|FG001|Overall Study|History of carcinoma|0|||
161881185|NCT00574249|584607217|FG000|Overall Study|Withdrawal by Subject|3|||
161881186|NCT00574249|584607218|FG001|Overall Study|Withdrawal by Subject|0|||
161881187|NCT00574249|584607217|FG000|Overall Study|Physician Decision|1|||
161991546|NCT00408434|585018522|FG003|Overall Study|Terminated by Investigator|0|||
161881188|NCT00574249|584607218|FG001|Overall Study|Physician Decision|0|||
161881189|NCT00574249|584607217|FG000|Overall Study|Pregnancy|1|||
161881190|NCT00574249|584607218|FG001|Overall Study|Pregnancy|0|||
161881191|NCT00574249|584607217|FG000|Overall Study|Excluded by company|0|||
161881192|NCT00574249|584607218|FG001|Overall Study|Excluded by company|1|||
161881193|NCT00574249|584607217|FG000|Overall Study|PPD test taken twice|0|||
161881194|NCT00574249|584607218|FG001|Overall Study|PPD test taken twice|1|||
161881195|NCT01542034|584607219|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
161881196|NCT01542034|584607220|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
161881197|NCT01542034|584607219|FG000|Overall Study|Administrative decision|0|||
161991547|NCT00408434|585018523|FG004|Overall Study|Terminated by Investigator|1|||
161881198|NCT01542034|584607220|FG001|Overall Study|Administrative decision|3|||
161881199|NCT01542034|584607219|FG000|Overall Study|Subject Noncompliance|1|||
161881200|NCT01542034|584607220|FG001|Overall Study|Subject Noncompliance|0|||
161881201|NCT01542034|584607219|FG000|Overall Study|Adverse Event|2|||
161881202|NCT01542034|584607220|FG001|Overall Study|Adverse Event|2|||
161881203|NCT01542034|584607219|FG000|Overall Study|Lost to Follow-up|7|||
161881204|NCT01542034|584607220|FG001|Overall Study|Lost to Follow-up|6|||
161881205|NCT02612610|584607221|FG000|Overall Study|Withdrawal by Subject|1|||
161881206|NCT02612610|584607222|FG001|Overall Study|Withdrawal by Subject|1|||
161881207|NCT02612610|584607223|FG002|Overall Study|Withdrawal by Subject|0|||
161881208|NCT02612610|584607224|FG003|Overall Study|Withdrawal by Subject|2|||
161881209|NCT02612610|584607221|FG000|Overall Study|Adverse Event|2|||
161881210|NCT02612610|584607222|FG001|Overall Study|Adverse Event|2|||
161881211|NCT02612610|584607223|FG002|Overall Study|Adverse Event|3|||
161881212|NCT02612610|584607224|FG003|Overall Study|Adverse Event|10|||
161881213|NCT02612610|584607221|FG000|Overall Study|Lost to Follow-up|0|||
161881214|NCT02612610|584607222|FG001|Overall Study|Lost to Follow-up|1|||
161881215|NCT02612610|584607223|FG002|Overall Study|Lost to Follow-up|0|||
161881216|NCT02612610|584607224|FG003|Overall Study|Lost to Follow-up|0|||
161881217|NCT02612610|584607221|FG000|Overall Study|Protocol Violation|0|||
161881218|NCT02612610|584607222|FG001|Overall Study|Protocol Violation|1|||
161881219|NCT02612610|584607223|FG002|Overall Study|Protocol Violation|1|||
161881220|NCT02612610|584607224|FG003|Overall Study|Protocol Violation|0|||
161881221|NCT02612610|584607221|FG000|Overall Study|Lack of Efficacy|1|||
161881222|NCT02612610|584607222|FG001|Overall Study|Lack of Efficacy|2|||
161881223|NCT02612610|584607223|FG002|Overall Study|Lack of Efficacy|0|||
161881224|NCT02612610|584607224|FG003|Overall Study|Lack of Efficacy|1|||
161881225|NCT02612610|584607221|FG000|Overall Study|Physician Decision|0|||
161881226|NCT02612610|584607222|FG001|Overall Study|Physician Decision|1|||
161881227|NCT02612610|584607223|FG002|Overall Study|Physician Decision|0|||
161881228|NCT02612610|584607224|FG003|Overall Study|Physician Decision|0|||
161881229|NCT02612610|584607221|FG000|Overall Study|Noncompliance|1|||
161881230|NCT02612610|584607222|FG001|Overall Study|Noncompliance|0|||
161881231|NCT02612610|584607223|FG002|Overall Study|Noncompliance|0|||
161881232|NCT02612610|584607224|FG003|Overall Study|Noncompliance|0|||
161881233|NCT02612610|584607221|FG000|Overall Study|Cough Improvement|0|||
161881234|NCT02612610|584607222|FG001|Overall Study|Cough Improvement|0|||
161881235|NCT02612610|584607223|FG002|Overall Study|Cough Improvement|1|||
161881236|NCT02612610|584607224|FG003|Overall Study|Cough Improvement|0|||
161881237|NCT01546571|584607227|FG000|Overall Study|Adverse Event|1|||
161881238|NCT01546571|584607228|FG001|Overall Study|Adverse Event|0|||
161881239|NCT01546571|584607229|FG002|Overall Study|Adverse Event|0|||
161881240|NCT01546571|584607230|FG003|Overall Study|Adverse Event|1|||
161881241|NCT01546571|584607231|FG004|Overall Study|Adverse Event|0|||
161881242|NCT01546571|584607227|FG000|Overall Study|assigned placebo in Part A|0|||
161881243|NCT01546571|584607228|FG001|Overall Study|assigned placebo in Part A|0|||
161881244|NCT01546571|584607229|FG002|Overall Study|assigned placebo in Part A|22|||
161881245|NCT01546571|584607230|FG003|Overall Study|assigned placebo in Part A|0|||
161881246|NCT01546571|584607231|FG004|Overall Study|assigned placebo in Part A|0|||
161881247|NCT01546571|584607227|FG000|Overall Study|Death|0|||
161881248|NCT01546571|584607228|FG001|Overall Study|Death|1|||
161881249|NCT01546571|584607229|FG002|Overall Study|Death|0|||
161881250|NCT01546571|584607230|FG003|Overall Study|Death|0|||
161881251|NCT01546571|584607231|FG004|Overall Study|Death|0|||
161881252|NCT01546571|584607227|FG000|Overall Study|Lost to Follow-up|0|||
161881253|NCT01546571|584607228|FG001|Overall Study|Lost to Follow-up|0|||
161881254|NCT01546571|584607229|FG002|Overall Study|Lost to Follow-up|2|||
161881255|NCT01546571|584607230|FG003|Overall Study|Lost to Follow-up|2|||
161881256|NCT01546571|584607231|FG004|Overall Study|Lost to Follow-up|3|||
161881257|NCT01546571|584607227|FG000|Overall Study|Pregnancy|0|||
161881258|NCT01546571|584607228|FG001|Overall Study|Pregnancy|0|||
161881259|NCT01546571|584607229|FG002|Overall Study|Pregnancy|0|||
161881260|NCT01546571|584607230|FG003|Overall Study|Pregnancy|1|||
161881261|NCT01546571|584607231|FG004|Overall Study|Pregnancy|0|||
161881262|NCT01546571|584607227|FG000|Overall Study|Disease Progression|20|||
161881263|NCT01546571|584607228|FG001|Overall Study|Disease Progression|18|||
161881264|NCT01546571|584607229|FG002|Overall Study|Disease Progression|15|||
161881265|NCT01546571|584607230|FG003|Overall Study|Disease Progression|73|||
161881266|NCT01546571|584607231|FG004|Overall Study|Disease Progression|37|||
161881267|NCT01546571|584607227|FG000|Overall Study|Withdrawal by Subject|1|||
161881268|NCT01546571|584607228|FG001|Overall Study|Withdrawal by Subject|2|||
161881269|NCT01546571|584607229|FG002|Overall Study|Withdrawal by Subject|4|||
161881270|NCT01546571|584607230|FG003|Overall Study|Withdrawal by Subject|9|||
161881271|NCT01546571|584607231|FG004|Overall Study|Withdrawal by Subject|2|||
161881272|NCT01546571|584607227|FG000|Overall Study|Intercurrent Illness|1|||
161881273|NCT01546571|584607228|FG001|Overall Study|Intercurrent Illness|2|||
161881274|NCT01546571|584607229|FG002|Overall Study|Intercurrent Illness|0|||
161881275|NCT01546571|584607230|FG003|Overall Study|Intercurrent Illness|0|||
161881276|NCT01546571|584607231|FG004|Overall Study|Intercurrent Illness|0|||
161881277|NCT01546571|584607227|FG000|Overall Study|Other Cancers|0|||
161881278|NCT01546571|584607228|FG001|Overall Study|Other Cancers|0|||
161881279|NCT01546571|584607229|FG002|Overall Study|Other Cancers|0|||
161881280|NCT01546571|584607230|FG003|Overall Study|Other Cancers|3|||
161881281|NCT01546571|584607231|FG004|Overall Study|Other Cancers|1|||
161881282|NCT01546571|584607227|FG000|Overall Study|Other|0|||
161881283|NCT01546571|584607228|FG001|Overall Study|Other|0|||
161881284|NCT01546571|584607229|FG002|Overall Study|Other|3|||
161881285|NCT01546571|584607230|FG003|Overall Study|Other|0|||
161881286|NCT01546571|584607231|FG004|Overall Study|Other|0|||
161881287|NCT00478699|584607232|FG000|Overall Study|Inclusion Error|1|||
161881288|NCT00478699|584607233|FG001|Overall Study|Inclusion Error|7|||
161881289|NCT00478699|584607232|FG000|Overall Study|Not receive study treatment|6|||
161881290|NCT00478699|584607233|FG001|Overall Study|Not receive study treatment|30|||
161881291|NCT01880086|584607237|FG000|Overall Study|Lost to Follow-up|1|||
161881292|NCT01880086|584607238|FG001|Overall Study|Lost to Follow-up|1|||
161881293|NCT00471718|584607242|FG000|Overall Study|Adverse Event|3|||
161881294|NCT00471718|584607242|FG000|Overall Study|other complicating disease|1|||
161881295|NCT00471718|584607242|FG000|Overall Study|disease progression|22|||
161881296|NCT00471718|584607242|FG000|Overall Study|Withdrawal by Subject|1|||
161881297|NCT01446237|584607243|FG000|Overall Study|Adverse Event|1|||
161881298|NCT01446237|584607243|FG000|Overall Study|Lost to Follow-up|2|||
161881299|NCT01446237|584607243|FG000|Overall Study|Withdrawal by Subject|7|||
161881300|NCT01817582|584607260|FG000|Overall Study|Withdrawal by Subject|0|||
161881301|NCT01817582|584607261|FG001|Overall Study|Withdrawal by Subject|1|||
161881302|NCT01817582|584607262|FG002|Overall Study|Withdrawal by Subject|0|||
161881303|NCT01817582|584607260|FG000|Overall Study|Participant revealed masked treatment|1|||
161881304|NCT01817582|584607261|FG001|Overall Study|Participant revealed masked treatment|0|||
161881305|NCT01817582|584607262|FG002|Overall Study|Participant revealed masked treatment|0|||
161881306|NCT01817582|584607260|FG000|Overall Study|Randomized but exclusion criteria met|1|||
161881307|NCT01817582|584607261|FG001|Overall Study|Randomized but exclusion criteria met|0|||
161881308|NCT01817582|584607262|FG002|Overall Study|Randomized but exclusion criteria met|0|||
161881309|NCT03053063|584607268|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
161881310|NCT03053063|584607269|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
161881311|NCT03053063|584607270|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
161881312|NCT03053063|584607271|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
161881313|NCT03053063|584607268|FG000|Randomized Phase|Withdrew consent|8|||
161881314|NCT03053063|584607269|FG001|Randomized Phase|Withdrew consent|11|||
161881315|NCT03053063|584607270|FG002|Randomized Phase|Withdrew consent|5|||
161881316|NCT03053063|584607271|FG003|Randomized Phase|Withdrew consent|0|||
161881317|NCT03053063|584607268|FG000|Randomized Phase|Investigator's Discretion|8|||
161881318|NCT03053063|584607269|FG001|Randomized Phase|Investigator's Discretion|6|||
161881319|NCT03053063|584607270|FG002|Randomized Phase|Investigator's Discretion|2|||
161881320|NCT03053063|584607271|FG003|Randomized Phase|Investigator's Discretion|0|||
161881321|NCT03053063|584607268|FG000|Randomized Phase|Lost to Follow-up|3|||
161881322|NCT03053063|584607269|FG001|Randomized Phase|Lost to Follow-up|5|||
161881323|NCT03053063|584607270|FG002|Randomized Phase|Lost to Follow-up|1|||
161881324|NCT03053063|584607271|FG003|Randomized Phase|Lost to Follow-up|0|||
161881325|NCT03053063|584607268|FG000|Randomized Phase|Adverse Event|0|||
161881326|NCT03053063|584607269|FG001|Randomized Phase|Adverse Event|1|||
161881327|NCT03053063|584607270|FG002|Randomized Phase|Adverse Event|0|||
161881328|NCT03053063|584607271|FG003|Randomized Phase|Adverse Event|0|||
161881329|NCT03053063|584607268|FG000|Randomized Phase|Randomized but Never Treated|1|||
161881330|NCT03053063|584607269|FG001|Randomized Phase|Randomized but Never Treated|3|||
161881331|NCT03053063|584607270|FG002|Randomized Phase|Randomized but Never Treated|2|||
161881332|NCT03053063|584607271|FG003|Randomized Phase|Randomized but Never Treated|0|||
161881333|NCT03053063|584607268|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
161881334|NCT03053063|584607269|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
161881335|NCT03053063|584607270|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
161881336|NCT03053063|584607271|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
161881337|NCT03053063|584607268|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
161881338|NCT03053063|584607269|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
161881339|NCT03053063|584607270|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
161881340|NCT03053063|584607271|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
161881341|NCT03053063|584607268|FG000|Open-Label Phase|Death|0|||
161881342|NCT03053063|584607269|FG001|Open-Label Phase|Death|0|||
161881343|NCT03053063|584607270|FG002|Open-Label Phase|Death|0|||
161881344|NCT03053063|584607271|FG003|Open-Label Phase|Death|2|||
161881345|NCT03053063|584607268|FG000|Open-Label Phase|Investigator's discretion|0|||
161881346|NCT03053063|584607269|FG001|Open-Label Phase|Investigator's discretion|0|||
161881347|NCT03053063|584607270|FG002|Open-Label Phase|Investigator's discretion|0|||
161881348|NCT03053063|584607271|FG003|Open-Label Phase|Investigator's discretion|2|||
161881349|NCT02600845|584607272|FG000|Overall Study|Reason Not Specified|3|||
161881350|NCT02600845|584607272|FG000|Overall Study|Non-compliance with Study Procedures|10|||
161881351|NCT02600845|584607272|FG000|Overall Study|Consent Withdrawal|5|||
161881352|NCT03569293|584609291|FG000|Overall Study|Adverse Event|4|||
161881353|NCT03569293|584609292|FG001|Overall Study|Adverse Event|1|||
161881354|NCT03569293|584609293|FG002|Overall Study|Adverse Event|5|||
161881355|NCT03569293|584609294|FG003|Overall Study|Adverse Event|1|||
161881356|NCT03569293|584609295|FG004|Overall Study|Adverse Event|0|||
161881357|NCT03569293|584609296|FG005|Overall Study|Adverse Event|0|||
161881358|NCT03569293|584609291|FG000|Overall Study|Withdrawal by Subject|16|||
161881359|NCT03569293|584609292|FG001|Overall Study|Withdrawal by Subject|2|||
161881360|NCT03569293|584609293|FG002|Overall Study|Withdrawal by Subject|4|||
161881361|NCT03569293|584609294|FG003|Overall Study|Withdrawal by Subject|1|||
161881362|NCT03569293|584609295|FG004|Overall Study|Withdrawal by Subject|0|||
161881363|NCT03569293|584609296|FG005|Overall Study|Withdrawal by Subject|0|||
161881364|NCT03569293|584609291|FG000|Overall Study|Lost to Follow-up|1|||
161881365|NCT03569293|584609292|FG001|Overall Study|Lost to Follow-up|3|||
161881366|NCT03569293|584609293|FG002|Overall Study|Lost to Follow-up|1|||
161777978|NCT01856257|584228869|FG002|Overall Study|Death|0|||
161777979|NCT01856257|584228870|FG003|Overall Study|Death|0|||
161777980|NCT01856257|584228867|FG000|Overall Study|Physician Decision|0|||
161777981|NCT01856257|584228868|FG001|Overall Study|Physician Decision|0|||
161777982|NCT01856257|584228869|FG002|Overall Study|Physician Decision|0|||
161777983|NCT01856257|584228870|FG003|Overall Study|Physician Decision|1|||
161777984|NCT01856257|584228867|FG000|Overall Study|Withdrawal by Subject|1|||
161777985|NCT01856257|584228868|FG001|Overall Study|Withdrawal by Subject|1|||
161777986|NCT01856257|584228869|FG002|Overall Study|Withdrawal by Subject|0|||
161777987|NCT01856257|584228870|FG003|Overall Study|Withdrawal by Subject|0|||
161777988|NCT01856257|584228867|FG000|Overall Study|Donor complication|0|||
161777989|NCT01856257|584228868|FG001|Overall Study|Donor complication|0|||
161777990|NCT01856257|584228869|FG002|Overall Study|Donor complication|0|||
161777991|NCT01856257|584228870|FG003|Overall Study|Donor complication|1|||
161777992|NCT00424632|584228874|FG000|Overall Study|Death|0|||
161777993|NCT00424632|584228875|FG001|Overall Study|Death|0|||
161777994|NCT00424632|584228876|FG002|Overall Study|Death|0|||
161777995|NCT00424632|584228877|FG003|Overall Study|Death|0|||
161777996|NCT00424632|584228878|FG004|Overall Study|Death|0|||
161777997|NCT00424632|584228879|FG005|Overall Study|Death|2|||
161777998|NCT00424632|584228880|FG006|Overall Study|Death|0|||
161777999|NCT00424632|584228881|FG007|Overall Study|Death|0|||
161778000|NCT00424632|584228882|FG008|Overall Study|Death|0|||
161778001|NCT00424632|584228883|FG009|Overall Study|Death|0|||
161778002|NCT00424632|584228874|FG000|Overall Study|Adverse Event|0|||
161778003|NCT00424632|584228875|FG001|Overall Study|Adverse Event|0|||
161778004|NCT00424632|584228876|FG002|Overall Study|Adverse Event|0|||
161778005|NCT00424632|584228877|FG003|Overall Study|Adverse Event|0|||
161778006|NCT00424632|584228878|FG004|Overall Study|Adverse Event|0|||
161778007|NCT00424632|584228879|FG005|Overall Study|Adverse Event|0|||
161778008|NCT00424632|584228880|FG006|Overall Study|Adverse Event|0|||
161778009|NCT00424632|584228881|FG007|Overall Study|Adverse Event|0|||
161778010|NCT00424632|584228882|FG008|Overall Study|Adverse Event|3|||
161778011|NCT00424632|584228883|FG009|Overall Study|Adverse Event|2|||
161778012|NCT00424632|584228874|FG000|Overall Study|Global deterioration of health status|0|||
161778013|NCT00424632|584228875|FG001|Overall Study|Global deterioration of health status|0|||
161778014|NCT00424632|584228876|FG002|Overall Study|Global deterioration of health status|0|||
161778015|NCT00424632|584228877|FG003|Overall Study|Global deterioration of health status|1|||
161778016|NCT00424632|584228878|FG004|Overall Study|Global deterioration of health status|1|||
161778017|NCT00424632|584228879|FG005|Overall Study|Global deterioration of health status|0|||
161778018|NCT00424632|584228880|FG006|Overall Study|Global deterioration of health status|0|||
161778019|NCT00424632|584228881|FG007|Overall Study|Global deterioration of health status|0|||
161778020|NCT00424632|584228882|FG008|Overall Study|Global deterioration of health status|0|||
161778021|NCT00424632|584228883|FG009|Overall Study|Global deterioration of health status|0|||
161778022|NCT00424632|584228874|FG000|Overall Study|Objective progression or relapse|1|||
161778023|NCT00424632|584228875|FG001|Overall Study|Objective progression or relapse|1|||
161778024|NCT00424632|584228876|FG002|Overall Study|Objective progression or relapse|1|||
161778025|NCT00424632|584228877|FG003|Overall Study|Objective progression or relapse|2|||
161778026|NCT00424632|584228878|FG004|Overall Study|Objective progression or relapse|2|||
161778027|NCT00424632|584228879|FG005|Overall Study|Objective progression or relapse|13|||
161778028|NCT00424632|584228880|FG006|Overall Study|Objective progression or relapse|7|||
161778029|NCT00424632|584228881|FG007|Overall Study|Objective progression or relapse|3|||
161778030|NCT00424632|584228882|FG008|Overall Study|Objective progression or relapse|12|||
161778031|NCT00424632|584228883|FG009|Overall Study|Objective progression or relapse|4|||
161778032|NCT00424632|584228874|FG000|Overall Study|Other|0|||
161778033|NCT00424632|584228875|FG001|Overall Study|Other|0|||
161778034|NCT00424632|584228876|FG002|Overall Study|Other|0|||
161778035|NCT00424632|584228877|FG003|Overall Study|Other|1|||
161778036|NCT00424632|584228878|FG004|Overall Study|Other|0|||
161778037|NCT00424632|584228879|FG005|Overall Study|Other|0|||
161778038|NCT00424632|584228880|FG006|Overall Study|Other|0|||
161778039|NCT00424632|584228881|FG007|Overall Study|Other|0|||
161778040|NCT00424632|584228882|FG008|Overall Study|Other|1|||
161778041|NCT00424632|584228883|FG009|Overall Study|Other|0|||
161881367|NCT03569293|584609294|FG003|Overall Study|Lost to Follow-up|1|||
161881368|NCT03569293|584609295|FG004|Overall Study|Lost to Follow-up|0|||
161881369|NCT03569293|584609296|FG005|Overall Study|Lost to Follow-up|0|||
161881370|NCT03569293|584609291|FG000|Overall Study|Other|8|||
161881371|NCT03569293|584609292|FG001|Overall Study|Other|2|||
161881372|NCT03569293|584609293|FG002|Overall Study|Other|1|||
161881373|NCT03569293|584609294|FG003|Overall Study|Other|1|||
161881374|NCT03569293|584609295|FG004|Overall Study|Other|0|||
161881375|NCT03569293|584609296|FG005|Overall Study|Other|0|||
161881376|NCT03569293|584609291|FG000|Overall Study|Ongoing at Time of Analysis|8|||
161881377|NCT03569293|584609292|FG001|Overall Study|Ongoing at Time of Analysis|1|||
161881378|NCT03569293|584609293|FG002|Overall Study|Ongoing at Time of Analysis|3|||
161881379|NCT03569293|584609294|FG003|Overall Study|Ongoing at Time of Analysis|0|||
161881380|NCT03569293|584609295|FG004|Overall Study|Ongoing at Time of Analysis|0|||
161881381|NCT03569293|584609296|FG005|Overall Study|Ongoing at Time of Analysis|0|||
161881382|NCT05072106|584609307|FG000|Overall Study|Progressive disease|3|||
161881383|NCT05072106|584609308|FG001|Overall Study|Progressive disease|3|||
161881384|NCT05072106|584609307|FG000|Overall Study|Compassionate use|3|||
161881385|NCT05072106|584609308|FG001|Overall Study|Compassionate use|1|||
161881386|NCT05072106|584609307|FG000|Overall Study|Withdrawal by Subject|1|||
161881387|NCT05072106|584609308|FG001|Overall Study|Withdrawal by Subject|0|||
161881388|NCT03839459|584609309|FG000|Overall Study|Withdrawal by Subject|2|||
161881389|NCT03839459|584609309|FG000|Overall Study|progression of disease|3|||
161881390|NCT05376241|584609310|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
161881391|NCT05376241|584609310|FG000|Overall Study|103 did not complete the survey|103|||
161881392|NCT05376241|584609310|FG000|Overall Study|17 failed 2 attention check questions|17|||
161881393|NCT03036098|584609311|FG000|Pre-Treatment|Other Reasons|1|||
161881394|NCT03036098|584609312|FG001|Pre-Treatment|Other Reasons|2|||
161881395|NCT03036098|584609313|FG002|Pre-Treatment|Other Reasons|0|||
161881396|NCT03036098|584609314|FG003|Pre-Treatment|Other Reasons|5|||
161881397|NCT03036098|584609311|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
161881398|NCT03036098|584609312|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
161881399|NCT03036098|584609313|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
161881400|NCT03036098|584609314|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
161881401|NCT03036098|584609311|FG000|Pre-Treatment|Withdrawal by Subject|1|||
161881402|NCT03036098|584609312|FG001|Pre-Treatment|Withdrawal by Subject|14|||
161881403|NCT03036098|584609313|FG002|Pre-Treatment|Withdrawal by Subject|0|||
161881404|NCT03036098|584609314|FG003|Pre-Treatment|Withdrawal by Subject|5|||
161881405|NCT03036098|584609311|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
161881406|NCT03036098|584609312|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
161881407|NCT03036098|584609313|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
161881408|NCT03036098|584609314|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
161881409|NCT03036098|584609311|FG000|Treatment|Disease Progression|130|||
161881410|NCT03036098|584609312|FG001|Treatment|Disease Progression|77|||
161881411|NCT03036098|584609313|FG002|Treatment|Disease Progression|168|||
161881412|NCT03036098|584609314|FG003|Treatment|Disease Progression|50|||
161881413|NCT03036098|584609311|FG000|Treatment|Study Drug Toxicity|95|||
161881414|NCT03036098|584609312|FG001|Treatment|Study Drug Toxicity|45|||
161881415|NCT03036098|584609313|FG002|Treatment|Study Drug Toxicity|26|||
161881416|NCT03036098|584609314|FG003|Treatment|Study Drug Toxicity|22|||
161881417|NCT03036098|584609311|FG000|Treatment|Death|9|||
161881418|NCT03036098|584609312|FG001|Treatment|Death|3|||
161881419|NCT03036098|584609313|FG002|Treatment|Death|1|||
161881420|NCT03036098|584609314|FG003|Treatment|Death|2|||
161881421|NCT03036098|584609311|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
161881422|NCT03036098|584609312|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
161881423|NCT03036098|584609313|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
161881424|NCT03036098|584609314|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
161881425|NCT03036098|584609311|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
161881426|NCT03036098|584609312|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
161881427|NCT03036098|584609313|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
161881428|NCT03036098|584609314|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
161881429|NCT03036098|584609311|FG000|Treatment|Withdrawal by Subject|2|||
161881430|NCT03036098|584609312|FG001|Treatment|Withdrawal by Subject|9|||
161991548|NCT00408434|585018524|FG005|Overall Study|Terminated by Investigator|1|||
161881431|NCT03036098|584609313|FG002|Treatment|Withdrawal by Subject|2|||
161881432|NCT03036098|584609314|FG003|Treatment|Withdrawal by Subject|4|||
161881433|NCT03036098|584609311|FG000|Treatment|Maximum Clinical Benefit|6|||
161881434|NCT03036098|584609312|FG001|Treatment|Maximum Clinical Benefit|1|||
161881435|NCT03036098|584609313|FG002|Treatment|Maximum Clinical Benefit|6|||
161881436|NCT03036098|584609314|FG003|Treatment|Maximum Clinical Benefit|10|||
161881437|NCT03036098|584609311|FG000|Treatment|Poor/Non Compliance|1|||
161881438|NCT03036098|584609312|FG001|Treatment|Poor/Non Compliance|2|||
161881439|NCT03036098|584609313|FG002|Treatment|Poor/Non Compliance|0|||
161881440|NCT03036098|584609314|FG003|Treatment|Poor/Non Compliance|1|||
161991549|NCT00408434|585018525|FG006|Overall Study|Terminated by Investigator|0|||
161881441|NCT03036098|584609311|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
161881442|NCT03036098|584609312|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
161881443|NCT03036098|584609313|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
161881444|NCT03036098|584609314|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
161881445|NCT03036098|584609311|FG000|Treatment|Administrative Reason by Sponsor|1|||
161881446|NCT03036098|584609312|FG001|Treatment|Administrative Reason by Sponsor|0|||
161881447|NCT03036098|584609313|FG002|Treatment|Administrative Reason by Sponsor|2|||
161881448|NCT03036098|584609314|FG003|Treatment|Administrative Reason by Sponsor|1|||
161881449|NCT03036098|584609311|FG000|Treatment|Other Reasons|31|||
161881450|NCT03036098|584609312|FG001|Treatment|Other Reasons|5|||
161881451|NCT03036098|584609313|FG002|Treatment|Other Reasons|21|||
161881452|NCT03036098|584609314|FG003|Treatment|Other Reasons|8|||
161881453|NCT03036098|584609311|FG000|Treatment|Ongoing Treatment|0|||
161881454|NCT03036098|584609312|FG001|Treatment|Ongoing Treatment|0|||
161881455|NCT03036098|584609313|FG002|Treatment|Ongoing Treatment|23|||
161881456|NCT03036098|584609314|FG003|Treatment|Ongoing Treatment|0|||
161881457|NCT04240886|584609317|FG000|Treatment Phase|Death|4|||
161881458|NCT04240886|584609317|FG000|Treatment Phase|Discontinuation by Subject|1|||
161881459|NCT04240886|584609317|FG000|Treatment Phase|Adverse Event|5|||
161881460|NCT04240886|584609317|FG000|Follow-up Phase|Withdrawal by Subject|1|||
161881461|NCT04240886|584609317|FG000|Follow-up Phase|Discontinuation by Subject|1|||
161881462|NCT04240886|584609317|FG000|Follow-up Phase|Death|2|||
161881463|NCT02276053|584609320|FG000|Overall Study|Death|2|||
161881464|NCT02276053|584609320|FG000|Overall Study|Adverse Event|5|||
161881465|NCT02276053|584609320|FG000|Overall Study|Lack of Efficacy|2|||
161881466|NCT02276053|584609320|FG000|Overall Study|Withdrawal by Subject|1|||
161881467|NCT02276053|584609320|FG000|Overall Study|Patient does not meet selection criteria|3|||
161881468|NCT02276053|584609320|FG000|Overall Study|Patient needs to increase baseline AED|1|||
161881469|NCT01632904|584609321|FG000|Overall Study|Adverse Event|4|||
161881470|NCT01632904|584609322|FG001|Overall Study|Adverse Event|1|||
161881471|NCT01632904|584609321|FG000|Overall Study|Physician Decision|0|||
161881472|NCT01632904|584609322|FG001|Overall Study|Physician Decision|1|||
161881473|NCT01632904|584609321|FG000|Overall Study|Subject decision|3|||
161881474|NCT01632904|584609322|FG001|Overall Study|Subject decision|2|||
161881475|NCT01632904|584609321|FG000|Overall Study|Disease Progression|0|||
161881476|NCT01632904|584609322|FG001|Overall Study|Disease Progression|1|||
161881477|NCT01632904|584609321|FG000|Overall Study|Reason for discontinuation not available|0|||
161881478|NCT01632904|584609322|FG001|Overall Study|Reason for discontinuation not available|1|||
161881479|NCT02059434|584609323|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
161881480|NCT02059434|584609324|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
161881481|NCT02059434|584609325|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
161881482|NCT02059434|584609326|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
161881483|NCT02059434|584609327|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
161881484|NCT02059434|584609328|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
161881485|NCT02059434|584609329|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
161881486|NCT02059434|584609330|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
161881487|NCT02059434|584609331|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
161881488|NCT02059434|584609323|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
161881489|NCT02059434|584609324|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
161881490|NCT02059434|584609325|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
161881491|NCT02059434|584609326|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
161881492|NCT02059434|584609327|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
161881493|NCT02059434|584609328|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
161881494|NCT02059434|584609329|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
161881495|NCT02059434|584609330|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
161881496|NCT02059434|584609331|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
161881497|NCT02059434|584609323|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
161881498|NCT02059434|584609324|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
161881499|NCT02059434|584609325|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
161881500|NCT02059434|584609326|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
161881501|NCT02059434|584609327|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
161881502|NCT02059434|584609328|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
161881503|NCT02059434|584609329|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
161881504|NCT02059434|584609330|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
161881505|NCT02059434|584609331|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
161881506|NCT02059434|584609323|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
161881507|NCT02059434|584609324|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
161881508|NCT02059434|584609325|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
161881509|NCT02059434|584609326|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
161881510|NCT02059434|584609327|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
161881511|NCT02059434|584609328|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
161881512|NCT02059434|584609329|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
161881513|NCT02059434|584609330|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
161881514|NCT02059434|584609331|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
161881515|NCT02059434|584609323|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881516|NCT02059434|584609324|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881517|NCT02059434|584609325|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881518|NCT02059434|584609326|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881519|NCT02059434|584609327|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881520|NCT02059434|584609328|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881521|NCT02059434|584609329|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881522|NCT02059434|584609330|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161881523|NCT02059434|584609331|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
161881524|NCT01004406|584609336|FG000|Overall Study|Withdrawal by Subject|2|||
161881525|NCT01004406|584609337|FG001|Overall Study|Withdrawal by Subject|0|||
161881526|NCT01004406|584609336|FG000|Overall Study|Lost to Follow-up|1|||
161881527|NCT01004406|584609337|FG001|Overall Study|Lost to Follow-up|0|||
161881528|NCT02928770|584609338|FG000|Overall Study|Withdrawal by Subject|2|||
161881529|NCT03201874|584609339|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
161881530|NCT03201874|584609340|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
161881531|NCT03201874|584609339|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
161881532|NCT03201874|584609340|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
161881533|NCT03339726|584609345|FG000|Overall Study|Withdrawal by Subject|1|||
161881534|NCT03339726|584609346|FG001|Overall Study|Withdrawal by Subject|0|||
161881535|NCT03339726|584609347|FG002|Overall Study|Withdrawal by Subject|0|||
161881536|NCT03339726|584609345|FG000|Overall Study|Lost to Follow-up|0|||
161881537|NCT03339726|584609346|FG001|Overall Study|Lost to Follow-up|1|||
161881538|NCT03339726|584609347|FG002|Overall Study|Lost to Follow-up|0|||
161881539|NCT04542499|584609348|FG000|Overall Study|Adverse Event|23|||
161881540|NCT04542499|584609349|FG001|Overall Study|Adverse Event|43|||
161881541|NCT04542499|584609348|FG000|Overall Study|Lack of Efficacy|5|||
161881542|NCT04542499|584609349|FG001|Overall Study|Lack of Efficacy|2|||
161881543|NCT04542499|584609348|FG000|Overall Study|Lost to Follow-up|3|||
161881544|NCT04542499|584609349|FG001|Overall Study|Lost to Follow-up|4|||
161881545|NCT04542499|584609348|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
161881546|NCT04542499|584609349|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
161881547|NCT04542499|584609348|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
161881548|NCT04542499|584609349|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
161881549|NCT04542499|584609348|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161881550|NCT04542499|584609349|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161881551|NCT04542499|584609348|FG000|Overall Study|Physician Decision|0|||
161881552|NCT04542499|584609349|FG001|Overall Study|Physician Decision|1|||
161881553|NCT04542499|584609348|FG000|Overall Study|Site Terminated by Sponsor|3|||
161881554|NCT04542499|584609349|FG001|Overall Study|Site Terminated by Sponsor|5|||
161881555|NCT04542499|584609348|FG000|Overall Study|Withdrawal by Subject|12|||
161881556|NCT04542499|584609349|FG001|Overall Study|Withdrawal by Subject|33|||
161881557|NCT04542499|584609348|FG000|Overall Study|Other|2|||
161881558|NCT04542499|584609349|FG001|Overall Study|Other|2|||
161881559|NCT04035434|584609355|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881560|NCT04035434|584609356|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161881561|NCT04035434|584609357|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881562|NCT04035434|584609358|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
161881563|NCT04035434|584609359|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161881564|NCT04035434|584609360|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881565|NCT04035434|584609361|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881566|NCT04035434|584609362|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881567|NCT04035434|584609363|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881568|NCT04035434|584609364|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881569|NCT04035434|584609365|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161881570|NCT04035434|584609366|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161881571|NCT04035434|584609367|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881572|NCT04035434|584609355|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161881573|NCT04035434|584609356|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
161881574|NCT04035434|584609357|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
161881575|NCT04035434|584609358|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161881576|NCT04035434|584609359|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
161881577|NCT04035434|584609360|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161881578|NCT04035434|584609361|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
161881579|NCT04035434|584609362|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
161881580|NCT04035434|584609363|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161881581|NCT04035434|584609364|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
161881582|NCT04035434|584609365|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161881583|NCT04035434|584609366|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
161881584|NCT04035434|584609367|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
161881585|NCT04035434|584609355|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881586|NCT04035434|584609356|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
161881587|NCT04035434|584609357|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
161881588|NCT04035434|584609358|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881589|NCT04035434|584609359|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
161881590|NCT04035434|584609360|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
161881591|NCT04035434|584609361|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881592|NCT04035434|584609362|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881593|NCT04035434|584609363|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
161881594|NCT04035434|584609364|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
161881595|NCT04035434|584609365|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881596|NCT04035434|584609366|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
161881597|NCT04035434|584609367|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
161881598|NCT04035434|584609355|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881599|NCT04035434|584609356|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881600|NCT04035434|584609357|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881601|NCT04035434|584609358|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
161881602|NCT04035434|584609359|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881603|NCT04035434|584609360|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881604|NCT04035434|584609361|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881605|NCT04035434|584609362|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881606|NCT04035434|584609363|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881607|NCT04035434|584609364|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881608|NCT04035434|584609365|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881609|NCT04035434|584609366|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881610|NCT04035434|584609367|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161881611|NCT04035434|584609355|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881612|NCT04035434|584609356|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881613|NCT04035434|584609357|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881614|NCT04035434|584609358|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881615|NCT04035434|584609359|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881616|NCT04035434|584609360|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
161881617|NCT04035434|584609361|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
161881618|NCT04035434|584609362|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881619|NCT04035434|584609363|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881620|NCT04035434|584609364|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881621|NCT04035434|584609365|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881622|NCT04035434|584609366|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881623|NCT04035434|584609367|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161881624|NCT04035434|584609355|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881625|NCT04035434|584609356|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881626|NCT04035434|584609357|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881627|NCT04035434|584609358|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881628|NCT04035434|584609359|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881629|NCT04035434|584609360|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161881630|NCT04035434|584609361|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161881631|NCT04035434|584609362|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881632|NCT04035434|584609363|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881633|NCT04035434|584609364|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881634|NCT04035434|584609365|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881635|NCT04035434|584609366|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881636|NCT04035434|584609367|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161881637|NCT04035434|584609355|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881638|NCT04035434|584609356|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161991550|NCT00106353|585018526|FG000|Part 1|Disease progression|3|||
161991551|NCT00106353|585018527|FG001|Part 1|Disease progression|4|||
161991552|NCT00106353|585018528|FG002|Part 1|Disease progression|1|||
161991553|NCT00106353|585018529|FG003|Part 1|Disease progression|3|||
161991554|NCT00106353|585018530|FG004|Part 1|Disease progression|0|||
161991555|NCT00106353|585018531|FG005|Part 1|Disease progression|0|||
161991556|NCT00106353|585018532|FG006|Part 1|Disease progression|0|||
161991557|NCT00106353|585018526|FG000|Part 1|Withdrawal by Subject|0|||
161881639|NCT04035434|584609357|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881640|NCT04035434|584609358|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161778042|NCT05674721|584228885|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
161778043|NCT05674721|584228886|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
161778044|NCT05674721|584228885|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
161778045|NCT05674721|584228886|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
161778046|NCT03506425|584228901|FG000|Overall Study|Adverse Event|1|||
161778047|NCT03506425|584228902|FG001|Overall Study|Adverse Event|3|||
161778048|NCT03506425|584228903|FG002|Overall Study|Adverse Event|0|||
161778049|NCT03506425|584228901|FG000|Overall Study|Death|1|||
161778050|NCT03506425|584228902|FG001|Overall Study|Death|0|||
161778051|NCT03506425|584228903|FG002|Overall Study|Death|0|||
161778052|NCT03506425|584228901|FG000|Overall Study|Withdrawal by Subject|0|||
161778053|NCT03506425|584228902|FG001|Overall Study|Withdrawal by Subject|0|||
161778054|NCT03506425|584228903|FG002|Overall Study|Withdrawal by Subject|1|||
161778055|NCT02057549|584228907|FG000|Overall Study|Lost to Follow-up|1|||
161778056|NCT02057549|584228908|FG001|Overall Study|Lost to Follow-up|0|||
161778057|NCT02057549|584228907|FG000|Overall Study|Physician Decision|1|||
161778058|NCT02057549|584228908|FG001|Overall Study|Physician Decision|0|||
161778059|NCT02057549|584228907|FG000|Overall Study|Withdrawal by Subject|1|||
161778060|NCT02057549|584228908|FG001|Overall Study|Withdrawal by Subject|0|||
161778061|NCT01418365|584228909|FG000|First Intervention|Withdrawal by Subject|0|||
161778062|NCT01418365|584228910|FG001|First Intervention|Withdrawal by Subject|1|||
161778063|NCT01418365|584228909|FG000|First Intervention|Non-compliance|1|||
161778064|NCT01418365|584228910|FG001|First Intervention|Non-compliance|0|||
161881641|NCT04035434|584609359|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881642|NCT04035434|584609360|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
161881643|NCT04035434|584609361|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
161881644|NCT04035434|584609362|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881645|NCT04035434|584609363|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881646|NCT04035434|584609364|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881647|NCT04035434|584609365|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881648|NCT04035434|584609366|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881649|NCT04035434|584609367|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161881650|NCT04322539|584609368|FG000|Overall Study|Adverse Event|2|||
161881651|NCT04322539|584609369|FG001|Overall Study|Adverse Event|0|||
161881652|NCT04322539|584609368|FG000|Overall Study|Death|411|||
161881653|NCT04322539|584609369|FG001|Overall Study|Death|203|||
161778065|NCT01418365|584228909|FG000|Second Intervention|Withdrawal by Subject|0|||
161778066|NCT01418365|584228910|FG001|Second Intervention|Withdrawal by Subject|1|||
161778067|NCT03319368|584228911|FG000|Overall Study|Discharge swabs not collected from resident|57|||
161778068|NCT03319368|584228912|FG001|Overall Study|Discharge swabs not collected from resident|46|||
161778069|NCT04150107|584228919|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
161778070|NCT04150107|584228920|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
161778071|NCT04150107|584228919|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
161778072|NCT04150107|584228920|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
161778073|NCT00824993|584228921|FG000|Overall Study|Withdrawal by Subject|1|||
161778074|NCT00824993|584228922|FG001|Overall Study|Withdrawal by Subject|1|||
161881654|NCT04322539|584609368|FG000|Overall Study|Lost to Follow-up|3|||
161881655|NCT04322539|584609369|FG001|Overall Study|Lost to Follow-up|1|||
161881656|NCT04322539|584609368|FG000|Overall Study|Withdrawal of consent|14|||
161881657|NCT04322539|584609369|FG001|Overall Study|Withdrawal of consent|8|||
161881658|NCT04322539|584609368|FG000|Overall Study|Radiological Disease Progression|6|||
161881659|NCT04322539|584609369|FG001|Overall Study|Radiological Disease Progression|0|||
161881660|NCT04322539|584609368|FG000|Overall Study|Sponsor Decision|19|||
161881661|NCT04322539|584609369|FG001|Overall Study|Sponsor Decision|14|||
161881662|NCT04322539|584609368|FG000|Overall Study|Other|6|||
161881663|NCT04322539|584609369|FG001|Overall Study|Other|4|||
161881664|NCT04161079|584609372|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
161881665|NCT04045132|584609375|FG000|Overall Study|Lost to Follow-up|3|||
161881666|NCT04045132|584609376|FG001|Overall Study|Lost to Follow-up|6|||
161881667|NCT04063657|584609377|FG000|Overall Study|Lost to Follow-up|1|||
161881668|NCT04063657|584609378|FG001|Overall Study|Lost to Follow-up|0|||
161881669|NCT00552032|584609379|FG000|Overall Study|Withdrawal by Subject|2|||
161881670|NCT00552032|584609380|FG001|Overall Study|Withdrawal by Subject|2|||
161881671|NCT00552032|584609379|FG000|Overall Study|Protocol Violation|7|||
161778075|NCT00824993|584228921|FG000|Overall Study|Malignancy Relapse|9|||
161778076|NCT00824993|584228922|FG001|Overall Study|Malignancy Relapse|10|||
161778077|NCT00824993|584228921|FG000|Overall Study|Rapid Bone Loss|0|||
161778078|NCT00824993|584228922|FG001|Overall Study|Rapid Bone Loss|1|||
161778079|NCT00824993|584228921|FG000|Overall Study|Non-Compliant|2|||
161778080|NCT00824993|584228922|FG001|Overall Study|Non-Compliant|1|||
161778081|NCT00824993|584228921|FG000|Overall Study|Insurance Issue|2|||
161881672|NCT00552032|584609380|FG001|Overall Study|Protocol Violation|12|||
161881673|NCT00552032|584609379|FG000|Overall Study|Lost to Follow-up|8|||
161881674|NCT00552032|584609380|FG001|Overall Study|Lost to Follow-up|5|||
161881675|NCT05845567|584609383|FG000|Overall Study|Withdrawal by Subject|1|||
161881676|NCT01104246|584609388|FG000|Overall Study|Withdrawal by Subject|1|||
161881677|NCT01104246|584609388|FG000|Overall Study|did not meet inclusion criteria|4|||
161881678|NCT05178641|584609391|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
161881679|NCT05178641|584609392|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
161881680|NCT05178641|584609391|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
161881681|NCT05178641|584609392|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
161881682|NCT01869699|584609393|FG000|Overall Study|Withdrawal by Subject|1|||
161881683|NCT01869699|584609394|FG001|Overall Study|Withdrawal by Subject|0|||
161881684|NCT01083186|584609399|FG000|Overall Study|Lost to Follow-up|48|||
161881685|NCT01083186|584609399|FG000|Overall Study|Consent Withdrawal|7|||
161881686|NCT01083186|584609399|FG000|Overall Study|Death|3|||
161881687|NCT01083186|584609399|FG000|Overall Study|Adverse Event|3|||
161881688|NCT01083186|584609399|FG000|Overall Study|Lack of Efficacy|2|||
161881689|NCT01083186|584609399|FG000|Overall Study|Hemodialysis Initiation|28|||
161881690|NCT01083186|584609399|FG000|Overall Study|Administrative Reasons|2|||
161881691|NCT01083186|584609399|FG000|Overall Study|Non-compliance to Study Treatment|1|||
161881692|NCT01867294|584609410|FG000|Overall Study|Withdrawal by Subject|1|||
161881693|NCT01867294|584609411|FG001|Overall Study|Withdrawal by Subject|1|||
161881694|NCT01867294|584609412|FG002|Overall Study|Withdrawal by Subject|0|||
161881695|NCT01867294|584609413|FG003|Overall Study|Withdrawal by Subject|0|||
161881696|NCT02062944|584609414|FG000|Overall Study|Lost to Follow-up|1|||
161881697|NCT02062944|584609414|FG000|Overall Study|New hemotological disorder identified|1|||
161881698|NCT02062944|584609414|FG000|Overall Study|Uncontrolled Hypertension|1|||
161881699|NCT02062944|584609414|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
161881700|NCT00278148|584609415|FG000|Phase II - Expansion Phase|Disease progression|0|||
161881701|NCT00278148|584609416|FG001|Phase II - Expansion Phase|Disease progression|0|||
161881702|NCT00278148|584609417|FG002|Phase II - Expansion Phase|Disease progression|4|||
161881703|NCT00278148|584609415|FG000|Phase II - Expansion Phase|Adverse Event|0|||
161881704|NCT00278148|584609416|FG001|Phase II - Expansion Phase|Adverse Event|0|||
161881705|NCT00278148|584609417|FG002|Phase II - Expansion Phase|Adverse Event|2|||
161881706|NCT02035748|584609418|FG000|Overall Study|Adverse Event|5|||
161881707|NCT02035748|584609418|FG000|Overall Study|Death|3|||
161881708|NCT02035748|584609418|FG000|Overall Study|Lost to Follow-up|2|||
161881709|NCT02035748|584609418|FG000|Overall Study|Physician Decision|3|||
161881710|NCT02035748|584609418|FG000|Overall Study|Withdrawal by Subject|6|||
161881711|NCT02035748|584609418|FG000|Overall Study|Progressive Disease|1|||
161881712|NCT00976209|584609421|FG000|Treatment Period 1|Protocol Violation|1|||
161881713|NCT00976209|584609422|FG001|Treatment Period 1|Protocol Violation|0|||
161881714|NCT00976209|584609421|FG000|Treatment Period 1|Lost to Follow-up|2|||
161881715|NCT00976209|584609422|FG001|Treatment Period 1|Lost to Follow-up|0|||
161881716|NCT00976209|584609421|FG000|Treatment Period 1|Other|0|||
161881717|NCT00976209|584609422|FG001|Treatment Period 1|Other|1|||
161881718|NCT00976209|584609421|FG000|Wash-out Period|Adverse Event|1|||
161881719|NCT00976209|584609422|FG001|Wash-out Period|Adverse Event|2|||
161881720|NCT00976209|584609421|FG000|Wash-out Period|Lost to Follow-up|1|||
161881721|NCT00976209|584609422|FG001|Wash-out Period|Lost to Follow-up|0|||
161881722|NCT00976209|584609421|FG000|Wash-out Period|Protocol Violation|1|||
161881723|NCT00976209|584609422|FG001|Wash-out Period|Protocol Violation|0|||
161881724|NCT00976209|584609421|FG000|Wash-out Period|Other|1|||
161881725|NCT00976209|584609422|FG001|Wash-out Period|Other|0|||
161881726|NCT00976209|584609421|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161881727|NCT00976209|584609422|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161881728|NCT00976209|584609421|FG000|Treatment Period 2|Lost to Follow-up|0|||
161881729|NCT00976209|584609422|FG001|Treatment Period 2|Lost to Follow-up|1|||
161881730|NCT01252563|584609423|FG000|Overall Study|Contract Deviation|41|||
161881731|NCT01252563|584609423|FG000|Overall Study|Centralized Registration Deviation|30|||
161881732|NCT01252563|584609423|FG000|Overall Study|Lost to Follow-up|161|||
161881733|NCT01252563|584609423|FG000|Overall Study|No visit after first day of treatment|194|||
161881734|NCT01252563|584609423|FG000|Overall Study|No drug administration|6|||
161881735|NCT01866657|584609429|FG000|Overall Study|Surgery canceled|2|||
161881736|NCT01866657|584609430|FG001|Overall Study|Surgery canceled|0|||
161991558|NCT00106353|585018527|FG001|Part 1|Withdrawal by Subject|0|||
161991559|NCT00106353|585018528|FG002|Part 1|Withdrawal by Subject|1|||
161991560|NCT00106353|585018529|FG003|Part 1|Withdrawal by Subject|2|||
161881737|NCT00978250|584609431|FG000|Overall Study|Late determination of ineligibility|0|||
161881738|NCT00978250|584609432|FG001|Overall Study|Late determination of ineligibility|1|||
161881739|NCT00978250|584609433|FG002|Overall Study|Late determination of ineligibility|0|||
161881740|NCT00978250|584609434|FG003|Overall Study|Late determination of ineligibility|1|||
161881741|NCT02951533|584609440|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
161991561|NCT00106353|585018530|FG004|Part 1|Withdrawal by Subject|0|||
161881742|NCT02951533|584609441|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
161991562|NCT00106353|585018531|FG005|Part 1|Withdrawal by Subject|0|||
161991563|NCT00106353|585018532|FG006|Part 1|Withdrawal by Subject|0|||
161778082|NCT00824993|584228922|FG001|Overall Study|Insurance Issue|1|||
161778083|NCT00824993|584228921|FG000|Overall Study|Death|0|||
161778084|NCT00824993|584228922|FG001|Overall Study|Death|3|||
161778085|NCT00440193|584228923|FG000|Treatment Period|Adverse Event|74|||
161778086|NCT00440193|584228924|FG001|Treatment Period|Adverse Event|67|||
161778087|NCT00440193|584228923|FG000|Treatment Period|Death|19|||
161778088|NCT00440193|584228924|FG001|Treatment Period|Death|22|||
161778089|NCT00440193|584228923|FG000|Treatment Period|Lack of Efficacy|0|||
161778090|NCT00440193|584228924|FG001|Treatment Period|Lack of Efficacy|1|||
161778091|NCT00440193|584228923|FG000|Treatment Period|Lost to Follow-up|12|||
161778092|NCT00440193|584228924|FG001|Treatment Period|Lost to Follow-up|18|||
161778093|NCT00440193|584228923|FG000|Treatment Period|Physician Decision|3|||
161778094|NCT00440193|584228924|FG001|Treatment Period|Physician Decision|6|||
161778095|NCT00440193|584228923|FG000|Treatment Period|Protocol Violation|16|||
161778096|NCT00440193|584228924|FG001|Treatment Period|Protocol Violation|19|||
161778097|NCT00440193|584228923|FG000|Treatment Period|Withdrawal by Subject|36|||
161778098|NCT00440193|584228924|FG001|Treatment Period|Withdrawal by Subject|77|||
161778099|NCT00440193|584228923|FG000|Treatment Period|Clinical endpoint reached|28|||
161778100|NCT00440193|584228924|FG001|Treatment Period|Clinical endpoint reached|25|||
161778101|NCT00440193|584228923|FG000|Treatment Period|Study terminated by sponsor|102|||
161778102|NCT00440193|584228924|FG001|Treatment Period|Study terminated by sponsor|94|||
161778103|NCT00440193|584228923|FG000|Treatment Period|Protocol driven decision point|2|||
161778104|NCT00440193|584228924|FG001|Treatment Period|Protocol driven decision point|2|||
161778105|NCT00440193|584228923|FG000|Treatment Period|Switch to commercial drug|0|||
161778106|NCT00440193|584228924|FG001|Treatment Period|Switch to commercial drug|2|||
161778107|NCT00440193|584228923|FG000|Treatment Period|Technical problems|1|||
161778108|NCT00440193|584228924|FG001|Treatment Period|Technical problems|1|||
161778109|NCT00440193|584228923|FG000|Treatment Period|Participant convenience|5|||
161778110|NCT00440193|584228924|FG001|Treatment Period|Participant convenience|2|||
161778111|NCT00440193|584228923|FG000|Treatment Period|Participant did not receive treatment|7|||
161778112|NCT00440193|584228924|FG001|Treatment Period|Participant did not receive treatment|13|||
161778113|NCT00440193|584228923|FG000|Treatment Period|Site closed by investigator|0|||
161778114|NCT00440193|584228924|FG001|Treatment Period|Site closed by investigator|2|||
161778115|NCT00440193|584228923|FG000|Observational Period|Adverse Event|2|||
161778116|NCT00440193|584228924|FG001|Observational Period|Adverse Event|2|||
161778117|NCT00440193|584228923|FG000|Observational Period|Death|15|||
161778118|NCT00440193|584228924|FG001|Observational Period|Death|20|||
161778119|NCT00440193|584228923|FG000|Observational Period|Lost to Follow-up|12|||
161778120|NCT00440193|584228924|FG001|Observational Period|Lost to Follow-up|8|||
161778121|NCT00440193|584228923|FG000|Observational Period|Protocol Violation|1|||
161778122|NCT00440193|584228924|FG001|Observational Period|Protocol Violation|0|||
161778123|NCT00440193|584228923|FG000|Observational Period|Withdrawal by Subject|11|||
161778124|NCT00440193|584228924|FG001|Observational Period|Withdrawal by Subject|8|||
161778125|NCT00440193|584228923|FG000|Observational Period|Physician Decision|1|||
161778126|NCT00440193|584228924|FG001|Observational Period|Physician Decision|0|||
161778127|NCT00440193|584228923|FG000|Observational Period|Clinical endpoint reached|1|||
161778128|NCT00440193|584228924|FG001|Observational Period|Clinical endpoint reached|0|||
161778129|NCT00440193|584228923|FG000|Observational Period|Participant convenience|2|||
161778130|NCT00440193|584228924|FG001|Observational Period|Participant convenience|0|||
161778131|NCT00834366|584228925|FG000|Treatment Period 1|Adverse Event|1|||
161778132|NCT00834366|584228926|FG001|Treatment Period 1|Adverse Event|1|||
161778133|NCT03409328|584228932|FG000|Overall Study|Lost to Follow-up|6|||
161778134|NCT03409328|584228933|FG001|Overall Study|Lost to Follow-up|3|||
161778135|NCT02998645|584228934|FG000|Treatment Period 1|Adverse Event|6|||
161778136|NCT02998645|584228934|FG000|Treatment Period 1|Death|5|||
161778137|NCT02998645|584228934|FG000|Treatment Period 1|Technical Problems|4|||
161778138|NCT02998645|584228934|FG000|Treatment Period 1|Lack of Efficacy|2|||
161778139|NCT02998645|584228934|FG000|Treatment Period 1|Progressive disease|1|||
161778140|NCT02998645|584228934|FG000|Treatment Period 1|Subject/guardian decision|1|||
161778141|NCT02998645|584228934|FG000|Treatment Period 2|Lack of Efficacy|5|||
161778142|NCT02998645|584228934|FG000|Treatment Period 2|Adverse Event|2|||
161778143|NCT02998645|584228934|FG000|Treatment Period 2|Progressive disease|2|||
161778144|NCT02998645|584228934|FG000|Treatment Period 2|Physician Decision|1|||
161778145|NCT03701516|584228935|FG000|Period 1|Lost to Follow-up|0|||
161778146|NCT03701516|584228936|FG001|Period 1|Lost to Follow-up|1|||
161778147|NCT03701516|584228935|FG000|Period 1|Adverse Event|0|||
161778148|NCT03701516|584228936|FG001|Period 1|Adverse Event|2|||
161778149|NCT03701516|584228935|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
161778150|NCT03701516|584228936|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
161778151|NCT03701516|584228935|FG000|Period 1|Non Compliance to Protocol|2|||
161778152|NCT03701516|584228936|FG001|Period 1|Non Compliance to Protocol|1|||
161778153|NCT03701516|584228935|FG000|Period 1|Withdrawal by Subject|0|||
161881743|NCT02951533|584609442|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
161881744|NCT02951533|584609440|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
161881745|NCT02951533|584609441|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
161881746|NCT02951533|584609442|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
161881747|NCT02951533|584609440|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
161881748|NCT02951533|584609441|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
161881749|NCT02951533|584609442|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
161881750|NCT02951533|584609440|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
161881751|NCT02951533|584609441|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
161881752|NCT02951533|584609442|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
161881753|NCT02951533|584609440|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
161881754|NCT02951533|584609441|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
161881755|NCT02951533|584609442|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
161881756|NCT02951533|584609440|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
161881757|NCT02951533|584609441|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
161881758|NCT02951533|584609442|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
161881759|NCT02951533|584609440|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
161881760|NCT02951533|584609441|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
161881761|NCT02951533|584609442|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
161881762|NCT02951533|584609440|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
161881763|NCT02951533|584609441|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
161881764|NCT02951533|584609442|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
161881765|NCT02951533|584609440|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
161881766|NCT02951533|584609441|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
161881767|NCT02951533|584609442|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
161881768|NCT02951533|584609440|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
161881769|NCT02951533|584609441|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
161881770|NCT02951533|584609442|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
161881771|NCT02951533|584609440|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
161881772|NCT02951533|584609441|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
161881773|NCT02951533|584609442|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
161881774|NCT05174949|584609443|FG000|Overall Study|Physician Decision|1|||
161881775|NCT05174949|584609444|FG001|Overall Study|Physician Decision|2|||
161881776|NCT05174949|584609445|FG002|Overall Study|Physician Decision|0|||
161881777|NCT05174949|584609446|FG003|Overall Study|Physician Decision|1|||
161881778|NCT05174949|584609447|FG004|Overall Study|Physician Decision|0|||
161881779|NCT05174949|584609448|FG005|Overall Study|Physician Decision|0|||
161881780|NCT05174949|584609443|FG000|Overall Study|Withdrawal by Subject|0|||
161881781|NCT05174949|584609444|FG001|Overall Study|Withdrawal by Subject|1|||
161881782|NCT05174949|584609445|FG002|Overall Study|Withdrawal by Subject|0|||
161881783|NCT05174949|584609446|FG003|Overall Study|Withdrawal by Subject|0|||
161881784|NCT05174949|584609447|FG004|Overall Study|Withdrawal by Subject|0|||
161881785|NCT05174949|584609448|FG005|Overall Study|Withdrawal by Subject|0|||
161881786|NCT05174949|584609443|FG000|Overall Study|Lost to Follow-up|0|||
161881787|NCT05174949|584609444|FG001|Overall Study|Lost to Follow-up|0|||
161881788|NCT05174949|584609445|FG002|Overall Study|Lost to Follow-up|0|||
161881789|NCT05174949|584609446|FG003|Overall Study|Lost to Follow-up|1|||
161881790|NCT05174949|584609447|FG004|Overall Study|Lost to Follow-up|0|||
161881791|NCT05174949|584609448|FG005|Overall Study|Lost to Follow-up|0|||
161881792|NCT02029989|584609449|FG000|Overall Study|Withdrawal by Subject|1|||
161881793|NCT02029989|584609450|FG001|Overall Study|Withdrawal by Subject|0|||
161881794|NCT02029989|584609449|FG000|Overall Study|Withdrawal: Fear of needles|1|||
161881795|NCT02029989|584609450|FG001|Overall Study|Withdrawal: Fear of needles|0|||
161881796|NCT02029989|584609449|FG000|Overall Study|Change of location|2|||
161881797|NCT02029989|584609450|FG001|Overall Study|Change of location|3|||
161881798|NCT02029989|584609449|FG000|Overall Study|Physician Decision|2|||
161881799|NCT02029989|584609450|FG001|Overall Study|Physician Decision|0|||
161881800|NCT02029989|584609449|FG000|Overall Study|Lost to Follow-up|9|||
161881801|NCT02029989|584609450|FG001|Overall Study|Lost to Follow-up|7|||
161881802|NCT02029989|584609449|FG000|Overall Study|Death|0|||
161881803|NCT02029989|584609450|FG001|Overall Study|Death|1|||
161881804|NCT02029989|584609449|FG000|Overall Study|Protocol Violation|1|||
161881805|NCT02029989|584609450|FG001|Overall Study|Protocol Violation|0|||
161881806|NCT04351373|584609451|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
161881807|NCT01123941|584609457|FG000|Overall Study|Lost to Follow-up|2|||
161881808|NCT01123941|584609458|FG001|Overall Study|Lost to Follow-up|1|||
161881809|NCT05036668|584609459|FG000|Overall Study|lost to follow Up|0|||
161881810|NCT05036668|584609460|FG001|Overall Study|lost to follow Up|0|||
161881811|NCT05036668|584609461|FG002|Overall Study|lost to follow Up|1|||
161881812|NCT01537068|584609462|FG000|Overall Study|Lost to Follow-up|2|||
161881813|NCT01537068|584609463|FG001|Overall Study|Lost to Follow-up|1|||
161881814|NCT01537068|584609462|FG000|Overall Study|Adverse Event|0|||
161881815|NCT01537068|584609463|FG001|Overall Study|Adverse Event|1|||
161881816|NCT01537068|584609462|FG000|Overall Study|Withdrawal by Subject|1|||
161881817|NCT01537068|584609463|FG001|Overall Study|Withdrawal by Subject|1|||
161881818|NCT01537068|584609462|FG000|Overall Study|Lack of Efficacy|1|||
161881819|NCT01537068|584609463|FG001|Overall Study|Lack of Efficacy|0|||
161881820|NCT00072280|584609465|FG000|Treatment|Found ineligible|1|||
161881821|NCT00072280|584609466|FG001|Treatment|Found ineligible|2|||
161881822|NCT00072280|584609465|FG000|Follow-up|Early termination of study|2|||
161881823|NCT00072280|584609466|FG001|Follow-up|Early termination of study|2|||
161881824|NCT00833482|584609468|FG000|Days 11-20|Adverse Event|0|||
161881825|NCT00833482|584609469|FG001|Days 11-20|Adverse Event|2|||
161881826|NCT00833482|584609470|FG002|Days 11-20|Adverse Event|0|||
161881827|NCT00833482|584609471|FG003|Days 11-20|Adverse Event|0|||
161881828|NCT00833482|584609472|FG004|Days 11-20|Adverse Event|0|||
161881829|NCT00833482|584609473|FG005|Days 11-20|Adverse Event|0|||
161881830|NCT00833482|584609468|FG000|Days 11-20|Withdrawal by Subject|0|||
161881831|NCT00833482|584609469|FG001|Days 11-20|Withdrawal by Subject|1|||
161881832|NCT00833482|584609470|FG002|Days 11-20|Withdrawal by Subject|0|||
161881833|NCT00833482|584609471|FG003|Days 11-20|Withdrawal by Subject|0|||
161881834|NCT00833482|584609472|FG004|Days 11-20|Withdrawal by Subject|0|||
161881835|NCT00833482|584609473|FG005|Days 11-20|Withdrawal by Subject|0|||
161881836|NCT00833482|584609468|FG000|Days 21-30|Adverse Event|0|||
161881837|NCT00833482|584609469|FG001|Days 21-30|Adverse Event|0|||
161881838|NCT00833482|584609470|FG002|Days 21-30|Adverse Event|1|||
161881839|NCT00833482|584609471|FG003|Days 21-30|Adverse Event|0|||
161881840|NCT00833482|584609472|FG004|Days 21-30|Adverse Event|0|||
161881841|NCT00833482|584609473|FG005|Days 21-30|Adverse Event|0|||
161881842|NCT00833482|584609468|FG000|Days 21-30|Withdrawal by Subject|0|||
161881843|NCT00833482|584609469|FG001|Days 21-30|Withdrawal by Subject|0|||
161881844|NCT00833482|584609470|FG002|Days 21-30|Withdrawal by Subject|0|||
161881845|NCT00833482|584609471|FG003|Days 21-30|Withdrawal by Subject|0|||
161881846|NCT00833482|584609472|FG004|Days 21-30|Withdrawal by Subject|1|||
161881847|NCT00833482|584609473|FG005|Days 21-30|Withdrawal by Subject|0|||
161881848|NCT02234596|584609474|FG000|Overall Study|Participant not treated|2|||
161881849|NCT01944670|584611571|FG000|Overall Study|Lost to Follow-up|2|||
161881850|NCT02907593|584611572|FG000|Overall Study|Withdrawal by Subject|0|||
161881851|NCT02907593|584611573|FG001|Overall Study|Withdrawal by Subject|0|||
161881852|NCT02907593|584611574|FG002|Overall Study|Withdrawal by Subject|1|||
161881853|NCT02907593|584611575|FG003|Overall Study|Withdrawal by Subject|0|||
161881854|NCT05128773|584611584|FG000|Overall Study|Sponsor decision to terminate study|3|||
161881855|NCT05906836|584611586|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
161881856|NCT05906836|584611586|FG000|Overall Study|Lost to Follow-up|1|||
161881857|NCT04488497|584611587|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
161881858|NCT04488497|584611588|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
161881859|NCT04488497|584611587|FG000|Intervention|Physician Decision|2|||
161881860|NCT04488497|584611588|FG001|Intervention|Physician Decision|1|||
161881861|NCT04488497|584611587|FG000|Intervention|Withdrawal by Subject|5|||
161881862|NCT04488497|584611588|FG001|Intervention|Withdrawal by Subject|6|||
161881863|NCT04488497|584611587|FG000|Intervention|Lost to Follow-up|2|||
161881864|NCT04488497|584611588|FG001|Intervention|Lost to Follow-up|0|||
161881865|NCT04488497|584611587|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
161881866|NCT04488497|584611588|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
161881867|NCT04488497|584611587|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
161881868|NCT04488497|584611588|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
161881869|NCT01702532|584611589|FG000|Overall Study|Adverse Event|0|||
161881870|NCT01702532|584611590|FG001|Overall Study|Adverse Event|1|||
161881871|NCT03617861|584611591|FG000|Second Intervention (1 Day)|Adverse Event|0|||
161881872|NCT03617861|584611592|FG001|Second Intervention (1 Day)|Adverse Event|0|||
161881873|NCT03617861|584611593|FG002|Second Intervention (1 Day)|Adverse Event|1|||
161991564|NCT00106353|585018526|FG000|Part 1|Symptomatic deterioration|0|||
161991565|NCT00106353|585018527|FG001|Part 1|Symptomatic deterioration|0|||
161991566|NCT00106353|585018528|FG002|Part 1|Symptomatic deterioration|1|||
161991567|NCT00106353|585018529|FG003|Part 1|Symptomatic deterioration|0|||
161991568|NCT00106353|585018530|FG004|Part 1|Symptomatic deterioration|0|||
161881874|NCT03617861|584611594|FG003|Second Intervention (1 Day)|Adverse Event|0|||
161881875|NCT00623597|584611595|FG000|Overall Study|Failed to return|1|||
161991569|NCT00106353|585018531|FG005|Part 1|Symptomatic deterioration|0|||
161881876|NCT00623597|584611596|FG001|Overall Study|Failed to return|0|||
161881877|NCT01451164|584611597|FG000|Overall Study|Adverse Event|19|||
161881878|NCT01451164|584611598|FG001|Overall Study|Adverse Event|12|||
161881879|NCT01451164|584611599|FG002|Overall Study|Adverse Event|18|||
161881880|NCT01451164|584611600|FG003|Overall Study|Adverse Event|21|||
161881881|NCT01451164|584611597|FG000|Overall Study|Withdrawal Criteria|1|||
161881882|NCT01451164|584611598|FG001|Overall Study|Withdrawal Criteria|1|||
161881883|NCT01451164|584611599|FG002|Overall Study|Withdrawal Criteria|1|||
161881884|NCT01451164|584611600|FG003|Overall Study|Withdrawal Criteria|1|||
161881885|NCT01451164|584611597|FG000|Overall Study|Physician Decision|2|||
161881886|NCT01451164|584611598|FG001|Overall Study|Physician Decision|0|||
161881887|NCT01451164|584611599|FG002|Overall Study|Physician Decision|1|||
161991570|NCT00106353|585018532|FG006|Part 1|Symptomatic deterioration|0|||
161881888|NCT01451164|584611600|FG003|Overall Study|Physician Decision|0|||
161881889|NCT01451164|584611597|FG000|Overall Study|Withdrawal by Subject|14|||
161881890|NCT01451164|584611598|FG001|Overall Study|Withdrawal by Subject|11|||
161881891|NCT01451164|584611599|FG002|Overall Study|Withdrawal by Subject|16|||
161881892|NCT01451164|584611600|FG003|Overall Study|Withdrawal by Subject|17|||
161881893|NCT01451164|584611597|FG000|Overall Study|Protocol Violation|0|||
161881894|NCT01451164|584611598|FG001|Overall Study|Protocol Violation|1|||
161881895|NCT01451164|584611599|FG002|Overall Study|Protocol Violation|0|||
161881896|NCT01451164|584611600|FG003|Overall Study|Protocol Violation|0|||
161881897|NCT01451164|584611597|FG000|Overall Study|Lack of Efficacy|7|||
161881898|NCT01451164|584611598|FG001|Overall Study|Lack of Efficacy|9|||
161881899|NCT01451164|584611599|FG002|Overall Study|Lack of Efficacy|9|||
161881900|NCT01451164|584611600|FG003|Overall Study|Lack of Efficacy|7|||
161881901|NCT02963558|584611603|FG000|Overall Study|Withdrawn by investigator|1|||
161881902|NCT02963558|584611604|FG001|Overall Study|Withdrawn by investigator|0|||
161881903|NCT02963558|584611603|FG000|Overall Study|Withdrawal by Subject|0|||
161881904|NCT02963558|584611604|FG001|Overall Study|Withdrawal by Subject|1|||
161881905|NCT01214252|584611608|FG000|Overall Study|Not eligible per protocol|82|||
161881906|NCT01371877|584611610|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
161881907|NCT01371877|584611611|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
161881908|NCT05932225|584611612|FG000|Overall Study|Lost to Follow-up|0|||
161881909|NCT05932225|584611613|FG001|Overall Study|Lost to Follow-up|1|||
161881910|NCT05932225|584611614|FG002|Overall Study|Lost to Follow-up|0|||
161881911|NCT05932225|584611612|FG000|Overall Study|Withdrawal by Subject|1|||
161881912|NCT05932225|584611613|FG001|Overall Study|Withdrawal by Subject|0|||
161881913|NCT05932225|584611614|FG002|Overall Study|Withdrawal by Subject|0|||
161881914|NCT05932225|584611612|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
161881915|NCT05932225|584611613|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
161881916|NCT05932225|584611614|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
161881917|NCT00345878|584611615|FG000|Overall Study|Adverse Event|1|||
161881918|NCT00345878|584611616|FG001|Overall Study|Adverse Event|0|||
161881919|NCT00345878|584611615|FG000|Overall Study|Lost to Follow-up|2|||
161881920|NCT00345878|584611616|FG001|Overall Study|Lost to Follow-up|1|||
161881921|NCT00345878|584611615|FG000|Overall Study|Other|1|||
161881922|NCT00345878|584611616|FG001|Overall Study|Other|0|||
161881923|NCT02045732|584611617|FG000|Overall Study|At the discretion of the investigator|1|||
161881924|NCT02045732|584611618|FG001|Overall Study|At the discretion of the investigator|1|||
161881925|NCT01877551|584611622|FG000|Overall Study|Physician Decision|0|||
161881926|NCT01877551|584611623|FG001|Overall Study|Physician Decision|1|||
161881927|NCT02659514|584611624|FG000|Overall Study|Adverse Event|3|||
161881928|NCT02659514|584611625|FG001|Overall Study|Adverse Event|12|||
161881929|NCT02659514|584611624|FG000|Overall Study|Disease Progression|23|||
161881930|NCT02659514|584611625|FG001|Overall Study|Disease Progression|13|||
161881931|NCT02659514|584611624|FG000|Overall Study|Withdrawal by Subject|0|||
161881932|NCT02659514|584611625|FG001|Overall Study|Withdrawal by Subject|4|||
161881933|NCT02659514|584611624|FG000|Overall Study|Lost to Follow-up|0|||
161881934|NCT02659514|584611625|FG001|Overall Study|Lost to Follow-up|1|||
161881935|NCT02659514|584611624|FG000|Overall Study|Death|6|||
161881936|NCT02659514|584611625|FG001|Overall Study|Death|1|||
161881937|NCT02659514|584611624|FG000|Overall Study|Reason Unspecified|0|||
161881938|NCT02659514|584611625|FG001|Overall Study|Reason Unspecified|3|||
161881939|NCT03409107|584611626|FG000|Overall Study|Withdrawal by Subject|4|||
161881940|NCT03409107|584611627|FG001|Overall Study|Withdrawal by Subject|2|||
161881941|NCT03409107|584611626|FG000|Overall Study|Physician Decision|1|||
161881942|NCT03409107|584611627|FG001|Overall Study|Physician Decision|0|||
161881943|NCT03409107|584611626|FG000|Overall Study|Lost to Follow-up|7|||
161881944|NCT03409107|584611627|FG001|Overall Study|Lost to Follow-up|2|||
161881945|NCT03409107|584611626|FG000|Overall Study|Adverse Event|5|||
161881946|NCT03409107|584611627|FG001|Overall Study|Adverse Event|3|||
161881947|NCT05007041|584611643|FG000|Overall Study|Missing Diary Entries|0|||
161881948|NCT05007041|584611644|FG001|Overall Study|Missing Diary Entries|1|||
161881949|NCT04495816|584611645|FG000|Overall Study|Lost to Follow-up|10|||
161881950|NCT04495816|584611646|FG001|Overall Study|Lost to Follow-up|4|||
161881951|NCT04495816|584611645|FG000|Overall Study|Withdrawal by Subject|3|||
161991571|NCT00106353|585018526|FG000|Part 1|Entered follow-up phase|1|||
161991572|NCT00106353|585018527|FG001|Part 1|Entered follow-up phase|1|||
161881952|NCT04495816|584611646|FG001|Overall Study|Withdrawal by Subject|5|||
161881953|NCT00705718|584611647|FG000|Overall Study|Death|6|||
161881954|NCT00705718|584611648|FG001|Overall Study|Death|6|||
161881955|NCT00705718|584611647|FG000|Overall Study|Not due for Visit|0|||
161881956|NCT00705718|584611648|FG001|Overall Study|Not due for Visit|12|||
161881957|NCT00705718|584611647|FG000|Overall Study|Follow up not done|1|||
161881958|NCT00705718|584611648|FG001|Overall Study|Follow up not done|4|||
161881959|NCT01459718|584611652|FG000|Overall Study|Physician Decision|1|||
161881960|NCT01459718|584611652|FG000|Overall Study|Lost to Follow-up|1|||
161881961|NCT01459718|584611652|FG000|Overall Study|Adverse Event|1|||
161881962|NCT01258075|584611653|FG000|Overall Study|Adverse Event|8|||
161881963|NCT01258075|584611654|FG001|Overall Study|Adverse Event|3|||
161881964|NCT01258075|584611653|FG000|Overall Study|Lost to Follow-up|11|||
161881965|NCT01258075|584611654|FG001|Overall Study|Lost to Follow-up|6|||
161881966|NCT01258075|584611653|FG000|Overall Study|Withdrawal by Subject|10|||
161881967|NCT01258075|584611654|FG001|Overall Study|Withdrawal by Subject|7|||
161881968|NCT01258075|584611653|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
161881969|NCT01258075|584611654|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
161881970|NCT01258075|584611653|FG000|Overall Study|Other|12|||
161881971|NCT01258075|584611654|FG001|Overall Study|Other|5|||
161881972|NCT04021121|584611659|FG000|Overall Study|Death|3|||
161881973|NCT04021121|584611660|FG001|Overall Study|Death|3|||
161881974|NCT04021121|584611661|FG002|Overall Study|Death|5|||
161881975|NCT04021121|584611662|FG003|Overall Study|Death|4|||
161881976|NCT06011161|584611663|FG000|Overall Study|Withdrawal by Subject|2|||
161881977|NCT06011161|584611663|FG000|Overall Study|Lost to Follow-up|5|||
161881978|NCT02291601|584611666|FG000|Abdomen|Did not qualify|333|||
161881979|NCT02291601|584611667|FG001|Abdomen|Did not qualify|54|||
161881980|NCT02291601|584611668|FG002|Abdomen|Did not qualify|339|||
161881981|NCT02291601|584611666|FG000|Groin|Did not qualify|183|||
161881982|NCT02291601|584611667|FG001|Groin|Did not qualify|30|||
161881983|NCT02291601|584611668|FG002|Groin|Did not qualify|177|||
161881984|NCT01597375|584611676|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
161881985|NCT01597375|584611677|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
161881986|NCT01597375|584611676|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
161881987|NCT01597375|584611677|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
161881988|NCT01597375|584611676|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
161881989|NCT01597375|584611677|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
161881990|NCT01597375|584611676|FG000|Washout (2 Weeks)|Adverse Event|1|||
161881991|NCT01597375|584611677|FG001|Washout (2 Weeks)|Adverse Event|0|||
161881992|NCT01597375|584611676|FG000|Second Intervention|Failed to react at both Aspirin|1|||
161881993|NCT01597375|584611677|FG001|Second Intervention|Failed to react at both Aspirin|1|||
161881994|NCT04017832|584611680|FG000|Overall Study|Withdrawal by Subject|13|||
161881995|NCT04017832|584611681|FG001|Overall Study|Withdrawal by Subject|12|||
161881996|NCT04017832|584611682|FG002|Overall Study|Withdrawal by Subject|21|||
161881997|NCT04017832|584611683|FG003|Overall Study|Withdrawal by Subject|7|||
161881998|NCT04017832|584611680|FG000|Overall Study|Lost to Follow-up|0|||
161881999|NCT04017832|584611681|FG001|Overall Study|Lost to Follow-up|3|||
161882000|NCT04017832|584611682|FG002|Overall Study|Lost to Follow-up|3|||
161882001|NCT04017832|584611683|FG003|Overall Study|Lost to Follow-up|1|||
161882002|NCT04017832|584611680|FG000|Overall Study|Physician Decision|1|||
161882003|NCT04017832|584611681|FG001|Overall Study|Physician Decision|1|||
161882004|NCT04017832|584611682|FG002|Overall Study|Physician Decision|1|||
161882005|NCT04017832|584611683|FG003|Overall Study|Physician Decision|1|||
161882006|NCT04017832|584611680|FG000|Overall Study|Death|2|||
161882007|NCT04017832|584611681|FG001|Overall Study|Death|2|||
161882008|NCT04017832|584611682|FG002|Overall Study|Death|1|||
161882009|NCT04017832|584611683|FG003|Overall Study|Death|0|||
161882010|NCT02375555|584611684|FG000|Induction Period|Adverse Event|7|||
161882011|NCT02375555|584611684|FG000|Induction Period|Withdrawal by Subject|2|||
161882012|NCT02375555|584611684|FG000|Induction Period|Other|1|||
161882013|NCT02375555|584611684|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
161882014|NCT02375555|584611684|FG000|Maintenance Period|Adverse Event|2|||
161882015|NCT02375555|584611684|FG000|Maintenance Period|Withdrawal by Subject|4|||
161882016|NCT02375555|584611684|FG000|Maintenance Period|Death|1|||
161882017|NCT02375555|584611684|FG000|Maintenance Period|Disease Progression|5|||
161882018|NCT02375555|584611684|FG000|Maintenance Period|Patient Non-compliance|1|||
161882019|NCT02375555|584611684|FG000|Maintenance Period|Still on maintenance|16|||
161882020|NCT01744184|584611690|FG000|Overall Study|Adverse Event|1|||
161882021|NCT01744184|584611691|FG001|Overall Study|Adverse Event|0|||
161882022|NCT01744184|584611690|FG000|Overall Study|Withdrawal by Subject|0|||
161882023|NCT01744184|584611691|FG001|Overall Study|Withdrawal by Subject|1|||
161882024|NCT02091986|584611692|FG000|Overall Study|7 rand in error 1 patient decision|2|||
161882025|NCT02091986|584611693|FG001|Overall Study|7 rand in error 1 patient decision|3|||
161882026|NCT02091986|584611694|FG002|Overall Study|7 rand in error 1 patient decision|3|||
161882027|NCT02091986|584611692|FG000|Overall Study|Lost to Follow-up|1|||
161882028|NCT02091986|584611693|FG001|Overall Study|Lost to Follow-up|0|||
161882029|NCT02091986|584611694|FG002|Overall Study|Lost to Follow-up|0|||
161882030|NCT02091986|584611692|FG000|Overall Study|Withdrawal by Subject|4|||
161882031|NCT02091986|584611693|FG001|Overall Study|Withdrawal by Subject|8|||
161882032|NCT02091986|584611694|FG002|Overall Study|Withdrawal by Subject|3|||
161882033|NCT02091986|584611692|FG000|Overall Study|Adverse Event|0|||
161882034|NCT02091986|584611693|FG001|Overall Study|Adverse Event|0|||
161882035|NCT02091986|584611694|FG002|Overall Study|Adverse Event|2|||
161882036|NCT02841280|584611695|FG000|Overall Study|Adverse Event|2|||
161882037|NCT02841280|584611696|FG001|Overall Study|Adverse Event|1|||
161882038|NCT02841280|584611695|FG000|Overall Study|Death|1|||
161882039|NCT02841280|584611696|FG001|Overall Study|Death|0|||
161882040|NCT02841280|584611695|FG000|Overall Study|Lost to Follow-up|2|||
161882041|NCT02841280|584611696|FG001|Overall Study|Lost to Follow-up|2|||
161882042|NCT02841280|584611695|FG000|Overall Study|Withdrawal by Subject|7|||
161882043|NCT02841280|584611696|FG001|Overall Study|Withdrawal by Subject|3|||
161882044|NCT02841280|584611695|FG000|Overall Study|Stop Point: BP above threshold|2|||
161882045|NCT02841280|584611696|FG001|Overall Study|Stop Point: BP above threshold|0|||
161882046|NCT00125242|584611697|FG000|Overall Study|did not qualify|7|||
161882047|NCT00125242|584611698|FG001|Overall Study|did not qualify|2|||
161882048|NCT01664949|584611699|FG000|Overall Study|Adverse Event|11|||
161882049|NCT01664949|584611700|FG001|Overall Study|Adverse Event|12|||
161882050|NCT01664949|584611699|FG000|Overall Study|Lack of Efficacy|1|||
161882051|NCT01664949|584611700|FG001|Overall Study|Lack of Efficacy|1|||
161882052|NCT01664949|584611699|FG000|Overall Study|Lost to Follow-up|1|||
161882053|NCT01664949|584611700|FG001|Overall Study|Lost to Follow-up|2|||
161882054|NCT01664949|584611699|FG000|Overall Study|Personal Reasons|3|||
161882055|NCT01664949|584611700|FG001|Overall Study|Personal Reasons|4|||
161882056|NCT01664949|584611699|FG000|Overall Study|Protocol Violation|5|||
161882057|NCT01664949|584611700|FG001|Overall Study|Protocol Violation|5|||
161882058|NCT01664949|584611699|FG000|Overall Study|Other Miscellaneous Reasons|3|||
161882059|NCT01664949|584611700|FG001|Overall Study|Other Miscellaneous Reasons|1|||
161882060|NCT02727777|584611707|FG000|Overall Study|Screen Failure|2|||
161882061|NCT02727777|584611708|FG001|Overall Study|Screen Failure|0|||
161882062|NCT02727777|584611709|FG002|Overall Study|Screen Failure|0|||
161882063|NCT02727777|584611707|FG000|Overall Study|Progressive disease|2|||
161882064|NCT02727777|584611708|FG001|Overall Study|Progressive disease|0|||
161882065|NCT02727777|584611709|FG002|Overall Study|Progressive disease|0|||
161882066|NCT00957268|584611710|FG000|Overall Study|Voluntary Withdrawal|0|||
161882067|NCT00957268|584611711|FG001|Overall Study|Voluntary Withdrawal|0|||
161882068|NCT00957268|584611712|FG002|Overall Study|Voluntary Withdrawal|1|||
161882069|NCT00957268|584611713|FG003|Overall Study|Voluntary Withdrawal|0|||
161882070|NCT00957268|584611714|FG004|Overall Study|Voluntary Withdrawal|0|||
161882071|NCT03003494|584611715|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
161882072|NCT01738503|584611716|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
161882073|NCT01738503|584611717|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
161882074|NCT01738503|584611718|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
161882075|NCT01738503|584611719|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
161882076|NCT01738503|584611720|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
161882077|NCT01738503|584611721|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
161882078|NCT01738503|584611722|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
161882079|NCT01738503|584611716|FG000|Treatment Period|Adverse Event|0|||
161882080|NCT01738503|584611717|FG001|Treatment Period|Adverse Event|1|||
161882081|NCT01738503|584611718|FG002|Treatment Period|Adverse Event|0|||
161882082|NCT01738503|584611719|FG003|Treatment Period|Adverse Event|1|||
161882083|NCT01738503|584611720|FG004|Treatment Period|Adverse Event|2|||
161882084|NCT01738503|584611721|FG005|Treatment Period|Adverse Event|2|||
161882085|NCT01738503|584611722|FG006|Treatment Period|Adverse Event|2|||
161882086|NCT01738503|584611716|FG000|Treatment Period|Lost to Follow-up|0|||
161882087|NCT01738503|584611717|FG001|Treatment Period|Lost to Follow-up|0|||
161882088|NCT01738503|584611718|FG002|Treatment Period|Lost to Follow-up|3|||
161882089|NCT01738503|584611719|FG003|Treatment Period|Lost to Follow-up|4|||
161882090|NCT01738503|584611720|FG004|Treatment Period|Lost to Follow-up|1|||
161882091|NCT01738503|584611721|FG005|Treatment Period|Lost to Follow-up|1|||
161882092|NCT01738503|584611722|FG006|Treatment Period|Lost to Follow-up|5|||
161882093|NCT01738503|584611716|FG000|Treatment Period|Withdrawal by Subject|0|||
161882094|NCT01738503|584611717|FG001|Treatment Period|Withdrawal by Subject|1|||
161882095|NCT01738503|584611718|FG002|Treatment Period|Withdrawal by Subject|0|||
161882096|NCT01738503|584611719|FG003|Treatment Period|Withdrawal by Subject|1|||
161882097|NCT01738503|584611720|FG004|Treatment Period|Withdrawal by Subject|1|||
161882098|NCT01738503|584611721|FG005|Treatment Period|Withdrawal by Subject|1|||
161882099|NCT01738503|584611722|FG006|Treatment Period|Withdrawal by Subject|1|||
161882100|NCT01738503|584611716|FG000|Treatment Period|Protocol Violation|0|||
161882101|NCT01738503|584611717|FG001|Treatment Period|Protocol Violation|3|||
161882102|NCT01738503|584611718|FG002|Treatment Period|Protocol Violation|1|||
161882103|NCT01738503|584611719|FG003|Treatment Period|Protocol Violation|0|||
161882104|NCT01738503|584611720|FG004|Treatment Period|Protocol Violation|4|||
161882105|NCT01738503|584611721|FG005|Treatment Period|Protocol Violation|2|||
161882106|NCT01738503|584611722|FG006|Treatment Period|Protocol Violation|0|||
161882107|NCT01738503|584611716|FG000|Treatment Period|Other|0|||
161882108|NCT01738503|584611717|FG001|Treatment Period|Other|0|||
161882109|NCT01738503|584611718|FG002|Treatment Period|Other|1|||
161882110|NCT01738503|584611719|FG003|Treatment Period|Other|0|||
161882111|NCT01738503|584611720|FG004|Treatment Period|Other|0|||
161882112|NCT01738503|584611721|FG005|Treatment Period|Other|0|||
161882113|NCT01738503|584611722|FG006|Treatment Period|Other|0|||
161882114|NCT01738503|584611716|FG000|PET Imaging Sub-study|Adverse Event|0|||
161882115|NCT01738503|584611717|FG001|PET Imaging Sub-study|Adverse Event|0|||
161882116|NCT01738503|584611718|FG002|PET Imaging Sub-study|Adverse Event|0|||
161882117|NCT01738503|584611719|FG003|PET Imaging Sub-study|Adverse Event|0|||
161882118|NCT01738503|584611720|FG004|PET Imaging Sub-study|Adverse Event|0|||
161882119|NCT01738503|584611721|FG005|PET Imaging Sub-study|Adverse Event|1|||
161882120|NCT01738503|584611722|FG006|PET Imaging Sub-study|Adverse Event|0|||
161882121|NCT01738503|584611716|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161882122|NCT01738503|584611717|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161882123|NCT01738503|584611718|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161882124|NCT01738503|584611719|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161882125|NCT01738503|584611720|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161882126|NCT01738503|584611721|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
161882127|NCT01738503|584611722|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
161882128|NCT01340027|584611723|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
161882129|NCT01340027|584611724|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
161882130|NCT01340027|584611725|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
161882131|NCT01340027|584611726|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
161882132|NCT01340027|584611727|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
161882133|NCT01340027|584611728|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
161882134|NCT01340027|584611729|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
161882135|NCT01340027|584611730|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
161882136|NCT01340027|584611731|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
161882137|NCT01340027|584611732|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
161882138|NCT01340027|584611733|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
161882139|NCT01340027|584611734|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
161882140|NCT01340027|584611723|FG000|Overall Study|Adverse Event|0|||
161882141|NCT01340027|584611724|FG001|Overall Study|Adverse Event|1|||
161778154|NCT03701516|584228936|FG001|Period 1|Withdrawal by Subject|1|||
161778155|NCT03701516|584228935|FG000|Period 2|failed to meet all eligibility creiteria|1|||
161778156|NCT03701516|584228936|FG001|Period 2|failed to meet all eligibility creiteria|0|||
161778157|NCT03701516|584228935|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
161778158|NCT03701516|584228936|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
161778159|NCT00478673|584228937|FG000|30-Days Post-Procedure|Death|2|||
161778160|NCT00478673|584228937|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
161778161|NCT00478673|584228937|FG000|30-Days Post-Procedure|Missed Visit|7|||
161778162|NCT00478673|584228937|FG000|12-Months Post-Procedure|Death|23|||
161778163|NCT00478673|584228937|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
161778164|NCT00478673|584228937|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
161778165|NCT00478673|584228937|FG000|12-Months Post-Procedure|Missed Visit|25|||
161778166|NCT00478673|584228937|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
161778167|NCT03930615|584228938|FG000|Overall Study|Death|9|||
161778168|NCT03930615|584228939|FG001|Overall Study|Death|3|||
161778169|NCT03930615|584228938|FG000|Overall Study|Lost to Follow-up|1|||
161778170|NCT03930615|584228939|FG001|Overall Study|Lost to Follow-up|2|||
161778171|NCT03930615|584228938|FG000|Overall Study|Physician Decision|3|||
161778172|NCT03930615|584228939|FG001|Overall Study|Physician Decision|4|||
161778173|NCT03930615|584228938|FG000|Overall Study|Withdrawal by Subject|13|||
161778174|NCT03930615|584228939|FG001|Overall Study|Withdrawal by Subject|2|||
161778175|NCT03930615|584228938|FG000|Overall Study|Not treated|1|||
161778176|NCT03930615|584228939|FG001|Overall Study|Not treated|1|||
161778177|NCT02864953|584228940|FG000|Overall Study|Adverse Event|22|||
161778178|NCT02864953|584228941|FG001|Overall Study|Adverse Event|19|||
161778179|NCT02864953|584228940|FG000|Overall Study|Withdrawal by Subject|1|||
161778180|NCT02864953|584228941|FG001|Overall Study|Withdrawal by Subject|0|||
161778181|NCT02864953|584228940|FG000|Overall Study|Physician Decision|4|||
161778182|NCT02864953|584228941|FG001|Overall Study|Physician Decision|2|||
161778183|NCT02864953|584228940|FG000|Overall Study|Death|3|||
161778184|NCT02864953|584228941|FG001|Overall Study|Death|13|||
161778185|NCT02864953|584228940|FG000|Overall Study|Reason not specified|14|||
161778186|NCT02864953|584228941|FG001|Overall Study|Reason not specified|12|||
161778187|NCT02864953|584228940|FG000|Overall Study|Withdrew Prior to Dosing|9|||
161778188|NCT02864953|584228941|FG001|Overall Study|Withdrew Prior to Dosing|8|||
161778189|NCT00358670|584228942|FG000|Overall Study|Adverse Event|26|||
161778190|NCT00358670|584228943|FG001|Overall Study|Adverse Event|29|||
161778191|NCT00358670|584228942|FG000|Overall Study|Lack of Efficacy|20|||
161778192|NCT00358670|584228943|FG001|Overall Study|Lack of Efficacy|23|||
161778193|NCT00358670|584228942|FG000|Overall Study|Protocol Violation|6|||
161778194|NCT00358670|584228943|FG001|Overall Study|Protocol Violation|9|||
161778195|NCT00358670|584228942|FG000|Overall Study|Lost to Follow-up|4|||
161778196|NCT00358670|584228943|FG001|Overall Study|Lost to Follow-up|5|||
161778197|NCT00358670|584228942|FG000|Overall Study|Withdrawal by Subject|13|||
161778198|NCT00358670|584228943|FG001|Overall Study|Withdrawal by Subject|24|||
161778199|NCT00358670|584228942|FG000|Overall Study|Protocol Defined Clinical Event|0|||
161778200|NCT00358670|584228943|FG001|Overall Study|Protocol Defined Clinical Event|1|||
161778201|NCT00358670|584228942|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
161882142|NCT01340027|584611725|FG002|Overall Study|Adverse Event|2|||
161882143|NCT01340027|584611726|FG003|Overall Study|Adverse Event|0|||
161882144|NCT01340027|584611727|FG004|Overall Study|Adverse Event|1|||
161882145|NCT01340027|584611728|FG005|Overall Study|Adverse Event|2|||
161882146|NCT01340027|584611729|FG006|Overall Study|Adverse Event|2|||
161882147|NCT01340027|584611730|FG007|Overall Study|Adverse Event|1|||
161882148|NCT01340027|584611731|FG008|Overall Study|Adverse Event|4|||
161882149|NCT01340027|584611732|FG009|Overall Study|Adverse Event|1|||
161882150|NCT01340027|584611733|FG010|Overall Study|Adverse Event|1|||
161882151|NCT01340027|584611734|FG011|Overall Study|Adverse Event|3|||
161882152|NCT01340027|584611723|FG000|Overall Study|Lack of Efficacy|0|||
161882153|NCT01340027|584611724|FG001|Overall Study|Lack of Efficacy|0|||
161882154|NCT01340027|584611725|FG002|Overall Study|Lack of Efficacy|0|||
161882155|NCT01340027|584611726|FG003|Overall Study|Lack of Efficacy|0|||
161882156|NCT01340027|584611727|FG004|Overall Study|Lack of Efficacy|0|||
161882157|NCT01340027|584611728|FG005|Overall Study|Lack of Efficacy|0|||
161882158|NCT01340027|584611729|FG006|Overall Study|Lack of Efficacy|1|||
161882159|NCT01340027|584611730|FG007|Overall Study|Lack of Efficacy|1|||
161882160|NCT01340027|584611731|FG008|Overall Study|Lack of Efficacy|1|||
161882161|NCT01340027|584611732|FG009|Overall Study|Lack of Efficacy|0|||
161882162|NCT01340027|584611733|FG010|Overall Study|Lack of Efficacy|0|||
161882163|NCT01340027|584611734|FG011|Overall Study|Lack of Efficacy|0|||
161882164|NCT01340027|584611723|FG000|Overall Study|Lost to Follow-up|0|||
161882165|NCT01340027|584611724|FG001|Overall Study|Lost to Follow-up|1|||
161882166|NCT01340027|584611725|FG002|Overall Study|Lost to Follow-up|0|||
161882167|NCT01340027|584611726|FG003|Overall Study|Lost to Follow-up|0|||
161882168|NCT01340027|584611727|FG004|Overall Study|Lost to Follow-up|0|||
161882169|NCT01340027|584611728|FG005|Overall Study|Lost to Follow-up|0|||
161882170|NCT01340027|584611729|FG006|Overall Study|Lost to Follow-up|1|||
161882171|NCT01340027|584611730|FG007|Overall Study|Lost to Follow-up|0|||
161882172|NCT01340027|584611731|FG008|Overall Study|Lost to Follow-up|0|||
161882173|NCT01340027|584611732|FG009|Overall Study|Lost to Follow-up|1|||
161882174|NCT01340027|584611733|FG010|Overall Study|Lost to Follow-up|0|||
161882175|NCT01340027|584611734|FG011|Overall Study|Lost to Follow-up|0|||
161882176|NCT01340027|584611723|FG000|Overall Study|Protocol Violation|1|||
161882177|NCT01340027|584611724|FG001|Overall Study|Protocol Violation|2|||
161882178|NCT01340027|584611725|FG002|Overall Study|Protocol Violation|0|||
161882179|NCT01340027|584611726|FG003|Overall Study|Protocol Violation|0|||
161882180|NCT01340027|584611727|FG004|Overall Study|Protocol Violation|6|||
161882181|NCT01340027|584611728|FG005|Overall Study|Protocol Violation|0|||
161882182|NCT01340027|584611729|FG006|Overall Study|Protocol Violation|0|||
161882183|NCT01340027|584611730|FG007|Overall Study|Protocol Violation|1|||
161882184|NCT01340027|584611731|FG008|Overall Study|Protocol Violation|2|||
161882185|NCT01340027|584611732|FG009|Overall Study|Protocol Violation|2|||
161882186|NCT01340027|584611733|FG010|Overall Study|Protocol Violation|0|||
161882187|NCT01340027|584611734|FG011|Overall Study|Protocol Violation|0|||
161882188|NCT01340027|584611723|FG000|Overall Study|Withdrawal by Subject|4|||
161882189|NCT01340027|584611724|FG001|Overall Study|Withdrawal by Subject|3|||
161882190|NCT01340027|584611725|FG002|Overall Study|Withdrawal by Subject|1|||
161882191|NCT01340027|584611726|FG003|Overall Study|Withdrawal by Subject|3|||
161882192|NCT01340027|584611727|FG004|Overall Study|Withdrawal by Subject|3|||
161882193|NCT01340027|584611728|FG005|Overall Study|Withdrawal by Subject|2|||
161882194|NCT01340027|584611729|FG006|Overall Study|Withdrawal by Subject|3|||
161882195|NCT01340027|584611730|FG007|Overall Study|Withdrawal by Subject|4|||
161882196|NCT01340027|584611731|FG008|Overall Study|Withdrawal by Subject|1|||
161882197|NCT01340027|584611732|FG009|Overall Study|Withdrawal by Subject|2|||
161882198|NCT01340027|584611733|FG010|Overall Study|Withdrawal by Subject|0|||
161882199|NCT01340027|584611734|FG011|Overall Study|Withdrawal by Subject|1|||
161882200|NCT01340027|584611723|FG000|Overall Study|Miscellaneous|0|||
161882201|NCT01340027|584611724|FG001|Overall Study|Miscellaneous|0|||
161882202|NCT01340027|584611725|FG002|Overall Study|Miscellaneous|0|||
161882203|NCT01340027|584611726|FG003|Overall Study|Miscellaneous|1|||
161882204|NCT01340027|584611727|FG004|Overall Study|Miscellaneous|0|||
161882205|NCT01340027|584611728|FG005|Overall Study|Miscellaneous|0|||
161882206|NCT01340027|584611729|FG006|Overall Study|Miscellaneous|0|||
161882207|NCT01340027|584611730|FG007|Overall Study|Miscellaneous|0|||
161882208|NCT01340027|584611731|FG008|Overall Study|Miscellaneous|0|||
161882209|NCT01340027|584611732|FG009|Overall Study|Miscellaneous|0|||
161882210|NCT01340027|584611733|FG010|Overall Study|Miscellaneous|1|||
161882211|NCT01340027|584611734|FG011|Overall Study|Miscellaneous|0|||
161882212|NCT03005327|584611735|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
161991573|NCT00106353|585018528|FG002|Part 1|Entered follow-up phase|0|||
161991574|NCT00106353|585018529|FG003|Part 1|Entered follow-up phase|1|||
161882213|NCT03005327|584611736|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
161882214|NCT03005327|584611737|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
161882215|NCT03005327|584611738|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
161882216|NCT03005327|584611735|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161882217|NCT03005327|584611736|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161882218|NCT03005327|584611737|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161882219|NCT03005327|584611738|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161882220|NCT01794793|584611740|FG000|Treatment Period|Withdrawal by Subject|24|||
161882221|NCT01794793|584611740|FG000|Treatment Period|Lack of Efficacy|22|||
161882222|NCT01794793|584611740|FG000|Treatment Period|Adverse Event|17|||
161882223|NCT01794793|584611740|FG000|Treatment Period|Physician Decision|14|||
161882224|NCT01794793|584611740|FG000|Treatment Period|Lost to Follow-up|7|||
161882225|NCT01794793|584611740|FG000|Treatment Period|Death|6|||
161882226|NCT01794793|584611740|FG000|Treatment Period|Protocol Violation|5|||
161882227|NCT01794793|584611740|FG000|Treatment Period|administrative problem|3|||
161882228|NCT01794793|584611740|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
161882229|NCT01794793|584611740|FG000|Post-treatment Follow-up|Adverse Event|8|||
161882230|NCT01794793|584611740|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
161882231|NCT01794793|584611740|FG000|Post-treatment Follow-up|administrative problem|5|||
161882232|NCT01794793|584611740|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
161882233|NCT01794793|584611740|FG000|Post-treatment Follow-up|Protocol Violation|3|||
161882234|NCT04852679|584611741|FG000|Main Intervention Period|Withdrawal by Subject|3|||
161882235|NCT04852679|584611741|FG000|Main Intervention Period|Adverse Event|1|||
161882236|NCT04852679|584611741|FG000|Main Intervention Period|Progressive Disease|16|||
161882237|NCT04852679|584611741|FG000|Main Intervention Period|Refused study visit|1|||
161882238|NCT04852679|584611741|FG000|Independent Injection Period|Missed study visit|1|||
161882239|NCT02000882|584612841|FG000|Overall Study|Adverse Event|3|||
161882240|NCT02000882|584612841|FG000|Overall Study|Physician Decision|2|||
161882241|NCT02000882|584612841|FG000|Overall Study|Withdrawal by Subject|1|||
161882242|NCT02417961|584612842|FG000|Overall Study|Adverse Event|1|||
161882243|NCT02417961|584612842|FG000|Overall Study|Lost to Follow-up|1|||
161882244|NCT02417961|584612842|FG000|Overall Study|Withdrawal by Subject|2|||
161882245|NCT01390428|584612843|FG000|Overall Study|Elective Surgery|0|||
161882246|NCT01390428|584612844|FG001|Overall Study|Elective Surgery|0|||
161882247|NCT01390428|584612845|FG002|Overall Study|Elective Surgery|0|||
161882248|NCT01390428|584612846|FG003|Overall Study|Elective Surgery|0|||
161882249|NCT01390428|584612847|FG004|Overall Study|Elective Surgery|1|||
161991575|NCT00106353|585018530|FG004|Part 1|Entered follow-up phase|0|||
161991576|NCT00106353|585018531|FG005|Part 1|Entered follow-up phase|0|||
161991577|NCT00106353|585018532|FG006|Part 1|Entered follow-up phase|0|||
161991578|NCT00106353|585018526|FG000|Part 1|Adverse Event|0|||
161991579|NCT00106353|585018527|FG001|Part 1|Adverse Event|0|||
161991580|NCT00106353|585018528|FG002|Part 1|Adverse Event|0|||
161991581|NCT00106353|585018529|FG003|Part 1|Adverse Event|1|||
161991582|NCT00106353|585018530|FG004|Part 1|Adverse Event|0|||
161991583|NCT00106353|585018531|FG005|Part 1|Adverse Event|0|||
161991584|NCT00106353|585018532|FG006|Part 1|Adverse Event|0|||
161991585|NCT00106353|585018526|FG000|Part 2|Disease progression|0|||
161991586|NCT00106353|585018527|FG001|Part 2|Disease progression|0|||
161991587|NCT00106353|585018528|FG002|Part 2|Disease progression|0|||
161991588|NCT00106353|585018529|FG003|Part 2|Disease progression|0|||
161991589|NCT00106353|585018530|FG004|Part 2|Disease progression|8|||
161991590|NCT00106353|585018531|FG005|Part 2|Disease progression|14|||
161991591|NCT00106353|585018532|FG006|Part 2|Disease progression|13|||
161991592|NCT00106353|585018526|FG000|Part 2|Death|0|||
161991593|NCT00106353|585018527|FG001|Part 2|Death|0|||
161991594|NCT00106353|585018528|FG002|Part 2|Death|0|||
161991595|NCT00106353|585018529|FG003|Part 2|Death|0|||
161991596|NCT00106353|585018530|FG004|Part 2|Death|3|||
161991597|NCT00106353|585018531|FG005|Part 2|Death|0|||
161991598|NCT00106353|585018532|FG006|Part 2|Death|1|||
161991599|NCT00106353|585018526|FG000|Part 2|Symptomatic deterioration|0|||
161991600|NCT00106353|585018527|FG001|Part 2|Symptomatic deterioration|0|||
161991601|NCT00106353|585018528|FG002|Part 2|Symptomatic deterioration|0|||
161991602|NCT00106353|585018529|FG003|Part 2|Symptomatic deterioration|0|||
161991603|NCT00106353|585018530|FG004|Part 2|Symptomatic deterioration|3|||
161991604|NCT00106353|585018531|FG005|Part 2|Symptomatic deterioration|0|||
161991605|NCT00106353|585018532|FG006|Part 2|Symptomatic deterioration|0|||
161991606|NCT00106353|585018526|FG000|Part 2|Adverse Event|0|||
161991607|NCT00106353|585018527|FG001|Part 2|Adverse Event|0|||
161991608|NCT00106353|585018528|FG002|Part 2|Adverse Event|0|||
161991609|NCT00106353|585018529|FG003|Part 2|Adverse Event|0|||
161882250|NCT01390428|584612848|FG005|Overall Study|Elective Surgery|0|||
161882251|NCT01390428|584612843|FG000|Overall Study|Withdrawal by Subject|0|||
161882252|NCT01390428|584612844|FG001|Overall Study|Withdrawal by Subject|0|||
161882253|NCT01390428|584612845|FG002|Overall Study|Withdrawal by Subject|1|||
161991610|NCT00106353|585018530|FG004|Part 2|Adverse Event|0|||
161991611|NCT00106353|585018531|FG005|Part 2|Adverse Event|2|||
161882254|NCT01390428|584612846|FG003|Overall Study|Withdrawal by Subject|0|||
161991612|NCT00106353|585018532|FG006|Part 2|Adverse Event|1|||
161991613|NCT00106353|585018526|FG000|Part 2|Other|0|||
161991614|NCT00106353|585018527|FG001|Part 2|Other|0|||
161991615|NCT00106353|585018528|FG002|Part 2|Other|0|||
161991616|NCT00106353|585018529|FG003|Part 2|Other|0|||
161991617|NCT00106353|585018530|FG004|Part 2|Other|1|||
161991618|NCT00106353|585018531|FG005|Part 2|Other|1|||
161991619|NCT00106353|585018532|FG006|Part 2|Other|1|||
161991620|NCT00106353|585018526|FG000|Part 2|Withdrawal by Subject|0|||
161991621|NCT00106353|585018527|FG001|Part 2|Withdrawal by Subject|0|||
161991622|NCT00106353|585018528|FG002|Part 2|Withdrawal by Subject|0|||
161991623|NCT00106353|585018529|FG003|Part 2|Withdrawal by Subject|0|||
161991624|NCT00106353|585018530|FG004|Part 2|Withdrawal by Subject|1|||
161991625|NCT00106353|585018531|FG005|Part 2|Withdrawal by Subject|0|||
161991626|NCT00106353|585018532|FG006|Part 2|Withdrawal by Subject|0|||
161991627|NCT00106353|585018526|FG000|Part 2|Physician Decision|0|||
161991628|NCT00106353|585018527|FG001|Part 2|Physician Decision|0|||
161991629|NCT00106353|585018528|FG002|Part 2|Physician Decision|0|||
161991630|NCT00106353|585018529|FG003|Part 2|Physician Decision|0|||
161991631|NCT00106353|585018530|FG004|Part 2|Physician Decision|0|||
161991632|NCT00106353|585018531|FG005|Part 2|Physician Decision|1|||
161991633|NCT00106353|585018532|FG006|Part 2|Physician Decision|0|||
161991634|NCT04039217|585018533|FG000|Overall Study|Lost to Follow-up|1|||
161991635|NCT01278797|585018534|FG000|Period 1|Adverse Event|0|||
161778202|NCT00358670|584228943|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
161778203|NCT00358670|584228942|FG000|Overall Study|Administrative|153|||
161778204|NCT00358670|584228943|FG001|Overall Study|Administrative|125|||
161778205|NCT00981019|584228944|FG000|Overall Study|Did not respond|65|||
161778206|NCT00981019|584228944|FG000|Overall Study|Did not match target population|94|||
161778207|NCT00981019|584228944|FG000|Overall Study|Inadvertent exclusion|239|||
161778208|NCT00981019|584228944|FG000|Overall Study|Hit the survey after closure|79|||
161778209|NCT00865306|584228945|FG000|Controlled Trial|Lost to Follow-up|1|||
161778210|NCT00865306|584228946|FG001|Controlled Trial|Lost to Follow-up|1|||
161778211|NCT00865306|584228945|FG000|Controlled Trial|Difficulty commuting|2|||
161778212|NCT00865306|584228946|FG001|Controlled Trial|Difficulty commuting|0|||
161778213|NCT00865306|584228945|FG000|Controlled Trial|Improved btw baseline and first session|1|||
161778214|NCT00865306|584228946|FG001|Controlled Trial|Improved btw baseline and first session|0|||
161778215|NCT00865306|584228945|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
161778216|NCT00865306|584228946|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
161778217|NCT00865306|584228945|FG000|Controlled Trial|Withdrawal by Subject|0|||
161778218|NCT00865306|584228946|FG001|Controlled Trial|Withdrawal by Subject|1|||
161778219|NCT05083559|584228947|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
161778220|NCT05083559|584228948|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
161778221|NCT05083559|584228947|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
161778222|NCT05083559|584228948|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
161778223|NCT05083559|584228947|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
161778224|NCT05083559|584228948|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
161778225|NCT02704130|584228950|FG000|Overall Study|Physician Decision|5|||
161778226|NCT02704130|584228951|FG001|Overall Study|Physician Decision|3|||
161778227|NCT01023022|584228954|FG000|Overall Study|Death|5|||
161778228|NCT01023022|584228954|FG000|Overall Study|Lost to Follow-up|7|||
161778229|NCT01023022|584228954|FG000|Overall Study|due to technical issues|2|||
161778230|NCT00359073|584230373|FG000|Overall Study|Withdrawal by Subject|1|||
161778231|NCT00359073|584230374|FG001|Overall Study|Withdrawal by Subject|1|||
161778232|NCT00359073|584230373|FG000|Overall Study|Eligibility criteria no longer met|3|||
161778233|NCT00359073|584230374|FG001|Overall Study|Eligibility criteria no longer met|0|||
161778234|NCT00359073|584230373|FG000|Overall Study|developed RV16 antibody|0|||
161778235|NCT00359073|584230374|FG001|Overall Study|developed RV16 antibody|1|||
161778236|NCT00684645|584230375|FG000|Overall Study|Death|2|||
161778237|NCT00684645|584230375|FG000|Overall Study|Progressive disease|67|||
161778238|NCT00684645|584230375|FG000|Overall Study|Adverse Event|27|||
161778239|NCT00684645|584230375|FG000|Overall Study|Lost to Follow-up|3|||
161778240|NCT00684645|584230375|FG000|Overall Study|Other|15|||
161778241|NCT01819467|584230380|FG000|Overall Study|Physician Decision|20|||
161778242|NCT01819467|584230381|FG001|Overall Study|Physician Decision|9|||
161778243|NCT03514121|584230382|FG000|Overall Study|Withdrawal by Subject|0|||
161778244|NCT03514121|584230383|FG001|Overall Study|Withdrawal by Subject|0|||
161778245|NCT03514121|584230384|FG002|Overall Study|Withdrawal by Subject|0|||
161778246|NCT03514121|584230385|FG003|Overall Study|Withdrawal by Subject|0|||
161778247|NCT03514121|584230386|FG004|Overall Study|Withdrawal by Subject|1|||
161778248|NCT03514121|584230387|FG005|Overall Study|Withdrawal by Subject|2|||
161778249|NCT03514121|584230388|FG006|Overall Study|Withdrawal by Subject|1|||
161778250|NCT03514121|584230389|FG007|Overall Study|Withdrawal by Subject|1|||
161778251|NCT03514121|584230390|FG008|Overall Study|Withdrawal by Subject|7|||
161778252|NCT03514121|584230391|FG009|Overall Study|Withdrawal by Subject|2|||
161778253|NCT03514121|584230382|FG000|Overall Study|Death|0|||
161778254|NCT03514121|584230383|FG001|Overall Study|Death|0|||
161778255|NCT03514121|584230384|FG002|Overall Study|Death|0|||
161778256|NCT03514121|584230385|FG003|Overall Study|Death|0|||
161778257|NCT03514121|584230386|FG004|Overall Study|Death|0|||
161778258|NCT03514121|584230387|FG005|Overall Study|Death|3|||
161778259|NCT03514121|584230388|FG006|Overall Study|Death|2|||
161778260|NCT03514121|584230389|FG007|Overall Study|Death|1|||
161778261|NCT03514121|584230390|FG008|Overall Study|Death|26|||
161882255|NCT01390428|584612847|FG004|Overall Study|Withdrawal by Subject|0|||
161882256|NCT01390428|584612848|FG005|Overall Study|Withdrawal by Subject|0|||
161882257|NCT05079750|584612849|FG000|Overall Study|Lost to Follow-up|0|||
161882258|NCT05079750|584612850|FG001|Overall Study|Lost to Follow-up|0|||
161882259|NCT05079750|584612851|FG002|Overall Study|Lost to Follow-up|1|||
161882260|NCT05091346|584612854|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
161882261|NCT05091346|584612855|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
161882262|NCT05091346|584612856|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
161882263|NCT05091346|584612857|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
161882264|NCT05091346|584612858|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
161882265|NCT05091346|584612854|FG000|Overall Study|Death|6|||
161882266|NCT05091346|584612855|FG001|Overall Study|Death|5|||
161882267|NCT05091346|584612856|FG002|Overall Study|Death|8|||
161882268|NCT05091346|584612857|FG003|Overall Study|Death|16|||
161882269|NCT05091346|584612858|FG004|Overall Study|Death|26|||
161882270|NCT05091346|584612854|FG000|Overall Study|Lost to Follow-up|0|||
161882271|NCT05091346|584612855|FG001|Overall Study|Lost to Follow-up|0|||
161882272|NCT05091346|584612856|FG002|Overall Study|Lost to Follow-up|0|||
161882273|NCT05091346|584612857|FG003|Overall Study|Lost to Follow-up|1|||
161882274|NCT05091346|584612858|FG004|Overall Study|Lost to Follow-up|0|||
161882275|NCT05091346|584612854|FG000|Overall Study|Withdrawal by Subject|0|||
161882276|NCT05091346|584612855|FG001|Overall Study|Withdrawal by Subject|1|||
161882277|NCT05091346|584612856|FG002|Overall Study|Withdrawal by Subject|2|||
161882278|NCT05091346|584612857|FG003|Overall Study|Withdrawal by Subject|2|||
161882279|NCT05091346|584612858|FG004|Overall Study|Withdrawal by Subject|1|||
161882280|NCT05897827|584612859|FG000|Overall Study|Lost to Follow-up|33|||
161882281|NCT05897827|584612860|FG001|Overall Study|Lost to Follow-up|14|||
161882282|NCT05897827|584612859|FG000|Overall Study|Withdrawal by Subject|1|||
161882283|NCT05897827|584612860|FG001|Overall Study|Withdrawal by Subject|1|||
161882284|NCT01752634|584612861|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
161882285|NCT01752634|584612862|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
161882286|NCT01752634|584612863|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
161882287|NCT01752634|584612864|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
161882288|NCT01752634|584612865|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
161882289|NCT01752634|584612866|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
161882290|NCT01752634|584612861|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161882291|NCT01752634|584612862|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
161882292|NCT01752634|584612863|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161882293|NCT01752634|584612864|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161882294|NCT01752634|584612865|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161882295|NCT01752634|584612866|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161882296|NCT01752634|584612861|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
161882297|NCT01752634|584612862|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
161882298|NCT01752634|584612863|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
161882299|NCT01752634|584612864|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
161882300|NCT01752634|584612865|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
161882301|NCT01752634|584612866|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
161882302|NCT01752634|584612861|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
161778262|NCT03514121|584230391|FG009|Overall Study|Death|3|||
161778263|NCT03514121|584230382|FG000|Overall Study|Lost to Follow-up|0|||
161778264|NCT03514121|584230383|FG001|Overall Study|Lost to Follow-up|0|||
161778265|NCT03514121|584230384|FG002|Overall Study|Lost to Follow-up|1|||
161778266|NCT03514121|584230385|FG003|Overall Study|Lost to Follow-up|0|||
161778267|NCT03514121|584230386|FG004|Overall Study|Lost to Follow-up|0|||
161778268|NCT03514121|584230387|FG005|Overall Study|Lost to Follow-up|0|||
161778269|NCT03514121|584230388|FG006|Overall Study|Lost to Follow-up|0|||
161778270|NCT03514121|584230389|FG007|Overall Study|Lost to Follow-up|0|||
161778271|NCT03514121|584230390|FG008|Overall Study|Lost to Follow-up|1|||
161778272|NCT03514121|584230391|FG009|Overall Study|Lost to Follow-up|0|||
161778273|NCT03514121|584230382|FG000|Overall Study|Adverse Event|0|||
161778274|NCT03514121|584230383|FG001|Overall Study|Adverse Event|0|||
161778275|NCT03514121|584230384|FG002|Overall Study|Adverse Event|0|||
161778276|NCT03514121|584230385|FG003|Overall Study|Adverse Event|0|||
161778277|NCT03514121|584230386|FG004|Overall Study|Adverse Event|0|||
161778278|NCT03514121|584230387|FG005|Overall Study|Adverse Event|0|||
161778279|NCT03514121|584230388|FG006|Overall Study|Adverse Event|1|||
161778280|NCT03514121|584230389|FG007|Overall Study|Adverse Event|0|||
161778281|NCT03514121|584230390|FG008|Overall Study|Adverse Event|0|||
161778282|NCT03514121|584230391|FG009|Overall Study|Adverse Event|0|||
161778283|NCT03514121|584230382|FG000|Overall Study|Other|0|||
161778284|NCT03514121|584230383|FG001|Overall Study|Other|1|||
161778285|NCT03514121|584230384|FG002|Overall Study|Other|1|||
161778286|NCT03514121|584230385|FG003|Overall Study|Other|0|||
161778287|NCT03514121|584230386|FG004|Overall Study|Other|1|||
161882303|NCT01752634|584612862|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
161882304|NCT01752634|584612863|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
161882305|NCT01752634|584612864|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
161882306|NCT01752634|584612865|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
161882307|NCT01752634|584612866|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
161882308|NCT01752634|584612861|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
161882309|NCT01752634|584612862|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
161882310|NCT01752634|584612863|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
161882311|NCT01752634|584612864|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
161882312|NCT01752634|584612865|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
161778288|NCT03514121|584230387|FG005|Overall Study|Other|2|||
161778289|NCT03514121|584230388|FG006|Overall Study|Other|3|||
161778290|NCT03514121|584230389|FG007|Overall Study|Other|2|||
161778291|NCT03514121|584230390|FG008|Overall Study|Other|7|||
161778292|NCT03514121|584230391|FG009|Overall Study|Other|3|||
161778293|NCT03514121|584230382|FG000|Overall Study|Study termination by Sponsor|0|||
161778294|NCT03514121|584230383|FG001|Overall Study|Study termination by Sponsor|0|||
161778295|NCT03514121|584230384|FG002|Overall Study|Study termination by Sponsor|0|||
161778296|NCT03514121|584230385|FG003|Overall Study|Study termination by Sponsor|0|||
161778297|NCT03514121|584230386|FG004|Overall Study|Study termination by Sponsor|0|||
161778298|NCT03514121|584230387|FG005|Overall Study|Study termination by Sponsor|0|||
161778299|NCT03514121|584230388|FG006|Overall Study|Study termination by Sponsor|0|||
161778300|NCT03514121|584230389|FG007|Overall Study|Study termination by Sponsor|0|||
161778301|NCT03514121|584230390|FG008|Overall Study|Study termination by Sponsor|11|||
161778302|NCT03514121|584230391|FG009|Overall Study|Study termination by Sponsor|3|||
161778303|NCT03514121|584230382|FG000|Overall Study|Investigator decision|0|||
161778304|NCT03514121|584230383|FG001|Overall Study|Investigator decision|0|||
161778305|NCT03514121|584230384|FG002|Overall Study|Investigator decision|0|||
161778306|NCT03514121|584230385|FG003|Overall Study|Investigator decision|0|||
161778307|NCT03514121|584230386|FG004|Overall Study|Investigator decision|0|||
161778308|NCT03514121|584230387|FG005|Overall Study|Investigator decision|0|||
161778309|NCT03514121|584230388|FG006|Overall Study|Investigator decision|0|||
161778310|NCT03514121|584230389|FG007|Overall Study|Investigator decision|0|||
161778311|NCT03514121|584230390|FG008|Overall Study|Investigator decision|1|||
161778312|NCT03514121|584230391|FG009|Overall Study|Investigator decision|0|||
161778313|NCT00391092|584230392|FG000|Overall Study|Death|78|||
161778314|NCT00391092|584230393|FG001|Overall Study|Death|81|||
161778315|NCT00391092|584230392|FG000|Overall Study|Lost to Follow-up|13|||
161778316|NCT00391092|584230393|FG001|Overall Study|Lost to Follow-up|18|||
161778317|NCT00391092|584230392|FG000|Overall Study|Alive on treatment|29|||
161778318|NCT00391092|584230393|FG001|Overall Study|Alive on treatment|33|||
161778319|NCT00391092|584230392|FG000|Overall Study|Alive in follow-up|88|||
161778320|NCT00391092|584230393|FG001|Overall Study|Alive in follow-up|84|||
161778321|NCT02545868|584230398|FG000|Overall Study|Lack of Efficacy|1|||
161778322|NCT02545868|584230399|FG001|Overall Study|Lack of Efficacy|1|||
161778323|NCT02545868|584230400|FG002|Overall Study|Lack of Efficacy|0|||
161778324|NCT02545868|584230398|FG000|Overall Study|Lost to Follow-up|1|||
161778325|NCT02545868|584230399|FG001|Overall Study|Lost to Follow-up|5|||
161778326|NCT02545868|584230400|FG002|Overall Study|Lost to Follow-up|1|||
161778327|NCT02545868|584230398|FG000|Overall Study|Non-compliance|1|||
161778328|NCT02545868|584230399|FG001|Overall Study|Non-compliance|1|||
161778329|NCT02545868|584230400|FG002|Overall Study|Non-compliance|1|||
161778330|NCT02545868|584230398|FG000|Overall Study|Treatment change|21|||
161778331|NCT02545868|584230399|FG001|Overall Study|Treatment change|19|||
161778332|NCT02545868|584230400|FG002|Overall Study|Treatment change|22|||
161778333|NCT02545868|584230398|FG000|Overall Study|Physician Decision|1|||
161778334|NCT02545868|584230399|FG001|Overall Study|Physician Decision|1|||
161778335|NCT02545868|584230400|FG002|Overall Study|Physician Decision|1|||
161778336|NCT02545868|584230398|FG000|Overall Study|Withdrawal by Subject|6|||
161778337|NCT02545868|584230399|FG001|Overall Study|Withdrawal by Subject|7|||
161778338|NCT02545868|584230400|FG002|Overall Study|Withdrawal by Subject|9|||
161778339|NCT01777191|584230401|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
161778340|NCT01777191|584230402|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
161778341|NCT01777191|584230401|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
161778342|NCT01777191|584230402|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
161778343|NCT01777191|584230401|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
161778344|NCT01777191|584230402|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
161778345|NCT01777191|584230401|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
161778346|NCT01777191|584230402|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
161778347|NCT01777191|584230401|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
161778348|NCT01777191|584230402|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
161778349|NCT01777191|584230401|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
161882313|NCT01752634|584612866|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
161882314|NCT01752634|584612861|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
161882315|NCT01752634|584612862|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
161882316|NCT01752634|584612863|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
161882317|NCT01752634|584612864|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
161882318|NCT01752634|584612865|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
161882319|NCT01752634|584612866|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
161882320|NCT01752634|584612861|FG000|Week 24 to Week 260|Physician Decision|1|||
161882321|NCT01752634|584612862|FG001|Week 24 to Week 260|Physician Decision|2|||
161882322|NCT01752634|584612863|FG002|Week 24 to Week 260|Physician Decision|4|||
161882323|NCT01752634|584612864|FG003|Week 24 to Week 260|Physician Decision|2|||
161882324|NCT01752634|584612865|FG004|Week 24 to Week 260|Physician Decision|1|||
161882325|NCT01752634|584612866|FG005|Week 24 to Week 260|Physician Decision|0|||
161882326|NCT01752634|584612861|FG000|Week 24 to Week 260|Death|0|||
161882327|NCT01752634|584612862|FG001|Week 24 to Week 260|Death|1|||
161882328|NCT01752634|584612863|FG002|Week 24 to Week 260|Death|0|||
161882329|NCT01752634|584612864|FG003|Week 24 to Week 260|Death|0|||
161882330|NCT01752634|584612865|FG004|Week 24 to Week 260|Death|0|||
161882331|NCT01752634|584612866|FG005|Week 24 to Week 260|Death|0|||
161882332|NCT01752634|584612861|FG000|Week 24 to Week 260|Pregnancy|0|||
161882333|NCT01752634|584612862|FG001|Week 24 to Week 260|Pregnancy|0|||
161882334|NCT01752634|584612863|FG002|Week 24 to Week 260|Pregnancy|1|||
161882335|NCT01752634|584612864|FG003|Week 24 to Week 260|Pregnancy|0|||
161882336|NCT01752634|584612865|FG004|Week 24 to Week 260|Pregnancy|0|||
161882337|NCT01752634|584612866|FG005|Week 24 to Week 260|Pregnancy|0|||
161882338|NCT01752634|584612861|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
161882339|NCT01752634|584612862|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
161882340|NCT01752634|584612863|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
161882341|NCT01752634|584612864|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
161882342|NCT01752634|584612865|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
161882343|NCT01752634|584612866|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
161882344|NCT01752634|584612861|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
161882345|NCT01752634|584612862|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
161882346|NCT01752634|584612863|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
161882347|NCT01752634|584612864|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
161882348|NCT01752634|584612865|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
161882349|NCT01752634|584612866|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
161882350|NCT01752634|584612861|FG000|Week 24 to Week 260|Adverse Event|4|||
161882351|NCT01752634|584612862|FG001|Week 24 to Week 260|Adverse Event|8|||
161882352|NCT01752634|584612863|FG002|Week 24 to Week 260|Adverse Event|8|||
161882353|NCT01752634|584612864|FG003|Week 24 to Week 260|Adverse Event|4|||
161882354|NCT01752634|584612865|FG004|Week 24 to Week 260|Adverse Event|2|||
161882355|NCT01752634|584612866|FG005|Week 24 to Week 260|Adverse Event|0|||
161882356|NCT04250714|584612870|FG000|Overall Study|Treatment - withdrawal by subject|14|||
161882357|NCT04250714|584612870|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
161882358|NCT04250714|584612870|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
161882359|NCT04250714|584612870|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
161882360|NCT04250714|584612870|FG000|Overall Study|Treatment - Death|1|||
161882361|NCT04250714|584612870|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
161882362|NCT04250714|584612870|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
161882363|NCT04250714|584612870|FG000|Overall Study|Attempt|2|||
161882364|NCT04250714|584612870|FG000|Overall Study|Intent|7|||
161882365|NCT04697056|584612871|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
161882366|NCT04697056|584612872|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
161882367|NCT00308750|584612877|FG000|Overall Study|Adverse Event|9|||
161882368|NCT00308750|584612878|FG001|Overall Study|Adverse Event|9|||
161882369|NCT00308750|584612879|FG002|Overall Study|Adverse Event|13|||
161882370|NCT00308750|584612877|FG000|Overall Study|Withdrawal by Subject|6|||
161882371|NCT00308750|584612878|FG001|Overall Study|Withdrawal by Subject|2|||
161882372|NCT00308750|584612879|FG002|Overall Study|Withdrawal by Subject|3|||
161882373|NCT00308750|584612877|FG000|Overall Study|Physician Decision|3|||
161882374|NCT00308750|584612878|FG001|Overall Study|Physician Decision|4|||
161882375|NCT00308750|584612879|FG002|Overall Study|Physician Decision|3|||
161882376|NCT00308750|584612877|FG000|Overall Study|Sponsor Decision|1|||
161882377|NCT00308750|584612878|FG001|Overall Study|Sponsor Decision|0|||
161882378|NCT00308750|584612879|FG002|Overall Study|Sponsor Decision|0|||
161882379|NCT00308750|584612877|FG000|Overall Study|Disease Progression|47|||
161882380|NCT00308750|584612878|FG001|Overall Study|Disease Progression|24|||
161882381|NCT00308750|584612879|FG002|Overall Study|Disease Progression|28|||
161882382|NCT00308750|584612877|FG000|Overall Study|Unrelated Complication|3|||
161882383|NCT00308750|584612878|FG001|Overall Study|Unrelated Complication|0|||
161882384|NCT00308750|584612879|FG002|Overall Study|Unrelated Complication|1|||
161882385|NCT00308750|584612877|FG000|Overall Study|Death|1|||
161882386|NCT00308750|584612878|FG001|Overall Study|Death|0|||
161882387|NCT00308750|584612879|FG002|Overall Study|Death|1|||
161882388|NCT00308750|584612877|FG000|Overall Study|Protocol Violation|1|||
161882389|NCT00308750|584612878|FG001|Overall Study|Protocol Violation|0|||
161882390|NCT00308750|584612879|FG002|Overall Study|Protocol Violation|0|||
161882391|NCT00308750|584612877|FG000|Overall Study|New Primary Disease Identified|1|||
161882392|NCT00308750|584612878|FG001|Overall Study|New Primary Disease Identified|1|||
161882393|NCT00308750|584612879|FG002|Overall Study|New Primary Disease Identified|0|||
161882394|NCT01911780|584612880|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
161778350|NCT01777191|584230402|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
161778351|NCT01777191|584230401|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
161778352|NCT01777191|584230402|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
161778353|NCT01777191|584230401|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
161778354|NCT01777191|584230402|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
161778355|NCT01777191|584230401|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
161778356|NCT01777191|584230402|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
161882395|NCT01911780|584612881|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
161882396|NCT01911780|584612880|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
161882397|NCT01911780|584612881|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
161882398|NCT01911780|584612880|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
161882399|NCT01911780|584612881|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
161882400|NCT01911780|584612880|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
161882401|NCT01911780|584612881|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
161882402|NCT01911780|584612880|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
161882403|NCT01911780|584612881|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
161882404|NCT01911780|584612880|FG000|Extension Period (52 Weeks)|Personal reason|1|||
161882405|NCT01911780|584612881|FG001|Extension Period (52 Weeks)|Personal reason|1|||
161882406|NCT00348790|584612884|FG000|Completed Treatment|Withdrawal by Subject|4|||
161882407|NCT00348790|584612884|FG000|Completed Treatment|Disease progression|14|||
161882408|NCT00348790|584612884|FG000|Completed Treatment|Adverse Event|4|||
161882409|NCT00348790|584612884|FG000|Completed Treatment|Required surgery|2|||
161882410|NCT00348790|584612884|FG000|Completed Treatment|Unable to travel to study site|1|||
161882411|NCT01185509|584612888|FG000|Overall Study|Progression/Relapse|9|||
161882412|NCT01185509|584612889|FG001|Overall Study|Progression/Relapse|15|||
161882413|NCT01185509|584612888|FG000|Overall Study|Physician Decision|2|||
161882414|NCT01185509|584612889|FG001|Overall Study|Physician Decision|2|||
161882415|NCT01185509|584612888|FG000|Overall Study|Withdrawal by Subject|0|||
161882416|NCT01185509|584612889|FG001|Overall Study|Withdrawal by Subject|1|||
161882417|NCT01185509|584612888|FG000|Overall Study|Death|0|||
161882418|NCT01185509|584612889|FG001|Overall Study|Death|1|||
161882419|NCT01185509|584612888|FG000|Overall Study|Intercurrent Illness|0|||
161882420|NCT01185509|584612889|FG001|Overall Study|Intercurrent Illness|1|||
161882421|NCT03687372|584612890|FG000|Overall Study|Lost to Follow-up|12|||
161882422|NCT03687372|584612891|FG001|Overall Study|Lost to Follow-up|21|||
161882423|NCT03687372|584612890|FG000|Overall Study|Withdrawal by Subject|4|||
161882424|NCT03687372|584612891|FG001|Overall Study|Withdrawal by Subject|17|||
161882425|NCT03687372|584612890|FG000|Overall Study|Investigator Decision|1|||
161882426|NCT03687372|584612891|FG001|Overall Study|Investigator Decision|1|||
161882427|NCT01088243|584612895|FG000|Overall Study|Adverse Event|1|||
161882428|NCT01088243|584612896|FG001|Overall Study|Adverse Event|0|||
161882429|NCT02370667|584612899|FG000|Overall Study|Lost to Follow-up|0|||
161882430|NCT02370667|584612900|FG001|Overall Study|Lost to Follow-up|1|||
161882431|NCT02370667|584612901|FG002|Overall Study|Lost to Follow-up|0|||
161882432|NCT03536949|584612902|FG000|Overall Study|Adverse Event|4|||
161882433|NCT03536949|584612903|FG001|Overall Study|Adverse Event|0|||
161882434|NCT03536949|584612902|FG000|Overall Study|Lost to Follow-up|2|||
161882435|NCT03536949|584612903|FG001|Overall Study|Lost to Follow-up|1|||
161882436|NCT03536949|584612902|FG000|Overall Study|Withdrawal by Subject|6|||
161882437|NCT03536949|584612903|FG001|Overall Study|Withdrawal by Subject|0|||
161882438|NCT03536949|584612902|FG000|Overall Study|Non-compliance|2|||
161882439|NCT03536949|584612903|FG001|Overall Study|Non-compliance|1|||
161882440|NCT00423189|584612907|FG000|Overall Study|Death|0|||
161882441|NCT00423189|584612908|FG001|Overall Study|Death|1|||
161882442|NCT00423189|584612909|FG002|Overall Study|Death|0|||
161882443|NCT03787303|584612910|FG000|Overall Study|Death|1|||
161778357|NCT01777191|584230401|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
161882444|NCT03787303|584612910|FG000|Overall Study|Premature Termination of Study|1|||
161882445|NCT01826370|584612913|FG000|Overall Study|Protocol Violation|6|||
161882446|NCT01826370|584612913|FG000|Overall Study|Lost to Follow-up|12|||
161882447|NCT01826370|584612913|FG000|Overall Study|Other reason not defined above|2|||
161882448|NCT04416737|584612914|FG000|Week 1 (First Injection)|Physician Decision|0|||
161882449|NCT04416737|584612915|FG001|Week 1 (First Injection)|Physician Decision|1|||
161882450|NCT03332628|584612916|FG000|Overall Study|Physician Decision|2|||
161882451|NCT01195844|584612924|FG000|Overall Study|Fecal sample not collected|40|||
161882452|NCT00176644|584612925|FG000|Overall Study|Withdrawal by Subject|1|||
161882453|NCT01801280|584612926|FG000|Period 1|Withdrawal by Subject|0|||
161882454|NCT01801280|584612927|FG001|Period 1|Withdrawal by Subject|1|||
161778358|NCT01777191|584230402|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
161778359|NCT01777191|584230401|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
161778360|NCT01777191|584230402|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
161778361|NCT03286400|584230407|FG000|Overall Study|Death|10|||
161778362|NCT03286400|584230407|FG000|Overall Study|Lost to Follow-up|10|||
161778363|NCT03286400|584230407|FG000|Overall Study|Physician Decision|1|||
161778364|NCT03286400|584230407|FG000|Overall Study|Scheduling difficulty|4|||
161778365|NCT00602979|584230410|FG000|Overall Study|Lost to Follow-up|3|||
161778366|NCT00602979|584230411|FG001|Overall Study|Lost to Follow-up|2|||
161778367|NCT00602979|584230412|FG002|Overall Study|Lost to Follow-up|3|||
161778368|NCT00602979|584230413|FG003|Overall Study|Lost to Follow-up|2|||
161778369|NCT00602979|584230414|FG004|Overall Study|Lost to Follow-up|3|||
161778370|NCT00602979|584230410|FG000|Overall Study|Failed Intubation|0|||
161778371|NCT00602979|584230411|FG001|Overall Study|Failed Intubation|1|||
161778372|NCT00602979|584230412|FG002|Overall Study|Failed Intubation|0|||
161778373|NCT00602979|584230413|FG003|Overall Study|Failed Intubation|1|||
161778374|NCT00602979|584230414|FG004|Overall Study|Failed Intubation|0|||
161778375|NCT01461369|584230415|FG000|Overall Study|Lack of Efficacy|2|||
161778376|NCT01461369|584230416|FG001|Overall Study|Lack of Efficacy|0|||
161778377|NCT01461369|584230417|FG002|Overall Study|Lack of Efficacy|6|||
161778378|NCT01461369|584230415|FG000|Overall Study|Lost to Follow-up|0|||
161778379|NCT01461369|584230416|FG001|Overall Study|Lost to Follow-up|0|||
161778380|NCT01461369|584230417|FG002|Overall Study|Lost to Follow-up|3|||
161778381|NCT01461369|584230415|FG000|Overall Study|Adverse Event|9|||
161778382|NCT01461369|584230416|FG001|Overall Study|Adverse Event|12|||
161778383|NCT01461369|584230417|FG002|Overall Study|Adverse Event|4|||
161778384|NCT01461369|584230415|FG000|Overall Study|Protocol Violation|1|||
161778385|NCT01461369|584230416|FG001|Overall Study|Protocol Violation|2|||
161778386|NCT01461369|584230417|FG002|Overall Study|Protocol Violation|2|||
161778387|NCT01461369|584230415|FG000|Overall Study|Withdrawal by Subject|1|||
161778388|NCT01461369|584230416|FG001|Overall Study|Withdrawal by Subject|3|||
161778389|NCT01461369|584230417|FG002|Overall Study|Withdrawal by Subject|2|||
161778390|NCT00734617|584230422|FG000|Overall Study|Adverse Event|4|||
161778391|NCT00734617|584230423|FG001|Overall Study|Adverse Event|7|||
161778392|NCT00734617|584230422|FG000|Overall Study|Withdrawal by Subject|103|||
161778393|NCT00734617|584230423|FG001|Overall Study|Withdrawal by Subject|95|||
161778394|NCT03692078|584230426|FG000|Overall Study|Adverse Event|0|||
161778395|NCT03692078|584230427|FG001|Overall Study|Adverse Event|0|||
161778396|NCT03692078|584230428|FG002|Overall Study|Adverse Event|0|||
161778397|NCT03692078|584230429|FG003|Overall Study|Adverse Event|0|||
161778398|NCT03692078|584230430|FG004|Overall Study|Adverse Event|0|||
161778399|NCT03692078|584230431|FG005|Overall Study|Adverse Event|1|||
161778400|NCT03692078|584230432|FG006|Overall Study|Adverse Event|0|||
161778401|NCT03692078|584230426|FG000|Overall Study|Enrollment Closed|5|||
161778402|NCT03692078|584230427|FG001|Overall Study|Enrollment Closed|0|||
161778403|NCT03692078|584230428|FG002|Overall Study|Enrollment Closed|0|||
161778404|NCT03692078|584230429|FG003|Overall Study|Enrollment Closed|0|||
161778405|NCT03692078|584230430|FG004|Overall Study|Enrollment Closed|0|||
161778406|NCT03692078|584230431|FG005|Overall Study|Enrollment Closed|0|||
161778407|NCT03692078|584230432|FG006|Overall Study|Enrollment Closed|0|||
161778408|NCT03692078|584230426|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
161778409|NCT03692078|584230427|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
161778410|NCT03692078|584230428|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
161778411|NCT03692078|584230429|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
161778412|NCT03692078|584230430|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
161778413|NCT03692078|584230431|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
161778414|NCT03692078|584230432|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
161778415|NCT03692078|584230426|FG000|Overall Study|Withdrawal by Subject|0|||
161778416|NCT03692078|584230427|FG001|Overall Study|Withdrawal by Subject|2|||
161778417|NCT03692078|584230428|FG002|Overall Study|Withdrawal by Subject|0|||
161778418|NCT03692078|584230429|FG003|Overall Study|Withdrawal by Subject|1|||
161778419|NCT03692078|584230430|FG004|Overall Study|Withdrawal by Subject|5|||
161778420|NCT03692078|584230431|FG005|Overall Study|Withdrawal by Subject|3|||
161778421|NCT03692078|584230432|FG006|Overall Study|Withdrawal by Subject|3|||
161778422|NCT00996632|584230435|FG000|Overall Study|Physician Decision|0|||
161778423|NCT00996632|584230436|FG001|Overall Study|Physician Decision|0|||
161778424|NCT01615822|584230438|FG000|Period 1|Withdrawal by Subject|0|||
161778425|NCT01615822|584230439|FG001|Period 1|Withdrawal by Subject|1|||
161778426|NCT01615822|584230440|FG002|Period 1|Withdrawal by Subject|0|||
161778427|NCT01615822|584230438|FG000|Period 1|Adverse Event|1|||
161778428|NCT01615822|584230439|FG001|Period 1|Adverse Event|1|||
161778429|NCT01615822|584230440|FG002|Period 1|Adverse Event|0|||
161778430|NCT01615822|584230438|FG000|Period 2|Lost to Follow-up|0|||
161778431|NCT01615822|584230439|FG001|Period 2|Lost to Follow-up|1|||
161778432|NCT01615822|584230440|FG002|Period 2|Lost to Follow-up|2|||
161882455|NCT01801280|584612928|FG002|Period 1|Withdrawal by Subject|0|||
161882456|NCT01801280|584612929|FG003|Period 1|Withdrawal by Subject|0|||
161882457|NCT01801280|584612926|FG000|Period 2|Withdrawal by Subject|1|||
161882458|NCT01801280|584612927|FG001|Period 2|Withdrawal by Subject|0|||
161882459|NCT01801280|584612928|FG002|Period 2|Withdrawal by Subject|0|||
161882460|NCT01801280|584612929|FG003|Period 2|Withdrawal by Subject|0|||
161882461|NCT01801280|584612926|FG000|Period 4|Protocol Violation|0|||
161882462|NCT01801280|584612927|FG001|Period 4|Protocol Violation|0|||
161882463|NCT01801280|584612928|FG002|Period 4|Protocol Violation|1|||
161778433|NCT02861534|584230441|FG000|Overall Study|Death|541|||
161778434|NCT02861534|584230442|FG001|Overall Study|Death|552|||
161778435|NCT02861534|584230441|FG000|Overall Study|Lost to Follow-up|14|||
161778436|NCT02861534|584230442|FG001|Overall Study|Lost to Follow-up|14|||
161778437|NCT02861534|584230441|FG000|Overall Study|Site Terminated by Sponsor|4|||
161778438|NCT02861534|584230442|FG001|Overall Study|Site Terminated by Sponsor|3|||
161778439|NCT02861534|584230441|FG000|Overall Study|Withdrawal by Subject|15|||
161778440|NCT02861534|584230442|FG001|Overall Study|Withdrawal by Subject|18|||
161778441|NCT02886494|584230445|FG000|Overall Study|Adverse Event|1|||
161778442|NCT02886494|584230446|FG001|Overall Study|Adverse Event|0|||
161778443|NCT02886494|584230445|FG000|Overall Study|Withdrawal by Subject|12|||
161778444|NCT02886494|584230446|FG001|Overall Study|Withdrawal by Subject|3|||
161778445|NCT02886494|584230445|FG000|Overall Study|Protocol Violation|4|||
161778446|NCT02886494|584230446|FG001|Overall Study|Protocol Violation|1|||
161778447|NCT00916617|584230449|FG000|Overall Study|Adverse Event|3|||
161778448|NCT00916617|584230450|FG001|Overall Study|Adverse Event|2|||
161778449|NCT00916617|584230451|FG002|Overall Study|Adverse Event|6|||
161778450|NCT00916617|584230452|FG003|Overall Study|Adverse Event|3|||
161778451|NCT00916617|584230449|FG000|Overall Study|Withdrawal by Subject|3|||
161778452|NCT00916617|584230450|FG001|Overall Study|Withdrawal by Subject|2|||
161778453|NCT00916617|584230451|FG002|Overall Study|Withdrawal by Subject|0|||
161778454|NCT00916617|584230452|FG003|Overall Study|Withdrawal by Subject|1|||
161778455|NCT00916617|584230449|FG000|Overall Study|Caregiver Request|3|||
161778456|NCT00916617|584230450|FG001|Overall Study|Caregiver Request|2|||
161778457|NCT00916617|584230451|FG002|Overall Study|Caregiver Request|1|||
161778458|NCT00916617|584230452|FG003|Overall Study|Caregiver Request|0|||
161778459|NCT00916617|584230449|FG000|Overall Study|Physician Decision|1|||
161778460|NCT00916617|584230450|FG001|Overall Study|Physician Decision|1|||
161778461|NCT00916617|584230451|FG002|Overall Study|Physician Decision|0|||
161778462|NCT00916617|584230452|FG003|Overall Study|Physician Decision|0|||
161778463|NCT00916617|584230449|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
161991636|NCT01278797|585018535|FG001|Period 1|Adverse Event|1|||
161991637|NCT01278797|585018534|FG000|Period 1|Protocol Violation|1|||
161991638|NCT01278797|585018535|FG001|Period 1|Protocol Violation|0|||
161991639|NCT00588354|585018536|FG000|Baseline to 2 Weeks|Adverse Event|1|||
161991640|NCT00588354|585018537|FG001|Baseline to 2 Weeks|Adverse Event|0|||
161991641|NCT00588354|585018536|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
161991642|NCT00588354|585018537|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
161991643|NCT00588354|585018536|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
161991644|NCT00588354|585018537|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
161991645|NCT01371552|585018538|FG000|Part 1, First 3 Days|Inconvenience|0|||
161991646|NCT01371552|585018539|FG001|Part 1, First 3 Days|Inconvenience|0|||
161991647|NCT01371552|585018540|FG002|Part 1, First 3 Days|Inconvenience|1|||
161991648|NCT01371552|585018541|FG003|Part 1, First 3 Days|Inconvenience|0|||
161991649|NCT01371552|585018542|FG004|Part 1, First 3 Days|Inconvenience|0|||
161991650|NCT01371552|585018543|FG005|Part 1, First 3 Days|Inconvenience|0|||
161991651|NCT03364309|585018544|FG000|Induction Period|Adverse Event|4|||
161991652|NCT03364309|585018545|FG001|Induction Period|Adverse Event|0|||
161991653|NCT03364309|585018546|FG002|Induction Period|Adverse Event|1|||
161991654|NCT03364309|585018547|FG003|Induction Period|Adverse Event|0|||
161991655|NCT03364309|585018548|FG004|Induction Period|Adverse Event|0|||
161991656|NCT03364309|585018549|FG005|Induction Period|Adverse Event|0|||
161991657|NCT03364309|585018550|FG006|Induction Period|Adverse Event|0|||
161991658|NCT03364309|585018551|FG007|Induction Period|Adverse Event|0|||
161991659|NCT03364309|585018552|FG008|Induction Period|Adverse Event|0|||
161778464|NCT00916617|584230450|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
161778465|NCT00916617|584230451|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
161778466|NCT00916617|584230452|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
161778467|NCT00916617|584230449|FG000|Overall Study|Lost to Follow-up|2|||
161778468|NCT00916617|584230450|FG001|Overall Study|Lost to Follow-up|1|||
161778469|NCT00916617|584230451|FG002|Overall Study|Lost to Follow-up|0|||
161778470|NCT00916617|584230452|FG003|Overall Study|Lost to Follow-up|0|||
161778471|NCT00916617|584230449|FG000|Overall Study|Lack of Efficacy|1|||
161882464|NCT01801280|584612929|FG003|Period 4|Protocol Violation|0|||
161882465|NCT00581542|584612930|FG000|Overall Study|they met an exclusion criteria|2|||
161882466|NCT00581542|584612931|FG001|Overall Study|they met an exclusion criteria|2|||
161991660|NCT03364309|585018553|FG009|Induction Period|Adverse Event|0|||
161991661|NCT03364309|585018554|FG010|Induction Period|Adverse Event|0|||
161991662|NCT03364309|585018555|FG011|Induction Period|Adverse Event|0|||
161991663|NCT03364309|585018556|FG012|Induction Period|Adverse Event|0|||
161778472|NCT00916617|584230450|FG001|Overall Study|Lack of Efficacy|0|||
161778473|NCT00916617|584230451|FG002|Overall Study|Lack of Efficacy|0|||
161778474|NCT00916617|584230452|FG003|Overall Study|Lack of Efficacy|0|||
161778475|NCT00916617|584230449|FG000|Overall Study|Other|2|||
161778476|NCT00916617|584230450|FG001|Overall Study|Other|0|||
161778477|NCT00916617|584230451|FG002|Overall Study|Other|0|||
161778478|NCT00916617|584230452|FG003|Overall Study|Other|2|||
161778479|NCT00499252|584230454|FG000|Overall Study|Adverse Event|3|||
161778480|NCT00499252|584230454|FG000|Overall Study|Refused further treatment|2|||
161778481|NCT00499252|584230454|FG000|Overall Study|Ineligible|4|||
161778482|NCT00499252|584230454|FG000|Overall Study|<no further label>|3|||
161778483|NCT02230332|584230455|FG000|Overall Study|Adverse Event|2|||
161778484|NCT02230332|584230456|FG001|Overall Study|Adverse Event|1|||
161778485|NCT02230332|584230455|FG000|Overall Study|Lost to Follow-up|1|||
161778486|NCT02230332|584230456|FG001|Overall Study|Lost to Follow-up|0|||
161778487|NCT02230332|584230455|FG000|Overall Study|Protocol Violation|1|||
161778488|NCT02230332|584230456|FG001|Overall Study|Protocol Violation|0|||
161778489|NCT01260194|584230459|FG000|Overall Study|Withdrawal of Consent|1|||
161778490|NCT00537056|584230463|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
161778491|NCT00244881|584230469|FG000|Overall Study|Withdrawal by Subject|3|||
161778492|NCT00445458|584230470|FG000|Overall Study|Disease Progression|3|||
161778493|NCT00445458|584230471|FG001|Overall Study|Disease Progression|4|||
161778494|NCT00445458|584230472|FG002|Overall Study|Disease Progression|54|||
161778495|NCT00445458|584230473|FG003|Overall Study|Disease Progression|27|||
161778496|NCT00445458|584230470|FG000|Overall Study|Withdrawal by Subject|0|||
161778497|NCT00445458|584230471|FG001|Overall Study|Withdrawal by Subject|0|||
161778498|NCT00445458|584230472|FG002|Overall Study|Withdrawal by Subject|7|||
161778499|NCT00445458|584230473|FG003|Overall Study|Withdrawal by Subject|0|||
161778500|NCT00445458|584230470|FG000|Overall Study|Adverse Event|0|||
161778501|NCT00445458|584230471|FG001|Overall Study|Adverse Event|0|||
161778502|NCT00445458|584230472|FG002|Overall Study|Adverse Event|3|||
161778503|NCT00445458|584230473|FG003|Overall Study|Adverse Event|0|||
161778504|NCT00445458|584230470|FG000|Overall Study|Death|0|||
161778505|NCT00445458|584230471|FG001|Overall Study|Death|1|||
161778506|NCT00445458|584230472|FG002|Overall Study|Death|2|||
161778507|NCT00445458|584230473|FG003|Overall Study|Death|0|||
161778508|NCT00445458|584230470|FG000|Overall Study|Physician Decision|0|||
161778509|NCT00445458|584230471|FG001|Overall Study|Physician Decision|0|||
161778510|NCT00445458|584230472|FG002|Overall Study|Physician Decision|1|||
161778511|NCT00445458|584230473|FG003|Overall Study|Physician Decision|1|||
161778512|NCT00445458|584230470|FG000|Overall Study|Surgery|0|||
161778513|NCT00445458|584230471|FG001|Overall Study|Surgery|0|||
161778514|NCT00445458|584230472|FG002|Overall Study|Surgery|1|||
161778515|NCT00445458|584230473|FG003|Overall Study|Surgery|0|||
161778516|NCT01393626|584230477|FG000|Overall Study|Adverse Event|2|||
161778517|NCT01393626|584230478|FG001|Overall Study|Adverse Event|1|||
161778518|NCT01393626|584230479|FG002|Overall Study|Adverse Event|5|||
161778519|NCT01393626|584230480|FG003|Overall Study|Adverse Event|0|||
161778520|NCT01393626|584230477|FG000|Overall Study|Did not meet entrance criteria|1|||
161778521|NCT01393626|584230478|FG001|Overall Study|Did not meet entrance criteria|0|||
161778522|NCT01393626|584230479|FG002|Overall Study|Did not meet entrance criteria|0|||
161778523|NCT01393626|584230480|FG003|Overall Study|Did not meet entrance criteria|0|||
161778524|NCT01393626|584230477|FG000|Overall Study|Lack of Efficacy|6|||
161778525|NCT01393626|584230478|FG001|Overall Study|Lack of Efficacy|6|||
161778526|NCT01393626|584230479|FG002|Overall Study|Lack of Efficacy|4|||
161778527|NCT01393626|584230480|FG003|Overall Study|Lack of Efficacy|1|||
161778528|NCT01393626|584230477|FG000|Overall Study|Lost to Follow-up|1|||
161778529|NCT01393626|584230478|FG001|Overall Study|Lost to Follow-up|1|||
161778530|NCT01393626|584230479|FG002|Overall Study|Lost to Follow-up|1|||
161778531|NCT01393626|584230480|FG003|Overall Study|Lost to Follow-up|0|||
161778532|NCT01393626|584230477|FG000|Overall Study|Withdrawal by Subject|6|||
161778533|NCT01393626|584230478|FG001|Overall Study|Withdrawal by Subject|4|||
161778534|NCT01393626|584230479|FG002|Overall Study|Withdrawal by Subject|0|||
161778535|NCT01393626|584230480|FG003|Overall Study|Withdrawal by Subject|0|||
161778536|NCT01393626|584230477|FG000|Overall Study|Other|1|||
161778537|NCT01393626|584230478|FG001|Overall Study|Other|0|||
161778538|NCT01393626|584230479|FG002|Overall Study|Other|0|||
161778539|NCT01393626|584230480|FG003|Overall Study|Other|0|||
161778540|NCT01393626|584230477|FG000|Overall Study|Protocol Violation|1|||
161778541|NCT01393626|584230478|FG001|Overall Study|Protocol Violation|0|||
161778542|NCT01393626|584230479|FG002|Overall Study|Protocol Violation|2|||
161778543|NCT01393626|584230480|FG003|Overall Study|Protocol Violation|0|||
161778544|NCT02426125|584230481|FG000|Overall Study|Lost to Follow-up|14|||
161778545|NCT02426125|584230482|FG001|Overall Study|Lost to Follow-up|12|||
161778546|NCT02426125|584230481|FG000|Overall Study|Withdrawal by Subject|13|||
161778547|NCT02426125|584230482|FG001|Overall Study|Withdrawal by Subject|14|||
161778548|NCT02426125|584230481|FG000|Overall Study|Death|185|||
161778549|NCT02426125|584230482|FG001|Overall Study|Death|200|||
161778550|NCT02426125|584230481|FG000|Overall Study|Randomized, But Never Treated|5|||
161778551|NCT02426125|584230482|FG001|Overall Study|Randomized, But Never Treated|2|||
161991664|NCT03364309|585018557|FG013|Induction Period|Adverse Event|0|||
161991665|NCT03364309|585018558|FG014|Induction Period|Adverse Event|0|||
161991666|NCT03364309|585018559|FG015|Induction Period|Adverse Event|0|||
161991667|NCT03364309|585018560|FG016|Induction Period|Adverse Event|0|||
161991668|NCT03364309|585018561|FG017|Induction Period|Adverse Event|0|||
161991669|NCT03364309|585018562|FG018|Induction Period|Adverse Event|0|||
161991670|NCT03364309|585018544|FG000|Induction Period|Withdrawal by Subject|1|||
161991671|NCT03364309|585018545|FG001|Induction Period|Withdrawal by Subject|3|||
161991672|NCT03364309|585018546|FG002|Induction Period|Withdrawal by Subject|0|||
161991673|NCT03364309|585018547|FG003|Induction Period|Withdrawal by Subject|0|||
161991674|NCT03364309|585018548|FG004|Induction Period|Withdrawal by Subject|0|||
161991675|NCT03364309|585018549|FG005|Induction Period|Withdrawal by Subject|0|||
161991676|NCT03364309|585018550|FG006|Induction Period|Withdrawal by Subject|0|||
161991677|NCT03364309|585018551|FG007|Induction Period|Withdrawal by Subject|0|||
161991678|NCT03364309|585018552|FG008|Induction Period|Withdrawal by Subject|0|||
161991679|NCT03364309|585018553|FG009|Induction Period|Withdrawal by Subject|0|||
161991680|NCT03364309|585018554|FG010|Induction Period|Withdrawal by Subject|0|||
161991681|NCT03364309|585018555|FG011|Induction Period|Withdrawal by Subject|0|||
161991682|NCT03364309|585018556|FG012|Induction Period|Withdrawal by Subject|0|||
161991683|NCT03364309|585018557|FG013|Induction Period|Withdrawal by Subject|0|||
161991684|NCT03364309|585018558|FG014|Induction Period|Withdrawal by Subject|0|||
161991685|NCT03364309|585018559|FG015|Induction Period|Withdrawal by Subject|0|||
161991686|NCT03364309|585018560|FG016|Induction Period|Withdrawal by Subject|0|||
161991687|NCT03364309|585018561|FG017|Induction Period|Withdrawal by Subject|0|||
161991688|NCT03364309|585018562|FG018|Induction Period|Withdrawal by Subject|0|||
161991689|NCT03364309|585018544|FG000|Induction Period|Lost to Follow-up|1|||
161991690|NCT03364309|585018545|FG001|Induction Period|Lost to Follow-up|0|||
161991691|NCT03364309|585018546|FG002|Induction Period|Lost to Follow-up|0|||
161991692|NCT03364309|585018547|FG003|Induction Period|Lost to Follow-up|0|||
161991693|NCT03364309|585018548|FG004|Induction Period|Lost to Follow-up|0|||
161991694|NCT03364309|585018549|FG005|Induction Period|Lost to Follow-up|0|||
161991695|NCT03364309|585018550|FG006|Induction Period|Lost to Follow-up|0|||
161991696|NCT03364309|585018551|FG007|Induction Period|Lost to Follow-up|0|||
161991697|NCT03364309|585018552|FG008|Induction Period|Lost to Follow-up|0|||
161991698|NCT03364309|585018553|FG009|Induction Period|Lost to Follow-up|0|||
161991699|NCT03364309|585018554|FG010|Induction Period|Lost to Follow-up|0|||
161991700|NCT03364309|585018555|FG011|Induction Period|Lost to Follow-up|0|||
161991701|NCT03364309|585018556|FG012|Induction Period|Lost to Follow-up|0|||
161991702|NCT03364309|585018557|FG013|Induction Period|Lost to Follow-up|0|||
161991703|NCT03364309|585018558|FG014|Induction Period|Lost to Follow-up|0|||
161991704|NCT03364309|585018559|FG015|Induction Period|Lost to Follow-up|0|||
161991705|NCT03364309|585018560|FG016|Induction Period|Lost to Follow-up|0|||
161991706|NCT03364309|585018561|FG017|Induction Period|Lost to Follow-up|0|||
161991707|NCT03364309|585018562|FG018|Induction Period|Lost to Follow-up|0|||
161991708|NCT03364309|585018544|FG000|Induction Period|Physician Decision|0|||
161991709|NCT03364309|585018545|FG001|Induction Period|Physician Decision|1|||
161991710|NCT03364309|585018546|FG002|Induction Period|Physician Decision|0|||
161991711|NCT03364309|585018547|FG003|Induction Period|Physician Decision|0|||
161991712|NCT03364309|585018548|FG004|Induction Period|Physician Decision|0|||
161991713|NCT03364309|585018549|FG005|Induction Period|Physician Decision|0|||
161991714|NCT03364309|585018550|FG006|Induction Period|Physician Decision|0|||
161991715|NCT03364309|585018551|FG007|Induction Period|Physician Decision|0|||
161991716|NCT03364309|585018552|FG008|Induction Period|Physician Decision|0|||
161991717|NCT03364309|585018553|FG009|Induction Period|Physician Decision|0|||
161991718|NCT03364309|585018554|FG010|Induction Period|Physician Decision|0|||
161991719|NCT03364309|585018555|FG011|Induction Period|Physician Decision|0|||
161991720|NCT03364309|585018556|FG012|Induction Period|Physician Decision|0|||
161991721|NCT03364309|585018557|FG013|Induction Period|Physician Decision|0|||
161991722|NCT03364309|585018558|FG014|Induction Period|Physician Decision|0|||
161991723|NCT03364309|585018559|FG015|Induction Period|Physician Decision|0|||
161991724|NCT03364309|585018560|FG016|Induction Period|Physician Decision|0|||
161991725|NCT03364309|585018561|FG017|Induction Period|Physician Decision|0|||
161991726|NCT03364309|585018562|FG018|Induction Period|Physician Decision|0|||
161991727|NCT03364309|585018544|FG000|Maintenance Period|Withdrawal by Subject|0|||
161991728|NCT03364309|585018545|FG001|Maintenance Period|Withdrawal by Subject|0|||
161991729|NCT03364309|585018546|FG002|Maintenance Period|Withdrawal by Subject|0|||
161991730|NCT03364309|585018547|FG003|Maintenance Period|Withdrawal by Subject|1|||
161991731|NCT03364309|585018548|FG004|Maintenance Period|Withdrawal by Subject|3|||
161991732|NCT03364309|585018549|FG005|Maintenance Period|Withdrawal by Subject|1|||
161991733|NCT03364309|585018550|FG006|Maintenance Period|Withdrawal by Subject|3|||
161991734|NCT03364309|585018551|FG007|Maintenance Period|Withdrawal by Subject|0|||
161991735|NCT03364309|585018552|FG008|Maintenance Period|Withdrawal by Subject|1|||
161991736|NCT03364309|585018553|FG009|Maintenance Period|Withdrawal by Subject|1|||
161991737|NCT03364309|585018554|FG010|Maintenance Period|Withdrawal by Subject|2|||
161991738|NCT03364309|585018555|FG011|Maintenance Period|Withdrawal by Subject|0|||
161991739|NCT03364309|585018556|FG012|Maintenance Period|Withdrawal by Subject|0|||
161778552|NCT03644927|584230485|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
161778553|NCT03644927|584230486|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
161778554|NCT00956813|584230487|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
161778555|NCT00956813|584230488|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
161778556|NCT00956813|584230487|FG000|Flaxseed and Placebo|Ineligible|3|||
161778557|NCT00956813|584230488|FG001|Flaxseed and Placebo|Ineligible|1|||
161778558|NCT02380248|584230489|FG000|Overall Study|Lost to Follow-up|11|||
161778559|NCT02380248|584230489|FG000|Overall Study|Withdrawal by Subject|3|||
161778560|NCT03128931|584230491|FG000|Overall Study|Physician Decision|1|||
161778561|NCT03128931|584230491|FG000|Overall Study|Equipment Issues|3|||
161778562|NCT03151226|584230492|FG000|Overall Study|Withdrawal by Subject|2|||
161778563|NCT03151226|584230492|FG000|Overall Study|not wear device correctly|1|||
161778564|NCT00903409|584230493|FG000|Overall Study|Adverse Event|11|||
161778565|NCT00903409|584230494|FG001|Overall Study|Adverse Event|9|||
161778566|NCT00903409|584230493|FG000|Overall Study|Non-compliance with Protocol|1|||
161778567|NCT00903409|584230494|FG001|Overall Study|Non-compliance with Protocol|1|||
161778568|NCT00903409|584230493|FG000|Overall Study|Laboratory Abnormality|2|||
161778569|NCT00903409|584230494|FG001|Overall Study|Laboratory Abnormality|0|||
161778570|NCT00903409|584230493|FG000|Overall Study|Withdrawal by Subject|8|||
161778571|NCT00903409|584230494|FG001|Overall Study|Withdrawal by Subject|8|||
161778572|NCT00903409|584230493|FG000|Overall Study|Other|2|||
161778573|NCT00903409|584230494|FG001|Overall Study|Other|3|||
161778574|NCT00903409|584230493|FG000|Overall Study|Lost to Follow-up|2|||
161778575|NCT00903409|584230494|FG001|Overall Study|Lost to Follow-up|6|||
161778576|NCT03239340|584230495|FG000|Overall Study|Other|26|||
161778577|NCT03239340|584230495|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
161778578|NCT03239340|584230495|FG000|Overall Study|Death|40|||
161778579|NCT03239340|584230495|FG000|Overall Study|Lost to Follow-up|2|||
161778580|NCT03239340|584230495|FG000|Overall Study|Physician Decision|16|||
161778581|NCT03239340|584230495|FG000|Overall Study|Withdrawal by Subject|27|||
161778582|NCT03539952|584230497|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
161778583|NCT03539952|584230498|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
161778584|NCT03539952|584230497|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
161778585|NCT03539952|584230498|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
161778586|NCT03539952|584230497|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
161778587|NCT03539952|584230498|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
161778588|NCT03539952|584230497|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
161778589|NCT03539952|584230498|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
161778590|NCT03539952|584230497|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
161778591|NCT03539952|584230498|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
161778592|NCT03539952|584230497|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
161778593|NCT03539952|584230498|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
161778594|NCT03539952|584230497|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
161778595|NCT03539952|584230498|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
161778596|NCT02184988|584230499|FG000|Overall Study|Pregnancy|2|||
161778597|NCT02184988|584230499|FG000|Overall Study|Adverse Event|2|||
161778598|NCT02184988|584230499|FG000|Overall Study|moving away/travelling/unable to complet|6|||
161778599|NCT02184988|584230499|FG000|Overall Study|work scheduling issues|4|||
161778600|NCT02184988|584230499|FG000|Overall Study|various other reasons|9|||
161778601|NCT02184988|584230499|FG000|Overall Study|Lost to Follow-up|32|||
161778602|NCT05378269|584232277|FG000|Overall Study|Protocol Violation|1|||
161778603|NCT05378269|584232278|FG001|Overall Study|Protocol Violation|0|||
161778604|NCT05378269|584232279|FG002|Overall Study|Protocol Violation|2|||
161778605|NCT05378269|584232280|FG003|Overall Study|Protocol Violation|0|||
161778606|NCT05378269|584232281|FG004|Overall Study|Protocol Violation|0|||
161778607|NCT01371006|584232282|FG000|Overall Study|Adverse Event|1|||
161778608|NCT01371006|584232283|FG001|Overall Study|Adverse Event|0|||
161778609|NCT03256526|584232284|FG000|Overall Study|Adverse Event|1|||
161778610|NCT03256526|584232285|FG001|Overall Study|Adverse Event|0|||
161778611|NCT03256526|584232286|FG002|Overall Study|Adverse Event|1|||
161778612|NCT03256526|584232284|FG000|Overall Study|Lost to Follow-up|1|||
161778613|NCT03256526|584232285|FG001|Overall Study|Lost to Follow-up|0|||
161778614|NCT03256526|584232286|FG002|Overall Study|Lost to Follow-up|2|||
161778615|NCT00891527|584232287|FG000|Overall Study|Withdrawal by Subject|2|||
161778616|NCT01186744|584232288|FG000|Overall Study|Lack of Efficacy|156|||
161778617|NCT01186744|584232289|FG001|Overall Study|Lack of Efficacy|99|||
161778618|NCT01186744|584232290|FG002|Overall Study|Lack of Efficacy|0|||
161778619|NCT01186744|584232291|FG003|Overall Study|Lack of Efficacy|2|||
161778620|NCT01186744|584232292|FG004|Overall Study|Lack of Efficacy|2|||
161778621|NCT01186744|584232293|FG005|Overall Study|Lack of Efficacy|5|||
161778622|NCT01186744|584232288|FG000|Overall Study|Protocol Violation|1|||
161778623|NCT01186744|584232289|FG001|Overall Study|Protocol Violation|2|||
161778624|NCT01186744|584232290|FG002|Overall Study|Protocol Violation|0|||
161778625|NCT01186744|584232291|FG003|Overall Study|Protocol Violation|1|||
161778626|NCT01186744|584232292|FG004|Overall Study|Protocol Violation|1|||
161778627|NCT01186744|584232293|FG005|Overall Study|Protocol Violation|2|||
161778628|NCT01186744|584232288|FG000|Overall Study|Lost to Follow-up|15|||
161778629|NCT01186744|584232289|FG001|Overall Study|Lost to Follow-up|16|||
161778630|NCT01186744|584232290|FG002|Overall Study|Lost to Follow-up|2|||
161778631|NCT01186744|584232291|FG003|Overall Study|Lost to Follow-up|1|||
161778632|NCT01186744|584232292|FG004|Overall Study|Lost to Follow-up|1|||
161778633|NCT01186744|584232293|FG005|Overall Study|Lost to Follow-up|4|||
161778634|NCT01186744|584232288|FG000|Overall Study|Screen failure|1|||
161778635|NCT01186744|584232289|FG001|Overall Study|Screen failure|1|||
161778636|NCT01186744|584232290|FG002|Overall Study|Screen failure|0|||
161778637|NCT01186744|584232291|FG003|Overall Study|Screen failure|1|||
161778638|NCT01186744|584232292|FG004|Overall Study|Screen failure|0|||
161778639|NCT01186744|584232293|FG005|Overall Study|Screen failure|0|||
161778640|NCT01186744|584232288|FG000|Overall Study|Withdrawal by Subject|14|||
161778641|NCT01186744|584232289|FG001|Overall Study|Withdrawal by Subject|10|||
161778642|NCT01186744|584232290|FG002|Overall Study|Withdrawal by Subject|2|||
161778643|NCT01186744|584232291|FG003|Overall Study|Withdrawal by Subject|5|||
161778644|NCT01186744|584232292|FG004|Overall Study|Withdrawal by Subject|0|||
161778645|NCT01186744|584232293|FG005|Overall Study|Withdrawal by Subject|6|||
161778646|NCT01186744|584232288|FG000|Overall Study|Study terminated by Sponsor|1|||
161778647|NCT01186744|584232289|FG001|Overall Study|Study terminated by Sponsor|0|||
161778648|NCT01186744|584232290|FG002|Overall Study|Study terminated by Sponsor|0|||
161778649|NCT01186744|584232291|FG003|Overall Study|Study terminated by Sponsor|0|||
161778650|NCT01186744|584232292|FG004|Overall Study|Study terminated by Sponsor|0|||
161778651|NCT01186744|584232293|FG005|Overall Study|Study terminated by Sponsor|0|||
161778652|NCT01186744|584232288|FG000|Overall Study|Other|9|||
161778653|NCT01186744|584232289|FG001|Overall Study|Other|10|||
161778654|NCT01186744|584232290|FG002|Overall Study|Other|1|||
161778655|NCT01186744|584232291|FG003|Overall Study|Other|2|||
161778656|NCT01186744|584232292|FG004|Overall Study|Other|1|||
161778657|NCT01186744|584232293|FG005|Overall Study|Other|5|||
161778658|NCT01186744|584232288|FG000|Overall Study|Adverse Event|10|||
161991740|NCT03364309|585018557|FG013|Maintenance Period|Withdrawal by Subject|0|||
161991741|NCT03364309|585018558|FG014|Maintenance Period|Withdrawal by Subject|0|||
161991742|NCT03364309|585018559|FG015|Maintenance Period|Withdrawal by Subject|0|||
161991743|NCT03364309|585018560|FG016|Maintenance Period|Withdrawal by Subject|0|||
161991744|NCT03364309|585018561|FG017|Maintenance Period|Withdrawal by Subject|0|||
161991745|NCT03364309|585018562|FG018|Maintenance Period|Withdrawal by Subject|0|||
161991746|NCT03364309|585018544|FG000|Maintenance Period|Adverse Event|0|||
161991747|NCT03364309|585018545|FG001|Maintenance Period|Adverse Event|0|||
161991748|NCT03364309|585018546|FG002|Maintenance Period|Adverse Event|0|||
161991749|NCT03364309|585018547|FG003|Maintenance Period|Adverse Event|0|||
161991750|NCT03364309|585018548|FG004|Maintenance Period|Adverse Event|2|||
161991751|NCT03364309|585018549|FG005|Maintenance Period|Adverse Event|0|||
161991752|NCT03364309|585018550|FG006|Maintenance Period|Adverse Event|3|||
161991753|NCT03364309|585018551|FG007|Maintenance Period|Adverse Event|0|||
161991754|NCT03364309|585018552|FG008|Maintenance Period|Adverse Event|1|||
161991755|NCT03364309|585018553|FG009|Maintenance Period|Adverse Event|0|||
161991756|NCT03364309|585018554|FG010|Maintenance Period|Adverse Event|2|||
161991757|NCT03364309|585018555|FG011|Maintenance Period|Adverse Event|0|||
161991758|NCT03364309|585018556|FG012|Maintenance Period|Adverse Event|0|||
161991759|NCT03364309|585018557|FG013|Maintenance Period|Adverse Event|0|||
161991760|NCT03364309|585018558|FG014|Maintenance Period|Adverse Event|0|||
161991761|NCT03364309|585018559|FG015|Maintenance Period|Adverse Event|0|||
161991762|NCT03364309|585018560|FG016|Maintenance Period|Adverse Event|0|||
161991763|NCT03364309|585018561|FG017|Maintenance Period|Adverse Event|0|||
161991764|NCT03364309|585018562|FG018|Maintenance Period|Adverse Event|0|||
161991765|NCT03364309|585018544|FG000|Maintenance Period|Relapsed|0|||
161991766|NCT03364309|585018545|FG001|Maintenance Period|Relapsed|0|||
161991767|NCT03364309|585018546|FG002|Maintenance Period|Relapsed|0|||
161991768|NCT03364309|585018547|FG003|Maintenance Period|Relapsed|43|||
161991769|NCT03364309|585018548|FG004|Maintenance Period|Relapsed|7|||
161991770|NCT03364309|585018549|FG005|Maintenance Period|Relapsed|45|||
161991771|NCT03364309|585018550|FG006|Maintenance Period|Relapsed|10|||
161991772|NCT03364309|585018551|FG007|Maintenance Period|Relapsed|2|||
161991773|NCT03364309|585018552|FG008|Maintenance Period|Relapsed|0|||
161991774|NCT03364309|585018553|FG009|Maintenance Period|Relapsed|0|||
161991775|NCT03364309|585018554|FG010|Maintenance Period|Relapsed|0|||
161991776|NCT03364309|585018555|FG011|Maintenance Period|Relapsed|0|||
161778659|NCT01186744|584232289|FG001|Overall Study|Adverse Event|14|||
161778660|NCT01186744|584232290|FG002|Overall Study|Adverse Event|1|||
161778661|NCT01186744|584232291|FG003|Overall Study|Adverse Event|0|||
161778662|NCT01186744|584232292|FG004|Overall Study|Adverse Event|1|||
161778663|NCT01186744|584232293|FG005|Overall Study|Adverse Event|4|||
161778664|NCT01186744|584232288|FG000|Overall Study|Death|1|||
161778665|NCT01186744|584232289|FG001|Overall Study|Death|0|||
161778666|NCT01186744|584232290|FG002|Overall Study|Death|0|||
161991777|NCT03364309|585018556|FG012|Maintenance Period|Relapsed|0|||
161991778|NCT03364309|585018557|FG013|Maintenance Period|Relapsed|0|||
161778667|NCT01186744|584232291|FG003|Overall Study|Death|0|||
161778668|NCT01186744|584232292|FG004|Overall Study|Death|0|||
161778669|NCT01186744|584232293|FG005|Overall Study|Death|0|||
161778670|NCT03515837|584232297|FG000|Overall Study|Death|219|||
161778671|NCT03515837|584232298|FG001|Overall Study|Death|227|||
161882467|NCT00581542|584612930|FG000|Overall Study|Lost to Follow-up|9|||
161778672|NCT03515837|584232297|FG000|Overall Study|Lost to Follow-up|0|||
161778673|NCT03515837|584232298|FG001|Overall Study|Lost to Follow-up|1|||
161778674|NCT03515837|584232297|FG000|Overall Study|Withdrawal by Subject|0|||
161778675|NCT03515837|584232298|FG001|Overall Study|Withdrawal by Subject|4|||
161778676|NCT03515837|584232297|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
161778677|NCT03515837|584232298|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
161778678|NCT02325401|584232299|FG000|Overall Study|Withdrawal by Subject|0|||
161778679|NCT02325401|584232300|FG001|Overall Study|Withdrawal by Subject|1|||
161778680|NCT02325401|584232301|FG002|Overall Study|Withdrawal by Subject|1|||
161778681|NCT01856686|584232302|FG000|Overall Study|Lost to Follow-up|5|||
161778682|NCT01856686|584232303|FG001|Overall Study|Lost to Follow-up|11|||
161778683|NCT02086968|584232310|FG000|Overall Study|Adverse Event|1|||
161778684|NCT02086968|584232311|FG001|Overall Study|Adverse Event|5|||
161778685|NCT02086968|584232310|FG000|Overall Study|Lost to Follow-up|2|||
161778686|NCT02086968|584232311|FG001|Overall Study|Lost to Follow-up|3|||
161778687|NCT02086968|584232310|FG000|Overall Study|Study drug received outside protocol|0|||
161778688|NCT02086968|584232311|FG001|Overall Study|Study drug received outside protocol|1|||
161778689|NCT02086968|584232310|FG000|Overall Study|Physician Decision|4|||
161778690|NCT02086968|584232311|FG001|Overall Study|Physician Decision|0|||
161778691|NCT02086968|584232310|FG000|Overall Study|Withdrawal by Subject|1|||
161778692|NCT02086968|584232311|FG001|Overall Study|Withdrawal by Subject|4|||
161778693|NCT04101721|584232312|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
161778694|NCT04101721|584232313|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
161778695|NCT04101721|584232312|FG000|Overall Study|Death|0|||
161778696|NCT04101721|584232313|FG001|Overall Study|Death|1|||
161778697|NCT04101721|584232312|FG000|Overall Study|Lost to Follow-up|0|||
161778698|NCT04101721|584232313|FG001|Overall Study|Lost to Follow-up|3|||
161778699|NCT01215955|584232314|FG000|Overall Study|Adverse Event|1|||
161778700|NCT01215955|584232315|FG001|Overall Study|Adverse Event|4|||
161778701|NCT01215955|584232316|FG002|Overall Study|Adverse Event|2|||
161778702|NCT01215955|584232317|FG003|Overall Study|Adverse Event|3|||
161778703|NCT01215955|584232314|FG000|Overall Study|Death|2|||
161778704|NCT01215955|584232315|FG001|Overall Study|Death|0|||
161778705|NCT01215955|584232316|FG002|Overall Study|Death|1|||
161778706|NCT01215955|584232317|FG003|Overall Study|Death|3|||
161778707|NCT01215955|584232314|FG000|Overall Study|Entry Criteria Not Met|1|||
161778708|NCT01215955|584232315|FG001|Overall Study|Entry Criteria Not Met|3|||
161778709|NCT01215955|584232316|FG002|Overall Study|Entry Criteria Not Met|4|||
161778710|NCT01215955|584232317|FG003|Overall Study|Entry Criteria Not Met|7|||
161778711|NCT01215955|584232314|FG000|Overall Study|Lack of Efficacy|1|||
161778712|NCT01215955|584232315|FG001|Overall Study|Lack of Efficacy|2|||
161778713|NCT01215955|584232316|FG002|Overall Study|Lack of Efficacy|1|||
161778714|NCT01215955|584232317|FG003|Overall Study|Lack of Efficacy|0|||
161778715|NCT01215955|584232314|FG000|Overall Study|Lost to Follow-up|4|||
161778716|NCT01215955|584232315|FG001|Overall Study|Lost to Follow-up|4|||
161778717|NCT01215955|584232316|FG002|Overall Study|Lost to Follow-up|8|||
161778718|NCT01215955|584232317|FG003|Overall Study|Lost to Follow-up|9|||
161778719|NCT01215955|584232314|FG000|Overall Study|Physician Decision|4|||
161778720|NCT01215955|584232315|FG001|Overall Study|Physician Decision|10|||
161778721|NCT01215955|584232316|FG002|Overall Study|Physician Decision|8|||
161778722|NCT01215955|584232317|FG003|Overall Study|Physician Decision|11|||
161778723|NCT01215955|584232314|FG000|Overall Study|Protocol Violation|17|||
161778724|NCT01215955|584232315|FG001|Overall Study|Protocol Violation|13|||
161778725|NCT01215955|584232316|FG002|Overall Study|Protocol Violation|8|||
161778726|NCT01215955|584232317|FG003|Overall Study|Protocol Violation|8|||
161882468|NCT00581542|584612931|FG001|Overall Study|Lost to Follow-up|21|||
161882469|NCT00195494|584612937|FG000|Year 1|Adverse Event|0|||
161882470|NCT00195494|584612938|FG001|Year 1|Adverse Event|0|||
161882471|NCT00195494|584612939|FG002|Year 1|Adverse Event|0|||
161882472|NCT00195494|584612940|FG003|Year 1|Adverse Event|0|||
161882473|NCT00195494|584612941|FG004|Year 1|Adverse Event|34|||
161778727|NCT01215955|584232314|FG000|Overall Study|Sponsor Decision|1|||
161778728|NCT01215955|584232315|FG001|Overall Study|Sponsor Decision|2|||
161778729|NCT01215955|584232316|FG002|Overall Study|Sponsor Decision|0|||
161778730|NCT01215955|584232317|FG003|Overall Study|Sponsor Decision|1|||
161778731|NCT01215955|584232314|FG000|Overall Study|Withdrawal by Subject|14|||
161778732|NCT01215955|584232315|FG001|Overall Study|Withdrawal by Subject|15|||
161778733|NCT01215955|584232316|FG002|Overall Study|Withdrawal by Subject|13|||
161778734|NCT01215955|584232317|FG003|Overall Study|Withdrawal by Subject|9|||
161778735|NCT01215955|584232314|FG000|Overall Study|Quality Issues|0|||
161778736|NCT01215955|584232315|FG001|Overall Study|Quality Issues|0|||
161778737|NCT01215955|584232316|FG002|Overall Study|Quality Issues|3|||
161778738|NCT01215955|584232317|FG003|Overall Study|Quality Issues|2|||
161882474|NCT00195494|584612942|FG005|Year 1|Adverse Event|27|||
161882475|NCT00195494|584612937|FG000|Year 1|System Toxicity|0|||
161882476|NCT00195494|584612938|FG001|Year 1|System Toxicity|0|||
161882477|NCT00195494|584612939|FG002|Year 1|System Toxicity|0|||
161882478|NCT00195494|584612940|FG003|Year 1|System Toxicity|0|||
161882479|NCT00195494|584612941|FG004|Year 1|System Toxicity|0|||
161882480|NCT00195494|584612942|FG005|Year 1|System Toxicity|1|||
161882481|NCT00195494|584612937|FG000|Year 1|Lack of Efficacy|0|||
161882482|NCT00195494|584612938|FG001|Year 1|Lack of Efficacy|0|||
161882483|NCT00195494|584612939|FG002|Year 1|Lack of Efficacy|0|||
161882484|NCT00195494|584612940|FG003|Year 1|Lack of Efficacy|0|||
161882485|NCT00195494|584612941|FG004|Year 1|Lack of Efficacy|24|||
161882486|NCT00195494|584612942|FG005|Year 1|Lack of Efficacy|9|||
161882487|NCT00195494|584612937|FG000|Year 1|Compliance|0|||
161882488|NCT00195494|584612938|FG001|Year 1|Compliance|0|||
161882489|NCT00195494|584612939|FG002|Year 1|Compliance|0|||
161882490|NCT00195494|584612940|FG003|Year 1|Compliance|0|||
161882491|NCT00195494|584612941|FG004|Year 1|Compliance|5|||
161882492|NCT00195494|584612942|FG005|Year 1|Compliance|1|||
161882493|NCT00195494|584612937|FG000|Year 1|Lost to Follow-up|0|||
161882494|NCT00195494|584612938|FG001|Year 1|Lost to Follow-up|0|||
161882495|NCT00195494|584612939|FG002|Year 1|Lost to Follow-up|0|||
161882496|NCT00195494|584612940|FG003|Year 1|Lost to Follow-up|0|||
161882497|NCT00195494|584612941|FG004|Year 1|Lost to Follow-up|1|||
161882498|NCT00195494|584612942|FG005|Year 1|Lost to Follow-up|0|||
161882499|NCT00195494|584612937|FG000|Year 1|Missed >4 consecutive doses|0|||
161882500|NCT00195494|584612938|FG001|Year 1|Missed >4 consecutive doses|0|||
161882501|NCT00195494|584612939|FG002|Year 1|Missed >4 consecutive doses|0|||
161882502|NCT00195494|584612940|FG003|Year 1|Missed >4 consecutive doses|0|||
161882503|NCT00195494|584612941|FG004|Year 1|Missed >4 consecutive doses|3|||
161882504|NCT00195494|584612942|FG005|Year 1|Missed >4 consecutive doses|2|||
161882505|NCT00195494|584612937|FG000|Year 1|Protocol deviation|0|||
161882506|NCT00195494|584612938|FG001|Year 1|Protocol deviation|0|||
161882507|NCT00195494|584612939|FG002|Year 1|Protocol deviation|0|||
161882508|NCT00195494|584612940|FG003|Year 1|Protocol deviation|0|||
161882509|NCT00195494|584612941|FG004|Year 1|Protocol deviation|2|||
161882510|NCT00195494|584612942|FG005|Year 1|Protocol deviation|3|||
161882511|NCT00195494|584612937|FG000|Year 1|Physician Decision|0|||
161882512|NCT00195494|584612938|FG001|Year 1|Physician Decision|0|||
161882513|NCT00195494|584612939|FG002|Year 1|Physician Decision|0|||
161882514|NCT00195494|584612940|FG003|Year 1|Physician Decision|0|||
161882515|NCT00195494|584612941|FG004|Year 1|Physician Decision|1|||
161882516|NCT00195494|584612942|FG005|Year 1|Physician Decision|0|||
161882517|NCT00195494|584612937|FG000|Year 1|Withdrawal by Subject|0|||
161882518|NCT00195494|584612938|FG001|Year 1|Withdrawal by Subject|0|||
161882519|NCT00195494|584612939|FG002|Year 1|Withdrawal by Subject|0|||
161882520|NCT00195494|584612940|FG003|Year 1|Withdrawal by Subject|0|||
161882521|NCT00195494|584612941|FG004|Year 1|Withdrawal by Subject|8|||
161882522|NCT00195494|584612942|FG005|Year 1|Withdrawal by Subject|9|||
161882523|NCT00195494|584612937|FG000|Year 1|Protocol Violation|0|||
161882524|NCT00195494|584612938|FG001|Year 1|Protocol Violation|0|||
161882525|NCT00195494|584612939|FG002|Year 1|Protocol Violation|0|||
161882526|NCT00195494|584612940|FG003|Year 1|Protocol Violation|0|||
161882527|NCT00195494|584612941|FG004|Year 1|Protocol Violation|1|||
161882528|NCT00195494|584612942|FG005|Year 1|Protocol Violation|1|||
161882529|NCT00195494|584612937|FG000|Year 2|Adverse Event|3|||
161882530|NCT00195494|584612938|FG001|Year 2|Adverse Event|7|||
161882531|NCT00195494|584612939|FG002|Year 2|Adverse Event|5|||
161882532|NCT00195494|584612940|FG003|Year 2|Adverse Event|9|||
161882533|NCT00195494|584612941|FG004|Year 2|Adverse Event|0|||
161882534|NCT00195494|584612942|FG005|Year 2|Adverse Event|0|||
161882535|NCT00195494|584612937|FG000|Year 2|Lack of Efficacy|0|||
161882536|NCT00195494|584612938|FG001|Year 2|Lack of Efficacy|1|||
161882537|NCT00195494|584612939|FG002|Year 2|Lack of Efficacy|7|||
161882538|NCT00195494|584612940|FG003|Year 2|Lack of Efficacy|7|||
161882539|NCT00195494|584612941|FG004|Year 2|Lack of Efficacy|0|||
161882540|NCT00195494|584612942|FG005|Year 2|Lack of Efficacy|0|||
161882541|NCT00195494|584612937|FG000|Year 2|Compliance|1|||
161991779|NCT03364309|585018558|FG014|Maintenance Period|Relapsed|0|||
161991780|NCT03364309|585018559|FG015|Maintenance Period|Relapsed|0|||
161991781|NCT03364309|585018560|FG016|Maintenance Period|Relapsed|0|||
161882542|NCT00195494|584612938|FG001|Year 2|Compliance|0|||
161882543|NCT00195494|584612939|FG002|Year 2|Compliance|0|||
161882544|NCT00195494|584612940|FG003|Year 2|Compliance|2|||
161882545|NCT00195494|584612941|FG004|Year 2|Compliance|0|||
161882546|NCT00195494|584612942|FG005|Year 2|Compliance|0|||
161882547|NCT00195494|584612937|FG000|Year 2|Lost to Follow-up|0|||
161882548|NCT00195494|584612938|FG001|Year 2|Lost to Follow-up|0|||
161882549|NCT00195494|584612939|FG002|Year 2|Lost to Follow-up|1|||
161882550|NCT00195494|584612940|FG003|Year 2|Lost to Follow-up|1|||
161882551|NCT00195494|584612941|FG004|Year 2|Lost to Follow-up|0|||
161882552|NCT00195494|584612942|FG005|Year 2|Lost to Follow-up|0|||
161882553|NCT00195494|584612937|FG000|Year 2|Missed >4 consecutive doses|1|||
161882554|NCT00195494|584612938|FG001|Year 2|Missed >4 consecutive doses|1|||
161882555|NCT00195494|584612939|FG002|Year 2|Missed >4 consecutive doses|1|||
161882556|NCT00195494|584612940|FG003|Year 2|Missed >4 consecutive doses|0|||
161882557|NCT00195494|584612941|FG004|Year 2|Missed >4 consecutive doses|0|||
161991782|NCT03364309|585018561|FG017|Maintenance Period|Relapsed|0|||
161882558|NCT00195494|584612942|FG005|Year 2|Missed >4 consecutive doses|0|||
161882559|NCT00195494|584612937|FG000|Year 2|Protocol deviation|0|||
161882560|NCT00195494|584612938|FG001|Year 2|Protocol deviation|1|||
161882561|NCT00195494|584612939|FG002|Year 2|Protocol deviation|0|||
161882562|NCT00195494|584612940|FG003|Year 2|Protocol deviation|0|||
161882563|NCT00195494|584612941|FG004|Year 2|Protocol deviation|0|||
161882564|NCT00195494|584612942|FG005|Year 2|Protocol deviation|0|||
161882565|NCT00195494|584612937|FG000|Year 2|Physician Decision|1|||
161882566|NCT00195494|584612938|FG001|Year 2|Physician Decision|1|||
161882567|NCT00195494|584612939|FG002|Year 2|Physician Decision|0|||
161882568|NCT00195494|584612940|FG003|Year 2|Physician Decision|0|||
161882569|NCT00195494|584612941|FG004|Year 2|Physician Decision|0|||
161882570|NCT00195494|584612942|FG005|Year 2|Physician Decision|0|||
161882571|NCT00195494|584612937|FG000|Year 2|Withdrawal by Subject|1|||
161882572|NCT00195494|584612938|FG001|Year 2|Withdrawal by Subject|5|||
161882573|NCT00195494|584612939|FG002|Year 2|Withdrawal by Subject|4|||
161882574|NCT00195494|584612940|FG003|Year 2|Withdrawal by Subject|3|||
161882575|NCT00195494|584612941|FG004|Year 2|Withdrawal by Subject|0|||
161882576|NCT00195494|584612942|FG005|Year 2|Withdrawal by Subject|0|||
161882577|NCT00195494|584612937|FG000|Year 2|System toxicity|0|||
161882578|NCT00195494|584612938|FG001|Year 2|System toxicity|0|||
161882579|NCT00195494|584612939|FG002|Year 2|System toxicity|0|||
161882580|NCT00195494|584612940|FG003|Year 2|System toxicity|1|||
161882581|NCT00195494|584612941|FG004|Year 2|System toxicity|0|||
161882582|NCT00195494|584612942|FG005|Year 2|System toxicity|0|||
161882583|NCT00381043|584612951|FG000|Overall Study|Lost to Follow-up|8|||
161882584|NCT00381043|584612952|FG001|Overall Study|Lost to Follow-up|6|||
161882585|NCT00381043|584612951|FG000|Overall Study|Withdrawal by Subject|3|||
161882586|NCT00381043|584612952|FG001|Overall Study|Withdrawal by Subject|1|||
161882587|NCT00381043|584612951|FG000|Overall Study|wanted more care|0|||
161882588|NCT00381043|584612952|FG001|Overall Study|wanted more care|1|||
161882589|NCT00381043|584612951|FG000|Overall Study|incarcerated|1|||
161882590|NCT00381043|584612952|FG001|Overall Study|incarcerated|0|||
161882591|NCT03045276|584612953|FG000|Intervention Phase|Withdrawal by Subject|7|||
161882592|NCT03045276|584612954|FG001|Intervention Phase|Withdrawal by Subject|2|||
161882593|NCT03045276|584612955|FG002|Intervention Phase|Withdrawal by Subject|3|||
161882594|NCT03045276|584612956|FG003|Intervention Phase|Withdrawal by Subject|7|||
161882595|NCT03045276|584612953|FG000|Intervention Phase|Developed exclusionary criteria|3|||
161882596|NCT03045276|584612954|FG001|Intervention Phase|Developed exclusionary criteria|3|||
161882597|NCT03045276|584612955|FG002|Intervention Phase|Developed exclusionary criteria|0|||
161882598|NCT03045276|584612956|FG003|Intervention Phase|Developed exclusionary criteria|0|||
161882599|NCT03045276|584612953|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
161882600|NCT03045276|584612954|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
161882601|NCT03045276|584612955|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
161882602|NCT03045276|584612956|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
161882603|NCT03045276|584612953|FG000|Follow-Up Phase|Lost to Follow-up|0|||
161882604|NCT03045276|584612954|FG001|Follow-Up Phase|Lost to Follow-up|1|||
161882605|NCT03045276|584612955|FG002|Follow-Up Phase|Lost to Follow-up|0|||
161882606|NCT03045276|584612956|FG003|Follow-Up Phase|Lost to Follow-up|1|||
161882607|NCT03045276|584612953|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
161882608|NCT03045276|584612954|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
161882609|NCT03045276|584612955|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
161882610|NCT03045276|584612956|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
161882611|NCT00915876|584612961|FG000|Overall Study|Adverse Event|0|||
161882612|NCT00915876|584612962|FG001|Overall Study|Adverse Event|1|||
161882613|NCT02496091|584612968|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161882614|NCT02272842|584612969|FG000|Overall Study|Lost to Follow-up|8|||
161882615|NCT02272842|584612970|FG001|Overall Study|Lost to Follow-up|8|||
161882616|NCT02272842|584612969|FG000|Overall Study|Withdrawal by Subject|8|||
161882617|NCT02272842|584612970|FG001|Overall Study|Withdrawal by Subject|2|||
161882618|NCT01984892|584612973|FG000|Overall Study|Progressive disease|7|||
161882619|NCT04464720|584612974|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
161882620|NCT05723328|584612976|FG000|Overall Study|Investigator's Decision|5|||
161882621|NCT05723328|584612977|FG001|Overall Study|Investigator's Decision|2|||
161882622|NCT04599933|584615032|FG000|Overall Study|Adverse Event|4|||
161882623|NCT04599933|584615033|FG001|Overall Study|Adverse Event|1|||
161882624|NCT04599933|584615032|FG000|Overall Study|Withdrawal by Subject|4|||
161882625|NCT04599933|584615033|FG001|Overall Study|Withdrawal by Subject|2|||
161882626|NCT04599933|584615032|FG000|Overall Study|Lost to Follow-up|0|||
161882627|NCT04599933|584615033|FG001|Overall Study|Lost to Follow-up|1|||
161882628|NCT04599933|584615032|FG000|Overall Study|Physician Decision|0|||
161882629|NCT04599933|584615033|FG001|Overall Study|Physician Decision|1|||
161882630|NCT04599933|584615032|FG000|Overall Study|Screen Failure|1|||
161882631|NCT04599933|584615033|FG001|Overall Study|Screen Failure|2|||
161882632|NCT01358578|584615041|FG000|Induction Period|Adverse Event|2|||
161882633|NCT01358578|584615042|FG001|Induction Period|Adverse Event|4|||
161882634|NCT01358578|584615043|FG002|Induction Period|Adverse Event|2|||
161882635|NCT01358578|584615044|FG003|Induction Period|Adverse Event|6|||
161882636|NCT01358578|584615045|FG004|Induction Period|Adverse Event|0|||
161882637|NCT01358578|584615046|FG005|Induction Period|Adverse Event|0|||
161882638|NCT01358578|584615041|FG000|Induction Period|Lack of Efficacy|0|||
161882639|NCT01358578|584615042|FG001|Induction Period|Lack of Efficacy|0|||
161882640|NCT01358578|584615043|FG002|Induction Period|Lack of Efficacy|9|||
161882641|NCT01358578|584615044|FG003|Induction Period|Lack of Efficacy|1|||
161882642|NCT01358578|584615045|FG004|Induction Period|Lack of Efficacy|0|||
161882643|NCT01358578|584615046|FG005|Induction Period|Lack of Efficacy|0|||
161882644|NCT01358578|584615041|FG000|Induction Period|Lost to Follow-up|0|||
161882645|NCT01358578|584615042|FG001|Induction Period|Lost to Follow-up|0|||
161882646|NCT01358578|584615043|FG002|Induction Period|Lost to Follow-up|1|||
161882647|NCT01358578|584615044|FG003|Induction Period|Lost to Follow-up|4|||
161882648|NCT01358578|584615045|FG004|Induction Period|Lost to Follow-up|0|||
161882649|NCT01358578|584615046|FG005|Induction Period|Lost to Follow-up|0|||
161882650|NCT01358578|584615041|FG000|Induction Period|Physician Decision|2|||
161882651|NCT01358578|584615042|FG001|Induction Period|Physician Decision|1|||
161882652|NCT01358578|584615043|FG002|Induction Period|Physician Decision|2|||
161882653|NCT01358578|584615044|FG003|Induction Period|Physician Decision|0|||
161882654|NCT01358578|584615045|FG004|Induction Period|Physician Decision|0|||
161882655|NCT01358578|584615046|FG005|Induction Period|Physician Decision|0|||
161882656|NCT01358578|584615041|FG000|Induction Period|Protocol Deviation|3|||
161882657|NCT01358578|584615042|FG001|Induction Period|Protocol Deviation|5|||
161882658|NCT01358578|584615043|FG002|Induction Period|Protocol Deviation|0|||
161882659|NCT01358578|584615044|FG003|Induction Period|Protocol Deviation|3|||
161882660|NCT01358578|584615045|FG004|Induction Period|Protocol Deviation|0|||
161882661|NCT01358578|584615046|FG005|Induction Period|Protocol Deviation|0|||
161882662|NCT01358578|584615041|FG000|Induction Period|technical problems|0|||
161882663|NCT01358578|584615042|FG001|Induction Period|technical problems|0|||
161882664|NCT01358578|584615043|FG002|Induction Period|technical problems|1|||
161882665|NCT01358578|584615044|FG003|Induction Period|technical problems|1|||
161882666|NCT01358578|584615045|FG004|Induction Period|technical problems|0|||
161882667|NCT01358578|584615046|FG005|Induction Period|technical problems|0|||
161882668|NCT01358578|584615041|FG000|Induction Period|Withdrawal by Subject|5|||
161882669|NCT01358578|584615042|FG001|Induction Period|Withdrawal by Subject|5|||
161882670|NCT01358578|584615043|FG002|Induction Period|Withdrawal by Subject|10|||
161882671|NCT01358578|584615044|FG003|Induction Period|Withdrawal by Subject|6|||
161882672|NCT01358578|584615045|FG004|Induction Period|Withdrawal by Subject|0|||
161882673|NCT01358578|584615046|FG005|Induction Period|Withdrawal by Subject|0|||
161882674|NCT01358578|584615041|FG000|Maintenance Period|Adverse Event|2|||
161882675|NCT01358578|584615042|FG001|Maintenance Period|Adverse Event|7|||
161882676|NCT01358578|584615043|FG002|Maintenance Period|Adverse Event|0|||
161882677|NCT01358578|584615044|FG003|Maintenance Period|Adverse Event|6|||
161882678|NCT01358578|584615045|FG004|Maintenance Period|Adverse Event|4|||
161882679|NCT01358578|584615046|FG005|Maintenance Period|Adverse Event|3|||
161882680|NCT01358578|584615041|FG000|Maintenance Period|Lack of Efficacy|10|||
161882681|NCT01358578|584615042|FG001|Maintenance Period|Lack of Efficacy|2|||
161882682|NCT01358578|584615043|FG002|Maintenance Period|Lack of Efficacy|0|||
161882683|NCT01358578|584615044|FG003|Maintenance Period|Lack of Efficacy|11|||
161882684|NCT01358578|584615045|FG004|Maintenance Period|Lack of Efficacy|3|||
161882685|NCT01358578|584615046|FG005|Maintenance Period|Lack of Efficacy|0|||
161882686|NCT01358578|584615041|FG000|Maintenance Period|Lost to Follow-up|4|||
161882687|NCT01358578|584615042|FG001|Maintenance Period|Lost to Follow-up|0|||
161882688|NCT01358578|584615043|FG002|Maintenance Period|Lost to Follow-up|0|||
161882689|NCT01358578|584615044|FG003|Maintenance Period|Lost to Follow-up|5|||
161882690|NCT01358578|584615045|FG004|Maintenance Period|Lost to Follow-up|1|||
161882691|NCT01358578|584615046|FG005|Maintenance Period|Lost to Follow-up|1|||
161882692|NCT01358578|584615041|FG000|Maintenance Period|Non-compliance with study treatment|3|||
161991783|NCT03364309|585018562|FG018|Maintenance Period|Relapsed|0|||
161991784|NCT03364309|585018544|FG000|Maintenance Period|Lack of Efficacy|0|||
161882693|NCT01358578|584615042|FG001|Maintenance Period|Non-compliance with study treatment|1|||
161882694|NCT01358578|584615043|FG002|Maintenance Period|Non-compliance with study treatment|0|||
161882695|NCT01358578|584615044|FG003|Maintenance Period|Non-compliance with study treatment|2|||
161882696|NCT01358578|584615045|FG004|Maintenance Period|Non-compliance with study treatment|1|||
161882697|NCT01358578|584615046|FG005|Maintenance Period|Non-compliance with study treatment|2|||
161882698|NCT01358578|584615041|FG000|Maintenance Period|Physician Decision|0|||
161882699|NCT01358578|584615042|FG001|Maintenance Period|Physician Decision|1|||
161882700|NCT01358578|584615043|FG002|Maintenance Period|Physician Decision|0|||
161882701|NCT01358578|584615044|FG003|Maintenance Period|Physician Decision|1|||
161882702|NCT01358578|584615045|FG004|Maintenance Period|Physician Decision|0|||
161882703|NCT01358578|584615046|FG005|Maintenance Period|Physician Decision|0|||
161882704|NCT01358578|584615041|FG000|Maintenance Period|Pregnancy|1|||
161882705|NCT01358578|584615042|FG001|Maintenance Period|Pregnancy|0|||
161882706|NCT01358578|584615043|FG002|Maintenance Period|Pregnancy|0|||
161882707|NCT01358578|584615044|FG003|Maintenance Period|Pregnancy|0|||
161882708|NCT01358578|584615045|FG004|Maintenance Period|Pregnancy|0|||
161882709|NCT01358578|584615046|FG005|Maintenance Period|Pregnancy|0|||
161778739|NCT05013749|584232318|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
161778740|NCT05013749|584232319|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
161778741|NCT05013749|584232318|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
161778742|NCT05013749|584232319|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
161778743|NCT02858076|584232320|FG000|Overall Study|Death|6|||
161778744|NCT02858076|584232321|FG001|Overall Study|Death|3|||
161778745|NCT02858076|584232320|FG000|Overall Study|Withdrawal by Subject|1|||
161778746|NCT02858076|584232321|FG001|Overall Study|Withdrawal by Subject|5|||
161778747|NCT02858076|584232320|FG000|Overall Study|Lost to Follow-up|2|||
161778748|NCT02858076|584232321|FG001|Overall Study|Lost to Follow-up|7|||
161778749|NCT02858076|584232320|FG000|Overall Study|Completed Out of Window|1|||
161778750|NCT02858076|584232321|FG001|Overall Study|Completed Out of Window|3|||
161778751|NCT02643394|584232322|FG000|Overall Study|Protocol Violation|4|||
161778752|NCT02643394|584232323|FG001|Overall Study|Protocol Violation|5|||
161778753|NCT00943384|584232324|FG000|Overall Study|Dispositioned prior to treatment|23|||
161778754|NCT00943384|584232324|FG000|Overall Study|Treated off protocol-protocol violation|5|||
161778755|NCT00943384|584232324|FG000|Overall Study|Lost to Follow-up|16|||
161778756|NCT00943384|584232324|FG000|Overall Study|Withdrawal by Subject|5|||
161778757|NCT00096200|584232325|FG000|Overall Study|Adverse Event|0|||
161778758|NCT00096200|584232326|FG001|Overall Study|Adverse Event|4|||
161778759|NCT00096200|584232327|FG002|Overall Study|Adverse Event|0|||
161778760|NCT00096200|584232325|FG000|Overall Study|Withdrawal by Subject|1|||
161778761|NCT00096200|584232326|FG001|Overall Study|Withdrawal by Subject|2|||
161778762|NCT00096200|584232327|FG002|Overall Study|Withdrawal by Subject|0|||
161778763|NCT00096200|584232325|FG000|Overall Study|Ineligible pathology|0|||
161778764|NCT00096200|584232326|FG001|Overall Study|Ineligible pathology|1|||
161778765|NCT00096200|584232327|FG002|Overall Study|Ineligible pathology|0|||
161778766|NCT00077766|584232329|FG000|Overall Study|Adverse Event|1|||
161778767|NCT00077766|584232330|FG001|Overall Study|Adverse Event|1|||
161778768|NCT00077766|584232329|FG000|Overall Study|Withdrawal by Subject|4|||
161778769|NCT00077766|584232330|FG001|Overall Study|Withdrawal by Subject|3|||
161778770|NCT00077766|584232329|FG000|Overall Study|Death|12|||
161778771|NCT00077766|584232330|FG001|Overall Study|Death|10|||
161778772|NCT00077766|584232329|FG000|Overall Study|Lost to Follow-up|2|||
161778773|NCT00077766|584232330|FG001|Overall Study|Lost to Follow-up|0|||
161778774|NCT00077766|584232329|FG000|Overall Study|Protocol Violation|1|||
161778775|NCT00077766|584232330|FG001|Overall Study|Protocol Violation|0|||
161778776|NCT00077766|584232329|FG000|Overall Study|Kidney Transplantation|9|||
161778777|NCT00077766|584232330|FG001|Overall Study|Kidney Transplantation|5|||
161778778|NCT00077766|584232329|FG000|Overall Study|Transplantation|5|||
161778779|NCT00077766|584232330|FG001|Overall Study|Transplantation|1|||
161778780|NCT00077766|584232329|FG000|Overall Study|Investigators Discretion|1|||
161778781|NCT00077766|584232330|FG001|Overall Study|Investigators Discretion|0|||
161778782|NCT00077766|584232329|FG000|Overall Study|Participant's decision|1|||
161778783|NCT00077766|584232330|FG001|Overall Study|Participant's decision|0|||
161778784|NCT00077766|584232329|FG000|Overall Study|Dialysis Discontinued|1|||
161778785|NCT00077766|584232330|FG001|Overall Study|Dialysis Discontinued|0|||
161778786|NCT00077766|584232329|FG000|Overall Study|Dialysis|0|||
161778787|NCT00077766|584232330|FG001|Overall Study|Dialysis|1|||
161778788|NCT00077766|584232329|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
161778789|NCT00077766|584232330|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
161778790|NCT00077766|584232329|FG000|Overall Study|Started Nocturnal Dialysis|0|||
161778791|NCT00077766|584232330|FG001|Overall Study|Started Nocturnal Dialysis|1|||
161778792|NCT00077766|584232329|FG000|Overall Study|Stop Dialysis|0|||
161778793|NCT00077766|584232330|FG001|Overall Study|Stop Dialysis|1|||
161778794|NCT00077766|584232329|FG000|Overall Study|Participants Vacation|2|||
161778795|NCT00077766|584232330|FG001|Overall Study|Participants Vacation|1|||
161778796|NCT00938015|584232331|FG000|Overall Study|Death|2|||
161778797|NCT00938015|584232331|FG000|Overall Study|Lost to Follow-up|32|||
161778798|NCT00938015|584232331|FG000|Overall Study|Adverse Event|32|||
161778799|NCT00938015|584232331|FG000|Overall Study|Non-responder|52|||
161778800|NCT00938015|584232331|FG000|Overall Study|Reason not related to Etanercept|29|||
161778801|NCT02341482|584232332|FG000|Overall Study|Adverse Event|1|||
161778802|NCT03186794|584232333|FG000|Overall Study|Physician Decision|2|||
161778803|NCT03186794|584232333|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
161778804|NCT02575807|584232338|FG000|Overall Study|Death|8|||
161778805|NCT02575807|584232339|FG001|Overall Study|Death|3|||
161778806|NCT02575807|584232340|FG002|Overall Study|Death|7|||
161778807|NCT02575807|584232341|FG003|Overall Study|Death|0|||
161778808|NCT02575807|584232342|FG004|Overall Study|Death|1|||
161778809|NCT02575807|584232338|FG000|Overall Study|Study terminated by Sponsor|0|||
161778810|NCT02575807|584232339|FG001|Overall Study|Study terminated by Sponsor|1|||
161778811|NCT02575807|584232340|FG002|Overall Study|Study terminated by Sponsor|7|||
161778812|NCT02575807|584232341|FG003|Overall Study|Study terminated by Sponsor|0|||
161778813|NCT02575807|584232342|FG004|Overall Study|Study terminated by Sponsor|1|||
161778814|NCT02575807|584232338|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
161991785|NCT03364309|585018545|FG001|Maintenance Period|Lack of Efficacy|0|||
161991786|NCT03364309|585018546|FG002|Maintenance Period|Lack of Efficacy|0|||
161991787|NCT03364309|585018547|FG003|Maintenance Period|Lack of Efficacy|0|||
161991788|NCT03364309|585018548|FG004|Maintenance Period|Lack of Efficacy|0|||
161991789|NCT03364309|585018549|FG005|Maintenance Period|Lack of Efficacy|0|||
161991790|NCT03364309|585018550|FG006|Maintenance Period|Lack of Efficacy|0|||
161991791|NCT03364309|585018551|FG007|Maintenance Period|Lack of Efficacy|0|||
161991792|NCT03364309|585018552|FG008|Maintenance Period|Lack of Efficacy|1|||
161991793|NCT03364309|585018553|FG009|Maintenance Period|Lack of Efficacy|3|||
161991794|NCT03364309|585018554|FG010|Maintenance Period|Lack of Efficacy|2|||
161991795|NCT03364309|585018555|FG011|Maintenance Period|Lack of Efficacy|0|||
161991796|NCT03364309|585018556|FG012|Maintenance Period|Lack of Efficacy|0|||
161991797|NCT03364309|585018557|FG013|Maintenance Period|Lack of Efficacy|0|||
161991798|NCT03364309|585018558|FG014|Maintenance Period|Lack of Efficacy|0|||
161991799|NCT03364309|585018559|FG015|Maintenance Period|Lack of Efficacy|0|||
161991800|NCT03364309|585018560|FG016|Maintenance Period|Lack of Efficacy|0|||
161991801|NCT03364309|585018561|FG017|Maintenance Period|Lack of Efficacy|0|||
161991802|NCT03364309|585018562|FG018|Maintenance Period|Lack of Efficacy|0|||
161991803|NCT03364309|585018544|FG000|Maintenance Period|Death|0|||
161991804|NCT03364309|585018545|FG001|Maintenance Period|Death|0|||
161991805|NCT03364309|585018546|FG002|Maintenance Period|Death|0|||
161991806|NCT03364309|585018547|FG003|Maintenance Period|Death|0|||
161991807|NCT03364309|585018548|FG004|Maintenance Period|Death|0|||
161991808|NCT03364309|585018549|FG005|Maintenance Period|Death|0|||
161991809|NCT03364309|585018550|FG006|Maintenance Period|Death|0|||
161991810|NCT03364309|585018551|FG007|Maintenance Period|Death|0|||
161991811|NCT03364309|585018552|FG008|Maintenance Period|Death|1|||
161991812|NCT03364309|585018553|FG009|Maintenance Period|Death|0|||
161991813|NCT03364309|585018554|FG010|Maintenance Period|Death|0|||
161991814|NCT03364309|585018555|FG011|Maintenance Period|Death|0|||
161991815|NCT03364309|585018556|FG012|Maintenance Period|Death|0|||
161991816|NCT03364309|585018557|FG013|Maintenance Period|Death|0|||
161991817|NCT03364309|585018558|FG014|Maintenance Period|Death|0|||
161991818|NCT03364309|585018559|FG015|Maintenance Period|Death|0|||
161991819|NCT03364309|585018560|FG016|Maintenance Period|Death|0|||
161991820|NCT03364309|585018561|FG017|Maintenance Period|Death|0|||
161991821|NCT03364309|585018562|FG018|Maintenance Period|Death|0|||
161991822|NCT03364309|585018544|FG000|Maintenance Period|Lost to Follow-up|0|||
161991823|NCT03364309|585018545|FG001|Maintenance Period|Lost to Follow-up|0|||
161991824|NCT03364309|585018546|FG002|Maintenance Period|Lost to Follow-up|0|||
161991825|NCT03364309|585018547|FG003|Maintenance Period|Lost to Follow-up|0|||
161991826|NCT03364309|585018548|FG004|Maintenance Period|Lost to Follow-up|0|||
161991827|NCT03364309|585018549|FG005|Maintenance Period|Lost to Follow-up|0|||
161991828|NCT03364309|585018550|FG006|Maintenance Period|Lost to Follow-up|0|||
161991829|NCT03364309|585018551|FG007|Maintenance Period|Lost to Follow-up|0|||
161991830|NCT03364309|585018552|FG008|Maintenance Period|Lost to Follow-up|1|||
161991831|NCT03364309|585018553|FG009|Maintenance Period|Lost to Follow-up|0|||
161991832|NCT03364309|585018554|FG010|Maintenance Period|Lost to Follow-up|0|||
161991833|NCT03364309|585018555|FG011|Maintenance Period|Lost to Follow-up|0|||
161991834|NCT03364309|585018556|FG012|Maintenance Period|Lost to Follow-up|0|||
161991835|NCT03364309|585018557|FG013|Maintenance Period|Lost to Follow-up|0|||
161991836|NCT03364309|585018558|FG014|Maintenance Period|Lost to Follow-up|0|||
161991837|NCT03364309|585018559|FG015|Maintenance Period|Lost to Follow-up|0|||
161991838|NCT03364309|585018560|FG016|Maintenance Period|Lost to Follow-up|0|||
161991839|NCT03364309|585018561|FG017|Maintenance Period|Lost to Follow-up|0|||
161991840|NCT03364309|585018562|FG018|Maintenance Period|Lost to Follow-up|0|||
161991841|NCT03364309|585018544|FG000|Maintenance Period|Miscellaneous|0|||
161991842|NCT03364309|585018545|FG001|Maintenance Period|Miscellaneous|0|||
161991843|NCT03364309|585018546|FG002|Maintenance Period|Miscellaneous|0|||
161991844|NCT03364309|585018547|FG003|Maintenance Period|Miscellaneous|0|||
161991845|NCT03364309|585018548|FG004|Maintenance Period|Miscellaneous|0|||
161991846|NCT03364309|585018549|FG005|Maintenance Period|Miscellaneous|0|||
161991847|NCT03364309|585018550|FG006|Maintenance Period|Miscellaneous|0|||
161991848|NCT03364309|585018551|FG007|Maintenance Period|Miscellaneous|0|||
161991849|NCT03364309|585018552|FG008|Maintenance Period|Miscellaneous|1|||
161991850|NCT03364309|585018553|FG009|Maintenance Period|Miscellaneous|0|||
161991851|NCT03364309|585018554|FG010|Maintenance Period|Miscellaneous|0|||
161991852|NCT03364309|585018555|FG011|Maintenance Period|Miscellaneous|0|||
161991853|NCT03364309|585018556|FG012|Maintenance Period|Miscellaneous|0|||
161991854|NCT03364309|585018557|FG013|Maintenance Period|Miscellaneous|0|||
161991855|NCT03364309|585018558|FG014|Maintenance Period|Miscellaneous|0|||
161991856|NCT03364309|585018559|FG015|Maintenance Period|Miscellaneous|0|||
161991857|NCT03364309|585018560|FG016|Maintenance Period|Miscellaneous|0|||
161991858|NCT03364309|585018561|FG017|Maintenance Period|Miscellaneous|0|||
161991859|NCT03364309|585018562|FG018|Maintenance Period|Miscellaneous|0|||
161991860|NCT03364309|585018544|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161991861|NCT03364309|585018545|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161991862|NCT03364309|585018546|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161991863|NCT03364309|585018547|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161778815|NCT02575807|584232339|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
161778816|NCT02575807|584232340|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
161778817|NCT02575807|584232341|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
161778818|NCT02575807|584232342|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
161778819|NCT02575807|584232338|FG000|Overall Study|Terminated due to physician decision|0|||
161778820|NCT02575807|584232339|FG001|Overall Study|Terminated due to physician decision|0|||
161882710|NCT01358578|584615041|FG000|Maintenance Period|Protocol deviation|7|||
161882711|NCT01358578|584615042|FG001|Maintenance Period|Protocol deviation|4|||
161882712|NCT01358578|584615043|FG002|Maintenance Period|Protocol deviation|0|||
161882713|NCT01358578|584615044|FG003|Maintenance Period|Protocol deviation|2|||
161882714|NCT01358578|584615045|FG004|Maintenance Period|Protocol deviation|2|||
161882715|NCT01358578|584615046|FG005|Maintenance Period|Protocol deviation|2|||
161882716|NCT01358578|584615041|FG000|Maintenance Period|Withdrawal by Subject|12|||
161882717|NCT01358578|584615042|FG001|Maintenance Period|Withdrawal by Subject|7|||
161882718|NCT01358578|584615043|FG002|Maintenance Period|Withdrawal by Subject|2|||
161882719|NCT01358578|584615044|FG003|Maintenance Period|Withdrawal by Subject|15|||
161882720|NCT01358578|584615045|FG004|Maintenance Period|Withdrawal by Subject|6|||
161882721|NCT01358578|584615046|FG005|Maintenance Period|Withdrawal by Subject|3|||
161882722|NCT01358578|584615041|FG000|Follow-up Period|Adverse Event|1|||
161882723|NCT01358578|584615042|FG001|Follow-up Period|Adverse Event|1|||
161882724|NCT01358578|584615043|FG002|Follow-up Period|Adverse Event|0|||
161882725|NCT01358578|584615044|FG003|Follow-up Period|Adverse Event|0|||
161882726|NCT01358578|584615045|FG004|Follow-up Period|Adverse Event|0|||
161882727|NCT01358578|584615046|FG005|Follow-up Period|Adverse Event|0|||
161882728|NCT01358578|584615041|FG000|Follow-up Period|Lack of Efficacy|3|||
161882729|NCT01358578|584615042|FG001|Follow-up Period|Lack of Efficacy|0|||
161882730|NCT01358578|584615043|FG002|Follow-up Period|Lack of Efficacy|4|||
161882731|NCT01358578|584615044|FG003|Follow-up Period|Lack of Efficacy|1|||
161882732|NCT01358578|584615045|FG004|Follow-up Period|Lack of Efficacy|0|||
161882733|NCT01358578|584615046|FG005|Follow-up Period|Lack of Efficacy|0|||
161882734|NCT01358578|584615041|FG000|Follow-up Period|Lost to Follow-up|0|||
161882735|NCT01358578|584615042|FG001|Follow-up Period|Lost to Follow-up|1|||
161882736|NCT01358578|584615043|FG002|Follow-up Period|Lost to Follow-up|0|||
161882737|NCT01358578|584615044|FG003|Follow-up Period|Lost to Follow-up|4|||
161882738|NCT01358578|584615045|FG004|Follow-up Period|Lost to Follow-up|0|||
161882739|NCT01358578|584615046|FG005|Follow-up Period|Lost to Follow-up|0|||
161882740|NCT01358578|584615041|FG000|Follow-up Period|non- compliance with study treatment|1|||
161882741|NCT01358578|584615042|FG001|Follow-up Period|non- compliance with study treatment|0|||
161882742|NCT01358578|584615043|FG002|Follow-up Period|non- compliance with study treatment|0|||
161882743|NCT01358578|584615044|FG003|Follow-up Period|non- compliance with study treatment|0|||
161882744|NCT01358578|584615045|FG004|Follow-up Period|non- compliance with study treatment|0|||
161882745|NCT01358578|584615046|FG005|Follow-up Period|non- compliance with study treatment|0|||
161882746|NCT01358578|584615041|FG000|Follow-up Period|Pregnancy|1|||
161882747|NCT01358578|584615042|FG001|Follow-up Period|Pregnancy|0|||
161882748|NCT01358578|584615043|FG002|Follow-up Period|Pregnancy|0|||
161882749|NCT01358578|584615044|FG003|Follow-up Period|Pregnancy|0|||
161882750|NCT01358578|584615045|FG004|Follow-up Period|Pregnancy|0|||
161882751|NCT01358578|584615046|FG005|Follow-up Period|Pregnancy|0|||
161882752|NCT01358578|584615041|FG000|Follow-up Period|Withdrawal by Subject|3|||
161882753|NCT01358578|584615042|FG001|Follow-up Period|Withdrawal by Subject|3|||
161882754|NCT01358578|584615043|FG002|Follow-up Period|Withdrawal by Subject|1|||
161882755|NCT01358578|584615044|FG003|Follow-up Period|Withdrawal by Subject|12|||
161882756|NCT01358578|584615045|FG004|Follow-up Period|Withdrawal by Subject|0|||
161882757|NCT01358578|584615046|FG005|Follow-up Period|Withdrawal by Subject|0|||
161882758|NCT01358578|584615041|FG000|Follow-up Period|Physician Decision|1|||
161882759|NCT01358578|584615042|FG001|Follow-up Period|Physician Decision|1|||
161882760|NCT01358578|584615043|FG002|Follow-up Period|Physician Decision|0|||
161882761|NCT01358578|584615044|FG003|Follow-up Period|Physician Decision|2|||
161882762|NCT01358578|584615045|FG004|Follow-up Period|Physician Decision|0|||
161882763|NCT01358578|584615046|FG005|Follow-up Period|Physician Decision|0|||
161882764|NCT01643798|584615047|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
161882765|NCT01643798|584615048|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
161882766|NCT03605849|584615049|FG000|Overall Study|Adverse Event|20|||
161882767|NCT03605849|584615050|FG001|Overall Study|Adverse Event|21|||
161882768|NCT03605849|584615051|FG002|Overall Study|Adverse Event|29|||
161882769|NCT03605849|584615052|FG003|Overall Study|Adverse Event|11|||
161882770|NCT03605849|584615049|FG000|Overall Study|Lack of Efficacy|4|||
161882771|NCT03605849|584615050|FG001|Overall Study|Lack of Efficacy|7|||
161882772|NCT03605849|584615051|FG002|Overall Study|Lack of Efficacy|9|||
161882773|NCT03605849|584615052|FG003|Overall Study|Lack of Efficacy|2|||
161778821|NCT02575807|584232340|FG002|Overall Study|Terminated due to physician decision|1|||
161882774|NCT03605849|584615049|FG000|Overall Study|Lost to Follow-up|8|||
161882775|NCT03605849|584615050|FG001|Overall Study|Lost to Follow-up|8|||
161882776|NCT03605849|584615051|FG002|Overall Study|Lost to Follow-up|14|||
161882777|NCT03605849|584615052|FG003|Overall Study|Lost to Follow-up|11|||
161882778|NCT03605849|584615049|FG000|Overall Study|Non-compliance With IMP|6|||
161882779|NCT03605849|584615050|FG001|Overall Study|Non-compliance With IMP|5|||
161882780|NCT03605849|584615051|FG002|Overall Study|Non-compliance With IMP|2|||
161882781|NCT03605849|584615052|FG003|Overall Study|Non-compliance With IMP|1|||
161882782|NCT03605849|584615049|FG000|Overall Study|Protocol Deviation|1|||
161882783|NCT03605849|584615050|FG001|Overall Study|Protocol Deviation|2|||
161882784|NCT03605849|584615051|FG002|Overall Study|Protocol Deviation|1|||
161882785|NCT03605849|584615052|FG003|Overall Study|Protocol Deviation|3|||
161882786|NCT03605849|584615049|FG000|Overall Study|Withdrawal by Subject|33|||
161882787|NCT03605849|584615050|FG001|Overall Study|Withdrawal by Subject|28|||
161882788|NCT03605849|584615051|FG002|Overall Study|Withdrawal by Subject|30|||
161882789|NCT03605849|584615052|FG003|Overall Study|Withdrawal by Subject|28|||
161882790|NCT03605849|584615049|FG000|Overall Study|Site Terminated by Sponsor|0|||
161882791|NCT03605849|584615050|FG001|Overall Study|Site Terminated by Sponsor|0|||
161882792|NCT03605849|584615051|FG002|Overall Study|Site Terminated by Sponsor|0|||
161882793|NCT03605849|584615052|FG003|Overall Study|Site Terminated by Sponsor|1|||
161882794|NCT03605849|584615049|FG000|Overall Study|Physician Decision|2|||
161882795|NCT03605849|584615050|FG001|Overall Study|Physician Decision|1|||
161882796|NCT03605849|584615051|FG002|Overall Study|Physician Decision|2|||
161882797|NCT03605849|584615052|FG003|Overall Study|Physician Decision|1|||
161882798|NCT03605849|584615049|FG000|Overall Study|Enrolled, but not Treated|2|||
161882799|NCT03605849|584615050|FG001|Overall Study|Enrolled, but not Treated|2|||
161882800|NCT03605849|584615051|FG002|Overall Study|Enrolled, but not Treated|3|||
161882801|NCT03605849|584615052|FG003|Overall Study|Enrolled, but not Treated|2|||
161882802|NCT03605849|584615049|FG000|Overall Study|Other (COVID-19 Related)|0|||
161882803|NCT03605849|584615050|FG001|Overall Study|Other (COVID-19 Related)|1|||
161882804|NCT03605849|584615051|FG002|Overall Study|Other (COVID-19 Related)|1|||
161882805|NCT03605849|584615052|FG003|Overall Study|Other (COVID-19 Related)|0|||
161882806|NCT03605849|584615049|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
161882807|NCT03605849|584615050|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
161882808|NCT03605849|584615051|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
161882809|NCT03605849|584615052|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
161882810|NCT05014815|584615053|FG000|Overall Study|Death|63|||
161882811|NCT05014815|584615054|FG001|Overall Study|Death|70|||
161882812|NCT05014815|584615053|FG000|Overall Study|Withdrawal by Subject|10|||
161882813|NCT05014815|584615054|FG001|Overall Study|Withdrawal by Subject|10|||
161882814|NCT05014815|584615053|FG000|Overall Study|Lost to Follow-up|4|||
161882815|NCT05014815|584615054|FG001|Overall Study|Lost to Follow-up|2|||
161882816|NCT05014815|584615053|FG000|Overall Study|Physician Decision|2|||
161882817|NCT05014815|584615054|FG001|Overall Study|Physician Decision|4|||
161882818|NCT06303167|584615065|FG000|Overall Study|Ineligible|1|||
161882819|NCT06303167|584615065|FG000|Overall Study|Never start protocol therapy|2|||
161882820|NCT06303167|584615065|FG000|Overall Study|Disease progression|16|||
161882821|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Death|117|||
161882822|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Death|197|||
161882823|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
161882824|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
161882825|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
161882826|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
161882827|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
161882828|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
161882829|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
161882830|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
161882831|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
161882832|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
161882833|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
161882834|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
161882835|NCT02677896|584615066|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
161882836|NCT02677896|584615067|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
161882837|NCT02677896|584615066|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
161882838|NCT02677896|584615067|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
161882839|NCT02677896|584615066|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
161882840|NCT02677896|584615067|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
161882841|NCT02677896|584615066|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
161882842|NCT02677896|584615067|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
161882843|NCT02677896|584615066|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
161882844|NCT02677896|584615067|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
161882845|NCT02677896|584615066|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
161882846|NCT02677896|584615067|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
161882847|NCT02677896|584615066|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
161882848|NCT02677896|584615067|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
161882849|NCT00655733|584615073|FG000|Overall Study|Lost to Follow-up|2|||
161882850|NCT00655733|584615074|FG001|Overall Study|Lost to Follow-up|2|||
161882851|NCT00655733|584615073|FG000|Overall Study|Adverse Event|2|||
161882852|NCT00655733|584615074|FG001|Overall Study|Adverse Event|2|||
161882853|NCT00655733|584615073|FG000|Overall Study|Withdrawal by Subject|3|||
161882854|NCT00655733|584615074|FG001|Overall Study|Withdrawal by Subject|3|||
161882855|NCT00655733|584615073|FG000|Overall Study|Physician Decision|0|||
161882856|NCT00655733|584615074|FG001|Overall Study|Physician Decision|1|||
161882857|NCT01482962|584615078|FG000|Overall Study|Progressive Disease|65|||
161882858|NCT01482962|584615079|FG001|Overall Study|Progressive Disease|53|||
161882859|NCT01482962|584615078|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
161882860|NCT01482962|584615079|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
161882861|NCT01482962|584615078|FG000|Overall Study|Adverse Event|18|||
161882862|NCT01482962|584615079|FG001|Overall Study|Adverse Event|22|||
161882863|NCT01482962|584615078|FG000|Overall Study|Withdrawal by Participant|8|||
161882864|NCT01482962|584615079|FG001|Overall Study|Withdrawal by Participant|13|||
161882865|NCT01482962|584615078|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
161882866|NCT01482962|584615079|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
161882867|NCT01482962|584615078|FG000|Overall Study|Other Reason|1|||
161882868|NCT01482962|584615079|FG001|Overall Study|Other Reason|5|||
161882869|NCT01482962|584615078|FG000|Overall Study|Study Terminated by Sponsor|5|||
161882870|NCT01482962|584615079|FG001|Overall Study|Study Terminated by Sponsor|2|||
161882871|NCT01482962|584615078|FG000|Overall Study|Did not Receive Study Drug|1|||
161882872|NCT01482962|584615079|FG001|Overall Study|Did not Receive Study Drug|6|||
161882873|NCT02407457|584615080|FG000|1 Month|Death|3|||
161882874|NCT02407457|584615081|FG001|1 Month|Death|0|||
161882875|NCT02407457|584615080|FG000|1 Month|Lost to Follow-up|1|||
161882876|NCT02407457|584615081|FG001|1 Month|Lost to Follow-up|1|||
161882877|NCT02407457|584615080|FG000|1 Month|missed visit|2|||
161882878|NCT02407457|584615081|FG001|1 Month|missed visit|5|||
161882879|NCT02407457|584615080|FG000|6-Month|Death|2|||
161882880|NCT02407457|584615081|FG001|6-Month|Death|8|||
161882881|NCT02407457|584615080|FG000|6-Month|Lost to Follow-up|2|||
161882882|NCT02407457|584615081|FG001|6-Month|Lost to Follow-up|2|||
161882883|NCT02407457|584615080|FG000|6-Month|missed visit|16|||
161882884|NCT02407457|584615081|FG001|6-Month|missed visit|14|||
161882885|NCT02407457|584615080|FG000|6-Month|Open Repair|0|||
161882886|NCT02407457|584615081|FG001|6-Month|Open Repair|1|||
161882887|NCT02407457|584615080|FG000|1 Year|Death|6|||
161882888|NCT02407457|584615081|FG001|1 Year|Death|11|||
161882889|NCT02407457|584615080|FG000|1 Year|Lost to Follow-up|3|||
161882890|NCT02407457|584615081|FG001|1 Year|Lost to Follow-up|2|||
161882891|NCT02407457|584615080|FG000|1 Year|Missed Visit|24|||
161882892|NCT02407457|584615081|FG001|1 Year|Missed Visit|14|||
161882893|NCT02407457|584615080|FG000|1 Year|Open Repair|0|||
161882894|NCT02407457|584615081|FG001|1 Year|Open Repair|1|||
161882895|NCT02407457|584615080|FG000|2-year|Death|14|||
161882896|NCT02407457|584615081|FG001|2-year|Death|8|||
161882897|NCT02407457|584615080|FG000|2-year|Lost to Follow-up|7|||
161882898|NCT02407457|584615081|FG001|2-year|Lost to Follow-up|10|||
161882899|NCT02407457|584615080|FG000|2-year|Missed Visit|13|||
161882900|NCT02407457|584615081|FG001|2-year|Missed Visit|15|||
161882901|NCT02407457|584615080|FG000|2-year|Open Repair|0|||
161882902|NCT02407457|584615081|FG001|2-year|Open Repair|2|||
161882903|NCT02407457|584615080|FG000|3-year|Death|11|||
161882904|NCT02407457|584615081|FG001|3-year|Death|10|||
161882905|NCT02407457|584615080|FG000|3-year|Lost to Follow-up|9|||
161778822|NCT02575807|584232341|FG003|Overall Study|Terminated due to physician decision|0|||
161778823|NCT02575807|584232342|FG004|Overall Study|Terminated due to physician decision|0|||
161778824|NCT02575807|584232338|FG000|Overall Study|Subject ineligible - medical implant|0|||
161778825|NCT02575807|584232339|FG001|Overall Study|Subject ineligible - medical implant|0|||
161778826|NCT02575807|584232340|FG002|Overall Study|Subject ineligible - medical implant|0|||
161778827|NCT02575807|584232341|FG003|Overall Study|Subject ineligible - medical implant|1|||
161778828|NCT02575807|584232342|FG004|Overall Study|Subject ineligible - medical implant|0|||
161778829|NCT02575807|584232338|FG000|Overall Study|Withdrawal by Subject|0|||
161778830|NCT02575807|584232339|FG001|Overall Study|Withdrawal by Subject|0|||
161778831|NCT02575807|584232340|FG002|Overall Study|Withdrawal by Subject|1|||
161778832|NCT02575807|584232341|FG003|Overall Study|Withdrawal by Subject|1|||
161778833|NCT02575807|584232342|FG004|Overall Study|Withdrawal by Subject|2|||
161778834|NCT02180659|584232343|FG000|Overall Study|Adverse Event|1|||
161778835|NCT02180659|584232344|FG001|Overall Study|Adverse Event|0|||
161778836|NCT02180659|584232343|FG000|Overall Study|Lost to Follow-up|4|||
161778837|NCT02180659|584232344|FG001|Overall Study|Lost to Follow-up|2|||
161778838|NCT02180659|584232343|FG000|Overall Study|Subject incarcerated during conduct|1|||
161778839|NCT02180659|584232344|FG001|Overall Study|Subject incarcerated during conduct|0|||
161778840|NCT02180659|584232343|FG000|Overall Study|Withdrawal by Subject|0|||
161778841|NCT02180659|584232344|FG001|Overall Study|Withdrawal by Subject|2|||
161778842|NCT02180659|584232343|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
161778843|NCT02180659|584232344|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
161778844|NCT01154673|584232345|FG000|Overall Study|Lost to Follow-up|1|||
161882906|NCT02407457|584615081|FG001|3-year|Lost to Follow-up|10|||
161882907|NCT02407457|584615080|FG000|3-year|Missed Visit|19|||
161882908|NCT02407457|584615081|FG001|3-year|Missed Visit|16|||
161882909|NCT02407457|584615080|FG000|4-year|Death|18|||
161882910|NCT02407457|584615081|FG001|4-year|Death|10|||
161882911|NCT02407457|584615080|FG000|4-year|Lost to Follow-up|10|||
161882912|NCT02407457|584615081|FG001|4-year|Lost to Follow-up|12|||
161882913|NCT02407457|584615080|FG000|4-year|Missed Visit|18|||
161882914|NCT02407457|584615081|FG001|4-year|Missed Visit|16|||
161882915|NCT02407457|584615080|FG000|5-year|Death|10|||
161882916|NCT02407457|584615081|FG001|5-year|Death|3|||
161882917|NCT02407457|584615080|FG000|5-year|Lost to Follow-up|22|||
161882918|NCT02407457|584615081|FG001|5-year|Lost to Follow-up|13|||
161882919|NCT02407457|584615080|FG000|5-year|Missed Visit|9|||
161882920|NCT02407457|584615081|FG001|5-year|Missed Visit|1|||
161882921|NCT02954653|584615084|FG000|Overall Study|Death|3|||
161882922|NCT02954653|584615085|FG001|Overall Study|Death|1|||
161882923|NCT02954653|584615086|FG002|Overall Study|Death|0|||
161882924|NCT02954653|584615087|FG003|Overall Study|Death|0|||
161882925|NCT02954653|584615088|FG004|Overall Study|Death|0|||
161882926|NCT02954653|584615089|FG005|Overall Study|Death|0|||
161882927|NCT02954653|584615090|FG006|Overall Study|Death|0|||
161882928|NCT02954653|584615091|FG007|Overall Study|Death|0|||
161882929|NCT02954653|584615092|FG008|Overall Study|Death|0|||
161882930|NCT02954653|584615084|FG000|Overall Study|Randomized but did not receive treatment|1|||
161882931|NCT02954653|584615085|FG001|Overall Study|Randomized but did not receive treatment|0|||
161882932|NCT02954653|584615086|FG002|Overall Study|Randomized but did not receive treatment|0|||
161882933|NCT02954653|584615087|FG003|Overall Study|Randomized but did not receive treatment|0|||
161882934|NCT02954653|584615088|FG004|Overall Study|Randomized but did not receive treatment|0|||
161882935|NCT02954653|584615089|FG005|Overall Study|Randomized but did not receive treatment|0|||
161882936|NCT02954653|584615090|FG006|Overall Study|Randomized but did not receive treatment|0|||
161882937|NCT02954653|584615091|FG007|Overall Study|Randomized but did not receive treatment|0|||
161882938|NCT02954653|584615092|FG008|Overall Study|Randomized but did not receive treatment|0|||
161882939|NCT02954653|584615084|FG000|Overall Study|Started another anti-cancer therapy|0|||
161882940|NCT02954653|584615085|FG001|Overall Study|Started another anti-cancer therapy|1|||
161882941|NCT02954653|584615086|FG002|Overall Study|Started another anti-cancer therapy|0|||
161882942|NCT02954653|584615087|FG003|Overall Study|Started another anti-cancer therapy|0|||
161882943|NCT02954653|584615088|FG004|Overall Study|Started another anti-cancer therapy|0|||
161882944|NCT02954653|584615089|FG005|Overall Study|Started another anti-cancer therapy|0|||
161882945|NCT02954653|584615090|FG006|Overall Study|Started another anti-cancer therapy|0|||
161882946|NCT02954653|584615091|FG007|Overall Study|Started another anti-cancer therapy|0|||
161882947|NCT02954653|584615092|FG008|Overall Study|Started another anti-cancer therapy|0|||
161882948|NCT02954653|584615084|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
161882949|NCT02954653|584615085|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
161882950|NCT02954653|584615086|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
161882951|NCT02954653|584615087|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
161882952|NCT02954653|584615088|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
161882953|NCT02954653|584615089|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
161882954|NCT02954653|584615090|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
161882955|NCT02954653|584615091|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
161882956|NCT02954653|584615092|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
161882957|NCT04329091|584615095|FG000|Overall Study|Physician Decision|5|||
161882958|NCT01210495|584615098|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
161882959|NCT01210495|584615099|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
161882960|NCT01210495|584615100|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
161882961|NCT01210495|584615101|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
161882962|NCT01210495|584615098|FG000|Overall Study|Death|14|||
161882963|NCT01210495|584615099|FG001|Overall Study|Death|7|||
161882964|NCT01210495|584615100|FG002|Overall Study|Death|112|||
161882965|NCT01210495|584615101|FG003|Overall Study|Death|54|||
161778845|NCT01154673|584232346|FG001|Overall Study|Lost to Follow-up|0|||
161778846|NCT01154673|584232345|FG000|Overall Study|moved out of province|1|||
161778847|NCT01154673|584232346|FG001|Overall Study|moved out of province|0|||
161778848|NCT00518011|584232347|FG000|Overall Study|Death|1|||
161778849|NCT00518011|584232348|FG001|Overall Study|Death|1|||
161778850|NCT00518011|584232347|FG000|Overall Study|Adverse Event|2|||
161778851|NCT00518011|584232348|FG001|Overall Study|Adverse Event|3|||
161778852|NCT00518011|584232347|FG000|Overall Study|Disease Progression|2|||
161778853|NCT00518011|584232348|FG001|Overall Study|Disease Progression|2|||
161778854|NCT00518011|584232347|FG000|Overall Study|Other Reasons|3|||
161778855|NCT00518011|584232348|FG001|Overall Study|Other Reasons|2|||
161778856|NCT00518011|584232347|FG000|Overall Study|Withdrawal by Subject|1|||
161778857|NCT00518011|584232348|FG001|Overall Study|Withdrawal by Subject|0|||
161778858|NCT00090259|584232349|FG000|Overall Study|Lost to Follow-up|30|||
161778859|NCT00090259|584232350|FG001|Overall Study|Lost to Follow-up|26|||
161778860|NCT00090259|584232349|FG000|Overall Study|Withdrawal by Subject|21|||
161882966|NCT01210495|584615098|FG000|Overall Study|Study Terminated by Sponsor|0|||
161882967|NCT01210495|584615099|FG001|Overall Study|Study Terminated by Sponsor|0|||
161882968|NCT01210495|584615100|FG002|Overall Study|Study Terminated by Sponsor|4|||
161882969|NCT01210495|584615101|FG003|Overall Study|Study Terminated by Sponsor|11|||
161882970|NCT01210495|584615098|FG000|Overall Study|Lost to Follow-up|0|||
161882971|NCT01210495|584615099|FG001|Overall Study|Lost to Follow-up|0|||
161882972|NCT01210495|584615100|FG002|Overall Study|Lost to Follow-up|1|||
161882973|NCT01210495|584615101|FG003|Overall Study|Lost to Follow-up|1|||
161882974|NCT01210495|584615098|FG000|Overall Study|Other unspecified|0|||
161882975|NCT01210495|584615099|FG001|Overall Study|Other unspecified|0|||
161882976|NCT01210495|584615100|FG002|Overall Study|Other unspecified|6|||
161882977|NCT01210495|584615101|FG003|Overall Study|Other unspecified|0|||
161882978|NCT04489381|584615112|FG000|Overall Study|Lost to Follow-up|2|||
161882979|NCT04489381|584615113|FG001|Overall Study|Lost to Follow-up|3|||
161882980|NCT04489381|584615112|FG000|Overall Study|Withdrawal by Subject|1|||
161882981|NCT04489381|584615113|FG001|Overall Study|Withdrawal by Subject|0|||
161882982|NCT03199612|584615114|FG000|Overall Study|Adverse Event|1|||
161882983|NCT03199612|584615115|FG001|Overall Study|Adverse Event|0|||
161882984|NCT02543892|584615116|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
161882985|NCT02543892|584615117|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
161882986|NCT02543892|584615118|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
161882987|NCT02543892|584615119|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
161882988|NCT02543892|584615120|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
161882989|NCT02543892|584615121|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
161882990|NCT02543892|584615122|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
161882991|NCT02543892|584615123|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
161882992|NCT02543892|584615116|FG000|Received Vaccination 2|Physician Decision|0|||
161882993|NCT02543892|584615117|FG001|Received Vaccination 2|Physician Decision|0|||
161882994|NCT02543892|584615118|FG002|Received Vaccination 2|Physician Decision|0|||
161882995|NCT02543892|584615119|FG003|Received Vaccination 2|Physician Decision|0|||
161882996|NCT02543892|584615120|FG004|Received Vaccination 2|Physician Decision|0|||
161882997|NCT02543892|584615121|FG005|Received Vaccination 2|Physician Decision|1|||
161882998|NCT02543892|584615122|FG006|Received Vaccination 2|Physician Decision|0|||
161882999|NCT02543892|584615123|FG007|Received Vaccination 2|Physician Decision|0|||
161883000|NCT02543892|584615116|FG000|Received Vaccination 2|Adverse Event|0|||
161883001|NCT02543892|584615117|FG001|Received Vaccination 2|Adverse Event|1|||
161883002|NCT02543892|584615118|FG002|Received Vaccination 2|Adverse Event|0|||
161883003|NCT02543892|584615119|FG003|Received Vaccination 2|Adverse Event|0|||
161883004|NCT02543892|584615120|FG004|Received Vaccination 2|Adverse Event|0|||
161883005|NCT02543892|584615121|FG005|Received Vaccination 2|Adverse Event|0|||
161883006|NCT02543892|584615122|FG006|Received Vaccination 2|Adverse Event|0|||
161883007|NCT02543892|584615123|FG007|Received Vaccination 2|Adverse Event|0|||
161883008|NCT02543892|584615116|FG000|Had Immunology Data|Withdrawal by Subject|0|||
161883009|NCT02543892|584615117|FG001|Had Immunology Data|Withdrawal by Subject|0|||
161883010|NCT02543892|584615118|FG002|Had Immunology Data|Withdrawal by Subject|0|||
161883011|NCT02543892|584615119|FG003|Had Immunology Data|Withdrawal by Subject|0|||
161883012|NCT02543892|584615120|FG004|Had Immunology Data|Withdrawal by Subject|0|||
161883013|NCT02543892|584615121|FG005|Had Immunology Data|Withdrawal by Subject|0|||
161883014|NCT02543892|584615122|FG006|Had Immunology Data|Withdrawal by Subject|1|||
161883015|NCT02543892|584615123|FG007|Had Immunology Data|Withdrawal by Subject|0|||
161883016|NCT01199822|584615126|FG000|Overall Study|Investigator discontinued therapy|0|||
161883017|NCT01199822|584615127|FG001|Overall Study|Investigator discontinued therapy|1|||
161883018|NCT01199822|584615128|FG002|Overall Study|Investigator discontinued therapy|0|||
161883019|NCT01500213|584615129|FG000|Overall Study|Adverse Event|35|||
161883020|NCT01500213|584615130|FG001|Overall Study|Adverse Event|35|||
161883021|NCT01500213|584615129|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
161883022|NCT01500213|584615130|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
161883023|NCT01500213|584615129|FG000|Overall Study|Withdrawal by Subject|28|||
161883024|NCT01500213|584615130|FG001|Overall Study|Withdrawal by Subject|37|||
161883025|NCT01500213|584615129|FG000|Overall Study|Death|7|||
161883026|NCT01500213|584615130|FG001|Overall Study|Death|3|||
161883027|NCT01500213|584615129|FG000|Overall Study|Disease Progression|13|||
161883028|NCT01500213|584615130|FG001|Overall Study|Disease Progression|21|||
161883029|NCT01500213|584615129|FG000|Overall Study|Protocol Violation|19|||
161883030|NCT01500213|584615130|FG001|Overall Study|Protocol Violation|19|||
161883031|NCT01500213|584615129|FG000|Overall Study|Physician Decision|12|||
161883032|NCT01500213|584615130|FG001|Overall Study|Physician Decision|10|||
161883033|NCT01500213|584615129|FG000|Overall Study|Lack of Efficacy|9|||
161883034|NCT01500213|584615130|FG001|Overall Study|Lack of Efficacy|7|||
161883035|NCT01500213|584615129|FG000|Overall Study|Lost to Follow-up|3|||
161883036|NCT01500213|584615130|FG001|Overall Study|Lost to Follow-up|6|||
161883037|NCT01500213|584615129|FG000|Overall Study|Other Reasons|7|||
161883038|NCT01500213|584615130|FG001|Overall Study|Other Reasons|5|||
161883039|NCT00785213|584615131|FG000|Quinine Sulfate Alone|Adverse Event|4|||
161883040|NCT00785213|584615131|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
161883041|NCT02386345|584615132|FG000|Overall Study|Not treated|14|||
161778861|NCT00090259|584232350|FG001|Overall Study|Withdrawal by Subject|15|||
161778862|NCT00090259|584232349|FG000|Overall Study|Investigator site closed|11|||
161778863|NCT00090259|584232350|FG001|Overall Study|Investigator site closed|7|||
161778864|NCT04797637|584232356|FG000|Overall Study|Lost to Follow-up|23|||
161778865|NCT04797637|584232357|FG001|Overall Study|Lost to Follow-up|32|||
161778866|NCT04797637|584232356|FG000|Overall Study|Withdrawal by Subject|0|||
161778867|NCT04797637|584232357|FG001|Overall Study|Withdrawal by Subject|1|||
161778868|NCT03083639|584232358|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
161778869|NCT03083639|584232359|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
161778870|NCT03083639|584232358|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
161778871|NCT03083639|584232359|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
161778872|NCT00960687|584232363|FG000|Washout Period of 7 Days|Adverse Event|3|||
161778873|NCT00960687|584232364|FG001|Washout Period of 7 Days|Adverse Event|2|||
161778874|NCT00960687|584232363|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
161778875|NCT00960687|584232364|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161778876|NCT01216319|584232367|FG000|Overall Study|Lost to Follow-up|2|||
161778877|NCT01216319|584232367|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
161778878|NCT03611751|584232371|FG000|Pre-treatment|Randomized but not treated|1|||
161778879|NCT03611751|584232372|FG001|Pre-treatment|Randomized but not treated|1|||
161778880|NCT03611751|584232373|FG002|Pre-treatment|Randomized but not treated|0|||
161778881|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
161778882|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
161778883|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
161778884|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
161778885|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
161778886|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
161778887|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
161778888|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
161778889|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
161778890|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
161778891|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
161778892|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
161778893|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
161778894|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
161778895|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
161778896|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
161778897|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
161778898|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
161778899|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
161778900|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
161778901|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
161778902|NCT03611751|584232371|FG000|Treatment Week 0 - Week 16|Death|0|||
161778903|NCT03611751|584232372|FG001|Treatment Week 0 - Week 16|Death|0|||
161778904|NCT03611751|584232373|FG002|Treatment Week 0 - Week 16|Death|1|||
161778905|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
161778906|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
161778907|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
161778908|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
161778909|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
161778910|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
161778911|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
161778912|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
161778913|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
161778914|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
161778915|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
161778916|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
161778917|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
161778918|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
161778919|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
161778920|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
161778921|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
161778922|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
161778923|NCT03611751|584232371|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
161778924|NCT03611751|584232372|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
161778925|NCT03611751|584232373|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
161778926|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
161778927|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
161778928|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
161778929|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
161778930|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
161778931|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
161778932|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
161883042|NCT02386345|584615132|FG000|Overall Study|Lost to Follow-up|1|||
161883043|NCT02386345|584615132|FG000|Overall Study|Adverse Event|5|||
161883044|NCT02386345|584615132|FG000|Overall Study|Repeat Procedure|10|||
161883045|NCT02386345|584615132|FG000|Overall Study|Did not complete 12-month follow-up|72|||
161883046|NCT04027075|584615133|FG000|Overall Study|Lost to Follow-up|41|||
161883047|NCT04027075|584615134|FG001|Overall Study|Lost to Follow-up|22|||
161883048|NCT03448939|584615135|FG000|Overall Study|Adverse Event|5|||
161883049|NCT03448939|584615136|FG001|Overall Study|Adverse Event|1|||
161883050|NCT03448939|584615135|FG000|Overall Study|Lost to Follow-up|6|||
161883051|NCT03448939|584615136|FG001|Overall Study|Lost to Follow-up|6|||
161883052|NCT03448939|584615135|FG000|Overall Study|Pregnancy|1|||
161883053|NCT03448939|584615136|FG001|Overall Study|Pregnancy|1|||
161883054|NCT03448939|584615135|FG000|Overall Study|Withdrawal by Subject|9|||
161883055|NCT03448939|584615136|FG001|Overall Study|Withdrawal by Subject|3|||
161883056|NCT01259375|584615137|FG000|Overall Study|Adverse Event|1|||
161883057|NCT00986986|584615138|FG000|Overall Study|Lost to Follow-up|0|||
161883058|NCT00986986|584615139|FG001|Overall Study|Lost to Follow-up|1|||
161883059|NCT00628095|584615140|FG000|Overall Study|Adverse Event|5|||
161883060|NCT00628095|584615141|FG001|Overall Study|Adverse Event|3|||
161883061|NCT00628095|584615140|FG000|Overall Study|Lack of Efficacy|0|||
161883062|NCT00628095|584615141|FG001|Overall Study|Lack of Efficacy|3|||
161883063|NCT00628095|584615140|FG000|Overall Study|Withdrawal by Subject|2|||
161883064|NCT00628095|584615141|FG001|Overall Study|Withdrawal by Subject|0|||
161883065|NCT00628095|584615140|FG000|Overall Study|Other|0|||
161883066|NCT00628095|584615141|FG001|Overall Study|Other|1|||
161883067|NCT01043705|584615146|FG000|Overall Study|Death|28|||
161883068|NCT01043705|584615147|FG001|Overall Study|Death|60|||
161883069|NCT01043705|584615148|FG002|Overall Study|Death|26|||
161883070|NCT01043705|584615146|FG000|Overall Study|Lost to Follow-up|27|||
161883071|NCT01043705|584615147|FG001|Overall Study|Lost to Follow-up|12|||
161883072|NCT01043705|584615148|FG002|Overall Study|Lost to Follow-up|0|||
161883073|NCT01043705|584615146|FG000|Overall Study|Multiple Reasons|4|||
161883074|NCT01043705|584615147|FG001|Overall Study|Multiple Reasons|7|||
161883075|NCT01043705|584615148|FG002|Overall Study|Multiple Reasons|0|||
161883076|NCT01043705|584615146|FG000|Overall Study|Protocol Violation|2|||
161883077|NCT01043705|584615147|FG001|Overall Study|Protocol Violation|1|||
161883078|NCT01043705|584615148|FG002|Overall Study|Protocol Violation|0|||
161883079|NCT01043705|584615146|FG000|Overall Study|Withdrawal by Subject|8|||
161883080|NCT01043705|584615147|FG001|Overall Study|Withdrawal by Subject|6|||
161778933|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
161778934|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
161778935|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
161778936|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
161778937|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
161778938|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
161778939|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
161778940|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
161778941|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
161778942|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
161778943|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
161778944|NCT03611751|584232371|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
161778945|NCT03611751|584232372|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
161778946|NCT03611751|584232373|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
161778947|NCT02666768|584232376|FG000|Overall Study|Withdrawal by Subject|4|||
161778948|NCT03728257|584232377|FG000|Overall Study|Death|3|||
161778949|NCT03728257|584232378|FG001|Overall Study|Death|0|||
161778950|NCT03940742|584232379|FG000|Overall Study|Lost to Follow-up|0|||
161778951|NCT03940742|584232380|FG001|Overall Study|Lost to Follow-up|0|||
161778952|NCT03940742|584232381|FG002|Overall Study|Lost to Follow-up|0|||
161778953|NCT03940742|584232382|FG003|Overall Study|Lost to Follow-up|1|||
161778954|NCT04993339|584232383|FG000|Overall Study|Lost to Follow-up|0|||
161778955|NCT04993339|584232384|FG001|Overall Study|Lost to Follow-up|1|||
161778956|NCT04993339|584232383|FG000|Overall Study|no MRI scan|3|||
161778957|NCT04993339|584232384|FG001|Overall Study|no MRI scan|1|||
161778958|NCT00797316|584232385|FG000|Overall Study|Administrative problems|1|||
161778959|NCT00797316|584232386|FG001|Overall Study|Administrative problems|0|||
161778960|NCT00797316|584232385|FG000|Overall Study|Adverse Event|5|||
161778961|NCT00797316|584232386|FG001|Overall Study|Adverse Event|3|||
161778962|NCT00797316|584232385|FG000|Overall Study|Lost to Follow-up|4|||
161778963|NCT00797316|584232386|FG001|Overall Study|Lost to Follow-up|8|||
161778964|NCT00797316|584232385|FG000|Overall Study|Protocol Deviation|1|||
161778965|NCT00797316|584232386|FG001|Overall Study|Protocol Deviation|2|||
161778966|NCT00797316|584232385|FG000|Overall Study|Patient withdrew consent|12|||
161778967|NCT00797316|584232386|FG001|Overall Study|Patient withdrew consent|6|||
161778968|NCT00797316|584232385|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161883081|NCT01043705|584615148|FG002|Overall Study|Withdrawal by Subject|0|||
161883082|NCT01043705|584615146|FG000|Overall Study|Site Closure|8|||
161883083|NCT01043705|584615147|FG001|Overall Study|Site Closure|0|||
161883084|NCT01043705|584615148|FG002|Overall Study|Site Closure|0|||
161883085|NCT01043705|584615146|FG000|Overall Study|Subsequent Procedure|9|||
161883086|NCT01043705|584615147|FG001|Overall Study|Subsequent Procedure|24|||
161883087|NCT01043705|584615148|FG002|Overall Study|Subsequent Procedure|29|||
161883088|NCT01043705|584615146|FG000|Overall Study|Adverse Event|0|||
161883089|NCT01043705|584615147|FG001|Overall Study|Adverse Event|2|||
161883090|NCT01043705|584615148|FG002|Overall Study|Adverse Event|0|||
161883091|NCT01043705|584615146|FG000|Overall Study|Screen Fail|21|||
161883092|NCT01043705|584615147|FG001|Overall Study|Screen Fail|0|||
161883093|NCT01043705|584615148|FG002|Overall Study|Screen Fail|0|||
161883094|NCT01043705|584615146|FG000|Overall Study|Other|0|||
161883095|NCT01043705|584615147|FG001|Overall Study|Other|19|||
161883096|NCT01043705|584615148|FG002|Overall Study|Other|25|||
161883097|NCT02003963|584615152|FG000|Overall Study|Lost to Follow-up|2|||
161883098|NCT02003963|584615153|FG001|Overall Study|Lost to Follow-up|1|||
161883099|NCT05020366|584615154|FG000|Overall Study|Lost to Follow-up|2|||
161883100|NCT05020366|584615155|FG001|Overall Study|Lost to Follow-up|0|||
161883101|NCT05020366|584615154|FG000|Overall Study|Withdrawal by Subject|2|||
161883102|NCT05020366|584615155|FG001|Overall Study|Withdrawal by Subject|0|||
161883103|NCT05083923|584615161|FG000|Overall Study|Adverse Event|2|||
161883104|NCT05083923|584615162|FG001|Overall Study|Adverse Event|0|||
161883105|NCT05083923|584615161|FG000|Overall Study|Lack of Efficacy|1|||
161883106|NCT05083923|584615162|FG001|Overall Study|Lack of Efficacy|3|||
161883107|NCT05083923|584615161|FG000|Overall Study|Withdrawal by Subject|2|||
161883108|NCT05083923|584615162|FG001|Overall Study|Withdrawal by Subject|6|||
161883109|NCT05083923|584615161|FG000|Overall Study|Reason Not Specified|0|||
161883110|NCT05083923|584615162|FG001|Overall Study|Reason Not Specified|1|||
161883111|NCT02880865|584615163|FG000|Overall Study|Adverse Event|1|||
161883112|NCT02880865|584615164|FG001|Overall Study|Adverse Event|0|||
161883113|NCT02880865|584615163|FG000|Overall Study|Withdrawal by Subject|0|||
161883114|NCT02880865|584615164|FG001|Overall Study|Withdrawal by Subject|2|||
161883115|NCT02880865|584615163|FG000|Overall Study|Physician Decision|0|||
161883116|NCT02880865|584615164|FG001|Overall Study|Physician Decision|1|||
161883117|NCT03379753|584615165|FG000|Overall Study|Withdrawal by Subject|2|||
161883118|NCT03379753|584615166|FG001|Overall Study|Withdrawal by Subject|1|||
161883119|NCT03379753|584615165|FG000|Overall Study|not having correct procedure|1|||
161883120|NCT03379753|584615166|FG001|Overall Study|not having correct procedure|2|||
161883121|NCT03379753|584615165|FG000|Overall Study|No primary outcome|12|||
161883122|NCT03379753|584615166|FG001|Overall Study|No primary outcome|22|||
161883123|NCT00347919|584615167|FG000|Overall Study|Lost to Follow-up|11|||
161883124|NCT00347919|584615168|FG001|Overall Study|Lost to Follow-up|13|||
161883125|NCT00347919|584615169|FG002|Overall Study|Lost to Follow-up|0|||
161883126|NCT00347919|584615167|FG000|Overall Study|Withdrawal by Subject|6|||
161883127|NCT00347919|584615168|FG001|Overall Study|Withdrawal by Subject|8|||
161883128|NCT00347919|584615169|FG002|Overall Study|Withdrawal by Subject|0|||
161883129|NCT00347919|584615167|FG000|Overall Study|Physician Decision|1|||
161883130|NCT00347919|584615168|FG001|Overall Study|Physician Decision|1|||
161883131|NCT00347919|584615169|FG002|Overall Study|Physician Decision|0|||
161883132|NCT00347919|584615167|FG000|Overall Study|Sponsor terminated study|15|||
161883133|NCT00347919|584615168|FG001|Overall Study|Sponsor terminated study|10|||
161883134|NCT00347919|584615169|FG002|Overall Study|Sponsor terminated study|16|||
161883135|NCT00347919|584615167|FG000|Overall Study|Death|35|||
161883136|NCT00347919|584615168|FG001|Overall Study|Death|42|||
161883137|NCT00347919|584615169|FG002|Overall Study|Death|19|||
161883138|NCT00347919|584615167|FG000|Overall Study|Par. Started Other Treatment|1|||
161883139|NCT00347919|584615168|FG001|Overall Study|Par. Started Other Treatment|1|||
161883140|NCT00347919|584615169|FG002|Overall Study|Par. Started Other Treatment|1|||
161883141|NCT00347919|584615167|FG000|Overall Study|Missing|2|||
161883142|NCT00347919|584615168|FG001|Overall Study|Missing|1|||
161883143|NCT00347919|584615169|FG002|Overall Study|Missing|2|||
161883144|NCT01190267|584615174|FG000|Overall Study|Adverse Event|10|||
161883145|NCT01190267|584615175|FG001|Overall Study|Adverse Event|0|||
161991864|NCT03364309|585018548|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161991865|NCT03364309|585018549|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161991866|NCT03364309|585018550|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161883146|NCT01190267|584615174|FG000|Overall Study|Treatment Failure|8|||
161883147|NCT01190267|584615175|FG001|Overall Study|Treatment Failure|2|||
161883148|NCT01190267|584615174|FG000|Overall Study|Lost to Follow-up|2|||
161883149|NCT01190267|584615175|FG001|Overall Study|Lost to Follow-up|0|||
161883150|NCT01190267|584615174|FG000|Overall Study|Withdrawal by Subject|13|||
161883151|NCT01190267|584615175|FG001|Overall Study|Withdrawal by Subject|1|||
161883152|NCT01190267|584615174|FG000|Overall Study|Protocol Violation|8|||
161991867|NCT03364309|585018551|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161991868|NCT03364309|585018552|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161883153|NCT01190267|584615175|FG001|Overall Study|Protocol Violation|1|||
161883154|NCT04687072|584615186|FG000|Overall Study|Adverse Event|2|||
161883155|NCT04687072|584615187|FG001|Overall Study|Adverse Event|0|||
161883156|NCT04687072|584615186|FG000|Overall Study|Death|1|||
161883157|NCT04687072|584615187|FG001|Overall Study|Death|0|||
161883158|NCT04687072|584615186|FG000|Overall Study|Lack of Efficacy|2|||
161883159|NCT04687072|584615187|FG001|Overall Study|Lack of Efficacy|1|||
161883160|NCT04687072|584615186|FG000|Overall Study|Physician Decision|1|||
161883161|NCT04687072|584615187|FG001|Overall Study|Physician Decision|0|||
161883162|NCT04687072|584615186|FG000|Overall Study|Pregnancy|1|||
161883163|NCT04687072|584615187|FG001|Overall Study|Pregnancy|0|||
161883164|NCT04687072|584615186|FG000|Overall Study|Requires Prohibited Medication|2|||
161883165|NCT04687072|584615187|FG001|Overall Study|Requires Prohibited Medication|0|||
161883166|NCT04687072|584615186|FG000|Overall Study|Withdrawal of Consent|11|||
161883167|NCT04687072|584615187|FG001|Overall Study|Withdrawal of Consent|6|||
161883168|NCT04687072|584615186|FG000|Overall Study|Miscellaneous|4|||
161883169|NCT04687072|584615187|FG001|Overall Study|Miscellaneous|1|||
161883170|NCT01263782|584615188|FG000|Overall Study|Death|0|||
161883171|NCT01263782|584615189|FG001|Overall Study|Death|0|||
161883172|NCT01263782|584615190|FG002|Overall Study|Death|1|||
161883173|NCT01263782|584615191|FG003|Overall Study|Death|0|||
161883174|NCT01263782|584615188|FG000|Overall Study|Progressive disease|0|||
161883175|NCT01263782|584615189|FG001|Overall Study|Progressive disease|0|||
161883176|NCT01263782|584615190|FG002|Overall Study|Progressive disease|0|||
161883177|NCT01263782|584615191|FG003|Overall Study|Progressive disease|1|||
161883178|NCT01263782|584615188|FG000|Overall Study|Too early|0|||
161883179|NCT01263782|584615189|FG001|Overall Study|Too early|0|||
161883180|NCT01263782|584615190|FG002|Overall Study|Too early|1|||
161883181|NCT01263782|584615191|FG003|Overall Study|Too early|0|||
161883182|NCT01263782|584615188|FG000|Overall Study|Inevaluable|0|||
161883183|NCT01263782|584615189|FG001|Overall Study|Inevaluable|0|||
161883184|NCT01263782|584615190|FG002|Overall Study|Inevaluable|1|||
161883185|NCT01263782|584615191|FG003|Overall Study|Inevaluable|0|||
161883186|NCT04545567|584615192|FG000|Overall Study|tested positive for SARS-co-V2|1|||
161883187|NCT04545567|584615193|FG001|Overall Study|tested positive for SARS-co-V2|1|||
161883188|NCT04545567|584615192|FG000|Overall Study|Withdrawal by Subject|0|||
161883189|NCT04545567|584615193|FG001|Overall Study|Withdrawal by Subject|1|||
161883190|NCT00533702|584615194|FG000|Overall Study|Withdrawal by Subject|3|||
161883191|NCT00533702|584615195|FG001|Overall Study|Withdrawal by Subject|1|||
161883192|NCT00533702|584615194|FG000|Overall Study|Found ineligible after randomization|2|||
161883193|NCT00533702|584615195|FG001|Overall Study|Found ineligible after randomization|1|||
161883194|NCT01970475|584615198|FG000|Overall Study|Withdrawal by Subject|11|||
161883195|NCT01970475|584615199|FG001|Overall Study|Withdrawal by Subject|6|||
161883196|NCT01970475|584615198|FG000|Overall Study|Adverse Event|7|||
161883197|NCT01970475|584615199|FG001|Overall Study|Adverse Event|3|||
161883198|NCT01970475|584615198|FG000|Overall Study|Lost to Follow-up|2|||
161883199|NCT01970475|584615199|FG001|Overall Study|Lost to Follow-up|2|||
161883200|NCT01970475|584615198|FG000|Overall Study|Protocol Violation|1|||
161883201|NCT01970475|584615199|FG001|Overall Study|Protocol Violation|0|||
161883202|NCT04413552|584615204|FG000|Overall Study|Adverse Event|0|||
161883203|NCT04413552|584615205|FG001|Overall Study|Adverse Event|0|||
161883204|NCT04413552|584615206|FG002|Overall Study|Adverse Event|0|||
161883205|NCT04413552|584615207|FG003|Overall Study|Adverse Event|0|||
161883206|NCT04413552|584615208|FG004|Overall Study|Adverse Event|0|||
161991869|NCT03364309|585018553|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161991870|NCT03364309|585018554|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161991871|NCT03364309|585018555|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161778969|NCT00797316|584232386|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
161778970|NCT00402779|584232389|FG000|Overall Study|Screen Failure|77|||
161778971|NCT00402779|584232390|FG001|Overall Study|Screen Failure|76|||
161778972|NCT03075215|584232391|FG000|12-Month Primary Endpoint|Death|152|||
161778973|NCT03075215|584232391|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
161778974|NCT03075215|584232391|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
161778975|NCT03075215|584232391|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
161778976|NCT00690573|584232400|FG000|Overall Study|Lack of Efficacy|8|||
161778977|NCT00690573|584232400|FG000|Overall Study|Withdrawal by Subject|1|||
161778978|NCT00777920|584232401|FG000|Overall Study|Adverse Event|39|||
161778979|NCT00777920|584232401|FG000|Overall Study|Withdrawal of Consent|4|||
161778980|NCT00777920|584232401|FG000|Overall Study|Lost to Follow-up|1|||
161778981|NCT00777920|584232401|FG000|Overall Study|Investigator's discretion|1|||
161778982|NCT00777920|584232401|FG000|Overall Study|Clinical status did not improve|1|||
161778983|NCT00777920|584232401|FG000|Overall Study|Other, not specified|4|||
161778984|NCT02146365|584232402|FG000|Overall Study|Lost to Follow-up|2|||
161778985|NCT02146365|584232403|FG001|Overall Study|Lost to Follow-up|1|||
161778986|NCT02146365|584232404|FG002|Overall Study|Lost to Follow-up|3|||
161778987|NCT02146365|584232405|FG003|Overall Study|Lost to Follow-up|3|||
161778988|NCT02146365|584232406|FG004|Overall Study|Lost to Follow-up|1|||
161778989|NCT02146365|584232407|FG005|Overall Study|Lost to Follow-up|1|||
161778990|NCT02146365|584232408|FG006|Overall Study|Lost to Follow-up|0|||
161883207|NCT04413552|584615209|FG005|Overall Study|Adverse Event|0|||
161883208|NCT04413552|584615210|FG006|Overall Study|Adverse Event|1|||
161883209|NCT04413552|584615211|FG007|Overall Study|Adverse Event|0|||
161883210|NCT04413552|584615212|FG008|Overall Study|Adverse Event|0|||
161883211|NCT04413552|584615213|FG009|Overall Study|Adverse Event|0|||
161883212|NCT01317797|584615214|FG000|Overall Study|Other|0|||
161883213|NCT01317797|584615215|FG001|Overall Study|Other|1|||
161883214|NCT01317797|584615216|FG002|Overall Study|Other|0|||
161883215|NCT01317797|584615214|FG000|Overall Study|Withdrawal of Patient|0|||
161883216|NCT01317797|584615215|FG001|Overall Study|Withdrawal of Patient|0|||
161883217|NCT01317797|584615216|FG002|Overall Study|Withdrawal of Patient|1|||
161883218|NCT03026530|584615217|FG000|Overall Study|Lost to Follow-up|19|||
161883219|NCT03026530|584615218|FG001|Overall Study|Lost to Follow-up|24|||
161883220|NCT03026530|584615217|FG000|Overall Study|Protocol Violation|2|||
161883221|NCT03026530|584615218|FG001|Overall Study|Protocol Violation|5|||
161883222|NCT03721835|584615220|FG000|Overall Study|Participant not able to return|1|||
161883223|NCT03721835|584615220|FG000|Overall Study|Lost to Follow-up|1|||
161883224|NCT03721835|584615220|FG000|Overall Study|Revision of the components of the study device|2|||
161883225|NCT03721835|584615220|FG000|Overall Study|Sponsor terminated study|6|||
161883226|NCT03721835|584615220|FG000|Overall Study|Death|1|||
161883227|NCT03721835|584615220|FG000|Overall Study|Sponsor decision|1|||
161883228|NCT03495154|584615221|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
161883229|NCT03495154|584615221|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
161883230|NCT03495154|584615221|FG000|Overall Study|Screen Failures During Surgery|6|||
161883231|NCT03495154|584615221|FG000|Overall Study|Death|2|||
161883232|NCT03495154|584615221|FG000|Overall Study|Lost to Follow-up|16|||
161883233|NCT03495154|584615221|FG000|Overall Study|Withdrawal by Subject|2|||
161883234|NCT03495154|584615221|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
161883235|NCT01294696|584615225|FG000|Overall Study|Screening failures|7|||
161883236|NCT01294696|584615225|FG000|Overall Study|Protocol Violation|8|||
161883237|NCT01294696|584615225|FG000|Overall Study|Missing BPI Response|7|||
161883238|NCT01294696|584615225|FG000|Overall Study|Site closure|52|||
161883239|NCT05741346|584616577|FG000|Overall Study|Withdrawn due to termination of study|28|||
161883240|NCT02339155|584616580|FG000|Overall Study|Adverse Event|0|||
161883241|NCT02339155|584616581|FG001|Overall Study|Adverse Event|6|||
161883242|NCT02339155|584616580|FG000|Overall Study|Death|1|||
161883243|NCT02339155|584616581|FG001|Overall Study|Death|1|||
161883244|NCT02339155|584616580|FG000|Overall Study|Lost to Follow-up|8|||
161883245|NCT02339155|584616581|FG001|Overall Study|Lost to Follow-up|9|||
161883246|NCT02339155|584616580|FG000|Overall Study|Physician Decision|2|||
161883247|NCT02339155|584616581|FG001|Overall Study|Physician Decision|1|||
161883248|NCT02339155|584616580|FG000|Overall Study|Withdrawal by Subject|4|||
161883249|NCT02339155|584616581|FG001|Overall Study|Withdrawal by Subject|4|||
161883250|NCT03226678|584616586|FG000|Part A (Core Study Phase)|Adverse Event|0|||
161883251|NCT03226678|584616587|FG001|Part A (Core Study Phase)|Adverse Event|1|||
161883252|NCT03226678|584616588|FG002|Part A (Core Study Phase)|Adverse Event|0|||
161883253|NCT03226678|584616589|FG003|Part A (Core Study Phase)|Adverse Event|0|||
161883254|NCT03226678|584616590|FG004|Part A (Core Study Phase)|Adverse Event|0|||
161883255|NCT03226678|584616591|FG005|Part A (Core Study Phase)|Adverse Event|0|||
161883256|NCT03226678|584616586|FG000|Part A (Core Study Phase)|Death|0|||
161883257|NCT03226678|584616587|FG001|Part A (Core Study Phase)|Death|0|||
161883258|NCT03226678|584616588|FG002|Part A (Core Study Phase)|Death|1|||
161883259|NCT03226678|584616589|FG003|Part A (Core Study Phase)|Death|0|||
161883260|NCT03226678|584616590|FG004|Part A (Core Study Phase)|Death|0|||
161883261|NCT03226678|584616591|FG005|Part A (Core Study Phase)|Death|0|||
161883262|NCT03226678|584616586|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
161883263|NCT03226678|584616587|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
161883264|NCT03226678|584616588|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
161883265|NCT03226678|584616589|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
161883266|NCT03226678|584616590|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
161883267|NCT03226678|584616591|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
161883268|NCT03226678|584616586|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161883269|NCT03226678|584616587|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161883270|NCT03226678|584616588|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
161883271|NCT03226678|584616589|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161883272|NCT03226678|584616590|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161883273|NCT03226678|584616591|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161883274|NCT03226678|584616586|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161883275|NCT03226678|584616587|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161883276|NCT03226678|584616588|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161883277|NCT03226678|584616589|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
161883278|NCT03226678|584616590|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161883279|NCT03226678|584616591|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161883280|NCT03226678|584616586|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
161883281|NCT03226678|584616587|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
161883282|NCT03226678|584616588|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
161883283|NCT03226678|584616589|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
161883284|NCT03226678|584616590|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
161883285|NCT03226678|584616591|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
161883286|NCT03226678|584616586|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
161883287|NCT03226678|584616587|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
161883288|NCT03226678|584616588|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
161883289|NCT03226678|584616589|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
161883290|NCT03226678|584616590|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
161883291|NCT03226678|584616591|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
161883292|NCT03226678|584616586|FG000|Part B (Long-Term Extension Phase)|Death|0|||
161883293|NCT03226678|584616587|FG001|Part B (Long-Term Extension Phase)|Death|0|||
161883294|NCT03226678|584616588|FG002|Part B (Long-Term Extension Phase)|Death|0|||
161883295|NCT03226678|584616589|FG003|Part B (Long-Term Extension Phase)|Death|0|||
161883296|NCT03226678|584616590|FG004|Part B (Long-Term Extension Phase)|Death|0|||
161883297|NCT03226678|584616591|FG005|Part B (Long-Term Extension Phase)|Death|1|||
161883298|NCT03226678|584616586|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161883299|NCT03226678|584616587|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161883300|NCT03226678|584616588|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161883301|NCT03226678|584616589|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161883302|NCT03226678|584616590|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161883303|NCT03226678|584616591|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
161883304|NCT03226678|584616586|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
161883305|NCT03226678|584616587|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
161883306|NCT03226678|584616588|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
161883307|NCT03226678|584616589|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
161883308|NCT03226678|584616590|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
161883309|NCT03226678|584616591|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
161883310|NCT03226678|584616586|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161883311|NCT03226678|584616587|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161883312|NCT03226678|584616588|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161883313|NCT03226678|584616589|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161883314|NCT03226678|584616590|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161883315|NCT03226678|584616591|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
161883316|NCT00916344|584616600|FG000|Overall Study|Death|2|||
161883317|NCT00916344|584616600|FG000|Overall Study|ICD upgrade|1|||
161883318|NCT00916344|584616600|FG000|Overall Study|Drop-out|5|||
161883319|NCT03602391|584616601|FG000|Overall Study|COVID-19|7|||
161883320|NCT03602391|584616602|FG001|Overall Study|COVID-19|6|||
161883321|NCT00108485|584616607|FG000|Overall Study|Withdrawal by Subject|3|||
161883322|NCT00108485|584616608|FG001|Overall Study|Withdrawal by Subject|0|||
161883323|NCT00108485|584616607|FG000|Overall Study|Lost to Follow-up|0|||
161883324|NCT00108485|584616608|FG001|Overall Study|Lost to Follow-up|2|||
161883325|NCT00878969|584616613|FG000|Overall Study|Physician Decision|5|||
161883326|NCT00878969|584616614|FG001|Overall Study|Physician Decision|3|||
161883327|NCT00878969|584616615|FG002|Overall Study|Physician Decision|2|||
161883328|NCT00878969|584616613|FG000|Overall Study|Withdrawal by Subject|1|||
161883329|NCT00878969|584616614|FG001|Overall Study|Withdrawal by Subject|6|||
161883330|NCT00878969|584616615|FG002|Overall Study|Withdrawal by Subject|3|||
161883331|NCT00878969|584616613|FG000|Overall Study|kidney transplant|2|||
161883332|NCT00878969|584616614|FG001|Overall Study|kidney transplant|3|||
161883333|NCT00878969|584616615|FG002|Overall Study|kidney transplant|2|||
161883334|NCT00878969|584616613|FG000|Overall Study|Adverse Event|3|||
161883335|NCT00878969|584616614|FG001|Overall Study|Adverse Event|1|||
161778991|NCT02146365|584232409|FG007|Overall Study|Lost to Follow-up|1|||
161778992|NCT02146365|584232402|FG000|Overall Study|Withdrawal by Subject|1|||
161778993|NCT02146365|584232403|FG001|Overall Study|Withdrawal by Subject|2|||
161778994|NCT02146365|584232404|FG002|Overall Study|Withdrawal by Subject|1|||
161778995|NCT02146365|584232405|FG003|Overall Study|Withdrawal by Subject|5|||
161778996|NCT02146365|584232406|FG004|Overall Study|Withdrawal by Subject|1|||
161778997|NCT02146365|584232407|FG005|Overall Study|Withdrawal by Subject|0|||
161778998|NCT02146365|584232408|FG006|Overall Study|Withdrawal by Subject|0|||
161778999|NCT02146365|584232409|FG007|Overall Study|Withdrawal by Subject|0|||
161779000|NCT02146365|584232402|FG000|Overall Study|Unable to Comply with Protocol|0|||
161779001|NCT02146365|584232403|FG001|Overall Study|Unable to Comply with Protocol|1|||
161779002|NCT02146365|584232404|FG002|Overall Study|Unable to Comply with Protocol|1|||
161779003|NCT02146365|584232405|FG003|Overall Study|Unable to Comply with Protocol|0|||
161779004|NCT02146365|584232406|FG004|Overall Study|Unable to Comply with Protocol|0|||
161779005|NCT02146365|584232407|FG005|Overall Study|Unable to Comply with Protocol|0|||
161779006|NCT02146365|584232408|FG006|Overall Study|Unable to Comply with Protocol|0|||
161779007|NCT02146365|584232409|FG007|Overall Study|Unable to Comply with Protocol|0|||
161779008|NCT02146365|584232402|FG000|Overall Study|Other|1|||
161779009|NCT02146365|584232403|FG001|Overall Study|Other|0|||
161779010|NCT02146365|584232404|FG002|Overall Study|Other|2|||
161779011|NCT02146365|584232405|FG003|Overall Study|Other|1|||
161779012|NCT02146365|584232406|FG004|Overall Study|Other|0|||
161883336|NCT00878969|584616615|FG002|Overall Study|Adverse Event|2|||
161883337|NCT00878969|584616613|FG000|Overall Study|Lost to Follow-up|2|||
161883338|NCT00878969|584616614|FG001|Overall Study|Lost to Follow-up|1|||
161883339|NCT00878969|584616615|FG002|Overall Study|Lost to Follow-up|0|||
161883340|NCT00878969|584616613|FG000|Overall Study|Protocol Violation|2|||
161883341|NCT00878969|584616614|FG001|Overall Study|Protocol Violation|0|||
161883342|NCT00878969|584616615|FG002|Overall Study|Protocol Violation|0|||
161883343|NCT00878969|584616613|FG000|Overall Study|Death|0|||
161883344|NCT00878969|584616614|FG001|Overall Study|Death|0|||
161883345|NCT00878969|584616615|FG002|Overall Study|Death|2|||
161883346|NCT00878969|584616613|FG000|Overall Study|Pregnancy|0|||
161883347|NCT00878969|584616614|FG001|Overall Study|Pregnancy|1|||
161883348|NCT00878969|584616615|FG002|Overall Study|Pregnancy|0|||
161883349|NCT01701193|584616618|FG000|Overall Study|Withdrawal by Subject|2|||
161883350|NCT01701193|584616619|FG001|Overall Study|Withdrawal by Subject|2|||
161883351|NCT01701193|584616620|FG002|Overall Study|Withdrawal by Subject|1|||
161883352|NCT01701193|584616621|FG003|Overall Study|Withdrawal by Subject|2|||
161883353|NCT01701193|584616618|FG000|Overall Study|Adverse Event|1|||
161883354|NCT01701193|584616619|FG001|Overall Study|Adverse Event|0|||
161883355|NCT01701193|584616620|FG002|Overall Study|Adverse Event|0|||
161883356|NCT01701193|584616621|FG003|Overall Study|Adverse Event|0|||
161883357|NCT03054064|584616622|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
161883358|NCT03054064|584616622|FG000|Overall Study|Investigator Decision|2|||
161883359|NCT03054064|584616622|FG000|Overall Study|Bladder Issue|1|||
161883360|NCT03054064|584616622|FG000|Overall Study|High Blood Pressure|1|||
161883361|NCT03054064|584616622|FG000|Overall Study|Change in Status|1|||
161883362|NCT01527487|584616623|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
161883363|NCT01527487|584616624|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
161883364|NCT01527487|584616623|FG000|Overall Study|Disease Progression|4|||
161883365|NCT01527487|584616624|FG001|Overall Study|Disease Progression|1|||
161883366|NCT01527487|584616623|FG000|Overall Study|Adverse Event|1|||
161883367|NCT01527487|584616624|FG001|Overall Study|Adverse Event|1|||
161883368|NCT01527487|584616623|FG000|Overall Study|Death|0|||
161883369|NCT01527487|584616624|FG001|Overall Study|Death|1|||
161883370|NCT01384019|584616625|FG000|Overall Study|Withdrawal by Subject|3|||
161883371|NCT01384019|584616626|FG001|Overall Study|Withdrawal by Subject|0|||
161883372|NCT01384019|584616625|FG000|Overall Study|Death|1|||
161883373|NCT01384019|584616626|FG001|Overall Study|Death|0|||
161883374|NCT01384019|584616625|FG000|Overall Study|MRI refusal|6|||
161883375|NCT01384019|584616626|FG001|Overall Study|MRI refusal|6|||
161883376|NCT00081731|584616630|FG000|Overall Study|scientific integrity issue|8|||
161883377|NCT00081731|584616631|FG001|Overall Study|scientific integrity issue|8|||
161883378|NCT01629823|584616636|FG000|Trial Period|Missed visit|11|||
161883379|NCT01629823|584616637|FG001|Trial Period|Missed visit|9|||
161883380|NCT01629823|584616638|FG002|Trial Period|Missed visit|8|||
161883381|NCT01629823|584616636|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
161883382|NCT01629823|584616637|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
161883383|NCT01629823|584616638|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
161883384|NCT01629823|584616636|FG000|Trial Period|Pregnancy|1|||
161883385|NCT01629823|584616637|FG001|Trial Period|Pregnancy|0|||
161883386|NCT01629823|584616638|FG002|Trial Period|Pregnancy|0|||
161883387|NCT01629823|584616636|FG000|Trial Period|Adverse Event|0|||
161883388|NCT01629823|584616637|FG001|Trial Period|Adverse Event|1|||
161883389|NCT01629823|584616638|FG002|Trial Period|Adverse Event|0|||
161883390|NCT01629823|584616636|FG000|Trial Period|Out-of-window visit|0|||
161883391|NCT01629823|584616637|FG001|Trial Period|Out-of-window visit|2|||
161883392|NCT01629823|584616638|FG002|Trial Period|Out-of-window visit|0|||
161883393|NCT01629823|584616636|FG000|Trial Period|Failed to hold medication|0|||
161883394|NCT01629823|584616637|FG001|Trial Period|Failed to hold medication|0|||
161883395|NCT01629823|584616638|FG002|Trial Period|Failed to hold medication|1|||
161883396|NCT01629823|584616636|FG000|Washout Period|Safety|2|||
161883397|NCT01629823|584616637|FG001|Washout Period|Safety|5|||
161883398|NCT01629823|584616638|FG002|Washout Period|Safety|0|||
161883399|NCT01629823|584616636|FG000|Washout Period|Pregnancy|1|||
161883400|NCT01629823|584616637|FG001|Washout Period|Pregnancy|0|||
161883401|NCT01629823|584616638|FG002|Washout Period|Pregnancy|0|||
161883402|NCT01629823|584616636|FG000|Washout Period|Protocol Violation|0|||
161883403|NCT01629823|584616637|FG001|Washout Period|Protocol Violation|1|||
161883404|NCT01629823|584616638|FG002|Washout Period|Protocol Violation|0|||
161883405|NCT00526331|584616639|FG000|Overall Study|Sponsor Termination|55|||
161883406|NCT00455520|584616640|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
161883407|NCT00455520|584616641|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
161883408|NCT00455520|584616640|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
161883409|NCT00455520|584616641|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
161883410|NCT00455520|584616640|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
161883411|NCT00455520|584616641|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
161883412|NCT00455520|584616640|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
161883413|NCT00455520|584616641|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
161883414|NCT00455520|584616640|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
161883415|NCT00455520|584616641|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
161883416|NCT00455520|584616640|FG000|Open Label Tapentadol Extended Release|All other|33|||
161883417|NCT00455520|584616641|FG001|Open Label Tapentadol Extended Release|All other|0|||
161883418|NCT00455520|584616640|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
161883419|NCT00455520|584616641|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
161883420|NCT00455520|584616640|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
161883421|NCT00455520|584616641|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
161883422|NCT00455520|584616640|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
161883423|NCT00455520|584616641|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
161883424|NCT00455520|584616640|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
161883425|NCT00455520|584616641|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
161883426|NCT00455520|584616640|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
161883427|NCT00455520|584616641|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
161883428|NCT00455520|584616640|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
161883429|NCT00455520|584616641|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
161883430|NCT03973918|584616645|FG000|Overall Study|Adverse Event|0|||
161883431|NCT03973918|584616646|FG001|Overall Study|Adverse Event|0|||
161883432|NCT03973918|584616647|FG002|Overall Study|Adverse Event|0|||
161883433|NCT03973918|584616648|FG003|Overall Study|Adverse Event|1|||
161883434|NCT03973918|584616645|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
161883435|NCT03973918|584616646|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
161883436|NCT03973918|584616647|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
161883437|NCT03973918|584616648|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
161779013|NCT02146365|584232407|FG005|Overall Study|Other|0|||
161779014|NCT02146365|584232408|FG006|Overall Study|Other|0|||
161779015|NCT02146365|584232409|FG007|Overall Study|Other|0|||
161779016|NCT02332655|584232410|FG000|Overall Study|Lack of Efficacy|1|||
161779017|NCT01977482|584232411|FG000|Overall Study|Adverse Event|0|||
161779018|NCT01977482|584232412|FG001|Overall Study|Adverse Event|1|||
161779019|NCT01977482|584232413|FG002|Overall Study|Adverse Event|1|||
161779020|NCT01977482|584232414|FG003|Overall Study|Adverse Event|0|||
161779021|NCT01977482|584232415|FG004|Overall Study|Adverse Event|2|||
161779022|NCT01977482|584232416|FG005|Overall Study|Adverse Event|0|||
161779023|NCT01977482|584232411|FG000|Overall Study|Lost to Follow-up|1|||
161779024|NCT01977482|584232412|FG001|Overall Study|Lost to Follow-up|0|||
161779025|NCT01977482|584232413|FG002|Overall Study|Lost to Follow-up|0|||
161779026|NCT01977482|584232414|FG003|Overall Study|Lost to Follow-up|0|||
161779027|NCT01977482|584232415|FG004|Overall Study|Lost to Follow-up|0|||
161779028|NCT01977482|584232416|FG005|Overall Study|Lost to Follow-up|0|||
161779029|NCT01977482|584232411|FG000|Overall Study|Physician Decision|0|||
161779030|NCT01977482|584232412|FG001|Overall Study|Physician Decision|1|||
161779031|NCT01977482|584232413|FG002|Overall Study|Physician Decision|0|||
161779032|NCT01977482|584232414|FG003|Overall Study|Physician Decision|0|||
161779033|NCT01977482|584232415|FG004|Overall Study|Physician Decision|0|||
161779034|NCT01977482|584232416|FG005|Overall Study|Physician Decision|0|||
161779035|NCT01977482|584232411|FG000|Overall Study|Protocol Violation|0|||
161779036|NCT01977482|584232412|FG001|Overall Study|Protocol Violation|0|||
161779037|NCT01977482|584232413|FG002|Overall Study|Protocol Violation|1|||
161779038|NCT01977482|584232414|FG003|Overall Study|Protocol Violation|0|||
161779039|NCT01977482|584232415|FG004|Overall Study|Protocol Violation|0|||
161779040|NCT01977482|584232416|FG005|Overall Study|Protocol Violation|0|||
161779041|NCT01977482|584232411|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
161779042|NCT01977482|584232412|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
161779043|NCT01977482|584232413|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
161779044|NCT01977482|584232414|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
161779045|NCT01977482|584232415|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
161779046|NCT01977482|584232416|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
161779047|NCT01977482|584232411|FG000|Overall Study|Withdrawal by Subject|2|||
161779048|NCT01977482|584232412|FG001|Overall Study|Withdrawal by Subject|4|||
161779049|NCT01977482|584232413|FG002|Overall Study|Withdrawal by Subject|1|||
161779050|NCT01977482|584232414|FG003|Overall Study|Withdrawal by Subject|3|||
161779051|NCT01977482|584232415|FG004|Overall Study|Withdrawal by Subject|1|||
161779052|NCT01977482|584232416|FG005|Overall Study|Withdrawal by Subject|5|||
161779053|NCT01525407|584232423|FG000|Overall Study|Change in recipient treatment plan|2|||
161779054|NCT01525407|584232424|FG001|Overall Study|Change in recipient treatment plan|2|||
161779055|NCT01525407|584232423|FG000|Overall Study|Withdrawal by Subject|0|||
161779056|NCT01525407|584232424|FG001|Overall Study|Withdrawal by Subject|1|||
161779057|NCT01525407|584232423|FG000|Overall Study|Transplant was delayed|0|||
161779058|NCT01525407|584232424|FG001|Overall Study|Transplant was delayed|1|||
161779059|NCT01525407|584232423|FG000|Overall Study|Delay in Transplant|1|||
161779060|NCT01525407|584232424|FG001|Overall Study|Delay in Transplant|0|||
161883438|NCT04050124|584616649|FG000|Overall Study|Death|1|||
161883439|NCT04050124|584616650|FG001|Overall Study|Death|0|||
161883440|NCT04601103|584616653|FG000|Overall Study|Needed crown & cleaning|0|||
161883441|NCT04601103|584616654|FG001|Overall Study|Needed crown & cleaning|0|||
161883442|NCT04601103|584616655|FG002|Overall Study|Needed crown & cleaning|1|||
161883443|NCT04601103|584616653|FG000|Overall Study|study was terminated|18|||
161883444|NCT04601103|584616654|FG001|Overall Study|study was terminated|18|||
161883445|NCT04601103|584616655|FG002|Overall Study|study was terminated|16|||
161883446|NCT01068626|584616663|FG000|Overall Study|Adverse Event|3|||
161883447|NCT01068626|584616664|FG001|Overall Study|Adverse Event|0|||
161883448|NCT01068626|584616663|FG000|Overall Study|Withdrawal by Subject|0|||
161883449|NCT01068626|584616664|FG001|Overall Study|Withdrawal by Subject|2|||
161883450|NCT01785849|584616665|FG000|Overall Study|Death|7|||
161883451|NCT01785849|584616666|FG001|Overall Study|Death|9|||
161883452|NCT01785849|584616665|FG000|Overall Study|Protocol Specified Criteria|29|||
161883453|NCT01785849|584616666|FG001|Overall Study|Protocol Specified Criteria|1|||
161883454|NCT01785849|584616665|FG000|Overall Study|Withdrawal by Subject|15|||
161883455|NCT01785849|584616666|FG001|Overall Study|Withdrawal by Subject|12|||
161883456|NCT01785849|584616665|FG000|Overall Study|Sponsor Decision|0|||
161883457|NCT01785849|584616666|FG001|Overall Study|Sponsor Decision|1|||
161883458|NCT01785849|584616665|FG000|Overall Study|Lost to Follow-up|10|||
161883459|NCT01785849|584616666|FG001|Overall Study|Lost to Follow-up|11|||
161883460|NCT03932331|584616668|FG000|Overall Study|Death|0|||
161883461|NCT03932331|584616669|FG001|Overall Study|Death|7|||
161883462|NCT03932331|584616670|FG002|Overall Study|Death|2|||
161883463|NCT03932331|584616668|FG000|Overall Study|Withdrawal by Subject|0|||
161883464|NCT03932331|584616669|FG001|Overall Study|Withdrawal by Subject|3|||
161883465|NCT03932331|584616670|FG002|Overall Study|Withdrawal by Subject|0|||
161883466|NCT03932331|584616668|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
161883467|NCT03932331|584616669|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
161883468|NCT03932331|584616670|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
161883469|NCT03932331|584616668|FG000|Overall Study|Progressive disease|3|||
161883470|NCT03932331|584616669|FG001|Overall Study|Progressive disease|0|||
161883471|NCT03932331|584616670|FG002|Overall Study|Progressive disease|0|||
161883472|NCT03932331|584616668|FG000|Overall Study|Lung infection|1|||
161883473|NCT03932331|584616669|FG001|Overall Study|Lung infection|0|||
161883474|NCT03932331|584616670|FG002|Overall Study|Lung infection|0|||
161883475|NCT03932331|584616668|FG000|Overall Study|Other|0|||
161883476|NCT03932331|584616669|FG001|Overall Study|Other|0|||
161883477|NCT03932331|584616670|FG002|Overall Study|Other|58|||
161883478|NCT01032239|584616671|FG000|Overall Study|Lost to Follow-up|3|||
161883479|NCT01032239|584616672|FG001|Overall Study|Lost to Follow-up|2|||
161883480|NCT01032239|584616671|FG000|Overall Study|Withdrawal by Subject|2|||
161883481|NCT01032239|584616672|FG001|Overall Study|Withdrawal by Subject|3|||
161883482|NCT01032239|584616671|FG000|Overall Study|Death|1|||
161883483|NCT01032239|584616672|FG001|Overall Study|Death|0|||
161883484|NCT01032239|584616671|FG000|Overall Study|Protocol Violation|1|||
161883485|NCT01032239|584616672|FG001|Overall Study|Protocol Violation|0|||
161883486|NCT00204477|584616675|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
161883487|NCT00204477|584616676|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
161883488|NCT00204477|584616675|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
161883489|NCT00204477|584616676|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
161883490|NCT05513703|584616684|FG000|Overall Study|Death|4|||
161883491|NCT05513703|584616684|FG000|Overall Study|Study terminated by sponsor|5|||
161883492|NCT04450407|584616688|FG000|Overall Study|Withdrawal by Subject|10|||
161883493|NCT04450407|584616689|FG001|Overall Study|Withdrawal by Subject|1|||
161883494|NCT04450407|584616690|FG002|Overall Study|Withdrawal by Subject|4|||
161883495|NCT04450407|584616688|FG000|Overall Study|Adverse Event|0|||
161883496|NCT04450407|584616689|FG001|Overall Study|Adverse Event|0|||
161883497|NCT04450407|584616690|FG002|Overall Study|Adverse Event|1|||
161883498|NCT04450407|584616688|FG000|Overall Study|Lost to Follow-up|1|||
161883499|NCT04450407|584616689|FG001|Overall Study|Lost to Follow-up|0|||
161883500|NCT04450407|584616690|FG002|Overall Study|Lost to Follow-up|0|||
161883501|NCT04450407|584616688|FG000|Overall Study|Physician Decision|0|||
161883502|NCT04450407|584616689|FG001|Overall Study|Physician Decision|0|||
161883503|NCT04450407|584616690|FG002|Overall Study|Physician Decision|1|||
161883504|NCT04450407|584616688|FG000|Overall Study|Pregnancy|1|||
161883505|NCT04450407|584616689|FG001|Overall Study|Pregnancy|0|||
161883506|NCT04450407|584616690|FG002|Overall Study|Pregnancy|0|||
161883507|NCT04450407|584616688|FG000|Overall Study|Protocol Violation|2|||
161883508|NCT04450407|584616689|FG001|Overall Study|Protocol Violation|0|||
161883509|NCT04450407|584616690|FG002|Overall Study|Protocol Violation|0|||
161883510|NCT04450407|584616688|FG000|Overall Study|Investigational site terminated by sponsor|3|||
161883511|NCT04450407|584616689|FG001|Overall Study|Investigational site terminated by sponsor|0|||
161883512|NCT04450407|584616690|FG002|Overall Study|Investigational site terminated by sponsor|2|||
161883513|NCT00794040|584616692|FG000|Overall Study|Withdrawal by Subject|3|||
161883514|NCT00794040|584616693|FG001|Overall Study|Withdrawal by Subject|4|||
161883515|NCT00794040|584616692|FG000|Overall Study|Physician Decision|0|||
161883516|NCT00794040|584616693|FG001|Overall Study|Physician Decision|1|||
161883517|NCT04696354|584616696|FG000|Overall Study|Study termination|6|||
161883518|NCT04696354|584616697|FG001|Overall Study|Study termination|6|||
161883519|NCT03626363|584616701|FG000|Overall Study|Protocol Violation|4|||
161883520|NCT03626363|584616702|FG001|Overall Study|Protocol Violation|0|||
161883521|NCT03626363|584616701|FG000|Overall Study|Lost to Follow-up|5|||
161883522|NCT03626363|584616702|FG001|Overall Study|Lost to Follow-up|7|||
161883523|NCT00965341|584616703|FG000|Overall Study|Withdrew consent|1|||
161883524|NCT00965341|584616704|FG001|Overall Study|Withdrew consent|5|||
161883525|NCT00965341|584616703|FG000|Overall Study|Lost to Follow-up|1|||
161883526|NCT00965341|584616704|FG001|Overall Study|Lost to Follow-up|0|||
161883527|NCT00965341|584616703|FG000|Overall Study|Transportation issues|4|||
161883528|NCT00965341|584616704|FG001|Overall Study|Transportation issues|3|||
161883529|NCT01077739|584616705|FG000|Overall Study|Premature withdrawal|1|||
161883530|NCT01077739|584616706|FG001|Overall Study|Premature withdrawal|3|||
161883531|NCT01077739|584616705|FG000|Overall Study|Withdrawal by Subject|1|||
161883532|NCT01077739|584616706|FG001|Overall Study|Withdrawal by Subject|0|||
161883533|NCT01077739|584616705|FG000|Overall Study|Death|0|||
161883534|NCT01077739|584616706|FG001|Overall Study|Death|3|||
161883535|NCT01077739|584616705|FG000|Overall Study|Unacceptable toxicity|1|||
161883536|NCT01077739|584616706|FG001|Overall Study|Unacceptable toxicity|2|||
161883537|NCT01077739|584616705|FG000|Overall Study|Other|2|||
161883538|NCT01077739|584616706|FG001|Overall Study|Other|2|||
161883539|NCT00960986|584616707|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
161883540|NCT00960986|584616708|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
161883541|NCT00960986|584616709|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
161883542|NCT00960986|584616710|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
161883543|NCT00960986|584616707|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
161883544|NCT00960986|584616708|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
161883545|NCT00960986|584616709|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
161883546|NCT00960986|584616710|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
161883547|NCT00960986|584616707|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
161883548|NCT00960986|584616708|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
161883549|NCT00960986|584616709|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
161883550|NCT00960986|584616710|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
161883551|NCT00960986|584616707|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
161883552|NCT00960986|584616708|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
161883553|NCT00960986|584616709|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
161883554|NCT00960986|584616710|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
161883555|NCT00960986|584616707|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
161883556|NCT00960986|584616708|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
161883557|NCT00960986|584616709|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
161883558|NCT00960986|584616710|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
161883559|NCT00960986|584616707|FG000|Period 3 (7-week Therapy Period)|Death|0|||
161883560|NCT00960986|584616708|FG001|Period 3 (7-week Therapy Period)|Death|0|||
161883561|NCT00960986|584616709|FG002|Period 3 (7-week Therapy Period)|Death|1|||
161883562|NCT00960986|584616710|FG003|Period 3 (7-week Therapy Period)|Death|0|||
161883563|NCT00960986|584616707|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
161883564|NCT00960986|584616708|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
161883565|NCT00960986|584616709|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
161883566|NCT00960986|584616710|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
161883567|NCT00960986|584616707|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
161883568|NCT00960986|584616708|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
161883569|NCT00960986|584616709|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
161883570|NCT00960986|584616710|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
161883571|NCT00960986|584616707|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
161883572|NCT00960986|584616708|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
161883573|NCT00960986|584616709|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
161883574|NCT00960986|584616710|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
161883575|NCT00960986|584616707|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
161883576|NCT00960986|584616708|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
161883577|NCT00960986|584616709|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
161883578|NCT00960986|584616710|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
161883579|NCT00877071|584616711|FG000|Overall Study|disease progression|2|||
161883580|NCT02100670|584616717|FG000|Overall Study|Adverse Event|10|||
161883581|NCT02100670|584616718|FG001|Overall Study|Adverse Event|3|||
161883582|NCT02100670|584616719|FG002|Overall Study|Adverse Event|3|||
161883583|NCT02100670|584616720|FG003|Overall Study|Adverse Event|0|||
161883584|NCT02100670|584616717|FG000|Overall Study|Lost to Follow-up|1|||
161883585|NCT02100670|584616718|FG001|Overall Study|Lost to Follow-up|0|||
161883586|NCT02100670|584616719|FG002|Overall Study|Lost to Follow-up|0|||
161883587|NCT02100670|584616720|FG003|Overall Study|Lost to Follow-up|0|||
161883588|NCT02100670|584616717|FG000|Overall Study|Protocol Violation|0|||
161883589|NCT02100670|584616718|FG001|Overall Study|Protocol Violation|1|||
161883590|NCT02100670|584616719|FG002|Overall Study|Protocol Violation|0|||
161883591|NCT02100670|584616720|FG003|Overall Study|Protocol Violation|1|||
161883592|NCT02100670|584616717|FG000|Overall Study|Withdrawal of Consent|0|||
161883593|NCT02100670|584616718|FG001|Overall Study|Withdrawal of Consent|1|||
161883594|NCT02100670|584616719|FG002|Overall Study|Withdrawal of Consent|1|||
161883595|NCT02100670|584616720|FG003|Overall Study|Withdrawal of Consent|0|||
161883596|NCT02100670|584616717|FG000|Overall Study|No swelling no pain|1|||
161883597|NCT02100670|584616718|FG001|Overall Study|No swelling no pain|0|||
161883598|NCT02100670|584616719|FG002|Overall Study|No swelling no pain|0|||
161883599|NCT02100670|584616720|FG003|Overall Study|No swelling no pain|0|||
161883600|NCT02100670|584616717|FG000|Overall Study|Poor Efficacy|0|||
161883601|NCT02100670|584616718|FG001|Overall Study|Poor Efficacy|1|||
161883602|NCT02100670|584616719|FG002|Overall Study|Poor Efficacy|0|||
161883603|NCT02100670|584616720|FG003|Overall Study|Poor Efficacy|0|||
161883604|NCT02100670|584616717|FG000|Overall Study|Physician Decision|0|||
161883605|NCT02100670|584616718|FG001|Overall Study|Physician Decision|1|||
161883606|NCT02100670|584616719|FG002|Overall Study|Physician Decision|0|||
161883607|NCT02100670|584616720|FG003|Overall Study|Physician Decision|0|||
161883608|NCT02100670|584616717|FG000|Overall Study|Withdrawal by Subject|1|||
161883609|NCT02100670|584616718|FG001|Overall Study|Withdrawal by Subject|0|||
161883610|NCT02100670|584616719|FG002|Overall Study|Withdrawal by Subject|0|||
161883611|NCT02100670|584616720|FG003|Overall Study|Withdrawal by Subject|0|||
161883612|NCT04439357|584618257|FG000|Overall Study|Disease Progression|4|||
161883613|NCT01668966|584618266|FG000|Overall Study|Withdrawal by Subject|1|||
161883614|NCT01668966|584618266|FG000|Overall Study|Death|1|||
161883615|NCT01668966|584618266|FG000|Overall Study|Not treated|2|||
161883616|NCT01573767|584618267|FG000|Overall Study|Adverse Event|0|||
161883617|NCT01573767|584618268|FG001|Overall Study|Adverse Event|1|||
161883618|NCT01573767|584618269|FG002|Overall Study|Adverse Event|0|||
161883619|NCT01573767|584618270|FG003|Overall Study|Adverse Event|1|||
161883620|NCT01573767|584618267|FG000|Overall Study|Lack of Efficacy|18|||
161883621|NCT01573767|584618268|FG001|Overall Study|Lack of Efficacy|15|||
161883622|NCT01573767|584618269|FG002|Overall Study|Lack of Efficacy|12|||
161883623|NCT01573767|584618270|FG003|Overall Study|Lack of Efficacy|17|||
161883624|NCT01573767|584618267|FG000|Overall Study|Protocol Violation|3|||
161883625|NCT01573767|584618268|FG001|Overall Study|Protocol Violation|1|||
161883626|NCT01573767|584618269|FG002|Overall Study|Protocol Violation|1|||
161883627|NCT01573767|584618270|FG003|Overall Study|Protocol Violation|3|||
161883628|NCT01573767|584618267|FG000|Overall Study|Lost to Follow-up|0|||
161883629|NCT01573767|584618268|FG001|Overall Study|Lost to Follow-up|1|||
161883630|NCT01573767|584618269|FG002|Overall Study|Lost to Follow-up|1|||
161883631|NCT01573767|584618270|FG003|Overall Study|Lost to Follow-up|1|||
161883632|NCT01573767|584618267|FG000|Overall Study|Physician Decision|1|||
161883633|NCT01573767|584618268|FG001|Overall Study|Physician Decision|2|||
161883634|NCT01573767|584618269|FG002|Overall Study|Physician Decision|0|||
161883635|NCT01573767|584618270|FG003|Overall Study|Physician Decision|2|||
161883636|NCT01573767|584618267|FG000|Overall Study|Withdrawal by Subject|0|||
161883637|NCT01573767|584618268|FG001|Overall Study|Withdrawal by Subject|1|||
161883638|NCT01573767|584618269|FG002|Overall Study|Withdrawal by Subject|0|||
161883639|NCT01573767|584618270|FG003|Overall Study|Withdrawal by Subject|0|||
161883640|NCT04247880|584618271|FG000|Overall Study|Lost to Follow-up|24|||
161883641|NCT04247880|584618272|FG001|Overall Study|Lost to Follow-up|17|||
161883642|NCT04247880|584618271|FG000|Overall Study|Withdrawal by Subject|3|||
161883643|NCT04247880|584618272|FG001|Overall Study|Withdrawal by Subject|0|||
161883644|NCT02122770|584618273|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
161883645|NCT02122770|584618274|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
161883646|NCT02122770|584618275|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
161883647|NCT02122770|584618276|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
161883648|NCT02122770|584618277|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
161883649|NCT02122770|584618278|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
161883650|NCT02122770|584618273|FG000|Part A: Drug-drug Interaction 2|Other|0|||
161883651|NCT02122770|584618274|FG001|Part A: Drug-drug Interaction 2|Other|0|||
161883652|NCT02122770|584618275|FG002|Part A: Drug-drug Interaction 2|Other|1|||
161883653|NCT02122770|584618276|FG003|Part A: Drug-drug Interaction 2|Other|0|||
161883654|NCT02122770|584618277|FG004|Part A: Drug-drug Interaction 2|Other|0|||
161883655|NCT02122770|584618278|FG005|Part A: Drug-drug Interaction 2|Other|0|||
161883656|NCT02122770|584618273|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161883657|NCT02122770|584618274|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
161883658|NCT02122770|584618275|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161883659|NCT02122770|584618276|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161883660|NCT02122770|584618277|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161883661|NCT02122770|584618278|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161883662|NCT02122770|584618273|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
161883663|NCT02122770|584618274|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
161883664|NCT02122770|584618275|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
161883665|NCT02122770|584618276|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
161883666|NCT02122770|584618277|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
161883667|NCT02122770|584618278|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
161883668|NCT02122770|584618273|FG000|Part B: Standard of Care|Adverse Event|0|||
161883669|NCT02122770|584618274|FG001|Part B: Standard of Care|Adverse Event|0|||
161883670|NCT02122770|584618275|FG002|Part B: Standard of Care|Adverse Event|0|||
161883671|NCT02122770|584618276|FG003|Part B: Standard of Care|Adverse Event|0|||
161883672|NCT02122770|584618277|FG004|Part B: Standard of Care|Adverse Event|4|||
161883673|NCT02122770|584618278|FG005|Part B: Standard of Care|Adverse Event|1|||
161883674|NCT02122770|584618273|FG000|Part B: Standard of Care|Other|0|||
161883675|NCT02122770|584618274|FG001|Part B: Standard of Care|Other|0|||
161883676|NCT02122770|584618275|FG002|Part B: Standard of Care|Other|0|||
161883677|NCT02122770|584618276|FG003|Part B: Standard of Care|Other|0|||
161883678|NCT02122770|584618277|FG004|Part B: Standard of Care|Other|0|||
161883679|NCT02122770|584618278|FG005|Part B: Standard of Care|Other|2|||
161883680|NCT02122770|584618273|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
161883681|NCT02122770|584618274|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
161883682|NCT02122770|584618275|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
161883683|NCT02122770|584618276|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
161883684|NCT02122770|584618277|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
161883685|NCT02122770|584618278|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
161883686|NCT02122770|584618273|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
161883687|NCT02122770|584618274|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
161883688|NCT02122770|584618275|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
161883689|NCT02122770|584618276|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
161883690|NCT02122770|584618277|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
161883691|NCT02122770|584618278|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
161883692|NCT02122770|584618273|FG000|Part B: Standard of Care|Progressive Disease|0|||
161883693|NCT02122770|584618274|FG001|Part B: Standard of Care|Progressive Disease|0|||
161883694|NCT02122770|584618275|FG002|Part B: Standard of Care|Progressive Disease|0|||
161883695|NCT02122770|584618276|FG003|Part B: Standard of Care|Progressive Disease|0|||
161883696|NCT02122770|584618277|FG004|Part B: Standard of Care|Progressive Disease|10|||
161883697|NCT02122770|584618278|FG005|Part B: Standard of Care|Progressive Disease|8|||
161883698|NCT00250458|584618280|FG000|Overall Study|Lost to Follow-up|4|||
161883699|NCT00250458|584618281|FG001|Overall Study|Lost to Follow-up|2|||
161883700|NCT00250458|584618280|FG000|Overall Study|Protocol Violation|0|||
161883701|NCT00250458|584618281|FG001|Overall Study|Protocol Violation|1|||
161883702|NCT00250458|584618280|FG000|Overall Study|Withdrawal by Subject|4|||
161883703|NCT00250458|584618281|FG001|Overall Study|Withdrawal by Subject|2|||
161883704|NCT00250458|584618280|FG000|Overall Study|Lack of Migraine Attack|20|||
161883705|NCT00250458|584618281|FG001|Overall Study|Lack of Migraine Attack|9|||
161883706|NCT00250458|584618280|FG000|Overall Study|Qualifying migraine but did not treat|3|||
161883707|NCT00250458|584618281|FG001|Overall Study|Qualifying migraine but did not treat|3|||
161883708|NCT00250458|584618280|FG000|Overall Study|Other|1|||
161883709|NCT00250458|584618281|FG001|Overall Study|Other|0|||
161883710|NCT06137703|584618282|FG000|Overall Study|Other|0|||
161883711|NCT06137703|584618283|FG001|Overall Study|Other|1|||
161883712|NCT06137703|584618284|FG002|Overall Study|Other|0|||
161883713|NCT06137703|584618285|FG003|Overall Study|Other|0|||
161883714|NCT06137703|584618282|FG000|Overall Study|Adverse Event|0|||
161883715|NCT06137703|584618283|FG001|Overall Study|Adverse Event|0|||
161883716|NCT06137703|584618284|FG002|Overall Study|Adverse Event|1|||
161883717|NCT06137703|584618285|FG003|Overall Study|Adverse Event|0|||
161883718|NCT00767039|584618288|FG000|Overall Study|Death|5|||
161883719|NCT00767039|584618289|FG001|Overall Study|Death|2|||
161883720|NCT01472757|584618290|FG000|Overall Study|Withdrawal by Subject|1|||
161883721|NCT01472757|584618291|FG001|Overall Study|Withdrawal by Subject|2|||
161883722|NCT01472757|584618292|FG002|Overall Study|Withdrawal by Subject|2|||
161883723|NCT01472757|584618293|FG003|Overall Study|Withdrawal by Subject|0|||
161883724|NCT01472757|584618290|FG000|Overall Study|Asthma exacerbation|4|||
161883725|NCT01472757|584618291|FG001|Overall Study|Asthma exacerbation|1|||
161883726|NCT01472757|584618292|FG002|Overall Study|Asthma exacerbation|2|||
161883727|NCT01472757|584618293|FG003|Overall Study|Asthma exacerbation|1|||
161883728|NCT01472757|584618290|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
161883729|NCT01472757|584618291|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
161883730|NCT01472757|584618292|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
161883731|NCT01472757|584618293|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
161883732|NCT01472757|584618290|FG000|Overall Study|Protocol Violation|3|||
161883733|NCT01472757|584618291|FG001|Overall Study|Protocol Violation|2|||
161883734|NCT01472757|584618292|FG002|Overall Study|Protocol Violation|4|||
161883735|NCT01472757|584618293|FG003|Overall Study|Protocol Violation|4|||
161883736|NCT01472757|584618290|FG000|Overall Study|Other reasons|1|||
161883737|NCT01472757|584618291|FG001|Overall Study|Other reasons|0|||
161883738|NCT01472757|584618292|FG002|Overall Study|Other reasons|2|||
161883739|NCT01472757|584618293|FG003|Overall Study|Other reasons|2|||
161883740|NCT02505334|584618296|FG000|Main Treatment Period|Adverse Event|3|||
161883741|NCT02505334|584618297|FG001|Main Treatment Period|Adverse Event|3|||
161883742|NCT02505334|584618296|FG000|Main Treatment Period|Lack of Efficacy|7|||
161883743|NCT02505334|584618297|FG001|Main Treatment Period|Lack of Efficacy|17|||
161883744|NCT02505334|584618296|FG000|Main Treatment Period|Protocol Violation|0|||
161883745|NCT02505334|584618297|FG001|Main Treatment Period|Protocol Violation|1|||
161883746|NCT02505334|584618296|FG000|Main Treatment Period|Withdrawal by Subject|1|||
161883747|NCT02505334|584618297|FG001|Main Treatment Period|Withdrawal by Subject|8|||
161883748|NCT02505334|584618296|FG000|Main Treatment Period|Unclassified|4|||
161883749|NCT02505334|584618297|FG001|Main Treatment Period|Unclassified|10|||
161883750|NCT02505334|584618296|FG000|Extension Treatment Period|Adverse Event|5|||
161883751|NCT02505334|584618297|FG001|Extension Treatment Period|Adverse Event|0|||
161883752|NCT02505334|584618296|FG000|Extension Treatment Period|Lack of Efficacy|4|||
161883753|NCT02505334|584618297|FG001|Extension Treatment Period|Lack of Efficacy|0|||
161883754|NCT02505334|584618296|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
161883755|NCT02505334|584618297|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
161883756|NCT02505334|584618296|FG000|Extension Treatment Period|Unclassified|3|||
161883757|NCT02505334|584618297|FG001|Extension Treatment Period|Unclassified|0|||
161883758|NCT01549041|584618298|FG000|Overall Study|Lack of Efficacy|2|||
161883759|NCT01549041|584618299|FG001|Overall Study|Lack of Efficacy|4|||
161883760|NCT01549041|584618298|FG000|Overall Study|Adverse Event|0|||
161883761|NCT01549041|584618299|FG001|Overall Study|Adverse Event|4|||
161883762|NCT00597506|584618300|FG000|Overall Study|Subject is being followed for survival|1|||
161883763|NCT00525902|584618304|FG000|Overall Study|Lack of Efficacy|1|||
161883764|NCT03747302|584618305|FG000|Overall Study|Withdrawal by Subject|1|||
161883765|NCT03747302|584618306|FG001|Overall Study|Withdrawal by Subject|2|||
161883766|NCT00738062|584618309|FG000|Open Label Treatment|Lack of Efficacy|5|||
161883767|NCT00738062|584618310|FG001|Open Label Treatment|Lack of Efficacy|0|||
161883768|NCT00738062|584618311|FG002|Open Label Treatment|Lack of Efficacy|0|||
161883769|NCT00738062|584618309|FG000|Open Label Treatment|Adverse Event|11|||
161883770|NCT00738062|584618310|FG001|Open Label Treatment|Adverse Event|0|||
161883771|NCT00738062|584618311|FG002|Open Label Treatment|Adverse Event|0|||
161883772|NCT00738062|584618309|FG000|Open Label Treatment|Protocol Violation|2|||
161883773|NCT00738062|584618310|FG001|Open Label Treatment|Protocol Violation|0|||
161883774|NCT00738062|584618311|FG002|Open Label Treatment|Protocol Violation|0|||
161883775|NCT00738062|584618309|FG000|Open Label Treatment|Withdrawal by Subject|9|||
161883776|NCT00738062|584618310|FG001|Open Label Treatment|Withdrawal by Subject|0|||
161883777|NCT00738062|584618311|FG002|Open Label Treatment|Withdrawal by Subject|0|||
161883778|NCT00738062|584618309|FG000|Open Label Treatment|Investigator Decision|1|||
161883779|NCT00738062|584618310|FG001|Open Label Treatment|Investigator Decision|0|||
161883780|NCT00738062|584618311|FG002|Open Label Treatment|Investigator Decision|0|||
161883781|NCT00738062|584618309|FG000|Open-Label Extension|Adverse Event|5|||
161883782|NCT00738062|584618310|FG001|Open-Label Extension|Adverse Event|0|||
161883783|NCT00738062|584618311|FG002|Open-Label Extension|Adverse Event|0|||
161883784|NCT00738062|584618309|FG000|Open-Label Extension|Physician Decision|1|||
161883785|NCT00738062|584618310|FG001|Open-Label Extension|Physician Decision|0|||
161883786|NCT00738062|584618311|FG002|Open-Label Extension|Physician Decision|0|||
161883787|NCT00738062|584618309|FG000|Open-Label Extension|Lack of Efficacy|2|||
161883788|NCT00738062|584618310|FG001|Open-Label Extension|Lack of Efficacy|0|||
161883789|NCT00738062|584618311|FG002|Open-Label Extension|Lack of Efficacy|0|||
161883790|NCT00738062|584618309|FG000|Open-Label Extension|Withdrawal by Subject|6|||
161883791|NCT00738062|584618310|FG001|Open-Label Extension|Withdrawal by Subject|0|||
161883792|NCT00738062|584618311|FG002|Open-Label Extension|Withdrawal by Subject|0|||
161883793|NCT00738062|584618309|FG000|Open-Label Extension|Protocol Violation|1|||
161883794|NCT00738062|584618310|FG001|Open-Label Extension|Protocol Violation|0|||
161883795|NCT00738062|584618311|FG002|Open-Label Extension|Protocol Violation|0|||
161883796|NCT00738062|584618309|FG000|Open-Label Extension|Study Terminated|2|||
161883797|NCT00738062|584618310|FG001|Open-Label Extension|Study Terminated|0|||
161883798|NCT00738062|584618311|FG002|Open-Label Extension|Study Terminated|0|||
161883799|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
161883800|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
161883801|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
161883802|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
161883803|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|Death|1|||
161883804|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|Death|1|||
161883805|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
161883806|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
161883807|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
161883808|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
161883809|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
161883810|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
161883811|NCT00033657|584618313|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
161883812|NCT00033657|584618314|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
161883813|NCT00033657|584618313|FG000|Surgical Resection|not complete resection|0|||
161883814|NCT00033657|584618314|FG001|Surgical Resection|not complete resection|3|||
161883815|NCT00033657|584618313|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
161883816|NCT00033657|584618314|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
161883817|NCT00033657|584618313|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
161883818|NCT00033657|584618314|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
161883819|NCT00033657|584618313|FG000|Adjuvant Chemotherapy|Death|2|||
161883820|NCT00033657|584618314|FG001|Adjuvant Chemotherapy|Death|1|||
161883821|NCT00033657|584618313|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
161883822|NCT00033657|584618314|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
161883823|NCT00033657|584618313|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
161883824|NCT00033657|584618314|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
161883825|NCT00033657|584618313|FG000|Adjuvant Chemotherapy|Other|0|||
161883826|NCT00033657|584618314|FG001|Adjuvant Chemotherapy|Other|2|||
161883827|NCT03235115|584618315|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161883828|NCT03235115|584618316|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161883829|NCT03235115|584618317|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161883830|NCT03235115|584618318|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161883831|NCT03235115|584618319|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161883832|NCT03235115|584618320|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
161883833|NCT00503997|584618322|FG000|Overall Study|disease progression|1|||
161883834|NCT00503997|584618322|FG000|Overall Study|Adverse Event|5|||
161883835|NCT00503997|584618322|FG000|Overall Study|Death|1|||
161883836|NCT00503997|584618322|FG000|Overall Study|Withdrawal by Subject|1|||
161883837|NCT00656851|584618327|FG000|Overall Study|Withdrawal by Subject|0|||
161883838|NCT00656851|584618328|FG001|Overall Study|Withdrawal by Subject|4|||
161883839|NCT00955968|584618333|FG000|Overall Study|Death|2|||
161883840|NCT00955968|584618334|FG001|Overall Study|Death|4|||
161883841|NCT00955968|584618333|FG000|Overall Study|Withdrawal by Subject|35|||
161883842|NCT00955968|584618334|FG001|Overall Study|Withdrawal by Subject|31|||
161883843|NCT00955968|584618333|FG000|Overall Study|Lost to Follow-up|45|||
161883844|NCT00955968|584618334|FG001|Overall Study|Lost to Follow-up|39|||
161883845|NCT00955968|584618333|FG000|Overall Study|Site closed|55|||
161883846|NCT00955968|584618334|FG001|Overall Study|Site closed|52|||
161883847|NCT05020899|584618336|FG000|8 Week Follow-up|Lost to Follow-up|3|||
161883848|NCT05020899|584618337|FG001|8 Week Follow-up|Lost to Follow-up|6|||
161883849|NCT05020899|584618336|FG000|12 Week Follow-up|Lost to Follow-up|1|||
161883850|NCT05020899|584618337|FG001|12 Week Follow-up|Lost to Follow-up|0|||
161883851|NCT05020899|584618336|FG000|12 Week Follow-up|Death|0|||
161883852|NCT05020899|584618337|FG001|12 Week Follow-up|Death|1|||
161883853|NCT01940900|584618340|FG000|Overall Study|Physician Decision|4|||
161883854|NCT01940900|584618341|FG001|Overall Study|Physician Decision|0|||
161883855|NCT01940900|584618340|FG000|Overall Study|Adverse Event|10|||
161883856|NCT01940900|584618341|FG001|Overall Study|Adverse Event|15|||
161883857|NCT01940900|584618340|FG000|Overall Study|Withdrawal by Subject|11|||
161883858|NCT01940900|584618341|FG001|Overall Study|Withdrawal by Subject|15|||
161883859|NCT01940900|584618340|FG000|Overall Study|Lost to Follow-up|1|||
161883860|NCT01940900|584618341|FG001|Overall Study|Lost to Follow-up|0|||
161883861|NCT01940900|584618340|FG000|Overall Study|Sponsor Decision|1|||
161883862|NCT01940900|584618341|FG001|Overall Study|Sponsor Decision|0|||
161883863|NCT01940900|584618340|FG000|Overall Study|subject non-compliance|1|||
161883864|NCT01940900|584618341|FG001|Overall Study|subject non-compliance|1|||
161883865|NCT01940900|584618340|FG000|Overall Study|other|1|||
161883866|NCT01940900|584618341|FG001|Overall Study|other|0|||
161883867|NCT04713592|584618342|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
161883868|NCT04713592|584618343|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
161883869|NCT04713592|584618344|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
161883870|NCT04713592|584618345|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
161883871|NCT04713592|584618342|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
161883872|NCT04713592|584618343|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
161883873|NCT04713592|584618344|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
161883874|NCT04713592|584618345|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
161883875|NCT04713592|584618342|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
161883876|NCT04713592|584618343|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
161883877|NCT04713592|584618344|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
161883878|NCT04713592|584618345|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
161883879|NCT04713592|584618342|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161883880|NCT04713592|584618343|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161883881|NCT04713592|584618344|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
161883882|NCT04713592|584618345|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
161883883|NCT04713592|584618342|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
161883884|NCT04713592|584618343|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
161883885|NCT04713592|584618344|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
161883886|NCT04713592|584618345|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
161883887|NCT04713592|584618342|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161883888|NCT04713592|584618343|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161883889|NCT04713592|584618344|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
161883890|NCT04713592|584618345|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
161883891|NCT04713592|584618342|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
161883892|NCT04713592|584618343|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
161883893|NCT04713592|584618344|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
161883894|NCT04713592|584618345|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
161883895|NCT02225366|584618350|FG000|Overall Study|Lack of Efficacy|1|||
161883896|NCT02225366|584618351|FG001|Overall Study|Lack of Efficacy|0|||
161883897|NCT03782298|584618352|FG000|Overall Study|Protocol Deviation|4|||
161883898|NCT02431806|584618353|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
161883899|NCT02431806|584618354|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
161883900|NCT02431806|584618355|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
161883901|NCT02431806|584618356|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
161883902|NCT02431806|584618353|FG000|Double-blind Treatment Period|Adverse Event|4|||
161883903|NCT02431806|584618354|FG001|Double-blind Treatment Period|Adverse Event|7|||
161883904|NCT02431806|584618355|FG002|Double-blind Treatment Period|Adverse Event|11|||
161883905|NCT02431806|584618356|FG003|Double-blind Treatment Period|Adverse Event|7|||
161883906|NCT02431806|584618353|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
161883907|NCT02431806|584618354|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
161883908|NCT02431806|584618355|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
161883909|NCT02431806|584618356|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
161883910|NCT02431806|584618353|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
161883911|NCT02431806|584618354|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
161883912|NCT02431806|584618355|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
161883913|NCT02431806|584618356|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
161883914|NCT02431806|584618353|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
161883915|NCT02431806|584618354|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
161883916|NCT02431806|584618355|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
161883917|NCT02431806|584618356|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
161883918|NCT02431806|584618353|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
161883919|NCT02431806|584618354|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
161883920|NCT02431806|584618355|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
161883921|NCT02431806|584618356|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
161883922|NCT02431806|584618353|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
161883923|NCT02431806|584618354|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
161883924|NCT02431806|584618355|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
161883925|NCT02431806|584618356|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
161883926|NCT00742508|584618357|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
161883927|NCT00742508|584618358|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
161883928|NCT00742508|584618357|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
161883929|NCT00742508|584618358|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
161883930|NCT00742508|584618357|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
161883931|NCT00742508|584618358|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
161883932|NCT00742508|584618357|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
161883933|NCT00742508|584618358|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
161883934|NCT00742508|584618357|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
161883935|NCT00742508|584618358|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
161883936|NCT01382225|584618359|FG000|Overall Study|Adverse Event|3|||
161883937|NCT01382225|584618360|FG001|Overall Study|Adverse Event|2|||
161883938|NCT01382225|584618359|FG000|Overall Study|Protocol Violation|2|||
161883939|NCT01382225|584618360|FG001|Overall Study|Protocol Violation|1|||
161883940|NCT01382225|584618359|FG000|Overall Study|Subject Withdrew Consent|5|||
161883941|NCT01382225|584618360|FG001|Overall Study|Subject Withdrew Consent|2|||
161883942|NCT01382225|584618359|FG000|Overall Study|Other|4|||
161883943|NCT01382225|584618360|FG001|Overall Study|Other|2|||
161883944|NCT01797081|584618361|FG000|Overall Study|Adverse Event|1|||
161883945|NCT01797081|584618362|FG001|Overall Study|Adverse Event|0|||
161883946|NCT01797081|584618363|FG002|Overall Study|Adverse Event|1|||
161883947|NCT01797081|584618364|FG003|Overall Study|Adverse Event|0|||
161883948|NCT01797081|584618361|FG000|Overall Study|Pregnancy|1|||
161883949|NCT01797081|584618362|FG001|Overall Study|Pregnancy|0|||
161883950|NCT01797081|584618363|FG002|Overall Study|Pregnancy|0|||
161883951|NCT01797081|584618364|FG003|Overall Study|Pregnancy|0|||
161883952|NCT01797081|584618361|FG000|Overall Study|Personal Reasons|12|||
161883953|NCT01797081|584618362|FG001|Overall Study|Personal Reasons|4|||
161883954|NCT01797081|584618363|FG002|Overall Study|Personal Reasons|4|||
161883955|NCT01797081|584618364|FG003|Overall Study|Personal Reasons|8|||
161883956|NCT01797081|584618361|FG000|Overall Study|Protocol Violation|0|||
161883957|NCT01797081|584618362|FG001|Overall Study|Protocol Violation|0|||
161883958|NCT01797081|584618363|FG002|Overall Study|Protocol Violation|0|||
161883959|NCT01797081|584618364|FG003|Overall Study|Protocol Violation|1|||
161883960|NCT02484651|584618370|FG000|Overall Study|Patients' data files were corrupted.|1|||
161883961|NCT02484651|584618371|FG001|Overall Study|Patients' data files were corrupted.|1|||
161883962|NCT02484651|584618370|FG000|Overall Study|BIS monitoring failed.|1|||
161883963|NCT02484651|584618371|FG001|Overall Study|BIS monitoring failed.|1|||
161883964|NCT02484651|584618370|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
161883965|NCT02484651|584618371|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
161883966|NCT01419080|584618372|FG000|Overall Study|Withdrawal by Subject|75|||
161883967|NCT01419080|584618372|FG000|Overall Study|Death|30|||
161883968|NCT01419080|584618372|FG000|Overall Study|Lost to Follow-up|23|||
161883969|NCT01419080|584618372|FG000|Overall Study|Too Ill|3|||
161883970|NCT00150800|584618373|FG000|Overall Study|Adverse Event|89|||
161883971|NCT00150800|584618373|FG000|Overall Study|Death|18|||
161883972|NCT00150800|584618373|FG000|Overall Study|Lack of Efficacy|166|||
161883973|NCT00150800|584618373|FG000|Overall Study|Lost to Follow-up|58|||
161883974|NCT00150800|584618373|FG000|Overall Study|Subject's choice|90|||
161883975|NCT00150800|584618373|FG000|Overall Study|No compliance|18|||
161883976|NCT00150800|584618373|FG000|Overall Study|IP misshandling|1|||
161883977|NCT00150800|584618373|FG000|Overall Study|Site closure|24|||
161883978|NCT00150800|584618373|FG000|Overall Study|Protocol non-adherence|2|||
161883979|NCT00150800|584618373|FG000|Overall Study|Nobody to accompany patient|1|||
161883980|NCT00150800|584618373|FG000|Overall Study|Distance too long for patient|1|||
161883981|NCT00150800|584618373|FG000|Overall Study|Neurosurgery|2|||
161883982|NCT00150800|584618373|FG000|Overall Study|BRV monotherapy|1|||
161883983|NCT00150800|584618373|FG000|Overall Study|Visit refusal|3|||
161883984|NCT00150800|584618373|FG000|Overall Study|Sponsor's request|2|||
161883985|NCT00150800|584618373|FG000|Overall Study|Generalized Epilepsy|1|||
161883986|NCT00150800|584618373|FG000|Overall Study|Moved from area/country|8|||
161883987|NCT00150800|584618373|FG000|Overall Study|PI retiring|2|||
161883988|NCT00150800|584618373|FG000|Overall Study|PI leaving site|2|||
161883989|NCT00150800|584618373|FG000|Overall Study|Patient insurance|1|||
161883990|NCT00150800|584618373|FG000|Overall Study|Surgical intervention|4|||
161883991|NCT00150800|584618373|FG000|Overall Study|Pregnancy planned|1|||
161883992|NCT00150800|584618373|FG000|Overall Study|PI discontinuation request|1|||
161883993|NCT04972968|584618374|FG000|Overall Study|Adverse Event|3|||
161883994|NCT04972968|584618375|FG001|Overall Study|Adverse Event|1|||
161883995|NCT04972968|584618376|FG002|Overall Study|Adverse Event|1|||
161883996|NCT04972968|584618377|FG003|Overall Study|Adverse Event|7|||
161883997|NCT04972968|584618374|FG000|Overall Study|Lack of Efficacy|2|||
161883998|NCT04972968|584618375|FG001|Overall Study|Lack of Efficacy|1|||
161883999|NCT04972968|584618376|FG002|Overall Study|Lack of Efficacy|0|||
161884000|NCT04972968|584618377|FG003|Overall Study|Lack of Efficacy|0|||
161884001|NCT04972968|584618374|FG000|Overall Study|Withdrawal by Subject|7|||
161884002|NCT04972968|584618375|FG001|Overall Study|Withdrawal by Subject|4|||
161884003|NCT04972968|584618376|FG002|Overall Study|Withdrawal by Subject|3|||
161884004|NCT04972968|584618377|FG003|Overall Study|Withdrawal by Subject|2|||
161884005|NCT04972968|584618374|FG000|Overall Study|Study Terminated by Sponsor|25|||
161884006|NCT04972968|584618375|FG001|Overall Study|Study Terminated by Sponsor|28|||
161884007|NCT04972968|584618376|FG002|Overall Study|Study Terminated by Sponsor|32|||
161884008|NCT04972968|584618377|FG003|Overall Study|Study Terminated by Sponsor|27|||
161884009|NCT04972968|584618374|FG000|Overall Study|Other|1|||
161884010|NCT04972968|584618375|FG001|Overall Study|Other|0|||
161884011|NCT04972968|584618376|FG002|Overall Study|Other|1|||
161884012|NCT04972968|584618377|FG003|Overall Study|Other|1|||
161884013|NCT01698879|584618378|FG000|Overall Study|Withdrawal by Subject|1|||
161884014|NCT01698879|584618379|FG001|Overall Study|Withdrawal by Subject|0|||
161884015|NCT01698879|584618380|FG002|Overall Study|Withdrawal by Subject|0|||
161884016|NCT03649178|584618381|FG000|Overall Study|Adverse Event|1|||
161884017|NCT03649178|584618382|FG001|Overall Study|Adverse Event|2|||
161884018|NCT03649178|584618381|FG000|Overall Study|Withdrawal by Subject|0|||
161884019|NCT03649178|584618382|FG001|Overall Study|Withdrawal by Subject|2|||
161884020|NCT03649178|584618381|FG000|Overall Study|COVID regulation required halt in protocol|1|||
161884021|NCT03649178|584618382|FG001|Overall Study|COVID regulation required halt in protocol|0|||
161991872|NCT03364309|585018556|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161991873|NCT03364309|585018557|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
161884022|NCT03619902|584618384|FG000|Overall Study|Termination of Study by Investigator|1|||
161884023|NCT03619902|584618384|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
161884024|NCT03814720|584618390|FG000|Overall Study|Lost to Follow-up|0|||
161884025|NCT03814720|584618391|FG001|Overall Study|Lost to Follow-up|1|||
161884026|NCT03814720|584618392|FG002|Overall Study|Lost to Follow-up|0|||
161884027|NCT03814720|584618393|FG003|Overall Study|Lost to Follow-up|0|||
161884028|NCT03814720|584618394|FG004|Overall Study|Lost to Follow-up|0|||
161884029|NCT01095978|584618395|FG000|Overall Study|Did not take Klacid SR|2|||
161884030|NCT01095978|584618395|FG000|Overall Study|Adverse Event|1|||
161991874|NCT03364309|585018558|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
161884031|NCT03197324|584618399|FG000|Overall Study|Adverse Event|0|||
161884032|NCT03197324|584618400|FG001|Overall Study|Adverse Event|1|||
161884033|NCT03589976|584618407|FG000|Overall Study|Death|5|||
161884034|NCT03589976|584618408|FG001|Overall Study|Death|1|||
161884035|NCT03589976|584618407|FG000|Overall Study|Adverse Event|5|||
161884036|NCT03589976|584618408|FG001|Overall Study|Adverse Event|1|||
161884037|NCT03589976|584618407|FG000|Overall Study|Withdrawal by Subject|4|||
161884038|NCT03589976|584618408|FG001|Overall Study|Withdrawal by Subject|1|||
161884039|NCT03589976|584618407|FG000|Overall Study|Lost to Follow-up|1|||
161884040|NCT03589976|584618408|FG001|Overall Study|Lost to Follow-up|0|||
161884041|NCT03589976|584618407|FG000|Overall Study|Other|4|||
161884042|NCT03589976|584618408|FG001|Overall Study|Other|3|||
161884043|NCT00710684|584618409|FG000|Overall Study|Adverse Event|11|||
161884044|NCT00710684|584618410|FG001|Overall Study|Adverse Event|19|||
161884045|NCT00710684|584618411|FG002|Overall Study|Adverse Event|16|||
161884046|NCT00710684|584618409|FG000|Overall Study|Lack of Efficacy|4|||
161884047|NCT00710684|584618410|FG001|Overall Study|Lack of Efficacy|3|||
161884048|NCT00710684|584618411|FG002|Overall Study|Lack of Efficacy|5|||
161884049|NCT00710684|584618409|FG000|Overall Study|Protocol Violation|5|||
161884050|NCT00710684|584618410|FG001|Overall Study|Protocol Violation|5|||
161884051|NCT00710684|584618411|FG002|Overall Study|Protocol Violation|5|||
161884052|NCT00710684|584618409|FG000|Overall Study|Lost to Follow-up|4|||
161884053|NCT00710684|584618410|FG001|Overall Study|Lost to Follow-up|6|||
161884054|NCT00710684|584618411|FG002|Overall Study|Lost to Follow-up|7|||
161884055|NCT00710684|584618409|FG000|Overall Study|Physician Decision|0|||
161884056|NCT00710684|584618410|FG001|Overall Study|Physician Decision|2|||
161884057|NCT00710684|584618411|FG002|Overall Study|Physician Decision|4|||
161884058|NCT00710684|584618409|FG000|Overall Study|Withdrawal by Subject|24|||
161884059|NCT00710684|584618410|FG001|Overall Study|Withdrawal by Subject|18|||
161884060|NCT00710684|584618411|FG002|Overall Study|Withdrawal by Subject|11|||
161884061|NCT00710684|584618409|FG000|Overall Study|Missing|1|||
161884062|NCT00710684|584618410|FG001|Overall Study|Missing|0|||
161884063|NCT00710684|584618411|FG002|Overall Study|Missing|0|||
161884064|NCT00710684|584618409|FG000|Overall Study|Did not continue after week 24|25|||
161884065|NCT00710684|584618410|FG001|Overall Study|Did not continue after week 24|21|||
161884066|NCT00710684|584618411|FG002|Overall Study|Did not continue after week 24|16|||
161884067|NCT04778059|584618412|FG000|Overall Study|Death|2|||
161884068|NCT04778059|584618413|FG001|Overall Study|Death|2|||
161884069|NCT04778059|584618414|FG002|Overall Study|Death|1|||
161884070|NCT04778059|584618415|FG003|Overall Study|Death|1|||
161884071|NCT04778059|584618416|FG004|Overall Study|Death|1|||
161884072|NCT04778059|584618412|FG000|Overall Study|Lost to Follow-up|0|||
161884073|NCT04778059|584618413|FG001|Overall Study|Lost to Follow-up|0|||
161884074|NCT04778059|584618414|FG002|Overall Study|Lost to Follow-up|0|||
161884075|NCT04778059|584618415|FG003|Overall Study|Lost to Follow-up|0|||
161884076|NCT04778059|584618416|FG004|Overall Study|Lost to Follow-up|1|||
161884077|NCT04778059|584618412|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
161884078|NCT04778059|584618413|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
161884079|NCT04778059|584618414|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
161884080|NCT04778059|584618415|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
161884081|NCT04778059|584618416|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
161884082|NCT02832375|584618417|FG000|Overall Study|Lost to Follow-up|1|||
161884083|NCT02832375|584618418|FG001|Overall Study|Lost to Follow-up|0|||
161884084|NCT02832375|584618417|FG000|Overall Study|Withdrawal of Consent|1|||
161884085|NCT02832375|584618418|FG001|Overall Study|Withdrawal of Consent|0|||
161884086|NCT00514904|584618419|FG000|Overall Study|Withdrawal by Subject|3|||
161884087|NCT00514904|584618420|FG001|Overall Study|Withdrawal by Subject|2|||
161884088|NCT00514904|584618419|FG000|Overall Study|Lost to Follow-up|21|||
161884089|NCT00514904|584618420|FG001|Overall Study|Lost to Follow-up|3|||
161884090|NCT00084318|584618421|FG000|Overall Study|Withdrawal by Subject|5|||
161884091|NCT00084318|584618422|FG001|Overall Study|Withdrawal by Subject|2|||
161884092|NCT00084318|584618421|FG000|Overall Study|Protocol Violation|15|||
161884093|NCT00084318|584618422|FG001|Overall Study|Protocol Violation|11|||
161884094|NCT00084318|584618421|FG000|Overall Study|No protocol treatment|2|||
161884095|NCT00084318|584618422|FG001|Overall Study|No protocol treatment|0|||
161884096|NCT00549601|584620005|FG000|Randomized|Protocol Violation|0|||
161884097|NCT00549601|584620006|FG001|Randomized|Protocol Violation|0|||
161884098|NCT00549601|584620007|FG002|Randomized|Protocol Violation|1|||
161884099|NCT00549601|584620005|FG000|Randomized|Withdrawal by Subject|0|||
161884100|NCT00549601|584620006|FG001|Randomized|Withdrawal by Subject|1|||
161884101|NCT00549601|584620007|FG002|Randomized|Withdrawal by Subject|1|||
161884102|NCT00549601|584620005|FG000|Received Study Drug|Adverse Event|2|||
161884103|NCT00549601|584620006|FG001|Received Study Drug|Adverse Event|5|||
161884104|NCT00549601|584620007|FG002|Received Study Drug|Adverse Event|1|||
161884105|NCT00549601|584620005|FG000|Received Study Drug|Death|0|||
161884106|NCT00549601|584620006|FG001|Received Study Drug|Death|1|||
161884107|NCT00549601|584620007|FG002|Received Study Drug|Death|0|||
161884108|NCT00549601|584620005|FG000|Received Study Drug|Lost to Follow-up|0|||
161884109|NCT00549601|584620006|FG001|Received Study Drug|Lost to Follow-up|1|||
161884110|NCT00549601|584620007|FG002|Received Study Drug|Lost to Follow-up|1|||
161884111|NCT00549601|584620005|FG000|Received Study Drug|Protocol Violation|3|||
161884112|NCT00549601|584620006|FG001|Received Study Drug|Protocol Violation|4|||
161884113|NCT00549601|584620007|FG002|Received Study Drug|Protocol Violation|1|||
161884114|NCT00549601|584620005|FG000|Received Study Drug|Withdrawal by Subject|2|||
161884115|NCT00549601|584620006|FG001|Received Study Drug|Withdrawal by Subject|0|||
161884116|NCT00549601|584620007|FG002|Received Study Drug|Withdrawal by Subject|1|||
161884117|NCT00908596|584620011|FG000|Overall Study|Other reasons|46|||
161884118|NCT00908596|584620012|FG001|Overall Study|Other reasons|6|||
161884119|NCT00908596|584620013|FG002|Overall Study|Other reasons|2|||
161884120|NCT00908596|584620014|FG003|Overall Study|Other reasons|0|||
161884121|NCT00908596|584620011|FG000|Overall Study|Lost to Follow-up|0|||
161884122|NCT00908596|584620012|FG001|Overall Study|Lost to Follow-up|1|||
161884123|NCT00908596|584620013|FG002|Overall Study|Lost to Follow-up|12|||
161884124|NCT00908596|584620014|FG003|Overall Study|Lost to Follow-up|4|||
161884125|NCT00908596|584620011|FG000|Overall Study|Death|0|||
161884126|NCT00908596|584620012|FG001|Overall Study|Death|5|||
161884127|NCT00908596|584620013|FG002|Overall Study|Death|57|||
161884128|NCT00908596|584620014|FG003|Overall Study|Death|32|||
161884129|NCT00908596|584620011|FG000|Overall Study|Protocol Violation|1|||
161884130|NCT00908596|584620012|FG001|Overall Study|Protocol Violation|0|||
161884131|NCT00908596|584620013|FG002|Overall Study|Protocol Violation|0|||
161884132|NCT00908596|584620014|FG003|Overall Study|Protocol Violation|0|||
161884133|NCT00908596|584620011|FG000|Overall Study|Withdrawal by Subject|0|||
161884134|NCT00908596|584620012|FG001|Overall Study|Withdrawal by Subject|1|||
161884135|NCT00908596|584620013|FG002|Overall Study|Withdrawal by Subject|3|||
161884136|NCT00908596|584620014|FG003|Overall Study|Withdrawal by Subject|1|||
161884137|NCT01556997|584620017|FG000|Overall Study|Adverse Event|10|||
161884138|NCT01556997|584620018|FG001|Overall Study|Adverse Event|12|||
161884139|NCT01556997|584620019|FG002|Overall Study|Adverse Event|12|||
161884140|NCT01556997|584620017|FG000|Overall Study|Lost to Follow-up|6|||
161884141|NCT01556997|584620018|FG001|Overall Study|Lost to Follow-up|6|||
161884142|NCT01556997|584620019|FG002|Overall Study|Lost to Follow-up|4|||
161884143|NCT01556997|584620017|FG000|Overall Study|Physician Decision|1|||
161884144|NCT01556997|584620018|FG001|Overall Study|Physician Decision|1|||
161884145|NCT01556997|584620019|FG002|Overall Study|Physician Decision|1|||
161884146|NCT01556997|584620017|FG000|Overall Study|Withdrawal by Subject|7|||
161884147|NCT01556997|584620018|FG001|Overall Study|Withdrawal by Subject|6|||
161884148|NCT01556997|584620019|FG002|Overall Study|Withdrawal by Subject|8|||
161884149|NCT01556997|584620017|FG000|Overall Study|Other|2|||
161884150|NCT01556997|584620018|FG001|Overall Study|Other|3|||
161884151|NCT01556997|584620019|FG002|Overall Study|Other|7|||
161884152|NCT05459558|584620020|FG000|Overall Study|Adverse Event|1|||
161884153|NCT05459558|584620021|FG001|Overall Study|Adverse Event|0|||
161884154|NCT05459558|584620022|FG002|Overall Study|Adverse Event|0|||
161884155|NCT05459558|584620020|FG000|Overall Study|Scheduling issue|0|||
161884156|NCT05459558|584620021|FG001|Overall Study|Scheduling issue|1|||
161884157|NCT05459558|584620022|FG002|Overall Study|Scheduling issue|3|||
161884158|NCT05459558|584620020|FG000|Overall Study|Withdrawal by Subject|0|||
161884159|NCT05459558|584620021|FG001|Overall Study|Withdrawal by Subject|0|||
161884160|NCT05459558|584620022|FG002|Overall Study|Withdrawal by Subject|2|||
161884161|NCT01250171|584620028|FG000|Overall Study|Administrative reasons|1|||
161884162|NCT01250171|584620029|FG001|Overall Study|Administrative reasons|0|||
161884163|NCT01250171|584620030|FG002|Overall Study|Administrative reasons|0|||
161884164|NCT01458951|584620048|FG000|Overall Study|Other|1|||
161884165|NCT01458951|584620049|FG001|Overall Study|Other|0|||
161884166|NCT01458951|584620050|FG002|Overall Study|Other|0|||
161884167|NCT01458951|584620048|FG000|Overall Study|Protocol Violation|5|||
161884168|NCT01458951|584620049|FG001|Overall Study|Protocol Violation|1|||
161884169|NCT01458951|584620050|FG002|Overall Study|Protocol Violation|0|||
161884170|NCT01458951|584620048|FG000|Overall Study|Withdrawal by Subject|2|||
161884171|NCT01458951|584620049|FG001|Overall Study|Withdrawal by Subject|0|||
161884172|NCT01458951|584620050|FG002|Overall Study|Withdrawal by Subject|2|||
161884173|NCT01458951|584620048|FG000|Overall Study|Adverse Event|7|||
161884174|NCT01458951|584620049|FG001|Overall Study|Adverse Event|0|||
161884175|NCT01458951|584620050|FG002|Overall Study|Adverse Event|2|||
161884176|NCT01458951|584620048|FG000|Overall Study|Insufficient Clinical Response|17|||
161884177|NCT01458951|584620049|FG001|Overall Study|Insufficient Clinical Response|0|||
161884178|NCT01458951|584620050|FG002|Overall Study|Insufficient Clinical Response|11|||
161884179|NCT01846221|584620053|FG000|Overall Study|Catheter Failure|2|||
161884180|NCT01846221|584620054|FG001|Overall Study|Catheter Failure|0|||
161884181|NCT01846221|584620053|FG000|Overall Study|Age Exclusion|1|||
161884182|NCT01846221|584620054|FG001|Overall Study|Age Exclusion|0|||
161884183|NCT04392167|584620055|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
161884184|NCT03427268|584620056|FG000|Overall Study|Progressive disease|25|||
161884185|NCT03427268|584620056|FG000|Overall Study|Never treated|2|||
161884186|NCT03427268|584620056|FG000|Overall Study|Compassionate use|1|||
161884187|NCT03427268|584620056|FG000|Overall Study|Withdrawal by Subject|1|||
161884188|NCT03427268|584620056|FG000|Overall Study|Adverse Event|3|||
161884189|NCT03117881|584620057|FG000|Baseline|Withdrawal by Subject|21|||
161884190|NCT03117881|584620058|FG001|Baseline|Withdrawal by Subject|10|||
161884191|NCT03117881|584620059|FG002|Baseline|Withdrawal by Subject|0|||
161884192|NCT03117881|584620057|FG000|Baseline|Lost to Follow-up|22|||
161884193|NCT03117881|584620058|FG001|Baseline|Lost to Follow-up|25|||
161884194|NCT03117881|584620059|FG002|Baseline|Lost to Follow-up|0|||
161884195|NCT03117881|584620057|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
161884196|NCT03117881|584620058|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
161884197|NCT03117881|584620059|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
161884198|NCT03117881|584620057|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
161884199|NCT03117881|584620058|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
161884200|NCT03117881|584620059|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
161884201|NCT03117881|584620057|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
161884202|NCT03117881|584620058|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
161884203|NCT03117881|584620059|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
161884204|NCT03117881|584620057|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
161884205|NCT03117881|584620058|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
161884206|NCT03117881|584620059|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
161884207|NCT03117881|584620057|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
161884208|NCT03117881|584620058|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
161884209|NCT03117881|584620059|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
161884210|NCT03117881|584620057|FG000|6-Month Follow-Up|Did not complete test|53|||
161884211|NCT03117881|584620058|FG001|6-Month Follow-Up|Did not complete test|25|||
161884212|NCT03117881|584620059|FG002|6-Month Follow-Up|Did not complete test|7|||
161884213|NCT03117881|584620057|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
161884214|NCT03117881|584620058|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
161884215|NCT03117881|584620059|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
161884216|NCT03117881|584620057|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
161884217|NCT03117881|584620058|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
161884218|NCT03117881|584620059|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
161884219|NCT03117881|584620057|FG000|12-Month Follow-Up|Did not complete test|40|||
161884220|NCT03117881|584620058|FG001|12-Month Follow-Up|Did not complete test|0|||
161884221|NCT03117881|584620059|FG002|12-Month Follow-Up|Did not complete test|0|||
161884222|NCT00473824|584620060|FG000|Overall Study|Virologic Breakthrough|1|||
161884223|NCT00473824|584620061|FG001|Overall Study|Virologic Breakthrough|0|||
161884224|NCT00473824|584620060|FG000|Overall Study|Adverse Event|1|||
161884225|NCT00473824|584620061|FG001|Overall Study|Adverse Event|0|||
161884226|NCT00473824|584620060|FG000|Overall Study|Death|1|||
161884227|NCT00473824|584620061|FG001|Overall Study|Death|0|||
161884228|NCT00473824|584620060|FG000|Overall Study|Lost to Follow-up|1|||
161884229|NCT00473824|584620061|FG001|Overall Study|Lost to Follow-up|0|||
161884230|NCT00473824|584620060|FG000|Overall Study|Withdrawal by physician|1|||
161884231|NCT00473824|584620061|FG001|Overall Study|Withdrawal by physician|0|||
161884232|NCT04076059|584620067|FG000|Double Blind Phase|Progressive disease|22|||
161884233|NCT04076059|584620068|FG001|Double Blind Phase|Progressive disease|26|||
161884234|NCT04076059|584620069|FG002|Double Blind Phase|Progressive disease|0|||
161884235|NCT04076059|584620067|FG000|Double Blind Phase|Withdrawal by Subject|4|||
161884236|NCT04076059|584620068|FG001|Double Blind Phase|Withdrawal by Subject|11|||
161884237|NCT04076059|584620069|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161884238|NCT04076059|584620067|FG000|Double Blind Phase|Death|1|||
161884239|NCT04076059|584620068|FG001|Double Blind Phase|Death|1|||
161884240|NCT04076059|584620069|FG002|Double Blind Phase|Death|0|||
161884241|NCT04076059|584620067|FG000|Double Blind Phase|Lost to Follow-up|1|||
161884242|NCT04076059|584620068|FG001|Double Blind Phase|Lost to Follow-up|0|||
161884243|NCT04076059|584620069|FG002|Double Blind Phase|Lost to Follow-up|0|||
161884244|NCT04076059|584620067|FG000|Double Blind Phase|Adverse Event|5|||
161884245|NCT04076059|584620068|FG001|Double Blind Phase|Adverse Event|1|||
161884246|NCT04076059|584620069|FG002|Double Blind Phase|Adverse Event|0|||
161884247|NCT04076059|584620067|FG000|Double Blind Phase|Ongoing Participants|82|||
161884248|NCT04076059|584620068|FG001|Double Blind Phase|Ongoing Participants|18|||
161884249|NCT04076059|584620069|FG002|Double Blind Phase|Ongoing Participants|0|||
161884250|NCT04076059|584620067|FG000|Double Blind Phase|Miscellaneous|3|||
161884251|NCT04076059|584620068|FG001|Double Blind Phase|Miscellaneous|1|||
161884252|NCT04076059|584620069|FG002|Double Blind Phase|Miscellaneous|0|||
161884253|NCT04076059|584620067|FG000|Double Blind Phase|Protocol Deviation|1|||
161884254|NCT04076059|584620068|FG001|Double Blind Phase|Protocol Deviation|1|||
161884255|NCT04076059|584620069|FG002|Double Blind Phase|Protocol Deviation|0|||
161884256|NCT04076059|584620067|FG000|Double Blind Phase|Did not take study drug|1|||
161884257|NCT04076059|584620068|FG001|Double Blind Phase|Did not take study drug|1|||
161884258|NCT04076059|584620069|FG002|Double Blind Phase|Did not take study drug|0|||
161884259|NCT04076059|584620067|FG000|Open Label Phase|Progressive disease|0|||
161884260|NCT04076059|584620068|FG001|Open Label Phase|Progressive disease|0|||
161884261|NCT04076059|584620069|FG002|Open Label Phase|Progressive disease|7|||
161884262|NCT04076059|584620067|FG000|Open Label Phase|Withdrawal by Subject|0|||
161884263|NCT04076059|584620068|FG001|Open Label Phase|Withdrawal by Subject|0|||
161884264|NCT04076059|584620069|FG002|Open Label Phase|Withdrawal by Subject|3|||
161884265|NCT04076059|584620067|FG000|Open Label Phase|Death|0|||
161884266|NCT04076059|584620068|FG001|Open Label Phase|Death|0|||
161884267|NCT04076059|584620069|FG002|Open Label Phase|Death|2|||
161884268|NCT04076059|584620067|FG000|Open Label Phase|Ongoing Participants|0|||
161884269|NCT04076059|584620068|FG001|Open Label Phase|Ongoing Participants|0|||
161884270|NCT04076059|584620069|FG002|Open Label Phase|Ongoing Participants|11|||
161884271|NCT04186806|584620070|FG000|Period 1: 7 Days|Adverse Event|1|||
161884272|NCT04186806|584620071|FG001|Period 1: 7 Days|Adverse Event|0|||
161884273|NCT02720744|584620073|FG000|Overall Study|Protocol Violation|0|||
161884274|NCT02720744|584620074|FG001|Overall Study|Protocol Violation|2|||
161884275|NCT02720744|584620073|FG000|Overall Study|Pregnancy|2|||
161884276|NCT02720744|584620074|FG001|Overall Study|Pregnancy|0|||
161884277|NCT02720744|584620073|FG000|Overall Study|Lack of Efficacy|2|||
161884278|NCT02720744|584620074|FG001|Overall Study|Lack of Efficacy|8|||
161884279|NCT02720744|584620073|FG000|Overall Study|Adverse Event|21|||
161884280|NCT02720744|584620074|FG001|Overall Study|Adverse Event|3|||
161884281|NCT02720744|584620073|FG000|Overall Study|Withdrawal by Subject|11|||
161884282|NCT02720744|584620074|FG001|Overall Study|Withdrawal by Subject|11|||
161884283|NCT02720744|584620073|FG000|Overall Study|Lost to follow up|2|||
161884284|NCT02720744|584620074|FG001|Overall Study|Lost to follow up|0|||
161884285|NCT02720744|584620073|FG000|Overall Study|Non Compliance with Investigational Product|0|||
161884286|NCT02720744|584620074|FG001|Overall Study|Non Compliance with Investigational Product|1|||
161884287|NCT02720744|584620073|FG000|Overall Study|Excluded Concomitant Medication|0|||
161884288|NCT02720744|584620074|FG001|Overall Study|Excluded Concomitant Medication|1|||
161884289|NCT00741091|584620075|FG000|Overall Study|Death|13|||
161884290|NCT00741091|584620075|FG000|Overall Study|Lost to Follow-up|16|||
161884291|NCT00741091|584620075|FG000|Overall Study|Withdrawal by Subject|6|||
161884292|NCT00741091|584620075|FG000|Overall Study|Missed Visit|22|||
161884293|NCT01801358|584620076|FG000|Overall Study|Adverse Event|0|||
161884294|NCT01801358|584620077|FG001|Overall Study|Adverse Event|2|||
161884295|NCT01801358|584620078|FG002|Overall Study|Adverse Event|1|||
161884296|NCT01801358|584620079|FG003|Overall Study|Adverse Event|0|||
161884297|NCT01801358|584620080|FG004|Overall Study|Adverse Event|0|||
161884298|NCT01801358|584620081|FG005|Overall Study|Adverse Event|1|||
161884299|NCT01801358|584620076|FG000|Overall Study|Physician Decision|0|||
161884300|NCT01801358|584620077|FG001|Overall Study|Physician Decision|0|||
161884301|NCT01801358|584620078|FG002|Overall Study|Physician Decision|1|||
161884302|NCT01801358|584620079|FG003|Overall Study|Physician Decision|0|||
161884303|NCT01801358|584620080|FG004|Overall Study|Physician Decision|0|||
161884304|NCT01801358|584620081|FG005|Overall Study|Physician Decision|0|||
161884305|NCT01801358|584620076|FG000|Overall Study|Progressive Disease|6|||
161884306|NCT01801358|584620077|FG001|Overall Study|Progressive Disease|4|||
161884307|NCT01801358|584620078|FG002|Overall Study|Progressive Disease|4|||
161884308|NCT01801358|584620079|FG003|Overall Study|Progressive Disease|5|||
161884309|NCT01801358|584620080|FG004|Overall Study|Progressive Disease|6|||
161884310|NCT01801358|584620081|FG005|Overall Study|Progressive Disease|5|||
161884311|NCT01801358|584620076|FG000|Overall Study|Withdrawal by Subject|0|||
161884312|NCT01801358|584620077|FG001|Overall Study|Withdrawal by Subject|0|||
161884313|NCT01801358|584620078|FG002|Overall Study|Withdrawal by Subject|0|||
161884314|NCT01801358|584620079|FG003|Overall Study|Withdrawal by Subject|1|||
161884315|NCT01801358|584620080|FG004|Overall Study|Withdrawal by Subject|0|||
161884316|NCT01801358|584620081|FG005|Overall Study|Withdrawal by Subject|2|||
161884317|NCT01892085|584620082|FG000|Overall Study|Death|4|||
161884318|NCT01892085|584620083|FG001|Overall Study|Death|1|||
161884319|NCT01892085|584620084|FG002|Overall Study|Death|3|||
161884320|NCT01892085|584620082|FG000|Overall Study|Withdrawal by Subject|2|||
161884321|NCT01892085|584620083|FG001|Overall Study|Withdrawal by Subject|0|||
161884322|NCT01892085|584620084|FG002|Overall Study|Withdrawal by Subject|2|||
161884323|NCT00480493|584620085|FG000|Overall Study|moved|2|||
161884324|NCT00480493|584620086|FG001|Overall Study|moved|7|||
161884325|NCT03769675|584620087|FG000|Overall Study|Lost to Follow-up|1|||
161884326|NCT02844907|584620088|FG000|With Dexamethasone|No IV access|1|||
161884327|NCT02945254|584620096|FG000|Overall Study|Lost to Follow-up|1|||
161884328|NCT02945254|584620097|FG001|Overall Study|Lost to Follow-up|0|||
161884329|NCT02945254|584620096|FG000|Overall Study|Withdrawal by Subject|1|||
161884330|NCT02945254|584620097|FG001|Overall Study|Withdrawal by Subject|0|||
161884331|NCT00783224|584620098|FG000|Overall Study|Adverse Event|0|||
161884332|NCT00783224|584620099|FG001|Overall Study|Adverse Event|0|||
161884333|NCT00783224|584620100|FG002|Overall Study|Adverse Event|1|||
161884334|NCT00783224|584620101|FG003|Overall Study|Adverse Event|0|||
161884335|NCT00783224|584620098|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
161884336|NCT00783224|584620099|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
161884337|NCT00783224|584620100|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
161884338|NCT00783224|584620101|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
161884339|NCT00783224|584620098|FG000|Overall Study|Inappropriate as a study subject|0|||
161884340|NCT00783224|584620099|FG001|Overall Study|Inappropriate as a study subject|0|||
161884341|NCT00783224|584620100|FG002|Overall Study|Inappropriate as a study subject|0|||
161884342|NCT00783224|584620101|FG003|Overall Study|Inappropriate as a study subject|1|||
161884343|NCT01711619|584620102|FG000|Overall Study|Early study termination|10|||
161884344|NCT01711619|584620103|FG001|Overall Study|Early study termination|14|||
161884345|NCT01711619|584620102|FG000|Overall Study|Withdrawal by Subject|3|||
161884346|NCT01711619|584620103|FG001|Overall Study|Withdrawal by Subject|7|||
161884347|NCT01711619|584620102|FG000|Overall Study|Protocol Violation|2|||
161884348|NCT01711619|584620103|FG001|Overall Study|Protocol Violation|3|||
161884349|NCT01711619|584620102|FG000|Overall Study|Adverse Event|2|||
161884350|NCT01711619|584620103|FG001|Overall Study|Adverse Event|0|||
161884351|NCT01711619|584620102|FG000|Overall Study|Lost to Follow-up|1|||
161884352|NCT01711619|584620103|FG001|Overall Study|Lost to Follow-up|0|||
161884353|NCT03422159|584620104|FG000|Overall Study|Exclusion due to terminal disease|2|||
161884354|NCT03422159|584620105|FG001|Overall Study|Exclusion due to terminal disease|1|||
161884355|NCT04631107|584620106|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
161884356|NCT04631107|584620106|FG000|Second Intervention (1 Night)|Adverse Event|1|||
161884357|NCT04631107|584620106|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
161884358|NCT04631107|584620106|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
161884359|NCT00087126|584620110|FG000|Overall Study|Ineligible - second primary|1|||
161884360|NCT00087126|584620110|FG000|Overall Study|Never treated|1|||
161884361|NCT01432275|584620111|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
161884362|NCT01432275|584620112|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
161884363|NCT01432275|584620111|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
161884364|NCT01432275|584620112|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
161884365|NCT01432275|584620111|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
161884366|NCT01432275|584620112|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
161884367|NCT01432275|584620111|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
161884368|NCT01432275|584620112|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
161884369|NCT01432275|584620111|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
161884370|NCT01432275|584620112|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
161884371|NCT01432275|584620111|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
161884372|NCT01432275|584620112|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
161884373|NCT01432275|584620111|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
161884374|NCT01432275|584620112|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
161884375|NCT01432275|584620111|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
161884376|NCT01432275|584620112|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
161884377|NCT01432275|584620111|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
161884378|NCT01432275|584620112|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
161884379|NCT01935700|584620117|FG000|Overall Study|Withdrawal by Subject|1|||
161884380|NCT01935700|584620118|FG001|Overall Study|Withdrawal by Subject|0|||
161884381|NCT01935700|584620117|FG000|Overall Study|Physician Decision|4|||
161884382|NCT01935700|584620118|FG001|Overall Study|Physician Decision|0|||
161884383|NCT00096993|584620119|FG000|Overall Study|Death|1|||
161884384|NCT00096993|584620120|FG001|Overall Study|Death|0|||
161884385|NCT00096993|584620119|FG000|Overall Study|Disease progression|56|||
161884386|NCT00096993|584620120|FG001|Overall Study|Disease progression|53|||
161884387|NCT00096993|584620119|FG000|Overall Study|Adverse Event|2|||
161884388|NCT00096993|584620120|FG001|Overall Study|Adverse Event|8|||
161884389|NCT00096993|584620119|FG000|Overall Study|Subject's decision|3|||
161884390|NCT00096993|584620120|FG001|Overall Study|Subject's decision|1|||
161884391|NCT00096993|584620119|FG000|Overall Study|Physician Decision|2|||
161884392|NCT00096993|584620120|FG001|Overall Study|Physician Decision|1|||
161884393|NCT00096993|584620119|FG000|Overall Study|Non-compliance|0|||
161884394|NCT00096993|584620120|FG001|Overall Study|Non-compliance|1|||
161884395|NCT00096993|584620119|FG000|Overall Study|Other unspecified|1|||
161884396|NCT00096993|584620120|FG001|Overall Study|Other unspecified|1|||
161884397|NCT01935128|584620123|FG000|Overall Study|Death|1|||
161884398|NCT01935128|584620123|FG000|Overall Study|Adverse Event|6|||
161884399|NCT01162122|584620126|FG000|Overall Study|Withdrawal by Subject|52|||
161884400|NCT01162122|584620127|FG001|Overall Study|Withdrawal by Subject|43|||
161884401|NCT01162122|584620126|FG000|Overall Study|Lost to Follow-up|73|||
161884402|NCT01162122|584620127|FG001|Overall Study|Lost to Follow-up|91|||
161884403|NCT01162122|584620126|FG000|Overall Study|Adverse Event|3|||
161884404|NCT01162122|584620127|FG001|Overall Study|Adverse Event|2|||
161884405|NCT01162122|584620126|FG000|Overall Study|Death|51|||
161884406|NCT01162122|584620127|FG001|Overall Study|Death|46|||
161884407|NCT01162122|584620126|FG000|Overall Study|Protocol Violation|2|||
161884408|NCT01162122|584620127|FG001|Overall Study|Protocol Violation|2|||
161884409|NCT01162122|584620126|FG000|Overall Study|Inappropriate enrollment|5|||
161884410|NCT01162122|584620127|FG001|Overall Study|Inappropriate enrollment|4|||
161884411|NCT01162122|584620126|FG000|Overall Study|Administrative reason|1|||
161884412|NCT01162122|584620127|FG001|Overall Study|Administrative reason|1|||
161884413|NCT01162122|584620126|FG000|Overall Study|Unable to classify|3|||
161884414|NCT01162122|584620127|FG001|Overall Study|Unable to classify|7|||
161884415|NCT01162122|584620126|FG000|Overall Study|Missing primary reason|1|||
161884416|NCT01162122|584620127|FG001|Overall Study|Missing primary reason|0|||
161884417|NCT02020512|584620128|FG000|Overall Study|Adverse Event|1|||
161884418|NCT02020512|584620128|FG000|Overall Study|Lost to Follow-up|3|||
161884419|NCT02020512|584620128|FG000|Overall Study|Protocol Violation|4|||
161884420|NCT00835679|584620129|FG000|Overall Study|Withdrawal by Subject|1|||
161884421|NCT00835679|584620130|FG001|Overall Study|Withdrawal by Subject|0|||
161884422|NCT00835679|584620131|FG002|Overall Study|Withdrawal by Subject|0|||
161884423|NCT00835679|584620132|FG003|Overall Study|Withdrawal by Subject|0|||
161884424|NCT01793688|584620133|FG000|Overall Study|Protocol Violation|2|||
161884425|NCT02419612|584620134|FG000|Short-term Treatment Period|Adverse Event|1|||
161884426|NCT02419612|584620135|FG001|Short-term Treatment Period|Adverse Event|1|||
161884427|NCT02419612|584620134|FG000|Short-term Treatment Period|Death|0|||
161884428|NCT02419612|584620135|FG001|Short-term Treatment Period|Death|2|||
161884429|NCT02419612|584620134|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
161884430|NCT02419612|584620135|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
161884431|NCT02419612|584620134|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
161884432|NCT02419612|584620135|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
161884433|NCT02419612|584620134|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
161884434|NCT02419612|584620135|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
161884435|NCT02419612|584620134|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
161884436|NCT02419612|584620135|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
161884437|NCT02419612|584620134|FG000|Short-term Treatment Period|Worsening of liver function|0|||
161884438|NCT02419612|584620135|FG001|Short-term Treatment Period|Worsening of liver function|1|||
161884439|NCT02419612|584620134|FG000|Short-term Treatment Period|Subject moved out of state|0|||
161884440|NCT02419612|584620135|FG001|Short-term Treatment Period|Subject moved out of state|1|||
161884441|NCT02419612|584620134|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
161884442|NCT02419612|584620135|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
161884443|NCT02419612|584620134|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
161884444|NCT02419612|584620135|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
161884445|NCT02419612|584620134|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
161884446|NCT02419612|584620135|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
161884447|NCT02419612|584620134|FG000|Long-term Treatment Period|Death|0|||
161884448|NCT02419612|584620135|FG001|Long-term Treatment Period|Death|1|||
161884449|NCT02419612|584620134|FG000|Long-term Treatment Period|Adverse Event|0|||
161884450|NCT02419612|584620135|FG001|Long-term Treatment Period|Adverse Event|5|||
161884451|NCT02419612|584620134|FG000|Long-term Treatment Period|Other|4|||
161884452|NCT02419612|584620135|FG001|Long-term Treatment Period|Other|4|||
161884453|NCT02419612|584620134|FG000|Long-term Treatment Period|Subject Decision|2|||
161884454|NCT02419612|584620135|FG001|Long-term Treatment Period|Subject Decision|4|||
161884455|NCT02419612|584620134|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
161884456|NCT02419612|584620135|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
161884457|NCT02135107|584620142|FG000|Treatment Period|Withdrawal by Subject|11|||
161884458|NCT02135107|584620143|FG001|Treatment Period|Withdrawal by Subject|0|||
161884459|NCT02135107|584620144|FG002|Treatment Period|Withdrawal by Subject|0|||
161884460|NCT02135107|584620145|FG003|Treatment Period|Withdrawal by Subject|0|||
161884461|NCT02135107|584620142|FG000|Treatment Period|Adverse Event|5|||
161884462|NCT02135107|584620143|FG001|Treatment Period|Adverse Event|2|||
161884463|NCT02135107|584620144|FG002|Treatment Period|Adverse Event|0|||
161884464|NCT02135107|584620145|FG003|Treatment Period|Adverse Event|0|||
161884465|NCT02135107|584620142|FG000|Treatment Period|Pregnancy|1|||
161884466|NCT02135107|584620143|FG001|Treatment Period|Pregnancy|0|||
161884467|NCT02135107|584620144|FG002|Treatment Period|Pregnancy|0|||
161884468|NCT02135107|584620145|FG003|Treatment Period|Pregnancy|0|||
161884469|NCT02135107|584620142|FG000|Treatment Period|Other|115|||
161884470|NCT02135107|584620143|FG001|Treatment Period|Other|24|||
161884471|NCT02135107|584620144|FG002|Treatment Period|Other|0|||
161884472|NCT02135107|584620145|FG003|Treatment Period|Other|0|||
161884473|NCT02135107|584620142|FG000|Maintenance Therapy Period|Adverse Event|0|||
161884474|NCT02135107|584620143|FG001|Maintenance Therapy Period|Adverse Event|0|||
161884475|NCT02135107|584620144|FG002|Maintenance Therapy Period|Adverse Event|3|||
161884476|NCT02135107|584620145|FG003|Maintenance Therapy Period|Adverse Event|7|||
161884477|NCT02135107|584620142|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
161884478|NCT02135107|584620143|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
161884479|NCT02135107|584620144|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
161884480|NCT02135107|584620145|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
161884481|NCT02135107|584620142|FG000|Maintenance Therapy Period|Pregnancy|0|||
161884482|NCT02135107|584620143|FG001|Maintenance Therapy Period|Pregnancy|0|||
161884483|NCT02135107|584620144|FG002|Maintenance Therapy Period|Pregnancy|0|||
161884484|NCT02135107|584620145|FG003|Maintenance Therapy Period|Pregnancy|1|||
161884485|NCT02135107|584620142|FG000|Maintenance Therapy Period|Other|0|||
161884486|NCT02135107|584620143|FG001|Maintenance Therapy Period|Other|0|||
161884487|NCT02135107|584620144|FG002|Maintenance Therapy Period|Other|7|||
161884488|NCT02135107|584620145|FG003|Maintenance Therapy Period|Other|8|||
161884489|NCT00474045|584620146|FG000|Overall Study|Adverse Event|18|||
161884490|NCT00474045|584620147|FG001|Overall Study|Adverse Event|8|||
161884491|NCT00474045|584620146|FG000|Overall Study|Unclassified|1|||
161884492|NCT00474045|584620147|FG001|Overall Study|Unclassified|3|||
161884493|NCT00474045|584620146|FG000|Overall Study|Lack of Efficacy|0|||
161884494|NCT00474045|584620147|FG001|Overall Study|Lack of Efficacy|9|||
161884495|NCT00474045|584620146|FG000|Overall Study|Lost to Follow-up|1|||
161884496|NCT00474045|584620147|FG001|Overall Study|Lost to Follow-up|1|||
161884497|NCT00474045|584620146|FG000|Overall Study|Protocol Violation|10|||
161884498|NCT00474045|584620147|FG001|Overall Study|Protocol Violation|12|||
161884499|NCT00474045|584620146|FG000|Overall Study|Withdrawal by Subject|16|||
161884500|NCT00474045|584620147|FG001|Overall Study|Withdrawal by Subject|18|||
161884501|NCT00474045|584620146|FG000|Overall Study|Withdrawal criteria|60|||
161884502|NCT00474045|584620147|FG001|Overall Study|Withdrawal criteria|50|||
161884503|NCT02009397|584620151|FG000|Overall Study|Protocol Violation|6|||
161884504|NCT02009397|584620151|FG000|Overall Study|Death|8|||
161884505|NCT02009397|584620151|FG000|Overall Study|Lost to Follow-up|6|||
161884506|NCT02278120|584620153|FG000|Treatment Period|Progressive disease|234|||
161884507|NCT02278120|584620154|FG001|Treatment Period|Progressive disease|260|||
161884508|NCT02278120|584620153|FG000|Treatment Period|Subject/guardian decision|23|||
161884509|NCT02278120|584620154|FG001|Treatment Period|Subject/guardian decision|20|||
161884510|NCT02278120|584620153|FG000|Treatment Period|Adverse Event|16|||
161884511|NCT02278120|584620154|FG001|Treatment Period|Adverse Event|14|||
161884512|NCT02278120|584620153|FG000|Treatment Period|Physician Decision|14|||
161884513|NCT02278120|584620154|FG001|Treatment Period|Physician Decision|27|||
161884514|NCT02278120|584620153|FG000|Treatment Period|Death|3|||
161884515|NCT02278120|584620154|FG001|Treatment Period|Death|3|||
161884516|NCT02278120|584620153|FG000|Treatment Period|Lost to Follow-up|2|||
161884517|NCT02278120|584620154|FG001|Treatment Period|Lost to Follow-up|0|||
161884518|NCT02278120|584620153|FG000|Treatment Period|Protocol deviation|0|||
161884519|NCT02278120|584620154|FG001|Treatment Period|Protocol deviation|2|||
161884520|NCT02278120|584620153|FG000|Treatment Period|Study terminated as per protocol|43|||
161884521|NCT02278120|584620154|FG001|Treatment Period|Study terminated as per protocol|11|||
161884522|NCT02278120|584620153|FG000|Post-treatment Efficacy Follow-up|Death|0|||
161884523|NCT02278120|584620154|FG001|Post-treatment Efficacy Follow-up|Death|1|||
161884524|NCT02278120|584620153|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
161884525|NCT02278120|584620154|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
161884526|NCT02278120|584620153|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
161884527|NCT02278120|584620154|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
161884528|NCT02278120|584620153|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
161884529|NCT02278120|584620154|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
161884530|NCT02278120|584620153|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161884531|NCT02278120|584620154|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161884532|NCT01966068|584620157|FG000|Overall Study|Withdrawal by Subject|57|||
161884533|NCT01966068|584620157|FG000|Overall Study|Lost to Follow-up|81|||
161884534|NCT00808639|584620158|FG000|Overall Study|Disease progression before surgery.|1|||
161884535|NCT00224406|584622130|FG000|Overall Study|Re-transplant|0|||
161884536|NCT00224406|584622131|FG001|Overall Study|Re-transplant|2|||
161884537|NCT00224406|584622130|FG000|Overall Study|Death|0|||
161884538|NCT00224406|584622131|FG001|Overall Study|Death|1|||
161884539|NCT00224406|584622130|FG000|Overall Study|Transplant cancelled|0|||
161884540|NCT00224406|584622131|FG001|Overall Study|Transplant cancelled|4|||
161884541|NCT00224406|584622130|FG000|Overall Study|Drug not delivered|2|||
161884542|NCT00224406|584622131|FG001|Overall Study|Drug not delivered|0|||
161884543|NCT00224406|584622130|FG000|Overall Study|Other|4|||
161884544|NCT00224406|584622131|FG001|Overall Study|Other|0|||
161884545|NCT00224406|584622130|FG000|Overall Study|Transplant cancelled|3|||
161884546|NCT00224406|584622131|FG001|Overall Study|Transplant cancelled|0|||
161884547|NCT04676412|584622136|FG000|Overall Study|Death|28|||
161884548|NCT04676412|584622137|FG001|Overall Study|Death|31|||
161884549|NCT04676412|584622136|FG000|Overall Study|Lost to Follow-up|1|||
161884550|NCT04676412|584622137|FG001|Overall Study|Lost to Follow-up|2|||
161884551|NCT04676412|584622136|FG000|Overall Study|Sponsor Decision|20|||
161884552|NCT04676412|584622137|FG001|Overall Study|Sponsor Decision|23|||
161884553|NCT04676412|584622136|FG000|Overall Study|Withdrawal by Subject|0|||
161884554|NCT04676412|584622137|FG001|Overall Study|Withdrawal by Subject|2|||
161884555|NCT04550832|584622138|FG000|Overall Study|Adverse Event|0|||
161884556|NCT04550832|584622139|FG001|Overall Study|Adverse Event|0|||
161991875|NCT03364309|585018559|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
161884557|NCT04550832|584622140|FG002|Overall Study|Adverse Event|2|||
161884558|NCT04550832|584622141|FG003|Overall Study|Adverse Event|0|||
161884559|NCT04550832|584622142|FG004|Overall Study|Adverse Event|1|||
161884560|NCT04823130|584622143|FG000|Overall Study|Withdrawal by Subject|2|||
161884561|NCT04823130|584622144|FG001|Overall Study|Withdrawal by Subject|3|||
161884562|NCT04823130|584622143|FG000|Overall Study|Failure to meet inclusion criteria|6|||
161884563|NCT04823130|584622144|FG001|Overall Study|Failure to meet inclusion criteria|4|||
161884564|NCT04823130|584622143|FG000|Overall Study|Other-unspecified|1|||
161884565|NCT04823130|584622144|FG001|Overall Study|Other-unspecified|0|||
161884566|NCT03315455|584622146|FG000|Overall Study|Ongoing in the Study|13|||
161884567|NCT03315455|584622147|FG001|Overall Study|Ongoing in the Study|24|||
161884568|NCT03315455|584622148|FG002|Overall Study|Ongoing in the Study|17|||
161884569|NCT03315455|584622149|FG003|Overall Study|Ongoing in the Study|15|||
161884570|NCT03315455|584622146|FG000|Overall Study|Withdrawal by Subject|0|||
161884571|NCT03315455|584622147|FG001|Overall Study|Withdrawal by Subject|1|||
161884572|NCT03315455|584622148|FG002|Overall Study|Withdrawal by Subject|0|||
161884573|NCT03315455|584622149|FG003|Overall Study|Withdrawal by Subject|0|||
161884574|NCT02304380|584622153|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161884575|NCT02304380|584622154|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161884576|NCT02304380|584622155|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161884577|NCT02304380|584622156|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
161884578|NCT02304380|584622157|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161884579|NCT02304380|584622158|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161884580|NCT01027897|584622159|FG000|Overall Study|Protocol Violation|1|||
161884581|NCT01027897|584622159|FG000|Overall Study|Withdrawal by Subject|1|||
161884582|NCT00328094|584622160|FG000|Overall Study|Physician Decision|3|||
161884583|NCT00328094|584622161|FG001|Overall Study|Physician Decision|3|||
161884584|NCT01349322|584622162|FG000|Overall Study|Protocol Violation|45|||
161884585|NCT01349322|584622163|FG001|Overall Study|Protocol Violation|47|||
161884586|NCT02453282|584622164|FG000|Overall Study|Death|275|||
161884587|NCT02453282|584622165|FG001|Overall Study|Death|277|||
161884588|NCT02453282|584622166|FG002|Overall Study|Death|296|||
161884589|NCT02453282|584622164|FG000|Overall Study|Lost to Follow-up|1|||
161884590|NCT02453282|584622165|FG001|Overall Study|Lost to Follow-up|0|||
161884591|NCT02453282|584622166|FG002|Overall Study|Lost to Follow-up|2|||
161884592|NCT02453282|584622164|FG000|Overall Study|Withdrawal by Subject|12|||
161884593|NCT02453282|584622165|FG001|Overall Study|Withdrawal by Subject|10|||
161884594|NCT02453282|584622166|FG002|Overall Study|Withdrawal by Subject|11|||
161884595|NCT02453282|584622164|FG000|Overall Study|Participants ongoing at data cut-off|85|||
161884596|NCT02453282|584622165|FG001|Overall Study|Participants ongoing at data cut-off|84|||
161884597|NCT02453282|584622166|FG002|Overall Study|Participants ongoing at data cut-off|62|||
161884598|NCT02453282|584622164|FG000|Overall Study|Other|1|||
161884599|NCT02453282|584622165|FG001|Overall Study|Other|1|||
161884600|NCT02453282|584622166|FG002|Overall Study|Other|1|||
161884601|NCT01143064|584622167|FG000|Overall Study|Death|109|||
161884602|NCT01143064|584622168|FG001|Overall Study|Death|91|||
161884603|NCT01143064|584622167|FG000|Overall Study|Adverse Event|0|||
161884604|NCT01143064|584622168|FG001|Overall Study|Adverse Event|1|||
161884605|NCT01143064|584622167|FG000|Overall Study|Withdrawal by Subject|7|||
161884606|NCT01143064|584622168|FG001|Overall Study|Withdrawal by Subject|5|||
161884607|NCT01143064|584622167|FG000|Overall Study|Lost to Follow-up|17|||
161884608|NCT01143064|584622168|FG001|Overall Study|Lost to Follow-up|14|||
161884609|NCT01143064|584622167|FG000|Overall Study|Physician Decision|0|||
161884610|NCT01143064|584622168|FG001|Overall Study|Physician Decision|4|||
161884611|NCT00985426|584622169|FG000|Overall Study|Adverse Event|0|||
161884612|NCT00985426|584622170|FG001|Overall Study|Adverse Event|1|||
161884613|NCT00985426|584622169|FG000|Overall Study|Subject Non-Compliance|3|||
161884614|NCT00985426|584622170|FG001|Overall Study|Subject Non-Compliance|3|||
161884615|NCT00985426|584622169|FG000|Overall Study|Withdrawal by Subject|12|||
161884616|NCT00985426|584622170|FG001|Overall Study|Withdrawal by Subject|16|||
161884617|NCT00985426|584622169|FG000|Overall Study|Lost to Follow-up|8|||
161884618|NCT00985426|584622170|FG001|Overall Study|Lost to Follow-up|10|||
161884619|NCT00985426|584622169|FG000|Overall Study|Death|7|||
161884620|NCT00985426|584622170|FG001|Overall Study|Death|3|||
161884621|NCT00985426|584622169|FG000|Overall Study|Protocol Violation|2|||
161884622|NCT00985426|584622170|FG001|Overall Study|Protocol Violation|0|||
161884623|NCT00985426|584622169|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
161884624|NCT00985426|584622170|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
161884625|NCT02327013|584622173|FG000|Overall Study|Adverse Event|4|||
161884626|NCT02327013|584622174|FG001|Overall Study|Adverse Event|4|||
161884627|NCT02327013|584622175|FG002|Overall Study|Adverse Event|3|||
161884628|NCT02327013|584622176|FG003|Overall Study|Adverse Event|0|||
161884629|NCT02327013|584622177|FG004|Overall Study|Adverse Event|1|||
161884630|NCT02327013|584622173|FG000|Overall Study|Lack of Efficacy|2|||
161884631|NCT02327013|584622174|FG001|Overall Study|Lack of Efficacy|0|||
161884632|NCT02327013|584622175|FG002|Overall Study|Lack of Efficacy|5|||
161884633|NCT02327013|584622176|FG003|Overall Study|Lack of Efficacy|0|||
161884634|NCT02327013|584622177|FG004|Overall Study|Lack of Efficacy|1|||
161884635|NCT02327013|584622173|FG000|Overall Study|Non-compliance with IMP|1|||
161884636|NCT02327013|584622174|FG001|Overall Study|Non-compliance with IMP|2|||
161884637|NCT02327013|584622175|FG002|Overall Study|Non-compliance with IMP|7|||
161884638|NCT02327013|584622176|FG003|Overall Study|Non-compliance with IMP|0|||
161884639|NCT02327013|584622177|FG004|Overall Study|Non-compliance with IMP|0|||
161884640|NCT02327013|584622173|FG000|Overall Study|Withdrawal of Consent|1|||
161884641|NCT02327013|584622174|FG001|Overall Study|Withdrawal of Consent|0|||
161884642|NCT02327013|584622175|FG002|Overall Study|Withdrawal of Consent|3|||
161884643|NCT02327013|584622176|FG003|Overall Study|Withdrawal of Consent|0|||
161884644|NCT02327013|584622177|FG004|Overall Study|Withdrawal of Consent|0|||
161884645|NCT02327013|584622173|FG000|Overall Study|Lost to Follow-up|2|||
161884646|NCT02327013|584622174|FG001|Overall Study|Lost to Follow-up|4|||
161884647|NCT02327013|584622175|FG002|Overall Study|Lost to Follow-up|5|||
161884648|NCT02327013|584622176|FG003|Overall Study|Lost to Follow-up|0|||
161884649|NCT02327013|584622177|FG004|Overall Study|Lost to Follow-up|0|||
161884650|NCT02327013|584622173|FG000|Overall Study|Administrative or other reason(s)|1|||
161884651|NCT02327013|584622174|FG001|Overall Study|Administrative or other reason(s)|5|||
161884652|NCT02327013|584622175|FG002|Overall Study|Administrative or other reason(s)|11|||
161884653|NCT02327013|584622176|FG003|Overall Study|Administrative or other reason(s)|1|||
161884654|NCT02327013|584622177|FG004|Overall Study|Administrative or other reason(s)|1|||
161884655|NCT02327013|584622173|FG000|Overall Study|Protocol Violation|0|||
161884656|NCT02327013|584622174|FG001|Overall Study|Protocol Violation|0|||
161884657|NCT02327013|584622175|FG002|Overall Study|Protocol Violation|3|||
161884658|NCT02327013|584622176|FG003|Overall Study|Protocol Violation|0|||
161884659|NCT02327013|584622177|FG004|Overall Study|Protocol Violation|1|||
161884660|NCT02327013|584622173|FG000|Overall Study|Withdrawal before treatment|2|||
161884661|NCT02327013|584622174|FG001|Overall Study|Withdrawal before treatment|1|||
161884662|NCT02327013|584622175|FG002|Overall Study|Withdrawal before treatment|5|||
161884663|NCT02327013|584622176|FG003|Overall Study|Withdrawal before treatment|0|||
161884664|NCT02327013|584622177|FG004|Overall Study|Withdrawal before treatment|0|||
161884665|NCT02380859|584622178|FG000|Overall Study|Withdrawal by Subject|2|||
161884666|NCT02380859|584622179|FG001|Overall Study|Withdrawal by Subject|0|||
161884667|NCT01661933|584622180|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
161884668|NCT01661933|584622180|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
161884669|NCT03385304|584622181|FG000|Overall Study|Death|19|||
161884670|NCT03385304|584622182|FG001|Overall Study|Death|7|||
161884671|NCT03385304|584622181|FG000|Overall Study|Lost to Follow-up|17|||
161884672|NCT03385304|584622182|FG001|Overall Study|Lost to Follow-up|14|||
161884673|NCT03385304|584622181|FG000|Overall Study|Withdrawal by Subject|3|||
161884674|NCT03385304|584622182|FG001|Overall Study|Withdrawal by Subject|2|||
161884675|NCT03385304|584622181|FG000|Overall Study|Incarceration|2|||
161884676|NCT03385304|584622182|FG001|Overall Study|Incarceration|3|||
161884677|NCT02772276|584622185|FG000|Overall Study|Lost to Follow-up|0|||
161884678|NCT02772276|584622186|FG001|Overall Study|Lost to Follow-up|0|||
161884679|NCT02772276|584622187|FG002|Overall Study|Lost to Follow-up|0|||
161884680|NCT02772276|584622188|FG003|Overall Study|Lost to Follow-up|0|||
161884681|NCT02772276|584622189|FG004|Overall Study|Lost to Follow-up|0|||
161884682|NCT02772276|584622190|FG005|Overall Study|Lost to Follow-up|0|||
161884683|NCT02772276|584622191|FG006|Overall Study|Lost to Follow-up|1|||
161884684|NCT02772276|584622192|FG007|Overall Study|Lost to Follow-up|0|||
161884685|NCT02772276|584622193|FG008|Overall Study|Lost to Follow-up|0|||
161884686|NCT02772276|584622194|FG009|Overall Study|Lost to Follow-up|0|||
161884687|NCT02772276|584622195|FG010|Overall Study|Lost to Follow-up|0|||
161884688|NCT02772276|584622196|FG011|Overall Study|Lost to Follow-up|0|||
161884689|NCT02772276|584622197|FG012|Overall Study|Lost to Follow-up|0|||
161884690|NCT02772276|584622185|FG000|Overall Study|Withdrew consent|0|||
161884691|NCT02772276|584622186|FG001|Overall Study|Withdrew consent|0|||
161884692|NCT02772276|584622187|FG002|Overall Study|Withdrew consent|0|||
161884693|NCT02772276|584622188|FG003|Overall Study|Withdrew consent|0|||
161884694|NCT02772276|584622189|FG004|Overall Study|Withdrew consent|0|||
161884695|NCT02772276|584622190|FG005|Overall Study|Withdrew consent|0|||
161884696|NCT02772276|584622191|FG006|Overall Study|Withdrew consent|0|||
161884697|NCT02772276|584622192|FG007|Overall Study|Withdrew consent|1|||
161884698|NCT02772276|584622193|FG008|Overall Study|Withdrew consent|0|||
161884699|NCT02772276|584622194|FG009|Overall Study|Withdrew consent|0|||
161884700|NCT02772276|584622195|FG010|Overall Study|Withdrew consent|0|||
161884701|NCT02772276|584622196|FG011|Overall Study|Withdrew consent|0|||
161884702|NCT02772276|584622197|FG012|Overall Study|Withdrew consent|0|||
161884703|NCT00550862|584622198|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
161884704|NCT00550862|584622199|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
161884705|NCT00550862|584622200|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
161884706|NCT00550862|584622201|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
161884707|NCT00550862|584622202|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
161884708|NCT00550862|584622198|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
161884709|NCT00550862|584622199|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
161884710|NCT00550862|584622200|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
161884711|NCT00550862|584622201|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
161884712|NCT00550862|584622202|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
161884713|NCT00550862|584622198|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
161884714|NCT00550862|584622199|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
161991876|NCT03364309|585018560|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161884715|NCT00550862|584622200|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
161884716|NCT00550862|584622201|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
161884717|NCT00550862|584622202|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
161884718|NCT00550862|584622198|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
161884719|NCT00550862|584622199|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
161884720|NCT00550862|584622200|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
161884721|NCT00550862|584622201|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
161884722|NCT00550862|584622202|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
161884723|NCT00550862|584622198|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
161884724|NCT00550862|584622199|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
161884725|NCT00550862|584622200|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
161884726|NCT00550862|584622201|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
161884727|NCT00550862|584622202|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
161884728|NCT00550862|584622198|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
161884729|NCT00550862|584622199|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
161884730|NCT00550862|584622200|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
161884731|NCT00550862|584622201|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
161884732|NCT00550862|584622202|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
161884733|NCT00550862|584622198|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
161884734|NCT00550862|584622199|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
161884735|NCT00550862|584622200|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
161884736|NCT00550862|584622201|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
161884737|NCT00550862|584622202|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
161884738|NCT00550862|584622198|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
161884739|NCT00550862|584622199|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
161884740|NCT00550862|584622200|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
161884741|NCT00550862|584622201|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
161884742|NCT00550862|584622202|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
161884743|NCT00550862|584622198|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
161991877|NCT03364309|585018561|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161884744|NCT00550862|584622199|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
161884745|NCT00550862|584622200|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
161884746|NCT00550862|584622201|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
161884747|NCT00550862|584622202|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
161884748|NCT00550862|584622198|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
161884749|NCT00550862|584622199|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
161884750|NCT00550862|584622200|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
161884751|NCT00550862|584622201|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
161884752|NCT00550862|584622202|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
161884753|NCT02248974|584622203|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
161884754|NCT02248974|584622204|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
161884755|NCT02248974|584622203|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
161884756|NCT02248974|584622204|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
161884757|NCT02248974|584622203|FG000|1-Day Follow-Up|Enrolled in another study|1|||
161884758|NCT02248974|584622204|FG001|1-Day Follow-Up|Enrolled in another study|0|||
161884759|NCT02248974|584622203|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
161884760|NCT02248974|584622204|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
161884761|NCT02248974|584622203|FG000|1-Week Follow-Up|Enrolled in another study|1|||
161884762|NCT02248974|584622204|FG001|1-Week Follow-Up|Enrolled in another study|1|||
161884763|NCT02248974|584622203|FG000|1-Week Follow-Up|Transferred to another facility|1|||
161884764|NCT02248974|584622204|FG001|1-Week Follow-Up|Transferred to another facility|0|||
161884765|NCT02248974|584622203|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
161884766|NCT02248974|584622204|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
161884767|NCT02248974|584622203|FG000|1-Week Follow-Up|Death|1|||
161884768|NCT02248974|584622204|FG001|1-Week Follow-Up|Death|1|||
161884769|NCT02248974|584622203|FG000|1-Week Follow-Up|Excluded because of age|0|||
161884770|NCT02248974|584622204|FG001|1-Week Follow-Up|Excluded because of age|1|||
161884771|NCT02248974|584622203|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
161884772|NCT02248974|584622204|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
161884773|NCT02248974|584622203|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
161884774|NCT02248974|584622204|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
161884775|NCT02248974|584622203|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
161884776|NCT02248974|584622204|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
161884777|NCT02248974|584622203|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
161884778|NCT02248974|584622204|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
161884779|NCT02248974|584622203|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
161884780|NCT02248974|584622204|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
161884781|NCT03488225|584622205|FG000|Overall Study|Off Protocol Therapy|2|||
161884782|NCT03488225|584622205|FG000|Overall Study|Stem Cell Transplant|2|||
161884783|NCT04093492|584622206|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
161884784|NCT04093492|584622207|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
161884785|NCT04093492|584622208|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
161884786|NCT04093492|584622209|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
161884787|NCT04093492|584622206|FG000|25 Weeks Gestational Age (GA)|No response|5|||
161884788|NCT04093492|584622207|FG001|25 Weeks Gestational Age (GA)|No response|5|||
161884789|NCT04093492|584622208|FG002|25 Weeks Gestational Age (GA)|No response|5|||
161884790|NCT04093492|584622209|FG003|25 Weeks Gestational Age (GA)|No response|2|||
161884791|NCT04093492|584622206|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
161884792|NCT04093492|584622207|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
161884793|NCT04093492|584622208|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
161884794|NCT04093492|584622209|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
161884795|NCT04093492|584622206|FG000|30 Weeks GA|Delivered before assessment|1|||
161884796|NCT04093492|584622207|FG001|30 Weeks GA|Delivered before assessment|2|||
161884797|NCT04093492|584622208|FG002|30 Weeks GA|Delivered before assessment|0|||
161884798|NCT04093492|584622209|FG003|30 Weeks GA|Delivered before assessment|0|||
161884799|NCT04093492|584622206|FG000|30 Weeks GA|No response|7|||
161884800|NCT04093492|584622207|FG001|30 Weeks GA|No response|5|||
161884801|NCT04093492|584622208|FG002|30 Weeks GA|No response|5|||
161884802|NCT04093492|584622209|FG003|30 Weeks GA|No response|2|||
161884803|NCT04093492|584622206|FG000|30 Weeks GA|Lost to Follow-up|0|||
161884804|NCT04093492|584622207|FG001|30 Weeks GA|Lost to Follow-up|1|||
161884805|NCT04093492|584622208|FG002|30 Weeks GA|Lost to Follow-up|0|||
161884806|NCT04093492|584622209|FG003|30 Weeks GA|Lost to Follow-up|0|||
161884807|NCT04093492|584622206|FG000|34 Weeks GA|Delivered before assessment|6|||
161884808|NCT04093492|584622207|FG001|34 Weeks GA|Delivered before assessment|3|||
161884809|NCT04093492|584622208|FG002|34 Weeks GA|Delivered before assessment|0|||
161884810|NCT04093492|584622209|FG003|34 Weeks GA|Delivered before assessment|0|||
161884811|NCT04093492|584622206|FG000|34 Weeks GA|No response|0|||
161884812|NCT04093492|584622207|FG001|34 Weeks GA|No response|7|||
161884813|NCT04093492|584622208|FG002|34 Weeks GA|No response|5|||
161884814|NCT04093492|584622209|FG003|34 Weeks GA|No response|3|||
161884815|NCT04093492|584622206|FG000|34 Weeks GA|Lost to Follow-up|0|||
161884816|NCT04093492|584622207|FG001|34 Weeks GA|Lost to Follow-up|1|||
161884817|NCT04093492|584622208|FG002|34 Weeks GA|Lost to Follow-up|0|||
161884818|NCT04093492|584622209|FG003|34 Weeks GA|Lost to Follow-up|0|||
161884819|NCT01438814|584622212|FG000|Overall Study|Adverse Event|3|||
161884820|NCT01438814|584622213|FG001|Overall Study|Adverse Event|3|||
161884821|NCT01438814|584622212|FG000|Overall Study|Protocol Violation|1|||
161884822|NCT01438814|584622213|FG001|Overall Study|Protocol Violation|2|||
161884823|NCT01438814|584622212|FG000|Overall Study|Lost to Follow-up|4|||
161884824|NCT01438814|584622213|FG001|Overall Study|Lost to Follow-up|3|||
161884825|NCT01438814|584622212|FG000|Overall Study|Withdrawal by Subject|4|||
161884826|NCT01438814|584622213|FG001|Overall Study|Withdrawal by Subject|2|||
161884827|NCT01438814|584622212|FG000|Overall Study|Other|2|||
161884828|NCT01438814|584622213|FG001|Overall Study|Other|4|||
161884829|NCT01739764|584622214|FG000|Overall Study|Adverse Event|0|||
161884830|NCT01739764|584622215|FG001|Overall Study|Adverse Event|3|||
161884831|NCT01739764|584622216|FG002|Overall Study|Adverse Event|4|||
161884832|NCT01739764|584622214|FG000|Overall Study|Death|4|||
161884833|NCT01739764|584622215|FG001|Overall Study|Death|6|||
161884834|NCT01739764|584622216|FG002|Overall Study|Death|38|||
161884835|NCT01739764|584622214|FG000|Overall Study|Lost to Follow-up|0|||
161884836|NCT01739764|584622215|FG001|Overall Study|Lost to Follow-up|0|||
161884837|NCT01739764|584622216|FG002|Overall Study|Lost to Follow-up|5|||
161884838|NCT01739764|584622214|FG000|Overall Study|Non-Compliance|0|||
161884839|NCT01739764|584622215|FG001|Overall Study|Non-Compliance|0|||
161884840|NCT01739764|584622216|FG002|Overall Study|Non-Compliance|1|||
161884841|NCT01739764|584622214|FG000|Overall Study|Multiple Reasons|3|||
161884842|NCT01739764|584622215|FG001|Overall Study|Multiple Reasons|2|||
161884843|NCT01739764|584622216|FG002|Overall Study|Multiple Reasons|3|||
161884844|NCT01739764|584622214|FG000|Overall Study|Physician Decision|2|||
161991878|NCT03364309|585018562|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161884845|NCT01739764|584622215|FG001|Overall Study|Physician Decision|2|||
161884846|NCT01739764|584622216|FG002|Overall Study|Physician Decision|4|||
161884847|NCT01739764|584622214|FG000|Overall Study|Progressive Disease|3|||
161884848|NCT01739764|584622215|FG001|Overall Study|Progressive Disease|5|||
161884849|NCT01739764|584622216|FG002|Overall Study|Progressive Disease|16|||
161884850|NCT01739764|584622214|FG000|Overall Study|Protocol Violation|0|||
161884851|NCT01739764|584622215|FG001|Overall Study|Protocol Violation|0|||
161884852|NCT01739764|584622216|FG002|Overall Study|Protocol Violation|2|||
161884853|NCT01739764|584622214|FG000|Overall Study|Study Terminated by Sponsor|8|||
161884854|NCT01739764|584622215|FG001|Overall Study|Study Terminated by Sponsor|13|||
161884855|NCT01739764|584622216|FG002|Overall Study|Study Terminated by Sponsor|26|||
161884856|NCT01739764|584622214|FG000|Overall Study|Withdrawal by Subject|6|||
161884857|NCT01739764|584622215|FG001|Overall Study|Withdrawal by Subject|5|||
161884858|NCT01739764|584622216|FG002|Overall Study|Withdrawal by Subject|27|||
161884859|NCT00404924|584622217|FG000|Overall Study|Adverse Event|75|||
161884860|NCT00404924|584622218|FG001|Overall Study|Adverse Event|16|||
161884861|NCT00404924|584622217|FG000|Overall Study|Condition under investigation worsened|475|||
161884862|NCT00404924|584622218|FG001|Overall Study|Condition under investigation worsened|264|||
161884863|NCT00404924|584622217|FG000|Overall Study|Lost to Follow-up|1|||
161884864|NCT00404924|584622218|FG001|Overall Study|Lost to Follow-up|1|||
161884865|NCT00404924|584622217|FG000|Overall Study|Withdrawal by Subject|26|||
161884866|NCT00404924|584622218|FG001|Overall Study|Withdrawal by Subject|13|||
161884867|NCT00404924|584622217|FG000|Overall Study|Other|25|||
161884868|NCT00404924|584622218|FG001|Overall Study|Other|11|||
161884869|NCT00404924|584622217|FG000|Overall Study|Randomised but not received treatment|1|||
161884870|NCT00404924|584622218|FG001|Overall Study|Randomised but not received treatment|1|||
161884871|NCT00513357|584622223|FG000|Overall Study|did not receive allocated placebo|2|||
161884872|NCT00513357|584622224|FG001|Overall Study|did not receive allocated placebo|3|||
161884873|NCT00513357|584622223|FG000|Overall Study|Adverse Event|4|||
161884874|NCT00513357|584622224|FG001|Overall Study|Adverse Event|2|||
161884875|NCT00513357|584622223|FG000|Overall Study|Death|2|||
161884876|NCT00513357|584622224|FG001|Overall Study|Death|0|||
161884877|NCT00513357|584622223|FG000|Overall Study|Withdrawal by Subject|5|||
161884878|NCT00513357|584622224|FG001|Overall Study|Withdrawal by Subject|4|||
161884879|NCT00513357|584622223|FG000|Overall Study|Disease Progression|2|||
161884880|NCT00513357|584622224|FG001|Overall Study|Disease Progression|1|||
161884881|NCT00435487|584622233|FG000|Overall Study|Death|3|||
161884882|NCT00435487|584622234|FG001|Overall Study|Death|4|||
161884883|NCT00435487|584622233|FG000|Overall Study|Adverse Event|0|||
161884884|NCT00435487|584622234|FG001|Overall Study|Adverse Event|3|||
161884885|NCT00435487|584622233|FG000|Overall Study|Lost to Follow-up|2|||
161884886|NCT00435487|584622234|FG001|Overall Study|Lost to Follow-up|2|||
161884887|NCT00435487|584622233|FG000|Overall Study|Other|5|||
161884888|NCT00435487|584622234|FG001|Overall Study|Other|2|||
161884889|NCT00435487|584622233|FG000|Overall Study|Withdrawal by Subject|2|||
161884890|NCT00435487|584622234|FG001|Overall Study|Withdrawal by Subject|1|||
161884891|NCT00435487|584622233|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
161884892|NCT00435487|584622234|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
161884893|NCT00435487|584622233|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
161884894|NCT00435487|584622234|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
161884895|NCT05087966|584622236|FG000|Overall Study|Lost to Follow-up|1|||
161884896|NCT05087966|584622236|FG000|Overall Study|Withdrawal by Subject|5|||
161884897|NCT02537431|584622245|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
161884898|NCT05238025|584622246|FG000|Overall Study|Adverse Event|2|||
161884899|NCT05238025|584622247|FG001|Overall Study|Adverse Event|2|||
161884900|NCT05238025|584622246|FG000|Overall Study|Lost to Follow-up|334|||
161884901|NCT05238025|584622247|FG001|Overall Study|Lost to Follow-up|339|||
161884902|NCT05238025|584622246|FG000|Overall Study|Withdrawal by Subject|203|||
161884903|NCT05238025|584622247|FG001|Overall Study|Withdrawal by Subject|222|||
161884904|NCT05238025|584622246|FG000|Overall Study|Physician Decision|20|||
161884905|NCT05238025|584622247|FG001|Overall Study|Physician Decision|8|||
161884906|NCT05238025|584622246|FG000|Overall Study|Protocol Violation|6|||
161884907|NCT05238025|584622247|FG001|Overall Study|Protocol Violation|2|||
161884908|NCT05238025|584622246|FG000|Overall Study|Death|38|||
161884909|NCT05238025|584622247|FG001|Overall Study|Death|32|||
161884910|NCT05238025|584622246|FG000|Overall Study|Study terminated by Sponsor|6358|||
161884911|NCT05238025|584622247|FG001|Overall Study|Study terminated by Sponsor|6358|||
161884912|NCT05238025|584622246|FG000|Overall Study|Other Reason|669|||
161884913|NCT05238025|584622247|FG001|Overall Study|Other Reason|690|||
161884914|NCT00191282|584622250|FG000|Overall Study|Adverse Event|5|||
161884915|NCT00191282|584622251|FG001|Overall Study|Adverse Event|6|||
161884916|NCT00191282|584622250|FG000|Overall Study|Death|51|||
161884917|NCT00191282|584622251|FG001|Overall Study|Death|51|||
161884918|NCT00191282|584622250|FG000|Overall Study|Lack of Efficacy|11|||
161884919|NCT00191282|584622251|FG001|Overall Study|Lack of Efficacy|6|||
161884920|NCT00191282|584622250|FG000|Overall Study|Noncompliance|14|||
161884921|NCT00191282|584622251|FG001|Overall Study|Noncompliance|17|||
161884922|NCT00191282|584622250|FG000|Overall Study|Patient moved|11|||
161884923|NCT00191282|584622251|FG001|Overall Study|Patient moved|14|||
161884924|NCT00191282|584622250|FG000|Overall Study|Withdrawal by Subject|59|||
161884925|NCT00191282|584622251|FG001|Overall Study|Withdrawal by Subject|44|||
161884926|NCT00191282|584622250|FG000|Overall Study|Physician Decision|18|||
161884927|NCT00191282|584622251|FG001|Overall Study|Physician Decision|15|||
161884928|NCT00191282|584622250|FG000|Overall Study|Protocol entry criteria not met|14|||
161884929|NCT00191282|584622251|FG001|Overall Study|Protocol entry criteria not met|9|||
161884930|NCT00191282|584622250|FG000|Overall Study|Protocol Violation|9|||
161884931|NCT00191282|584622251|FG001|Overall Study|Protocol Violation|12|||
161884932|NCT00191282|584622250|FG000|Overall Study|Severity of outcome|2|||
161884933|NCT00191282|584622251|FG001|Overall Study|Severity of outcome|5|||
161884934|NCT00191282|584622250|FG000|Overall Study|Sponsor's decision|2|||
161884935|NCT00191282|584622251|FG001|Overall Study|Sponsor's decision|2|||
161884936|NCT00191282|584622250|FG000|Overall Study|Lost to Follow-up|24|||
161884937|NCT00191282|584622251|FG001|Overall Study|Lost to Follow-up|31|||
161884938|NCT00102531|584622252|FG000|Overall Study|Adverse Event|0|||
161884939|NCT00102531|584622253|FG001|Overall Study|Adverse Event|1|||
161884940|NCT00102531|584622252|FG000|Overall Study|Disease Progression|5|||
161884941|NCT00102531|584622253|FG001|Overall Study|Disease Progression|9|||
161884942|NCT00102531|584622252|FG000|Overall Study|Physician Decision|0|||
161884943|NCT00102531|584622253|FG001|Overall Study|Physician Decision|1|||
161884944|NCT04756154|584622254|FG000|Overall Study|Did not meet treatment day baseline|30|||
161884945|NCT04756154|584622255|FG001|Overall Study|Did not meet treatment day baseline|28|||
161884946|NCT04756154|584622256|FG002|Overall Study|Did not meet treatment day baseline|7|||
161884947|NCT04756154|584622254|FG000|Overall Study|Did not return for final sample collection|1|||
161884948|NCT04756154|584622255|FG001|Overall Study|Did not return for final sample collection|1|||
161884949|NCT04756154|584622256|FG002|Overall Study|Did not return for final sample collection|0|||
161884950|NCT01790828|584622257|FG000|Overall Study|Other|34|||
161884951|NCT02089334|584622259|FG000|Overall Study|Withdrawal by Subject|0|||
161884952|NCT02089334|584622260|FG001|Overall Study|Withdrawal by Subject|0|||
161884953|NCT02089334|584622261|FG002|Overall Study|Withdrawal by Subject|0|||
161884954|NCT02089334|584622262|FG003|Overall Study|Withdrawal by Subject|2|||
161884955|NCT02089334|584622259|FG000|Overall Study|Adverse Event|0|||
161884956|NCT02089334|584622260|FG001|Overall Study|Adverse Event|0|||
161884957|NCT02089334|584622261|FG002|Overall Study|Adverse Event|0|||
161884958|NCT02089334|584622262|FG003|Overall Study|Adverse Event|2|||
161884959|NCT02089334|584622259|FG000|Overall Study|Progressive disease|0|||
161884960|NCT02089334|584622260|FG001|Overall Study|Progressive disease|0|||
161884961|NCT02089334|584622261|FG002|Overall Study|Progressive disease|0|||
161884962|NCT02089334|584622262|FG003|Overall Study|Progressive disease|2|||
161884963|NCT02089334|584622259|FG000|Overall Study|Physician Decision|0|||
161884964|NCT02089334|584622260|FG001|Overall Study|Physician Decision|0|||
161884965|NCT02089334|584622261|FG002|Overall Study|Physician Decision|1|||
161884966|NCT02089334|584622262|FG003|Overall Study|Physician Decision|1|||
161884967|NCT00954512|584622270|FG000|Overall Study|Withdrawal by Subject|0|||
161884968|NCT00954512|584622271|FG001|Overall Study|Withdrawal by Subject|0|||
161884969|NCT00954512|584622272|FG002|Overall Study|Withdrawal by Subject|0|||
161884970|NCT00954512|584622273|FG003|Overall Study|Withdrawal by Subject|0|||
161884971|NCT00954512|584622274|FG004|Overall Study|Withdrawal by Subject|0|||
161884972|NCT00954512|584622275|FG005|Overall Study|Withdrawal by Subject|1|||
161884973|NCT00954512|584622270|FG000|Overall Study|Adverse Event|0|||
161884974|NCT00954512|584622271|FG001|Overall Study|Adverse Event|0|||
161884975|NCT00954512|584622272|FG002|Overall Study|Adverse Event|0|||
161884976|NCT00954512|584622273|FG003|Overall Study|Adverse Event|0|||
161884977|NCT00954512|584622274|FG004|Overall Study|Adverse Event|1|||
161884978|NCT00954512|584622275|FG005|Overall Study|Adverse Event|2|||
161884979|NCT00954512|584622270|FG000|Overall Study|Physician Decision|0|||
161884980|NCT00954512|584622271|FG001|Overall Study|Physician Decision|1|||
161884981|NCT00954512|584622272|FG002|Overall Study|Physician Decision|0|||
161884982|NCT00954512|584622273|FG003|Overall Study|Physician Decision|1|||
161884983|NCT00954512|584622274|FG004|Overall Study|Physician Decision|0|||
161884984|NCT00954512|584622275|FG005|Overall Study|Physician Decision|0|||
161884985|NCT00954512|584622270|FG000|Overall Study|Symptomatic Deterioration|0|||
161884986|NCT00954512|584622271|FG001|Overall Study|Symptomatic Deterioration|1|||
161884987|NCT00954512|584622272|FG002|Overall Study|Symptomatic Deterioration|0|||
161884988|NCT00954512|584622273|FG003|Overall Study|Symptomatic Deterioration|0|||
161884989|NCT00954512|584622274|FG004|Overall Study|Symptomatic Deterioration|2|||
161884990|NCT00954512|584622275|FG005|Overall Study|Symptomatic Deterioration|0|||
161884991|NCT00954512|584622270|FG000|Overall Study|Progression of Disease|2|||
161884992|NCT00954512|584622271|FG001|Overall Study|Progression of Disease|1|||
161884993|NCT00954512|584622272|FG002|Overall Study|Progression of Disease|0|||
161884994|NCT00954512|584622273|FG003|Overall Study|Progression of Disease|1|||
161884995|NCT00954512|584622274|FG004|Overall Study|Progression of Disease|1|||
161884996|NCT00954512|584622275|FG005|Overall Study|Progression of Disease|1|||
161884997|NCT04814368|584622279|FG000|Overall Study|Study Terminated by Sponsor|0|||
161884998|NCT04814368|584622280|FG001|Overall Study|Study Terminated by Sponsor|3|||
161884999|NCT04814368|584622281|FG002|Overall Study|Study Terminated by Sponsor|0|||
161885000|NCT04814368|584622282|FG003|Overall Study|Study Terminated by Sponsor|2|||
161885001|NCT04814368|584622279|FG000|Overall Study|Subject Decision|1|||
161885002|NCT04814368|584622280|FG001|Overall Study|Subject Decision|2|||
161885003|NCT04814368|584622281|FG002|Overall Study|Subject Decision|0|||
161885004|NCT04814368|584622282|FG003|Overall Study|Subject Decision|0|||
161885005|NCT01173055|584622284|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
161885006|NCT01173055|584622285|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
161991879|NCT03364309|585018544|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
161885007|NCT01173055|584622284|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
161885008|NCT01173055|584622285|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
161885009|NCT04216589|584622287|FG000|Overall Study|Withdrawal by Subject|2|||
161885010|NCT04216589|584622287|FG000|Overall Study|Protocol Violation|1|||
161991880|NCT03364309|585018545|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
161885011|NCT04216589|584622287|FG000|Overall Study|Incarceration|1|||
161885012|NCT02824562|584624385|FG000|Overall Study|Lost to Follow-up|3|||
161885013|NCT02824562|584624386|FG001|Overall Study|Lost to Follow-up|4|||
161885014|NCT02824562|584624385|FG000|Overall Study|Death|0|||
161885015|NCT02824562|584624386|FG001|Overall Study|Death|1|||
161885016|NCT02921750|584624387|FG000|Overall Study|Adverse Event|1|||
161885017|NCT02921750|584624388|FG001|Overall Study|Adverse Event|2|||
161885018|NCT02921750|584624387|FG000|Overall Study|Withdrawal by Subject|1|||
161885019|NCT02921750|584624388|FG001|Overall Study|Withdrawal by Subject|1|||
161885020|NCT02921750|584624387|FG000|Overall Study|Lost to Follow-up|3|||
161885021|NCT02921750|584624388|FG001|Overall Study|Lost to Follow-up|3|||
161885022|NCT02921750|584624387|FG000|Overall Study|Wound healed|3|||
161885023|NCT02921750|584624388|FG001|Overall Study|Wound healed|3|||
161885024|NCT02921750|584624387|FG000|Overall Study|Serious Adverse Event|1|||
161885025|NCT02921750|584624388|FG001|Overall Study|Serious Adverse Event|2|||
161885026|NCT03309696|584624390|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
161885027|NCT03309696|584624391|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
161885028|NCT03309696|584624392|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
161885029|NCT03309696|584624393|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
161885030|NCT02638129|584624394|FG000|Overall Study|Study terminated|28|||
161885031|NCT02638129|584624395|FG001|Overall Study|Study terminated|30|||
161885032|NCT02368210|584624398|FG000|Overall Study|Withdrawal by Subject|1|||
161885033|NCT02368210|584624399|FG001|Overall Study|Withdrawal by Subject|0|||
161885034|NCT02368210|584624398|FG000|Overall Study|Adverse Event|0|||
161885035|NCT02368210|584624399|FG001|Overall Study|Adverse Event|1|||
161885036|NCT00078949|584624400|FG000|Overall Study|No treated|4|||
161885037|NCT00078949|584624401|FG001|Overall Study|No treated|5|||
161885038|NCT00078949|584624402|FG002|Overall Study|No treated|3|||
161885039|NCT00078949|584624403|FG003|Overall Study|No treated|3|||
161885040|NCT00577005|584624404|FG000|Overall Study|Lost to Follow-up|3|||
161885041|NCT00577005|584624405|FG001|Overall Study|Lost to Follow-up|2|||
161885042|NCT00577005|584624404|FG000|Overall Study|Withdrawal by Subject|2|||
161885043|NCT00577005|584624405|FG001|Overall Study|Withdrawal by Subject|1|||
161885044|NCT02667626|584624406|FG000|Overall Study|Withdrawal by Subject|0|||
161885045|NCT02667626|584624407|FG001|Overall Study|Withdrawal by Subject|1|||
161885046|NCT02309723|584624408|FG000|Overall Study|Withdrawal by Subject|24|||
161885047|NCT02309723|584624409|FG001|Overall Study|Withdrawal by Subject|23|||
161885048|NCT02309723|584624410|FG002|Overall Study|Withdrawal by Subject|24|||
161885049|NCT02560623|584624411|FG000|Overall Study|Unable to swallow sponge|0|||
161885050|NCT02560623|584624412|FG001|Overall Study|Unable to swallow sponge|1|||
161885051|NCT02560623|584624413|FG002|Overall Study|Unable to swallow sponge|0|||
161885052|NCT02560623|584624414|FG003|Overall Study|Unable to swallow sponge|0|||
161885053|NCT02560623|584624411|FG000|Overall Study|Intervention prior to sponge administration|0|||
161885054|NCT02560623|584624412|FG001|Overall Study|Intervention prior to sponge administration|1|||
161885055|NCT02560623|584624413|FG002|Overall Study|Intervention prior to sponge administration|0|||
161885056|NCT02560623|584624414|FG003|Overall Study|Intervention prior to sponge administration|0|||
161885057|NCT01565668|584624415|FG000|Overall Study|Death|2|||
161885058|NCT01565668|584624416|FG001|Overall Study|Death|1|||
161885059|NCT01565668|584624415|FG000|Overall Study|Lack of Efficacy|4|||
161885060|NCT01565668|584624416|FG001|Overall Study|Lack of Efficacy|2|||
161885061|NCT01565668|584624415|FG000|Overall Study|Participant went on Hospice Care|1|||
161885062|NCT01565668|584624416|FG001|Overall Study|Participant went on Hospice Care|0|||
161885063|NCT01565668|584624415|FG000|Overall Study|Adverse Event|6|||
161885064|NCT01565668|584624416|FG001|Overall Study|Adverse Event|1|||
161885065|NCT01565668|584624415|FG000|Overall Study|Randomized, but never received drug|0|||
161885066|NCT01565668|584624416|FG001|Overall Study|Randomized, but never received drug|2|||
161885067|NCT01565668|584624415|FG000|Overall Study|Progressive disease|13|||
161885068|NCT01565668|584624416|FG001|Overall Study|Progressive disease|14|||
161885069|NCT01565668|584624415|FG000|Overall Study|Withdrawal by Subject|1|||
161885070|NCT01565668|584624416|FG001|Overall Study|Withdrawal by Subject|3|||
161885071|NCT01565668|584624415|FG000|Overall Study|HSCT Transplant|11|||
161885072|NCT01565668|584624416|FG001|Overall Study|HSCT Transplant|15|||
161885073|NCT01097421|584624417|FG000|Overall Study|Adverse Event|8|||
161885074|NCT01097421|584624417|FG000|Overall Study|Protocol Violation|2|||
161885075|NCT01097421|584624417|FG000|Overall Study|Lost to Follow-up|1|||
161885076|NCT01097421|584624417|FG000|Overall Study|Withdrawal by Subject|3|||
161885077|NCT01120249|584624418|FG000|Overall Study|No protocol treatment received|21|||
161885078|NCT01120249|584624419|FG001|Overall Study|No protocol treatment received|15|||
161885079|NCT01120249|584624418|FG000|Overall Study|Disease recurrence|107|||
161885080|NCT01120249|584624419|FG001|Overall Study|Disease recurrence|57|||
161885081|NCT01120249|584624418|FG000|Overall Study|Death|1|||
161885082|NCT01120249|584624419|FG001|Overall Study|Death|0|||
161885083|NCT01120249|584624418|FG000|Overall Study|Adverse Event|40|||
161885084|NCT01120249|584624419|FG001|Overall Study|Adverse Event|276|||
161885085|NCT01120249|584624418|FG000|Overall Study|Participant refusal|34|||
161885086|NCT01120249|584624419|FG001|Overall Study|Participant refusal|42|||
161885087|NCT01120249|584624418|FG000|Overall Study|Other reasons, not protocol specified|29|||
161885088|NCT01120249|584624419|FG001|Overall Study|Other reasons, not protocol specified|22|||
161885089|NCT04258254|584624420|FG000|Overall Study|Withdrawal by Subject|0|||
161885090|NCT04258254|584624421|FG001|Overall Study|Withdrawal by Subject|1|||
161885091|NCT04258254|584624422|FG002|Overall Study|Withdrawal by Subject|0|||
161885092|NCT00723190|584624427|FG000|Overall Study|Withdrawal by Subject|45|||
161885093|NCT00723190|584624427|FG000|Overall Study|Lost to Follow-up|37|||
161885094|NCT00723190|584624427|FG000|Overall Study|Adverse Event|18|||
161885095|NCT00723190|584624427|FG000|Overall Study|Lack of Efficacy|16|||
161885096|NCT00723190|584624427|FG000|Overall Study|Protocol Violation|15|||
161885097|NCT00723190|584624427|FG000|Overall Study|Other-Premature Discontinuation|9|||
161885098|NCT00723190|584624427|FG000|Overall Study|Other-Not included in safety population|2|||
161885099|NCT04472026|584624431|FG000|Overall Study|Lost to Follow-up|5|||
161885100|NCT01404208|584624432|FG000|Overall Study|Discontinued|3|||
161885101|NCT01404208|584624433|FG001|Overall Study|Discontinued|0|||
161885102|NCT03436199|584624438|FG000|Overall Study|Adverse Event|15|||
161885103|NCT03436199|584624439|FG001|Overall Study|Adverse Event|40|||
161885104|NCT03436199|584624440|FG002|Overall Study|Adverse Event|7|||
161885105|NCT03436199|584624438|FG000|Overall Study|Withdrawal by Subject|4|||
161885106|NCT03436199|584624439|FG001|Overall Study|Withdrawal by Subject|10|||
161885107|NCT03436199|584624440|FG002|Overall Study|Withdrawal by Subject|3|||
161885108|NCT03436199|584624438|FG000|Overall Study|Lost to Follow-up|1|||
161885109|NCT03436199|584624439|FG001|Overall Study|Lost to Follow-up|0|||
161885110|NCT03436199|584624440|FG002|Overall Study|Lost to Follow-up|2|||
161885111|NCT03436199|584624438|FG000|Overall Study|Protocol Violation|1|||
161885112|NCT03436199|584624439|FG001|Overall Study|Protocol Violation|1|||
161885113|NCT03436199|584624440|FG002|Overall Study|Protocol Violation|0|||
161885114|NCT03436199|584624438|FG000|Overall Study|Physician Decision|0|||
161885115|NCT03436199|584624439|FG001|Overall Study|Physician Decision|1|||
161885116|NCT03436199|584624440|FG002|Overall Study|Physician Decision|0|||
161885117|NCT03436199|584624438|FG000|Overall Study|Could not return to clinic|1|||
161885118|NCT03436199|584624439|FG001|Overall Study|Could not return to clinic|0|||
161885119|NCT03436199|584624440|FG002|Overall Study|Could not return to clinic|0|||
161885120|NCT03436199|584624438|FG000|Overall Study|Withdrawn per physician|0|||
161885121|NCT03436199|584624439|FG001|Overall Study|Withdrawn per physician|1|||
161885122|NCT03436199|584624440|FG002|Overall Study|Withdrawn per physician|0|||
161885123|NCT00085098|584624441|FG000|Overall Study|Withdrawal by Subject|0|||
161885124|NCT00085098|584624442|FG001|Overall Study|Withdrawal by Subject|1|||
161885125|NCT00085098|584624441|FG000|Overall Study|Ineligible|1|||
161885126|NCT00085098|584624442|FG001|Overall Study|Ineligible|1|||
161885127|NCT01886781|584624443|FG000|Overall Study|Protocol Violation|5|||
161885128|NCT01886781|584624444|FG001|Overall Study|Protocol Violation|0|||
161885129|NCT01886781|584624443|FG000|Overall Study|Adverse Event|1|||
161885130|NCT01886781|584624444|FG001|Overall Study|Adverse Event|0|||
161885131|NCT01886781|584624443|FG000|Overall Study|Lost to Follow-up|5|||
161885132|NCT01886781|584624444|FG001|Overall Study|Lost to Follow-up|0|||
161885133|NCT01886781|584624443|FG000|Overall Study|Withdrawal by Subject|2|||
161885134|NCT01886781|584624444|FG001|Overall Study|Withdrawal by Subject|1|||
161885135|NCT01886781|584624443|FG000|Overall Study|Worsening of symptoms|1|||
161885136|NCT01886781|584624444|FG001|Overall Study|Worsening of symptoms|1|||
161885137|NCT00772005|584624451|FG000|Overall Study|Adverse Event|9|||
161885138|NCT00772005|584624452|FG001|Overall Study|Adverse Event|14|||
161885139|NCT00772005|584624453|FG002|Overall Study|Adverse Event|10|||
161885140|NCT00772005|584624454|FG003|Overall Study|Adverse Event|13|||
161885141|NCT00772005|584624451|FG000|Overall Study|Lack of Efficacy|0|||
161885142|NCT00772005|584624452|FG001|Overall Study|Lack of Efficacy|1|||
161885143|NCT00772005|584624453|FG002|Overall Study|Lack of Efficacy|0|||
161885144|NCT00772005|584624454|FG003|Overall Study|Lack of Efficacy|0|||
161885145|NCT00772005|584624451|FG000|Overall Study|Withdrawal by Subject|3|||
161885146|NCT00772005|584624452|FG001|Overall Study|Withdrawal by Subject|7|||
161885147|NCT00772005|584624453|FG002|Overall Study|Withdrawal by Subject|10|||
161885148|NCT00772005|584624454|FG003|Overall Study|Withdrawal by Subject|2|||
161885149|NCT00772005|584624451|FG000|Overall Study|Protocol Violation|2|||
161885150|NCT00772005|584624452|FG001|Overall Study|Protocol Violation|4|||
161885151|NCT00772005|584624453|FG002|Overall Study|Protocol Violation|1|||
161991881|NCT03364309|585018546|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
161885152|NCT00772005|584624454|FG003|Overall Study|Protocol Violation|6|||
161885153|NCT00772005|584624451|FG000|Overall Study|Lost to Follow-up|7|||
161885154|NCT00772005|584624452|FG001|Overall Study|Lost to Follow-up|3|||
161885155|NCT00772005|584624453|FG002|Overall Study|Lost to Follow-up|6|||
161991882|NCT03364309|585018547|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
161991883|NCT03364309|585018548|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
161991884|NCT03364309|585018549|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
161885156|NCT00772005|584624454|FG003|Overall Study|Lost to Follow-up|3|||
161885157|NCT00772005|584624451|FG000|Overall Study|Non-compliance with study procedures|1|||
161885158|NCT00772005|584624452|FG001|Overall Study|Non-compliance with study procedures|1|||
161885159|NCT00772005|584624453|FG002|Overall Study|Non-compliance with study procedures|0|||
161885160|NCT00772005|584624454|FG003|Overall Study|Non-compliance with study procedures|1|||
161885161|NCT00772005|584624451|FG000|Overall Study|Non-compliance with drug administration|3|||
161885162|NCT00772005|584624452|FG001|Overall Study|Non-compliance with drug administration|0|||
161885163|NCT00772005|584624453|FG002|Overall Study|Non-compliance with drug administration|1|||
161885164|NCT00772005|584624454|FG003|Overall Study|Non-compliance with drug administration|1|||
161885165|NCT01273155|584624458|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
161885166|NCT01273155|584624459|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
161885167|NCT01273155|584624460|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
161885168|NCT01273155|584624461|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
161885169|NCT01273155|584624462|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
161885170|NCT01273155|584624463|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
161885171|NCT01273155|584624464|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
161885172|NCT01273155|584624458|FG000|Overall Study|Change in liver function/no longer eval.|0|||
161885173|NCT01273155|584624459|FG001|Overall Study|Change in liver function/no longer eval.|1|||
161885174|NCT01273155|584624460|FG002|Overall Study|Change in liver function/no longer eval.|0|||
161885175|NCT01273155|584624461|FG003|Overall Study|Change in liver function/no longer eval.|0|||
161885176|NCT01273155|584624462|FG004|Overall Study|Change in liver function/no longer eval.|1|||
161885177|NCT01273155|584624463|FG005|Overall Study|Change in liver function/no longer eval.|0|||
161885178|NCT01273155|584624464|FG006|Overall Study|Change in liver function/no longer eval.|0|||
161885179|NCT01273155|584624458|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
161885180|NCT01273155|584624459|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
161885181|NCT01273155|584624460|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
161885182|NCT01273155|584624461|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
161885183|NCT01273155|584624462|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
161885184|NCT01273155|584624463|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
161885185|NCT01273155|584624464|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
161885186|NCT01273155|584624458|FG000|Overall Study|Died during Cycle 1|0|||
161885187|NCT01273155|584624459|FG001|Overall Study|Died during Cycle 1|0|||
161885188|NCT01273155|584624460|FG002|Overall Study|Died during Cycle 1|1|||
161885189|NCT01273155|584624461|FG003|Overall Study|Died during Cycle 1|1|||
161885190|NCT01273155|584624462|FG004|Overall Study|Died during Cycle 1|0|||
161885191|NCT01273155|584624463|FG005|Overall Study|Died during Cycle 1|2|||
161885192|NCT01273155|584624464|FG006|Overall Study|Died during Cycle 1|2|||
161885193|NCT01273155|584624458|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
161885194|NCT01273155|584624459|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
161885195|NCT01273155|584624460|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
161885196|NCT01273155|584624461|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
161885197|NCT01273155|584624462|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
161885198|NCT01273155|584624463|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
161885199|NCT01273155|584624464|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
161885200|NCT01440569|584624465|FG000|Main Study|Enrolled but not treated|1|||
161885201|NCT01440569|584624466|FG001|Main Study|Enrolled but not treated|0|||
161885202|NCT01440569|584624465|FG000|Main Study|Adverse Event|9|||
161885203|NCT01440569|584624466|FG001|Main Study|Adverse Event|0|||
161885204|NCT01440569|584624465|FG000|Main Study|Pregnancy|1|||
161885205|NCT01440569|584624466|FG001|Main Study|Pregnancy|0|||
161885206|NCT01440569|584624465|FG000|Main Study|Investigator's Discretion|1|||
161885207|NCT01440569|584624466|FG001|Main Study|Investigator's Discretion|1|||
161885208|NCT01440569|584624465|FG000|Main Study|Withdrew Consent|7|||
161885209|NCT01440569|584624466|FG001|Main Study|Withdrew Consent|1|||
161885210|NCT01440569|584624465|FG000|Main Study|Lost to Follow-up|13|||
161885211|NCT01440569|584624466|FG001|Main Study|Lost to Follow-up|2|||
161885212|NCT01440569|584624465|FG000|Main Study|Subject Non-Compliance|3|||
161885213|NCT01440569|584624466|FG001|Main Study|Subject Non-Compliance|0|||
161885214|NCT01440569|584624465|FG000|Main Study|Protocol Violation|1|||
161885215|NCT01440569|584624466|FG001|Main Study|Protocol Violation|0|||
161885216|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Adverse Event|3|||
161885217|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Adverse Event|0|||
161885218|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Pregnancy|1|||
161885219|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Pregnancy|0|||
161885220|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
161885221|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
161885222|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
161885223|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
161991885|NCT03364309|585018550|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
161885224|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
161885225|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
161885226|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
161885227|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
161885228|NCT01440569|584624465|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
161885229|NCT01440569|584624466|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
161885230|NCT03887117|584624474|FG000|Overall Study|Discontinued prematurely|0|||
161885231|NCT03887117|584624475|FG001|Overall Study|Discontinued prematurely|1|||
161885232|NCT03887117|584624476|FG002|Overall Study|Discontinued prematurely|1|||
161885233|NCT03887117|584624477|FG003|Overall Study|Discontinued prematurely|2|||
161885234|NCT04908475|584624478|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
161885235|NCT04908475|584624479|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161885236|NCT04908475|584624480|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161885237|NCT04908475|584624481|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161885238|NCT04908475|584624482|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161885239|NCT04908475|584624483|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161885240|NCT04908475|584624478|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
161885241|NCT04908475|584624479|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161885242|NCT04908475|584624480|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161885243|NCT04908475|584624481|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161885244|NCT04908475|584624482|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161885245|NCT04908475|584624483|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161885246|NCT04908475|584624478|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
161885247|NCT04908475|584624479|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161885248|NCT04908475|584624480|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161885249|NCT04908475|584624481|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161885250|NCT04908475|584624482|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161885251|NCT04908475|584624483|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161885252|NCT04908475|584624478|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161885253|NCT04908475|584624479|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
161885254|NCT04908475|584624480|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
161885255|NCT04908475|584624481|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
161885256|NCT04908475|584624482|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161885257|NCT04908475|584624483|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161885258|NCT04908475|584624478|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
161885259|NCT04908475|584624479|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
161885260|NCT04908475|584624480|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
161885261|NCT04908475|584624481|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
161885262|NCT04908475|584624482|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
161885263|NCT04908475|584624483|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
161885264|NCT04908475|584624478|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
161885265|NCT04908475|584624479|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
161885266|NCT04908475|584624480|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
161885267|NCT04908475|584624481|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
161885268|NCT04908475|584624482|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
161885269|NCT04908475|584624483|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
161885270|NCT02584959|584624484|FG000|Period 1|Withdrawn from study|3|||
161885271|NCT02584959|584624485|FG001|Period 1|Withdrawn from study|4|||
161885272|NCT02584959|584624486|FG002|Period 1|Withdrawn from study|0|||
161885273|NCT02584959|584624484|FG000|Period 2|Withdrawn from study|6|||
161885274|NCT02584959|584624485|FG001|Period 2|Withdrawn from study|1|||
161885275|NCT02584959|584624486|FG002|Period 2|Withdrawn from study|2|||
161885276|NCT00926536|584624487|FG000|Overall Study|Physician Decision|1|||
161885277|NCT00926536|584624488|FG001|Overall Study|Physician Decision|2|||
161885278|NCT01267201|584624490|FG000|First Intervention Period|Withdrawal by Subject|1|||
161885279|NCT01267201|584624491|FG001|First Intervention Period|Withdrawal by Subject|0|||
161885280|NCT01267201|584624492|FG002|First Intervention Period|Withdrawal by Subject|0|||
161885281|NCT01267201|584624493|FG003|First Intervention Period|Withdrawal by Subject|0|||
161885282|NCT01267201|584624494|FG004|First Intervention Period|Withdrawal by Subject|0|||
161885283|NCT01267201|584624495|FG005|First Intervention Period|Withdrawal by Subject|0|||
161885284|NCT01267201|584624490|FG000|Second Intervention Period|Withdrawal by Subject|0|||
161885285|NCT01267201|584624491|FG001|Second Intervention Period|Withdrawal by Subject|1|||
161885286|NCT01267201|584624492|FG002|Second Intervention Period|Withdrawal by Subject|0|||
161885287|NCT01267201|584624493|FG003|Second Intervention Period|Withdrawal by Subject|0|||
161885288|NCT01267201|584624494|FG004|Second Intervention Period|Withdrawal by Subject|0|||
161885289|NCT01267201|584624495|FG005|Second Intervention Period|Withdrawal by Subject|0|||
161885290|NCT00483704|584624496|FG000|Randomization|Withdrawal by Subject|19|||
161885291|NCT00483704|584624497|FG001|Randomization|Withdrawal by Subject|28|||
161885292|NCT00483704|584624498|FG002|Randomization|Withdrawal by Subject|18|||
161885293|NCT00483704|584624496|FG000|Randomization|Protocol Violation|14|||
161885294|NCT00483704|584624497|FG001|Randomization|Protocol Violation|25|||
161885295|NCT00483704|584624498|FG002|Randomization|Protocol Violation|22|||
161885296|NCT00483704|584624496|FG000|Randomization|Lost to Follow-up|14|||
161885297|NCT00483704|584624497|FG001|Randomization|Lost to Follow-up|14|||
161885298|NCT00483704|584624498|FG002|Randomization|Lost to Follow-up|19|||
161991886|NCT03364309|585018551|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
161885299|NCT00483704|584624496|FG000|Randomization|Pregnancy|1|||
161991887|NCT03364309|585018552|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
161885300|NCT00483704|584624497|FG001|Randomization|Pregnancy|0|||
161885301|NCT00483704|584624498|FG002|Randomization|Pregnancy|0|||
161885302|NCT00483704|584624496|FG000|Randomization|Physician Decision|2|||
161885303|NCT00483704|584624497|FG001|Randomization|Physician Decision|4|||
161885304|NCT00483704|584624498|FG002|Randomization|Physician Decision|0|||
161885305|NCT00483704|584624496|FG000|Randomization|Progressive disease|0|||
161885306|NCT00483704|584624497|FG001|Randomization|Progressive disease|0|||
161885307|NCT00483704|584624498|FG002|Randomization|Progressive disease|1|||
161885308|NCT00483704|584624496|FG000|Randomization|Lack of qualifying migraines|21|||
161885309|NCT00483704|584624497|FG001|Randomization|Lack of qualifying migraines|25|||
161885310|NCT00483704|584624498|FG002|Randomization|Lack of qualifying migraines|31|||
161885311|NCT00483704|584624496|FG000|Treatment|Lack of qualifying migraines|101|||
161885312|NCT00483704|584624497|FG001|Treatment|Lack of qualifying migraines|99|||
161885313|NCT00483704|584624498|FG002|Treatment|Lack of qualifying migraines|116|||
161885314|NCT00483704|584624496|FG000|Treatment|Adverse Event|3|||
161885315|NCT00483704|584624497|FG001|Treatment|Adverse Event|5|||
161885316|NCT00483704|584624498|FG002|Treatment|Adverse Event|4|||
161885317|NCT00483704|584624496|FG000|Treatment|Withdrawal by Subject|16|||
161885318|NCT00483704|584624497|FG001|Treatment|Withdrawal by Subject|12|||
161885319|NCT00483704|584624498|FG002|Treatment|Withdrawal by Subject|21|||
161885320|NCT00483704|584624496|FG000|Treatment|Protocol Violation|6|||
161885321|NCT00483704|584624497|FG001|Treatment|Protocol Violation|3|||
161885322|NCT00483704|584624498|FG002|Treatment|Protocol Violation|5|||
161885323|NCT00483704|584624496|FG000|Treatment|Lost to Follow-up|2|||
161885324|NCT00483704|584624497|FG001|Treatment|Lost to Follow-up|7|||
161885325|NCT00483704|584624498|FG002|Treatment|Lost to Follow-up|5|||
161885326|NCT00483704|584624496|FG000|Treatment|Lack of Efficacy|1|||
161885327|NCT00483704|584624497|FG001|Treatment|Lack of Efficacy|1|||
161885328|NCT00483704|584624498|FG002|Treatment|Lack of Efficacy|1|||
161885329|NCT00483704|584624496|FG000|Treatment|Pregnancy|0|||
161885330|NCT00483704|584624497|FG001|Treatment|Pregnancy|1|||
161885331|NCT00483704|584624498|FG002|Treatment|Pregnancy|0|||
161885332|NCT00483704|584624496|FG000|Treatment|Physician Decision|0|||
161885333|NCT00483704|584624497|FG001|Treatment|Physician Decision|1|||
161885334|NCT00483704|584624498|FG002|Treatment|Physician Decision|4|||
161885335|NCT04272606|584624499|FG000|Overall Study|Protocol Violation|1|||
161885336|NCT04272606|584624500|FG001|Overall Study|Protocol Violation|1|||
161885337|NCT04272606|584624499|FG000|Overall Study|Physician Decision|0|||
161885338|NCT04272606|584624500|FG001|Overall Study|Physician Decision|1|||
161885339|NCT03912428|584624501|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
161885340|NCT03912428|584624502|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
161885341|NCT03912428|584624503|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
161885342|NCT03912428|584624504|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
161885343|NCT03912428|584624501|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
161885344|NCT03912428|584624502|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
161885345|NCT03912428|584624503|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
161885346|NCT03912428|584624504|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
161885347|NCT03912428|584624501|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
161885348|NCT03912428|584624502|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
161885349|NCT03912428|584624503|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
161885350|NCT03912428|584624504|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
161885351|NCT01037127|584624506|FG000|Overall Study|Lost to Follow-up|2|||
161885352|NCT01037127|584624507|FG001|Overall Study|Lost to Follow-up|4|||
161885353|NCT01037127|584624506|FG000|Overall Study|Physician Decision|1|||
161885354|NCT01037127|584624507|FG001|Overall Study|Physician Decision|0|||
161885355|NCT01037127|584624506|FG000|Overall Study|Study Closed Terminated|2|||
161885356|NCT01037127|584624507|FG001|Overall Study|Study Closed Terminated|17|||
161885357|NCT04325698|584624508|FG000|Overall Study|Study Terminated By Sponsor|1|||
161885358|NCT04325698|584624509|FG001|Overall Study|Study Terminated By Sponsor|1|||
161885359|NCT04325698|584624508|FG000|Overall Study|Withdrawal by Subject|0|||
161885360|NCT04325698|584624509|FG001|Overall Study|Withdrawal by Subject|2|||
161885361|NCT04253782|584624510|FG000|Overall Study|Death|2|||
161885362|NCT04253782|584624511|FG001|Overall Study|Death|0|||
161885363|NCT02326298|584624516|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885364|NCT02326298|584624517|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885365|NCT02326298|584624518|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
161885366|NCT02326298|584624519|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885367|NCT02326298|584624520|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885368|NCT02326298|584624521|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885369|NCT02326298|584624522|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161991888|NCT03364309|585018553|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
161991889|NCT03364309|585018554|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
161885370|NCT02326298|584624523|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161991890|NCT03364309|585018555|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
161885371|NCT02326298|584624524|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885372|NCT02326298|584624525|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885373|NCT02326298|584624526|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885374|NCT02326298|584624527|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885375|NCT02326298|584624528|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885376|NCT02326298|584624529|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161885377|NCT02326298|584624516|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
161885378|NCT02326298|584624517|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885379|NCT02326298|584624518|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885380|NCT02326298|584624519|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885381|NCT02326298|584624520|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885382|NCT02326298|584624521|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885383|NCT02326298|584624522|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885384|NCT02326298|584624523|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885385|NCT02326298|584624524|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885386|NCT02326298|584624525|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885387|NCT02326298|584624526|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885388|NCT02326298|584624527|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885389|NCT02326298|584624528|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885390|NCT02326298|584624529|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161885391|NCT02326298|584624516|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
161885392|NCT02326298|584624517|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
161885393|NCT02326298|584624518|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885394|NCT02326298|584624519|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885395|NCT02326298|584624520|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885396|NCT02326298|584624521|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885397|NCT02326298|584624522|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885398|NCT02326298|584624523|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885399|NCT02326298|584624524|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885400|NCT02326298|584624525|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885401|NCT02326298|584624526|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885402|NCT02326298|584624527|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885403|NCT02326298|584624528|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885404|NCT02326298|584624529|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161885405|NCT02326298|584624516|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
161885406|NCT02326298|584624517|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
161885407|NCT02326298|584624518|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885408|NCT02326298|584624519|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885409|NCT02326298|584624520|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885410|NCT02326298|584624521|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885411|NCT02326298|584624522|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885412|NCT02326298|584624523|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885413|NCT02326298|584624524|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885414|NCT02326298|584624525|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885415|NCT02326298|584624526|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885416|NCT02326298|584624527|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885417|NCT02326298|584624528|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885418|NCT02326298|584624529|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161885419|NCT02326298|584624516|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885420|NCT02326298|584624517|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885421|NCT02326298|584624518|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
161885422|NCT02326298|584624519|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885423|NCT02326298|584624520|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885424|NCT02326298|584624521|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885425|NCT02326298|584624522|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885426|NCT02326298|584624523|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885427|NCT02326298|584624524|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885428|NCT02326298|584624525|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885429|NCT02326298|584624526|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885430|NCT02326298|584624527|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885431|NCT02326298|584624528|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885432|NCT02326298|584624529|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161885433|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885434|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885435|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885436|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885437|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885438|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161885439|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
161885440|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161885441|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161885442|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161885443|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885444|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885445|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885446|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161885447|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885448|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885449|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885450|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885451|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885452|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
161885453|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
161885454|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885455|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
161885456|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885457|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885458|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885459|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885460|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161885461|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885462|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885463|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885464|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885465|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885466|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
161885467|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885468|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885469|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885470|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885471|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885472|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885473|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885474|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161885475|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885476|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885477|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885478|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885479|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885480|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885481|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
161885482|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885483|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885484|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885485|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885486|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885487|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885488|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161885489|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885490|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885491|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885492|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885493|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885494|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885495|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885496|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
161991891|NCT03364309|585018556|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
161991892|NCT03364309|585018557|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
161991893|NCT03364309|585018558|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
161991894|NCT03364309|585018559|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
161991895|NCT03364309|585018560|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
161991896|NCT03364309|585018561|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
161991897|NCT03364309|585018562|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
161991898|NCT03364309|585018544|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
161885497|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885498|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885499|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885500|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885501|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885502|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161885503|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885504|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885505|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885506|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885507|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885508|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885509|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
161885510|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
161885511|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885512|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885513|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885514|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885515|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885516|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161885517|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885518|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885519|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885520|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885521|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885522|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885523|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885524|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
161885525|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885526|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885527|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885528|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885529|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885530|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161885531|NCT02326298|584624516|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885532|NCT02326298|584624517|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885533|NCT02326298|584624518|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885534|NCT02326298|584624519|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885535|NCT02326298|584624520|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885536|NCT02326298|584624521|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
161885537|NCT02326298|584624522|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885538|NCT02326298|584624523|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885539|NCT02326298|584624524|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885540|NCT02326298|584624525|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885541|NCT02326298|584624526|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885542|NCT02326298|584624527|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885543|NCT02326298|584624528|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885544|NCT02326298|584624529|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161885545|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
161885546|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
161885547|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
161885548|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
161885549|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
161885550|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
161885551|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
161885552|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
161885553|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
161885554|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
161885555|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
161885556|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
161885557|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
161885558|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
161885559|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885560|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885561|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885562|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885563|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885564|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885565|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885566|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885567|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885568|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885569|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885570|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
161885571|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
161885572|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161885573|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885574|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885575|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885576|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885577|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885578|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885579|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885580|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885581|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885582|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885583|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885584|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161885585|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161885586|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161885587|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885588|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885589|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885590|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885591|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885592|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885593|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885594|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885595|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885596|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885597|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885598|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885599|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161885600|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
161885601|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885602|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885603|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885604|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885605|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885606|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885607|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885608|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885609|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885610|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885611|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161885612|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
161885613|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
161885614|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
161991899|NCT03364309|585018545|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
161885615|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885616|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885617|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885618|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885619|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885620|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885621|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885622|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885623|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885624|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885625|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161885626|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
161885627|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
161885628|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
161885629|NCT02326298|584624516|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885630|NCT02326298|584624517|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885631|NCT02326298|584624518|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885632|NCT02326298|584624519|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885633|NCT02326298|584624520|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885634|NCT02326298|584624521|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885635|NCT02326298|584624522|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885636|NCT02326298|584624523|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885637|NCT02326298|584624524|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885638|NCT02326298|584624525|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885639|NCT02326298|584624526|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161885640|NCT02326298|584624527|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
161885641|NCT02326298|584624528|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
161885642|NCT02326298|584624529|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
161885643|NCT02889835|584624530|FG000|Overall Study|Lost to Follow-up|13|||
161885644|NCT02889835|584624531|FG001|Overall Study|Lost to Follow-up|13|||
161885645|NCT02889835|584624532|FG002|Overall Study|Lost to Follow-up|13|||
161885646|NCT02889835|584624530|FG000|Overall Study|Withdrawal by Subject|2|||
161885647|NCT02889835|584624531|FG001|Overall Study|Withdrawal by Subject|2|||
161885648|NCT02889835|584624532|FG002|Overall Study|Withdrawal by Subject|2|||
161885649|NCT02889835|584624530|FG000|Overall Study|Protocol Violation|1|||
161885650|NCT02889835|584624531|FG001|Overall Study|Protocol Violation|1|||
161885651|NCT02889835|584624532|FG002|Overall Study|Protocol Violation|1|||
161885652|NCT02889835|584624530|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
161885653|NCT02889835|584624531|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
161885654|NCT02889835|584624532|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
161885655|NCT02889835|584624530|FG000|Overall Study|Death|1|||
161885656|NCT02889835|584624531|FG001|Overall Study|Death|1|||
161885657|NCT02889835|584624532|FG002|Overall Study|Death|1|||
161885658|NCT02987972|584624535|FG000|Overall Study|Adverse Event|1|||
161885659|NCT02987972|584624536|FG001|Overall Study|Adverse Event|1|||
161885660|NCT02987972|584624537|FG002|Overall Study|Adverse Event|0|||
161885661|NCT02987972|584624535|FG000|Overall Study|Death|1|||
161885662|NCT02987972|584624536|FG001|Overall Study|Death|0|||
161885663|NCT02987972|584624537|FG002|Overall Study|Death|0|||
161885664|NCT02987972|584624535|FG000|Overall Study|Lack of Efficacy|9|||
161885665|NCT02987972|584624536|FG001|Overall Study|Lack of Efficacy|12|||
161885666|NCT02987972|584624537|FG002|Overall Study|Lack of Efficacy|12|||
161885667|NCT02987972|584624535|FG000|Overall Study|Lost to Follow-up|7|||
161885668|NCT02987972|584624536|FG001|Overall Study|Lost to Follow-up|8|||
161885669|NCT02987972|584624537|FG002|Overall Study|Lost to Follow-up|4|||
161885670|NCT02987972|584624535|FG000|Overall Study|Physician Decision|1|||
161885671|NCT02987972|584624536|FG001|Overall Study|Physician Decision|6|||
161885672|NCT02987972|584624537|FG002|Overall Study|Physician Decision|0|||
161885673|NCT02987972|584624535|FG000|Overall Study|Protocol Violation|2|||
161885674|NCT02987972|584624536|FG001|Overall Study|Protocol Violation|1|||
161885675|NCT02987972|584624537|FG002|Overall Study|Protocol Violation|5|||
161885676|NCT02987972|584624535|FG000|Overall Study|Withdrawal by Subject|22|||
161885677|NCT02987972|584624536|FG001|Overall Study|Withdrawal by Subject|17|||
161885678|NCT02987972|584624537|FG002|Overall Study|Withdrawal by Subject|21|||
161885679|NCT02342548|584624538|FG000|Overall Study|Adverse Event|12|||
161885680|NCT02342548|584624539|FG001|Overall Study|Adverse Event|17|||
161885681|NCT02342548|584624540|FG002|Overall Study|Adverse Event|13|||
161885682|NCT02342548|584624538|FG000|Overall Study|Lost to Follow-up|0|||
161885683|NCT02342548|584624539|FG001|Overall Study|Lost to Follow-up|1|||
161885684|NCT02342548|584624540|FG002|Overall Study|Lost to Follow-up|0|||
161885685|NCT02342548|584624538|FG000|Overall Study|Study terminated by sponsor|20|||
161885686|NCT02342548|584624539|FG001|Overall Study|Study terminated by sponsor|39|||
161885687|NCT02342548|584624540|FG002|Overall Study|Study terminated by sponsor|25|||
161885688|NCT02342548|584624538|FG000|Overall Study|Protocol Violation|0|||
161885689|NCT02342548|584624539|FG001|Overall Study|Protocol Violation|1|||
161885690|NCT02342548|584624540|FG002|Overall Study|Protocol Violation|0|||
161885691|NCT02342548|584624538|FG000|Overall Study|Withdrawal by Subject|1|||
161885692|NCT02342548|584624539|FG001|Overall Study|Withdrawal by Subject|3|||
161885693|NCT02342548|584624540|FG002|Overall Study|Withdrawal by Subject|4|||
161885694|NCT02342548|584624538|FG000|Overall Study|Other|1|||
161885695|NCT02342548|584624539|FG001|Overall Study|Other|1|||
161885696|NCT02342548|584624540|FG002|Overall Study|Other|1|||
161885697|NCT01047332|584624543|FG000|Overall Study|SEMS Obstruction|11|||
161885698|NCT01047332|584624544|FG001|Overall Study|SEMS Obstruction|20|||
161885699|NCT01047332|584624543|FG000|Overall Study|Died Unobstructed|38|||
161885700|NCT01047332|584624544|FG001|Overall Study|Died Unobstructed|41|||
161885701|NCT01047332|584624543|FG000|Overall Study|Lost to Follow-up|8|||
161885702|NCT01047332|584624544|FG001|Overall Study|Lost to Follow-up|3|||
161885703|NCT03521817|584624545|FG000|Overall Study|Protocol Violation|0|||
161885704|NCT03521817|584624546|FG001|Overall Study|Protocol Violation|1|||
161885705|NCT00787917|584624547|FG000|Blinded Treatment|Adverse Event|1|||
161885706|NCT00787917|584624548|FG001|Blinded Treatment|Adverse Event|0|||
161885707|NCT00787917|584624547|FG000|Blinded Treatment|Lack of Efficacy|1|||
161885708|NCT00787917|584624548|FG001|Blinded Treatment|Lack of Efficacy|0|||
161885709|NCT00787917|584624547|FG000|Blinded Treatment|Administrative problems|3|||
161885710|NCT00787917|584624548|FG001|Blinded Treatment|Administrative problems|2|||
161885711|NCT00787917|584624547|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
161885712|NCT00787917|584624548|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
161885713|NCT00787917|584624547|FG000|Open Label|Administrative problems|3|||
161885714|NCT00787917|584624548|FG001|Open Label|Administrative problems|0|||
161885715|NCT05685732|584624550|FG000|Overall Study|Withdrawal by Subject|2|||
161885716|NCT05685732|584624551|FG001|Overall Study|Withdrawal by Subject|0|||
161885717|NCT05685732|584624552|FG002|Overall Study|Withdrawal by Subject|2|||
161885718|NCT05685732|584624553|FG003|Overall Study|Withdrawal by Subject|3|||
161885719|NCT05685732|584624550|FG000|Overall Study|Protocol Violation|1|||
161885720|NCT05685732|584624551|FG001|Overall Study|Protocol Violation|2|||
161885721|NCT05685732|584624552|FG002|Overall Study|Protocol Violation|4|||
161885722|NCT05685732|584624553|FG003|Overall Study|Protocol Violation|1|||
161885723|NCT05685732|584624550|FG000|Overall Study|Lost to Follow-up|5|||
161885724|NCT05685732|584624551|FG001|Overall Study|Lost to Follow-up|1|||
161885725|NCT05685732|584624552|FG002|Overall Study|Lost to Follow-up|3|||
161885726|NCT05685732|584624553|FG003|Overall Study|Lost to Follow-up|1|||
161885727|NCT05685732|584624550|FG000|Overall Study|Adverse Event|2|||
161885728|NCT05685732|584624551|FG001|Overall Study|Adverse Event|1|||
161885729|NCT05685732|584624552|FG002|Overall Study|Adverse Event|0|||
161885730|NCT05685732|584624553|FG003|Overall Study|Adverse Event|0|||
161885731|NCT05685732|584624550|FG000|Overall Study|Physician Decision|1|||
161885732|NCT05685732|584624551|FG001|Overall Study|Physician Decision|0|||
161885733|NCT05685732|584624552|FG002|Overall Study|Physician Decision|0|||
161885734|NCT05685732|584624553|FG003|Overall Study|Physician Decision|0|||
161885735|NCT02640404|584624554|FG000|Overall Study|Protocol Violation|1|||
161885736|NCT02640404|584624555|FG001|Overall Study|Protocol Violation|0|||
161885737|NCT02640404|584624554|FG000|Overall Study|Withdrawal by Subject|1|||
161885738|NCT02640404|584624555|FG001|Overall Study|Withdrawal by Subject|0|||
161885739|NCT00778102|584624556|FG000|Overall Study|Adverse Event|8|||
161885740|NCT00778102|584624557|FG001|Overall Study|Adverse Event|5|||
161885741|NCT00778102|584624556|FG000|Overall Study|Death|1|||
161885742|NCT00778102|584624557|FG001|Overall Study|Death|1|||
161885743|NCT00778102|584624556|FG000|Overall Study|Lost to Follow-up|1|||
161885744|NCT00778102|584624557|FG001|Overall Study|Lost to Follow-up|0|||
161885745|NCT00778102|584624556|FG000|Overall Study|Violation of Selection Criteria|1|||
161885746|NCT00778102|584624557|FG001|Overall Study|Violation of Selection Criteria|1|||
161885747|NCT00778102|584624556|FG000|Overall Study|Protocol Violation|0|||
161885748|NCT00778102|584624557|FG001|Overall Study|Protocol Violation|1|||
161885749|NCT00778102|584624556|FG000|Overall Study|Refused Treatment|2|||
161885750|NCT00778102|584624557|FG001|Overall Study|Refused Treatment|3|||
161885751|NCT00778102|584624556|FG000|Overall Study|Withdrawal by Subject|1|||
161885752|NCT00778102|584624557|FG001|Overall Study|Withdrawal by Subject|1|||
161885753|NCT00778102|584624556|FG000|Overall Study|Administrative Reason|7|||
161885754|NCT00778102|584624557|FG001|Overall Study|Administrative Reason|10|||
161885755|NCT05397171|584624558|FG000|Overall Study|Death|2|||
161885756|NCT05397171|584624559|FG001|Overall Study|Death|3|||
161885757|NCT05397171|584624560|FG002|Overall Study|Death|3|||
161885758|NCT05397171|584624558|FG000|Overall Study|Study Terminated By Sponsor|1|||
161885759|NCT05397171|584624559|FG001|Overall Study|Study Terminated By Sponsor|2|||
161885760|NCT05397171|584624560|FG002|Overall Study|Study Terminated By Sponsor|3|||
161885761|NCT05397171|584624558|FG000|Overall Study|Withdrawal by Subject|0|||
161885762|NCT05397171|584624559|FG001|Overall Study|Withdrawal by Subject|1|||
161885763|NCT05397171|584624560|FG002|Overall Study|Withdrawal by Subject|1|||
161885764|NCT01328548|584624561|FG000|Overall Study|Death|3|||
161885765|NCT01328548|584624562|FG001|Overall Study|Death|0|||
161885766|NCT01328548|584624561|FG000|Overall Study|Protocol Violation|1|||
161885767|NCT01328548|584624562|FG001|Overall Study|Protocol Violation|0|||
161885768|NCT01709864|584626621|FG000|Overall Study|Physician Decision|0|||
161885769|NCT01709864|584626622|FG001|Overall Study|Physician Decision|1|||
161885770|NCT01709864|584626621|FG000|Overall Study|subject/guardian decision|5|||
161885771|NCT01709864|584626622|FG001|Overall Study|subject/guardian decision|6|||
161885772|NCT01709864|584626621|FG000|Overall Study|Lost to Follow-up|1|||
161885773|NCT01709864|584626622|FG001|Overall Study|Lost to Follow-up|0|||
161885774|NCT01709864|584626621|FG000|Overall Study|non-compliance with study treatment|1|||
161885775|NCT01709864|584626622|FG001|Overall Study|non-compliance with study treatment|1|||
161885776|NCT01709864|584626621|FG000|Overall Study|Adverse Event|0|||
161885777|NCT01709864|584626622|FG001|Overall Study|Adverse Event|2|||
161885778|NCT01709864|584626621|FG000|Overall Study|Death|0|||
161885779|NCT01709864|584626622|FG001|Overall Study|Death|1|||
161885780|NCT01066793|584626623|FG000|Overall Study|Death|4|||
161885781|NCT01066793|584626624|FG001|Overall Study|Death|1|||
161885782|NCT01066793|584626625|FG002|Overall Study|Death|1|||
161885783|NCT01066793|584626626|FG003|Overall Study|Death|0|||
161885784|NCT01066793|584626627|FG004|Overall Study|Death|0|||
161885785|NCT01066793|584626628|FG005|Overall Study|Death|0|||
161885786|NCT01066793|584626623|FG000|Overall Study|Lack of Efficacy|2|||
161885787|NCT01066793|584626624|FG001|Overall Study|Lack of Efficacy|1|||
161885788|NCT01066793|584626625|FG002|Overall Study|Lack of Efficacy|0|||
161885789|NCT01066793|584626626|FG003|Overall Study|Lack of Efficacy|0|||
161885790|NCT01066793|584626627|FG004|Overall Study|Lack of Efficacy|0|||
161885791|NCT01066793|584626628|FG005|Overall Study|Lack of Efficacy|0|||
161885792|NCT01066793|584626623|FG000|Overall Study|Lost to Follow-up|180|||
161885793|NCT01066793|584626624|FG001|Overall Study|Lost to Follow-up|39|||
161885794|NCT01066793|584626625|FG002|Overall Study|Lost to Follow-up|82|||
161885795|NCT01066793|584626626|FG003|Overall Study|Lost to Follow-up|16|||
161885796|NCT01066793|584626627|FG004|Overall Study|Lost to Follow-up|0|||
161885797|NCT01066793|584626628|FG005|Overall Study|Lost to Follow-up|1|||
161885798|NCT01066793|584626623|FG000|Overall Study|Physician Decision|3|||
161885799|NCT01066793|584626624|FG001|Overall Study|Physician Decision|0|||
161885800|NCT01066793|584626625|FG002|Overall Study|Physician Decision|0|||
161885801|NCT01066793|584626626|FG003|Overall Study|Physician Decision|0|||
161885802|NCT01066793|584626627|FG004|Overall Study|Physician Decision|0|||
161885803|NCT01066793|584626628|FG005|Overall Study|Physician Decision|0|||
161885804|NCT01066793|584626623|FG000|Overall Study|Protocol Violation|3|||
161885805|NCT01066793|584626624|FG001|Overall Study|Protocol Violation|2|||
161885806|NCT01066793|584626625|FG002|Overall Study|Protocol Violation|2|||
161885807|NCT01066793|584626626|FG003|Overall Study|Protocol Violation|0|||
161885808|NCT01066793|584626627|FG004|Overall Study|Protocol Violation|0|||
161885809|NCT01066793|584626628|FG005|Overall Study|Protocol Violation|0|||
161885810|NCT01066793|584626623|FG000|Overall Study|Withdrawal by Subject|7|||
161885811|NCT01066793|584626624|FG001|Overall Study|Withdrawal by Subject|4|||
161885812|NCT01066793|584626625|FG002|Overall Study|Withdrawal by Subject|1|||
161885813|NCT01066793|584626626|FG003|Overall Study|Withdrawal by Subject|0|||
161885814|NCT01066793|584626627|FG004|Overall Study|Withdrawal by Subject|0|||
161885815|NCT01066793|584626628|FG005|Overall Study|Withdrawal by Subject|0|||
161885816|NCT01066793|584626623|FG000|Overall Study|Early Termination|3|||
161885817|NCT01066793|584626624|FG001|Overall Study|Early Termination|0|||
161885818|NCT01066793|584626625|FG002|Overall Study|Early Termination|0|||
161885819|NCT01066793|584626626|FG003|Overall Study|Early Termination|0|||
161885820|NCT01066793|584626627|FG004|Overall Study|Early Termination|0|||
161885821|NCT01066793|584626628|FG005|Overall Study|Early Termination|0|||
161885822|NCT01066793|584626623|FG000|Overall Study|Lab test not done|7|||
161885823|NCT01066793|584626624|FG001|Overall Study|Lab test not done|0|||
161885824|NCT01066793|584626625|FG002|Overall Study|Lab test not done|0|||
161885825|NCT01066793|584626626|FG003|Overall Study|Lab test not done|1|||
161885826|NCT01066793|584626627|FG004|Overall Study|Lab test not done|0|||
161885827|NCT01066793|584626628|FG005|Overall Study|Lab test not done|0|||
161885828|NCT01066793|584626623|FG000|Overall Study|Miscellaneous|4|||
161885829|NCT01066793|584626624|FG001|Overall Study|Miscellaneous|5|||
161885830|NCT01066793|584626625|FG002|Overall Study|Miscellaneous|6|||
161885831|NCT01066793|584626626|FG003|Overall Study|Miscellaneous|0|||
161885832|NCT01066793|584626627|FG004|Overall Study|Miscellaneous|0|||
161885833|NCT01066793|584626628|FG005|Overall Study|Miscellaneous|0|||
161885834|NCT01066793|584626623|FG000|Overall Study|Non-responders|104|||
161885835|NCT01066793|584626624|FG001|Overall Study|Non-responders|5|||
161885836|NCT01066793|584626625|FG002|Overall Study|Non-responders|11|||
161885837|NCT01066793|584626626|FG003|Overall Study|Non-responders|25|||
161885838|NCT01066793|584626627|FG004|Overall Study|Non-responders|0|||
161885839|NCT01066793|584626628|FG005|Overall Study|Non-responders|0|||
161885840|NCT01066793|584626623|FG000|Overall Study|Other|15|||
161885841|NCT01066793|584626624|FG001|Overall Study|Other|5|||
161885842|NCT01066793|584626625|FG002|Overall Study|Other|6|||
161885843|NCT01066793|584626626|FG003|Overall Study|Other|2|||
161885844|NCT01066793|584626627|FG004|Overall Study|Other|0|||
161885845|NCT01066793|584626628|FG005|Overall Study|Other|0|||
161885846|NCT01066793|584626623|FG000|Overall Study|Relapse|20|||
161885847|NCT01066793|584626624|FG001|Overall Study|Relapse|8|||
161885848|NCT01066793|584626625|FG002|Overall Study|Relapse|2|||
161885849|NCT01066793|584626626|FG003|Overall Study|Relapse|3|||
161885850|NCT01066793|584626627|FG004|Overall Study|Relapse|0|||
161885851|NCT01066793|584626628|FG005|Overall Study|Relapse|0|||
161885852|NCT01066793|584626623|FG000|Overall Study|Result Not Available|1|||
161885853|NCT01066793|584626624|FG001|Overall Study|Result Not Available|0|||
161885854|NCT01066793|584626625|FG002|Overall Study|Result Not Available|0|||
161885855|NCT01066793|584626626|FG003|Overall Study|Result Not Available|0|||
161885856|NCT01066793|584626627|FG004|Overall Study|Result Not Available|0|||
161885857|NCT01066793|584626628|FG005|Overall Study|Result Not Available|0|||
161885858|NCT01066793|584626623|FG000|Overall Study|Treatment Interrupted|1|||
161885859|NCT01066793|584626624|FG001|Overall Study|Treatment Interrupted|1|||
161885860|NCT01066793|584626625|FG002|Overall Study|Treatment Interrupted|0|||
161885861|NCT01066793|584626626|FG003|Overall Study|Treatment Interrupted|0|||
161885862|NCT01066793|584626627|FG004|Overall Study|Treatment Interrupted|0|||
161885863|NCT01066793|584626628|FG005|Overall Study|Treatment Interrupted|0|||
161885864|NCT01066793|584626623|FG000|Overall Study|Treatment Never Started|18|||
161885865|NCT01066793|584626624|FG001|Overall Study|Treatment Never Started|5|||
161885866|NCT01066793|584626625|FG002|Overall Study|Treatment Never Started|4|||
161885867|NCT01066793|584626626|FG003|Overall Study|Treatment Never Started|1|||
161885868|NCT01066793|584626627|FG004|Overall Study|Treatment Never Started|0|||
161885869|NCT01066793|584626628|FG005|Overall Study|Treatment Never Started|0|||
161885870|NCT01066793|584626623|FG000|Overall Study|Treatment Stopped|2|||
161885871|NCT01066793|584626624|FG001|Overall Study|Treatment Stopped|1|||
161885872|NCT01066793|584626625|FG002|Overall Study|Treatment Stopped|0|||
161885873|NCT01066793|584626626|FG003|Overall Study|Treatment Stopped|1|||
161885874|NCT01066793|584626627|FG004|Overall Study|Treatment Stopped|0|||
161885875|NCT01066793|584626628|FG005|Overall Study|Treatment Stopped|0|||
161885876|NCT02697916|584626630|FG000|Overall Study|Death|357|||
161885877|NCT02697916|584626631|FG001|Overall Study|Death|315|||
161885878|NCT02697916|584626630|FG000|Overall Study|Withdrawal by Subject|221|||
161885879|NCT02697916|584626631|FG001|Overall Study|Withdrawal by Subject|393|||
161885880|NCT04643964|584626632|FG000|Overall Study|Lost to Follow-up|55|||
161885881|NCT04643964|584626633|FG001|Overall Study|Lost to Follow-up|59|||
161885882|NCT04643964|584626634|FG002|Overall Study|Lost to Follow-up|54|||
161885883|NCT04643964|584626635|FG003|Overall Study|Lost to Follow-up|129|||
161885884|NCT04643964|584626636|FG004|Overall Study|Lost to Follow-up|48|||
161885885|NCT04643964|584626632|FG000|Overall Study|Failed attention check|1|||
161885886|NCT04643964|584626633|FG001|Overall Study|Failed attention check|8|||
161885887|NCT04643964|584626634|FG002|Overall Study|Failed attention check|2|||
161885888|NCT04643964|584626635|FG003|Overall Study|Failed attention check|14|||
161885889|NCT04643964|584626636|FG004|Overall Study|Failed attention check|11|||
161885890|NCT00590538|584626637|FG000|Overall Study|Study terminated before completed|2|||
161885891|NCT01125813|584626638|FG000|Overall Study|Death|1|||
161885892|NCT01125813|584626638|FG000|Overall Study|Withdrawal by Subject|1|||
161885893|NCT01125813|584626638|FG000|Overall Study|Screen Failures|4|||
161885894|NCT02539134|584626641|FG000|Overall Study|Lost to Follow-up|1|||
161885895|NCT02539134|584626642|FG001|Overall Study|Lost to Follow-up|0|||
161885896|NCT02539134|584626643|FG002|Overall Study|Lost to Follow-up|0|||
161885897|NCT02539134|584626644|FG003|Overall Study|Lost to Follow-up|0|||
161885898|NCT02539134|584626645|FG004|Overall Study|Lost to Follow-up|0|||
161885899|NCT02539134|584626646|FG005|Overall Study|Lost to Follow-up|0|||
161885900|NCT02255552|584626647|FG000|Overall Study|Participants enrolled into another study|0|||
161885901|NCT02255552|584626648|FG001|Overall Study|Participants enrolled into another study|11|||
161885902|NCT02255552|584626647|FG000|Overall Study|Withdrawal by Subject|1|||
161885903|NCT02255552|584626648|FG001|Overall Study|Withdrawal by Subject|4|||
161885904|NCT00558896|584626649|FG000|Overall Study|Adverse Event|1|||
161885905|NCT00558896|584626650|FG001|Overall Study|Adverse Event|1|||
161885906|NCT00558896|584626651|FG002|Overall Study|Adverse Event|1|||
161885907|NCT00558896|584626652|FG003|Overall Study|Adverse Event|3|||
161885908|NCT00558896|584626653|FG004|Overall Study|Adverse Event|4|||
161885909|NCT00558896|584626654|FG005|Overall Study|Adverse Event|10|||
161885910|NCT00558896|584626655|FG006|Overall Study|Adverse Event|3|||
161885911|NCT00558896|584626649|FG000|Overall Study|Death|3|||
161885912|NCT00558896|584626650|FG001|Overall Study|Death|0|||
161885913|NCT00558896|584626651|FG002|Overall Study|Death|2|||
161885914|NCT00558896|584626652|FG003|Overall Study|Death|3|||
161885915|NCT00558896|584626653|FG004|Overall Study|Death|2|||
161885916|NCT00558896|584626654|FG005|Overall Study|Death|2|||
161885917|NCT00558896|584626655|FG006|Overall Study|Death|6|||
161885918|NCT00558896|584626649|FG000|Overall Study|Withdrawal by Subject|2|||
161885919|NCT00558896|584626650|FG001|Overall Study|Withdrawal by Subject|1|||
161885920|NCT00558896|584626651|FG002|Overall Study|Withdrawal by Subject|1|||
161885921|NCT00558896|584626652|FG003|Overall Study|Withdrawal by Subject|1|||
161885922|NCT00558896|584626653|FG004|Overall Study|Withdrawal by Subject|1|||
161885923|NCT00558896|584626654|FG005|Overall Study|Withdrawal by Subject|5|||
161885924|NCT00558896|584626655|FG006|Overall Study|Withdrawal by Subject|5|||
161885925|NCT00558896|584626649|FG000|Overall Study|Alternative Treatment|2|||
161885926|NCT00558896|584626650|FG001|Overall Study|Alternative Treatment|2|||
161885927|NCT00558896|584626651|FG002|Overall Study|Alternative Treatment|0|||
161885928|NCT00558896|584626652|FG003|Overall Study|Alternative Treatment|2|||
161885929|NCT00558896|584626653|FG004|Overall Study|Alternative Treatment|6|||
161885930|NCT00558896|584626654|FG005|Overall Study|Alternative Treatment|7|||
161885931|NCT00558896|584626655|FG006|Overall Study|Alternative Treatment|1|||
161885932|NCT00558896|584626649|FG000|Overall Study|Physician discretion|3|||
161885933|NCT00558896|584626650|FG001|Overall Study|Physician discretion|2|||
161885934|NCT00558896|584626651|FG002|Overall Study|Physician discretion|1|||
161885935|NCT00558896|584626652|FG003|Overall Study|Physician discretion|2|||
161885936|NCT00558896|584626653|FG004|Overall Study|Physician discretion|1|||
161885937|NCT00558896|584626654|FG005|Overall Study|Physician discretion|3|||
161885938|NCT00558896|584626655|FG006|Overall Study|Physician discretion|3|||
161885939|NCT00558896|584626649|FG000|Overall Study|Continues on treatment|10|||
161885940|NCT00558896|584626650|FG001|Overall Study|Continues on treatment|1|||
161885941|NCT00558896|584626651|FG002|Overall Study|Continues on treatment|0|||
161885942|NCT00558896|584626652|FG003|Overall Study|Continues on treatment|1|||
161885943|NCT00558896|584626653|FG004|Overall Study|Continues on treatment|9|||
161885944|NCT00558896|584626654|FG005|Overall Study|Continues on treatment|25|||
161885945|NCT00558896|584626655|FG006|Overall Study|Continues on treatment|6|||
161885946|NCT03181503|584626656|FG000|Overall Study|Adverse Event|2|||
161885947|NCT03181503|584626657|FG001|Overall Study|Adverse Event|2|||
161885948|NCT03181503|584626656|FG000|Overall Study|Protocol Violation|1|||
161885949|NCT03181503|584626657|FG001|Overall Study|Protocol Violation|0|||
161885950|NCT03181503|584626656|FG000|Overall Study|Withdrawal by Subject|3|||
161885951|NCT03181503|584626657|FG001|Overall Study|Withdrawal by Subject|0|||
161885952|NCT03181503|584626656|FG000|Overall Study|Lost to Follow-up|1|||
161885953|NCT03181503|584626657|FG001|Overall Study|Lost to Follow-up|1|||
161885954|NCT02382796|584626660|FG000|Overall Study|Global deterioration of health status|1|||
161885955|NCT02382796|584626660|FG000|Overall Study|Objective progression or relapse|3|||
161885956|NCT02382796|584626660|FG000|Overall Study|Commercial dacomitinib became available|3|||
161885957|NCT03077659|584626661|FG000|Overall Study|Withdrawal by Subject|0|||
161885958|NCT03077659|584626662|FG001|Overall Study|Withdrawal by Subject|0|||
161885959|NCT03077659|584626663|FG002|Overall Study|Withdrawal by Subject|1|||
161885960|NCT02258542|584626670|FG000|Overall Study|eg. not made to the visit|7|||
161885961|NCT02258542|584626671|FG001|Overall Study|eg. not made to the visit|4|||
161885962|NCT02258542|584626672|FG002|Overall Study|eg. not made to the visit|0|||
161885963|NCT02258542|584626673|FG003|Overall Study|eg. not made to the visit|1|||
161885964|NCT02258542|584626670|FG000|Overall Study|study specific discount. criteria|1|||
161885965|NCT02258542|584626671|FG001|Overall Study|study specific discount. criteria|1|||
161885966|NCT02258542|584626672|FG002|Overall Study|study specific discount. criteria|0|||
161885967|NCT02258542|584626673|FG003|Overall Study|study specific discount. criteria|0|||
161885968|NCT02258542|584626670|FG000|Overall Study|Withdrawal by Subject|20|||
161885969|NCT02258542|584626671|FG001|Overall Study|Withdrawal by Subject|20|||
161885970|NCT02258542|584626672|FG002|Overall Study|Withdrawal by Subject|7|||
161885971|NCT02258542|584626673|FG003|Overall Study|Withdrawal by Subject|1|||
161885972|NCT02258542|584626670|FG000|Overall Study|Lost to Follow-up|5|||
161885973|NCT02258542|584626671|FG001|Overall Study|Lost to Follow-up|12|||
161885974|NCT02258542|584626672|FG002|Overall Study|Lost to Follow-up|1|||
161885975|NCT02258542|584626673|FG003|Overall Study|Lost to Follow-up|2|||
161885976|NCT02258542|584626670|FG000|Overall Study|Death|5|||
161885977|NCT02258542|584626671|FG001|Overall Study|Death|4|||
161885978|NCT02258542|584626672|FG002|Overall Study|Death|0|||
161885979|NCT02258542|584626673|FG003|Overall Study|Death|1|||
161885980|NCT02258542|584626670|FG000|Overall Study|Adverse Event|3|||
161885981|NCT02258542|584626671|FG001|Overall Study|Adverse Event|4|||
161885982|NCT02258542|584626672|FG002|Overall Study|Adverse Event|0|||
161885983|NCT02258542|584626673|FG003|Overall Study|Adverse Event|0|||
161885984|NCT02258542|584626670|FG000|Overall Study|Protocol Violation|1|||
161885985|NCT02258542|584626671|FG001|Overall Study|Protocol Violation|2|||
161885986|NCT02258542|584626672|FG002|Overall Study|Protocol Violation|0|||
161885987|NCT02258542|584626673|FG003|Overall Study|Protocol Violation|0|||
161885988|NCT02258542|584626670|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161885989|NCT02258542|584626671|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
161885990|NCT02258542|584626672|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
161885991|NCT02258542|584626673|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
161885992|NCT04068688|584626674|FG000|Overall Study|Lost to Follow-up|1|||
161885993|NCT04068688|584626675|FG001|Overall Study|Lost to Follow-up|1|||
161885994|NCT04068688|584626676|FG002|Overall Study|Lost to Follow-up|0|||
161885995|NCT04068688|584626677|FG003|Overall Study|Lost to Follow-up|0|||
161885996|NCT04068688|584626678|FG004|Overall Study|Lost to Follow-up|5|||
161885997|NCT04068688|584626679|FG005|Overall Study|Lost to Follow-up|5|||
161885998|NCT04068688|584626680|FG006|Overall Study|Lost to Follow-up|0|||
161885999|NCT04068688|584626681|FG007|Overall Study|Lost to Follow-up|0|||
161886000|NCT04068688|584626682|FG008|Overall Study|Lost to Follow-up|1|||
161886001|NCT04068688|584626683|FG009|Overall Study|Lost to Follow-up|0|||
161886002|NCT04068688|584626674|FG000|Overall Study|Withdrawal by Subject|1|||
161886003|NCT04068688|584626675|FG001|Overall Study|Withdrawal by Subject|1|||
161886004|NCT04068688|584626676|FG002|Overall Study|Withdrawal by Subject|0|||
161886005|NCT04068688|584626677|FG003|Overall Study|Withdrawal by Subject|0|||
161886006|NCT04068688|584626678|FG004|Overall Study|Withdrawal by Subject|0|||
161886007|NCT04068688|584626679|FG005|Overall Study|Withdrawal by Subject|0|||
161886008|NCT04068688|584626680|FG006|Overall Study|Withdrawal by Subject|0|||
161886009|NCT04068688|584626681|FG007|Overall Study|Withdrawal by Subject|0|||
161886010|NCT04068688|584626682|FG008|Overall Study|Withdrawal by Subject|0|||
161886011|NCT04068688|584626683|FG009|Overall Study|Withdrawal by Subject|0|||
161886012|NCT04068688|584626674|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
161886013|NCT04068688|584626675|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
161886014|NCT04068688|584626676|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886015|NCT04068688|584626677|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886016|NCT04068688|584626678|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886017|NCT04068688|584626679|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886018|NCT04068688|584626680|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886019|NCT04068688|584626681|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886020|NCT04068688|584626682|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886021|NCT04068688|584626683|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161886022|NCT04679051|584626684|FG000|Overall Study|felt tired after restricted time in bed|3|||
161886023|NCT04679051|584626685|FG001|Overall Study|felt tired after restricted time in bed|0|||
161886024|NCT04679051|584626684|FG000|Overall Study|discomfort with blood pressure cuff|2|||
161886025|NCT04679051|584626685|FG001|Overall Study|discomfort with blood pressure cuff|0|||
161886026|NCT04679051|584626684|FG000|Overall Study|scheduling conflict|1|||
161886027|NCT04679051|584626685|FG001|Overall Study|scheduling conflict|1|||
161886028|NCT04679051|584626684|FG000|Overall Study|Protocol Violation|0|||
161886029|NCT04679051|584626685|FG001|Overall Study|Protocol Violation|4|||
161886030|NCT02554318|584626686|FG000|Overall Study|Withdrawal by Subject|10|||
161886031|NCT02554318|584626687|FG001|Overall Study|Withdrawal by Subject|8|||
161886032|NCT01472965|584626688|FG000|Overall Study|Withdrawal by Subject|1|||
161886033|NCT01472965|584626689|FG001|Overall Study|Withdrawal by Subject|0|||
161886034|NCT00334802|584626693|FG000|Overall Study|Progressive Disease|2|||
161886035|NCT00334802|584626694|FG001|Overall Study|Progressive Disease|24|||
161886036|NCT00334802|584626693|FG000|Overall Study|Toxicity|1|||
161886037|NCT00334802|584626694|FG001|Overall Study|Toxicity|5|||
161886038|NCT00334802|584626693|FG000|Overall Study|Lack of Efficacy|1|||
161886039|NCT00334802|584626694|FG001|Overall Study|Lack of Efficacy|3|||
161886040|NCT00334802|584626693|FG000|Overall Study|Patient Condition Aggrevated|1|||
161886041|NCT00334802|584626694|FG001|Overall Study|Patient Condition Aggrevated|0|||
161886042|NCT00334802|584626693|FG000|Overall Study|Physician Decision|1|||
161886043|NCT00334802|584626694|FG001|Overall Study|Physician Decision|0|||
161886044|NCT00334802|584626693|FG000|Overall Study|Withdrawal by Subject|0|||
161886045|NCT00334802|584626694|FG001|Overall Study|Withdrawal by Subject|4|||
161886046|NCT00334802|584626693|FG000|Overall Study|Adverse Event|0|||
161886047|NCT00334802|584626694|FG001|Overall Study|Adverse Event|3|||
161886048|NCT00334802|584626693|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
161886049|NCT00334802|584626694|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
161886050|NCT00980018|584626700|FG000|Overall Study|Adverse Event|8|||
161886051|NCT00980018|584626700|FG000|Overall Study|Patient withdrew consent|3|||
161886052|NCT00980018|584626700|FG000|Overall Study|Lost to Follow-up|1|||
161886053|NCT00551161|584626701|FG000|Overall Study|Withdrawal by Subject|1|||
161886054|NCT00934856|584626702|FG000|Feasibility Part|Progressive disease|4|||
161886055|NCT00934856|584626703|FG001|Feasibility Part|Progressive disease|4|||
161886056|NCT00934856|584626704|FG002|Feasibility Part|Progressive disease|2|||
161886057|NCT00934856|584626705|FG003|Feasibility Part|Progressive disease|3|||
161886058|NCT00934856|584626706|FG004|Feasibility Part|Progressive disease|0|||
161886059|NCT00934856|584626707|FG005|Feasibility Part|Progressive disease|0|||
161886060|NCT00934856|584626702|FG000|Feasibility Part|Physician Decision|0|||
161886061|NCT00934856|584626703|FG001|Feasibility Part|Physician Decision|0|||
161886062|NCT00934856|584626704|FG002|Feasibility Part|Physician Decision|1|||
161886063|NCT00934856|584626705|FG003|Feasibility Part|Physician Decision|0|||
161886064|NCT00934856|584626706|FG004|Feasibility Part|Physician Decision|0|||
161886065|NCT00934856|584626707|FG005|Feasibility Part|Physician Decision|0|||
161886066|NCT00934856|584626702|FG000|Feasibility Part|Adverse Event|1|||
161886067|NCT00934856|584626703|FG001|Feasibility Part|Adverse Event|1|||
161886068|NCT00934856|584626704|FG002|Feasibility Part|Adverse Event|0|||
161886069|NCT00934856|584626705|FG003|Feasibility Part|Adverse Event|1|||
161886070|NCT00934856|584626706|FG004|Feasibility Part|Adverse Event|0|||
161886071|NCT00934856|584626707|FG005|Feasibility Part|Adverse Event|2|||
161886072|NCT00934856|584626702|FG000|Feasibility Part|Withdrawal by Subject|0|||
161886073|NCT00934856|584626703|FG001|Feasibility Part|Withdrawal by Subject|0|||
161886074|NCT00934856|584626704|FG002|Feasibility Part|Withdrawal by Subject|0|||
161991900|NCT03364309|585018546|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
161886075|NCT00934856|584626705|FG003|Feasibility Part|Withdrawal by Subject|1|||
161886076|NCT00934856|584626706|FG004|Feasibility Part|Withdrawal by Subject|0|||
161886077|NCT00934856|584626707|FG005|Feasibility Part|Withdrawal by Subject|1|||
161886078|NCT00934856|584626702|FG000|Extension Part|Adverse Event|0|||
161886079|NCT00934856|584626703|FG001|Extension Part|Adverse Event|0|||
161886080|NCT00934856|584626704|FG002|Extension Part|Adverse Event|0|||
161886081|NCT00934856|584626705|FG003|Extension Part|Adverse Event|1|||
161886082|NCT00934856|584626706|FG004|Extension Part|Adverse Event|4|||
161886083|NCT00934856|584626707|FG005|Extension Part|Adverse Event|4|||
161886084|NCT00934856|584626702|FG000|Extension Part|Progressive disease|0|||
161886085|NCT00934856|584626703|FG001|Extension Part|Progressive disease|0|||
161886086|NCT00934856|584626704|FG002|Extension Part|Progressive disease|0|||
161886087|NCT00934856|584626705|FG003|Extension Part|Progressive disease|1|||
161886088|NCT00934856|584626706|FG004|Extension Part|Progressive disease|0|||
161886089|NCT00934856|584626707|FG005|Extension Part|Progressive disease|0|||
161886090|NCT00934856|584626702|FG000|Extension Part|Non-compliance with drug|0|||
161886091|NCT00934856|584626703|FG001|Extension Part|Non-compliance with drug|0|||
161886092|NCT00934856|584626704|FG002|Extension Part|Non-compliance with drug|0|||
161886093|NCT00934856|584626705|FG003|Extension Part|Non-compliance with drug|0|||
161886094|NCT00934856|584626706|FG004|Extension Part|Non-compliance with drug|0|||
161886095|NCT00934856|584626707|FG005|Extension Part|Non-compliance with drug|1|||
161886096|NCT01256385|584626708|FG000|Overall Study|Physician Decision|1|||
161886097|NCT01256385|584626709|FG001|Overall Study|Physician Decision|1|||
161886098|NCT01256385|584626708|FG000|Overall Study|Withdrawal by Subject|2|||
161886099|NCT01256385|584626709|FG001|Overall Study|Withdrawal by Subject|2|||
161886100|NCT03430895|584626714|FG000|Overall Study|Not Treated|2|||
161886101|NCT01645891|584626717|FG000|Overall Study|Adverse Event|6|||
161886102|NCT01645891|584626718|FG001|Overall Study|Adverse Event|10|||
161886103|NCT01645891|584626717|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
161886104|NCT01645891|584626718|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
161886105|NCT01645891|584626717|FG000|Overall Study|Withdrawal by Subject|3|||
161886106|NCT01645891|584626718|FG001|Overall Study|Withdrawal by Subject|3|||
161886107|NCT01645891|584626717|FG000|Overall Study|Protocol Violation|4|||
161886108|NCT01645891|584626718|FG001|Overall Study|Protocol Violation|0|||
161886109|NCT01645891|584626717|FG000|Overall Study|Lost to Follow-up|4|||
161886110|NCT01645891|584626718|FG001|Overall Study|Lost to Follow-up|1|||
161886111|NCT01645891|584626717|FG000|Overall Study|Death|0|||
161886112|NCT01645891|584626718|FG001|Overall Study|Death|2|||
161886113|NCT00138073|584626721|FG000|Overall Study|lack of resources|55|||
161886114|NCT03301740|584626722|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
161886115|NCT03301740|584626723|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
161886116|NCT03301740|584626722|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
161886117|NCT03301740|584626723|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
161886118|NCT02847182|584626724|FG000|Overall Study|Withdrawal by Subject|0|||
161886119|NCT02847182|584626725|FG001|Overall Study|Withdrawal by Subject|1|||
161886120|NCT01306045|584626726|FG000|Met General Eligibility Criteria|Screen failures|193|||
161886121|NCT01306045|584626727|FG001|Met General Eligibility Criteria|Screen failures|11|||
161886122|NCT01306045|584626728|FG002|Met General Eligibility Criteria|Screen failures|8|||
161886123|NCT03191864|584626729|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
161886124|NCT03191864|584626730|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
161886125|NCT03191864|584626731|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
161886126|NCT03191864|584626732|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
161886127|NCT03191864|584626733|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
161886128|NCT03191864|584626734|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
161886129|NCT03191864|584626729|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161886130|NCT03191864|584626730|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161886131|NCT03191864|584626731|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161886132|NCT03191864|584626732|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161886133|NCT03191864|584626733|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161886134|NCT03191864|584626734|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
161886135|NCT03191864|584626729|FG000|Baseline Symptom Assessment|Adverse Event|0|||
161886136|NCT03191864|584626730|FG001|Baseline Symptom Assessment|Adverse Event|0|||
161886137|NCT03191864|584626731|FG002|Baseline Symptom Assessment|Adverse Event|0|||
161886138|NCT03191864|584626732|FG003|Baseline Symptom Assessment|Adverse Event|0|||
161886139|NCT03191864|584626733|FG004|Baseline Symptom Assessment|Adverse Event|0|||
161886140|NCT03191864|584626734|FG005|Baseline Symptom Assessment|Adverse Event|2|||
161886141|NCT03191864|584626729|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161886142|NCT03191864|584626730|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161991901|NCT03364309|585018547|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
161886143|NCT03191864|584626731|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161886144|NCT03191864|584626732|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161991902|NCT03364309|585018548|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
161991903|NCT03364309|585018549|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
161991904|NCT03364309|585018550|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
161991905|NCT03364309|585018551|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
161991906|NCT03364309|585018552|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
161991907|NCT03364309|585018553|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
161991908|NCT03364309|585018554|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
161991909|NCT03364309|585018555|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
161991910|NCT03364309|585018556|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
161991911|NCT03364309|585018557|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
161991912|NCT03364309|585018558|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
161991913|NCT03364309|585018559|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
161991914|NCT03364309|585018560|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
161991915|NCT03364309|585018561|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
161991916|NCT03364309|585018562|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
161991917|NCT03364309|585018544|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991918|NCT03364309|585018545|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991919|NCT03364309|585018546|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991920|NCT03364309|585018547|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991921|NCT03364309|585018548|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991922|NCT03364309|585018549|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991923|NCT03364309|585018550|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161886145|NCT03191864|584626733|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161886146|NCT03191864|584626734|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
161886147|NCT03191864|584626729|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161886148|NCT03191864|584626730|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161886149|NCT03191864|584626731|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161886150|NCT03191864|584626732|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161886151|NCT03191864|584626733|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161886152|NCT03191864|584626734|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
161886153|NCT03191864|584626729|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
161886154|NCT03191864|584626730|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
161886155|NCT03191864|584626731|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
161886156|NCT03191864|584626732|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
161886157|NCT03191864|584626733|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
161886158|NCT03191864|584626734|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
161886159|NCT03191864|584626729|FG000|Part 1 - Induction|Adverse Event|0|||
161886160|NCT03191864|584626730|FG001|Part 1 - Induction|Adverse Event|2|||
161886161|NCT03191864|584626731|FG002|Part 1 - Induction|Adverse Event|0|||
161886162|NCT03191864|584626732|FG003|Part 1 - Induction|Adverse Event|1|||
161886163|NCT03191864|584626733|FG004|Part 1 - Induction|Adverse Event|0|||
161886164|NCT03191864|584626734|FG005|Part 1 - Induction|Adverse Event|2|||
161886165|NCT03191864|584626729|FG000|Part 1 - Induction|Randomized but never dosed|0|||
161886166|NCT03191864|584626730|FG001|Part 1 - Induction|Randomized but never dosed|0|||
161886167|NCT03191864|584626731|FG002|Part 1 - Induction|Randomized but never dosed|1|||
161886168|NCT03191864|584626732|FG003|Part 1 - Induction|Randomized but never dosed|0|||
161886169|NCT03191864|584626733|FG004|Part 1 - Induction|Randomized but never dosed|0|||
161886170|NCT03191864|584626734|FG005|Part 1 - Induction|Randomized but never dosed|0|||
161886171|NCT03191864|584626729|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
161886172|NCT03191864|584626730|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
161886173|NCT03191864|584626731|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
161886174|NCT03191864|584626732|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
161886175|NCT03191864|584626733|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
161886176|NCT03191864|584626734|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
161886177|NCT03191864|584626729|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161886178|NCT03191864|584626730|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161886179|NCT03191864|584626731|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
161886180|NCT03191864|584626732|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161886181|NCT03191864|584626733|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161886182|NCT03191864|584626734|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161886183|NCT03191864|584626729|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
161886184|NCT03191864|584626730|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161886185|NCT03191864|584626731|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161886186|NCT03191864|584626732|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161886187|NCT03191864|584626733|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161886188|NCT03191864|584626734|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161886189|NCT03191864|584626729|FG000|Part 2 - Maintenance|Physician Decision|1|||
161886190|NCT03191864|584626730|FG001|Part 2 - Maintenance|Physician Decision|0|||
161991924|NCT03364309|585018551|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991925|NCT03364309|585018552|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991926|NCT03364309|585018553|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991927|NCT03364309|585018554|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991928|NCT03364309|585018555|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991929|NCT03364309|585018556|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991930|NCT03364309|585018557|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991931|NCT03364309|585018558|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991932|NCT03364309|585018559|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161991933|NCT03364309|585018560|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
161991934|NCT03364309|585018561|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
161991935|NCT03364309|585018562|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
161991936|NCT03364309|585018544|FG000|Post-Treatment Followup Period|Adverse Event|0|||
161991937|NCT03364309|585018545|FG001|Post-Treatment Followup Period|Adverse Event|0|||
161991938|NCT03364309|585018546|FG002|Post-Treatment Followup Period|Adverse Event|0|||
161991939|NCT03364309|585018547|FG003|Post-Treatment Followup Period|Adverse Event|0|||
161991940|NCT03364309|585018548|FG004|Post-Treatment Followup Period|Adverse Event|0|||
161991941|NCT03364309|585018549|FG005|Post-Treatment Followup Period|Adverse Event|0|||
161991942|NCT03364309|585018550|FG006|Post-Treatment Followup Period|Adverse Event|0|||
161991943|NCT03364309|585018551|FG007|Post-Treatment Followup Period|Adverse Event|0|||
161991944|NCT03364309|585018552|FG008|Post-Treatment Followup Period|Adverse Event|0|||
161991945|NCT03364309|585018553|FG009|Post-Treatment Followup Period|Adverse Event|0|||
161991946|NCT03364309|585018554|FG010|Post-Treatment Followup Period|Adverse Event|0|||
161991947|NCT03364309|585018555|FG011|Post-Treatment Followup Period|Adverse Event|0|||
161991948|NCT03364309|585018556|FG012|Post-Treatment Followup Period|Adverse Event|0|||
161991949|NCT03364309|585018557|FG013|Post-Treatment Followup Period|Adverse Event|0|||
161991950|NCT03364309|585018558|FG014|Post-Treatment Followup Period|Adverse Event|0|||
161991951|NCT03364309|585018559|FG015|Post-Treatment Followup Period|Adverse Event|0|||
161991952|NCT03364309|585018560|FG016|Post-Treatment Followup Period|Adverse Event|2|||
161991953|NCT03364309|585018561|FG017|Post-Treatment Followup Period|Adverse Event|6|||
161991954|NCT03364309|585018562|FG018|Post-Treatment Followup Period|Adverse Event|1|||
161991955|NCT03364309|585018544|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991956|NCT03364309|585018545|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991957|NCT03364309|585018546|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991958|NCT03364309|585018547|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991959|NCT03364309|585018548|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991960|NCT03364309|585018549|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991961|NCT03364309|585018550|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991962|NCT03364309|585018551|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991963|NCT03364309|585018552|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991964|NCT03364309|585018553|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991965|NCT03364309|585018554|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991966|NCT03364309|585018555|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991967|NCT03364309|585018556|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991968|NCT03364309|585018557|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991969|NCT03364309|585018558|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991970|NCT03364309|585018559|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991971|NCT03364309|585018560|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991972|NCT03364309|585018561|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
161991973|NCT03364309|585018562|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
161991974|NCT03364309|585018544|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
161991975|NCT03364309|585018545|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
161991976|NCT03364309|585018546|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
161991977|NCT03364309|585018547|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
161991978|NCT03364309|585018548|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
161991979|NCT03364309|585018549|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
161991980|NCT03364309|585018550|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
161991981|NCT03364309|585018551|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
161991982|NCT03364309|585018552|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
161991983|NCT03364309|585018553|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
161991984|NCT03364309|585018554|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
161991985|NCT03364309|585018555|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
161991986|NCT03364309|585018556|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
161991987|NCT03364309|585018557|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
161991988|NCT03364309|585018558|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
161991989|NCT03364309|585018559|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
161991990|NCT03364309|585018560|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
161991991|NCT03364309|585018561|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
161991992|NCT03364309|585018562|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
161991993|NCT00167310|585018563|FG000|Overall Study|Protocol Violation|5|||
161991994|NCT00167310|585018564|FG001|Overall Study|Protocol Violation|3|||
161991995|NCT00167310|585018563|FG000|Overall Study|Withdrawal by Subject|3|||
161991996|NCT00167310|585018564|FG001|Overall Study|Withdrawal by Subject|7|||
161886191|NCT03191864|584626731|FG002|Part 2 - Maintenance|Physician Decision|0|||
161886192|NCT03191864|584626732|FG003|Part 2 - Maintenance|Physician Decision|0|||
161886193|NCT03191864|584626733|FG004|Part 2 - Maintenance|Physician Decision|0|||
161886194|NCT03191864|584626734|FG005|Part 2 - Maintenance|Physician Decision|0|||
161886195|NCT03191864|584626729|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
161886196|NCT03191864|584626730|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
161886197|NCT03191864|584626731|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
161886198|NCT03191864|584626732|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
161886199|NCT03191864|584626733|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
161886200|NCT03191864|584626734|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
161886201|NCT03191864|584626729|FG000|Part 2 - Maintenance|Adverse Event|0|||
161886202|NCT03191864|584626730|FG001|Part 2 - Maintenance|Adverse Event|0|||
161886203|NCT03191864|584626731|FG002|Part 2 - Maintenance|Adverse Event|0|||
161886204|NCT03191864|584626732|FG003|Part 2 - Maintenance|Adverse Event|0|||
161886205|NCT03191864|584626733|FG004|Part 2 - Maintenance|Adverse Event|1|||
161886206|NCT03191864|584626734|FG005|Part 2 - Maintenance|Adverse Event|0|||
161886207|NCT03191864|584626729|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
161886208|NCT03191864|584626730|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
161886209|NCT03191864|584626731|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
161886210|NCT03191864|584626732|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
161886211|NCT03191864|584626733|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
161886212|NCT03191864|584626734|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
161886213|NCT03191864|584626729|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161886214|NCT03191864|584626730|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161886215|NCT03191864|584626731|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161886216|NCT03191864|584626732|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161886217|NCT03191864|584626733|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
161886218|NCT03191864|584626734|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161886219|NCT02044874|584626735|FG000|Overall Study|Adverse Event|5|||
161886220|NCT02044874|584626736|FG001|Overall Study|Adverse Event|6|||
161886221|NCT02044874|584626737|FG002|Overall Study|Adverse Event|6|||
161886222|NCT02044874|584626735|FG000|Overall Study|Withdrawal by Subject|8|||
161886223|NCT02044874|584626736|FG001|Overall Study|Withdrawal by Subject|16|||
161886224|NCT02044874|584626737|FG002|Overall Study|Withdrawal by Subject|23|||
161886225|NCT02044874|584626735|FG000|Overall Study|Physician Decision|0|||
161886226|NCT02044874|584626736|FG001|Overall Study|Physician Decision|2|||
161886227|NCT02044874|584626737|FG002|Overall Study|Physician Decision|1|||
161886228|NCT02044874|584626735|FG000|Overall Study|Lost to Follow-up|10|||
161886229|NCT02044874|584626736|FG001|Overall Study|Lost to Follow-up|27|||
161886230|NCT02044874|584626737|FG002|Overall Study|Lost to Follow-up|21|||
161886231|NCT02044874|584626735|FG000|Overall Study|Sponsor Decision|0|||
161886232|NCT02044874|584626736|FG001|Overall Study|Sponsor Decision|1|||
161886233|NCT02044874|584626737|FG002|Overall Study|Sponsor Decision|1|||
161886234|NCT02044874|584626735|FG000|Overall Study|Other|7|||
161886235|NCT02044874|584626736|FG001|Overall Study|Other|3|||
161886236|NCT02044874|584626737|FG002|Overall Study|Other|8|||
161886237|NCT05072964|584626738|FG000|Overall Study|Withdrawal by Subject|4|||
161886238|NCT05072964|584626738|FG000|Overall Study|Death|1|||
161886239|NCT00415597|584626739|FG000|Enrollment|Withdrawal by Subject|1|||
161886240|NCT00415597|584626739|FG000|Enrollment|Protocol Violation|1|||
161886241|NCT00415597|584626739|FG000|Treatment|Adverse Event|110|||
161886242|NCT00415597|584626739|FG000|Treatment|Lack of Efficacy|39|||
161886243|NCT00415597|584626739|FG000|Treatment|Protocol Violation|67|||
161886244|NCT00415597|584626739|FG000|Treatment|Physician Decision|3|||
161886245|NCT00415597|584626739|FG000|Treatment|Withdrawal by Subject|51|||
161886246|NCT00415597|584626739|FG000|Treatment|Lost to Follow-up|28|||
161886247|NCT00415597|584626739|FG000|Treatment|Drug Screen|2|||
161886248|NCT00415597|584626739|FG000|Treatment|Administrative|3|||
161886249|NCT00415597|584626739|FG000|Treatment|Sponsor Decision|1|||
161886250|NCT00415597|584626739|FG000|Treatment|Multiple Reasons|1|||
161886251|NCT02172040|584626741|FG000|Overall Study|Adverse Event|0|||
161886252|NCT02172040|584626742|FG001|Overall Study|Adverse Event|2|||
161886253|NCT02172040|584626743|FG002|Overall Study|Adverse Event|0|||
161886254|NCT02172040|584626744|FG003|Overall Study|Adverse Event|0|||
161886255|NCT02172040|584626741|FG000|Overall Study|Protocol Violation|0|||
161886256|NCT02172040|584626742|FG001|Overall Study|Protocol Violation|1|||
161886257|NCT02172040|584626743|FG002|Overall Study|Protocol Violation|0|||
161886258|NCT02172040|584626744|FG003|Overall Study|Protocol Violation|0|||
161886259|NCT02172040|584626741|FG000|Overall Study|Withdrawal by Subject|0|||
161886260|NCT02172040|584626742|FG001|Overall Study|Withdrawal by Subject|0|||
161886261|NCT02172040|584626743|FG002|Overall Study|Withdrawal by Subject|1|||
161886262|NCT02172040|584626744|FG003|Overall Study|Withdrawal by Subject|0|||
161886263|NCT02172040|584626741|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
161886264|NCT02172040|584626742|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
161886265|NCT02172040|584626743|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
161886266|NCT02172040|584626744|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
161886267|NCT02172040|584626741|FG000|Overall Study|Family emergency abroad|0|||
161886268|NCT02172040|584626742|FG001|Overall Study|Family emergency abroad|0|||
161886269|NCT02172040|584626743|FG002|Overall Study|Family emergency abroad|0|||
161886270|NCT02172040|584626744|FG003|Overall Study|Family emergency abroad|1|||
161886271|NCT04908202|584626749|FG000|Pre-Treatment Period|OTHER REASONS|3|||
161886272|NCT04908202|584626750|FG001|Pre-Treatment Period|OTHER REASONS|1|||
161886273|NCT04908202|584626751|FG002|Pre-Treatment Period|OTHER REASONS|0|||
161886274|NCT04908202|584626752|FG003|Pre-Treatment Period|OTHER REASONS|0|||
161991997|NCT00615992|585018565|FG000|Overall Study|Protocol Violation|67|||
161991998|NCT03304873|585018567|FG000|Overall Study|Lost to Follow-up|1|||
161991999|NCT03304873|585018568|FG001|Overall Study|Lost to Follow-up|8|||
161992000|NCT00400569|585018569|FG000|Overall Study|Death|1|||
161992001|NCT00620113|585018572|FG000|Overall Study|Adverse Event|3|||
161992002|NCT00620113|585018573|FG001|Overall Study|Adverse Event|2|||
161992003|NCT00620113|585018574|FG002|Overall Study|Adverse Event|2|||
161992004|NCT00620113|585018575|FG003|Overall Study|Adverse Event|1|||
161992005|NCT00620113|585018572|FG000|Overall Study|Lack of Efficacy|2|||
161992006|NCT00620113|585018573|FG001|Overall Study|Lack of Efficacy|3|||
161992007|NCT00620113|585018574|FG002|Overall Study|Lack of Efficacy|0|||
161992008|NCT00620113|585018575|FG003|Overall Study|Lack of Efficacy|2|||
161992009|NCT00620113|585018572|FG000|Overall Study|Physician Decision|1|||
161992010|NCT00620113|585018573|FG001|Overall Study|Physician Decision|0|||
161992011|NCT00620113|585018574|FG002|Overall Study|Physician Decision|0|||
161992012|NCT00620113|585018575|FG003|Overall Study|Physician Decision|2|||
161992013|NCT00620113|585018572|FG000|Overall Study|Protocol Violation|2|||
161992014|NCT00620113|585018573|FG001|Overall Study|Protocol Violation|1|||
161992015|NCT00620113|585018574|FG002|Overall Study|Protocol Violation|0|||
161992016|NCT00620113|585018575|FG003|Overall Study|Protocol Violation|0|||
161992017|NCT00620113|585018572|FG000|Overall Study|Withdrawal by Subject|5|||
161992018|NCT00620113|585018573|FG001|Overall Study|Withdrawal by Subject|1|||
161992019|NCT00620113|585018574|FG002|Overall Study|Withdrawal by Subject|3|||
161992020|NCT00620113|585018575|FG003|Overall Study|Withdrawal by Subject|5|||
161992021|NCT00856297|585018578|FG000|Overall Study|Unable to classify|2|||
161992022|NCT00856297|585018579|FG001|Overall Study|Unable to classify|0|||
161992023|NCT00856297|585018580|FG002|Overall Study|Unable to classify|0|||
161992024|NCT00856297|585018581|FG003|Overall Study|Unable to classify|0|||
161992025|NCT00856297|585018582|FG004|Overall Study|Unable to classify|0|||
161992026|NCT00368641|585019807|FG000|Overall Study|Adverse Event|2|||
161992027|NCT00368641|585019808|FG001|Overall Study|Adverse Event|1|||
161992028|NCT00368641|585019807|FG000|Overall Study|Death|1|||
161992029|NCT00368641|585019808|FG001|Overall Study|Death|0|||
161992030|NCT00368641|585019807|FG000|Overall Study|Withdrawal by Subject|1|||
161992031|NCT00368641|585019808|FG001|Overall Study|Withdrawal by Subject|0|||
161992032|NCT00368641|585019807|FG000|Overall Study|Sponsor decision to terminate study|2|||
161992033|NCT00368641|585019808|FG001|Overall Study|Sponsor decision to terminate study|5|||
161992034|NCT02751580|585019809|FG000|Overall Study|Lost to Follow-up|4|||
161992035|NCT02751580|585019809|FG000|Overall Study|Death|2|||
161992036|NCT04343755|585019814|FG000|Overall Study|Death|11|||
161992037|NCT04343755|585019814|FG000|Overall Study|Screen Failure|1|||
161992038|NCT00108862|585019816|FG000|Overall Study|Death|31|||
161992039|NCT00108862|585019817|FG001|Overall Study|Death|37|||
161992040|NCT00108862|585019816|FG000|Overall Study|Withdrawal by Subject|10|||
161992041|NCT00108862|585019817|FG001|Overall Study|Withdrawal by Subject|6|||
161992042|NCT00108862|585019816|FG000|Overall Study|Lost to Follow-up|27|||
161992043|NCT00108862|585019817|FG001|Overall Study|Lost to Follow-up|19|||
161992044|NCT04854551|585019820|FG000|Overall Study|Withdrawal by Subject|1|||
161992045|NCT04854551|585019821|FG001|Overall Study|Withdrawal by Subject|1|||
161992046|NCT00687804|585019824|FG000|Core Study|Adverse Event|5|||
161992047|NCT00687804|585019825|FG001|Core Study|Adverse Event|3|||
161992048|NCT00687804|585019826|FG002|Core Study|Adverse Event|3|||
161992049|NCT00687804|585019824|FG000|Core Study|Abnormal laboratory value(s)|1|||
161886275|NCT04908202|584626749|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
162035873|NCT02361346|585187174|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
161886276|NCT04908202|584626750|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161886277|NCT04908202|584626751|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161992050|NCT00687804|585019825|FG001|Core Study|Abnormal laboratory value(s)|0|||
161992051|NCT00687804|585019826|FG002|Core Study|Abnormal laboratory value(s)|0|||
161992052|NCT00687804|585019824|FG000|Core Study|Lack of Efficacy|1|||
161992053|NCT00687804|585019825|FG001|Core Study|Lack of Efficacy|1|||
161992054|NCT00687804|585019826|FG002|Core Study|Lack of Efficacy|1|||
161992055|NCT00687804|585019824|FG000|Core Study|Withdrawal by Subject|4|||
161992056|NCT00687804|585019825|FG001|Core Study|Withdrawal by Subject|7|||
161992057|NCT00687804|585019826|FG002|Core Study|Withdrawal by Subject|7|||
161992058|NCT00687804|585019824|FG000|Core Study|Lost to Follow-up|0|||
161992059|NCT00687804|585019825|FG001|Core Study|Lost to Follow-up|1|||
161992060|NCT00687804|585019826|FG002|Core Study|Lost to Follow-up|0|||
161992061|NCT00687804|585019824|FG000|Core Study|Death|2|||
161992062|NCT00687804|585019825|FG001|Core Study|Death|2|||
161992063|NCT00687804|585019826|FG002|Core Study|Death|2|||
161992064|NCT00687804|585019824|FG000|Core Study|Protocol Violation|1|||
161886278|NCT04908202|584626752|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161886279|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
161886280|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
161886281|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
161886282|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
161886283|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
161886284|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
161886285|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
161886286|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
161886287|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
161886288|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161886289|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161886290|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161886291|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
161886292|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
162035874|NCT02361346|585187175|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
162035875|NCT02361346|585187167|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
162035876|NCT02361346|585187168|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
162035877|NCT02361346|585187169|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
162035878|NCT02361346|585187170|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
162035879|NCT02361346|585187171|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
162035880|NCT02361346|585187172|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
162035881|NCT02361346|585187173|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
162035882|NCT02361346|585187174|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
162035883|NCT02361346|585187175|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
162035884|NCT02361346|585187167|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162035885|NCT02361346|585187168|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162035886|NCT02361346|585187169|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162035887|NCT02361346|585187170|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162035888|NCT02361346|585187171|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162035889|NCT02361346|585187172|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162035890|NCT02361346|585187173|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162035891|NCT02361346|585187174|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
162035892|NCT02361346|585187175|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
162035893|NCT02361346|585187167|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162035894|NCT02361346|585187168|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162035895|NCT02361346|585187169|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162035896|NCT02361346|585187170|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162035897|NCT02361346|585187171|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162035898|NCT02361346|585187172|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162035899|NCT02361346|585187173|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162035900|NCT02361346|585187174|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
162035901|NCT02361346|585187175|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
162035902|NCT02361346|585187167|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162035903|NCT02361346|585187168|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162035904|NCT02361346|585187169|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162035905|NCT02361346|585187170|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162035906|NCT02361346|585187171|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162035907|NCT02361346|585187172|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162035908|NCT02361346|585187173|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162035909|NCT02361346|585187174|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
162035910|NCT02361346|585187175|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
162035911|NCT01683019|585188840|FG000|Overall Study|Withdrawal by Subject|2|||
162035912|NCT01683019|585188841|FG001|Overall Study|Withdrawal by Subject|1|||
162035913|NCT01683019|585188842|FG002|Overall Study|Withdrawal by Subject|4|||
162035914|NCT03437512|585188843|FG000|Randomized|Withdrawal by Subject|0|||
161886293|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161886294|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
162035915|NCT03437512|585188844|FG001|Randomized|Withdrawal by Subject|2|||
162035916|NCT03437512|585188843|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
162035917|NCT03437512|585188844|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
162035918|NCT04854642|585188845|FG000|Overall Study|Adverse Event|1|||
162035919|NCT04854642|585188846|FG001|Overall Study|Adverse Event|2|||
162035920|NCT04854642|585188845|FG000|Overall Study|Withdrawal by Subject|0|||
162035921|NCT04854642|585188846|FG001|Overall Study|Withdrawal by Subject|1|||
162035922|NCT00301821|585188850|FG000|Overall Study|Ineligible|25|||
162035923|NCT00301821|585188850|FG000|Overall Study|Cancel|1|||
162035924|NCT02294773|585188851|FG000|Overall Study|Withdrawal by Subject|0|||
162035925|NCT02294773|585188852|FG001|Overall Study|Withdrawal by Subject|2|||
162035926|NCT01865084|585188853|FG000|Double Blind Period (DB)|Adverse Event|2|||
162035927|NCT01865084|585188854|FG001|Double Blind Period (DB)|Adverse Event|2|||
162035928|NCT01865084|585188855|FG002|Double Blind Period (DB)|Adverse Event|1|||
162035929|NCT01865084|585188853|FG000|Double Blind Period (DB)|Protocol Violation|0|||
162035930|NCT01865084|585188854|FG001|Double Blind Period (DB)|Protocol Violation|0|||
162035931|NCT01865084|585188855|FG002|Double Blind Period (DB)|Protocol Violation|1|||
162035932|NCT01865084|585188853|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
162035933|NCT01865084|585188854|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
162035934|NCT01865084|585188855|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
162035935|NCT01865084|585188853|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
162035936|NCT01865084|585188854|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
162035937|NCT01865084|585188855|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
162035938|NCT01865084|585188853|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
162035939|NCT01865084|585188854|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
162035940|NCT01865084|585188855|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
162035941|NCT01865084|585188853|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
162035942|NCT01865084|585188854|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
162035943|NCT01865084|585188855|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
162035944|NCT01865084|585188853|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
162035945|NCT01865084|585188854|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
162035946|NCT01865084|585188855|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
162035947|NCT01865084|585188853|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
162035948|NCT01865084|585188854|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
162035949|NCT01865084|585188855|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
162035950|NCT01865084|585188853|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
162035951|NCT01865084|585188854|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
162035952|NCT01865084|585188855|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
162035953|NCT03332771|585188856|FG000|Overall Study|Adverse Event|6|||
162035954|NCT03332771|585188857|FG001|Overall Study|Adverse Event|4|||
162035955|NCT03332771|585188858|FG002|Overall Study|Adverse Event|1|||
162035956|NCT03332771|585188859|FG003|Overall Study|Adverse Event|3|||
162035957|NCT03332771|585188856|FG000|Overall Study|Poor Compliance to Protocol|0|||
162035958|NCT03332771|585188857|FG001|Overall Study|Poor Compliance to Protocol|1|||
162035959|NCT03332771|585188858|FG002|Overall Study|Poor Compliance to Protocol|0|||
162035960|NCT03332771|585188859|FG003|Overall Study|Poor Compliance to Protocol|1|||
162035961|NCT03332771|585188856|FG000|Overall Study|Lost to Follow-up|2|||
162035962|NCT03332771|585188857|FG001|Overall Study|Lost to Follow-up|2|||
162035963|NCT03332771|585188858|FG002|Overall Study|Lost to Follow-up|1|||
162035964|NCT03332771|585188859|FG003|Overall Study|Lost to Follow-up|2|||
162035965|NCT03332771|585188856|FG000|Overall Study|At the Participant's own request|20|||
162035966|NCT03332771|585188857|FG001|Overall Study|At the Participant's own request|26|||
162035967|NCT03332771|585188858|FG002|Overall Study|At the Participant's own request|14|||
162035968|NCT03332771|585188859|FG003|Overall Study|At the Participant's own request|23|||
162035969|NCT03332771|585188856|FG000|Overall Study|Reason Not Specified|6|||
162035970|NCT03332771|585188857|FG001|Overall Study|Reason Not Specified|18|||
162035971|NCT03332771|585188858|FG002|Overall Study|Reason Not Specified|16|||
162035972|NCT03332771|585188859|FG003|Overall Study|Reason Not Specified|19|||
162035973|NCT03442764|585188860|FG000|Overall Study|Adverse Event|1|||
162035974|NCT03442764|585188861|FG001|Overall Study|Adverse Event|0|||
162035975|NCT03442764|585188862|FG002|Overall Study|Adverse Event|0|||
162035976|NCT01801072|585188863|FG000|Overall Study|Lost to Follow-up|17|||
162035977|NCT01801072|585188864|FG001|Overall Study|Lost to Follow-up|14|||
162035978|NCT01801072|585188863|FG000|Overall Study|Physician Decision|2|||
162035979|NCT01801072|585188864|FG001|Overall Study|Physician Decision|3|||
162035980|NCT01801072|585188863|FG000|Overall Study|Withdrawal by Subject|1|||
162035981|NCT01801072|585188864|FG001|Overall Study|Withdrawal by Subject|0|||
162035982|NCT01801072|585188863|FG000|Overall Study|Protocol Violation|2|||
162035983|NCT01801072|585188864|FG001|Overall Study|Protocol Violation|0|||
162035984|NCT01801072|585188863|FG000|Overall Study|Death|7|||
162035985|NCT01801072|585188864|FG001|Overall Study|Death|8|||
162035986|NCT03693170|585188865|FG000|Overall Study|Disease Progression|48|||
162035987|NCT03693170|585188865|FG000|Overall Study|Adverse Event|16|||
161886295|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
162035988|NCT03693170|585188865|FG000|Overall Study|Physician Decision|6|||
162035989|NCT03693170|585188865|FG000|Overall Study|Protocol Violation|2|||
162035990|NCT03693170|585188865|FG000|Overall Study|Death|1|||
162035991|NCT03693170|585188865|FG000|Overall Study|Non compliance with study drug|1|||
162035992|NCT03693170|585188865|FG000|Overall Study|Withdrawal by Subject|1|||
162035993|NCT04444895|585188866|FG000|Overall Study|Adverse Event|2|||
162035994|NCT04444895|585188866|FG000|Overall Study|Lost to Follow-up|2|||
162035995|NCT04444895|585188866|FG000|Overall Study|Withdrawal by Subject|5|||
162035996|NCT03034200|585188867|FG000|Overall Study|Disease progression|8|||
161886296|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
161886297|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
161886298|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
161886299|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161886300|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
161886301|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161886302|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161886303|NCT04908202|584626749|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
161886304|NCT04908202|584626750|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
161886305|NCT04908202|584626751|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
161886306|NCT04908202|584626752|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
161886307|NCT04908202|584626749|FG000|Active Treatment Period|OTHER REASONS|0|||
161886308|NCT04908202|584626750|FG001|Active Treatment Period|OTHER REASONS|0|||
161886309|NCT04908202|584626751|FG002|Active Treatment Period|OTHER REASONS|1|||
161886310|NCT04908202|584626752|FG003|Active Treatment Period|OTHER REASONS|3|||
161886311|NCT04908202|584626749|FG000|Active Treatment Period|Lack of Efficacy|0|||
161886312|NCT04908202|584626750|FG001|Active Treatment Period|Lack of Efficacy|0|||
161886313|NCT04908202|584626751|FG002|Active Treatment Period|Lack of Efficacy|4|||
161886314|NCT04908202|584626752|FG003|Active Treatment Period|Lack of Efficacy|5|||
161886315|NCT04908202|584626749|FG000|Active Treatment Period|Adverse Event|0|||
161886316|NCT04908202|584626750|FG001|Active Treatment Period|Adverse Event|0|||
161886317|NCT04908202|584626751|FG002|Active Treatment Period|Adverse Event|5|||
161886318|NCT04908202|584626752|FG003|Active Treatment Period|Adverse Event|8|||
161886319|NCT04908202|584626749|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161886320|NCT04908202|584626750|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161886321|NCT04908202|584626751|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
161886322|NCT04908202|584626752|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
161886323|NCT04908202|584626749|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161886324|NCT04908202|584626750|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161886325|NCT04908202|584626751|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
161886326|NCT04908202|584626752|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
161886327|NCT04908202|584626749|FG000|Active Treatment Period|Lost to Follow-up|0|||
161886328|NCT04908202|584626750|FG001|Active Treatment Period|Lost to Follow-up|0|||
161886329|NCT04908202|584626751|FG002|Active Treatment Period|Lost to Follow-up|2|||
161886330|NCT04908202|584626752|FG003|Active Treatment Period|Lost to Follow-up|2|||
161886331|NCT04908202|584626749|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
161886332|NCT04908202|584626750|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
161886333|NCT04908202|584626751|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
161886334|NCT04908202|584626752|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
161886335|NCT04908202|584626749|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161886336|NCT04908202|584626750|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161886337|NCT04908202|584626751|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
161886338|NCT04908202|584626752|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
161886339|NCT04908202|584626749|FG000|Active Treatment Period|ONGOING Treatment|0|||
161886340|NCT04908202|584626750|FG001|Active Treatment Period|ONGOING Treatment|0|||
161886341|NCT04908202|584626751|FG002|Active Treatment Period|ONGOING Treatment|117|||
161886342|NCT04908202|584626752|FG003|Active Treatment Period|ONGOING Treatment|114|||
161886343|NCT04506905|584626755|FG000|Overall Study|Lost to Follow-up|1|||
161886344|NCT04506905|584626756|FG001|Overall Study|Lost to Follow-up|0|||
161886345|NCT04506905|584626757|FG002|Overall Study|Lost to Follow-up|0|||
161886346|NCT04506905|584626758|FG003|Overall Study|Lost to Follow-up|1|||
161992065|NCT00687804|585019825|FG001|Core Study|Protocol Violation|1|||
161992066|NCT00687804|585019826|FG002|Core Study|Protocol Violation|0|||
161992067|NCT00687804|585019824|FG000|Open-Label Extension Study|Adverse Event|2|||
161992068|NCT00687804|585019825|FG001|Open-Label Extension Study|Adverse Event|2|||
161992069|NCT00687804|585019826|FG002|Open-Label Extension Study|Adverse Event|2|||
161992070|NCT00687804|585019824|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
161992071|NCT00687804|585019825|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
161992072|NCT00687804|585019826|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
161992073|NCT00687804|585019824|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
161992074|NCT00687804|585019825|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
161992075|NCT00687804|585019826|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
161992076|NCT00687804|585019824|FG000|Open-Label Extension Study|Administrative problems|1|||
161992077|NCT00687804|585019825|FG001|Open-Label Extension Study|Administrative problems|1|||
161992078|NCT00687804|585019826|FG002|Open-Label Extension Study|Administrative problems|0|||
161992079|NCT00687804|585019824|FG000|Open-Label Extension Study|Death|2|||
161992080|NCT00687804|585019825|FG001|Open-Label Extension Study|Death|3|||
161886347|NCT04506905|584626759|FG004|Overall Study|Lost to Follow-up|0|||
161886348|NCT04506905|584626760|FG005|Overall Study|Lost to Follow-up|0|||
161886349|NCT04506905|584626761|FG006|Overall Study|Lost to Follow-up|0|||
162035997|NCT03034200|585188868|FG001|Overall Study|Disease progression|10|||
162035998|NCT03034200|585188869|FG002|Overall Study|Disease progression|4|||
162035999|NCT03034200|585188867|FG000|Overall Study|Physician Decision|2|||
162036000|NCT03034200|585188868|FG001|Overall Study|Physician Decision|0|||
162036001|NCT03034200|585188869|FG002|Overall Study|Physician Decision|3|||
162036002|NCT03034200|585188867|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
162036003|NCT03034200|585188868|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
162036004|NCT03034200|585188869|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
162036005|NCT03034200|585188867|FG000|Overall Study|Adjuvant Therapy|0|||
162036006|NCT03034200|585188868|FG001|Overall Study|Adjuvant Therapy|0|||
162036007|NCT03034200|585188869|FG002|Overall Study|Adjuvant Therapy|1|||
162036008|NCT00510874|585188870|FG000|Overall Study|Withdrawal by Subject|1|||
162036009|NCT00510874|585188871|FG001|Overall Study|Withdrawal by Subject|1|||
162036010|NCT00510874|585188872|FG002|Overall Study|Withdrawal by Subject|0|||
162036011|NCT00510874|585188873|FG003|Overall Study|Withdrawal by Subject|0|||
162036012|NCT00510874|585188874|FG004|Overall Study|Withdrawal by Subject|3|||
162036013|NCT00510874|585188875|FG005|Overall Study|Withdrawal by Subject|0|||
162036014|NCT00510874|585188876|FG006|Overall Study|Withdrawal by Subject|0|||
162036015|NCT00510874|585188870|FG000|Overall Study|Lost to Follow-up|2|||
162036016|NCT00510874|585188871|FG001|Overall Study|Lost to Follow-up|3|||
162036017|NCT00510874|585188872|FG002|Overall Study|Lost to Follow-up|1|||
162036018|NCT00510874|585188873|FG003|Overall Study|Lost to Follow-up|3|||
162036019|NCT00510874|585188874|FG004|Overall Study|Lost to Follow-up|4|||
162036020|NCT00510874|585188875|FG005|Overall Study|Lost to Follow-up|0|||
162036021|NCT00510874|585188876|FG006|Overall Study|Lost to Follow-up|1|||
162036022|NCT00636987|585188877|FG000|Overall Study|Death|44|||
162036023|NCT00636987|585188877|FG000|Overall Study|Explanted|13|||
162036024|NCT00636987|585188877|FG000|Overall Study|Lost to Follow-up|63|||
162036025|NCT00636987|585188877|FG000|Overall Study|5 year visit window not complete|69|||
162036026|NCT01251146|585188878|FG000|Overall Study|Lost to Follow-up|3|||
162036027|NCT01251146|585188879|FG001|Overall Study|Lost to Follow-up|10|||
162036028|NCT00053365|585188881|FG000|Overall Study|Incorrect cell type|1|||
162036029|NCT00053365|585188881|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
162036030|NCT00053365|585188881|FG000|Overall Study|Never treated|4|||
162036031|NCT00737464|585188890|FG000|Overall Study|Adverse Event|1|||
162036032|NCT00737464|585188890|FG000|Overall Study|Death|6|||
162036033|NCT00737464|585188890|FG000|Overall Study|Other - Failure to Return|1|||
162036034|NCT00737464|585188890|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
162036035|NCT00737464|585188890|FG000|Overall Study|Other reasons|4|||
162036036|NCT02423109|585188894|FG000|Lens 1|Adverse Event|1|||
162036037|NCT02423109|585188895|FG001|Lens 1|Adverse Event|0|||
162036038|NCT03347188|585188896|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
162036039|NCT03347188|585188897|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
162036040|NCT03347188|585188896|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
162036041|NCT03347188|585188897|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
162036042|NCT03347188|585188896|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
162036043|NCT03347188|585188897|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
162036044|NCT03347188|585188896|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
162036045|NCT03347188|585188897|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
162036046|NCT03347188|585188896|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
162036047|NCT03347188|585188897|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
162036048|NCT03347188|585188896|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
161886350|NCT04506905|584626762|FG007|Overall Study|Lost to Follow-up|0|||
161886351|NCT04506905|584626763|FG008|Overall Study|Lost to Follow-up|0|||
161886352|NCT04506905|584626755|FG000|Overall Study|Withdrawal by Subject|0|||
162036049|NCT03347188|585188897|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
162036050|NCT03347188|585188896|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
162036051|NCT03347188|585188897|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
162036052|NCT03347188|585188896|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
162036053|NCT03347188|585188897|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
162036054|NCT03868124|585188898|FG000|Overall Study|Withdrawal by Subject|4|||
162036055|NCT03868124|585188899|FG001|Overall Study|Withdrawal by Subject|0|||
161886353|NCT04506905|584626756|FG001|Overall Study|Withdrawal by Subject|0|||
161886354|NCT04506905|584626757|FG002|Overall Study|Withdrawal by Subject|0|||
161886355|NCT04506905|584626758|FG003|Overall Study|Withdrawal by Subject|2|||
162036056|NCT03868124|585188900|FG002|Overall Study|Withdrawal by Subject|1|||
162036057|NCT03868124|585188898|FG000|Overall Study|Physician Decision|1|||
162036058|NCT03868124|585188899|FG001|Overall Study|Physician Decision|0|||
162036059|NCT03868124|585188900|FG002|Overall Study|Physician Decision|1|||
162036060|NCT03868124|585188898|FG000|Overall Study|Lost to Follow-up|1|||
162036061|NCT03868124|585188899|FG001|Overall Study|Lost to Follow-up|1|||
162036062|NCT03868124|585188900|FG002|Overall Study|Lost to Follow-up|2|||
162036063|NCT03868124|585188898|FG000|Overall Study|Death|1|||
162036064|NCT03868124|585188899|FG001|Overall Study|Death|1|||
162036065|NCT03868124|585188900|FG002|Overall Study|Death|2|||
161992081|NCT00687804|585019826|FG002|Open-Label Extension Study|Death|3|||
161992082|NCT02221674|585019827|FG000|Overall Study|Lost to Follow-up|1|||
161992083|NCT02221674|585019828|FG001|Overall Study|Lost to Follow-up|0|||
161992084|NCT02221674|585019829|FG002|Overall Study|Lost to Follow-up|0|||
161992085|NCT05292131|585019830|FG000|Overall Study|Lost to Follow-up|1|||
161992086|NCT05292131|585019831|FG001|Overall Study|Lost to Follow-up|1|||
161992087|NCT05292131|585019830|FG000|Overall Study|Withdrawal by Subject|0|||
161992088|NCT05292131|585019831|FG001|Overall Study|Withdrawal by Subject|1|||
161992089|NCT02557542|585019832|FG000|Overall Study|Poor recruitment|3|||
161992090|NCT02557542|585019833|FG001|Overall Study|Poor recruitment|0|||
161992091|NCT04390880|585019834|FG000|Overall Study|Withdrawal by Subject|1|||
161992092|NCT00195091|585019835|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
161992093|NCT01345188|585019836|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
161992094|NCT01345188|585019836|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
161992095|NCT00475709|585019840|FG000|Overall Study|Did not meet eligibility criteria|8|||
161992096|NCT00475709|585019840|FG000|Overall Study|Death|41|||
161992097|NCT00475709|585019840|FG000|Overall Study|Device Explant|6|||
161992098|NCT00475709|585019840|FG000|Overall Study|Lost to Follow-up|21|||
161992099|NCT04752358|585019841|FG000|Overall Study|Death|2|||
161992100|NCT04752358|585019842|FG001|Overall Study|Death|1|||
161992101|NCT00555672|585019845|FG000|Overall Study|Death|0|||
161992102|NCT00555672|585019846|FG001|Overall Study|Death|2|||
161992103|NCT00555672|585019845|FG000|Overall Study|Adverse Event|8|||
161992104|NCT00555672|585019846|FG001|Overall Study|Adverse Event|2|||
161992105|NCT00555672|585019845|FG000|Overall Study|Objective progression or relapse|11|||
161992106|NCT00555672|585019846|FG001|Overall Study|Objective progression or relapse|5|||
161992107|NCT00555672|585019845|FG000|Overall Study|Other|3|||
161992108|NCT00555672|585019846|FG001|Overall Study|Other|1|||
161992109|NCT00555672|585019845|FG000|Overall Study|Participant refused|2|||
161992110|NCT00555672|585019846|FG001|Overall Study|Participant refused|0|||
161992111|NCT04526145|585019847|FG000|Overall Study|Withdrawal by Subject|5|||
161992112|NCT05236257|585019850|FG000|Overall Study|Ongoing with study treatment|29|||
161992113|NCT05236257|585019851|FG001|Overall Study|Ongoing with study treatment|1|||
161992114|NCT05236257|585019850|FG000|Overall Study|Discontinued study treatment|22|||
161992115|NCT05236257|585019851|FG001|Overall Study|Discontinued study treatment|41|||
161992116|NCT05870865|585019852|FG000|Randomized|Did not receive study treatment|2|||
161992117|NCT05870865|585019853|FG001|Randomized|Did not receive study treatment|4|||
161992118|NCT05870865|585019854|FG002|Randomized|Did not receive study treatment|4|||
161992119|NCT05870865|585019855|FG003|Randomized|Did not receive study treatment|3|||
161992120|NCT05870865|585019852|FG000|Treatment Period|Adverse Event|1|||
161992121|NCT05870865|585019853|FG001|Treatment Period|Adverse Event|1|||
161992122|NCT05870865|585019854|FG002|Treatment Period|Adverse Event|1|||
161992123|NCT05870865|585019855|FG003|Treatment Period|Adverse Event|1|||
161992124|NCT05870865|585019852|FG000|Treatment Period|Lost to Follow-up|0|||
161992125|NCT05870865|585019853|FG001|Treatment Period|Lost to Follow-up|1|||
161992126|NCT05870865|585019854|FG002|Treatment Period|Lost to Follow-up|2|||
161992127|NCT05870865|585019855|FG003|Treatment Period|Lost to Follow-up|0|||
161992128|NCT05870865|585019852|FG000|Treatment Period|Protocol Violation|0|||
161992129|NCT05870865|585019853|FG001|Treatment Period|Protocol Violation|0|||
161992130|NCT05870865|585019854|FG002|Treatment Period|Protocol Violation|0|||
161992131|NCT05870865|585019855|FG003|Treatment Period|Protocol Violation|1|||
161992132|NCT05870865|585019852|FG000|Treatment Period|Withdrawal by Subject|0|||
161992133|NCT05870865|585019853|FG001|Treatment Period|Withdrawal by Subject|1|||
161992134|NCT05870865|585019854|FG002|Treatment Period|Withdrawal by Subject|1|||
161992135|NCT05870865|585019855|FG003|Treatment Period|Withdrawal by Subject|1|||
161992136|NCT03828019|585019858|FG000|Overall Study|Withdrawal by Subject|3|||
161992137|NCT03828019|585019859|FG001|Overall Study|Withdrawal by Subject|8|||
161992138|NCT03828019|585019858|FG000|Overall Study|Lost to Follow-up|1|||
161992139|NCT03828019|585019859|FG001|Overall Study|Lost to Follow-up|6|||
161992140|NCT03828019|585019858|FG000|Overall Study|Incarcerated|1|||
161992141|NCT03828019|585019859|FG001|Overall Study|Incarcerated|0|||
161992142|NCT03828019|585019858|FG000|Overall Study|Adverse Event|0|||
161992143|NCT03828019|585019859|FG001|Overall Study|Adverse Event|1|||
161992144|NCT02305238|585019861|FG000|Overall Study|Death|2|||
161992145|NCT02305238|585019862|FG001|Overall Study|Death|1|||
161992146|NCT02305238|585019863|FG002|Overall Study|Death|0|||
161992147|NCT02305238|585019861|FG000|Overall Study|Progressive disease|4|||
161992148|NCT02305238|585019862|FG001|Overall Study|Progressive disease|4|||
161992149|NCT02305238|585019863|FG002|Overall Study|Progressive disease|0|||
161992150|NCT02305238|585019861|FG000|Overall Study|Logistical difficulties|1|||
161992151|NCT02305238|585019862|FG001|Overall Study|Logistical difficulties|3|||
161992152|NCT02305238|585019863|FG002|Overall Study|Logistical difficulties|0|||
161992153|NCT02305238|585019861|FG000|Overall Study|Protocol Violation|0|||
161992154|NCT02305238|585019862|FG001|Overall Study|Protocol Violation|3|||
161992155|NCT02305238|585019863|FG002|Overall Study|Protocol Violation|0|||
162036066|NCT03868124|585188898|FG000|Overall Study|Adverse Event|0|||
162036067|NCT03868124|585188899|FG001|Overall Study|Adverse Event|0|||
162036068|NCT03868124|585188900|FG002|Overall Study|Adverse Event|3|||
162036069|NCT03868124|585188898|FG000|Overall Study|Explanted|2|||
162036070|NCT03868124|585188899|FG001|Overall Study|Explanted|1|||
162036071|NCT03868124|585188900|FG002|Overall Study|Explanted|0|||
162036072|NCT03868124|585188898|FG000|Overall Study|Ongoing in study|176|||
162036073|NCT03868124|585188899|FG001|Overall Study|Ongoing in study|180|||
162036074|NCT03868124|585188900|FG002|Overall Study|Ongoing in study|183|||
162036075|NCT04177355|585188901|FG000|Overall Study|Lost to Follow-up|0|||
162036076|NCT04177355|585188902|FG001|Overall Study|Lost to Follow-up|2|||
162036077|NCT04177355|585188903|FG002|Overall Study|Lost to Follow-up|0|||
162036078|NCT04177355|585188904|FG003|Overall Study|Lost to Follow-up|1|||
162036079|NCT04177355|585188905|FG004|Overall Study|Lost to Follow-up|2|||
162036080|NCT04177355|585188906|FG005|Overall Study|Lost to Follow-up|0|||
162036081|NCT04177355|585188907|FG006|Overall Study|Lost to Follow-up|1|||
162036082|NCT04177355|585188908|FG007|Overall Study|Lost to Follow-up|0|||
162036083|NCT04177355|585188909|FG008|Overall Study|Lost to Follow-up|0|||
162036084|NCT04177355|585188910|FG009|Overall Study|Lost to Follow-up|0|||
162036085|NCT04177355|585188911|FG010|Overall Study|Lost to Follow-up|0|||
162036086|NCT04177355|585188901|FG000|Overall Study|Withdrawal by Subject|0|||
162036087|NCT04177355|585188902|FG001|Overall Study|Withdrawal by Subject|0|||
162036088|NCT04177355|585188903|FG002|Overall Study|Withdrawal by Subject|0|||
162036089|NCT04177355|585188904|FG003|Overall Study|Withdrawal by Subject|1|||
162036090|NCT04177355|585188905|FG004|Overall Study|Withdrawal by Subject|1|||
162036091|NCT04177355|585188906|FG005|Overall Study|Withdrawal by Subject|0|||
162036092|NCT04177355|585188907|FG006|Overall Study|Withdrawal by Subject|0|||
162036093|NCT04177355|585188908|FG007|Overall Study|Withdrawal by Subject|0|||
162036094|NCT04177355|585188909|FG008|Overall Study|Withdrawal by Subject|1|||
162036095|NCT04177355|585188910|FG009|Overall Study|Withdrawal by Subject|0|||
162036096|NCT04177355|585188911|FG010|Overall Study|Withdrawal by Subject|0|||
162036097|NCT02742246|585188912|FG000|Overall Study|Never initiated treatment|5|||
162036098|NCT02742246|585188913|FG001|Overall Study|Never initiated treatment|3|||
162036099|NCT02742246|585188914|FG002|Overall Study|Never initiated treatment|1|||
162036100|NCT02742246|585188912|FG000|Overall Study|dropped out during treatment|7|||
162036101|NCT02742246|585188913|FG001|Overall Study|dropped out during treatment|13|||
162036102|NCT02742246|585188914|FG002|Overall Study|dropped out during treatment|10|||
162036103|NCT02742246|585188912|FG000|Overall Study|Death|1|||
162036104|NCT02742246|585188913|FG001|Overall Study|Death|0|||
162036105|NCT02742246|585188914|FG002|Overall Study|Death|0|||
162036106|NCT03489551|585188915|FG000|Overall Study|Withdrawal by Subject|2|||
162036107|NCT00054717|585188916|FG000|Overall Study|Randomized but not treated|2|||
162036108|NCT00054717|585188917|FG001|Overall Study|Randomized but not treated|8|||
162036109|NCT00054717|585188916|FG000|Overall Study|Adverse Event|70|||
162036110|NCT00054717|585188917|FG001|Overall Study|Adverse Event|22|||
162036111|NCT00054717|585188916|FG000|Overall Study|Protocol Violation|18|||
162036112|NCT00054717|585188917|FG001|Overall Study|Protocol Violation|19|||
162036113|NCT00054717|585188916|FG000|Overall Study|Lost to Follow-up|23|||
162036114|NCT00054717|585188917|FG001|Overall Study|Lost to Follow-up|13|||
162036115|NCT00054717|585188916|FG000|Overall Study|Withdrawal by Subject|32|||
162036116|NCT00054717|585188917|FG001|Overall Study|Withdrawal by Subject|20|||
162036117|NCT00054717|585188916|FG000|Overall Study|Other reason not defined above|117|||
162036118|NCT00054717|585188917|FG001|Overall Study|Other reason not defined above|217|||
162036119|NCT03139604|585188918|FG000|Overall Study|Other|7|||
162036120|NCT03139604|585188919|FG001|Overall Study|Other|3|||
162036121|NCT03139604|585188918|FG000|Overall Study|Withdrawal by Subject|16|||
161886356|NCT04506905|584626759|FG004|Overall Study|Withdrawal by Subject|0|||
161886357|NCT04506905|584626760|FG005|Overall Study|Withdrawal by Subject|0|||
162036122|NCT03139604|585188919|FG001|Overall Study|Withdrawal by Subject|17|||
162036123|NCT03139604|585188918|FG000|Overall Study|Physician Decision|1|||
161886358|NCT04506905|584626761|FG006|Overall Study|Withdrawal by Subject|0|||
161886359|NCT04506905|584626762|FG007|Overall Study|Withdrawal by Subject|0|||
161886360|NCT04506905|584626763|FG008|Overall Study|Withdrawal by Subject|0|||
161886361|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
162036124|NCT03139604|585188919|FG001|Overall Study|Physician Decision|2|||
162036125|NCT03139604|585188918|FG000|Overall Study|Lost to Follow-up|3|||
162036126|NCT03139604|585188919|FG001|Overall Study|Lost to Follow-up|1|||
162036127|NCT03139604|585188918|FG000|Overall Study|Death|65|||
162036128|NCT03139604|585188919|FG001|Overall Study|Death|67|||
162036129|NCT03139604|585188918|FG000|Overall Study|Study Terminated by Sponsor|122|||
162036130|NCT03139604|585188919|FG001|Overall Study|Study Terminated by Sponsor|127|||
162036131|NCT03139604|585188918|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
162036132|NCT03139604|585188919|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
162036133|NCT04148911|585188920|FG000|Overall Study|Death|104|||
162036134|NCT04148911|585188920|FG000|Overall Study|Lost to Follow-up|5|||
162036135|NCT04148911|585188920|FG000|Overall Study|Withdrawal by Subject|17|||
162036136|NCT04148911|585188920|FG000|Overall Study|Study Ended by Sponsor|56|||
161992156|NCT02305238|585019861|FG000|Overall Study|Physician Decision|2|||
161992157|NCT02305238|585019862|FG001|Overall Study|Physician Decision|1|||
161992158|NCT02305238|585019863|FG002|Overall Study|Physician Decision|0|||
161992159|NCT02305238|585019861|FG000|Overall Study|Adverse Event|4|||
161992160|NCT02305238|585019862|FG001|Overall Study|Adverse Event|2|||
161992161|NCT02305238|585019863|FG002|Overall Study|Adverse Event|0|||
161992162|NCT02305238|585019861|FG000|Overall Study|Withdrawal by Subject|3|||
161992163|NCT02305238|585019862|FG001|Overall Study|Withdrawal by Subject|4|||
161992164|NCT02305238|585019863|FG002|Overall Study|Withdrawal by Subject|0|||
161992165|NCT02305238|585019861|FG000|Overall Study|Randomized failure|0|||
161992166|NCT02305238|585019862|FG001|Overall Study|Randomized failure|0|||
161992167|NCT02305238|585019863|FG002|Overall Study|Randomized failure|8|||
161992168|NCT02305238|585019861|FG000|Overall Study|Required procedure failed|0|||
161992169|NCT02305238|585019862|FG001|Overall Study|Required procedure failed|1|||
161992170|NCT02305238|585019863|FG002|Overall Study|Required procedure failed|0|||
161992171|NCT04522141|585019866|FG000|Overall Study|Withdrawal by Subject|1|||
161992172|NCT04522141|585019867|FG001|Overall Study|Withdrawal by Subject|0|||
161992173|NCT03052049|585019868|FG000|Overall Study|Withdrawal by Subject|2|||
161992174|NCT03508609|585019869|FG000|Overall Study|Withdrawal by Subject|1|||
161992175|NCT02328027|585019870|FG000|Overall Study|Withdrawal by Subject|0|||
161992176|NCT02328027|585019871|FG001|Overall Study|Withdrawal by Subject|1|||
161992177|NCT03319212|585019872|FG000|Overall Study|Discontinued as moving out of local area|0|||
161992178|NCT03319212|585019873|FG001|Overall Study|Discontinued as moving out of local area|1|||
161992179|NCT03319212|585019872|FG000|Overall Study|Adverse Event|2|||
161992180|NCT03319212|585019873|FG001|Overall Study|Adverse Event|2|||
161992181|NCT03319212|585019872|FG000|Overall Study|Withdrawal by Subject|0|||
161992182|NCT03319212|585019873|FG001|Overall Study|Withdrawal by Subject|1|||
161992183|NCT03319212|585019872|FG000|Overall Study|Lost to Follow-up|0|||
161992184|NCT03319212|585019873|FG001|Overall Study|Lost to Follow-up|1|||
161992185|NCT03319212|585019872|FG000|Overall Study|Physician Decision|1|||
161992186|NCT03319212|585019873|FG001|Overall Study|Physician Decision|0|||
161992187|NCT01868477|585019874|FG000|Overall Study|Adverse Event|2|||
161992188|NCT01868477|585019875|FG001|Overall Study|Adverse Event|4|||
161992189|NCT01868477|585019874|FG000|Overall Study|Disease progression|1|||
161992190|NCT01868477|585019875|FG001|Overall Study|Disease progression|1|||
161992191|NCT01868477|585019874|FG000|Overall Study|Withdrawal by Subject|1|||
161992192|NCT01868477|585019875|FG001|Overall Study|Withdrawal by Subject|0|||
161992193|NCT02465203|585019876|FG000|Overall Study|Protocol Violation|1|||
161992194|NCT02465203|585019877|FG001|Overall Study|Protocol Violation|1|||
161992195|NCT02465203|585019878|FG002|Overall Study|Protocol Violation|1|||
161992196|NCT02465203|585019876|FG000|Overall Study|Study terminated by sponsor|50|||
161992197|NCT02465203|585019877|FG001|Overall Study|Study terminated by sponsor|34|||
161992198|NCT02465203|585019878|FG002|Overall Study|Study terminated by sponsor|11|||
161992199|NCT02465203|585019876|FG000|Overall Study|New therapy for study indication|4|||
161992200|NCT02465203|585019877|FG001|Overall Study|New therapy for study indication|0|||
161992201|NCT02465203|585019878|FG002|Overall Study|New therapy for study indication|0|||
161992202|NCT02465203|585019876|FG000|Overall Study|Patient/guardian decision|1|||
161992203|NCT02465203|585019877|FG001|Overall Study|Patient/guardian decision|1|||
161992204|NCT02465203|585019878|FG002|Overall Study|Patient/guardian decision|1|||
161992205|NCT04072887|585019883|FG000|Overall Study|Withdrawal by Subject|3|||
161992206|NCT04072887|585019884|FG001|Overall Study|Withdrawal by Subject|8|||
161992207|NCT04072887|585019885|FG002|Overall Study|Withdrawal by Subject|1|||
161992208|NCT04072887|585019886|FG003|Overall Study|Withdrawal by Subject|3|||
161992209|NCT04072887|585019887|FG004|Overall Study|Withdrawal by Subject|3|||
161992210|NCT04072887|585019888|FG005|Overall Study|Withdrawal by Subject|13|||
162036137|NCT00470184|585188925|FG000|Overall Study|Not Treated(became ineligible)|4|||
161886362|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
161886363|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
161886364|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
161886365|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
161886366|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
161886367|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
161886368|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
161886369|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
161992211|NCT04072887|585019883|FG000|Overall Study|Adverse Event|2|||
161992212|NCT04072887|585019884|FG001|Overall Study|Adverse Event|4|||
161992213|NCT04072887|585019885|FG002|Overall Study|Adverse Event|1|||
161992214|NCT04072887|585019886|FG003|Overall Study|Adverse Event|4|||
161992215|NCT04072887|585019887|FG004|Overall Study|Adverse Event|0|||
161992216|NCT04072887|585019888|FG005|Overall Study|Adverse Event|1|||
161992217|NCT04072887|585019883|FG000|Overall Study|Physician Decision|2|||
161992218|NCT04072887|585019884|FG001|Overall Study|Physician Decision|0|||
161992219|NCT04072887|585019885|FG002|Overall Study|Physician Decision|0|||
161992220|NCT04072887|585019886|FG003|Overall Study|Physician Decision|0|||
161992221|NCT04072887|585019887|FG004|Overall Study|Physician Decision|0|||
161992222|NCT04072887|585019888|FG005|Overall Study|Physician Decision|1|||
162036138|NCT00470184|585188925|FG000|Overall Study|Not treated (other)|1|||
162036139|NCT00470184|585188925|FG000|Overall Study|disease Progression|4|||
162036140|NCT00470184|585188925|FG000|Overall Study|Adverse Event|3|||
162036141|NCT00470184|585188925|FG000|Overall Study|Withdrawal by Subject|4|||
162036142|NCT00470184|585188925|FG000|Overall Study|other|5|||
162036143|NCT00470184|585188925|FG000|Overall Study|recurrence|1|||
162036144|NCT01606254|585188928|FG000|Overall Study|Withdrawal by Subject|1|||
162036145|NCT01606254|585188929|FG001|Overall Study|Withdrawal by Subject|3|||
162036146|NCT01606254|585188930|FG002|Overall Study|Withdrawal by Subject|0|||
162036147|NCT01606254|585188931|FG003|Overall Study|Withdrawal by Subject|2|||
162036148|NCT01606254|585188928|FG000|Overall Study|Adverse Event|1|||
162036149|NCT01606254|585188929|FG001|Overall Study|Adverse Event|1|||
162036150|NCT01606254|585188930|FG002|Overall Study|Adverse Event|0|||
162036151|NCT01606254|585188931|FG003|Overall Study|Adverse Event|1|||
162036152|NCT04543409|585188932|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162036153|NCT04543409|585188933|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
162036154|NCT04543409|585188932|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
162036155|NCT04543409|585188933|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
162036156|NCT04543409|585188932|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
162036157|NCT04543409|585188933|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
162036158|NCT04543409|585188932|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
162036159|NCT04543409|585188933|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
162036160|NCT04543409|585188932|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
162036161|NCT04543409|585188933|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
162036162|NCT04543409|585188932|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
162036163|NCT04543409|585188933|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
162036164|NCT04543409|585188932|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
162036165|NCT04543409|585188933|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
162036166|NCT04543409|585188932|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
162036167|NCT04543409|585188933|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
162036168|NCT04543409|585188932|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
162036169|NCT04543409|585188933|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
162036170|NCT04543409|585188932|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
162036171|NCT04543409|585188933|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
162036172|NCT04543409|585188932|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
162036173|NCT04543409|585188933|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
162036174|NCT01052844|585188934|FG000|Overall Study|Adverse Event|0|||
162036175|NCT01052844|585188935|FG001|Overall Study|Adverse Event|1|||
162036176|NCT02093026|585188936|FG000|Overall Study|Adverse Event|26|||
162036177|NCT02093026|585188936|FG000|Overall Study|Death|10|||
162036178|NCT02093026|585188936|FG000|Overall Study|Other|157|||
162036179|NCT02195011|585188946|FG000|Overall Study|Adverse Event|4|||
162036180|NCT02195011|585188947|FG001|Overall Study|Adverse Event|0|||
162036181|NCT02195011|585188946|FG000|Overall Study|Progressive Disease|18|||
162036182|NCT02195011|585188947|FG001|Overall Study|Progressive Disease|1|||
162036183|NCT02195011|585188946|FG000|Overall Study|Withdrawal by Subject|3|||
162036184|NCT02195011|585188947|FG001|Overall Study|Withdrawal by Subject|0|||
162036185|NCT01466595|585188948|FG000|Overall Study|Withdrawal by Subject|0|||
162036186|NCT01466595|585188949|FG001|Overall Study|Withdrawal by Subject|1|||
162036187|NCT00450112|585188952|FG000|Overall Study|Other Treatment Required|5|||
162036188|NCT00450112|585188953|FG001|Overall Study|Other Treatment Required|1|||
162036189|NCT00450112|585188952|FG000|Overall Study|Withdrawal by Subject|4|||
162036190|NCT00450112|585188953|FG001|Overall Study|Withdrawal by Subject|1|||
162036191|NCT00450112|585188952|FG000|Overall Study|Lost to Follow-up|2|||
162036192|NCT00450112|585188953|FG001|Overall Study|Lost to Follow-up|1|||
162036193|NCT00450112|585188952|FG000|Overall Study|Others|2|||
162036194|NCT00450112|585188953|FG001|Overall Study|Others|3|||
162036195|NCT03418571|585188954|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
162036196|NCT03418571|585188955|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
162036197|NCT00559754|585188956|FG000|Overall Study|Disease progression|1|||
162036198|NCT00559754|585188956|FG000|Overall Study|Adverse Event|5|||
162036199|NCT00559754|585188956|FG000|Overall Study|Protocol Violation|1|||
162036200|NCT00559754|585188956|FG000|Overall Study|Investigator criteria|2|||
162036201|NCT00559754|585188956|FG000|Overall Study|Withdrawal by Subject|2|||
162036202|NCT00586326|585188957|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
162036203|NCT00586326|585188957|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
162036204|NCT00586326|585188957|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
162036205|NCT00586326|585188957|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
162036206|NCT00586326|585188957|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
162036207|NCT00586326|585188957|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
162036208|NCT00586326|585188957|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
162036209|NCT00586326|585188957|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
161886370|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
161886371|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
161886372|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
161886373|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
161886374|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
161886375|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
161886376|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
161886377|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
161886378|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
161886379|NCT02294461|584626764|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
161886380|NCT02294461|584626765|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
161886381|NCT02294461|584626766|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
161886382|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
161886383|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
161886384|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
161886385|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
161886386|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
161886387|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
161886388|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
161886389|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
161886390|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
161886391|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
161886392|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
161886393|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
161886394|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
161886395|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
161886396|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
161886397|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
161886398|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
161886399|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
161886400|NCT02294461|584626764|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
161886401|NCT02294461|584626765|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
161886402|NCT02294461|584626766|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
161886403|NCT03800836|584626767|FG000|Overall Study|Other|2|||
161886404|NCT03800836|584626768|FG001|Overall Study|Other|1|||
161886405|NCT03800836|584626769|FG002|Overall Study|Other|0|||
161886406|NCT03800836|584626770|FG003|Overall Study|Other|2|||
161886407|NCT03800836|584626771|FG004|Overall Study|Other|0|||
161886408|NCT03800836|584626772|FG005|Overall Study|Other|1|||
161886409|NCT03800836|584626767|FG000|Overall Study|Lost to Follow-up|2|||
161886410|NCT03800836|584626768|FG001|Overall Study|Lost to Follow-up|0|||
161886411|NCT03800836|584626769|FG002|Overall Study|Lost to Follow-up|1|||
161886412|NCT03800836|584626770|FG003|Overall Study|Lost to Follow-up|1|||
161886413|NCT03800836|584626771|FG004|Overall Study|Lost to Follow-up|3|||
161886414|NCT03800836|584626772|FG005|Overall Study|Lost to Follow-up|0|||
161886415|NCT03800836|584626767|FG000|Overall Study|Withdrawal by Subject|1|||
161886416|NCT03800836|584626768|FG001|Overall Study|Withdrawal by Subject|0|||
161886417|NCT03800836|584626769|FG002|Overall Study|Withdrawal by Subject|0|||
161886418|NCT03800836|584626770|FG003|Overall Study|Withdrawal by Subject|0|||
161886419|NCT03800836|584626771|FG004|Overall Study|Withdrawal by Subject|0|||
161886420|NCT03800836|584626772|FG005|Overall Study|Withdrawal by Subject|0|||
161886421|NCT03800836|584626767|FG000|Overall Study|Physician Decision|31|||
161886422|NCT03800836|584626768|FG001|Overall Study|Physician Decision|3|||
161886423|NCT03800836|584626769|FG002|Overall Study|Physician Decision|6|||
161886424|NCT03800836|584626770|FG003|Overall Study|Physician Decision|4|||
161886425|NCT03800836|584626771|FG004|Overall Study|Physician Decision|4|||
161886426|NCT03800836|584626772|FG005|Overall Study|Physician Decision|5|||
161886427|NCT03800836|584626767|FG000|Overall Study|Death|34|||
161886428|NCT03800836|584626768|FG001|Overall Study|Death|16|||
161886429|NCT03800836|584626769|FG002|Overall Study|Death|5|||
161886430|NCT03800836|584626770|FG003|Overall Study|Death|5|||
161886431|NCT03800836|584626771|FG004|Overall Study|Death|10|||
161886432|NCT03800836|584626772|FG005|Overall Study|Death|0|||
161886433|NCT03800836|584626767|FG000|Overall Study|Symptomatic Deterioration|1|||
161886434|NCT03800836|584626768|FG001|Overall Study|Symptomatic Deterioration|0|||
161886435|NCT03800836|584626769|FG002|Overall Study|Symptomatic Deterioration|1|||
161886436|NCT03800836|584626770|FG003|Overall Study|Symptomatic Deterioration|0|||
161886437|NCT03800836|584626771|FG004|Overall Study|Symptomatic Deterioration|0|||
161886438|NCT03800836|584626772|FG005|Overall Study|Symptomatic Deterioration|0|||
161886439|NCT02864316|584628185|FG000|Overall Study|Progressive Disease|2|||
161886440|NCT02864316|584628186|FG001|Overall Study|Progressive Disease|1|||
161886441|NCT02864316|584628185|FG000|Overall Study|Adverse Event|0|||
161886442|NCT02864316|584628186|FG001|Overall Study|Adverse Event|1|||
162036210|NCT00586326|585188957|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
162036211|NCT00586326|585188957|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
162036212|NCT00586326|585188957|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
162036213|NCT00586326|585188957|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
162036214|NCT00586326|585188957|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
162036215|NCT00586326|585188957|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
162036216|NCT00586326|585188957|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
162036217|NCT00586326|585188957|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
162036218|NCT00586326|585188957|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
162036219|NCT01439347|585188958|FG000|Overall Study|Death|10|||
162036220|NCT01439347|585188959|FG001|Overall Study|Death|9|||
162036221|NCT01439347|585188958|FG000|Overall Study|Withdrawal by Subject|0|||
162036222|NCT01439347|585188959|FG001|Overall Study|Withdrawal by Subject|1|||
162036223|NCT01439347|585188958|FG000|Overall Study|Physician Decision|1|||
162036224|NCT01439347|585188959|FG001|Overall Study|Physician Decision|0|||
162036225|NCT01439347|585188958|FG000|Overall Study|Sponsor Terminated Study|2|||
162036226|NCT01439347|585188959|FG001|Overall Study|Sponsor Terminated Study|3|||
162036227|NCT03595774|585188960|FG000|Overall Study|Adverse Event|1|||
162036228|NCT03595774|585188961|FG001|Overall Study|Adverse Event|0|||
162036229|NCT03595774|585188962|FG002|Overall Study|Adverse Event|1|||
162036230|NCT03595774|585188963|FG003|Overall Study|Adverse Event|0|||
162036231|NCT03595774|585188960|FG000|Overall Study|screen failure|0|||
162036232|NCT03595774|585188961|FG001|Overall Study|screen failure|1|||
162036233|NCT03595774|585188962|FG002|Overall Study|screen failure|0|||
162036234|NCT03595774|585188963|FG003|Overall Study|screen failure|1|||
162036235|NCT03519386|585188968|FG000|Overall Study|Withdrawal by Subject|4|||
162036236|NCT03519386|585188969|FG001|Overall Study|Withdrawal by Subject|1|||
162036237|NCT03519386|585188970|FG002|Overall Study|Withdrawal by Subject|2|||
162036238|NCT03519386|585188968|FG000|Overall Study|Physician Decision|1|||
162036239|NCT03519386|585188969|FG001|Overall Study|Physician Decision|1|||
162036240|NCT03519386|585188970|FG002|Overall Study|Physician Decision|1|||
162036241|NCT03519386|585188968|FG000|Overall Study|Lost to Follow-up|0|||
162036242|NCT03519386|585188969|FG001|Overall Study|Lost to Follow-up|1|||
162036243|NCT03519386|585188970|FG002|Overall Study|Lost to Follow-up|1|||
162036244|NCT03519386|585188968|FG000|Overall Study|Death|1|||
162036245|NCT03519386|585188969|FG001|Overall Study|Death|0|||
162036246|NCT03519386|585188970|FG002|Overall Study|Death|4|||
162036247|NCT03519386|585188968|FG000|Overall Study|Adverse Event|2|||
162036248|NCT03519386|585188969|FG001|Overall Study|Adverse Event|1|||
162036249|NCT03519386|585188970|FG002|Overall Study|Adverse Event|2|||
162036250|NCT03519386|585188968|FG000|Overall Study|Explanted|2|||
162036251|NCT03519386|585188969|FG001|Overall Study|Explanted|1|||
162036252|NCT03519386|585188970|FG002|Overall Study|Explanted|0|||
162036253|NCT03519386|585188968|FG000|Overall Study|Ongoing in study|190|||
162036254|NCT03519386|585188969|FG001|Overall Study|Ongoing in study|192|||
162036255|NCT03519386|585188970|FG002|Overall Study|Ongoing in study|183|||
162036256|NCT01582854|585188976|FG000|Overall Study|Death|8|||
162036257|NCT01582854|585188977|FG001|Overall Study|Death|5|||
162036258|NCT01582854|585188976|FG000|Overall Study|Adverse Event|2|||
162036259|NCT01582854|585188977|FG001|Overall Study|Adverse Event|3|||
162036260|NCT01582854|585188976|FG000|Overall Study|Withdrawal by Participant|8|||
162036261|NCT01582854|585188977|FG001|Overall Study|Withdrawal by Participant|11|||
162036262|NCT01582854|585188976|FG000|Overall Study|Lost to Follow-up|1|||
162036263|NCT01582854|585188977|FG001|Overall Study|Lost to Follow-up|2|||
162036264|NCT01582854|585188976|FG000|Overall Study|Physician Decision|0|||
162036265|NCT01582854|585188977|FG001|Overall Study|Physician Decision|1|||
162036266|NCT01582854|585188976|FG000|Overall Study|Recurrent Stroke|13|||
162036267|NCT01582854|585188977|FG001|Overall Study|Recurrent Stroke|8|||
162036268|NCT01582854|585188976|FG000|Overall Study|Disallowed Concomitant Medication|3|||
162036269|NCT01582854|585188977|FG001|Overall Study|Disallowed Concomitant Medication|2|||
162036270|NCT01582854|585188976|FG000|Overall Study|Carotid or Neurosurgery|0|||
162036271|NCT01582854|585188977|FG001|Overall Study|Carotid or Neurosurgery|1|||
162036272|NCT01582854|585188976|FG000|Overall Study|General Anaesthesia|0|||
162036273|NCT01582854|585188977|FG001|Overall Study|General Anaesthesia|1|||
162036274|NCT01582854|585188976|FG000|Overall Study|Other Miscellaneous Reason|1|||
162036275|NCT01582854|585188977|FG001|Overall Study|Other Miscellaneous Reason|0|||
162036276|NCT03101267|585188978|FG000|Primary Study Period|Withdrawal by Subject|1|||
162036277|NCT03101267|585188979|FG001|Primary Study Period|Withdrawal by Subject|2|||
162036278|NCT03101267|585188980|FG002|Primary Study Period|Withdrawal by Subject|3|||
162036279|NCT03101267|585188978|FG000|Primary Study Period|Miscellaneous|2|||
162036280|NCT03101267|585188979|FG001|Primary Study Period|Miscellaneous|0|||
162036281|NCT03101267|585188980|FG002|Primary Study Period|Miscellaneous|0|||
162036282|NCT04068896|585188981|FG000|Overall Study|Adverse Event|2|||
162036283|NCT04068896|585188982|FG001|Overall Study|Adverse Event|0|||
162036284|NCT04068896|585188983|FG002|Overall Study|Adverse Event|1|||
162036285|NCT04068896|585188984|FG003|Overall Study|Adverse Event|0|||
162036286|NCT04068896|585188985|FG004|Overall Study|Adverse Event|0|||
162036287|NCT04068896|585188986|FG005|Overall Study|Adverse Event|0|||
161886443|NCT03030118|584628191|FG000|Overall Study|Achieved SLE Diagnosis|11|||
161886444|NCT03030118|584628192|FG001|Overall Study|Achieved SLE Diagnosis|10|||
161886445|NCT03030118|584628191|FG000|Overall Study|Adverse Event|1|||
161886446|NCT03030118|584628192|FG001|Overall Study|Adverse Event|1|||
161886447|NCT03030118|584628191|FG000|Overall Study|Pregnancy|2|||
161886448|NCT03030118|584628192|FG001|Overall Study|Pregnancy|2|||
161886449|NCT03030118|584628191|FG000|Overall Study|Lost to Follow-up|5|||
161886450|NCT03030118|584628192|FG001|Overall Study|Lost to Follow-up|6|||
161886451|NCT03030118|584628191|FG000|Overall Study|Concomitant Medications|1|||
161886452|NCT03030118|584628192|FG001|Overall Study|Concomitant Medications|1|||
161886453|NCT03030118|584628191|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
161886454|NCT03030118|584628192|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
161886455|NCT03030118|584628191|FG000|Overall Study|Other|2|||
161886456|NCT03030118|584628192|FG001|Overall Study|Other|0|||
161886457|NCT03030118|584628191|FG000|Overall Study|Withdrawal by Subject|26|||
161886458|NCT03030118|584628192|FG001|Overall Study|Withdrawal by Subject|21|||
161886459|NCT03030118|584628191|FG000|Overall Study|Protocol Violation|1|||
161886460|NCT03030118|584628192|FG001|Overall Study|Protocol Violation|6|||
161886461|NCT02607280|584628194|FG000|Overall Study|Adverse Event|4|||
161886462|NCT02607280|584628195|FG001|Overall Study|Adverse Event|0|||
161886463|NCT02607280|584628194|FG000|Overall Study|Decrease in CrCl <15|0|||
161886464|NCT02607280|584628195|FG001|Overall Study|Decrease in CrCl <15|1|||
161886465|NCT01447446|584628196|FG000|Overall Study|Death|6|||
161886466|NCT01447446|584628197|FG001|Overall Study|Death|3|||
161886467|NCT01447446|584628198|FG002|Overall Study|Death|2|||
161886468|NCT01447446|584628199|FG003|Overall Study|Death|1|||
161886469|NCT01447446|584628200|FG004|Overall Study|Death|7|||
161886470|NCT01447446|584628201|FG005|Overall Study|Death|0|||
161886471|NCT01447446|584628196|FG000|Overall Study|Adverse Event|3|||
161886472|NCT01447446|584628197|FG001|Overall Study|Adverse Event|0|||
161886473|NCT01447446|584628198|FG002|Overall Study|Adverse Event|1|||
161886474|NCT01447446|584628199|FG003|Overall Study|Adverse Event|0|||
161886475|NCT01447446|584628200|FG004|Overall Study|Adverse Event|2|||
161886476|NCT01447446|584628201|FG005|Overall Study|Adverse Event|0|||
161886477|NCT01447446|584628196|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
161886478|NCT01447446|584628197|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
161886479|NCT01447446|584628198|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
161886480|NCT01447446|584628199|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
161886481|NCT01447446|584628200|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
161886482|NCT01447446|584628201|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
161886483|NCT01447446|584628196|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
161886484|NCT01447446|584628197|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
161886485|NCT01447446|584628198|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
161886486|NCT01447446|584628199|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
161886487|NCT01447446|584628200|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
161886488|NCT01447446|584628201|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
161886489|NCT01447446|584628196|FG000|Overall Study|Administrative/Other|34|||
161886490|NCT01447446|584628197|FG001|Overall Study|Administrative/Other|9|||
161886491|NCT01447446|584628198|FG002|Overall Study|Administrative/Other|10|||
161886492|NCT01447446|584628199|FG003|Overall Study|Administrative/Other|2|||
161886493|NCT01447446|584628200|FG004|Overall Study|Administrative/Other|33|||
161886494|NCT01447446|584628201|FG005|Overall Study|Administrative/Other|4|||
161886495|NCT01447446|584628196|FG000|Overall Study|SVR12 Assessment|13|||
161886496|NCT01447446|584628197|FG001|Overall Study|SVR12 Assessment|1|||
161886497|NCT01447446|584628198|FG002|Overall Study|SVR12 Assessment|2|||
161992223|NCT04072887|585019883|FG000|Overall Study|Lost to Follow-up|1|||
161992224|NCT04072887|585019884|FG001|Overall Study|Lost to Follow-up|3|||
161992225|NCT04072887|585019885|FG002|Overall Study|Lost to Follow-up|0|||
161992226|NCT04072887|585019886|FG003|Overall Study|Lost to Follow-up|0|||
161992227|NCT04072887|585019887|FG004|Overall Study|Lost to Follow-up|0|||
161992228|NCT04072887|585019888|FG005|Overall Study|Lost to Follow-up|0|||
161992229|NCT04072887|585019883|FG000|Overall Study|Death|0|||
161992230|NCT04072887|585019884|FG001|Overall Study|Death|2|||
161992231|NCT04072887|585019885|FG002|Overall Study|Death|0|||
161992232|NCT04072887|585019886|FG003|Overall Study|Death|2|||
161992233|NCT04072887|585019887|FG004|Overall Study|Death|3|||
161992234|NCT04072887|585019888|FG005|Overall Study|Death|0|||
161992235|NCT00423449|585019891|FG000|Overall Study|Clinical Adverse Event|1|||
161992236|NCT00423449|585019892|FG001|Overall Study|Clinical Adverse Event|0|||
161992237|NCT00423449|585019893|FG002|Overall Study|Clinical Adverse Event|1|||
161992238|NCT00423449|585019894|FG003|Overall Study|Clinical Adverse Event|8|||
161992239|NCT00423449|585019895|FG004|Overall Study|Clinical Adverse Event|2|||
161992240|NCT00423449|585019891|FG000|Overall Study|Death|1|||
161992241|NCT00423449|585019892|FG001|Overall Study|Death|0|||
161992242|NCT00423449|585019893|FG002|Overall Study|Death|2|||
161992243|NCT00423449|585019894|FG003|Overall Study|Death|1|||
161992244|NCT00423449|585019895|FG004|Overall Study|Death|1|||
161992245|NCT00423449|585019891|FG000|Overall Study|Progressive Disease|1|||
161992246|NCT00423449|585019892|FG001|Overall Study|Progressive Disease|3|||
161886498|NCT01447446|584628199|FG003|Overall Study|SVR12 Assessment|1|||
161886499|NCT01447446|584628200|FG004|Overall Study|SVR12 Assessment|5|||
161886500|NCT01447446|584628201|FG005|Overall Study|SVR12 Assessment|5|||
161886501|NCT01447446|584628196|FG000|Overall Study|New Treatment Started|8|||
161886502|NCT01447446|584628197|FG001|Overall Study|New Treatment Started|2|||
161886503|NCT01447446|584628198|FG002|Overall Study|New Treatment Started|1|||
161886504|NCT01447446|584628199|FG003|Overall Study|New Treatment Started|0|||
161886505|NCT01447446|584628200|FG004|Overall Study|New Treatment Started|2|||
161886506|NCT01447446|584628201|FG005|Overall Study|New Treatment Started|0|||
161886507|NCT01447446|584628196|FG000|Overall Study|Reason not Specified|1|||
161886508|NCT01447446|584628197|FG001|Overall Study|Reason not Specified|1|||
161886509|NCT01447446|584628198|FG002|Overall Study|Reason not Specified|1|||
161886510|NCT01447446|584628199|FG003|Overall Study|Reason not Specified|1|||
161886511|NCT01447446|584628200|FG004|Overall Study|Reason not Specified|1|||
161886512|NCT01447446|584628201|FG005|Overall Study|Reason not Specified|0|||
161886513|NCT02052596|584628202|FG000|Active Phase|Adverse Event|3|||
161886514|NCT02052596|584628203|FG001|Active Phase|Adverse Event|2|||
161886515|NCT02052596|584628202|FG000|Active Phase|Lost to Follow-up|8|||
161886516|NCT02052596|584628203|FG001|Active Phase|Lost to Follow-up|11|||
161886517|NCT02052596|584628202|FG000|Active Phase|Protocol Violation|1|||
161886518|NCT02052596|584628203|FG001|Active Phase|Protocol Violation|2|||
161886519|NCT02052596|584628202|FG000|Active Phase|Withdrawal by Subject|3|||
161886520|NCT02052596|584628203|FG001|Active Phase|Withdrawal by Subject|4|||
161886521|NCT02052596|584628202|FG000|Active Phase|Enrolled in error|1|||
161886522|NCT02052596|584628203|FG001|Active Phase|Enrolled in error|0|||
161886523|NCT02052596|584628202|FG000|Active Phase|Lost due to Crohn's disease|0|||
161886524|NCT02052596|584628203|FG001|Active Phase|Lost due to Crohn's disease|1|||
161886525|NCT02052596|584628202|FG000|Safety Phase|Adverse Event|6|||
161886526|NCT02052596|584628203|FG001|Safety Phase|Adverse Event|3|||
161886527|NCT02052596|584628202|FG000|Safety Phase|Lost to Follow-up|11|||
161886528|NCT02052596|584628203|FG001|Safety Phase|Lost to Follow-up|18|||
161886529|NCT02052596|584628202|FG000|Safety Phase|Protocol Violation|1|||
161886530|NCT02052596|584628203|FG001|Safety Phase|Protocol Violation|2|||
161886531|NCT02052596|584628202|FG000|Safety Phase|Withdrawal by Subject|8|||
161886532|NCT02052596|584628203|FG001|Safety Phase|Withdrawal by Subject|11|||
161886533|NCT02052596|584628202|FG000|Safety Phase|Enrolled in error|1|||
161886534|NCT02052596|584628203|FG001|Safety Phase|Enrolled in error|0|||
161886535|NCT02052596|584628202|FG000|Safety Phase|Lost due to Crohn's disease|0|||
161886536|NCT02052596|584628203|FG001|Safety Phase|Lost due to Crohn's disease|1|||
161886537|NCT04829331|584628206|FG000|Overall Study|Lost to Follow-up|1|||
161886538|NCT04829331|584628207|FG001|Overall Study|Lost to Follow-up|0|||
161886539|NCT00943670|584628213|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
161886540|NCT00943670|584628213|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
161886541|NCT00943670|584628213|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
161886542|NCT00943670|584628213|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
161886543|NCT00943670|584628213|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
161886544|NCT00943670|584628213|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
161886545|NCT00943670|584628213|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
161886546|NCT00943670|584628213|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
161886547|NCT00943670|584628213|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
161886548|NCT00943670|584628213|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
161886549|NCT04526574|584628214|FG000|Overall Study|Protocol Violation|3|||
161886550|NCT04526574|584628215|FG001|Overall Study|Protocol Violation|1|||
161886551|NCT04526574|584628214|FG000|Overall Study|Withdrawal by Subject|12|||
161886552|NCT04526574|584628215|FG001|Overall Study|Withdrawal by Subject|9|||
161886553|NCT04526574|584628214|FG000|Overall Study|Other|1|||
161886554|NCT04526574|584628215|FG001|Overall Study|Other|2|||
161886555|NCT04526574|584628214|FG000|Overall Study|Adverse Event|1|||
161886556|NCT04526574|584628215|FG001|Overall Study|Adverse Event|1|||
161886557|NCT04526574|584628214|FG000|Overall Study|Death|2|||
161886558|NCT04526574|584628215|FG001|Overall Study|Death|3|||
161886559|NCT04526574|584628214|FG000|Overall Study|Lost to Follow-up|9|||
161886560|NCT04526574|584628215|FG001|Overall Study|Lost to Follow-up|9|||
161886561|NCT04526574|584628214|FG000|Overall Study|No longer meets eligibility criteria|8|||
161886562|NCT04526574|584628215|FG001|Overall Study|No longer meets eligibility criteria|8|||
161886563|NCT01032070|584628216|FG000|Overall Study|Disease progression|13|||
161886564|NCT01032070|584628217|FG001|Overall Study|Disease progression|8|||
161886565|NCT01032070|584628216|FG000|Overall Study|Medical or ethical reasons|0|||
161886566|NCT01032070|584628217|FG001|Overall Study|Medical or ethical reasons|2|||
161886567|NCT01032070|584628216|FG000|Overall Study|Withdrawal by Subject|0|||
161886568|NCT01032070|584628217|FG001|Overall Study|Withdrawal by Subject|2|||
161886569|NCT02332239|584628218|FG000|Overall Study|Lost to Follow-up|4|||
161886570|NCT02332239|584628219|FG001|Overall Study|Lost to Follow-up|6|||
161886571|NCT00894790|584628222|FG000|Overall Study|Protocol Violation|0|||
161886572|NCT00894790|584628223|FG001|Overall Study|Protocol Violation|1|||
161886573|NCT00894790|584628222|FG000|Overall Study|Lost to Follow-up|0|||
162036288|NCT04068896|585188981|FG000|Overall Study|Death|3|||
162036289|NCT04068896|585188982|FG001|Overall Study|Death|1|||
162036290|NCT04068896|585188983|FG002|Overall Study|Death|3|||
162036291|NCT04068896|585188984|FG003|Overall Study|Death|19|||
162036292|NCT04068896|585188985|FG004|Overall Study|Death|17|||
162036293|NCT04068896|585188986|FG005|Overall Study|Death|0|||
162036294|NCT04068896|585188981|FG000|Overall Study|Physician Decision|0|||
162036295|NCT04068896|585188982|FG001|Overall Study|Physician Decision|0|||
162036296|NCT04068896|585188983|FG002|Overall Study|Physician Decision|0|||
162036297|NCT04068896|585188984|FG003|Overall Study|Physician Decision|1|||
162036298|NCT04068896|585188985|FG004|Overall Study|Physician Decision|0|||
162036299|NCT04068896|585188986|FG005|Overall Study|Physician Decision|0|||
162036300|NCT04068896|585188981|FG000|Overall Study|progressive disease|3|||
162036301|NCT04068896|585188982|FG001|Overall Study|progressive disease|5|||
162036302|NCT04068896|585188983|FG002|Overall Study|progressive disease|3|||
162036303|NCT04068896|585188984|FG003|Overall Study|progressive disease|2|||
162036304|NCT04068896|585188985|FG004|Overall Study|progressive disease|1|||
162036305|NCT04068896|585188986|FG005|Overall Study|progressive disease|2|||
162036306|NCT04068896|585188981|FG000|Overall Study|Study terminated by sponsor|0|||
162036307|NCT04068896|585188982|FG001|Overall Study|Study terminated by sponsor|0|||
162036308|NCT04068896|585188983|FG002|Overall Study|Study terminated by sponsor|1|||
162036309|NCT04068896|585188984|FG003|Overall Study|Study terminated by sponsor|2|||
162036310|NCT04068896|585188985|FG004|Overall Study|Study terminated by sponsor|1|||
162036311|NCT04068896|585188986|FG005|Overall Study|Study terminated by sponsor|4|||
162036312|NCT04068896|585188981|FG000|Overall Study|Protocol Violation|0|||
162036313|NCT04068896|585188982|FG001|Overall Study|Protocol Violation|0|||
162036314|NCT04068896|585188983|FG002|Overall Study|Protocol Violation|0|||
162036315|NCT04068896|585188984|FG003|Overall Study|Protocol Violation|1|||
162036316|NCT04068896|585188985|FG004|Overall Study|Protocol Violation|0|||
162036317|NCT04068896|585188986|FG005|Overall Study|Protocol Violation|0|||
162036318|NCT04068896|585188981|FG000|Overall Study|Withdrawal by Subject|0|||
161886574|NCT00894790|584628223|FG001|Overall Study|Lost to Follow-up|1|||
161886575|NCT00894790|584628222|FG000|Overall Study|Did not meet entrance criteria|1|||
161886576|NCT00894790|584628223|FG001|Overall Study|Did not meet entrance criteria|0|||
161886577|NCT00396877|584628224|FG000|Overall Study|Lost to Follow-up|2|||
161886578|NCT00396877|584628225|FG001|Overall Study|Lost to Follow-up|1|||
161886579|NCT00396877|584628224|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
161886580|NCT00396877|584628225|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
161886581|NCT02273908|584628233|FG000|Overall Study|Adverse Event|16|||
161886582|NCT02273908|584628234|FG001|Overall Study|Adverse Event|0|||
161886583|NCT02273908|584628233|FG000|Overall Study|Lost to Follow-up|10|||
161886584|NCT02273908|584628234|FG001|Overall Study|Lost to Follow-up|1|||
161886585|NCT02273908|584628233|FG000|Overall Study|Did not meet entrance criteria|3|||
161886586|NCT02273908|584628234|FG001|Overall Study|Did not meet entrance criteria|2|||
161886587|NCT02273908|584628233|FG000|Overall Study|Withdrawal by Subject|4|||
161886588|NCT02273908|584628234|FG001|Overall Study|Withdrawal by Subject|2|||
161886589|NCT00422422|584628235|FG000|Overall Study|Lack of Efficacy|1|||
161886590|NCT00422422|584628235|FG000|Overall Study|Protocol Violation|1|||
161886591|NCT00422422|584628235|FG000|Overall Study|Withdrawal by Subject|2|||
161886592|NCT00422422|584628235|FG000|Overall Study|SAE, non-fatal|1|||
161886593|NCT00422422|584628235|FG000|Overall Study|AE, non-serious non-fatal|5|||
161886594|NCT03301844|584628236|FG000|Overall Study|suspected colon cancer|1|||
161886595|NCT03301844|584628237|FG001|Overall Study|suspected colon cancer|1|||
161886596|NCT00501059|584628238|FG000|Overall Study|Protocol Violation|80|||
161886597|NCT00501059|584628239|FG001|Overall Study|Protocol Violation|69|||
161886598|NCT00501059|584628238|FG000|Overall Study|Death|140|||
161886599|NCT00501059|584628239|FG001|Overall Study|Death|137|||
161886600|NCT00501059|584628238|FG000|Overall Study|Other|236|||
162036319|NCT04068896|585188982|FG001|Overall Study|Withdrawal by Subject|3|||
162036320|NCT04068896|585188983|FG002|Overall Study|Withdrawal by Subject|0|||
162036321|NCT04068896|585188984|FG003|Overall Study|Withdrawal by Subject|2|||
162036322|NCT04068896|585188985|FG004|Overall Study|Withdrawal by Subject|1|||
162036323|NCT04068896|585188986|FG005|Overall Study|Withdrawal by Subject|0|||
162036324|NCT04068896|585188981|FG000|Overall Study|Symptomatic deterioration|2|||
161886601|NCT00501059|584628239|FG001|Overall Study|Other|239|||
161886602|NCT00501059|584628238|FG000|Overall Study|Missing end-of-study page|91|||
161886603|NCT00501059|584628239|FG001|Overall Study|Missing end-of-study page|92|||
161886604|NCT00501059|584628238|FG000|Overall Study|Clinical endpoint reached|110|||
161886605|NCT00501059|584628239|FG001|Overall Study|Clinical endpoint reached|123|||
161886606|NCT00501059|584628238|FG000|Overall Study|Insufficient therapeutic effect|4|||
162036325|NCT04068896|585188982|FG001|Overall Study|Symptomatic deterioration|0|||
162036326|NCT04068896|585188983|FG002|Overall Study|Symptomatic deterioration|0|||
162036327|NCT04068896|585188984|FG003|Overall Study|Symptomatic deterioration|0|||
162036328|NCT04068896|585188985|FG004|Overall Study|Symptomatic deterioration|0|||
162036329|NCT04068896|585188986|FG005|Overall Study|Symptomatic deterioration|0|||
162036330|NCT00555425|585188989|FG000|Overall Study|Missed Medication > 1 wk|34|||
162036331|NCT00555425|585188990|FG001|Overall Study|Missed Medication > 1 wk|15|||
162036332|NCT00555425|585188989|FG000|Overall Study|Missed 3 physician management visits|1|||
161886607|NCT00501059|584628239|FG001|Overall Study|Insufficient therapeutic effect|5|||
161886608|NCT00501059|584628238|FG000|Overall Study|Consent withdrawn by subject|817|||
161886609|NCT00501059|584628239|FG001|Overall Study|Consent withdrawn by subject|873|||
161886610|NCT00501059|584628238|FG000|Overall Study|Non-compliant with study treatment|23|||
161886611|NCT00501059|584628239|FG001|Overall Study|Non-compliant with study treatment|16|||
161886612|NCT00501059|584628238|FG000|Overall Study|Reason not given|3|||
161886613|NCT00501059|584628239|FG001|Overall Study|Reason not given|1|||
161886614|NCT00501059|584628238|FG000|Overall Study|Adverse Event|129|||
161886615|NCT00501059|584628239|FG001|Overall Study|Adverse Event|122|||
161886616|NCT00501059|584628238|FG000|Overall Study|Lost to Follow-up|210|||
161886617|NCT00501059|584628239|FG001|Overall Study|Lost to Follow-up|198|||
161886618|NCT00501059|584628238|FG000|Overall Study|Not treated|25|||
161886619|NCT00501059|584628239|FG001|Overall Study|Not treated|17|||
161886620|NCT02124759|584628240|FG000|Overall Study|Withdrawal by Subject|3|||
161886621|NCT02124759|584628241|FG001|Overall Study|Withdrawal by Subject|1|||
161886622|NCT02124759|584628242|FG002|Overall Study|Withdrawal by Subject|1|||
161886623|NCT02124759|584628240|FG000|Overall Study|Screen Fail|2|||
161886624|NCT02124759|584628241|FG001|Overall Study|Screen Fail|2|||
161886625|NCT02124759|584628242|FG002|Overall Study|Screen Fail|3|||
161886626|NCT02968433|584628244|FG000|Overall Study|Withdrawal by Subject|1|||
161886627|NCT00875433|584628245|FG000|Overall Study|Progressive disease|41|||
161886628|NCT00875433|584628245|FG000|Overall Study|Other Adverse Event|14|||
161886629|NCT00875433|584628245|FG000|Overall Study|Withdrawal by Subject|2|||
161886630|NCT00875433|584628245|FG000|Overall Study|Other|3|||
161886631|NCT00725101|584628246|FG000|Overall Study|Death|3|||
161886632|NCT00725101|584628246|FG000|Overall Study|Lost to Follow-up|353|||
161886633|NCT00725101|584628246|FG000|Overall Study|Protocol Violation|1|||
161886634|NCT00725101|584628246|FG000|Overall Study|Withdrawal by Subject|127|||
161886635|NCT00725101|584628246|FG000|Overall Study|not specified/no reason given|11|||
161886636|NCT03325894|584628247|FG000|Overall Study|Adverse Event|2|||
161886637|NCT03325894|584628248|FG001|Overall Study|Adverse Event|3|||
161886638|NCT03325894|584628247|FG000|Overall Study|Protocol Violation|1|||
161886639|NCT03325894|584628248|FG001|Overall Study|Protocol Violation|2|||
161886640|NCT03325894|584628247|FG000|Overall Study|Withdrawal by Subject|10|||
161886641|NCT03325894|584628248|FG001|Overall Study|Withdrawal by Subject|6|||
161886642|NCT03325894|584628247|FG000|Overall Study|Lost to Follow-up|4|||
161886643|NCT03325894|584628248|FG001|Overall Study|Lost to Follow-up|9|||
161886644|NCT03325894|584628247|FG000|Overall Study|Lack of Efficacy|8|||
161886645|NCT03325894|584628248|FG001|Overall Study|Lack of Efficacy|14|||
161886646|NCT03325894|584628247|FG000|Overall Study|Study Terminated by Sponsor|38|||
161992247|NCT00423449|585019893|FG002|Overall Study|Progressive Disease|8|||
161992248|NCT00423449|585019894|FG003|Overall Study|Progressive Disease|11|||
161992249|NCT00423449|585019895|FG004|Overall Study|Progressive Disease|4|||
161992250|NCT00423449|585019891|FG000|Overall Study|Laboratory Adverse Event|0|||
161992251|NCT00423449|585019892|FG001|Overall Study|Laboratory Adverse Event|1|||
161992252|NCT00423449|585019893|FG002|Overall Study|Laboratory Adverse Event|2|||
161992253|NCT00423449|585019894|FG003|Overall Study|Laboratory Adverse Event|0|||
161992254|NCT00423449|585019895|FG004|Overall Study|Laboratory Adverse Event|0|||
161992255|NCT00423449|585019891|FG000|Overall Study|Other|0|||
161992256|NCT00423449|585019892|FG001|Overall Study|Other|0|||
161992257|NCT00423449|585019893|FG002|Overall Study|Other|0|||
161992258|NCT00423449|585019894|FG003|Overall Study|Other|1|||
161992259|NCT00423449|585019895|FG004|Overall Study|Other|0|||
161992260|NCT00423449|585019891|FG000|Overall Study|Protocol Violation|0|||
161992261|NCT00423449|585019892|FG001|Overall Study|Protocol Violation|0|||
161992262|NCT00423449|585019893|FG002|Overall Study|Protocol Violation|2|||
161992263|NCT00423449|585019894|FG003|Overall Study|Protocol Violation|1|||
161992264|NCT00423449|585019895|FG004|Overall Study|Protocol Violation|0|||
161992265|NCT01153724|585019896|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161886647|NCT03325894|584628248|FG001|Overall Study|Study Terminated by Sponsor|43|||
161886648|NCT03325894|584628247|FG000|Overall Study|Other (Not received Treatment)|1|||
161886649|NCT03325894|584628248|FG001|Overall Study|Other (Not received Treatment)|0|||
161886650|NCT03482167|584628251|FG000|Allocated to Intervention|Physician Decision|1|||
161992266|NCT01153724|585019896|FG000|Treatment Period 2|Adverse Event|1|||
161886651|NCT03482167|584628252|FG001|Allocated to Intervention|Physician Decision|2|||
161886652|NCT03482167|584628251|FG000|Received Intervention|Adverse Event|3|||
161886653|NCT03482167|584628252|FG001|Received Intervention|Adverse Event|1|||
161886654|NCT03482167|584628251|FG000|Received Intervention|Physician Decision|1|||
161886655|NCT03482167|584628252|FG001|Received Intervention|Physician Decision|1|||
161886656|NCT03482167|584628251|FG000|Received Intervention|Withdrawal by Subject|1|||
161992267|NCT01153724|585019896|FG000|Treatment Period 2|Other reason not defined above|1|||
161992268|NCT04371666|585019901|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
161992269|NCT04371666|585019902|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
161886657|NCT03482167|584628252|FG001|Received Intervention|Withdrawal by Subject|0|||
161886658|NCT00819780|584628254|FG000|Overall Study|Did not receive study drug|3|||
161886659|NCT00819780|584628255|FG001|Overall Study|Did not receive study drug|4|||
161992270|NCT04371666|585019901|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
161886660|NCT00819780|584628254|FG000|Overall Study|Still in treatment|25|||
161886661|NCT00819780|584628255|FG001|Overall Study|Still in treatment|17|||
161886662|NCT00622336|584628256|FG000|Treatment Phase|Progression of Disease|181|||
161886663|NCT00622336|584628256|FG000|Treatment Phase|Adverse Event|46|||
161886664|NCT00622336|584628256|FG000|Treatment Phase|Other|40|||
161886665|NCT00622336|584628256|FG000|Treatment Phase|Death|14|||
161886666|NCT00622336|584628256|FG000|Treatment Phase|Lack of therapeutic effect|13|||
161886667|NCT00622336|584628256|FG000|Treatment Phase|Withdrawal by Subject|13|||
161886668|NCT00622336|584628256|FG000|Treatment Phase|Lost to Follow-up|2|||
161992271|NCT04371666|585019902|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
161992272|NCT04371666|585019901|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
161992273|NCT04371666|585019902|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
161992274|NCT04371666|585019901|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
161992275|NCT04371666|585019902|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
161992276|NCT04371666|585019901|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
161992277|NCT04371666|585019902|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
161992278|NCT04371666|585019901|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
161992279|NCT04371666|585019902|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
161992280|NCT00445770|585019903|FG000|Overall Study|Adverse Event|9|||
161992281|NCT00445770|585019904|FG001|Overall Study|Adverse Event|15|||
161992282|NCT00445770|585019905|FG002|Overall Study|Adverse Event|19|||
161992283|NCT00445770|585019903|FG000|Overall Study|Lack of Efficacy|38|||
161992284|NCT00445770|585019904|FG001|Overall Study|Lack of Efficacy|13|||
161992285|NCT00445770|585019905|FG002|Overall Study|Lack of Efficacy|6|||
161992286|NCT00445770|585019903|FG000|Overall Study|Lost to Follow-up|0|||
161992287|NCT00445770|585019904|FG001|Overall Study|Lost to Follow-up|2|||
161992288|NCT00445770|585019905|FG002|Overall Study|Lost to Follow-up|0|||
161992289|NCT00445770|585019903|FG000|Overall Study|Other|6|||
161992290|NCT00445770|585019904|FG001|Overall Study|Other|5|||
161992291|NCT00445770|585019905|FG002|Overall Study|Other|6|||
161992292|NCT00947115|585019906|FG000|Overall Study|Missed reporting interval|3|||
161992293|NCT00947115|585019907|FG001|Overall Study|Missed reporting interval|4|||
161992294|NCT00947115|585019908|FG002|Overall Study|Missed reporting interval|2|||
161992295|NCT00947115|585019906|FG000|Overall Study|Physician Decision|0|||
161992296|NCT00947115|585019907|FG001|Overall Study|Physician Decision|2|||
161992297|NCT00947115|585019908|FG002|Overall Study|Physician Decision|0|||
161992298|NCT00947115|585019906|FG000|Overall Study|Death|0|||
161992299|NCT00947115|585019907|FG001|Overall Study|Death|1|||
161992300|NCT00947115|585019908|FG002|Overall Study|Death|1|||
161992301|NCT00947115|585019906|FG000|Overall Study|Migrated from study area|2|||
161992302|NCT00947115|585019907|FG001|Overall Study|Migrated from study area|0|||
161992303|NCT00947115|585019908|FG002|Overall Study|Migrated from study area|0|||
161992304|NCT00947115|585019906|FG000|Overall Study|Withdrawal by Subject|1|||
161992305|NCT00947115|585019907|FG001|Overall Study|Withdrawal by Subject|3|||
161992306|NCT00947115|585019908|FG002|Overall Study|Withdrawal by Subject|4|||
161992307|NCT00947115|585019906|FG000|Overall Study|Lost to Follow-up|11|||
161992308|NCT00947115|585019907|FG001|Overall Study|Lost to Follow-up|12|||
161992309|NCT00947115|585019908|FG002|Overall Study|Lost to Follow-up|8|||
161992310|NCT02092025|585019909|FG000|Overall Study|Case Report Forms Uncollected|44|||
161992311|NCT02092025|585019909|FG000|Overall Study|Protocol Deviation|24|||
161992312|NCT02927938|585019910|FG000|Overall Study|Death|0|||
161992313|NCT02927938|585019911|FG001|Overall Study|Death|1|||
161992314|NCT02927938|585019912|FG002|Overall Study|Death|0|||
161992315|NCT02927938|585019913|FG003|Overall Study|Death|4|||
161992316|NCT02927938|585019910|FG000|Overall Study|Early Study Termination|1|||
161992317|NCT02927938|585019911|FG001|Overall Study|Early Study Termination|5|||
161992318|NCT02927938|585019912|FG002|Overall Study|Early Study Termination|4|||
161992319|NCT02927938|585019913|FG003|Overall Study|Early Study Termination|3|||
161992320|NCT03228212|585019916|FG000|Period 1|Adverse Event|1|||
161992321|NCT03228212|585019917|FG001|Period 1|Adverse Event|0|||
161992322|NCT03228212|585019916|FG000|Period 1|no longer meets eligibility criteria|0|||
161992323|NCT03228212|585019917|FG001|Period 1|no longer meets eligibility criteria|1|||
162036333|NCT00555425|585188990|FG001|Overall Study|Missed 3 physician management visits|0|||
161886669|NCT00622336|584628256|FG000|Extension Phase|Adverse Event|2|||
161992324|NCT03228212|585019916|FG000|Period 2|Lost to Follow-up|1|||
161992325|NCT03228212|585019917|FG001|Period 2|Lost to Follow-up|0|||
161992326|NCT00934128|585019918|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
161992327|NCT00934128|585019919|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
161992328|NCT00934128|585019918|FG000|First Intervention (2 Hours)|Adverse Event|4|||
161992329|NCT00934128|585019919|FG001|First Intervention (2 Hours)|Adverse Event|1|||
161886670|NCT00622336|584628256|FG000|Extension Phase|Progressive Disease|6|||
161886671|NCT00622336|584628256|FG000|Extension Phase|Lack of therapeutic effect|2|||
161886672|NCT00622336|584628256|FG000|Extension Phase|Withdrawal by Subject|1|||
161992330|NCT00934128|585019918|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
161992331|NCT00934128|585019919|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
161886673|NCT00622336|584628256|FG000|Extension Phase|Lost to Follow-up|1|||
161886674|NCT00622336|584628256|FG000|Extension Phase|Other|9|||
161886675|NCT04148287|584628261|FG000|Overall Study|Death|2|||
161886676|NCT00106639|584628263|FG000|Overall Study|Adverse Event|3|||
161886677|NCT00106639|584628264|FG001|Overall Study|Adverse Event|4|||
161886678|NCT00106639|584628265|FG002|Overall Study|Adverse Event|1|||
161886679|NCT00106639|584628263|FG000|Overall Study|Protocol Violation|0|||
161886680|NCT00106639|584628264|FG001|Overall Study|Protocol Violation|1|||
161886681|NCT00106639|584628265|FG002|Overall Study|Protocol Violation|0|||
161886682|NCT00106639|584628263|FG000|Overall Study|Withdrawal by Subject|0|||
161886683|NCT00106639|584628264|FG001|Overall Study|Withdrawal by Subject|1|||
161886684|NCT00106639|584628265|FG002|Overall Study|Withdrawal by Subject|0|||
161886685|NCT00106639|584628263|FG000|Overall Study|Participant defaulted|0|||
161886686|NCT00106639|584628264|FG001|Overall Study|Participant defaulted|1|||
161886687|NCT00106639|584628265|FG002|Overall Study|Participant defaulted|1|||
161886688|NCT02637713|584628273|FG000|Overall Study|Screen Failure|2|||
161886689|NCT02345889|584628274|FG000|Overall Study|Inadequate Bowel Prep|17|||
161886690|NCT02345889|584628275|FG001|Overall Study|Inadequate Bowel Prep|16|||
161886691|NCT02345889|584628276|FG002|Overall Study|Inadequate Bowel Prep|18|||
161886692|NCT02345889|584628277|FG003|Overall Study|Inadequate Bowel Prep|14|||
161886693|NCT02345889|584628274|FG000|Overall Study|Polyposis identified during procedure|1|||
161886694|NCT02345889|584628275|FG001|Overall Study|Polyposis identified during procedure|1|||
161886695|NCT02345889|584628276|FG002|Overall Study|Polyposis identified during procedure|0|||
161886696|NCT02345889|584628277|FG003|Overall Study|Polyposis identified during procedure|1|||
161886697|NCT02345889|584628274|FG000|Overall Study|Recognized ineligible post-randomization|1|||
161886698|NCT02345889|584628275|FG001|Overall Study|Recognized ineligible post-randomization|0|||
161886699|NCT02345889|584628276|FG002|Overall Study|Recognized ineligible post-randomization|2|||
161886700|NCT02345889|584628277|FG003|Overall Study|Recognized ineligible post-randomization|1|||
161886701|NCT02345889|584628274|FG000|Overall Study|Ulcerative Colitis identified|1|||
161886702|NCT02345889|584628275|FG001|Overall Study|Ulcerative Colitis identified|0|||
161886703|NCT02345889|584628276|FG002|Overall Study|Ulcerative Colitis identified|0|||
161886704|NCT02345889|584628277|FG003|Overall Study|Ulcerative Colitis identified|0|||
161886705|NCT02345889|584628274|FG000|Overall Study|Cecum not intubated|1|||
161886706|NCT02345889|584628275|FG001|Overall Study|Cecum not intubated|0|||
161886707|NCT02345889|584628276|FG002|Overall Study|Cecum not intubated|0|||
161886708|NCT02345889|584628277|FG003|Overall Study|Cecum not intubated|0|||
161886709|NCT00962091|584628278|FG000|Overall Study|Withdrawal by Subject|1|||
161886710|NCT00962091|584628279|FG001|Overall Study|Withdrawal by Subject|2|||
161886711|NCT00962091|584628280|FG002|Overall Study|Withdrawal by Subject|1|||
161886712|NCT00962091|584628281|FG003|Overall Study|Withdrawal by Subject|1|||
161886713|NCT00962091|584628282|FG004|Overall Study|Withdrawal by Subject|0|||
161886714|NCT00962091|584628283|FG005|Overall Study|Withdrawal by Subject|1|||
161886715|NCT00962091|584628284|FG006|Overall Study|Withdrawal by Subject|0|||
161886716|NCT00962091|584628278|FG000|Overall Study|Adverse Event|0|||
161886717|NCT00962091|584628279|FG001|Overall Study|Adverse Event|0|||
161886718|NCT00962091|584628280|FG002|Overall Study|Adverse Event|0|||
161886719|NCT00962091|584628281|FG003|Overall Study|Adverse Event|0|||
161886720|NCT00962091|584628282|FG004|Overall Study|Adverse Event|0|||
161886721|NCT00962091|584628283|FG005|Overall Study|Adverse Event|0|||
161886722|NCT00962091|584628284|FG006|Overall Study|Adverse Event|1|||
161886723|NCT02093390|584628291|FG000|Overall Study|Withdrawal by Subject|0|||
161886724|NCT02093390|584628292|FG001|Overall Study|Withdrawal by Subject|1|||
161886725|NCT00073983|584628293|FG000|Overall Study|not evaluable|1|||
161886726|NCT03976323|584628296|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
161886727|NCT03976323|584628297|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
161886728|NCT03976323|584628298|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
161886729|NCT03976323|584628296|FG000|Induction Phase|Death|80|||
161886730|NCT03976323|584628297|FG001|Induction Phase|Death|0|||
161886731|NCT03976323|584628298|FG002|Induction Phase|Death|0|||
161886732|NCT03976323|584628296|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
161886733|NCT03976323|584628297|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
161886734|NCT03976323|584628298|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
161886735|NCT03976323|584628296|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161886736|NCT03976323|584628297|FG001|Maintenance Phase|Withdrawal by Subject|9|||
161886737|NCT03976323|584628298|FG002|Maintenance Phase|Withdrawal by Subject|3|||
161886738|NCT03976323|584628296|FG000|Maintenance Phase|Physician Decision|0|||
161886739|NCT03976323|584628297|FG001|Maintenance Phase|Physician Decision|0|||
161886740|NCT03976323|584628298|FG002|Maintenance Phase|Physician Decision|1|||
161886741|NCT03976323|584628296|FG000|Maintenance Phase|Death|0|||
161886742|NCT03976323|584628297|FG001|Maintenance Phase|Death|228|||
161886743|NCT03976323|584628298|FG002|Maintenance Phase|Death|234|||
161886744|NCT03774394|584630120|FG000|Overall Study|Withdrawal by Subject|2|||
161886745|NCT03774394|584630121|FG001|Overall Study|Withdrawal by Subject|0|||
161886746|NCT03334422|584630122|FG000|Overall Study|Adverse Event|1|||
161886747|NCT03334422|584630123|FG001|Overall Study|Adverse Event|3|||
162036334|NCT00555425|585188989|FG000|Overall Study|Met criteria for protective transfer|16|||
162036335|NCT00555425|585188990|FG001|Overall Study|Met criteria for protective transfer|3|||
162036336|NCT00555425|585188989|FG000|Overall Study|Became pregnant and transferred care|0|||
162036337|NCT00555425|585188990|FG001|Overall Study|Became pregnant and transferred care|1|||
162036338|NCT01897714|585190802|FG000|Phase I (Dose Escalation)|Disease progression|3|||
162036339|NCT01897714|585190803|FG001|Phase I (Dose Escalation)|Disease progression|5|||
162036340|NCT01897714|585190804|FG002|Phase I (Dose Escalation)|Disease progression|1|||
162036341|NCT01897714|585190805|FG003|Phase I (Dose Escalation)|Disease progression|3|||
162036342|NCT01897714|585190806|FG004|Phase I (Dose Escalation)|Disease progression|0|||
162036343|NCT01897714|585190807|FG005|Phase I (Dose Escalation)|Disease progression|0|||
162036344|NCT01897714|585190802|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
162036345|NCT01897714|585190803|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
162036346|NCT01897714|585190804|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
162036347|NCT01897714|585190805|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
162036348|NCT01897714|585190806|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
162036349|NCT01897714|585190807|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
162036350|NCT01897714|585190802|FG000|Phase I (Dose Escalation)|Other|0|||
162036351|NCT01897714|585190803|FG001|Phase I (Dose Escalation)|Other|1|||
162036352|NCT01897714|585190804|FG002|Phase I (Dose Escalation)|Other|0|||
162036353|NCT01897714|585190805|FG003|Phase I (Dose Escalation)|Other|0|||
162036354|NCT01897714|585190806|FG004|Phase I (Dose Escalation)|Other|0|||
162036355|NCT01897714|585190807|FG005|Phase I (Dose Escalation)|Other|0|||
162036356|NCT01897714|585190802|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
162036357|NCT01897714|585190803|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
162036358|NCT01897714|585190804|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
162036359|NCT01897714|585190805|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
162036360|NCT01897714|585190806|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
162036361|NCT01897714|585190807|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
162036362|NCT01897714|585190802|FG000|Phase II (MTD)|Lost to Follow-up|0|||
162036363|NCT01897714|585190803|FG001|Phase II (MTD)|Lost to Follow-up|0|||
162036364|NCT01897714|585190804|FG002|Phase II (MTD)|Lost to Follow-up|0|||
162036365|NCT01897714|585190805|FG003|Phase II (MTD)|Lost to Follow-up|0|||
162036366|NCT01897714|585190806|FG004|Phase II (MTD)|Lost to Follow-up|1|||
162036367|NCT01897714|585190807|FG005|Phase II (MTD)|Lost to Follow-up|0|||
162036368|NCT01897714|585190802|FG000|Phase II (MTD)|Death|0|||
162036369|NCT01897714|585190803|FG001|Phase II (MTD)|Death|0|||
162036370|NCT01897714|585190804|FG002|Phase II (MTD)|Death|0|||
162036371|NCT01897714|585190805|FG003|Phase II (MTD)|Death|0|||
162036372|NCT01897714|585190806|FG004|Phase II (MTD)|Death|25|||
162036373|NCT01897714|585190807|FG005|Phase II (MTD)|Death|10|||
162036374|NCT01897714|585190802|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
162036375|NCT01897714|585190803|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
162036376|NCT01897714|585190804|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
162036377|NCT01897714|585190805|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
162036378|NCT01897714|585190806|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
162036379|NCT01897714|585190807|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
162036380|NCT01897714|585190802|FG000|Phase II (MTD)|Other|0|||
162036381|NCT01897714|585190803|FG001|Phase II (MTD)|Other|0|||
162036382|NCT01897714|585190804|FG002|Phase II (MTD)|Other|0|||
162036383|NCT01897714|585190805|FG003|Phase II (MTD)|Other|0|||
162036384|NCT01897714|585190806|FG004|Phase II (MTD)|Other|3|||
162036385|NCT01897714|585190807|FG005|Phase II (MTD)|Other|0|||
162036386|NCT05828095|585190814|FG000|Overall Study|Lost to Follow-up|1|||
162036387|NCT05828095|585190815|FG001|Overall Study|Lost to Follow-up|0|||
162036388|NCT05828095|585190814|FG000|Overall Study|Reactogenicity symptom|0|||
162036389|NCT05828095|585190815|FG001|Overall Study|Reactogenicity symptom|1|||
162036390|NCT03206073|585190816|FG000|Overall Study|Participant Noncompliance|0|||
162036391|NCT03206073|585190817|FG001|Overall Study|Participant Noncompliance|1|||
162036392|NCT03206073|585190818|FG002|Overall Study|Participant Noncompliance|0|||
162036393|NCT03206073|585190819|FG003|Overall Study|Participant Noncompliance|0|||
162036394|NCT03206073|585190816|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
162036395|NCT03206073|585190817|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
162036396|NCT03206073|585190818|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
162036397|NCT03206073|585190819|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
162036398|NCT03206073|585190816|FG000|Overall Study|Death|0|||
162036399|NCT03206073|585190817|FG001|Overall Study|Death|0|||
162036400|NCT03206073|585190818|FG002|Overall Study|Death|1|||
162036401|NCT03206073|585190819|FG003|Overall Study|Death|0|||
162036402|NCT03206073|585190816|FG000|Overall Study|Taken off active treatment|0|||
162036403|NCT03206073|585190817|FG001|Overall Study|Taken off active treatment|0|||
162036404|NCT03206073|585190818|FG002|Overall Study|Taken off active treatment|3|||
162036405|NCT03206073|585190819|FG003|Overall Study|Taken off active treatment|0|||
162036406|NCT05523323|585190820|FG000|Overall Study|Death|26|||
162036407|NCT05523323|585190821|FG001|Overall Study|Death|21|||
162036408|NCT05523323|585190820|FG000|Overall Study|Ongoing participants|35|||
162036409|NCT05523323|585190821|FG001|Overall Study|Ongoing participants|30|||
162036410|NCT02428608|585190826|FG000|Overall Study|Pregnancy|2|||
162036411|NCT02428608|585190826|FG000|Overall Study|Lost to Follow-up|37|||
162036412|NCT02428608|585190826|FG000|Overall Study|Withdrawal by Subject|2|||
162036413|NCT02428608|585190826|FG000|Overall Study|scheduling conflicts|15|||
162036414|NCT02428608|585190826|FG000|Overall Study|moved away|10|||
162036415|NCT02428608|585190826|FG000|Overall Study|Death|1|||
162036416|NCT02428608|585190826|FG000|Overall Study|various|16|||
162036417|NCT01117051|585190830|FG000|Overall Study|Withdrawal by Subject|5|||
162036418|NCT01117051|585190831|FG001|Overall Study|Withdrawal by Subject|3|||
162036419|NCT01117051|585190830|FG000|Overall Study|Adverse Event|4|||
162036420|NCT01117051|585190831|FG001|Overall Study|Adverse Event|3|||
162036421|NCT01117051|585190830|FG000|Overall Study|Lost to Follow-up|0|||
162036422|NCT01117051|585190831|FG001|Overall Study|Lost to Follow-up|1|||
162036423|NCT01117051|585190830|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
162036424|NCT01117051|585190831|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
162036425|NCT01117051|585190830|FG000|Overall Study|Sponsor's decision|3|||
162036426|NCT01117051|585190831|FG001|Overall Study|Sponsor's decision|1|||
162036427|NCT01117051|585190830|FG000|Overall Study|Surgical procedure|0|||
162036428|NCT01117051|585190831|FG001|Overall Study|Surgical procedure|1|||
162036429|NCT01117051|585190830|FG000|Overall Study|Randomized by mistake|0|||
162036430|NCT01117051|585190831|FG001|Overall Study|Randomized by mistake|1|||
162036431|NCT01117051|585190830|FG000|Overall Study|Convenience issue|1|||
162036432|NCT01117051|585190831|FG001|Overall Study|Convenience issue|0|||
162036433|NCT00206076|585190833|FG000|Overall Study|Physician Decision|2|||
161886748|NCT03334422|584630124|FG002|Overall Study|Adverse Event|2|||
161886749|NCT03334422|584630125|FG003|Overall Study|Adverse Event|2|||
161886750|NCT03334422|584630122|FG000|Overall Study|Lack of Efficacy|10|||
162036434|NCT00206076|585190834|FG001|Overall Study|Physician Decision|0|||
162036435|NCT00206076|585190833|FG000|Overall Study|Withdrawal by Subject|1|||
162036436|NCT00206076|585190834|FG001|Overall Study|Withdrawal by Subject|1|||
162036437|NCT00427960|585190835|FG000|Overall Study|Adverse Event|2|||
162036438|NCT00427960|585190836|FG001|Overall Study|Adverse Event|0|||
162036439|NCT00427960|585190835|FG000|Overall Study|Withdrawal by Subject|0|||
162036440|NCT00427960|585190836|FG001|Overall Study|Withdrawal by Subject|3|||
162036441|NCT00427960|585190835|FG000|Overall Study|Other|0|||
162036442|NCT00427960|585190836|FG001|Overall Study|Other|1|||
162036443|NCT01142128|585190837|FG000|Overall Study|Physician Decision|1|||
162036444|NCT01142128|585190837|FG000|Overall Study|Lost to Follow-up|1|||
162036445|NCT01142128|585190837|FG000|Overall Study|Withdrawal by Subject|2|||
162036446|NCT03355664|585190838|FG000|Overall Study|Adverse Event|1|||
162036447|NCT03355664|585190839|FG001|Overall Study|Adverse Event|2|||
162036448|NCT03355664|585190838|FG000|Overall Study|Lost to Follow-up|11|||
162036449|NCT03355664|585190839|FG001|Overall Study|Lost to Follow-up|7|||
162036450|NCT03355664|585190838|FG000|Overall Study|Protocol Violation|1|||
162036451|NCT03355664|585190839|FG001|Overall Study|Protocol Violation|2|||
162036452|NCT03355664|585190838|FG000|Overall Study|Withdrawal by Subject|2|||
162036453|NCT03355664|585190839|FG001|Overall Study|Withdrawal by Subject|1|||
162036454|NCT00521001|585190842|FG000|Overall Study|Ineligible|1|||
162036455|NCT02821910|585190843|FG000|Overall Study|Withdrawal by Subject|0|||
162036456|NCT02821910|585190844|FG001|Overall Study|Withdrawal by Subject|0|||
162036457|NCT02821910|585190845|FG002|Overall Study|Withdrawal by Subject|1|||
162036458|NCT02821910|585190846|FG003|Overall Study|Withdrawal by Subject|0|||
162036459|NCT02821910|585190847|FG004|Overall Study|Withdrawal by Subject|0|||
162036460|NCT02821910|585190848|FG005|Overall Study|Withdrawal by Subject|1|||
162036461|NCT02821910|585190843|FG000|Overall Study|Other than specified|1|||
162036462|NCT02821910|585190844|FG001|Overall Study|Other than specified|0|||
161886751|NCT03334422|584630123|FG001|Overall Study|Lack of Efficacy|2|||
162036463|NCT02821910|585190845|FG002|Overall Study|Other than specified|1|||
162036464|NCT02821910|585190846|FG003|Overall Study|Other than specified|0|||
162036465|NCT02821910|585190847|FG004|Overall Study|Other than specified|0|||
161886752|NCT03334422|584630124|FG002|Overall Study|Lack of Efficacy|7|||
161886753|NCT03334422|584630125|FG003|Overall Study|Lack of Efficacy|3|||
161886754|NCT03334422|584630122|FG000|Overall Study|Withdrawal by Subject|8|||
162036466|NCT02821910|585190848|FG005|Overall Study|Other than specified|0|||
162036467|NCT01082640|585190852|FG000|Overall Study|Adverse Event|9|||
162036468|NCT01082640|585190853|FG001|Overall Study|Adverse Event|5|||
162036469|NCT01082640|585190854|FG002|Overall Study|Adverse Event|3|||
162036470|NCT01082640|585190852|FG000|Overall Study|Withdrawal by Subject|3|||
162036471|NCT01082640|585190853|FG001|Overall Study|Withdrawal by Subject|3|||
162036472|NCT01082640|585190854|FG002|Overall Study|Withdrawal by Subject|2|||
162036473|NCT01082640|585190852|FG000|Overall Study|Major protocol deviation|3|||
162036474|NCT01082640|585190853|FG001|Overall Study|Major protocol deviation|3|||
162036475|NCT01082640|585190854|FG002|Overall Study|Major protocol deviation|0|||
162036476|NCT01082640|585190852|FG000|Overall Study|Lost to Follow-up|0|||
162036477|NCT01082640|585190853|FG001|Overall Study|Lost to Follow-up|3|||
161886755|NCT03334422|584630123|FG001|Overall Study|Withdrawal by Subject|3|||
161886756|NCT03334422|584630124|FG002|Overall Study|Withdrawal by Subject|1|||
162036478|NCT01082640|585190854|FG002|Overall Study|Lost to Follow-up|0|||
162036479|NCT01082640|585190852|FG000|Overall Study|Other|2|||
161886757|NCT03334422|584630125|FG003|Overall Study|Withdrawal by Subject|0|||
161886758|NCT03334422|584630122|FG000|Overall Study|Lost to Follow-up|0|||
161886759|NCT03334422|584630123|FG001|Overall Study|Lost to Follow-up|0|||
161886760|NCT03334422|584630124|FG002|Overall Study|Lost to Follow-up|0|||
161886761|NCT03334422|584630125|FG003|Overall Study|Lost to Follow-up|1|||
161886762|NCT03334422|584630122|FG000|Overall Study|Inability to obtain laboratory samples|0|||
161886763|NCT03334422|584630123|FG001|Overall Study|Inability to obtain laboratory samples|1|||
161886764|NCT03334422|584630124|FG002|Overall Study|Inability to obtain laboratory samples|0|||
161886765|NCT03334422|584630125|FG003|Overall Study|Inability to obtain laboratory samples|0|||
161886766|NCT03334422|584630122|FG000|Overall Study|Pregnancy|0|||
161886767|NCT03334422|584630123|FG001|Overall Study|Pregnancy|1|||
161886768|NCT03334422|584630124|FG002|Overall Study|Pregnancy|0|||
161886769|NCT03334422|584630125|FG003|Overall Study|Pregnancy|0|||
161886770|NCT05916131|584630126|FG000|Overall Study|Lost to Follow-up|0|||
161886771|NCT05916131|584630127|FG001|Overall Study|Lost to Follow-up|0|||
161886772|NCT05916131|584630128|FG002|Overall Study|Lost to Follow-up|1|||
161886773|NCT05916131|584630129|FG003|Overall Study|Lost to Follow-up|0|||
161886774|NCT02949908|584630130|FG000|Overall Study|Study termination|2|||
161886775|NCT05323994|584630131|FG000|Overall Study|Protocol Violation|1|||
161886776|NCT00454818|584630132|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
161886777|NCT00454818|584630133|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
161886778|NCT00454818|584630134|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
161886779|NCT00454818|584630135|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
161886780|NCT00454818|584630136|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
161886781|NCT00454818|584630132|FG000|Phase I: Open-label Dose-escalation|Death|0|||
161886782|NCT00454818|584630133|FG001|Phase I: Open-label Dose-escalation|Death|1|||
161886783|NCT00454818|584630134|FG002|Phase I: Open-label Dose-escalation|Death|0|||
161886784|NCT00454818|584630135|FG003|Phase I: Open-label Dose-escalation|Death|0|||
161886785|NCT00454818|584630136|FG004|Phase I: Open-label Dose-escalation|Death|0|||
161886786|NCT00454818|584630132|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
161886787|NCT00454818|584630133|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
161886788|NCT00454818|584630134|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
161886789|NCT00454818|584630135|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
161886790|NCT00454818|584630136|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
161886791|NCT00454818|584630132|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
161886792|NCT00454818|584630133|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
161886793|NCT00454818|584630134|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
161886794|NCT00454818|584630135|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
161886795|NCT00454818|584630136|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
161886796|NCT00454818|584630132|FG000|Phase 2: Randomized Double-blind|Death|0|||
161886797|NCT00454818|584630133|FG001|Phase 2: Randomized Double-blind|Death|1|||
161886798|NCT00454818|584630134|FG002|Phase 2: Randomized Double-blind|Death|0|||
161886799|NCT00454818|584630135|FG003|Phase 2: Randomized Double-blind|Death|0|||
161886800|NCT00454818|584630136|FG004|Phase 2: Randomized Double-blind|Death|1|||
161886801|NCT00454818|584630132|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
161886802|NCT00454818|584630133|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
161886803|NCT00454818|584630134|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
161886804|NCT00454818|584630135|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
161886805|NCT00454818|584630136|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
161886806|NCT00454818|584630132|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
161886807|NCT00454818|584630133|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
161886808|NCT00454818|584630134|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
161886809|NCT00454818|584630135|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
161886810|NCT00454818|584630136|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
161886811|NCT00616603|584630137|FG000|Overall Study|Physician Decision|2|||
161886812|NCT00616603|584630138|FG001|Overall Study|Physician Decision|0|||
161886813|NCT00616603|584630139|FG002|Overall Study|Physician Decision|2|||
161886814|NCT00766467|584630141|FG000|Overall Study|Withdrawal by Subject|7|||
161886815|NCT00766467|584630142|FG001|Overall Study|Withdrawal by Subject|2|||
161886816|NCT00766467|584630141|FG000|Overall Study|Adverse Event|1|||
161886817|NCT00766467|584630142|FG001|Overall Study|Adverse Event|1|||
161886818|NCT00766467|584630141|FG000|Overall Study|Protocol Violation|2|||
161886819|NCT00766467|584630142|FG001|Overall Study|Protocol Violation|4|||
161886820|NCT00766467|584630141|FG000|Overall Study|Tumor Progression on Study|0|||
161886821|NCT00766467|584630142|FG001|Overall Study|Tumor Progression on Study|1|||
161886822|NCT00766467|584630141|FG000|Overall Study|Physician Decision|1|||
161886823|NCT00766467|584630142|FG001|Overall Study|Physician Decision|0|||
161886824|NCT02604550|584630148|FG000|Overall Study|Lost to Follow-up|7|||
161886825|NCT02604550|584630149|FG001|Overall Study|Lost to Follow-up|6|||
161886826|NCT02604550|584630148|FG000|Overall Study|Withdrawal by Subject|0|||
161886827|NCT02604550|584630149|FG001|Overall Study|Withdrawal by Subject|1|||
161886828|NCT02604550|584630148|FG000|Overall Study|Incomplete data using paper journal|18|||
161886829|NCT02604550|584630149|FG001|Overall Study|Incomplete data using paper journal|19|||
161886830|NCT00908076|584630150|FG000|Overall Study|Lack of Efficacy|1|||
161886831|NCT00908076|584630151|FG001|Overall Study|Lack of Efficacy|1|||
161886832|NCT00662558|584630152|FG000|Overall Study|Adverse Event|21|||
161886833|NCT00662558|584630153|FG001|Overall Study|Adverse Event|59|||
161886834|NCT00662558|584630152|FG000|Overall Study|Lack of Efficacy|4|||
161886835|NCT00662558|584630153|FG001|Overall Study|Lack of Efficacy|7|||
161886836|NCT00662558|584630152|FG000|Overall Study|Lost to Follow-up|13|||
161886837|NCT00662558|584630153|FG001|Overall Study|Lost to Follow-up|10|||
161886838|NCT00662558|584630152|FG000|Overall Study|Other|9|||
161886839|NCT00662558|584630153|FG001|Overall Study|Other|14|||
161886840|NCT00662558|584630152|FG000|Overall Study|Withdrawal by Subject|7|||
161886841|NCT00662558|584630153|FG001|Overall Study|Withdrawal by Subject|12|||
161886842|NCT00662558|584630152|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
161886843|NCT00662558|584630153|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
161886844|NCT03329248|584630163|FG000|Overall Study|Progressive Disease|6|||
161886845|NCT00987402|584630164|FG000|Overall Study|Insufficient data entry|86|||
161886846|NCT00987402|584630165|FG001|Overall Study|Insufficient data entry|98|||
161886847|NCT03000530|584630169|FG000|Overall Study|Adverse Event|0|||
161886848|NCT03000530|584630170|FG001|Overall Study|Adverse Event|0|||
161886849|NCT03000530|584630171|FG002|Overall Study|Adverse Event|2|||
161886850|NCT03000530|584630169|FG000|Overall Study|Lost to Follow-up|0|||
161886851|NCT03000530|584630170|FG001|Overall Study|Lost to Follow-up|3|||
161886852|NCT03000530|584630171|FG002|Overall Study|Lost to Follow-up|1|||
161886853|NCT03000530|584630169|FG000|Overall Study|Withdrawal by Subject|0|||
161886854|NCT03000530|584630170|FG001|Overall Study|Withdrawal by Subject|2|||
161992332|NCT00934128|585019918|FG000|Washout Period (1 Hour)|Patient preference|1|||
161992333|NCT00934128|585019919|FG001|Washout Period (1 Hour)|Patient preference|3|||
161992334|NCT00934128|585019918|FG000|Washout Period (1 Hour)|Pain|1|||
161992335|NCT00934128|585019919|FG001|Washout Period (1 Hour)|Pain|0|||
161992336|NCT00934128|585019918|FG000|Washout Period (1 Hour)|Too tired|1|||
161992337|NCT00934128|585019919|FG001|Washout Period (1 Hour)|Too tired|0|||
161992338|NCT00934128|585019918|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
161992339|NCT00934128|585019919|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
161992340|NCT00934128|585019918|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
161992341|NCT00934128|585019919|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
161992342|NCT02834247|585019920|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
161992343|NCT02834247|585019921|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
161992344|NCT02834247|585019922|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
161992345|NCT02834247|585019923|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
161992346|NCT02834247|585019920|FG000|Dose Escalation Phase|Death|5|||
161992347|NCT02834247|585019921|FG001|Dose Escalation Phase|Death|6|||
161992348|NCT02834247|585019922|FG002|Dose Escalation Phase|Death|5|||
161992349|NCT02834247|585019923|FG003|Dose Escalation Phase|Death|0|||
161992350|NCT02834247|585019920|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
161992351|NCT02834247|585019921|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
161992352|NCT02834247|585019922|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
161992353|NCT02834247|585019923|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
161992354|NCT02834247|585019920|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
161992355|NCT02834247|585019921|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
161992356|NCT02834247|585019922|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
161992357|NCT02834247|585019923|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161992358|NCT02834247|585019920|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
161992359|NCT02834247|585019921|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
161992360|NCT02834247|585019922|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
161992361|NCT02834247|585019923|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
161992362|NCT02834247|585019920|FG000|Dose Expansion Phase|Death|0|||
161992363|NCT02834247|585019921|FG001|Dose Expansion Phase|Death|0|||
161992364|NCT02834247|585019922|FG002|Dose Expansion Phase|Death|0|||
161992365|NCT02834247|585019923|FG003|Dose Expansion Phase|Death|8|||
161992366|NCT02834247|585019920|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
161992367|NCT02834247|585019921|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
161992368|NCT02834247|585019922|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
161992369|NCT02834247|585019923|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
161992370|NCT02834247|585019920|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
161992371|NCT02834247|585019921|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
161992372|NCT02834247|585019922|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
161992373|NCT02834247|585019923|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
161992374|NCT01807299|585019930|FG000|Overall Study|Protocol Violation|3|||
161992375|NCT01807299|585019931|FG001|Overall Study|Protocol Violation|1|||
161992376|NCT01807299|585019932|FG002|Overall Study|Protocol Violation|0|||
161992377|NCT01807299|585019933|FG003|Overall Study|Protocol Violation|2|||
161992378|NCT02476006|585019934|FG000|Overall Study|Death|4|||
161992379|NCT02476006|585019934|FG000|Overall Study|Lack of treatment efficacy|2|||
162036480|NCT01082640|585190853|FG001|Overall Study|Other|1|||
162036481|NCT01082640|585190854|FG002|Overall Study|Other|3|||
162036482|NCT03823378|585190859|FG000|Overall Study|Adverse Event|2|||
162036483|NCT03823378|585190860|FG001|Overall Study|Adverse Event|2|||
162036484|NCT03823378|585190861|FG002|Overall Study|Adverse Event|0|||
162036485|NCT03823378|585190862|FG003|Overall Study|Adverse Event|0|||
162036486|NCT03823378|585190863|FG004|Overall Study|Adverse Event|0|||
162036487|NCT03823378|585190864|FG005|Overall Study|Adverse Event|0|||
162036488|NCT03823378|585190859|FG000|Overall Study|Lost to Follow-up|0|||
162036489|NCT03823378|585190860|FG001|Overall Study|Lost to Follow-up|1|||
162036490|NCT03823378|585190861|FG002|Overall Study|Lost to Follow-up|0|||
162036491|NCT03823378|585190862|FG003|Overall Study|Lost to Follow-up|0|||
162036492|NCT03823378|585190863|FG004|Overall Study|Lost to Follow-up|1|||
162036493|NCT03823378|585190864|FG005|Overall Study|Lost to Follow-up|0|||
162036494|NCT03823378|585190859|FG000|Overall Study|Withdrawal by Subject|0|||
162036495|NCT03823378|585190860|FG001|Overall Study|Withdrawal by Subject|1|||
162036496|NCT03823378|585190861|FG002|Overall Study|Withdrawal by Subject|4|||
162036497|NCT03823378|585190862|FG003|Overall Study|Withdrawal by Subject|2|||
162036498|NCT03823378|585190863|FG004|Overall Study|Withdrawal by Subject|0|||
162036499|NCT03823378|585190864|FG005|Overall Study|Withdrawal by Subject|1|||
162036500|NCT03823378|585190859|FG000|Overall Study|Other, not specified|19|||
162036501|NCT03823378|585190860|FG001|Overall Study|Other, not specified|12|||
162036502|NCT03823378|585190861|FG002|Overall Study|Other, not specified|6|||
162036503|NCT03823378|585190862|FG003|Overall Study|Other, not specified|8|||
162036504|NCT03823378|585190863|FG004|Overall Study|Other, not specified|17|||
162036505|NCT03823378|585190864|FG005|Overall Study|Other, not specified|7|||
161886855|NCT03000530|584630171|FG002|Overall Study|Withdrawal by Subject|1|||
161886856|NCT01672294|584630172|FG000|Overall Study|Withdrawal by Subject|4|||
161886857|NCT01672294|584630173|FG001|Overall Study|Withdrawal by Subject|4|||
161886858|NCT01672294|584630174|FG002|Overall Study|Withdrawal by Subject|4|||
161886859|NCT01672294|584630175|FG003|Overall Study|Withdrawal by Subject|4|||
161886860|NCT01672294|584630172|FG000|Overall Study|Excluded by study|1|||
161886861|NCT01672294|584630173|FG001|Overall Study|Excluded by study|1|||
161886862|NCT01672294|584630174|FG002|Overall Study|Excluded by study|0|||
161886863|NCT01672294|584630175|FG003|Overall Study|Excluded by study|0|||
161886864|NCT01672294|584630172|FG000|Overall Study|Lost to Follow-up|1|||
161886865|NCT01672294|584630173|FG001|Overall Study|Lost to Follow-up|16|||
161886866|NCT01672294|584630174|FG002|Overall Study|Lost to Follow-up|7|||
161886867|NCT01672294|584630175|FG003|Overall Study|Lost to Follow-up|9|||
161886868|NCT01285492|584630176|FG000|Overall Study|Adverse Event|11|||
161886869|NCT01285492|584630177|FG001|Overall Study|Adverse Event|0|||
161886870|NCT01285492|584630176|FG000|Overall Study|Protocol Violation|3|||
161886871|NCT01285492|584630177|FG001|Overall Study|Protocol Violation|0|||
161886872|NCT01285492|584630176|FG000|Overall Study|Withdrawal by Subject|2|||
161886873|NCT01285492|584630177|FG001|Overall Study|Withdrawal by Subject|1|||
161886874|NCT01285492|584630176|FG000|Overall Study|Death|1|||
161886875|NCT01285492|584630177|FG001|Overall Study|Death|0|||
161886876|NCT03379792|584630178|FG000|Overall Study|Physician Decision|0|||
161886877|NCT03379792|584630179|FG001|Overall Study|Physician Decision|0|||
161886878|NCT03379792|584630180|FG002|Overall Study|Physician Decision|0|||
161886879|NCT03379792|584630181|FG003|Overall Study|Physician Decision|1|||
161886880|NCT03379792|584630182|FG004|Overall Study|Physician Decision|0|||
161886881|NCT03379792|584630183|FG005|Overall Study|Physician Decision|0|||
161886882|NCT03379792|584630178|FG000|Overall Study|Withdrawal by Subject|0|||
161886883|NCT03379792|584630179|FG001|Overall Study|Withdrawal by Subject|0|||
161886884|NCT03379792|584630180|FG002|Overall Study|Withdrawal by Subject|0|||
161886885|NCT03379792|584630181|FG003|Overall Study|Withdrawal by Subject|0|||
161886886|NCT03379792|584630182|FG004|Overall Study|Withdrawal by Subject|1|||
161886887|NCT03379792|584630183|FG005|Overall Study|Withdrawal by Subject|1|||
161886888|NCT01121536|584630185|FG000|Overall Study|Adverse Event|63|||
161886889|NCT01121536|584630185|FG000|Overall Study|Lack of Efficacy|35|||
161886890|NCT01121536|584630185|FG000|Overall Study|Withdrawal by Subject|65|||
161886891|NCT01121536|584630185|FG000|Overall Study|Protocol Violation|20|||
161886892|NCT01121536|584630185|FG000|Overall Study|Noncompliance with study medication|12|||
161886893|NCT01121536|584630185|FG000|Overall Study|Noncompliance with study procedures|9|||
161886894|NCT01121536|584630185|FG000|Overall Study|Lost to Follow-up|39|||
161886895|NCT01121536|584630185|FG000|Overall Study|Other|118|||
161886896|NCT02649426|584630186|FG000|Overall Study|Follow-up on going|1|||
161886897|NCT02649426|584630187|FG001|Overall Study|Follow-up on going|26|||
161886898|NCT02649426|584630188|FG002|Overall Study|Follow-up on going|28|||
161886899|NCT02649426|584630189|FG003|Overall Study|Follow-up on going|31|||
162036506|NCT03190369|585190865|FG000|Overall Study|Poor compliance to protocol|0|||
162036507|NCT03190369|585190866|FG001|Overall Study|Poor compliance to protocol|1|||
162036508|NCT03190369|585190865|FG000|Overall Study|Withdraw before treatment|1|||
162036509|NCT03190369|585190866|FG001|Overall Study|Withdraw before treatment|5|||
162036510|NCT03190369|585190865|FG000|Overall Study|Randomized but not treated|0|||
162036511|NCT03190369|585190866|FG001|Overall Study|Randomized but not treated|2|||
162036512|NCT01289782|585190867|FG000|Overall Study|Lost to Follow-up|14|||
161886900|NCT01606202|584630190|FG000|Overall Study|Adverse Event|5|||
161886901|NCT01606202|584630191|FG001|Overall Study|Adverse Event|0|||
161886902|NCT01606202|584630190|FG000|Overall Study|Withdrawal by Subject|2|||
161886903|NCT01606202|584630191|FG001|Overall Study|Withdrawal by Subject|1|||
161886904|NCT01606202|584630190|FG000|Overall Study|Personal problems|0|||
161886905|NCT01606202|584630191|FG001|Overall Study|Personal problems|1|||
161886906|NCT01606202|584630190|FG000|Overall Study|Problems with administration|0|||
161886907|NCT01606202|584630191|FG001|Overall Study|Problems with administration|1|||
161886908|NCT00306787|584630192|FG000|Overall Study|Discontinued without taking study drug|208|||
161886909|NCT00306787|584630193|FG001|Overall Study|Discontinued without taking study drug|215|||
161886910|NCT00306787|584630192|FG000|Overall Study|Adverse Event|1|||
161886911|NCT00306787|584630193|FG001|Overall Study|Adverse Event|1|||
161886912|NCT00306787|584630192|FG000|Overall Study|Lack of Efficacy|1|||
161886913|NCT00306787|584630193|FG001|Overall Study|Lack of Efficacy|0|||
161886914|NCT00306787|584630192|FG000|Overall Study|Protocol Violation|8|||
161886915|NCT00306787|584630193|FG001|Overall Study|Protocol Violation|10|||
161886916|NCT00306787|584630192|FG000|Overall Study|Withdrawal by Subject|2|||
161886917|NCT00306787|584630193|FG001|Overall Study|Withdrawal by Subject|9|||
161886918|NCT00306787|584630192|FG000|Overall Study|Lost to Follow-up|9|||
161886919|NCT00306787|584630193|FG001|Overall Study|Lost to Follow-up|6|||
161886920|NCT00306787|584630192|FG000|Overall Study|Administrative problems|4|||
161886921|NCT00306787|584630193|FG001|Overall Study|Administrative problems|0|||
161886922|NCT00306787|584630192|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161886923|NCT00306787|584630193|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161886924|NCT00369161|584630194|FG000|Overall Study|Adverse Event|15|||
161886925|NCT00369161|584630195|FG001|Overall Study|Adverse Event|13|||
161886926|NCT00369161|584630194|FG000|Overall Study|Abnormal laboratory value|0|||
161886927|NCT00369161|584630195|FG001|Overall Study|Abnormal laboratory value|1|||
161886928|NCT00369161|584630194|FG000|Overall Study|Lack of Efficacy|3|||
161886929|NCT00369161|584630195|FG001|Overall Study|Lack of Efficacy|1|||
161886930|NCT00369161|584630194|FG000|Overall Study|Protocol Violation|0|||
161886931|NCT00369161|584630195|FG001|Overall Study|Protocol Violation|2|||
161886932|NCT00369161|584630194|FG000|Overall Study|Withdrawal by Subject|2|||
161886933|NCT00369161|584630195|FG001|Overall Study|Withdrawal by Subject|3|||
161886934|NCT00369161|584630194|FG000|Overall Study|Death|1|||
161886935|NCT00369161|584630195|FG001|Overall Study|Death|2|||
161886936|NCT00369161|584630194|FG000|Overall Study|Graft loss|4|||
161886937|NCT00369161|584630195|FG001|Overall Study|Graft loss|0|||
161886938|NCT00369161|584630194|FG000|Overall Study|Administrative Problem|2|||
161992380|NCT02476006|585019934|FG000|Overall Study|Pregnancy|1|||
161992381|NCT02476006|585019934|FG000|Overall Study|Participant did not wish to continue|39|||
161992382|NCT02476006|585019934|FG000|Overall Study|Adverse Event|41|||
161992383|NCT02476006|585019934|FG000|Overall Study|Poor compliance to study protocol|3|||
161992384|NCT02476006|585019934|FG000|Overall Study|Sponsor decision|6|||
161992385|NCT02476006|585019934|FG000|Overall Study|Lost to Follow-up|5|||
161992386|NCT02476006|585019934|FG000|Overall Study|Physician Decision|5|||
161992387|NCT02476006|585019934|FG000|Overall Study|Study ended treatment not available|4|||
161992388|NCT02476006|585019934|FG000|Overall Study|Switched to commercial drug|4|||
161992389|NCT02476006|585019934|FG000|Overall Study|Excluded from study|1|||
161992390|NCT02476006|585019934|FG000|Overall Study|Protocol Violation|1|||
161992391|NCT02476006|585019934|FG000|Overall Study|Enrolled but not treated|4|||
161992392|NCT00811174|585019935|FG000|Overall Study|Protocol Violation|2|||
161992393|NCT00811174|585019935|FG000|Overall Study|Sponsors Decision|1|||
161992394|NCT00447226|585021577|FG000|12-Week Open-label Phase|Adverse Event|0|||
161992395|NCT00447226|585021578|FG001|12-Week Open-label Phase|Adverse Event|3|||
161992396|NCT00447226|585021577|FG000|12-Week Open-label Phase|Protocol Violation|0|||
161992397|NCT00447226|585021578|FG001|12-Week Open-label Phase|Protocol Violation|1|||
161992398|NCT00447226|585021577|FG000|12-Week Open-label Phase|Disease Progression|0|||
161992399|NCT00447226|585021578|FG001|12-Week Open-label Phase|Disease Progression|20|||
161992400|NCT00447226|585021577|FG000|12-Week Open-label Phase|Physician Decision|0|||
161992401|NCT00447226|585021578|FG001|12-Week Open-label Phase|Physician Decision|1|||
161992402|NCT00447226|585021577|FG000|Double-blind Phase|Disease Progression|4|||
161992403|NCT00447226|585021578|FG001|Double-blind Phase|Disease Progression|3|||
161992404|NCT03449758|585021586|FG000|Overall Study|Major protocol deviation|1|||
161992405|NCT03449758|585021586|FG000|Overall Study|Treatment inefficacy|5|||
161992406|NCT03449758|585021586|FG000|Overall Study|Adverse Event|9|||
161886939|NCT00369161|584630195|FG001|Overall Study|Administrative Problem|2|||
161886940|NCT01870297|584630198|FG000|Overall Study|Adverse Event|0|||
161886941|NCT01870297|584630199|FG001|Overall Study|Adverse Event|0|||
161886942|NCT01870297|584630200|FG002|Overall Study|Adverse Event|0|||
161886943|NCT01870297|584630201|FG003|Overall Study|Adverse Event|0|||
161886944|NCT01870297|584630202|FG004|Overall Study|Adverse Event|2|||
161992407|NCT03449758|585021586|FG000|Overall Study|Consent withdrawal|1|||
161992408|NCT03449758|585021586|FG000|Overall Study|Other unspecified reason|3|||
161992409|NCT01478971|585021595|FG000|Standard of Care Period|Adverse Event|1|||
161886945|NCT01870297|584630203|FG005|Overall Study|Adverse Event|0|||
161886946|NCT01870297|584630204|FG006|Overall Study|Adverse Event|0|||
161886947|NCT01870297|584630198|FG000|Overall Study|Lost to Follow-up|0|||
162036513|NCT01289782|585190868|FG001|Overall Study|Lost to Follow-up|7|||
162036514|NCT01289782|585190867|FG000|Overall Study|Protocol Violation|1|||
162036515|NCT01289782|585190868|FG001|Overall Study|Protocol Violation|1|||
162036516|NCT01289782|585190867|FG000|Overall Study|Withdrawal by Subject|8|||
162036517|NCT01289782|585190868|FG001|Overall Study|Withdrawal by Subject|2|||
162036518|NCT01289782|585190867|FG000|Overall Study|Sponsor's Decision|1|||
162036519|NCT01289782|585190868|FG001|Overall Study|Sponsor's Decision|0|||
162036520|NCT01289782|585190867|FG000|Overall Study|Reason not specified|1|||
162036521|NCT01289782|585190868|FG001|Overall Study|Reason not specified|2|||
162036522|NCT01264016|585190874|FG000|Overall Study|Withdrawal by Subject|1|||
162036523|NCT01264016|585190874|FG000|Overall Study|Felt faint at sight of blood|1|||
162036524|NCT01629706|585190875|FG000|Phase 1 PureVision|Screen Failure|4|||
162036525|NCT01629706|585190875|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
162036526|NCT01629706|585190875|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
162036527|NCT01629706|585190875|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
162036528|NCT01629706|585190875|FG000|Phase 2 Habitual|Screen Failure|6|||
162036529|NCT01629706|585190875|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
162036530|NCT01629706|585190875|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
162036531|NCT01629706|585190875|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
162036532|NCT01629706|585190875|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
162036533|NCT00048061|585190876|FG000|Overall Study|Adverse Event|41|||
162036534|NCT00048061|585190877|FG001|Overall Study|Adverse Event|32|||
162036535|NCT00048061|585190878|FG002|Overall Study|Adverse Event|44|||
162036536|NCT00048061|585190879|FG003|Overall Study|Adverse Event|37|||
162036537|NCT00048061|585190876|FG000|Overall Study|Lost to Follow-up|3|||
162036538|NCT00048061|585190877|FG001|Overall Study|Lost to Follow-up|2|||
162036539|NCT00048061|585190878|FG002|Overall Study|Lost to Follow-up|4|||
162036540|NCT00048061|585190879|FG003|Overall Study|Lost to Follow-up|5|||
162036541|NCT00048061|585190876|FG000|Overall Study|Withdrawal by Subject|20|||
162036542|NCT00048061|585190877|FG001|Overall Study|Withdrawal by Subject|29|||
162036543|NCT00048061|585190878|FG002|Overall Study|Withdrawal by Subject|29|||
162036544|NCT00048061|585190879|FG003|Overall Study|Withdrawal by Subject|32|||
162036545|NCT00048061|585190876|FG000|Overall Study|Did not follow-up|5|||
162036546|NCT00048061|585190877|FG001|Overall Study|Did not follow-up|5|||
162036547|NCT00048061|585190878|FG002|Overall Study|Did not follow-up|4|||
162036548|NCT00048061|585190879|FG003|Overall Study|Did not follow-up|5|||
162036549|NCT00048061|585190876|FG000|Overall Study|Early improvement|6|||
162036550|NCT00048061|585190877|FG001|Overall Study|Early improvement|5|||
162036551|NCT00048061|585190878|FG002|Overall Study|Early improvement|3|||
162036552|NCT00048061|585190879|FG003|Overall Study|Early improvement|0|||
162036553|NCT01262352|585190880|FG000|Period 1|Illness after randomization|1|||
162036554|NCT01262352|585190881|FG001|Period 1|Illness after randomization|0|||
162036555|NCT01262352|585190880|FG000|Washout|Adverse Event|1|||
162036556|NCT01262352|585190881|FG001|Washout|Adverse Event|1|||
162036557|NCT01262352|585190880|FG000|Washout|Extended Washout|0|||
162036558|NCT01262352|585190881|FG001|Washout|Extended Washout|1|||
162036559|NCT01298193|585190882|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
162036560|NCT01298193|585190882|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
162036561|NCT01298193|585190882|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
162036562|NCT01298193|585190882|FG000|Efficacy Phase (Second Cycle)|Death|1|||
162036563|NCT01975831|585190883|FG000|Overall Study|Adverse Event|1|||
162036564|NCT01975831|585190884|FG001|Overall Study|Adverse Event|2|||
162036565|NCT01975831|585190885|FG002|Overall Study|Adverse Event|2|||
162036566|NCT01975831|585190886|FG003|Overall Study|Adverse Event|0|||
162036567|NCT01975831|585190887|FG004|Overall Study|Adverse Event|1|||
162036568|NCT01975831|585190888|FG005|Overall Study|Adverse Event|1|||
162036569|NCT01975831|585190889|FG006|Overall Study|Adverse Event|3|||
162036570|NCT01975831|585190890|FG007|Overall Study|Adverse Event|4|||
162036571|NCT01975831|585190891|FG008|Overall Study|Adverse Event|1|||
162036572|NCT01975831|585190883|FG000|Overall Study|Death|1|||
161886948|NCT01870297|584630199|FG001|Overall Study|Lost to Follow-up|1|||
161886949|NCT01870297|584630200|FG002|Overall Study|Lost to Follow-up|1|||
162036573|NCT01975831|585190884|FG001|Overall Study|Death|1|||
162036574|NCT01975831|585190885|FG002|Overall Study|Death|0|||
162036575|NCT01975831|585190886|FG003|Overall Study|Death|0|||
162036576|NCT01975831|585190887|FG004|Overall Study|Death|1|||
162036577|NCT01975831|585190888|FG005|Overall Study|Death|0|||
162036578|NCT01975831|585190889|FG006|Overall Study|Death|1|||
162036579|NCT01975831|585190890|FG007|Overall Study|Death|0|||
162036580|NCT01975831|585190891|FG008|Overall Study|Death|0|||
162036581|NCT01975831|585190883|FG000|Overall Study|Progressive Disease|1|||
162036582|NCT01975831|585190884|FG001|Overall Study|Progressive Disease|3|||
162036583|NCT01975831|585190885|FG002|Overall Study|Progressive Disease|2|||
162036584|NCT01975831|585190886|FG003|Overall Study|Progressive Disease|4|||
162036585|NCT01975831|585190887|FG004|Overall Study|Progressive Disease|13|||
162036586|NCT01975831|585190888|FG005|Overall Study|Progressive Disease|9|||
162036587|NCT01975831|585190889|FG006|Overall Study|Progressive Disease|10|||
162036588|NCT01975831|585190890|FG007|Overall Study|Progressive Disease|8|||
162036589|NCT01975831|585190891|FG008|Overall Study|Progressive Disease|10|||
161886950|NCT01870297|584630201|FG003|Overall Study|Lost to Follow-up|0|||
161886951|NCT01870297|584630202|FG004|Overall Study|Lost to Follow-up|0|||
161886952|NCT01870297|584630203|FG005|Overall Study|Lost to Follow-up|0|||
161992410|NCT01478971|585021595|FG000|Standard of Care Period|Withdrawal by Subject|3|||
161992411|NCT01478971|585021595|FG000|Standard of Care Period|Death|8|||
161992412|NCT01478971|585021595|FG000|Standard of Care Period|Lost to Follow-up|9|||
161992413|NCT01478971|585021595|FG000|Standard of Care Period|Other|4|||
161992414|NCT01478971|585021595|FG000|Peginesatide Treatment Period|Adverse Event|1|||
161992415|NCT01478971|585021595|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
161992416|NCT01478971|585021595|FG000|Peginesatide Treatment Period|Death|4|||
161992417|NCT01478971|585021595|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
161992418|NCT01478971|585021595|FG000|Peginesatide Treatment Period|Other|4|||
161992419|NCT00584012|585021596|FG000|Overall Study|Withdrawal by Subject|1|||
161992420|NCT04404556|585021597|FG000|Intervention|Withdrawal by Subject|15|||
161992421|NCT04404556|585021598|FG001|Intervention|Withdrawal by Subject|3|||
161992422|NCT04404556|585021597|FG000|Intervention|Did not complete all intervention sessions|2|||
161992423|NCT04404556|585021598|FG001|Intervention|Did not complete all intervention sessions|1|||
161992424|NCT04404556|585021597|FG000|Post-Intervention|Missing Data|1|||
161992425|NCT04404556|585021598|FG001|Post-Intervention|Missing Data|2|||
161992426|NCT04404556|585021597|FG000|Follow-up 1|Withdrawal by Subject|5|||
161992427|NCT04404556|585021598|FG001|Follow-up 1|Withdrawal by Subject|1|||
161992428|NCT04404556|585021597|FG000|Follow-up 1|Missing Data|4|||
161992429|NCT04404556|585021598|FG001|Follow-up 1|Missing Data|7|||
161992430|NCT04404556|585021597|FG000|Follow-up 2|Withdrawal by Subject|1|||
161992431|NCT04404556|585021598|FG001|Follow-up 2|Withdrawal by Subject|1|||
161992432|NCT04404556|585021597|FG000|Follow-up 2|Missing Data|6|||
161992433|NCT04404556|585021598|FG001|Follow-up 2|Missing Data|5|||
161992434|NCT02451943|585021602|FG000|Overall Study|Withdrawal by Subject|13|||
161992435|NCT02451943|585021603|FG001|Overall Study|Withdrawal by Subject|16|||
161992436|NCT02451943|585021602|FG000|Overall Study|Lost to Follow-up|3|||
161992437|NCT02451943|585021603|FG001|Overall Study|Lost to Follow-up|4|||
161992438|NCT02451943|585021602|FG000|Overall Study|Sponsor Decision|0|||
161886953|NCT01870297|584630204|FG006|Overall Study|Lost to Follow-up|0|||
161886954|NCT01870297|584630198|FG000|Overall Study|Withdrawal by Subject|0|||
161886955|NCT01870297|584630199|FG001|Overall Study|Withdrawal by Subject|0|||
161886956|NCT01870297|584630200|FG002|Overall Study|Withdrawal by Subject|0|||
161886957|NCT01870297|584630201|FG003|Overall Study|Withdrawal by Subject|0|||
161886958|NCT01870297|584630202|FG004|Overall Study|Withdrawal by Subject|1|||
161886959|NCT01870297|584630203|FG005|Overall Study|Withdrawal by Subject|1|||
161886960|NCT01870297|584630204|FG006|Overall Study|Withdrawal by Subject|1|||
161886961|NCT01870297|584630198|FG000|Overall Study|Sponsor Decision|0|||
161886962|NCT01870297|584630199|FG001|Overall Study|Sponsor Decision|6|||
161886963|NCT01870297|584630200|FG002|Overall Study|Sponsor Decision|0|||
161886964|NCT01870297|584630201|FG003|Overall Study|Sponsor Decision|0|||
161886965|NCT01870297|584630202|FG004|Overall Study|Sponsor Decision|0|||
161886966|NCT01870297|584630203|FG005|Overall Study|Sponsor Decision|0|||
161886967|NCT01870297|584630204|FG006|Overall Study|Sponsor Decision|1|||
161886968|NCT00337779|584630205|FG000|Overall Study|Withdrawal by Subject|10|||
161886969|NCT00337779|584630206|FG001|Overall Study|Withdrawal by Subject|12|||
161886970|NCT00337779|584630205|FG000|Overall Study|Sponsor decision|1|||
161886971|NCT00337779|584630206|FG001|Overall Study|Sponsor decision|1|||
161886972|NCT00337779|584630205|FG000|Overall Study|Physician Decision|3|||
161886973|NCT00337779|584630206|FG001|Overall Study|Physician Decision|6|||
161886974|NCT00337779|584630205|FG000|Overall Study|Protocol Violation|1|||
161886975|NCT00337779|584630206|FG001|Overall Study|Protocol Violation|1|||
161886976|NCT00337779|584630205|FG000|Overall Study|Lost to Follow-up|6|||
161886977|NCT00337779|584630206|FG001|Overall Study|Lost to Follow-up|5|||
161886978|NCT00337779|584630205|FG000|Overall Study|Adverse Event|28|||
161886979|NCT00337779|584630206|FG001|Overall Study|Adverse Event|51|||
161886980|NCT00337779|584630205|FG000|Overall Study|Pregnancy|3|||
161886981|NCT00337779|584630206|FG001|Overall Study|Pregnancy|2|||
161886982|NCT00337779|584630205|FG000|Overall Study|Death|0|||
161992439|NCT02451943|585021603|FG001|Overall Study|Sponsor Decision|4|||
161992440|NCT03937713|585021604|FG000|Overall Study|Withdrawal by Subject|3|||
161886983|NCT00337779|584630206|FG001|Overall Study|Death|1|||
161886984|NCT01593254|584630209|FG000|Overall Study|Disease progression|2|||
161886985|NCT01593254|584630210|FG001|Overall Study|Disease progression|7|||
161992441|NCT03937713|585021605|FG001|Overall Study|Withdrawal by Subject|6|||
161992442|NCT03937713|585021604|FG000|Overall Study|Lost to Follow-up|1|||
161992443|NCT03937713|585021605|FG001|Overall Study|Lost to Follow-up|0|||
161992444|NCT00763386|585021611|FG000|Overall Study|Adverse Event|43|||
161992445|NCT00763386|585021612|FG001|Overall Study|Adverse Event|33|||
161992446|NCT00763386|585021611|FG000|Overall Study|Death|1|||
161886986|NCT01593254|584630209|FG000|Overall Study|Study drug toxicity|6|||
161886987|NCT01593254|584630210|FG001|Overall Study|Study drug toxicity|20|||
161886988|NCT01593254|584630209|FG000|Overall Study|Death|3|||
161886989|NCT01593254|584630210|FG001|Overall Study|Death|3|||
161886990|NCT01593254|584630209|FG000|Overall Study|AE unrelated to study drug|0|||
161886991|NCT01593254|584630210|FG001|Overall Study|AE unrelated to study drug|1|||
161886992|NCT01593254|584630209|FG000|Overall Study|participant request to discontinue study treatment|1|||
161886993|NCT01593254|584630210|FG001|Overall Study|participant request to discontinue study treatment|3|||
161886994|NCT01593254|584630209|FG000|Overall Study|participant withdrew consent|0|||
161886995|NCT01593254|584630210|FG001|Overall Study|participant withdrew consent|9|||
161886996|NCT01593254|584630209|FG000|Overall Study|lost to follow up|1|||
161886997|NCT01593254|584630210|FG001|Overall Study|lost to follow up|6|||
161886998|NCT01593254|584630209|FG000|Overall Study|maximum clinical benefit|1|||
161886999|NCT01593254|584630210|FG001|Overall Study|maximum clinical benefit|2|||
161887000|NCT01593254|584630209|FG000|Overall Study|Poor/non compliance|1|||
161887001|NCT01593254|584630210|FG001|Overall Study|Poor/non compliance|1|||
161887002|NCT01593254|584630209|FG000|Overall Study|Pregnancy|0|||
161887003|NCT01593254|584630210|FG001|Overall Study|Pregnancy|3|||
161887004|NCT01593254|584630209|FG000|Overall Study|participant no longer meets study criteria|1|||
161887005|NCT01593254|584630210|FG001|Overall Study|participant no longer meets study criteria|1|||
161887006|NCT01593254|584630209|FG000|Overall Study|Admin reason by sponsor|7|||
161887007|NCT01593254|584630210|FG001|Overall Study|Admin reason by sponsor|3|||
161887008|NCT01593254|584630209|FG000|Overall Study|Imatinib treatment failure|2|||
161887009|NCT01593254|584630210|FG001|Overall Study|Imatinib treatment failure|0|||
161887010|NCT01593254|584630209|FG000|Overall Study|Other Reasons|61|||
161887011|NCT01593254|584630210|FG001|Overall Study|Other Reasons|115|||
161887012|NCT04249622|584630213|FG000|Overall Study|Withdrawal by Subject|1|||
161887013|NCT04249622|584630214|FG001|Overall Study|Withdrawal by Subject|1|||
161887014|NCT04249622|584630213|FG000|Overall Study|Alternative therapy|1|||
161887015|NCT04249622|584630214|FG001|Overall Study|Alternative therapy|0|||
161887016|NCT04249622|584630213|FG000|Overall Study|Discontinuation of pertuzumab|1|||
161887017|NCT04249622|584630214|FG001|Overall Study|Discontinuation of pertuzumab|0|||
161887018|NCT03689543|584630216|FG000|Overall Study|Adverse Event|0|||
161887019|NCT03689543|584630217|FG001|Overall Study|Adverse Event|0|||
161887020|NCT03689543|584630218|FG002|Overall Study|Adverse Event|1|||
161887021|NCT00932451|584630219|FG000|Overall Study|Withdrawal by Subject|69|||
161887022|NCT00932451|584630219|FG000|Overall Study|Lost to Follow-up|22|||
161887023|NCT00932451|584630219|FG000|Overall Study|Death|726|||
161887024|NCT00932451|584630219|FG000|Overall Study|Other reasons|5|||
161887025|NCT00586508|584630220|FG000|Overall Study|Progressive disease|52|||
161887026|NCT00586508|584630221|FG001|Overall Study|Progressive disease|8|||
161887027|NCT00586508|584630220|FG000|Overall Study|Death|0|||
161887028|NCT00586508|584630221|FG001|Overall Study|Death|1|||
161887029|NCT00586508|584630220|FG000|Overall Study|Adverse Event|12|||
161887030|NCT00586508|584630221|FG001|Overall Study|Adverse Event|4|||
161887031|NCT00586508|584630220|FG000|Overall Study|Withdrawal by Subject|4|||
161887032|NCT00586508|584630221|FG001|Overall Study|Withdrawal by Subject|0|||
161887033|NCT01294371|584630222|FG000|Overall Study|Adverse Event|1|||
161887034|NCT01294371|584630222|FG000|Overall Study|Withdrawal by Subject|12|||
161887035|NCT01294371|584630222|FG000|Overall Study|Lost to Follow-up|6|||
161887036|NCT01294371|584630222|FG000|Overall Study|Administrative Reason|1|||
161887037|NCT01294371|584630222|FG000|Overall Study|Other|14|||
161887038|NCT05619536|584630223|FG000|Overall Study|Withdrawal by Subject|0|||
161887039|NCT05619536|584630224|FG001|Overall Study|Withdrawal by Subject|1|||
161887040|NCT05619536|584630225|FG002|Overall Study|Withdrawal by Subject|0|||
161887041|NCT05619536|584630226|FG003|Overall Study|Withdrawal by Subject|1|||
161887042|NCT05619536|584630223|FG000|Overall Study|Lost to Follow-up|0|||
161887043|NCT05619536|584630224|FG001|Overall Study|Lost to Follow-up|1|||
161887044|NCT05619536|584630225|FG002|Overall Study|Lost to Follow-up|1|||
161887045|NCT05619536|584630226|FG003|Overall Study|Lost to Follow-up|0|||
161887046|NCT01592292|584630227|FG000|Overall Study|Follow-up loss|3|||
161887047|NCT01592292|584630228|FG001|Overall Study|Follow-up loss|3|||
161887048|NCT01592292|584630229|FG002|Overall Study|Follow-up loss|1|||
161887049|NCT01592292|584630230|FG003|Overall Study|Follow-up loss|0|||
161887050|NCT01592292|584630227|FG000|Overall Study|Withdrew consent|2|||
161887051|NCT01592292|584630228|FG001|Overall Study|Withdrew consent|1|||
161887052|NCT01592292|584630229|FG002|Overall Study|Withdrew consent|0|||
161887053|NCT01592292|584630230|FG003|Overall Study|Withdrew consent|0|||
161887054|NCT01592292|584630227|FG000|Overall Study|Other|1|||
161887055|NCT01592292|584630228|FG001|Overall Study|Other|1|||
161887056|NCT01592292|584630229|FG002|Overall Study|Other|2|||
161887057|NCT01592292|584630230|FG003|Overall Study|Other|1|||
161887058|NCT02923245|584630234|FG000|Overall Study|ultrasound order was cancelled|2|||
161887059|NCT02923245|584630235|FG001|Overall Study|ultrasound order was cancelled|1|||
162036590|NCT01975831|585190883|FG000|Overall Study|Withdrawal by Subject|0|||
161887060|NCT02680834|584630236|FG000|Overall Study|Physician Decision|5|||
161887061|NCT02680834|584630237|FG001|Overall Study|Physician Decision|2|||
161887062|NCT02680834|584630236|FG000|Overall Study|Withdrawal by Subject|6|||
161887063|NCT02680834|584630237|FG001|Overall Study|Withdrawal by Subject|0|||
161887064|NCT02680834|584630236|FG000|Overall Study|Lost to Follow-up|0|||
161887065|NCT02680834|584630237|FG001|Overall Study|Lost to Follow-up|1|||
161887066|NCT02520427|584630238|FG000|Overall Study|Decision by sponsor|0|||
161887067|NCT02520427|584630239|FG001|Overall Study|Decision by sponsor|0|||
162036591|NCT01975831|585190884|FG001|Overall Study|Withdrawal by Subject|3|||
162036592|NCT01975831|585190885|FG002|Overall Study|Withdrawal by Subject|0|||
162036593|NCT01975831|585190886|FG003|Overall Study|Withdrawal by Subject|0|||
162036594|NCT01975831|585190887|FG004|Overall Study|Withdrawal by Subject|3|||
162036595|NCT01975831|585190888|FG005|Overall Study|Withdrawal by Subject|1|||
162036596|NCT01975831|585190889|FG006|Overall Study|Withdrawal by Subject|1|||
162036597|NCT01975831|585190890|FG007|Overall Study|Withdrawal by Subject|0|||
162036598|NCT01975831|585190891|FG008|Overall Study|Withdrawal by Subject|0|||
162036599|NCT01975831|585190883|FG000|Overall Study|Physician Decision|0|||
162036600|NCT01975831|585190884|FG001|Overall Study|Physician Decision|0|||
162036601|NCT01975831|585190885|FG002|Overall Study|Physician Decision|0|||
162036602|NCT01975831|585190886|FG003|Overall Study|Physician Decision|0|||
162036603|NCT01975831|585190887|FG004|Overall Study|Physician Decision|0|||
162036604|NCT01975831|585190888|FG005|Overall Study|Physician Decision|1|||
162036605|NCT01975831|585190889|FG006|Overall Study|Physician Decision|0|||
162036606|NCT01975831|585190890|FG007|Overall Study|Physician Decision|1|||
162036607|NCT01975831|585190891|FG008|Overall Study|Physician Decision|0|||
162036608|NCT01975831|585190883|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
162036609|NCT01975831|585190884|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
162036610|NCT01975831|585190885|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
162036611|NCT01975831|585190886|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
162036612|NCT01975831|585190887|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
162036613|NCT01975831|585190888|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
162036614|NCT01975831|585190889|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
162036615|NCT01975831|585190890|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
162036616|NCT01975831|585190891|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
162036617|NCT01975831|585190883|FG000|Overall Study|Entered Hospice|0|||
162036618|NCT01975831|585190884|FG001|Overall Study|Entered Hospice|0|||
162036619|NCT01975831|585190885|FG002|Overall Study|Entered Hospice|0|||
162036620|NCT01975831|585190886|FG003|Overall Study|Entered Hospice|0|||
162036621|NCT01975831|585190887|FG004|Overall Study|Entered Hospice|0|||
162036622|NCT01975831|585190888|FG005|Overall Study|Entered Hospice|1|||
162036623|NCT01975831|585190889|FG006|Overall Study|Entered Hospice|0|||
162036624|NCT01975831|585190890|FG007|Overall Study|Entered Hospice|0|||
162036625|NCT01975831|585190891|FG008|Overall Study|Entered Hospice|0|||
162036626|NCT01975831|585190883|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
162036627|NCT01975831|585190884|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
162036628|NCT01975831|585190885|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
162036629|NCT01975831|585190886|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
162036630|NCT01975831|585190887|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
162036631|NCT01975831|585190888|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
162036632|NCT01975831|585190889|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
162036633|NCT01975831|585190890|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
162036634|NCT01975831|585190891|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
162036635|NCT02925793|585190892|FG000|Overall Study|Adverse Event|3|||
162036636|NCT02925793|585190893|FG001|Overall Study|Adverse Event|3|||
162036637|NCT02925793|585190894|FG002|Overall Study|Adverse Event|6|||
162036638|NCT02925793|585190892|FG000|Overall Study|Withdrawal by Subject|16|||
162036639|NCT02925793|585190893|FG001|Overall Study|Withdrawal by Subject|15|||
162036640|NCT02925793|585190894|FG002|Overall Study|Withdrawal by Subject|13|||
162036641|NCT02925793|585190892|FG000|Overall Study|Investigator Discretion|0|||
162036642|NCT02925793|585190893|FG001|Overall Study|Investigator Discretion|1|||
162036643|NCT02925793|585190894|FG002|Overall Study|Investigator Discretion|1|||
162036644|NCT02925793|585190892|FG000|Overall Study|Lost to Follow-up|2|||
162036645|NCT02925793|585190893|FG001|Overall Study|Lost to Follow-up|3|||
162036646|NCT02925793|585190894|FG002|Overall Study|Lost to Follow-up|1|||
162036647|NCT02925793|585190892|FG000|Overall Study|Lack of Efficacy|2|||
162036648|NCT02925793|585190893|FG001|Overall Study|Lack of Efficacy|6|||
162036649|NCT02925793|585190894|FG002|Overall Study|Lack of Efficacy|4|||
162036650|NCT02925793|585190892|FG000|Overall Study|Other:|2|||
162036651|NCT02925793|585190893|FG001|Overall Study|Other:|1|||
162036652|NCT02925793|585190894|FG002|Overall Study|Other:|3|||
162036653|NCT00393042|585190897|FG000|First Intervention|Withdrawal by Subject|1|||
162036654|NCT00393042|585190898|FG001|First Intervention|Withdrawal by Subject|2|||
162036655|NCT00393042|585190897|FG000|First Intervention|Lost to Follow-up|3|||
162036656|NCT00393042|585190898|FG001|First Intervention|Lost to Follow-up|3|||
162036657|NCT00393042|585190897|FG000|First Intervention|Protocol Violation|1|||
162036658|NCT00393042|585190898|FG001|First Intervention|Protocol Violation|0|||
162036659|NCT00393042|585190897|FG000|First Intervention|Adverse Event|0|||
162036660|NCT00393042|585190898|FG001|First Intervention|Adverse Event|1|||
162036661|NCT00393042|585190897|FG000|Second Intervetion|Adverse Event|0|||
162036662|NCT00393042|585190898|FG001|Second Intervetion|Adverse Event|3|||
162036663|NCT00393042|585190897|FG000|Second Intervetion|Withdrawal by Subject|0|||
162036664|NCT00393042|585190898|FG001|Second Intervetion|Withdrawal by Subject|2|||
162036665|NCT00393042|585190897|FG000|Second Intervetion|Lack of Efficacy|1|||
162036666|NCT00393042|585190898|FG001|Second Intervetion|Lack of Efficacy|0|||
162036667|NCT00393042|585190897|FG000|Second Intervetion|Lost to Follow-up|0|||
161887068|NCT02520427|584630240|FG002|Overall Study|Decision by sponsor|0|||
161887069|NCT02520427|584630241|FG003|Overall Study|Decision by sponsor|0|||
161887070|NCT02520427|584630242|FG004|Overall Study|Decision by sponsor|0|||
161887071|NCT02520427|584630243|FG005|Overall Study|Decision by sponsor|0|||
161887072|NCT02520427|584630244|FG006|Overall Study|Decision by sponsor|0|||
161887073|NCT02520427|584630245|FG007|Overall Study|Decision by sponsor|0|||
161992447|NCT00763386|585021612|FG001|Overall Study|Death|2|||
161992448|NCT00763386|585021611|FG000|Overall Study|Lost to Follow-up|3|||
161992449|NCT00763386|585021612|FG001|Overall Study|Lost to Follow-up|3|||
161992450|NCT00763386|585021611|FG000|Overall Study|Withdrawal by Subject|0|||
161992451|NCT00763386|585021612|FG001|Overall Study|Withdrawal by Subject|1|||
161992452|NCT00763386|585021611|FG000|Overall Study|CRF missing|0|||
161992453|NCT00763386|585021612|FG001|Overall Study|CRF missing|1|||
161992454|NCT00763386|585021611|FG000|Overall Study|Study Prosthesis Removed|1|||
161992455|NCT00763386|585021612|FG001|Overall Study|Study Prosthesis Removed|0|||
161992456|NCT00922623|585021613|FG000|Overall Study|Other|4|||
161992457|NCT00922623|585021613|FG000|Overall Study|Lost to Follow-up|1|||
161992458|NCT02451917|585021614|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
161992459|NCT02451917|585021615|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
161992460|NCT02451917|585021614|FG000|First Intervention (24 Weeks)|Death|0|||
161992461|NCT02451917|585021615|FG001|First Intervention (24 Weeks)|Death|1|||
161992462|NCT02451917|585021614|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
161992463|NCT02451917|585021615|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
161992464|NCT02871635|585021616|FG000|Overall Study|Primary lack of efficacy|4|||
161992465|NCT02871635|585021617|FG001|Overall Study|Primary lack of efficacy|4|||
161992466|NCT02871635|585021616|FG000|Overall Study|Protocol Violation|3|||
161992467|NCT02871635|585021617|FG001|Overall Study|Protocol Violation|1|||
161992468|NCT02871635|585021616|FG000|Overall Study|Lost to Follow-up|1|||
161992469|NCT02871635|585021617|FG001|Overall Study|Lost to Follow-up|2|||
161992470|NCT02871635|585021616|FG000|Overall Study|Pregnancy|0|||
161992471|NCT02871635|585021617|FG001|Overall Study|Pregnancy|2|||
161992472|NCT02871635|585021616|FG000|Overall Study|Physician Decision|1|||
161992473|NCT02871635|585021617|FG001|Overall Study|Physician Decision|1|||
161992474|NCT02871635|585021616|FG000|Overall Study|Withdrawal by Subject|3|||
161992475|NCT02871635|585021617|FG001|Overall Study|Withdrawal by Subject|4|||
161992476|NCT02871635|585021616|FG000|Overall Study|Adverse Event|4|||
161992477|NCT02871635|585021617|FG001|Overall Study|Adverse Event|4|||
161992478|NCT02871635|585021616|FG000|Overall Study|Secondary lack of efficacy|2|||
161992479|NCT02871635|585021617|FG001|Overall Study|Secondary lack of efficacy|1|||
161992480|NCT02420379|585021618|FG000|Overall Study|Withdrawal by Subject|0|||
161992481|NCT02420379|585021619|FG001|Overall Study|Withdrawal by Subject|3|||
161992482|NCT02420379|585021618|FG000|Overall Study|Unable to complete due to schooling|0|||
161992483|NCT02420379|585021619|FG001|Overall Study|Unable to complete due to schooling|1|||
161992484|NCT02420379|585021618|FG000|Overall Study|Transitioned to commercial drug|1|||
161992485|NCT02420379|585021619|FG001|Overall Study|Transitioned to commercial drug|0|||
161992486|NCT01402817|585021620|FG000|Overall Study|Withdrawal by Subject|3|||
161992487|NCT01402817|585021620|FG000|Overall Study|Study Suspended by FDA|8|||
161992488|NCT00502671|585021621|FG000|Overall Study|Disease Progression|13|||
161992489|NCT00502671|585021621|FG000|Overall Study|Personal Reasons|22|||
161992490|NCT00502671|585021621|FG000|Overall Study|Lost to Follow-up|7|||
161992491|NCT00502671|585021621|FG000|Overall Study|Protocol Violation|16|||
161992492|NCT00502671|585021621|FG000|Overall Study|Adverse Event|19|||
161992493|NCT00681629|585021628|FG000|Overall Study|Study termination|4|||
161992494|NCT00681629|585021629|FG001|Overall Study|Study termination|2|||
161992495|NCT00681629|585021628|FG000|Overall Study|Adverse Event|1|||
161992496|NCT00681629|585021629|FG001|Overall Study|Adverse Event|0|||
161992497|NCT01410890|585021632|FG000|Overall Study|Withdrawal by Subject|0|||
161992498|NCT01410890|585021633|FG001|Overall Study|Withdrawal by Subject|1|||
161992499|NCT00412893|585021634|FG000|Overall Study|Adverse Event|31|||
161887074|NCT02520427|584630246|FG008|Overall Study|Decision by sponsor|1|||
161992500|NCT00412893|585021635|FG001|Overall Study|Adverse Event|53|||
161992501|NCT00412893|585021634|FG000|Overall Study|Death|17|||
161992502|NCT00412893|585021635|FG001|Overall Study|Death|21|||
161992503|NCT00412893|585021634|FG000|Overall Study|Insufficient Therapeutic Response|39|||
161992504|NCT00412893|585021635|FG001|Overall Study|Insufficient Therapeutic Response|23|||
161992505|NCT00412893|585021634|FG000|Overall Study|Lost to Follow-up|2|||
161992506|NCT00412893|585021635|FG001|Overall Study|Lost to Follow-up|1|||
161992507|NCT00412893|585021634|FG000|Overall Study|Violation of Selection at Entry|17|||
161992508|NCT00412893|585021635|FG001|Overall Study|Violation of Selection at Entry|10|||
161992509|NCT00412893|585021634|FG000|Overall Study|Other Protocol Violation|10|||
161887075|NCT02520427|584630247|FG009|Overall Study|Decision by sponsor|1|||
161887076|NCT02520427|584630248|FG010|Overall Study|Decision by sponsor|0|||
161887077|NCT02520427|584630249|FG011|Overall Study|Decision by sponsor|0|||
161992510|NCT00412893|585021635|FG001|Overall Study|Other Protocol Violation|6|||
161992511|NCT00412893|585021634|FG000|Overall Study|Did Not Cooperate|12|||
161992512|NCT00412893|585021635|FG001|Overall Study|Did Not Cooperate|9|||
161992513|NCT00412893|585021634|FG000|Overall Study|Administrative Reason|12|||
161992514|NCT00412893|585021635|FG001|Overall Study|Administrative Reason|15|||
161887078|NCT02520427|584630250|FG012|Overall Study|Decision by sponsor|0|||
161887079|NCT02520427|584630251|FG013|Overall Study|Decision by sponsor|0|||
161887080|NCT02520427|584630252|FG014|Overall Study|Decision by sponsor|0|||
161887081|NCT02520427|584630253|FG015|Overall Study|Decision by sponsor|0|||
161887082|NCT02520427|584630254|FG016|Overall Study|Decision by sponsor|0|||
161887083|NCT02520427|584630255|FG017|Overall Study|Decision by sponsor|0|||
161992515|NCT00412893|585021634|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
161992516|NCT00412893|585021635|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
161992517|NCT03951077|585021636|FG000|Overall Study|Adverse Event|1|||
161992518|NCT03951077|585021637|FG001|Overall Study|Adverse Event|0|||
161992519|NCT03951077|585021638|FG002|Overall Study|Adverse Event|0|||
161992520|NCT03951077|585021639|FG003|Overall Study|Adverse Event|0|||
161992521|NCT03951077|585021640|FG004|Overall Study|Adverse Event|0|||
161992522|NCT03951077|585021641|FG005|Overall Study|Adverse Event|0|||
161992523|NCT03951077|585021636|FG000|Overall Study|Withdrawal by Subject|3|||
161992524|NCT03951077|585021637|FG001|Overall Study|Withdrawal by Subject|3|||
161992525|NCT03951077|585021638|FG002|Overall Study|Withdrawal by Subject|0|||
161992526|NCT03951077|585021639|FG003|Overall Study|Withdrawal by Subject|3|||
161992527|NCT03951077|585021640|FG004|Overall Study|Withdrawal by Subject|3|||
161992528|NCT03951077|585021641|FG005|Overall Study|Withdrawal by Subject|2|||
161992529|NCT03951077|585021636|FG000|Overall Study|Lost to Follow-up|1|||
161992530|NCT03951077|585021637|FG001|Overall Study|Lost to Follow-up|1|||
161992531|NCT03951077|585021638|FG002|Overall Study|Lost to Follow-up|2|||
161992532|NCT03951077|585021639|FG003|Overall Study|Lost to Follow-up|3|||
161992533|NCT03951077|585021640|FG004|Overall Study|Lost to Follow-up|2|||
161992534|NCT03951077|585021641|FG005|Overall Study|Lost to Follow-up|3|||
161992535|NCT03951077|585021636|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
161992536|NCT03951077|585021637|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
161992537|NCT03951077|585021638|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
161992538|NCT03951077|585021639|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
161992539|NCT03951077|585021640|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
161992540|NCT03951077|585021641|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
161992541|NCT03951077|585021636|FG000|Overall Study|Other, Not Specified|12|||
161992542|NCT03951077|585021637|FG001|Overall Study|Other, Not Specified|10|||
161992543|NCT03951077|585021638|FG002|Overall Study|Other, Not Specified|10|||
161992544|NCT03951077|585021639|FG003|Overall Study|Other, Not Specified|5|||
161992545|NCT03951077|585021640|FG004|Overall Study|Other, Not Specified|9|||
161992546|NCT03951077|585021641|FG005|Overall Study|Other, Not Specified|6|||
161992547|NCT03951077|585021636|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
161992548|NCT03951077|585021637|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
161992549|NCT03951077|585021638|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
161992550|NCT03951077|585021639|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
161992551|NCT03951077|585021640|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
161992552|NCT03951077|585021641|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
161992553|NCT00086047|585021642|FG000|Overall Study|Lost to Follow-up|7|||
161992554|NCT00086047|585021643|FG001|Overall Study|Lost to Follow-up|6|||
161992555|NCT00086047|585021642|FG000|Overall Study|Physician Decision|0|||
161992556|NCT00086047|585021643|FG001|Overall Study|Physician Decision|1|||
161992557|NCT01395901|585021644|FG000|Overall Study|Lost to Follow-up|4|||
161992558|NCT01395901|585021645|FG001|Overall Study|Lost to Follow-up|0|||
161992559|NCT01395901|585021644|FG000|Overall Study|Randomized but not received study drug|5|||
161992560|NCT01395901|585021645|FG001|Overall Study|Randomized but not received study drug|4|||
161887084|NCT02520427|584630256|FG018|Overall Study|Decision by sponsor|0|||
161887085|NCT02520427|584630257|FG019|Overall Study|Decision by sponsor|0|||
161887086|NCT02520427|584630258|FG020|Overall Study|Decision by sponsor|0|||
161887087|NCT02520427|584630259|FG021|Overall Study|Decision by sponsor|0|||
161887088|NCT02520427|584630260|FG022|Overall Study|Decision by sponsor|0|||
161887089|NCT02520427|584630261|FG023|Overall Study|Decision by sponsor|0|||
161887090|NCT02520427|584630262|FG024|Overall Study|Decision by sponsor|0|||
161887091|NCT02520427|584630263|FG025|Overall Study|Decision by sponsor|0|||
161887092|NCT02520427|584630238|FG000|Overall Study|Withdrawal by Subject|0|||
161887093|NCT02520427|584630239|FG001|Overall Study|Withdrawal by Subject|0|||
161887094|NCT02520427|584630240|FG002|Overall Study|Withdrawal by Subject|1|||
161887095|NCT02520427|584630241|FG003|Overall Study|Withdrawal by Subject|0|||
161887096|NCT02520427|584630242|FG004|Overall Study|Withdrawal by Subject|0|||
161887097|NCT02520427|584630243|FG005|Overall Study|Withdrawal by Subject|0|||
161992561|NCT01395901|585021644|FG000|Overall Study|Adverse Event|0|||
161992562|NCT01395901|585021645|FG001|Overall Study|Adverse Event|1|||
161992563|NCT01395901|585021644|FG000|Overall Study|Withdrawal of consent|1|||
161887098|NCT02520427|584630244|FG006|Overall Study|Withdrawal by Subject|0|||
161887099|NCT02520427|584630245|FG007|Overall Study|Withdrawal by Subject|0|||
161887100|NCT02520427|584630246|FG008|Overall Study|Withdrawal by Subject|0|||
161992564|NCT01395901|585021645|FG001|Overall Study|Withdrawal of consent|0|||
161992565|NCT03579940|585021650|FG000|Period 2|Withdrawal by Subject|0|||
161992566|NCT03579940|585021651|FG001|Period 2|Withdrawal by Subject|0|||
161992567|NCT03579940|585021652|FG002|Period 2|Withdrawal by Subject|1|||
161887101|NCT02520427|584630247|FG009|Overall Study|Withdrawal by Subject|0|||
161887102|NCT02520427|584630248|FG010|Overall Study|Withdrawal by Subject|0|||
161887103|NCT02520427|584630249|FG011|Overall Study|Withdrawal by Subject|0|||
161887104|NCT02520427|584630250|FG012|Overall Study|Withdrawal by Subject|1|||
161887105|NCT02520427|584630251|FG013|Overall Study|Withdrawal by Subject|1|||
161887106|NCT02520427|584630252|FG014|Overall Study|Withdrawal by Subject|1|||
161887107|NCT02520427|584630253|FG015|Overall Study|Withdrawal by Subject|0|||
161887108|NCT02520427|584630254|FG016|Overall Study|Withdrawal by Subject|1|||
161887109|NCT02520427|584630255|FG017|Overall Study|Withdrawal by Subject|0|||
161887110|NCT02520427|584630256|FG018|Overall Study|Withdrawal by Subject|0|||
161887111|NCT02520427|584630257|FG019|Overall Study|Withdrawal by Subject|3|||
161887112|NCT02520427|584630258|FG020|Overall Study|Withdrawal by Subject|2|||
161887113|NCT02520427|584630259|FG021|Overall Study|Withdrawal by Subject|0|||
161887114|NCT02520427|584630260|FG022|Overall Study|Withdrawal by Subject|0|||
161887115|NCT02520427|584630261|FG023|Overall Study|Withdrawal by Subject|0|||
161887116|NCT02520427|584630262|FG024|Overall Study|Withdrawal by Subject|0|||
161887117|NCT02520427|584630263|FG025|Overall Study|Withdrawal by Subject|0|||
161887118|NCT02520427|584630238|FG000|Overall Study|Death|1|||
161887119|NCT02520427|584630239|FG001|Overall Study|Death|0|||
161887120|NCT02520427|584630240|FG002|Overall Study|Death|0|||
161887121|NCT02520427|584630241|FG003|Overall Study|Death|0|||
161887122|NCT02520427|584630242|FG004|Overall Study|Death|0|||
161887123|NCT02520427|584630243|FG005|Overall Study|Death|0|||
161887124|NCT02520427|584630244|FG006|Overall Study|Death|0|||
161887125|NCT02520427|584630245|FG007|Overall Study|Death|0|||
161887126|NCT02520427|584630246|FG008|Overall Study|Death|0|||
161992568|NCT03579940|585021653|FG003|Period 2|Withdrawal by Subject|0|||
161992569|NCT03579940|585021654|FG004|Period 2|Withdrawal by Subject|0|||
161992570|NCT03579940|585021655|FG005|Period 2|Withdrawal by Subject|0|||
161992571|NCT03579940|585021656|FG006|Period 2|Withdrawal by Subject|0|||
161992572|NCT03579940|585021657|FG007|Period 2|Withdrawal by Subject|0|||
161992573|NCT03579940|585021658|FG008|Period 2|Withdrawal by Subject|0|||
161992574|NCT03579940|585021659|FG009|Period 2|Withdrawal by Subject|0|||
161992575|NCT03579940|585021660|FG010|Period 2|Withdrawal by Subject|0|||
161992576|NCT01217944|585021661|FG000|Overall Study|Protocol Violation|1|||
161992577|NCT01217944|585021662|FG001|Overall Study|Protocol Violation|1|||
161992578|NCT01217944|585021663|FG002|Overall Study|Protocol Violation|0|||
161992579|NCT01217944|585021661|FG000|Overall Study|Lost to Follow-up|3|||
161992580|NCT01217944|585021662|FG001|Overall Study|Lost to Follow-up|1|||
161992581|NCT01217944|585021663|FG002|Overall Study|Lost to Follow-up|0|||
161992582|NCT01217944|585021661|FG000|Overall Study|Withdrawal by Subject|1|||
161992583|NCT01217944|585021662|FG001|Overall Study|Withdrawal by Subject|2|||
161992584|NCT01217944|585021663|FG002|Overall Study|Withdrawal by Subject|0|||
161992585|NCT01217944|585021661|FG000|Overall Study|Lack of Efficacy|1|||
161992586|NCT01217944|585021662|FG001|Overall Study|Lack of Efficacy|0|||
161992587|NCT01217944|585021663|FG002|Overall Study|Lack of Efficacy|0|||
161992588|NCT00853151|585021666|FG000|Overall Study|Adverse Event|1|||
161992589|NCT00853151|585021667|FG001|Overall Study|Adverse Event|4|||
161992590|NCT00853151|585021668|FG002|Overall Study|Adverse Event|2|||
161992591|NCT00853151|585021669|FG003|Overall Study|Adverse Event|0|||
161992592|NCT00853151|585021666|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161992593|NCT00853151|585021667|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161992594|NCT00853151|585021668|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161992595|NCT00853151|585021669|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161992596|NCT00853151|585021666|FG000|Overall Study|Lost to Follow-up|2|||
161992597|NCT00853151|585021667|FG001|Overall Study|Lost to Follow-up|0|||
161992598|NCT00853151|585021668|FG002|Overall Study|Lost to Follow-up|3|||
161992599|NCT00853151|585021669|FG003|Overall Study|Lost to Follow-up|0|||
161992600|NCT00853151|585021666|FG000|Overall Study|Death|1|||
161992601|NCT00853151|585021667|FG001|Overall Study|Death|0|||
161992602|NCT00853151|585021668|FG002|Overall Study|Death|0|||
161992603|NCT00853151|585021669|FG003|Overall Study|Death|1|||
161992604|NCT00853151|585021666|FG000|Overall Study|Protocol Violation|0|||
161992605|NCT00853151|585021667|FG001|Overall Study|Protocol Violation|0|||
161992606|NCT00853151|585021668|FG002|Overall Study|Protocol Violation|0|||
161992607|NCT00853151|585021669|FG003|Overall Study|Protocol Violation|1|||
161992608|NCT00853151|585021666|FG000|Overall Study|Withdrawal by Subject|5|||
161992609|NCT00853151|585021667|FG001|Overall Study|Withdrawal by Subject|4|||
161992610|NCT00853151|585021668|FG002|Overall Study|Withdrawal by Subject|2|||
161992611|NCT00853151|585021669|FG003|Overall Study|Withdrawal by Subject|1|||
161992612|NCT00853151|585021666|FG000|Overall Study|Physician Decision|0|||
161992613|NCT00853151|585021667|FG001|Overall Study|Physician Decision|2|||
161992614|NCT00853151|585021668|FG002|Overall Study|Physician Decision|1|||
161992615|NCT00853151|585021669|FG003|Overall Study|Physician Decision|0|||
161992616|NCT00853151|585021666|FG000|Overall Study|Sponsor Decision|0|||
161992617|NCT00853151|585021667|FG001|Overall Study|Sponsor Decision|3|||
161887127|NCT02520427|584630247|FG009|Overall Study|Death|0|||
161887128|NCT02520427|584630248|FG010|Overall Study|Death|0|||
161887129|NCT02520427|584630249|FG011|Overall Study|Death|0|||
161992618|NCT00853151|585021668|FG002|Overall Study|Sponsor Decision|0|||
161887130|NCT02520427|584630250|FG012|Overall Study|Death|0|||
161887131|NCT02520427|584630251|FG013|Overall Study|Death|0|||
161887132|NCT02520427|584630252|FG014|Overall Study|Death|0|||
161887133|NCT02520427|584630253|FG015|Overall Study|Death|0|||
161887134|NCT02520427|584630254|FG016|Overall Study|Death|2|||
161887135|NCT02520427|584630255|FG017|Overall Study|Death|1|||
161887136|NCT02520427|584630256|FG018|Overall Study|Death|3|||
161887137|NCT02520427|584630257|FG019|Overall Study|Death|2|||
161887138|NCT02520427|584630258|FG020|Overall Study|Death|0|||
161887139|NCT02520427|584630259|FG021|Overall Study|Death|0|||
161887140|NCT02520427|584630260|FG022|Overall Study|Death|1|||
161887141|NCT02520427|584630261|FG023|Overall Study|Death|0|||
161887142|NCT02520427|584630262|FG024|Overall Study|Death|1|||
161887143|NCT02520427|584630263|FG025|Overall Study|Death|0|||
161887144|NCT00793624|584630264|FG000|Overall Study|Adverse Event|18|||
161887145|NCT00793624|584630265|FG001|Overall Study|Adverse Event|16|||
161887146|NCT00793624|584630266|FG002|Overall Study|Adverse Event|15|||
161887147|NCT00793624|584630267|FG003|Overall Study|Adverse Event|20|||
161887148|NCT00793624|584630264|FG000|Overall Study|Lost to Follow-up|2|||
161887149|NCT00793624|584630265|FG001|Overall Study|Lost to Follow-up|2|||
161887150|NCT00793624|584630266|FG002|Overall Study|Lost to Follow-up|4|||
161887151|NCT00793624|584630267|FG003|Overall Study|Lost to Follow-up|0|||
161887152|NCT00793624|584630264|FG000|Overall Study|Withdrawal by Subject|20|||
161887153|NCT00793624|584630265|FG001|Overall Study|Withdrawal by Subject|9|||
161887154|NCT00793624|584630266|FG002|Overall Study|Withdrawal by Subject|11|||
161887155|NCT00793624|584630267|FG003|Overall Study|Withdrawal by Subject|14|||
161887156|NCT00793624|584630264|FG000|Overall Study|Lack of Efficacy|9|||
161887157|NCT00793624|584630265|FG001|Overall Study|Lack of Efficacy|2|||
161887158|NCT00793624|584630266|FG002|Overall Study|Lack of Efficacy|1|||
161887159|NCT00793624|584630267|FG003|Overall Study|Lack of Efficacy|3|||
161887160|NCT00793624|584630264|FG000|Overall Study|Non compliance with protocol|2|||
161887161|NCT00793624|584630265|FG001|Overall Study|Non compliance with protocol|3|||
161887162|NCT00793624|584630266|FG002|Overall Study|Non compliance with protocol|2|||
161887163|NCT00793624|584630267|FG003|Overall Study|Non compliance with protocol|3|||
161887164|NCT00793624|584630264|FG000|Overall Study|Other reason not described above|6|||
162036668|NCT00393042|585190898|FG001|Second Intervetion|Lost to Follow-up|2|||
161887165|NCT00793624|584630265|FG001|Overall Study|Other reason not described above|4|||
161887166|NCT00793624|584630266|FG002|Overall Study|Other reason not described above|6|||
161887167|NCT00793624|584630267|FG003|Overall Study|Other reason not described above|3|||
161887168|NCT00157248|584630268|FG000|Overall Study|Adverse Event|36|||
161887169|NCT00157248|584630269|FG001|Overall Study|Adverse Event|25|||
161887170|NCT00157248|584630270|FG002|Overall Study|Adverse Event|13|||
161887171|NCT00157248|584630271|FG003|Overall Study|Adverse Event|33|||
161887172|NCT00157248|584630268|FG000|Overall Study|Protocol Violation|4|||
161887173|NCT00157248|584630269|FG001|Overall Study|Protocol Violation|0|||
161887174|NCT00157248|584630270|FG002|Overall Study|Protocol Violation|2|||
161887175|NCT00157248|584630271|FG003|Overall Study|Protocol Violation|2|||
161887176|NCT00157248|584630268|FG000|Overall Study|Lost to Follow-up|0|||
161887177|NCT00157248|584630269|FG001|Overall Study|Lost to Follow-up|1|||
161887178|NCT00157248|584630270|FG002|Overall Study|Lost to Follow-up|0|||
161887179|NCT00157248|584630271|FG003|Overall Study|Lost to Follow-up|0|||
161887180|NCT00157248|584630268|FG000|Overall Study|Withdrawal by Subject|1|||
161887181|NCT00157248|584630269|FG001|Overall Study|Withdrawal by Subject|4|||
161887182|NCT00157248|584630270|FG002|Overall Study|Withdrawal by Subject|3|||
161887183|NCT00157248|584630271|FG003|Overall Study|Withdrawal by Subject|3|||
161887184|NCT00157248|584630268|FG000|Overall Study|site closures, subject moving|7|||
161887185|NCT00157248|584630269|FG001|Overall Study|site closures, subject moving|7|||
161887186|NCT00157248|584630270|FG002|Overall Study|site closures, subject moving|3|||
161887187|NCT00157248|584630271|FG003|Overall Study|site closures, subject moving|9|||
161887188|NCT04102865|584630272|FG000|Overall Study|Adverse Event|4|||
161887189|NCT04102865|584630273|FG001|Overall Study|Adverse Event|0|||
161887190|NCT04102865|584630272|FG000|Overall Study|Lost to Follow-up|1|||
161887191|NCT04102865|584630273|FG001|Overall Study|Lost to Follow-up|0|||
161887192|NCT04102865|584630272|FG000|Overall Study|Withdrawal by Subject|2|||
161887193|NCT04102865|584630273|FG001|Overall Study|Withdrawal by Subject|0|||
161887194|NCT02073565|584630274|FG000|Cohort A|Withdrawal by Subject|1|||
161887195|NCT02073565|584630275|FG001|Cohort A|Withdrawal by Subject|0|||
161887196|NCT02073565|584630274|FG000|Cohort B|Withdrawal by Subject|1|||
161887197|NCT02073565|584630275|FG001|Cohort B|Withdrawal by Subject|2|||
161887198|NCT02073565|584630274|FG000|Cohort C|Withdrawal by Subject|0|||
161887199|NCT02073565|584630275|FG001|Cohort C|Withdrawal by Subject|2|||
161887200|NCT02073565|584630274|FG000|Cohort C|Lost to Follow-up|0|||
161887201|NCT02073565|584630275|FG001|Cohort C|Lost to Follow-up|2|||
161887202|NCT01764997|584630280|FG000|Run-in Period|Adverse Event|15|||
161887203|NCT01764997|584630281|FG001|Run-in Period|Adverse Event|0|||
161887204|NCT01764997|584630282|FG002|Run-in Period|Adverse Event|0|||
161887205|NCT01764997|584630283|FG003|Run-in Period|Adverse Event|0|||
161887206|NCT01764997|584630284|FG004|Run-in Period|Adverse Event|0|||
161887207|NCT01764997|584630280|FG000|Run-in Period|Lack of Efficacy|5|||
162036669|NCT00393042|585190897|FG000|Second Intervetion|Protocol Violation|1|||
162036670|NCT00393042|585190898|FG001|Second Intervetion|Protocol Violation|1|||
162036671|NCT03475875|585190899|FG000|Period 1|Lost to Follow-up|1|||
162036672|NCT03475875|585190900|FG001|Period 1|Lost to Follow-up|0|||
162036673|NCT03475875|585190899|FG000|Period 1|Adverse Event|2|||
162036674|NCT03475875|585190900|FG001|Period 1|Adverse Event|1|||
162036675|NCT03475875|585190899|FG000|Period 2|Adverse Event|3|||
162036676|NCT03475875|585190900|FG001|Period 2|Adverse Event|0|||
162036677|NCT03475875|585190899|FG000|Period 2|Protocol Violation|0|||
162036678|NCT03475875|585190900|FG001|Period 2|Protocol Violation|1|||
162036679|NCT01642407|585190904|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
162036680|NCT01642407|585190904|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
162036681|NCT01642407|585190904|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
162036682|NCT00256282|585190905|FG000|Overall Study|Disease progression, relapse during acti|12|||
162036683|NCT00256282|585190905|FG000|Overall Study|Adverse Event|3|||
162036684|NCT00256282|585190905|FG000|Overall Study|Physician Decision|1|||
162036685|NCT02431247|585190906|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
162036686|NCT02431247|585190907|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
162036687|NCT02431247|585190908|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
162036688|NCT02431247|585190906|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
162036689|NCT02431247|585190907|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
162036690|NCT02431247|585190908|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
162036691|NCT02431247|585190906|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
162036692|NCT02431247|585190907|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
162036693|NCT02431247|585190908|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
162036694|NCT02431247|585190906|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
162036695|NCT02431247|585190907|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
162036696|NCT02431247|585190908|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
162036697|NCT02431247|585190906|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
162036698|NCT02431247|585190907|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
162036699|NCT02431247|585190908|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
162036700|NCT02431247|585190906|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
162036701|NCT02431247|585190907|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
162036702|NCT02431247|585190908|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
162036703|NCT02431247|585190906|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
162036704|NCT02431247|585190907|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
162036705|NCT02431247|585190908|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
162036706|NCT02431247|585190906|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
162036707|NCT02431247|585190907|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
162036708|NCT02431247|585190908|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
162036709|NCT02431247|585190906|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
162036710|NCT02431247|585190907|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
162036711|NCT02431247|585190908|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
162036712|NCT02431247|585190906|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
162036713|NCT02431247|585190907|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
162036714|NCT02431247|585190908|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
162036715|NCT02431247|585190906|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
162036716|NCT02431247|585190907|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
162036717|NCT02431247|585190908|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
162036718|NCT02431247|585190906|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
162036719|NCT02431247|585190907|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
162036720|NCT02431247|585190908|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
162036721|NCT02431247|585190906|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
162036722|NCT02431247|585190907|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
162036723|NCT02431247|585190908|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
162036724|NCT02431247|585190906|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
162036725|NCT02431247|585190907|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
162036726|NCT02431247|585190908|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
162036727|NCT00667446|585190909|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
162036728|NCT00667446|585190910|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
162036729|NCT00667446|585190909|FG000|Treatment Period (36 Months)|Other|2|||
162036730|NCT00667446|585190910|FG001|Treatment Period (36 Months)|Other|2|||
162036731|NCT00667446|585190909|FG000|Treatment Period (36 Months)|Personal reasons|2|||
162036732|NCT00667446|585190910|FG001|Treatment Period (36 Months)|Personal reasons|2|||
162036733|NCT00667446|585190909|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
162036734|NCT00667446|585190910|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
162036735|NCT00667446|585190909|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
161887208|NCT01764997|584630281|FG001|Run-in Period|Lack of Efficacy|0|||
161887209|NCT01764997|584630282|FG002|Run-in Period|Lack of Efficacy|0|||
162036736|NCT00667446|585190910|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
162036737|NCT00667446|585190909|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
162036738|NCT00667446|585190910|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
162036739|NCT00667446|585190909|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
162036740|NCT00667446|585190910|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
162036741|NCT00667446|585190909|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
162036742|NCT00667446|585190910|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
162036743|NCT00667446|585190909|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
162036744|NCT00667446|585190910|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
162036745|NCT00591578|585190912|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
162036746|NCT00591578|585190913|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
162036747|NCT00591578|585190914|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
162036748|NCT00591578|585190912|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
162036749|NCT00591578|585190913|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
162036750|NCT00591578|585190914|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
162036751|NCT00591578|585190912|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
162036752|NCT00591578|585190913|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
162036753|NCT00591578|585190914|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
162036754|NCT00591578|585190912|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
162036755|NCT00591578|585190913|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
162036756|NCT00591578|585190914|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
162036757|NCT00591578|585190912|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
162036758|NCT00591578|585190913|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
162036759|NCT00591578|585190914|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
162036760|NCT00591578|585190912|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
162036761|NCT00591578|585190913|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
162036762|NCT00591578|585190914|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
162036763|NCT00591578|585190912|FG000|Double-Blind Treatment Phase|Other|4|||
162036764|NCT00591578|585190913|FG001|Double-Blind Treatment Phase|Other|9|||
162036765|NCT00591578|585190914|FG002|Double-Blind Treatment Phase|Other|4|||
162036766|NCT00591578|585190912|FG000|Open-Label Extension Phase|Adverse Event|3|||
162036767|NCT00591578|585190913|FG001|Open-Label Extension Phase|Adverse Event|5|||
162036768|NCT00591578|585190914|FG002|Open-Label Extension Phase|Adverse Event|0|||
162036769|NCT00591578|585190912|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
162036770|NCT00591578|585190913|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
162036771|NCT00591578|585190914|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
162036772|NCT00591578|585190912|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
162036773|NCT00591578|585190913|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
162036774|NCT00591578|585190914|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
162036775|NCT00591578|585190912|FG000|Open-Label Extension Phase|Other|1|||
162036776|NCT00591578|585190913|FG001|Open-Label Extension Phase|Other|0|||
162036777|NCT00591578|585190914|FG002|Open-Label Extension Phase|Other|0|||
162036778|NCT03631355|585190915|FG000|Overall Study|Lost to Follow-up|1|||
162036779|NCT03631355|585190916|FG001|Overall Study|Lost to Follow-up|2|||
162036780|NCT02810340|585190917|FG000|Overall Study|Withdrawal by Subject|1|||
162036781|NCT02810340|585190918|FG001|Overall Study|Withdrawal by Subject|0|||
162036782|NCT02810340|585190919|FG002|Overall Study|Withdrawal by Subject|0|||
162036783|NCT02810340|585190917|FG000|Overall Study|Incarceration|0|||
162036784|NCT02810340|585190918|FG001|Overall Study|Incarceration|1|||
162036785|NCT02810340|585190919|FG002|Overall Study|Incarceration|0|||
162036786|NCT02810340|585190917|FG000|Overall Study|Lost to Follow-up|0|||
162036787|NCT02810340|585190918|FG001|Overall Study|Lost to Follow-up|0|||
162036788|NCT02810340|585190919|FG002|Overall Study|Lost to Follow-up|1|||
162036789|NCT01307020|585190930|FG000|Overall Study|Lost to Follow-up|0|||
162036790|NCT01307020|585190931|FG001|Overall Study|Lost to Follow-up|0|||
162036791|NCT01307020|585190932|FG002|Overall Study|Lost to Follow-up|1|||
162036792|NCT01307020|585190933|FG003|Overall Study|Lost to Follow-up|1|||
162036793|NCT01307020|585190934|FG004|Overall Study|Lost to Follow-up|0|||
162036794|NCT01307020|585190935|FG005|Overall Study|Lost to Follow-up|0|||
162036795|NCT01307020|585190936|FG006|Overall Study|Lost to Follow-up|1|||
162036796|NCT01307020|585190937|FG007|Overall Study|Lost to Follow-up|0|||
162036797|NCT01307020|585190938|FG008|Overall Study|Lost to Follow-up|0|||
162036798|NCT01307020|585190939|FG009|Overall Study|Lost to Follow-up|0|||
162036799|NCT01307020|585190930|FG000|Overall Study|Electronic data capture failure|0|||
162036800|NCT01307020|585190931|FG001|Overall Study|Electronic data capture failure|1|||
162036801|NCT01307020|585190932|FG002|Overall Study|Electronic data capture failure|0|||
162036802|NCT01307020|585190933|FG003|Overall Study|Electronic data capture failure|0|||
162036803|NCT01307020|585190934|FG004|Overall Study|Electronic data capture failure|0|||
162036804|NCT01307020|585190935|FG005|Overall Study|Electronic data capture failure|0|||
162036805|NCT01307020|585190936|FG006|Overall Study|Electronic data capture failure|0|||
162036806|NCT01307020|585190937|FG007|Overall Study|Electronic data capture failure|0|||
162036807|NCT01307020|585190938|FG008|Overall Study|Electronic data capture failure|0|||
162036808|NCT01307020|585190939|FG009|Overall Study|Electronic data capture failure|0|||
162036809|NCT02125604|585190940|FG000|Overall Study|Other|4|||
162036810|NCT02125604|585190940|FG000|Overall Study|Investigator Decision|1|||
162036811|NCT02125604|585190940|FG000|Overall Study|Lost to Follow-up|2|||
162036812|NCT02125604|585190940|FG000|Overall Study|Consent Withdrawn|4|||
162036813|NCT02125604|585190940|FG000|Overall Study|Adverse Event|20|||
162036814|NCT00782795|585190943|FG000|Overall Study|Withdrawal by Subject|1|||
162036815|NCT00782795|585190944|FG001|Overall Study|Withdrawal by Subject|2|||
162036816|NCT04480424|585190945|FG000|Overall Study|Withdrawal by Subject|0|||
162036817|NCT04480424|585190946|FG001|Overall Study|Withdrawal by Subject|2|||
162036818|NCT04480424|585190945|FG000|Overall Study|Lost to Follow-up|3|||
162036819|NCT04480424|585190946|FG001|Overall Study|Lost to Follow-up|3|||
162036820|NCT04480424|585190945|FG000|Overall Study|Death|14|||
162036821|NCT04480424|585190946|FG001|Overall Study|Death|16|||
162036822|NCT04480424|585190945|FG000|Overall Study|Reason not Specified|5|||
162036823|NCT04480424|585190946|FG001|Overall Study|Reason not Specified|5|||
162036824|NCT00993044|585190947|FG000|Irinotecan 50 mg|Physician Decision|1|||
162036825|NCT00397943|585192587|FG000|Overall Study|Unspecified reasons|12|||
162036826|NCT00397943|585192588|FG001|Overall Study|Unspecified reasons|9|||
162036827|NCT00397943|585192589|FG002|Overall Study|Unspecified reasons|0|||
162036828|NCT00397943|585192590|FG003|Overall Study|Unspecified reasons|0|||
162036829|NCT00397943|585192591|FG004|Overall Study|Unspecified reasons|0|||
162036830|NCT05007717|585192592|FG000|Overall Study|Death|3|||
162036831|NCT05007717|585192593|FG001|Overall Study|Death|2|||
162036832|NCT00423670|585192595|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
162036833|NCT00423670|585192596|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
162036834|NCT00423670|585192597|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
162036835|NCT00423670|585192598|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
162036836|NCT00423670|585192599|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
162036837|NCT00423670|585192600|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
162036838|NCT00423670|585192601|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
162036839|NCT00423670|585192602|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
162036840|NCT00423670|585192595|FG000|Treatment Period|Adverse Event|8|||
162036841|NCT00423670|585192596|FG001|Treatment Period|Adverse Event|12|||
162036842|NCT00423670|585192597|FG002|Treatment Period|Adverse Event|15|||
162036843|NCT00423670|585192598|FG003|Treatment Period|Adverse Event|20|||
162036844|NCT00423670|585192599|FG004|Treatment Period|Adverse Event|9|||
162036845|NCT00423670|585192600|FG005|Treatment Period|Adverse Event|4|||
162036846|NCT00423670|585192601|FG006|Treatment Period|Adverse Event|7|||
162036847|NCT00423670|585192602|FG007|Treatment Period|Adverse Event|2|||
162036848|NCT00423670|585192595|FG000|Treatment Period|Protocol-defined clinical event|0|||
162036849|NCT00423670|585192596|FG001|Treatment Period|Protocol-defined clinical event|7|||
162036850|NCT00423670|585192597|FG002|Treatment Period|Protocol-defined clinical event|4|||
162036851|NCT00423670|585192598|FG003|Treatment Period|Protocol-defined clinical event|12|||
162036852|NCT00423670|585192599|FG004|Treatment Period|Protocol-defined clinical event|5|||
162036853|NCT00423670|585192600|FG005|Treatment Period|Protocol-defined clinical event|4|||
162036854|NCT00423670|585192601|FG006|Treatment Period|Protocol-defined clinical event|16|||
162036855|NCT00423670|585192602|FG007|Treatment Period|Protocol-defined clinical event|15|||
162036856|NCT00423670|585192595|FG000|Treatment Period|Lost to Follow-up|2|||
162036857|NCT00423670|585192596|FG001|Treatment Period|Lost to Follow-up|1|||
162036858|NCT00423670|585192597|FG002|Treatment Period|Lost to Follow-up|3|||
162036859|NCT00423670|585192598|FG003|Treatment Period|Lost to Follow-up|1|||
162036860|NCT00423670|585192599|FG004|Treatment Period|Lost to Follow-up|6|||
162036861|NCT00423670|585192600|FG005|Treatment Period|Lost to Follow-up|0|||
162036862|NCT00423670|585192601|FG006|Treatment Period|Lost to Follow-up|3|||
162036863|NCT00423670|585192602|FG007|Treatment Period|Lost to Follow-up|1|||
162036864|NCT00423670|585192595|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
162036865|NCT00423670|585192596|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
162036866|NCT00423670|585192597|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
162036867|NCT00423670|585192598|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
162036868|NCT00423670|585192599|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
162036869|NCT00423670|585192600|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
162036870|NCT00423670|585192601|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
162036871|NCT00423670|585192602|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
162036872|NCT00423670|585192595|FG000|Treatment Period|Investigator decision|0|||
162036873|NCT00423670|585192596|FG001|Treatment Period|Investigator decision|0|||
162036874|NCT00423670|585192597|FG002|Treatment Period|Investigator decision|0|||
162036875|NCT00423670|585192598|FG003|Treatment Period|Investigator decision|0|||
162036876|NCT00423670|585192599|FG004|Treatment Period|Investigator decision|0|||
162036877|NCT00423670|585192600|FG005|Treatment Period|Investigator decision|0|||
162036878|NCT00423670|585192601|FG006|Treatment Period|Investigator decision|0|||
162036879|NCT00423670|585192602|FG007|Treatment Period|Investigator decision|1|||
162036880|NCT00423670|585192595|FG000|Treatment Period|Non-compliance with protocol|3|||
162036881|NCT00423670|585192596|FG001|Treatment Period|Non-compliance with protocol|1|||
162036882|NCT00423670|585192597|FG002|Treatment Period|Non-compliance with protocol|1|||
162036883|NCT00423670|585192598|FG003|Treatment Period|Non-compliance with protocol|3|||
161992619|NCT00853151|585021669|FG003|Overall Study|Sponsor Decision|0|||
161992620|NCT01751984|585021670|FG000|Overall Study|Adverse Event|5|||
161992621|NCT01751984|585021671|FG001|Overall Study|Adverse Event|3|||
161992622|NCT01751984|585021670|FG000|Overall Study|Withdrawal by Subject|0|||
161992623|NCT01751984|585021671|FG001|Overall Study|Withdrawal by Subject|1|||
161992624|NCT01751984|585021670|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
161992625|NCT01751984|585021671|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
161992626|NCT00587158|585021672|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
161992627|NCT00587158|585021673|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
161992628|NCT00587158|585021672|FG000|Overall Study|Physician Decision|0|||
161992629|NCT00587158|585021673|FG001|Overall Study|Physician Decision|1|||
161992630|NCT00587158|585021672|FG000|Overall Study|Lost to Follow-up|1|||
161992631|NCT00587158|585021673|FG001|Overall Study|Lost to Follow-up|2|||
161992632|NCT00587158|585021672|FG000|Overall Study|Death|0|||
161992633|NCT00587158|585021673|FG001|Overall Study|Death|1|||
161992634|NCT00587158|585021672|FG000|Overall Study|Subject did not want to take study med|0|||
161992635|NCT00587158|585021673|FG001|Overall Study|Subject did not want to take study med|1|||
161992636|NCT01136408|585021674|FG000|Overall Study|Adverse Event|4|||
161992637|NCT01136408|585021675|FG001|Overall Study|Adverse Event|8|||
161992638|NCT01136408|585021676|FG002|Overall Study|Adverse Event|4|||
161992639|NCT01136408|585021674|FG000|Overall Study|Protocol Violation|1|||
161992640|NCT01136408|585021675|FG001|Overall Study|Protocol Violation|1|||
161992641|NCT01136408|585021676|FG002|Overall Study|Protocol Violation|1|||
161992642|NCT02274792|585021677|FG000|Overall Study|Withdrawal by Subject|13|||
161992643|NCT02274792|585021677|FG000|Overall Study|Lost to Follow-up|8|||
161992644|NCT02274792|585021677|FG000|Overall Study|Protocol Specified Criteria|2|||
161992645|NCT02274792|585021677|FG000|Overall Study|Sponsor Decision|2|||
161992646|NCT01510158|585021678|FG000|Overall Study|Adverse Event|7|||
161992647|NCT01510158|585021679|FG001|Overall Study|Adverse Event|8|||
161992648|NCT01510158|585021680|FG002|Overall Study|Adverse Event|5|||
161992649|NCT01510158|585021678|FG000|Overall Study|Gout flare|1|||
161992650|NCT01510158|585021679|FG001|Overall Study|Gout flare|0|||
161992651|NCT01510158|585021680|FG002|Overall Study|Gout flare|0|||
161992652|NCT01510158|585021678|FG000|Overall Study|Protocol Violation|17|||
161992653|NCT01510158|585021679|FG001|Overall Study|Protocol Violation|16|||
161992654|NCT01510158|585021680|FG002|Overall Study|Protocol Violation|24|||
161992655|NCT01510158|585021678|FG000|Overall Study|Sponsor terminated study.|2|||
161992656|NCT01510158|585021679|FG001|Overall Study|Sponsor terminated study.|0|||
161992657|NCT01510158|585021680|FG002|Overall Study|Sponsor terminated study.|2|||
161992658|NCT01510158|585021678|FG000|Overall Study|Lost to Follow-up|13|||
161992659|NCT01510158|585021679|FG001|Overall Study|Lost to Follow-up|16|||
161992660|NCT01510158|585021680|FG002|Overall Study|Lost to Follow-up|9|||
161992661|NCT01510158|585021678|FG000|Overall Study|Withdrawal by Subject|10|||
161992662|NCT01510158|585021679|FG001|Overall Study|Withdrawal by Subject|13|||
161992663|NCT01510158|585021680|FG002|Overall Study|Withdrawal by Subject|10|||
161992664|NCT01510158|585021678|FG000|Overall Study|Death|1|||
161992665|NCT01510158|585021679|FG001|Overall Study|Death|0|||
161992666|NCT01510158|585021680|FG002|Overall Study|Death|0|||
161992667|NCT01076036|585021686|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
161992668|NCT04607837|585021687|FG000|Overall Study|Adverse Event|8|||
161992669|NCT04607837|585021688|FG001|Overall Study|Adverse Event|2|||
161992670|NCT04607837|585021687|FG000|Overall Study|Withdrawal by Subject|8|||
161992671|NCT04607837|585021688|FG001|Overall Study|Withdrawal by Subject|7|||
161992672|NCT04607837|585021687|FG000|Overall Study|Physician Decision|2|||
161992673|NCT04607837|585021688|FG001|Overall Study|Physician Decision|0|||
161992674|NCT04607837|585021687|FG000|Overall Study|Lack of Efficacy|2|||
161992675|NCT04607837|585021688|FG001|Overall Study|Lack of Efficacy|0|||
161992676|NCT04607837|585021687|FG000|Overall Study|Participant terminated by sponsor|1|||
161992677|NCT04607837|585021688|FG001|Overall Study|Participant terminated by sponsor|0|||
161992678|NCT04607837|585021687|FG000|Overall Study|Disease worsening|36|||
161992679|NCT04607837|585021688|FG001|Overall Study|Disease worsening|36|||
161992680|NCT04607837|585021687|FG000|Overall Study|Other|1|||
161992681|NCT04607837|585021688|FG001|Overall Study|Other|0|||
161992682|NCT02023996|585021698|FG000|Overall Study|Protocol Violation|6|||
161992683|NCT00465452|585021699|FG000|Overall Study|Adverse Event|1|||
161992684|NCT04209205|585021703|FG000|Overall Study|Adverse Event|2|||
161992685|NCT04209205|585021704|FG001|Overall Study|Adverse Event|3|||
161992686|NCT04209205|585021703|FG000|Overall Study|Lost to Follow-up|3|||
161992687|NCT04209205|585021704|FG001|Overall Study|Lost to Follow-up|1|||
161992688|NCT04209205|585021703|FG000|Overall Study|Physician Decision|1|||
161992689|NCT04209205|585021704|FG001|Overall Study|Physician Decision|1|||
161992690|NCT04209205|585021703|FG000|Overall Study|Subject decision|10|||
161992691|NCT04209205|585021704|FG001|Overall Study|Subject decision|10|||
161992692|NCT04209205|585021703|FG000|Overall Study|Progressive disease|1|||
161992693|NCT04209205|585021704|FG001|Overall Study|Progressive disease|0|||
161992694|NCT04209205|585021703|FG000|Overall Study|Protocol deviation|0|||
161992695|NCT04209205|585021704|FG001|Overall Study|Protocol deviation|1|||
161992696|NCT04209205|585021703|FG000|Overall Study|New therapy for study indication|1|||
161992697|NCT04209205|585021704|FG001|Overall Study|New therapy for study indication|0|||
161992698|NCT04209205|585021703|FG000|Overall Study|Adverse event - placebo not switched|0|||
161992699|NCT04209205|585021704|FG001|Overall Study|Adverse event - placebo not switched|1|||
161992700|NCT04209205|585021703|FG000|Overall Study|Subject decision - placebo not switched|0|||
161992701|NCT04209205|585021704|FG001|Overall Study|Subject decision - placebo not switched|5|||
161992702|NCT04209205|585021703|FG000|Overall Study|Death - placebo not switched|0|||
161992703|NCT04209205|585021704|FG001|Overall Study|Death - placebo not switched|1|||
161992704|NCT05715242|585021705|FG000|Overall Study|Lost to Follow-up|0|||
161992705|NCT05715242|585021706|FG001|Overall Study|Lost to Follow-up|0|||
161992706|NCT05715242|585021707|FG002|Overall Study|Lost to Follow-up|1|||
161992707|NCT05715242|585021708|FG003|Overall Study|Lost to Follow-up|0|||
161992708|NCT05715242|585021709|FG004|Overall Study|Lost to Follow-up|0|||
161992709|NCT05715242|585021710|FG005|Overall Study|Lost to Follow-up|1|||
161992710|NCT05715242|585021711|FG006|Overall Study|Lost to Follow-up|0|||
161992711|NCT05715242|585021712|FG007|Overall Study|Lost to Follow-up|0|||
161992712|NCT05715242|585021713|FG008|Overall Study|Lost to Follow-up|0|||
161992713|NCT05715242|585021714|FG009|Overall Study|Lost to Follow-up|0|||
161992714|NCT05715242|585021715|FG010|Overall Study|Lost to Follow-up|0|||
161992715|NCT05715242|585021716|FG011|Overall Study|Lost to Follow-up|0|||
161992716|NCT05715242|585021717|FG012|Overall Study|Lost to Follow-up|0|||
161992717|NCT05715242|585021718|FG013|Overall Study|Lost to Follow-up|0|||
161992718|NCT05715242|585021719|FG014|Overall Study|Lost to Follow-up|0|||
161992719|NCT05715242|585021720|FG015|Overall Study|Lost to Follow-up|0|||
161992720|NCT03400176|585021721|FG000|Dose Escalation|Progressive disease|1|||
161992721|NCT03400176|585021722|FG001|Dose Escalation|Progressive disease|1|||
161992722|NCT03400176|585021723|FG002|Dose Escalation|Progressive disease|0|||
161992723|NCT03400176|585021724|FG003|Dose Escalation|Progressive disease|0|||
161992724|NCT03400176|585021725|FG004|Dose Escalation|Progressive disease|1|||
161992725|NCT03400176|585021721|FG000|Dose Escalation|Patient decision|0|||
161992726|NCT03400176|585021722|FG001|Dose Escalation|Patient decision|0|||
161992727|NCT03400176|585021723|FG002|Dose Escalation|Patient decision|0|||
161992728|NCT03400176|585021724|FG003|Dose Escalation|Patient decision|0|||
161992729|NCT03400176|585021725|FG004|Dose Escalation|Patient decision|1|||
161992730|NCT03400176|585021721|FG000|Dose Expansion|Patient decision|0|||
161992731|NCT03400176|585021722|FG001|Dose Expansion|Patient decision|0|||
161992732|NCT03400176|585021723|FG002|Dose Expansion|Patient decision|0|||
161992733|NCT03400176|585021724|FG003|Dose Expansion|Patient decision|1|||
161992734|NCT03400176|585021725|FG004|Dose Expansion|Patient decision|0|||
161992735|NCT03400176|585021721|FG000|Dose Expansion|Adverse Event|0|||
161992736|NCT03400176|585021722|FG001|Dose Expansion|Adverse Event|0|||
161992737|NCT03400176|585021723|FG002|Dose Expansion|Adverse Event|0|||
161992738|NCT03400176|585021724|FG003|Dose Expansion|Adverse Event|1|||
161992739|NCT03400176|585021725|FG004|Dose Expansion|Adverse Event|0|||
161992740|NCT03400176|585021721|FG000|Dose Expansion|Physician Decision|0|||
161992741|NCT03400176|585021722|FG001|Dose Expansion|Physician Decision|0|||
161992742|NCT03400176|585021723|FG002|Dose Expansion|Physician Decision|0|||
161992743|NCT03400176|585021724|FG003|Dose Expansion|Physician Decision|1|||
161992744|NCT03400176|585021725|FG004|Dose Expansion|Physician Decision|0|||
161992745|NCT03400176|585021721|FG000|Dose Expansion|Progressive disease|0|||
161992746|NCT03400176|585021722|FG001|Dose Expansion|Progressive disease|0|||
161992747|NCT03400176|585021723|FG002|Dose Expansion|Progressive disease|1|||
161992748|NCT03400176|585021724|FG003|Dose Expansion|Progressive disease|1|||
161992749|NCT03400176|585021725|FG004|Dose Expansion|Progressive disease|0|||
161992750|NCT01090063|585021733|FG000|Screen|Screen Failed|4|||
161992751|NCT01090063|585021733|FG000|Treatment|Withdrawal by Subject|4|||
161992752|NCT00048347|585021734|FG000|Overall Study|Screen failure|2|||
161992753|NCT02863328|585021735|FG000|Overall Study|Lost to Follow-up|4|||
161992754|NCT02863328|585021736|FG001|Overall Study|Lost to Follow-up|10|||
161992755|NCT02863328|585021735|FG000|Overall Study|Withdrawal by Subject|7|||
161992756|NCT02863328|585021736|FG001|Overall Study|Withdrawal by Subject|12|||
161992757|NCT02863328|585021735|FG000|Overall Study|Died|0|||
161992758|NCT02863328|585021736|FG001|Overall Study|Died|1|||
161992759|NCT04565951|585021739|FG000|Overall Study|Lost to Follow-up|66|||
161992760|NCT04565951|585021740|FG001|Overall Study|Lost to Follow-up|38|||
161992761|NCT04565951|585021739|FG000|Overall Study|Withdrawal by Subject|14|||
161992762|NCT04565951|585021740|FG001|Overall Study|Withdrawal by Subject|7|||
161992763|NCT04565951|585021739|FG000|Overall Study|Death|0|||
161992764|NCT04565951|585021740|FG001|Overall Study|Death|1|||
161992765|NCT00429169|585021741|FG000|Overall Study|Lost to Follow-up|0|||
161992766|NCT00429169|585021742|FG001|Overall Study|Lost to Follow-up|1|||
161992767|NCT00429169|585021741|FG000|Overall Study|Ineligibility discovered after entry|2|||
161992768|NCT00429169|585021742|FG001|Overall Study|Ineligibility discovered after entry|1|||
161992769|NCT02936635|585023292|FG000|Overall Study|Adverse Event|43|||
161992770|NCT02936635|585023293|FG001|Overall Study|Adverse Event|25|||
161992771|NCT02936635|585023292|FG000|Overall Study|Progressive Disease|10|||
161992772|NCT02936635|585023293|FG001|Overall Study|Progressive Disease|18|||
161992773|NCT02936635|585023292|FG000|Overall Study|Sponsor Discretion|10|||
161992774|NCT02936635|585023293|FG001|Overall Study|Sponsor Discretion|16|||
161992775|NCT02936635|585023292|FG000|Overall Study|Death|9|||
161992776|NCT02936635|585023293|FG001|Overall Study|Death|15|||
161887210|NCT01764997|584630283|FG003|Run-in Period|Lack of Efficacy|0|||
161887211|NCT01764997|584630284|FG004|Run-in Period|Lack of Efficacy|0|||
161887212|NCT01764997|584630280|FG000|Run-in Period|Poor compliance to protocol|1|||
161887213|NCT01764997|584630281|FG001|Run-in Period|Poor compliance to protocol|0|||
161887214|NCT01764997|584630282|FG002|Run-in Period|Poor compliance to protocol|0|||
161887215|NCT01764997|584630283|FG003|Run-in Period|Poor compliance to protocol|0|||
161887216|NCT01764997|584630284|FG004|Run-in Period|Poor compliance to protocol|0|||
161887217|NCT01764997|584630280|FG000|Run-in Period|Other than specified above|17|||
161887218|NCT01764997|584630281|FG001|Run-in Period|Other than specified above|0|||
161887219|NCT01764997|584630282|FG002|Run-in Period|Other than specified above|0|||
161887220|NCT01764997|584630283|FG003|Run-in Period|Other than specified above|0|||
161887221|NCT01764997|584630284|FG004|Run-in Period|Other than specified above|0|||
161887222|NCT01764997|584630280|FG000|Study Drug Treatment Period|Adverse Event|0|||
161887223|NCT01764997|584630281|FG001|Study Drug Treatment Period|Adverse Event|1|||
161887224|NCT01764997|584630282|FG002|Study Drug Treatment Period|Adverse Event|0|||
161887225|NCT01764997|584630283|FG003|Study Drug Treatment Period|Adverse Event|0|||
161887226|NCT01764997|584630284|FG004|Study Drug Treatment Period|Adverse Event|24|||
161887227|NCT01764997|584630280|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
161887228|NCT01764997|584630281|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
161887229|NCT01764997|584630282|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
161887230|NCT01764997|584630283|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
161887231|NCT01764997|584630284|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
161887232|NCT01764997|584630280|FG000|Study Drug Treatment Period|Other than specified above|0|||
161887233|NCT01764997|584630281|FG001|Study Drug Treatment Period|Other than specified above|0|||
161887234|NCT01764997|584630282|FG002|Study Drug Treatment Period|Other than specified above|0|||
161887235|NCT01764997|584630283|FG003|Study Drug Treatment Period|Other than specified above|0|||
161887236|NCT01764997|584630284|FG004|Study Drug Treatment Period|Other than specified above|10|||
161887237|NCT00441363|584632312|FG000|Overall Study|Adverse Event|4|||
161887238|NCT00441363|584632313|FG001|Overall Study|Adverse Event|2|||
161887239|NCT00441363|584632312|FG000|Overall Study|Withdrawal by Subject|3|||
161887240|NCT00441363|584632313|FG001|Overall Study|Withdrawal by Subject|4|||
161887241|NCT00441363|584632312|FG000|Overall Study|Physician Decision|6|||
161887242|NCT00441363|584632313|FG001|Overall Study|Physician Decision|7|||
161887243|NCT00441363|584632312|FG000|Overall Study|Lost to Follow-up|2|||
161887244|NCT00441363|584632313|FG001|Overall Study|Lost to Follow-up|2|||
161992777|NCT02936635|585023292|FG000|Overall Study|Withdrawal by Subject|8|||
161992778|NCT02936635|585023293|FG001|Overall Study|Withdrawal by Subject|15|||
161992779|NCT02936635|585023292|FG000|Overall Study|Physician Decision|2|||
161992780|NCT02936635|585023293|FG001|Overall Study|Physician Decision|9|||
161992781|NCT02936635|585023292|FG000|Overall Study|Lost to Follow-up|1|||
161992782|NCT02936635|585023293|FG001|Overall Study|Lost to Follow-up|2|||
161992783|NCT02936635|585023292|FG000|Overall Study|Protocol Violation|1|||
161992784|NCT02936635|585023293|FG001|Overall Study|Protocol Violation|0|||
161992785|NCT02936635|585023292|FG000|Overall Study|Lack of effect/Entry into other study|31|||
161992786|NCT02936635|585023293|FG001|Overall Study|Lack of effect/Entry into other study|65|||
161992787|NCT02407223|585023294|FG000|Overall Study|Adverse Event|1|||
161992788|NCT02407223|585023295|FG001|Overall Study|Adverse Event|0|||
161992789|NCT02407223|585023296|FG002|Overall Study|Adverse Event|1|||
161992790|NCT02407223|585023294|FG000|Overall Study|Lack of Efficacy|6|||
161992791|NCT02407223|585023295|FG001|Overall Study|Lack of Efficacy|6|||
161992792|NCT02407223|585023296|FG002|Overall Study|Lack of Efficacy|4|||
161992793|NCT02407223|585023294|FG000|Overall Study|Lost to Follow-up|1|||
161992794|NCT02407223|585023295|FG001|Overall Study|Lost to Follow-up|0|||
161992795|NCT02407223|585023296|FG002|Overall Study|Lost to Follow-up|2|||
161992796|NCT02407223|585023294|FG000|Overall Study|Withdrawal by Subject|2|||
161992797|NCT02407223|585023295|FG001|Overall Study|Withdrawal by Subject|4|||
161992798|NCT02407223|585023296|FG002|Overall Study|Withdrawal by Subject|4|||
161992799|NCT02407223|585023294|FG000|Overall Study|Study Terminated by Sponsor|77|||
161992800|NCT02407223|585023295|FG001|Overall Study|Study Terminated by Sponsor|80|||
161992801|NCT02407223|585023296|FG002|Overall Study|Study Terminated by Sponsor|86|||
161992802|NCT02407223|585023294|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
161992803|NCT02407223|585023295|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
161992804|NCT02407223|585023296|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
161992805|NCT02407223|585023294|FG000|Overall Study|Other|29|||
161992806|NCT02407223|585023295|FG001|Overall Study|Other|27|||
161992807|NCT02407223|585023296|FG002|Overall Study|Other|25|||
161992808|NCT03078556|585023298|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
161992809|NCT03078556|585023299|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
161992810|NCT03078556|585023300|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
161992811|NCT03078556|585023301|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
161992812|NCT03078556|585023298|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
161992813|NCT03078556|585023299|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
161992814|NCT03078556|585023300|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
161887245|NCT00441363|584632312|FG000|Overall Study|Other|2|||
161887246|NCT00441363|584632313|FG001|Overall Study|Other|0|||
161887247|NCT01313221|584632316|FG000|Overall Study|Protocol Violation|0|||
162036884|NCT00423670|585192599|FG004|Treatment Period|Non-compliance with protocol|2|||
162036885|NCT00423670|585192600|FG005|Treatment Period|Non-compliance with protocol|0|||
162036886|NCT00423670|585192601|FG006|Treatment Period|Non-compliance with protocol|2|||
162036887|NCT00423670|585192602|FG007|Treatment Period|Non-compliance with protocol|2|||
162036888|NCT00423670|585192595|FG000|Follow-up Period|Lost to Follow-up|0|||
162036889|NCT00423670|585192596|FG001|Follow-up Period|Lost to Follow-up|12|||
162036890|NCT00423670|585192597|FG002|Follow-up Period|Lost to Follow-up|8|||
162036891|NCT00423670|585192598|FG003|Follow-up Period|Lost to Follow-up|3|||
162036892|NCT00423670|585192599|FG004|Follow-up Period|Lost to Follow-up|1|||
162036893|NCT00423670|585192600|FG005|Follow-up Period|Lost to Follow-up|0|||
162036894|NCT00423670|585192601|FG006|Follow-up Period|Lost to Follow-up|5|||
162036895|NCT00423670|585192602|FG007|Follow-up Period|Lost to Follow-up|0|||
162036896|NCT00423670|585192595|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
162036897|NCT00423670|585192596|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
162036898|NCT00423670|585192597|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
162036899|NCT00423670|585192598|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
162036900|NCT00423670|585192599|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
162036901|NCT00423670|585192600|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
162036902|NCT00423670|585192601|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
162036903|NCT00423670|585192602|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
162036904|NCT00423670|585192595|FG000|Follow-up Period|Non-compliance with protocol|2|||
162036905|NCT00423670|585192596|FG001|Follow-up Period|Non-compliance with protocol|0|||
162036906|NCT00423670|585192597|FG002|Follow-up Period|Non-compliance with protocol|1|||
162036907|NCT00423670|585192598|FG003|Follow-up Period|Non-compliance with protocol|1|||
162036908|NCT00423670|585192599|FG004|Follow-up Period|Non-compliance with protocol|0|||
162036909|NCT00423670|585192600|FG005|Follow-up Period|Non-compliance with protocol|0|||
162036910|NCT00423670|585192601|FG006|Follow-up Period|Non-compliance with protocol|3|||
162036911|NCT00423670|585192602|FG007|Follow-up Period|Non-compliance with protocol|2|||
162036912|NCT00900601|585192603|FG000|Overall Study|Physician Decision|1|||
162036913|NCT02131532|585192604|FG000|Overall Study|Withdrawal by Subject|1|||
162036914|NCT02131532|585192604|FG000|Overall Study|Physician Decision|1|||
162036915|NCT02131532|585192604|FG000|Overall Study|Other health conditions|2|||
162036916|NCT01056380|585192605|FG000|Overall Study|Lost to Follow-up|2|||
162036917|NCT01056380|585192606|FG001|Overall Study|Lost to Follow-up|3|||
162036918|NCT03583073|585192607|FG000|Overall Study|Lost to Follow-up|8|||
162036919|NCT03583073|585192608|FG001|Overall Study|Lost to Follow-up|12|||
162036920|NCT02045303|585192609|FG000|Overall Study|Protocol Violation|2|||
162036921|NCT02045303|585192610|FG001|Overall Study|Protocol Violation|1|||
162036922|NCT02045303|585192611|FG002|Overall Study|Protocol Violation|0|||
162036923|NCT02045303|585192609|FG000|Overall Study|Withdrawal by Subject|0|||
162036924|NCT02045303|585192610|FG001|Overall Study|Withdrawal by Subject|2|||
162036925|NCT02045303|585192611|FG002|Overall Study|Withdrawal by Subject|0|||
162036926|NCT01856023|585192612|FG000|Overall Study|Death|1|||
162036927|NCT01856023|585192613|FG001|Overall Study|Death|2|||
162036928|NCT01856023|585192612|FG000|Overall Study|Adverse Event|2|||
162036929|NCT01856023|585192613|FG001|Overall Study|Adverse Event|1|||
162036930|NCT01856023|585192612|FG000|Overall Study|Lack of Efficacy|5|||
162036931|NCT01856023|585192613|FG001|Overall Study|Lack of Efficacy|5|||
162036932|NCT01856023|585192612|FG000|Overall Study|non compliance, study closure|1|||
162036933|NCT01856023|585192613|FG001|Overall Study|non compliance, study closure|3|||
162036934|NCT01856023|585192612|FG000|Overall Study|Withdrawal by Subject|1|||
162036935|NCT01856023|585192613|FG001|Overall Study|Withdrawal by Subject|1|||
162036936|NCT00829283|585192614|FG000|Overall Study|Lost to Follow-up|7|||
162036937|NCT00829283|585192615|FG001|Overall Study|Lost to Follow-up|25|||
162036938|NCT00424255|585192616|FG000|Overall Study|Death|115|||
162036939|NCT00424255|585192617|FG001|Overall Study|Death|111|||
162036940|NCT00424255|585192616|FG000|Overall Study|Lost to Follow-up|26|||
162036941|NCT00424255|585192617|FG001|Overall Study|Lost to Follow-up|20|||
162036942|NCT00424255|585192616|FG000|Overall Study|Protocol Violation|0|||
162036943|NCT00424255|585192617|FG001|Overall Study|Protocol Violation|1|||
162036944|NCT00424255|585192616|FG000|Overall Study|Withdrawal by Subject|34|||
162036945|NCT00424255|585192617|FG001|Overall Study|Withdrawal by Subject|38|||
162036946|NCT00424255|585192616|FG000|Overall Study|Physician Decision|3|||
162036947|NCT00424255|585192617|FG001|Overall Study|Physician Decision|7|||
162036948|NCT00424255|585192616|FG000|Overall Study|Cognitive Disturbance|1|||
162036949|NCT00424255|585192617|FG001|Overall Study|Cognitive Disturbance|0|||
162036950|NCT00424255|585192616|FG000|Overall Study|Non-compliance by Participants|1|||
162036951|NCT00424255|585192617|FG001|Overall Study|Non-compliance by Participants|0|||
162036952|NCT00424255|585192616|FG000|Overall Study|Fatigue|1|||
162036953|NCT00424255|585192617|FG001|Overall Study|Fatigue|0|||
162036954|NCT00424255|585192616|FG000|Overall Study|Disease Progression|0|||
162036955|NCT00424255|585192617|FG001|Overall Study|Disease Progression|2|||
162036956|NCT00424255|585192616|FG000|Overall Study|Sponsor Terminated Study|161|||
162036957|NCT00424255|585192617|FG001|Overall Study|Sponsor Terminated Study|167|||
162036958|NCT03945175|585192618|FG000|Overall Study|Did not meet inclusion criteria|31|||
161887248|NCT01313221|584632317|FG001|Overall Study|Protocol Violation|1|||
161887249|NCT01313221|584632318|FG002|Overall Study|Protocol Violation|1|||
161887250|NCT01313221|584632316|FG000|Overall Study|Non-compliance|3|||
161887251|NCT01313221|584632317|FG001|Overall Study|Non-compliance|0|||
161887252|NCT01313221|584632318|FG002|Overall Study|Non-compliance|2|||
161887253|NCT01313221|584632316|FG000|Overall Study|Withdrawal by Subject|2|||
161887254|NCT01313221|584632317|FG001|Overall Study|Withdrawal by Subject|3|||
161887255|NCT01313221|584632318|FG002|Overall Study|Withdrawal by Subject|5|||
161887256|NCT01313221|584632316|FG000|Overall Study|Requirement for alternative therapy|0|||
161887257|NCT01313221|584632317|FG001|Overall Study|Requirement for alternative therapy|1|||
161887258|NCT01313221|584632318|FG002|Overall Study|Requirement for alternative therapy|1|||
161992815|NCT03078556|585023301|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
161992816|NCT03078556|585023298|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
161992817|NCT03078556|585023299|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
161992818|NCT03078556|585023300|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
161992819|NCT03078556|585023301|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
161992820|NCT03078556|585023298|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
161992821|NCT03078556|585023299|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
161992822|NCT03078556|585023300|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
161992823|NCT03078556|585023301|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
161992824|NCT00832416|585023308|FG000|Overall Study|Lack of Efficacy|17|||
161992825|NCT00832416|585023309|FG001|Overall Study|Lack of Efficacy|15|||
161992826|NCT00832416|585023310|FG002|Overall Study|Lack of Efficacy|13|||
161992827|NCT00832416|585023311|FG003|Overall Study|Lack of Efficacy|52|||
161992828|NCT00832416|585023308|FG000|Overall Study|Withdrawal by Subject|5|||
161992829|NCT00832416|585023309|FG001|Overall Study|Withdrawal by Subject|7|||
161992830|NCT00832416|585023310|FG002|Overall Study|Withdrawal by Subject|2|||
161992831|NCT00832416|585023311|FG003|Overall Study|Withdrawal by Subject|10|||
161992832|NCT00832416|585023308|FG000|Overall Study|Physician Decision|2|||
161992833|NCT00832416|585023309|FG001|Overall Study|Physician Decision|12|||
161992834|NCT00832416|585023310|FG002|Overall Study|Physician Decision|5|||
161992835|NCT00832416|585023311|FG003|Overall Study|Physician Decision|10|||
161992836|NCT00832416|585023308|FG000|Overall Study|Administrative|0|||
161992837|NCT00832416|585023309|FG001|Overall Study|Administrative|0|||
161992838|NCT00832416|585023310|FG002|Overall Study|Administrative|0|||
161992839|NCT00832416|585023311|FG003|Overall Study|Administrative|1|||
161992840|NCT00832416|585023308|FG000|Overall Study|Adverse Event|21|||
161992841|NCT00832416|585023309|FG001|Overall Study|Adverse Event|19|||
161992842|NCT00832416|585023310|FG002|Overall Study|Adverse Event|41|||
161992843|NCT00832416|585023311|FG003|Overall Study|Adverse Event|10|||
161992844|NCT00832416|585023308|FG000|Overall Study|Death|1|||
161992845|NCT00832416|585023309|FG001|Overall Study|Death|0|||
161992846|NCT00832416|585023310|FG002|Overall Study|Death|0|||
161992847|NCT00832416|585023311|FG003|Overall Study|Death|0|||
161992848|NCT04421482|585023318|FG000|Overall Study|Physician Decision|1|||
161992849|NCT00571038|585023321|FG000|Overall Study|Lost to Follow-up|1|||
161992850|NCT00571038|585023322|FG001|Overall Study|Lost to Follow-up|4|||
161992851|NCT00571038|585023321|FG000|Overall Study|Death|7|||
161992852|NCT00571038|585023322|FG001|Overall Study|Death|5|||
161992853|NCT00571038|585023321|FG000|Overall Study|Withdrawal by Subject|1|||
161992854|NCT00571038|585023322|FG001|Overall Study|Withdrawal by Subject|3|||
161992855|NCT00571038|585023321|FG000|Overall Study|Moved out of state|2|||
161992856|NCT00571038|585023322|FG001|Overall Study|Moved out of state|2|||
161992857|NCT05786508|585023323|FG000|Overall Study|Withdrawal by Subject|2|||
161992858|NCT05786508|585023324|FG001|Overall Study|Withdrawal by Subject|0|||
161992859|NCT04426318|585023325|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
161992860|NCT04426318|585023326|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
161992861|NCT02588261|585023329|FG000|Overall Study|Study Terminated by Sponsor|157|||
161992862|NCT02588261|585023330|FG001|Overall Study|Study Terminated by Sponsor|142|||
161992863|NCT02588261|585023329|FG000|Overall Study|Protocol Deviation|1|||
161992864|NCT02588261|585023330|FG001|Overall Study|Protocol Deviation|0|||
161992865|NCT02588261|585023329|FG000|Overall Study|Death|1|||
161992866|NCT02588261|585023330|FG001|Overall Study|Death|2|||
161992867|NCT02588261|585023329|FG000|Overall Study|Withdrawal by Subject|12|||
161992868|NCT02588261|585023330|FG001|Overall Study|Withdrawal by Subject|8|||
161992869|NCT02588261|585023329|FG000|Overall Study|Noncompliance with Study Drug|0|||
161992870|NCT02588261|585023330|FG001|Overall Study|Noncompliance with Study Drug|1|||
161992871|NCT02588261|585023329|FG000|Overall Study|Miscellaneous|5|||
161992872|NCT02588261|585023330|FG001|Overall Study|Miscellaneous|4|||
161992873|NCT02588261|585023329|FG000|Overall Study|Progressive Disease|61|||
161992874|NCT02588261|585023330|FG001|Overall Study|Progressive Disease|82|||
161992875|NCT02588261|585023329|FG000|Overall Study|Adverse Event|29|||
161887259|NCT01313221|584632316|FG000|Overall Study|Lost to Follow-up|6|||
161992876|NCT02588261|585023330|FG001|Overall Study|Adverse Event|24|||
161992877|NCT02588261|585023329|FG000|Overall Study|Lost to Follow-up|1|||
161992878|NCT02588261|585023330|FG001|Overall Study|Lost to Follow-up|0|||
161992879|NCT03781778|585023331|FG000|Overall Study|Withdrawal by Subject|2|||
161992880|NCT03781778|585023332|FG001|Overall Study|Withdrawal by Subject|2|||
161992881|NCT02287467|585023333|FG000|Overall Study|Protocol Violation|12|||
161992882|NCT02287467|585023334|FG001|Overall Study|Protocol Violation|9|||
161992883|NCT01456169|585023338|FG000|Overall Study|Adverse Event|1|||
161992884|NCT01456169|585023339|FG001|Overall Study|Adverse Event|2|||
161992885|NCT01456169|585023340|FG002|Overall Study|Adverse Event|7|||
161992886|NCT01456169|585023338|FG000|Overall Study|Major Protocol Deviation|3|||
161992887|NCT01456169|585023339|FG001|Overall Study|Major Protocol Deviation|2|||
161992888|NCT01456169|585023340|FG002|Overall Study|Major Protocol Deviation|3|||
161992889|NCT01456169|585023338|FG000|Overall Study|Voluntary Withdrawal|3|||
161992890|NCT01456169|585023339|FG001|Overall Study|Voluntary Withdrawal|0|||
161992891|NCT01456169|585023340|FG002|Overall Study|Voluntary Withdrawal|2|||
161992892|NCT01456169|585023338|FG000|Overall Study|Lack of Efficacy|2|||
161992893|NCT01456169|585023339|FG001|Overall Study|Lack of Efficacy|0|||
161992894|NCT01456169|585023340|FG002|Overall Study|Lack of Efficacy|0|||
161992895|NCT01456169|585023338|FG000|Overall Study|Other|1|||
161992896|NCT01456169|585023339|FG001|Overall Study|Other|1|||
161992897|NCT01456169|585023340|FG002|Overall Study|Other|0|||
161992898|NCT02292446|585023341|FG000|Overall Study|Adverse Event|12|||
161992899|NCT02292446|585023341|FG000|Overall Study|Death|1|||
161992900|NCT02292446|585023341|FG000|Overall Study|Disease progression|2|||
161992901|NCT02292446|585023341|FG000|Overall Study|Subject/guardian decision|2|||
161992902|NCT02292446|585023341|FG000|Overall Study|Withdrawal by Subject|3|||
161992903|NCT02652156|585023342|FG000|Overall Study|Physician Decision|1|||
161992904|NCT02652156|585023343|FG001|Overall Study|Physician Decision|0|||
161992905|NCT02652156|585023344|FG002|Overall Study|Physician Decision|0|||
161992906|NCT00496080|585023347|FG000|Overall Study|Lost to Follow-up|9|||
161992907|NCT00496080|585023347|FG000|Overall Study|Surgical re-intervention|7|||
161992908|NCT00496080|585023347|FG000|Overall Study|Withdrawal by Subject|5|||
161992909|NCT00496080|585023347|FG000|Overall Study|Physician Decision|6|||
161992910|NCT00479336|585023348|FG000|Overall Study|Adverse Event|1|||
161992911|NCT00479336|585023349|FG001|Overall Study|Adverse Event|1|||
161992912|NCT00479336|585023350|FG002|Overall Study|Adverse Event|1|||
161992913|NCT00479336|585023351|FG003|Overall Study|Adverse Event|3|||
161992914|NCT00479336|585023348|FG000|Overall Study|Lack of Efficacy|1|||
161992915|NCT00479336|585023349|FG001|Overall Study|Lack of Efficacy|0|||
161992916|NCT00479336|585023350|FG002|Overall Study|Lack of Efficacy|0|||
161992917|NCT00479336|585023351|FG003|Overall Study|Lack of Efficacy|0|||
161992918|NCT00479336|585023348|FG000|Overall Study|Protocol Violation|0|||
161992919|NCT00479336|585023349|FG001|Overall Study|Protocol Violation|1|||
161992920|NCT00479336|585023350|FG002|Overall Study|Protocol Violation|0|||
161992921|NCT00479336|585023351|FG003|Overall Study|Protocol Violation|0|||
161992922|NCT00479336|585023348|FG000|Overall Study|Withdrawal by Subject|1|||
161992923|NCT00479336|585023349|FG001|Overall Study|Withdrawal by Subject|2|||
161992924|NCT00479336|585023350|FG002|Overall Study|Withdrawal by Subject|0|||
161992925|NCT00479336|585023351|FG003|Overall Study|Withdrawal by Subject|0|||
161992926|NCT00479336|585023348|FG000|Overall Study|Physician Decision|0|||
161992927|NCT00479336|585023349|FG001|Overall Study|Physician Decision|1|||
161992928|NCT00479336|585023350|FG002|Overall Study|Physician Decision|0|||
161992929|NCT00479336|585023351|FG003|Overall Study|Physician Decision|2|||
161992930|NCT00479336|585023348|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
161992931|NCT00479336|585023349|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
161992932|NCT00479336|585023350|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
161992933|NCT00479336|585023351|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
161992934|NCT03329846|585023352|FG000|Overall Study|Disease progression|4|||
161992935|NCT03329846|585023353|FG001|Overall Study|Disease progression|6|||
161992936|NCT03329846|585023352|FG000|Overall Study|Study drug toxicity|1|||
161992937|NCT03329846|585023353|FG001|Overall Study|Study drug toxicity|0|||
161992938|NCT03329846|585023352|FG000|Overall Study|Participant request to discontinue treatment|0|||
161992939|NCT03329846|585023353|FG001|Overall Study|Participant request to discontinue treatment|1|||
161992940|NCT03329846|585023352|FG000|Overall Study|Participant withdrew consent|1|||
161992941|NCT03329846|585023353|FG001|Overall Study|Participant withdrew consent|0|||
161992942|NCT03329846|585023352|FG000|Overall Study|Other reasons|2|||
161992943|NCT03329846|585023353|FG001|Overall Study|Other reasons|2|||
161992944|NCT02741596|585023354|FG000|Overall Study|Adverse Event|1|||
161992945|NCT02741596|585023355|FG001|Overall Study|Adverse Event|5|||
161992946|NCT02741596|585023354|FG000|Overall Study|Lost to Follow-up|1|||
161992947|NCT02741596|585023355|FG001|Overall Study|Lost to Follow-up|1|||
161992948|NCT02741596|585023354|FG000|Overall Study|Physician Decision|2|||
161992949|NCT02741596|585023355|FG001|Overall Study|Physician Decision|1|||
161992950|NCT02741596|585023354|FG000|Overall Study|Pregnancy|3|||
161992951|NCT02741596|585023355|FG001|Overall Study|Pregnancy|1|||
161992952|NCT02741596|585023354|FG000|Overall Study|Other (Unspecified)|0|||
161992953|NCT02741596|585023355|FG001|Overall Study|Other (Unspecified)|3|||
161992954|NCT02741596|585023354|FG000|Overall Study|Subject withdrawn-Other|17|||
161992955|NCT02741596|585023355|FG001|Overall Study|Subject withdrawn-Other|4|||
161992956|NCT02741596|585023354|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
161992957|NCT02741596|585023355|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
161992958|NCT03066193|585023356|FG000|Overall Study|Withdrawal by Subject|1|||
161992959|NCT02021643|585023357|FG000|Overall Study|Enrolled but Never Treated|1|||
161992960|NCT02021643|585023358|FG001|Overall Study|Enrolled but Never Treated|0|||
161992961|NCT02021643|585023359|FG002|Overall Study|Enrolled but Never Treated|0|||
161992962|NCT02021643|585023360|FG003|Overall Study|Enrolled but Never Treated|0|||
161992963|NCT02021643|585023357|FG000|Overall Study|Adverse Event|0|||
161992964|NCT02021643|585023358|FG001|Overall Study|Adverse Event|1|||
161992965|NCT02021643|585023359|FG002|Overall Study|Adverse Event|0|||
161992966|NCT02021643|585023360|FG003|Overall Study|Adverse Event|0|||
161992967|NCT02021643|585023357|FG000|Overall Study|Death|0|||
161992968|NCT02021643|585023358|FG001|Overall Study|Death|1|||
161992969|NCT02021643|585023359|FG002|Overall Study|Death|0|||
161992970|NCT02021643|585023360|FG003|Overall Study|Death|0|||
161992971|NCT02021643|585023357|FG000|Overall Study|Investigator's Discretion|1|||
161992972|NCT02021643|585023358|FG001|Overall Study|Investigator's Discretion|0|||
161992973|NCT02021643|585023359|FG002|Overall Study|Investigator's Discretion|0|||
161992974|NCT02021643|585023360|FG003|Overall Study|Investigator's Discretion|0|||
161992975|NCT02021643|585023357|FG000|Overall Study|Lack of Efficacy|7|||
161992976|NCT02021643|585023358|FG001|Overall Study|Lack of Efficacy|6|||
161992977|NCT02021643|585023359|FG002|Overall Study|Lack of Efficacy|0|||
161992978|NCT02021643|585023360|FG003|Overall Study|Lack of Efficacy|12|||
161992979|NCT02021643|585023357|FG000|Overall Study|Lost to Follow-up|0|||
161992980|NCT02021643|585023358|FG001|Overall Study|Lost to Follow-up|1|||
161992981|NCT02021643|585023359|FG002|Overall Study|Lost to Follow-up|0|||
161992982|NCT02021643|585023360|FG003|Overall Study|Lost to Follow-up|0|||
161992983|NCT02021643|585023357|FG000|Overall Study|Withdrew Consent|0|||
161992984|NCT02021643|585023358|FG001|Overall Study|Withdrew Consent|1|||
161992985|NCT02021643|585023359|FG002|Overall Study|Withdrew Consent|0|||
161992986|NCT02021643|585023360|FG003|Overall Study|Withdrew Consent|0|||
161992987|NCT02631551|585023361|FG000|Overall Study|Adverse Event|1|||
161992988|NCT02631551|585023362|FG001|Overall Study|Adverse Event|2|||
161992989|NCT02631551|585023363|FG002|Overall Study|Adverse Event|4|||
161992990|NCT02631551|585023364|FG003|Overall Study|Adverse Event|0|||
161992991|NCT02631551|585023361|FG000|Overall Study|Lack of Efficacy|0|||
161992992|NCT02631551|585023362|FG001|Overall Study|Lack of Efficacy|0|||
161992993|NCT02631551|585023363|FG002|Overall Study|Lack of Efficacy|1|||
161992994|NCT02631551|585023364|FG003|Overall Study|Lack of Efficacy|0|||
161992995|NCT02631551|585023361|FG000|Overall Study|Lost to Follow-up|1|||
161992996|NCT02631551|585023362|FG001|Overall Study|Lost to Follow-up|2|||
161992997|NCT02631551|585023363|FG002|Overall Study|Lost to Follow-up|0|||
161992998|NCT02631551|585023364|FG003|Overall Study|Lost to Follow-up|3|||
161992999|NCT02631551|585023361|FG000|Overall Study|Withdrawal by Subject|2|||
161993000|NCT02631551|585023362|FG001|Overall Study|Withdrawal by Subject|2|||
161993001|NCT02631551|585023363|FG002|Overall Study|Withdrawal by Subject|0|||
161993002|NCT02631551|585023364|FG003|Overall Study|Withdrawal by Subject|5|||
161993003|NCT02631551|585023361|FG000|Overall Study|Protocol deviation|3|||
161993004|NCT02631551|585023362|FG001|Overall Study|Protocol deviation|6|||
161993005|NCT02631551|585023363|FG002|Overall Study|Protocol deviation|3|||
161993006|NCT02631551|585023364|FG003|Overall Study|Protocol deviation|0|||
161993007|NCT02631551|585023361|FG000|Overall Study|Non-compliance with study procedures|0|||
161993008|NCT02631551|585023362|FG001|Overall Study|Non-compliance with study procedures|0|||
161993009|NCT02631551|585023363|FG002|Overall Study|Non-compliance with study procedures|1|||
161993010|NCT02631551|585023364|FG003|Overall Study|Non-compliance with study procedures|1|||
161993011|NCT02631551|585023361|FG000|Overall Study|Non-compliance with study drug|1|||
161993012|NCT02631551|585023362|FG001|Overall Study|Non-compliance with study drug|0|||
161993013|NCT02631551|585023363|FG002|Overall Study|Non-compliance with study drug|0|||
161993014|NCT02631551|585023364|FG003|Overall Study|Non-compliance with study drug|0|||
161993015|NCT02631551|585023361|FG000|Overall Study|Other, specific reasons not collected|5|||
161993016|NCT02631551|585023362|FG001|Overall Study|Other, specific reasons not collected|7|||
161993017|NCT02631551|585023363|FG002|Overall Study|Other, specific reasons not collected|2|||
161993018|NCT02631551|585023364|FG003|Overall Study|Other, specific reasons not collected|2|||
161993019|NCT04390243|585023370|FG000|Overall Study|Death|1|||
161993020|NCT04390243|585023370|FG000|Overall Study|Disease Progression|4|||
161993021|NCT04390243|585023370|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
161993022|NCT01521507|585023377|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
161993023|NCT01521507|585023378|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
161993024|NCT01521507|585023377|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
161993025|NCT01521507|585023378|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
161993026|NCT01521507|585023377|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
161993027|NCT01521507|585023378|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
161993028|NCT01521507|585023377|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
161993029|NCT01521507|585023378|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
161993030|NCT01521507|585023377|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
161993031|NCT01521507|585023378|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
161993032|NCT01521507|585023377|FG000|Stage 2: Observational Design|Physician Decision|1|||
161993033|NCT01521507|585023378|FG001|Stage 2: Observational Design|Physician Decision|0|||
162036959|NCT03945175|585192618|FG000|Overall Study|Withdrew consent|2|||
162036960|NCT03945175|585192618|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
162036961|NCT03945175|585192618|FG000|Overall Study|Early termination during Mydayis treatment|1|||
162036962|NCT00870233|585192619|FG000|Overall Study|Withdrawal by Subject|18|||
162036963|NCT00870233|585192619|FG000|Overall Study|Did not undergo laparotomy|3|||
162036964|NCT00870233|585192619|FG000|Overall Study|Incompatible internet browser|2|||
162036965|NCT00870233|585192619|FG000|Overall Study|Death|1|||
162036966|NCT01369485|585192620|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
162036967|NCT01369485|585192621|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
162036968|NCT01369485|585192620|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
162036969|NCT01369485|585192621|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
162036970|NCT01369485|585192620|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
162036971|NCT01369485|585192621|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
162036972|NCT01369485|585192620|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
162036973|NCT01369485|585192621|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
162036974|NCT01369485|585192620|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
162036975|NCT01369485|585192621|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
162036976|NCT01369485|585192620|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
162036977|NCT01369485|585192621|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
162036978|NCT01369485|585192620|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
161887260|NCT01313221|584632317|FG001|Overall Study|Lost to Follow-up|3|||
161887261|NCT01313221|584632318|FG002|Overall Study|Lost to Follow-up|1|||
161887262|NCT01313221|584632316|FG000|Overall Study|Other|1|||
161887263|NCT01313221|584632317|FG001|Overall Study|Other|0|||
161887264|NCT01313221|584632318|FG002|Overall Study|Other|0|||
161887265|NCT01313221|584632316|FG000|Overall Study|Adverse Event|0|||
161887266|NCT01313221|584632317|FG001|Overall Study|Adverse Event|0|||
161993034|NCT04034004|585023379|FG000|Overall Study|Withdrawal by Subject|1|||
161993035|NCT04034004|585023380|FG001|Overall Study|Withdrawal by Subject|2|||
161993036|NCT04034004|585023381|FG002|Overall Study|Withdrawal by Subject|2|||
161993037|NCT04034004|585023382|FG003|Overall Study|Withdrawal by Subject|3|||
161993038|NCT04034004|585023379|FG000|Overall Study|could not find vein to administer IV|2|||
161993039|NCT04034004|585023380|FG001|Overall Study|could not find vein to administer IV|1|||
161993040|NCT04034004|585023381|FG002|Overall Study|could not find vein to administer IV|0|||
161993041|NCT04034004|585023382|FG003|Overall Study|could not find vein to administer IV|0|||
161993042|NCT04034004|585023379|FG000|Overall Study|nurse accidentally unblinded subject|0|||
161993043|NCT04034004|585023380|FG001|Overall Study|nurse accidentally unblinded subject|0|||
161993044|NCT04034004|585023381|FG002|Overall Study|nurse accidentally unblinded subject|0|||
161993045|NCT04034004|585023382|FG003|Overall Study|nurse accidentally unblinded subject|1|||
161993046|NCT04317040|585023383|FG000|Overall Study|Lost to Follow-up|2|||
161993047|NCT04317040|585023384|FG001|Overall Study|Lost to Follow-up|0|||
161993048|NCT04317040|585023383|FG000|Overall Study|Death|16|||
161993049|NCT04317040|585023384|FG001|Overall Study|Death|18|||
161993050|NCT04317040|585023383|FG000|Overall Study|Withdrawal by Subject|0|||
161993051|NCT04317040|585023384|FG001|Overall Study|Withdrawal by Subject|1|||
161993052|NCT04317040|585023383|FG000|Overall Study|Incomplete assessments|0|||
161993053|NCT04317040|585023384|FG001|Overall Study|Incomplete assessments|1|||
161993054|NCT03672292|585023385|FG000|Overall Study|Adverse Event|3|||
161993055|NCT03672292|585023386|FG001|Overall Study|Adverse Event|1|||
161993056|NCT03672292|585023385|FG000|Overall Study|Physician Decision|0|||
161993057|NCT03672292|585023386|FG001|Overall Study|Physician Decision|1|||
161993058|NCT03672292|585023385|FG000|Overall Study|Withdrawal by Subject|1|||
161993059|NCT03672292|585023386|FG001|Overall Study|Withdrawal by Subject|2|||
161993060|NCT00799903|585023387|FG000|Overall Study|Investigator Site Closed|25|||
161993061|NCT00799903|585023388|FG001|Overall Study|Investigator Site Closed|23|||
161993062|NCT00799903|585023387|FG000|Overall Study|Withdrawal by Subject|179|||
161993063|NCT00799903|585023388|FG001|Overall Study|Withdrawal by Subject|175|||
161993064|NCT00799903|585023387|FG000|Overall Study|Lost to Follow-up|69|||
161993065|NCT00799903|585023388|FG001|Overall Study|Lost to Follow-up|80|||
161993066|NCT02518971|585023389|FG000|Overall Study|Lost to Follow-up|0|||
161993067|NCT02518971|585023390|FG001|Overall Study|Lost to Follow-up|1|||
161993068|NCT02518971|585023389|FG000|Overall Study|Physician Decision|6|||
161993069|NCT02518971|585023390|FG001|Overall Study|Physician Decision|6|||
161993070|NCT02518971|585023389|FG000|Overall Study|Protocol Violation|6|||
161993071|NCT02518971|585023390|FG001|Overall Study|Protocol Violation|4|||
161887267|NCT01313221|584632318|FG002|Overall Study|Adverse Event|7|||
161887268|NCT01313221|584632316|FG000|Overall Study|Disease progression|0|||
161887269|NCT01313221|584632317|FG001|Overall Study|Disease progression|0|||
161993072|NCT02518971|585023389|FG000|Overall Study|Withdrawal by Subject|4|||
162036979|NCT01369485|585192621|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
162036980|NCT01369485|585192620|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
161887270|NCT01313221|584632318|FG002|Overall Study|Disease progression|2|||
161993073|NCT02518971|585023390|FG001|Overall Study|Withdrawal by Subject|5|||
161993074|NCT02518971|585023389|FG000|Overall Study|Side effects|1|||
161993075|NCT02518971|585023390|FG001|Overall Study|Side effects|0|||
161993076|NCT02518971|585023389|FG000|Overall Study|medication lost in mail|0|||
161993077|NCT02518971|585023390|FG001|Overall Study|medication lost in mail|1|||
161993078|NCT02518971|585023389|FG000|Overall Study|eligibility criteria no longer met|6|||
161993079|NCT02518971|585023390|FG001|Overall Study|eligibility criteria no longer met|3|||
161993080|NCT03088917|585023391|FG000|Overall Study|In care/cured elsewhere|15|||
161993081|NCT03088917|585023391|FG000|Overall Study|Refuse re-evaluation|13|||
161993082|NCT03088917|585023391|FG000|Overall Study|Contact not established|13|||
161993083|NCT03088917|585023391|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
161993084|NCT03088917|585023391|FG000|Overall Study|Moved outside study region|50|||
161993085|NCT00757237|585023392|FG000|Overall Study|Lost to Follow-up|0|||
161993086|NCT00757237|585023393|FG001|Overall Study|Lost to Follow-up|1|||
161993087|NCT00757237|585023392|FG000|Overall Study|Protocol Violation|0|||
161993088|NCT00757237|585023393|FG001|Overall Study|Protocol Violation|2|||
161993089|NCT00757237|585023392|FG000|Overall Study|Physician Decision|2|||
161993090|NCT00757237|585023393|FG001|Overall Study|Physician Decision|3|||
161993091|NCT00757237|585023392|FG000|Overall Study|Withdrawal by Subject|8|||
161993092|NCT00757237|585023393|FG001|Overall Study|Withdrawal by Subject|12|||
161993093|NCT00757237|585023392|FG000|Overall Study|Safety or Tolerability|3|||
161993094|NCT00757237|585023393|FG001|Overall Study|Safety or Tolerability|5|||
161993095|NCT00757237|585023392|FG000|Overall Study|Other|0|||
161993096|NCT00757237|585023393|FG001|Overall Study|Other|2|||
161993097|NCT05150990|585023398|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
161993098|NCT05150990|585023399|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
161993099|NCT05150990|585023398|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
161993100|NCT05150990|585023399|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
161993101|NCT05150990|585023398|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
161993102|NCT05150990|585023399|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
161993103|NCT05150990|585023398|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
161993104|NCT05150990|585023399|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
161993105|NCT05150990|585023398|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
161993106|NCT05150990|585023399|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
161993107|NCT05150990|585023398|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
161993108|NCT05150990|585023399|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
161993109|NCT05150990|585023398|FG000|Overall Study|Death (unrelated to the intervention)|1|||
161993110|NCT05150990|585023399|FG001|Overall Study|Death (unrelated to the intervention)|2|||
161993111|NCT01843023|585023400|FG000|Overall Study|Death|1|||
161993112|NCT01843023|585023401|FG001|Overall Study|Death|0|||
161993113|NCT01843023|585023400|FG000|Overall Study|Lost to Follow-up|24|||
161993114|NCT01843023|585023401|FG001|Overall Study|Lost to Follow-up|29|||
161993115|NCT01843023|585023400|FG000|Overall Study|Withdrawal by Subject|8|||
161993116|NCT01843023|585023401|FG001|Overall Study|Withdrawal by Subject|6|||
161993117|NCT01397461|585023403|FG000|Overall Study|Withdrawal by Subject|2|||
161993118|NCT01397461|585023404|FG001|Overall Study|Withdrawal by Subject|1|||
161993119|NCT01397461|585023405|FG002|Overall Study|Withdrawal by Subject|0|||
161993120|NCT01397461|585023403|FG000|Overall Study|Lost to Follow-up|0|||
161993121|NCT01397461|585023404|FG001|Overall Study|Lost to Follow-up|2|||
161993122|NCT01397461|585023405|FG002|Overall Study|Lost to Follow-up|1|||
161993123|NCT01397461|585023403|FG000|Overall Study|Lack of Efficacy|0|||
161993124|NCT01397461|585023404|FG001|Overall Study|Lack of Efficacy|3|||
161993125|NCT01397461|585023405|FG002|Overall Study|Lack of Efficacy|0|||
161993126|NCT01397461|585023403|FG000|Overall Study|Not treated|0|||
161993127|NCT01397461|585023404|FG001|Overall Study|Not treated|0|||
161993128|NCT01397461|585023405|FG002|Overall Study|Not treated|1|||
161993129|NCT04980612|585023422|FG000|Overall Study|Withdrawal by Subject|7|||
161993130|NCT04980612|585023423|FG001|Overall Study|Withdrawal by Subject|5|||
161993131|NCT03364738|585023430|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
161993132|NCT03364738|585023430|FG000|Overall Study|Withdrawal by Subject|1|||
161993133|NCT03364738|585023430|FG000|Overall Study|Adverse Event|1|||
161993134|NCT03245398|585023431|FG000|Overall Study|Travelled to another island|1|||
161993135|NCT03245398|585023432|FG001|Overall Study|Travelled to another island|0|||
161993136|NCT01514201|585023433|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
161993137|NCT01514201|585023434|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161993138|NCT01514201|585023435|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161993139|NCT01514201|585023436|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161993140|NCT01514201|585023433|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
161993141|NCT01514201|585023434|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
161993142|NCT01514201|585023435|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
161993143|NCT01514201|585023436|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
161993144|NCT01514201|585023433|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
161993145|NCT01514201|585023434|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
161993146|NCT01514201|585023435|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
161993147|NCT01514201|585023436|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
161993148|NCT01514201|585023433|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
161993149|NCT01514201|585023434|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
161993150|NCT01514201|585023435|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
161993151|NCT01514201|585023436|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
161993152|NCT01514201|585023433|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
161993153|NCT01514201|585023434|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
161993154|NCT01514201|585023435|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
161993155|NCT01514201|585023436|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
161993156|NCT01514201|585023433|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
161993157|NCT01514201|585023434|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
161993158|NCT01514201|585023435|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
161993159|NCT01514201|585023436|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
161993160|NCT01514201|585023433|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
161993161|NCT01514201|585023434|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
161993162|NCT01514201|585023435|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
161993163|NCT01514201|585023436|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
161993164|NCT01514201|585023433|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161993165|NCT01514201|585023434|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161993166|NCT01514201|585023435|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161993167|NCT01514201|585023436|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
161993168|NCT01514201|585023433|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
161993169|NCT01514201|585023434|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
161993170|NCT01514201|585023435|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
161993171|NCT01514201|585023436|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
161993172|NCT01514201|585023433|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
161993173|NCT01514201|585023434|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
161993174|NCT01514201|585023435|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
161993175|NCT01514201|585023436|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
161993176|NCT01514201|585023433|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
161993177|NCT01514201|585023434|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
161993178|NCT01514201|585023435|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
161993179|NCT01514201|585023436|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
161993180|NCT01514201|585023433|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
161993181|NCT01514201|585023434|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
161993182|NCT01514201|585023435|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
161993183|NCT01514201|585023436|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
161993184|NCT02735343|585023439|FG000|Overall Study|screen fail|0|||
161993185|NCT02735343|585023440|FG001|Overall Study|screen fail|2|||
161993186|NCT00566852|585023451|FG000|Overall Study|Protocol Violation|22|||
161993187|NCT00566852|585023452|FG001|Overall Study|Protocol Violation|24|||
161993188|NCT00566852|585023451|FG000|Overall Study|Death|95|||
161993189|NCT00566852|585023452|FG001|Overall Study|Death|78|||
161993190|NCT00566852|585023451|FG000|Overall Study|Withdrawal by Subject|30|||
161993191|NCT00566852|585023452|FG001|Overall Study|Withdrawal by Subject|25|||
161993192|NCT00566852|585023451|FG000|Overall Study|Patient refusal|37|||
161993193|NCT00566852|585023452|FG001|Overall Study|Patient refusal|37|||
161993194|NCT00566852|585023451|FG000|Overall Study|Not tested due to disability|6|||
161993195|NCT00566852|585023452|FG001|Overall Study|Not tested due to disability|12|||
161993196|NCT00566852|585023451|FG000|Overall Study|Missing reason not specified|1|||
161993197|NCT00566852|585023452|FG001|Overall Study|Missing reason not specified|2|||
161993198|NCT00566852|585023451|FG000|Overall Study|Missing reason not reported|16|||
161993199|NCT00566852|585023452|FG001|Overall Study|Missing reason not reported|20|||
161993200|NCT04531241|585023455|FG000|Period 1|Withdrawal by Subject|2|||
161993201|NCT04531241|585023456|FG001|Period 1|Withdrawal by Subject|0|||
161993202|NCT04531241|585023455|FG000|Period 1|Dispesed incorrect lens power|1|||
161993203|NCT04531241|585023456|FG001|Period 1|Dispesed incorrect lens power|0|||
161993204|NCT04531241|585023455|FG000|Period 1|Protocol Violation|1|||
161993205|NCT04531241|585023456|FG001|Period 1|Protocol Violation|0|||
161993206|NCT04531241|585023455|FG000|Period 1|No longer eligible|0|||
162036981|NCT01369485|585192621|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
161993207|NCT04531241|585023456|FG001|Period 1|No longer eligible|1|||
161993208|NCT04531241|585023455|FG000|Period 1|Lens Discomfort|0|||
161993209|NCT04531241|585023456|FG001|Period 1|Lens Discomfort|1|||
161993210|NCT04531241|585023455|FG000|Period 2|Covid-19 Related|1|||
161993211|NCT04531241|585023456|FG001|Period 2|Covid-19 Related|1|||
161993212|NCT02715609|585023460|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
162036982|NCT01369485|585192620|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
162036983|NCT01369485|585192621|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
162036984|NCT01369485|585192620|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
162036985|NCT01369485|585192621|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
162036986|NCT02942576|585192627|FG000|Overall Study|Adverse Event|28|||
162036987|NCT02942576|585192628|FG001|Overall Study|Adverse Event|6|||
162036988|NCT02942576|585192627|FG000|Overall Study|Withdrawal by Subject|7|||
162036989|NCT02942576|585192628|FG001|Overall Study|Withdrawal by Subject|5|||
162036990|NCT02942576|585192627|FG000|Overall Study|Physician Decision|1|||
162036991|NCT02942576|585192628|FG001|Overall Study|Physician Decision|4|||
162036992|NCT02942576|585192627|FG000|Overall Study|Other|10|||
162036993|NCT02942576|585192628|FG001|Overall Study|Other|8|||
162036994|NCT00769483|585192629|FG000|Overall Study|Withdrawal by Subject|0|||
162036995|NCT00769483|585192630|FG001|Overall Study|Withdrawal by Subject|1|||
161887271|NCT01313221|584632316|FG000|Overall Study|Physician Decision|0|||
161887272|NCT01313221|584632317|FG001|Overall Study|Physician Decision|0|||
161887273|NCT01313221|584632318|FG002|Overall Study|Physician Decision|2|||
161887274|NCT01313221|584632316|FG000|Overall Study|Pregnancy|0|||
161887275|NCT01313221|584632317|FG001|Overall Study|Pregnancy|0|||
161887276|NCT01313221|584632318|FG002|Overall Study|Pregnancy|2|||
161887277|NCT00994214|584632319|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
161887278|NCT00994214|584632320|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
161887279|NCT00994214|584632321|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
161887280|NCT00994214|584632322|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
161887281|NCT00994214|584632319|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
161887282|NCT00994214|584632320|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
161887283|NCT00994214|584632321|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
161887284|NCT00994214|584632322|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
161887285|NCT00994214|584632319|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
161887286|NCT00994214|584632320|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
161887287|NCT00994214|584632321|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
161887288|NCT00994214|584632322|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
161887289|NCT00994214|584632319|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
161887290|NCT00994214|584632320|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
161887291|NCT00994214|584632321|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
161887292|NCT00994214|584632322|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
161887293|NCT00994214|584632319|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
161887294|NCT00994214|584632320|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
161887295|NCT00994214|584632321|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
161887296|NCT00994214|584632322|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
161887297|NCT00994214|584632319|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
161887298|NCT00994214|584632320|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
161887299|NCT00994214|584632321|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
161887300|NCT00994214|584632322|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
161887301|NCT03246061|584632323|FG000|Overall Study|Still in follow-up|15|||
161887302|NCT03246061|584632324|FG001|Overall Study|Still in follow-up|21|||
161887303|NCT04710368|584632329|FG000|Overall Study|Withdrawal by Subject|9|||
161887304|NCT04710368|584632329|FG000|Overall Study|Lost to Follow-up|4|||
161887305|NCT04710368|584632329|FG000|Overall Study|Death|2|||
161887306|NCT04710368|584632329|FG000|Overall Study|Patient preference|11|||
161887307|NCT04710368|584632329|FG000|Overall Study|Treatment discontinuation|1|||
161887308|NCT01777139|584632332|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
161887309|NCT01777139|584632333|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
161887310|NCT01777139|584632332|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
161887311|NCT01777139|584632333|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
161887312|NCT01777139|584632332|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
161887313|NCT01777139|584632333|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
161887314|NCT01777139|584632332|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
161887315|NCT01777139|584632333|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
161887316|NCT01777139|584632332|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
161887317|NCT01777139|584632333|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
161887318|NCT01777139|584632332|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
161887319|NCT01777139|584632333|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
161887320|NCT01777139|584632332|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
161887321|NCT01777139|584632333|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
161887322|NCT01777139|584632332|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
161887323|NCT01777139|584632333|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
162036996|NCT00769483|585192631|FG002|Overall Study|Withdrawal by Subject|0|||
162036997|NCT00769483|585192632|FG003|Overall Study|Withdrawal by Subject|0|||
162036998|NCT00769483|585192633|FG004|Overall Study|Withdrawal by Subject|1|||
162036999|NCT00769483|585192634|FG005|Overall Study|Withdrawal by Subject|0|||
162037000|NCT01306877|585192635|FG000|Overall Study|Lost to Follow-up|3|||
162037001|NCT01306877|585192636|FG001|Overall Study|Lost to Follow-up|3|||
162037002|NCT01306877|585192635|FG000|Overall Study|Physician Decision|0|||
162037003|NCT01306877|585192636|FG001|Overall Study|Physician Decision|1|||
162037004|NCT00006389|585192637|FG000|Overall Study|Adverse Event|1|||
162037005|NCT01285960|585192645|FG000|Overall Study|Withdrawal by Subject|2|||
162037006|NCT01285960|585192645|FG000|Overall Study|Lost to Follow-up|2|||
162037007|NCT01285960|585192645|FG000|Overall Study|2 subjects received less 10 sonications|2|||
162037008|NCT01309308|585192646|FG000|Overall Study|Lost to Follow-up|6|||
162037009|NCT01309308|585192647|FG001|Overall Study|Lost to Follow-up|4|||
162037010|NCT00473746|585192648|FG000|Period 1 (Phase 1)|Adverse Event|1|||
162037011|NCT00473746|585192649|FG001|Period 1 (Phase 1)|Adverse Event|0|||
162037012|NCT00473746|585192650|FG002|Period 1 (Phase 1)|Adverse Event|0|||
162037013|NCT00473746|585192651|FG003|Period 1 (Phase 1)|Adverse Event|0|||
162037014|NCT00473746|585192652|FG004|Period 1 (Phase 1)|Adverse Event|0|||
162037015|NCT00473746|585192648|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
162037016|NCT00473746|585192649|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
162037017|NCT00473746|585192650|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
162037018|NCT00473746|585192651|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
162037019|NCT00473746|585192652|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
162037020|NCT00473746|585192648|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
162037021|NCT00473746|585192649|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
162037022|NCT00473746|585192650|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
162037023|NCT00473746|585192651|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
162037024|NCT00473746|585192652|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
162037025|NCT00473746|585192648|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
162037026|NCT00473746|585192649|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
161993213|NCT02715609|585023461|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
161993214|NCT02715609|585023462|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
161993215|NCT02715609|585023460|FG000|Overall Study|Withdrawal by Subject|0|||
161993216|NCT02715609|585023461|FG001|Overall Study|Withdrawal by Subject|0|||
161993217|NCT02715609|585023462|FG002|Overall Study|Withdrawal by Subject|1|||
161993218|NCT03983304|585023463|FG000|Overall Study|Withdrawal by Subject|5|||
161993219|NCT03983304|585023463|FG000|Overall Study|Lost to Follow-up|2|||
161993220|NCT01702246|585023464|FG000|Overall Study|Lost to Follow-up|2|||
161993221|NCT01702246|585023464|FG000|Overall Study|Withdrawal by Subject|2|||
161993222|NCT01702246|585023464|FG000|Overall Study|Physician Decision|1|||
161993223|NCT01518374|585023467|FG000|Overall Study|Withdrawal by Subject|2|||
161993224|NCT01518374|585023467|FG000|Overall Study|Protocol Violation|3|||
161993225|NCT01518374|585023467|FG000|Overall Study|Lost to Follow-up|2|||
161993226|NCT00999544|585025441|FG000|Overall Study|Withdrawal by Subject|1|||
161993227|NCT01392547|585025442|FG000|Overall Study|Adverse Event|2|||
161993228|NCT01392547|585025442|FG000|Overall Study|Non-compliance|2|||
161993229|NCT01392547|585025442|FG000|Overall Study|Withdrawal criteria|3|||
161993230|NCT01392547|585025442|FG000|Overall Study|Unclassified|1|||
161993231|NCT00950846|585025447|FG000|Overall Study|Death|6|||
161993232|NCT00950846|585025447|FG000|Overall Study|Lost to Follow-up|3|||
161993233|NCT00950846|585025447|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
161993234|NCT01799226|585025448|FG000|Overall Study|Withdrawal by Subject|1|||
161993235|NCT01799226|585025449|FG001|Overall Study|Withdrawal by Subject|0|||
161993236|NCT01799226|585025448|FG000|Overall Study|Disqualified at Day 14|1|||
161993237|NCT01799226|585025449|FG001|Overall Study|Disqualified at Day 14|0|||
161993238|NCT02178995|585025450|FG000|Double Blind|Adverse Event|0|||
161993239|NCT02178995|585025451|FG001|Double Blind|Adverse Event|0|||
161993240|NCT02178995|585025452|FG002|Double Blind|Adverse Event|0|||
161993241|NCT02178995|585025453|FG003|Double Blind|Adverse Event|0|||
161993242|NCT02178995|585025454|FG004|Double Blind|Adverse Event|0|||
161993243|NCT02178995|585025455|FG005|Double Blind|Adverse Event|1|||
161993244|NCT02178995|585025456|FG006|Double Blind|Adverse Event|0|||
161993245|NCT02178995|585025457|FG007|Double Blind|Adverse Event|1|||
161993246|NCT02178995|585025458|FG008|Double Blind|Adverse Event|1|||
161993247|NCT02178995|585025450|FG000|Double Blind|Lost to Follow-up|0|||
161993248|NCT02178995|585025451|FG001|Double Blind|Lost to Follow-up|1|||
161993249|NCT02178995|585025452|FG002|Double Blind|Lost to Follow-up|0|||
161993250|NCT02178995|585025453|FG003|Double Blind|Lost to Follow-up|0|||
161993251|NCT02178995|585025454|FG004|Double Blind|Lost to Follow-up|0|||
162037027|NCT00473746|585192650|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
161993252|NCT02178995|585025455|FG005|Double Blind|Lost to Follow-up|0|||
161993253|NCT02178995|585025456|FG006|Double Blind|Lost to Follow-up|0|||
161993254|NCT02178995|585025457|FG007|Double Blind|Lost to Follow-up|1|||
161993255|NCT02178995|585025458|FG008|Double Blind|Lost to Follow-up|0|||
162037028|NCT00473746|585192651|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
162037029|NCT00473746|585192652|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
161993256|NCT02178995|585025450|FG000|Open Label|Adverse Event|2|||
161993257|NCT02178995|585025451|FG001|Open Label|Adverse Event|0|||
161887324|NCT01887288|584632335|FG000|Overall Study|The study was terminated and the PI has|16|||
161887325|NCT00290693|584632336|FG000|Overall Study|Withdrawal by Subject|2|||
161887326|NCT05625477|584632337|FG000|Overall Study|Lost to Follow-up|2|||
161887327|NCT05625477|584632338|FG001|Overall Study|Lost to Follow-up|2|||
161887328|NCT05625477|584632339|FG002|Overall Study|Lost to Follow-up|1|||
161887329|NCT05625477|584632340|FG003|Overall Study|Lost to Follow-up|1|||
161887330|NCT05625477|584632341|FG004|Overall Study|Lost to Follow-up|0|||
161887331|NCT05625477|584632337|FG000|Overall Study|Covid quarantine|1|||
161887332|NCT05625477|584632338|FG001|Overall Study|Covid quarantine|0|||
161887333|NCT05625477|584632339|FG002|Overall Study|Covid quarantine|0|||
161887334|NCT05625477|584632340|FG003|Overall Study|Covid quarantine|0|||
161887335|NCT05625477|584632341|FG004|Overall Study|Covid quarantine|0|||
161887336|NCT04849416|584632344|FG000|Overall Study|Ongoing Treatment|12|||
161887337|NCT04849416|584632345|FG001|Overall Study|Ongoing Treatment|5|||
161887338|NCT04849416|584632346|FG002|Overall Study|Ongoing Treatment|3|||
161993258|NCT02178995|585025452|FG002|Open Label|Adverse Event|0|||
161993259|NCT02178995|585025453|FG003|Open Label|Adverse Event|0|||
161993260|NCT02178995|585025454|FG004|Open Label|Adverse Event|0|||
161993261|NCT02178995|585025455|FG005|Open Label|Adverse Event|0|||
161993262|NCT02178995|585025456|FG006|Open Label|Adverse Event|0|||
161993263|NCT02178995|585025457|FG007|Open Label|Adverse Event|0|||
161993264|NCT02178995|585025458|FG008|Open Label|Adverse Event|0|||
161993265|NCT02114606|585025460|FG000|Overall Study|Unable to swallow Cytosponge|6|||
161993266|NCT00981461|585025461|FG000|Overall Study|Lost to Follow-up|5|||
161993267|NCT00981461|585025462|FG001|Overall Study|Lost to Follow-up|2|||
161993268|NCT01388907|585025463|FG000|Overall Study|Adverse Event|2|||
161993269|NCT01388907|585025464|FG001|Overall Study|Adverse Event|0|||
161993270|NCT03361293|585025465|FG000|Overall Study|Lost to Follow-up|0|||
161993271|NCT03361293|585025466|FG001|Overall Study|Lost to Follow-up|2|||
161993272|NCT03361293|585025465|FG000|Overall Study|Withdrawal by Subject|1|||
161993273|NCT03361293|585025466|FG001|Overall Study|Withdrawal by Subject|3|||
161993274|NCT01910402|585025467|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
161993275|NCT01910402|585025468|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
161993276|NCT01910402|585025469|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
161993277|NCT01910402|585025467|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
161993278|NCT01910402|585025468|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
161993279|NCT01910402|585025469|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
161993280|NCT01910402|585025467|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
161993281|NCT01910402|585025468|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
161993282|NCT01910402|585025469|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
161993283|NCT01910402|585025467|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
161993284|NCT01910402|585025468|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
161993285|NCT01910402|585025469|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
161993286|NCT01910402|585025467|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
161993287|NCT01910402|585025468|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
161993288|NCT01910402|585025469|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
161993289|NCT01910402|585025467|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
161993290|NCT01910402|585025468|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
161993291|NCT01910402|585025469|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
161993292|NCT01910402|585025467|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
161993293|NCT01910402|585025468|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
161993294|NCT01910402|585025469|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
161993295|NCT01910402|585025467|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
161993296|NCT01910402|585025468|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
161993297|NCT01910402|585025469|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
161993298|NCT01910402|585025467|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
161993299|NCT01910402|585025468|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
161993300|NCT01910402|585025469|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
161993301|NCT01910402|585025467|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
161993302|NCT01910402|585025468|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
161993303|NCT01910402|585025469|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
162037030|NCT00473746|585192648|FG000|Period 1 (Phase 1)|Reason not specified|0|||
162037031|NCT00473746|585192649|FG001|Period 1 (Phase 1)|Reason not specified|1|||
161887339|NCT04849416|584632344|FG000|Overall Study|On Post-Treatment Follow-up|8|||
161887340|NCT04849416|584632345|FG001|Overall Study|On Post-Treatment Follow-up|9|||
161887341|NCT04849416|584632346|FG002|Overall Study|On Post-Treatment Follow-up|10|||
161887342|NCT04849416|584632344|FG000|Overall Study|Withdrawal by Subject|0|||
161887343|NCT04849416|584632345|FG001|Overall Study|Withdrawal by Subject|0|||
161887344|NCT04849416|584632346|FG002|Overall Study|Withdrawal by Subject|1|||
161887345|NCT04849416|584632344|FG000|Overall Study|Lost to Follow-up|1|||
161887346|NCT04849416|584632345|FG001|Overall Study|Lost to Follow-up|0|||
161887347|NCT04849416|584632346|FG002|Overall Study|Lost to Follow-up|0|||
162037032|NCT00473746|585192650|FG002|Period 1 (Phase 1)|Reason not specified|0|||
162037033|NCT00473746|585192651|FG003|Period 1 (Phase 1)|Reason not specified|0|||
162037034|NCT00473746|585192652|FG004|Period 1 (Phase 1)|Reason not specified|0|||
162037035|NCT00473746|585192648|FG000|Period 2 (Phase 2)|Adverse Event|0|||
162037036|NCT00473746|585192649|FG001|Period 2 (Phase 2)|Adverse Event|0|||
162037037|NCT00473746|585192650|FG002|Period 2 (Phase 2)|Adverse Event|0|||
162037038|NCT00473746|585192651|FG003|Period 2 (Phase 2)|Adverse Event|0|||
162037039|NCT00473746|585192652|FG004|Period 2 (Phase 2)|Adverse Event|3|||
162037040|NCT00473746|585192648|FG000|Period 2 (Phase 2)|Death|0|||
161887348|NCT01092637|584632347|FG000|Overall Study|Death|47|||
161887349|NCT01092637|584632348|FG001|Overall Study|Death|49|||
161887350|NCT01716520|584632349|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
161887351|NCT01716520|584632350|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
161887352|NCT01716520|584632351|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
161887353|NCT01716520|584632352|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
161887354|NCT01716520|584632353|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
161887355|NCT01716520|584632354|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
161887356|NCT01716520|584632349|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
161887357|NCT01716520|584632350|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887358|NCT01716520|584632351|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
161887359|NCT01716520|584632352|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
161887360|NCT01716520|584632353|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887361|NCT01716520|584632354|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
161887362|NCT01716520|584632349|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161887363|NCT01716520|584632350|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161887364|NCT01716520|584632351|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161887365|NCT01716520|584632352|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161887366|NCT01716520|584632353|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161887367|NCT01716520|584632354|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161993304|NCT01910402|585025467|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
161993305|NCT01910402|585025468|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
161993306|NCT01910402|585025469|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
161993307|NCT01910402|585025467|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
161993308|NCT01910402|585025468|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
161993309|NCT01910402|585025469|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
161993310|NCT01910402|585025467|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
161993311|NCT01910402|585025468|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
161993312|NCT01910402|585025469|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
161993313|NCT00483405|585025470|FG000|Overall Study|Adverse Event|8|||
161993314|NCT00483405|585025470|FG000|Overall Study|Lack of Efficacy|14|||
161993315|NCT00483405|585025470|FG000|Overall Study|Death|3|||
161993316|NCT00483405|585025470|FG000|Overall Study|Withdrawal by Subject|2|||
161993317|NCT00483405|585025470|FG000|Overall Study|Other complicating disease|1|||
161993318|NCT03010319|585025471|FG000|Overall Study|Adverse Event|15|||
161993319|NCT03010319|585025472|FG001|Overall Study|Adverse Event|9|||
161993320|NCT03010319|585025471|FG000|Overall Study|Withdrawal by Subject|1|||
161993321|NCT03010319|585025472|FG001|Overall Study|Withdrawal by Subject|6|||
161993322|NCT03010319|585025471|FG000|Overall Study|Physician Decision|2|||
161993323|NCT03010319|585025472|FG001|Overall Study|Physician Decision|4|||
161993324|NCT03010319|585025471|FG000|Overall Study|Sponsor requested withdrawal|2|||
161993325|NCT03010319|585025472|FG001|Overall Study|Sponsor requested withdrawal|2|||
161993326|NCT03010319|585025471|FG000|Overall Study|Death|1|||
161993327|NCT03010319|585025472|FG001|Overall Study|Death|0|||
161993328|NCT03010319|585025471|FG000|Overall Study|Lost to Follow-up|0|||
161993329|NCT03010319|585025472|FG001|Overall Study|Lost to Follow-up|1|||
161993330|NCT03010319|585025471|FG000|Overall Study|Other Reason|5|||
161993331|NCT03010319|585025472|FG001|Overall Study|Other Reason|7|||
161993332|NCT02128724|585025473|FG000|Overall Study|Death|1|||
161993333|NCT02128724|585025474|FG001|Overall Study|Death|0|||
161993334|NCT02128724|585025475|FG002|Overall Study|Death|0|||
161993335|NCT02128724|585025476|FG003|Overall Study|Death|0|||
161993336|NCT02128724|585025473|FG000|Overall Study|Adverse Event|0|||
161993337|NCT02128724|585025474|FG001|Overall Study|Adverse Event|1|||
161993338|NCT02128724|585025475|FG002|Overall Study|Adverse Event|0|||
161993339|NCT02128724|585025476|FG003|Overall Study|Adverse Event|0|||
161993340|NCT02128724|585025473|FG000|Overall Study|Physician Decision|0|||
161993341|NCT02128724|585025474|FG001|Overall Study|Physician Decision|0|||
161993342|NCT02128724|585025475|FG002|Overall Study|Physician Decision|0|||
161993343|NCT02128724|585025476|FG003|Overall Study|Physician Decision|2|||
161993344|NCT02128724|585025473|FG000|Overall Study|Withdrawal by Subject|0|||
161993345|NCT02128724|585025474|FG001|Overall Study|Withdrawal by Subject|0|||
162037041|NCT00473746|585192649|FG001|Period 2 (Phase 2)|Death|0|||
162037042|NCT00473746|585192650|FG002|Period 2 (Phase 2)|Death|0|||
162037043|NCT00473746|585192651|FG003|Period 2 (Phase 2)|Death|0|||
162037044|NCT00473746|585192652|FG004|Period 2 (Phase 2)|Death|1|||
162037045|NCT00473746|585192648|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
162037046|NCT00473746|585192649|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
162037047|NCT00473746|585192650|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
162037048|NCT00473746|585192651|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
162037049|NCT00473746|585192652|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
162037050|NCT00473746|585192648|FG000|Period 2 (Phase 2)|Reason not specified|0|||
162037051|NCT00473746|585192649|FG001|Period 2 (Phase 2)|Reason not specified|0|||
162037052|NCT00473746|585192650|FG002|Period 2 (Phase 2)|Reason not specified|0|||
162037053|NCT00473746|585192651|FG003|Period 2 (Phase 2)|Reason not specified|0|||
162037054|NCT00473746|585192652|FG004|Period 2 (Phase 2)|Reason not specified|3|||
162037055|NCT01017575|585192655|FG000|Overall Study|Lack of Efficacy|0|||
162037056|NCT01017575|585192656|FG001|Overall Study|Lack of Efficacy|1|||
162037057|NCT01017575|585192657|FG002|Overall Study|Lack of Efficacy|0|||
162037058|NCT01017575|585192658|FG003|Overall Study|Lack of Efficacy|1|||
162037059|NCT01017575|585192659|FG004|Overall Study|Lack of Efficacy|1|||
162037060|NCT01017575|585192655|FG000|Overall Study|Adverse Event|0|||
162037061|NCT01017575|585192656|FG001|Overall Study|Adverse Event|1|||
162037062|NCT01017575|585192657|FG002|Overall Study|Adverse Event|0|||
162037063|NCT01017575|585192658|FG003|Overall Study|Adverse Event|0|||
162037064|NCT01017575|585192659|FG004|Overall Study|Adverse Event|2|||
162037065|NCT01017575|585192655|FG000|Overall Study|Withdrawal by Subject|1|||
162037066|NCT01017575|585192656|FG001|Overall Study|Withdrawal by Subject|0|||
162037067|NCT01017575|585192657|FG002|Overall Study|Withdrawal by Subject|0|||
162037068|NCT01017575|585192658|FG003|Overall Study|Withdrawal by Subject|0|||
162037069|NCT01017575|585192659|FG004|Overall Study|Withdrawal by Subject|0|||
162037070|NCT01962922|585192660|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
162037071|NCT01962922|585192661|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
162037072|NCT01962922|585192660|FG000|PK Portion Day 7|non-compliance|1|||
162037073|NCT01962922|585192661|FG001|PK Portion Day 7|non-compliance|0|||
162037074|NCT01962922|585192660|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
162037075|NCT01962922|585192661|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
162037076|NCT01962922|585192660|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
162037077|NCT01962922|585192661|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
162037078|NCT00976573|585192669|FG000|Overall Study|Ineligible|0|||
162037079|NCT00976573|585192670|FG001|Overall Study|Ineligible|1|||
162037080|NCT00976573|585192669|FG000|Overall Study|Cancel prior to receiving treatment|4|||
162037081|NCT00976573|585192670|FG001|Overall Study|Cancel prior to receiving treatment|2|||
162037082|NCT02730208|585192671|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
162037083|NCT02730208|585192672|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
162037084|NCT00995865|585192677|FG000|Overall Study|Protocol Violation|2|||
162037085|NCT00995865|585192678|FG001|Overall Study|Protocol Violation|0|||
162037086|NCT00995865|585192679|FG002|Overall Study|Protocol Violation|0|||
162037087|NCT00995865|585192677|FG000|Overall Study|Lost to Follow-up|0|||
162037088|NCT00995865|585192678|FG001|Overall Study|Lost to Follow-up|0|||
162037089|NCT00995865|585192679|FG002|Overall Study|Lost to Follow-up|1|||
162037090|NCT02021656|585192685|FG000|Overall Study|Adverse Event|1|||
162037091|NCT02021656|585192685|FG000|Overall Study|Lack of Efficacy|2|||
162037092|NCT02021656|585192685|FG000|Overall Study|Lost to Follow-up|1|||
162037093|NCT02021656|585192685|FG000|Overall Study|Withdrew Consent|2|||
162037094|NCT00510952|585192688|FG000|Overall Study|Adverse Event|1|||
162037095|NCT00510952|585192689|FG001|Overall Study|Adverse Event|0|||
162037096|NCT00510952|585192688|FG000|Overall Study|Entry Criteria Not Met|3|||
162037097|NCT00510952|585192689|FG001|Overall Study|Entry Criteria Not Met|1|||
162037098|NCT00510952|585192688|FG000|Overall Study|Lost to Follow-up|5|||
162037099|NCT00510952|585192689|FG001|Overall Study|Lost to Follow-up|3|||
162037100|NCT00510952|585192688|FG000|Overall Study|Physician Decision|1|||
162037101|NCT00510952|585192689|FG001|Overall Study|Physician Decision|1|||
162037102|NCT00510952|585192688|FG000|Overall Study|Protocol Violation|7|||
161887368|NCT01716520|584632349|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161887369|NCT01716520|584632350|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
161887370|NCT01716520|584632351|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161887371|NCT01716520|584632352|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
162037103|NCT00510952|585192689|FG001|Overall Study|Protocol Violation|4|||
161887372|NCT01716520|584632353|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
162037104|NCT00510952|585192688|FG000|Overall Study|Sponsor Decision|1|||
162037105|NCT00510952|585192689|FG001|Overall Study|Sponsor Decision|0|||
162037106|NCT00510952|585192688|FG000|Overall Study|Withdrawal by Subject|6|||
162037107|NCT00510952|585192689|FG001|Overall Study|Withdrawal by Subject|7|||
162037108|NCT00510952|585192688|FG000|Overall Study|Did Not Receive Study Drug|2|||
162037109|NCT00510952|585192689|FG001|Overall Study|Did Not Receive Study Drug|0|||
162037110|NCT00817479|585192696|FG000|Overall Study|Physician Decision|1|||
162037111|NCT00817479|585192697|FG001|Overall Study|Physician Decision|1|||
162037112|NCT05985980|585192700|FG000|Overall Study|Withdrawal by Subject|1|||
162037113|NCT05985980|585192700|FG000|Overall Study|Withdrawal by Subject|1|||
162037114|NCT05985980|585192700|FG000|Overall Study|Withdrawal by Subject|1|||
162037115|NCT05985980|585192700|FG000|Overall Study|Withdrawal by Subject|1|||
162037116|NCT00523367|585192701|FG000|Overall Study|19 screen failures|19|||
162037117|NCT00523367|585192701|FG000|Overall Study|4 Withdrawn by PI|4|||
162037118|NCT02793128|585192702|FG000|Overall Study|Death|4|||
162037119|NCT02793128|585192702|FG000|Overall Study|Withdrawal by Subject|2|||
162037120|NCT02793128|585192702|FG000|Overall Study|Physician Decision|1|||
162037121|NCT02793128|585192702|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
162037122|NCT02793128|585192702|FG000|Overall Study|Patient elected nephroureterectomy|1|||
162037123|NCT02359851|585192706|FG000|Overall Study|Death|1|||
162037124|NCT02359851|585192706|FG000|Overall Study|Disease progression|1|||
162037125|NCT00055471|585192707|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
162037126|NCT00055471|585192708|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
162037127|NCT00055471|585192709|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
162037128|NCT00055471|585192707|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
162037129|NCT00055471|585192708|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
162037130|NCT00055471|585192709|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
162037131|NCT00055471|585192707|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
162037132|NCT00055471|585192708|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
162037133|NCT00055471|585192709|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
162037134|NCT01854944|585192710|FG000|Overall Study|Withdrawal by Subject|0|||
162037135|NCT01854944|585192711|FG001|Overall Study|Withdrawal by Subject|0|||
162037136|NCT01854944|585192712|FG002|Overall Study|Withdrawal by Subject|1|||
162037137|NCT00282347|585192715|FG000|Treatment Period|Death|2|||
162037138|NCT00282347|585192716|FG001|Treatment Period|Death|0|||
162037139|NCT00282347|585192715|FG000|Treatment Period|Lost to Follow-up|2|||
162037140|NCT00282347|585192716|FG001|Treatment Period|Lost to Follow-up|5|||
162037141|NCT00282347|585192715|FG000|Treatment Period|Withdrawal by Subject|1|||
162037142|NCT00282347|585192716|FG001|Treatment Period|Withdrawal by Subject|3|||
162037143|NCT00282347|585192715|FG000|Treatment Period|Physician Decision|0|||
161993346|NCT02128724|585025475|FG002|Overall Study|Withdrawal by Subject|0|||
161993347|NCT02128724|585025476|FG003|Overall Study|Withdrawal by Subject|1|||
161993348|NCT04829916|585025478|FG000|Overall Study|Withdrawal by Subject|1|||
161993349|NCT04829916|585025479|FG001|Overall Study|Withdrawal by Subject|0|||
161993350|NCT01957202|585025481|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993351|NCT01957202|585025482|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
161993352|NCT01957202|585025483|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993353|NCT01957202|585025484|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993354|NCT01957202|585025485|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993355|NCT01957202|585025486|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993356|NCT01957202|585025487|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993357|NCT01957202|585025488|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993358|NCT01957202|585025489|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993359|NCT01957202|585025490|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993360|NCT01957202|585025491|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993361|NCT01957202|585025492|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993362|NCT01957202|585025493|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993363|NCT01957202|585025494|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993364|NCT01957202|585025495|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993365|NCT01957202|585025496|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993366|NCT01957202|585025497|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
161993367|NCT01957202|585025498|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161993368|NCT01957202|585025481|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993369|NCT01957202|585025482|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993370|NCT01957202|585025483|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993371|NCT01957202|585025484|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993372|NCT01957202|585025485|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993373|NCT01957202|585025486|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993374|NCT01957202|585025487|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993375|NCT01957202|585025488|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993376|NCT01957202|585025489|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993377|NCT01957202|585025490|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
162037144|NCT00282347|585192716|FG001|Treatment Period|Physician Decision|1|||
162037145|NCT00282347|585192715|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
162037146|NCT00282347|585192716|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
162037147|NCT00282347|585192715|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
162037148|NCT00282347|585192716|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
162037149|NCT00282347|585192715|FG000|Safety Follow-up Period|Physician Decision|1|||
161993378|NCT01957202|585025491|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993379|NCT01957202|585025492|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993380|NCT01957202|585025493|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993381|NCT01957202|585025494|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993382|NCT01957202|585025495|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993383|NCT01957202|585025496|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993384|NCT01957202|585025497|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
161993385|NCT01957202|585025498|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
161993386|NCT03594773|585025500|FG000|Overall Study|Withdrawal by Subject|3|||
161993387|NCT03594773|585025501|FG001|Overall Study|Withdrawal by Subject|2|||
161993388|NCT03594773|585025500|FG000|Overall Study|Lost to Follow-up|3|||
161993389|NCT03594773|585025501|FG001|Overall Study|Lost to Follow-up|4|||
161993390|NCT04098809|585025504|FG000|Overall Study|Withdrawal by Subject|1|||
161993391|NCT04098809|585025505|FG001|Overall Study|Withdrawal by Subject|3|||
161993392|NCT04098809|585025504|FG000|Overall Study|Physician Decision|2|||
161993393|NCT04098809|585025505|FG001|Overall Study|Physician Decision|1|||
161993394|NCT00193206|585025506|FG000|Preoperative Therapy|Lack of Efficacy|2|||
161993395|NCT00193206|585025506|FG000|Preoperative Therapy|Adverse Event|2|||
161993396|NCT00193206|585025506|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
161993397|NCT00193206|585025506|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
161993398|NCT00193206|585025506|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
161993399|NCT00193206|585025506|FG000|Postoperative Therapy|Physician Decision|3|||
161993400|NCT00193206|585025506|FG000|Postoperative Therapy|Intercurrent Illness|2|||
161993401|NCT00193206|585025506|FG000|Postoperative Therapy|Lack of Efficacy|1|||
161993402|NCT00193206|585025506|FG000|Postoperative Therapy|Protocol Violation|1|||
161993403|NCT01200368|585025511|FG000|Infant Series|Adverse Event|2|||
161993404|NCT01200368|585025512|FG001|Infant Series|Adverse Event|2|||
161993405|NCT01200368|585025513|FG002|Infant Series|Adverse Event|3|||
161993406|NCT01200368|585025511|FG000|Infant Series|Withdrawal by Subject|0|||
161993407|NCT01200368|585025512|FG001|Infant Series|Withdrawal by Subject|2|||
161993408|NCT01200368|585025513|FG002|Infant Series|Withdrawal by Subject|2|||
161993409|NCT01200368|585025511|FG000|Infant Series|Did not meet entrance criteria|0|||
161993410|NCT01200368|585025512|FG001|Infant Series|Did not meet entrance criteria|1|||
161993411|NCT01200368|585025513|FG002|Infant Series|Did not meet entrance criteria|0|||
161993412|NCT01200368|585025511|FG000|Infant Series|Randomized, not vaccinated|0|||
161993413|NCT01200368|585025512|FG001|Infant Series|Randomized, not vaccinated|1|||
161993414|NCT01200368|585025513|FG002|Infant Series|Randomized, not vaccinated|1|||
161993415|NCT01200368|585025511|FG000|Infant Series|Other|1|||
161993416|NCT01200368|585025512|FG001|Infant Series|Other|0|||
161993417|NCT01200368|585025513|FG002|Infant Series|Other|0|||
161993418|NCT01200368|585025511|FG000|After Infant Series|Adverse Event|6|||
161993419|NCT01200368|585025512|FG001|After Infant Series|Adverse Event|6|||
161993420|NCT01200368|585025513|FG002|After Infant Series|Adverse Event|3|||
161993421|NCT01200368|585025511|FG000|After Infant Series|Withdrawal by Subject|10|||
161993422|NCT01200368|585025512|FG001|After Infant Series|Withdrawal by Subject|8|||
161993423|NCT01200368|585025513|FG002|After Infant Series|Withdrawal by Subject|4|||
161993424|NCT01200368|585025511|FG000|After Infant Series|Lost to Follow-up|1|||
161993425|NCT01200368|585025512|FG001|After Infant Series|Lost to Follow-up|0|||
161993426|NCT01200368|585025513|FG002|After Infant Series|Lost to Follow-up|0|||
161993427|NCT01200368|585025511|FG000|After Infant Series|Other|1|||
161993428|NCT01200368|585025512|FG001|After Infant Series|Other|2|||
161993429|NCT01200368|585025513|FG002|After Infant Series|Other|2|||
161993430|NCT01200368|585025511|FG000|Toddler Dose|Adverse Event|0|||
161993431|NCT01200368|585025512|FG001|Toddler Dose|Adverse Event|3|||
161993432|NCT01200368|585025513|FG002|Toddler Dose|Adverse Event|1|||
161993433|NCT01290757|585025514|FG000|Overall Study|Adverse Event|1|||
161993434|NCT01290757|585025515|FG001|Overall Study|Adverse Event|0|||
161993435|NCT01290757|585025514|FG000|Overall Study|Protocol Violation|1|||
161993436|NCT01290757|585025515|FG001|Overall Study|Protocol Violation|1|||
161993437|NCT01290757|585025514|FG000|Overall Study|Other|0|||
161993438|NCT01290757|585025515|FG001|Overall Study|Other|1|||
161993439|NCT00570310|585025516|FG000|Overall Study|Adverse Event|1|||
161993440|NCT00570310|585025517|FG001|Overall Study|Adverse Event|2|||
161993441|NCT00570310|585025516|FG000|Overall Study|Lack of Efficacy|1|||
161993442|NCT00570310|585025517|FG001|Overall Study|Lack of Efficacy|4|||
161993443|NCT00080301|585025520|FG000|Overall Study|Randomized but Never Treated|5|||
161993444|NCT00080301|585025521|FG001|Overall Study|Randomized but Never Treated|10|||
161993445|NCT00080301|585025520|FG000|Overall Study|Still on Treatment as of CSR date|0|||
161993446|NCT00080301|585025521|FG001|Overall Study|Still on Treatment as of CSR date|1|||
161993447|NCT00181766|585025531|FG000|Overall Study|Lost to Follow-up|6|||
161993448|NCT00181766|585025531|FG000|Overall Study|Adverse Event|4|||
161993449|NCT00181766|585025531|FG000|Overall Study|non-compliance|2|||
162037150|NCT00282347|585192716|FG001|Safety Follow-up Period|Physician Decision|1|||
161993450|NCT01965704|585025534|FG000|Overall Study|Withdrawal by Subject|2|||
162037151|NCT00282347|585192715|FG000|Safety Follow-up Period|Protocol Deviation|0|||
162037152|NCT00282347|585192716|FG001|Safety Follow-up Period|Protocol Deviation|2|||
162037153|NCT00282347|585192715|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
161993451|NCT01965704|585025535|FG001|Overall Study|Withdrawal by Subject|2|||
161993452|NCT01965704|585025536|FG002|Overall Study|Withdrawal by Subject|1|||
161993453|NCT01965704|585025537|FG003|Overall Study|Withdrawal by Subject|1|||
161993454|NCT01965704|585025534|FG000|Overall Study|Delivered at home|1|||
161993455|NCT01965704|585025535|FG001|Overall Study|Delivered at home|1|||
161993456|NCT01965704|585025536|FG002|Overall Study|Delivered at home|0|||
161993457|NCT01965704|585025537|FG003|Overall Study|Delivered at home|0|||
161993458|NCT01965704|585025534|FG000|Overall Study|Experienced complications|0|||
161993459|NCT01965704|585025535|FG001|Overall Study|Experienced complications|0|||
161993460|NCT01965704|585025536|FG002|Overall Study|Experienced complications|2|||
161993461|NCT01965704|585025537|FG003|Overall Study|Experienced complications|2|||
161993462|NCT01965704|585025534|FG000|Overall Study|Adverse Event|0|||
161993463|NCT01965704|585025535|FG001|Overall Study|Adverse Event|0|||
161993464|NCT01965704|585025536|FG002|Overall Study|Adverse Event|1|||
161993465|NCT01965704|585025537|FG003|Overall Study|Adverse Event|1|||
161993466|NCT01965704|585025534|FG000|Overall Study|Did not meet inclusion criteria|0|||
161993467|NCT01965704|585025535|FG001|Overall Study|Did not meet inclusion criteria|0|||
161993468|NCT01965704|585025536|FG002|Overall Study|Did not meet inclusion criteria|1|||
161993469|NCT01965704|585025537|FG003|Overall Study|Did not meet inclusion criteria|1|||
161993470|NCT05730387|585025540|FG000|Overall Study|Stillbirth|0|||
161993471|NCT05730387|585025541|FG001|Overall Study|Stillbirth|262|||
161993472|NCT05730387|585025540|FG000|Overall Study|Died during or after delivery|2|||
161993473|NCT05730387|585025541|FG001|Overall Study|Died during or after delivery|85|||
161993474|NCT05730387|585025540|FG000|Overall Study|Died after being admitted|0|||
161993475|NCT05730387|585025541|FG001|Overall Study|Died after being admitted|44|||
161993476|NCT05730387|585025540|FG000|Overall Study|Lost to Follow-up|69|||
161993477|NCT05730387|585025541|FG001|Overall Study|Lost to Follow-up|77|||
161993478|NCT00637416|585025545|FG000|Overall Study|Lost to Follow-up|1|||
161993479|NCT00637416|585025546|FG001|Overall Study|Lost to Follow-up|1|||
161993480|NCT00637416|585025545|FG000|Overall Study|Unable to take study drug|0|||
161993481|NCT00637416|585025546|FG001|Overall Study|Unable to take study drug|1|||
161993482|NCT04137731|585025549|FG000|Overall Study|Surgery Cancellation|1|||
161993483|NCT04137731|585025550|FG001|Overall Study|Surgery Cancellation|2|||
161993484|NCT04137731|585025549|FG000|Overall Study|Withdrawal by Subject|2|||
161993485|NCT04137731|585025550|FG001|Overall Study|Withdrawal by Subject|0|||
161993486|NCT04137731|585025549|FG000|Overall Study|Protocol Violation|0|||
161993487|NCT04137731|585025550|FG001|Overall Study|Protocol Violation|1|||
161993488|NCT02204072|585025552|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
161993489|NCT02204072|585025553|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
161993490|NCT02204072|585025554|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
161993491|NCT02204072|585025555|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
161993492|NCT02204072|585025556|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
161993493|NCT02204072|585025552|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
161993494|NCT02204072|585025553|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
161993495|NCT02204072|585025554|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
161993496|NCT02204072|585025555|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
161993497|NCT02204072|585025556|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
161993498|NCT02204072|585025552|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
161993499|NCT02204072|585025553|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
161993500|NCT02204072|585025554|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
161993501|NCT02204072|585025555|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
161993502|NCT02204072|585025556|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
161993503|NCT02204072|585025552|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
161993504|NCT02204072|585025553|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
161993505|NCT02204072|585025554|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
161993506|NCT02204072|585025555|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
161993507|NCT02204072|585025556|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
161993508|NCT00310817|585025557|FG000|Overall Study|AE or Death|3|||
161993509|NCT00310817|585025558|FG001|Overall Study|AE or Death|1|||
161993510|NCT00310817|585025559|FG002|Overall Study|AE or Death|0|||
161993511|NCT00310817|585025560|FG003|Overall Study|AE or Death|0|||
161993512|NCT00310817|585025557|FG000|Overall Study|Withdrawal by Subject|1|||
161993513|NCT00310817|585025558|FG001|Overall Study|Withdrawal by Subject|4|||
161993514|NCT00310817|585025559|FG002|Overall Study|Withdrawal by Subject|6|||
161993515|NCT00310817|585025560|FG003|Overall Study|Withdrawal by Subject|7|||
161993516|NCT00310817|585025557|FG000|Overall Study|Lost to Follow-up|2|||
161993517|NCT00310817|585025558|FG001|Overall Study|Lost to Follow-up|1|||
161993518|NCT00310817|585025559|FG002|Overall Study|Lost to Follow-up|0|||
161993519|NCT00310817|585025560|FG003|Overall Study|Lost to Follow-up|0|||
161993520|NCT00310817|585025557|FG000|Overall Study|Inappropriate Enrollment|1|||
161993521|NCT00310817|585025558|FG001|Overall Study|Inappropriate Enrollment|0|||
161993522|NCT00310817|585025559|FG002|Overall Study|Inappropriate Enrollment|1|||
161993523|NCT00310817|585025560|FG003|Overall Study|Inappropriate Enrollment|0|||
161993524|NCT00310817|585025557|FG000|Overall Study|Protocol Violation|1|||
161993525|NCT00310817|585025558|FG001|Overall Study|Protocol Violation|1|||
161993526|NCT00310817|585025559|FG002|Overall Study|Protocol Violation|1|||
161993527|NCT00310817|585025560|FG003|Overall Study|Protocol Violation|1|||
161993528|NCT00310817|585025557|FG000|Overall Study|Unable to classify|3|||
161887373|NCT01716520|584632354|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161887374|NCT01716520|584632349|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161887375|NCT01716520|584632350|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161887376|NCT01716520|584632351|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161887377|NCT01716520|584632352|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161887378|NCT01716520|584632353|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161887379|NCT01716520|584632354|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
161993529|NCT00310817|585025558|FG001|Overall Study|Unable to classify|1|||
161993530|NCT00310817|585025559|FG002|Overall Study|Unable to classify|0|||
161993531|NCT00310817|585025560|FG003|Overall Study|Unable to classify|0|||
161993532|NCT01587040|585025566|FG000|Overall Study|Protocol Violation|0|||
161993533|NCT01587040|585025567|FG001|Overall Study|Protocol Violation|0|||
161993534|NCT01587040|585025568|FG002|Overall Study|Protocol Violation|1|||
161993535|NCT01587040|585025569|FG003|Overall Study|Protocol Violation|0|||
161993536|NCT01587040|585025566|FG000|Overall Study|Adverse Event|0|||
161993537|NCT01587040|585025567|FG001|Overall Study|Adverse Event|1|||
161993538|NCT01587040|585025568|FG002|Overall Study|Adverse Event|10|||
161993539|NCT01587040|585025569|FG003|Overall Study|Adverse Event|0|||
161993540|NCT01587040|585025566|FG000|Overall Study|Disease progression|12|||
161993541|NCT01587040|585025567|FG001|Overall Study|Disease progression|1|||
161993542|NCT01587040|585025568|FG002|Overall Study|Disease progression|15|||
161993543|NCT01587040|585025569|FG003|Overall Study|Disease progression|3|||
161993544|NCT01587040|585025566|FG000|Overall Study|Other than specified|5|||
161993545|NCT01587040|585025567|FG001|Overall Study|Other than specified|1|||
161993546|NCT01587040|585025568|FG002|Overall Study|Other than specified|11|||
161993547|NCT01587040|585025569|FG003|Overall Study|Other than specified|1|||
161993548|NCT00367835|585025573|FG000|Overall Study|Adverse Event|14|||
161993549|NCT00367835|585025574|FG001|Overall Study|Adverse Event|1|||
161993550|NCT00367835|585025573|FG000|Overall Study|Protocol Violation|1|||
161993551|NCT00367835|585025574|FG001|Overall Study|Protocol Violation|7|||
161993552|NCT00367835|585025573|FG000|Overall Study|Withdrawal by Subject|7|||
161993553|NCT00367835|585025574|FG001|Overall Study|Withdrawal by Subject|6|||
161993554|NCT00367835|585025573|FG000|Overall Study|Lost to Follow-up|1|||
161993555|NCT00367835|585025574|FG001|Overall Study|Lost to Follow-up|4|||
161993556|NCT00367835|585025573|FG000|Overall Study|Lack of Efficacy|3|||
161993557|NCT00367835|585025574|FG001|Overall Study|Lack of Efficacy|12|||
161993558|NCT00367835|585025573|FG000|Overall Study|Subject in juvenile detention center|1|||
161993559|NCT00367835|585025574|FG001|Overall Study|Subject in juvenile detention center|0|||
161993560|NCT00367835|585025573|FG000|Overall Study|refused blood collection|1|||
161993561|NCT00367835|585025574|FG001|Overall Study|refused blood collection|0|||
161993562|NCT00367835|585025573|FG000|Overall Study|Did not respond to calls|1|||
161993563|NCT00367835|585025574|FG001|Overall Study|Did not respond to calls|0|||
161993564|NCT00367835|585025573|FG000|Overall Study|History of lead poisoning|0|||
161993565|NCT00367835|585025574|FG001|Overall Study|History of lead poisoning|1|||
161993566|NCT04346654|585025576|FG000|Overall Study|Adverse Event|2|||
161993567|NCT04346654|585025577|FG001|Overall Study|Adverse Event|0|||
161993568|NCT04346654|585025576|FG000|Overall Study|Non-response|1|||
161993569|NCT04346654|585025577|FG001|Overall Study|Non-response|1|||
161993570|NCT04346654|585025576|FG000|Overall Study|Withdrawal by Subject|2|||
161993571|NCT04346654|585025577|FG001|Overall Study|Withdrawal by Subject|0|||
161993572|NCT04346654|585025576|FG000|Overall Study|Lost to Follow-up|0|||
161993573|NCT04346654|585025577|FG001|Overall Study|Lost to Follow-up|1|||
161993574|NCT04346654|585025576|FG000|Overall Study|Pregnancy|0|||
161993575|NCT04346654|585025577|FG001|Overall Study|Pregnancy|1|||
161993576|NCT00286429|585025589|FG000|Overall Study|Adverse Event|4|||
161993577|NCT00286429|585025590|FG001|Overall Study|Adverse Event|1|||
161993578|NCT00286429|585025591|FG002|Overall Study|Adverse Event|6|||
161993579|NCT00286429|585025589|FG000|Overall Study|Lack of Efficacy|52|||
161993580|NCT00286429|585025590|FG001|Overall Study|Lack of Efficacy|27|||
161993581|NCT00286429|585025591|FG002|Overall Study|Lack of Efficacy|25|||
161993582|NCT00286429|585025589|FG000|Overall Study|Lost to Follow-up|2|||
161993583|NCT00286429|585025590|FG001|Overall Study|Lost to Follow-up|4|||
161993584|NCT00286429|585025591|FG002|Overall Study|Lost to Follow-up|3|||
161993585|NCT00286429|585025589|FG000|Overall Study|Physician Decision|10|||
161993586|NCT00286429|585025590|FG001|Overall Study|Physician Decision|7|||
161993587|NCT00286429|585025591|FG002|Overall Study|Physician Decision|7|||
161993588|NCT00286429|585025589|FG000|Overall Study|Protocol Violation|3|||
161993589|NCT00286429|585025590|FG001|Overall Study|Protocol Violation|5|||
161993590|NCT00286429|585025591|FG002|Overall Study|Protocol Violation|4|||
161993591|NCT00286429|585025589|FG000|Overall Study|Withdrawal by Subject|3|||
161993592|NCT00286429|585025590|FG001|Overall Study|Withdrawal by Subject|2|||
161993593|NCT00286429|585025591|FG002|Overall Study|Withdrawal by Subject|6|||
161993594|NCT00286429|585025589|FG000|Overall Study|Administrative Error|1|||
161993595|NCT00286429|585025590|FG001|Overall Study|Administrative Error|1|||
161993596|NCT00286429|585025591|FG002|Overall Study|Administrative Error|1|||
161993597|NCT00286429|585025589|FG000|Overall Study|Administrative Decision|0|||
161993598|NCT00286429|585025590|FG001|Overall Study|Administrative Decision|1|||
161887380|NCT01716520|584632349|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
161887381|NCT01716520|584632350|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
161887382|NCT01716520|584632351|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
161887383|NCT01716520|584632352|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
161887384|NCT01716520|584632353|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
161993599|NCT00286429|585025591|FG002|Overall Study|Administrative Decision|0|||
161993600|NCT03197376|585025595|FG000|Primary and Booster Phase|Adverse Event|0|||
161993601|NCT03197376|585025596|FG001|Primary and Booster Phase|Adverse Event|0|||
161993602|NCT03197376|585025597|FG002|Primary and Booster Phase|Adverse Event|0|||
161993603|NCT03197376|585025598|FG003|Primary and Booster Phase|Adverse Event|1|||
161993604|NCT03197376|585025595|FG000|Primary and Booster Phase|Death|1|||
161993605|NCT03197376|585025596|FG001|Primary and Booster Phase|Death|0|||
161993606|NCT03197376|585025597|FG002|Primary and Booster Phase|Death|0|||
161993607|NCT03197376|585025598|FG003|Primary and Booster Phase|Death|2|||
161993608|NCT03197376|585025595|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
161993609|NCT03197376|585025596|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
161993610|NCT03197376|585025597|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
161993611|NCT03197376|585025598|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
161993612|NCT03197376|585025595|FG000|Primary and Booster Phase|Physician Decision|1|||
161993613|NCT03197376|585025596|FG001|Primary and Booster Phase|Physician Decision|0|||
161993614|NCT03197376|585025597|FG002|Primary and Booster Phase|Physician Decision|1|||
161887385|NCT01716520|584632354|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
161887386|NCT01716520|584632349|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
161887387|NCT01716520|584632350|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
161887388|NCT01716520|584632351|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
161887389|NCT01716520|584632352|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
161887390|NCT01716520|584632353|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
161887391|NCT01716520|584632354|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
161887392|NCT01716520|584632349|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161887393|NCT01716520|584632350|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161887394|NCT01716520|584632351|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161887395|NCT01716520|584632352|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161887396|NCT01716520|584632353|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
161887397|NCT01716520|584632354|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161887398|NCT01716520|584632349|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887399|NCT01716520|584632350|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887400|NCT01716520|584632351|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887401|NCT01716520|584632352|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
161887402|NCT01716520|584632353|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887403|NCT01716520|584632354|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161887404|NCT01716520|584632349|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
161887405|NCT01716520|584632350|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
161887406|NCT01716520|584632351|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
161887407|NCT01716520|584632352|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
161887408|NCT01716520|584632353|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
161887409|NCT01716520|584632354|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
161993615|NCT03197376|585025598|FG003|Primary and Booster Phase|Physician Decision|3|||
161993616|NCT03197376|585025595|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
161993617|NCT03197376|585025596|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
161993618|NCT03197376|585025597|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
161993619|NCT03197376|585025598|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
161993620|NCT03197376|585025595|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
161993621|NCT03197376|585025596|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
161993622|NCT03197376|585025597|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
161993623|NCT03197376|585025598|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
161993624|NCT03197376|585025595|FG000|Primary and Booster Phase|Not vaccine related|1|||
161993625|NCT03197376|585025596|FG001|Primary and Booster Phase|Not vaccine related|2|||
161993626|NCT03197376|585025597|FG002|Primary and Booster Phase|Not vaccine related|0|||
161993627|NCT03197376|585025598|FG003|Primary and Booster Phase|Not vaccine related|6|||
161993628|NCT03197376|585025595|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
161993629|NCT03197376|585025596|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
161993630|NCT03197376|585025597|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
161993631|NCT03197376|585025598|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
161993632|NCT03197376|585025595|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
161993633|NCT03197376|585025596|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
161993634|NCT03197376|585025597|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
161993635|NCT03197376|585025598|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
161993636|NCT03197376|585025595|FG000|Immune Persistence Phase|Not vaccine related|1|||
161993637|NCT03197376|585025596|FG001|Immune Persistence Phase|Not vaccine related|0|||
161993638|NCT03197376|585025597|FG002|Immune Persistence Phase|Not vaccine related|1|||
162037154|NCT00282347|585192716|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
162037155|NCT00282347|585192715|FG000|B Cell Follow-up Period|Physician Decision|1|||
162037156|NCT00282347|585192716|FG001|B Cell Follow-up Period|Physician Decision|0|||
162037157|NCT00282347|585192715|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
162037158|NCT00282347|585192716|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
162037159|NCT02101112|585192717|FG000|Overall Study|Adverse Event|0|||
162037160|NCT02101112|585192718|FG001|Overall Study|Adverse Event|0|||
162037161|NCT02101112|585192719|FG002|Overall Study|Adverse Event|1|||
162037162|NCT02101112|585192720|FG003|Overall Study|Adverse Event|0|||
162037163|NCT02101112|585192721|FG004|Overall Study|Adverse Event|0|||
162037164|NCT02101112|585192722|FG005|Overall Study|Adverse Event|0|||
162037165|NCT02101112|585192717|FG000|Overall Study|Withdrawal by Subject|0|||
162037166|NCT02101112|585192718|FG001|Overall Study|Withdrawal by Subject|0|||
162037167|NCT02101112|585192719|FG002|Overall Study|Withdrawal by Subject|0|||
162037168|NCT02101112|585192720|FG003|Overall Study|Withdrawal by Subject|0|||
162037169|NCT02101112|585192721|FG004|Overall Study|Withdrawal by Subject|1|||
162037170|NCT02101112|585192722|FG005|Overall Study|Withdrawal by Subject|0|||
162037171|NCT04340063|585192723|FG000|Overall Study|Withdrawal by Subject|1|||
162037172|NCT04340063|585192724|FG001|Overall Study|Withdrawal by Subject|2|||
162037173|NCT04340063|585192723|FG000|Overall Study|Lost to Follow-up|3|||
162037174|NCT04340063|585192724|FG001|Overall Study|Lost to Follow-up|1|||
162037175|NCT04340063|585192723|FG000|Overall Study|Protocol Violation|0|||
162037176|NCT04340063|585192724|FG001|Overall Study|Protocol Violation|1|||
162037177|NCT00491556|585192725|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
162037178|NCT00491556|585192726|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
162037179|NCT00491556|585192725|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
162037180|NCT00491556|585192726|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
162037181|NCT00491556|585192725|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
162037182|NCT00491556|585192726|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
162037183|NCT00491556|585192725|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
162037184|NCT00491556|585192726|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
162037185|NCT00491556|585192725|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
162037186|NCT00491556|585192726|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
162037187|NCT00491556|585192725|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
162037188|NCT00491556|585192726|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
162037189|NCT00491556|585192725|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
162037190|NCT00491556|585192726|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
162037191|NCT00491556|585192725|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
162037192|NCT00491556|585192726|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
162037193|NCT00491556|585192725|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
162037194|NCT00491556|585192726|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
162037195|NCT00491556|585192725|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
162037196|NCT00491556|585192726|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
162037197|NCT00491556|585192725|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
162037198|NCT00491556|585192726|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
162037199|NCT00491556|585192725|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
162037200|NCT00491556|585192726|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
162037201|NCT00491556|585192725|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
162037202|NCT00491556|585192726|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
162037203|NCT00491556|585192725|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
162037204|NCT00491556|585192726|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
162037205|NCT00491556|585192725|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
162037206|NCT00491556|585192726|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
162037207|NCT00491556|585192725|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
162037208|NCT00491556|585192726|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
162037209|NCT00491556|585192725|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
162037210|NCT00491556|585192726|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
162037211|NCT00491556|585192725|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
162037212|NCT00491556|585192726|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
162037213|NCT00491556|585192725|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
162037214|NCT00491556|585192726|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
162037215|NCT00491556|585192725|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
162037216|NCT00491556|585192726|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
162037217|NCT02782923|585192727|FG000|Overall Study|Lost to Follow-up|15|||
162037218|NCT00734747|585192728|FG000|SRS Procedure|No staples placed|3|||
162037219|NCT00734747|585192728|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
162037220|NCT05063318|585192734|FG000|Overall Study|Progressive disease|2|||
162037221|NCT05063318|585192735|FG001|Overall Study|Progressive disease|0|||
162037222|NCT05063318|585192736|FG002|Overall Study|Progressive disease|3|||
161993639|NCT03197376|585025598|FG003|Immune Persistence Phase|Not vaccine related|1|||
161993640|NCT00999518|585025600|FG000|Overall Study|Adverse Event|1|||
161993641|NCT00999518|585025601|FG001|Overall Study|Adverse Event|6|||
161993642|NCT00999518|585025602|FG002|Overall Study|Adverse Event|3|||
161993643|NCT00999518|585025603|FG003|Overall Study|Adverse Event|1|||
161993644|NCT00999518|585025604|FG004|Overall Study|Adverse Event|2|||
161993645|NCT00999518|585025600|FG000|Overall Study|Lack of Efficacy|2|||
161993646|NCT00999518|585025601|FG001|Overall Study|Lack of Efficacy|0|||
161993647|NCT00999518|585025602|FG002|Overall Study|Lack of Efficacy|0|||
161993648|NCT00999518|585025603|FG003|Overall Study|Lack of Efficacy|2|||
161993649|NCT00999518|585025604|FG004|Overall Study|Lack of Efficacy|2|||
161993650|NCT00999518|585025600|FG000|Overall Study|Lost to Follow-up|0|||
161993651|NCT00999518|585025601|FG001|Overall Study|Lost to Follow-up|0|||
161993652|NCT00999518|585025602|FG002|Overall Study|Lost to Follow-up|0|||
161993653|NCT00999518|585025603|FG003|Overall Study|Lost to Follow-up|4|||
161993654|NCT00999518|585025604|FG004|Overall Study|Lost to Follow-up|1|||
161993655|NCT00999518|585025600|FG000|Overall Study|Did not meet entrance criteria|0|||
161993656|NCT00999518|585025601|FG001|Overall Study|Did not meet entrance criteria|0|||
161993657|NCT00999518|585025602|FG002|Overall Study|Did not meet entrance criteria|0|||
161993658|NCT00999518|585025603|FG003|Overall Study|Did not meet entrance criteria|0|||
161993659|NCT00999518|585025604|FG004|Overall Study|Did not meet entrance criteria|1|||
161993660|NCT00999518|585025600|FG000|Overall Study|Study terminated by sponsor|10|||
161993661|NCT00999518|585025601|FG001|Overall Study|Study terminated by sponsor|6|||
161993662|NCT00999518|585025602|FG002|Overall Study|Study terminated by sponsor|5|||
161993663|NCT00999518|585025603|FG003|Overall Study|Study terminated by sponsor|5|||
161993664|NCT00999518|585025604|FG004|Overall Study|Study terminated by sponsor|9|||
161993665|NCT00999518|585025600|FG000|Overall Study|Pregnancy|0|||
161993666|NCT00999518|585025601|FG001|Overall Study|Pregnancy|0|||
161993667|NCT00999518|585025602|FG002|Overall Study|Pregnancy|1|||
161993668|NCT00999518|585025603|FG003|Overall Study|Pregnancy|0|||
161993669|NCT00999518|585025604|FG004|Overall Study|Pregnancy|0|||
161993670|NCT00999518|585025600|FG000|Overall Study|Protocol Violation|0|||
161993671|NCT00999518|585025601|FG001|Overall Study|Protocol Violation|1|||
161993672|NCT00999518|585025602|FG002|Overall Study|Protocol Violation|0|||
161993673|NCT00999518|585025603|FG003|Overall Study|Protocol Violation|0|||
161993674|NCT00999518|585025604|FG004|Overall Study|Protocol Violation|2|||
161993675|NCT00999518|585025600|FG000|Overall Study|Withdrawal by Subject|5|||
161993676|NCT00999518|585025601|FG001|Overall Study|Withdrawal by Subject|4|||
161993677|NCT00999518|585025602|FG002|Overall Study|Withdrawal by Subject|10|||
161993678|NCT00999518|585025603|FG003|Overall Study|Withdrawal by Subject|6|||
161993679|NCT00999518|585025604|FG004|Overall Study|Withdrawal by Subject|1|||
161993680|NCT00999518|585025600|FG000|Overall Study|Other|5|||
161993681|NCT00999518|585025601|FG001|Overall Study|Other|7|||
161993682|NCT00999518|585025602|FG002|Overall Study|Other|1|||
161993683|NCT00999518|585025603|FG003|Overall Study|Other|4|||
161993684|NCT00999518|585025604|FG004|Overall Study|Other|5|||
161993685|NCT00999518|585025600|FG000|Overall Study|Randomized but not Treated|1|||
161993686|NCT00999518|585025601|FG001|Overall Study|Randomized but not Treated|1|||
161993687|NCT00999518|585025602|FG002|Overall Study|Randomized but not Treated|2|||
161993688|NCT00999518|585025603|FG003|Overall Study|Randomized but not Treated|0|||
161993689|NCT00999518|585025604|FG004|Overall Study|Randomized but not Treated|1|||
161993690|NCT01811186|585025608|FG000|Overall Study|Adverse Event|54|||
161993691|NCT01811186|585025609|FG001|Overall Study|Adverse Event|38|||
161993692|NCT01811186|585025608|FG000|Overall Study|Protocol Violation|5|||
161993693|NCT01811186|585025609|FG001|Overall Study|Protocol Violation|6|||
161993694|NCT01811186|585025608|FG000|Overall Study|Withdrawal by Subject|5|||
161993695|NCT01811186|585025609|FG001|Overall Study|Withdrawal by Subject|10|||
161993696|NCT01811186|585025608|FG000|Overall Study|Lack of Efficacy|3|||
161993697|NCT01811186|585025609|FG001|Overall Study|Lack of Efficacy|6|||
161993698|NCT01811186|585025608|FG000|Overall Study|Lost to Follow-up|4|||
161993699|NCT01811186|585025609|FG001|Overall Study|Lost to Follow-up|2|||
161993700|NCT01445080|585025617|FG000|Overall Study|Adverse Event|5|||
161993701|NCT01445080|585025618|FG001|Overall Study|Adverse Event|3|||
161993702|NCT01445080|585025619|FG002|Overall Study|Adverse Event|11|||
161993703|NCT01445080|585025620|FG003|Overall Study|Adverse Event|6|||
161993704|NCT01445080|585025621|FG004|Overall Study|Adverse Event|2|||
161993705|NCT01445080|585025622|FG005|Overall Study|Adverse Event|3|||
161993706|NCT01445080|585025623|FG006|Overall Study|Adverse Event|0|||
161993707|NCT01445080|585025624|FG007|Overall Study|Adverse Event|3|||
161993708|NCT01445080|585025625|FG008|Overall Study|Adverse Event|10|||
161993709|NCT01445080|585025617|FG000|Overall Study|Physician Decision|0|||
161993710|NCT01445080|585025618|FG001|Overall Study|Physician Decision|0|||
161993711|NCT01445080|585025619|FG002|Overall Study|Physician Decision|1|||
161993712|NCT01445080|585025620|FG003|Overall Study|Physician Decision|0|||
161993713|NCT01445080|585025621|FG004|Overall Study|Physician Decision|0|||
161993714|NCT01445080|585025622|FG005|Overall Study|Physician Decision|3|||
161993715|NCT01445080|585025623|FG006|Overall Study|Physician Decision|2|||
161993716|NCT01445080|585025624|FG007|Overall Study|Physician Decision|2|||
161993717|NCT01445080|585025625|FG008|Overall Study|Physician Decision|0|||
161993718|NCT01445080|585025617|FG000|Overall Study|Withdrawal by Subject|1|||
162037223|NCT05063318|585192734|FG000|Overall Study|Compassionate use|1|||
162037224|NCT05063318|585192735|FG001|Overall Study|Compassionate use|3|||
162037225|NCT05063318|585192736|FG002|Overall Study|Compassionate use|3|||
162037226|NCT05063318|585192734|FG000|Overall Study|Adverse Event|0|||
162037227|NCT05063318|585192735|FG001|Overall Study|Adverse Event|1|||
162037228|NCT05063318|585192736|FG002|Overall Study|Adverse Event|0|||
162037229|NCT05063318|585192734|FG000|Overall Study|Withdrawal by Subject|0|||
162037230|NCT05063318|585192735|FG001|Overall Study|Withdrawal by Subject|1|||
162037231|NCT05063318|585192736|FG002|Overall Study|Withdrawal by Subject|0|||
162037232|NCT03287635|585192737|FG000|Overall Study|Lost to Follow-up|5|||
162037233|NCT03287635|585192737|FG000|Overall Study|Withdrawal by Subject|1|||
162037234|NCT03287635|585192737|FG000|Overall Study|Physician Decision|1|||
162037235|NCT04090957|585192740|FG000|Overall Study|Lost to Follow-up|22|||
162037236|NCT04090957|585192741|FG001|Overall Study|Lost to Follow-up|25|||
162037237|NCT04090957|585192742|FG002|Overall Study|Lost to Follow-up|25|||
162037238|NCT04090957|585192743|FG003|Overall Study|Lost to Follow-up|36|||
162037239|NCT04090957|585192740|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
162037240|NCT04090957|585192741|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
162037241|NCT04090957|585192742|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
162037242|NCT04090957|585192743|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
162037243|NCT04090957|585192740|FG000|Overall Study|Adverse Event|19|||
162037244|NCT04090957|585192741|FG001|Overall Study|Adverse Event|25|||
162037245|NCT04090957|585192742|FG002|Overall Study|Adverse Event|8|||
162037246|NCT04090957|585192743|FG003|Overall Study|Adverse Event|104|||
162037247|NCT04090957|585192740|FG000|Overall Study|Other|10|||
162037248|NCT04090957|585192741|FG001|Overall Study|Other|6|||
162037249|NCT04090957|585192742|FG002|Overall Study|Other|5|||
162037250|NCT04090957|585192743|FG003|Overall Study|Other|12|||
162037251|NCT04090957|585192740|FG000|Overall Study|Serious Adverse Event|7|||
162037252|NCT04090957|585192741|FG001|Overall Study|Serious Adverse Event|11|||
162037253|NCT04090957|585192742|FG002|Overall Study|Serious Adverse Event|1|||
162037254|NCT04090957|585192743|FG003|Overall Study|Serious Adverse Event|32|||
162037255|NCT04090957|585192740|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
162037256|NCT04090957|585192741|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
162037257|NCT04090957|585192742|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
162037258|NCT04090957|585192743|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
162037259|NCT04090957|585192740|FG000|Overall Study|Lack of Efficacy|1|||
162037260|NCT04090957|585192741|FG001|Overall Study|Lack of Efficacy|1|||
162037261|NCT04090957|585192742|FG002|Overall Study|Lack of Efficacy|9|||
162037262|NCT04090957|585192743|FG003|Overall Study|Lack of Efficacy|0|||
162037263|NCT04090957|585192740|FG000|Overall Study|Protocol Violation|3|||
162037264|NCT04090957|585192741|FG001|Overall Study|Protocol Violation|5|||
162037265|NCT04090957|585192742|FG002|Overall Study|Protocol Violation|2|||
162037266|NCT04090957|585192743|FG003|Overall Study|Protocol Violation|1|||
162037267|NCT04090957|585192740|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
162037268|NCT04090957|585192741|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
162037269|NCT04090957|585192742|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
162037270|NCT04090957|585192743|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
162037271|NCT04090957|585192740|FG000|Overall Study|COVID-19|2|||
162037272|NCT04090957|585192741|FG001|Overall Study|COVID-19|2|||
162037273|NCT04090957|585192742|FG002|Overall Study|COVID-19|3|||
162037274|NCT04090957|585192743|FG003|Overall Study|COVID-19|7|||
162037275|NCT04090957|585192740|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
162037276|NCT04090957|585192741|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
162037277|NCT04090957|585192742|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
162037278|NCT04090957|585192743|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
162037279|NCT04090957|585192740|FG000|Overall Study|Physician Decision|2|||
162037280|NCT04090957|585192741|FG001|Overall Study|Physician Decision|1|||
162037281|NCT04090957|585192742|FG002|Overall Study|Physician Decision|1|||
162037282|NCT04090957|585192743|FG003|Overall Study|Physician Decision|5|||
162037283|NCT04090957|585192740|FG000|Overall Study|Sponsor Decision|1|||
162037284|NCT04090957|585192741|FG001|Overall Study|Sponsor Decision|1|||
162037285|NCT04090957|585192742|FG002|Overall Study|Sponsor Decision|1|||
162037286|NCT04090957|585192743|FG003|Overall Study|Sponsor Decision|3|||
162037287|NCT04090957|585192740|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
162037288|NCT04090957|585192741|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
162037289|NCT04090957|585192742|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
162037290|NCT04090957|585192743|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
162037291|NCT04090957|585192740|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
162037292|NCT04090957|585192741|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
162037293|NCT04090957|585192742|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
162037294|NCT04090957|585192743|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
162037295|NCT04090957|585192740|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
162037296|NCT04090957|585192741|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
162037297|NCT04090957|585192742|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
162037298|NCT04090957|585192743|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
162037299|NCT04090957|585192740|FG000|Overall Study|Death|1|||
162037300|NCT04090957|585192741|FG001|Overall Study|Death|0|||
162037301|NCT04090957|585192742|FG002|Overall Study|Death|0|||
162037302|NCT04090957|585192743|FG003|Overall Study|Death|0|||
162037303|NCT04090957|585192740|FG000|Overall Study|No Treatment Administered|2|||
162037304|NCT04090957|585192741|FG001|Overall Study|No Treatment Administered|1|||
162037305|NCT04090957|585192742|FG002|Overall Study|No Treatment Administered|2|||
162037306|NCT04090957|585192743|FG003|Overall Study|No Treatment Administered|1|||
162037307|NCT00920829|585194274|FG000|Allocation|No post randomization data|3|||
162037308|NCT00920829|585194275|FG001|Allocation|No post randomization data|1|||
162037309|NCT00920829|585194276|FG002|Allocation|No post randomization data|0|||
162037310|NCT00920829|585194277|FG003|Allocation|No post randomization data|2|||
162037311|NCT00920829|585194274|FG000|Available for Analysis|Withdrawal by Subject|6|||
162037312|NCT00920829|585194275|FG001|Available for Analysis|Withdrawal by Subject|6|||
162037313|NCT00920829|585194276|FG002|Available for Analysis|Withdrawal by Subject|6|||
162037314|NCT00920829|585194277|FG003|Available for Analysis|Withdrawal by Subject|10|||
162037315|NCT00920829|585194274|FG000|Available for Analysis|Required Medical Treatment|0|||
162037316|NCT00920829|585194275|FG001|Available for Analysis|Required Medical Treatment|1|||
162037317|NCT00920829|585194276|FG002|Available for Analysis|Required Medical Treatment|2|||
162037318|NCT00920829|585194277|FG003|Available for Analysis|Required Medical Treatment|0|||
162037319|NCT00920829|585194274|FG000|Available for Analysis|Adverse Event|1|||
162037320|NCT00920829|585194275|FG001|Available for Analysis|Adverse Event|2|||
162037321|NCT00920829|585194276|FG002|Available for Analysis|Adverse Event|1|||
162037322|NCT00920829|585194277|FG003|Available for Analysis|Adverse Event|0|||
162037323|NCT00920829|585194274|FG000|Available for Analysis|Death|1|||
162037324|NCT00920829|585194275|FG001|Available for Analysis|Death|0|||
161887410|NCT01716520|584632349|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
162037325|NCT00920829|585194276|FG002|Available for Analysis|Death|0|||
162037326|NCT00920829|585194277|FG003|Available for Analysis|Death|0|||
161887411|NCT01716520|584632350|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161887412|NCT01716520|584632351|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161887413|NCT01716520|584632352|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161887414|NCT01716520|584632353|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161887415|NCT01716520|584632354|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161887416|NCT01716520|584632349|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161887417|NCT01716520|584632350|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161887418|NCT01716520|584632351|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161887419|NCT01716520|584632352|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161887420|NCT01716520|584632353|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161887421|NCT01716520|584632354|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
161887422|NCT01716520|584632349|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161887423|NCT01716520|584632350|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
161887424|NCT01716520|584632351|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161887425|NCT01716520|584632352|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161887426|NCT01716520|584632353|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161887427|NCT01716520|584632354|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161887428|NCT01716520|584632349|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161887429|NCT01716520|584632350|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161887430|NCT01716520|584632351|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161887431|NCT01716520|584632352|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161887432|NCT01716520|584632353|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161887433|NCT01716520|584632354|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
161887434|NCT01716520|584632349|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161887435|NCT01716520|584632350|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161887436|NCT01716520|584632351|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
161887437|NCT01716520|584632352|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161887438|NCT01716520|584632353|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161887439|NCT01716520|584632354|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161887440|NCT02278367|584632359|FG000|Overall Study|Physician Decision|5|||
161887441|NCT02278367|584632360|FG001|Overall Study|Physician Decision|0|||
161887442|NCT02278367|584632359|FG000|Overall Study|Withdrawal by Subject|5|||
161887443|NCT02278367|584632360|FG001|Overall Study|Withdrawal by Subject|0|||
161887444|NCT04105010|584632361|FG000|Overall Study|Death|3|||
161887445|NCT04105010|584632362|FG001|Overall Study|Death|1|||
161887446|NCT04105010|584632363|FG002|Overall Study|Death|1|||
161887447|NCT04105010|584632364|FG003|Overall Study|Death|54|||
162037327|NCT00920829|585194274|FG000|Available for Analysis|Protocol Violation|0|||
162037328|NCT00920829|585194275|FG001|Available for Analysis|Protocol Violation|0|||
161993719|NCT01445080|585025618|FG001|Overall Study|Withdrawal by Subject|0|||
161993720|NCT01445080|585025619|FG002|Overall Study|Withdrawal by Subject|0|||
161993721|NCT01445080|585025620|FG003|Overall Study|Withdrawal by Subject|1|||
161993722|NCT01445080|585025621|FG004|Overall Study|Withdrawal by Subject|0|||
161993723|NCT01445080|585025622|FG005|Overall Study|Withdrawal by Subject|0|||
161993724|NCT01445080|585025623|FG006|Overall Study|Withdrawal by Subject|0|||
161993725|NCT01445080|585025624|FG007|Overall Study|Withdrawal by Subject|0|||
161993726|NCT01445080|585025625|FG008|Overall Study|Withdrawal by Subject|2|||
161993727|NCT01445080|585025617|FG000|Overall Study|Ineligible/Inevaluable|1|||
161993728|NCT01445080|585025618|FG001|Overall Study|Ineligible/Inevaluable|2|||
161993729|NCT01445080|585025619|FG002|Overall Study|Ineligible/Inevaluable|0|||
161993730|NCT01445080|585025620|FG003|Overall Study|Ineligible/Inevaluable|1|||
161993731|NCT01445080|585025621|FG004|Overall Study|Ineligible/Inevaluable|2|||
161993732|NCT01445080|585025622|FG005|Overall Study|Ineligible/Inevaluable|3|||
161993733|NCT01445080|585025623|FG006|Overall Study|Ineligible/Inevaluable|0|||
161993734|NCT01445080|585025624|FG007|Overall Study|Ineligible/Inevaluable|0|||
161993735|NCT01445080|585025625|FG008|Overall Study|Ineligible/Inevaluable|6|||
161993736|NCT03887221|585025626|FG000|Overall Study|Protocol Violation|1|||
161993737|NCT03887221|585025627|FG001|Overall Study|Protocol Violation|0|||
161993738|NCT02487030|585025628|FG000|Overall Study|Lack of Efficacy|2|||
161993739|NCT02487030|585025629|FG001|Overall Study|Lack of Efficacy|4|||
161993740|NCT02487030|585025630|FG002|Overall Study|Lack of Efficacy|1|||
161993741|NCT02487030|585025631|FG003|Overall Study|Lack of Efficacy|0|||
161993742|NCT02487030|585025632|FG004|Overall Study|Lack of Efficacy|1|||
161993743|NCT02487030|585025633|FG005|Overall Study|Lack of Efficacy|0|||
161993744|NCT02487030|585025634|FG006|Overall Study|Lack of Efficacy|0|||
161993745|NCT02487030|585025628|FG000|Overall Study|Lost to Follow-up|0|||
161993746|NCT02487030|585025629|FG001|Overall Study|Lost to Follow-up|0|||
161993747|NCT02487030|585025630|FG002|Overall Study|Lost to Follow-up|1|||
161993748|NCT02487030|585025631|FG003|Overall Study|Lost to Follow-up|1|||
161993749|NCT02487030|585025632|FG004|Overall Study|Lost to Follow-up|0|||
161993750|NCT02487030|585025633|FG005|Overall Study|Lost to Follow-up|1|||
161993751|NCT02487030|585025634|FG006|Overall Study|Lost to Follow-up|0|||
161993752|NCT02487030|585025628|FG000|Overall Study|Adverse Event|0|||
161993753|NCT02487030|585025629|FG001|Overall Study|Adverse Event|0|||
161993754|NCT02487030|585025630|FG002|Overall Study|Adverse Event|0|||
161993755|NCT02487030|585025631|FG003|Overall Study|Adverse Event|1|||
161993756|NCT02487030|585025632|FG004|Overall Study|Adverse Event|0|||
161993757|NCT02487030|585025633|FG005|Overall Study|Adverse Event|0|||
161993758|NCT02487030|585025634|FG006|Overall Study|Adverse Event|0|||
161993759|NCT02487030|585025628|FG000|Overall Study|Death|0|||
161993760|NCT02487030|585025629|FG001|Overall Study|Death|0|||
161993761|NCT02487030|585025630|FG002|Overall Study|Death|0|||
161993762|NCT02487030|585025631|FG003|Overall Study|Death|0|||
161993763|NCT02487030|585025632|FG004|Overall Study|Death|1|||
161993764|NCT02487030|585025633|FG005|Overall Study|Death|0|||
161993765|NCT02487030|585025634|FG006|Overall Study|Death|0|||
161993766|NCT03857542|585025635|FG000|Overall Study|Adverse Event|1|||
161993767|NCT03857542|585025636|FG001|Overall Study|Adverse Event|3|||
161993768|NCT03857542|585025635|FG000|Overall Study|Withdrawal by Subject|2|||
161993769|NCT03857542|585025636|FG001|Overall Study|Withdrawal by Subject|1|||
161993770|NCT03857542|585025635|FG000|Overall Study|Lost to Follow-up|2|||
161993771|NCT03857542|585025636|FG001|Overall Study|Lost to Follow-up|1|||
161993772|NCT03857542|585025635|FG000|Overall Study|Reason not Specified|1|||
161993773|NCT03857542|585025636|FG001|Overall Study|Reason not Specified|0|||
161993774|NCT02123576|585025637|FG000|Overall Study|Adverse Event|1|||
161993775|NCT02123576|585025638|FG001|Overall Study|Adverse Event|0|||
161993776|NCT04864639|585027364|FG000|Overall Study|Death|1|||
161993777|NCT04864639|585027364|FG000|Overall Study|Lost to Follow-up|1|||
161993778|NCT04050618|585027365|FG000|First Intervention|Withdrawal by Subject|2|||
161993779|NCT04050618|585027366|FG001|First Intervention|Withdrawal by Subject|0|||
161993780|NCT04050618|585027365|FG000|Second Intervention|Withdrawal by Subject|1|||
161993781|NCT04050618|585027366|FG001|Second Intervention|Withdrawal by Subject|0|||
161993782|NCT01101035|585027373|FG000|Overall Study|Adverse Event|191|||
161993783|NCT01101035|585027374|FG001|Overall Study|Adverse Event|172|||
161993784|NCT01101035|585027373|FG000|Overall Study|Major Protocol Deviation|52|||
161993785|NCT01101035|585027374|FG001|Overall Study|Major Protocol Deviation|46|||
161993786|NCT01101035|585027373|FG000|Overall Study|Lost to Follow-up|226|||
161993787|NCT01101035|585027374|FG001|Overall Study|Lost to Follow-up|223|||
161993788|NCT01101035|585027373|FG000|Overall Study|Voluntary Withdrawal|595|||
161993789|NCT01101035|585027374|FG001|Overall Study|Voluntary Withdrawal|587|||
161993790|NCT01101035|585027373|FG000|Overall Study|Reason not Specified|333|||
161993791|NCT01101035|585027374|FG001|Overall Study|Reason not Specified|363|||
161993792|NCT00713544|585027385|FG000|Overall Study|Adverse Event|5|||
161993793|NCT00713544|585027386|FG001|Overall Study|Adverse Event|3|||
161993794|NCT00713544|585027387|FG002|Overall Study|Adverse Event|7|||
161993795|NCT00713544|585027388|FG003|Overall Study|Adverse Event|7|||
161993796|NCT00713544|585027389|FG004|Overall Study|Adverse Event|3|||
161993797|NCT00713544|585027390|FG005|Overall Study|Adverse Event|5|||
161887448|NCT04105010|584632361|FG000|Overall Study|Lost to Follow-up|0|||
161887449|NCT04105010|584632362|FG001|Overall Study|Lost to Follow-up|0|||
161887450|NCT04105010|584632363|FG002|Overall Study|Lost to Follow-up|0|||
161887451|NCT04105010|584632364|FG003|Overall Study|Lost to Follow-up|4|||
161887452|NCT04105010|584632361|FG000|Overall Study|Withdrawal by Subject|8|||
161887453|NCT04105010|584632362|FG001|Overall Study|Withdrawal by Subject|1|||
161887454|NCT04105010|584632363|FG002|Overall Study|Withdrawal by Subject|1|||
161887455|NCT04105010|584632364|FG003|Overall Study|Withdrawal by Subject|4|||
161887456|NCT04105010|584632361|FG000|Overall Study|Other reason|4|||
161887457|NCT04105010|584632362|FG001|Overall Study|Other reason|7|||
161887458|NCT04105010|584632363|FG002|Overall Study|Other reason|0|||
161887459|NCT04105010|584632364|FG003|Overall Study|Other reason|19|||
161887460|NCT01211483|584632365|FG000|Phase 1b|Death|6|||
161887461|NCT01211483|584632366|FG001|Phase 1b|Death|0|||
161887462|NCT01211483|584632367|FG002|Phase 1b|Death|0|||
161887463|NCT01211483|584632368|FG003|Phase 1b|Death|0|||
161887464|NCT01211483|584632365|FG000|Phase 1b|Withdrawal by Subject|1|||
161887465|NCT01211483|584632366|FG001|Phase 1b|Withdrawal by Subject|0|||
161887466|NCT01211483|584632367|FG002|Phase 1b|Withdrawal by Subject|0|||
161887467|NCT01211483|584632368|FG003|Phase 1b|Withdrawal by Subject|0|||
161887468|NCT01211483|584632365|FG000|Phase 2|Lost to Follow-up|0|||
161887469|NCT01211483|584632366|FG001|Phase 2|Lost to Follow-up|1|||
161887470|NCT01211483|584632367|FG002|Phase 2|Lost to Follow-up|1|||
161887471|NCT01211483|584632368|FG003|Phase 2|Lost to Follow-up|2|||
161887472|NCT01211483|584632365|FG000|Phase 2|Death|0|||
161887473|NCT01211483|584632366|FG001|Phase 2|Death|64|||
161887474|NCT01211483|584632367|FG002|Phase 2|Death|53|||
161887475|NCT01211483|584632368|FG003|Phase 2|Death|53|||
161887476|NCT01211483|584632365|FG000|Phase 2|Withdrawal by Subject|0|||
161887477|NCT01211483|584632366|FG001|Phase 2|Withdrawal by Subject|1|||
161887478|NCT01211483|584632367|FG002|Phase 2|Withdrawal by Subject|10|||
161887479|NCT01211483|584632368|FG003|Phase 2|Withdrawal by Subject|5|||
161887480|NCT01211483|584632365|FG000|Phase 2|Study terminated by Sponsor|0|||
161887481|NCT01211483|584632366|FG001|Phase 2|Study terminated by Sponsor|6|||
161887482|NCT01211483|584632367|FG002|Phase 2|Study terminated by Sponsor|8|||
161887483|NCT01211483|584632368|FG003|Phase 2|Study terminated by Sponsor|11|||
161887484|NCT01675154|584632369|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
161887485|NCT01675154|584632370|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
161887486|NCT01675154|584632371|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
161887487|NCT01675154|584632372|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
161887488|NCT02971800|584632375|FG000|Overall Study|Protocol Violation|1|||
161887489|NCT02971800|584632375|FG000|Overall Study|Withdrawal by Subject|1|||
161887490|NCT02971800|584632375|FG000|Overall Study|Exclusion criteria prior intervention|1|||
161887491|NCT02971800|584632375|FG000|Overall Study|Number evaluable participant already reached|4|||
161887492|NCT01149421|584632377|FG000|Overall Study|Adverse Event|22|||
161887493|NCT01149421|584632378|FG001|Overall Study|Adverse Event|6|||
161887494|NCT01149421|584632379|FG002|Overall Study|Adverse Event|11|||
161887495|NCT01149421|584632377|FG000|Overall Study|Withdrawal by Subject|20|||
161887496|NCT01149421|584632378|FG001|Overall Study|Withdrawal by Subject|12|||
161887497|NCT01149421|584632379|FG002|Overall Study|Withdrawal by Subject|13|||
161887498|NCT01149421|584632377|FG000|Overall Study|Sponsor Decision|0|||
161887499|NCT01149421|584632378|FG001|Overall Study|Sponsor Decision|1|||
161887500|NCT01149421|584632379|FG002|Overall Study|Sponsor Decision|1|||
161887501|NCT01149421|584632377|FG000|Overall Study|Lost to Follow-up|2|||
161887502|NCT01149421|584632378|FG001|Overall Study|Lost to Follow-up|4|||
161887503|NCT01149421|584632379|FG002|Overall Study|Lost to Follow-up|5|||
161887504|NCT01149421|584632377|FG000|Overall Study|Physician Decision|5|||
161887505|NCT01149421|584632378|FG001|Overall Study|Physician Decision|3|||
161887506|NCT01149421|584632379|FG002|Overall Study|Physician Decision|6|||
161887507|NCT01149421|584632377|FG000|Overall Study|Entry Criteria Not Met|1|||
161887508|NCT01149421|584632378|FG001|Overall Study|Entry Criteria Not Met|1|||
161887509|NCT01149421|584632379|FG002|Overall Study|Entry Criteria Not Met|2|||
161887510|NCT01149421|584632377|FG000|Overall Study|Protocol Violation|2|||
161887511|NCT01149421|584632378|FG001|Overall Study|Protocol Violation|2|||
161887512|NCT01149421|584632379|FG002|Overall Study|Protocol Violation|6|||
161887513|NCT03738800|584632382|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
161887514|NCT03738800|584632383|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
161887515|NCT03738800|584632384|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161887516|NCT03738800|584632382|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
161887517|NCT03738800|584632383|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
161887518|NCT03738800|584632384|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
161887519|NCT03738800|584632382|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
161887520|NCT03738800|584632383|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
161887521|NCT03738800|584632384|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
161887522|NCT02223819|584632387|FG000|Overall Study|Lost to Follow-up|2|||
161887523|NCT01917344|584632389|FG000|Overall Study|Withdrawal by Subject|1|||
161887524|NCT03435224|584632390|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
162037329|NCT00920829|585194276|FG002|Available for Analysis|Protocol Violation|1|||
162037330|NCT00920829|585194277|FG003|Available for Analysis|Protocol Violation|0|||
162037331|NCT00920829|585194274|FG000|Available for Analysis|Required more treatment|0|||
162037332|NCT00920829|585194275|FG001|Available for Analysis|Required more treatment|2|||
162037333|NCT00920829|585194276|FG002|Available for Analysis|Required more treatment|0|||
162037334|NCT00920829|585194277|FG003|Available for Analysis|Required more treatment|1|||
162037335|NCT03875118|585194278|FG000|Overall Study|Withdrawal by Subject|4|||
162037336|NCT03875118|585194279|FG001|Overall Study|Withdrawal by Subject|4|||
162037337|NCT02237911|585194280|FG000|Overall Study|Withdrawal by Subject|4|||
162037338|NCT02237911|585194281|FG001|Overall Study|Withdrawal by Subject|7|||
162037339|NCT02237911|585194282|FG002|Overall Study|Withdrawal by Subject|2|||
162037340|NCT02237911|585194280|FG000|Overall Study|Lost to Follow-up|3|||
162037341|NCT02237911|585194281|FG001|Overall Study|Lost to Follow-up|1|||
162037342|NCT02237911|585194282|FG002|Overall Study|Lost to Follow-up|1|||
162037343|NCT00721123|585194283|FG000|Overall Study|Adverse Event|96|||
162037344|NCT00721123|585194283|FG000|Overall Study|Death|10|||
162037345|NCT00721123|585194283|FG000|Overall Study|Insufficient Therapeutic Response|21|||
162037346|NCT00721123|585194283|FG000|Overall Study|Protocol Violation|1|||
162037347|NCT00721123|585194283|FG000|Overall Study|Refused Treatment|41|||
162037348|NCT00721123|585194283|FG000|Overall Study|Failure to Return|9|||
162037349|NCT00721123|585194283|FG000|Overall Study|Withdrawal by Subject|5|||
162037350|NCT03468985|585194284|FG000|Overall Study|Adverse Event|0|||
162037351|NCT03468985|585194285|FG001|Overall Study|Adverse Event|2|||
162037352|NCT03468985|585194286|FG002|Overall Study|Adverse Event|0|||
162037353|NCT03468985|585194287|FG003|Overall Study|Adverse Event|0|||
162037354|NCT03468985|585194284|FG000|Overall Study|Withdrawal by Subject|0|||
162037355|NCT03468985|585194285|FG001|Overall Study|Withdrawal by Subject|0|||
162037356|NCT03468985|585194286|FG002|Overall Study|Withdrawal by Subject|0|||
162037357|NCT03468985|585194287|FG003|Overall Study|Withdrawal by Subject|1|||
162037358|NCT03981822|585194288|FG000|Overall Study|Lost to Follow-up|0|||
162037359|NCT03981822|585194289|FG001|Overall Study|Lost to Follow-up|1|||
162037360|NCT03981822|585194290|FG002|Overall Study|Lost to Follow-up|1|||
162037361|NCT03981822|585194291|FG003|Overall Study|Lost to Follow-up|0|||
162037362|NCT03981822|585194292|FG004|Overall Study|Lost to Follow-up|6|||
162037363|NCT03981822|585194293|FG005|Overall Study|Lost to Follow-up|4|||
162037364|NCT03981822|585194294|FG006|Overall Study|Lost to Follow-up|4|||
162037365|NCT03981822|585194295|FG007|Overall Study|Lost to Follow-up|2|||
162037366|NCT03981822|585194288|FG000|Overall Study|Withdrawal by Subject|0|||
162037367|NCT03981822|585194289|FG001|Overall Study|Withdrawal by Subject|1|||
162037368|NCT03981822|585194290|FG002|Overall Study|Withdrawal by Subject|0|||
162037369|NCT03981822|585194291|FG003|Overall Study|Withdrawal by Subject|0|||
162037370|NCT03981822|585194292|FG004|Overall Study|Withdrawal by Subject|0|||
162037371|NCT03981822|585194293|FG005|Overall Study|Withdrawal by Subject|1|||
162037372|NCT03981822|585194294|FG006|Overall Study|Withdrawal by Subject|0|||
162037373|NCT03981822|585194295|FG007|Overall Study|Withdrawal by Subject|2|||
162037374|NCT03981822|585194288|FG000|Overall Study|COVID-19 Related|0|||
162037375|NCT03981822|585194289|FG001|Overall Study|COVID-19 Related|0|||
162037376|NCT03981822|585194290|FG002|Overall Study|COVID-19 Related|0|||
162037377|NCT03981822|585194291|FG003|Overall Study|COVID-19 Related|0|||
162037378|NCT03981822|585194292|FG004|Overall Study|COVID-19 Related|2|||
162037379|NCT03981822|585194293|FG005|Overall Study|COVID-19 Related|1|||
162037380|NCT03981822|585194294|FG006|Overall Study|COVID-19 Related|2|||
162037381|NCT03981822|585194295|FG007|Overall Study|COVID-19 Related|1|||
162037382|NCT04521777|585194297|FG000|Overall Study|Death|2|||
162037383|NCT04521777|585194297|FG000|Overall Study|Withdrawal by Subject|2|||
162037384|NCT01143207|585194304|FG000|Overall Study|Lost to Follow-up|2|||
162037385|NCT03463031|585194307|FG000|Overall Study|Withdrawal by Subject|4|||
162037386|NCT03463031|585194308|FG001|Overall Study|Withdrawal by Subject|2|||
162037387|NCT03463031|585194307|FG000|Overall Study|Investigator/Sponsor Decision|0|||
162037388|NCT03463031|585194308|FG001|Overall Study|Investigator/Sponsor Decision|1|||
162037389|NCT03463031|585194307|FG000|Overall Study|Lost to Follow-up|1|||
162037390|NCT03463031|585194308|FG001|Overall Study|Lost to Follow-up|1|||
162037391|NCT03463031|585194307|FG000|Overall Study|Adverse Event|4|||
162037392|NCT03463031|585194308|FG001|Overall Study|Adverse Event|1|||
162037393|NCT03463031|585194307|FG000|Overall Study|Use of prohibited medication by subject|1|||
162037394|NCT03463031|585194308|FG001|Overall Study|Use of prohibited medication by subject|0|||
162037395|NCT01241240|585194309|FG000|Overall Study|Adverse Event|5|||
162037396|NCT01241240|585194310|FG001|Overall Study|Adverse Event|4|||
162037397|NCT01241240|585194309|FG000|Overall Study|Lost to Follow-up|2|||
162037398|NCT01241240|585194310|FG001|Overall Study|Lost to Follow-up|4|||
162037399|NCT01241240|585194309|FG000|Overall Study|Personal Reasons|1|||
162037400|NCT01241240|585194310|FG001|Overall Study|Personal Reasons|1|||
162037401|NCT02376829|585194317|FG000|Overall Study|Withdrawal by Subject|27|||
162037402|NCT02376829|585194318|FG001|Overall Study|Withdrawal by Subject|44|||
162037403|NCT00057954|585194319|FG000|Overall Study|Death|1|||
162037404|NCT00057954|585194319|FG000|Overall Study|Disease progression|1|||
162037405|NCT02147184|585194320|FG000|Overall Study|Lost to Follow-up|28|||
162037406|NCT02147184|585194321|FG001|Overall Study|Lost to Follow-up|15|||
162037407|NCT02147184|585194320|FG000|Overall Study|Study Burden|11|||
162037408|NCT02147184|585194321|FG001|Overall Study|Study Burden|7|||
162037409|NCT02147184|585194320|FG000|Overall Study|Pregnancy|6|||
162037410|NCT02147184|585194321|FG001|Overall Study|Pregnancy|0|||
162037411|NCT02147184|585194320|FG000|Overall Study|Moved out of state|3|||
162037412|NCT02147184|585194321|FG001|Overall Study|Moved out of state|3|||
162037413|NCT02147184|585194320|FG000|Overall Study|Physician Decision|0|||
162037414|NCT02147184|585194321|FG001|Overall Study|Physician Decision|2|||
161993798|NCT00713544|585027385|FG000|Overall Study|Withdrawal by Subject|2|||
161993799|NCT00713544|585027386|FG001|Overall Study|Withdrawal by Subject|0|||
161993800|NCT00713544|585027387|FG002|Overall Study|Withdrawal by Subject|3|||
161993801|NCT00713544|585027388|FG003|Overall Study|Withdrawal by Subject|2|||
161993802|NCT00713544|585027389|FG004|Overall Study|Withdrawal by Subject|3|||
161993803|NCT00713544|585027390|FG005|Overall Study|Withdrawal by Subject|1|||
161993804|NCT00713544|585027385|FG000|Overall Study|Protocol Violation|0|||
161993805|NCT00713544|585027386|FG001|Overall Study|Protocol Violation|0|||
161993806|NCT00713544|585027387|FG002|Overall Study|Protocol Violation|0|||
161993807|NCT00713544|585027388|FG003|Overall Study|Protocol Violation|0|||
161993808|NCT00713544|585027389|FG004|Overall Study|Protocol Violation|0|||
161993809|NCT00713544|585027390|FG005|Overall Study|Protocol Violation|1|||
161993810|NCT00713544|585027385|FG000|Overall Study|Physician Decision|0|||
161993811|NCT00713544|585027386|FG001|Overall Study|Physician Decision|0|||
161993812|NCT00713544|585027387|FG002|Overall Study|Physician Decision|0|||
161993813|NCT00713544|585027388|FG003|Overall Study|Physician Decision|0|||
161993814|NCT00713544|585027389|FG004|Overall Study|Physician Decision|0|||
161993815|NCT00713544|585027390|FG005|Overall Study|Physician Decision|2|||
161993816|NCT00713544|585027385|FG000|Overall Study|Lack of Efficacy|0|||
161993817|NCT00713544|585027386|FG001|Overall Study|Lack of Efficacy|1|||
161993818|NCT00713544|585027387|FG002|Overall Study|Lack of Efficacy|0|||
161993819|NCT00713544|585027388|FG003|Overall Study|Lack of Efficacy|1|||
161993820|NCT00713544|585027389|FG004|Overall Study|Lack of Efficacy|1|||
161993821|NCT00713544|585027390|FG005|Overall Study|Lack of Efficacy|0|||
161993822|NCT00713544|585027385|FG000|Overall Study|Lost to Follow-up|0|||
161993823|NCT00713544|585027386|FG001|Overall Study|Lost to Follow-up|0|||
161993824|NCT00713544|585027387|FG002|Overall Study|Lost to Follow-up|1|||
161993825|NCT00713544|585027388|FG003|Overall Study|Lost to Follow-up|0|||
162037415|NCT02147184|585194320|FG000|Overall Study|Other|1|||
162037416|NCT02147184|585194321|FG001|Overall Study|Other|0|||
162037417|NCT02117414|585194322|FG000|Overall Study|Death|5|||
162037418|NCT02117414|585194323|FG001|Overall Study|Death|2|||
162037419|NCT02117414|585194322|FG000|Overall Study|Withdrawal by Subject|10|||
162037420|NCT02117414|585194323|FG001|Overall Study|Withdrawal by Subject|4|||
162037421|NCT02663687|585194325|FG000|Overall Study|Adverse Event|1|||
162037422|NCT02663687|585194326|FG001|Overall Study|Adverse Event|0|||
162037423|NCT02663687|585194327|FG002|Overall Study|Adverse Event|0|||
162037424|NCT02663687|585194328|FG003|Overall Study|Adverse Event|0|||
162037425|NCT02663687|585194329|FG004|Overall Study|Adverse Event|0|||
162037426|NCT02663687|585194325|FG000|Overall Study|Other|1|||
162037427|NCT02663687|585194326|FG001|Overall Study|Other|0|||
162037428|NCT02663687|585194327|FG002|Overall Study|Other|1|||
162037429|NCT02663687|585194328|FG003|Overall Study|Other|0|||
162037430|NCT02663687|585194329|FG004|Overall Study|Other|0|||
162037431|NCT03189381|585194330|FG000|Overall Study|Death|1|||
162037432|NCT03189381|585194331|FG001|Overall Study|Death|0|||
162037433|NCT00107952|585194332|FG000|Overall Study|Death|75|||
161993826|NCT00713544|585027389|FG004|Overall Study|Lost to Follow-up|0|||
161993827|NCT00713544|585027390|FG005|Overall Study|Lost to Follow-up|0|||
161993828|NCT00713544|585027385|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
162037434|NCT00107952|585194333|FG001|Overall Study|Death|61|||
162037435|NCT00107952|585194332|FG000|Overall Study|Lost to Follow-up|0|||
162037436|NCT00107952|585194333|FG001|Overall Study|Lost to Follow-up|3|||
162037437|NCT00107952|585194332|FG000|Overall Study|Withdrawal by Subject|9|||
162037438|NCT00107952|585194333|FG001|Overall Study|Withdrawal by Subject|6|||
162037439|NCT00107952|585194332|FG000|Overall Study|Other|2|||
162037440|NCT00107952|585194333|FG001|Overall Study|Other|5|||
162037441|NCT00107952|585194332|FG000|Overall Study|Never received study treatment|9|||
162037442|NCT00107952|585194333|FG001|Overall Study|Never received study treatment|6|||
162037443|NCT00887744|585194334|FG000|Overall Study|Adverse Event|3|||
162037444|NCT00887744|585194334|FG000|Overall Study|Death|1|||
162037445|NCT00887744|585194334|FG000|Overall Study|Lost to Follow-up|3|||
162037446|NCT00887744|585194334|FG000|Overall Study|Withdrawal by Subject|18|||
162037447|NCT00887744|585194334|FG000|Overall Study|Various reasons|9|||
162037448|NCT01569464|585194335|FG000|Overall Study|Adverse Event|4|||
162037449|NCT01569464|585194336|FG001|Overall Study|Adverse Event|0|||
162037450|NCT01569464|585194335|FG000|Overall Study|Lack of Efficacy|1|||
161993829|NCT00713544|585027386|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
162037451|NCT01569464|585194336|FG001|Overall Study|Lack of Efficacy|0|||
162037452|NCT01569464|585194335|FG000|Overall Study|Protocol Violation|1|||
162037453|NCT01569464|585194336|FG001|Overall Study|Protocol Violation|0|||
162037454|NCT01569464|585194335|FG000|Overall Study|Lost to Follow-up|2|||
162037455|NCT01569464|585194336|FG001|Overall Study|Lost to Follow-up|3|||
161993830|NCT00713544|585027387|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
161993831|NCT00713544|585027388|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
161993832|NCT00713544|585027389|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
161993833|NCT00713544|585027390|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
161993834|NCT00713544|585027385|FG000|Overall Study|Incorrect enrollment|0|||
161993835|NCT00713544|585027386|FG001|Overall Study|Incorrect enrollment|1|||
161993836|NCT00713544|585027387|FG002|Overall Study|Incorrect enrollment|0|||
161993837|NCT00713544|585027388|FG003|Overall Study|Incorrect enrollment|0|||
161993838|NCT00713544|585027389|FG004|Overall Study|Incorrect enrollment|0|||
161993839|NCT00713544|585027390|FG005|Overall Study|Incorrect enrollment|0|||
161993840|NCT00713544|585027385|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
161993841|NCT00713544|585027386|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
161993842|NCT00713544|585027387|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
161993843|NCT00713544|585027388|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
161993844|NCT00713544|585027389|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
161993845|NCT00713544|585027390|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
161993846|NCT00269919|585027391|FG000|Overall Study|Other|26|||
161993847|NCT00269919|585027391|FG000|Overall Study|Started but not treated|1|||
161993848|NCT00786799|585027394|FG000|Overall Study|Lost to Follow-up|1|||
161993849|NCT00786799|585027395|FG001|Overall Study|Lost to Follow-up|1|||
161993850|NCT02544503|585027396|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
161993851|NCT02544503|585027397|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
161993852|NCT02544503|585027396|FG000|Overall Study|Lost to Follow-up|9|||
161993853|NCT02544503|585027397|FG001|Overall Study|Lost to Follow-up|0|||
161993854|NCT02544503|585027396|FG000|Overall Study|Withdrawal by Subject|1|||
161993855|NCT02544503|585027397|FG001|Overall Study|Withdrawal by Subject|0|||
161993856|NCT04640311|585027398|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
161993857|NCT04640311|585027399|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993858|NCT04640311|585027400|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993859|NCT04640311|585027401|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993860|NCT04640311|585027402|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993861|NCT04640311|585027403|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993862|NCT04640311|585027404|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993863|NCT04640311|585027405|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993864|NCT04640311|585027406|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993865|NCT04640311|585027407|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993866|NCT04640311|585027408|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993867|NCT04640311|585027409|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993868|NCT04640311|585027410|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993869|NCT04640311|585027398|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161993870|NCT04640311|585027399|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
161993871|NCT04640311|585027400|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161993872|NCT04640311|585027401|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161993873|NCT04640311|585027402|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161993874|NCT04640311|585027403|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161993875|NCT04640311|585027404|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161993876|NCT04640311|585027405|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161993877|NCT04640311|585027406|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161993878|NCT04640311|585027407|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161993879|NCT04640311|585027408|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161993880|NCT04640311|585027409|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161993881|NCT04640311|585027410|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
161993882|NCT04640311|585027398|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993883|NCT04640311|585027399|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
161993884|NCT04640311|585027400|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993885|NCT04640311|585027401|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993886|NCT04640311|585027402|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993887|NCT04640311|585027403|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993888|NCT04640311|585027404|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993889|NCT04640311|585027405|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993890|NCT04640311|585027406|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993891|NCT04640311|585027407|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
162037456|NCT01569464|585194335|FG000|Overall Study|Withdrawal by Subject|1|||
162037457|NCT01569464|585194336|FG001|Overall Study|Withdrawal by Subject|1|||
162037458|NCT01569464|585194335|FG000|Overall Study|Other|1|||
162037459|NCT01569464|585194336|FG001|Overall Study|Other|1|||
162037460|NCT04025710|585194342|FG000|Overall Study|Death|3|||
162037461|NCT04025710|585194342|FG000|Overall Study|Lost to Follow-up|5|||
162037462|NCT04025710|585194342|FG000|Overall Study|Withdrawal by Subject|1|||
162037463|NCT04025710|585194342|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
162037464|NCT04025710|585194342|FG000|Overall Study|Drop-out according to protocol|34|||
162037465|NCT03533686|585194343|FG000|Overall Study|Withdrawal by Subject|1|||
162037466|NCT03533686|585194344|FG001|Overall Study|Withdrawal by Subject|0|||
162037467|NCT03533686|585194345|FG002|Overall Study|Withdrawal by Subject|0|||
162037468|NCT03533686|585194346|FG003|Overall Study|Withdrawal by Subject|3|||
162037469|NCT03533686|585194347|FG004|Overall Study|Withdrawal by Subject|5|||
162037470|NCT03533686|585194348|FG005|Overall Study|Withdrawal by Subject|1|||
162037471|NCT03533686|585194343|FG000|Overall Study|Lost to Follow-up|0|||
162037472|NCT03533686|585194344|FG001|Overall Study|Lost to Follow-up|1|||
162037473|NCT03533686|585194345|FG002|Overall Study|Lost to Follow-up|0|||
162037474|NCT03533686|585194346|FG003|Overall Study|Lost to Follow-up|0|||
162037475|NCT03533686|585194347|FG004|Overall Study|Lost to Follow-up|2|||
162037476|NCT03533686|585194348|FG005|Overall Study|Lost to Follow-up|0|||
162037477|NCT03533686|585194343|FG000|Overall Study|Screen Failure|0|||
162037478|NCT03533686|585194344|FG001|Overall Study|Screen Failure|0|||
162037479|NCT03533686|585194345|FG002|Overall Study|Screen Failure|0|||
162037480|NCT03533686|585194346|FG003|Overall Study|Screen Failure|2|||
162037481|NCT03533686|585194347|FG004|Overall Study|Screen Failure|0|||
162037482|NCT03533686|585194348|FG005|Overall Study|Screen Failure|0|||
162037483|NCT02632838|585194351|FG000|Overall Study|Withdrawal by Subject|3|||
162037484|NCT02632838|585194352|FG001|Overall Study|Withdrawal by Subject|0|||
162037485|NCT02632838|585194351|FG000|Overall Study|Lost to Follow-up|0|||
162037486|NCT02632838|585194352|FG001|Overall Study|Lost to Follow-up|2|||
162037487|NCT01343901|585194353|FG000|Overall Study|Death|85|||
162037488|NCT01343901|585194353|FG000|Overall Study|Physician Decision|4|||
162037489|NCT01343901|585194353|FG000|Overall Study|Lost to Follow-up|12|||
162037490|NCT01343901|585194353|FG000|Overall Study|Management by another medical team|11|||
162037491|NCT01343901|585194353|FG000|Overall Study|Participant decision|1|||
162037492|NCT05308290|585194367|FG000|Overall Study|Death|1|||
162037493|NCT05308290|585194368|FG001|Overall Study|Death|0|||
162037494|NCT05308290|585194367|FG000|Overall Study|Lost to Follow-up|2|||
162037495|NCT05308290|585194368|FG001|Overall Study|Lost to Follow-up|1|||
162037496|NCT05308290|585194367|FG000|Overall Study|still in study followup|0|||
162037497|NCT05308290|585194368|FG001|Overall Study|still in study followup|1|||
162037498|NCT03500679|585194369|FG000|Overall Study|Lost to Follow-up|6|||
162037499|NCT03500679|585194370|FG001|Overall Study|Lost to Follow-up|3|||
162037500|NCT03500679|585194369|FG000|Overall Study|Withdrawal by Subject|3|||
162037501|NCT03500679|585194370|FG001|Overall Study|Withdrawal by Subject|0|||
162037502|NCT04706416|585194371|FG000|Overall Study|Lost to Follow-up|2|||
162037503|NCT04706416|585194372|FG001|Overall Study|Lost to Follow-up|0|||
162037504|NCT01484054|585194373|FG000|Period 1|Withdrawal by Subject|0|||
162037505|NCT01484054|585194374|FG001|Period 1|Withdrawal by Subject|1|||
162037506|NCT02117427|585194377|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
162037507|NCT02117427|585194378|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
162037508|NCT02117427|585194379|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
162037509|NCT02117427|585194377|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
162037510|NCT02117427|585194378|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
162037511|NCT02117427|585194379|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
162037512|NCT02117427|585194377|FG000|Overall Study|Physician Decision|0|||
162037513|NCT02117427|585194378|FG001|Overall Study|Physician Decision|2|||
162037514|NCT02117427|585194379|FG002|Overall Study|Physician Decision|0|||
162037515|NCT02117427|585194377|FG000|Overall Study|No longer meets inclusion criteria|0|||
162037516|NCT02117427|585194378|FG001|Overall Study|No longer meets inclusion criteria|1|||
162037517|NCT02117427|585194379|FG002|Overall Study|No longer meets inclusion criteria|0|||
162037518|NCT02117427|585194377|FG000|Overall Study|Death|0|||
162037519|NCT02117427|585194378|FG001|Overall Study|Death|1|||
162037520|NCT02117427|585194379|FG002|Overall Study|Death|0|||
162037521|NCT05281601|585194380|FG000|Overall Study|Physician Decision|2|||
162037522|NCT05281601|585194381|FG001|Overall Study|Physician Decision|0|||
162037523|NCT05281601|585194380|FG000|Overall Study|Lost to Follow-up|2|||
162037524|NCT05281601|585194381|FG001|Overall Study|Lost to Follow-up|0|||
162037525|NCT05281601|585194380|FG000|Overall Study|Death|1|||
162037526|NCT05281601|585194381|FG001|Overall Study|Death|0|||
162037527|NCT05281601|585194380|FG000|Overall Study|Withdrawal by parent/guardian|2|||
162037528|NCT05281601|585194381|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162037529|NCT00410202|585194385|FG000|On-Treatment|Continuing treatment|69|||
162037530|NCT00410202|585194386|FG001|On-Treatment|Continuing treatment|71|||
162037531|NCT00410202|585194387|FG002|On-Treatment|Continuing treatment|66|||
162037532|NCT00410202|585194385|FG000|On-Treatment|Adverse Event|1|||
162037533|NCT00410202|585194386|FG001|On-Treatment|Adverse Event|3|||
161887525|NCT00367484|584632391|FG000|Overall Study|Adverse Event|7|||
161887526|NCT00367484|584632391|FG000|Overall Study|Withdrew informed consent|5|||
161887527|NCT00367484|584632391|FG000|Overall Study|Travel to USA|1|||
161887528|NCT00367484|584632391|FG000|Overall Study|Lost to Follow-up|1|||
161887529|NCT00367484|584632391|FG000|Overall Study|Protocol Violation|1|||
161887530|NCT00367484|584632391|FG000|Overall Study|The choice of the patient|1|||
161887531|NCT00367484|584632391|FG000|Overall Study|Lack of Efficacy|1|||
161887532|NCT00412217|584632392|FG000|Overall Study|Insufficient Data Available|8|||
161887533|NCT00412217|584632393|FG001|Overall Study|Insufficient Data Available|3|||
161887534|NCT00412217|584632392|FG000|Overall Study|Death|5|||
161887535|NCT00412217|584632393|FG001|Overall Study|Death|4|||
161887536|NCT00412217|584632392|FG000|Overall Study|Disease Progression|2|||
161887537|NCT00412217|584632393|FG001|Overall Study|Disease Progression|3|||
161887538|NCT00412217|584632392|FG000|Overall Study|Investigator Decision|1|||
161887539|NCT00412217|584632393|FG001|Overall Study|Investigator Decision|0|||
161887540|NCT00412217|584632392|FG000|Overall Study|Withdrawal by Subject|2|||
161887541|NCT00412217|584632393|FG001|Overall Study|Withdrawal by Subject|0|||
161887542|NCT00412217|584632392|FG000|Overall Study|Lost to Follow-up|1|||
161887543|NCT00412217|584632393|FG001|Overall Study|Lost to Follow-up|4|||
161887544|NCT00412217|584632392|FG000|Overall Study|Study Terminated by Sponsor|26|||
161887545|NCT00412217|584632393|FG001|Overall Study|Study Terminated by Sponsor|33|||
161887546|NCT00412217|584632392|FG000|Overall Study|Other|1|||
161887547|NCT00412217|584632393|FG001|Overall Study|Other|1|||
161887548|NCT01777295|584632394|FG000|Overall Study|Withdrawal by Subject|2|||
161887549|NCT01777295|584632395|FG001|Overall Study|Withdrawal by Subject|2|||
161887550|NCT01777295|584632394|FG000|Overall Study|Pregnancy|0|||
161887551|NCT01777295|584632395|FG001|Overall Study|Pregnancy|1|||
161887552|NCT01777295|584632394|FG000|Overall Study|Personal problem|1|||
161887553|NCT01777295|584632395|FG001|Overall Study|Personal problem|0|||
161887554|NCT01777295|584632394|FG000|Overall Study|Investigator call for AEs check|1|||
161887555|NCT01777295|584632395|FG001|Overall Study|Investigator call for AEs check|0|||
161887556|NCT02609724|584632396|FG000|Overall Study|Death|2|||
161887557|NCT02609724|584632397|FG001|Overall Study|Death|0|||
161887558|NCT02609724|584632398|FG002|Overall Study|Death|1|||
161887559|NCT02609724|584632396|FG000|Overall Study|Withdrawal by Subject|1|||
161887560|NCT02609724|584632397|FG001|Overall Study|Withdrawal by Subject|2|||
161887561|NCT02609724|584632398|FG002|Overall Study|Withdrawal by Subject|3|||
161887562|NCT02609724|584632396|FG000|Overall Study|Illness|2|||
161887563|NCT02609724|584632397|FG001|Overall Study|Illness|1|||
161887564|NCT02609724|584632398|FG002|Overall Study|Illness|0|||
161887565|NCT04007107|584632403|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
161887566|NCT04007107|584632404|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
161887567|NCT04007107|584632405|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
161887568|NCT04007107|584632406|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
161887569|NCT00426660|584632412|FG000|Overall Study|Death|14|||
161887570|NCT00426660|584632412|FG000|Overall Study|Adverse Event|23|||
161887571|NCT00426660|584632412|FG000|Overall Study|Insufficient Clinical Response|22|||
161887572|NCT00426660|584632412|FG000|Overall Study|Lost to Follow-up|15|||
161887573|NCT00426660|584632412|FG000|Overall Study|Other|23|||
161887574|NCT00426660|584632412|FG000|Overall Study|Withdrawal by Subject|18|||
161887575|NCT00426660|584632412|FG000|Overall Study|Protocol Violation|1|||
161887576|NCT00426660|584632412|FG000|Overall Study|Enrolled Not Treated|15|||
161887577|NCT00006305|584632413|FG000|Overall Study|Withdrawal by Subject|17|||
161887578|NCT00006305|584632414|FG001|Overall Study|Withdrawal by Subject|10|||
161887579|NCT00006305|584632415|FG002|Overall Study|Withdrawal by Subject|15|||
161887580|NCT00006305|584632416|FG003|Overall Study|Withdrawal by Subject|14|||
161887581|NCT00329641|584632417|FG000|Overall Study|Did not start treatment|1|||
161887582|NCT00329641|584632417|FG000|Overall Study|Not eligible|1|||
161887583|NCT00329641|584632417|FG000|Overall Study|Adverse Event|3|||
161887584|NCT00329641|584632417|FG000|Overall Study|Other reason, not protocol specified|1|||
161887585|NCT00115037|584632418|FG000|Phase1|Lost to Follow-up|16|||
161887586|NCT00115037|584632419|FG001|Phase1|Lost to Follow-up|23|||
161887587|NCT00115037|584632420|FG002|Phase1|Lost to Follow-up|0|||
161887588|NCT00115037|584632421|FG003|Phase1|Lost to Follow-up|0|||
161887589|NCT00115037|584632422|FG004|Phase1|Lost to Follow-up|0|||
161887590|NCT00115037|584632423|FG005|Phase1|Lost to Follow-up|0|||
161887591|NCT00115037|584632418|FG000|Phase1|Withdrawal by Subject|9|||
161887592|NCT00115037|584632419|FG001|Phase1|Withdrawal by Subject|4|||
161887593|NCT00115037|584632420|FG002|Phase1|Withdrawal by Subject|0|||
161887594|NCT00115037|584632421|FG003|Phase1|Withdrawal by Subject|0|||
161887595|NCT00115037|584632422|FG004|Phase1|Withdrawal by Subject|0|||
161887596|NCT00115037|584632423|FG005|Phase1|Withdrawal by Subject|0|||
161887597|NCT00115037|584632418|FG000|Phase2|Death|0|||
161887598|NCT00115037|584632419|FG001|Phase2|Death|0|||
161887599|NCT00115037|584632420|FG002|Phase2|Death|1|||
161887600|NCT00115037|584632421|FG003|Phase2|Death|0|||
161887601|NCT00115037|584632422|FG004|Phase2|Death|0|||
161887602|NCT00115037|584632423|FG005|Phase2|Death|1|||
161887603|NCT00115037|584632418|FG000|Phase2|Withdrawal by Subject|0|||
161887604|NCT00115037|584632419|FG001|Phase2|Withdrawal by Subject|0|||
161887605|NCT00115037|584632420|FG002|Phase2|Withdrawal by Subject|2|||
161887606|NCT00115037|584632421|FG003|Phase2|Withdrawal by Subject|1|||
161887607|NCT00115037|584632422|FG004|Phase2|Withdrawal by Subject|2|||
161887608|NCT00115037|584632423|FG005|Phase2|Withdrawal by Subject|1|||
161887609|NCT00115037|584632418|FG000|Phase2|Lost to Follow-up|0|||
161887610|NCT00115037|584632419|FG001|Phase2|Lost to Follow-up|0|||
161887611|NCT00115037|584632420|FG002|Phase2|Lost to Follow-up|12|||
161887612|NCT00115037|584632421|FG003|Phase2|Lost to Follow-up|14|||
161887613|NCT00115037|584632422|FG004|Phase2|Lost to Follow-up|4|||
161887614|NCT00115037|584632423|FG005|Phase2|Lost to Follow-up|10|||
161887615|NCT01398410|584632424|FG000|Overall Study|Adverse Event|12|||
161887616|NCT01398410|584632425|FG001|Overall Study|Adverse Event|16|||
161887617|NCT01398410|584632424|FG000|Overall Study|Participants Choice|8|||
161887618|NCT01398410|584632425|FG001|Overall Study|Participants Choice|11|||
161887619|NCT01398410|584632424|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
161887620|NCT01398410|584632425|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
161887621|NCT01398410|584632424|FG000|Overall Study|Other|36|||
161887622|NCT01398410|584632425|FG001|Overall Study|Other|29|||
161887623|NCT02470403|584632426|FG000|Overall Study|Adverse Event|1|||
161887624|NCT02470403|584632427|FG001|Overall Study|Adverse Event|0|||
161887625|NCT02470403|584632428|FG002|Overall Study|Adverse Event|0|||
161887626|NCT02470403|584632429|FG003|Overall Study|Adverse Event|0|||
161887627|NCT02470403|584632430|FG004|Overall Study|Adverse Event|0|||
161887628|NCT02470403|584632426|FG000|Overall Study|Lost to Follow-up|0|||
161887629|NCT02470403|584632427|FG001|Overall Study|Lost to Follow-up|1|||
161887630|NCT02470403|584632428|FG002|Overall Study|Lost to Follow-up|0|||
161887631|NCT02470403|584632429|FG003|Overall Study|Lost to Follow-up|0|||
161887632|NCT02470403|584632430|FG004|Overall Study|Lost to Follow-up|0|||
161887633|NCT02470403|584632426|FG000|Overall Study|Subject/guardian decision|1|||
161887634|NCT02470403|584632427|FG001|Overall Study|Subject/guardian decision|0|||
161887635|NCT02470403|584632428|FG002|Overall Study|Subject/guardian decision|0|||
161887636|NCT02470403|584632429|FG003|Overall Study|Subject/guardian decision|4|||
161887637|NCT02470403|584632430|FG004|Overall Study|Subject/guardian decision|0|||
161887638|NCT02631070|584632431|FG000|Overall Study|Withdrawal by Subject|35|||
161887639|NCT02631070|584632432|FG001|Overall Study|Withdrawal by Subject|13|||
161887640|NCT02631070|584632431|FG000|Overall Study|Death|45|||
161887641|NCT02631070|584632432|FG001|Overall Study|Death|24|||
161887642|NCT02631070|584632431|FG000|Overall Study|Lost to Follow-up|5|||
161887643|NCT02631070|584632432|FG001|Overall Study|Lost to Follow-up|1|||
161887644|NCT02631070|584632431|FG000|Overall Study|Transition to rollover protocol|52|||
161887645|NCT02631070|584632432|FG001|Overall Study|Transition to rollover protocol|21|||
161887646|NCT02631070|584632431|FG000|Overall Study|Other reasons|12|||
161887647|NCT02631070|584632432|FG001|Overall Study|Other reasons|5|||
161887648|NCT03515629|584632433|FG000|Overall Study|Death|0|||
161887649|NCT03515629|584632434|FG001|Overall Study|Death|1|||
161887650|NCT03515629|584632435|FG002|Overall Study|Death|1|||
161887651|NCT03515629|584632433|FG000|Overall Study|Progressive disease|0|||
161887652|NCT03515629|584632434|FG001|Overall Study|Progressive disease|1|||
161887653|NCT03515629|584632435|FG002|Overall Study|Progressive disease|0|||
161887654|NCT01522235|584632436|FG000|Overall Study|Physician Decision|1|||
161887655|NCT01522235|584632437|FG001|Overall Study|Physician Decision|1|||
161887656|NCT03597022|584632440|FG000|Overall Study|Premature termination of the study|7|||
161887657|NCT03597022|584632441|FG001|Overall Study|Premature termination of the study|7|||
161887658|NCT03597022|584632442|FG002|Overall Study|Premature termination of the study|8|||
161887659|NCT03597022|584632440|FG000|Overall Study|Serious adverse event|1|||
161887660|NCT03597022|584632441|FG001|Overall Study|Serious adverse event|1|||
161887661|NCT03597022|584632442|FG002|Overall Study|Serious adverse event|0|||
161887662|NCT05385224|584632443|FG000|Overall Study|Unable to swallow capsule|2|||
161887663|NCT05385224|584632443|FG000|Overall Study|Withdrawal by Subject|2|||
161887664|NCT05385224|584632443|FG000|Overall Study|Did not meet study criteria|1|||
161887665|NCT01430624|584632444|FG000|Overall Study|Lost to Follow-up|23|||
161887666|NCT01430624|584632445|FG001|Overall Study|Lost to Follow-up|29|||
161887667|NCT01430624|584632446|FG002|Overall Study|Lost to Follow-up|27|||
161887668|NCT01430624|584632444|FG000|Overall Study|technical or eligibility|5|||
161887669|NCT01430624|584632445|FG001|Overall Study|technical or eligibility|5|||
161887670|NCT01430624|584632446|FG002|Overall Study|technical or eligibility|2|||
161887671|NCT00401960|584632451|FG000|Overall Study|Lost to Follow-up|3|||
161887672|NCT00401960|584632452|FG001|Overall Study|Lost to Follow-up|0|||
161887673|NCT00401960|584632451|FG000|Overall Study|Death|2|||
161887674|NCT00401960|584632452|FG001|Overall Study|Death|0|||
161887675|NCT03627416|584632456|FG000|Overall Study|Adverse Event|0|||
161887676|NCT03627416|584632457|FG001|Overall Study|Adverse Event|1|||
161887677|NCT02079636|584632458|FG000|Overall Study|Death|2|||
161887678|NCT02079636|584632459|FG001|Overall Study|Death|1|||
161887679|NCT02079636|584632460|FG002|Overall Study|Death|0|||
161887680|NCT02079636|584632461|FG003|Overall Study|Death|5|||
161887681|NCT02079636|584632462|FG004|Overall Study|Death|1|||
161887682|NCT02079636|584632463|FG005|Overall Study|Death|2|||
161887683|NCT02079636|584632464|FG006|Overall Study|Death|1|||
161887684|NCT02079636|584632465|FG007|Overall Study|Death|0|||
161887685|NCT02079636|584632466|FG008|Overall Study|Death|0|||
161887686|NCT02079636|584632467|FG009|Overall Study|Death|0|||
161887687|NCT02079636|584632468|FG010|Overall Study|Death|0|||
161887688|NCT02079636|584632469|FG011|Overall Study|Death|1|||
161887689|NCT02079636|584632470|FG012|Overall Study|Death|1|||
161887690|NCT02079636|584632471|FG013|Overall Study|Death|0|||
161887691|NCT02079636|584632472|FG014|Overall Study|Death|2|||
161887692|NCT02079636|584632458|FG000|Overall Study|Adverse Event|1|||
161887693|NCT02079636|584632459|FG001|Overall Study|Adverse Event|1|||
161887694|NCT02079636|584632460|FG002|Overall Study|Adverse Event|0|||
161887695|NCT02079636|584632461|FG003|Overall Study|Adverse Event|1|||
161887696|NCT02079636|584632462|FG004|Overall Study|Adverse Event|1|||
161887697|NCT02079636|584632463|FG005|Overall Study|Adverse Event|2|||
161887698|NCT02079636|584632464|FG006|Overall Study|Adverse Event|0|||
161887699|NCT02079636|584632465|FG007|Overall Study|Adverse Event|0|||
161887700|NCT02079636|584632466|FG008|Overall Study|Adverse Event|0|||
161887701|NCT02079636|584632467|FG009|Overall Study|Adverse Event|0|||
161887702|NCT02079636|584632468|FG010|Overall Study|Adverse Event|0|||
161887703|NCT02079636|584632469|FG011|Overall Study|Adverse Event|0|||
161887704|NCT02079636|584632470|FG012|Overall Study|Adverse Event|0|||
161887705|NCT02079636|584632471|FG013|Overall Study|Adverse Event|0|||
161887706|NCT02079636|584632472|FG014|Overall Study|Adverse Event|0|||
161887707|NCT02079636|584632458|FG000|Overall Study|Progressive disease|0|||
161887708|NCT02079636|584632459|FG001|Overall Study|Progressive disease|0|||
161887709|NCT02079636|584632460|FG002|Overall Study|Progressive disease|0|||
161887710|NCT02079636|584632461|FG003|Overall Study|Progressive disease|2|||
161887711|NCT02079636|584632462|FG004|Overall Study|Progressive disease|0|||
161887712|NCT02079636|584632463|FG005|Overall Study|Progressive disease|0|||
161887713|NCT02079636|584632464|FG006|Overall Study|Progressive disease|0|||
161887714|NCT02079636|584632465|FG007|Overall Study|Progressive disease|0|||
161887715|NCT02079636|584632466|FG008|Overall Study|Progressive disease|0|||
161887716|NCT02079636|584632467|FG009|Overall Study|Progressive disease|0|||
161887717|NCT02079636|584632468|FG010|Overall Study|Progressive disease|0|||
161887718|NCT02079636|584632469|FG011|Overall Study|Progressive disease|0|||
161887719|NCT02079636|584632470|FG012|Overall Study|Progressive disease|1|||
161887720|NCT02079636|584632471|FG013|Overall Study|Progressive disease|0|||
161887721|NCT02079636|584632472|FG014|Overall Study|Progressive disease|0|||
161887722|NCT02079636|584632458|FG000|Overall Study|Withdrawal by Subject|0|||
161887723|NCT02079636|584632459|FG001|Overall Study|Withdrawal by Subject|0|||
161887724|NCT02079636|584632460|FG002|Overall Study|Withdrawal by Subject|0|||
161887725|NCT02079636|584632461|FG003|Overall Study|Withdrawal by Subject|4|||
161887726|NCT02079636|584632462|FG004|Overall Study|Withdrawal by Subject|0|||
161887727|NCT02079636|584632463|FG005|Overall Study|Withdrawal by Subject|1|||
161887728|NCT02079636|584632464|FG006|Overall Study|Withdrawal by Subject|0|||
161887729|NCT02079636|584632465|FG007|Overall Study|Withdrawal by Subject|0|||
161887730|NCT02079636|584632466|FG008|Overall Study|Withdrawal by Subject|0|||
161887731|NCT02079636|584632467|FG009|Overall Study|Withdrawal by Subject|2|||
161887732|NCT02079636|584632468|FG010|Overall Study|Withdrawal by Subject|1|||
161887733|NCT02079636|584632469|FG011|Overall Study|Withdrawal by Subject|1|||
161887734|NCT02079636|584632470|FG012|Overall Study|Withdrawal by Subject|1|||
161887735|NCT02079636|584632471|FG013|Overall Study|Withdrawal by Subject|0|||
161887736|NCT02079636|584632472|FG014|Overall Study|Withdrawal by Subject|2|||
161887737|NCT02079636|584632458|FG000|Overall Study|Physician Decision|0|||
161887738|NCT02079636|584632459|FG001|Overall Study|Physician Decision|0|||
161887739|NCT02079636|584632460|FG002|Overall Study|Physician Decision|0|||
161887740|NCT02079636|584632461|FG003|Overall Study|Physician Decision|0|||
161887741|NCT02079636|584632462|FG004|Overall Study|Physician Decision|0|||
161887742|NCT02079636|584632463|FG005|Overall Study|Physician Decision|1|||
161887743|NCT02079636|584632464|FG006|Overall Study|Physician Decision|0|||
161993892|NCT04640311|585027408|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993893|NCT04640311|585027409|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993894|NCT04640311|585027410|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993895|NCT04640311|585027398|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
161993896|NCT04640311|585027399|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
161993897|NCT04640311|585027400|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
162037534|NCT00410202|585194387|FG002|On-Treatment|Adverse Event|2|||
161887744|NCT02079636|584632465|FG007|Overall Study|Physician Decision|0|||
161887745|NCT02079636|584632466|FG008|Overall Study|Physician Decision|0|||
161887746|NCT02079636|584632467|FG009|Overall Study|Physician Decision|1|||
161887747|NCT02079636|584632468|FG010|Overall Study|Physician Decision|1|||
161887748|NCT02079636|584632469|FG011|Overall Study|Physician Decision|0|||
161887749|NCT02079636|584632470|FG012|Overall Study|Physician Decision|0|||
161887750|NCT02079636|584632471|FG013|Overall Study|Physician Decision|0|||
161887751|NCT02079636|584632472|FG014|Overall Study|Physician Decision|1|||
161887752|NCT02079636|584632458|FG000|Overall Study|Lost to Follow-up|0|||
161887753|NCT02079636|584632459|FG001|Overall Study|Lost to Follow-up|0|||
161887754|NCT02079636|584632460|FG002|Overall Study|Lost to Follow-up|0|||
161887755|NCT02079636|584632461|FG003|Overall Study|Lost to Follow-up|0|||
162037535|NCT00410202|585194385|FG000|On-Treatment|Death|1|||
162037536|NCT00410202|585194386|FG001|On-Treatment|Death|0|||
162037537|NCT00410202|585194387|FG002|On-Treatment|Death|0|||
162037538|NCT00410202|585194385|FG000|On-Treatment|Lost to Follow-up|1|||
162037539|NCT00410202|585194386|FG001|On-Treatment|Lost to Follow-up|0|||
162037540|NCT00410202|585194387|FG002|On-Treatment|Lost to Follow-up|1|||
162037541|NCT00410202|585194385|FG000|On-Treatment|Lack of Efficacy|1|||
162037542|NCT00410202|585194386|FG001|On-Treatment|Lack of Efficacy|4|||
162037543|NCT00410202|585194387|FG002|On-Treatment|Lack of Efficacy|0|||
162037544|NCT00410202|585194385|FG000|On-Treatment|Withdrawal by Subject|2|||
162037545|NCT00410202|585194386|FG001|On-Treatment|Withdrawal by Subject|1|||
162037546|NCT00410202|585194387|FG002|On-Treatment|Withdrawal by Subject|1|||
162037547|NCT00410202|585194385|FG000|On-Treatment|Other Reason|0|||
162037548|NCT00410202|585194386|FG001|On-Treatment|Other Reason|0|||
162037549|NCT00410202|585194387|FG002|On-Treatment|Other Reason|1|||
162037550|NCT00410202|585194385|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
162037551|NCT00410202|585194386|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
162037552|NCT00410202|585194387|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
162037553|NCT00410202|585194385|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
162037554|NCT00410202|585194386|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
162037555|NCT00410202|585194387|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
162037556|NCT00410202|585194385|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
162037557|NCT00410202|585194386|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
162037558|NCT00410202|585194387|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
162037559|NCT01178073|585194390|FG000|Overall Study|Adverse Event|34|||
162037560|NCT01178073|585194391|FG001|Overall Study|Adverse Event|27|||
162037561|NCT01178073|585194392|FG002|Overall Study|Adverse Event|24|||
162037562|NCT01178073|585194390|FG000|Overall Study|Protocol Violation|1|||
162037563|NCT01178073|585194391|FG001|Overall Study|Protocol Violation|1|||
162037564|NCT01178073|585194392|FG002|Overall Study|Protocol Violation|1|||
162037565|NCT01178073|585194390|FG000|Overall Study|Lost to Follow-up|2|||
162037566|NCT01178073|585194391|FG001|Overall Study|Lost to Follow-up|0|||
162037567|NCT01178073|585194392|FG002|Overall Study|Lost to Follow-up|3|||
162037568|NCT01178073|585194390|FG000|Overall Study|Physician Decision|14|||
162037569|NCT01178073|585194391|FG001|Overall Study|Physician Decision|10|||
162037570|NCT01178073|585194392|FG002|Overall Study|Physician Decision|10|||
162037571|NCT01178073|585194390|FG000|Overall Study|Withdrawal by Subject|10|||
162037572|NCT01178073|585194391|FG001|Overall Study|Withdrawal by Subject|6|||
162037573|NCT01178073|585194392|FG002|Overall Study|Withdrawal by Subject|8|||
162037574|NCT01178073|585194390|FG000|Overall Study|Missing Completion Status|1|||
162037575|NCT01178073|585194391|FG001|Overall Study|Missing Completion Status|0|||
162037576|NCT01178073|585194392|FG002|Overall Study|Missing Completion Status|0|||
162037577|NCT01674634|585194393|FG000|Overall Study|Withdrawal by Subject|3|||
162037578|NCT01674634|585194393|FG000|Overall Study|Lost to Follow-up|3|||
162037579|NCT00937391|585194394|FG000|Stage 2|Withdrawal by Subject|1|||
162037580|NCT01226043|585194404|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
162037581|NCT01226043|585194405|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
162037582|NCT01226043|585194406|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
162037583|NCT01226043|585194407|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
162037584|NCT01226043|585194404|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
162037585|NCT01226043|585194405|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
162037586|NCT01226043|585194406|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
162037587|NCT01226043|585194407|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
162037588|NCT01226043|585194404|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
162037589|NCT01226043|585194405|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
162037590|NCT01226043|585194406|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
162037591|NCT01226043|585194407|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
162037592|NCT01226043|585194404|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
162037593|NCT01226043|585194405|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
162037594|NCT01226043|585194406|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
162037595|NCT01226043|585194407|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
162037596|NCT01226043|585194404|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
162037597|NCT01226043|585194405|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
162037598|NCT01226043|585194406|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
162037599|NCT01226043|585194407|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
162037600|NCT01226043|585194404|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
162037601|NCT01226043|585194405|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
162037602|NCT01226043|585194406|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
162037603|NCT01226043|585194407|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
162037604|NCT01226043|585194404|FG000|6-week Re-randomization Phase|Adverse Event|0|||
162037605|NCT01226043|585194405|FG001|6-week Re-randomization Phase|Adverse Event|0|||
162037606|NCT01226043|585194406|FG002|6-week Re-randomization Phase|Adverse Event|1|||
162037607|NCT01226043|585194407|FG003|6-week Re-randomization Phase|Adverse Event|1|||
162037608|NCT01226043|585194404|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
162037609|NCT01226043|585194405|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
162037610|NCT01226043|585194406|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
162037611|NCT01226043|585194407|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
162037612|NCT01226043|585194404|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
162037613|NCT01226043|585194405|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
162037614|NCT01226043|585194406|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
162037615|NCT01226043|585194407|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
162037616|NCT01226043|585194404|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
162037617|NCT01226043|585194405|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
162037618|NCT01226043|585194406|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
162037619|NCT01226043|585194407|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
162037620|NCT01226043|585194404|FG000|6-week Re-randomization Phase|Physician Decision|0|||
162037621|NCT01226043|585194405|FG001|6-week Re-randomization Phase|Physician Decision|0|||
161887756|NCT02079636|584632462|FG004|Overall Study|Lost to Follow-up|0|||
161887757|NCT02079636|584632463|FG005|Overall Study|Lost to Follow-up|0|||
161887758|NCT02079636|584632464|FG006|Overall Study|Lost to Follow-up|0|||
161887759|NCT02079636|584632465|FG007|Overall Study|Lost to Follow-up|1|||
161887760|NCT02079636|584632466|FG008|Overall Study|Lost to Follow-up|0|||
161887761|NCT02079636|584632467|FG009|Overall Study|Lost to Follow-up|0|||
161887762|NCT02079636|584632468|FG010|Overall Study|Lost to Follow-up|0|||
161887763|NCT02079636|584632469|FG011|Overall Study|Lost to Follow-up|0|||
161887764|NCT02079636|584632470|FG012|Overall Study|Lost to Follow-up|0|||
161887765|NCT02079636|584632471|FG013|Overall Study|Lost to Follow-up|0|||
161887766|NCT02079636|584632472|FG014|Overall Study|Lost to Follow-up|0|||
161887767|NCT00561470|584632473|FG000|Overall Study|Adverse Event|74|||
161887768|NCT00561470|584632474|FG001|Overall Study|Adverse Event|163|||
161887769|NCT00561470|584632473|FG000|Overall Study|Disease progression|437|||
161887770|NCT00561470|584632474|FG001|Overall Study|Disease progression|305|||
161887771|NCT00561470|584632473|FG000|Overall Study|poor compliance to protocol|4|||
161887772|NCT00561470|584632474|FG001|Overall Study|poor compliance to protocol|4|||
161887773|NCT00561470|584632473|FG000|Overall Study|Lost to Follow-up|2|||
161887774|NCT00561470|584632474|FG001|Overall Study|Lost to Follow-up|0|||
161887775|NCT00561470|584632473|FG000|Overall Study|Physician Decision|21|||
161887776|NCT00561470|584632474|FG001|Overall Study|Physician Decision|20|||
161887777|NCT00561470|584632473|FG000|Overall Study|Consent Withdrawn|2|||
161887778|NCT00561470|584632474|FG001|Overall Study|Consent Withdrawn|6|||
161887779|NCT00561470|584632473|FG000|Overall Study|Subject request|43|||
161887780|NCT00561470|584632474|FG001|Overall Study|Subject request|77|||
161887781|NCT00561470|584632473|FG000|Overall Study|Metastatic surgery|10|||
161887782|NCT00561470|584632474|FG001|Overall Study|Metastatic surgery|12|||
161887783|NCT00561470|584632473|FG000|Overall Study|Unauthorized procedure|3|||
161887784|NCT00561470|584632474|FG001|Overall Study|Unauthorized procedure|1|||
161887785|NCT00561470|584632473|FG000|Overall Study|Randomized but not treated|5|||
161887786|NCT00561470|584632474|FG001|Overall Study|Randomized but not treated|5|||
161887787|NCT00561470|584632473|FG000|Overall Study|Missed visit window|1|||
161887788|NCT00561470|584632474|FG001|Overall Study|Missed visit window|4|||
161887789|NCT00561470|584632473|FG000|Overall Study|Planning surgery|1|||
161887790|NCT00561470|584632474|FG001|Overall Study|Planning surgery|1|||
161887791|NCT00561470|584632473|FG000|Overall Study|Ongoing Treatment|11|||
161887792|NCT00561470|584632474|FG001|Overall Study|Ongoing Treatment|14|||
161887793|NCT00637806|584632475|FG000|Double-blind Phase|Study Discontinued|2|||
161887794|NCT00637806|584632476|FG001|Double-blind Phase|Study Discontinued|0|||
161887795|NCT00637806|584632477|FG002|Double-blind Phase|Study Discontinued|1|||
161887796|NCT00637806|584632478|FG003|Double-blind Phase|Study Discontinued|0|||
161887797|NCT00637806|584632475|FG000|Extension Phase|Study Discontinued|0|||
161887798|NCT00637806|584632476|FG001|Extension Phase|Study Discontinued|0|||
161887799|NCT00637806|584632477|FG002|Extension Phase|Study Discontinued|0|||
161887800|NCT00637806|584632478|FG003|Extension Phase|Study Discontinued|1|||
161887801|NCT02028169|584632479|FG000|Overall Study|Lost to Follow-up|21|||
161887802|NCT02028169|584632479|FG000|Overall Study|Lack of Efficacy|2|||
161887803|NCT02028169|584632479|FG000|Overall Study|Withdrawal by Subject|2|||
161887804|NCT02028169|584632479|FG000|Overall Study|Adverse Event|1|||
161887805|NCT02028169|584632479|FG000|Overall Study|Cessation of Drug|1|||
161887806|NCT02028169|584632479|FG000|Overall Study|Concomitant Medication Usage|1|||
161887807|NCT01876979|584632484|FG000|Overall Study|Physician Decision|2|||
161887808|NCT01876979|584632485|FG001|Overall Study|Physician Decision|3|||
161887809|NCT02240069|584632486|FG000|Overall Study|Withdrawal by Subject|5|||
161887810|NCT02240069|584632487|FG001|Overall Study|Withdrawal by Subject|5|||
162037622|NCT01226043|585194406|FG002|6-week Re-randomization Phase|Physician Decision|3|||
161887811|NCT02240069|584632488|FG002|Overall Study|Withdrawal by Subject|2|||
161887812|NCT01096589|584632489|FG000|Overall Study|Adverse Event|2|||
161887813|NCT01096589|584632490|FG001|Overall Study|Adverse Event|1|||
161887814|NCT01096589|584632491|FG002|Overall Study|Adverse Event|2|||
161887815|NCT01096589|584632492|FG003|Overall Study|Adverse Event|1|||
161887816|NCT01096589|584632489|FG000|Overall Study|Withdrawal by Subject|2|||
161993898|NCT04640311|585027401|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993899|NCT04640311|585027402|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993900|NCT04640311|585027403|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993901|NCT04640311|585027404|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993902|NCT04640311|585027405|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993903|NCT04640311|585027406|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993904|NCT04640311|585027407|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993905|NCT04640311|585027408|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993906|NCT04640311|585027409|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993907|NCT04640311|585027410|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
161993908|NCT04640311|585027398|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161993909|NCT04640311|585027399|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161993910|NCT04640311|585027400|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
161993911|NCT04640311|585027401|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161993912|NCT04640311|585027402|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161993913|NCT04640311|585027403|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161993914|NCT04640311|585027404|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161993915|NCT04640311|585027405|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161993916|NCT04640311|585027406|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161993917|NCT04640311|585027407|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161993918|NCT04640311|585027408|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161993919|NCT04640311|585027409|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161993920|NCT04640311|585027410|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
161993921|NCT04640311|585027398|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161993922|NCT04640311|585027399|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161993923|NCT04640311|585027400|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161993924|NCT04640311|585027401|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
161993925|NCT04640311|585027402|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161993926|NCT04640311|585027403|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161993927|NCT04640311|585027404|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
161993928|NCT04640311|585027405|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161993929|NCT04640311|585027406|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161993930|NCT04640311|585027407|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161993931|NCT04640311|585027408|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161993932|NCT04640311|585027409|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161993933|NCT04640311|585027410|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161993934|NCT04640311|585027398|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993935|NCT04640311|585027399|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993936|NCT04640311|585027400|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993937|NCT04640311|585027401|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993938|NCT04640311|585027402|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993939|NCT04640311|585027403|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
161993940|NCT04640311|585027404|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993941|NCT04640311|585027405|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993942|NCT04640311|585027406|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
161993943|NCT04640311|585027407|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993944|NCT04640311|585027408|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993945|NCT04640311|585027409|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993946|NCT04640311|585027410|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
161993947|NCT04640311|585027398|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161993948|NCT04640311|585027399|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161993949|NCT04640311|585027400|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161993950|NCT04640311|585027401|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161993951|NCT04640311|585027402|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161993952|NCT04640311|585027403|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161993953|NCT04640311|585027404|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
161993954|NCT04640311|585027405|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161993955|NCT04640311|585027406|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161993956|NCT04640311|585027407|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161993957|NCT04640311|585027408|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
161993958|NCT04640311|585027409|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161993959|NCT04640311|585027410|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
161993960|NCT04640311|585027398|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161993961|NCT04640311|585027399|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161993962|NCT04640311|585027400|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161993963|NCT04640311|585027401|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161993964|NCT04640311|585027402|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161993965|NCT04640311|585027403|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161993966|NCT04640311|585027404|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161993967|NCT04640311|585027405|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161993968|NCT04640311|585027406|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161993969|NCT04640311|585027407|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161993970|NCT04640311|585027408|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161993971|NCT04640311|585027409|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
161993972|NCT04640311|585027410|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
161993973|NCT01641601|585027411|FG000|Overall Study|Study discontinued.|3|||
161993974|NCT01641601|585027412|FG001|Overall Study|Study discontinued.|5|||
161993975|NCT02640547|585027413|FG000|Overall Study|Failure to Return|1|||
161993976|NCT02640547|585027413|FG000|Overall Study|Withdrawal by Subject|1|||
161993977|NCT02640547|585027413|FG000|Overall Study|Death|6|||
161993978|NCT02640547|585027413|FG000|Overall Study|Miscellaneous|3|||
161993979|NCT00991939|585027416|FG000|Overall Study|Lost to Follow-up|0|||
161993980|NCT00991939|585027417|FG001|Overall Study|Lost to Follow-up|1|||
161993981|NCT00991939|585027416|FG000|Overall Study|Withdrawal by Subject|1|||
161993982|NCT00991939|585027417|FG001|Overall Study|Withdrawal by Subject|0|||
161993983|NCT00991939|585027416|FG000|Overall Study|Entire study terminated|4|||
161993984|NCT00991939|585027417|FG001|Overall Study|Entire study terminated|1|||
161993985|NCT01196026|585027419|FG000|Overall Study|Withdrawal by Subject|1|||
161993986|NCT01196026|585027420|FG001|Overall Study|Withdrawal by Subject|4|||
161993987|NCT01196026|585027421|FG002|Overall Study|Withdrawal by Subject|0|||
161993988|NCT01196026|585027422|FG003|Overall Study|Withdrawal by Subject|0|||
161993989|NCT01196026|585027423|FG004|Overall Study|Withdrawal by Subject|0|||
161993990|NCT01196026|585027424|FG005|Overall Study|Withdrawal by Subject|0|||
161993991|NCT01196026|585027419|FG000|Overall Study|Lost to Follow-up|0|||
161993992|NCT01196026|585027420|FG001|Overall Study|Lost to Follow-up|3|||
161993993|NCT01196026|585027421|FG002|Overall Study|Lost to Follow-up|0|||
161993994|NCT01196026|585027422|FG003|Overall Study|Lost to Follow-up|0|||
161993995|NCT01196026|585027423|FG004|Overall Study|Lost to Follow-up|1|||
161993996|NCT01196026|585027424|FG005|Overall Study|Lost to Follow-up|0|||
161993997|NCT01196026|585027419|FG000|Overall Study|Other|0|||
161993998|NCT01196026|585027420|FG001|Overall Study|Other|1|||
161993999|NCT01196026|585027421|FG002|Overall Study|Other|0|||
161994000|NCT01196026|585027422|FG003|Overall Study|Other|0|||
161994001|NCT01196026|585027423|FG004|Overall Study|Other|0|||
161994002|NCT01196026|585027424|FG005|Overall Study|Other|0|||
161994003|NCT02524171|585027425|FG000|6-month Follow-up|Lost to Follow-up|53|||
161994004|NCT02524171|585027426|FG001|6-month Follow-up|Lost to Follow-up|45|||
161994005|NCT02524171|585027425|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
161994006|NCT02524171|585027426|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
161994007|NCT02868554|585027427|FG000|Overall Study|Lost to Follow-up|3|||
161994008|NCT02868554|585027428|FG001|Overall Study|Lost to Follow-up|0|||
161994009|NCT02868554|585027429|FG002|Overall Study|Lost to Follow-up|1|||
161994010|NCT05447663|585027434|FG000|Overall Study|Study terminated by Sponsor|5|||
161994011|NCT05447663|585027434|FG000|Overall Study|Death|2|||
161994012|NCT05447663|585027434|FG000|Overall Study|Withdrawal by Subject|1|||
161994013|NCT01100320|585027435|FG000|Period 1|Withdrawal by Subject|2|||
161994014|NCT01100320|585027436|FG001|Period 1|Withdrawal by Subject|4|||
161994015|NCT01100320|585027435|FG000|Period 1|Positive Drug Screen|1|||
161994016|NCT01100320|585027436|FG001|Period 1|Positive Drug Screen|1|||
161994017|NCT01100320|585027435|FG000|Period 1|Adverse Event|2|||
161994018|NCT01100320|585027436|FG001|Period 1|Adverse Event|2|||
161994019|NCT01100320|585027435|FG000|Period 2|Withdrawal by Subject|1|||
161994020|NCT01100320|585027436|FG001|Period 2|Withdrawal by Subject|1|||
161994021|NCT04181762|585027437|FG000|Overall Study|Adverse Event|1|||
161994022|NCT04181762|585027438|FG001|Overall Study|Adverse Event|3|||
161994023|NCT04181762|585027437|FG000|Overall Study|Lost to Follow-up|1|||
161994024|NCT04181762|585027438|FG001|Overall Study|Lost to Follow-up|1|||
161994025|NCT04181762|585027437|FG000|Overall Study|Physician Decision|1|||
161994026|NCT04181762|585027438|FG001|Overall Study|Physician Decision|3|||
161994027|NCT04181762|585027437|FG000|Overall Study|Pregnancy|0|||
161994028|NCT04181762|585027438|FG001|Overall Study|Pregnancy|1|||
161994029|NCT04181762|585027437|FG000|Overall Study|Lack of Efficacy|2|||
161994030|NCT04181762|585027438|FG001|Overall Study|Lack of Efficacy|2|||
161994031|NCT04181762|585027437|FG000|Overall Study|Study terminated by sponsor|95|||
161994032|NCT04181762|585027438|FG001|Overall Study|Study terminated by sponsor|97|||
161994033|NCT04181762|585027437|FG000|Overall Study|Subject decision|11|||
161887817|NCT01096589|584632490|FG001|Overall Study|Withdrawal by Subject|1|||
161887818|NCT01096589|584632491|FG002|Overall Study|Withdrawal by Subject|1|||
161887819|NCT01096589|584632492|FG003|Overall Study|Withdrawal by Subject|1|||
161887820|NCT01096589|584632489|FG000|Overall Study|Compliance with protocol|0|||
161887821|NCT01096589|584632490|FG001|Overall Study|Compliance with protocol|0|||
161887822|NCT01096589|584632491|FG002|Overall Study|Compliance with protocol|1|||
161887823|NCT01096589|584632492|FG003|Overall Study|Compliance with protocol|0|||
161887824|NCT01096589|584632489|FG000|Overall Study|found treatment exhausting|0|||
161887825|NCT01096589|584632490|FG001|Overall Study|found treatment exhausting|0|||
161887826|NCT01096589|584632491|FG002|Overall Study|found treatment exhausting|0|||
161994034|NCT04181762|585027438|FG001|Overall Study|Subject decision|4|||
161994035|NCT04181762|585027437|FG000|Overall Study|Death|1|||
161994036|NCT04181762|585027438|FG001|Overall Study|Death|1|||
161994037|NCT04181762|585027437|FG000|Overall Study|Protocol deviation|1|||
161994038|NCT04181762|585027438|FG001|Overall Study|Protocol deviation|0|||
161994039|NCT04181762|585027437|FG000|Overall Study|Withdrawal of informed consent|1|||
161994040|NCT04181762|585027438|FG001|Overall Study|Withdrawal of informed consent|3|||
161994041|NCT01502228|585027439|FG000|Overall Study|Death|1|||
161994042|NCT04669301|585027440|FG000|Overall Study|Lost to Follow-up|0|||
161994043|NCT04669301|585027441|FG001|Overall Study|Lost to Follow-up|1|||
161994044|NCT04669301|585027442|FG002|Overall Study|Lost to Follow-up|0|||
161994045|NCT04669301|585027440|FG000|Overall Study|Withdrawal by Subject|3|||
161994046|NCT04669301|585027441|FG001|Overall Study|Withdrawal by Subject|2|||
161994047|NCT04669301|585027442|FG002|Overall Study|Withdrawal by Subject|0|||
161994048|NCT02586727|585027443|FG000|Overall Study|Lost to Follow-up|1|||
161994049|NCT02586727|585027444|FG001|Overall Study|Lost to Follow-up|0|||
161994050|NCT05888181|585027447|FG000|Overall Study|Lost to Follow-up|1|||
161994051|NCT05888181|585027448|FG001|Overall Study|Lost to Follow-up|1|||
161994052|NCT05888181|585027449|FG002|Overall Study|Lost to Follow-up|0|||
161994053|NCT02534909|585027452|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
161994054|NCT02326597|585027455|FG000|Overall Study|Lost to Follow-up|42|||
161994055|NCT02326597|585027456|FG001|Overall Study|Lost to Follow-up|32|||
161994056|NCT00132808|585027457|FG000|Stratum I|Adverse Event|2|||
161994057|NCT00132808|585027458|FG001|Stratum I|Adverse Event|1|||
161994058|NCT00132808|585027459|FG002|Stratum I|Adverse Event|0|||
161994059|NCT00132808|585027457|FG000|Stratum I|Lost to Follow-up|3|||
161994060|NCT00132808|585027458|FG001|Stratum I|Lost to Follow-up|4|||
161994061|NCT00132808|585027459|FG002|Stratum I|Lost to Follow-up|1|||
161994062|NCT00132808|585027457|FG000|Stratum I|Withdrawal by Subject|4|||
161994063|NCT00132808|585027458|FG001|Stratum I|Withdrawal by Subject|7|||
161994064|NCT00132808|585027459|FG002|Stratum I|Withdrawal by Subject|3|||
161994065|NCT00132808|585027457|FG000|Stratum I|Abnormal test procedure result (s)|0|||
161994066|NCT00132808|585027458|FG001|Stratum I|Abnormal test procedure result (s)|0|||
161994067|NCT00132808|585027459|FG002|Stratum I|Abnormal test procedure result (s)|1|||
161994068|NCT00132808|585027457|FG000|Stratum II|Adverse Event|1|||
161994069|NCT00132808|585027458|FG001|Stratum II|Adverse Event|2|||
161994070|NCT00132808|585027459|FG002|Stratum II|Adverse Event|1|||
161994071|NCT00132808|585027457|FG000|Stratum II|Death|1|||
161994072|NCT00132808|585027458|FG001|Stratum II|Death|0|||
161994073|NCT00132808|585027459|FG002|Stratum II|Death|0|||
161994074|NCT00132808|585027457|FG000|Stratum II|Lost to Follow-up|2|||
161994075|NCT00132808|585027458|FG001|Stratum II|Lost to Follow-up|2|||
161994076|NCT00132808|585027459|FG002|Stratum II|Lost to Follow-up|1|||
161994077|NCT00132808|585027457|FG000|Stratum II|Protocol Violation|0|||
161994078|NCT00132808|585027458|FG001|Stratum II|Protocol Violation|2|||
161994079|NCT00132808|585027459|FG002|Stratum II|Protocol Violation|1|||
161994080|NCT00132808|585027457|FG000|Stratum II|Withdrawal by Subject|4|||
161994081|NCT00132808|585027458|FG001|Stratum II|Withdrawal by Subject|9|||
161994082|NCT00132808|585027459|FG002|Stratum II|Withdrawal by Subject|6|||
161994083|NCT00428948|585027463|FG000|Overall Study|Lost to Follow-up|15|||
161994084|NCT00428948|585027464|FG001|Overall Study|Lost to Follow-up|8|||
161994085|NCT00428948|585027463|FG000|Overall Study|Adverse Event|148|||
161994086|NCT00428948|585027464|FG001|Overall Study|Adverse Event|24|||
161994087|NCT00428948|585027463|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
161994088|NCT00428948|585027464|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
161994089|NCT00428948|585027463|FG000|Overall Study|Investigator Withdrew Subject|3|||
161994090|NCT00428948|585027464|FG001|Overall Study|Investigator Withdrew Subject|4|||
161994091|NCT00428948|585027463|FG000|Overall Study|Subject Withdrew Consent|50|||
161994092|NCT00428948|585027464|FG001|Overall Study|Subject Withdrew Consent|30|||
161887827|NCT01096589|584632492|FG003|Overall Study|found treatment exhausting|1|||
161994093|NCT00428948|585027463|FG000|Overall Study|Protocol Deviation|1|||
161994094|NCT00428948|585027464|FG001|Overall Study|Protocol Deviation|1|||
161994095|NCT00577824|585027465|FG000|Overall Study|Adverse Event|6|||
161994096|NCT00577824|585027466|FG001|Overall Study|Adverse Event|18|||
161887828|NCT00948506|584632493|FG000|Overall Study|Withdrawal by Subject|3|||
161994097|NCT00577824|585027467|FG002|Overall Study|Adverse Event|1|||
161994098|NCT00577824|585027465|FG000|Overall Study|Patient decision|0|||
161994099|NCT00577824|585027466|FG001|Overall Study|Patient decision|1|||
161994100|NCT00577824|585027467|FG002|Overall Study|Patient decision|1|||
162037623|NCT01226043|585194407|FG003|6-week Re-randomization Phase|Physician Decision|2|||
162037624|NCT01226043|585194404|FG000|6-week Re-randomization Phase|completed in error|0|||
162037625|NCT01226043|585194405|FG001|6-week Re-randomization Phase|completed in error|0|||
162037626|NCT01226043|585194406|FG002|6-week Re-randomization Phase|completed in error|0|||
162037627|NCT01226043|585194407|FG003|6-week Re-randomization Phase|completed in error|1|||
162037628|NCT01226043|585194404|FG000|30-week Observational Phase|Adverse Event|0|||
162037629|NCT01226043|585194405|FG001|30-week Observational Phase|Adverse Event|0|||
162037630|NCT01226043|585194406|FG002|30-week Observational Phase|Adverse Event|1|||
162037631|NCT01226043|585194407|FG003|30-week Observational Phase|Adverse Event|1|||
162037632|NCT01226043|585194404|FG000|30-week Observational Phase|Protocol Violation|0|||
161887829|NCT00948506|584632494|FG001|Overall Study|Withdrawal by Subject|1|||
161887830|NCT03233204|584632496|FG000|Overall Study|Adverse Event|1|||
161887831|NCT03233204|584632496|FG000|Overall Study|Death|1|||
161887832|NCT03233204|584632496|FG000|Overall Study|Withdrawal by Subject|1|||
161887833|NCT03233204|584632496|FG000|Overall Study|Progressive Disease|3|||
161887834|NCT01712334|584632499|FG000|Treatment Period 1|Randomized in Error|0|||
161887835|NCT01712334|584632500|FG001|Treatment Period 1|Randomized in Error|2|||
161887836|NCT00232596|584632501|FG000|6-Week Titration Phase|Adverse Event|6|||
161887837|NCT00232596|584632502|FG001|6-Week Titration Phase|Adverse Event|19|||
161887838|NCT00232596|584632501|FG000|6-Week Titration Phase|Failed to Return|2|||
161887839|NCT00232596|584632502|FG001|6-Week Titration Phase|Failed to Return|1|||
161887840|NCT00232596|584632501|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
161887841|NCT00232596|584632502|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
161887842|NCT00232596|584632501|FG000|6-Week Titration Phase|Protocol Violation|1|||
161887843|NCT00232596|584632502|FG001|6-Week Titration Phase|Protocol Violation|3|||
161887844|NCT00232596|584632501|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
161887845|NCT00232596|584632502|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
161887846|NCT00232596|584632501|FG000|6-Week Titration Phase|Other|3|||
161887847|NCT00232596|584632502|FG001|6-Week Titration Phase|Other|3|||
161887848|NCT00232596|584632501|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
161887849|NCT00232596|584632502|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
161887850|NCT00232596|584632501|FG000|12-Week Maintenance Phase|Adverse Event|7|||
161887851|NCT00232596|584632502|FG001|12-Week Maintenance Phase|Adverse Event|22|||
161887852|NCT00232596|584632501|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
161887853|NCT00232596|584632502|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
161887854|NCT00232596|584632501|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
161887855|NCT00232596|584632502|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
161887856|NCT00232596|584632501|FG000|12-Week Maintenance Phase|Other|1|||
161887857|NCT00232596|584632502|FG001|12-Week Maintenance Phase|Other|3|||
161887858|NCT03467763|584632505|FG000|Overall Study|Lost to Follow-up|1|||
161887859|NCT03467763|584632505|FG000|Overall Study|Protocol Violation|2|||
161887860|NCT02407054|584632506|FG000|Overall Study|Adverse Event|1|||
161887861|NCT02407054|584632507|FG001|Overall Study|Adverse Event|4|||
161887862|NCT02407054|584632508|FG002|Overall Study|Adverse Event|1|||
161887863|NCT02407054|584632506|FG000|Overall Study|Non-compliance with Study|0|||
161887864|NCT02407054|584632507|FG001|Overall Study|Non-compliance with Study|2|||
161887865|NCT02407054|584632508|FG002|Overall Study|Non-compliance with Study|1|||
161887866|NCT02407054|584632506|FG000|Overall Study|Physician Decision|1|||
161887867|NCT02407054|584632507|FG001|Overall Study|Physician Decision|3|||
161887868|NCT02407054|584632508|FG002|Overall Study|Physician Decision|3|||
161887869|NCT02407054|584632506|FG000|Overall Study|Withdrawal by Subject|5|||
161887870|NCT02407054|584632507|FG001|Overall Study|Withdrawal by Subject|9|||
161887871|NCT02407054|584632508|FG002|Overall Study|Withdrawal by Subject|2|||
161887872|NCT00932698|584632509|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
161887873|NCT00932698|584632510|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
161887874|NCT00932698|584632511|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
161887875|NCT00932698|584632512|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
162037633|NCT01226043|585194405|FG001|30-week Observational Phase|Protocol Violation|0|||
162037634|NCT01226043|585194406|FG002|30-week Observational Phase|Protocol Violation|0|||
162037635|NCT01226043|585194407|FG003|30-week Observational Phase|Protocol Violation|1|||
162037636|NCT01226043|585194404|FG000|30-week Observational Phase|Lost to Follow-up|0|||
162037637|NCT01226043|585194405|FG001|30-week Observational Phase|Lost to Follow-up|0|||
161887876|NCT00932698|584632513|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
162037638|NCT01226043|585194406|FG002|30-week Observational Phase|Lost to Follow-up|2|||
162037639|NCT01226043|585194407|FG003|30-week Observational Phase|Lost to Follow-up|2|||
162037640|NCT01226043|585194404|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
162037641|NCT01226043|585194405|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
161887877|NCT00932698|584632514|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
161887878|NCT00932698|584632515|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
161887879|NCT00932698|584632516|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
161887880|NCT00932698|584632517|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
161887881|NCT00932698|584632518|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
162037642|NCT01226043|585194406|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
162037643|NCT01226043|585194407|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
162037644|NCT01226043|585194404|FG000|30-week Observational Phase|Physician Decision|0|||
162037645|NCT01226043|585194405|FG001|30-week Observational Phase|Physician Decision|0|||
162037646|NCT01226043|585194406|FG002|30-week Observational Phase|Physician Decision|2|||
162037647|NCT01226043|585194407|FG003|30-week Observational Phase|Physician Decision|2|||
162037648|NCT00596362|585194418|FG000|Overall Study|Progressive Disease|1|||
162037649|NCT02418156|585194419|FG000|Overall Study|Lost to Follow-up|12|||
162037650|NCT02418156|585194419|FG000|Overall Study|Death|2|||
162037651|NCT02418156|585194419|FG000|Overall Study|Physician Decision|1|||
162037652|NCT02418156|585194419|FG000|Overall Study|Withdrawal by Subject|1|||
162037653|NCT02418156|585194419|FG000|Overall Study|Subject refused to return|1|||
162037654|NCT00323869|585194422|FG000|Overall Study|Death|1|||
162037655|NCT01909453|585194423|FG000|Overall Study|Ongoing|118|||
162037656|NCT01909453|585194424|FG001|Overall Study|Ongoing|103|||
162037657|NCT01909453|585194425|FG002|Overall Study|Ongoing|83|||
162037658|NCT01909453|585194426|FG003|Overall Study|Ongoing|164|||
162037659|NCT01909453|585194427|FG004|Overall Study|Ongoing|50|||
162037660|NCT01909453|585194423|FG000|Overall Study|Death|69|||
162037661|NCT01909453|585194424|FG001|Overall Study|Death|74|||
162037662|NCT01909453|585194425|FG002|Overall Study|Death|88|||
162037663|NCT01909453|585194426|FG003|Overall Study|Death|86|||
162037664|NCT01909453|585194427|FG004|Overall Study|Death|29|||
162037665|NCT01909453|585194423|FG000|Overall Study|Lost to Follow-up|3|||
162037666|NCT01909453|585194424|FG001|Overall Study|Lost to Follow-up|4|||
162037667|NCT01909453|585194425|FG002|Overall Study|Lost to Follow-up|4|||
162037668|NCT01909453|585194426|FG003|Overall Study|Lost to Follow-up|3|||
162037669|NCT01909453|585194427|FG004|Overall Study|Lost to Follow-up|3|||
162037670|NCT01909453|585194423|FG000|Overall Study|Withdrawal by Subject|2|||
162037671|NCT01909453|585194424|FG001|Overall Study|Withdrawal by Subject|13|||
162037672|NCT01909453|585194425|FG002|Overall Study|Withdrawal by Subject|16|||
162037673|NCT01909453|585194426|FG003|Overall Study|Withdrawal by Subject|5|||
162037674|NCT01909453|585194427|FG004|Overall Study|Withdrawal by Subject|4|||
162048465|NCT01058655|585233338|FG000|Overall Study|Withdrawal by Subject|1|||
162048466|NCT01058655|585233339|FG001|Overall Study|Withdrawal by Subject|0|||
162048467|NCT01058655|585233340|FG002|Overall Study|Withdrawal by Subject|3|||
162048468|NCT01058655|585233341|FG003|Overall Study|Withdrawal by Subject|4|||
162048469|NCT01058655|585233338|FG000|Overall Study|Prolonged Treatment Delay|0|||
162048470|NCT01058655|585233339|FG001|Overall Study|Prolonged Treatment Delay|0|||
162048471|NCT01058655|585233340|FG002|Overall Study|Prolonged Treatment Delay|0|||
162048472|NCT01058655|585233341|FG003|Overall Study|Prolonged Treatment Delay|2|||
162048473|NCT01058655|585233338|FG000|Overall Study|Symptomatic Deterioration|0|||
162048474|NCT01058655|585233339|FG001|Overall Study|Symptomatic Deterioration|0|||
162048475|NCT01058655|585233340|FG002|Overall Study|Symptomatic Deterioration|0|||
162048476|NCT01058655|585233341|FG003|Overall Study|Symptomatic Deterioration|1|||
162048477|NCT01058655|585233338|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
162048478|NCT01058655|585233339|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
162048479|NCT01058655|585233340|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
162048480|NCT01058655|585233341|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
162048481|NCT01058655|585233338|FG000|Overall Study|Death|0|||
162048482|NCT01058655|585233339|FG001|Overall Study|Death|1|||
162048483|NCT01058655|585233340|FG002|Overall Study|Death|1|||
161887882|NCT00932698|584632519|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
161887883|NCT00932698|584632509|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161887884|NCT00932698|584632510|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
161887885|NCT00932698|584632511|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161887886|NCT00932698|584632512|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
161887887|NCT00932698|584632513|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161887888|NCT00932698|584632514|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
161887889|NCT00932698|584632515|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
161887890|NCT00932698|584632516|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161887891|NCT00932698|584632517|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
162048484|NCT01058655|585233341|FG003|Overall Study|Death|0|||
162048485|NCT01058655|585233338|FG000|Overall Study|Disease Progression|1|||
161887892|NCT00932698|584632518|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161887893|NCT00932698|584632519|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
162048486|NCT01058655|585233339|FG001|Overall Study|Disease Progression|2|||
162048487|NCT01058655|585233340|FG002|Overall Study|Disease Progression|4|||
162048488|NCT01058655|585233341|FG003|Overall Study|Disease Progression|24|||
162048489|NCT01058655|585233338|FG000|Overall Study|Other|0|||
162048490|NCT01058655|585233339|FG001|Overall Study|Other|0|||
162048491|NCT01058655|585233340|FG002|Overall Study|Other|0|||
162048492|NCT01058655|585233341|FG003|Overall Study|Other|4|||
162048493|NCT04545060|585233342|FG000|Overall Study|Adverse Event|0|||
162048494|NCT04545060|585233343|FG001|Overall Study|Adverse Event|1|||
162048495|NCT04545060|585233342|FG000|Overall Study|Death|0|||
162048496|NCT04545060|585233343|FG001|Overall Study|Death|5|||
162048497|NCT04545060|585233342|FG000|Overall Study|Lost to Follow-up|10|||
161887894|NCT00932698|584632509|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
161887895|NCT00932698|584632510|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
161887896|NCT00932698|584632511|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
162037675|NCT02247531|585196009|FG000|Overall Study|Adverse Event|3|||
162037676|NCT02247531|585196010|FG001|Overall Study|Adverse Event|4|||
162037677|NCT02247531|585196011|FG002|Overall Study|Adverse Event|9|||
161887897|NCT00932698|584632512|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
161887898|NCT00932698|584632513|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
161887899|NCT00932698|584632514|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
161887900|NCT00932698|584632515|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
161887901|NCT00932698|584632516|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
161887902|NCT00932698|584632517|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
161887903|NCT00932698|584632518|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
161887904|NCT00932698|584632519|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
161887905|NCT00932698|584632509|FG000|Part 1 (Dose Escalation)|Other|0|||
161887906|NCT00932698|584632510|FG001|Part 1 (Dose Escalation)|Other|0|||
161887907|NCT00932698|584632511|FG002|Part 1 (Dose Escalation)|Other|1|||
161887908|NCT00932698|584632512|FG003|Part 1 (Dose Escalation)|Other|0|||
161887909|NCT00932698|584632513|FG004|Part 1 (Dose Escalation)|Other|0|||
161887910|NCT00932698|584632514|FG005|Part 1 (Dose Escalation)|Other|0|||
161887911|NCT00932698|584632515|FG006|Part 1 (Dose Escalation)|Other|1|||
161887912|NCT00932698|584632516|FG007|Part 1 (Dose Escalation)|Other|0|||
161887913|NCT00932698|584632517|FG008|Part 1 (Dose Escalation)|Other|0|||
161887914|NCT00932698|584632518|FG009|Part 1 (Dose Escalation)|Other|0|||
161887915|NCT00932698|584632519|FG010|Part 1 (Dose Escalation)|Other|0|||
161887916|NCT00932698|584632509|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887917|NCT00932698|584632510|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887918|NCT00932698|584632511|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887919|NCT00932698|584632512|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887920|NCT00932698|584632513|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887921|NCT00932698|584632514|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887922|NCT00932698|584632515|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
161887923|NCT00932698|584632516|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
161887924|NCT00932698|584632517|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
161887925|NCT00932698|584632518|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
161887926|NCT00932698|584632519|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
161887927|NCT00932698|584632509|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887928|NCT00932698|584632510|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887929|NCT00932698|584632511|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887930|NCT00932698|584632512|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887931|NCT00932698|584632513|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887932|NCT00932698|584632514|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887933|NCT00932698|584632515|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887934|NCT00932698|584632516|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
161887935|NCT00932698|584632517|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
161887936|NCT00932698|584632518|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
161887937|NCT00932698|584632519|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161887938|NCT00932698|584632509|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
161887939|NCT00932698|584632510|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
161887940|NCT00932698|584632511|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
161887941|NCT00932698|584632512|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
161887942|NCT00932698|584632513|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
161887943|NCT00932698|584632514|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
161887944|NCT00932698|584632515|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
161887945|NCT00932698|584632516|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
161887946|NCT00932698|584632517|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
161887947|NCT00932698|584632518|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
161887948|NCT00932698|584632519|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
161887949|NCT01447927|584632522|FG000|Overall Study|Adverse Event|4|||
161887950|NCT01447927|584632523|FG001|Overall Study|Adverse Event|3|||
161887951|NCT01447927|584632522|FG000|Overall Study|Withdrawal by Subject|1|||
161887952|NCT01447927|584632523|FG001|Overall Study|Withdrawal by Subject|0|||
161887953|NCT02913105|584634456|FG000|Overall Study|Adverse Event|11|||
161887954|NCT02913105|584634457|FG001|Overall Study|Adverse Event|0|||
161887955|NCT02913105|584634458|FG002|Overall Study|Adverse Event|4|||
161887956|NCT02913105|584634456|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161887957|NCT02913105|584634457|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161887958|NCT02913105|584634458|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161887959|NCT02913105|584634456|FG000|Overall Study|Reason Not Specified|3|||
161887960|NCT02913105|584634457|FG001|Overall Study|Reason Not Specified|1|||
161887961|NCT02913105|584634458|FG002|Overall Study|Reason Not Specified|1|||
161887962|NCT02913105|584634456|FG000|Overall Study|Physician Decision|1|||
161887963|NCT02913105|584634457|FG001|Overall Study|Physician Decision|1|||
162037678|NCT02247531|585196009|FG000|Overall Study|Death|8|||
161887964|NCT02913105|584634458|FG002|Overall Study|Physician Decision|0|||
161887965|NCT02913105|584634456|FG000|Overall Study|Withdrawal by Subject|0|||
161887966|NCT02913105|584634457|FG001|Overall Study|Withdrawal by Subject|3|||
161887967|NCT02913105|584634458|FG002|Overall Study|Withdrawal by Subject|1|||
161887968|NCT02168777|584634459|FG000|Overall Study|Withdrawal by Subject|1|||
161887969|NCT02168777|584634460|FG001|Overall Study|Withdrawal by Subject|0|||
161887970|NCT02168777|584634461|FG002|Overall Study|Withdrawal by Subject|2|||
161887971|NCT02168777|584634459|FG000|Overall Study|Adverse Event|1|||
162037679|NCT02247531|585196010|FG001|Overall Study|Death|9|||
162037680|NCT02247531|585196011|FG002|Overall Study|Death|5|||
162037681|NCT02247531|585196009|FG000|Overall Study|Lost to Follow-up|1|||
162037682|NCT02247531|585196010|FG001|Overall Study|Lost to Follow-up|8|||
162037683|NCT02247531|585196011|FG002|Overall Study|Lost to Follow-up|3|||
162037684|NCT02247531|585196009|FG000|Overall Study|Non-compliance|2|||
161887972|NCT02168777|584634460|FG001|Overall Study|Adverse Event|0|||
161887973|NCT02168777|584634461|FG002|Overall Study|Adverse Event|1|||
161887974|NCT02168777|584634459|FG000|Overall Study|Disease recurrence|0|||
161887975|NCT02168777|584634460|FG001|Overall Study|Disease recurrence|0|||
161887976|NCT02168777|584634461|FG002|Overall Study|Disease recurrence|1|||
161887977|NCT02168777|584634459|FG000|Overall Study|Radiological disease progression|0|||
161887978|NCT02168777|584634460|FG001|Overall Study|Radiological disease progression|5|||
161887979|NCT02168777|584634461|FG002|Overall Study|Radiological disease progression|5|||
161887980|NCT02168777|584634459|FG000|Overall Study|Clinical disease progression|0|||
161887981|NCT02168777|584634460|FG001|Overall Study|Clinical disease progression|1|||
161887982|NCT02168777|584634461|FG002|Overall Study|Clinical disease progression|2|||
161887983|NCT02168777|584634459|FG000|Overall Study|Other reason|0|||
161887984|NCT02168777|584634460|FG001|Overall Study|Other reason|1|||
161887985|NCT02168777|584634461|FG002|Overall Study|Other reason|0|||
161887986|NCT05243563|584634462|FG000|Overall Study|Withdrawal by Subject|1|||
161887987|NCT05243563|584634463|FG001|Overall Study|Withdrawal by Subject|0|||
161887988|NCT05243563|584634462|FG000|Overall Study|Physician Decision|1|||
161887989|NCT05243563|584634463|FG001|Overall Study|Physician Decision|0|||
161887990|NCT02437188|584634466|FG000|Overall Study|Randomized but did not receive surgery|4|||
161887991|NCT02437188|584634467|FG001|Overall Study|Randomized but did not receive surgery|8|||
161887992|NCT02437188|584634466|FG000|Overall Study|Adverse Event|0|||
161887993|NCT02437188|584634467|FG001|Overall Study|Adverse Event|1|||
161887994|NCT01663857|584634468|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
161887995|NCT01663857|584634469|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
161887996|NCT01663857|584634470|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
161887997|NCT01663857|584634471|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
161887998|NCT01663857|584634468|FG000|Overall Study|Lost to Follow-up|0|||
161887999|NCT01663857|584634469|FG001|Overall Study|Lost to Follow-up|0|||
161888000|NCT01663857|584634470|FG002|Overall Study|Lost to Follow-up|3|||
161888001|NCT01663857|584634471|FG003|Overall Study|Lost to Follow-up|1|||
161888002|NCT01172808|584634474|FG000|Overall Study|Adverse Event|8|||
161888003|NCT01172808|584634475|FG001|Overall Study|Adverse Event|4|||
161888004|NCT01172808|584634476|FG002|Overall Study|Adverse Event|8|||
161888005|NCT01172808|584634477|FG003|Overall Study|Adverse Event|3|||
161888006|NCT01172808|584634474|FG000|Overall Study|Lack of Efficacy|1|||
161888007|NCT01172808|584634475|FG001|Overall Study|Lack of Efficacy|0|||
161888008|NCT01172808|584634476|FG002|Overall Study|Lack of Efficacy|0|||
161888009|NCT01172808|584634477|FG003|Overall Study|Lack of Efficacy|0|||
161888010|NCT01172808|584634474|FG000|Overall Study|Protocol Violation|2|||
161888011|NCT01172808|584634475|FG001|Overall Study|Protocol Violation|2|||
161888012|NCT01172808|584634476|FG002|Overall Study|Protocol Violation|2|||
161888013|NCT01172808|584634477|FG003|Overall Study|Protocol Violation|0|||
161888014|NCT01172808|584634474|FG000|Overall Study|Lost to Follow-up|0|||
161888015|NCT01172808|584634475|FG001|Overall Study|Lost to Follow-up|1|||
161888016|NCT01172808|584634476|FG002|Overall Study|Lost to Follow-up|1|||
161888017|NCT01172808|584634477|FG003|Overall Study|Lost to Follow-up|3|||
161888018|NCT01172808|584634474|FG000|Overall Study|Withdrawal by Subject|4|||
161888019|NCT01172808|584634475|FG001|Overall Study|Withdrawal by Subject|1|||
161888020|NCT01172808|584634476|FG002|Overall Study|Withdrawal by Subject|3|||
161888021|NCT01172808|584634477|FG003|Overall Study|Withdrawal by Subject|2|||
161888022|NCT01172808|584634474|FG000|Overall Study|Other|6|||
161888023|NCT01172808|584634475|FG001|Overall Study|Other|5|||
161888024|NCT01172808|584634476|FG002|Overall Study|Other|9|||
161888025|NCT01172808|584634477|FG003|Overall Study|Other|7|||
161888026|NCT02578940|584634482|FG000|Overall Study|Screening failure|5|||
161888027|NCT02578940|584634482|FG000|Overall Study|Lost to Follow-up|1|||
161888028|NCT01911793|584634483|FG000|Overall Study|Physician Decision|1|||
161888029|NCT01911793|584634484|FG001|Overall Study|Physician Decision|5|||
161888030|NCT03959488|584634491|FG000|Season 1|Other|6|||
161888031|NCT03959488|584634492|FG001|Season 1|Other|7|||
161888032|NCT03959488|584634493|FG002|Season 1|Other|0|||
161888033|NCT03959488|584634494|FG003|Season 1|Other|0|||
161888034|NCT03959488|584634495|FG004|Season 1|Other|0|||
161888035|NCT03959488|584634491|FG000|Season 1|Withdrawal by parent/guardian|43|||
161888036|NCT03959488|584634492|FG001|Season 1|Withdrawal by parent/guardian|28|||
162037685|NCT02247531|585196010|FG001|Overall Study|Non-compliance|2|||
162037686|NCT02247531|585196011|FG002|Overall Study|Non-compliance|0|||
162037687|NCT02247531|585196009|FG000|Overall Study|Withdrawal by Subject|26|||
162037688|NCT02247531|585196010|FG001|Overall Study|Withdrawal by Subject|31|||
162037689|NCT02247531|585196011|FG002|Overall Study|Withdrawal by Subject|25|||
162037690|NCT02247531|585196009|FG000|Overall Study|Study Terminated by Sponsor|64|||
162037691|NCT02247531|585196010|FG001|Overall Study|Study Terminated by Sponsor|66|||
162037692|NCT02247531|585196011|FG002|Overall Study|Study Terminated by Sponsor|62|||
162037693|NCT02247531|585196009|FG000|Overall Study|Physician Decision|0|||
162037694|NCT02247531|585196010|FG001|Overall Study|Physician Decision|2|||
162037695|NCT02247531|585196011|FG002|Overall Study|Physician Decision|2|||
162037696|NCT02247531|585196009|FG000|Overall Study|Unspecified Reason|2|||
162037697|NCT02247531|585196010|FG001|Overall Study|Unspecified Reason|3|||
162037698|NCT02247531|585196011|FG002|Overall Study|Unspecified Reason|4|||
162037699|NCT01751802|585196021|FG000|Overall Study|Adverse Event|4|||
162037700|NCT01751802|585196022|FG001|Overall Study|Adverse Event|2|||
162037701|NCT01229397|585196023|FG000|Overall Study|Withdrawal by Subject|3|||
162037702|NCT01229397|585196024|FG001|Overall Study|Withdrawal by Subject|3|||
162037703|NCT01229397|585196023|FG000|Overall Study|Lost to Follow-up|7|||
162037704|NCT01229397|585196024|FG001|Overall Study|Lost to Follow-up|6|||
162037705|NCT01229397|585196023|FG000|Overall Study|Migrated/moved from study area|1|||
162037706|NCT01229397|585196024|FG001|Overall Study|Migrated/moved from study area|0|||
162037707|NCT00608543|585196025|FG000|Overall Study|Adverse Event|4|||
162037708|NCT01869725|585196026|FG000|Overall Study|ineligible after registration|1|||
162037709|NCT01869725|585196026|FG000|Overall Study|Death|1|||
162037710|NCT01869725|585196026|FG000|Overall Study|Lost to Follow-up|2|||
162037711|NCT03416374|585196029|FG000|Between Treatment Period I and II|Other|0|||
162037712|NCT03416374|585196030|FG001|Between Treatment Period I and II|Other|9|||
162037713|NCT03416374|585196029|FG000|Treatment Period II|Lack of Efficacy|3|||
162037714|NCT03416374|585196030|FG001|Treatment Period II|Lack of Efficacy|11|||
162037715|NCT03416374|585196029|FG000|Treatment Period II|Adverse Event|1|||
162037716|NCT03416374|585196030|FG001|Treatment Period II|Adverse Event|4|||
162037717|NCT03416374|585196029|FG000|Treatment Period II|Death|0|||
161888037|NCT03959488|584634493|FG002|Season 1|Withdrawal by parent/guardian|0|||
161888038|NCT03959488|584634494|FG003|Season 1|Withdrawal by parent/guardian|0|||
161888039|NCT03959488|584634495|FG004|Season 1|Withdrawal by parent/guardian|0|||
161888040|NCT03959488|584634491|FG000|Season 1|Due to COVID-19 pandemic|2|||
161888041|NCT03959488|584634492|FG001|Season 1|Due to COVID-19 pandemic|3|||
161888042|NCT03959488|584634493|FG002|Season 1|Due to COVID-19 pandemic|0|||
161888043|NCT03959488|584634494|FG003|Season 1|Due to COVID-19 pandemic|0|||
161888044|NCT03959488|584634495|FG004|Season 1|Due to COVID-19 pandemic|0|||
161888045|NCT03959488|584634491|FG000|Season 1|Lost to Follow-up|17|||
161888046|NCT03959488|584634492|FG001|Season 1|Lost to Follow-up|7|||
161888047|NCT03959488|584634493|FG002|Season 1|Lost to Follow-up|0|||
161888048|NCT03959488|584634494|FG003|Season 1|Lost to Follow-up|0|||
161888049|NCT03959488|584634495|FG004|Season 1|Lost to Follow-up|0|||
161888050|NCT03959488|584634491|FG000|Season 1|Death|5|||
161888051|NCT03959488|584634492|FG001|Season 1|Death|1|||
161888052|NCT03959488|584634493|FG002|Season 1|Death|0|||
161888053|NCT03959488|584634494|FG003|Season 1|Death|0|||
161888054|NCT03959488|584634495|FG004|Season 1|Death|0|||
161888055|NCT03959488|584634491|FG000|Season 2|Other|0|||
161888056|NCT03959488|584634492|FG001|Season 2|Other|0|||
161888057|NCT03959488|584634493|FG002|Season 2|Other|2|||
161888058|NCT03959488|584634494|FG003|Season 2|Other|0|||
161888059|NCT03959488|584634495|FG004|Season 2|Other|0|||
161888060|NCT03959488|584634491|FG000|Season 2|Withdrawal by parent/guardian|0|||
161888061|NCT03959488|584634492|FG001|Season 2|Withdrawal by parent/guardian|0|||
161888062|NCT03959488|584634493|FG002|Season 2|Withdrawal by parent/guardian|3|||
161888063|NCT03959488|584634494|FG003|Season 2|Withdrawal by parent/guardian|1|||
161888064|NCT03959488|584634495|FG004|Season 2|Withdrawal by parent/guardian|1|||
161888065|NCT03959488|584634491|FG000|Season 2|Lost to Follow-up|0|||
161888066|NCT03959488|584634492|FG001|Season 2|Lost to Follow-up|0|||
161888067|NCT03959488|584634493|FG002|Season 2|Lost to Follow-up|1|||
161888068|NCT03959488|584634494|FG003|Season 2|Lost to Follow-up|0|||
161888069|NCT03959488|584634495|FG004|Season 2|Lost to Follow-up|1|||
161888070|NCT03341936|584634496|FG000|Overall Study|Ineligible|1|||
161888071|NCT03341936|584634496|FG000|Overall Study|Disease Progression|2|||
161994101|NCT00577824|585027465|FG000|Overall Study|Protocol Violation|1|||
161994102|NCT00577824|585027466|FG001|Overall Study|Protocol Violation|1|||
161994103|NCT00577824|585027467|FG002|Overall Study|Protocol Violation|0|||
161994104|NCT00362648|585027468|FG000|Overall Study|Adverse Event|12|||
161994105|NCT00362648|585027469|FG001|Overall Study|Adverse Event|21|||
161994106|NCT00362648|585027470|FG002|Overall Study|Adverse Event|1|||
161994107|NCT00362648|585027471|FG003|Overall Study|Adverse Event|0|||
161994108|NCT00362648|585027468|FG000|Overall Study|Lost to Follow-up|62|||
161994109|NCT00362648|585027469|FG001|Overall Study|Lost to Follow-up|69|||
161994110|NCT00362648|585027470|FG002|Overall Study|Lost to Follow-up|4|||
161888072|NCT03341936|584634496|FG000|Overall Study|Withdrew Consent|4|||
161994111|NCT00362648|585027471|FG003|Overall Study|Lost to Follow-up|3|||
161994112|NCT00362648|585027468|FG000|Overall Study|Protocol Violation|4|||
162037718|NCT03416374|585196030|FG001|Treatment Period II|Death|1|||
161994113|NCT00362648|585027469|FG001|Overall Study|Protocol Violation|2|||
161994114|NCT00362648|585027470|FG002|Overall Study|Protocol Violation|2|||
161994115|NCT00362648|585027471|FG003|Overall Study|Protocol Violation|2|||
161994116|NCT00362648|585027468|FG000|Overall Study|Withdrawal by Subject|48|||
161994117|NCT00362648|585027469|FG001|Overall Study|Withdrawal by Subject|42|||
161994118|NCT00362648|585027470|FG002|Overall Study|Withdrawal by Subject|2|||
161994119|NCT00362648|585027471|FG003|Overall Study|Withdrawal by Subject|6|||
161994120|NCT04752332|585027472|FG000|Overall Study|Adverse Event|3|||
161994121|NCT04752332|585027473|FG001|Overall Study|Adverse Event|1|||
161994122|NCT04752332|585027472|FG000|Overall Study|Disease Relapse|1|||
161994123|NCT04752332|585027473|FG001|Overall Study|Disease Relapse|0|||
161994124|NCT04752332|585027472|FG000|Overall Study|Non-compliance With Study Drug|2|||
161994125|NCT04752332|585027473|FG001|Overall Study|Non-compliance With Study Drug|0|||
161994126|NCT04752332|585027472|FG000|Overall Study|Physician Decision|2|||
161994127|NCT04752332|585027473|FG001|Overall Study|Physician Decision|1|||
161994128|NCT04752332|585027472|FG000|Overall Study|Protocol Violation|1|||
161994129|NCT04752332|585027473|FG001|Overall Study|Protocol Violation|1|||
161994130|NCT04752332|585027472|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
161994131|NCT04752332|585027473|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
161994132|NCT04752332|585027472|FG000|Overall Study|Study Terminated by Sponsor|10|||
161994133|NCT04752332|585027473|FG001|Overall Study|Study Terminated by Sponsor|48|||
161994134|NCT04752332|585027472|FG000|Overall Study|Withdrawal by Subject|11|||
161994135|NCT04752332|585027473|FG001|Overall Study|Withdrawal by Subject|3|||
161994136|NCT00924443|585027474|FG000|Overall Study|Physician Decision|2|||
161994137|NCT00924443|585027474|FG000|Overall Study|Protocol Violation|1|||
161994138|NCT02978833|585027477|FG000|Overall Study|Study terminated|1|||
161994139|NCT02978833|585027478|FG001|Overall Study|Study terminated|1|||
161994140|NCT01123395|585027481|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
161994141|NCT01123395|585027482|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
161994142|NCT00186901|585027483|FG000|Overall Study|Pregnancy|6|||
161994143|NCT00186901|585027484|FG001|Overall Study|Pregnancy|3|||
161994144|NCT00186901|585027485|FG002|Overall Study|Pregnancy|0|||
161994145|NCT00186901|585027483|FG000|Overall Study|Lost to Follow-up|6|||
161994146|NCT00186901|585027484|FG001|Overall Study|Lost to Follow-up|3|||
161994147|NCT00186901|585027485|FG002|Overall Study|Lost to Follow-up|0|||
161994148|NCT00186901|585027483|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
161994149|NCT00186901|585027484|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
161994150|NCT00186901|585027485|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
161994151|NCT00186901|585027483|FG000|Overall Study|ALL relapse or second malignancy|1|||
161994152|NCT00186901|585027484|FG001|Overall Study|ALL relapse or second malignancy|2|||
161994153|NCT00186901|585027485|FG002|Overall Study|ALL relapse or second malignancy|0|||
161994154|NCT00186901|585027483|FG000|Overall Study|Withdrawal by Subject|4|||
161994155|NCT00186901|585027484|FG001|Overall Study|Withdrawal by Subject|5|||
161994156|NCT00186901|585027485|FG002|Overall Study|Withdrawal by Subject|0|||
161994157|NCT00186901|585027483|FG000|Overall Study|Open label|3|||
161994158|NCT00186901|585027484|FG001|Overall Study|Open label|2|||
161994159|NCT00186901|585027485|FG002|Overall Study|Open label|0|||
161994160|NCT00186901|585027483|FG000|Overall Study|Limited adherence to study requirements|20|||
161888073|NCT03341936|584634496|FG000|Overall Study|Non-Compliance|1|||
161888074|NCT03341936|584634496|FG000|Overall Study|Physician Decision|1|||
161888075|NCT03341936|584634496|FG000|Overall Study|Withdrawal by Subject|1|||
161888076|NCT03341936|584634496|FG000|Overall Study|Other|1|||
161888077|NCT00981058|584634505|FG000|Overall Study|Progressive Disease|38|||
161888078|NCT00981058|584634506|FG001|Overall Study|Progressive Disease|31|||
161888079|NCT00981058|584634505|FG000|Overall Study|Lost to Follow-up|3|||
161888080|NCT00981058|584634506|FG001|Overall Study|Lost to Follow-up|2|||
161888081|NCT00981058|584634505|FG000|Overall Study|Physician Decision|4|||
161888082|NCT00981058|584634506|FG001|Overall Study|Physician Decision|5|||
161888083|NCT00981058|584634505|FG000|Overall Study|Randomization Error|0|||
161888084|NCT00981058|584634506|FG001|Overall Study|Randomization Error|1|||
161994161|NCT00186901|585027484|FG001|Overall Study|Limited adherence to study requirements|23|||
161994162|NCT00186901|585027485|FG002|Overall Study|Limited adherence to study requirements|0|||
161994163|NCT00186901|585027483|FG000|Overall Study|Bone Mineral Density > 0|0|||
161994164|NCT00186901|585027484|FG001|Overall Study|Bone Mineral Density > 0|0|||
162037719|NCT03416374|585196029|FG000|Treatment Period II|Other|0|||
161888085|NCT00981058|584634505|FG000|Overall Study|Withdrawal by Subject|24|||
161888086|NCT00981058|584634506|FG001|Overall Study|Withdrawal by Subject|22|||
161888087|NCT02667587|584634507|FG000|Pre-Treatment|Not reported|1|||
161888088|NCT02667587|584634508|FG001|Pre-Treatment|Not reported|0|||
161888089|NCT02667587|584634507|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
161888090|NCT02667587|584634508|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
161888091|NCT02667587|584634507|FG000|Pre-Treatment|Participant withdrew consent|0|||
161888092|NCT02667587|584634508|FG001|Pre-Treatment|Participant withdrew consent|1|||
161888093|NCT02667587|584634507|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
161888094|NCT02667587|584634508|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
161888095|NCT02667587|584634507|FG000|End of Treatment|Disease Progression|193|||
161994165|NCT00186901|585027485|FG002|Overall Study|Bone Mineral Density > 0|149|||
161888096|NCT02667587|584634508|FG001|End of Treatment|Disease Progression|226|||
161888097|NCT02667587|584634507|FG000|End of Treatment|Study Drug Toxicity|75|||
161888098|NCT02667587|584634508|FG001|End of Treatment|Study Drug Toxicity|19|||
161888099|NCT02667587|584634507|FG000|End of Treatment|Death|2|||
161888100|NCT02667587|584634508|FG001|End of Treatment|Death|1|||
161888101|NCT02667587|584634507|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
161888102|NCT02667587|584634508|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
161888103|NCT02667587|584634507|FG000|End of Treatment|participant request to discontinue treatment|33|||
161888104|NCT02667587|584634508|FG001|End of Treatment|participant request to discontinue treatment|35|||
161888105|NCT02667587|584634507|FG000|End of Treatment|participant withdrew consent|5|||
161888106|NCT02667587|584634508|FG001|End of Treatment|participant withdrew consent|6|||
161888107|NCT02667587|584634507|FG000|End of Treatment|Lost to Follow-up|1|||
161888108|NCT02667587|584634508|FG001|End of Treatment|Lost to Follow-up|2|||
161888109|NCT02667587|584634507|FG000|End of Treatment|maximum clinical benefit|4|||
161888110|NCT02667587|584634508|FG001|End of Treatment|maximum clinical benefit|4|||
161888111|NCT02667587|584634507|FG000|End of Treatment|poor or non compliant|0|||
161888112|NCT02667587|584634508|FG001|End of Treatment|poor or non compliant|1|||
161888113|NCT02667587|584634507|FG000|End of Treatment|participant no longer meets study criteria|1|||
161888114|NCT02667587|584634508|FG001|End of Treatment|participant no longer meets study criteria|1|||
161888115|NCT02667587|584634507|FG000|End of Treatment|administrative reason by sponsor|1|||
161888116|NCT02667587|584634508|FG001|End of Treatment|administrative reason by sponsor|29|||
161888117|NCT02667587|584634507|FG000|End of Treatment|other reasonse|21|||
161888118|NCT02667587|584634508|FG001|End of Treatment|other reasonse|10|||
161888119|NCT02542293|584634509|FG000|Overall Study|Death|367|||
161888120|NCT02542293|584634510|FG001|Overall Study|Death|377|||
161888121|NCT02542293|584634509|FG000|Overall Study|Withdrawal by Subject|8|||
161888122|NCT02542293|584634510|FG001|Overall Study|Withdrawal by Subject|19|||
161888123|NCT04529850|584634511|FG000|Overall Study|Death|2|||
161888124|NCT04529850|584634511|FG000|Overall Study|Physician Decision|1|||
161888125|NCT04529850|584634511|FG000|Overall Study|Withdrawal by Subject|2|||
161888126|NCT00593606|584634514|FG000|Overall Study|Adverse Event|13|||
161888127|NCT00593606|584634514|FG000|Overall Study|Withdrawal by Subject|1|||
161888128|NCT00593606|584634514|FG000|Overall Study|Protocol Violation|3|||
161888129|NCT00593606|584634514|FG000|Overall Study|Lost to Follow-up|2|||
161888130|NCT00593606|584634514|FG000|Overall Study|Run-In Failure|5|||
161888131|NCT00593606|584634514|FG000|Overall Study|Screen Failure|3|||
161888132|NCT00869557|584634515|FG000|Randomized Phase|Lost to Follow-up|2|||
161888133|NCT00869557|584634516|FG001|Randomized Phase|Lost to Follow-up|1|||
161888134|NCT00869557|584634515|FG000|Randomized Phase|Investigator's Discretion|1|||
161888135|NCT00869557|584634516|FG001|Randomized Phase|Investigator's Discretion|0|||
161888136|NCT00869557|584634515|FG000|Randomized Phase|Withdrew Consent|0|||
161888137|NCT00869557|584634516|FG001|Randomized Phase|Withdrew Consent|1|||
161888138|NCT00869557|584634515|FG000|Extension Phase|Adverse Event|2|||
161888139|NCT00869557|584634516|FG001|Extension Phase|Adverse Event|2|||
161888140|NCT00869557|584634515|FG000|Extension Phase|Lack of Efficacy|1|||
161888141|NCT00869557|584634516|FG001|Extension Phase|Lack of Efficacy|0|||
161888142|NCT00869557|584634515|FG000|Extension Phase|Lost to Follow-up|3|||
161888143|NCT00869557|584634516|FG001|Extension Phase|Lost to Follow-up|1|||
161888144|NCT00869557|584634515|FG000|Extension Phase|Investigator's Discretion|2|||
161888145|NCT00869557|584634516|FG001|Extension Phase|Investigator's Discretion|0|||
161888146|NCT00869557|584634515|FG000|Extension Phase|Withdrew Consent|2|||
161888147|NCT00869557|584634516|FG001|Extension Phase|Withdrew Consent|0|||
161888148|NCT01472939|584634519|FG000|Overall Study|Adverse Event|3|||
161888149|NCT01472939|584634520|FG001|Overall Study|Adverse Event|7|||
161888150|NCT01472939|584634521|FG002|Overall Study|Adverse Event|7|||
161888151|NCT01472939|584634522|FG003|Overall Study|Adverse Event|14|||
161888152|NCT01472939|584634519|FG000|Overall Study|Lack of Efficacy|1|||
161888153|NCT01472939|584634520|FG001|Overall Study|Lack of Efficacy|0|||
161888154|NCT01472939|584634521|FG002|Overall Study|Lack of Efficacy|0|||
161888155|NCT01472939|584634522|FG003|Overall Study|Lack of Efficacy|1|||
161888156|NCT01472939|584634519|FG000|Overall Study|Lost to Follow-up|3|||
161888157|NCT01472939|584634520|FG001|Overall Study|Lost to Follow-up|0|||
161888158|NCT01472939|584634521|FG002|Overall Study|Lost to Follow-up|2|||
161888159|NCT01472939|584634522|FG003|Overall Study|Lost to Follow-up|0|||
161888160|NCT01472939|584634519|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
161888161|NCT01472939|584634520|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
161888162|NCT01472939|584634521|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
161888163|NCT01472939|584634522|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
161888164|NCT01472939|584634519|FG000|Overall Study|Prohibited Medication|0|||
161888165|NCT01472939|584634520|FG001|Overall Study|Prohibited Medication|1|||
161888166|NCT01472939|584634521|FG002|Overall Study|Prohibited Medication|0|||
161888167|NCT01472939|584634522|FG003|Overall Study|Prohibited Medication|0|||
161888168|NCT01472939|584634519|FG000|Overall Study|Withdrawal By PI|1|||
161888169|NCT01472939|584634520|FG001|Overall Study|Withdrawal By PI|0|||
161888170|NCT01472939|584634521|FG002|Overall Study|Withdrawal By PI|0|||
161888171|NCT01472939|584634522|FG003|Overall Study|Withdrawal By PI|0|||
161888172|NCT01472939|584634519|FG000|Overall Study|Protocol Violation|3|||
161888173|NCT01472939|584634520|FG001|Overall Study|Protocol Violation|3|||
161888174|NCT01472939|584634521|FG002|Overall Study|Protocol Violation|0|||
161888175|NCT01472939|584634522|FG003|Overall Study|Protocol Violation|1|||
161888176|NCT01472939|584634519|FG000|Overall Study|Withdrawal by Subject|9|||
161888177|NCT01472939|584634520|FG001|Overall Study|Withdrawal by Subject|3|||
161888178|NCT01472939|584634521|FG002|Overall Study|Withdrawal by Subject|1|||
161888179|NCT01472939|584634522|FG003|Overall Study|Withdrawal by Subject|4|||
161888180|NCT00114738|584634523|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
161888181|NCT00114738|584634524|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
161888182|NCT00114738|584634525|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
161888183|NCT00114738|584634523|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
161888184|NCT00114738|584634524|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
161888185|NCT00114738|584634525|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
161888186|NCT00114738|584634523|FG000|Screening for Randomization|Neuropathy|17|||
161888187|NCT00114738|584634524|FG001|Screening for Randomization|Neuropathy|0|||
161888188|NCT00114738|584634525|FG002|Screening for Randomization|Neuropathy|0|||
161888189|NCT00114738|584634523|FG000|Screening for Randomization|Progressive disease|2|||
161888190|NCT00114738|584634524|FG001|Screening for Randomization|Progressive disease|0|||
161888191|NCT00114738|584634525|FG002|Screening for Randomization|Progressive disease|0|||
161888192|NCT00114738|584634523|FG000|Screening for Randomization|CNS Hemorrhage|1|||
161888193|NCT00114738|584634524|FG001|Screening for Randomization|CNS Hemorrhage|0|||
161888194|NCT00114738|584634525|FG002|Screening for Randomization|CNS Hemorrhage|0|||
161888195|NCT00114738|584634523|FG000|Screening for Randomization|Other|1|||
161888196|NCT00114738|584634524|FG001|Screening for Randomization|Other|0|||
161888197|NCT00114738|584634525|FG002|Screening for Randomization|Other|0|||
161888198|NCT05940077|584634526|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
161888199|NCT01492101|584634527|FG000|Overall Study|Death|323|||
161888200|NCT01492101|584634528|FG001|Overall Study|Death|322|||
161888201|NCT01492101|584634527|FG000|Overall Study|Withdrawal by Subject|14|||
161888202|NCT01492101|584634528|FG001|Overall Study|Withdrawal by Subject|18|||
161888203|NCT01492101|584634527|FG000|Overall Study|Lost to Follow-up|0|||
161888204|NCT01492101|584634528|FG001|Overall Study|Lost to Follow-up|2|||
161888205|NCT01004432|584634529|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
161888206|NCT01004432|584634530|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
161888207|NCT01004432|584634531|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
161888208|NCT01004432|584634532|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
161888209|NCT01004432|584634533|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
161888210|NCT01004432|584634529|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
161888211|NCT01004432|584634530|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
161888212|NCT01004432|584634531|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
161888213|NCT01004432|584634532|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
161888214|NCT01004432|584634533|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
161888215|NCT01004432|584634529|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
161888216|NCT01004432|584634530|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
161888217|NCT01004432|584634531|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
161888218|NCT01004432|584634532|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
161888219|NCT01004432|584634533|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
161888220|NCT01004432|584634529|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
161888221|NCT01004432|584634530|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
161888222|NCT01004432|584634531|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
161888223|NCT01004432|584634532|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
161888224|NCT01004432|584634533|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
161888225|NCT01004432|584634529|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
161888226|NCT01004432|584634530|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
161888227|NCT01004432|584634531|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
161888228|NCT01004432|584634532|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
161888229|NCT01004432|584634533|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
161888230|NCT01004432|584634529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
161888231|NCT01004432|584634530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
161888232|NCT01004432|584634531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
162037720|NCT03416374|585196030|FG001|Treatment Period II|Other|2|||
161888233|NCT01004432|584634532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
161888234|NCT01004432|584634533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
161888235|NCT01004432|584634529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
161888236|NCT01004432|584634530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
161888237|NCT01004432|584634531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
161888238|NCT01004432|584634532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
161888239|NCT01004432|584634533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
161888240|NCT01004432|584634529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
161888241|NCT01004432|584634530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
161888242|NCT01004432|584634531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
161888243|NCT01004432|584634532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
161888244|NCT01004432|584634533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
161888245|NCT01004432|584634529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
161888246|NCT01004432|584634530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
161888247|NCT01004432|584634531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
161888248|NCT01004432|584634532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
161888249|NCT01004432|584634533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
161888250|NCT01004432|584634529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
161888251|NCT01004432|584634530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
161888252|NCT01004432|584634531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
161888253|NCT01004432|584634532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
161888254|NCT01004432|584634533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
161888255|NCT01004432|584634529|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
161888256|NCT01004432|584634530|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
161888257|NCT01004432|584634531|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
161888258|NCT01004432|584634532|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
161888259|NCT01004432|584634533|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
161888260|NCT01004432|584634529|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
161888261|NCT01004432|584634530|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
161888262|NCT01004432|584634531|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
161888263|NCT01004432|584634532|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
161888264|NCT01004432|584634533|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
161888265|NCT01004432|584634529|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
161888266|NCT01004432|584634530|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
161994166|NCT00782483|585027488|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
161994167|NCT01052077|585027489|FG000|Phase A|Lost to Follow-up|22|||
161994168|NCT01052077|585027490|FG001|Phase A|Lost to Follow-up|0|||
161994169|NCT01052077|585027491|FG002|Phase A|Lost to Follow-up|0|||
161994170|NCT01052077|585027492|FG003|Phase A|Lost to Follow-up|0|||
161994171|NCT01052077|585027489|FG000|Phase A|Adverse Event|32|||
161994172|NCT01052077|585027490|FG001|Phase A|Adverse Event|0|||
161994173|NCT01052077|585027491|FG002|Phase A|Adverse Event|0|||
161994174|NCT01052077|585027492|FG003|Phase A|Adverse Event|0|||
161994175|NCT01052077|585027489|FG000|Phase A|Met Withdrawal Criteria|26|||
161994176|NCT01052077|585027490|FG001|Phase A|Met Withdrawal Criteria|0|||
161994177|NCT01052077|585027491|FG002|Phase A|Met Withdrawal Criteria|0|||
161994178|NCT01052077|585027492|FG003|Phase A|Met Withdrawal Criteria|0|||
161994179|NCT01052077|585027489|FG000|Phase A|Physician Decision|10|||
161994180|NCT01052077|585027490|FG001|Phase A|Physician Decision|0|||
161994181|NCT01052077|585027491|FG002|Phase A|Physician Decision|0|||
161994182|NCT01052077|585027492|FG003|Phase A|Physician Decision|0|||
161994183|NCT01052077|585027489|FG000|Phase A|Withdrawal by Subject|29|||
161994184|NCT01052077|585027490|FG001|Phase A|Withdrawal by Subject|0|||
161994185|NCT01052077|585027491|FG002|Phase A|Withdrawal by Subject|0|||
161994186|NCT01052077|585027492|FG003|Phase A|Withdrawal by Subject|0|||
161994187|NCT01052077|585027489|FG000|Phase A|Protocol Deviation|27|||
161994188|NCT01052077|585027490|FG001|Phase A|Protocol Deviation|0|||
161994189|NCT01052077|585027491|FG002|Phase A|Protocol Deviation|0|||
161994190|NCT01052077|585027492|FG003|Phase A|Protocol Deviation|0|||
161994191|NCT01052077|585027489|FG000|Phase B|Lost to Follow-up|0|||
161994192|NCT01052077|585027490|FG001|Phase B|Lost to Follow-up|2|||
161994193|NCT01052077|585027491|FG002|Phase B|Lost to Follow-up|3|||
161994194|NCT01052077|585027492|FG003|Phase B|Lost to Follow-up|0|||
162037721|NCT01025154|585196033|FG000|Overall Study|Lost to Follow-up|1|||
162037722|NCT01025154|585196033|FG000|Overall Study|Withdrawal by Subject|1|||
162037723|NCT01810432|585196034|FG000|Washout|Protocol Violation|0|||
161994195|NCT01052077|585027489|FG000|Phase B|Adverse Event|0|||
161994196|NCT01052077|585027490|FG001|Phase B|Adverse Event|9|||
161994197|NCT01052077|585027491|FG002|Phase B|Adverse Event|2|||
161994198|NCT01052077|585027492|FG003|Phase B|Adverse Event|0|||
161994199|NCT01052077|585027489|FG000|Phase B|Met Withdrawal Criteria|0|||
162037724|NCT01810432|585196035|FG001|Washout|Protocol Violation|1|||
162037725|NCT01810432|585196034|FG000|Washout|Adverse Event|1|||
161888267|NCT01004432|584634531|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
161888268|NCT01004432|584634532|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
161888269|NCT01004432|584634533|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
161888270|NCT01004432|584634529|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
161888271|NCT01004432|584634530|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
161888272|NCT01004432|584634531|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
161994200|NCT01052077|585027490|FG001|Phase B|Met Withdrawal Criteria|2|||
161994201|NCT01052077|585027491|FG002|Phase B|Met Withdrawal Criteria|1|||
162037726|NCT01810432|585196035|FG001|Washout|Adverse Event|0|||
162037727|NCT01810432|585196034|FG000|Period 2|Withdrawal by Subject|2|||
162037728|NCT01810432|585196035|FG001|Period 2|Withdrawal by Subject|1|||
162037729|NCT01810432|585196034|FG000|Period 2|Physician Decision|1|||
162037730|NCT01810432|585196035|FG001|Period 2|Physician Decision|0|||
162037731|NCT01810432|585196034|FG000|Period 2|Lost to Follow-up|1|||
162037732|NCT01810432|585196035|FG001|Period 2|Lost to Follow-up|1|||
162037733|NCT01251744|585196036|FG000|Overall Study|Lost to Follow-up|1|||
162037734|NCT01251744|585196037|FG001|Overall Study|Lost to Follow-up|0|||
162037735|NCT00214500|585196038|FG000|Treatment Period|Adverse Event|1|||
162037736|NCT00214500|585196038|FG000|Extension Period|Withdrawal by Subject|2|||
162037737|NCT01068652|585196039|FG000|Overall Study|Adverse Event|4|||
162037738|NCT01068652|585196040|FG001|Overall Study|Adverse Event|0|||
162037739|NCT01068652|585196039|FG000|Overall Study|Lack of Efficacy|0|||
162037740|NCT01068652|585196040|FG001|Overall Study|Lack of Efficacy|2|||
162037741|NCT01068652|585196039|FG000|Overall Study|Lost to Follow-up|2|||
162037742|NCT01068652|585196040|FG001|Overall Study|Lost to Follow-up|1|||
162037743|NCT01068652|585196039|FG000|Overall Study|Protocol Violation|3|||
162037744|NCT01068652|585196040|FG001|Overall Study|Protocol Violation|6|||
162037745|NCT01068652|585196039|FG000|Overall Study|Withdrawal criteria|1|||
162037746|NCT01068652|585196040|FG001|Overall Study|Withdrawal criteria|2|||
162037747|NCT01068652|585196039|FG000|Overall Study|Patient was not eligible|1|||
162037748|NCT01068652|585196040|FG001|Overall Study|Patient was not eligible|0|||
162037749|NCT01068652|585196039|FG000|Overall Study|Unclassified|7|||
162037750|NCT01068652|585196040|FG001|Overall Study|Unclassified|4|||
162037751|NCT03170232|585196041|FG000|Overall Study|Adverse Event|0|||
162037752|NCT03170232|585196042|FG001|Overall Study|Adverse Event|1|||
162037753|NCT03170232|585196041|FG000|Overall Study|Protocol Violation|0|||
162037754|NCT03170232|585196042|FG001|Overall Study|Protocol Violation|1|||
162037755|NCT03170232|585196041|FG000|Overall Study|Lack of Efficacy|0|||
162037756|NCT03170232|585196042|FG001|Overall Study|Lack of Efficacy|1|||
162037757|NCT03170232|585196041|FG000|Overall Study|Study closed/terminated|26|||
162037758|NCT03170232|585196042|FG001|Overall Study|Study closed/terminated|23|||
162037759|NCT03170232|585196041|FG000|Overall Study|Lost to Follow-up|1|||
162037760|NCT03170232|585196042|FG001|Overall Study|Lost to Follow-up|0|||
162037761|NCT03170232|585196041|FG000|Overall Study|Withdrawal by Subject|0|||
162037762|NCT03170232|585196042|FG001|Overall Study|Withdrawal by Subject|1|||
162037763|NCT00147251|585196043|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
162037764|NCT00147251|585196044|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
162037765|NCT02537574|585196045|FG000|Overall Study|Adverse Event|1|||
162037766|NCT02537574|585196046|FG001|Overall Study|Adverse Event|3|||
162037767|NCT02537574|585196047|FG002|Overall Study|Adverse Event|2|||
162037768|NCT02537574|585196045|FG000|Overall Study|Lost to Follow-up|40|||
162037769|NCT02537574|585196046|FG001|Overall Study|Lost to Follow-up|51|||
162037770|NCT02537574|585196047|FG002|Overall Study|Lost to Follow-up|55|||
162037771|NCT02537574|585196045|FG000|Overall Study|Noncompliance with study drug|0|||
162037772|NCT02537574|585196046|FG001|Overall Study|Noncompliance with study drug|1|||
162037773|NCT02537574|585196047|FG002|Overall Study|Noncompliance with study drug|1|||
162037774|NCT02537574|585196045|FG000|Overall Study|Physician Decision|2|||
162037775|NCT02537574|585196046|FG001|Overall Study|Physician Decision|0|||
162037776|NCT02537574|585196047|FG002|Overall Study|Physician Decision|0|||
162037777|NCT02537574|585196045|FG000|Overall Study|Protocol Violation|4|||
162037778|NCT02537574|585196046|FG001|Overall Study|Protocol Violation|2|||
162037779|NCT02537574|585196047|FG002|Overall Study|Protocol Violation|3|||
162037780|NCT02537574|585196045|FG000|Overall Study|Withdrawal by Subject|37|||
162037781|NCT02537574|585196046|FG001|Overall Study|Withdrawal by Subject|27|||
162037782|NCT02537574|585196047|FG002|Overall Study|Withdrawal by Subject|29|||
162037783|NCT02537574|585196045|FG000|Overall Study|Lack of Efficacy|14|||
162037784|NCT02537574|585196046|FG001|Overall Study|Lack of Efficacy|16|||
162037785|NCT02537574|585196047|FG002|Overall Study|Lack of Efficacy|15|||
162037786|NCT02537574|585196045|FG000|Overall Study|Duplicate Patient|1|||
162037787|NCT02537574|585196046|FG001|Overall Study|Duplicate Patient|0|||
162037788|NCT02537574|585196047|FG002|Overall Study|Duplicate Patient|0|||
162037789|NCT02537574|585196045|FG000|Overall Study|Patient not Stable|0|||
162037790|NCT02537574|585196046|FG001|Overall Study|Patient not Stable|1|||
162037791|NCT02537574|585196047|FG002|Overall Study|Patient not Stable|0|||
162037792|NCT02537574|585196045|FG000|Overall Study|Incarceration|0|||
162037793|NCT02537574|585196046|FG001|Overall Study|Incarceration|1|||
162037794|NCT02537574|585196047|FG002|Overall Study|Incarceration|0|||
162037795|NCT02537574|585196045|FG000|Overall Study|Failed Naloxone Challenge|0|||
162037796|NCT02537574|585196046|FG001|Overall Study|Failed Naloxone Challenge|1|||
162037797|NCT02537574|585196047|FG002|Overall Study|Failed Naloxone Challenge|0|||
162037798|NCT02537574|585196045|FG000|Overall Study|Transportation Issues|0|||
162037799|NCT02537574|585196046|FG001|Overall Study|Transportation Issues|0|||
162037800|NCT02537574|585196047|FG002|Overall Study|Transportation Issues|1|||
162037801|NCT02537574|585196045|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
162037802|NCT02537574|585196046|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
162037803|NCT02537574|585196047|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
161888273|NCT01004432|584634532|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
161888274|NCT01004432|584634533|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
161888275|NCT01004432|584634529|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
161888276|NCT01004432|584634530|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
161888277|NCT01004432|584634531|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
161888278|NCT01004432|584634532|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
161888279|NCT01004432|584634533|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
161888280|NCT02696434|584634537|FG000|Overall Study|Adverse Event|3|||
161994202|NCT01052077|585027492|FG003|Phase B|Met Withdrawal Criteria|0|||
161994203|NCT01052077|585027489|FG000|Phase B|Physician Decision|0|||
161994204|NCT01052077|585027490|FG001|Phase B|Physician Decision|1|||
161994205|NCT01052077|585027491|FG002|Phase B|Physician Decision|1|||
161994206|NCT01052077|585027492|FG003|Phase B|Physician Decision|0|||
161994207|NCT01052077|585027489|FG000|Phase B|Withdrawal by Subject|0|||
161994208|NCT01052077|585027490|FG001|Phase B|Withdrawal by Subject|0|||
161994209|NCT01052077|585027491|FG002|Phase B|Withdrawal by Subject|5|||
161994210|NCT01052077|585027492|FG003|Phase B|Withdrawal by Subject|0|||
161994211|NCT01052077|585027489|FG000|Phase B|Protocol Deviation|0|||
161994212|NCT01052077|585027490|FG001|Phase B|Protocol Deviation|3|||
161994213|NCT01052077|585027491|FG002|Phase B|Protocol Deviation|4|||
161994214|NCT01052077|585027492|FG003|Phase B|Protocol Deviation|0|||
161994215|NCT01052077|585027489|FG000|Phase B|Lack of Efficacy|0|||
161994216|NCT01052077|585027490|FG001|Phase B|Lack of Efficacy|1|||
161994217|NCT01052077|585027491|FG002|Phase B|Lack of Efficacy|0|||
161994218|NCT01052077|585027492|FG003|Phase B|Lack of Efficacy|0|||
161994219|NCT01052077|585027489|FG000|Phase A+|Lost to Follow-up|0|||
161994220|NCT01052077|585027490|FG001|Phase A+|Lost to Follow-up|0|||
161994221|NCT01052077|585027491|FG002|Phase A+|Lost to Follow-up|0|||
161994222|NCT01052077|585027492|FG003|Phase A+|Lost to Follow-up|8|||
161994223|NCT01052077|585027489|FG000|Phase A+|Adverse Event|0|||
161994224|NCT01052077|585027490|FG001|Phase A+|Adverse Event|0|||
161994225|NCT01052077|585027491|FG002|Phase A+|Adverse Event|0|||
161994226|NCT01052077|585027492|FG003|Phase A+|Adverse Event|4|||
161994227|NCT01052077|585027489|FG000|Phase A+|Met Withdrawal Criteria|0|||
161994228|NCT01052077|585027490|FG001|Phase A+|Met Withdrawal Criteria|0|||
161994229|NCT01052077|585027491|FG002|Phase A+|Met Withdrawal Criteria|0|||
161994230|NCT01052077|585027492|FG003|Phase A+|Met Withdrawal Criteria|2|||
161994231|NCT01052077|585027489|FG000|Phase A+|Withdrawal by Subject|0|||
161994232|NCT01052077|585027490|FG001|Phase A+|Withdrawal by Subject|0|||
161994233|NCT01052077|585027491|FG002|Phase A+|Withdrawal by Subject|0|||
161994234|NCT01052077|585027492|FG003|Phase A+|Withdrawal by Subject|7|||
161994235|NCT00003199|585027497|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
161994236|NCT00003199|585027497|FG000|Overall Study|Lack of insurance clearance|2|||
161994237|NCT00003199|585027497|FG000|Overall Study|Screen fail|15|||
161994238|NCT00940498|585027498|FG000|Overall Study|Death|2|||
161994239|NCT00940498|585027499|FG001|Overall Study|Death|0|||
161994240|NCT00940498|585027500|FG002|Overall Study|Death|0|||
161994241|NCT00940498|585027501|FG003|Overall Study|Death|1|||
161994242|NCT00940498|585027502|FG004|Overall Study|Death|5|||
161994243|NCT00940498|585027503|FG005|Overall Study|Death|0|||
161994244|NCT00940498|585027504|FG006|Overall Study|Death|1|||
161994245|NCT00940498|585027505|FG007|Overall Study|Death|0|||
161994246|NCT00940498|585027498|FG000|Overall Study|Lost to Follow-up|1|||
161994247|NCT00940498|585027499|FG001|Overall Study|Lost to Follow-up|1|||
161994248|NCT00940498|585027500|FG002|Overall Study|Lost to Follow-up|2|||
161994249|NCT00940498|585027501|FG003|Overall Study|Lost to Follow-up|0|||
161994250|NCT00940498|585027502|FG004|Overall Study|Lost to Follow-up|1|||
161994251|NCT00940498|585027503|FG005|Overall Study|Lost to Follow-up|0|||
161994252|NCT00940498|585027504|FG006|Overall Study|Lost to Follow-up|0|||
161994253|NCT00940498|585027505|FG007|Overall Study|Lost to Follow-up|1|||
161994254|NCT00940498|585027498|FG000|Overall Study|Disease Progression|0|||
161994255|NCT00940498|585027499|FG001|Overall Study|Disease Progression|0|||
161994256|NCT00940498|585027500|FG002|Overall Study|Disease Progression|1|||
161994257|NCT00940498|585027501|FG003|Overall Study|Disease Progression|1|||
161994258|NCT00940498|585027502|FG004|Overall Study|Disease Progression|0|||
161994259|NCT00940498|585027503|FG005|Overall Study|Disease Progression|1|||
161994260|NCT00940498|585027504|FG006|Overall Study|Disease Progression|0|||
161994261|NCT00940498|585027505|FG007|Overall Study|Disease Progression|0|||
161994262|NCT00940498|585027498|FG000|Overall Study|Physician Decision|0|||
161994263|NCT00940498|585027499|FG001|Overall Study|Physician Decision|0|||
161994264|NCT00940498|585027500|FG002|Overall Study|Physician Decision|0|||
161888281|NCT02696434|584634538|FG001|Overall Study|Adverse Event|1|||
161888282|NCT02696434|584634537|FG000|Overall Study|Lost to Follow-up|5|||
161888283|NCT02696434|584634538|FG001|Overall Study|Lost to Follow-up|4|||
161994265|NCT00940498|585027501|FG003|Overall Study|Physician Decision|0|||
161994266|NCT00940498|585027502|FG004|Overall Study|Physician Decision|2|||
161994267|NCT00940498|585027503|FG005|Overall Study|Physician Decision|0|||
161994268|NCT00940498|585027504|FG006|Overall Study|Physician Decision|0|||
161994269|NCT00940498|585027505|FG007|Overall Study|Physician Decision|0|||
161994270|NCT00940498|585027498|FG000|Overall Study|Not treated due to disease related pain|0|||
161888284|NCT02696434|584634537|FG000|Overall Study|Withdrawal by Subject|14|||
161888285|NCT02696434|584634538|FG001|Overall Study|Withdrawal by Subject|12|||
161888286|NCT02696434|584634537|FG000|Overall Study|Physician Decision|0|||
161888287|NCT02696434|584634538|FG001|Overall Study|Physician Decision|1|||
161888288|NCT03570554|584634543|FG000|Overall Study|Non-compliance with study drug|0|||
161888289|NCT03570554|584634544|FG001|Overall Study|Non-compliance with study drug|0|||
161888290|NCT03570554|584634545|FG002|Overall Study|Non-compliance with study drug|1|||
161888291|NCT03570554|584634546|FG003|Overall Study|Non-compliance with study drug|0|||
161888292|NCT03570554|584634543|FG000|Overall Study|Adverse Event|0|||
161888293|NCT03570554|584634544|FG001|Overall Study|Adverse Event|0|||
161888294|NCT03570554|584634545|FG002|Overall Study|Adverse Event|0|||
161888295|NCT03570554|584634546|FG003|Overall Study|Adverse Event|1|||
161888296|NCT02719353|584634550|FG000|First Intervention|Physician Decision|0|||
161888297|NCT02719353|584634551|FG001|First Intervention|Physician Decision|1|||
161888298|NCT03114657|584634552|FG000|Overall Study|Adverse Event|9|||
161888299|NCT03114657|584634553|FG001|Overall Study|Adverse Event|6|||
161888300|NCT03114657|584634552|FG000|Overall Study|Death|4|||
161888301|NCT03114657|584634553|FG001|Overall Study|Death|0|||
161888302|NCT03114657|584634552|FG000|Overall Study|Multiple Reasons|1|||
161888303|NCT03114657|584634553|FG001|Overall Study|Multiple Reasons|2|||
161888304|NCT03114657|584634552|FG000|Overall Study|Physician Decision|2|||
161888305|NCT03114657|584634553|FG001|Overall Study|Physician Decision|2|||
161888306|NCT03114657|584634552|FG000|Overall Study|Study Terminated By Sponsor|355|||
161888307|NCT03114657|584634553|FG001|Overall Study|Study Terminated By Sponsor|374|||
161888308|NCT03114657|584634552|FG000|Overall Study|Symptomatic Deterioration|0|||
161888309|NCT03114657|584634553|FG001|Overall Study|Symptomatic Deterioration|1|||
161888310|NCT03114657|584634552|FG000|Overall Study|Withdrawal by Subject|28|||
161888311|NCT03114657|584634553|FG001|Overall Study|Withdrawal by Subject|22|||
161888312|NCT04245202|584634554|FG000|Overall Study|Lack of Efficacy|10|||
161888313|NCT04245202|584634555|FG001|Overall Study|Lack of Efficacy|1|||
161888314|NCT00717275|584634556|FG000|Overall Study|Premature study termination.|3|||
161888315|NCT03769194|584634560|FG000|Overall Study|Withdrawal by Subject|0|||
161888316|NCT03769194|584634561|FG001|Overall Study|Withdrawal by Subject|7|||
161888317|NCT03769194|584634562|FG002|Overall Study|Withdrawal by Subject|4|||
161888318|NCT03769194|584634563|FG003|Overall Study|Withdrawal by Subject|1|||
161888319|NCT03769194|584634560|FG000|Overall Study|moved from study area|0|||
161888320|NCT03769194|584634561|FG001|Overall Study|moved from study area|2|||
161888321|NCT03769194|584634562|FG002|Overall Study|moved from study area|1|||
161888322|NCT03769194|584634563|FG003|Overall Study|moved from study area|1|||
161888323|NCT03769194|584634560|FG000|Overall Study|Lost to Follow-up|3|||
161888324|NCT03769194|584634561|FG001|Overall Study|Lost to Follow-up|6|||
161888325|NCT03769194|584634562|FG002|Overall Study|Lost to Follow-up|3|||
161888326|NCT03769194|584634563|FG003|Overall Study|Lost to Follow-up|6|||
161888327|NCT03769194|584634560|FG000|Overall Study|other|1|||
161888328|NCT03769194|584634561|FG001|Overall Study|other|3|||
161888329|NCT03769194|584634562|FG002|Overall Study|other|0|||
161888330|NCT03769194|584634563|FG003|Overall Study|other|1|||
161888331|NCT00312572|584634565|FG000|Overall Study|Adverse Event|10|||
161888332|NCT00312572|584634566|FG001|Overall Study|Adverse Event|16|||
161888333|NCT00312572|584634565|FG000|Overall Study|Lost to Follow-up|1|||
161888334|NCT00312572|584634566|FG001|Overall Study|Lost to Follow-up|1|||
161888335|NCT00312572|584634565|FG000|Overall Study|Administrative|4|||
161888336|NCT00312572|584634566|FG001|Overall Study|Administrative|2|||
161888337|NCT00312572|584634565|FG000|Overall Study|Lack of Efficacy|1|||
161888338|NCT00312572|584634566|FG001|Overall Study|Lack of Efficacy|2|||
161888339|NCT04521114|584634573|FG000|Overall Study|Lost to Follow-up|1|||
161888340|NCT04521114|584634574|FG001|Overall Study|Lost to Follow-up|2|||
161888341|NCT04521114|584634575|FG002|Overall Study|Lost to Follow-up|0|||
161888342|NCT04521114|584634573|FG000|Overall Study|Withdrawal by Subject|1|||
161888343|NCT04521114|584634574|FG001|Overall Study|Withdrawal by Subject|2|||
161888344|NCT04521114|584634575|FG002|Overall Study|Withdrawal by Subject|2|||
161888345|NCT04521114|584634573|FG000|Overall Study|Adverse Event|1|||
161888346|NCT04521114|584634574|FG001|Overall Study|Adverse Event|0|||
161888347|NCT04521114|584634575|FG002|Overall Study|Adverse Event|0|||
161888348|NCT04521114|584634573|FG000|Overall Study|Sponsor Wish|1|||
161888349|NCT04521114|584634574|FG001|Overall Study|Sponsor Wish|0|||
161888350|NCT04521114|584634575|FG002|Overall Study|Sponsor Wish|0|||
161888351|NCT04521114|584634573|FG000|Overall Study|Withdrawal of Consent|2|||
161888352|NCT04521114|584634574|FG001|Overall Study|Withdrawal of Consent|2|||
161888353|NCT04521114|584634575|FG002|Overall Study|Withdrawal of Consent|0|||
161888354|NCT01362517|584634576|FG000|Overall Study|Protocol Violation|1|||
161888355|NCT01362517|584634576|FG000|Overall Study|Lost to Follow-up|1|||
161888356|NCT01133288|584634579|FG000|Eligibility Assessment|met exclusion criteria|5|||
161888357|NCT01133288|584634579|FG000|Intervention Allocation|study terminated|2|||
161888358|NCT02614131|584634580|FG000|Overall Study|Withdrawal by Subject|1|||
161888359|NCT02614131|584634581|FG001|Overall Study|Withdrawal by Subject|0|||
161888360|NCT02614131|584634582|FG002|Overall Study|Withdrawal by Subject|0|||
161888361|NCT02614131|584634583|FG003|Overall Study|Withdrawal by Subject|0|||
161888362|NCT02614131|584634584|FG004|Overall Study|Withdrawal by Subject|0|||
161888363|NCT02614131|584634585|FG005|Overall Study|Withdrawal by Subject|0|||
161888364|NCT02614131|584634586|FG006|Overall Study|Withdrawal by Subject|0|||
161888365|NCT02614131|584634580|FG000|Overall Study|Adverse Event|0|||
161888366|NCT02614131|584634581|FG001|Overall Study|Adverse Event|0|||
161888367|NCT02614131|584634582|FG002|Overall Study|Adverse Event|0|||
161888368|NCT02614131|584634583|FG003|Overall Study|Adverse Event|0|||
161888369|NCT02614131|584634584|FG004|Overall Study|Adverse Event|0|||
161888370|NCT02614131|584634585|FG005|Overall Study|Adverse Event|0|||
161888371|NCT02614131|584634586|FG006|Overall Study|Adverse Event|1|||
161888372|NCT03209518|584634587|FG000|Overall Study|Case Report Forms Uncollected|1|||
161888373|NCT03209518|584634587|FG000|Overall Study|Protocol Deviation|1|||
161888374|NCT01832818|584634588|FG000|Overall Study|Lost to Follow-up|6|||
161888375|NCT00236899|584634593|FG000|Overall Study|Adverse Event (Study Related)|1|||
161888376|NCT00236899|584634594|FG001|Overall Study|Adverse Event (Study Related)|1|||
161888377|NCT00236899|584634595|FG002|Overall Study|Adverse Event (Study Related)|2|||
161888378|NCT00236899|584634596|FG003|Overall Study|Adverse Event (Study Related)|1|||
161888379|NCT00236899|584634593|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
161888380|NCT00236899|584634594|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
161888381|NCT00236899|584634595|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
161888382|NCT00236899|584634596|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
161888383|NCT00236899|584634593|FG000|Overall Study|Death (Study Disease)|1|||
161888384|NCT00236899|584634594|FG001|Overall Study|Death (Study Disease)|4|||
161888385|NCT00236899|584634595|FG002|Overall Study|Death (Study Disease)|0|||
161888386|NCT00236899|584634596|FG003|Overall Study|Death (Study Disease)|0|||
161888387|NCT00236899|584634593|FG000|Overall Study|Death (Not Study Related)|2|||
161888388|NCT00236899|584634594|FG001|Overall Study|Death (Not Study Related)|0|||
161888389|NCT00236899|584634595|FG002|Overall Study|Death (Not Study Related)|0|||
162037804|NCT02537574|585196045|FG000|Overall Study|Noncompliance with Protocol|0|||
162037805|NCT02537574|585196046|FG001|Overall Study|Noncompliance with Protocol|0|||
162037806|NCT02537574|585196047|FG002|Overall Study|Noncompliance with Protocol|1|||
162037807|NCT01151098|585196048|FG000|Overall Study|Adverse Event|82|||
162037808|NCT01151098|585196048|FG000|Overall Study|Lost to Follow-up|6|||
162037809|NCT01151098|585196048|FG000|Overall Study|Lack of Efficacy|15|||
162037810|NCT01151098|585196048|FG000|Overall Study|Protocol Violation|1|||
162037811|NCT01151098|585196048|FG000|Overall Study|Miscellaneous|13|||
162037812|NCT00417482|585196049|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
161888390|NCT00236899|584634596|FG003|Overall Study|Death (Not Study Related)|0|||
161888391|NCT00236899|584634593|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
161888392|NCT00236899|584634594|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
161888393|NCT00236899|584634595|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
161888394|NCT00236899|584634596|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
161888395|NCT00236899|584634593|FG000|Overall Study|Lost to Follow-up|0|||
161888396|NCT00236899|584634594|FG001|Overall Study|Lost to Follow-up|1|||
161888397|NCT00236899|584634595|FG002|Overall Study|Lost to Follow-up|0|||
161888398|NCT00236899|584634596|FG003|Overall Study|Lost to Follow-up|0|||
161888399|NCT00236899|584634593|FG000|Overall Study|Entry Criteria Exclusion|0|||
161888400|NCT00236899|584634594|FG001|Overall Study|Entry Criteria Exclusion|1|||
161888401|NCT00236899|584634595|FG002|Overall Study|Entry Criteria Exclusion|1|||
161888402|NCT00236899|584634596|FG003|Overall Study|Entry Criteria Exclusion|0|||
161888403|NCT00236899|584634593|FG000|Overall Study|Protocol Violation|1|||
161888404|NCT00236899|584634594|FG001|Overall Study|Protocol Violation|0|||
161888405|NCT00236899|584634595|FG002|Overall Study|Protocol Violation|0|||
161888406|NCT00236899|584634596|FG003|Overall Study|Protocol Violation|0|||
161888407|NCT00236899|584634593|FG000|Overall Study|Withdrawal by Subject|6|||
162037813|NCT00417482|585196050|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
162037814|NCT00417482|585196051|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
161888408|NCT00236899|584634594|FG001|Overall Study|Withdrawal by Subject|4|||
161888409|NCT00236899|584634595|FG002|Overall Study|Withdrawal by Subject|5|||
161888410|NCT00236899|584634596|FG003|Overall Study|Withdrawal by Subject|2|||
161888411|NCT00236899|584634593|FG000|Overall Study|Physician Decision|7|||
161888412|NCT00236899|584634594|FG001|Overall Study|Physician Decision|8|||
161888413|NCT00236899|584634595|FG002|Overall Study|Physician Decision|7|||
161888414|NCT00236899|584634596|FG003|Overall Study|Physician Decision|6|||
161888415|NCT00236899|584634593|FG000|Overall Study|Satisfactory Response|2|||
161888416|NCT00236899|584634594|FG001|Overall Study|Satisfactory Response|0|||
161888417|NCT00236899|584634595|FG002|Overall Study|Satisfactory Response|0|||
161888418|NCT00236899|584634596|FG003|Overall Study|Satisfactory Response|1|||
161888419|NCT00236899|584634593|FG000|Overall Study|Lack of Efficacy|18|||
161888420|NCT00236899|584634594|FG001|Overall Study|Lack of Efficacy|18|||
161888421|NCT00236899|584634595|FG002|Overall Study|Lack of Efficacy|25|||
161888422|NCT00236899|584634596|FG003|Overall Study|Lack of Efficacy|23|||
161888423|NCT02565706|584634597|FG000|Overall Study|Withdrawal by Subject|5|||
161888424|NCT02565706|584634598|FG001|Overall Study|Withdrawal by Subject|7|||
162037815|NCT00417482|585196049|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
162037816|NCT00417482|585196050|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
162037817|NCT00417482|585196051|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
162037818|NCT00417482|585196049|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
162037819|NCT00417482|585196050|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
162037820|NCT00417482|585196051|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
162037821|NCT00417482|585196049|FG000|Phase B 1st 16 Weeks|Death|1|||
162037822|NCT00417482|585196050|FG001|Phase B 1st 16 Weeks|Death|0|||
162037823|NCT00417482|585196051|FG002|Phase B 1st 16 Weeks|Death|0|||
162037824|NCT00417482|585196049|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
162037825|NCT00417482|585196050|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
162037826|NCT00417482|585196051|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
162037827|NCT00417482|585196049|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
162037828|NCT00417482|585196050|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
162037829|NCT00417482|585196051|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
162037830|NCT00417482|585196049|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
162037831|NCT00417482|585196050|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
162037832|NCT00417482|585196051|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
162037833|NCT00417482|585196049|FG000|Phase B 2nd 16 Weeks|Death|1|||
162037834|NCT00417482|585196050|FG001|Phase B 2nd 16 Weeks|Death|1|||
162037835|NCT00417482|585196051|FG002|Phase B 2nd 16 Weeks|Death|0|||
162037836|NCT01323946|585196054|FG000|Overall Study|Lost to Follow-up|0|||
162037837|NCT01323946|585196055|FG001|Overall Study|Lost to Follow-up|1|||
162037838|NCT01323946|585196056|FG002|Overall Study|Lost to Follow-up|0|||
162037839|NCT01323946|585196054|FG000|Overall Study|Parents refused the last blood draw|1|||
162037840|NCT01323946|585196055|FG001|Overall Study|Parents refused the last blood draw|0|||
162037841|NCT01323946|585196056|FG002|Overall Study|Parents refused the last blood draw|0|||
162037842|NCT01323946|585196054|FG000|Overall Study|Withdrawal by Subject|2|||
162037843|NCT01323946|585196055|FG001|Overall Study|Withdrawal by Subject|2|||
162037844|NCT01323946|585196056|FG002|Overall Study|Withdrawal by Subject|0|||
162037845|NCT00251004|585196060|FG000|Overall Study|Withdrawal by Subject|23|||
162037846|NCT00251004|585196061|FG001|Overall Study|Withdrawal by Subject|16|||
162037847|NCT00251004|585196062|FG002|Overall Study|Withdrawal by Subject|14|||
162037848|NCT00251004|585196060|FG000|Overall Study|Death|9|||
162037849|NCT00251004|585196061|FG001|Overall Study|Death|10|||
162037850|NCT00251004|585196062|FG002|Overall Study|Death|8|||
162037851|NCT00251004|585196060|FG000|Overall Study|Lost to Follow-up|1|||
162037852|NCT00251004|585196061|FG001|Overall Study|Lost to Follow-up|2|||
162037853|NCT00251004|585196062|FG002|Overall Study|Lost to Follow-up|1|||
162037854|NCT00251004|585196060|FG000|Overall Study|Graft Loss|12|||
162037855|NCT00251004|585196061|FG001|Overall Study|Graft Loss|13|||
162037856|NCT00251004|585196062|FG002|Overall Study|Graft Loss|8|||
162037857|NCT01562873|585196063|FG000|Overall Study|Disease Progression per RECIST|10|||
162037858|NCT01562873|585196064|FG001|Overall Study|Disease Progression per RECIST|0|||
162037859|NCT01562873|585196063|FG000|Overall Study|Adverse Event|1|||
162037860|NCT01562873|585196064|FG001|Overall Study|Adverse Event|0|||
162037861|NCT01562873|585196063|FG000|Overall Study|Clinical Disease Progression|9|||
162037862|NCT01562873|585196064|FG001|Overall Study|Clinical Disease Progression|0|||
162037863|NCT01562873|585196063|FG000|Overall Study|Clinical PD and adverse event|1|||
162037864|NCT01562873|585196064|FG001|Overall Study|Clinical PD and adverse event|0|||
162037865|NCT03370289|585196067|FG000|Overall Study|Screen Failure|1|||
162037866|NCT03370289|585196067|FG000|Overall Study|Sample Size Sufficient|4|||
162037867|NCT01484938|585196068|FG000|Overall Study|Adverse Event|2|||
162037868|NCT01484938|585196068|FG000|Overall Study|Lost to Follow-up|1|||
162037869|NCT01484938|585196068|FG000|Overall Study|Noncompliance|1|||
162037870|NCT02140775|585196070|FG000|Overall Study|Withdrawal by Subject|30|||
162037871|NCT02140775|585196071|FG001|Overall Study|Withdrawal by Subject|7|||
162037872|NCT00938964|585196073|FG000|Overall Study|Death|3|||
162037873|NCT00938964|585196074|FG001|Overall Study|Death|3|||
162037874|NCT00938964|585196073|FG000|Overall Study|Lost to Follow-up|2|||
162037875|NCT00938964|585196074|FG001|Overall Study|Lost to Follow-up|3|||
162037876|NCT00938964|585196073|FG000|Overall Study|Withdrawal by Subject|22|||
162037877|NCT00938964|585196074|FG001|Overall Study|Withdrawal by Subject|18|||
161888425|NCT02565706|584634599|FG002|Overall Study|Withdrawal by Subject|7|||
162037878|NCT00938964|585196073|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
162037879|NCT00938964|585196074|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
162037880|NCT01858636|585196075|FG000|Overall Study|No Device Deployment Attempted|24|||
162037881|NCT01858636|585196075|FG000|Overall Study|Physician Decision|1|||
162037882|NCT01858636|585196075|FG000|Overall Study|Death|1|||
162037883|NCT01858636|585196075|FG000|Overall Study|Lost to Follow-up|1|||
162037884|NCT01858636|585196075|FG000|Overall Study|Withdrawal by Subject|1|||
162037885|NCT01227564|585196081|FG000|Overall Study|No Longer Willing to Participate|4|||
162037886|NCT01227564|585196082|FG001|Overall Study|No Longer Willing to Participate|2|||
162037887|NCT01227564|585196083|FG002|Overall Study|No Longer Willing to Participate|5|||
162037888|NCT01227564|585196081|FG000|Overall Study|Participant moved to another town|0|||
162037889|NCT01227564|585196082|FG001|Overall Study|Participant moved to another town|0|||
161888426|NCT02565706|584634600|FG003|Overall Study|Withdrawal by Subject|11|||
162037890|NCT01227564|585196083|FG002|Overall Study|Participant moved to another town|1|||
162037891|NCT00999921|585196098|FG000|Overall Study|Lost to Follow-up|10|||
162037892|NCT00999921|585196099|FG001|Overall Study|Lost to Follow-up|19|||
162037893|NCT04650854|585196100|FG000|Overall Study|Adverse Event|1|||
162037894|NCT04650854|585196101|FG001|Overall Study|Adverse Event|12|||
161888427|NCT02565706|584634597|FG000|Overall Study|Lost to Follow-up|72|||
161888428|NCT02565706|584634598|FG001|Overall Study|Lost to Follow-up|75|||
161888429|NCT02565706|584634599|FG002|Overall Study|Lost to Follow-up|82|||
161888430|NCT02565706|584634600|FG003|Overall Study|Lost to Follow-up|74|||
161888431|NCT00568334|584634601|FG000|Overall Study|Withdrawal by Subject|0|||
161888432|NCT00568334|584634602|FG001|Overall Study|Withdrawal by Subject|1|||
161888433|NCT00568334|584634601|FG000|Overall Study|Lost to Follow-up|1|||
161888434|NCT00568334|584634602|FG001|Overall Study|Lost to Follow-up|0|||
161888435|NCT01897571|584634603|FG000|Overall Study|Lost to Follow-up|3|||
161888436|NCT01897571|584634604|FG001|Overall Study|Lost to Follow-up|0|||
161888437|NCT01897571|584634605|FG002|Overall Study|Lost to Follow-up|0|||
161888438|NCT01897571|584634606|FG003|Overall Study|Lost to Follow-up|0|||
161888439|NCT01897571|584634607|FG004|Overall Study|Lost to Follow-up|2|||
161888440|NCT01897571|584634608|FG005|Overall Study|Lost to Follow-up|0|||
161888441|NCT01897571|584634609|FG006|Overall Study|Lost to Follow-up|0|||
161888442|NCT01897571|584634610|FG007|Overall Study|Lost to Follow-up|0|||
161888443|NCT01897571|584634611|FG008|Overall Study|Lost to Follow-up|1|||
161888444|NCT01897571|584634612|FG009|Overall Study|Lost to Follow-up|2|||
161888445|NCT01897571|584634613|FG010|Overall Study|Lost to Follow-up|4|||
161888446|NCT01897571|584634603|FG000|Overall Study|Withdrawal by Subject|0|||
161888447|NCT01897571|584634604|FG001|Overall Study|Withdrawal by Subject|0|||
161888448|NCT01897571|584634605|FG002|Overall Study|Withdrawal by Subject|0|||
161888449|NCT01897571|584634606|FG003|Overall Study|Withdrawal by Subject|0|||
161888450|NCT01897571|584634607|FG004|Overall Study|Withdrawal by Subject|0|||
161888451|NCT01897571|584634608|FG005|Overall Study|Withdrawal by Subject|0|||
161888452|NCT01897571|584634609|FG006|Overall Study|Withdrawal by Subject|0|||
161888453|NCT01897571|584634610|FG007|Overall Study|Withdrawal by Subject|1|||
161888454|NCT01897571|584634611|FG008|Overall Study|Withdrawal by Subject|4|||
161888455|NCT01897571|584634612|FG009|Overall Study|Withdrawal by Subject|3|||
161888456|NCT01897571|584634613|FG010|Overall Study|Withdrawal by Subject|1|||
161888457|NCT01897571|584634603|FG000|Overall Study|Other|1|||
161888458|NCT01897571|584634604|FG001|Overall Study|Other|0|||
161888459|NCT01897571|584634605|FG002|Overall Study|Other|0|||
161888460|NCT01897571|584634606|FG003|Overall Study|Other|3|||
161888461|NCT01897571|584634607|FG004|Overall Study|Other|3|||
161888462|NCT01897571|584634608|FG005|Overall Study|Other|4|||
161888463|NCT01897571|584634609|FG006|Overall Study|Other|7|||
161888464|NCT01897571|584634610|FG007|Overall Study|Other|0|||
161888465|NCT01897571|584634611|FG008|Overall Study|Other|0|||
161888466|NCT01897571|584634612|FG009|Overall Study|Other|0|||
161888467|NCT01897571|584634613|FG010|Overall Study|Other|0|||
161888468|NCT01897571|584634603|FG000|Overall Study|Enrolled in rollover study|0|||
161888469|NCT01897571|584634604|FG001|Overall Study|Enrolled in rollover study|0|||
161888470|NCT01897571|584634605|FG002|Overall Study|Enrolled in rollover study|0|||
161888471|NCT01897571|584634606|FG003|Overall Study|Enrolled in rollover study|0|||
161888472|NCT01897571|584634607|FG004|Overall Study|Enrolled in rollover study|0|||
161888473|NCT01897571|584634608|FG005|Overall Study|Enrolled in rollover study|0|||
161888474|NCT01897571|584634609|FG006|Overall Study|Enrolled in rollover study|0|||
161888475|NCT01897571|584634610|FG007|Overall Study|Enrolled in rollover study|9|||
161888476|NCT01897571|584634611|FG008|Overall Study|Enrolled in rollover study|7|||
161888477|NCT01897571|584634612|FG009|Overall Study|Enrolled in rollover study|9|||
161888478|NCT01897571|584634613|FG010|Overall Study|Enrolled in rollover study|1|||
161888479|NCT01897571|584634603|FG000|Overall Study|Death|2|||
161888480|NCT01897571|584634604|FG001|Overall Study|Death|2|||
161888481|NCT01897571|584634605|FG002|Overall Study|Death|3|||
161888482|NCT01897571|584634606|FG003|Overall Study|Death|6|||
161888483|NCT01897571|584634607|FG004|Overall Study|Death|7|||
161888484|NCT01897571|584634608|FG005|Overall Study|Death|9|||
162037895|NCT04650854|585196102|FG002|Overall Study|Adverse Event|14|||
161888485|NCT01897571|584634609|FG006|Overall Study|Death|5|||
161888486|NCT01897571|584634610|FG007|Overall Study|Death|22|||
161888487|NCT01897571|584634611|FG008|Overall Study|Death|23|||
161888488|NCT01897571|584634612|FG009|Overall Study|Death|129|||
162037896|NCT04650854|585196100|FG000|Overall Study|Lack of Efficacy|1|||
162037897|NCT04650854|585196101|FG001|Overall Study|Lack of Efficacy|3|||
162037898|NCT04650854|585196102|FG002|Overall Study|Lack of Efficacy|6|||
161888489|NCT01897571|584634613|FG010|Overall Study|Death|59|||
161888490|NCT01797094|584634614|FG000|Overall Study|Adverse Event|1|||
161888491|NCT01797094|584634615|FG001|Overall Study|Adverse Event|1|||
161888492|NCT01797094|584634614|FG000|Overall Study|Personal Reasons|4|||
161888493|NCT01797094|584634615|FG001|Overall Study|Personal Reasons|0|||
161888494|NCT01797094|584634614|FG000|Overall Study|Protocol Violation|0|||
161888495|NCT01797094|584634615|FG001|Overall Study|Protocol Violation|1|||
161888496|NCT01797094|584634614|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161888497|NCT01797094|584634615|FG001|Overall Study|Other Miscellaneous Reasons|0|||
162037899|NCT04650854|585196100|FG000|Overall Study|Lost to Follow-up|1|||
161888498|NCT01281956|584634619|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
161888499|NCT01281956|584634620|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
161888500|NCT03677934|584634635|FG000|Overall Study|Adverse Event|1|||
161888501|NCT03677934|584634636|FG001|Overall Study|Adverse Event|1|||
161888502|NCT03677934|584634635|FG000|Overall Study|Death|8|||
161888503|NCT03677934|584634636|FG001|Overall Study|Death|4|||
161888504|NCT03677934|584634635|FG000|Overall Study|Lost to Follow-up|3|||
161888505|NCT03677934|584634636|FG001|Overall Study|Lost to Follow-up|0|||
161888506|NCT03677934|584634635|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161888507|NCT03677934|584634636|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161888508|NCT03677934|584634635|FG000|Overall Study|Physician Decision|0|||
161888509|NCT03677934|584634636|FG001|Overall Study|Physician Decision|1|||
161888510|NCT03677934|584634635|FG000|Overall Study|Withdrawal by Subject|1|||
161888511|NCT03677934|584634636|FG001|Overall Study|Withdrawal by Subject|7|||
161888512|NCT04769739|584634637|FG000|Overall Study|Colorectal cancer obstruction|2|||
161888513|NCT04769739|584634638|FG001|Overall Study|Colorectal cancer obstruction|0|||
161888514|NCT04769739|584634639|FG002|Overall Study|Colorectal cancer obstruction|0|||
161994271|NCT00940498|585027499|FG001|Overall Study|Not treated due to disease related pain|0|||
161994272|NCT00940498|585027500|FG002|Overall Study|Not treated due to disease related pain|0|||
161994273|NCT00940498|585027501|FG003|Overall Study|Not treated due to disease related pain|0|||
161994274|NCT00940498|585027502|FG004|Overall Study|Not treated due to disease related pain|1|||
161994275|NCT00940498|585027503|FG005|Overall Study|Not treated due to disease related pain|0|||
161994276|NCT00940498|585027504|FG006|Overall Study|Not treated due to disease related pain|0|||
161994277|NCT00940498|585027505|FG007|Overall Study|Not treated due to disease related pain|0|||
161994278|NCT00900029|585027506|FG000|Overall Study|Lost to Follow-up|0|||
161994279|NCT00900029|585027507|FG001|Overall Study|Lost to Follow-up|2|||
161994280|NCT00900029|585027508|FG002|Overall Study|Lost to Follow-up|1|||
161994281|NCT00900029|585027509|FG003|Overall Study|Lost to Follow-up|4|||
161994282|NCT00900029|585027510|FG004|Overall Study|Lost to Follow-up|4|||
161994283|NCT00900029|585027506|FG000|Overall Study|Withdrawal by Subject|2|||
161994284|NCT00900029|585027507|FG001|Overall Study|Withdrawal by Subject|2|||
161994285|NCT00900029|585027508|FG002|Overall Study|Withdrawal by Subject|1|||
161994286|NCT00900029|585027509|FG003|Overall Study|Withdrawal by Subject|1|||
161994287|NCT00900029|585027510|FG004|Overall Study|Withdrawal by Subject|1|||
161994288|NCT00900029|585027506|FG000|Overall Study|Adverse Event|0|||
161994289|NCT00900029|585027507|FG001|Overall Study|Adverse Event|0|||
161994290|NCT00900029|585027508|FG002|Overall Study|Adverse Event|1|||
161994291|NCT00900029|585027509|FG003|Overall Study|Adverse Event|1|||
161994292|NCT00900029|585027510|FG004|Overall Study|Adverse Event|1|||
161994293|NCT00900029|585027506|FG000|Overall Study|Death|1|||
161994294|NCT00900029|585027507|FG001|Overall Study|Death|0|||
161994295|NCT00900029|585027508|FG002|Overall Study|Death|0|||
161994296|NCT00900029|585027509|FG003|Overall Study|Death|1|||
161994297|NCT00900029|585027510|FG004|Overall Study|Death|0|||
161994298|NCT02709330|585027511|FG000|Overall Study|Death|5|||
161994299|NCT02709330|585027512|FG001|Overall Study|Death|0|||
161994300|NCT02709330|585027511|FG000|Overall Study|Lost to Follow-up|2|||
161994301|NCT02709330|585027512|FG001|Overall Study|Lost to Follow-up|0|||
161994302|NCT02709330|585027511|FG000|Overall Study|Physician Decision|2|||
161994303|NCT02709330|585027512|FG001|Overall Study|Physician Decision|0|||
161994304|NCT02709330|585027511|FG000|Overall Study|Withdrawal by Subject|4|||
161994305|NCT02709330|585027512|FG001|Overall Study|Withdrawal by Subject|0|||
161994306|NCT02587819|585027515|FG000|Overall Study|Adverse Event|1|||
161994307|NCT02587819|585027515|FG000|Overall Study|Lost to Follow-up|1|||
161994308|NCT01525615|585030394|FG000|Overall Study|Adverse Event|11|||
161994309|NCT01525615|585030395|FG001|Overall Study|Adverse Event|7|||
161994310|NCT01525615|585030396|FG002|Overall Study|Adverse Event|5|||
161994311|NCT01525615|585030394|FG000|Overall Study|Lost to Follow-up|1|||
161994312|NCT01525615|585030395|FG001|Overall Study|Lost to Follow-up|0|||
161994313|NCT01525615|585030396|FG002|Overall Study|Lost to Follow-up|0|||
161994314|NCT01525615|585030394|FG000|Overall Study|Withdrawal by Subject|1|||
161994315|NCT01525615|585030395|FG001|Overall Study|Withdrawal by Subject|0|||
161994316|NCT01525615|585030396|FG002|Overall Study|Withdrawal by Subject|0|||
161994317|NCT01525615|585030394|FG000|Overall Study|Other reason not described above|1|||
161994318|NCT01525615|585030395|FG001|Overall Study|Other reason not described above|0|||
161888515|NCT04769739|584634640|FG003|Overall Study|Colorectal cancer obstruction|0|||
161994319|NCT01525615|585030396|FG002|Overall Study|Other reason not described above|1|||
161994320|NCT00859547|585030397|FG000|Overall Study|Lost to Follow-up|1|||
161994321|NCT00859547|585030397|FG000|Overall Study|Parent withdrew consent|1|||
161994322|NCT00217425|585030398|FG000|Overall Study|Never started treatment|2|||
161888516|NCT04769739|584634637|FG000|Overall Study|Failed cecal intubation|1|||
161888517|NCT04769739|584634638|FG001|Overall Study|Failed cecal intubation|0|||
161888518|NCT04769739|584634639|FG002|Overall Study|Failed cecal intubation|0|||
161994323|NCT00217425|585030398|FG000|Overall Study|Patient ineligible|5|||
161994324|NCT00217425|585030398|FG000|Overall Study|Lack of Efficacy|13|||
161994325|NCT00217425|585030398|FG000|Overall Study|Adverse Event|8|||
161994326|NCT00217425|585030398|FG000|Overall Study|Withdrawal by Subject|4|||
162037900|NCT04650854|585196101|FG001|Overall Study|Lost to Follow-up|1|||
162037901|NCT04650854|585196102|FG002|Overall Study|Lost to Follow-up|0|||
162037902|NCT04650854|585196100|FG000|Overall Study|Withdrawal by Subject|2|||
162037903|NCT04650854|585196101|FG001|Overall Study|Withdrawal by Subject|17|||
162037904|NCT04650854|585196102|FG002|Overall Study|Withdrawal by Subject|9|||
162037905|NCT04650854|585196100|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
162037906|NCT04650854|585196101|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
162037907|NCT04650854|585196102|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
162037908|NCT04650854|585196100|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
162037909|NCT04650854|585196101|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
162037910|NCT04650854|585196102|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
162037911|NCT04650854|585196100|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
162037912|NCT04650854|585196101|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
162037913|NCT04650854|585196102|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
162037914|NCT04650854|585196100|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
162037915|NCT04650854|585196101|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
162037916|NCT04650854|585196102|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
162037917|NCT04650854|585196100|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
162037918|NCT04650854|585196101|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
162037919|NCT04650854|585196102|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
162037920|NCT04650854|585196100|FG000|Overall Study|Use of Rescue Medication|0|||
162037921|NCT04650854|585196101|FG001|Overall Study|Use of Rescue Medication|0|||
162037922|NCT04650854|585196102|FG002|Overall Study|Use of Rescue Medication|1|||
162037923|NCT04650854|585196100|FG000|Overall Study|Last Treatment Per Sponsor|0|||
162037924|NCT04650854|585196101|FG001|Overall Study|Last Treatment Per Sponsor|0|||
162037925|NCT04650854|585196102|FG002|Overall Study|Last Treatment Per Sponsor|2|||
162037926|NCT04650854|585196100|FG000|Overall Study|Rescue Medication|0|||
162037927|NCT04650854|585196101|FG001|Overall Study|Rescue Medication|0|||
162037928|NCT04650854|585196102|FG002|Overall Study|Rescue Medication|1|||
162037929|NCT04650854|585196100|FG000|Overall Study|Participant Want to Start a Family|0|||
162037930|NCT04650854|585196101|FG001|Overall Study|Participant Want to Start a Family|0|||
162037931|NCT04650854|585196102|FG002|Overall Study|Participant Want to Start a Family|1|||
162037932|NCT04650854|585196100|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
162037933|NCT04650854|585196101|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
162037934|NCT04650854|585196102|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
162037935|NCT04650854|585196100|FG000|Overall Study|Participant Screened For MG0020|0|||
162037936|NCT04650854|585196101|FG001|Overall Study|Participant Screened For MG0020|2|||
162037937|NCT04650854|585196102|FG002|Overall Study|Participant Screened For MG0020|3|||
162037938|NCT04650854|585196100|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
162037939|NCT04650854|585196101|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
162037940|NCT04650854|585196102|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
162037941|NCT04650854|585196100|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
162037942|NCT04650854|585196101|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
162037943|NCT04650854|585196102|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
162037944|NCT04650854|585196100|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
162037945|NCT04650854|585196101|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
162037946|NCT04650854|585196102|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
162037947|NCT04650854|585196100|FG000|Overall Study|End Of Study|0|||
162037948|NCT04650854|585196101|FG001|Overall Study|End Of Study|2|||
162037949|NCT04650854|585196102|FG002|Overall Study|End Of Study|1|||
162037950|NCT04650854|585196100|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
162037951|NCT04650854|585196101|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
162037952|NCT04650854|585196102|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
162037953|NCT04650854|585196100|FG000|Overall Study|Participant Received Rescue Medication|0|||
162037954|NCT04650854|585196101|FG001|Overall Study|Participant Received Rescue Medication|1|||
162037955|NCT04650854|585196102|FG002|Overall Study|Participant Received Rescue Medication|0|||
162037956|NCT04650854|585196100|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
162037957|NCT04650854|585196101|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
162037958|NCT04650854|585196102|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
162037959|NCT04650854|585196100|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
162037960|NCT04650854|585196101|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
162048498|NCT04545060|585233343|FG001|Overall Study|Lost to Follow-up|13|||
161888519|NCT04769739|584634640|FG003|Overall Study|Failed cecal intubation|1|||
161888520|NCT04769739|584634637|FG000|Overall Study|Poor bowel preparation|0|||
161888521|NCT04769739|584634638|FG001|Overall Study|Poor bowel preparation|0|||
161888522|NCT04769739|584634639|FG002|Overall Study|Poor bowel preparation|0|||
161888523|NCT04769739|584634640|FG003|Overall Study|Poor bowel preparation|1|||
161888524|NCT02227368|584636203|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
161888525|NCT02227368|584636204|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
162037961|NCT04650854|585196102|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
162037962|NCT04650854|585196100|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
162037963|NCT04650854|585196101|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
162037964|NCT04650854|585196102|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
162037965|NCT04650854|585196100|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
162037966|NCT04650854|585196101|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
162037967|NCT04650854|585196102|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
162037968|NCT04650854|585196100|FG000|Overall Study|Enrollment Cup|0|||
162037969|NCT04650854|585196101|FG001|Overall Study|Enrollment Cup|0|||
162037970|NCT04650854|585196102|FG002|Overall Study|Enrollment Cup|1|||
162037971|NCT00704808|585196117|FG000|Overall Study|Discontinued prior to starting treatment|14|||
162037972|NCT00704808|585196117|FG000|Overall Study|Death|7|||
162037973|NCT00704808|585196117|FG000|Overall Study|Tumor progression|80|||
162037974|NCT00704808|585196117|FG000|Overall Study|Patient's decision|11|||
162037975|NCT00704808|585196117|FG000|Overall Study|Early therapy discontinuation|16|||
162037976|NCT00704808|585196117|FG000|Overall Study|Adverse Event|1|||
162037977|NCT00704808|585196117|FG000|Overall Study|Lost to Follow-up|1|||
162037978|NCT00704808|585196117|FG000|Overall Study|Treatment change|1|||
162037979|NCT01982331|585196121|FG000|Received Vaccination 2|Adverse Event|1|||
162037980|NCT01982331|585196122|FG001|Received Vaccination 2|Adverse Event|2|||
162037981|NCT01982331|585196121|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
162037982|NCT01982331|585196122|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
162037983|NCT01982331|585196121|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
162037984|NCT01982331|585196122|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
162037985|NCT00744471|585196124|FG000|Overall Study|Randomized but not treated|1|||
162037986|NCT00744471|585196125|FG001|Overall Study|Randomized but not treated|1|||
162037987|NCT00744471|585196126|FG002|Overall Study|Randomized but not treated|4|||
162037988|NCT00744471|585196127|FG003|Overall Study|Randomized but not treated|0|||
162037989|NCT00744471|585196124|FG000|Overall Study|Death|0|||
162037990|NCT00744471|585196125|FG001|Overall Study|Death|0|||
162037991|NCT00744471|585196126|FG002|Overall Study|Death|0|||
162037992|NCT00744471|585196127|FG003|Overall Study|Death|1|||
162037993|NCT00744471|585196124|FG000|Overall Study|Adverse Event|6|||
162037994|NCT00744471|585196125|FG001|Overall Study|Adverse Event|7|||
162037995|NCT00744471|585196126|FG002|Overall Study|Adverse Event|5|||
162037996|NCT00744471|585196127|FG003|Overall Study|Adverse Event|9|||
162037997|NCT00744471|585196124|FG000|Overall Study|Withdrawal by Subject|9|||
162037998|NCT00744471|585196125|FG001|Overall Study|Withdrawal by Subject|9|||
162037999|NCT00744471|585196126|FG002|Overall Study|Withdrawal by Subject|15|||
162038000|NCT00744471|585196127|FG003|Overall Study|Withdrawal by Subject|12|||
162038001|NCT00744471|585196124|FG000|Overall Study|Protocol Violation|1|||
162038002|NCT00744471|585196125|FG001|Overall Study|Protocol Violation|4|||
162038003|NCT00744471|585196126|FG002|Overall Study|Protocol Violation|1|||
162038004|NCT00744471|585196127|FG003|Overall Study|Protocol Violation|2|||
162038005|NCT00744471|585196124|FG000|Overall Study|Entered extension study|41|||
162038006|NCT00744471|585196125|FG001|Overall Study|Entered extension study|84|||
162038007|NCT00744471|585196126|FG002|Overall Study|Entered extension study|100|||
162038008|NCT00744471|585196127|FG003|Overall Study|Entered extension study|91|||
162038009|NCT00744471|585196124|FG000|Overall Study|Other|2|||
162038010|NCT00744471|585196125|FG001|Overall Study|Other|3|||
162038011|NCT00744471|585196126|FG002|Overall Study|Other|6|||
162038012|NCT00744471|585196127|FG003|Overall Study|Other|2|||
162038013|NCT00744471|585196124|FG000|Overall Study|Lack of Efficacy|83|||
162038014|NCT00744471|585196125|FG001|Overall Study|Lack of Efficacy|37|||
161888526|NCT02227368|584636203|FG000|Overall Study|Lost to Follow-up|1|||
161888527|NCT02227368|584636204|FG001|Overall Study|Lost to Follow-up|0|||
162038015|NCT00744471|585196126|FG002|Overall Study|Lack of Efficacy|19|||
162038016|NCT00744471|585196127|FG003|Overall Study|Lack of Efficacy|31|||
162038017|NCT00744471|585196124|FG000|Overall Study|Lost to Follow-up|0|||
162038018|NCT00744471|585196125|FG001|Overall Study|Lost to Follow-up|0|||
162038019|NCT00744471|585196126|FG002|Overall Study|Lost to Follow-up|2|||
162038020|NCT00744471|585196127|FG003|Overall Study|Lost to Follow-up|0|||
162038021|NCT01280955|585196130|FG000|Overall Study|Death|2|||
162038022|NCT01280955|585196130|FG000|Overall Study|Withdrawal by Subject|1|||
162038023|NCT03119701|585196138|FG000|6-day Dosing|Death|4|||
162038024|NCT03119701|585196139|FG001|6-day Dosing|Death|1|||
162038025|NCT03119701|585196138|FG000|6-day Dosing|Adverse Event|3|||
162038026|NCT03119701|585196139|FG001|6-day Dosing|Adverse Event|0|||
162038027|NCT03119701|585196138|FG000|6-day Dosing|Physician Decision|0|||
162038028|NCT03119701|585196139|FG001|6-day Dosing|Physician Decision|1|||
162038029|NCT03119701|585196138|FG000|6-day Dosing|Withdrawal by Subject|0|||
162038030|NCT03119701|585196139|FG001|6-day Dosing|Withdrawal by Subject|1|||
162038031|NCT03119701|585196138|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
162038032|NCT03119701|585196139|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
162038033|NCT00406718|585196145|FG000|Overall Study|Withdrawal by Subject|2|||
162038034|NCT00406718|585196146|FG001|Overall Study|Withdrawal by Subject|9|||
162038035|NCT00406718|585196147|FG002|Overall Study|Withdrawal by Subject|4|||
162038036|NCT00406718|585196145|FG000|Overall Study|Lost to Follow-up|2|||
162038037|NCT00406718|585196146|FG001|Overall Study|Lost to Follow-up|5|||
162038038|NCT00406718|585196147|FG002|Overall Study|Lost to Follow-up|4|||
162038039|NCT01888003|585196150|FG000|Overall Study|Study Terminated|5|||
162038040|NCT01888003|585196151|FG001|Overall Study|Study Terminated|6|||
162038041|NCT01888003|585196152|FG002|Overall Study|Study Terminated|40|||
162038042|NCT03187756|585196153|FG000|Overall Study|Termination of study|4|||
162038043|NCT03172910|585197920|FG000|Overall Study|Adverse Event|0|||
162038044|NCT03172910|585197921|FG001|Overall Study|Adverse Event|0|||
162038045|NCT03172910|585197922|FG002|Overall Study|Adverse Event|0|||
162038046|NCT03172910|585197923|FG003|Overall Study|Adverse Event|0|||
162038047|NCT03172910|585197924|FG004|Overall Study|Adverse Event|1|||
162038048|NCT01659658|585197925|FG000|Overall Study|Withdrawal by Patient|18|||
162038049|NCT01659658|585197926|FG001|Overall Study|Withdrawal by Patient|4|||
162038050|NCT01659658|585197927|FG002|Overall Study|Withdrawal by Patient|2|||
162038051|NCT01659658|585197928|FG003|Overall Study|Withdrawal by Patient|0|||
162038052|NCT01659658|585197929|FG004|Overall Study|Withdrawal by Patient|11|||
162038053|NCT01659658|585197925|FG000|Overall Study|Study Terminated by Sponsor|9|||
162038054|NCT01659658|585197926|FG001|Overall Study|Study Terminated by Sponsor|7|||
162038055|NCT01659658|585197927|FG002|Overall Study|Study Terminated by Sponsor|0|||
162038056|NCT01659658|585197928|FG003|Overall Study|Study Terminated by Sponsor|1|||
162038057|NCT01659658|585197929|FG004|Overall Study|Study Terminated by Sponsor|4|||
162038058|NCT01659658|585197925|FG000|Overall Study|Reason not Specified|61|||
162038059|NCT01659658|585197926|FG001|Overall Study|Reason not Specified|15|||
162038060|NCT01659658|585197927|FG002|Overall Study|Reason not Specified|8|||
162038061|NCT01659658|585197928|FG003|Overall Study|Reason not Specified|1|||
162038062|NCT01659658|585197929|FG004|Overall Study|Reason not Specified|34|||
162038063|NCT01659658|585197925|FG000|Overall Study|Lost to Follow-up|2|||
162038064|NCT01659658|585197926|FG001|Overall Study|Lost to Follow-up|0|||
162038065|NCT01659658|585197927|FG002|Overall Study|Lost to Follow-up|0|||
162038066|NCT01659658|585197928|FG003|Overall Study|Lost to Follow-up|0|||
162038067|NCT01659658|585197929|FG004|Overall Study|Lost to Follow-up|0|||
162038068|NCT00122278|585197932|FG000|Overall Study|Lost to Follow-up|2|||
162038069|NCT00122278|585197933|FG001|Overall Study|Lost to Follow-up|0|||
162038070|NCT01002482|585197934|FG000|Overall Study|Withdrawal by Subject|14|||
162038071|NCT01002482|585197935|FG001|Overall Study|Withdrawal by Subject|21|||
162038072|NCT01002482|585197934|FG000|Overall Study|Included twice|1|||
162038073|NCT01002482|585197935|FG001|Overall Study|Included twice|0|||
162038074|NCT04879225|585197936|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
162038075|NCT04879225|585197936|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
162038076|NCT00736957|585197939|FG000|Overall Study|Adverse Event|43|||
162038077|NCT00736957|585197939|FG000|Overall Study|Withdrawal by Subject|49|||
162038078|NCT00736957|585197939|FG000|Overall Study|violation of eligibility criteria|2|||
162038079|NCT00736957|585197939|FG000|Overall Study|did not attend hospital appointments|1|||
162038080|NCT00736957|585197939|FG000|Overall Study|not eligible for Treatment Period I|22|||
162038081|NCT00736957|585197939|FG000|Overall Study|Physician Decision|5|||
162038082|NCT03646643|585197940|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
162038083|NCT03646643|585197941|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
162038084|NCT03646643|585197940|FG000|Overall Study|Lost to Follow-up|0|||
162038085|NCT03646643|585197941|FG001|Overall Study|Lost to Follow-up|1|||
162038086|NCT02806973|585197942|FG000|Period 1|Withdrawal by Subject|0|||
162038087|NCT02806973|585197943|FG001|Period 1|Withdrawal by Subject|2|||
162038088|NCT02806973|585197944|FG002|Period 1|Withdrawal by Subject|1|||
162038089|NCT02806973|585197945|FG003|Period 1|Withdrawal by Subject|1|||
161888528|NCT02227368|584636203|FG000|Overall Study|Adverse Event|1|||
161888529|NCT02227368|584636204|FG001|Overall Study|Adverse Event|0|||
161888530|NCT03046056|584636206|FG000|Overall Study|Non-responder at Week 10|6|||
161888531|NCT03046056|584636207|FG001|Overall Study|Non-responder at Week 10|6|||
162038090|NCT02806973|585197942|FG000|Period 1|Adverse Event|0|||
161888532|NCT03046056|584636208|FG002|Overall Study|Non-responder at Week 10|4|||
162038091|NCT02806973|585197943|FG001|Period 1|Adverse Event|0|||
162038092|NCT02806973|585197944|FG002|Period 1|Adverse Event|0|||
162038093|NCT02806973|585197945|FG003|Period 1|Adverse Event|1|||
162038094|NCT02806973|585197942|FG000|Period 3|Withdrawal by Subject|0|||
162038095|NCT02806973|585197943|FG001|Period 3|Withdrawal by Subject|0|||
162038096|NCT02806973|585197944|FG002|Period 3|Withdrawal by Subject|0|||
162038097|NCT02806973|585197945|FG003|Period 3|Withdrawal by Subject|3|||
161888533|NCT03046056|584636206|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
161888534|NCT03046056|584636207|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
162038098|NCT02806973|585197942|FG000|Period 3|Adverse Event|0|||
162038099|NCT02806973|585197943|FG001|Period 3|Adverse Event|0|||
162038100|NCT02806973|585197944|FG002|Period 3|Adverse Event|1|||
162038101|NCT02806973|585197945|FG003|Period 3|Adverse Event|0|||
162038102|NCT04209426|585197948|FG000|Overall Study|Lost to Follow-up|3|||
162038103|NCT04209426|585197949|FG001|Overall Study|Lost to Follow-up|2|||
162038104|NCT04060862|585197950|FG000|Overall Study|Symptomatic Deterioration|1|||
162038105|NCT04060862|585197950|FG000|Overall Study|Un-specified|6|||
162038106|NCT04060862|585197950|FG000|Overall Study|Progressive disease|12|||
162038107|NCT04060862|585197950|FG000|Overall Study|Physician Decision|1|||
162038108|NCT03343067|585197953|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
162038109|NCT03343067|585197954|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
162038110|NCT03343067|585197955|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
162038111|NCT00542451|585197956|FG000|Overall Study|Adverse Event|31|||
162038112|NCT00542451|585197956|FG000|Overall Study|Withdrawal by Subject|30|||
162038113|NCT00542451|585197956|FG000|Overall Study|Physician Decision|4|||
162038114|NCT00542451|585197956|FG000|Overall Study|Recurrent disease|1|||
161888535|NCT03046056|584636208|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
161888536|NCT03046056|584636206|FG000|Overall Study|Adverse Event|1|||
161888537|NCT03046056|584636207|FG001|Overall Study|Adverse Event|5|||
161888538|NCT03046056|584636208|FG002|Overall Study|Adverse Event|0|||
162038115|NCT00542451|585197956|FG000|Overall Study|unknown reason|1|||
161888539|NCT03046056|584636206|FG000|Overall Study|Non-compliance With Study Drug|0|||
161888540|NCT03046056|584636207|FG001|Overall Study|Non-compliance With Study Drug|0|||
161888541|NCT03046056|584636208|FG002|Overall Study|Non-compliance With Study Drug|2|||
161888542|NCT03046056|584636206|FG000|Overall Study|Protocol Violation|1|||
161888543|NCT03046056|584636207|FG001|Overall Study|Protocol Violation|1|||
161888544|NCT03046056|584636208|FG002|Overall Study|Protocol Violation|0|||
161888545|NCT03046056|584636206|FG000|Overall Study|Investigator's Discretion|0|||
161888546|NCT03046056|584636207|FG001|Overall Study|Investigator's Discretion|1|||
161888547|NCT03046056|584636208|FG002|Overall Study|Investigator's Discretion|0|||
161888548|NCT03046056|584636206|FG000|Overall Study|Withdrew Consent|1|||
161888549|NCT03046056|584636207|FG001|Overall Study|Withdrew Consent|0|||
161888550|NCT03046056|584636208|FG002|Overall Study|Withdrew Consent|0|||
161888551|NCT03089853|584636209|FG000|Overall Study|Lost to Follow-up|2|||
161888552|NCT03089853|584636210|FG001|Overall Study|Lost to Follow-up|1|||
161888553|NCT01317004|584636211|FG000|Overall Study|Withdrawal by Subject|1|||
161888554|NCT01317004|584636212|FG001|Overall Study|Withdrawal by Subject|4|||
161888555|NCT01317004|584636211|FG000|Overall Study|Protocol Violation|0|||
161888556|NCT01317004|584636212|FG001|Overall Study|Protocol Violation|2|||
161888557|NCT01317004|584636211|FG000|Overall Study|Adverse Event|3|||
161888558|NCT01317004|584636212|FG001|Overall Study|Adverse Event|3|||
161888559|NCT01344759|584636215|FG000|Overall Study|Patients failed to reach sedation level|0|||
161888560|NCT01344759|584636216|FG001|Overall Study|Patients failed to reach sedation level|2|||
161888561|NCT01890759|584636217|FG000|Overall Study|Protocol Violation|0|||
161888562|NCT01890759|584636218|FG001|Overall Study|Protocol Violation|2|||
161888563|NCT01890759|584636217|FG000|Overall Study|Lost to Follow-up|0|||
161888564|NCT01890759|584636218|FG001|Overall Study|Lost to Follow-up|2|||
161888565|NCT01890759|584636217|FG000|Overall Study|Withdrawal by Subject|2|||
161888566|NCT01890759|584636218|FG001|Overall Study|Withdrawal by Subject|8|||
161888567|NCT04114656|584636219|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
161888568|NCT04114656|584636220|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
161888569|NCT04114656|584636219|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
161888570|NCT04114656|584636220|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
161888571|NCT04114656|584636219|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
161888572|NCT04114656|584636220|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
161888573|NCT04114656|584636219|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
161888574|NCT04114656|584636220|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
161888575|NCT04114656|584636219|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
161888576|NCT04114656|584636220|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
161888577|NCT00703326|584636221|FG000|Overall Study|Lost to Follow-up|47|||
161888578|NCT00703326|584636222|FG001|Overall Study|Lost to Follow-up|18|||
161888579|NCT00703326|584636221|FG000|Overall Study|Withdrawal by Subject|54|||
161888580|NCT00703326|584636222|FG001|Overall Study|Withdrawal by Subject|20|||
161888581|NCT00703326|584636221|FG000|Overall Study|Adverse Event|1|||
161888582|NCT00703326|584636222|FG001|Overall Study|Adverse Event|0|||
161888583|NCT02661061|584636224|FG000|Overall Study|Lack of Efficacy|1|||
161888584|NCT02661061|584636225|FG001|Overall Study|Lack of Efficacy|1|||
161888585|NCT02661061|584636224|FG000|Overall Study|Withdrawal by Subject|1|||
161888586|NCT02661061|584636225|FG001|Overall Study|Withdrawal by Subject|1|||
161888587|NCT01393106|584636226|FG000|Overall Study|Adverse Event|3|||
161888588|NCT01393106|584636226|FG000|Overall Study|Withdrawal by Subject|1|||
161888589|NCT01393106|584636226|FG000|Overall Study|Lack of Efficacy|1|||
161888590|NCT02732015|584636227|FG000|Overall Study|Lost to Follow-up|0|||
161888591|NCT02732015|584636228|FG001|Overall Study|Lost to Follow-up|1|||
161888592|NCT03052920|584636229|FG000|Overall Study|Withdrawal by Subject|1|||
161888593|NCT01980628|584636230|FG000|Overall Study|Adverse Event|12|||
161888594|NCT01980628|584636230|FG000|Overall Study|Physician Decision|5|||
162038116|NCT00542451|585197956|FG000|Overall Study|Death|2|||
162038117|NCT00542451|585197956|FG000|Overall Study|Lost to Follow-up|10|||
162038118|NCT00116168|585197959|FG000|Overall Study|Lost to Follow-up|6|||
162038119|NCT00116168|585197960|FG001|Overall Study|Lost to Follow-up|5|||
162038120|NCT00116168|585197961|FG002|Overall Study|Lost to Follow-up|0|||
162038121|NCT00116168|585197962|FG003|Overall Study|Lost to Follow-up|0|||
162038122|NCT05153473|585197963|FG000|Overall Study|Death|46|||
162038123|NCT05153473|585197963|FG000|Overall Study|Lost to Follow-up|3|||
162038124|NCT00245583|585197965|FG000|Overall Study|Lost to Follow-up|1|||
162038125|NCT00245583|585197966|FG001|Overall Study|Lost to Follow-up|5|||
162038126|NCT00245583|585197965|FG000|Overall Study|Adverse Event|2|||
162038127|NCT00245583|585197966|FG001|Overall Study|Adverse Event|1|||
162038128|NCT00245583|585197965|FG000|Overall Study|Lack of Efficacy|1|||
162038129|NCT00245583|585197966|FG001|Overall Study|Lack of Efficacy|0|||
162038130|NCT00245583|585197965|FG000|Overall Study|Withdrawal by Subject|2|||
162038131|NCT00245583|585197966|FG001|Overall Study|Withdrawal by Subject|3|||
162038132|NCT01309893|585197967|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
162038133|NCT01309893|585197968|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
162038134|NCT01309893|585197967|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
162038135|NCT01309893|585197968|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
162038136|NCT02017171|585197969|FG000|Overall Study|Death|10|||
162038137|NCT02017171|585197970|FG001|Overall Study|Death|4|||
162038138|NCT02017171|585197969|FG000|Overall Study|Withdrawal by Subject|23|||
162038139|NCT02017171|585197970|FG001|Overall Study|Withdrawal by Subject|17|||
162038140|NCT02017171|585197969|FG000|Overall Study|Lost to Follow-up|21|||
162038141|NCT02017171|585197970|FG001|Overall Study|Lost to Follow-up|20|||
162038142|NCT02017171|585197969|FG000|Overall Study|ESKD|6|||
162038143|NCT02017171|585197970|FG001|Overall Study|ESKD|2|||
162038144|NCT02017171|585197969|FG000|Overall Study|Miscellaneous|2|||
162038145|NCT02017171|585197970|FG001|Overall Study|Miscellaneous|3|||
162038146|NCT01172275|585197973|FG000|Overall Study|Lost to Follow-up|1|||
162038147|NCT01172275|585197974|FG001|Overall Study|Lost to Follow-up|0|||
162038148|NCT01172275|585197973|FG000|Overall Study|Protocol Violation|1|||
162038149|NCT01172275|585197974|FG001|Overall Study|Protocol Violation|0|||
162038150|NCT02862600|585197975|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
162038151|NCT02862600|585197975|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
162038152|NCT02862600|585197975|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
162038153|NCT02862600|585197975|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
162038154|NCT00194675|585197976|FG000|Overall Study|Lost to Follow-up|1|||
162038155|NCT00194675|585197977|FG001|Overall Study|Lost to Follow-up|1|||
162038156|NCT00194675|585197976|FG000|Overall Study|lack of interest|1|||
162038157|NCT00194675|585197977|FG001|Overall Study|lack of interest|1|||
162038158|NCT00194675|585197976|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
162038159|NCT00194675|585197977|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
162038160|NCT00194675|585197976|FG000|Overall Study|Protocol Violation|1|||
162038161|NCT00194675|585197977|FG001|Overall Study|Protocol Violation|0|||
162038162|NCT00194675|585197976|FG000|Overall Study|Death|1|||
162038163|NCT00194675|585197977|FG001|Overall Study|Death|0|||
162038164|NCT00667420|585197979|FG000|Overall Study|Adverse Event|2|||
162038165|NCT00667420|585197979|FG000|Overall Study|Lack of Efficacy|5|||
162038166|NCT00667420|585197979|FG000|Overall Study|Physician Decision|1|||
162038167|NCT00667420|585197979|FG000|Overall Study|Withdrawal by Subject|2|||
162038168|NCT04437368|585197983|FG000|Overall Study|Death|3|||
162038169|NCT04437368|585197984|FG001|Overall Study|Death|0|||
162038170|NCT04437368|585197985|FG002|Overall Study|Death|2|||
162038171|NCT04437368|585197983|FG000|Overall Study|Study terminated by sponsor|16|||
162038172|NCT04437368|585197984|FG001|Overall Study|Study terminated by sponsor|1|||
162038173|NCT04437368|585197985|FG002|Overall Study|Study terminated by sponsor|25|||
162038174|NCT04437368|585197983|FG000|Overall Study|Withdrawal by Subject|4|||
162038175|NCT04437368|585197984|FG001|Overall Study|Withdrawal by Subject|0|||
162038176|NCT04437368|585197985|FG002|Overall Study|Withdrawal by Subject|3|||
162038177|NCT04437368|585197983|FG000|Overall Study|Sponsor instructions|23|||
162038178|NCT04437368|585197984|FG001|Overall Study|Sponsor instructions|0|||
162038179|NCT04437368|585197985|FG002|Overall Study|Sponsor instructions|0|||
162038180|NCT00095628|585197986|FG000|Overall Study|Disease progression prior to treatment|1|||
162038181|NCT04271280|585197987|FG000|Overall Study|Lost to Follow-up|300|||
161888595|NCT01980628|584636230|FG000|Overall Study|Withdrawal by Subject|4|||
161888596|NCT01980628|584636230|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
161888597|NCT05437640|584636233|FG000|Washout (1 Week)|Adverse Event|1|||
161888598|NCT05437640|584636234|FG001|Washout (1 Week)|Adverse Event|0|||
161888599|NCT02474355|584636235|FG000|Overall Study|Other|43|||
161888600|NCT02474355|584636235|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
161888601|NCT02474355|584636235|FG000|Overall Study|Lost to Follow-up|98|||
161888602|NCT02474355|584636235|FG000|Overall Study|Withdrawal by Subject|124|||
161888603|NCT02474355|584636235|FG000|Overall Study|Death|1361|||
162038182|NCT04271280|585197987|FG000|Overall Study|Death|153|||
162038183|NCT04271280|585197987|FG000|Overall Study|Withdrawal of consent by patient|59|||
162038184|NCT04271280|585197987|FG000|Overall Study|Other|51|||
162038185|NCT04271280|585197987|FG000|Overall Study|No end of study information|42|||
162038186|NCT00495131|585197988|FG000|Overall Study|Adverse Event|6|||
162038187|NCT00495131|585197989|FG001|Overall Study|Adverse Event|2|||
162038188|NCT00495131|585197988|FG000|Overall Study|Lack of Efficacy|0|||
162038189|NCT00495131|585197989|FG001|Overall Study|Lack of Efficacy|2|||
162038190|NCT00495131|585197988|FG000|Overall Study|Lost to Follow-up|0|||
162038191|NCT00495131|585197989|FG001|Overall Study|Lost to Follow-up|2|||
162038192|NCT00495131|585197988|FG000|Overall Study|Withdrawal by Subject|1|||
162038193|NCT00495131|585197989|FG001|Overall Study|Withdrawal by Subject|0|||
162038194|NCT03224546|585197990|FG000|Overall Study|Lost to Follow-up|9|||
162038195|NCT03224546|585197991|FG001|Overall Study|Lost to Follow-up|8|||
162038196|NCT03224546|585197992|FG002|Overall Study|Lost to Follow-up|3|||
162038197|NCT03224546|585197990|FG000|Overall Study|Withdrawal by Subject|7|||
162038198|NCT03224546|585197991|FG001|Overall Study|Withdrawal by Subject|14|||
162038199|NCT03224546|585197992|FG002|Overall Study|Withdrawal by Subject|12|||
162038200|NCT01539317|585197995|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
162038201|NCT01539317|585197996|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
162038202|NCT04223232|585197997|FG000|Overall Study|Withdrawal by Subject|1|||
162038203|NCT00364130|585197998|FG000|Intervention Period|Lost to Follow-up|4|||
162038204|NCT00364130|585197999|FG001|Intervention Period|Lost to Follow-up|3|||
162038205|NCT00364130|585197998|FG000|Intervention Period|Pregnancy|1|||
162038206|NCT00364130|585197999|FG001|Intervention Period|Pregnancy|0|||
162038207|NCT00364130|585197998|FG000|Intervention Period|Withdrawal by Subject|4|||
162038208|NCT00364130|585197999|FG001|Intervention Period|Withdrawal by Subject|5|||
162038209|NCT00364130|585197998|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
162038210|NCT00364130|585197999|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
161994327|NCT00217425|585030398|FG000|Overall Study|Other complicating disease|1|||
161994328|NCT00217425|585030398|FG000|Overall Study|Other|4|||
161994329|NCT00330759|585030399|FG000|Overall Study|Death|316|||
161994330|NCT00330759|585030400|FG001|Overall Study|Death|310|||
161994331|NCT00330759|585030399|FG000|Overall Study|Disease progression|104|||
161994332|NCT00330759|585030400|FG001|Overall Study|Disease progression|126|||
161994333|NCT00330759|585030399|FG000|Overall Study|Withdrawal by Subject|143|||
161994334|NCT00330759|585030400|FG001|Overall Study|Withdrawal by Subject|124|||
161994335|NCT00330759|585030399|FG000|Overall Study|Adverse Event|48|||
161994336|NCT00330759|585030400|FG001|Overall Study|Adverse Event|36|||
161994337|NCT00330759|585030399|FG000|Overall Study|Participant request|31|||
161994338|NCT00330759|585030400|FG001|Overall Study|Participant request|22|||
161994339|NCT00330759|585030399|FG000|Overall Study|Lost to Follow-up|16|||
161994340|NCT00330759|585030400|FG001|Overall Study|Lost to Follow-up|22|||
161994341|NCT00330759|585030399|FG000|Overall Study|Noncompliance|15|||
161994342|NCT00330759|585030400|FG001|Overall Study|Noncompliance|17|||
161994343|NCT00330759|585030399|FG000|Overall Study|Physician Decision|1|||
161994344|NCT00330759|585030400|FG001|Overall Study|Physician Decision|2|||
161994345|NCT00330759|585030399|FG000|Overall Study|Protocol deviation|0|||
161994346|NCT00330759|585030400|FG001|Overall Study|Protocol deviation|2|||
161994347|NCT00330759|585030399|FG000|Overall Study|Ineligibility determined|2|||
161994348|NCT00330759|585030400|FG001|Overall Study|Ineligibility determined|1|||
161994349|NCT00330759|585030399|FG000|Overall Study|Other|36|||
161994350|NCT00330759|585030400|FG001|Overall Study|Other|44|||
161994351|NCT00671034|585030401|FG000|Overall Study|Adverse Event|5|||
161994352|NCT00671034|585030402|FG001|Overall Study|Adverse Event|7|||
161994353|NCT00671034|585030403|FG002|Overall Study|Adverse Event|1|||
161994354|NCT00671034|585030401|FG000|Overall Study|Death|3|||
161994355|NCT00671034|585030402|FG001|Overall Study|Death|2|||
161994356|NCT00671034|585030403|FG002|Overall Study|Death|1|||
161994357|NCT00671034|585030401|FG000|Overall Study|Physician Decision|12|||
161994358|NCT00671034|585030402|FG001|Overall Study|Physician Decision|4|||
161994359|NCT00671034|585030403|FG002|Overall Study|Physician Decision|5|||
161994360|NCT00671034|585030401|FG000|Overall Study|VHR ALL feature|8|||
161994361|NCT00671034|585030402|FG001|Overall Study|VHR ALL feature|3|||
161994362|NCT00671034|585030403|FG002|Overall Study|VHR ALL feature|5|||
161994363|NCT00671034|585030401|FG000|Overall Study|Refusal|5|||
161994364|NCT00671034|585030402|FG001|Overall Study|Refusal|3|||
161994365|NCT00671034|585030403|FG002|Overall Study|Refusal|5|||
161994366|NCT00671034|585030401|FG000|Overall Study|includes Alternative therapy, etc.|6|||
161994367|NCT00671034|585030402|FG001|Overall Study|includes Alternative therapy, etc.|1|||
161994368|NCT00671034|585030403|FG002|Overall Study|includes Alternative therapy, etc.|7|||
161994369|NCT02380287|585030404|FG000|Overall Study|Adverse Event|0|||
161994370|NCT02380287|585030405|FG001|Overall Study|Adverse Event|0|||
161994371|NCT02380287|585030406|FG002|Overall Study|Adverse Event|1|||
162038211|NCT00901927|585198009|FG000|Overall Study|Lack of Efficacy|1|||
162038212|NCT00901927|585198009|FG000|Overall Study|Protocol Violation|3|||
162038213|NCT00901927|585198009|FG000|Overall Study|Withdrawal by Subject|2|||
162038214|NCT00586846|585198010|FG000|Overall Study|Physician Decision|1|||
162038215|NCT00586846|585198010|FG000|Overall Study|Death|1|||
162038216|NCT00586846|585198010|FG000|Overall Study|Evaluable for Toxicity Only|4|||
162038217|NCT01702571|585198019|FG000|Overall Study|Death|1067|||
161994372|NCT02380287|585030407|FG003|Overall Study|Adverse Event|0|||
161994373|NCT02380287|585030408|FG004|Overall Study|Adverse Event|0|||
161994374|NCT02380287|585030409|FG005|Overall Study|Adverse Event|0|||
161994375|NCT02380287|585030410|FG006|Overall Study|Adverse Event|0|||
161994376|NCT02380287|585030411|FG007|Overall Study|Adverse Event|0|||
161888604|NCT03015194|584636237|FG000|Overall Study|Death|10|||
161888605|NCT03015194|584636237|FG000|Overall Study|Withdrawal by Subject|2|||
161888606|NCT01698268|584636241|FG000|Overall Study|Physician Decision|2|||
161888607|NCT01698268|584636242|FG001|Overall Study|Physician Decision|1|||
161888608|NCT02263729|584636243|FG000|Overall Study|Lost to Follow-up|1|||
161888609|NCT02263729|584636244|FG001|Overall Study|Lost to Follow-up|1|||
161888610|NCT04591015|584636245|FG000|Overall Study|Death|6|||
161888611|NCT04591015|584636246|FG001|Overall Study|Death|4|||
161888612|NCT04591015|584636245|FG000|Overall Study|Withdrawal by Subject|6|||
161888613|NCT04591015|584636246|FG001|Overall Study|Withdrawal by Subject|3|||
161888614|NCT04591015|584636245|FG000|Overall Study|Lost to Follow-up|16|||
161888615|NCT04591015|584636246|FG001|Overall Study|Lost to Follow-up|11|||
161888616|NCT02509078|584636247|FG000|Overall Study|Protocol Violation|1|||
161888617|NCT02509078|584636248|FG001|Overall Study|Protocol Violation|1|||
161888618|NCT00631163|584636250|FG000|Number of Participants in Year 1|Adverse Event|12|||
161888619|NCT00631163|584636250|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
161888620|NCT00631163|584636250|FG000|Number of Participants in Year 1|Death|6|||
161888621|NCT00631163|584636250|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
161888622|NCT00631163|584636250|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
161888623|NCT00631163|584636250|FG000|Number of Participants in Year 1|Administrative problems|6|||
161888624|NCT00631163|584636250|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
161888625|NCT00631163|584636250|FG000|Number of Participants in Year 2|Adverse Event|1|||
161888626|NCT00631163|584636250|FG000|Number of Participants in Year 2|Protocol Violation|1|||
161888627|NCT00631163|584636250|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
161888628|NCT02290925|584636251|FG000|First Period of Three Months|Lost to Follow-up|2|||
161888629|NCT02290925|584636252|FG001|First Period of Three Months|Lost to Follow-up|1|||
161888630|NCT02290925|584636251|FG000|First Period of Three Months|Death|1|||
161888631|NCT02290925|584636252|FG001|First Period of Three Months|Death|0|||
161888632|NCT02290925|584636251|FG000|First Period of Three Months|Insulin Started|1|||
161888633|NCT02290925|584636252|FG001|First Period of Three Months|Insulin Started|1|||
161888634|NCT02290925|584636251|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
161888635|NCT02290925|584636252|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
161994377|NCT04473963|585030428|FG000|Overall Study|Withdrawal by Subject|1|||
161994378|NCT04473963|585030429|FG001|Overall Study|Withdrawal by Subject|1|||
161994379|NCT04473963|585030430|FG002|Overall Study|Withdrawal by Subject|0|||
161994380|NCT04473963|585030428|FG000|Overall Study|Not inducible in AF|0|||
161994381|NCT04473963|585030429|FG001|Overall Study|Not inducible in AF|0|||
161994382|NCT04473963|585030430|FG002|Overall Study|Not inducible in AF|2|||
161994383|NCT04685798|585030431|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
161994384|NCT03906071|585030436|FG000|Overall Study|Death|180|||
161994385|NCT03906071|585030437|FG001|Overall Study|Death|185|||
161994386|NCT03906071|585030436|FG000|Overall Study|Lost to Follow-up|3|||
161994387|NCT03906071|585030437|FG001|Overall Study|Lost to Follow-up|3|||
161994388|NCT03906071|585030436|FG000|Overall Study|Withdrawal by Subject|15|||
161994389|NCT03906071|585030437|FG001|Overall Study|Withdrawal by Subject|27|||
161994390|NCT03906071|585030436|FG000|Overall Study|Other|2|||
161994391|NCT03906071|585030437|FG001|Overall Study|Other|1|||
161994392|NCT02152761|585030438|FG000|Epoch: Treatment Epoch|Technical problems|0|||
161994393|NCT02152761|585030439|FG001|Epoch: Treatment Epoch|Technical problems|0|||
161994394|NCT02152761|585030440|FG002|Epoch: Treatment Epoch|Technical problems|0|||
161994395|NCT02152761|585030441|FG003|Epoch: Treatment Epoch|Technical problems|1|||
161994396|NCT02152761|585030438|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
161994397|NCT02152761|585030439|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
161994398|NCT02152761|585030440|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
161994399|NCT02152761|585030441|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
161994400|NCT02152761|585030438|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
161994401|NCT02152761|585030439|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
161994402|NCT02152761|585030440|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
161994403|NCT02152761|585030441|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
161994404|NCT02152761|585030438|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
161994405|NCT02152761|585030439|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
161994406|NCT02152761|585030440|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
161994407|NCT02152761|585030441|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
161994408|NCT02152761|585030438|FG000|Epoch: Treatment Epoch|Death|0|||
161888636|NCT02290925|584636251|FG000|Second Period of 3 Months|insulin started|0|||
161888637|NCT02290925|584636252|FG001|Second Period of 3 Months|insulin started|1|||
161888638|NCT00388297|584636266|FG000|Overall Study|Lost to Follow-up|16|||
161994409|NCT02152761|585030439|FG001|Epoch: Treatment Epoch|Death|3|||
161994410|NCT02152761|585030440|FG002|Epoch: Treatment Epoch|Death|1|||
161888639|NCT00388297|584636267|FG001|Overall Study|Lost to Follow-up|12|||
161888640|NCT00388297|584636268|FG002|Overall Study|Lost to Follow-up|11|||
161888641|NCT00388297|584636269|FG003|Overall Study|Lost to Follow-up|8|||
161888642|NCT00316914|584636271|FG000|Overall Study|Withdrawal by Subject|5|||
161888643|NCT00316914|584636272|FG001|Overall Study|Withdrawal by Subject|3|||
161994411|NCT02152761|585030441|FG003|Epoch: Treatment Epoch|Death|0|||
161888644|NCT00316914|584636271|FG000|Overall Study|Adverse Event|8|||
161888645|NCT00316914|584636272|FG001|Overall Study|Adverse Event|7|||
161888646|NCT00316914|584636271|FG000|Overall Study|Other Problems|6|||
161888647|NCT00316914|584636272|FG001|Overall Study|Other Problems|11|||
161888648|NCT00316914|584636271|FG000|Overall Study|Missing end of treatment documentation|14|||
161888649|NCT00316914|584636272|FG001|Overall Study|Missing end of treatment documentation|15|||
161888650|NCT02284568|584636273|FG000|Overall Study|Adverse Event|2|||
161888651|NCT02284568|584636274|FG001|Overall Study|Adverse Event|9|||
161888652|NCT02284568|584636275|FG002|Overall Study|Adverse Event|4|||
161888653|NCT02284568|584636273|FG000|Overall Study|Withdrawal by Subject|22|||
161888654|NCT02284568|584636274|FG001|Overall Study|Withdrawal by Subject|21|||
161888655|NCT02284568|584636275|FG002|Overall Study|Withdrawal by Subject|1|||
161888656|NCT02284568|584636273|FG000|Overall Study|Noncompliance with study drug admin|1|||
161888657|NCT02284568|584636274|FG001|Overall Study|Noncompliance with study drug admin|2|||
161888658|NCT02284568|584636275|FG002|Overall Study|Noncompliance with study drug admin|0|||
161888659|NCT02284568|584636273|FG000|Overall Study|Noncompliance|1|||
162038218|NCT01702571|585198020|FG001|Overall Study|Death|76|||
162038219|NCT01702571|585198019|FG000|Overall Study|Lost to Follow-up|144|||
162038220|NCT01702571|585198020|FG001|Overall Study|Lost to Follow-up|10|||
162038221|NCT01702571|585198019|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
162038222|NCT01702571|585198020|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
162038223|NCT01702571|585198019|FG000|Overall Study|Investigator Decision|5|||
162038224|NCT01702571|585198020|FG001|Overall Study|Investigator Decision|0|||
162038225|NCT01702571|585198019|FG000|Overall Study|Not Classifiable|1|||
161888660|NCT02284568|584636274|FG001|Overall Study|Noncompliance|0|||
161888661|NCT02284568|584636275|FG002|Overall Study|Noncompliance|0|||
161888662|NCT02284568|584636273|FG000|Overall Study|Protocol Violation|0|||
161888663|NCT02284568|584636274|FG001|Overall Study|Protocol Violation|1|||
161888664|NCT02284568|584636275|FG002|Overall Study|Protocol Violation|0|||
161888665|NCT02284568|584636273|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
161994412|NCT02152761|585030438|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
161994413|NCT02152761|585030439|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
161994414|NCT02152761|585030440|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
161994415|NCT02152761|585030441|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
161994416|NCT02152761|585030438|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
161994417|NCT02152761|585030439|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
161994418|NCT02152761|585030440|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
161994419|NCT02152761|585030441|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
161994420|NCT02152761|585030438|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
161994421|NCT02152761|585030439|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
161994422|NCT02152761|585030440|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
161994423|NCT02152761|585030441|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
161994424|NCT02152761|585030438|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
161994425|NCT02152761|585030439|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
161994426|NCT02152761|585030440|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
161994427|NCT02152761|585030441|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
161994428|NCT02152761|585030438|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
161994429|NCT02152761|585030439|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
161994430|NCT02152761|585030440|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
161994431|NCT02152761|585030441|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
161994432|NCT01797263|585030442|FG000|Overall Study|Withdrawal by Subject|21|||
161994433|NCT01797263|585030443|FG001|Overall Study|Withdrawal by Subject|25|||
161994434|NCT01797263|585030442|FG000|Overall Study|Death|1|||
161994435|NCT01797263|585030443|FG001|Overall Study|Death|0|||
161994436|NCT01797263|585030442|FG000|Overall Study|Lost to Follow-up|15|||
161994437|NCT01797263|585030443|FG001|Overall Study|Lost to Follow-up|15|||
161994438|NCT01550757|585030444|FG000|Overall Study|Lost to Follow-up|21|||
161994439|NCT01550757|585030445|FG001|Overall Study|Lost to Follow-up|14|||
161994440|NCT01550757|585030446|FG002|Overall Study|Lost to Follow-up|42|||
161994441|NCT01550757|585030447|FG003|Overall Study|Lost to Follow-up|53|||
161994442|NCT01550757|585030444|FG000|Overall Study|Withdrawal by Subject|2|||
161994443|NCT01550757|585030445|FG001|Overall Study|Withdrawal by Subject|0|||
161994444|NCT01550757|585030446|FG002|Overall Study|Withdrawal by Subject|3|||
161994445|NCT01550757|585030447|FG003|Overall Study|Withdrawal by Subject|1|||
161994446|NCT02342223|585030448|FG000|Overall Study|Lost to Follow-up|1|||
162038226|NCT01702571|585198020|FG001|Overall Study|Not Classifiable|0|||
162038227|NCT01702571|585198019|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
161888666|NCT02284568|584636274|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
161888667|NCT02284568|584636275|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
161888668|NCT02284568|584636273|FG000|Overall Study|Lost to Follow-up|0|||
162038228|NCT01702571|585198020|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
161888669|NCT02284568|584636274|FG001|Overall Study|Lost to Follow-up|3|||
161888670|NCT02284568|584636275|FG002|Overall Study|Lost to Follow-up|0|||
161888671|NCT02284568|584636273|FG000|Overall Study|Lack of Efficacy|4|||
161888672|NCT02284568|584636274|FG001|Overall Study|Lack of Efficacy|7|||
161888673|NCT02284568|584636275|FG002|Overall Study|Lack of Efficacy|0|||
161888674|NCT02284568|584636273|FG000|Overall Study|Other|1|||
161888675|NCT02284568|584636274|FG001|Overall Study|Other|2|||
161888676|NCT02284568|584636275|FG002|Overall Study|Other|0|||
161888677|NCT02284568|584636273|FG000|Overall Study|Withdrew before taking study drug|0|||
161888678|NCT02284568|584636274|FG001|Overall Study|Withdrew before taking study drug|1|||
161888679|NCT02284568|584636275|FG002|Overall Study|Withdrew before taking study drug|0|||
161888680|NCT00980174|584636279|FG000|Overall Study|Withdrawal by Subject|1|||
161888681|NCT00980174|584636280|FG001|Overall Study|Withdrawal by Subject|4|||
161888682|NCT00980174|584636279|FG000|Overall Study|Adverse Event|0|||
161888683|NCT00980174|584636280|FG001|Overall Study|Adverse Event|3|||
161888684|NCT00980174|584636279|FG000|Overall Study|Ineligibility determined|2|||
161888685|NCT00980174|584636280|FG001|Overall Study|Ineligibility determined|1|||
161888686|NCT00980174|584636279|FG000|Overall Study|Death|1|||
161888687|NCT00980174|584636280|FG001|Overall Study|Death|1|||
161888688|NCT00980174|584636279|FG000|Overall Study|Other|0|||
161888689|NCT00980174|584636280|FG001|Overall Study|Other|1|||
161888690|NCT01546038|584636282|FG000|Overall Study|Death|15|||
161888691|NCT01546038|584636283|FG001|Overall Study|Death|6|||
161888692|NCT01546038|584636284|FG002|Overall Study|Death|4|||
161888693|NCT01546038|584636285|FG003|Overall Study|Death|2|||
161888694|NCT01546038|584636286|FG004|Overall Study|Death|9|||
161888695|NCT01546038|584636287|FG005|Overall Study|Death|3|||
161888696|NCT01546038|584636288|FG006|Overall Study|Death|46|||
161888697|NCT01546038|584636289|FG007|Overall Study|Death|76|||
161888698|NCT01546038|584636290|FG008|Overall Study|Death|39|||
161888699|NCT01546038|584636282|FG000|Overall Study|Lost to Follow-up|0|||
161888700|NCT01546038|584636283|FG001|Overall Study|Lost to Follow-up|0|||
161888701|NCT01546038|584636284|FG002|Overall Study|Lost to Follow-up|0|||
161888702|NCT01546038|584636285|FG003|Overall Study|Lost to Follow-up|0|||
161888703|NCT01546038|584636286|FG004|Overall Study|Lost to Follow-up|1|||
161888704|NCT01546038|584636287|FG005|Overall Study|Lost to Follow-up|0|||
161888705|NCT01546038|584636288|FG006|Overall Study|Lost to Follow-up|2|||
161888706|NCT01546038|584636289|FG007|Overall Study|Lost to Follow-up|1|||
161888707|NCT01546038|584636290|FG008|Overall Study|Lost to Follow-up|0|||
161888708|NCT01546038|584636282|FG000|Overall Study|Withdrawal by Subject|1|||
161888709|NCT01546038|584636283|FG001|Overall Study|Withdrawal by Subject|0|||
161888710|NCT01546038|584636284|FG002|Overall Study|Withdrawal by Subject|0|||
161888711|NCT01546038|584636285|FG003|Overall Study|Withdrawal by Subject|1|||
161888712|NCT01546038|584636286|FG004|Overall Study|Withdrawal by Subject|0|||
161888713|NCT01546038|584636287|FG005|Overall Study|Withdrawal by Subject|1|||
161888714|NCT01546038|584636288|FG006|Overall Study|Withdrawal by Subject|3|||
161888715|NCT01546038|584636289|FG007|Overall Study|Withdrawal by Subject|3|||
161888716|NCT01546038|584636290|FG008|Overall Study|Withdrawal by Subject|1|||
161888717|NCT01546038|584636282|FG000|Overall Study|: Randomized, not treated|0|||
161888718|NCT01546038|584636283|FG001|Overall Study|: Randomized, not treated|0|||
161888719|NCT01546038|584636284|FG002|Overall Study|: Randomized, not treated|0|||
161888720|NCT01546038|584636285|FG003|Overall Study|: Randomized, not treated|0|||
161888721|NCT01546038|584636286|FG004|Overall Study|: Randomized, not treated|0|||
162038229|NCT01702571|585198019|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
162038230|NCT01702571|585198020|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
162038231|NCT01702571|585198019|FG000|Overall Study|Progressive Disease|3|||
162038232|NCT01702571|585198020|FG001|Overall Study|Progressive Disease|0|||
162038233|NCT01702571|585198019|FG000|Overall Study|Protocol Violation|2|||
162038234|NCT01702571|585198020|FG001|Overall Study|Protocol Violation|0|||
162038235|NCT01702571|585198019|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
162038236|NCT01702571|585198020|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
162038237|NCT01702571|585198019|FG000|Overall Study|Termination By Sponsor|4|||
162038238|NCT01702571|585198020|FG001|Overall Study|Termination By Sponsor|0|||
162038239|NCT01702571|585198019|FG000|Overall Study|Withdrawal by Subject|177|||
162038240|NCT01702571|585198020|FG001|Overall Study|Withdrawal by Subject|29|||
162038241|NCT03004443|585198021|FG000|Overall Study|Pregnancy|0|||
162038242|NCT03004443|585198022|FG001|Overall Study|Pregnancy|1|||
161888722|NCT01546038|584636287|FG005|Overall Study|: Randomized, not treated|0|||
161888723|NCT01546038|584636288|FG006|Overall Study|: Randomized, not treated|2|||
161888724|NCT01546038|584636289|FG007|Overall Study|: Randomized, not treated|4|||
162038243|NCT00828854|585198023|FG000|Overall Study|Disease Progression|17|||
161888725|NCT01546038|584636290|FG008|Overall Study|: Randomized, not treated|3|||
161888726|NCT00424021|584636291|FG000|NCT00046319 Study Period|Adverse Event|1|||
161888727|NCT00424021|584636292|FG001|NCT00046319 Study Period|Adverse Event|0|||
161888728|NCT00424021|584636293|FG002|NCT00046319 Study Period|Adverse Event|1|||
161888729|NCT00424021|584636294|FG003|NCT00046319 Study Period|Adverse Event|1|||
161888730|NCT00424021|584636291|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
161888731|NCT00424021|584636292|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
161888732|NCT00424021|584636293|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
161888733|NCT00424021|584636294|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
161888734|NCT00424021|584636291|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
161888735|NCT00424021|584636292|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
161888736|NCT00424021|584636293|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
161888737|NCT00424021|584636294|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
161888738|NCT00424021|584636291|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
161888739|NCT00424021|584636292|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
161888740|NCT00424021|584636293|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
161888741|NCT00424021|584636294|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
161888742|NCT00424021|584636291|FG000|AMB-220-E Study Period|Adverse Event|1|||
161888743|NCT00424021|584636292|FG001|AMB-220-E Study Period|Adverse Event|1|||
161888744|NCT00424021|584636293|FG002|AMB-220-E Study Period|Adverse Event|3|||
161888745|NCT00424021|584636294|FG003|AMB-220-E Study Period|Adverse Event|7|||
161888746|NCT00424021|584636291|FG000|AMB-220-E Study Period|Death|0|||
161994447|NCT03018691|585030449|FG000|Overall Study|Adverse Event|1|||
161994448|NCT03018691|585030450|FG001|Overall Study|Adverse Event|1|||
161994449|NCT03018691|585030451|FG002|Overall Study|Adverse Event|4|||
161994450|NCT03018691|585030449|FG000|Overall Study|Lack of Efficacy|0|||
161994451|NCT03018691|585030450|FG001|Overall Study|Lack of Efficacy|0|||
161994452|NCT03018691|585030451|FG002|Overall Study|Lack of Efficacy|1|||
161994453|NCT03018691|585030449|FG000|Overall Study|Withdrawal by Subject|0|||
161994454|NCT03018691|585030450|FG001|Overall Study|Withdrawal by Subject|0|||
161994455|NCT03018691|585030451|FG002|Overall Study|Withdrawal by Subject|1|||
161994456|NCT03018691|585030449|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161994457|NCT03018691|585030450|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161994458|NCT03018691|585030451|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161994459|NCT03369418|585030452|FG000|Overall Study|Withdrawal by Subject|3|||
161994460|NCT03369418|585030453|FG001|Overall Study|Withdrawal by Subject|3|||
161994461|NCT01485094|585030454|FG000|Overall Study|Adverse Event|1|||
161994462|NCT01485094|585030455|FG001|Overall Study|Adverse Event|1|||
161994463|NCT01485094|585030456|FG002|Overall Study|Adverse Event|1|||
161994464|NCT01485094|585030454|FG000|Overall Study|Lost to Follow-up|1|||
161994465|NCT01485094|585030455|FG001|Overall Study|Lost to Follow-up|0|||
161994466|NCT01485094|585030456|FG002|Overall Study|Lost to Follow-up|0|||
161994467|NCT01485094|585030454|FG000|Overall Study|Withdrawal by Subject|1|||
161994468|NCT01485094|585030455|FG001|Overall Study|Withdrawal by Subject|1|||
161994469|NCT01485094|585030456|FG002|Overall Study|Withdrawal by Subject|0|||
161994470|NCT01426958|585030457|FG000|Overall Study|Adverse Event|2|||
161994471|NCT02859246|585030463|FG000|Overall Study|Screen fails|3|||
161994472|NCT02859246|585030463|FG000|Overall Study|Adverse Event|1|||
161994473|NCT02859246|585030463|FG000|Overall Study|Withdrawal by Subject|1|||
161994474|NCT05280717|585030464|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
161994475|NCT05280717|585030465|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
161994476|NCT05280717|585030466|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
161994477|NCT05280717|585030467|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
161994478|NCT05280717|585030468|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
161994479|NCT05280717|585030469|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
161994480|NCT05280717|585030470|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
161994481|NCT05280717|585030464|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
161994482|NCT05280717|585030465|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161994483|NCT05280717|585030466|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161994484|NCT05280717|585030467|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161994485|NCT05280717|585030468|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161994486|NCT05280717|585030469|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161994487|NCT05280717|585030470|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161994488|NCT05280717|585030464|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
161994489|NCT05280717|585030465|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
161994490|NCT05280717|585030466|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
161994491|NCT05280717|585030467|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
161994492|NCT05280717|585030468|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
161994493|NCT05280717|585030469|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
161994494|NCT05280717|585030470|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
161994495|NCT05280717|585030464|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
161994496|NCT05280717|585030465|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
161994497|NCT05280717|585030466|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
162038244|NCT00828854|585198023|FG000|Overall Study|Adverse Event|9|||
161888747|NCT00424021|584636292|FG001|AMB-220-E Study Period|Death|0|||
161888748|NCT00424021|584636293|FG002|AMB-220-E Study Period|Death|1|||
161888749|NCT00424021|584636294|FG003|AMB-220-E Study Period|Death|1|||
161994498|NCT05280717|585030467|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
161994499|NCT05280717|585030468|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
161994500|NCT05280717|585030469|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
161994501|NCT05280717|585030470|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
161994502|NCT05280717|585030464|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
161994503|NCT05280717|585030465|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
161994504|NCT05280717|585030466|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
161994505|NCT05280717|585030467|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
161994506|NCT05280717|585030468|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
161994507|NCT05280717|585030469|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
161994508|NCT05280717|585030470|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
161994509|NCT05280717|585030464|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
161994510|NCT05280717|585030465|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
161994511|NCT05280717|585030466|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
161994512|NCT05280717|585030467|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
161994513|NCT05280717|585030468|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
161994514|NCT05280717|585030469|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
161994515|NCT05280717|585030470|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
161994516|NCT00740584|585030473|FG000|Overall Study|Withdrawal by Subject|1|||
161994517|NCT00855816|585030474|FG000|Overall Study|Withdrawal by Subject|22|||
161994518|NCT00855816|585030475|FG001|Overall Study|Withdrawal by Subject|15|||
161994519|NCT00855816|585030474|FG000|Overall Study|Lost to Follow-up|3|||
161994520|NCT00855816|585030475|FG001|Overall Study|Lost to Follow-up|5|||
161994521|NCT00855816|585030474|FG000|Overall Study|Death|1|||
161994522|NCT00855816|585030475|FG001|Overall Study|Death|0|||
161994523|NCT00855816|585030474|FG000|Overall Study|Became ineligible|0|||
161994524|NCT00855816|585030475|FG001|Overall Study|Became ineligible|1|||
161994525|NCT00337207|585030482|FG000|Overall Study|Withdrawal by Subject|3|||
161994526|NCT03188432|585030483|FG000|Overall Study|Death|3|||
161994527|NCT03188432|585030483|FG000|Overall Study|Withdrawal by Subject|15|||
161994528|NCT03188432|585030483|FG000|Overall Study|Did not complete protocol treatment|9|||
161994529|NCT02562716|585030486|FG000|Overall Study|Adverse Event|7|||
161994530|NCT02562716|585030487|FG001|Overall Study|Adverse Event|14|||
161994531|NCT02562716|585030486|FG000|Overall Study|Withdrawal unrelated to AE|7|||
161994532|NCT02562716|585030487|FG001|Overall Study|Withdrawal unrelated to AE|1|||
161994533|NCT02562716|585030486|FG000|Overall Study|Progression|8|||
161994534|NCT02562716|585030487|FG001|Overall Study|Progression|10|||
161994535|NCT02562716|585030486|FG000|Overall Study|Death|2|||
161994536|NCT02562716|585030487|FG001|Overall Study|Death|1|||
161994537|NCT02562716|585030486|FG000|Overall Study|Not protocol specified|4|||
161994538|NCT02562716|585030487|FG001|Overall Study|Not protocol specified|2|||
161994539|NCT02753946|585030488|FG000|Overall Study|Adverse Event|7|||
161994540|NCT02753946|585030489|FG001|Overall Study|Adverse Event|6|||
161994541|NCT02753946|585030488|FG000|Overall Study|Withdrawal by Subject|6|||
161994542|NCT02753946|585030489|FG001|Overall Study|Withdrawal by Subject|1|||
161994543|NCT02753946|585030488|FG000|Overall Study|Lack of Efficacy|1|||
161994544|NCT02753946|585030489|FG001|Overall Study|Lack of Efficacy|0|||
161994545|NCT02753946|585030488|FG000|Overall Study|Physician Decision|0|||
161994546|NCT02753946|585030489|FG001|Overall Study|Physician Decision|2|||
161994547|NCT02175017|585030490|FG000|Overall Study|Did not receive the investigational product|1|||
161994548|NCT02175017|585030491|FG001|Overall Study|Did not receive the investigational product|2|||
161994549|NCT02175017|585030490|FG000|Overall Study|Withdrawal by Subject|6|||
161994550|NCT02175017|585030491|FG001|Overall Study|Withdrawal by Subject|3|||
161994551|NCT02175017|585030490|FG000|Overall Study|Met an exclusion criteria|0|||
161994552|NCT02175017|585030491|FG001|Overall Study|Met an exclusion criteria|1|||
161994553|NCT02175017|585030490|FG000|Overall Study|Adverse Event|3|||
161994554|NCT02175017|585030491|FG001|Overall Study|Adverse Event|10|||
161994555|NCT02175017|585030490|FG000|Overall Study|Disease progression|20|||
161994556|NCT02175017|585030491|FG001|Overall Study|Disease progression|27|||
161994557|NCT02175017|585030490|FG000|Overall Study|Other than above reasons|3|||
161994558|NCT02175017|585030491|FG001|Overall Study|Other than above reasons|0|||
161994559|NCT04915729|585030492|FG000|Overall Study|Lost to Follow-up|20|||
161994560|NCT04915729|585030493|FG001|Overall Study|Lost to Follow-up|10|||
161994561|NCT04915729|585030492|FG000|Overall Study|Withdrawal by Subject|12|||
161994562|NCT04915729|585030493|FG001|Overall Study|Withdrawal by Subject|5|||
161994563|NCT04915729|585030492|FG000|Overall Study|Death|34|||
161994564|NCT04915729|585030493|FG001|Overall Study|Death|44|||
161994565|NCT04915729|585030492|FG000|Overall Study|not treated|3|||
161994566|NCT04915729|585030493|FG001|Overall Study|not treated|6|||
161994567|NCT04915729|585030492|FG000|Overall Study|Investigator removed subject|1|||
161994568|NCT04915729|585030493|FG001|Overall Study|Investigator removed subject|2|||
161994569|NCT04915729|585030492|FG000|Overall Study|questionnaire result not evaluated|1|||
161994570|NCT04915729|585030493|FG001|Overall Study|questionnaire result not evaluated|0|||
162038245|NCT00828854|585198023|FG000|Overall Study|Reason not Specified|1|||
162038246|NCT04221230|585198024|FG000|Overall Study|Lost to Follow-up|12|||
162038247|NCT04221230|585198025|FG001|Overall Study|Lost to Follow-up|12|||
162038248|NCT04221230|585198024|FG000|Overall Study|Protocol Violation|2|||
162038249|NCT04221230|585198025|FG001|Overall Study|Protocol Violation|2|||
162038250|NCT04221230|585198024|FG000|Overall Study|Adverse Event|0|||
162038251|NCT04221230|585198025|FG001|Overall Study|Adverse Event|8|||
162038252|NCT04221230|585198024|FG000|Overall Study|Physician Decision|1|||
162038253|NCT04221230|585198025|FG001|Overall Study|Physician Decision|0|||
162038254|NCT04221230|585198024|FG000|Overall Study|Withdrawal by Subject|13|||
162038255|NCT04221230|585198025|FG001|Overall Study|Withdrawal by Subject|11|||
162038256|NCT04221230|585198024|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162038257|NCT04221230|585198025|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162038258|NCT04221230|585198024|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162038259|NCT04221230|585198025|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
162038260|NCT04221230|585198024|FG000|Overall Study|Pregnancy|0|||
162038261|NCT04221230|585198025|FG001|Overall Study|Pregnancy|1|||
162038262|NCT04221230|585198024|FG000|Overall Study|Other|1|||
162038263|NCT04221230|585198025|FG001|Overall Study|Other|2|||
162038264|NCT00915356|585198026|FG000|Overall Study|Withdrawal by Subject|1|||
162038265|NCT00915356|585198027|FG001|Overall Study|Withdrawal by Subject|0|||
162038266|NCT00915356|585198028|FG002|Overall Study|Withdrawal by Subject|0|||
162038267|NCT00915356|585198029|FG003|Overall Study|Withdrawal by Subject|0|||
162038268|NCT00915356|585198030|FG004|Overall Study|Withdrawal by Subject|0|||
162038269|NCT00191646|585198032|FG000|Overall Study|Toxicity|26|||
162038270|NCT00191646|585198033|FG001|Overall Study|Toxicity|37|||
162038271|NCT00191646|585198032|FG000|Overall Study|Disease Progression|5|||
162038272|NCT00191646|585198033|FG001|Overall Study|Disease Progression|6|||
162038273|NCT00191646|585198032|FG000|Overall Study|Physician Decision|20|||
162038274|NCT00191646|585198033|FG001|Overall Study|Physician Decision|11|||
162038275|NCT00191646|585198032|FG000|Overall Study|Withdrawal by Subject|58|||
162038276|NCT00191646|585198033|FG001|Overall Study|Withdrawal by Subject|39|||
162038277|NCT00191646|585198032|FG000|Overall Study|Protocol Violation|5|||
162038278|NCT00191646|585198033|FG001|Overall Study|Protocol Violation|7|||
162038279|NCT00191646|585198032|FG000|Overall Study|Death|6|||
162038280|NCT00191646|585198033|FG001|Overall Study|Death|8|||
162038281|NCT00191646|585198032|FG000|Overall Study|Other|33|||
162038282|NCT00191646|585198033|FG001|Overall Study|Other|34|||
162038283|NCT00191646|585198032|FG000|Overall Study|Missing Data|18|||
162038284|NCT00191646|585198033|FG001|Overall Study|Missing Data|11|||
162038285|NCT05211284|585198041|FG000|Overall Study|Study Terminated|3|||
162038286|NCT05211284|585198042|FG001|Overall Study|Study Terminated|1|||
162038287|NCT00395538|585198048|FG000|Overall Study|Did not re-consent to revised protocol|1|||
162038288|NCT00395538|585198049|FG001|Overall Study|Did not re-consent to revised protocol|10|||
162038289|NCT00395538|585198050|FG002|Overall Study|Did not re-consent to revised protocol|0|||
162038290|NCT00395538|585198048|FG000|Overall Study|FDA partial hold on PTH|0|||
162038291|NCT00395538|585198049|FG001|Overall Study|FDA partial hold on PTH|0|||
162038292|NCT00395538|585198050|FG002|Overall Study|FDA partial hold on PTH|11|||
162038293|NCT00395538|585198048|FG000|Overall Study|Failed screening|0|||
162038294|NCT00395538|585198049|FG001|Overall Study|Failed screening|0|||
162038295|NCT00395538|585198050|FG002|Overall Study|Failed screening|4|||
162038296|NCT00395538|585198048|FG000|Overall Study|Switch to Natpara|0|||
162038297|NCT00395538|585198049|FG001|Overall Study|Switch to Natpara|0|||
162038298|NCT00395538|585198050|FG002|Overall Study|Switch to Natpara|3|||
162038299|NCT00395538|585198048|FG000|Overall Study|Adverse Event|1|||
162038300|NCT00395538|585198049|FG001|Overall Study|Adverse Event|0|||
162038301|NCT00395538|585198050|FG002|Overall Study|Adverse Event|2|||
162038302|NCT00395538|585198048|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
162038303|NCT00395538|585198049|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
162038304|NCT00395538|585198050|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
162038305|NCT00395538|585198048|FG000|Overall Study|Non-compliance with study protocol|0|||
162038306|NCT00395538|585198049|FG001|Overall Study|Non-compliance with study protocol|1|||
162038307|NCT00395538|585198050|FG002|Overall Study|Non-compliance with study protocol|0|||
162038308|NCT00395538|585198048|FG000|Overall Study|PTH resistance|0|||
162038309|NCT00395538|585198049|FG001|Overall Study|PTH resistance|0|||
162038310|NCT00395538|585198050|FG002|Overall Study|PTH resistance|1|||
162038311|NCT00395538|585198048|FG000|Overall Study|Pregnancy|1|||
162038312|NCT00395538|585198049|FG001|Overall Study|Pregnancy|0|||
162038313|NCT00395538|585198050|FG002|Overall Study|Pregnancy|0|||
162038314|NCT00395538|585198048|FG000|Overall Study|Partial recovery of parathyroid function|0|||
162038315|NCT00395538|585198049|FG001|Overall Study|Partial recovery of parathyroid function|0|||
162038316|NCT00395538|585198050|FG002|Overall Study|Partial recovery of parathyroid function|1|||
162038317|NCT00395538|585198048|FG000|Overall Study|Participant elected to discontinue|0|||
162038318|NCT00395538|585198049|FG001|Overall Study|Participant elected to discontinue|0|||
162038319|NCT00395538|585198050|FG002|Overall Study|Participant elected to discontinue|1|||
162038320|NCT01074047|585198051|FG000|Treatment Phase|Adverse Event|89|||
162038321|NCT01074047|585198052|FG001|Treatment Phase|Adverse Event|66|||
162038322|NCT01074047|585198051|FG000|Treatment Phase|Disease Progression|16|||
161888750|NCT00424021|584636291|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
161888751|NCT00424021|584636292|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
161888752|NCT00424021|584636293|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
161888753|NCT00424021|584636294|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
161888754|NCT00424021|584636291|FG000|AMB-220-E Study Period|Physician Decision|0|||
161888755|NCT00424021|584636292|FG001|AMB-220-E Study Period|Physician Decision|0|||
161888756|NCT00424021|584636293|FG002|AMB-220-E Study Period|Physician Decision|0|||
161888757|NCT00424021|584636294|FG003|AMB-220-E Study Period|Physician Decision|1|||
161888758|NCT03217968|584636295|FG000|Overall Study|Withdrawal by Subject|4|||
161888759|NCT03217968|584636295|FG000|Overall Study|Lost to Follow-up|1|||
161888760|NCT03217968|584636295|FG000|Overall Study|Protocol Violation|6|||
161888761|NCT03008278|584636296|FG000|Overall Study|Progressive Disease|0|||
161888762|NCT03008278|584636297|FG001|Overall Study|Progressive Disease|0|||
161888763|NCT03008278|584636298|FG002|Overall Study|Progressive Disease|32|||
161888764|NCT03008278|584636296|FG000|Overall Study|Adverse Event|0|||
161888765|NCT03008278|584636297|FG001|Overall Study|Adverse Event|0|||
161888766|NCT03008278|584636298|FG002|Overall Study|Adverse Event|4|||
161888767|NCT03008278|584636296|FG000|Overall Study|Withdrawal by Subject|0|||
161888768|NCT03008278|584636297|FG001|Overall Study|Withdrawal by Subject|0|||
161888769|NCT03008278|584636298|FG002|Overall Study|Withdrawal by Subject|3|||
161888770|NCT03008278|584636296|FG000|Overall Study|Physician Decision|0|||
161888771|NCT03008278|584636297|FG001|Overall Study|Physician Decision|2|||
161888772|NCT03008278|584636298|FG002|Overall Study|Physician Decision|0|||
161888773|NCT01074255|584636299|FG000|Overall Study|Did not receive EMEND|2|||
161888774|NCT01389258|584636300|FG000|Overall Study|Lost to Follow-up|5|||
161888775|NCT03313310|584636301|FG000|Phase 2|Lost to Follow-up|4|||
161888776|NCT03313310|584636302|FG001|Phase 2|Lost to Follow-up|0|||
161888777|NCT03313310|584636301|FG000|Phase 3|Lost to Follow-up|0|||
161888778|NCT03313310|584636302|FG001|Phase 3|Lost to Follow-up|1|||
161888779|NCT03170609|584636305|FG000|Overall Study|Death|0|||
161888780|NCT03170609|584636306|FG001|Overall Study|Death|0|||
161888781|NCT03170609|584636307|FG002|Overall Study|Death|1|||
161888782|NCT03170609|584636308|FG003|Overall Study|Death|0|||
161888783|NCT03170609|584636309|FG004|Overall Study|Death|0|||
161888784|NCT03170609|584636310|FG005|Overall Study|Death|0|||
161888785|NCT03170609|584636311|FG006|Overall Study|Death|0|||
161888786|NCT03170609|584636305|FG000|Overall Study|Withdrawal by Subject|1|||
161888787|NCT03170609|584636306|FG001|Overall Study|Withdrawal by Subject|2|||
161888788|NCT03170609|584636307|FG002|Overall Study|Withdrawal by Subject|0|||
161888789|NCT03170609|584636308|FG003|Overall Study|Withdrawal by Subject|0|||
161888790|NCT03170609|584636309|FG004|Overall Study|Withdrawal by Subject|0|||
161888791|NCT03170609|584636310|FG005|Overall Study|Withdrawal by Subject|0|||
161888792|NCT03170609|584636311|FG006|Overall Study|Withdrawal by Subject|1|||
161888793|NCT03170609|584636305|FG000|Overall Study|Lost to Follow-up|1|||
161888794|NCT03170609|584636306|FG001|Overall Study|Lost to Follow-up|0|||
161888795|NCT03170609|584636307|FG002|Overall Study|Lost to Follow-up|5|||
161888796|NCT03170609|584636308|FG003|Overall Study|Lost to Follow-up|2|||
161888797|NCT03170609|584636309|FG004|Overall Study|Lost to Follow-up|1|||
161888798|NCT03170609|584636310|FG005|Overall Study|Lost to Follow-up|1|||
161888799|NCT03170609|584636311|FG006|Overall Study|Lost to Follow-up|0|||
161888800|NCT03170609|584636305|FG000|Overall Study|Other|1|||
161888801|NCT03170609|584636306|FG001|Overall Study|Other|0|||
161888802|NCT03170609|584636307|FG002|Overall Study|Other|0|||
161888803|NCT03170609|584636308|FG003|Overall Study|Other|0|||
161888804|NCT03170609|584636309|FG004|Overall Study|Other|0|||
161888805|NCT03170609|584636310|FG005|Overall Study|Other|1|||
161888806|NCT03170609|584636311|FG006|Overall Study|Other|0|||
161888807|NCT01904903|584636312|FG000|Overall Study|Withdrawal by Subject|1|||
161888808|NCT00314132|584636313|FG000|Overall Study|Lost to Follow-up|3|||
161888809|NCT00314132|584636314|FG001|Overall Study|Lost to Follow-up|13|||
161888810|NCT00314132|584636313|FG000|Overall Study|Withdrawal by Subject|3|||
161888811|NCT00314132|584636314|FG001|Overall Study|Withdrawal by Subject|5|||
161994571|NCT04915729|585030492|FG000|Overall Study|refuse of hospital visit|1|||
161994572|NCT04915729|585030493|FG001|Overall Study|refuse of hospital visit|3|||
161994573|NCT04915729|585030492|FG000|Overall Study|Subject withdrew|1|||
161888812|NCT00314132|584636313|FG000|Overall Study|Adverse Event|1|||
161888813|NCT00314132|584636314|FG001|Overall Study|Adverse Event|0|||
161994574|NCT04915729|585030493|FG001|Overall Study|Subject withdrew|0|||
161888814|NCT00314132|584636313|FG000|Overall Study|Physician Decision|1|||
161888815|NCT00314132|584636314|FG001|Overall Study|Physician Decision|0|||
161888816|NCT01634659|584636316|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
161888817|NCT01634659|584636317|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
161888818|NCT01634659|584636316|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
161994575|NCT04961541|585030494|FG000|Overall Study|Adverse Event|0|||
161888819|NCT01634659|584636317|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
161888820|NCT02918552|584636318|FG000|Overall Study|Failed Pharmacokinetics|1|||
161888821|NCT02918552|584636319|FG001|Overall Study|Failed Pharmacokinetics|0|||
161888822|NCT02918552|584636318|FG000|Overall Study|Withdrawal by Subject|0|||
161888823|NCT02918552|584636319|FG001|Overall Study|Withdrawal by Subject|1|||
161888824|NCT02918552|584636318|FG000|Overall Study|Lost to Follow-up|0|||
161888825|NCT02918552|584636319|FG001|Overall Study|Lost to Follow-up|1|||
161888826|NCT04395274|584636320|FG000|Overall Study|Lost to Follow-up|20|||
161888827|NCT04395274|584636321|FG001|Overall Study|Lost to Follow-up|11|||
161888828|NCT04395274|584636320|FG000|Overall Study|Withdrawal by Subject|13|||
161888829|NCT04395274|584636321|FG001|Overall Study|Withdrawal by Subject|10|||
161888830|NCT04395274|584636320|FG000|Overall Study|Moved Abroad|0|||
161888831|NCT04395274|584636321|FG001|Overall Study|Moved Abroad|1|||
161888832|NCT00335959|584636322|FG000|Overall Study|Adverse Event|2|||
161888833|NCT00335959|584636322|FG000|Overall Study|Ineligible|1|||
161888834|NCT00824382|584636325|FG000|Overall Study|Adverse Event|4|||
161888835|NCT00824382|584636326|FG001|Overall Study|Adverse Event|1|||
161888836|NCT00824382|584636327|FG002|Overall Study|Adverse Event|1|||
161888837|NCT00824382|584636328|FG003|Overall Study|Adverse Event|4|||
161888838|NCT00824382|584636325|FG000|Overall Study|Protocol Violation|1|||
161888839|NCT00824382|584636326|FG001|Overall Study|Protocol Violation|0|||
161888840|NCT00824382|584636327|FG002|Overall Study|Protocol Violation|0|||
161888841|NCT00824382|584636328|FG003|Overall Study|Protocol Violation|1|||
161888842|NCT00824382|584636325|FG000|Overall Study|Investigator's decision|0|||
161888843|NCT00824382|584636326|FG001|Overall Study|Investigator's decision|1|||
161888844|NCT00824382|584636327|FG002|Overall Study|Investigator's decision|2|||
161888845|NCT00824382|584636328|FG003|Overall Study|Investigator's decision|0|||
161888846|NCT02908074|584636329|FG000|Overall Study|sponsor/ICON decision|0|||
161888847|NCT02908074|584636330|FG001|Overall Study|sponsor/ICON decision|0|||
161888848|NCT02908074|584636331|FG002|Overall Study|sponsor/ICON decision|1|||
161888849|NCT02908074|584636332|FG003|Overall Study|sponsor/ICON decision|0|||
161888850|NCT02908074|584636333|FG004|Overall Study|sponsor/ICON decision|0|||
161888851|NCT02908074|584636334|FG005|Overall Study|sponsor/ICON decision|0|||
161888852|NCT02908074|584636329|FG000|Overall Study|Protocol Violation|0|||
161888853|NCT02908074|584636330|FG001|Overall Study|Protocol Violation|1|||
161888854|NCT02908074|584636331|FG002|Overall Study|Protocol Violation|0|||
161888855|NCT02908074|584636332|FG003|Overall Study|Protocol Violation|0|||
161888856|NCT02908074|584636333|FG004|Overall Study|Protocol Violation|0|||
161888857|NCT02908074|584636334|FG005|Overall Study|Protocol Violation|0|||
161888858|NCT02908074|584636329|FG000|Overall Study|Adverse Event|5|||
161888859|NCT02908074|584636330|FG001|Overall Study|Adverse Event|2|||
161888860|NCT02908074|584636331|FG002|Overall Study|Adverse Event|0|||
161888861|NCT02908074|584636332|FG003|Overall Study|Adverse Event|0|||
161888862|NCT02908074|584636333|FG004|Overall Study|Adverse Event|1|||
161888863|NCT02908074|584636334|FG005|Overall Study|Adverse Event|0|||
161888864|NCT02908074|584636329|FG000|Overall Study|AESI|1|||
161888865|NCT02908074|584636330|FG001|Overall Study|AESI|0|||
161888866|NCT02908074|584636331|FG002|Overall Study|AESI|1|||
161888867|NCT02908074|584636332|FG003|Overall Study|AESI|0|||
161888868|NCT02908074|584636333|FG004|Overall Study|AESI|1|||
161888869|NCT02908074|584636334|FG005|Overall Study|AESI|0|||
161888870|NCT02908074|584636329|FG000|Overall Study|Discontinuation criteria per protocol|0|||
161888871|NCT02908074|584636330|FG001|Overall Study|Discontinuation criteria per protocol|0|||
161888872|NCT02908074|584636331|FG002|Overall Study|Discontinuation criteria per protocol|1|||
161888873|NCT02908074|584636332|FG003|Overall Study|Discontinuation criteria per protocol|0|||
161888874|NCT02908074|584636333|FG004|Overall Study|Discontinuation criteria per protocol|0|||
161888875|NCT02908074|584636334|FG005|Overall Study|Discontinuation criteria per protocol|1|||
161888876|NCT02908074|584636329|FG000|Overall Study|Withdrawal by Subject|3|||
161888877|NCT02908074|584636330|FG001|Overall Study|Withdrawal by Subject|2|||
161888878|NCT02908074|584636331|FG002|Overall Study|Withdrawal by Subject|2|||
161888879|NCT02908074|584636332|FG003|Overall Study|Withdrawal by Subject|2|||
161888880|NCT02908074|584636333|FG004|Overall Study|Withdrawal by Subject|2|||
161888881|NCT02908074|584636334|FG005|Overall Study|Withdrawal by Subject|2|||
161888882|NCT02908074|584636329|FG000|Overall Study|Lost to Follow-up|0|||
161888883|NCT02908074|584636330|FG001|Overall Study|Lost to Follow-up|1|||
161888884|NCT02908074|584636331|FG002|Overall Study|Lost to Follow-up|1|||
161888885|NCT02908074|584636332|FG003|Overall Study|Lost to Follow-up|1|||
161888886|NCT02908074|584636333|FG004|Overall Study|Lost to Follow-up|0|||
161888887|NCT02908074|584636334|FG005|Overall Study|Lost to Follow-up|1|||
161888888|NCT00642954|584638188|FG000|Overall Study|Progressive Disease|3|||
161888889|NCT00642954|584638189|FG001|Overall Study|Progressive Disease|3|||
161888890|NCT00642954|584638190|FG002|Overall Study|Progressive Disease|3|||
161888891|NCT00642954|584638191|FG003|Overall Study|Progressive Disease|3|||
161888892|NCT00642954|584638192|FG004|Overall Study|Progressive Disease|9|||
161888893|NCT00642954|584638188|FG000|Overall Study|Withdrawal by Subject|0|||
161888894|NCT00642954|584638189|FG001|Overall Study|Withdrawal by Subject|0|||
161888895|NCT00642954|584638190|FG002|Overall Study|Withdrawal by Subject|0|||
161888896|NCT00642954|584638191|FG003|Overall Study|Withdrawal by Subject|0|||
161888897|NCT00642954|584638192|FG004|Overall Study|Withdrawal by Subject|1|||
161888898|NCT00642954|584638188|FG000|Overall Study|Adverse Event|1|||
161888899|NCT00642954|584638189|FG001|Overall Study|Adverse Event|1|||
161888900|NCT00642954|584638190|FG002|Overall Study|Adverse Event|0|||
161888901|NCT00642954|584638191|FG003|Overall Study|Adverse Event|0|||
161994576|NCT04961541|585030495|FG001|Overall Study|Adverse Event|0|||
161994577|NCT04961541|585030496|FG002|Overall Study|Adverse Event|0|||
161994578|NCT04961541|585030497|FG003|Overall Study|Adverse Event|0|||
161994579|NCT04961541|585030498|FG004|Overall Study|Adverse Event|0|||
161994580|NCT04961541|585030499|FG005|Overall Study|Adverse Event|1|||
161994581|NCT04961541|585030500|FG006|Overall Study|Adverse Event|0|||
161994582|NCT04961541|585030501|FG007|Overall Study|Adverse Event|0|||
161994583|NCT04961541|585030502|FG008|Overall Study|Adverse Event|0|||
161994584|NCT04961541|585030503|FG009|Overall Study|Adverse Event|0|||
161994585|NCT04961541|585030504|FG010|Overall Study|Adverse Event|0|||
161994586|NCT04961541|585030505|FG011|Overall Study|Adverse Event|0|||
161994587|NCT04961541|585030506|FG012|Overall Study|Adverse Event|0|||
161994588|NCT04961541|585030507|FG013|Overall Study|Adverse Event|0|||
161994589|NCT04961541|585030494|FG000|Overall Study|Lost to Follow-up|0|||
161994590|NCT04961541|585030495|FG001|Overall Study|Lost to Follow-up|0|||
161994591|NCT04961541|585030496|FG002|Overall Study|Lost to Follow-up|3|||
161994592|NCT04961541|585030497|FG003|Overall Study|Lost to Follow-up|0|||
161994593|NCT04961541|585030498|FG004|Overall Study|Lost to Follow-up|0|||
161994594|NCT04961541|585030499|FG005|Overall Study|Lost to Follow-up|0|||
161994595|NCT04961541|585030500|FG006|Overall Study|Lost to Follow-up|1|||
161994596|NCT04961541|585030501|FG007|Overall Study|Lost to Follow-up|1|||
161994597|NCT04961541|585030502|FG008|Overall Study|Lost to Follow-up|0|||
161994598|NCT04961541|585030503|FG009|Overall Study|Lost to Follow-up|1|||
161994599|NCT04961541|585030504|FG010|Overall Study|Lost to Follow-up|0|||
161994600|NCT04961541|585030505|FG011|Overall Study|Lost to Follow-up|0|||
161994601|NCT04961541|585030506|FG012|Overall Study|Lost to Follow-up|1|||
161994602|NCT04961541|585030507|FG013|Overall Study|Lost to Follow-up|0|||
161994603|NCT04961541|585030494|FG000|Overall Study|Withdrawal by Subject|0|||
161994604|NCT04961541|585030495|FG001|Overall Study|Withdrawal by Subject|0|||
161994605|NCT04961541|585030496|FG002|Overall Study|Withdrawal by Subject|1|||
161994606|NCT04961541|585030497|FG003|Overall Study|Withdrawal by Subject|1|||
161994607|NCT04961541|585030498|FG004|Overall Study|Withdrawal by Subject|0|||
161994608|NCT04961541|585030499|FG005|Overall Study|Withdrawal by Subject|0|||
161994609|NCT04961541|585030500|FG006|Overall Study|Withdrawal by Subject|0|||
161994610|NCT04961541|585030501|FG007|Overall Study|Withdrawal by Subject|0|||
161994611|NCT04961541|585030502|FG008|Overall Study|Withdrawal by Subject|0|||
161994612|NCT04961541|585030503|FG009|Overall Study|Withdrawal by Subject|1|||
161994613|NCT04961541|585030504|FG010|Overall Study|Withdrawal by Subject|0|||
161994614|NCT04961541|585030505|FG011|Overall Study|Withdrawal by Subject|0|||
161994615|NCT04961541|585030506|FG012|Overall Study|Withdrawal by Subject|0|||
161888902|NCT00642954|584638192|FG004|Overall Study|Adverse Event|6|||
161888903|NCT01937715|584638195|FG000|Overall Study|Death|0|||
161888904|NCT01937715|584638196|FG001|Overall Study|Death|0|||
161888905|NCT01937715|584638197|FG002|Overall Study|Death|0|||
161888906|NCT01937715|584638198|FG003|Overall Study|Death|1|||
161888907|NCT01937715|584638199|FG004|Overall Study|Death|0|||
161888908|NCT01937715|584638195|FG000|Overall Study|Withdrawal by Subject|0|||
161888909|NCT01937715|584638196|FG001|Overall Study|Withdrawal by Subject|1|||
161888910|NCT01937715|584638197|FG002|Overall Study|Withdrawal by Subject|0|||
161888911|NCT01937715|584638198|FG003|Overall Study|Withdrawal by Subject|0|||
161888912|NCT01937715|584638199|FG004|Overall Study|Withdrawal by Subject|2|||
161888913|NCT01937715|584638195|FG000|Overall Study|Other|0|||
161888914|NCT01937715|584638196|FG001|Overall Study|Other|0|||
161888915|NCT01937715|584638197|FG002|Overall Study|Other|0|||
161888916|NCT01937715|584638198|FG003|Overall Study|Other|3|||
161888917|NCT01937715|584638199|FG004|Overall Study|Other|0|||
161888918|NCT00433017|584638202|FG000|Overall Study|Adverse Event|5|||
161888919|NCT00433017|584638203|FG001|Overall Study|Adverse Event|3|||
161888920|NCT00433017|584638202|FG000|Overall Study|Withdrawal by Subject|4|||
161888921|NCT00433017|584638203|FG001|Overall Study|Withdrawal by Subject|5|||
161888922|NCT00433017|584638202|FG000|Overall Study|Lost to Follow-up|3|||
161888923|NCT00433017|584638203|FG001|Overall Study|Lost to Follow-up|4|||
161888924|NCT00433017|584638202|FG000|Overall Study|Administrative problems|80|||
161888925|NCT00433017|584638203|FG001|Overall Study|Administrative problems|86|||
161888926|NCT00433017|584638202|FG000|Overall Study|Protocol Violation|1|||
161888927|NCT00433017|584638203|FG001|Overall Study|Protocol Violation|0|||
161888928|NCT00433017|584638202|FG000|Overall Study|Death|2|||
161888929|NCT00433017|584638203|FG001|Overall Study|Death|2|||
161888930|NCT00433017|584638202|FG000|Overall Study|Subject no longer requires study drug|1|||
161994616|NCT04961541|585030507|FG013|Overall Study|Withdrawal by Subject|0|||
161994617|NCT00466921|585030508|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
161994618|NCT00466921|585030508|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
161994619|NCT00466921|585030508|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
161888931|NCT00433017|584638203|FG001|Overall Study|Subject no longer requires study drug|1|||
161888932|NCT00153816|584638204|FG000|Overall Study|Death|6|||
161888933|NCT00153816|584638205|FG001|Overall Study|Death|5|||
161888934|NCT00153816|584638206|FG002|Overall Study|Death|4|||
161994620|NCT00466921|585030508|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
161994621|NCT00466921|585030508|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
161888935|NCT00153816|584638207|FG003|Overall Study|Death|6|||
161888936|NCT00153816|584638208|FG004|Overall Study|Death|0|||
161888937|NCT00153816|584638209|FG005|Overall Study|Death|2|||
161888938|NCT00153816|584638204|FG000|Overall Study|Lost to Follow-up|7|||
161888939|NCT00153816|584638205|FG001|Overall Study|Lost to Follow-up|8|||
161888940|NCT00153816|584638206|FG002|Overall Study|Lost to Follow-up|5|||
161888941|NCT00153816|584638207|FG003|Overall Study|Lost to Follow-up|8|||
161888942|NCT00153816|584638208|FG004|Overall Study|Lost to Follow-up|7|||
161994622|NCT00466921|585030508|FG000|Follow up for a Minimum of 1 Year|Death|6|||
161994623|NCT03305770|585030509|FG000|Overall Study|Physician Decision - prior to dispense|0|||
161994624|NCT03305770|585030510|FG001|Overall Study|Physician Decision - prior to dispense|1|||
161994625|NCT03305770|585030509|FG000|Overall Study|Subject moved|1|||
161994626|NCT03305770|585030510|FG001|Overall Study|Subject moved|0|||
161994627|NCT03539601|585030511|FG000|Overall Study|Withdraw by parent/guardian|1|||
161994628|NCT03539601|585030512|FG001|Overall Study|Withdraw by parent/guardian|0|||
161994629|NCT03539601|585030513|FG002|Overall Study|Withdraw by parent/guardian|1|||
161994630|NCT03539601|585030514|FG003|Overall Study|Withdraw by parent/guardian|0|||
161994631|NCT03539601|585030511|FG000|Overall Study|Adverse Event|0|||
161994632|NCT03539601|585030512|FG001|Overall Study|Adverse Event|2|||
161994633|NCT03539601|585030513|FG002|Overall Study|Adverse Event|0|||
161994634|NCT03539601|585030514|FG003|Overall Study|Adverse Event|0|||
161994635|NCT03539601|585030511|FG000|Overall Study|Lost to Follow-up|2|||
161994636|NCT03539601|585030512|FG001|Overall Study|Lost to Follow-up|4|||
161994637|NCT03539601|585030513|FG002|Overall Study|Lost to Follow-up|5|||
161994638|NCT03539601|585030514|FG003|Overall Study|Lost to Follow-up|0|||
161994639|NCT03539601|585030511|FG000|Overall Study|Withdrawal by Subject|2|||
161994640|NCT03539601|585030512|FG001|Overall Study|Withdrawal by Subject|0|||
161994641|NCT03539601|585030513|FG002|Overall Study|Withdrawal by Subject|0|||
161994642|NCT03539601|585030514|FG003|Overall Study|Withdrawal by Subject|1|||
161994643|NCT03539601|585030511|FG000|Overall Study|Randomized but not treated|1|||
161994644|NCT03539601|585030512|FG001|Overall Study|Randomized but not treated|1|||
161994645|NCT03539601|585030513|FG002|Overall Study|Randomized but not treated|0|||
161994646|NCT03539601|585030514|FG003|Overall Study|Randomized but not treated|0|||
161994647|NCT03710642|585030515|FG000|Overall Study|Adverse Event|5|||
161994648|NCT03710642|585030516|FG001|Overall Study|Adverse Event|1|||
161994649|NCT03710642|585030515|FG000|Overall Study|non-site physician recommendation|1|||
161994650|NCT03710642|585030516|FG001|Overall Study|non-site physician recommendation|0|||
161994651|NCT03710642|585030515|FG000|Overall Study|Participant unwilling or unable to participate|1|||
161994652|NCT03710642|585030516|FG001|Overall Study|Participant unwilling or unable to participate|1|||
161994653|NCT03710642|585030515|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
161994654|NCT03710642|585030516|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
161994655|NCT03710642|585030515|FG000|Overall Study|NA-no code provided|1|||
161994656|NCT03710642|585030516|FG001|Overall Study|NA-no code provided|0|||
161994657|NCT03710642|585030515|FG000|Overall Study|Withdrawal by Subject|1|||
161994658|NCT03710642|585030516|FG001|Overall Study|Withdrawal by Subject|0|||
161994659|NCT00226811|585030517|FG000|Overall Study|Death|8|||
161888943|NCT00153816|584638209|FG005|Overall Study|Lost to Follow-up|9|||
161888944|NCT00153816|584638204|FG000|Overall Study|Withdrawal by Subject|9|||
161888945|NCT00153816|584638205|FG001|Overall Study|Withdrawal by Subject|9|||
161888946|NCT00153816|584638206|FG002|Overall Study|Withdrawal by Subject|9|||
161888947|NCT00153816|584638207|FG003|Overall Study|Withdrawal by Subject|4|||
161888948|NCT00153816|584638208|FG004|Overall Study|Withdrawal by Subject|1|||
161888949|NCT00153816|584638209|FG005|Overall Study|Withdrawal by Subject|5|||
161888950|NCT00153816|584638204|FG000|Overall Study|Follow-up exam not done|8|||
161888951|NCT00153816|584638205|FG001|Overall Study|Follow-up exam not done|7|||
161888952|NCT00153816|584638206|FG002|Overall Study|Follow-up exam not done|11|||
161888953|NCT00153816|584638207|FG003|Overall Study|Follow-up exam not done|10|||
161888954|NCT00153816|584638208|FG004|Overall Study|Follow-up exam not done|8|||
161888955|NCT00153816|584638209|FG005|Overall Study|Follow-up exam not done|9|||
161888956|NCT00153816|584638204|FG000|Overall Study|Follow-up exam done, histology missing|2|||
161888957|NCT00153816|584638205|FG001|Overall Study|Follow-up exam done, histology missing|3|||
161994660|NCT00226811|585030517|FG000|Overall Study|Adverse Event|11|||
161994661|NCT00226811|585030517|FG000|Overall Study|Lack of Efficacy|55|||
161994662|NCT00226811|585030517|FG000|Overall Study|Withdrawal by Subject|2|||
161994663|NCT01633541|585030521|FG000|Overall Study|Death|1|||
161888958|NCT00153816|584638206|FG002|Overall Study|Follow-up exam done, histology missing|3|||
161888959|NCT00153816|584638207|FG003|Overall Study|Follow-up exam done, histology missing|3|||
161888960|NCT00153816|584638208|FG004|Overall Study|Follow-up exam done, histology missing|1|||
161888961|NCT00153816|584638209|FG005|Overall Study|Follow-up exam done, histology missing|2|||
161888962|NCT03594955|584638212|FG000|Overall Study|Adverse Event|1|||
161994664|NCT01633541|585030522|FG001|Overall Study|Death|0|||
161994665|NCT01010971|585030523|FG000|Overall Study|Adverse Event|2|||
161994666|NCT01010971|585030524|FG001|Overall Study|Adverse Event|4|||
161994667|NCT01010971|585030525|FG002|Overall Study|Adverse Event|3|||
161994668|NCT01010971|585030523|FG000|Overall Study|Withdrawal by Subject|0|||
161994669|NCT01010971|585030524|FG001|Overall Study|Withdrawal by Subject|2|||
161888963|NCT03594955|584638212|FG000|Overall Study|Progressive disease|5|||
161888964|NCT03594955|584638212|FG000|Overall Study|Sponsor's decision|1|||
161888965|NCT03539484|584638214|FG000|Overall Study|Death|1|||
161888966|NCT03539484|584638215|FG001|Overall Study|Death|0|||
161888967|NCT03539484|584638216|FG002|Overall Study|Death|0|||
161888968|NCT03539484|584638217|FG003|Overall Study|Death|2|||
161888969|NCT03539484|584638218|FG004|Overall Study|Death|8|||
161888970|NCT03539484|584638219|FG005|Overall Study|Death|3|||
161888971|NCT03539484|584638220|FG006|Overall Study|Death|0|||
161888972|NCT03539484|584638214|FG000|Overall Study|Lost to Follow-up|0|||
161888973|NCT03539484|584638215|FG001|Overall Study|Lost to Follow-up|1|||
161888974|NCT03539484|584638216|FG002|Overall Study|Lost to Follow-up|0|||
161888975|NCT03539484|584638217|FG003|Overall Study|Lost to Follow-up|0|||
161888976|NCT03539484|584638218|FG004|Overall Study|Lost to Follow-up|1|||
161888977|NCT03539484|584638219|FG005|Overall Study|Lost to Follow-up|0|||
161888978|NCT03539484|584638220|FG006|Overall Study|Lost to Follow-up|0|||
161888979|NCT03539484|584638214|FG000|Overall Study|Withdrawal by Subject|0|||
161888980|NCT03539484|584638215|FG001|Overall Study|Withdrawal by Subject|0|||
161888981|NCT03539484|584638216|FG002|Overall Study|Withdrawal by Subject|0|||
161888982|NCT03539484|584638217|FG003|Overall Study|Withdrawal by Subject|0|||
161888983|NCT03539484|584638218|FG004|Overall Study|Withdrawal by Subject|2|||
161888984|NCT03539484|584638219|FG005|Overall Study|Withdrawal by Subject|0|||
161888985|NCT03539484|584638220|FG006|Overall Study|Withdrawal by Subject|1|||
161888986|NCT03539484|584638214|FG000|Overall Study|Study Terminated by Sponsor|0|||
161888987|NCT03539484|584638215|FG001|Overall Study|Study Terminated by Sponsor|0|||
161888988|NCT03539484|584638216|FG002|Overall Study|Study Terminated by Sponsor|1|||
161888989|NCT03539484|584638217|FG003|Overall Study|Study Terminated by Sponsor|1|||
161888990|NCT03539484|584638218|FG004|Overall Study|Study Terminated by Sponsor|2|||
161888991|NCT03539484|584638219|FG005|Overall Study|Study Terminated by Sponsor|2|||
161888992|NCT03539484|584638220|FG006|Overall Study|Study Terminated by Sponsor|1|||
161994670|NCT01010971|585030525|FG002|Overall Study|Withdrawal by Subject|5|||
161994671|NCT01010971|585030523|FG000|Overall Study|Lost to Follow-up|0|||
161994672|NCT01010971|585030524|FG001|Overall Study|Lost to Follow-up|2|||
161994673|NCT01010971|585030525|FG002|Overall Study|Lost to Follow-up|3|||
161994674|NCT01010971|585030523|FG000|Overall Study|Other|1|||
161994675|NCT01010971|585030524|FG001|Overall Study|Other|0|||
161994676|NCT01010971|585030525|FG002|Overall Study|Other|2|||
161994677|NCT02330055|585030528|FG000|Overall Study|technical issues|2|||
161994678|NCT02330055|585030529|FG001|Overall Study|technical issues|0|||
161994679|NCT02330055|585030528|FG000|Overall Study|participant forgot to wear device|5|||
161994680|NCT02330055|585030529|FG001|Overall Study|participant forgot to wear device|5|||
161994681|NCT02330055|585030528|FG000|Overall Study|data for less than 60 minutes|3|||
161994682|NCT02330055|585030529|FG001|Overall Study|data for less than 60 minutes|3|||
161994683|NCT02330055|585030528|FG000|Overall Study|participant did not sleep|0|||
161994684|NCT02330055|585030529|FG001|Overall Study|participant did not sleep|1|||
161994685|NCT05729568|585030531|FG000|Overall Study|Still on Study|52|||
161994686|NCT05729568|585030532|FG001|Overall Study|Still on Study|26|||
161994687|NCT05729568|585030531|FG000|Overall Study|Randomized but Never Treated|3|||
161994688|NCT05729568|585030532|FG001|Overall Study|Randomized but Never Treated|0|||
161994689|NCT05729568|585030531|FG000|Overall Study|Adverse Event|0|||
161994690|NCT05729568|585030532|FG001|Overall Study|Adverse Event|1|||
161994691|NCT05729568|585030531|FG000|Overall Study|Investigator's Discretion|1|||
161994692|NCT05729568|585030532|FG001|Overall Study|Investigator's Discretion|0|||
161994693|NCT00550953|585030533|FG000|Overall Study|Adverse Event|4|||
161994694|NCT00550953|585030534|FG001|Overall Study|Adverse Event|3|||
161994695|NCT00550953|585030533|FG000|Overall Study|Not able to visit the site|2|||
161994696|NCT00550953|585030534|FG001|Overall Study|Not able to visit the site|3|||
161994697|NCT02728089|585030535|FG000|Overall Study|Physician Decision|2|||
161994698|NCT02728089|585030535|FG000|Overall Study|Withdrawal by Subject|1|||
161994699|NCT01221350|585030536|FG000|Overall Study|Discontinued intervention (GERD)|1|||
161994700|NCT01221350|585030537|FG001|Overall Study|Discontinued intervention (GERD)|0|||
161994701|NCT01221350|585030536|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
161994702|NCT01221350|585030537|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
161994703|NCT01221350|585030536|FG000|Overall Study|Withdrawal by Subject|4|||
161994704|NCT01221350|585030537|FG001|Overall Study|Withdrawal by Subject|2|||
161994705|NCT04739436|585030540|FG000|Overall Study|Lost to Follow-up|21|||
161994706|NCT04739436|585030541|FG001|Overall Study|Lost to Follow-up|23|||
161994707|NCT04739436|585030540|FG000|Overall Study|Withdrawal by Subject|4|||
161888993|NCT02131636|584638226|FG000|Overall Study|Personal Reasons|4|||
161888994|NCT02131636|584638227|FG001|Overall Study|Personal Reasons|4|||
161888995|NCT02131636|584638226|FG000|Overall Study|Lost to Follow-up|4|||
161888996|NCT02131636|584638227|FG001|Overall Study|Lost to Follow-up|0|||
161888997|NCT02131636|584638226|FG000|Overall Study|Adverse Event|4|||
161994708|NCT04739436|585030541|FG001|Overall Study|Withdrawal by Subject|6|||
161888998|NCT02131636|584638227|FG001|Overall Study|Adverse Event|1|||
161994709|NCT04739436|585030540|FG000|Overall Study|not randomized properly|1|||
161994710|NCT04739436|585030541|FG001|Overall Study|not randomized properly|0|||
161994711|NCT02915978|585030545|FG000|Overall Study|Adverse Event|2|||
161888999|NCT02173379|584638228|FG000|Overall Study|Lost to Follow-up|89|||
161889000|NCT02173379|584638229|FG001|Overall Study|Lost to Follow-up|81|||
161889001|NCT02173379|584638228|FG000|Overall Study|Withdrawal by Subject|24|||
161889002|NCT02173379|584638229|FG001|Overall Study|Withdrawal by Subject|29|||
161889003|NCT02173379|584638228|FG000|Overall Study|Physician Decision|8|||
161889004|NCT02173379|584638229|FG001|Overall Study|Physician Decision|8|||
161889005|NCT02173379|584638228|FG000|Overall Study|Death|75|||
161889006|NCT02173379|584638229|FG001|Overall Study|Death|72|||
161889007|NCT02173379|584638228|FG000|Overall Study|Other Reason|1|||
161889008|NCT02173379|584638229|FG001|Overall Study|Other Reason|0|||
161889009|NCT06226649|584638231|FG000|Overall Study|Withdrawal by Subject|4|||
161889010|NCT06226649|584638232|FG001|Overall Study|Withdrawal by Subject|1|||
161889011|NCT02305446|584638237|FG000|Overall Study|Adverse Event|1|||
161889012|NCT01636947|584638238|FG000|Overall Study|Not Treated|2|||
161889013|NCT01636947|584638239|FG001|Overall Study|Not Treated|2|||
161889014|NCT01636947|584638238|FG000|Overall Study|Lost to Follow-up|4|||
161889015|NCT01636947|584638239|FG001|Overall Study|Lost to Follow-up|0|||
161889016|NCT01636947|584638238|FG000|Overall Study|Protocol Violation|1|||
161889017|NCT01636947|584638239|FG001|Overall Study|Protocol Violation|1|||
161889018|NCT01636947|584638238|FG000|Overall Study|Withdrawal by Subject|3|||
161889019|NCT01636947|584638239|FG001|Overall Study|Withdrawal by Subject|3|||
161889020|NCT01636947|584638238|FG000|Overall Study|Adverse Event|1|||
161889021|NCT01636947|584638239|FG001|Overall Study|Adverse Event|1|||
161889022|NCT01636947|584638238|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
161889023|NCT01636947|584638239|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
161889024|NCT00427999|584638244|FG000|Overall Study|Adverse Event|6|||
161889025|NCT00427999|584638244|FG000|Overall Study|Abnormal laboratory values|1|||
161889026|NCT00427999|584638244|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
161889027|NCT00427999|584638244|FG000|Overall Study|Protocol Violation|2|||
161889028|NCT00427999|584638244|FG000|Overall Study|Withdrawal by Subject|9|||
161889029|NCT00427999|584638244|FG000|Overall Study|Death|1|||
161889030|NCT00460265|584638245|FG000|Overall Study|Lost to Follow-up|14|||
161889031|NCT00460265|584638246|FG001|Overall Study|Lost to Follow-up|15|||
161889032|NCT00460265|584638245|FG000|Overall Study|Physician Decision|1|||
161889033|NCT00460265|584638246|FG001|Overall Study|Physician Decision|2|||
161889034|NCT00460265|584638245|FG000|Overall Study|Withdrawal by Subject|10|||
161889035|NCT00460265|584638246|FG001|Overall Study|Withdrawal by Subject|25|||
161889036|NCT00460265|584638245|FG000|Overall Study|Ongoing|60|||
161889037|NCT00460265|584638246|FG001|Overall Study|Ongoing|47|||
161889038|NCT02956057|584638258|FG000|Overall Study|Discontinued intervention|14|||
161889039|NCT02956057|584638259|FG001|Overall Study|Discontinued intervention|10|||
161889040|NCT02956057|584638260|FG002|Overall Study|Discontinued intervention|7|||
161889041|NCT02956057|584638261|FG003|Overall Study|Discontinued intervention|14|||
161889042|NCT02956057|584638262|FG004|Overall Study|Discontinued intervention|4|||
161889043|NCT02956057|584638263|FG005|Overall Study|Discontinued intervention|17|||
161889044|NCT02956057|584638258|FG000|Overall Study|Lost to Follow-up|0|||
161889045|NCT02956057|584638259|FG001|Overall Study|Lost to Follow-up|2|||
161889046|NCT02956057|584638260|FG002|Overall Study|Lost to Follow-up|1|||
161889047|NCT02956057|584638261|FG003|Overall Study|Lost to Follow-up|1|||
161889048|NCT02956057|584638262|FG004|Overall Study|Lost to Follow-up|1|||
161889049|NCT02956057|584638263|FG005|Overall Study|Lost to Follow-up|0|||
161889050|NCT01420679|584638268|FG000|Overall Study|Disease Progression|3|||
161889051|NCT01420679|584638269|FG001|Overall Study|Disease Progression|2|||
161994712|NCT02915978|585030546|FG001|Overall Study|Adverse Event|1|||
161994713|NCT02915978|585030547|FG002|Overall Study|Adverse Event|0|||
161994714|NCT02119663|585030552|FG000|Overall Study|Disease progression|26|||
161994715|NCT02119663|585030553|FG001|Overall Study|Disease progression|27|||
161994716|NCT02119663|585030552|FG000|Overall Study|Adverse Event|5|||
161994717|NCT02119663|585030553|FG001|Overall Study|Adverse Event|5|||
161994718|NCT02119663|585030552|FG000|Overall Study|Death|3|||
161994719|NCT02119663|585030553|FG001|Overall Study|Death|2|||
161994720|NCT02119663|585030552|FG000|Overall Study|Physician Decision|1|||
161889052|NCT01420679|584638268|FG000|Overall Study|Adverse Event|4|||
161889053|NCT01420679|584638269|FG001|Overall Study|Adverse Event|0|||
161889054|NCT01420679|584638268|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
161889055|NCT01420679|584638269|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
161994721|NCT02119663|585030553|FG001|Overall Study|Physician Decision|2|||
161994722|NCT02119663|585030552|FG000|Overall Study|Other unspecified|2|||
161994723|NCT02119663|585030553|FG001|Overall Study|Other unspecified|0|||
161889056|NCT01420679|584638268|FG000|Overall Study|Patient Decision|1|||
161889057|NCT01420679|584638269|FG001|Overall Study|Patient Decision|0|||
161889058|NCT01420679|584638268|FG000|Overall Study|Investigator Decision|1|||
161889059|NCT01420679|584638269|FG001|Overall Study|Investigator Decision|2|||
161889060|NCT01420679|584638268|FG000|Overall Study|Sponsor Decision|3|||
161889061|NCT01420679|584638269|FG001|Overall Study|Sponsor Decision|3|||
161889062|NCT01420679|584638268|FG000|Overall Study|Other|1|||
161889063|NCT01420679|584638269|FG001|Overall Study|Other|0|||
161889064|NCT03956615|584638270|FG000|Overall Study|No multiple myeloma confirmed|2|||
161889065|NCT03956615|584638270|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
161889066|NCT03956615|584638270|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
161889067|NCT03956615|584638270|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
161889068|NCT01069419|584638271|FG000|Overall Study|Adverse Event|233|||
161889069|NCT01069419|584638271|FG000|Overall Study|Lack of Efficacy|332|||
161889070|NCT01069419|584638271|FG000|Overall Study|Lost to Follow-up|49|||
161889071|NCT01069419|584638271|FG000|Overall Study|Remission of disease|11|||
161889072|NCT01069419|584638271|FG000|Overall Study|Withdrawal by Subject|34|||
161889073|NCT01069419|584638271|FG000|Overall Study|Other Reason|43|||
161889074|NCT01069419|584638271|FG000|Overall Study|Missing termination information|13|||
161889075|NCT01179737|584638274|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
161889076|NCT01179737|584638275|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
161889077|NCT01179737|584638276|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
161889078|NCT01179737|584638277|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
161889079|NCT01179737|584638274|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
161889080|NCT01179737|584638275|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
161889081|NCT01179737|584638276|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
161889082|NCT01179737|584638277|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
161889083|NCT01179737|584638274|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
161889084|NCT01179737|584638275|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
161889085|NCT01179737|584638276|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
161889086|NCT01179737|584638277|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
161889087|NCT01179737|584638274|FG000|Cohort 1 & Cohort 2|Death|0|||
161889088|NCT01179737|584638275|FG001|Cohort 1 & Cohort 2|Death|0|||
161889089|NCT01179737|584638276|FG002|Cohort 1 & Cohort 2|Death|1|||
161889090|NCT01179737|584638277|FG003|Cohort 1 & Cohort 2|Death|0|||
161889091|NCT01179737|584638274|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
161889092|NCT01179737|584638275|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
161889093|NCT01179737|584638276|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
161889094|NCT01179737|584638277|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
161889095|NCT01179737|584638274|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
161889096|NCT01179737|584638275|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
161889097|NCT01179737|584638276|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
161889098|NCT01179737|584638277|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
161889099|NCT01179737|584638274|FG000|Extension|The study was terminated|3|||
161889100|NCT01179737|584638275|FG001|Extension|The study was terminated|0|||
161889101|NCT01179737|584638276|FG002|Extension|The study was terminated|0|||
161889102|NCT01179737|584638277|FG003|Extension|The study was terminated|0|||
161994724|NCT02119663|585030552|FG000|Overall Study|Subject decision|0|||
161994725|NCT02119663|585030553|FG001|Overall Study|Subject decision|1|||
161994726|NCT02119663|585030552|FG000|Overall Study|Study Terminated by the Sponsor|3|||
161994727|NCT02119663|585030553|FG001|Overall Study|Study Terminated by the Sponsor|4|||
161994728|NCT01248949|585030554|FG000|Overall Study|Lost to Follow-up|2|||
161994729|NCT01248949|585030555|FG001|Overall Study|Lost to Follow-up|2|||
161994730|NCT01248949|585030556|FG002|Overall Study|Lost to Follow-up|2|||
161994731|NCT01248949|585030557|FG003|Overall Study|Lost to Follow-up|1|||
161994732|NCT01248949|585030558|FG004|Overall Study|Lost to Follow-up|0|||
161994733|NCT01248949|585030554|FG000|Overall Study|Withdrawal by Subject|5|||
161994734|NCT01248949|585030555|FG001|Overall Study|Withdrawal by Subject|3|||
161994735|NCT01248949|585030556|FG002|Overall Study|Withdrawal by Subject|11|||
161994736|NCT01248949|585030557|FG003|Overall Study|Withdrawal by Subject|3|||
161994737|NCT01248949|585030558|FG004|Overall Study|Withdrawal by Subject|1|||
161994738|NCT01248949|585030554|FG000|Overall Study|Death|22|||
161994739|NCT01248949|585030555|FG001|Overall Study|Death|7|||
161994740|NCT01248949|585030556|FG002|Overall Study|Death|21|||
161994741|NCT01248949|585030557|FG003|Overall Study|Death|6|||
161994742|NCT01248949|585030558|FG004|Overall Study|Death|2|||
161994743|NCT01248949|585030554|FG000|Overall Study|Alternative Therapy|1|||
161994744|NCT01248949|585030555|FG001|Overall Study|Alternative Therapy|0|||
161994745|NCT01248949|585030556|FG002|Overall Study|Alternative Therapy|0|||
161994746|NCT01248949|585030557|FG003|Overall Study|Alternative Therapy|0|||
162038323|NCT01074047|585198052|FG001|Treatment Phase|Disease Progression|21|||
161889103|NCT01254721|584638278|FG000|Overall Study|Lost to Follow-up|0|||
161889104|NCT01254721|584638279|FG001|Overall Study|Lost to Follow-up|4|||
161994747|NCT01248949|585030558|FG004|Overall Study|Alternative Therapy|0|||
161994748|NCT01248949|585030554|FG000|Overall Study|Alternative Therapy.|1|||
162038324|NCT01074047|585198051|FG000|Treatment Phase|Withdrawal by Subject|27|||
162038325|NCT01074047|585198052|FG001|Treatment Phase|Withdrawal by Subject|48|||
162038326|NCT01074047|585198051|FG000|Treatment Phase|Death|53|||
161889105|NCT01254721|584638278|FG000|Overall Study|Lack of Efficacy|4|||
161889106|NCT01254721|584638279|FG001|Overall Study|Lack of Efficacy|2|||
161889107|NCT01254721|584638278|FG000|Overall Study|Death|0|||
161889108|NCT01254721|584638279|FG001|Overall Study|Death|1|||
161889109|NCT01254721|584638278|FG000|Overall Study|technical problum|1|||
161889110|NCT01254721|584638279|FG001|Overall Study|technical problum|0|||
161889111|NCT01254721|584638278|FG000|Overall Study|Adverse Event|2|||
161994749|NCT01248949|585030555|FG001|Overall Study|Alternative Therapy.|0|||
161994750|NCT01248949|585030556|FG002|Overall Study|Alternative Therapy.|0|||
162038327|NCT01074047|585198052|FG001|Treatment Phase|Death|58|||
162038328|NCT01074047|585198051|FG000|Treatment Phase|Lost to Follow-up|0|||
162038329|NCT01074047|585198052|FG001|Treatment Phase|Lost to Follow-up|1|||
162038330|NCT01074047|585198051|FG000|Treatment Phase|Protocol Violation|0|||
162038331|NCT01074047|585198052|FG001|Treatment Phase|Protocol Violation|1|||
162038332|NCT01074047|585198051|FG000|Treatment Phase|Miscellaneous|32|||
162038333|NCT01074047|585198052|FG001|Treatment Phase|Miscellaneous|39|||
162038334|NCT01074047|585198051|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
162038335|NCT01074047|585198052|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
162038336|NCT01074047|585198051|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
162038337|NCT01074047|585198052|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
162038338|NCT01074047|585198051|FG000|Survival Follow-Up Phase|Death|116|||
162038339|NCT01074047|585198052|FG001|Survival Follow-Up Phase|Death|124|||
162038340|NCT01074047|585198051|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
162038341|NCT01074047|585198052|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
162038342|NCT01074047|585198051|FG000|Extension Phase|Physician Decision|1|||
162038343|NCT01074047|585198052|FG001|Extension Phase|Physician Decision|0|||
162038344|NCT01074047|585198051|FG000|Extension Phase|Adverse Event|5|||
162038345|NCT01074047|585198052|FG001|Extension Phase|Adverse Event|0|||
162038346|NCT01074047|585198051|FG000|Extension Phase|Disease Progression|9|||
162038347|NCT01074047|585198052|FG001|Extension Phase|Disease Progression|0|||
162038348|NCT01074047|585198051|FG000|Extension Phase|Withdrawal by Subject|2|||
162038349|NCT01074047|585198052|FG001|Extension Phase|Withdrawal by Subject|0|||
162038350|NCT01074047|585198051|FG000|Extension Phase|Death|5|||
162038351|NCT01074047|585198052|FG001|Extension Phase|Death|0|||
162038352|NCT02211638|585198053|FG000|Overall Study|Case Report Forms Uncollected|291|||
162038353|NCT02211638|585198053|FG000|Overall Study|Protocol Violation|692|||
162038354|NCT03120624|585198055|FG000|Overall Study|Withdrawal by Subject|0|||
162038355|NCT03120624|585198056|FG001|Overall Study|Withdrawal by Subject|1|||
162038356|NCT03120624|585198057|FG002|Overall Study|Withdrawal by Subject|0|||
162038357|NCT03120624|585198058|FG003|Overall Study|Withdrawal by Subject|0|||
162038358|NCT03120624|585198059|FG004|Overall Study|Withdrawal by Subject|0|||
162038359|NCT03120624|585198060|FG005|Overall Study|Withdrawal by Subject|0|||
162038360|NCT03120624|585198061|FG006|Overall Study|Withdrawal by Subject|0|||
162038361|NCT03120624|585198062|FG007|Overall Study|Withdrawal by Subject|0|||
162038362|NCT05140382|585198063|FG000|Overall Study|Death|3|||
162038363|NCT05140382|585198064|FG001|Overall Study|Death|0|||
162038364|NCT05140382|585198065|FG002|Overall Study|Death|0|||
161889112|NCT01254721|584638279|FG001|Overall Study|Adverse Event|3|||
161889113|NCT01254721|584638278|FG000|Overall Study|Withdrawal by Subject|8|||
161889114|NCT01254721|584638279|FG001|Overall Study|Withdrawal by Subject|11|||
161889115|NCT01254721|584638278|FG000|Overall Study|Wrongly randomization|0|||
161889116|NCT01254721|584638279|FG001|Overall Study|Wrongly randomization|1|||
161889117|NCT01955109|584638280|FG000|Overall Study|Adverse Event|2|||
161889118|NCT01955109|584638281|FG001|Overall Study|Adverse Event|0|||
161889119|NCT01955109|584638280|FG000|Overall Study|Participant unwilling to continue|35|||
161889120|NCT01955109|584638281|FG001|Overall Study|Participant unwilling to continue|7|||
161889121|NCT01955109|584638280|FG000|Overall Study|Physician Decision|2|||
161889122|NCT01955109|584638281|FG001|Overall Study|Physician Decision|0|||
161889123|NCT01955109|584638280|FG000|Overall Study|Lost to Follow-up|3|||
161889124|NCT01955109|584638281|FG001|Overall Study|Lost to Follow-up|1|||
161889125|NCT01955109|584638280|FG000|Overall Study|Non-compliance|3|||
161889126|NCT01955109|584638281|FG001|Overall Study|Non-compliance|1|||
161889127|NCT00904839|584638282|FG000|Overall Study|Adverse Event|0|||
161889128|NCT00904839|584638283|FG001|Overall Study|Adverse Event|5|||
161889129|NCT00904839|584638284|FG002|Overall Study|Adverse Event|4|||
161889130|NCT00904839|584638282|FG000|Overall Study|Protocol Violation|0|||
161889131|NCT00904839|584638283|FG001|Overall Study|Protocol Violation|1|||
161889132|NCT00904839|584638284|FG002|Overall Study|Protocol Violation|1|||
161889133|NCT00904839|584638282|FG000|Overall Study|Lost to Follow-up|0|||
161889134|NCT00904839|584638283|FG001|Overall Study|Lost to Follow-up|1|||
161889135|NCT00904839|584638284|FG002|Overall Study|Lost to Follow-up|2|||
161889136|NCT00904839|584638282|FG000|Overall Study|Withdrawal by Subject|0|||
161889137|NCT00904839|584638283|FG001|Overall Study|Withdrawal by Subject|2|||
161889138|NCT00904839|584638284|FG002|Overall Study|Withdrawal by Subject|0|||
161889139|NCT00904839|584638282|FG000|Overall Study|Not treated|1|||
161889140|NCT00904839|584638283|FG001|Overall Study|Not treated|0|||
161889141|NCT00904839|584638284|FG002|Overall Study|Not treated|1|||
161889142|NCT00904839|584638282|FG000|Overall Study|Other than above|0|||
161889143|NCT00904839|584638283|FG001|Overall Study|Other than above|9|||
161889144|NCT00904839|584638284|FG002|Overall Study|Other than above|7|||
161889145|NCT01853696|584638287|FG000|Overall Study|Withdrawal by Subject|1|||
161889146|NCT01853696|584638288|FG001|Overall Study|Withdrawal by Subject|1|||
162038365|NCT05140382|585198063|FG000|Overall Study|Investigator decision|1|||
162038366|NCT05140382|585198064|FG001|Overall Study|Investigator decision|0|||
162038367|NCT05140382|585198065|FG002|Overall Study|Investigator decision|0|||
162038368|NCT05140382|585198063|FG000|Overall Study|Other|4|||
162038369|NCT05140382|585198064|FG001|Overall Study|Other|0|||
161889147|NCT01853696|584638287|FG000|Overall Study|Lost to Follow-up|5|||
161889148|NCT01853696|584638288|FG001|Overall Study|Lost to Follow-up|4|||
161889149|NCT01167634|584638289|FG000|Overall Study|Lost to Follow-up|1|||
161889150|NCT01167634|584638290|FG001|Overall Study|Lost to Follow-up|3|||
161889151|NCT01167634|584638291|FG002|Overall Study|Lost to Follow-up|3|||
161889152|NCT01167634|584638292|FG003|Overall Study|Lost to Follow-up|4|||
161889153|NCT01167634|584638289|FG000|Overall Study|Withdrawal by Subject|1|||
161889154|NCT01167634|584638290|FG001|Overall Study|Withdrawal by Subject|1|||
161889155|NCT01167634|584638291|FG002|Overall Study|Withdrawal by Subject|0|||
161889156|NCT01167634|584638292|FG003|Overall Study|Withdrawal by Subject|0|||
161889157|NCT00553358|584638293|FG000|Overall Study|Randomized but did not receive treatment|3|||
161889158|NCT00553358|584638294|FG001|Overall Study|Randomized but did not receive treatment|3|||
161889159|NCT00553358|584638295|FG002|Overall Study|Randomized but did not receive treatment|1|||
161889160|NCT00553358|584638293|FG000|Overall Study|Lost to Follow-up|22|||
161889161|NCT00553358|584638294|FG001|Overall Study|Lost to Follow-up|26|||
162038370|NCT05140382|585198065|FG002|Overall Study|Other|1|||
162038371|NCT05140382|585198063|FG000|Overall Study|Progressive disease|20|||
162038372|NCT05140382|585198064|FG001|Overall Study|Progressive disease|1|||
162038373|NCT05140382|585198065|FG002|Overall Study|Progressive disease|12|||
162038374|NCT05140382|585198063|FG000|Overall Study|Subjective disease progression|2|||
161889162|NCT00553358|584638295|FG002|Overall Study|Lost to Follow-up|18|||
161889163|NCT00553358|584638293|FG000|Overall Study|Withdrew completely|23|||
161889164|NCT00553358|584638294|FG001|Overall Study|Withdrew completely|33|||
161889165|NCT00553358|584638295|FG002|Overall Study|Withdrew completely|34|||
161889166|NCT00553358|584638293|FG000|Overall Study|Died during clinical follow-up|25|||
161889167|NCT00553358|584638294|FG001|Overall Study|Died during clinical follow-up|29|||
161889168|NCT00553358|584638295|FG002|Overall Study|Died during clinical follow-up|32|||
161889169|NCT00553358|584638293|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
161889170|NCT00553358|584638294|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
161889171|NCT00553358|584638295|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
161889172|NCT00553358|584638293|FG000|Overall Study|Died after clinical follow-up ended|1|||
162038375|NCT05140382|585198064|FG001|Overall Study|Subjective disease progression|1|||
161889173|NCT00553358|584638294|FG001|Overall Study|Died after clinical follow-up ended|2|||
161889174|NCT00553358|584638295|FG002|Overall Study|Died after clinical follow-up ended|0|||
161889175|NCT00553358|584638293|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
161889176|NCT00553358|584638294|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
161889177|NCT00553358|584638295|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
161994751|NCT01248949|585030557|FG003|Overall Study|Alternative Therapy.|0|||
161994752|NCT01248949|585030558|FG004|Overall Study|Alternative Therapy.|0|||
161994753|NCT01248949|585030554|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
161994754|NCT01248949|585030555|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
161994755|NCT01248949|585030556|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
161994756|NCT01248949|585030557|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
161994757|NCT01248949|585030558|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
161994758|NCT01248949|585030554|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
161994759|NCT01248949|585030555|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
161994760|NCT01248949|585030556|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
161994761|NCT01248949|585030557|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
161994762|NCT01248949|585030558|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
161994763|NCT01248949|585030554|FG000|Overall Study|Participant Went To Hospice|0|||
161994764|NCT01248949|585030555|FG001|Overall Study|Participant Went To Hospice|0|||
161994765|NCT01248949|585030556|FG002|Overall Study|Participant Went To Hospice|1|||
161994766|NCT01248949|585030557|FG003|Overall Study|Participant Went To Hospice|0|||
161994767|NCT01248949|585030558|FG004|Overall Study|Participant Went To Hospice|0|||
161994768|NCT01248949|585030554|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
161994769|NCT01248949|585030555|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
161994770|NCT01248949|585030556|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
161994771|NCT01248949|585030557|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
161994772|NCT01248949|585030558|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
161994773|NCT01248949|585030554|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
161994774|NCT01248949|585030555|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
161994775|NCT01248949|585030556|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
161994776|NCT01248949|585030557|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
161994777|NCT01248949|585030558|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
161994778|NCT01248949|585030554|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
161994779|NCT01248949|585030555|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
161994780|NCT01248949|585030556|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
162038376|NCT05140382|585198065|FG002|Overall Study|Subjective disease progression|0|||
162038377|NCT05140382|585198063|FG000|Overall Study|Unknown at data cut-off|0|||
162038378|NCT05140382|585198064|FG001|Overall Study|Unknown at data cut-off|0|||
161889178|NCT02854605|584638300|FG000|Overall Study|Adverse Event|1|||
161889179|NCT02854605|584638301|FG001|Overall Study|Adverse Event|5|||
161889180|NCT02854605|584638302|FG002|Overall Study|Adverse Event|2|||
161889181|NCT02854605|584638300|FG000|Overall Study|Lost to Follow-up|0|||
161889182|NCT02854605|584638301|FG001|Overall Study|Lost to Follow-up|2|||
161889183|NCT02854605|584638302|FG002|Overall Study|Lost to Follow-up|0|||
161889184|NCT02854605|584638300|FG000|Overall Study|Withdrew Consent|1|||
161889185|NCT02854605|584638301|FG001|Overall Study|Withdrew Consent|0|||
161889186|NCT02854605|584638302|FG002|Overall Study|Withdrew Consent|1|||
161889187|NCT02854605|584638300|FG000|Overall Study|Investigator's Discretion|1|||
161889188|NCT02854605|584638301|FG001|Overall Study|Investigator's Discretion|0|||
161889189|NCT02854605|584638302|FG002|Overall Study|Investigator's Discretion|0|||
161889190|NCT02854605|584638300|FG000|Overall Study|Protocol Violation|0|||
161889191|NCT02854605|584638301|FG001|Overall Study|Protocol Violation|0|||
161889192|NCT02854605|584638302|FG002|Overall Study|Protocol Violation|1|||
161889193|NCT03003000|584638303|FG000|Overall Study|Adverse Event|1|||
161889194|NCT03003000|584638304|FG001|Overall Study|Adverse Event|2|||
161889195|NCT03003000|584638305|FG002|Overall Study|Adverse Event|3|||
161889196|NCT03003000|584638303|FG000|Overall Study|Lack of Efficacy|1|||
161889197|NCT03003000|584638304|FG001|Overall Study|Lack of Efficacy|0|||
161889198|NCT03003000|584638305|FG002|Overall Study|Lack of Efficacy|0|||
161889199|NCT03003000|584638303|FG000|Overall Study|Non-compliant with protocol|0|||
161889200|NCT03003000|584638304|FG001|Overall Study|Non-compliant with protocol|1|||
161889201|NCT03003000|584638305|FG002|Overall Study|Non-compliant with protocol|1|||
161889202|NCT03003000|584638303|FG000|Overall Study|Refused to continue medication|2|||
161889203|NCT03003000|584638304|FG001|Overall Study|Refused to continue medication|0|||
161889204|NCT03003000|584638305|FG002|Overall Study|Refused to continue medication|0|||
161889205|NCT03003000|584638303|FG000|Overall Study|Other than listed|1|||
161889206|NCT03003000|584638304|FG001|Overall Study|Other than listed|1|||
161889207|NCT03003000|584638305|FG002|Overall Study|Other than listed|1|||
161889208|NCT04933617|584638307|FG000|Dose Escalation|Early closure of study|0|||
161889209|NCT04933617|584638308|FG001|Dose Escalation|Early closure of study|3|||
161889210|NCT04933617|584638309|FG002|Dose Escalation|Early closure of study|0|||
161889211|NCT04933617|584638310|FG003|Dose Escalation|Early closure of study|0|||
161889212|NCT04933617|584638311|FG004|Dose Escalation|Early closure of study|0|||
161889213|NCT05268016|584638312|FG000|Overall Study|Unacceptable toxicity or AE|2|||
161889214|NCT05268016|584638313|FG001|Overall Study|Unacceptable toxicity or AE|2|||
161889215|NCT05268016|584638314|FG002|Overall Study|Unacceptable toxicity or AE|4|||
161889216|NCT05268016|584638315|FG003|Overall Study|Unacceptable toxicity or AE|3|||
161889217|NCT05268016|584638316|FG004|Overall Study|Unacceptable toxicity or AE|1|||
161889218|NCT05268016|584638312|FG000|Overall Study|Withdrawal by Subject|1|||
161889219|NCT05268016|584638313|FG001|Overall Study|Withdrawal by Subject|3|||
161889220|NCT05268016|584638314|FG002|Overall Study|Withdrawal by Subject|2|||
161889221|NCT05268016|584638315|FG003|Overall Study|Withdrawal by Subject|2|||
161889222|NCT05268016|584638316|FG004|Overall Study|Withdrawal by Subject|1|||
161889223|NCT05268016|584638312|FG000|Overall Study|Lost to Follow-up|4|||
161889224|NCT05268016|584638313|FG001|Overall Study|Lost to Follow-up|7|||
161889225|NCT05268016|584638314|FG002|Overall Study|Lost to Follow-up|1|||
161994781|NCT01248949|585030557|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
161994782|NCT01248949|585030558|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
161994783|NCT01248949|585030554|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
161994784|NCT01248949|585030555|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
161994785|NCT01248949|585030556|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
161994786|NCT01248949|585030557|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
161994787|NCT01248949|585030558|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
161994788|NCT03245775|585030561|FG000|Overall Study|Lost to Follow-up|25|||
161994789|NCT03245775|585030562|FG001|Overall Study|Lost to Follow-up|26|||
161994790|NCT03245775|585030563|FG002|Overall Study|Lost to Follow-up|16|||
161994791|NCT03245775|585030564|FG003|Overall Study|Lost to Follow-up|16|||
161994792|NCT01099397|585030566|FG000|Overall Study|Lost to Follow-up|4|||
161994793|NCT01099397|585030566|FG000|Overall Study|Protocol Violation|4|||
162038379|NCT05140382|585198065|FG002|Overall Study|Unknown at data cut-off|1|||
161889226|NCT05268016|584638315|FG003|Overall Study|Lost to Follow-up|3|||
161889227|NCT05268016|584638316|FG004|Overall Study|Lost to Follow-up|5|||
161889228|NCT05268016|584638312|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
161889229|NCT05268016|584638313|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
161889230|NCT05268016|584638314|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
161889231|NCT05268016|584638315|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
161889232|NCT05268016|584638316|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
161889233|NCT05268016|584638312|FG000|Overall Study|Lack of Efficacy|0|||
161889234|NCT05268016|584638313|FG001|Overall Study|Lack of Efficacy|0|||
161889235|NCT05268016|584638314|FG002|Overall Study|Lack of Efficacy|0|||
161889236|NCT05268016|584638315|FG003|Overall Study|Lack of Efficacy|0|||
161889237|NCT05268016|584638316|FG004|Overall Study|Lack of Efficacy|4|||
161889238|NCT05268016|584638312|FG000|Overall Study|Physician Decision|0|||
161889239|NCT05268016|584638313|FG001|Overall Study|Physician Decision|0|||
161889240|NCT05268016|584638314|FG002|Overall Study|Physician Decision|0|||
161889241|NCT05268016|584638315|FG003|Overall Study|Physician Decision|1|||
161889242|NCT05268016|584638316|FG004|Overall Study|Physician Decision|0|||
161889243|NCT05268016|584638312|FG000|Overall Study|Other|1|||
161889244|NCT05268016|584638313|FG001|Overall Study|Other|0|||
161889245|NCT05268016|584638314|FG002|Overall Study|Other|1|||
161889246|NCT05268016|584638315|FG003|Overall Study|Other|2|||
161889247|NCT05268016|584638316|FG004|Overall Study|Other|0|||
161889248|NCT01217385|584638318|FG000|Overall Study|Withdrawal by Subject|3|||
161889249|NCT01217385|584638318|FG000|Overall Study|DOSI not performed/not eval|12|||
161889250|NCT01217385|584638318|FG000|Overall Study|Central Path not Available|1|||
161889251|NCT01217385|584638318|FG000|Overall Study|Normal Breast TOI not available|10|||
161889252|NCT00090987|584638319|FG000|Overall Study|Adverse Event|5|||
161889253|NCT00090987|584638319|FG000|Overall Study|Lack of Efficacy|7|||
161889254|NCT00090987|584638319|FG000|Overall Study|Withdrawal by Subject|3|||
161889255|NCT00090987|584638319|FG000|Overall Study|alternative therapy|1|||
161889256|NCT00090987|584638319|FG000|Overall Study|Non-compliance|4|||
161889257|NCT00090987|584638319|FG000|Overall Study|Incarcerated|1|||
161889258|NCT00990665|584638324|FG000|Overall Study|Unsuccessful Implant|8|||
161889259|NCT00990665|584638324|FG000|Overall Study|Death|29|||
161889260|NCT00990665|584638324|FG000|Overall Study|Heart Transplant|1|||
161889261|NCT00990665|584638324|FG000|Overall Study|Withdrawal by Subject|6|||
161889262|NCT00990665|584638324|FG000|Overall Study|Lost to Follow-up|1|||
161889263|NCT00990665|584638324|FG000|Overall Study|System Explant|3|||
161889264|NCT00957905|584638325|FG000|Part B|Not Treated|0|||
161889265|NCT00957905|584638326|FG001|Part B|Not Treated|1|||
161889266|NCT00957905|584638325|FG000|Part B|Physician Decision|0|||
161889267|NCT00957905|584638326|FG001|Part B|Physician Decision|1|||
161889268|NCT00957905|584638325|FG000|Part B|Death|0|||
161889269|NCT00957905|584638326|FG001|Part B|Death|1|||
161889270|NCT00957905|584638325|FG000|Part B|Protocol Violation|0|||
161889271|NCT00957905|584638326|FG001|Part B|Protocol Violation|1|||
161889272|NCT01260584|584638343|FG000|Period 1|Protocol Violation|0|||
161889273|NCT01260584|584638344|FG001|Period 1|Protocol Violation|0|||
161889274|NCT01260584|584638345|FG002|Period 1|Protocol Violation|1|||
161889275|NCT01260584|584638346|FG003|Period 1|Protocol Violation|1|||
161889276|NCT01260584|584638343|FG000|Period 1|Adverse Event|0|||
161889277|NCT01260584|584638344|FG001|Period 1|Adverse Event|0|||
161889278|NCT01260584|584638345|FG002|Period 1|Adverse Event|1|||
161889279|NCT01260584|584638346|FG003|Period 1|Adverse Event|0|||
161889280|NCT01260584|584638343|FG000|Period 2|Protocol Violation|0|||
161889281|NCT01260584|584638344|FG001|Period 2|Protocol Violation|2|||
161889282|NCT01260584|584638345|FG002|Period 2|Protocol Violation|3|||
161889283|NCT01260584|584638346|FG003|Period 2|Protocol Violation|1|||
161889284|NCT01260584|584638343|FG000|Period 2|Adverse Event|1|||
161889285|NCT01260584|584638344|FG001|Period 2|Adverse Event|0|||
161889286|NCT01260584|584638345|FG002|Period 2|Adverse Event|2|||
161889287|NCT01260584|584638346|FG003|Period 2|Adverse Event|0|||
161889288|NCT01260584|584638343|FG000|Period 2|Withdrawal by Subject|0|||
161889289|NCT01260584|584638344|FG001|Period 2|Withdrawal by Subject|1|||
161889290|NCT01260584|584638345|FG002|Period 2|Withdrawal by Subject|0|||
161889291|NCT01260584|584638346|FG003|Period 2|Withdrawal by Subject|0|||
161889292|NCT00045734|584638347|FG000|Overall Study|Protocol Violation|1|||
161889293|NCT02069093|584638348|FG000|Overall Study|Disease progression|14|||
161889294|NCT02069093|584638348|FG000|Overall Study|New cancer therapy|1|||
161889295|NCT02069093|584638348|FG000|Overall Study|Death|1|||
161889296|NCT02069093|584638348|FG000|Overall Study|Administrative problems|1|||
161889297|NCT02069093|584638348|FG000|Overall Study|Withdrawal by Subject|2|||
161889298|NCT02069093|584638348|FG000|Overall Study|Abnormal laboratory values|1|||
161889299|NCT02069093|584638348|FG000|Overall Study|Adverse Event|10|||
161889300|NCT01969084|584638352|FG000|Overall Study|Adverse Event|0|||
161889301|NCT01969084|584638353|FG001|Overall Study|Adverse Event|1|||
161889302|NCT01362244|584638354|FG000|Overall Study|Adverse Event|3|||
161889303|NCT01362244|584638355|FG001|Overall Study|Adverse Event|5|||
161889304|NCT01362244|584638354|FG000|Overall Study|Lack of Efficacy|5|||
161889305|NCT01362244|584638355|FG001|Overall Study|Lack of Efficacy|11|||
161994794|NCT01099397|585030566|FG000|Overall Study|Withdrawal by Subject|5|||
161994795|NCT02363959|585030567|FG000|Overall Study|Medical instability|1|||
161994796|NCT02363959|585030568|FG001|Overall Study|Medical instability|0|||
161889306|NCT01362244|584638354|FG000|Overall Study|Lost to Follow-up|0|||
161889307|NCT01362244|584638355|FG001|Overall Study|Lost to Follow-up|2|||
161889308|NCT01362244|584638354|FG000|Overall Study|Protocol Violation|5|||
161889309|NCT01362244|584638355|FG001|Overall Study|Protocol Violation|1|||
161889310|NCT01362244|584638354|FG000|Overall Study|Withdrawal by Subject|2|||
161889311|NCT01362244|584638355|FG001|Overall Study|Withdrawal by Subject|1|||
161889312|NCT01362244|584638354|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
161889313|NCT01362244|584638355|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
161889314|NCT01362244|584638354|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
161889315|NCT01362244|584638355|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
161889316|NCT01253174|584638356|FG000|Period 1|Randomized but not treated|0|||
161889317|NCT01253174|584638357|FG001|Period 1|Randomized but not treated|1|||
161889318|NCT01253174|584638358|FG002|Period 1|Randomized but not treated|1|||
161889319|NCT01253174|584638359|FG003|Period 1|Randomized but not treated|0|||
161889320|NCT01253174|584638360|FG004|Period 1|Randomized but not treated|1|||
161889321|NCT01253174|584638361|FG005|Period 1|Randomized but not treated|0|||
161889322|NCT01253174|584638356|FG000|Period 2|Adverse Event|0|||
161889323|NCT01253174|584638357|FG001|Period 2|Adverse Event|0|||
161889324|NCT01253174|584638358|FG002|Period 2|Adverse Event|1|||
161889325|NCT01253174|584638359|FG003|Period 2|Adverse Event|0|||
161889326|NCT01253174|584638360|FG004|Period 2|Adverse Event|0|||
161889327|NCT01253174|584638361|FG005|Period 2|Adverse Event|0|||
161889328|NCT01253174|584638356|FG000|Period 3|Withdrawal by Subject|0|||
161889329|NCT01253174|584638357|FG001|Period 3|Withdrawal by Subject|1|||
161889330|NCT01253174|584638358|FG002|Period 3|Withdrawal by Subject|0|||
161889331|NCT01253174|584638359|FG003|Period 3|Withdrawal by Subject|0|||
161889332|NCT01253174|584638360|FG004|Period 3|Withdrawal by Subject|1|||
161889333|NCT01253174|584638361|FG005|Period 3|Withdrawal by Subject|0|||
161889334|NCT01253174|584638356|FG000|Period 3|Pregnancy|0|||
161889335|NCT01253174|584638357|FG001|Period 3|Pregnancy|0|||
161889336|NCT01253174|584638358|FG002|Period 3|Pregnancy|1|||
161889337|NCT01253174|584638359|FG003|Period 3|Pregnancy|0|||
161889338|NCT01253174|584638360|FG004|Period 3|Pregnancy|0|||
161889339|NCT01253174|584638361|FG005|Period 3|Pregnancy|0|||
161889340|NCT02267135|584638362|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
161889341|NCT02267135|584638363|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
161889342|NCT02267135|584638362|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
161889343|NCT02267135|584638363|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
161889344|NCT02267135|584638362|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
161889345|NCT02267135|584638363|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
161889346|NCT02267135|584638362|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
161889347|NCT02267135|584638363|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
161889348|NCT02267135|584638362|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
161889349|NCT02267135|584638363|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
161889350|NCT03806231|584638364|FG000|Overall Study|Physician Decision|1|||
161889351|NCT03806231|584638365|FG001|Overall Study|Physician Decision|0|||
161889352|NCT03806231|584638364|FG000|Overall Study|Withdrawal by Subject|1|||
161889353|NCT03806231|584638365|FG001|Overall Study|Withdrawal by Subject|0|||
161889354|NCT02919267|584638366|FG000|Overall Study|Protocol Violation|0|||
161889355|NCT02919267|584638367|FG001|Overall Study|Protocol Violation|3|||
161889356|NCT02919267|584638368|FG002|Overall Study|Protocol Violation|3|||
161889357|NCT02919267|584638369|FG003|Overall Study|Protocol Violation|4|||
161889358|NCT00467961|584638370|FG000|Overall Study|Technical Failures|5|||
161889359|NCT00467961|584638370|FG000|Overall Study|Disease Progression|2|||
161889360|NCT00394433|584638372|FG000|Overall Study|Adverse Event|2|||
161889361|NCT00394433|584638372|FG000|Overall Study|Alternative Therapy|1|||
161889362|NCT06439095|584639773|FG000|Overall Study|Lost to Follow-up|2|||
161889363|NCT03484403|584639775|FG000|Overall Study|Withdrawal by Subject|6|||
161889364|NCT03484403|584639776|FG001|Overall Study|Withdrawal by Subject|4|||
161889365|NCT01937884|584639778|FG000|Overall Study|Withdrawal by Subject|1|||
161889366|NCT01937884|584639779|FG001|Overall Study|Withdrawal by Subject|0|||
161889367|NCT02191046|584639780|FG000|Overall Study|low compliance|5|||
161889368|NCT02191046|584639781|FG001|Overall Study|low compliance|1|||
161889369|NCT01964716|584639782|FG000|Overall Study|Withdrawal by Subject|2|||
161889370|NCT01964716|584639783|FG001|Overall Study|Withdrawal by Subject|3|||
161889371|NCT01964716|584639782|FG000|Overall Study|Lost to Follow-up|1|||
161889372|NCT01964716|584639783|FG001|Overall Study|Lost to Follow-up|2|||
161889373|NCT01964716|584639782|FG000|Overall Study|No longer met eligibility criteria|1|||
161889374|NCT01964716|584639783|FG001|Overall Study|No longer met eligibility criteria|1|||
161889375|NCT01964716|584639782|FG000|Overall Study|Death|1|||
161889376|NCT01964716|584639783|FG001|Overall Study|Death|0|||
161994797|NCT00950248|585030571|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
161994798|NCT00950248|585030572|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
161889377|NCT02147067|584639784|FG000|Overall Study|Withdrawal by Subject|2|||
161889378|NCT02147067|584639785|FG001|Overall Study|Withdrawal by Subject|2|||
161889379|NCT00089635|584639786|FG000|Overall Study|Adverse Event|2|||
161994799|NCT00950248|585030573|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
161994800|NCT00950248|585030571|FG000|Year 1: Baseline|worsening of symptoms|2|||
161889380|NCT00089635|584639786|FG000|Overall Study|Death|17|||
161889381|NCT00089635|584639786|FG000|Overall Study|Disease Progression|12|||
161889382|NCT00089635|584639786|FG000|Overall Study|Lost to Follow-up|3|||
161889383|NCT00089635|584639786|FG000|Overall Study|Withdrawal by Subject|6|||
161889384|NCT00089635|584639786|FG000|Overall Study|Ineligibility determined|1|||
161889385|NCT00089635|584639786|FG000|Overall Study|Other|2|||
161889386|NCT02943785|584639787|FG000|Overall Study|Adverse Event|112|||
161889387|NCT02943785|584639788|FG001|Overall Study|Adverse Event|97|||
161889388|NCT02943785|584639787|FG000|Overall Study|Withdrawal by Subject|63|||
161889389|NCT02943785|584639788|FG001|Overall Study|Withdrawal by Subject|126|||
161889390|NCT02943785|584639787|FG000|Overall Study|Physician Decision|23|||
161889391|NCT02943785|584639788|FG001|Overall Study|Physician Decision|47|||
161889392|NCT02943785|584639787|FG000|Overall Study|Death|46|||
161889393|NCT02943785|584639788|FG001|Overall Study|Death|46|||
161889394|NCT02943785|584639787|FG000|Overall Study|Lost to Follow-up|1|||
161889395|NCT02943785|584639788|FG001|Overall Study|Lost to Follow-up|0|||
161889396|NCT02943785|584639787|FG000|Overall Study|Other|16|||
161889397|NCT02943785|584639788|FG001|Overall Study|Other|19|||
161889398|NCT02943785|584639787|FG000|Overall Study|Did not receive any study medication|21|||
161889399|NCT02943785|584639788|FG001|Overall Study|Did not receive any study medication|28|||
161889400|NCT02603107|584639789|FG000|Randomized Phase|Withdrew consent|8|||
161889401|NCT02603107|584639790|FG001|Randomized Phase|Withdrew consent|15|||
161889402|NCT02603107|584639789|FG000|Randomized Phase|Lost to Follow-up|1|||
161889403|NCT02603107|584639790|FG001|Randomized Phase|Lost to Follow-up|3|||
161889404|NCT02603107|584639789|FG000|Randomized Phase|Adverse Event|2|||
161889405|NCT02603107|584639790|FG001|Randomized Phase|Adverse Event|0|||
161889406|NCT02603107|584639789|FG000|Randomized Phase|Death|1|||
161889407|NCT02603107|584639790|FG001|Randomized Phase|Death|1|||
161889408|NCT02603107|584639789|FG000|Randomized Phase|Non-compliance with study drug|1|||
161889409|NCT02603107|584639790|FG001|Randomized Phase|Non-compliance with study drug|1|||
161889410|NCT02603107|584639789|FG000|Randomized Phase|Investigator's discretion|0|||
161889411|NCT02603107|584639790|FG001|Randomized Phase|Investigator's discretion|1|||
161889412|NCT02603107|584639789|FG000|Randomized Phase|Lack of Efficacy|1|||
161889413|NCT02603107|584639790|FG001|Randomized Phase|Lack of Efficacy|0|||
161889414|NCT02603107|584639789|FG000|Randomized Phase|Protocol Violation|1|||
161889415|NCT02603107|584639790|FG001|Randomized Phase|Protocol Violation|0|||
161889416|NCT02603107|584639789|FG000|Optional Extension Phase|Lost to Follow-up|3|||
161889417|NCT02603107|584639790|FG001|Optional Extension Phase|Lost to Follow-up|3|||
161889418|NCT02603107|584639789|FG000|Optional Extension Phase|Withdrew consent|3|||
161889419|NCT02603107|584639790|FG001|Optional Extension Phase|Withdrew consent|2|||
161889420|NCT02603107|584639789|FG000|Optional Extension Phase|Investigator's discretion|2|||
161889421|NCT02603107|584639790|FG001|Optional Extension Phase|Investigator's discretion|2|||
161889422|NCT02603107|584639789|FG000|Optional Extension Phase|Pregnancy|0|||
161889423|NCT02603107|584639790|FG001|Optional Extension Phase|Pregnancy|3|||
161889424|NCT02603107|584639789|FG000|Optional Extension Phase|Adverse Event|0|||
161889425|NCT02603107|584639790|FG001|Optional Extension Phase|Adverse Event|2|||
161889426|NCT02603107|584639789|FG000|Optional Extension Phase|Not treated in extension phase|0|||
161889427|NCT02603107|584639790|FG001|Optional Extension Phase|Not treated in extension phase|1|||
161889428|NCT02603107|584639789|FG000|Optional Extension Phase|Protocol Violation|1|||
161889429|NCT02603107|584639790|FG001|Optional Extension Phase|Protocol Violation|0|||
161889430|NCT00821015|584639793|FG000|Overall Study|Lost to Follow-up|12|||
161889431|NCT03013985|584639799|FG000|Overall Study|Protocol Violation|2|||
161889432|NCT03013985|584639800|FG001|Overall Study|Protocol Violation|2|||
161889433|NCT03013985|584639799|FG000|Overall Study|Withdrawal by Subject|14|||
161889434|NCT03013985|584639800|FG001|Overall Study|Withdrawal by Subject|17|||
161889435|NCT01887678|584639801|FG000|Overall Study|Adverse Event|4|||
161889436|NCT01887678|584639802|FG001|Overall Study|Adverse Event|6|||
161889437|NCT01887678|584639801|FG000|Overall Study|Exceeded rescue medication dosage|4|||
161889438|NCT01887678|584639802|FG001|Overall Study|Exceeded rescue medication dosage|5|||
161889439|NCT01887678|584639801|FG000|Overall Study|Withdrawal of consent|3|||
161889440|NCT01887678|584639802|FG001|Overall Study|Withdrawal of consent|4|||
161889441|NCT01887678|584639801|FG000|Overall Study|Lost to Follow-up|4|||
161889442|NCT01887678|584639802|FG001|Overall Study|Lost to Follow-up|2|||
161889443|NCT01887678|584639801|FG000|Overall Study|Deterioration of clinical condition|0|||
161889444|NCT01887678|584639802|FG001|Overall Study|Deterioration of clinical condition|4|||
161889445|NCT01887678|584639801|FG000|Overall Study|Lack of Efficacy|1|||
161889446|NCT01887678|584639802|FG001|Overall Study|Lack of Efficacy|2|||
161889447|NCT01887678|584639801|FG000|Overall Study|Non-compliance|0|||
161889448|NCT01887678|584639802|FG001|Overall Study|Non-compliance|3|||
161889449|NCT01887678|584639801|FG000|Overall Study|Specified|1|||
161889450|NCT01887678|584639802|FG001|Overall Study|Specified|2|||
161889451|NCT00791492|584639806|FG000|Overall Study|Withdrawal by Subject|1|||
161889452|NCT00791492|584639807|FG001|Overall Study|Withdrawal by Subject|2|||
161889453|NCT00791492|584639806|FG000|Overall Study|Liver transplantation|5|||
161889454|NCT00791492|584639807|FG001|Overall Study|Liver transplantation|1|||
161889455|NCT01370616|584639808|FG000|Overall Study|Adverse Event|11|||
161889456|NCT01370616|584639809|FG001|Overall Study|Adverse Event|16|||
161889457|NCT01370616|584639808|FG000|Overall Study|Death|1|||
161889458|NCT01370616|584639809|FG001|Overall Study|Death|0|||
161889459|NCT01370616|584639808|FG000|Overall Study|Lack of Efficacy|6|||
161889460|NCT01370616|584639809|FG001|Overall Study|Lack of Efficacy|2|||
161889461|NCT01370616|584639808|FG000|Overall Study|Lost to Follow-up|0|||
161889462|NCT01370616|584639809|FG001|Overall Study|Lost to Follow-up|3|||
161889463|NCT01370616|584639808|FG000|Overall Study|Physician Decision|6|||
161889464|NCT01370616|584639809|FG001|Overall Study|Physician Decision|6|||
161889465|NCT01370616|584639808|FG000|Overall Study|Progressive Disease|0|||
161889466|NCT01370616|584639809|FG001|Overall Study|Progressive Disease|1|||
161889467|NCT01370616|584639808|FG000|Overall Study|Recovery|1|||
161889468|NCT01370616|584639809|FG001|Overall Study|Recovery|0|||
161889469|NCT01370616|584639808|FG000|Overall Study|Technical Problems|3|||
161889470|NCT01370616|584639809|FG001|Overall Study|Technical Problems|5|||
161889471|NCT01370616|584639808|FG000|Overall Study|Withdrawal by Subject|34|||
161889472|NCT01370616|584639809|FG001|Overall Study|Withdrawal by Subject|34|||
161889473|NCT01017601|584639810|FG000|Overall Study|Disease Progression|12|||
161889474|NCT01017601|584639811|FG001|Overall Study|Disease Progression|12|||
161889475|NCT01017601|584639810|FG000|Overall Study|Withdrawal by Subject|0|||
161889476|NCT01017601|584639811|FG001|Overall Study|Withdrawal by Subject|1|||
161889477|NCT00076999|584639812|FG000|Overall Study|Adverse Event|2|||
161889478|NCT00076999|584639813|FG001|Overall Study|Adverse Event|8|||
161889479|NCT00076999|584639814|FG002|Overall Study|Adverse Event|6|||
161889480|NCT00076999|584639815|FG003|Overall Study|Adverse Event|0|||
161889481|NCT00076999|584639816|FG004|Overall Study|Adverse Event|2|||
161889482|NCT00076999|584639812|FG000|Overall Study|Protocol Violation|0|||
161889483|NCT00076999|584639813|FG001|Overall Study|Protocol Violation|3|||
161889484|NCT00076999|584639814|FG002|Overall Study|Protocol Violation|4|||
161889485|NCT00076999|584639815|FG003|Overall Study|Protocol Violation|0|||
161889486|NCT00076999|584639816|FG004|Overall Study|Protocol Violation|9|||
161889487|NCT00076999|584639812|FG000|Overall Study|Lost to Follow-up|2|||
161889488|NCT00076999|584639813|FG001|Overall Study|Lost to Follow-up|1|||
161889489|NCT00076999|584639814|FG002|Overall Study|Lost to Follow-up|0|||
161889490|NCT00076999|584639815|FG003|Overall Study|Lost to Follow-up|0|||
161889491|NCT00076999|584639816|FG004|Overall Study|Lost to Follow-up|0|||
161889492|NCT00076999|584639812|FG000|Overall Study|Withdrawal by Subject|0|||
161889493|NCT00076999|584639813|FG001|Overall Study|Withdrawal by Subject|4|||
161889494|NCT00076999|584639814|FG002|Overall Study|Withdrawal by Subject|3|||
161889495|NCT00076999|584639815|FG003|Overall Study|Withdrawal by Subject|0|||
161889496|NCT00076999|584639816|FG004|Overall Study|Withdrawal by Subject|1|||
161889497|NCT00076999|584639812|FG000|Overall Study|Other reason (not specified)|8|||
161889498|NCT00076999|584639813|FG001|Overall Study|Other reason (not specified)|8|||
161889499|NCT00076999|584639814|FG002|Overall Study|Other reason (not specified)|4|||
161889500|NCT00076999|584639815|FG003|Overall Study|Other reason (not specified)|1|||
161889501|NCT00076999|584639816|FG004|Overall Study|Other reason (not specified)|13|||
161889502|NCT00803205|584639818|FG000|Overall Study|Adverse Event|7|||
161889503|NCT00803205|584639819|FG001|Overall Study|Adverse Event|2|||
161889504|NCT00803205|584639818|FG000|Overall Study|Lost to Follow-up|1|||
161889505|NCT00803205|584639819|FG001|Overall Study|Lost to Follow-up|0|||
161889506|NCT00803205|584639818|FG000|Overall Study|Withdrawal by Subject|9|||
161889507|NCT00803205|584639819|FG001|Overall Study|Withdrawal by Subject|9|||
161889508|NCT00803205|584639818|FG000|Overall Study|Physician Decision|1|||
161889509|NCT00803205|584639819|FG001|Overall Study|Physician Decision|0|||
161889510|NCT00803205|584639818|FG000|Overall Study|Protocol Violation|1|||
161889511|NCT00803205|584639819|FG001|Overall Study|Protocol Violation|1|||
161889512|NCT00803205|584639818|FG000|Overall Study|Medical Monitor Decision|1|||
161889513|NCT00803205|584639819|FG001|Overall Study|Medical Monitor Decision|0|||
161889514|NCT00803205|584639818|FG000|Overall Study|Acquired a Lung Infection|0|||
161889515|NCT00803205|584639819|FG001|Overall Study|Acquired a Lung Infection|1|||
161889516|NCT00803205|584639818|FG000|Overall Study|Sponsor Decision|0|||
161889517|NCT00803205|584639819|FG001|Overall Study|Sponsor Decision|1|||
161889518|NCT01857102|584639820|FG000|Period 1|No longer meets Eligibility Criteria|0|||
161889519|NCT01857102|584639821|FG001|Period 1|No longer meets Eligibility Criteria|2|||
161889520|NCT01857102|584639820|FG000|Period 1|Lost to Follow-up|0|||
161889521|NCT01857102|584639821|FG001|Period 1|Lost to Follow-up|3|||
161889522|NCT01857102|584639820|FG000|Period 1|Unsatisfactory Lens Fit|1|||
161889523|NCT01857102|584639821|FG001|Period 1|Unsatisfactory Lens Fit|0|||
161889524|NCT01857102|584639820|FG000|Period 1|Unsatisfactory Visual Response|1|||
161889525|NCT01857102|584639821|FG001|Period 1|Unsatisfactory Visual Response|0|||
161889526|NCT01857102|584639820|FG000|Period 1|Physician Decision|1|||
161889527|NCT01857102|584639821|FG001|Period 1|Physician Decision|0|||
161889528|NCT01857102|584639820|FG000|Period 2|Lens Discomfort|1|||
161889529|NCT01857102|584639821|FG001|Period 2|Lens Discomfort|0|||
161889530|NCT01857102|584639820|FG000|Period 2|Unsatisfactory Lens Fit|1|||
161889531|NCT01857102|584639821|FG001|Period 2|Unsatisfactory Lens Fit|0|||
161889532|NCT02603562|584639822|FG000|Overall Study|Lost to Follow-up|1|||
161994801|NCT00950248|585030572|FG001|Year 1: Baseline|worsening of symptoms|0|||
161994802|NCT00950248|585030573|FG002|Year 1: Baseline|worsening of symptoms|0|||
161889533|NCT00270231|584639823|FG000|First Intervention|Lost to Follow-up|1|||
161994803|NCT00950248|585030571|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
161889534|NCT00270231|584639824|FG001|First Intervention|Lost to Follow-up|1|||
161889535|NCT00270231|584639823|FG000|Washout Period|Lost to Follow-up|1|||
161889536|NCT00270231|584639824|FG001|Washout Period|Lost to Follow-up|0|||
161889537|NCT00270231|584639823|FG000|Second Intervention|Lost to Follow-up|0|||
161889538|NCT00270231|584639824|FG001|Second Intervention|Lost to Follow-up|1|||
161889539|NCT00574795|584639826|FG000|Infant Series|Withdrawal by Subject|2|||
161889540|NCT00574795|584639826|FG000|Infant Series|Protocol Violation|2|||
161889541|NCT00574795|584639826|FG000|Infant Series|Adverse Event|1|||
161889542|NCT00574795|584639826|FG000|After Infant Series|Withdrawal by Subject|1|||
161889543|NCT00574795|584639826|FG000|After Infant Series|Adverse Event|2|||
161889544|NCT00574795|584639826|FG000|Toddler Dose|Withdrawal by Subject|1|||
161889545|NCT02638259|584639827|FG000|Treatment Period 1|Adverse Event|1|||
161889546|NCT02638259|584639828|FG001|Treatment Period 1|Adverse Event|5|||
161889547|NCT02638259|584639827|FG000|Treatment Period 1|Death|0|||
161889548|NCT02638259|584639828|FG001|Treatment Period 1|Death|1|||
161889549|NCT02638259|584639827|FG000|Treatment Period 1|Lack of Efficacy|0|||
161889550|NCT02638259|584639828|FG001|Treatment Period 1|Lack of Efficacy|1|||
161889551|NCT02638259|584639827|FG000|Treatment Period 1|Protocol Violation|0|||
161889552|NCT02638259|584639828|FG001|Treatment Period 1|Protocol Violation|3|||
161889553|NCT02638259|584639827|FG000|Treatment Period 1|Withdrawal by Subject|4|||
161889554|NCT02638259|584639828|FG001|Treatment Period 1|Withdrawal by Subject|6|||
161889555|NCT02638259|584639827|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
161889556|NCT02638259|584639828|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
161889557|NCT02638259|584639827|FG000|Treatment Period 2|Adverse Event|5|||
161889558|NCT02638259|584639828|FG001|Treatment Period 2|Adverse Event|4|||
161889559|NCT02638259|584639827|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161889560|NCT02638259|584639828|FG001|Treatment Period 2|Withdrawal by Subject|7|||
161889561|NCT04299048|584639829|FG000|Overall Study|Death|1|||
161889562|NCT04299048|584639829|FG000|Overall Study|Global deterioration of health status|2|||
161889563|NCT04299048|584639829|FG000|Overall Study|Enrolled and not treated|1|||
161889564|NCT00634049|584639830|FG000|Overall Study|Never received study drug|1|||
161889565|NCT00634049|584639830|FG000|Overall Study|Died prior to receiving study drug|1|||
161889566|NCT00634049|584639830|FG000|Overall Study|Screening failure|1|||
161889567|NCT01717391|584639831|FG000|Overall Study|Withdrawal by Subject|5|||
161889568|NCT01717391|584639831|FG000|Overall Study|Physician Decision|1|||
161889569|NCT01717391|584639831|FG000|Overall Study|FLT technical failure|3|||
161889570|NCT03434249|584639835|FG000|Overall Study|Adverse Event|1|||
161889571|NCT03434249|584639836|FG001|Overall Study|Adverse Event|0|||
161889572|NCT03434249|584639835|FG000|Overall Study|Lost to Follow-up|0|||
161889573|NCT03434249|584639836|FG001|Overall Study|Lost to Follow-up|1|||
161889574|NCT03434249|584639835|FG000|Overall Study|Non-compliance of family|2|||
161889575|NCT03434249|584639836|FG001|Overall Study|Non-compliance of family|1|||
161889576|NCT03434249|584639835|FG000|Overall Study|Difficulties in completing daily diary|2|||
161889577|NCT03434249|584639836|FG001|Overall Study|Difficulties in completing daily diary|1|||
161889578|NCT01001598|584639837|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
161889579|NCT01001598|584639837|FG000|Overall Study|Adverse Event|1|||
161889580|NCT02920177|584639841|FG000|Overall Study|Withdrawal by Subject|1|||
161889581|NCT02920177|584639842|FG001|Overall Study|Withdrawal by Subject|1|||
161889582|NCT02920177|584639841|FG000|Overall Study|Physician Decision|1|||
161889583|NCT02920177|584639842|FG001|Overall Study|Physician Decision|0|||
161889584|NCT02920177|584639841|FG000|Overall Study|Lost to Follow-up|0|||
161889585|NCT02920177|584639842|FG001|Overall Study|Lost to Follow-up|1|||
161889586|NCT03164265|584639843|FG000|Overall Study|Physician Decision|3|||
161889587|NCT04907227|584639844|FG000|Overall Study|Death|12|||
161889588|NCT04907227|584639845|FG001|Overall Study|Death|8|||
161889589|NCT04907227|584639844|FG000|Overall Study|Withdrawal by Subject|2|||
161889590|NCT04907227|584639845|FG001|Overall Study|Withdrawal by Subject|2|||
161889591|NCT04907227|584639844|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
161889592|NCT04907227|584639845|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
161889593|NCT04907227|584639844|FG000|Overall Study|Sponsor Decision|25|||
161889594|NCT04907227|584639845|FG001|Overall Study|Sponsor Decision|30|||
161889595|NCT04907227|584639844|FG000|Overall Study|Physician Decision|1|||
161889596|NCT04907227|584639845|FG001|Overall Study|Physician Decision|0|||
161889597|NCT02208050|584639846|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
161889598|NCT02208050|584639847|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
161889599|NCT00721279|584639851|FG000|Overall Study|Lack of Efficacy|6|||
161889600|NCT00721279|584639852|FG001|Overall Study|Lack of Efficacy|3|||
161889601|NCT00721279|584639851|FG000|Overall Study|Tolerability insufficient|5|||
161889602|NCT00721279|584639852|FG001|Overall Study|Tolerability insufficient|2|||
161889603|NCT00721279|584639851|FG000|Overall Study|Withdrawal by Subject|13|||
161889604|NCT00721279|584639852|FG001|Overall Study|Withdrawal by Subject|3|||
161889605|NCT00721279|584639851|FG000|Overall Study|Other|12|||
161889606|NCT00721279|584639852|FG001|Overall Study|Other|16|||
161994804|NCT00950248|585030572|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
161994805|NCT00950248|585030573|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
161994806|NCT00950248|585030571|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
161994807|NCT00950248|585030572|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
161994808|NCT00950248|585030573|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
161994809|NCT00950248|585030571|FG000|Year 2&3 Treatment Randomization|Death|0|||
161889607|NCT03673345|584639853|FG000|Overall Study|Lost to Follow-up|1|||
161889608|NCT03673345|584639854|FG001|Overall Study|Lost to Follow-up|0|||
161889609|NCT03673345|584639855|FG002|Overall Study|Lost to Follow-up|3|||
161889610|NCT03673345|584639856|FG003|Overall Study|Lost to Follow-up|3|||
161889611|NCT03673345|584639857|FG004|Overall Study|Lost to Follow-up|2|||
161889612|NCT03673345|584639858|FG005|Overall Study|Lost to Follow-up|1|||
161889613|NCT03673345|584639859|FG006|Overall Study|Lost to Follow-up|0|||
161994810|NCT00950248|585030572|FG001|Year 2&3 Treatment Randomization|Death|0|||
161889614|NCT03673345|584639860|FG007|Overall Study|Lost to Follow-up|0|||
161889615|NCT03673345|584639853|FG000|Overall Study|Withdrawal by Subject|1|||
161889616|NCT03673345|584639854|FG001|Overall Study|Withdrawal by Subject|0|||
161889617|NCT03673345|584639855|FG002|Overall Study|Withdrawal by Subject|4|||
161889618|NCT03673345|584639856|FG003|Overall Study|Withdrawal by Subject|2|||
161889619|NCT03673345|584639857|FG004|Overall Study|Withdrawal by Subject|0|||
161889620|NCT03673345|584639858|FG005|Overall Study|Withdrawal by Subject|0|||
161889621|NCT03673345|584639859|FG006|Overall Study|Withdrawal by Subject|0|||
161889622|NCT03673345|584639860|FG007|Overall Study|Withdrawal by Subject|0|||
161889623|NCT03673345|584639853|FG000|Overall Study|Physician Decision|0|||
161889624|NCT03673345|584639854|FG001|Overall Study|Physician Decision|0|||
161889625|NCT03673345|584639855|FG002|Overall Study|Physician Decision|2|||
161889626|NCT03673345|584639856|FG003|Overall Study|Physician Decision|0|||
161889627|NCT03673345|584639857|FG004|Overall Study|Physician Decision|0|||
161889628|NCT03673345|584639858|FG005|Overall Study|Physician Decision|0|||
161889629|NCT03673345|584639859|FG006|Overall Study|Physician Decision|0|||
161889630|NCT03673345|584639860|FG007|Overall Study|Physician Decision|0|||
161889631|NCT04608344|584639861|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
161889632|NCT04608344|584639862|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
161889633|NCT04608344|584639861|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
161889634|NCT04608344|584639862|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
161889635|NCT02429310|584639863|FG000|Overall Study|Lost to Follow-up|1|||
161889636|NCT02429310|584639864|FG001|Overall Study|Lost to Follow-up|2|||
161889637|NCT02429310|584639863|FG000|Overall Study|Protocol Violation|1|||
161889638|NCT02429310|584639864|FG001|Overall Study|Protocol Violation|1|||
161889639|NCT03646305|584639865|FG000|Overall Study|Lost to Follow-up|4|||
161889640|NCT03646305|584639866|FG001|Overall Study|Lost to Follow-up|2|||
161889641|NCT03646305|584639867|FG002|Overall Study|Lost to Follow-up|2|||
161889642|NCT03646305|584639868|FG003|Overall Study|Lost to Follow-up|1|||
161889643|NCT03646305|584639865|FG000|Overall Study|Withdrawal by Subject|1|||
161889644|NCT03646305|584639866|FG001|Overall Study|Withdrawal by Subject|0|||
161889645|NCT03646305|584639867|FG002|Overall Study|Withdrawal by Subject|0|||
161889646|NCT03646305|584639868|FG003|Overall Study|Withdrawal by Subject|1|||
161889647|NCT01554176|584639869|FG000|Treatment Phase|Protocol Violation|1|||
161889648|NCT01554176|584639870|FG001|Treatment Phase|Protocol Violation|2|||
161889649|NCT01554176|584639871|FG002|Treatment Phase|Protocol Violation|0|||
161889650|NCT01554176|584639872|FG003|Treatment Phase|Protocol Violation|0|||
161889651|NCT01554176|584639873|FG004|Treatment Phase|Protocol Violation|0|||
161889652|NCT01554176|584639869|FG000|Treatment Phase|Physician Decision|1|||
161889653|NCT01554176|584639870|FG001|Treatment Phase|Physician Decision|1|||
161889654|NCT01554176|584639871|FG002|Treatment Phase|Physician Decision|0|||
161889655|NCT01554176|584639872|FG003|Treatment Phase|Physician Decision|0|||
161889656|NCT01554176|584639873|FG004|Treatment Phase|Physician Decision|0|||
161889657|NCT01554176|584639869|FG000|Treatment Phase|Lack of Efficacy|0|||
161889658|NCT01554176|584639870|FG001|Treatment Phase|Lack of Efficacy|1|||
161889659|NCT01554176|584639871|FG002|Treatment Phase|Lack of Efficacy|0|||
161889660|NCT01554176|584639872|FG003|Treatment Phase|Lack of Efficacy|0|||
161889661|NCT01554176|584639873|FG004|Treatment Phase|Lack of Efficacy|0|||
161889662|NCT01554176|584639869|FG000|Treatment Phase|Adverse event, non-fatal|1|||
161889663|NCT01554176|584639870|FG001|Treatment Phase|Adverse event, non-fatal|1|||
162038380|NCT05140382|585198063|FG000|Overall Study|Withdrawal by Subject|1|||
161889664|NCT01554176|584639871|FG002|Treatment Phase|Adverse event, non-fatal|0|||
161889665|NCT01554176|584639872|FG003|Treatment Phase|Adverse event, non-fatal|0|||
161889666|NCT01554176|584639873|FG004|Treatment Phase|Adverse event, non-fatal|0|||
161889667|NCT01554176|584639869|FG000|Treatment Phase|Non-compliance with study drug|1|||
161889668|NCT01554176|584639870|FG001|Treatment Phase|Non-compliance with study drug|0|||
161889669|NCT01554176|584639871|FG002|Treatment Phase|Non-compliance with study drug|0|||
161889670|NCT01554176|584639872|FG003|Treatment Phase|Non-compliance with study drug|0|||
161889671|NCT01554176|584639873|FG004|Treatment Phase|Non-compliance with study drug|0|||
161889672|NCT01554176|584639869|FG000|Treatment Phase|Withdrawal by Subject|1|||
161889673|NCT01554176|584639870|FG001|Treatment Phase|Withdrawal by Subject|0|||
161889674|NCT01554176|584639871|FG002|Treatment Phase|Withdrawal by Subject|0|||
161889675|NCT01554176|584639872|FG003|Treatment Phase|Withdrawal by Subject|0|||
161889676|NCT01554176|584639873|FG004|Treatment Phase|Withdrawal by Subject|0|||
161889677|NCT01554176|584639869|FG000|Treatment Phase|Lost to Follow-up|3|||
161889678|NCT01554176|584639870|FG001|Treatment Phase|Lost to Follow-up|0|||
161889679|NCT01554176|584639871|FG002|Treatment Phase|Lost to Follow-up|0|||
161889680|NCT01554176|584639872|FG003|Treatment Phase|Lost to Follow-up|0|||
161889681|NCT01554176|584639873|FG004|Treatment Phase|Lost to Follow-up|0|||
161889682|NCT01554176|584639869|FG000|Run-out Phase|Protocol Violation|0|||
161889683|NCT01554176|584639870|FG001|Run-out Phase|Protocol Violation|0|||
161889684|NCT01554176|584639871|FG002|Run-out Phase|Protocol Violation|0|||
161889685|NCT01554176|584639872|FG003|Run-out Phase|Protocol Violation|1|||
161889686|NCT01554176|584639873|FG004|Run-out Phase|Protocol Violation|0|||
161889687|NCT02678000|584639876|FG000|PART 2|Adverse Event|0|||
161889688|NCT02678000|584639877|FG001|PART 2|Adverse Event|0|||
161889689|NCT02678000|584639878|FG002|PART 2|Adverse Event|2|||
161889690|NCT02678000|584639879|FG003|PART 2|Adverse Event|1|||
161889691|NCT02678000|584639880|FG004|PART 2|Adverse Event|0|||
161889692|NCT02678000|584639876|FG000|PART 2|Withdrawal by Subject|0|||
161889693|NCT02678000|584639877|FG001|PART 2|Withdrawal by Subject|0|||
161889694|NCT02678000|584639878|FG002|PART 2|Withdrawal by Subject|1|||
161889695|NCT02678000|584639879|FG003|PART 2|Withdrawal by Subject|0|||
161889696|NCT02678000|584639880|FG004|PART 2|Withdrawal by Subject|0|||
161889697|NCT03053427|584639881|FG000|Overall Study|Adverse Event|4|||
161889698|NCT03053427|584639882|FG001|Overall Study|Adverse Event|4|||
161889699|NCT03053427|584639881|FG000|Overall Study|Lack of Efficacy|1|||
161889700|NCT03053427|584639882|FG001|Overall Study|Lack of Efficacy|3|||
161889701|NCT03053427|584639881|FG000|Overall Study|Lost to Follow-up|2|||
161889702|NCT03053427|584639882|FG001|Overall Study|Lost to Follow-up|2|||
161889703|NCT03053427|584639881|FG000|Overall Study|Worsening of the target disease|0|||
161889704|NCT03053427|584639882|FG001|Overall Study|Worsening of the target disease|1|||
161889705|NCT03053427|584639881|FG000|Overall Study|Protocol Deviation|3|||
161889706|NCT03053427|584639882|FG001|Overall Study|Protocol Deviation|3|||
161889707|NCT03053427|584639881|FG000|Overall Study|Withdrawal by Subject|3|||
161889708|NCT03053427|584639882|FG001|Overall Study|Withdrawal by Subject|2|||
161889709|NCT03053427|584639881|FG000|Overall Study|Miscellaneous|0|||
161889710|NCT03053427|584639882|FG001|Overall Study|Miscellaneous|1|||
161889711|NCT02510820|584641754|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161889712|NCT02510820|584641755|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161889713|NCT02510820|584641754|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161889714|NCT02510820|584641755|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
161889715|NCT01533688|584641756|FG000|Overall Study|Withdrawal by Subject|5|||
161889716|NCT01533688|584641757|FG001|Overall Study|Withdrawal by Subject|4|||
161889717|NCT01533688|584641758|FG002|Overall Study|Withdrawal by Subject|3|||
161889718|NCT01533688|584641756|FG000|Overall Study|Medically unstable|1|||
161889719|NCT01533688|584641757|FG001|Overall Study|Medically unstable|3|||
161889720|NCT01533688|584641758|FG002|Overall Study|Medically unstable|3|||
161889721|NCT01533688|584641756|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
161889722|NCT01533688|584641757|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
161889723|NCT01533688|584641758|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
161889724|NCT02190721|584641759|FG000|Overall Study|Patient was out of the city|0|||
161889725|NCT02190721|584641760|FG001|Overall Study|Patient was out of the city|1|||
161889726|NCT02190721|584641761|FG002|Overall Study|Patient was out of the city|0|||
161889727|NCT01760447|584641762|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
161889728|NCT01760447|584641763|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
161889729|NCT01760447|584641764|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
161889730|NCT01760447|584641765|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
161889731|NCT01760447|584641762|FG000|Weeks 0-20|Withdrawal by Subject|2|||
161889732|NCT01760447|584641763|FG001|Weeks 0-20|Withdrawal by Subject|0|||
161889733|NCT01760447|584641764|FG002|Weeks 0-20|Withdrawal by Subject|1|||
161889734|NCT01760447|584641765|FG003|Weeks 0-20|Withdrawal by Subject|0|||
161889735|NCT01760447|584641762|FG000|Weeks 0-20|Lost to Follow-up|1|||
161889736|NCT01760447|584641763|FG001|Weeks 0-20|Lost to Follow-up|0|||
161889737|NCT01760447|584641764|FG002|Weeks 0-20|Lost to Follow-up|1|||
161889738|NCT01760447|584641765|FG003|Weeks 0-20|Lost to Follow-up|1|||
161889739|NCT01760447|584641762|FG000|Weeks 0-20|Randomized but not treated|0|||
161889740|NCT01760447|584641763|FG001|Weeks 0-20|Randomized but not treated|0|||
161889741|NCT01760447|584641764|FG002|Weeks 0-20|Randomized but not treated|2|||
161889742|NCT01760447|584641765|FG003|Weeks 0-20|Randomized but not treated|0|||
161889743|NCT01760447|584641762|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
161889744|NCT01760447|584641763|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
161889745|NCT01760447|584641764|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
161994811|NCT00950248|585030573|FG002|Year 2&3 Treatment Randomization|Death|1|||
161994812|NCT00950248|585030571|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
161994813|NCT00950248|585030572|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
161994814|NCT00950248|585030573|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
161889746|NCT01760447|584641765|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
161889747|NCT01760447|584641762|FG000|Weeks 20-54|Withdrawal by Subject|2|||
161889748|NCT01760447|584641763|FG001|Weeks 20-54|Withdrawal by Subject|1|||
161889749|NCT01760447|584641764|FG002|Weeks 20-54|Withdrawal by Subject|1|||
161889750|NCT01760447|584641765|FG003|Weeks 20-54|Withdrawal by Subject|2|||
161889751|NCT01760447|584641762|FG000|Weeks 20-54|Lost to Follow-up|0|||
161889752|NCT01760447|584641763|FG001|Weeks 20-54|Lost to Follow-up|0|||
161889753|NCT01760447|584641764|FG002|Weeks 20-54|Lost to Follow-up|1|||
161889754|NCT01760447|584641765|FG003|Weeks 20-54|Lost to Follow-up|2|||
161889755|NCT01214668|584641766|FG000|Overall Study|Adverse Event|0|||
161889756|NCT01214668|584641767|FG001|Overall Study|Adverse Event|1|||
161889757|NCT01214668|584641768|FG002|Overall Study|Adverse Event|0|||
161889758|NCT01214668|584641769|FG003|Overall Study|Adverse Event|2|||
161889759|NCT01214668|584641770|FG004|Overall Study|Adverse Event|1|||
161889760|NCT01214668|584641771|FG005|Overall Study|Adverse Event|1|||
161889761|NCT01214668|584641766|FG000|Overall Study|Death|0|||
161889762|NCT01214668|584641767|FG001|Overall Study|Death|0|||
161889763|NCT01214668|584641768|FG002|Overall Study|Death|1|||
161889764|NCT01214668|584641769|FG003|Overall Study|Death|0|||
161889765|NCT01214668|584641770|FG004|Overall Study|Death|0|||
161889766|NCT01214668|584641771|FG005|Overall Study|Death|0|||
161889767|NCT01214668|584641766|FG000|Overall Study|Progressive Disease|4|||
161889768|NCT01214668|584641767|FG001|Overall Study|Progressive Disease|2|||
161889769|NCT01214668|584641768|FG002|Overall Study|Progressive Disease|5|||
161889770|NCT01214668|584641769|FG003|Overall Study|Progressive Disease|4|||
161889771|NCT01214668|584641770|FG004|Overall Study|Progressive Disease|4|||
161889772|NCT01214668|584641771|FG005|Overall Study|Progressive Disease|5|||
161889773|NCT01214668|584641766|FG000|Overall Study|Withdrawal by Subject|0|||
161889774|NCT01214668|584641767|FG001|Overall Study|Withdrawal by Subject|0|||
161889775|NCT01214668|584641768|FG002|Overall Study|Withdrawal by Subject|0|||
161889776|NCT01214668|584641769|FG003|Overall Study|Withdrawal by Subject|0|||
161889777|NCT01214668|584641770|FG004|Overall Study|Withdrawal by Subject|1|||
161889778|NCT01214668|584641771|FG005|Overall Study|Withdrawal by Subject|0|||
161889779|NCT02907619|584641772|FG000|Overall Study|Study terminated by sponsor|18|||
161889780|NCT02907619|584641773|FG001|Overall Study|Study terminated by sponsor|18|||
161889781|NCT02907619|584641774|FG002|Overall Study|Study terminated by sponsor|19|||
161889782|NCT02907619|584641772|FG000|Overall Study|Death|0|||
161889783|NCT02907619|584641773|FG001|Overall Study|Death|0|||
161889784|NCT02907619|584641774|FG002|Overall Study|Death|1|||
161889785|NCT02907619|584641772|FG000|Overall Study|Withdrawal by Subject|1|||
161889786|NCT02907619|584641773|FG001|Overall Study|Withdrawal by Subject|1|||
161889787|NCT02907619|584641774|FG002|Overall Study|Withdrawal by Subject|0|||
161889788|NCT02907619|584641772|FG000|Overall Study|Other|0|||
161889789|NCT02907619|584641773|FG001|Overall Study|Other|1|||
161889790|NCT02907619|584641774|FG002|Overall Study|Other|0|||
161889791|NCT03326518|584641775|FG000|Overall Study|Protocol Violation|1|||
161889792|NCT03326518|584641776|FG001|Overall Study|Protocol Violation|0|||
161889793|NCT03326518|584641777|FG002|Overall Study|Protocol Violation|0|||
161889794|NCT03326518|584641775|FG000|Overall Study|Withdrawal by Subject|1|||
161889795|NCT03326518|584641776|FG001|Overall Study|Withdrawal by Subject|0|||
161889796|NCT03326518|584641777|FG002|Overall Study|Withdrawal by Subject|0|||
161889797|NCT03326518|584641775|FG000|Overall Study|Lost to Follow-up|1|||
161889798|NCT03326518|584641776|FG001|Overall Study|Lost to Follow-up|0|||
161889799|NCT03326518|584641777|FG002|Overall Study|Lost to Follow-up|1|||
161889800|NCT03411902|584641795|FG000|Overall Study|Lost to Follow-up|3|||
161889801|NCT03411902|584641796|FG001|Overall Study|Lost to Follow-up|0|||
161889802|NCT01693185|584641797|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
161889803|NCT01693185|584641798|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
161889804|NCT00419159|584641803|FG000|Overall Study|Adverse Event|7|||
161889805|NCT00419159|584641804|FG001|Overall Study|Adverse Event|15|||
161889806|NCT00419159|584641803|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161889807|NCT00419159|584641804|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161889808|NCT00419159|584641803|FG000|Overall Study|Subject's no longer requires study drug|0|||
161889809|NCT00419159|584641804|FG001|Overall Study|Subject's no longer requires study drug|1|||
161889810|NCT00419159|584641803|FG000|Overall Study|Protocol Violation|1|||
161889811|NCT00419159|584641804|FG001|Overall Study|Protocol Violation|0|||
161889812|NCT00419159|584641803|FG000|Overall Study|Withdrawal by Subject|10|||
161889813|NCT00419159|584641804|FG001|Overall Study|Withdrawal by Subject|3|||
161889814|NCT00419159|584641803|FG000|Overall Study|Lost to Follow-up|0|||
161889815|NCT00419159|584641804|FG001|Overall Study|Lost to Follow-up|1|||
161994815|NCT00650845|585030578|FG000|Overall Study|Withdrawal by Subject|5|||
161994816|NCT00650845|585030579|FG001|Overall Study|Withdrawal by Subject|0|||
161994817|NCT00650845|585030578|FG000|Overall Study|Protocol Violation|0|||
161994818|NCT00650845|585030579|FG001|Overall Study|Protocol Violation|13|||
161994819|NCT01594931|585032199|FG000|Overall Study|Adverse Event|3|||
161994820|NCT01594931|585032200|FG001|Overall Study|Adverse Event|1|||
161994821|NCT01594931|585032201|FG002|Overall Study|Adverse Event|1|||
161994822|NCT01594931|585032199|FG000|Overall Study|Withdrawal by Subject|2|||
161994823|NCT01594931|585032200|FG001|Overall Study|Withdrawal by Subject|1|||
161994824|NCT01594931|585032201|FG002|Overall Study|Withdrawal by Subject|1|||
161994825|NCT01594931|585032199|FG000|Overall Study|Lack of Efficacy|7|||
161889816|NCT00419159|584641803|FG000|Overall Study|Death|2|||
161889817|NCT00419159|584641804|FG001|Overall Study|Death|2|||
161889818|NCT00419159|584641803|FG000|Overall Study|Disease progression|79|||
161889819|NCT00419159|584641804|FG001|Overall Study|Disease progression|76|||
161889820|NCT02735096|584641812|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
161889821|NCT01080391|584641820|FG000|Overall Study|Randomized but not treated|7|||
161994826|NCT01594931|585032200|FG001|Overall Study|Lack of Efficacy|2|||
161994827|NCT01594931|585032201|FG002|Overall Study|Lack of Efficacy|2|||
161994828|NCT01594931|585032199|FG000|Overall Study|Lost to Follow-up|4|||
161994829|NCT01594931|585032200|FG001|Overall Study|Lost to Follow-up|3|||
161889822|NCT01080391|584641821|FG001|Overall Study|Randomized but not treated|4|||
161889823|NCT01534208|584641825|FG000|Overall Study|Lost to Follow-up|19|||
161889824|NCT01534208|584641826|FG001|Overall Study|Lost to Follow-up|14|||
161889825|NCT01534208|584641825|FG000|Overall Study|Withdrawal by Subject|6|||
161994830|NCT01594931|585032201|FG002|Overall Study|Lost to Follow-up|3|||
161889826|NCT01534208|584641826|FG001|Overall Study|Withdrawal by Subject|20|||
161889827|NCT01534208|584641825|FG000|Overall Study|Adverse Event|15|||
161889828|NCT01534208|584641826|FG001|Overall Study|Adverse Event|8|||
161889829|NCT01534208|584641825|FG000|Overall Study|Physician Decision|2|||
161889830|NCT01534208|584641826|FG001|Overall Study|Physician Decision|0|||
161889831|NCT01534208|584641825|FG000|Overall Study|Lack of Efficacy|0|||
161889832|NCT01534208|584641826|FG001|Overall Study|Lack of Efficacy|3|||
161889833|NCT01534208|584641825|FG000|Overall Study|Protocol Violation|2|||
161889834|NCT01534208|584641826|FG001|Overall Study|Protocol Violation|2|||
161889835|NCT01534208|584641825|FG000|Overall Study|Sponsor decision|4|||
161889836|NCT01534208|584641826|FG001|Overall Study|Sponsor decision|1|||
161889837|NCT01534208|584641825|FG000|Overall Study|Subject relocation|2|||
161889838|NCT01534208|584641826|FG001|Overall Study|Subject relocation|0|||
161889839|NCT01534208|584641825|FG000|Overall Study|Lab assessment|2|||
161889840|NCT01534208|584641826|FG001|Overall Study|Lab assessment|1|||
161889841|NCT01534208|584641825|FG000|Overall Study|Eligibility error|3|||
161889842|NCT01534208|584641826|FG001|Overall Study|Eligibility error|0|||
161889843|NCT01534208|584641825|FG000|Overall Study|PCP decision|1|||
161889844|NCT01534208|584641826|FG001|Overall Study|PCP decision|0|||
161889845|NCT01534208|584641825|FG000|Overall Study|Needed prohibited meds|1|||
161889846|NCT01534208|584641826|FG001|Overall Study|Needed prohibited meds|0|||
161889847|NCT02117713|584641837|FG000|Week 48|Adverse Event|4|||
161889848|NCT02117713|584641837|FG000|Week 48|Withdrawal by caregiver|2|||
161889849|NCT02117713|584641837|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
161889850|NCT02117713|584641837|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
161889851|NCT02117713|584641837|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
161889852|NCT02117713|584641837|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
161889853|NCT00672841|584641838|FG000|Overall Study|Comfort care|1|||
161889854|NCT00672841|584641839|FG001|Overall Study|Comfort care|4|||
161889855|NCT00672841|584641838|FG000|Overall Study|icteric specimens|0|||
161889856|NCT00672841|584641839|FG001|Overall Study|icteric specimens|3|||
161889857|NCT00672841|584641838|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
161889858|NCT00672841|584641839|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
161889859|NCT00672841|584641838|FG000|Overall Study|Adverse Event|0|||
161889860|NCT00672841|584641839|FG001|Overall Study|Adverse Event|3|||
161889861|NCT00672841|584641838|FG000|Overall Study|Pregnancy|0|||
161889862|NCT00672841|584641839|FG001|Overall Study|Pregnancy|1|||
161889863|NCT03578146|584641841|FG000|Overall Study|Did Not Receive Treatment|1|||
161889864|NCT03578146|584641842|FG001|Overall Study|Did Not Receive Treatment|0|||
161889865|NCT03578146|584641843|FG002|Overall Study|Did Not Receive Treatment|0|||
161889866|NCT03578146|584641844|FG003|Overall Study|Did Not Receive Treatment|0|||
161889867|NCT03578146|584641845|FG004|Overall Study|Did Not Receive Treatment|0|||
161889868|NCT03578146|584641846|FG005|Overall Study|Did Not Receive Treatment|2|||
161889869|NCT03578146|584641841|FG000|Overall Study|Lost to Follow-up|0|||
161889870|NCT03578146|584641842|FG001|Overall Study|Lost to Follow-up|1|||
161889871|NCT03578146|584641843|FG002|Overall Study|Lost to Follow-up|1|||
161889872|NCT03578146|584641844|FG003|Overall Study|Lost to Follow-up|0|||
161889873|NCT03578146|584641845|FG004|Overall Study|Lost to Follow-up|0|||
161889874|NCT03578146|584641846|FG005|Overall Study|Lost to Follow-up|1|||
161889875|NCT01094782|584641847|FG000|Overall Study|Withdrawal by Subject|5|||
161889876|NCT01094782|584641848|FG001|Overall Study|Withdrawal by Subject|5|||
161889877|NCT01094782|584641849|FG002|Overall Study|Withdrawal by Subject|1|||
161889878|NCT01094782|584641850|FG003|Overall Study|Withdrawal by Subject|5|||
161889879|NCT01094782|584641851|FG004|Overall Study|Withdrawal by Subject|5|||
161889880|NCT01094782|584641852|FG005|Overall Study|Withdrawal by Subject|0|||
161889881|NCT01094782|584641847|FG000|Overall Study|Lost to Follow-up|1|||
161889882|NCT01094782|584641848|FG001|Overall Study|Lost to Follow-up|0|||
161889883|NCT01094782|584641849|FG002|Overall Study|Lost to Follow-up|0|||
161889884|NCT01094782|584641850|FG003|Overall Study|Lost to Follow-up|2|||
161889885|NCT01094782|584641851|FG004|Overall Study|Lost to Follow-up|1|||
161889886|NCT01094782|584641852|FG005|Overall Study|Lost to Follow-up|4|||
161889887|NCT01094782|584641847|FG000|Overall Study|Positive Drug Screen|2|||
161889888|NCT01094782|584641848|FG001|Overall Study|Positive Drug Screen|2|||
161889889|NCT01094782|584641849|FG002|Overall Study|Positive Drug Screen|1|||
161889890|NCT01094782|584641850|FG003|Overall Study|Positive Drug Screen|1|||
161889891|NCT01094782|584641851|FG004|Overall Study|Positive Drug Screen|3|||
161889892|NCT01094782|584641852|FG005|Overall Study|Positive Drug Screen|2|||
161889893|NCT01094782|584641847|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
161889894|NCT01094782|584641848|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
161889895|NCT01094782|584641849|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
161889896|NCT01094782|584641850|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
161889897|NCT01094782|584641851|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
161889898|NCT01094782|584641852|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
161889899|NCT01094782|584641847|FG000|Overall Study|Unable to Complete Questionnaires|0|||
161889900|NCT01094782|584641848|FG001|Overall Study|Unable to Complete Questionnaires|1|||
161889901|NCT01094782|584641849|FG002|Overall Study|Unable to Complete Questionnaires|0|||
161889902|NCT01094782|584641850|FG003|Overall Study|Unable to Complete Questionnaires|0|||
161889903|NCT01094782|584641851|FG004|Overall Study|Unable to Complete Questionnaires|0|||
161889904|NCT01094782|584641852|FG005|Overall Study|Unable to Complete Questionnaires|0|||
161889905|NCT01094782|584641847|FG000|Overall Study|Healthy Subject Had Pain|0|||
161889906|NCT01094782|584641848|FG001|Overall Study|Healthy Subject Had Pain|1|||
161889907|NCT01094782|584641849|FG002|Overall Study|Healthy Subject Had Pain|0|||
161889908|NCT01094782|584641850|FG003|Overall Study|Healthy Subject Had Pain|0|||
161889909|NCT01094782|584641851|FG004|Overall Study|Healthy Subject Had Pain|0|||
161889910|NCT01094782|584641852|FG005|Overall Study|Healthy Subject Had Pain|0|||
161889911|NCT01094782|584641847|FG000|Overall Study|Hypertension|0|||
161889912|NCT01094782|584641848|FG001|Overall Study|Hypertension|0|||
161889913|NCT01094782|584641849|FG002|Overall Study|Hypertension|1|||
161889914|NCT01094782|584641850|FG003|Overall Study|Hypertension|0|||
161889915|NCT01094782|584641851|FG004|Overall Study|Hypertension|0|||
161889916|NCT01094782|584641852|FG005|Overall Study|Hypertension|0|||
161889917|NCT01094782|584641847|FG000|Overall Study|Wrong Pain Condition|0|||
161889918|NCT01094782|584641848|FG001|Overall Study|Wrong Pain Condition|0|||
161889919|NCT01094782|584641849|FG002|Overall Study|Wrong Pain Condition|0|||
161889920|NCT01094782|584641850|FG003|Overall Study|Wrong Pain Condition|2|||
161889921|NCT01094782|584641851|FG004|Overall Study|Wrong Pain Condition|1|||
161889922|NCT01094782|584641852|FG005|Overall Study|Wrong Pain Condition|1|||
161889923|NCT01094782|584641847|FG000|Overall Study|Recent Interventional Injection|0|||
161889924|NCT01094782|584641848|FG001|Overall Study|Recent Interventional Injection|0|||
161889925|NCT01094782|584641849|FG002|Overall Study|Recent Interventional Injection|0|||
161889926|NCT01094782|584641850|FG003|Overall Study|Recent Interventional Injection|0|||
161889927|NCT01094782|584641851|FG004|Overall Study|Recent Interventional Injection|0|||
161889928|NCT01094782|584641852|FG005|Overall Study|Recent Interventional Injection|1|||
161889929|NCT01094782|584641847|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161889930|NCT01094782|584641848|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161889931|NCT01094782|584641849|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161889932|NCT01094782|584641850|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161889933|NCT01094782|584641851|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
161889934|NCT01094782|584641852|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161889935|NCT01094782|584641847|FG000|Overall Study|Noncompliance With Study Schedule|0|||
161889936|NCT01094782|584641848|FG001|Overall Study|Noncompliance With Study Schedule|0|||
161889937|NCT01094782|584641849|FG002|Overall Study|Noncompliance With Study Schedule|0|||
161889938|NCT01094782|584641850|FG003|Overall Study|Noncompliance With Study Schedule|1|||
161889939|NCT01094782|584641851|FG004|Overall Study|Noncompliance With Study Schedule|0|||
161889940|NCT01094782|584641852|FG005|Overall Study|Noncompliance With Study Schedule|0|||
161889941|NCT02536781|584641857|FG000|Overall Study|Lost to Follow-up|2|||
161889942|NCT02536781|584641858|FG001|Overall Study|Lost to Follow-up|0|||
161889943|NCT03423147|584641859|FG000|Overall Study|Lost to Follow-up|5|||
161889944|NCT03423147|584641860|FG001|Overall Study|Lost to Follow-up|8|||
161889945|NCT03423147|584641859|FG000|Overall Study|Withdrawal by Subject|1|||
161889946|NCT03423147|584641860|FG001|Overall Study|Withdrawal by Subject|0|||
161889947|NCT03423147|584641859|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
161889948|NCT03423147|584641860|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
161889949|NCT03423147|584641859|FG000|Overall Study|Age < 18|1|||
161889950|NCT03423147|584641860|FG001|Overall Study|Age < 18|0|||
161889951|NCT03423147|584641859|FG000|Overall Study|No Trial of Labor|0|||
161889952|NCT03423147|584641860|FG001|Overall Study|No Trial of Labor|1|||
161889953|NCT02450552|584641862|FG000|Overall Study|Withdrawal by Subject|4|||
161889954|NCT02450552|584641863|FG001|Overall Study|Withdrawal by Subject|0|||
161889955|NCT02450552|584641864|FG002|Overall Study|Withdrawal by Subject|4|||
161889956|NCT02450552|584641862|FG000|Overall Study|Physician Decision|1|||
161889957|NCT02450552|584641863|FG001|Overall Study|Physician Decision|0|||
161889958|NCT02450552|584641864|FG002|Overall Study|Physician Decision|1|||
161889959|NCT01524783|584641865|FG000|Blinded Period|Adverse Event|64|||
161889960|NCT01524783|584641866|FG001|Blinded Period|Adverse Event|7|||
161994831|NCT01594931|585032199|FG000|Overall Study|Protocol Violation|2|||
161994832|NCT01594931|585032200|FG001|Overall Study|Protocol Violation|1|||
161994833|NCT01594931|585032201|FG002|Overall Study|Protocol Violation|0|||
161994834|NCT01594931|585032199|FG000|Overall Study|No defiined|11|||
161994835|NCT01594931|585032200|FG001|Overall Study|No defiined|4|||
161889961|NCT01524783|584641867|FG002|Blinded Period|Adverse Event|0|||
161889962|NCT01524783|584641865|FG000|Blinded Period|Disease Progression|89|||
161889963|NCT01524783|584641866|FG001|Blinded Period|Disease Progression|75|||
161889964|NCT01524783|584641867|FG002|Blinded Period|Disease Progression|0|||
161889965|NCT01524783|584641865|FG000|Blinded Period|Withdrawal by Subject|19|||
161889966|NCT01524783|584641866|FG001|Blinded Period|Withdrawal by Subject|6|||
161889967|NCT01524783|584641867|FG002|Blinded Period|Withdrawal by Subject|0|||
161889968|NCT01524783|584641865|FG000|Blinded Period|Protocol deviation|2|||
161889969|NCT01524783|584641866|FG001|Blinded Period|Protocol deviation|1|||
161994836|NCT01594931|585032201|FG002|Overall Study|No defiined|7|||
161994837|NCT01929226|585032206|FG000|Overall Study|Lost to Follow-up|4|||
161889970|NCT01524783|584641867|FG002|Blinded Period|Protocol deviation|0|||
161889971|NCT01524783|584641865|FG000|Blinded Period|Death|5|||
161889972|NCT01524783|584641866|FG001|Blinded Period|Death|2|||
161889973|NCT01524783|584641867|FG002|Blinded Period|Death|0|||
161889974|NCT01524783|584641865|FG000|Open-label Period|Disease progression|13|||
161889975|NCT01524783|584641866|FG001|Open-label Period|Disease progression|0|||
161889976|NCT01524783|584641867|FG002|Open-label Period|Disease progression|2|||
161889977|NCT01524783|584641865|FG000|Open-label Period|Administrative problems|5|||
161889978|NCT01524783|584641866|FG001|Open-label Period|Administrative problems|0|||
161889979|NCT01524783|584641867|FG002|Open-label Period|Administrative problems|2|||
162038381|NCT05140382|585198064|FG001|Overall Study|Withdrawal by Subject|0|||
162038382|NCT05140382|585198065|FG002|Overall Study|Withdrawal by Subject|4|||
162038383|NCT05140382|585198063|FG000|Overall Study|Withdrawal of consent|0|||
162038384|NCT05140382|585198064|FG001|Overall Study|Withdrawal of consent|0|||
162038385|NCT05140382|585198065|FG002|Overall Study|Withdrawal of consent|1|||
162038386|NCT01397201|585199503|FG000|Overall Study|Not treated|0|||
162038387|NCT01397201|585199504|FG001|Overall Study|Not treated|0|||
162038388|NCT01397201|585199505|FG002|Overall Study|Not treated|1|||
162038389|NCT01397201|585199506|FG003|Overall Study|Not treated|0|||
162038390|NCT01397201|585199507|FG004|Overall Study|Not treated|0|||
162038391|NCT01397201|585199503|FG000|Overall Study|Not yet defined|3|||
161889980|NCT01524783|584641865|FG000|Open-label Period|Adverse Event|5|||
161889981|NCT01524783|584641866|FG001|Open-label Period|Adverse Event|0|||
161889982|NCT01524783|584641867|FG002|Open-label Period|Adverse Event|1|||
161889983|NCT01524783|584641865|FG000|Open-label Period|Withdrawal by Subject|2|||
161889984|NCT01524783|584641866|FG001|Open-label Period|Withdrawal by Subject|0|||
161889985|NCT01524783|584641867|FG002|Open-label Period|Withdrawal by Subject|1|||
161889986|NCT01524783|584641865|FG000|Open-label Period|Protocol deviation|1|||
161889987|NCT01524783|584641866|FG001|Open-label Period|Protocol deviation|0|||
161889988|NCT01524783|584641867|FG002|Open-label Period|Protocol deviation|0|||
161889989|NCT01625689|584641868|FG000|Overall Study|Migration|2|||
161889990|NCT01625689|584641869|FG001|Overall Study|Migration|1|||
161889991|NCT03723070|584641874|FG000|Overall Study|Lost to Follow-up|2|||
161889992|NCT03723070|584641874|FG000|Overall Study|Physician Decision|1|||
161889993|NCT03723070|584641874|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
161889994|NCT05153148|584641875|FG000|Overall Study|Adverse Event|1|||
161889995|NCT05153148|584641876|FG001|Overall Study|Adverse Event|0|||
161889996|NCT05153148|584641877|FG002|Overall Study|Adverse Event|3|||
161889997|NCT05153148|584641878|FG003|Overall Study|Adverse Event|5|||
161889998|NCT05153148|584641875|FG000|Overall Study|Lost to Follow-up|1|||
161889999|NCT05153148|584641876|FG001|Overall Study|Lost to Follow-up|1|||
161890000|NCT05153148|584641877|FG002|Overall Study|Lost to Follow-up|2|||
161890001|NCT05153148|584641878|FG003|Overall Study|Lost to Follow-up|0|||
161890002|NCT05153148|584641875|FG000|Overall Study|Withdrawal by Subject|6|||
161890003|NCT05153148|584641876|FG001|Overall Study|Withdrawal by Subject|8|||
161890004|NCT05153148|584641877|FG002|Overall Study|Withdrawal by Subject|6|||
161890005|NCT05153148|584641878|FG003|Overall Study|Withdrawal by Subject|8|||
161890006|NCT05153148|584641875|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
161994838|NCT01929226|585032207|FG001|Overall Study|Lost to Follow-up|0|||
161994839|NCT01929226|585032206|FG000|Overall Study|Withdrawal by Subject|1|||
161994840|NCT01929226|585032207|FG001|Overall Study|Withdrawal by Subject|1|||
161994841|NCT01473732|585032210|FG000|Overall Study|Adverse Event|1|||
161994842|NCT01473732|585032211|FG001|Overall Study|Adverse Event|0|||
161994843|NCT01473732|585032210|FG000|Overall Study|Death|1|||
161994844|NCT01473732|585032211|FG001|Overall Study|Death|0|||
161994845|NCT00592904|585032216|FG000|Overall Study|Adverse Event|15|||
161994846|NCT00592904|585032217|FG001|Overall Study|Adverse Event|25|||
161994847|NCT00592904|585032218|FG002|Overall Study|Adverse Event|13|||
161994848|NCT00592904|585032219|FG003|Overall Study|Adverse Event|5|||
161994849|NCT00592904|585032216|FG000|Overall Study|Protocol Violation|1|||
161994850|NCT00592904|585032217|FG001|Overall Study|Protocol Violation|1|||
161994851|NCT00592904|585032218|FG002|Overall Study|Protocol Violation|0|||
161994852|NCT00592904|585032219|FG003|Overall Study|Protocol Violation|1|||
161994853|NCT00592904|585032216|FG000|Overall Study|Withdrawal by Subject|4|||
161994854|NCT00592904|585032217|FG001|Overall Study|Withdrawal by Subject|16|||
161994855|NCT00592904|585032218|FG002|Overall Study|Withdrawal by Subject|1|||
162038392|NCT01397201|585199504|FG001|Overall Study|Not yet defined|6|||
161890007|NCT05153148|584641876|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
162038393|NCT01397201|585199505|FG002|Overall Study|Not yet defined|5|||
162038394|NCT01397201|585199506|FG003|Overall Study|Not yet defined|5|||
162038395|NCT01397201|585199507|FG004|Overall Study|Not yet defined|4|||
162038396|NCT01397201|585199503|FG000|Overall Study|Adverse Event|2|||
161890008|NCT05153148|584641877|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
161890009|NCT05153148|584641878|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
161890010|NCT05153148|584641875|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
161994856|NCT00592904|585032219|FG003|Overall Study|Withdrawal by Subject|2|||
161994857|NCT00592904|585032216|FG000|Overall Study|Lack of Efficacy|2|||
161994858|NCT00592904|585032217|FG001|Overall Study|Lack of Efficacy|7|||
162038397|NCT01397201|585199504|FG001|Overall Study|Adverse Event|0|||
162038398|NCT01397201|585199505|FG002|Overall Study|Adverse Event|0|||
161890011|NCT05153148|584641876|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
161890012|NCT05153148|584641877|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
161890013|NCT05153148|584641878|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
161890014|NCT05153148|584641875|FG000|Overall Study|Reason not Specified|1|||
161890015|NCT05153148|584641876|FG001|Overall Study|Reason not Specified|1|||
161890016|NCT05153148|584641877|FG002|Overall Study|Reason not Specified|1|||
161890017|NCT05153148|584641878|FG003|Overall Study|Reason not Specified|1|||
161890018|NCT01732471|584641879|FG000|Overall Study|Withdrawal by Subject|1|||
161890019|NCT00474786|584641880|FG000|Overall Study|Not Meeting Study Criteria|0|||
161890020|NCT00474786|584641881|FG001|Overall Study|Not Meeting Study Criteria|1|||
161890021|NCT00474786|584641880|FG000|Overall Study|Investigator Request|2|||
161890022|NCT00474786|584641881|FG001|Overall Study|Investigator Request|1|||
161890023|NCT00474786|584641880|FG000|Overall Study|Death|189|||
161890024|NCT00474786|584641881|FG001|Overall Study|Death|170|||
161890025|NCT00474786|584641880|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
161890026|NCT00474786|584641881|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
161890027|NCT00474786|584641880|FG000|Overall Study|Lost to Follow-up|4|||
161890028|NCT00474786|584641881|FG001|Overall Study|Lost to Follow-up|7|||
161890029|NCT00474786|584641880|FG000|Overall Study|Protocol Violation|2|||
161890030|NCT00474786|584641881|FG001|Overall Study|Protocol Violation|0|||
161890031|NCT00474786|584641880|FG000|Overall Study|Withdrawal by Subject|15|||
161890032|NCT00474786|584641881|FG001|Overall Study|Withdrawal by Subject|15|||
161890033|NCT00474786|584641880|FG000|Overall Study|Other|5|||
161890034|NCT00474786|584641881|FG001|Overall Study|Other|0|||
161890035|NCT02892513|584641882|FG000|Overall Study|Withdrawal by Subject|0|||
161890036|NCT02892513|584641883|FG001|Overall Study|Withdrawal by Subject|1|||
161890037|NCT00900731|584641884|FG000|Overall Study|Adverse Event|31|||
161890038|NCT00900731|584641885|FG001|Overall Study|Adverse Event|27|||
161890039|NCT00900731|584641884|FG000|Overall Study|Withdrawal by Subject|8|||
161890040|NCT00900731|584641885|FG001|Overall Study|Withdrawal by Subject|7|||
161890041|NCT00900731|584641884|FG000|Overall Study|Protocol Deviation|8|||
161890042|NCT00900731|584641885|FG001|Overall Study|Protocol Deviation|11|||
161890043|NCT00900731|584641884|FG000|Overall Study|Administrative Problems|5|||
161890044|NCT00900731|584641885|FG001|Overall Study|Administrative Problems|4|||
161890045|NCT00900731|584641884|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
161890046|NCT00900731|584641885|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
161890047|NCT00900731|584641884|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
161890048|NCT00900731|584641885|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
161890049|NCT00900731|584641884|FG000|Overall Study|Lost to Follow-up|2|||
161890050|NCT00900731|584641885|FG001|Overall Study|Lost to Follow-up|3|||
161890051|NCT00900731|584641884|FG000|Overall Study|Lack of Efficacy|1|||
161890052|NCT00900731|584641885|FG001|Overall Study|Lack of Efficacy|3|||
161890053|NCT00900731|584641884|FG000|Overall Study|Death|0|||
161890054|NCT00900731|584641885|FG001|Overall Study|Death|2|||
161890055|NCT00131365|584641886|FG000|Overall Study|Withdrawal by Subject|1|||
161890056|NCT00131365|584641886|FG000|Overall Study|Alternative treatment|3|||
161890057|NCT05249127|584641887|FG000|Overall Study|Protocol Violation|13|||
161890058|NCT05249127|584641887|FG000|Overall Study|Physician Decision|4|||
161890059|NCT05249127|584641887|FG000|Overall Study|Withdrawal by Subject|2|||
161890060|NCT05249127|584641887|FG000|Overall Study|Participant Non-compliance|1|||
161890061|NCT02607306|584641888|FG000|Overall Study|Adverse Event|8|||
161890062|NCT02607306|584641889|FG001|Overall Study|Adverse Event|6|||
161890063|NCT02607306|584641890|FG002|Overall Study|Adverse Event|6|||
161890064|NCT02607306|584641888|FG000|Overall Study|Unclassified|1|||
161890065|NCT02607306|584641889|FG001|Overall Study|Unclassified|4|||
161890066|NCT02607306|584641890|FG002|Overall Study|Unclassified|0|||
161890067|NCT02607306|584641888|FG000|Overall Study|Withdrawal by Subject|8|||
161890068|NCT02607306|584641889|FG001|Overall Study|Withdrawal by Subject|10|||
161890069|NCT02607306|584641890|FG002|Overall Study|Withdrawal by Subject|2|||
161890070|NCT02607306|584641888|FG000|Overall Study|Lack of Efficacy|0|||
161890071|NCT02607306|584641889|FG001|Overall Study|Lack of Efficacy|1|||
161890072|NCT02607306|584641890|FG002|Overall Study|Lack of Efficacy|1|||
161994859|NCT00592904|585032218|FG002|Overall Study|Lack of Efficacy|2|||
161994860|NCT00592904|585032219|FG003|Overall Study|Lack of Efficacy|3|||
161994861|NCT00592904|585032216|FG000|Overall Study|Physician Decision|0|||
161994862|NCT00592904|585032217|FG001|Overall Study|Physician Decision|3|||
161994863|NCT00592904|585032218|FG002|Overall Study|Physician Decision|1|||
161994864|NCT00592904|585032219|FG003|Overall Study|Physician Decision|0|||
161890073|NCT02607306|584641888|FG000|Overall Study|Protocol Violation|4|||
161890074|NCT02607306|584641889|FG001|Overall Study|Protocol Violation|2|||
161994865|NCT00592904|585032216|FG000|Overall Study|Other|3|||
161890075|NCT02607306|584641890|FG002|Overall Study|Protocol Violation|1|||
161890076|NCT01324570|584641891|FG000|Overall Study|Adverse Event|4|||
161994866|NCT00592904|585032217|FG001|Overall Study|Other|3|||
161994867|NCT00592904|585032218|FG002|Overall Study|Other|0|||
161890077|NCT01324570|584641892|FG001|Overall Study|Adverse Event|7|||
161890078|NCT01324570|584641891|FG000|Overall Study|Withdrawal by Subject|0|||
161890079|NCT01324570|584641892|FG001|Overall Study|Withdrawal by Subject|3|||
161890080|NCT01324570|584641891|FG000|Overall Study|Lack of Efficacy|0|||
161890081|NCT01324570|584641892|FG001|Overall Study|Lack of Efficacy|1|||
161890082|NCT01324570|584641891|FG000|Overall Study|Confirmed or suspected diversion|0|||
161890083|NCT01324570|584641892|FG001|Overall Study|Confirmed or suspected diversion|1|||
161890084|NCT01324570|584641891|FG000|Overall Study|Administrative|0|||
161890085|NCT01324570|584641892|FG001|Overall Study|Administrative|2|||
161890086|NCT02360475|584641895|FG000|Overall Study|Lost to Follow-up|4|||
161890087|NCT02360475|584641896|FG001|Overall Study|Lost to Follow-up|12|||
161890088|NCT02360475|584641897|FG002|Overall Study|Lost to Follow-up|6|||
161890089|NCT02360475|584641898|FG003|Overall Study|Lost to Follow-up|4|||
161890090|NCT02360475|584641895|FG000|Overall Study|Withdrawal by Subject|0|||
161890091|NCT02360475|584641896|FG001|Overall Study|Withdrawal by Subject|1|||
161890092|NCT02360475|584641897|FG002|Overall Study|Withdrawal by Subject|2|||
161890093|NCT02360475|584641898|FG003|Overall Study|Withdrawal by Subject|0|||
161890094|NCT02360475|584641895|FG000|Overall Study|Migrated/moved from study area|0|||
161890095|NCT02360475|584641896|FG001|Overall Study|Migrated/moved from study area|0|||
161890096|NCT02360475|584641897|FG002|Overall Study|Migrated/moved from study area|0|||
161890097|NCT02360475|584641898|FG003|Overall Study|Migrated/moved from study area|1|||
161890098|NCT00539032|584641900|FG000|Overall Study|Withdrawal by Subject|2|||
161890099|NCT00539032|584641901|FG001|Overall Study|Withdrawal by Subject|1|||
161890100|NCT04438499|584641902|FG000|Overall Study|Lack of Efficacy|3|||
161890101|NCT01859949|584643904|FG000|Overall Study|Family Matters|0|||
161890102|NCT01859949|584643905|FG001|Overall Study|Family Matters|1|||
161890103|NCT01859949|584643904|FG000|Overall Study|Physician Decision|2|||
161890104|NCT01859949|584643905|FG001|Overall Study|Physician Decision|4|||
161890105|NCT01859949|584643904|FG000|Overall Study|Withdrawal by Subject|11|||
161890106|NCT01859949|584643905|FG001|Overall Study|Withdrawal by Subject|10|||
161890107|NCT01859949|584643904|FG000|Overall Study|Protocol Violation|1|||
161890108|NCT01859949|584643905|FG001|Overall Study|Protocol Violation|1|||
161890109|NCT01859949|584643904|FG000|Overall Study|Adverse Event|0|||
161890110|NCT01859949|584643905|FG001|Overall Study|Adverse Event|1|||
161890111|NCT01153009|584643906|FG000|Overall Study|Adverse Event|4|||
161890112|NCT01153009|584643907|FG001|Overall Study|Adverse Event|14|||
161890113|NCT01153009|584643908|FG002|Overall Study|Adverse Event|14|||
161890114|NCT01153009|584643909|FG003|Overall Study|Adverse Event|10|||
161890115|NCT01153009|584643906|FG000|Overall Study|Lack of Efficacy|9|||
161890116|NCT01153009|584643907|FG001|Overall Study|Lack of Efficacy|0|||
161890117|NCT01153009|584643908|FG002|Overall Study|Lack of Efficacy|2|||
161890118|NCT01153009|584643909|FG003|Overall Study|Lack of Efficacy|1|||
161890119|NCT01153009|584643906|FG000|Overall Study|Noncompliance with Study Medication|1|||
161890120|NCT01153009|584643907|FG001|Overall Study|Noncompliance with Study Medication|3|||
161890121|NCT01153009|584643908|FG002|Overall Study|Noncompliance with Study Medication|4|||
161890122|NCT01153009|584643909|FG003|Overall Study|Noncompliance with Study Medication|1|||
161890123|NCT01153009|584643906|FG000|Overall Study|Protocol Deviations|4|||
161890124|NCT01153009|584643907|FG001|Overall Study|Protocol Deviations|3|||
161890125|NCT01153009|584643908|FG002|Overall Study|Protocol Deviations|3|||
161890126|NCT01153009|584643909|FG003|Overall Study|Protocol Deviations|2|||
161890127|NCT01153009|584643906|FG000|Overall Study|Withdrawal of Consent|5|||
161890128|NCT01153009|584643907|FG001|Overall Study|Withdrawal of Consent|5|||
161890129|NCT01153009|584643908|FG002|Overall Study|Withdrawal of Consent|4|||
161890130|NCT01153009|584643909|FG003|Overall Study|Withdrawal of Consent|6|||
161890131|NCT01153009|584643906|FG000|Overall Study|Lost to Follow-up|8|||
161890132|NCT01153009|584643907|FG001|Overall Study|Lost to Follow-up|8|||
161890133|NCT01153009|584643908|FG002|Overall Study|Lost to Follow-up|11|||
161890134|NCT01153009|584643909|FG003|Overall Study|Lost to Follow-up|15|||
161890135|NCT01153009|584643906|FG000|Overall Study|Other|1|||
161890136|NCT01153009|584643907|FG001|Overall Study|Other|1|||
161890137|NCT01153009|584643908|FG002|Overall Study|Other|3|||
161890138|NCT01153009|584643909|FG003|Overall Study|Other|2|||
161890139|NCT04494425|584643912|FG000|Overall Study|Death|160|||
161890140|NCT04494425|584643913|FG001|Overall Study|Death|166|||
161890141|NCT04494425|584643912|FG000|Overall Study|Withdrawal by Subject|10|||
161890142|NCT04494425|584643913|FG001|Overall Study|Withdrawal by Subject|40|||
161890143|NCT04494425|584643912|FG000|Overall Study|Other|1|||
161890144|NCT04494425|584643913|FG001|Overall Study|Other|1|||
161890145|NCT04494425|584643912|FG000|Overall Study|Ongoing at the time of PCD|265|||
161890146|NCT04494425|584643913|FG001|Overall Study|Ongoing at the time of PCD|223|||
161890147|NCT01270321|584643914|FG000|Overall Study|Death|3|||
161890148|NCT01270321|584643915|FG001|Overall Study|Death|1|||
161890149|NCT01270321|584643916|FG002|Overall Study|Death|4|||
161890150|NCT01270321|584643914|FG000|Overall Study|Adverse Event|7|||
161890151|NCT01270321|584643915|FG001|Overall Study|Adverse Event|9|||
161890152|NCT01270321|584643916|FG002|Overall Study|Adverse Event|5|||
161890153|NCT04003623|584643920|FG000|Overall Study|Withdrawal by Subject|1|||
161890154|NCT04003623|584643921|FG001|Overall Study|Withdrawal by Subject|0|||
161890155|NCT03307837|584643927|FG000|Overall Study|Withdrawal by Subject|0|||
161890156|NCT03307837|584643928|FG001|Overall Study|Withdrawal by Subject|0|||
161890157|NCT03307837|584643929|FG002|Overall Study|Withdrawal by Subject|1|||
161890158|NCT03307837|584643930|FG003|Overall Study|Withdrawal by Subject|0|||
161890159|NCT03307837|584643931|FG004|Overall Study|Withdrawal by Subject|0|||
161890160|NCT03307837|584643932|FG005|Overall Study|Withdrawal by Subject|1|||
161890161|NCT03307837|584643927|FG000|Overall Study|Lost to Follow-up|1|||
161890162|NCT03307837|584643928|FG001|Overall Study|Lost to Follow-up|1|||
161890163|NCT03307837|584643929|FG002|Overall Study|Lost to Follow-up|0|||
161890164|NCT03307837|584643930|FG003|Overall Study|Lost to Follow-up|0|||
161890165|NCT03307837|584643931|FG004|Overall Study|Lost to Follow-up|0|||
161890166|NCT03307837|584643932|FG005|Overall Study|Lost to Follow-up|1|||
161890167|NCT01744483|584643933|FG000|Overall Study|Death|9|||
161890168|NCT01744483|584643934|FG001|Overall Study|Death|4|||
161890169|NCT01744483|584643935|FG002|Overall Study|Death|11|||
161890170|NCT01744483|584643933|FG000|Overall Study|Lost to Follow-up|8|||
161890171|NCT01744483|584643934|FG001|Overall Study|Lost to Follow-up|9|||
161890172|NCT01744483|584643935|FG002|Overall Study|Lost to Follow-up|11|||
161890173|NCT01744483|584643933|FG000|Overall Study|Protocol Violation|1|||
161890174|NCT01744483|584643934|FG001|Overall Study|Protocol Violation|2|||
161890175|NCT01744483|584643935|FG002|Overall Study|Protocol Violation|1|||
161890176|NCT01744483|584643933|FG000|Overall Study|Withdrawal by Subject|4|||
161890177|NCT01744483|584643934|FG001|Overall Study|Withdrawal by Subject|6|||
161890178|NCT01744483|584643935|FG002|Overall Study|Withdrawal by Subject|2|||
161890179|NCT01744483|584643933|FG000|Overall Study|No ICU Admit|5|||
161890180|NCT01744483|584643934|FG001|Overall Study|No ICU Admit|1|||
161890181|NCT01744483|584643935|FG002|Overall Study|No ICU Admit|2|||
161890182|NCT01744483|584643933|FG000|Overall Study|Routed to OSH|2|||
161890183|NCT01744483|584643934|FG001|Overall Study|Routed to OSH|0|||
161890184|NCT01744483|584643935|FG002|Overall Study|Routed to OSH|1|||
161890185|NCT03041467|584643936|FG000|Overall Study|Death|46|||
161890186|NCT03041467|584643937|FG001|Overall Study|Death|39|||
161890187|NCT03041467|584643936|FG000|Overall Study|Withdrawal by Subject|36|||
161890188|NCT03041467|584643937|FG001|Overall Study|Withdrawal by Subject|37|||
161890189|NCT03041467|584643936|FG000|Overall Study|Lost to Follow-up|6|||
161890190|NCT03041467|584643937|FG001|Overall Study|Lost to Follow-up|8|||
161890191|NCT03041467|584643936|FG000|Overall Study|Declined consent for study extension|21|||
161890192|NCT03041467|584643937|FG001|Overall Study|Declined consent for study extension|33|||
161890193|NCT03041467|584643936|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
161890194|NCT03041467|584643937|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
161890195|NCT00734656|584643942|FG000|Lab Session 1|Withdrawal by Subject|2|||
161890196|NCT00734656|584643943|FG001|Lab Session 1|Withdrawal by Subject|0|||
161890197|NCT00734656|584643944|FG002|Lab Session 1|Withdrawal by Subject|0|||
161890198|NCT00734656|584643945|FG003|Lab Session 1|Withdrawal by Subject|0|||
161890199|NCT00734656|584643942|FG000|Washout 1|Withdrawal by Subject|1|||
161890200|NCT00734656|584643943|FG001|Washout 1|Withdrawal by Subject|5|||
161890201|NCT00734656|584643944|FG002|Washout 1|Withdrawal by Subject|2|||
161890202|NCT00734656|584643945|FG003|Washout 1|Withdrawal by Subject|3|||
161890203|NCT00734656|584643942|FG000|Lab Session 2|Withdrawal by Subject|1|||
161890204|NCT00734656|584643943|FG001|Lab Session 2|Withdrawal by Subject|0|||
161890205|NCT00734656|584643944|FG002|Lab Session 2|Withdrawal by Subject|0|||
161890206|NCT00734656|584643945|FG003|Lab Session 2|Withdrawal by Subject|1|||
161890207|NCT00734656|584643942|FG000|Washout 2|Withdrawal by Subject|1|||
161890208|NCT00734656|584643943|FG001|Washout 2|Withdrawal by Subject|1|||
161890209|NCT00734656|584643944|FG002|Washout 2|Withdrawal by Subject|1|||
161890210|NCT00734656|584643945|FG003|Washout 2|Withdrawal by Subject|0|||
161890211|NCT00734656|584643942|FG000|Washout 3|Withdrawal by Subject|1|||
161890212|NCT00734656|584643943|FG001|Washout 3|Withdrawal by Subject|0|||
161890213|NCT00734656|584643944|FG002|Washout 3|Withdrawal by Subject|0|||
161890214|NCT00734656|584643945|FG003|Washout 3|Withdrawal by Subject|1|||
161890215|NCT00734656|584643942|FG000|Lab Session 4|Withdrawal by Subject|0|||
161890216|NCT00734656|584643943|FG001|Lab Session 4|Withdrawal by Subject|0|||
161890217|NCT00734656|584643944|FG002|Lab Session 4|Withdrawal by Subject|0|||
161890218|NCT00734656|584643945|FG003|Lab Session 4|Withdrawal by Subject|1|||
161890219|NCT03214679|584643948|FG000|Overall Study|Lost to Follow-up|12|||
161890220|NCT03214679|584643949|FG001|Overall Study|Lost to Follow-up|14|||
161890221|NCT03214679|584643948|FG000|Overall Study|not eligible|2|||
161890222|NCT03214679|584643949|FG001|Overall Study|not eligible|0|||
161890223|NCT01754766|584643957|FG000|Overall Study|Personal reasons|1|||
161890224|NCT01754766|584643958|FG001|Overall Study|Personal reasons|1|||
161890225|NCT01754766|584643959|FG002|Overall Study|Personal reasons|0|||
161890226|NCT02469168|584643961|FG000|Overall Study|Trial closed|1|||
161890227|NCT02469168|584643962|FG001|Overall Study|Trial closed|0|||
161890228|NCT00298363|584643963|FG000|Overall Study|Lost to Follow-up|0|||
161890229|NCT00298363|584643964|FG001|Overall Study|Lost to Follow-up|0|||
161890230|NCT00298363|584643965|FG002|Overall Study|Lost to Follow-up|1|||
161890231|NCT00298363|584643963|FG000|Overall Study|Physician Decision|4|||
161890232|NCT00298363|584643964|FG001|Overall Study|Physician Decision|1|||
161890233|NCT00298363|584643965|FG002|Overall Study|Physician Decision|0|||
161994868|NCT00592904|585032219|FG003|Overall Study|Other|0|||
161890234|NCT00298363|584643963|FG000|Overall Study|Protocol Violation|1|||
161890235|NCT00298363|584643964|FG001|Overall Study|Protocol Violation|1|||
161890236|NCT00298363|584643965|FG002|Overall Study|Protocol Violation|0|||
161890237|NCT00298363|584643963|FG000|Overall Study|Withdrawal by Subject|5|||
161890238|NCT00298363|584643964|FG001|Overall Study|Withdrawal by Subject|1|||
161890239|NCT00298363|584643965|FG002|Overall Study|Withdrawal by Subject|3|||
161890240|NCT00298363|584643963|FG000|Overall Study|Adverse Event|5|||
161890241|NCT00298363|584643964|FG001|Overall Study|Adverse Event|2|||
161890242|NCT00298363|584643965|FG002|Overall Study|Adverse Event|2|||
161890243|NCT00298363|584643963|FG000|Overall Study|Lack of Efficacy|2|||
161890244|NCT00298363|584643964|FG001|Overall Study|Lack of Efficacy|3|||
161890245|NCT00298363|584643965|FG002|Overall Study|Lack of Efficacy|0|||
161890246|NCT00135356|584643966|FG000|Overall Study|Adverse Event|6|||
161890247|NCT00135356|584643967|FG001|Overall Study|Adverse Event|2|||
161890248|NCT00135356|584643966|FG000|Overall Study|Lack of Efficacy|2|||
161890249|NCT00135356|584643967|FG001|Overall Study|Lack of Efficacy|0|||
161890250|NCT00135356|584643966|FG000|Overall Study|Lost to Follow-up|3|||
161890251|NCT00135356|584643967|FG001|Overall Study|Lost to Follow-up|1|||
161890252|NCT00135356|584643966|FG000|Overall Study|Surgery for abdominal fat|1|||
161890253|NCT00135356|584643967|FG001|Overall Study|Surgery for abdominal fat|0|||
161890254|NCT00135356|584643966|FG000|Overall Study|Change in antiviral regimen|0|||
161890255|NCT00135356|584643967|FG001|Overall Study|Change in antiviral regimen|1|||
161890256|NCT00135356|584643966|FG000|Overall Study|Poor/noncompliance|1|||
161890257|NCT00135356|584643967|FG001|Overall Study|Poor/noncompliance|1|||
161890258|NCT00135356|584643966|FG000|Overall Study|No longer meets study criteria|2|||
161890259|NCT00135356|584643967|FG001|Overall Study|No longer meets study criteria|0|||
161890260|NCT00135356|584643966|FG000|Overall Study|Withdrawal by Subject|2|||
161890261|NCT00135356|584643967|FG001|Overall Study|Withdrawal by Subject|4|||
161890262|NCT02412878|584643968|FG000|Overall Study|Withdrawal by Subject|19|||
161890263|NCT02412878|584643969|FG001|Overall Study|Withdrawal by Subject|10|||
161890264|NCT02412878|584643968|FG000|Overall Study|Lost to Follow-up|2|||
161890265|NCT02412878|584643969|FG001|Overall Study|Lost to Follow-up|3|||
161890266|NCT04676152|584643971|FG000|Overall Study|screen fail|9|||
161890267|NCT01306214|584643972|FG000|Overall Study|Death|0|||
161890268|NCT01306214|584643973|FG001|Overall Study|Death|0|||
161890269|NCT01306214|584643974|FG002|Overall Study|Death|1|||
161890270|NCT01306214|584643972|FG000|Overall Study|Lost to Follow-up|3|||
161890271|NCT01306214|584643973|FG001|Overall Study|Lost to Follow-up|5|||
161890272|NCT01306214|584643974|FG002|Overall Study|Lost to Follow-up|4|||
161890273|NCT01306214|584643972|FG000|Overall Study|Withdrawal by Subject|24|||
161890274|NCT01306214|584643973|FG001|Overall Study|Withdrawal by Subject|22|||
161890275|NCT01306214|584643974|FG002|Overall Study|Withdrawal by Subject|16|||
161890276|NCT01306214|584643972|FG000|Overall Study|Not treated|1|||
161890277|NCT01306214|584643973|FG001|Overall Study|Not treated|1|||
161890278|NCT01306214|584643974|FG002|Overall Study|Not treated|1|||
161890279|NCT02686814|584643975|FG000|Overall Study|Physician Decision|14|||
161890280|NCT02686814|584643975|FG000|Overall Study|Withdrawal by Subject|4|||
161890281|NCT02686814|584643975|FG000|Overall Study|Death|1|||
161890282|NCT01026818|584643983|FG000|Screening Period|Entry Criteria Not Met|105|||
161890283|NCT01026818|584643984|FG001|Screening Period|Entry Criteria Not Met|0|||
161890284|NCT01026818|584643985|FG002|Screening Period|Entry Criteria Not Met|0|||
161890285|NCT01026818|584643986|FG003|Screening Period|Entry Criteria Not Met|0|||
161890286|NCT01026818|584643983|FG000|Screening Period|Withdrawal by Subject|49|||
161890287|NCT01026818|584643984|FG001|Screening Period|Withdrawal by Subject|0|||
161890288|NCT01026818|584643985|FG002|Screening Period|Withdrawal by Subject|0|||
161890289|NCT01026818|584643986|FG003|Screening Period|Withdrawal by Subject|0|||
161890290|NCT01026818|584643983|FG000|Screening Period|Protocol Deviation|3|||
161890291|NCT01026818|584643984|FG001|Screening Period|Protocol Deviation|0|||
161890292|NCT01026818|584643985|FG002|Screening Period|Protocol Deviation|0|||
161890293|NCT01026818|584643986|FG003|Screening Period|Protocol Deviation|0|||
161890294|NCT01026818|584643983|FG000|Screening Period|Adverse Event|2|||
161890295|NCT01026818|584643984|FG001|Screening Period|Adverse Event|0|||
161890296|NCT01026818|584643985|FG002|Screening Period|Adverse Event|0|||
161890297|NCT01026818|584643986|FG003|Screening Period|Adverse Event|0|||
161890298|NCT01026818|584643983|FG000|Screening Period|Physician Decision|1|||
161890299|NCT01026818|584643984|FG001|Screening Period|Physician Decision|0|||
161890300|NCT01026818|584643985|FG002|Screening Period|Physician Decision|0|||
161890301|NCT01026818|584643986|FG003|Screening Period|Physician Decision|0|||
161890302|NCT01026818|584643983|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
161890303|NCT01026818|584643984|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
161890304|NCT01026818|584643985|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
161890305|NCT01026818|584643986|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
161890306|NCT01026818|584643983|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
161890307|NCT01026818|584643984|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
161890308|NCT01026818|584643985|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
161890309|NCT01026818|584643986|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
161890310|NCT01026818|584643983|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
161890311|NCT01026818|584643984|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
161890312|NCT01026818|584643985|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
161994869|NCT00824473|585032222|FG000|Overall Study|Adverse Event|4|||
161890313|NCT01026818|584643986|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
161890314|NCT01026818|584643983|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
161890315|NCT01026818|584643984|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
161890316|NCT01026818|584643985|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
161890317|NCT01026818|584643986|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
161890318|NCT01026818|584643983|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
161890319|NCT01026818|584643984|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
161890320|NCT01026818|584643985|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
161890321|NCT01026818|584643986|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
161890322|NCT01026818|584643983|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
161890323|NCT01026818|584643984|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
161890324|NCT01026818|584643985|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
161890325|NCT01026818|584643986|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
161890326|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
161890327|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
161890328|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
161890329|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
161890330|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
161890331|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
161890332|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
161890333|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
161890334|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
161890335|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
161890336|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
161890337|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
161890338|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
161890339|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
161890340|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
161890341|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
161890342|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
161890343|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
161890344|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
161890345|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
161890346|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
161890347|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
161890348|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
161890349|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
161890350|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
161890351|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
161890352|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
161890353|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
161890354|NCT01026818|584643983|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
161890355|NCT01026818|584643984|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
161890356|NCT01026818|584643985|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
161890357|NCT01026818|584643986|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
161890358|NCT01026818|584643983|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
161890359|NCT01026818|584643984|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
161890360|NCT01026818|584643985|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
161890361|NCT01026818|584643986|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
161890362|NCT01026818|584643983|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
161890363|NCT01026818|584643984|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
161890364|NCT01026818|584643985|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
161890365|NCT01026818|584643986|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
161890366|NCT01026818|584643983|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
161890367|NCT01026818|584643984|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
161890368|NCT01026818|584643985|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
161890369|NCT01026818|584643986|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
161890370|NCT01026818|584643983|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
161890371|NCT01026818|584643984|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
161890372|NCT01026818|584643985|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
161890373|NCT01026818|584643986|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
161890374|NCT01026818|584643983|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
161890375|NCT01026818|584643984|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
161890376|NCT01026818|584643985|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
161890377|NCT01026818|584643986|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
161890378|NCT01908582|584643987|FG000|Period 2|Physician Decision|1|||
162038399|NCT01397201|585199506|FG003|Overall Study|Adverse Event|0|||
161890379|NCT01908582|584643987|FG000|Period 2|Withdrawal by Subject|1|||
161890380|NCT00424593|584643988|FG000|Acute Double-Blind Period|Adverse Event|16|||
161890381|NCT00424593|584643989|FG001|Acute Double-Blind Period|Adverse Event|7|||
161890382|NCT00424593|584643988|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
161890383|NCT00424593|584643989|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
161890384|NCT00424593|584643988|FG000|Acute Double-Blind Period|Protocol Violation|2|||
161890385|NCT00424593|584643989|FG001|Acute Double-Blind Period|Protocol Violation|2|||
161890386|NCT00424593|584643988|FG000|Acute Double-Blind Period|Physician Decision|1|||
161890387|NCT00424593|584643989|FG001|Acute Double-Blind Period|Physician Decision|2|||
161890388|NCT00424593|584643988|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
161890389|NCT00424593|584643989|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
161890390|NCT00424593|584643988|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
161890391|NCT00424593|584643989|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
161890392|NCT00424593|584643988|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
161890393|NCT00424593|584643989|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
161890394|NCT00424593|584643988|FG000|Dose-Blind Extension Period|Adverse Event|18|||
161890395|NCT00424593|584643989|FG001|Dose-Blind Extension Period|Adverse Event|0|||
161890396|NCT00424593|584643988|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
161890397|NCT00424593|584643989|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
161890398|NCT00424593|584643988|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
161890399|NCT00424593|584643989|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
161890400|NCT00424593|584643988|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
161890401|NCT00424593|584643989|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
161890402|NCT00424593|584643988|FG000|Dose-Blind Extension Period|Physician Decision|3|||
161890403|NCT00424593|584643989|FG001|Dose-Blind Extension Period|Physician Decision|0|||
161890404|NCT02065518|584643990|FG000|Overall Study|Lost to Follow-up|3|||
161890405|NCT02065518|584643991|FG001|Overall Study|Lost to Follow-up|4|||
161890406|NCT02065518|584643992|FG002|Overall Study|Lost to Follow-up|0|||
161890407|NCT02065518|584643993|FG003|Overall Study|Lost to Follow-up|3|||
161890408|NCT02065518|584643990|FG000|Overall Study|Withdrawal by Subject|3|||
161890409|NCT02065518|584643991|FG001|Overall Study|Withdrawal by Subject|4|||
161890410|NCT02065518|584643992|FG002|Overall Study|Withdrawal by Subject|9|||
161890411|NCT02065518|584643993|FG003|Overall Study|Withdrawal by Subject|2|||
161890412|NCT01066663|584643995|FG000|Overall Study|Adverse Event|0|||
161890413|NCT01066663|584643996|FG001|Overall Study|Adverse Event|0|||
161890414|NCT01066663|584643997|FG002|Overall Study|Adverse Event|1|||
161890415|NCT01090050|584643998|FG000|Overall Study|Lost to Follow-up|0|||
161890416|NCT01090050|584643999|FG001|Overall Study|Lost to Follow-up|1|||
161890417|NCT01090050|584643998|FG000|Overall Study|Lack of Efficacy|1|||
161890418|NCT01090050|584643999|FG001|Overall Study|Lack of Efficacy|5|||
161890419|NCT01090050|584643998|FG000|Overall Study|Physician Decision|0|||
161890420|NCT01090050|584643999|FG001|Overall Study|Physician Decision|1|||
161890421|NCT02232061|584644000|FG000|Overall Study|Administrative problems|1|||
161890422|NCT02232061|584644000|FG000|Overall Study|Withdrawal by Subject|1|||
161890423|NCT00571103|584644001|FG000|Overall Study|Withdrawal by Subject|1|||
161890424|NCT00571103|584644001|FG000|Overall Study|Lost to Follow-up|1|||
161890425|NCT02368886|584644002|FG000|Overall Study|Cancel|1|||
161890426|NCT02368886|584644003|FG001|Overall Study|Cancel|1|||
161890427|NCT02368886|584644004|FG002|Overall Study|Cancel|1|||
162038400|NCT01397201|585199507|FG004|Overall Study|Adverse Event|0|||
162038401|NCT02598960|585199514|FG000|Treatment Period|Disease Progression|4|||
162038402|NCT02598960|585199515|FG001|Treatment Period|Disease Progression|4|||
162038403|NCT02598960|585199516|FG002|Treatment Period|Disease Progression|4|||
162038404|NCT02598960|585199517|FG003|Treatment Period|Disease Progression|6|||
162038405|NCT02598960|585199518|FG004|Treatment Period|Disease Progression|8|||
162038406|NCT02598960|585199519|FG005|Treatment Period|Disease Progression|2|||
162038407|NCT02598960|585199520|FG006|Treatment Period|Disease Progression|2|||
162038408|NCT02598960|585199521|FG007|Treatment Period|Disease Progression|3|||
162038409|NCT02598960|585199522|FG008|Treatment Period|Disease Progression|7|||
162038410|NCT02598960|585199523|FG009|Treatment Period|Disease Progression|9|||
161890428|NCT02368886|584644005|FG003|Overall Study|Cancel|3|||
161890429|NCT02368886|584644002|FG000|Overall Study|Ineligible|0|||
162038411|NCT02598960|585199524|FG010|Treatment Period|Disease Progression|7|||
162038412|NCT02598960|585199525|FG011|Treatment Period|Disease Progression|143|||
162038413|NCT02598960|585199526|FG012|Treatment Period|Disease Progression|23|||
162038414|NCT02598960|585199514|FG000|Treatment Period|Study drug toxicity|0|||
162038415|NCT02598960|585199515|FG001|Treatment Period|Study drug toxicity|0|||
162038416|NCT02598960|585199516|FG002|Treatment Period|Study drug toxicity|0|||
162038417|NCT02598960|585199517|FG003|Treatment Period|Study drug toxicity|0|||
161890430|NCT02368886|584644003|FG001|Overall Study|Ineligible|0|||
161890431|NCT02368886|584644004|FG002|Overall Study|Ineligible|0|||
162038418|NCT02598960|585199518|FG004|Treatment Period|Study drug toxicity|0|||
161890432|NCT02368886|584644005|FG003|Overall Study|Ineligible|1|||
161890433|NCT04278924|584644007|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
162038419|NCT02598960|585199519|FG005|Treatment Period|Study drug toxicity|0|||
161890434|NCT04278924|584644008|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
161890435|NCT04278924|584644009|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
161890436|NCT04278924|584644010|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
161890437|NCT04278924|584644011|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
161890438|NCT04278924|584644012|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
161890439|NCT04278924|584644013|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
161890440|NCT04278924|584644007|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
161890441|NCT04278924|584644008|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
161890442|NCT04278924|584644009|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
161890443|NCT04278924|584644010|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
161890444|NCT04278924|584644011|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
161890445|NCT04278924|584644012|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
161890446|NCT04278924|584644013|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
161890447|NCT04767529|584644014|FG000|Overall Study|Adverse Event|0|||
161890448|NCT04767529|584644015|FG001|Overall Study|Adverse Event|4|||
161890449|NCT04767529|584644016|FG002|Overall Study|Adverse Event|3|||
161890450|NCT04767529|584644014|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
161890451|NCT04767529|584644015|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
161890452|NCT04767529|584644016|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
161890453|NCT04767529|584644014|FG000|Overall Study|Required use of a prohibited medication|0|||
161890454|NCT04767529|584644015|FG001|Overall Study|Required use of a prohibited medication|1|||
161890455|NCT04767529|584644016|FG002|Overall Study|Required use of a prohibited medication|0|||
161890456|NCT04767529|584644014|FG000|Overall Study|Withdrawal by Subject|7|||
161890457|NCT04767529|584644015|FG001|Overall Study|Withdrawal by Subject|5|||
161890458|NCT04767529|584644016|FG002|Overall Study|Withdrawal by Subject|4|||
161890459|NCT04767529|584644014|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
161890460|NCT04767529|584644015|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
161890461|NCT04767529|584644016|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
161890462|NCT04767529|584644014|FG000|Overall Study|Lost to Follow-up|0|||
161890463|NCT04767529|584644015|FG001|Overall Study|Lost to Follow-up|2|||
161890464|NCT04767529|584644016|FG002|Overall Study|Lost to Follow-up|3|||
161890465|NCT04847232|584644017|FG000|Overall Study|Death|123|||
161890466|NCT04847232|584644018|FG001|Overall Study|Death|115|||
161890467|NCT04847232|584644017|FG000|Overall Study|Lost to Follow-up|3|||
161890468|NCT04847232|584644018|FG001|Overall Study|Lost to Follow-up|10|||
161890469|NCT04847232|584644017|FG000|Overall Study|Withdrawal by Subject|73|||
161890470|NCT04847232|584644018|FG001|Overall Study|Withdrawal by Subject|101|||
161890471|NCT04847232|584644017|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
161890472|NCT04847232|584644018|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
161890473|NCT02476916|584644019|FG000|Core Period|Adverse Event|2|||
161890474|NCT02476916|584644020|FG001|Core Period|Adverse Event|2|||
161890475|NCT02476916|584644019|FG000|Core Period|Investigator decision|1|||
161890476|NCT02476916|584644020|FG001|Core Period|Investigator decision|1|||
161890477|NCT02476916|584644019|FG000|Core Period|Withdrawal by Subject|3|||
161890478|NCT02476916|584644020|FG001|Core Period|Withdrawal by Subject|0|||
161890479|NCT02476916|584644019|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
161890480|NCT02476916|584644020|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
161890481|NCT02476916|584644019|FG000|Extension Period|On Treatment|12|||
161890482|NCT02476916|584644020|FG001|Extension Period|On Treatment|17|||
161890483|NCT06010732|584644021|FG000|Crossover Period 1|Protocol Violation|0|||
161890484|NCT06010732|584644022|FG001|Crossover Period 1|Protocol Violation|0|||
161890485|NCT06010732|584644023|FG002|Crossover Period 1|Protocol Violation|1|||
161890486|NCT06010732|584644024|FG003|Crossover Period 1|Protocol Violation|0|||
161890487|NCT06010732|584644025|FG004|Crossover Period 1|Protocol Violation|1|||
161890488|NCT06010732|584644026|FG005|Crossover Period 1|Protocol Violation|0|||
161890489|NCT06010732|584644021|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161890490|NCT06010732|584644022|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
161890491|NCT06010732|584644023|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161890492|NCT06010732|584644024|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161890493|NCT06010732|584644025|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161890494|NCT06010732|584644026|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161890495|NCT06010732|584644021|FG000|Crossover Period 2|Adverse Event|0|||
161890496|NCT06010732|584644022|FG001|Crossover Period 2|Adverse Event|1|||
161890497|NCT06010732|584644023|FG002|Crossover Period 2|Adverse Event|0|||
161890498|NCT06010732|584644024|FG003|Crossover Period 2|Adverse Event|0|||
161890499|NCT06010732|584644025|FG004|Crossover Period 2|Adverse Event|0|||
161890500|NCT06010732|584644026|FG005|Crossover Period 2|Adverse Event|0|||
161890501|NCT06010732|584644021|FG000|Crossover Period 2|broken denture|0|||
161890502|NCT06010732|584644022|FG001|Crossover Period 2|broken denture|0|||
161890503|NCT06010732|584644023|FG002|Crossover Period 2|broken denture|1|||
161890504|NCT06010732|584644024|FG003|Crossover Period 2|broken denture|0|||
161890505|NCT06010732|584644025|FG004|Crossover Period 2|broken denture|0|||
162038420|NCT02598960|585199520|FG006|Treatment Period|Study drug toxicity|0|||
162038421|NCT02598960|585199521|FG007|Treatment Period|Study drug toxicity|0|||
162038422|NCT02598960|585199522|FG008|Treatment Period|Study drug toxicity|0|||
162038423|NCT02598960|585199523|FG009|Treatment Period|Study drug toxicity|1|||
162038424|NCT02598960|585199524|FG010|Treatment Period|Study drug toxicity|0|||
162038425|NCT02598960|585199525|FG011|Treatment Period|Study drug toxicity|3|||
162038426|NCT02598960|585199526|FG012|Treatment Period|Study drug toxicity|0|||
162038427|NCT02598960|585199514|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
162038428|NCT02598960|585199515|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
162038429|NCT02598960|585199516|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
161890506|NCT06010732|584644026|FG005|Crossover Period 2|broken denture|0|||
161890507|NCT00253370|584644028|FG000|Overall Study|Adverse Event|18|||
161890508|NCT00253370|584644028|FG000|Overall Study|Disease progression|13|||
161890509|NCT00253370|584644028|FG000|Overall Study|Death|2|||
161890510|NCT00253370|584644028|FG000|Overall Study|Withdrawal by Subject|6|||
161890511|NCT00253370|584644028|FG000|Overall Study|Non-protocol therapy|1|||
161890512|NCT00253370|584644028|FG000|Overall Study|Physician Decision|1|||
161890513|NCT00253370|584644028|FG000|Overall Study|Protocol Violation|1|||
162038430|NCT02598960|585199517|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
162038431|NCT02598960|585199518|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
162038432|NCT02598960|585199519|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
162038433|NCT02598960|585199520|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
162038434|NCT02598960|585199521|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
162038435|NCT02598960|585199522|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
162038436|NCT02598960|585199523|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
162038437|NCT02598960|585199524|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
162038438|NCT02598960|585199525|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
162038439|NCT02598960|585199526|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
162038440|NCT02598960|585199514|FG000|Treatment Period|participant request to discontinue|0|||
162038441|NCT02598960|585199515|FG001|Treatment Period|participant request to discontinue|1|||
162038442|NCT02598960|585199516|FG002|Treatment Period|participant request to discontinue|0|||
162038443|NCT02598960|585199517|FG003|Treatment Period|participant request to discontinue|0|||
162038444|NCT02598960|585199518|FG004|Treatment Period|participant request to discontinue|1|||
162038445|NCT02598960|585199519|FG005|Treatment Period|participant request to discontinue|0|||
162038446|NCT02598960|585199520|FG006|Treatment Period|participant request to discontinue|0|||
162038447|NCT02598960|585199521|FG007|Treatment Period|participant request to discontinue|0|||
162038448|NCT02598960|585199522|FG008|Treatment Period|participant request to discontinue|0|||
162038449|NCT02598960|585199523|FG009|Treatment Period|participant request to discontinue|0|||
162038450|NCT02598960|585199524|FG010|Treatment Period|participant request to discontinue|1|||
162038451|NCT02598960|585199525|FG011|Treatment Period|participant request to discontinue|4|||
162038452|NCT02598960|585199526|FG012|Treatment Period|participant request to discontinue|0|||
162038453|NCT02598960|585199514|FG000|Treatment Period|participant withdrew consent|0|||
161890514|NCT00253370|584644028|FG000|Overall Study|Abdominal pain due to disease|1|||
161890515|NCT03699540|584644029|FG000|Overall Study|Lost to Follow-up|1|||
161890516|NCT02697591|584644030|FG000|Overall Study|Lost to Follow-up|0|||
161890517|NCT02697591|584644031|FG001|Overall Study|Lost to Follow-up|0|||
161890518|NCT02697591|584644032|FG002|Overall Study|Lost to Follow-up|0|||
161890519|NCT02697591|584644033|FG003|Overall Study|Lost to Follow-up|0|||
161890520|NCT02697591|584644034|FG004|Overall Study|Lost to Follow-up|0|||
161890521|NCT02697591|584644035|FG005|Overall Study|Lost to Follow-up|1|||
161890522|NCT02697591|584644036|FG006|Overall Study|Lost to Follow-up|1|||
161890523|NCT02697591|584644037|FG007|Overall Study|Lost to Follow-up|0|||
161890524|NCT02697591|584644038|FG008|Overall Study|Lost to Follow-up|0|||
161890525|NCT02697591|584644039|FG009|Overall Study|Lost to Follow-up|1|||
161890526|NCT02697591|584644030|FG000|Overall Study|Withdrawal by Subject|1|||
161890527|NCT02697591|584644031|FG001|Overall Study|Withdrawal by Subject|1|||
161890528|NCT02697591|584644032|FG002|Overall Study|Withdrawal by Subject|2|||
161890529|NCT02697591|584644033|FG003|Overall Study|Withdrawal by Subject|1|||
161890530|NCT02697591|584644034|FG004|Overall Study|Withdrawal by Subject|7|||
161890531|NCT02697591|584644035|FG005|Overall Study|Withdrawal by Subject|6|||
161890532|NCT02697591|584644036|FG006|Overall Study|Withdrawal by Subject|9|||
161890533|NCT02697591|584644037|FG007|Overall Study|Withdrawal by Subject|1|||
161890534|NCT02697591|584644038|FG008|Overall Study|Withdrawal by Subject|6|||
161890535|NCT02697591|584644039|FG009|Overall Study|Withdrawal by Subject|10|||
161890536|NCT02697591|584644030|FG000|Overall Study|Physician Decision|1|||
161890537|NCT02697591|584644031|FG001|Overall Study|Physician Decision|0|||
161890538|NCT02697591|584644032|FG002|Overall Study|Physician Decision|0|||
161890539|NCT02697591|584644033|FG003|Overall Study|Physician Decision|0|||
161890540|NCT02697591|584644034|FG004|Overall Study|Physician Decision|1|||
161890541|NCT02697591|584644035|FG005|Overall Study|Physician Decision|2|||
161890542|NCT02697591|584644036|FG006|Overall Study|Physician Decision|0|||
162038454|NCT02598960|585199515|FG001|Treatment Period|participant withdrew consent|0|||
162038455|NCT02598960|585199516|FG002|Treatment Period|participant withdrew consent|0|||
161994870|NCT00824473|585032223|FG001|Overall Study|Adverse Event|5|||
161994871|NCT00824473|585032222|FG000|Overall Study|Lack of Efficacy|2|||
161994872|NCT00824473|585032223|FG001|Overall Study|Lack of Efficacy|2|||
161994873|NCT00824473|585032222|FG000|Overall Study|Protocol Violation|2|||
161994874|NCT00824473|585032223|FG001|Overall Study|Protocol Violation|0|||
161890543|NCT02697591|584644037|FG007|Overall Study|Physician Decision|0|||
161994875|NCT00824473|585032222|FG000|Overall Study|Non-Compliance|4|||
161994876|NCT00824473|585032223|FG001|Overall Study|Non-Compliance|2|||
161994877|NCT00824473|585032222|FG000|Overall Study|Withdrawal by Subject|2|||
161994878|NCT00824473|585032223|FG001|Overall Study|Withdrawal by Subject|3|||
161994879|NCT00824473|585032222|FG000|Overall Study|Other|1|||
161994880|NCT00824473|585032223|FG001|Overall Study|Other|1|||
161994881|NCT01359904|585032224|FG000|Overall Study|Withdrawal by Subject|1|||
161994882|NCT01359904|585032225|FG001|Overall Study|Withdrawal by Subject|0|||
161994883|NCT01172535|585032228|FG000|Overall Study|Death|3|||
161994884|NCT01172535|585032228|FG000|Overall Study|Withdrawal by Subject|2|||
161994885|NCT01172535|585032228|FG000|Overall Study|Lost to Follow-up|1|||
161994886|NCT01172535|585032228|FG000|Overall Study|Ineligible at study entry|1|||
161994887|NCT01172535|585032228|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
161994888|NCT01461707|585032229|FG000|Overall Study|Withdrawal by Subject|1|||
161994889|NCT01461707|585032230|FG001|Overall Study|Withdrawal by Subject|0|||
161994890|NCT03573323|585032231|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
161994891|NCT03573323|585032232|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
161994892|NCT03573323|585032231|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
161994893|NCT03573323|585032232|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
161994894|NCT03573323|585032231|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
161994895|NCT03573323|585032232|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
161994896|NCT03573323|585032231|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
161994897|NCT03573323|585032232|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
161994898|NCT03573323|585032231|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
161994899|NCT03573323|585032232|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
161994900|NCT03573323|585032231|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
161994901|NCT03573323|585032232|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
161994902|NCT03573323|585032231|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
161994903|NCT03573323|585032232|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
161994904|NCT03573323|585032231|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
161994905|NCT03573323|585032232|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
161994906|NCT03573323|585032231|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
161994907|NCT03573323|585032232|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
161994908|NCT03573323|585032231|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
161994909|NCT03573323|585032232|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
161994910|NCT03573323|585032231|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
161994911|NCT03573323|585032232|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
161994912|NCT03573323|585032231|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
161994913|NCT03573323|585032232|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
161994914|NCT03573323|585032231|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
161994915|NCT03573323|585032232|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
161994916|NCT03573323|585032231|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
161994917|NCT03573323|585032232|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
161994918|NCT03573323|585032231|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
161994919|NCT03573323|585032232|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
161994920|NCT03573323|585032231|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
161994921|NCT03573323|585032232|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
161994922|NCT03573323|585032231|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
161994923|NCT03573323|585032232|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
161994924|NCT03573323|585032231|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
161994925|NCT03573323|585032232|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
161994926|NCT03573323|585032231|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
161994927|NCT03573323|585032232|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
161994928|NCT00413218|585032234|FG000|Overall Study|Randomized but didn't receive study drug|2|||
161890544|NCT02697591|584644038|FG008|Overall Study|Physician Decision|1|||
161890545|NCT02697591|584644039|FG009|Overall Study|Physician Decision|1|||
161890546|NCT02697591|584644030|FG000|Overall Study|Death|2|||
161890547|NCT02697591|584644031|FG001|Overall Study|Death|3|||
161890548|NCT02697591|584644032|FG002|Overall Study|Death|1|||
161890549|NCT02697591|584644033|FG003|Overall Study|Death|1|||
161890550|NCT02697591|584644034|FG004|Overall Study|Death|4|||
161890551|NCT02697591|584644035|FG005|Overall Study|Death|5|||
161890552|NCT02697591|584644036|FG006|Overall Study|Death|3|||
162038456|NCT02598960|585199517|FG003|Treatment Period|participant withdrew consent|0|||
162038457|NCT02598960|585199518|FG004|Treatment Period|participant withdrew consent|0|||
161890553|NCT02697591|584644037|FG007|Overall Study|Death|1|||
161890554|NCT02697591|584644038|FG008|Overall Study|Death|1|||
161890555|NCT02697591|584644039|FG009|Overall Study|Death|5|||
161890556|NCT02697591|584644030|FG000|Overall Study|Reason not Specified|0|||
161890557|NCT02697591|584644031|FG001|Overall Study|Reason not Specified|0|||
161890558|NCT02697591|584644032|FG002|Overall Study|Reason not Specified|0|||
161890559|NCT02697591|584644033|FG003|Overall Study|Reason not Specified|1|||
162038458|NCT02598960|585199519|FG005|Treatment Period|participant withdrew consent|0|||
162038459|NCT02598960|585199520|FG006|Treatment Period|participant withdrew consent|0|||
162038460|NCT02598960|585199521|FG007|Treatment Period|participant withdrew consent|0|||
162038461|NCT02598960|585199522|FG008|Treatment Period|participant withdrew consent|0|||
162038462|NCT02598960|585199523|FG009|Treatment Period|participant withdrew consent|0|||
162038463|NCT02598960|585199524|FG010|Treatment Period|participant withdrew consent|0|||
162038464|NCT02598960|585199525|FG011|Treatment Period|participant withdrew consent|3|||
162038465|NCT02598960|585199526|FG012|Treatment Period|participant withdrew consent|0|||
162038466|NCT02598960|585199514|FG000|Treatment Period|No longer meets study criteria|0|||
162038467|NCT02598960|585199515|FG001|Treatment Period|No longer meets study criteria|0|||
162038468|NCT02598960|585199516|FG002|Treatment Period|No longer meets study criteria|0|||
162038469|NCT02598960|585199517|FG003|Treatment Period|No longer meets study criteria|0|||
162038470|NCT02598960|585199518|FG004|Treatment Period|No longer meets study criteria|0|||
161890560|NCT02697591|584644034|FG004|Overall Study|Reason not Specified|1|||
161890561|NCT02697591|584644035|FG005|Overall Study|Reason not Specified|2|||
161890562|NCT02697591|584644036|FG006|Overall Study|Reason not Specified|3|||
161890563|NCT02697591|584644037|FG007|Overall Study|Reason not Specified|1|||
161890564|NCT02697591|584644038|FG008|Overall Study|Reason not Specified|1|||
161890565|NCT02697591|584644039|FG009|Overall Study|Reason not Specified|3|||
161890566|NCT00004088|584644041|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
162038471|NCT02598960|585199519|FG005|Treatment Period|No longer meets study criteria|0|||
162038472|NCT02598960|585199520|FG006|Treatment Period|No longer meets study criteria|0|||
162038473|NCT02598960|585199521|FG007|Treatment Period|No longer meets study criteria|0|||
162038474|NCT02598960|585199522|FG008|Treatment Period|No longer meets study criteria|0|||
162038475|NCT02598960|585199523|FG009|Treatment Period|No longer meets study criteria|0|||
162038476|NCT02598960|585199524|FG010|Treatment Period|No longer meets study criteria|0|||
162038477|NCT02598960|585199525|FG011|Treatment Period|No longer meets study criteria|1|||
162038478|NCT02598960|585199526|FG012|Treatment Period|No longer meets study criteria|0|||
162038479|NCT02598960|585199514|FG000|Treatment Period|Other Reasons|0|||
162038480|NCT02598960|585199515|FG001|Treatment Period|Other Reasons|0|||
162038481|NCT02598960|585199516|FG002|Treatment Period|Other Reasons|0|||
162038482|NCT02598960|585199517|FG003|Treatment Period|Other Reasons|0|||
162038483|NCT02598960|585199518|FG004|Treatment Period|Other Reasons|0|||
162038484|NCT02598960|585199519|FG005|Treatment Period|Other Reasons|0|||
162038485|NCT02598960|585199520|FG006|Treatment Period|Other Reasons|0|||
162038486|NCT02598960|585199521|FG007|Treatment Period|Other Reasons|0|||
162038487|NCT02598960|585199522|FG008|Treatment Period|Other Reasons|0|||
162038488|NCT02598960|585199523|FG009|Treatment Period|Other Reasons|0|||
162038489|NCT02598960|585199524|FG010|Treatment Period|Other Reasons|0|||
162038490|NCT02598960|585199525|FG011|Treatment Period|Other Reasons|0|||
162038491|NCT02598960|585199526|FG012|Treatment Period|Other Reasons|1|||
162038492|NCT02598960|585199514|FG000|Participants Entering Follow Up Period|Death|1|||
162038493|NCT02598960|585199515|FG001|Participants Entering Follow Up Period|Death|0|||
162038494|NCT02598960|585199516|FG002|Participants Entering Follow Up Period|Death|0|||
162038495|NCT02598960|585199517|FG003|Participants Entering Follow Up Period|Death|0|||
162038496|NCT02598960|585199518|FG004|Participants Entering Follow Up Period|Death|0|||
162038497|NCT02598960|585199519|FG005|Participants Entering Follow Up Period|Death|0|||
162038498|NCT02598960|585199520|FG006|Participants Entering Follow Up Period|Death|0|||
162038499|NCT02598960|585199521|FG007|Participants Entering Follow Up Period|Death|0|||
161890567|NCT00004088|584644041|FG000|Overall Study|Withdrawal by Subject|1|||
162038500|NCT02598960|585199522|FG008|Participants Entering Follow Up Period|Death|0|||
162038501|NCT02598960|585199523|FG009|Participants Entering Follow Up Period|Death|1|||
162038502|NCT02598960|585199524|FG010|Participants Entering Follow Up Period|Death|0|||
162038503|NCT02598960|585199525|FG011|Participants Entering Follow Up Period|Death|11|||
162038504|NCT02598960|585199526|FG012|Participants Entering Follow Up Period|Death|2|||
162038505|NCT02598960|585199514|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
162038506|NCT02598960|585199515|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
161890568|NCT00004088|584644041|FG000|Overall Study|Protocol Violation|3|||
161890569|NCT00004088|584644041|FG000|Overall Study|Physician Decision|1|||
161890570|NCT02636699|584644042|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
162038507|NCT02598960|585199516|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
162038508|NCT02598960|585199517|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
162038509|NCT02598960|585199518|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
161890571|NCT02636699|584644043|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
161890572|NCT02636699|584644044|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
161890573|NCT02636699|584644042|FG000|Screening Period|Withdrawal by Subject|0|||
161890574|NCT02636699|584644043|FG001|Screening Period|Withdrawal by Subject|0|||
161890575|NCT02636699|584644044|FG002|Screening Period|Withdrawal by Subject|23|||
161890576|NCT02636699|584644042|FG000|Screening Period|Adverse Event|0|||
161890577|NCT02636699|584644043|FG001|Screening Period|Adverse Event|0|||
161890578|NCT02636699|584644044|FG002|Screening Period|Adverse Event|1|||
161890579|NCT02636699|584644042|FG000|Screening Period|Other not specified|0|||
161890580|NCT02636699|584644043|FG001|Screening Period|Other not specified|0|||
161890581|NCT02636699|584644044|FG002|Screening Period|Other not specified|3|||
161890582|NCT02636699|584644042|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
161890583|NCT02636699|584644043|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
161890584|NCT02636699|584644044|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
161890585|NCT02636699|584644042|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
161890586|NCT02636699|584644043|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
161890587|NCT02636699|584644044|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
161890588|NCT02636699|584644042|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
161890589|NCT02636699|584644043|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
161890590|NCT02636699|584644044|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
161890591|NCT02636699|584644042|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
161890592|NCT02636699|584644043|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
161890593|NCT02636699|584644044|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
161890594|NCT02636699|584644042|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
161890595|NCT02636699|584644043|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
161890596|NCT02636699|584644044|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
161890597|NCT02636699|584644042|FG000|Treatment and Follow-up Periods|Other|3|||
161890598|NCT02636699|584644043|FG001|Treatment and Follow-up Periods|Other|1|||
161890599|NCT02636699|584644044|FG002|Treatment and Follow-up Periods|Other|0|||
161890600|NCT00624832|584644045|FG000|Overall Study|Adverse Event|0|||
161890601|NCT00624832|584644046|FG001|Overall Study|Adverse Event|1|||
161890602|NCT00624832|584644047|FG002|Overall Study|Adverse Event|0|||
161890603|NCT00624832|584644048|FG003|Overall Study|Adverse Event|1|||
161890604|NCT00624832|584644045|FG000|Overall Study|Abnormal Laboratory Value|2|||
161890605|NCT00624832|584644046|FG001|Overall Study|Abnormal Laboratory Value|0|||
161890606|NCT00624832|584644047|FG002|Overall Study|Abnormal Laboratory Value|0|||
161890607|NCT00624832|584644048|FG003|Overall Study|Abnormal Laboratory Value|0|||
161890608|NCT01939223|584644049|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
161890609|NCT01939223|584644050|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
161890610|NCT01939223|584644049|FG000|Overall Study|Disease recurrence (radiological)|1|||
161890611|NCT01939223|584644050|FG001|Overall Study|Disease recurrence (radiological)|3|||
161890612|NCT01939223|584644049|FG000|Overall Study|Study stopped by Sponsor|5|||
161890613|NCT01939223|584644050|FG001|Overall Study|Study stopped by Sponsor|7|||
161890614|NCT01939223|584644049|FG000|Overall Study|Withdrawal by Subject|6|||
161890615|NCT01939223|584644050|FG001|Overall Study|Withdrawal by Subject|0|||
161890616|NCT04379700|584644051|FG000|Overall Study|Withdrawal by Subject|10|||
161890617|NCT04379700|584644051|FG000|Overall Study|Screen Fail|4|||
161890618|NCT04379700|584644051|FG000|Overall Study|Lost to Follow-up|3|||
161890619|NCT03624569|584644053|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161890620|NCT03624569|584644054|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
161994929|NCT00413218|585032235|FG001|Overall Study|Randomized but didn't receive study drug|8|||
161994930|NCT00413218|585032234|FG000|Overall Study|Death|57|||
161994931|NCT00413218|585032235|FG001|Overall Study|Death|56|||
161994932|NCT00413218|585032234|FG000|Overall Study|Lost to Follow-up|14|||
161994933|NCT00413218|585032235|FG001|Overall Study|Lost to Follow-up|17|||
161994934|NCT00413218|585032234|FG000|Overall Study|Admin|20|||
161994935|NCT00413218|585032235|FG001|Overall Study|Admin|14|||
161994936|NCT00413218|585032234|FG000|Overall Study|Missing|1|||
161994937|NCT00413218|585032235|FG001|Overall Study|Missing|0|||
161994938|NCT00413218|585032234|FG000|Overall Study|Withdrawal by Subject|9|||
161994939|NCT00413218|585032235|FG001|Overall Study|Withdrawal by Subject|1|||
161994940|NCT00837213|585032238|FG000|Overall Study|Lost to Follow-up|3|||
161994941|NCT00837213|585032239|FG001|Overall Study|Lost to Follow-up|2|||
161994942|NCT00837213|585032238|FG000|Overall Study|Withdrawal by Subject|2|||
161890621|NCT03624569|584644053|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
161994943|NCT00837213|585032239|FG001|Overall Study|Withdrawal by Subject|2|||
161994944|NCT00837213|585032238|FG000|Overall Study|not stated|1|||
161890622|NCT03624569|584644054|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
161994945|NCT00837213|585032239|FG001|Overall Study|not stated|1|||
161994946|NCT02336230|585032249|FG000|Overall Study|Adverse Event|1|||
161994947|NCT02336230|585032249|FG000|Overall Study|Withdrawal of consent|1|||
161994948|NCT02336230|585032249|FG000|Overall Study|Death|9|||
161994949|NCT02336230|585032249|FG000|Overall Study|Dose not received due to shipping delay|1|||
161994950|NCT02336230|585032249|FG000|Overall Study|Discontinuation of MSC infusion|1|||
161890623|NCT03004924|584644081|FG000|Overall Study|Adverse Event|6|||
161890624|NCT03004924|584644082|FG001|Overall Study|Adverse Event|5|||
161890625|NCT03004924|584644083|FG002|Overall Study|Adverse Event|10|||
161890626|NCT03004924|584644081|FG000|Overall Study|Protocol Violation|4|||
161890627|NCT03004924|584644082|FG001|Overall Study|Protocol Violation|0|||
161890628|NCT03004924|584644083|FG002|Overall Study|Protocol Violation|1|||
161890629|NCT03004924|584644081|FG000|Overall Study|Withdrawal by Subject|5|||
161890630|NCT03004924|584644082|FG001|Overall Study|Withdrawal by Subject|3|||
161890631|NCT03004924|584644083|FG002|Overall Study|Withdrawal by Subject|5|||
161890632|NCT03004924|584644081|FG000|Overall Study|Lost to Follow-up|6|||
161890633|NCT03004924|584644082|FG001|Overall Study|Lost to Follow-up|1|||
161890634|NCT03004924|584644083|FG002|Overall Study|Lost to Follow-up|4|||
161890635|NCT03004924|584644081|FG000|Overall Study|Lack of Efficacy|2|||
161890636|NCT03004924|584644082|FG001|Overall Study|Lack of Efficacy|4|||
161890637|NCT03004924|584644083|FG002|Overall Study|Lack of Efficacy|2|||
161890638|NCT03004924|584644081|FG000|Overall Study|Physician Decision|1|||
161890639|NCT03004924|584644082|FG001|Overall Study|Physician Decision|0|||
161890640|NCT03004924|584644083|FG002|Overall Study|Physician Decision|1|||
161890641|NCT03004924|584644081|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161890642|NCT03004924|584644082|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161890643|NCT03004924|584644083|FG002|Overall Study|Withdrawal by parent/guardian|2|||
161890644|NCT03004924|584644081|FG000|Overall Study|Screen Failure|1|||
161890645|NCT03004924|584644082|FG001|Overall Study|Screen Failure|0|||
161890646|NCT03004924|584644083|FG002|Overall Study|Screen Failure|0|||
161890647|NCT03004924|584644081|FG000|Overall Study|Pregnancy|0|||
161890648|NCT03004924|584644082|FG001|Overall Study|Pregnancy|1|||
161890649|NCT03004924|584644083|FG002|Overall Study|Pregnancy|0|||
161890650|NCT03004924|584644081|FG000|Overall Study|Terminated by Sponsor|0|||
161890651|NCT03004924|584644082|FG001|Overall Study|Terminated by Sponsor|0|||
161890652|NCT03004924|584644083|FG002|Overall Study|Terminated by Sponsor|1|||
161890653|NCT03004924|584644081|FG000|Overall Study|Missed Study Visit|0|||
161890654|NCT03004924|584644082|FG001|Overall Study|Missed Study Visit|0|||
161890655|NCT03004924|584644083|FG002|Overall Study|Missed Study Visit|2|||
161890656|NCT03004924|584644081|FG000|Overall Study|HSV1 Positive|1|||
161890657|NCT03004924|584644082|FG001|Overall Study|HSV1 Positive|0|||
161890658|NCT03004924|584644083|FG002|Overall Study|HSV1 Positive|0|||
161890659|NCT02083653|584644088|FG000|Overall Study|Randomized but not Treated|0|||
161890660|NCT02083653|584644089|FG001|Overall Study|Randomized but not Treated|2|||
161890661|NCT02083653|584644090|FG002|Overall Study|Randomized but not Treated|7|||
161890662|NCT02083653|584644088|FG000|Overall Study|Adverse Event|12|||
161890663|NCT02083653|584644089|FG001|Overall Study|Adverse Event|5|||
161890664|NCT02083653|584644090|FG002|Overall Study|Adverse Event|4|||
161890665|NCT02083653|584644088|FG000|Overall Study|Lost to Follow-up|1|||
161890666|NCT02083653|584644089|FG001|Overall Study|Lost to Follow-up|0|||
161890667|NCT02083653|584644090|FG002|Overall Study|Lost to Follow-up|0|||
161890668|NCT02083653|584644088|FG000|Overall Study|Death|2|||
161890669|NCT02083653|584644089|FG001|Overall Study|Death|2|||
161890670|NCT02083653|584644090|FG002|Overall Study|Death|2|||
161890671|NCT02083653|584644088|FG000|Overall Study|Progressive Disease|65|||
161890672|NCT02083653|584644089|FG001|Overall Study|Progressive Disease|73|||
161890673|NCT02083653|584644090|FG002|Overall Study|Progressive Disease|63|||
161890674|NCT02083653|584644088|FG000|Overall Study|Withdrawal by Subject|2|||
161890675|NCT02083653|584644089|FG001|Overall Study|Withdrawal by Subject|1|||
161890676|NCT02083653|584644090|FG002|Overall Study|Withdrawal by Subject|2|||
161890677|NCT02083653|584644088|FG000|Overall Study|Other Events|0|||
161890678|NCT02083653|584644089|FG001|Overall Study|Other Events|2|||
161890679|NCT02083653|584644090|FG002|Overall Study|Other Events|2|||
161890680|NCT02083653|584644088|FG000|Overall Study|Reason Missing|0|||
161890681|NCT02083653|584644089|FG001|Overall Study|Reason Missing|0|||
161890682|NCT02083653|584644090|FG002|Overall Study|Reason Missing|4|||
161890683|NCT02073656|584644091|FG000|Primary Study|Lost to Follow-up|6|||
161890684|NCT02073656|584644091|FG000|Primary Study|Death|1|||
161890685|NCT02073656|584644091|FG000|Primary Study|Withdrew Consent|1|||
161890686|NCT05079230|584644092|FG000|Overall Study|Study Terminated by Sponsor|101|||
161890687|NCT05079230|584644093|FG001|Overall Study|Study Terminated by Sponsor|102|||
161890688|NCT05079230|584644092|FG000|Overall Study|Death|72|||
161890689|NCT05079230|584644093|FG001|Overall Study|Death|66|||
161890690|NCT05079230|584644092|FG000|Overall Study|Withdrew Consent|16|||
161890691|NCT05079230|584644093|FG001|Overall Study|Withdrew Consent|18|||
161890692|NCT05079230|584644092|FG000|Overall Study|Lost to Follow-up|0|||
161890693|NCT05079230|584644093|FG001|Overall Study|Lost to Follow-up|3|||
161890694|NCT02054910|584644098|FG000|Overall Study|Lost to Follow-up|4|||
161890695|NCT02054910|584644099|FG001|Overall Study|Lost to Follow-up|1|||
161890696|NCT00207727|584644100|FG000|Overall Study|Withdrawal by Subject|0|||
161890697|NCT00207727|584644101|FG001|Overall Study|Withdrawal by Subject|0|||
161890698|NCT00207727|584644102|FG002|Overall Study|Withdrawal by Subject|0|||
161890699|NCT00207727|584644103|FG003|Overall Study|Withdrawal by Subject|0|||
161890700|NCT00207727|584644104|FG004|Overall Study|Withdrawal by Subject|1|||
161890701|NCT00207727|584644100|FG000|Overall Study|Lost to Follow-up|0|||
161890702|NCT00207727|584644101|FG001|Overall Study|Lost to Follow-up|1|||
161890703|NCT00207727|584644102|FG002|Overall Study|Lost to Follow-up|0|||
161890704|NCT00207727|584644103|FG003|Overall Study|Lost to Follow-up|0|||
161890705|NCT00207727|584644104|FG004|Overall Study|Lost to Follow-up|0|||
161890706|NCT00207727|584644100|FG000|Overall Study|Other|38|||
161890707|NCT00207727|584644101|FG001|Overall Study|Other|41|||
161890708|NCT00207727|584644102|FG002|Overall Study|Other|41|||
161890709|NCT00207727|584644103|FG003|Overall Study|Other|37|||
161890710|NCT00207727|584644104|FG004|Overall Study|Other|33|||
161890711|NCT03759366|584644105|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
161890712|NCT03759366|584644105|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
161890713|NCT03759366|584644105|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
161890714|NCT03759366|584644105|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
161890715|NCT03759366|584644105|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
161890716|NCT03759366|584644105|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
161890717|NCT03759366|584644105|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
161890718|NCT03611582|584644106|FG000|Overall Study|Adverse Event|26|||
161890719|NCT03611582|584644107|FG001|Overall Study|Adverse Event|6|||
161890720|NCT03611582|584644106|FG000|Overall Study|Protocol Violation|0|||
161890721|NCT03611582|584644107|FG001|Overall Study|Protocol Violation|1|||
161890722|NCT03611582|584644106|FG000|Overall Study|Pregnancy|1|||
161890723|NCT03611582|584644107|FG001|Overall Study|Pregnancy|2|||
161890724|NCT03611582|584644106|FG000|Overall Study|Lack of Efficacy|0|||
161890725|NCT03611582|584644107|FG001|Overall Study|Lack of Efficacy|1|||
161890726|NCT03611582|584644106|FG000|Overall Study|At the discretion of the investigator|1|||
161890727|NCT03611582|584644107|FG001|Overall Study|At the discretion of the investigator|0|||
161890728|NCT03611582|584644106|FG000|Overall Study|Safety concern as judged by the investigator|1|||
161890729|NCT03611582|584644107|FG001|Overall Study|Safety concern as judged by the investigator|2|||
161890730|NCT03611582|584644106|FG000|Overall Study|Withdrawal by Subject|4|||
161890731|NCT03611582|584644107|FG001|Overall Study|Withdrawal by Subject|3|||
161890732|NCT03611582|584644106|FG000|Overall Study|Lost to Follow-up|18|||
161890733|NCT03611582|584644107|FG001|Overall Study|Lost to Follow-up|7|||
161890734|NCT03611582|584644106|FG000|Overall Study|other|17|||
161890735|NCT03611582|584644107|FG001|Overall Study|other|16|||
161890736|NCT00463840|584644108|FG000|Overall Study|Disease progression|7|||
161890737|NCT00463840|584644108|FG000|Overall Study|Withdrawal by Subject|2|||
161890738|NCT00463840|584644108|FG000|Overall Study|Adverse Event|3|||
161890739|NCT01653327|584644109|FG000|Overall Study|Withdrawal by Subject|1|||
161890740|NCT00422292|584644110|FG000|Overall Study|Serious adverse events|1|||
161890741|NCT00422292|584644111|FG001|Overall Study|Serious adverse events|4|||
161890742|NCT00422292|584644112|FG002|Overall Study|Serious adverse events|0|||
161890743|NCT00422292|584644113|FG003|Overall Study|Serious adverse events|0|||
161890744|NCT00422292|584644110|FG000|Overall Study|Adverse Event|1|||
161890745|NCT00422292|584644111|FG001|Overall Study|Adverse Event|0|||
161890746|NCT00422292|584644112|FG002|Overall Study|Adverse Event|1|||
161890747|NCT00422292|584644113|FG003|Overall Study|Adverse Event|0|||
161890748|NCT00422292|584644110|FG000|Overall Study|Protocol Violation|4|||
161890749|NCT00422292|584644111|FG001|Overall Study|Protocol Violation|25|||
161890750|NCT00422292|584644112|FG002|Overall Study|Protocol Violation|8|||
161890751|NCT00422292|584644113|FG003|Overall Study|Protocol Violation|5|||
161890752|NCT00422292|584644110|FG000|Overall Study|Lost to Follow-up|6|||
161890753|NCT00422292|584644111|FG001|Overall Study|Lost to Follow-up|12|||
161890754|NCT00422292|584644112|FG002|Overall Study|Lost to Follow-up|6|||
161994951|NCT01620086|585032256|FG000|Overall Study|Withdrawal by Subject|3|||
161994952|NCT01620086|585032257|FG001|Overall Study|Withdrawal by Subject|3|||
161994953|NCT01620086|585032258|FG002|Overall Study|Withdrawal by Subject|0|||
161994954|NCT01620086|585032256|FG000|Overall Study|failed study criteria|1|||
161994955|NCT01620086|585032257|FG001|Overall Study|failed study criteria|4|||
161890755|NCT00422292|584644113|FG003|Overall Study|Lost to Follow-up|6|||
161890756|NCT00422292|584644110|FG000|Overall Study|Withdrawal by Subject|6|||
161994956|NCT01620086|585032258|FG002|Overall Study|failed study criteria|0|||
161994957|NCT01620086|585032256|FG000|Overall Study|Physician Decision|1|||
161994958|NCT01620086|585032257|FG001|Overall Study|Physician Decision|0|||
161890757|NCT00422292|584644111|FG001|Overall Study|Withdrawal by Subject|25|||
161890758|NCT00422292|584644112|FG002|Overall Study|Withdrawal by Subject|7|||
161890759|NCT00422292|584644113|FG003|Overall Study|Withdrawal by Subject|13|||
161890760|NCT01190189|584646058|FG000|Overall Study|Lost to Follow-up|4|||
161890761|NCT01190189|584646058|FG000|Overall Study|Withdrawal by Subject|1|||
161890762|NCT01190189|584646058|FG000|Overall Study|Migrated/moved from study area|1|||
161890763|NCT00762034|584646061|FG000|Induction Period|Protocol Violation|1|||
161890764|NCT00762034|584646062|FG001|Induction Period|Protocol Violation|2|||
161890765|NCT00762034|584646061|FG000|Induction Period|Entry Criterion Not Met|12|||
161890766|NCT00762034|584646062|FG001|Induction Period|Entry Criterion Not Met|11|||
161890767|NCT00762034|584646061|FG000|Induction Period|Adverse Event|27|||
161890768|NCT00762034|584646062|FG001|Induction Period|Adverse Event|38|||
161994959|NCT01620086|585032258|FG002|Overall Study|Physician Decision|0|||
161994960|NCT01695135|585032259|FG000|Double-blind Treatment Phase|Progressive disease|50|||
161890769|NCT00762034|584646061|FG000|Induction Period|Lost to Follow-up|1|||
161890770|NCT00762034|584646062|FG001|Induction Period|Lost to Follow-up|1|||
161890771|NCT00762034|584646061|FG000|Induction Period|Progressive Disease|73|||
161890772|NCT00762034|584646062|FG001|Induction Period|Progressive Disease|55|||
161890773|NCT00762034|584646061|FG000|Induction Period|Physician Decision|21|||
161890774|NCT00762034|584646062|FG001|Induction Period|Physician Decision|20|||
161890775|NCT00762034|584646061|FG000|Induction Period|Withdrawal by Subject|15|||
161890776|NCT00762034|584646062|FG001|Induction Period|Withdrawal by Subject|19|||
161890777|NCT00762034|584646061|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
161890778|NCT00762034|584646062|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
161890779|NCT00762034|584646061|FG000|Induction Period|Deaths Due to Study Disease|9|||
161890780|NCT00762034|584646062|FG001|Induction Period|Deaths Due to Study Disease|9|||
161890781|NCT00762034|584646061|FG000|Maintenance Period|Protocol Violation|1|||
161890782|NCT00762034|584646062|FG001|Maintenance Period|Protocol Violation|3|||
161890783|NCT00762034|584646061|FG000|Maintenance Period|Entry Criterion Not Met|0|||
161890784|NCT00762034|584646062|FG001|Maintenance Period|Entry Criterion Not Met|2|||
161890785|NCT00762034|584646061|FG000|Maintenance Period|Adverse Event|42|||
161890786|NCT00762034|584646062|FG001|Maintenance Period|Adverse Event|26|||
161890787|NCT00762034|584646061|FG000|Maintenance Period|Progressive Disease|186|||
161890788|NCT00762034|584646062|FG001|Maintenance Period|Progressive Disease|224|||
161890789|NCT00762034|584646061|FG000|Maintenance Period|Physician Decision|25|||
161890790|NCT00762034|584646062|FG001|Maintenance Period|Physician Decision|20|||
161890791|NCT00762034|584646061|FG000|Maintenance Period|Withdrawal by Subject|34|||
161890792|NCT00762034|584646062|FG001|Maintenance Period|Withdrawal by Subject|14|||
161890793|NCT00762034|584646061|FG000|Maintenance Period|Death not due to study disease|2|||
161890794|NCT00762034|584646062|FG001|Maintenance Period|Death not due to study disease|5|||
161890795|NCT00762034|584646061|FG000|Maintenance Period|Death due to study disease|3|||
161890796|NCT00762034|584646062|FG001|Maintenance Period|Death due to study disease|3|||
161890797|NCT00762034|584646061|FG000|Maintenance Period|Other|1|||
161890798|NCT00762034|584646062|FG001|Maintenance Period|Other|1|||
161890799|NCT04228965|584646063|FG000|Overall Study|Lost to Follow-up|26|||
161890800|NCT04228965|584646064|FG001|Overall Study|Lost to Follow-up|11|||
161890801|NCT04228965|584646063|FG000|Overall Study|Withdrawal by Subject|18|||
161890802|NCT04228965|584646064|FG001|Overall Study|Withdrawal by Subject|5|||
161890803|NCT02442206|584646065|FG000|Period 1|Adverse Event|1|||
161890804|NCT02442206|584646066|FG001|Period 1|Adverse Event|1|||
161890805|NCT02442206|584646065|FG000|Period 1|withdrew consent|0|||
161890806|NCT02442206|584646066|FG001|Period 1|withdrew consent|1|||
161890807|NCT02442206|584646065|FG000|Period 1|COPD exacerbation|0|||
161890808|NCT02442206|584646066|FG001|Period 1|COPD exacerbation|1|||
161890809|NCT02442206|584646065|FG000|Period 2|Adverse Event|1|||
161890810|NCT02442206|584646066|FG001|Period 2|Adverse Event|0|||
161890811|NCT03300050|584646069|FG000|Overall Study|Lost to Follow-up|2|||
161890812|NCT03300050|584646070|FG001|Overall Study|Lost to Follow-up|1|||
161890813|NCT03300050|584646071|FG002|Overall Study|Lost to Follow-up|0|||
161890814|NCT03300050|584646072|FG003|Overall Study|Lost to Follow-up|0|||
161890815|NCT03300050|584646073|FG004|Overall Study|Lost to Follow-up|1|||
161890816|NCT03300050|584646069|FG000|Overall Study|Withdrawal by Subject|1|||
161890817|NCT03300050|584646070|FG001|Overall Study|Withdrawal by Subject|1|||
161890818|NCT03300050|584646071|FG002|Overall Study|Withdrawal by Subject|1|||
161890819|NCT03300050|584646072|FG003|Overall Study|Withdrawal by Subject|0|||
161890820|NCT03300050|584646073|FG004|Overall Study|Withdrawal by Subject|0|||
161890821|NCT03300050|584646069|FG000|Overall Study|Death|0|||
161890822|NCT03300050|584646070|FG001|Overall Study|Death|0|||
161890823|NCT03300050|584646071|FG002|Overall Study|Death|1|||
161890824|NCT03300050|584646072|FG003|Overall Study|Death|0|||
161890825|NCT03300050|584646073|FG004|Overall Study|Death|0|||
161890826|NCT03300050|584646069|FG000|Overall Study|Not Eligible at Randomization|0|||
161890827|NCT03300050|584646070|FG001|Overall Study|Not Eligible at Randomization|0|||
161890828|NCT03300050|584646071|FG002|Overall Study|Not Eligible at Randomization|1|||
161890829|NCT03300050|584646072|FG003|Overall Study|Not Eligible at Randomization|1|||
161890830|NCT03300050|584646073|FG004|Overall Study|Not Eligible at Randomization|0|||
161890831|NCT01375374|584646074|FG000|Overall Study|Adverse Event|1|||
161890832|NCT03297021|584646075|FG000|Overall Study|Incomplete/illegible data sheet|4|||
161890833|NCT03297021|584646076|FG001|Overall Study|Incomplete/illegible data sheet|2|||
161890834|NCT03297021|584646077|FG002|Overall Study|Incomplete/illegible data sheet|3|||
161890835|NCT03297021|584646075|FG000|Overall Study|Missing Post-Op Data|1|||
161994961|NCT01695135|585032260|FG001|Double-blind Treatment Phase|Progressive disease|110|||
161890836|NCT03297021|584646076|FG001|Overall Study|Missing Post-Op Data|2|||
161890837|NCT03297021|584646077|FG002|Overall Study|Missing Post-Op Data|1|||
161890838|NCT02784288|584646079|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
161890839|NCT02734862|584646080|FG000|Part A|Death|3|||
161890840|NCT02734862|584646081|FG001|Part A|Death|4|||
161890841|NCT02734862|584646082|FG002|Part A|Death|6|||
161890842|NCT02734862|584646080|FG000|Part A|Lost to Follow-up|2|||
161890843|NCT02734862|584646081|FG001|Part A|Lost to Follow-up|1|||
161890844|NCT02734862|584646082|FG002|Part A|Lost to Follow-up|1|||
161890845|NCT02734862|584646080|FG000|Part A|Withdrawal by Subject|1|||
161890846|NCT02734862|584646081|FG001|Part A|Withdrawal by Subject|1|||
161890847|NCT02734862|584646082|FG002|Part A|Withdrawal by Subject|2|||
161890848|NCT02734862|584646080|FG000|Part A|Physician Decision|2|||
161890849|NCT02734862|584646081|FG001|Part A|Physician Decision|0|||
161890850|NCT02734862|584646082|FG002|Part A|Physician Decision|1|||
161890851|NCT02734862|584646080|FG000|Part A|Adverse Event|2|||
161890852|NCT02734862|584646081|FG001|Part A|Adverse Event|0|||
161890853|NCT02734862|584646082|FG002|Part A|Adverse Event|1|||
161890854|NCT02734862|584646080|FG000|Part A|Noncompliance|1|||
161890855|NCT02734862|584646081|FG001|Part A|Noncompliance|1|||
161890856|NCT02734862|584646082|FG002|Part A|Noncompliance|0|||
161890857|NCT02734862|584646080|FG000|Part A|Other|1|||
161890858|NCT02734862|584646081|FG001|Part A|Other|1|||
161890859|NCT02734862|584646082|FG002|Part A|Other|3|||
161890860|NCT02734862|584646080|FG000|Part B|Death|8|||
161890861|NCT02734862|584646081|FG001|Part B|Death|3|||
161890862|NCT02734862|584646082|FG002|Part B|Death|5|||
161890863|NCT02734862|584646080|FG000|Part B|Lost to Follow-up|2|||
161890864|NCT02734862|584646081|FG001|Part B|Lost to Follow-up|2|||
161890865|NCT02734862|584646082|FG002|Part B|Lost to Follow-up|0|||
161890866|NCT02734862|584646080|FG000|Part B|Withdrawal by Subject|3|||
161890867|NCT02734862|584646081|FG001|Part B|Withdrawal by Subject|1|||
161890868|NCT02734862|584646082|FG002|Part B|Withdrawal by Subject|0|||
161890869|NCT02734862|584646080|FG000|Part B|Other|0|||
161890870|NCT02734862|584646081|FG001|Part B|Other|1|||
161890871|NCT02734862|584646082|FG002|Part B|Other|0|||
161890872|NCT02757625|584646083|FG000|Overall Study|Investigator's discretion|0|||
161890873|NCT02757625|584646084|FG001|Overall Study|Investigator's discretion|0|||
161890874|NCT02757625|584646085|FG002|Overall Study|Investigator's discretion|1|||
161890875|NCT02757625|584646086|FG003|Overall Study|Investigator's discretion|0|||
161890876|NCT02757625|584646083|FG000|Overall Study|Adverse Event|0|||
161890877|NCT02757625|584646084|FG001|Overall Study|Adverse Event|0|||
161890878|NCT02757625|584646085|FG002|Overall Study|Adverse Event|1|||
161890879|NCT02757625|584646086|FG003|Overall Study|Adverse Event|0|||
161890880|NCT00564278|584646087|FG000|Overall Study|Lost to Follow-up|35|||
161890881|NCT00564278|584646088|FG001|Overall Study|Lost to Follow-up|33|||
161890882|NCT00564278|584646087|FG000|Overall Study|Physician Decision|1|||
161890883|NCT00564278|584646088|FG001|Overall Study|Physician Decision|2|||
161890884|NCT00564278|584646087|FG000|Overall Study|Withdrawal by Subject|11|||
161890885|NCT00564278|584646088|FG001|Overall Study|Withdrawal by Subject|7|||
161890886|NCT00560703|584646089|FG000|Overall Study|Adverse Event|0|||
161890887|NCT00560703|584646090|FG001|Overall Study|Adverse Event|2|||
161890888|NCT00560703|584646089|FG000|Overall Study|Protocol Violation|0|||
161890889|NCT00560703|584646090|FG001|Overall Study|Protocol Violation|2|||
161890890|NCT00560703|584646089|FG000|Overall Study|Withdrawal by Subject|0|||
161890891|NCT00560703|584646090|FG001|Overall Study|Withdrawal by Subject|1|||
161890892|NCT00560703|584646089|FG000|Overall Study|non-compliance|0|||
161890893|NCT00560703|584646090|FG001|Overall Study|non-compliance|1|||
161890894|NCT02095197|584646091|FG000|Overall Study|Lost to Follow-up|0|||
161890895|NCT02095197|584646092|FG001|Overall Study|Lost to Follow-up|3|||
161890896|NCT02779075|584646093|FG000|Overall Study|Withdrawal by Subject|1|||
161890897|NCT02779075|584646094|FG001|Overall Study|Withdrawal by Subject|3|||
161890898|NCT02779075|584646093|FG000|Overall Study|IV lost during 2nd study|1|||
161890899|NCT02779075|584646094|FG001|Overall Study|IV lost during 2nd study|0|||
161890900|NCT02714036|584646095|FG000|Overall Study|Adverse Event|9|||
161890901|NCT02714036|584646096|FG001|Overall Study|Adverse Event|2|||
161890902|NCT02714036|584646095|FG000|Overall Study|Withdrawal by Subject|3|||
161890903|NCT02714036|584646096|FG001|Overall Study|Withdrawal by Subject|2|||
161890904|NCT01618916|584646097|FG000|Overall Study|Adverse Event|1|||
161890905|NCT01618916|584646098|FG001|Overall Study|Adverse Event|0|||
161890906|NCT01618916|584646099|FG002|Overall Study|Adverse Event|0|||
161890907|NCT01618916|584646100|FG003|Overall Study|Adverse Event|0|||
161890908|NCT01618916|584646101|FG004|Overall Study|Adverse Event|0|||
161890909|NCT01618916|584646102|FG005|Overall Study|Adverse Event|0|||
161890910|NCT01618916|584646097|FG000|Overall Study|Withdrawal by Subject|0|||
161890911|NCT01618916|584646098|FG001|Overall Study|Withdrawal by Subject|1|||
161890912|NCT01618916|584646099|FG002|Overall Study|Withdrawal by Subject|1|||
161890913|NCT01618916|584646100|FG003|Overall Study|Withdrawal by Subject|0|||
162038510|NCT02598960|585199519|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
161890914|NCT01618916|584646101|FG004|Overall Study|Withdrawal by Subject|1|||
161890915|NCT01618916|584646102|FG005|Overall Study|Withdrawal by Subject|0|||
161890916|NCT01618916|584646097|FG000|Overall Study|Lost to Follow-up|1|||
162048499|NCT04545060|585233342|FG000|Overall Study|Physician Decision|3|||
161890917|NCT01618916|584646098|FG001|Overall Study|Lost to Follow-up|0|||
161890918|NCT01618916|584646099|FG002|Overall Study|Lost to Follow-up|0|||
161890919|NCT01618916|584646100|FG003|Overall Study|Lost to Follow-up|2|||
161890920|NCT01618916|584646101|FG004|Overall Study|Lost to Follow-up|0|||
161890921|NCT01618916|584646102|FG005|Overall Study|Lost to Follow-up|0|||
161890922|NCT00938587|584646106|FG000|Overall Study|Adverse Event|2|||
161890923|NCT00938587|584646107|FG001|Overall Study|Adverse Event|0|||
161890924|NCT00938587|584646108|FG002|Overall Study|Adverse Event|0|||
161890925|NCT00938587|584646109|FG003|Overall Study|Adverse Event|2|||
161890926|NCT00938587|584646106|FG000|Overall Study|Did not meet entrance criteria|0|||
161890927|NCT00938587|584646107|FG001|Overall Study|Did not meet entrance criteria|0|||
161890928|NCT00938587|584646108|FG002|Overall Study|Did not meet entrance criteria|1|||
161890929|NCT00938587|584646109|FG003|Overall Study|Did not meet entrance criteria|0|||
161890930|NCT00938587|584646106|FG000|Overall Study|Withdrawal by Subject|1|||
161890931|NCT00938587|584646107|FG001|Overall Study|Withdrawal by Subject|1|||
161890932|NCT00938587|584646108|FG002|Overall Study|Withdrawal by Subject|0|||
161890933|NCT00938587|584646109|FG003|Overall Study|Withdrawal by Subject|0|||
161890934|NCT01464619|584646114|FG000|Overall Study|Lost to Follow-up|3|||
161890935|NCT01464619|584646115|FG001|Overall Study|Lost to Follow-up|4|||
161890936|NCT02819440|584646116|FG000|Overall Study|Adverse Event|3|||
161890937|NCT02819440|584646117|FG001|Overall Study|Adverse Event|1|||
161890938|NCT02819440|584646116|FG000|Overall Study|Lost to Follow-up|1|||
161890939|NCT02819440|584646117|FG001|Overall Study|Lost to Follow-up|3|||
161890940|NCT02819440|584646116|FG000|Overall Study|Withdrawal by Subject|9|||
161890941|NCT02819440|584646117|FG001|Overall Study|Withdrawal by Subject|8|||
161890942|NCT01490697|584646120|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
161890943|NCT01490697|584646121|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
161890944|NCT00090584|584646122|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
161890945|NCT00090584|584646123|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
161890946|NCT00090584|584646122|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
161890947|NCT00090584|584646123|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
161890948|NCT00379808|584646124|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
161890949|NCT00379808|584646125|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
161890950|NCT01048099|584646134|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
161890951|NCT01048099|584646134|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
161890952|NCT00508157|584646135|FG000|Overall Study|Adverse Event|0|||
161890953|NCT00508157|584646136|FG001|Overall Study|Adverse Event|1|||
161890954|NCT00508157|584646135|FG000|Overall Study|Subject Withdrew Consent|1|||
161890955|NCT00508157|584646136|FG001|Overall Study|Subject Withdrew Consent|0|||
161890956|NCT00508157|584646135|FG000|Overall Study|Lost to Follow-up|1|||
161890957|NCT00508157|584646136|FG001|Overall Study|Lost to Follow-up|0|||
161890958|NCT00508157|584646135|FG000|Overall Study|Subject no longer met study criteria|0|||
161890959|NCT00508157|584646136|FG001|Overall Study|Subject no longer met study criteria|1|||
161890960|NCT00508157|584646135|FG000|Overall Study|Other known cause|0|||
161890961|NCT00508157|584646136|FG001|Overall Study|Other known cause|1|||
161890962|NCT01987232|584646137|FG000|Overall Study|Ongoing in Study|0|||
161890963|NCT01987232|584646138|FG001|Overall Study|Ongoing in Study|0|||
161890964|NCT01987232|584646139|FG002|Overall Study|Ongoing in Study|0|||
161890965|NCT01987232|584646140|FG003|Overall Study|Ongoing in Study|1|||
161890966|NCT01987232|584646141|FG004|Overall Study|Ongoing in Study|0|||
161890967|NCT01731470|584646144|FG000|Overall Study|Withdrawal by Subject|1|||
161890968|NCT01731470|584646144|FG000|Overall Study|Did not meet study criteria|1|||
161890969|NCT02258334|584646147|FG000|Overall Study|Adverse Event|1|||
161890970|NCT02258334|584646148|FG001|Overall Study|Adverse Event|0|||
161890971|NCT02258334|584646149|FG002|Overall Study|Adverse Event|0|||
161890972|NCT02258334|584646150|FG003|Overall Study|Adverse Event|0|||
161890973|NCT03564795|584646157|FG000|Overall Study|Withdrawal by Subject|3|||
161890974|NCT03564795|584646157|FG000|Overall Study|Lost to Follow-up|6|||
161890975|NCT03564795|584646157|FG000|Overall Study|Physician Decision|2|||
161890976|NCT00564395|584646158|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
161890977|NCT00564395|584646159|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
161890978|NCT00564395|584646158|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
161890979|NCT00564395|584646159|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
161890980|NCT00477607|584646165|FG000|Overall Study|Lost to Follow-up|7|||
161890981|NCT00477607|584646166|FG001|Overall Study|Lost to Follow-up|7|||
161890982|NCT00432276|584646167|FG000|Overall Study|Hyperglycemic Rescue|44|||
161890983|NCT00432276|584646168|FG001|Overall Study|Hyperglycemic Rescue|87|||
161890984|NCT00432276|584646167|FG000|Overall Study|Adverse Event|13|||
161890985|NCT00432276|584646168|FG001|Overall Study|Adverse Event|16|||
161890986|NCT00432276|584646167|FG000|Overall Study|Protocol Violation|25|||
161890987|NCT00432276|584646168|FG001|Overall Study|Protocol Violation|20|||
161890988|NCT00432276|584646167|FG000|Overall Study|Lost to Follow-up|6|||
161890989|NCT00432276|584646168|FG001|Overall Study|Lost to Follow-up|2|||
161890990|NCT00432276|584646167|FG000|Overall Study|Withdrawal by Subject|25|||
161890991|NCT00432276|584646168|FG001|Overall Study|Withdrawal by Subject|20|||
161890992|NCT00432276|584646167|FG000|Overall Study|Physician Decision|6|||
161890993|NCT00432276|584646168|FG001|Overall Study|Physician Decision|8|||
161890994|NCT00432276|584646167|FG000|Overall Study|Other|2|||
161890995|NCT00432276|584646168|FG001|Overall Study|Other|3|||
161890996|NCT00594386|584646169|FG000|Overall Study|Major protocol violation|2|||
161890997|NCT00594386|584646169|FG000|Overall Study|Lack of Efficacy|12|||
161890998|NCT00594386|584646169|FG000|Overall Study|Adverse Event|68|||
161890999|NCT00594386|584646169|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
161891000|NCT00594386|584646169|FG000|Overall Study|Subject withdrew consent|35|||
161891001|NCT00594386|584646169|FG000|Overall Study|Study ended per sponsor|115|||
161891002|NCT00594386|584646169|FG000|Overall Study|Lost to Follow-up|6|||
161891003|NCT00594386|584646169|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
161891004|NCT00594386|584646169|FG000|Overall Study|Other: Subject moved to Seattle|1|||
161891005|NCT00594386|584646169|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
161891006|NCT00594386|584646169|FG000|Overall Study|Other: Study terminated per investigator|2|||
161891007|NCT00594386|584646169|FG000|Overall Study|Other: Sponsor closure of study|1|||
161891008|NCT00594386|584646169|FG000|Overall Study|Other: Site terminated participation|1|||
161891009|NCT00594386|584646169|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
161891010|NCT00594386|584646169|FG000|Overall Study|Other: Loss of drivers license|1|||
161891011|NCT01210144|584646173|FG000|Overall Study|Lack of ovarian response|1|||
161891012|NCT01210144|584646174|FG001|Overall Study|Lack of ovarian response|0|||
161891013|NCT01210144|584646173|FG000|Overall Study|No fertilization|1|||
161891014|NCT01210144|584646174|FG001|Overall Study|No fertilization|0|||
161891015|NCT01210144|584646173|FG000|Overall Study|No transfer|1|||
161891016|NCT01210144|584646174|FG001|Overall Study|No transfer|0|||
161891017|NCT00505661|584646186|FG000|Overall Study|Not Eligible|4|||
161891018|NCT01573754|584646191|FG000|Overall Study|Noncompliance or remission not achieved|3|||
161891019|NCT01573754|584646192|FG001|Overall Study|Noncompliance or remission not achieved|15|||
161891020|NCT00866333|584646193|FG000|Overall Study|Withdrawal of consent|0|||
161891021|NCT00866333|584646194|FG001|Overall Study|Withdrawal of consent|1|||
161891022|NCT00866333|584646195|FG002|Overall Study|Withdrawal of consent|2|||
161891023|NCT00866333|584646193|FG000|Overall Study|Reason not Specified|3|||
161891024|NCT00866333|584646194|FG001|Overall Study|Reason not Specified|1|||
161891025|NCT00866333|584646195|FG002|Overall Study|Reason not Specified|1|||
161891026|NCT00866333|584646193|FG000|Overall Study|Study Terminated by Sponsor|2|||
161891027|NCT00866333|584646194|FG001|Overall Study|Study Terminated by Sponsor|5|||
161891028|NCT00866333|584646195|FG002|Overall Study|Study Terminated by Sponsor|9|||
161891029|NCT02243046|584646196|FG000|Overall Study|Lost to Follow-up|1|||
161891030|NCT02243046|584646197|FG001|Overall Study|Lost to Follow-up|1|||
161891031|NCT02243046|584646198|FG002|Overall Study|Lost to Follow-up|4|||
161891032|NCT04918355|584646199|FG000|Overall Study|no qualifying health encounter|497|||
161891033|NCT04918355|584646200|FG001|Overall Study|no qualifying health encounter|192|||
161891034|NCT04918355|584646201|FG002|Overall Study|no qualifying health encounter|438|||
161891035|NCT04918355|584646202|FG003|Overall Study|no qualifying health encounter|424|||
161891036|NCT04683939|584646203|FG000|Overall Study|Study termination by the sponsor|0|||
161891037|NCT04683939|584646204|FG001|Overall Study|Study termination by the sponsor|1|||
161891038|NCT04683939|584646205|FG002|Overall Study|Study termination by the sponsor|2|||
161891039|NCT04683939|584646206|FG003|Overall Study|Study termination by the sponsor|2|||
161891040|NCT04683939|584646203|FG000|Overall Study|Death|1|||
161891041|NCT04683939|584646204|FG001|Overall Study|Death|1|||
161891042|NCT04683939|584646205|FG002|Overall Study|Death|2|||
161891043|NCT04683939|584646206|FG003|Overall Study|Death|1|||
161891044|NCT04683939|584646203|FG000|Overall Study|Withdrawal by Subject|1|||
161891045|NCT04683939|584646204|FG001|Overall Study|Withdrawal by Subject|0|||
161891046|NCT04683939|584646205|FG002|Overall Study|Withdrawal by Subject|0|||
161891047|NCT04683939|584646206|FG003|Overall Study|Withdrawal by Subject|0|||
161891048|NCT04683939|584646203|FG000|Overall Study|Physician Decision|1|||
161891049|NCT04683939|584646204|FG001|Overall Study|Physician Decision|0|||
161891050|NCT04683939|584646205|FG002|Overall Study|Physician Decision|0|||
161891051|NCT04683939|584646206|FG003|Overall Study|Physician Decision|0|||
161891052|NCT04683939|584646203|FG000|Overall Study|Lost to Follow-up|0|||
161891053|NCT04683939|584646204|FG001|Overall Study|Lost to Follow-up|1|||
161891054|NCT04683939|584646205|FG002|Overall Study|Lost to Follow-up|0|||
161891055|NCT04683939|584646206|FG003|Overall Study|Lost to Follow-up|0|||
161891056|NCT04852276|584646207|FG000|Overall Study|Death|2|||
161891057|NCT04852276|584646208|FG001|Overall Study|Death|0|||
161891058|NCT04852276|584646207|FG000|Overall Study|Lost to Follow-up|15|||
161891059|NCT04852276|584646208|FG001|Overall Study|Lost to Follow-up|9|||
161891060|NCT04852276|584646207|FG000|Overall Study|Withdrawal by Subject|26|||
161891061|NCT04852276|584646208|FG001|Overall Study|Withdrawal by Subject|6|||
161891062|NCT01687283|584648067|FG000|Overall Study|Adverse Event|11|||
161891063|NCT01687283|584648068|FG001|Overall Study|Adverse Event|4|||
161891064|NCT01687283|584648067|FG000|Overall Study|Lack of Efficacy|3|||
161891065|NCT01687283|584648068|FG001|Overall Study|Lack of Efficacy|1|||
161891066|NCT01687283|584648067|FG000|Overall Study|Protocol Violation|1|||
161891067|NCT01687283|584648068|FG001|Overall Study|Protocol Violation|3|||
161891068|NCT01687283|584648067|FG000|Overall Study|protocol defined stopping criteria|8|||
161891069|NCT01687283|584648068|FG001|Overall Study|protocol defined stopping criteria|10|||
161891070|NCT01687283|584648067|FG000|Overall Study|Lost to Follow-up|1|||
161891071|NCT01687283|584648068|FG001|Overall Study|Lost to Follow-up|1|||
161891072|NCT01687283|584648067|FG000|Overall Study|Investigator discretion|2|||
161891073|NCT01687283|584648068|FG001|Overall Study|Investigator discretion|0|||
161891074|NCT01687283|584648067|FG000|Overall Study|Withdrawal by Subject|9|||
161891075|NCT01687283|584648068|FG001|Overall Study|Withdrawal by Subject|8|||
161891076|NCT00410072|584648072|FG000|Day 1 to Week 48|Adverse Event|1|||
161891077|NCT00410072|584648073|FG001|Day 1 to Week 48|Adverse Event|2|||
161891078|NCT00410072|584648072|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
161891079|NCT00410072|584648073|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
161891080|NCT00410072|584648072|FG000|Day 1 to Week 48|Other|0|||
161891081|NCT00410072|584648073|FG001|Day 1 to Week 48|Other|1|||
161891082|NCT00410072|584648072|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
161891083|NCT00410072|584648073|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
161891084|NCT00410072|584648072|FG000|Day 1 to Week 48|Pregnancy|0|||
161891085|NCT00410072|584648073|FG001|Day 1 to Week 48|Pregnancy|2|||
161891086|NCT00410072|584648072|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
161891087|NCT00410072|584648073|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
161891088|NCT00410072|584648072|FG000|After Week 48 to Week 96|Adverse Event|1|||
161891089|NCT00410072|584648073|FG001|After Week 48 to Week 96|Adverse Event|2|||
161891090|NCT00410072|584648072|FG000|After Week 48 to Week 96|Death|0|||
161891091|NCT00410072|584648073|FG001|After Week 48 to Week 96|Death|1|||
161891092|NCT00410072|584648072|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
161891093|NCT00410072|584648073|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
161891094|NCT00410072|584648072|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
161891095|NCT00410072|584648073|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
161891096|NCT00410072|584648072|FG000|After Week 48 to Week 96|Other|2|||
161891097|NCT00410072|584648073|FG001|After Week 48 to Week 96|Other|0|||
161994962|NCT01695135|585032261|FG002|Double-blind Treatment Phase|Progressive disease|0|||
161994963|NCT01695135|585032262|FG003|Double-blind Treatment Phase|Progressive disease|0|||
161994964|NCT01695135|585032259|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
161994965|NCT01695135|585032260|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
161994966|NCT01695135|585032261|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161994967|NCT01695135|585032262|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161994968|NCT01695135|585032259|FG000|Double-blind Treatment Phase|Adverse Event|7|||
161994969|NCT01695135|585032260|FG001|Double-blind Treatment Phase|Adverse Event|7|||
161994970|NCT01695135|585032261|FG002|Double-blind Treatment Phase|Adverse Event|0|||
161994971|NCT01695135|585032262|FG003|Double-blind Treatment Phase|Adverse Event|0|||
161994972|NCT01695135|585032259|FG000|Double-blind Treatment Phase|Other|1|||
161994973|NCT01695135|585032260|FG001|Double-blind Treatment Phase|Other|3|||
161994974|NCT01695135|585032261|FG002|Double-blind Treatment Phase|Other|0|||
161994975|NCT01695135|585032262|FG003|Double-blind Treatment Phase|Other|0|||
161994976|NCT01695135|585032259|FG000|Double-blind Treatment Phase|Physician Decision|6|||
161994977|NCT01695135|585032260|FG001|Double-blind Treatment Phase|Physician Decision|3|||
161994978|NCT01695135|585032261|FG002|Double-blind Treatment Phase|Physician Decision|0|||
161994979|NCT01695135|585032262|FG003|Double-blind Treatment Phase|Physician Decision|0|||
161994980|NCT01695135|585032259|FG000|Double-blind Treatment Phase|Death|1|||
161994981|NCT01695135|585032260|FG001|Double-blind Treatment Phase|Death|1|||
161994982|NCT01695135|585032261|FG002|Double-blind Treatment Phase|Death|0|||
161994983|NCT01695135|585032262|FG003|Double-blind Treatment Phase|Death|0|||
161994984|NCT01695135|585032259|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
161994985|NCT01695135|585032260|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
161994986|NCT01695135|585032261|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
161994987|NCT01695135|585032262|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
161994988|NCT01695135|585032259|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
161994989|NCT01695135|585032260|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
161994990|NCT01695135|585032261|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
161994991|NCT01695135|585032262|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
161994992|NCT01695135|585032259|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
161994993|NCT01695135|585032260|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
161994994|NCT01695135|585032261|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
161994995|NCT01695135|585032262|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
161994996|NCT01695135|585032259|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
161994997|NCT01695135|585032260|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
161994998|NCT01695135|585032261|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
161994999|NCT01695135|585032262|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
161995000|NCT01695135|585032259|FG000|Open Label Extension Treatment Phase|Other|0|||
161995001|NCT01695135|585032260|FG001|Open Label Extension Treatment Phase|Other|0|||
161995002|NCT01695135|585032261|FG002|Open Label Extension Treatment Phase|Other|4|||
161995003|NCT01695135|585032262|FG003|Open Label Extension Treatment Phase|Other|7|||
161995004|NCT01695135|585032259|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
161995005|NCT01695135|585032260|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
161995006|NCT01695135|585032261|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
161891098|NCT00410072|584648072|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
161891099|NCT00410072|584648073|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
161891100|NCT00410072|584648072|FG000|After Week 48 to Week 96|Pregnancy|0|||
161891101|NCT00410072|584648073|FG001|After Week 48 to Week 96|Pregnancy|2|||
162038511|NCT02598960|585199520|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
162038512|NCT02598960|585199521|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
162038513|NCT02598960|585199522|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
162038514|NCT02598960|585199523|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
162038515|NCT02598960|585199524|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
162038516|NCT02598960|585199525|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
162038517|NCT02598960|585199526|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
162038518|NCT02598960|585199514|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
162038519|NCT02598960|585199515|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
162038520|NCT02598960|585199516|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
162038521|NCT02598960|585199517|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
162038522|NCT02598960|585199518|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
162038523|NCT02598960|585199519|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
162038524|NCT02598960|585199520|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
162038525|NCT02598960|585199521|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
162038526|NCT02598960|585199522|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
162038527|NCT02598960|585199523|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
162038528|NCT02598960|585199524|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
162038529|NCT02598960|585199525|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
162038530|NCT02598960|585199526|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
162038531|NCT02598960|585199514|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162038532|NCT02598960|585199515|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162038533|NCT02598960|585199516|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162038534|NCT02598960|585199517|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162038535|NCT02598960|585199518|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162038536|NCT02598960|585199519|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162038537|NCT02598960|585199520|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162038538|NCT02598960|585199521|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
161995007|NCT01695135|585032262|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
161995008|NCT01695135|585032259|FG000|Open Label Extension Treatment Phase|Death|0|||
161995009|NCT01695135|585032260|FG001|Open Label Extension Treatment Phase|Death|0|||
161995010|NCT01695135|585032261|FG002|Open Label Extension Treatment Phase|Death|2|||
161995011|NCT01695135|585032262|FG003|Open Label Extension Treatment Phase|Death|7|||
161995012|NCT01695135|585032259|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
161995013|NCT01695135|585032260|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
161995014|NCT01695135|585032261|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
161995015|NCT01695135|585032262|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
161995016|NCT00580723|585032268|FG000|Overall Study|Did not want to participate in extension|3|||
161995017|NCT00580723|585032268|FG000|Overall Study|Lost to Follow-up|5|||
161995018|NCT00684996|585032269|FG000|Overall Study|Adverse Event|1|||
161995019|NCT00684996|585032269|FG000|Overall Study|Refusal unrelated to adverse event|1|||
161995020|NCT00684996|585032269|FG000|Overall Study|Progression/relapse|2|||
161995021|NCT00684996|585032269|FG000|Overall Study|Other reasons not protocol specified|1|||
161995022|NCT00556998|585032270|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
161995023|NCT00556998|585032270|FG000|Voriconazole Intravenous (IV)|Other|4|||
161995024|NCT00556998|585032270|FG000|Voriconazole Oral|Adverse Event|1|||
161995025|NCT00556998|585032270|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
161995026|NCT02519439|585032273|FG000|Overall Study|Study Termination|19|||
161995027|NCT02519439|585032273|FG000|Overall Study|Withdrawal by Subject|1|||
161995028|NCT02519439|585032273|FG000|Overall Study|Adverse Event|1|||
161995029|NCT03030417|585032280|FG000|Dose Expansion|Disease progression before treatment|0|||
161995030|NCT03030417|585032281|FG001|Dose Expansion|Disease progression before treatment|0|||
161995031|NCT03030417|585032282|FG002|Dose Expansion|Disease progression before treatment|0|||
161995032|NCT03030417|585032283|FG003|Dose Expansion|Disease progression before treatment|0|||
161995033|NCT03030417|585032284|FG004|Dose Expansion|Disease progression before treatment|0|||
161995034|NCT03030417|585032285|FG005|Dose Expansion|Disease progression before treatment|0|||
161995035|NCT03030417|585032286|FG006|Dose Expansion|Disease progression before treatment|0|||
161995036|NCT03030417|585032287|FG007|Dose Expansion|Disease progression before treatment|0|||
161995037|NCT03030417|585032288|FG008|Dose Expansion|Disease progression before treatment|0|||
161995038|NCT03030417|585032289|FG009|Dose Expansion|Disease progression before treatment|0|||
161995039|NCT03030417|585032290|FG010|Dose Expansion|Disease progression before treatment|0|||
161995040|NCT03030417|585032291|FG011|Dose Expansion|Disease progression before treatment|0|||
161995041|NCT03030417|585032292|FG012|Dose Expansion|Disease progression before treatment|1|||
161995042|NCT01078441|585032293|FG000|Overall Study|Withdrawal by Subject|1|||
161995043|NCT00216671|585032294|FG000|Overall Study|Adverse Event|4|||
162038539|NCT02598960|585199522|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162038540|NCT02598960|585199523|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162038541|NCT02598960|585199524|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162038542|NCT02598960|585199525|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
162038543|NCT02598960|585199526|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
162038544|NCT02598960|585199514|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
162038545|NCT02598960|585199515|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
162038546|NCT02598960|585199516|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
162038547|NCT02598960|585199517|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
162038548|NCT02598960|585199518|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
162038549|NCT02598960|585199519|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
162038550|NCT02598960|585199520|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
162038551|NCT02598960|585199521|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
162038552|NCT02598960|585199522|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
162038553|NCT02598960|585199523|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
162038554|NCT02598960|585199524|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
162038555|NCT02598960|585199525|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
162038556|NCT02598960|585199526|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
162038557|NCT00398411|585199527|FG000|Overall Study|Death|0|||
162038558|NCT00398411|585199528|FG001|Overall Study|Death|1|||
162038559|NCT00401531|585199529|FG000|Overall Study|Adverse Event|2|||
162038560|NCT00401531|585199530|FG001|Overall Study|Adverse Event|0|||
162038561|NCT00401531|585199529|FG000|Overall Study|Protocol Violation|3|||
162038562|NCT00401531|585199530|FG001|Overall Study|Protocol Violation|7|||
162038563|NCT00401531|585199529|FG000|Overall Study|Lost to Follow-up|1|||
162038564|NCT00401531|585199530|FG001|Overall Study|Lost to Follow-up|1|||
162038565|NCT00401531|585199529|FG000|Overall Study|Withdrawal by Subject|3|||
162038566|NCT00401531|585199530|FG001|Overall Study|Withdrawal by Subject|2|||
162038567|NCT01614600|585199535|FG000|Overall Study|Unacceptable fit|1|||
162038568|NCT01614600|585199535|FG000|Overall Study|Discomfort|1|||
162038569|NCT01614600|585199535|FG000|Overall Study|Unable to remove lens at the end of day|1|||
162038570|NCT01614600|585199535|FG000|Overall Study|Protocol deviation|1|||
162038571|NCT03403374|585199536|FG000|Overall Study|Lost to Follow-up|1|||
162038572|NCT01031381|585199544|FG000|Overall Study|Physician Decision|3|||
162038573|NCT01031381|585199544|FG000|Overall Study|Withdrawal by Subject|6|||
162038574|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
162038575|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
162038576|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
162038577|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
162038578|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
162038579|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
162038580|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
162038581|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
162038582|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
162038583|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
162038584|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
162038585|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
162038586|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
162038587|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
162038588|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
162038589|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
162038590|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Program Termination|3|||
162038591|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Program Termination|0|||
162038592|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Program Termination|1|||
162038593|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Program Termination|1|||
162038594|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
162038595|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
162038596|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
162038597|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
162038598|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
162038599|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
162038600|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
162038601|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
162038602|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
162038603|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
162038604|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
162038605|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
162038606|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
162038607|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
162038608|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
161891102|NCT00410072|584648072|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
161891103|NCT00410072|584648073|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
161891104|NCT01471444|584648074|FG000|Overall Study|Physician Decision|3|||
161891105|NCT01471444|584648075|FG001|Overall Study|Physician Decision|2|||
161891106|NCT01471444|584648074|FG000|Overall Study|Withdrawal by Subject|0|||
161891107|NCT01471444|584648075|FG001|Overall Study|Withdrawal by Subject|1|||
161891108|NCT03915626|584648076|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
161891109|NCT01709409|584648079|FG000|Overall Study|Protocol Violation|1|||
161891110|NCT01709409|584648080|FG001|Overall Study|Protocol Violation|0|||
161891111|NCT04571385|584648081|FG000|Overall Study|Participant non-compliance|1|||
161891112|NCT04571385|584648082|FG001|Overall Study|Participant non-compliance|0|||
161891113|NCT04571385|584648083|FG002|Overall Study|Participant non-compliance|0|||
161891114|NCT04571385|584648081|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
161891115|NCT04571385|584648082|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
161891116|NCT04571385|584648083|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
161891117|NCT04571385|584648081|FG000|Overall Study|Screen failure|0|||
161891118|NCT04571385|584648082|FG001|Overall Study|Screen failure|0|||
161891119|NCT04571385|584648083|FG002|Overall Study|Screen failure|1|||
161891120|NCT05025332|584648084|FG000|Screening|Screen failure|12|||
161891121|NCT05025332|584648084|FG000|Treatment & Follow Up|Protocol Violation|1|||
161891122|NCT05025332|584648084|FG000|Treatment & Follow Up|Adverse Event|4|||
161891123|NCT01928199|584648087|FG000|Overall Study|Lost to Follow-up|2|||
161891124|NCT01928199|584648088|FG001|Overall Study|Lost to Follow-up|1|||
161891125|NCT01928199|584648087|FG000|Overall Study|Withdrawal by Subject|3|||
161891126|NCT01928199|584648088|FG001|Overall Study|Withdrawal by Subject|5|||
161891127|NCT01641471|584648089|FG000|Overall Study|Withdrawal by Subject|19|||
161891128|NCT01641471|584648090|FG001|Overall Study|Withdrawal by Subject|19|||
161891129|NCT01641471|584648089|FG000|Overall Study|Lost to Follow-up|2|||
161891130|NCT01641471|584648090|FG001|Overall Study|Lost to Follow-up|4|||
161891131|NCT01641471|584648089|FG000|Overall Study|Protocol Violation|2|||
161891132|NCT01641471|584648090|FG001|Overall Study|Protocol Violation|4|||
161891133|NCT02499263|584648091|FG000|Overall Study|Lost to Follow-up|9|||
161891134|NCT02499263|584648091|FG000|Overall Study|Participant's withdrawal of consent|4|||
161891135|NCT02499263|584648091|FG000|Overall Study|Lack of Efficacy|22|||
161891136|NCT02499263|584648091|FG000|Overall Study|investigator's judgment|12|||
161891137|NCT02499263|584648091|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
161891138|NCT02499263|584648091|FG000|Overall Study|Participant's decision|3|||
161891139|NCT02499263|584648091|FG000|Overall Study|Pregnancy|1|||
161891140|NCT01108237|584648092|FG000|Overall Study|No alignment data|2|||
161891141|NCT01108237|584648093|FG001|Overall Study|No alignment data|15|||
161891142|NCT01108237|584648092|FG000|Overall Study|Did not meet criteria for analysis|7|||
161891143|NCT01108237|584648093|FG001|Overall Study|Did not meet criteria for analysis|0|||
161891144|NCT00790556|584648094|FG000|Treatment Period 1|Physician Decision|1|||
161891145|NCT00790556|584648095|FG001|Treatment Period 1|Physician Decision|0|||
161891146|NCT00790556|584648094|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161891147|NCT00790556|584648095|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161891148|NCT03077607|584648096|FG000|Period 1 (15 Days)|Adverse Event|1|||
161891149|NCT03077607|584648097|FG001|Period 1 (15 Days)|Adverse Event|0|||
161891150|NCT03077607|584648096|FG000|Period 1 (15 Days)|Death|1|||
161891151|NCT03077607|584648097|FG001|Period 1 (15 Days)|Death|0|||
161891152|NCT03077607|584648096|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
161891153|NCT03077607|584648097|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
161891154|NCT03077607|584648096|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
161891155|NCT03077607|584648097|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
161891156|NCT04401202|584648099|FG000|Overall Study|Lost to Follow-up|2|||
161891157|NCT04401202|584648100|FG001|Overall Study|Lost to Follow-up|2|||
161891158|NCT04401202|584648099|FG000|Overall Study|Adverse Event|0|||
161891159|NCT04401202|584648100|FG001|Overall Study|Adverse Event|1|||
161891160|NCT04401202|584648099|FG000|Overall Study|Hospitalized|4|||
161891161|NCT04401202|584648100|FG001|Overall Study|Hospitalized|1|||
161891162|NCT05697627|584648104|FG000|Overall Study|Adverse Event|1|||
161891163|NCT04122625|584648105|FG000|Part A (up to 2.92 Years)|Death|2|||
161891164|NCT04122625|584648106|FG001|Part A (up to 2.92 Years)|Death|4|||
161891165|NCT04122625|584648107|FG002|Part A (up to 2.92 Years)|Death|0|||
161891166|NCT04122625|584648108|FG003|Part A (up to 2.92 Years)|Death|0|||
161891167|NCT04122625|584648109|FG004|Part A (up to 2.92 Years)|Death|0|||
161891168|NCT04122625|584648110|FG005|Part A (up to 2.92 Years)|Death|0|||
161891169|NCT04122625|584648105|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
161891170|NCT04122625|584648106|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
161891171|NCT04122625|584648107|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
161891172|NCT04122625|584648108|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
161891173|NCT04122625|584648109|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
161891174|NCT04122625|584648110|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
161891175|NCT04122625|584648105|FG000|Part B (up to 2.33 Years)|Death|0|||
161891176|NCT04122625|584648106|FG001|Part B (up to 2.33 Years)|Death|0|||
161891177|NCT04122625|584648107|FG002|Part B (up to 2.33 Years)|Death|5|||
161891178|NCT04122625|584648108|FG003|Part B (up to 2.33 Years)|Death|7|||
161995044|NCT00216671|585032295|FG001|Overall Study|Adverse Event|9|||
161891179|NCT04122625|584648109|FG004|Part B (up to 2.33 Years)|Death|6|||
161891180|NCT04122625|584648110|FG005|Part B (up to 2.33 Years)|Death|7|||
161891181|NCT02722746|584648111|FG000|Overall Study|Withdrawal by Subject|0|||
161891182|NCT02722746|584648112|FG001|Overall Study|Withdrawal by Subject|1|||
161891183|NCT02722746|584648113|FG002|Overall Study|Withdrawal by Subject|0|||
161891184|NCT02722746|584648111|FG000|Overall Study|Protocol Violation|8|||
161891185|NCT02722746|584648112|FG001|Overall Study|Protocol Violation|4|||
161891186|NCT02722746|584648113|FG002|Overall Study|Protocol Violation|6|||
161891187|NCT01038752|584648114|FG000|Overall Study|Tumor Progression|2|||
161891188|NCT01038752|584648115|FG001|Overall Study|Tumor Progression|2|||
161891189|NCT01038752|584648114|FG000|Overall Study|Lost to Follow-up|3|||
161891190|NCT01038752|584648115|FG001|Overall Study|Lost to Follow-up|3|||
161891191|NCT02700698|584648122|FG000|Overall Study|Withdrawal by Subject|1|||
161891192|NCT02700698|584648123|FG001|Overall Study|Withdrawal by Subject|0|||
161891193|NCT00703118|584648124|FG000|Overall Study|Adverse Event|1|||
161891194|NCT00703118|584648125|FG001|Overall Study|Adverse Event|2|||
161891195|NCT00703118|584648126|FG002|Overall Study|Adverse Event|2|||
161891196|NCT00703118|584648124|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
161891197|NCT00703118|584648125|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
161891198|NCT00703118|584648126|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
161891199|NCT00703118|584648124|FG000|Overall Study|Lost to Follow-up|6|||
161891200|NCT00703118|584648125|FG001|Overall Study|Lost to Follow-up|4|||
161891201|NCT00703118|584648126|FG002|Overall Study|Lost to Follow-up|4|||
161891202|NCT00703118|584648124|FG000|Overall Study|Withdrawal by Subject|8|||
161891203|NCT00703118|584648125|FG001|Overall Study|Withdrawal by Subject|7|||
161891204|NCT00703118|584648126|FG002|Overall Study|Withdrawal by Subject|13|||
161891205|NCT00703118|584648124|FG000|Overall Study|Other|0|||
161891206|NCT00703118|584648125|FG001|Overall Study|Other|0|||
161891207|NCT00703118|584648126|FG002|Overall Study|Other|1|||
161891208|NCT04165135|584648129|FG000|Overall Study|Protocol Violation|10|||
161891209|NCT04165135|584648129|FG000|Overall Study|Participants withdrawal of consent|5|||
161891210|NCT00530790|584648130|FG000|Overall Study|Adverse Event|2|||
161891211|NCT00530790|584648130|FG000|Overall Study|Withdrawal by Subject|2|||
161891212|NCT00530790|584648130|FG000|Overall Study|Physician Decision|1|||
161891213|NCT05053035|584648137|FG000|Overall Study|Withdrawal by Subject|1|||
161891214|NCT05053035|584648138|FG001|Overall Study|Withdrawal by Subject|0|||
161891215|NCT00438256|584648139|FG000|Overall Study|Ineligible for Resection|2|||
161891216|NCT00438256|584648140|FG001|Overall Study|Ineligible for Resection|1|||
161891217|NCT00438256|584648141|FG002|Overall Study|Ineligible for Resection|1|||
161891218|NCT00438256|584648142|FG003|Overall Study|Ineligible for Resection|7|||
161891219|NCT00438256|584648139|FG000|Overall Study|Excluded final Diagnosis|0|||
161891220|NCT00438256|584648140|FG001|Overall Study|Excluded final Diagnosis|0|||
161891221|NCT00438256|584648141|FG002|Overall Study|Excluded final Diagnosis|0|||
161891222|NCT00438256|584648142|FG003|Overall Study|Excluded final Diagnosis|2|||
161891223|NCT02005627|584648143|FG000|Overall Study|Lost to Follow-up|1|||
161891224|NCT02005627|584648144|FG001|Overall Study|Lost to Follow-up|2|||
161891225|NCT02005627|584648143|FG000|Overall Study|Withdrawal by Subject|1|||
161891226|NCT02005627|584648144|FG001|Overall Study|Withdrawal by Subject|2|||
161891227|NCT00849290|584648150|FG000|Overall Study|Adverse Event|3|||
161891228|NCT00849290|584648150|FG000|Overall Study|Death|14|||
161891229|NCT00849290|584648150|FG000|Overall Study|Withdrawal by Subject|11|||
161891230|NCT00849290|584648150|FG000|Overall Study|Lost to Follow-up|2|||
161891231|NCT00849290|584648150|FG000|Overall Study|Protocol Violation|5|||
161891232|NCT00849290|584648150|FG000|Overall Study|Disease Progression|20|||
161891233|NCT02334384|584648166|FG000|Overall Study|Lost to Follow-up|1|||
161891234|NCT02334384|584648167|FG001|Overall Study|Lost to Follow-up|1|||
161891235|NCT00055497|584648168|FG000|Overall Study|Adverse Event|1|||
161891236|NCT00055497|584648169|FG001|Overall Study|Adverse Event|1|||
161891237|NCT00055497|584648170|FG002|Overall Study|Adverse Event|1|||
161891238|NCT00055497|584648171|FG003|Overall Study|Adverse Event|28|||
161891239|NCT00055497|584648168|FG000|Overall Study|Withdrawal by Subject|3|||
161891240|NCT00055497|584648169|FG001|Overall Study|Withdrawal by Subject|1|||
161891241|NCT00055497|584648170|FG002|Overall Study|Withdrawal by Subject|1|||
161891242|NCT00055497|584648171|FG003|Overall Study|Withdrawal by Subject|15|||
161891243|NCT00055497|584648168|FG000|Overall Study|Lost to Follow-up|0|||
161891244|NCT00055497|584648169|FG001|Overall Study|Lost to Follow-up|1|||
161891245|NCT00055497|584648170|FG002|Overall Study|Lost to Follow-up|0|||
161891246|NCT00055497|584648171|FG003|Overall Study|Lost to Follow-up|5|||
161995045|NCT00216671|585032294|FG000|Overall Study|Pregnancy|0|||
161891247|NCT00055497|584648168|FG000|Overall Study|Protocol Violation|0|||
161995046|NCT00216671|585032295|FG001|Overall Study|Pregnancy|1|||
161891248|NCT00055497|584648169|FG001|Overall Study|Protocol Violation|0|||
161891249|NCT00055497|584648170|FG002|Overall Study|Protocol Violation|0|||
161891250|NCT00055497|584648171|FG003|Overall Study|Protocol Violation|3|||
161891251|NCT00055497|584648168|FG000|Overall Study|Lack of Efficacy|1|||
161891252|NCT00055497|584648169|FG001|Overall Study|Lack of Efficacy|0|||
162038609|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
161891253|NCT00055497|584648170|FG002|Overall Study|Lack of Efficacy|0|||
161891254|NCT00055497|584648171|FG003|Overall Study|Lack of Efficacy|27|||
161891255|NCT00055497|584648168|FG000|Overall Study|Administrative Reasons|0|||
162038610|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
162038611|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
162038612|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
162038613|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
162038614|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
162038615|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
162038616|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
162038617|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
162038618|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
162038619|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
162038620|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
162038621|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
162038622|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
162038623|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
162038624|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
162038625|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
162038626|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
162038627|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
162038628|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
162038629|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
162038630|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
162038631|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
162038632|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
162038633|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
162038634|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
162038635|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
162038636|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
162038637|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
162038638|NCT03739840|585199545|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
162038639|NCT03739840|585199546|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
162038640|NCT03739840|585199547|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
162038641|NCT03739840|585199548|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
162038642|NCT03739840|585199545|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
162038643|NCT03739840|585199546|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
162038644|NCT03739840|585199547|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
162038645|NCT03739840|585199548|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
162038646|NCT03739840|585199545|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
162038647|NCT03739840|585199546|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
162038648|NCT03739840|585199547|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
162038649|NCT03739840|585199548|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
162038650|NCT03739840|585199545|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
162038651|NCT03739840|585199546|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
162038652|NCT03739840|585199547|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
162038653|NCT03739840|585199548|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
162038654|NCT03739840|585199545|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
162038655|NCT03739840|585199546|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
162038656|NCT03739840|585199547|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
162038657|NCT03739840|585199548|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
162038658|NCT03739840|585199545|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
161891256|NCT00055497|584648169|FG001|Overall Study|Administrative Reasons|0|||
161891257|NCT00055497|584648170|FG002|Overall Study|Administrative Reasons|0|||
161891258|NCT00055497|584648171|FG003|Overall Study|Administrative Reasons|1|||
161891259|NCT00055497|584648168|FG000|Overall Study|Other|0|||
161891260|NCT00055497|584648169|FG001|Overall Study|Other|0|||
161891261|NCT00055497|584648170|FG002|Overall Study|Other|0|||
161891262|NCT00055497|584648171|FG003|Overall Study|Other|11|||
161891263|NCT00048165|584648172|FG000|Completed 6 Months Study|Administration/Other|8|||
161891264|NCT00048165|584648173|FG001|Completed 6 Months Study|Administration/Other|8|||
162038659|NCT03739840|585199546|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
162038660|NCT03739840|585199547|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
161891265|NCT00048165|584648172|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
161891266|NCT00048165|584648173|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
161891267|NCT00048165|584648172|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
162038661|NCT03739840|585199548|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
162038662|NCT03739840|585199545|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
162038663|NCT03739840|585199546|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
162038664|NCT03739840|585199547|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
162038665|NCT03739840|585199548|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
162038666|NCT03739840|585199545|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
162038667|NCT03739840|585199546|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
162038668|NCT03739840|585199547|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
162038669|NCT03739840|585199548|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
162038670|NCT03739840|585199545|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
162038671|NCT03739840|585199546|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
162038672|NCT03739840|585199547|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
162038673|NCT03739840|585199548|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
162038674|NCT02788474|585199549|FG000|Double Blind Treatment Period|Not treated|1|||
162038675|NCT02788474|585199550|FG001|Double Blind Treatment Period|Not treated|0|||
162038676|NCT02788474|585199549|FG000|Double Blind Treatment Period|Patient's refusal|3|||
162038677|NCT02788474|585199550|FG001|Double Blind Treatment Period|Patient's refusal|0|||
162038678|NCT02788474|585199549|FG000|Double Blind Treatment Period|Adverse Event|6|||
162038679|NCT02788474|585199550|FG001|Double Blind Treatment Period|Adverse Event|4|||
162038680|NCT02788474|585199549|FG000|Open Label Treatment Period|Adverse Event|29|||
162038681|NCT02788474|585199550|FG001|Open Label Treatment Period|Adverse Event|9|||
162038682|NCT02788474|585199549|FG000|Open Label Treatment Period|Other than reason specified|1|||
162038683|NCT02788474|585199550|FG001|Open Label Treatment Period|Other than reason specified|0|||
162038684|NCT02788474|585199549|FG000|Open Label Treatment Period|Patient's refusal|1|||
162038685|NCT02788474|585199550|FG001|Open Label Treatment Period|Patient's refusal|3|||
162038686|NCT02788474|585199549|FG000|Open Label Treatment Period|Non-compliance|1|||
162038687|NCT02788474|585199550|FG001|Open Label Treatment Period|Non-compliance|0|||
162038688|NCT03555435|585199551|FG000|Overall Study|Lost to Follow-up|17|||
162038689|NCT03555435|585199552|FG001|Overall Study|Lost to Follow-up|19|||
162038690|NCT03555435|585199553|FG002|Overall Study|Lost to Follow-up|8|||
162038691|NCT02694523|585199556|FG000|Part A|Adverse Event|7|||
162038692|NCT02694523|585199557|FG001|Part A|Adverse Event|3|||
162038693|NCT02694523|585199558|FG002|Part A|Adverse Event|0|||
162038694|NCT02694523|585199559|FG003|Part A|Adverse Event|0|||
162038695|NCT02694523|585199560|FG004|Part A|Adverse Event|0|||
162038696|NCT02694523|585199561|FG005|Part A|Adverse Event|0|||
162038697|NCT02694523|585199562|FG006|Part A|Adverse Event|0|||
161891268|NCT00048165|584648173|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
162038698|NCT02694523|585199556|FG000|Part A|Protocol Violation|1|||
162038699|NCT02694523|585199557|FG001|Part A|Protocol Violation|0|||
162038700|NCT02694523|585199558|FG002|Part A|Protocol Violation|0|||
162038701|NCT02694523|585199559|FG003|Part A|Protocol Violation|0|||
162038702|NCT02694523|585199560|FG004|Part A|Protocol Violation|0|||
162038703|NCT02694523|585199561|FG005|Part A|Protocol Violation|0|||
162038704|NCT02694523|585199562|FG006|Part A|Protocol Violation|0|||
162038705|NCT02694523|585199556|FG000|Part A|Lost to Follow-up|1|||
162038706|NCT02694523|585199557|FG001|Part A|Lost to Follow-up|2|||
162038707|NCT02694523|585199558|FG002|Part A|Lost to Follow-up|0|||
162038708|NCT02694523|585199559|FG003|Part A|Lost to Follow-up|0|||
162038709|NCT02694523|585199560|FG004|Part A|Lost to Follow-up|0|||
161891269|NCT00048165|584648172|FG000|Completed 6 Months Study|Death|12|||
161891270|NCT00048165|584648173|FG001|Completed 6 Months Study|Death|6|||
161891271|NCT00048165|584648172|FG000|Completed 6 Months Study|Insufficient therapy|1|||
161891272|NCT00048165|584648173|FG001|Completed 6 Months Study|Insufficient therapy|4|||
161891273|NCT00048165|584648172|FG000|Completed 6 Months Study|Other violation|4|||
161891274|NCT00048165|584648173|FG001|Completed 6 Months Study|Other violation|6|||
161891275|NCT00048165|584648172|FG000|Completed 6 Months Study|Refused treatment|5|||
161891276|NCT00048165|584648173|FG001|Completed 6 Months Study|Refused treatment|5|||
161891277|NCT00048165|584648172|FG000|Completed 6 Months Study|Violation criteria|0|||
161891278|NCT00048165|584648173|FG001|Completed 6 Months Study|Violation criteria|2|||
161891279|NCT00048165|584648172|FG000|Completed 6 Months Study|Did not receive study drug|6|||
161891280|NCT00048165|584648173|FG001|Completed 6 Months Study|Did not receive study drug|6|||
161891281|NCT00048165|584648172|FG000|Completed 12 Months Study|Administration/Other|0|||
162038710|NCT02694523|585199561|FG005|Part A|Lost to Follow-up|0|||
162038711|NCT02694523|585199562|FG006|Part A|Lost to Follow-up|0|||
162038712|NCT02694523|585199556|FG000|Part A|Withdrawal by Subject|3|||
162038713|NCT02694523|585199557|FG001|Part A|Withdrawal by Subject|1|||
161891282|NCT00048165|584648173|FG001|Completed 12 Months Study|Administration/Other|2|||
161891283|NCT00048165|584648172|FG000|Completed 12 Months Study|Death|2|||
161891284|NCT00048165|584648173|FG001|Completed 12 Months Study|Death|1|||
162038714|NCT02694523|585199558|FG002|Part A|Withdrawal by Subject|0|||
162038715|NCT02694523|585199559|FG003|Part A|Withdrawal by Subject|0|||
162038716|NCT02694523|585199560|FG004|Part A|Withdrawal by Subject|0|||
162038717|NCT02694523|585199561|FG005|Part A|Withdrawal by Subject|0|||
162038718|NCT02694523|585199562|FG006|Part A|Withdrawal by Subject|0|||
162038719|NCT02694523|585199556|FG000|Part A|Other|1|||
162038720|NCT02694523|585199557|FG001|Part A|Other|1|||
162038721|NCT02694523|585199558|FG002|Part A|Other|0|||
162038722|NCT02694523|585199559|FG003|Part A|Other|0|||
162038723|NCT02694523|585199560|FG004|Part A|Other|0|||
162038724|NCT02694523|585199561|FG005|Part A|Other|0|||
162038725|NCT02694523|585199562|FG006|Part A|Other|0|||
162038726|NCT02694523|585199556|FG000|Part B|Adverse Event|0|||
162038727|NCT02694523|585199557|FG001|Part B|Adverse Event|0|||
162038728|NCT02694523|585199558|FG002|Part B|Adverse Event|7|||
162038729|NCT02694523|585199559|FG003|Part B|Adverse Event|1|||
162038730|NCT02694523|585199560|FG004|Part B|Adverse Event|1|||
162038731|NCT02694523|585199561|FG005|Part B|Adverse Event|2|||
162038732|NCT02694523|585199562|FG006|Part B|Adverse Event|0|||
162038733|NCT02694523|585199556|FG000|Part B|Protocol Violation|0|||
162038734|NCT02694523|585199557|FG001|Part B|Protocol Violation|0|||
162038735|NCT02694523|585199558|FG002|Part B|Protocol Violation|1|||
161891285|NCT00048165|584648172|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
161891286|NCT00048165|584648173|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
161891287|NCT00731731|584648174|FG000|Overall Study|Protocol Violation|0|||
161891288|NCT00731731|584648175|FG001|Overall Study|Protocol Violation|0|||
161891289|NCT00731731|584648176|FG002|Overall Study|Protocol Violation|1|||
161891290|NCT00731731|584648174|FG000|Overall Study|Cancel prior to treatment|0|||
161891291|NCT00731731|584648175|FG001|Overall Study|Cancel prior to treatment|0|||
161891292|NCT00731731|584648176|FG002|Overall Study|Cancel prior to treatment|2|||
161891293|NCT01084538|584648177|FG000|Overall Study|Drug not available|30|||
161891294|NCT01084538|584648177|FG000|Overall Study|Adverse Event|9|||
161891295|NCT01084538|584648177|FG000|Overall Study|Kidney transplant|6|||
161891296|NCT01084538|584648177|FG000|Overall Study|Serious Adverse Event|3|||
161891297|NCT01084538|584648177|FG000|Overall Study|Lack of effectiveness|2|||
161891298|NCT01084538|584648177|FG000|Overall Study|Patient noncompliance|2|||
161891299|NCT01084538|584648177|FG000|Overall Study|Hyperphosphatemia|2|||
161891300|NCT01084538|584648177|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
161891301|NCT01084538|584648177|FG000|Overall Study|Change of residence|2|||
161891302|NCT01084538|584648177|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
161891303|NCT01084538|584648177|FG000|Overall Study|Reason unknown|8|||
161891304|NCT03742258|584648182|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
161891305|NCT03742258|584648183|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
161891306|NCT03742258|584648184|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
161891307|NCT03742258|584648182|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
161891308|NCT03742258|584648183|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
161891309|NCT03742258|584648184|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
161891310|NCT03742258|584648182|FG000|Survival Follow-Up|Still in Follow-up|0|||
161891311|NCT03742258|584648183|FG001|Survival Follow-Up|Still in Follow-up|0|||
161891312|NCT03742258|584648184|FG002|Survival Follow-Up|Still in Follow-up|2|||
161891313|NCT01952080|584648186|FG000|Overall Study|Withdrawal by Subject|0|||
161891314|NCT01952080|584648187|FG001|Overall Study|Withdrawal by Subject|0|||
161891315|NCT01952080|584648188|FG002|Overall Study|Withdrawal by Subject|0|||
161891316|NCT01952080|584648189|FG003|Overall Study|Withdrawal by Subject|1|||
161891317|NCT01952080|584648186|FG000|Overall Study|Protocol Non-compliance|0|||
161891318|NCT01952080|584648187|FG001|Overall Study|Protocol Non-compliance|1|||
161891319|NCT01952080|584648188|FG002|Overall Study|Protocol Non-compliance|0|||
161891320|NCT01952080|584648189|FG003|Overall Study|Protocol Non-compliance|0|||
161891321|NCT00862459|584648190|FG000|Overall Study|Lost to Follow-up|1|||
161891322|NCT00862459|584648191|FG001|Overall Study|Lost to Follow-up|2|||
161891323|NCT00862459|584648192|FG002|Overall Study|Lost to Follow-up|2|||
161891324|NCT00862459|584648190|FG000|Overall Study|Protocol Violation|1|||
161891325|NCT00862459|584648191|FG001|Overall Study|Protocol Violation|0|||
161891326|NCT00862459|584648192|FG002|Overall Study|Protocol Violation|0|||
161891327|NCT00862459|584648190|FG000|Overall Study|Withdrawal by Subject|1|||
161891328|NCT00862459|584648191|FG001|Overall Study|Withdrawal by Subject|1|||
161891329|NCT00862459|584648192|FG002|Overall Study|Withdrawal by Subject|3|||
161891330|NCT00862459|584648190|FG000|Overall Study|Adverse Event|0|||
161891331|NCT00862459|584648191|FG001|Overall Study|Adverse Event|1|||
161891332|NCT00862459|584648192|FG002|Overall Study|Adverse Event|0|||
161891333|NCT00862459|584648190|FG000|Overall Study|Personal reasons|1|||
161891334|NCT00862459|584648191|FG001|Overall Study|Personal reasons|0|||
161891335|NCT00862459|584648192|FG002|Overall Study|Personal reasons|0|||
161891336|NCT00862459|584648190|FG000|Overall Study|Operation|1|||
161891337|NCT00862459|584648191|FG001|Overall Study|Operation|1|||
162038736|NCT02694523|585199559|FG003|Part B|Protocol Violation|0|||
162038737|NCT02694523|585199560|FG004|Part B|Protocol Violation|0|||
162038738|NCT02694523|585199561|FG005|Part B|Protocol Violation|0|||
162038739|NCT02694523|585199562|FG006|Part B|Protocol Violation|0|||
162038740|NCT02694523|585199556|FG000|Part B|Lost to Follow-up|0|||
162038741|NCT02694523|585199557|FG001|Part B|Lost to Follow-up|0|||
162038742|NCT02694523|585199558|FG002|Part B|Lost to Follow-up|2|||
162038743|NCT02694523|585199559|FG003|Part B|Lost to Follow-up|3|||
162038744|NCT02694523|585199560|FG004|Part B|Lost to Follow-up|2|||
162038745|NCT02694523|585199561|FG005|Part B|Lost to Follow-up|0|||
161891338|NCT00862459|584648192|FG002|Overall Study|Operation|0|||
161891339|NCT00862459|584648190|FG000|Overall Study|Intravenous (IV) site problems|1|||
161891340|NCT00862459|584648191|FG001|Overall Study|Intravenous (IV) site problems|0|||
161891341|NCT00862459|584648192|FG002|Overall Study|Intravenous (IV) site problems|1|||
161891342|NCT00862459|584648190|FG000|Overall Study|Unable to hold still for imaging|0|||
161891343|NCT00862459|584648191|FG001|Overall Study|Unable to hold still for imaging|1|||
161891344|NCT00862459|584648192|FG002|Overall Study|Unable to hold still for imaging|0|||
161891345|NCT00862459|584648190|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
162038746|NCT02694523|585199562|FG006|Part B|Lost to Follow-up|1|||
162038747|NCT02694523|585199556|FG000|Part B|Withdrawal by Subject|0|||
161891346|NCT00862459|584648191|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
161891347|NCT00862459|584648192|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
161891348|NCT00862459|584648190|FG000|Overall Study|Administrative problems|0|||
161891349|NCT00862459|584648191|FG001|Overall Study|Administrative problems|1|||
161891350|NCT00862459|584648192|FG002|Overall Study|Administrative problems|0|||
161891351|NCT01333956|584648193|FG000|Overall Study|Lost to Follow-up|1|||
161891352|NCT01333956|584648194|FG001|Overall Study|Lost to Follow-up|2|||
161891353|NCT01333956|584648195|FG002|Overall Study|Lost to Follow-up|0|||
161891354|NCT01333956|584648196|FG003|Overall Study|Lost to Follow-up|1|||
161891355|NCT01333956|584648193|FG000|Overall Study|Unable to complete study procedure|1|||
161891356|NCT01333956|584648194|FG001|Overall Study|Unable to complete study procedure|0|||
161891357|NCT01333956|584648195|FG002|Overall Study|Unable to complete study procedure|0|||
161891358|NCT01333956|584648196|FG003|Overall Study|Unable to complete study procedure|1|||
161891359|NCT01333956|584648193|FG000|Overall Study|Withdrawal by Subject|0|||
161891360|NCT01333956|584648194|FG001|Overall Study|Withdrawal by Subject|2|||
161891361|NCT01333956|584648195|FG002|Overall Study|Withdrawal by Subject|1|||
161891362|NCT01333956|584648196|FG003|Overall Study|Withdrawal by Subject|0|||
161891363|NCT02134353|584648197|FG000|Overall Study|Adverse Event|10|||
161891364|NCT02134353|584648198|FG001|Overall Study|Adverse Event|6|||
161891365|NCT02134353|584648197|FG000|Overall Study|Lost to Follow-up|1|||
161891366|NCT02134353|584648198|FG001|Overall Study|Lost to Follow-up|1|||
161891367|NCT02134353|584648197|FG000|Overall Study|Lack of Efficacy|2|||
161891368|NCT02134353|584648198|FG001|Overall Study|Lack of Efficacy|1|||
161891369|NCT02134353|584648197|FG000|Overall Study|Withdrawal by Subject|12|||
161891370|NCT02134353|584648198|FG001|Overall Study|Withdrawal by Subject|13|||
161891371|NCT02134353|584648197|FG000|Overall Study|Death|0|||
161891372|NCT02134353|584648198|FG001|Overall Study|Death|1|||
161891373|NCT02134353|584648197|FG000|Overall Study|Pregnancy|0|||
161891374|NCT02134353|584648198|FG001|Overall Study|Pregnancy|1|||
161891375|NCT02134353|584648197|FG000|Overall Study|Relocation|1|||
161891376|NCT02134353|584648198|FG001|Overall Study|Relocation|0|||
161891377|NCT02134353|584648197|FG000|Overall Study|Other - Patient's Choice|0|||
161891378|NCT02134353|584648198|FG001|Overall Study|Other - Patient's Choice|1|||
161891379|NCT03426436|584648201|FG000|Overall Study|Incorrect lead placement|12|||
161891380|NCT03426436|584648201|FG000|Overall Study|Withdrawal by Subject|2|||
161891381|NCT03426436|584648201|FG000|Overall Study|Consent issue|1|||
161891382|NCT03426436|584648201|FG000|Overall Study|ECGs not saved|4|||
161891383|NCT00655681|584648202|FG000|Overall Study|Lost to Follow-up|1|||
161891384|NCT00655681|584648203|FG001|Overall Study|Lost to Follow-up|1|||
161891385|NCT03168919|584648204|FG000|Overall Study|Withdrawal by Subject|2|||
161891386|NCT01085136|584648205|FG000|Part A|Other Adverse event|223|||
161891387|NCT01085136|584648206|FG001|Part A|Other Adverse event|0|||
161891388|NCT01085136|584648207|FG002|Part A|Other Adverse event|0|||
161891389|NCT01085136|584648205|FG000|Part A|Protocol Violation|3|||
161891390|NCT01085136|584648206|FG001|Part A|Protocol Violation|0|||
161891391|NCT01085136|584648207|FG002|Part A|Protocol Violation|0|||
161891392|NCT01085136|584648205|FG000|Part A|Lost to Follow-up|3|||
161891393|NCT01085136|584648206|FG001|Part A|Lost to Follow-up|0|||
161891394|NCT01085136|584648207|FG002|Part A|Lost to Follow-up|0|||
161891395|NCT01085136|584648205|FG000|Part A|Refusal to continue trial medication|64|||
161891396|NCT01085136|584648206|FG001|Part A|Refusal to continue trial medication|0|||
161891397|NCT01085136|584648207|FG002|Part A|Refusal to continue trial medication|0|||
161891398|NCT01085136|584648205|FG000|Part A|Other reason not defined above|30|||
161891399|NCT01085136|584648206|FG001|Part A|Other reason not defined above|0|||
161891400|NCT01085136|584648207|FG002|Part A|Other reason not defined above|0|||
161891401|NCT01085136|584648205|FG000|Part B|Other AE|0|||
161891402|NCT01085136|584648206|FG001|Part B|Other AE|29|||
161891403|NCT01085136|584648207|FG002|Part B|Other AE|8|||
161891404|NCT01085136|584648205|FG000|Part B|Refusal to continue trial medication|0|||
161891405|NCT01085136|584648206|FG001|Part B|Refusal to continue trial medication|12|||
161891406|NCT01085136|584648207|FG002|Part B|Refusal to continue trial medication|7|||
161891407|NCT01085136|584648205|FG000|Part B|Not treated|0|||
161891408|NCT01085136|584648206|FG001|Part B|Not treated|4|||
161891409|NCT01085136|584648207|FG002|Part B|Not treated|8|||
161891410|NCT01085136|584648205|FG000|Part B|Other reason not defined above|0|||
161891411|NCT01085136|584648206|FG001|Part B|Other reason not defined above|6|||
161891412|NCT01085136|584648207|FG002|Part B|Other reason not defined above|3|||
161891413|NCT02655419|584648208|FG000|Overall Study|Enrolled but not treated|1|||
162038748|NCT02694523|585199557|FG001|Part B|Withdrawal by Subject|0|||
162038749|NCT02694523|585199558|FG002|Part B|Withdrawal by Subject|9|||
162038750|NCT02694523|585199559|FG003|Part B|Withdrawal by Subject|0|||
161891414|NCT02655419|584648209|FG001|Overall Study|Enrolled but not treated|5|||
161891415|NCT02655419|584648208|FG000|Overall Study|Withdrawal by Subject|4|||
161891416|NCT02655419|584648209|FG001|Overall Study|Withdrawal by Subject|1|||
161891417|NCT02655419|584648208|FG000|Overall Study|Other|0|||
161891418|NCT02655419|584648209|FG001|Overall Study|Other|1|||
161891419|NCT04226495|584648213|FG000|Overall Study|Withdrawal by Subject|3|||
161891420|NCT04226495|584648214|FG001|Overall Study|Withdrawal by Subject|3|||
161891421|NCT04226495|584648213|FG000|Overall Study|PI discretion|3|||
161891422|NCT04226495|584648214|FG001|Overall Study|PI discretion|4|||
162038751|NCT02694523|585199560|FG004|Part B|Withdrawal by Subject|1|||
162038752|NCT02694523|585199561|FG005|Part B|Withdrawal by Subject|3|||
162038753|NCT02694523|585199562|FG006|Part B|Withdrawal by Subject|0|||
162038754|NCT02694523|585199556|FG000|Part B|Other|0|||
162038755|NCT02694523|585199557|FG001|Part B|Other|0|||
162038756|NCT02694523|585199558|FG002|Part B|Other|1|||
162038757|NCT02694523|585199559|FG003|Part B|Other|0|||
162038758|NCT02694523|585199560|FG004|Part B|Other|0|||
162038759|NCT02694523|585199561|FG005|Part B|Other|0|||
162038760|NCT02694523|585199562|FG006|Part B|Other|1|||
162038761|NCT01058265|585199564|FG000|Overall Study|Lost to Follow-up|11|||
162038762|NCT01058265|585199565|FG001|Overall Study|Lost to Follow-up|12|||
162038763|NCT01243671|585199566|FG000|Overall Study|Adverse Event|3|||
162038764|NCT01243671|585199566|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
162038765|NCT01243671|585199566|FG000|Overall Study|Other|1|||
162038766|NCT02962765|585199567|FG000|Overall Study|Protocol Violation|9|||
162038767|NCT02962765|585199567|FG000|Overall Study|Withdrawal by Subject|3|||
162038768|NCT02962765|585199567|FG000|Overall Study|Lost to Follow-up|1|||
162038769|NCT02962765|585199567|FG000|Overall Study|Death|1|||
162038770|NCT02962765|585199567|FG000|Overall Study|Limited access to study medication|3|||
162038771|NCT02169284|585199568|FG000|Overall Study|Physician Decision|0|||
162038772|NCT02169284|585199569|FG001|Overall Study|Physician Decision|1|||
162038773|NCT01367119|585199570|FG000|Overall Study|Adverse Event|1|||
162038774|NCT01367119|585199571|FG001|Overall Study|Adverse Event|0|||
162038775|NCT01367119|585199570|FG000|Overall Study|Withdrawal by Subject|1|||
162038776|NCT01367119|585199571|FG001|Overall Study|Withdrawal by Subject|1|||
162038777|NCT02964507|585199574|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
162038778|NCT02964507|585199575|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
162038779|NCT02964507|585199576|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
162038780|NCT02964507|585199577|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
162038781|NCT02964507|585199578|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
162038782|NCT02964507|585199579|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
162038783|NCT02964507|585199580|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
162038784|NCT02964507|585199581|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
162038785|NCT02964507|585199574|FG000|Overall Study|Study terminated by Sponsor|9|||
162038786|NCT02964507|585199575|FG001|Overall Study|Study terminated by Sponsor|1|||
162038787|NCT02964507|585199576|FG002|Overall Study|Study terminated by Sponsor|9|||
162038788|NCT02964507|585199577|FG003|Overall Study|Study terminated by Sponsor|3|||
162038789|NCT02964507|585199578|FG004|Overall Study|Study terminated by Sponsor|3|||
162038790|NCT02964507|585199579|FG005|Overall Study|Study terminated by Sponsor|2|||
162038791|NCT02964507|585199580|FG006|Overall Study|Study terminated by Sponsor|0|||
162038792|NCT02964507|585199581|FG007|Overall Study|Study terminated by Sponsor|0|||
162038793|NCT02964507|585199574|FG000|Overall Study|Other|3|||
162038794|NCT02964507|585199575|FG001|Overall Study|Other|0|||
162038795|NCT02964507|585199576|FG002|Overall Study|Other|0|||
162038796|NCT02964507|585199577|FG003|Overall Study|Other|0|||
162038797|NCT02964507|585199578|FG004|Overall Study|Other|1|||
162038798|NCT02964507|585199579|FG005|Overall Study|Other|0|||
161891423|NCT01783821|584648216|FG000|Overall Study|Screen Failure|1|||
161891424|NCT01783821|584648217|FG001|Overall Study|Screen Failure|1|||
161891425|NCT02333383|584648218|FG000|Overall Study|Adalimumab discontinuation|21|||
161891426|NCT02333383|584648218|FG000|Overall Study|Lost to Follow-up|15|||
162038799|NCT02964507|585199580|FG006|Overall Study|Other|0|||
162038800|NCT02964507|585199581|FG007|Overall Study|Other|0|||
162038801|NCT02964507|585199574|FG000|Overall Study|Death|11|||
162038802|NCT02964507|585199575|FG001|Overall Study|Death|9|||
162038803|NCT02964507|585199576|FG002|Overall Study|Death|12|||
162038804|NCT02964507|585199577|FG003|Overall Study|Death|2|||
162038805|NCT02964507|585199578|FG004|Overall Study|Death|10|||
162038806|NCT02964507|585199579|FG005|Overall Study|Death|5|||
162038807|NCT02964507|585199580|FG006|Overall Study|Death|0|||
162038808|NCT02964507|585199581|FG007|Overall Study|Death|0|||
162038809|NCT02964507|585199574|FG000|Overall Study|Withdrawal by Subject|1|||
162038810|NCT02964507|585199575|FG001|Overall Study|Withdrawal by Subject|0|||
162038811|NCT02964507|585199576|FG002|Overall Study|Withdrawal by Subject|1|||
162038812|NCT02964507|585199577|FG003|Overall Study|Withdrawal by Subject|1|||
162038813|NCT02964507|585199578|FG004|Overall Study|Withdrawal by Subject|0|||
162038814|NCT02964507|585199579|FG005|Overall Study|Withdrawal by Subject|1|||
161891427|NCT02333383|584648218|FG000|Overall Study|Withdrawal by Subject|3|||
161891428|NCT02333383|584648218|FG000|Overall Study|Transfer to another hospital|2|||
161891429|NCT04459598|584648219|FG000|Overall Study|Adverse Event|1|||
161891430|NCT04459598|584648220|FG001|Overall Study|Adverse Event|1|||
161891431|NCT02440854|584648227|FG000|Overall Study|Relocation of patient|1|||
161891432|NCT02440854|584648227|FG000|Overall Study|Death|6|||
161891433|NCT02440854|584648227|FG000|Overall Study|Lost to Follow-up|10|||
161891434|NCT02440854|584648227|FG000|Overall Study|Afatinib discontinuation|46|||
161891435|NCT02440854|584648227|FG000|Overall Study|stopped study at earlier timepoint|14|||
161891436|NCT02440854|584648227|FG000|Overall Study|Study medication not received|1|||
161891437|NCT02440854|584648227|FG000|Overall Study|Violation of inclusion criteria|2|||
161891438|NCT02669082|584648228|FG000|Overall Study|Adverse Event|1|||
161891439|NCT00904917|584650316|FG000|Overall Study|Lost to Follow-up|2|||
161891440|NCT00904917|584650317|FG001|Overall Study|Lost to Follow-up|2|||
161891441|NCT00904917|584650318|FG002|Overall Study|Lost to Follow-up|2|||
161891442|NCT00904917|584650319|FG003|Overall Study|Lost to Follow-up|2|||
161891443|NCT00497146|584650320|FG000|Treatment Period|Adverse Event|6|||
161995047|NCT00216671|585032294|FG000|Overall Study|Withdrawal by Subject|4|||
161995048|NCT00216671|585032295|FG001|Overall Study|Withdrawal by Subject|2|||
161995049|NCT00216671|585032294|FG000|Overall Study|Refused Injections|3|||
161995050|NCT00216671|585032295|FG001|Overall Study|Refused Injections|13|||
161995051|NCT00216671|585032294|FG000|Overall Study|No Need to Continue Medication|1|||
161995052|NCT00216671|585032295|FG001|Overall Study|No Need to Continue Medication|1|||
161995053|NCT00216671|585032294|FG000|Overall Study|Insufficient Response|9|||
161995054|NCT00216671|585032295|FG001|Overall Study|Insufficient Response|4|||
161995055|NCT00216671|585032294|FG000|Overall Study|Lost to Follow-up|3|||
161995056|NCT00216671|585032295|FG001|Overall Study|Lost to Follow-up|5|||
161995057|NCT00216671|585032294|FG000|Overall Study|Non compliant|2|||
161995058|NCT00216671|585032295|FG001|Overall Study|Non compliant|2|||
161995059|NCT00216671|585032294|FG000|Overall Study|Ineligible|0|||
161995060|NCT00216671|585032295|FG001|Overall Study|Ineligible|2|||
161995061|NCT00216671|585032294|FG000|Overall Study|Physician Decision|1|||
161995062|NCT00216671|585032295|FG001|Overall Study|Physician Decision|1|||
161995063|NCT00216671|585032294|FG000|Overall Study|Protocol Violation|3|||
161995064|NCT00216671|585032295|FG001|Overall Study|Protocol Violation|5|||
161995065|NCT00216671|585032294|FG000|Overall Study|Relapse|1|||
161995066|NCT00216671|585032295|FG001|Overall Study|Relapse|0|||
161995067|NCT00216671|585032294|FG000|Overall Study|Investigator Illness|0|||
161995068|NCT00216671|585032295|FG001|Overall Study|Investigator Illness|1|||
161995069|NCT00216671|585032294|FG000|Overall Study|Patient Moved|0|||
161995070|NCT00216671|585032295|FG001|Overall Study|Patient Moved|1|||
161995071|NCT00216671|585032294|FG000|Overall Study|Ineligible, no efficacy data|2|||
161995072|NCT00216671|585032295|FG001|Overall Study|Ineligible, no efficacy data|2|||
161995073|NCT00216671|585032294|FG000|Overall Study|Insufficient Response Adverse Event|2|||
161995074|NCT00216671|585032295|FG001|Overall Study|Insufficient Response Adverse Event|1|||
161995075|NCT02714569|585032296|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
161995076|NCT02714569|585032297|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
161995077|NCT02714569|585032298|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
161995078|NCT02714569|585032299|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
161995079|NCT02714569|585032300|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
161995080|NCT02714569|585032301|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
161995081|NCT02714569|585032302|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
161995082|NCT02714569|585032303|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
161995083|NCT02714569|585032304|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
161995084|NCT02714569|585032305|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
161995085|NCT02714569|585032306|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
161995086|NCT02714569|585032296|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161995087|NCT02714569|585032297|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161995088|NCT02714569|585032298|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161995089|NCT02714569|585032299|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
161995090|NCT02714569|585032300|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161995091|NCT02714569|585032301|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161995092|NCT02714569|585032302|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161995093|NCT02714569|585032303|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
162038815|NCT02964507|585199580|FG006|Overall Study|Withdrawal by Subject|0|||
162038816|NCT02964507|585199581|FG007|Overall Study|Withdrawal by Subject|0|||
161891444|NCT00497146|584650321|FG001|Treatment Period|Adverse Event|2|||
161891445|NCT00497146|584650320|FG000|Treatment Period|Withdrawal by Subject|5|||
161891446|NCT00497146|584650321|FG001|Treatment Period|Withdrawal by Subject|9|||
161891447|NCT00497146|584650320|FG000|Treatment Period|Lost to Follow-up|1|||
161891448|NCT00497146|584650321|FG001|Treatment Period|Lost to Follow-up|3|||
161891449|NCT00497146|584650320|FG000|Treatment Period|Required dialysis|4|||
161891450|NCT00497146|584650321|FG001|Treatment Period|Required dialysis|1|||
162038817|NCT02964507|585199574|FG000|Overall Study|Physician Decision|2|||
161891451|NCT00497146|584650320|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
161891452|NCT00497146|584650321|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
161891453|NCT00497146|584650320|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
161891454|NCT00497146|584650321|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
161891455|NCT00497146|584650320|FG000|Treatment Period|Other Reason|2|||
162038818|NCT02964507|585199575|FG001|Overall Study|Physician Decision|0|||
161891456|NCT00497146|584650321|FG001|Treatment Period|Other Reason|3|||
161891457|NCT00497146|584650320|FG000|Long-term Follow-up Period|Adverse Event|2|||
161891458|NCT00497146|584650321|FG001|Long-term Follow-up Period|Adverse Event|2|||
161891459|NCT00497146|584650320|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
161891460|NCT00497146|584650321|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
161891461|NCT00497146|584650320|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
161891462|NCT00497146|584650321|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
161891463|NCT00497146|584650320|FG000|Long-term Follow-up Period|Other|0|||
161891464|NCT00497146|584650321|FG001|Long-term Follow-up Period|Other|1|||
161891465|NCT02107313|584650324|FG000|Overall Study|One participant did not do the FED cohor|0|||
161891466|NCT02107313|584650325|FG001|Overall Study|One participant did not do the FED cohor|1|||
161891467|NCT01031004|584650328|FG000|Overall Study|Protocol Violation|0|||
161891468|NCT01031004|584650329|FG001|Overall Study|Protocol Violation|1|||
161891469|NCT01031004|584650328|FG000|Overall Study|Lost to Follow-up|1|||
161891470|NCT01031004|584650329|FG001|Overall Study|Lost to Follow-up|0|||
161891471|NCT04575584|584650330|FG000|Overall Study|Death|6|||
161891472|NCT04575584|584650331|FG001|Overall Study|Death|4|||
161891473|NCT04575584|584650332|FG002|Overall Study|Death|6|||
161891474|NCT04575584|584650333|FG003|Overall Study|Death|2|||
161891475|NCT04575584|584650334|FG004|Overall Study|Death|0|||
161891476|NCT04575584|584650335|FG005|Overall Study|Death|0|||
161891477|NCT04575584|584650330|FG000|Overall Study|Lost to Follow-up|1|||
161891478|NCT04575584|584650331|FG001|Overall Study|Lost to Follow-up|1|||
161891479|NCT04575584|584650332|FG002|Overall Study|Lost to Follow-up|1|||
161891480|NCT04575584|584650333|FG003|Overall Study|Lost to Follow-up|1|||
161891481|NCT04575584|584650334|FG004|Overall Study|Lost to Follow-up|0|||
161891482|NCT04575584|584650335|FG005|Overall Study|Lost to Follow-up|0|||
161891483|NCT04575584|584650330|FG000|Overall Study|Physician Decision|0|||
161891484|NCT04575584|584650331|FG001|Overall Study|Physician Decision|1|||
161891485|NCT04575584|584650332|FG002|Overall Study|Physician Decision|1|||
161891486|NCT04575584|584650333|FG003|Overall Study|Physician Decision|1|||
161891487|NCT04575584|584650334|FG004|Overall Study|Physician Decision|0|||
161891488|NCT04575584|584650335|FG005|Overall Study|Physician Decision|0|||
161891489|NCT04575584|584650330|FG000|Overall Study|Withdrawal by Subject|7|||
161891490|NCT04575584|584650331|FG001|Overall Study|Withdrawal by Subject|9|||
161891491|NCT04575584|584650332|FG002|Overall Study|Withdrawal by Subject|5|||
161891492|NCT04575584|584650333|FG003|Overall Study|Withdrawal by Subject|3|||
161891493|NCT04575584|584650334|FG004|Overall Study|Withdrawal by Subject|0|||
161891494|NCT04575584|584650335|FG005|Overall Study|Withdrawal by Subject|0|||
161891495|NCT04575584|584650330|FG000|Overall Study|Not recorded|0|||
161891496|NCT04575584|584650331|FG001|Overall Study|Not recorded|0|||
161891497|NCT04575584|584650332|FG002|Overall Study|Not recorded|0|||
161891498|NCT04575584|584650333|FG003|Overall Study|Not recorded|1|||
161891499|NCT04575584|584650334|FG004|Overall Study|Not recorded|0|||
161891500|NCT04575584|584650335|FG005|Overall Study|Not recorded|0|||
161891501|NCT02634801|584650336|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
161891502|NCT02634801|584650337|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
161891503|NCT02634801|584650338|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
161891504|NCT02634801|584650336|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
161891505|NCT02634801|584650337|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
161891506|NCT02634801|584650338|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
161891507|NCT02634801|584650336|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
161891508|NCT02634801|584650337|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
161891509|NCT02634801|584650338|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
161891510|NCT02634801|584650336|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
161891511|NCT02634801|584650337|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
161891512|NCT02634801|584650338|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
161891513|NCT02634801|584650336|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
161891514|NCT02634801|584650337|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
161891515|NCT02634801|584650338|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
161891516|NCT02634801|584650336|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
161891517|NCT02634801|584650337|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
161891518|NCT02634801|584650338|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
161891519|NCT02634801|584650336|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
161891520|NCT02634801|584650337|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
161891521|NCT02634801|584650338|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
161891522|NCT02634801|584650336|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
161891523|NCT02634801|584650337|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
162038819|NCT02964507|585199576|FG002|Overall Study|Physician Decision|3|||
161891524|NCT02634801|584650338|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
161891525|NCT02634801|584650336|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
161891526|NCT02634801|584650337|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
161891527|NCT02634801|584650338|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
161891528|NCT02634801|584650336|FG000|Follow-up Period|Lost to Follow-up|3|||
161891529|NCT02634801|584650337|FG001|Follow-up Period|Lost to Follow-up|1|||
161891530|NCT02634801|584650338|FG002|Follow-up Period|Lost to Follow-up|2|||
161891531|NCT02634801|584650336|FG000|Follow-up Period|Physician Decision|0|||
161891532|NCT02634801|584650337|FG001|Follow-up Period|Physician Decision|0|||
161891533|NCT02634801|584650338|FG002|Follow-up Period|Physician Decision|1|||
161891534|NCT02634801|584650336|FG000|Follow-up Period|Withdrawal by Subject|1|||
161891535|NCT02634801|584650337|FG001|Follow-up Period|Withdrawal by Subject|2|||
161891536|NCT02634801|584650338|FG002|Follow-up Period|Withdrawal by Subject|5|||
161891537|NCT02634801|584650336|FG000|Follow-up Period|Adverse Event|1|||
161891538|NCT02634801|584650337|FG001|Follow-up Period|Adverse Event|5|||
161891539|NCT02634801|584650338|FG002|Follow-up Period|Adverse Event|0|||
161891540|NCT00199849|584650346|FG000|Overall Study|Unrelated illness or complication|0|||
161891541|NCT00199849|584650347|FG001|Overall Study|Unrelated illness or complication|1|||
161891542|NCT00199849|584650348|FG002|Overall Study|Unrelated illness or complication|0|||
161891543|NCT00199849|584650346|FG000|Overall Study|Progressive disease requiring intervention|0|||
161891544|NCT00199849|584650347|FG001|Overall Study|Progressive disease requiring intervention|0|||
161995094|NCT02714569|585032304|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161995095|NCT02714569|585032305|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161995096|NCT02714569|585032306|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
161995097|NCT02714569|585032296|FG000|Part A Third Intervention|Adverse Event|0|||
161995098|NCT02714569|585032297|FG001|Part A Third Intervention|Adverse Event|0|||
161995099|NCT02714569|585032298|FG002|Part A Third Intervention|Adverse Event|1|||
161995100|NCT02714569|585032299|FG003|Part A Third Intervention|Adverse Event|0|||
161995101|NCT02714569|585032300|FG004|Part A Third Intervention|Adverse Event|0|||
161995102|NCT02714569|585032301|FG005|Part A Third Intervention|Adverse Event|0|||
161995103|NCT02714569|585032302|FG006|Part A Third Intervention|Adverse Event|0|||
161995104|NCT02714569|585032303|FG007|Part A Third Intervention|Adverse Event|0|||
161995105|NCT02714569|585032304|FG008|Part A Third Intervention|Adverse Event|0|||
161995106|NCT02714569|585032305|FG009|Part A Third Intervention|Adverse Event|0|||
161995107|NCT02714569|585032306|FG010|Part A Third Intervention|Adverse Event|0|||
161995108|NCT02714569|585032296|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
161995109|NCT02714569|585032297|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161995110|NCT02714569|585032298|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161995111|NCT02714569|585032299|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161995112|NCT02714569|585032300|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161995113|NCT02714569|585032301|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
161995114|NCT02714569|585032302|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161995115|NCT02714569|585032303|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161995116|NCT02714569|585032304|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161995117|NCT02714569|585032305|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161995118|NCT02714569|585032306|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
161995119|NCT02714569|585032296|FG000|Part B (Overall)|Lost to Follow-up|0|||
161995120|NCT02714569|585032297|FG001|Part B (Overall)|Lost to Follow-up|0|||
161995121|NCT02714569|585032298|FG002|Part B (Overall)|Lost to Follow-up|0|||
161995122|NCT02714569|585032299|FG003|Part B (Overall)|Lost to Follow-up|0|||
161995123|NCT02714569|585032300|FG004|Part B (Overall)|Lost to Follow-up|0|||
161995124|NCT02714569|585032301|FG005|Part B (Overall)|Lost to Follow-up|0|||
161995125|NCT02714569|585032302|FG006|Part B (Overall)|Lost to Follow-up|1|||
161995126|NCT02714569|585032303|FG007|Part B (Overall)|Lost to Follow-up|0|||
161995127|NCT02714569|585032304|FG008|Part B (Overall)|Lost to Follow-up|0|||
161995128|NCT02714569|585032305|FG009|Part B (Overall)|Lost to Follow-up|0|||
161995129|NCT02714569|585032306|FG010|Part B (Overall)|Lost to Follow-up|0|||
161995130|NCT02714569|585032296|FG000|Part B (Overall)|Withdrawal by Subject|0|||
161995131|NCT02714569|585032297|FG001|Part B (Overall)|Withdrawal by Subject|0|||
161995132|NCT02714569|585032298|FG002|Part B (Overall)|Withdrawal by Subject|0|||
161995133|NCT02714569|585032299|FG003|Part B (Overall)|Withdrawal by Subject|0|||
161995134|NCT02714569|585032300|FG004|Part B (Overall)|Withdrawal by Subject|0|||
161995135|NCT02714569|585032301|FG005|Part B (Overall)|Withdrawal by Subject|0|||
161995136|NCT02714569|585032302|FG006|Part B (Overall)|Withdrawal by Subject|0|||
161995137|NCT02714569|585032303|FG007|Part B (Overall)|Withdrawal by Subject|1|||
161995138|NCT02714569|585032304|FG008|Part B (Overall)|Withdrawal by Subject|0|||
161995139|NCT02714569|585032305|FG009|Part B (Overall)|Withdrawal by Subject|1|||
161995140|NCT02714569|585032306|FG010|Part B (Overall)|Withdrawal by Subject|0|||
161995141|NCT02714569|585032296|FG000|Part B (Overall)|Adverse Event|0|||
161995142|NCT02714569|585032297|FG001|Part B (Overall)|Adverse Event|0|||
161995143|NCT02714569|585032298|FG002|Part B (Overall)|Adverse Event|0|||
161891545|NCT00199849|584650348|FG002|Overall Study|Progressive disease requiring intervention|1|||
161891546|NCT00199849|584650346|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
161891547|NCT00199849|584650347|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
161891548|NCT00199849|584650348|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
161891549|NCT00662311|584650349|FG000|Overall Study|Respiratory Infection|1|||
161891550|NCT00662311|584650350|FG001|Overall Study|Respiratory Infection|0|||
161891551|NCT00662311|584650351|FG002|Overall Study|Respiratory Infection|0|||
161891552|NCT02164318|584650352|FG000|Overall Study|Withdrawal by Subject|0|||
161891553|NCT02164318|584650353|FG001|Overall Study|Withdrawal by Subject|1|||
161891554|NCT02164318|584650354|FG002|Overall Study|Withdrawal by Subject|0|||
161891555|NCT02164318|584650355|FG003|Overall Study|Withdrawal by Subject|1|||
161891556|NCT02335346|584650356|FG000|Overall Study|Adverse Event|11|||
161891557|NCT02335346|584650356|FG000|Overall Study|Withdrawal by Subject|1|||
161891558|NCT01548768|584650357|FG000|Overall Study|Withdrawal by Subject|0|||
161891559|NCT01548768|584650358|FG001|Overall Study|Withdrawal by Subject|2|||
161891560|NCT01548768|584650359|FG002|Overall Study|Withdrawal by Subject|1|||
161891561|NCT01548768|584650360|FG003|Overall Study|Withdrawal by Subject|0|||
161891562|NCT01548768|584650357|FG000|Overall Study|Physician Decision|1|||
161891563|NCT01548768|584650358|FG001|Overall Study|Physician Decision|0|||
161891564|NCT01548768|584650359|FG002|Overall Study|Physician Decision|0|||
161891565|NCT01548768|584650360|FG003|Overall Study|Physician Decision|0|||
161891566|NCT01548768|584650357|FG000|Overall Study|Adverse Event|0|||
161891567|NCT01548768|584650358|FG001|Overall Study|Adverse Event|0|||
161891568|NCT01548768|584650359|FG002|Overall Study|Adverse Event|0|||
161891569|NCT01548768|584650360|FG003|Overall Study|Adverse Event|1|||
161891570|NCT01548768|584650357|FG000|Overall Study|Non-Compliance|0|||
161891571|NCT01548768|584650358|FG001|Overall Study|Non-Compliance|0|||
161891572|NCT01548768|584650359|FG002|Overall Study|Non-Compliance|0|||
161891573|NCT01548768|584650360|FG003|Overall Study|Non-Compliance|3|||
161891574|NCT02178358|584650363|FG000|Overall Study|Withdrawal by Subject|0|||
161891575|NCT02178358|584650364|FG001|Overall Study|Withdrawal by Subject|2|||
161891576|NCT02178358|584650365|FG002|Overall Study|Withdrawal by Subject|2|||
161891577|NCT02178358|584650363|FG000|Overall Study|Lost to Follow-up|1|||
161891578|NCT02178358|584650364|FG001|Overall Study|Lost to Follow-up|0|||
161891579|NCT02178358|584650365|FG002|Overall Study|Lost to Follow-up|0|||
161891580|NCT00645671|584650367|FG000|Overall Study|Protocol Violation|1|||
161891581|NCT00645671|584650368|FG001|Overall Study|Protocol Violation|0|||
161891582|NCT00645671|584650367|FG000|Overall Study|Withdrawal by Subject|0|||
161891583|NCT00645671|584650368|FG001|Overall Study|Withdrawal by Subject|4|||
161891584|NCT00645671|584650367|FG000|Overall Study|Adverse Event|0|||
161891585|NCT00645671|584650368|FG001|Overall Study|Adverse Event|1|||
161891586|NCT00645671|584650367|FG000|Overall Study|Physician Decision|0|||
161891587|NCT00645671|584650368|FG001|Overall Study|Physician Decision|1|||
161891588|NCT00493311|584650369|FG000|Overall Study|Need for rescue medication|2|||
161891589|NCT00493311|584650370|FG001|Overall Study|Need for rescue medication|2|||
161891590|NCT01005901|584650373|FG000|Overall Study|Withdrawal by Subject|38|||
161891591|NCT01005901|584650374|FG001|Overall Study|Withdrawal by Subject|14|||
161891592|NCT01005901|584650373|FG000|Overall Study|Adverse Event|30|||
161891593|NCT01005901|584650374|FG001|Overall Study|Adverse Event|16|||
161891594|NCT01005901|584650373|FG000|Overall Study|Administrative problems|21|||
161891595|NCT01005901|584650374|FG001|Overall Study|Administrative problems|13|||
161891596|NCT01005901|584650373|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
161891597|NCT01005901|584650374|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
161891598|NCT01005901|584650373|FG000|Overall Study|Protocol Violation|4|||
161891599|NCT01005901|584650374|FG001|Overall Study|Protocol Violation|3|||
161891600|NCT01005901|584650373|FG000|Overall Study|Death|2|||
161891601|NCT01005901|584650374|FG001|Overall Study|Death|3|||
161891602|NCT01005901|584650373|FG000|Overall Study|Lost to Follow-up|1|||
161891603|NCT01005901|584650374|FG001|Overall Study|Lost to Follow-up|2|||
161891604|NCT01005901|584650373|FG000|Overall Study|Patient's inability to use the device|1|||
161891605|NCT01005901|584650374|FG001|Overall Study|Patient's inability to use the device|1|||
161891606|NCT01005901|584650373|FG000|Overall Study|No longer requires study drug|0|||
161891607|NCT01005901|584650374|FG001|Overall Study|No longer requires study drug|1|||
161891608|NCT05600036|584650379|FG000|Overall Study|Adverse Event|0|||
161891609|NCT05600036|584650380|FG001|Overall Study|Adverse Event|2|||
161891610|NCT05600036|584650381|FG002|Overall Study|Adverse Event|1|||
161891611|NCT05600036|584650382|FG003|Overall Study|Adverse Event|0|||
161891612|NCT05600036|584650383|FG004|Overall Study|Adverse Event|1|||
161891613|NCT05600036|584650384|FG005|Overall Study|Adverse Event|0|||
161891614|NCT05600036|584650379|FG000|Overall Study|Lost to Follow-up|0|||
161891615|NCT05600036|584650380|FG001|Overall Study|Lost to Follow-up|2|||
161891616|NCT05600036|584650381|FG002|Overall Study|Lost to Follow-up|1|||
161891617|NCT05600036|584650382|FG003|Overall Study|Lost to Follow-up|1|||
161891618|NCT05600036|584650383|FG004|Overall Study|Lost to Follow-up|0|||
161891619|NCT05600036|584650384|FG005|Overall Study|Lost to Follow-up|0|||
161891620|NCT05600036|584650379|FG000|Overall Study|Protocol Violation|0|||
161891621|NCT05600036|584650380|FG001|Overall Study|Protocol Violation|0|||
161891622|NCT05600036|584650381|FG002|Overall Study|Protocol Violation|2|||
161891623|NCT05600036|584650382|FG003|Overall Study|Protocol Violation|0|||
161891624|NCT05600036|584650383|FG004|Overall Study|Protocol Violation|0|||
161891625|NCT05600036|584650384|FG005|Overall Study|Protocol Violation|0|||
161891626|NCT05600036|584650379|FG000|Overall Study|Withdrawal by Subject|0|||
161891627|NCT05600036|584650380|FG001|Overall Study|Withdrawal by Subject|1|||
161891628|NCT05600036|584650381|FG002|Overall Study|Withdrawal by Subject|2|||
161891629|NCT05600036|584650382|FG003|Overall Study|Withdrawal by Subject|0|||
161891630|NCT05600036|584650383|FG004|Overall Study|Withdrawal by Subject|3|||
161891631|NCT05600036|584650384|FG005|Overall Study|Withdrawal by Subject|5|||
161891632|NCT05600036|584650379|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161891633|NCT05600036|584650380|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161891634|NCT05600036|584650381|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161891635|NCT05600036|584650382|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
161891636|NCT05600036|584650383|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161891637|NCT05600036|584650384|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161891638|NCT05600036|584650379|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161891639|NCT05600036|584650380|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
161891640|NCT05600036|584650381|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161891641|NCT05600036|584650382|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161891642|NCT05600036|584650383|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161995144|NCT02714569|585032299|FG003|Part B (Overall)|Adverse Event|0|||
161995145|NCT02714569|585032300|FG004|Part B (Overall)|Adverse Event|0|||
161995146|NCT02714569|585032301|FG005|Part B (Overall)|Adverse Event|0|||
161995147|NCT02714569|585032302|FG006|Part B (Overall)|Adverse Event|0|||
161995148|NCT02714569|585032303|FG007|Part B (Overall)|Adverse Event|0|||
161995149|NCT02714569|585032304|FG008|Part B (Overall)|Adverse Event|0|||
161995150|NCT02714569|585032305|FG009|Part B (Overall)|Adverse Event|1|||
161995151|NCT02714569|585032306|FG010|Part B (Overall)|Adverse Event|0|||
161995152|NCT01684202|585032307|FG000|Dose-escalation Period|Adverse Event|0|||
161995153|NCT01684202|585032308|FG001|Dose-escalation Period|Adverse Event|1|||
161995154|NCT01684202|585032309|FG002|Dose-escalation Period|Adverse Event|0|||
161995155|NCT01684202|585032310|FG003|Dose-escalation Period|Adverse Event|0|||
161995156|NCT01684202|585032307|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
161995157|NCT01684202|585032308|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
161995158|NCT01684202|585032309|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
161995159|NCT01684202|585032310|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
161995160|NCT01684202|585032307|FG000|Maintenance Period|Adverse Event|1|||
161995161|NCT01684202|585032308|FG001|Maintenance Period|Adverse Event|1|||
161995162|NCT01684202|585032309|FG002|Maintenance Period|Adverse Event|1|||
161995163|NCT01684202|585032310|FG003|Maintenance Period|Adverse Event|1|||
161995164|NCT01684202|585032307|FG000|Maintenance Period|Physician Decision|0|||
161995165|NCT01684202|585032308|FG001|Maintenance Period|Physician Decision|1|||
161995166|NCT01684202|585032309|FG002|Maintenance Period|Physician Decision|0|||
161995167|NCT01684202|585032310|FG003|Maintenance Period|Physician Decision|0|||
161995168|NCT01684202|585032307|FG000|Maintenance Period|Withdrawal by Subject|0|||
161995169|NCT01684202|585032308|FG001|Maintenance Period|Withdrawal by Subject|1|||
161995170|NCT01684202|585032309|FG002|Maintenance Period|Withdrawal by Subject|0|||
161995171|NCT01684202|585032310|FG003|Maintenance Period|Withdrawal by Subject|0|||
161995172|NCT00191308|585032311|FG000|Overall Study|Adverse Event|1|||
161995173|NCT00779025|585032312|FG000|Overall Study|Withdrawal by Subject|1|||
161995174|NCT01970306|585032316|FG000|Overall Study|Not eligible|3|||
161995175|NCT01970306|585032316|FG000|Overall Study|Not able to be treated|9|||
161995176|NCT02741635|585032317|FG000|Overall Study|Withdrawal by Subject|1|||
161995177|NCT01427933|585032318|FG000|Overall Study|Withdrawal by Subject|5|||
161995178|NCT01427933|585032319|FG001|Overall Study|Withdrawal by Subject|8|||
161995179|NCT01427933|585032318|FG000|Overall Study|Lost to Follow-up|1|||
161995180|NCT01427933|585032319|FG001|Overall Study|Lost to Follow-up|5|||
161995181|NCT01427933|585032318|FG000|Overall Study|Other|1|||
161995182|NCT01427933|585032319|FG001|Overall Study|Other|0|||
161995183|NCT01427933|585032318|FG000|Overall Study|Investigator's Decision|1|||
161995184|NCT01427933|585032319|FG001|Overall Study|Investigator's Decision|0|||
161995185|NCT03472326|585032320|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
161995186|NCT03472326|585032321|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
161995187|NCT03472326|585032322|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
161995188|NCT03472326|585032323|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
161995189|NCT03472326|585032320|FG000|Part 2: Combination Therapy|Pregnancy|0|||
161995190|NCT03472326|585032321|FG001|Part 2: Combination Therapy|Pregnancy|0|||
162038820|NCT02964507|585199577|FG003|Overall Study|Physician Decision|0|||
162038821|NCT02964507|585199578|FG004|Overall Study|Physician Decision|1|||
161891643|NCT05600036|584650384|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161995191|NCT03472326|585032322|FG002|Part 2: Combination Therapy|Pregnancy|0|||
161995192|NCT03472326|585032323|FG003|Part 2: Combination Therapy|Pregnancy|1|||
161891644|NCT05600036|584650379|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161891645|NCT05600036|584650380|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161891646|NCT05600036|584650381|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161891647|NCT05600036|584650382|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
161891648|NCT05600036|584650383|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161891649|NCT05600036|584650384|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161891650|NCT00715520|584650385|FG000|Overall Study|Screen failure|8|||
161891651|NCT00715520|584650386|FG001|Overall Study|Screen failure|1|||
161891652|NCT00715520|584650387|FG002|Overall Study|Screen failure|1|||
161891653|NCT00715520|584650385|FG000|Overall Study|Withdrawal by Subject|2|||
161891654|NCT00715520|584650386|FG001|Overall Study|Withdrawal by Subject|0|||
161891655|NCT00715520|584650387|FG002|Overall Study|Withdrawal by Subject|1|||
161891656|NCT01006590|584650388|FG000|Overall Study|Adverse Event|2|||
161891657|NCT01006590|584650389|FG001|Overall Study|Adverse Event|3|||
161891658|NCT01006590|584650388|FG000|Overall Study|Death|1|||
161891659|NCT01006590|584650389|FG001|Overall Study|Death|1|||
161891660|NCT01006590|584650388|FG000|Overall Study|Lost to Follow-up|1|||
161891661|NCT01006590|584650389|FG001|Overall Study|Lost to Follow-up|1|||
161891662|NCT01006590|584650388|FG000|Overall Study|Protocol Violation|1|||
161891663|NCT01006590|584650389|FG001|Overall Study|Protocol Violation|0|||
161891664|NCT01006590|584650388|FG000|Overall Study|Withdrawal by Subject|4|||
161891665|NCT01006590|584650389|FG001|Overall Study|Withdrawal by Subject|2|||
161891666|NCT01006590|584650388|FG000|Overall Study|Study specific discontinuation criteria|16|||
161891667|NCT01006590|584650389|FG001|Overall Study|Study specific discontinuation criteria|23|||
161891668|NCT01006590|584650388|FG000|Overall Study|Other|3|||
161891669|NCT01006590|584650389|FG001|Overall Study|Other|2|||
161891670|NCT03332095|584650390|FG000|Overall Study|Lost to Follow-up|1|||
161891671|NCT03332095|584650391|FG001|Overall Study|Lost to Follow-up|0|||
161891672|NCT03332095|584650390|FG000|Overall Study|Pregnancy|0|||
161891673|NCT03332095|584650391|FG001|Overall Study|Pregnancy|1|||
162038822|NCT02964507|585199579|FG005|Overall Study|Physician Decision|0|||
162038823|NCT02964507|585199580|FG006|Overall Study|Physician Decision|0|||
162038824|NCT02964507|585199581|FG007|Overall Study|Physician Decision|0|||
162038825|NCT04341662|585199582|FG000|Overall Study|Did not have source-verified blood loss data|423|||
162038826|NCT04341662|585199583|FG001|Overall Study|Did not have source-verified blood loss data|514|||
162038827|NCT02675231|585199584|FG000|Overall Study|Withdrawal by Subject|2|||
162038828|NCT02675231|585199585|FG001|Overall Study|Withdrawal by Subject|4|||
162038829|NCT02675231|585199586|FG002|Overall Study|Withdrawal by Subject|2|||
162038830|NCT02675231|585199584|FG000|Overall Study|Lost to Follow-up|3|||
162038831|NCT02675231|585199585|FG001|Overall Study|Lost to Follow-up|4|||
162038832|NCT02675231|585199586|FG002|Overall Study|Lost to Follow-up|3|||
162038833|NCT05323656|585199587|FG000|Overall Study|Still On-Treatment|6|||
162038834|NCT05323656|585199588|FG001|Overall Study|Still On-Treatment|6|||
162038835|NCT05323656|585199587|FG000|Overall Study|Progressive Disease|15|||
162038836|NCT05323656|585199588|FG001|Overall Study|Progressive Disease|14|||
162038837|NCT05323656|585199587|FG000|Overall Study|Adverse Event|2|||
162038838|NCT05323656|585199588|FG001|Overall Study|Adverse Event|3|||
162038839|NCT05323656|585199587|FG000|Overall Study|Death|1|||
162038840|NCT05323656|585199588|FG001|Overall Study|Death|2|||
162038841|NCT05323656|585199587|FG000|Overall Study|Withdrawal by Subject|1|||
162038842|NCT05323656|585199588|FG001|Overall Study|Withdrawal by Subject|0|||
162038843|NCT05323656|585199587|FG000|Overall Study|Clinical disease progression|0|||
162038844|NCT05323656|585199588|FG001|Overall Study|Clinical disease progression|1|||
162038845|NCT05323656|585199587|FG000|Overall Study|Patient and Investigator decision|1|||
162038846|NCT05323656|585199588|FG001|Overall Study|Patient and Investigator decision|0|||
162038847|NCT05323656|585199587|FG000|Overall Study|Physician Decision|0|||
162038848|NCT05323656|585199588|FG001|Overall Study|Physician Decision|1|||
162038849|NCT03953183|585199589|FG000|Overall Study|Physician Decision|0|||
162038850|NCT03953183|585199590|FG001|Overall Study|Physician Decision|1|||
162038851|NCT03953183|585199589|FG000|Overall Study|Withdrawal by Subject|0|||
162038852|NCT03953183|585199590|FG001|Overall Study|Withdrawal by Subject|1|||
161891674|NCT04942210|584650395|FG000|Overall Study|Adverse Event|0|||
161891675|NCT04942210|584650396|FG001|Overall Study|Adverse Event|1|||
161891676|NCT04942210|584650395|FG000|Overall Study|Protocol Deviation|4|||
161891677|NCT04942210|584650396|FG001|Overall Study|Protocol Deviation|1|||
161891678|NCT04942210|584650395|FG000|Overall Study|Withdrawal by Subject|5|||
161891679|NCT04942210|584650396|FG001|Overall Study|Withdrawal by Subject|2|||
161891680|NCT04942210|584650395|FG000|Overall Study|Lost to Follow-up|16|||
162038853|NCT00064298|585199599|FG000|Overall Study|Withdrawal by Subject|2|||
162038854|NCT00064298|585199600|FG001|Overall Study|Withdrawal by Subject|1|||
162038855|NCT00064298|585199599|FG000|Overall Study|Lost to Follow-up|2|||
162038856|NCT00064298|585199600|FG001|Overall Study|Lost to Follow-up|2|||
162038857|NCT00064298|585199599|FG000|Overall Study|Death|0|||
162038858|NCT00064298|585199600|FG001|Overall Study|Death|1|||
162038859|NCT00064298|585199599|FG000|Overall Study|Disease Progression|2|||
162038860|NCT00064298|585199600|FG001|Overall Study|Disease Progression|1|||
162038861|NCT04718103|585199601|FG000|Overall Study|Adverse Event|1|||
162038862|NCT04718103|585199602|FG001|Overall Study|Adverse Event|1|||
162038863|NCT04718103|585199601|FG000|Overall Study|Lack of Efficacy|4|||
162038864|NCT04718103|585199602|FG001|Overall Study|Lack of Efficacy|1|||
162038865|NCT04718103|585199601|FG000|Overall Study|Lost to Follow-up|2|||
162038866|NCT04718103|585199602|FG001|Overall Study|Lost to Follow-up|2|||
162038867|NCT04718103|585199601|FG000|Overall Study|Physician Decision|2|||
162038868|NCT04718103|585199602|FG001|Overall Study|Physician Decision|0|||
162038869|NCT04718103|585199601|FG000|Overall Study|Pregnancy|0|||
162038870|NCT04718103|585199602|FG001|Overall Study|Pregnancy|1|||
162038871|NCT04718103|585199601|FG000|Overall Study|Withdrawal by Subject|10|||
162038872|NCT04718103|585199602|FG001|Overall Study|Withdrawal by Subject|6|||
162038873|NCT04718103|585199601|FG000|Overall Study|Randomized, not treated|4|||
162038874|NCT04718103|585199602|FG001|Overall Study|Randomized, not treated|1|||
162038875|NCT04718103|585199601|FG000|Overall Study|GCP violations|7|||
162038876|NCT04718103|585199602|FG001|Overall Study|GCP violations|5|||
162038877|NCT02220998|585199603|FG000|Overall Study|Randomized but Never Treated|1|||
162038878|NCT02220998|585199604|FG001|Overall Study|Randomized but Never Treated|2|||
162038879|NCT02220998|585199603|FG000|Overall Study|Death|2|||
162038880|NCT02220998|585199604|FG001|Overall Study|Death|0|||
162038881|NCT02220998|585199603|FG000|Overall Study|Lack of Efficacy|0|||
162038882|NCT02220998|585199604|FG001|Overall Study|Lack of Efficacy|5|||
162038883|NCT02220998|585199603|FG000|Overall Study|Lost to Follow-up|4|||
162038884|NCT02220998|585199604|FG001|Overall Study|Lost to Follow-up|4|||
162038885|NCT03309046|585199605|FG000|Overall Study|Withdrawal by Subject|4|||
162038886|NCT03309046|585199606|FG001|Overall Study|Withdrawal by Subject|17|||
162038887|NCT00873860|585199607|FG000|Overall Study|Lost to Follow-up|1|||
162038888|NCT00873860|585199608|FG001|Overall Study|Lost to Follow-up|0|||
162038889|NCT00873860|585199609|FG002|Overall Study|Lost to Follow-up|0|||
162038890|NCT00873860|585199610|FG003|Overall Study|Lost to Follow-up|1|||
162038891|NCT00873860|585199607|FG000|Overall Study|Withdrawal by Subject|1|||
162038892|NCT00873860|585199608|FG001|Overall Study|Withdrawal by Subject|0|||
162038893|NCT00873860|585199609|FG002|Overall Study|Withdrawal by Subject|2|||
162038894|NCT00873860|585199610|FG003|Overall Study|Withdrawal by Subject|0|||
162038895|NCT00873860|585199607|FG000|Overall Study|Death|1|||
162038896|NCT00873860|585199608|FG001|Overall Study|Death|0|||
162038897|NCT00873860|585199609|FG002|Overall Study|Death|0|||
162038898|NCT00873860|585199610|FG003|Overall Study|Death|0|||
162038899|NCT00873860|585199607|FG000|Overall Study|Other|1|||
162038900|NCT00873860|585199608|FG001|Overall Study|Other|0|||
162038901|NCT00873860|585199609|FG002|Overall Study|Other|1|||
162038902|NCT00873860|585199610|FG003|Overall Study|Other|0|||
162038903|NCT02764190|585199611|FG000|Overall Study|Lost to Follow-up|17|||
162038904|NCT02764190|585199612|FG001|Overall Study|Lost to Follow-up|13|||
162038905|NCT00591266|585199613|FG000|Overall Study|Adverse Event|2|||
162038906|NCT00591266|585199614|FG001|Overall Study|Adverse Event|2|||
162038907|NCT00591266|585199615|FG002|Overall Study|Adverse Event|3|||
162038908|NCT00591266|585199613|FG000|Overall Study|Lost to Follow-up|0|||
162038909|NCT00591266|585199614|FG001|Overall Study|Lost to Follow-up|1|||
162038910|NCT00591266|585199615|FG002|Overall Study|Lost to Follow-up|0|||
162038911|NCT00591266|585199613|FG000|Overall Study|Protocol Violation|0|||
162038912|NCT00591266|585199614|FG001|Overall Study|Protocol Violation|0|||
162038913|NCT00591266|585199615|FG002|Overall Study|Protocol Violation|1|||
162038914|NCT00591266|585199613|FG000|Overall Study|Withdrawal by Subject|6|||
162038915|NCT00591266|585199614|FG001|Overall Study|Withdrawal by Subject|2|||
162038916|NCT00591266|585199615|FG002|Overall Study|Withdrawal by Subject|5|||
162038917|NCT00591266|585199613|FG000|Overall Study|Lack of Efficacy|0|||
162038918|NCT00591266|585199614|FG001|Overall Study|Lack of Efficacy|2|||
162038919|NCT00591266|585199615|FG002|Overall Study|Lack of Efficacy|0|||
162038920|NCT00591266|585199613|FG000|Overall Study|Other|1|||
162038921|NCT00591266|585199614|FG001|Overall Study|Other|4|||
162038922|NCT00591266|585199615|FG002|Overall Study|Other|5|||
162038923|NCT03488927|585199616|FG000|Overall Study|Withdrawal by Subject|44|||
162038924|NCT03488927|585199617|FG001|Overall Study|Withdrawal by Subject|118|||
162038925|NCT03488927|585199618|FG002|Overall Study|Withdrawal by Subject|217|||
162038926|NCT03497676|585199619|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
162038927|NCT03497676|585199620|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
162038928|NCT03497676|585199621|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
162038929|NCT03497676|585199622|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
162038930|NCT03497676|585199619|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
162038931|NCT03497676|585199620|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
162038932|NCT03497676|585199621|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
162038933|NCT03497676|585199622|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
162038934|NCT03497676|585199619|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
162038935|NCT03497676|585199620|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
162038936|NCT03497676|585199621|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
161891681|NCT04942210|584650396|FG001|Overall Study|Lost to Follow-up|7|||
162038937|NCT03497676|585199622|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
162038938|NCT03497676|585199619|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
162038939|NCT03497676|585199620|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
162038940|NCT03497676|585199621|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
162038941|NCT03497676|585199622|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
162038942|NCT03497676|585199619|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
162038943|NCT03497676|585199620|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
162038944|NCT03497676|585199621|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
162038945|NCT03497676|585199622|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
162038946|NCT03497676|585199619|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
162038947|NCT03497676|585199620|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
162038948|NCT03497676|585199621|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
162038949|NCT03497676|585199622|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
162038950|NCT03497676|585199619|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
162038951|NCT03497676|585199620|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
162038952|NCT03497676|585199621|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
162038953|NCT03497676|585199622|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
162038954|NCT03497676|585199619|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
162038955|NCT03497676|585199620|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
162038956|NCT03497676|585199621|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
162038957|NCT03497676|585199622|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
162038958|NCT01977937|585199623|FG000|Overall Study|Withdrawal by Subject|2|||
162038959|NCT01977937|585199624|FG001|Overall Study|Withdrawal by Subject|1|||
162038960|NCT01977937|585199623|FG000|Overall Study|Adverse Event|1|||
162038961|NCT01977937|585199624|FG001|Overall Study|Adverse Event|0|||
162038962|NCT01977937|585199623|FG000|Overall Study|Physician Decision|0|||
162038963|NCT01977937|585199624|FG001|Overall Study|Physician Decision|1|||
161891682|NCT04942210|584650395|FG000|Overall Study|Ongoing at the time of DBL date|60|||
161891683|NCT04942210|584650396|FG001|Overall Study|Ongoing at the time of DBL date|25|||
161891684|NCT04942210|584650395|FG000|Overall Study|Randomized but did not receive vaccination|3|||
161891685|NCT04942210|584650396|FG001|Overall Study|Randomized but did not receive vaccination|0|||
161891686|NCT04348500|584650397|FG000|Overall Study|Death|2|||
161891687|NCT04348500|584650398|FG001|Overall Study|Death|2|||
161891688|NCT04348500|584650397|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
161891689|NCT04348500|584650398|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
161891690|NCT02776670|584650399|FG000|Overall Study|Adverse Event|0|||
161891691|NCT02776670|584650400|FG001|Overall Study|Adverse Event|2|||
162038964|NCT03194490|585199628|FG000|Overall Study|Lost to Follow-up|1|||
162038965|NCT03194490|585199629|FG001|Overall Study|Lost to Follow-up|3|||
162038966|NCT03194490|585199628|FG000|Overall Study|participant developed specific neck pain|1|||
162038967|NCT03194490|585199629|FG001|Overall Study|participant developed specific neck pain|0|||
162038968|NCT03911843|585199630|FG000|Overall Study|Adverse Event|2|||
162038969|NCT03911843|585199631|FG001|Overall Study|Adverse Event|0|||
162038970|NCT03911843|585199630|FG000|Overall Study|Protocol Violation|2|||
161891692|NCT02776670|584650399|FG000|Overall Study|Protocol Violation|0|||
161891693|NCT02776670|584650400|FG001|Overall Study|Protocol Violation|2|||
161891694|NCT02776670|584650399|FG000|Overall Study|Withdrawal by Subject|0|||
161891695|NCT02776670|584650400|FG001|Overall Study|Withdrawal by Subject|1|||
161891696|NCT02776670|584650399|FG000|Overall Study|Other - Reason not given|0|||
161891697|NCT02776670|584650400|FG001|Overall Study|Other - Reason not given|1|||
161891698|NCT00957424|584650409|FG000|Overall Study|Lost to Follow-up|19|||
161891699|NCT00957424|584650409|FG000|Overall Study|Protocol Violation|3|||
161891700|NCT00957424|584650409|FG000|Overall Study|Withdrawal by Subject|1|||
161891701|NCT03760458|584650419|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
161891702|NCT03760458|584650420|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
161891703|NCT03760458|584650421|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
161891704|NCT03760458|584650422|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
161891705|NCT03760458|584650423|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
161891706|NCT00750919|584650424|FG000|Overall Study|Adverse Event|9|||
161891707|NCT00750919|584650424|FG000|Overall Study|Withdrawal by Subject|1|||
161891708|NCT00750919|584650424|FG000|Overall Study|Lack of Efficacy|8|||
161891709|NCT00750919|584650424|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
161891710|NCT00750919|584650424|FG000|Overall Study|Other|36|||
161891711|NCT03913104|584650429|FG000|Overall Study|Lost to Follow-up|20|||
161891712|NCT03913104|584650429|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
162038971|NCT03911843|585199631|FG001|Overall Study|Protocol Violation|0|||
162038972|NCT03911843|585199630|FG000|Overall Study|Lost to Follow-up|0|||
162038973|NCT03911843|585199631|FG001|Overall Study|Lost to Follow-up|1|||
162038974|NCT02819518|585199632|FG000|Overall Study|Death|9|||
162038975|NCT02819518|585199633|FG001|Overall Study|Death|12|||
161891713|NCT03913104|584650429|FG000|Overall Study|Withdrawal by Subject|2|||
161891714|NCT01119846|584650430|FG000|Overall Study|Adverse Event|1|||
161891715|NCT01119846|584650431|FG001|Overall Study|Adverse Event|0|||
161891716|NCT01119846|584650432|FG002|Overall Study|Adverse Event|6|||
161891717|NCT01119846|584650430|FG000|Overall Study|Physician Decision|1|||
161891718|NCT01119846|584650431|FG001|Overall Study|Physician Decision|0|||
161891719|NCT01119846|584650432|FG002|Overall Study|Physician Decision|0|||
161891720|NCT01119846|584650430|FG000|Overall Study|Protocol Violation|0|||
161891721|NCT01119846|584650431|FG001|Overall Study|Protocol Violation|0|||
161891722|NCT01119846|584650432|FG002|Overall Study|Protocol Violation|1|||
161891723|NCT01119846|584650430|FG000|Overall Study|Withdrawal by Subject|0|||
161891724|NCT01119846|584650431|FG001|Overall Study|Withdrawal by Subject|0|||
161891725|NCT01119846|584650432|FG002|Overall Study|Withdrawal by Subject|4|||
161891726|NCT00048997|584650433|FG000|Overall Study|Protocol Violation|7|||
161891727|NCT00048997|584650434|FG001|Overall Study|Protocol Violation|2|||
161891728|NCT00048997|584650433|FG000|Overall Study|Withdrawal by Subject|6|||
161891729|NCT00048997|584650434|FG001|Overall Study|Withdrawal by Subject|1|||
161891730|NCT00002525|584650435|FG000|Overall Study|Adverse Event|36|||
161891731|NCT00002525|584650436|FG001|Overall Study|Adverse Event|0|||
161891732|NCT00002525|584650435|FG000|Overall Study|Death|5|||
161891733|NCT00002525|584650436|FG001|Overall Study|Death|0|||
161891734|NCT00002525|584650435|FG000|Overall Study|Withdrawal by Subject|11|||
161891735|NCT00002525|584650436|FG001|Overall Study|Withdrawal by Subject|0|||
161891736|NCT00002525|584650435|FG000|Overall Study|Start non-protocol therapy|1|||
161891737|NCT00002525|584650436|FG001|Overall Study|Start non-protocol therapy|0|||
161891738|NCT00002525|584650435|FG000|Overall Study|Other complicating disease|1|||
161891739|NCT00002525|584650436|FG001|Overall Study|Other complicating disease|0|||
161891740|NCT00002525|584650435|FG000|Overall Study|Duke's A, B1, D disease|92|||
161891741|NCT00002525|584650436|FG001|Overall Study|Duke's A, B1, D disease|0|||
162038976|NCT02819518|585199634|FG002|Overall Study|Death|9|||
162038977|NCT02819518|585199635|FG003|Overall Study|Death|475|||
162038978|NCT02819518|585199636|FG004|Overall Study|Death|244|||
162038979|NCT02819518|585199632|FG000|Overall Study|Withdrawal by Subject|0|||
162038980|NCT02819518|585199633|FG001|Overall Study|Withdrawal by Subject|0|||
162038981|NCT02819518|585199634|FG002|Overall Study|Withdrawal by Subject|0|||
161891742|NCT00002525|584650435|FG000|Overall Study|Error|6|||
161891743|NCT00002525|584650436|FG001|Overall Study|Error|0|||
161891744|NCT00002525|584650435|FG000|Overall Study|Other|26|||
161891745|NCT00002525|584650436|FG001|Overall Study|Other|0|||
161891746|NCT00002525|584650435|FG000|Overall Study|Never start protocol therapy|8|||
161891747|NCT00002525|584650436|FG001|Overall Study|Never start protocol therapy|0|||
161891748|NCT03304184|584650437|FG000|Overall Study|Withdrawal by Subject|1|||
161891749|NCT03304184|584650438|FG001|Overall Study|Withdrawal by Subject|2|||
161891750|NCT03420222|584650441|FG000|Overall Study|Withdrawal by Subject|5|||
161891751|NCT03420222|584650442|FG001|Overall Study|Withdrawal by Subject|0|||
161891752|NCT03420222|584650441|FG000|Overall Study|Physician Decision|0|||
161891753|NCT03420222|584650442|FG001|Overall Study|Physician Decision|1|||
161891754|NCT04527978|584650444|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
161891755|NCT04527978|584650445|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
161891756|NCT02112877|584650447|FG000|Overall Study|Withdrawal by Subject|1|||
161891757|NCT02112877|584650448|FG001|Overall Study|Withdrawal by Subject|7|||
161891758|NCT02112877|584650447|FG000|Overall Study|Visit Missed|1|||
161891759|NCT02112877|584650448|FG001|Overall Study|Visit Missed|6|||
161891760|NCT00187278|584650454|FG000|Overall Study|Protocol Violation|10|||
161891761|NCT00187278|584650455|FG001|Overall Study|Protocol Violation|13|||
161891762|NCT01578499|584650456|FG000|Overall Study|Reason not Specified|0|||
161891763|NCT01578499|584650457|FG001|Overall Study|Reason not Specified|1|||
161891764|NCT01578499|584650456|FG000|Overall Study|Lost to Follow-up|2|||
161891765|NCT01578499|584650457|FG001|Overall Study|Lost to Follow-up|1|||
161891766|NCT01578499|584650456|FG000|Overall Study|Withdrawal by Subject|10|||
161891767|NCT01578499|584650457|FG001|Overall Study|Withdrawal by Subject|16|||
161891768|NCT01578499|584650456|FG000|Overall Study|Death|20|||
161891769|NCT01578499|584650457|FG001|Overall Study|Death|25|||
161891770|NCT01578499|584650456|FG000|Overall Study|Died and End of Study Page not Completed|2|||
161891771|NCT01578499|584650457|FG001|Overall Study|Died and End of Study Page not Completed|0|||
162038982|NCT02819518|585199635|FG003|Overall Study|Withdrawal by Subject|25|||
161891772|NCT02791438|584650459|FG000|Treatment Period|Adverse Event|1|||
161891773|NCT02791438|584650460|FG001|Treatment Period|Adverse Event|0|||
161891774|NCT02791438|584650459|FG000|Treatment Period|Withdrawal by Subject|0|||
162038983|NCT02819518|585199636|FG004|Overall Study|Withdrawal by Subject|8|||
162038984|NCT02819518|585199632|FG000|Overall Study|Lost to Follow-up|0|||
161891775|NCT02791438|584650460|FG001|Treatment Period|Withdrawal by Subject|1|||
161891776|NCT02791438|584650459|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
161891777|NCT02791438|584650460|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
161891778|NCT01603394|584650462|FG000|Overall Study|Adverse Event|1|||
161891779|NCT01854879|584650473|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
161891780|NCT01854879|584650473|FG000|Overall Study|screen fail|3|||
161891781|NCT01854879|584650473|FG000|Overall Study|incomplete data set|1|||
161891782|NCT00385827|584651513|FG000|Part 1|Adverse Event|1|||
161891783|NCT00385827|584651514|FG001|Part 1|Adverse Event|0|||
161891784|NCT00385827|584651515|FG002|Part 1|Adverse Event|0|||
161891785|NCT00385827|584651513|FG000|Part 1|Death|2|||
161891786|NCT00385827|584651514|FG001|Part 1|Death|0|||
161891787|NCT00385827|584651515|FG002|Part 1|Death|0|||
161891788|NCT00385827|584651513|FG000|Part 1|Lack of Efficacy|5|||
161891789|NCT00385827|584651514|FG001|Part 1|Lack of Efficacy|0|||
161891790|NCT00385827|584651515|FG002|Part 1|Lack of Efficacy|0|||
161891791|NCT00385827|584651513|FG000|Part 1|Other|1|||
161891792|NCT00385827|584651514|FG001|Part 1|Other|0|||
161891793|NCT00385827|584651515|FG002|Part 1|Other|0|||
161891794|NCT00385827|584651513|FG000|Part 2|Adverse Event|0|||
161891795|NCT00385827|584651514|FG001|Part 2|Adverse Event|6|||
161891796|NCT00385827|584651515|FG002|Part 2|Adverse Event|10|||
161891797|NCT00385827|584651513|FG000|Part 2|Death|0|||
161891798|NCT00385827|584651514|FG001|Part 2|Death|0|||
161891799|NCT00385827|584651515|FG002|Part 2|Death|2|||
161891800|NCT00385827|584651513|FG000|Part 2|Lack of Efficacy|0|||
161995193|NCT00773513|585032324|FG000|Overall Study|Renal Transplant|254|||
161995194|NCT00773513|585032325|FG001|Overall Study|Renal Transplant|263|||
161995195|NCT00773513|585032324|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
161995196|NCT00773513|585032325|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
161995197|NCT00773513|585032324|FG000|Overall Study|Withdrew Consent|68|||
161995198|NCT00773513|585032325|FG001|Overall Study|Withdrew Consent|69|||
161995199|NCT00773513|585032324|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
161995200|NCT00773513|585032325|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
161995201|NCT00773513|585032324|FG000|Overall Study|Failure to Return|22|||
161995202|NCT00773513|585032325|FG001|Overall Study|Failure to Return|8|||
161995203|NCT00773513|585032324|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161995204|NCT00773513|585032325|FG001|Overall Study|Insufficient Therapeutic Response|18|||
161995205|NCT00773513|585032324|FG000|Overall Study|Reason Not Specified|159|||
161995206|NCT00773513|585032325|FG001|Overall Study|Reason Not Specified|126|||
161995207|NCT00773513|585032324|FG000|Overall Study|Death|531|||
161995208|NCT00773513|585032325|FG001|Overall Study|Death|545|||
161995209|NCT00700713|585032326|FG000|Overall Study|Protocol Violation|1|||
161995210|NCT00700713|585032327|FG001|Overall Study|Protocol Violation|0|||
161995211|NCT00700713|585032328|FG002|Overall Study|Protocol Violation|1|||
161995212|NCT00700713|585032326|FG000|Overall Study|Withdrawal by Subject|0|||
161995213|NCT00700713|585032327|FG001|Overall Study|Withdrawal by Subject|0|||
161995214|NCT00700713|585032328|FG002|Overall Study|Withdrawal by Subject|1|||
161995215|NCT03359174|585032329|FG000|Overall Study|Adverse Event|1|||
161995216|NCT02680665|585032330|FG000|Overall Study|No visit after the first prescription|5|||
161995217|NCT02905266|585032331|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
161995218|NCT02905266|585032332|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
161995219|NCT02905266|585032331|FG000|Treatment Phase Part 1|Disease Progression|6|||
161995220|NCT02905266|585032332|FG001|Treatment Phase Part 1|Disease Progression|7|||
161995221|NCT02905266|585032331|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
161995222|NCT02905266|585032332|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
161995223|NCT02905266|585032331|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
161995224|NCT02905266|585032332|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
161995225|NCT02905266|585032331|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
161995226|NCT02905266|585032332|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
161995227|NCT02905266|585032331|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
161995228|NCT02905266|585032332|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
161995229|NCT02905266|585032331|FG000|Transition From Part 1 to Part 2|Death|0|||
161995230|NCT02905266|585032332|FG001|Transition From Part 1 to Part 2|Death|1|||
161995231|NCT02905266|585032331|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
161995232|NCT02905266|585032332|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
161995233|NCT02905266|585032331|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
161995234|NCT02905266|585032332|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
161995235|NCT02905266|585032331|FG000|Maintenance Phase Part 2|Disease Progression|9|||
161995236|NCT02905266|585032332|FG001|Maintenance Phase Part 2|Disease Progression|2|||
161995237|NCT02905266|585032331|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
161995238|NCT02905266|585032332|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
161995239|NCT02905266|585032331|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
161995240|NCT02905266|585032332|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
161995241|NCT00596752|585032335|FG000|Overall Study|Other Reason|44|||
161995242|NCT00596752|585032336|FG001|Overall Study|Other Reason|49|||
161891801|NCT00385827|584651514|FG001|Part 2|Lack of Efficacy|14|||
161891802|NCT00385827|584651515|FG002|Part 2|Lack of Efficacy|13|||
161891803|NCT00385827|584651513|FG000|Part 2|Randomized but not treated|0|||
161891804|NCT00385827|584651514|FG001|Part 2|Randomized but not treated|2|||
161891805|NCT00385827|584651515|FG002|Part 2|Randomized but not treated|2|||
161891806|NCT00385827|584651513|FG000|Part 2|Other|0|||
161891807|NCT00385827|584651514|FG001|Part 2|Other|11|||
161891808|NCT00385827|584651515|FG002|Part 2|Other|21|||
161891809|NCT01421147|584651516|FG000|Treatment Period|Adverse Event|2|||
161891810|NCT01421147|584651517|FG001|Treatment Period|Adverse Event|3|||
161891811|NCT01421147|584651516|FG000|Treatment Period|Lost to Follow-up|2|||
161891812|NCT01421147|584651517|FG001|Treatment Period|Lost to Follow-up|1|||
161891813|NCT01421147|584651516|FG000|Treatment Period|Physician Decision|2|||
161891814|NCT01421147|584651517|FG001|Treatment Period|Physician Decision|2|||
161891815|NCT01421147|584651516|FG000|Treatment Period|Withdrawal by Subject|10|||
161891816|NCT01421147|584651517|FG001|Treatment Period|Withdrawal by Subject|5|||
161891817|NCT01421147|584651516|FG000|Extension Period|Adverse Event|0|||
161891818|NCT01421147|584651517|FG001|Extension Period|Adverse Event|2|||
161891819|NCT01421147|584651516|FG000|Extension Period|Death|0|||
161891820|NCT01421147|584651517|FG001|Extension Period|Death|1|||
161891821|NCT01421147|584651516|FG000|Extension Period|Lost to Follow-up|2|||
161891822|NCT01421147|584651517|FG001|Extension Period|Lost to Follow-up|5|||
161891823|NCT01421147|584651516|FG000|Extension Period|Physician Decision|1|||
161891824|NCT01421147|584651517|FG001|Extension Period|Physician Decision|0|||
161891825|NCT01421147|584651516|FG000|Extension Period|Withdrawal by Subject|5|||
161995243|NCT00596752|585032335|FG000|Overall Study|Adverse Event|34|||
161995244|NCT00596752|585032336|FG001|Overall Study|Adverse Event|34|||
161995245|NCT00596752|585032335|FG000|Overall Study|Lost to Follow-up|22|||
161995246|NCT00596752|585032336|FG001|Overall Study|Lost to Follow-up|38|||
161995247|NCT00596752|585032335|FG000|Overall Study|Withdrawal by Subject|12|||
161995248|NCT00596752|585032336|FG001|Overall Study|Withdrawal by Subject|9|||
161995249|NCT00596752|585032335|FG000|Overall Study|Unsatisfactory Compliance|9|||
161995250|NCT00596752|585032336|FG001|Overall Study|Unsatisfactory Compliance|6|||
161995251|NCT00596752|585032335|FG000|Overall Study|Lack of Efficacy|4|||
161995252|NCT00596752|585032336|FG001|Overall Study|Lack of Efficacy|7|||
161995253|NCT00596752|585032335|FG000|Overall Study|Protocol Violation|1|||
161995254|NCT00596752|585032336|FG001|Overall Study|Protocol Violation|0|||
161995255|NCT04445662|585032339|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
161995256|NCT04445662|585032340|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
161995257|NCT04445662|585032339|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
161995258|NCT04445662|585032340|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
161995259|NCT04445662|585032339|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
161995260|NCT04445662|585032340|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
161995261|NCT04445662|585032339|FG000|Post-treatment (12-24 weeks)|Death|1|||
161995262|NCT04445662|585032340|FG001|Post-treatment (12-24 weeks)|Death|0|||
161995263|NCT02451124|585032351|FG000|Overall Study|Withdrawal by Subject|1|||
161995264|NCT01870726|585032352|FG000|Overall Study|Withdrawal of informed consent|0|||
161995265|NCT01870726|585032353|FG001|Overall Study|Withdrawal of informed consent|0|||
161995266|NCT01870726|585032354|FG002|Overall Study|Withdrawal of informed consent|0|||
161995267|NCT01870726|585032355|FG003|Overall Study|Withdrawal of informed consent|1|||
161995268|NCT01870726|585032356|FG004|Overall Study|Withdrawal of informed consent|0|||
161995269|NCT01870726|585032357|FG005|Overall Study|Withdrawal of informed consent|0|||
161995270|NCT01870726|585032358|FG006|Overall Study|Withdrawal of informed consent|0|||
161995271|NCT01870726|585032352|FG000|Overall Study|Withdrawal by Subject|0|||
161995272|NCT01870726|585032353|FG001|Overall Study|Withdrawal by Subject|1|||
161995273|NCT01870726|585032354|FG002|Overall Study|Withdrawal by Subject|0|||
161995274|NCT01870726|585032355|FG003|Overall Study|Withdrawal by Subject|0|||
161995275|NCT01870726|585032356|FG004|Overall Study|Withdrawal by Subject|0|||
161995276|NCT01870726|585032357|FG005|Overall Study|Withdrawal by Subject|0|||
161995277|NCT01870726|585032358|FG006|Overall Study|Withdrawal by Subject|0|||
161995278|NCT01870726|585032352|FG000|Overall Study|Adverse Event|0|||
161995279|NCT01870726|585032353|FG001|Overall Study|Adverse Event|0|||
161995280|NCT01870726|585032354|FG002|Overall Study|Adverse Event|0|||
161995281|NCT01870726|585032355|FG003|Overall Study|Adverse Event|0|||
161995282|NCT01870726|585032356|FG004|Overall Study|Adverse Event|1|||
161995283|NCT01870726|585032357|FG005|Overall Study|Adverse Event|1|||
161995284|NCT01870726|585032358|FG006|Overall Study|Adverse Event|0|||
161995285|NCT01870726|585032352|FG000|Overall Study|Progressive disease|5|||
161995286|NCT01870726|585032353|FG001|Overall Study|Progressive disease|5|||
161995287|NCT01870726|585032354|FG002|Overall Study|Progressive disease|4|||
161995288|NCT01870726|585032355|FG003|Overall Study|Progressive disease|5|||
161995289|NCT01870726|585032356|FG004|Overall Study|Progressive disease|6|||
161995290|NCT01870726|585032357|FG005|Overall Study|Progressive disease|4|||
161995291|NCT01870726|585032358|FG006|Overall Study|Progressive disease|10|||
161995292|NCT00103740|585032361|FG000|Period 1 - Core|Adverse Event|1|||
161995293|NCT00103740|585032362|FG001|Period 1 - Core|Adverse Event|0|||
161995294|NCT00103740|585032361|FG000|Period 1 - Core|Protocol Violation|3|||
161995295|NCT00103740|585032362|FG001|Period 1 - Core|Protocol Violation|2|||
161995296|NCT00103740|585032361|FG000|Period 1 - Core|Patient withdrew consent|3|||
161995297|NCT00103740|585032362|FG001|Period 1 - Core|Patient withdrew consent|2|||
161995298|NCT00103740|585032361|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
161995299|NCT00103740|585032362|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
161995300|NCT00103740|585032361|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
162038985|NCT02819518|585199633|FG001|Overall Study|Lost to Follow-up|0|||
162038986|NCT02819518|585199634|FG002|Overall Study|Lost to Follow-up|0|||
162038987|NCT02819518|585199635|FG003|Overall Study|Lost to Follow-up|0|||
162038988|NCT02819518|585199636|FG004|Overall Study|Lost to Follow-up|1|||
162038989|NCT02819518|585199632|FG000|Overall Study|Sponsor Decision|1|||
162038990|NCT02819518|585199633|FG001|Overall Study|Sponsor Decision|1|||
162038991|NCT02819518|585199634|FG002|Overall Study|Sponsor Decision|0|||
162038992|NCT02819518|585199635|FG003|Overall Study|Sponsor Decision|34|||
162038993|NCT02819518|585199636|FG004|Overall Study|Sponsor Decision|17|||
162038994|NCT02819518|585199632|FG000|Overall Study|Transferred to extension study|1|||
162038995|NCT02819518|585199633|FG001|Overall Study|Transferred to extension study|1|||
162038996|NCT02819518|585199634|FG002|Overall Study|Transferred to extension study|1|||
162038997|NCT02819518|585199635|FG003|Overall Study|Transferred to extension study|32|||
162038998|NCT02819518|585199636|FG004|Overall Study|Transferred to extension study|11|||
162038999|NCT00880165|585199637|FG000|Overall Study|Withdrawal by Subject|27|||
162039000|NCT00880165|585199638|FG001|Overall Study|Withdrawal by Subject|23|||
162039001|NCT00880165|585199637|FG000|Overall Study|Not diagnosed with OSA|14|||
162039002|NCT00880165|585199638|FG001|Overall Study|Not diagnosed with OSA|8|||
162039003|NCT00880165|585199637|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
162039004|NCT00880165|585199638|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
162039005|NCT00880165|585199637|FG000|Overall Study|Lost to follow|9|||
162039006|NCT00880165|585199638|FG001|Overall Study|Lost to follow|15|||
162039007|NCT01505647|585199639|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
162039008|NCT01505647|585199640|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
162039009|NCT01505647|585199639|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
162039010|NCT01505647|585199640|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
162039011|NCT01505647|585199639|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
162039012|NCT01505647|585199640|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
162039013|NCT01505647|585199639|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
162039014|NCT01505647|585199640|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
162039015|NCT01505647|585199639|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
162039016|NCT01505647|585199640|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
162039017|NCT02750943|585199644|FG000|Overall Study|Lost to Follow-up|1|||
162039018|NCT02750943|585199645|FG001|Overall Study|Lost to Follow-up|2|||
162039019|NCT02750943|585199644|FG000|Overall Study|Withdrawal by Subject|5|||
162039020|NCT02750943|585199645|FG001|Overall Study|Withdrawal by Subject|7|||
162039021|NCT04597918|585199646|FG000|Overall Study|Withdrawal by Subject|6|||
162039022|NCT04597918|585199646|FG000|Overall Study|Lost to Follow-up|3|||
162039023|NCT04597918|585199646|FG000|Overall Study|Death|1|||
162039024|NCT01927341|585201415|FG000|Phase 1b|Lost to Follow-up|1|||
162039025|NCT01927341|585201416|FG001|Phase 1b|Lost to Follow-up|0|||
162039026|NCT01927341|585201417|FG002|Phase 1b|Lost to Follow-up|0|||
162039027|NCT01927341|585201418|FG003|Phase 1b|Lost to Follow-up|0|||
162039028|NCT01927341|585201419|FG004|Phase 1b|Lost to Follow-up|0|||
162039029|NCT01927341|585201415|FG000|Phase 1b|Death|2|||
162039030|NCT01927341|585201416|FG001|Phase 1b|Death|0|||
162039031|NCT01927341|585201417|FG002|Phase 1b|Death|0|||
162039032|NCT01927341|585201418|FG003|Phase 1b|Death|0|||
162039033|NCT01927341|585201419|FG004|Phase 1b|Death|0|||
162039034|NCT01927341|585201415|FG000|Phase 1b|Follow-up completed|7|||
162039035|NCT01927341|585201416|FG001|Phase 1b|Follow-up completed|0|||
162039036|NCT01927341|585201417|FG002|Phase 1b|Follow-up completed|0|||
162039037|NCT01927341|585201418|FG003|Phase 1b|Follow-up completed|0|||
162039038|NCT01927341|585201419|FG004|Phase 1b|Follow-up completed|0|||
162039039|NCT01927341|585201415|FG000|Phase 2|Lost to Follow-up|0|||
162039040|NCT01927341|585201416|FG001|Phase 2|Lost to Follow-up|1|||
162039041|NCT01927341|585201417|FG002|Phase 2|Lost to Follow-up|0|||
162039042|NCT01927341|585201418|FG003|Phase 2|Lost to Follow-up|0|||
162039043|NCT01927341|585201419|FG004|Phase 2|Lost to Follow-up|0|||
162039044|NCT01927341|585201415|FG000|Phase 2|Participant withdrew consent|0|||
162039045|NCT01927341|585201416|FG001|Phase 2|Participant withdrew consent|2|||
162039046|NCT01927341|585201417|FG002|Phase 2|Participant withdrew consent|1|||
162039047|NCT01927341|585201418|FG003|Phase 2|Participant withdrew consent|2|||
162039048|NCT01927341|585201419|FG004|Phase 2|Participant withdrew consent|3|||
162039049|NCT01927341|585201415|FG000|Phase 2|Death|0|||
162039050|NCT01927341|585201416|FG001|Phase 2|Death|4|||
162039051|NCT01927341|585201417|FG002|Phase 2|Death|0|||
162039052|NCT01927341|585201418|FG003|Phase 2|Death|3|||
162039053|NCT01927341|585201419|FG004|Phase 2|Death|2|||
162039054|NCT01927341|585201415|FG000|Phase 2|New cancer therapy|0|||
162039055|NCT01927341|585201416|FG001|Phase 2|New cancer therapy|1|||
162039056|NCT01927341|585201417|FG002|Phase 2|New cancer therapy|0|||
162039057|NCT01927341|585201418|FG003|Phase 2|New cancer therapy|4|||
162039058|NCT01927341|585201419|FG004|Phase 2|New cancer therapy|1|||
162039059|NCT01927341|585201415|FG000|Phase 2|Disease progression|0|||
162039060|NCT01927341|585201416|FG001|Phase 2|Disease progression|1|||
162039061|NCT01927341|585201417|FG002|Phase 2|Disease progression|1|||
162039062|NCT01927341|585201418|FG003|Phase 2|Disease progression|1|||
162039063|NCT01927341|585201419|FG004|Phase 2|Disease progression|0|||
162039064|NCT01927341|585201415|FG000|Phase 2|Follow-up completed|0|||
161891826|NCT01421147|584651517|FG001|Extension Period|Withdrawal by Subject|3|||
161891827|NCT00582426|584651518|FG000|Overall Study|Lost to Follow-up|0|||
161891828|NCT00582426|584651519|FG001|Overall Study|Lost to Follow-up|2|||
161891829|NCT00582426|584651518|FG000|Overall Study|Adverse Event|4|||
161891830|NCT00582426|584651519|FG001|Overall Study|Adverse Event|2|||
161891831|NCT00582426|584651518|FG000|Overall Study|Protocol Violation|6|||
161891832|NCT00582426|584651519|FG001|Overall Study|Protocol Violation|2|||
161891833|NCT00582426|584651518|FG000|Overall Study|Death|4|||
161891834|NCT00582426|584651519|FG001|Overall Study|Death|3|||
161891835|NCT00582426|584651518|FG000|Overall Study|Withdrawal by Subject|3|||
161891836|NCT00582426|584651519|FG001|Overall Study|Withdrawal by Subject|2|||
161891837|NCT00582426|584651518|FG000|Overall Study|Disease Progression|2|||
161891838|NCT00582426|584651519|FG001|Overall Study|Disease Progression|2|||
161891839|NCT00582426|584651518|FG000|Overall Study|Use of illicit drugs|1|||
161891840|NCT00582426|584651519|FG001|Overall Study|Use of illicit drugs|0|||
161891841|NCT04727528|584651522|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
161891842|NCT04727528|584651523|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
161891843|NCT04727528|584651522|FG000|Open-label Period|Randomized who did not receive treatment|1|||
161891844|NCT04727528|584651523|FG001|Open-label Period|Randomized who did not receive treatment|0|||
161891845|NCT04727528|584651522|FG000|Double-blind Treatment Phase|Adverse Event|0|||
161891846|NCT04727528|584651523|FG001|Double-blind Treatment Phase|Adverse Event|1|||
161891847|NCT04727528|584651522|FG000|Double-blind Treatment Phase|Death|0|||
161891848|NCT04727528|584651523|FG001|Double-blind Treatment Phase|Death|1|||
161891849|NCT04727528|584651522|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
161891850|NCT04727528|584651523|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
161891851|NCT04727528|584651522|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
161891852|NCT04727528|584651523|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
161891853|NCT04727528|584651522|FG000|Double-blind Treatment Phase|Physician Decision|0|||
161891854|NCT04727528|584651523|FG001|Double-blind Treatment Phase|Physician Decision|1|||
161891855|NCT04727528|584651522|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
161891856|NCT04727528|584651523|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161891857|NCT01964989|584651527|FG000|Overall Study|Protocol Violation|3|||
161891858|NCT01964989|584651528|FG001|Overall Study|Protocol Violation|4|||
161891859|NCT01964989|584651527|FG000|Overall Study|Administrative Reason|103|||
161891860|NCT01964989|584651528|FG001|Overall Study|Administrative Reason|95|||
161891861|NCT01964989|584651527|FG000|Overall Study|Adverse Event|0|||
161891862|NCT01964989|584651528|FG001|Overall Study|Adverse Event|1|||
161995301|NCT00103740|585032362|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
161995302|NCT00103740|585032361|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
161995303|NCT00103740|585032362|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
161995304|NCT00103740|585032361|FG000|Period 2 - Extended Observation Period|Death|6|||
161995305|NCT00103740|585032362|FG001|Period 2 - Extended Observation Period|Death|2|||
161995306|NCT00103740|585032361|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
161995307|NCT00103740|585032362|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
161995308|NCT03691571|585032363|FG000|Overall Study|Withdrawal by Subject|9|||
161995309|NCT03691571|585032364|FG001|Overall Study|Withdrawal by Subject|2|||
161995310|NCT01463306|585032365|FG000|Overall Study|Adverse Event|6|||
161995311|NCT01463306|585032366|FG001|Overall Study|Adverse Event|9|||
161995312|NCT01463306|585032367|FG002|Overall Study|Adverse Event|3|||
161995313|NCT01463306|585032365|FG000|Overall Study|Death|3|||
161995314|NCT01463306|585032366|FG001|Overall Study|Death|3|||
161995315|NCT01463306|585032367|FG002|Overall Study|Death|0|||
161995316|NCT01463306|585032365|FG000|Overall Study|Lack of Efficacy|22|||
161995317|NCT01463306|585032366|FG001|Overall Study|Lack of Efficacy|16|||
161995318|NCT01463306|585032367|FG002|Overall Study|Lack of Efficacy|1|||
161995319|NCT01463306|585032365|FG000|Overall Study|Lost to Follow-up|5|||
161995320|NCT01463306|585032366|FG001|Overall Study|Lost to Follow-up|2|||
161995321|NCT01463306|585032367|FG002|Overall Study|Lost to Follow-up|0|||
161995322|NCT01463306|585032365|FG000|Overall Study|Protocol Violation|4|||
161995323|NCT01463306|585032366|FG001|Overall Study|Protocol Violation|0|||
161995324|NCT01463306|585032367|FG002|Overall Study|Protocol Violation|0|||
161995325|NCT01463306|585032365|FG000|Overall Study|Withdrawal by Subject|19|||
161995326|NCT01463306|585032366|FG001|Overall Study|Withdrawal by Subject|9|||
161995327|NCT01463306|585032367|FG002|Overall Study|Withdrawal by Subject|1|||
161995328|NCT01463306|585032365|FG000|Overall Study|Other|26|||
161995329|NCT01463306|585032366|FG001|Overall Study|Other|13|||
161995330|NCT01463306|585032367|FG002|Overall Study|Other|0|||
161995331|NCT01463306|585032365|FG000|Overall Study|Approval expiry at site|1|||
161995332|NCT01463306|585032366|FG001|Overall Study|Approval expiry at site|0|||
161995333|NCT01463306|585032367|FG002|Overall Study|Approval expiry at site|0|||
161995334|NCT00250276|585032372|FG000|Overall Study|Serious Adverse Event|0|||
161891863|NCT01964989|584651527|FG000|Overall Study|Death|1|||
161891864|NCT01964989|584651528|FG001|Overall Study|Death|3|||
161891865|NCT01964989|584651527|FG000|Overall Study|Withdrawal by Subject|156|||
161891866|NCT01964989|584651528|FG001|Overall Study|Withdrawal by Subject|160|||
161891867|NCT01964989|584651527|FG000|Overall Study|Lost to Follow-up|254|||
161891868|NCT01964989|584651528|FG001|Overall Study|Lost to Follow-up|232|||
161891869|NCT01964989|584651527|FG000|Overall Study|Other|267|||
161891870|NCT01964989|584651528|FG001|Overall Study|Other|252|||
161891871|NCT02769312|584651529|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
161891872|NCT02769312|584651530|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
161891873|NCT02769312|584651529|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
161891874|NCT02769312|584651530|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
161891875|NCT02769312|584651529|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
161891876|NCT02769312|584651530|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
161891877|NCT02769312|584651529|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
161891878|NCT02769312|584651530|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
161891879|NCT02769312|584651529|FG000|Follow-up|Lost to Follow-up|1|||
161891880|NCT02769312|584651530|FG001|Follow-up|Lost to Follow-up|1|||
161891881|NCT01148459|584651533|FG000|Overall Study|Serious Adverse Event|5|||
161891882|NCT01148459|584651534|FG001|Overall Study|Serious Adverse Event|4|||
161891883|NCT01148459|584651533|FG000|Overall Study|Withdrawal by Subject|1|||
161891884|NCT01148459|584651534|FG001|Overall Study|Withdrawal by Subject|0|||
161891885|NCT01148459|584651533|FG000|Overall Study|Migrated/moved from study area|3|||
161891886|NCT01148459|584651534|FG001|Overall Study|Migrated/moved from study area|6|||
161891887|NCT01148459|584651533|FG000|Overall Study|Lost to Follow-up|2|||
161891888|NCT01148459|584651534|FG001|Overall Study|Lost to Follow-up|0|||
161891889|NCT01148459|584651533|FG000|Overall Study|Refusal|1|||
161891890|NCT01148459|584651534|FG001|Overall Study|Refusal|0|||
161891891|NCT01148459|584651533|FG000|Overall Study|Failure to comply with study procedures|0|||
161891892|NCT01148459|584651534|FG001|Overall Study|Failure to comply with study procedures|1|||
161891893|NCT02496039|584651535|FG000|Overall Study|Adverse Event|3|||
161891894|NCT02496039|584651535|FG000|Overall Study|Protocol Violation|1|||
161891895|NCT00948922|584651536|FG000|Overall Study|Did not start study treatment|2|||
161891896|NCT00948922|584651537|FG001|Overall Study|Did not start study treatment|5|||
161891897|NCT00948922|584651538|FG002|Overall Study|Did not start study treatment|0|||
161891898|NCT00948922|584651536|FG000|Overall Study|Withdrawal by Subject|0|||
161891899|NCT00948922|584651537|FG001|Overall Study|Withdrawal by Subject|2|||
161891900|NCT00948922|584651538|FG002|Overall Study|Withdrawal by Subject|1|||
161891901|NCT00948922|584651536|FG000|Overall Study|Death|3|||
161891902|NCT00948922|584651537|FG001|Overall Study|Death|0|||
161891903|NCT00948922|584651538|FG002|Overall Study|Death|0|||
161891904|NCT00948922|584651536|FG000|Overall Study|Disease progression|0|||
161891905|NCT00948922|584651537|FG001|Overall Study|Disease progression|1|||
161891906|NCT00948922|584651538|FG002|Overall Study|Disease progression|0|||
161891907|NCT00948922|584651536|FG000|Overall Study|Insurance issues|1|||
161891908|NCT00948922|584651537|FG001|Overall Study|Insurance issues|0|||
161891909|NCT00948922|584651538|FG002|Overall Study|Insurance issues|0|||
161891910|NCT00948922|584651536|FG000|Overall Study|Transplant eligibility issues|2|||
161891911|NCT00948922|584651537|FG001|Overall Study|Transplant eligibility issues|3|||
161891912|NCT00948922|584651538|FG002|Overall Study|Transplant eligibility issues|0|||
161891913|NCT00948922|584651536|FG000|Overall Study|Not evaluable at time of analysis|0|||
161891914|NCT00948922|584651537|FG001|Overall Study|Not evaluable at time of analysis|3|||
161891915|NCT00948922|584651538|FG002|Overall Study|Not evaluable at time of analysis|0|||
161891916|NCT04854057|584651539|FG000|Overall Study|Adverse Event|0|||
161891917|NCT04854057|584651540|FG001|Overall Study|Adverse Event|1|||
161891918|NCT02131233|584651541|FG000|Overall Study|Not Treated|2|||
161995335|NCT00250276|585032373|FG001|Overall Study|Serious Adverse Event|0|||
161995336|NCT00250276|585032374|FG002|Overall Study|Serious Adverse Event|1|||
161995337|NCT00250276|585032375|FG003|Overall Study|Serious Adverse Event|0|||
161995338|NCT00250276|585032372|FG000|Overall Study|Non-serious Adverse Event|2|||
161995339|NCT00250276|585032373|FG001|Overall Study|Non-serious Adverse Event|0|||
161995340|NCT00250276|585032374|FG002|Overall Study|Non-serious Adverse Event|0|||
161995341|NCT00250276|585032375|FG003|Overall Study|Non-serious Adverse Event|2|||
161995342|NCT00250276|585032372|FG000|Overall Study|Protocol Violation|0|||
161995343|NCT00250276|585032373|FG001|Overall Study|Protocol Violation|1|||
161995344|NCT00250276|585032374|FG002|Overall Study|Protocol Violation|0|||
161995345|NCT00250276|585032375|FG003|Overall Study|Protocol Violation|0|||
161995346|NCT00250276|585032372|FG000|Overall Study|Withdrawal by Subject|1|||
161995347|NCT00250276|585032373|FG001|Overall Study|Withdrawal by Subject|2|||
161891919|NCT02131233|584651542|FG001|Overall Study|Not Treated|3|||
161891920|NCT02131233|584651541|FG000|Overall Study|Adverse Event|7|||
161891921|NCT02131233|584651542|FG001|Overall Study|Adverse Event|6|||
161891922|NCT02131233|584651541|FG000|Overall Study|Death|0|||
161891923|NCT02131233|584651542|FG001|Overall Study|Death|1|||
161891924|NCT02131233|584651541|FG000|Overall Study|Lack of Efficacy|6|||
161891925|NCT02131233|584651542|FG001|Overall Study|Lack of Efficacy|3|||
161891926|NCT02131233|584651541|FG000|Overall Study|Lost to Follow-up|14|||
161891927|NCT02131233|584651542|FG001|Overall Study|Lost to Follow-up|13|||
161891928|NCT02131233|584651541|FG000|Overall Study|Non-Compliance With Study Drug|8|||
161891929|NCT02131233|584651542|FG001|Overall Study|Non-Compliance With Study Drug|5|||
161891930|NCT02131233|584651541|FG000|Overall Study|Physician Decision|7|||
161891931|NCT02131233|584651542|FG001|Overall Study|Physician Decision|0|||
161891932|NCT02131233|584651541|FG000|Overall Study|Pregnancy|4|||
161891933|NCT02131233|584651542|FG001|Overall Study|Pregnancy|0|||
161891934|NCT02131233|584651541|FG000|Overall Study|Withdrawal by Subject|18|||
161891935|NCT02131233|584651542|FG001|Overall Study|Withdrawal by Subject|11|||
161891936|NCT05114564|584651544|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
161891937|NCT05114564|584651545|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
161891938|NCT05114564|584651544|FG000|First Intervention|Adverse Event|0|||
161891939|NCT05114564|584651545|FG001|First Intervention|Adverse Event|1|||
161891940|NCT00255840|584651546|FG000|Overall Study|Lost to Follow-up|10|||
161891941|NCT00255840|584651547|FG001|Overall Study|Lost to Follow-up|14|||
161891942|NCT00255840|584651546|FG000|Overall Study|Discontinued intervention|53|||
161891943|NCT00255840|584651547|FG001|Overall Study|Discontinued intervention|56|||
161891944|NCT01280682|584651548|FG000|Overall Study|Lost to Follow-up|0|||
161891945|NCT01280682|584651549|FG001|Overall Study|Lost to Follow-up|6|||
161891946|NCT01280682|584651548|FG000|Overall Study|Withdrawal by Subject|0|||
161891947|NCT01280682|584651549|FG001|Overall Study|Withdrawal by Subject|7|||
161891948|NCT00431067|584651555|FG000|Overall Study|Other Adverse Event|9|||
161891949|NCT00431067|584651555|FG000|Overall Study|Progressive disease|30|||
161891950|NCT00431067|584651555|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
161891951|NCT00548249|584651556|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
161891952|NCT00548249|584651557|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
161891953|NCT00548249|584651558|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
161891954|NCT00548249|584651559|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
161891955|NCT00548249|584651560|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
161891956|NCT00548249|584651556|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
161891957|NCT00548249|584651557|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
161891958|NCT00548249|584651558|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
161891959|NCT00548249|584651559|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
161891960|NCT00548249|584651560|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
161891961|NCT00548249|584651556|FG000|Overall Study|Protocol Violation|1|||
161891962|NCT00548249|584651557|FG001|Overall Study|Protocol Violation|1|||
161891963|NCT00548249|584651558|FG002|Overall Study|Protocol Violation|4|||
161891964|NCT00548249|584651559|FG003|Overall Study|Protocol Violation|0|||
161891965|NCT00548249|584651560|FG004|Overall Study|Protocol Violation|3|||
161891966|NCT00548249|584651556|FG000|Overall Study|Miscellaneous|2|||
161891967|NCT00548249|584651557|FG001|Overall Study|Miscellaneous|3|||
161891968|NCT00548249|584651558|FG002|Overall Study|Miscellaneous|2|||
161891969|NCT00548249|584651559|FG003|Overall Study|Miscellaneous|0|||
161891970|NCT00548249|584651560|FG004|Overall Study|Miscellaneous|2|||
161891971|NCT00548249|584651556|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
161891972|NCT00548249|584651557|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
161891973|NCT00548249|584651558|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
161891974|NCT00548249|584651559|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
161891975|NCT00548249|584651560|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
161891976|NCT00548249|584651556|FG000|Overall Study|Adverse Event|2|||
161891977|NCT00548249|584651557|FG001|Overall Study|Adverse Event|2|||
161995348|NCT00250276|585032374|FG002|Overall Study|Withdrawal by Subject|3|||
161995349|NCT00250276|585032375|FG003|Overall Study|Withdrawal by Subject|2|||
161995350|NCT00250276|585032372|FG000|Overall Study|Migrated/moved from study area|3|||
161995351|NCT00250276|585032373|FG001|Overall Study|Migrated/moved from study area|0|||
161995352|NCT00250276|585032374|FG002|Overall Study|Migrated/moved from study area|2|||
161995353|NCT00250276|585032375|FG003|Overall Study|Migrated/moved from study area|7|||
161995354|NCT00250276|585032372|FG000|Overall Study|Lost to Follow-up|11|||
161995355|NCT00250276|585032373|FG001|Overall Study|Lost to Follow-up|18|||
161995356|NCT00250276|585032374|FG002|Overall Study|Lost to Follow-up|13|||
161995357|NCT00250276|585032375|FG003|Overall Study|Lost to Follow-up|8|||
161995358|NCT01479868|585034045|FG000|Overall Study|Adverse Event|1|||
161995359|NCT01479868|585034045|FG000|Overall Study|Lost to Follow-up|4|||
161995360|NCT01479868|585034045|FG000|Overall Study|Protocol Violation|1|||
161995361|NCT01479868|585034045|FG000|Overall Study|Withdrawal by Subject|1|||
161891978|NCT00548249|584651558|FG002|Overall Study|Adverse Event|0|||
161891979|NCT00548249|584651559|FG003|Overall Study|Adverse Event|1|||
161891980|NCT00548249|584651560|FG004|Overall Study|Adverse Event|1|||
161891981|NCT00548249|584651556|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
161891982|NCT00548249|584651557|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
161891983|NCT00548249|584651558|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
161891984|NCT00548249|584651559|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
161891985|NCT00548249|584651560|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
161891986|NCT00548249|584651556|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
161995362|NCT01479868|585034045|FG000|Overall Study|Sponsor's Decision|1|||
161995363|NCT01479868|585034045|FG000|Overall Study|Initiation of new HCV Therapy|1|||
161995364|NCT01618669|585034046|FG000|Overall Study|Lost to Follow-up|1|||
161891987|NCT00548249|584651557|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
161891988|NCT00548249|584651558|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
161891989|NCT00548249|584651559|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
161891990|NCT00548249|584651560|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
161891991|NCT00548249|584651556|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
161891992|NCT00548249|584651557|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
161891993|NCT00548249|584651558|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
161891994|NCT00548249|584651559|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
161891995|NCT00548249|584651560|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
161891996|NCT00548249|584651556|FG000|Overall Study|Prolonged hospitalization|0|||
161891997|NCT00548249|584651557|FG001|Overall Study|Prolonged hospitalization|0|||
161891998|NCT00548249|584651558|FG002|Overall Study|Prolonged hospitalization|2|||
161891999|NCT00548249|584651559|FG003|Overall Study|Prolonged hospitalization|1|||
161892000|NCT00548249|584651560|FG004|Overall Study|Prolonged hospitalization|0|||
161892001|NCT00548249|584651556|FG000|Overall Study|Withdrawal by Subject|2|||
161892002|NCT00548249|584651557|FG001|Overall Study|Withdrawal by Subject|0|||
161892003|NCT00548249|584651558|FG002|Overall Study|Withdrawal by Subject|0|||
161892004|NCT00548249|584651559|FG003|Overall Study|Withdrawal by Subject|0|||
161892005|NCT00548249|584651560|FG004|Overall Study|Withdrawal by Subject|0|||
161892006|NCT00548249|584651556|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
161892007|NCT00548249|584651557|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
161892008|NCT00548249|584651558|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
161892009|NCT00548249|584651559|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
161892010|NCT00548249|584651560|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
161892011|NCT00548249|584651556|FG000|Overall Study|Sponsor's request|0|||
161892012|NCT00548249|584651557|FG001|Overall Study|Sponsor's request|0|||
161892013|NCT00548249|584651558|FG002|Overall Study|Sponsor's request|0|||
161892014|NCT00548249|584651559|FG003|Overall Study|Sponsor's request|1|||
161892015|NCT00548249|584651560|FG004|Overall Study|Sponsor's request|0|||
161892016|NCT00080483|584651562|FG000|Overall Study|Lost to Follow-up|1|||
161892017|NCT00080483|584651563|FG001|Overall Study|Lost to Follow-up|1|||
161892018|NCT00080483|584651562|FG000|Overall Study|Physician Decision|1|||
161892019|NCT00080483|584651563|FG001|Overall Study|Physician Decision|1|||
161892020|NCT01380691|584651573|FG000|Washout (7 Days)|Protocol Violation|0|||
161995365|NCT01618669|585034047|FG001|Overall Study|Lost to Follow-up|1|||
161995366|NCT01618669|585034046|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
161995367|NCT01618669|585034047|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
161995368|NCT01618669|585034046|FG000|Overall Study|Adverse Event|16|||
161995369|NCT01618669|585034047|FG001|Overall Study|Adverse Event|7|||
161995370|NCT01618669|585034046|FG000|Overall Study|Protocol Violation|5|||
161995371|NCT01618669|585034047|FG001|Overall Study|Protocol Violation|3|||
161995372|NCT01618669|585034046|FG000|Overall Study|Withdrawal by Subject|9|||
161995373|NCT01618669|585034047|FG001|Overall Study|Withdrawal by Subject|9|||
161995374|NCT01618669|585034046|FG000|Overall Study|Miscellaneous Reason|0|||
161995375|NCT01618669|585034047|FG001|Overall Study|Miscellaneous Reason|1|||
161995376|NCT01508169|585034048|FG000|Overall Study|Adverse Event|1|||
161995377|NCT01508169|585034049|FG001|Overall Study|Adverse Event|0|||
161995378|NCT01508169|585034048|FG000|Overall Study|Withdrawal by Subject|1|||
161995379|NCT01508169|585034049|FG001|Overall Study|Withdrawal by Subject|0|||
161995380|NCT01508169|585034048|FG000|Overall Study|Lost to Follow-up|1|||
161995381|NCT01508169|585034049|FG001|Overall Study|Lost to Follow-up|2|||
161995382|NCT03600740|585034058|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
161995383|NCT02721875|585034063|FG000|Overall Study|Progressive disease/relapse|1|||
161995384|NCT02721875|585034064|FG001|Overall Study|Progressive disease/relapse|0|||
161995385|NCT02888106|585034065|FG000|Overall Study|Withdrawal by Subject|1|||
161995386|NCT02888106|585034066|FG001|Overall Study|Withdrawal by Subject|2|||
161995387|NCT02888106|585034067|FG002|Overall Study|Withdrawal by Subject|0|||
161995388|NCT02888106|585034068|FG003|Overall Study|Withdrawal by Subject|1|||
161995389|NCT02888106|585034069|FG004|Overall Study|Withdrawal by Subject|0|||
161995390|NCT02888106|585034070|FG005|Overall Study|Withdrawal by Subject|0|||
161892021|NCT01380691|584651574|FG001|Washout (7 Days)|Protocol Violation|0|||
161892022|NCT01380691|584651575|FG002|Washout (7 Days)|Protocol Violation|0|||
161892023|NCT01380691|584651576|FG003|Washout (7 Days)|Protocol Violation|1|||
161995391|NCT02888106|585034065|FG000|Overall Study|Lost to Follow-up|1|||
161995392|NCT02888106|585034066|FG001|Overall Study|Lost to Follow-up|0|||
161995393|NCT02888106|585034067|FG002|Overall Study|Lost to Follow-up|0|||
161892024|NCT01380691|584651573|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
161892025|NCT01380691|584651574|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
161892026|NCT01380691|584651575|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
161892027|NCT01380691|584651576|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
161892028|NCT03084315|584651580|FG000|Overall Study|Lost to Follow-up|8|||
161995394|NCT02888106|585034068|FG003|Overall Study|Lost to Follow-up|1|||
161995395|NCT02888106|585034069|FG004|Overall Study|Lost to Follow-up|0|||
161995396|NCT02888106|585034070|FG005|Overall Study|Lost to Follow-up|1|||
161995397|NCT02888106|585034065|FG000|Overall Study|Adverse Event|2|||
161892029|NCT03084315|584651581|FG001|Overall Study|Lost to Follow-up|7|||
161892030|NCT03084315|584651580|FG000|Overall Study|Withdrawal by Subject|2|||
161892031|NCT03084315|584651581|FG001|Overall Study|Withdrawal by Subject|2|||
161892032|NCT04424914|584651582|FG000|Overall Study|Other|0|||
161892033|NCT04424914|584651583|FG001|Overall Study|Other|0|||
161892034|NCT04424914|584651584|FG002|Overall Study|Other|28|||
161892035|NCT04424914|584651582|FG000|Overall Study|Withdrawal by Subject|3|||
161892036|NCT04424914|584651583|FG001|Overall Study|Withdrawal by Subject|0|||
161892037|NCT04424914|584651584|FG002|Overall Study|Withdrawal by Subject|0|||
161892038|NCT04424914|584651582|FG000|Overall Study|Study terminated by sponsor|23|||
161892039|NCT04424914|584651583|FG001|Overall Study|Study terminated by sponsor|7|||
161892040|NCT04424914|584651584|FG002|Overall Study|Study terminated by sponsor|0|||
161892041|NCT04424914|584651582|FG000|Overall Study|Lost to Follow-up|0|||
161892042|NCT04424914|584651583|FG001|Overall Study|Lost to Follow-up|0|||
161892043|NCT04424914|584651584|FG002|Overall Study|Lost to Follow-up|1|||
161892044|NCT04424914|584651582|FG000|Overall Study|Death|3|||
161892045|NCT04424914|584651583|FG001|Overall Study|Death|1|||
161892046|NCT04424914|584651584|FG002|Overall Study|Death|0|||
161892047|NCT00460746|584651587|FG000|Overall Study|Adverse Event|1|||
161892048|NCT00460746|584651587|FG000|Overall Study|Lost to Follow-up|1|||
161892049|NCT00394771|584651590|FG000|Overall Study|Did not meet protocol requirements|1|||
161892050|NCT00394771|584651591|FG001|Overall Study|Did not meet protocol requirements|0|||
161892051|NCT00394771|584651592|FG002|Overall Study|Did not meet protocol requirements|2|||
161892052|NCT00394771|584651593|FG003|Overall Study|Did not meet protocol requirements|0|||
161892053|NCT00394771|584651590|FG000|Overall Study|Protocol Violation|2|||
161892054|NCT00394771|584651591|FG001|Overall Study|Protocol Violation|4|||
161892055|NCT00394771|584651592|FG002|Overall Study|Protocol Violation|9|||
161892056|NCT00394771|584651593|FG003|Overall Study|Protocol Violation|7|||
161892057|NCT00394771|584651590|FG000|Overall Study|Withdrawal by Subject|10|||
161892058|NCT00394771|584651591|FG001|Overall Study|Withdrawal by Subject|6|||
161892059|NCT00394771|584651592|FG002|Overall Study|Withdrawal by Subject|8|||
161892060|NCT00394771|584651593|FG003|Overall Study|Withdrawal by Subject|12|||
161892061|NCT00394771|584651590|FG000|Overall Study|Adverse Event|10|||
161892062|NCT00394771|584651591|FG001|Overall Study|Adverse Event|5|||
161892063|NCT00394771|584651592|FG002|Overall Study|Adverse Event|12|||
161892064|NCT00394771|584651593|FG003|Overall Study|Adverse Event|8|||
161892065|NCT00394771|584651590|FG000|Overall Study|Participant pregnant|0|||
161892066|NCT00394771|584651591|FG001|Overall Study|Participant pregnant|1|||
161892067|NCT00394771|584651592|FG002|Overall Study|Participant pregnant|2|||
161892068|NCT00394771|584651593|FG003|Overall Study|Participant pregnant|2|||
161892069|NCT00394771|584651590|FG000|Overall Study|Lost to Follow-up|15|||
161892070|NCT00394771|584651591|FG001|Overall Study|Lost to Follow-up|15|||
161892071|NCT00394771|584651592|FG002|Overall Study|Lost to Follow-up|13|||
161892072|NCT00394771|584651593|FG003|Overall Study|Lost to Follow-up|10|||
161892073|NCT00394771|584651590|FG000|Overall Study|Other|3|||
161892074|NCT00394771|584651591|FG001|Overall Study|Other|3|||
161892075|NCT00394771|584651592|FG002|Overall Study|Other|1|||
161892076|NCT00394771|584651593|FG003|Overall Study|Other|0|||
161892077|NCT02906033|584651595|FG000|Baseline|Protocol Violation|37|||
161892078|NCT02906033|584651596|FG001|Baseline|Protocol Violation|33|||
161892079|NCT02906033|584651595|FG000|Follow-up|Lost to Follow-up|46|||
161892080|NCT02906033|584651596|FG001|Follow-up|Lost to Follow-up|62|||
161892081|NCT00358956|584651597|FG000|Overall Study|Adverse Event|3|||
161892082|NCT00358956|584651597|FG000|Overall Study|condition under investigation worsened|4|||
161892083|NCT00358956|584651597|FG000|Overall Study|Withdrawal by Subject|1|||
161892084|NCT03417024|584651600|FG000|Overall Study|Study Termination prior to follow-up|11|||
161892085|NCT03417024|584651600|FG000|Overall Study|Physician Decision|2|||
161892086|NCT02195427|584651601|FG000|Overall Study|Did not consent to study extension|13|||
161892087|NCT02195427|584651602|FG001|Overall Study|Did not consent to study extension|9|||
161892088|NCT02195427|584651601|FG000|Overall Study|Withdrawal by Subject|4|||
161892089|NCT02195427|584651602|FG001|Overall Study|Withdrawal by Subject|2|||
161892090|NCT02195427|584651601|FG000|Overall Study|Lost to Follow-up|0|||
161892091|NCT02195427|584651602|FG001|Overall Study|Lost to Follow-up|1|||
161892092|NCT02195427|584651601|FG000|Overall Study|Protocol Violation|7|||
162039065|NCT01927341|585201416|FG001|Phase 2|Follow-up completed|6|||
161892093|NCT02195427|584651602|FG001|Overall Study|Protocol Violation|14|||
161892094|NCT02195427|584651601|FG000|Overall Study|Conditional re-treatment at W52|2|||
161892095|NCT02195427|584651602|FG001|Overall Study|Conditional re-treatment at W52|1|||
161892096|NCT00386425|584651603|FG000|Overall Study|Physician Decision|3|||
161892097|NCT00386425|584651604|FG001|Overall Study|Physician Decision|0|||
161892098|NCT00386425|584651605|FG002|Overall Study|Physician Decision|0|||
161892099|NCT00386425|584651603|FG000|Overall Study|Withdrawal by Subject|0|||
161892100|NCT00386425|584651604|FG001|Overall Study|Withdrawal by Subject|1|||
161892101|NCT00386425|584651605|FG002|Overall Study|Withdrawal by Subject|0|||
161892102|NCT03782974|584651608|FG000|Overall Study|Withdrawal by Subject|7|||
161892103|NCT03782974|584651609|FG001|Overall Study|Withdrawal by Subject|7|||
161892104|NCT03782974|584651608|FG000|Overall Study|Pregnancy|1|||
161892105|NCT03782974|584651609|FG001|Overall Study|Pregnancy|0|||
161892106|NCT01907217|584651610|FG000|Overall Study|Withdrawal by Subject|0|||
161892107|NCT01907217|584651611|FG001|Overall Study|Withdrawal by Subject|2|||
161892108|NCT04607980|584651617|FG000|Overall Study|Adverse Event|3|||
161892109|NCT04607980|584651618|FG001|Overall Study|Adverse Event|4|||
161892110|NCT04607980|584651617|FG000|Overall Study|Death|0|||
161892111|NCT04607980|584651618|FG001|Overall Study|Death|1|||
161892112|NCT04607980|584651617|FG000|Overall Study|Withdrawal by Subject|2|||
161892113|NCT04607980|584651618|FG001|Overall Study|Withdrawal by Subject|5|||
161892114|NCT04607980|584651617|FG000|Overall Study|Lost to Follow-up|4|||
161892115|NCT04607980|584651618|FG001|Overall Study|Lost to Follow-up|8|||
161892116|NCT04607980|584651617|FG000|Overall Study|Protocol Violation|0|||
161892117|NCT04607980|584651618|FG001|Overall Study|Protocol Violation|3|||
161892118|NCT04607980|584651617|FG000|Overall Study|Other|3|||
161892119|NCT04607980|584651618|FG001|Overall Study|Other|0|||
161892120|NCT00448812|584651619|FG000|Year 2|Missed visit but remained in study|4|||
161892121|NCT00448812|584651620|FG001|Year 2|Missed visit but remained in study|1|||
161892122|NCT00448812|584651619|FG000|Year 3|Withdrawal by Subject|1|||
161892123|NCT00448812|584651620|FG001|Year 3|Withdrawal by Subject|3|||
161892124|NCT00448812|584651619|FG000|Year 3|Lost to Follow-up|1|||
161892125|NCT00448812|584651620|FG001|Year 3|Lost to Follow-up|0|||
161892126|NCT00448812|584651619|FG000|Year 3|Missed visit but remained in study|2|||
161892127|NCT00448812|584651620|FG001|Year 3|Missed visit but remained in study|0|||
161892128|NCT00448812|584651619|FG000|Year 5|Missed visit but remained in study|1|||
161892129|NCT00448812|584651620|FG001|Year 5|Missed visit but remained in study|0|||
161892130|NCT02012959|584651621|FG000|Treatment Phase A|Adverse Event|2|||
161892131|NCT02012959|584651622|FG001|Treatment Phase A|Adverse Event|0|||
161892132|NCT02012959|584651623|FG002|Treatment Phase A|Adverse Event|0|||
161892133|NCT02012959|584651624|FG003|Treatment Phase A|Adverse Event|0|||
161892134|NCT02012959|584651625|FG004|Treatment Phase A|Adverse Event|0|||
161892135|NCT04985942|584653148|FG000|Overall Study|Adverse Event|14|||
161892136|NCT04985942|584653149|FG001|Overall Study|Adverse Event|2|||
161892137|NCT04985942|584653148|FG000|Overall Study|Lack of Efficacy|0|||
161892138|NCT04985942|584653149|FG001|Overall Study|Lack of Efficacy|3|||
161892139|NCT04985942|584653148|FG000|Overall Study|Lost to Follow-up|1|||
161892140|NCT04985942|584653149|FG001|Overall Study|Lost to Follow-up|1|||
161892141|NCT04985942|584653148|FG000|Overall Study|Protocol Violation|1|||
161892142|NCT04985942|584653149|FG001|Overall Study|Protocol Violation|1|||
161892143|NCT04985942|584653148|FG000|Overall Study|Withdrawal by Subject|5|||
161892144|NCT04985942|584653149|FG001|Overall Study|Withdrawal by Subject|4|||
161892145|NCT00171158|584653150|FG000|Core Study|Death|27|||
161892146|NCT00171158|584653150|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
161892147|NCT00171158|584653150|FG000|Core Study|Protocol Violation|4|||
161892148|NCT00171158|584653150|FG000|Core Study|Administrative problems|1|||
161892149|NCT00171158|584653150|FG000|Core Study|Adverse event, non-fatal|21|||
161892150|NCT00171158|584653150|FG000|Core Study|Consent withdrawn by subject|6|||
161892151|NCT00171158|584653150|FG000|Core Study|No longer required drug (BMT)|14|||
161892152|NCT00171158|584653150|FG000|Core Study|Abnormal Laboratory Values|2|||
161892153|NCT00171158|584653150|FG000|Core Study|Lost to Follow-up|1|||
161892154|NCT00171158|584653150|FG000|E2 Extension|Other|7|||
161892155|NCT03630705|584653151|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
161892156|NCT03630705|584653152|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
161892157|NCT03630705|584653153|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
161892158|NCT03630705|584653154|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161892159|NCT03630705|584653151|FG000|Overall Study|Lost to Follow-up|1|||
161892160|NCT03630705|584653152|FG001|Overall Study|Lost to Follow-up|2|||
161995398|NCT02888106|585034066|FG001|Overall Study|Adverse Event|0|||
161995399|NCT02888106|585034067|FG002|Overall Study|Adverse Event|0|||
161995400|NCT02888106|585034068|FG003|Overall Study|Adverse Event|0|||
161995401|NCT02888106|585034069|FG004|Overall Study|Adverse Event|0|||
161995402|NCT02888106|585034070|FG005|Overall Study|Adverse Event|0|||
161995403|NCT02888106|585034065|FG000|Overall Study|Withdrawal of consent|0|||
161995404|NCT02888106|585034066|FG001|Overall Study|Withdrawal of consent|0|||
161995405|NCT02888106|585034067|FG002|Overall Study|Withdrawal of consent|0|||
161995406|NCT02888106|585034068|FG003|Overall Study|Withdrawal of consent|0|||
161892161|NCT03630705|584653153|FG002|Overall Study|Lost to Follow-up|0|||
161892162|NCT03630705|584653154|FG003|Overall Study|Lost to Follow-up|0|||
161892163|NCT02757352|584653155|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
161892164|NCT02757352|584653156|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892165|NCT02757352|584653157|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
161892166|NCT02757352|584653158|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892167|NCT02757352|584653159|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892168|NCT02757352|584653160|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892169|NCT02757352|584653161|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892170|NCT02757352|584653162|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892171|NCT02757352|584653163|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161995407|NCT02888106|585034069|FG004|Overall Study|Withdrawal of consent|1|||
161995408|NCT02888106|585034070|FG005|Overall Study|Withdrawal of consent|0|||
162039066|NCT01927341|585201417|FG002|Phase 2|Follow-up completed|3|||
162039067|NCT01927341|585201418|FG003|Phase 2|Follow-up completed|5|||
162039068|NCT01927341|585201419|FG004|Phase 2|Follow-up completed|2|||
162039069|NCT00674973|585201420|FG000|Overall Study|Insufficient Therapeutic Response|77|||
162039070|NCT00674973|585201421|FG001|Overall Study|Insufficient Therapeutic Response|72|||
162039071|NCT00674973|585201420|FG000|Overall Study|Refused Treatment|1|||
162039072|NCT00674973|585201421|FG001|Overall Study|Refused Treatment|5|||
162039073|NCT00674973|585201420|FG000|Overall Study|Failure to Return|1|||
162039074|NCT00674973|585201421|FG001|Overall Study|Failure to Return|0|||
162039075|NCT00674973|585201420|FG000|Overall Study|Adverse Event|2|||
162039076|NCT00674973|585201421|FG001|Overall Study|Adverse Event|9|||
162039077|NCT00674973|585201420|FG000|Overall Study|Death|19|||
162039078|NCT00674973|585201421|FG001|Overall Study|Death|15|||
162039079|NCT00674973|585201420|FG000|Overall Study|Protocol Violation|0|||
162039080|NCT00674973|585201421|FG001|Overall Study|Protocol Violation|1|||
162039081|NCT00451451|585201422|FG000|Overall Study|Adverse Event|11|||
162039082|NCT00451451|585201423|FG001|Overall Study|Adverse Event|21|||
162039083|NCT00451451|585201424|FG002|Overall Study|Adverse Event|26|||
162039084|NCT00451451|585201425|FG003|Overall Study|Adverse Event|10|||
162039085|NCT00451451|585201422|FG000|Overall Study|Lost to Follow-up|11|||
162039086|NCT00451451|585201423|FG001|Overall Study|Lost to Follow-up|9|||
162039087|NCT00451451|585201424|FG002|Overall Study|Lost to Follow-up|8|||
162039088|NCT00451451|585201425|FG003|Overall Study|Lost to Follow-up|11|||
162039089|NCT00451451|585201422|FG000|Overall Study|Consent Withdrawn|14|||
162039090|NCT00451451|585201423|FG001|Overall Study|Consent Withdrawn|9|||
162039091|NCT00451451|585201424|FG002|Overall Study|Consent Withdrawn|17|||
162039092|NCT00451451|585201425|FG003|Overall Study|Consent Withdrawn|17|||
162039093|NCT00451451|585201422|FG000|Overall Study|Investigator Decision|6|||
162039094|NCT00451451|585201423|FG001|Overall Study|Investigator Decision|2|||
162039095|NCT00451451|585201424|FG002|Overall Study|Investigator Decision|1|||
162039096|NCT00451451|585201425|FG003|Overall Study|Investigator Decision|2|||
162039097|NCT00451451|585201422|FG000|Overall Study|Subject Non-Compliance|8|||
162039098|NCT00451451|585201423|FG001|Overall Study|Subject Non-Compliance|4|||
162039099|NCT00451451|585201424|FG002|Overall Study|Subject Non-Compliance|3|||
162039100|NCT00451451|585201425|FG003|Overall Study|Subject Non-Compliance|3|||
162039101|NCT00451451|585201422|FG000|Overall Study|Death|1|||
162039102|NCT00451451|585201423|FG001|Overall Study|Death|0|||
162039103|NCT00451451|585201424|FG002|Overall Study|Death|0|||
162039104|NCT00451451|585201425|FG003|Overall Study|Death|1|||
162039105|NCT00451451|585201422|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
162039106|NCT00451451|585201423|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
162039107|NCT00451451|585201424|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
162039108|NCT00451451|585201425|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
162039109|NCT00084838|585201428|FG000|Overall Study|Death|1|||
162039110|NCT00084838|585201428|FG000|Overall Study|Adverse Event|2|||
162039111|NCT00084838|585201428|FG000|Overall Study|Withdrawal by Subject|1|||
162039112|NCT00084838|585201428|FG000|Overall Study|Progressive Disease|4|||
162039113|NCT00084838|585201428|FG000|Overall Study|Pt Non-Compliance|1|||
162039114|NCT00084838|585201428|FG000|Overall Study|Ineligible|4|||
162039115|NCT00518687|585201429|FG000|Overall Study|Adverse Event|201|||
162039116|NCT00518687|585201430|FG001|Overall Study|Adverse Event|177|||
162039117|NCT00518687|585201429|FG000|Overall Study|Lost to Follow-up|144|||
162039118|NCT00518687|585201430|FG001|Overall Study|Lost to Follow-up|155|||
162039119|NCT00518687|585201429|FG000|Overall Study|Physician Decision|42|||
162039120|NCT00518687|585201430|FG001|Overall Study|Physician Decision|48|||
162039121|NCT00518687|585201429|FG000|Overall Study|Progressive disease|2|||
162039122|NCT00518687|585201430|FG001|Overall Study|Progressive disease|2|||
162039123|NCT00518687|585201429|FG000|Overall Study|Protocol Violation|8|||
162039124|NCT00518687|585201430|FG001|Overall Study|Protocol Violation|10|||
162039125|NCT00518687|585201429|FG000|Overall Study|Study terminated by sponsor|930|||
162039126|NCT00518687|585201430|FG001|Overall Study|Study terminated by sponsor|918|||
161892172|NCT02757352|584653164|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161892173|NCT02757352|584653155|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
162039127|NCT00518687|585201429|FG000|Overall Study|Withdrawal by Subject|110|||
162039128|NCT00518687|585201430|FG001|Overall Study|Withdrawal by Subject|110|||
162039129|NCT01442038|585201433|FG000|Overall Study|Death|35|||
162039130|NCT01442038|585201434|FG001|Overall Study|Death|29|||
162039131|NCT01442038|585201433|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
162039132|NCT01442038|585201434|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
162039133|NCT01442038|585201433|FG000|Overall Study|Participant Withdrew Consent|137|||
162039134|NCT01442038|585201434|FG001|Overall Study|Participant Withdrew Consent|102|||
161892174|NCT02757352|584653156|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
162039135|NCT01442038|585201433|FG000|Overall Study|Lost to Follow-up|37|||
162039136|NCT01442038|585201434|FG001|Overall Study|Lost to Follow-up|51|||
162039137|NCT01442038|585201433|FG000|Overall Study|Adverse Event|26|||
162039138|NCT01442038|585201434|FG001|Overall Study|Adverse Event|15|||
162039139|NCT01442038|585201433|FG000|Overall Study|Protocol Deviation|9|||
162039140|NCT01442038|585201434|FG001|Overall Study|Protocol Deviation|20|||
162039141|NCT01442038|585201433|FG000|Overall Study|Investigator's Discretion|13|||
162039142|NCT01442038|585201434|FG001|Overall Study|Investigator's Discretion|16|||
162039143|NCT01442038|585201433|FG000|Overall Study|Study Terminated By Sponsor|2|||
162039144|NCT01442038|585201434|FG001|Overall Study|Study Terminated By Sponsor|3|||
162039145|NCT00089284|585201435|FG000|Overall Study|Adverse event before starting treatment|0|||
162039146|NCT00089284|585201436|FG001|Overall Study|Adverse event before starting treatment|0|||
162039147|NCT00089284|585201437|FG002|Overall Study|Adverse event before starting treatment|0|||
162039148|NCT00089284|585201438|FG003|Overall Study|Adverse event before starting treatment|0|||
162039149|NCT00089284|585201439|FG004|Overall Study|Adverse event before starting treatment|0|||
162039150|NCT00089284|585201440|FG005|Overall Study|Adverse event before starting treatment|0|||
162039151|NCT00089284|585201441|FG006|Overall Study|Adverse event before starting treatment|1|||
162039152|NCT02395666|585201442|FG000|Overall Study|Physician Decision|3|||
162039153|NCT02395666|585201443|FG001|Overall Study|Physician Decision|0|||
162039154|NCT02395666|585201442|FG000|Overall Study|Lost to Follow-up|1|||
162039155|NCT02395666|585201443|FG001|Overall Study|Lost to Follow-up|0|||
162039156|NCT02395666|585201442|FG000|Overall Study|Withdrawal by Subject|2|||
162039157|NCT02395666|585201443|FG001|Overall Study|Withdrawal by Subject|1|||
162039158|NCT02611960|585201444|FG000|Overall Study|Adverse Event|7|||
162039159|NCT02611960|585201445|FG001|Overall Study|Adverse Event|8|||
162039160|NCT02611960|585201444|FG000|Overall Study|Death|98|||
162039161|NCT02611960|585201445|FG001|Overall Study|Death|92|||
162039162|NCT02611960|585201444|FG000|Overall Study|Withdrawal by Subject|1|||
162039163|NCT02611960|585201445|FG001|Overall Study|Withdrawal by Subject|5|||
162039164|NCT02611960|585201444|FG000|Overall Study|Sponsor Decision|11|||
162039165|NCT02611960|585201445|FG001|Overall Study|Sponsor Decision|11|||
162039166|NCT00137631|585201446|FG000|Overall Study|Lost to Follow-up|37|||
162039167|NCT00137631|585201447|FG001|Overall Study|Lost to Follow-up|41|||
162039168|NCT01092507|585201448|FG000|Overall Study|Withdrawal by Subject|2|||
162039169|NCT01092507|585201449|FG001|Overall Study|Withdrawal by Subject|0|||
162039170|NCT00085709|585201461|FG000|Overall Study|Adverse Event|8|||
162039171|NCT00085709|585201462|FG001|Overall Study|Adverse Event|0|||
162039172|NCT00085709|585201461|FG000|Overall Study|Death|8|||
162039173|NCT00085709|585201462|FG001|Overall Study|Death|2|||
162039174|NCT00085709|585201461|FG000|Overall Study|Refusal unrelated to adverse events|1|||
162039175|NCT00085709|585201462|FG001|Overall Study|Refusal unrelated to adverse events|2|||
162039176|NCT00085709|585201461|FG000|Overall Study|Progression|3|||
162039177|NCT00085709|585201462|FG001|Overall Study|Progression|4|||
162039178|NCT00085709|585201461|FG000|Overall Study|Not protocol specified|12|||
162039179|NCT00085709|585201462|FG001|Overall Study|Not protocol specified|22|||
162039180|NCT00085709|585201461|FG000|Overall Study|Not eligible|19|||
162039181|NCT00085709|585201462|FG001|Overall Study|Not eligible|19|||
162039182|NCT00085709|585201461|FG000|Overall Study|Withdrawal by Subject|2|||
162039183|NCT00085709|585201462|FG001|Overall Study|Withdrawal by Subject|1|||
162039184|NCT04131556|585201463|FG000|Overall Study|Adverse Event|1|||
162039185|NCT04131556|585201463|FG000|Overall Study|Withdrawal by Subject|1|||
162039186|NCT01229371|585201464|FG000|Overall Study|Withdrawal by Subject|0|||
162039187|NCT01229371|585201465|FG001|Overall Study|Withdrawal by Subject|1|||
162039188|NCT01229371|585201466|FG002|Overall Study|Withdrawal by Subject|0|||
162039189|NCT01229371|585201467|FG003|Overall Study|Withdrawal by Subject|0|||
162039190|NCT05314478|585201468|FG000|Overall Study|Physician Decision|1|||
162039191|NCT00145600|585201469|FG000|Overall Study|Death|1|||
162039192|NCT00145600|585201470|FG001|Overall Study|Death|2|||
162039193|NCT00145600|585201471|FG002|Overall Study|Death|2|||
162039194|NCT00145600|585201472|FG003|Overall Study|Death|6|||
162039195|NCT00145600|585201469|FG000|Overall Study|Ineligible|3|||
162039196|NCT00145600|585201470|FG001|Overall Study|Ineligible|0|||
162039197|NCT00145600|585201471|FG002|Overall Study|Ineligible|1|||
162039198|NCT00145600|585201472|FG003|Overall Study|Ineligible|5|||
162039199|NCT00145600|585201469|FG000|Overall Study|Lost to Follow-up|2|||
162039200|NCT00145600|585201470|FG001|Overall Study|Lost to Follow-up|6|||
162039201|NCT00145600|585201471|FG002|Overall Study|Lost to Follow-up|2|||
162039202|NCT00145600|585201472|FG003|Overall Study|Lost to Follow-up|4|||
162039203|NCT00145600|585201469|FG000|Overall Study|Noncompliance|1|||
162039204|NCT00145600|585201470|FG001|Overall Study|Noncompliance|0|||
162039205|NCT00145600|585201471|FG002|Overall Study|Noncompliance|0|||
162039206|NCT00145600|585201472|FG003|Overall Study|Noncompliance|0|||
162039207|NCT00145600|585201469|FG000|Overall Study|Withdrawal by Subject|1|||
162039208|NCT00145600|585201470|FG001|Overall Study|Withdrawal by Subject|2|||
162039209|NCT00145600|585201471|FG002|Overall Study|Withdrawal by Subject|0|||
162039210|NCT00145600|585201472|FG003|Overall Study|Withdrawal by Subject|1|||
162039211|NCT00736879|585201476|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
162039212|NCT00736879|585201477|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
162039213|NCT00736879|585201478|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
162039214|NCT00736879|585201479|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
162039215|NCT00736879|585201476|FG000|Double Blind Treatment Period|Adverse Event|0|||
162039216|NCT00736879|585201477|FG001|Double Blind Treatment Period|Adverse Event|1|||
162039217|NCT00736879|585201478|FG002|Double Blind Treatment Period|Adverse Event|1|||
161892175|NCT02757352|584653157|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
161892176|NCT02757352|584653158|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892177|NCT02757352|584653159|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892178|NCT02757352|584653160|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892179|NCT02757352|584653161|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892180|NCT02757352|584653162|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892181|NCT02757352|584653163|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892182|NCT02757352|584653164|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161892183|NCT02757352|584653155|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
161892184|NCT02757352|584653156|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
161892185|NCT02757352|584653157|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
161892186|NCT02757352|584653158|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892187|NCT02757352|584653159|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892188|NCT02757352|584653160|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892189|NCT02757352|584653161|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892190|NCT02757352|584653162|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892191|NCT02757352|584653163|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892192|NCT02757352|584653164|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161892193|NCT02757352|584653155|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892194|NCT02757352|584653156|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
161892195|NCT02757352|584653157|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892196|NCT02757352|584653158|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892197|NCT02757352|584653159|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161995409|NCT02888106|585034065|FG000|Overall Study|Pregnancy|1|||
161995410|NCT02888106|585034066|FG001|Overall Study|Pregnancy|0|||
161995411|NCT02888106|585034067|FG002|Overall Study|Pregnancy|0|||
161995412|NCT02888106|585034068|FG003|Overall Study|Pregnancy|0|||
161995413|NCT02888106|585034069|FG004|Overall Study|Pregnancy|0|||
161995414|NCT02888106|585034070|FG005|Overall Study|Pregnancy|0|||
161995415|NCT01425801|585034076|FG000|Period 1|Withdrawal by Subject|0|||
161995416|NCT01425801|585034077|FG001|Period 1|Withdrawal by Subject|0|||
161995417|NCT01425801|585034078|FG002|Period 1|Withdrawal by Subject|0|||
161995418|NCT01425801|585034079|FG003|Period 1|Withdrawal by Subject|0|||
161995419|NCT01425801|585034080|FG004|Period 1|Withdrawal by Subject|1|||
161995420|NCT01425801|585034081|FG005|Period 1|Withdrawal by Subject|0|||
161995421|NCT01425801|585034076|FG000|Period 2|Withdrawal by Subject|0|||
161995422|NCT01425801|585034077|FG001|Period 2|Withdrawal by Subject|0|||
161995423|NCT01425801|585034078|FG002|Period 2|Withdrawal by Subject|0|||
161995424|NCT01425801|585034079|FG003|Period 2|Withdrawal by Subject|0|||
161995425|NCT01425801|585034080|FG004|Period 2|Withdrawal by Subject|1|||
161995426|NCT01425801|585034081|FG005|Period 2|Withdrawal by Subject|0|||
161995427|NCT01425801|585034076|FG000|Period 3|Stability criteria not fullfilled|0|||
161995428|NCT01425801|585034077|FG001|Period 3|Stability criteria not fullfilled|0|||
161995429|NCT01425801|585034078|FG002|Period 3|Stability criteria not fullfilled|1|||
161995430|NCT01425801|585034079|FG003|Period 3|Stability criteria not fullfilled|0|||
161995431|NCT01425801|585034080|FG004|Period 3|Stability criteria not fullfilled|0|||
161995432|NCT01425801|585034081|FG005|Period 3|Stability criteria not fullfilled|0|||
161995433|NCT01425801|585034076|FG000|Period 4|Not able to maintain visit schedule|0|||
161995434|NCT01425801|585034077|FG001|Period 4|Not able to maintain visit schedule|0|||
161995435|NCT01425801|585034078|FG002|Period 4|Not able to maintain visit schedule|1|||
161995436|NCT01425801|585034079|FG003|Period 4|Not able to maintain visit schedule|0|||
161995437|NCT01425801|585034080|FG004|Period 4|Not able to maintain visit schedule|0|||
161995438|NCT01425801|585034081|FG005|Period 4|Not able to maintain visit schedule|0|||
161995439|NCT03386721|585034082|FG000|Overall Study|Death|12|||
161995440|NCT03386721|585034083|FG001|Overall Study|Death|21|||
161995441|NCT03386721|585034084|FG002|Overall Study|Death|2|||
161995442|NCT03386721|585034085|FG003|Overall Study|Death|5|||
161995443|NCT03386721|585034086|FG004|Overall Study|Death|1|||
161995444|NCT03386721|585034087|FG005|Overall Study|Death|12|||
161995445|NCT03386721|585034088|FG006|Overall Study|Death|1|||
161995446|NCT03386721|585034089|FG007|Overall Study|Death|1|||
161995447|NCT03386721|585034090|FG008|Overall Study|Death|12|||
161995448|NCT03386721|585034091|FG009|Overall Study|Death|20|||
161995449|NCT03386721|585034092|FG010|Overall Study|Death|21|||
161995450|NCT03386721|585034093|FG011|Overall Study|Death|21|||
161995451|NCT03386721|585034094|FG012|Overall Study|Death|14|||
161995452|NCT03386721|585034095|FG013|Overall Study|Death|2|||
161995453|NCT03386721|585034096|FG014|Overall Study|Death|1|||
161995454|NCT03386721|585034082|FG000|Overall Study|Lost to Follow-up|1|||
161995455|NCT03386721|585034083|FG001|Overall Study|Lost to Follow-up|3|||
161995456|NCT03386721|585034084|FG002|Overall Study|Lost to Follow-up|0|||
161995457|NCT03386721|585034085|FG003|Overall Study|Lost to Follow-up|0|||
161995458|NCT03386721|585034086|FG004|Overall Study|Lost to Follow-up|0|||
161995459|NCT03386721|585034087|FG005|Overall Study|Lost to Follow-up|2|||
161995460|NCT03386721|585034088|FG006|Overall Study|Lost to Follow-up|1|||
161995461|NCT03386721|585034089|FG007|Overall Study|Lost to Follow-up|0|||
161995462|NCT03386721|585034090|FG008|Overall Study|Lost to Follow-up|1|||
161995463|NCT03386721|585034091|FG009|Overall Study|Lost to Follow-up|2|||
161995464|NCT03386721|585034092|FG010|Overall Study|Lost to Follow-up|1|||
161995465|NCT03386721|585034093|FG011|Overall Study|Lost to Follow-up|0|||
161995466|NCT03386721|585034094|FG012|Overall Study|Lost to Follow-up|0|||
161995467|NCT03386721|585034095|FG013|Overall Study|Lost to Follow-up|0|||
161995468|NCT03386721|585034096|FG014|Overall Study|Lost to Follow-up|0|||
161995469|NCT03386721|585034082|FG000|Overall Study|Reason not specified|3|||
161995470|NCT03386721|585034083|FG001|Overall Study|Reason not specified|0|||
161995471|NCT03386721|585034084|FG002|Overall Study|Reason not specified|0|||
161995472|NCT03386721|585034085|FG003|Overall Study|Reason not specified|0|||
161995473|NCT03386721|585034086|FG004|Overall Study|Reason not specified|0|||
161995474|NCT03386721|585034087|FG005|Overall Study|Reason not specified|3|||
161995475|NCT03386721|585034088|FG006|Overall Study|Reason not specified|1|||
161995476|NCT03386721|585034089|FG007|Overall Study|Reason not specified|0|||
161995477|NCT03386721|585034090|FG008|Overall Study|Reason not specified|0|||
161995478|NCT03386721|585034091|FG009|Overall Study|Reason not specified|1|||
161995479|NCT03386721|585034092|FG010|Overall Study|Reason not specified|2|||
161995480|NCT03386721|585034093|FG011|Overall Study|Reason not specified|6|||
161995481|NCT03386721|585034094|FG012|Overall Study|Reason not specified|1|||
161995482|NCT03386721|585034095|FG013|Overall Study|Reason not specified|0|||
161995483|NCT03386721|585034096|FG014|Overall Study|Reason not specified|0|||
161995484|NCT03386721|585034082|FG000|Overall Study|Progressive Disease|0|||
161995485|NCT03386721|585034083|FG001|Overall Study|Progressive Disease|0|||
161995486|NCT03386721|585034084|FG002|Overall Study|Progressive Disease|1|||
161995487|NCT03386721|585034085|FG003|Overall Study|Progressive Disease|0|||
161995488|NCT03386721|585034086|FG004|Overall Study|Progressive Disease|0|||
161995489|NCT03386721|585034087|FG005|Overall Study|Progressive Disease|1|||
161995490|NCT03386721|585034088|FG006|Overall Study|Progressive Disease|0|||
161995491|NCT03386721|585034089|FG007|Overall Study|Progressive Disease|0|||
161995492|NCT03386721|585034090|FG008|Overall Study|Progressive Disease|2|||
161995493|NCT03386721|585034091|FG009|Overall Study|Progressive Disease|1|||
161995494|NCT03386721|585034092|FG010|Overall Study|Progressive Disease|1|||
161995495|NCT03386721|585034093|FG011|Overall Study|Progressive Disease|0|||
161995496|NCT03386721|585034094|FG012|Overall Study|Progressive Disease|1|||
161995497|NCT03386721|585034095|FG013|Overall Study|Progressive Disease|0|||
161995498|NCT03386721|585034096|FG014|Overall Study|Progressive Disease|0|||
161995499|NCT03386721|585034082|FG000|Overall Study|Site Terminated by Sponsor|5|||
161995500|NCT03386721|585034083|FG001|Overall Study|Site Terminated by Sponsor|5|||
161995501|NCT03386721|585034084|FG002|Overall Study|Site Terminated by Sponsor|0|||
161995502|NCT03386721|585034085|FG003|Overall Study|Site Terminated by Sponsor|0|||
161995503|NCT03386721|585034086|FG004|Overall Study|Site Terminated by Sponsor|1|||
161995504|NCT03386721|585034087|FG005|Overall Study|Site Terminated by Sponsor|3|||
161995505|NCT03386721|585034088|FG006|Overall Study|Site Terminated by Sponsor|0|||
161995506|NCT03386721|585034089|FG007|Overall Study|Site Terminated by Sponsor|1|||
161995507|NCT03386721|585034090|FG008|Overall Study|Site Terminated by Sponsor|4|||
161995508|NCT03386721|585034091|FG009|Overall Study|Site Terminated by Sponsor|5|||
161995509|NCT03386721|585034092|FG010|Overall Study|Site Terminated by Sponsor|3|||
161995510|NCT03386721|585034093|FG011|Overall Study|Site Terminated by Sponsor|11|||
161995511|NCT03386721|585034094|FG012|Overall Study|Site Terminated by Sponsor|6|||
161995512|NCT03386721|585034095|FG013|Overall Study|Site Terminated by Sponsor|0|||
161995513|NCT03386721|585034096|FG014|Overall Study|Site Terminated by Sponsor|0|||
161995514|NCT03386721|585034082|FG000|Overall Study|Symptomatic Deterioration|0|||
161995515|NCT03386721|585034083|FG001|Overall Study|Symptomatic Deterioration|0|||
161995516|NCT03386721|585034084|FG002|Overall Study|Symptomatic Deterioration|0|||
161995517|NCT03386721|585034085|FG003|Overall Study|Symptomatic Deterioration|0|||
161995518|NCT03386721|585034086|FG004|Overall Study|Symptomatic Deterioration|0|||
161995519|NCT03386721|585034087|FG005|Overall Study|Symptomatic Deterioration|0|||
161995520|NCT03386721|585034088|FG006|Overall Study|Symptomatic Deterioration|0|||
161995521|NCT03386721|585034089|FG007|Overall Study|Symptomatic Deterioration|0|||
161995522|NCT03386721|585034090|FG008|Overall Study|Symptomatic Deterioration|1|||
161995523|NCT03386721|585034091|FG009|Overall Study|Symptomatic Deterioration|0|||
161995524|NCT03386721|585034092|FG010|Overall Study|Symptomatic Deterioration|0|||
161995525|NCT03386721|585034093|FG011|Overall Study|Symptomatic Deterioration|1|||
161995526|NCT03386721|585034094|FG012|Overall Study|Symptomatic Deterioration|0|||
161995527|NCT03386721|585034095|FG013|Overall Study|Symptomatic Deterioration|0|||
161995528|NCT03386721|585034096|FG014|Overall Study|Symptomatic Deterioration|0|||
161995529|NCT03386721|585034082|FG000|Overall Study|Withdrawal by Subject|1|||
161995530|NCT03386721|585034083|FG001|Overall Study|Withdrawal by Subject|2|||
161995531|NCT03386721|585034084|FG002|Overall Study|Withdrawal by Subject|0|||
161995532|NCT03386721|585034085|FG003|Overall Study|Withdrawal by Subject|0|||
161995533|NCT03386721|585034086|FG004|Overall Study|Withdrawal by Subject|0|||
161995534|NCT03386721|585034087|FG005|Overall Study|Withdrawal by Subject|0|||
161995535|NCT03386721|585034088|FG006|Overall Study|Withdrawal by Subject|0|||
161995536|NCT03386721|585034089|FG007|Overall Study|Withdrawal by Subject|0|||
161995537|NCT03386721|585034090|FG008|Overall Study|Withdrawal by Subject|2|||
161995538|NCT03386721|585034091|FG009|Overall Study|Withdrawal by Subject|1|||
161995539|NCT03386721|585034092|FG010|Overall Study|Withdrawal by Subject|3|||
161995540|NCT03386721|585034093|FG011|Overall Study|Withdrawal by Subject|2|||
161995541|NCT03386721|585034094|FG012|Overall Study|Withdrawal by Subject|3|||
161995542|NCT03386721|585034095|FG013|Overall Study|Withdrawal by Subject|0|||
161995543|NCT03386721|585034096|FG014|Overall Study|Withdrawal by Subject|0|||
161995544|NCT03066596|585034097|FG000|Overall Study|Withdrawal by Subject|4|||
161995545|NCT03066596|585034098|FG001|Overall Study|Withdrawal by Subject|2|||
161995546|NCT03066596|585034097|FG000|Overall Study|Lost to Follow-up|14|||
161995547|NCT03066596|585034098|FG001|Overall Study|Lost to Follow-up|10|||
161995548|NCT03797586|585034099|FG000|Overall Study|Lost to Follow-up|3|||
161995549|NCT03797586|585034100|FG001|Overall Study|Lost to Follow-up|6|||
161995550|NCT03797586|585034099|FG000|Overall Study|Death|1|||
161995551|NCT03797586|585034100|FG001|Overall Study|Death|1|||
161995552|NCT03797586|585034099|FG000|Overall Study|Adverse Event|0|||
161995553|NCT03797586|585034100|FG001|Overall Study|Adverse Event|2|||
161995554|NCT02959437|585034101|FG000|Overall Study|Death|33|||
161995555|NCT02959437|585034102|FG001|Overall Study|Death|3|||
161995556|NCT02959437|585034103|FG002|Overall Study|Death|0|||
161995557|NCT02959437|585034104|FG003|Overall Study|Death|0|||
161995558|NCT02959437|585034101|FG000|Overall Study|Lost to Follow-up|3|||
161995559|NCT02959437|585034102|FG001|Overall Study|Lost to Follow-up|1|||
161995560|NCT02959437|585034103|FG002|Overall Study|Lost to Follow-up|0|||
161995561|NCT02959437|585034104|FG003|Overall Study|Lost to Follow-up|0|||
161995562|NCT02959437|585034101|FG000|Overall Study|Withdrawal by Subject|11|||
161995563|NCT02959437|585034102|FG001|Overall Study|Withdrawal by Subject|3|||
161995564|NCT02959437|585034103|FG002|Overall Study|Withdrawal by Subject|0|||
161995565|NCT02959437|585034104|FG003|Overall Study|Withdrawal by Subject|0|||
161995566|NCT02959437|585034101|FG000|Overall Study|Progressive Disease|9|||
161995567|NCT02959437|585034102|FG001|Overall Study|Progressive Disease|1|||
161995568|NCT02959437|585034103|FG002|Overall Study|Progressive Disease|0|||
161995569|NCT02959437|585034104|FG003|Overall Study|Progressive Disease|0|||
161995570|NCT02959437|585034101|FG000|Overall Study|Study Terminated by Sponsor|4|||
161995571|NCT02959437|585034102|FG001|Overall Study|Study Terminated by Sponsor|0|||
161995572|NCT02959437|585034103|FG002|Overall Study|Study Terminated by Sponsor|0|||
161995573|NCT02959437|585034104|FG003|Overall Study|Study Terminated by Sponsor|0|||
161995574|NCT02959437|585034101|FG000|Overall Study|Other Unspecified|2|||
161995575|NCT02959437|585034102|FG001|Overall Study|Other Unspecified|0|||
161995576|NCT02959437|585034103|FG002|Overall Study|Other Unspecified|0|||
161995577|NCT02959437|585034104|FG003|Overall Study|Other Unspecified|0|||
161995578|NCT02864901|585034105|FG000|Overall Study|Withdrawal by Subject|1|||
161995579|NCT02864901|585034106|FG001|Overall Study|Withdrawal by Subject|0|||
161995580|NCT01369784|585034113|FG000|Overall Study|Protocol Violation|12|||
161995581|NCT01219985|585034114|FG000|Overall Study|Physician Decision|20|||
161995582|NCT04797780|585034117|FG000|Overall Study|Lost to Follow-up|1|||
161995583|NCT04797780|585034118|FG001|Overall Study|Lost to Follow-up|1|||
161995584|NCT04797780|585034117|FG000|Overall Study|Withdrawal by Subject|14|||
161995585|NCT04797780|585034118|FG001|Overall Study|Withdrawal by Subject|9|||
161995586|NCT04797780|585034117|FG000|Overall Study|Death|49|||
161995587|NCT04797780|585034118|FG001|Overall Study|Death|20|||
161995588|NCT02940496|585034119|FG000|Overall Study|Adverse Event|1|||
161995589|NCT02940496|585034120|FG001|Overall Study|Adverse Event|0|||
161995590|NCT02940496|585034119|FG000|Overall Study|Death|2|||
161995591|NCT02940496|585034120|FG001|Overall Study|Death|0|||
161995592|NCT02940496|585034119|FG000|Overall Study|Hospice Care|1|||
161995593|NCT02940496|585034120|FG001|Overall Study|Hospice Care|0|||
161995594|NCT02940496|585034119|FG000|Overall Study|No MRE Done|1|||
161995595|NCT02940496|585034120|FG001|Overall Study|No MRE Done|0|||
161995596|NCT02940496|585034119|FG000|Overall Study|MRE Failure|1|||
161995597|NCT02940496|585034120|FG001|Overall Study|MRE Failure|0|||
161995598|NCT05973006|585034121|FG000|Overall Study|Early termination|3|||
161995599|NCT05973006|585034122|FG001|Overall Study|Early termination|9|||
161995600|NCT05167825|585034123|FG000|Overall Study|Ongoing|3|||
161995601|NCT01807598|585034124|FG000|Overall Study|Withdrawal by Subject|4|||
161995602|NCT01807598|585034124|FG000|Overall Study|Adverse Event|1|||
161995603|NCT01807598|585034124|FG000|Overall Study|Other Physician Decision|1|||
161995604|NCT04089761|585034127|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
161995605|NCT04089761|585034127|FG000|"Run In Phase"|Lost to Follow-up|1|||
161995606|NCT04089761|585034127|FG000|"Treatment Phase"|No evaluable data|5|||
161995607|NCT04089761|585034127|FG000|"Treatment Phase"|Lost to Follow-up|1|||
161995608|NCT03622814|585034128|FG000|Overall Study|Lost to Follow-up|8|||
161995609|NCT03622814|585034129|FG001|Overall Study|Lost to Follow-up|14|||
161995610|NCT04417361|585034130|FG000|Overall Study|Withdrawal by Subject|1|||
161995611|NCT04417361|585034131|FG001|Overall Study|Withdrawal by Subject|0|||
161995612|NCT04417361|585034130|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
161995613|NCT04417361|585034131|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
161995614|NCT00165672|585034132|FG000|Overall Study|Adverse Event|0|||
161995615|NCT00165672|585034133|FG001|Overall Study|Adverse Event|1|||
161995616|NCT03868943|585034134|FG000|Overall Study|Adverse Event|1|||
161892198|NCT02757352|584653160|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892199|NCT02757352|584653161|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892200|NCT02757352|584653162|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892201|NCT02757352|584653163|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892202|NCT02757352|584653164|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161892203|NCT02757352|584653155|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892204|NCT02757352|584653156|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
161892205|NCT02757352|584653157|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892206|NCT02757352|584653158|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892207|NCT02757352|584653159|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892208|NCT02757352|584653160|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892209|NCT02757352|584653161|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892210|NCT02757352|584653162|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892211|NCT02757352|584653163|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892212|NCT02757352|584653164|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892213|NCT02757352|584653155|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
161892214|NCT02757352|584653156|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
161892215|NCT02757352|584653157|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
161892216|NCT02757352|584653158|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892217|NCT02757352|584653159|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892218|NCT02757352|584653160|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892219|NCT02757352|584653161|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892220|NCT02757352|584653162|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892221|NCT02757352|584653163|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892222|NCT02757352|584653164|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892223|NCT02757352|584653155|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
161892224|NCT02757352|584653156|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
161892225|NCT02757352|584653157|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
161892226|NCT02757352|584653158|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892227|NCT02757352|584653159|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892228|NCT02757352|584653160|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892229|NCT02757352|584653161|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892230|NCT02757352|584653162|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892231|NCT02757352|584653163|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892232|NCT02757352|584653164|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161892233|NCT02757352|584653155|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892234|NCT02757352|584653156|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892235|NCT02757352|584653157|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892236|NCT02757352|584653158|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
161892237|NCT02757352|584653159|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892238|NCT02757352|584653160|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
161892239|NCT02757352|584653161|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892240|NCT02757352|584653162|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892241|NCT02757352|584653163|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892242|NCT02757352|584653164|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161892243|NCT02757352|584653155|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892244|NCT02757352|584653156|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892245|NCT02757352|584653157|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892246|NCT02757352|584653158|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
161892247|NCT02757352|584653159|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
161892248|NCT02757352|584653160|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
161892249|NCT02757352|584653161|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892250|NCT02757352|584653162|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892251|NCT02757352|584653163|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892252|NCT02757352|584653164|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161892253|NCT02757352|584653155|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892254|NCT02757352|584653156|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892255|NCT02757352|584653157|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892256|NCT02757352|584653158|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892257|NCT02757352|584653159|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
161892258|NCT02757352|584653160|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892259|NCT02757352|584653161|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892260|NCT02757352|584653162|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161995617|NCT04896593|585034137|FG000|Overall Study|Withdrawal by Subject|2|||
161995618|NCT04896593|585034137|FG000|Overall Study|Lost to Follow-up|1|||
161995619|NCT04896593|585034137|FG000|Overall Study|Did not complete onboarding|2|||
161995620|NCT00892775|585034138|FG000|Overall Study|Protocol Violation|1|||
161995621|NCT00892775|585034139|FG001|Overall Study|Protocol Violation|0|||
161995622|NCT00892775|585034138|FG000|Overall Study|Subject difficulties with blood drawing|1|||
161995623|NCT00892775|585034139|FG001|Overall Study|Subject difficulties with blood drawing|0|||
161995624|NCT00892775|585034138|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
161995625|NCT00892775|585034139|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
161995626|NCT00892775|585034138|FG000|Overall Study|Migrated/ moved from study area|1|||
161995627|NCT00892775|585034139|FG001|Overall Study|Migrated/ moved from study area|0|||
161995628|NCT00892775|585034138|FG000|Overall Study|Withdrawal by Subject|0|||
161995629|NCT00892775|585034139|FG001|Overall Study|Withdrawal by Subject|1|||
161995630|NCT00892775|585034138|FG000|Overall Study|Lost to Follow-up|1|||
161995631|NCT00892775|585034139|FG001|Overall Study|Lost to Follow-up|0|||
161995632|NCT00555217|585034142|FG000|Overall Study|Withdrawal by Subject|35|||
161995633|NCT00555217|585034143|FG001|Overall Study|Withdrawal by Subject|31|||
161995634|NCT00555217|585034142|FG000|Overall Study|Lost to Follow-up|19|||
161995635|NCT00555217|585034143|FG001|Overall Study|Lost to Follow-up|20|||
161995636|NCT00555217|585034142|FG000|Overall Study|close out sites|21|||
161995637|NCT00555217|585034143|FG001|Overall Study|close out sites|17|||
161995638|NCT01546688|585034144|FG000|Overall Study|Adverse Event|0|||
161995639|NCT01546688|585034145|FG001|Overall Study|Adverse Event|4|||
162039218|NCT00736879|585201479|FG003|Double Blind Treatment Period|Adverse Event|0|||
162039219|NCT00736879|585201476|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
162039220|NCT00736879|585201477|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
162039221|NCT00736879|585201478|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
162039222|NCT00736879|585201479|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
162039223|NCT00736879|585201476|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
162039224|NCT00736879|585201477|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
162039225|NCT00736879|585201478|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
162039226|NCT00736879|585201479|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
162039227|NCT00736879|585201476|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
162039228|NCT00736879|585201477|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
162039229|NCT00736879|585201478|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
162039230|NCT00736879|585201479|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
162039231|NCT00736879|585201476|FG000|Double Blind Treatment Period|No longer met criteria|0|||
162039232|NCT00736879|585201477|FG001|Double Blind Treatment Period|No longer met criteria|1|||
162039233|NCT00736879|585201478|FG002|Double Blind Treatment Period|No longer met criteria|0|||
162039234|NCT00736879|585201479|FG003|Double Blind Treatment Period|No longer met criteria|0|||
162039235|NCT00736879|585201476|FG000|Double Blind Treatment Period|non-specified|0|||
162039236|NCT00736879|585201477|FG001|Double Blind Treatment Period|non-specified|1|||
162039237|NCT00736879|585201478|FG002|Double Blind Treatment Period|non-specified|0|||
162039238|NCT00736879|585201479|FG003|Double Blind Treatment Period|non-specified|0|||
162039239|NCT00736879|585201476|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
162039240|NCT00736879|585201477|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
162039241|NCT00736879|585201478|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
162039242|NCT00736879|585201479|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
162039243|NCT00736879|585201476|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
162039244|NCT00736879|585201477|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
162039245|NCT00736879|585201478|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
162039246|NCT00736879|585201479|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
162039247|NCT03583164|585201486|FG000|Overall Study|Death in Main Phase|35|||
162039248|NCT03583164|585201486|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
162039249|NCT03583164|585201486|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
162039250|NCT03583164|585201486|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
162039251|NCT03583164|585201486|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
162039252|NCT03583164|585201486|FG000|Overall Study|Physician decision in Main Phase|1|||
162039253|NCT03583164|585201486|FG000|Overall Study|Physician decision in Extended Phase|2|||
161995640|NCT01546688|585034144|FG000|Overall Study|Withdrawal by Subject|2|||
161995641|NCT01546688|585034145|FG001|Overall Study|Withdrawal by Subject|1|||
161995642|NCT01546688|585034144|FG000|Overall Study|Lack of Efficacy|1|||
161995643|NCT01546688|585034145|FG001|Overall Study|Lack of Efficacy|0|||
161995644|NCT03543137|585034146|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
161995645|NCT03543137|585034147|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
161995646|NCT03543137|585034146|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
161995647|NCT03543137|585034147|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
161995648|NCT03543137|585034146|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
161995649|NCT03543137|585034147|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
162039254|NCT03583164|585201486|FG000|Overall Study|Death in Extended Phase|13|||
162039255|NCT03583164|585201486|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
162039256|NCT03583164|585201486|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
162039257|NCT03583164|585201486|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
162039258|NCT03583164|585201486|FG000|Overall Study|Treatment failure in Main Phase|2|||
162039259|NCT03583164|585201486|FG000|Overall Study|Treatment failure in Extended Phase|4|||
162039260|NCT03583164|585201486|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
162039261|NCT03583164|585201486|FG000|Overall Study|Other not specified reason in Main Phase|2|||
162039262|NCT02869438|585201494|FG000|Overall Study|Lost to Follow-up|1|||
162039263|NCT02869438|585201495|FG001|Overall Study|Lost to Follow-up|0|||
162039264|NCT02869438|585201494|FG000|Overall Study|Adverse Event|1|||
162039265|NCT02869438|585201495|FG001|Overall Study|Adverse Event|0|||
162039266|NCT02869438|585201494|FG000|Overall Study|Withdrawal by Subject|1|||
162039267|NCT02869438|585201495|FG001|Overall Study|Withdrawal by Subject|2|||
162039268|NCT03880461|585201498|FG000|Overall Study|Determined ineligible after enrollment|45|||
162039269|NCT03880461|585201499|FG001|Overall Study|Determined ineligible after enrollment|44|||
162039270|NCT03880461|585201498|FG000|Overall Study|No weight measurement after enrollment|24|||
162039271|NCT03880461|585201499|FG001|Overall Study|No weight measurement after enrollment|17|||
162039272|NCT01115803|585201506|FG000|Overall Study|Withdrawal by Subject|0|||
162039273|NCT01115803|585201507|FG001|Overall Study|Withdrawal by Subject|0|||
162039274|NCT01115803|585201508|FG002|Overall Study|Withdrawal by Subject|0|||
162039275|NCT01115803|585201509|FG003|Overall Study|Withdrawal by Subject|0|||
162039276|NCT01115803|585201510|FG004|Overall Study|Withdrawal by Subject|0|||
162039277|NCT01115803|585201511|FG005|Overall Study|Withdrawal by Subject|0|||
162039278|NCT01115803|585201512|FG006|Overall Study|Withdrawal by Subject|1|||
162039279|NCT01115803|585201506|FG000|Overall Study|Lost to Follow-up|0|||
162039280|NCT01115803|585201507|FG001|Overall Study|Lost to Follow-up|0|||
162039281|NCT01115803|585201508|FG002|Overall Study|Lost to Follow-up|1|||
162039282|NCT01115803|585201509|FG003|Overall Study|Lost to Follow-up|0|||
162039283|NCT01115803|585201510|FG004|Overall Study|Lost to Follow-up|0|||
162039284|NCT01115803|585201511|FG005|Overall Study|Lost to Follow-up|0|||
162039285|NCT01115803|585201512|FG006|Overall Study|Lost to Follow-up|0|||
162039286|NCT01115803|585201506|FG000|Overall Study|Progressive Disease during Cycle1|0|||
162039287|NCT01115803|585201507|FG001|Overall Study|Progressive Disease during Cycle1|0|||
162039288|NCT01115803|585201508|FG002|Overall Study|Progressive Disease during Cycle1|0|||
162039289|NCT01115803|585201509|FG003|Overall Study|Progressive Disease during Cycle1|0|||
162039290|NCT01115803|585201510|FG004|Overall Study|Progressive Disease during Cycle1|0|||
162039291|NCT01115803|585201511|FG005|Overall Study|Progressive Disease during Cycle1|0|||
162039292|NCT01115803|585201512|FG006|Overall Study|Progressive Disease during Cycle1|1|||
162039293|NCT03063203|585201513|FG000|Overall Study|Chose alternative therapy|3|||
162039294|NCT03063203|585201513|FG000|Overall Study|Death|2|||
162039295|NCT03063203|585201513|FG000|Overall Study|Disease progression|4|||
162039296|NCT03063203|585201513|FG000|Overall Study|Physician Decision|5|||
162039297|NCT02273739|585201514|FG000|Overall Study|Progression of Disease|3|||
162039298|NCT02273739|585201515|FG001|Overall Study|Progression of Disease|4|||
162039299|NCT02273739|585201516|FG002|Overall Study|Progression of Disease|5|||
162039300|NCT02273739|585201517|FG003|Overall Study|Progression of Disease|2|||
162039301|NCT02273739|585201514|FG000|Overall Study|Death|0|||
162039302|NCT02273739|585201515|FG001|Overall Study|Death|0|||
162039303|NCT02273739|585201516|FG002|Overall Study|Death|0|||
162039304|NCT02273739|585201517|FG003|Overall Study|Death|2|||
162039305|NCT02273739|585201514|FG000|Overall Study|Adverse Event|0|||
162039306|NCT02273739|585201515|FG001|Overall Study|Adverse Event|0|||
162039307|NCT02273739|585201516|FG002|Overall Study|Adverse Event|0|||
162039308|NCT02273739|585201517|FG003|Overall Study|Adverse Event|1|||
162039309|NCT02273739|585201514|FG000|Overall Study|Withdrawal by Subject|0|||
162039310|NCT02273739|585201515|FG001|Overall Study|Withdrawal by Subject|0|||
162039311|NCT02273739|585201516|FG002|Overall Study|Withdrawal by Subject|2|||
162039312|NCT02273739|585201517|FG003|Overall Study|Withdrawal by Subject|1|||
162039313|NCT02273739|585201514|FG000|Overall Study|Physician Decision|0|||
162039314|NCT02273739|585201515|FG001|Overall Study|Physician Decision|0|||
162039315|NCT02273739|585201516|FG002|Overall Study|Physician Decision|0|||
162039316|NCT02273739|585201517|FG003|Overall Study|Physician Decision|1|||
162039317|NCT02280473|585201519|FG000|Overall Study|Adverse Event|1|||
162039318|NCT02280473|585201520|FG001|Overall Study|Adverse Event|1|||
162039319|NCT02280473|585201519|FG000|Overall Study|Lack of Efficacy|0|||
162039320|NCT02280473|585201520|FG001|Overall Study|Lack of Efficacy|1|||
162039321|NCT02280473|585201519|FG000|Overall Study|Lost to Follow-up|0|||
162039322|NCT02280473|585201520|FG001|Overall Study|Lost to Follow-up|1|||
162039323|NCT02393690|585201521|FG000|Overall Study|Ineligible|0|||
162039324|NCT02393690|585201522|FG001|Overall Study|Ineligible|1|||
162039325|NCT05298306|585201523|FG000|Overall Study|Physician Decision|0|||
162039326|NCT05298306|585201524|FG001|Overall Study|Physician Decision|0|||
161892261|NCT02757352|584653163|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
162039327|NCT05298306|585201525|FG002|Overall Study|Physician Decision|0|||
162039328|NCT05298306|585201526|FG003|Overall Study|Physician Decision|1|||
162039329|NCT05298306|585201527|FG004|Overall Study|Physician Decision|0|||
162039330|NCT05298306|585201528|FG005|Overall Study|Physician Decision|0|||
162039331|NCT00144027|585201530|FG000|Overall Study|Lost to Follow-up|1|||
162039332|NCT00144027|585201531|FG001|Overall Study|Lost to Follow-up|3|||
162039333|NCT00144027|585201530|FG000|Overall Study|Withdrawal by Subject|2|||
162039334|NCT00144027|585201531|FG001|Overall Study|Withdrawal by Subject|2|||
162039335|NCT00144027|585201530|FG000|Overall Study|did not complete baseline assessment|0|||
162039336|NCT00144027|585201531|FG001|Overall Study|did not complete baseline assessment|6|||
162039337|NCT05080660|585201532|FG000|Overall Study|Adverse Event|4|||
161892262|NCT02757352|584653164|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161892263|NCT02757352|584653155|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892264|NCT02757352|584653156|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892265|NCT02757352|584653157|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892266|NCT02757352|584653158|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892267|NCT02757352|584653159|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892268|NCT02757352|584653160|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
161892269|NCT02757352|584653161|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
162039338|NCT05080660|585201533|FG001|Overall Study|Adverse Event|0|||
162039339|NCT05080660|585201532|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
162039340|NCT05080660|585201533|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
162039341|NCT05080660|585201532|FG000|Overall Study|Physician Decision|1|||
162039342|NCT05080660|585201533|FG001|Overall Study|Physician Decision|0|||
162039343|NCT05080660|585201532|FG000|Overall Study|Protocol Deviation|2|||
162039344|NCT05080660|585201533|FG001|Overall Study|Protocol Deviation|0|||
162039345|NCT05080660|585201532|FG000|Overall Study|Withdrawal by Subject|5|||
162039346|NCT05080660|585201533|FG001|Overall Study|Withdrawal by Subject|2|||
162039347|NCT00237185|585201534|FG000|Core|Adverse Event|3|||
162039348|NCT00237185|585201535|FG001|Core|Adverse Event|4|||
162039349|NCT00237185|585201534|FG000|Core|Abnormal laboratory value|0|||
162039350|NCT00237185|585201535|FG001|Core|Abnormal laboratory value|4|||
162039351|NCT00237185|585201534|FG000|Core|Abnormal test procedure results|1|||
162039352|NCT00237185|585201535|FG001|Core|Abnormal test procedure results|0|||
162039353|NCT00237185|585201534|FG000|Core|Lack of Efficacy|30|||
162039354|NCT00237185|585201535|FG001|Core|Lack of Efficacy|23|||
162039355|NCT00237185|585201534|FG000|Core|Protocol Violation|1|||
162039356|NCT00237185|585201535|FG001|Core|Protocol Violation|1|||
162039357|NCT00237185|585201534|FG000|Core|Withdrawal by Subject|4|||
162039358|NCT00237185|585201535|FG001|Core|Withdrawal by Subject|4|||
162039359|NCT00237185|585201534|FG000|Core|Administrative problems|0|||
162039360|NCT00237185|585201535|FG001|Core|Administrative problems|1|||
162039361|NCT00237185|585201534|FG000|Core|Death|4|||
162039362|NCT00237185|585201535|FG001|Core|Death|0|||
162039363|NCT00237185|585201534|FG000|Core|Determined ineligible post randomization|1|||
162039364|NCT00237185|585201535|FG001|Core|Determined ineligible post randomization|0|||
162039365|NCT00237185|585201534|FG000|Extension|Adverse Event|1|||
162039366|NCT00237185|585201535|FG001|Extension|Adverse Event|0|||
162039367|NCT00237185|585201534|FG000|Extension|Abnormal laboratory value|0|||
162039368|NCT00237185|585201535|FG001|Extension|Abnormal laboratory value|1|||
162039369|NCT00237185|585201534|FG000|Extension|Lack of Efficacy|9|||
162039370|NCT00237185|585201535|FG001|Extension|Lack of Efficacy|14|||
162039371|NCT00237185|585201534|FG000|Extension|Condition no longer required study drug|0|||
162039372|NCT00237185|585201535|FG001|Extension|Condition no longer required study drug|1|||
162039373|NCT00237185|585201534|FG000|Extension|Withdrawal by Subject|3|||
162039374|NCT00237185|585201535|FG001|Extension|Withdrawal by Subject|2|||
162039375|NCT00237185|585201534|FG000|Extension|Lost to Follow-up|1|||
162039376|NCT00237185|585201535|FG001|Extension|Lost to Follow-up|0|||
162039377|NCT00237185|585201534|FG000|Extension|Administrative problems|1|||
162039378|NCT00237185|585201535|FG001|Extension|Administrative problems|0|||
162039379|NCT00237185|585201534|FG000|Extension|Death|1|||
162039380|NCT00237185|585201535|FG001|Extension|Death|1|||
162039381|NCT02204007|585201536|FG000|Overall Study|Surgery Canceled|1|||
162039382|NCT02204007|585201537|FG001|Overall Study|Surgery Canceled|1|||
162039383|NCT00910988|585201538|FG000|Overall Study|Lost to Follow-up|2|||
162039384|NCT00910988|585201539|FG001|Overall Study|Lost to Follow-up|4|||
162039385|NCT00910988|585201540|FG002|Overall Study|Lost to Follow-up|3|||
162039386|NCT00910988|585201541|FG003|Overall Study|Lost to Follow-up|0|||
162039387|NCT02766465|585201542|FG000|Overall Study|Withdrawal by Subject|0|||
162039388|NCT02766465|585201543|FG001|Overall Study|Withdrawal by Subject|10|||
162039389|NCT01907100|585201544|FG000|Overall Study|PD based on modified RECIST criteria|31|||
161892270|NCT02757352|584653162|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
162039390|NCT01907100|585201545|FG001|Overall Study|PD based on modified RECIST criteria|32|||
162039391|NCT01907100|585201546|FG002|Overall Study|PD based on modified RECIST criteria|95|||
162039392|NCT01907100|585201547|FG003|Overall Study|PD based on modified RECIST criteria|92|||
162039393|NCT01907100|585201544|FG000|Overall Study|Withdrawal by Subject|2|||
162039394|NCT01907100|585201545|FG001|Overall Study|Withdrawal by Subject|5|||
162039395|NCT01907100|585201546|FG002|Overall Study|Withdrawal by Subject|10|||
162039396|NCT01907100|585201547|FG003|Overall Study|Withdrawal by Subject|13|||
162039397|NCT01907100|585201544|FG000|Overall Study|Protocol Violation|0|||
162039398|NCT01907100|585201545|FG001|Overall Study|Protocol Violation|0|||
161892271|NCT02757352|584653163|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892272|NCT02757352|584653164|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161892273|NCT02757352|584653155|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892274|NCT02757352|584653156|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892275|NCT02757352|584653157|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892276|NCT02757352|584653158|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
161892277|NCT02757352|584653159|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
161892278|NCT02757352|584653160|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
161892279|NCT02757352|584653161|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892280|NCT02757352|584653162|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892281|NCT02757352|584653163|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892282|NCT02757352|584653164|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161892283|NCT02757352|584653155|FG000|Follow-Up Period|Adverse Event|0|||
161892284|NCT02757352|584653156|FG001|Follow-Up Period|Adverse Event|0|||
161892285|NCT02757352|584653157|FG002|Follow-Up Period|Adverse Event|0|||
161892286|NCT02757352|584653158|FG003|Follow-Up Period|Adverse Event|0|||
161892287|NCT02757352|584653159|FG004|Follow-Up Period|Adverse Event|0|||
161892288|NCT02757352|584653160|FG005|Follow-Up Period|Adverse Event|0|||
161892289|NCT02757352|584653161|FG006|Follow-Up Period|Adverse Event|1|||
161892290|NCT02757352|584653162|FG007|Follow-Up Period|Adverse Event|0|||
161892291|NCT02757352|584653163|FG008|Follow-Up Period|Adverse Event|2|||
161892292|NCT02757352|584653164|FG009|Follow-Up Period|Adverse Event|0|||
161892293|NCT02757352|584653155|FG000|Follow-Up Period|Lost to Follow-up|0|||
161892294|NCT02757352|584653156|FG001|Follow-Up Period|Lost to Follow-up|0|||
161892295|NCT02757352|584653157|FG002|Follow-Up Period|Lost to Follow-up|0|||
161892296|NCT02757352|584653158|FG003|Follow-Up Period|Lost to Follow-up|0|||
161892297|NCT02757352|584653159|FG004|Follow-Up Period|Lost to Follow-up|0|||
161892298|NCT02757352|584653160|FG005|Follow-Up Period|Lost to Follow-up|0|||
161892299|NCT02757352|584653161|FG006|Follow-Up Period|Lost to Follow-up|0|||
161892300|NCT02757352|584653162|FG007|Follow-Up Period|Lost to Follow-up|0|||
161892301|NCT02757352|584653163|FG008|Follow-Up Period|Lost to Follow-up|1|||
161892302|NCT02757352|584653164|FG009|Follow-Up Period|Lost to Follow-up|0|||
161892303|NCT02757352|584653155|FG000|Follow-Up Period|Lack of Efficacy|0|||
161892304|NCT02757352|584653156|FG001|Follow-Up Period|Lack of Efficacy|0|||
161892305|NCT02757352|584653157|FG002|Follow-Up Period|Lack of Efficacy|0|||
161892306|NCT02757352|584653158|FG003|Follow-Up Period|Lack of Efficacy|0|||
161892307|NCT02757352|584653159|FG004|Follow-Up Period|Lack of Efficacy|0|||
161892308|NCT02757352|584653160|FG005|Follow-Up Period|Lack of Efficacy|0|||
161892309|NCT02757352|584653161|FG006|Follow-Up Period|Lack of Efficacy|0|||
161892310|NCT02757352|584653162|FG007|Follow-Up Period|Lack of Efficacy|0|||
161892311|NCT02757352|584653163|FG008|Follow-Up Period|Lack of Efficacy|1|||
161892312|NCT02757352|584653164|FG009|Follow-Up Period|Lack of Efficacy|1|||
161892313|NCT02757352|584653155|FG000|Follow-Up Period|Withdrawal by Subject|0|||
161995650|NCT01045694|585034153|FG000|Overall Study|Withdrawal by Subject|2|||
161995651|NCT01657292|585034154|FG000|Overall Study|Adverse Event|6|||
161995652|NCT01657292|585034154|FG000|Overall Study|Withdrawal by Subject|2|||
161995653|NCT01657292|585034154|FG000|Overall Study|Violation of eligibility criteria|1|||
161995654|NCT01657292|585034154|FG000|Overall Study|Change of therapy|1|||
161995655|NCT01900652|585034155|FG000|Overall Study|Progressive Disease|1|||
161995656|NCT01900652|585034156|FG001|Overall Study|Progressive Disease|0|||
161995657|NCT01900652|585034155|FG000|Overall Study|Consent withdrawn by subject|1|||
161995658|NCT01900652|585034156|FG001|Overall Study|Consent withdrawn by subject|1|||
161995659|NCT01900652|585034155|FG000|Overall Study|Death|3|||
161995660|NCT01900652|585034156|FG001|Overall Study|Death|0|||
161995661|NCT01900652|585034155|FG000|Overall Study|Adverse Event|2|||
161995662|NCT01900652|585034156|FG001|Overall Study|Adverse Event|1|||
161995663|NCT01900652|585034155|FG000|Overall Study|Physician Decision|1|||
161995664|NCT01900652|585034156|FG001|Overall Study|Physician Decision|1|||
161995665|NCT03761810|585034157|FG000|Overall Study|Adverse Event|12|||
161995666|NCT03761810|585034158|FG001|Overall Study|Adverse Event|0|||
161995667|NCT03761810|585034157|FG000|Overall Study|Lost to Follow-up|15|||
161995668|NCT03761810|585034158|FG001|Overall Study|Lost to Follow-up|7|||
161995669|NCT03761810|585034157|FG000|Overall Study|Pregnancy|1|||
161995670|NCT03761810|585034158|FG001|Overall Study|Pregnancy|0|||
161995671|NCT03761810|585034157|FG000|Overall Study|Withdrawal by Subject|14|||
161995672|NCT03761810|585034158|FG001|Overall Study|Withdrawal by Subject|5|||
161892314|NCT02757352|584653156|FG001|Follow-Up Period|Withdrawal by Subject|0|||
161892315|NCT02757352|584653157|FG002|Follow-Up Period|Withdrawal by Subject|0|||
161892316|NCT02757352|584653158|FG003|Follow-Up Period|Withdrawal by Subject|0|||
161892317|NCT02757352|584653159|FG004|Follow-Up Period|Withdrawal by Subject|0|||
161995673|NCT03761810|585034157|FG000|Overall Study|Physician Decision|1|||
161995674|NCT03761810|585034158|FG001|Overall Study|Physician Decision|0|||
161995675|NCT03761810|585034157|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
161995676|NCT03761810|585034158|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161995677|NCT03761810|585034157|FG000|Overall Study|Other Than Specified|1|||
161892318|NCT02757352|584653160|FG005|Follow-Up Period|Withdrawal by Subject|0|||
161892319|NCT02757352|584653161|FG006|Follow-Up Period|Withdrawal by Subject|0|||
161892320|NCT02757352|584653162|FG007|Follow-Up Period|Withdrawal by Subject|1|||
161892321|NCT02757352|584653163|FG008|Follow-Up Period|Withdrawal by Subject|6|||
161892322|NCT02757352|584653164|FG009|Follow-Up Period|Withdrawal by Subject|2|||
161892323|NCT04750278|584653165|FG000|Overall Study|Death|9|||
161892324|NCT04750278|584653166|FG001|Overall Study|Death|10|||
161892325|NCT04750278|584653167|FG002|Overall Study|Death|10|||
161892326|NCT04750278|584653165|FG000|Overall Study|Withdrawal by Subject|4|||
161892327|NCT04750278|584653166|FG001|Overall Study|Withdrawal by Subject|1|||
161892328|NCT04750278|584653167|FG002|Overall Study|Withdrawal by Subject|2|||
161892329|NCT04750278|584653165|FG000|Overall Study|Lost to Follow-up|1|||
161892330|NCT04750278|584653166|FG001|Overall Study|Lost to Follow-up|1|||
161892331|NCT04750278|584653167|FG002|Overall Study|Lost to Follow-up|1|||
161892332|NCT04750278|584653165|FG000|Overall Study|Pregnancy|1|||
161892333|NCT04750278|584653166|FG001|Overall Study|Pregnancy|0|||
161892334|NCT04750278|584653167|FG002|Overall Study|Pregnancy|0|||
161892335|NCT04750278|584653165|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
161892336|NCT04750278|584653166|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
161892337|NCT04750278|584653167|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
161892338|NCT04750278|584653165|FG000|Overall Study|Non-compliance|0|||
161892339|NCT04750278|584653166|FG001|Overall Study|Non-compliance|0|||
161892340|NCT04750278|584653167|FG002|Overall Study|Non-compliance|1|||
161892341|NCT04750278|584653165|FG000|Overall Study|Transfer to Outside Facility|0|||
161892342|NCT04750278|584653166|FG001|Overall Study|Transfer to Outside Facility|2|||
161892343|NCT04750278|584653167|FG002|Overall Study|Transfer to Outside Facility|1|||
161892344|NCT04750278|584653165|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
161892345|NCT04750278|584653166|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
161892346|NCT04750278|584653167|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
162039399|NCT01907100|585201546|FG002|Overall Study|Protocol Violation|1|||
162039400|NCT01907100|585201547|FG003|Overall Study|Protocol Violation|1|||
162039401|NCT01907100|585201544|FG000|Overall Study|Lost to Follow-up|0|||
162039402|NCT01907100|585201545|FG001|Overall Study|Lost to Follow-up|0|||
162039403|NCT01907100|585201546|FG002|Overall Study|Lost to Follow-up|0|||
162039404|NCT01907100|585201547|FG003|Overall Study|Lost to Follow-up|1|||
162039405|NCT01907100|585201544|FG000|Overall Study|Not treated|2|||
162039406|NCT01907100|585201545|FG001|Overall Study|Not treated|0|||
162039407|NCT01907100|585201546|FG002|Overall Study|Not treated|1|||
162039408|NCT01907100|585201547|FG003|Overall Study|Not treated|2|||
162039409|NCT01907100|585201544|FG000|Overall Study|Other than reasons specified|1|||
162039410|NCT01907100|585201545|FG001|Overall Study|Other than reasons specified|0|||
162039411|NCT01907100|585201546|FG002|Overall Study|Other than reasons specified|10|||
162039412|NCT01907100|585201547|FG003|Overall Study|Other than reasons specified|6|||
162039413|NCT01907100|585201544|FG000|Overall Study|Adverse event (AE)|6|||
162039414|NCT01907100|585201545|FG001|Overall Study|Adverse event (AE)|3|||
162039415|NCT01907100|585201546|FG002|Overall Study|Adverse event (AE)|22|||
162039416|NCT01907100|585201547|FG003|Overall Study|Adverse event (AE)|23|||
162039417|NCT01907100|585201544|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
162039418|NCT01907100|585201545|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
162039419|NCT01907100|585201546|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
162039420|NCT01907100|585201547|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
162039421|NCT01758289|585201548|FG000|Overall Study|Premature Study Termination|44|||
162039422|NCT01758289|585201548|FG000|Overall Study|Adverse Event|9|||
162039423|NCT01574079|585201549|FG000|Overall Study|Physician Decision|0|||
162039424|NCT01574079|585201550|FG001|Overall Study|Physician Decision|2|||
162039425|NCT01574079|585201549|FG000|Overall Study|Lost to Follow-up|1|||
162039426|NCT01574079|585201550|FG001|Overall Study|Lost to Follow-up|0|||
162039427|NCT02059005|585201553|FG000|Overall Study|Death|1|||
162039428|NCT02059005|585201554|FG001|Overall Study|Death|3|||
162039429|NCT02059005|585201553|FG000|Overall Study|Lost to Follow-up|19|||
162039430|NCT02059005|585201554|FG001|Overall Study|Lost to Follow-up|19|||
162039431|NCT02059005|585201553|FG000|Overall Study|Incarceration|0|||
162039432|NCT02059005|585201554|FG001|Overall Study|Incarceration|1|||
162039433|NCT02059005|585201553|FG000|Overall Study|Inpatient|0|||
162039434|NCT02059005|585201554|FG001|Overall Study|Inpatient|1|||
162039435|NCT00908011|585201555|FG000|Overall Study|Withdrawal by Subject|2|||
162039436|NCT00908011|585201556|FG001|Overall Study|Withdrawal by Subject|2|||
162039437|NCT00843726|585201557|FG000|Overall Study|Death|1|||
162039438|NCT00843726|585201558|FG001|Overall Study|Death|0|||
162039439|NCT00843726|585201557|FG000|Overall Study|Withdrawal by Subject|0|||
161892347|NCT04750278|584653165|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
161892348|NCT04750278|584653166|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
161892349|NCT04750278|584653167|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
162039440|NCT00843726|585201558|FG001|Overall Study|Withdrawal by Subject|1|||
162039441|NCT00667602|585201559|FG000|Overall Study|Withdrawal by Subject|4|||
161892350|NCT01212159|584653168|FG000|Overall Study|Withdrawal by Subject|12|||
161892351|NCT01212159|584653169|FG001|Overall Study|Withdrawal by Subject|12|||
161892352|NCT01299896|584653170|FG000|Overall Study|Withdrawal by Subject|1|||
161892353|NCT01299896|584653171|FG001|Overall Study|Withdrawal by Subject|7|||
161892354|NCT01299896|584653170|FG000|Overall Study|Lost to Follow-up|0|||
161892355|NCT01299896|584653171|FG001|Overall Study|Lost to Follow-up|11|||
161892356|NCT03488563|584653172|FG000|Overall Study|Lost to Follow-up|7|||
161892357|NCT03488563|584653173|FG001|Overall Study|Lost to Follow-up|6|||
161892358|NCT03488563|584653174|FG002|Overall Study|Lost to Follow-up|7|||
161892359|NCT03488563|584653172|FG000|Overall Study|Withdrawal by Subject|8|||
161892360|NCT03488563|584653173|FG001|Overall Study|Withdrawal by Subject|7|||
161892361|NCT03488563|584653174|FG002|Overall Study|Withdrawal by Subject|7|||
161892362|NCT03488563|584653172|FG000|Overall Study|Physician Decision|0|||
161892363|NCT03488563|584653173|FG001|Overall Study|Physician Decision|0|||
161892364|NCT03488563|584653174|FG002|Overall Study|Physician Decision|1|||
161892365|NCT03488563|584653172|FG000|Overall Study|Protocol Violation|3|||
161892366|NCT03488563|584653173|FG001|Overall Study|Protocol Violation|2|||
161892367|NCT03488563|584653174|FG002|Overall Study|Protocol Violation|6|||
161892368|NCT03488563|584653172|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
161892369|NCT03488563|584653173|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
161892370|NCT03488563|584653174|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
161892371|NCT03488563|584653172|FG000|Overall Study|Use of prohibited medication|2|||
161892372|NCT03488563|584653173|FG001|Overall Study|Use of prohibited medication|0|||
161892373|NCT03488563|584653174|FG002|Overall Study|Use of prohibited medication|0|||
161892374|NCT03488563|584653172|FG000|Overall Study|Adverse Event|1|||
161892375|NCT03488563|584653173|FG001|Overall Study|Adverse Event|0|||
161892376|NCT03488563|584653174|FG002|Overall Study|Adverse Event|1|||
161892377|NCT03488563|584653172|FG000|Overall Study|Subject returned for ET visit|0|||
161892378|NCT03488563|584653173|FG001|Overall Study|Subject returned for ET visit|1|||
161892379|NCT03488563|584653174|FG002|Overall Study|Subject returned for ET visit|0|||
161892380|NCT03488563|584653172|FG000|Overall Study|Sponsor's decision|0|||
161892381|NCT03488563|584653173|FG001|Overall Study|Sponsor's decision|0|||
161892382|NCT03488563|584653174|FG002|Overall Study|Sponsor's decision|1|||
161892383|NCT02626000|584653191|FG000|Overall Study|Decision by Sponsor|1|||
161892384|NCT02626000|584653191|FG000|Overall Study|Death|29|||
161892385|NCT01467271|584653194|FG000|Overall Study|Death|84|||
161892386|NCT01467271|584653194|FG000|Overall Study|Lost to Follow-up|83|||
161892387|NCT01467271|584653194|FG000|Overall Study|Retraction of patient's consent|21|||
161892388|NCT01467271|584653194|FG000|Overall Study|Other reason|14|||
161892389|NCT01411319|584653218|FG000|Overall Study|Lost to Follow-up|1|||
161892390|NCT02815267|584653219|FG000|Double-Blind Phase|Adverse Event|0|||
161892391|NCT02815267|584653220|FG001|Double-Blind Phase|Adverse Event|3|||
161892392|NCT02815267|584653219|FG000|Double-Blind Phase|Lost to Follow-up|17|||
161892393|NCT02815267|584653220|FG001|Double-Blind Phase|Lost to Follow-up|9|||
161892394|NCT02815267|584653219|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
161892395|NCT02815267|584653220|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
161892396|NCT02815267|584653219|FG000|Double-Blind Phase|Protocol Violation|3|||
161892397|NCT02815267|584653220|FG001|Double-Blind Phase|Protocol Violation|2|||
161892398|NCT02815267|584653219|FG000|Double-Blind Phase|Site withdrawal|1|||
161892399|NCT02815267|584653220|FG001|Double-Blind Phase|Site withdrawal|6|||
161892400|NCT02815267|584653219|FG000|Double-Blind Phase|Received a disallowed medication|1|||
161892401|NCT02815267|584653220|FG001|Double-Blind Phase|Received a disallowed medication|1|||
161892402|NCT02815267|584653219|FG000|Open-Label Phase|Adverse Event|1|||
161892403|NCT02815267|584653220|FG001|Open-Label Phase|Adverse Event|1|||
161892404|NCT02815267|584653219|FG000|Open-Label Phase|Lost to Follow-up|23|||
161892405|NCT02815267|584653220|FG001|Open-Label Phase|Lost to Follow-up|9|||
161892406|NCT02815267|584653219|FG000|Open-Label Phase|Withdrawal by Subject|24|||
161892407|NCT02815267|584653220|FG001|Open-Label Phase|Withdrawal by Subject|13|||
161892408|NCT02815267|584653219|FG000|Open-Label Phase|Protocol Violation|0|||
161892409|NCT02815267|584653220|FG001|Open-Label Phase|Protocol Violation|1|||
161892410|NCT02815267|584653219|FG000|Open-Label Phase|Administrative|21|||
161892411|NCT02815267|584653220|FG001|Open-Label Phase|Administrative|12|||
161892412|NCT02815267|584653219|FG000|Open-Label Phase|Other|2|||
161892413|NCT02815267|584653220|FG001|Open-Label Phase|Other|5|||
162039442|NCT00667602|585201560|FG001|Overall Study|Withdrawal by Subject|9|||
162039443|NCT00667602|585201561|FG002|Overall Study|Withdrawal by Subject|10|||
161892414|NCT04126317|584653237|FG000|Overall Study|Adverse Event|0|||
161892415|NCT04126317|584653238|FG001|Overall Study|Adverse Event|1|||
161892416|NCT04126317|584653237|FG000|Overall Study|Withdrawal by Subject|4|||
161892417|NCT04126317|584653238|FG001|Overall Study|Withdrawal by Subject|1|||
161892418|NCT01796301|584653241|FG000|Overall Study|Withdrawal by Subject|15|||
161892419|NCT01796301|584653242|FG001|Overall Study|Withdrawal by Subject|15|||
161892420|NCT01796301|584653241|FG000|Overall Study|Lost to Follow-up|3|||
161892421|NCT01796301|584653242|FG001|Overall Study|Lost to Follow-up|3|||
161892422|NCT01796301|584653241|FG000|Overall Study|Death|0|||
161892423|NCT01796301|584653242|FG001|Overall Study|Death|1|||
161892424|NCT01796301|584653241|FG000|Overall Study|Decision by Sponsor|0|||
161892425|NCT01796301|584653242|FG001|Overall Study|Decision by Sponsor|1|||
161892426|NCT00660595|584653243|FG000|Overall Study|Lost to Follow-up|0|||
161892427|NCT00660595|584653244|FG001|Overall Study|Lost to Follow-up|1|||
161892428|NCT00660595|584653243|FG000|Overall Study|Did not consent to participate in study|12|||
161892429|NCT00660595|584653244|FG001|Overall Study|Did not consent to participate in study|8|||
161892430|NCT00660595|584653243|FG000|Overall Study|Participant left hospital|1|||
161892431|NCT00660595|584653244|FG001|Overall Study|Participant left hospital|0|||
161892432|NCT00660595|584653243|FG000|Overall Study|Non Specified reasons|5|||
161892433|NCT00660595|584653244|FG001|Overall Study|Non Specified reasons|0|||
161892434|NCT00339833|584653255|FG000|Overall Study|Withdrawal by Subject|1|||
161892435|NCT00339833|584653256|FG001|Overall Study|Withdrawal by Subject|2|||
161892436|NCT00339833|584653255|FG000|Overall Study|toothache|0|||
161892437|NCT00339833|584653256|FG001|Overall Study|toothache|1|||
161892438|NCT00339833|584653255|FG000|Overall Study|indigestion|0|||
161892439|NCT00339833|584653256|FG001|Overall Study|indigestion|1|||
161892440|NCT00339833|584653255|FG000|Overall Study|Chest pain|0|||
161892441|NCT00339833|584653256|FG001|Overall Study|Chest pain|1|||
161892442|NCT00339833|584653255|FG000|Overall Study|minor infection|0|||
161892443|NCT00339833|584653256|FG001|Overall Study|minor infection|1|||
161892444|NCT00339833|584653255|FG000|Overall Study|Poor venous access|2|||
161892445|NCT00339833|584653256|FG001|Overall Study|Poor venous access|2|||
161892446|NCT00339833|584653255|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
161892447|NCT00339833|584653256|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
161892448|NCT00339833|584653255|FG000|Overall Study|Error in data records|1|||
161892449|NCT00339833|584653256|FG001|Overall Study|Error in data records|0|||
161892450|NCT00217581|584653257|FG000|Overall Study|Withdrawal by Subject|1|||
161892451|NCT02829047|584653258|FG000|Overall Study|Withdrawal by Subject|1|||
161892452|NCT01204918|584653278|FG000|Overall Study|Withdrawal by Subject|4|||
161892453|NCT01204918|584653279|FG001|Overall Study|Withdrawal by Subject|10|||
161892454|NCT01204918|584653280|FG002|Overall Study|Withdrawal by Subject|5|||
161892455|NCT00269477|584653285|FG000|Overall Study|Protocol Violation|5|||
161892456|NCT00269477|584653286|FG001|Overall Study|Protocol Violation|5|||
161892457|NCT00269477|584653287|FG002|Overall Study|Protocol Violation|1|||
161892458|NCT00269477|584653288|FG003|Overall Study|Protocol Violation|0|||
161892459|NCT00269477|584653285|FG000|Overall Study|Missed post-vaccination blood draw|0|||
161892460|NCT00269477|584653286|FG001|Overall Study|Missed post-vaccination blood draw|1|||
161892461|NCT00269477|584653287|FG002|Overall Study|Missed post-vaccination blood draw|0|||
162039444|NCT00667602|585201559|FG000|Overall Study|Lost to Follow-up|4|||
162039445|NCT00667602|585201560|FG001|Overall Study|Lost to Follow-up|5|||
162039446|NCT00667602|585201561|FG002|Overall Study|Lost to Follow-up|6|||
162039447|NCT00667602|585201559|FG000|Overall Study|Administrative reason|0|||
162039448|NCT00667602|585201560|FG001|Overall Study|Administrative reason|0|||
162039449|NCT00667602|585201561|FG002|Overall Study|Administrative reason|2|||
162039450|NCT00667602|585201559|FG000|Overall Study|Protocol Violation|0|||
162039451|NCT00667602|585201560|FG001|Overall Study|Protocol Violation|1|||
162039452|NCT00667602|585201561|FG002|Overall Study|Protocol Violation|0|||
162039453|NCT01436162|585201564|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
162039454|NCT01436162|585201565|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
162039455|NCT01436162|585201566|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
162039456|NCT01436162|585201564|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
162039457|NCT01436162|585201565|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
162039458|NCT01436162|585201566|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
162039459|NCT01436162|585201564|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
162039460|NCT01436162|585201565|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
162039461|NCT01436162|585201566|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
162039462|NCT01436162|585201564|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
162039463|NCT01436162|585201565|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
162039464|NCT01436162|585201566|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
162039465|NCT01436162|585201564|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
162039466|NCT01436162|585201565|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
162039467|NCT01436162|585201566|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
162039468|NCT01436162|585201564|FG000|Single-blind Lead-in Phase|Other|107|||
162039469|NCT01436162|585201565|FG001|Single-blind Lead-in Phase|Other|0|||
162039470|NCT01436162|585201566|FG002|Single-blind Lead-in Phase|Other|0|||
162039471|NCT01436162|585201564|FG000|Randomized Phase|Adverse Event|1|||
162039472|NCT01436162|585201565|FG001|Randomized Phase|Adverse Event|5|||
162039473|NCT01436162|585201566|FG002|Randomized Phase|Adverse Event|6|||
162039474|NCT01436162|585201564|FG000|Randomized Phase|Protocol Violation|4|||
162039475|NCT01436162|585201565|FG001|Randomized Phase|Protocol Violation|4|||
161892462|NCT00269477|584653288|FG003|Overall Study|Missed post-vaccination blood draw|0|||
161892463|NCT01404949|584653289|FG000|Overall Study|Not Treated|1|||
161892464|NCT02007278|584653290|FG000|Overall Study|Failure to comply with an eligibility|0|||
161892465|NCT02007278|584653291|FG001|Overall Study|Failure to comply with an eligibility|1|||
161892466|NCT02007278|584653290|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
161892467|NCT02007278|584653291|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
161892468|NCT02007278|584653290|FG000|Overall Study|Incorrect medication administration|1|||
161892469|NCT02007278|584653291|FG001|Overall Study|Incorrect medication administration|0|||
161892470|NCT02007278|584653290|FG000|Overall Study|Mis-randomization|1|||
161892471|NCT02007278|584653291|FG001|Overall Study|Mis-randomization|1|||
161892472|NCT02886884|584653294|FG000|Follow-up|Withdrawal by Subject|0|||
161892473|NCT02886884|584653295|FG001|Follow-up|Withdrawal by Subject|0|||
161892474|NCT02886884|584653296|FG002|Follow-up|Withdrawal by Subject|0|||
161892475|NCT02886884|584653297|FG003|Follow-up|Withdrawal by Subject|1|||
161892476|NCT02651688|584653301|FG000|Overall Study|Non-compliance|0|||
161892477|NCT02651688|584653302|FG001|Overall Study|Non-compliance|0|||
161892478|NCT02651688|584653303|FG002|Overall Study|Non-compliance|1|||
161892479|NCT02651688|584653301|FG000|Overall Study|Principal Investigator (PI) decision|0|||
161892480|NCT02651688|584653302|FG001|Overall Study|Principal Investigator (PI) decision|2|||
161892481|NCT02651688|584653303|FG002|Overall Study|Principal Investigator (PI) decision|0|||
161892482|NCT02651688|584653301|FG000|Overall Study|Lost to Follow-up|1|||
161892483|NCT02651688|584653302|FG001|Overall Study|Lost to Follow-up|3|||
161892484|NCT02651688|584653303|FG002|Overall Study|Lost to Follow-up|0|||
161892485|NCT02651688|584653301|FG000|Overall Study|Withdrawal by Subject|1|||
161892486|NCT02651688|584653302|FG001|Overall Study|Withdrawal by Subject|0|||
161892487|NCT02651688|584653303|FG002|Overall Study|Withdrawal by Subject|2|||
161892488|NCT00625183|584653304|FG000|Overall Study|Disease Progression|1|||
161892489|NCT01429441|584653305|FG000|Overall Study|Adverse Event|5|||
161892490|NCT01429441|584653306|FG001|Overall Study|Adverse Event|1|||
161892491|NCT01429441|584653305|FG000|Overall Study|Death|0|||
161892492|NCT01429441|584653306|FG001|Overall Study|Death|2|||
161892493|NCT01429441|584653305|FG000|Overall Study|Lost to Follow-up|5|||
161892494|NCT01429441|584653306|FG001|Overall Study|Lost to Follow-up|2|||
161892495|NCT01429441|584653305|FG000|Overall Study|Physician Decision|1|||
161892496|NCT01429441|584653306|FG001|Overall Study|Physician Decision|0|||
161892497|NCT01429441|584653305|FG000|Overall Study|Withdrawal by Subject|27|||
161892498|NCT01429441|584653306|FG001|Overall Study|Withdrawal by Subject|18|||
161892499|NCT01606748|584653308|FG000|Overall Study|Adverse Event|1|||
161892500|NCT01606748|584653309|FG001|Overall Study|Adverse Event|0|||
161892501|NCT01606748|584653308|FG000|Overall Study|Progressive Disease|1|||
161892502|NCT01606748|584653309|FG001|Overall Study|Progressive Disease|0|||
161892503|NCT01606748|584653308|FG000|Overall Study|Withdrawal by Subject|1|||
161892504|NCT01606748|584653309|FG001|Overall Study|Withdrawal by Subject|0|||
161892505|NCT02670382|584653311|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
161892506|NCT02670382|584653312|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
161892507|NCT03244618|584653313|FG000|Overall Study|Lost to Follow-up|3|||
161892508|NCT03244618|584653314|FG001|Overall Study|Lost to Follow-up|4|||
161892509|NCT03244618|584653313|FG000|Overall Study|Protocol Violation|4|||
161892510|NCT03244618|584653314|FG001|Overall Study|Protocol Violation|3|||
162039476|NCT01436162|585201566|FG002|Randomized Phase|Protocol Violation|2|||
162039477|NCT01436162|585201564|FG000|Randomized Phase|Withdrawal by Subject|16|||
162039478|NCT01436162|585201565|FG001|Randomized Phase|Withdrawal by Subject|9|||
162039479|NCT01436162|585201566|FG002|Randomized Phase|Withdrawal by Subject|8|||
162039480|NCT01436162|585201564|FG000|Randomized Phase|Lost to Follow-up|17|||
162039481|NCT01436162|585201565|FG001|Randomized Phase|Lost to Follow-up|5|||
162039482|NCT01436162|585201566|FG002|Randomized Phase|Lost to Follow-up|4|||
162039483|NCT01436162|585201564|FG000|Randomized Phase|Lack of Efficacy|0|||
162039484|NCT01436162|585201565|FG001|Randomized Phase|Lack of Efficacy|1|||
162039485|NCT01436162|585201566|FG002|Randomized Phase|Lack of Efficacy|1|||
162039486|NCT01436162|585201564|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
162039487|NCT01436162|585201565|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
162039488|NCT01436162|585201566|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
162039489|NCT01436162|585201564|FG000|Randomized Phase|Other|2|||
162039490|NCT01436162|585201565|FG001|Randomized Phase|Other|5|||
162039491|NCT01436162|585201566|FG002|Randomized Phase|Other|4|||
162039492|NCT04382755|585201567|FG000|Overall Study|Withdrawal by Subject|1|||
162039493|NCT04382755|585201568|FG001|Overall Study|Withdrawal by Subject|0|||
162039494|NCT04382755|585201567|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
161892511|NCT03244618|584653313|FG000|Overall Study|Withdrawal by Subject|0|||
161892512|NCT03244618|584653314|FG001|Overall Study|Withdrawal by Subject|2|||
161892513|NCT02155322|584653315|FG000|Overall Study|Adverse Event|1|||
161892514|NCT02155322|584653315|FG000|Overall Study|Physician Decision|1|||
161892515|NCT02155322|584653315|FG000|Overall Study|Relapse/Recurrence|8|||
161892516|NCT02155322|584653315|FG000|Overall Study|Withdrawal by Subject|4|||
161892517|NCT04776018|584653319|FG000|Overall Study|Death|0|||
161892518|NCT04776018|584653320|FG001|Overall Study|Death|1|||
161892519|NCT04776018|584653321|FG002|Overall Study|Death|4|||
161892520|NCT04776018|584653322|FG003|Overall Study|Death|1|||
161892521|NCT04776018|584653323|FG004|Overall Study|Death|4|||
161892522|NCT04776018|584653324|FG005|Overall Study|Death|0|||
162039495|NCT04382755|585201568|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
162039496|NCT04382755|585201567|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
162048500|NCT04545060|585233343|FG001|Overall Study|Physician Decision|0|||
161892523|NCT04776018|584653325|FG006|Overall Study|Death|0|||
161892524|NCT04776018|584653319|FG000|Overall Study|Study terminated by sponsor|2|||
161892525|NCT04776018|584653320|FG001|Overall Study|Study terminated by sponsor|1|||
161892526|NCT04776018|584653321|FG002|Overall Study|Study terminated by sponsor|4|||
161892527|NCT04776018|584653322|FG003|Overall Study|Study terminated by sponsor|0|||
161892528|NCT04776018|584653323|FG004|Overall Study|Study terminated by sponsor|3|||
161892529|NCT04776018|584653324|FG005|Overall Study|Study terminated by sponsor|0|||
161892530|NCT04776018|584653325|FG006|Overall Study|Study terminated by sponsor|0|||
161892531|NCT04776018|584653319|FG000|Overall Study|Withdrawal by Subject|1|||
161892532|NCT04776018|584653320|FG001|Overall Study|Withdrawal by Subject|0|||
161892533|NCT04776018|584653321|FG002|Overall Study|Withdrawal by Subject|0|||
161892534|NCT04776018|584653322|FG003|Overall Study|Withdrawal by Subject|2|||
161892535|NCT04776018|584653323|FG004|Overall Study|Withdrawal by Subject|1|||
161892536|NCT04776018|584653324|FG005|Overall Study|Withdrawal by Subject|0|||
161892537|NCT04776018|584653325|FG006|Overall Study|Withdrawal by Subject|0|||
161892538|NCT04776018|584653319|FG000|Overall Study|Other|0|||
161892539|NCT04776018|584653320|FG001|Overall Study|Other|1|||
161892540|NCT04776018|584653321|FG002|Overall Study|Other|1|||
161892541|NCT04776018|584653322|FG003|Overall Study|Other|0|||
161892542|NCT04776018|584653323|FG004|Overall Study|Other|0|||
161892543|NCT04776018|584653324|FG005|Overall Study|Other|0|||
161892544|NCT04776018|584653325|FG006|Overall Study|Other|0|||
161892545|NCT04776018|584653319|FG000|Overall Study|Lost to Follow-up|0|||
161892546|NCT04776018|584653320|FG001|Overall Study|Lost to Follow-up|0|||
161892547|NCT04776018|584653321|FG002|Overall Study|Lost to Follow-up|1|||
161892548|NCT04776018|584653322|FG003|Overall Study|Lost to Follow-up|0|||
161892549|NCT04776018|584653323|FG004|Overall Study|Lost to Follow-up|0|||
161892550|NCT04776018|584653324|FG005|Overall Study|Lost to Follow-up|0|||
161892551|NCT04776018|584653325|FG006|Overall Study|Lost to Follow-up|0|||
161892552|NCT03396822|584655046|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
161892553|NCT03396822|584655046|FG000|Overall Study|Physician Decision|1|||
161892554|NCT03536663|584655051|FG000|Endexo|Protocol Violation|1|||
161892555|NCT01128400|584655052|FG000|Overall Study|Lost to Follow-up|1|||
161892556|NCT01128400|584655053|FG001|Overall Study|Lost to Follow-up|0|||
161892557|NCT01128400|584655054|FG002|Overall Study|Lost to Follow-up|1|||
161892558|NCT01128400|584655052|FG000|Overall Study|Screening failure|1|||
161892559|NCT01128400|584655053|FG001|Overall Study|Screening failure|0|||
161892560|NCT01128400|584655054|FG002|Overall Study|Screening failure|0|||
161892561|NCT01128400|584655052|FG000|Overall Study|were not invited to participate on taste|0|||
161892562|NCT01128400|584655053|FG001|Overall Study|were not invited to participate on taste|0|||
161892563|NCT01128400|584655054|FG002|Overall Study|were not invited to participate on taste|15|||
161892564|NCT01128400|584655052|FG000|Overall Study|Excluded due to sinus problems|0|||
161892565|NCT01128400|584655053|FG001|Overall Study|Excluded due to sinus problems|1|||
161892566|NCT01128400|584655054|FG002|Overall Study|Excluded due to sinus problems|0|||
161892567|NCT03782571|584655060|FG000|Period 1|Withdrawal by Subject|1|||
161892568|NCT03782571|584655061|FG001|Period 1|Withdrawal by Subject|0|||
161892569|NCT03782571|584655062|FG002|Period 1|Withdrawal by Subject|0|||
161892570|NCT03782571|584655063|FG003|Period 1|Withdrawal by Subject|0|||
161892571|NCT03782571|584655060|FG000|Period 3|Subject Unable to Attend V5|1|||
161892572|NCT03782571|584655061|FG001|Period 3|Subject Unable to Attend V5|0|||
161892573|NCT03782571|584655062|FG002|Period 3|Subject Unable to Attend V5|0|||
161892574|NCT03782571|584655063|FG003|Period 3|Subject Unable to Attend V5|0|||
161892575|NCT03782571|584655060|FG000|Period 3|Adverse Event|1|||
161892576|NCT03782571|584655061|FG001|Period 3|Adverse Event|0|||
161892577|NCT03782571|584655062|FG002|Period 3|Adverse Event|0|||
161892578|NCT03782571|584655063|FG003|Period 3|Adverse Event|0|||
161892579|NCT03504189|584655064|FG000|Overall Study|Withdrawal by Subject|1|||
161892580|NCT03504189|584655064|FG000|Overall Study|Screening Failure|1|||
161892581|NCT03504189|584655064|FG000|Overall Study|Device Failure|2|||
161995678|NCT03761810|585034158|FG001|Overall Study|Other Than Specified|0|||
161995679|NCT04178720|585034159|FG000|Overall Study|Withdrawal by Subject|2|||
161995680|NCT04178720|585034160|FG001|Overall Study|Withdrawal by Subject|0|||
161892582|NCT01597492|584655065|FG000|Overall Study|Withdrawal by Subject|1|||
161892583|NCT01597492|584655066|FG001|Overall Study|Withdrawal by Subject|2|||
161892584|NCT01597492|584655065|FG000|Overall Study|Adverse Event|3|||
161892585|NCT01597492|584655066|FG001|Overall Study|Adverse Event|0|||
161892586|NCT01597492|584655065|FG000|Overall Study|Lost to Follow-up|0|||
161892587|NCT01597492|584655066|FG001|Overall Study|Lost to Follow-up|2|||
161892588|NCT01597492|584655065|FG000|Overall Study|Other Reason|2|||
161892589|NCT01597492|584655066|FG001|Overall Study|Other Reason|0|||
161892590|NCT02570750|584655067|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
161892591|NCT02570750|584655068|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
161892592|NCT02570750|584655067|FG000|Overall Study|Protocol deviation|4|||
161892593|NCT02570750|584655068|FG001|Overall Study|Protocol deviation|2|||
161892594|NCT02570750|584655067|FG000|Overall Study|Withdrawal by Subject|5|||
161892595|NCT02570750|584655068|FG001|Overall Study|Withdrawal by Subject|0|||
161892596|NCT02570750|584655067|FG000|Overall Study|Lost to Follow-up|2|||
161892597|NCT02570750|584655068|FG001|Overall Study|Lost to Follow-up|2|||
161892598|NCT02570750|584655067|FG000|Overall Study|Adverse Event|2|||
161892599|NCT02570750|584655068|FG001|Overall Study|Adverse Event|1|||
161892600|NCT01884545|584655069|FG000|Overall Study|Lost to Follow-up|6|||
161892601|NCT01884545|584655070|FG001|Overall Study|Lost to Follow-up|4|||
161892602|NCT01884545|584655071|FG002|Overall Study|Lost to Follow-up|9|||
161892603|NCT01884545|584655072|FG003|Overall Study|Lost to Follow-up|4|||
161892604|NCT01884545|584655069|FG000|Overall Study|Patient withdrawn|7|||
161892605|NCT01884545|584655070|FG001|Overall Study|Patient withdrawn|12|||
161892606|NCT01884545|584655071|FG002|Overall Study|Patient withdrawn|5|||
161892607|NCT01884545|584655072|FG003|Overall Study|Patient withdrawn|5|||
161892608|NCT01884545|584655069|FG000|Overall Study|Non-adherence|0|||
161892609|NCT01884545|584655070|FG001|Overall Study|Non-adherence|2|||
161892610|NCT01884545|584655071|FG002|Overall Study|Non-adherence|0|||
161892611|NCT01884545|584655072|FG003|Overall Study|Non-adherence|0|||
161892612|NCT01410240|584655073|FG000|Overall Study|Physician Decision|0|||
161892613|NCT01410240|584655074|FG001|Overall Study|Physician Decision|0|||
161892614|NCT01410240|584655075|FG002|Overall Study|Physician Decision|1|||
161892615|NCT01410240|584655073|FG000|Overall Study|Missed week 6 assessments|1|||
161892616|NCT01410240|584655074|FG001|Overall Study|Missed week 6 assessments|1|||
161892617|NCT01410240|584655075|FG002|Overall Study|Missed week 6 assessments|1|||
161892618|NCT00496587|584655076|FG000|Overall Study|Adverse Event|2|||
161892619|NCT00496587|584655076|FG000|Overall Study|Progressive Disease|24|||
161892620|NCT00496587|584655076|FG000|Overall Study|Withdrawal by Subject|2|||
161892621|NCT00496587|584655076|FG000|Overall Study|Death|1|||
161892622|NCT00496587|584655076|FG000|Overall Study|Complications unrelated|2|||
161892623|NCT00482170|584655078|FG000|Overall Study|Adverse Event|5|||
161892624|NCT00482170|584655079|FG001|Overall Study|Adverse Event|14|||
161892625|NCT00482170|584655078|FG000|Overall Study|Withdrawal by Subject|6|||
161892626|NCT00482170|584655079|FG001|Overall Study|Withdrawal by Subject|1|||
161892627|NCT00482170|584655078|FG000|Overall Study|Protocol Violation|2|||
161892628|NCT00482170|584655079|FG001|Overall Study|Protocol Violation|3|||
161892629|NCT00482170|584655078|FG000|Overall Study|Lost to Follow-up|2|||
161892630|NCT00482170|584655079|FG001|Overall Study|Lost to Follow-up|0|||
161892631|NCT00482170|584655078|FG000|Overall Study|Unspecified reason|0|||
161892632|NCT00482170|584655079|FG001|Overall Study|Unspecified reason|2|||
161892633|NCT00592592|584655083|FG000|Overall Study|Patient found ineligible upon chart review|1|||
161892634|NCT01134263|584655084|FG000|Overall Study|Serious adverse event|2|||
161892635|NCT01134263|584655085|FG001|Overall Study|Serious adverse event|1|||
161892636|NCT01134263|584655086|FG002|Overall Study|Serious adverse event|1|||
161892637|NCT01134263|584655087|FG003|Overall Study|Serious adverse event|1|||
161892638|NCT01134263|584655088|FG004|Overall Study|Serious adverse event|1|||
161892639|NCT01134263|584655084|FG000|Overall Study|Other adverse event|1|||
161892640|NCT01134263|584655085|FG001|Overall Study|Other adverse event|2|||
161892641|NCT01134263|584655086|FG002|Overall Study|Other adverse event|5|||
161892642|NCT01134263|584655087|FG003|Overall Study|Other adverse event|3|||
161892643|NCT01134263|584655088|FG004|Overall Study|Other adverse event|0|||
161892644|NCT01134263|584655084|FG000|Overall Study|Protocol Violation|8|||
161892645|NCT01134263|584655085|FG001|Overall Study|Protocol Violation|7|||
161892646|NCT01134263|584655086|FG002|Overall Study|Protocol Violation|2|||
161892647|NCT01134263|584655087|FG003|Overall Study|Protocol Violation|4|||
161892648|NCT01134263|584655088|FG004|Overall Study|Protocol Violation|2|||
161892649|NCT01134263|584655084|FG000|Overall Study|Lost to Follow-up|4|||
161892650|NCT01134263|584655085|FG001|Overall Study|Lost to Follow-up|3|||
161892651|NCT01134263|584655086|FG002|Overall Study|Lost to Follow-up|5|||
161892652|NCT01134263|584655087|FG003|Overall Study|Lost to Follow-up|3|||
161892653|NCT01134263|584655088|FG004|Overall Study|Lost to Follow-up|1|||
161892654|NCT01134263|584655084|FG000|Overall Study|Withdrawal by Subject|8|||
161892655|NCT01134263|584655085|FG001|Overall Study|Withdrawal by Subject|6|||
161892656|NCT01134263|584655086|FG002|Overall Study|Withdrawal by Subject|16|||
161892657|NCT01134263|584655087|FG003|Overall Study|Withdrawal by Subject|7|||
161892658|NCT01134263|584655088|FG004|Overall Study|Withdrawal by Subject|5|||
161892659|NCT01134263|584655084|FG000|Overall Study|Enrolled, but not treated|1|||
161892660|NCT01134263|584655085|FG001|Overall Study|Enrolled, but not treated|1|||
161892661|NCT01134263|584655086|FG002|Overall Study|Enrolled, but not treated|0|||
161892662|NCT01134263|584655087|FG003|Overall Study|Enrolled, but not treated|1|||
161892663|NCT01134263|584655088|FG004|Overall Study|Enrolled, but not treated|0|||
161892664|NCT01557517|584655089|FG000|Overall Study|Death|1|||
161892665|NCT01557517|584655090|FG001|Overall Study|Death|0|||
161892666|NCT01557517|584655089|FG000|Overall Study|Refused further treatment|0|||
161892667|NCT01557517|584655090|FG001|Overall Study|Refused further treatment|2|||
161892668|NCT01557517|584655089|FG000|Overall Study|Adverse Event|0|||
161892669|NCT01557517|584655090|FG001|Overall Study|Adverse Event|2|||
161892670|NCT01557517|584655089|FG000|Overall Study|Pt declined before treatment started|1|||
161892671|NCT01557517|584655090|FG001|Overall Study|Pt declined before treatment started|0|||
161892672|NCT00162097|584655091|FG000|Overall Study|Participant no longer met study criteria|0|||
161892673|NCT00162097|584655092|FG001|Overall Study|Participant no longer met study criteria|0|||
161892674|NCT00162097|584655093|FG002|Overall Study|Participant no longer met study criteria|0|||
161892675|NCT00162097|584655094|FG003|Overall Study|Participant no longer met study criteria|1|||
161892676|NCT00770913|584655095|FG000|Overall Study|Adverse Event|1|||
161892677|NCT00770913|584655096|FG001|Overall Study|Adverse Event|3|||
161892678|NCT00770913|584655097|FG002|Overall Study|Adverse Event|6|||
161892679|NCT00770913|584655095|FG000|Overall Study|Refusal to continue participation|6|||
161892680|NCT00770913|584655096|FG001|Overall Study|Refusal to continue participation|4|||
161892681|NCT00770913|584655097|FG002|Overall Study|Refusal to continue participation|5|||
161892682|NCT00770913|584655095|FG000|Overall Study|Physician Decision|0|||
161892683|NCT00770913|584655096|FG001|Overall Study|Physician Decision|1|||
161892684|NCT00770913|584655097|FG002|Overall Study|Physician Decision|1|||
161892685|NCT00770913|584655095|FG000|Overall Study|Protocol Violation|3|||
161892686|NCT00770913|584655096|FG001|Overall Study|Protocol Violation|0|||
161892687|NCT00770913|584655097|FG002|Overall Study|Protocol Violation|1|||
161892688|NCT00770913|584655095|FG000|Overall Study|Incorrect drug was allocated|1|||
161892689|NCT00770913|584655096|FG001|Overall Study|Incorrect drug was allocated|0|||
161892690|NCT00770913|584655097|FG002|Overall Study|Incorrect drug was allocated|0|||
161892691|NCT01134393|584655098|FG000|Overall Study|Adverse Event|18|||
161892692|NCT01134393|584655098|FG000|Overall Study|Lack of Efficacy|2|||
161892693|NCT01134393|584655098|FG000|Overall Study|Protocol Violation|12|||
161892694|NCT01134393|584655098|FG000|Overall Study|Lost to Follow-up|3|||
161892695|NCT01134393|584655098|FG000|Overall Study|Withdrawal by Subject|11|||
161892696|NCT01134393|584655098|FG000|Overall Study|Other|6|||
161892697|NCT00575510|584655105|FG000|Overall Study|Lost to Follow-up|4|||
161892698|NCT00575510|584655106|FG001|Overall Study|Lost to Follow-up|6|||
161892699|NCT00575510|584655107|FG002|Overall Study|Lost to Follow-up|9|||
161892700|NCT00575510|584655105|FG000|Overall Study|Withdrawal by Subject|1|||
161892701|NCT00575510|584655106|FG001|Overall Study|Withdrawal by Subject|0|||
161892702|NCT00575510|584655107|FG002|Overall Study|Withdrawal by Subject|0|||
161892703|NCT00575510|584655105|FG000|Overall Study|Clinic Called Patient|7|||
161892704|NCT00575510|584655106|FG001|Overall Study|Clinic Called Patient|7|||
161892705|NCT00575510|584655107|FG002|Overall Study|Clinic Called Patient|7|||
161892706|NCT00575510|584655105|FG000|Overall Study|Pregnancy|0|||
161892707|NCT00575510|584655106|FG001|Overall Study|Pregnancy|0|||
161892708|NCT00575510|584655107|FG002|Overall Study|Pregnancy|1|||
161892709|NCT02697734|584655108|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
161892710|NCT02697734|584655109|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
161892711|NCT02697734|584655108|FG000|Core Phase - up to Week 48|Adverse Event|1|||
161892712|NCT02697734|584655109|FG001|Core Phase - up to Week 48|Adverse Event|2|||
161892713|NCT02697734|584655108|FG000|Core Phase - up to Week 48|Physician Decision|1|||
161892714|NCT02697734|584655109|FG001|Core Phase - up to Week 48|Physician Decision|0|||
161892715|NCT02697734|584655108|FG000|Optional Extension Phase|Adverse Event|5|||
161892716|NCT02697734|584655109|FG001|Optional Extension Phase|Adverse Event|1|||
161892717|NCT02697734|584655108|FG000|Optional Extension Phase|Physician Decision|0|||
161892718|NCT02697734|584655109|FG001|Optional Extension Phase|Physician Decision|1|||
161892719|NCT03970200|584655110|FG000|Overall Study|Death|2|||
161892720|NCT03970200|584655111|FG001|Overall Study|Death|2|||
161892721|NCT03970200|584655112|FG002|Overall Study|Death|1|||
161892722|NCT03970200|584655110|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
161892723|NCT03970200|584655111|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
161892724|NCT03970200|584655112|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
161995681|NCT04178720|585034159|FG000|Overall Study|Relocation|0|||
161892725|NCT02279745|584655113|FG000|Overall Study|Adverse Event|7|||
161995682|NCT04178720|585034160|FG001|Overall Study|Relocation|1|||
161995683|NCT00869518|585034161|FG000|Overall Study|Lost to Follow-up|1|||
161995684|NCT00869518|585034162|FG001|Overall Study|Lost to Follow-up|1|||
161995685|NCT03566082|585034163|FG000|Overall Study|Death|7|||
161995686|NCT03566082|585034163|FG000|Overall Study|Failures (revision required)|2|||
161995687|NCT03566082|585034163|FG000|Overall Study|Lost to Follow-up|8|||
161995688|NCT03922620|585034164|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
161995689|NCT03922620|585034165|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
161995690|NCT00983385|585034166|FG000|Observation Period|Not eligible to be dosed|20|||
161995691|NCT00983385|585034166|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
161995692|NCT02663622|585034167|FG000|Overall Study|Death|3|||
161995693|NCT02663622|585034168|FG001|Overall Study|Death|1|||
161892726|NCT02279745|584655113|FG000|Overall Study|Death|6|||
161892727|NCT02279745|584655113|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
161892728|NCT02279745|584655113|FG000|Overall Study|Withdrawal by Subject|2|||
161892729|NCT02279745|584655113|FG000|Overall Study|Pregnancy|1|||
161892730|NCT02279745|584655113|FG000|Overall Study|Study Non-compliance|1|||
161892731|NCT02279745|584655113|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
161892732|NCT01706575|584655117|FG000|Overall Study|Participant Withdrew Consent|4|||
161892733|NCT01706575|584655117|FG000|Overall Study|Lost to Follow-up|2|||
161892734|NCT01706575|584655117|FG000|Overall Study|Started but not Treated|6|||
161892735|NCT03469999|584655122|FG000|Overall Study|Lost to Follow-up|2|||
161892736|NCT01863732|584655123|FG000|Overall Study|Adverse Event|2|||
161995694|NCT02663622|585034169|FG002|Overall Study|Death|1|||
161995695|NCT02663622|585034170|FG003|Overall Study|Death|8|||
161995696|NCT02663622|585034167|FG000|Overall Study|Protocol Violation|0|||
162039497|NCT04382755|585201568|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
162039498|NCT04041700|585201573|FG000|Overall Study|Pregnancy|1|||
162039499|NCT04041700|585201573|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
162039500|NCT00458536|585201576|FG000|Overall Study|Disease progression prior to treatment|7|||
162039501|NCT00458536|585201576|FG000|Overall Study|Unable to make vaccine|3|||
162039502|NCT00458536|585201576|FG000|Overall Study|No measurable disease after surgery|2|||
162039503|NCT00458536|585201576|FG000|Overall Study|Did not have renal cell carcinoma|2|||
162039504|NCT00458536|585201576|FG000|Overall Study|Patient did not have surgery|1|||
162039505|NCT00458536|585201576|FG000|Overall Study|Ineligible due to toxicity|1|||
162039506|NCT00458536|585201576|FG000|Overall Study|Withdrawal by Subject|1|||
162039507|NCT00458536|585201576|FG000|Overall Study|Progressive disease during treatment|2|||
162039508|NCT00285207|585201577|FG000|Overall Study|Lost to Follow-up|3|||
162039509|NCT00285207|585201578|FG001|Overall Study|Lost to Follow-up|2|||
162039510|NCT00285207|585201577|FG000|Overall Study|Withdrawal by Subject|5|||
162039511|NCT00285207|585201578|FG001|Overall Study|Withdrawal by Subject|2|||
162039512|NCT00285207|585201577|FG000|Overall Study|Pregnancy|1|||
162039513|NCT00285207|585201578|FG001|Overall Study|Pregnancy|1|||
162039514|NCT00285207|585201577|FG000|Overall Study|non-compliance|0|||
162039515|NCT00285207|585201578|FG001|Overall Study|non-compliance|1|||
162039516|NCT05419908|585201579|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
162039517|NCT05419908|585201580|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
162039518|NCT05419908|585201579|FG000|Overall Study|Serious Adverse Event|0|||
162039519|NCT05419908|585201580|FG001|Overall Study|Serious Adverse Event|2|||
162039520|NCT05419908|585201579|FG000|Overall Study|Withdrawal by Subject|2|||
162039521|NCT05419908|585201580|FG001|Overall Study|Withdrawal by Subject|0|||
162039522|NCT05419908|585201579|FG000|Overall Study|Miscellaneous|1|||
162039523|NCT05419908|585201580|FG001|Overall Study|Miscellaneous|1|||
162039524|NCT03670836|585201581|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
162039525|NCT03670836|585201582|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
162039526|NCT03670836|585201581|FG000|Per Protocol Population (PP)|Physician Decision|9|||
162039527|NCT03670836|585201582|FG001|Per Protocol Population (PP)|Physician Decision|10|||
162039528|NCT03670836|585201581|FG000|Per Protocol Population (PP)|Physician Decision|4|||
162039529|NCT03670836|585201582|FG001|Per Protocol Population (PP)|Physician Decision|6|||
162039530|NCT03670836|585201581|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
162039531|NCT03670836|585201582|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
162039532|NCT02160782|585202946|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
162039533|NCT02160782|585202947|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
161892737|NCT01863732|584655124|FG001|Overall Study|Adverse Event|0|||
161892738|NCT01863732|584655125|FG002|Overall Study|Adverse Event|3|||
161892739|NCT01863732|584655126|FG003|Overall Study|Adverse Event|3|||
161892740|NCT01863732|584655123|FG000|Overall Study|Lack of Efficacy|1|||
161892741|NCT01863732|584655124|FG001|Overall Study|Lack of Efficacy|0|||
161892742|NCT01863732|584655125|FG002|Overall Study|Lack of Efficacy|2|||
161892743|NCT01863732|584655126|FG003|Overall Study|Lack of Efficacy|1|||
161892744|NCT01863732|584655123|FG000|Overall Study|Lost to Follow-up|2|||
161892745|NCT01863732|584655124|FG001|Overall Study|Lost to Follow-up|2|||
161892746|NCT01863732|584655125|FG002|Overall Study|Lost to Follow-up|1|||
161892747|NCT01863732|584655126|FG003|Overall Study|Lost to Follow-up|1|||
161892748|NCT01863732|584655123|FG000|Overall Study|Physician Decision|1|||
161892749|NCT01863732|584655124|FG001|Overall Study|Physician Decision|0|||
161892750|NCT01863732|584655125|FG002|Overall Study|Physician Decision|1|||
161892751|NCT01863732|584655126|FG003|Overall Study|Physician Decision|0|||
161892752|NCT01863732|584655123|FG000|Overall Study|Pregnancy|0|||
162039534|NCT02160782|585202948|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
162039535|NCT02160782|585202949|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
162039536|NCT02160782|585202950|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
161892753|NCT01863732|584655124|FG001|Overall Study|Pregnancy|0|||
162039537|NCT02160782|585202946|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
162039538|NCT02160782|585202947|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
162039539|NCT02160782|585202948|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
162039540|NCT02160782|585202949|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
161892754|NCT01863732|584655125|FG002|Overall Study|Pregnancy|0|||
162039541|NCT02160782|585202950|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
162039542|NCT02160782|585202946|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
161892755|NCT01863732|584655126|FG003|Overall Study|Pregnancy|1|||
161892756|NCT01863732|584655123|FG000|Overall Study|Technical problems|0|||
161892757|NCT01863732|584655124|FG001|Overall Study|Technical problems|1|||
161892758|NCT01863732|584655125|FG002|Overall Study|Technical problems|1|||
161892759|NCT01863732|584655126|FG003|Overall Study|Technical problems|0|||
161892760|NCT01863732|584655123|FG000|Overall Study|Subject/guardian decision|6|||
161892761|NCT01863732|584655124|FG001|Overall Study|Subject/guardian decision|9|||
161892762|NCT01863732|584655125|FG002|Overall Study|Subject/guardian decision|3|||
161995697|NCT02663622|585034168|FG001|Overall Study|Protocol Violation|0|||
161995698|NCT02663622|585034169|FG002|Overall Study|Protocol Violation|0|||
161995699|NCT02663622|585034170|FG003|Overall Study|Protocol Violation|1|||
161995700|NCT00930930|585034172|FG000|Overall Study|Death|1|||
161995701|NCT00930930|585034173|FG001|Overall Study|Death|0|||
161995702|NCT00930930|585034172|FG000|Overall Study|Physician Decision|1|||
161995703|NCT00930930|585034173|FG001|Overall Study|Physician Decision|0|||
161995704|NCT00930930|585034172|FG000|Overall Study|Adverse Event|13|||
161995705|NCT00930930|585034173|FG001|Overall Study|Adverse Event|3|||
161995706|NCT00930930|585034172|FG000|Overall Study|Withdrawal by Subject|3|||
161995707|NCT00930930|585034173|FG001|Overall Study|Withdrawal by Subject|1|||
161995708|NCT00930930|585034172|FG000|Overall Study|Disease progression|2|||
161995709|NCT00930930|585034173|FG001|Overall Study|Disease progression|3|||
161995710|NCT00930930|585034172|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
161995711|NCT00930930|585034173|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
161995712|NCT00930930|585034172|FG000|Overall Study|patients not compliant|1|||
161995713|NCT00930930|585034173|FG001|Overall Study|patients not compliant|1|||
161995714|NCT00511238|585034174|FG000|Overall Study|Adverse Event|13|||
161995715|NCT00511238|585034175|FG001|Overall Study|Adverse Event|33|||
161995716|NCT00511238|585034174|FG000|Overall Study|Withdrawal by Subject|2|||
161995717|NCT00511238|585034175|FG001|Overall Study|Withdrawal by Subject|22|||
161995718|NCT00511238|585034174|FG000|Overall Study|Progressive Disease|23|||
161995719|NCT00511238|585034175|FG001|Overall Study|Progressive Disease|157|||
161995720|NCT00511238|585034174|FG000|Overall Study|various reasons|4|||
161995721|NCT00511238|585034175|FG001|Overall Study|various reasons|14|||
161995722|NCT00163020|585034176|FG000|Overall Study|Lost to Follow-up|0|||
161995723|NCT00163020|585034177|FG001|Overall Study|Lost to Follow-up|2|||
161995724|NCT03790111|585036261|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
161995725|NCT00985673|585036264|FG000|Overall Study|Lost to Follow-up|6|||
161995726|NCT00985673|585036265|FG001|Overall Study|Lost to Follow-up|7|||
161995727|NCT00985673|585036266|FG002|Overall Study|Lost to Follow-up|6|||
161995728|NCT00985673|585036267|FG003|Overall Study|Lost to Follow-up|10|||
161995729|NCT00985673|585036268|FG004|Overall Study|Lost to Follow-up|5|||
161995730|NCT00985673|585036269|FG005|Overall Study|Lost to Follow-up|3|||
161995731|NCT00985673|585036264|FG000|Overall Study|Withdrawal by Subject|0|||
161995732|NCT00985673|585036265|FG001|Overall Study|Withdrawal by Subject|4|||
161995733|NCT00985673|585036266|FG002|Overall Study|Withdrawal by Subject|5|||
161995734|NCT00985673|585036267|FG003|Overall Study|Withdrawal by Subject|2|||
161995735|NCT00985673|585036268|FG004|Overall Study|Withdrawal by Subject|2|||
161995736|NCT00985673|585036269|FG005|Overall Study|Withdrawal by Subject|3|||
161995737|NCT00985673|585036264|FG000|Overall Study|Other|1|||
161995738|NCT00985673|585036265|FG001|Overall Study|Other|0|||
161995739|NCT00985673|585036266|FG002|Overall Study|Other|1|||
161995740|NCT00985673|585036267|FG003|Overall Study|Other|0|||
161995741|NCT00985673|585036268|FG004|Overall Study|Other|1|||
161995742|NCT00985673|585036269|FG005|Overall Study|Other|0|||
161995743|NCT02252146|585036270|FG000|Overall Study|Lack of Efficacy|4|||
161995744|NCT02252146|585036270|FG000|Overall Study|Entered hospice care|1|||
161995745|NCT02252146|585036270|FG000|Overall Study|Inability to travel to study site|1|||
161995746|NCT00531284|585036271|FG000|Overall Study|Progressive Disease|1|||
161995747|NCT00531284|585036272|FG001|Overall Study|Progressive Disease|3|||
161995748|NCT00531284|585036273|FG002|Overall Study|Progressive Disease|5|||
161995749|NCT00531284|585036274|FG003|Overall Study|Progressive Disease|42|||
161995750|NCT00531284|585036275|FG004|Overall Study|Progressive Disease|4|||
161995751|NCT00531284|585036276|FG005|Overall Study|Progressive Disease|4|||
161995752|NCT00531284|585036277|FG006|Overall Study|Progressive Disease|3|||
161995753|NCT00531284|585036278|FG007|Overall Study|Progressive Disease|8|||
161995754|NCT00531284|585036279|FG008|Overall Study|Progressive Disease|6|||
161995755|NCT00531284|585036280|FG009|Overall Study|Progressive Disease|3|||
161995756|NCT00531284|585036281|FG010|Overall Study|Progressive Disease|3|||
161995757|NCT00531284|585036282|FG011|Overall Study|Progressive Disease|14|||
161995758|NCT00531284|585036283|FG012|Overall Study|Progressive Disease|2|||
161995759|NCT00531284|585036284|FG013|Overall Study|Progressive Disease|1|||
161995760|NCT00531284|585036285|FG014|Overall Study|Progressive Disease|2|||
161995761|NCT00531284|585036286|FG015|Overall Study|Progressive Disease|11|||
161995762|NCT00531284|585036287|FG016|Overall Study|Progressive Disease|5|||
161995763|NCT00531284|585036271|FG000|Overall Study|Adverse Event|0|||
161995764|NCT00531284|585036272|FG001|Overall Study|Adverse Event|1|||
161995765|NCT00531284|585036273|FG002|Overall Study|Adverse Event|1|||
161995766|NCT00531284|585036274|FG003|Overall Study|Adverse Event|7|||
161995767|NCT00531284|585036275|FG004|Overall Study|Adverse Event|0|||
161995768|NCT00531284|585036276|FG005|Overall Study|Adverse Event|2|||
161995769|NCT00531284|585036277|FG006|Overall Study|Adverse Event|3|||
161995770|NCT00531284|585036278|FG007|Overall Study|Adverse Event|2|||
161995771|NCT00531284|585036279|FG008|Overall Study|Adverse Event|3|||
161995772|NCT00531284|585036280|FG009|Overall Study|Adverse Event|0|||
161995773|NCT00531284|585036281|FG010|Overall Study|Adverse Event|0|||
161995774|NCT00531284|585036282|FG011|Overall Study|Adverse Event|5|||
161995775|NCT00531284|585036283|FG012|Overall Study|Adverse Event|0|||
161995776|NCT00531284|585036284|FG013|Overall Study|Adverse Event|1|||
161892763|NCT01863732|584655126|FG003|Overall Study|Subject/guardian decision|1|||
161892764|NCT01863732|584655123|FG000|Overall Study|Death|1|||
161892765|NCT01863732|584655124|FG001|Overall Study|Death|0|||
161892766|NCT01863732|584655125|FG002|Overall Study|Death|0|||
161892767|NCT01863732|584655126|FG003|Overall Study|Death|1|||
161892768|NCT01215435|584655132|FG000|Overall Study|Adverse Event|1|||
161892769|NCT01215435|584655133|FG001|Overall Study|Adverse Event|0|||
161892770|NCT01215435|584655132|FG000|Overall Study|Protocol Violation|2|||
161892771|NCT01215435|584655133|FG001|Overall Study|Protocol Violation|0|||
161892772|NCT01215435|584655132|FG000|Overall Study|Withdrawal Criteria|8|||
161892773|NCT01215435|584655133|FG001|Overall Study|Withdrawal Criteria|11|||
161892774|NCT01215435|584655132|FG000|Overall Study|Lost to Follow-up|3|||
161892775|NCT01215435|584655133|FG001|Overall Study|Lost to Follow-up|0|||
161892776|NCT01215435|584655132|FG000|Overall Study|Unclassified|5|||
161892777|NCT01215435|584655133|FG001|Overall Study|Unclassified|5|||
161892778|NCT00840034|584655134|FG000|Acute Treatment Phase|Adverse Event|6|||
161892779|NCT00840034|584655135|FG001|Acute Treatment Phase|Adverse Event|8|||
161892780|NCT00840034|584655134|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
161892781|NCT00840034|584655135|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
161892782|NCT00840034|584655134|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
161892783|NCT00840034|584655135|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
161892784|NCT00840034|584655134|FG000|Acute Treatment Phase|Physician Decision|0|||
161892785|NCT00840034|584655135|FG001|Acute Treatment Phase|Physician Decision|1|||
161892786|NCT00840034|584655134|FG000|Acute Treatment Phase|Protocol Violation|2|||
161892787|NCT00840034|584655135|FG001|Acute Treatment Phase|Protocol Violation|4|||
161995777|NCT00531284|585036285|FG014|Overall Study|Adverse Event|1|||
161995778|NCT00531284|585036286|FG015|Overall Study|Adverse Event|0|||
161995779|NCT00531284|585036287|FG016|Overall Study|Adverse Event|2|||
161995780|NCT00531284|585036271|FG000|Overall Study|Withdrawal by Subject|1|||
161995781|NCT00531284|585036272|FG001|Overall Study|Withdrawal by Subject|0|||
161995782|NCT00531284|585036273|FG002|Overall Study|Withdrawal by Subject|0|||
161995783|NCT00531284|585036274|FG003|Overall Study|Withdrawal by Subject|4|||
161995784|NCT00531284|585036275|FG004|Overall Study|Withdrawal by Subject|0|||
161995785|NCT00531284|585036276|FG005|Overall Study|Withdrawal by Subject|0|||
161995786|NCT00531284|585036277|FG006|Overall Study|Withdrawal by Subject|0|||
161995787|NCT00531284|585036278|FG007|Overall Study|Withdrawal by Subject|0|||
161995788|NCT00531284|585036279|FG008|Overall Study|Withdrawal by Subject|0|||
161995789|NCT00531284|585036280|FG009|Overall Study|Withdrawal by Subject|0|||
161995790|NCT00531284|585036281|FG010|Overall Study|Withdrawal by Subject|0|||
161995791|NCT00531284|585036282|FG011|Overall Study|Withdrawal by Subject|3|||
161995792|NCT00531284|585036283|FG012|Overall Study|Withdrawal by Subject|0|||
161995793|NCT00531284|585036284|FG013|Overall Study|Withdrawal by Subject|1|||
161995794|NCT00531284|585036285|FG014|Overall Study|Withdrawal by Subject|0|||
161995795|NCT00531284|585036286|FG015|Overall Study|Withdrawal by Subject|1|||
161995796|NCT00531284|585036287|FG016|Overall Study|Withdrawal by Subject|1|||
161995797|NCT00531284|585036271|FG000|Overall Study|Other|1|||
161995798|NCT00531284|585036272|FG001|Overall Study|Other|0|||
161995799|NCT00531284|585036273|FG002|Overall Study|Other|0|||
161995800|NCT00531284|585036274|FG003|Overall Study|Other|10|||
161995801|NCT00531284|585036275|FG004|Overall Study|Other|2|||
161995802|NCT00531284|585036276|FG005|Overall Study|Other|1|||
161995803|NCT00531284|585036277|FG006|Overall Study|Other|0|||
161995804|NCT00531284|585036278|FG007|Overall Study|Other|0|||
161995805|NCT00531284|585036279|FG008|Overall Study|Other|2|||
161995806|NCT00531284|585036280|FG009|Overall Study|Other|1|||
161995807|NCT00531284|585036281|FG010|Overall Study|Other|0|||
161995808|NCT00531284|585036282|FG011|Overall Study|Other|2|||
161995809|NCT00531284|585036283|FG012|Overall Study|Other|0|||
161995810|NCT00531284|585036284|FG013|Overall Study|Other|0|||
161995811|NCT00531284|585036285|FG014|Overall Study|Other|1|||
161995812|NCT00531284|585036286|FG015|Overall Study|Other|0|||
161995813|NCT00531284|585036287|FG016|Overall Study|Other|0|||
161995814|NCT03057496|585036288|FG000|Overall Study|Withdrawal by Subject|8|||
161995815|NCT03057496|585036288|FG000|Overall Study|Lost to Follow-up|5|||
161995816|NCT03057496|585036288|FG000|Overall Study|Did not use device during home trial|3|||
161995817|NCT03057496|585036288|FG000|Overall Study|Device failure|2|||
161995818|NCT00280917|585036289|FG000|Overall Study|Adverse Event|1|||
161995819|NCT00280917|585036290|FG001|Overall Study|Adverse Event|1|||
161995820|NCT00280917|585036291|FG002|Overall Study|Adverse Event|4|||
161995821|NCT00280917|585036292|FG003|Overall Study|Adverse Event|1|||
161995822|NCT00280917|585036289|FG000|Overall Study|Change Therapy|1|||
161995823|NCT00280917|585036290|FG001|Overall Study|Change Therapy|2|||
161995824|NCT00280917|585036291|FG002|Overall Study|Change Therapy|0|||
161995825|NCT00280917|585036292|FG003|Overall Study|Change Therapy|0|||
161995826|NCT00280917|585036289|FG000|Overall Study|Withdrawal by Subject|0|||
161995827|NCT00280917|585036290|FG001|Overall Study|Withdrawal by Subject|2|||
161995828|NCT00280917|585036291|FG002|Overall Study|Withdrawal by Subject|0|||
161995829|NCT00280917|585036292|FG003|Overall Study|Withdrawal by Subject|1|||
161995830|NCT00280917|585036289|FG000|Overall Study|Noncompliance|0|||
161995831|NCT00280917|585036290|FG001|Overall Study|Noncompliance|1|||
161892788|NCT00840034|584655134|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
161892789|NCT00840034|584655135|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
161892790|NCT00840034|584655134|FG000|Taper Phase|Adverse Event|1|||
161892791|NCT00840034|584655135|FG001|Taper Phase|Adverse Event|0|||
161892792|NCT00840034|584655134|FG000|Taper Phase|Lost to Follow-up|1|||
161892793|NCT00840034|584655135|FG001|Taper Phase|Lost to Follow-up|1|||
161892794|NCT00840034|584655134|FG000|Taper Phase|Withdrawal by Subject|1|||
161892795|NCT00840034|584655135|FG001|Taper Phase|Withdrawal by Subject|1|||
161892796|NCT03383692|584655142|FG000|Overall Study|Progressive disease as per RECIST|3|||
161892797|NCT03383692|584655143|FG001|Overall Study|Progressive disease as per RECIST|3|||
161892798|NCT03383692|584655142|FG000|Overall Study|Clinical progression|0|||
161892799|NCT03383692|584655143|FG001|Overall Study|Clinical progression|1|||
161892800|NCT03383692|584655142|FG000|Overall Study|Adverse Event|3|||
161892801|NCT03383692|584655143|FG001|Overall Study|Adverse Event|0|||
161892802|NCT03816007|584655145|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
161892803|NCT03816007|584655146|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
161892804|NCT03816007|584655145|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
161892805|NCT03816007|584655146|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
161892806|NCT03816007|584655145|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
161892807|NCT03816007|584655146|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
161892808|NCT02179749|584655149|FG000|Overall Study|Adverse Event|0|||
161892809|NCT02179749|584655150|FG001|Overall Study|Adverse Event|0|||
161892810|NCT02179749|584655151|FG002|Overall Study|Adverse Event|1|||
161892811|NCT02179749|584655149|FG000|Overall Study|Withdrawal by Subject|0|||
161892812|NCT02179749|584655150|FG001|Overall Study|Withdrawal by Subject|0|||
161892813|NCT02179749|584655151|FG002|Overall Study|Withdrawal by Subject|1|||
161892814|NCT01810783|584655153|FG000|Overall Study|Adverse Event|32|||
161892815|NCT01810783|584655153|FG000|Overall Study|Withdrawal by Subject|22|||
161892816|NCT01810783|584655153|FG000|Overall Study|Lack of Efficacy|12|||
161892817|NCT01810783|584655153|FG000|Overall Study|Lost to Follow-up|10|||
161892818|NCT01810783|584655153|FG000|Overall Study|Protocol Violation|5|||
161892819|NCT01810783|584655153|FG000|Overall Study|Non-compliance with IMP|4|||
161892820|NCT01810783|584655153|FG000|Overall Study|Adminstrative or other reason(s)|23|||
161892821|NCT01810783|584655153|FG000|Overall Study|Enrolled, not treated|1|||
161892822|NCT00793546|584655154|FG000|Overall Study|Death|3|||
161892823|NCT00793546|584655155|FG001|Overall Study|Death|0|||
161892824|NCT00793546|584655154|FG000|Overall Study|Lost to Follow-up|1|||
161892825|NCT00793546|584655155|FG001|Overall Study|Lost to Follow-up|0|||
161892826|NCT00793546|584655154|FG000|Overall Study|Withdrawal by Subject|1|||
161892827|NCT00793546|584655155|FG001|Overall Study|Withdrawal by Subject|1|||
161892828|NCT00793546|584655154|FG000|Overall Study|Study Terminated by Sponsor|8|||
161892829|NCT00793546|584655155|FG001|Overall Study|Study Terminated by Sponsor|27|||
161892830|NCT00793546|584655154|FG000|Overall Study|Other|1|||
161892831|NCT00793546|584655155|FG001|Overall Study|Other|0|||
161892832|NCT02071082|584655156|FG000|Overall Study|Enrolled and Never Treated|1|||
161892833|NCT02071082|584655157|FG001|Overall Study|Enrolled and Never Treated|1|||
161892834|NCT02071082|584655156|FG000|Overall Study|Adverse Event|0|||
161892835|NCT02071082|584655157|FG001|Overall Study|Adverse Event|1|||
161892836|NCT02071082|584655156|FG000|Overall Study|Withdrew Consent|0|||
161892837|NCT02071082|584655157|FG001|Overall Study|Withdrew Consent|4|||
161892838|NCT02071082|584655156|FG000|Overall Study|Lost to Follow-up|1|||
161892839|NCT02071082|584655157|FG001|Overall Study|Lost to Follow-up|1|||
161892840|NCT00630747|584655159|FG000|Overall Study|Death|1|||
161892841|NCT00630747|584655159|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
161892842|NCT00630747|584655159|FG000|Overall Study|Returned to country of origin|1|||
161892843|NCT00435019|584655162|FG000|Overall Study|Adverse Event|1|||
161892844|NCT00435019|584655163|FG001|Overall Study|Adverse Event|0|||
161892845|NCT00435019|584655162|FG000|Overall Study|Lack of Efficacy|1|||
161892846|NCT00435019|584655163|FG001|Overall Study|Lack of Efficacy|2|||
161892847|NCT00435019|584655162|FG000|Overall Study|Protocol Violation|3|||
161892848|NCT00435019|584655163|FG001|Overall Study|Protocol Violation|1|||
161892849|NCT00435019|584655162|FG000|Overall Study|Personal reasons for withdrawal|8|||
161892850|NCT00435019|584655163|FG001|Overall Study|Personal reasons for withdrawal|7|||
161892851|NCT04503668|584655164|FG000|Overall Study|Incomplete data|4|||
161892852|NCT04503668|584655165|FG001|Overall Study|Incomplete data|3|||
161892853|NCT04503668|584655164|FG000|Overall Study|Withdrawal by Subject|1|||
161892854|NCT04503668|584655165|FG001|Overall Study|Withdrawal by Subject|1|||
161892855|NCT04503668|584655164|FG000|Overall Study|Adverse Event|2|||
161892856|NCT04503668|584655165|FG001|Overall Study|Adverse Event|0|||
161892857|NCT02306694|584655166|FG000|Overall Study|Withdrawal by Subject|3|||
161892858|NCT02306694|584655166|FG000|Overall Study|Lost to Follow-up|1|||
161892859|NCT00603382|584655167|FG000|Overall Study|Adverse Event|0|||
161892860|NCT00603382|584655168|FG001|Overall Study|Adverse Event|1|||
161892861|NCT00603382|584655169|FG002|Overall Study|Adverse Event|1|||
161892862|NCT00603382|584655170|FG003|Overall Study|Adverse Event|2|||
161892863|NCT00603382|584655171|FG004|Overall Study|Adverse Event|1|||
161892864|NCT00603382|584655172|FG005|Overall Study|Adverse Event|2|||
161892865|NCT00603382|584655167|FG000|Overall Study|Lack of Efficacy|14|||
161892866|NCT00603382|584655168|FG001|Overall Study|Lack of Efficacy|9|||
161892867|NCT00603382|584655169|FG002|Overall Study|Lack of Efficacy|3|||
161892868|NCT00603382|584655170|FG003|Overall Study|Lack of Efficacy|6|||
161892869|NCT00603382|584655171|FG004|Overall Study|Lack of Efficacy|6|||
161892870|NCT00603382|584655172|FG005|Overall Study|Lack of Efficacy|11|||
161892871|NCT00603382|584655167|FG000|Overall Study|Protocol Violation|1|||
161892872|NCT00603382|584655168|FG001|Overall Study|Protocol Violation|0|||
161892873|NCT00603382|584655169|FG002|Overall Study|Protocol Violation|1|||
161892874|NCT00603382|584655170|FG003|Overall Study|Protocol Violation|2|||
161892875|NCT00603382|584655171|FG004|Overall Study|Protocol Violation|1|||
161892876|NCT00603382|584655172|FG005|Overall Study|Protocol Violation|0|||
161892877|NCT00603382|584655167|FG000|Overall Study|Lost to Follow-up|0|||
161892878|NCT00603382|584655168|FG001|Overall Study|Lost to Follow-up|1|||
161892879|NCT00603382|584655169|FG002|Overall Study|Lost to Follow-up|1|||
161892880|NCT00603382|584655170|FG003|Overall Study|Lost to Follow-up|1|||
161892881|NCT00603382|584655171|FG004|Overall Study|Lost to Follow-up|0|||
161892882|NCT00603382|584655172|FG005|Overall Study|Lost to Follow-up|1|||
161892883|NCT00603382|584655167|FG000|Overall Study|Physician Decision|0|||
161892884|NCT00603382|584655168|FG001|Overall Study|Physician Decision|0|||
161892885|NCT00603382|584655169|FG002|Overall Study|Physician Decision|2|||
161892886|NCT00603382|584655170|FG003|Overall Study|Physician Decision|0|||
161892887|NCT00603382|584655171|FG004|Overall Study|Physician Decision|1|||
161892888|NCT00603382|584655172|FG005|Overall Study|Physician Decision|3|||
161892889|NCT00603382|584655167|FG000|Overall Study|Withdrawal by Subject|3|||
161892890|NCT00603382|584655168|FG001|Overall Study|Withdrawal by Subject|3|||
161892891|NCT00603382|584655169|FG002|Overall Study|Withdrawal by Subject|1|||
161892892|NCT00603382|584655170|FG003|Overall Study|Withdrawal by Subject|1|||
161892893|NCT00603382|584655171|FG004|Overall Study|Withdrawal by Subject|0|||
161892894|NCT00603382|584655172|FG005|Overall Study|Withdrawal by Subject|1|||
161892895|NCT01078298|584655175|FG000|Overall Study|Lost to Follow-up|12|||
161892896|NCT01078298|584655176|FG001|Overall Study|Lost to Follow-up|13|||
161892897|NCT01078298|584655175|FG000|Overall Study|Withdrawal by Subject|31|||
161892898|NCT01078298|584655176|FG001|Overall Study|Withdrawal by Subject|33|||
161892899|NCT01078298|584655175|FG000|Overall Study|Protocol Violation|6|||
161892900|NCT01078298|584655176|FG001|Overall Study|Protocol Violation|6|||
161892901|NCT01078298|584655175|FG000|Overall Study|Adverse Event|6|||
161892902|NCT01078298|584655176|FG001|Overall Study|Adverse Event|5|||
161892903|NCT01078298|584655175|FG000|Overall Study|Death|2|||
161892904|NCT01078298|584655176|FG001|Overall Study|Death|0|||
161892905|NCT01078298|584655175|FG000|Overall Study|Did not meet entrance criteria|0|||
161892906|NCT01078298|584655176|FG001|Overall Study|Did not meet entrance criteria|1|||
161892907|NCT01078298|584655175|FG000|Overall Study|Other|24|||
161892908|NCT01078298|584655176|FG001|Overall Study|Other|32|||
161892909|NCT00742027|584655177|FG000|Overall Study|Disease Progression|76|||
161892910|NCT00742027|584655177|FG000|Overall Study|New Cancer Therapy|19|||
161892911|NCT00742027|584655177|FG000|Overall Study|Withdrawal by Subject|18|||
161892912|NCT00742027|584655177|FG000|Overall Study|Death|7|||
161892913|NCT00742027|584655177|FG000|Overall Study|Lost to Follow-up|4|||
161892914|NCT00742027|584655177|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
161892915|NCT00742027|584655177|FG000|Overall Study|Missing|2|||
161892916|NCT00742027|584655177|FG000|Overall Study|Administrative Problems|1|||
161892917|NCT01180049|584655178|FG000|Overall Study|Other|9|||
161892918|NCT01180049|584655179|FG001|Overall Study|Other|7|||
161892919|NCT01180049|584655178|FG000|Overall Study|Lost to Follow-up|8|||
161892920|NCT01180049|584655179|FG001|Overall Study|Lost to Follow-up|6|||
161892921|NCT01180049|584655178|FG000|Overall Study|Death|36|||
161892922|NCT01180049|584655179|FG001|Overall Study|Death|35|||
161892923|NCT01764659|584655180|FG000|Overall Study|Death|1|||
161892924|NCT01764659|584655180|FG000|Overall Study|Physician Decision|1|||
161892925|NCT01210352|584655181|FG000|Overall Study|Adverse Event|0|||
161892926|NCT01210352|584655182|FG001|Overall Study|Adverse Event|0|||
161892927|NCT01210352|584655183|FG002|Overall Study|Adverse Event|0|||
161892928|NCT01210352|584655184|FG003|Overall Study|Adverse Event|0|||
161892929|NCT01210352|584655185|FG004|Overall Study|Adverse Event|0|||
161892930|NCT01210352|584655186|FG005|Overall Study|Adverse Event|0|||
161892931|NCT01210352|584655187|FG006|Overall Study|Adverse Event|0|||
161892932|NCT01210352|584655188|FG007|Overall Study|Adverse Event|2|||
161892933|NCT01210352|584655189|FG008|Overall Study|Adverse Event|1|||
161892934|NCT01210352|584655181|FG000|Overall Study|Lack of Efficacy|0|||
161892935|NCT01210352|584655182|FG001|Overall Study|Lack of Efficacy|0|||
161892936|NCT01210352|584655183|FG002|Overall Study|Lack of Efficacy|0|||
161892937|NCT01210352|584655184|FG003|Overall Study|Lack of Efficacy|0|||
161892938|NCT01210352|584655185|FG004|Overall Study|Lack of Efficacy|0|||
161892939|NCT01210352|584655186|FG005|Overall Study|Lack of Efficacy|0|||
161892940|NCT01210352|584655187|FG006|Overall Study|Lack of Efficacy|1|||
161892941|NCT01210352|584655188|FG007|Overall Study|Lack of Efficacy|0|||
161892942|NCT01210352|584655189|FG008|Overall Study|Lack of Efficacy|0|||
161892943|NCT01210352|584655181|FG000|Overall Study|Physician Decision|0|||
161892944|NCT01210352|584655182|FG001|Overall Study|Physician Decision|0|||
161892945|NCT01210352|584655183|FG002|Overall Study|Physician Decision|0|||
161892946|NCT01210352|584655184|FG003|Overall Study|Physician Decision|0|||
161892947|NCT01210352|584655185|FG004|Overall Study|Physician Decision|0|||
161892948|NCT01210352|584655186|FG005|Overall Study|Physician Decision|0|||
161892949|NCT01210352|584655187|FG006|Overall Study|Physician Decision|0|||
161892950|NCT01210352|584655188|FG007|Overall Study|Physician Decision|1|||
161892951|NCT01210352|584655189|FG008|Overall Study|Physician Decision|2|||
161892952|NCT01210352|584655181|FG000|Overall Study|Withdrawal by Subject|0|||
161892953|NCT01210352|584655182|FG001|Overall Study|Withdrawal by Subject|0|||
161892954|NCT01210352|584655183|FG002|Overall Study|Withdrawal by Subject|1|||
161892955|NCT01210352|584655184|FG003|Overall Study|Withdrawal by Subject|0|||
161892956|NCT01210352|584655185|FG004|Overall Study|Withdrawal by Subject|0|||
161892957|NCT01210352|584655186|FG005|Overall Study|Withdrawal by Subject|0|||
161892958|NCT01210352|584655187|FG006|Overall Study|Withdrawal by Subject|1|||
161892959|NCT01210352|584655188|FG007|Overall Study|Withdrawal by Subject|0|||
161892960|NCT01210352|584655189|FG008|Overall Study|Withdrawal by Subject|1|||
161892961|NCT01210352|584655181|FG000|Overall Study|Patient Discharged Early|0|||
161892962|NCT01210352|584655182|FG001|Overall Study|Patient Discharged Early|0|||
161892963|NCT01210352|584655183|FG002|Overall Study|Patient Discharged Early|1|||
161892964|NCT01210352|584655184|FG003|Overall Study|Patient Discharged Early|0|||
161892965|NCT01210352|584655185|FG004|Overall Study|Patient Discharged Early|0|||
161892966|NCT01210352|584655186|FG005|Overall Study|Patient Discharged Early|0|||
161892967|NCT01210352|584655187|FG006|Overall Study|Patient Discharged Early|0|||
161892968|NCT01210352|584655188|FG007|Overall Study|Patient Discharged Early|0|||
161892969|NCT01210352|584655189|FG008|Overall Study|Patient Discharged Early|0|||
161892970|NCT03338569|584655190|FG000|Overall Study|Physician Decision|8|||
161892971|NCT03338569|584655191|FG001|Overall Study|Physician Decision|3|||
161892972|NCT03338569|584655190|FG000|Overall Study|Withdrawal by Subject|0|||
161892973|NCT03338569|584655191|FG001|Overall Study|Withdrawal by Subject|1|||
161892974|NCT03338569|584655190|FG000|Overall Study|Lost to Follow-up|0|||
161892975|NCT03338569|584655191|FG001|Overall Study|Lost to Follow-up|1|||
161892976|NCT02526160|584656768|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
161892977|NCT02526160|584656769|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
161892978|NCT02526160|584656768|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
161892979|NCT02526160|584656769|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
161892980|NCT02526160|584656768|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
161892981|NCT02526160|584656769|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
161892982|NCT02526160|584656768|FG000|Open-Label Treatment Extension Period I|Death|0|||
161892983|NCT02526160|584656769|FG001|Open-Label Treatment Extension Period I|Death|1|||
161892984|NCT02526160|584656768|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
161892985|NCT02526160|584656769|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
161892986|NCT02526160|584656768|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
161892987|NCT02526160|584656769|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
161892988|NCT02526160|584656768|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
161892989|NCT02526160|584656769|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
161892990|NCT02526160|584656768|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
161892991|NCT02526160|584656769|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
161892992|NCT04227405|584656770|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
161892993|NCT04227405|584656771|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
161892994|NCT04227405|584656770|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
161892995|NCT04227405|584656771|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
161892996|NCT04227405|584656770|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
161892997|NCT04227405|584656771|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
161892998|NCT01502956|584656772|FG000|Overall Study|Death|0|||
161892999|NCT01502956|584656773|FG001|Overall Study|Death|2|||
161893000|NCT01502956|584656772|FG000|Overall Study|Lost to Follow-up|14|||
161893001|NCT01502956|584656773|FG001|Overall Study|Lost to Follow-up|11|||
161893002|NCT01502956|584656772|FG000|Overall Study|Physician Decision|2|||
161893003|NCT01502956|584656773|FG001|Overall Study|Physician Decision|3|||
161893004|NCT01502956|584656772|FG000|Overall Study|Withdrawal by Subject|8|||
161893005|NCT01502956|584656773|FG001|Overall Study|Withdrawal by Subject|10|||
161893006|NCT01616758|584656774|FG000|Overall Study|Adverse Event|1|||
161893007|NCT01616758|584656774|FG000|Overall Study|Withdrawal by Subject|2|||
161995832|NCT00280917|585036291|FG002|Overall Study|Noncompliance|2|||
161995833|NCT00280917|585036292|FG003|Overall Study|Noncompliance|0|||
161893008|NCT01616758|584656774|FG000|Overall Study|Disease progression|18|||
161893009|NCT01616758|584656774|FG000|Overall Study|Study termination by Sponsor|1|||
161893010|NCT04076319|584656779|FG000|Overall Study|Withdrawal by Subject|2|||
161893011|NCT04076319|584656780|FG001|Overall Study|Withdrawal by Subject|0|||
161893012|NCT04076319|584656779|FG000|Overall Study|Death|1|||
161893013|NCT04076319|584656780|FG001|Overall Study|Death|0|||
161893014|NCT01054222|584656781|FG000|Overall Study|Lack of Efficacy|1|||
161893015|NCT01054222|584656781|FG000|Overall Study|Lost to Follow-up|4|||
161893016|NCT01054222|584656781|FG000|Overall Study|Withdrawal by Subject|6|||
161893017|NCT03252145|584656785|FG000|Overall Study|Withdrawal by Subject|1|||
161893018|NCT03252145|584656786|FG001|Overall Study|Withdrawal by Subject|0|||
161893019|NCT03252145|584656785|FG000|Overall Study|Complicating Disease|1|||
161893020|NCT03252145|584656786|FG001|Overall Study|Complicating Disease|2|||
161893021|NCT01763827|584656790|FG000|Overall Study|Withdrawal by Subject|1|||
161893022|NCT01763827|584656791|FG001|Overall Study|Withdrawal by Subject|0|||
161893023|NCT01763827|584656792|FG002|Overall Study|Withdrawal by Subject|0|||
161893024|NCT01763827|584656793|FG003|Overall Study|Withdrawal by Subject|0|||
161893025|NCT01763827|584656794|FG004|Overall Study|Withdrawal by Subject|2|||
161893026|NCT01763827|584656795|FG005|Overall Study|Withdrawal by Subject|0|||
161893027|NCT01763827|584656790|FG000|Overall Study|Decision by sponsor|2|||
161893028|NCT01763827|584656791|FG001|Overall Study|Decision by sponsor|0|||
161893029|NCT01763827|584656792|FG002|Overall Study|Decision by sponsor|3|||
161893030|NCT01763827|584656793|FG003|Overall Study|Decision by sponsor|0|||
161893031|NCT01763827|584656794|FG004|Overall Study|Decision by sponsor|2|||
161893032|NCT01763827|584656795|FG005|Overall Study|Decision by sponsor|1|||
161893033|NCT01763827|584656790|FG000|Overall Study|Lost to Follow-up|0|||
161893034|NCT01763827|584656791|FG001|Overall Study|Lost to Follow-up|1|||
161893035|NCT01763827|584656792|FG002|Overall Study|Lost to Follow-up|1|||
161893036|NCT01763827|584656793|FG003|Overall Study|Lost to Follow-up|1|||
161893037|NCT01763827|584656794|FG004|Overall Study|Lost to Follow-up|2|||
161893038|NCT01763827|584656795|FG005|Overall Study|Lost to Follow-up|1|||
161893039|NCT02187029|584656798|FG000|Overall Study|Adverse Event|0|||
161893040|NCT02187029|584656799|FG001|Overall Study|Adverse Event|1|||
161893041|NCT02187029|584656800|FG002|Overall Study|Adverse Event|1|||
161893042|NCT02187029|584656801|FG003|Overall Study|Adverse Event|0|||
161893043|NCT02187029|584656798|FG000|Overall Study|Study Terminated by Sponsor|0|||
161893044|NCT02187029|584656799|FG001|Overall Study|Study Terminated by Sponsor|0|||
161893045|NCT02187029|584656800|FG002|Overall Study|Study Terminated by Sponsor|10|||
161893046|NCT02187029|584656801|FG003|Overall Study|Study Terminated by Sponsor|3|||
161893047|NCT02187029|584656798|FG000|Overall Study|Withdrawal by Subject|1|||
161893048|NCT02187029|584656799|FG001|Overall Study|Withdrawal by Subject|0|||
161893049|NCT02187029|584656800|FG002|Overall Study|Withdrawal by Subject|0|||
161893050|NCT02187029|584656801|FG003|Overall Study|Withdrawal by Subject|0|||
161893051|NCT02985021|584656802|FG000|Overall Study|Inability to comply with study procedures|1|||
161893052|NCT04105842|584656803|FG000|Overall Study|Withdrawal by Subject|2|||
161893053|NCT01535443|584656809|FG000|Overall Study|Physician Decision|3|||
161893054|NCT00760487|584656811|FG000|Overall Study|Unilateral implantation|3|||
161893055|NCT02260817|584656815|FG000|Overall Study|Lost to Follow-up|0|||
161893056|NCT02260817|584656816|FG001|Overall Study|Lost to Follow-up|14|||
161893057|NCT02260817|584656815|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
161893058|NCT02260817|584656816|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
161893059|NCT02260817|584656815|FG000|Overall Study|Observation, no biopsy|0|||
161893060|NCT02260817|584656816|FG001|Overall Study|Observation, no biopsy|1|||
161893061|NCT02260817|584656815|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
161893062|NCT02260817|584656816|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
161893063|NCT02260817|584656815|FG000|Overall Study|Protocol Violation|0|||
161893064|NCT02260817|584656816|FG001|Overall Study|Protocol Violation|14|||
161893065|NCT03299101|584656817|FG000|Overall Study|Lost to Follow-up|1|||
161893066|NCT03299101|584656817|FG000|Overall Study|Withdrawal by Subject|5|||
161893067|NCT03299101|584656817|FG000|Overall Study|Surgery was changed|3|||
161893068|NCT03299101|584656817|FG000|Overall Study|Not enough time to complete prehab|1|||
161893069|NCT04217317|584656820|FG000|Overall Study|Lack of Efficacy|4|||
161893070|NCT04217317|584656820|FG000|Overall Study|Physician Decision|1|||
161893071|NCT00329745|584656821|FG000|Overall Study|Protocol Violation|1|||
161893072|NCT00329745|584656822|FG001|Overall Study|Protocol Violation|0|||
161893073|NCT00329745|584656821|FG000|Overall Study|Withdrawal by Subject|0|||
161893074|NCT00329745|584656822|FG001|Overall Study|Withdrawal by Subject|1|||
161893075|NCT00329745|584656821|FG000|Overall Study|Lost to Follow-up|86|||
161893076|NCT00329745|584656822|FG001|Overall Study|Lost to Follow-up|101|||
161893077|NCT03146741|584656823|FG000|Overall Study|Txp with non-HCV+ heart|4|||
161893078|NCT03146741|584656823|FG000|Overall Study|Listeted for MOT|2|||
161893079|NCT03146741|584656823|FG000|Overall Study|Physician Decision|2|||
161893080|NCT03146741|584656823|FG000|Overall Study|Awaiting txp|2|||
161893081|NCT03224624|584656824|FG000|Overall Study|Lost to Follow-up|9|||
161893082|NCT03224624|584656825|FG001|Overall Study|Lost to Follow-up|4|||
161893083|NCT03224624|584656824|FG000|Overall Study|Death|1|||
161893084|NCT03224624|584656825|FG001|Overall Study|Death|0|||
161893085|NCT01424241|584656828|FG000|Overall Study|Withdrawal by Subject|1|||
161893086|NCT01424241|584656828|FG000|Overall Study|Time constraints|2|||
161995834|NCT03310723|585036297|FG000|Overall Study|Withdrawal by Subject|0|||
161995835|NCT03310723|585036298|FG001|Overall Study|Withdrawal by Subject|1|||
161995836|NCT03310723|585036297|FG000|Overall Study|Protocol Violation|0|||
161893087|NCT03585712|584656836|FG000|Treatment Period 1|Protocol Violation|1|||
161893088|NCT03585712|584656837|FG001|Treatment Period 1|Protocol Violation|0|||
161893089|NCT03585712|584656838|FG002|Treatment Period 1|Protocol Violation|0|||
161893090|NCT03585712|584656836|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
161893091|NCT03585712|584656837|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
161893092|NCT03585712|584656838|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
161893093|NCT03585712|584656836|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
161893094|NCT03585712|584656837|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
161893095|NCT03585712|584656838|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
161893096|NCT03585712|584656836|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
161893097|NCT03585712|584656837|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
161893098|NCT03585712|584656838|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
161893099|NCT03517449|584656839|FG000|Overall Study|Death|184|||
161893100|NCT03517449|584656840|FG001|Overall Study|Death|236|||
161893101|NCT03517449|584656839|FG000|Overall Study|Lost to Follow-up|0|||
161893102|NCT03517449|584656840|FG001|Overall Study|Lost to Follow-up|2|||
161893103|NCT03517449|584656839|FG000|Overall Study|Withdrawal by Subject|7|||
161893104|NCT03517449|584656840|FG001|Overall Study|Withdrawal by Subject|26|||
161893105|NCT03517449|584656839|FG000|Overall Study|Participants Ongoing|220|||
161893106|NCT03517449|584656840|FG001|Overall Study|Participants Ongoing|152|||
161893107|NCT02347072|584656844|FG000|Overall Study|Adverse Event|2|||
161893108|NCT02347072|584656844|FG000|Overall Study|Withdrawal by Subject|6|||
161893109|NCT02347072|584656844|FG000|Overall Study|Physician Decision|1|||
161893110|NCT02347072|584656844|FG000|Overall Study|Lost to Follow-up|2|||
161893111|NCT02347072|584656844|FG000|Overall Study|Protocol Violation|1|||
161893112|NCT02347072|584656844|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
161893113|NCT03230838|584656849|FG000|Overall Study|Withdrawal by Subject|3|||
161893114|NCT03230838|584656850|FG001|Overall Study|Withdrawal by Subject|0|||
161893115|NCT03230838|584656849|FG000|Overall Study|Temperature excursion|1|||
161893116|NCT03230838|584656850|FG001|Overall Study|Temperature excursion|0|||
161893117|NCT02324699|584656851|FG000|Overall Study|study terminated|1|||
161893118|NCT01607346|584656852|FG000|Overall Study|Adverse Event|3|||
161893119|NCT01098162|584656853|FG000|Overall Study|Adverse Event|37|||
161893120|NCT01098162|584656853|FG000|Overall Study|Lack of Efficacy|4|||
161893121|NCT01098162|584656853|FG000|Overall Study|Wish of Patient|7|||
161893122|NCT01098162|584656853|FG000|Overall Study|Lost to Follow-up|9|||
161893123|NCT01098162|584656853|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
161893124|NCT01098162|584656853|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
161893125|NCT01098162|584656853|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
161893126|NCT01098162|584656853|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
161893127|NCT01098162|584656853|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
161893128|NCT01098162|584656853|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
161893129|NCT01098162|584656853|FG000|Overall Study|Other Reason|1|||
161893130|NCT01098162|584656853|FG000|Overall Study|Reason Unknown|26|||
161893131|NCT01605825|584656854|FG000|Overall Study|Adverse Event|4|||
161893132|NCT01605825|584656855|FG001|Overall Study|Adverse Event|2|||
161893133|NCT01605825|584656854|FG000|Overall Study|Withdrawal by Subject|0|||
161893134|NCT01605825|584656855|FG001|Overall Study|Withdrawal by Subject|1|||
161893135|NCT01605825|584656854|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
161893136|NCT01605825|584656855|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
161893137|NCT01605825|584656854|FG000|Overall Study|Non-Compliance with Protocol|3|||
161893138|NCT01605825|584656855|FG001|Overall Study|Non-Compliance with Protocol|0|||
161893139|NCT00380718|584656858|FG000|Overall Study|Adverse Event|1|||
161893140|NCT00380718|584656858|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
161893141|NCT04318132|584656859|FG000|Overall Study|Protocol Violation|0|||
161893142|NCT04318132|584656860|FG001|Overall Study|Protocol Violation|0|||
161893143|NCT04318132|584656861|FG002|Overall Study|Protocol Violation|3|||
161893144|NCT04318132|584656862|FG003|Overall Study|Protocol Violation|0|||
161893145|NCT02839876|584656864|FG000|Overall Study|Protocol Violation|10|||
161893146|NCT02839876|584656865|FG001|Overall Study|Protocol Violation|11|||
161893147|NCT01156051|584656866|FG000|Overall Study|Lost to Follow-up|1|||
161893148|NCT01156051|584656867|FG001|Overall Study|Lost to Follow-up|0|||
161893149|NCT01156051|584656866|FG000|Overall Study|patient not compliant with protocol|0|||
161893150|NCT01156051|584656867|FG001|Overall Study|patient not compliant with protocol|1|||
161893151|NCT03628716|584656868|FG000|Overall Study|Adverse Event|1|||
161893152|NCT03628716|584656869|FG001|Overall Study|Adverse Event|1|||
161893153|NCT03628716|584656868|FG000|Overall Study|Death|1|||
161893154|NCT03628716|584656869|FG001|Overall Study|Death|0|||
161893155|NCT03628716|584656868|FG000|Overall Study|Lack of Efficacy|15|||
161893156|NCT03628716|584656869|FG001|Overall Study|Lack of Efficacy|20|||
161893157|NCT03628716|584656868|FG000|Overall Study|Withdrawal by Subject|1|||
161893158|NCT03628716|584656869|FG001|Overall Study|Withdrawal by Subject|2|||
161893159|NCT03628716|584656868|FG000|Overall Study|Study Terminated by Sponsor|1|||
161893160|NCT03628716|584656869|FG001|Overall Study|Study Terminated by Sponsor|0|||
161893161|NCT02620384|584656870|FG000|Overall Study|Adverse Event|2|||
161893162|NCT02620384|584656871|FG001|Overall Study|Adverse Event|1|||
161893163|NCT02620384|584656870|FG000|Overall Study|Discharged prior to 2nd dose|2|||
161893164|NCT02620384|584656871|FG001|Overall Study|Discharged prior to 2nd dose|5|||
161893165|NCT02620384|584656870|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
161893166|NCT02620384|584656871|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
161893167|NCT00094536|584656872|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
161893168|NCT00094536|584656872|FG000|Treatment and Follow-up|Adverse Event|4|||
161893169|NCT00094536|584656872|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
161893170|NCT00094536|584656872|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
161893171|NCT00094536|584656872|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
161893172|NCT00094536|584656872|FG000|Treatment and Follow-up|Subject non-compliance|9|||
161893173|NCT00094536|584656872|FG000|Treatment and Follow-up|Unable to attend visits|1|||
161893174|NCT02101359|584656873|FG000|Overall Study|Not included|23|||
161893175|NCT02101359|584656874|FG001|Overall Study|Not included|13|||
161893176|NCT02101359|584656873|FG000|Overall Study|Withdrawal by Subject|5|||
161893177|NCT02101359|584656874|FG001|Overall Study|Withdrawal by Subject|4|||
161893178|NCT02101359|584656873|FG000|Overall Study|Lost to Follow-up|1|||
161893179|NCT02101359|584656874|FG001|Overall Study|Lost to Follow-up|0|||
161893180|NCT02101359|584656873|FG000|Overall Study|Protocol Violation|0|||
161893181|NCT02101359|584656874|FG001|Overall Study|Protocol Violation|2|||
161893182|NCT00494221|584656875|FG000|Overall Study|Death|15|||
161893183|NCT00494221|584656876|FG001|Overall Study|Death|9|||
161893184|NCT00494221|584656877|FG002|Overall Study|Death|14|||
161893185|NCT00494221|584656875|FG000|Overall Study|Withdrawal by Subject|1|||
161893186|NCT00494221|584656876|FG001|Overall Study|Withdrawal by Subject|2|||
161893187|NCT00494221|584656877|FG002|Overall Study|Withdrawal by Subject|0|||
161893188|NCT01900431|584656881|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
161893189|NCT01900431|584656882|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
161893190|NCT01900431|584656883|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
161893191|NCT01900431|584656881|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
161893192|NCT01900431|584656882|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
161893193|NCT01900431|584656883|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
161893194|NCT01900431|584656881|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
161893195|NCT01900431|584656882|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
161893196|NCT01900431|584656883|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
161893197|NCT01900431|584656881|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
161893198|NCT01900431|584656882|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
161893199|NCT01900431|584656883|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
161893200|NCT01900431|584656881|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
161893201|NCT01900431|584656882|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
161893202|NCT01900431|584656883|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
161893203|NCT01900431|584656881|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
161893204|NCT01900431|584656882|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
161893205|NCT01900431|584656883|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
161893206|NCT01900431|584656881|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
161893207|NCT01900431|584656882|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
161893208|NCT01900431|584656883|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
161893209|NCT01900431|584656881|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
161893210|NCT01900431|584656882|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
161893211|NCT01900431|584656883|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
161893212|NCT01900431|584656881|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
161893213|NCT01900431|584656882|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
161893214|NCT01900431|584656883|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
161893215|NCT01841567|584656884|FG000|Overall Study|Adverse Event|3|||
161893216|NCT03172364|584656885|FG000|Overall Study|Adverse Event|1|||
161893217|NCT03172364|584656886|FG001|Overall Study|Adverse Event|1|||
161893218|NCT03172364|584656885|FG000|Overall Study|Protocol Violation|1|||
161893219|NCT03172364|584656886|FG001|Overall Study|Protocol Violation|0|||
161893220|NCT02732327|584656887|FG000|Overall Study|Protocol Violation|0|||
161893221|NCT02732327|584656888|FG001|Overall Study|Protocol Violation|1|||
161893222|NCT00659776|584656893|FG000|Overall Study|Withdrawal by Subject|12|||
161893223|NCT00659776|584656894|FG001|Overall Study|Withdrawal by Subject|2|||
161893224|NCT00659776|584656895|FG002|Overall Study|Withdrawal by Subject|0|||
161995837|NCT03310723|585036298|FG001|Overall Study|Protocol Violation|2|||
161995838|NCT02098746|585036299|FG000|Overall Study|Changes of Investigator|2|||
161995839|NCT02098746|585036299|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161995840|NCT02098746|585036299|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
161995841|NCT02098746|585036299|FG000|Overall Study|Data Not Available After Treatment|1|||
161995842|NCT00997035|585036303|FG000|3-week Followup Visit|Lost to Follow-up|9|||
161995843|NCT00997035|585036304|FG001|3-week Followup Visit|Lost to Follow-up|6|||
161995844|NCT00997035|585036303|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
161995845|NCT00997035|585036304|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
161995846|NCT02471014|585036305|FG000|Overall Study|Lost to Follow-up|2|||
161995847|NCT02471014|585036306|FG001|Overall Study|Lost to Follow-up|2|||
161995848|NCT01508312|585036309|FG000|Overall Study|Lost to Follow-up|1|||
161995849|NCT01508312|585036310|FG001|Overall Study|Lost to Follow-up|0|||
161995850|NCT01508312|585036311|FG002|Overall Study|Lost to Follow-up|0|||
161995851|NCT01508312|585036312|FG003|Overall Study|Lost to Follow-up|0|||
161995852|NCT01508312|585036309|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
161995853|NCT01508312|585036310|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
161995854|NCT01508312|585036311|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
161995855|NCT01508312|585036312|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
161995856|NCT01508312|585036309|FG000|Overall Study|Adverse Event|0|||
161995857|NCT01508312|585036310|FG001|Overall Study|Adverse Event|0|||
161995858|NCT01508312|585036311|FG002|Overall Study|Adverse Event|2|||
161995859|NCT01508312|585036312|FG003|Overall Study|Adverse Event|0|||
161995860|NCT01508312|585036309|FG000|Overall Study|Lack of Efficacy|0|||
161995861|NCT01508312|585036310|FG001|Overall Study|Lack of Efficacy|0|||
161995862|NCT01508312|585036311|FG002|Overall Study|Lack of Efficacy|1|||
161995863|NCT01508312|585036312|FG003|Overall Study|Lack of Efficacy|0|||
161995864|NCT01508312|585036309|FG000|Overall Study|Withdrawal by Subject|0|||
161995865|NCT01508312|585036310|FG001|Overall Study|Withdrawal by Subject|0|||
161995866|NCT01508312|585036311|FG002|Overall Study|Withdrawal by Subject|1|||
161995867|NCT01508312|585036312|FG003|Overall Study|Withdrawal by Subject|0|||
161995868|NCT02222558|585036313|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
161995869|NCT02222558|585036314|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
161995870|NCT02222558|585036315|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
161995871|NCT02222558|585036316|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
161995872|NCT02222558|585036317|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
161995873|NCT02222558|585036318|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
161995874|NCT02222558|585036313|FG000|Period 3|Withdrawal by Subject|0|||
161995875|NCT02222558|585036314|FG001|Period 3|Withdrawal by Subject|0|||
161995876|NCT02222558|585036315|FG002|Period 3|Withdrawal by Subject|0|||
161995877|NCT02222558|585036316|FG003|Period 3|Withdrawal by Subject|0|||
161995878|NCT02222558|585036317|FG004|Period 3|Withdrawal by Subject|0|||
161995879|NCT02222558|585036318|FG005|Period 3|Withdrawal by Subject|1|||
161995880|NCT02322281|585036321|FG000|Overall Study|Progressive Disease|42|||
161995881|NCT02322281|585036322|FG001|Overall Study|Progressive Disease|14|||
161995882|NCT02322281|585036323|FG002|Overall Study|Progressive Disease|49|||
161995883|NCT02322281|585036321|FG000|Overall Study|Adverse Event|3|||
161995884|NCT02322281|585036322|FG001|Overall Study|Adverse Event|4|||
161995885|NCT02322281|585036323|FG002|Overall Study|Adverse Event|6|||
161995886|NCT02322281|585036321|FG000|Overall Study|Death|3|||
161995887|NCT02322281|585036322|FG001|Overall Study|Death|3|||
161995888|NCT02322281|585036323|FG002|Overall Study|Death|3|||
161995889|NCT02322281|585036321|FG000|Overall Study|Withdrawal by Subject|1|||
161995890|NCT02322281|585036322|FG001|Overall Study|Withdrawal by Subject|1|||
161995891|NCT02322281|585036323|FG002|Overall Study|Withdrawal by Subject|6|||
161995892|NCT02322281|585036321|FG000|Overall Study|Physician Decision|2|||
161995893|NCT02322281|585036322|FG001|Overall Study|Physician Decision|0|||
161995894|NCT02322281|585036323|FG002|Overall Study|Physician Decision|5|||
162039543|NCT02160782|585202947|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
162039544|NCT02160782|585202948|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
162039545|NCT02160782|585202949|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
162039546|NCT02160782|585202950|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
162039547|NCT02160782|585202946|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
162039548|NCT02160782|585202947|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
161995895|NCT02322281|585036321|FG000|Overall Study|Study Terminated by Sponsor|2|||
161995896|NCT02322281|585036322|FG001|Overall Study|Study Terminated by Sponsor|0|||
161995897|NCT02322281|585036323|FG002|Overall Study|Study Terminated by Sponsor|0|||
161995898|NCT02322281|585036321|FG000|Overall Study|Missing|0|||
161995899|NCT02322281|585036322|FG001|Overall Study|Missing|0|||
161995900|NCT02322281|585036323|FG002|Overall Study|Missing|1|||
161995901|NCT02322281|585036321|FG000|Overall Study|Miscellaneous|0|||
161995902|NCT02322281|585036322|FG001|Overall Study|Miscellaneous|0|||
161995903|NCT02322281|585036323|FG002|Overall Study|Miscellaneous|4|||
161995904|NCT00936702|585036324|FG000|Overall Study|Disease progression|34|||
161995905|NCT00936702|585036324|FG000|Overall Study|Adverse Event|8|||
162039549|NCT02160782|585202948|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
162039550|NCT02160782|585202949|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
162039551|NCT02160782|585202950|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
161995906|NCT00936702|585036324|FG000|Overall Study|Withdrawal by Subject|2|||
161995907|NCT00936702|585036324|FG000|Overall Study|Alternative Treatment|1|||
161995908|NCT00936702|585036324|FG000|Overall Study|Other|1|||
161995909|NCT02532465|585036325|FG000|Overall Study|Protocol Violation|1|||
161995910|NCT02532465|585036326|FG001|Overall Study|Protocol Violation|0|||
161995911|NCT02532465|585036325|FG000|Overall Study|Lack of Efficacy|0|||
161995912|NCT02532465|585036326|FG001|Overall Study|Lack of Efficacy|1|||
161995913|NCT00354679|585036331|FG000|Overall Study|Patient Not Treated|1|||
161995914|NCT03456076|585036332|FG000|Overall Study|Withdrawal by Subject|5|||
161995915|NCT03456076|585036333|FG001|Overall Study|Withdrawal by Subject|9|||
161995916|NCT03456076|585036332|FG000|Overall Study|Protocol deviation|0|||
161995917|NCT03456076|585036333|FG001|Overall Study|Protocol deviation|1|||
161995918|NCT03456076|585036332|FG000|Overall Study|Lost to Follow-up|0|||
161995919|NCT03456076|585036333|FG001|Overall Study|Lost to Follow-up|1|||
161995920|NCT03456076|585036332|FG000|Overall Study|Death|2|||
161995921|NCT03456076|585036333|FG001|Overall Study|Death|5|||
161995922|NCT03456076|585036332|FG000|Overall Study|Study ongoing|123|||
161995923|NCT03456076|585036333|FG001|Overall Study|Study ongoing|111|||
161995924|NCT00466440|585036334|FG000|Overall Study|Adverse Event|0|||
161995925|NCT00466440|585036335|FG001|Overall Study|Adverse Event|3|||
161995926|NCT00466440|585036336|FG002|Overall Study|Adverse Event|1|||
161995927|NCT00466440|585036334|FG000|Overall Study|Death|1|||
161995928|NCT00466440|585036335|FG001|Overall Study|Death|1|||
161995929|NCT00466440|585036336|FG002|Overall Study|Death|0|||
161995930|NCT00466440|585036334|FG000|Overall Study|Progressive disease|13|||
161995931|NCT00466440|585036335|FG001|Overall Study|Progressive disease|5|||
161995932|NCT00466440|585036336|FG002|Overall Study|Progressive disease|4|||
161995933|NCT00466440|585036334|FG000|Overall Study|Lost to Follow-up|0|||
161995934|NCT00466440|585036335|FG001|Overall Study|Lost to Follow-up|1|||
161995935|NCT00466440|585036336|FG002|Overall Study|Lost to Follow-up|0|||
161995936|NCT00466440|585036334|FG000|Overall Study|Physician Decision|0|||
161995937|NCT00466440|585036335|FG001|Overall Study|Physician Decision|1|||
161995938|NCT00466440|585036336|FG002|Overall Study|Physician Decision|2|||
161995939|NCT00466440|585036334|FG000|Overall Study|Protocol entry criteria not met|0|||
161995940|NCT00466440|585036335|FG001|Overall Study|Protocol entry criteria not met|0|||
161995941|NCT00466440|585036336|FG002|Overall Study|Protocol entry criteria not met|4|||
161995942|NCT00466440|585036334|FG000|Overall Study|Withdrawal by Subject|0|||
161995943|NCT00466440|585036335|FG001|Overall Study|Withdrawal by Subject|1|||
161995944|NCT00466440|585036336|FG002|Overall Study|Withdrawal by Subject|0|||
161995945|NCT00466440|585036334|FG000|Overall Study|Sponsor decision|0|||
161995946|NCT00466440|585036335|FG001|Overall Study|Sponsor decision|0|||
161995947|NCT00466440|585036336|FG002|Overall Study|Sponsor decision|1|||
161995948|NCT03187132|585036342|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
161995949|NCT03187132|585036343|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
161995950|NCT03187132|585036342|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
161995951|NCT03187132|585036343|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
161995952|NCT03187132|585036342|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
161995953|NCT03187132|585036343|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
161995954|NCT03187132|585036342|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
161995955|NCT03187132|585036343|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
161995956|NCT03187132|585036342|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
161995957|NCT03187132|585036343|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
161995958|NCT03187132|585036342|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
161995959|NCT03187132|585036343|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
161995960|NCT03187132|585036342|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
161995961|NCT03187132|585036343|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
161995962|NCT03187132|585036342|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
161995963|NCT03187132|585036343|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
161995964|NCT03187132|585036342|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
161995965|NCT03187132|585036343|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
161995966|NCT03187132|585036342|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
161995967|NCT03187132|585036343|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
161995968|NCT03187132|585036342|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
161995969|NCT03187132|585036343|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
161995970|NCT02045095|585036344|FG000|Overall Study|Other|0|||
161995971|NCT02045095|585036345|FG001|Overall Study|Other|0|||
161995972|NCT02045095|585036346|FG002|Overall Study|Other|1|||
161995973|NCT02045095|585036347|FG003|Overall Study|Other|0|||
161995974|NCT02045095|585036348|FG004|Overall Study|Other|0|||
161995975|NCT02045095|585036349|FG005|Overall Study|Other|2|||
161995976|NCT02045095|585036350|FG006|Overall Study|Other|0|||
161995977|NCT02045095|585036344|FG000|Overall Study|Progressive Disease|3|||
161995978|NCT02045095|585036345|FG001|Overall Study|Progressive Disease|3|||
162039552|NCT02160782|585202946|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
161995979|NCT02045095|585036346|FG002|Overall Study|Progressive Disease|2|||
161995980|NCT02045095|585036347|FG003|Overall Study|Progressive Disease|4|||
161995981|NCT02045095|585036348|FG004|Overall Study|Progressive Disease|2|||
161995982|NCT02045095|585036349|FG005|Overall Study|Progressive Disease|4|||
161995983|NCT02045095|585036350|FG006|Overall Study|Progressive Disease|1|||
161995984|NCT02045095|585036344|FG000|Overall Study|Withdrawal by Subject|0|||
161995985|NCT02045095|585036345|FG001|Overall Study|Withdrawal by Subject|0|||
161995986|NCT02045095|585036346|FG002|Overall Study|Withdrawal by Subject|0|||
161995987|NCT02045095|585036347|FG003|Overall Study|Withdrawal by Subject|0|||
162039553|NCT02160782|585202947|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
161995988|NCT02045095|585036348|FG004|Overall Study|Withdrawal by Subject|3|||
161995989|NCT02045095|585036349|FG005|Overall Study|Withdrawal by Subject|0|||
161995990|NCT02045095|585036350|FG006|Overall Study|Withdrawal by Subject|0|||
161995991|NCT02045095|585036344|FG000|Overall Study|Adverse Event|0|||
161995992|NCT02045095|585036345|FG001|Overall Study|Adverse Event|1|||
161995993|NCT02045095|585036346|FG002|Overall Study|Adverse Event|1|||
161995994|NCT02045095|585036347|FG003|Overall Study|Adverse Event|0|||
161995995|NCT02045095|585036348|FG004|Overall Study|Adverse Event|0|||
161995996|NCT02045095|585036349|FG005|Overall Study|Adverse Event|2|||
161995997|NCT02045095|585036350|FG006|Overall Study|Adverse Event|0|||
161995998|NCT03191630|585036351|FG000|Overall Study|Lost to Follow-up|7|||
161995999|NCT03191630|585036352|FG001|Overall Study|Lost to Follow-up|7|||
161996000|NCT02525588|585036355|FG000|Overall Study|Death|3|||
161996001|NCT02525588|585036356|FG001|Overall Study|Death|1|||
161996002|NCT02525588|585036355|FG000|Overall Study|Lost to Follow-up|2|||
161996003|NCT02525588|585036356|FG001|Overall Study|Lost to Follow-up|0|||
161996004|NCT02525588|585036355|FG000|Overall Study|Withdrawal by Subject|1|||
161996005|NCT02525588|585036356|FG001|Overall Study|Withdrawal by Subject|1|||
162039554|NCT02160782|585202948|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
162039555|NCT02160782|585202949|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
162039556|NCT02160782|585202950|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
162039557|NCT02160782|585202946|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
162039558|NCT02160782|585202947|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
162039559|NCT02160782|585202948|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
161996006|NCT02525588|585036355|FG000|Overall Study|Adverse Event|0|||
161996007|NCT02525588|585036356|FG001|Overall Study|Adverse Event|1|||
161996008|NCT00714415|585036367|FG000|Overall Study|Lack of Efficacy|1|||
161996009|NCT00714415|585036368|FG001|Overall Study|Lack of Efficacy|0|||
161996010|NCT00714415|585036367|FG000|Overall Study|Death|1|||
161996011|NCT00714415|585036368|FG001|Overall Study|Death|0|||
161996012|NCT01450761|585036373|FG000|Randomization|Subject no longer meets study criteria|1|||
161996013|NCT01450761|585036374|FG001|Randomization|Subject no longer meets study criteria|2|||
161996014|NCT01450761|585036373|FG000|Randomization|Withdrawal by Subject|2|||
161996015|NCT01450761|585036374|FG001|Randomization|Withdrawal by Subject|0|||
161996016|NCT01450761|585036373|FG000|Randomization|Disease progression|0|||
161996017|NCT01450761|585036374|FG001|Randomization|Disease progression|2|||
161996018|NCT01450761|585036373|FG000|Randomization|Adverse Event unrelated to study drug|1|||
161996019|NCT01450761|585036374|FG001|Randomization|Adverse Event unrelated to study drug|0|||
161996020|NCT01450761|585036373|FG000|Randomization|Other|0|||
161996021|NCT01450761|585036374|FG001|Randomization|Other|1|||
161996022|NCT01450761|585036373|FG000|Lead-in Chemotherapy|Disease progression|33|||
161996023|NCT01450761|585036374|FG001|Lead-in Chemotherapy|Disease progression|32|||
161996024|NCT01450761|585036373|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
162039560|NCT02160782|585202949|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
162039561|NCT02160782|585202950|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
162039562|NCT02160782|585202946|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
162039563|NCT02160782|585202947|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
162039564|NCT02160782|585202948|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
162039565|NCT02160782|585202949|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
162039566|NCT02160782|585202950|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
162039567|NCT01104701|585202951|FG000|Overall Study|Withdrawal by Subject|0|||
162039568|NCT01104701|585202952|FG001|Overall Study|Withdrawal by Subject|1|||
162039569|NCT01104701|585202953|FG002|Overall Study|Withdrawal by Subject|2|||
162039570|NCT01104701|585202954|FG003|Overall Study|Withdrawal by Subject|1|||
162039571|NCT01104701|585202951|FG000|Overall Study|Adverse Event|0|||
162039572|NCT01104701|585202952|FG001|Overall Study|Adverse Event|0|||
162039573|NCT01104701|585202953|FG002|Overall Study|Adverse Event|0|||
161996025|NCT01450761|585036374|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
161996026|NCT01450761|585036373|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
161996027|NCT01450761|585036374|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
161996028|NCT01450761|585036373|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
161996029|NCT01450761|585036374|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
161996030|NCT01450761|585036373|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
162039574|NCT01104701|585202954|FG003|Overall Study|Adverse Event|1|||
162039575|NCT01104701|585202951|FG000|Overall Study|Physician Decision|0|||
161996031|NCT01450761|585036374|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
161996032|NCT01450761|585036373|FG000|Lead-in Chemotherapy|Death|3|||
162039576|NCT01104701|585202952|FG001|Overall Study|Physician Decision|2|||
162039577|NCT01104701|585202953|FG002|Overall Study|Physician Decision|0|||
162039578|NCT01104701|585202954|FG003|Overall Study|Physician Decision|0|||
161996033|NCT01450761|585036374|FG001|Lead-in Chemotherapy|Death|3|||
161996034|NCT01450761|585036373|FG000|Lead-in Chemotherapy|Other|2|||
161996035|NCT01450761|585036374|FG001|Lead-in Chemotherapy|Other|2|||
161996036|NCT01450761|585036373|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
161996037|NCT01450761|585036374|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
161996038|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
161996039|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
161996040|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
161996041|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
161996042|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
161996043|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
161996044|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
161996045|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
161996046|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
161996047|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
161996048|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|Death|5|||
161996049|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|Death|6|||
161996050|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
161996051|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
161996052|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
161996053|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
161996054|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
161996055|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
161996056|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
161996057|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
161996058|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
161996059|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
161996060|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
161996061|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
161996062|NCT01450761|585036373|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
161996063|NCT01450761|585036374|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
161996064|NCT01818596|585036375|FG000|Overall Study|Enrolled but Not Treated|4|||
161996065|NCT01818596|585036376|FG001|Overall Study|Enrolled but Not Treated|0|||
161996066|NCT01818596|585036375|FG000|Overall Study|Adverse Event|7|||
161996067|NCT01818596|585036376|FG001|Overall Study|Adverse Event|0|||
161996068|NCT01818596|585036375|FG000|Overall Study|Death|3|||
161996069|NCT01818596|585036376|FG001|Overall Study|Death|0|||
161996070|NCT01818596|585036375|FG000|Overall Study|Investigator's Discretion|4|||
161996071|NCT01818596|585036376|FG001|Overall Study|Investigator's Discretion|0|||
161996072|NCT01818596|585036375|FG000|Overall Study|Protocol Violation|1|||
161996073|NCT01818596|585036376|FG001|Overall Study|Protocol Violation|0|||
161996074|NCT01818596|585036375|FG000|Overall Study|Withdrew Consent|5|||
161996075|NCT01818596|585036376|FG001|Overall Study|Withdrew Consent|0|||
161996076|NCT01818596|585036375|FG000|Overall Study|Lost to Follow-up|7|||
161996077|NCT01818596|585036376|FG001|Overall Study|Lost to Follow-up|0|||
161996078|NCT02073682|585036389|FG000|Overall Study|Low Creatinine Clearance|1|||
161996079|NCT02073682|585036390|FG001|Overall Study|Low Creatinine Clearance|2|||
161996080|NCT02073682|585036389|FG000|Overall Study|Death|86|||
161996081|NCT02073682|585036390|FG001|Overall Study|Death|100|||
161996082|NCT02073682|585036389|FG000|Overall Study|Cancer Cured|10|||
161996083|NCT02073682|585036390|FG001|Overall Study|Cancer Cured|15|||
161996084|NCT02073682|585036389|FG000|Overall Study|ID: Patient Noncompliance|1|||
161996085|NCT02073682|585036390|FG001|Overall Study|ID: Patient Noncompliance|2|||
161996086|NCT02073682|585036389|FG000|Overall Study|ID: Palliative Treatment Only|10|||
161996087|NCT02073682|585036390|FG001|Overall Study|ID: Palliative Treatment Only|7|||
161996088|NCT02073682|585036389|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
161996089|NCT02073682|585036390|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
161996090|NCT02073682|585036389|FG000|Overall Study|Platelet Count <50,000/mL|1|||
161996091|NCT02073682|585036390|FG001|Overall Study|Platelet Count <50,000/mL|2|||
161996092|NCT02073682|585036389|FG000|Overall Study|Surgery/Medical Procedure|3|||
161996093|NCT02073682|585036390|FG001|Overall Study|Surgery/Medical Procedure|1|||
161996094|NCT02073682|585036389|FG000|Overall Study|Withdrawal by Subject|6|||
161996095|NCT02073682|585036390|FG001|Overall Study|Withdrawal by Subject|8|||
161996096|NCT02073682|585036389|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
161996097|NCT02073682|585036390|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
161996098|NCT02073682|585036389|FG000|Overall Study|Cancer Progression|53|||
161996099|NCT02073682|585036390|FG001|Overall Study|Cancer Progression|33|||
161996100|NCT02073682|585036389|FG000|Overall Study|Protocol Violation|1|||
161996101|NCT02073682|585036390|FG001|Overall Study|Protocol Violation|0|||
161996102|NCT02073682|585036389|FG000|Overall Study|Adverse Event|79|||
161996103|NCT02073682|585036390|FG001|Overall Study|Adverse Event|62|||
161996104|NCT02073682|585036389|FG000|Overall Study|No reason provided|11|||
161996105|NCT02073682|585036390|FG001|Overall Study|No reason provided|9|||
161996106|NCT02073682|585036389|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
161996107|NCT02073682|585036390|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
161996108|NCT02073682|585036389|FG000|Overall Study|Lost to Follow-up|1|||
161996109|NCT02073682|585036390|FG001|Overall Study|Lost to Follow-up|1|||
161996110|NCT02073682|585036389|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
161996111|NCT02073682|585036390|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
161996112|NCT03801174|585036391|FG000|Overall Study|Withdrawal by Subject|14|||
161996113|NCT03801174|585036392|FG001|Overall Study|Withdrawal by Subject|15|||
161996114|NCT03801174|585036391|FG000|Overall Study|Death|1|||
161996115|NCT03801174|585036392|FG001|Overall Study|Death|0|||
161996116|NCT03801174|585036391|FG000|Overall Study|Pregnancy|2|||
161996117|NCT03801174|585036392|FG001|Overall Study|Pregnancy|2|||
161996118|NCT03801174|585036391|FG000|Overall Study|Lost to Follow-up|19|||
161996119|NCT03801174|585036392|FG001|Overall Study|Lost to Follow-up|10|||
161996120|NCT03801174|585036391|FG000|Overall Study|Other|4|||
161996121|NCT03801174|585036392|FG001|Overall Study|Other|3|||
161996122|NCT03801174|585036391|FG000|Overall Study|Lack of Efficacy|4|||
161996123|NCT03801174|585036392|FG001|Overall Study|Lack of Efficacy|0|||
161996124|NCT03801174|585036391|FG000|Overall Study|Unwilling to complete activities|5|||
161996125|NCT03801174|585036392|FG001|Overall Study|Unwilling to complete activities|6|||
161996126|NCT03801174|585036391|FG000|Overall Study|Moved out of area|3|||
161996127|NCT03801174|585036392|FG001|Overall Study|Moved out of area|0|||
161996128|NCT04435366|585036398|FG000|Year 1 (12 Months)|Adverse Event|3|||
161996129|NCT04435366|585036399|FG001|Year 1 (12 Months)|Adverse Event|0|||
161996130|NCT04435366|585036400|FG002|Year 1 (12 Months)|Adverse Event|2|||
161996131|NCT04435366|585036398|FG000|Year 1 (12 Months)|Death|2|||
161996132|NCT04435366|585036399|FG001|Year 1 (12 Months)|Death|0|||
161996133|NCT04435366|585036400|FG002|Year 1 (12 Months)|Death|1|||
161996134|NCT04435366|585036398|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
161996135|NCT04435366|585036399|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
161996136|NCT04435366|585036400|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
161996137|NCT04435366|585036398|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
161996138|NCT04435366|585036399|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
161996139|NCT04435366|585036400|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
161996140|NCT04435366|585036398|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
161996141|NCT04435366|585036399|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
161996142|NCT04435366|585036400|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
161996143|NCT04435366|585036398|FG000|Year 1 (12 Months)|Not treated|0|||
161996144|NCT04435366|585036399|FG001|Year 1 (12 Months)|Not treated|0|||
161996145|NCT04435366|585036400|FG002|Year 1 (12 Months)|Not treated|1|||
161996146|NCT04435366|585036398|FG000|Year 2 (12 Months)|Death|1|||
161996147|NCT04435366|585036399|FG001|Year 2 (12 Months)|Death|4|||
161996148|NCT04435366|585036400|FG002|Year 2 (12 Months)|Death|6|||
161996149|NCT04435366|585036398|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
161996150|NCT04435366|585036399|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
161996151|NCT04435366|585036400|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
161996152|NCT04435366|585036398|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
161996153|NCT04435366|585036399|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
161996154|NCT04435366|585036400|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
161996155|NCT04435366|585036398|FG000|Year 2 (12 Months)|Adverse Event|2|||
161996156|NCT04435366|585036399|FG001|Year 2 (12 Months)|Adverse Event|1|||
161996157|NCT04435366|585036400|FG002|Year 2 (12 Months)|Adverse Event|6|||
161996158|NCT04112810|585036401|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
161996159|NCT01687296|585036403|FG000|Overall Study|Lack of Efficacy|1|||
161996160|NCT01687296|585036404|FG001|Overall Study|Lack of Efficacy|1|||
161996161|NCT01687296|585036403|FG000|Overall Study|Protocol Violation|0|||
161996162|NCT01687296|585036404|FG001|Overall Study|Protocol Violation|1|||
161996163|NCT01687296|585036403|FG000|Overall Study|Withdrawal by Subject|6|||
161996164|NCT01687296|585036404|FG001|Overall Study|Withdrawal by Subject|3|||
161996165|NCT04497116|585036406|FG000|Overall Study|Lost to Follow-up|1|||
161996166|NCT04497116|585036407|FG001|Overall Study|Lost to Follow-up|0|||
161996167|NCT04497116|585036408|FG002|Overall Study|Lost to Follow-up|0|||
161996168|NCT04497116|585036409|FG003|Overall Study|Lost to Follow-up|0|||
161996169|NCT04497116|585036410|FG004|Overall Study|Lost to Follow-up|0|||
161996170|NCT04497116|585036411|FG005|Overall Study|Lost to Follow-up|0|||
161996171|NCT04497116|585036412|FG006|Overall Study|Lost to Follow-up|0|||
161996172|NCT04497116|585036413|FG007|Overall Study|Lost to Follow-up|3|||
161996173|NCT04497116|585036414|FG008|Overall Study|Lost to Follow-up|3|||
161996174|NCT04497116|585036415|FG009|Overall Study|Lost to Follow-up|0|||
161996175|NCT04497116|585036416|FG010|Overall Study|Lost to Follow-up|0|||
161996176|NCT04497116|585036417|FG011|Overall Study|Lost to Follow-up|0|||
161996177|NCT04497116|585036418|FG012|Overall Study|Lost to Follow-up|0|||
161996178|NCT04497116|585036419|FG013|Overall Study|Lost to Follow-up|0|||
161996179|NCT04497116|585036420|FG014|Overall Study|Lost to Follow-up|0|||
161996180|NCT04497116|585036421|FG015|Overall Study|Lost to Follow-up|0|||
161996181|NCT04497116|585036422|FG016|Overall Study|Lost to Follow-up|0|||
161996182|NCT04497116|585036423|FG017|Overall Study|Lost to Follow-up|0|||
161996183|NCT04497116|585036424|FG018|Overall Study|Lost to Follow-up|0|||
161996184|NCT04497116|585036425|FG019|Overall Study|Lost to Follow-up|0|||
161996185|NCT04497116|585036426|FG020|Overall Study|Lost to Follow-up|0|||
161996186|NCT04497116|585036427|FG021|Overall Study|Lost to Follow-up|0|||
161996187|NCT04497116|585036428|FG022|Overall Study|Lost to Follow-up|1|||
161996188|NCT04497116|585036429|FG023|Overall Study|Lost to Follow-up|0|||
161996189|NCT04497116|585036430|FG024|Overall Study|Lost to Follow-up|0|||
161996190|NCT04497116|585036406|FG000|Overall Study|Sponsor decision to terminate study|0|||
161996191|NCT04497116|585036407|FG001|Overall Study|Sponsor decision to terminate study|0|||
161996192|NCT04497116|585036408|FG002|Overall Study|Sponsor decision to terminate study|0|||
161996193|NCT04497116|585036409|FG003|Overall Study|Sponsor decision to terminate study|0|||
161996194|NCT04497116|585036410|FG004|Overall Study|Sponsor decision to terminate study|0|||
161996195|NCT04497116|585036411|FG005|Overall Study|Sponsor decision to terminate study|0|||
161996196|NCT04497116|585036412|FG006|Overall Study|Sponsor decision to terminate study|1|||
161996197|NCT04497116|585036413|FG007|Overall Study|Sponsor decision to terminate study|0|||
161996198|NCT04497116|585036414|FG008|Overall Study|Sponsor decision to terminate study|0|||
161996199|NCT04497116|585036415|FG009|Overall Study|Sponsor decision to terminate study|1|||
161996200|NCT04497116|585036416|FG010|Overall Study|Sponsor decision to terminate study|0|||
161996201|NCT04497116|585036417|FG011|Overall Study|Sponsor decision to terminate study|0|||
161996202|NCT04497116|585036418|FG012|Overall Study|Sponsor decision to terminate study|0|||
161996203|NCT04497116|585036419|FG013|Overall Study|Sponsor decision to terminate study|0|||
161996204|NCT04497116|585036420|FG014|Overall Study|Sponsor decision to terminate study|0|||
161996205|NCT04497116|585036421|FG015|Overall Study|Sponsor decision to terminate study|0|||
161996206|NCT04497116|585036422|FG016|Overall Study|Sponsor decision to terminate study|0|||
161996207|NCT04497116|585036423|FG017|Overall Study|Sponsor decision to terminate study|0|||
161996208|NCT04497116|585036424|FG018|Overall Study|Sponsor decision to terminate study|0|||
161996209|NCT04497116|585036425|FG019|Overall Study|Sponsor decision to terminate study|1|||
161996210|NCT04497116|585036426|FG020|Overall Study|Sponsor decision to terminate study|0|||
161996211|NCT04497116|585036427|FG021|Overall Study|Sponsor decision to terminate study|0|||
161996212|NCT04497116|585036428|FG022|Overall Study|Sponsor decision to terminate study|0|||
161996213|NCT04497116|585036429|FG023|Overall Study|Sponsor decision to terminate study|0|||
161996214|NCT04497116|585036430|FG024|Overall Study|Sponsor decision to terminate study|0|||
161996215|NCT04497116|585036406|FG000|Overall Study|Death|4|||
161996216|NCT04497116|585036407|FG001|Overall Study|Death|5|||
161996217|NCT04497116|585036408|FG002|Overall Study|Death|2|||
161996218|NCT04497116|585036409|FG003|Overall Study|Death|2|||
161996219|NCT04497116|585036410|FG004|Overall Study|Death|1|||
161996220|NCT04497116|585036411|FG005|Overall Study|Death|1|||
161996221|NCT04497116|585036412|FG006|Overall Study|Death|3|||
161996222|NCT04497116|585036413|FG007|Overall Study|Death|10|||
161996223|NCT04497116|585036414|FG008|Overall Study|Death|37|||
161996224|NCT04497116|585036415|FG009|Overall Study|Death|17|||
161996225|NCT04497116|585036416|FG010|Overall Study|Death|2|||
161996226|NCT04497116|585036417|FG011|Overall Study|Death|1|||
161996227|NCT04497116|585036418|FG012|Overall Study|Death|1|||
161996228|NCT04497116|585036419|FG013|Overall Study|Death|3|||
161996229|NCT04497116|585036420|FG014|Overall Study|Death|18|||
161996230|NCT04497116|585036421|FG015|Overall Study|Death|3|||
161996231|NCT04497116|585036422|FG016|Overall Study|Death|2|||
161996232|NCT04497116|585036423|FG017|Overall Study|Death|1|||
161996233|NCT04497116|585036424|FG018|Overall Study|Death|4|||
161996234|NCT04497116|585036425|FG019|Overall Study|Death|17|||
161996235|NCT04497116|585036426|FG020|Overall Study|Death|1|||
161996236|NCT04497116|585036427|FG021|Overall Study|Death|0|||
161996237|NCT04497116|585036428|FG022|Overall Study|Death|3|||
161996238|NCT04497116|585036429|FG023|Overall Study|Death|5|||
161996239|NCT04497116|585036430|FG024|Overall Study|Death|4|||
161996240|NCT04497116|585036406|FG000|Overall Study|Withdrawal by Subject|1|||
161996241|NCT04497116|585036407|FG001|Overall Study|Withdrawal by Subject|0|||
161996242|NCT04497116|585036408|FG002|Overall Study|Withdrawal by Subject|1|||
161996243|NCT04497116|585036409|FG003|Overall Study|Withdrawal by Subject|0|||
161996244|NCT04497116|585036410|FG004|Overall Study|Withdrawal by Subject|0|||
161996245|NCT04497116|585036411|FG005|Overall Study|Withdrawal by Subject|0|||
161996246|NCT04497116|585036412|FG006|Overall Study|Withdrawal by Subject|0|||
161996247|NCT04497116|585036413|FG007|Overall Study|Withdrawal by Subject|7|||
161996248|NCT04497116|585036414|FG008|Overall Study|Withdrawal by Subject|14|||
161996249|NCT04497116|585036415|FG009|Overall Study|Withdrawal by Subject|3|||
161996250|NCT04497116|585036416|FG010|Overall Study|Withdrawal by Subject|3|||
161996251|NCT04497116|585036417|FG011|Overall Study|Withdrawal by Subject|0|||
161996252|NCT04497116|585036418|FG012|Overall Study|Withdrawal by Subject|1|||
161996253|NCT04497116|585036419|FG013|Overall Study|Withdrawal by Subject|0|||
161996254|NCT04497116|585036420|FG014|Overall Study|Withdrawal by Subject|7|||
161996255|NCT04497116|585036421|FG015|Overall Study|Withdrawal by Subject|1|||
161996256|NCT04497116|585036422|FG016|Overall Study|Withdrawal by Subject|3|||
161996257|NCT04497116|585036423|FG017|Overall Study|Withdrawal by Subject|1|||
161996258|NCT04497116|585036424|FG018|Overall Study|Withdrawal by Subject|1|||
161996259|NCT04497116|585036425|FG019|Overall Study|Withdrawal by Subject|5|||
161996260|NCT04497116|585036426|FG020|Overall Study|Withdrawal by Subject|2|||
161996261|NCT04497116|585036427|FG021|Overall Study|Withdrawal by Subject|2|||
161996262|NCT04497116|585036428|FG022|Overall Study|Withdrawal by Subject|2|||
161996263|NCT04497116|585036429|FG023|Overall Study|Withdrawal by Subject|4|||
161996264|NCT04497116|585036430|FG024|Overall Study|Withdrawal by Subject|3|||
161996265|NCT04497116|585036406|FG000|Overall Study|Physician Decision|0|||
161996266|NCT04497116|585036407|FG001|Overall Study|Physician Decision|0|||
161996267|NCT04497116|585036408|FG002|Overall Study|Physician Decision|0|||
161996268|NCT04497116|585036409|FG003|Overall Study|Physician Decision|0|||
161996269|NCT04497116|585036410|FG004|Overall Study|Physician Decision|0|||
161996270|NCT04497116|585036411|FG005|Overall Study|Physician Decision|0|||
161996271|NCT04497116|585036412|FG006|Overall Study|Physician Decision|0|||
161996272|NCT04497116|585036413|FG007|Overall Study|Physician Decision|0|||
161996273|NCT04497116|585036414|FG008|Overall Study|Physician Decision|0|||
161996274|NCT04497116|585036415|FG009|Overall Study|Physician Decision|0|||
161996275|NCT04497116|585036416|FG010|Overall Study|Physician Decision|0|||
161996276|NCT04497116|585036417|FG011|Overall Study|Physician Decision|0|||
161996277|NCT04497116|585036418|FG012|Overall Study|Physician Decision|0|||
161996278|NCT04497116|585036419|FG013|Overall Study|Physician Decision|0|||
161996279|NCT04497116|585036420|FG014|Overall Study|Physician Decision|0|||
161996280|NCT04497116|585036421|FG015|Overall Study|Physician Decision|0|||
161996281|NCT04497116|585036422|FG016|Overall Study|Physician Decision|0|||
161996282|NCT04497116|585036423|FG017|Overall Study|Physician Decision|0|||
161996283|NCT04497116|585036424|FG018|Overall Study|Physician Decision|0|||
161996284|NCT04497116|585036425|FG019|Overall Study|Physician Decision|0|||
161996285|NCT04497116|585036426|FG020|Overall Study|Physician Decision|0|||
161996286|NCT04497116|585036427|FG021|Overall Study|Physician Decision|0|||
161996287|NCT04497116|585036428|FG022|Overall Study|Physician Decision|0|||
161996288|NCT04497116|585036429|FG023|Overall Study|Physician Decision|1|||
161996289|NCT04497116|585036430|FG024|Overall Study|Physician Decision|0|||
161996290|NCT04497116|585036406|FG000|Overall Study|Clinical Progression Related|0|||
161996291|NCT04497116|585036407|FG001|Overall Study|Clinical Progression Related|0|||
161996292|NCT04497116|585036408|FG002|Overall Study|Clinical Progression Related|0|||
161996293|NCT04497116|585036409|FG003|Overall Study|Clinical Progression Related|0|||
161996294|NCT04497116|585036410|FG004|Overall Study|Clinical Progression Related|0|||
161996295|NCT04497116|585036411|FG005|Overall Study|Clinical Progression Related|0|||
161996296|NCT04497116|585036412|FG006|Overall Study|Clinical Progression Related|0|||
161996297|NCT04497116|585036413|FG007|Overall Study|Clinical Progression Related|0|||
161996298|NCT04497116|585036414|FG008|Overall Study|Clinical Progression Related|0|||
161996299|NCT04497116|585036415|FG009|Overall Study|Clinical Progression Related|1|||
161996300|NCT04497116|585036416|FG010|Overall Study|Clinical Progression Related|0|||
161996301|NCT04497116|585036417|FG011|Overall Study|Clinical Progression Related|0|||
161996302|NCT04497116|585036418|FG012|Overall Study|Clinical Progression Related|0|||
161996303|NCT04497116|585036419|FG013|Overall Study|Clinical Progression Related|0|||
161996304|NCT04497116|585036420|FG014|Overall Study|Clinical Progression Related|0|||
161996305|NCT04497116|585036421|FG015|Overall Study|Clinical Progression Related|0|||
161996306|NCT04497116|585036422|FG016|Overall Study|Clinical Progression Related|0|||
161996307|NCT04497116|585036423|FG017|Overall Study|Clinical Progression Related|0|||
161996308|NCT04497116|585036424|FG018|Overall Study|Clinical Progression Related|0|||
161996309|NCT04497116|585036425|FG019|Overall Study|Clinical Progression Related|0|||
161996310|NCT04497116|585036426|FG020|Overall Study|Clinical Progression Related|0|||
161996311|NCT04497116|585036427|FG021|Overall Study|Clinical Progression Related|0|||
161996312|NCT04497116|585036428|FG022|Overall Study|Clinical Progression Related|0|||
161996313|NCT04497116|585036429|FG023|Overall Study|Clinical Progression Related|0|||
161996314|NCT04497116|585036430|FG024|Overall Study|Clinical Progression Related|0|||
161996315|NCT05963022|585036434|FG000|Overall Study|Adverse Event|0|||
161996316|NCT05963022|585036435|FG001|Overall Study|Adverse Event|1|||
161996317|NCT05963022|585036436|FG002|Overall Study|Adverse Event|1|||
161996318|NCT05963022|585036437|FG003|Overall Study|Adverse Event|0|||
161996319|NCT05963022|585036434|FG000|Overall Study|Protocol Violation|0|||
161996320|NCT05963022|585036435|FG001|Overall Study|Protocol Violation|3|||
161996321|NCT05963022|585036436|FG002|Overall Study|Protocol Violation|0|||
161996322|NCT05963022|585036437|FG003|Overall Study|Protocol Violation|0|||
161996323|NCT05963022|585036434|FG000|Overall Study|Pregnancy|0|||
161996324|NCT05963022|585036435|FG001|Overall Study|Pregnancy|1|||
161996325|NCT05963022|585036436|FG002|Overall Study|Pregnancy|1|||
161996326|NCT05963022|585036437|FG003|Overall Study|Pregnancy|1|||
161996327|NCT05963022|585036434|FG000|Overall Study|Withdrawal by Subject|0|||
161996328|NCT05963022|585036435|FG001|Overall Study|Withdrawal by Subject|0|||
161996329|NCT05963022|585036436|FG002|Overall Study|Withdrawal by Subject|2|||
161996330|NCT05963022|585036437|FG003|Overall Study|Withdrawal by Subject|1|||
161996331|NCT05963022|585036434|FG000|Overall Study|Lost to Follow-up|0|||
161996332|NCT05963022|585036435|FG001|Overall Study|Lost to Follow-up|0|||
161996333|NCT05963022|585036436|FG002|Overall Study|Lost to Follow-up|0|||
161996334|NCT05963022|585036437|FG003|Overall Study|Lost to Follow-up|1|||
161996335|NCT05963022|585036434|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
161996336|NCT05963022|585036435|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
161996337|NCT05963022|585036436|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
161996338|NCT05963022|585036437|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
161996339|NCT02698826|585036442|FG000|Overall Study|Death|13|||
161996340|NCT02698826|585036442|FG000|Overall Study|Adverse Event|1|||
161996341|NCT02915263|585036445|FG000|Overall Study|Covid|3|||
161996342|NCT02915263|585036446|FG001|Overall Study|Covid|2|||
161996343|NCT02478463|585036447|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
161996344|NCT02478463|585036447|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
161996345|NCT02478463|585036447|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
161996346|NCT01358825|585036448|FG000|Overall Study|Blood sample not drawn|0|||
161996347|NCT01358825|585036449|FG001|Overall Study|Blood sample not drawn|1|||
161996348|NCT01177007|585036450|FG000|Overall Study|Lost to Follow-up|2|||
161996349|NCT01177007|585036450|FG000|Overall Study|Death|4|||
161996350|NCT01177007|585036450|FG000|Overall Study|Entered hospice care|5|||
161996351|NCT01177007|585036450|FG000|Overall Study|Required additional Y90 treatment|6|||
161996352|NCT01177007|585036450|FG000|Overall Study|Change in treatment modality|21|||
161996353|NCT01702558|585036451|FG000|Overall Study|Withdrawal by Subject|0|||
161996354|NCT01702558|585036452|FG001|Overall Study|Withdrawal by Subject|0|||
161996355|NCT01702558|585036453|FG002|Overall Study|Withdrawal by Subject|0|||
161996356|NCT01702558|585036454|FG003|Overall Study|Withdrawal by Subject|12|||
161996357|NCT01702558|585036455|FG004|Overall Study|Withdrawal by Subject|4|||
161996358|NCT01702558|585036451|FG000|Overall Study|Lost to Follow-up|0|||
161996359|NCT01702558|585036452|FG001|Overall Study|Lost to Follow-up|0|||
161996360|NCT01702558|585036453|FG002|Overall Study|Lost to Follow-up|0|||
161996361|NCT01702558|585036454|FG003|Overall Study|Lost to Follow-up|3|||
161996362|NCT01702558|585036455|FG004|Overall Study|Lost to Follow-up|0|||
161996363|NCT01702558|585036451|FG000|Overall Study|Death|4|||
161996364|NCT01702558|585036452|FG001|Overall Study|Death|3|||
161996365|NCT01702558|585036453|FG002|Overall Study|Death|3|||
161996366|NCT01702558|585036454|FG003|Overall Study|Death|16|||
161996367|NCT01702558|585036455|FG004|Overall Study|Death|20|||
161996368|NCT01702558|585036451|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
161996369|NCT01702558|585036452|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
161996370|NCT01702558|585036453|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
161996371|NCT01702558|585036454|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
161996372|NCT01702558|585036455|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
161996373|NCT01702558|585036451|FG000|Overall Study|Study Terminated by Sponsor|0|||
161996374|NCT01702558|585036452|FG001|Overall Study|Study Terminated by Sponsor|1|||
161996375|NCT01702558|585036453|FG002|Overall Study|Study Terminated by Sponsor|0|||
161996376|NCT01702558|585036454|FG003|Overall Study|Study Terminated by Sponsor|0|||
161996377|NCT01702558|585036455|FG004|Overall Study|Study Terminated by Sponsor|1|||
161996378|NCT01702558|585036451|FG000|Overall Study|Other|0|||
161996379|NCT01702558|585036452|FG001|Overall Study|Other|0|||
161996380|NCT01702558|585036453|FG002|Overall Study|Other|0|||
161996381|NCT01702558|585036454|FG003|Overall Study|Other|16|||
161996382|NCT01702558|585036455|FG004|Overall Study|Other|17|||
161996383|NCT03259087|585036461|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
161996384|NCT03259087|585036462|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
161996385|NCT03259087|585036463|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
161996386|NCT03259087|585036464|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
161996387|NCT03259087|585036465|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
161996388|NCT03259087|585036461|FG000|Period 2 of Part 2|Adverse Event|0|||
161996389|NCT03259087|585036462|FG001|Period 2 of Part 2|Adverse Event|0|||
161996390|NCT03259087|585036463|FG002|Period 2 of Part 2|Adverse Event|0|||
161996391|NCT03259087|585036464|FG003|Period 2 of Part 2|Adverse Event|0|||
161996392|NCT03259087|585036465|FG004|Period 2 of Part 2|Adverse Event|1|||
161996393|NCT04524858|585036466|FG000|Overall Study|Adverse Event|1|||
161996394|NCT03571204|585036467|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
161996395|NCT03571204|585036468|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
161996396|NCT03571204|585036469|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
161996397|NCT03571204|585036467|FG000|Overall Study|Physician Decision|0|||
161996398|NCT03571204|585036468|FG001|Overall Study|Physician Decision|1|||
161996399|NCT03571204|585036469|FG002|Overall Study|Physician Decision|0|||
162039579|NCT00423722|585202955|FG000|Overall Study|Death|4|||
162039580|NCT00423722|585202956|FG001|Overall Study|Death|4|||
162039581|NCT00423722|585202955|FG000|Overall Study|Declined to participate|2|||
162039582|NCT00423722|585202956|FG001|Overall Study|Declined to participate|3|||
162039583|NCT00423722|585202955|FG000|Overall Study|Unable to complete questionnaires|4|||
162039584|NCT00423722|585202956|FG001|Overall Study|Unable to complete questionnaires|4|||
161996400|NCT02396212|585036470|FG000|Overall Study|Adverse Event|1|||
161996401|NCT02396212|585036470|FG000|Overall Study|Lack of Efficacy|2|||
161996402|NCT01623115|585036471|FG000|Overall Study|Randomized but not treated|0|||
161996403|NCT01623115|585036472|FG001|Overall Study|Randomized but not treated|1|||
161996404|NCT01623115|585036471|FG000|Overall Study|Physician Decision|1|||
161996405|NCT01623115|585036472|FG001|Overall Study|Physician Decision|0|||
161996406|NCT01623115|585036471|FG000|Overall Study|Participants moved|1|||
161996407|NCT01623115|585036472|FG001|Overall Study|Participants moved|5|||
161996408|NCT01623115|585036471|FG000|Overall Study|Adverse Event|10|||
161996409|NCT01623115|585036472|FG001|Overall Study|Adverse Event|13|||
161996410|NCT01623115|585036471|FG000|Overall Study|Poor compliance to protocol|4|||
161996411|NCT01623115|585036472|FG001|Overall Study|Poor compliance to protocol|10|||
161996412|NCT01623115|585036471|FG000|Overall Study|Consent withdrawn by participant|2|||
161996413|NCT01623115|585036472|FG001|Overall Study|Consent withdrawn by participant|6|||
161996414|NCT01623115|585036471|FG000|Overall Study|Related to study drug administration|0|||
161996415|NCT01623115|585036472|FG001|Overall Study|Related to study drug administration|2|||
161996416|NCT01623115|585036471|FG000|Overall Study|Last visit outside protocol visit window|14|||
161996417|NCT01623115|585036472|FG001|Overall Study|Last visit outside protocol visit window|26|||
161996418|NCT01623115|585036471|FG000|Overall Study|Site closure|1|||
161996419|NCT01623115|585036472|FG001|Overall Study|Site closure|7|||
161996420|NCT01623115|585036471|FG000|Overall Study|Death|0|||
161996421|NCT01623115|585036472|FG001|Overall Study|Death|4|||
161996422|NCT01623115|585036471|FG000|Overall Study|Other than specified above|0|||
161996423|NCT01623115|585036472|FG001|Overall Study|Other than specified above|3|||
161996424|NCT04950465|585036473|FG000|Overall Study|Lost to Follow-up|1|||
161996425|NCT04950465|585036474|FG001|Overall Study|Lost to Follow-up|0|||
161996426|NCT04950465|585036475|FG002|Overall Study|Lost to Follow-up|0|||
161996427|NCT01788566|585036478|FG000|Overall Study|Death|4|||
161996428|NCT01788566|585036478|FG000|Overall Study|Adverse Event|1|||
161996429|NCT01788566|585036478|FG000|Overall Study|Clinical Progressive Disease|3|||
161996430|NCT00857285|585036481|FG000|Overall Study|Adverse Event|4|||
161996431|NCT00857285|585036482|FG001|Overall Study|Adverse Event|2|||
161996432|NCT00857285|585036481|FG000|Overall Study|Lack of Efficacy|0|||
161996433|NCT00857285|585036482|FG001|Overall Study|Lack of Efficacy|2|||
161996434|NCT00857285|585036481|FG000|Overall Study|Protocol Violation|3|||
161996435|NCT00857285|585036482|FG001|Overall Study|Protocol Violation|1|||
161996436|NCT00857285|585036481|FG000|Overall Study|Withdrawal by Subject|4|||
161996437|NCT00857285|585036482|FG001|Overall Study|Withdrawal by Subject|0|||
161996438|NCT00857285|585036481|FG000|Overall Study|Randomization criteria not met|1|||
161996439|NCT00857285|585036482|FG001|Overall Study|Randomization criteria not met|1|||
161996440|NCT01633788|585038127|FG000|Overall Study|Adverse Event|1|||
161996441|NCT01633788|585038128|FG001|Overall Study|Adverse Event|3|||
161996442|NCT01633788|585038129|FG002|Overall Study|Adverse Event|3|||
161996443|NCT01633788|585038130|FG003|Overall Study|Adverse Event|3|||
161996444|NCT01633788|585038127|FG000|Overall Study|Lost to Follow-up|2|||
161996445|NCT01633788|585038128|FG001|Overall Study|Lost to Follow-up|2|||
161996446|NCT01633788|585038129|FG002|Overall Study|Lost to Follow-up|2|||
161996447|NCT01633788|585038130|FG003|Overall Study|Lost to Follow-up|0|||
161996448|NCT01633788|585038127|FG000|Overall Study|Personal Reasons|3|||
161996449|NCT01633788|585038128|FG001|Overall Study|Personal Reasons|1|||
161996450|NCT01633788|585038129|FG002|Overall Study|Personal Reasons|1|||
161996451|NCT01633788|585038130|FG003|Overall Study|Personal Reasons|3|||
161996452|NCT01633788|585038127|FG000|Overall Study|Protocol Violation|1|||
161996453|NCT01633788|585038128|FG001|Overall Study|Protocol Violation|0|||
161996454|NCT01633788|585038129|FG002|Overall Study|Protocol Violation|1|||
161996455|NCT01633788|585038130|FG003|Overall Study|Protocol Violation|0|||
161996456|NCT01633788|585038127|FG000|Overall Study|Other Reasons|0|||
161996457|NCT01633788|585038128|FG001|Overall Study|Other Reasons|2|||
161996458|NCT01633788|585038129|FG002|Overall Study|Other Reasons|3|||
161996459|NCT01633788|585038130|FG003|Overall Study|Other Reasons|7|||
161996460|NCT01389882|585038136|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
161996461|NCT01389882|585038137|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
161996462|NCT01389882|585038136|FG000|Overall Study|Withdrawal by Subject|0|||
161996463|NCT01389882|585038137|FG001|Overall Study|Withdrawal by Subject|1|||
161996464|NCT03811340|585038139|FG000|Overall Study|subjects did not complete the survey.|90|||
161996465|NCT01045967|585038140|FG000|Second Intervention|Protocol Violation|0|||
161996466|NCT01045967|585038141|FG001|Second Intervention|Protocol Violation|1|||
161996467|NCT00404651|585038142|FG000|Overall Study|Serious Adverse Event|0|||
161996468|NCT00404651|585038143|FG001|Overall Study|Serious Adverse Event|0|||
161996469|NCT00404651|585038144|FG002|Overall Study|Serious Adverse Event|2|||
161996470|NCT00404651|585038145|FG003|Overall Study|Serious Adverse Event|0|||
161996471|NCT00404651|585038142|FG000|Overall Study|Protocol Violation|10|||
161996472|NCT00404651|585038143|FG001|Overall Study|Protocol Violation|5|||
161996473|NCT00404651|585038144|FG002|Overall Study|Protocol Violation|14|||
161996474|NCT00404651|585038145|FG003|Overall Study|Protocol Violation|5|||
161996475|NCT00404651|585038142|FG000|Overall Study|Lost to Follow-up|15|||
161996476|NCT00404651|585038143|FG001|Overall Study|Lost to Follow-up|11|||
161996477|NCT00404651|585038144|FG002|Overall Study|Lost to Follow-up|13|||
161996478|NCT00404651|585038145|FG003|Overall Study|Lost to Follow-up|10|||
161996479|NCT00404651|585038142|FG000|Overall Study|Withdrawal by Subject|14|||
161996480|NCT00404651|585038143|FG001|Overall Study|Withdrawal by Subject|12|||
161996481|NCT00404651|585038144|FG002|Overall Study|Withdrawal by Subject|16|||
161996482|NCT00404651|585038145|FG003|Overall Study|Withdrawal by Subject|6|||
161996483|NCT03922581|585038158|FG000|Overall Study|Lost to Follow-up|20|||
161996484|NCT03922581|585038159|FG001|Overall Study|Lost to Follow-up|9|||
161996485|NCT03922581|585038158|FG000|Overall Study|Physician Decision|1|||
161996486|NCT03922581|585038159|FG001|Overall Study|Physician Decision|1|||
161996487|NCT03922581|585038158|FG000|Overall Study|Withdrawal by Subject|1|||
161996488|NCT03922581|585038159|FG001|Overall Study|Withdrawal by Subject|0|||
161996489|NCT00764699|585038160|FG000|Overall Study|PI left and study terminated|3|||
161996490|NCT02223715|585038166|FG000|Overall Study|Death|31|||
161996491|NCT02223715|585038166|FG000|Overall Study|Lost to Follow-up|73|||
161996492|NCT00965081|585038168|FG000|Overall Study|Adverse Event|14|||
161996493|NCT00965081|585038169|FG001|Overall Study|Adverse Event|9|||
161996494|NCT00965081|585038168|FG000|Overall Study|Lack of Efficacy|2|||
161996495|NCT00965081|585038169|FG001|Overall Study|Lack of Efficacy|5|||
161996496|NCT00965081|585038168|FG000|Overall Study|Lost to Follow-up|4|||
161996497|NCT00965081|585038169|FG001|Overall Study|Lost to Follow-up|5|||
161996498|NCT00965081|585038168|FG000|Overall Study|Physician Decision|2|||
161996499|NCT00965081|585038169|FG001|Overall Study|Physician Decision|0|||
161996500|NCT00965081|585038168|FG000|Overall Study|Protocol Violation|2|||
161996501|NCT00965081|585038169|FG001|Overall Study|Protocol Violation|5|||
161996502|NCT00965081|585038168|FG000|Overall Study|Sponsor Decision|1|||
161996503|NCT00965081|585038169|FG001|Overall Study|Sponsor Decision|0|||
161996504|NCT00965081|585038168|FG000|Overall Study|Withdrawal by Subject|4|||
161996505|NCT00965081|585038169|FG001|Overall Study|Withdrawal by Subject|7|||
161996506|NCT00965081|585038168|FG000|Overall Study|Switched to Rescue Arm|5|||
161996507|NCT00965081|585038169|FG001|Overall Study|Switched to Rescue Arm|12|||
161996508|NCT01020786|585038170|FG000|Induction Period|Entry Criteria Not Met|2|||
161996509|NCT01020786|585038170|FG000|Induction Period|Adverse Event|10|||
161996510|NCT01020786|585038170|FG000|Induction Period|Progressive Disease|31|||
161996511|NCT01020786|585038170|FG000|Induction Period|Investigator Decision|3|||
161996512|NCT01020786|585038170|FG000|Induction Period|Withdrawal by Subject|3|||
161996513|NCT01020786|585038170|FG000|Maintenance Period|Adverse Event|8|||
161996514|NCT01020786|585038170|FG000|Maintenance Period|Progressive Disease|43|||
161996515|NCT01020786|585038170|FG000|Maintenance Period|Withdrawal by Subject|8|||
161996516|NCT01020786|585038170|FG000|Maintenance Period|Sponsor Decision|1|||
161996517|NCT01539759|585038171|FG000|Overall Study|Lost to Follow-up|6|||
161996518|NCT01539759|585038172|FG001|Overall Study|Lost to Follow-up|8|||
161996519|NCT01076959|585038173|FG000|Overall Study|Adverse Event|767|||
161996520|NCT01076959|585038173|FG000|Overall Study|Lack of Efficacy|849|||
161996521|NCT01076959|585038173|FG000|Overall Study|Non-compliance|274|||
161996522|NCT01076959|585038173|FG000|Overall Study|Lost to Follow-up|241|||
161996523|NCT01076959|585038173|FG000|Overall Study|Other|119|||
161996524|NCT02491983|585038174|FG000|Overall Study|Physician Decision|1|||
161996525|NCT02491983|585038175|FG001|Overall Study|Physician Decision|0|||
161996526|NCT02491983|585038174|FG000|Overall Study|Not meet selection criteria|1|||
161996527|NCT02491983|585038175|FG001|Overall Study|Not meet selection criteria|0|||
161996528|NCT02491983|585038174|FG000|Overall Study|Withdrawal by Subject|0|||
161996529|NCT02491983|585038175|FG001|Overall Study|Withdrawal by Subject|1|||
161996530|NCT02292719|585038178|FG000|Overall Study|Withdrawal by Subject|0|||
161996531|NCT02292719|585038179|FG001|Overall Study|Withdrawal by Subject|0|||
161996532|NCT02292719|585038180|FG002|Overall Study|Withdrawal by Subject|0|||
161996533|NCT02292719|585038181|FG003|Overall Study|Withdrawal by Subject|1|||
161996534|NCT02292719|585038182|FG004|Overall Study|Withdrawal by Subject|1|||
161996535|NCT02292719|585038183|FG005|Overall Study|Withdrawal by Subject|0|||
161996536|NCT02292719|585038178|FG000|Overall Study|Subject enrolled in new study.|0|||
161996537|NCT02292719|585038179|FG001|Overall Study|Subject enrolled in new study.|0|||
161996538|NCT02292719|585038180|FG002|Overall Study|Subject enrolled in new study.|1|||
161996539|NCT02292719|585038181|FG003|Overall Study|Subject enrolled in new study.|0|||
161996540|NCT02292719|585038182|FG004|Overall Study|Subject enrolled in new study.|0|||
161996541|NCT02292719|585038183|FG005|Overall Study|Subject enrolled in new study.|0|||
161996542|NCT04170543|585038186|FG000|Overall Study|Death|1|||
161996543|NCT04170543|585038187|FG001|Overall Study|Death|1|||
161996544|NCT04170543|585038188|FG002|Overall Study|Death|1|||
161996545|NCT04170543|585038189|FG003|Overall Study|Death|1|||
161996546|NCT04170543|585038190|FG004|Overall Study|Death|1|||
161996547|NCT04170543|585038186|FG000|Overall Study|Lost to Follow-up|3|||
161996548|NCT04170543|585038187|FG001|Overall Study|Lost to Follow-up|3|||
161996549|NCT04170543|585038188|FG002|Overall Study|Lost to Follow-up|0|||
161996550|NCT04170543|585038189|FG003|Overall Study|Lost to Follow-up|3|||
161996551|NCT04170543|585038190|FG004|Overall Study|Lost to Follow-up|1|||
161996552|NCT04170543|585038186|FG000|Overall Study|Withdrawal by Subject|13|||
161996553|NCT04170543|585038187|FG001|Overall Study|Withdrawal by Subject|6|||
161996554|NCT04170543|585038188|FG002|Overall Study|Withdrawal by Subject|5|||
161996555|NCT04170543|585038189|FG003|Overall Study|Withdrawal by Subject|4|||
161996556|NCT04170543|585038190|FG004|Overall Study|Withdrawal by Subject|9|||
161996557|NCT04170543|585038186|FG000|Overall Study|Not able to transition to phase 2b|8|||
161996558|NCT04170543|585038187|FG001|Overall Study|Not able to transition to phase 2b|0|||
161996559|NCT04170543|585038188|FG002|Overall Study|Not able to transition to phase 2b|10|||
161996560|NCT04170543|585038189|FG003|Overall Study|Not able to transition to phase 2b|0|||
161996561|NCT04170543|585038190|FG004|Overall Study|Not able to transition to phase 2b|6|||
161996562|NCT04170543|585038186|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
161996563|NCT04170543|585038187|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
161996564|NCT04170543|585038188|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
161996565|NCT04170543|585038189|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
161996566|NCT04170543|585038190|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
161996567|NCT04170543|585038186|FG000|Overall Study|Not Treated|0|||
161996568|NCT04170543|585038187|FG001|Overall Study|Not Treated|0|||
161996569|NCT04170543|585038188|FG002|Overall Study|Not Treated|0|||
161996570|NCT04170543|585038189|FG003|Overall Study|Not Treated|0|||
161996571|NCT04170543|585038190|FG004|Overall Study|Not Treated|2|||
161996572|NCT04170543|585038186|FG000|Overall Study|(CRF)|16|||
161996573|NCT04170543|585038187|FG001|Overall Study|(CRF)|15|||
161996574|NCT04170543|585038188|FG002|Overall Study|(CRF)|12|||
161996575|NCT04170543|585038189|FG003|Overall Study|(CRF)|17|||
161996576|NCT04170543|585038190|FG004|Overall Study|(CRF)|17|||
161996577|NCT04170543|585038186|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
161996578|NCT04170543|585038187|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
161996579|NCT04170543|585038188|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
161996580|NCT04170543|585038189|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
161996581|NCT04170543|585038190|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
161996582|NCT00770601|585038191|FG000|Overall Study|Withdrawal by Subject|1|||
161996583|NCT01987102|585038192|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
161996584|NCT01987102|585038193|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
161996585|NCT01987102|585038192|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
161996586|NCT01987102|585038193|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
161996587|NCT01987102|585038192|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
161996588|NCT01987102|585038193|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
161996589|NCT01987102|585038192|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
161996590|NCT01987102|585038193|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
161996591|NCT01987102|585038192|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
161996592|NCT01987102|585038193|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
161996593|NCT01987102|585038192|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
161996594|NCT01987102|585038193|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
161996595|NCT04378270|585038196|FG000|Overall Study|Lack of Efficacy|1|||
161996596|NCT04378270|585038196|FG000|Overall Study|Withdrawal by Subject|1|||
161996597|NCT04378270|585038196|FG000|Overall Study|Screen Failure|1|||
161996598|NCT04378270|585038196|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
161996599|NCT01327599|585038197|FG000|Overall Study|Adverse Event|1|||
161996600|NCT01327599|585038197|FG000|Overall Study|Could Not Attend Visit|1|||
161996601|NCT01327599|585038197|FG000|Overall Study|Withdrawal of Consent|1|||
161996602|NCT01132313|585038198|FG000|Overall Study|Lack of Efficacy|1|||
161996603|NCT01132313|585038199|FG001|Overall Study|Lack of Efficacy|0|||
161996604|NCT01132313|585038200|FG002|Overall Study|Lack of Efficacy|0|||
161996605|NCT01132313|585038201|FG003|Overall Study|Lack of Efficacy|0|||
161996606|NCT01132313|585038202|FG004|Overall Study|Lack of Efficacy|0|||
161996607|NCT01132313|585038203|FG005|Overall Study|Lack of Efficacy|0|||
161996608|NCT01132313|585038204|FG006|Overall Study|Lack of Efficacy|0|||
161996609|NCT01132313|585038205|FG007|Overall Study|Lack of Efficacy|3|||
161996610|NCT01132313|585038206|FG008|Overall Study|Lack of Efficacy|14|||
161996611|NCT01132313|585038207|FG009|Overall Study|Lack of Efficacy|16|||
161996612|NCT01132313|585038208|FG010|Overall Study|Lack of Efficacy|0|||
161996613|NCT01132313|585038209|FG011|Overall Study|Lack of Efficacy|0|||
161996614|NCT01132313|585038198|FG000|Overall Study|Not treated|2|||
161996615|NCT01132313|585038199|FG001|Overall Study|Not treated|0|||
161996616|NCT01132313|585038200|FG002|Overall Study|Not treated|0|||
161996617|NCT01132313|585038201|FG003|Overall Study|Not treated|0|||
161996618|NCT01132313|585038202|FG004|Overall Study|Not treated|2|||
161996619|NCT01132313|585038203|FG005|Overall Study|Not treated|1|||
161996620|NCT01132313|585038204|FG006|Overall Study|Not treated|3|||
161996621|NCT01132313|585038205|FG007|Overall Study|Not treated|0|||
161996622|NCT01132313|585038206|FG008|Overall Study|Not treated|0|||
161996623|NCT01132313|585038207|FG009|Overall Study|Not treated|0|||
161996624|NCT01132313|585038208|FG010|Overall Study|Not treated|0|||
161996625|NCT01132313|585038209|FG011|Overall Study|Not treated|0|||
161996626|NCT01132313|585038198|FG000|Overall Study|Adverse Event|0|||
161996627|NCT01132313|585038199|FG001|Overall Study|Adverse Event|0|||
161996628|NCT01132313|585038200|FG002|Overall Study|Adverse Event|4|||
161996629|NCT01132313|585038201|FG003|Overall Study|Adverse Event|10|||
161996630|NCT01132313|585038202|FG004|Overall Study|Adverse Event|19|||
161996631|NCT01132313|585038203|FG005|Overall Study|Adverse Event|6|||
161996632|NCT01132313|585038204|FG006|Overall Study|Adverse Event|5|||
161996633|NCT01132313|585038205|FG007|Overall Study|Adverse Event|3|||
161996634|NCT01132313|585038206|FG008|Overall Study|Adverse Event|7|||
161996635|NCT01132313|585038207|FG009|Overall Study|Adverse Event|2|||
161996636|NCT01132313|585038208|FG010|Overall Study|Adverse Event|0|||
161996637|NCT01132313|585038209|FG011|Overall Study|Adverse Event|0|||
161996638|NCT01132313|585038198|FG000|Overall Study|Protocol Violation|0|||
161996639|NCT01132313|585038199|FG001|Overall Study|Protocol Violation|0|||
161996640|NCT01132313|585038200|FG002|Overall Study|Protocol Violation|0|||
161996641|NCT01132313|585038201|FG003|Overall Study|Protocol Violation|1|||
161996642|NCT01132313|585038202|FG004|Overall Study|Protocol Violation|0|||
161996643|NCT01132313|585038203|FG005|Overall Study|Protocol Violation|0|||
161996644|NCT01132313|585038204|FG006|Overall Study|Protocol Violation|0|||
161996645|NCT01132313|585038205|FG007|Overall Study|Protocol Violation|0|||
161996646|NCT01132313|585038206|FG008|Overall Study|Protocol Violation|0|||
161996647|NCT01132313|585038207|FG009|Overall Study|Protocol Violation|0|||
161996648|NCT01132313|585038208|FG010|Overall Study|Protocol Violation|0|||
161996649|NCT01132313|585038209|FG011|Overall Study|Protocol Violation|0|||
161996650|NCT01132313|585038198|FG000|Overall Study|Lost to Follow-up|0|||
161996651|NCT01132313|585038199|FG001|Overall Study|Lost to Follow-up|0|||
161996652|NCT01132313|585038200|FG002|Overall Study|Lost to Follow-up|1|||
161996653|NCT01132313|585038201|FG003|Overall Study|Lost to Follow-up|0|||
161996654|NCT01132313|585038202|FG004|Overall Study|Lost to Follow-up|0|||
161996655|NCT01132313|585038203|FG005|Overall Study|Lost to Follow-up|0|||
161996656|NCT01132313|585038204|FG006|Overall Study|Lost to Follow-up|0|||
161996657|NCT01132313|585038205|FG007|Overall Study|Lost to Follow-up|1|||
161996658|NCT01132313|585038206|FG008|Overall Study|Lost to Follow-up|0|||
161996659|NCT01132313|585038207|FG009|Overall Study|Lost to Follow-up|0|||
161996660|NCT01132313|585038208|FG010|Overall Study|Lost to Follow-up|0|||
161996661|NCT01132313|585038209|FG011|Overall Study|Lost to Follow-up|0|||
161996662|NCT01132313|585038198|FG000|Overall Study|Withdrawal by Subject|0|||
161996663|NCT01132313|585038199|FG001|Overall Study|Withdrawal by Subject|0|||
161996664|NCT01132313|585038200|FG002|Overall Study|Withdrawal by Subject|3|||
161996665|NCT01132313|585038201|FG003|Overall Study|Withdrawal by Subject|3|||
161996666|NCT01132313|585038202|FG004|Overall Study|Withdrawal by Subject|6|||
161996667|NCT01132313|585038203|FG005|Overall Study|Withdrawal by Subject|0|||
161996668|NCT01132313|585038204|FG006|Overall Study|Withdrawal by Subject|1|||
161996669|NCT01132313|585038205|FG007|Overall Study|Withdrawal by Subject|0|||
161996670|NCT01132313|585038206|FG008|Overall Study|Withdrawal by Subject|0|||
161996671|NCT01132313|585038207|FG009|Overall Study|Withdrawal by Subject|2|||
161996672|NCT01132313|585038208|FG010|Overall Study|Withdrawal by Subject|0|||
161996673|NCT01132313|585038209|FG011|Overall Study|Withdrawal by Subject|0|||
161996674|NCT01132313|585038198|FG000|Overall Study|Lack of antiviral response|0|||
161996675|NCT01132313|585038199|FG001|Overall Study|Lack of antiviral response|0|||
161996676|NCT01132313|585038200|FG002|Overall Study|Lack of antiviral response|12|||
161996677|NCT01132313|585038201|FG003|Overall Study|Lack of antiviral response|18|||
161996678|NCT01132313|585038202|FG004|Overall Study|Lack of antiviral response|18|||
161996679|NCT01132313|585038203|FG005|Overall Study|Lack of antiviral response|18|||
161996680|NCT01132313|585038204|FG006|Overall Study|Lack of antiviral response|21|||
161996681|NCT01132313|585038205|FG007|Overall Study|Lack of antiviral response|0|||
161996682|NCT01132313|585038206|FG008|Overall Study|Lack of antiviral response|0|||
161996683|NCT01132313|585038207|FG009|Overall Study|Lack of antiviral response|0|||
161996684|NCT01132313|585038208|FG010|Overall Study|Lack of antiviral response|1|||
161996685|NCT01132313|585038209|FG011|Overall Study|Lack of antiviral response|0|||
161996686|NCT01132313|585038198|FG000|Overall Study|Other reason not defined above|0|||
161996687|NCT01132313|585038199|FG001|Overall Study|Other reason not defined above|0|||
161996688|NCT01132313|585038200|FG002|Overall Study|Other reason not defined above|0|||
161996689|NCT01132313|585038201|FG003|Overall Study|Other reason not defined above|0|||
161996690|NCT01132313|585038202|FG004|Overall Study|Other reason not defined above|0|||
161996691|NCT01132313|585038203|FG005|Overall Study|Other reason not defined above|0|||
161996692|NCT01132313|585038204|FG006|Overall Study|Other reason not defined above|0|||
161996693|NCT01132313|585038205|FG007|Overall Study|Other reason not defined above|1|||
161996694|NCT01132313|585038206|FG008|Overall Study|Other reason not defined above|0|||
161996695|NCT01132313|585038207|FG009|Overall Study|Other reason not defined above|0|||
161996696|NCT01132313|585038208|FG010|Overall Study|Other reason not defined above|0|||
161996697|NCT01132313|585038209|FG011|Overall Study|Other reason not defined above|0|||
161996698|NCT01236521|585038210|FG000|Overall Study|Withdrawal by Subject|12|||
161996699|NCT01236521|585038211|FG001|Overall Study|Withdrawal by Subject|17|||
161996700|NCT01236521|585038210|FG000|Overall Study|Death|2|||
161996701|NCT01236521|585038211|FG001|Overall Study|Death|1|||
161996702|NCT01236521|585038210|FG000|Overall Study|Lost to Follow-up|9|||
161996703|NCT01236521|585038211|FG001|Overall Study|Lost to Follow-up|7|||
161996704|NCT03201419|585038217|FG000|Overall Study|Adverse Event|3|||
161996705|NCT03201419|585038218|FG001|Overall Study|Adverse Event|1|||
161996706|NCT03201419|585038219|FG002|Overall Study|Adverse Event|0|||
161996707|NCT03201419|585038220|FG003|Overall Study|Adverse Event|0|||
161996708|NCT03201419|585038221|FG004|Overall Study|Adverse Event|1|||
161996709|NCT03201419|585038222|FG005|Overall Study|Adverse Event|1|||
161996710|NCT03201419|585038223|FG006|Overall Study|Adverse Event|5|||
161996711|NCT03201419|585038224|FG007|Overall Study|Adverse Event|0|||
161996712|NCT03201419|585038225|FG008|Overall Study|Adverse Event|0|||
161996713|NCT03201419|585038217|FG000|Overall Study|Lost to Follow-up|1|||
161996714|NCT03201419|585038218|FG001|Overall Study|Lost to Follow-up|0|||
161996715|NCT03201419|585038219|FG002|Overall Study|Lost to Follow-up|0|||
161996716|NCT03201419|585038220|FG003|Overall Study|Lost to Follow-up|0|||
161996717|NCT03201419|585038221|FG004|Overall Study|Lost to Follow-up|0|||
161996718|NCT03201419|585038222|FG005|Overall Study|Lost to Follow-up|0|||
161996719|NCT03201419|585038223|FG006|Overall Study|Lost to Follow-up|0|||
161996720|NCT03201419|585038224|FG007|Overall Study|Lost to Follow-up|0|||
161996721|NCT03201419|585038225|FG008|Overall Study|Lost to Follow-up|0|||
161996722|NCT03201419|585038217|FG000|Overall Study|Protocol Deviation|0|||
161996723|NCT03201419|585038218|FG001|Overall Study|Protocol Deviation|0|||
161996724|NCT03201419|585038219|FG002|Overall Study|Protocol Deviation|0|||
161996725|NCT03201419|585038220|FG003|Overall Study|Protocol Deviation|0|||
161996726|NCT03201419|585038221|FG004|Overall Study|Protocol Deviation|0|||
161996727|NCT03201419|585038222|FG005|Overall Study|Protocol Deviation|0|||
161996728|NCT03201419|585038223|FG006|Overall Study|Protocol Deviation|1|||
161996729|NCT03201419|585038224|FG007|Overall Study|Protocol Deviation|0|||
161996730|NCT03201419|585038225|FG008|Overall Study|Protocol Deviation|0|||
161996731|NCT03201419|585038217|FG000|Overall Study|Withdrawal by Subject|4|||
161996732|NCT03201419|585038218|FG001|Overall Study|Withdrawal by Subject|2|||
161996733|NCT03201419|585038219|FG002|Overall Study|Withdrawal by Subject|1|||
161996734|NCT03201419|585038220|FG003|Overall Study|Withdrawal by Subject|0|||
161996735|NCT03201419|585038221|FG004|Overall Study|Withdrawal by Subject|0|||
161996736|NCT03201419|585038222|FG005|Overall Study|Withdrawal by Subject|0|||
161996737|NCT03201419|585038223|FG006|Overall Study|Withdrawal by Subject|0|||
161996738|NCT03201419|585038224|FG007|Overall Study|Withdrawal by Subject|1|||
161996739|NCT03201419|585038225|FG008|Overall Study|Withdrawal by Subject|2|||
161996740|NCT03201419|585038217|FG000|Overall Study|Other|0|||
161996741|NCT03201419|585038218|FG001|Overall Study|Other|0|||
161996742|NCT03201419|585038219|FG002|Overall Study|Other|1|||
161996743|NCT03201419|585038220|FG003|Overall Study|Other|0|||
161996744|NCT03201419|585038221|FG004|Overall Study|Other|0|||
161996745|NCT03201419|585038222|FG005|Overall Study|Other|0|||
161996746|NCT03201419|585038223|FG006|Overall Study|Other|0|||
161996747|NCT03201419|585038224|FG007|Overall Study|Other|0|||
161996748|NCT03201419|585038225|FG008|Overall Study|Other|0|||
161996749|NCT04661150|585038233|FG000|Overall Study|Ongoing in study|19|||
161996750|NCT04661150|585038234|FG001|Overall Study|Ongoing in study|20|||
161996751|NCT04661150|585038233|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
161996752|NCT04661150|585038234|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
161996753|NCT04661150|585038233|FG000|Overall Study|Death|2|||
161996754|NCT04661150|585038234|FG001|Overall Study|Death|0|||
161996755|NCT04965688|585038235|FG000|Overall Study|Withdrawal by Subject|2|||
161996756|NCT05864586|585038236|FG000|Overall Study|Ineligible|4|||
161996757|NCT05864586|585038237|FG001|Overall Study|Ineligible|12|||
161996758|NCT05864586|585038236|FG000|Overall Study|Pregnancy|0|||
161996759|NCT05864586|585038237|FG001|Overall Study|Pregnancy|1|||
161996760|NCT05864586|585038236|FG000|Overall Study|Withdrawal by Subject|0|||
161996761|NCT05864586|585038237|FG001|Overall Study|Withdrawal by Subject|1|||
161996762|NCT03635424|585038238|FG000|Overall Study|Adverse Event|1|||
161996763|NCT03635424|585038238|FG000|Overall Study|Death|1|||
161996764|NCT03635424|585038238|FG000|Overall Study|Device not implanted|1|||
161996765|NCT02701283|585038239|FG000|Overall Study|Death|25|||
161996766|NCT02701283|585038240|FG001|Overall Study|Death|29|||
161996767|NCT02701283|585038241|FG002|Overall Study|Death|19|||
161996768|NCT02701283|585038239|FG000|Overall Study|Lost to Follow-up|3|||
161996769|NCT02701283|585038240|FG001|Overall Study|Lost to Follow-up|8|||
161996770|NCT02701283|585038241|FG002|Overall Study|Lost to Follow-up|1|||
161996771|NCT02701283|585038239|FG000|Overall Study|Withdrawal by Subject|12|||
161996772|NCT02701283|585038240|FG001|Overall Study|Withdrawal by Subject|41|||
161996773|NCT02701283|585038241|FG002|Overall Study|Withdrawal by Subject|1|||
161996774|NCT02701283|585038239|FG000|Overall Study|Missed 2-year visit|22|||
161996775|NCT02701283|585038240|FG001|Overall Study|Missed 2-year visit|27|||
161996776|NCT02701283|585038241|FG002|Overall Study|Missed 2-year visit|0|||
161996777|NCT02701283|585038239|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
161996778|NCT02701283|585038240|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
161996779|NCT02701283|585038241|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
161996780|NCT04544956|585038242|FG000|Overall Study|Withdrawal by Subject|1|||
161996781|NCT04266795|585038243|FG000|Overall Study|Adverse Event|10|||
161996782|NCT04266795|585038244|FG001|Overall Study|Adverse Event|19|||
161996783|NCT04266795|585038243|FG000|Overall Study|Death|7|||
161996784|NCT04266795|585038244|FG001|Overall Study|Death|8|||
161996785|NCT04266795|585038243|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
161996786|NCT04266795|585038244|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
161996787|NCT04266795|585038243|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161996788|NCT04266795|585038244|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161996789|NCT04266795|585038243|FG000|Overall Study|Progressive Disease|12|||
161996790|NCT04266795|585038244|FG001|Overall Study|Progressive Disease|9|||
161996791|NCT04266795|585038243|FG000|Overall Study|Withdrawal by Patient|5|||
161996792|NCT04266795|585038244|FG001|Overall Study|Withdrawal by Patient|6|||
161996793|NCT04266795|585038243|FG000|Overall Study|Disease Relapse|3|||
161996794|NCT04266795|585038244|FG001|Overall Study|Disease Relapse|6|||
161996795|NCT04266795|585038243|FG000|Overall Study|Reason not Specified|12|||
161996796|NCT04266795|585038244|FG001|Overall Study|Reason not Specified|10|||
161996797|NCT04266795|585038243|FG000|Overall Study|Participants Ongoing on Treatment|25|||
161996798|NCT04266795|585038244|FG001|Overall Study|Participants Ongoing on Treatment|23|||
161996799|NCT00369577|585038247|FG000|Overall Study|Withdrawal by Subject|0|||
161996800|NCT00369577|585038248|FG001|Overall Study|Withdrawal by Subject|0|||
161996801|NCT00369577|585038249|FG002|Overall Study|Withdrawal by Subject|1|||
161996802|NCT00699660|585038250|FG000|Overall Study|Lost to Follow-up|4|||
161996803|NCT00699660|585038251|FG001|Overall Study|Lost to Follow-up|2|||
161996804|NCT00699660|585038250|FG000|Overall Study|missing reports and recording failures|10|||
161996805|NCT00699660|585038251|FG001|Overall Study|missing reports and recording failures|6|||
161996806|NCT03915470|585038252|FG000|Overall Study|Death|3|||
161996807|NCT03915470|585038253|FG001|Overall Study|Death|1|||
161996808|NCT03915470|585038252|FG000|Overall Study|Adverse Event|1|||
161996809|NCT03915470|585038253|FG001|Overall Study|Adverse Event|0|||
161996810|NCT03915470|585038252|FG000|Overall Study|Physician Decision|1|||
161996811|NCT03915470|585038253|FG001|Overall Study|Physician Decision|0|||
161996812|NCT03915470|585038252|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
161996813|NCT03915470|585038253|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
161996814|NCT03160898|585038254|FG000|Overall Study|Adverse Event|4|||
161996815|NCT03160898|585038255|FG001|Overall Study|Adverse Event|8|||
161996816|NCT03160898|585038256|FG002|Overall Study|Adverse Event|7|||
161996817|NCT03160898|585038257|FG003|Overall Study|Adverse Event|10|||
161996818|NCT03160898|585038254|FG000|Overall Study|Death|1|||
161996819|NCT03160898|585038255|FG001|Overall Study|Death|0|||
161996820|NCT03160898|585038256|FG002|Overall Study|Death|0|||
161996821|NCT03160898|585038257|FG003|Overall Study|Death|1|||
161996822|NCT03160898|585038254|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
161996823|NCT03160898|585038255|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
161996824|NCT03160898|585038256|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
161996825|NCT03160898|585038257|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
161996826|NCT03160898|585038254|FG000|Overall Study|Lost to Follow-up|1|||
161996827|NCT03160898|585038255|FG001|Overall Study|Lost to Follow-up|1|||
161996828|NCT03160898|585038256|FG002|Overall Study|Lost to Follow-up|1|||
161996829|NCT03160898|585038257|FG003|Overall Study|Lost to Follow-up|2|||
161996830|NCT03160898|585038254|FG000|Overall Study|Physician Decision|1|||
161996831|NCT03160898|585038255|FG001|Overall Study|Physician Decision|0|||
161996832|NCT03160898|585038256|FG002|Overall Study|Physician Decision|0|||
161996833|NCT03160898|585038257|FG003|Overall Study|Physician Decision|1|||
161996834|NCT03160898|585038254|FG000|Overall Study|Progressive Disease|4|||
161996835|NCT03160898|585038255|FG001|Overall Study|Progressive Disease|1|||
161996836|NCT03160898|585038256|FG002|Overall Study|Progressive Disease|2|||
161996837|NCT03160898|585038257|FG003|Overall Study|Progressive Disease|1|||
161996838|NCT03160898|585038254|FG000|Overall Study|Protocol Violation|1|||
161996839|NCT03160898|585038255|FG001|Overall Study|Protocol Violation|0|||
161996840|NCT03160898|585038256|FG002|Overall Study|Protocol Violation|2|||
161996841|NCT03160898|585038257|FG003|Overall Study|Protocol Violation|0|||
161996842|NCT03160898|585038254|FG000|Overall Study|Sponsor Discretion|2|||
161996843|NCT03160898|585038255|FG001|Overall Study|Sponsor Discretion|0|||
161996844|NCT03160898|585038256|FG002|Overall Study|Sponsor Discretion|0|||
161996845|NCT03160898|585038257|FG003|Overall Study|Sponsor Discretion|0|||
161996846|NCT03160898|585038254|FG000|Overall Study|Withdrawal by Subject|1|||
161996847|NCT03160898|585038255|FG001|Overall Study|Withdrawal by Subject|3|||
161996848|NCT03160898|585038256|FG002|Overall Study|Withdrawal by Subject|2|||
161996849|NCT03160898|585038257|FG003|Overall Study|Withdrawal by Subject|1|||
161996850|NCT03160898|585038254|FG000|Overall Study|Other|2|||
161996851|NCT03160898|585038255|FG001|Overall Study|Other|0|||
161996852|NCT03160898|585038256|FG002|Overall Study|Other|2|||
161996853|NCT03160898|585038257|FG003|Overall Study|Other|2|||
161996854|NCT03405818|585038260|FG000|Overall Study|Withdrawal by Subject|4|||
161996855|NCT03405818|585038260|FG000|Overall Study|Lost to Follow-up|4|||
161996856|NCT00434109|585038261|FG000|Overall Study|Physician Decision|9|||
161996857|NCT00434109|585038261|FG000|Overall Study|Adverse Event|5|||
161996858|NCT00434109|585038261|FG000|Overall Study|Protocol Violation|1|||
161996859|NCT00434109|585038261|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
161996860|NCT04186871|585038264|FG000|Overall Study|Lack of Efficacy|0|||
161996861|NCT04186871|585038265|FG001|Overall Study|Lack of Efficacy|1|||
161996862|NCT04186871|585038266|FG002|Overall Study|Lack of Efficacy|0|||
161996863|NCT04186871|585038267|FG003|Overall Study|Lack of Efficacy|0|||
161996864|NCT04186871|585038268|FG004|Overall Study|Lack of Efficacy|1|||
161996865|NCT04186871|585038269|FG005|Overall Study|Lack of Efficacy|1|||
161996866|NCT04186871|585038264|FG000|Overall Study|Adverse Event|1|||
161996867|NCT04186871|585038265|FG001|Overall Study|Adverse Event|1|||
161996868|NCT04186871|585038266|FG002|Overall Study|Adverse Event|0|||
161996869|NCT04186871|585038267|FG003|Overall Study|Adverse Event|0|||
161996870|NCT04186871|585038268|FG004|Overall Study|Adverse Event|0|||
161996871|NCT04186871|585038269|FG005|Overall Study|Adverse Event|2|||
161996872|NCT04186871|585038264|FG000|Overall Study|Study terminated by sponsor|1|||
161996873|NCT04186871|585038265|FG001|Overall Study|Study terminated by sponsor|2|||
161996874|NCT04186871|585038266|FG002|Overall Study|Study terminated by sponsor|0|||
161996875|NCT04186871|585038267|FG003|Overall Study|Study terminated by sponsor|1|||
161996876|NCT04186871|585038268|FG004|Overall Study|Study terminated by sponsor|0|||
161996877|NCT04186871|585038269|FG005|Overall Study|Study terminated by sponsor|0|||
161996878|NCT04186871|585038264|FG000|Overall Study|Other reasons|0|||
161996879|NCT04186871|585038265|FG001|Overall Study|Other reasons|0|||
161996880|NCT04186871|585038266|FG002|Overall Study|Other reasons|0|||
161996881|NCT04186871|585038267|FG003|Overall Study|Other reasons|0|||
161996882|NCT04186871|585038268|FG004|Overall Study|Other reasons|0|||
161996883|NCT04186871|585038269|FG005|Overall Study|Other reasons|1|||
161996884|NCT04186871|585038264|FG000|Overall Study|Withdrawal by Subject|0|||
161996885|NCT04186871|585038265|FG001|Overall Study|Withdrawal by Subject|0|||
161996886|NCT04186871|585038266|FG002|Overall Study|Withdrawal by Subject|0|||
161996887|NCT04186871|585038267|FG003|Overall Study|Withdrawal by Subject|0|||
161996888|NCT04186871|585038268|FG004|Overall Study|Withdrawal by Subject|0|||
161996889|NCT04186871|585038269|FG005|Overall Study|Withdrawal by Subject|1|||
161996890|NCT04186871|585038264|FG000|Overall Study|Lost to Follow-up|0|||
161996891|NCT04186871|585038265|FG001|Overall Study|Lost to Follow-up|0|||
161996892|NCT04186871|585038266|FG002|Overall Study|Lost to Follow-up|0|||
161996893|NCT04186871|585038267|FG003|Overall Study|Lost to Follow-up|0|||
161996894|NCT04186871|585038268|FG004|Overall Study|Lost to Follow-up|0|||
161996895|NCT04186871|585038269|FG005|Overall Study|Lost to Follow-up|1|||
161996896|NCT00549445|585038276|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
161996897|NCT00549445|585038277|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
161996898|NCT03932760|585038278|FG000|Overall Study|Became Ineligible|2|||
161996899|NCT03932760|585038279|FG001|Overall Study|Became Ineligible|5|||
161996900|NCT03932760|585038278|FG000|Overall Study|Withdrawal by Subject|6|||
161996901|NCT03932760|585038279|FG001|Overall Study|Withdrawal by Subject|6|||
161996902|NCT04725500|585038280|FG000|Screening|Screen Failure|26|||
161996903|NCT04725500|585038280|FG000|Screening|Withdrawal by Subject|1|||
161996904|NCT04725500|585038280|FG000|2 Week Take Home|Screen Fail|5|||
161996905|NCT04618744|585038283|FG000|Overall Study|Adverse Event|0|||
161996906|NCT04618744|585038284|FG001|Overall Study|Adverse Event|1|||
161996907|NCT04618744|585038283|FG000|Overall Study|Withdrawal by Subject|0|||
161996908|NCT04618744|585038284|FG001|Overall Study|Withdrawal by Subject|1|||
162039585|NCT00423722|585202955|FG000|Overall Study|Withdrawal by Subject|4|||
162039586|NCT00423722|585202956|FG001|Overall Study|Withdrawal by Subject|2|||
162039587|NCT00215683|585202959|FG000|Overall Study|Adverse Event|15|||
162039588|NCT00215683|585202960|FG001|Overall Study|Adverse Event|16|||
162039589|NCT00215683|585202961|FG002|Overall Study|Adverse Event|15|||
162039590|NCT00215683|585202959|FG000|Overall Study|Lack of Efficacy|5|||
162039591|NCT00215683|585202960|FG001|Overall Study|Lack of Efficacy|1|||
162039592|NCT00215683|585202961|FG002|Overall Study|Lack of Efficacy|2|||
162039593|NCT00215683|585202959|FG000|Overall Study|Lost to Follow-up|0|||
162039594|NCT00215683|585202960|FG001|Overall Study|Lost to Follow-up|2|||
162039595|NCT00215683|585202961|FG002|Overall Study|Lost to Follow-up|1|||
162039596|NCT00215683|585202959|FG000|Overall Study|Withdrawal by Subject|9|||
162039597|NCT00215683|585202960|FG001|Overall Study|Withdrawal by Subject|4|||
162039598|NCT00215683|585202961|FG002|Overall Study|Withdrawal by Subject|13|||
162039599|NCT00215683|585202959|FG000|Overall Study|Physician Decision|0|||
162039600|NCT00215683|585202960|FG001|Overall Study|Physician Decision|0|||
162039601|NCT00215683|585202961|FG002|Overall Study|Physician Decision|1|||
162039602|NCT00215683|585202959|FG000|Overall Study|Difficult to attend visits|0|||
162039603|NCT00215683|585202960|FG001|Overall Study|Difficult to attend visits|1|||
162039604|NCT00215683|585202961|FG002|Overall Study|Difficult to attend visits|0|||
161996909|NCT01467505|585040011|FG000|Overall Study|Adverse Event|1|||
161996910|NCT01467505|585040012|FG001|Overall Study|Adverse Event|0|||
161996911|NCT01467505|585040011|FG000|Overall Study|Withdrawal by Subject|4|||
161996912|NCT01467505|585040012|FG001|Overall Study|Withdrawal by Subject|0|||
161996913|NCT01467505|585040011|FG000|Overall Study|Study Terminated by Sponsor|28|||
161996914|NCT01467505|585040012|FG001|Overall Study|Study Terminated by Sponsor|3|||
161996915|NCT00227721|585040013|FG000|Overall Study|On study, but never treated.|1|||
161996916|NCT00383786|585040016|FG000|Overall Study|Protocol Violation|2|||
161996917|NCT00383786|585040017|FG001|Overall Study|Protocol Violation|6|||
161996918|NCT00383786|585040016|FG000|Overall Study|Withdrawal by Subject|2|||
161996919|NCT00383786|585040017|FG001|Overall Study|Withdrawal by Subject|5|||
162039605|NCT00215683|585202959|FG000|Overall Study|No study drug available|0|||
162039606|NCT00215683|585202960|FG001|Overall Study|No study drug available|1|||
162039607|NCT00215683|585202961|FG002|Overall Study|No study drug available|0|||
161996920|NCT00383786|585040016|FG000|Overall Study|Physician Decision|0|||
161996921|NCT00383786|585040017|FG001|Overall Study|Physician Decision|1|||
161996922|NCT02219464|585040021|FG000|Overall Study|Withdrawal by Subject|1|||
161996923|NCT02219464|585040022|FG001|Overall Study|Withdrawal by Subject|0|||
161996924|NCT02219464|585040021|FG000|Overall Study|case cancelled|1|||
161996925|NCT02219464|585040022|FG001|Overall Study|case cancelled|0|||
161996926|NCT02219464|585040021|FG000|Overall Study|catheter malfunction|1|||
162039608|NCT00215683|585202959|FG000|Overall Study|Intermittent therapy required|0|||
162039609|NCT00215683|585202960|FG001|Overall Study|Intermittent therapy required|1|||
162039610|NCT00215683|585202961|FG002|Overall Study|Intermittent therapy required|0|||
161996927|NCT02219464|585040022|FG001|Overall Study|catheter malfunction|0|||
161996928|NCT00984256|585040023|FG000|Overall Study|Withdrawal by Subject|0|||
161996929|NCT00984256|585040024|FG001|Overall Study|Withdrawal by Subject|1|||
161996930|NCT02544321|585040030|FG000|Overall Study|Withdrawal by Subject|1|||
161996931|NCT02544321|585040031|FG001|Overall Study|Withdrawal by Subject|2|||
161996932|NCT02544321|585040030|FG000|Overall Study|Adverse Event|1|||
161996933|NCT02544321|585040031|FG001|Overall Study|Adverse Event|1|||
161996934|NCT02544321|585040030|FG000|Overall Study|Protocol Violation|0|||
161996935|NCT02544321|585040031|FG001|Overall Study|Protocol Violation|1|||
161996936|NCT03529110|585040032|FG000|Overall Study|Progressive Disease|66|||
161996937|NCT03529110|585040033|FG001|Overall Study|Progressive Disease|158|||
161996938|NCT03529110|585040032|FG000|Overall Study|Clinical Progression|4|||
161996939|NCT03529110|585040033|FG001|Overall Study|Clinical Progression|12|||
161996940|NCT03529110|585040032|FG000|Overall Study|Adverse Event|35|||
161996941|NCT03529110|585040033|FG001|Overall Study|Adverse Event|17|||
161996942|NCT03529110|585040032|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
161996943|NCT03529110|585040033|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
161996944|NCT03529110|585040032|FG000|Overall Study|Lack of Efficacy|3|||
161996945|NCT03529110|585040033|FG001|Overall Study|Lack of Efficacy|3|||
161996946|NCT03529110|585040032|FG000|Overall Study|Physician Decision|2|||
161996947|NCT03529110|585040033|FG001|Overall Study|Physician Decision|8|||
161996948|NCT03529110|585040032|FG000|Overall Study|Miscellaneous|2|||
161996949|NCT03529110|585040033|FG001|Overall Study|Miscellaneous|5|||
161996950|NCT03493945|585040034|FG000|Phase I Dose Escalation|Ineligible|0|||
161996951|NCT03493945|585040035|FG001|Phase I Dose Escalation|Ineligible|0|||
161996952|NCT03493945|585040036|FG002|Phase I Dose Escalation|Ineligible|1|||
161996953|NCT03493945|585040037|FG003|Phase I Dose Escalation|Ineligible|0|||
161996954|NCT03493945|585040038|FG004|Phase I Dose Escalation|Ineligible|0|||
161996955|NCT03493945|585040039|FG005|Phase I Dose Escalation|Ineligible|0|||
161996956|NCT03493945|585040040|FG006|Phase I Dose Escalation|Ineligible|0|||
161996957|NCT03493945|585040034|FG000|Phase I Dose Escalation|New therapy|0|||
161996958|NCT03493945|585040035|FG001|Phase I Dose Escalation|New therapy|1|||
161996959|NCT03493945|585040036|FG002|Phase I Dose Escalation|New therapy|0|||
161996960|NCT03493945|585040037|FG003|Phase I Dose Escalation|New therapy|0|||
161996961|NCT03493945|585040038|FG004|Phase I Dose Escalation|New therapy|0|||
161996962|NCT03493945|585040039|FG005|Phase I Dose Escalation|New therapy|0|||
161996963|NCT03493945|585040040|FG006|Phase I Dose Escalation|New therapy|0|||
161996964|NCT03493945|585040034|FG000|Phase II Dose Expansion|Refused further treatment|0|||
161996965|NCT03493945|585040035|FG001|Phase II Dose Expansion|Refused further treatment|0|||
161996966|NCT03493945|585040036|FG002|Phase II Dose Expansion|Refused further treatment|0|||
161996967|NCT03493945|585040037|FG003|Phase II Dose Expansion|Refused further treatment|0|||
161996968|NCT03493945|585040038|FG004|Phase II Dose Expansion|Refused further treatment|1|||
161996969|NCT03493945|585040039|FG005|Phase II Dose Expansion|Refused further treatment|1|||
161996970|NCT03493945|585040040|FG006|Phase II Dose Expansion|Refused further treatment|0|||
161996971|NCT03493945|585040034|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
161996972|NCT03493945|585040035|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
161996973|NCT03493945|585040036|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
161996974|NCT03493945|585040037|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
161996975|NCT03493945|585040038|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
161996976|NCT03493945|585040039|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
161996977|NCT03493945|585040040|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
161996978|NCT05104450|585040041|FG000|Overall Study|Death|1|||
161996979|NCT05104450|585040042|FG001|Overall Study|Death|2|||
161996980|NCT05104450|585040041|FG000|Overall Study|Withdrawal by Subject|3|||
161996981|NCT05104450|585040042|FG001|Overall Study|Withdrawal by Subject|1|||
161996982|NCT01584232|585040043|FG000|Overall Study|Adverse Event|3|||
161996983|NCT01584232|585040044|FG001|Overall Study|Adverse Event|1|||
161996984|NCT01584232|585040043|FG000|Overall Study|Withdrawal by Subject|2|||
161996985|NCT01584232|585040044|FG001|Overall Study|Withdrawal by Subject|1|||
161996986|NCT01584232|585040043|FG000|Overall Study|Physician Decision|2|||
161996987|NCT01584232|585040044|FG001|Overall Study|Physician Decision|1|||
161996988|NCT01584232|585040043|FG000|Overall Study|Lost to Follow-up|1|||
161996989|NCT01584232|585040044|FG001|Overall Study|Lost to Follow-up|0|||
161996990|NCT01307319|585040045|FG000|Overall Study|Adverse Event|2|||
161996991|NCT01307319|585040046|FG001|Overall Study|Adverse Event|2|||
161996992|NCT01307319|585040047|FG002|Overall Study|Adverse Event|1|||
161996993|NCT01307319|585040045|FG000|Overall Study|Lost to Follow-up|1|||
161996994|NCT01307319|585040046|FG001|Overall Study|Lost to Follow-up|0|||
162039611|NCT02171065|585202962|FG000|Overall Study|Withdrawal by Subject|1|||
161996995|NCT01307319|585040047|FG002|Overall Study|Lost to Follow-up|1|||
161996996|NCT01307319|585040045|FG000|Overall Study|Protocol Violation|1|||
161996997|NCT01307319|585040046|FG001|Overall Study|Protocol Violation|1|||
161996998|NCT01307319|585040047|FG002|Overall Study|Protocol Violation|0|||
161996999|NCT01307319|585040045|FG000|Overall Study|Withdrawal by Subject|0|||
161997000|NCT01307319|585040046|FG001|Overall Study|Withdrawal by Subject|1|||
161997001|NCT01307319|585040047|FG002|Overall Study|Withdrawal by Subject|2|||
161997002|NCT01307319|585040045|FG000|Overall Study|Other|0|||
161997003|NCT01307319|585040046|FG001|Overall Study|Other|4|||
161997004|NCT01307319|585040047|FG002|Overall Study|Other|3|||
161997005|NCT02735239|585040049|FG000|Overall Study|Adverse Event|0|||
161997006|NCT02735239|585040050|FG001|Overall Study|Adverse Event|0|||
161997007|NCT02735239|585040051|FG002|Overall Study|Adverse Event|4|||
161997008|NCT02735239|585040052|FG003|Overall Study|Adverse Event|0|||
161997009|NCT02735239|585040053|FG004|Overall Study|Adverse Event|0|||
161997010|NCT02735239|585040054|FG005|Overall Study|Adverse Event|0|||
161997011|NCT02735239|585040049|FG000|Overall Study|Death|1|||
161997012|NCT02735239|585040050|FG001|Overall Study|Death|1|||
161997013|NCT02735239|585040051|FG002|Overall Study|Death|0|||
161997014|NCT02735239|585040052|FG003|Overall Study|Death|0|||
161997015|NCT02735239|585040053|FG004|Overall Study|Death|0|||
161997016|NCT02735239|585040054|FG005|Overall Study|Death|0|||
161997017|NCT02735239|585040049|FG000|Overall Study|Physician Decision|0|||
161997018|NCT02735239|585040050|FG001|Overall Study|Physician Decision|0|||
161997019|NCT02735239|585040051|FG002|Overall Study|Physician Decision|1|||
161997020|NCT02735239|585040052|FG003|Overall Study|Physician Decision|0|||
161997021|NCT02735239|585040053|FG004|Overall Study|Physician Decision|0|||
161997022|NCT02735239|585040054|FG005|Overall Study|Physician Decision|0|||
161997023|NCT02735239|585040049|FG000|Overall Study|Progressive disease|3|||
161997024|NCT02735239|585040050|FG001|Overall Study|Progressive disease|1|||
161997025|NCT02735239|585040051|FG002|Overall Study|Progressive disease|3|||
161997026|NCT02735239|585040052|FG003|Overall Study|Progressive disease|0|||
162039612|NCT02171065|585202963|FG001|Overall Study|Withdrawal by Subject|0|||
162039613|NCT02171065|585202964|FG002|Overall Study|Withdrawal by Subject|0|||
162039614|NCT02171065|585202962|FG000|Overall Study|Lost to Follow-up|0|||
162039615|NCT02171065|585202963|FG001|Overall Study|Lost to Follow-up|0|||
162039616|NCT02171065|585202964|FG002|Overall Study|Lost to Follow-up|1|||
162039617|NCT00851630|585202967|FG000|Overall Study|Death|2|||
162039618|NCT00851630|585202968|FG001|Overall Study|Death|1|||
162039619|NCT00851630|585202967|FG000|Overall Study|Clinical failure|0|||
162039620|NCT00851630|585202968|FG001|Overall Study|Clinical failure|1|||
162039621|NCT03061097|585202969|FG000|Overall Study|Withdrawal by Subject|0|||
162039622|NCT03061097|585202970|FG001|Overall Study|Withdrawal by Subject|3|||
162039623|NCT02437513|585202971|FG000|Overall Study|Withdrawal by Subject|2|||
162039624|NCT03956056|585202972|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
162039625|NCT03956056|585202972|FG000|Overall Study|Lack of Efficacy|1|||
162039626|NCT00595465|585202973|FG000|Overall Study|Adverse Event|4|||
162039627|NCT00595465|585202974|FG001|Overall Study|Adverse Event|3|||
162039628|NCT00595465|585202975|FG002|Overall Study|Adverse Event|3|||
162039629|NCT00595465|585202973|FG000|Overall Study|Pregnancy|0|||
162039630|NCT00595465|585202974|FG001|Overall Study|Pregnancy|0|||
162039631|NCT00595465|585202975|FG002|Overall Study|Pregnancy|1|||
162039632|NCT00595465|585202973|FG000|Overall Study|Protocol Violation|2|||
162039633|NCT00595465|585202974|FG001|Overall Study|Protocol Violation|1|||
162039634|NCT00595465|585202975|FG002|Overall Study|Protocol Violation|0|||
162039635|NCT00595465|585202973|FG000|Overall Study|Lost to Follow-up|0|||
162039636|NCT00595465|585202974|FG001|Overall Study|Lost to Follow-up|0|||
162039637|NCT00595465|585202975|FG002|Overall Study|Lost to Follow-up|2|||
161997027|NCT02735239|585040053|FG004|Overall Study|Progressive disease|0|||
161997028|NCT02735239|585040054|FG005|Overall Study|Progressive disease|2|||
161997029|NCT02735239|585040049|FG000|Overall Study|Withdrawal by Subject|0|||
161997030|NCT02735239|585040050|FG001|Overall Study|Withdrawal by Subject|1|||
161997031|NCT02735239|585040051|FG002|Overall Study|Withdrawal by Subject|0|||
161997032|NCT02735239|585040052|FG003|Overall Study|Withdrawal by Subject|0|||
161997033|NCT02735239|585040053|FG004|Overall Study|Withdrawal by Subject|0|||
161997034|NCT02735239|585040054|FG005|Overall Study|Withdrawal by Subject|0|||
161997035|NCT02152631|585040062|FG000|Overall Study|Adverse Event|32|||
161997036|NCT02152631|585040063|FG001|Overall Study|Adverse Event|4|||
161997037|NCT02152631|585040062|FG000|Overall Study|Withdrawal by Subject|13|||
161997038|NCT02152631|585040063|FG001|Overall Study|Withdrawal by Subject|16|||
161997039|NCT02152631|585040062|FG000|Overall Study|Noncompliance with study drug|1|||
161997040|NCT02152631|585040063|FG001|Overall Study|Noncompliance with study drug|0|||
161997041|NCT02152631|585040062|FG000|Overall Study|Physician Decision|1|||
161997042|NCT02152631|585040063|FG001|Overall Study|Physician Decision|2|||
161997043|NCT02152631|585040062|FG000|Overall Study|Lost to Follow-up|0|||
161997044|NCT02152631|585040063|FG001|Overall Study|Lost to Follow-up|1|||
161997045|NCT02152631|585040062|FG000|Overall Study|On Treatment|19|||
161997046|NCT02152631|585040063|FG001|Overall Study|On Treatment|3|||
161997047|NCT00527735|585040068|FG000|Overall Study|Disease progression|47|||
161997048|NCT00527735|585040069|FG001|Overall Study|Disease progression|61|||
161997049|NCT00527735|585040070|FG002|Overall Study|Disease progression|53|||
161997050|NCT00527735|585040068|FG000|Overall Study|Death|23|||
161997051|NCT00527735|585040069|FG001|Overall Study|Death|13|||
161997052|NCT00527735|585040070|FG002|Overall Study|Death|15|||
161997053|NCT00527735|585040068|FG000|Overall Study|Completed treatment in treatment phase|14|||
161997054|NCT00527735|585040069|FG001|Overall Study|Completed treatment in treatment phase|13|||
162039638|NCT00595465|585202973|FG000|Overall Study|administrative reason|0|||
162039639|NCT00595465|585202974|FG001|Overall Study|administrative reason|0|||
162039640|NCT00595465|585202975|FG002|Overall Study|administrative reason|1|||
161997055|NCT00527735|585040070|FG002|Overall Study|Completed treatment in treatment phase|18|||
161997056|NCT00527735|585040068|FG000|Overall Study|Adverse Event|10|||
161997057|NCT00527735|585040069|FG001|Overall Study|Adverse Event|6|||
161997058|NCT00527735|585040070|FG002|Overall Study|Adverse Event|7|||
161997059|NCT00527735|585040068|FG000|Overall Study|Not identified|5|||
161997060|NCT00527735|585040069|FG001|Overall Study|Not identified|5|||
161997061|NCT00527735|585040070|FG002|Overall Study|Not identified|5|||
161997062|NCT00527735|585040068|FG000|Overall Study|Withdrawal by Subject|5|||
161997063|NCT00527735|585040069|FG001|Overall Study|Withdrawal by Subject|4|||
161997064|NCT00527735|585040070|FG002|Overall Study|Withdrawal by Subject|3|||
162039641|NCT00107783|585202976|FG000|Overall Study|Adverse Event|0|||
162039642|NCT00107783|585202977|FG001|Overall Study|Adverse Event|2|||
162039643|NCT00107783|585202976|FG000|Overall Study|Death|0|||
162039644|NCT00107783|585202977|FG001|Overall Study|Death|1|||
162039645|NCT00107783|585202976|FG000|Overall Study|Withdrawal by Subject|2|||
162039646|NCT00107783|585202977|FG001|Overall Study|Withdrawal by Subject|0|||
162039647|NCT00107783|585202976|FG000|Overall Study|Second hip replacement|1|||
162039648|NCT00107783|585202977|FG001|Overall Study|Second hip replacement|1|||
162039649|NCT01298531|585202978|FG000|Overall Study|Lack of Efficacy|0|||
162039650|NCT01298531|585202979|FG001|Overall Study|Lack of Efficacy|1|||
162039651|NCT01298531|585202978|FG000|Overall Study|Lost to Follow-up|2|||
162039652|NCT01298531|585202979|FG001|Overall Study|Lost to Follow-up|0|||
162039653|NCT01298531|585202978|FG000|Overall Study|Protocol Violation|1|||
162039654|NCT01298531|585202979|FG001|Overall Study|Protocol Violation|1|||
162039655|NCT01298531|585202978|FG000|Overall Study|Adverse Event|4|||
162039656|NCT01298531|585202979|FG001|Overall Study|Adverse Event|3|||
162039657|NCT01298531|585202978|FG000|Overall Study|Does not meet entrance criteria|0|||
162039658|NCT01298531|585202979|FG001|Overall Study|Does not meet entrance criteria|1|||
162039659|NCT01298531|585202978|FG000|Overall Study|Other|2|||
162039660|NCT01298531|585202979|FG001|Overall Study|Other|1|||
162039661|NCT00422097|585202980|FG000|Dose Level 2|Still on treatment|0|||
162039662|NCT00422097|585202981|FG001|Dose Level 2|Still on treatment|1|||
162039663|NCT00422097|585202982|FG002|Dose Level 2|Still on treatment|0|||
162039664|NCT00422097|585202983|FG003|Dose Level 2|Still on treatment|0|||
162039665|NCT00422097|585202984|FG004|Dose Level 2|Still on treatment|0|||
162039666|NCT00422097|585202985|FG005|Dose Level 2|Still on treatment|0|||
162039667|NCT00422097|585202986|FG006|Dose Level 2|Still on treatment|0|||
162039668|NCT00422097|585202987|FG007|Dose Level 2|Still on treatment|0|||
162039669|NCT02360995|585202988|FG000|Overall Study|Lost to Follow-up|2|||
162039670|NCT02360995|585202989|FG001|Overall Study|Lost to Follow-up|0|||
162039671|NCT02360995|585202990|FG002|Overall Study|Lost to Follow-up|2|||
162039672|NCT02360995|585202988|FG000|Overall Study|Withdrawal by Subject|0|||
162039673|NCT02360995|585202989|FG001|Overall Study|Withdrawal by Subject|1|||
162039674|NCT02360995|585202990|FG002|Overall Study|Withdrawal by Subject|0|||
162039675|NCT02231918|585202991|FG000|Overall Study|Withdrawal by Subject|0|||
162039676|NCT02231918|585202992|FG001|Overall Study|Withdrawal by Subject|1|||
162039677|NCT02231918|585202993|FG002|Overall Study|Withdrawal by Subject|0|||
162039678|NCT02231918|585202991|FG000|Overall Study|Adverse Event|0|||
162039679|NCT02231918|585202992|FG001|Overall Study|Adverse Event|0|||
162039680|NCT02231918|585202993|FG002|Overall Study|Adverse Event|1|||
162039681|NCT04622735|585202996|FG000|Overall Study|Lost to Follow-up|1|||
162039682|NCT04622735|585202997|FG001|Overall Study|Lost to Follow-up|2|||
161997065|NCT00527735|585040068|FG000|Overall Study|No longer met study criteria|2|||
161997066|NCT00527735|585040069|FG001|Overall Study|No longer met study criteria|2|||
161997067|NCT00527735|585040070|FG002|Overall Study|No longer met study criteria|1|||
161997068|NCT00527735|585040068|FG000|Overall Study|Lost to Follow-up|0|||
161997069|NCT00527735|585040069|FG001|Overall Study|Lost to Follow-up|0|||
161997070|NCT00527735|585040070|FG002|Overall Study|Lost to Follow-up|3|||
161997071|NCT00527735|585040068|FG000|Overall Study|Poor compliance or noncompliance|0|||
162039683|NCT04622735|585202998|FG002|Overall Study|Lost to Follow-up|1|||
162039684|NCT04622735|585202996|FG000|Overall Study|Adverse Event|0|||
162039685|NCT04622735|585202997|FG001|Overall Study|Adverse Event|0|||
162039686|NCT04622735|585202998|FG002|Overall Study|Adverse Event|1|||
162039687|NCT04622735|585202996|FG000|Overall Study|Protocol Violation|1|||
162039688|NCT04622735|585202997|FG001|Overall Study|Protocol Violation|0|||
162039689|NCT04622735|585202998|FG002|Overall Study|Protocol Violation|0|||
161997072|NCT00527735|585040069|FG001|Overall Study|Poor compliance or noncompliance|1|||
162039690|NCT04629508|585203000|FG000|Overall Study|Adverse Event|1|||
162039691|NCT04629508|585203000|FG000|Overall Study|Death|2|||
162039692|NCT04629508|585203000|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
162039693|NCT04073368|585203005|FG000|Overall Study|Adverse Event|2|||
162039694|NCT04073368|585203006|FG001|Overall Study|Adverse Event|0|||
162039695|NCT04073368|585203007|FG002|Overall Study|Adverse Event|1|||
162039696|NCT04073368|585203008|FG003|Overall Study|Adverse Event|1|||
162039697|NCT04073368|585203005|FG000|Overall Study|Withdrawal by Subject|2|||
162039698|NCT04073368|585203006|FG001|Overall Study|Withdrawal by Subject|2|||
162039699|NCT04073368|585203007|FG002|Overall Study|Withdrawal by Subject|1|||
162039700|NCT04073368|585203008|FG003|Overall Study|Withdrawal by Subject|1|||
162039701|NCT04073368|585203005|FG000|Overall Study|Lost to Follow-up|1|||
161997073|NCT00527735|585040070|FG002|Overall Study|Poor compliance or noncompliance|1|||
161997074|NCT00527735|585040068|FG000|Overall Study|Completed treatment during maintenance|2|||
161997075|NCT00527735|585040069|FG001|Overall Study|Completed treatment during maintenance|2|||
161997076|NCT00527735|585040070|FG002|Overall Study|Completed treatment during maintenance|1|||
161997077|NCT01121146|585040071|FG000|Overall Study|Death|17|||
161997078|NCT01121146|585040072|FG001|Overall Study|Death|15|||
161997079|NCT01121146|585040071|FG000|Overall Study|Adverse Event|2|||
161997080|NCT01121146|585040072|FG001|Overall Study|Adverse Event|11|||
161997081|NCT01121146|585040071|FG000|Overall Study|Lost to Follow-up|7|||
161997082|NCT01121146|585040072|FG001|Overall Study|Lost to Follow-up|16|||
161997083|NCT01080807|585040077|FG000|Overall Study|Adverse Event|9|||
161997084|NCT01080807|585040078|FG001|Overall Study|Adverse Event|1|||
161997085|NCT01080807|585040077|FG000|Overall Study|Lack of Efficacy|0|||
161997086|NCT01080807|585040078|FG001|Overall Study|Lack of Efficacy|1|||
161997087|NCT01080807|585040077|FG000|Overall Study|Withdrawal by Subject|7|||
161997088|NCT01080807|585040078|FG001|Overall Study|Withdrawal by Subject|2|||
161997089|NCT01080807|585040077|FG000|Overall Study|Protocol Violation|7|||
161997090|NCT01080807|585040078|FG001|Overall Study|Protocol Violation|6|||
161997091|NCT01080807|585040077|FG000|Overall Study|Lost to Follow-up|6|||
161997092|NCT01080807|585040078|FG001|Overall Study|Lost to Follow-up|4|||
161997093|NCT01080807|585040077|FG000|Overall Study|Noncompliance with drug administration|1|||
161997094|NCT01080807|585040078|FG001|Overall Study|Noncompliance with drug administration|1|||
161997095|NCT01080807|585040077|FG000|Overall Study|Noncompliance to study procedures|1|||
161997096|NCT01080807|585040078|FG001|Overall Study|Noncompliance to study procedures|1|||
161997097|NCT01080807|585040077|FG000|Overall Study|Began working day shift|0|||
161997098|NCT01080807|585040078|FG001|Overall Study|Began working day shift|2|||
161997099|NCT01080807|585040077|FG000|Overall Study|Laid off or terminated from job|1|||
161997100|NCT01080807|585040078|FG001|Overall Study|Laid off or terminated from job|2|||
161997101|NCT01080807|585040077|FG000|Overall Study|Stopped working consistent night shifts|0|||
161997102|NCT01080807|585040078|FG001|Overall Study|Stopped working consistent night shifts|1|||
161997103|NCT01080807|585040077|FG000|Overall Study|Work schedule changing|1|||
161997104|NCT01080807|585040078|FG001|Overall Study|Work schedule changing|1|||
161997105|NCT01080807|585040077|FG000|Overall Study|Work schedule and travel|0|||
161997106|NCT01080807|585040078|FG001|Overall Study|Work schedule and travel|1|||
161997107|NCT01080807|585040077|FG000|Overall Study|Switched to first shift|1|||
161997108|NCT01080807|585040078|FG001|Overall Study|Switched to first shift|0|||
161997109|NCT01080807|585040077|FG000|Overall Study|Moved away without notifying center|1|||
161997110|NCT01080807|585040078|FG001|Overall Study|Moved away without notifying center|0|||
161997111|NCT01745367|585040085|FG000|Overall Study|Death|1|||
161997112|NCT01745367|585040086|FG001|Overall Study|Death|0|||
161997113|NCT01745367|585040085|FG000|Overall Study|Withdrawal by Subject|1|||
161997114|NCT01745367|585040086|FG001|Overall Study|Withdrawal by Subject|2|||
161997115|NCT01745367|585040085|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
161997116|NCT01745367|585040086|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
161997117|NCT01745367|585040085|FG000|Overall Study|Other Reasons Unspecified|0|||
161997118|NCT01745367|585040086|FG001|Overall Study|Other Reasons Unspecified|2|||
161997119|NCT02107703|585040089|FG000|Overall Study|Withdrawal by Subject|46|||
161997120|NCT02107703|585040090|FG001|Overall Study|Withdrawal by Subject|21|||
161997121|NCT02107703|585040089|FG000|Overall Study|Lost to Follow-up|20|||
161997122|NCT02107703|585040090|FG001|Overall Study|Lost to Follow-up|9|||
161997123|NCT02107703|585040089|FG000|Overall Study|On study treatment/follow up|48|||
161997124|NCT02107703|585040090|FG001|Overall Study|On study treatment/follow up|5|||
161997125|NCT02366312|585040091|FG000|Overall Study|Lost to Follow-up|0|||
161997126|NCT02366312|585040092|FG001|Overall Study|Lost to Follow-up|1|||
161997127|NCT01338818|585040105|FG000|Overall Study|Adverse Event|8|||
161997128|NCT01338818|585040105|FG000|Overall Study|Lack of Efficacy|5|||
161997129|NCT01338818|585040105|FG000|Overall Study|no longer require study drug|1|||
161997130|NCT01338818|585040105|FG000|Overall Study|Withdrawal by Subject|11|||
161997131|NCT01338818|585040105|FG000|Overall Study|Lost to Follow-up|4|||
161997132|NCT01338818|585040105|FG000|Overall Study|Administrative problems|3|||
161997133|NCT01338818|585040105|FG000|Overall Study|Protocol Deviation|4|||
161997134|NCT05202418|585040106|FG000|Overall Study|Withdrawal by Subject|2|||
161997135|NCT05202418|585040107|FG001|Overall Study|Withdrawal by Subject|1|||
161997136|NCT05202418|585040106|FG000|Overall Study|Lost to Follow-up|1|||
161997137|NCT05202418|585040107|FG001|Overall Study|Lost to Follow-up|1|||
161997138|NCT03901144|585040112|FG000|Overall Study|Lost to Follow-up|1|||
161997139|NCT03901144|585040113|FG001|Overall Study|Lost to Follow-up|1|||
161997140|NCT03901144|585040114|FG002|Overall Study|Lost to Follow-up|1|||
161997141|NCT03901144|585040115|FG003|Overall Study|Lost to Follow-up|1|||
161997142|NCT02021565|585040116|FG000|Baseline Through Intervention|Death|0|||
161997143|NCT02021565|585040117|FG001|Baseline Through Intervention|Death|1|||
161997144|NCT02021565|585040116|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
161997145|NCT02021565|585040117|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
161997146|NCT02021565|585040116|FG000|Baseline Through Intervention|Protocol Violation|0|||
161997147|NCT02021565|585040117|FG001|Baseline Through Intervention|Protocol Violation|7|||
162039702|NCT04073368|585203006|FG001|Overall Study|Lost to Follow-up|1|||
162039703|NCT04073368|585203007|FG002|Overall Study|Lost to Follow-up|1|||
162039704|NCT04073368|585203008|FG003|Overall Study|Lost to Follow-up|0|||
162039705|NCT04073368|585203005|FG000|Overall Study|Protocol Violation|0|||
162039706|NCT04073368|585203006|FG001|Overall Study|Protocol Violation|1|||
162039707|NCT04073368|585203007|FG002|Overall Study|Protocol Violation|0|||
162039708|NCT04073368|585203008|FG003|Overall Study|Protocol Violation|0|||
162039709|NCT04073368|585203005|FG000|Overall Study|Subject noncompliance|7|||
162039710|NCT04073368|585203006|FG001|Overall Study|Subject noncompliance|4|||
162039711|NCT04073368|585203007|FG002|Overall Study|Subject noncompliance|0|||
162039712|NCT04073368|585203008|FG003|Overall Study|Subject noncompliance|0|||
162039713|NCT03026088|585203009|FG000|Overall Study|Study termination|20|||
162039714|NCT02476422|585203010|FG000|Overall Study|Subject/guardian decision|0|||
162039715|NCT02476422|585203011|FG001|Overall Study|Subject/guardian decision|1|||
162039716|NCT03960554|585203017|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
162039717|NCT03960554|585203018|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
162039718|NCT02545075|585203019|FG000|Randomization|Lost to Follow-up|0|||
162039719|NCT02545075|585203020|FG001|Randomization|Lost to Follow-up|1|||
162039720|NCT02545075|585203019|FG000|Randomization|Withdrawal by Subject|0|||
162039721|NCT02545075|585203020|FG001|Randomization|Withdrawal by Subject|6|||
162039722|NCT02545075|585203019|FG000|Treatment|Disease progression|71|||
162039723|NCT02545075|585203020|FG001|Treatment|Disease progression|32|||
162039724|NCT02545075|585203019|FG000|Treatment|Participant dicontinued study treatment|7|||
162039725|NCT02545075|585203020|FG001|Treatment|Participant dicontinued study treatment|9|||
162039726|NCT02545075|585203019|FG000|Treatment|Withdrawal by Subject|1|||
162039727|NCT02545075|585203020|FG001|Treatment|Withdrawal by Subject|0|||
162039728|NCT02545075|585203019|FG000|Treatment|Adverse event not related to study drug|1|||
162039729|NCT02545075|585203020|FG001|Treatment|Adverse event not related to study drug|0|||
162039730|NCT02545075|585203019|FG000|Treatment|Death|1|||
162039731|NCT02545075|585203020|FG001|Treatment|Death|0|||
162039732|NCT02545075|585203019|FG000|Treatment|Participant drug toxicity|1|||
162039733|NCT02545075|585203020|FG001|Treatment|Participant drug toxicity|0|||
162039734|NCT02545075|585203019|FG000|Treatment|Completed treatment|40|||
161997148|NCT02021565|585040116|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
161997149|NCT02021565|585040117|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
161997150|NCT02021565|585040116|FG000|3-month Follow-up|Death|3|||
161997151|NCT02021565|585040117|FG001|3-month Follow-up|Death|0|||
161997152|NCT02021565|585040116|FG000|3-month Follow-up|Withdrawal by Subject|4|||
161997153|NCT02021565|585040117|FG001|3-month Follow-up|Withdrawal by Subject|0|||
161997154|NCT02021565|585040116|FG000|3-month Follow-up|Protocol Violation|3|||
161997155|NCT02021565|585040117|FG001|3-month Follow-up|Protocol Violation|2|||
161997156|NCT03575403|585040118|FG000|Overall Study|Adverse Event|1|||
161997157|NCT03575403|585040119|FG001|Overall Study|Adverse Event|0|||
161997158|NCT03575403|585040120|FG002|Overall Study|Adverse Event|0|||
161997159|NCT03575403|585040118|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
161997160|NCT03575403|585040119|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
161997161|NCT03575403|585040120|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
161997162|NCT01332994|585040121|FG000|Overall Study|Adverse Event|34|||
161997163|NCT01332994|585040121|FG000|Overall Study|Death|1|||
161997164|NCT01332994|585040121|FG000|Overall Study|Lack of Efficacy|1|||
161997165|NCT01332994|585040121|FG000|Overall Study|Lost to Follow-up|4|||
161997166|NCT01332994|585040121|FG000|Overall Study|Protocol Violation|6|||
161997167|NCT01332994|585040121|FG000|Overall Study|Withdrawal by Subject|15|||
161997168|NCT01332994|585040121|FG000|Overall Study|Administrative Problem|2|||
161997169|NCT01332994|585040121|FG000|Overall Study|Other|8|||
161997170|NCT00731679|585040123|FG000|Overall Study|Adverse Event|7|||
161997171|NCT00731679|585040124|FG001|Overall Study|Adverse Event|8|||
161997172|NCT00731679|585040123|FG000|Overall Study|Withdrawal by Subject|8|||
161997173|NCT00731679|585040124|FG001|Overall Study|Withdrawal by Subject|8|||
161997174|NCT00731679|585040123|FG000|Overall Study|Lost to Follow-up|7|||
161997175|NCT00731679|585040124|FG001|Overall Study|Lost to Follow-up|8|||
161997176|NCT00731679|585040123|FG000|Overall Study|Noncompliance|0|||
161997177|NCT00731679|585040124|FG001|Overall Study|Noncompliance|1|||
161997178|NCT00731679|585040123|FG000|Overall Study|Pregnancy|0|||
161997179|NCT00731679|585040124|FG001|Overall Study|Pregnancy|1|||
161997180|NCT03089580|585040130|FG000|Overall Study|Lost to Follow-up|2|||
161997181|NCT03087513|585040131|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
161997182|NCT04628780|585040132|FG000|Overall Study|Death|0|||
161997183|NCT04628780|585040133|FG001|Overall Study|Death|1|||
161997184|NCT04628780|585040134|FG002|Overall Study|Death|0|||
161997185|NCT04628780|585040135|FG003|Overall Study|Death|0|||
161997186|NCT04628780|585040136|FG004|Overall Study|Death|1|||
161997187|NCT04628780|585040137|FG005|Overall Study|Death|0|||
161997188|NCT04628780|585040132|FG000|Overall Study|Physician Decision|2|||
161997189|NCT04628780|585040133|FG001|Overall Study|Physician Decision|0|||
161997190|NCT04628780|585040134|FG002|Overall Study|Physician Decision|0|||
161997191|NCT04628780|585040135|FG003|Overall Study|Physician Decision|0|||
161997192|NCT04628780|585040136|FG004|Overall Study|Physician Decision|2|||
161997193|NCT04628780|585040137|FG005|Overall Study|Physician Decision|0|||
161997194|NCT04628780|585040132|FG000|Overall Study|Progressive disease|2|||
161997195|NCT04628780|585040133|FG001|Overall Study|Progressive disease|2|||
161997196|NCT04628780|585040134|FG002|Overall Study|Progressive disease|2|||
161997197|NCT04628780|585040135|FG003|Overall Study|Progressive disease|3|||
161997198|NCT04628780|585040136|FG004|Overall Study|Progressive disease|9|||
161997199|NCT04628780|585040137|FG005|Overall Study|Progressive disease|4|||
161997200|NCT04628780|585040132|FG000|Overall Study|Withdrawal by Subject|0|||
161997201|NCT04628780|585040133|FG001|Overall Study|Withdrawal by Subject|1|||
161997202|NCT04628780|585040134|FG002|Overall Study|Withdrawal by Subject|2|||
161997203|NCT04628780|585040135|FG003|Overall Study|Withdrawal by Subject|0|||
161997204|NCT04628780|585040136|FG004|Overall Study|Withdrawal by Subject|3|||
161997205|NCT04628780|585040137|FG005|Overall Study|Withdrawal by Subject|1|||
161997206|NCT04628780|585040132|FG000|Overall Study|Global deterioration of health status|0|||
161997207|NCT04628780|585040133|FG001|Overall Study|Global deterioration of health status|0|||
161997208|NCT04628780|585040134|FG002|Overall Study|Global deterioration of health status|0|||
161997209|NCT04628780|585040135|FG003|Overall Study|Global deterioration of health status|0|||
161997210|NCT04628780|585040136|FG004|Overall Study|Global deterioration of health status|1|||
161997211|NCT04628780|585040137|FG005|Overall Study|Global deterioration of health status|1|||
161997212|NCT03269994|585040139|FG000|Overall Study|Withdrawal by Subject|4|||
161997213|NCT03269994|585040140|FG001|Overall Study|Withdrawal by Subject|5|||
161997214|NCT03269994|585040139|FG000|Overall Study|Unresectable at surgery|39|||
161997215|NCT03269994|585040140|FG001|Overall Study|Unresectable at surgery|58|||
161997216|NCT03269994|585040139|FG000|Overall Study|Patient canceled surgery|5|||
161997217|NCT03269994|585040140|FG001|Overall Study|Patient canceled surgery|14|||
161997218|NCT03269994|585040139|FG000|Overall Study|Preoperative progression|14|||
161997219|NCT03269994|585040140|FG001|Overall Study|Preoperative progression|9|||
161997220|NCT03269994|585040139|FG000|Overall Study|Preoperative infection|10|||
161997221|NCT03269994|585040140|FG001|Overall Study|Preoperative infection|4|||
161997222|NCT03269994|585040139|FG000|Overall Study|Kidney insufficiency|1|||
161997223|NCT03269994|585040140|FG001|Overall Study|Kidney insufficiency|0|||
161997224|NCT03269994|585040139|FG000|Overall Study|Drug allergy|0|||
161997225|NCT03269994|585040140|FG001|Overall Study|Drug allergy|2|||
161997226|NCT03269994|585040139|FG000|Overall Study|Operation changed to different resection|9|||
161997227|NCT03269994|585040140|FG001|Overall Study|Operation changed to different resection|0|||
161997228|NCT03269994|585040139|FG000|Overall Study|Preoperative steroid|0|||
161997229|NCT03269994|585040140|FG001|Overall Study|Preoperative steroid|3|||
161997230|NCT03269994|585040139|FG000|Overall Study|Accrual Closed|2|||
161997231|NCT03269994|585040140|FG001|Overall Study|Accrual Closed|0|||
161997232|NCT03269994|585040139|FG000|Overall Study|Operation changed to different resection|0|||
161997233|NCT03269994|585040140|FG001|Overall Study|Operation changed to different resection|10|||
161997234|NCT01288989|585040142|FG000|Overall Study|Death|0|||
161997235|NCT01288989|585040143|FG001|Overall Study|Death|0|||
161997236|NCT01288989|585040144|FG002|Overall Study|Death|0|||
161997237|NCT01288989|585040145|FG003|Overall Study|Death|1|||
161997238|NCT01288989|585040146|FG004|Overall Study|Death|0|||
161997239|NCT01288989|585040142|FG000|Overall Study|Dose limiting toxicity|1|||
161997240|NCT01288989|585040143|FG001|Overall Study|Dose limiting toxicity|0|||
161997241|NCT01288989|585040144|FG002|Overall Study|Dose limiting toxicity|0|||
161997242|NCT01288989|585040145|FG003|Overall Study|Dose limiting toxicity|0|||
161997243|NCT01288989|585040146|FG004|Overall Study|Dose limiting toxicity|0|||
161997244|NCT01288989|585040142|FG000|Overall Study|Adverse Event|0|||
161997245|NCT01288989|585040143|FG001|Overall Study|Adverse Event|0|||
161997246|NCT01288989|585040144|FG002|Overall Study|Adverse Event|0|||
161997247|NCT01288989|585040145|FG003|Overall Study|Adverse Event|0|||
161997248|NCT01288989|585040146|FG004|Overall Study|Adverse Event|2|||
161997249|NCT01288989|585040142|FG000|Overall Study|Physician Decision|0|||
161997250|NCT01288989|585040143|FG001|Overall Study|Physician Decision|0|||
161997251|NCT01288989|585040144|FG002|Overall Study|Physician Decision|0|||
161997252|NCT01288989|585040145|FG003|Overall Study|Physician Decision|0|||
161997253|NCT01288989|585040146|FG004|Overall Study|Physician Decision|1|||
161997254|NCT01288989|585040142|FG000|Overall Study|Withdrawal by Subject|0|||
161997255|NCT01288989|585040143|FG001|Overall Study|Withdrawal by Subject|0|||
161997256|NCT01288989|585040144|FG002|Overall Study|Withdrawal by Subject|0|||
161997257|NCT01288989|585040145|FG003|Overall Study|Withdrawal by Subject|0|||
161997258|NCT01288989|585040146|FG004|Overall Study|Withdrawal by Subject|3|||
161997259|NCT02777827|585040151|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
161997260|NCT02777827|585040152|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
161997261|NCT02777827|585040153|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
161997262|NCT02777827|585040154|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
161997263|NCT02777827|585040155|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
161997264|NCT02777827|585040156|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
161997265|NCT04551066|585040157|FG000|Overall Study|Death|5|||
161997266|NCT04551066|585040158|FG001|Overall Study|Death|3|||
162039735|NCT02545075|585203020|FG001|Treatment|Completed treatment|12|||
162039736|NCT00735254|585203025|FG000|Overall Study|Protocol Violation|1|||
162039737|NCT00735254|585203026|FG001|Overall Study|Protocol Violation|1|||
162039738|NCT00735254|585203027|FG002|Overall Study|Protocol Violation|1|||
162039739|NCT00735254|585203028|FG003|Overall Study|Protocol Violation|0|||
162039740|NCT06400979|585203029|FG000|Overall Study|Lost to Follow-up|29|||
162039741|NCT06400979|585203029|FG000|Overall Study|Withdrawal by Subject|1|||
162039742|NCT00750880|585203036|FG000|Overall Study|Adverse Event|76|||
162039743|NCT00750880|585203036|FG000|Overall Study|Death|4|||
162039744|NCT00750880|585203036|FG000|Overall Study|Lack of Efficacy|46|||
162039745|NCT00750880|585203036|FG000|Overall Study|Lost to Follow-up|10|||
162039746|NCT00750880|585203036|FG000|Overall Study|Protocol Violation|15|||
162039747|NCT00750880|585203036|FG000|Overall Study|Withdrawal by Subject|33|||
162039748|NCT00750880|585203036|FG000|Overall Study|Physician Decision|20|||
162039749|NCT00750880|585203036|FG000|Overall Study|Administrative|11|||
162039750|NCT00925990|585203040|FG000|Overall Study|Adverse Event|1|||
162039751|NCT00925990|585203041|FG001|Overall Study|Adverse Event|3|||
162039752|NCT00925990|585203040|FG000|Overall Study|Withdrawal by Subject|2|||
162039753|NCT00925990|585203041|FG001|Overall Study|Withdrawal by Subject|2|||
162039754|NCT00925990|585203040|FG000|Overall Study|Lost to Follow-up|1|||
162039755|NCT00925990|585203041|FG001|Overall Study|Lost to Follow-up|3|||
162039756|NCT00925990|585203040|FG000|Overall Study|Physician Decision|1|||
162039757|NCT00925990|585203041|FG001|Overall Study|Physician Decision|1|||
162039758|NCT00925990|585203040|FG000|Overall Study|moved out of state, missed medication|0|||
162039759|NCT00925990|585203041|FG001|Overall Study|moved out of state, missed medication|2|||
162039760|NCT00573248|585203047|FG000|Overall Study|scheduling conflicts|15|||
162039761|NCT00573248|585203048|FG001|Overall Study|scheduling conflicts|11|||
162039762|NCT02652767|585203049|FG000|Overall Study|Death|2|||
162039763|NCT02652767|585203049|FG000|Overall Study|Lost to Follow-up|1|||
162039764|NCT02652767|585203049|FG000|Overall Study|Withdrawal by Subject|1|||
162039765|NCT01028378|585203050|FG000|Overall Study|Lost to Follow-up|12|||
162039766|NCT01028378|585203050|FG000|Overall Study|Withdrawal by Subject|1|||
162039767|NCT01028378|585203050|FG000|Overall Study|Adminstrative Reasons|4|||
162039768|NCT00450385|585203051|FG000|Overall Study|Death|3|||
162039769|NCT00450385|585203051|FG000|Overall Study|Protocol Violation|1|||
162039770|NCT00450385|585203051|FG000|Overall Study|Withdrawal by Subject|2|||
162039771|NCT00450385|585203051|FG000|Overall Study|Lack of Efficacy|2|||
162039772|NCT00450385|585203051|FG000|Overall Study|Adverse Event|1|||
162039773|NCT00450385|585203051|FG000|Overall Study|Physician Decision|1|||
162039774|NCT00450385|585203051|FG000|Overall Study|Other|3|||
162039775|NCT03091777|585203054|FG000|Overall Study|Pregnancy|2|||
162039776|NCT03091777|585203055|FG001|Overall Study|Pregnancy|1|||
162039777|NCT03091777|585203056|FG002|Overall Study|Pregnancy|0|||
162039778|NCT03091777|585203054|FG000|Overall Study|Adverse Event|2|||
162039779|NCT03091777|585203055|FG001|Overall Study|Adverse Event|1|||
162039780|NCT03091777|585203056|FG002|Overall Study|Adverse Event|4|||
162039781|NCT03091777|585203054|FG000|Overall Study|Withdrawal by Subject|4|||
162039782|NCT03091777|585203055|FG001|Overall Study|Withdrawal by Subject|2|||
162039783|NCT03091777|585203056|FG002|Overall Study|Withdrawal by Subject|6|||
162039784|NCT03091777|585203054|FG000|Overall Study|Protocol Violation|2|||
162039785|NCT03091777|585203055|FG001|Overall Study|Protocol Violation|1|||
162039786|NCT03091777|585203056|FG002|Overall Study|Protocol Violation|1|||
162039787|NCT03091777|585203054|FG000|Overall Study|Lost to Follow-up|12|||
162039788|NCT03091777|585203055|FG001|Overall Study|Lost to Follow-up|14|||
162039789|NCT03091777|585203056|FG002|Overall Study|Lost to Follow-up|7|||
162039790|NCT03091777|585203054|FG000|Overall Study|Lack of Efficacy|0|||
162039791|NCT03091777|585203055|FG001|Overall Study|Lack of Efficacy|0|||
162039792|NCT03091777|585203056|FG002|Overall Study|Lack of Efficacy|5|||
162039793|NCT03091777|585203054|FG000|Overall Study|Noncompliance with study drug|2|||
162039794|NCT03091777|585203055|FG001|Overall Study|Noncompliance with study drug|3|||
162039795|NCT03091777|585203056|FG002|Overall Study|Noncompliance with study drug|1|||
162039796|NCT03091777|585203054|FG000|Overall Study|Physician Decision|1|||
162039797|NCT03091777|585203055|FG001|Overall Study|Physician Decision|0|||
162039798|NCT03091777|585203056|FG002|Overall Study|Physician Decision|1|||
162039799|NCT03091777|585203054|FG000|Overall Study|Abnormal Laboratory Value|7|||
162039800|NCT03091777|585203055|FG001|Overall Study|Abnormal Laboratory Value|11|||
162039801|NCT03091777|585203056|FG002|Overall Study|Abnormal Laboratory Value|12|||
162039802|NCT02536833|585203057|FG000|Overall Study|Discontinued Before Treatment|0|||
162039803|NCT02536833|585203058|FG001|Overall Study|Discontinued Before Treatment|0|||
162039804|NCT02536833|585203059|FG002|Overall Study|Discontinued Before Treatment|1|||
162039805|NCT02536833|585203060|FG003|Overall Study|Discontinued Before Treatment|2|||
162039806|NCT02536833|585203057|FG000|Overall Study|Adverse Event|1|||
162039807|NCT02536833|585203058|FG001|Overall Study|Adverse Event|3|||
162039808|NCT02536833|585203059|FG002|Overall Study|Adverse Event|4|||
162039809|NCT02536833|585203060|FG003|Overall Study|Adverse Event|1|||
162039810|NCT02536833|585203057|FG000|Overall Study|Lost to Follow-up|2|||
162039811|NCT02536833|585203058|FG001|Overall Study|Lost to Follow-up|1|||
162039812|NCT02536833|585203059|FG002|Overall Study|Lost to Follow-up|2|||
162039813|NCT02536833|585203060|FG003|Overall Study|Lost to Follow-up|2|||
162039814|NCT02536833|585203057|FG000|Overall Study|Physician Decision|0|||
162039815|NCT02536833|585203058|FG001|Overall Study|Physician Decision|0|||
162039816|NCT02536833|585203059|FG002|Overall Study|Physician Decision|0|||
162039817|NCT02536833|585203060|FG003|Overall Study|Physician Decision|1|||
162039818|NCT02536833|585203057|FG000|Overall Study|Site Terminated by Sponsor|2|||
162039819|NCT02536833|585203058|FG001|Overall Study|Site Terminated by Sponsor|2|||
162039820|NCT02536833|585203059|FG002|Overall Study|Site Terminated by Sponsor|2|||
162039821|NCT02536833|585203060|FG003|Overall Study|Site Terminated by Sponsor|2|||
162039822|NCT02536833|585203057|FG000|Overall Study|Subject Non-Compliance|0|||
162039823|NCT02536833|585203058|FG001|Overall Study|Subject Non-Compliance|1|||
162039824|NCT02536833|585203059|FG002|Overall Study|Subject Non-Compliance|1|||
162039825|NCT02536833|585203060|FG003|Overall Study|Subject Non-Compliance|0|||
162039826|NCT02536833|585203057|FG000|Overall Study|Withdrawal by Subject|4|||
162039827|NCT02536833|585203058|FG001|Overall Study|Withdrawal by Subject|3|||
162039828|NCT02536833|585203059|FG002|Overall Study|Withdrawal by Subject|5|||
162039829|NCT02536833|585203060|FG003|Overall Study|Withdrawal by Subject|11|||
162039830|NCT00089674|585203061|FG000|Overall Study|Physician Decision|4|||
162039831|NCT00089674|585203062|FG001|Overall Study|Physician Decision|2|||
162039832|NCT00089674|585203061|FG000|Overall Study|Adverse Event|23|||
162039833|NCT00089674|585203062|FG001|Overall Study|Adverse Event|29|||
162039834|NCT00089674|585203061|FG000|Overall Study|Withdrawal by Subject|143|||
162039835|NCT00089674|585203062|FG001|Overall Study|Withdrawal by Subject|127|||
162039836|NCT00089674|585203061|FG000|Overall Study|Death|43|||
162039837|NCT00089674|585203062|FG001|Overall Study|Death|43|||
162039838|NCT00089674|585203061|FG000|Overall Study|Disease progression|21|||
162039839|NCT00089674|585203062|FG001|Overall Study|Disease progression|23|||
162039840|NCT00089674|585203061|FG000|Overall Study|Ineligibility determined|8|||
162039841|NCT00089674|585203062|FG001|Overall Study|Ineligibility determined|10|||
162039842|NCT00089674|585203061|FG000|Overall Study|Lost to Follow-up|21|||
162039843|NCT00089674|585203062|FG001|Overall Study|Lost to Follow-up|17|||
162039844|NCT00089674|585203061|FG000|Overall Study|Noncompliance|7|||
162039845|NCT00089674|585203062|FG001|Overall Study|Noncompliance|3|||
162039846|NCT00089674|585203061|FG000|Overall Study|Other|5|||
162039847|NCT00089674|585203062|FG001|Overall Study|Other|9|||
162039848|NCT00089674|585203061|FG000|Overall Study|Requirement for alternative therapy|14|||
162039849|NCT00089674|585203062|FG001|Overall Study|Requirement for alternative therapy|4|||
162039850|NCT01462227|585203063|FG000|Second Assignment|Lost to Follow-up|1|||
162039851|NCT01462227|585203064|FG001|Second Assignment|Lost to Follow-up|0|||
162039852|NCT01462227|585203065|FG002|Second Assignment|Lost to Follow-up|0|||
162039853|NCT01462227|585203066|FG003|Second Assignment|Lost to Follow-up|0|||
162039854|NCT01462227|585203063|FG000|Second Assignment|Protocol Violation|0|||
162039855|NCT01462227|585203064|FG001|Second Assignment|Protocol Violation|1|||
162039856|NCT01462227|585203065|FG002|Second Assignment|Protocol Violation|1|||
162039857|NCT01462227|585203066|FG003|Second Assignment|Protocol Violation|0|||
162039858|NCT00586066|585203069|FG000|Overall Study|Lost to Follow-up|6|||
162039859|NCT00586066|585203070|FG001|Overall Study|Lost to Follow-up|3|||
162039860|NCT00586066|585203069|FG000|Overall Study|Lack of Efficacy|5|||
162039861|NCT00586066|585203070|FG001|Overall Study|Lack of Efficacy|3|||
162039862|NCT00586066|585203069|FG000|Overall Study|Adverse Event|2|||
161997267|NCT04551066|585040157|FG000|Overall Study|Lost to Follow-up|1|||
161997268|NCT04551066|585040158|FG001|Overall Study|Lost to Follow-up|0|||
161997269|NCT04551066|585040157|FG000|Overall Study|Sponsor Decision|104|||
161997270|NCT04551066|585040158|FG001|Overall Study|Sponsor Decision|117|||
161997271|NCT04551066|585040157|FG000|Overall Study|Withdrawal by Subject|8|||
161997272|NCT04551066|585040158|FG001|Overall Study|Withdrawal by Subject|2|||
161997273|NCT04551066|585040157|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
162039863|NCT00586066|585203070|FG001|Overall Study|Adverse Event|2|||
162039864|NCT00586066|585203069|FG000|Overall Study|Physician Decision|1|||
162039865|NCT00586066|585203070|FG001|Overall Study|Physician Decision|0|||
162039866|NCT00586066|585203069|FG000|Overall Study|Withdrawal of consent|4|||
162039867|NCT00586066|585203070|FG001|Overall Study|Withdrawal of consent|2|||
162039868|NCT03640559|585203071|FG000|Overall Study|Physician Decision|1|||
161997274|NCT04551066|585040158|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
162039869|NCT03640559|585203072|FG001|Overall Study|Physician Decision|1|||
162039870|NCT03640559|585203071|FG000|Overall Study|Withdrawal by Subject|1|||
162039871|NCT03640559|585203072|FG001|Overall Study|Withdrawal by Subject|0|||
162039872|NCT02567552|585203073|FG000|Overall Study|Adverse Event|0|||
162039873|NCT02567552|585203074|FG001|Overall Study|Adverse Event|1|||
162039874|NCT00171054|585203079|FG000|Overall Study|Protocol Violation|1|||
162039875|NCT00171054|585203080|FG001|Overall Study|Protocol Violation|2|||
162039876|NCT00171054|585203079|FG000|Overall Study|Patient withdrew consent|1|||
162039877|NCT00171054|585203080|FG001|Overall Study|Patient withdrew consent|0|||
162039878|NCT00171054|585203079|FG000|Overall Study|Lost to Follow-up|0|||
162039879|NCT00171054|585203080|FG001|Overall Study|Lost to Follow-up|1|||
162039880|NCT00171054|585203079|FG000|Overall Study|Adverse Event|8|||
162039881|NCT00171054|585203080|FG001|Overall Study|Adverse Event|8|||
162039882|NCT00171054|585203079|FG000|Overall Study|Condition no longer required study drug|0|||
161997275|NCT04551066|585040157|FG000|Overall Study|Adverse Event|2|||
161997276|NCT04551066|585040158|FG001|Overall Study|Adverse Event|0|||
161997277|NCT04551066|585040157|FG000|Overall Study|Physician Decision|2|||
161997278|NCT04551066|585040158|FG001|Overall Study|Physician Decision|0|||
161997279|NCT04551066|585040157|FG000|Overall Study|Protocol Violation|1|||
161997280|NCT04551066|585040158|FG001|Overall Study|Protocol Violation|0|||
161997281|NCT04551066|585040157|FG000|Overall Study|Lack of Efficacy|0|||
161997282|NCT04551066|585040158|FG001|Overall Study|Lack of Efficacy|1|||
161997283|NCT04551066|585040157|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
161997284|NCT04551066|585040158|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
161997285|NCT04491136|585040159|FG000|Overall Study|Patient withdraw informed consent|9|||
161997286|NCT04491136|585040159|FG000|Overall Study|Adverse Event|2|||
161997287|NCT04491136|585040159|FG000|Overall Study|Death|3|||
161997288|NCT04491136|585040159|FG000|Overall Study|Lost to Follow-up|3|||
161997289|NCT04491136|585040159|FG000|Overall Study|Physician Decision|45|||
161997290|NCT04491136|585040159|FG000|Overall Study|sponsor terminated the study early|16|||
161997291|NCT04491136|585040159|FG000|Overall Study|Patient/guardian's decision|1|||
161997292|NCT00319254|585040162|FG000|Overall Study|Withdrawal by Subject|4|||
161997293|NCT00319254|585040162|FG000|Overall Study|Death|46|||
161997294|NCT00319254|585040162|FG000|Overall Study|Lost to Follow-up|2|||
161997295|NCT00319254|585040162|FG000|Overall Study|Enrolled, Not Treated|2|||
161997296|NCT01712204|585040166|FG000|Overall Study|Adverse Event|3|||
161997297|NCT01712204|585040167|FG001|Overall Study|Adverse Event|1|||
161997298|NCT01712204|585040166|FG000|Overall Study|Withdrawal by Subject|3|||
161997299|NCT01712204|585040167|FG001|Overall Study|Withdrawal by Subject|3|||
161997300|NCT01712204|585040166|FG000|Overall Study|Lost to Follow-up|1|||
161997301|NCT01712204|585040167|FG001|Overall Study|Lost to Follow-up|0|||
161997302|NCT01712204|585040166|FG000|Overall Study|Protocol Violation|1|||
161997303|NCT01712204|585040167|FG001|Overall Study|Protocol Violation|1|||
161997304|NCT02452424|585040168|FG000|Overall Study|Death|2|||
161997305|NCT02452424|585040169|FG001|Overall Study|Death|2|||
161997306|NCT02452424|585040170|FG002|Overall Study|Death|2|||
161997307|NCT02452424|585040171|FG003|Overall Study|Death|6|||
161997308|NCT02452424|585040172|FG004|Overall Study|Death|2|||
161997309|NCT02452424|585040173|FG005|Overall Study|Death|0|||
161997310|NCT02452424|585040174|FG006|Overall Study|Death|5|||
161997311|NCT02452424|585040175|FG007|Overall Study|Death|1|||
161997312|NCT02452424|585040176|FG008|Overall Study|Death|3|||
161997313|NCT02452424|585040177|FG009|Overall Study|Death|1|||
161997314|NCT02452424|585040178|FG010|Overall Study|Death|0|||
161997315|NCT02452424|585040168|FG000|Overall Study|Lost to Follow-up|0|||
161997316|NCT02452424|585040169|FG001|Overall Study|Lost to Follow-up|1|||
161997317|NCT02452424|585040170|FG002|Overall Study|Lost to Follow-up|1|||
161997318|NCT02452424|585040171|FG003|Overall Study|Lost to Follow-up|0|||
161997319|NCT02452424|585040172|FG004|Overall Study|Lost to Follow-up|0|||
161997320|NCT02452424|585040173|FG005|Overall Study|Lost to Follow-up|0|||
161997321|NCT02452424|585040174|FG006|Overall Study|Lost to Follow-up|0|||
161997322|NCT02452424|585040175|FG007|Overall Study|Lost to Follow-up|0|||
161997323|NCT02452424|585040176|FG008|Overall Study|Lost to Follow-up|0|||
161997324|NCT02452424|585040177|FG009|Overall Study|Lost to Follow-up|0|||
161997325|NCT02452424|585040178|FG010|Overall Study|Lost to Follow-up|0|||
161997326|NCT02452424|585040168|FG000|Overall Study|Withdrawal by Subject|0|||
161997327|NCT02452424|585040169|FG001|Overall Study|Withdrawal by Subject|0|||
161997328|NCT02452424|585040170|FG002|Overall Study|Withdrawal by Subject|3|||
161997329|NCT02452424|585040171|FG003|Overall Study|Withdrawal by Subject|2|||
161997330|NCT02452424|585040172|FG004|Overall Study|Withdrawal by Subject|0|||
161997331|NCT02452424|585040173|FG005|Overall Study|Withdrawal by Subject|0|||
161997332|NCT02452424|585040174|FG006|Overall Study|Withdrawal by Subject|1|||
161997333|NCT02452424|585040175|FG007|Overall Study|Withdrawal by Subject|0|||
161997334|NCT02452424|585040176|FG008|Overall Study|Withdrawal by Subject|1|||
161997335|NCT02452424|585040177|FG009|Overall Study|Withdrawal by Subject|1|||
161997336|NCT02452424|585040178|FG010|Overall Study|Withdrawal by Subject|0|||
161997337|NCT02452424|585040168|FG000|Overall Study|Other|0|||
161997338|NCT02452424|585040169|FG001|Overall Study|Other|0|||
161997339|NCT02452424|585040170|FG002|Overall Study|Other|1|||
161997340|NCT02452424|585040171|FG003|Overall Study|Other|0|||
161997341|NCT02452424|585040172|FG004|Overall Study|Other|0|||
161997342|NCT02452424|585040173|FG005|Overall Study|Other|1|||
161997343|NCT02452424|585040174|FG006|Overall Study|Other|4|||
161997344|NCT02452424|585040175|FG007|Overall Study|Other|3|||
161997345|NCT02452424|585040176|FG008|Overall Study|Other|0|||
161997346|NCT02452424|585040177|FG009|Overall Study|Other|0|||
161997347|NCT02452424|585040178|FG010|Overall Study|Other|1|||
161997348|NCT02452424|585040168|FG000|Overall Study|Progressive disease (per RECIST)|0|||
161997349|NCT02452424|585040169|FG001|Overall Study|Progressive disease (per RECIST)|0|||
161997350|NCT02452424|585040170|FG002|Overall Study|Progressive disease (per RECIST)|0|||
161997351|NCT02452424|585040171|FG003|Overall Study|Progressive disease (per RECIST)|0|||
161997352|NCT02452424|585040172|FG004|Overall Study|Progressive disease (per RECIST)|0|||
161997353|NCT02452424|585040173|FG005|Overall Study|Progressive disease (per RECIST)|0|||
161997354|NCT02452424|585040174|FG006|Overall Study|Progressive disease (per RECIST)|0|||
161997355|NCT02452424|585040175|FG007|Overall Study|Progressive disease (per RECIST)|0|||
161997356|NCT02452424|585040176|FG008|Overall Study|Progressive disease (per RECIST)|2|||
161997357|NCT02452424|585040177|FG009|Overall Study|Progressive disease (per RECIST)|0|||
161997358|NCT02452424|585040178|FG010|Overall Study|Progressive disease (per RECIST)|0|||
161997359|NCT02452424|585040168|FG000|Overall Study|Adverse Event|0|||
161997360|NCT02452424|585040169|FG001|Overall Study|Adverse Event|0|||
161997361|NCT02452424|585040170|FG002|Overall Study|Adverse Event|0|||
161997362|NCT02452424|585040171|FG003|Overall Study|Adverse Event|0|||
161997363|NCT02452424|585040172|FG004|Overall Study|Adverse Event|0|||
161997364|NCT02452424|585040173|FG005|Overall Study|Adverse Event|0|||
161997365|NCT02452424|585040174|FG006|Overall Study|Adverse Event|0|||
161997366|NCT02452424|585040175|FG007|Overall Study|Adverse Event|0|||
161997367|NCT02452424|585040176|FG008|Overall Study|Adverse Event|0|||
161997368|NCT02452424|585040177|FG009|Overall Study|Adverse Event|0|||
161997369|NCT02452424|585040178|FG010|Overall Study|Adverse Event|1|||
161997370|NCT01059318|585040179|FG000|Core Study (26 Week)|Adverse Event|3|||
161997371|NCT01059318|585040179|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
161997372|NCT01059318|585040179|FG000|Extension (36 Week)|Adverse Event|3|||
161997373|NCT03790917|585040180|FG000|Overall Study|Death|1|||
161997374|NCT01223183|585040186|FG000|Imaging Day 1|Physician Decision|0|||
161997375|NCT01223183|585040187|FG001|Imaging Day 1|Physician Decision|1|||
161997376|NCT01223183|585040186|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
161997377|NCT01223183|585040187|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
161997378|NCT01223183|585040186|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
161997379|NCT01223183|585040187|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
161997380|NCT03772665|585040188|FG000|Overall Study|Protocol Violation|1|||
161997381|NCT03772665|585040189|FG001|Overall Study|Protocol Violation|0|||
161997382|NCT03553758|585042303|FG000|Overall Study|Lost to Follow-up|1|||
161997383|NCT02807623|585042304|FG000|Overall Study|Lost to Follow-up|23|||
161997384|NCT02807623|585042305|FG001|Overall Study|Lost to Follow-up|18|||
161997385|NCT02807623|585042306|FG002|Overall Study|Lost to Follow-up|22|||
161997386|NCT02807623|585042304|FG000|Overall Study|Drug intolerance|0|||
161997387|NCT02807623|585042305|FG001|Overall Study|Drug intolerance|1|||
161997388|NCT02807623|585042306|FG002|Overall Study|Drug intolerance|0|||
161997389|NCT02807623|585042304|FG000|Overall Study|incomplete blood draw|0|||
161997390|NCT02807623|585042305|FG001|Overall Study|incomplete blood draw|2|||
161997391|NCT02807623|585042306|FG002|Overall Study|incomplete blood draw|1|||
161997392|NCT02614729|585042307|FG000|Overall Study|Withdrawal by Subject|1|||
161997393|NCT02614729|585042308|FG001|Overall Study|Withdrawal by Subject|0|||
161997394|NCT04002960|585042313|FG000|Overall Study|Withdrawn prior to Completion|2|||
161997395|NCT01276639|585042319|FG000|Week 0 to 16|Death|1|||
161997396|NCT01276639|585042320|FG001|Week 0 to 16|Death|0|||
161997397|NCT01276639|585042321|FG002|Week 0 to 16|Death|0|||
161997398|NCT01276639|585042322|FG003|Week 0 to 16|Death|0|||
161997399|NCT01276639|585042323|FG004|Week 0 to 16|Death|0|||
161997400|NCT01276639|585042319|FG000|Week 0 to 16|Adverse Event|11|||
161997401|NCT01276639|585042320|FG001|Week 0 to 16|Adverse Event|8|||
161997402|NCT01276639|585042321|FG002|Week 0 to 16|Adverse Event|11|||
161997403|NCT01276639|585042322|FG003|Week 0 to 16|Adverse Event|0|||
161997404|NCT01276639|585042323|FG004|Week 0 to 16|Adverse Event|0|||
161997405|NCT01276639|585042319|FG000|Week 0 to 16|Lack of Efficacy|20|||
161997406|NCT01276639|585042320|FG001|Week 0 to 16|Lack of Efficacy|15|||
161997407|NCT01276639|585042321|FG002|Week 0 to 16|Lack of Efficacy|25|||
161997408|NCT01276639|585042322|FG003|Week 0 to 16|Lack of Efficacy|0|||
161997409|NCT01276639|585042323|FG004|Week 0 to 16|Lack of Efficacy|0|||
161997410|NCT01276639|585042319|FG000|Week 0 to 16|Lost to Follow-up|3|||
161997411|NCT01276639|585042320|FG001|Week 0 to 16|Lost to Follow-up|5|||
161997412|NCT01276639|585042321|FG002|Week 0 to 16|Lost to Follow-up|3|||
161997413|NCT01276639|585042322|FG003|Week 0 to 16|Lost to Follow-up|0|||
161997414|NCT01276639|585042323|FG004|Week 0 to 16|Lost to Follow-up|0|||
161997415|NCT01276639|585042319|FG000|Week 0 to 16|Withdrawal by Subject|8|||
161997416|NCT01276639|585042320|FG001|Week 0 to 16|Withdrawal by Subject|5|||
161997417|NCT01276639|585042321|FG002|Week 0 to 16|Withdrawal by Subject|4|||
161997418|NCT01276639|585042322|FG003|Week 0 to 16|Withdrawal by Subject|0|||
161997419|NCT01276639|585042323|FG004|Week 0 to 16|Withdrawal by Subject|0|||
161997420|NCT01276639|585042319|FG000|Week 0 to 16|Other|7|||
161997421|NCT01276639|585042320|FG001|Week 0 to 16|Other|7|||
161997422|NCT01276639|585042321|FG002|Week 0 to 16|Other|2|||
161997423|NCT01276639|585042322|FG003|Week 0 to 16|Other|0|||
161997424|NCT01276639|585042323|FG004|Week 0 to 16|Other|0|||
161997425|NCT01276639|585042319|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
161997426|NCT01276639|585042320|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
161997427|NCT01276639|585042321|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
161997428|NCT01276639|585042322|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
161997429|NCT01276639|585042323|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
161997430|NCT01276639|585042319|FG000|Week 16 to 52|Death|1|||
161997431|NCT01276639|585042320|FG001|Week 16 to 52|Death|0|||
161997432|NCT01276639|585042321|FG002|Week 16 to 52|Death|0|||
162039883|NCT00171054|585203080|FG001|Overall Study|Condition no longer required study drug|1|||
162039884|NCT04669535|585203081|FG000|Overall Study|Death|1|||
162039885|NCT04669535|585203082|FG001|Overall Study|Death|1|||
162039886|NCT04669535|585203083|FG002|Overall Study|Death|0|||
162039887|NCT04669535|585203084|FG003|Overall Study|Death|0|||
162039888|NCT01876810|585203085|FG000|Overall Study|Physician Decision|0|||
162039889|NCT01876810|585203086|FG001|Overall Study|Physician Decision|1|||
162039890|NCT01857583|585203090|FG000|Overall Study|Adverse Event|0|||
162039891|NCT01857583|585203091|FG001|Overall Study|Adverse Event|0|||
162039892|NCT01857583|585203092|FG002|Overall Study|Adverse Event|1|||
162039893|NCT01857583|585203093|FG003|Overall Study|Adverse Event|1|||
162039894|NCT01857583|585203090|FG000|Overall Study|Death|0|||
162039895|NCT01857583|585203091|FG001|Overall Study|Death|1|||
162039896|NCT01857583|585203092|FG002|Overall Study|Death|1|||
162039897|NCT01857583|585203093|FG003|Overall Study|Death|0|||
162039898|NCT01857583|585203090|FG000|Overall Study|Physician Decision|0|||
162039899|NCT01857583|585203091|FG001|Overall Study|Physician Decision|0|||
162039900|NCT01857583|585203092|FG002|Overall Study|Physician Decision|0|||
162039901|NCT01857583|585203093|FG003|Overall Study|Physician Decision|1|||
162039902|NCT01857583|585203090|FG000|Overall Study|Withdrawal by Subject|1|||
162039903|NCT01857583|585203091|FG001|Overall Study|Withdrawal by Subject|0|||
162039904|NCT01857583|585203092|FG002|Overall Study|Withdrawal by Subject|1|||
162039905|NCT01857583|585203093|FG003|Overall Study|Withdrawal by Subject|2|||
162039906|NCT00891462|585204219|FG000|Overall Study|Withdrawal by Subject|9|||
162039907|NCT00891462|585204220|FG001|Overall Study|Withdrawal by Subject|6|||
162039908|NCT00891462|585204221|FG002|Overall Study|Withdrawal by Subject|7|||
162039909|NCT00891462|585204219|FG000|Overall Study|Adverse Event|7|||
162039910|NCT00891462|585204220|FG001|Overall Study|Adverse Event|8|||
162039911|NCT00891462|585204221|FG002|Overall Study|Adverse Event|7|||
162039912|NCT00891462|585204219|FG000|Overall Study|Lack of Efficacy|10|||
162039913|NCT00891462|585204220|FG001|Overall Study|Lack of Efficacy|5|||
162039914|NCT00891462|585204221|FG002|Overall Study|Lack of Efficacy|1|||
162039915|NCT00891462|585204219|FG000|Overall Study|COPD exacerbation|7|||
162039916|NCT00891462|585204220|FG001|Overall Study|COPD exacerbation|4|||
161997433|NCT01276639|585042322|FG003|Week 16 to 52|Death|0|||
161997434|NCT01276639|585042323|FG004|Week 16 to 52|Death|0|||
161997435|NCT01276639|585042319|FG000|Week 16 to 52|Adverse Event|10|||
161997436|NCT01276639|585042320|FG001|Week 16 to 52|Adverse Event|13|||
161997437|NCT01276639|585042321|FG002|Week 16 to 52|Adverse Event|0|||
161997438|NCT01276639|585042322|FG003|Week 16 to 52|Adverse Event|1|||
161997439|NCT01276639|585042323|FG004|Week 16 to 52|Adverse Event|3|||
161997440|NCT01276639|585042319|FG000|Week 16 to 52|Lack of Efficacy|99|||
161997441|NCT01276639|585042320|FG001|Week 16 to 52|Lack of Efficacy|71|||
162039917|NCT00891462|585204221|FG002|Overall Study|COPD exacerbation|1|||
162039918|NCT00891462|585204219|FG000|Overall Study|Other Reason|2|||
162039919|NCT00891462|585204220|FG001|Overall Study|Other Reason|5|||
162039920|NCT00891462|585204221|FG002|Overall Study|Other Reason|3|||
162039921|NCT00891462|585204219|FG000|Overall Study|Protocol Violation|2|||
162039922|NCT00891462|585204220|FG001|Overall Study|Protocol Violation|1|||
162039923|NCT00891462|585204221|FG002|Overall Study|Protocol Violation|3|||
162039924|NCT00891462|585204219|FG000|Overall Study|Inclusion/exclusion criteria|0|||
162039925|NCT00891462|585204220|FG001|Overall Study|Inclusion/exclusion criteria|2|||
162039926|NCT00891462|585204221|FG002|Overall Study|Inclusion/exclusion criteria|2|||
162039927|NCT00891462|585204219|FG000|Overall Study|Lost to Follow-up|0|||
162039928|NCT00891462|585204220|FG001|Overall Study|Lost to Follow-up|2|||
161997442|NCT01276639|585042321|FG002|Week 16 to 52|Lack of Efficacy|0|||
161997443|NCT01276639|585042322|FG003|Week 16 to 52|Lack of Efficacy|14|||
161997444|NCT01276639|585042323|FG004|Week 16 to 52|Lack of Efficacy|13|||
161997445|NCT01276639|585042319|FG000|Week 16 to 52|Lost to Follow-up|3|||
161997446|NCT01276639|585042320|FG001|Week 16 to 52|Lost to Follow-up|1|||
161997447|NCT01276639|585042321|FG002|Week 16 to 52|Lost to Follow-up|0|||
161997448|NCT01276639|585042322|FG003|Week 16 to 52|Lost to Follow-up|0|||
161997449|NCT01276639|585042323|FG004|Week 16 to 52|Lost to Follow-up|1|||
161997450|NCT01276639|585042319|FG000|Week 16 to 52|Withdrawal by Subject|4|||
162039929|NCT00891462|585204221|FG002|Overall Study|Lost to Follow-up|0|||
162039930|NCT01083485|585204222|FG000|Overall Study|Adverse Event|0|||
162039931|NCT01083485|585204223|FG001|Overall Study|Adverse Event|1|||
162039932|NCT01083485|585204222|FG000|Overall Study|Protocol Violation|1|||
162039933|NCT01083485|585204223|FG001|Overall Study|Protocol Violation|0|||
161997451|NCT01276639|585042320|FG001|Week 16 to 52|Withdrawal by Subject|4|||
161997452|NCT01276639|585042321|FG002|Week 16 to 52|Withdrawal by Subject|0|||
161997453|NCT01276639|585042322|FG003|Week 16 to 52|Withdrawal by Subject|0|||
161997454|NCT01276639|585042323|FG004|Week 16 to 52|Withdrawal by Subject|1|||
161997455|NCT01276639|585042319|FG000|Week 16 to 52|Other|10|||
161997456|NCT01276639|585042320|FG001|Week 16 to 52|Other|12|||
161997457|NCT01276639|585042321|FG002|Week 16 to 52|Other|0|||
162039934|NCT01083485|585204222|FG000|Overall Study|Withdrawal by Subject|5|||
162039935|NCT01083485|585204223|FG001|Overall Study|Withdrawal by Subject|2|||
162039936|NCT01083485|585204222|FG000|Overall Study|Other|1|||
162039937|NCT01083485|585204223|FG001|Overall Study|Other|0|||
162039938|NCT00761579|585204235|FG000|Overall Study|Adverse Event|10|||
161997458|NCT01276639|585042322|FG003|Week 16 to 52|Other|1|||
161997459|NCT01276639|585042323|FG004|Week 16 to 52|Other|3|||
161997460|NCT01132807|585042328|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
161997461|NCT01132807|585042329|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
161997462|NCT01132807|585042330|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
161997463|NCT01132807|585042328|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
161997464|NCT01132807|585042329|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
162039939|NCT00761579|585204235|FG000|Overall Study|Death|2|||
162039940|NCT00761579|585204235|FG000|Overall Study|Lack of Efficacy|21|||
162039941|NCT00761579|585204235|FG000|Overall Study|Lost to Follow-up|16|||
162039942|NCT00761579|585204235|FG000|Overall Study|Pregnancy|1|||
162039943|NCT00761579|585204235|FG000|Overall Study|Withdrawal by Subject|34|||
162039944|NCT00761579|585204235|FG000|Overall Study|Lack of compliance|2|||
162039945|NCT00761579|585204235|FG000|Overall Study|Protocol deviation|1|||
162039946|NCT00761579|585204235|FG000|Overall Study|Drug overdose|1|||
162039947|NCT00761579|585204235|FG000|Overall Study|Aggravation of depression|1|||
162039948|NCT00761579|585204235|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
162039949|NCT00761579|585204235|FG000|Overall Study|Lost survey form|1|||
162039950|NCT00761579|585204235|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
162039951|NCT00950911|585204236|FG000|Overall Study|Adverse Event|0|||
162039952|NCT00950911|585204237|FG001|Overall Study|Adverse Event|2|||
162039953|NCT00950911|585204236|FG000|Overall Study|Death|4|||
162039954|NCT00950911|585204237|FG001|Overall Study|Death|6|||
162039955|NCT00950911|585204236|FG000|Overall Study|Disease progression|2|||
162039956|NCT00950911|585204237|FG001|Overall Study|Disease progression|2|||
162039957|NCT00950911|585204236|FG000|Overall Study|Consent withdrawn|1|||
162039958|NCT00950911|585204237|FG001|Overall Study|Consent withdrawn|3|||
162039959|NCT00950911|585204236|FG000|Overall Study|Administrative decision|3|||
162039960|NCT00950911|585204237|FG001|Overall Study|Administrative decision|1|||
162039961|NCT00950911|585204236|FG000|Overall Study|Ineligibility determined|1|||
162039962|NCT00950911|585204237|FG001|Overall Study|Ineligibility determined|0|||
162039963|NCT00950911|585204236|FG000|Overall Study|Noncompliance|1|||
162039964|NCT00950911|585204237|FG001|Overall Study|Noncompliance|0|||
162039965|NCT00950911|585204236|FG000|Overall Study|Poor performance status|0|||
162039966|NCT00950911|585204237|FG001|Overall Study|Poor performance status|1|||
162039967|NCT02600351|585204238|FG000|Overall Study|Lack of Efficacy|3|||
162039968|NCT02600351|585204239|FG001|Overall Study|Lack of Efficacy|0|||
162039969|NCT02600351|585204240|FG002|Overall Study|Lack of Efficacy|5|||
162039970|NCT02600351|585204241|FG003|Overall Study|Lack of Efficacy|2|||
162039971|NCT02600351|585204238|FG000|Overall Study|Lost to Follow-up|1|||
162039972|NCT02600351|585204239|FG001|Overall Study|Lost to Follow-up|0|||
162039973|NCT02600351|585204240|FG002|Overall Study|Lost to Follow-up|0|||
162039974|NCT02600351|585204241|FG003|Overall Study|Lost to Follow-up|0|||
162039975|NCT02600351|585204238|FG000|Overall Study|Randomized but Not Treated|1|||
162039976|NCT02600351|585204239|FG001|Overall Study|Randomized but Not Treated|0|||
162039977|NCT02600351|585204240|FG002|Overall Study|Randomized but Not Treated|1|||
162039978|NCT02600351|585204241|FG003|Overall Study|Randomized but Not Treated|3|||
162039979|NCT02063880|585204242|FG000|Overall Study|Death|21|||
162039980|NCT02063880|585204243|FG001|Overall Study|Death|18|||
162039981|NCT02063880|585204242|FG000|Overall Study|Lost to Follow-up|7|||
162039982|NCT02063880|585204243|FG001|Overall Study|Lost to Follow-up|7|||
162039983|NCT02063880|585204242|FG000|Overall Study|Ineligible|0|||
162039984|NCT02063880|585204243|FG001|Overall Study|Ineligible|2|||
161997465|NCT01132807|585042330|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
161997466|NCT01380769|585042331|FG000|Overall Study|Withdrawal by Subject|7|||
161997467|NCT01380769|585042332|FG001|Overall Study|Withdrawal by Subject|11|||
161997468|NCT01380769|585042331|FG000|Overall Study|Physician Decision|1|||
162039985|NCT00567593|585204244|FG000|Overall Study|Adverse Event|1|||
162039986|NCT00567593|585204244|FG000|Overall Study|Physician Decision|1|||
162039987|NCT02106910|585204245|FG000|Overall Study|Lost to Follow-up|1|||
162039988|NCT02106910|585204246|FG001|Overall Study|Lost to Follow-up|1|||
162039989|NCT04087213|585204249|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
162039990|NCT04087213|585204249|FG000|In-Facility Introduction|Adverse Event|1|||
162039991|NCT04087213|585204249|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
162039992|NCT04087213|585204249|FG000|Assisted Evaluable Period|Personal reasons|3|||
162039993|NCT04087213|585204249|FG000|Transition Period B|Renal Transplantation|1|||
161997469|NCT01380769|585042332|FG001|Overall Study|Physician Decision|1|||
161997470|NCT01380769|585042331|FG000|Overall Study|Adverse Event|1|||
162039994|NCT01272661|585204252|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
162039995|NCT01272661|585204253|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
162039996|NCT01272661|585204254|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
162039997|NCT01086423|585204255|FG000|Overall Study|Protocol Violation|0|||
162039998|NCT01086423|585204256|FG001|Overall Study|Protocol Violation|0|||
162039999|NCT01086423|585204257|FG002|Overall Study|Protocol Violation|1|||
162040000|NCT01086423|585204255|FG000|Overall Study|Migrated/moved from study area|2|||
162040001|NCT01086423|585204256|FG001|Overall Study|Migrated/moved from study area|0|||
162040002|NCT01086423|585204257|FG002|Overall Study|Migrated/moved from study area|4|||
161997471|NCT01380769|585042332|FG001|Overall Study|Adverse Event|1|||
162040003|NCT01086423|585204255|FG000|Overall Study|Adverse event, fatal|1|||
162040004|NCT01086423|585204256|FG001|Overall Study|Adverse event, fatal|1|||
162040005|NCT01086423|585204257|FG002|Overall Study|Adverse event, fatal|0|||
162040006|NCT01086423|585204255|FG000|Overall Study|Adverse event, non-fatal|2|||
162040007|NCT01086423|585204256|FG001|Overall Study|Adverse event, non-fatal|1|||
162040008|NCT01086423|585204257|FG002|Overall Study|Adverse event, non-fatal|0|||
162040009|NCT01086423|585204255|FG000|Overall Study|Withdrawal by Subject|5|||
162040010|NCT01086423|585204256|FG001|Overall Study|Withdrawal by Subject|1|||
162040011|NCT01086423|585204257|FG002|Overall Study|Withdrawal by Subject|3|||
162040012|NCT01086423|585204255|FG000|Overall Study|Lost to Follow-up|0|||
162040013|NCT01086423|585204256|FG001|Overall Study|Lost to Follow-up|0|||
162040014|NCT01086423|585204257|FG002|Overall Study|Lost to Follow-up|1|||
162040015|NCT02057393|585204258|FG000|Overall Study|Withdrawal by Subject|1|||
162040016|NCT02057393|585204258|FG000|Overall Study|Patient did not meet criteria|1|||
162040017|NCT01130103|585204261|FG000|Randomized Treatment|Adverse Event|1|||
161997472|NCT01380769|585042331|FG000|Overall Study|Protocol Violation|0|||
161997473|NCT01380769|585042332|FG001|Overall Study|Protocol Violation|1|||
161997474|NCT03654690|585042334|FG000|Overall Study|Withdrawal by Subject|1|||
161997475|NCT03654690|585042335|FG001|Overall Study|Withdrawal by Subject|0|||
161997476|NCT03654690|585042336|FG002|Overall Study|Withdrawal by Subject|0|||
161997477|NCT00742183|585042339|FG000|Overall Study|Adverse Event|2|||
161997478|NCT00742183|585042340|FG001|Overall Study|Adverse Event|2|||
161997479|NCT00742183|585042339|FG000|Overall Study|Death|1|||
161997480|NCT00742183|585042340|FG001|Overall Study|Death|0|||
161997481|NCT00742183|585042339|FG000|Overall Study|Physician Decision|0|||
161997482|NCT00742183|585042340|FG001|Overall Study|Physician Decision|2|||
161997483|NCT00742183|585042339|FG000|Overall Study|Lost to Follow-up|4|||
161997484|NCT00742183|585042340|FG001|Overall Study|Lost to Follow-up|4|||
161997485|NCT00742183|585042339|FG000|Overall Study|Required skin-graft|1|||
161997486|NCT00742183|585042340|FG001|Overall Study|Required skin-graft|1|||
161997487|NCT00742183|585042339|FG000|Overall Study|Withdrawal by Subject|1|||
161997488|NCT00742183|585042340|FG001|Overall Study|Withdrawal by Subject|0|||
161997489|NCT00742183|585042339|FG000|Overall Study|Lack of Efficacy|0|||
161997490|NCT00742183|585042340|FG001|Overall Study|Lack of Efficacy|3|||
161997491|NCT01176058|585042352|FG000|Overall Study|Adverse Event|1|||
161997492|NCT01176058|585042353|FG001|Overall Study|Adverse Event|0|||
161997493|NCT01176058|585042352|FG000|Overall Study|Insufficient clinical response|2|||
161997494|NCT01176058|585042353|FG001|Overall Study|Insufficient clinical response|2|||
161997495|NCT01176058|585042352|FG000|Overall Study|Insufficient mycological response|0|||
161997496|NCT01176058|585042353|FG001|Overall Study|Insufficient mycological response|1|||
161997497|NCT01176058|585042352|FG000|Overall Study|Withdrawal by Subject|1|||
161997498|NCT01176058|585042353|FG001|Overall Study|Withdrawal by Subject|0|||
161997499|NCT00256724|585042356|FG000|Overall Study|Physician Decision|2|||
161997500|NCT00256724|585042357|FG001|Overall Study|Physician Decision|5|||
161997501|NCT00256724|585042356|FG000|Overall Study|Protocol Violation|3|||
161997502|NCT00256724|585042357|FG001|Overall Study|Protocol Violation|3|||
161997503|NCT01217463|585042358|FG000|Overall Study|Adverse Event|8|||
161997504|NCT01217463|585042359|FG001|Overall Study|Adverse Event|5|||
161997505|NCT01217463|585042358|FG000|Overall Study|Physician Decision|0|||
161997506|NCT01217463|585042359|FG001|Overall Study|Physician Decision|1|||
161997507|NCT01217463|585042358|FG000|Overall Study|Withdrawal by Subject|3|||
161997508|NCT01217463|585042359|FG001|Overall Study|Withdrawal by Subject|0|||
161997509|NCT01217463|585042358|FG000|Overall Study|Surgery on the Target Limb|0|||
161997510|NCT01217463|585042359|FG001|Overall Study|Surgery on the Target Limb|1|||
161997511|NCT01217463|585042358|FG000|Overall Study|Patient Non-compliant|1|||
161997512|NCT01217463|585042359|FG001|Overall Study|Patient Non-compliant|0|||
161997513|NCT01217463|585042358|FG000|Overall Study|Other|1|||
161997514|NCT01217463|585042359|FG001|Overall Study|Other|1|||
161997515|NCT01569841|585042360|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
161997516|NCT01569841|585042361|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
161997517|NCT01879683|585042366|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
161997518|NCT00782717|585042367|FG000|Overall Study|Adverse Event|2|||
161997519|NCT00782717|585042368|FG001|Overall Study|Adverse Event|5|||
162040018|NCT01130103|585204262|FG001|Randomized Treatment|Adverse Event|1|||
162040019|NCT01130103|585204261|FG000|Randomized Treatment|Lost to Follow-up|1|||
162040020|NCT01130103|585204262|FG001|Randomized Treatment|Lost to Follow-up|0|||
162040021|NCT01130103|585204261|FG000|Randomized Treatment|Protocol Violation|3|||
161997520|NCT00782717|585042367|FG000|Overall Study|Patient decision unrelated to AE|6|||
161997521|NCT00782717|585042368|FG001|Overall Study|Patient decision unrelated to AE|3|||
161997522|NCT00782717|585042367|FG000|Overall Study|Noncompliance|2|||
161997523|NCT00782717|585042368|FG001|Overall Study|Noncompliance|1|||
161997524|NCT00782717|585042367|FG000|Overall Study|Treatment failure|3|||
161997525|NCT00782717|585042368|FG001|Overall Study|Treatment failure|14|||
161997526|NCT00782717|585042367|FG000|Overall Study|Enrollment close prior to surgery|1|||
161997527|NCT00782717|585042368|FG001|Overall Study|Enrollment close prior to surgery|0|||
161997528|NCT00782717|585042367|FG000|Overall Study|Did not meet entrance criteria|1|||
162040022|NCT01130103|585204262|FG001|Randomized Treatment|Protocol Violation|2|||
162040023|NCT01130103|585204261|FG000|Randomized Treatment|Withdrawal by Subject|1|||
162040024|NCT01130103|585204262|FG001|Randomized Treatment|Withdrawal by Subject|2|||
162040025|NCT01130103|585204261|FG000|Maintenance Treatment|Lack of Efficacy|0|||
162040026|NCT01130103|585204262|FG001|Maintenance Treatment|Lack of Efficacy|1|||
162040027|NCT01130103|585204261|FG000|Maintenance Treatment|Lost to Follow-up|1|||
162040028|NCT01130103|585204262|FG001|Maintenance Treatment|Lost to Follow-up|1|||
162040029|NCT01130103|585204261|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
162040030|NCT01130103|585204262|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
162040031|NCT00249288|585204263|FG000|Overall Study|Lost to Follow-up|3|||
162040032|NCT00249288|585204264|FG001|Overall Study|Lost to Follow-up|3|||
162040033|NCT00249288|585204263|FG000|Overall Study|Withdrawal by Subject|2|||
162040034|NCT00249288|585204264|FG001|Overall Study|Withdrawal by Subject|2|||
162040035|NCT01437878|585204265|FG000|Overall Study|Withdrawal by Subject|1|||
162040036|NCT01437878|585204266|FG001|Overall Study|Withdrawal by Subject|0|||
162040037|NCT01476644|585204273|FG000|Overall Study|Death|5|||
162040038|NCT01476644|585204273|FG000|Overall Study|moved to another state|2|||
162040039|NCT01476644|585204273|FG000|Overall Study|Lost to Follow-up|19|||
162040040|NCT01476644|585204273|FG000|Overall Study|Withdrawal by Subject|13|||
162040041|NCT00471146|585204275|FG000|Overall Study|Adverse Event|32|||
162040042|NCT00471146|585204276|FG001|Overall Study|Adverse Event|33|||
162040043|NCT00471146|585204275|FG000|Overall Study|Withdrawal by Subject|14|||
162040044|NCT00471146|585204276|FG001|Overall Study|Withdrawal by Subject|11|||
162040045|NCT00471146|585204275|FG000|Overall Study|Death|11|||
162040046|NCT00471146|585204276|FG001|Overall Study|Death|12|||
162040047|NCT00471146|585204275|FG000|Overall Study|Lost to Follow-up|4|||
162040048|NCT00471146|585204276|FG001|Overall Study|Lost to Follow-up|2|||
162040049|NCT00471146|585204275|FG000|Overall Study|Protocol Violation|2|||
162040050|NCT00471146|585204276|FG001|Overall Study|Protocol Violation|2|||
162040051|NCT00471146|585204275|FG000|Overall Study|Objective progression or relapse|84|||
162040052|NCT00471146|585204276|FG001|Overall Study|Objective progression or relapse|87|||
162040053|NCT00471146|585204275|FG000|Overall Study|Global deterioration of health status|12|||
162040054|NCT00471146|585204276|FG001|Overall Study|Global deterioration of health status|14|||
162040055|NCT00471146|585204275|FG000|Overall Study|Randomized but not treated|9|||
162040056|NCT00471146|585204276|FG001|Overall Study|Randomized but not treated|8|||
162040057|NCT00471146|585204275|FG000|Overall Study|Other|4|||
162040058|NCT00471146|585204276|FG001|Overall Study|Other|5|||
162040059|NCT00467610|585204279|FG000|Overall Study|Withdrawal by Subject|1|||
162040060|NCT02676466|585204280|FG000|Overall Study|Death|0|||
162040061|NCT02676466|585204281|FG001|Overall Study|Death|2|||
162040062|NCT02676466|585204282|FG002|Overall Study|Death|1|||
162040063|NCT02676466|585204283|FG003|Overall Study|Death|0|||
162040064|NCT02676466|585204284|FG004|Overall Study|Death|0|||
162040065|NCT02676466|585204285|FG005|Overall Study|Death|0|||
162040066|NCT02676466|585204286|FG006|Overall Study|Death|0|||
162040067|NCT02676466|585204287|FG007|Overall Study|Death|0|||
162040068|NCT02676466|585204280|FG000|Overall Study|Withdrawal by Subject|4|||
162040069|NCT02676466|585204281|FG001|Overall Study|Withdrawal by Subject|3|||
162040070|NCT02676466|585204282|FG002|Overall Study|Withdrawal by Subject|1|||
162040071|NCT02676466|585204283|FG003|Overall Study|Withdrawal by Subject|0|||
162040072|NCT02676466|585204284|FG004|Overall Study|Withdrawal by Subject|3|||
162040073|NCT02676466|585204285|FG005|Overall Study|Withdrawal by Subject|1|||
162040074|NCT02676466|585204286|FG006|Overall Study|Withdrawal by Subject|1|||
162040075|NCT02676466|585204287|FG007|Overall Study|Withdrawal by Subject|1|||
162040076|NCT02001181|585204291|FG000|Overall Study|Adverse Event|0|||
162040077|NCT02001181|585204292|FG001|Overall Study|Adverse Event|2|||
162040078|NCT02001181|585204291|FG000|Overall Study|Lost to Follow-up|1|||
162040079|NCT02001181|585204292|FG001|Overall Study|Lost to Follow-up|0|||
162040080|NCT02001181|585204291|FG000|Overall Study|Withdrawal by Subject|0|||
162040081|NCT02001181|585204292|FG001|Overall Study|Withdrawal by Subject|1|||
162040082|NCT01090973|585204293|FG000|Overall Study|Disease progression|1|||
162040083|NCT00445978|585204295|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
162040084|NCT00445978|585204295|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
162040085|NCT00445978|585204295|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
162040086|NCT00445978|585204295|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
162040087|NCT00445978|585204295|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
162040088|NCT00445978|585204295|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
162040089|NCT00445978|585204295|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
162040090|NCT00445978|585204295|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
162040091|NCT00445978|585204295|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
162040092|NCT00739596|585204296|FG000|Overall Study|Adverse Event|12|||
162040093|NCT00739596|585204297|FG001|Overall Study|Adverse Event|6|||
162040094|NCT00739596|585204296|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
162040095|NCT00739596|585204297|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
162040096|NCT00739596|585204296|FG000|Overall Study|Patient Withdrew Consent|8|||
162040097|NCT00739596|585204297|FG001|Overall Study|Patient Withdrew Consent|8|||
162040098|NCT00739596|585204296|FG000|Overall Study|Lost to Follow-up|0|||
162040099|NCT00739596|585204297|FG001|Overall Study|Lost to Follow-up|2|||
162040100|NCT00739596|585204296|FG000|Overall Study|Protocol Deviation|1|||
162040101|NCT00739596|585204297|FG001|Overall Study|Protocol Deviation|1|||
162040102|NCT02520661|585204298|FG000|Overall Study|Lost to Follow-up|7|||
162040103|NCT02520661|585204299|FG001|Overall Study|Lost to Follow-up|3|||
162040104|NCT02520661|585204298|FG000|Overall Study|Admitted from ED|49|||
162040105|NCT02520661|585204299|FG001|Overall Study|Admitted from ED|48|||
162040106|NCT02520661|585204298|FG000|Overall Study|ED greater than 24 hours|29|||
162040107|NCT02520661|585204299|FG001|Overall Study|ED greater than 24 hours|38|||
162040108|NCT02520661|585204298|FG000|Overall Study|other ineligibility|14|||
162040109|NCT02520661|585204299|FG001|Overall Study|other ineligibility|22|||
162040110|NCT02520661|585204298|FG000|Overall Study|Withdrawal by Subject|7|||
162040111|NCT02520661|585204299|FG001|Overall Study|Withdrawal by Subject|16|||
162040112|NCT01414608|585204305|FG000|Overall Study|Ineligible|5|||
162040113|NCT01414608|585204306|FG001|Overall Study|Ineligible|2|||
162040114|NCT00760084|585204308|FG000|Overall Study|Physician Decision|5|||
162040115|NCT00760084|585204308|FG000|Overall Study|Withdrawal by Subject|2|||
162040116|NCT00760084|585204308|FG000|Overall Study|Progressive Disease|3|||
162040117|NCT02301988|585204309|FG000|Overall Study|Withdrawal by Subject|2|||
162040118|NCT02301988|585204310|FG001|Overall Study|Withdrawal by Subject|1|||
162040119|NCT02301988|585204309|FG000|Overall Study|Physician Decision|2|||
162040120|NCT02301988|585204310|FG001|Overall Study|Physician Decision|2|||
161997529|NCT00782717|585042368|FG001|Overall Study|Did not meet entrance criteria|3|||
161997530|NCT00782717|585042367|FG000|Overall Study|Exited in error|0|||
161997531|NCT00782717|585042368|FG001|Overall Study|Exited in error|2|||
161997532|NCT02446717|585042369|FG000|Overall Study|Adverse Event|0|||
161997533|NCT02446717|585042370|FG001|Overall Study|Adverse Event|0|||
161997534|NCT02446717|585042371|FG002|Overall Study|Adverse Event|1|||
161997535|NCT02446717|585042372|FG003|Overall Study|Adverse Event|0|||
161997536|NCT02446717|585042373|FG004|Overall Study|Adverse Event|0|||
161997537|NCT02446717|585042369|FG000|Overall Study|Lost to Follow-up|0|||
161997538|NCT02446717|585042370|FG001|Overall Study|Lost to Follow-up|1|||
161997539|NCT02446717|585042371|FG002|Overall Study|Lost to Follow-up|1|||
161997540|NCT02446717|585042372|FG003|Overall Study|Lost to Follow-up|0|||
161997541|NCT02446717|585042373|FG004|Overall Study|Lost to Follow-up|1|||
161997542|NCT02446717|585042369|FG000|Overall Study|Withdrew consent|0|||
161997543|NCT02446717|585042370|FG001|Overall Study|Withdrew consent|0|||
161997544|NCT02446717|585042371|FG002|Overall Study|Withdrew consent|0|||
161997545|NCT02446717|585042372|FG003|Overall Study|Withdrew consent|1|||
162040121|NCT02301988|585204309|FG000|Overall Study|Unknown Reason|1|||
162040122|NCT02301988|585204310|FG001|Overall Study|Unknown Reason|3|||
162040123|NCT02301988|585204309|FG000|Overall Study|Lack of Efficacy|3|||
162040124|NCT02301988|585204310|FG001|Overall Study|Lack of Efficacy|2|||
162040125|NCT02301988|585204309|FG000|Overall Study|Death|1|||
162040126|NCT02301988|585204310|FG001|Overall Study|Death|0|||
162040127|NCT02301988|585204309|FG000|Overall Study|Adverse Event|1|||
162040128|NCT02301988|585204310|FG001|Overall Study|Adverse Event|1|||
162040129|NCT02891161|585204311|FG000|Study Treatment|Disease Progression|2|||
162040130|NCT02891161|585204312|FG001|Study Treatment|Disease Progression|4|||
162040131|NCT02891161|585204311|FG000|Study Treatment|AE/Side Effects/Complications|1|||
162040132|NCT02891161|585204312|FG001|Study Treatment|AE/Side Effects/Complications|5|||
162040133|NCT02891161|585204311|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
162040134|NCT02891161|585204312|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
162040135|NCT02891161|585204311|FG000|Follow up|Death|4|||
162040136|NCT02891161|585204312|FG001|Follow up|Death|8|||
162040137|NCT02891161|585204311|FG000|Follow up|Refused to Follow up|0|||
162040138|NCT02891161|585204312|FG001|Follow up|Refused to Follow up|2|||
162040139|NCT02891161|585204311|FG000|Follow up|Symptomatic deterioration|0|||
162040140|NCT02891161|585204312|FG001|Follow up|Symptomatic deterioration|1|||
162040141|NCT02891161|585204311|FG000|Follow up|Study terminated|0|||
162040142|NCT02891161|585204312|FG001|Follow up|Study terminated|6|||
162040143|NCT01931202|585204315|FG000|Overall Study|Withdrawal by Subject|0|||
162040144|NCT01931202|585204316|FG001|Overall Study|Withdrawal by Subject|0|||
161997546|NCT02446717|585042373|FG004|Overall Study|Withdrew consent|0|||
162040145|NCT01931202|585204317|FG002|Overall Study|Withdrawal by Subject|2|||
162040146|NCT01931202|585204315|FG000|Overall Study|Lost to Follow-up|0|||
162040147|NCT01931202|585204316|FG001|Overall Study|Lost to Follow-up|5|||
161997547|NCT00279916|585042381|FG000|Overall Study|Withdrawal by Subject|4|||
161997548|NCT00279916|585042382|FG001|Overall Study|Withdrawal by Subject|3|||
161997549|NCT00279916|585042381|FG000|Overall Study|Lost to Follow-up|3|||
162040148|NCT01931202|585204317|FG002|Overall Study|Lost to Follow-up|2|||
162040149|NCT02775903|585204320|FG000|Overall Study|Death|7|||
162040150|NCT02775903|585204321|FG001|Overall Study|Death|11|||
162040151|NCT02775903|585204322|FG002|Overall Study|Death|12|||
162040152|NCT02775903|585204323|FG003|Overall Study|Death|11|||
162040153|NCT02775903|585204320|FG000|Overall Study|Adverse Event|0|||
161997550|NCT00279916|585042382|FG001|Overall Study|Lost to Follow-up|2|||
161997551|NCT02488005|585042387|FG000|Overall Study|Lost to Follow-up|2|||
161997552|NCT00650767|585042392|FG000|Overall Study|Adverse Event|0|||
162040154|NCT02775903|585204321|FG001|Overall Study|Adverse Event|1|||
162040155|NCT02775903|585204322|FG002|Overall Study|Adverse Event|12|||
161997553|NCT00650767|585042393|FG001|Overall Study|Adverse Event|3|||
161997554|NCT00650767|585042394|FG002|Overall Study|Adverse Event|10|||
161997555|NCT00650767|585042395|FG003|Overall Study|Adverse Event|8|||
161997556|NCT00650767|585042392|FG000|Overall Study|Death|1|||
161997557|NCT00650767|585042393|FG001|Overall Study|Death|0|||
161997558|NCT00650767|585042394|FG002|Overall Study|Death|0|||
161997559|NCT00650767|585042395|FG003|Overall Study|Death|0|||
161997560|NCT00650767|585042392|FG000|Overall Study|Withdrawal by Subject|2|||
161997561|NCT00650767|585042393|FG001|Overall Study|Withdrawal by Subject|4|||
161997562|NCT00650767|585042394|FG002|Overall Study|Withdrawal by Subject|3|||
161997563|NCT00650767|585042395|FG003|Overall Study|Withdrawal by Subject|3|||
161997564|NCT00650767|585042392|FG000|Overall Study|Lost to Follow-up|1|||
161997565|NCT00650767|585042393|FG001|Overall Study|Lost to Follow-up|1|||
161997566|NCT00650767|585042394|FG002|Overall Study|Lost to Follow-up|1|||
161997567|NCT00650767|585042395|FG003|Overall Study|Lost to Follow-up|0|||
161997568|NCT00650767|585042392|FG000|Overall Study|Other|1|||
161997569|NCT00650767|585042393|FG001|Overall Study|Other|1|||
161997570|NCT00650767|585042394|FG002|Overall Study|Other|0|||
161997571|NCT00650767|585042395|FG003|Overall Study|Other|0|||
161997572|NCT03384940|585042396|FG000|Overall Study|Progressive disease|36|||
161997573|NCT03384940|585042397|FG001|Overall Study|Progressive disease|11|||
161997574|NCT03384940|585042398|FG002|Overall Study|Progressive disease|13|||
161997575|NCT03384940|585042396|FG000|Overall Study|Clinical progression|4|||
161997576|NCT03384940|585042397|FG001|Overall Study|Clinical progression|0|||
161997577|NCT03384940|585042398|FG002|Overall Study|Clinical progression|3|||
161997578|NCT03384940|585042396|FG000|Overall Study|Adverse Event|7|||
161997579|NCT03384940|585042397|FG001|Overall Study|Adverse Event|1|||
161997580|NCT03384940|585042398|FG002|Overall Study|Adverse Event|1|||
161997581|NCT03384940|585042396|FG000|Overall Study|Withdrawal by Subject|3|||
161997582|NCT03384940|585042397|FG001|Overall Study|Withdrawal by Subject|1|||
161997583|NCT03384940|585042398|FG002|Overall Study|Withdrawal by Subject|0|||
161997584|NCT03384940|585042396|FG000|Overall Study|Physician Decision|1|||
161997585|NCT03384940|585042397|FG001|Overall Study|Physician Decision|1|||
161997586|NCT03384940|585042398|FG002|Overall Study|Physician Decision|0|||
161997587|NCT03384940|585042396|FG000|Overall Study|Death|2|||
161997588|NCT03384940|585042397|FG001|Overall Study|Death|1|||
161997589|NCT03384940|585042398|FG002|Overall Study|Death|0|||
161997590|NCT03384940|585042396|FG000|Overall Study|Other|0|||
161997591|NCT03384940|585042397|FG001|Overall Study|Other|0|||
161997592|NCT03384940|585042398|FG002|Overall Study|Other|1|||
161997593|NCT03649074|585042401|FG000|Overall Study|Lost to Follow-up|2|||
161997594|NCT03649074|585042402|FG001|Overall Study|Lost to Follow-up|1|||
161997595|NCT03649074|585042401|FG000|Overall Study|Adverse Event|1|||
161997596|NCT03649074|585042402|FG001|Overall Study|Adverse Event|0|||
161997597|NCT03649074|585042401|FG000|Overall Study|Physician Decision|1|||
161997598|NCT03649074|585042402|FG001|Overall Study|Physician Decision|0|||
161997599|NCT03649074|585042401|FG000|Overall Study|Withdrawal by Subject|0|||
161997600|NCT03649074|585042402|FG001|Overall Study|Withdrawal by Subject|2|||
161997601|NCT03649074|585042401|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
161997602|NCT03649074|585042402|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
161997603|NCT03649074|585042401|FG000|Overall Study|Other|1|||
161997604|NCT03649074|585042402|FG001|Overall Study|Other|0|||
161997605|NCT04303559|585042403|FG000|Overall Study|Study closed due to poor enrollment.|1|||
161997606|NCT01156714|585042406|FG000|Overall Study|Withdrawal by Subject|9|||
161997607|NCT01156714|585042407|FG001|Overall Study|Withdrawal by Subject|4|||
161997608|NCT01156714|585042408|FG002|Overall Study|Withdrawal by Subject|3|||
161997609|NCT03775486|585042409|FG000|Initial Therapy Phase|Other reason provided|0|||
161997610|NCT03775486|585042410|FG001|Initial Therapy Phase|Other reason provided|15|||
161997611|NCT03775486|585042409|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
161997612|NCT03775486|585042410|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
161997613|NCT03775486|585042409|FG000|Initial Therapy Phase|Protocol Violation|0|||
161997614|NCT03775486|585042410|FG001|Initial Therapy Phase|Protocol Violation|2|||
161997615|NCT03775486|585042409|FG000|Initial Therapy Phase|Adverse Event|0|||
161997616|NCT03775486|585042410|FG001|Initial Therapy Phase|Adverse Event|34|||
161997617|NCT03775486|585042409|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
161997618|NCT03775486|585042410|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
161997619|NCT03775486|585042409|FG000|Maintenance Phase|Withdrawal by Subject|13|||
161997620|NCT03775486|585042410|FG001|Maintenance Phase|Withdrawal by Subject|12|||
161997621|NCT03775486|585042409|FG000|Maintenance Phase|Death|44|||
161997622|NCT03775486|585042410|FG001|Maintenance Phase|Death|45|||
161997623|NCT00801216|585042411|FG000|Overall Study|Screening Failure|2|||
161997624|NCT05907395|585042412|FG000|Period 1|No longer met eligibility criteria|0|||
161997625|NCT05907395|585042413|FG001|Period 1|No longer met eligibility criteria|1|||
161997626|NCT05907395|585042414|FG002|Period 1|No longer met eligibility criteria|0|||
161997627|NCT05907395|585042415|FG003|Period 1|No longer met eligibility criteria|0|||
161997628|NCT05907395|585042416|FG004|Period 1|No longer met eligibility criteria|0|||
161997629|NCT05907395|585042417|FG005|Period 1|No longer met eligibility criteria|1|||
161997630|NCT05907395|585042418|FG006|Period 1|No longer met eligibility criteria|1|||
161997631|NCT05907395|585042419|FG007|Period 1|No longer met eligibility criteria|0|||
161997632|NCT05907395|585042420|FG008|Period 1|No longer met eligibility criteria|0|||
161997633|NCT05907395|585042421|FG009|Period 1|No longer met eligibility criteria|0|||
161997634|NCT05907395|585042422|FG010|Period 1|No longer met eligibility criteria|0|||
161997635|NCT05907395|585042423|FG011|Period 1|No longer met eligibility criteria|0|||
161997636|NCT05907395|585042412|FG000|Period 2|Adverse Event|0|||
161997637|NCT05907395|585042413|FG001|Period 2|Adverse Event|0|||
161997638|NCT05907395|585042414|FG002|Period 2|Adverse Event|0|||
161997639|NCT05907395|585042415|FG003|Period 2|Adverse Event|1|||
161997640|NCT05907395|585042416|FG004|Period 2|Adverse Event|0|||
161997641|NCT05907395|585042417|FG005|Period 2|Adverse Event|0|||
161997642|NCT05907395|585042418|FG006|Period 2|Adverse Event|0|||
161997643|NCT05907395|585042419|FG007|Period 2|Adverse Event|1|||
161997644|NCT05907395|585042420|FG008|Period 2|Adverse Event|0|||
161997645|NCT05907395|585042421|FG009|Period 2|Adverse Event|0|||
161997646|NCT05907395|585042422|FG010|Period 2|Adverse Event|0|||
161997647|NCT05907395|585042423|FG011|Period 2|Adverse Event|0|||
161997648|NCT05907395|585042412|FG000|Period 2|Personal reason|0|||
161997649|NCT05907395|585042413|FG001|Period 2|Personal reason|0|||
161997650|NCT05907395|585042414|FG002|Period 2|Personal reason|0|||
161997651|NCT05907395|585042415|FG003|Period 2|Personal reason|0|||
161997652|NCT05907395|585042416|FG004|Period 2|Personal reason|0|||
161997653|NCT05907395|585042417|FG005|Period 2|Personal reason|0|||
161997654|NCT05907395|585042418|FG006|Period 2|Personal reason|0|||
161997655|NCT05907395|585042419|FG007|Period 2|Personal reason|0|||
161997656|NCT05907395|585042420|FG008|Period 2|Personal reason|0|||
161997657|NCT05907395|585042421|FG009|Period 2|Personal reason|1|||
161997658|NCT05907395|585042422|FG010|Period 2|Personal reason|0|||
161997659|NCT05907395|585042423|FG011|Period 2|Personal reason|0|||
161997660|NCT05907395|585042412|FG000|Period 3|Adverse Event|0|||
161997661|NCT05907395|585042413|FG001|Period 3|Adverse Event|0|||
161997662|NCT05907395|585042414|FG002|Period 3|Adverse Event|0|||
161997663|NCT05907395|585042415|FG003|Period 3|Adverse Event|0|||
161997664|NCT05907395|585042416|FG004|Period 3|Adverse Event|1|||
161997665|NCT05907395|585042417|FG005|Period 3|Adverse Event|0|||
161997666|NCT05907395|585042418|FG006|Period 3|Adverse Event|0|||
161997667|NCT05907395|585042419|FG007|Period 3|Adverse Event|0|||
161997668|NCT05907395|585042420|FG008|Period 3|Adverse Event|0|||
161997669|NCT05907395|585042421|FG009|Period 3|Adverse Event|0|||
161997670|NCT05907395|585042422|FG010|Period 3|Adverse Event|0|||
161997671|NCT05907395|585042423|FG011|Period 3|Adverse Event|0|||
161997672|NCT05214768|585042424|FG000|Induction Period|Withdrawal by Subject|1|||
161997673|NCT05214768|585042425|FG001|Induction Period|Withdrawal by Subject|0|||
161997674|NCT05214768|585042426|FG002|Induction Period|Withdrawal by Subject|0|||
161997675|NCT05214768|585042427|FG003|Induction Period|Withdrawal by Subject|0|||
161997676|NCT05214768|585042428|FG004|Induction Period|Withdrawal by Subject|0|||
161997677|NCT05214768|585042429|FG005|Induction Period|Withdrawal by Subject|0|||
161997678|NCT05214768|585042424|FG000|Induction Period|Physician Decision|1|||
161997679|NCT05214768|585042425|FG001|Induction Period|Physician Decision|0|||
161997680|NCT05214768|585042426|FG002|Induction Period|Physician Decision|0|||
161997681|NCT05214768|585042427|FG003|Induction Period|Physician Decision|0|||
161997682|NCT05214768|585042428|FG004|Induction Period|Physician Decision|0|||
161997683|NCT05214768|585042429|FG005|Induction Period|Physician Decision|0|||
161997684|NCT05214768|585042424|FG000|Maintenance Period|Other Reasons|0|||
161997685|NCT05214768|585042425|FG001|Maintenance Period|Other Reasons|0|||
161997686|NCT05214768|585042426|FG002|Maintenance Period|Other Reasons|1|||
161997687|NCT05214768|585042427|FG003|Maintenance Period|Other Reasons|1|||
161997688|NCT05214768|585042428|FG004|Maintenance Period|Other Reasons|0|||
161997689|NCT05214768|585042429|FG005|Maintenance Period|Other Reasons|0|||
161997690|NCT05214768|585042424|FG000|Maintenance Period|Withdrawal by Subject|0|||
161997691|NCT05214768|585042425|FG001|Maintenance Period|Withdrawal by Subject|0|||
161997692|NCT05214768|585042426|FG002|Maintenance Period|Withdrawal by Subject|0|||
161997693|NCT05214768|585042427|FG003|Maintenance Period|Withdrawal by Subject|1|||
161997694|NCT05214768|585042428|FG004|Maintenance Period|Withdrawal by Subject|0|||
161997695|NCT05214768|585042429|FG005|Maintenance Period|Withdrawal by Subject|0|||
161997696|NCT05214768|585042424|FG000|Maintenance Period|Lack of Efficacy|0|||
161997697|NCT05214768|585042425|FG001|Maintenance Period|Lack of Efficacy|0|||
161997698|NCT05214768|585042426|FG002|Maintenance Period|Lack of Efficacy|1|||
161997699|NCT05214768|585042427|FG003|Maintenance Period|Lack of Efficacy|0|||
161997700|NCT05214768|585042428|FG004|Maintenance Period|Lack of Efficacy|1|||
161997701|NCT05214768|585042429|FG005|Maintenance Period|Lack of Efficacy|0|||
161997702|NCT05214768|585042424|FG000|Open Label Extension Period|Physician Decision|0|||
161997703|NCT05214768|585042425|FG001|Open Label Extension Period|Physician Decision|0|||
161997704|NCT05214768|585042426|FG002|Open Label Extension Period|Physician Decision|0|||
161997705|NCT05214768|585042427|FG003|Open Label Extension Period|Physician Decision|0|||
161997706|NCT05214768|585042428|FG004|Open Label Extension Period|Physician Decision|0|||
161997707|NCT05214768|585042429|FG005|Open Label Extension Period|Physician Decision|1|||
162040156|NCT02775903|585204323|FG003|Overall Study|Adverse Event|3|||
162040157|NCT02775903|585204320|FG000|Overall Study|Progressive disease|15|||
162040158|NCT02775903|585204321|FG001|Overall Study|Progressive disease|14|||
162040159|NCT02775903|585204322|FG002|Overall Study|Progressive disease|30|||
162040160|NCT02775903|585204323|FG003|Overall Study|Progressive disease|20|||
162040161|NCT02775903|585204320|FG000|Overall Study|Lack of Efficacy|2|||
162040162|NCT02775903|585204321|FG001|Overall Study|Lack of Efficacy|2|||
162040163|NCT02775903|585204322|FG002|Overall Study|Lack of Efficacy|2|||
162040164|NCT02775903|585204323|FG003|Overall Study|Lack of Efficacy|6|||
162040165|NCT02775903|585204320|FG000|Overall Study|Withdrawal by Subject|7|||
162040166|NCT02775903|585204321|FG001|Overall Study|Withdrawal by Subject|5|||
162040167|NCT02775903|585204322|FG002|Overall Study|Withdrawal by Subject|5|||
162040168|NCT02775903|585204323|FG003|Overall Study|Withdrawal by Subject|8|||
162040169|NCT02775903|585204320|FG000|Overall Study|Other reasons|7|||
162040170|NCT02775903|585204321|FG001|Overall Study|Other reasons|8|||
162040171|NCT02775903|585204322|FG002|Overall Study|Other reasons|2|||
162040172|NCT02775903|585204323|FG003|Overall Study|Other reasons|12|||
162040173|NCT03552965|585204327|FG000|Overall Study|Death|1|||
162040174|NCT03552965|585204328|FG001|Overall Study|Death|1|||
162040175|NCT03552965|585204327|FG000|Overall Study|Lost to Follow-up|1|||
162040176|NCT03552965|585204328|FG001|Overall Study|Lost to Follow-up|1|||
162040177|NCT03552965|585204327|FG000|Overall Study|Physician Decision|1|||
162040178|NCT03552965|585204328|FG001|Overall Study|Physician Decision|1|||
162040179|NCT03552965|585204327|FG000|Overall Study|Withdrawal by Subject|0|||
162040180|NCT03552965|585204328|FG001|Overall Study|Withdrawal by Subject|2|||
162040181|NCT03552965|585204327|FG000|Overall Study|Continuation not in patient best interest|1|||
162040182|NCT03552965|585204328|FG001|Overall Study|Continuation not in patient best interest|0|||
162040183|NCT03552965|585204327|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
162040184|NCT03552965|585204328|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
162040185|NCT05108922|585205606|FG000|Overall Study|Adverse Event|2|||
162040186|NCT05108922|585205607|FG001|Overall Study|Adverse Event|3|||
162040187|NCT05108922|585205606|FG000|Overall Study|Lost to Follow-up|2|||
162040188|NCT05108922|585205607|FG001|Overall Study|Lost to Follow-up|1|||
162040189|NCT05108922|585205606|FG000|Overall Study|Inadvertent enrollment|0|||
162040190|NCT05108922|585205607|FG001|Overall Study|Inadvertent enrollment|1|||
162040191|NCT05108922|585205606|FG000|Overall Study|Physician Decision|2|||
162040192|NCT05108922|585205607|FG001|Overall Study|Physician Decision|3|||
162040193|NCT05108922|585205606|FG000|Overall Study|Protocol deviation|1|||
162040194|NCT05108922|585205607|FG001|Overall Study|Protocol deviation|0|||
162040195|NCT05108922|585205606|FG000|Overall Study|Screen failure|1|||
162040196|NCT05108922|585205607|FG001|Overall Study|Screen failure|0|||
162040197|NCT05108922|585205606|FG000|Overall Study|Withdrawal by Subject|11|||
162040198|NCT05108922|585205607|FG001|Overall Study|Withdrawal by Subject|8|||
162040199|NCT05036369|585205608|FG000|Overall Study|Run In non compliance|1|||
162040200|NCT05036369|585205609|FG001|Overall Study|Run In non compliance|2|||
162040201|NCT05036369|585205608|FG000|Overall Study|Change in eligibility criteria|0|||
162040202|NCT05036369|585205609|FG001|Overall Study|Change in eligibility criteria|1|||
162040203|NCT01846104|585205610|FG000|Overall Study|Withdrawal by Subject|1|||
162040204|NCT01854658|585205615|FG000|Overall Study|Protocol Violation|6|||
162040205|NCT01854658|585205616|FG001|Overall Study|Protocol Violation|2|||
162040206|NCT01854658|585205617|FG002|Overall Study|Protocol Violation|2|||
162040207|NCT01854658|585205618|FG003|Overall Study|Protocol Violation|1|||
162040208|NCT01854658|585205615|FG000|Overall Study|Physician Decision|7|||
162040209|NCT01854658|585205616|FG001|Overall Study|Physician Decision|5|||
162040210|NCT01854658|585205617|FG002|Overall Study|Physician Decision|2|||
162040211|NCT01854658|585205618|FG003|Overall Study|Physician Decision|4|||
162040212|NCT01854658|585205615|FG000|Overall Study|Lost to Follow-up|8|||
162040213|NCT01854658|585205616|FG001|Overall Study|Lost to Follow-up|9|||
162040214|NCT01854658|585205617|FG002|Overall Study|Lost to Follow-up|8|||
162040215|NCT01854658|585205618|FG003|Overall Study|Lost to Follow-up|4|||
162040216|NCT01854658|585205615|FG000|Overall Study|Withdrawal by Subject|28|||
162040217|NCT01854658|585205616|FG001|Overall Study|Withdrawal by Subject|21|||
162040218|NCT01854658|585205617|FG002|Overall Study|Withdrawal by Subject|29|||
162040219|NCT01854658|585205618|FG003|Overall Study|Withdrawal by Subject|15|||
162040220|NCT01854658|585205615|FG000|Overall Study|Protocol-specified criteria|15|||
162040221|NCT01854658|585205616|FG001|Overall Study|Protocol-specified criteria|15|||
162040222|NCT01854658|585205617|FG002|Overall Study|Protocol-specified criteria|10|||
162040223|NCT01854658|585205618|FG003|Overall Study|Protocol-specified criteria|7|||
162040224|NCT01854658|585205615|FG000|Overall Study|Lack of Efficacy|3|||
162040225|NCT01854658|585205616|FG001|Overall Study|Lack of Efficacy|8|||
162040226|NCT01854658|585205617|FG002|Overall Study|Lack of Efficacy|4|||
162040227|NCT01854658|585205618|FG003|Overall Study|Lack of Efficacy|7|||
162040228|NCT01854658|585205615|FG000|Overall Study|Adverse Event|21|||
162040229|NCT01854658|585205616|FG001|Overall Study|Adverse Event|14|||
162040230|NCT01854658|585205617|FG002|Overall Study|Adverse Event|23|||
162040231|NCT01854658|585205618|FG003|Overall Study|Adverse Event|19|||
162040232|NCT01854658|585205615|FG000|Overall Study|Administrative reasons|5|||
162040233|NCT01854658|585205616|FG001|Overall Study|Administrative reasons|1|||
162040234|NCT01854658|585205617|FG002|Overall Study|Administrative reasons|2|||
162040235|NCT01854658|585205618|FG003|Overall Study|Administrative reasons|2|||
162040236|NCT03906461|585205619|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
162040237|NCT03906461|585205619|FG000|Completed 12-month Follow-up|Missed Visit|6|||
162040238|NCT01795638|585205622|FG000|Overall Study|Death|0|||
162040239|NCT01795638|585205623|FG001|Overall Study|Death|3|||
162040240|NCT01795638|585205622|FG000|Overall Study|transferred to quaternary hospital|2|||
162040241|NCT01795638|585205623|FG001|Overall Study|transferred to quaternary hospital|3|||
162040242|NCT01795638|585205622|FG000|Overall Study|Protocol Violation|3|||
162040243|NCT01795638|585205623|FG001|Overall Study|Protocol Violation|0|||
162040244|NCT01795638|585205622|FG000|Overall Study|discharged from hospital|7|||
162040245|NCT01795638|585205623|FG001|Overall Study|discharged from hospital|5|||
162040246|NCT01795638|585205622|FG000|Overall Study|Withdrawal by Subject|1|||
162040247|NCT01795638|585205623|FG001|Overall Study|Withdrawal by Subject|0|||
162040248|NCT00331864|585205632|FG000|Overall Study|Adverse Event|30|||
162040249|NCT00331864|585205633|FG001|Overall Study|Adverse Event|1|||
162040250|NCT00331864|585205632|FG000|Overall Study|Lack of Efficacy|4|||
162040251|NCT00331864|585205633|FG001|Overall Study|Lack of Efficacy|0|||
162040252|NCT00331864|585205632|FG000|Overall Study|Protocol Violation|3|||
162040253|NCT00331864|585205633|FG001|Overall Study|Protocol Violation|0|||
162040254|NCT00331864|585205632|FG000|Overall Study|Withdrawal by Subject|10|||
162040255|NCT00331864|585205633|FG001|Overall Study|Withdrawal by Subject|0|||
162040256|NCT00331864|585205632|FG000|Overall Study|Lost to Follow-up|4|||
162040257|NCT00331864|585205633|FG001|Overall Study|Lost to Follow-up|3|||
162040258|NCT00331864|585205632|FG000|Overall Study|Administrative Problems|1|||
162040259|NCT00331864|585205633|FG001|Overall Study|Administrative Problems|0|||
162040260|NCT00331864|585205632|FG000|Overall Study|Death|6|||
162040261|NCT00331864|585205633|FG001|Overall Study|Death|0|||
162040262|NCT01409434|585205635|FG000|Overall Study|Protocol Violation|4|||
162040263|NCT00293215|585205636|FG000|Overall Study|Progressive disease|3|||
162040264|NCT00293215|585205637|FG001|Overall Study|Progressive disease|1|||
162040265|NCT00293215|585205636|FG000|Overall Study|Adverse Event|2|||
162040266|NCT00293215|585205637|FG001|Overall Study|Adverse Event|2|||
162040267|NCT02213042|585205638|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
162040268|NCT02213042|585205639|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
162040269|NCT02213042|585205640|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
162040270|NCT02213042|585205638|FG000|Overall Study|Adverse Event|2|||
162040271|NCT02213042|585205639|FG001|Overall Study|Adverse Event|1|||
162040272|NCT02213042|585205640|FG002|Overall Study|Adverse Event|0|||
162040273|NCT02213042|585205638|FG000|Overall Study|Withdrawal by Subject|0|||
162040274|NCT02213042|585205639|FG001|Overall Study|Withdrawal by Subject|1|||
162040275|NCT02213042|585205640|FG002|Overall Study|Withdrawal by Subject|1|||
162040276|NCT02213042|585205638|FG000|Overall Study|Protocol Violation|1|||
162040277|NCT02213042|585205639|FG001|Overall Study|Protocol Violation|0|||
162040278|NCT02213042|585205640|FG002|Overall Study|Protocol Violation|0|||
162040279|NCT02213042|585205638|FG000|Overall Study|Investigator discretion|0|||
162040280|NCT02213042|585205639|FG001|Overall Study|Investigator discretion|0|||
162040281|NCT02213042|585205640|FG002|Overall Study|Investigator discretion|1|||
162040282|NCT02007512|585205641|FG000|Double Blind Treatment Period|Adverse Event|4|||
162040283|NCT02007512|585205642|FG001|Double Blind Treatment Period|Adverse Event|6|||
162040284|NCT02007512|585205643|FG002|Double Blind Treatment Period|Adverse Event|2|||
162040285|NCT02007512|585205644|FG003|Double Blind Treatment Period|Adverse Event|2|||
162040286|NCT02007512|585205641|FG000|Double Blind Treatment Period|Death|1|||
162040287|NCT02007512|585205642|FG001|Double Blind Treatment Period|Death|0|||
162040288|NCT02007512|585205643|FG002|Double Blind Treatment Period|Death|0|||
162040289|NCT02007512|585205644|FG003|Double Blind Treatment Period|Death|0|||
162040290|NCT02007512|585205641|FG000|Double Blind Treatment Period|Disease progression|51|||
162040291|NCT02007512|585205642|FG001|Double Blind Treatment Period|Disease progression|50|||
162040292|NCT02007512|585205643|FG002|Double Blind Treatment Period|Disease progression|57|||
162040293|NCT02007512|585205644|FG003|Double Blind Treatment Period|Disease progression|52|||
162040294|NCT02007512|585205641|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
162040295|NCT02007512|585205642|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
162040296|NCT02007512|585205643|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
162040297|NCT02007512|585205644|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
162040298|NCT02007512|585205641|FG000|Double Blind Treatment Period|Protocol Violation|1|||
162040299|NCT02007512|585205642|FG001|Double Blind Treatment Period|Protocol Violation|0|||
162040300|NCT02007512|585205643|FG002|Double Blind Treatment Period|Protocol Violation|0|||
162040301|NCT02007512|585205644|FG003|Double Blind Treatment Period|Protocol Violation|1|||
162040302|NCT02007512|585205641|FG000|Double Blind Treatment Period|Other|2|||
162040303|NCT02007512|585205642|FG001|Double Blind Treatment Period|Other|1|||
162040304|NCT02007512|585205643|FG002|Double Blind Treatment Period|Other|1|||
162040305|NCT02007512|585205644|FG003|Double Blind Treatment Period|Other|2|||
162040306|NCT02007512|585205641|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
162040307|NCT02007512|585205642|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
162040308|NCT02007512|585205643|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
162040309|NCT02007512|585205644|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
162040310|NCT02007512|585205641|FG000|Open Label Treatment Period|Adverse Event|1|||
162040311|NCT02007512|585205642|FG001|Open Label Treatment Period|Adverse Event|0|||
162040312|NCT02007512|585205643|FG002|Open Label Treatment Period|Adverse Event|0|||
162040313|NCT02007512|585205644|FG003|Open Label Treatment Period|Adverse Event|0|||
162040314|NCT02007512|585205641|FG000|Open Label Treatment Period|Other|1|||
162040315|NCT02007512|585205642|FG001|Open Label Treatment Period|Other|1|||
162040316|NCT02007512|585205643|FG002|Open Label Treatment Period|Other|0|||
162040317|NCT02007512|585205644|FG003|Open Label Treatment Period|Other|0|||
162040318|NCT02007512|585205641|FG000|Open Label Treatment Period|Disease progression|23|||
162040319|NCT02007512|585205642|FG001|Open Label Treatment Period|Disease progression|11|||
162040320|NCT02007512|585205643|FG002|Open Label Treatment Period|Disease progression|0|||
162040321|NCT02007512|585205644|FG003|Open Label Treatment Period|Disease progression|0|||
162040322|NCT01225887|585205650|FG000|Overall Study|Ineligible:required test not done|2|||
162040323|NCT01225887|585205650|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
162040324|NCT01225887|585205650|FG000|Overall Study|Ineligible:inadequate pathology|2|||
162040325|NCT04505540|585205653|FG000|Baseline|Protocol Violation|10|||
161997708|NCT05214768|585042424|FG000|Open Label Extension Period|Lack of Efficacy|0|||
161997709|NCT05214768|585042425|FG001|Open Label Extension Period|Lack of Efficacy|0|||
161997710|NCT05214768|585042426|FG002|Open Label Extension Period|Lack of Efficacy|0|||
161997711|NCT05214768|585042427|FG003|Open Label Extension Period|Lack of Efficacy|0|||
162040326|NCT04505540|585205653|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
162040327|NCT04505540|585205653|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
162040328|NCT04505540|585205653|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
162040329|NCT04505540|585205653|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
162040330|NCT04505540|585205653|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
162040331|NCT04505540|585205653|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
162040332|NCT04505540|585205653|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
162040333|NCT04505540|585205653|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
162040334|NCT04505540|585205653|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
162040335|NCT04505540|585205653|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
162040336|NCT04505540|585205653|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
162040337|NCT04505540|585205653|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
162040338|NCT05342532|585205656|FG000|Overall Study|Adverse Event|5|||
162040339|NCT05342532|585205657|FG001|Overall Study|Adverse Event|20|||
162040340|NCT05342532|585205656|FG000|Overall Study|Lost to Follow-up|10|||
162040341|NCT05342532|585205657|FG001|Overall Study|Lost to Follow-up|15|||
162040342|NCT01123850|585205660|FG000|Overall Study|Slow enrollment|45|||
162040343|NCT03180684|585205663|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
162040344|NCT03180684|585205664|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
162040345|NCT03180684|585205663|FG000|Overall Study|Physician Decision|1|||
162040346|NCT03180684|585205664|FG001|Overall Study|Physician Decision|0|||
162040347|NCT03180684|585205663|FG000|Overall Study|Lost to Follow-up|1|||
162040348|NCT03180684|585205664|FG001|Overall Study|Lost to Follow-up|0|||
162040349|NCT03180684|585205663|FG000|Overall Study|Progressive Disease|1|||
162040350|NCT03180684|585205664|FG001|Overall Study|Progressive Disease|0|||
162040351|NCT02495233|585205668|FG000|Overall Study|Miscellaneous|0|||
162040352|NCT02495233|585205669|FG001|Overall Study|Miscellaneous|1|||
162040353|NCT00857415|585205672|FG000|Overall Study|Image acquisition failure|2|||
162040354|NCT00857415|585205673|FG001|Overall Study|Image acquisition failure|0|||
162040355|NCT00857415|585205672|FG000|Overall Study|Invalid image or not imaged|3|||
162040356|NCT00857415|585205673|FG001|Overall Study|Invalid image or not imaged|0|||
162040357|NCT00857415|585205672|FG000|Overall Study|Subject still living at end of study|110|||
162040358|NCT00857415|585205673|FG001|Overall Study|Subject still living at end of study|0|||
162040359|NCT00857415|585205672|FG000|Overall Study|Deceased with no autopsy|2|||
162040360|NCT00857415|585205673|FG001|Overall Study|Deceased with no autopsy|0|||
162040361|NCT04508140|585205674|FG000|Overall Study|Adverse Event|2|||
162040362|NCT04508140|585205675|FG001|Overall Study|Adverse Event|2|||
162040363|NCT04508140|585205674|FG000|Overall Study|Withdrawal by Subject|0|||
161997712|NCT05214768|585042428|FG004|Open Label Extension Period|Lack of Efficacy|0|||
161997713|NCT05214768|585042429|FG005|Open Label Extension Period|Lack of Efficacy|1|||
161997714|NCT05214768|585042424|FG000|Open Label Extension Period|Ongoing Study|0|||
162040364|NCT04508140|585205675|FG001|Overall Study|Withdrawal by Subject|2|||
162040365|NCT04508140|585205674|FG000|Overall Study|progressive disease|9|||
162040366|NCT04508140|585205675|FG001|Overall Study|progressive disease|3|||
162040367|NCT02456103|585205676|FG000|Overall Study|Study Closure|207|||
162040368|NCT02456103|585205676|FG000|Overall Study|Physician Decision|1|||
162040369|NCT02456103|585205676|FG000|Overall Study|Required prohibited medications|5|||
162040370|NCT02456103|585205676|FG000|Overall Study|Protocol Violation|1|||
162040371|NCT02456103|585205676|FG000|Overall Study|Adverse Event|5|||
162040372|NCT02456103|585205676|FG000|Overall Study|Abnormal Laboratory Value|2|||
162040373|NCT02456103|585205676|FG000|Overall Study|Lost to Follow-up|1|||
161997715|NCT05214768|585042425|FG001|Open Label Extension Period|Ongoing Study|0|||
161997716|NCT05214768|585042426|FG002|Open Label Extension Period|Ongoing Study|0|||
161997717|NCT05214768|585042427|FG003|Open Label Extension Period|Ongoing Study|0|||
161997718|NCT05214768|585042428|FG004|Open Label Extension Period|Ongoing Study|0|||
161997719|NCT05214768|585042429|FG005|Open Label Extension Period|Ongoing Study|42|||
161997720|NCT05481359|585042430|FG000|Overall Study|Lost to Follow-up|3|||
161997721|NCT05481359|585042430|FG000|Overall Study|Withdrawal by Subject|1|||
161997722|NCT03043872|585042435|FG000|Overall Study|Withdrawal by Subject|6|||
161997723|NCT03043872|585042436|FG001|Overall Study|Withdrawal by Subject|6|||
161997724|NCT03043872|585042437|FG002|Overall Study|Withdrawal by Subject|15|||
161997725|NCT03043872|585042435|FG000|Overall Study|Lost to Follow-up|2|||
161997726|NCT03043872|585042436|FG001|Overall Study|Lost to Follow-up|1|||
161997727|NCT03043872|585042437|FG002|Overall Study|Lost to Follow-up|1|||
161997728|NCT03043872|585042435|FG000|Overall Study|Death|270|||
161997729|NCT03043872|585042436|FG001|Overall Study|Death|269|||
161997730|NCT03043872|585042437|FG002|Overall Study|Death|296|||
161997731|NCT00398320|585042439|FG000|Overall Study|Death|1|||
161997732|NCT00398320|585042439|FG000|Overall Study|Adverse Event|4|||
161997733|NCT00398320|585042439|FG000|Overall Study|Physician Decision|1|||
161997734|NCT00064792|585042440|FG000|Overall Study|Withdrawal by Subject|2|||
161997735|NCT00064792|585042441|FG001|Overall Study|Withdrawal by Subject|0|||
161997736|NCT00064792|585042440|FG000|Overall Study|Adverse Event|3|||
161997737|NCT00064792|585042441|FG001|Overall Study|Adverse Event|0|||
161997738|NCT00291486|585042446|FG000|Overall Study|Adverse Event|0|||
161997739|NCT00291486|585042447|FG001|Overall Study|Adverse Event|3|||
161997740|NCT00291486|585042448|FG002|Overall Study|Adverse Event|0|||
161997741|NCT00291486|585042449|FG003|Overall Study|Adverse Event|1|||
161997742|NCT00291486|585042450|FG004|Overall Study|Adverse Event|0|||
161997743|NCT00291486|585042446|FG000|Overall Study|Withdrawal by Subject|0|||
161997744|NCT00291486|585042447|FG001|Overall Study|Withdrawal by Subject|0|||
161997745|NCT00291486|585042448|FG002|Overall Study|Withdrawal by Subject|0|||
161997746|NCT00291486|585042449|FG003|Overall Study|Withdrawal by Subject|0|||
161997747|NCT00291486|585042450|FG004|Overall Study|Withdrawal by Subject|1|||
161997748|NCT00291486|585042446|FG000|Overall Study|Disease progression|1|||
161997749|NCT00291486|585042447|FG001|Overall Study|Disease progression|0|||
161997750|NCT00291486|585042448|FG002|Overall Study|Disease progression|1|||
161997751|NCT00291486|585042449|FG003|Overall Study|Disease progression|0|||
161997752|NCT00291486|585042450|FG004|Overall Study|Disease progression|0|||
161997753|NCT01150097|585042455|FG000|Months 24 to 36 Post-transplantation|Death|2|||
161997754|NCT01150097|585042456|FG001|Months 24 to 36 Post-transplantation|Death|0|||
161997755|NCT01150097|585042457|FG002|Months 24 to 36 Post-transplantation|Death|0|||
161997756|NCT01150097|585042455|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
161997757|NCT01150097|585042456|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
161997758|NCT01150097|585042457|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
161997759|NCT01150097|585042455|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
161997760|NCT01150097|585042456|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
161997761|NCT01150097|585042457|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
161997762|NCT01150097|585042455|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
161997763|NCT01150097|585042456|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
161997764|NCT01150097|585042457|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
161997765|NCT01150097|585042455|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
161997766|NCT01150097|585042456|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
161997767|NCT01150097|585042457|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
161997768|NCT01150097|585042455|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
161997769|NCT01150097|585042456|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
161997770|NCT01150097|585042457|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
161997771|NCT01150097|585042455|FG000|Months 24 to 48 Post-transplantation|Death|2|||
161997772|NCT01150097|585042456|FG001|Months 24 to 48 Post-transplantation|Death|0|||
161997773|NCT01150097|585042457|FG002|Months 24 to 48 Post-transplantation|Death|0|||
161997774|NCT01408459|585042458|FG000|Overall Study|Withdrawal by Subject|1|||
161997775|NCT01408459|585042459|FG001|Overall Study|Withdrawal by Subject|1|||
161997776|NCT00992459|585042460|FG000|Overall Study|Withdrawal by Subject|0|||
161997777|NCT00992459|585042461|FG001|Overall Study|Withdrawal by Subject|1|||
161997778|NCT00992459|585042460|FG000|Overall Study|Adverse Event|1|||
161997779|NCT00992459|585042461|FG001|Overall Study|Adverse Event|0|||
161997780|NCT00543387|585042466|FG000|Panel 1 + Panel 2|Adverse Event|0|||
161997781|NCT00543387|585042467|FG001|Panel 1 + Panel 2|Adverse Event|1|||
161997782|NCT00543387|585042468|FG002|Panel 1 + Panel 2|Adverse Event|0|||
161997783|NCT00543387|585042469|FG003|Panel 1 + Panel 2|Adverse Event|0|||
161997784|NCT00543387|585042470|FG004|Panel 1 + Panel 2|Adverse Event|0|||
161997785|NCT00543387|585042471|FG005|Panel 1 + Panel 2|Adverse Event|0|||
161997786|NCT00543387|585042472|FG006|Panel 1 + Panel 2|Adverse Event|0|||
162040374|NCT02456103|585205676|FG000|Overall Study|Withdrawal by Subject|24|||
162040375|NCT03614975|585205677|FG000|Overall Study|Physician Decision|7|||
162040376|NCT03614975|585205678|FG001|Overall Study|Physician Decision|5|||
162040377|NCT03614975|585205677|FG000|Overall Study|Withdrawal by Subject|2|||
162040378|NCT03614975|585205678|FG001|Overall Study|Withdrawal by Subject|2|||
162040379|NCT03614975|585205677|FG000|Overall Study|Specimens not in lab batch shipment|1|||
162040380|NCT03614975|585205678|FG001|Overall Study|Specimens not in lab batch shipment|1|||
162040381|NCT01390220|585205679|FG000|Test Dose Phase|Adverse Event|17|||
162040382|NCT01390220|585205680|FG001|Test Dose Phase|Adverse Event|0|||
162040383|NCT01390220|585205681|FG002|Test Dose Phase|Adverse Event|0|||
162040384|NCT01390220|585205679|FG000|Test Dose Phase|Withdrawal by Subject|8|||
162040385|NCT01390220|585205680|FG001|Test Dose Phase|Withdrawal by Subject|0|||
162040386|NCT01390220|585205681|FG002|Test Dose Phase|Withdrawal by Subject|0|||
162040387|NCT01390220|585205679|FG000|Test Dose Phase|Lost to Follow-up|2|||
162040388|NCT01390220|585205680|FG001|Test Dose Phase|Lost to Follow-up|0|||
162040389|NCT01390220|585205681|FG002|Test Dose Phase|Lost to Follow-up|0|||
162040390|NCT01390220|585205679|FG000|Test Dose Phase|Protocol Violation|8|||
162040391|NCT01390220|585205680|FG001|Test Dose Phase|Protocol Violation|0|||
162040392|NCT01390220|585205681|FG002|Test Dose Phase|Protocol Violation|0|||
162040393|NCT01390220|585205679|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
162040394|NCT01390220|585205680|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
162040395|NCT01390220|585205681|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
162040396|NCT01390220|585205679|FG000|Test Dose Phase|Study/Site closure|6|||
162040397|NCT01390220|585205680|FG001|Test Dose Phase|Study/Site closure|0|||
162040398|NCT01390220|585205681|FG002|Test Dose Phase|Study/Site closure|0|||
162040399|NCT01390220|585205679|FG000|Test Dose Phase|Caregiver no longer available|5|||
162040400|NCT01390220|585205680|FG001|Test Dose Phase|Caregiver no longer available|0|||
162040401|NCT01390220|585205681|FG002|Test Dose Phase|Caregiver no longer available|0|||
162040402|NCT01390220|585205679|FG000|Test Dose Phase|Noncompliance|2|||
162040403|NCT01390220|585205680|FG001|Test Dose Phase|Noncompliance|0|||
162040404|NCT01390220|585205681|FG002|Test Dose Phase|Noncompliance|0|||
162040405|NCT01390220|585205679|FG000|Test Dose Phase|Logistical|6|||
162040406|NCT01390220|585205680|FG001|Test Dose Phase|Logistical|0|||
162040407|NCT01390220|585205681|FG002|Test Dose Phase|Logistical|0|||
162040408|NCT01390220|585205679|FG000|Comparative Phase|Withdrawal by Subject|0|||
162040409|NCT01390220|585205680|FG001|Comparative Phase|Withdrawal by Subject|1|||
162040410|NCT01390220|585205681|FG002|Comparative Phase|Withdrawal by Subject|0|||
162040411|NCT00136604|585205682|FG000|Overall Study|Lost to Follow-up|1|||
162040412|NCT00136604|585205683|FG001|Overall Study|Lost to Follow-up|0|||
162040413|NCT00136604|585205684|FG002|Overall Study|Lost to Follow-up|0|||
162040414|NCT00136604|585205685|FG003|Overall Study|Lost to Follow-up|0|||
162040415|NCT00136604|585205686|FG004|Overall Study|Lost to Follow-up|1|||
162040416|NCT00136604|585205682|FG000|Overall Study|Migrated/moved from study area|0|||
162040417|NCT00136604|585205683|FG001|Overall Study|Migrated/moved from study area|1|||
162040418|NCT00136604|585205684|FG002|Overall Study|Migrated/moved from study area|0|||
162040419|NCT00136604|585205685|FG003|Overall Study|Migrated/moved from study area|0|||
162040420|NCT00136604|585205686|FG004|Overall Study|Migrated/moved from study area|0|||
162040421|NCT00470847|585205687|FG000|Overall Study|Pt still receiving treatment|1|||
162040422|NCT01369615|585205689|FG000|Overall Study|Withdrawal by Subject|0|||
162040423|NCT01369615|585205690|FG001|Overall Study|Withdrawal by Subject|1|||
162040424|NCT01369615|585205689|FG000|Overall Study|Lost to Follow-up|0|||
162040425|NCT01369615|585205690|FG001|Overall Study|Lost to Follow-up|1|||
162040426|NCT04263454|585205691|FG000|Overall Study|Adverse Event|0|||
162040427|NCT04263454|585205692|FG001|Overall Study|Adverse Event|2|||
162040428|NCT04263454|585205691|FG000|Overall Study|Physician Decision|3|||
162040429|NCT04263454|585205692|FG001|Overall Study|Physician Decision|5|||
162040430|NCT04263454|585205691|FG000|Overall Study|Poor Data Quality|0|||
162040431|NCT04263454|585205692|FG001|Overall Study|Poor Data Quality|1|||
162040432|NCT01231347|585205693|FG000|Overall Study|Full Consent withdrawn|19|||
162040433|NCT01231347|585205694|FG001|Overall Study|Full Consent withdrawn|19|||
162040434|NCT01231347|585205695|FG002|Overall Study|Full Consent withdrawn|11|||
162040435|NCT01231347|585205693|FG000|Overall Study|Lost to Follow-up|4|||
162040436|NCT01231347|585205694|FG001|Overall Study|Lost to Follow-up|2|||
162040437|NCT01231347|585205695|FG002|Overall Study|Lost to Follow-up|2|||
162040438|NCT01231347|585205693|FG000|Overall Study|Death|202|||
162040439|NCT01231347|585205694|FG001|Overall Study|Death|210|||
162040440|NCT01231347|585205695|FG002|Overall Study|Death|101|||
162040441|NCT01231347|585205693|FG000|Overall Study|other event|7|||
162040442|NCT01231347|585205694|FG001|Overall Study|other event|9|||
162040443|NCT01231347|585205695|FG002|Overall Study|other event|3|||
162040444|NCT01460368|585205696|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
162040445|NCT01460368|585205697|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
162040446|NCT01460368|585205698|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
162040447|NCT01460368|585205699|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
162040448|NCT01460368|585205700|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
162040449|NCT01460368|585205701|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
161997787|NCT00543387|585042473|FG007|Panel 1 + Panel 2|Adverse Event|1|||
161997788|NCT00543387|585042474|FG008|Panel 1 + Panel 2|Adverse Event|1|||
161997789|NCT00543387|585042475|FG009|Panel 1 + Panel 2|Adverse Event|0|||
161997790|NCT00543387|585042476|FG010|Panel 1 + Panel 2|Adverse Event|0|||
161997791|NCT00543387|585042466|FG000|Panel 1 + Panel 2|Physician Decision|0|||
161997792|NCT00543387|585042467|FG001|Panel 1 + Panel 2|Physician Decision|0|||
161997793|NCT00543387|585042468|FG002|Panel 1 + Panel 2|Physician Decision|1|||
161997794|NCT00543387|585042469|FG003|Panel 1 + Panel 2|Physician Decision|0|||
161997795|NCT00543387|585042470|FG004|Panel 1 + Panel 2|Physician Decision|0|||
161997796|NCT00543387|585042471|FG005|Panel 1 + Panel 2|Physician Decision|0|||
161997797|NCT00543387|585042472|FG006|Panel 1 + Panel 2|Physician Decision|0|||
161997798|NCT00543387|585042473|FG007|Panel 1 + Panel 2|Physician Decision|1|||
161997799|NCT00543387|585042474|FG008|Panel 1 + Panel 2|Physician Decision|0|||
161997800|NCT00543387|585042475|FG009|Panel 1 + Panel 2|Physician Decision|0|||
161997801|NCT00543387|585042476|FG010|Panel 1 + Panel 2|Physician Decision|0|||
161997802|NCT00543387|585042466|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
161997803|NCT00543387|585042467|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
161997804|NCT00543387|585042468|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
161997805|NCT00543387|585042469|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
161997806|NCT00543387|585042470|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
161997807|NCT00543387|585042471|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
161997808|NCT00543387|585042472|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
161997809|NCT00543387|585042473|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
161997810|NCT00543387|585042474|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
161997811|NCT00543387|585042475|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
161997812|NCT00543387|585042476|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
161997813|NCT00543387|585042466|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161997814|NCT00543387|585042467|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161997815|NCT00543387|585042468|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161997816|NCT00543387|585042469|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161997817|NCT00543387|585042470|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161997818|NCT00543387|585042471|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161997819|NCT00543387|585042472|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
161997820|NCT00543387|585042473|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161997821|NCT00543387|585042474|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161997822|NCT00543387|585042475|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161997823|NCT00543387|585042476|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
161997824|NCT00543387|585042466|FG000|Crossover Participants|Progressive Disease|0|||
161997825|NCT00543387|585042467|FG001|Crossover Participants|Progressive Disease|0|||
161997826|NCT00543387|585042468|FG002|Crossover Participants|Progressive Disease|0|||
161997827|NCT00543387|585042469|FG003|Crossover Participants|Progressive Disease|0|||
161997828|NCT00543387|585042470|FG004|Crossover Participants|Progressive Disease|0|||
161997829|NCT00543387|585042471|FG005|Crossover Participants|Progressive Disease|0|||
161997830|NCT00543387|585042472|FG006|Crossover Participants|Progressive Disease|0|||
161997831|NCT00543387|585042473|FG007|Crossover Participants|Progressive Disease|0|||
161997832|NCT00543387|585042474|FG008|Crossover Participants|Progressive Disease|0|||
161997833|NCT00543387|585042475|FG009|Crossover Participants|Progressive Disease|1|||
161997834|NCT00543387|585042476|FG010|Crossover Participants|Progressive Disease|2|||
161997835|NCT00543387|585042466|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
161997836|NCT00543387|585042467|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
161997837|NCT00543387|585042468|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
161997838|NCT00543387|585042469|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
161997839|NCT00543387|585042470|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
161997840|NCT00543387|585042471|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
161997841|NCT00543387|585042472|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
161997842|NCT00543387|585042473|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
161997843|NCT00543387|585042474|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
161997844|NCT00543387|585042475|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
161997845|NCT00543387|585042476|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
161997846|NCT02719171|585043855|FG000|Overall Study|Adverse Event|1|||
161997847|NCT02719171|585043856|FG001|Overall Study|Adverse Event|2|||
161997848|NCT02719171|585043857|FG002|Overall Study|Adverse Event|0|||
161997849|NCT02719171|585043858|FG003|Overall Study|Adverse Event|0|||
161997850|NCT02719171|585043859|FG004|Overall Study|Adverse Event|2|||
161997851|NCT02719171|585043855|FG000|Overall Study|Lost to Follow-up|0|||
161997852|NCT02719171|585043856|FG001|Overall Study|Lost to Follow-up|0|||
161997853|NCT02719171|585043857|FG002|Overall Study|Lost to Follow-up|1|||
161997854|NCT02719171|585043858|FG003|Overall Study|Lost to Follow-up|0|||
161997855|NCT02719171|585043859|FG004|Overall Study|Lost to Follow-up|0|||
161997856|NCT02719171|585043855|FG000|Overall Study|Subject Withdrawal|0|||
162040450|NCT01460368|585205702|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
161997857|NCT02719171|585043856|FG001|Overall Study|Subject Withdrawal|2|||
161997858|NCT02719171|585043857|FG002|Overall Study|Subject Withdrawal|2|||
161997859|NCT02719171|585043858|FG003|Overall Study|Subject Withdrawal|1|||
161997860|NCT02719171|585043859|FG004|Overall Study|Subject Withdrawal|0|||
161997861|NCT02719171|585043855|FG000|Overall Study|Other|0|||
161997862|NCT02719171|585043856|FG001|Overall Study|Other|0|||
161997863|NCT02719171|585043857|FG002|Overall Study|Other|0|||
161997864|NCT02719171|585043858|FG003|Overall Study|Other|1|||
161997865|NCT02719171|585043859|FG004|Overall Study|Other|0|||
161997866|NCT01232868|585043862|FG000|Overall Study|Lost to Follow-up|2|||
161997867|NCT01232868|585043863|FG001|Overall Study|Lost to Follow-up|4|||
161997868|NCT04481243|585043865|FG000|Overall Study|Withdrawal by Subject|4|||
161997869|NCT02831764|585043866|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
161997870|NCT02831764|585043867|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
161997871|NCT02831764|585043868|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
161997872|NCT02831764|585043869|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
161997873|NCT02831764|585043870|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
161997874|NCT02831764|585043866|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
161997875|NCT02831764|585043867|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
161997876|NCT02831764|585043868|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
161997877|NCT02831764|585043869|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
161997878|NCT02831764|585043870|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
161997879|NCT02831764|585043866|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
161997880|NCT02831764|585043867|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
161997881|NCT02831764|585043868|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
161997882|NCT02831764|585043869|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
161997883|NCT02831764|585043870|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
161997884|NCT02831764|585043866|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
161997885|NCT02831764|585043867|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
161997886|NCT02831764|585043868|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
161997887|NCT02831764|585043869|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
161997888|NCT02831764|585043870|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
161997889|NCT02831764|585043866|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
161997890|NCT02831764|585043867|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
161997891|NCT02831764|585043868|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
161997892|NCT02831764|585043869|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
161997893|NCT02831764|585043870|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
161997894|NCT02831764|585043866|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
161997895|NCT02831764|585043867|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
161997896|NCT02831764|585043868|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
161997897|NCT02831764|585043869|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
161997898|NCT02831764|585043870|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
161997899|NCT02831764|585043866|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
161997900|NCT02831764|585043867|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
161997901|NCT02831764|585043868|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
161997902|NCT02831764|585043869|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
161997903|NCT02831764|585043870|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
161997904|NCT02831764|585043866|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
161997905|NCT02831764|585043867|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
161997906|NCT02831764|585043868|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
161997907|NCT02831764|585043869|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
161997908|NCT02831764|585043870|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
161997909|NCT02831764|585043866|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161997910|NCT02831764|585043867|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161997911|NCT02831764|585043868|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
161997912|NCT02831764|585043869|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
161997913|NCT02831764|585043870|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161997914|NCT02831764|585043866|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161997915|NCT02831764|585043867|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161997916|NCT02831764|585043868|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
161997917|NCT02831764|585043869|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161997918|NCT02831764|585043870|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161997919|NCT02831764|585043866|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161997920|NCT02831764|585043867|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161997921|NCT02831764|585043868|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
162040451|NCT01460368|585205696|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
162040452|NCT01460368|585205697|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
162040453|NCT01460368|585205698|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
162040454|NCT01460368|585205699|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
162040455|NCT01460368|585205700|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
162040456|NCT01460368|585205701|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
162040457|NCT01460368|585205702|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
162040458|NCT01460368|585205696|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
162040459|NCT01460368|585205697|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
162040460|NCT01460368|585205698|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
162040461|NCT01460368|585205699|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
162040462|NCT01460368|585205700|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
162040463|NCT01460368|585205701|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
162040464|NCT01460368|585205702|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
162040465|NCT01460368|585205696|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162040466|NCT01460368|585205697|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162040467|NCT01460368|585205698|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
162040468|NCT01460368|585205699|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162040469|NCT01460368|585205700|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162040470|NCT01460368|585205701|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162040471|NCT01460368|585205702|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
162040472|NCT01460368|585205696|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
162040473|NCT01460368|585205697|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
162040474|NCT01460368|585205698|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
162040475|NCT01460368|585205699|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
162040476|NCT01460368|585205700|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
162040477|NCT01460368|585205701|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
162040478|NCT01460368|585205702|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
162040479|NCT02047227|585205703|FG000|Overall Study|Adverse Event|2|||
162040480|NCT02047227|585205704|FG001|Overall Study|Adverse Event|4|||
162040481|NCT02047227|585205703|FG000|Overall Study|Lost to Follow-up|0|||
162040482|NCT02047227|585205704|FG001|Overall Study|Lost to Follow-up|3|||
162040483|NCT02047227|585205703|FG000|Overall Study|Protocol Violation|1|||
162040484|NCT02047227|585205704|FG001|Overall Study|Protocol Violation|0|||
162040485|NCT02047227|585205703|FG000|Overall Study|Spontaneous pregnancy|1|||
162040486|NCT02047227|585205704|FG001|Overall Study|Spontaneous pregnancy|0|||
162040487|NCT02047227|585205703|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
162040488|NCT02047227|585205704|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
162040489|NCT02047227|585205703|FG000|Overall Study|No oocytes retrieved|21|||
162040490|NCT02047227|585205704|FG001|Overall Study|No oocytes retrieved|20|||
162040491|NCT02047227|585205703|FG000|Overall Study|No fertilization|61|||
162040492|NCT02047227|585205704|FG001|Overall Study|No fertilization|51|||
162040493|NCT02047227|585205703|FG000|Overall Study|Intention to freeze all embryos|1|||
162040494|NCT02047227|585205704|FG001|Overall Study|Intention to freeze all embryos|0|||
162040495|NCT02047227|585205703|FG000|Overall Study|All embryos discarded|12|||
162040496|NCT02047227|585205704|FG001|Overall Study|All embryos discarded|11|||
162040497|NCT02047227|585205703|FG000|Overall Study|Other|10|||
162040498|NCT02047227|585205704|FG001|Overall Study|Other|9|||
162040499|NCT01385371|585205717|FG000|Overall Study|Adverse Event|54|||
162040500|NCT01385371|585205718|FG001|Overall Study|Adverse Event|19|||
162040501|NCT01385371|585205717|FG000|Overall Study|Lost to Follow-up|16|||
162040502|NCT01385371|585205718|FG001|Overall Study|Lost to Follow-up|16|||
162040503|NCT01385371|585205717|FG000|Overall Study|Withdrawal by Subject|52|||
162040504|NCT01385371|585205718|FG001|Overall Study|Withdrawal by Subject|39|||
162040505|NCT01385371|585205717|FG000|Overall Study|Protocol Violation|25|||
162040506|NCT01385371|585205718|FG001|Overall Study|Protocol Violation|21|||
162040507|NCT01385371|585205717|FG000|Overall Study|Administrative|2|||
162040508|NCT01385371|585205718|FG001|Overall Study|Administrative|2|||
162040509|NCT03112590|585205723|FG000|Overall Study|Adverse Event|0|||
162040510|NCT03112590|585205724|FG001|Overall Study|Adverse Event|1|||
162040511|NCT03112590|585205725|FG002|Overall Study|Adverse Event|0|||
162040512|NCT02436681|585205726|FG000|Overall Study|Lost to Follow-up|10|||
162040513|NCT02436681|585205726|FG000|Overall Study|Withdrawal by Subject|2|||
162040514|NCT02436681|585205726|FG000|Overall Study|Death|2|||
162040515|NCT03635788|585205734|FG000|Step 1|Death|1|||
162040516|NCT03635788|585205735|FG001|Step 1|Death|0|||
162040517|NCT03635788|585205736|FG002|Step 1|Death|0|||
162040518|NCT03635788|585205734|FG000|Step 1|Lost to Follow-up|31|||
162040519|NCT03635788|585205735|FG001|Step 1|Lost to Follow-up|0|||
162040520|NCT03635788|585205736|FG002|Step 1|Lost to Follow-up|0|||
162040521|NCT03635788|585205734|FG000|Step 1|Pregnancy|1|||
162040522|NCT03635788|585205735|FG001|Step 1|Pregnancy|0|||
162040523|NCT03635788|585205736|FG002|Step 1|Pregnancy|0|||
161997922|NCT02831764|585043869|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
161997923|NCT02831764|585043870|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161997924|NCT02831764|585043866|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
161997925|NCT02831764|585043867|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
161997926|NCT02831764|585043868|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
161997927|NCT02831764|585043869|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
161997928|NCT02831764|585043870|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
161997929|NCT02831764|585043866|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161997930|NCT02831764|585043867|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161997931|NCT02831764|585043868|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
161997932|NCT02831764|585043869|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
161997933|NCT02831764|585043870|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161997934|NCT02831764|585043866|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161997935|NCT02831764|585043867|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161997936|NCT02831764|585043868|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
161997937|NCT02831764|585043869|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
161997938|NCT02831764|585043870|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161997939|NCT02831764|585043866|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161997940|NCT02831764|585043867|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161997941|NCT02831764|585043868|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
161997942|NCT02831764|585043869|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
161997943|NCT02831764|585043870|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161997944|NCT02831764|585043866|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161997945|NCT02831764|585043867|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161997946|NCT02831764|585043868|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161997947|NCT02831764|585043869|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161997948|NCT02831764|585043870|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
161997949|NCT02831764|585043866|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161997950|NCT02831764|585043867|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161997951|NCT02831764|585043868|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161997952|NCT02831764|585043869|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161997953|NCT02831764|585043870|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
161997954|NCT02831764|585043866|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161997955|NCT02831764|585043867|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161997956|NCT02831764|585043868|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161997957|NCT02831764|585043869|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161997958|NCT02831764|585043870|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
161997959|NCT02831764|585043866|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161997960|NCT02831764|585043867|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161997961|NCT02831764|585043868|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161997962|NCT02831764|585043869|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161997963|NCT02831764|585043870|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
161997964|NCT02539797|585043871|FG000|Overall Study|Lost to Follow-up|0|||
161997965|NCT02539797|585043872|FG001|Overall Study|Lost to Follow-up|1|||
161997966|NCT02539797|585043873|FG002|Overall Study|Lost to Follow-up|0|||
161997967|NCT02796677|585043879|FG000|Overall Study|Adverse Event|11|||
161997968|NCT02796677|585043880|FG001|Overall Study|Adverse Event|22|||
161997969|NCT02796677|585043881|FG002|Overall Study|Adverse Event|14|||
161997970|NCT02796677|585043882|FG003|Overall Study|Adverse Event|14|||
161997971|NCT02796677|585043879|FG000|Overall Study|Protocol Violation|7|||
161997972|NCT02796677|585043880|FG001|Overall Study|Protocol Violation|5|||
161997973|NCT02796677|585043881|FG002|Overall Study|Protocol Violation|4|||
161997974|NCT02796677|585043882|FG003|Overall Study|Protocol Violation|8|||
161997975|NCT02796677|585043879|FG000|Overall Study|Lost to Follow-up|1|||
161997976|NCT02796677|585043880|FG001|Overall Study|Lost to Follow-up|5|||
161997977|NCT02796677|585043881|FG002|Overall Study|Lost to Follow-up|2|||
161997978|NCT02796677|585043882|FG003|Overall Study|Lost to Follow-up|2|||
161997979|NCT02796677|585043879|FG000|Overall Study|Lack of Efficacy|7|||
161997980|NCT02796677|585043880|FG001|Overall Study|Lack of Efficacy|9|||
161997981|NCT02796677|585043881|FG002|Overall Study|Lack of Efficacy|14|||
161997982|NCT02796677|585043882|FG003|Overall Study|Lack of Efficacy|20|||
161997983|NCT02796677|585043879|FG000|Overall Study|Withdrawal by Subject|4|||
161997984|NCT02796677|585043880|FG001|Overall Study|Withdrawal by Subject|14|||
161997985|NCT02796677|585043881|FG002|Overall Study|Withdrawal by Subject|6|||
161997986|NCT02796677|585043882|FG003|Overall Study|Withdrawal by Subject|7|||
161997987|NCT02796677|585043879|FG000|Overall Study|Progressive disease|6|||
161997988|NCT02796677|585043880|FG001|Overall Study|Progressive disease|15|||
161997989|NCT02796677|585043881|FG002|Overall Study|Progressive disease|13|||
161997990|NCT02796677|585043882|FG003|Overall Study|Progressive disease|18|||
161997991|NCT02796677|585043879|FG000|Overall Study|Reason not mentioned|2|||
161997992|NCT02796677|585043880|FG001|Overall Study|Reason not mentioned|3|||
161997993|NCT02796677|585043881|FG002|Overall Study|Reason not mentioned|0|||
161997994|NCT02796677|585043882|FG003|Overall Study|Reason not mentioned|5|||
161997995|NCT00961181|585043883|FG000|Overall Study|Death|2|||
161997996|NCT00961181|585043883|FG000|Overall Study|Withdrawal by Subject|2|||
161997997|NCT00961181|585043883|FG000|Overall Study|Lost to Follow-up|1|||
161997998|NCT01777308|585043886|FG000|Overall Study|Withdrawal by Subject|5|||
161997999|NCT01777308|585043887|FG001|Overall Study|Withdrawal by Subject|1|||
161998000|NCT01777308|585043886|FG000|Overall Study|Migrated/moved from study area|1|||
161998001|NCT01777308|585043887|FG001|Overall Study|Migrated/moved from study area|0|||
161998002|NCT01777308|585043886|FG000|Overall Study|Lost to Follow-up|7|||
161998003|NCT01777308|585043887|FG001|Overall Study|Lost to Follow-up|2|||
161998004|NCT01777308|585043886|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
161998005|NCT01777308|585043887|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
161998006|NCT03212326|585043889|FG000|Overall Study|Physician Decision|4|||
161998007|NCT01131507|585043903|FG000|Overall Study|Adverse Event|1|||
161998008|NCT01131507|585043903|FG000|Overall Study|Lost to Follow-up|1|||
161998009|NCT01131507|585043903|FG000|Overall Study|Withdrawal by Subject|1|||
161998010|NCT01517750|585043904|FG000|Overall Study|Lost to Follow-up|1|||
161998011|NCT01517750|585043905|FG001|Overall Study|Lost to Follow-up|2|||
161998012|NCT01517750|585043906|FG002|Overall Study|Lost to Follow-up|4|||
161998013|NCT01517750|585043907|FG003|Overall Study|Lost to Follow-up|1|||
161998014|NCT01855412|585043909|FG000|Overall Study|Death|77|||
161998015|NCT01855412|585043910|FG001|Overall Study|Death|123|||
161998016|NCT01855412|585043911|FG002|Overall Study|Death|30|||
161998017|NCT01855412|585043909|FG000|Overall Study|Lost to Follow-up|28|||
161998018|NCT01855412|585043910|FG001|Overall Study|Lost to Follow-up|46|||
161998019|NCT01855412|585043911|FG002|Overall Study|Lost to Follow-up|15|||
161998020|NCT01855412|585043909|FG000|Overall Study|Withdrawal by Subject|77|||
161998021|NCT01855412|585043910|FG001|Overall Study|Withdrawal by Subject|123|||
161998022|NCT01855412|585043911|FG002|Overall Study|Withdrawal by Subject|24|||
161998023|NCT01855412|585043909|FG000|Overall Study|Physician Decision|25|||
161998024|NCT01855412|585043910|FG001|Overall Study|Physician Decision|31|||
161998025|NCT01855412|585043911|FG002|Overall Study|Physician Decision|3|||
161998026|NCT01855412|585043909|FG000|Overall Study|Site Closure|4|||
161998027|NCT01855412|585043910|FG001|Overall Study|Site Closure|18|||
161998028|NCT01855412|585043911|FG002|Overall Study|Site Closure|1|||
161998029|NCT01855412|585043909|FG000|Overall Study|Reason not Specified|1|||
161998030|NCT01855412|585043910|FG001|Overall Study|Reason not Specified|2|||
161998031|NCT01855412|585043911|FG002|Overall Study|Reason not Specified|3|||
161998032|NCT03347123|585043912|FG000|Overall Study|Death|1|||
161998033|NCT03347123|585043913|FG001|Overall Study|Death|2|||
161998034|NCT03347123|585043914|FG002|Overall Study|Death|0|||
161998035|NCT03347123|585043915|FG003|Overall Study|Death|0|||
161998036|NCT03347123|585043916|FG004|Overall Study|Death|0|||
161998037|NCT03347123|585043917|FG005|Overall Study|Death|0|||
161998038|NCT03347123|585043918|FG006|Overall Study|Death|0|||
161998039|NCT03347123|585043912|FG000|Overall Study|Withdrawal by Subject|1|||
161998040|NCT03347123|585043913|FG001|Overall Study|Withdrawal by Subject|0|||
161998041|NCT03347123|585043914|FG002|Overall Study|Withdrawal by Subject|0|||
161998042|NCT03347123|585043915|FG003|Overall Study|Withdrawal by Subject|0|||
161998043|NCT03347123|585043916|FG004|Overall Study|Withdrawal by Subject|0|||
161998044|NCT03347123|585043917|FG005|Overall Study|Withdrawal by Subject|0|||
161998045|NCT03347123|585043918|FG006|Overall Study|Withdrawal by Subject|0|||
161998046|NCT03347123|585043912|FG000|Overall Study|Reason not Specified|3|||
161998047|NCT03347123|585043913|FG001|Overall Study|Reason not Specified|4|||
161998048|NCT03347123|585043914|FG002|Overall Study|Reason not Specified|0|||
161998049|NCT03347123|585043915|FG003|Overall Study|Reason not Specified|0|||
161998050|NCT03347123|585043916|FG004|Overall Study|Reason not Specified|0|||
161998051|NCT03347123|585043917|FG005|Overall Study|Reason not Specified|0|||
161998052|NCT03347123|585043918|FG006|Overall Study|Reason not Specified|0|||
161998053|NCT00346216|585043925|FG000|Overall Study|Other|181|||
161998054|NCT00346216|585043926|FG001|Overall Study|Other|231|||
161998055|NCT00346216|585043927|FG002|Overall Study|Other|205|||
161998056|NCT00346216|585043925|FG000|Overall Study|No longer willing to participate|600|||
161998057|NCT00346216|585043926|FG001|Overall Study|No longer willing to participate|606|||
161998058|NCT00346216|585043927|FG002|Overall Study|No longer willing to participate|585|||
161998059|NCT00346216|585043925|FG000|Overall Study|Withdrawal by Subject|661|||
161998060|NCT00346216|585043926|FG001|Overall Study|Withdrawal by Subject|692|||
161998061|NCT00346216|585043927|FG002|Overall Study|Withdrawal by Subject|651|||
161998062|NCT00346216|585043925|FG000|Overall Study|Lost to Follow-up|611|||
162040524|NCT03635788|585205734|FG000|Step 1|Protocol Violation|8|||
162040525|NCT03635788|585205735|FG001|Step 1|Protocol Violation|0|||
162040526|NCT03635788|585205736|FG002|Step 1|Protocol Violation|0|||
162040527|NCT03635788|585205734|FG000|Step 1|Withdrawal by Subject|13|||
162040528|NCT03635788|585205735|FG001|Step 1|Withdrawal by Subject|0|||
162040529|NCT03635788|585205736|FG002|Step 1|Withdrawal by Subject|0|||
162040530|NCT03635788|585205734|FG000|Step 1|Other reasons|12|||
162040531|NCT03635788|585205735|FG001|Step 1|Other reasons|0|||
162040532|NCT03635788|585205736|FG002|Step 1|Other reasons|0|||
162040533|NCT03635788|585205734|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
162040534|NCT03635788|585205735|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
162040535|NCT03635788|585205736|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
162040536|NCT03635788|585205734|FG000|Step 2|Lost to Follow-up|0|||
162040537|NCT03635788|585205735|FG001|Step 2|Lost to Follow-up|8|||
162040538|NCT03635788|585205736|FG002|Step 2|Lost to Follow-up|15|||
162040539|NCT03635788|585205734|FG000|Step 2|Withdrawal by Subject|0|||
162040540|NCT03635788|585205735|FG001|Step 2|Withdrawal by Subject|6|||
162040541|NCT03635788|585205736|FG002|Step 2|Withdrawal by Subject|6|||
162040542|NCT03635788|585205734|FG000|Step 2|Death|0|||
162040543|NCT03635788|585205735|FG001|Step 2|Death|2|||
162040544|NCT03635788|585205736|FG002|Step 2|Death|0|||
162040545|NCT03635788|585205734|FG000|Step 2|Incarceration|0|||
162040546|NCT03635788|585205735|FG001|Step 2|Incarceration|2|||
162040547|NCT03635788|585205736|FG002|Step 2|Incarceration|0|||
162040548|NCT03635788|585205734|FG000|Step 2|Non-Compliance With Study Requirements|0|||
162040549|NCT03635788|585205735|FG001|Step 2|Non-Compliance With Study Requirements|1|||
162040550|NCT03635788|585205736|FG002|Step 2|Non-Compliance With Study Requirements|1|||
162040551|NCT03635788|585205734|FG000|Step 2|Confounding Medical Condition|0|||
162040552|NCT03635788|585205735|FG001|Step 2|Confounding Medical Condition|0|||
162040553|NCT03635788|585205736|FG002|Step 2|Confounding Medical Condition|1|||
161998063|NCT00346216|585043926|FG001|Overall Study|Lost to Follow-up|588|||
161998064|NCT00346216|585043927|FG002|Overall Study|Lost to Follow-up|542|||
161998065|NCT00346216|585043925|FG000|Overall Study|Physician Decision|80|||
161998066|NCT00346216|585043926|FG001|Overall Study|Physician Decision|76|||
161998067|NCT00346216|585043927|FG002|Overall Study|Physician Decision|59|||
161998068|NCT00346216|585043925|FG000|Overall Study|Does not meet entrance criteria|13|||
161998069|NCT00346216|585043926|FG001|Overall Study|Does not meet entrance criteria|10|||
161998070|NCT00346216|585043927|FG002|Overall Study|Does not meet entrance criteria|8|||
161998071|NCT00346216|585043925|FG000|Overall Study|Death|189|||
161998072|NCT00346216|585043926|FG001|Overall Study|Death|192|||
161998073|NCT00346216|585043927|FG002|Overall Study|Death|228|||
161998074|NCT00346216|585043925|FG000|Overall Study|Study terminated by sponsor|11|||
161998075|NCT00346216|585043926|FG001|Overall Study|Study terminated by sponsor|4|||
161998076|NCT00346216|585043927|FG002|Overall Study|Study terminated by sponsor|8|||
161998077|NCT00346216|585043925|FG000|Overall Study|Missing Subject Summary Status|62|||
161998078|NCT00346216|585043926|FG001|Overall Study|Missing Subject Summary Status|61|||
161998079|NCT00346216|585043927|FG002|Overall Study|Missing Subject Summary Status|62|||
161998080|NCT05030350|585043931|FG000|Overall Study|Adverse Event|13|||
161998081|NCT05030350|585043931|FG000|Overall Study|Lack of Efficacy|8|||
161998082|NCT05030350|585043931|FG000|Overall Study|Lost to Follow-up|35|||
161998083|NCT05030350|585043931|FG000|Overall Study|Pregnancy|2|||
161998084|NCT05030350|585043931|FG000|Overall Study|Protocol Violation|2|||
161998085|NCT05030350|585043931|FG000|Overall Study|Withdrawal by Subject|60|||
161998086|NCT05030350|585043931|FG000|Overall Study|Study terminated by sponsor|349|||
161998087|NCT05030350|585043931|FG000|Overall Study|Positive Drug Screen|4|||
161998088|NCT05030350|585043931|FG000|Overall Study|Other|8|||
161998089|NCT03985761|585043935|FG000|Overall Study|Withdrawal by Subject|2|||
161998090|NCT03985761|585043936|FG001|Overall Study|Withdrawal by Subject|3|||
161998091|NCT01858363|585043942|FG000|Overall Study|Death|35|||
161998092|NCT01858363|585043943|FG001|Overall Study|Death|9|||
161998093|NCT01858363|585043942|FG000|Overall Study|Withdrawal by Subject|28|||
161998094|NCT01858363|585043943|FG001|Overall Study|Withdrawal by Subject|14|||
161998095|NCT01858363|585043942|FG000|Overall Study|Lost to Follow-up|13|||
161998096|NCT01858363|585043943|FG001|Overall Study|Lost to Follow-up|3|||
161998097|NCT01859923|585043949|FG000|Overall Study|Adverse Event|0|||
161998098|NCT01859923|585043950|FG001|Overall Study|Adverse Event|0|||
161998099|NCT01859923|585043951|FG002|Overall Study|Adverse Event|1|||
161998100|NCT01859923|585043952|FG003|Overall Study|Adverse Event|1|||
161998101|NCT00764361|585043958|FG000|Overall Study|Withdrawal by Subject|2|||
161998102|NCT00764361|585043959|FG001|Overall Study|Withdrawal by Subject|3|||
161998103|NCT00764361|585043958|FG000|Overall Study|Adverse Event|0|||
161998104|NCT00764361|585043959|FG001|Overall Study|Adverse Event|1|||
161998105|NCT02090426|585043960|FG000|Overall Study|Lost to Follow-up|12|||
161998106|NCT02090426|585043961|FG001|Overall Study|Lost to Follow-up|6|||
161998107|NCT01012258|585043965|FG000|Overall Study|Death|14|||
161998108|NCT01012258|585043965|FG000|Overall Study|Lost to Follow-up|1|||
161998109|NCT01012258|585043965|FG000|Overall Study|Adverse Event|1|||
161998110|NCT01012258|585043965|FG000|Overall Study|Progressive Disease (PD)|18|||
161998111|NCT01012258|585043965|FG000|Overall Study|Symptomatic Deterioration|1|||
162040554|NCT03635788|585205734|FG000|Step 2|Out Of State With No Plan To Return|0|||
162040555|NCT03635788|585205735|FG001|Step 2|Out Of State With No Plan To Return|1|||
162040556|NCT03635788|585205736|FG002|Step 2|Out Of State With No Plan To Return|0|||
162040557|NCT03635788|585205734|FG000|Step 2|Switched To Injectables|0|||
162040558|NCT03635788|585205735|FG001|Step 2|Switched To Injectables|0|||
162040559|NCT03635788|585205736|FG002|Step 2|Switched To Injectables|1|||
162040560|NCT03635788|585205734|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
162040561|NCT03635788|585205735|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
162040562|NCT03635788|585205736|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
162040563|NCT04571515|585205740|FG000|Overall Study|Physician Decision|0|||
162040564|NCT04571515|585205741|FG001|Overall Study|Physician Decision|0|||
162040565|NCT04571515|585205742|FG002|Overall Study|Physician Decision|0|||
162040566|NCT04571515|585205743|FG003|Overall Study|Physician Decision|0|||
162040567|NCT04571515|585205744|FG004|Overall Study|Physician Decision|1|||
162040568|NCT04571515|585205740|FG000|Overall Study|Withdrawal by Subject|0|||
162040569|NCT04571515|585205741|FG001|Overall Study|Withdrawal by Subject|0|||
162040570|NCT04571515|585205742|FG002|Overall Study|Withdrawal by Subject|0|||
162040571|NCT04571515|585205743|FG003|Overall Study|Withdrawal by Subject|0|||
162040572|NCT04571515|585205744|FG004|Overall Study|Withdrawal by Subject|1|||
162040573|NCT04571515|585205740|FG000|Overall Study|insufficient pain|1|||
162040574|NCT04571515|585205741|FG001|Overall Study|insufficient pain|0|||
162040575|NCT04571515|585205742|FG002|Overall Study|insufficient pain|0|||
162040576|NCT04571515|585205743|FG003|Overall Study|insufficient pain|0|||
162040577|NCT04571515|585205744|FG004|Overall Study|insufficient pain|1|||
162040578|NCT05098938|585205753|FG000|Overall Study|Adverse Event|4|||
162040579|NCT05098938|585205754|FG001|Overall Study|Adverse Event|3|||
162040580|NCT05098938|585205753|FG000|Overall Study|inclusion/exclusion criteria change|11|||
162040581|NCT05098938|585205754|FG001|Overall Study|inclusion/exclusion criteria change|5|||
162040582|NCT05098938|585205753|FG000|Overall Study|lack of compliance|26|||
161998112|NCT01012258|585043965|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
161998113|NCT01012258|585043965|FG000|Overall Study|Another Tumor Discovered|1|||
161998114|NCT01012258|585043965|FG000|Overall Study|Ongoing|29|||
161998115|NCT01814527|585043966|FG000|Overall Study|RTP greater than 30 days|6|||
161998116|NCT01814527|585043967|FG001|Overall Study|RTP greater than 30 days|1|||
161998117|NCT00687401|585043968|FG000|Overall Study|Protocol Violation|7|||
161998118|NCT00687401|585043968|FG000|Overall Study|Adverse Event|6|||
161998119|NCT00687401|585043968|FG000|Overall Study|Lack of Efficacy|6|||
161998120|NCT00687401|585043968|FG000|Overall Study|Withdrawal by Subject|4|||
161998121|NCT00687401|585043968|FG000|Overall Study|Did not return for visit|3|||
161998122|NCT00687401|585043968|FG000|Overall Study|For reasons different from those above|4|||
161998123|NCT02366195|585043969|FG000|Overall Study|Protocol-specified criteria|3|||
161998124|NCT02366195|585043969|FG000|Overall Study|Withdrawal by Subject|9|||
161998125|NCT02366195|585043969|FG000|Overall Study|Lost to Follow-up|1|||
161998126|NCT02366195|585043969|FG000|Overall Study|Death|41|||
161998127|NCT00113841|585043970|FG000|Overall Study|Disease progression|0|||
161998128|NCT00113841|585043971|FG001|Overall Study|Disease progression|2|||
161998129|NCT00113841|585043970|FG000|Overall Study|Non-compliant|1|||
161998130|NCT00113841|585043971|FG001|Overall Study|Non-compliant|0|||
161998131|NCT02520726|585043972|FG000|Overall Study|Lost to Follow-up|3|||
161998132|NCT02520726|585043973|FG001|Overall Study|Lost to Follow-up|2|||
161998133|NCT00721396|585043974|FG000|Overall Study|Adverse Event|4|||
161998134|NCT00721396|585043975|FG001|Overall Study|Adverse Event|7|||
161998135|NCT00721396|585043976|FG002|Overall Study|Adverse Event|2|||
161998136|NCT00721396|585043977|FG003|Overall Study|Adverse Event|0|||
161998137|NCT00721396|585043974|FG000|Overall Study|Withdrawal by Subject|12|||
161998138|NCT00721396|585043975|FG001|Overall Study|Withdrawal by Subject|15|||
161998139|NCT00721396|585043976|FG002|Overall Study|Withdrawal by Subject|3|||
161998140|NCT00721396|585043977|FG003|Overall Study|Withdrawal by Subject|7|||
161998141|NCT00721396|585043974|FG000|Overall Study|Lost to Follow-up|7|||
161998142|NCT00721396|585043975|FG001|Overall Study|Lost to Follow-up|9|||
161998143|NCT00721396|585043976|FG002|Overall Study|Lost to Follow-up|3|||
161998144|NCT00721396|585043977|FG003|Overall Study|Lost to Follow-up|3|||
161998145|NCT00721396|585043974|FG000|Overall Study|Protocol Violation|4|||
161998146|NCT00721396|585043975|FG001|Overall Study|Protocol Violation|3|||
161998147|NCT00721396|585043976|FG002|Overall Study|Protocol Violation|1|||
161998148|NCT00721396|585043977|FG003|Overall Study|Protocol Violation|0|||
161998149|NCT00721396|585043974|FG000|Overall Study|Inappropriate enrollment|0|||
161998150|NCT00721396|585043975|FG001|Overall Study|Inappropriate enrollment|2|||
161998151|NCT00721396|585043976|FG002|Overall Study|Inappropriate enrollment|0|||
161998152|NCT00721396|585043977|FG003|Overall Study|Inappropriate enrollment|0|||
161998153|NCT00721396|585043974|FG000|Overall Study|Administrative reason|3|||
161998154|NCT00721396|585043975|FG001|Overall Study|Administrative reason|0|||
161998155|NCT00721396|585043976|FG002|Overall Study|Administrative reason|1|||
161998156|NCT00721396|585043977|FG003|Overall Study|Administrative reason|0|||
161998157|NCT00148759|585043978|FG000|Overall Study|Withdrawal by Subject|1|||
161998158|NCT00148759|585043979|FG001|Overall Study|Withdrawal by Subject|1|||
162040583|NCT05098938|585205754|FG001|Overall Study|lack of compliance|19|||
162040584|NCT05098938|585205753|FG000|Overall Study|Lost to Follow-up|37|||
162040585|NCT05098938|585205754|FG001|Overall Study|Lost to Follow-up|40|||
162040586|NCT05098938|585205753|FG000|Overall Study|Lost in treatment period|17|||
162040587|NCT05098938|585205754|FG001|Overall Study|Lost in treatment period|13|||
162040588|NCT05098938|585205753|FG000|Overall Study|Met an exclusion criterion|0|||
162040589|NCT05098938|585205754|FG001|Overall Study|Met an exclusion criterion|3|||
162040590|NCT05098938|585205753|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
162040591|NCT05098938|585205754|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
162040592|NCT05098938|585205753|FG000|Overall Study|Physician Decision|25|||
162040593|NCT05098938|585205754|FG001|Overall Study|Physician Decision|32|||
162040594|NCT05098938|585205753|FG000|Overall Study|Run in failure in treatment phase|1|||
162040595|NCT05098938|585205754|FG001|Overall Study|Run in failure in treatment phase|1|||
162040596|NCT05098938|585205753|FG000|Overall Study|Withdrawal by Subject|0|||
162040597|NCT05098938|585205754|FG001|Overall Study|Withdrawal by Subject|3|||
162040598|NCT05098938|585205753|FG000|Overall Study|Run-in Failure in early study|505|||
162040599|NCT05098938|585205754|FG001|Overall Study|Run-in Failure in early study|514|||
162040600|NCT05098938|585205753|FG000|Overall Study|IMP delivery missed|1|||
162040601|NCT05098938|585205754|FG001|Overall Study|IMP delivery missed|5|||
162040602|NCT05098938|585205753|FG000|Overall Study|6 months visit was missed|2|||
162040603|NCT05098938|585205754|FG001|Overall Study|6 months visit was missed|0|||
162040604|NCT05098938|585205753|FG000|Overall Study|fit for use was not completed within window|3|||
162040605|NCT05098938|585205754|FG001|Overall Study|fit for use was not completed within window|0|||
162040606|NCT05098938|585205753|FG000|Overall Study|V2 visit was not completed within window|0|||
162040607|NCT05098938|585205754|FG001|Overall Study|V2 visit was not completed within window|1|||
162040608|NCT05098938|585205753|FG000|Overall Study|exclusionary medication use|1|||
162040609|NCT05098938|585205754|FG001|Overall Study|exclusionary medication use|2|||
162040610|NCT05098938|585205753|FG000|Overall Study|change in medication|1|||
162040611|NCT05098938|585205754|FG001|Overall Study|change in medication|0|||
162040612|NCT05098938|585205753|FG000|Overall Study|treatment failure|2|||
162040613|NCT05098938|585205754|FG001|Overall Study|treatment failure|1|||
162040614|NCT01828320|585205756|FG000|Overall Study|Lost to Follow-up|1|||
162040615|NCT01828320|585205757|FG001|Overall Study|Lost to Follow-up|3|||
162040616|NCT01828320|585205756|FG000|Overall Study|Withdrawal by Subject|7|||
162040617|NCT01828320|585205757|FG001|Overall Study|Withdrawal by Subject|2|||
162040618|NCT02570074|585207652|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
162040619|NCT02570074|585207653|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
162040620|NCT01859143|585207655|FG000|Overall Study|Lost to Follow-up|2|||
162040621|NCT01859143|585207656|FG001|Overall Study|Lost to Follow-up|0|||
162040622|NCT00760214|585207657|FG000|Overall Study|Adverse Event|8|||
162040623|NCT00760214|585207658|FG001|Overall Study|Adverse Event|9|||
162040624|NCT00760214|585207659|FG002|Overall Study|Adverse Event|12|||
162040625|NCT00760214|585207657|FG000|Overall Study|Protocol Violation|3|||
162040626|NCT00760214|585207658|FG001|Overall Study|Protocol Violation|0|||
162040627|NCT00760214|585207659|FG002|Overall Study|Protocol Violation|3|||
162040628|NCT00760214|585207657|FG000|Overall Study|Lost to Follow-up|0|||
162040629|NCT00760214|585207658|FG001|Overall Study|Lost to Follow-up|0|||
162040630|NCT00760214|585207659|FG002|Overall Study|Lost to Follow-up|1|||
162040631|NCT00760214|585207657|FG000|Overall Study|Withdrawal by Subject|12|||
162040632|NCT00760214|585207658|FG001|Overall Study|Withdrawal by Subject|14|||
162040633|NCT00760214|585207659|FG002|Overall Study|Withdrawal by Subject|13|||
161998159|NCT00148759|585043978|FG000|Overall Study|Lost to Follow-up|1|||
161998160|NCT00148759|585043979|FG001|Overall Study|Lost to Follow-up|0|||
161998161|NCT00430716|585043981|FG000|Double Blind Phase|Death|1|||
161998162|NCT00430716|585043982|FG001|Double Blind Phase|Death|0|||
161998163|NCT00430716|585043983|FG002|Double Blind Phase|Death|0|||
161998164|NCT00430716|585043981|FG000|Double Blind Phase|No longer willing to participate|2|||
161998165|NCT00430716|585043982|FG001|Double Blind Phase|No longer willing to participate|1|||
161998166|NCT00430716|585043983|FG002|Double Blind Phase|No longer willing to participate|1|||
161998167|NCT00430716|585043981|FG000|Double Blind Phase|Other|0|||
161998168|NCT00430716|585043982|FG001|Double Blind Phase|Other|2|||
161998169|NCT00430716|585043983|FG002|Double Blind Phase|Other|0|||
161998170|NCT00430716|585043981|FG000|Double Blind Phase|Study terminated by sponsor|1|||
161998171|NCT00430716|585043982|FG001|Double Blind Phase|Study terminated by sponsor|1|||
161998172|NCT00430716|585043983|FG002|Double Blind Phase|Study terminated by sponsor|2|||
161998173|NCT00430716|585043981|FG000|Double Blind Phase|Adverse Event|1|||
161998174|NCT00430716|585043982|FG001|Double Blind Phase|Adverse Event|1|||
161998175|NCT00430716|585043983|FG002|Double Blind Phase|Adverse Event|3|||
161998176|NCT00430716|585043981|FG000|Double Blind Phase|Not treated|1|||
161998177|NCT00430716|585043982|FG001|Double Blind Phase|Not treated|0|||
161998178|NCT00430716|585043983|FG002|Double Blind Phase|Not treated|0|||
162040634|NCT00760214|585207657|FG000|Overall Study|Lack of Efficacy|3|||
162040635|NCT00760214|585207658|FG001|Overall Study|Lack of Efficacy|2|||
162040636|NCT00760214|585207659|FG002|Overall Study|Lack of Efficacy|4|||
162040637|NCT00760214|585207657|FG000|Overall Study|Pregnancy|0|||
162040638|NCT00760214|585207658|FG001|Overall Study|Pregnancy|0|||
161998179|NCT00430716|585043981|FG000|Open Label Phase|Lost to Follow-up|1|||
162040639|NCT00760214|585207659|FG002|Overall Study|Pregnancy|1|||
162040640|NCT00760214|585207657|FG000|Overall Study|Physician Decision|1|||
162040641|NCT00760214|585207658|FG001|Overall Study|Physician Decision|1|||
162040642|NCT00760214|585207659|FG002|Overall Study|Physician Decision|1|||
162040643|NCT00760214|585207657|FG000|Overall Study|Other|3|||
162040644|NCT00760214|585207658|FG001|Overall Study|Other|4|||
162040645|NCT00760214|585207659|FG002|Overall Study|Other|6|||
162040646|NCT00700570|585207660|FG000|Overall Study|Adverse Event|2|||
162040647|NCT00700570|585207661|FG001|Overall Study|Adverse Event|6|||
162040648|NCT00700570|585207660|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
162040649|NCT00700570|585207661|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
162040650|NCT00700570|585207660|FG000|Overall Study|Disease Progression|8|||
162040651|NCT00700570|585207661|FG001|Overall Study|Disease Progression|11|||
162040652|NCT00700570|585207660|FG000|Overall Study|Withdrawal by Subject|1|||
162040653|NCT00700570|585207661|FG001|Overall Study|Withdrawal by Subject|6|||
162040654|NCT01134315|585207662|FG000|Overall Study|Adverse Event|1|||
162040655|NCT01134315|585207663|FG001|Overall Study|Adverse Event|2|||
162040656|NCT01134315|585207662|FG000|Overall Study|Other Reason|8|||
162040657|NCT01134315|585207663|FG001|Overall Study|Other Reason|17|||
162040658|NCT04587271|585207666|FG000|Overall Study|Lost to Follow-up|2|||
162040659|NCT04587271|585207667|FG001|Overall Study|Lost to Follow-up|2|||
162040660|NCT04587271|585207668|FG002|Overall Study|Lost to Follow-up|0|||
162040661|NCT04587271|585207669|FG003|Overall Study|Lost to Follow-up|2|||
162040662|NCT04587271|585207670|FG004|Overall Study|Lost to Follow-up|2|||
162040663|NCT04587271|585207671|FG005|Overall Study|Lost to Follow-up|0|||
162040664|NCT04587271|585207666|FG000|Overall Study|Caregiver brought child to visits|0|||
162040665|NCT04587271|585207667|FG001|Overall Study|Caregiver brought child to visits|0|||
162040666|NCT04587271|585207668|FG002|Overall Study|Caregiver brought child to visits|0|||
162040667|NCT04587271|585207669|FG003|Overall Study|Caregiver brought child to visits|1|||
162040668|NCT04587271|585207670|FG004|Overall Study|Caregiver brought child to visits|0|||
162040669|NCT04587271|585207671|FG005|Overall Study|Caregiver brought child to visits|0|||
162040670|NCT02360111|585207672|FG000|Overall Study|Death|2|||
162040671|NCT00611533|585207673|FG000|First Intervention (6 Weeks)|Never started study|0|||
162040672|NCT00611533|585207674|FG001|First Intervention (6 Weeks)|Never started study|1|||
162040673|NCT00611533|585207673|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
162040674|NCT00611533|585207674|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
162040675|NCT00611533|585207673|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
162040676|NCT00611533|585207674|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
162040677|NCT01933217|585207675|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
162040678|NCT01933217|585207676|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
162040679|NCT01933217|585207675|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
162040680|NCT01933217|585207676|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
162040681|NCT02180165|585207677|FG000|Overall Study|Not Treated|0|||
162040682|NCT02180165|585207678|FG001|Overall Study|Not Treated|0|||
162040683|NCT02180165|585207679|FG002|Overall Study|Not Treated|1|||
162040684|NCT02180165|585207680|FG003|Overall Study|Not Treated|0|||
162040685|NCT02180165|585207677|FG000|Overall Study|Adverse Event|7|||
162040686|NCT02180165|585207678|FG001|Overall Study|Adverse Event|0|||
162040687|NCT02180165|585207679|FG002|Overall Study|Adverse Event|18|||
162040688|NCT02180165|585207680|FG003|Overall Study|Adverse Event|3|||
162040689|NCT02180165|585207677|FG000|Overall Study|Lack of Efficacy|0|||
162040690|NCT02180165|585207678|FG001|Overall Study|Lack of Efficacy|1|||
162040691|NCT02180165|585207679|FG002|Overall Study|Lack of Efficacy|3|||
162040692|NCT02180165|585207680|FG003|Overall Study|Lack of Efficacy|2|||
162040693|NCT02180165|585207677|FG000|Overall Study|Physician Decision|1|||
162040694|NCT02180165|585207678|FG001|Overall Study|Physician Decision|0|||
162040695|NCT02180165|585207679|FG002|Overall Study|Physician Decision|5|||
162040696|NCT02180165|585207680|FG003|Overall Study|Physician Decision|0|||
162040697|NCT02180165|585207677|FG000|Overall Study|Withdrawal by Subject|3|||
161998180|NCT00430716|585043982|FG001|Open Label Phase|Lost to Follow-up|0|||
161998181|NCT00430716|585043983|FG002|Open Label Phase|Lost to Follow-up|1|||
161998182|NCT00430716|585043981|FG000|Open Label Phase|No longer willing to participate|0|||
161998183|NCT00430716|585043982|FG001|Open Label Phase|No longer willing to participate|1|||
161998184|NCT00430716|585043983|FG002|Open Label Phase|No longer willing to participate|1|||
161998185|NCT00430716|585043981|FG000|Open Label Phase|Other|3|||
161998186|NCT00430716|585043982|FG001|Open Label Phase|Other|1|||
161998187|NCT00430716|585043983|FG002|Open Label Phase|Other|1|||
161998188|NCT00430716|585043981|FG000|Open Label Phase|Protocol Violation|1|||
161998189|NCT00430716|585043982|FG001|Open Label Phase|Protocol Violation|0|||
162040698|NCT02180165|585207678|FG001|Overall Study|Withdrawal by Subject|0|||
162040699|NCT02180165|585207679|FG002|Overall Study|Withdrawal by Subject|2|||
162040700|NCT02180165|585207680|FG003|Overall Study|Withdrawal by Subject|1|||
161998190|NCT00430716|585043983|FG002|Open Label Phase|Protocol Violation|0|||
162040701|NCT03923738|585207684|FG000|Period 1|Adverse Event|1|||
162040702|NCT03923738|585207684|FG000|Period 1|Withdrawal by Subject|1|||
162040703|NCT05246397|585207685|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
162040704|NCT03875768|585207687|FG000|Overall Study|Lost to Follow-up|16|||
161998191|NCT00430716|585043981|FG000|Open Label Phase|Study terminated by sponsor|4|||
161998192|NCT00430716|585043982|FG001|Open Label Phase|Study terminated by sponsor|5|||
161998193|NCT00430716|585043983|FG002|Open Label Phase|Study terminated by sponsor|4|||
161998194|NCT03948334|585043986|FG000|Overall Study|Adverse Event|1|||
161998195|NCT03948334|585043987|FG001|Overall Study|Adverse Event|4|||
161998196|NCT03948334|585043986|FG000|Overall Study|Lack of Efficacy|2|||
161998197|NCT03948334|585043987|FG001|Overall Study|Lack of Efficacy|0|||
161998198|NCT03948334|585043986|FG000|Overall Study|Lost to Follow-up|1|||
161998199|NCT03948334|585043987|FG001|Overall Study|Lost to Follow-up|0|||
161998200|NCT03948334|585043986|FG000|Overall Study|Physician Decision|1|||
161998201|NCT03948334|585043987|FG001|Overall Study|Physician Decision|0|||
161998202|NCT03948334|585043986|FG000|Overall Study|Pregnancy|0|||
161998203|NCT03948334|585043987|FG001|Overall Study|Pregnancy|1|||
161998204|NCT03948334|585043986|FG000|Overall Study|Protocol Deviation|1|||
161998205|NCT03948334|585043987|FG001|Overall Study|Protocol Deviation|0|||
161998206|NCT03948334|585043986|FG000|Overall Study|Study terminated by Sponsor|50|||
161998207|NCT03948334|585043987|FG001|Overall Study|Study terminated by Sponsor|51|||
161998208|NCT03948334|585043986|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
161998209|NCT03948334|585043987|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
161998210|NCT05114473|585043988|FG000|Overall Study|Lost to Follow-up|2|||
161998211|NCT05114473|585043989|FG001|Overall Study|Lost to Follow-up|2|||
161998212|NCT05114473|585043990|FG002|Overall Study|Lost to Follow-up|0|||
161998213|NCT00154297|585043994|FG000|Overall Study|Death|5|||
161998214|NCT00154297|585043995|FG001|Overall Study|Death|2|||
161998215|NCT00154297|585043994|FG000|Overall Study|Withdrawal by Subject|0|||
161998216|NCT00154297|585043995|FG001|Overall Study|Withdrawal by Subject|5|||
161998217|NCT00154297|585043994|FG000|Overall Study|Lost to Follow-up|3|||
161998218|NCT00154297|585043995|FG001|Overall Study|Lost to Follow-up|0|||
161998219|NCT04332107|585043996|FG000|Day 3|Lost to Follow-up|23|||
161998220|NCT04332107|585043997|FG001|Day 3|Lost to Follow-up|14|||
161998221|NCT04332107|585043996|FG000|Day 3|Missing outcome data|3|||
161998222|NCT04332107|585043997|FG001|Day 3|Missing outcome data|6|||
161998223|NCT04332107|585043996|FG000|Day 14|Lost to Follow-up|13|||
161998224|NCT04332107|585043997|FG001|Day 14|Lost to Follow-up|4|||
161998225|NCT04332107|585043996|FG000|Day 14|Missing outcome data|4|||
161998226|NCT04332107|585043997|FG001|Day 14|Missing outcome data|4|||
161998227|NCT04332107|585043996|FG000|Day 21|Lost to Follow-up|10|||
161998228|NCT04332107|585043997|FG001|Day 21|Lost to Follow-up|2|||
161998229|NCT03116685|585044000|FG000|Overall Study|Physician Decision|0|||
161998230|NCT03116685|585044001|FG001|Overall Study|Physician Decision|1|||
161998231|NCT04177212|585044006|FG000|Overall Study|Withdrawal by Subject|9|||
161998232|NCT04177212|585044007|FG001|Overall Study|Withdrawal by Subject|7|||
161998233|NCT04177212|585044006|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
161998234|NCT04177212|585044007|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
161998235|NCT04177212|585044006|FG000|Overall Study|Physician Decision|1|||
161998236|NCT04177212|585044007|FG001|Overall Study|Physician Decision|0|||
161998237|NCT04177212|585044006|FG000|Overall Study|Lost to Follow-up|0|||
161998238|NCT04177212|585044007|FG001|Overall Study|Lost to Follow-up|3|||
161998239|NCT04177212|585044006|FG000|Overall Study|Adverse Event|0|||
161998240|NCT04177212|585044007|FG001|Overall Study|Adverse Event|1|||
161998241|NCT04177212|585044006|FG000|Overall Study|Other|1|||
161998242|NCT04177212|585044007|FG001|Overall Study|Other|2|||
161998243|NCT01792115|585044008|FG000|Overall Study|Lost to Follow-up|0|||
161998244|NCT01792115|585044009|FG001|Overall Study|Lost to Follow-up|1|||
161998245|NCT01792115|585044010|FG002|Overall Study|Lost to Follow-up|0|||
161998246|NCT01279681|585044011|FG000|Overall Study|Disease Progression|9|||
161998247|NCT01279681|585044012|FG001|Overall Study|Disease Progression|6|||
161998248|NCT01279681|585044011|FG000|Overall Study|Withdrawal by Subject|3|||
161998249|NCT01279681|585044012|FG001|Overall Study|Withdrawal by Subject|4|||
161998250|NCT01279681|585044011|FG000|Overall Study|Adverse Event|2|||
161998251|NCT01279681|585044012|FG001|Overall Study|Adverse Event|3|||
161998252|NCT01279681|585044011|FG000|Overall Study|Death|0|||
161998253|NCT01279681|585044012|FG001|Overall Study|Death|1|||
161998254|NCT01279681|585044011|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
161998255|NCT01279681|585044012|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
161998256|NCT01279681|585044011|FG000|Overall Study|Physician Decision|1|||
161998257|NCT01279681|585044012|FG001|Overall Study|Physician Decision|0|||
161998258|NCT01279681|585044011|FG000|Overall Study|Other Reason|0|||
161998259|NCT01279681|585044012|FG001|Overall Study|Other Reason|2|||
161998260|NCT01943591|585044013|FG000|Overall Study|Lost to Follow-up|3|||
161998261|NCT01943591|585044014|FG001|Overall Study|Lost to Follow-up|4|||
161998262|NCT01943591|585044013|FG000|Overall Study|Death|2|||
161998263|NCT01943591|585044014|FG001|Overall Study|Death|7|||
161998264|NCT01790594|585045198|FG000|Overall Study|Death|1|||
161998265|NCT01790594|585045199|FG001|Overall Study|Death|0|||
161998266|NCT01790594|585045200|FG002|Overall Study|Death|0|||
161998267|NCT01790594|585045198|FG000|Overall Study|Physician Decision|2|||
161998268|NCT01790594|585045199|FG001|Overall Study|Physician Decision|1|||
161998269|NCT01790594|585045200|FG002|Overall Study|Physician Decision|0|||
161998270|NCT01790594|585045198|FG000|Overall Study|Withdrawal by Subject|2|||
161998271|NCT01790594|585045199|FG001|Overall Study|Withdrawal by Subject|0|||
162040705|NCT03875768|585207688|FG001|Overall Study|Lost to Follow-up|13|||
162040706|NCT03875768|585207687|FG000|Overall Study|Withdrawal by Subject|10|||
162040707|NCT03875768|585207688|FG001|Overall Study|Withdrawal by Subject|21|||
162040708|NCT03875768|585207687|FG000|Overall Study|Did not complete assessment|21|||
162040709|NCT03875768|585207688|FG001|Overall Study|Did not complete assessment|12|||
162040710|NCT03875768|585207687|FG000|Overall Study|Became ineligible|1|||
162040711|NCT03875768|585207688|FG001|Overall Study|Became ineligible|0|||
162040712|NCT01925274|585207689|FG000|Overall Study|Death|1|||
162040713|NCT01925274|585207690|FG001|Overall Study|Death|0|||
162040714|NCT01925274|585207691|FG002|Overall Study|Death|0|||
162040715|NCT01925274|585207689|FG000|Overall Study|Lost to Follow-up|0|||
162040716|NCT01925274|585207690|FG001|Overall Study|Lost to Follow-up|1|||
162040717|NCT01925274|585207691|FG002|Overall Study|Lost to Follow-up|0|||
162040718|NCT01925274|585207689|FG000|Overall Study|Withdrawal by Subject|1|||
162040719|NCT01925274|585207690|FG001|Overall Study|Withdrawal by Subject|2|||
162040720|NCT01925274|585207691|FG002|Overall Study|Withdrawal by Subject|0|||
162040721|NCT01925274|585207689|FG000|Overall Study|Study terminated by sponsor|4|||
162040722|NCT01925274|585207690|FG001|Overall Study|Study terminated by sponsor|0|||
162040723|NCT01925274|585207691|FG002|Overall Study|Study terminated by sponsor|0|||
162040724|NCT01925274|585207689|FG000|Overall Study|Protocol amendment|1|||
162040725|NCT01925274|585207690|FG001|Overall Study|Protocol amendment|3|||
162040726|NCT01925274|585207691|FG002|Overall Study|Protocol amendment|6|||
162040727|NCT04327674|585207692|FG000|Overall Study|Protocol Violation|19|||
162040728|NCT00723398|585207697|FG000|Overall Study|Withdrawal by Subject|2|||
162040729|NCT00723398|585207698|FG001|Overall Study|Withdrawal by Subject|6|||
162040730|NCT00723398|585207699|FG002|Overall Study|Withdrawal by Subject|4|||
162040731|NCT00723398|585207700|FG003|Overall Study|Withdrawal by Subject|4|||
162040732|NCT00723398|585207701|FG004|Overall Study|Withdrawal by Subject|4|||
162040733|NCT00723398|585207697|FG000|Overall Study|Protocol Violation|2|||
162040734|NCT00723398|585207698|FG001|Overall Study|Protocol Violation|1|||
162040735|NCT00723398|585207699|FG002|Overall Study|Protocol Violation|5|||
162040736|NCT00723398|585207700|FG003|Overall Study|Protocol Violation|0|||
162040737|NCT00723398|585207701|FG004|Overall Study|Protocol Violation|0|||
162040738|NCT00723398|585207697|FG000|Overall Study|Physician Decision|2|||
162040739|NCT00723398|585207698|FG001|Overall Study|Physician Decision|2|||
162040740|NCT00723398|585207699|FG002|Overall Study|Physician Decision|5|||
162040741|NCT00723398|585207700|FG003|Overall Study|Physician Decision|0|||
162040742|NCT00723398|585207701|FG004|Overall Study|Physician Decision|1|||
162040743|NCT00723398|585207697|FG000|Overall Study|Adverse Event|0|||
162040744|NCT00723398|585207698|FG001|Overall Study|Adverse Event|5|||
162040745|NCT00723398|585207699|FG002|Overall Study|Adverse Event|3|||
162040746|NCT00723398|585207700|FG003|Overall Study|Adverse Event|1|||
162040747|NCT00723398|585207701|FG004|Overall Study|Adverse Event|4|||
162040748|NCT00723398|585207697|FG000|Overall Study|Lost to Follow-up|0|||
162040749|NCT00723398|585207698|FG001|Overall Study|Lost to Follow-up|1|||
162040750|NCT00723398|585207699|FG002|Overall Study|Lost to Follow-up|0|||
162040751|NCT00723398|585207700|FG003|Overall Study|Lost to Follow-up|0|||
162040752|NCT00723398|585207701|FG004|Overall Study|Lost to Follow-up|0|||
162040753|NCT00267189|585207702|FG000|Overall Study|Patient withdrew consent|1|||
162040754|NCT00267189|585207703|FG001|Overall Study|Patient withdrew consent|1|||
162040755|NCT00267189|585207702|FG000|Overall Study|Death|1|||
162040756|NCT00267189|585207703|FG001|Overall Study|Death|0|||
162040757|NCT00267189|585207702|FG000|Overall Study|Missing|3|||
162040758|NCT00267189|585207703|FG001|Overall Study|Missing|0|||
162040759|NCT00751621|585207704|FG000|Overall Study|Adverse Event|1|||
162040760|NCT00751621|585207704|FG000|Overall Study|Withdrawal by Subject|1|||
162040761|NCT00751621|585207704|FG000|Overall Study|Subject moved to another country|1|||
162040762|NCT00751621|585207704|FG000|Overall Study|Poor adherence to asthma treatment|1|||
162040763|NCT03719586|585207705|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
162040764|NCT03719586|585207706|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
162040765|NCT03719586|585207707|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
162040766|NCT03719586|585207708|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
162040767|NCT02791594|585207709|FG000|Overall Study|Physician Decision|2|||
162040768|NCT01400815|585207710|FG000|Overall Study|Adverse Event|3|||
162040769|NCT01400815|585207711|FG001|Overall Study|Adverse Event|0|||
162040770|NCT01400815|585207710|FG000|Overall Study|Death|0|||
162040771|NCT01400815|585207711|FG001|Overall Study|Death|1|||
162040772|NCT01400815|585207710|FG000|Overall Study|Lost to Follow-up|18|||
162040773|NCT01400815|585207711|FG001|Overall Study|Lost to Follow-up|11|||
162040774|NCT01400815|585207710|FG000|Overall Study|Protocol Violation|0|||
162040775|NCT01400815|585207711|FG001|Overall Study|Protocol Violation|1|||
162040776|NCT01400815|585207710|FG000|Overall Study|Physician Decision|1|||
162040777|NCT01400815|585207711|FG001|Overall Study|Physician Decision|0|||
162040778|NCT01400815|585207710|FG000|Overall Study|Withdrawal by Subject|15|||
162040779|NCT01400815|585207711|FG001|Overall Study|Withdrawal by Subject|8|||
162040780|NCT01400815|585207710|FG000|Overall Study|Subject in jail|1|||
162040781|NCT01400815|585207711|FG001|Overall Study|Subject in jail|0|||
161998272|NCT01790594|585045200|FG002|Overall Study|Withdrawal by Subject|0|||
161998273|NCT01790594|585045198|FG000|Overall Study|Transplant was not done|0|||
161998274|NCT01790594|585045199|FG001|Overall Study|Transplant was not done|0|||
161998275|NCT01790594|585045200|FG002|Overall Study|Transplant was not done|3|||
161998276|NCT01790594|585045198|FG000|Overall Study|Terminated prior to week 76|0|||
161998277|NCT01790594|585045199|FG001|Overall Study|Terminated prior to week 76|2|||
161998278|NCT01790594|585045200|FG002|Overall Study|Terminated prior to week 76|0|||
161998279|NCT03431441|585045201|FG000|Overall Study|Withdrawal by Subject|2|||
161998280|NCT03431441|585045201|FG000|Overall Study|Adverse Event|2|||
161998281|NCT03431441|585045201|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
161998282|NCT01794000|585045206|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
161998283|NCT01794000|585045207|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
161998284|NCT01794000|585045206|FG000|Double-Blind Phase (DBP)|Death|1|||
161998285|NCT01794000|585045207|FG001|Double-Blind Phase (DBP)|Death|2|||
161998286|NCT01794000|585045206|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
161998287|NCT01794000|585045207|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
161998288|NCT01794000|585045206|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
161998289|NCT01794000|585045207|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
161998290|NCT01794000|585045206|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
161998291|NCT01794000|585045207|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
161998292|NCT01794000|585045206|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
161998293|NCT01794000|585045207|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
161998294|NCT01794000|585045206|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
161998295|NCT01794000|585045207|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
161998296|NCT01794000|585045206|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
161998297|NCT01794000|585045207|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161998298|NCT00796666|585045208|FG000|Overall Study|Death|2|||
161998299|NCT00796666|585045209|FG001|Overall Study|Death|4|||
161998300|NCT00796666|585045208|FG000|Overall Study|Withdrawal by Subject|2|||
161998301|NCT00796666|585045209|FG001|Overall Study|Withdrawal by Subject|0|||
161998302|NCT00796666|585045208|FG000|Overall Study|Adverse Event|7|||
161998303|NCT00796666|585045209|FG001|Overall Study|Adverse Event|5|||
161998304|NCT00796666|585045208|FG000|Overall Study|Protocol Violation|1|||
161998305|NCT00796666|585045209|FG001|Overall Study|Protocol Violation|0|||
161998306|NCT00796666|585045208|FG000|Overall Study|Other|1|||
161998307|NCT00796666|585045209|FG001|Overall Study|Other|0|||
161998308|NCT00796666|585045208|FG000|Overall Study|Terminated by sponsor|53|||
161998309|NCT00796666|585045209|FG001|Overall Study|Terminated by sponsor|55|||
161998310|NCT00796666|585045208|FG000|Overall Study|Randomized and not treated|1|||
161998311|NCT00796666|585045209|FG001|Overall Study|Randomized and not treated|0|||
161998312|NCT01367834|585045210|FG000|Overall Study|Withdrawal by Subject|2|||
161998313|NCT01367834|585045211|FG001|Overall Study|Withdrawal by Subject|2|||
161998314|NCT01367834|585045210|FG000|Overall Study|Study was ended.|0|||
161998315|NCT01367834|585045211|FG001|Overall Study|Study was ended.|1|||
161998316|NCT01156480|585045212|FG000|Overall Study|change in diagnosis|0|||
161998317|NCT01156480|585045213|FG001|Overall Study|change in diagnosis|1|||
161998318|NCT04537793|585045214|FG000|Part B (24 Weeks)|Adverse Event|0|||
161998319|NCT04537793|585045215|FG001|Part B (24 Weeks)|Adverse Event|1|||
161998320|NCT00988598|585045216|FG000|Overall Study|Withdrawal by Subject|2|||
161998321|NCT00988598|585045217|FG001|Overall Study|Withdrawal by Subject|0|||
161998322|NCT03367858|585045218|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
161998323|NCT03367858|585045219|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
161998324|NCT03367858|585045218|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
161998325|NCT03367858|585045219|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
161998326|NCT03367858|585045218|FG000|3 Month Follow Up|Lost to Follow-up|8|||
161998327|NCT03367858|585045219|FG001|3 Month Follow Up|Lost to Follow-up|3|||
161998328|NCT03367858|585045218|FG000|3 Month Follow Up|Moved out of study area|2|||
161998329|NCT03367858|585045219|FG001|3 Month Follow Up|Moved out of study area|6|||
161998330|NCT03367858|585045218|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
161998331|NCT03367858|585045219|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
161998332|NCT03367858|585045218|FG000|3 Month Follow Up|MRI contraindication|2|||
161998333|NCT03367858|585045219|FG001|3 Month Follow Up|MRI contraindication|1|||
161998334|NCT03367858|585045218|FG000|3 Month Follow Up|Incarcerated|0|||
161998335|NCT03367858|585045219|FG001|3 Month Follow Up|Incarcerated|1|||
161998336|NCT03367858|585045218|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
161998337|NCT03367858|585045219|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
161998338|NCT03367858|585045218|FG000|6 Month Follow Up|Lost to Follow-up|5|||
161998339|NCT03367858|585045219|FG001|6 Month Follow Up|Lost to Follow-up|2|||
161998340|NCT03367858|585045218|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
161998341|NCT03367858|585045219|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
161998342|NCT03367858|585045218|FG000|12 Month Follow Up|Lost to Follow-up|3|||
161998343|NCT03367858|585045219|FG001|12 Month Follow Up|Lost to Follow-up|3|||
161998344|NCT03367858|585045218|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
161998345|NCT03367858|585045219|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
161998346|NCT00057863|585045225|FG000|Overall Study|Death|1|||
162040782|NCT02310321|585207713|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
162040783|NCT02310321|585207714|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
162040784|NCT02310321|585207715|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
162040785|NCT02310321|585207713|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
162040786|NCT02310321|585207714|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
162040787|NCT02310321|585207715|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
162040788|NCT02310321|585207713|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
162040789|NCT02310321|585207714|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
162040790|NCT02310321|585207715|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
162040791|NCT02310321|585207713|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
162040792|NCT02310321|585207714|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
162040793|NCT02310321|585207715|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
162040794|NCT02310321|585207713|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
162040795|NCT02310321|585207714|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
162040796|NCT02310321|585207715|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
162040797|NCT02310321|585207713|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
162040798|NCT02310321|585207714|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
162040799|NCT02310321|585207715|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
162040800|NCT02310321|585207713|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
162040801|NCT02310321|585207714|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
162040802|NCT02310321|585207715|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
162040803|NCT02310321|585207713|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
162040804|NCT02310321|585207714|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
162040805|NCT02310321|585207715|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
162040806|NCT02310321|585207713|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
162040807|NCT02310321|585207714|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
162040808|NCT02310321|585207715|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
162040809|NCT02310321|585207713|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
162040810|NCT02310321|585207714|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
162040811|NCT02310321|585207715|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
162040812|NCT02310321|585207713|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
162040813|NCT02310321|585207714|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
162040814|NCT02310321|585207715|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
162040815|NCT02310321|585207713|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
162040816|NCT02310321|585207714|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
162040817|NCT02310321|585207715|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
162040818|NCT02310321|585207713|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
162040819|NCT02310321|585207714|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
162040820|NCT02310321|585207715|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
162040821|NCT02310321|585207713|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
162040822|NCT02310321|585207714|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
162040823|NCT02310321|585207715|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
162040824|NCT02310321|585207713|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
162040825|NCT02310321|585207714|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
162040826|NCT02310321|585207715|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
162040827|NCT02310321|585207713|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
162040828|NCT02310321|585207714|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
162040829|NCT02310321|585207715|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
162040830|NCT02310321|585207713|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
162040831|NCT02310321|585207714|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
162040832|NCT02310321|585207715|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
162040833|NCT02310321|585207713|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
162040834|NCT02310321|585207714|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
162040835|NCT02310321|585207715|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
162040836|NCT02310321|585207713|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
162040837|NCT02310321|585207714|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
162040838|NCT02310321|585207715|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
162040839|NCT02310321|585207713|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
162040840|NCT02310321|585207714|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
162040841|NCT02310321|585207715|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
162040842|NCT02310321|585207713|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
162040843|NCT02310321|585207714|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
162040844|NCT02310321|585207715|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
162040845|NCT02310321|585207713|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
161998347|NCT00057863|585045225|FG000|Overall Study|Withdrawal by Subject|2|||
161998348|NCT02079038|585045227|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
161998349|NCT02079038|585045228|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
161998350|NCT02079038|585045227|FG000|Modified Intent to Treat Population|Death|1|||
161998351|NCT02079038|585045228|FG001|Modified Intent to Treat Population|Death|0|||
161998352|NCT02079038|585045227|FG000|Completed 6 Months|Lost to Follow-up|2|||
161998353|NCT02079038|585045228|FG001|Completed 6 Months|Lost to Follow-up|1|||
161998354|NCT01141712|585045229|FG000|Overall Study|Disease progression|3|||
161998355|NCT03480152|585045230|FG000|Phase I|Signed consent. Died before treatment.|1|||
161998356|NCT03480152|585045231|FG001|Phase I|Signed consent. Died before treatment.|0|||
161998357|NCT03480152|585045232|FG002|Phase I|Signed consent. Died before treatment.|0|||
161998358|NCT01308736|585045239|FG000|Overall Study|Did not attend a single session|6|||
161998359|NCT01308736|585045240|FG001|Overall Study|Did not attend a single session|5|||
161998360|NCT03634085|585045241|FG000|Overall Study|Adverse Event|1|||
161998361|NCT03634085|585045242|FG001|Overall Study|Adverse Event|0|||
161998362|NCT03634085|585045241|FG000|Overall Study|Withdrawal by Subject|0|||
161998363|NCT03634085|585045242|FG001|Overall Study|Withdrawal by Subject|2|||
161998364|NCT04276233|585045243|FG000|Overall Study|Adverse Event|1|||
161998365|NCT04276233|585045243|FG000|Overall Study|Lost to Follow-up|3|||
161998366|NCT04276233|585045243|FG000|Overall Study|Physician Decision|4|||
161998367|NCT04276233|585045243|FG000|Overall Study|Withdrawal by Subject|2|||
161998368|NCT01946139|585045248|FG000|Overall Study|Withdrawal by Subject|8|||
161998369|NCT01946139|585045248|FG000|Overall Study|ineligible|8|||
161998370|NCT01946139|585045248|FG000|Overall Study|Specimens not available|4|||
161998371|NCT00101686|585045255|FG000|Overall Study|Progressive Disease|37|||
161998372|NCT00101686|585045256|FG001|Overall Study|Progressive Disease|28|||
161998373|NCT00101686|585045257|FG002|Overall Study|Progressive Disease|37|||
161998374|NCT00101686|585045258|FG003|Overall Study|Progressive Disease|38|||
161998375|NCT00101686|585045259|FG004|Overall Study|Progressive Disease|28|||
161998376|NCT00101686|585045260|FG005|Overall Study|Progressive Disease|25|||
161998377|NCT00101686|585045261|FG006|Overall Study|Progressive Disease|5|||
161998378|NCT00101686|585045262|FG007|Overall Study|Progressive Disease|7|||
161998379|NCT00101686|585045263|FG008|Overall Study|Progressive Disease|10|||
161998380|NCT00101686|585045264|FG009|Overall Study|Progressive Disease|8|||
161998381|NCT00101686|585045255|FG000|Overall Study|initiation other anti-cancer treatment|4|||
161998382|NCT00101686|585045256|FG001|Overall Study|initiation other anti-cancer treatment|3|||
161998383|NCT00101686|585045257|FG002|Overall Study|initiation other anti-cancer treatment|4|||
161998384|NCT00101686|585045258|FG003|Overall Study|initiation other anti-cancer treatment|3|||
161998385|NCT00101686|585045259|FG004|Overall Study|initiation other anti-cancer treatment|1|||
161998386|NCT00101686|585045260|FG005|Overall Study|initiation other anti-cancer treatment|1|||
161998387|NCT00101686|585045261|FG006|Overall Study|initiation other anti-cancer treatment|2|||
161998388|NCT00101686|585045262|FG007|Overall Study|initiation other anti-cancer treatment|2|||
161998389|NCT00101686|585045263|FG008|Overall Study|initiation other anti-cancer treatment|3|||
161998390|NCT00101686|585045264|FG009|Overall Study|initiation other anti-cancer treatment|3|||
161998391|NCT00101686|585045255|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
161998392|NCT00101686|585045256|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
161998393|NCT00101686|585045257|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
161998394|NCT00101686|585045258|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
161998395|NCT00101686|585045259|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
161998396|NCT00101686|585045260|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
161998397|NCT00101686|585045261|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
161998398|NCT00101686|585045262|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
161998399|NCT00101686|585045263|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
161998400|NCT00101686|585045264|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
161998401|NCT00101686|585045255|FG000|Overall Study|unacceptable toxicity|3|||
161998402|NCT00101686|585045256|FG001|Overall Study|unacceptable toxicity|9|||
161998403|NCT00101686|585045257|FG002|Overall Study|unacceptable toxicity|10|||
161998404|NCT00101686|585045258|FG003|Overall Study|unacceptable toxicity|6|||
161998405|NCT00101686|585045259|FG004|Overall Study|unacceptable toxicity|16|||
161998406|NCT00101686|585045260|FG005|Overall Study|unacceptable toxicity|10|||
161998407|NCT00101686|585045261|FG006|Overall Study|unacceptable toxicity|4|||
161998408|NCT00101686|585045262|FG007|Overall Study|unacceptable toxicity|2|||
161998409|NCT00101686|585045263|FG008|Overall Study|unacceptable toxicity|1|||
161998410|NCT00101686|585045264|FG009|Overall Study|unacceptable toxicity|4|||
161998411|NCT00101686|585045255|FG000|Overall Study|Randomized but did not receive treament|1|||
161998412|NCT00101686|585045256|FG001|Overall Study|Randomized but did not receive treament|6|||
161998413|NCT00101686|585045257|FG002|Overall Study|Randomized but did not receive treament|2|||
161998414|NCT00101686|585045258|FG003|Overall Study|Randomized but did not receive treament|2|||
161998415|NCT00101686|585045259|FG004|Overall Study|Randomized but did not receive treament|2|||
161998416|NCT00101686|585045260|FG005|Overall Study|Randomized but did not receive treament|2|||
161998417|NCT00101686|585045261|FG006|Overall Study|Randomized but did not receive treament|0|||
161998418|NCT00101686|585045262|FG007|Overall Study|Randomized but did not receive treament|1|||
162040846|NCT02310321|585207714|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
162040847|NCT02310321|585207715|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
162040848|NCT02310321|585207713|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
162040849|NCT02310321|585207714|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
162040850|NCT02310321|585207715|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
162040851|NCT04950166|585207716|FG000|Overall Study|Withdrawal by Subject|1|||
162040852|NCT01698905|585207717|FG000|Overall Study|Adverse Event|4|||
162040853|NCT01698905|585207717|FG000|Overall Study|Physician Decision|2|||
162040854|NCT01698905|585207717|FG000|Overall Study|Pregnancy|1|||
162040855|NCT01698905|585207717|FG000|Overall Study|Protocol Violation|1|||
162040856|NCT01698905|585207717|FG000|Overall Study|Subject/guardian decision|2|||
162040857|NCT01698905|585207717|FG000|Overall Study|Death|1|||
162040858|NCT05896748|585207718|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
162040859|NCT05896748|585207718|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
162040860|NCT05896748|585207718|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
162040861|NCT05896748|585207718|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
162040862|NCT05896748|585207718|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
162040863|NCT01822678|585207725|FG000|Overall Study|Withdrawal by Subject|5|||
162040864|NCT01822678|585207726|FG001|Overall Study|Withdrawal by Subject|4|||
162040865|NCT01822678|585207727|FG002|Overall Study|Withdrawal by Subject|4|||
162040866|NCT01822678|585207725|FG000|Overall Study|Adverse Event|4|||
162040867|NCT01822678|585207726|FG001|Overall Study|Adverse Event|3|||
162040868|NCT01822678|585207727|FG002|Overall Study|Adverse Event|1|||
162040869|NCT01822678|585207725|FG000|Overall Study|Lack of Efficacy|3|||
162040870|NCT01822678|585207726|FG001|Overall Study|Lack of Efficacy|6|||
162040871|NCT01822678|585207727|FG002|Overall Study|Lack of Efficacy|5|||
162040872|NCT01822678|585207725|FG000|Overall Study|Lost to Follow-up|0|||
162040873|NCT01822678|585207726|FG001|Overall Study|Lost to Follow-up|2|||
162040874|NCT01822678|585207727|FG002|Overall Study|Lost to Follow-up|1|||
162040875|NCT00764504|585207728|FG000|Overall Study|Death|12|||
162040876|NCT00764504|585207729|FG001|Overall Study|Death|6|||
162040877|NCT00764504|585207730|FG002|Overall Study|Death|13|||
162040878|NCT00764504|585207728|FG000|Overall Study|Revision of Device|12|||
162040879|NCT00764504|585207729|FG001|Overall Study|Revision of Device|23|||
162040880|NCT00764504|585207730|FG002|Overall Study|Revision of Device|14|||
162040881|NCT00764504|585207728|FG000|Overall Study|Physician Decision|1|||
162040882|NCT00764504|585207729|FG001|Overall Study|Physician Decision|0|||
162040883|NCT00764504|585207730|FG002|Overall Study|Physician Decision|0|||
162040884|NCT00764504|585207728|FG000|Overall Study|Withdrawal by Subject|1|||
162040885|NCT00764504|585207729|FG001|Overall Study|Withdrawal by Subject|7|||
162040886|NCT00764504|585207730|FG002|Overall Study|Withdrawal by Subject|4|||
162040887|NCT00764504|585207728|FG000|Overall Study|Lost to Follow-up|40|||
162040888|NCT00764504|585207729|FG001|Overall Study|Lost to Follow-up|34|||
162040889|NCT00764504|585207730|FG002|Overall Study|Lost to Follow-up|72|||
162040890|NCT01465191|585207734|FG000|Overall Study|Protocol Violation|6|||
162040891|NCT01465191|585207735|FG001|Overall Study|Protocol Violation|3|||
162040892|NCT01465191|585207736|FG002|Overall Study|Protocol Violation|3|||
161998419|NCT00101686|585045263|FG008|Overall Study|Randomized but did not receive treament|0|||
161998420|NCT00101686|585045264|FG009|Overall Study|Randomized but did not receive treament|1|||
161998421|NCT00101686|585045255|FG000|Overall Study|intercurrent non-cancer related illness|0|||
161998422|NCT00101686|585045256|FG001|Overall Study|intercurrent non-cancer related illness|0|||
161998423|NCT00101686|585045257|FG002|Overall Study|intercurrent non-cancer related illness|2|||
161998424|NCT00101686|585045258|FG003|Overall Study|intercurrent non-cancer related illness|0|||
161998425|NCT00101686|585045259|FG004|Overall Study|intercurrent non-cancer related illness|1|||
161998426|NCT00101686|585045260|FG005|Overall Study|intercurrent non-cancer related illness|3|||
161998427|NCT00101686|585045261|FG006|Overall Study|intercurrent non-cancer related illness|1|||
161998428|NCT00101686|585045262|FG007|Overall Study|intercurrent non-cancer related illness|0|||
161998429|NCT00101686|585045263|FG008|Overall Study|intercurrent non-cancer related illness|1|||
161998430|NCT00101686|585045264|FG009|Overall Study|intercurrent non-cancer related illness|1|||
161998431|NCT00101686|585045255|FG000|Overall Study|Physician Decision|10|||
161998432|NCT00101686|585045256|FG001|Overall Study|Physician Decision|13|||
161998433|NCT00101686|585045257|FG002|Overall Study|Physician Decision|6|||
161998434|NCT00101686|585045258|FG003|Overall Study|Physician Decision|7|||
161998435|NCT00101686|585045259|FG004|Overall Study|Physician Decision|8|||
161998436|NCT00101686|585045260|FG005|Overall Study|Physician Decision|9|||
161998437|NCT00101686|585045261|FG006|Overall Study|Physician Decision|5|||
161998438|NCT00101686|585045262|FG007|Overall Study|Physician Decision|5|||
161998439|NCT00101686|585045263|FG008|Overall Study|Physician Decision|1|||
161998440|NCT00101686|585045264|FG009|Overall Study|Physician Decision|1|||
161998441|NCT00101686|585045255|FG000|Overall Study|Other|1|||
161998442|NCT00101686|585045256|FG001|Overall Study|Other|4|||
161998443|NCT00101686|585045257|FG002|Overall Study|Other|1|||
161998444|NCT00101686|585045258|FG003|Overall Study|Other|6|||
161998445|NCT00101686|585045259|FG004|Overall Study|Other|2|||
161998446|NCT00101686|585045260|FG005|Overall Study|Other|12|||
162040893|NCT01465191|585207734|FG000|Overall Study|Lost to Follow-up|3|||
162040894|NCT01465191|585207735|FG001|Overall Study|Lost to Follow-up|6|||
161998447|NCT00101686|585045261|FG006|Overall Study|Other|1|||
161998448|NCT00101686|585045262|FG007|Overall Study|Other|5|||
161998449|NCT00101686|585045263|FG008|Overall Study|Other|3|||
161998450|NCT00101686|585045264|FG009|Overall Study|Other|3|||
161998451|NCT00101686|585045255|FG000|Overall Study|Withdrawal by Subject|9|||
161998452|NCT00101686|585045256|FG001|Overall Study|Withdrawal by Subject|8|||
161998453|NCT00101686|585045257|FG002|Overall Study|Withdrawal by Subject|6|||
161998454|NCT00101686|585045258|FG003|Overall Study|Withdrawal by Subject|8|||
161998455|NCT00101686|585045259|FG004|Overall Study|Withdrawal by Subject|8|||
161998456|NCT00101686|585045260|FG005|Overall Study|Withdrawal by Subject|7|||
161998457|NCT00101686|585045261|FG006|Overall Study|Withdrawal by Subject|7|||
161998458|NCT00101686|585045262|FG007|Overall Study|Withdrawal by Subject|7|||
161998459|NCT00101686|585045263|FG008|Overall Study|Withdrawal by Subject|8|||
161998460|NCT00101686|585045264|FG009|Overall Study|Withdrawal by Subject|9|||
161998461|NCT00296816|585045265|FG000|Overall Study|Disease Progression|37|||
161998462|NCT00296816|585045265|FG000|Overall Study|Adverse Event|18|||
161998463|NCT00296816|585045265|FG000|Overall Study|Investigator/Participant request|5|||
161998464|NCT00296816|585045265|FG000|Overall Study|Non-compliance|1|||
161998465|NCT00296816|585045265|FG000|Overall Study|Missing for end of treatment|4|||
161998466|NCT00296816|585045265|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
161998467|NCT00296816|585045265|FG000|Overall Study|Poor performance status|1|||
161998468|NCT00296816|585045265|FG000|Overall Study|Relocation to Florida|1|||
161998469|NCT00296816|585045265|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
161998470|NCT00296816|585045265|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
161998471|NCT00296816|585045265|FG000|Overall Study|Neuropathy/patient preference|1|||
161998472|NCT00296816|585045265|FG000|Overall Study|Proteinuria|1|||
161998473|NCT00296816|585045265|FG000|Overall Study|ineligibility due to radiation treatment|1|||
161998474|NCT00985465|585045268|FG000|Overall Study|Withdrawal by Subject|1|||
161998475|NCT00985465|585045269|FG001|Overall Study|Withdrawal by Subject|2|||
161998476|NCT00985465|585045268|FG000|Overall Study|Considered to be part of the other group|0|||
161998477|NCT00985465|585045269|FG001|Overall Study|Considered to be part of the other group|1|||
161998478|NCT01054456|585045270|FG000|Overall Study|Other|1|||
161998479|NCT04701333|585045271|FG000|Overall Study|Lost to Follow-up|3|||
161998480|NCT04701333|585045272|FG001|Overall Study|Lost to Follow-up|7|||
161998481|NCT04701333|585045271|FG000|Overall Study|Withdrawal by Subject|0|||
161998482|NCT04701333|585045272|FG001|Overall Study|Withdrawal by Subject|1|||
161998483|NCT01292187|585045273|FG000|Overall Study|Adverse Event|10|||
161998484|NCT01292187|585045274|FG001|Overall Study|Adverse Event|5|||
161998485|NCT01292187|585045273|FG000|Overall Study|Withdrawal by Subject|6|||
161998486|NCT01292187|585045274|FG001|Overall Study|Withdrawal by Subject|5|||
161998487|NCT01292187|585045273|FG000|Overall Study|All other reasons|1|||
161998488|NCT01292187|585045274|FG001|Overall Study|All other reasons|3|||
161998489|NCT01670721|585045276|FG000|Overall Study|Participant's decision|15|||
161998490|NCT01670721|585045276|FG000|Overall Study|Other than specified above|38|||
161998491|NCT00141102|585045281|FG000|Overall Study|Adverse Event|233|||
161998492|NCT00141102|585045282|FG001|Overall Study|Adverse Event|305|||
161998493|NCT00141102|585045281|FG000|Overall Study|Laboratory Abnormality|9|||
161998494|NCT00141102|585045282|FG001|Overall Study|Laboratory Abnormality|33|||
161998495|NCT00141102|585045281|FG000|Overall Study|Lack of Efficacy|21|||
161998496|NCT00141102|585045282|FG001|Overall Study|Lack of Efficacy|26|||
161998497|NCT00141102|585045281|FG000|Overall Study|Lost to Follow-up|29|||
161998498|NCT00141102|585045282|FG001|Overall Study|Lost to Follow-up|32|||
161998499|NCT00141102|585045281|FG000|Overall Study|Other|87|||
161998500|NCT00141102|585045282|FG001|Overall Study|Other|76|||
161998501|NCT00141102|585045281|FG000|Overall Study|Withdrawal by Subject|112|||
161998502|NCT00141102|585045282|FG001|Overall Study|Withdrawal by Subject|142|||
161998503|NCT00141102|585045281|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
161998504|NCT00141102|585045282|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
161998505|NCT00141102|585045281|FG000|Overall Study|Death|2|||
161998506|NCT00141102|585045282|FG001|Overall Study|Death|2|||
161998507|NCT05477485|585045283|FG000|Overall Study|Lost to Follow-up|0|||
161998508|NCT05477485|585045284|FG001|Overall Study|Lost to Follow-up|4|||
161998509|NCT03061201|585045285|FG000|Overall Study|Participants Terminated at Month 36|0|||
161998510|NCT03061201|585045286|FG001|Overall Study|Participants Terminated at Month 36|1|||
161998511|NCT03061201|585045287|FG002|Overall Study|Participants Terminated at Month 36|0|||
161998512|NCT03061201|585045288|FG003|Overall Study|Participants Terminated at Month 36|1|||
161998513|NCT03061201|585045285|FG000|Overall Study|Lost to Follow-up|1|||
162040895|NCT01465191|585207736|FG002|Overall Study|Lost to Follow-up|4|||
161998514|NCT03061201|585045286|FG001|Overall Study|Lost to Follow-up|0|||
161998515|NCT03061201|585045287|FG002|Overall Study|Lost to Follow-up|0|||
161998516|NCT03061201|585045288|FG003|Overall Study|Lost to Follow-up|0|||
161998517|NCT01572480|585045289|FG000|Participants Enrolled|Withdrawal by Subject|1|||
161998518|NCT01572480|585045289|FG000|Drug Administration|Discontinued drug/Off Study|1|||
161998519|NCT01572480|585045289|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
162040896|NCT00943124|585207737|FG000|Period 1|Withdrawal by Subject|1|||
162040897|NCT00943124|585207738|FG001|Period 1|Withdrawal by Subject|1|||
162040898|NCT00943124|585207737|FG000|Period 1|Did Not Follow Study Procedures|1|||
162040899|NCT00943124|585207738|FG001|Period 1|Did Not Follow Study Procedures|0|||
162040900|NCT00943124|585207737|FG000|Period 1|Personal Reasons|0|||
162040901|NCT00943124|585207738|FG001|Period 1|Personal Reasons|1|||
162040902|NCT03059446|585207739|FG000|Overall Study|Adverse Event|11|||
162040903|NCT03059446|585207739|FG000|Overall Study|Withdrawal of Consent|16|||
162040904|NCT03059446|585207739|FG000|Overall Study|Lost to Follow-up|3|||
162040905|NCT03059446|585207739|FG000|Overall Study|Protocol Violation|1|||
162040906|NCT03059446|585207739|FG000|Overall Study|Study Terminated by Sponsor|131|||
162040907|NCT03059446|585207739|FG000|Overall Study|Reason not Specified|5|||
162040908|NCT02992132|585207740|FG000|Overall Study|Adverse Event|4|||
162040909|NCT02992132|585207741|FG001|Overall Study|Adverse Event|1|||
162040910|NCT02992132|585207742|FG002|Overall Study|Adverse Event|3|||
162040911|NCT02992132|585207740|FG000|Overall Study|Lack of Efficacy|2|||
162040912|NCT02992132|585207741|FG001|Overall Study|Lack of Efficacy|0|||
162040913|NCT02992132|585207742|FG002|Overall Study|Lack of Efficacy|0|||
162040914|NCT02992132|585207740|FG000|Overall Study|Non-compliance with study drug|2|||
162040915|NCT02992132|585207741|FG001|Overall Study|Non-compliance with study drug|0|||
162040916|NCT02992132|585207742|FG002|Overall Study|Non-compliance with study drug|0|||
162040917|NCT02992132|585207740|FG000|Overall Study|Progressive disease|1|||
162040918|NCT02992132|585207741|FG001|Overall Study|Progressive disease|0|||
162040919|NCT02992132|585207742|FG002|Overall Study|Progressive disease|0|||
162040920|NCT02992132|585207740|FG000|Overall Study|Protocol Violation|2|||
162040921|NCT02992132|585207741|FG001|Overall Study|Protocol Violation|2|||
162040922|NCT02992132|585207742|FG002|Overall Study|Protocol Violation|0|||
162040923|NCT02992132|585207740|FG000|Overall Study|Caregiver withdrew consent|2|||
162040924|NCT02992132|585207741|FG001|Overall Study|Caregiver withdrew consent|3|||
162040925|NCT02992132|585207742|FG002|Overall Study|Caregiver withdrew consent|2|||
161998520|NCT01572480|585045289|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
161998521|NCT05081219|585045290|FG000|Overall Study|Withdrawal by Subject|4|||
161998522|NCT05081219|585045291|FG001|Overall Study|Withdrawal by Subject|0|||
161998523|NCT05081219|585045292|FG002|Overall Study|Withdrawal by Subject|0|||
161998524|NCT05081219|585045293|FG003|Overall Study|Withdrawal by Subject|1|||
161998525|NCT03446313|585045294|FG000|Overall Study|Lost to Follow-up|1|||
161998526|NCT03446313|585045295|FG001|Overall Study|Lost to Follow-up|2|||
161998527|NCT03446313|585045294|FG000|Overall Study|Failed primary screening|3|||
161998528|NCT03446313|585045295|FG001|Overall Study|Failed primary screening|0|||
161998529|NCT03446313|585045294|FG000|Overall Study|Diagnosed with terminal cancer|1|||
161998530|NCT03446313|585045295|FG001|Overall Study|Diagnosed with terminal cancer|0|||
161998531|NCT03446313|585045294|FG000|Overall Study|Excluded from analysis|1|||
161998532|NCT03446313|585045295|FG001|Overall Study|Excluded from analysis|1|||
161998533|NCT05274958|585045296|FG000|Overall Study|Only completed 1 set of PROMs|22|||
161998534|NCT05274958|585045297|FG001|Overall Study|Only completed 1 set of PROMs|35|||
161998535|NCT06235905|585045298|FG000|Overall Study|Adverse Event|1|||
161998536|NCT06235905|585045298|FG000|Overall Study|Non-compliant with protocol procedures|1|||
161998537|NCT00866814|585045300|FG000|Overall Study|Lost to Follow-up|12|||
161998538|NCT00866814|585045300|FG000|Overall Study|Adverse Event|2|||
161998539|NCT00866814|585045300|FG000|Overall Study|Physician Decision|1|||
161998540|NCT00866814|585045300|FG000|Overall Study|Death|1|||
161998541|NCT00866814|585045300|FG000|Overall Study|No longer wished to participate|1|||
161998542|NCT00866814|585045300|FG000|Overall Study|Unable to meet follow-up requirements|2|||
161998543|NCT00866814|585045300|FG000|Overall Study|Moved to area without study site|1|||
161998544|NCT01505374|585045304|FG000|Overall Study|Lost to Follow-up|1|||
161998545|NCT01505374|585045305|FG001|Overall Study|Lost to Follow-up|0|||
161998546|NCT00176462|585045311|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
161998547|NCT00176462|585045312|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
161998548|NCT00176462|585045311|FG000|Induction (4 Weeks)|Death|1|||
161998549|NCT00176462|585045312|FG001|Induction (4 Weeks)|Death|2|||
161998550|NCT00176462|585045311|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
161998551|NCT00176462|585045312|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
161998552|NCT00176462|585045311|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
161998553|NCT00176462|585045312|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
161998554|NCT00176462|585045311|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
161998555|NCT00176462|585045312|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
161998556|NCT00176462|585045311|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
161998557|NCT00176462|585045312|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
161998558|NCT00176462|585045311|FG000|Consolidation (12 Weeks)|Not documented|0|||
161998559|NCT00176462|585045312|FG001|Consolidation (12 Weeks)|Not documented|1|||
161998560|NCT00176462|585045311|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
161998561|NCT00176462|585045312|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
161998562|NCT00176462|585045311|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
161998563|NCT00176462|585045312|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
161998564|NCT02679287|585045315|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
161998565|NCT02679287|585045316|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
161998566|NCT02679287|585045315|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
161998567|NCT02679287|585045316|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
161998568|NCT02679287|585045315|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
161998569|NCT02679287|585045316|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
161998570|NCT02679287|585045315|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
161998571|NCT02679287|585045316|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
161998572|NCT02679287|585045315|FG000|Period 2|Work/Scheduling Conflict|1|||
161998573|NCT02679287|585045316|FG001|Period 2|Work/Scheduling Conflict|0|||
161998574|NCT02679287|585045315|FG000|Period 2|Disliked Mobile System|2|||
161998575|NCT02679287|585045316|FG001|Period 2|Disliked Mobile System|0|||
161998576|NCT02679287|585045315|FG000|Period 3|Work/Scheduling Conflict|0|||
161998577|NCT02679287|585045316|FG001|Period 3|Work/Scheduling Conflict|1|||
161998578|NCT00320515|585045319|FG000|Overall Study|Death|33|||
161998579|NCT00320515|585045319|FG000|Overall Study|Lost to Follow-up|6|||
161998580|NCT00320515|585045319|FG000|Overall Study|Physician Decision|2|||
161998581|NCT00320515|585045319|FG000|Overall Study|Withdrawal by Subject|8|||
161998582|NCT01114828|585045320|FG000|Overall Study|Adverse Event|1|||
161998583|NCT01114828|585045321|FG001|Overall Study|Adverse Event|1|||
161998584|NCT01114828|585045320|FG000|Overall Study|Lack of Efficacy|0|||
161998585|NCT01114828|585045321|FG001|Overall Study|Lack of Efficacy|2|||
161998586|NCT01114828|585045320|FG000|Overall Study|Protocol Violation|2|||
161998587|NCT01114828|585045321|FG001|Overall Study|Protocol Violation|0|||
161998588|NCT01114828|585045320|FG000|Overall Study|Withdrawal by Subject|0|||
161998589|NCT01114828|585045321|FG001|Overall Study|Withdrawal by Subject|1|||
161998590|NCT00794950|585045322|FG000|BCG Induction|Withdrawal by Subject|2|||
161998591|NCT00794950|585045322|FG000|BCG Induction|ineligible|3|||
161998592|NCT00794950|585045322|FG000|BCG Induction|noncompliant w. BCG|1|||
161998593|NCT00794950|585045322|FG000|BCG Induction|Adverse Event|1|||
161998594|NCT00794950|585045322|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
161998595|NCT00794950|585045322|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
161998596|NCT00794950|585045322|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
161998597|NCT00794950|585045322|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
161998598|NCT02485704|585045323|FG000|Overall Study|Lost to Follow-up|4|||
161998599|NCT02485704|585045324|FG001|Overall Study|Lost to Follow-up|5|||
161998600|NCT02485704|585045323|FG000|Overall Study|Withdrawal by Subject|0|||
161998601|NCT02485704|585045324|FG001|Overall Study|Withdrawal by Subject|3|||
161998602|NCT02485704|585045323|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
161998603|NCT02485704|585045324|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
161998604|NCT00851786|585045327|FG000|Overall Study|Withdrawal by Subject|0|||
161998605|NCT00851786|585045328|FG001|Overall Study|Withdrawal by Subject|1|||
161998606|NCT00851786|585045327|FG000|Overall Study|Protocol Violation|0|||
161998607|NCT00851786|585045328|FG001|Overall Study|Protocol Violation|1|||
161998608|NCT00851786|585045327|FG000|Overall Study|Lost to Follow-up|1|||
161998609|NCT00851786|585045328|FG001|Overall Study|Lost to Follow-up|0|||
161998610|NCT00851786|585045327|FG000|Overall Study|Incarceration|1|||
161998611|NCT00851786|585045328|FG001|Overall Study|Incarceration|0|||
161998612|NCT00851786|585045327|FG000|Overall Study|Site Closure|1|||
161998613|NCT00851786|585045328|FG001|Overall Study|Site Closure|0|||
161998614|NCT00851786|585045327|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
161998615|NCT00851786|585045328|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
161998616|NCT02711137|585047257|FG000|Overall Study|Death|1|||
161998617|NCT02711137|585047258|FG001|Overall Study|Death|4|||
161998618|NCT02711137|585047259|FG002|Overall Study|Death|5|||
161998619|NCT02711137|585047260|FG003|Overall Study|Death|5|||
161998620|NCT02711137|585047261|FG004|Overall Study|Death|3|||
161998621|NCT02711137|585047262|FG005|Overall Study|Death|1|||
161998622|NCT02711137|585047263|FG006|Overall Study|Death|61|||
161998623|NCT02711137|585047264|FG007|Overall Study|Death|3|||
161998624|NCT02711137|585047265|FG008|Overall Study|Death|0|||
161998625|NCT02711137|585047266|FG009|Overall Study|Death|1|||
161998626|NCT02711137|585047267|FG010|Overall Study|Death|1|||
161998627|NCT02711137|585047268|FG011|Overall Study|Death|1|||
161998628|NCT02711137|585047269|FG012|Overall Study|Death|0|||
161998629|NCT02711137|585047270|FG013|Overall Study|Death|0|||
161998630|NCT02711137|585047271|FG014|Overall Study|Death|0|||
161998631|NCT02711137|585047257|FG000|Overall Study|Study Terminated by Sponsor|0|||
161998632|NCT02711137|585047258|FG001|Overall Study|Study Terminated by Sponsor|0|||
161998633|NCT02711137|585047259|FG002|Overall Study|Study Terminated by Sponsor|1|||
161998634|NCT02711137|585047260|FG003|Overall Study|Study Terminated by Sponsor|0|||
161998635|NCT02711137|585047261|FG004|Overall Study|Study Terminated by Sponsor|0|||
161998636|NCT02711137|585047262|FG005|Overall Study|Study Terminated by Sponsor|0|||
161998637|NCT02711137|585047263|FG006|Overall Study|Study Terminated by Sponsor|1|||
161998638|NCT02711137|585047264|FG007|Overall Study|Study Terminated by Sponsor|0|||
161998639|NCT02711137|585047265|FG008|Overall Study|Study Terminated by Sponsor|0|||
161998640|NCT02711137|585047266|FG009|Overall Study|Study Terminated by Sponsor|0|||
161998641|NCT02711137|585047267|FG010|Overall Study|Study Terminated by Sponsor|0|||
161998642|NCT02711137|585047268|FG011|Overall Study|Study Terminated by Sponsor|0|||
161998643|NCT02711137|585047269|FG012|Overall Study|Study Terminated by Sponsor|0|||
161998644|NCT02711137|585047270|FG013|Overall Study|Study Terminated by Sponsor|0|||
161998645|NCT02711137|585047271|FG014|Overall Study|Study Terminated by Sponsor|0|||
161998646|NCT02711137|585047257|FG000|Overall Study|Physician Decision|1|||
161998647|NCT02711137|585047258|FG001|Overall Study|Physician Decision|0|||
161998648|NCT02711137|585047259|FG002|Overall Study|Physician Decision|2|||
161998649|NCT02711137|585047260|FG003|Overall Study|Physician Decision|1|||
161998650|NCT02711137|585047261|FG004|Overall Study|Physician Decision|1|||
161998651|NCT02711137|585047262|FG005|Overall Study|Physician Decision|0|||
161998652|NCT02711137|585047263|FG006|Overall Study|Physician Decision|12|||
161998653|NCT02711137|585047264|FG007|Overall Study|Physician Decision|2|||
161998654|NCT02711137|585047265|FG008|Overall Study|Physician Decision|1|||
161998655|NCT02711137|585047266|FG009|Overall Study|Physician Decision|1|||
161998656|NCT02711137|585047267|FG010|Overall Study|Physician Decision|3|||
161998657|NCT02711137|585047268|FG011|Overall Study|Physician Decision|2|||
161998658|NCT02711137|585047269|FG012|Overall Study|Physician Decision|1|||
161998659|NCT02711137|585047270|FG013|Overall Study|Physician Decision|1|||
161998660|NCT02711137|585047271|FG014|Overall Study|Physician Decision|2|||
161998661|NCT02711137|585047257|FG000|Overall Study|Other|0|||
161998662|NCT02711137|585047258|FG001|Overall Study|Other|1|||
161998663|NCT02711137|585047259|FG002|Overall Study|Other|0|||
161998664|NCT02711137|585047260|FG003|Overall Study|Other|0|||
161998665|NCT02711137|585047261|FG004|Overall Study|Other|0|||
161998666|NCT02711137|585047262|FG005|Overall Study|Other|0|||
161998667|NCT02711137|585047263|FG006|Overall Study|Other|3|||
161998668|NCT02711137|585047264|FG007|Overall Study|Other|0|||
161998669|NCT02711137|585047265|FG008|Overall Study|Other|0|||
161998670|NCT02711137|585047266|FG009|Overall Study|Other|0|||
161998671|NCT02711137|585047267|FG010|Overall Study|Other|0|||
161998672|NCT02711137|585047268|FG011|Overall Study|Other|0|||
161998673|NCT02711137|585047269|FG012|Overall Study|Other|0|||
161998674|NCT02711137|585047270|FG013|Overall Study|Other|0|||
161998675|NCT02711137|585047271|FG014|Overall Study|Other|1|||
161998676|NCT02711137|585047257|FG000|Overall Study|Withdrawal by Subject|1|||
161998677|NCT02711137|585047258|FG001|Overall Study|Withdrawal by Subject|0|||
161998678|NCT02711137|585047259|FG002|Overall Study|Withdrawal by Subject|0|||
161998679|NCT02711137|585047260|FG003|Overall Study|Withdrawal by Subject|1|||
161998680|NCT02711137|585047261|FG004|Overall Study|Withdrawal by Subject|1|||
161998681|NCT02711137|585047262|FG005|Overall Study|Withdrawal by Subject|0|||
161998682|NCT02711137|585047263|FG006|Overall Study|Withdrawal by Subject|7|||
161998683|NCT02711137|585047264|FG007|Overall Study|Withdrawal by Subject|0|||
161998684|NCT02711137|585047265|FG008|Overall Study|Withdrawal by Subject|0|||
161998685|NCT02711137|585047266|FG009|Overall Study|Withdrawal by Subject|0|||
161998686|NCT02711137|585047267|FG010|Overall Study|Withdrawal by Subject|0|||
161998687|NCT02711137|585047268|FG011|Overall Study|Withdrawal by Subject|0|||
161998688|NCT02711137|585047269|FG012|Overall Study|Withdrawal by Subject|0|||
161998689|NCT02711137|585047270|FG013|Overall Study|Withdrawal by Subject|1|||
161998690|NCT02711137|585047271|FG014|Overall Study|Withdrawal by Subject|0|||
161998691|NCT02711137|585047257|FG000|Overall Study|Lost to Follow-up|1|||
161998692|NCT02711137|585047258|FG001|Overall Study|Lost to Follow-up|0|||
161998693|NCT02711137|585047259|FG002|Overall Study|Lost to Follow-up|0|||
161998694|NCT02711137|585047260|FG003|Overall Study|Lost to Follow-up|0|||
161998695|NCT02711137|585047261|FG004|Overall Study|Lost to Follow-up|0|||
161998696|NCT02711137|585047262|FG005|Overall Study|Lost to Follow-up|0|||
161998697|NCT02711137|585047263|FG006|Overall Study|Lost to Follow-up|2|||
161998698|NCT02711137|585047264|FG007|Overall Study|Lost to Follow-up|0|||
161998699|NCT02711137|585047265|FG008|Overall Study|Lost to Follow-up|0|||
161998700|NCT02711137|585047266|FG009|Overall Study|Lost to Follow-up|0|||
161998701|NCT02711137|585047267|FG010|Overall Study|Lost to Follow-up|0|||
161998702|NCT02711137|585047268|FG011|Overall Study|Lost to Follow-up|0|||
161998703|NCT02711137|585047269|FG012|Overall Study|Lost to Follow-up|0|||
161998704|NCT02711137|585047270|FG013|Overall Study|Lost to Follow-up|0|||
161998705|NCT02711137|585047271|FG014|Overall Study|Lost to Follow-up|0|||
161998706|NCT03956550|585047272|FG000|Overall Study|Sponsor decision|65|||
161998707|NCT03956550|585047273|FG001|Overall Study|Sponsor decision|66|||
161998708|NCT03956550|585047274|FG002|Overall Study|Sponsor decision|64|||
161998709|NCT03956550|585047272|FG000|Overall Study|Adverse Event|0|||
161998710|NCT03956550|585047273|FG001|Overall Study|Adverse Event|1|||
161998711|NCT03956550|585047274|FG002|Overall Study|Adverse Event|0|||
161998712|NCT03956550|585047272|FG000|Overall Study|Withdrawal by Subject|5|||
161998713|NCT03956550|585047273|FG001|Overall Study|Withdrawal by Subject|5|||
161998714|NCT03956550|585047274|FG002|Overall Study|Withdrawal by Subject|6|||
161998715|NCT03400852|585047275|FG000|Blinded Treatment Period|Physician Decision|0|||
161998716|NCT03400852|585047276|FG001|Blinded Treatment Period|Physician Decision|1|||
161998717|NCT03400852|585047277|FG002|Blinded Treatment Period|Physician Decision|0|||
161998718|NCT03400852|585047275|FG000|Blinded Treatment Period|Adverse Event|1|||
161998719|NCT03400852|585047276|FG001|Blinded Treatment Period|Adverse Event|1|||
161998720|NCT03400852|585047277|FG002|Blinded Treatment Period|Adverse Event|0|||
161998721|NCT03400852|585047275|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
161998722|NCT03400852|585047276|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
161998723|NCT03400852|585047277|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
161998724|NCT03400852|585047275|FG000|Open Label Period|Physician Decision|0|||
161998725|NCT03400852|585047276|FG001|Open Label Period|Physician Decision|0|||
161998726|NCT03400852|585047277|FG002|Open Label Period|Physician Decision|1|||
161998727|NCT03400852|585047275|FG000|Open Label Period|Study terminated by sponsor|0|||
161998728|NCT03400852|585047276|FG001|Open Label Period|Study terminated by sponsor|0|||
161998729|NCT03400852|585047277|FG002|Open Label Period|Study terminated by sponsor|21|||
161998730|NCT00248495|585047278|FG000|Overall Study|Withdrawal by Subject|1|||
161998731|NCT01285401|585047279|FG000|Overall Study|Prematurely withdrawn from the study|17|||
161998732|NCT01285401|585047280|FG001|Overall Study|Prematurely withdrawn from the study|29|||
161998733|NCT03719131|585047284|FG000|Overall Study|Death|1|||
161998734|NCT03719131|585047285|FG001|Overall Study|Death|2|||
161998735|NCT04244253|585047286|FG000|Overall Study|Adverse Event|2|||
161998736|NCT04244253|585047287|FG001|Overall Study|Adverse Event|2|||
161998737|NCT04244253|585047288|FG002|Overall Study|Adverse Event|4|||
161998738|NCT04244253|585047286|FG000|Overall Study|Protocol Violation|1|||
161998739|NCT04244253|585047287|FG001|Overall Study|Protocol Violation|2|||
161998740|NCT04244253|585047288|FG002|Overall Study|Protocol Violation|1|||
161998741|NCT04244253|585047286|FG000|Overall Study|Withdrawal by Subject|0|||
161998742|NCT04244253|585047287|FG001|Overall Study|Withdrawal by Subject|1|||
161998743|NCT04244253|585047288|FG002|Overall Study|Withdrawal by Subject|6|||
161998744|NCT04244253|585047286|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161998745|NCT04244253|585047287|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161998746|NCT04244253|585047288|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161998747|NCT01544920|585047289|FG000|Overall Study|Adverse Event|0|||
161998748|NCT01544920|585047290|FG001|Overall Study|Adverse Event|3|||
161998749|NCT01544920|585047289|FG000|Overall Study|Death|0|||
161998750|NCT01544920|585047290|FG001|Overall Study|Death|1|||
161998751|NCT01544920|585047289|FG000|Overall Study|Lost to Follow-up|11|||
161998752|NCT01544920|585047290|FG001|Overall Study|Lost to Follow-up|12|||
161998753|NCT01544920|585047289|FG000|Overall Study|Protocol Violation|0|||
161998754|NCT01544920|585047290|FG001|Overall Study|Protocol Violation|2|||
161998755|NCT01544920|585047289|FG000|Overall Study|Physician Decision|4|||
161998756|NCT01544920|585047290|FG001|Overall Study|Physician Decision|1|||
161998757|NCT01544920|585047289|FG000|Overall Study|Withdrawal by Subject|4|||
161998758|NCT01544920|585047290|FG001|Overall Study|Withdrawal by Subject|4|||
161998759|NCT02420093|585047291|FG000|Overall Study|Withdrawal by Subject|1|||
161998760|NCT02420093|585047292|FG001|Overall Study|Withdrawal by Subject|1|||
161998761|NCT03001557|585047297|FG000|Core Phase|Randomized but not treated|0|||
161998762|NCT03001557|585047298|FG001|Core Phase|Randomized but not treated|0|||
161998763|NCT03001557|585047299|FG002|Core Phase|Randomized but not treated|1|||
161998764|NCT03001557|585047300|FG003|Core Phase|Randomized but not treated|0|||
161998765|NCT03001557|585047301|FG004|Core Phase|Randomized but not treated|0|||
161998766|NCT03001557|585047302|FG005|Core Phase|Randomized but not treated|0|||
161998767|NCT03001557|585047303|FG006|Core Phase|Randomized but not treated|0|||
161998768|NCT03001557|585047304|FG007|Core Phase|Randomized but not treated|0|||
161998769|NCT03001557|585047297|FG000|Extension Phase|Adverse Event|0|||
161998770|NCT03001557|585047298|FG001|Extension Phase|Adverse Event|0|||
161998771|NCT03001557|585047299|FG002|Extension Phase|Adverse Event|0|||
161998772|NCT03001557|585047300|FG003|Extension Phase|Adverse Event|0|||
161998773|NCT03001557|585047301|FG004|Extension Phase|Adverse Event|0|||
161998774|NCT03001557|585047302|FG005|Extension Phase|Adverse Event|2|||
161998775|NCT03001557|585047303|FG006|Extension Phase|Adverse Event|0|||
161998776|NCT03001557|585047304|FG007|Extension Phase|Adverse Event|0|||
161998777|NCT03001557|585047297|FG000|Extension Phase|Withdrawal by Subject|0|||
161998778|NCT03001557|585047298|FG001|Extension Phase|Withdrawal by Subject|0|||
161998779|NCT03001557|585047299|FG002|Extension Phase|Withdrawal by Subject|0|||
161998780|NCT03001557|585047300|FG003|Extension Phase|Withdrawal by Subject|0|||
161998781|NCT03001557|585047301|FG004|Extension Phase|Withdrawal by Subject|0|||
161998782|NCT03001557|585047302|FG005|Extension Phase|Withdrawal by Subject|1|||
161998783|NCT03001557|585047303|FG006|Extension Phase|Withdrawal by Subject|5|||
161998784|NCT03001557|585047304|FG007|Extension Phase|Withdrawal by Subject|2|||
161998785|NCT03001557|585047297|FG000|Extension Phase|Lost to Follow-up|0|||
161998786|NCT03001557|585047298|FG001|Extension Phase|Lost to Follow-up|0|||
161998787|NCT03001557|585047299|FG002|Extension Phase|Lost to Follow-up|0|||
161998788|NCT03001557|585047300|FG003|Extension Phase|Lost to Follow-up|0|||
161998789|NCT03001557|585047301|FG004|Extension Phase|Lost to Follow-up|0|||
161998790|NCT03001557|585047302|FG005|Extension Phase|Lost to Follow-up|0|||
161998791|NCT03001557|585047303|FG006|Extension Phase|Lost to Follow-up|2|||
161998792|NCT03001557|585047304|FG007|Extension Phase|Lost to Follow-up|1|||
161998793|NCT03001557|585047297|FG000|Extension Phase|Administrative Reason|0|||
161998794|NCT03001557|585047298|FG001|Extension Phase|Administrative Reason|0|||
161998795|NCT03001557|585047299|FG002|Extension Phase|Administrative Reason|0|||
161998796|NCT03001557|585047300|FG003|Extension Phase|Administrative Reason|0|||
162040926|NCT02992132|585207740|FG000|Overall Study|Withdrawal by Subject|0|||
162040927|NCT02992132|585207741|FG001|Overall Study|Withdrawal by Subject|2|||
162040928|NCT02992132|585207742|FG002|Overall Study|Withdrawal by Subject|1|||
162040929|NCT02992132|585207740|FG000|Overall Study|Physician Decision|0|||
162040930|NCT02992132|585207741|FG001|Overall Study|Physician Decision|0|||
162040931|NCT02992132|585207742|FG002|Overall Study|Physician Decision|1|||
162040932|NCT02448810|585207743|FG000|Overall Study|Adverse Event|0|||
162040933|NCT02448810|585207744|FG001|Overall Study|Adverse Event|0|||
162040934|NCT02448810|585207745|FG002|Overall Study|Adverse Event|1|||
162040935|NCT02448810|585207746|FG003|Overall Study|Adverse Event|0|||
162040936|NCT02448810|585207747|FG004|Overall Study|Adverse Event|0|||
162040937|NCT02448810|585207748|FG005|Overall Study|Adverse Event|0|||
162040938|NCT02448810|585207749|FG006|Overall Study|Adverse Event|0|||
162040939|NCT02448810|585207750|FG007|Overall Study|Adverse Event|0|||
162040940|NCT02448810|585207743|FG000|Overall Study|Withdrawal by Subject|0|||
162040941|NCT02448810|585207744|FG001|Overall Study|Withdrawal by Subject|0|||
162040942|NCT02448810|585207745|FG002|Overall Study|Withdrawal by Subject|1|||
162040943|NCT02448810|585207746|FG003|Overall Study|Withdrawal by Subject|0|||
162040944|NCT02448810|585207747|FG004|Overall Study|Withdrawal by Subject|3|||
162040945|NCT02448810|585207748|FG005|Overall Study|Withdrawal by Subject|5|||
162040946|NCT02448810|585207749|FG006|Overall Study|Withdrawal by Subject|0|||
162040947|NCT02448810|585207750|FG007|Overall Study|Withdrawal by Subject|2|||
162040948|NCT02448810|585207743|FG000|Overall Study|Other (study terminated by sponsor)|0|||
162040949|NCT02448810|585207744|FG001|Overall Study|Other (study terminated by sponsor)|0|||
162040950|NCT02448810|585207745|FG002|Overall Study|Other (study terminated by sponsor)|0|||
162040951|NCT02448810|585207746|FG003|Overall Study|Other (study terminated by sponsor)|0|||
162040952|NCT02448810|585207747|FG004|Overall Study|Other (study terminated by sponsor)|4|||
162040953|NCT02448810|585207748|FG005|Overall Study|Other (study terminated by sponsor)|2|||
162040954|NCT02448810|585207749|FG006|Overall Study|Other (study terminated by sponsor)|2|||
162040955|NCT02448810|585207750|FG007|Overall Study|Other (study terminated by sponsor)|1|||
162040956|NCT02448810|585207743|FG000|Overall Study|Death|1|||
162040957|NCT02448810|585207744|FG001|Overall Study|Death|0|||
162040958|NCT02448810|585207745|FG002|Overall Study|Death|1|||
162040959|NCT02448810|585207746|FG003|Overall Study|Death|0|||
162040960|NCT02448810|585207747|FG004|Overall Study|Death|1|||
162040961|NCT02448810|585207748|FG005|Overall Study|Death|0|||
162040962|NCT02448810|585207749|FG006|Overall Study|Death|0|||
162040963|NCT02448810|585207750|FG007|Overall Study|Death|0|||
162040964|NCT02448810|585207743|FG000|Overall Study|Other (Progressive disease)|2|||
162040965|NCT02448810|585207744|FG001|Overall Study|Other (Progressive disease)|2|||
162040966|NCT02448810|585207745|FG002|Overall Study|Other (Progressive disease)|0|||
162040967|NCT02448810|585207746|FG003|Overall Study|Other (Progressive disease)|3|||
162040968|NCT02448810|585207747|FG004|Overall Study|Other (Progressive disease)|23|||
162040969|NCT02448810|585207748|FG005|Overall Study|Other (Progressive disease)|9|||
162040970|NCT02448810|585207749|FG006|Overall Study|Other (Progressive disease)|14|||
162040971|NCT02448810|585207750|FG007|Overall Study|Other (Progressive disease)|5|||
162040972|NCT02448810|585207743|FG000|Overall Study|Lost to Follow-up|0|||
162040973|NCT02448810|585207744|FG001|Overall Study|Lost to Follow-up|1|||
162040974|NCT02448810|585207745|FG002|Overall Study|Lost to Follow-up|0|||
162040975|NCT02448810|585207746|FG003|Overall Study|Lost to Follow-up|0|||
162040976|NCT02448810|585207747|FG004|Overall Study|Lost to Follow-up|0|||
162040977|NCT02448810|585207748|FG005|Overall Study|Lost to Follow-up|0|||
162040978|NCT02448810|585207749|FG006|Overall Study|Lost to Follow-up|0|||
162040979|NCT02448810|585207750|FG007|Overall Study|Lost to Follow-up|0|||
162040980|NCT02448810|585207743|FG000|Overall Study|Other (unspecified)|0|||
162040981|NCT02448810|585207744|FG001|Overall Study|Other (unspecified)|0|||
162040982|NCT02448810|585207745|FG002|Overall Study|Other (unspecified)|0|||
162040983|NCT02448810|585207746|FG003|Overall Study|Other (unspecified)|0|||
162040984|NCT02448810|585207747|FG004|Overall Study|Other (unspecified)|0|||
162040985|NCT02448810|585207748|FG005|Overall Study|Other (unspecified)|0|||
162040986|NCT02448810|585207749|FG006|Overall Study|Other (unspecified)|2|||
162040987|NCT02448810|585207750|FG007|Overall Study|Other (unspecified)|0|||
162040988|NCT04795622|585207753|FG000|Overall Study|Adverse Event|1|||
162040989|NCT04795622|585207754|FG001|Overall Study|Adverse Event|0|||
162040990|NCT04795622|585207753|FG000|Overall Study|Withdrawal by Subject|3|||
162040991|NCT04795622|585207754|FG001|Overall Study|Withdrawal by Subject|3|||
162040992|NCT04795622|585207753|FG000|Overall Study|Protocol Violation|0|||
162040993|NCT04795622|585207754|FG001|Overall Study|Protocol Violation|2|||
162040994|NCT04795622|585207753|FG000|Overall Study|Lost to Follow-up|2|||
162040995|NCT04795622|585207754|FG001|Overall Study|Lost to Follow-up|3|||
162040996|NCT04795622|585207753|FG000|Overall Study|Other|7|||
162040997|NCT04795622|585207754|FG001|Overall Study|Other|8|||
162040998|NCT02314143|585207755|FG000|Overall Study|Adverse Event|0|||
162040999|NCT02314143|585207756|FG001|Overall Study|Adverse Event|6|||
162041000|NCT02314143|585207757|FG002|Overall Study|Adverse Event|4|||
162041001|NCT02314143|585207755|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
162041002|NCT02314143|585207756|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
162041003|NCT02314143|585207757|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
162041004|NCT02314143|585207755|FG000|Overall Study|Physician Decision|2|||
161998797|NCT03001557|585047301|FG004|Extension Phase|Administrative Reason|0|||
162041005|NCT02314143|585207756|FG001|Overall Study|Physician Decision|1|||
162041006|NCT02314143|585207757|FG002|Overall Study|Physician Decision|0|||
162041007|NCT02314143|585207755|FG000|Overall Study|Withdrawal by Subject|1|||
162041008|NCT02314143|585207756|FG001|Overall Study|Withdrawal by Subject|0|||
162041009|NCT02314143|585207757|FG002|Overall Study|Withdrawal by Subject|1|||
162041010|NCT03963401|585207761|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
162041011|NCT03963401|585207762|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
162041012|NCT03963401|585207763|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
162041013|NCT03963401|585207764|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
162041014|NCT03963401|585207765|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
162041015|NCT03963401|585207766|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
162041016|NCT03963401|585207761|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
162041017|NCT03963401|585207762|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
162041018|NCT03963401|585207763|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
162041019|NCT03963401|585207764|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
162041020|NCT03963401|585207765|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
162041021|NCT03963401|585207766|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
162041022|NCT03963401|585207761|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
161998798|NCT03001557|585047302|FG005|Extension Phase|Administrative Reason|1|||
161998799|NCT03001557|585047303|FG006|Extension Phase|Administrative Reason|3|||
161998800|NCT03001557|585047304|FG007|Extension Phase|Administrative Reason|3|||
161998801|NCT03001557|585047297|FG000|Extension Phase|Loss of caregiver|0|||
161998802|NCT03001557|585047298|FG001|Extension Phase|Loss of caregiver|0|||
161998803|NCT03001557|585047299|FG002|Extension Phase|Loss of caregiver|0|||
161998804|NCT03001557|585047300|FG003|Extension Phase|Loss of caregiver|0|||
161998805|NCT03001557|585047301|FG004|Extension Phase|Loss of caregiver|0|||
161998806|NCT03001557|585047302|FG005|Extension Phase|Loss of caregiver|0|||
161998807|NCT03001557|585047303|FG006|Extension Phase|Loss of caregiver|1|||
161998808|NCT03001557|585047304|FG007|Extension Phase|Loss of caregiver|0|||
161998809|NCT03001557|585047297|FG000|Extension Phase|Others|0|||
161998810|NCT03001557|585047298|FG001|Extension Phase|Others|0|||
161998811|NCT03001557|585047299|FG002|Extension Phase|Others|0|||
161998812|NCT03001557|585047300|FG003|Extension Phase|Others|0|||
161998813|NCT03001557|585047301|FG004|Extension Phase|Others|0|||
161998814|NCT03001557|585047302|FG005|Extension Phase|Others|1|||
161998815|NCT03001557|585047303|FG006|Extension Phase|Others|3|||
161998816|NCT03001557|585047304|FG007|Extension Phase|Others|0|||
161998817|NCT01272232|585047305|FG000|Weeks 0-56|Adverse Event|39|||
161998818|NCT01272232|585047306|FG001|Weeks 0-56|Adverse Event|18|||
161998819|NCT01272232|585047307|FG002|Weeks 0-56|Adverse Event|7|||
161998820|NCT01272232|585047305|FG000|Weeks 0-56|Lack of Efficacy|0|||
161998821|NCT01272232|585047306|FG001|Weeks 0-56|Lack of Efficacy|0|||
161998822|NCT01272232|585047307|FG002|Weeks 0-56|Lack of Efficacy|3|||
161998823|NCT01272232|585047305|FG000|Weeks 0-56|Protocol Violation|12|||
161998824|NCT01272232|585047306|FG001|Weeks 0-56|Protocol Violation|8|||
161998825|NCT01272232|585047307|FG002|Weeks 0-56|Protocol Violation|13|||
161998826|NCT01272232|585047305|FG000|Weeks 0-56|Withdrawal criteria|32|||
161998827|NCT01272232|585047306|FG001|Weeks 0-56|Withdrawal criteria|14|||
161998828|NCT01272232|585047307|FG002|Weeks 0-56|Withdrawal criteria|37|||
161998829|NCT01272232|585047305|FG000|Weeks 0-56|Unclassified|16|||
161998830|NCT01272232|585047306|FG001|Weeks 0-56|Unclassified|7|||
161998831|NCT01272232|585047307|FG002|Weeks 0-56|Unclassified|12|||
161998832|NCT01272232|585047305|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
161998833|NCT01272232|585047306|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
161998834|NCT01272232|585047307|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
161998835|NCT01272232|585047305|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
161998836|NCT01272232|585047306|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
161998837|NCT01272232|585047307|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
161998838|NCT01272232|585047305|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
161998839|NCT01272232|585047306|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
161998840|NCT01272232|585047307|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
162041023|NCT03963401|585207762|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
162041024|NCT03963401|585207763|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
161998841|NCT01272232|585047305|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
161998842|NCT01272232|585047306|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
161998843|NCT01272232|585047307|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
161998844|NCT01272232|585047305|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
161998845|NCT01272232|585047306|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
161998846|NCT01272232|585047307|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
161998847|NCT02159066|585047308|FG000|Part I|Adverse Event|7|||
161998848|NCT02159066|585047309|FG001|Part I|Adverse Event|5|||
161998849|NCT02159066|585047310|FG002|Part I|Adverse Event|0|||
161998850|NCT02159066|585047311|FG003|Part I|Adverse Event|0|||
161998851|NCT02159066|585047312|FG004|Part I|Adverse Event|0|||
161998852|NCT02159066|585047313|FG005|Part I|Adverse Event|0|||
161998853|NCT02159066|585047308|FG000|Part I|Death|11|||
161998854|NCT02159066|585047309|FG001|Part I|Death|9|||
161998855|NCT02159066|585047310|FG002|Part I|Death|0|||
161998856|NCT02159066|585047311|FG003|Part I|Death|0|||
161998857|NCT02159066|585047312|FG004|Part I|Death|0|||
161998858|NCT02159066|585047313|FG005|Part I|Death|0|||
161998859|NCT02159066|585047308|FG000|Part I|Progressive Disease|37|||
161998860|NCT02159066|585047309|FG001|Part I|Progressive Disease|46|||
161998861|NCT02159066|585047310|FG002|Part I|Progressive Disease|0|||
161998862|NCT02159066|585047311|FG003|Part I|Progressive Disease|0|||
161998863|NCT02159066|585047312|FG004|Part I|Progressive Disease|0|||
161998864|NCT02159066|585047313|FG005|Part I|Progressive Disease|0|||
161998865|NCT02159066|585047308|FG000|Part I|New Therapy for Study Indication|5|||
161998866|NCT02159066|585047309|FG001|Part I|New Therapy for Study Indication|4|||
161998867|NCT02159066|585047310|FG002|Part I|New Therapy for Study Indication|0|||
161998868|NCT02159066|585047311|FG003|Part I|New Therapy for Study Indication|0|||
161998869|NCT02159066|585047312|FG004|Part I|New Therapy for Study Indication|0|||
161998870|NCT02159066|585047313|FG005|Part I|New Therapy for Study Indication|0|||
161998871|NCT02159066|585047308|FG000|Part I|Termination of participants from the study|3|||
161998872|NCT02159066|585047309|FG001|Part I|Termination of participants from the study|3|||
161998873|NCT02159066|585047310|FG002|Part I|Termination of participants from the study|0|||
161998874|NCT02159066|585047311|FG003|Part I|Termination of participants from the study|0|||
161998875|NCT02159066|585047312|FG004|Part I|Termination of participants from the study|0|||
161998876|NCT02159066|585047313|FG005|Part I|Termination of participants from the study|0|||
161998877|NCT02159066|585047308|FG000|Part I|Physician Decision|2|||
161998878|NCT02159066|585047309|FG001|Part I|Physician Decision|9|||
161998879|NCT02159066|585047310|FG002|Part I|Physician Decision|0|||
161998880|NCT02159066|585047311|FG003|Part I|Physician Decision|0|||
161998881|NCT02159066|585047312|FG004|Part I|Physician Decision|0|||
161998882|NCT02159066|585047313|FG005|Part I|Physician Decision|0|||
161998883|NCT02159066|585047308|FG000|Part I|Participant/Guardian Decision|9|||
161998884|NCT02159066|585047309|FG001|Part I|Participant/Guardian Decision|3|||
161998885|NCT02159066|585047310|FG002|Part I|Participant/Guardian Decision|0|||
161998886|NCT02159066|585047311|FG003|Part I|Participant/Guardian Decision|0|||
161998887|NCT02159066|585047312|FG004|Part I|Participant/Guardian Decision|0|||
161998888|NCT02159066|585047313|FG005|Part I|Participant/Guardian Decision|0|||
161998889|NCT02159066|585047308|FG000|Part I|Missing Data|1|||
161998890|NCT02159066|585047309|FG001|Part I|Missing Data|0|||
161998891|NCT02159066|585047310|FG002|Part I|Missing Data|0|||
161998892|NCT02159066|585047311|FG003|Part I|Missing Data|0|||
161998893|NCT02159066|585047312|FG004|Part I|Missing Data|0|||
161998894|NCT02159066|585047313|FG005|Part I|Missing Data|0|||
161998895|NCT02159066|585047308|FG000|Part II|Adverse Event|0|||
161998896|NCT02159066|585047309|FG001|Part II|Adverse Event|0|||
161998897|NCT02159066|585047310|FG002|Part II|Adverse Event|1|||
161998898|NCT02159066|585047311|FG003|Part II|Adverse Event|0|||
161998899|NCT02159066|585047312|FG004|Part II|Adverse Event|1|||
161998900|NCT02159066|585047313|FG005|Part II|Adverse Event|1|||
161998901|NCT02159066|585047308|FG000|Part II|Death|0|||
161998902|NCT02159066|585047309|FG001|Part II|Death|0|||
161998903|NCT02159066|585047310|FG002|Part II|Death|1|||
161998904|NCT02159066|585047311|FG003|Part II|Death|0|||
161998905|NCT02159066|585047312|FG004|Part II|Death|2|||
161998906|NCT02159066|585047313|FG005|Part II|Death|1|||
161998907|NCT02159066|585047308|FG000|Part II|Progressive Disease|0|||
161998908|NCT02159066|585047309|FG001|Part II|Progressive Disease|0|||
161998909|NCT02159066|585047310|FG002|Part II|Progressive Disease|35|||
161998910|NCT02159066|585047311|FG003|Part II|Progressive Disease|1|||
161998911|NCT02159066|585047312|FG004|Part II|Progressive Disease|7|||
161998912|NCT02159066|585047313|FG005|Part II|Progressive Disease|4|||
161998913|NCT02159066|585047308|FG000|Part II|New Therapy for Study Indication|0|||
161998914|NCT02159066|585047309|FG001|Part II|New Therapy for Study Indication|0|||
161998915|NCT02159066|585047310|FG002|Part II|New Therapy for Study Indication|0|||
161998916|NCT02159066|585047311|FG003|Part II|New Therapy for Study Indication|0|||
161998917|NCT02159066|585047312|FG004|Part II|New Therapy for Study Indication|1|||
161998918|NCT02159066|585047313|FG005|Part II|New Therapy for Study Indication|0|||
161998919|NCT02159066|585047308|FG000|Part II|Physician Decision|0|||
161998920|NCT02159066|585047309|FG001|Part II|Physician Decision|0|||
161998921|NCT02159066|585047310|FG002|Part II|Physician Decision|1|||
161998922|NCT02159066|585047311|FG003|Part II|Physician Decision|0|||
161998923|NCT02159066|585047312|FG004|Part II|Physician Decision|0|||
161998924|NCT02159066|585047313|FG005|Part II|Physician Decision|0|||
161998925|NCT02159066|585047308|FG000|Part II|Participant/Guardian Decision|0|||
161998926|NCT02159066|585047309|FG001|Part II|Participant/Guardian Decision|0|||
161998927|NCT02159066|585047310|FG002|Part II|Participant/Guardian Decision|0|||
161998928|NCT02159066|585047311|FG003|Part II|Participant/Guardian Decision|0|||
161998929|NCT02159066|585047312|FG004|Part II|Participant/Guardian Decision|2|||
161998930|NCT02159066|585047313|FG005|Part II|Participant/Guardian Decision|0|||
161998931|NCT00255190|585047315|FG000|Overall Study|Adverse Event|17|||
161998932|NCT00255190|585047316|FG001|Overall Study|Adverse Event|36|||
161998933|NCT00255190|585047315|FG000|Overall Study|Protocol Violation|2|||
161998934|NCT00255190|585047316|FG001|Overall Study|Protocol Violation|2|||
161998935|NCT00255190|585047315|FG000|Overall Study|Lost to Follow-up|10|||
161998936|NCT00255190|585047316|FG001|Overall Study|Lost to Follow-up|27|||
161998937|NCT00255190|585047315|FG000|Overall Study|Withdrew Consent|17|||
161998938|NCT00255190|585047316|FG001|Overall Study|Withdrew Consent|48|||
161998939|NCT00255190|585047315|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
161998940|NCT00255190|585047316|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
161998941|NCT00255190|585047315|FG000|Overall Study|Erosive esophagitis not healed|0|||
161998942|NCT00255190|585047316|FG001|Overall Study|Erosive esophagitis not healed|20|||
161998943|NCT00255190|585047315|FG000|Overall Study|Various|4|||
161998944|NCT00255190|585047316|FG001|Overall Study|Various|23|||
161998945|NCT00628030|585047317|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
161998946|NCT00628030|585047318|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
161998947|NCT00628030|585047317|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
161998948|NCT00628030|585047318|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
161998949|NCT00628030|585047317|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
161998950|NCT00628030|585047318|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
161998951|NCT01255423|585047319|FG000|Overall Study|Abnormal Laboratory value|3|||
161998952|NCT01255423|585047320|FG001|Overall Study|Abnormal Laboratory value|2|||
161998953|NCT01255423|585047319|FG000|Overall Study|Use of prohibited medications|0|||
161998954|NCT01255423|585047320|FG001|Overall Study|Use of prohibited medications|1|||
161998955|NCT05470387|585047321|FG000|Overall Study|Protocol Violation|0|||
161998956|NCT05470387|585047322|FG001|Overall Study|Protocol Violation|3|||
161998957|NCT01454596|585047339|FG000|Overall Study|Death|0|||
161998958|NCT01454596|585047340|FG001|Overall Study|Death|0|||
161998959|NCT01454596|585047341|FG002|Overall Study|Death|0|||
161998960|NCT01454596|585047342|FG003|Overall Study|Death|0|||
161998961|NCT01454596|585047343|FG004|Overall Study|Death|0|||
161998962|NCT01454596|585047344|FG005|Overall Study|Death|0|||
161998963|NCT01454596|585047345|FG006|Overall Study|Death|0|||
161998964|NCT01454596|585047346|FG007|Overall Study|Death|0|||
161998965|NCT01454596|585047347|FG008|Overall Study|Death|0|||
161998966|NCT01454596|585047348|FG009|Overall Study|Death|1|||
161998967|NCT01454596|585047349|FG010|Overall Study|Death|1|||
161998968|NCT01454596|585047350|FG011|Overall Study|Death|0|||
161998969|NCT01188772|585047359|FG000|Overall Study|Randomized but Not Treated|0|||
161998970|NCT01188772|585047360|FG001|Overall Study|Randomized but Not Treated|1|||
161998971|NCT01188772|585047361|FG002|Overall Study|Randomized but Not Treated|0|||
161998972|NCT01188772|585047362|FG003|Overall Study|Randomized but Not Treated|0|||
161998973|NCT01188772|585047359|FG000|Overall Study|Adverse Event|0|||
161998974|NCT01188772|585047360|FG001|Overall Study|Adverse Event|1|||
161998975|NCT01188772|585047361|FG002|Overall Study|Adverse Event|2|||
161998976|NCT01188772|585047362|FG003|Overall Study|Adverse Event|0|||
161998977|NCT01188772|585047359|FG000|Overall Study|Lost to Follow-up|4|||
161998978|NCT01188772|585047360|FG001|Overall Study|Lost to Follow-up|1|||
161998979|NCT01188772|585047361|FG002|Overall Study|Lost to Follow-up|1|||
161998980|NCT01188772|585047362|FG003|Overall Study|Lost to Follow-up|1|||
161998981|NCT01188772|585047359|FG000|Overall Study|Non-responder|0|||
161998982|NCT01188772|585047360|FG001|Overall Study|Non-responder|0|||
161998983|NCT01188772|585047361|FG002|Overall Study|Non-responder|3|||
161998984|NCT01188772|585047362|FG003|Overall Study|Non-responder|0|||
161998985|NCT01188772|585047359|FG000|Overall Study|Physician Decision|0|||
161998986|NCT01188772|585047360|FG001|Overall Study|Physician Decision|0|||
161998987|NCT01188772|585047361|FG002|Overall Study|Physician Decision|1|||
161998988|NCT01188772|585047362|FG003|Overall Study|Physician Decision|0|||
161998989|NCT01188772|585047359|FG000|Overall Study|Terminated by Sponsor|0|||
161998990|NCT01188772|585047360|FG001|Overall Study|Terminated by Sponsor|0|||
161998991|NCT01188772|585047361|FG002|Overall Study|Terminated by Sponsor|1|||
161998992|NCT01188772|585047362|FG003|Overall Study|Terminated by Sponsor|0|||
161998993|NCT01188772|585047359|FG000|Overall Study|Treatment Failure|0|||
161998994|NCT01188772|585047360|FG001|Overall Study|Treatment Failure|0|||
161998995|NCT01188772|585047361|FG002|Overall Study|Treatment Failure|1|||
161998996|NCT01188772|585047362|FG003|Overall Study|Treatment Failure|0|||
161998997|NCT01188772|585047359|FG000|Overall Study|Virologic Failure|1|||
161998998|NCT01188772|585047360|FG001|Overall Study|Virologic Failure|0|||
161998999|NCT01188772|585047361|FG002|Overall Study|Virologic Failure|0|||
161999000|NCT01188772|585047362|FG003|Overall Study|Virologic Failure|0|||
161999001|NCT01188772|585047359|FG000|Overall Study|Withdrawal by Subject|0|||
161999002|NCT01188772|585047360|FG001|Overall Study|Withdrawal by Subject|0|||
161999003|NCT01188772|585047361|FG002|Overall Study|Withdrawal by Subject|2|||
161999004|NCT01188772|585047362|FG003|Overall Study|Withdrawal by Subject|0|||
161999005|NCT01894607|585047363|FG000|Overall Study|Ineligible|1|||
161999006|NCT01787461|585047378|FG000|Overall Study|Adverse Event|4|||
161999007|NCT01787461|585047379|FG001|Overall Study|Adverse Event|3|||
161999008|NCT01787461|585047378|FG000|Overall Study|Lost to Follow-up|3|||
161999009|NCT01787461|585047379|FG001|Overall Study|Lost to Follow-up|2|||
161999010|NCT01787461|585047378|FG000|Overall Study|No longer met eligibility criteria|1|||
161999011|NCT01787461|585047379|FG001|Overall Study|No longer met eligibility criteria|0|||
161999012|NCT01787461|585047378|FG000|Overall Study|Withdrawal by Subject|3|||
161999013|NCT01787461|585047379|FG001|Overall Study|Withdrawal by Subject|4|||
161999014|NCT01787461|585047378|FG000|Overall Study|Protocol Violation|3|||
161999015|NCT01787461|585047379|FG001|Overall Study|Protocol Violation|0|||
161999016|NCT00152503|585047380|FG000|Overall Study|Adverse Event|4|||
161999017|NCT03259555|585047381|FG000|Overall Study|Adverse Event|6|||
161999018|NCT03259555|585047382|FG001|Overall Study|Adverse Event|4|||
161999019|NCT03259555|585047381|FG000|Overall Study|Lack of Efficacy|6|||
161999020|NCT03259555|585047382|FG001|Overall Study|Lack of Efficacy|4|||
161999021|NCT03259555|585047381|FG000|Overall Study|Lost to Follow-up|0|||
161999022|NCT03259555|585047382|FG001|Overall Study|Lost to Follow-up|2|||
161999023|NCT03259555|585047381|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161999024|NCT03259555|585047382|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161999025|NCT03259555|585047381|FG000|Overall Study|Progressive Disease|0|||
161999026|NCT03259555|585047382|FG001|Overall Study|Progressive Disease|2|||
161999027|NCT03259555|585047381|FG000|Overall Study|Withdrawal by Subject|19|||
161999028|NCT03259555|585047382|FG001|Overall Study|Withdrawal by Subject|16|||
161999029|NCT03259555|585047381|FG000|Overall Study|Physician Decision|1|||
161999030|NCT03259555|585047382|FG001|Overall Study|Physician Decision|2|||
161999031|NCT03259555|585047381|FG000|Overall Study|Other|1|||
161999032|NCT03259555|585047382|FG001|Overall Study|Other|0|||
161999033|NCT02800863|585047383|FG000|Overall Study|Adverse Event|14|||
161999034|NCT02800863|585047383|FG000|Overall Study|Another Device Implanted|1|||
161999035|NCT02800863|585047383|FG000|Overall Study|Device Explanted|1|||
161999036|NCT02800863|585047383|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
161999037|NCT02800863|585047383|FG000|Overall Study|Health Issues|1|||
161999038|NCT02800863|585047383|FG000|Overall Study|Insurance Denial|8|||
161999039|NCT02800863|585047383|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
161999040|NCT02800863|585047383|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
161999041|NCT02800863|585047383|FG000|Overall Study|Screen Failure|1|||
161999042|NCT02800863|585047383|FG000|Overall Study|Sponsor Request|6|||
161999043|NCT02800863|585047383|FG000|Overall Study|Death|3|||
161999044|NCT02800863|585047383|FG000|Overall Study|Subject Implant at Another Facility|1|||
161999045|NCT02800863|585047383|FG000|Overall Study|Lost to Follow-up|26|||
161999046|NCT02800863|585047383|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
161999047|NCT02800863|585047383|FG000|Overall Study|Subject and/or Family Request|64|||
161999048|NCT02800863|585047383|FG000|Overall Study|Trial Failure|81|||
161999049|NCT02800863|585047383|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
161999050|NCT03957551|585047384|FG000|Overall Study|Adverse Event|2|||
161999051|NCT03957551|585047385|FG001|Overall Study|Adverse Event|2|||
161999052|NCT03957551|585047386|FG002|Overall Study|Adverse Event|6|||
161999053|NCT03957551|585047384|FG000|Overall Study|Physician Decision|1|||
161999054|NCT03957551|585047385|FG001|Overall Study|Physician Decision|0|||
161999055|NCT03957551|585047386|FG002|Overall Study|Physician Decision|2|||
161999056|NCT03957551|585047384|FG000|Overall Study|Withdrawal by Subject|1|||
161999057|NCT03957551|585047385|FG001|Overall Study|Withdrawal by Subject|0|||
161999058|NCT03957551|585047386|FG002|Overall Study|Withdrawal by Subject|2|||
161999059|NCT03957551|585047384|FG000|Overall Study|Disease progression|1|||
161999060|NCT03957551|585047385|FG001|Overall Study|Disease progression|0|||
161999061|NCT03957551|585047386|FG002|Overall Study|Disease progression|8|||
161999062|NCT00607087|585047387|FG000|Overall Study|Withdrawal by Subject|9|||
161999063|NCT00607087|585047388|FG001|Overall Study|Withdrawal by Subject|4|||
161999064|NCT00607087|585047389|FG002|Overall Study|Withdrawal by Subject|4|||
161999065|NCT00607087|585047387|FG000|Overall Study|Adverse Event|3|||
161999066|NCT00607087|585047388|FG001|Overall Study|Adverse Event|2|||
161999067|NCT00607087|585047389|FG002|Overall Study|Adverse Event|3|||
161999068|NCT00607087|585047387|FG000|Overall Study|Other reason|1|||
161999069|NCT00607087|585047388|FG001|Overall Study|Other reason|5|||
161999070|NCT00607087|585047389|FG002|Overall Study|Other reason|2|||
161999071|NCT00607087|585047387|FG000|Overall Study|Poor compliance to protocol|1|||
161999072|NCT00607087|585047388|FG001|Overall Study|Poor compliance to protocol|0|||
161999073|NCT00607087|585047389|FG002|Overall Study|Poor compliance to protocol|1|||
161999074|NCT00607087|585047387|FG000|Overall Study|Lost to Follow-up|1|||
161999075|NCT00607087|585047388|FG001|Overall Study|Lost to Follow-up|0|||
161999076|NCT00607087|585047389|FG002|Overall Study|Lost to Follow-up|0|||
161999077|NCT00607087|585047387|FG000|Period 1|Withdrawal by Subject|7|||
161999078|NCT00607087|585047388|FG001|Period 1|Withdrawal by Subject|2|||
161999079|NCT00607087|585047389|FG002|Period 1|Withdrawal by Subject|3|||
161999080|NCT00607087|585047387|FG000|Period 1|Adverse Event|3|||
161999081|NCT00607087|585047388|FG001|Period 1|Adverse Event|0|||
161999082|NCT00607087|585047389|FG002|Period 1|Adverse Event|0|||
161999083|NCT00607087|585047387|FG000|Period 1|Poor compliance to protocol|1|||
161999084|NCT00607087|585047388|FG001|Period 1|Poor compliance to protocol|0|||
162041025|NCT03963401|585207764|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
162041026|NCT03963401|585207765|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
162041027|NCT03963401|585207766|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
162041028|NCT03963401|585207761|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
162041029|NCT03963401|585207762|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
162041030|NCT03963401|585207763|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
162041031|NCT03963401|585207764|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
162041032|NCT03963401|585207765|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
162041033|NCT03963401|585207766|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
162041034|NCT03963401|585207761|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
162041035|NCT03963401|585207762|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
162041036|NCT03963401|585207763|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
162041037|NCT03963401|585207764|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
162041038|NCT03963401|585207765|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
162041039|NCT03963401|585207766|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
162041040|NCT03963401|585207761|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
162041041|NCT03963401|585207762|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
162041042|NCT03963401|585207763|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
162041043|NCT03963401|585207764|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
162041044|NCT03963401|585207765|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
162041045|NCT03963401|585207766|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
162041046|NCT03963401|585207761|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
162041047|NCT03963401|585207762|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
162041048|NCT03963401|585207763|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
162041049|NCT03963401|585207764|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
162041050|NCT03963401|585207765|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
162041051|NCT03963401|585207766|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
162041052|NCT03963401|585207761|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
162041053|NCT03963401|585207762|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
162041054|NCT03963401|585207763|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
162041055|NCT03963401|585207764|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
162041056|NCT03963401|585207765|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
162041057|NCT03963401|585207766|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
162041058|NCT03963401|585207761|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
162041059|NCT03963401|585207762|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
162041060|NCT03963401|585207763|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
162041061|NCT03963401|585207764|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
162041062|NCT03963401|585207765|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
162041063|NCT03963401|585207766|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
162041064|NCT03963401|585207761|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
162041065|NCT03963401|585207762|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
162041066|NCT03963401|585207763|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
162041067|NCT03963401|585207764|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
162041068|NCT03963401|585207765|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
162041069|NCT03963401|585207766|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
162041070|NCT03963401|585207761|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
162041071|NCT03963401|585207762|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
162041072|NCT03963401|585207763|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
162041073|NCT03963401|585207764|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
162041074|NCT03963401|585207765|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
162041075|NCT03963401|585207766|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
162041076|NCT01070043|585207778|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
162041077|NCT01070043|585207779|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
162041078|NCT01070043|585207780|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
162041079|NCT01070043|585207778|FG000|Double-Blind Treatment|Adverse Event|0|||
162041080|NCT01070043|585207779|FG001|Double-Blind Treatment|Adverse Event|0|||
162041081|NCT01070043|585207780|FG002|Double-Blind Treatment|Adverse Event|2|||
162041082|NCT01528215|585207781|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
162041083|NCT01528215|585207782|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
162041084|NCT01528215|585207781|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
162041085|NCT01528215|585207782|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
162041086|NCT01528215|585207781|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
162041087|NCT01528215|585207782|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
162041088|NCT01528215|585207781|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
162041089|NCT01528215|585207782|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
162041090|NCT01610271|585207785|FG000|Overall Study|Surgery not complete|0|||
162041091|NCT01610271|585207786|FG001|Overall Study|Surgery not complete|1|||
162041092|NCT01610271|585207785|FG000|Overall Study|Prosthesis not implanted|2|||
162041093|NCT01610271|585207786|FG001|Overall Study|Prosthesis not implanted|3|||
162041094|NCT01638819|585207787|FG000|Overall Study|Lost to Follow-up|1|||
162041095|NCT01638819|585207788|FG001|Overall Study|Lost to Follow-up|0|||
162041096|NCT00923936|585207789|FG000|Overall Study|progressive disease on study|2|||
162041097|NCT00923936|585207790|FG001|Overall Study|progressive disease on study|1|||
162041098|NCT00923936|585207789|FG000|Overall Study|Adverse Event|2|||
162041099|NCT00923936|585207790|FG001|Overall Study|Adverse Event|1|||
162041100|NCT00923936|585207789|FG000|Overall Study|Lost to follow up|2|||
162041101|NCT00923936|585207790|FG001|Overall Study|Lost to follow up|0|||
162041102|NCT00923936|585207789|FG000|Overall Study|Continuing in follow up period|2|||
162041103|NCT00923936|585207790|FG001|Overall Study|Continuing in follow up period|1|||
162041104|NCT02038452|585207791|FG000|Overall Study|Withdrawal by Subject|7|||
162041105|NCT02038452|585207792|FG001|Overall Study|Withdrawal by Subject|9|||
162041106|NCT02038452|585207791|FG000|Overall Study|Lost to Follow-up|31|||
162041107|NCT02038452|585207792|FG001|Overall Study|Lost to Follow-up|28|||
162041108|NCT00986479|585207793|FG000|Period 1|Improved mood|1|||
162041109|NCT00986479|585207794|FG001|Period 1|Improved mood|0|||
162041110|NCT00986479|585207793|FG000|Period 1|Administrative reasons|1|||
162041111|NCT00986479|585207794|FG001|Period 1|Administrative reasons|0|||
162041112|NCT01721070|585207795|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
162041113|NCT02035475|585207796|FG000|Overall Study|Withdrawal by Subject|4|||
162041114|NCT02035475|585207796|FG000|Overall Study|Physician Decision|1|||
162041115|NCT02035475|585207796|FG000|Overall Study|Equipment Error|1|||
162041116|NCT01626495|585207802|FG000|Overall Study|Adverse Event|3|||
162041117|NCT01626495|585207802|FG000|Overall Study|Disease progression|27|||
162041118|NCT01626495|585207802|FG000|Overall Study|Withdrawal by Subject|1|||
162041119|NCT01626495|585207802|FG000|Overall Study|Administrative problem|1|||
162041120|NCT01626495|585207802|FG000|Overall Study|Death|2|||
162041121|NCT01626495|585207802|FG000|Overall Study|Physician Decision|1|||
162041122|NCT01626495|585207802|FG000|Overall Study|New cancer therapy|16|||
162041123|NCT01626495|585207802|FG000|Overall Study|Manufacturing failure|1|||
162041124|NCT00304239|585207803|FG000|Overall Study|Protocol Deviations/Violations|15|||
162041125|NCT00304239|585207804|FG001|Overall Study|Protocol Deviations/Violations|0|||
162041126|NCT00304239|585207803|FG000|Overall Study|Adverse Event|2|||
162041127|NCT00304239|585207804|FG001|Overall Study|Adverse Event|0|||
162041128|NCT05430022|585207815|FG000|Overall Study|Withdrawal by Subject|4|||
162041129|NCT05430022|585207816|FG001|Overall Study|Withdrawal by Subject|4|||
162041130|NCT05521906|585207817|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
162041131|NCT05521906|585207818|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
162041132|NCT03148275|585207819|FG000|Overall Study|Death|6|||
162041133|NCT03148275|585207819|FG000|Overall Study|Adverse Event|3|||
162041134|NCT03148275|585207819|FG000|Overall Study|Liver transplant|2|||
162041135|NCT03148275|585207819|FG000|Overall Study|Patient decision|5|||
162041136|NCT03148275|585207819|FG000|Overall Study|transition to commercial drug|1|||
161999085|NCT00607087|585047389|FG002|Period 1|Poor compliance to protocol|0|||
161999086|NCT00607087|585047387|FG000|Period 1|Lost to Follow-up|1|||
161999087|NCT00607087|585047388|FG001|Period 1|Lost to Follow-up|0|||
161999088|NCT00607087|585047389|FG002|Period 1|Lost to Follow-up|0|||
161999089|NCT00607087|585047387|FG000|Period 1|Other reason|0|||
161999090|NCT00607087|585047388|FG001|Period 1|Other reason|4|||
161999091|NCT00607087|585047389|FG002|Period 1|Other reason|2|||
161999092|NCT00607087|585047387|FG000|Period 2|Withdrawal by Subject|0|||
161999093|NCT00607087|585047388|FG001|Period 2|Withdrawal by Subject|1|||
161999094|NCT00607087|585047389|FG002|Period 2|Withdrawal by Subject|1|||
161999095|NCT00607087|585047387|FG000|Period 2|Other reason|1|||
161999096|NCT00607087|585047388|FG001|Period 2|Other reason|1|||
161999097|NCT00607087|585047389|FG002|Period 2|Other reason|0|||
161999098|NCT00607087|585047387|FG000|Period 2|Adverse Event|0|||
161999099|NCT00607087|585047388|FG001|Period 2|Adverse Event|1|||
161999100|NCT00607087|585047389|FG002|Period 2|Adverse Event|3|||
161999101|NCT00607087|585047387|FG000|Period 2|Poor compliance to protocol|0|||
161999102|NCT00607087|585047388|FG001|Period 2|Poor compliance to protocol|0|||
161999103|NCT00607087|585047389|FG002|Period 2|Poor compliance to protocol|1|||
161999104|NCT00607087|585047387|FG000|Period 3|Withdrawal by Subject|2|||
161999105|NCT00607087|585047388|FG001|Period 3|Withdrawal by Subject|1|||
161999106|NCT00607087|585047389|FG002|Period 3|Withdrawal by Subject|0|||
161999107|NCT00607087|585047387|FG000|Period 3|Adverse Event|0|||
161999108|NCT00607087|585047388|FG001|Period 3|Adverse Event|1|||
161999109|NCT00607087|585047389|FG002|Period 3|Adverse Event|0|||
161999110|NCT02717494|585047392|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
161999111|NCT02717494|585047393|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
161999112|NCT02717494|585047394|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
161999113|NCT02717494|585047392|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
162041137|NCT03148275|585207819|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
162041138|NCT00866788|585210305|FG000|Overall Study|Adverse Event|0|||
162041139|NCT00866788|585210306|FG001|Overall Study|Adverse Event|2|||
162041140|NCT00866788|585210307|FG002|Overall Study|Adverse Event|0|||
162041141|NCT00866788|585210308|FG003|Overall Study|Adverse Event|1|||
162041142|NCT00866788|585210305|FG000|Overall Study|Lost to Follow-up|1|||
162041143|NCT00866788|585210306|FG001|Overall Study|Lost to Follow-up|1|||
162041144|NCT00866788|585210307|FG002|Overall Study|Lost to Follow-up|0|||
162041145|NCT00866788|585210308|FG003|Overall Study|Lost to Follow-up|2|||
162041146|NCT00866788|585210305|FG000|Overall Study|Withdrawal by Subject|2|||
162041147|NCT00866788|585210306|FG001|Overall Study|Withdrawal by Subject|1|||
162041148|NCT00866788|585210307|FG002|Overall Study|Withdrawal by Subject|0|||
162041149|NCT00866788|585210308|FG003|Overall Study|Withdrawal by Subject|1|||
162041150|NCT00866788|585210305|FG000|Overall Study|Pregnancy|0|||
162041151|NCT00866788|585210306|FG001|Overall Study|Pregnancy|1|||
162041152|NCT00866788|585210307|FG002|Overall Study|Pregnancy|0|||
162041153|NCT00866788|585210308|FG003|Overall Study|Pregnancy|0|||
162041154|NCT00866788|585210305|FG000|Overall Study|Disease progression|3|||
162041155|NCT00866788|585210306|FG001|Overall Study|Disease progression|1|||
162041156|NCT00866788|585210307|FG002|Overall Study|Disease progression|1|||
162041157|NCT00866788|585210308|FG003|Overall Study|Disease progression|0|||
162041158|NCT00866788|585210305|FG000|Overall Study|Physician Decision|0|||
162041159|NCT00866788|585210306|FG001|Overall Study|Physician Decision|0|||
162041160|NCT00866788|585210307|FG002|Overall Study|Physician Decision|1|||
162041161|NCT00866788|585210308|FG003|Overall Study|Physician Decision|1|||
162041162|NCT02349061|585210310|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
162041163|NCT02349061|585210311|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
162041164|NCT02349061|585210312|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
162041165|NCT02349061|585210310|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
162041166|NCT02349061|585210311|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
162041167|NCT02349061|585210312|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
162041168|NCT02349061|585210310|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
162041169|NCT02349061|585210311|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
162041170|NCT02349061|585210312|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
162041171|NCT02349061|585210310|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
162041172|NCT02349061|585210311|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
162041173|NCT02349061|585210312|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
162041174|NCT02349061|585210310|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
162041175|NCT02349061|585210311|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
162041176|NCT02349061|585210312|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
162041177|NCT02349061|585210310|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
162041178|NCT02349061|585210311|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
162041179|NCT02349061|585210312|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
162041180|NCT02349061|585210310|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
162041181|NCT02349061|585210311|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
162041182|NCT02349061|585210312|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
162041183|NCT02349061|585210310|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
162041184|NCT02349061|585210311|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
162041185|NCT02349061|585210312|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
162041186|NCT02349061|585210310|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
162041187|NCT02349061|585210311|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
162041188|NCT02349061|585210312|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
162041189|NCT02349061|585210310|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
162041190|NCT02349061|585210311|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
162041191|NCT02349061|585210312|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
162041192|NCT02349061|585210310|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
161999114|NCT02717494|585047393|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
161999115|NCT02717494|585047394|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
161999116|NCT02717494|585047392|FG000|First Intervention (Step 1)|Death|0|||
161999117|NCT02717494|585047393|FG001|First Intervention (Step 1)|Death|0|||
161999118|NCT02717494|585047394|FG002|First Intervention (Step 1)|Death|1|||
161999119|NCT02717494|585047392|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
161999120|NCT02717494|585047393|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
161999121|NCT02717494|585047394|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
161999122|NCT01774799|585047400|FG000|Overall Study|Lost to Follow-up|1|||
162041193|NCT02349061|585210311|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
162041194|NCT02349061|585210312|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
162041195|NCT02349061|585210310|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
162041196|NCT02349061|585210311|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
162041197|NCT02349061|585210312|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
162041198|NCT02349061|585210310|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
161999123|NCT01774799|585047401|FG001|Overall Study|Lost to Follow-up|1|||
161999124|NCT01774799|585047402|FG002|Overall Study|Lost to Follow-up|0|||
161999125|NCT01774799|585047403|FG003|Overall Study|Lost to Follow-up|0|||
161999126|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
161999127|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
161999128|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
161999129|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
161999130|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
161999131|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
161999132|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
161999133|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
161999134|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
161999135|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
161999136|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
161999137|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
161999138|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
161999139|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
161999140|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
161999141|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
161999142|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
161999143|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
161999144|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
161999145|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
161999146|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
161999147|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
161999148|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
161999149|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
161999150|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
161999151|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
161999152|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
161999153|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
161999154|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
161999155|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
161999156|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
161999157|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
161999158|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
161999159|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
161999160|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
161999161|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
161999162|NCT02586623|585047404|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
161999163|NCT02586623|585047405|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
161999164|NCT02586623|585047406|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
161999165|NCT02586623|585047404|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
161999166|NCT02586623|585047405|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
161999167|NCT02586623|585047406|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
161999168|NCT02586623|585047404|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
161999169|NCT02586623|585047405|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
161999170|NCT02586623|585047406|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
161999171|NCT02586623|585047404|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
161999172|NCT02586623|585047405|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
161999173|NCT02586623|585047406|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
161999174|NCT02586623|585047404|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
161999175|NCT02586623|585047405|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
161999176|NCT02586623|585047406|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
161999177|NCT02586623|585047404|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
161999178|NCT02586623|585047405|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
161999179|NCT02586623|585047406|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
161999180|NCT02586623|585047404|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
161999181|NCT02586623|585047405|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
161999182|NCT02586623|585047406|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
161999183|NCT02586623|585047404|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
161999184|NCT02586623|585047405|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
161999185|NCT02586623|585047406|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
161999186|NCT02586623|585047404|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
161999187|NCT02586623|585047405|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
161999188|NCT02586623|585047406|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
161999189|NCT04393493|585047409|FG000|First 4 Days of Intervention|Early improvement|5|||
161999190|NCT04393493|585047410|FG001|First 4 Days of Intervention|Early improvement|7|||
161999191|NCT02910466|585047411|FG000|Overall Study|Adverse Event|1|||
161999192|NCT02910466|585047411|FG000|Overall Study|Withdrawal by Subject|3|||
161999193|NCT02910466|585047411|FG000|Overall Study|Lost to Follow-up|5|||
161999194|NCT02910466|585047411|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
161999195|NCT02910466|585047411|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
161999196|NCT01125800|585047413|FG000|Phase I|Protocol Violation|0|||
161999197|NCT01125800|585047414|FG001|Phase I|Protocol Violation|3|||
161999198|NCT01125800|585047415|FG002|Phase I|Protocol Violation|1|||
161999199|NCT01125800|585047416|FG003|Phase I|Protocol Violation|1|||
161999200|NCT01125800|585047417|FG004|Phase I|Protocol Violation|0|||
161999201|NCT01125800|585047413|FG000|Phase I|Adverse Event|2|||
161999202|NCT01125800|585047414|FG001|Phase I|Adverse Event|2|||
161999203|NCT01125800|585047415|FG002|Phase I|Adverse Event|1|||
161999204|NCT01125800|585047416|FG003|Phase I|Adverse Event|7|||
161999205|NCT01125800|585047417|FG004|Phase I|Adverse Event|0|||
161999206|NCT01125800|585047413|FG000|Phase I|Administrative problems|1|||
161999207|NCT01125800|585047414|FG001|Phase I|Administrative problems|0|||
161999208|NCT01125800|585047415|FG002|Phase I|Administrative problems|0|||
161999209|NCT01125800|585047416|FG003|Phase I|Administrative problems|0|||
161999210|NCT01125800|585047417|FG004|Phase I|Administrative problems|0|||
161999211|NCT01125800|585047413|FG000|Phase I|Withdrawal by Subject|0|||
161999212|NCT01125800|585047414|FG001|Phase I|Withdrawal by Subject|0|||
161999213|NCT01125800|585047415|FG002|Phase I|Withdrawal by Subject|1|||
161999214|NCT01125800|585047416|FG003|Phase I|Withdrawal by Subject|0|||
161999215|NCT01125800|585047417|FG004|Phase I|Withdrawal by Subject|0|||
161999216|NCT01125800|585047413|FG000|Phase I|Disease progression|5|||
161999217|NCT01125800|585047414|FG001|Phase I|Disease progression|4|||
161999218|NCT01125800|585047415|FG002|Phase I|Disease progression|1|||
161999219|NCT01125800|585047416|FG003|Phase I|Disease progression|3|||
161999220|NCT01125800|585047417|FG004|Phase I|Disease progression|0|||
161999221|NCT01125800|585047413|FG000|Phase II|Protocol Violation|0|||
161999222|NCT01125800|585047414|FG001|Phase II|Protocol Violation|0|||
161999223|NCT01125800|585047415|FG002|Phase II|Protocol Violation|0|||
161999224|NCT01125800|585047416|FG003|Phase II|Protocol Violation|0|||
161999225|NCT01125800|585047417|FG004|Phase II|Protocol Violation|1|||
161999226|NCT01125800|585047413|FG000|Phase II|Adverse Event|0|||
161999227|NCT01125800|585047414|FG001|Phase II|Adverse Event|0|||
161999228|NCT01125800|585047415|FG002|Phase II|Adverse Event|0|||
161999229|NCT01125800|585047416|FG003|Phase II|Adverse Event|0|||
161999230|NCT01125800|585047417|FG004|Phase II|Adverse Event|2|||
161999231|NCT01125800|585047413|FG000|Phase II|Disease progression|0|||
161999232|NCT01125800|585047414|FG001|Phase II|Disease progression|0|||
161999233|NCT01125800|585047415|FG002|Phase II|Disease progression|0|||
161999234|NCT01125800|585047416|FG003|Phase II|Disease progression|1|||
161999235|NCT01125800|585047417|FG004|Phase II|Disease progression|8|||
161999236|NCT05051579|585047421|FG000|Overall Study|Withdrawal by Subject|3|||
161999237|NCT05051579|585047422|FG001|Overall Study|Withdrawal by Subject|5|||
161999238|NCT05051579|585047423|FG002|Overall Study|Withdrawal by Subject|2|||
161999239|NCT05051579|585047424|FG003|Overall Study|Withdrawal by Subject|1|||
161999240|NCT05051579|585047425|FG004|Overall Study|Withdrawal by Subject|4|||
161999241|NCT05051579|585047426|FG005|Overall Study|Withdrawal by Subject|0|||
161999242|NCT05051579|585047427|FG006|Overall Study|Withdrawal by Subject|4|||
161999243|NCT05051579|585047421|FG000|Overall Study|Lost to Follow-up|1|||
161999244|NCT05051579|585047422|FG001|Overall Study|Lost to Follow-up|0|||
161999245|NCT05051579|585047423|FG002|Overall Study|Lost to Follow-up|0|||
161999246|NCT05051579|585047424|FG003|Overall Study|Lost to Follow-up|0|||
161999247|NCT05051579|585047425|FG004|Overall Study|Lost to Follow-up|1|||
161999248|NCT05051579|585047426|FG005|Overall Study|Lost to Follow-up|0|||
161999249|NCT05051579|585047427|FG006|Overall Study|Lost to Follow-up|1|||
161999250|NCT05051579|585047421|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
161999251|NCT05051579|585047422|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
161999252|NCT05051579|585047423|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
161999253|NCT05051579|585047424|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
161999254|NCT05051579|585047425|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
161999255|NCT05051579|585047426|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
161999256|NCT05051579|585047427|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
161999257|NCT05051579|585047421|FG000|Overall Study|Adverse Event|2|||
161999258|NCT05051579|585047422|FG001|Overall Study|Adverse Event|1|||
161999259|NCT05051579|585047423|FG002|Overall Study|Adverse Event|0|||
161999260|NCT05051579|585047424|FG003|Overall Study|Adverse Event|4|||
161999261|NCT05051579|585047425|FG004|Overall Study|Adverse Event|1|||
161999262|NCT05051579|585047426|FG005|Overall Study|Adverse Event|2|||
161999263|NCT05051579|585047427|FG006|Overall Study|Adverse Event|0|||
161999264|NCT05051579|585047421|FG000|Overall Study|Inadvertent Enrollment|0|||
161999265|NCT05051579|585047422|FG001|Overall Study|Inadvertent Enrollment|0|||
161999266|NCT05051579|585047423|FG002|Overall Study|Inadvertent Enrollment|0|||
162041199|NCT02349061|585210311|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
162041200|NCT02349061|585210312|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
162041201|NCT02095223|585210313|FG000|Overall Study|Withdrawal by Subject|1|||
162041202|NCT02095223|585210314|FG001|Overall Study|Withdrawal by Subject|0|||
162041203|NCT01397162|585210315|FG000|Overall Study|Adverse Event|4|||
162041204|NCT01397162|585210316|FG001|Overall Study|Adverse Event|0|||
162041205|NCT01397162|585210317|FG002|Overall Study|Adverse Event|0|||
162041206|NCT01397162|585210318|FG003|Overall Study|Adverse Event|0|||
162041207|NCT01397162|585210319|FG004|Overall Study|Adverse Event|0|||
162041208|NCT01397162|585210315|FG000|Overall Study|Not yet defined|3|||
162041209|NCT01397162|585210316|FG001|Overall Study|Not yet defined|4|||
162041210|NCT01397162|585210317|FG002|Overall Study|Not yet defined|3|||
162041211|NCT01397162|585210318|FG003|Overall Study|Not yet defined|5|||
162041212|NCT01397162|585210319|FG004|Overall Study|Not yet defined|3|||
162041213|NCT02339285|585210320|FG000|Overall Study|Withdrawal by Subject|0|||
162041214|NCT02339285|585210321|FG001|Overall Study|Withdrawal by Subject|1|||
162041215|NCT02339285|585210322|FG002|Overall Study|Withdrawal by Subject|1|||
162041216|NCT02339285|585210320|FG000|Overall Study|Lost to Follow-up|1|||
162041217|NCT02339285|585210321|FG001|Overall Study|Lost to Follow-up|1|||
162041218|NCT02339285|585210322|FG002|Overall Study|Lost to Follow-up|1|||
162041219|NCT02339285|585210320|FG000|Overall Study|Protocol Deviation|0|||
162041220|NCT02339285|585210321|FG001|Overall Study|Protocol Deviation|1|||
162041221|NCT02339285|585210322|FG002|Overall Study|Protocol Deviation|0|||
162041222|NCT01507298|585210325|FG000|Overall Study|Protocol Violation|0|||
162041223|NCT01507298|585210326|FG001|Overall Study|Protocol Violation|6|||
162041224|NCT01920555|585210327|FG000|Overall Study|Physician Decision|1|||
162041225|NCT01920555|585210328|FG001|Overall Study|Physician Decision|2|||
162041226|NCT01920555|585210329|FG002|Overall Study|Physician Decision|1|||
162041227|NCT01920555|585210330|FG003|Overall Study|Physician Decision|2|||
162041228|NCT01920555|585210331|FG004|Overall Study|Physician Decision|0|||
162041229|NCT01920555|585210327|FG000|Overall Study|Lack of Efficacy|2|||
162041230|NCT01920555|585210328|FG001|Overall Study|Lack of Efficacy|0|||
162041231|NCT01920555|585210329|FG002|Overall Study|Lack of Efficacy|0|||
162041232|NCT01920555|585210330|FG003|Overall Study|Lack of Efficacy|0|||
162041233|NCT01920555|585210331|FG004|Overall Study|Lack of Efficacy|0|||
162041234|NCT01920555|585210327|FG000|Overall Study|Travel Difficulties|1|||
162041235|NCT01920555|585210328|FG001|Overall Study|Travel Difficulties|1|||
162041236|NCT01920555|585210329|FG002|Overall Study|Travel Difficulties|0|||
162041237|NCT01920555|585210330|FG003|Overall Study|Travel Difficulties|0|||
162041238|NCT01920555|585210331|FG004|Overall Study|Travel Difficulties|1|||
162041239|NCT01920555|585210327|FG000|Overall Study|Lost to Follow-up|0|||
162041240|NCT01920555|585210328|FG001|Overall Study|Lost to Follow-up|1|||
162041241|NCT01920555|585210329|FG002|Overall Study|Lost to Follow-up|0|||
162041242|NCT01920555|585210330|FG003|Overall Study|Lost to Follow-up|1|||
162041243|NCT01920555|585210331|FG004|Overall Study|Lost to Follow-up|0|||
162041244|NCT00195273|585210332|FG000|Overall Study|Adverse Event|9|||
162041245|NCT00195273|585210333|FG001|Overall Study|Adverse Event|9|||
162041246|NCT00195273|585210332|FG000|Overall Study|Protocol deviation|0|||
162041247|NCT00195273|585210333|FG001|Overall Study|Protocol deviation|1|||
162041248|NCT00195273|585210332|FG000|Overall Study|Lack of Efficacy|3|||
162041249|NCT00195273|585210333|FG001|Overall Study|Lack of Efficacy|1|||
162041250|NCT00195273|585210332|FG000|Overall Study|Procedural complications|9|||
162041251|NCT00195273|585210333|FG001|Overall Study|Procedural complications|3|||
162041252|NCT02367131|585210337|FG000|Overall Study|Adverse Event|64|||
162041253|NCT02367131|585210337|FG000|Overall Study|No visit since the first visit|3|||
162041254|NCT02367131|585210337|FG000|Overall Study|Request by patient|53|||
162041255|NCT02367131|585210337|FG000|Overall Study|Improvement/remission|2|||
161999267|NCT05051579|585047424|FG003|Overall Study|Inadvertent Enrollment|0|||
161999268|NCT05051579|585047425|FG004|Overall Study|Inadvertent Enrollment|0|||
161999269|NCT05051579|585047426|FG005|Overall Study|Inadvertent Enrollment|0|||
162041256|NCT02367131|585210337|FG000|Overall Study|No change/progressive disease|78|||
162041257|NCT02367131|585210337|FG000|Overall Study|Other than stated above|20|||
162041258|NCT02367131|585210337|FG000|Overall Study|Not treated|2|||
162041259|NCT00810108|585210340|FG000|Overall Study|Withdrawal by Subject|1|||
162041260|NCT00810108|585210341|FG001|Overall Study|Withdrawal by Subject|0|||
162041261|NCT01051466|585210342|FG000|Overall Study|Adverse Event|1|||
161999270|NCT05051579|585047427|FG006|Overall Study|Inadvertent Enrollment|1|||
161999271|NCT05051579|585047421|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
161999272|NCT05051579|585047422|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
161999273|NCT05051579|585047423|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
161999274|NCT05051579|585047424|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
161999275|NCT05051579|585047425|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
161999276|NCT05051579|585047426|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
161999277|NCT05051579|585047427|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
161999278|NCT05051579|585047421|FG000|Overall Study|Sponsor Decision|0|||
162041262|NCT01051466|585210343|FG001|Overall Study|Adverse Event|0|||
162041263|NCT01051466|585210342|FG000|Overall Study|Lost to Follow-up|1|||
162041264|NCT01051466|585210343|FG001|Overall Study|Lost to Follow-up|1|||
162041265|NCT01051466|585210342|FG000|Overall Study|Withdrawal by Subject|5|||
162041266|NCT01051466|585210343|FG001|Overall Study|Withdrawal by Subject|1|||
162041267|NCT01051466|585210342|FG000|Overall Study|Entry Criteria Not Met|0|||
162041268|NCT01051466|585210343|FG001|Overall Study|Entry Criteria Not Met|3|||
162041269|NCT01051466|585210342|FG000|Overall Study|Physician Decision|1|||
162041270|NCT01051466|585210343|FG001|Overall Study|Physician Decision|0|||
162041271|NCT03793556|585210349|FG000|Overall Study|Withdrawal by Subject|12|||
162041272|NCT03793556|585210350|FG001|Overall Study|Withdrawal by Subject|1|||
162041273|NCT03793556|585210349|FG000|Overall Study|Lost to Follow-up|1|||
162041274|NCT03793556|585210350|FG001|Overall Study|Lost to Follow-up|1|||
162041275|NCT01325623|585210351|FG000|Overall Study|Withdrawal by Subject|3|||
162041276|NCT02556203|585210360|FG000|Overall Study|Withdrawal by Subject|21|||
162041277|NCT02556203|585210361|FG001|Overall Study|Withdrawal by Subject|21|||
162041278|NCT02556203|585210360|FG000|Overall Study|Lost to Follow-up|5|||
161999279|NCT05051579|585047422|FG001|Overall Study|Sponsor Decision|0|||
161999280|NCT05051579|585047423|FG002|Overall Study|Sponsor Decision|0|||
161999281|NCT05051579|585047424|FG003|Overall Study|Sponsor Decision|0|||
161999282|NCT05051579|585047425|FG004|Overall Study|Sponsor Decision|1|||
161999283|NCT05051579|585047426|FG005|Overall Study|Sponsor Decision|0|||
161999284|NCT05051579|585047427|FG006|Overall Study|Sponsor Decision|0|||
161999285|NCT05051579|585047421|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
161999286|NCT05051579|585047422|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
161999287|NCT05051579|585047423|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
161999288|NCT05051579|585047424|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
161999289|NCT05051579|585047425|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
161999290|NCT05051579|585047426|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
161999291|NCT05051579|585047427|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
161999292|NCT00717249|585047430|FG000|Overall Study|Lens Discomfort|4|||
161999293|NCT00717249|585047431|FG001|Overall Study|Lens Discomfort|1|||
161999294|NCT00717249|585047430|FG000|Overall Study|Unsatisfactory visual Response|0|||
161999295|NCT00717249|585047431|FG001|Overall Study|Unsatisfactory visual Response|2|||
161999296|NCT00717249|585047430|FG000|Overall Study|Adverse Event|4|||
161999297|NCT00717249|585047431|FG001|Overall Study|Adverse Event|2|||
161999298|NCT00717249|585047430|FG000|Overall Study|Lost to Follow-up|2|||
161999299|NCT00717249|585047431|FG001|Overall Study|Lost to Follow-up|0|||
161999300|NCT00717249|585047430|FG000|Overall Study|Withdrawal by Subject|1|||
161999301|NCT00717249|585047431|FG001|Overall Study|Withdrawal by Subject|2|||
161999302|NCT00717249|585047430|FG000|Overall Study|Pregnancy|6|||
161999303|NCT00717249|585047431|FG001|Overall Study|Pregnancy|3|||
161999304|NCT00717249|585047430|FG000|Overall Study|Protocol Violation|0|||
161999305|NCT00717249|585047431|FG001|Overall Study|Protocol Violation|2|||
161999306|NCT00717249|585047430|FG000|Overall Study|Subject became Ineligible|1|||
161999307|NCT00717249|585047431|FG001|Overall Study|Subject became Ineligible|1|||
161999308|NCT00717249|585047430|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
161999309|NCT00717249|585047431|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
161999310|NCT00717249|585047430|FG000|Overall Study|Gastric Surgery|0|||
161999311|NCT00717249|585047431|FG001|Overall Study|Gastric Surgery|1|||
161999312|NCT00717249|585047430|FG000|Overall Study|Diagnosed with Diabetes|1|||
161999313|NCT00717249|585047431|FG001|Overall Study|Diagnosed with Diabetes|0|||
161999314|NCT00717249|585047430|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
161999315|NCT00717249|585047431|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
162041279|NCT02556203|585210361|FG001|Overall Study|Lost to Follow-up|5|||
162041280|NCT02556203|585210360|FG000|Overall Study|Adverse Event|1|||
162041281|NCT02556203|585210361|FG001|Overall Study|Adverse Event|0|||
161999316|NCT00717249|585047430|FG000|Overall Study|Subject relocated|1|||
162041282|NCT02943460|585210367|FG000|Blinded Study Phase|Adverse Event|3|||
162041283|NCT02943460|585210368|FG001|Blinded Study Phase|Adverse Event|0|||
162041284|NCT02943460|585210369|FG002|Blinded Study Phase|Adverse Event|0|||
162041285|NCT02943460|585210367|FG000|Blinded Study Phase|Withdrew Consent|0|||
162041286|NCT02943460|585210368|FG001|Blinded Study Phase|Withdrew Consent|1|||
161999317|NCT00717249|585047431|FG001|Overall Study|Subject relocated|0|||
161999318|NCT00717249|585047430|FG000|Overall Study|Headaches|1|||
161999319|NCT00717249|585047431|FG001|Overall Study|Headaches|0|||
162041287|NCT02943460|585210369|FG002|Blinded Study Phase|Withdrew Consent|0|||
162041288|NCT02943460|585210367|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
162041289|NCT02943460|585210368|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
162041290|NCT02943460|585210369|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
162041291|NCT02943460|585210367|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
162041292|NCT02943460|585210368|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
162041293|NCT02943460|585210369|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
161999320|NCT01808196|585047435|FG000|Overall Study|Lost to Follow-up|1|||
161999321|NCT03370718|585047436|FG000|Overall Study|Withdrawal by Subject|1|||
162041294|NCT02943460|585210367|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
162041295|NCT02943460|585210368|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
162041296|NCT02943460|585210369|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
162041297|NCT00369122|585210370|FG000|Overall Study|Ineligible|10|||
162041298|NCT00369122|585210370|FG000|Overall Study|No protocol treatment|1|||
162041299|NCT04171765|585210371|FG000|Overall Study|Adverse Event|2|||
162041300|NCT04171765|585210372|FG001|Overall Study|Adverse Event|0|||
162041301|NCT04171765|585210373|FG002|Overall Study|Adverse Event|1|||
162041302|NCT04171765|585210374|FG003|Overall Study|Adverse Event|0|||
162041303|NCT04171765|585210371|FG000|Overall Study|Lost to Follow-up|0|||
162041304|NCT04171765|585210372|FG001|Overall Study|Lost to Follow-up|2|||
162041305|NCT04171765|585210373|FG002|Overall Study|Lost to Follow-up|2|||
162041306|NCT04171765|585210374|FG003|Overall Study|Lost to Follow-up|2|||
162041307|NCT04171765|585210371|FG000|Overall Study|Week 58 visit missed|0|||
162041308|NCT04171765|585210372|FG001|Overall Study|Week 58 visit missed|0|||
162041309|NCT04171765|585210373|FG002|Overall Study|Week 58 visit missed|1|||
162041310|NCT04171765|585210374|FG003|Overall Study|Week 58 visit missed|0|||
162041311|NCT04171765|585210371|FG000|Overall Study|Study terminated by sponsor|2|||
162041312|NCT04171765|585210372|FG001|Overall Study|Study terminated by sponsor|0|||
162041313|NCT04171765|585210373|FG002|Overall Study|Study terminated by sponsor|0|||
162041314|NCT04171765|585210374|FG003|Overall Study|Study terminated by sponsor|0|||
162041315|NCT04171765|585210371|FG000|Overall Study|Withdrawal by Subject|1|||
162041316|NCT04171765|585210372|FG001|Overall Study|Withdrawal by Subject|0|||
162041317|NCT04171765|585210373|FG002|Overall Study|Withdrawal by Subject|0|||
162041318|NCT04171765|585210374|FG003|Overall Study|Withdrawal by Subject|3|||
162041319|NCT03633617|585210375|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
162041320|NCT03633617|585210376|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
162041321|NCT03633617|585210377|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162041322|NCT03633617|585210378|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162041323|NCT03633617|585210379|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162041324|NCT03633617|585210380|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162041325|NCT03633617|585210381|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162041326|NCT03633617|585210382|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162041327|NCT03633617|585210383|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162041328|NCT03633617|585210384|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162041329|NCT03633617|585210385|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
162041330|NCT03633617|585210375|FG000|Part A|Unconfirmed early termination visit|1|||
162041331|NCT03633617|585210376|FG001|Part A|Unconfirmed early termination visit|0|||
162041332|NCT03633617|585210377|FG002|Part A|Unconfirmed early termination visit|0|||
161999322|NCT00479713|585047437|FG000|Overall Study|Adverse Event|8|||
161999323|NCT00479713|585047438|FG001|Overall Study|Adverse Event|6|||
161999324|NCT00479713|585047437|FG000|Overall Study|Death|1|||
161999325|NCT00479713|585047438|FG001|Overall Study|Death|0|||
161999326|NCT00479713|585047437|FG000|Overall Study|Lost to Follow-up|0|||
161999327|NCT00479713|585047438|FG001|Overall Study|Lost to Follow-up|1|||
161999328|NCT00479713|585047437|FG000|Overall Study|Protocol Violation|0|||
161999329|NCT00479713|585047438|FG001|Overall Study|Protocol Violation|1|||
161999330|NCT00479713|585047437|FG000|Overall Study|Withdrawal by Subject|4|||
161999331|NCT00479713|585047438|FG001|Overall Study|Withdrawal by Subject|1|||
161999332|NCT03798717|585049293|FG000|Overall Study|Failed Screening|0|||
161999333|NCT03798717|585049294|FG001|Overall Study|Failed Screening|0|||
161999334|NCT03798717|585049295|FG002|Overall Study|Failed Screening|0|||
161999335|NCT03798717|585049296|FG003|Overall Study|Failed Screening|0|||
161999336|NCT03798717|585049297|FG004|Overall Study|Failed Screening|0|||
161999337|NCT03798717|585049298|FG005|Overall Study|Failed Screening|1|||
161999338|NCT03798717|585049293|FG000|Overall Study|Physician Decision|1|||
161999339|NCT03798717|585049294|FG001|Overall Study|Physician Decision|0|||
161999340|NCT03798717|585049295|FG002|Overall Study|Physician Decision|1|||
161999341|NCT03798717|585049296|FG003|Overall Study|Physician Decision|0|||
161999342|NCT03798717|585049297|FG004|Overall Study|Physician Decision|0|||
161999343|NCT03798717|585049298|FG005|Overall Study|Physician Decision|0|||
161999344|NCT03798717|585049293|FG000|Overall Study|Withdrawal by Subject|0|||
161999345|NCT03798717|585049294|FG001|Overall Study|Withdrawal by Subject|0|||
161999346|NCT03798717|585049295|FG002|Overall Study|Withdrawal by Subject|0|||
161999347|NCT03798717|585049296|FG003|Overall Study|Withdrawal by Subject|1|||
161999348|NCT03798717|585049297|FG004|Overall Study|Withdrawal by Subject|0|||
161999349|NCT03798717|585049298|FG005|Overall Study|Withdrawal by Subject|0|||
161999350|NCT03798717|585049293|FG000|Overall Study|Lost to Follow-up|1|||
161999351|NCT03798717|585049294|FG001|Overall Study|Lost to Follow-up|0|||
161999352|NCT03798717|585049295|FG002|Overall Study|Lost to Follow-up|0|||
162041333|NCT03633617|585210378|FG003|Part A|Unconfirmed early termination visit|0|||
162041334|NCT03633617|585210379|FG004|Part A|Unconfirmed early termination visit|0|||
162041335|NCT03633617|585210380|FG005|Part A|Unconfirmed early termination visit|0|||
162041336|NCT03633617|585210381|FG006|Part A|Unconfirmed early termination visit|0|||
162041337|NCT03633617|585210382|FG007|Part A|Unconfirmed early termination visit|0|||
162041338|NCT03633617|585210383|FG008|Part A|Unconfirmed early termination visit|0|||
162041339|NCT03633617|585210384|FG009|Part A|Unconfirmed early termination visit|0|||
162041340|NCT03633617|585210385|FG010|Part A|Unconfirmed early termination visit|0|||
162041341|NCT03633617|585210375|FG000|Part A|Adverse Event|0|||
162041342|NCT03633617|585210376|FG001|Part A|Adverse Event|1|||
162041343|NCT03633617|585210377|FG002|Part A|Adverse Event|0|||
162041344|NCT03633617|585210378|FG003|Part A|Adverse Event|0|||
162041345|NCT03633617|585210379|FG004|Part A|Adverse Event|0|||
162041346|NCT03633617|585210380|FG005|Part A|Adverse Event|0|||
162041347|NCT03633617|585210381|FG006|Part A|Adverse Event|0|||
162041348|NCT03633617|585210382|FG007|Part A|Adverse Event|0|||
162041349|NCT03633617|585210383|FG008|Part A|Adverse Event|0|||
162041350|NCT03633617|585210384|FG009|Part A|Adverse Event|0|||
162041351|NCT03633617|585210385|FG010|Part A|Adverse Event|0|||
162041352|NCT03633617|585210375|FG000|Part A|Pregnancy|1|||
162041353|NCT03633617|585210376|FG001|Part A|Pregnancy|0|||
162041354|NCT03633617|585210377|FG002|Part A|Pregnancy|0|||
162041355|NCT03633617|585210378|FG003|Part A|Pregnancy|0|||
162041356|NCT03633617|585210379|FG004|Part A|Pregnancy|0|||
162041357|NCT03633617|585210380|FG005|Part A|Pregnancy|0|||
162041358|NCT03633617|585210381|FG006|Part A|Pregnancy|0|||
162041359|NCT03633617|585210382|FG007|Part A|Pregnancy|0|||
162041360|NCT03633617|585210383|FG008|Part A|Pregnancy|0|||
162041361|NCT03633617|585210384|FG009|Part A|Pregnancy|0|||
162041362|NCT03633617|585210385|FG010|Part A|Pregnancy|0|||
162041363|NCT03633617|585210375|FG000|Part A|Withdrawal by Subject|0|||
162041364|NCT03633617|585210376|FG001|Part A|Withdrawal by Subject|1|||
162041365|NCT03633617|585210377|FG002|Part A|Withdrawal by Subject|0|||
162041366|NCT03633617|585210378|FG003|Part A|Withdrawal by Subject|0|||
162041367|NCT03633617|585210379|FG004|Part A|Withdrawal by Subject|0|||
162041368|NCT03633617|585210380|FG005|Part A|Withdrawal by Subject|0|||
162041369|NCT03633617|585210381|FG006|Part A|Withdrawal by Subject|0|||
162041370|NCT03633617|585210382|FG007|Part A|Withdrawal by Subject|0|||
162041371|NCT03633617|585210383|FG008|Part A|Withdrawal by Subject|0|||
162041372|NCT03633617|585210384|FG009|Part A|Withdrawal by Subject|0|||
162041373|NCT03633617|585210385|FG010|Part A|Withdrawal by Subject|0|||
162041374|NCT03633617|585210375|FG000|Part B|Adverse Event|0|||
162041375|NCT03633617|585210376|FG001|Part B|Adverse Event|0|||
162041376|NCT03633617|585210377|FG002|Part B|Adverse Event|2|||
161999353|NCT03798717|585049296|FG003|Overall Study|Lost to Follow-up|1|||
161999354|NCT03798717|585049297|FG004|Overall Study|Lost to Follow-up|0|||
161999355|NCT03798717|585049298|FG005|Overall Study|Lost to Follow-up|0|||
161999356|NCT03798717|585049293|FG000|Overall Study|Adverse Event|0|||
161999357|NCT03798717|585049294|FG001|Overall Study|Adverse Event|1|||
161999358|NCT03798717|585049295|FG002|Overall Study|Adverse Event|0|||
161999359|NCT03798717|585049296|FG003|Overall Study|Adverse Event|0|||
161999360|NCT03798717|585049297|FG004|Overall Study|Adverse Event|0|||
161999361|NCT03798717|585049298|FG005|Overall Study|Adverse Event|0|||
161999362|NCT03798717|585049293|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
161999363|NCT03798717|585049294|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
161999364|NCT03798717|585049295|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
161999365|NCT03798717|585049296|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
162041377|NCT03633617|585210378|FG003|Part B|Adverse Event|2|||
162041378|NCT03633617|585210379|FG004|Part B|Adverse Event|1|||
162041379|NCT03633617|585210380|FG005|Part B|Adverse Event|0|||
162041380|NCT03633617|585210381|FG006|Part B|Adverse Event|0|||
162041381|NCT03633617|585210382|FG007|Part B|Adverse Event|0|||
162041382|NCT03633617|585210383|FG008|Part B|Adverse Event|0|||
162041383|NCT03633617|585210384|FG009|Part B|Adverse Event|0|||
162041384|NCT03633617|585210385|FG010|Part B|Adverse Event|0|||
162041385|NCT03633617|585210375|FG000|Part B|Withdrawal by Subject|0|||
162041386|NCT03633617|585210376|FG001|Part B|Withdrawal by Subject|0|||
162041387|NCT03633617|585210377|FG002|Part B|Withdrawal by Subject|1|||
162041388|NCT03633617|585210378|FG003|Part B|Withdrawal by Subject|0|||
162041389|NCT03633617|585210379|FG004|Part B|Withdrawal by Subject|2|||
162041390|NCT03633617|585210380|FG005|Part B|Withdrawal by Subject|0|||
162041391|NCT03633617|585210381|FG006|Part B|Withdrawal by Subject|0|||
162041392|NCT03633617|585210382|FG007|Part B|Withdrawal by Subject|0|||
162041393|NCT03633617|585210383|FG008|Part B|Withdrawal by Subject|0|||
162041394|NCT03633617|585210384|FG009|Part B|Withdrawal by Subject|0|||
162041395|NCT03633617|585210385|FG010|Part B|Withdrawal by Subject|0|||
161999366|NCT03798717|585049297|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
162041396|NCT03633617|585210375|FG000|Part B|Lost to Follow-up|0|||
162041397|NCT03633617|585210376|FG001|Part B|Lost to Follow-up|0|||
162041398|NCT03633617|585210377|FG002|Part B|Lost to Follow-up|0|||
162041399|NCT03633617|585210378|FG003|Part B|Lost to Follow-up|0|||
162041400|NCT03633617|585210379|FG004|Part B|Lost to Follow-up|1|||
162041401|NCT03633617|585210380|FG005|Part B|Lost to Follow-up|0|||
162041402|NCT03633617|585210381|FG006|Part B|Lost to Follow-up|0|||
162041403|NCT03633617|585210382|FG007|Part B|Lost to Follow-up|0|||
162041404|NCT03633617|585210383|FG008|Part B|Lost to Follow-up|0|||
162041405|NCT03633617|585210384|FG009|Part B|Lost to Follow-up|0|||
162041406|NCT03633617|585210385|FG010|Part B|Lost to Follow-up|0|||
162041407|NCT03633617|585210375|FG000|Part B|Physician Decision|0|||
161999367|NCT03798717|585049298|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
161999368|NCT00445549|585049299|FG000|Overall Study|progressive disease|12|||
161999369|NCT03858049|585049302|FG000|Overall Study|Adverse Event|16|||
162041408|NCT03633617|585210376|FG001|Part B|Physician Decision|0|||
162041409|NCT03633617|585210377|FG002|Part B|Physician Decision|0|||
162041410|NCT03633617|585210378|FG003|Part B|Physician Decision|0|||
162041411|NCT03633617|585210379|FG004|Part B|Physician Decision|1|||
162041412|NCT03633617|585210380|FG005|Part B|Physician Decision|0|||
162041413|NCT03633617|585210381|FG006|Part B|Physician Decision|0|||
162041414|NCT03633617|585210382|FG007|Part B|Physician Decision|0|||
162041415|NCT03633617|585210383|FG008|Part B|Physician Decision|0|||
162041416|NCT03633617|585210384|FG009|Part B|Physician Decision|0|||
162041417|NCT03633617|585210385|FG010|Part B|Physician Decision|0|||
162041418|NCT03633617|585210375|FG000|Part B|COVID-19 Restrictions|0|||
162041419|NCT03633617|585210376|FG001|Part B|COVID-19 Restrictions|0|||
162041420|NCT03633617|585210377|FG002|Part B|COVID-19 Restrictions|1|||
162041421|NCT03633617|585210378|FG003|Part B|COVID-19 Restrictions|0|||
162041422|NCT03633617|585210379|FG004|Part B|COVID-19 Restrictions|0|||
162041423|NCT03633617|585210380|FG005|Part B|COVID-19 Restrictions|0|||
162041424|NCT03633617|585210381|FG006|Part B|COVID-19 Restrictions|0|||
162041425|NCT03633617|585210382|FG007|Part B|COVID-19 Restrictions|0|||
162041426|NCT03633617|585210383|FG008|Part B|COVID-19 Restrictions|0|||
162041427|NCT03633617|585210384|FG009|Part B|COVID-19 Restrictions|0|||
162041428|NCT03633617|585210385|FG010|Part B|COVID-19 Restrictions|0|||
162041429|NCT03633617|585210375|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162041430|NCT03633617|585210376|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162041431|NCT03633617|585210377|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
162041432|NCT03633617|585210378|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162041433|NCT03633617|585210379|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162041434|NCT03633617|585210380|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162041435|NCT03633617|585210381|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162041436|NCT03633617|585210382|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162041437|NCT03633617|585210383|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162041438|NCT03633617|585210384|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162041439|NCT03633617|585210385|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
162041440|NCT03633617|585210375|FG000|Part C (& Follow-up)|Adverse Event|0|||
162041441|NCT03633617|585210376|FG001|Part C (& Follow-up)|Adverse Event|0|||
162041442|NCT03633617|585210377|FG002|Part C (& Follow-up)|Adverse Event|0|||
162041443|NCT03633617|585210378|FG003|Part C (& Follow-up)|Adverse Event|0|||
162041444|NCT03633617|585210379|FG004|Part C (& Follow-up)|Adverse Event|0|||
162041445|NCT03633617|585210380|FG005|Part C (& Follow-up)|Adverse Event|1|||
162041446|NCT03633617|585210381|FG006|Part C (& Follow-up)|Adverse Event|0|||
162041447|NCT03633617|585210382|FG007|Part C (& Follow-up)|Adverse Event|1|||
162041448|NCT03633617|585210383|FG008|Part C (& Follow-up)|Adverse Event|0|||
162041449|NCT03633617|585210384|FG009|Part C (& Follow-up)|Adverse Event|0|||
162041450|NCT03633617|585210385|FG010|Part C (& Follow-up)|Adverse Event|0|||
162041451|NCT03633617|585210375|FG000|Part C (& Follow-up)|Pregnancy|0|||
162041452|NCT03633617|585210376|FG001|Part C (& Follow-up)|Pregnancy|0|||
162041453|NCT03633617|585210377|FG002|Part C (& Follow-up)|Pregnancy|0|||
162041454|NCT03633617|585210378|FG003|Part C (& Follow-up)|Pregnancy|0|||
162041455|NCT03633617|585210379|FG004|Part C (& Follow-up)|Pregnancy|0|||
162041456|NCT03633617|585210380|FG005|Part C (& Follow-up)|Pregnancy|0|||
162041457|NCT03633617|585210381|FG006|Part C (& Follow-up)|Pregnancy|0|||
162041458|NCT03633617|585210382|FG007|Part C (& Follow-up)|Pregnancy|0|||
162041459|NCT03633617|585210383|FG008|Part C (& Follow-up)|Pregnancy|0|||
162041460|NCT03633617|585210384|FG009|Part C (& Follow-up)|Pregnancy|1|||
162041461|NCT03633617|585210385|FG010|Part C (& Follow-up)|Pregnancy|0|||
162041462|NCT03633617|585210375|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
161999370|NCT03858049|585049303|FG001|Overall Study|Adverse Event|9|||
161999371|NCT03858049|585049302|FG000|Overall Study|Other|1|||
161999372|NCT03858049|585049303|FG001|Overall Study|Other|1|||
161999373|NCT01600326|585049304|FG000|Overall Study|Lost to Follow-up|1|||
161999374|NCT01600326|585049305|FG001|Overall Study|Lost to Follow-up|1|||
161999375|NCT02079740|585049306|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
161999376|NCT02079740|585049307|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
161999377|NCT02079740|585049308|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
161999378|NCT02079740|585049309|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
162041463|NCT03633617|585210376|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
162041464|NCT03633617|585210377|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
161999379|NCT02079740|585049310|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
161999380|NCT02079740|585049311|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
161999381|NCT02079740|585049312|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
161999382|NCT02079740|585049313|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
161999383|NCT02079740|585049314|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
161999384|NCT02079740|585049315|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
161999385|NCT02079740|585049316|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
161999386|NCT02079740|585049317|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
161999387|NCT02079740|585049318|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
161999388|NCT02079740|585049306|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
161999389|NCT02079740|585049307|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
161999390|NCT02079740|585049308|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
161999391|NCT02079740|585049309|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
161999392|NCT02079740|585049310|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
161999393|NCT02079740|585049311|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
161999394|NCT02079740|585049312|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
161999395|NCT02079740|585049313|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
161999396|NCT02079740|585049314|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
161999397|NCT02079740|585049315|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
161999398|NCT02079740|585049316|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
161999399|NCT02079740|585049317|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
161999400|NCT02079740|585049318|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
161999401|NCT02079740|585049306|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
161999402|NCT02079740|585049307|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
161999403|NCT02079740|585049308|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
161999404|NCT02079740|585049309|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
161999405|NCT02079740|585049310|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
161999406|NCT02079740|585049311|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
161999407|NCT02079740|585049312|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
161999408|NCT02079740|585049313|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
161999409|NCT02079740|585049314|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
161999410|NCT02079740|585049315|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
161999411|NCT02079740|585049316|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
161999412|NCT02079740|585049317|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
161999413|NCT02079740|585049318|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
161999414|NCT02079740|585049306|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161999415|NCT02079740|585049307|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161999416|NCT02079740|585049308|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161999417|NCT02079740|585049309|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161999418|NCT02079740|585049310|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161999419|NCT02079740|585049311|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161999420|NCT02079740|585049312|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161999421|NCT02079740|585049313|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
161999422|NCT02079740|585049314|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161999423|NCT02079740|585049315|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161999424|NCT02079740|585049316|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161999425|NCT02079740|585049317|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161999426|NCT02079740|585049318|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
161999427|NCT02079740|585049306|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161999428|NCT02079740|585049307|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161999429|NCT02079740|585049308|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161999430|NCT02079740|585049309|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161999431|NCT02079740|585049310|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161999432|NCT02079740|585049311|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161999433|NCT02079740|585049312|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161999434|NCT02079740|585049313|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161999435|NCT02079740|585049314|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161999436|NCT02079740|585049315|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
161999437|NCT02079740|585049316|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
161999438|NCT02079740|585049317|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
161999439|NCT02079740|585049318|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
161999440|NCT04617782|585049319|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
161999441|NCT04617782|585049319|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
161999442|NCT04617782|585049319|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
161999443|NCT04617782|585049319|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
161999444|NCT04617782|585049319|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
161999445|NCT04617782|585049319|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
161999446|NCT01405768|585049332|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
162041465|NCT03633617|585210378|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
162041466|NCT03633617|585210379|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
162041467|NCT03633617|585210380|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
162041468|NCT03633617|585210381|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
162041469|NCT03633617|585210382|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
162041470|NCT03633617|585210383|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
162041471|NCT03633617|585210384|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
162041472|NCT03633617|585210385|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
162041473|NCT03633617|585210375|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
162041474|NCT03633617|585210376|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
162041475|NCT03633617|585210377|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
162041476|NCT03633617|585210378|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
162041477|NCT03633617|585210379|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
162041478|NCT03633617|585210380|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
162041479|NCT03633617|585210381|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
162041480|NCT03633617|585210382|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
162041481|NCT03633617|585210383|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
162041482|NCT03633617|585210384|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
162041483|NCT03633617|585210385|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
162041484|NCT03633617|585210375|FG000|Part C (& Follow-up)|Physician Decision|0|||
162041485|NCT03633617|585210376|FG001|Part C (& Follow-up)|Physician Decision|0|||
162041486|NCT03633617|585210377|FG002|Part C (& Follow-up)|Physician Decision|0|||
162041487|NCT03633617|585210378|FG003|Part C (& Follow-up)|Physician Decision|0|||
162041488|NCT03633617|585210379|FG004|Part C (& Follow-up)|Physician Decision|0|||
162041489|NCT03633617|585210380|FG005|Part C (& Follow-up)|Physician Decision|0|||
162041490|NCT03633617|585210381|FG006|Part C (& Follow-up)|Physician Decision|0|||
162041491|NCT03633617|585210382|FG007|Part C (& Follow-up)|Physician Decision|1|||
162041492|NCT03633617|585210383|FG008|Part C (& Follow-up)|Physician Decision|0|||
162041493|NCT03633617|585210384|FG009|Part C (& Follow-up)|Physician Decision|0|||
162041494|NCT03633617|585210385|FG010|Part C (& Follow-up)|Physician Decision|1|||
162041495|NCT03633617|585210375|FG000|Part C (& Follow-up)|COVID-19 related|0|||
162041496|NCT03633617|585210376|FG001|Part C (& Follow-up)|COVID-19 related|0|||
162041497|NCT03633617|585210377|FG002|Part C (& Follow-up)|COVID-19 related|0|||
162041498|NCT03633617|585210378|FG003|Part C (& Follow-up)|COVID-19 related|0|||
162041499|NCT03633617|585210379|FG004|Part C (& Follow-up)|COVID-19 related|0|||
162041500|NCT03633617|585210380|FG005|Part C (& Follow-up)|COVID-19 related|1|||
162041501|NCT03633617|585210381|FG006|Part C (& Follow-up)|COVID-19 related|0|||
162041502|NCT03633617|585210382|FG007|Part C (& Follow-up)|COVID-19 related|0|||
162041503|NCT03633617|585210383|FG008|Part C (& Follow-up)|COVID-19 related|0|||
162041504|NCT03633617|585210384|FG009|Part C (& Follow-up)|COVID-19 related|0|||
162041505|NCT03633617|585210385|FG010|Part C (& Follow-up)|COVID-19 related|0|||
162041506|NCT03633617|585210375|FG000|Part C (& Follow-up)|Protocol Violation|0|||
162041507|NCT03633617|585210376|FG001|Part C (& Follow-up)|Protocol Violation|0|||
162041508|NCT03633617|585210377|FG002|Part C (& Follow-up)|Protocol Violation|0|||
162041509|NCT03633617|585210378|FG003|Part C (& Follow-up)|Protocol Violation|0|||
162041510|NCT03633617|585210379|FG004|Part C (& Follow-up)|Protocol Violation|0|||
162041511|NCT03633617|585210380|FG005|Part C (& Follow-up)|Protocol Violation|0|||
162041512|NCT03633617|585210381|FG006|Part C (& Follow-up)|Protocol Violation|0|||
162041513|NCT03633617|585210382|FG007|Part C (& Follow-up)|Protocol Violation|0|||
162041514|NCT03633617|585210383|FG008|Part C (& Follow-up)|Protocol Violation|0|||
162041515|NCT03633617|585210384|FG009|Part C (& Follow-up)|Protocol Violation|3|||
162041516|NCT03633617|585210385|FG010|Part C (& Follow-up)|Protocol Violation|1|||
162041517|NCT03633617|585210375|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
162041518|NCT03633617|585210376|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
161999447|NCT01405768|585049333|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
161999448|NCT04388111|585049336|FG000|Overall Study|Lost to Follow-up|5|||
161999449|NCT04388111|585049337|FG001|Overall Study|Lost to Follow-up|3|||
161999450|NCT04388111|585049336|FG000|Overall Study|Adverse Event|1|||
161999451|NCT04388111|585049337|FG001|Overall Study|Adverse Event|1|||
161999452|NCT04388111|585049336|FG000|Overall Study|Protocol Violation|2|||
161999453|NCT04388111|585049337|FG001|Overall Study|Protocol Violation|4|||
161999454|NCT04388111|585049336|FG000|Overall Study|Withdrawal by Subject|1|||
161999455|NCT04388111|585049337|FG001|Overall Study|Withdrawal by Subject|0|||
161999456|NCT01474317|585049345|FG000|Overall Study|Adverse Event|1|||
161999457|NCT01474317|585049345|FG000|Overall Study|Subject ineligible for study|1|||
161999458|NCT00387881|585049346|FG000|Overall Study|Lost to Follow-up|23|||
161999459|NCT00387881|585049347|FG001|Overall Study|Lost to Follow-up|23|||
161999460|NCT00387881|585049346|FG000|Overall Study|Protocol Violation|2|||
161999461|NCT00387881|585049347|FG001|Overall Study|Protocol Violation|12|||
161999462|NCT00387881|585049346|FG000|Overall Study|Withdrawal by Subject|15|||
161999463|NCT00387881|585049347|FG001|Overall Study|Withdrawal by Subject|18|||
161999464|NCT00387881|585049346|FG000|Overall Study|Sponsor terminated Study|0|||
161999465|NCT00387881|585049347|FG001|Overall Study|Sponsor terminated Study|1|||
161999466|NCT00387881|585049346|FG000|Overall Study|Not eligible|6|||
161999467|NCT00387881|585049347|FG001|Overall Study|Not eligible|7|||
161999468|NCT00387881|585049346|FG000|Overall Study|No opportunity to treat headache|32|||
161999469|NCT00387881|585049347|FG001|Overall Study|No opportunity to treat headache|34|||
161999470|NCT00387881|585049346|FG000|Overall Study|Not otherwise specified|11|||
161999471|NCT00387881|585049347|FG001|Overall Study|Not otherwise specified|7|||
161999472|NCT00453154|585049350|FG000|Double BIind Maintenance|Adverse Event|0|||
161999473|NCT00453154|585049351|FG001|Double BIind Maintenance|Adverse Event|0|||
161999474|NCT00453154|585049352|FG002|Double BIind Maintenance|Adverse Event|3|||
161999475|NCT00453154|585049353|FG003|Double BIind Maintenance|Adverse Event|12|||
161999476|NCT00453154|585049350|FG000|Double BIind Maintenance|Death|0|||
161999477|NCT00453154|585049351|FG001|Double BIind Maintenance|Death|0|||
161999478|NCT00453154|585049352|FG002|Double BIind Maintenance|Death|2|||
161999479|NCT00453154|585049353|FG003|Double BIind Maintenance|Death|1|||
161999480|NCT00453154|585049350|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
161999481|NCT00453154|585049351|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
161999482|NCT00453154|585049352|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
161999483|NCT00453154|585049353|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
161999484|NCT00453154|585049350|FG000|Double BIind Maintenance|Progression|0|||
161999485|NCT00453154|585049351|FG001|Double BIind Maintenance|Progression|0|||
161999486|NCT00453154|585049352|FG002|Double BIind Maintenance|Progression|29|||
161999487|NCT00453154|585049353|FG003|Double BIind Maintenance|Progression|26|||
161999488|NCT00453154|585049350|FG000|Double BIind Maintenance|Medical Issues|0|||
161999489|NCT00453154|585049351|FG001|Double BIind Maintenance|Medical Issues|0|||
161999490|NCT00453154|585049352|FG002|Double BIind Maintenance|Medical Issues|3|||
161999491|NCT00453154|585049353|FG003|Double BIind Maintenance|Medical Issues|1|||
161999492|NCT00453154|585049350|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
161999493|NCT00453154|585049351|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
161999494|NCT00453154|585049352|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
161999495|NCT00453154|585049353|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
161999496|NCT03629886|585049355|FG000|Overall Study|Migrated / moved from the study area|0|||
161999497|NCT03629886|585049356|FG001|Overall Study|Migrated / moved from the study area|55|||
161999498|NCT03629886|585049355|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
161999499|NCT03629886|585049356|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
161999500|NCT03629886|585049355|FG000|Overall Study|Study vaccine not administrated|0|||
161999501|NCT03629886|585049356|FG001|Overall Study|Study vaccine not administrated|3|||
161999502|NCT03629886|585049355|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
161999503|NCT03629886|585049356|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
161999504|NCT03629886|585049355|FG000|Overall Study|Refused vaccination step of the study|0|||
161999505|NCT03629886|585049356|FG001|Overall Study|Refused vaccination step of the study|44|||
161999506|NCT05473026|585049358|FG000|Overall Study|Lost to Follow-up|5|||
161999507|NCT05473026|585049359|FG001|Overall Study|Lost to Follow-up|2|||
161999508|NCT02038153|585049360|FG000|Overall Study|Withdrawal by Subject|1|||
161999509|NCT03683173|585049361|FG000|Completed Follow-up|Unavailable|235|||
161999510|NCT03683173|585049362|FG001|Completed Follow-up|Unavailable|217|||
161999511|NCT03683173|585049361|FG000|Completed Follow-up|Refused|69|||
161999512|NCT03683173|585049362|FG001|Completed Follow-up|Refused|59|||
161999513|NCT03683173|585049361|FG000|Completed Follow-up|Disconnected phone|65|||
161999514|NCT03683173|585049362|FG001|Completed Follow-up|Disconnected phone|95|||
161999515|NCT03683173|585049361|FG000|Completed Follow-up|Health issue/deceased|10|||
161999516|NCT03683173|585049362|FG001|Completed Follow-up|Health issue/deceased|4|||
161999517|NCT03683173|585049361|FG000|Completed Follow-up|Moved away|8|||
161999518|NCT03683173|585049362|FG001|Completed Follow-up|Moved away|1|||
161999519|NCT02647281|585049363|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161999520|NCT02647281|585049364|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161999521|NCT02647281|585049365|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161999522|NCT02647281|585049366|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161999523|NCT02647281|585049367|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161999524|NCT02647281|585049368|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161999525|NCT02647281|585049369|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161999526|NCT02647281|585049370|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
161999527|NCT02647281|585049371|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
161999528|NCT01050634|585049372|FG000|Overall Study|Enrolled, but Not Treated|56|||
161999529|NCT01050634|585049372|FG000|Overall Study|Death|2|||
161999530|NCT01050634|585049372|FG000|Overall Study|Adverse Event|42|||
161999531|NCT01050634|585049372|FG000|Overall Study|Lost to Follow-up|2|||
161999532|NCT01050634|585049372|FG000|Overall Study|Other|21|||
161999533|NCT01050634|585049372|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
161999534|NCT00496015|585049373|FG000|Overall Study|Other|1|||
161999535|NCT00496015|585049374|FG001|Overall Study|Other|0|||
161999536|NCT00496015|585049375|FG002|Overall Study|Other|0|||
162041519|NCT03633617|585210377|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
162041520|NCT03633617|585210378|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
162041521|NCT03633617|585210379|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
162041522|NCT03633617|585210380|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
162041523|NCT03633617|585210381|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
162041524|NCT03633617|585210382|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
162041525|NCT03633617|585210383|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
162041526|NCT03633617|585210384|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
162041527|NCT03633617|585210385|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
162041528|NCT00809354|585210388|FG000|Overall Study|Adverse Event|32|||
162041529|NCT00809354|585210389|FG001|Overall Study|Adverse Event|45|||
162041530|NCT00809354|585210390|FG002|Overall Study|Adverse Event|37|||
161999537|NCT00496015|585049376|FG003|Overall Study|Other|1|||
161999538|NCT00496015|585049377|FG004|Overall Study|Other|0|||
161999539|NCT02730728|585049380|FG000|Overall Study|Withdrawal by Subject|0|||
161999540|NCT02730728|585049381|FG001|Overall Study|Withdrawal by Subject|1|||
161999541|NCT02730728|585049382|FG002|Overall Study|Withdrawal by Subject|0|||
161999542|NCT02730728|585049380|FG000|Overall Study|Lack of Efficacy|0|||
161999543|NCT02730728|585049381|FG001|Overall Study|Lack of Efficacy|1|||
161999544|NCT02730728|585049382|FG002|Overall Study|Lack of Efficacy|1|||
161999545|NCT03360682|585049401|FG000|Overall Study|Adverse Event|3|||
161999546|NCT03244917|585049402|FG000|Overall Study|Lost to Follow-up|2|||
161999547|NCT03244917|585049403|FG001|Overall Study|Lost to Follow-up|2|||
161999548|NCT01147666|585049404|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
161999549|NCT01147666|585049405|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
161999550|NCT01147666|585049406|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
161999551|NCT01147666|585049407|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161999552|NCT01147666|585049408|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161999553|NCT01147666|585049409|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161999554|NCT01147666|585049410|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161999555|NCT01147666|585049411|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161999556|NCT01147666|585049412|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161999557|NCT01147666|585049413|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161999558|NCT01147666|585049414|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161999559|NCT01147666|585049415|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161999560|NCT01147666|585049416|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
161999561|NCT01147666|585049417|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161999562|NCT01147666|585049418|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
161999563|NCT01147666|585049404|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161999564|NCT01147666|585049405|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
161999565|NCT01147666|585049406|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161999566|NCT01147666|585049407|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161999567|NCT01147666|585049408|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
161999568|NCT01147666|585049409|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
161999569|NCT01147666|585049410|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
161999570|NCT01147666|585049411|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
161999571|NCT01147666|585049412|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161999572|NCT01147666|585049413|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
161999573|NCT01147666|585049414|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161999574|NCT01147666|585049415|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
162041531|NCT00809354|585210391|FG003|Overall Study|Adverse Event|53|||
162041532|NCT00809354|585210392|FG004|Overall Study|Adverse Event|26|||
162041533|NCT00809354|585210393|FG005|Overall Study|Adverse Event|33|||
162041534|NCT00809354|585210394|FG006|Overall Study|Adverse Event|44|||
161999575|NCT01147666|585049416|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
161999576|NCT01147666|585049417|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
161999577|NCT01147666|585049418|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
161999578|NCT01147666|585049404|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
161999579|NCT01147666|585049405|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
161999580|NCT01147666|585049406|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
161999581|NCT01147666|585049407|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
161999582|NCT01147666|585049408|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
161999583|NCT01147666|585049409|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
161999584|NCT01147666|585049410|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
161999585|NCT01147666|585049411|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
161999586|NCT01147666|585049412|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
161999587|NCT01147666|585049413|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
161999588|NCT01147666|585049414|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
161999589|NCT01147666|585049415|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
162041535|NCT00809354|585210395|FG007|Overall Study|Adverse Event|40|||
161999590|NCT01147666|585049416|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
162041536|NCT00809354|585210396|FG008|Overall Study|Adverse Event|46|||
162041537|NCT00809354|585210397|FG009|Overall Study|Adverse Event|26|||
162041538|NCT00809354|585210388|FG000|Overall Study|Lack of Efficacy|23|||
162041539|NCT00809354|585210389|FG001|Overall Study|Lack of Efficacy|23|||
162041540|NCT00809354|585210390|FG002|Overall Study|Lack of Efficacy|22|||
162041541|NCT00809354|585210391|FG003|Overall Study|Lack of Efficacy|15|||
162041542|NCT00809354|585210392|FG004|Overall Study|Lack of Efficacy|40|||
162041543|NCT00809354|585210393|FG005|Overall Study|Lack of Efficacy|19|||
162041544|NCT00809354|585210394|FG006|Overall Study|Lack of Efficacy|21|||
162041545|NCT00809354|585210395|FG007|Overall Study|Lack of Efficacy|15|||
162041546|NCT00809354|585210396|FG008|Overall Study|Lack of Efficacy|18|||
162041547|NCT00809354|585210397|FG009|Overall Study|Lack of Efficacy|38|||
162041548|NCT00809354|585210388|FG000|Overall Study|Lost to Follow-up|10|||
162041549|NCT00809354|585210389|FG001|Overall Study|Lost to Follow-up|11|||
162041550|NCT00809354|585210390|FG002|Overall Study|Lost to Follow-up|8|||
162041551|NCT00809354|585210391|FG003|Overall Study|Lost to Follow-up|13|||
162041552|NCT00809354|585210392|FG004|Overall Study|Lost to Follow-up|6|||
162041553|NCT00809354|585210393|FG005|Overall Study|Lost to Follow-up|2|||
162041554|NCT00809354|585210394|FG006|Overall Study|Lost to Follow-up|0|||
162041555|NCT00809354|585210395|FG007|Overall Study|Lost to Follow-up|5|||
162041556|NCT00809354|585210396|FG008|Overall Study|Lost to Follow-up|4|||
162041557|NCT00809354|585210397|FG009|Overall Study|Lost to Follow-up|0|||
162041558|NCT00809354|585210388|FG000|Overall Study|Protocol Violation|7|||
162041559|NCT00809354|585210389|FG001|Overall Study|Protocol Violation|14|||
162041560|NCT00809354|585210390|FG002|Overall Study|Protocol Violation|14|||
162041561|NCT00809354|585210391|FG003|Overall Study|Protocol Violation|12|||
162041562|NCT00809354|585210392|FG004|Overall Study|Protocol Violation|14|||
162041563|NCT00809354|585210393|FG005|Overall Study|Protocol Violation|6|||
162041564|NCT00809354|585210394|FG006|Overall Study|Protocol Violation|4|||
162041565|NCT00809354|585210395|FG007|Overall Study|Protocol Violation|6|||
162041566|NCT00809354|585210396|FG008|Overall Study|Protocol Violation|9|||
162041567|NCT00809354|585210397|FG009|Overall Study|Protocol Violation|3|||
162041568|NCT00809354|585210388|FG000|Overall Study|Withdrawal by Subject|32|||
162041569|NCT00809354|585210389|FG001|Overall Study|Withdrawal by Subject|27|||
162041570|NCT00809354|585210390|FG002|Overall Study|Withdrawal by Subject|31|||
162041571|NCT00809354|585210391|FG003|Overall Study|Withdrawal by Subject|33|||
162041572|NCT00809354|585210392|FG004|Overall Study|Withdrawal by Subject|34|||
162041573|NCT00809354|585210393|FG005|Overall Study|Withdrawal by Subject|29|||
162041574|NCT00809354|585210394|FG006|Overall Study|Withdrawal by Subject|27|||
162041575|NCT00809354|585210395|FG007|Overall Study|Withdrawal by Subject|19|||
162041576|NCT00809354|585210396|FG008|Overall Study|Withdrawal by Subject|18|||
162041577|NCT00809354|585210397|FG009|Overall Study|Withdrawal by Subject|20|||
162041578|NCT00809354|585210388|FG000|Overall Study|Other|10|||
162041579|NCT00809354|585210389|FG001|Overall Study|Other|2|||
162041580|NCT00809354|585210390|FG002|Overall Study|Other|7|||
162041581|NCT00809354|585210391|FG003|Overall Study|Other|10|||
162041582|NCT00809354|585210392|FG004|Overall Study|Other|5|||
161999591|NCT01147666|585049417|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
161999592|NCT01147666|585049418|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
161999593|NCT01147666|585049404|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
161999594|NCT01147666|585049405|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161999595|NCT01147666|585049406|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161999596|NCT01147666|585049407|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
161999597|NCT01147666|585049408|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161999598|NCT01147666|585049409|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161999599|NCT01147666|585049410|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
162041583|NCT00809354|585210393|FG005|Overall Study|Other|3|||
162041584|NCT00809354|585210394|FG006|Overall Study|Other|2|||
162041585|NCT00809354|585210395|FG007|Overall Study|Other|3|||
162041586|NCT00809354|585210396|FG008|Overall Study|Other|4|||
162041587|NCT00809354|585210397|FG009|Overall Study|Other|3|||
161999600|NCT01147666|585049411|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161999601|NCT01147666|585049412|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161999602|NCT01147666|585049413|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161999603|NCT01147666|585049414|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
161999604|NCT01147666|585049415|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161999605|NCT01147666|585049416|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161999606|NCT01147666|585049417|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161999607|NCT01147666|585049418|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
161999608|NCT01147666|585049404|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161999609|NCT01147666|585049405|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
162041588|NCT00809354|585210388|FG000|Overall Study|Study terminated by sponsor|138|||
162041589|NCT00809354|585210389|FG001|Overall Study|Study terminated by sponsor|134|||
162041590|NCT00809354|585210390|FG002|Overall Study|Study terminated by sponsor|129|||
162041591|NCT00809354|585210391|FG003|Overall Study|Study terminated by sponsor|120|||
162041592|NCT00809354|585210392|FG004|Overall Study|Study terminated by sponsor|126|||
162041593|NCT00809354|585210393|FG005|Overall Study|Study terminated by sponsor|133|||
162041594|NCT00809354|585210394|FG006|Overall Study|Study terminated by sponsor|124|||
161999610|NCT01147666|585049406|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161999611|NCT01147666|585049407|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161999612|NCT01147666|585049408|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
161999613|NCT01147666|585049409|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
161999614|NCT01147666|585049410|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161999615|NCT01147666|585049411|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
161999616|NCT01147666|585049412|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161999617|NCT01147666|585049413|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
161999618|NCT01147666|585049414|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161999619|NCT01147666|585049415|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
161999620|NCT01147666|585049416|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161999621|NCT01147666|585049417|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
161999622|NCT01147666|585049418|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
161999623|NCT01147666|585049404|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999624|NCT01147666|585049405|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999625|NCT01147666|585049406|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999626|NCT01147666|585049407|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
161999627|NCT01147666|585049408|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999628|NCT01147666|585049409|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999629|NCT01147666|585049410|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999630|NCT01147666|585049411|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999631|NCT01147666|585049412|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999632|NCT01147666|585049413|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999633|NCT01147666|585049414|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
161999634|NCT01147666|585049415|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999635|NCT01147666|585049416|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999636|NCT01147666|585049417|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999637|NCT01147666|585049418|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
161999638|NCT01147666|585049404|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161999639|NCT01147666|585049405|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161999640|NCT01147666|585049406|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161999641|NCT01147666|585049407|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161999642|NCT01147666|585049408|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161999643|NCT01147666|585049409|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161999644|NCT01147666|585049410|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161999645|NCT01147666|585049411|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161999646|NCT01147666|585049412|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161999647|NCT01147666|585049413|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161999648|NCT01147666|585049414|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161999649|NCT01147666|585049415|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
161999650|NCT01147666|585049416|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
161999651|NCT01147666|585049417|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
161999652|NCT01147666|585049418|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
161999653|NCT01147666|585049404|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
161999654|NCT01147666|585049405|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
161999655|NCT01147666|585049406|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
161999656|NCT01147666|585049407|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
161999657|NCT01147666|585049408|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
161999658|NCT01147666|585049409|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
161999659|NCT01147666|585049410|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
161999660|NCT01147666|585049411|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
161999661|NCT01147666|585049412|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
161999662|NCT01147666|585049413|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
161999663|NCT01147666|585049414|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
161999664|NCT01147666|585049415|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
161999665|NCT01147666|585049416|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
161999666|NCT01147666|585049417|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
161999667|NCT01147666|585049418|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
161999668|NCT01147666|585049404|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161999669|NCT01147666|585049405|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161999670|NCT01147666|585049406|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161999671|NCT01147666|585049407|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161999672|NCT01147666|585049408|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
161999673|NCT01147666|585049409|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
162041595|NCT00809354|585210395|FG007|Overall Study|Study terminated by sponsor|148|||
162041596|NCT00809354|585210396|FG008|Overall Study|Study terminated by sponsor|127|||
162041597|NCT00809354|585210397|FG009|Overall Study|Study terminated by sponsor|135|||
162041598|NCT00809354|585210388|FG000|Overall Study|Withdrawn due to pregnancy|0|||
162041599|NCT00809354|585210389|FG001|Overall Study|Withdrawn due to pregnancy|1|||
162041600|NCT00809354|585210390|FG002|Overall Study|Withdrawn due to pregnancy|0|||
162041601|NCT00809354|585210391|FG003|Overall Study|Withdrawn due to pregnancy|0|||
162041602|NCT00809354|585210392|FG004|Overall Study|Withdrawn due to pregnancy|0|||
162041603|NCT00809354|585210393|FG005|Overall Study|Withdrawn due to pregnancy|0|||
162041604|NCT00809354|585210394|FG006|Overall Study|Withdrawn due to pregnancy|0|||
162041605|NCT00809354|585210395|FG007|Overall Study|Withdrawn due to pregnancy|0|||
162041606|NCT00809354|585210396|FG008|Overall Study|Withdrawn due to pregnancy|0|||
162041607|NCT00809354|585210397|FG009|Overall Study|Withdrawn due to pregnancy|0|||
162041608|NCT00809354|585210388|FG000|Overall Study|Randomized but not Treated|3|||
162041609|NCT00809354|585210389|FG001|Overall Study|Randomized but not Treated|1|||
162041610|NCT00809354|585210390|FG002|Overall Study|Randomized but not Treated|6|||
162041611|NCT00809354|585210391|FG003|Overall Study|Randomized but not Treated|0|||
162041612|NCT00809354|585210392|FG004|Overall Study|Randomized but not Treated|5|||
162041613|NCT00809354|585210393|FG005|Overall Study|Randomized but not Treated|0|||
162041614|NCT00809354|585210394|FG006|Overall Study|Randomized but not Treated|1|||
162041615|NCT00809354|585210395|FG007|Overall Study|Randomized but not Treated|1|||
162041616|NCT00809354|585210396|FG008|Overall Study|Randomized but not Treated|2|||
162041617|NCT00809354|585210397|FG009|Overall Study|Randomized but not Treated|1|||
162041618|NCT00809354|585210388|FG000|Overall Study|Death|0|||
162041619|NCT00809354|585210389|FG001|Overall Study|Death|0|||
162041620|NCT00809354|585210390|FG002|Overall Study|Death|0|||
162041621|NCT00809354|585210391|FG003|Overall Study|Death|0|||
162041622|NCT00809354|585210392|FG004|Overall Study|Death|0|||
162041623|NCT00809354|585210393|FG005|Overall Study|Death|0|||
162041624|NCT00809354|585210394|FG006|Overall Study|Death|0|||
162041625|NCT00809354|585210395|FG007|Overall Study|Death|1|||
162041626|NCT00809354|585210396|FG008|Overall Study|Death|0|||
162041627|NCT00809354|585210397|FG009|Overall Study|Death|0|||
162041628|NCT04137224|585210400|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
162041629|NCT04137224|585210401|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
162041630|NCT04137224|585210400|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
162041631|NCT04137224|585210401|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
162041632|NCT04137224|585210400|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
162041633|NCT04137224|585210401|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
162041634|NCT01669928|585210402|FG000|First Intervention|Withdrawal by Subject|3|||
162041635|NCT01669928|585210403|FG001|First Intervention|Withdrawal by Subject|5|||
162041636|NCT05085730|585210412|FG000|Overall Study|Withdrawal by Subject|4|||
162041637|NCT05085730|585210412|FG000|Overall Study|Physician Decision|1|||
162041638|NCT01199731|585210413|FG000|Overall Study|Adverse Event|0|||
162041639|NCT01199731|585210414|FG001|Overall Study|Adverse Event|1|||
162041640|NCT01199731|585210415|FG002|Overall Study|Adverse Event|0|||
162041641|NCT01199731|585210413|FG000|Overall Study|Study closed/terminated|7|||
162041642|NCT01199731|585210414|FG001|Overall Study|Study closed/terminated|9|||
162041643|NCT01199731|585210415|FG002|Overall Study|Study closed/terminated|7|||
162041644|NCT01199731|585210413|FG000|Overall Study|Lost to Follow-up|0|||
162041645|NCT01199731|585210414|FG001|Overall Study|Lost to Follow-up|0|||
162041646|NCT01199731|585210415|FG002|Overall Study|Lost to Follow-up|2|||
162041647|NCT01199731|585210413|FG000|Overall Study|Physician Decision|0|||
162041648|NCT01199731|585210414|FG001|Overall Study|Physician Decision|1|||
162041649|NCT01199731|585210415|FG002|Overall Study|Physician Decision|1|||
162041650|NCT01199731|585210413|FG000|Overall Study|Withdrawal by Subject|2|||
162041651|NCT01199731|585210414|FG001|Overall Study|Withdrawal by Subject|0|||
162041652|NCT01199731|585210415|FG002|Overall Study|Withdrawal by Subject|0|||
162041653|NCT04010539|585210416|FG000|Overall Study|Withdrawal by Subject|4|||
162041654|NCT04010539|585210417|FG001|Overall Study|Withdrawal by Subject|1|||
162041655|NCT04010539|585210416|FG000|Overall Study|Physician Decision|0|||
162041656|NCT04010539|585210417|FG001|Overall Study|Physician Decision|2|||
162041657|NCT04010539|585210416|FG000|Overall Study|Lost to Follow-up|10|||
162041658|NCT04010539|585210417|FG001|Overall Study|Lost to Follow-up|14|||
162041659|NCT04010539|585210416|FG000|Overall Study|Adverse Event|3|||
162041660|NCT04010539|585210417|FG001|Overall Study|Adverse Event|0|||
162041661|NCT04010539|585210416|FG000|Overall Study|Participant Did Not Receive IP|0|||
162041662|NCT04010539|585210417|FG001|Overall Study|Participant Did Not Receive IP|1|||
162041663|NCT04010539|585210416|FG000|Overall Study|Protocol Deviation|0|||
162041664|NCT04010539|585210417|FG001|Overall Study|Protocol Deviation|1|||
162041665|NCT04010539|585210416|FG000|Overall Study|Randomized in Error/ Mistake|2|||
162041666|NCT04010539|585210417|FG001|Overall Study|Randomized in Error/ Mistake|0|||
162041667|NCT04010539|585210416|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
162041668|NCT04010539|585210417|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
162041669|NCT02028871|585210418|FG000|Overall Study|Positive urine drug screen|1|||
162041670|NCT02028871|585210419|FG001|Overall Study|Positive urine drug screen|1|||
161999674|NCT01147666|585049410|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
161999675|NCT01147666|585049411|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
161999676|NCT01147666|585049412|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161999677|NCT01147666|585049413|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
161999678|NCT01147666|585049414|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161999679|NCT01147666|585049415|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161999680|NCT01147666|585049416|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
161999681|NCT01147666|585049417|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
161999682|NCT01147666|585049418|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
161999683|NCT01147666|585049404|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999684|NCT01147666|585049405|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999685|NCT01147666|585049406|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999686|NCT01147666|585049407|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
161999687|NCT01147666|585049408|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999688|NCT01147666|585049409|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999689|NCT01147666|585049410|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999690|NCT01147666|585049411|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999691|NCT01147666|585049412|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999692|NCT01147666|585049413|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999693|NCT01147666|585049414|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999694|NCT01147666|585049415|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999695|NCT01147666|585049416|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999696|NCT01147666|585049417|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999697|NCT01147666|585049418|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
161999698|NCT01147666|585049404|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161999699|NCT01147666|585049405|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161999700|NCT01147666|585049406|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161999701|NCT01147666|585049407|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161999702|NCT01147666|585049408|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
161999703|NCT01147666|585049409|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
161999704|NCT01147666|585049410|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161999705|NCT01147666|585049411|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
161999706|NCT01147666|585049412|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161999707|NCT01147666|585049413|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
161999708|NCT01147666|585049414|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161999709|NCT01147666|585049415|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161999710|NCT01147666|585049416|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161999711|NCT01147666|585049417|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
161999712|NCT01147666|585049418|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
161999713|NCT01147666|585049404|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999714|NCT01147666|585049405|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999715|NCT01147666|585049406|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999716|NCT01147666|585049407|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
161999717|NCT01147666|585049408|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999718|NCT01147666|585049409|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999719|NCT01147666|585049410|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999720|NCT01147666|585049411|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999721|NCT01147666|585049412|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999722|NCT01147666|585049413|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999723|NCT01147666|585049414|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
161999724|NCT01147666|585049415|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999725|NCT01147666|585049416|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999726|NCT01147666|585049417|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999727|NCT01147666|585049418|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161999728|NCT01147666|585049404|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999729|NCT01147666|585049405|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999730|NCT01147666|585049406|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999731|NCT01147666|585049407|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999732|NCT01147666|585049408|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999733|NCT01147666|585049409|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999734|NCT01147666|585049410|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999735|NCT01147666|585049411|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999736|NCT01147666|585049412|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999737|NCT01147666|585049413|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999738|NCT01147666|585049414|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999739|NCT01147666|585049415|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999740|NCT01147666|585049416|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
161999741|NCT01147666|585049417|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999742|NCT01147666|585049418|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
161999743|NCT01147666|585049404|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999744|NCT01147666|585049405|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999745|NCT01147666|585049406|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999746|NCT01147666|585049407|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999747|NCT01147666|585049408|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999748|NCT01147666|585049409|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999749|NCT01147666|585049410|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999750|NCT01147666|585049411|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999751|NCT01147666|585049412|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999752|NCT01147666|585049413|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999753|NCT01147666|585049414|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999754|NCT01147666|585049415|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999755|NCT01147666|585049416|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
161999756|NCT01147666|585049417|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
161999757|NCT01147666|585049418|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
161999758|NCT02748863|585049419|FG000|Treatment Period 1|Adverse Event|0|||
161999759|NCT02748863|585049420|FG001|Treatment Period 1|Adverse Event|1|||
161999760|NCT02748863|585049421|FG002|Treatment Period 1|Adverse Event|0|||
161999761|NCT02748863|585049422|FG003|Treatment Period 1|Adverse Event|0|||
161999762|NCT02748863|585049423|FG004|Treatment Period 1|Adverse Event|0|||
161999763|NCT02748863|585049419|FG000|Treatment Period 1|Lack of Efficacy|0|||
161999764|NCT02748863|585049420|FG001|Treatment Period 1|Lack of Efficacy|0|||
161999765|NCT02748863|585049421|FG002|Treatment Period 1|Lack of Efficacy|1|||
161999766|NCT02748863|585049422|FG003|Treatment Period 1|Lack of Efficacy|0|||
161999767|NCT02748863|585049423|FG004|Treatment Period 1|Lack of Efficacy|0|||
161999768|NCT02748863|585049419|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161999769|NCT02748863|585049420|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161999770|NCT02748863|585049421|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161999771|NCT02748863|585049422|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161999772|NCT02748863|585049423|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161999773|NCT02748863|585049419|FG000|Treatment Period 2|Lost to Follow-up|2|||
161999774|NCT02748863|585049420|FG001|Treatment Period 2|Lost to Follow-up|0|||
161999775|NCT02748863|585049421|FG002|Treatment Period 2|Lost to Follow-up|0|||
161999776|NCT02748863|585049422|FG003|Treatment Period 2|Lost to Follow-up|0|||
161999777|NCT02748863|585049423|FG004|Treatment Period 2|Lost to Follow-up|0|||
161999778|NCT02748863|585049419|FG000|Treatment Period 2|Adverse Event|3|||
161999779|NCT02748863|585049420|FG001|Treatment Period 2|Adverse Event|2|||
161999780|NCT02748863|585049421|FG002|Treatment Period 2|Adverse Event|0|||
161999781|NCT02748863|585049422|FG003|Treatment Period 2|Adverse Event|2|||
161999782|NCT02748863|585049423|FG004|Treatment Period 2|Adverse Event|0|||
161999783|NCT02748863|585049419|FG000|Treatment Period 2|Lack of Efficacy|0|||
161999784|NCT02748863|585049420|FG001|Treatment Period 2|Lack of Efficacy|1|||
161999785|NCT02748863|585049421|FG002|Treatment Period 2|Lack of Efficacy|0|||
161999786|NCT02748863|585049422|FG003|Treatment Period 2|Lack of Efficacy|0|||
161999787|NCT02748863|585049423|FG004|Treatment Period 2|Lack of Efficacy|0|||
161999788|NCT02748863|585049419|FG000|Treatment Period 2|Pregnancy|0|||
161999789|NCT02748863|585049420|FG001|Treatment Period 2|Pregnancy|0|||
161999790|NCT02748863|585049421|FG002|Treatment Period 2|Pregnancy|0|||
161999791|NCT02748863|585049422|FG003|Treatment Period 2|Pregnancy|0|||
161999792|NCT02748863|585049423|FG004|Treatment Period 2|Pregnancy|1|||
161999793|NCT01135134|585049424|FG000|Overall Study|Adverse Event|1|||
161999794|NCT01135134|585049425|FG001|Overall Study|Adverse Event|1|||
161999795|NCT01135134|585049424|FG000|Overall Study|Did not meet protocol eligibility|1|||
161999796|NCT01135134|585049425|FG001|Overall Study|Did not meet protocol eligibility|0|||
161999797|NCT02576639|585049426|FG000|Overall Study|Withdrawal by Subject|1|||
161999798|NCT02576639|585049427|FG001|Overall Study|Withdrawal by Subject|2|||
161999799|NCT02576639|585049428|FG002|Overall Study|Withdrawal by Subject|1|||
161999800|NCT02576639|585049429|FG003|Overall Study|Withdrawal by Subject|0|||
161999801|NCT02576639|585049430|FG004|Overall Study|Withdrawal by Subject|1|||
161999802|NCT02576639|585049426|FG000|Overall Study|Adverse Event|1|||
161999803|NCT02576639|585049427|FG001|Overall Study|Adverse Event|0|||
161999804|NCT02576639|585049428|FG002|Overall Study|Adverse Event|1|||
161999805|NCT02576639|585049429|FG003|Overall Study|Adverse Event|1|||
161999806|NCT02576639|585049430|FG004|Overall Study|Adverse Event|2|||
161999807|NCT02576639|585049426|FG000|Overall Study|Physician Decision|0|||
161999808|NCT02576639|585049427|FG001|Overall Study|Physician Decision|0|||
161999809|NCT02576639|585049428|FG002|Overall Study|Physician Decision|0|||
161999810|NCT02576639|585049429|FG003|Overall Study|Physician Decision|0|||
161999811|NCT02576639|585049430|FG004|Overall Study|Physician Decision|1|||
161999812|NCT01329978|585049442|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
162041671|NCT02028871|585210418|FG000|Overall Study|Withdrawal by Subject|1|||
162041672|NCT02028871|585210419|FG001|Overall Study|Withdrawal by Subject|2|||
162041673|NCT02028871|585210418|FG000|Overall Study|IV placement difficulty|1|||
162041674|NCT02028871|585210419|FG001|Overall Study|IV placement difficulty|0|||
162041675|NCT02028871|585210418|FG000|Overall Study|Current Illness|1|||
162041676|NCT02028871|585210419|FG001|Overall Study|Current Illness|0|||
162041677|NCT01916967|585210422|FG000|Overall Study|Adverse Event|0|||
162041678|NCT01916967|585210423|FG001|Overall Study|Adverse Event|0|||
162041679|NCT01916967|585210424|FG002|Overall Study|Adverse Event|2|||
162041680|NCT01916967|585210422|FG000|Overall Study|Lack of Efficacy|0|||
162041681|NCT01916967|585210423|FG001|Overall Study|Lack of Efficacy|0|||
162041682|NCT01916967|585210424|FG002|Overall Study|Lack of Efficacy|6|||
162041683|NCT01916967|585210422|FG000|Overall Study|Physician Decision|0|||
162041684|NCT01916967|585210423|FG001|Overall Study|Physician Decision|0|||
162041685|NCT01916967|585210424|FG002|Overall Study|Physician Decision|1|||
162041686|NCT01916967|585210422|FG000|Overall Study|Protocol Violation|0|||
162041687|NCT01916967|585210423|FG001|Overall Study|Protocol Violation|1|||
162041688|NCT01916967|585210424|FG002|Overall Study|Protocol Violation|0|||
162041689|NCT02337738|585210425|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
162041690|NCT02337738|585210426|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
162041691|NCT02337738|585210427|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
162041692|NCT02337738|585210425|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
162041693|NCT02337738|585210426|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
162041694|NCT02337738|585210427|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
162041695|NCT02337738|585210425|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
162041696|NCT02337738|585210426|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
162041697|NCT02337738|585210427|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
162041698|NCT02337738|585210425|FG000|Overall Study|Voluntary Withdrawal|10|||
162041699|NCT02337738|585210426|FG001|Overall Study|Voluntary Withdrawal|5|||
162041700|NCT02337738|585210427|FG002|Overall Study|Voluntary Withdrawal|2|||
162041701|NCT02337738|585210425|FG000|Overall Study|Lack of Efficacy|2|||
162041702|NCT02337738|585210426|FG001|Overall Study|Lack of Efficacy|4|||
162041703|NCT02337738|585210427|FG002|Overall Study|Lack of Efficacy|0|||
162041704|NCT02337738|585210425|FG000|Overall Study|Investigator's Judgment|1|||
162041705|NCT02337738|585210426|FG001|Overall Study|Investigator's Judgment|1|||
162041706|NCT02337738|585210427|FG002|Overall Study|Investigator's Judgment|3|||
162041707|NCT02322021|585210428|FG000|Core Phase|Adverse Event|1|||
162041708|NCT02322021|585210429|FG001|Core Phase|Adverse Event|3|||
162041709|NCT02322021|585210430|FG002|Core Phase|Adverse Event|4|||
162041710|NCT02322021|585210431|FG003|Core Phase|Adverse Event|2|||
162041711|NCT02322021|585210432|FG004|Core Phase|Adverse Event|0|||
162041712|NCT02322021|585210428|FG000|Core Phase|Participant Choice|4|||
162041713|NCT02322021|585210429|FG001|Core Phase|Participant Choice|5|||
162041714|NCT02322021|585210430|FG002|Core Phase|Participant Choice|4|||
162041715|NCT02322021|585210431|FG003|Core Phase|Participant Choice|2|||
162041716|NCT02322021|585210432|FG004|Core Phase|Participant Choice|0|||
162041717|NCT02322021|585210428|FG000|Core Phase|Lost to Follow-up|0|||
162041718|NCT02322021|585210429|FG001|Core Phase|Lost to Follow-up|0|||
162041719|NCT02322021|585210430|FG002|Core Phase|Lost to Follow-up|0|||
162041720|NCT02322021|585210431|FG003|Core Phase|Lost to Follow-up|1|||
162041721|NCT02322021|585210432|FG004|Core Phase|Lost to Follow-up|0|||
162041722|NCT02322021|585210428|FG000|Core Phase|Other|0|||
162041723|NCT02322021|585210429|FG001|Core Phase|Other|0|||
162041724|NCT02322021|585210430|FG002|Core Phase|Other|1|||
161999813|NCT01329978|585049443|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
161999814|NCT01329978|585049444|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
161999815|NCT01329978|585049445|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
161999816|NCT01329978|585049446|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
161999817|NCT01329978|585049442|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
161999818|NCT01329978|585049443|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
161999819|NCT01329978|585049444|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
161999820|NCT01329978|585049445|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
161999821|NCT01329978|585049446|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
161999822|NCT01329978|585049442|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
161999823|NCT01329978|585049443|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
161999824|NCT01329978|585049444|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
161999825|NCT01329978|585049445|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
161999826|NCT01329978|585049446|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
161999827|NCT01329978|585049442|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
161999828|NCT01329978|585049443|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
161999829|NCT01329978|585049444|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
162041725|NCT02322021|585210431|FG003|Core Phase|Other|0|||
162041726|NCT02322021|585210432|FG004|Core Phase|Other|0|||
162041727|NCT02322021|585210428|FG000|Extension Phase|Adverse Event|0|||
162041728|NCT02322021|585210429|FG001|Extension Phase|Adverse Event|0|||
162041729|NCT02322021|585210430|FG002|Extension Phase|Adverse Event|0|||
162041730|NCT02322021|585210431|FG003|Extension Phase|Adverse Event|0|||
162041731|NCT02322021|585210432|FG004|Extension Phase|Adverse Event|3|||
162041732|NCT02322021|585210428|FG000|Extension Phase|Participant Choice|0|||
162041733|NCT02322021|585210429|FG001|Extension Phase|Participant Choice|0|||
162041734|NCT02322021|585210430|FG002|Extension Phase|Participant Choice|0|||
162041735|NCT02322021|585210431|FG003|Extension Phase|Participant Choice|0|||
162041736|NCT02322021|585210432|FG004|Extension Phase|Participant Choice|6|||
162041737|NCT02322021|585210428|FG000|Extension Phase|Other|0|||
162041738|NCT02322021|585210429|FG001|Extension Phase|Other|0|||
162041739|NCT02322021|585210430|FG002|Extension Phase|Other|0|||
162041740|NCT02322021|585210431|FG003|Extension Phase|Other|0|||
162041741|NCT02322021|585210432|FG004|Extension Phase|Other|3|||
162041742|NCT02322021|585210428|FG000|Extension Phase|Lost to Follow-up|0|||
162041743|NCT02322021|585210429|FG001|Extension Phase|Lost to Follow-up|0|||
162041744|NCT02322021|585210430|FG002|Extension Phase|Lost to Follow-up|0|||
162041745|NCT02322021|585210431|FG003|Extension Phase|Lost to Follow-up|0|||
162041746|NCT02322021|585210432|FG004|Extension Phase|Lost to Follow-up|1|||
162041747|NCT02322021|585210428|FG000|Extension Phase|Study terminated by sponsor|0|||
162041748|NCT02322021|585210429|FG001|Extension Phase|Study terminated by sponsor|0|||
162041749|NCT02322021|585210430|FG002|Extension Phase|Study terminated by sponsor|0|||
162041750|NCT02322021|585210431|FG003|Extension Phase|Study terminated by sponsor|0|||
162041751|NCT02322021|585210432|FG004|Extension Phase|Study terminated by sponsor|28|||
162041752|NCT01934972|585210433|FG000|Overall Study|Withdrawal by Subject|9|||
162041753|NCT01934972|585210434|FG001|Overall Study|Withdrawal by Subject|6|||
162041754|NCT01278160|585210435|FG000|Overall Study|Adverse Event|1|||
162041755|NCT01278160|585210436|FG001|Overall Study|Adverse Event|1|||
162041756|NCT01278160|585210435|FG000|Overall Study|Lost to Follow-up|0|||
162041757|NCT01278160|585210436|FG001|Overall Study|Lost to Follow-up|1|||
162041758|NCT01278160|585210435|FG000|Overall Study|Withdrawal by Subject|3|||
162041759|NCT01278160|585210436|FG001|Overall Study|Withdrawal by Subject|2|||
162041760|NCT01278160|585210435|FG000|Overall Study|Unclassified|1|||
162041761|NCT01278160|585210436|FG001|Overall Study|Unclassified|2|||
162041762|NCT02979197|585210439|FG000|Overall Study|Adverse Event|4|||
162041763|NCT02979197|585210440|FG001|Overall Study|Adverse Event|2|||
162041764|NCT02979197|585210441|FG002|Overall Study|Adverse Event|0|||
162041765|NCT02979197|585210439|FG000|Overall Study|Protocol Violation|0|||
162041766|NCT02979197|585210440|FG001|Overall Study|Protocol Violation|1|||
162041767|NCT02979197|585210441|FG002|Overall Study|Protocol Violation|0|||
162041768|NCT02979197|585210439|FG000|Overall Study|Subject unable to commit to study dates|0|||
162041769|NCT02979197|585210440|FG001|Overall Study|Subject unable to commit to study dates|1|||
162041770|NCT02979197|585210441|FG002|Overall Study|Subject unable to commit to study dates|0|||
162041771|NCT03438383|585210442|FG000|Overall Study|Protocol Violation|9|||
162041772|NCT03438383|585210443|FG001|Overall Study|Protocol Violation|3|||
162041773|NCT02435069|585210444|FG000|Dose Response - First Intervention|Adverse Event|0|||
162041774|NCT02435069|585210445|FG001|Dose Response - First Intervention|Adverse Event|1|||
162041775|NCT02435069|585210446|FG002|Dose Response - First Intervention|Adverse Event|1|||
162041776|NCT02435069|585210447|FG003|Dose Response - First Intervention|Adverse Event|0|||
162041777|NCT02435069|585210448|FG004|Dose Response - First Intervention|Adverse Event|0|||
162041778|NCT02435069|585210444|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
162041779|NCT02435069|585210445|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
162041780|NCT02435069|585210446|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
162041781|NCT02435069|585210447|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
162041782|NCT02435069|585210448|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
162041783|NCT02030938|585210453|FG000|Overall Study|Lost to Follow-up|4|||
162041784|NCT02030938|585210453|FG000|Overall Study|Withdrawal by Subject|1|||
162041785|NCT00932737|585210457|FG000|Overall Study|Not treated in second episode|1|||
162041786|NCT00932737|585210458|FG001|Overall Study|Not treated in second episode|0|||
162041787|NCT00932737|585210457|FG000|Overall Study|Adverse Event|0|||
162041788|NCT00932737|585210458|FG001|Overall Study|Adverse Event|1|||
162041789|NCT02949700|585210461|FG000|Phase I|Withdrawal by Subject|1|||
162041790|NCT02949700|585210462|FG001|Phase I|Withdrawal by Subject|1|||
162041791|NCT02949700|585210463|FG002|Phase I|Withdrawal by Subject|0|||
162041792|NCT02949700|585210464|FG003|Phase I|Withdrawal by Subject|0|||
162041793|NCT02949700|585210461|FG000|Phase I|Protocol Violation|1|||
162041794|NCT02949700|585210462|FG001|Phase I|Protocol Violation|0|||
162041795|NCT02949700|585210463|FG002|Phase I|Protocol Violation|0|||
162041796|NCT02949700|585210464|FG003|Phase I|Protocol Violation|0|||
162041797|NCT02949700|585210461|FG000|Phase II|Withdrawal by Subject|0|||
162041798|NCT02949700|585210462|FG001|Phase II|Withdrawal by Subject|0|||
162041799|NCT02949700|585210463|FG002|Phase II|Withdrawal by Subject|0|||
162041800|NCT02949700|585210464|FG003|Phase II|Withdrawal by Subject|2|||
162041801|NCT02949700|585210461|FG000|Phase II|Protocol Violation|0|||
162041802|NCT02949700|585210462|FG001|Phase II|Protocol Violation|0|||
162041803|NCT02949700|585210463|FG002|Phase II|Protocol Violation|1|||
162041804|NCT02949700|585210464|FG003|Phase II|Protocol Violation|3|||
162041805|NCT02452697|585210470|FG000|Overall Study|Physician Decision|4|||
162041806|NCT02452697|585210471|FG001|Overall Study|Physician Decision|4|||
161999830|NCT01329978|585049445|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
161999831|NCT01329978|585049446|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
161999832|NCT01329978|585049442|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
161999833|NCT01329978|585049443|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
161999834|NCT01329978|585049444|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
161999835|NCT01329978|585049445|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
161999836|NCT01329978|585049446|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
161999837|NCT01329978|585049442|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
161999838|NCT01329978|585049443|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
161999839|NCT01329978|585049444|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
161999840|NCT01329978|585049445|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
161999841|NCT01329978|585049446|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
161999842|NCT01329978|585049442|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
161999843|NCT01329978|585049443|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
161999844|NCT01329978|585049444|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
161999845|NCT01329978|585049445|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
161999846|NCT01329978|585049446|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
161999847|NCT03081884|585049451|FG000|Overall Study|deferred prostate cancer treatment|1|||
161999848|NCT03081884|585049451|FG000|Overall Study|metastasis managed with systemic therapy|3|||
161999849|NCT02294058|585049452|FG000|Overall Study|Adverse Event|16|||
161999850|NCT02294058|585049453|FG001|Overall Study|Adverse Event|7|||
161999851|NCT02294058|585049454|FG002|Overall Study|Adverse Event|13|||
161999852|NCT02294058|585049452|FG000|Overall Study|Lack of Efficacy|3|||
161999853|NCT02294058|585049453|FG001|Overall Study|Lack of Efficacy|3|||
161999854|NCT02294058|585049454|FG002|Overall Study|Lack of Efficacy|0|||
161999855|NCT02294058|585049452|FG000|Overall Study|Lost to Follow-up|1|||
161999856|NCT02294058|585049453|FG001|Overall Study|Lost to Follow-up|0|||
161999857|NCT02294058|585049454|FG002|Overall Study|Lost to Follow-up|2|||
161999858|NCT02294058|585049452|FG000|Overall Study|Withdrawal by Subject|10|||
161999859|NCT02294058|585049453|FG001|Overall Study|Withdrawal by Subject|14|||
161999860|NCT02294058|585049454|FG002|Overall Study|Withdrawal by Subject|13|||
161999861|NCT02294058|585049452|FG000|Overall Study|Physician Decision|2|||
161999862|NCT02294058|585049453|FG001|Overall Study|Physician Decision|1|||
161999863|NCT02294058|585049454|FG002|Overall Study|Physician Decision|0|||
161999864|NCT02294058|585049452|FG000|Overall Study|Miscellaneous|4|||
161999865|NCT02294058|585049453|FG001|Overall Study|Miscellaneous|1|||
161999866|NCT02294058|585049454|FG002|Overall Study|Miscellaneous|1|||
161999867|NCT06172348|585049456|FG000|Treatment Period 2|Adverse Event|0|||
161999868|NCT06172348|585049457|FG001|Treatment Period 2|Adverse Event|0|||
161999869|NCT06172348|585049458|FG002|Treatment Period 2|Adverse Event|1|||
161999870|NCT06172348|585049459|FG003|Treatment Period 2|Adverse Event|0|||
161999871|NCT06172348|585049460|FG004|Treatment Period 2|Adverse Event|0|||
161999872|NCT06172348|585049461|FG005|Treatment Period 2|Adverse Event|0|||
161999873|NCT03799341|585049462|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
161999874|NCT03799341|585049463|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
161999875|NCT03799341|585049464|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
161999876|NCT03799341|585049462|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
161999877|NCT03799341|585049463|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
161999878|NCT03799341|585049464|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
161999879|NCT03799341|585049462|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
161999880|NCT03799341|585049463|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
161999881|NCT03799341|585049464|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
161999882|NCT03799341|585049462|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
161999883|NCT03799341|585049463|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
161999884|NCT03799341|585049464|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
161999885|NCT03799341|585049462|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
161999886|NCT03799341|585049463|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
161999887|NCT03799341|585049464|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
161999888|NCT03799341|585049462|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
161999889|NCT03799341|585049463|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
161999890|NCT03799341|585049464|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
161999891|NCT04539938|585049465|FG000|Overall Study|Death|30|||
161999892|NCT04539938|585049465|FG000|Overall Study|Withdrawal by Subject|4|||
161999893|NCT04037891|585049466|FG000|Open-label Period|Withdrawal by Subject|1|||
161999894|NCT04037891|585049467|FG001|Open-label Period|Withdrawal by Subject|0|||
161999895|NCT04037891|585049468|FG002|Open-label Period|Withdrawal by Subject|0|||
161999896|NCT04037891|585049466|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
161999897|NCT04037891|585049467|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
161999898|NCT04037891|585049468|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
161999899|NCT00990106|585049469|FG000|Overall Study|"too busy to continue"|1|||
161999900|NCT00990106|585049470|FG001|Overall Study|"too busy to continue"|2|||
161999901|NCT00990106|585049469|FG000|Overall Study|Lost to Follow-up|1|||
161999902|NCT00990106|585049470|FG001|Overall Study|Lost to Follow-up|3|||
161999903|NCT00990106|585049469|FG000|Overall Study|Withdrawal by Subject|2|||
161999904|NCT00990106|585049470|FG001|Overall Study|Withdrawal by Subject|1|||
161999905|NCT00990106|585049469|FG000|Overall Study|opted for open label prazosin|1|||
161999906|NCT00990106|585049470|FG001|Overall Study|opted for open label prazosin|1|||
161999907|NCT00990106|585049469|FG000|Overall Study|relocation/deployment|4|||
161999908|NCT00990106|585049470|FG001|Overall Study|relocation/deployment|1|||
161999909|NCT00990106|585049469|FG000|Overall Study|started exclusionary medication|0|||
161999910|NCT00990106|585049470|FG001|Overall Study|started exclusionary medication|1|||
161999911|NCT00990106|585049469|FG000|Overall Study|planned major surgery|0|||
161999912|NCT00990106|585049470|FG001|Overall Study|planned major surgery|1|||
161999913|NCT00990106|585049469|FG000|Overall Study|scheduling conflicts|0|||
161999914|NCT00990106|585049470|FG001|Overall Study|scheduling conflicts|2|||
161999915|NCT04194944|585049471|FG000|Overall Study|Lost to Follow-up|3|||
161999916|NCT04194944|585049472|FG001|Overall Study|Lost to Follow-up|0|||
161999917|NCT04194944|585049471|FG000|Overall Study|Withdrawal by Subject|2|||
161999918|NCT04194944|585049472|FG001|Overall Study|Withdrawal by Subject|2|||
161999919|NCT04194944|585049471|FG000|Overall Study|On Treatment|93|||
161999920|NCT04194944|585049472|FG001|Overall Study|On Treatment|30|||
161999921|NCT00348673|585049475|FG000|Stage 1|Randomized but not Treated|0|||
161999922|NCT00348673|585049476|FG001|Stage 1|Randomized but not Treated|0|||
161999923|NCT00348673|585049477|FG002|Stage 1|Randomized but not Treated|1|||
161999924|NCT00348673|585049478|FG003|Stage 1|Randomized but not Treated|0|||
161999925|NCT00348673|585049479|FG004|Stage 1|Randomized but not Treated|0|||
161999926|NCT00348673|585049480|FG005|Stage 1|Randomized but not Treated|0|||
161999927|NCT00348673|585049481|FG006|Stage 1|Randomized but not Treated|0|||
161999928|NCT00348673|585049482|FG007|Stage 1|Randomized but not Treated|0|||
161999929|NCT00348673|585049483|FG008|Stage 1|Randomized but not Treated|0|||
161999930|NCT03096834|585051891|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
161999931|NCT03096834|585051892|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
161999932|NCT03096834|585051893|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
161999933|NCT03096834|585051894|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
161999934|NCT03096834|585051891|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
161999935|NCT03096834|585051892|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
161999936|NCT03096834|585051893|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
161999937|NCT03096834|585051894|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
161999938|NCT03096834|585051891|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
161999939|NCT03096834|585051892|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
161999940|NCT03096834|585051893|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
161999941|NCT03096834|585051894|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
161999942|NCT03096834|585051891|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
161999943|NCT03096834|585051892|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
161999944|NCT03096834|585051893|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
161999945|NCT03096834|585051894|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
161999946|NCT03096834|585051891|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
161999947|NCT03096834|585051892|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
161999948|NCT03096834|585051893|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
161999949|NCT03096834|585051894|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
161999950|NCT03096834|585051891|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
161999951|NCT03096834|585051892|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
161999952|NCT03096834|585051893|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
161999953|NCT03096834|585051894|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
161999954|NCT03096834|585051891|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
161999955|NCT03096834|585051892|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
161999956|NCT03096834|585051893|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
161999957|NCT03096834|585051894|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
161999958|NCT03096834|585051891|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
161999959|NCT03096834|585051892|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
161999960|NCT03096834|585051893|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
161999961|NCT03096834|585051894|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
161999962|NCT03096834|585051891|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
161999963|NCT03096834|585051892|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
161999964|NCT03096834|585051893|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
161999965|NCT03096834|585051894|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
161999966|NCT03096834|585051891|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
161999967|NCT03096834|585051892|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
161999968|NCT03096834|585051893|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
161999969|NCT03096834|585051894|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
161999970|NCT03096834|585051891|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
161999971|NCT03096834|585051892|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
161999972|NCT03096834|585051893|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
161999973|NCT03096834|585051894|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
161999974|NCT03096834|585051891|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
161999975|NCT03096834|585051892|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
161999976|NCT03096834|585051893|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
161999977|NCT03096834|585051894|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
161999978|NCT01005251|585051897|FG000|Overall Study|Withdrawal by Subject|2|||
161999979|NCT01005251|585051898|FG001|Overall Study|Withdrawal by Subject|5|||
161999980|NCT01005251|585051899|FG002|Overall Study|Withdrawal by Subject|3|||
161999981|NCT01005251|585051900|FG003|Overall Study|Withdrawal by Subject|4|||
161999982|NCT01005251|585051901|FG004|Overall Study|Withdrawal by Subject|9|||
161999983|NCT01005251|585051897|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
161999984|NCT01005251|585051898|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161999985|NCT01005251|585051899|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
161999986|NCT01005251|585051900|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
161999987|NCT01005251|585051901|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
161999988|NCT01005251|585051897|FG000|Overall Study|Adverse Event|2|||
161999989|NCT01005251|585051898|FG001|Overall Study|Adverse Event|6|||
161999990|NCT01005251|585051899|FG002|Overall Study|Adverse Event|8|||
161999991|NCT01005251|585051900|FG003|Overall Study|Adverse Event|5|||
161999992|NCT01005251|585051901|FG004|Overall Study|Adverse Event|4|||
161999993|NCT01005251|585051897|FG000|Overall Study|Protocol Violation|1|||
161999994|NCT01005251|585051898|FG001|Overall Study|Protocol Violation|0|||
161999995|NCT01005251|585051899|FG002|Overall Study|Protocol Violation|0|||
161999996|NCT01005251|585051900|FG003|Overall Study|Protocol Violation|0|||
161999997|NCT01005251|585051901|FG004|Overall Study|Protocol Violation|2|||
161999998|NCT01005251|585051897|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
161999999|NCT01005251|585051898|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
162000000|NCT01005251|585051899|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
162000001|NCT01005251|585051900|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
162000002|NCT01005251|585051901|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
162000003|NCT01005251|585051897|FG000|Overall Study|Lost to Follow-up|1|||
162000004|NCT01005251|585051898|FG001|Overall Study|Lost to Follow-up|4|||
162000005|NCT01005251|585051899|FG002|Overall Study|Lost to Follow-up|2|||
162000006|NCT01005251|585051900|FG003|Overall Study|Lost to Follow-up|0|||
162000007|NCT01005251|585051901|FG004|Overall Study|Lost to Follow-up|0|||
162000008|NCT01005251|585051897|FG000|Overall Study|Physician Decision|0|||
162000009|NCT01005251|585051898|FG001|Overall Study|Physician Decision|0|||
162000010|NCT01005251|585051899|FG002|Overall Study|Physician Decision|0|||
162000011|NCT01005251|585051900|FG003|Overall Study|Physician Decision|0|||
162000012|NCT01005251|585051901|FG004|Overall Study|Physician Decision|2|||
162000013|NCT01005251|585051897|FG000|Overall Study|Patient moved|1|||
162000014|NCT01005251|585051898|FG001|Overall Study|Patient moved|0|||
162000015|NCT01005251|585051899|FG002|Overall Study|Patient moved|0|||
162000016|NCT01005251|585051900|FG003|Overall Study|Patient moved|0|||
162000017|NCT01005251|585051901|FG004|Overall Study|Patient moved|0|||
162000018|NCT01005251|585051897|FG000|Overall Study|Wrong drug dispensed|0|||
162000019|NCT01005251|585051898|FG001|Overall Study|Wrong drug dispensed|1|||
162000020|NCT01005251|585051899|FG002|Overall Study|Wrong drug dispensed|0|||
162000021|NCT01005251|585051900|FG003|Overall Study|Wrong drug dispensed|0|||
162000022|NCT01005251|585051901|FG004|Overall Study|Wrong drug dispensed|0|||
162000023|NCT01005251|585051897|FG000|Overall Study|Randomized in error|0|||
162000024|NCT01005251|585051898|FG001|Overall Study|Randomized in error|0|||
162000025|NCT01005251|585051899|FG002|Overall Study|Randomized in error|1|||
162000026|NCT01005251|585051900|FG003|Overall Study|Randomized in error|1|||
162000027|NCT01005251|585051901|FG004|Overall Study|Randomized in error|0|||
162000028|NCT01005251|585051897|FG000|Overall Study|Lack of Efficacy|0|||
162000029|NCT01005251|585051898|FG001|Overall Study|Lack of Efficacy|0|||
162000030|NCT01005251|585051899|FG002|Overall Study|Lack of Efficacy|1|||
162000031|NCT01005251|585051900|FG003|Overall Study|Lack of Efficacy|1|||
162000032|NCT01005251|585051901|FG004|Overall Study|Lack of Efficacy|0|||
162000033|NCT02193776|585051902|FG000|Overall Study|Consent withdrawn|1|||
162000034|NCT02193776|585051903|FG001|Overall Study|Consent withdrawn|0|||
162000035|NCT02193776|585051904|FG002|Overall Study|Consent withdrawn|0|||
162000036|NCT02193776|585051905|FG003|Overall Study|Consent withdrawn|0|||
162000037|NCT02193776|585051902|FG000|Overall Study|Failure to comply with protocol|0|||
162000038|NCT02193776|585051903|FG001|Overall Study|Failure to comply with protocol|1|||
162000039|NCT02193776|585051904|FG002|Overall Study|Failure to comply with protocol|0|||
162000040|NCT02193776|585051905|FG003|Overall Study|Failure to comply with protocol|0|||
162000041|NCT02193776|585051902|FG000|Overall Study|Investigator/Sponsor decision|1|||
162000042|NCT02193776|585051903|FG001|Overall Study|Investigator/Sponsor decision|1|||
162000043|NCT02193776|585051904|FG002|Overall Study|Investigator/Sponsor decision|0|||
162000044|NCT02193776|585051905|FG003|Overall Study|Investigator/Sponsor decision|0|||
162000045|NCT02193776|585051902|FG000|Overall Study|Death|1|||
162000046|NCT02193776|585051903|FG001|Overall Study|Death|0|||
162000047|NCT02193776|585051904|FG002|Overall Study|Death|0|||
162000048|NCT02193776|585051905|FG003|Overall Study|Death|0|||
162000049|NCT02193776|585051902|FG000|Overall Study|Adverse event/Specific toxicity|5|||
162000050|NCT02193776|585051903|FG001|Overall Study|Adverse event/Specific toxicity|5|||
162000051|NCT02193776|585051904|FG002|Overall Study|Adverse event/Specific toxicity|2|||
162000052|NCT02193776|585051905|FG003|Overall Study|Adverse event/Specific toxicity|2|||
162000053|NCT02995980|585051906|FG000|Overall Study|Lost to Follow-up|14|||
162000054|NCT01169103|585051907|FG000|Overall Study|Lost to Follow-up|3|||
162000055|NCT01169103|585051908|FG001|Overall Study|Lost to Follow-up|3|||
162000056|NCT01169103|585051907|FG000|Overall Study|Withdrawal by Subject|3|||
162000057|NCT01169103|585051908|FG001|Overall Study|Withdrawal by Subject|1|||
162000058|NCT00981149|585051912|FG000|Overall Study|Lost to Follow-up|1|||
162000059|NCT00981149|585051913|FG001|Overall Study|Lost to Follow-up|2|||
162000060|NCT00981149|585051912|FG000|Overall Study|Withdrawal by Subject|1|||
162000061|NCT00981149|585051913|FG001|Overall Study|Withdrawal by Subject|1|||
162000062|NCT02634333|585051917|FG000|Overall Study|Completed out of Window|3|||
162000063|NCT02634333|585051918|FG001|Overall Study|Completed out of Window|2|||
162000064|NCT02634333|585051917|FG000|Overall Study|Missed Visit|5|||
162000065|NCT02634333|585051918|FG001|Overall Study|Missed Visit|2|||
162000066|NCT02634333|585051917|FG000|Overall Study|Lost to Follow-up|12|||
162000067|NCT02634333|585051918|FG001|Overall Study|Lost to Follow-up|7|||
162000068|NCT02634333|585051917|FG000|Overall Study|Withdrawal by Subject|9|||
162000069|NCT02634333|585051918|FG001|Overall Study|Withdrawal by Subject|13|||
162000070|NCT02634333|585051917|FG000|Overall Study|Death|11|||
162000071|NCT02634333|585051918|FG001|Overall Study|Death|8|||
162000072|NCT00657046|585051921|FG000|Overall Study|Adverse Event|1|||
162000073|NCT00657046|585051922|FG001|Overall Study|Adverse Event|1|||
162000074|NCT00657046|585051923|FG002|Overall Study|Adverse Event|0|||
162000075|NCT00657046|585051921|FG000|Overall Study|Protocol Violation|2|||
162000076|NCT00657046|585051922|FG001|Overall Study|Protocol Violation|2|||
162000077|NCT00657046|585051923|FG002|Overall Study|Protocol Violation|0|||
162000078|NCT00657046|585051921|FG000|Overall Study|Withdrawal by Subject|1|||
162000079|NCT00657046|585051922|FG001|Overall Study|Withdrawal by Subject|0|||
162000080|NCT00657046|585051923|FG002|Overall Study|Withdrawal by Subject|0|||
162000081|NCT00657046|585051921|FG000|Overall Study|Death|0|||
162000082|NCT00657046|585051922|FG001|Overall Study|Death|0|||
162000083|NCT00657046|585051923|FG002|Overall Study|Death|1|||
162000084|NCT00657046|585051921|FG000|Overall Study|Surgery|0|||
162000085|NCT00657046|585051922|FG001|Overall Study|Surgery|0|||
162000086|NCT00657046|585051923|FG002|Overall Study|Surgery|1|||
162000087|NCT03827655|585051924|FG000|Overall Study|Death|0|||
162000088|NCT03827655|585051925|FG001|Overall Study|Death|0|||
162000089|NCT03827655|585051926|FG002|Overall Study|Death|0|||
162000090|NCT03827655|585051927|FG003|Overall Study|Death|0|||
162000091|NCT03827655|585051928|FG004|Overall Study|Death|1|||
162000092|NCT03827655|585051924|FG000|Overall Study|Protocol Deviation|1|||
162000093|NCT03827655|585051925|FG001|Overall Study|Protocol Deviation|0|||
162000094|NCT03827655|585051926|FG002|Overall Study|Protocol Deviation|1|||
162000095|NCT03827655|585051927|FG003|Overall Study|Protocol Deviation|1|||
162000096|NCT03827655|585051928|FG004|Overall Study|Protocol Deviation|0|||
162000097|NCT03827655|585051924|FG000|Overall Study|Withdrawal by Subject|3|||
162000098|NCT03827655|585051925|FG001|Overall Study|Withdrawal by Subject|2|||
162000099|NCT03827655|585051926|FG002|Overall Study|Withdrawal by Subject|2|||
162000100|NCT03827655|585051927|FG003|Overall Study|Withdrawal by Subject|0|||
162000101|NCT03827655|585051928|FG004|Overall Study|Withdrawal by Subject|1|||
162000102|NCT03827655|585051924|FG000|Overall Study|Reason not Specified|3|||
162000103|NCT03827655|585051925|FG001|Overall Study|Reason not Specified|1|||
162000104|NCT03827655|585051926|FG002|Overall Study|Reason not Specified|1|||
162000105|NCT03827655|585051927|FG003|Overall Study|Reason not Specified|1|||
162000106|NCT03827655|585051928|FG004|Overall Study|Reason not Specified|1|||
162000107|NCT03935126|585051931|FG000|Overall Study|Study termination by sponsor|3|||
162000108|NCT01092728|585051932|FG000|Overall Study|Withdrawal by Subject|2|||
162000109|NCT01092728|585051933|FG001|Overall Study|Withdrawal by Subject|0|||
162000110|NCT01092728|585051932|FG000|Overall Study|Adverse Event|0|||
162000111|NCT01092728|585051933|FG001|Overall Study|Adverse Event|1|||
162000112|NCT01092728|585051932|FG000|Overall Study|Disease Progression|1|||
162000113|NCT01092728|585051933|FG001|Overall Study|Disease Progression|13|||
162000114|NCT01092728|585051932|FG000|Overall Study|Prohibited Concomitant Medications|1|||
162000115|NCT01092728|585051933|FG001|Overall Study|Prohibited Concomitant Medications|0|||
162000116|NCT02336607|585051934|FG000|Overall Study|Physician Decision|1|||
162000117|NCT02336607|585051935|FG001|Overall Study|Physician Decision|4|||
162000118|NCT02336607|585051936|FG002|Overall Study|Physician Decision|3|||
162000119|NCT02336607|585051937|FG003|Overall Study|Physician Decision|15|||
162000120|NCT02336607|585051934|FG000|Overall Study|Lack of Efficacy|1|||
162000121|NCT02336607|585051935|FG001|Overall Study|Lack of Efficacy|0|||
162000122|NCT02336607|585051936|FG002|Overall Study|Lack of Efficacy|0|||
162000123|NCT02336607|585051937|FG003|Overall Study|Lack of Efficacy|2|||
162000124|NCT02336607|585051934|FG000|Overall Study|Lost to Follow-up|2|||
162000125|NCT02336607|585051935|FG001|Overall Study|Lost to Follow-up|1|||
162000126|NCT02336607|585051936|FG002|Overall Study|Lost to Follow-up|0|||
162000127|NCT02336607|585051937|FG003|Overall Study|Lost to Follow-up|21|||
162000128|NCT02336607|585051934|FG000|Overall Study|Protocol Violation|0|||
162000129|NCT02336607|585051935|FG001|Overall Study|Protocol Violation|1|||
162000130|NCT02336607|585051936|FG002|Overall Study|Protocol Violation|1|||
162000131|NCT02336607|585051937|FG003|Overall Study|Protocol Violation|3|||
162000132|NCT02336607|585051934|FG000|Overall Study|Adverse Event|0|||
162000133|NCT02336607|585051935|FG001|Overall Study|Adverse Event|2|||
162000134|NCT02336607|585051936|FG002|Overall Study|Adverse Event|2|||
162000135|NCT02336607|585051937|FG003|Overall Study|Adverse Event|26|||
162000136|NCT02336607|585051934|FG000|Overall Study|Withdrawal by Subject|0|||
162000137|NCT02336607|585051935|FG001|Overall Study|Withdrawal by Subject|2|||
162000138|NCT02336607|585051936|FG002|Overall Study|Withdrawal by Subject|0|||
162000139|NCT02336607|585051937|FG003|Overall Study|Withdrawal by Subject|20|||
162000140|NCT02552966|585051938|FG000|Overall Study|Lost to Follow-up|2|||
162000141|NCT02552966|585051938|FG000|Overall Study|Withdrawal by Subject|3|||
162000142|NCT02365649|585051952|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
162000143|NCT02365649|585051953|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
162000144|NCT02365649|585051954|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
162000145|NCT02365649|585051955|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
162000146|NCT02365649|585051956|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
162000147|NCT02365649|585051957|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
162000148|NCT02365649|585051958|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
162000149|NCT02365649|585051959|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
162000150|NCT02365649|585051960|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
162000151|NCT02365649|585051961|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
162000152|NCT02365649|585051952|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
162000153|NCT02365649|585051953|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
162000154|NCT02365649|585051954|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
162000155|NCT02365649|585051955|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
162000156|NCT02365649|585051956|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
162000157|NCT02365649|585051957|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
162000158|NCT02365649|585051958|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
162000159|NCT02365649|585051959|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
162000160|NCT02365649|585051960|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
162000161|NCT02365649|585051961|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
162000162|NCT02365649|585051952|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
162000163|NCT02365649|585051953|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
162000164|NCT02365649|585051954|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
162000165|NCT02365649|585051955|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
162000166|NCT02365649|585051956|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
162000167|NCT02365649|585051957|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
162000168|NCT02365649|585051958|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
162000169|NCT02365649|585051959|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
162000170|NCT02365649|585051960|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
162000171|NCT02365649|585051961|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
162000172|NCT02365649|585051952|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
162000173|NCT02365649|585051953|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
162000174|NCT02365649|585051954|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
162000175|NCT02365649|585051955|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
162000176|NCT02365649|585051956|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
162000177|NCT02365649|585051957|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
162000178|NCT02365649|585051958|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
162000179|NCT02365649|585051959|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
162000180|NCT02365649|585051960|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
162000181|NCT02365649|585051961|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
162000182|NCT02365649|585051952|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
162000183|NCT02365649|585051953|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
162000184|NCT02365649|585051954|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
162000185|NCT02365649|585051955|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
162000186|NCT02365649|585051956|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
162000187|NCT02365649|585051957|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
162000188|NCT02365649|585051958|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
162000189|NCT02365649|585051959|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
162000190|NCT02365649|585051960|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
162000191|NCT02365649|585051961|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
162000192|NCT02365649|585051952|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
162000193|NCT02365649|585051953|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
162000194|NCT02365649|585051954|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
162000195|NCT02365649|585051955|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
162000196|NCT02365649|585051956|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
162041807|NCT02452697|585210472|FG002|Overall Study|Physician Decision|3|||
162000197|NCT02365649|585051957|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
162000198|NCT02365649|585051958|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
162000199|NCT02365649|585051959|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
162000200|NCT02365649|585051960|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
162000201|NCT02365649|585051961|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
162000202|NCT02365649|585051952|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
162000203|NCT02365649|585051953|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
162041808|NCT02452697|585210473|FG003|Overall Study|Physician Decision|2|||
162041809|NCT02452697|585210470|FG000|Overall Study|Withdrawal by Subject|1|||
162041810|NCT02452697|585210471|FG001|Overall Study|Withdrawal by Subject|0|||
162041811|NCT02452697|585210472|FG002|Overall Study|Withdrawal by Subject|0|||
162041812|NCT02452697|585210473|FG003|Overall Study|Withdrawal by Subject|0|||
162041813|NCT02452697|585210470|FG000|Overall Study|still in follow-up|2|||
162041814|NCT02452697|585210471|FG001|Overall Study|still in follow-up|2|||
162041815|NCT02452697|585210472|FG002|Overall Study|still in follow-up|1|||
162041816|NCT02452697|585210473|FG003|Overall Study|still in follow-up|3|||
162041817|NCT00560885|585210476|FG000|Overall Study|Death|7|||
162041818|NCT00560885|585210476|FG000|Overall Study|Withdrawal by Subject|1|||
162041819|NCT03803683|585210477|FG000|Overall Study|Lost to Follow-up|41|||
162041820|NCT03803683|585210478|FG001|Overall Study|Lost to Follow-up|18|||
162041821|NCT03803683|585210479|FG002|Overall Study|Lost to Follow-up|12|||
162041822|NCT03803683|585210477|FG000|Overall Study|Withdrawal by Subject|9|||
162041823|NCT03803683|585210478|FG001|Overall Study|Withdrawal by Subject|1|||
162041824|NCT03803683|585210479|FG002|Overall Study|Withdrawal by Subject|4|||
162041825|NCT00697073|585211846|FG000|Overall Study|Withdrawal by Subject|2|||
162041826|NCT00697073|585211846|FG000|Overall Study|Pregnancy|1|||
162041827|NCT00697073|585211846|FG000|Overall Study|non compliance and other|6|||
162041828|NCT00426231|585211847|FG000|Overall Study|Withdrawal by Subject|9|||
162041829|NCT00426231|585211848|FG001|Overall Study|Withdrawal by Subject|12|||
162041830|NCT03911713|585211849|FG000|Overall Study|Lost to Follow-up|0|||
162041831|NCT03911713|585211850|FG001|Overall Study|Lost to Follow-up|2|||
162041832|NCT03911713|585211851|FG002|Overall Study|Lost to Follow-up|0|||
162041833|NCT03911713|585211852|FG003|Overall Study|Lost to Follow-up|0|||
162041834|NCT03911713|585211853|FG004|Overall Study|Lost to Follow-up|0|||
162041835|NCT03911713|585211849|FG000|Overall Study|Other|0|||
162041836|NCT03911713|585211850|FG001|Overall Study|Other|0|||
162041837|NCT03911713|585211851|FG002|Overall Study|Other|0|||
162041838|NCT03911713|585211852|FG003|Overall Study|Other|1|||
162041839|NCT03911713|585211853|FG004|Overall Study|Other|0|||
162041840|NCT03911713|585211849|FG000|Overall Study|Randomized, Never Dosed|1|||
162041841|NCT03911713|585211850|FG001|Overall Study|Randomized, Never Dosed|0|||
162041842|NCT03911713|585211851|FG002|Overall Study|Randomized, Never Dosed|0|||
162041843|NCT03911713|585211852|FG003|Overall Study|Randomized, Never Dosed|1|||
162041844|NCT03911713|585211853|FG004|Overall Study|Randomized, Never Dosed|0|||
162041845|NCT00108433|585211854|FG000|Overall Study|Lack of Efficacy|1|||
162041846|NCT00108433|585211855|FG001|Overall Study|Lack of Efficacy|2|||
162041847|NCT00108433|585211854|FG000|Overall Study|Death|3|||
162041848|NCT00108433|585211855|FG001|Overall Study|Death|0|||
162041849|NCT00108433|585211854|FG000|Overall Study|Adverse Event|3|||
162041850|NCT00108433|585211855|FG001|Overall Study|Adverse Event|1|||
162041851|NCT00108433|585211854|FG000|Overall Study|Other|14|||
162041852|NCT00108433|585211855|FG001|Overall Study|Other|14|||
162041853|NCT01193660|585211856|FG000|Overall Study|Withdrawal by Subject|2|||
162041854|NCT01193660|585211857|FG001|Overall Study|Withdrawal by Subject|3|||
162041855|NCT01193660|585211858|FG002|Overall Study|Withdrawal by Subject|1|||
162041856|NCT01193660|585211856|FG000|Overall Study|Death|1|||
162041857|NCT01193660|585211857|FG001|Overall Study|Death|0|||
162041858|NCT01193660|585211858|FG002|Overall Study|Death|0|||
162041859|NCT01193660|585211856|FG000|Overall Study|Physician Decision|1|||
162041860|NCT01193660|585211857|FG001|Overall Study|Physician Decision|0|||
162041861|NCT01193660|585211858|FG002|Overall Study|Physician Decision|1|||
162041862|NCT01886716|585211859|FG000|Week 1|Lost to Follow-up|0|||
162041863|NCT01886716|585211860|FG001|Week 1|Lost to Follow-up|0|||
162041864|NCT01886716|585211861|FG002|Week 1|Lost to Follow-up|2|||
162041865|NCT01886716|585211862|FG003|Week 1|Lost to Follow-up|2|||
162041866|NCT01886716|585211859|FG000|Week 2|Lost to Follow-up|3|||
162041867|NCT01886716|585211860|FG001|Week 2|Lost to Follow-up|2|||
162041868|NCT01886716|585211861|FG002|Week 2|Lost to Follow-up|1|||
162041869|NCT01886716|585211862|FG003|Week 2|Lost to Follow-up|3|||
162041870|NCT01886716|585211859|FG000|Week 3|Lost to Follow-up|1|||
162041871|NCT01886716|585211860|FG001|Week 3|Lost to Follow-up|1|||
162041872|NCT01886716|585211861|FG002|Week 3|Lost to Follow-up|0|||
162041873|NCT01886716|585211862|FG003|Week 3|Lost to Follow-up|1|||
162041874|NCT02572388|585211863|FG000|Overall Study|Withdrawal by Subject|1|||
162041875|NCT02572388|585211864|FG001|Overall Study|Withdrawal by Subject|1|||
162041876|NCT02572388|585211865|FG002|Overall Study|Withdrawal by Subject|2|||
162041877|NCT02572388|585211866|FG003|Overall Study|Withdrawal by Subject|2|||
162041878|NCT04806503|585211872|FG000|Overall Study|Lost to Follow-up|0|||
162041879|NCT04806503|585211873|FG001|Overall Study|Lost to Follow-up|0|||
162000204|NCT02365649|585051954|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
162000205|NCT02365649|585051955|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
162000206|NCT02365649|585051956|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
162000207|NCT02365649|585051957|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
162000208|NCT02365649|585051958|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
162000209|NCT02365649|585051959|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
162000210|NCT02365649|585051960|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
162000211|NCT02365649|585051961|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
162000212|NCT02365649|585051952|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
162000213|NCT02365649|585051953|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
162000214|NCT02365649|585051954|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
162000215|NCT02365649|585051955|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
162000216|NCT02365649|585051956|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
162000217|NCT02365649|585051957|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
162000218|NCT02365649|585051958|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
162000219|NCT02365649|585051959|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
162000220|NCT02365649|585051960|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
162000221|NCT02365649|585051961|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
162000222|NCT02365649|585051952|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
162000223|NCT02365649|585051953|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
162000224|NCT02365649|585051954|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
162000225|NCT02365649|585051955|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
162000226|NCT02365649|585051956|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
162000227|NCT02365649|585051957|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
162000228|NCT02365649|585051958|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
162000229|NCT02365649|585051959|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
162000230|NCT02365649|585051960|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
162000231|NCT02365649|585051961|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
162000232|NCT02365649|585051952|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
162000233|NCT02365649|585051953|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
162000234|NCT02365649|585051954|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
162000235|NCT02365649|585051955|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
162000236|NCT02365649|585051956|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
162000237|NCT02365649|585051957|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
162000238|NCT02365649|585051958|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
162000239|NCT02365649|585051959|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
162000240|NCT02365649|585051960|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
162000241|NCT02365649|585051961|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
162000242|NCT02365649|585051952|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
162000243|NCT02365649|585051953|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
162000244|NCT02365649|585051954|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
162000245|NCT02365649|585051955|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
162000246|NCT02365649|585051956|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
162000247|NCT02365649|585051957|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
162000248|NCT02365649|585051958|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
162000249|NCT02365649|585051959|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
162000250|NCT02365649|585051960|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
162000251|NCT02365649|585051961|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
162000252|NCT02365649|585051952|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
162000253|NCT02365649|585051953|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
162000254|NCT02365649|585051954|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
162000255|NCT02365649|585051955|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
162000256|NCT02365649|585051956|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
162000257|NCT02365649|585051957|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
162000258|NCT02365649|585051958|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
162000259|NCT02365649|585051959|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
162000260|NCT02365649|585051960|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
162000261|NCT02365649|585051961|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
162000262|NCT01506271|585051966|FG000|Overall Study|Progressive disease|0|||
162000263|NCT01506271|585051967|FG001|Overall Study|Progressive disease|1|||
162000264|NCT01506271|585051968|FG002|Overall Study|Progressive disease|0|||
162000265|NCT01506271|585051966|FG000|Overall Study|Protocol Violation|3|||
162000266|NCT01506271|585051967|FG001|Overall Study|Protocol Violation|1|||
162000267|NCT01506271|585051968|FG002|Overall Study|Protocol Violation|0|||
162000268|NCT01506271|585051966|FG000|Overall Study|Death|0|||
162000269|NCT01506271|585051967|FG001|Overall Study|Death|1|||
162000270|NCT01506271|585051968|FG002|Overall Study|Death|0|||
162000271|NCT01506271|585051966|FG000|Overall Study|Adverse Event|0|||
162000272|NCT01506271|585051967|FG001|Overall Study|Adverse Event|2|||
162000273|NCT01506271|585051968|FG002|Overall Study|Adverse Event|0|||
162000274|NCT01506271|585051966|FG000|Overall Study|Insufficient supply of study drug|1|||
162000275|NCT01506271|585051967|FG001|Overall Study|Insufficient supply of study drug|0|||
162000276|NCT01506271|585051968|FG002|Overall Study|Insufficient supply of study drug|0|||
162000277|NCT01506271|585051966|FG000|Overall Study|Withdrawal by Subject|0|||
162000278|NCT01506271|585051967|FG001|Overall Study|Withdrawal by Subject|1|||
162000279|NCT01506271|585051968|FG002|Overall Study|Withdrawal by Subject|1|||
162000280|NCT01506271|585051966|FG000|Overall Study|Lost to Follow-up|0|||
162000281|NCT01506271|585051967|FG001|Overall Study|Lost to Follow-up|1|||
162000282|NCT01506271|585051968|FG002|Overall Study|Lost to Follow-up|2|||
162000283|NCT00689390|585051974|FG000|Overall Study|Adverse Event|19|||
162000284|NCT00689390|585051975|FG001|Overall Study|Adverse Event|0|||
162000285|NCT00689390|585051974|FG000|Overall Study|Lost to Follow-up|179|||
162000286|NCT00689390|585051975|FG001|Overall Study|Lost to Follow-up|7|||
162000287|NCT00689390|585051974|FG000|Overall Study|Withdrawal by Subject|117|||
162000288|NCT00689390|585051975|FG001|Overall Study|Withdrawal by Subject|3|||
162000289|NCT00689390|585051974|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
162000290|NCT00689390|585051975|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
162000291|NCT00689390|585051974|FG000|Overall Study|Non-Compliance With Protocol|21|||
162000292|NCT00689390|585051975|FG001|Overall Study|Non-Compliance With Protocol|0|||
162000293|NCT00689390|585051974|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
162000294|NCT00689390|585051975|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
162000295|NCT00689390|585051974|FG000|Overall Study|Administrative|37|||
162000296|NCT00689390|585051975|FG001|Overall Study|Administrative|0|||
162000297|NCT03318549|585051977|FG000|Overall Study|Withdrawal by Subject|5|||
162000298|NCT03318549|585051978|FG001|Overall Study|Withdrawal by Subject|19|||
162000299|NCT03318549|585051979|FG002|Overall Study|Withdrawal by Subject|2|||
162000300|NCT03318549|585051980|FG003|Overall Study|Withdrawal by Subject|0|||
162000301|NCT03318549|585051981|FG004|Overall Study|Withdrawal by Subject|0|||
162000302|NCT03318549|585051982|FG005|Overall Study|Withdrawal by Subject|0|||
162000303|NCT03318549|585051983|FG006|Overall Study|Withdrawal by Subject|0|||
162000304|NCT03318549|585051977|FG000|Overall Study|Physician Decision|0|||
162000305|NCT03318549|585051978|FG001|Overall Study|Physician Decision|4|||
162000306|NCT03318549|585051979|FG002|Overall Study|Physician Decision|1|||
162000307|NCT03318549|585051980|FG003|Overall Study|Physician Decision|0|||
162000308|NCT03318549|585051981|FG004|Overall Study|Physician Decision|0|||
162000309|NCT03318549|585051982|FG005|Overall Study|Physician Decision|0|||
162000310|NCT03318549|585051983|FG006|Overall Study|Physician Decision|0|||
162000311|NCT03318549|585051977|FG000|Overall Study|Lost to Follow-up|0|||
162000312|NCT03318549|585051978|FG001|Overall Study|Lost to Follow-up|3|||
162000313|NCT03318549|585051979|FG002|Overall Study|Lost to Follow-up|3|||
162000314|NCT03318549|585051980|FG003|Overall Study|Lost to Follow-up|0|||
162000315|NCT03318549|585051981|FG004|Overall Study|Lost to Follow-up|0|||
162000316|NCT03318549|585051982|FG005|Overall Study|Lost to Follow-up|0|||
162000317|NCT03318549|585051983|FG006|Overall Study|Lost to Follow-up|0|||
162000318|NCT01433172|585051984|FG000|Overall Study|Withdrawal by Subject|0|||
162000319|NCT01433172|585051985|FG001|Overall Study|Withdrawal by Subject|1|||
162000320|NCT01433172|585051986|FG002|Overall Study|Withdrawal by Subject|0|||
162000321|NCT01433172|585051984|FG000|Overall Study|Disease Progression|0|||
162000322|NCT01433172|585051985|FG001|Overall Study|Disease Progression|0|||
162000323|NCT01433172|585051986|FG002|Overall Study|Disease Progression|1|||
162000324|NCT01433172|585051984|FG000|Overall Study|Death|0|||
162000325|NCT01433172|585051985|FG001|Overall Study|Death|2|||
162000326|NCT01433172|585051986|FG002|Overall Study|Death|0|||
162000327|NCT00104650|585051987|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
162000328|NCT00104650|585051988|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
162000329|NCT00104650|585051989|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
162000330|NCT00104650|585051987|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
162000331|NCT00104650|585051988|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
162000332|NCT00104650|585051989|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
162000333|NCT00104650|585051987|FG000|Treatment Period (25 Weeks)|Death|7|||
162000334|NCT00104650|585051988|FG001|Treatment Period (25 Weeks)|Death|5|||
162000335|NCT00104650|585051989|FG002|Treatment Period (25 Weeks)|Death|6|||
162000336|NCT00104650|585051987|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
162000337|NCT00104650|585051988|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
162000338|NCT00104650|585051989|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
162000339|NCT00104650|585051987|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
162000340|NCT00104650|585051988|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
162000341|NCT00104650|585051989|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
162000342|NCT00104650|585051987|FG000|Treatment Period (25 Weeks)|Other|1|||
162041880|NCT04806503|585211874|FG002|Overall Study|Lost to Follow-up|1|||
162041881|NCT04806503|585211875|FG003|Overall Study|Lost to Follow-up|0|||
162041882|NCT04806503|585211876|FG004|Overall Study|Lost to Follow-up|0|||
162041883|NCT04806503|585211872|FG000|Overall Study|Withdrawal by Subject|1|||
162041884|NCT04806503|585211873|FG001|Overall Study|Withdrawal by Subject|0|||
162041885|NCT04806503|585211874|FG002|Overall Study|Withdrawal by Subject|1|||
162041886|NCT04806503|585211875|FG003|Overall Study|Withdrawal by Subject|1|||
162041887|NCT04806503|585211876|FG004|Overall Study|Withdrawal by Subject|1|||
162041888|NCT04806503|585211872|FG000|Overall Study|Adverse Event|1|||
162041889|NCT04806503|585211873|FG001|Overall Study|Adverse Event|1|||
162000343|NCT00104650|585051988|FG001|Treatment Period (25 Weeks)|Other|0|||
162000344|NCT00104650|585051989|FG002|Treatment Period (25 Weeks)|Other|0|||
162000345|NCT00104650|585051987|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
162000346|NCT00104650|585051988|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
162000347|NCT00104650|585051989|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
162000348|NCT00104650|585051987|FG000|Follow-up Period|Physician Decision|1|||
162000349|NCT00104650|585051988|FG001|Follow-up Period|Physician Decision|1|||
162041890|NCT04806503|585211874|FG002|Overall Study|Adverse Event|0|||
162041891|NCT04806503|585211875|FG003|Overall Study|Adverse Event|1|||
162041892|NCT04806503|585211876|FG004|Overall Study|Adverse Event|0|||
162041893|NCT03589469|585211877|FG000|Overall Study|Withdrawal by Subject|8|||
162041894|NCT03589469|585211877|FG000|Overall Study|Physician Decision|20|||
162041895|NCT03589469|585211877|FG000|Overall Study|Death|97|||
162041896|NCT03589469|585211877|FG000|Overall Study|Lost to Follow-up|8|||
162041897|NCT03589469|585211877|FG000|Overall Study|Miscellaneous|1|||
162041898|NCT05061966|585211880|FG000|Overall Study|Lost to Follow-up|13|||
162041899|NCT05061966|585211881|FG001|Overall Study|Lost to Follow-up|13|||
162041900|NCT00598702|585211882|FG000|Overall Study|Other|0|||
162041901|NCT00598702|585211883|FG001|Overall Study|Other|2|||
162041902|NCT00598702|585211884|FG002|Overall Study|Other|0|||
162041903|NCT00598702|585211885|FG003|Overall Study|Other|0|||
162041904|NCT00598702|585211886|FG004|Overall Study|Other|0|||
162041905|NCT00598702|585211887|FG005|Overall Study|Other|1|||
162041906|NCT00598702|585211888|FG006|Overall Study|Other|0|||
162000350|NCT00104650|585051989|FG002|Follow-up Period|Physician Decision|0|||
162041907|NCT00598702|585211889|FG007|Overall Study|Other|0|||
162041908|NCT00598702|585211882|FG000|Overall Study|Early discharge from hospital|0|||
162041909|NCT00598702|585211883|FG001|Overall Study|Early discharge from hospital|0|||
162041910|NCT00598702|585211884|FG002|Overall Study|Early discharge from hospital|2|||
162041911|NCT00598702|585211885|FG003|Overall Study|Early discharge from hospital|5|||
162041912|NCT00598702|585211886|FG004|Overall Study|Early discharge from hospital|0|||
162041913|NCT00598702|585211887|FG005|Overall Study|Early discharge from hospital|10|||
162041914|NCT00598702|585211888|FG006|Overall Study|Early discharge from hospital|1|||
162041915|NCT00598702|585211889|FG007|Overall Study|Early discharge from hospital|0|||
162041916|NCT00598702|585211882|FG000|Overall Study|Adverse Event|0|||
162041917|NCT00598702|585211883|FG001|Overall Study|Adverse Event|0|||
162041918|NCT00598702|585211884|FG002|Overall Study|Adverse Event|0|||
162041919|NCT00598702|585211885|FG003|Overall Study|Adverse Event|1|||
162041920|NCT00598702|585211886|FG004|Overall Study|Adverse Event|0|||
162041921|NCT00598702|585211887|FG005|Overall Study|Adverse Event|0|||
162041922|NCT00598702|585211888|FG006|Overall Study|Adverse Event|0|||
162041923|NCT00598702|585211889|FG007|Overall Study|Adverse Event|0|||
162041924|NCT00598702|585211882|FG000|Overall Study|Withdrawal by Subject|0|||
162041925|NCT00598702|585211883|FG001|Overall Study|Withdrawal by Subject|0|||
162041926|NCT00598702|585211884|FG002|Overall Study|Withdrawal by Subject|0|||
162041927|NCT00598702|585211885|FG003|Overall Study|Withdrawal by Subject|1|||
162041928|NCT00598702|585211886|FG004|Overall Study|Withdrawal by Subject|1|||
162041929|NCT00598702|585211887|FG005|Overall Study|Withdrawal by Subject|0|||
162041930|NCT00598702|585211888|FG006|Overall Study|Withdrawal by Subject|0|||
162041931|NCT00598702|585211889|FG007|Overall Study|Withdrawal by Subject|0|||
162041932|NCT00598702|585211882|FG000|Overall Study|Physician Decision|0|||
162041933|NCT00598702|585211883|FG001|Overall Study|Physician Decision|0|||
162041934|NCT00598702|585211884|FG002|Overall Study|Physician Decision|0|||
162041935|NCT00598702|585211885|FG003|Overall Study|Physician Decision|0|||
162041936|NCT00598702|585211886|FG004|Overall Study|Physician Decision|1|||
162041937|NCT00598702|585211887|FG005|Overall Study|Physician Decision|0|||
162041938|NCT00598702|585211888|FG006|Overall Study|Physician Decision|0|||
162041939|NCT00598702|585211889|FG007|Overall Study|Physician Decision|0|||
162041940|NCT00598702|585211882|FG000|Overall Study|Dose limiting toxicity|0|||
162000351|NCT00104650|585051987|FG000|Follow-up Period|Adverse Event|1|||
162041941|NCT00598702|585211883|FG001|Overall Study|Dose limiting toxicity|0|||
162041942|NCT00598702|585211884|FG002|Overall Study|Dose limiting toxicity|0|||
162000352|NCT00104650|585051988|FG001|Follow-up Period|Adverse Event|0|||
162041943|NCT00598702|585211885|FG003|Overall Study|Dose limiting toxicity|1|||
162041944|NCT00598702|585211886|FG004|Overall Study|Dose limiting toxicity|1|||
162041945|NCT00598702|585211887|FG005|Overall Study|Dose limiting toxicity|1|||
162041946|NCT00598702|585211888|FG006|Overall Study|Dose limiting toxicity|0|||
162041947|NCT00598702|585211889|FG007|Overall Study|Dose limiting toxicity|0|||
162041948|NCT02413372|585211893|FG000|Treatment|Lost to Follow-up|0|||
162041949|NCT02413372|585211894|FG001|Treatment|Lost to Follow-up|2|||
162041950|NCT02413372|585211895|FG002|Treatment|Lost to Follow-up|1|||
162041951|NCT02413372|585211893|FG000|Treatment|Withdrawal by Subject|1|||
162041952|NCT02413372|585211894|FG001|Treatment|Withdrawal by Subject|0|||
162041953|NCT02413372|585211895|FG002|Treatment|Withdrawal by Subject|0|||
162041954|NCT02413372|585211893|FG000|Follow-up|Lost to Follow-up|1|||
162041955|NCT02413372|585211894|FG001|Follow-up|Lost to Follow-up|1|||
162041956|NCT02413372|585211895|FG002|Follow-up|Lost to Follow-up|0|||
162041957|NCT02413372|585211893|FG000|Follow-up|Subject Withdrew Consent|1|||
162041958|NCT02413372|585211894|FG001|Follow-up|Subject Withdrew Consent|0|||
162041959|NCT02413372|585211895|FG002|Follow-up|Subject Withdrew Consent|1|||
162041960|NCT02413372|585211893|FG000|Follow-up|Subject unable to return for visit|0|||
162041961|NCT02413372|585211894|FG001|Follow-up|Subject unable to return for visit|0|||
162041962|NCT02413372|585211895|FG002|Follow-up|Subject unable to return for visit|1|||
162041963|NCT03053271|585211905|FG000|Overall Study|Did not meet randomization criteria|3|||
162041964|NCT03053271|585211905|FG000|Overall Study|Withdrawal by Subject|1|||
162041965|NCT00580970|585211906|FG000|Pre-treatment|Non-compliance|1|||
162041966|NCT00580970|585211906|FG000|Treatment (Lovastatin)|Non-compliance|6|||
162041967|NCT00580970|585211906|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
162041968|NCT00580970|585211906|FG000|Treatment (Lovastatin)|Physician Decision|4|||
162041969|NCT00580970|585211906|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
162041970|NCT00580970|585211906|FG000|Treatment (Lovastatin)|Death|1|||
162041971|NCT03161093|585211909|FG000|Overall Study|Protocol Violation|11|||
162041972|NCT03161093|585211910|FG001|Overall Study|Protocol Violation|14|||
162041973|NCT03161093|585211911|FG002|Overall Study|Protocol Violation|6|||
162041974|NCT03161093|585211912|FG003|Overall Study|Protocol Violation|13|||
162041975|NCT03161093|585211913|FG004|Overall Study|Protocol Violation|1|||
162041976|NCT03161093|585211914|FG005|Overall Study|Protocol Violation|0|||
162041977|NCT03161093|585211909|FG000|Overall Study|Adverse Event|5|||
162041978|NCT03161093|585211910|FG001|Overall Study|Adverse Event|21|||
162041979|NCT03161093|585211911|FG002|Overall Study|Adverse Event|16|||
162041980|NCT03161093|585211912|FG003|Overall Study|Adverse Event|35|||
162041981|NCT03161093|585211913|FG004|Overall Study|Adverse Event|2|||
162041982|NCT03161093|585211914|FG005|Overall Study|Adverse Event|1|||
162041983|NCT03161093|585211909|FG000|Overall Study|Lack of Efficacy|9|||
162041984|NCT03161093|585211910|FG001|Overall Study|Lack of Efficacy|13|||
162041985|NCT03161093|585211911|FG002|Overall Study|Lack of Efficacy|9|||
162041986|NCT03161093|585211912|FG003|Overall Study|Lack of Efficacy|24|||
162041987|NCT03161093|585211913|FG004|Overall Study|Lack of Efficacy|4|||
162041988|NCT03161093|585211914|FG005|Overall Study|Lack of Efficacy|1|||
162041989|NCT03161093|585211909|FG000|Overall Study|Physician Decision|0|||
162041990|NCT03161093|585211910|FG001|Overall Study|Physician Decision|1|||
162041991|NCT03161093|585211911|FG002|Overall Study|Physician Decision|0|||
162041992|NCT03161093|585211912|FG003|Overall Study|Physician Decision|2|||
162041993|NCT03161093|585211913|FG004|Overall Study|Physician Decision|17|||
162041994|NCT03161093|585211914|FG005|Overall Study|Physician Decision|15|||
162041995|NCT03161093|585211909|FG000|Overall Study|Withdrawal by Subject|24|||
162041996|NCT03161093|585211910|FG001|Overall Study|Withdrawal by Subject|73|||
162041997|NCT03161093|585211911|FG002|Overall Study|Withdrawal by Subject|44|||
162041998|NCT03161093|585211912|FG003|Overall Study|Withdrawal by Subject|97|||
162041999|NCT03161093|585211913|FG004|Overall Study|Withdrawal by Subject|11|||
162042000|NCT03161093|585211914|FG005|Overall Study|Withdrawal by Subject|10|||
162042001|NCT03161093|585211909|FG000|Overall Study|Lost to Follow-up|3|||
162042002|NCT03161093|585211910|FG001|Overall Study|Lost to Follow-up|12|||
162042003|NCT03161093|585211911|FG002|Overall Study|Lost to Follow-up|4|||
162042004|NCT03161093|585211912|FG003|Overall Study|Lost to Follow-up|7|||
162042005|NCT03161093|585211913|FG004|Overall Study|Lost to Follow-up|8|||
162042006|NCT03161093|585211914|FG005|Overall Study|Lost to Follow-up|13|||
162042007|NCT03161093|585211909|FG000|Overall Study|Death|3|||
162042008|NCT03161093|585211910|FG001|Overall Study|Death|9|||
162042009|NCT03161093|585211911|FG002|Overall Study|Death|7|||
162042010|NCT03161093|585211912|FG003|Overall Study|Death|9|||
162042011|NCT03161093|585211913|FG004|Overall Study|Death|0|||
162042012|NCT03161093|585211914|FG005|Overall Study|Death|0|||
162042013|NCT03161093|585211909|FG000|Overall Study|Unknown - Not reported|0|||
162042014|NCT03161093|585211910|FG001|Overall Study|Unknown - Not reported|1|||
162042015|NCT03161093|585211911|FG002|Overall Study|Unknown - Not reported|0|||
162042016|NCT03161093|585211912|FG003|Overall Study|Unknown - Not reported|0|||
162042017|NCT03161093|585211913|FG004|Overall Study|Unknown - Not reported|0|||
162042018|NCT03161093|585211914|FG005|Overall Study|Unknown - Not reported|1|||
162042019|NCT00570765|585211915|FG000|DB Phase|Withdrawal by Subject|1|||
162042020|NCT00570765|585211916|FG001|DB Phase|Withdrawal by Subject|0|||
162042021|NCT00570765|585211917|FG002|DB Phase|Withdrawal by Subject|0|||
162042022|NCT00570765|585211918|FG003|DB Phase|Withdrawal by Subject|0|||
162042023|NCT00570765|585211915|FG000|DB Phase|Protocol Violation|0|||
162042024|NCT00570765|585211916|FG001|DB Phase|Protocol Violation|1|||
162042025|NCT00570765|585211917|FG002|DB Phase|Protocol Violation|0|||
162042026|NCT00570765|585211918|FG003|DB Phase|Protocol Violation|0|||
162000353|NCT00104650|585051989|FG002|Follow-up Period|Adverse Event|1|||
162000354|NCT00104650|585051987|FG000|Follow-up Period|Withdrawal by Subject|0|||
162000355|NCT00104650|585051988|FG001|Follow-up Period|Withdrawal by Subject|3|||
162000356|NCT00104650|585051989|FG002|Follow-up Period|Withdrawal by Subject|3|||
162000357|NCT00104650|585051987|FG000|Follow-up Period|Death|6|||
162000358|NCT00104650|585051988|FG001|Follow-up Period|Death|6|||
162000359|NCT00104650|585051989|FG002|Follow-up Period|Death|4|||
162000360|NCT00104650|585051987|FG000|Follow-up Period|Disease progression|3|||
162000361|NCT00104650|585051988|FG001|Follow-up Period|Disease progression|1|||
162000362|NCT00104650|585051989|FG002|Follow-up Period|Disease progression|0|||
162000363|NCT00104650|585051987|FG000|Follow-up Period|Lost to Follow-up|0|||
162000364|NCT00104650|585051988|FG001|Follow-up Period|Lost to Follow-up|1|||
162000365|NCT00104650|585051989|FG002|Follow-up Period|Lost to Follow-up|2|||
162000366|NCT00104650|585051987|FG000|Follow-up Period|Other|0|||
162000367|NCT00104650|585051988|FG001|Follow-up Period|Other|1|||
162000368|NCT00104650|585051989|FG002|Follow-up Period|Other|0|||
162000369|NCT01391663|585051990|FG000|Overall Study|Withdrawal by Subject|0|||
162000370|NCT01391663|585051991|FG001|Overall Study|Withdrawal by Subject|0|||
162000371|NCT01391663|585051992|FG002|Overall Study|Withdrawal by Subject|1|||
162000372|NCT01391663|585051993|FG003|Overall Study|Withdrawal by Subject|0|||
162000373|NCT03515824|585051994|FG000|Overall Study|Death|3|||
162000374|NCT03515824|585051995|FG001|Overall Study|Death|2|||
162000375|NCT03515824|585051996|FG002|Overall Study|Death|6|||
162000376|NCT03515824|585051997|FG003|Overall Study|Death|0|||
162000377|NCT03515824|585051994|FG000|Overall Study|Lost to Follow-up|0|||
162000378|NCT03515824|585051995|FG001|Overall Study|Lost to Follow-up|1|||
162000379|NCT03515824|585051996|FG002|Overall Study|Lost to Follow-up|1|||
162000380|NCT03515824|585051997|FG003|Overall Study|Lost to Follow-up|0|||
162000381|NCT03515824|585051994|FG000|Overall Study|Study terminated by sponsor|0|||
162000382|NCT03515824|585051995|FG001|Overall Study|Study terminated by sponsor|1|||
162000383|NCT03515824|585051996|FG002|Overall Study|Study terminated by sponsor|6|||
162000384|NCT03515824|585051997|FG003|Overall Study|Study terminated by sponsor|0|||
162000385|NCT03515824|585051994|FG000|Overall Study|Status not recorded|0|||
162000386|NCT03515824|585051995|FG001|Overall Study|Status not recorded|0|||
162000387|NCT03515824|585051996|FG002|Overall Study|Status not recorded|2|||
162000388|NCT03515824|585051997|FG003|Overall Study|Status not recorded|0|||
162000389|NCT00920855|585051999|FG000|Overall Study|Adverse Event|1|||
162000390|NCT00920855|585052000|FG001|Overall Study|Adverse Event|1|||
162000391|NCT00920855|585052001|FG002|Overall Study|Adverse Event|4|||
162000392|NCT00920855|585051999|FG000|Overall Study|Withdrawal by Subject|2|||
162000393|NCT00920855|585052000|FG001|Overall Study|Withdrawal by Subject|1|||
162000394|NCT00920855|585052001|FG002|Overall Study|Withdrawal by Subject|6|||
162000395|NCT00920855|585051999|FG000|Overall Study|Disease progression|2|||
162000396|NCT00920855|585052000|FG001|Overall Study|Disease progression|1|||
162000397|NCT00920855|585052001|FG002|Overall Study|Disease progression|10|||
162000398|NCT00920855|585051999|FG000|Overall Study|Noncompliance to study medication|0|||
162000399|NCT00920855|585052000|FG001|Overall Study|Noncompliance to study medication|0|||
162000400|NCT00920855|585052001|FG002|Overall Study|Noncompliance to study medication|1|||
162000401|NCT00920855|585051999|FG000|Overall Study|Response plateau; started maintenance|0|||
162000402|NCT00920855|585052000|FG001|Overall Study|Response plateau; started maintenance|0|||
162000403|NCT00920855|585052001|FG002|Overall Study|Response plateau; started maintenance|1|||
162000404|NCT00539994|585052002|FG000|Overall Study|Lost to Follow-up|2|||
162000405|NCT00539994|585052003|FG001|Overall Study|Lost to Follow-up|1|||
162000406|NCT00539994|585052004|FG002|Overall Study|Lost to Follow-up|0|||
162000407|NCT00539994|585052002|FG000|Overall Study|Withdrawal by Subject|1|||
162000408|NCT00539994|585052003|FG001|Overall Study|Withdrawal by Subject|0|||
162000409|NCT00539994|585052004|FG002|Overall Study|Withdrawal by Subject|1|||
162000410|NCT00539994|585052002|FG000|Overall Study|Physician Decision|0|||
162000411|NCT00539994|585052003|FG001|Overall Study|Physician Decision|0|||
162000412|NCT00539994|585052004|FG002|Overall Study|Physician Decision|1|||
162000413|NCT00510835|585052005|FG000|Overall Study|Withdrawal by Subject|6|||
162000414|NCT00510835|585052006|FG001|Overall Study|Withdrawal by Subject|2|||
162000415|NCT00510835|585052007|FG002|Overall Study|Withdrawal by Subject|2|||
162000416|NCT03084796|585052008|FG000|Overall Study|Adverse Event|4|||
162000417|NCT03084796|585052009|FG001|Overall Study|Adverse Event|5|||
162000418|NCT03084796|585052010|FG002|Overall Study|Adverse Event|6|||
162000419|NCT03084796|585052011|FG003|Overall Study|Adverse Event|2|||
162000420|NCT03084796|585052012|FG004|Overall Study|Adverse Event|3|||
162000421|NCT03084796|585052013|FG005|Overall Study|Adverse Event|5|||
162000422|NCT03084796|585052008|FG000|Overall Study|Withdrawal by Subject|3|||
162000423|NCT03084796|585052009|FG001|Overall Study|Withdrawal by Subject|5|||
162000424|NCT03084796|585052010|FG002|Overall Study|Withdrawal by Subject|2|||
162000425|NCT03084796|585052011|FG003|Overall Study|Withdrawal by Subject|1|||
162000426|NCT03084796|585052012|FG004|Overall Study|Withdrawal by Subject|3|||
162000427|NCT03084796|585052013|FG005|Overall Study|Withdrawal by Subject|0|||
162000428|NCT03084796|585052008|FG000|Overall Study|Protocol Violation|0|||
162000429|NCT03084796|585052009|FG001|Overall Study|Protocol Violation|0|||
162000430|NCT03084796|585052010|FG002|Overall Study|Protocol Violation|1|||
162042027|NCT00570765|585211915|FG000|DB Phase|Adverse Event|3|||
162000431|NCT03084796|585052011|FG003|Overall Study|Protocol Violation|0|||
162000432|NCT03084796|585052012|FG004|Overall Study|Protocol Violation|1|||
162000433|NCT03084796|585052013|FG005|Overall Study|Protocol Violation|1|||
162000434|NCT03084796|585052008|FG000|Overall Study|Lack of Efficacy|0|||
162000435|NCT03084796|585052009|FG001|Overall Study|Lack of Efficacy|0|||
162000436|NCT03084796|585052010|FG002|Overall Study|Lack of Efficacy|1|||
162000437|NCT03084796|585052011|FG003|Overall Study|Lack of Efficacy|0|||
162000438|NCT03084796|585052012|FG004|Overall Study|Lack of Efficacy|1|||
162000439|NCT03084796|585052013|FG005|Overall Study|Lack of Efficacy|0|||
162000440|NCT03084796|585052008|FG000|Overall Study|Lost to Follow-up|0|||
162000441|NCT03084796|585052009|FG001|Overall Study|Lost to Follow-up|0|||
162000442|NCT03084796|585052010|FG002|Overall Study|Lost to Follow-up|1|||
162000443|NCT03084796|585052011|FG003|Overall Study|Lost to Follow-up|1|||
162000444|NCT03084796|585052012|FG004|Overall Study|Lost to Follow-up|3|||
162000445|NCT03084796|585052013|FG005|Overall Study|Lost to Follow-up|1|||
162000446|NCT03084796|585052008|FG000|Overall Study|Randomization error|0|||
162000447|NCT03084796|585052009|FG001|Overall Study|Randomization error|0|||
162000448|NCT03084796|585052010|FG002|Overall Study|Randomization error|1|||
162000449|NCT03084796|585052011|FG003|Overall Study|Randomization error|0|||
162000450|NCT03084796|585052012|FG004|Overall Study|Randomization error|0|||
162000451|NCT03084796|585052013|FG005|Overall Study|Randomization error|0|||
162000452|NCT05470985|585052014|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
162000453|NCT05470985|585052015|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
162000454|NCT05470985|585052014|FG000|Double Blind Treatment Period|Physician Decision|0|||
162000455|NCT05470985|585052015|FG001|Double Blind Treatment Period|Physician Decision|1|||
162000456|NCT05470985|585052014|FG000|Long Term Extension|Adverse Event|0|||
162000457|NCT05470985|585052015|FG001|Long Term Extension|Adverse Event|1|||
162000458|NCT05470985|585052014|FG000|Long Term Extension|Study terminated by sponsor|2|||
162000459|NCT05470985|585052015|FG001|Long Term Extension|Study terminated by sponsor|0|||
162000460|NCT01917747|585052016|FG000|Overall Study|Withdrawal by Subject|1|||
162000461|NCT01917747|585052017|FG001|Overall Study|Withdrawal by Subject|2|||
162000462|NCT01917747|585052016|FG000|Overall Study|Lost to Follow-up|18|||
162000463|NCT01917747|585052017|FG001|Overall Study|Lost to Follow-up|9|||
162000464|NCT02741245|585052028|FG000|Overall Study|Adverse Event|0|||
162000465|NCT02741245|585052029|FG001|Overall Study|Adverse Event|0|||
162000466|NCT02741245|585052030|FG002|Overall Study|Adverse Event|0|||
162000467|NCT02741245|585052031|FG003|Overall Study|Adverse Event|2|||
162000468|NCT02741245|585052032|FG004|Overall Study|Adverse Event|2|||
162000469|NCT02741245|585052028|FG000|Overall Study|Protocol Violation|0|||
162000470|NCT02741245|585052029|FG001|Overall Study|Protocol Violation|1|||
162000471|NCT02741245|585052030|FG002|Overall Study|Protocol Violation|0|||
162000472|NCT02741245|585052031|FG003|Overall Study|Protocol Violation|1|||
162000473|NCT02741245|585052032|FG004|Overall Study|Protocol Violation|0|||
162000474|NCT02741245|585052028|FG000|Overall Study|Withdrawal by Subject|0|||
162000475|NCT02741245|585052029|FG001|Overall Study|Withdrawal by Subject|0|||
162000476|NCT02741245|585052030|FG002|Overall Study|Withdrawal by Subject|0|||
162000477|NCT02741245|585052031|FG003|Overall Study|Withdrawal by Subject|1|||
162000478|NCT02741245|585052032|FG004|Overall Study|Withdrawal by Subject|0|||
162000479|NCT01116648|585052033|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
162000480|NCT01116648|585052034|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
162000481|NCT01116648|585052035|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
162000482|NCT01116648|585052036|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
162000483|NCT01116648|585052037|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
162000484|NCT01116648|585052038|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
162000485|NCT01116648|585052039|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
162000486|NCT01116648|585052040|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
162000487|NCT01116648|585052041|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
162042028|NCT00570765|585211916|FG001|DB Phase|Adverse Event|6|||
162042029|NCT00570765|585211917|FG002|DB Phase|Adverse Event|0|||
162000488|NCT01116648|585052042|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
162000489|NCT01116648|585052043|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
162000490|NCT01116648|585052044|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
162000491|NCT01116648|585052045|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
162000492|NCT01116648|585052046|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
162000493|NCT01116648|585052047|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
162000494|NCT03064490|585052048|FG000|Overall Study|Physician Decision|5|||
162000495|NCT05579977|585052053|FG000|Treatment Phase|Other|0|||
162000496|NCT05579977|585052054|FG001|Treatment Phase|Other|0|||
162000497|NCT05579977|585052055|FG002|Treatment Phase|Other|0|||
162000498|NCT05579977|585052056|FG003|Treatment Phase|Other|2|||
162000499|NCT05579977|585052057|FG004|Treatment Phase|Other|1|||
162000500|NCT05579977|585052058|FG005|Treatment Phase|Other|2|||
162000501|NCT05579977|585052059|FG006|Treatment Phase|Other|1|||
162000502|NCT05579977|585052060|FG007|Treatment Phase|Other|2|||
162000503|NCT05579977|585052061|FG008|Treatment Phase|Other|2|||
162000504|NCT05579977|585052062|FG009|Treatment Phase|Other|1|||
162000505|NCT05579977|585052063|FG010|Treatment Phase|Other|0|||
162000506|NCT05579977|585052064|FG011|Treatment Phase|Other|0|||
162042030|NCT00570765|585211918|FG003|DB Phase|Adverse Event|0|||
162042031|NCT00570765|585211915|FG000|DB Phase|Did Not Receive Study Drug|0|||
162042032|NCT00570765|585211916|FG001|DB Phase|Did Not Receive Study Drug|0|||
162042033|NCT00570765|585211917|FG002|DB Phase|Did Not Receive Study Drug|1|||
162042034|NCT00570765|585211918|FG003|DB Phase|Did Not Receive Study Drug|0|||
162042035|NCT00570765|585211915|FG000|LTSE Phase|Withdrawal by Subject|0|||
162042036|NCT00570765|585211916|FG001|LTSE Phase|Withdrawal by Subject|0|||
162042037|NCT00570765|585211917|FG002|LTSE Phase|Withdrawal by Subject|0|||
162042038|NCT00570765|585211918|FG003|LTSE Phase|Withdrawal by Subject|1|||
162042039|NCT00570765|585211915|FG000|LTSE Phase|Adverse Event|0|||
162042040|NCT00570765|585211916|FG001|LTSE Phase|Adverse Event|0|||
162042041|NCT00570765|585211917|FG002|LTSE Phase|Adverse Event|0|||
162042042|NCT00570765|585211918|FG003|LTSE Phase|Adverse Event|7|||
162042043|NCT00570765|585211915|FG000|LTSE Phase|Physician Decision|0|||
162042044|NCT00570765|585211916|FG001|LTSE Phase|Physician Decision|0|||
162042045|NCT00570765|585211917|FG002|LTSE Phase|Physician Decision|0|||
162042046|NCT00570765|585211918|FG003|LTSE Phase|Physician Decision|4|||
162042047|NCT01031706|585211919|FG000|Overall Study|Adverse Event|1|||
162042048|NCT01031706|585211920|FG001|Overall Study|Adverse Event|0|||
162042049|NCT01031706|585211919|FG000|Overall Study|Withdrawal by Subject|1|||
162042050|NCT01031706|585211920|FG001|Overall Study|Withdrawal by Subject|1|||
162042051|NCT02124161|585211921|FG000|Overall Study|Other unspecified|0|||
162042052|NCT02124161|585211922|FG001|Overall Study|Other unspecified|1|||
162042053|NCT02124161|585211921|FG000|Overall Study|Death|1|||
162042054|NCT02124161|585211922|FG001|Overall Study|Death|0|||
162042055|NCT02124161|585211921|FG000|Overall Study|Protocol Violation|2|||
162042056|NCT02124161|585211922|FG001|Overall Study|Protocol Violation|1|||
162042057|NCT02124161|585211921|FG000|Overall Study|Withdrawal by Subject|1|||
162042058|NCT02124161|585211922|FG001|Overall Study|Withdrawal by Subject|2|||
162042059|NCT02124161|585211921|FG000|Overall Study|Adverse Event|2|||
162042060|NCT02124161|585211922|FG001|Overall Study|Adverse Event|0|||
162042061|NCT02124161|585211921|FG000|Overall Study|Does not meet entrance criteria|2|||
162042062|NCT02124161|585211922|FG001|Overall Study|Does not meet entrance criteria|3|||
162042063|NCT02124161|585211921|FG000|Overall Study|No longer meets eligibility criteria|5|||
162042064|NCT02124161|585211922|FG001|Overall Study|No longer meets eligibility criteria|4|||
162042065|NCT02124161|585211921|FG000|Overall Study|Lost to Follow-up|3|||
162042066|NCT02124161|585211922|FG001|Overall Study|Lost to Follow-up|4|||
162042067|NCT01954342|585211926|FG000|Overall Study|Missing data from 13-16week study visit|0|||
162042068|NCT01954342|585211927|FG001|Overall Study|Missing data from 13-16week study visit|0|||
162042069|NCT01954342|585211928|FG002|Overall Study|Missing data from 13-16week study visit|0|||
162042070|NCT01954342|585211929|FG003|Overall Study|Missing data from 13-16week study visit|1|||
162042071|NCT01954342|585211926|FG000|Overall Study|Miscarriage|0|||
162042072|NCT01954342|585211927|FG001|Overall Study|Miscarriage|0|||
162042073|NCT01954342|585211928|FG002|Overall Study|Miscarriage|0|||
162042074|NCT01954342|585211929|FG003|Overall Study|Miscarriage|3|||
162042075|NCT01954342|585211926|FG000|Overall Study|Lost to Follow-up|0|||
162042076|NCT01954342|585211927|FG001|Overall Study|Lost to Follow-up|0|||
162042077|NCT01954342|585211928|FG002|Overall Study|Lost to Follow-up|0|||
162042078|NCT01954342|585211929|FG003|Overall Study|Lost to Follow-up|5|||
162042079|NCT01954342|585211926|FG000|Overall Study|Preterm delivery|0|||
162042080|NCT01954342|585211927|FG001|Overall Study|Preterm delivery|0|||
162042081|NCT01954342|585211928|FG002|Overall Study|Preterm delivery|0|||
162042082|NCT01954342|585211929|FG003|Overall Study|Preterm delivery|3|||
162042083|NCT01954342|585211926|FG000|Overall Study|Pre-eclampsia|0|||
162042084|NCT01954342|585211927|FG001|Overall Study|Pre-eclampsia|0|||
162042085|NCT01954342|585211928|FG002|Overall Study|Pre-eclampsia|0|||
162042086|NCT01954342|585211929|FG003|Overall Study|Pre-eclampsia|4|||
162042087|NCT01954342|585211926|FG000|Overall Study|Unreliable Data|0|||
162042088|NCT01954342|585211927|FG001|Overall Study|Unreliable Data|0|||
162042089|NCT01954342|585211928|FG002|Overall Study|Unreliable Data|0|||
162042090|NCT01954342|585211929|FG003|Overall Study|Unreliable Data|2|||
162042091|NCT00984568|585211933|FG000|Overall Study|Withdrawal by Subject|1|||
162042092|NCT00984568|585211934|FG001|Overall Study|Withdrawal by Subject|2|||
162042093|NCT00984568|585211933|FG000|Overall Study|Lack of Efficacy|2|||
162042094|NCT00984568|585211934|FG001|Overall Study|Lack of Efficacy|0|||
162042095|NCT00984568|585211933|FG000|Overall Study|Adverse Event|2|||
162042096|NCT00984568|585211934|FG001|Overall Study|Adverse Event|0|||
162042097|NCT00984568|585211933|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
162042098|NCT00984568|585211934|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
162042099|NCT00984568|585211933|FG000|Overall Study|Lost to Follow-up|0|||
162042100|NCT00984568|585211934|FG001|Overall Study|Lost to Follow-up|1|||
162042101|NCT00984568|585211933|FG000|Overall Study|Opportunistic Infection|1|||
162042102|NCT00984568|585211934|FG001|Overall Study|Opportunistic Infection|0|||
162042103|NCT00984568|585211933|FG000|Overall Study|Unknown Reason|1|||
162042104|NCT00984568|585211934|FG001|Overall Study|Unknown Reason|3|||
162042105|NCT01649804|585211938|FG000|Overall Study|Administrative/Other|8|||
162042106|NCT03845543|585211939|FG000|Overall Study|Death|25|||
162042107|NCT03845543|585211939|FG000|Overall Study|Withdrawal by Subject|2|||
162042108|NCT03845543|585211939|FG000|Overall Study|Lost to Follow-up|12|||
162042109|NCT03845543|585211939|FG000|Overall Study|Adverse Event|17|||
162042110|NCT01912963|585211945|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
162042111|NCT01912963|585211946|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
162042112|NCT01912963|585211947|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
162042113|NCT01912963|585211945|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
162042114|NCT01912963|585211946|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
162042115|NCT01912963|585211947|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
162042116|NCT01912963|585211945|FG000|Overall Study|Adverse Event|0|||
162042117|NCT01912963|585211946|FG001|Overall Study|Adverse Event|1|||
162042118|NCT01912963|585211947|FG002|Overall Study|Adverse Event|1|||
162042119|NCT01912963|585211945|FG000|Overall Study|Withdrawal by Subject|0|||
162042120|NCT01912963|585211946|FG001|Overall Study|Withdrawal by Subject|1|||
162042121|NCT01912963|585211947|FG002|Overall Study|Withdrawal by Subject|0|||
162042122|NCT01912963|585211945|FG000|Overall Study|Sought treatment locally|0|||
162042123|NCT01912963|585211946|FG001|Overall Study|Sought treatment locally|1|||
162042124|NCT01912963|585211947|FG002|Overall Study|Sought treatment locally|0|||
162042125|NCT01336569|585211949|FG000|Overall Study|Lost to Follow-up|4|||
162042126|NCT00406354|585211952|FG000|All Randomized Patients|Protocol Violation|0|||
162042127|NCT00406354|585211953|FG001|All Randomized Patients|Protocol Violation|0|||
162042128|NCT00406354|585211954|FG002|All Randomized Patients|Protocol Violation|1|||
162042129|NCT00406354|585211952|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
162042130|NCT00406354|585211953|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
162042131|NCT00406354|585211954|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
162042132|NCT00406354|585211952|FG000|All Randomized and Treated Patients|Adverse Event|6|||
162042133|NCT00406354|585211953|FG001|All Randomized and Treated Patients|Adverse Event|2|||
162042134|NCT00406354|585211954|FG002|All Randomized and Treated Patients|Adverse Event|1|||
162042135|NCT00406354|585211952|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
162000507|NCT05579977|585052065|FG012|Treatment Phase|Other|3|||
162000508|NCT05579977|585052053|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
162000509|NCT05579977|585052054|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
162000510|NCT05579977|585052055|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
162000511|NCT05579977|585052056|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
162000512|NCT05579977|585052057|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
162000513|NCT05579977|585052058|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
162000514|NCT05579977|585052059|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
162000515|NCT05579977|585052060|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
162000516|NCT05579977|585052061|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
162000517|NCT05579977|585052062|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
162000518|NCT05579977|585052063|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
162000519|NCT05579977|585052064|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
162000520|NCT05579977|585052065|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
162000521|NCT05579977|585052053|FG000|Treatment Phase|Withdrawal by Subject|2|||
162042136|NCT00406354|585211953|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
162042137|NCT00406354|585211954|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
162042138|NCT00406354|585211952|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
162042139|NCT00406354|585211953|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
162042140|NCT00406354|585211954|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
162042141|NCT00406354|585211952|FG000|All Randomized and Treated Patients|Physician Decision|0|||
162042142|NCT00406354|585211953|FG001|All Randomized and Treated Patients|Physician Decision|0|||
162042143|NCT00406354|585211954|FG002|All Randomized and Treated Patients|Physician Decision|1|||
162042144|NCT02027376|585211969|FG000|Overall Study|Death|1|||
162042145|NCT02027376|585211970|FG001|Overall Study|Death|0|||
162042146|NCT02027376|585211971|FG002|Overall Study|Death|0|||
162042147|NCT01565642|585211972|FG000|Overall Study|Withdrawal by Subject|2|||
162042148|NCT01565642|585211973|FG001|Overall Study|Withdrawal by Subject|1|||
162042149|NCT01528033|585211977|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
162000522|NCT05579977|585052054|FG001|Treatment Phase|Withdrawal by Subject|0|||
162042150|NCT01528033|585211978|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
162042151|NCT01528033|585211977|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
162042152|NCT01528033|585211978|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
162042153|NCT01528033|585211977|FG000|Primary Endpoint Assessment ITT|Death|2|||
162042154|NCT01528033|585211978|FG001|Primary Endpoint Assessment ITT|Death|2|||
162042155|NCT01528033|585211977|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
162042156|NCT01528033|585211978|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
162042157|NCT01528033|585211977|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
162042158|NCT01528033|585211978|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
162042159|NCT01528033|585211977|FG000|Follow Up|No data available|46|||
162042160|NCT01528033|585211978|FG001|Follow Up|No data available|44|||
162042161|NCT03954132|585211979|FG000|Overall Study|Adverse Event|2|||
162042162|NCT03954132|585211980|FG001|Overall Study|Adverse Event|0|||
162000523|NCT05579977|585052055|FG002|Treatment Phase|Withdrawal by Subject|0|||
162000524|NCT05579977|585052056|FG003|Treatment Phase|Withdrawal by Subject|1|||
162000525|NCT05579977|585052057|FG004|Treatment Phase|Withdrawal by Subject|2|||
162000526|NCT05579977|585052058|FG005|Treatment Phase|Withdrawal by Subject|0|||
162000527|NCT05579977|585052059|FG006|Treatment Phase|Withdrawal by Subject|1|||
162000528|NCT05579977|585052060|FG007|Treatment Phase|Withdrawal by Subject|8|||
162000529|NCT05579977|585052061|FG008|Treatment Phase|Withdrawal by Subject|3|||
162000530|NCT05579977|585052062|FG009|Treatment Phase|Withdrawal by Subject|3|||
162000531|NCT05579977|585052063|FG010|Treatment Phase|Withdrawal by Subject|5|||
162000532|NCT05579977|585052064|FG011|Treatment Phase|Withdrawal by Subject|1|||
162000533|NCT05579977|585052065|FG012|Treatment Phase|Withdrawal by Subject|3|||
162000534|NCT05579977|585052053|FG000|Treatment Phase|Study terminated by sponsor|70|||
162000535|NCT05579977|585052054|FG001|Treatment Phase|Study terminated by sponsor|70|||
162000536|NCT05579977|585052055|FG002|Treatment Phase|Study terminated by sponsor|61|||
162000537|NCT05579977|585052056|FG003|Treatment Phase|Study terminated by sponsor|59|||
162000538|NCT05579977|585052057|FG004|Treatment Phase|Study terminated by sponsor|63|||
162000539|NCT05579977|585052058|FG005|Treatment Phase|Study terminated by sponsor|53|||
162000540|NCT05579977|585052059|FG006|Treatment Phase|Study terminated by sponsor|66|||
162000541|NCT05579977|585052060|FG007|Treatment Phase|Study terminated by sponsor|48|||
162000542|NCT05579977|585052061|FG008|Treatment Phase|Study terminated by sponsor|47|||
162000543|NCT05579977|585052062|FG009|Treatment Phase|Study terminated by sponsor|37|||
162000544|NCT05579977|585052063|FG010|Treatment Phase|Study terminated by sponsor|44|||
162000545|NCT05579977|585052064|FG011|Treatment Phase|Study terminated by sponsor|36|||
162000546|NCT05579977|585052065|FG012|Treatment Phase|Study terminated by sponsor|32|||
162000547|NCT05579977|585052053|FG000|Treatment Phase|Pregnancy|0|||
162000548|NCT05579977|585052054|FG001|Treatment Phase|Pregnancy|0|||
162000549|NCT05579977|585052055|FG002|Treatment Phase|Pregnancy|0|||
162000550|NCT05579977|585052056|FG003|Treatment Phase|Pregnancy|0|||
162000551|NCT05579977|585052057|FG004|Treatment Phase|Pregnancy|0|||
162000552|NCT05579977|585052058|FG005|Treatment Phase|Pregnancy|0|||
162000553|NCT05579977|585052059|FG006|Treatment Phase|Pregnancy|0|||
162000554|NCT05579977|585052060|FG007|Treatment Phase|Pregnancy|0|||
162000555|NCT05579977|585052061|FG008|Treatment Phase|Pregnancy|0|||
162000556|NCT05579977|585052062|FG009|Treatment Phase|Pregnancy|1|||
162000557|NCT05579977|585052063|FG010|Treatment Phase|Pregnancy|0|||
162000558|NCT05579977|585052064|FG011|Treatment Phase|Pregnancy|0|||
162000559|NCT05579977|585052065|FG012|Treatment Phase|Pregnancy|0|||
162000560|NCT05579977|585052053|FG000|Treatment Phase|Physician Decision|0|||
162000561|NCT05579977|585052054|FG001|Treatment Phase|Physician Decision|0|||
162000562|NCT05579977|585052055|FG002|Treatment Phase|Physician Decision|0|||
162000563|NCT05579977|585052056|FG003|Treatment Phase|Physician Decision|0|||
162000564|NCT05579977|585052057|FG004|Treatment Phase|Physician Decision|0|||
162000565|NCT05579977|585052058|FG005|Treatment Phase|Physician Decision|0|||
162000566|NCT05579977|585052059|FG006|Treatment Phase|Physician Decision|0|||
162000567|NCT05579977|585052060|FG007|Treatment Phase|Physician Decision|0|||
162000568|NCT05579977|585052061|FG008|Treatment Phase|Physician Decision|0|||
162000569|NCT05579977|585052062|FG009|Treatment Phase|Physician Decision|0|||
162000570|NCT05579977|585052063|FG010|Treatment Phase|Physician Decision|0|||
162000571|NCT05579977|585052064|FG011|Treatment Phase|Physician Decision|1|||
162000572|NCT05579977|585052065|FG012|Treatment Phase|Physician Decision|0|||
162000573|NCT05579977|585052053|FG000|Treatment Phase|Lost to Follow-up|0|||
162000574|NCT05579977|585052054|FG001|Treatment Phase|Lost to Follow-up|0|||
162000575|NCT05579977|585052055|FG002|Treatment Phase|Lost to Follow-up|0|||
162000576|NCT05579977|585052056|FG003|Treatment Phase|Lost to Follow-up|1|||
162000577|NCT05579977|585052057|FG004|Treatment Phase|Lost to Follow-up|1|||
162000578|NCT05579977|585052058|FG005|Treatment Phase|Lost to Follow-up|1|||
162000579|NCT05579977|585052059|FG006|Treatment Phase|Lost to Follow-up|0|||
162000580|NCT05579977|585052060|FG007|Treatment Phase|Lost to Follow-up|1|||
162000581|NCT05579977|585052061|FG008|Treatment Phase|Lost to Follow-up|2|||
162000582|NCT05579977|585052062|FG009|Treatment Phase|Lost to Follow-up|2|||
162000583|NCT05579977|585052063|FG010|Treatment Phase|Lost to Follow-up|1|||
162000584|NCT05579977|585052064|FG011|Treatment Phase|Lost to Follow-up|4|||
162000585|NCT05579977|585052065|FG012|Treatment Phase|Lost to Follow-up|3|||
162000586|NCT05579977|585052053|FG000|Treatment Phase|Death|1|||
162000587|NCT05579977|585052054|FG001|Treatment Phase|Death|0|||
162000588|NCT05579977|585052055|FG002|Treatment Phase|Death|0|||
162000589|NCT05579977|585052056|FG003|Treatment Phase|Death|0|||
162000590|NCT05579977|585052057|FG004|Treatment Phase|Death|0|||
162000591|NCT05579977|585052058|FG005|Treatment Phase|Death|0|||
162000592|NCT05579977|585052059|FG006|Treatment Phase|Death|0|||
162000593|NCT05579977|585052060|FG007|Treatment Phase|Death|0|||
162000594|NCT05579977|585052061|FG008|Treatment Phase|Death|0|||
162000595|NCT05579977|585052062|FG009|Treatment Phase|Death|0|||
162000596|NCT05579977|585052063|FG010|Treatment Phase|Death|0|||
162000597|NCT05579977|585052064|FG011|Treatment Phase|Death|0|||
162000598|NCT05579977|585052065|FG012|Treatment Phase|Death|0|||
162000599|NCT05579977|585052053|FG000|Treatment Phase|Adverse Event|0|||
162000600|NCT05579977|585052054|FG001|Treatment Phase|Adverse Event|3|||
162000601|NCT05579977|585052055|FG002|Treatment Phase|Adverse Event|11|||
162042163|NCT03954132|585211979|FG000|Overall Study|Patient's wish|5|||
162042164|NCT03954132|585211980|FG001|Overall Study|Patient's wish|0|||
162042165|NCT03954132|585211979|FG000|Overall Study|Lost to Follow-up|10|||
162042166|NCT03954132|585211980|FG001|Overall Study|Lost to Follow-up|0|||
162042167|NCT03954132|585211979|FG000|Overall Study|Screening failure|0|||
162042168|NCT03954132|585211980|FG001|Overall Study|Screening failure|1|||
162042169|NCT03954132|585211979|FG000|Overall Study|No registration after Visit 1|5|||
162042170|NCT03954132|585211980|FG001|Overall Study|No registration after Visit 1|2|||
162042171|NCT03954132|585211979|FG000|Overall Study|Other reason than listed|2|||
162042172|NCT03954132|585211980|FG001|Overall Study|Other reason than listed|2|||
162042173|NCT03954132|585211979|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
162042174|NCT03954132|585211980|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
162042175|NCT03954132|585211979|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
162042176|NCT03954132|585211980|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
162042177|NCT05156073|585211981|FG000|Overall Study|Patient canceled appointment with PCP|1|||
162042178|NCT00973349|585211982|FG000|Overall Study|Adverse Event|0|||
162042179|NCT00973349|585211983|FG001|Overall Study|Adverse Event|0|||
162042180|NCT00973349|585211984|FG002|Overall Study|Adverse Event|0|||
162042181|NCT00973349|585211985|FG003|Overall Study|Adverse Event|0|||
162042182|NCT00973349|585211986|FG004|Overall Study|Adverse Event|1|||
162042183|NCT00973349|585211987|FG005|Overall Study|Adverse Event|0|||
162042184|NCT00973349|585211988|FG006|Overall Study|Adverse Event|0|||
162042185|NCT00973349|585211989|FG007|Overall Study|Adverse Event|0|||
162042186|NCT00973349|585211990|FG008|Overall Study|Adverse Event|1|||
162042187|NCT00973349|585211991|FG009|Overall Study|Adverse Event|0|||
162042188|NCT00973349|585211992|FG010|Overall Study|Adverse Event|0|||
162042189|NCT00973349|585211993|FG011|Overall Study|Adverse Event|0|||
162042190|NCT00973349|585211994|FG012|Overall Study|Adverse Event|0|||
162042191|NCT00973349|585211995|FG013|Overall Study|Adverse Event|0|||
162042192|NCT00973349|585211996|FG014|Overall Study|Adverse Event|1|||
162042193|NCT00973349|585211997|FG015|Overall Study|Adverse Event|0|||
162042194|NCT00973349|585211982|FG000|Overall Study|Withdrawal by Subject|1|||
162042195|NCT00973349|585211983|FG001|Overall Study|Withdrawal by Subject|2|||
162042196|NCT00973349|585211984|FG002|Overall Study|Withdrawal by Subject|2|||
162042197|NCT00973349|585211985|FG003|Overall Study|Withdrawal by Subject|3|||
162042198|NCT00973349|585211986|FG004|Overall Study|Withdrawal by Subject|2|||
162042199|NCT00973349|585211987|FG005|Overall Study|Withdrawal by Subject|0|||
162042200|NCT00973349|585211988|FG006|Overall Study|Withdrawal by Subject|2|||
162042201|NCT00973349|585211989|FG007|Overall Study|Withdrawal by Subject|2|||
162042202|NCT00973349|585211990|FG008|Overall Study|Withdrawal by Subject|0|||
162042203|NCT00973349|585211991|FG009|Overall Study|Withdrawal by Subject|2|||
162042204|NCT00973349|585211992|FG010|Overall Study|Withdrawal by Subject|0|||
162042205|NCT00973349|585211993|FG011|Overall Study|Withdrawal by Subject|1|||
162042206|NCT00973349|585211994|FG012|Overall Study|Withdrawal by Subject|0|||
162042207|NCT00973349|585211995|FG013|Overall Study|Withdrawal by Subject|0|||
162042208|NCT00973349|585211996|FG014|Overall Study|Withdrawal by Subject|0|||
162042209|NCT00973349|585211997|FG015|Overall Study|Withdrawal by Subject|0|||
162042210|NCT00973349|585211982|FG000|Overall Study|Lost to Follow-up|3|||
162042211|NCT00973349|585211983|FG001|Overall Study|Lost to Follow-up|1|||
162042212|NCT00973349|585211984|FG002|Overall Study|Lost to Follow-up|2|||
162042213|NCT00973349|585211985|FG003|Overall Study|Lost to Follow-up|2|||
162042214|NCT00973349|585211986|FG004|Overall Study|Lost to Follow-up|1|||
162042215|NCT00973349|585211987|FG005|Overall Study|Lost to Follow-up|3|||
162042216|NCT00973349|585211988|FG006|Overall Study|Lost to Follow-up|0|||
162042217|NCT00973349|585211989|FG007|Overall Study|Lost to Follow-up|1|||
162042218|NCT00973349|585211990|FG008|Overall Study|Lost to Follow-up|2|||
162042219|NCT00973349|585211991|FG009|Overall Study|Lost to Follow-up|1|||
162042220|NCT00973349|585211992|FG010|Overall Study|Lost to Follow-up|0|||
162042221|NCT00973349|585211993|FG011|Overall Study|Lost to Follow-up|1|||
162042222|NCT00973349|585211994|FG012|Overall Study|Lost to Follow-up|0|||
162042223|NCT00973349|585211995|FG013|Overall Study|Lost to Follow-up|0|||
162042224|NCT00973349|585211996|FG014|Overall Study|Lost to Follow-up|0|||
162042225|NCT00973349|585211997|FG015|Overall Study|Lost to Follow-up|1|||
162042226|NCT00973349|585211982|FG000|Overall Study|Inappropriate enrolment|0|||
162042227|NCT00973349|585211983|FG001|Overall Study|Inappropriate enrolment|0|||
162042228|NCT00973349|585211984|FG002|Overall Study|Inappropriate enrolment|1|||
162042229|NCT00973349|585211985|FG003|Overall Study|Inappropriate enrolment|0|||
162042230|NCT00973349|585211986|FG004|Overall Study|Inappropriate enrolment|0|||
162042231|NCT00973349|585211987|FG005|Overall Study|Inappropriate enrolment|0|||
162042232|NCT00973349|585211988|FG006|Overall Study|Inappropriate enrolment|0|||
162042233|NCT00973349|585211989|FG007|Overall Study|Inappropriate enrolment|0|||
162042234|NCT00973349|585211990|FG008|Overall Study|Inappropriate enrolment|0|||
162042235|NCT00973349|585211991|FG009|Overall Study|Inappropriate enrolment|2|||
162042236|NCT00973349|585211992|FG010|Overall Study|Inappropriate enrolment|0|||
162042237|NCT00973349|585211993|FG011|Overall Study|Inappropriate enrolment|0|||
162042238|NCT00973349|585211994|FG012|Overall Study|Inappropriate enrolment|1|||
162042239|NCT00973349|585211995|FG013|Overall Study|Inappropriate enrolment|0|||
162000602|NCT05579977|585052056|FG003|Treatment Phase|Adverse Event|10|||
162000603|NCT05579977|585052057|FG004|Treatment Phase|Adverse Event|5|||
162000604|NCT05579977|585052058|FG005|Treatment Phase|Adverse Event|17|||
162000605|NCT05579977|585052059|FG006|Treatment Phase|Adverse Event|5|||
162000606|NCT05579977|585052060|FG007|Treatment Phase|Adverse Event|5|||
162000607|NCT05579977|585052061|FG008|Treatment Phase|Adverse Event|12|||
162000608|NCT05579977|585052062|FG009|Treatment Phase|Adverse Event|20|||
162000609|NCT05579977|585052063|FG010|Treatment Phase|Adverse Event|15|||
162000610|NCT05579977|585052064|FG011|Treatment Phase|Adverse Event|24|||
162000611|NCT05579977|585052065|FG012|Treatment Phase|Adverse Event|23|||
162000612|NCT05579977|585052053|FG000|Treatment Phase|Randomized not treated|0|||
162000613|NCT05579977|585052054|FG001|Treatment Phase|Randomized not treated|0|||
162000614|NCT05579977|585052055|FG002|Treatment Phase|Randomized not treated|0|||
162000615|NCT05579977|585052056|FG003|Treatment Phase|Randomized not treated|0|||
162000616|NCT05579977|585052057|FG004|Treatment Phase|Randomized not treated|1|||
162000617|NCT05579977|585052058|FG005|Treatment Phase|Randomized not treated|0|||
162000618|NCT05579977|585052059|FG006|Treatment Phase|Randomized not treated|0|||
162000619|NCT05579977|585052060|FG007|Treatment Phase|Randomized not treated|0|||
162000620|NCT05579977|585052061|FG008|Treatment Phase|Randomized not treated|0|||
162000621|NCT05579977|585052062|FG009|Treatment Phase|Randomized not treated|0|||
162000622|NCT05579977|585052063|FG010|Treatment Phase|Randomized not treated|0|||
162000623|NCT05579977|585052064|FG011|Treatment Phase|Randomized not treated|0|||
162000624|NCT05579977|585052065|FG012|Treatment Phase|Randomized not treated|0|||
162000625|NCT05579977|585052053|FG000|Follow up|Death|1|||
162000626|NCT05579977|585052054|FG001|Follow up|Death|0|||
162000627|NCT05579977|585052055|FG002|Follow up|Death|0|||
162000628|NCT05579977|585052056|FG003|Follow up|Death|0|||
162000629|NCT05579977|585052057|FG004|Follow up|Death|0|||
162000630|NCT05579977|585052058|FG005|Follow up|Death|0|||
162000631|NCT05579977|585052059|FG006|Follow up|Death|0|||
162000632|NCT05579977|585052060|FG007|Follow up|Death|0|||
162000633|NCT05579977|585052061|FG008|Follow up|Death|0|||
162000634|NCT05579977|585052062|FG009|Follow up|Death|0|||
162000635|NCT05579977|585052063|FG010|Follow up|Death|0|||
162000636|NCT05579977|585052064|FG011|Follow up|Death|0|||
162000637|NCT05579977|585052065|FG012|Follow up|Death|0|||
162000638|NCT05579977|585052053|FG000|Follow up|Lost to Follow-up|0|||
162000639|NCT05579977|585052054|FG001|Follow up|Lost to Follow-up|0|||
162000640|NCT05579977|585052055|FG002|Follow up|Lost to Follow-up|0|||
162000641|NCT05579977|585052056|FG003|Follow up|Lost to Follow-up|1|||
162000642|NCT05579977|585052057|FG004|Follow up|Lost to Follow-up|1|||
162000643|NCT05579977|585052058|FG005|Follow up|Lost to Follow-up|2|||
162000644|NCT05579977|585052059|FG006|Follow up|Lost to Follow-up|1|||
162000645|NCT05579977|585052060|FG007|Follow up|Lost to Follow-up|1|||
162000646|NCT05579977|585052061|FG008|Follow up|Lost to Follow-up|3|||
162000647|NCT05579977|585052062|FG009|Follow up|Lost to Follow-up|2|||
162000648|NCT05579977|585052063|FG010|Follow up|Lost to Follow-up|2|||
162000649|NCT05579977|585052064|FG011|Follow up|Lost to Follow-up|4|||
162000650|NCT05579977|585052065|FG012|Follow up|Lost to Follow-up|4|||
162000651|NCT05579977|585052053|FG000|Follow up|Withdrawal by Subject|2|||
162000652|NCT05579977|585052054|FG001|Follow up|Withdrawal by Subject|0|||
162000653|NCT05579977|585052055|FG002|Follow up|Withdrawal by Subject|0|||
162000654|NCT05579977|585052056|FG003|Follow up|Withdrawal by Subject|0|||
162000655|NCT05579977|585052057|FG004|Follow up|Withdrawal by Subject|1|||
162000656|NCT05579977|585052058|FG005|Follow up|Withdrawal by Subject|0|||
162000657|NCT05579977|585052059|FG006|Follow up|Withdrawal by Subject|1|||
162000658|NCT05579977|585052060|FG007|Follow up|Withdrawal by Subject|4|||
162000659|NCT05579977|585052061|FG008|Follow up|Withdrawal by Subject|2|||
162000660|NCT05579977|585052062|FG009|Follow up|Withdrawal by Subject|3|||
162000661|NCT05579977|585052063|FG010|Follow up|Withdrawal by Subject|3|||
162000662|NCT05579977|585052064|FG011|Follow up|Withdrawal by Subject|1|||
162000663|NCT05579977|585052065|FG012|Follow up|Withdrawal by Subject|3|||
162000664|NCT01777776|585052067|FG000|Overall Study|Adverse Event|2|||
162000665|NCT01777776|585052068|FG001|Overall Study|Adverse Event|4|||
162000666|NCT01777776|585052069|FG002|Overall Study|Adverse Event|0|||
162000667|NCT01777776|585052070|FG003|Overall Study|Adverse Event|0|||
162000668|NCT01777776|585052067|FG000|Overall Study|Disease Progression|4|||
162000669|NCT01777776|585052068|FG001|Overall Study|Disease Progression|8|||
162000670|NCT01777776|585052069|FG002|Overall Study|Disease Progression|6|||
162000671|NCT01777776|585052070|FG003|Overall Study|Disease Progression|3|||
162000672|NCT01777776|585052067|FG000|Overall Study|Withdrawal by Subject|0|||
162000673|NCT01777776|585052068|FG001|Overall Study|Withdrawal by Subject|0|||
162000674|NCT01777776|585052069|FG002|Overall Study|Withdrawal by Subject|0|||
162000675|NCT01777776|585052070|FG003|Overall Study|Withdrawal by Subject|1|||
162000676|NCT01420926|585052073|FG000|Overall Study|Adverse Event|6|||
162000677|NCT01420926|585052074|FG001|Overall Study|Adverse Event|4|||
162000678|NCT01420926|585052073|FG000|Overall Study|Death|18|||
162000679|NCT01420926|585052074|FG001|Overall Study|Death|17|||
162000680|NCT01420926|585052073|FG000|Overall Study|Withdrawal by Subject|11|||
162042240|NCT00973349|585211996|FG014|Overall Study|Inappropriate enrolment|1|||
162042241|NCT00973349|585211997|FG015|Overall Study|Inappropriate enrolment|1|||
162042242|NCT00973349|585211982|FG000|Overall Study|Protocol Violation|0|||
162042243|NCT00973349|585211983|FG001|Overall Study|Protocol Violation|0|||
162042244|NCT00973349|585211984|FG002|Overall Study|Protocol Violation|0|||
162042245|NCT00973349|585211985|FG003|Overall Study|Protocol Violation|0|||
162042246|NCT00973349|585211986|FG004|Overall Study|Protocol Violation|0|||
162042247|NCT00973349|585211987|FG005|Overall Study|Protocol Violation|0|||
162042248|NCT00973349|585211988|FG006|Overall Study|Protocol Violation|0|||
162042249|NCT00973349|585211989|FG007|Overall Study|Protocol Violation|0|||
162042250|NCT00973349|585211990|FG008|Overall Study|Protocol Violation|1|||
162042251|NCT00973349|585211991|FG009|Overall Study|Protocol Violation|0|||
162042252|NCT00973349|585211992|FG010|Overall Study|Protocol Violation|0|||
162042253|NCT00973349|585211993|FG011|Overall Study|Protocol Violation|0|||
162042254|NCT00973349|585211994|FG012|Overall Study|Protocol Violation|0|||
162042255|NCT00973349|585211995|FG013|Overall Study|Protocol Violation|0|||
162042256|NCT00973349|585211996|FG014|Overall Study|Protocol Violation|0|||
162042257|NCT00973349|585211997|FG015|Overall Study|Protocol Violation|0|||
162042258|NCT00973349|585211982|FG000|Overall Study|Unable to classify|0|||
162042259|NCT00973349|585211983|FG001|Overall Study|Unable to classify|0|||
162042260|NCT00973349|585211984|FG002|Overall Study|Unable to classify|0|||
162042261|NCT00973349|585211985|FG003|Overall Study|Unable to classify|0|||
162042262|NCT00973349|585211986|FG004|Overall Study|Unable to classify|1|||
162042263|NCT00973349|585211987|FG005|Overall Study|Unable to classify|1|||
162042264|NCT00973349|585211988|FG006|Overall Study|Unable to classify|0|||
162042265|NCT00973349|585211989|FG007|Overall Study|Unable to classify|0|||
162042266|NCT00973349|585211990|FG008|Overall Study|Unable to classify|0|||
162042267|NCT00973349|585211991|FG009|Overall Study|Unable to classify|1|||
162042268|NCT00973349|585211992|FG010|Overall Study|Unable to classify|0|||
162042269|NCT00973349|585211993|FG011|Overall Study|Unable to classify|0|||
162042270|NCT00973349|585211994|FG012|Overall Study|Unable to classify|0|||
162042271|NCT00973349|585211995|FG013|Overall Study|Unable to classify|0|||
162042272|NCT00973349|585211996|FG014|Overall Study|Unable to classify|0|||
162042273|NCT00973349|585211997|FG015|Overall Study|Unable to classify|0|||
162042274|NCT02898116|585212002|FG000|Overall Study|Adverse Event|1|||
162042275|NCT02898116|585212002|FG000|Overall Study|Progressive disease|1|||
162042276|NCT02130024|585212003|FG000|Overall Study|Adverse Event|10|||
162042277|NCT02130024|585212004|FG001|Overall Study|Adverse Event|11|||
162042278|NCT02130024|585212003|FG000|Overall Study|Death|2|||
162042279|NCT02130024|585212004|FG001|Overall Study|Death|2|||
162042280|NCT02130024|585212003|FG000|Overall Study|Lost to Follow-up|1|||
162042281|NCT02130024|585212004|FG001|Overall Study|Lost to Follow-up|1|||
162042282|NCT02130024|585212003|FG000|Overall Study|Physician Decision|1|||
162042283|NCT02130024|585212004|FG001|Overall Study|Physician Decision|3|||
162042284|NCT02130024|585212003|FG000|Overall Study|Protocol Deviation|4|||
162042285|NCT02130024|585212004|FG001|Overall Study|Protocol Deviation|0|||
162042286|NCT02130024|585212003|FG000|Overall Study|Site Administration Problems|1|||
162042287|NCT02130024|585212004|FG001|Overall Study|Site Administration Problems|0|||
162042288|NCT02130024|585212003|FG000|Overall Study|Subject Withdrew Consent|6|||
162042289|NCT02130024|585212004|FG001|Overall Study|Subject Withdrew Consent|14|||
162042290|NCT05597020|585212005|FG000|Washout|Forbidden medication|2|||
162042291|NCT05597020|585212006|FG001|Washout|Forbidden medication|0|||
162042292|NCT05597020|585212005|FG000|Treatment Period II|Advice from primary care physician|1|||
162042293|NCT05597020|585212006|FG001|Treatment Period II|Advice from primary care physician|0|||
162042294|NCT05597020|585212005|FG000|Treatment Period II|Subject lost investigational product|1|||
162042295|NCT05597020|585212006|FG001|Treatment Period II|Subject lost investigational product|0|||
162042296|NCT05597020|585212005|FG000|Treatment Period II|Private reasons|0|||
162042297|NCT05597020|585212006|FG001|Treatment Period II|Private reasons|1|||
162042298|NCT05736224|585212007|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
162042299|NCT01015131|585212008|FG000|Overall Study|Physician Decision|1|||
162042300|NCT01015131|585212008|FG000|Overall Study|Protocol Violation|1|||
162042301|NCT01015131|585212008|FG000|Overall Study|Withdrawal by Subject|2|||
162042302|NCT01015131|585212008|FG000|Overall Study|Other Protocol Specified Criteria|4|||
162042303|NCT04526509|585212009|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
162042304|NCT04526509|585212010|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
162042305|NCT04526509|585212011|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
162042306|NCT04526509|585212012|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
162042307|NCT04526509|585212013|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
162042308|NCT04526509|585212014|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
162042309|NCT04526509|585212015|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
162042310|NCT04526509|585212009|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
162042311|NCT04526509|585212010|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
162048501|NCT04545060|585233342|FG000|Overall Study|Withdrawal by Subject|17|||
162000681|NCT01420926|585052074|FG001|Overall Study|Withdrawal by Subject|17|||
162000682|NCT01420926|585052073|FG000|Overall Study|Non-protocol treatment|17|||
162000683|NCT01420926|585052074|FG001|Overall Study|Non-protocol treatment|20|||
162000684|NCT01420926|585052073|FG000|Overall Study|Physician Decision|8|||
162000685|NCT01420926|585052074|FG001|Overall Study|Physician Decision|5|||
162000686|NCT04564846|585053677|FG000|Overall Study|Withdrawal by Subject|2|||
162000687|NCT04564846|585053678|FG001|Overall Study|Withdrawal by Subject|1|||
162000688|NCT04564846|585053677|FG000|Overall Study|Physician Decision|0|||
162000689|NCT04564846|585053678|FG001|Overall Study|Physician Decision|1|||
162000690|NCT04564846|585053677|FG000|Overall Study|Lost to Follow-up|0|||
162000691|NCT04564846|585053678|FG001|Overall Study|Lost to Follow-up|1|||
162000692|NCT04564846|585053677|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
162000693|NCT04564846|585053678|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
162000694|NCT04564846|585053677|FG000|Overall Study|Subject non-compliance|1|||
162000695|NCT04564846|585053678|FG001|Overall Study|Subject non-compliance|0|||
162000696|NCT03737123|585053679|FG000|Study Treatment|Adverse Event|2|||
162000697|NCT03737123|585053680|FG001|Study Treatment|Adverse Event|0|||
162000698|NCT03737123|585053679|FG000|Study Treatment|Disease Progression|2|||
162000699|NCT03737123|585053680|FG001|Study Treatment|Disease Progression|0|||
162000700|NCT03737123|585053679|FG000|Study Treatment|Withdrawal by Subject|2|||
162000701|NCT03737123|585053680|FG001|Study Treatment|Withdrawal by Subject|0|||
162000702|NCT03737123|585053679|FG000|Follow up|Death|1|||
162000703|NCT03737123|585053680|FG001|Follow up|Death|0|||
162000704|NCT03737123|585053679|FG000|Follow up|Withdrawal by Subject|1|||
162000705|NCT03737123|585053680|FG001|Follow up|Withdrawal by Subject|0|||
162000706|NCT03737123|585053679|FG000|Follow up|Termination of study|4|||
162000707|NCT03737123|585053680|FG001|Follow up|Termination of study|0|||
162000708|NCT01519323|585053681|FG000|Overall Study|Death|3|||
162000709|NCT01519323|585053682|FG001|Overall Study|Death|2|||
162000710|NCT01519323|585053681|FG000|Overall Study|Study terminated by sponsor|0|||
162000711|NCT01519323|585053682|FG001|Overall Study|Study terminated by sponsor|1|||
162000712|NCT00966654|585053687|FG000|Overall Study|Study was terminated,PI left institution|12|||
162000713|NCT00762359|585053690|FG000|Overall Study|Adverse Event|20|||
162000714|NCT00762359|585053691|FG001|Overall Study|Adverse Event|23|||
162000715|NCT00762359|585053690|FG000|Overall Study|Protocol Violation|21|||
162000716|NCT00762359|585053691|FG001|Overall Study|Protocol Violation|13|||
162000717|NCT00762359|585053690|FG000|Overall Study|Withdrawal by Subject|13|||
162000718|NCT00762359|585053691|FG001|Overall Study|Withdrawal by Subject|10|||
162000719|NCT00762359|585053690|FG000|Overall Study|Lack of Efficacy|0|||
162000720|NCT00762359|585053691|FG001|Overall Study|Lack of Efficacy|4|||
162000721|NCT00762359|585053690|FG000|Overall Study|Institution closed|2|||
162000722|NCT00762359|585053691|FG001|Overall Study|Institution closed|3|||
162000723|NCT00762359|585053690|FG000|Overall Study|Physician Decision|2|||
162000724|NCT00762359|585053691|FG001|Overall Study|Physician Decision|3|||
162000725|NCT00762359|585053690|FG000|Overall Study|Removal|0|||
162000726|NCT00762359|585053691|FG001|Overall Study|Removal|1|||
162000727|NCT00762359|585053690|FG000|Overall Study|Withdrew consent|1|||
162000728|NCT00762359|585053691|FG001|Overall Study|Withdrew consent|0|||
162000729|NCT01421017|585053696|FG000|Overall Study|Withdrawal by Subject|2|||
162000730|NCT01421017|585053697|FG001|Overall Study|Withdrawal by Subject|0|||
162000731|NCT01421017|585053698|FG002|Overall Study|Withdrawal by Subject|0|||
162000732|NCT01421017|585053696|FG000|Overall Study|POD|0|||
162000733|NCT01421017|585053697|FG001|Overall Study|POD|6|||
162000734|NCT01421017|585053698|FG002|Overall Study|POD|3|||
162000735|NCT02313766|585053699|FG000|Overall Study|surgery cancelled|1|||
162000736|NCT02313766|585053700|FG001|Overall Study|surgery cancelled|0|||
162000737|NCT02313766|585053701|FG002|Overall Study|surgery cancelled|0|||
162000738|NCT02313766|585053699|FG000|Overall Study|Lost to Follow-up|0|||
162000739|NCT02313766|585053700|FG001|Overall Study|Lost to Follow-up|2|||
162000740|NCT02313766|585053701|FG002|Overall Study|Lost to Follow-up|0|||
162000741|NCT02313766|585053699|FG000|Overall Study|Adverse Event|0|||
162000742|NCT02313766|585053700|FG001|Overall Study|Adverse Event|1|||
162000743|NCT02313766|585053701|FG002|Overall Study|Adverse Event|0|||
162000744|NCT00416624|585053704|FG000|Overall Study|Withdrawal by Subject|1|||
162000745|NCT00416624|585053705|FG001|Overall Study|Withdrawal by Subject|6|||
162000746|NCT00416624|585053706|FG002|Overall Study|Withdrawal by Subject|4|||
162000747|NCT00416624|585053707|FG003|Overall Study|Withdrawal by Subject|9|||
162000748|NCT00416624|585053704|FG000|Overall Study|Death|4|||
162000749|NCT00416624|585053705|FG001|Overall Study|Death|7|||
162000750|NCT00416624|585053706|FG002|Overall Study|Death|7|||
162000751|NCT00416624|585053707|FG003|Overall Study|Death|1|||
162000752|NCT00416624|585053704|FG000|Overall Study|Adverse Event|8|||
162000753|NCT00416624|585053705|FG001|Overall Study|Adverse Event|3|||
162000754|NCT00416624|585053706|FG002|Overall Study|Adverse Event|2|||
162000755|NCT00416624|585053707|FG003|Overall Study|Adverse Event|2|||
162000756|NCT00416624|585053704|FG000|Overall Study|Other|8|||
162000757|NCT00416624|585053705|FG001|Overall Study|Other|11|||
162000758|NCT00416624|585053706|FG002|Overall Study|Other|5|||
162000759|NCT00416624|585053707|FG003|Overall Study|Other|5|||
162000760|NCT00416624|585053704|FG000|Overall Study|Cancel|1|||
162042312|NCT04526509|585212011|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
162042313|NCT04526509|585212012|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
162042314|NCT04526509|585212013|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
162042315|NCT04526509|585212014|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
162042316|NCT04526509|585212015|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
162042317|NCT04526509|585212009|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
162042318|NCT04526509|585212010|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162042319|NCT04526509|585212011|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162042320|NCT04526509|585212012|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162042321|NCT04526509|585212013|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162042322|NCT04526509|585212014|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162042323|NCT04526509|585212015|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
162042324|NCT04526509|585212009|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
162042325|NCT04526509|585212010|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
162042326|NCT04526509|585212011|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
162042327|NCT04526509|585212012|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
162042328|NCT04526509|585212013|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
162042329|NCT04526509|585212014|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
162042330|NCT04526509|585212015|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
162042331|NCT04526509|585212009|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
162042332|NCT04526509|585212010|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
162042333|NCT04526509|585212011|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
162042334|NCT04526509|585212012|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
162042335|NCT04526509|585212013|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
162000761|NCT00416624|585053705|FG001|Overall Study|Cancel|0|||
162000762|NCT00416624|585053706|FG002|Overall Study|Cancel|0|||
162000763|NCT00416624|585053707|FG003|Overall Study|Cancel|0|||
162000764|NCT01702844|585053708|FG000|Overall Study|Adverse Event|9|||
162000765|NCT01702844|585053708|FG000|Overall Study|Death|1|||
162000766|NCT01702844|585053708|FG000|Overall Study|Withdrawal by Subject|3|||
162000767|NCT01702844|585053708|FG000|Overall Study|Physician Decision|6|||
162000768|NCT01458639|585053710|FG000|Overall Study|Physician Decision|4|||
162000769|NCT01458639|585053710|FG000|Overall Study|Equipment issue|1|||
162000770|NCT01458639|585053710|FG000|Overall Study|Inability to obtain subject blood sample|1|||
162000771|NCT04245111|585053711|FG000|Overall Study|Lost to Follow-up|5|||
162000772|NCT04245111|585053712|FG001|Overall Study|Lost to Follow-up|1|||
162000773|NCT04245111|585053713|FG002|Overall Study|Lost to Follow-up|1|||
162000774|NCT06039579|585053714|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
162000775|NCT06039579|585053715|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
162000776|NCT06039579|585053716|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
162000777|NCT06039579|585053717|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
162000778|NCT06039579|585053718|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
162000779|NCT06039579|585053719|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
162000780|NCT06039579|585053720|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
162000781|NCT06039579|585053721|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
162000782|NCT02792231|585053726|FG000|Overall Study|Patient/guardian decision|32|||
162000783|NCT02792231|585053727|FG001|Overall Study|Patient/guardian decision|42|||
162000784|NCT02792231|585053726|FG000|Overall Study|Adverse Event|15|||
162000785|NCT02792231|585053727|FG001|Overall Study|Adverse Event|11|||
162000786|NCT02792231|585053726|FG000|Overall Study|Physician Decision|14|||
162000787|NCT02792231|585053727|FG001|Overall Study|Physician Decision|12|||
162000788|NCT02792231|585053726|FG000|Overall Study|Lack of Efficacy|7|||
162000789|NCT02792231|585053727|FG001|Overall Study|Lack of Efficacy|9|||
162000790|NCT02792231|585053726|FG000|Overall Study|Lost to Follow-up|9|||
162000791|NCT02792231|585053727|FG001|Overall Study|Lost to Follow-up|5|||
162000792|NCT02792231|585053726|FG000|Overall Study|Pregnancy|1|||
162000793|NCT02792231|585053727|FG001|Overall Study|Pregnancy|3|||
162000794|NCT02792231|585053726|FG000|Overall Study|Non-compliance with study treatment|2|||
162000795|NCT02792231|585053727|FG001|Overall Study|Non-compliance with study treatment|1|||
162000796|NCT02792231|585053726|FG000|Overall Study|Protocol deviation|2|||
162000797|NCT02792231|585053727|FG001|Overall Study|Protocol deviation|0|||
162000798|NCT02792231|585053726|FG000|Overall Study|Technical problems|0|||
162042336|NCT04526509|585212014|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
162042337|NCT04526509|585212015|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
162042338|NCT04526509|585212009|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
162000799|NCT02792231|585053727|FG001|Overall Study|Technical problems|1|||
162000800|NCT03309878|585053728|FG000|Overall Study|Adverse Event|1|||
162000801|NCT03309878|585053729|FG001|Overall Study|Adverse Event|0|||
162000802|NCT03309878|585053730|FG002|Overall Study|Adverse Event|0|||
162000803|NCT03309878|585053731|FG003|Overall Study|Adverse Event|0|||
162000804|NCT03309878|585053728|FG000|Overall Study|Did not maintain eligibility|2|||
162000805|NCT03309878|585053729|FG001|Overall Study|Did not maintain eligibility|1|||
162000806|NCT03309878|585053730|FG002|Overall Study|Did not maintain eligibility|0|||
162000807|NCT03309878|585053731|FG003|Overall Study|Did not maintain eligibility|0|||
162000808|NCT03309878|585053728|FG000|Overall Study|Withdrawal by Subject|0|||
162000809|NCT03309878|585053729|FG001|Overall Study|Withdrawal by Subject|1|||
162000810|NCT03309878|585053730|FG002|Overall Study|Withdrawal by Subject|0|||
162000811|NCT03309878|585053731|FG003|Overall Study|Withdrawal by Subject|0|||
162000812|NCT01884077|585053732|FG000|Overall Study|screen fail|0|||
162000813|NCT01884077|585053733|FG001|Overall Study|screen fail|2|||
162000814|NCT01884077|585053732|FG000|Overall Study|canceled surgery|2|||
162000815|NCT01884077|585053733|FG001|Overall Study|canceled surgery|0|||
162000816|NCT01884077|585053732|FG000|Overall Study|Lost to Follow-up|0|||
162000817|NCT01884077|585053733|FG001|Overall Study|Lost to Follow-up|4|||
162000818|NCT01884077|585053732|FG000|Overall Study|study closed|6|||
162000819|NCT01884077|585053733|FG001|Overall Study|study closed|4|||
162000820|NCT01755234|585053734|FG000|Overall Study|Lost to Follow-up|11|||
162000821|NCT01755234|585053735|FG001|Overall Study|Lost to Follow-up|6|||
162000822|NCT01755234|585053734|FG000|Overall Study|Change in surgical case|2|||
162000823|NCT01755234|585053735|FG001|Overall Study|Change in surgical case|1|||
162000824|NCT01755234|585053734|FG000|Overall Study|case cancelled|1|||
162000825|NCT01755234|585053735|FG001|Overall Study|case cancelled|0|||
162000826|NCT01755234|585053734|FG000|Overall Study|Withdrawal by Subject|0|||
162000827|NCT01755234|585053735|FG001|Overall Study|Withdrawal by Subject|1|||
162000828|NCT01755234|585053734|FG000|Overall Study|unblinded|1|||
162000829|NCT01755234|585053735|FG001|Overall Study|unblinded|0|||
162000830|NCT02836652|585053736|FG000|Overall Study|Death|3|||
162000831|NCT02836652|585053737|FG001|Overall Study|Death|3|||
162000832|NCT02836652|585053736|FG000|Overall Study|Transplant/Explant|3|||
162000833|NCT02836652|585053737|FG001|Overall Study|Transplant/Explant|4|||
162000834|NCT02836652|585053736|FG000|Overall Study|Withdrawn|9|||
162000835|NCT02836652|585053737|FG001|Overall Study|Withdrawn|9|||
162000836|NCT02836652|585053736|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
162000837|NCT02836652|585053737|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
162000838|NCT03812380|585053738|FG000|Overall Study|Protocol Violation|3|||
162000839|NCT03812380|585053739|FG001|Overall Study|Protocol Violation|3|||
162000840|NCT03812380|585053738|FG000|Overall Study|Withdrawal by Subject|5|||
162000841|NCT03812380|585053739|FG001|Overall Study|Withdrawal by Subject|4|||
162000842|NCT03812380|585053738|FG000|Overall Study|Early termination of study|14|||
162000843|NCT03812380|585053739|FG001|Overall Study|Early termination of study|14|||
162000844|NCT01220167|585053740|FG000|Period 3|Urine positive for substance abuse|0|||
162000845|NCT01220167|585053741|FG001|Period 3|Urine positive for substance abuse|1|||
162000846|NCT01220167|585053742|FG002|Period 3|Urine positive for substance abuse|0|||
162000847|NCT01008943|585053743|FG000|Overall Study|Withdrawal by Subject|1|||
162000848|NCT00861705|585053744|FG000|Overall Study|Never Began Treatment|7|||
162000849|NCT00861705|585053745|FG001|Overall Study|Never Began Treatment|3|||
162000850|NCT00861705|585053746|FG002|Overall Study|Never Began Treatment|0|||
162000851|NCT00861705|585053747|FG003|Overall Study|Never Began Treatment|1|||
162000852|NCT02611479|585053748|FG000|Baseline Enrollment|Exited study|13|||
162000853|NCT02611479|585053748|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
162000854|NCT02611479|585053748|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
162000855|NCT02611479|585053748|FG000|Data Cleaning|No baseline function or pain metrics|2|||
162000856|NCT00743249|585053749|FG000|Overall Study|Adverse Event|0|||
162000857|NCT00743249|585053750|FG001|Overall Study|Adverse Event|4|||
162000858|NCT00743249|585053749|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
162000859|NCT00743249|585053750|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
162000860|NCT00743249|585053749|FG000|Overall Study|Unsuccessful insertion of stent|2|||
162000861|NCT00743249|585053750|FG001|Overall Study|Unsuccessful insertion of stent|1|||
162000862|NCT02314052|585053753|FG000|Cycle One|Adverse Event|0|||
162000863|NCT02314052|585053754|FG001|Cycle One|Adverse Event|0|||
162000864|NCT02314052|585053755|FG002|Cycle One|Adverse Event|0|||
162000865|NCT02314052|585053756|FG003|Cycle One|Adverse Event|1|||
162000866|NCT02314052|585053757|FG004|Cycle One|Adverse Event|0|||
162000867|NCT02314052|585053758|FG005|Cycle One|Adverse Event|0|||
162000868|NCT01960140|585053760|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
162000869|NCT06237049|585053764|FG000|Overall Study|Death|0|||
162000870|NCT06237049|585053765|FG001|Overall Study|Death|0|||
162000871|NCT06237049|585053766|FG002|Overall Study|Death|0|||
162000872|NCT06237049|585053767|FG003|Overall Study|Death|1|||
162000873|NCT06237049|585053764|FG000|Overall Study|Lost to Follow-up|11|||
162000874|NCT06237049|585053765|FG001|Overall Study|Lost to Follow-up|5|||
162000875|NCT06237049|585053766|FG002|Overall Study|Lost to Follow-up|8|||
162000876|NCT06237049|585053767|FG003|Overall Study|Lost to Follow-up|8|||
162000877|NCT06237049|585053764|FG000|Overall Study|Protocol Violation|0|||
162000878|NCT06237049|585053765|FG001|Overall Study|Protocol Violation|1|||
162000879|NCT06237049|585053766|FG002|Overall Study|Protocol Violation|0|||
162000880|NCT06237049|585053767|FG003|Overall Study|Protocol Violation|1|||
162000881|NCT06237049|585053764|FG000|Overall Study|Withdrawal by Subject|4|||
162000882|NCT06237049|585053765|FG001|Overall Study|Withdrawal by Subject|2|||
162000883|NCT06237049|585053766|FG002|Overall Study|Withdrawal by Subject|1|||
162000884|NCT06237049|585053767|FG003|Overall Study|Withdrawal by Subject|0|||
162000885|NCT04678115|585053768|FG000|Overall Study|Lost to Follow-up|1|||
162000886|NCT04678115|585053769|FG001|Overall Study|Lost to Follow-up|0|||
162000887|NCT00890825|585053770|FG000|Overall Study|Withdrawal by Subject|1|||
162000888|NCT00890825|585053771|FG001|Overall Study|Withdrawal by Subject|0|||
162000889|NCT00890825|585053770|FG000|Overall Study|Alive at data cut off (DCO)|13|||
162000890|NCT00890825|585053771|FG001|Overall Study|Alive at data cut off (DCO)|14|||
162000891|NCT01091675|585053772|FG000|Overall Study|Adverse Event|7|||
162000892|NCT01091675|585053772|FG000|Overall Study|Lack of Efficacy|27|||
162000893|NCT01611194|585053780|FG000|Overall Study|Lost to Follow-up|0|||
162000894|NCT01611194|585053781|FG001|Overall Study|Lost to Follow-up|1|||
162000895|NCT01611194|585053780|FG000|Overall Study|Withdrawal by Subject|0|||
162000896|NCT01611194|585053781|FG001|Overall Study|Withdrawal by Subject|1|||
162000897|NCT01611194|585053780|FG000|Overall Study|drug use|0|||
162000898|NCT01611194|585053781|FG001|Overall Study|drug use|1|||
162000899|NCT00452790|585053782|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
162000900|NCT00452790|585053783|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
162000901|NCT00452790|585053782|FG000|Infant Series|Parent/legal guardian request|8|||
162000902|NCT00452790|585053783|FG001|Infant Series|Parent/legal guardian request|6|||
162000903|NCT00452790|585053782|FG000|Infant Series|Failed to return|4|||
162000904|NCT00452790|585053783|FG001|Infant Series|Failed to return|1|||
162000905|NCT00452790|585053782|FG000|Infant Series|Protocol Violation|1|||
162000906|NCT00452790|585053783|FG001|Infant Series|Protocol Violation|3|||
162000907|NCT00452790|585053782|FG000|Infant Series|Lost to Follow-up|2|||
162000908|NCT00452790|585053783|FG001|Infant Series|Lost to Follow-up|2|||
162000909|NCT00452790|585053782|FG000|Infant Series|Adverse Event|1|||
162000910|NCT00452790|585053783|FG001|Infant Series|Adverse Event|2|||
162000911|NCT00452790|585053782|FG000|Infant Series|Other reasons|1|||
162000912|NCT00452790|585053783|FG001|Infant Series|Other reasons|2|||
162000913|NCT00452790|585053782|FG000|Infant Series|Investigator request|0|||
162000914|NCT00452790|585053783|FG001|Infant Series|Investigator request|1|||
162000915|NCT00452790|585053782|FG000|Infant Series|Death|0|||
162000916|NCT00452790|585053783|FG001|Infant Series|Death|1|||
162000917|NCT00452790|585053782|FG000|After Infant Series|Investigator request|10|||
162000918|NCT00452790|585053783|FG001|After Infant Series|Investigator request|10|||
162000919|NCT00452790|585053782|FG000|After Infant Series|Adverse Event|4|||
162000920|NCT00452790|585053783|FG001|After Infant Series|Adverse Event|1|||
162000921|NCT00452790|585053782|FG000|After Infant Series|Parent/legal guardian request|1|||
162000922|NCT00452790|585053783|FG001|After Infant Series|Parent/legal guardian request|3|||
162000923|NCT00452790|585053782|FG000|After Infant Series|Lost to Follow-up|4|||
162000924|NCT00452790|585053783|FG001|After Infant Series|Lost to Follow-up|0|||
162000925|NCT00452790|585053782|FG000|After Infant Series|Failed to return|1|||
162000926|NCT00452790|585053783|FG001|After Infant Series|Failed to return|0|||
162000927|NCT00452790|585053782|FG000|After Infant Series|Other reasons|1|||
162000928|NCT00452790|585053783|FG001|After Infant Series|Other reasons|0|||
162000929|NCT00452790|585053782|FG000|Toddler Dose|Failed to return|0|||
162000930|NCT00452790|585053783|FG001|Toddler Dose|Failed to return|1|||
162000931|NCT00452790|585053782|FG000|Toddler Dose|Parent/legal guardian request|0|||
162000932|NCT00452790|585053783|FG001|Toddler Dose|Parent/legal guardian request|1|||
162000933|NCT02926638|585053799|FG000|Overall Study|Progression|2|||
162000934|NCT02926638|585053800|FG001|Overall Study|Progression|5|||
162000935|NCT02926638|585053799|FG000|Overall Study|Ineligible|1|||
162000936|NCT02926638|585053800|FG001|Overall Study|Ineligible|0|||
162000937|NCT02926638|585053799|FG000|Overall Study|Not protocol specified|1|||
162000938|NCT02926638|585053800|FG001|Overall Study|Not protocol specified|0|||
162000939|NCT02360228|585053802|FG000|Overall Study|Withdrawal by Subject|1|||
162000940|NCT02360228|585053803|FG001|Overall Study|Withdrawal by Subject|0|||
162000941|NCT02360228|585053804|FG002|Overall Study|Withdrawal by Subject|0|||
162000942|NCT02360228|585053802|FG000|Overall Study|Self-discontinued medication|0|||
162000943|NCT02360228|585053803|FG001|Overall Study|Self-discontinued medication|1|||
162000944|NCT02360228|585053804|FG002|Overall Study|Self-discontinued medication|0|||
162000945|NCT02360228|585053802|FG000|Overall Study|Unstable symptoms during screening|0|||
162000946|NCT02360228|585053803|FG001|Overall Study|Unstable symptoms during screening|0|||
162000947|NCT02360228|585053804|FG002|Overall Study|Unstable symptoms during screening|1|||
162000948|NCT02464410|585053805|FG000|Overall Study|Death|3|||
162000949|NCT02464410|585053806|FG001|Overall Study|Death|4|||
162000950|NCT02464410|585053805|FG000|Overall Study|Lost to Follow-up|7|||
162000951|NCT02464410|585053806|FG001|Overall Study|Lost to Follow-up|9|||
162000952|NCT02464410|585053805|FG000|Overall Study|Withdrawal by Subject|12|||
162000953|NCT02464410|585053806|FG001|Overall Study|Withdrawal by Subject|3|||
162000954|NCT01928927|585053807|FG000|Overall Study|Lost to Follow-up|1|||
162000955|NCT01928927|585053808|FG001|Overall Study|Lost to Follow-up|0|||
162000956|NCT01928927|585053807|FG000|Overall Study|Withdrawal by Subject|1|||
162000957|NCT01928927|585053808|FG001|Overall Study|Withdrawal by Subject|1|||
162000958|NCT01871519|585053813|FG000|Overall Study|Death|26|||
162000959|NCT01871519|585053813|FG000|Overall Study|Lost to Follow-up|15|||
162000960|NCT01871519|585053813|FG000|Overall Study|Withdrawal by Subject|49|||
162000961|NCT00350844|585053814|FG000|Overall Study|Lost to Follow-up|1|||
162000962|NCT02775916|585053815|FG000|Overall Study|Adverse Event|1|||
162000963|NCT02775916|585053816|FG001|Overall Study|Adverse Event|0|||
162000964|NCT02775916|585053815|FG000|Overall Study|Subject/Guardian Decision|2|||
162000965|NCT02775916|585053816|FG001|Overall Study|Subject/Guardian Decision|0|||
162000966|NCT00179621|585055126|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
162000967|NCT00179621|585055127|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
162000968|NCT00179621|585055128|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
162000969|NCT00179621|585055129|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
162000970|NCT00179621|585055126|FG000|Double-Blind Period|Adverse Event|2|||
162000971|NCT00179621|585055127|FG001|Double-Blind Period|Adverse Event|7|||
162000972|NCT00179621|585055128|FG002|Double-Blind Period|Adverse Event|4|||
162000973|NCT00179621|585055129|FG003|Double-Blind Period|Adverse Event|0|||
162000974|NCT00179621|585055126|FG000|Double-Blind Period|Withdrawal by Subject|2|||
162000975|NCT00179621|585055127|FG001|Double-Blind Period|Withdrawal by Subject|1|||
162000976|NCT00179621|585055128|FG002|Double-Blind Period|Withdrawal by Subject|3|||
162000977|NCT00179621|585055129|FG003|Double-Blind Period|Withdrawal by Subject|0|||
162000978|NCT00179621|585055126|FG000|Double-Blind Period|Death|0|||
162000979|NCT00179621|585055127|FG001|Double-Blind Period|Death|1|||
162000980|NCT00179621|585055128|FG002|Double-Blind Period|Death|2|||
162000981|NCT00179621|585055129|FG003|Double-Blind Period|Death|0|||
162000982|NCT00179621|585055126|FG000|Double-Blind Period|Protocol Violation|1|||
162000983|NCT00179621|585055127|FG001|Double-Blind Period|Protocol Violation|0|||
162000984|NCT00179621|585055128|FG002|Double-Blind Period|Protocol Violation|0|||
162000985|NCT00179621|585055129|FG003|Double-Blind Period|Protocol Violation|0|||
162000986|NCT00179621|585055126|FG000|Double-Blind Period|Other|0|||
162000987|NCT00179621|585055127|FG001|Double-Blind Period|Other|2|||
162000988|NCT00179621|585055128|FG002|Double-Blind Period|Other|2|||
162000989|NCT00179621|585055129|FG003|Double-Blind Period|Other|0|||
162000990|NCT00179621|585055126|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
162000991|NCT00179621|585055127|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
162000992|NCT00179621|585055128|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
162000993|NCT00179621|585055129|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
162000994|NCT00179621|585055126|FG000|Open-Label Period|Adverse Event|0|||
162000995|NCT00179621|585055127|FG001|Open-Label Period|Adverse Event|6|||
162000996|NCT00179621|585055128|FG002|Open-Label Period|Adverse Event|5|||
162000997|NCT00179621|585055129|FG003|Open-Label Period|Adverse Event|6|||
162000998|NCT00179621|585055126|FG000|Open-Label Period|Withdrawal by Subject|0|||
162000999|NCT00179621|585055127|FG001|Open-Label Period|Withdrawal by Subject|2|||
162001000|NCT00179621|585055128|FG002|Open-Label Period|Withdrawal by Subject|2|||
162001001|NCT00179621|585055129|FG003|Open-Label Period|Withdrawal by Subject|2|||
162001002|NCT00179621|585055126|FG000|Open-Label Period|Death|0|||
162001003|NCT00179621|585055127|FG001|Open-Label Period|Death|0|||
162001004|NCT00179621|585055128|FG002|Open-Label Period|Death|1|||
162001005|NCT00179621|585055129|FG003|Open-Label Period|Death|2|||
162001006|NCT00179621|585055126|FG000|Open-Label Period|Other|0|||
162001007|NCT00179621|585055127|FG001|Open-Label Period|Other|1|||
162001008|NCT00179621|585055128|FG002|Open-Label Period|Other|1|||
162001009|NCT00179621|585055129|FG003|Open-Label Period|Other|2|||
162001010|NCT00865345|585055131|FG000|Overall Study|Withdrawal by Subject|2|||
162001011|NCT00383552|585055132|FG000|Overall Study|Adverse Event|7|||
162001012|NCT00383552|585055133|FG001|Overall Study|Adverse Event|6|||
162001013|NCT00383552|585055134|FG002|Overall Study|Adverse Event|9|||
162001014|NCT00383552|585055135|FG003|Overall Study|Adverse Event|6|||
162001015|NCT00383552|585055132|FG000|Overall Study|Lack of Efficacy|4|||
162001016|NCT00383552|585055133|FG001|Overall Study|Lack of Efficacy|13|||
162001017|NCT00383552|585055134|FG002|Overall Study|Lack of Efficacy|29|||
162001018|NCT00383552|585055135|FG003|Overall Study|Lack of Efficacy|42|||
162001019|NCT00383552|585055132|FG000|Overall Study|Lost to Follow-up|0|||
162001020|NCT00383552|585055133|FG001|Overall Study|Lost to Follow-up|1|||
162001021|NCT00383552|585055134|FG002|Overall Study|Lost to Follow-up|5|||
162001022|NCT00383552|585055135|FG003|Overall Study|Lost to Follow-up|1|||
162001023|NCT00383552|585055132|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
162001024|NCT00383552|585055133|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
162001025|NCT00383552|585055134|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
162001026|NCT00383552|585055135|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
162001027|NCT00383552|585055132|FG000|Overall Study|Did not wish to continue (related)|1|||
162001028|NCT00383552|585055133|FG001|Overall Study|Did not wish to continue (related)|0|||
162001029|NCT00383552|585055134|FG002|Overall Study|Did not wish to continue (related)|2|||
162001030|NCT00383552|585055135|FG003|Overall Study|Did not wish to continue (related)|3|||
162001031|NCT00383552|585055132|FG000|Overall Study|Noncompliance with the protocol|11|||
162001032|NCT00383552|585055133|FG001|Overall Study|Noncompliance with the protocol|6|||
162001033|NCT00383552|585055134|FG002|Overall Study|Noncompliance with the protocol|8|||
162001034|NCT00383552|585055135|FG003|Overall Study|Noncompliance with the protocol|10|||
162001035|NCT00383552|585055132|FG000|Overall Study|Did not meet protocol eligibility|8|||
162001036|NCT00383552|585055133|FG001|Overall Study|Did not meet protocol eligibility|6|||
162001037|NCT00383552|585055134|FG002|Overall Study|Did not meet protocol eligibility|2|||
162001038|NCT00383552|585055135|FG003|Overall Study|Did not meet protocol eligibility|3|||
162001039|NCT00383552|585055132|FG000|Overall Study|Administrative|1|||
162001040|NCT00383552|585055133|FG001|Overall Study|Administrative|0|||
162001041|NCT00383552|585055134|FG002|Overall Study|Administrative|1|||
162001042|NCT00383552|585055135|FG003|Overall Study|Administrative|1|||
162001043|NCT00882440|585055136|FG000|Overall Study|Adverse Event|2|||
162001044|NCT00882440|585055137|FG001|Overall Study|Adverse Event|2|||
162001045|NCT00882440|585055138|FG002|Overall Study|Adverse Event|2|||
162001046|NCT00882440|585055139|FG003|Overall Study|Adverse Event|1|||
162001047|NCT00882440|585055140|FG004|Overall Study|Adverse Event|1|||
162001048|NCT00882440|585055141|FG005|Overall Study|Adverse Event|4|||
162001049|NCT00882440|585055142|FG006|Overall Study|Adverse Event|2|||
162001050|NCT00882440|585055136|FG000|Overall Study|Lack of Efficacy|3|||
162001051|NCT00882440|585055137|FG001|Overall Study|Lack of Efficacy|5|||
162001052|NCT00882440|585055138|FG002|Overall Study|Lack of Efficacy|2|||
162001053|NCT00882440|585055139|FG003|Overall Study|Lack of Efficacy|0|||
162001054|NCT00882440|585055140|FG004|Overall Study|Lack of Efficacy|0|||
162001055|NCT00882440|585055141|FG005|Overall Study|Lack of Efficacy|3|||
162001056|NCT00882440|585055142|FG006|Overall Study|Lack of Efficacy|0|||
162001057|NCT00882440|585055136|FG000|Overall Study|Lost to Follow-up|2|||
162001058|NCT00882440|585055137|FG001|Overall Study|Lost to Follow-up|0|||
162001059|NCT00882440|585055138|FG002|Overall Study|Lost to Follow-up|1|||
162001060|NCT00882440|585055139|FG003|Overall Study|Lost to Follow-up|1|||
162001061|NCT00882440|585055140|FG004|Overall Study|Lost to Follow-up|1|||
162001062|NCT00882440|585055141|FG005|Overall Study|Lost to Follow-up|0|||
162001063|NCT00882440|585055142|FG006|Overall Study|Lost to Follow-up|1|||
162001064|NCT00882440|585055136|FG000|Overall Study|Protocol Violation|0|||
162001065|NCT00882440|585055137|FG001|Overall Study|Protocol Violation|0|||
162001066|NCT00882440|585055138|FG002|Overall Study|Protocol Violation|1|||
162001067|NCT00882440|585055139|FG003|Overall Study|Protocol Violation|1|||
162001068|NCT00882440|585055140|FG004|Overall Study|Protocol Violation|1|||
162001069|NCT00882440|585055141|FG005|Overall Study|Protocol Violation|0|||
162001070|NCT00882440|585055142|FG006|Overall Study|Protocol Violation|0|||
162001071|NCT00882440|585055136|FG000|Overall Study|Withdrawal by Subject|2|||
162001072|NCT00882440|585055137|FG001|Overall Study|Withdrawal by Subject|1|||
162001073|NCT00882440|585055138|FG002|Overall Study|Withdrawal by Subject|1|||
162001074|NCT00882440|585055139|FG003|Overall Study|Withdrawal by Subject|0|||
162001075|NCT00882440|585055140|FG004|Overall Study|Withdrawal by Subject|6|||
162001076|NCT00882440|585055141|FG005|Overall Study|Withdrawal by Subject|0|||
162001077|NCT00882440|585055142|FG006|Overall Study|Withdrawal by Subject|1|||
162001078|NCT00882440|585055136|FG000|Overall Study|Patient Uncooperative|2|||
162001079|NCT00882440|585055137|FG001|Overall Study|Patient Uncooperative|0|||
162001080|NCT00882440|585055138|FG002|Overall Study|Patient Uncooperative|0|||
162001081|NCT00882440|585055139|FG003|Overall Study|Patient Uncooperative|0|||
162001082|NCT00882440|585055140|FG004|Overall Study|Patient Uncooperative|1|||
162001083|NCT00882440|585055141|FG005|Overall Study|Patient Uncooperative|0|||
162001084|NCT00882440|585055142|FG006|Overall Study|Patient Uncooperative|0|||
162001085|NCT05482308|585055146|FG000|Overall Study|Withdrawal by Subject|1|||
162001086|NCT05482308|585055147|FG001|Overall Study|Withdrawal by Subject|0|||
162001087|NCT05482308|585055146|FG000|Overall Study|No longer meets eligibility criteria|0|||
162001088|NCT05482308|585055147|FG001|Overall Study|No longer meets eligibility criteria|1|||
162001089|NCT01693029|585055159|FG000|Overall Study|Withdrawal by Subject|15|||
162001090|NCT01693029|585055160|FG001|Overall Study|Withdrawal by Subject|22|||
162001091|NCT01693029|585055159|FG000|Overall Study|Kidney transplantation|7|||
162001092|NCT01693029|585055160|FG001|Overall Study|Kidney transplantation|7|||
162001093|NCT01693029|585055159|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
162001094|NCT01693029|585055160|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
162001095|NCT01693029|585055159|FG000|Overall Study|Protocol Violation|6|||
162001096|NCT01693029|585055160|FG001|Overall Study|Protocol Violation|7|||
162001097|NCT01693029|585055159|FG000|Overall Study|Change in dialysis modality|2|||
162001098|NCT01693029|585055160|FG001|Overall Study|Change in dialysis modality|1|||
162001099|NCT01693029|585055159|FG000|Overall Study|Physician Decision|0|||
162001100|NCT01693029|585055160|FG001|Overall Study|Physician Decision|2|||
162001101|NCT01693029|585055159|FG000|Overall Study|Lost to Follow-up|0|||
162001102|NCT01693029|585055160|FG001|Overall Study|Lost to Follow-up|1|||
162001103|NCT01693029|585055159|FG000|Overall Study|Adverse Event|1|||
162001104|NCT01693029|585055160|FG001|Overall Study|Adverse Event|6|||
162001105|NCT01693029|585055159|FG000|Overall Study|Death|5|||
162001106|NCT01693029|585055160|FG001|Overall Study|Death|8|||
162001107|NCT01693029|585055159|FG000|Overall Study|Non-compliance|2|||
162001108|NCT01693029|585055160|FG001|Overall Study|Non-compliance|1|||
162001109|NCT03016312|585055161|FG000|Overall Study|discontinued before the treatment started|0|||
162001110|NCT03016312|585055162|FG001|Overall Study|discontinued before the treatment started|1|||
162001111|NCT03016312|585055161|FG000|Overall Study|Withdrawal by Subject|37|||
162001112|NCT03016312|585055162|FG001|Overall Study|Withdrawal by Subject|44|||
162001113|NCT03016312|585055161|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
162001114|NCT03016312|585055162|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
162001115|NCT03016312|585055161|FG000|Overall Study|Physician Decision|1|||
162001116|NCT03016312|585055162|FG001|Overall Study|Physician Decision|3|||
162001117|NCT03016312|585055161|FG000|Overall Study|Lost to Follow-up|12|||
162001118|NCT03016312|585055162|FG001|Overall Study|Lost to Follow-up|12|||
162001119|NCT03016312|585055161|FG000|Overall Study|Death|210|||
162001120|NCT03016312|585055162|FG001|Overall Study|Death|184|||
162001121|NCT03016312|585055161|FG000|Overall Study|loss to contact|1|||
162001122|NCT03016312|585055162|FG001|Overall Study|loss to contact|0|||
162001123|NCT03016312|585055161|FG000|Overall Study|started a new cancer therapy|1|||
162001124|NCT03016312|585055162|FG001|Overall Study|started a new cancer therapy|0|||
162001125|NCT01535807|585055163|FG000|Overall Study|Withdrawal by Subject|1|||
162001126|NCT01535807|585055164|FG001|Overall Study|Withdrawal by Subject|1|||
162001127|NCT01535807|585055163|FG000|Overall Study|Data collection error|1|||
162001128|NCT01535807|585055164|FG001|Overall Study|Data collection error|1|||
162001129|NCT01329263|585055165|FG000|Overall Study|Lost to Follow-up|4|||
162001130|NCT01329263|585055166|FG001|Overall Study|Lost to Follow-up|21|||
162001131|NCT01329263|585055165|FG000|Overall Study|Withdrawal by Subject|1|||
162001132|NCT01329263|585055166|FG001|Overall Study|Withdrawal by Subject|2|||
162001133|NCT01631435|585055167|FG000|Overall Study|Adverse Event|2|||
162001134|NCT01631435|585055167|FG000|Overall Study|Withdrawal by Subject|2|||
162001135|NCT01631435|585055167|FG000|Overall Study|incomplete study procedure|5|||
162001136|NCT02123134|585055169|FG000|Overall Study|Withdrawal of consent|3|||
162001137|NCT02123134|585055170|FG001|Overall Study|Withdrawal of consent|2|||
162001138|NCT02123134|585055169|FG000|Overall Study|Administrative decision|0|||
162001139|NCT02123134|585055170|FG001|Overall Study|Administrative decision|1|||
162001140|NCT00657540|585055176|FG000|Overall Study|Lost to Follow-up|1|||
162001141|NCT00657540|585055177|FG001|Overall Study|Lost to Follow-up|4|||
162001142|NCT00141453|585055178|FG000|Overall Study|Protocol Violation|6|||
162001143|NCT00141453|585055179|FG001|Overall Study|Protocol Violation|5|||
162001144|NCT02656017|585055182|FG000|Overall Study|Study burden|3|||
162001145|NCT02656017|585055183|FG001|Overall Study|Study burden|3|||
162001146|NCT02656017|585055182|FG000|Overall Study|Adverse Event|2|||
162001147|NCT02656017|585055183|FG001|Overall Study|Adverse Event|1|||
162001148|NCT02656017|585055182|FG000|Overall Study|Unable/unwilling to take study medication|2|||
162001149|NCT02656017|585055183|FG001|Overall Study|Unable/unwilling to take study medication|1|||
162001150|NCT02656017|585055182|FG000|Overall Study|Began Tolvaptan|1|||
162001151|NCT02656017|585055183|FG001|Overall Study|Began Tolvaptan|1|||
162001152|NCT02656017|585055182|FG000|Overall Study|Withdrawal by Subject|1|||
162001153|NCT02656017|585055183|FG001|Overall Study|Withdrawal by Subject|0|||
162001154|NCT00474955|585055184|FG000|Overall Study|Adverse Event|2|||
162001155|NCT00474955|585055184|FG000|Overall Study|Drug unavailability|1|||
162001156|NCT00474955|585055184|FG000|Overall Study|Personal reasons|5|||
162001157|NCT02422498|585055185|FG000|Overall Study|Inevaluable|4|||
162001158|NCT02653326|585055186|FG000|Overall Study|Lost to Follow-up|10|||
162001159|NCT02653326|585055187|FG001|Overall Study|Lost to Follow-up|7|||
162001160|NCT01620060|585055189|FG000|Overall Study|Adverse Event|9|||
162001161|NCT01620060|585055189|FG000|Overall Study|Protocol Violation|1|||
162001162|NCT01620060|585055189|FG000|Overall Study|Withdrawal by Subject|1|||
162001163|NCT01620060|585055189|FG000|Overall Study|Did not comply with Study Produre|1|||
162001164|NCT01620060|585055189|FG000|Overall Study|Family emergency|1|||
162001165|NCT01620060|585055189|FG000|Overall Study|Per Sponsor Decision|2|||
162001166|NCT03452540|585055190|FG000|Overall Study|Adverse Event|1|||
162001167|NCT03452540|585055190|FG000|Overall Study|Withdrawal by Subject|1|||
162001168|NCT03452540|585055190|FG000|Overall Study|Other SAE and AE|2|||
162001169|NCT04664153|585055191|FG000|Overall Study|Lack of Efficacy|0|||
162001170|NCT04664153|585055192|FG001|Overall Study|Lack of Efficacy|0|||
162001171|NCT04664153|585055193|FG002|Overall Study|Lack of Efficacy|1|||
162001172|NCT04664153|585055194|FG003|Overall Study|Lack of Efficacy|0|||
162001173|NCT04664153|585055191|FG000|Overall Study|Physician Decision|0|||
162001174|NCT04664153|585055192|FG001|Overall Study|Physician Decision|0|||
162001175|NCT04664153|585055193|FG002|Overall Study|Physician Decision|1|||
162001176|NCT04664153|585055194|FG003|Overall Study|Physician Decision|0|||
162001177|NCT04664153|585055191|FG000|Overall Study|Withdrawal by Subject|3|||
162001178|NCT04664153|585055192|FG001|Overall Study|Withdrawal by Subject|2|||
162001179|NCT04664153|585055193|FG002|Overall Study|Withdrawal by Subject|1|||
162001180|NCT04664153|585055194|FG003|Overall Study|Withdrawal by Subject|2|||
162001181|NCT04664153|585055191|FG000|Overall Study|Other|0|||
162001182|NCT04664153|585055192|FG001|Overall Study|Other|1|||
162001183|NCT04664153|585055193|FG002|Overall Study|Other|0|||
162001184|NCT04664153|585055194|FG003|Overall Study|Other|0|||
162001185|NCT04664153|585055191|FG000|Overall Study|Adverse Event|4|||
162001186|NCT04664153|585055192|FG001|Overall Study|Adverse Event|0|||
162001187|NCT04664153|585055193|FG002|Overall Study|Adverse Event|1|||
162001188|NCT04664153|585055194|FG003|Overall Study|Adverse Event|0|||
162001189|NCT00231777|585055196|FG000|Overall Study|Lost to Follow-up|3|||
162001190|NCT00231777|585055197|FG001|Overall Study|Lost to Follow-up|0|||
162001191|NCT00231777|585055196|FG000|Overall Study|Other|3|||
162001192|NCT00231777|585055197|FG001|Overall Study|Other|2|||
162001193|NCT00524485|585055198|FG000|Overall Study|Withdrawal by Subject|5|||
162001194|NCT01600885|585055201|FG000|First Period|Adverse Event|1|||
162001195|NCT01600885|585055202|FG001|First Period|Adverse Event|1|||
162001196|NCT01600885|585055201|FG000|First Period|moved out of area|1|||
162001197|NCT01600885|585055202|FG001|First Period|moved out of area|0|||
162001198|NCT00642356|585055214|FG000|Overall Study|Adverse Event|1|||
162001199|NCT00642356|585055215|FG001|Overall Study|Adverse Event|0|||
162001200|NCT00642356|585055214|FG000|Overall Study|Protocol Violation|0|||
162001201|NCT00642356|585055215|FG001|Overall Study|Protocol Violation|3|||
162001202|NCT00642356|585055214|FG000|Overall Study|Lack of Efficacy|1|||
162001203|NCT00642356|585055215|FG001|Overall Study|Lack of Efficacy|0|||
162001204|NCT01009060|585055218|FG000|Overall Study|Adverse Event|1|||
162001205|NCT01009060|585055219|FG001|Overall Study|Adverse Event|2|||
162001206|NCT01009060|585055218|FG000|Overall Study|Protocol Violation|0|||
162001207|NCT01009060|585055219|FG001|Overall Study|Protocol Violation|1|||
162001208|NCT01009060|585055218|FG000|Overall Study|Lost to Follow-up|1|||
162001209|NCT01009060|585055219|FG001|Overall Study|Lost to Follow-up|0|||
162001210|NCT01009060|585055218|FG000|Overall Study|Physician Decision|1|||
162001211|NCT01009060|585055219|FG001|Overall Study|Physician Decision|1|||
162001212|NCT01009060|585055218|FG000|Overall Study|Withdrawal by Subject|1|||
162001213|NCT01009060|585055219|FG001|Overall Study|Withdrawal by Subject|1|||
162001214|NCT00005906|585055220|FG000|Overall Study|Lack of Efficacy|3|||
162001215|NCT04551989|585055221|FG000|Overall Study|Adverse Event|4|||
162001216|NCT04551989|585055221|FG000|Overall Study|Protocol Violation|3|||
162001217|NCT04551989|585055221|FG000|Overall Study|Lost to Follow-up|1|||
162001218|NCT04551989|585055221|FG000|Overall Study|Physician Decision|3|||
162001219|NCT04201431|585055222|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
162001220|NCT04201431|585055223|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
162001221|NCT04201431|585055224|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
162001222|NCT00088530|585055229|FG000|Overall Study|Progressive/Relapsed Disease|28|||
162001223|NCT00088530|585055230|FG001|Overall Study|Progressive/Relapsed Disease|39|||
162001224|NCT00088530|585055229|FG000|Overall Study|Adverse Event|15|||
162001225|NCT00088530|585055230|FG001|Overall Study|Adverse Event|9|||
162001226|NCT00088530|585055229|FG000|Overall Study|Withdrawal by Subject|2|||
162001227|NCT00088530|585055230|FG001|Overall Study|Withdrawal by Subject|5|||
162001228|NCT00088530|585055229|FG000|Overall Study|Lost to Follow-up|2|||
162001229|NCT00088530|585055230|FG001|Overall Study|Lost to Follow-up|0|||
162001230|NCT00088530|585055229|FG000|Overall Study|Physician Decision|2|||
162001231|NCT00088530|585055230|FG001|Overall Study|Physician Decision|0|||
162001232|NCT00088530|585055229|FG000|Overall Study|Sponsor decision|0|||
162001233|NCT00088530|585055230|FG001|Overall Study|Sponsor decision|1|||
162001234|NCT00088530|585055229|FG000|Overall Study|Patient never treated|1|||
162001235|NCT00088530|585055230|FG001|Overall Study|Patient never treated|0|||
162001236|NCT00300755|585055231|FG000|Overall Study|Adverse Event|1|||
162001237|NCT00300755|585055232|FG001|Overall Study|Adverse Event|2|||
162001238|NCT00300755|585055233|FG002|Overall Study|Adverse Event|1|||
162001239|NCT00300755|585055231|FG000|Overall Study|Withdrawal by Subject|0|||
162001240|NCT00300755|585055232|FG001|Overall Study|Withdrawal by Subject|2|||
162001241|NCT00300755|585055233|FG002|Overall Study|Withdrawal by Subject|0|||
162001242|NCT00300755|585055231|FG000|Overall Study|Protocol Violation|0|||
162001243|NCT00300755|585055232|FG001|Overall Study|Protocol Violation|0|||
162001244|NCT00300755|585055233|FG002|Overall Study|Protocol Violation|1|||
162001245|NCT04571944|585055234|FG000|Overall Study|Death|1|||
162001246|NCT04571944|585055235|FG001|Overall Study|Death|0|||
162001247|NCT04571944|585055234|FG000|Overall Study|Withdrawal by Subject|3|||
162001248|NCT04571944|585055235|FG001|Overall Study|Withdrawal by Subject|0|||
162001249|NCT04571944|585055234|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
162001250|NCT04571944|585055235|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
162001251|NCT02694744|585055241|FG000|Overall Study|Adverse Event|2|||
162001252|NCT02694744|585055242|FG001|Overall Study|Adverse Event|1|||
162001253|NCT02694744|585055241|FG000|Overall Study|Withdrawal by Subject|2|||
162001254|NCT02694744|585055242|FG001|Overall Study|Withdrawal by Subject|1|||
162001255|NCT02694744|585055241|FG000|Overall Study|Physician Decision|1|||
162001256|NCT02694744|585055242|FG001|Overall Study|Physician Decision|2|||
162001257|NCT02694744|585055241|FG000|Overall Study|Lost to Follow-up|1|||
162042339|NCT04526509|585212010|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
162042340|NCT04526509|585212011|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
162042341|NCT04526509|585212012|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
162042342|NCT04526509|585212013|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
162042343|NCT04526509|585212014|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
162042344|NCT04526509|585212015|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
162042345|NCT04526509|585212009|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
162042346|NCT04526509|585212010|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
162042347|NCT04526509|585212011|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
162042348|NCT04526509|585212012|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
162042349|NCT04526509|585212013|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
162042350|NCT04526509|585212014|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
162042351|NCT04526509|585212015|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
162042352|NCT04526509|585212009|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
162042353|NCT04526509|585212010|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
162042354|NCT04526509|585212011|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
162042355|NCT04526509|585212012|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
162042356|NCT04526509|585212013|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
162042357|NCT04526509|585212014|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
162042358|NCT04526509|585212015|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
162042359|NCT04526509|585212009|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
162042360|NCT04526509|585212010|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162042361|NCT04526509|585212011|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162042362|NCT04526509|585212012|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162042363|NCT04526509|585212013|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162042364|NCT04526509|585212014|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162042365|NCT04526509|585212015|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
162042366|NCT04526509|585212009|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
162042367|NCT04526509|585212010|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
162042368|NCT04526509|585212011|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
162042369|NCT04526509|585212012|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
162042370|NCT04526509|585212013|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
162042371|NCT04526509|585212014|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
162042372|NCT04526509|585212015|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
162042373|NCT04526509|585212009|FG000|Enrolled|Study Terminated by Sponsor|0|||
162042374|NCT04526509|585212010|FG001|Enrolled|Study Terminated by Sponsor|0|||
162042375|NCT04526509|585212011|FG002|Enrolled|Study Terminated by Sponsor|0|||
162042376|NCT04526509|585212012|FG003|Enrolled|Study Terminated by Sponsor|0|||
162042377|NCT04526509|585212013|FG004|Enrolled|Study Terminated by Sponsor|0|||
162042378|NCT04526509|585212014|FG005|Enrolled|Study Terminated by Sponsor|0|||
162042379|NCT04526509|585212015|FG006|Enrolled|Study Terminated by Sponsor|1|||
162042380|NCT04526509|585212009|FG000|Enrolled|Death prior to lymphodepletion|0|||
162042381|NCT04526509|585212010|FG001|Enrolled|Death prior to lymphodepletion|0|||
162042382|NCT04526509|585212011|FG002|Enrolled|Death prior to lymphodepletion|0|||
162042383|NCT04526509|585212012|FG003|Enrolled|Death prior to lymphodepletion|1|||
162042384|NCT04526509|585212013|FG004|Enrolled|Death prior to lymphodepletion|0|||
162042385|NCT04526509|585212014|FG005|Enrolled|Death prior to lymphodepletion|0|||
162042386|NCT04526509|585212015|FG006|Enrolled|Death prior to lymphodepletion|0|||
162042387|NCT04526509|585212009|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162042388|NCT04526509|585212010|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162042389|NCT04526509|585212011|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162042390|NCT04526509|585212012|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
162042391|NCT04526509|585212013|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162042392|NCT04526509|585212014|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162042393|NCT04526509|585212015|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
162042394|NCT04526509|585212009|FG000|Enrolled|Physician Decision|0|||
162042395|NCT04526509|585212010|FG001|Enrolled|Physician Decision|1|||
162042396|NCT04526509|585212011|FG002|Enrolled|Physician Decision|0|||
162042397|NCT04526509|585212012|FG003|Enrolled|Physician Decision|0|||
162042398|NCT04526509|585212013|FG004|Enrolled|Physician Decision|0|||
162042399|NCT04526509|585212014|FG005|Enrolled|Physician Decision|0|||
162042400|NCT04526509|585212015|FG006|Enrolled|Physician Decision|0|||
162042401|NCT01554397|585212016|FG000|Overall Study|Withdrawal by Subject|1|||
162042402|NCT01554397|585212017|FG001|Overall Study|Withdrawal by Subject|0|||
162042403|NCT01554397|585212016|FG000|Overall Study|Ineligible|7|||
162042404|NCT01554397|585212017|FG001|Overall Study|Ineligible|0|||
162042405|NCT04493333|585214037|FG000|Overall Study|Withdrawal by Subject|1|||
162042406|NCT04493333|585214038|FG001|Overall Study|Withdrawal by Subject|1|||
162042407|NCT04493333|585214037|FG000|Overall Study|Ineligible|0|||
162042408|NCT04493333|585214038|FG001|Overall Study|Ineligible|1|||
162042409|NCT04493333|585214037|FG000|Overall Study|Noncompliance|2|||
162042410|NCT04493333|585214038|FG001|Overall Study|Noncompliance|1|||
162042411|NCT02206048|585214044|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
162042412|NCT02925923|585214045|FG000|Overall Study|blood samples hemolyzed|0|||
162042413|NCT02925923|585214046|FG001|Overall Study|blood samples hemolyzed|2|||
162042414|NCT00282412|585214047|FG000|Overall Study|Death|2|||
162042415|NCT02203071|585214050|FG000|Overall Study|Lost to Follow-up|3|||
162042416|NCT02203071|585214051|FG001|Overall Study|Lost to Follow-up|1|||
162001258|NCT02694744|585055242|FG001|Overall Study|Lost to Follow-up|0|||
162001259|NCT02694744|585055241|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
162001260|NCT02694744|585055242|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
162001261|NCT00686777|585055243|FG000|Overall Study|Adverse Event|2|||
162001262|NCT00686777|585055243|FG000|Overall Study|Pregnancy|1|||
162001263|NCT00686777|585055243|FG000|Overall Study|Withdrawal by Subject|2|||
162001264|NCT00686777|585055243|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
162001265|NCT00686777|585055243|FG000|Overall Study|No Visit|1|||
162001266|NCT00667888|585055244|FG000|Overall Study|Death|1|||
162001267|NCT00667888|585055245|FG001|Overall Study|Death|1|||
162001268|NCT00667888|585055244|FG000|Overall Study|Withdrawal by Subject|6|||
162001269|NCT00667888|585055245|FG001|Overall Study|Withdrawal by Subject|3|||
162001270|NCT00667888|585055244|FG000|Overall Study|Proceed with other treatment|3|||
162001271|NCT00667888|585055245|FG001|Overall Study|Proceed with other treatment|3|||
162001272|NCT00667888|585055244|FG000|Overall Study|Ineligible after SIM|0|||
162001273|NCT00667888|585055245|FG001|Overall Study|Ineligible after SIM|2|||
162001274|NCT00883779|585055246|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
162001275|NCT00883779|585055247|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
162001276|NCT00883779|585055246|FG000|Primary Study Treatment Phase|Disease progression|75|||
162001277|NCT00883779|585055247|FG001|Primary Study Treatment Phase|Disease progression|59|||
162001278|NCT00883779|585055246|FG000|Primary Study Treatment Phase|Adverse Event|16|||
162001279|NCT00883779|585055247|FG001|Primary Study Treatment Phase|Adverse Event|16|||
162001280|NCT00883779|585055246|FG000|Primary Study Treatment Phase|Death|2|||
162001281|NCT00883779|585055247|FG001|Primary Study Treatment Phase|Death|3|||
162001282|NCT00883779|585055246|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
162001283|NCT00883779|585055247|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
162001284|NCT00883779|585055246|FG000|Primary Study Treatment Phase|Other|3|||
162001285|NCT00883779|585055247|FG001|Primary Study Treatment Phase|Other|0|||
162001286|NCT00883779|585055246|FG000|Post-Study Treatment Phase|Adverse Event|2|||
162001287|NCT00883779|585055247|FG001|Post-Study Treatment Phase|Adverse Event|3|||
162001288|NCT00883779|585055246|FG000|Post-Study Treatment Phase|Death|1|||
162001289|NCT00883779|585055247|FG001|Post-Study Treatment Phase|Death|3|||
162001290|NCT00883779|585055246|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
162001291|NCT00883779|585055247|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
162001292|NCT00883779|585055246|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
162001293|NCT00883779|585055247|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
162001294|NCT00883779|585055246|FG000|Post-Study Treatment Phase|Disease progression|103|||
162042417|NCT01845818|585214052|FG000|Overall Study|Withdrawal by Subject|0|||
162042418|NCT01845818|585214053|FG001|Overall Study|Withdrawal by Subject|1|||
162042419|NCT01845818|585214052|FG000|Overall Study|Lost to Follow-up|7|||
162042420|NCT01845818|585214053|FG001|Overall Study|Lost to Follow-up|5|||
162042421|NCT01845818|585214052|FG000|Overall Study|Administrative Reasons|3|||
162042422|NCT01845818|585214053|FG001|Overall Study|Administrative Reasons|1|||
162042423|NCT01845818|585214052|FG000|Overall Study|Serious Adverse Event|1|||
162001295|NCT00883779|585055247|FG001|Post-Study Treatment Phase|Disease progression|122|||
162001296|NCT00883779|585055246|FG000|Post-Study Treatment Phase|Other|3|||
162001297|NCT00883779|585055247|FG001|Post-Study Treatment Phase|Other|0|||
162042424|NCT01845818|585214053|FG001|Overall Study|Serious Adverse Event|1|||
162042425|NCT01845818|585214052|FG000|Overall Study|Other|25|||
162042426|NCT01845818|585214053|FG001|Overall Study|Other|8|||
162042427|NCT01845818|585214052|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
162042428|NCT01845818|585214053|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
162042429|NCT01845818|585214052|FG000|Overall Study|No Follow-Up Data Available|4|||
162042430|NCT01845818|585214053|FG001|Overall Study|No Follow-Up Data Available|1|||
162042431|NCT02595970|585214054|FG000|Overall Study|Withdrawal by Subject|2|||
162042432|NCT02595970|585214054|FG000|Overall Study|Physician Decision|2|||
162042433|NCT02595970|585214054|FG000|Overall Study|Protocol Violation|4|||
162042434|NCT02595970|585214054|FG000|Overall Study|Adverse Event|5|||
162042435|NCT02595970|585214054|FG000|Overall Study|Lack of Efficacy|7|||
162042436|NCT02202837|585214055|FG000|Overall Study|Enbrel treatment discontinued|36|||
162042437|NCT02202837|585214056|FG001|Overall Study|Enbrel treatment discontinued|4|||
162042438|NCT02202837|585214055|FG000|Overall Study|Other|10|||
162042439|NCT02202837|585214056|FG001|Overall Study|Other|0|||
162042440|NCT02202837|585214055|FG000|Overall Study|Lost to Follow-up|7|||
162042441|NCT02202837|585214056|FG001|Overall Study|Lost to Follow-up|1|||
162042442|NCT01871142|585214057|FG000|Overall Study|Adverse Event|1|||
162042443|NCT00231842|585214067|FG000|Overall Study|Withdrawal by Subject|3|||
162042444|NCT00231842|585214067|FG000|Overall Study|Did not complete the last 3 cycle|8|||
162042445|NCT02422303|585214068|FG000|Overall Study|Lost to Follow-up|1|||
162042446|NCT02422303|585214069|FG001|Overall Study|Lost to Follow-up|1|||
162042447|NCT00428792|585214071|FG000|Overall Study|Lack of Efficacy|1|||
162042448|NCT00428792|585214072|FG001|Overall Study|Lack of Efficacy|3|||
162042449|NCT00428792|585214071|FG000|Overall Study|Lost to Follow-up|0|||
162042450|NCT00428792|585214072|FG001|Overall Study|Lost to Follow-up|1|||
162042451|NCT00850343|585214073|FG000|Overall Study|Withdrawal by Subject|11|||
162042452|NCT00850343|585214074|FG001|Overall Study|Withdrawal by Subject|0|||
162042453|NCT00850343|585214075|FG002|Overall Study|Withdrawal by Subject|3|||
162042454|NCT00850343|585214076|FG003|Overall Study|Withdrawal by Subject|2|||
162042455|NCT00850343|585214073|FG000|Overall Study|Adverse Event|15|||
162042456|NCT00850343|585214074|FG001|Overall Study|Adverse Event|2|||
162042457|NCT00850343|585214075|FG002|Overall Study|Adverse Event|6|||
162042458|NCT00850343|585214076|FG003|Overall Study|Adverse Event|6|||
162042459|NCT00850343|585214073|FG000|Overall Study|Pregnancy|0|||
162042460|NCT00850343|585214074|FG001|Overall Study|Pregnancy|0|||
162042461|NCT00850343|585214075|FG002|Overall Study|Pregnancy|0|||
162042462|NCT00850343|585214076|FG003|Overall Study|Pregnancy|1|||
162042463|NCT00850343|585214073|FG000|Overall Study|Lack of Efficacy|17|||
162042464|NCT00850343|585214074|FG001|Overall Study|Lack of Efficacy|0|||
162042465|NCT00850343|585214075|FG002|Overall Study|Lack of Efficacy|3|||
162042466|NCT00850343|585214076|FG003|Overall Study|Lack of Efficacy|2|||
162042467|NCT00850343|585214073|FG000|Overall Study|Non-compliance with Study Procedures|1|||
162042468|NCT00850343|585214074|FG001|Overall Study|Non-compliance with Study Procedures|0|||
162042469|NCT00850343|585214075|FG002|Overall Study|Non-compliance with Study Procedures|1|||
162042470|NCT00850343|585214076|FG003|Overall Study|Non-compliance with Study Procedures|1|||
162042471|NCT00850343|585214073|FG000|Overall Study|Physician Decision|2|||
162042472|NCT00850343|585214074|FG001|Overall Study|Physician Decision|1|||
162042473|NCT00850343|585214075|FG002|Overall Study|Physician Decision|1|||
162042474|NCT00850343|585214076|FG003|Overall Study|Physician Decision|1|||
162001298|NCT00883779|585055246|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
162001299|NCT00883779|585055247|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
162001300|NCT00883779|585055246|FG000|Off-study Phase|Death|185|||
162001301|NCT00883779|585055247|FG001|Off-study Phase|Death|174|||
162001302|NCT00883779|585055246|FG000|Off-study Phase|Refused treatment|1|||
162001303|NCT00883779|585055247|FG001|Off-study Phase|Refused treatment|1|||
162001304|NCT00883779|585055246|FG000|Off-study Phase|Failure to return|5|||
162001305|NCT00883779|585055247|FG001|Off-study Phase|Failure to return|6|||
162001306|NCT00883779|585055246|FG000|Off-study Phase|Other|18|||
162001307|NCT00883779|585055247|FG001|Off-study Phase|Other|21|||
162001308|NCT00499681|585055248|FG000|Overall Study|toxicity|0|||
162001309|NCT00499681|585055249|FG001|Overall Study|toxicity|1|||
162001310|NCT00499681|585055248|FG000|Overall Study|disease progression|0|||
162001311|NCT00499681|585055249|FG001|Overall Study|disease progression|1|||
162042475|NCT00639678|585214077|FG000|Overall Study|Withdrawal by Subject|3|||
162042476|NCT00639678|585214078|FG001|Overall Study|Withdrawal by Subject|0|||
162042477|NCT00639678|585214079|FG002|Overall Study|Withdrawal by Subject|4|||
162042478|NCT00639678|585214080|FG003|Overall Study|Withdrawal by Subject|0|||
162042479|NCT00639678|585214077|FG000|Overall Study|Lost to Follow-up|1|||
162042480|NCT00639678|585214078|FG001|Overall Study|Lost to Follow-up|0|||
162042481|NCT00639678|585214079|FG002|Overall Study|Lost to Follow-up|6|||
162042482|NCT00639678|585214080|FG003|Overall Study|Lost to Follow-up|0|||
162042483|NCT00639678|585214077|FG000|Overall Study|Adverse Event|0|||
162042484|NCT00639678|585214078|FG001|Overall Study|Adverse Event|1|||
162042485|NCT00639678|585214079|FG002|Overall Study|Adverse Event|0|||
162042486|NCT00639678|585214080|FG003|Overall Study|Adverse Event|0|||
162001312|NCT00739401|585055250|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
162001313|NCT00739401|585055250|FG000|Overall Study|Death|3|||
162042487|NCT00639678|585214077|FG000|Overall Study|Lack of Compliance|0|||
162042488|NCT00639678|585214078|FG001|Overall Study|Lack of Compliance|0|||
162042489|NCT00639678|585214079|FG002|Overall Study|Lack of Compliance|1|||
162042490|NCT00639678|585214080|FG003|Overall Study|Lack of Compliance|0|||
162042491|NCT02468232|585214081|FG000|Core Part of Study|Adverse Event|0|||
162042492|NCT02468232|585214082|FG001|Core Part of Study|Adverse Event|1|||
162042493|NCT02468232|585214083|FG002|Core Part of Study|Adverse Event|0|||
162042494|NCT02468232|585214084|FG003|Core Part of Study|Adverse Event|0|||
162042495|NCT02468232|585214081|FG000|Core Part of Study|Death|20|||
162042496|NCT02468232|585214082|FG001|Core Part of Study|Death|17|||
162042497|NCT02468232|585214083|FG002|Core Part of Study|Death|0|||
162042498|NCT02468232|585214084|FG003|Core Part of Study|Death|0|||
162042499|NCT02468232|585214081|FG000|Core Part of Study|Technical Problems|1|||
162042500|NCT02468232|585214082|FG001|Core Part of Study|Technical Problems|1|||
162042501|NCT02468232|585214083|FG002|Core Part of Study|Technical Problems|0|||
162042502|NCT02468232|585214084|FG003|Core Part of Study|Technical Problems|0|||
162042503|NCT02468232|585214081|FG000|OLE Part of Study|Adverse Event|0|||
162042504|NCT02468232|585214082|FG001|OLE Part of Study|Adverse Event|0|||
162042505|NCT02468232|585214083|FG002|OLE Part of Study|Adverse Event|4|||
162042506|NCT02468232|585214084|FG003|OLE Part of Study|Adverse Event|5|||
162042507|NCT02468232|585214081|FG000|OLE Part of Study|Death|0|||
162042508|NCT02468232|585214082|FG001|OLE Part of Study|Death|0|||
162042509|NCT02468232|585214083|FG002|OLE Part of Study|Death|4|||
162042510|NCT02468232|585214084|FG003|OLE Part of Study|Death|2|||
162042511|NCT02468232|585214081|FG000|OLE Part of Study|Physician Decision|0|||
162042512|NCT02468232|585214082|FG001|OLE Part of Study|Physician Decision|0|||
162042513|NCT02468232|585214083|FG002|OLE Part of Study|Physician Decision|4|||
162042514|NCT02468232|585214084|FG003|OLE Part of Study|Physician Decision|0|||
162042515|NCT02468232|585214081|FG000|OLE Part of Study|Subject/Guardian decision|0|||
162042516|NCT02468232|585214082|FG001|OLE Part of Study|Subject/Guardian decision|0|||
162042517|NCT02468232|585214083|FG002|OLE Part of Study|Subject/Guardian decision|2|||
162042518|NCT02468232|585214084|FG003|OLE Part of Study|Subject/Guardian decision|5|||
162042519|NCT01973569|585214085|FG000|Overall Study|Adverse Event|9|||
162042520|NCT01973569|585214086|FG001|Overall Study|Adverse Event|2|||
162042521|NCT01973569|585214087|FG002|Overall Study|Adverse Event|4|||
162042522|NCT01973569|585214085|FG000|Overall Study|Protocol Violation|2|||
162042523|NCT01973569|585214086|FG001|Overall Study|Protocol Violation|1|||
162042524|NCT01973569|585214087|FG002|Overall Study|Protocol Violation|3|||
162042525|NCT01973569|585214085|FG000|Overall Study|Withdrawal by Subject|7|||
162042526|NCT01973569|585214086|FG001|Overall Study|Withdrawal by Subject|5|||
162042527|NCT01973569|585214087|FG002|Overall Study|Withdrawal by Subject|2|||
162042528|NCT01973569|585214085|FG000|Overall Study|Invasive dental treatment|3|||
162042529|NCT01973569|585214086|FG001|Overall Study|Invasive dental treatment|5|||
162042530|NCT01973569|585214087|FG002|Overall Study|Invasive dental treatment|6|||
162042531|NCT01973569|585214085|FG000|Overall Study|Prohibited concomitant d|1|||
162042532|NCT01973569|585214086|FG001|Overall Study|Prohibited concomitant d|5|||
162042533|NCT01973569|585214087|FG002|Overall Study|Prohibited concomitant d|0|||
162042534|NCT01973569|585214085|FG000|Overall Study|Disease progression|0|||
162042535|NCT01973569|585214086|FG001|Overall Study|Disease progression|3|||
162042536|NCT01973569|585214087|FG002|Overall Study|Disease progression|0|||
162042537|NCT01973569|585214085|FG000|Overall Study|Other|1|||
162042538|NCT01973569|585214086|FG001|Overall Study|Other|1|||
162042539|NCT01973569|585214087|FG002|Overall Study|Other|0|||
162042540|NCT01973569|585214085|FG000|Overall Study|Did not receive study drug|6|||
162042541|NCT01973569|585214086|FG001|Overall Study|Did not receive study drug|3|||
162042542|NCT01973569|585214087|FG002|Overall Study|Did not receive study drug|3|||
162042543|NCT00371826|585214088|FG000|Core Phase (12 Months)|Adverse Event|15|||
162042544|NCT00371826|585214089|FG001|Core Phase (12 Months)|Adverse Event|4|||
162042545|NCT00371826|585214090|FG002|Core Phase (12 Months)|Adverse Event|9|||
162042546|NCT00371826|585214088|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
162042547|NCT00371826|585214089|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
162042548|NCT00371826|585214090|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
162042549|NCT00371826|585214088|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
162042550|NCT00371826|585214089|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
162042551|NCT00371826|585214090|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
162042552|NCT00371826|585214088|FG000|Core Phase (12 Months)|Protocol Violation|1|||
162042553|NCT00371826|585214089|FG001|Core Phase (12 Months)|Protocol Violation|0|||
162042554|NCT00371826|585214090|FG002|Core Phase (12 Months)|Protocol Violation|1|||
162042555|NCT00371826|585214088|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
162042556|NCT00371826|585214089|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
162042557|NCT00371826|585214090|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
162042558|NCT00371826|585214088|FG000|Core Phase (12 Months)|Administrative problems|1|||
162042559|NCT00371826|585214089|FG001|Core Phase (12 Months)|Administrative problems|0|||
162042560|NCT00371826|585214090|FG002|Core Phase (12 Months)|Administrative problems|8|||
162042561|NCT00371826|585214088|FG000|Core Phase (12 Months)|Graft Loss|0|||
162042562|NCT00371826|585214089|FG001|Core Phase (12 Months)|Graft Loss|1|||
162042563|NCT00371826|585214090|FG002|Core Phase (12 Months)|Graft Loss|0|||
162001314|NCT00739401|585055250|FG000|Overall Study|Withdrawal by Subject|4|||
162001315|NCT04575155|585055251|FG000|2 Month|Withdrawal by Subject|1|||
162001316|NCT04575155|585055252|FG001|2 Month|Withdrawal by Subject|1|||
162001317|NCT04575155|585055251|FG000|2 Month|Lost to Follow-up|5|||
162001318|NCT04575155|585055252|FG001|2 Month|Lost to Follow-up|3|||
162001319|NCT04575155|585055251|FG000|2 Month|Ineligible|1|||
162001320|NCT04575155|585055252|FG001|2 Month|Ineligible|0|||
162001321|NCT01239381|585055254|FG000|Overall Study|Protocol Violation|1|||
162001322|NCT01239381|585055254|FG000|Overall Study|Withdrawal by Subject|1|||
162001323|NCT03748823|585055255|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
162001324|NCT03748823|585055256|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
162001325|NCT03748823|585055255|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
162001326|NCT03748823|585055256|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
162001327|NCT03748823|585055255|FG000|Extension Period|Withdrawal by Subject|9|||
162001328|NCT03748823|585055256|FG001|Extension Period|Withdrawal by Subject|12|||
162001329|NCT03748823|585055255|FG000|Extension Period|Death|2|||
162001330|NCT03748823|585055256|FG001|Extension Period|Death|2|||
162001331|NCT03748823|585055255|FG000|Extension Period|Other than Specified|0|||
162001332|NCT03748823|585055256|FG001|Extension Period|Other than Specified|1|||
162001333|NCT03748823|585055255|FG000|Extension Period|Protocol Violation|1|||
162001334|NCT03748823|585055256|FG001|Extension Period|Protocol Violation|0|||
162001335|NCT03748823|585055255|FG000|Extension Period|Lost to Follow-up|0|||
162001336|NCT03748823|585055256|FG001|Extension Period|Lost to Follow-up|1|||
162001337|NCT03748823|585055255|FG000|Extension Period|Lack of Efficacy|0|||
162001338|NCT03748823|585055256|FG001|Extension Period|Lack of Efficacy|1|||
162001339|NCT03748823|585055255|FG000|Extension Period|Physician Decision|1|||
162001340|NCT03748823|585055256|FG001|Extension Period|Physician Decision|2|||
162001341|NCT01363700|585055257|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
162001342|NCT01363700|585055258|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
162001343|NCT01363700|585055259|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
162001344|NCT01363700|585055260|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
162001345|NCT01363700|585055261|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
162001346|NCT02920892|585055262|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
162001347|NCT02920892|585055263|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
162001348|NCT02920892|585055264|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
162001349|NCT02920892|585055262|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
162001350|NCT02920892|585055263|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
162001351|NCT02920892|585055264|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
162001352|NCT02920892|585055262|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
162001353|NCT02920892|585055263|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
162001354|NCT02920892|585055264|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
162001355|NCT02920892|585055262|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
162001356|NCT02920892|585055263|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
162001357|NCT02920892|585055264|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
162001358|NCT02920892|585055262|FG000|Placebo-Controlled Period|Physician Decision|0|||
162001359|NCT02920892|585055263|FG001|Placebo-Controlled Period|Physician Decision|0|||
162001360|NCT02920892|585055264|FG002|Placebo-Controlled Period|Physician Decision|1|||
162001361|NCT02920892|585055262|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
162001362|NCT02920892|585055263|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
162001363|NCT02920892|585055264|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
162001364|NCT02920892|585055262|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
162001365|NCT02920892|585055263|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
162001366|NCT02920892|585055264|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
162001367|NCT02920892|585055262|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
162001368|NCT02920892|585055263|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
162001369|NCT02920892|585055264|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
162001370|NCT03649217|585055265|FG000|Overall Study|subject had severe ataxia not initially found|1|||
162001371|NCT03649217|585055265|FG000|Overall Study|subject had cognitive issues not initially found|1|||
162001372|NCT01721161|585055266|FG000|Overall Study|Adverse Event|2|||
162001373|NCT01721161|585055267|FG001|Overall Study|Adverse Event|3|||
162001374|NCT01721161|585055266|FG000|Overall Study|Lost to Follow-up|1|||
162001375|NCT01721161|585055267|FG001|Overall Study|Lost to Follow-up|2|||
162001376|NCT01721161|585055266|FG000|Overall Study|Withdrawal by Subject|1|||
162001377|NCT01721161|585055267|FG001|Overall Study|Withdrawal by Subject|1|||
162001378|NCT01721161|585055266|FG000|Overall Study|Other|0|||
162001379|NCT01721161|585055267|FG001|Overall Study|Other|1|||
162001380|NCT01216202|585055268|FG000|Overall Study|Withdrawal by Subject|8|||
162001381|NCT01216202|585055269|FG001|Overall Study|Withdrawal by Subject|0|||
162001382|NCT01216202|585055268|FG000|Overall Study|Death|0|||
162001383|NCT01216202|585055269|FG001|Overall Study|Death|2|||
162001384|NCT01216202|585055268|FG000|Overall Study|Lost to Follow-up|14|||
162001385|NCT01216202|585055269|FG001|Overall Study|Lost to Follow-up|0|||
162001386|NCT00614380|585055272|FG000|Overall Study|Adverse Event|14|||
162001387|NCT00614380|585055273|FG001|Overall Study|Adverse Event|4|||
162001388|NCT00614380|585055274|FG002|Overall Study|Adverse Event|0|||
162001389|NCT00614380|585055275|FG003|Overall Study|Adverse Event|0|||
162001390|NCT00614380|585055272|FG000|Overall Study|Lost to Follow-up|6|||
162001391|NCT00614380|585055273|FG001|Overall Study|Lost to Follow-up|1|||
162001392|NCT00614380|585055274|FG002|Overall Study|Lost to Follow-up|0|||
162001393|NCT00614380|585055275|FG003|Overall Study|Lost to Follow-up|0|||
162001394|NCT00614380|585055272|FG000|Overall Study|Non compliant with the protocol|12|||
162001395|NCT00614380|585055273|FG001|Overall Study|Non compliant with the protocol|2|||
162001396|NCT00614380|585055274|FG002|Overall Study|Non compliant with the protocol|1|||
162001397|NCT00614380|585055275|FG003|Overall Study|Non compliant with the protocol|2|||
162001398|NCT00614380|585055272|FG000|Overall Study|Consent withdrawn|3|||
162001399|NCT00614380|585055273|FG001|Overall Study|Consent withdrawn|1|||
162001400|NCT00614380|585055274|FG002|Overall Study|Consent withdrawn|0|||
162001401|NCT00614380|585055275|FG003|Overall Study|Consent withdrawn|0|||
162001402|NCT04908397|585055278|FG000|Overall Study|Withdrawal by Subject|2|||
162001403|NCT00462306|585055279|FG000|Overall Study|insufficient data|0|||
162001404|NCT00462306|585055280|FG001|Overall Study|insufficient data|13|||
162001405|NCT00191334|585055286|FG000|Overall Study|Adverse Event|4|||
162001406|NCT00191334|585055286|FG000|Overall Study|Disease Progression or Relapse|8|||
162001407|NCT00191334|585055286|FG000|Overall Study|Physician Decision|1|||
162001408|NCT00191334|585055286|FG000|Overall Study|Withdrawal by Subject|4|||
162001409|NCT01063153|585055287|FG000|Overall Study|Found Ineligible During Screening|2|||
162001410|NCT01063153|585055288|FG001|Overall Study|Found Ineligible During Screening|0|||
162001411|NCT01063153|585055287|FG000|Overall Study|Lost to Follow-up|0|||
162001412|NCT01063153|585055288|FG001|Overall Study|Lost to Follow-up|7|||
162001413|NCT01063153|585055287|FG000|Overall Study|Withdrawal by Subject|0|||
162001414|NCT01063153|585055288|FG001|Overall Study|Withdrawal by Subject|1|||
162001415|NCT01063153|585055287|FG000|Overall Study|Physician Decision|0|||
162001416|NCT01063153|585055288|FG001|Overall Study|Physician Decision|4|||
162001417|NCT02426580|585056601|FG000|Overall Study|Death|2|||
162001418|NCT02426580|585056602|FG001|Overall Study|Death|2|||
162001419|NCT02426580|585056601|FG000|Overall Study|Lost to Follow-up|0|||
162001420|NCT02426580|585056602|FG001|Overall Study|Lost to Follow-up|9|||
162001421|NCT02426580|585056601|FG000|Overall Study|transfer to hemodialysis|5|||
162001422|NCT02426580|585056602|FG001|Overall Study|transfer to hemodialysis|5|||
162001423|NCT02426580|585056601|FG000|Overall Study|Kidney transplant|3|||
162001424|NCT02426580|585056602|FG001|Overall Study|Kidney transplant|0|||
162001425|NCT02426580|585056601|FG000|Overall Study|Allergic to egg white|1|||
162001426|NCT02426580|585056602|FG001|Overall Study|Allergic to egg white|0|||
162001427|NCT01381016|585056604|FG000|Overall Study|Lost to Follow-up|1|||
162001428|NCT01381016|585056605|FG001|Overall Study|Lost to Follow-up|1|||
162001429|NCT01381016|585056604|FG000|Overall Study|Screen Failure|2|||
162001430|NCT01381016|585056605|FG001|Overall Study|Screen Failure|2|||
162001431|NCT01381016|585056604|FG000|Overall Study|Withdrawal by Subject|0|||
162001432|NCT01381016|585056605|FG001|Overall Study|Withdrawal by Subject|1|||
162001433|NCT01381016|585056604|FG000|Overall Study|Physician Decision|0|||
162001434|NCT01381016|585056605|FG001|Overall Study|Physician Decision|2|||
162001435|NCT03598036|585056611|FG000|Overall Study|Withdrawal by Subject|1|||
162001436|NCT03598036|585056612|FG001|Overall Study|Withdrawal by Subject|0|||
162001437|NCT05801991|585056613|FG000|Overall Study|Lost to Follow-up|1|||
162001438|NCT05801991|585056614|FG001|Overall Study|Lost to Follow-up|0|||
162001439|NCT01838694|585056615|FG000|Overall Study|Adverse Event|0|||
162001440|NCT01838694|585056616|FG001|Overall Study|Adverse Event|1|||
162001441|NCT04235140|585056617|FG000|Overall Study|Adverse Event|2|||
162001442|NCT04235140|585056617|FG000|Overall Study|Lost to Follow-up|1|||
162001443|NCT04235140|585056617|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
162001444|NCT04235140|585056617|FG000|Overall Study|Commercial drug is available for participants|7|||
162001445|NCT01451723|585056619|FG000|Overall Study|study halted|6|||
162001446|NCT01451723|585056620|FG001|Overall Study|study halted|5|||
162001447|NCT02210000|585056621|FG000|Overall Study|Study Terminated|11|||
162001448|NCT02210000|585056622|FG001|Overall Study|Study Terminated|12|||
162001449|NCT02210000|585056621|FG000|Overall Study|Withdrawal by Subject|7|||
162001450|NCT02210000|585056622|FG001|Overall Study|Withdrawal by Subject|1|||
162001451|NCT02210000|585056621|FG000|Overall Study|Adverse Event|1|||
162001452|NCT02210000|585056622|FG001|Overall Study|Adverse Event|5|||
162001453|NCT02210000|585056621|FG000|Overall Study|Lost to Follow-up|0|||
162001454|NCT02210000|585056622|FG001|Overall Study|Lost to Follow-up|2|||
162001455|NCT02210000|585056621|FG000|Overall Study|Physician Decision|0|||
162001456|NCT02210000|585056622|FG001|Overall Study|Physician Decision|1|||
162001457|NCT00833040|585056623|FG000|Overall Study|Adverse Event|0|||
162001458|NCT00833040|585056624|FG001|Overall Study|Adverse Event|0|||
162001459|NCT00833040|585056625|FG002|Overall Study|Adverse Event|0|||
162001460|NCT00833040|585056626|FG003|Overall Study|Adverse Event|0|||
162001461|NCT00833040|585056627|FG004|Overall Study|Adverse Event|0|||
162001462|NCT00833040|585056628|FG005|Overall Study|Adverse Event|1|||
162001463|NCT00962208|585056633|FG000|Overall Study|Could not achieve good vision|9|||
162001464|NCT00962208|585056634|FG001|Overall Study|Could not achieve good vision|0|||
162001465|NCT00962208|585056633|FG000|Overall Study|Contraindicated to continue study|5|||
162001466|NCT00962208|585056634|FG001|Overall Study|Contraindicated to continue study|1|||
162001467|NCT00962208|585056633|FG000|Overall Study|Lost to Follow-up|0|||
162001468|NCT00962208|585056634|FG001|Overall Study|Lost to Follow-up|9|||
162001469|NCT01731912|585056635|FG000|Overall Study|noncompliance|2|||
162001470|NCT02043938|585056636|FG000|Overall Study|Withdrawal by Subject|7|||
162001471|NCT02043938|585056636|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
162001472|NCT02043938|585056636|FG000|Overall Study|No show by subject|1|||
162001473|NCT02043938|585056636|FG000|Overall Study|Investigator decision|1|||
162001474|NCT00443040|585056639|FG000|Overall Study|Withdrawal by Subject|1|||
162001475|NCT00443040|585056640|FG001|Overall Study|Withdrawal by Subject|0|||
162001476|NCT00443040|585056641|FG002|Overall Study|Withdrawal by Subject|0|||
162001477|NCT00443040|585056639|FG000|Overall Study|Converted to an open laparotomy|3|||
162001478|NCT00443040|585056640|FG001|Overall Study|Converted to an open laparotomy|0|||
162001479|NCT00443040|585056641|FG002|Overall Study|Converted to an open laparotomy|1|||
162001480|NCT02349633|585056645|FG000|Overall Study|Death|0|||
162001481|NCT02349633|585056646|FG001|Overall Study|Death|1|||
162001482|NCT02349633|585056647|FG002|Overall Study|Death|0|||
162001483|NCT02349633|585056648|FG003|Overall Study|Death|0|||
162001484|NCT02349633|585056649|FG004|Overall Study|Death|0|||
162001485|NCT02349633|585056650|FG005|Overall Study|Death|1|||
162001486|NCT02349633|585056651|FG006|Overall Study|Death|1|||
162001487|NCT02349633|585056652|FG007|Overall Study|Death|1|||
162001488|NCT02349633|585056653|FG008|Overall Study|Death|0|||
162001489|NCT02349633|585056654|FG009|Overall Study|Death|1|||
162001490|NCT02349633|585056655|FG010|Overall Study|Death|0|||
162001491|NCT02349633|585056656|FG011|Overall Study|Death|0|||
162001492|NCT02349633|585056657|FG012|Overall Study|Death|0|||
162001493|NCT02349633|585056658|FG013|Overall Study|Death|0|||
162001494|NCT02349633|585056645|FG000|Overall Study|Withdrawal by Subject|0|||
162001495|NCT02349633|585056646|FG001|Overall Study|Withdrawal by Subject|0|||
162001496|NCT02349633|585056647|FG002|Overall Study|Withdrawal by Subject|0|||
162001497|NCT02349633|585056648|FG003|Overall Study|Withdrawal by Subject|1|||
162001498|NCT02349633|585056649|FG004|Overall Study|Withdrawal by Subject|0|||
162001499|NCT02349633|585056650|FG005|Overall Study|Withdrawal by Subject|0|||
162001500|NCT02349633|585056651|FG006|Overall Study|Withdrawal by Subject|0|||
162001501|NCT02349633|585056652|FG007|Overall Study|Withdrawal by Subject|2|||
162001502|NCT02349633|585056653|FG008|Overall Study|Withdrawal by Subject|2|||
162001503|NCT02349633|585056654|FG009|Overall Study|Withdrawal by Subject|1|||
162001504|NCT02349633|585056655|FG010|Overall Study|Withdrawal by Subject|0|||
162001505|NCT02349633|585056656|FG011|Overall Study|Withdrawal by Subject|0|||
162001506|NCT02349633|585056657|FG012|Overall Study|Withdrawal by Subject|0|||
162001507|NCT02349633|585056658|FG013|Overall Study|Withdrawal by Subject|0|||
162001508|NCT02349633|585056645|FG000|Overall Study|Withdrawal of informed consent|0|||
162001509|NCT02349633|585056646|FG001|Overall Study|Withdrawal of informed consent|0|||
162001510|NCT02349633|585056647|FG002|Overall Study|Withdrawal of informed consent|0|||
162001511|NCT02349633|585056648|FG003|Overall Study|Withdrawal of informed consent|1|||
162001512|NCT02349633|585056649|FG004|Overall Study|Withdrawal of informed consent|1|||
162001513|NCT02349633|585056650|FG005|Overall Study|Withdrawal of informed consent|0|||
162001514|NCT02349633|585056651|FG006|Overall Study|Withdrawal of informed consent|0|||
162001515|NCT02349633|585056652|FG007|Overall Study|Withdrawal of informed consent|3|||
162001516|NCT02349633|585056653|FG008|Overall Study|Withdrawal of informed consent|0|||
162001517|NCT02349633|585056654|FG009|Overall Study|Withdrawal of informed consent|0|||
162001518|NCT02349633|585056655|FG010|Overall Study|Withdrawal of informed consent|0|||
162001519|NCT02349633|585056656|FG011|Overall Study|Withdrawal of informed consent|0|||
162001520|NCT02349633|585056657|FG012|Overall Study|Withdrawal of informed consent|0|||
162001521|NCT02349633|585056658|FG013|Overall Study|Withdrawal of informed consent|0|||
162001522|NCT02349633|585056645|FG000|Overall Study|Transition to compassionate use|0|||
162001523|NCT02349633|585056646|FG001|Overall Study|Transition to compassionate use|0|||
162001524|NCT02349633|585056647|FG002|Overall Study|Transition to compassionate use|0|||
162001525|NCT02349633|585056648|FG003|Overall Study|Transition to compassionate use|0|||
162001526|NCT02349633|585056649|FG004|Overall Study|Transition to compassionate use|1|||
162001527|NCT02349633|585056650|FG005|Overall Study|Transition to compassionate use|0|||
162001528|NCT02349633|585056651|FG006|Overall Study|Transition to compassionate use|0|||
162001529|NCT02349633|585056652|FG007|Overall Study|Transition to compassionate use|3|||
162001530|NCT02349633|585056653|FG008|Overall Study|Transition to compassionate use|0|||
162001531|NCT02349633|585056654|FG009|Overall Study|Transition to compassionate use|1|||
162001532|NCT02349633|585056655|FG010|Overall Study|Transition to compassionate use|0|||
162001533|NCT02349633|585056656|FG011|Overall Study|Transition to compassionate use|0|||
162001534|NCT02349633|585056657|FG012|Overall Study|Transition to compassionate use|0|||
162001535|NCT02349633|585056658|FG013|Overall Study|Transition to compassionate use|0|||
162001536|NCT02349633|585056645|FG000|Overall Study|Early termination of survival follow-up|0|||
162001537|NCT02349633|585056646|FG001|Overall Study|Early termination of survival follow-up|0|||
162001538|NCT02349633|585056647|FG002|Overall Study|Early termination of survival follow-up|0|||
162001539|NCT02349633|585056648|FG003|Overall Study|Early termination of survival follow-up|0|||
162001540|NCT02349633|585056649|FG004|Overall Study|Early termination of survival follow-up|0|||
162001541|NCT02349633|585056650|FG005|Overall Study|Early termination of survival follow-up|0|||
162001542|NCT02349633|585056651|FG006|Overall Study|Early termination of survival follow-up|0|||
162001543|NCT02349633|585056652|FG007|Overall Study|Early termination of survival follow-up|4|||
162001544|NCT02349633|585056653|FG008|Overall Study|Early termination of survival follow-up|0|||
162001545|NCT02349633|585056654|FG009|Overall Study|Early termination of survival follow-up|0|||
162001546|NCT02349633|585056655|FG010|Overall Study|Early termination of survival follow-up|0|||
162001547|NCT02349633|585056656|FG011|Overall Study|Early termination of survival follow-up|0|||
162001548|NCT02349633|585056657|FG012|Overall Study|Early termination of survival follow-up|0|||
162001549|NCT02349633|585056658|FG013|Overall Study|Early termination of survival follow-up|0|||
162001550|NCT02349633|585056645|FG000|Overall Study|Termination by sponsor|0|||
162001551|NCT02349633|585056646|FG001|Overall Study|Termination by sponsor|0|||
162001552|NCT02349633|585056647|FG002|Overall Study|Termination by sponsor|0|||
162001553|NCT02349633|585056648|FG003|Overall Study|Termination by sponsor|0|||
162001554|NCT02349633|585056649|FG004|Overall Study|Termination by sponsor|0|||
162001555|NCT02349633|585056650|FG005|Overall Study|Termination by sponsor|0|||
162001556|NCT02349633|585056651|FG006|Overall Study|Termination by sponsor|0|||
162001557|NCT02349633|585056652|FG007|Overall Study|Termination by sponsor|1|||
162001558|NCT02349633|585056653|FG008|Overall Study|Termination by sponsor|0|||
162001559|NCT02349633|585056654|FG009|Overall Study|Termination by sponsor|2|||
162001560|NCT02349633|585056655|FG010|Overall Study|Termination by sponsor|0|||
162001561|NCT02349633|585056656|FG011|Overall Study|Termination by sponsor|0|||
162001562|NCT02349633|585056657|FG012|Overall Study|Termination by sponsor|0|||
162001563|NCT02349633|585056658|FG013|Overall Study|Termination by sponsor|0|||
162001564|NCT02349633|585056645|FG000|Overall Study|Other|0|||
162001565|NCT02349633|585056646|FG001|Overall Study|Other|0|||
162001566|NCT02349633|585056647|FG002|Overall Study|Other|0|||
162001567|NCT02349633|585056648|FG003|Overall Study|Other|0|||
162001568|NCT02349633|585056649|FG004|Overall Study|Other|0|||
162001569|NCT02349633|585056650|FG005|Overall Study|Other|0|||
162001570|NCT02349633|585056651|FG006|Overall Study|Other|0|||
162001571|NCT02349633|585056652|FG007|Overall Study|Other|2|||
162001572|NCT02349633|585056653|FG008|Overall Study|Other|0|||
162001573|NCT02349633|585056654|FG009|Overall Study|Other|0|||
162001574|NCT02349633|585056655|FG010|Overall Study|Other|0|||
162001575|NCT02349633|585056656|FG011|Overall Study|Other|0|||
162001576|NCT02349633|585056657|FG012|Overall Study|Other|0|||
162001577|NCT02349633|585056658|FG013|Overall Study|Other|0|||
162001578|NCT00667628|585056659|FG000|Overall Study|Lost to Follow-up|1|||
162001579|NCT00667628|585056660|FG001|Overall Study|Lost to Follow-up|0|||
162001580|NCT00667628|585056659|FG000|Overall Study|Death|6|||
162001581|NCT00667628|585056660|FG001|Overall Study|Death|6|||
162001582|NCT00667628|585056659|FG000|Overall Study|Investigator Considers in Best Interest|1|||
162001583|NCT00667628|585056660|FG001|Overall Study|Investigator Considers in Best Interest|0|||
162001584|NCT00667628|585056659|FG000|Overall Study|Sponsor Terminated Study|17|||
162001585|NCT00667628|585056660|FG001|Overall Study|Sponsor Terminated Study|21|||
162001586|NCT05789745|585056661|FG000|Overall Study|Withdrawal by Subject|0|||
162001587|NCT05789745|585056662|FG001|Overall Study|Withdrawal by Subject|0|||
162001588|NCT05789745|585056663|FG002|Overall Study|Withdrawal by Subject|0|||
162001589|NCT05789745|585056664|FG003|Overall Study|Withdrawal by Subject|0|||
162001590|NCT05789745|585056665|FG004|Overall Study|Withdrawal by Subject|1|||
162001591|NCT04663321|585056666|FG000|Overall Study|Study terminated by Sponsor|2|||
162001592|NCT04663321|585056667|FG001|Overall Study|Study terminated by Sponsor|1|||
162001593|NCT04663321|585056668|FG002|Overall Study|Study terminated by Sponsor|2|||
162001594|NCT04663321|585056666|FG000|Overall Study|Withdrawal by Subject|10|||
162001595|NCT04663321|585056667|FG001|Overall Study|Withdrawal by Subject|3|||
162001596|NCT04663321|585056668|FG002|Overall Study|Withdrawal by Subject|2|||
162001597|NCT04663321|585056666|FG000|Overall Study|Not provided|0|||
162001598|NCT04663321|585056667|FG001|Overall Study|Not provided|0|||
162001599|NCT04663321|585056668|FG002|Overall Study|Not provided|1|||
162001600|NCT00622505|585056671|FG000|Overall Study|Adverse Event|9|||
162001601|NCT00622505|585056672|FG001|Overall Study|Adverse Event|7|||
162001602|NCT00622505|585056671|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
162001603|NCT00622505|585056672|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
162001604|NCT00622505|585056671|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
162001605|NCT00622505|585056672|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
162001606|NCT00622505|585056671|FG000|Overall Study|Withdrawal by Subject|12|||
162001607|NCT00622505|585056672|FG001|Overall Study|Withdrawal by Subject|5|||
162001608|NCT00622505|585056671|FG000|Overall Study|Administrative Problems|2|||
162001609|NCT00622505|585056672|FG001|Overall Study|Administrative Problems|4|||
162001610|NCT00622505|585056671|FG000|Overall Study|Death|2|||
162001611|NCT00622505|585056672|FG001|Overall Study|Death|2|||
162001612|NCT00619515|585056673|FG000|Overall Study|Study Termination by IRB|73|||
162001613|NCT03294590|585056676|FG000|Overall Study|Lost to Follow-up|105|||
162001614|NCT03294590|585056677|FG001|Overall Study|Lost to Follow-up|107|||
162001615|NCT01962441|585056680|FG000|Randomized Period|Randomized but Never Treated|4|||
162001616|NCT01962441|585056681|FG001|Randomized Period|Randomized but Never Treated|2|||
162001617|NCT01962441|585056682|FG002|Randomized Period|Randomized but Never Treated|3|||
162001618|NCT01962441|585056680|FG000|Randomized Period|Lost to Follow-up|2|||
162001619|NCT01962441|585056681|FG001|Randomized Period|Lost to Follow-up|4|||
162001620|NCT01962441|585056682|FG002|Randomized Period|Lost to Follow-up|4|||
162001621|NCT01962441|585056680|FG000|Randomized Period|Withdrew Consent|3|||
162001622|NCT01962441|585056681|FG001|Randomized Period|Withdrew Consent|3|||
162001623|NCT01962441|585056682|FG002|Randomized Period|Withdrew Consent|2|||
162001624|NCT01962441|585056680|FG000|Randomized Period|Adverse Event|1|||
162001625|NCT01962441|585056681|FG001|Randomized Period|Adverse Event|1|||
162001626|NCT01962441|585056682|FG002|Randomized Period|Adverse Event|0|||
162001627|NCT01962441|585056680|FG000|Randomized Period|Death|0|||
162001628|NCT01962441|585056681|FG001|Randomized Period|Death|0|||
162001629|NCT01962441|585056682|FG002|Randomized Period|Death|2|||
162001630|NCT01962441|585056680|FG000|Randomized Period|Protocol Violation|0|||
162001631|NCT01962441|585056681|FG001|Randomized Period|Protocol Violation|1|||
162001632|NCT01962441|585056682|FG002|Randomized Period|Protocol Violation|0|||
162001633|NCT01962441|585056680|FG000|Retreatment Substudy|Lack of Efficacy|1|||
162001634|NCT01962441|585056681|FG001|Retreatment Substudy|Lack of Efficacy|0|||
162001635|NCT01962441|585056682|FG002|Retreatment Substudy|Lack of Efficacy|0|||
162001636|NCT01962441|585056680|FG000|Retreatment Substudy|Lost to Follow-up|1|||
162001637|NCT01962441|585056681|FG001|Retreatment Substudy|Lost to Follow-up|0|||
162001638|NCT01962441|585056682|FG002|Retreatment Substudy|Lost to Follow-up|0|||
162001639|NCT04862065|585056683|FG000|Screening|Protocol Violation|54|||
162001640|NCT04862065|585056684|FG001|Screening|Protocol Violation|0|||
162001641|NCT04862065|585056685|FG002|Screening|Protocol Violation|0|||
162001642|NCT04862065|585056683|FG000|Screening|Insufficient Sample|1|||
162001643|NCT04862065|585056684|FG001|Screening|Insufficient Sample|0|||
162001644|NCT04862065|585056685|FG002|Screening|Insufficient Sample|0|||
162001645|NCT04862065|585056683|FG000|Follow-Up|Lost to Follow-up|3|||
162001646|NCT04862065|585056684|FG001|Follow-Up|Lost to Follow-up|0|||
162001647|NCT04862065|585056685|FG002|Follow-Up|Lost to Follow-up|0|||
162001648|NCT01453140|585056686|FG000|Overall Study|Adverse Event|3|||
162001649|NCT00718510|585056687|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
162001650|NCT00718510|585056688|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
162001651|NCT00718510|585056687|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
162001652|NCT00718510|585056688|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
162001653|NCT00423657|585056690|FG000|Overall Study|Withdrew consent|10|||
162001654|NCT00423657|585056691|FG001|Overall Study|Withdrew consent|8|||
162001655|NCT00423657|585056690|FG000|Overall Study|Non-compliance|0|||
162001656|NCT00423657|585056691|FG001|Overall Study|Non-compliance|1|||
162001657|NCT00423657|585056690|FG000|Overall Study|Other|15|||
162001658|NCT00423657|585056691|FG001|Overall Study|Other|16|||
162001659|NCT00423657|585056690|FG000|Overall Study|Request of sponsor/investigator|1|||
162001660|NCT00423657|585056691|FG001|Overall Study|Request of sponsor/investigator|0|||
162001661|NCT02269124|585056692|FG000|Overall Study|Lost to Follow-up|1|||
162001662|NCT02269124|585056693|FG001|Overall Study|Lost to Follow-up|0|||
162001663|NCT02269124|585056692|FG000|Overall Study|Withdrawal by Subject|0|||
162001664|NCT02269124|585056693|FG001|Overall Study|Withdrawal by Subject|2|||
162001665|NCT00097500|585056696|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
162001666|NCT00097500|585056697|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
162001667|NCT00097500|585056696|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
162001668|NCT00097500|585056697|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
162001669|NCT00097500|585056696|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
162001670|NCT00097500|585056697|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
162001671|NCT00097500|585056696|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
162001672|NCT00097500|585056697|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
162001673|NCT00097500|585056696|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
162001674|NCT00097500|585056697|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
162001675|NCT00097500|585056696|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
162001676|NCT00097500|585056697|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
162001677|NCT00097500|585056696|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
162001678|NCT00097500|585056697|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
162001679|NCT01945021|585056698|FG000|Overall Study|Adverse Event|1|||
162001680|NCT01945021|585056698|FG000|Overall Study|Withdrawal of consent|12|||
162001681|NCT01945021|585056698|FG000|Overall Study|Lost to Follow-up|5|||
162001682|NCT01945021|585056698|FG000|Overall Study|Death|65|||
162001683|NCT01300234|585056700|FG000|Overall Study|Adverse Event|1|||
162001684|NCT01300234|585056701|FG001|Overall Study|Adverse Event|1|||
162001685|NCT01300234|585056700|FG000|Overall Study|Protocol Violation|2|||
162001686|NCT01300234|585056701|FG001|Overall Study|Protocol Violation|3|||
162001687|NCT01300234|585056700|FG000|Overall Study|Withdrawal by Subject|5|||
162001688|NCT01300234|585056701|FG001|Overall Study|Withdrawal by Subject|9|||
162001689|NCT01300234|585056700|FG000|Overall Study|Lost to Follow-up|14|||
162001690|NCT01300234|585056701|FG001|Overall Study|Lost to Follow-up|12|||
162001691|NCT01300234|585056700|FG000|Overall Study|Pregnancy|2|||
162001692|NCT01300234|585056701|FG001|Overall Study|Pregnancy|1|||
162001693|NCT01300234|585056700|FG000|Overall Study|Participant reached stopping critera|2|||
162001694|NCT01300234|585056701|FG001|Overall Study|Participant reached stopping critera|0|||
162001695|NCT01300234|585056700|FG000|Overall Study|Participant stopped medication|1|||
162001696|NCT01300234|585056701|FG001|Overall Study|Participant stopped medication|1|||
162001697|NCT01300234|585056700|FG000|Overall Study|Participant refused return to hospital|1|||
162001698|NCT01300234|585056701|FG001|Overall Study|Participant refused return to hospital|0|||
162001699|NCT03253679|585056702|FG000|Overall Study|Screen Failure|1|||
162001700|NCT04816214|585056703|FG000|Overall Study|Progressive Disease|4|||
162001701|NCT04816214|585056704|FG001|Overall Study|Progressive Disease|0|||
162001702|NCT04816214|585056705|FG002|Overall Study|Progressive Disease|0|||
162001703|NCT04816214|585056703|FG000|Overall Study|Death|1|||
162001704|NCT04816214|585056704|FG001|Overall Study|Death|0|||
162001705|NCT04816214|585056705|FG002|Overall Study|Death|0|||
162001706|NCT04816214|585056703|FG000|Overall Study|Study Terminated by Sponsor|1|||
162001707|NCT04816214|585056704|FG001|Overall Study|Study Terminated by Sponsor|0|||
162001708|NCT04816214|585056705|FG002|Overall Study|Study Terminated by Sponsor|0|||
162001709|NCT04879628|585056706|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
162001710|NCT04879628|585056707|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
162001711|NCT04879628|585056708|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
162001712|NCT04879628|585056709|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
162001713|NCT04879628|585056706|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
162001714|NCT04879628|585056707|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
162001715|NCT04879628|585056708|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
162001716|NCT04879628|585056709|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
162001717|NCT04879628|585056706|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
162001718|NCT04879628|585056707|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
162001719|NCT04879628|585056708|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
162001720|NCT04879628|585056709|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
162001721|NCT04879628|585056706|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
162001722|NCT04879628|585056707|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
162001723|NCT04879628|585056708|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
162001724|NCT04879628|585056709|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
162001725|NCT00360412|585056715|FG000|Overall Study|Adverse Event|37|||
162001726|NCT00360412|585056716|FG001|Overall Study|Adverse Event|65|||
162001727|NCT00360412|585056715|FG000|Overall Study|Protocol Violation|2|||
162001728|NCT00360412|585056716|FG001|Overall Study|Protocol Violation|5|||
162001729|NCT00360412|585056715|FG000|Overall Study|Patient withdrew consent|27|||
162001730|NCT00360412|585056716|FG001|Overall Study|Patient withdrew consent|52|||
162001731|NCT00360412|585056715|FG000|Overall Study|Lack of therapeutic efficacy|46|||
162001732|NCT00360412|585056716|FG001|Overall Study|Lack of therapeutic efficacy|61|||
162001733|NCT00360412|585056715|FG000|Overall Study|Physician Decision|2|||
162001734|NCT00360412|585056716|FG001|Overall Study|Physician Decision|4|||
162001735|NCT00360412|585056715|FG000|Overall Study|Other|5|||
162001736|NCT00360412|585056716|FG001|Overall Study|Other|6|||
162001737|NCT00360412|585056715|FG000|Overall Study|Study termination by Sponsor|214|||
162001738|NCT00360412|585056716|FG001|Overall Study|Study termination by Sponsor|469|||
162001739|NCT03863509|585056717|FG000|Overall Study|COVID-19 shutdown period|0|||
162001740|NCT03863509|585056718|FG001|Overall Study|COVID-19 shutdown period|4|||
162001741|NCT03863509|585056719|FG002|Overall Study|COVID-19 shutdown period|0|||
162001742|NCT03863509|585056717|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
162001743|NCT03863509|585056718|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
162001744|NCT03863509|585056719|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
162001745|NCT03863509|585056717|FG000|Overall Study|Lost to Follow-up|8|||
162001746|NCT03863509|585056718|FG001|Overall Study|Lost to Follow-up|0|||
162001747|NCT03863509|585056719|FG002|Overall Study|Lost to Follow-up|2|||
162001748|NCT03863509|585056717|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
162001749|NCT03863509|585056718|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
162001750|NCT03863509|585056719|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
162001751|NCT03863509|585056717|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
162001752|NCT03863509|585056718|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
162001753|NCT03863509|585056719|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
162001754|NCT03861273|585056720|FG000|Screening Phase (3 Weeks)|Other|1|||
162001755|NCT03861273|585056720|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
162001756|NCT03861273|585056720|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
162001757|NCT03861273|585056720|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
162042564|NCT00371826|585214088|FG000|Extension Phase (24 Months)|Adverse Event|4|||
162042565|NCT00371826|585214089|FG001|Extension Phase (24 Months)|Adverse Event|5|||
162042566|NCT00371826|585214090|FG002|Extension Phase (24 Months)|Adverse Event|0|||
162042567|NCT00371826|585214088|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
162042568|NCT00371826|585214089|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
162042569|NCT00371826|585214090|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
162042570|NCT00371826|585214088|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
162042571|NCT00371826|585214089|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
162042572|NCT00371826|585214090|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
162042573|NCT00371826|585214088|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
162042574|NCT00371826|585214089|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
162042575|NCT00371826|585214090|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
162042576|NCT00371826|585214088|FG000|Extension Phase (24 Months)|Administrative problems|0|||
162042577|NCT00371826|585214089|FG001|Extension Phase (24 Months)|Administrative problems|0|||
162042578|NCT00371826|585214090|FG002|Extension Phase (24 Months)|Administrative problems|2|||
162042579|NCT02436304|585214091|FG000|Overall Study|Lost to Follow-up|0|||
162042580|NCT02436304|585214092|FG001|Overall Study|Lost to Follow-up|1|||
162042581|NCT02436304|585214093|FG002|Overall Study|Lost to Follow-up|0|||
162042582|NCT02436304|585214091|FG000|Overall Study|Withdrawal by Subject|0|||
162042583|NCT02436304|585214092|FG001|Overall Study|Withdrawal by Subject|1|||
162042584|NCT02436304|585214093|FG002|Overall Study|Withdrawal by Subject|0|||
162042585|NCT02436304|585214091|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
162042586|NCT02436304|585214092|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
162042587|NCT02436304|585214093|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
162042588|NCT05274815|585214101|FG000|Overall Study|Adverse Event|1|||
162042589|NCT05274815|585214101|FG000|Overall Study|Death|2|||
162042590|NCT05274815|585214101|FG000|Overall Study|Lost to Follow-up|4|||
162042591|NCT05274815|585214101|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
162042592|NCT05274815|585214101|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
162042593|NCT05274815|585214101|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
162042594|NCT05274815|585214101|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
162042595|NCT05274815|585214101|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
162042596|NCT05274815|585214101|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
162042597|NCT05274815|585214101|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
162042598|NCT05274815|585214101|FG000|Overall Study|Withdrawal by Subject|11|||
162042599|NCT04416633|585214102|FG000|Overall Study|Death|1|||
162042600|NCT04416633|585214102|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
162042601|NCT04416633|585214102|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
162042602|NCT04416633|585214102|FG000|Overall Study|Adverse Event|6|||
162042603|NCT04416633|585214102|FG000|Overall Study|Withdrawal by Subject|6|||
162042604|NCT03914326|585214103|FG000|Overall Study|Withdrawal by Subject|27|||
162042605|NCT03914326|585214104|FG001|Overall Study|Withdrawal by Subject|34|||
162042606|NCT03914326|585214103|FG000|Overall Study|Lost to Follow-up|43|||
162042607|NCT03914326|585214104|FG001|Overall Study|Lost to Follow-up|51|||
162042608|NCT03914326|585214103|FG000|Overall Study|Randomised more than once|0|||
162042609|NCT03914326|585214104|FG001|Overall Study|Randomised more than once|1|||
162042610|NCT04612790|585214105|FG000|DB Period (Up to 36 Weeks)|Death|1|||
162042611|NCT04612790|585214106|FG001|DB Period (Up to 36 Weeks)|Death|1|||
162042612|NCT04612790|585214107|FG002|DB Period (Up to 36 Weeks)|Death|0|||
162042613|NCT04612790|585214108|FG003|DB Period (Up to 36 Weeks)|Death|0|||
162042614|NCT04612790|585214105|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
162042615|NCT04612790|585214106|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
162042616|NCT04612790|585214107|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
162042617|NCT04612790|585214108|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
162042618|NCT04612790|585214105|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
162042619|NCT04612790|585214106|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
162042620|NCT04612790|585214107|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
162042621|NCT04612790|585214108|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
162042622|NCT04612790|585214105|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
162042623|NCT04612790|585214106|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
162042624|NCT04612790|585214107|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
162042625|NCT04612790|585214108|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
162042626|NCT04612790|585214105|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
162042627|NCT04612790|585214106|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
162042628|NCT04612790|585214107|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
162042629|NCT04612790|585214108|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
162042630|NCT04612790|585214105|FG000|DB Period (Up to 36 Weeks)|Other|1|||
162042631|NCT04612790|585214106|FG001|DB Period (Up to 36 Weeks)|Other|0|||
162042632|NCT04612790|585214107|FG002|DB Period (Up to 36 Weeks)|Other|0|||
162001758|NCT03861273|585056720|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
162001759|NCT03409796|585058102|FG000|Overall Study|Adverse Event|2|||
162001760|NCT03409796|585058103|FG001|Overall Study|Adverse Event|0|||
162001761|NCT03409796|585058102|FG000|Overall Study|Other|0|||
162001762|NCT03409796|585058103|FG001|Overall Study|Other|1|||
162001763|NCT00740220|585058104|FG000|Overall Study|screen failures (non-COPD patients)|9|||
162001764|NCT00770653|585058108|FG000|Overall Study|Adverse Event|13|||
162001765|NCT00770653|585058109|FG001|Overall Study|Adverse Event|5|||
162001766|NCT00770653|585058108|FG000|Overall Study|Protocol Violation|8|||
162001767|NCT00770653|585058109|FG001|Overall Study|Protocol Violation|6|||
162001768|NCT00770653|585058108|FG000|Overall Study|Withdrawal by Subject|4|||
162001769|NCT00770653|585058109|FG001|Overall Study|Withdrawal by Subject|7|||
162001770|NCT00770653|585058108|FG000|Overall Study|Lack of Compliance|1|||
162001771|NCT00770653|585058109|FG001|Overall Study|Lack of Compliance|4|||
162001772|NCT00770653|585058108|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
162001773|NCT00770653|585058109|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
162001774|NCT00770653|585058108|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
162001775|NCT00770653|585058109|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
162001776|NCT00770653|585058108|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
162001777|NCT00770653|585058109|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
162001778|NCT00770653|585058108|FG000|Overall Study|Lost to Follow-up|1|||
162001779|NCT00770653|585058109|FG001|Overall Study|Lost to Follow-up|2|||
162001780|NCT00770653|585058108|FG000|Overall Study|Physician Decision|1|||
162001781|NCT00770653|585058109|FG001|Overall Study|Physician Decision|0|||
162001782|NCT01908426|585058112|FG000|Overall Study|Adverse Event|98|||
162001783|NCT01908426|585058113|FG001|Overall Study|Adverse Event|11|||
162001784|NCT01908426|585058112|FG000|Overall Study|Clinical Deterioration|72|||
162001785|NCT01908426|585058113|FG001|Overall Study|Clinical Deterioration|38|||
162001786|NCT01908426|585058112|FG000|Overall Study|Lack of Efficacy|3|||
162001787|NCT01908426|585058113|FG001|Overall Study|Lack of Efficacy|0|||
162001788|NCT01908426|585058112|FG000|Overall Study|Lost to Follow-up|0|||
162001789|NCT01908426|585058113|FG001|Overall Study|Lost to Follow-up|1|||
162001790|NCT01908426|585058112|FG000|Overall Study|Physician Decision|3|||
162001791|NCT01908426|585058113|FG001|Overall Study|Physician Decision|3|||
162001792|NCT01908426|585058112|FG000|Overall Study|Withdrawal by Subject|11|||
162001793|NCT01908426|585058113|FG001|Overall Study|Withdrawal by Subject|6|||
162001794|NCT01908426|585058112|FG000|Overall Study|Progressive Disease|206|||
162001795|NCT01908426|585058113|FG001|Overall Study|Progressive Disease|152|||
162001796|NCT01908426|585058112|FG000|Overall Study|Protocol Violation|1|||
162001797|NCT01908426|585058113|FG001|Overall Study|Protocol Violation|0|||
162001798|NCT01908426|585058112|FG000|Overall Study|No Study Treatment Given|3|||
162001799|NCT01908426|585058113|FG001|Overall Study|No Study Treatment Given|0|||
162001800|NCT02973100|585058118|FG000|Overall Study|Adverse Event|1|||
162001801|NCT02973100|585058119|FG001|Overall Study|Adverse Event|2|||
162001802|NCT02973100|585058120|FG002|Overall Study|Adverse Event|1|||
162001803|NCT02973100|585058121|FG003|Overall Study|Adverse Event|2|||
162001804|NCT02973100|585058118|FG000|Overall Study|Lost to Follow-up|3|||
162001805|NCT02973100|585058119|FG001|Overall Study|Lost to Follow-up|1|||
162001806|NCT02973100|585058120|FG002|Overall Study|Lost to Follow-up|1|||
162001807|NCT02973100|585058121|FG003|Overall Study|Lost to Follow-up|0|||
162001808|NCT02973100|585058118|FG000|Overall Study|Withdrawal by Subject|3|||
162001809|NCT02973100|585058119|FG001|Overall Study|Withdrawal by Subject|5|||
162001810|NCT02973100|585058120|FG002|Overall Study|Withdrawal by Subject|1|||
162001811|NCT02973100|585058121|FG003|Overall Study|Withdrawal by Subject|4|||
162001812|NCT02973100|585058118|FG000|Overall Study|Notification of change in address|0|||
162001813|NCT02973100|585058119|FG001|Overall Study|Notification of change in address|0|||
162001814|NCT02973100|585058120|FG002|Overall Study|Notification of change in address|0|||
162001815|NCT02973100|585058121|FG003|Overall Study|Notification of change in address|1|||
162001816|NCT02973100|585058118|FG000|Overall Study|Failed to attend Safety followup period|0|||
162001817|NCT02973100|585058119|FG001|Overall Study|Failed to attend Safety followup period|0|||
162001818|NCT02973100|585058120|FG002|Overall Study|Failed to attend Safety followup period|1|||
162001819|NCT02973100|585058121|FG003|Overall Study|Failed to attend Safety followup period|0|||
162001820|NCT01419236|585058128|FG000|Overall Study|Adverse Event|1|||
162001821|NCT01419236|585058129|FG001|Overall Study|Adverse Event|0|||
162001822|NCT01419236|585058128|FG000|Overall Study|Lack of Efficacy|0|||
162001823|NCT01419236|585058129|FG001|Overall Study|Lack of Efficacy|1|||
162001824|NCT01419236|585058128|FG000|Overall Study|Lost to Follow-up|1|||
162001825|NCT01419236|585058129|FG001|Overall Study|Lost to Follow-up|0|||
162001826|NCT01419236|585058128|FG000|Overall Study|Physician Decision|1|||
162001827|NCT01419236|585058129|FG001|Overall Study|Physician Decision|0|||
162001828|NCT01419236|585058128|FG000|Overall Study|Withdrawal by Subject|1|||
162001829|NCT01419236|585058129|FG001|Overall Study|Withdrawal by Subject|4|||
162001830|NCT01419236|585058128|FG000|Overall Study|Entry Criteria Not Met|1|||
162001831|NCT01419236|585058129|FG001|Overall Study|Entry Criteria Not Met|0|||
162042633|NCT04612790|585214108|FG003|DB Period (Up to 36 Weeks)|Other|0|||
162042634|NCT04612790|585214105|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
162042635|NCT04612790|585214106|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
162042636|NCT04612790|585214107|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
162042637|NCT04612790|585214108|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
162042638|NCT04612790|585214105|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
162042639|NCT04612790|585214106|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
162042640|NCT04612790|585214107|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
162042641|NCT04612790|585214108|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
162042642|NCT04612790|585214105|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
162042643|NCT04612790|585214106|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
162042644|NCT04612790|585214107|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
162042645|NCT04612790|585214108|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
162042646|NCT04612790|585214105|FG000|OLE Period (Up to 1 Year)|Other|0|||
162042647|NCT04612790|585214106|FG001|OLE Period (Up to 1 Year)|Other|0|||
162042648|NCT04612790|585214107|FG002|OLE Period (Up to 1 Year)|Other|0|||
162042649|NCT04612790|585214108|FG003|OLE Period (Up to 1 Year)|Other|1|||
162042650|NCT00785928|585214109|FG000|Treatment Phase|Adverse Event|1|||
162042651|NCT00785928|585214110|FG001|Treatment Phase|Adverse Event|1|||
162042652|NCT00785928|585214111|FG002|Treatment Phase|Adverse Event|2|||
162042653|NCT00785928|585214112|FG003|Treatment Phase|Adverse Event|0|||
162042654|NCT00785928|585214113|FG004|Treatment Phase|Adverse Event|0|||
162042655|NCT00785928|585214114|FG005|Treatment Phase|Adverse Event|0|||
162042656|NCT00785928|585214115|FG006|Treatment Phase|Adverse Event|2|||
162042657|NCT00785928|585214109|FG000|Treatment Phase|Inadequate Response|0|||
162042658|NCT00785928|585214110|FG001|Treatment Phase|Inadequate Response|1|||
162042659|NCT00785928|585214111|FG002|Treatment Phase|Inadequate Response|0|||
162042660|NCT00785928|585214112|FG003|Treatment Phase|Inadequate Response|0|||
162042661|NCT00785928|585214113|FG004|Treatment Phase|Inadequate Response|0|||
162042662|NCT00785928|585214114|FG005|Treatment Phase|Inadequate Response|0|||
162042663|NCT00785928|585214115|FG006|Treatment Phase|Inadequate Response|0|||
162042664|NCT00785928|585214109|FG000|Treatment Phase|Lack of Efficacy|0|||
162042665|NCT00785928|585214110|FG001|Treatment Phase|Lack of Efficacy|1|||
162042666|NCT00785928|585214111|FG002|Treatment Phase|Lack of Efficacy|1|||
162042667|NCT00785928|585214112|FG003|Treatment Phase|Lack of Efficacy|0|||
162042668|NCT00785928|585214113|FG004|Treatment Phase|Lack of Efficacy|0|||
162042669|NCT00785928|585214114|FG005|Treatment Phase|Lack of Efficacy|0|||
162042670|NCT00785928|585214115|FG006|Treatment Phase|Lack of Efficacy|0|||
162042671|NCT00785928|585214109|FG000|Treatment Phase|Physician Decision|0|||
162042672|NCT00785928|585214110|FG001|Treatment Phase|Physician Decision|0|||
162042673|NCT00785928|585214111|FG002|Treatment Phase|Physician Decision|0|||
162042674|NCT00785928|585214112|FG003|Treatment Phase|Physician Decision|0|||
162042675|NCT00785928|585214113|FG004|Treatment Phase|Physician Decision|1|||
162042676|NCT00785928|585214114|FG005|Treatment Phase|Physician Decision|0|||
162042677|NCT00785928|585214115|FG006|Treatment Phase|Physician Decision|0|||
162001832|NCT04456504|585058130|FG000|Overall Study|Lost to Follow-up|2|||
162001833|NCT01342913|585058133|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
162001834|NCT01342913|585058134|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
162001835|NCT01342913|585058135|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
162001836|NCT01342913|585058133|FG000|2-week Run-in Period|Physician Decision|6|||
162001837|NCT01342913|585058134|FG001|2-week Run-in Period|Physician Decision|0|||
162001838|NCT01342913|585058135|FG002|2-week Run-in Period|Physician Decision|0|||
162001839|NCT01342913|585058133|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
162001840|NCT01342913|585058134|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
162001841|NCT01342913|585058135|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
162001842|NCT01342913|585058133|FG000|2-week Run-in Period|Adverse Event|2|||
162001843|NCT01342913|585058134|FG001|2-week Run-in Period|Adverse Event|0|||
162001844|NCT01342913|585058135|FG002|2-week Run-in Period|Adverse Event|0|||
162001845|NCT01342913|585058133|FG000|2-week Run-in Period|Protocol Violation|5|||
162042678|NCT00785928|585214109|FG000|Treatment Phase|Sponsor Decision|1|||
162042679|NCT00785928|585214110|FG001|Treatment Phase|Sponsor Decision|0|||
162042680|NCT00785928|585214111|FG002|Treatment Phase|Sponsor Decision|0|||
162001846|NCT01342913|585058134|FG001|2-week Run-in Period|Protocol Violation|0|||
162001847|NCT01342913|585058135|FG002|2-week Run-in Period|Protocol Violation|0|||
162001848|NCT01342913|585058133|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
162001849|NCT01342913|585058134|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
162001850|NCT01342913|585058135|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
162042681|NCT00785928|585214112|FG003|Treatment Phase|Sponsor Decision|0|||
162042682|NCT00785928|585214113|FG004|Treatment Phase|Sponsor Decision|0|||
162042683|NCT00785928|585214114|FG005|Treatment Phase|Sponsor Decision|0|||
162042684|NCT00785928|585214115|FG006|Treatment Phase|Sponsor Decision|1|||
162042685|NCT00785928|585214109|FG000|Treatment Phase|Withdrawal by Subject|1|||
162042686|NCT00785928|585214110|FG001|Treatment Phase|Withdrawal by Subject|2|||
162042687|NCT00785928|585214111|FG002|Treatment Phase|Withdrawal by Subject|0|||
162042688|NCT00785928|585214112|FG003|Treatment Phase|Withdrawal by Subject|0|||
162001851|NCT01342913|585058133|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162001852|NCT01342913|585058134|FG001|Double-Blind Treatment Period|Adverse Event|3|||
162001853|NCT01342913|585058135|FG002|Double-Blind Treatment Period|Adverse Event|6|||
162001854|NCT01342913|585058133|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
162001855|NCT01342913|585058134|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
162001856|NCT01342913|585058135|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
162001857|NCT01342913|585058133|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
162001858|NCT01342913|585058134|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
162001859|NCT01342913|585058135|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
162001860|NCT01342913|585058133|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162001861|NCT01342913|585058134|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
162001862|NCT01342913|585058135|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
162001863|NCT01342913|585058133|FG000|Double-Blind Treatment Period|Physician Decision|0|||
162042689|NCT00785928|585214113|FG004|Treatment Phase|Withdrawal by Subject|1|||
162042690|NCT00785928|585214114|FG005|Treatment Phase|Withdrawal by Subject|0|||
162042691|NCT00785928|585214115|FG006|Treatment Phase|Withdrawal by Subject|0|||
162042692|NCT03323502|585214121|FG000|Overall Study|Resident could not be linked to CMS data|594|||
162042693|NCT03323502|585214122|FG001|Overall Study|Resident could not be linked to CMS data|435|||
162042694|NCT03323502|585214121|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
162042695|NCT03323502|585214122|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
162042696|NCT03323502|585214121|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
162042697|NCT03323502|585214122|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
162042698|NCT03323502|585214121|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
162042699|NCT03323502|585214122|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
162042700|NCT03323502|585214121|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
162042701|NCT03323502|585214122|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
162042702|NCT02923427|585214124|FG000|Overall Study|convert to laparatomy|2|||
162042703|NCT02923427|585214125|FG001|Overall Study|convert to laparatomy|2|||
162042704|NCT02923427|585214124|FG000|Overall Study|destaturation|1|||
162042705|NCT02923427|585214125|FG001|Overall Study|destaturation|0|||
162042706|NCT02923427|585214124|FG000|Overall Study|can not replace LMA|1|||
162042707|NCT02923427|585214125|FG001|Overall Study|can not replace LMA|0|||
162042708|NCT01539642|585214130|FG000|Overall Study|Lack of Efficacy|20|||
162042709|NCT01539642|585214131|FG001|Overall Study|Lack of Efficacy|18|||
162042710|NCT01539642|585214130|FG000|Overall Study|Patient ready for early discharge|8|||
162042711|NCT01539642|585214131|FG001|Overall Study|Patient ready for early discharge|7|||
162042712|NCT01539642|585214130|FG000|Overall Study|Adverse Event|6|||
162042713|NCT01539642|585214131|FG001|Overall Study|Adverse Event|4|||
162042714|NCT01539642|585214130|FG000|Overall Study|Withdrawal by Subject|2|||
162042715|NCT01539642|585214131|FG001|Overall Study|Withdrawal by Subject|2|||
162042716|NCT03611010|585214132|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
162042717|NCT03611010|585214133|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
162042718|NCT03611010|585214134|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
162042719|NCT03611010|585214135|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
162042720|NCT05021081|585214139|FG000|Phase 2|Subject enrolled in error|1|||
162042721|NCT05021081|585214140|FG001|Phase 2|Subject enrolled in error|1|||
162042722|NCT05021081|585214141|FG002|Phase 2|Subject enrolled in error|0|||
162042723|NCT01890746|585214144|FG000|Overall Study|Death|39|||
162042724|NCT01890746|585214145|FG001|Overall Study|Death|30|||
162042725|NCT01890746|585214144|FG000|Overall Study|Adverse Event|1|||
162042726|NCT01890746|585214145|FG001|Overall Study|Adverse Event|0|||
162042727|NCT01890746|585214144|FG000|Overall Study|Lost to Follow-up|4|||
162042728|NCT01890746|585214145|FG001|Overall Study|Lost to Follow-up|1|||
162042729|NCT01890746|585214144|FG000|Overall Study|Physician Decision|3|||
162042730|NCT01890746|585214145|FG001|Overall Study|Physician Decision|2|||
162042731|NCT01890746|585214144|FG000|Overall Study|Withdrawal by Subject|5|||
162042732|NCT01890746|585214145|FG001|Overall Study|Withdrawal by Subject|8|||
162042733|NCT03257371|585214150|FG000|Overall Study|Lost to Follow-up|1|||
162042734|NCT03114488|585214151|FG000|Time Period 2|Withdrawal by Subject|1|||
162001864|NCT01342913|585058134|FG001|Double-Blind Treatment Period|Physician Decision|2|||
162001865|NCT01342913|585058135|FG002|Double-Blind Treatment Period|Physician Decision|0|||
162001866|NCT01342913|585058133|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162001867|NCT01342913|585058134|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
162001868|NCT01342913|585058135|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
162001869|NCT02869633|585058139|FG000|Overall Study|Death|2|||
162001870|NCT02869633|585058140|FG001|Overall Study|Death|1|||
162042735|NCT03114488|585214152|FG001|Time Period 2|Withdrawal by Subject|3|||
162042736|NCT03711266|585214154|FG000|Overall Study|Lost to Follow-up|10|||
162042737|NCT03387683|585214155|FG000|Overall Study|In receipt of disallowed medication|1|||
162042738|NCT03387683|585214156|FG001|Overall Study|In receipt of disallowed medication|0|||
162042739|NCT03387683|585214155|FG000|Overall Study|Did not receive treatment|1|||
162001871|NCT02869633|585058139|FG000|Overall Study|Patient refused follow-up|1|||
162001872|NCT02869633|585058140|FG001|Overall Study|Patient refused follow-up|0|||
162001873|NCT02869633|585058139|FG000|Overall Study|Provider discretion|1|||
162001874|NCT02869633|585058140|FG001|Overall Study|Provider discretion|0|||
162001875|NCT02869633|585058139|FG000|Overall Study|Investigator decision|1|||
162001876|NCT02869633|585058140|FG001|Overall Study|Investigator decision|0|||
162001877|NCT02869633|585058139|FG000|Overall Study|Lost to Follow-up|0|||
162001878|NCT02869633|585058140|FG001|Overall Study|Lost to Follow-up|1|||
162001879|NCT02869633|585058139|FG000|Overall Study|Not eligible|6|||
162001880|NCT02869633|585058140|FG001|Overall Study|Not eligible|1|||
162001881|NCT02869633|585058139|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
162001882|NCT02869633|585058140|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
162001883|NCT02869633|585058139|FG000|Overall Study|Withdrawal by Subject|0|||
162001884|NCT02869633|585058140|FG001|Overall Study|Withdrawal by Subject|1|||
162001885|NCT03287791|585058141|FG000|Overall Study|Insufficient Therapeutic Response|0|||
162001886|NCT03287791|585058142|FG001|Overall Study|Insufficient Therapeutic Response|0|||
162001887|NCT03287791|585058143|FG002|Overall Study|Insufficient Therapeutic Response|1|||
162001888|NCT03287791|585058141|FG000|Overall Study|Adverse Event|0|||
162001889|NCT03287791|585058142|FG001|Overall Study|Adverse Event|4|||
162001890|NCT03287791|585058143|FG002|Overall Study|Adverse Event|3|||
162001891|NCT03287791|585058141|FG000|Overall Study|Withdrawal by Subject|12|||
162001892|NCT03287791|585058142|FG001|Overall Study|Withdrawal by Subject|12|||
162001893|NCT03287791|585058143|FG002|Overall Study|Withdrawal by Subject|17|||
162001894|NCT03287791|585058141|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
162001895|NCT03287791|585058142|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
162001896|NCT03287791|585058143|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
162001897|NCT03287791|585058141|FG000|Overall Study|Lost to Follow-up|8|||
162001898|NCT03287791|585058142|FG001|Overall Study|Lost to Follow-up|14|||
162001899|NCT03287791|585058143|FG002|Overall Study|Lost to Follow-up|11|||
162001900|NCT03287791|585058141|FG000|Overall Study|Protocol Violation|7|||
162001901|NCT03287791|585058142|FG001|Overall Study|Protocol Violation|2|||
162001902|NCT03287791|585058143|FG002|Overall Study|Protocol Violation|1|||
162001903|NCT03287791|585058141|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
162001904|NCT03287791|585058142|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
162001905|NCT03287791|585058143|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
162001906|NCT03287791|585058141|FG000|Overall Study|Too much time between 2 visits|0|||
162001907|NCT03287791|585058142|FG001|Overall Study|Too much time between 2 visits|1|||
162001908|NCT03287791|585058143|FG002|Overall Study|Too much time between 2 visits|0|||
162001909|NCT03287791|585058141|FG000|Overall Study|Non-compliance|0|||
162001910|NCT03287791|585058142|FG001|Overall Study|Non-compliance|1|||
162001911|NCT03287791|585058143|FG002|Overall Study|Non-compliance|0|||
162001912|NCT03287791|585058141|FG000|Overall Study|Did not meet inclusion criteria|1|||
162001913|NCT03287791|585058142|FG001|Overall Study|Did not meet inclusion criteria|0|||
162001914|NCT03287791|585058143|FG002|Overall Study|Did not meet inclusion criteria|0|||
162001915|NCT02891174|585058145|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
162001916|NCT02891174|585058146|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
162001917|NCT02891174|585058145|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
162001918|NCT02891174|585058146|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
162001919|NCT02891174|585058145|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
162001920|NCT02891174|585058146|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
162001921|NCT02891174|585058145|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
162001922|NCT02891174|585058146|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
162001923|NCT02891174|585058145|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
162001924|NCT02891174|585058146|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
162001925|NCT02891174|585058145|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
162001926|NCT02891174|585058146|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
162001927|NCT02891174|585058145|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
162001928|NCT02891174|585058146|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
162001929|NCT04319198|585058149|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
162001930|NCT04319198|585058150|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
162001931|NCT04319198|585058151|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
162001932|NCT04319198|585058149|FG000|Overall Study|Death|0|||
162001933|NCT04319198|585058150|FG001|Overall Study|Death|3|||
162001934|NCT04319198|585058151|FG002|Overall Study|Death|3|||
162001935|NCT04319198|585058149|FG000|Overall Study|Reason Not Specified|0|||
162001936|NCT04319198|585058150|FG001|Overall Study|Reason Not Specified|2|||
162001937|NCT04319198|585058151|FG002|Overall Study|Reason Not Specified|4|||
162001938|NCT04319198|585058149|FG000|Overall Study|Withdrawal of Consent|0|||
162001939|NCT04319198|585058150|FG001|Overall Study|Withdrawal of Consent|0|||
162001940|NCT04319198|585058151|FG002|Overall Study|Withdrawal of Consent|5|||
162001941|NCT04319198|585058149|FG000|Overall Study|Site Terminated by Sponsor|0|||
162001942|NCT04319198|585058150|FG001|Overall Study|Site Terminated by Sponsor|1|||
162001943|NCT04319198|585058151|FG002|Overall Study|Site Terminated by Sponsor|0|||
162001944|NCT04607668|585058153|FG000|Overall Study|Death|49|||
162001945|NCT04607668|585058154|FG001|Overall Study|Death|26|||
162001946|NCT04607668|585058153|FG000|Overall Study|Lost to Follow-up|3|||
162001947|NCT04607668|585058154|FG001|Overall Study|Lost to Follow-up|4|||
162001948|NCT04607668|585058153|FG000|Overall Study|Study terminated by Sponsor|92|||
162042740|NCT03387683|585214156|FG001|Overall Study|Did not receive treatment|0|||
162042741|NCT00566501|585214159|FG000|Overall Study|Adverse Event|68|||
162042742|NCT00566501|585214160|FG001|Overall Study|Adverse Event|59|||
162042743|NCT00566501|585214159|FG000|Overall Study|Medication Non-compliance|5|||
162042744|NCT00566501|585214160|FG001|Overall Study|Medication Non-compliance|0|||
162042745|NCT00566501|585214159|FG000|Overall Study|Protocol Violation|2|||
162042746|NCT00566501|585214160|FG001|Overall Study|Protocol Violation|2|||
162042747|NCT00566501|585214159|FG000|Overall Study|Request of Investigator or Sponsor|6|||
162042748|NCT00566501|585214160|FG001|Overall Study|Request of Investigator or Sponsor|7|||
162042749|NCT00566501|585214159|FG000|Overall Study|Withdrawal by Subject|33|||
162042750|NCT00566501|585214160|FG001|Overall Study|Withdrawal by Subject|30|||
162042751|NCT00566501|585214159|FG000|Overall Study|Lack of Efficacy|8|||
162042752|NCT00566501|585214160|FG001|Overall Study|Lack of Efficacy|3|||
162042753|NCT00566501|585214159|FG000|Overall Study|Other|25|||
162042754|NCT00566501|585214160|FG001|Overall Study|Other|21|||
162042755|NCT00057876|585214163|FG000|Overall Study|Adverse Event|8|||
162042756|NCT00057876|585214164|FG001|Overall Study|Adverse Event|8|||
162042757|NCT00057876|585214163|FG000|Overall Study|Death|2|||
162042758|NCT00057876|585214164|FG001|Overall Study|Death|1|||
162042759|NCT00057876|585214163|FG000|Overall Study|Withdrawal by Subject|5|||
162042760|NCT00057876|585214164|FG001|Overall Study|Withdrawal by Subject|6|||
162042761|NCT00057876|585214163|FG000|Overall Study|Lack of Efficacy|10|||
162042762|NCT00057876|585214164|FG001|Overall Study|Lack of Efficacy|8|||
162042763|NCT00057876|585214163|FG000|Overall Study|Ineligible|1|||
162042764|NCT00057876|585214164|FG001|Overall Study|Ineligible|2|||
162042765|NCT00057876|585214163|FG000|Overall Study|other reason|2|||
162042766|NCT00057876|585214164|FG001|Overall Study|other reason|2|||
162042767|NCT00057876|585214163|FG000|Overall Study|other complicating disease|1|||
162042768|NCT00057876|585214164|FG001|Overall Study|other complicating disease|0|||
162042769|NCT05095454|585214165|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
162042770|NCT05095454|585214166|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
162042771|NCT01368432|585214167|FG000|Overall Study|Lost to Follow-up|0|||
162042772|NCT01368432|585214168|FG001|Overall Study|Lost to Follow-up|1|||
162042773|NCT00853073|585214169|FG000|Overall Study|Withdrawal by Subject|3|||
162042774|NCT00853073|585214170|FG001|Overall Study|Withdrawal by Subject|2|||
162042775|NCT02758171|585214171|FG000|Wash-out|Withdrawal by Subject|1|||
162042776|NCT02758171|585214172|FG001|Wash-out|Withdrawal by Subject|0|||
162042777|NCT02758171|585214171|FG000|Wash-out|Other reason|1|||
162042778|NCT02758171|585214172|FG001|Wash-out|Other reason|0|||
162042779|NCT01999114|585214173|FG000|Overall Study|Adverse Event|8|||
162042780|NCT01999114|585214174|FG001|Overall Study|Adverse Event|7|||
162042781|NCT01999114|585214175|FG002|Overall Study|Adverse Event|2|||
162042782|NCT01999114|585214176|FG003|Overall Study|Adverse Event|2|||
162042783|NCT01999114|585214177|FG004|Overall Study|Adverse Event|1|||
162042784|NCT01999114|585214173|FG000|Overall Study|Withdrawal by Subject|0|||
162042785|NCT01999114|585214174|FG001|Overall Study|Withdrawal by Subject|0|||
162042786|NCT01999114|585214175|FG002|Overall Study|Withdrawal by Subject|1|||
162042787|NCT01999114|585214176|FG003|Overall Study|Withdrawal by Subject|0|||
162042788|NCT01999114|585214177|FG004|Overall Study|Withdrawal by Subject|1|||
162042789|NCT01999114|585214173|FG000|Overall Study|Lost to Follow-up|0|||
162042790|NCT01999114|585214174|FG001|Overall Study|Lost to Follow-up|0|||
162042791|NCT01999114|585214175|FG002|Overall Study|Lost to Follow-up|1|||
162042792|NCT01999114|585214176|FG003|Overall Study|Lost to Follow-up|0|||
162042793|NCT01999114|585214177|FG004|Overall Study|Lost to Follow-up|0|||
162001949|NCT04607668|585058154|FG001|Overall Study|Study terminated by Sponsor|114|||
162001950|NCT04607668|585058153|FG000|Overall Study|Withdrawal by Subject|12|||
162001951|NCT04607668|585058154|FG001|Overall Study|Withdrawal by Subject|11|||
162001952|NCT04607668|585058153|FG000|Overall Study|Other, unspecified|8|||
162042794|NCT01999114|585214173|FG000|Overall Study|Administrative|0|||
162042795|NCT01999114|585214174|FG001|Overall Study|Administrative|0|||
162042796|NCT01999114|585214175|FG002|Overall Study|Administrative|1|||
162042797|NCT01999114|585214176|FG003|Overall Study|Administrative|1|||
162042798|NCT01999114|585214177|FG004|Overall Study|Administrative|2|||
162042799|NCT03840174|585214178|FG000|Overall Study|Withdrawal by Subject|1|||
162042800|NCT03840174|585214179|FG001|Overall Study|Withdrawal by Subject|0|||
162001953|NCT04607668|585058154|FG001|Overall Study|Other, unspecified|7|||
162042801|NCT03840174|585214180|FG002|Overall Study|Withdrawal by Subject|0|||
162042802|NCT03840174|585214181|FG003|Overall Study|Withdrawal by Subject|0|||
162042803|NCT01008150|585214182|FG000|Overall Study|did not receive study drug|1|||
162042804|NCT01008150|585214183|FG001|Overall Study|did not receive study drug|1|||
162042805|NCT01008150|585214184|FG002|Overall Study|did not receive study drug|1|||
162042806|NCT01008150|585214185|FG003|Overall Study|did not receive study drug|0|||
162001954|NCT02250326|585058155|FG000|Treatment|Death|1|||
162001955|NCT02250326|585058156|FG001|Treatment|Death|13|||
162001956|NCT02250326|585058157|FG002|Treatment|Death|2|||
162001957|NCT02250326|585058155|FG000|Treatment|Adverse Event|8|||
162001958|NCT02250326|585058156|FG001|Treatment|Adverse Event|8|||
162001959|NCT02250326|585058157|FG002|Treatment|Adverse Event|9|||
162001960|NCT02250326|585058155|FG000|Treatment|Progressive Disease|42|||
162001961|NCT02250326|585058156|FG001|Treatment|Progressive Disease|40|||
162001962|NCT02250326|585058157|FG002|Treatment|Progressive Disease|47|||
162001963|NCT02250326|585058155|FG000|Treatment|Symptomatic Deterioration|9|||
162001964|NCT02250326|585058156|FG001|Treatment|Symptomatic Deterioration|4|||
162001965|NCT02250326|585058157|FG002|Treatment|Symptomatic Deterioration|10|||
162001966|NCT02250326|585058155|FG000|Treatment|Withdrawal by Subject|11|||
162001967|NCT02250326|585058156|FG001|Treatment|Withdrawal by Subject|6|||
162001968|NCT02250326|585058157|FG002|Treatment|Withdrawal by Subject|4|||
162001969|NCT02250326|585058155|FG000|Treatment|Other reasons|8|||
162001970|NCT02250326|585058156|FG001|Treatment|Other reasons|7|||
162001971|NCT02250326|585058157|FG002|Treatment|Other reasons|7|||
162001972|NCT02250326|585058155|FG000|Extension Period|Progressive Disease|0|||
162001973|NCT02250326|585058156|FG001|Extension Period|Progressive Disease|2|||
162001974|NCT02250326|585058157|FG002|Extension Period|Progressive Disease|0|||
162001975|NCT02250326|585058155|FG000|Extension Period|Withdrawal by Subject|0|||
162001976|NCT02250326|585058156|FG001|Extension Period|Withdrawal by Subject|1|||
162001977|NCT02250326|585058157|FG002|Extension Period|Withdrawal by Subject|0|||
162001978|NCT02250326|585058155|FG000|Extension Period|Withdrawal by investigator|0|||
162001979|NCT02250326|585058156|FG001|Extension Period|Withdrawal by investigator|1|||
162001980|NCT02250326|585058157|FG002|Extension Period|Withdrawal by investigator|0|||
162001981|NCT03010527|585058159|FG000|Overall Study|Death|0|||
162001982|NCT03010527|585058160|FG001|Overall Study|Death|0|||
162001983|NCT03010527|585058161|FG002|Overall Study|Death|1|||
162001984|NCT03010527|585058159|FG000|Overall Study|Adverse Event|0|||
162001985|NCT03010527|585058160|FG001|Overall Study|Adverse Event|4|||
162001986|NCT03010527|585058161|FG002|Overall Study|Adverse Event|2|||
162001987|NCT03010527|585058159|FG000|Overall Study|Protocol Violation|0|||
162001988|NCT03010527|585058160|FG001|Overall Study|Protocol Violation|1|||
162001989|NCT03010527|585058161|FG002|Overall Study|Protocol Violation|0|||
162001990|NCT03010527|585058159|FG000|Overall Study|Lost to Follow-up|0|||
162001991|NCT03010527|585058160|FG001|Overall Study|Lost to Follow-up|2|||
162001992|NCT03010527|585058161|FG002|Overall Study|Lost to Follow-up|1|||
162001993|NCT03010527|585058159|FG000|Overall Study|Withdrawal by Subject|0|||
162001994|NCT03010527|585058160|FG001|Overall Study|Withdrawal by Subject|3|||
162001995|NCT03010527|585058161|FG002|Overall Study|Withdrawal by Subject|4|||
162001996|NCT03010527|585058159|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
162001997|NCT03010527|585058160|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
162001998|NCT03010527|585058161|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
162001999|NCT03010527|585058159|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
162002000|NCT03010527|585058160|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
162002001|NCT03010527|585058161|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
162002002|NCT03010527|585058159|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
162002003|NCT03010527|585058160|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
162002004|NCT03010527|585058161|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
162002005|NCT02469623|585058162|FG000|Overall Study|Not consented for long-term follow-up|4|||
162002006|NCT02469623|585058162|FG000|Overall Study|Lost to Follow-up|4|||
162002007|NCT02469623|585058162|FG000|Overall Study|Withdrawal by Subject|2|||
162002008|NCT02469623|585058162|FG000|Overall Study|Death|3|||
162002009|NCT04073186|585058163|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
162002010|NCT04073186|585058163|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
162002011|NCT04073186|585058163|FG000|First Wearing Cycle|Protocol Violation|1|||
162002012|NCT04073186|585058163|FG000|First Wearing Cycle|Lens Discomfort|2|||
162002013|NCT04073186|585058163|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
162002014|NCT04073186|585058163|FG000|Second Wearing Cycle|Adverse Event|1|||
162002015|NCT01096316|585058164|FG000|Overall Study|Lost to Follow-up|15|||
162002016|NCT01096316|585058165|FG001|Overall Study|Lost to Follow-up|9|||
162002017|NCT00473434|585058166|FG000|Overall Study|Physician Decision|3|||
162002018|NCT00473434|585058166|FG000|Overall Study|Withdrawal by Subject|9|||
162002019|NCT00473434|585058166|FG000|Overall Study|Compliance|3|||
162002020|NCT00473434|585058166|FG000|Overall Study|Lack of Efficacy|3|||
162002021|NCT00473434|585058166|FG000|Overall Study|Adverse Event|3|||
162002022|NCT00473434|585058166|FG000|Overall Study|Patient was selling medication to others|1|||
162002023|NCT00473434|585058166|FG000|Overall Study|Safety evaluation|1|||
162002024|NCT00473434|585058166|FG000|Overall Study|Reason not specified|6|||
162002025|NCT00473434|585058166|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
162002026|NCT00473434|585058166|FG000|Overall Study|Switching to trial medication|1|||
162002027|NCT00473434|585058166|FG000|Overall Study|No longer required|1|||
162002028|NCT06418152|585058168|FG000|Overall Study|Frequent DBS setting changes|1|||
162002029|NCT06418152|585058168|FG000|Overall Study|Withdrawal by Subject|2|||
162002030|NCT02529852|585058171|FG000|Overall Study|Withdrawal by Subject|2|||
162002031|NCT02055898|585058172|FG000|First Intervention (5 Days)|Physician Decision|2|||
162002032|NCT02055898|585058173|FG001|First Intervention (5 Days)|Physician Decision|0|||
162002033|NCT02055898|585058172|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
162002034|NCT02055898|585058173|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
162002035|NCT02201524|585058175|FG000|Overall Study|Adverse Event|0|||
162042807|NCT01497275|585214186|FG000|Overall Study|Death|1|||
162042808|NCT01497275|585214186|FG000|Overall Study|Adverse Event|1|||
162042809|NCT00381381|585214195|FG000|Overall Study|Adverse Event|3|||
162042810|NCT00381381|585214195|FG000|Overall Study|Lost to Follow-up|52|||
162042811|NCT00381381|585214195|FG000|Overall Study|Withdrawal by Subject|9|||
162002036|NCT02201524|585058176|FG001|Overall Study|Adverse Event|2|||
162002037|NCT02201524|585058177|FG002|Overall Study|Adverse Event|1|||
162002038|NCT02201524|585058178|FG003|Overall Study|Adverse Event|0|||
162002039|NCT02201524|585058175|FG000|Overall Study|Insufficient clinical response|1|||
162002040|NCT02201524|585058176|FG001|Overall Study|Insufficient clinical response|0|||
162002041|NCT02201524|585058177|FG002|Overall Study|Insufficient clinical response|0|||
162002042|NCT02201524|585058178|FG003|Overall Study|Insufficient clinical response|0|||
162002043|NCT02201524|585058175|FG000|Overall Study|Lost to Follow-up|0|||
162002044|NCT02201524|585058176|FG001|Overall Study|Lost to Follow-up|0|||
162002045|NCT02201524|585058177|FG002|Overall Study|Lost to Follow-up|2|||
162002046|NCT02201524|585058178|FG003|Overall Study|Lost to Follow-up|0|||
162002047|NCT02201524|585058175|FG000|Overall Study|No longer meets eligibility criteria|0|||
162002048|NCT02201524|585058176|FG001|Overall Study|No longer meets eligibility criteria|0|||
162002049|NCT02201524|585058177|FG002|Overall Study|No longer meets eligibility criteria|0|||
162002050|NCT02201524|585058178|FG003|Overall Study|No longer meets eligibility criteria|2|||
162002051|NCT02201524|585058175|FG000|Overall Study|Protocol Violation|0|||
162002052|NCT02201524|585058176|FG001|Overall Study|Protocol Violation|0|||
162002053|NCT02201524|585058177|FG002|Overall Study|Protocol Violation|0|||
162002054|NCT02201524|585058178|FG003|Overall Study|Protocol Violation|1|||
162002055|NCT02201524|585058175|FG000|Overall Study|Withdrawal by Subject|0|||
162002056|NCT02201524|585058176|FG001|Overall Study|Withdrawal by Subject|0|||
162002057|NCT02201524|585058177|FG002|Overall Study|Withdrawal by Subject|1|||
162002058|NCT02201524|585058178|FG003|Overall Study|Withdrawal by Subject|1|||
162002059|NCT02201524|585058175|FG000|Overall Study|Other|1|||
162002060|NCT02201524|585058176|FG001|Overall Study|Other|1|||
162002061|NCT02201524|585058177|FG002|Overall Study|Other|0|||
162002062|NCT02201524|585058178|FG003|Overall Study|Other|0|||
162002063|NCT03206216|585058183|FG000|Overall Study|Withdrawal by Subject|0|||
162002064|NCT03206216|585058184|FG001|Overall Study|Withdrawal by Subject|1|||
162002065|NCT01045460|585058187|FG000|Overall Study|Physician Decision|3|||
162002066|NCT01045460|585058188|FG001|Overall Study|Physician Decision|2|||
162002067|NCT01045460|585058187|FG000|Overall Study|Lost to Follow-up|0|||
162002068|NCT01045460|585058188|FG001|Overall Study|Lost to Follow-up|1|||
162002069|NCT01045460|585058187|FG000|Overall Study|Lack of Efficacy|3|||
162002070|NCT01045460|585058188|FG001|Overall Study|Lack of Efficacy|0|||
162002071|NCT00265564|585058191|FG000|Overall Study|Lost to Follow-up|5|||
162002072|NCT00265564|585058192|FG001|Overall Study|Lost to Follow-up|7|||
162002073|NCT00265564|585058191|FG000|Overall Study|met exclusion criteria|5|||
162002074|NCT00265564|585058192|FG001|Overall Study|met exclusion criteria|2|||
162002075|NCT01553084|585058197|FG000|Overall Study|Withdrawal by Subject|15|||
162002076|NCT01553084|585058198|FG001|Overall Study|Withdrawal by Subject|13|||
162002077|NCT01553084|585058199|FG002|Overall Study|Withdrawal by Subject|35|||
162002078|NCT02163902|585058201|FG000|Overall Study|Subject's Request|3|||
162002079|NCT02163902|585058202|FG001|Overall Study|Subject's Request|4|||
162002080|NCT02163902|585058201|FG000|Overall Study|Lost to Follow-up|6|||
162002081|NCT02163902|585058202|FG001|Overall Study|Lost to Follow-up|7|||
162002082|NCT02163902|585058201|FG000|Overall Study|Administrative Decision|2|||
162002083|NCT02163902|585058202|FG001|Overall Study|Administrative Decision|2|||
162002084|NCT03119259|585058203|FG000|Overall Study|Withdrawn as no longer eligible|1|||
162002085|NCT03119259|585058204|FG001|Overall Study|Withdrawn as no longer eligible|0|||
162002086|NCT03119259|585058203|FG000|Overall Study|Withdrawal by Subject|4|||
162002087|NCT03119259|585058204|FG001|Overall Study|Withdrawal by Subject|2|||
162002088|NCT03119259|585058203|FG000|Overall Study|Lost to Follow-up|0|||
162002089|NCT03119259|585058204|FG001|Overall Study|Lost to Follow-up|1|||
162002090|NCT00844376|585058208|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
162002091|NCT00844376|585058209|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
162002092|NCT00539981|585058215|FG000|Overall Study|Adverse events (AE)|3|||
162002093|NCT00539981|585058216|FG001|Overall Study|Adverse events (AE)|3|||
162002094|NCT00539981|585058215|FG000|Overall Study|Lost to Follow-up|260|||
162002095|NCT00539981|585058216|FG001|Overall Study|Lost to Follow-up|251|||
162002096|NCT00539981|585058215|FG000|Overall Study|Withdrew consent|22|||
162002097|NCT00539981|585058216|FG001|Overall Study|Withdrew consent|14|||
162002098|NCT00539981|585058215|FG000|Overall Study|Death|1|||
162042812|NCT00568685|585214196|FG000|Overall Study|Adverse Event|2|||
162042813|NCT00568685|585214197|FG001|Overall Study|Adverse Event|3|||
162042814|NCT00568685|585214198|FG002|Overall Study|Adverse Event|3|||
162042815|NCT00568685|585214196|FG000|Overall Study|Withdrawal by Subject|7|||
162042816|NCT00568685|585214197|FG001|Overall Study|Withdrawal by Subject|2|||
162042817|NCT00568685|585214198|FG002|Overall Study|Withdrawal by Subject|2|||
162042818|NCT00568685|585214196|FG000|Overall Study|Protocol Violation|1|||
162042819|NCT00568685|585214197|FG001|Overall Study|Protocol Violation|0|||
162042820|NCT00568685|585214198|FG002|Overall Study|Protocol Violation|0|||
162042821|NCT02787551|585214199|FG000|Core Period: 26 Weeks|Adverse Event|10|||
162042822|NCT02787551|585214200|FG001|Core Period: 26 Weeks|Adverse Event|0|||
162042823|NCT02787551|585214199|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
162042824|NCT02787551|585214200|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
162042825|NCT02787551|585214199|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
162042826|NCT02787551|585214200|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
162042827|NCT02787551|585214199|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
162042828|NCT02787551|585214200|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
162042829|NCT02787551|585214199|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
162042830|NCT02787551|585214200|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
162042831|NCT02787551|585214199|FG000|Core Period: 26 Weeks|Other than specified|3|||
162042832|NCT02787551|585214200|FG001|Core Period: 26 Weeks|Other than specified|1|||
162042833|NCT02787551|585214199|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
162042834|NCT02787551|585214200|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
162042835|NCT02787551|585214199|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
162042836|NCT02787551|585214200|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
162042837|NCT02787551|585214199|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
162042838|NCT02787551|585214200|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
162042839|NCT03799211|585214201|FG000|Overall Study|Lost to Follow-up|2|||
162042840|NCT03799211|585214202|FG001|Overall Study|Lost to Follow-up|13|||
162042841|NCT03799211|585214201|FG000|Overall Study|Withdrawal by Subject|2|||
162042842|NCT03799211|585214202|FG001|Overall Study|Withdrawal by Subject|0|||
162042843|NCT00764491|585214203|FG000|Overall Study|Lost to Follow-up|35|||
162042844|NCT00764491|585214204|FG001|Overall Study|Lost to Follow-up|17|||
162042845|NCT03538431|585214207|FG000|Overall Study|Physician Decision|0|||
162042846|NCT03538431|585214208|FG001|Overall Study|Physician Decision|1|||
162042847|NCT03538431|585214207|FG000|Overall Study|Withdrawal by Subject|1|||
162042848|NCT03538431|585214208|FG001|Overall Study|Withdrawal by Subject|0|||
162042849|NCT00620464|585214209|FG000|Overall Study|Adverse Event|15|||
162042850|NCT00620464|585214210|FG001|Overall Study|Adverse Event|17|||
162042851|NCT00620464|585214209|FG000|Overall Study|Lost to Follow-up|1|||
162042852|NCT00620464|585214210|FG001|Overall Study|Lost to Follow-up|1|||
162042853|NCT00620464|585214209|FG000|Overall Study|Planning Pregnancy|1|||
162042854|NCT00620464|585214210|FG001|Overall Study|Planning Pregnancy|4|||
162042855|NCT00620464|585214209|FG000|Overall Study|Personal|2|||
162042856|NCT00620464|585214210|FG001|Overall Study|Personal|2|||
162042857|NCT00620464|585214209|FG000|Overall Study|Used prohibited medication|1|||
162042858|NCT00620464|585214210|FG001|Overall Study|Used prohibited medication|0|||
162042859|NCT03139279|585214211|FG000|Overall Study|Physician Decision|2|||
162042860|NCT03139279|585214212|FG001|Overall Study|Physician Decision|0|||
162042861|NCT03139279|585214211|FG000|Overall Study|Protocol Violation|5|||
162042862|NCT03139279|585214212|FG001|Overall Study|Protocol Violation|4|||
162042863|NCT03139279|585214211|FG000|Overall Study|Withdrawal by Subject|0|||
162042864|NCT03139279|585214212|FG001|Overall Study|Withdrawal by Subject|2|||
162042865|NCT05394350|585214213|FG000|Overall Study|Death|2|||
162042866|NCT05394350|585214214|FG001|Overall Study|Death|2|||
162042867|NCT05394350|585214215|FG002|Overall Study|Death|4|||
162042868|NCT05394350|585214216|FG003|Overall Study|Death|0|||
162002099|NCT00539981|585058216|FG001|Overall Study|Death|1|||
162002100|NCT00539981|585058215|FG000|Overall Study|Other reason-unspecified|9|||
162002101|NCT00539981|585058216|FG001|Overall Study|Other reason-unspecified|13|||
162002102|NCT01759420|585058217|FG000|Overall Study|Screen failure|5|||
162002103|NCT01759420|585058217|FG000|Overall Study|Inaccurate EKG machine readings|1|||
162002104|NCT01129622|585058218|FG000|Overall Study|Withdrawal by Subject|2|||
162002105|NCT00647296|585058222|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
162002106|NCT00647296|585058223|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
162002107|NCT00647296|585058224|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
162002108|NCT00647296|585058225|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
162002109|NCT00647296|585058222|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
162002110|NCT00647296|585058223|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
162002111|NCT00647296|585058224|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
162002112|NCT00647296|585058225|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
162002113|NCT00647296|585058222|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
162002114|NCT00647296|585058223|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
162002115|NCT00647296|585058224|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
162002116|NCT00647296|585058225|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
162002117|NCT00647296|585058222|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
162002118|NCT00647296|585058223|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
162002119|NCT00647296|585058224|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
162002120|NCT00647296|585058225|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
162002121|NCT00647296|585058222|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
162002122|NCT00647296|585058223|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
162002123|NCT00647296|585058224|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
162002124|NCT00647296|585058225|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
162002125|NCT00647296|585058222|FG000|Part 2: 4-week Placebo Washout|Death|3|||
162002126|NCT00647296|585058223|FG001|Part 2: 4-week Placebo Washout|Death|0|||
162002127|NCT00647296|585058224|FG002|Part 2: 4-week Placebo Washout|Death|0|||
162002128|NCT00647296|585058225|FG003|Part 2: 4-week Placebo Washout|Death|0|||
162002129|NCT00647296|585058222|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
162002130|NCT00647296|585058223|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
162002131|NCT00647296|585058224|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
162002132|NCT00647296|585058225|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
162002133|NCT00647296|585058222|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
162002134|NCT00647296|585058223|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
162002135|NCT00647296|585058224|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
162002136|NCT00647296|585058225|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
162002137|NCT00647296|585058222|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
162002138|NCT00647296|585058223|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
162002139|NCT00647296|585058224|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
162002140|NCT00647296|585058225|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
162002141|NCT00647296|585058222|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
162002142|NCT00647296|585058223|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
162002143|NCT00647296|585058224|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
162002144|NCT00647296|585058225|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
162002145|NCT00647296|585058222|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
162002146|NCT00647296|585058223|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
162002147|NCT00647296|585058224|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
162002148|NCT00647296|585058225|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
162002149|NCT00871871|585058226|FG000|Part I|Adverse Event|0|||
162002150|NCT00871871|585058227|FG001|Part I|Adverse Event|2|||
162002151|NCT00871871|585058228|FG002|Part I|Adverse Event|0|||
162002152|NCT00871871|585058229|FG003|Part I|Adverse Event|0|||
162002153|NCT00871871|585058226|FG000|Part I|Withdrawal by Subject|3|||
162002154|NCT00871871|585058227|FG001|Part I|Withdrawal by Subject|0|||
162002155|NCT00871871|585058228|FG002|Part I|Withdrawal by Subject|0|||
162002156|NCT00871871|585058229|FG003|Part I|Withdrawal by Subject|0|||
162002157|NCT00871871|585058226|FG000|Part I|Laboratory abnormality|0|||
162002158|NCT00871871|585058227|FG001|Part I|Laboratory abnormality|1|||
162002159|NCT00871871|585058228|FG002|Part I|Laboratory abnormality|0|||
162002160|NCT00871871|585058229|FG003|Part I|Laboratory abnormality|0|||
162002161|NCT00871871|585058226|FG000|Part II|Lack of Efficacy|0|||
162002162|NCT00871871|585058227|FG001|Part II|Lack of Efficacy|0|||
162002163|NCT00871871|585058228|FG002|Part II|Lack of Efficacy|1|||
162002164|NCT00871871|585058229|FG003|Part II|Lack of Efficacy|0|||
162002165|NCT00871871|585058226|FG000|Part II|Withdrawal by Subject|0|||
162002166|NCT00871871|585058227|FG001|Part II|Withdrawal by Subject|0|||
162002167|NCT00871871|585058228|FG002|Part II|Withdrawal by Subject|2|||
162002168|NCT00871871|585058229|FG003|Part II|Withdrawal by Subject|1|||
162002169|NCT00871871|585058226|FG000|Part II|Adverse Event|0|||
162002170|NCT00871871|585058227|FG001|Part II|Adverse Event|0|||
162002171|NCT00871871|585058228|FG002|Part II|Adverse Event|1|||
162002172|NCT00871871|585058229|FG003|Part II|Adverse Event|2|||
162002173|NCT00871871|585058226|FG000|Part II|Protocol Violation|0|||
162002174|NCT00871871|585058227|FG001|Part II|Protocol Violation|0|||
162002175|NCT00871871|585058228|FG002|Part II|Protocol Violation|0|||
162002176|NCT00871871|585058229|FG003|Part II|Protocol Violation|1|||
162002177|NCT04612725|585058230|FG000|Overall Study|Adverse Event|1|||
162002178|NCT04612725|585058231|FG001|Overall Study|Adverse Event|3|||
162002179|NCT04612725|585058232|FG002|Overall Study|Adverse Event|1|||
162002180|NCT04612725|585058233|FG003|Overall Study|Adverse Event|0|||
162002181|NCT04612725|585058234|FG004|Overall Study|Adverse Event|1|||
162002182|NCT04612725|585058230|FG000|Overall Study|Lost to Follow-up|0|||
162002183|NCT04612725|585058231|FG001|Overall Study|Lost to Follow-up|1|||
162002184|NCT04612725|585058232|FG002|Overall Study|Lost to Follow-up|0|||
162002185|NCT04612725|585058233|FG003|Overall Study|Lost to Follow-up|0|||
162002186|NCT04612725|585058234|FG004|Overall Study|Lost to Follow-up|0|||
162002187|NCT04612725|585058230|FG000|Overall Study|Physician Decision|2|||
162002188|NCT04612725|585058231|FG001|Overall Study|Physician Decision|0|||
162002189|NCT04612725|585058232|FG002|Overall Study|Physician Decision|0|||
162002190|NCT04612725|585058233|FG003|Overall Study|Physician Decision|0|||
162002191|NCT04612725|585058234|FG004|Overall Study|Physician Decision|0|||
162002192|NCT04612725|585058230|FG000|Overall Study|Study terminated by sponsor|3|||
162002193|NCT04612725|585058231|FG001|Overall Study|Study terminated by sponsor|1|||
162002194|NCT04612725|585058232|FG002|Overall Study|Study terminated by sponsor|2|||
162002195|NCT04612725|585058233|FG003|Overall Study|Study terminated by sponsor|4|||
162002196|NCT04612725|585058234|FG004|Overall Study|Study terminated by sponsor|5|||
162002197|NCT04612725|585058230|FG000|Overall Study|Withdrawal by Subject|8|||
162002198|NCT04612725|585058231|FG001|Overall Study|Withdrawal by Subject|3|||
162002199|NCT04612725|585058232|FG002|Overall Study|Withdrawal by Subject|5|||
162002200|NCT04612725|585058233|FG003|Overall Study|Withdrawal by Subject|1|||
162002201|NCT04612725|585058234|FG004|Overall Study|Withdrawal by Subject|9|||
162002202|NCT04612725|585058230|FG000|Overall Study|Other|0|||
162002203|NCT04612725|585058231|FG001|Overall Study|Other|0|||
162002204|NCT04612725|585058232|FG002|Overall Study|Other|0|||
162002205|NCT04612725|585058233|FG003|Overall Study|Other|0|||
162002206|NCT04612725|585058234|FG004|Overall Study|Other|1|||
162002207|NCT03069352|585058235|FG000|Overall Study|Ongoing|12|||
162002208|NCT03069352|585058236|FG001|Overall Study|Ongoing|40|||
162002209|NCT02621424|585058237|FG000|Overall Study|Withdrawal by Subject|1|||
162002210|NCT02621424|585058238|FG001|Overall Study|Withdrawal by Subject|2|||
162002211|NCT00948064|585060993|FG000|Phase I|No treatment received|1|||
162002212|NCT00948064|585060994|FG001|Phase I|No treatment received|0|||
162002213|NCT00948064|585060995|FG002|Phase I|No treatment received|0|||
162002214|NCT00948064|585060993|FG000|Phase II|Physician Decision|0|||
162002215|NCT00948064|585060994|FG001|Phase II|Physician Decision|0|||
162002216|NCT00948064|585060995|FG002|Phase II|Physician Decision|1|||
162002217|NCT00948064|585060993|FG000|Phase II|Withdrawal by Subject|0|||
162002218|NCT00948064|585060994|FG001|Phase II|Withdrawal by Subject|1|||
162002219|NCT00948064|585060995|FG002|Phase II|Withdrawal by Subject|0|||
162002220|NCT04416204|585061004|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
162002221|NCT04416204|585061005|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
162002222|NCT04416204|585061006|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
162002223|NCT04416204|585061007|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
162002224|NCT01959503|585061008|FG000|Overall Study|Death|2|||
162002225|NCT01959503|585061009|FG001|Overall Study|Death|1|||
162002226|NCT01959503|585061008|FG000|Overall Study|Randomized but not treated|1|||
162002227|NCT01959503|585061009|FG001|Overall Study|Randomized but not treated|1|||
162002228|NCT01393158|585061011|FG000|Overall Study|Adverse Event|1|||
162002229|NCT01393158|585061012|FG001|Overall Study|Adverse Event|0|||
162002230|NCT04233801|585061014|FG000|Overall Study|Other than listed|0|||
162002231|NCT04233801|585061015|FG001|Overall Study|Other than listed|0|||
162002232|NCT04233801|585061016|FG002|Overall Study|Other than listed|1|||
162002233|NCT04233801|585061014|FG000|Overall Study|Withdrawal by Subject|0|||
162002234|NCT04233801|585061015|FG001|Overall Study|Withdrawal by Subject|2|||
162002235|NCT04233801|585061016|FG002|Overall Study|Withdrawal by Subject|3|||
162002236|NCT02173769|585061017|FG000|Overall Study|Protocol Violation|4|||
162002237|NCT00683878|585061028|FG000|Overall Study|Lack of Efficacy|3|||
162002238|NCT00683878|585061029|FG001|Overall Study|Lack of Efficacy|0|||
162002239|NCT00683878|585061030|FG002|Overall Study|Lack of Efficacy|1|||
162002240|NCT00683878|585061028|FG000|Overall Study|Adverse Event|4|||
162002241|NCT00683878|585061029|FG001|Overall Study|Adverse Event|3|||
162002242|NCT00683878|585061030|FG002|Overall Study|Adverse Event|3|||
162002243|NCT00683878|585061028|FG000|Overall Study|Withdrawal by Subject|9|||
162002244|NCT00683878|585061029|FG001|Overall Study|Withdrawal by Subject|8|||
162002245|NCT00683878|585061030|FG002|Overall Study|Withdrawal by Subject|6|||
162002246|NCT00683878|585061028|FG000|Overall Study|Death|0|||
162002247|NCT00683878|585061029|FG001|Overall Study|Death|1|||
162002248|NCT00683878|585061030|FG002|Overall Study|Death|0|||
162002249|NCT00683878|585061028|FG000|Overall Study|Lost to Follow-up|4|||
162002250|NCT00683878|585061029|FG001|Overall Study|Lost to Follow-up|2|||
162002251|NCT00683878|585061030|FG002|Overall Study|Lost to Follow-up|4|||
162002252|NCT00683878|585061028|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
162002253|NCT00683878|585061029|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
162002254|NCT00683878|585061030|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
162002255|NCT04024891|585061031|FG000|Overall Study|Pregnancy|0|||
162002256|NCT04024891|585061032|FG001|Overall Study|Pregnancy|1|||
162002257|NCT03095651|585061040|FG000|Overall Study|Lost to Follow-up|1|||
162002258|NCT03095651|585061041|FG001|Overall Study|Lost to Follow-up|1|||
162002259|NCT03095651|585061042|FG002|Overall Study|Lost to Follow-up|0|||
162002260|NCT03095651|585061043|FG003|Overall Study|Lost to Follow-up|1|||
162002261|NCT03095651|585061044|FG004|Overall Study|Lost to Follow-up|0|||
162002262|NCT03095651|585061045|FG005|Overall Study|Lost to Follow-up|0|||
162002263|NCT03095651|585061046|FG006|Overall Study|Lost to Follow-up|0|||
162002264|NCT03095651|585061047|FG007|Overall Study|Lost to Follow-up|0|||
162002265|NCT03095651|585061040|FG000|Overall Study|Withdrawal by Subject|0|||
162002266|NCT03095651|585061041|FG001|Overall Study|Withdrawal by Subject|0|||
162002267|NCT03095651|585061042|FG002|Overall Study|Withdrawal by Subject|0|||
162002268|NCT03095651|585061043|FG003|Overall Study|Withdrawal by Subject|0|||
162002269|NCT03095651|585061044|FG004|Overall Study|Withdrawal by Subject|0|||
162002270|NCT03095651|585061045|FG005|Overall Study|Withdrawal by Subject|1|||
162002271|NCT03095651|585061046|FG006|Overall Study|Withdrawal by Subject|0|||
162002272|NCT03095651|585061047|FG007|Overall Study|Withdrawal by Subject|0|||
162002273|NCT04124939|585061053|FG000|Overall Study|Lost to Follow-up|1|||
162002274|NCT04124939|585061054|FG001|Overall Study|Lost to Follow-up|3|||
162002275|NCT00308139|585061057|FG000|Overall Study|Adverse Event|20|||
162002276|NCT00308139|585061058|FG001|Overall Study|Adverse Event|14|||
162002277|NCT00308139|585061057|FG000|Overall Study|Lost to Follow-up|13|||
162002278|NCT00308139|585061058|FG001|Overall Study|Lost to Follow-up|8|||
162002279|NCT00308139|585061057|FG000|Overall Study|Protocol Violation|3|||
162002280|NCT00308139|585061058|FG001|Overall Study|Protocol Violation|2|||
162002281|NCT00308139|585061057|FG000|Overall Study|Withdrawal of Consent|40|||
162002282|NCT00308139|585061058|FG001|Overall Study|Withdrawal of Consent|42|||
162002283|NCT00308139|585061057|FG000|Overall Study|Investigator Decision|11|||
162002284|NCT00308139|585061058|FG001|Overall Study|Investigator Decision|10|||
162002285|NCT00308139|585061057|FG000|Overall Study|Loss of Glucose Control|5|||
162002286|NCT00308139|585061058|FG001|Overall Study|Loss of Glucose Control|7|||
162002287|NCT00308139|585061057|FG000|Overall Study|Administrative|1|||
162002288|NCT00308139|585061058|FG001|Overall Study|Administrative|4|||
162002289|NCT00308139|585061057|FG000|Overall Study|Other|1|||
162002290|NCT00308139|585061058|FG001|Overall Study|Other|0|||
162002291|NCT00791388|585061063|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
162002292|NCT00791388|585061064|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
162002293|NCT00791388|585061065|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
162002294|NCT00791388|585061066|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
162002295|NCT00791388|585061067|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
162002296|NCT00791388|585061063|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
162002297|NCT00791388|585061064|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
162002298|NCT00791388|585061065|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
162002299|NCT00791388|585061066|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
162002300|NCT00791388|585061067|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
162002301|NCT00791388|585061063|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
162002302|NCT00791388|585061064|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
162002303|NCT00791388|585061065|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
162002304|NCT00791388|585061066|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
162002305|NCT00791388|585061067|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
162002306|NCT00435409|585061076|FG000|Overall Study|Protocol Violation|1|||
162002307|NCT00435409|585061077|FG001|Overall Study|Protocol Violation|2|||
162002308|NCT00435409|585061078|FG002|Overall Study|Protocol Violation|0|||
162002309|NCT00435409|585061076|FG000|Overall Study|Lost to Follow-up|1|||
162002310|NCT00435409|585061077|FG001|Overall Study|Lost to Follow-up|2|||
162002311|NCT00435409|585061078|FG002|Overall Study|Lost to Follow-up|0|||
162002312|NCT00435409|585061076|FG000|Overall Study|Death|8|||
162002313|NCT00435409|585061077|FG001|Overall Study|Death|6|||
162002314|NCT00435409|585061078|FG002|Overall Study|Death|6|||
162002315|NCT00435409|585061076|FG000|Overall Study|Objective progression or relapse|158|||
162002316|NCT00435409|585061077|FG001|Overall Study|Objective progression or relapse|93|||
162002317|NCT00435409|585061078|FG002|Overall Study|Objective progression or relapse|58|||
162002318|NCT00435409|585061076|FG000|Overall Study|Global deterioration of health status|0|||
162002319|NCT00435409|585061077|FG001|Overall Study|Global deterioration of health status|0|||
162002320|NCT00435409|585061078|FG002|Overall Study|Global deterioration of health status|4|||
162002321|NCT00435409|585061076|FG000|Overall Study|Withdrawal by Subject|8|||
162002322|NCT00435409|585061077|FG001|Overall Study|Withdrawal by Subject|7|||
162002323|NCT00435409|585061078|FG002|Overall Study|Withdrawal by Subject|1|||
162002324|NCT00435409|585061076|FG000|Overall Study|Other|45|||
162002325|NCT00435409|585061077|FG001|Overall Study|Other|30|||
162002326|NCT00435409|585061078|FG002|Overall Study|Other|1|||
162002327|NCT00435409|585061076|FG000|Overall Study|Adverse Event|0|||
162002328|NCT00435409|585061077|FG001|Overall Study|Adverse Event|0|||
162002329|NCT00435409|585061078|FG002|Overall Study|Adverse Event|8|||
162002330|NCT00435409|585061076|FG000|Overall Study|Sponsor decision|0|||
162002331|NCT00435409|585061077|FG001|Overall Study|Sponsor decision|3|||
162002332|NCT00435409|585061078|FG002|Overall Study|Sponsor decision|0|||
162002333|NCT04750824|585061079|FG000|Overall Study|Toxicity/intolerability|3|||
162002334|NCT04750824|585061080|FG001|Overall Study|Toxicity/intolerability|1|||
162002335|NCT04750824|585061079|FG000|Overall Study|Death|1|||
162002336|NCT04750824|585061080|FG001|Overall Study|Death|3|||
162002337|NCT04750824|585061079|FG000|Overall Study|Scheduled duration of therapy complete|1|||
162002338|NCT04750824|585061080|FG001|Overall Study|Scheduled duration of therapy complete|9|||
162002339|NCT04750824|585061079|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
162002340|NCT04750824|585061080|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
162002341|NCT05196828|585061081|FG000|Overall Study|Withdrawal by Subject|2|||
162002342|NCT05196828|585061082|FG001|Overall Study|Withdrawal by Subject|0|||
162002343|NCT05196828|585061081|FG000|Overall Study|Lost to Follow-up|0|||
162002344|NCT05196828|585061082|FG001|Overall Study|Lost to Follow-up|4|||
162002345|NCT05196828|585061081|FG000|Overall Study|Adverse Event|1|||
162002346|NCT05196828|585061082|FG001|Overall Study|Adverse Event|0|||
162002347|NCT02763644|585061083|FG000|Overall Study|Patient/guardian decision|1|||
162002348|NCT02763644|585061084|FG001|Overall Study|Patient/guardian decision|0|||
162002349|NCT02763644|585061083|FG000|Overall Study|Death|1|||
162002350|NCT02763644|585061084|FG001|Overall Study|Death|1|||
162002351|NCT02763644|585061083|FG000|Overall Study|Adverse Event|1|||
162002352|NCT02763644|585061084|FG001|Overall Study|Adverse Event|1|||
162002353|NCT02356159|585061085|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
162002354|NCT02356159|585061086|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
162002355|NCT02356159|585061087|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
162002356|NCT02356159|585061088|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
162002357|NCT02356159|585061089|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
162002358|NCT02356159|585061090|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
162002359|NCT03192176|585061091|FG000|Overall Study|Adverse Event|1|||
162002360|NCT03192176|585061092|FG001|Overall Study|Adverse Event|0|||
162002361|NCT03192176|585061093|FG002|Overall Study|Adverse Event|4|||
162002362|NCT03192176|585061094|FG003|Overall Study|Adverse Event|5|||
162002363|NCT03192176|585061095|FG004|Overall Study|Adverse Event|3|||
162002364|NCT03192176|585061096|FG005|Overall Study|Adverse Event|2|||
162002365|NCT03192176|585061097|FG006|Overall Study|Adverse Event|3|||
162002366|NCT03192176|585061098|FG007|Overall Study|Adverse Event|3|||
162002367|NCT03192176|585061091|FG000|Overall Study|Lost to Follow-up|0|||
162002368|NCT03192176|585061092|FG001|Overall Study|Lost to Follow-up|0|||
162002369|NCT03192176|585061093|FG002|Overall Study|Lost to Follow-up|1|||
162002370|NCT03192176|585061094|FG003|Overall Study|Lost to Follow-up|2|||
162002371|NCT03192176|585061095|FG004|Overall Study|Lost to Follow-up|3|||
162002372|NCT03192176|585061096|FG005|Overall Study|Lost to Follow-up|1|||
162002373|NCT03192176|585061097|FG006|Overall Study|Lost to Follow-up|1|||
162002374|NCT03192176|585061098|FG007|Overall Study|Lost to Follow-up|1|||
162002375|NCT03192176|585061091|FG000|Overall Study|Physician Decision|1|||
162002376|NCT03192176|585061092|FG001|Overall Study|Physician Decision|0|||
162002377|NCT03192176|585061093|FG002|Overall Study|Physician Decision|0|||
162002378|NCT03192176|585061094|FG003|Overall Study|Physician Decision|0|||
162002379|NCT03192176|585061095|FG004|Overall Study|Physician Decision|0|||
162002380|NCT03192176|585061096|FG005|Overall Study|Physician Decision|2|||
162002381|NCT03192176|585061097|FG006|Overall Study|Physician Decision|1|||
162002382|NCT03192176|585061098|FG007|Overall Study|Physician Decision|0|||
162002383|NCT03192176|585061091|FG000|Overall Study|Protocol Deviation|1|||
162002384|NCT03192176|585061092|FG001|Overall Study|Protocol Deviation|1|||
162002385|NCT03192176|585061093|FG002|Overall Study|Protocol Deviation|0|||
162002386|NCT03192176|585061094|FG003|Overall Study|Protocol Deviation|0|||
162002387|NCT03192176|585061095|FG004|Overall Study|Protocol Deviation|2|||
162002388|NCT03192176|585061096|FG005|Overall Study|Protocol Deviation|0|||
162002389|NCT03192176|585061097|FG006|Overall Study|Protocol Deviation|0|||
162002390|NCT03192176|585061098|FG007|Overall Study|Protocol Deviation|0|||
162002391|NCT03192176|585061091|FG000|Overall Study|Withdrawal by Subject|3|||
162002392|NCT03192176|585061092|FG001|Overall Study|Withdrawal by Subject|4|||
162002393|NCT03192176|585061093|FG002|Overall Study|Withdrawal by Subject|0|||
162002394|NCT03192176|585061094|FG003|Overall Study|Withdrawal by Subject|4|||
162002395|NCT03192176|585061095|FG004|Overall Study|Withdrawal by Subject|3|||
162002396|NCT03192176|585061096|FG005|Overall Study|Withdrawal by Subject|4|||
162002397|NCT03192176|585061097|FG006|Overall Study|Withdrawal by Subject|4|||
162002398|NCT03192176|585061098|FG007|Overall Study|Withdrawal by Subject|2|||
162002399|NCT03192176|585061091|FG000|Overall Study|Miscellaneous|1|||
162002400|NCT03192176|585061092|FG001|Overall Study|Miscellaneous|0|||
162002401|NCT03192176|585061093|FG002|Overall Study|Miscellaneous|1|||
162002402|NCT03192176|585061094|FG003|Overall Study|Miscellaneous|1|||
162002403|NCT03192176|585061095|FG004|Overall Study|Miscellaneous|1|||
162002404|NCT03192176|585061096|FG005|Overall Study|Miscellaneous|2|||
162002405|NCT03192176|585061097|FG006|Overall Study|Miscellaneous|0|||
162002406|NCT03192176|585061098|FG007|Overall Study|Miscellaneous|1|||
162002407|NCT00836589|585061103|FG000|Overall Study|Lost to Follow-up|246|||
162002408|NCT00836589|585061103|FG000|Overall Study|Death|429|||
162002409|NCT00836589|585061103|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
162002410|NCT00117637|585061104|FG000|First Intervention (Period 1)|Adverse Event|11|||
162002411|NCT00117637|585061105|FG001|First Intervention (Period 1)|Adverse Event|16|||
162002412|NCT00117637|585061104|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
162002413|NCT00117637|585061105|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
162002414|NCT00117637|585061104|FG000|First Intervention (Period 1)|Protocol Violation|1|||
162002415|NCT00117637|585061105|FG001|First Intervention (Period 1)|Protocol Violation|0|||
162002416|NCT00117637|585061104|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
162002417|NCT00117637|585061105|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
162002418|NCT00117637|585061104|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
162002419|NCT00117637|585061105|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
162002420|NCT00117637|585061104|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
162042869|NCT05394350|585214217|FG004|Overall Study|Death|1|||
162002421|NCT00117637|585061105|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
162002422|NCT00117637|585061104|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
162002423|NCT00117637|585061105|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
162002424|NCT00117637|585061104|FG000|First Intervention (Period 1)|reason not reported|0|||
162002425|NCT00117637|585061105|FG001|First Intervention (Period 1)|reason not reported|1|||
162002426|NCT00117637|585061104|FG000|Second Intervention (Period 2)|Adverse Event|0|||
162002427|NCT00117637|585061105|FG001|Second Intervention (Period 2)|Adverse Event|9|||
162002428|NCT00117637|585061104|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
162002429|NCT00117637|585061105|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
162002430|NCT00117637|585061104|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
162002431|NCT00117637|585061105|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
162002432|NCT00117637|585061104|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
162002433|NCT00117637|585061105|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
162002434|NCT00117637|585061104|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
162002435|NCT00117637|585061105|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
162002436|NCT00117637|585061104|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
162002437|NCT00117637|585061105|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
162002438|NCT00117637|585061104|FG000|Second Intervention (Period 2)|reason not reported|1|||
162002439|NCT00117637|585061105|FG001|Second Intervention (Period 2)|reason not reported|0|||
162002440|NCT02914639|585061108|FG000|Overall Study|Withdrawal by Subject|0|||
162002441|NCT02914639|585061109|FG001|Overall Study|Withdrawal by Subject|2|||
162002442|NCT01582061|585061110|FG000|Overall Study|Lack of Efficacy|3|||
162002443|NCT01582061|585061111|FG001|Overall Study|Lack of Efficacy|23|||
162002444|NCT01582061|585061110|FG000|Overall Study|Adverse Event|12|||
162002445|NCT01582061|585061111|FG001|Overall Study|Adverse Event|8|||
162002446|NCT01582061|585061110|FG000|Overall Study|Withdrawal by Subject|10|||
162002447|NCT01582061|585061111|FG001|Overall Study|Withdrawal by Subject|4|||
162002448|NCT01582061|585061110|FG000|Overall Study|Abnormal laboratory value(s)|1|||
162002449|NCT01582061|585061111|FG001|Overall Study|Abnormal laboratory value(s)|0|||
162002450|NCT01582061|585061110|FG000|Overall Study|Death|0|||
162002451|NCT01582061|585061111|FG001|Overall Study|Death|1|||
162002452|NCT01582061|585061110|FG000|Overall Study|condition no longer requires study drug|1|||
162002453|NCT01582061|585061111|FG001|Overall Study|condition no longer requires study drug|0|||
162002454|NCT01582061|585061110|FG000|Overall Study|Lost to Follow-up|1|||
162002455|NCT01582061|585061111|FG001|Overall Study|Lost to Follow-up|0|||
162002456|NCT00436332|585061115|FG000|Overall Study|Adverse Event|9|||
162002457|NCT00436332|585061115|FG000|Overall Study|Withdrawal by Subject|2|||
162002458|NCT00436332|585061115|FG000|Overall Study|Progression|59|||
162002459|NCT00436332|585061115|FG000|Overall Study|Death|2|||
162002460|NCT00436332|585061115|FG000|Overall Study|Not Protocol Specified|6|||
162002461|NCT00436332|585061115|FG000|Overall Study|Ineligible|2|||
162002462|NCT00436332|585061115|FG000|Overall Study|Never Received Treatment|3|||
162002463|NCT01924845|585061116|FG000|Overall Study|Adverse Event|3|||
162002464|NCT01924845|585061116|FG000|Overall Study|Withdrawal by Subject|2|||
162002465|NCT01924845|585061116|FG000|Overall Study|Protocol Violation|1|||
162002466|NCT00062439|585061117|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
162002467|NCT00062439|585061117|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
162002468|NCT00062439|585061117|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
162002469|NCT00062439|585061117|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
162002470|NCT00062439|585061117|FG000|Post Chemoradiation Assessment|Death|1|||
162002471|NCT00062439|585061117|FG000|Post Chemoradiation Assessment|Disease progression|2|||
162002472|NCT00062439|585061117|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
162002473|NCT00062439|585061117|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
162002474|NCT00062439|585061117|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
162002475|NCT00062439|585061117|FG000|Surgery|Physician Decision|4|||
162002476|NCT00062439|585061117|FG000|Surgery|Death|1|||
162002477|NCT00062439|585061117|FG000|Surgery|Adverse Event|2|||
162002478|NCT00062439|585061117|FG000|Consolidation Chemotherapy|Adverse Event|2|||
162002479|NCT03780452|585061118|FG000|Overall Study|Screening failure|2|||
162002480|NCT02388269|585061119|FG000|Overall Study|Adverse Event|2|||
162002481|NCT02388269|585061120|FG001|Overall Study|Adverse Event|0|||
162002482|NCT02388269|585061121|FG002|Overall Study|Adverse Event|0|||
162002483|NCT02388269|585061119|FG000|Overall Study|Withdrawal by Subject|1|||
162002484|NCT02388269|585061120|FG001|Overall Study|Withdrawal by Subject|2|||
162002485|NCT02388269|585061121|FG002|Overall Study|Withdrawal by Subject|0|||
162002486|NCT02388269|585061119|FG000|Overall Study|less than 50% stimulations|1|||
162002487|NCT02388269|585061120|FG001|Overall Study|less than 50% stimulations|0|||
162002488|NCT02388269|585061121|FG002|Overall Study|less than 50% stimulations|0|||
162002489|NCT02388269|585061119|FG000|Overall Study|no diary data|3|||
162002490|NCT02388269|585061120|FG001|Overall Study|no diary data|0|||
162002491|NCT02388269|585061121|FG002|Overall Study|no diary data|0|||
162002492|NCT02388269|585061119|FG000|Overall Study|Protocol Violation|2|||
162002493|NCT02388269|585061120|FG001|Overall Study|Protocol Violation|0|||
162002494|NCT02388269|585061121|FG002|Overall Study|Protocol Violation|0|||
162002495|NCT02388269|585061119|FG000|Overall Study|Screen Failure|0|||
162002496|NCT02388269|585061120|FG001|Overall Study|Screen Failure|0|||
162002497|NCT02388269|585061121|FG002|Overall Study|Screen Failure|10|||
162002498|NCT04698343|585061124|FG000|Overall Study|Withdrawal by Subject|6|||
162002499|NCT04698343|585061124|FG000|Overall Study|Physician Decision|2|||
162002500|NCT04698343|585061124|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
162002501|NCT04698343|585061124|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
162002502|NCT04698343|585061124|FG000|Overall Study|Personal reasons|3|||
162002503|NCT04698343|585061124|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
162002504|NCT00325897|585061128|FG000|Overall Study|Lost to Follow-up|12|||
162002505|NCT00325897|585061129|FG001|Overall Study|Lost to Follow-up|13|||
162002506|NCT03915717|585061132|FG000|Overall Study|EchoMark Not Implanted|6|||
162002507|NCT04079296|585061133|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
162002508|NCT04079296|585061134|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
162002509|NCT04079296|585061135|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
162002510|NCT04079296|585061136|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
162002511|NCT04079296|585061137|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
162002512|NCT04079296|585061133|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
162002513|NCT04079296|585061134|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
162002514|NCT04079296|585061135|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
162002515|NCT04079296|585061136|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
162002516|NCT04079296|585061137|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
162002517|NCT04079296|585061133|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
162002518|NCT04079296|585061134|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
162002519|NCT04079296|585061135|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
162002520|NCT04079296|585061136|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
162002521|NCT04079296|585061137|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
162002522|NCT04079296|585061133|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
162002523|NCT04079296|585061134|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
162002524|NCT04079296|585061135|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
162002525|NCT04079296|585061136|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
162002526|NCT04079296|585061137|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
162002527|NCT04079296|585061133|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
162002528|NCT04079296|585061134|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
162002529|NCT04079296|585061135|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
162002530|NCT04079296|585061136|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
162002531|NCT04079296|585061137|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
162002532|NCT04079296|585061133|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
162002533|NCT04079296|585061134|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
162002534|NCT04079296|585061135|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
162002535|NCT04079296|585061136|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
162002536|NCT04079296|585061137|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
162002537|NCT04079296|585061133|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
162002538|NCT04079296|585061134|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
162002539|NCT04079296|585061135|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
162002540|NCT04079296|585061136|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
162002541|NCT04079296|585061137|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
162002542|NCT04079296|585061133|FG000|Dose Expansion Phase (168 Days)|Death|0|||
162002543|NCT04079296|585061134|FG001|Dose Expansion Phase (168 Days)|Death|0|||
162002544|NCT04079296|585061135|FG002|Dose Expansion Phase (168 Days)|Death|0|||
162002545|NCT04079296|585061136|FG003|Dose Expansion Phase (168 Days)|Death|1|||
162002546|NCT04079296|585061137|FG004|Dose Expansion Phase (168 Days)|Death|0|||
162002547|NCT00467740|585061138|FG000|Overall Study|Adverse Event|0|||
162002548|NCT00467740|585061139|FG001|Overall Study|Adverse Event|0|||
162002549|NCT00467740|585061140|FG002|Overall Study|Adverse Event|1|||
162002550|NCT00467740|585061141|FG003|Overall Study|Adverse Event|0|||
162002551|NCT00467740|585061142|FG004|Overall Study|Adverse Event|0|||
162002552|NCT00467740|585061138|FG000|Overall Study|Protocol Violation|0|||
162002553|NCT00467740|585061139|FG001|Overall Study|Protocol Violation|0|||
162002554|NCT00467740|585061140|FG002|Overall Study|Protocol Violation|1|||
162002555|NCT00467740|585061141|FG003|Overall Study|Protocol Violation|0|||
162002556|NCT00467740|585061142|FG004|Overall Study|Protocol Violation|0|||
162002557|NCT00467740|585061138|FG000|Overall Study|Lost to Follow-up|0|||
162002558|NCT00467740|585061139|FG001|Overall Study|Lost to Follow-up|1|||
162002559|NCT00467740|585061140|FG002|Overall Study|Lost to Follow-up|0|||
162002560|NCT00467740|585061141|FG003|Overall Study|Lost to Follow-up|0|||
162002561|NCT00467740|585061142|FG004|Overall Study|Lost to Follow-up|0|||
162002562|NCT00467740|585061138|FG000|Overall Study|Withdrawal by Subject|1|||
162002563|NCT00467740|585061139|FG001|Overall Study|Withdrawal by Subject|1|||
162002564|NCT00467740|585061140|FG002|Overall Study|Withdrawal by Subject|0|||
162002565|NCT00467740|585061141|FG003|Overall Study|Withdrawal by Subject|1|||
162042870|NCT05394350|585214218|FG005|Overall Study|Death|0|||
162042871|NCT05394350|585214213|FG000|Overall Study|Study terminated by sponsor|1|||
162042872|NCT05394350|585214214|FG001|Overall Study|Study terminated by sponsor|1|||
162002566|NCT00467740|585061142|FG004|Overall Study|Withdrawal by Subject|0|||
162002567|NCT00467740|585061138|FG000|Overall Study|Lack of Efficacy|0|||
162002568|NCT00467740|585061139|FG001|Overall Study|Lack of Efficacy|1|||
162002569|NCT00467740|585061140|FG002|Overall Study|Lack of Efficacy|0|||
162002570|NCT00467740|585061141|FG003|Overall Study|Lack of Efficacy|0|||
162002571|NCT00467740|585061142|FG004|Overall Study|Lack of Efficacy|0|||
162002572|NCT02903160|585061143|FG000|Overall Study|Adverse Event|2|||
162002573|NCT02903160|585061143|FG000|Overall Study|Death|1|||
162002574|NCT02903160|585061143|FG000|Overall Study|Lost to Follow-up|2|||
162002575|NCT02903160|585061143|FG000|Overall Study|Withdrawal by Subject|1|||
162002576|NCT02903160|585061143|FG000|Overall Study|Medical Insurance Barriers|1|||
162002577|NCT01664910|585061146|FG000|Overall Study|Adverse Event|0|||
162002578|NCT01664910|585061147|FG001|Overall Study|Adverse Event|0|||
162002579|NCT01664910|585061148|FG002|Overall Study|Adverse Event|1|||
162002580|NCT02240485|585061149|FG000|3 Months Post-admission|Lost to Follow-up|1|||
162002581|NCT02240485|585061150|FG001|3 Months Post-admission|Lost to Follow-up|5|||
162002582|NCT02240485|585061149|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
162002583|NCT02240485|585061150|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
162002584|NCT02240485|585061149|FG000|9 Months Post-admission|Lost to Follow-up|3|||
162002585|NCT02240485|585061150|FG001|9 Months Post-admission|Lost to Follow-up|1|||
162002586|NCT02240485|585061149|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
162002587|NCT02240485|585061150|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
162002588|NCT02240485|585061149|FG000|18 Months Post-admission|Lost to Follow-up|1|||
162002589|NCT02240485|585061150|FG001|18 Months Post-admission|Lost to Follow-up|1|||
162002590|NCT02240485|585061149|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
162002591|NCT02240485|585061150|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
162002592|NCT02525471|585061151|FG000|Overall Study|Screen Failure|6|||
162002593|NCT02525471|585061151|FG000|Overall Study|Withdrawal by Subject|4|||
162002594|NCT02525471|585061151|FG000|Overall Study|Death|1|||
162002595|NCT00867165|585061155|FG000|Overall Study|Adverse Event|3|||
162002596|NCT00867165|585061156|FG001|Overall Study|Adverse Event|0|||
162002597|NCT00867165|585061155|FG000|Overall Study|Withdrawal by Subject|1|||
162002598|NCT00867165|585061156|FG001|Overall Study|Withdrawal by Subject|0|||
162002599|NCT03275740|585061157|FG000|Overall Study|Adverse Event|0|||
162002600|NCT03275740|585061158|FG001|Overall Study|Adverse Event|0|||
162002601|NCT03275740|585061159|FG002|Overall Study|Adverse Event|0|||
162002602|NCT03275740|585061160|FG003|Overall Study|Adverse Event|0|||
162002603|NCT03275740|585061161|FG004|Overall Study|Adverse Event|1|||
162002604|NCT03275740|585061162|FG005|Overall Study|Adverse Event|0|||
162002605|NCT03275740|585061163|FG006|Overall Study|Adverse Event|0|||
162002606|NCT03275740|585061164|FG007|Overall Study|Adverse Event|0|||
162002607|NCT03275740|585061165|FG008|Overall Study|Adverse Event|0|||
162002608|NCT03275740|585061166|FG009|Overall Study|Adverse Event|0|||
162002609|NCT03275740|585061167|FG010|Overall Study|Adverse Event|0|||
162002610|NCT03275740|585061168|FG011|Overall Study|Adverse Event|0|||
162002611|NCT03275740|585061157|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
162002612|NCT03275740|585061158|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
162002613|NCT03275740|585061159|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
162002614|NCT03275740|585061160|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
162002615|NCT03275740|585061161|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
162002616|NCT03275740|585061162|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
162002617|NCT03275740|585061163|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
162002618|NCT03275740|585061164|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
162002619|NCT03275740|585061165|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
162002620|NCT03275740|585061166|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
162002621|NCT03275740|585061167|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
162002622|NCT03275740|585061168|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
162002623|NCT03275740|585061157|FG000|Overall Study|Withdrawal by Subject|0|||
162002624|NCT03275740|585061158|FG001|Overall Study|Withdrawal by Subject|0|||
162002625|NCT03275740|585061159|FG002|Overall Study|Withdrawal by Subject|0|||
162002626|NCT03275740|585061160|FG003|Overall Study|Withdrawal by Subject|0|||
162002627|NCT03275740|585061161|FG004|Overall Study|Withdrawal by Subject|0|||
162002628|NCT03275740|585061162|FG005|Overall Study|Withdrawal by Subject|0|||
162002629|NCT03275740|585061163|FG006|Overall Study|Withdrawal by Subject|0|||
162002630|NCT03275740|585061164|FG007|Overall Study|Withdrawal by Subject|0|||
162002631|NCT03275740|585061165|FG008|Overall Study|Withdrawal by Subject|1|||
162002632|NCT03275740|585061166|FG009|Overall Study|Withdrawal by Subject|1|||
162002633|NCT03275740|585061167|FG010|Overall Study|Withdrawal by Subject|0|||
162002634|NCT03275740|585061168|FG011|Overall Study|Withdrawal by Subject|0|||
162002635|NCT00988884|585061169|FG000|Overall Study|Adverse Event|0|||
162002636|NCT00988884|585061170|FG001|Overall Study|Adverse Event|1|||
162002637|NCT00988884|585061169|FG000|Overall Study|Lost to Follow-up|20|||
162002638|NCT00988884|585061170|FG001|Overall Study|Lost to Follow-up|16|||
162002639|NCT00988884|585061169|FG000|Overall Study|Protocol Violation|0|||
162002640|NCT00988884|585061170|FG001|Overall Study|Protocol Violation|1|||
162002641|NCT00988884|585061169|FG000|Overall Study|Withdrawal by Subject|15|||
162002642|NCT00988884|585061170|FG001|Overall Study|Withdrawal by Subject|18|||
162002643|NCT04621448|585061172|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
162002644|NCT04621448|585061173|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
162002645|NCT04621448|585061174|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
162002646|NCT04621448|585061175|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
162002647|NCT04621448|585061172|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
162002648|NCT04621448|585061173|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
162002649|NCT04621448|585061174|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
162002650|NCT04621448|585061175|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
162002651|NCT04621448|585061172|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
162002652|NCT04621448|585061173|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
162002653|NCT04621448|585061174|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
162002654|NCT04621448|585061175|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
162002655|NCT04621448|585061172|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
162002656|NCT04621448|585061173|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
162002657|NCT04621448|585061174|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
162002658|NCT04621448|585061175|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
162002659|NCT00549640|585061176|FG000|Overall Study|Withdrawal by Subject|6|||
162002660|NCT00549640|585061177|FG001|Overall Study|Withdrawal by Subject|12|||
162002661|NCT00549640|585061176|FG000|Overall Study|Adverse Event|5|||
162042873|NCT05394350|585214215|FG002|Overall Study|Study terminated by sponsor|7|||
162042874|NCT05394350|585214216|FG003|Overall Study|Study terminated by sponsor|3|||
162002662|NCT00549640|585061177|FG001|Overall Study|Adverse Event|0|||
162002663|NCT00549640|585061176|FG000|Overall Study|Lost to Follow-up|7|||
162002664|NCT00549640|585061177|FG001|Overall Study|Lost to Follow-up|4|||
162002665|NCT02051764|585061178|FG000|Overall Study|Study terminated by sponsor|0|||
162002666|NCT02051764|585061179|FG001|Overall Study|Study terminated by sponsor|7|||
162002667|NCT00591006|585061180|FG000|Overall Study|Withdrawal by Subject|0|||
162002668|NCT00591006|585061181|FG001|Overall Study|Withdrawal by Subject|0|||
162002669|NCT00591006|585061182|FG002|Overall Study|Withdrawal by Subject|0|||
162002670|NCT00591006|585061183|FG003|Overall Study|Withdrawal by Subject|0|||
162002671|NCT00591006|585061184|FG004|Overall Study|Withdrawal by Subject|0|||
162002672|NCT00591006|585061185|FG005|Overall Study|Withdrawal by Subject|0|||
162002673|NCT00591006|585061186|FG006|Overall Study|Withdrawal by Subject|0|||
162002674|NCT00591006|585061187|FG007|Overall Study|Withdrawal by Subject|0|||
162002675|NCT00591006|585061188|FG008|Overall Study|Withdrawal by Subject|0|||
162002676|NCT00591006|585061189|FG009|Overall Study|Withdrawal by Subject|0|||
162002677|NCT00591006|585061190|FG010|Overall Study|Withdrawal by Subject|0|||
162002678|NCT00591006|585061191|FG011|Overall Study|Withdrawal by Subject|0|||
162002679|NCT00591006|585061192|FG012|Overall Study|Withdrawal by Subject|0|||
162002680|NCT00591006|585061193|FG013|Overall Study|Withdrawal by Subject|0|||
162002681|NCT00591006|585061194|FG014|Overall Study|Withdrawal by Subject|0|||
162002682|NCT00591006|585061195|FG015|Overall Study|Withdrawal by Subject|1|||
162002683|NCT00591006|585061196|FG016|Overall Study|Withdrawal by Subject|0|||
162002684|NCT00591006|585061197|FG017|Overall Study|Withdrawal by Subject|0|||
162002685|NCT00591006|585061198|FG018|Overall Study|Withdrawal by Subject|0|||
162002686|NCT00591006|585061199|FG019|Overall Study|Withdrawal by Subject|0|||
162002687|NCT00591006|585061200|FG020|Overall Study|Withdrawal by Subject|0|||
162002688|NCT00591006|585061201|FG021|Overall Study|Withdrawal by Subject|0|||
162002689|NCT00591006|585061202|FG022|Overall Study|Withdrawal by Subject|0|||
162002690|NCT00591006|585061203|FG023|Overall Study|Withdrawal by Subject|1|||
162002691|NCT00591006|585061180|FG000|Overall Study|Adverse Event|0|||
162002692|NCT00591006|585061181|FG001|Overall Study|Adverse Event|0|||
162002693|NCT00591006|585061182|FG002|Overall Study|Adverse Event|0|||
162002694|NCT00591006|585061183|FG003|Overall Study|Adverse Event|0|||
162002695|NCT00591006|585061184|FG004|Overall Study|Adverse Event|0|||
162002696|NCT00591006|585061185|FG005|Overall Study|Adverse Event|0|||
162002697|NCT00591006|585061186|FG006|Overall Study|Adverse Event|0|||
162002698|NCT00591006|585061187|FG007|Overall Study|Adverse Event|0|||
162002699|NCT00591006|585061188|FG008|Overall Study|Adverse Event|0|||
162002700|NCT00591006|585061189|FG009|Overall Study|Adverse Event|0|||
162002701|NCT00591006|585061190|FG010|Overall Study|Adverse Event|0|||
162002702|NCT00591006|585061191|FG011|Overall Study|Adverse Event|0|||
162002703|NCT00591006|585061192|FG012|Overall Study|Adverse Event|0|||
162002704|NCT00591006|585061193|FG013|Overall Study|Adverse Event|0|||
162002705|NCT00591006|585061194|FG014|Overall Study|Adverse Event|0|||
162002706|NCT00591006|585061195|FG015|Overall Study|Adverse Event|0|||
162002707|NCT00591006|585061196|FG016|Overall Study|Adverse Event|0|||
162002708|NCT00591006|585061197|FG017|Overall Study|Adverse Event|0|||
162002709|NCT00591006|585061198|FG018|Overall Study|Adverse Event|0|||
162002710|NCT00591006|585061199|FG019|Overall Study|Adverse Event|0|||
162002711|NCT00591006|585061200|FG020|Overall Study|Adverse Event|0|||
162002712|NCT00591006|585061201|FG021|Overall Study|Adverse Event|0|||
162002713|NCT00591006|585061202|FG022|Overall Study|Adverse Event|1|||
162002714|NCT00591006|585061203|FG023|Overall Study|Adverse Event|0|||
162042875|NCT05394350|585214217|FG004|Overall Study|Study terminated by sponsor|2|||
162042876|NCT05394350|585214218|FG005|Overall Study|Study terminated by sponsor|4|||
162042877|NCT02024555|585214223|FG000|Overall Study|Lost to Follow-up|1|||
162042878|NCT02024555|585214224|FG001|Overall Study|Lost to Follow-up|1|||
162042879|NCT02024555|585214223|FG000|Overall Study|Withdrawal by Subject|5|||
162042880|NCT02024555|585214224|FG001|Overall Study|Withdrawal by Subject|1|||
162042881|NCT02887859|585214225|FG000|Overall Study|Ongoing|6|||
162042882|NCT02887859|585214225|FG000|Overall Study|Adverse Event|7|||
162042883|NCT02887859|585214225|FG000|Overall Study|Death|1|||
162042884|NCT02887859|585214225|FG000|Overall Study|Physician Decision|1|||
162042885|NCT00492050|585214226|FG000|Overall Study|Adverse Event|1|||
162042886|NCT00492050|585214226|FG000|Overall Study|Lack of Efficacy|1|||
162042887|NCT00492050|585214226|FG000|Overall Study|Withdrawal by Subject|3|||
162042888|NCT00492050|585214226|FG000|Overall Study|Unable to collect SCT|2|||
162042889|NCT00492050|585214226|FG000|Overall Study|Progressive Disease|2|||
162042890|NCT00257608|585216217|FG000|Chemotherapy Phase|Adverse Event|138|||
162042891|NCT00257608|585216218|FG001|Chemotherapy Phase|Adverse Event|0|||
162042892|NCT00257608|585216219|FG002|Chemotherapy Phase|Adverse Event|0|||
162042893|NCT00257608|585216217|FG000|Chemotherapy Phase|Disease progression|139|||
162042894|NCT00257608|585216218|FG001|Chemotherapy Phase|Disease progression|0|||
162042895|NCT00257608|585216219|FG002|Chemotherapy Phase|Disease progression|0|||
162042896|NCT00257608|585216217|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
162042897|NCT00257608|585216218|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
162042898|NCT00257608|585216219|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
162042899|NCT00257608|585216217|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
162042900|NCT00257608|585216218|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
162042901|NCT00257608|585216219|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
162042902|NCT00257608|585216217|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
162042903|NCT00257608|585216218|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
162042904|NCT00257608|585216219|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
162042905|NCT00257608|585216217|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
162042906|NCT00257608|585216218|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
162042907|NCT00257608|585216219|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
162042908|NCT00257608|585216217|FG000|Chemotherapy Phase|Physician Decision|28|||
162042909|NCT00257608|585216218|FG001|Chemotherapy Phase|Physician Decision|0|||
162042910|NCT00257608|585216219|FG002|Chemotherapy Phase|Physician Decision|0|||
162042911|NCT00257608|585216217|FG000|Post Chemotherapy Phase|Adverse Event|0|||
162042912|NCT00257608|585216218|FG001|Post Chemotherapy Phase|Adverse Event|34|||
162042913|NCT00257608|585216219|FG002|Post Chemotherapy Phase|Adverse Event|38|||
162042914|NCT00257608|585216217|FG000|Post Chemotherapy Phase|Disease progression|0|||
162042915|NCT00257608|585216218|FG001|Post Chemotherapy Phase|Disease progression|204|||
162042916|NCT00257608|585216219|FG002|Post Chemotherapy Phase|Disease progression|168|||
162042917|NCT00257608|585216217|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
162042918|NCT00257608|585216218|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
162042919|NCT00257608|585216219|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
162042920|NCT00257608|585216217|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
162042921|NCT00257608|585216218|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
162042922|NCT00257608|585216219|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
162042923|NCT00257608|585216217|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
162042924|NCT00257608|585216218|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
162042925|NCT00257608|585216219|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
162042926|NCT00257608|585216217|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
162042927|NCT00257608|585216218|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
162042928|NCT00257608|585216219|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
162042929|NCT00257608|585216217|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
162042930|NCT00257608|585216218|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
162042931|NCT00257608|585216219|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
162042932|NCT00257608|585216217|FG000|Post Chemotherapy Phase|Physician Decision|0|||
162042933|NCT00257608|585216218|FG001|Post Chemotherapy Phase|Physician Decision|8|||
162042934|NCT00257608|585216219|FG002|Post Chemotherapy Phase|Physician Decision|11|||
162042935|NCT00257608|585216217|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
162042936|NCT00257608|585216218|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
162042937|NCT00257608|585216219|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
162042938|NCT00257608|585216217|FG000|Post Chemotherapy Phase|Not treated|0|||
162042939|NCT00257608|585216218|FG001|Post Chemotherapy Phase|Not treated|4|||
162042940|NCT00257608|585216219|FG002|Post Chemotherapy Phase|Not treated|7|||
162042941|NCT03817879|585216220|FG000|Overall Study|Drop out|5|||
162042942|NCT03817879|585216221|FG001|Overall Study|Drop out|12|||
162042943|NCT03817879|585216220|FG000|Overall Study|Withdrawal by Subject|0|||
162042944|NCT03817879|585216221|FG001|Overall Study|Withdrawal by Subject|1|||
162042945|NCT00392015|585216222|FG000|Overall Study|Lost to Follow-up|2|||
162042946|NCT00392015|585216223|FG001|Overall Study|Lost to Follow-up|0|||
162002715|NCT01384734|585061205|FG000|Overall Study|Adverse Event|0|||
162002716|NCT01384734|585061206|FG001|Overall Study|Adverse Event|3|||
162002717|NCT01384734|585061207|FG002|Overall Study|Adverse Event|0|||
162002718|NCT01384734|585061208|FG003|Overall Study|Adverse Event|2|||
162002719|NCT01384734|585061209|FG004|Overall Study|Adverse Event|7|||
162002720|NCT01384734|585061205|FG000|Overall Study|Death|1|||
162002721|NCT01384734|585061206|FG001|Overall Study|Death|0|||
162002722|NCT01384734|585061207|FG002|Overall Study|Death|1|||
162002723|NCT01384734|585061208|FG003|Overall Study|Death|0|||
162002724|NCT01384734|585061209|FG004|Overall Study|Death|0|||
162002725|NCT01384734|585061205|FG000|Overall Study|Continuation criteria not met|0|||
162002726|NCT01384734|585061206|FG001|Overall Study|Continuation criteria not met|0|||
162002727|NCT01384734|585061207|FG002|Overall Study|Continuation criteria not met|1|||
162002728|NCT01384734|585061208|FG003|Overall Study|Continuation criteria not met|1|||
162002729|NCT01384734|585061209|FG004|Overall Study|Continuation criteria not met|0|||
162002730|NCT01384734|585061205|FG000|Overall Study|Lack of Efficacy|3|||
162002731|NCT01384734|585061206|FG001|Overall Study|Lack of Efficacy|7|||
162002732|NCT01384734|585061207|FG002|Overall Study|Lack of Efficacy|4|||
162002733|NCT01384734|585061208|FG003|Overall Study|Lack of Efficacy|4|||
162002734|NCT01384734|585061209|FG004|Overall Study|Lack of Efficacy|2|||
162002735|NCT01384734|585061205|FG000|Overall Study|Lost to Follow-up|5|||
162002736|NCT01384734|585061206|FG001|Overall Study|Lost to Follow-up|3|||
162002737|NCT01384734|585061207|FG002|Overall Study|Lost to Follow-up|3|||
162002738|NCT01384734|585061208|FG003|Overall Study|Lost to Follow-up|8|||
162002739|NCT01384734|585061209|FG004|Overall Study|Lost to Follow-up|5|||
162002740|NCT01384734|585061205|FG000|Overall Study|Non-compliance with study drug|1|||
162002741|NCT01384734|585061206|FG001|Overall Study|Non-compliance with study drug|2|||
162002742|NCT01384734|585061207|FG002|Overall Study|Non-compliance with study drug|6|||
162002743|NCT01384734|585061208|FG003|Overall Study|Non-compliance with study drug|0|||
162002744|NCT01384734|585061209|FG004|Overall Study|Non-compliance with study drug|2|||
162002745|NCT01384734|585061205|FG000|Overall Study|Pregnancy|0|||
162002746|NCT01384734|585061206|FG001|Overall Study|Pregnancy|1|||
162002747|NCT01384734|585061207|FG002|Overall Study|Pregnancy|0|||
162002748|NCT01384734|585061208|FG003|Overall Study|Pregnancy|0|||
162002749|NCT01384734|585061209|FG004|Overall Study|Pregnancy|1|||
162002750|NCT01384734|585061205|FG000|Overall Study|Sponsor terminated|0|||
162002751|NCT01384734|585061206|FG001|Overall Study|Sponsor terminated|0|||
162002752|NCT01384734|585061207|FG002|Overall Study|Sponsor terminated|0|||
162002753|NCT01384734|585061208|FG003|Overall Study|Sponsor terminated|0|||
162002754|NCT01384734|585061209|FG004|Overall Study|Sponsor terminated|1|||
162002755|NCT01384734|585061205|FG000|Overall Study|Withdrawal by Subject|5|||
162002756|NCT01384734|585061206|FG001|Overall Study|Withdrawal by Subject|5|||
162002757|NCT01384734|585061207|FG002|Overall Study|Withdrawal by Subject|6|||
162002758|NCT01384734|585061208|FG003|Overall Study|Withdrawal by Subject|7|||
162002759|NCT01384734|585061209|FG004|Overall Study|Withdrawal by Subject|9|||
162002760|NCT01384734|585061205|FG000|Overall Study|Investigator relocating|0|||
162002761|NCT01384734|585061206|FG001|Overall Study|Investigator relocating|2|||
162002762|NCT01384734|585061207|FG002|Overall Study|Investigator relocating|0|||
162002763|NCT01384734|585061208|FG003|Overall Study|Investigator relocating|3|||
162002764|NCT01384734|585061209|FG004|Overall Study|Investigator relocating|1|||
162002765|NCT01384734|585061205|FG000|Overall Study|Unable to come back for visit|1|||
162002766|NCT01384734|585061206|FG001|Overall Study|Unable to come back for visit|0|||
162002767|NCT01384734|585061207|FG002|Overall Study|Unable to come back for visit|1|||
162042947|NCT00392015|585216224|FG002|Overall Study|Lost to Follow-up|2|||
162042948|NCT00392015|585216225|FG003|Overall Study|Lost to Follow-up|1|||
162042949|NCT00392015|585216226|FG004|Overall Study|Lost to Follow-up|1|||
162002768|NCT01384734|585061208|FG003|Overall Study|Unable to come back for visit|1|||
162002769|NCT01384734|585061209|FG004|Overall Study|Unable to come back for visit|0|||
162002770|NCT01384734|585061205|FG000|Overall Study|Prison|0|||
162002771|NCT01384734|585061206|FG001|Overall Study|Prison|0|||
162002772|NCT01384734|585061207|FG002|Overall Study|Prison|1|||
162002773|NCT01384734|585061208|FG003|Overall Study|Prison|0|||
162002774|NCT01384734|585061209|FG004|Overall Study|Prison|0|||
162002775|NCT01384734|585061205|FG000|Overall Study|As per Exclusion criteria|0|||
162002776|NCT01384734|585061206|FG001|Overall Study|As per Exclusion criteria|1|||
162002777|NCT01384734|585061207|FG002|Overall Study|As per Exclusion criteria|0|||
162002778|NCT01384734|585061208|FG003|Overall Study|As per Exclusion criteria|0|||
162002779|NCT01384734|585061209|FG004|Overall Study|As per Exclusion criteria|0|||
162002780|NCT01384734|585061205|FG000|Overall Study|Missed End of treatment visit|0|||
162002781|NCT01384734|585061206|FG001|Overall Study|Missed End of treatment visit|0|||
162002782|NCT01384734|585061207|FG002|Overall Study|Missed End of treatment visit|0|||
162042950|NCT00392015|585216227|FG005|Overall Study|Lost to Follow-up|0|||
162002783|NCT01384734|585061208|FG003|Overall Study|Missed End of treatment visit|1|||
162002784|NCT01384734|585061209|FG004|Overall Study|Missed End of treatment visit|0|||
162002785|NCT01384734|585061205|FG000|Overall Study|Adhesion problem|0|||
162002786|NCT01384734|585061206|FG001|Overall Study|Adhesion problem|0|||
162002787|NCT01384734|585061207|FG002|Overall Study|Adhesion problem|0|||
162002788|NCT01384734|585061208|FG003|Overall Study|Adhesion problem|1|||
162042951|NCT00392015|585216222|FG000|Overall Study|Withdrawal by Subject|0|||
162042952|NCT00392015|585216223|FG001|Overall Study|Withdrawal by Subject|0|||
162042953|NCT00392015|585216224|FG002|Overall Study|Withdrawal by Subject|2|||
162042954|NCT00392015|585216225|FG003|Overall Study|Withdrawal by Subject|0|||
162042955|NCT00392015|585216226|FG004|Overall Study|Withdrawal by Subject|0|||
162042956|NCT00392015|585216227|FG005|Overall Study|Withdrawal by Subject|0|||
162042957|NCT00392015|585216222|FG000|Overall Study|Adverse Event|0|||
162042958|NCT00392015|585216223|FG001|Overall Study|Adverse Event|0|||
162042959|NCT00392015|585216224|FG002|Overall Study|Adverse Event|0|||
162042960|NCT00392015|585216225|FG003|Overall Study|Adverse Event|0|||
162042961|NCT00392015|585216226|FG004|Overall Study|Adverse Event|1|||
162042962|NCT00392015|585216227|FG005|Overall Study|Adverse Event|0|||
162042963|NCT00392015|585216222|FG000|Overall Study|Previous trial recipient|0|||
162042964|NCT00392015|585216223|FG001|Overall Study|Previous trial recipient|0|||
162042965|NCT00392015|585216224|FG002|Overall Study|Previous trial recipient|0|||
162042966|NCT00392015|585216225|FG003|Overall Study|Previous trial recipient|0|||
162042967|NCT00392015|585216226|FG004|Overall Study|Previous trial recipient|1|||
162042968|NCT00392015|585216227|FG005|Overall Study|Previous trial recipient|0|||
162042969|NCT02742441|585216228|FG000|Overall Study|Lost to Follow-up|4|||
162042970|NCT02742441|585216229|FG001|Overall Study|Lost to Follow-up|4|||
162042971|NCT02742441|585216228|FG000|Overall Study|Withdrawal by Subject|2|||
162042972|NCT02742441|585216229|FG001|Overall Study|Withdrawal by Subject|2|||
162042973|NCT02742441|585216228|FG000|Overall Study|Adverse Event|0|||
162042974|NCT02742441|585216229|FG001|Overall Study|Adverse Event|2|||
162042975|NCT00537238|585216230|FG000|Overall Study|Death|1|||
162042976|NCT00537238|585216231|FG001|Overall Study|Death|2|||
162042977|NCT00537238|585216230|FG000|Overall Study|Adverse Event|31|||
162042978|NCT00537238|585216231|FG001|Overall Study|Adverse Event|22|||
162042979|NCT00537238|585216230|FG000|Overall Study|Lack of Efficacy|20|||
162042980|NCT00537238|585216231|FG001|Overall Study|Lack of Efficacy|21|||
162042981|NCT00537238|585216230|FG000|Overall Study|Lost to Follow-up|12|||
162042982|NCT00537238|585216231|FG001|Overall Study|Lost to Follow-up|8|||
162042983|NCT00537238|585216230|FG000|Overall Study|Withdrawal by Subject|51|||
162042984|NCT00537238|585216231|FG001|Overall Study|Withdrawal by Subject|47|||
162042985|NCT00537238|585216230|FG000|Overall Study|Protocol Violation|15|||
162042986|NCT00537238|585216231|FG001|Overall Study|Protocol Violation|19|||
162042987|NCT00537238|585216230|FG000|Overall Study|Does not meet entrance criteria|0|||
162042988|NCT00537238|585216231|FG001|Overall Study|Does not meet entrance criteria|2|||
162042989|NCT00537238|585216230|FG000|Overall Study|Other|44|||
162042990|NCT00537238|585216231|FG001|Overall Study|Other|52|||
162042991|NCT03265665|585216232|FG000|24-week Data Collection|Withdrawal by Subject|2|||
162042992|NCT03265665|585216233|FG001|24-week Data Collection|Withdrawal by Subject|2|||
162042993|NCT03265665|585216232|FG000|24-week Data Collection|Lost to Follow-up|4|||
162042994|NCT03265665|585216233|FG001|24-week Data Collection|Lost to Follow-up|5|||
162042995|NCT03265665|585216232|FG000|36-week Data Collection|Lost to Follow-up|6|||
162042996|NCT03265665|585216233|FG001|36-week Data Collection|Lost to Follow-up|8|||
162042997|NCT01858376|585216234|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
162042998|NCT01680965|585216238|FG000|Overall Study|Death|0|||
162042999|NCT01680965|585216239|FG001|Overall Study|Death|0|||
162043000|NCT01680965|585216240|FG002|Overall Study|Death|0|||
162043001|NCT01680965|585216241|FG003|Overall Study|Death|6|||
162043002|NCT02486302|585216253|FG000|Overall Study|Discontinued prematurely|410|||
162043003|NCT02486302|585216253|FG000|Overall Study|Documentation not completed|255|||
162043004|NCT02486302|585216253|FG000|Overall Study|Excluded due to legal reasons|8|||
162043005|NCT02486302|585216253|FG000|Overall Study|Not treated|3|||
162043006|NCT00734474|585216256|FG000|Overall Study|Entry Criteria Not Met|0|||
162002789|NCT01384734|585061209|FG004|Overall Study|Adhesion problem|0|||
162002790|NCT01384734|585061205|FG000|Overall Study|Early termination|0|||
162002791|NCT01384734|585061206|FG001|Overall Study|Early termination|0|||
162002792|NCT01384734|585061207|FG002|Overall Study|Early termination|0|||
162002793|NCT01384734|585061208|FG003|Overall Study|Early termination|0|||
162002794|NCT01384734|585061209|FG004|Overall Study|Early termination|1|||
162002795|NCT01384734|585061205|FG000|Overall Study|Physician Decision|1|||
162002796|NCT01384734|585061206|FG001|Overall Study|Physician Decision|0|||
162043007|NCT00734474|585216257|FG001|Overall Study|Entry Criteria Not Met|0|||
162043008|NCT00734474|585216258|FG002|Overall Study|Entry Criteria Not Met|5|||
162002797|NCT01384734|585061207|FG002|Overall Study|Physician Decision|0|||
162043009|NCT00734474|585216259|FG003|Overall Study|Entry Criteria Not Met|0|||
162043010|NCT00734474|585216260|FG004|Overall Study|Entry Criteria Not Met|3|||
162043011|NCT00734474|585216261|FG005|Overall Study|Entry Criteria Not Met|1|||
162043012|NCT00734474|585216262|FG006|Overall Study|Entry Criteria Not Met|0|||
162043013|NCT00734474|585216263|FG007|Overall Study|Entry Criteria Not Met|1|||
162043014|NCT00734474|585216264|FG008|Overall Study|Entry Criteria Not Met|1|||
162043015|NCT00734474|585216256|FG000|Overall Study|Lost to Follow-up|1|||
162043016|NCT00734474|585216257|FG001|Overall Study|Lost to Follow-up|0|||
162043017|NCT00734474|585216258|FG002|Overall Study|Lost to Follow-up|13|||
162002798|NCT01384734|585061208|FG003|Overall Study|Physician Decision|0|||
162002799|NCT01384734|585061209|FG004|Overall Study|Physician Decision|0|||
162043018|NCT00734474|585216259|FG003|Overall Study|Lost to Follow-up|0|||
162043019|NCT00734474|585216260|FG004|Overall Study|Lost to Follow-up|11|||
162043020|NCT00734474|585216261|FG005|Overall Study|Lost to Follow-up|1|||
162043021|NCT00734474|585216262|FG006|Overall Study|Lost to Follow-up|0|||
162002800|NCT03071263|585061210|FG000|Overall Study|Adverse Event|1|||
162002801|NCT03071263|585061211|FG001|Overall Study|Adverse Event|3|||
162002802|NCT03071263|585061210|FG000|Overall Study|Withdrawal by Subject|1|||
162002803|NCT03071263|585061211|FG001|Overall Study|Withdrawal by Subject|3|||
162002804|NCT03071263|585061210|FG000|Overall Study|Physician Decision|1|||
162002805|NCT03071263|585061211|FG001|Overall Study|Physician Decision|0|||
162002806|NCT03071263|585061210|FG000|Overall Study|Participant moved to another city|0|||
162002807|NCT03071263|585061211|FG001|Overall Study|Participant moved to another city|1|||
162002808|NCT02922725|585061213|FG000|Overall Study|Withdrawal by Subject|1|||
162002809|NCT02922725|585061214|FG001|Overall Study|Withdrawal by Subject|0|||
162002810|NCT02922725|585061215|FG002|Overall Study|Withdrawal by Subject|0|||
162002811|NCT05148234|585061217|FG000|Phase I|Ineligible|0|||
162002812|NCT05148234|585061218|FG001|Phase I|Ineligible|0|||
162002813|NCT05148234|585061219|FG002|Phase I|Ineligible|0|||
162002814|NCT05148234|585061220|FG003|Phase I|Ineligible|0|||
162002815|NCT05148234|585061221|FG004|Phase I|Ineligible|0|||
162002816|NCT05148234|585061222|FG005|Phase I|Ineligible|0|||
162002817|NCT05148234|585061223|FG006|Phase I|Ineligible|0|||
162043022|NCT00734474|585216263|FG007|Overall Study|Lost to Follow-up|9|||
162043023|NCT00734474|585216264|FG008|Overall Study|Lost to Follow-up|4|||
162043024|NCT00734474|585216256|FG000|Overall Study|Withdrawal by Subject|2|||
162043025|NCT00734474|585216257|FG001|Overall Study|Withdrawal by Subject|1|||
162043026|NCT00734474|585216258|FG002|Overall Study|Withdrawal by Subject|18|||
162043027|NCT00734474|585216259|FG003|Overall Study|Withdrawal by Subject|0|||
162043028|NCT00734474|585216260|FG004|Overall Study|Withdrawal by Subject|24|||
162043029|NCT00734474|585216261|FG005|Overall Study|Withdrawal by Subject|2|||
162043030|NCT00734474|585216262|FG006|Overall Study|Withdrawal by Subject|0|||
162043031|NCT00734474|585216263|FG007|Overall Study|Withdrawal by Subject|36|||
162043032|NCT00734474|585216264|FG008|Overall Study|Withdrawal by Subject|21|||
162043033|NCT00734474|585216256|FG000|Overall Study|Physician Decision|0|||
162043034|NCT00734474|585216257|FG001|Overall Study|Physician Decision|0|||
162043035|NCT00734474|585216258|FG002|Overall Study|Physician Decision|4|||
162043036|NCT00734474|585216259|FG003|Overall Study|Physician Decision|1|||
162043037|NCT00734474|585216260|FG004|Overall Study|Physician Decision|11|||
162043038|NCT00734474|585216261|FG005|Overall Study|Physician Decision|0|||
162043039|NCT00734474|585216262|FG006|Overall Study|Physician Decision|0|||
162043040|NCT00734474|585216263|FG007|Overall Study|Physician Decision|9|||
162043041|NCT00734474|585216264|FG008|Overall Study|Physician Decision|9|||
162043042|NCT00734474|585216256|FG000|Overall Study|Adverse Event|4|||
162043043|NCT00734474|585216257|FG001|Overall Study|Adverse Event|4|||
162043044|NCT00734474|585216258|FG002|Overall Study|Adverse Event|63|||
162043045|NCT00734474|585216259|FG003|Overall Study|Adverse Event|1|||
162043046|NCT00734474|585216260|FG004|Overall Study|Adverse Event|64|||
162043047|NCT00734474|585216261|FG005|Overall Study|Adverse Event|0|||
162043048|NCT00734474|585216262|FG006|Overall Study|Adverse Event|1|||
162043049|NCT00734474|585216263|FG007|Overall Study|Adverse Event|65|||
162043050|NCT00734474|585216264|FG008|Overall Study|Adverse Event|39|||
162043051|NCT00734474|585216256|FG000|Overall Study|Protocol Violation|0|||
162043052|NCT00734474|585216257|FG001|Overall Study|Protocol Violation|0|||
162043053|NCT00734474|585216258|FG002|Overall Study|Protocol Violation|4|||
162043054|NCT00734474|585216259|FG003|Overall Study|Protocol Violation|0|||
162043055|NCT00734474|585216260|FG004|Overall Study|Protocol Violation|3|||
162043056|NCT00734474|585216261|FG005|Overall Study|Protocol Violation|0|||
162043057|NCT00734474|585216262|FG006|Overall Study|Protocol Violation|0|||
162043058|NCT00734474|585216263|FG007|Overall Study|Protocol Violation|3|||
162043059|NCT00734474|585216264|FG008|Overall Study|Protocol Violation|1|||
162043060|NCT00734474|585216256|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
162043061|NCT00734474|585216257|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
162043062|NCT00734474|585216258|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
162043063|NCT00734474|585216259|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
162043064|NCT00734474|585216260|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
162043065|NCT00734474|585216261|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
162043066|NCT00734474|585216262|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
162043067|NCT00734474|585216263|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
162002818|NCT05148234|585061224|FG007|Phase I|Ineligible|1|||
162002819|NCT05148234|585061217|FG000|Phase I|Company closed the trial.|0|||
162043068|NCT00734474|585216264|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
162043069|NCT00734474|585216256|FG000|Overall Study|Sponsor Decision|0|||
162043070|NCT00734474|585216257|FG001|Overall Study|Sponsor Decision|0|||
162043071|NCT00734474|585216258|FG002|Overall Study|Sponsor Decision|0|||
162002820|NCT05148234|585061218|FG001|Phase I|Company closed the trial.|1|||
162002821|NCT05148234|585061219|FG002|Phase I|Company closed the trial.|0|||
162002822|NCT05148234|585061220|FG003|Phase I|Company closed the trial.|0|||
162002823|NCT05148234|585061221|FG004|Phase I|Company closed the trial.|0|||
162002824|NCT05148234|585061222|FG005|Phase I|Company closed the trial.|0|||
162002825|NCT05148234|585061223|FG006|Phase I|Company closed the trial.|0|||
162002826|NCT05148234|585061224|FG007|Phase I|Company closed the trial.|0|||
162002827|NCT04750642|585061225|FG000|Overall Study|Adverse Event|1|||
162002828|NCT04750642|585061226|FG001|Overall Study|Adverse Event|0|||
162002829|NCT04750642|585061225|FG000|Overall Study|Withdrawal by Subject|0|||
162002830|NCT04750642|585061226|FG001|Overall Study|Withdrawal by Subject|1|||
162002831|NCT04750642|585061225|FG000|Overall Study|Protocol Violation|0|||
162002832|NCT04750642|585061226|FG001|Overall Study|Protocol Violation|1|||
162002833|NCT00633477|585063088|FG000|Overall Study|Death|1|||
162002834|NCT00633477|585063089|FG001|Overall Study|Death|0|||
162002835|NCT00633477|585063088|FG000|Overall Study|Randomized but not treated|1|||
162002836|NCT00633477|585063089|FG001|Overall Study|Randomized but not treated|0|||
162002837|NCT04906499|585063091|FG000|Overall Study|Lack of time|1|||
162002838|NCT03346434|585063092|FG000|Overall Study|Randomized in Error|0|||
162002839|NCT03346434|585063093|FG001|Overall Study|Randomized in Error|0|||
162002840|NCT03346434|585063094|FG002|Overall Study|Randomized in Error|0|||
162002841|NCT03346434|585063095|FG003|Overall Study|Randomized in Error|0|||
162002842|NCT03346434|585063096|FG004|Overall Study|Randomized in Error|1|||
162002843|NCT03346434|585063097|FG005|Overall Study|Randomized in Error|0|||
162002844|NCT03346434|585063092|FG000|Overall Study|Withdrawal by Subject|0|||
162002845|NCT03346434|585063093|FG001|Overall Study|Withdrawal by Subject|0|||
162002846|NCT03346434|585063094|FG002|Overall Study|Withdrawal by Subject|1|||
162002847|NCT03346434|585063095|FG003|Overall Study|Withdrawal by Subject|0|||
162002848|NCT03346434|585063096|FG004|Overall Study|Withdrawal by Subject|1|||
162002849|NCT03346434|585063097|FG005|Overall Study|Withdrawal by Subject|0|||
162002850|NCT03346434|585063092|FG000|Overall Study|Lost to Follow-up|0|||
162002851|NCT03346434|585063093|FG001|Overall Study|Lost to Follow-up|0|||
162002852|NCT03346434|585063094|FG002|Overall Study|Lost to Follow-up|0|||
162002853|NCT03346434|585063095|FG003|Overall Study|Lost to Follow-up|0|||
162002854|NCT03346434|585063096|FG004|Overall Study|Lost to Follow-up|1|||
162002855|NCT03346434|585063097|FG005|Overall Study|Lost to Follow-up|1|||
162002856|NCT03346434|585063092|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
162002857|NCT03346434|585063093|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
162002858|NCT03346434|585063094|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
162002859|NCT03346434|585063095|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
162002860|NCT03346434|585063096|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
162002861|NCT03346434|585063097|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
162002862|NCT02081677|585063098|FG000|Overall Study|Adverse Event|0|||
162002863|NCT02081677|585063099|FG001|Overall Study|Adverse Event|0|||
162002864|NCT02081677|585063100|FG002|Overall Study|Adverse Event|1|||
162002865|NCT02081677|585063101|FG003|Overall Study|Adverse Event|0|||
162002866|NCT02081677|585063098|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
162002867|NCT02081677|585063099|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
162002868|NCT02081677|585063100|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
162002869|NCT02081677|585063101|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
162002870|NCT02081677|585063098|FG000|Overall Study|Not comfortable with lens care system|1|||
162002871|NCT02081677|585063099|FG001|Overall Study|Not comfortable with lens care system|0|||
162002872|NCT02081677|585063100|FG002|Overall Study|Not comfortable with lens care system|0|||
162002873|NCT02081677|585063101|FG003|Overall Study|Not comfortable with lens care system|0|||
162002874|NCT02081677|585063098|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
162002875|NCT02081677|585063099|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
162002876|NCT02081677|585063100|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
162002877|NCT02081677|585063101|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
162002878|NCT01751061|585063112|FG000|Overall Study|Death|1|||
162002879|NCT01751061|585063113|FG001|Overall Study|Death|0|||
162002880|NCT01751061|585063112|FG000|Overall Study|patient death|5|||
162002881|NCT01751061|585063113|FG001|Overall Study|patient death|0|||
162002882|NCT01751061|585063112|FG000|Overall Study|Lost to Follow-up|40|||
162002883|NCT01751061|585063113|FG001|Overall Study|Lost to Follow-up|25|||
162002884|NCT01751061|585063112|FG000|Overall Study|patient regained decisional capacity|4|||
162002885|NCT01751061|585063113|FG001|Overall Study|patient regained decisional capacity|8|||
162002886|NCT01751061|585063112|FG000|Overall Study|Withdrawal by Subject|4|||
162002887|NCT01751061|585063113|FG001|Overall Study|Withdrawal by Subject|1|||
162002888|NCT01751061|585063112|FG000|Overall Study|Physician Decision|2|||
162002889|NCT01751061|585063113|FG001|Overall Study|Physician Decision|0|||
162002890|NCT02412306|585063114|FG000|Overall Study|Lost to Follow-up|0|||
162002891|NCT02412306|585063115|FG001|Overall Study|Lost to Follow-up|1|||
162002892|NCT02412306|585063116|FG002|Overall Study|Lost to Follow-up|0|||
162002893|NCT02412306|585063117|FG003|Overall Study|Lost to Follow-up|0|||
162002894|NCT02412306|585063118|FG004|Overall Study|Lost to Follow-up|0|||
162002895|NCT02412306|585063114|FG000|Overall Study|Withdrawal by Subject|0|||
162002896|NCT02412306|585063115|FG001|Overall Study|Withdrawal by Subject|0|||
162002897|NCT02412306|585063116|FG002|Overall Study|Withdrawal by Subject|1|||
162002898|NCT02412306|585063117|FG003|Overall Study|Withdrawal by Subject|0|||
162002899|NCT02412306|585063118|FG004|Overall Study|Withdrawal by Subject|0|||
162002900|NCT02412306|585063114|FG000|Overall Study|Death|5|||
162002901|NCT02412306|585063115|FG001|Overall Study|Death|7|||
162002902|NCT02412306|585063116|FG002|Overall Study|Death|15|||
162002903|NCT02412306|585063117|FG003|Overall Study|Death|0|||
162002904|NCT02412306|585063118|FG004|Overall Study|Death|2|||
162002905|NCT05635461|585063119|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
162002906|NCT05635461|585063120|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
162002907|NCT05635461|585063121|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
162002908|NCT05635461|585063122|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
162002909|NCT05635461|585063123|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
162002910|NCT05635461|585063124|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
162002911|NCT05635461|585063119|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
162002912|NCT05635461|585063120|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
162002913|NCT05635461|585063121|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
162002914|NCT05635461|585063122|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
162002915|NCT05635461|585063123|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
162002916|NCT05635461|585063124|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
162002917|NCT05635461|585063119|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
162002918|NCT05635461|585063120|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
162002919|NCT05635461|585063121|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
162002920|NCT05635461|585063122|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
162002921|NCT05635461|585063123|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
162002922|NCT05635461|585063124|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
162002923|NCT00614575|585063125|FG000|Overall Study|Adverse Event|106|||
162002924|NCT00614575|585063125|FG000|Overall Study|Lost to Follow-up|55|||
162002925|NCT00614575|585063125|FG000|Overall Study|Lack of Efficacy|14|||
162002926|NCT00614575|585063125|FG000|Overall Study|Withdrawal by Subject|6|||
162002927|NCT00614575|585063125|FG000|Overall Study|Death|3|||
162002928|NCT00614575|585063125|FG000|Overall Study|Physician Decision|2|||
162002929|NCT00614575|585063125|FG000|Overall Study|No data were collected.|18|||
162002930|NCT00614575|585063125|FG000|Overall Study|Irregularly enrolled patients|23|||
162002931|NCT00614575|585063125|FG000|Overall Study|No treatment|1|||
162002932|NCT00189540|585063126|FG000|Overall Study|Withdrawal by Subject|3|||
162002933|NCT00189540|585063127|FG001|Overall Study|Withdrawal by Subject|0|||
162002934|NCT00189540|585063126|FG000|Overall Study|Death|4|||
162002935|NCT00189540|585063127|FG001|Overall Study|Death|1|||
162002936|NCT00472108|585063128|FG000|Overall Study|Lost to Follow-up|0|||
162002937|NCT00472108|585063129|FG001|Overall Study|Lost to Follow-up|1|||
162002938|NCT03882021|585063130|FG000|Enrollment|Procedure aborted/cancelled|2|||
162002939|NCT03882021|585063130|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
162002940|NCT03882021|585063130|FG000|Enrollment to 3-Month|Death|1|||
162002941|NCT03882021|585063130|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
162002942|NCT03882021|585063130|FG000|Enrollment to 3-Month|Missed Visit|4|||
162002943|NCT03882021|585063130|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
162002944|NCT03882021|585063130|FG000|6-Month to 12-Month Visit|Death|1|||
162002945|NCT03882021|585063130|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
162002946|NCT00286442|585063131|FG000|Overall Study|Hyperglycemic Rescue|19|||
162002947|NCT00286442|585063132|FG001|Overall Study|Hyperglycemic Rescue|17|||
162002948|NCT00286442|585063133|FG002|Overall Study|Hyperglycemic Rescue|25|||
162002949|NCT00286442|585063131|FG000|Overall Study|Adverse Event|7|||
162002950|NCT00286442|585063132|FG001|Overall Study|Adverse Event|6|||
162002951|NCT00286442|585063133|FG002|Overall Study|Adverse Event|1|||
162002952|NCT00286442|585063131|FG000|Overall Study|Protocol Violation|2|||
162002953|NCT00286442|585063132|FG001|Overall Study|Protocol Violation|4|||
162002954|NCT00286442|585063133|FG002|Overall Study|Protocol Violation|2|||
162002955|NCT00286442|585063131|FG000|Overall Study|Lost to Follow-up|5|||
162002956|NCT00286442|585063132|FG001|Overall Study|Lost to Follow-up|2|||
162002957|NCT00286442|585063133|FG002|Overall Study|Lost to Follow-up|1|||
162002958|NCT00286442|585063131|FG000|Overall Study|Physician Decision|1|||
162002959|NCT00286442|585063132|FG001|Overall Study|Physician Decision|1|||
162002960|NCT00286442|585063133|FG002|Overall Study|Physician Decision|1|||
162002961|NCT00286442|585063131|FG000|Overall Study|Administrative Error|1|||
162002962|NCT00286442|585063132|FG001|Overall Study|Administrative Error|1|||
162002963|NCT00286442|585063133|FG002|Overall Study|Administrative Error|0|||
162002964|NCT00286442|585063131|FG000|Overall Study|Withdrawal by Subject|2|||
162002965|NCT00286442|585063132|FG001|Overall Study|Withdrawal by Subject|14|||
162002966|NCT00286442|585063133|FG002|Overall Study|Withdrawal by Subject|2|||
162002967|NCT03582215|585063136|FG000|Overall Study|Adverse Event|1|||
162002968|NCT03582215|585063137|FG001|Overall Study|Adverse Event|0|||
162002969|NCT03582215|585063138|FG002|Overall Study|Adverse Event|0|||
162002970|NCT03582215|585063139|FG003|Overall Study|Adverse Event|0|||
162002971|NCT03582215|585063140|FG004|Overall Study|Adverse Event|0|||
162002972|NCT03582215|585063141|FG005|Overall Study|Adverse Event|0|||
162002973|NCT03582215|585063142|FG006|Overall Study|Adverse Event|2|||
162002974|NCT03582215|585063143|FG007|Overall Study|Adverse Event|2|||
162002975|NCT02174731|585063144|FG000|Overall Study|Participant decision|67|||
162002976|NCT02174731|585063145|FG001|Overall Study|Participant decision|64|||
162002977|NCT02174731|585063144|FG000|Overall Study|Incorrect enrolment before randomization|0|||
162002978|NCT02174731|585063145|FG001|Overall Study|Incorrect enrolment before randomization|1|||
162002979|NCT02174731|585063144|FG000|Overall Study|Missing|2|||
162002980|NCT02174731|585063145|FG001|Overall Study|Missing|0|||
162002981|NCT00079040|585063146|FG000|Overall Study|Withdrew before treatment|1|||
162002982|NCT00079040|585063146|FG000|Overall Study|Ineligible|1|||
162002983|NCT03550378|585063170|FG000|Overall Study|Death|0|||
162002984|NCT03550378|585063171|FG001|Overall Study|Death|1|||
162002985|NCT04486235|585063172|FG000|Overall Study|Pregnancy|1|||
162002986|NCT04486235|585063173|FG001|Overall Study|Pregnancy|0|||
162002987|NCT04486235|585063172|FG000|Overall Study|Lost to Follow-up|1|||
162002988|NCT04486235|585063173|FG001|Overall Study|Lost to Follow-up|0|||
162002989|NCT00626275|585063174|FG000|Part A - Treatment Period 1|Adverse Event|1|||
162002990|NCT00626275|585063175|FG001|Part A - Treatment Period 1|Adverse Event|0|||
162002991|NCT00626275|585063176|FG002|Part A - Treatment Period 1|Adverse Event|0|||
162002992|NCT00626275|585063177|FG003|Part A - Treatment Period 1|Adverse Event|0|||
162002993|NCT00626275|585063178|FG004|Part A - Treatment Period 1|Adverse Event|0|||
162002994|NCT00626275|585063179|FG005|Part A - Treatment Period 1|Adverse Event|0|||
162002995|NCT00626275|585063180|FG006|Part A - Treatment Period 1|Adverse Event|0|||
162002996|NCT00626275|585063181|FG007|Part A - Treatment Period 1|Adverse Event|0|||
162002997|NCT00626275|585063174|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
162002998|NCT00626275|585063175|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
162002999|NCT00626275|585063176|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
162003000|NCT00626275|585063177|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
162003001|NCT00626275|585063178|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
162003002|NCT00626275|585063179|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
162003003|NCT00626275|585063180|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
162003004|NCT00626275|585063181|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
162003005|NCT00626275|585063174|FG000|Part B|Lost to Follow-up|0|||
162003006|NCT00626275|585063175|FG001|Part B|Lost to Follow-up|0|||
162003007|NCT00626275|585063176|FG002|Part B|Lost to Follow-up|0|||
162003008|NCT00626275|585063177|FG003|Part B|Lost to Follow-up|0|||
162003009|NCT00626275|585063178|FG004|Part B|Lost to Follow-up|0|||
162003010|NCT00626275|585063179|FG005|Part B|Lost to Follow-up|0|||
162003011|NCT00626275|585063180|FG006|Part B|Lost to Follow-up|1|||
162003012|NCT00626275|585063181|FG007|Part B|Lost to Follow-up|0|||
162003013|NCT00626275|585063174|FG000|Part B|Withdrawal by Subject|0|||
162003014|NCT00626275|585063175|FG001|Part B|Withdrawal by Subject|0|||
162003015|NCT00626275|585063176|FG002|Part B|Withdrawal by Subject|0|||
162003016|NCT00626275|585063177|FG003|Part B|Withdrawal by Subject|0|||
162003017|NCT00626275|585063178|FG004|Part B|Withdrawal by Subject|0|||
162003018|NCT00626275|585063179|FG005|Part B|Withdrawal by Subject|0|||
162003019|NCT00626275|585063180|FG006|Part B|Withdrawal by Subject|0|||
162003020|NCT00626275|585063181|FG007|Part B|Withdrawal by Subject|1|||
162003021|NCT04590014|585063182|FG000|Overall Study|Withdrawal by Subject|1|||
162003022|NCT04590014|585063183|FG001|Overall Study|Withdrawal by Subject|0|||
162003023|NCT00468299|585063184|FG000|Overall Study|Withdrawal by Subject|0|||
162003024|NCT00468299|585063185|FG001|Overall Study|Withdrawal by Subject|1|||
162003025|NCT04999839|585063186|FG000|Overall Study|Adverse Event|1|||
162003026|NCT04999839|585063187|FG001|Overall Study|Adverse Event|1|||
162003027|NCT04999839|585063188|FG002|Overall Study|Adverse Event|1|||
162003028|NCT04999839|585063189|FG003|Overall Study|Adverse Event|1|||
162003029|NCT04999839|585063190|FG004|Overall Study|Adverse Event|1|||
162003030|NCT04999839|585063186|FG000|Overall Study|Lost to Follow-up|2|||
162003031|NCT04999839|585063187|FG001|Overall Study|Lost to Follow-up|0|||
162003032|NCT04999839|585063188|FG002|Overall Study|Lost to Follow-up|2|||
162003033|NCT04999839|585063189|FG003|Overall Study|Lost to Follow-up|4|||
162003034|NCT04999839|585063190|FG004|Overall Study|Lost to Follow-up|1|||
162003035|NCT04999839|585063186|FG000|Overall Study|Withdrawal by Subject|6|||
162003036|NCT04999839|585063187|FG001|Overall Study|Withdrawal by Subject|5|||
162003037|NCT04999839|585063188|FG002|Overall Study|Withdrawal by Subject|3|||
162003038|NCT04999839|585063189|FG003|Overall Study|Withdrawal by Subject|2|||
162003039|NCT04999839|585063190|FG004|Overall Study|Withdrawal by Subject|2|||
162003040|NCT04999839|585063186|FG000|Overall Study|Lack of Efficacy|0|||
162003041|NCT04999839|585063187|FG001|Overall Study|Lack of Efficacy|1|||
162003042|NCT04999839|585063188|FG002|Overall Study|Lack of Efficacy|0|||
162003043|NCT04999839|585063189|FG003|Overall Study|Lack of Efficacy|0|||
162003044|NCT04999839|585063190|FG004|Overall Study|Lack of Efficacy|0|||
162003045|NCT04999839|585063186|FG000|Overall Study|Physician Decision|0|||
162003046|NCT04999839|585063187|FG001|Overall Study|Physician Decision|0|||
162003047|NCT04999839|585063188|FG002|Overall Study|Physician Decision|0|||
162003048|NCT04999839|585063189|FG003|Overall Study|Physician Decision|0|||
162003049|NCT04999839|585063190|FG004|Overall Study|Physician Decision|1|||
162003050|NCT04999839|585063186|FG000|Overall Study|Sponsor request|0|||
162003051|NCT04999839|585063187|FG001|Overall Study|Sponsor request|1|||
162003052|NCT04999839|585063188|FG002|Overall Study|Sponsor request|0|||
162003053|NCT04999839|585063189|FG003|Overall Study|Sponsor request|0|||
162003054|NCT04999839|585063190|FG004|Overall Study|Sponsor request|0|||
162003055|NCT04999839|585063186|FG000|Overall Study|Other|0|||
162003056|NCT04999839|585063187|FG001|Overall Study|Other|0|||
162003057|NCT04999839|585063188|FG002|Overall Study|Other|1|||
162003058|NCT04999839|585063189|FG003|Overall Study|Other|0|||
162003059|NCT04999839|585063190|FG004|Overall Study|Other|0|||
162003060|NCT01362348|585063191|FG000|Overall Study|Protocol-defined stopping criteria|9|||
162003061|NCT01362348|585063191|FG000|Overall Study|Study closed/terminated|5|||
162003062|NCT00399516|585063192|FG000|Overall Study|Lost to Follow-up|2|||
162003063|NCT01046565|585063193|FG000|Overall Study|Adverse Event|2|||
162003064|NCT01046565|585063193|FG000|Overall Study|Withdrawal by Subject|7|||
162003065|NCT03546621|585063194|FG000|Overall Study|Withdrawal by Subject|0|||
162003066|NCT03546621|585063195|FG001|Overall Study|Withdrawal by Subject|1|||
162003067|NCT03546621|585063196|FG002|Overall Study|Withdrawal by Subject|2|||
162003068|NCT03546621|585063197|FG003|Overall Study|Withdrawal by Subject|1|||
162003069|NCT03546621|585063194|FG000|Overall Study|Lost to Follow-up|0|||
162003070|NCT03546621|585063195|FG001|Overall Study|Lost to Follow-up|1|||
162003071|NCT03546621|585063196|FG002|Overall Study|Lost to Follow-up|0|||
162003072|NCT03546621|585063197|FG003|Overall Study|Lost to Follow-up|0|||
162003073|NCT03546621|585063194|FG000|Overall Study|Adverse Event|0|||
162003074|NCT03546621|585063195|FG001|Overall Study|Adverse Event|1|||
162003075|NCT03546621|585063196|FG002|Overall Study|Adverse Event|0|||
162003076|NCT03546621|585063197|FG003|Overall Study|Adverse Event|1|||
162003077|NCT03546621|585063194|FG000|Overall Study|Progressive disease|0|||
162003078|NCT03546621|585063195|FG001|Overall Study|Progressive disease|0|||
162003079|NCT03546621|585063196|FG002|Overall Study|Progressive disease|0|||
162003080|NCT03546621|585063197|FG003|Overall Study|Progressive disease|1|||
162003081|NCT00660192|585063198|FG000|Overall Study|Lost to Follow-up|2|||
162003082|NCT00660192|585063199|FG001|Overall Study|Lost to Follow-up|3|||
162003083|NCT00377520|585063200|FG000|Overall Study|Ineligible (Prior radiation)|1|||
162003084|NCT00982735|585063201|FG000|Overall Study|Lost to Follow-up|6|||
162003085|NCT00982735|585063201|FG000|Overall Study|Patient ineligible for trial|224|||
162003086|NCT03740048|585063202|FG000|Overall Study|Withdrawal by Subject|1|||
162003087|NCT03740048|585063203|FG001|Overall Study|Withdrawal by Subject|1|||
162003088|NCT03740048|585063202|FG000|Overall Study|Death|1|||
162003089|NCT03740048|585063203|FG001|Overall Study|Death|6|||
162003090|NCT03740048|585063202|FG000|Overall Study|Switched to thrice-weekly HD|2|||
162003091|NCT03740048|585063203|FG001|Overall Study|Switched to thrice-weekly HD|0|||
162003092|NCT03740048|585063202|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
162003093|NCT03740048|585063203|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
162003094|NCT03740048|585063202|FG000|Overall Study|Lost to Follow-up|0|||
162003095|NCT03740048|585063203|FG001|Overall Study|Lost to Follow-up|1|||
162003096|NCT03740048|585063202|FG000|Overall Study|Non-compliance with HD|0|||
162003097|NCT03740048|585063203|FG001|Overall Study|Non-compliance with HD|1|||
162003098|NCT03261336|585063204|FG000|Overall Study|Adverse Event|1|||
162003099|NCT01069484|585063205|FG000|Overall Study|Death-in-near-family|1|||
162003100|NCT01069484|585063206|FG001|Overall Study|Death-in-near-family|0|||
162003101|NCT01069484|585063205|FG000|Overall Study|No specific reason|8|||
162003102|NCT01069484|585063206|FG001|Overall Study|No specific reason|2|||
162003103|NCT01069484|585063205|FG000|Overall Study|Illness mother or child|3|||
162003104|NCT01069484|585063206|FG001|Overall Study|Illness mother or child|1|||
162003105|NCT00292942|585063207|FG000|Overall Study|Withdrawal by Subject|0|||
162003106|NCT00292942|585063208|FG001|Overall Study|Withdrawal by Subject|0|||
162003107|NCT00292942|585063209|FG002|Overall Study|Withdrawal by Subject|1|||
162003108|NCT00292942|585063210|FG003|Overall Study|Withdrawal by Subject|0|||
162003109|NCT00292942|585063207|FG000|Overall Study|Adverse Event|0|||
162003110|NCT00292942|585063208|FG001|Overall Study|Adverse Event|0|||
162003111|NCT00292942|585063209|FG002|Overall Study|Adverse Event|0|||
162003112|NCT00292942|585063210|FG003|Overall Study|Adverse Event|1|||
162003113|NCT00644358|585063211|FG000|Overall Study|Adverse Event|124|||
162003114|NCT00644358|585063211|FG000|Overall Study|Lost to Follow-up|105|||
162003115|NCT00644358|585063211|FG000|Overall Study|Consent Withdrawal|64|||
162003116|NCT00644358|585063211|FG000|Overall Study|Lack of Effectiveness|39|||
162043072|NCT00734474|585216259|FG003|Overall Study|Sponsor Decision|0|||
162043073|NCT00734474|585216260|FG004|Overall Study|Sponsor Decision|2|||
162043074|NCT00734474|585216261|FG005|Overall Study|Sponsor Decision|0|||
162043075|NCT00734474|585216262|FG006|Overall Study|Sponsor Decision|0|||
162003117|NCT00644358|585063211|FG000|Overall Study|Protocol Violation|5|||
162003118|NCT00644358|585063211|FG000|Overall Study|Noncompliance|14|||
162003119|NCT00644358|585063211|FG000|Overall Study|Other Unspecified|11|||
162003120|NCT00651924|585063216|FG000|Overall Study|Withdrawal by PI|0|||
162003121|NCT00651924|585063217|FG001|Overall Study|Withdrawal by PI|2|||
162003122|NCT00651924|585063216|FG000|Overall Study|Withdrawal by Subject|0|||
162003123|NCT00651924|585063217|FG001|Overall Study|Withdrawal by Subject|5|||
162003124|NCT00758771|585063218|FG000|Overall Study|Withdrawal by Subject|1|||
162003125|NCT00758771|585063219|FG001|Overall Study|Withdrawal by Subject|1|||
162003126|NCT00758771|585063218|FG000|Overall Study|Did not meet eligibility criteria|2|||
162003127|NCT00758771|585063219|FG001|Overall Study|Did not meet eligibility criteria|4|||
162003128|NCT00960063|585063220|FG000|Overall Study|Adverse Event|1|||
162003129|NCT00960063|585063221|FG001|Overall Study|Adverse Event|0|||
162003130|NCT00960063|585063222|FG002|Overall Study|Adverse Event|0|||
162003131|NCT00960063|585063220|FG000|Overall Study|Progression of Disease|0|||
162003132|NCT00960063|585063221|FG001|Overall Study|Progression of Disease|0|||
162003133|NCT00960063|585063222|FG002|Overall Study|Progression of Disease|3|||
162003134|NCT02898454|585063229|FG000|Overall Study|Adverse Event|4|||
162003135|NCT02898454|585063230|FG001|Overall Study|Adverse Event|1|||
162003136|NCT02898454|585063231|FG002|Overall Study|Adverse Event|2|||
162003137|NCT02898454|585063229|FG000|Overall Study|Protocol Violation|1|||
162003138|NCT02898454|585063230|FG001|Overall Study|Protocol Violation|0|||
162003139|NCT02898454|585063231|FG002|Overall Study|Protocol Violation|1|||
162003140|NCT02898454|585063229|FG000|Overall Study|Lack of Efficacy|4|||
162003141|NCT02898454|585063230|FG001|Overall Study|Lack of Efficacy|1|||
162003142|NCT02898454|585063231|FG002|Overall Study|Lack of Efficacy|0|||
162003143|NCT02898454|585063229|FG000|Overall Study|Withdrawal by Subject|6|||
162003144|NCT02898454|585063230|FG001|Overall Study|Withdrawal by Subject|3|||
162003145|NCT02898454|585063231|FG002|Overall Study|Withdrawal by Subject|3|||
162003146|NCT02898454|585063229|FG000|Overall Study|Lost to Follow-up|1|||
162003147|NCT02898454|585063230|FG001|Overall Study|Lost to Follow-up|0|||
162003148|NCT02898454|585063231|FG002|Overall Study|Lost to Follow-up|0|||
162003149|NCT02898454|585063229|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
162003150|NCT02898454|585063230|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
162003151|NCT02898454|585063231|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
162003152|NCT02343263|585063232|FG000|Overall Study|Physician Decision|5|||
162003153|NCT02343263|585063233|FG001|Overall Study|Physician Decision|3|||
162003154|NCT02343263|585063234|FG002|Overall Study|Physician Decision|1|||
162003155|NCT03040141|585063235|FG000|Overall Study|Death|1|||
162003156|NCT03040141|585063236|FG001|Overall Study|Death|2|||
162003157|NCT03040141|585063237|FG002|Overall Study|Death|3|||
162003158|NCT03040141|585063235|FG000|Overall Study|Withdrawal by Subject|3|||
162003159|NCT03040141|585063236|FG001|Overall Study|Withdrawal by Subject|1|||
162003160|NCT03040141|585063237|FG002|Overall Study|Withdrawal by Subject|1|||
162003161|NCT03040141|585063235|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
162003162|NCT03040141|585063236|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
162003163|NCT03040141|585063237|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
162003164|NCT03040141|585063235|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
162003165|NCT03040141|585063236|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
162003166|NCT03040141|585063237|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
162003167|NCT01290523|585063238|FG000|Overall Study|Death|3|||
162003168|NCT01400698|585063242|FG000|Overall Study|Lost to Follow-up|2|||
162003169|NCT01400698|585063243|FG001|Overall Study|Lost to Follow-up|5|||
162003170|NCT01400698|585063244|FG002|Overall Study|Lost to Follow-up|2|||
162003171|NCT01400698|585063245|FG003|Overall Study|Lost to Follow-up|1|||
162003172|NCT01400698|585063246|FG004|Overall Study|Lost to Follow-up|4|||
162003173|NCT01400698|585063247|FG005|Overall Study|Lost to Follow-up|3|||
162003174|NCT01400698|585063242|FG000|Overall Study|Withdrawal by Subject|8|||
162003175|NCT01400698|585063243|FG001|Overall Study|Withdrawal by Subject|2|||
162003176|NCT01400698|585063244|FG002|Overall Study|Withdrawal by Subject|0|||
162003177|NCT01400698|585063245|FG003|Overall Study|Withdrawal by Subject|4|||
162003178|NCT01400698|585063246|FG004|Overall Study|Withdrawal by Subject|1|||
162003179|NCT01400698|585063247|FG005|Overall Study|Withdrawal by Subject|3|||
162003180|NCT01400698|585063242|FG000|Overall Study|Protocol Violation|0|||
162003181|NCT01400698|585063243|FG001|Overall Study|Protocol Violation|1|||
162003182|NCT01400698|585063244|FG002|Overall Study|Protocol Violation|0|||
162003183|NCT01400698|585063245|FG003|Overall Study|Protocol Violation|0|||
162003184|NCT01400698|585063246|FG004|Overall Study|Protocol Violation|1|||
162003185|NCT01400698|585063247|FG005|Overall Study|Protocol Violation|0|||
162003186|NCT01400698|585063242|FG000|Overall Study|Non-compliance|0|||
162003187|NCT01400698|585063243|FG001|Overall Study|Non-compliance|1|||
162003188|NCT01400698|585063244|FG002|Overall Study|Non-compliance|0|||
162003189|NCT01400698|585063245|FG003|Overall Study|Non-compliance|1|||
162003190|NCT01400698|585063246|FG004|Overall Study|Non-compliance|0|||
162043076|NCT00734474|585216263|FG007|Overall Study|Sponsor Decision|0|||
162003191|NCT01400698|585063247|FG005|Overall Study|Non-compliance|0|||
162003192|NCT01400698|585063242|FG000|Overall Study|Adverse Event|1|||
162003193|NCT01400698|585063243|FG001|Overall Study|Adverse Event|0|||
162003194|NCT01400698|585063244|FG002|Overall Study|Adverse Event|0|||
162003195|NCT01400698|585063245|FG003|Overall Study|Adverse Event|0|||
162003196|NCT01400698|585063246|FG004|Overall Study|Adverse Event|0|||
162003197|NCT01400698|585063247|FG005|Overall Study|Adverse Event|0|||
162003198|NCT01400698|585063242|FG000|Overall Study|Other|4|||
162003199|NCT01400698|585063243|FG001|Overall Study|Other|2|||
162003200|NCT01400698|585063244|FG002|Overall Study|Other|0|||
162003201|NCT01400698|585063245|FG003|Overall Study|Other|2|||
162003202|NCT01400698|585063246|FG004|Overall Study|Other|1|||
162003203|NCT01400698|585063247|FG005|Overall Study|Other|0|||
162003204|NCT01650194|585063248|FG000|Overall Study|Progressive Disease (PD)|35|||
162003205|NCT01650194|585063248|FG000|Overall Study|Withdrawal by Subject|2|||
162003206|NCT01650194|585063248|FG000|Overall Study|Miscellaneous|10|||
162003207|NCT01602224|585065140|FG000|Overall Study|Adverse Event|0|||
162003208|NCT01602224|585065141|FG001|Overall Study|Adverse Event|1|||
162003209|NCT01602224|585065142|FG002|Overall Study|Adverse Event|0|||
162003210|NCT01602224|585065140|FG000|Overall Study|Investigator Decison|1|||
162003211|NCT01602224|585065141|FG001|Overall Study|Investigator Decison|0|||
162003212|NCT01602224|585065142|FG002|Overall Study|Investigator Decison|0|||
162003213|NCT01602224|585065140|FG000|Overall Study|Lost to Follow-up|0|||
162003214|NCT01602224|585065141|FG001|Overall Study|Lost to Follow-up|0|||
162003215|NCT01602224|585065142|FG002|Overall Study|Lost to Follow-up|1|||
162003216|NCT01602224|585065140|FG000|Overall Study|Protocol Violation|0|||
162003217|NCT01602224|585065141|FG001|Overall Study|Protocol Violation|1|||
162003218|NCT01602224|585065142|FG002|Overall Study|Protocol Violation|0|||
162003219|NCT01602224|585065140|FG000|Overall Study|Sponsor Decision|2|||
162003220|NCT01602224|585065141|FG001|Overall Study|Sponsor Decision|3|||
162003221|NCT01602224|585065142|FG002|Overall Study|Sponsor Decision|2|||
162003222|NCT01602224|585065140|FG000|Overall Study|Withdrawal by Subject|5|||
162003223|NCT01602224|585065141|FG001|Overall Study|Withdrawal by Subject|3|||
162003224|NCT01602224|585065142|FG002|Overall Study|Withdrawal by Subject|3|||
162003225|NCT01352117|585065143|FG000|Overall Study|Death|15|||
162003226|NCT01352117|585065144|FG001|Overall Study|Death|16|||
162003227|NCT01352117|585065143|FG000|Overall Study|Withdrawal by Subject|1|||
162003228|NCT01352117|585065144|FG001|Overall Study|Withdrawal by Subject|0|||
162003229|NCT01352117|585065143|FG000|Overall Study|Lost to Follow-up|2|||
162003230|NCT01352117|585065144|FG001|Overall Study|Lost to Follow-up|7|||
162003231|NCT01352117|585065143|FG000|Overall Study|Non-adherent to study requirements|1|||
162003232|NCT01352117|585065144|FG001|Overall Study|Non-adherent to study requirements|1|||
162003233|NCT01352117|585065143|FG000|Overall Study|Did not initiate study treatment|1|||
162003234|NCT01352117|585065144|FG001|Overall Study|Did not initiate study treatment|0|||
162003235|NCT01352117|585065143|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
162003236|NCT01352117|585065144|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
162003237|NCT00644423|585065145|FG000|Overall Study|Lost to Follow-up|1|||
162003238|NCT00644423|585065146|FG001|Overall Study|Lost to Follow-up|1|||
162003239|NCT03525444|585065147|FG000|Overall Study|Adverse Event|0|||
162003240|NCT03525444|585065148|FG001|Overall Study|Adverse Event|1|||
162003241|NCT03525444|585065147|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
162003242|NCT03525444|585065148|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
162003243|NCT03525444|585065147|FG000|Overall Study|Other|0|||
162003244|NCT03525444|585065148|FG001|Overall Study|Other|1|||
162003245|NCT00262860|585065150|FG000|Overall Study|Adverse Event|2|||
162003246|NCT02741128|585065151|FG000|Overall Study|Protocol Violation|4|||
162003247|NCT02741128|585065152|FG001|Overall Study|Protocol Violation|1|||
162003248|NCT02741128|585065151|FG000|Overall Study|Withdrawal by Subject|2|||
162003249|NCT02741128|585065152|FG001|Overall Study|Withdrawal by Subject|0|||
162003250|NCT02741128|585065151|FG000|Overall Study|Lost to Follow-up|1|||
162003251|NCT02741128|585065152|FG001|Overall Study|Lost to Follow-up|0|||
162003252|NCT01419769|585065153|FG000|Overall Study|Did not receive the AXIOS stent|3|||
162003253|NCT01419769|585065153|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
162003254|NCT00878501|585065154|FG000|Overall Study|Adverse Event|11|||
162003255|NCT00878501|585065155|FG001|Overall Study|Adverse Event|3|||
162003256|NCT00878501|585065156|FG002|Overall Study|Adverse Event|3|||
162003257|NCT00878501|585065154|FG000|Overall Study|Lack of Efficacy|2|||
162003258|NCT00878501|585065155|FG001|Overall Study|Lack of Efficacy|1|||
162003259|NCT00878501|585065156|FG002|Overall Study|Lack of Efficacy|0|||
162003260|NCT00878501|585065154|FG000|Overall Study|Withdrawal by Subject|2|||
162003261|NCT00878501|585065155|FG001|Overall Study|Withdrawal by Subject|1|||
162003262|NCT00878501|585065156|FG002|Overall Study|Withdrawal by Subject|2|||
162003263|NCT00878501|585065154|FG000|Overall Study|Protocol Violation|0|||
162003264|NCT00878501|585065155|FG001|Overall Study|Protocol Violation|0|||
162003265|NCT00878501|585065156|FG002|Overall Study|Protocol Violation|1|||
162003266|NCT00878501|585065154|FG000|Overall Study|Incorrect enrolment|1|||
162003267|NCT00878501|585065155|FG001|Overall Study|Incorrect enrolment|2|||
162003268|NCT00878501|585065156|FG002|Overall Study|Incorrect enrolment|0|||
162003269|NCT00878501|585065154|FG000|Overall Study|Intake of prohibited concom. medication|0|||
162003270|NCT00878501|585065155|FG001|Overall Study|Intake of prohibited concom. medication|0|||
162003271|NCT00878501|585065156|FG002|Overall Study|Intake of prohibited concom. medication|1|||
162003272|NCT00878501|585065154|FG000|Overall Study|Mis-randomisation of patient|1|||
162043077|NCT00734474|585216264|FG008|Overall Study|Sponsor Decision|0|||
162003273|NCT00878501|585065155|FG001|Overall Study|Mis-randomisation of patient|0|||
162003274|NCT00878501|585065156|FG002|Overall Study|Mis-randomisation of patient|0|||
162003275|NCT00878501|585065154|FG000|Overall Study|Administrative|0|||
162003276|NCT00878501|585065155|FG001|Overall Study|Administrative|0|||
162003277|NCT00878501|585065156|FG002|Overall Study|Administrative|1|||
162003278|NCT03224130|585065163|FG000|Overall Study|consent issue|0|||
162003279|NCT03224130|585065164|FG001|Overall Study|consent issue|1|||
162003280|NCT01690052|585065165|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
162003281|NCT01690052|585065166|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
162003282|NCT01453049|585065167|FG000|Overall Study|Protocol Violation|2|||
162003283|NCT01453049|585065168|FG001|Overall Study|Protocol Violation|5|||
162003284|NCT01453049|585065167|FG000|Overall Study|Lost to Follow-up|2|||
162003285|NCT01453049|585065168|FG001|Overall Study|Lost to Follow-up|1|||
162003286|NCT01453049|585065167|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
162003287|NCT01453049|585065168|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
162003288|NCT01453049|585065167|FG000|Overall Study|Withdrawal by Subject|1|||
162003289|NCT01453049|585065168|FG001|Overall Study|Withdrawal by Subject|0|||
162003290|NCT01453049|585065167|FG000|Overall Study|Randomized in Error|1|||
162003291|NCT01453049|585065168|FG001|Overall Study|Randomized in Error|0|||
162003292|NCT02421172|585065169|FG000|Period 1|Adverse Event|1|||
162003293|NCT02421172|585065170|FG001|Period 1|Adverse Event|0|||
162003294|NCT02421172|585065171|FG002|Period 1|Adverse Event|0|||
162003295|NCT02421172|585065172|FG003|Period 1|Adverse Event|0|||
162003296|NCT02421172|585065173|FG004|Period 1|Adverse Event|0|||
162003297|NCT02421172|585065169|FG000|Period 1|Lost to Follow-up|3|||
162003298|NCT02421172|585065170|FG001|Period 1|Lost to Follow-up|1|||
162003299|NCT02421172|585065171|FG002|Period 1|Lost to Follow-up|0|||
162003300|NCT02421172|585065172|FG003|Period 1|Lost to Follow-up|0|||
162003301|NCT02421172|585065173|FG004|Period 1|Lost to Follow-up|0|||
162003302|NCT02421172|585065169|FG000|Period 1|Patient/guardian decision|0|||
162003303|NCT02421172|585065170|FG001|Period 1|Patient/guardian decision|1|||
162003304|NCT02421172|585065171|FG002|Period 1|Patient/guardian decision|0|||
162003305|NCT02421172|585065172|FG003|Period 1|Patient/guardian decision|0|||
162003306|NCT02421172|585065173|FG004|Period 1|Patient/guardian decision|0|||
162003307|NCT02421172|585065169|FG000|Period 2|Adverse Event|0|||
162003308|NCT02421172|585065170|FG001|Period 2|Adverse Event|0|||
162003309|NCT02421172|585065171|FG002|Period 2|Adverse Event|4|||
162003310|NCT02421172|585065172|FG003|Period 2|Adverse Event|0|||
162003311|NCT02421172|585065173|FG004|Period 2|Adverse Event|0|||
162003312|NCT02421172|585065169|FG000|Period 2|Lost to Follow-up|0|||
162003313|NCT02421172|585065170|FG001|Period 2|Lost to Follow-up|0|||
162003314|NCT02421172|585065171|FG002|Period 2|Lost to Follow-up|0|||
162003315|NCT02421172|585065172|FG003|Period 2|Lost to Follow-up|1|||
162003316|NCT02421172|585065173|FG004|Period 2|Lost to Follow-up|0|||
162003317|NCT02421172|585065169|FG000|Period 2|Patient/guardian decision|0|||
162003318|NCT02421172|585065170|FG001|Period 2|Patient/guardian decision|0|||
162003319|NCT02421172|585065171|FG002|Period 2|Patient/guardian decision|3|||
162003320|NCT02421172|585065172|FG003|Period 2|Patient/guardian decision|2|||
162003321|NCT02421172|585065173|FG004|Period 2|Patient/guardian decision|1|||
162003322|NCT00928486|585065174|FG000|Overall Study|Adverse Event|2|||
162003323|NCT00928486|585065174|FG000|Overall Study|Disease Progression|7|||
162003324|NCT00928486|585065174|FG000|Overall Study|Withdrawal by Subject|1|||
162003325|NCT03489863|585065178|FG000|Overall Study|Withdrawal by Subject|0|||
162003326|NCT03489863|585065179|FG001|Overall Study|Withdrawal by Subject|1|||
162003327|NCT00768989|585065182|FG000|Prior to Week 24|Withdrawal by Subject|1|||
162003328|NCT00768989|585065183|FG001|Prior to Week 24|Withdrawal by Subject|0|||
162003329|NCT00768989|585065182|FG000|Prior to Week 24|Adverse Event|3|||
162003330|NCT00768989|585065183|FG001|Prior to Week 24|Adverse Event|0|||
162003331|NCT00768989|585065182|FG000|Prior to Week 24|Lost to Follow-up|0|||
162003332|NCT00768989|585065183|FG001|Prior to Week 24|Lost to Follow-up|1|||
162003333|NCT00768989|585065182|FG000|Prior to Week 24|Protocol Violation|0|||
162003334|NCT00768989|585065183|FG001|Prior to Week 24|Protocol Violation|2|||
162003335|NCT00768989|585065182|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
162003336|NCT00768989|585065183|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
162003337|NCT00768989|585065182|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
162003338|NCT00768989|585065183|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
162003339|NCT00768989|585065182|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
162003340|NCT00768989|585065183|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
162003341|NCT00768989|585065182|FG000|On or After Week 36|Lack of Efficacy|1|||
162003342|NCT00768989|585065183|FG001|On or After Week 36|Lack of Efficacy|0|||
162003343|NCT00768989|585065182|FG000|On or After Week 36|Adverse Event|0|||
162003344|NCT00768989|585065183|FG001|On or After Week 36|Adverse Event|1|||
162003345|NCT00768989|585065182|FG000|On or After Week 36|Lost to Follow-up|1|||
162003346|NCT00768989|585065183|FG001|On or After Week 36|Lost to Follow-up|0|||
162003347|NCT00768989|585065182|FG000|On or After Week 36|Poor Compliance|1|||
162003348|NCT00768989|585065183|FG001|On or After Week 36|Poor Compliance|0|||
162003349|NCT00768989|585065182|FG000|On or After Week 36|Protocol Violation|1|||
162003350|NCT00768989|585065183|FG001|On or After Week 36|Protocol Violation|0|||
162003351|NCT00768989|585065182|FG000|On or After Week 36|Did not attend termination visit|2|||
162003352|NCT00768989|585065183|FG001|On or After Week 36|Did not attend termination visit|0|||
162003353|NCT00768989|585065182|FG000|On or After Week 36|Sponsor Termination|45|||
162003354|NCT00768989|585065183|FG001|On or After Week 36|Sponsor Termination|26|||
162003355|NCT02153086|585065184|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
162003356|NCT02153086|585065184|FG000|Overall Study|Other|2|||
162003357|NCT01194830|585065185|FG000|Overall Study|Adverse Event|3|||
162003358|NCT01194830|585065186|FG001|Overall Study|Adverse Event|2|||
162003359|NCT01194830|585065185|FG000|Overall Study|Protocol Violation|5|||
162003360|NCT01194830|585065186|FG001|Overall Study|Protocol Violation|4|||
162003361|NCT01194830|585065185|FG000|Overall Study|Lost to Follow-up|9|||
162003362|NCT01194830|585065186|FG001|Overall Study|Lost to Follow-up|7|||
162003363|NCT01194830|585065185|FG000|Overall Study|Withdrawal by Subject|2|||
162003364|NCT01194830|585065186|FG001|Overall Study|Withdrawal by Subject|1|||
162003365|NCT01194830|585065185|FG000|Overall Study|Lack of Efficacy|1|||
162003366|NCT01194830|585065186|FG001|Overall Study|Lack of Efficacy|1|||
162003367|NCT01194830|585065185|FG000|Overall Study|Non-compliance issues|4|||
162003368|NCT01194830|585065186|FG001|Overall Study|Non-compliance issues|4|||
162003369|NCT01194830|585065185|FG000|Overall Study|Other Reason|12|||
162003370|NCT01194830|585065186|FG001|Overall Study|Other Reason|8|||
162003371|NCT03115359|585065187|FG000|Overall Study|Withdrawal by Subject|29|||
162003372|NCT03115359|585065188|FG001|Overall Study|Withdrawal by Subject|39|||
162003373|NCT03115359|585065187|FG000|Overall Study|Scheduling conflict|25|||
162003374|NCT03115359|585065188|FG001|Overall Study|Scheduling conflict|23|||
162003375|NCT03115359|585065187|FG000|Overall Study|Personal reasons including health|12|||
162003376|NCT03115359|585065188|FG001|Overall Study|Personal reasons including health|9|||
162003377|NCT03115359|585065187|FG000|Overall Study|Transportation barriers|3|||
162003378|NCT03115359|585065188|FG001|Overall Study|Transportation barriers|0|||
162003379|NCT03115359|585065187|FG000|Overall Study|No longer interested|5|||
162003380|NCT03115359|585065188|FG001|Overall Study|No longer interested|4|||
162003381|NCT03115359|585065187|FG000|Overall Study|No reason provided|45|||
162003382|NCT03115359|585065188|FG001|Overall Study|No reason provided|47|||
162003383|NCT01317472|585065191|FG000|Overall Study|Withdrawal by Subject|1|||
162003384|NCT01317472|585065192|FG001|Overall Study|Withdrawal by Subject|0|||
162003385|NCT01317472|585065191|FG000|Overall Study|Unrelated hospitalization|1|||
162003386|NCT01317472|585065192|FG001|Overall Study|Unrelated hospitalization|0|||
162003387|NCT01815918|585065193|FG000|Overall Study|Patient samples not analyzable|3|||
162003388|NCT01815918|585065194|FG001|Overall Study|Patient samples not analyzable|4|||
162003389|NCT01815918|585065193|FG000|Overall Study|Lack of Efficacy|15|||
162003390|NCT01815918|585065194|FG001|Overall Study|Lack of Efficacy|15|||
162003391|NCT00866177|585065205|FG000|Overall Study|Withdrawal by Subject|1|||
162003392|NCT00866177|585065205|FG000|Overall Study|Not Treated|151|||
162003393|NCT03585660|585065208|FG000|Overall Study|operator error|1|||
162003394|NCT03585660|585065208|FG000|Overall Study|technical error|2|||
162003395|NCT03585660|585065208|FG000|Overall Study|hip prosthesis|2|||
162003396|NCT03585660|585065208|FG000|Overall Study|did not undergo biopsy|8|||
162003397|NCT03585660|585065208|FG000|Overall Study|scanner problem|2|||
162003398|NCT03661723|585065211|FG000|Overall Study|Disease Progression|4|||
162003399|NCT03661723|585065212|FG001|Overall Study|Disease Progression|24|||
162003400|NCT03661723|585065213|FG002|Overall Study|Disease Progression|4|||
162003401|NCT03661723|585065214|FG003|Overall Study|Disease Progression|19|||
162003402|NCT03661723|585065211|FG000|Overall Study|Withdrawal by Subject|1|||
162003403|NCT03661723|585065212|FG001|Overall Study|Withdrawal by Subject|0|||
162003404|NCT03661723|585065213|FG002|Overall Study|Withdrawal by Subject|2|||
162003405|NCT03661723|585065214|FG003|Overall Study|Withdrawal by Subject|4|||
162003406|NCT03661723|585065211|FG000|Overall Study|Physician Decision|1|||
162003407|NCT03661723|585065212|FG001|Overall Study|Physician Decision|0|||
162003408|NCT03661723|585065213|FG002|Overall Study|Physician Decision|0|||
162003409|NCT03661723|585065214|FG003|Overall Study|Physician Decision|0|||
162003410|NCT03661723|585065211|FG000|Overall Study|Clinical Deterioration|0|||
162003411|NCT03661723|585065212|FG001|Overall Study|Clinical Deterioration|0|||
162003412|NCT03661723|585065213|FG002|Overall Study|Clinical Deterioration|0|||
162003413|NCT03661723|585065214|FG003|Overall Study|Clinical Deterioration|1|||
162003414|NCT00807911|585065221|FG000|Overall Study|Withdrawal by Subject|12|||
162003415|NCT00807911|585065222|FG001|Overall Study|Withdrawal by Subject|10|||
162003416|NCT00807911|585065221|FG000|Overall Study|Ineligible|0|||
162003417|NCT00807911|585065222|FG001|Overall Study|Ineligible|4|||
162003418|NCT02648204|585065227|FG000|Overall Study|Withdrawal by Subject|12|||
162003419|NCT02648204|585065228|FG001|Overall Study|Withdrawal by Subject|8|||
162003420|NCT02648204|585065229|FG002|Overall Study|Withdrawal by Subject|2|||
162003421|NCT02648204|585065230|FG003|Overall Study|Withdrawal by Subject|6|||
162003422|NCT02648204|585065227|FG000|Overall Study|Lost to Follow-up|5|||
162003423|NCT02648204|585065228|FG001|Overall Study|Lost to Follow-up|8|||
162003424|NCT02648204|585065229|FG002|Overall Study|Lost to Follow-up|4|||
162003425|NCT02648204|585065230|FG003|Overall Study|Lost to Follow-up|6|||
162003426|NCT02648204|585065227|FG000|Overall Study|Missing follow-up information|4|||
162003427|NCT02648204|585065228|FG001|Overall Study|Missing follow-up information|4|||
162003428|NCT02648204|585065229|FG002|Overall Study|Missing follow-up information|4|||
162003429|NCT02648204|585065230|FG003|Overall Study|Missing follow-up information|2|||
162003430|NCT02648204|585065227|FG000|Overall Study|Death|1|||
162003431|NCT02648204|585065228|FG001|Overall Study|Death|1|||
162003432|NCT02648204|585065229|FG002|Overall Study|Death|2|||
162003433|NCT02648204|585065230|FG003|Overall Study|Death|2|||
162003434|NCT02648204|585065227|FG000|Overall Study|Adverse Event|0|||
162003435|NCT02648204|585065228|FG001|Overall Study|Adverse Event|0|||
162003436|NCT02648204|585065229|FG002|Overall Study|Adverse Event|1|||
162003437|NCT02648204|585065230|FG003|Overall Study|Adverse Event|0|||
162003438|NCT04349891|585065231|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
162003439|NCT04349891|585065232|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
162003440|NCT04349891|585065231|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
162003441|NCT04349891|585065232|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
162003442|NCT04349891|585065231|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
162003443|NCT04349891|585065232|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
162003444|NCT04349891|585065231|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
162003445|NCT04349891|585065232|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
162003446|NCT03532542|585065235|FG000|Overall Study|Death|1|||
162003447|NCT03532542|585065236|FG001|Overall Study|Death|0|||
162003448|NCT03532542|585065235|FG000|Overall Study|Study Terminated by Sponsor|41|||
162003449|NCT03532542|585065236|FG001|Overall Study|Study Terminated by Sponsor|65|||
162003450|NCT03532542|585065235|FG000|Overall Study|Withdrawal by Subject|6|||
162003451|NCT03532542|585065236|FG001|Overall Study|Withdrawal by Subject|5|||
162003452|NCT01018030|585065237|FG000|Overall Study|Adverse Event|10|||
162003453|NCT01018030|585065238|FG001|Overall Study|Adverse Event|5|||
162003454|NCT01018030|585065239|FG002|Overall Study|Adverse Event|5|||
162043078|NCT00734474|585216256|FG000|Overall Study|Death|0|||
162043079|NCT00734474|585216257|FG001|Overall Study|Death|0|||
162043080|NCT00734474|585216258|FG002|Overall Study|Death|1|||
162043081|NCT00734474|585216259|FG003|Overall Study|Death|0|||
162043082|NCT00734474|585216260|FG004|Overall Study|Death|0|||
162043083|NCT00734474|585216261|FG005|Overall Study|Death|0|||
162043084|NCT00734474|585216262|FG006|Overall Study|Death|0|||
162003455|NCT01018030|585065237|FG000|Overall Study|Withdrawal by Subject|2|||
162003456|NCT01018030|585065238|FG001|Overall Study|Withdrawal by Subject|2|||
162003457|NCT01018030|585065239|FG002|Overall Study|Withdrawal by Subject|4|||
162003458|NCT01018030|585065237|FG000|Overall Study|Lost to Follow-up|2|||
162003459|NCT01018030|585065238|FG001|Overall Study|Lost to Follow-up|0|||
162003460|NCT01018030|585065239|FG002|Overall Study|Lost to Follow-up|3|||
162003461|NCT01018030|585065237|FG000|Overall Study|Protocol Violation|2|||
162003462|NCT01018030|585065238|FG001|Overall Study|Protocol Violation|1|||
162003463|NCT01018030|585065239|FG002|Overall Study|Protocol Violation|0|||
162003464|NCT01018030|585065237|FG000|Overall Study|Physician Decision|1|||
162003465|NCT01018030|585065238|FG001|Overall Study|Physician Decision|0|||
162003466|NCT01018030|585065239|FG002|Overall Study|Physician Decision|1|||
162003467|NCT01018030|585065237|FG000|Overall Study|Lack of Efficacy|1|||
162003468|NCT01018030|585065238|FG001|Overall Study|Lack of Efficacy|0|||
162003469|NCT01018030|585065239|FG002|Overall Study|Lack of Efficacy|0|||
162003470|NCT01018030|585065237|FG000|Overall Study|Did Not Receive Study Drug|1|||
162003471|NCT01018030|585065238|FG001|Overall Study|Did Not Receive Study Drug|3|||
162003472|NCT01018030|585065239|FG002|Overall Study|Did Not Receive Study Drug|0|||
162003473|NCT00625131|585065249|FG000|Overall Study|Lost to Follow-up|3|||
162003474|NCT00625131|585065250|FG001|Overall Study|Lost to Follow-up|2|||
162003475|NCT00625131|585065251|FG002|Overall Study|Lost to Follow-up|0|||
162003476|NCT00625131|585065249|FG000|Overall Study|Withdrawal by Subject|1|||
162003477|NCT00625131|585065250|FG001|Overall Study|Withdrawal by Subject|0|||
162003478|NCT00625131|585065251|FG002|Overall Study|Withdrawal by Subject|5|||
162003479|NCT05083351|585065255|FG000|Overall Study|Adverse Event|3|||
162003480|NCT05083351|585065255|FG000|Overall Study|Did not meet data inclusion criteria|8|||
162003481|NCT05083351|585065255|FG000|Overall Study|Did not meet eligibility criteria|19|||
162003482|NCT05083351|585065255|FG000|Overall Study|Study Staff Decision|19|||
162003483|NCT00849940|585065264|FG000|Overall Study|Physician Decision|4|||
162003484|NCT03353675|585065268|FG000|Overall Study|Adverse Event|4|||
162003485|NCT00402168|585065269|FG000|Randomized|Lost to Follow-up|1|||
162003486|NCT00402168|585065270|FG001|Randomized|Lost to Follow-up|0|||
162003487|NCT00402168|585065269|FG000|Randomized|Withdrawal by Subject|0|||
162003488|NCT00402168|585065270|FG001|Randomized|Withdrawal by Subject|1|||
162003489|NCT00402168|585065269|FG000|Treatment (up to 12 Months)|Death|0|||
162003490|NCT00402168|585065270|FG001|Treatment (up to 12 Months)|Death|1|||
162003491|NCT00402168|585065269|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
162003492|NCT00402168|585065270|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
162003493|NCT00402168|585065269|FG000|Treatment (up to 12 Months)|non-specified|0|||
162003494|NCT00402168|585065270|FG001|Treatment (up to 12 Months)|non-specified|1|||
162043085|NCT00734474|585216263|FG007|Overall Study|Death|2|||
162043086|NCT00734474|585216264|FG008|Overall Study|Death|1|||
162003495|NCT00402168|585065269|FG000|Long Term (LT)|Adverse Event|1|||
162003496|NCT00402168|585065270|FG001|Long Term (LT)|Adverse Event|5|||
162003497|NCT00402168|585065269|FG000|Long Term (LT)|Withdrawal by Subject|4|||
162003498|NCT00402168|585065270|FG001|Long Term (LT)|Withdrawal by Subject|7|||
162003499|NCT00402168|585065269|FG000|Long Term (LT)|Pregnancy|0|||
162003500|NCT00402168|585065270|FG001|Long Term (LT)|Pregnancy|1|||
162003501|NCT00402168|585065269|FG000|Long Term (LT)|Lost to Follow-up|1|||
162043087|NCT00734474|585216256|FG000|Overall Study|Lack of Efficacy|0|||
162043088|NCT00734474|585216257|FG001|Overall Study|Lack of Efficacy|0|||
162003502|NCT00402168|585065270|FG001|Long Term (LT)|Lost to Follow-up|0|||
162003503|NCT00402168|585065269|FG000|Long Term (LT)|Death|4|||
162043089|NCT00734474|585216258|FG002|Overall Study|Lack of Efficacy|4|||
162043090|NCT00734474|585216259|FG003|Overall Study|Lack of Efficacy|0|||
162003504|NCT00402168|585065270|FG001|Long Term (LT)|Death|0|||
162003505|NCT00402168|585065269|FG000|Long Term (LT)|Lack of Efficacy|0|||
162003506|NCT00402168|585065270|FG001|Long Term (LT)|Lack of Efficacy|2|||
162003507|NCT00402168|585065269|FG000|Long Term (LT)|non-specified|1|||
162003508|NCT00402168|585065270|FG001|Long Term (LT)|non-specified|2|||
162003509|NCT00402168|585065269|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
162003510|NCT00402168|585065270|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
162003511|NCT00402168|585065269|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
162003512|NCT00402168|585065270|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
162003513|NCT00550407|585065273|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
162003514|NCT00550407|585065274|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
162003515|NCT00550407|585065275|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
162003516|NCT00550407|585065273|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
162003517|NCT00550407|585065274|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
162003518|NCT00550407|585065275|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
162003519|NCT00550407|585065273|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
162003520|NCT00550407|585065274|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
162003521|NCT00550407|585065275|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
162003522|NCT00550407|585065273|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
162003523|NCT00550407|585065274|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
162003524|NCT00550407|585065275|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
162003525|NCT00550407|585065273|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
162003526|NCT00550407|585065274|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
162003527|NCT00550407|585065275|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
162003528|NCT00550407|585065273|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
162003529|NCT00550407|585065274|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
162003530|NCT00550407|585065275|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
162003531|NCT00550407|585065273|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
162003532|NCT00550407|585065274|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
162003533|NCT00550407|585065275|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
162003534|NCT00550407|585065273|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
162003535|NCT00550407|585065274|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
162003536|NCT00550407|585065275|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
162003537|NCT00550407|585065273|FG000|26-Week Randomized Phase|Adverse Event|0|||
162003538|NCT00550407|585065274|FG001|26-Week Randomized Phase|Adverse Event|5|||
162003539|NCT00550407|585065275|FG002|26-Week Randomized Phase|Adverse Event|2|||
162003540|NCT00550407|585065273|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
162003541|NCT00550407|585065274|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
162003542|NCT00550407|585065275|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
162003543|NCT00550407|585065273|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
162003544|NCT00550407|585065274|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
162003545|NCT00550407|585065275|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
162003546|NCT00550407|585065273|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
162003547|NCT00550407|585065274|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
162003548|NCT00550407|585065275|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
162003549|NCT00584415|585065276|FG000|Overall Study|Adverse Event|7|||
162003550|NCT02370420|585065277|FG000|Overall Study|Physician Decision|3|||
162003551|NCT02370420|585065278|FG001|Overall Study|Physician Decision|3|||
162003552|NCT02370420|585065277|FG000|Overall Study|Lost to Follow-up|11|||
162003553|NCT02370420|585065278|FG001|Overall Study|Lost to Follow-up|9|||
162003554|NCT00556894|585065279|FG000|Overall Study|Adverse Event|2|||
162003555|NCT00556894|585065280|FG001|Overall Study|Adverse Event|3|||
162003556|NCT00556894|585065281|FG002|Overall Study|Adverse Event|3|||
162003557|NCT00556894|585065279|FG000|Overall Study|Death|1|||
162003558|NCT00556894|585065280|FG001|Overall Study|Death|0|||
162003559|NCT00556894|585065281|FG002|Overall Study|Death|0|||
162003560|NCT00556894|585065279|FG000|Overall Study|regulatory decision in Bulgaria|10|||
162003561|NCT00556894|585065280|FG001|Overall Study|regulatory decision in Bulgaria|14|||
162003562|NCT00556894|585065281|FG002|Overall Study|regulatory decision in Bulgaria|13|||
162003563|NCT00556894|585065279|FG000|Overall Study|Change in therapy|2|||
162003564|NCT00556894|585065280|FG001|Overall Study|Change in therapy|1|||
162003565|NCT00556894|585065281|FG002|Overall Study|Change in therapy|2|||
162003566|NCT00556894|585065279|FG000|Overall Study|Withdrawal by Subject|1|||
162003567|NCT00556894|585065280|FG001|Overall Study|Withdrawal by Subject|1|||
162003568|NCT00556894|585065281|FG002|Overall Study|Withdrawal by Subject|1|||
162003569|NCT03883581|585065282|FG000|Overall Study|Withdrawal by Subject|4|||
162003570|NCT04158583|585065283|FG000|Overall Study|Withdrawal by Subject|1|||
162003571|NCT04158583|585065284|FG001|Overall Study|Withdrawal by Subject|1|||
162003572|NCT04158583|585065285|FG002|Overall Study|Withdrawal by Subject|0|||
162003573|NCT04158583|585065286|FG003|Overall Study|Withdrawal by Subject|0|||
162003574|NCT04158583|585065287|FG004|Overall Study|Withdrawal by Subject|1|||
162003575|NCT04158583|585065288|FG005|Overall Study|Withdrawal by Subject|0|||
162003576|NCT04158583|585065289|FG006|Overall Study|Withdrawal by Subject|0|||
162003577|NCT04158583|585065290|FG007|Overall Study|Withdrawal by Subject|0|||
162003578|NCT04158583|585065291|FG008|Overall Study|Withdrawal by Subject|2|||
162003579|NCT04158583|585065292|FG009|Overall Study|Withdrawal by Subject|0|||
162003580|NCT04158583|585065283|FG000|Overall Study|Study Terminated by Sponsor|0|||
162003581|NCT04158583|585065284|FG001|Overall Study|Study Terminated by Sponsor|0|||
162003582|NCT04158583|585065285|FG002|Overall Study|Study Terminated by Sponsor|0|||
162003583|NCT04158583|585065286|FG003|Overall Study|Study Terminated by Sponsor|1|||
162003584|NCT04158583|585065287|FG004|Overall Study|Study Terminated by Sponsor|0|||
162003585|NCT04158583|585065288|FG005|Overall Study|Study Terminated by Sponsor|0|||
162003586|NCT04158583|585065289|FG006|Overall Study|Study Terminated by Sponsor|0|||
162003587|NCT04158583|585065290|FG007|Overall Study|Study Terminated by Sponsor|0|||
162003588|NCT04158583|585065291|FG008|Overall Study|Study Terminated by Sponsor|0|||
162003589|NCT04158583|585065292|FG009|Overall Study|Study Terminated by Sponsor|0|||
162003590|NCT04158583|585065283|FG000|Overall Study|Progressive Disease|1|||
162003591|NCT04158583|585065284|FG001|Overall Study|Progressive Disease|0|||
162003592|NCT04158583|585065285|FG002|Overall Study|Progressive Disease|3|||
162003593|NCT04158583|585065286|FG003|Overall Study|Progressive Disease|5|||
162003594|NCT04158583|585065287|FG004|Overall Study|Progressive Disease|0|||
162003595|NCT04158583|585065288|FG005|Overall Study|Progressive Disease|1|||
162003596|NCT04158583|585065289|FG006|Overall Study|Progressive Disease|6|||
162003597|NCT04158583|585065290|FG007|Overall Study|Progressive Disease|2|||
162003598|NCT04158583|585065291|FG008|Overall Study|Progressive Disease|1|||
162003599|NCT04158583|585065292|FG009|Overall Study|Progressive Disease|2|||
162003600|NCT04158583|585065283|FG000|Overall Study|Lost to Follow-up|0|||
162003601|NCT04158583|585065284|FG001|Overall Study|Lost to Follow-up|0|||
162003602|NCT04158583|585065285|FG002|Overall Study|Lost to Follow-up|1|||
162003603|NCT04158583|585065286|FG003|Overall Study|Lost to Follow-up|1|||
162003604|NCT04158583|585065287|FG004|Overall Study|Lost to Follow-up|1|||
162003605|NCT04158583|585065288|FG005|Overall Study|Lost to Follow-up|0|||
162003606|NCT04158583|585065289|FG006|Overall Study|Lost to Follow-up|0|||
162003607|NCT04158583|585065290|FG007|Overall Study|Lost to Follow-up|0|||
162003608|NCT04158583|585065291|FG008|Overall Study|Lost to Follow-up|0|||
162003609|NCT04158583|585065292|FG009|Overall Study|Lost to Follow-up|0|||
162003610|NCT04158583|585065283|FG000|Overall Study|Due To Patient Status|0|||
162003611|NCT04158583|585065284|FG001|Overall Study|Due To Patient Status|0|||
162003612|NCT04158583|585065285|FG002|Overall Study|Due To Patient Status|0|||
162003613|NCT04158583|585065286|FG003|Overall Study|Due To Patient Status|0|||
162003614|NCT04158583|585065287|FG004|Overall Study|Due To Patient Status|0|||
162003615|NCT04158583|585065288|FG005|Overall Study|Due To Patient Status|0|||
162003616|NCT04158583|585065289|FG006|Overall Study|Due To Patient Status|0|||
162003617|NCT04158583|585065290|FG007|Overall Study|Due To Patient Status|0|||
162003618|NCT04158583|585065291|FG008|Overall Study|Due To Patient Status|1|||
162003619|NCT04158583|585065292|FG009|Overall Study|Due To Patient Status|0|||
162003620|NCT04158583|585065283|FG000|Overall Study|Death|3|||
162003621|NCT04158583|585065284|FG001|Overall Study|Death|4|||
162003622|NCT04158583|585065285|FG002|Overall Study|Death|2|||
162003623|NCT04158583|585065286|FG003|Overall Study|Death|2|||
162003624|NCT04158583|585065287|FG004|Overall Study|Death|4|||
162003625|NCT04158583|585065288|FG005|Overall Study|Death|3|||
162043091|NCT00734474|585216260|FG004|Overall Study|Lack of Efficacy|0|||
162043092|NCT00734474|585216261|FG005|Overall Study|Lack of Efficacy|0|||
162043093|NCT00734474|585216262|FG006|Overall Study|Lack of Efficacy|0|||
162043094|NCT00734474|585216263|FG007|Overall Study|Lack of Efficacy|4|||
162043095|NCT00734474|585216264|FG008|Overall Study|Lack of Efficacy|6|||
162043096|NCT02104752|585216267|FG000|Overall Study|Withdrawal by Subject|1|||
162043097|NCT02104752|585216268|FG001|Overall Study|Withdrawal by Subject|0|||
162043098|NCT02104752|585216267|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
162043099|NCT02104752|585216268|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
162043100|NCT02899299|585216269|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
162003626|NCT04158583|585065289|FG006|Overall Study|Death|5|||
162043101|NCT02899299|585216270|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
162043102|NCT02899299|585216269|FG000|Pre-treatment|Participant withdrew consent|1|||
162043103|NCT02899299|585216270|FG001|Pre-treatment|Participant withdrew consent|11|||
162043104|NCT02899299|585216269|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
162043105|NCT02899299|585216270|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
162003627|NCT04158583|585065290|FG007|Overall Study|Death|2|||
162043106|NCT02899299|585216269|FG000|Pre-treatment|Not reported|0|||
162043107|NCT02899299|585216270|FG001|Pre-treatment|Not reported|1|||
162003628|NCT04158583|585065291|FG008|Overall Study|Death|0|||
162003629|NCT04158583|585065292|FG009|Overall Study|Death|1|||
162043108|NCT02899299|585216269|FG000|Treatment|Disease Progression|182|||
162003630|NCT04158583|585065283|FG000|Overall Study|Clinical Progression Disease|0|||
162003631|NCT04158583|585065284|FG001|Overall Study|Clinical Progression Disease|0|||
162003632|NCT04158583|585065285|FG002|Overall Study|Clinical Progression Disease|0|||
162003633|NCT04158583|585065286|FG003|Overall Study|Clinical Progression Disease|1|||
162003634|NCT04158583|585065287|FG004|Overall Study|Clinical Progression Disease|0|||
162003635|NCT04158583|585065288|FG005|Overall Study|Clinical Progression Disease|0|||
162003636|NCT04158583|585065289|FG006|Overall Study|Clinical Progression Disease|0|||
162003637|NCT04158583|585065290|FG007|Overall Study|Clinical Progression Disease|0|||
162003638|NCT04158583|585065291|FG008|Overall Study|Clinical Progression Disease|0|||
162003639|NCT04158583|585065292|FG009|Overall Study|Clinical Progression Disease|0|||
162003640|NCT04158583|585065283|FG000|Overall Study|Clinical Progression|0|||
162003641|NCT04158583|585065284|FG001|Overall Study|Clinical Progression|0|||
162003642|NCT04158583|585065285|FG002|Overall Study|Clinical Progression|0|||
162003643|NCT04158583|585065286|FG003|Overall Study|Clinical Progression|0|||
162003644|NCT04158583|585065287|FG004|Overall Study|Clinical Progression|1|||
162003645|NCT04158583|585065288|FG005|Overall Study|Clinical Progression|0|||
162003646|NCT04158583|585065289|FG006|Overall Study|Clinical Progression|2|||
162003647|NCT04158583|585065290|FG007|Overall Study|Clinical Progression|0|||
162003648|NCT04158583|585065291|FG008|Overall Study|Clinical Progression|0|||
162003649|NCT04158583|585065292|FG009|Overall Study|Clinical Progression|0|||
162003650|NCT04158583|585065283|FG000|Overall Study|Clinical Deterioration|0|||
162003651|NCT04158583|585065284|FG001|Overall Study|Clinical Deterioration|0|||
162003652|NCT04158583|585065285|FG002|Overall Study|Clinical Deterioration|0|||
162003653|NCT04158583|585065286|FG003|Overall Study|Clinical Deterioration|1|||
162003654|NCT04158583|585065287|FG004|Overall Study|Clinical Deterioration|0|||
162003655|NCT04158583|585065288|FG005|Overall Study|Clinical Deterioration|0|||
162003656|NCT04158583|585065289|FG006|Overall Study|Clinical Deterioration|0|||
162003657|NCT04158583|585065290|FG007|Overall Study|Clinical Deterioration|0|||
162003658|NCT04158583|585065291|FG008|Overall Study|Clinical Deterioration|0|||
162003659|NCT04158583|585065292|FG009|Overall Study|Clinical Deterioration|1|||
162003660|NCT05546476|585067583|FG000|Period 1: Part A|Adverse Event|2|||
162003661|NCT05546476|585067584|FG001|Period 1: Part A|Adverse Event|0|||
162003662|NCT05546476|585067585|FG002|Period 1: Part A|Adverse Event|0|||
162003663|NCT05546476|585067586|FG003|Period 1: Part A|Adverse Event|1|||
162003664|NCT05546476|585067583|FG000|Period 1: Part A|Death|4|||
162003665|NCT05546476|585067584|FG001|Period 1: Part A|Death|4|||
162003666|NCT05546476|585067585|FG002|Period 1: Part A|Death|5|||
162003667|NCT05546476|585067586|FG003|Period 1: Part A|Death|6|||
162003668|NCT05546476|585067583|FG000|Period 1: Part A|Lack of Efficacy|0|||
162003669|NCT05546476|585067584|FG001|Period 1: Part A|Lack of Efficacy|0|||
162003670|NCT05546476|585067585|FG002|Period 1: Part A|Lack of Efficacy|0|||
162003671|NCT05546476|585067586|FG003|Period 1: Part A|Lack of Efficacy|1|||
162003672|NCT05546476|585067583|FG000|Period 1: Part A|Lost to Follow-up|0|||
162003673|NCT05546476|585067584|FG001|Period 1: Part A|Lost to Follow-up|0|||
162003674|NCT05546476|585067585|FG002|Period 1: Part A|Lost to Follow-up|0|||
162003675|NCT05546476|585067586|FG003|Period 1: Part A|Lost to Follow-up|1|||
162003676|NCT05546476|585067583|FG000|Period 1: Part A|Physician Decision|1|||
162003677|NCT05546476|585067584|FG001|Period 1: Part A|Physician Decision|0|||
162003678|NCT05546476|585067585|FG002|Period 1: Part A|Physician Decision|0|||
162003679|NCT05546476|585067586|FG003|Period 1: Part A|Physician Decision|0|||
162003680|NCT05546476|585067583|FG000|Period 1: Part A|Progressive disease|3|||
162003681|NCT05546476|585067584|FG001|Period 1: Part A|Progressive disease|5|||
162003682|NCT05546476|585067585|FG002|Period 1: Part A|Progressive disease|0|||
162003683|NCT05546476|585067586|FG003|Period 1: Part A|Progressive disease|1|||
162003684|NCT05546476|585067583|FG000|Period 1: Part A|Withdrawal by Subject|1|||
162003685|NCT05546476|585067584|FG001|Period 1: Part A|Withdrawal by Subject|1|||
162003686|NCT05546476|585067585|FG002|Period 1: Part A|Withdrawal by Subject|1|||
162003687|NCT05546476|585067586|FG003|Period 1: Part A|Withdrawal by Subject|2|||
162003688|NCT05546476|585067583|FG000|Period 1: Part A|Global deterioration of health status|2|||
162003689|NCT05546476|585067584|FG001|Period 1: Part A|Global deterioration of health status|2|||
162003690|NCT05546476|585067585|FG002|Period 1: Part A|Global deterioration of health status|1|||
162003691|NCT05546476|585067586|FG003|Period 1: Part A|Global deterioration of health status|4|||
162003692|NCT05546476|585067583|FG000|Period 1: Part A|Other: Unspecified|0|||
162003693|NCT05546476|585067584|FG001|Period 1: Part A|Other: Unspecified|2|||
162003694|NCT05546476|585067585|FG002|Period 1: Part A|Other: Unspecified|0|||
162003695|NCT05546476|585067586|FG003|Period 1: Part A|Other: Unspecified|0|||
162003696|NCT05546476|585067583|FG000|Period 2: Part B|Ongoing|26|||
162003697|NCT05546476|585067584|FG001|Period 2: Part B|Ongoing|27|||
162003698|NCT05546476|585067585|FG002|Period 2: Part B|Ongoing|35|||
162003699|NCT05546476|585067586|FG003|Period 2: Part B|Ongoing|29|||
162003700|NCT03760029|585067594|FG000|Overall Study|Death|1|||
162003701|NCT03760029|585067595|FG001|Overall Study|Death|0|||
162003702|NCT03760029|585067596|FG002|Overall Study|Death|0|||
162003703|NCT03760029|585067594|FG000|Overall Study|Lost to Follow-up|0|||
162043109|NCT02899299|585216270|FG001|Treatment|Disease Progression|43|||
162003704|NCT03760029|585067595|FG001|Overall Study|Lost to Follow-up|2|||
162003705|NCT03760029|585067596|FG002|Overall Study|Lost to Follow-up|1|||
162003706|NCT03760029|585067594|FG000|Overall Study|Withdrawal by Subject|1|||
162003707|NCT03760029|585067595|FG001|Overall Study|Withdrawal by Subject|4|||
162043110|NCT02899299|585216269|FG000|Treatment|Study Drug Toxicity|60|||
162003708|NCT03760029|585067596|FG002|Overall Study|Withdrawal by Subject|1|||
162003709|NCT03760029|585067594|FG000|Overall Study|Withdrawal by parent/guardian|4|||
162003710|NCT03760029|585067595|FG001|Overall Study|Withdrawal by parent/guardian|4|||
162003711|NCT03760029|585067596|FG002|Overall Study|Withdrawal by parent/guardian|1|||
162003712|NCT03760029|585067594|FG000|Overall Study|Other|2|||
162003713|NCT03760029|585067595|FG001|Overall Study|Other|1|||
162003714|NCT03760029|585067596|FG002|Overall Study|Other|0|||
162003715|NCT04890652|585067602|FG000|Overall Study|Withdrawal by Subject|2|||
162003716|NCT02399215|585067611|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
162003717|NCT02399215|585067611|FG000|Overall Study|Withdrawal by Subject|1|||
162003718|NCT00772538|585067612|FG000|Overall Study|Adverse Event|6|||
162003719|NCT00772538|585067613|FG001|Overall Study|Adverse Event|6|||
162003720|NCT00772538|585067612|FG000|Overall Study|Protocol Violation|3|||
162003721|NCT00772538|585067613|FG001|Overall Study|Protocol Violation|3|||
162003722|NCT00772538|585067612|FG000|Overall Study|Lost to Follow-up|1|||
162003723|NCT00772538|585067613|FG001|Overall Study|Lost to Follow-up|1|||
162003724|NCT00772538|585067612|FG000|Overall Study|Withdrawal by Subject|3|||
162003725|NCT00772538|585067613|FG001|Overall Study|Withdrawal by Subject|8|||
162003726|NCT00772538|585067612|FG000|Overall Study|Lack of Efficacy|0|||
162003727|NCT00772538|585067613|FG001|Overall Study|Lack of Efficacy|1|||
162003728|NCT00772538|585067612|FG000|Overall Study|Other|7|||
162003729|NCT00772538|585067613|FG001|Overall Study|Other|7|||
162003730|NCT01089504|585067616|FG000|Overall Study|Lost to Follow-up|1|||
162003731|NCT01089504|585067617|FG001|Overall Study|Lost to Follow-up|1|||
162003732|NCT01089504|585067616|FG000|Overall Study|Withdrawal by Subject|2|||
162003733|NCT01089504|585067617|FG001|Overall Study|Withdrawal by Subject|0|||
162003734|NCT00001832|585067618|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
162003735|NCT00001832|585067619|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
162003736|NCT00001832|585067620|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
162003737|NCT00001832|585067621|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
162003738|NCT00001832|585067622|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
162003739|NCT00001832|585067623|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
162003740|NCT00001832|585067624|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
162003741|NCT00001832|585067625|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
162003742|NCT00001832|585067626|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
162003743|NCT00001832|585067627|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
162003744|NCT00001832|585067628|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
162003745|NCT00001832|585067629|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
162003746|NCT00001832|585067630|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
162003747|NCT00001832|585067631|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
162003748|NCT00001832|585067632|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
162003749|NCT00001832|585067618|FG000|Treatment Period|Death during treatment|0|||
162003750|NCT00001832|585067619|FG001|Treatment Period|Death during treatment|0|||
162003751|NCT00001832|585067620|FG002|Treatment Period|Death during treatment|0|||
162003752|NCT00001832|585067621|FG003|Treatment Period|Death during treatment|0|||
162003753|NCT00001832|585067622|FG004|Treatment Period|Death during treatment|0|||
162003754|NCT00001832|585067623|FG005|Treatment Period|Death during treatment|1|||
162003755|NCT00001832|585067624|FG006|Treatment Period|Death during treatment|0|||
162003756|NCT00001832|585067625|FG007|Treatment Period|Death during treatment|0|||
162003757|NCT00001832|585067626|FG008|Treatment Period|Death during treatment|0|||
162003758|NCT00001832|585067627|FG009|Treatment Period|Death during treatment|0|||
162003759|NCT00001832|585067628|FG010|Treatment Period|Death during treatment|0|||
162003760|NCT00001832|585067629|FG011|Treatment Period|Death during treatment|0|||
162003761|NCT00001832|585067630|FG012|Treatment Period|Death during treatment|0|||
162003762|NCT00001832|585067631|FG013|Treatment Period|Death during treatment|0|||
162003763|NCT00001832|585067632|FG014|Treatment Period|Death during treatment|0|||
162003764|NCT00001832|585067618|FG000|Treatment Period|Not treated|0|||
162003765|NCT00001832|585067619|FG001|Treatment Period|Not treated|0|||
162003766|NCT00001832|585067620|FG002|Treatment Period|Not treated|0|||
162003767|NCT00001832|585067621|FG003|Treatment Period|Not treated|0|||
162003768|NCT00001832|585067622|FG004|Treatment Period|Not treated|0|||
162003769|NCT00001832|585067623|FG005|Treatment Period|Not treated|0|||
162003770|NCT00001832|585067624|FG006|Treatment Period|Not treated|0|||
162003771|NCT00001832|585067625|FG007|Treatment Period|Not treated|1|||
162003772|NCT00001832|585067626|FG008|Treatment Period|Not treated|0|||
162003773|NCT00001832|585067627|FG009|Treatment Period|Not treated|0|||
162003774|NCT00001832|585067628|FG010|Treatment Period|Not treated|0|||
162003775|NCT00001832|585067629|FG011|Treatment Period|Not treated|0|||
162003776|NCT00001832|585067630|FG012|Treatment Period|Not treated|0|||
162003777|NCT00001832|585067631|FG013|Treatment Period|Not treated|0|||
162003778|NCT00001832|585067632|FG014|Treatment Period|Not treated|0|||
162003779|NCT01903356|585067633|FG000|Overall Study|Lost to Follow-up|7|||
162003780|NCT01903356|585067633|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
162003781|NCT01903356|585067633|FG000|Overall Study|Violated the dosage and administration|3|||
162003782|NCT00713609|585067634|FG000|Overall Study|Adverse Event|2|||
162003783|NCT00713609|585067635|FG001|Overall Study|Adverse Event|0|||
162003784|NCT00713609|585067636|FG002|Overall Study|Adverse Event|2|||
162003785|NCT00713609|585067637|FG003|Overall Study|Adverse Event|2|||
162003786|NCT00713609|585067638|FG004|Overall Study|Adverse Event|3|||
162003787|NCT00713609|585067639|FG005|Overall Study|Adverse Event|1|||
162003788|NCT00713609|585067634|FG000|Overall Study|Lost to Follow-up|5|||
162003789|NCT00713609|585067635|FG001|Overall Study|Lost to Follow-up|7|||
162003790|NCT00713609|585067636|FG002|Overall Study|Lost to Follow-up|5|||
162003791|NCT00713609|585067637|FG003|Overall Study|Lost to Follow-up|5|||
162003792|NCT00713609|585067638|FG004|Overall Study|Lost to Follow-up|7|||
162003793|NCT00713609|585067639|FG005|Overall Study|Lost to Follow-up|0|||
162003794|NCT00713609|585067634|FG000|Overall Study|Lack of Efficacy|1|||
162003795|NCT00713609|585067635|FG001|Overall Study|Lack of Efficacy|3|||
162003796|NCT00713609|585067636|FG002|Overall Study|Lack of Efficacy|0|||
162003797|NCT00713609|585067637|FG003|Overall Study|Lack of Efficacy|0|||
162003798|NCT00713609|585067638|FG004|Overall Study|Lack of Efficacy|1|||
162003799|NCT00713609|585067639|FG005|Overall Study|Lack of Efficacy|0|||
162003800|NCT00713609|585067634|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
162003801|NCT00713609|585067635|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
162003802|NCT00713609|585067636|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
162003803|NCT00713609|585067637|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
162003804|NCT00713609|585067638|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
162003805|NCT00713609|585067639|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
162003806|NCT00713609|585067634|FG000|Overall Study|Withdrawal by Subject|6|||
162003807|NCT00713609|585067635|FG001|Overall Study|Withdrawal by Subject|1|||
162003808|NCT00713609|585067636|FG002|Overall Study|Withdrawal by Subject|5|||
162003809|NCT00713609|585067637|FG003|Overall Study|Withdrawal by Subject|1|||
162003810|NCT00713609|585067638|FG004|Overall Study|Withdrawal by Subject|5|||
162003811|NCT00713609|585067639|FG005|Overall Study|Withdrawal by Subject|7|||
162003812|NCT00713609|585067634|FG000|Overall Study|Protocol Violation|6|||
162003813|NCT00713609|585067635|FG001|Overall Study|Protocol Violation|3|||
162003814|NCT00713609|585067636|FG002|Overall Study|Protocol Violation|1|||
162003815|NCT00713609|585067637|FG003|Overall Study|Protocol Violation|1|||
162003816|NCT00713609|585067638|FG004|Overall Study|Protocol Violation|2|||
162003817|NCT00713609|585067639|FG005|Overall Study|Protocol Violation|0|||
162003818|NCT04529083|585067640|FG000|Overall Study|Withdrawal by Subject|3|||
162003819|NCT03305666|585067645|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
162003820|NCT03305666|585067646|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
162003821|NCT04196686|585067647|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
162003822|NCT04196686|585067648|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
162003823|NCT00914849|585067654|FG000|Overall Study|Withdrawal by Subject|1|||
162003824|NCT00914849|585067655|FG001|Overall Study|Withdrawal by Subject|0|||
162003825|NCT00914849|585067654|FG000|Overall Study|Not eligible|0|||
162003826|NCT00914849|585067655|FG001|Overall Study|Not eligible|1|||
162003827|NCT01001221|585067656|FG000|Overall Study|Adverse Event|1|||
162003828|NCT01001221|585067657|FG001|Overall Study|Adverse Event|2|||
162003829|NCT01001221|585067658|FG002|Overall Study|Adverse Event|0|||
162003830|NCT01001221|585067659|FG003|Overall Study|Adverse Event|2|||
162003831|NCT01001221|585067660|FG004|Overall Study|Adverse Event|0|||
162003832|NCT01001221|585067656|FG000|Overall Study|Disease progression|3|||
162003833|NCT01001221|585067657|FG001|Overall Study|Disease progression|2|||
162003834|NCT01001221|585067658|FG002|Overall Study|Disease progression|2|||
162003835|NCT01001221|585067659|FG003|Overall Study|Disease progression|4|||
162003836|NCT01001221|585067660|FG004|Overall Study|Disease progression|0|||
162003837|NCT01001221|585067656|FG000|Overall Study|Other|1|||
162003838|NCT01001221|585067657|FG001|Overall Study|Other|1|||
162003839|NCT01001221|585067658|FG002|Overall Study|Other|0|||
162003840|NCT01001221|585067659|FG003|Overall Study|Other|0|||
162003841|NCT01001221|585067660|FG004|Overall Study|Other|0|||
162003842|NCT01001221|585067656|FG000|Overall Study|Not treated; protocol exclusion|0|||
162003843|NCT01001221|585067657|FG001|Overall Study|Not treated; protocol exclusion|0|||
162003844|NCT01001221|585067658|FG002|Overall Study|Not treated; protocol exclusion|1|||
162003845|NCT01001221|585067659|FG003|Overall Study|Not treated; protocol exclusion|0|||
162003846|NCT01001221|585067660|FG004|Overall Study|Not treated; protocol exclusion|0|||
162003847|NCT05106959|585067661|FG000|Overall Study|Lost to Follow-up|1|||
162003848|NCT03448406|585067662|FG000|Overall Study|Noncompliance of scheduled visits|1|||
162003849|NCT03448406|585067663|FG001|Overall Study|Noncompliance of scheduled visits|2|||
162003850|NCT03448406|585067662|FG000|Overall Study|Withdrawal by Subject|1|||
162003851|NCT03448406|585067663|FG001|Overall Study|Withdrawal by Subject|2|||
162003852|NCT03448406|585067662|FG000|Overall Study|Protocol Violation|1|||
162003853|NCT03448406|585067663|FG001|Overall Study|Protocol Violation|0|||
162003854|NCT03448406|585067662|FG000|Overall Study|Adverse Event|8|||
162003855|NCT03448406|585067663|FG001|Overall Study|Adverse Event|9|||
162003856|NCT00087152|585067664|FG000|Overall Study|Ineligible|6|||
162003857|NCT01292486|585067665|FG000|Overall Study|Protocol Violation|2|||
162003858|NCT01292486|585067665|FG000|Overall Study|Did not meet screening criteria|2|||
162003859|NCT01292486|585067665|FG000|Overall Study|Adverse Event|1|||
162003860|NCT01292486|585067665|FG000|Overall Study|Physician Decision|1|||
162003861|NCT04602390|585067672|FG000|Overall Study|Withdrawal by Subject|0|||
162003862|NCT04602390|585067673|FG001|Overall Study|Withdrawal by Subject|0|||
162003863|NCT04602390|585067674|FG002|Overall Study|Withdrawal by Subject|0|||
162003864|NCT04602390|585067675|FG003|Overall Study|Withdrawal by Subject|0|||
162003865|NCT04602390|585067676|FG004|Overall Study|Withdrawal by Subject|1|||
162003866|NCT04602390|585067677|FG005|Overall Study|Withdrawal by Subject|0|||
162003867|NCT04602390|585067672|FG000|Overall Study|Adverse Event|0|||
162003868|NCT04602390|585067673|FG001|Overall Study|Adverse Event|0|||
162003869|NCT04602390|585067674|FG002|Overall Study|Adverse Event|0|||
162003870|NCT04602390|585067675|FG003|Overall Study|Adverse Event|0|||
162003871|NCT04602390|585067676|FG004|Overall Study|Adverse Event|0|||
162003872|NCT04602390|585067677|FG005|Overall Study|Adverse Event|1|||
162003873|NCT01277744|585067682|FG000|Overall Study|Physician Decision|2|||
162003874|NCT01791244|585067683|FG000|Overall Study|Adverse Event|5|||
162003875|NCT01791244|585067684|FG001|Overall Study|Adverse Event|7|||
162003876|NCT01791244|585067683|FG000|Overall Study|Insufficient clinical response|10|||
162003877|NCT01791244|585067684|FG001|Overall Study|Insufficient clinical response|10|||
162003878|NCT01791244|585067683|FG000|Overall Study|Laboratory Abnormality|0|||
162003879|NCT01791244|585067684|FG001|Overall Study|Laboratory Abnormality|1|||
162003880|NCT02358473|585067686|FG000|Overall Study|Disease Progession|6|||
162003881|NCT02358473|585067686|FG000|Overall Study|Adverse Event|3|||
162003882|NCT02358473|585067686|FG000|Overall Study|Withdrawal by Subject|2|||
162003883|NCT02358473|585067686|FG000|Overall Study|Physician Decision|2|||
162003884|NCT00703014|585067689|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
162003885|NCT00703014|585067690|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
162003886|NCT00703014|585067691|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
162003887|NCT00703014|585067692|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
162003888|NCT00703014|585067689|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
162003889|NCT00703014|585067690|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
162003890|NCT00703014|585067691|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
162003891|NCT00703014|585067692|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
162003892|NCT04949191|585067693|FG000|Overall Study|Non-compliance with Study Drug|1|||
162003893|NCT04949191|585067694|FG001|Overall Study|Non-compliance with Study Drug|0|||
162003894|NCT04949191|585067695|FG002|Overall Study|Non-compliance with Study Drug|0|||
162003895|NCT04949191|585067696|FG003|Overall Study|Non-compliance with Study Drug|0|||
162003896|NCT04949191|585067693|FG000|Overall Study|Progressive Disease|0|||
162003897|NCT04949191|585067694|FG001|Overall Study|Progressive Disease|1|||
162003898|NCT04949191|585067695|FG002|Overall Study|Progressive Disease|0|||
162003899|NCT04949191|585067696|FG003|Overall Study|Progressive Disease|0|||
162003900|NCT04949191|585067693|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
162003901|NCT04949191|585067694|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
162003902|NCT04949191|585067695|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
162003903|NCT04949191|585067696|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
162003904|NCT04949191|585067693|FG000|Overall Study|Sponsor Terminated Study|0|||
162003905|NCT04949191|585067694|FG001|Overall Study|Sponsor Terminated Study|0|||
162003906|NCT04949191|585067695|FG002|Overall Study|Sponsor Terminated Study|1|||
162003907|NCT04949191|585067696|FG003|Overall Study|Sponsor Terminated Study|1|||
162003908|NCT00730158|585067697|FG000|Overall Study|Withdrawal by Subject|1|||
162003909|NCT00730158|585067698|FG001|Overall Study|Withdrawal by Subject|1|||
162003910|NCT03535974|585067700|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
162003911|NCT03535974|585067701|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
162003912|NCT03535974|585067702|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
162003913|NCT03535974|585067700|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
162003914|NCT03535974|585067701|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
162003915|NCT03535974|585067702|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
162003916|NCT04059549|585067703|FG000|Overall Study|Withdrawal by Subject|2|||
162003917|NCT04059549|585067704|FG001|Overall Study|Withdrawal by Subject|0|||
162003918|NCT03259230|585067705|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
162003919|NCT03259230|585067706|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
162003920|NCT02678351|585067707|FG000|Overall Study|Withdrawal by Subject|1|||
162003921|NCT02913482|585067708|FG000|Overall Study|Death|0|||
162003922|NCT02913482|585067709|FG001|Overall Study|Death|2|||
162003923|NCT02913482|585067710|FG002|Overall Study|Death|2|||
162003924|NCT02913482|585067708|FG000|Overall Study|Progressive Disease|1|||
162043111|NCT02899299|585216270|FG001|Treatment|Study Drug Toxicity|24|||
162003925|NCT02913482|585067709|FG001|Overall Study|Progressive Disease|1|||
162003926|NCT02913482|585067710|FG002|Overall Study|Progressive Disease|1|||
162003927|NCT02913482|585067708|FG000|Overall Study|Reason not specified|0|||
162003928|NCT02913482|585067709|FG001|Overall Study|Reason not specified|0|||
162003929|NCT02913482|585067710|FG002|Overall Study|Reason not specified|1|||
162043112|NCT02899299|585216269|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
162003930|NCT02913482|585067708|FG000|Overall Study|Withdrawal by Subject|0|||
162003931|NCT02913482|585067709|FG001|Overall Study|Withdrawal by Subject|1|||
162003932|NCT02913482|585067710|FG002|Overall Study|Withdrawal by Subject|1|||
162003933|NCT01919229|585067711|FG000|Overall Study|Subject/guardian decision|0|||
162003934|NCT01919229|585067712|FG001|Overall Study|Subject/guardian decision|0|||
162003935|NCT01919229|585067713|FG002|Overall Study|Subject/guardian decision|1|||
162003936|NCT01011673|585067714|FG000|Randomized|Secondary headache|2|||
162003937|NCT01011673|585067715|FG001|Randomized|Secondary headache|1|||
162003938|NCT01011673|585067714|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
162003939|NCT01011673|585067715|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
162003940|NCT05468814|585067716|FG000|Overall Study|Lost to Follow-up|5|||
162003941|NCT05468814|585067717|FG001|Overall Study|Lost to Follow-up|6|||
162003942|NCT04716426|585067722|FG000|Overall Study|Vaccination|1|||
162003943|NCT04716426|585067723|FG001|Overall Study|Vaccination|1|||
162003944|NCT04716426|585067722|FG000|Overall Study|Contamination|1|||
162003945|NCT04716426|585067723|FG001|Overall Study|Contamination|0|||
162003946|NCT01650558|585067726|FG000|Overall Study|Migration out of study area|61|||
162003947|NCT01650558|585067727|FG001|Overall Study|Migration out of study area|71|||
162003948|NCT01650558|585067728|FG002|Overall Study|Migration out of study area|56|||
162003949|NCT01650558|585067726|FG000|Overall Study|Lost to Follow-up|10|||
162003950|NCT01650558|585067727|FG001|Overall Study|Lost to Follow-up|13|||
162003951|NCT01650558|585067728|FG002|Overall Study|Lost to Follow-up|6|||
162003952|NCT01650558|585067726|FG000|Overall Study|Death|10|||
162003953|NCT01650558|585067727|FG001|Overall Study|Death|6|||
162003954|NCT01650558|585067728|FG002|Overall Study|Death|8|||
162003955|NCT01650558|585067726|FG000|Overall Study|Withdrawal by Subject|1|||
162003956|NCT01650558|585067727|FG001|Overall Study|Withdrawal by Subject|1|||
162003957|NCT01650558|585067728|FG002|Overall Study|Withdrawal by Subject|3|||
162003958|NCT01650558|585067726|FG000|Overall Study|Non-compliant participant|1|||
162003959|NCT01650558|585067727|FG001|Overall Study|Non-compliant participant|0|||
162003960|NCT01650558|585067728|FG002|Overall Study|Non-compliant participant|2|||
162043113|NCT02899299|585216270|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
162043114|NCT02899299|585216269|FG000|Treatment|Participant request to discontinue Study treatment|4|||
162043115|NCT02899299|585216270|FG001|Treatment|Participant request to discontinue Study treatment|10|||
162043116|NCT02899299|585216269|FG000|Treatment|Participant withdrew consent|6|||
162043117|NCT02899299|585216270|FG001|Treatment|Participant withdrew consent|3|||
162043118|NCT02899299|585216269|FG000|Treatment|Lost to Follow-up|0|||
162043119|NCT02899299|585216270|FG001|Treatment|Lost to Follow-up|2|||
162043120|NCT02899299|585216269|FG000|Treatment|Maximum Clinical Benefit|11|||
162043121|NCT02899299|585216270|FG001|Treatment|Maximum Clinical Benefit|2|||
162043122|NCT02899299|585216269|FG000|Treatment|Poor/Non-compliance|1|||
162003961|NCT01650558|585067726|FG000|Overall Study|Physician Decision|0|||
162003962|NCT01650558|585067727|FG001|Overall Study|Physician Decision|1|||
162003963|NCT01650558|585067728|FG002|Overall Study|Physician Decision|0|||
162003964|NCT02960217|585067729|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
162003965|NCT02960217|585067730|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
162003966|NCT02960217|585067729|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
162003967|NCT02960217|585067730|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
162003968|NCT02960217|585067729|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
162003969|NCT02960217|585067730|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
162003970|NCT02960217|585067729|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
162003971|NCT02960217|585067730|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
162003972|NCT02960217|585067729|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
162043123|NCT02899299|585216270|FG001|Treatment|Poor/Non-compliance|0|||
162043124|NCT02899299|585216269|FG000|Treatment|Participant no longer meets Study criteria|4|||
162043125|NCT02899299|585216270|FG001|Treatment|Participant no longer meets Study criteria|0|||
162043126|NCT02899299|585216269|FG000|Treatment|Administrative reason by Sponsor|2|||
162043127|NCT02899299|585216270|FG001|Treatment|Administrative reason by Sponsor|0|||
162043128|NCT02899299|585216269|FG000|Treatment|Other reasons|12|||
162043129|NCT02899299|585216270|FG001|Treatment|Other reasons|2|||
162043130|NCT02899299|585216269|FG000|Treatment|Not reported|7|||
162043131|NCT02899299|585216270|FG001|Treatment|Not reported|0|||
162003973|NCT02960217|585067730|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
162003974|NCT02960217|585067729|FG000|Open-Label Extension Phase|Adverse Event|1|||
162003975|NCT02960217|585067730|FG001|Open-Label Extension Phase|Adverse Event|0|||
162003976|NCT02960217|585067729|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
162003977|NCT02960217|585067730|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
162003978|NCT02960217|585067729|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
162003979|NCT02960217|585067730|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
162003980|NCT02960217|585067729|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
162003981|NCT02960217|585067730|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
162003982|NCT02734693|585067731|FG000|Overall Study|Adverse Event|1|||
162003983|NCT02734693|585067732|FG001|Overall Study|Adverse Event|3|||
162003984|NCT02734693|585067733|FG002|Overall Study|Adverse Event|3|||
162043132|NCT00313300|585216271|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
162003985|NCT02734693|585067731|FG000|Overall Study|Lack of Efficacy|1|||
162003986|NCT02734693|585067732|FG001|Overall Study|Lack of Efficacy|0|||
162003987|NCT02734693|585067733|FG002|Overall Study|Lack of Efficacy|0|||
162003988|NCT02734693|585067731|FG000|Overall Study|Lost to Follow-up|2|||
162003989|NCT02734693|585067732|FG001|Overall Study|Lost to Follow-up|0|||
162003990|NCT02734693|585067733|FG002|Overall Study|Lost to Follow-up|0|||
162003991|NCT02734693|585067731|FG000|Overall Study|Protocol Violation|1|||
162003992|NCT02734693|585067732|FG001|Overall Study|Protocol Violation|0|||
162003993|NCT02734693|585067733|FG002|Overall Study|Protocol Violation|0|||
162003994|NCT02734693|585067731|FG000|Overall Study|Withdrawal by Subject|1|||
162003995|NCT02734693|585067732|FG001|Overall Study|Withdrawal by Subject|0|||
162003996|NCT02734693|585067733|FG002|Overall Study|Withdrawal by Subject|0|||
162003997|NCT00528957|585067737|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
162003998|NCT00528957|585067738|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
162003999|NCT00528957|585067737|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
162004000|NCT00528957|585067738|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
162004001|NCT00528957|585067737|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
162004002|NCT00528957|585067738|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
162004003|NCT00528957|585067737|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
162004004|NCT00528957|585067738|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
162004005|NCT00528957|585067737|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
162004006|NCT00528957|585067738|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
162004007|NCT00528957|585067737|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
162004008|NCT00528957|585067738|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
162004009|NCT00528957|585067737|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
162004010|NCT00528957|585067738|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
162004011|NCT00528957|585067737|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
162004012|NCT00528957|585067738|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
162004013|NCT00528957|585067737|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
162004014|NCT00528957|585067738|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
162004015|NCT00528957|585067737|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
162004016|NCT00528957|585067738|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
162004017|NCT00528957|585067737|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
162004018|NCT00528957|585067738|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
162004019|NCT00528957|585067737|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
162004020|NCT00528957|585067738|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
162004021|NCT00528957|585067737|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
162004022|NCT00528957|585067738|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
162004023|NCT00528957|585067737|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
162004024|NCT00528957|585067738|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
162004025|NCT00528957|585067737|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
162004026|NCT00528957|585067738|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
162004027|NCT00528957|585067737|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
162004028|NCT00528957|585067738|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
162004029|NCT01611792|585067741|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
162004030|NCT01611792|585067742|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
162004031|NCT01611792|585067741|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
162004032|NCT01611792|585067742|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
162004033|NCT03416868|585067743|FG000|Overall Study|Withdrawal by Subject|2|||
162004034|NCT03416868|585067743|FG000|Overall Study|Lost to Follow-up|1|||
162004035|NCT00083889|585067746|FG000|Overall Study|Adverse Event|76|||
162004036|NCT00083889|585067747|FG001|Overall Study|Adverse Event|86|||
162043133|NCT00313300|585216272|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
162043134|NCT00313300|585216273|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
162043135|NCT00313300|585216274|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
162043136|NCT00313300|585216275|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
162043137|NCT00313300|585216271|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
162043138|NCT00313300|585216272|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
162043139|NCT00313300|585216273|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
162043140|NCT00313300|585216274|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
162043141|NCT00313300|585216275|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
162004037|NCT00083889|585067746|FG000|Overall Study|Protocol Violation|2|||
162004038|NCT00083889|585067747|FG001|Overall Study|Protocol Violation|2|||
162004039|NCT00083889|585067746|FG000|Overall Study|Withdrawal by Subject|22|||
162004040|NCT00083889|585067747|FG001|Overall Study|Withdrawal by Subject|24|||
162004041|NCT00083889|585067746|FG000|Overall Study|Lack of Efficacy|240|||
162004042|NCT00083889|585067747|FG001|Overall Study|Lack of Efficacy|219|||
162004043|NCT00083889|585067746|FG000|Overall Study|Decision of sponsor|32|||
162004044|NCT00083889|585067747|FG001|Overall Study|Decision of sponsor|4|||
162004045|NCT00083889|585067746|FG000|Overall Study|Randomized: did not take study drug|0|||
162004046|NCT00083889|585067747|FG001|Overall Study|Randomized: did not take study drug|15|||
162004047|NCT00083889|585067746|FG000|Overall Study|Completed on marketed sunitinub|3|||
162004048|NCT00083889|585067747|FG001|Overall Study|Completed on marketed sunitinub|0|||
162004049|NCT00083889|585067746|FG000|Overall Study|Crossover to SU011248|0|||
162004050|NCT00083889|585067747|FG001|Overall Study|Crossover to SU011248|25|||
162004051|NCT00960375|585067748|FG000|Overall Study|Lost to Follow-up|20|||
162004052|NCT00960375|585067749|FG001|Overall Study|Lost to Follow-up|22|||
162004053|NCT03624881|585067750|FG000|Overall Study|Screen Failure|14|||
162004054|NCT03624881|585067751|FG001|Overall Study|Screen Failure|0|||
162004055|NCT03624881|585067750|FG000|Overall Study|No Catheter Inserted|6|||
162004056|NCT03624881|585067751|FG001|Overall Study|No Catheter Inserted|1|||
162004057|NCT03624881|585067750|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
162004058|NCT03624881|585067751|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
162004059|NCT03624881|585067750|FG000|Overall Study|Death|2|||
162004060|NCT03624881|585067751|FG001|Overall Study|Death|0|||
162004061|NCT03624881|585067750|FG000|Overall Study|Lost to Follow-up|10|||
162004062|NCT03624881|585067751|FG001|Overall Study|Lost to Follow-up|4|||
162004063|NCT03624881|585067750|FG000|Overall Study|Withdrawal by Subject|12|||
162004064|NCT03624881|585067751|FG001|Overall Study|Withdrawal by Subject|1|||
162004065|NCT04264442|585067752|FG000|Overall Study|Lack of Efficacy|6|||
162004066|NCT04264442|585067752|FG000|Overall Study|Lost to Follow-up|2|||
162004067|NCT04264442|585067752|FG000|Overall Study|Sponsor Decision|23|||
162004068|NCT04264442|585067752|FG000|Overall Study|Withdrawal by Subject|11|||
162004069|NCT04264442|585067752|FG000|Overall Study|Study Termination|5|||
162004070|NCT05190120|585067756|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
162004071|NCT05190120|585067757|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
162004072|NCT05190120|585067758|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
162004073|NCT05190120|585067759|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
162004074|NCT05190120|585067756|FG000|Overall Study|Lost to Follow-up|5|||
162004075|NCT05190120|585067757|FG001|Overall Study|Lost to Follow-up|0|||
162004076|NCT05190120|585067758|FG002|Overall Study|Lost to Follow-up|2|||
162004077|NCT05190120|585067759|FG003|Overall Study|Lost to Follow-up|3|||
162004078|NCT05893862|585067760|FG000|Overall Study|Physician Decision|0|||
162004079|NCT05893862|585067761|FG001|Overall Study|Physician Decision|1|||
162004080|NCT05893862|585067762|FG002|Overall Study|Physician Decision|0|||
162004081|NCT05893862|585067763|FG003|Overall Study|Physician Decision|0|||
162004082|NCT05893862|585067764|FG004|Overall Study|Physician Decision|1|||
162004083|NCT05893862|585067765|FG005|Overall Study|Physician Decision|0|||
162004084|NCT05893862|585067760|FG000|Overall Study|Withdrawal by Subject|1|||
162043142|NCT00313300|585216271|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
162043143|NCT00313300|585216272|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
162043144|NCT00313300|585216273|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
162043145|NCT00313300|585216274|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
162043146|NCT00313300|585216275|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
162043147|NCT00313300|585216271|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
162043148|NCT00313300|585216272|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
162043149|NCT00313300|585216273|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
162043150|NCT00313300|585216274|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
162043151|NCT00313300|585216275|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
162043152|NCT00313300|585216271|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
162043153|NCT00313300|585216272|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
162043154|NCT00313300|585216273|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
162043155|NCT00313300|585216274|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
162043156|NCT00313300|585216275|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
162004085|NCT05893862|585067761|FG001|Overall Study|Withdrawal by Subject|7|||
162004086|NCT05893862|585067762|FG002|Overall Study|Withdrawal by Subject|1|||
162043157|NCT00313300|585216271|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
162043158|NCT00313300|585216272|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
162004087|NCT05893862|585067763|FG003|Overall Study|Withdrawal by Subject|3|||
162004088|NCT05893862|585067764|FG004|Overall Study|Withdrawal by Subject|3|||
162004089|NCT05893862|585067765|FG005|Overall Study|Withdrawal by Subject|2|||
162004090|NCT05893862|585067760|FG000|Overall Study|Adverse Event|1|||
162043159|NCT00313300|585216273|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
162043160|NCT00313300|585216274|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
162004091|NCT05893862|585067761|FG001|Overall Study|Adverse Event|4|||
162004092|NCT05893862|585067762|FG002|Overall Study|Adverse Event|2|||
162004093|NCT05893862|585067763|FG003|Overall Study|Adverse Event|2|||
162004094|NCT05893862|585067764|FG004|Overall Study|Adverse Event|1|||
162004095|NCT05893862|585067765|FG005|Overall Study|Adverse Event|0|||
162043161|NCT00313300|585216275|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
162043162|NCT00313300|585216271|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
162043163|NCT00313300|585216272|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
162043164|NCT00313300|585216273|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
162043165|NCT00313300|585216274|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
162043166|NCT00313300|585216275|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
162043167|NCT00313300|585216271|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
162043168|NCT00313300|585216272|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
162043169|NCT00313300|585216273|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
162043170|NCT00313300|585216274|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
162043171|NCT00313300|585216275|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
162043172|NCT00313300|585216271|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
162043173|NCT00313300|585216272|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
162043174|NCT00313300|585216273|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
162043175|NCT00313300|585216274|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
162043176|NCT00313300|585216275|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
162043177|NCT00313300|585216271|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
162043178|NCT00313300|585216272|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
162043179|NCT00313300|585216273|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
162043180|NCT00313300|585216274|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
162043181|NCT00313300|585216275|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
162043182|NCT00313300|585216271|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
162043183|NCT00313300|585216272|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
162043184|NCT00313300|585216273|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
162043185|NCT00313300|585216274|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
162043186|NCT00313300|585216275|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
162043187|NCT00313300|585216271|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
162043188|NCT00313300|585216272|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
162004096|NCT00410956|585067766|FG000|Overall Study|Adverse Event|1|||
162004097|NCT00410956|585067766|FG000|Overall Study|Death|2|||
162004098|NCT00410956|585067766|FG000|Overall Study|Lack of Efficacy|10|||
162004099|NCT00410956|585067766|FG000|Overall Study|Physician Decision|6|||
162004100|NCT00880698|585067767|FG000|Overall Study|Death|0|||
162004101|NCT00880698|585067768|FG001|Overall Study|Death|0|||
162004102|NCT00880698|585067769|FG002|Overall Study|Death|1|||
162004103|NCT00880698|585067770|FG003|Overall Study|Death|2|||
162004104|NCT00880698|585067767|FG000|Overall Study|Lost to Follow-up|1|||
162004105|NCT00880698|585067768|FG001|Overall Study|Lost to Follow-up|3|||
162004106|NCT00880698|585067769|FG002|Overall Study|Lost to Follow-up|0|||
162004107|NCT00880698|585067770|FG003|Overall Study|Lost to Follow-up|1|||
162004108|NCT01766050|585069405|FG000|Overall Study|Adverse Event|1|||
162004109|NCT01766050|585069405|FG000|Overall Study|Lost to Follow-up|1|||
162004110|NCT01766050|585069405|FG000|Overall Study|Withdrawal by Subject|2|||
162004111|NCT01097668|585069406|FG000|Overall Study|Withdrawal by Subject|1|||
162004112|NCT01097668|585069407|FG001|Overall Study|Withdrawal by Subject|2|||
162004113|NCT01097668|585069406|FG000|Overall Study|Lost to Follow-up|1|||
162004114|NCT01097668|585069407|FG001|Overall Study|Lost to Follow-up|0|||
162004115|NCT00812708|585069408|FG000|Overall Study|Device could not be implanted|2|||
162004116|NCT00812708|585069408|FG000|Overall Study|Lack of medical insurance|1|||
162004117|NCT00812708|585069408|FG000|Overall Study|Switched to another study|1|||
162004118|NCT00812708|585069408|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
162004119|NCT00812708|585069408|FG000|Overall Study|Signed consent but later withdrew|3|||
162004120|NCT01021020|585069409|FG000|Period I|Protocol Violation|1|||
162004121|NCT01021020|585069409|FG000|Period I|Withdrawal by Subject|1|||
162004122|NCT01021020|585069409|FG000|14 Day Washout Period A|Physician Decision|1|||
162004123|NCT00755183|585069410|FG000|Overall Study|Adverse Event|5|||
162004124|NCT00755183|585069411|FG001|Overall Study|Adverse Event|2|||
162004125|NCT00755183|585069410|FG000|Overall Study|Protocol Violation|0|||
162004126|NCT00755183|585069411|FG001|Overall Study|Protocol Violation|1|||
162004127|NCT00755183|585069410|FG000|Overall Study|Withdrawal by Subject|0|||
162004128|NCT00755183|585069411|FG001|Overall Study|Withdrawal by Subject|2|||
162004129|NCT00755183|585069410|FG000|Overall Study|Administrative|2|||
162043189|NCT00313300|585216273|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
162043190|NCT00313300|585216274|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
162043191|NCT00313300|585216275|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
162043192|NCT00313300|585216271|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
162004130|NCT00755183|585069411|FG001|Overall Study|Administrative|1|||
162004131|NCT02587520|585069414|FG000|Overall Study|Protocol Violation|2|||
162004132|NCT02587520|585069415|FG001|Overall Study|Protocol Violation|0|||
162004133|NCT02587520|585069416|FG002|Overall Study|Protocol Violation|0|||
162004134|NCT02587520|585069417|FG003|Overall Study|Protocol Violation|2|||
162004135|NCT02587520|585069418|FG004|Overall Study|Protocol Violation|0|||
162004136|NCT02587520|585069419|FG005|Overall Study|Protocol Violation|1|||
162004137|NCT02587520|585069420|FG006|Overall Study|Protocol Violation|1|||
162004138|NCT02587520|585069421|FG007|Overall Study|Protocol Violation|1|||
162004139|NCT02587520|585069422|FG008|Overall Study|Protocol Violation|3|||
162004140|NCT02587520|585069423|FG009|Overall Study|Protocol Violation|3|||
162004141|NCT02587520|585069424|FG010|Overall Study|Protocol Violation|1|||
162004142|NCT02587520|585069425|FG011|Overall Study|Protocol Violation|2|||
162004143|NCT02587520|585069426|FG012|Overall Study|Protocol Violation|0|||
162004144|NCT02587520|585069427|FG013|Overall Study|Protocol Violation|0|||
162004145|NCT02587520|585069428|FG014|Overall Study|Protocol Violation|0|||
162004146|NCT02587520|585069429|FG015|Overall Study|Protocol Violation|0|||
162004147|NCT02587520|585069430|FG016|Overall Study|Protocol Violation|0|||
162004148|NCT02587520|585069431|FG017|Overall Study|Protocol Violation|0|||
162004149|NCT02587520|585069414|FG000|Overall Study|Adverse Event|0|||
162004150|NCT02587520|585069415|FG001|Overall Study|Adverse Event|0|||
162004151|NCT02587520|585069416|FG002|Overall Study|Adverse Event|0|||
162004152|NCT02587520|585069417|FG003|Overall Study|Adverse Event|0|||
162004153|NCT02587520|585069418|FG004|Overall Study|Adverse Event|0|||
162004154|NCT02587520|585069419|FG005|Overall Study|Adverse Event|0|||
162004155|NCT02587520|585069420|FG006|Overall Study|Adverse Event|0|||
162004156|NCT02587520|585069421|FG007|Overall Study|Adverse Event|0|||
162004157|NCT02587520|585069422|FG008|Overall Study|Adverse Event|0|||
162004158|NCT02587520|585069423|FG009|Overall Study|Adverse Event|0|||
162004159|NCT02587520|585069424|FG010|Overall Study|Adverse Event|0|||
162004160|NCT02587520|585069425|FG011|Overall Study|Adverse Event|1|||
162004161|NCT02587520|585069426|FG012|Overall Study|Adverse Event|0|||
162004162|NCT02587520|585069427|FG013|Overall Study|Adverse Event|0|||
162004163|NCT02587520|585069428|FG014|Overall Study|Adverse Event|0|||
162004164|NCT02587520|585069429|FG015|Overall Study|Adverse Event|0|||
162004165|NCT02587520|585069430|FG016|Overall Study|Adverse Event|0|||
162004166|NCT02587520|585069431|FG017|Overall Study|Adverse Event|0|||
162004167|NCT02587520|585069414|FG000|Overall Study|Withdrawal by Subject|0|||
162004168|NCT02587520|585069415|FG001|Overall Study|Withdrawal by Subject|0|||
162004169|NCT02587520|585069416|FG002|Overall Study|Withdrawal by Subject|1|||
162004170|NCT02587520|585069417|FG003|Overall Study|Withdrawal by Subject|1|||
162004171|NCT02587520|585069418|FG004|Overall Study|Withdrawal by Subject|0|||
162004172|NCT02587520|585069419|FG005|Overall Study|Withdrawal by Subject|1|||
162004173|NCT02587520|585069420|FG006|Overall Study|Withdrawal by Subject|1|||
162004174|NCT02587520|585069421|FG007|Overall Study|Withdrawal by Subject|0|||
162004175|NCT02587520|585069422|FG008|Overall Study|Withdrawal by Subject|0|||
162004176|NCT02587520|585069423|FG009|Overall Study|Withdrawal by Subject|0|||
162004177|NCT02587520|585069424|FG010|Overall Study|Withdrawal by Subject|0|||
162004178|NCT02587520|585069425|FG011|Overall Study|Withdrawal by Subject|0|||
162004179|NCT02587520|585069426|FG012|Overall Study|Withdrawal by Subject|0|||
162004180|NCT02587520|585069427|FG013|Overall Study|Withdrawal by Subject|1|||
162004181|NCT02587520|585069428|FG014|Overall Study|Withdrawal by Subject|0|||
162004182|NCT02587520|585069429|FG015|Overall Study|Withdrawal by Subject|0|||
162004183|NCT02587520|585069430|FG016|Overall Study|Withdrawal by Subject|0|||
162004184|NCT02587520|585069431|FG017|Overall Study|Withdrawal by Subject|0|||
162004185|NCT02587520|585069414|FG000|Overall Study|Lost to Follow-up|0|||
162004186|NCT02587520|585069415|FG001|Overall Study|Lost to Follow-up|2|||
162004187|NCT02587520|585069416|FG002|Overall Study|Lost to Follow-up|0|||
162004188|NCT02587520|585069417|FG003|Overall Study|Lost to Follow-up|2|||
162004189|NCT02587520|585069418|FG004|Overall Study|Lost to Follow-up|0|||
162004190|NCT02587520|585069419|FG005|Overall Study|Lost to Follow-up|1|||
162004191|NCT02587520|585069420|FG006|Overall Study|Lost to Follow-up|1|||
162004192|NCT02587520|585069421|FG007|Overall Study|Lost to Follow-up|1|||
162004193|NCT02587520|585069422|FG008|Overall Study|Lost to Follow-up|0|||
162043193|NCT00313300|585216272|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
162004194|NCT02587520|585069423|FG009|Overall Study|Lost to Follow-up|2|||
162004195|NCT02587520|585069424|FG010|Overall Study|Lost to Follow-up|2|||
162004196|NCT02587520|585069425|FG011|Overall Study|Lost to Follow-up|1|||
162004197|NCT02587520|585069426|FG012|Overall Study|Lost to Follow-up|0|||
162004198|NCT02587520|585069427|FG013|Overall Study|Lost to Follow-up|0|||
162004199|NCT02587520|585069428|FG014|Overall Study|Lost to Follow-up|0|||
162004200|NCT02587520|585069429|FG015|Overall Study|Lost to Follow-up|0|||
162004201|NCT02587520|585069430|FG016|Overall Study|Lost to Follow-up|0|||
162004202|NCT02587520|585069431|FG017|Overall Study|Lost to Follow-up|0|||
162043194|NCT00313300|585216273|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
162043195|NCT00313300|585216274|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
162004203|NCT00672555|585069432|FG000|Overall Study|Lost to Follow-up|4|||
162004204|NCT00672555|585069432|FG000|Overall Study|Did not want to answer questionnaire|2|||
162004205|NCT04516746|585069435|FG000|Overall Study|Randomized but not Treated|51|||
162004206|NCT04516746|585069436|FG001|Overall Study|Randomized but not Treated|19|||
162004207|NCT04516746|585069435|FG000|Overall Study|Adverse Event|0|||
162004208|NCT04516746|585069436|FG001|Overall Study|Adverse Event|1|||
162043196|NCT00313300|585216275|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
162004209|NCT04516746|585069435|FG000|Overall Study|Death|62|||
162004210|NCT04516746|585069436|FG001|Overall Study|Death|32|||
162004211|NCT04516746|585069435|FG000|Overall Study|Lost to Follow-up|3431|||
162004212|NCT04516746|585069436|FG001|Overall Study|Lost to Follow-up|1831|||
162004213|NCT04516746|585069435|FG000|Overall Study|Withdrawal by Subject|1946|||
162004214|NCT04516746|585069436|FG001|Overall Study|Withdrawal by Subject|1696|||
162004215|NCT04516746|585069435|FG000|Overall Study|Physician Decision|10|||
162004216|NCT04516746|585069436|FG001|Overall Study|Physician Decision|8|||
162004217|NCT04516746|585069435|FG000|Overall Study|Other|35|||
162004218|NCT04516746|585069436|FG001|Overall Study|Other|16|||
162004219|NCT00446849|585069438|FG000|Acute Phase|Lack of Efficacy|64|||
162004220|NCT00446849|585069438|FG000|Acute Phase|Protocol Violation|10|||
162004221|NCT00446849|585069438|FG000|Acute Phase|Consent withdrawn|4|||
162004222|NCT00446849|585069438|FG000|Acute Phase|Lost to Follow-up|2|||
162004223|NCT00446849|585069438|FG000|Acute Phase|Physician Decision|1|||
162004224|NCT00446849|585069438|FG000|Acute Phase|noncompliance|1|||
162004225|NCT00446849|585069438|FG000|Maintenance Phase|Lack of Efficacy|40|||
162004226|NCT00446849|585069438|FG000|Maintenance Phase|Protocol Violation|7|||
162004227|NCT00446849|585069438|FG000|Maintenance Phase|Adverse Event|6|||
162004228|NCT00446849|585069438|FG000|Maintenance Phase|Consent withdrawn|5|||
162004229|NCT00446849|585069438|FG000|Maintenance Phase|Lost to Follow-up|3|||
162004230|NCT00446849|585069438|FG000|Maintenance Phase|Pregnancy|1|||
162004231|NCT00446849|585069438|FG000|Maintenance Phase|noncompliance|2|||
162004232|NCT00446849|585069438|FG000|Maintenance Phase|prohibited medication use|2|||
162004233|NCT00446849|585069438|FG000|Maintenance Phase|antibiotic use|1|||
162004234|NCT00446849|585069438|FG000|Maintenance Phase|study closure|1|||
162004235|NCT00446849|585069438|FG000|Maintenance Phase|hydrocodone use|1|||
162004236|NCT00446849|585069438|FG000|Maintenance Phase|concomitant medication use|1|||
162004237|NCT01706458|585069439|FG000|Overall Study|Physician Decision|3|||
162004238|NCT01706458|585069440|FG001|Overall Study|Physician Decision|4|||
162004239|NCT03547518|585069441|FG000|Overall Study|Lost to Follow-up|2|||
162004240|NCT03547518|585069442|FG001|Overall Study|Lost to Follow-up|0|||
162004241|NCT02766023|585069443|FG000|Overall Study|Lost to Follow-up|23|||
162004242|NCT02766023|585069444|FG001|Overall Study|Lost to Follow-up|11|||
162004243|NCT02766023|585069443|FG000|Overall Study|Pregnancy|1|||
162004244|NCT02766023|585069444|FG001|Overall Study|Pregnancy|0|||
162004245|NCT02766023|585069443|FG000|Overall Study|Adverse Event|1|||
162004246|NCT02766023|585069444|FG001|Overall Study|Adverse Event|0|||
162004247|NCT02766023|585069443|FG000|Overall Study|Withdrawal by Subject|4|||
162004248|NCT02766023|585069444|FG001|Overall Study|Withdrawal by Subject|5|||
162004249|NCT02766023|585069443|FG000|Overall Study|Physician Decision|1|||
162004250|NCT02766023|585069444|FG001|Overall Study|Physician Decision|0|||
162004251|NCT02766023|585069443|FG000|Overall Study|Not Eligible at Enrollment|0|||
162004252|NCT02766023|585069444|FG001|Overall Study|Not Eligible at Enrollment|1|||
162004253|NCT02953652|585069445|FG000|Overall Study|Adverse Event|18|||
162004254|NCT02953652|585069445|FG000|Overall Study|Withdrawal by Subject|6|||
162004255|NCT02953652|585069445|FG000|Overall Study|Protocol Violation|1|||
162004256|NCT02953652|585069445|FG000|Overall Study|Disease Progression|27|||
162004257|NCT02384551|585069449|FG000|Overall Study|Lost to Follow-up|13|||
162004258|NCT02384551|585069450|FG001|Overall Study|Lost to Follow-up|14|||
162004259|NCT02384551|585069451|FG002|Overall Study|Lost to Follow-up|14|||
162004260|NCT02384551|585069452|FG003|Overall Study|Lost to Follow-up|14|||
162004261|NCT04742556|585069457|FG000|Overall Study|Withdrawal by Subject|0|||
162004262|NCT04742556|585069458|FG001|Overall Study|Withdrawal by Subject|1|||
162004263|NCT04742556|585069459|FG002|Overall Study|Withdrawal by Subject|0|||
162004264|NCT04742556|585069457|FG000|Overall Study|Adverse Event|0|||
162004265|NCT04742556|585069458|FG001|Overall Study|Adverse Event|0|||
162004266|NCT04742556|585069459|FG002|Overall Study|Adverse Event|2|||
162004267|NCT04742556|585069457|FG000|Overall Study|Clinical disease progression|0|||
162004268|NCT04742556|585069458|FG001|Overall Study|Clinical disease progression|1|||
162004269|NCT04742556|585069459|FG002|Overall Study|Clinical disease progression|2|||
162004270|NCT04742556|585069457|FG000|Overall Study|Objective disease progression|3|||
162004271|NCT04742556|585069458|FG001|Overall Study|Objective disease progression|2|||
162004272|NCT04742556|585069459|FG002|Overall Study|Objective disease progression|4|||
162004273|NCT04247347|585069460|FG000|Overall Study|Withdrawal by Subject|2|||
162004274|NCT04247347|585069461|FG001|Overall Study|Withdrawal by Subject|3|||
162004275|NCT04247347|585069462|FG002|Overall Study|Withdrawal by Subject|3|||
162004276|NCT04247347|585069460|FG000|Overall Study|Lost to Follow-up|1|||
162043197|NCT00313300|585216271|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
162004277|NCT04247347|585069461|FG001|Overall Study|Lost to Follow-up|1|||
162004278|NCT04247347|585069462|FG002|Overall Study|Lost to Follow-up|1|||
162004279|NCT03035032|585069463|FG000|Overall Study|Adverse Event|2|||
162004280|NCT03035032|585069463|FG000|Overall Study|Death|9|||
162004281|NCT03035032|585069463|FG000|Overall Study|Lost to Follow-up|1|||
162004282|NCT03035032|585069463|FG000|Overall Study|Progressive Disease|22|||
162004283|NCT03035032|585069463|FG000|Overall Study|Protocol Violation|2|||
162004284|NCT03035032|585069463|FG000|Overall Study|Withdrawal by Subject|2|||
162004285|NCT03035032|585069463|FG000|Overall Study|Physician Decision|5|||
162004286|NCT03562195|585069464|FG000|Overall Study|Adverse Event|0|||
162004287|NCT03562195|585069465|FG001|Overall Study|Adverse Event|6|||
162004288|NCT03562195|585069464|FG000|Overall Study|Lack of Efficacy|0|||
162004289|NCT03562195|585069465|FG001|Overall Study|Lack of Efficacy|5|||
162004290|NCT03562195|585069464|FG000|Overall Study|Protocol Violation|0|||
162004291|NCT03562195|585069465|FG001|Overall Study|Protocol Violation|1|||
162004292|NCT03562195|585069464|FG000|Overall Study|Lost to Follow-up|0|||
162004293|NCT03562195|585069465|FG001|Overall Study|Lost to Follow-up|1|||
162004294|NCT03562195|585069464|FG000|Overall Study|Physician Decision|1|||
162004295|NCT03562195|585069465|FG001|Overall Study|Physician Decision|0|||
162004296|NCT03562195|585069464|FG000|Overall Study|Withdrawal by Subject|3|||
162004297|NCT03562195|585069465|FG001|Overall Study|Withdrawal by Subject|0|||
162004298|NCT02923726|585069466|FG000|Overall Study|Death|196|||
162004299|NCT02923726|585069467|FG001|Overall Study|Death|175|||
162004300|NCT02923726|585069466|FG000|Overall Study|Withdrawal by Subject|337|||
162004301|NCT02923726|585069467|FG001|Overall Study|Withdrawal by Subject|307|||
162004302|NCT02756338|585069481|FG000|Overall Study|Withdrawn by Investigator|1|||
162004303|NCT02756338|585069481|FG000|Overall Study|Device Replaced with Pacemaker|4|||
162004304|NCT01546857|585069483|FG000|Overall Study|Withdrawal by Subject|2|||
162004305|NCT01546857|585069484|FG001|Overall Study|Withdrawal by Subject|3|||
162004306|NCT02542865|585069485|FG000|Overall Study|Identified as screen failure|1|||
162004307|NCT02542865|585069486|FG001|Overall Study|Identified as screen failure|0|||
162004308|NCT02542865|585069485|FG000|Overall Study|Withdrawal by Subject|16|||
162004309|NCT02542865|585069486|FG001|Overall Study|Withdrawal by Subject|0|||
162004310|NCT01339689|585069487|FG000|Overall Study|Adverse Event|1|||
162004311|NCT01339689|585069488|FG001|Overall Study|Adverse Event|2|||
162004312|NCT01339689|585069487|FG000|Overall Study|Lost to Follow-up|9|||
162004313|NCT01339689|585069488|FG001|Overall Study|Lost to Follow-up|3|||
162004314|NCT01339689|585069487|FG000|Overall Study|Withdrawal by Subject|3|||
162004315|NCT01339689|585069488|FG001|Overall Study|Withdrawal by Subject|0|||
162004316|NCT01339689|585069487|FG000|Overall Study|Noncompliance|1|||
162004317|NCT01339689|585069488|FG001|Overall Study|Noncompliance|0|||
162004318|NCT01339689|585069487|FG000|Overall Study|Relocated out of area|0|||
162004319|NCT01339689|585069488|FG001|Overall Study|Relocated out of area|1|||
162004320|NCT01339689|585069487|FG000|Overall Study|Other|2|||
162004321|NCT01339689|585069488|FG001|Overall Study|Other|2|||
162004322|NCT01339689|585069487|FG000|Overall Study|multiple reasons|1|||
162004323|NCT01339689|585069488|FG001|Overall Study|multiple reasons|1|||
162004324|NCT01176032|585069489|FG000|Overall Study|Adverse Event|1|||
162004325|NCT01176032|585069490|FG001|Overall Study|Adverse Event|0|||
162004326|NCT01176032|585069489|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162004327|NCT01176032|585069490|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162004328|NCT01176032|585069489|FG000|Overall Study|Protocol Violation|1|||
162004329|NCT01176032|585069490|FG001|Overall Study|Protocol Violation|0|||
162004330|NCT01176032|585069489|FG000|Overall Study|Informed consent withdrawn|3|||
162004331|NCT01176032|585069490|FG001|Overall Study|Informed consent withdrawn|0|||
162004332|NCT01176032|585069489|FG000|Overall Study|Other|1|||
162004333|NCT01176032|585069490|FG001|Overall Study|Other|0|||
162004334|NCT01469221|585069491|FG000|Double Blind Phase|Protocol Violation|1|||
162004335|NCT01469221|585069492|FG001|Double Blind Phase|Protocol Violation|0|||
162004336|NCT01469221|585069493|FG002|Double Blind Phase|Protocol Violation|0|||
162004337|NCT01469221|585069491|FG000|Double Blind Phase|Physician Decision|1|||
162004338|NCT01469221|585069492|FG001|Double Blind Phase|Physician Decision|1|||
162004339|NCT01469221|585069493|FG002|Double Blind Phase|Physician Decision|0|||
162004340|NCT01469221|585069491|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
162004341|NCT01469221|585069492|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
162004342|NCT01469221|585069493|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
162004343|NCT00659061|585069495|FG000|Overall Study|Migration due to political unrest|21|||
162004344|NCT00659061|585069496|FG001|Overall Study|Migration due to political unrest|15|||
162004345|NCT05121766|585069503|FG000|Overall Study|Covid reinfection|3|||
162004346|NCT05121766|585069504|FG001|Overall Study|Covid reinfection|0|||
162004347|NCT05121766|585069503|FG000|Overall Study|Withdrawal by Subject|3|||
162004348|NCT05121766|585069504|FG001|Overall Study|Withdrawal by Subject|1|||
162004349|NCT05121766|585069503|FG000|Overall Study|Adverse Event|2|||
162004350|NCT05121766|585069504|FG001|Overall Study|Adverse Event|4|||
162004351|NCT05121766|585069503|FG000|Overall Study|Lost to Follow-up|0|||
162004352|NCT05121766|585069504|FG001|Overall Study|Lost to Follow-up|1|||
162004353|NCT01632020|585069505|FG000|Overall Study|Withdrawal by Subject|1|||
162004354|NCT01632020|585069506|FG001|Overall Study|Withdrawal by Subject|0|||
162004355|NCT01632020|585069505|FG000|Overall Study|Adverse Event|1|||
162004356|NCT01632020|585069506|FG001|Overall Study|Adverse Event|0|||
162004357|NCT02675907|585069509|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
162004358|NCT02675907|585069510|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
162004359|NCT02675907|585069509|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
162004360|NCT02675907|585069510|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
162004361|NCT02675907|585069509|FG000|Study Overall|Lack of Efficacy|1|||
162004362|NCT02675907|585069510|FG001|Study Overall|Lack of Efficacy|0|||
162004363|NCT02675907|585069509|FG000|Study Overall|Withdrawal by Subject|2|||
162004364|NCT02675907|585069510|FG001|Study Overall|Withdrawal by Subject|2|||
162004365|NCT02675907|585069509|FG000|Study Overall|Lost to Follow-up|0|||
162004366|NCT02675907|585069510|FG001|Study Overall|Lost to Follow-up|2|||
162004367|NCT01323582|585069511|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
162004368|NCT01323582|585069512|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
162004369|NCT01323582|585069511|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
162004370|NCT01323582|585069512|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
162004371|NCT01323582|585069511|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
162004372|NCT01323582|585069512|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
162004373|NCT00168844|585069513|FG000|Overall Study|Adverse Event|31|||
162004374|NCT00168844|585069514|FG001|Overall Study|Adverse Event|32|||
162004375|NCT00168844|585069515|FG002|Overall Study|Adverse Event|48|||
162004376|NCT00168844|585069513|FG000|Overall Study|Lost to Follow-up|4|||
162004377|NCT00168844|585069514|FG001|Overall Study|Lost to Follow-up|5|||
162004378|NCT00168844|585069515|FG002|Overall Study|Lost to Follow-up|11|||
162004379|NCT00168844|585069513|FG000|Overall Study|Withdrawal by Subject|12|||
162004380|NCT00168844|585069514|FG001|Overall Study|Withdrawal by Subject|9|||
162004381|NCT00168844|585069515|FG002|Overall Study|Withdrawal by Subject|19|||
162004382|NCT00168844|585069513|FG000|Overall Study|Protocol Violation|2|||
162004383|NCT00168844|585069514|FG001|Overall Study|Protocol Violation|2|||
162004384|NCT00168844|585069515|FG002|Overall Study|Protocol Violation|4|||
162004385|NCT00168844|585069513|FG000|Overall Study|Other|6|||
162004386|NCT00168844|585069514|FG001|Overall Study|Other|7|||
162004387|NCT00168844|585069515|FG002|Overall Study|Other|9|||
162004388|NCT03473236|585069517|FG000|Overall Study|Withdrawal by Subject|0|||
162004389|NCT03473236|585069518|FG001|Overall Study|Withdrawal by Subject|0|||
162004390|NCT03473236|585069519|FG002|Overall Study|Withdrawal by Subject|0|||
162004391|NCT03473236|585069520|FG003|Overall Study|Withdrawal by Subject|0|||
162004392|NCT03473236|585069521|FG004|Overall Study|Withdrawal by Subject|0|||
162004393|NCT03473236|585069522|FG005|Overall Study|Withdrawal by Subject|1|||
162004394|NCT03473236|585069523|FG006|Overall Study|Withdrawal by Subject|0|||
162004395|NCT03473236|585069524|FG007|Overall Study|Withdrawal by Subject|0|||
162004396|NCT03473236|585069525|FG008|Overall Study|Withdrawal by Subject|1|||
162004397|NCT03473236|585069526|FG009|Overall Study|Withdrawal by Subject|0|||
162004398|NCT03309020|585069529|FG000|Overall Study|Death|1|||
162004399|NCT03309020|585069530|FG001|Overall Study|Death|0|||
162004400|NCT03309020|585069529|FG000|Overall Study|Did not undergo surgery|2|||
162004401|NCT03309020|585069530|FG001|Overall Study|Did not undergo surgery|1|||
162004402|NCT02362724|585069539|FG000|Overall Study|Withdrawal by Subject|3|||
162004403|NCT02362724|585069540|FG001|Overall Study|Withdrawal by Subject|1|||
162004404|NCT02362724|585069539|FG000|Overall Study|Adverse Event|3|||
162004405|NCT02362724|585069540|FG001|Overall Study|Adverse Event|0|||
162004406|NCT03062358|585069543|FG000|Overall Study|Death|269|||
162004407|NCT03062358|585069544|FG001|Overall Study|Death|145|||
162004408|NCT03062358|585069543|FG000|Overall Study|Withdrawal by Subject|2|||
162004409|NCT03062358|585069544|FG001|Overall Study|Withdrawal by Subject|1|||
162004410|NCT03062358|585069543|FG000|Overall Study|Sponsor Decision|29|||
162004411|NCT03062358|585069544|FG001|Overall Study|Sponsor Decision|7|||
162004412|NCT02994108|585071667|FG000|Intervention Messages|Withdrawal by Subject|2|||
162004413|NCT02994108|585071668|FG001|Intervention Messages|Withdrawal by Subject|0|||
162004414|NCT02994108|585071667|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
162004415|NCT02994108|585071668|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
162004416|NCT02994108|585071667|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
162004417|NCT02994108|585071668|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
162004418|NCT02994108|585071667|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
162004419|NCT02994108|585071668|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
162004420|NCT00089297|585071669|FG000|Overall Study|Adverse Event|9|||
162004421|NCT00089297|585071669|FG000|Overall Study|Death|1|||
162004422|NCT00089297|585071669|FG000|Overall Study|Withdrawal by Subject|12|||
162004423|NCT00089297|585071669|FG000|Overall Study|Disease progression|2|||
162004424|NCT00089297|585071669|FG000|Overall Study|Ineligible|11|||
162004425|NCT00089297|585071669|FG000|Overall Study|Secondary malignancy|1|||
162004426|NCT00089297|585071669|FG000|Overall Study|IRB approval not ready|1|||
162004427|NCT00089297|585071669|FG000|Overall Study|Non-compliance|1|||
162004428|NCT00904969|585071670|FG000|Overall Study|Lost to Follow-up|4|||
162004429|NCT00904969|585071670|FG000|Overall Study|Withdrawal by Subject|3|||
162004430|NCT00904969|585071670|FG000|Overall Study|Additional Treatments|11|||
162004431|NCT00904969|585071670|FG000|Overall Study|Case Aborted; Subject Exited|1|||
162004432|NCT01295814|585071677|FG000|Overall Study|Lack of Efficacy|0|||
162004433|NCT01295814|585071678|FG001|Overall Study|Lack of Efficacy|2|||
162004434|NCT01295814|585071677|FG000|Overall Study|Withdrawal by Subject|2|||
162004435|NCT01295814|585071678|FG001|Overall Study|Withdrawal by Subject|0|||
162004436|NCT03414983|585071679|FG000|Pre-Treatment|Other reasons|1|||
162004437|NCT03414983|585071680|FG001|Pre-Treatment|Other reasons|0|||
162004438|NCT03414983|585071679|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
162004439|NCT03414983|585071680|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
162004440|NCT03414983|585071679|FG000|Pre-Treatment|Participant withdrew consent|1|||
162004441|NCT03414983|585071680|FG001|Pre-Treatment|Participant withdrew consent|3|||
162004442|NCT03414983|585071679|FG000|Treatment|Participant withdrew consent|4|||
162004443|NCT03414983|585071680|FG001|Treatment|Participant withdrew consent|3|||
162004444|NCT03414983|585071679|FG000|Treatment|Participant request to discontinue study treatment|8|||
162004445|NCT03414983|585071680|FG001|Treatment|Participant request to discontinue study treatment|10|||
162004446|NCT03414983|585071679|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
162004447|NCT03414983|585071680|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
162004448|NCT03414983|585071679|FG000|Treatment|Death|0|||
162004449|NCT03414983|585071680|FG001|Treatment|Death|1|||
162004450|NCT03414983|585071679|FG000|Treatment|Study Drug Toxicity|10|||
162004451|NCT03414983|585071680|FG001|Treatment|Study Drug Toxicity|5|||
162004452|NCT03414983|585071679|FG000|Treatment|Disease Progression|75|||
162004453|NCT03414983|585071680|FG001|Treatment|Disease Progression|29|||
162004454|NCT03414983|585071679|FG000|Treatment|Not reported|1|||
162004455|NCT03414983|585071680|FG001|Treatment|Not reported|0|||
162004456|NCT03414983|585071679|FG000|Treatment|Other reasons|3|||
162004457|NCT03414983|585071680|FG001|Treatment|Other reasons|2|||
162004458|NCT03414983|585071679|FG000|Treatment|Poor/non-compliance|2|||
162004459|NCT03414983|585071680|FG001|Treatment|Poor/non-compliance|0|||
162004460|NCT03414983|585071679|FG000|Treatment|Maximum clinical benefit|5|||
162004461|NCT03414983|585071680|FG001|Treatment|Maximum clinical benefit|9|||
162004462|NCT03414983|585071679|FG000|Treatment|Lost to Follow-up|0|||
162004463|NCT03414983|585071680|FG001|Treatment|Lost to Follow-up|1|||
162004464|NCT03414983|585071679|FG000|Treatment|Administrative reasons by sponsor|1|||
162004465|NCT03414983|585071680|FG001|Treatment|Administrative reasons by sponsor|0|||
162004466|NCT04515771|585071689|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
162004467|NCT04515771|585071690|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
162004468|NCT04515771|585071689|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
162004469|NCT04515771|585071690|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
162004470|NCT04515771|585071689|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
162004471|NCT04515771|585071690|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
162004472|NCT00948246|585071694|FG000|Overall Study|Lost to Follow-up|11|||
162004473|NCT00948246|585071694|FG000|Overall Study|Adverse Event|11|||
162004474|NCT00948246|585071694|FG000|Overall Study|Death|1|||
162004475|NCT00948246|585071694|FG000|Overall Study|Withdrawal by Subject|1|||
162004476|NCT00148317|585071695|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
162004477|NCT00148317|585071695|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
162004478|NCT00148317|585071695|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
162004479|NCT04199351|585071698|FG000|Overall Study|Decision by sponsor|0|||
162004480|NCT04199351|585071699|FG001|Overall Study|Decision by sponsor|0|||
162004481|NCT04199351|585071700|FG002|Overall Study|Decision by sponsor|0|||
162004482|NCT04199351|585071701|FG003|Overall Study|Decision by sponsor|2|||
162004483|NCT04199351|585071702|FG004|Overall Study|Decision by sponsor|0|||
162004484|NCT04199351|585071703|FG005|Overall Study|Decision by sponsor|0|||
162004485|NCT04199351|585071704|FG006|Overall Study|Decision by sponsor|0|||
162004486|NCT04199351|585071705|FG007|Overall Study|Decision by sponsor|0|||
162004487|NCT04199351|585071706|FG008|Overall Study|Decision by sponsor|0|||
162004488|NCT04199351|585071707|FG009|Overall Study|Decision by sponsor|6|||
162004489|NCT04199351|585071698|FG000|Overall Study|Lost to Follow-up|0|||
162004490|NCT04199351|585071699|FG001|Overall Study|Lost to Follow-up|0|||
162004491|NCT04199351|585071700|FG002|Overall Study|Lost to Follow-up|1|||
162004492|NCT04199351|585071701|FG003|Overall Study|Lost to Follow-up|0|||
162004493|NCT04199351|585071702|FG004|Overall Study|Lost to Follow-up|0|||
162004494|NCT04199351|585071703|FG005|Overall Study|Lost to Follow-up|1|||
162004495|NCT04199351|585071704|FG006|Overall Study|Lost to Follow-up|0|||
162004496|NCT04199351|585071705|FG007|Overall Study|Lost to Follow-up|0|||
162004497|NCT04199351|585071706|FG008|Overall Study|Lost to Follow-up|0|||
162004498|NCT04199351|585071707|FG009|Overall Study|Lost to Follow-up|0|||
162004499|NCT04199351|585071698|FG000|Overall Study|Withdrawal by Subject|0|||
162004500|NCT04199351|585071699|FG001|Overall Study|Withdrawal by Subject|1|||
162004501|NCT04199351|585071700|FG002|Overall Study|Withdrawal by Subject|0|||
162004502|NCT04199351|585071701|FG003|Overall Study|Withdrawal by Subject|0|||
162004503|NCT04199351|585071702|FG004|Overall Study|Withdrawal by Subject|1|||
162004504|NCT04199351|585071703|FG005|Overall Study|Withdrawal by Subject|4|||
162004505|NCT04199351|585071704|FG006|Overall Study|Withdrawal by Subject|2|||
162004506|NCT04199351|585071705|FG007|Overall Study|Withdrawal by Subject|0|||
162004507|NCT04199351|585071706|FG008|Overall Study|Withdrawal by Subject|3|||
162004508|NCT04199351|585071707|FG009|Overall Study|Withdrawal by Subject|0|||
162004509|NCT03623243|585071710|FG000|Overall Study|Adverse Event|15|||
162004510|NCT03623243|585071710|FG000|Overall Study|Guardian Decision|1|||
162004511|NCT03623243|585071710|FG000|Overall Study|New Therapy for Study Indication|1|||
162004512|NCT03623243|585071710|FG000|Overall Study|Protocol Deviation|3|||
162004513|NCT03623243|585071710|FG000|Overall Study|Physician Decision|4|||
162004514|NCT03623243|585071710|FG000|Overall Study|Patient Decision|15|||
162004515|NCT03007966|585071711|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
162004516|NCT03007966|585071712|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
162004517|NCT00979901|585071716|FG000|Overall Study|Adverse Event|1|||
162004518|NCT00979901|585071717|FG001|Overall Study|Adverse Event|3|||
162004519|NCT00979901|585071718|FG002|Overall Study|Adverse Event|9|||
162004520|NCT00979901|585071719|FG003|Overall Study|Adverse Event|2|||
162004521|NCT00979901|585071716|FG000|Overall Study|Lack of Efficacy|8|||
162004522|NCT00979901|585071717|FG001|Overall Study|Lack of Efficacy|4|||
162004523|NCT00979901|585071718|FG002|Overall Study|Lack of Efficacy|9|||
162004524|NCT00979901|585071719|FG003|Overall Study|Lack of Efficacy|0|||
162004525|NCT00979901|585071716|FG000|Overall Study|Lost to Follow-up|1|||
162004526|NCT00979901|585071717|FG001|Overall Study|Lost to Follow-up|1|||
162004527|NCT00979901|585071718|FG002|Overall Study|Lost to Follow-up|2|||
162004528|NCT00979901|585071719|FG003|Overall Study|Lost to Follow-up|0|||
162004529|NCT00979901|585071716|FG000|Overall Study|Protocol Violation|2|||
162004530|NCT00979901|585071717|FG001|Overall Study|Protocol Violation|2|||
162004531|NCT00979901|585071718|FG002|Overall Study|Protocol Violation|7|||
162004532|NCT00979901|585071719|FG003|Overall Study|Protocol Violation|1|||
162004533|NCT00979901|585071716|FG000|Overall Study|Withdrawal by Subject|2|||
162004534|NCT00979901|585071717|FG001|Overall Study|Withdrawal by Subject|1|||
162004535|NCT00979901|585071718|FG002|Overall Study|Withdrawal by Subject|1|||
162004536|NCT00979901|585071719|FG003|Overall Study|Withdrawal by Subject|1|||
162004537|NCT00979901|585071716|FG000|Overall Study|Noncompliance|1|||
162004538|NCT00979901|585071717|FG001|Overall Study|Noncompliance|0|||
162004539|NCT00979901|585071718|FG002|Overall Study|Noncompliance|0|||
162004540|NCT00979901|585071719|FG003|Overall Study|Noncompliance|0|||
162004541|NCT00979901|585071716|FG000|Overall Study|out-of-state|1|||
162004542|NCT00979901|585071717|FG001|Overall Study|out-of-state|0|||
162004543|NCT00979901|585071718|FG002|Overall Study|out-of-state|0|||
162004544|NCT00979901|585071719|FG003|Overall Study|out-of-state|0|||
162004545|NCT00979901|585071716|FG000|Overall Study|vacation|1|||
162004546|NCT00979901|585071717|FG001|Overall Study|vacation|0|||
162004547|NCT00979901|585071718|FG002|Overall Study|vacation|0|||
162004548|NCT00979901|585071719|FG003|Overall Study|vacation|0|||
162004549|NCT00979901|585071716|FG000|Overall Study|elevated lab values pre-randomization|1|||
162004550|NCT00979901|585071717|FG001|Overall Study|elevated lab values pre-randomization|0|||
162004551|NCT00979901|585071718|FG002|Overall Study|elevated lab values pre-randomization|0|||
162004552|NCT00979901|585071719|FG003|Overall Study|elevated lab values pre-randomization|0|||
162004553|NCT00979901|585071716|FG000|Overall Study|Discontinued in Error|0|||
162004554|NCT00979901|585071717|FG001|Overall Study|Discontinued in Error|1|||
162004555|NCT00979901|585071718|FG002|Overall Study|Discontinued in Error|0|||
162004556|NCT00979901|585071719|FG003|Overall Study|Discontinued in Error|0|||
162004557|NCT00979901|585071716|FG000|Overall Study|Left Country|0|||
162004558|NCT00979901|585071717|FG001|Overall Study|Left Country|0|||
162004559|NCT00979901|585071718|FG002|Overall Study|Left Country|1|||
162004560|NCT00979901|585071719|FG003|Overall Study|Left Country|0|||
162004561|NCT00979901|585071716|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
162004562|NCT00979901|585071717|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
162004563|NCT00979901|585071718|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
162004564|NCT00979901|585071719|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
162004565|NCT00248625|585071720|FG000|Overall Study|Withdrawal by Subject|0|||
162004566|NCT00248625|585071721|FG001|Overall Study|Withdrawal by Subject|2|||
162004567|NCT03284710|585071726|FG000|Overall Study|Withdrawal by Subject|1|||
162004568|NCT03284710|585071727|FG001|Overall Study|Withdrawal by Subject|0|||
162004569|NCT03284710|585071728|FG002|Overall Study|Withdrawal by Subject|1|||
162004570|NCT03284710|585071729|FG003|Overall Study|Withdrawal by Subject|6|||
162004571|NCT03284710|585071726|FG000|Overall Study|Lost to Follow-up|3|||
162004572|NCT03284710|585071727|FG001|Overall Study|Lost to Follow-up|3|||
162004573|NCT03284710|585071728|FG002|Overall Study|Lost to Follow-up|1|||
162004574|NCT03284710|585071729|FG003|Overall Study|Lost to Follow-up|0|||
162004575|NCT03284710|585071726|FG000|Overall Study|Physician Decision|1|||
162004576|NCT03284710|585071727|FG001|Overall Study|Physician Decision|0|||
162004577|NCT03284710|585071728|FG002|Overall Study|Physician Decision|0|||
162004578|NCT03284710|585071729|FG003|Overall Study|Physician Decision|0|||
162004579|NCT03284710|585071726|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
162004580|NCT03284710|585071727|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
162004581|NCT03284710|585071728|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
162004582|NCT03284710|585071729|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
162004583|NCT03284710|585071726|FG000|Overall Study|HIV Infection|0|||
162004584|NCT03284710|585071727|FG001|Overall Study|HIV Infection|2|||
162004585|NCT03284710|585071728|FG002|Overall Study|HIV Infection|2|||
162004586|NCT03284710|585071729|FG003|Overall Study|HIV Infection|1|||
162004587|NCT02814916|585071731|FG000|Overall Study|Withdrawal of consent|0|||
162004588|NCT02814916|585071732|FG001|Overall Study|Withdrawal of consent|2|||
162004589|NCT02814916|585071733|FG002|Overall Study|Withdrawal of consent|0|||
162004590|NCT02814916|585071731|FG000|Overall Study|Lost to Follow-up|0|||
162004591|NCT02814916|585071732|FG001|Overall Study|Lost to Follow-up|1|||
162004592|NCT02814916|585071733|FG002|Overall Study|Lost to Follow-up|0|||
162004593|NCT02814916|585071731|FG000|Overall Study|Other, not specified|0|||
162004594|NCT02814916|585071732|FG001|Overall Study|Other, not specified|1|||
162004595|NCT02814916|585071733|FG002|Overall Study|Other, not specified|0|||
162004596|NCT05316597|585071738|FG000|First Session|Withdrawal by Subject|0|||
162004597|NCT05316597|585071739|FG001|First Session|Withdrawal by Subject|1|||
162043198|NCT00313300|585216272|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
162043199|NCT00313300|585216273|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
162043200|NCT00313300|585216274|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
162043201|NCT00313300|585216275|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
162043202|NCT00313300|585216271|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
162043203|NCT00313300|585216272|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
162043204|NCT00313300|585216273|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
162043205|NCT00313300|585216274|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
162043206|NCT00313300|585216275|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
162043207|NCT00313300|585216271|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
162043208|NCT00313300|585216272|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
162043209|NCT00313300|585216273|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
162043210|NCT00313300|585216274|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
162043211|NCT00313300|585216275|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
162043212|NCT00313300|585216271|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
162043213|NCT00313300|585216272|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
162043214|NCT00313300|585216273|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
162043215|NCT00313300|585216274|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
162043216|NCT00313300|585216275|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
162043217|NCT00313300|585216271|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
162043218|NCT00313300|585216272|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
162043219|NCT00313300|585216273|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
162043220|NCT00313300|585216274|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
162043221|NCT00313300|585216275|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
162043222|NCT00313300|585216271|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
162043223|NCT00313300|585216272|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
162043224|NCT00313300|585216273|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
162043225|NCT00313300|585216274|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
162043226|NCT00313300|585216275|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
162043227|NCT00313300|585216271|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
162043228|NCT00313300|585216272|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
162043229|NCT00313300|585216273|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
162043230|NCT00313300|585216274|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
162043231|NCT00313300|585216275|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
162043232|NCT00313300|585216271|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
162043233|NCT00313300|585216272|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
162043234|NCT00313300|585216273|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
162043235|NCT00313300|585216274|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
162043236|NCT00313300|585216275|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
162043237|NCT04540497|585216278|FG000|Overall Study|Adverse Event|0|||
162043238|NCT04540497|585216279|FG001|Overall Study|Adverse Event|2|||
162043239|NCT04540497|585216278|FG000|Overall Study|Lost to Follow-up|1|||
162043240|NCT04540497|585216279|FG001|Overall Study|Lost to Follow-up|0|||
162043241|NCT04540497|585216278|FG000|Overall Study|Withdrawal by Subject|1|||
162043242|NCT04540497|585216279|FG001|Overall Study|Withdrawal by Subject|1|||
162043243|NCT04540497|585216278|FG000|Overall Study|Miscellaneous|2|||
162043244|NCT04540497|585216279|FG001|Overall Study|Miscellaneous|1|||
162043245|NCT01675427|585216283|FG000|Overall Study|Withdrawal by Subject|7|||
162043246|NCT01675427|585216283|FG000|Overall Study|Participant Refused Sample Collection|18|||
162043247|NCT01675427|585216283|FG000|Overall Study|Sample not Collected by Mistake|2|||
162043248|NCT01675427|585216283|FG000|Overall Study|Lost to Follow-up|5|||
162043249|NCT01675427|585216283|FG000|Overall Study|Other|2|||
162043250|NCT00902668|585216291|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
162043251|NCT01914757|585216292|FG000|Overall Study|Severe non-compliance to protocol|3|||
162043252|NCT01914757|585216293|FG001|Overall Study|Severe non-compliance to protocol|1|||
162043253|NCT01914757|585216294|FG002|Overall Study|Severe non-compliance to protocol|2|||
162043254|NCT01914757|585216292|FG000|Overall Study|Lost to Follow-up|5|||
162043255|NCT01914757|585216293|FG001|Overall Study|Lost to Follow-up|8|||
162043256|NCT01914757|585216294|FG002|Overall Study|Lost to Follow-up|6|||
162043257|NCT01914757|585216292|FG000|Overall Study|Withdrawal by Subject|15|||
162043258|NCT01914757|585216293|FG001|Overall Study|Withdrawal by Subject|27|||
162043259|NCT01914757|585216294|FG002|Overall Study|Withdrawal by Subject|19|||
162043260|NCT01914757|585216292|FG000|Overall Study|Death|2|||
162043261|NCT01914757|585216293|FG001|Overall Study|Death|2|||
162043262|NCT01914757|585216294|FG002|Overall Study|Death|1|||
162043263|NCT01914757|585216292|FG000|Overall Study|Adverse Event|4|||
162043264|NCT01914757|585216293|FG001|Overall Study|Adverse Event|3|||
162043265|NCT01914757|585216294|FG002|Overall Study|Adverse Event|4|||
162043266|NCT01914757|585216292|FG000|Overall Study|Study specific withdrawal criteria|0|||
162043267|NCT01914757|585216293|FG001|Overall Study|Study specific withdrawal criteria|1|||
162043268|NCT01914757|585216294|FG002|Overall Study|Study specific withdrawal criteria|0|||
162043269|NCT01914757|585216292|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
162043270|NCT01914757|585216293|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162043271|NCT01914757|585216294|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
162043272|NCT01914757|585216292|FG000|Overall Study|Other reasons|5|||
162043273|NCT01914757|585216293|FG001|Overall Study|Other reasons|9|||
162043274|NCT01914757|585216294|FG002|Overall Study|Other reasons|4|||
162043275|NCT00408629|585216297|FG000|Overall Study|Adverse Event|13|||
162043276|NCT00408629|585216298|FG001|Overall Study|Adverse Event|27|||
162043277|NCT00408629|585216297|FG000|Overall Study|Withdrawal by Subject|8|||
162043278|NCT00408629|585216298|FG001|Overall Study|Withdrawal by Subject|4|||
162043279|NCT00408629|585216297|FG000|Overall Study|Lost to Follow-up|1|||
162043280|NCT00408629|585216298|FG001|Overall Study|Lost to Follow-up|1|||
162043281|NCT00408629|585216297|FG000|Overall Study|Lack of Efficacy|63|||
162043282|NCT00408629|585216298|FG001|Overall Study|Lack of Efficacy|73|||
162043283|NCT00408629|585216297|FG000|Overall Study|Protocol Violation|1|||
162043284|NCT00408629|585216298|FG001|Overall Study|Protocol Violation|5|||
162043285|NCT00408629|585216297|FG000|Overall Study|Miscellaneous|11|||
162043286|NCT00408629|585216298|FG001|Overall Study|Miscellaneous|15|||
162043287|NCT01461980|585216299|FG000|Overall Study|Other|9|||
162043288|NCT01461980|585216300|FG001|Overall Study|Other|8|||
162043289|NCT01461980|585216301|FG002|Overall Study|Other|6|||
162043290|NCT01461980|585216299|FG000|Overall Study|Medication error|7|||
162043291|NCT01461980|585216300|FG001|Overall Study|Medication error|5|||
162043292|NCT01461980|585216301|FG002|Overall Study|Medication error|6|||
162043293|NCT01461980|585216299|FG000|Overall Study|Adverse Event|12|||
162043294|NCT01461980|585216300|FG001|Overall Study|Adverse Event|5|||
162043295|NCT01461980|585216301|FG002|Overall Study|Adverse Event|6|||
162043296|NCT01461980|585216299|FG000|Overall Study|Protocol Violation|12|||
162043297|NCT01461980|585216300|FG001|Overall Study|Protocol Violation|19|||
162043298|NCT01461980|585216301|FG002|Overall Study|Protocol Violation|16|||
162043299|NCT01461980|585216299|FG000|Overall Study|No longer meets eligibility criteria|18|||
162043300|NCT01461980|585216300|FG001|Overall Study|No longer meets eligibility criteria|9|||
162043301|NCT01461980|585216301|FG002|Overall Study|No longer meets eligibility criteria|19|||
162043302|NCT01461980|585216299|FG000|Overall Study|Lost to Follow-up|52|||
162043303|NCT01461980|585216300|FG001|Overall Study|Lost to Follow-up|53|||
162043304|NCT01461980|585216301|FG002|Overall Study|Lost to Follow-up|51|||
162043305|NCT01461980|585216299|FG000|Overall Study|No longer willing to participate|52|||
162043306|NCT01461980|585216300|FG001|Overall Study|No longer willing to participate|38|||
162043307|NCT01461980|585216301|FG002|Overall Study|No longer willing to participate|54|||
162043308|NCT01461980|585216299|FG000|Overall Study|Randomized but not vaccinated|4|||
162043309|NCT01461980|585216300|FG001|Overall Study|Randomized but not vaccinated|8|||
162043310|NCT01461980|585216301|FG002|Overall Study|Randomized but not vaccinated|7|||
162043311|NCT00122109|585216302|FG000|Overall Study|Did not meet criteria|6|||
162043312|NCT00122109|585216303|FG001|Overall Study|Did not meet criteria|7|||
162043313|NCT00100178|585216306|FG000|Overall Study|Lost to Follow-up|0|||
162043314|NCT00100178|585216307|FG001|Overall Study|Lost to Follow-up|6|||
162043315|NCT00100178|585216308|FG002|Overall Study|Lost to Follow-up|5|||
162043316|NCT00100178|585216306|FG000|Overall Study|Adverse Event|2|||
162043317|NCT00100178|585216307|FG001|Overall Study|Adverse Event|2|||
162043318|NCT00100178|585216308|FG002|Overall Study|Adverse Event|1|||
162043319|NCT00100178|585216306|FG000|Overall Study|Withdrawal by Subject|1|||
162043320|NCT00100178|585216307|FG001|Overall Study|Withdrawal by Subject|1|||
162043321|NCT00100178|585216308|FG002|Overall Study|Withdrawal by Subject|1|||
162043322|NCT00100178|585216306|FG000|Overall Study|Physician Decision|6|||
162043323|NCT00100178|585216307|FG001|Overall Study|Physician Decision|1|||
162043324|NCT00100178|585216308|FG002|Overall Study|Physician Decision|3|||
162043325|NCT02477839|585216309|FG000|Overall Study|Adverse Event|0|||
162043326|NCT02477839|585216310|FG001|Overall Study|Adverse Event|1|||
162043327|NCT02477839|585216309|FG000|Overall Study|Protocol Violation|0|||
162043328|NCT02477839|585216310|FG001|Overall Study|Protocol Violation|2|||
162043329|NCT02477839|585216309|FG000|Overall Study|Withdrawal by Subject|3|||
162043330|NCT02477839|585216310|FG001|Overall Study|Withdrawal by Subject|3|||
162043331|NCT02477839|585216309|FG000|Overall Study|Participant had PGS during V6|0|||
162043332|NCT02477839|585216310|FG001|Overall Study|Participant had PGS during V6|1|||
162043333|NCT02477839|585216309|FG000|Overall Study|Parents decided to stop medication|0|||
162043334|NCT02477839|585216310|FG001|Overall Study|Parents decided to stop medication|1|||
162043335|NCT02477839|585216309|FG000|Overall Study|Lack of tolerability|0|||
162043336|NCT02477839|585216310|FG001|Overall Study|Lack of tolerability|1|||
162043337|NCT02477839|585216309|FG000|Overall Study|Exclusion criterion|0|||
162043338|NCT02477839|585216310|FG001|Overall Study|Exclusion criterion|1|||
162043339|NCT00631696|585216313|FG000|Overall Study|Entered, not randomized to treatment|1|||
162043340|NCT00631696|585216314|FG001|Overall Study|Entered, not randomized to treatment|1|||
162043341|NCT00631696|585216313|FG000|Overall Study|Discontinued after database release date|1|||
162043342|NCT00631696|585216314|FG001|Overall Study|Discontinued after database release date|0|||
162043343|NCT00631696|585216313|FG000|Overall Study|Follow up after database release date|1|||
162043344|NCT00631696|585216314|FG001|Overall Study|Follow up after database release date|0|||
162043345|NCT00631696|585216313|FG000|Overall Study|Lost to Follow-up|7|||
162043346|NCT00631696|585216314|FG001|Overall Study|Lost to Follow-up|10|||
162043347|NCT00631696|585216313|FG000|Overall Study|Withdrawal by Subject|2|||
162043348|NCT00631696|585216314|FG001|Overall Study|Withdrawal by Subject|9|||
162043349|NCT00631696|585216313|FG000|Overall Study|Other|8|||
162043350|NCT00631696|585216314|FG001|Overall Study|Other|8|||
162043351|NCT00631696|585216313|FG000|Overall Study|Protocol Violation|9|||
162043352|NCT00631696|585216314|FG001|Overall Study|Protocol Violation|9|||
162043353|NCT00631696|585216313|FG000|Overall Study|Study terminated by sponsor|3|||
162043354|NCT00631696|585216314|FG001|Overall Study|Study terminated by sponsor|3|||
162043355|NCT00631696|585216313|FG000|Overall Study|Adverse Event|5|||
162043356|NCT00631696|585216314|FG001|Overall Study|Adverse Event|0|||
162043357|NCT01439568|585216316|FG000|Overall Study|Lost to Follow-up|1|||
162043358|NCT01439568|585216317|FG001|Overall Study|Lost to Follow-up|0|||
162043359|NCT01439568|585216316|FG000|Overall Study|Withdrawal by Subject|2|||
162043360|NCT01439568|585216317|FG001|Overall Study|Withdrawal by Subject|2|||
162043361|NCT03198078|585216318|FG000|Overall Study|Adverse Event|0|||
162043362|NCT03198078|585216319|FG001|Overall Study|Adverse Event|1|||
162043363|NCT03198078|585216320|FG002|Overall Study|Adverse Event|2|||
162043364|NCT03198078|585216318|FG000|Overall Study|Lack of Efficacy|0|||
162043365|NCT03198078|585216319|FG001|Overall Study|Lack of Efficacy|0|||
162043366|NCT03198078|585216320|FG002|Overall Study|Lack of Efficacy|3|||
162043367|NCT03198078|585216318|FG000|Overall Study|Lost to Follow-up|1|||
162043368|NCT03198078|585216319|FG001|Overall Study|Lost to Follow-up|0|||
162043369|NCT03198078|585216320|FG002|Overall Study|Lost to Follow-up|0|||
162043370|NCT03198078|585216318|FG000|Overall Study|Pregnancy|0|||
162043371|NCT03198078|585216319|FG001|Overall Study|Pregnancy|1|||
162043372|NCT03198078|585216320|FG002|Overall Study|Pregnancy|0|||
162043373|NCT03198078|585216318|FG000|Overall Study|Withdrawal by Subject|1|||
162043374|NCT03198078|585216319|FG001|Overall Study|Withdrawal by Subject|0|||
162043375|NCT03198078|585216320|FG002|Overall Study|Withdrawal by Subject|2|||
162004598|NCT05316597|585071738|FG000|Washout Period|Lost to Follow-up|1|||
162004599|NCT05316597|585071739|FG001|Washout Period|Lost to Follow-up|2|||
162004600|NCT05316597|585071738|FG000|Washout Period|Physician Decision|1|||
162004601|NCT05316597|585071739|FG001|Washout Period|Physician Decision|1|||
162004602|NCT05316597|585071738|FG000|Washout Period|Excluded before second session|1|||
162004603|NCT05316597|585071739|FG001|Washout Period|Excluded before second session|1|||
162004604|NCT05316597|585071738|FG000|Washout Period|Withdrawal by Subject|0|||
162004605|NCT05316597|585071739|FG001|Washout Period|Withdrawal by Subject|4|||
162004606|NCT02118584|585071740|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
162004607|NCT02118584|585071741|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
162004608|NCT02118584|585071742|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
162004609|NCT02118584|585071740|FG000|Part 1: Open Label Extension Period|Death|9|||
162004610|NCT02118584|585071741|FG001|Part 1: Open Label Extension Period|Death|0|||
162004611|NCT02118584|585071742|FG002|Part 1: Open Label Extension Period|Death|0|||
162004612|NCT02118584|585071740|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
162004613|NCT02118584|585071741|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
162004614|NCT02118584|585071742|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
162004615|NCT02118584|585071740|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
162004616|NCT02118584|585071741|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
162004617|NCT02118584|585071742|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
162004618|NCT02118584|585071740|FG000|Part 1: Open Label Extension Period|Other|135|||
162004619|NCT02118584|585071741|FG001|Part 1: Open Label Extension Period|Other|0|||
162004620|NCT02118584|585071742|FG002|Part 1: Open Label Extension Period|Other|0|||
162004621|NCT02118584|585071740|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
162004622|NCT02118584|585071741|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
162004623|NCT02118584|585071742|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
162004624|NCT02118584|585071740|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
162004625|NCT02118584|585071741|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
162004626|NCT02118584|585071742|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
162004627|NCT02118584|585071740|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
162004628|NCT02118584|585071741|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
162004629|NCT02118584|585071742|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
162004630|NCT02118584|585071740|FG000|Part 1: Open Label Extension Period|Other|3|||
162004631|NCT02118584|585071741|FG001|Part 1: Open Label Extension Period|Other|0|||
162004632|NCT02118584|585071742|FG002|Part 1: Open Label Extension Period|Other|0|||
162043376|NCT03198078|585216318|FG000|Overall Study|Withdrawal by Caregiver|1|||
162043377|NCT03198078|585216319|FG001|Overall Study|Withdrawal by Caregiver|3|||
162043378|NCT03198078|585216320|FG002|Overall Study|Withdrawal by Caregiver|5|||
162043379|NCT02607930|585216323|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
162043380|NCT02607930|585216324|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
162043381|NCT02607930|585216325|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
162043382|NCT02607930|585216326|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
162043383|NCT02607930|585216323|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
162043384|NCT02607930|585216324|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
162043385|NCT02607930|585216325|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
162043386|NCT02607930|585216326|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
162043387|NCT02607930|585216323|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
162043388|NCT02607930|585216324|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
162043389|NCT02607930|585216325|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
162043390|NCT02607930|585216326|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
162043391|NCT02607930|585216323|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
162043392|NCT02607930|585216324|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
162043393|NCT02607930|585216325|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
162043394|NCT02607930|585216326|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
162043395|NCT02607930|585216323|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
162043396|NCT02607930|585216324|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
162043397|NCT02607930|585216325|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
162043398|NCT02607930|585216326|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
162043399|NCT02607930|585216323|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
162043400|NCT02607930|585216324|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
162043401|NCT02607930|585216325|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
162043402|NCT02607930|585216326|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
162043403|NCT02607930|585216323|FG000|Double-Blinded Treatment Phase|Death|2|||
162043404|NCT02607930|585216324|FG001|Double-Blinded Treatment Phase|Death|1|||
162043405|NCT02607930|585216325|FG002|Double-Blinded Treatment Phase|Death|0|||
162043406|NCT02607930|585216326|FG003|Double-Blinded Treatment Phase|Death|0|||
162043407|NCT02607930|585216323|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
162043408|NCT02607930|585216324|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
162043409|NCT02607930|585216325|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
162043410|NCT02607930|585216326|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
162043411|NCT02607930|585216323|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
162043412|NCT02607930|585216324|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
162043413|NCT02607930|585216325|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
162043414|NCT02607930|585216326|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
162043415|NCT02607930|585216323|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
162043416|NCT02607930|585216324|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
162043417|NCT02607930|585216325|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
162043418|NCT02607930|585216326|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
162043419|NCT02607930|585216323|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
162043420|NCT02607930|585216324|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
162043421|NCT02607930|585216325|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
162043422|NCT02607930|585216326|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
162043423|NCT02607930|585216323|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
162043424|NCT02607930|585216324|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
162043425|NCT02607930|585216325|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
162043426|NCT02607930|585216326|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
162043427|NCT02607930|585216323|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
162043428|NCT02607930|585216324|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
162043429|NCT02607930|585216325|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
162043430|NCT02607930|585216326|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
162043431|NCT02607930|585216323|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
162043432|NCT02607930|585216324|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
162043433|NCT02607930|585216325|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
162043434|NCT02607930|585216326|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
162043435|NCT02607930|585216323|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
162043436|NCT02607930|585216324|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
162043437|NCT02607930|585216325|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
162043438|NCT02607930|585216326|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
162043439|NCT02607930|585216323|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
162043440|NCT02607930|585216324|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
162043441|NCT02607930|585216325|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
162043442|NCT02607930|585216326|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
162043443|NCT01578330|585216327|FG000|Overall Study|Adverse Event|2|||
162043444|NCT01578330|585216327|FG000|Overall Study|Protocol Violation|5|||
162043445|NCT01676727|585216328|FG000|Overall Study|Death|18|||
162043446|NCT01676727|585216328|FG000|Overall Study|Withdrawal by Subject|6|||
162043447|NCT01676727|585216328|FG000|Overall Study|Screening failure|5|||
162043448|NCT01676727|585216328|FG000|Overall Study|Not willing to attend 1-year visit|2|||
162043449|NCT01676727|585216328|FG000|Overall Study|Valve explanted|1|||
162043450|NCT01134731|585216329|FG000|Overall Study|Adverse Event|3|||
162004633|NCT02118584|585071740|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
162004634|NCT02118584|585071741|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
162004635|NCT02118584|585071742|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
162004636|NCT02118584|585071740|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
162004637|NCT02118584|585071741|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
162004638|NCT02118584|585071742|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
162004639|NCT02118584|585071740|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
162004640|NCT02118584|585071741|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
162004641|NCT02118584|585071742|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
162004642|NCT02118584|585071740|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
162004643|NCT02118584|585071741|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
162004644|NCT02118584|585071742|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
162004645|NCT02118584|585071740|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
162004646|NCT02118584|585071741|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
162004647|NCT02118584|585071742|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
162004648|NCT02118584|585071740|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
162004649|NCT02118584|585071741|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
162004650|NCT02118584|585071742|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
162004651|NCT02118584|585071740|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
162004652|NCT02118584|585071741|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
162004653|NCT02118584|585071742|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
162004654|NCT02118584|585071740|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
162004655|NCT02118584|585071741|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
162004656|NCT02118584|585071742|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
162004657|NCT02118584|585071740|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
162004658|NCT02118584|585071741|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
162004659|NCT02118584|585071742|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
162004660|NCT00286468|585071747|FG000|Overall Study|Hyperglycemic Rescue|28|||
162004661|NCT00286468|585071748|FG001|Overall Study|Hyperglycemic Rescue|30|||
162004662|NCT00286468|585071749|FG002|Overall Study|Hyperglycemic Rescue|31|||
162004663|NCT00286468|585071747|FG000|Overall Study|Adverse Event|2|||
162004664|NCT00286468|585071748|FG001|Overall Study|Adverse Event|6|||
162004665|NCT00286468|585071749|FG002|Overall Study|Adverse Event|4|||
162004666|NCT00286468|585071747|FG000|Overall Study|Protocol Violation|0|||
162004667|NCT00286468|585071748|FG001|Overall Study|Protocol Violation|3|||
162004668|NCT00286468|585071749|FG002|Overall Study|Protocol Violation|1|||
162004669|NCT00286468|585071747|FG000|Overall Study|Lost to Follow-up|1|||
162004670|NCT00286468|585071748|FG001|Overall Study|Lost to Follow-up|1|||
162004671|NCT00286468|585071749|FG002|Overall Study|Lost to Follow-up|2|||
162004672|NCT00286468|585071747|FG000|Overall Study|Withdrawal by Subject|3|||
162004673|NCT00286468|585071748|FG001|Overall Study|Withdrawal by Subject|8|||
162004674|NCT00286468|585071749|FG002|Overall Study|Withdrawal by Subject|11|||
162004675|NCT00286468|585071747|FG000|Overall Study|Physician Decision|3|||
162004676|NCT00286468|585071748|FG001|Overall Study|Physician Decision|2|||
162004677|NCT00286468|585071749|FG002|Overall Study|Physician Decision|1|||
162004678|NCT03103542|585071750|FG000|Overall Study|Physician Decision|2|||
162004679|NCT03103542|585071750|FG000|Overall Study|Adverse Event|2|||
162004680|NCT03103542|585071750|FG000|Overall Study|Other|2|||
162004681|NCT03103542|585071750|FG000|Overall Study|Withdrawal by Subject|1|||
162004682|NCT02927301|585071752|FG000|Overall Study|Death|39|||
162004683|NCT02927301|585071752|FG000|Overall Study|Lost to Follow-up|8|||
162004684|NCT02927301|585071752|FG000|Overall Study|Physician Decision|2|||
162004685|NCT02927301|585071752|FG000|Overall Study|Withdrawal by Subject|12|||
162004686|NCT02927301|585071752|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
162004687|NCT02903771|585071753|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
162004688|NCT02903771|585071754|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
162004689|NCT02903771|585071755|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
162004690|NCT02903771|585071756|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
162004691|NCT02903771|585071757|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
162004692|NCT02903771|585071758|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
162004693|NCT02903771|585071759|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
162004694|NCT02903771|585071753|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
162004695|NCT02903771|585071754|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
162004696|NCT02903771|585071755|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
162004697|NCT02903771|585071756|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
162004698|NCT02903771|585071757|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
162004699|NCT02903771|585071758|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
162004700|NCT02903771|585071759|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
162004701|NCT02903771|585071753|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
162004702|NCT02903771|585071754|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
162043451|NCT01134731|585216330|FG001|Overall Study|Adverse Event|2|||
162043452|NCT01134731|585216331|FG002|Overall Study|Adverse Event|1|||
162043453|NCT01134731|585216329|FG000|Overall Study|Physician Decision|2|||
162043454|NCT01134731|585216330|FG001|Overall Study|Physician Decision|2|||
162043455|NCT01134731|585216331|FG002|Overall Study|Physician Decision|2|||
162043456|NCT01134731|585216329|FG000|Overall Study|Lack of Efficacy|0|||
162043457|NCT01134731|585216330|FG001|Overall Study|Lack of Efficacy|0|||
162043458|NCT01134731|585216331|FG002|Overall Study|Lack of Efficacy|1|||
162043459|NCT01134731|585216329|FG000|Overall Study|Withdrawal by Subject|3|||
162043460|NCT01134731|585216330|FG001|Overall Study|Withdrawal by Subject|3|||
162043461|NCT01134731|585216331|FG002|Overall Study|Withdrawal by Subject|1|||
162043462|NCT01134731|585216329|FG000|Overall Study|Lost to Follow-up|5|||
162043463|NCT01134731|585216330|FG001|Overall Study|Lost to Follow-up|4|||
162043464|NCT01134731|585216331|FG002|Overall Study|Lost to Follow-up|3|||
162043465|NCT01050543|585216332|FG000|Overall Study|Withdrawal by Subject|0|||
162043466|NCT01050543|585216333|FG001|Overall Study|Withdrawal by Subject|2|||
162043467|NCT01050543|585216332|FG000|Overall Study|Protocol Violation|0|||
162043468|NCT01050543|585216333|FG001|Overall Study|Protocol Violation|1|||
162043469|NCT01050543|585216332|FG000|Overall Study|Administrative|4|||
162043470|NCT01050543|585216333|FG001|Overall Study|Administrative|1|||
162043471|NCT02517866|585216337|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
162043472|NCT02517866|585216338|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
162043473|NCT02517866|585216339|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
162043474|NCT02517866|585216337|FG000|Overall Study|Significant Protocol Deviation|4|||
162043475|NCT02517866|585216338|FG001|Overall Study|Significant Protocol Deviation|1|||
162043476|NCT02517866|585216339|FG002|Overall Study|Significant Protocol Deviation|0|||
162043477|NCT02517866|585216337|FG000|Overall Study|Lost to Follow-up|1|||
162043478|NCT02517866|585216338|FG001|Overall Study|Lost to Follow-up|0|||
162043479|NCT02517866|585216339|FG002|Overall Study|Lost to Follow-up|0|||
162043480|NCT02517866|585216337|FG000|Overall Study|Voluntary Withdrawal|2|||
162043481|NCT02517866|585216338|FG001|Overall Study|Voluntary Withdrawal|2|||
162043482|NCT02517866|585216339|FG002|Overall Study|Voluntary Withdrawal|0|||
162043483|NCT02517866|585216337|FG000|Overall Study|Investigator Decision|2|||
162043484|NCT02517866|585216338|FG001|Overall Study|Investigator Decision|1|||
162043485|NCT02517866|585216339|FG002|Overall Study|Investigator Decision|0|||
162043486|NCT02517866|585216337|FG000|Overall Study|Reason not specified|2|||
162043487|NCT02517866|585216338|FG001|Overall Study|Reason not specified|0|||
162043488|NCT02517866|585216339|FG002|Overall Study|Reason not specified|0|||
162043489|NCT01646073|585216340|FG000|Period A (12 Weeks)|Adverse Event|0|||
162043490|NCT01646073|585216341|FG001|Period A (12 Weeks)|Adverse Event|2|||
162004703|NCT02903771|585071755|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
162004704|NCT02903771|585071756|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
162004705|NCT02903771|585071757|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
162004706|NCT02903771|585071758|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
162004707|NCT02903771|585071759|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
162004708|NCT02903771|585071753|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
162004709|NCT02903771|585071754|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
162004710|NCT02903771|585071755|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
162004711|NCT02903771|585071756|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
162004712|NCT02903771|585071757|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
162004713|NCT02903771|585071758|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
162004714|NCT02903771|585071759|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
162004715|NCT02903771|585071753|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
162004716|NCT02903771|585071754|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
162004717|NCT02903771|585071755|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
162004718|NCT02903771|585071756|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
162004719|NCT02903771|585071757|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
162004720|NCT02903771|585071758|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
162004721|NCT02903771|585071759|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
162004722|NCT02903771|585071753|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
162004723|NCT02903771|585071754|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
162004724|NCT02903771|585071755|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
162004725|NCT02903771|585071756|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
162004726|NCT02903771|585071757|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
162043491|NCT01646073|585216340|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
162004727|NCT02903771|585071758|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
162043492|NCT01646073|585216341|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
162043493|NCT01646073|585216340|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
162043494|NCT01646073|585216341|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
162043495|NCT01646073|585216340|FG000|Period A (12 Weeks)|Protocol Violation|0|||
162043496|NCT01646073|585216341|FG001|Period A (12 Weeks)|Protocol Violation|1|||
162043497|NCT01646073|585216340|FG000|Period A (12 Weeks)|Other|0|||
162043498|NCT01646073|585216341|FG001|Period A (12 Weeks)|Other|1|||
162043499|NCT01646073|585216340|FG000|Period B (12 Weeks)|Adverse Event|0|||
162043500|NCT01646073|585216341|FG001|Period B (12 Weeks)|Adverse Event|7|||
162043501|NCT01646073|585216340|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
162043502|NCT01646073|585216341|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
162043503|NCT01646073|585216340|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
162043504|NCT01646073|585216341|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
162043505|NCT00679055|585216342|FG000|Overall Study|Adverse Event|0|||
162043506|NCT00679055|585216343|FG001|Overall Study|Adverse Event|1|||
162043507|NCT00679055|585216342|FG000|Overall Study|Other|0|||
162043508|NCT00679055|585216343|FG001|Overall Study|Other|3|||
162043509|NCT00679055|585216342|FG000|Overall Study|Study Terminated|2|||
162043510|NCT00679055|585216343|FG001|Overall Study|Study Terminated|1|||
162043511|NCT00629772|585216344|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
162043512|NCT00629772|585216345|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
162043513|NCT00629772|585216344|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
162043514|NCT00629772|585216345|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
162043515|NCT01393301|585216348|FG000|Overall Study|Lost to Follow-up|5|||
162043516|NCT01393301|585216349|FG001|Overall Study|Lost to Follow-up|3|||
162043517|NCT01393301|585216348|FG000|Overall Study|Withdrawal by Subject|2|||
162043518|NCT01393301|585216349|FG001|Overall Study|Withdrawal by Subject|0|||
162043519|NCT01393301|585216348|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
162043520|NCT01393301|585216349|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
162043521|NCT03342963|585216352|FG000|Overall Study|Adverse Event|1|||
162043522|NCT03342963|585216353|FG001|Overall Study|Adverse Event|2|||
162043523|NCT03342963|585216354|FG002|Overall Study|Adverse Event|0|||
162043524|NCT03342963|585216355|FG003|Overall Study|Adverse Event|0|||
162043525|NCT03342963|585216352|FG000|Overall Study|Withdrawal by Subject|1|||
162043526|NCT03342963|585216353|FG001|Overall Study|Withdrawal by Subject|0|||
162043527|NCT03342963|585216354|FG002|Overall Study|Withdrawal by Subject|0|||
162043528|NCT03342963|585216355|FG003|Overall Study|Withdrawal by Subject|0|||
162043529|NCT01309165|585216356|FG000|Overall Study|Lost to Follow-up|4|||
162043530|NCT01309165|585216357|FG001|Overall Study|Lost to Follow-up|3|||
162043531|NCT01309165|585216356|FG000|Overall Study|Return to work|1|||
162043532|NCT01309165|585216357|FG001|Overall Study|Return to work|2|||
162004728|NCT02903771|585071759|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
162004729|NCT02903771|585071753|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
162004730|NCT02903771|585071754|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
162004731|NCT02903771|585071755|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
162004732|NCT02903771|585071756|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
162004733|NCT02903771|585071757|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
162004734|NCT02903771|585071758|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
162004735|NCT02903771|585071759|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
162004736|NCT02903771|585071753|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
162004737|NCT02903771|585071754|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
162004738|NCT02903771|585071755|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
162004739|NCT02903771|585071756|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
162004740|NCT02903771|585071757|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
162004741|NCT02903771|585071758|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
162004742|NCT02903771|585071759|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
162004743|NCT02903771|585071753|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
162004744|NCT02903771|585071754|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
162004745|NCT02903771|585071755|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
162004746|NCT02903771|585071756|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
162004747|NCT02903771|585071757|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
162004748|NCT02903771|585071758|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
162004749|NCT02903771|585071759|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
162004750|NCT02903771|585071753|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
162004751|NCT02903771|585071754|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
162004752|NCT02903771|585071755|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
162004753|NCT02903771|585071756|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
162004754|NCT02903771|585071757|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
162004755|NCT02903771|585071758|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
162004756|NCT02903771|585071759|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
162004757|NCT02903771|585071753|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
162004758|NCT02903771|585071754|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
162043533|NCT01309165|585216356|FG000|Overall Study|Left country|0|||
162043534|NCT01309165|585216357|FG001|Overall Study|Left country|1|||
162043535|NCT01309165|585216356|FG000|Overall Study|No transportation|0|||
162043536|NCT01309165|585216357|FG001|Overall Study|No transportation|1|||
162043537|NCT01309165|585216356|FG000|Overall Study|Admitted to hospital for second stroke|1|||
162043538|NCT01309165|585216357|FG001|Overall Study|Admitted to hospital for second stroke|0|||
162043539|NCT01950169|585216358|FG000|Overall Study|Withdrawal by Subject|2|||
162004759|NCT02903771|585071755|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
162004760|NCT02903771|585071756|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
162004761|NCT02903771|585071757|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
162004762|NCT02903771|585071758|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
162004763|NCT02903771|585071759|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
162004764|NCT02218372|585071760|FG000|Overall Study|Adverse Event|1|||
162004765|NCT02218372|585071761|FG001|Overall Study|Adverse Event|1|||
162004766|NCT02218372|585071760|FG000|Overall Study|Miscellaneous|2|||
162004767|NCT02218372|585071761|FG001|Overall Study|Miscellaneous|1|||
162004768|NCT02218372|585071760|FG000|Overall Study|Randomized but did not receive treatment|2|||
162004769|NCT02218372|585071761|FG001|Overall Study|Randomized but did not receive treatment|3|||
162004770|NCT02218372|585071760|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162004771|NCT02218372|585071761|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162004772|NCT03406780|585071766|FG000|Overall Study|Withdrawal by Subject|1|||
162004773|NCT03406780|585071767|FG001|Overall Study|Withdrawal by Subject|1|||
162004774|NCT03406780|585071766|FG000|Overall Study|Other|0|||
162004775|NCT03406780|585071767|FG001|Overall Study|Other|2|||
162004776|NCT02546609|585071768|FG000|Overall Study|Withdrawal by Subject|0|||
162004777|NCT02546609|585071769|FG001|Overall Study|Withdrawal by Subject|1|||
162004778|NCT02546609|585071770|FG002|Overall Study|Withdrawal by Subject|2|||
162004779|NCT02546609|585071768|FG000|Overall Study|Adverse Event|0|||
162004780|NCT02546609|585071769|FG001|Overall Study|Adverse Event|6|||
162004781|NCT02546609|585071770|FG002|Overall Study|Adverse Event|1|||
162004782|NCT02546609|585071768|FG000|Overall Study|Protocol Violation|0|||
162004783|NCT02546609|585071769|FG001|Overall Study|Protocol Violation|1|||
162004784|NCT02546609|585071770|FG002|Overall Study|Protocol Violation|1|||
162004785|NCT02546609|585071768|FG000|Overall Study|Lost to Follow-up|2|||
162004786|NCT02546609|585071769|FG001|Overall Study|Lost to Follow-up|3|||
162004787|NCT02546609|585071770|FG002|Overall Study|Lost to Follow-up|1|||
162004788|NCT02546609|585071768|FG000|Overall Study|travel or work schedule restriction|0|||
162004789|NCT02546609|585071769|FG001|Overall Study|travel or work schedule restriction|0|||
162004790|NCT02546609|585071770|FG002|Overall Study|travel or work schedule restriction|2|||
162004791|NCT04038359|585071777|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
162004792|NCT04038359|585071778|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
162004793|NCT04038359|585071777|FG000|Overall Study|Death|8|||
162004794|NCT04038359|585071778|FG001|Overall Study|Death|7|||
162004795|NCT04038359|585071777|FG000|Overall Study|Lost to Follow-up|3|||
162004796|NCT04038359|585071778|FG001|Overall Study|Lost to Follow-up|0|||
162004797|NCT04038359|585071777|FG000|Overall Study|Participant Moved|1|||
162004798|NCT04038359|585071778|FG001|Overall Study|Participant Moved|0|||
162004799|NCT04038359|585071777|FG000|Overall Study|Withdrawal by Subject|4|||
162004800|NCT04038359|585071778|FG001|Overall Study|Withdrawal by Subject|3|||
162004801|NCT04038359|585071777|FG000|Overall Study|Physician Decision|3|||
162004802|NCT04038359|585071778|FG001|Overall Study|Physician Decision|2|||
162004803|NCT04038359|585071777|FG000|Overall Study|Adverse Event|0|||
162004804|NCT04038359|585071778|FG001|Overall Study|Adverse Event|2|||
162004805|NCT04038359|585071777|FG000|Overall Study|Progressive Disease|0|||
162004806|NCT04038359|585071778|FG001|Overall Study|Progressive Disease|1|||
162004807|NCT00475670|585071779|FG000|Overall Study|Death|0|||
162004808|NCT00475670|585071780|FG001|Overall Study|Death|1|||
162004809|NCT00475670|585071779|FG000|Overall Study|Lack of Efficacy|3|||
162004810|NCT00475670|585071780|FG001|Overall Study|Lack of Efficacy|34|||
162004811|NCT00475670|585071779|FG000|Overall Study|Refused treatment|0|||
162004812|NCT00475670|585071780|FG001|Overall Study|Refused treatment|2|||
162004813|NCT00475670|585071779|FG000|Overall Study|Failure to Return|0|||
162004814|NCT00475670|585071780|FG001|Overall Study|Failure to Return|1|||
162004815|NCT00475670|585071779|FG000|Overall Study|Other|0|||
162004816|NCT00475670|585071780|FG001|Overall Study|Other|3|||
162004817|NCT02004236|585071783|FG000|Overall Study|Lack of Efficacy|0|||
162004818|NCT02004236|585071784|FG001|Overall Study|Lack of Efficacy|0|||
162004819|NCT02004236|585071785|FG002|Overall Study|Lack of Efficacy|16|||
162004820|NCT01168349|585071787|FG000|Overall Study|Death|157|||
162004821|NCT01168349|585071787|FG000|Overall Study|Lost to Follow-up|34|||
162004822|NCT01168349|585071787|FG000|Overall Study|Withdrawal by Subject|9|||
162004823|NCT01168349|585071787|FG000|Overall Study|Kidney transplantation|3|||
162004824|NCT01168349|585071787|FG000|Overall Study|Other|22|||
162004825|NCT01168349|585071787|FG000|Overall Study|Protocol Violation|76|||
162004826|NCT01033240|585071788|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
162004827|NCT01033240|585071789|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
162004828|NCT01033240|585071790|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
162004829|NCT01033240|585071788|FG000|Overall Study|Death|2|||
162004830|NCT01033240|585071789|FG001|Overall Study|Death|0|||
162004831|NCT01033240|585071790|FG002|Overall Study|Death|0|||
162004832|NCT01033240|585071788|FG000|Overall Study|Withdrew Consent|2|||
162004833|NCT01033240|585071789|FG001|Overall Study|Withdrew Consent|9|||
162004834|NCT01033240|585071790|FG002|Overall Study|Withdrew Consent|2|||
162004835|NCT01033240|585071788|FG000|Overall Study|Disease Progression|35|||
162004836|NCT01033240|585071789|FG001|Overall Study|Disease Progression|32|||
162004837|NCT01033240|585071790|FG002|Overall Study|Disease Progression|41|||
162004838|NCT01033240|585071788|FG000|Overall Study|Investigator Discretion|0|||
162004839|NCT01033240|585071789|FG001|Overall Study|Investigator Discretion|0|||
162004840|NCT01033240|585071790|FG002|Overall Study|Investigator Discretion|2|||
162004841|NCT01033240|585071788|FG000|Overall Study|Other|0|||
162004842|NCT01033240|585071789|FG001|Overall Study|Other|1|||
162004843|NCT01033240|585071790|FG002|Overall Study|Other|2|||
162004844|NCT00918385|585071794|FG000|Monotherapy|Adverse Event|1|||
162004845|NCT00918385|585071795|FG001|Monotherapy|Adverse Event|6|||
162004846|NCT00918385|585071794|FG000|Monotherapy|Complicating illness|1|||
162004847|NCT00918385|585071795|FG001|Monotherapy|Complicating illness|0|||
162004848|NCT00918385|585071794|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
162004849|NCT00918385|585071795|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
162004850|NCT00918385|585071794|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
162004851|NCT00918385|585071795|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
162004852|NCT00918385|585071794|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
162004853|NCT00918385|585071795|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
162004854|NCT00918385|585071794|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
162004855|NCT00918385|585071795|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
162004856|NCT01476722|585071797|FG000|Overall Study|Adverse Event|1|||
162004857|NCT00918281|585071803|FG000|Overall Study|Physician Decision|29|||
162004858|NCT02978417|585071804|FG000|Overall Study|Lost to Follow-up|2|||
162004859|NCT02978417|585071805|FG001|Overall Study|Lost to Follow-up|2|||
162004860|NCT03557970|585071810|FG000|Overall Study|Study closure|1|||
162004861|NCT03557970|585071811|FG001|Overall Study|Study closure|0|||
162004862|NCT03557970|585071810|FG000|Overall Study|Physician Decision|0|||
162004863|NCT03557970|585071811|FG001|Overall Study|Physician Decision|1|||
162004864|NCT03557970|585071810|FG000|Overall Study|Death|0|||
162004865|NCT03557970|585071811|FG001|Overall Study|Death|1|||
162004866|NCT00525512|585071817|FG000|Double-Blind Phase|Adverse Event|48|||
162004867|NCT00525512|585071818|FG001|Double-Blind Phase|Adverse Event|28|||
162004868|NCT00525512|585071819|FG002|Double-Blind Phase|Adverse Event|0|||
162004869|NCT00525512|585071820|FG003|Double-Blind Phase|Adverse Event|0|||
162004870|NCT00525512|585071817|FG000|Double-Blind Phase|Protocol Violation|3|||
162004871|NCT00525512|585071818|FG001|Double-Blind Phase|Protocol Violation|1|||
162004872|NCT00525512|585071819|FG002|Double-Blind Phase|Protocol Violation|0|||
162004873|NCT00525512|585071820|FG003|Double-Blind Phase|Protocol Violation|0|||
162004874|NCT00525512|585071817|FG000|Double-Blind Phase|Lost to Follow-up|3|||
162004875|NCT00525512|585071818|FG001|Double-Blind Phase|Lost to Follow-up|7|||
162004876|NCT00525512|585071819|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162004877|NCT00525512|585071820|FG003|Double-Blind Phase|Lost to Follow-up|0|||
162004878|NCT00525512|585071817|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
162004879|NCT00525512|585071818|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
162004880|NCT00525512|585071819|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
162004881|NCT00525512|585071820|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
162004882|NCT00525512|585071817|FG000|Double-Blind Phase|Lack of Efficacy|13|||
162004883|NCT00525512|585071818|FG001|Double-Blind Phase|Lack of Efficacy|5|||
162004884|NCT00525512|585071819|FG002|Double-Blind Phase|Lack of Efficacy|0|||
162004885|NCT00525512|585071820|FG003|Double-Blind Phase|Lack of Efficacy|0|||
162004886|NCT00525512|585071817|FG000|Double-Blind Phase|Other reason (not specified)|12|||
162004887|NCT00525512|585071818|FG001|Double-Blind Phase|Other reason (not specified)|13|||
162004888|NCT00525512|585071819|FG002|Double-Blind Phase|Other reason (not specified)|0|||
162004889|NCT00525512|585071820|FG003|Double-Blind Phase|Other reason (not specified)|0|||
162004890|NCT00525512|585071817|FG000|Open-Label Phase|Adverse Event|0|||
162004891|NCT00525512|585071818|FG001|Open-Label Phase|Adverse Event|0|||
162004892|NCT00525512|585071819|FG002|Open-Label Phase|Adverse Event|1|||
162004893|NCT00525512|585071820|FG003|Open-Label Phase|Adverse Event|0|||
162004894|NCT00525512|585071817|FG000|Open-Label Phase|Lost to Follow-up|0|||
162004895|NCT00525512|585071818|FG001|Open-Label Phase|Lost to Follow-up|0|||
162004896|NCT00525512|585071819|FG002|Open-Label Phase|Lost to Follow-up|1|||
162004897|NCT00525512|585071820|FG003|Open-Label Phase|Lost to Follow-up|0|||
162004898|NCT00525512|585071817|FG000|Open-Label Phase|Other reason (not specified)|0|||
162004899|NCT00525512|585071818|FG001|Open-Label Phase|Other reason (not specified)|0|||
162004900|NCT00525512|585071819|FG002|Open-Label Phase|Other reason (not specified)|4|||
162004901|NCT00525512|585071820|FG003|Open-Label Phase|Other reason (not specified)|5|||
162004902|NCT01601535|585071825|FG000|Phase 1|Adverse Event|1|||
162004903|NCT01601535|585071826|FG001|Phase 1|Adverse Event|0|||
162004904|NCT01601535|585071827|FG002|Phase 1|Adverse Event|2|||
162004905|NCT01601535|585071828|FG003|Phase 1|Adverse Event|1|||
162004906|NCT01601535|585071829|FG004|Phase 1|Adverse Event|0|||
162004907|NCT01601535|585071830|FG005|Phase 1|Adverse Event|0|||
162004908|NCT01601535|585071825|FG000|Phase 1|Withdrawal by Subject|2|||
162004909|NCT01601535|585071826|FG001|Phase 1|Withdrawal by Subject|1|||
162004910|NCT01601535|585071827|FG002|Phase 1|Withdrawal by Subject|1|||
162004911|NCT01601535|585071828|FG003|Phase 1|Withdrawal by Subject|2|||
162004912|NCT01601535|585071829|FG004|Phase 1|Withdrawal by Subject|0|||
162043540|NCT01950169|585216359|FG001|Overall Study|Withdrawal by Subject|8|||
162004913|NCT01601535|585071830|FG005|Phase 1|Withdrawal by Subject|0|||
162004914|NCT01601535|585071825|FG000|Phase 1|Progressive Disease|2|||
162004915|NCT01601535|585071826|FG001|Phase 1|Progressive Disease|3|||
162004916|NCT01601535|585071827|FG002|Phase 1|Progressive Disease|2|||
162004917|NCT01601535|585071828|FG003|Phase 1|Progressive Disease|1|||
162004918|NCT01601535|585071829|FG004|Phase 1|Progressive Disease|0|||
162004919|NCT01601535|585071830|FG005|Phase 1|Progressive Disease|0|||
162004920|NCT01601535|585071825|FG000|Phase 1|Started Another Treatment|1|||
162004921|NCT01601535|585071826|FG001|Phase 1|Started Another Treatment|2|||
162004922|NCT01601535|585071827|FG002|Phase 1|Started Another Treatment|0|||
162004923|NCT01601535|585071828|FG003|Phase 1|Started Another Treatment|0|||
162004924|NCT01601535|585071829|FG004|Phase 1|Started Another Treatment|0|||
162004925|NCT01601535|585071830|FG005|Phase 1|Started Another Treatment|0|||
162004926|NCT01601535|585071825|FG000|Phase 2|Adverse Event|0|||
162004927|NCT01601535|585071826|FG001|Phase 2|Adverse Event|0|||
162004928|NCT01601535|585071827|FG002|Phase 2|Adverse Event|0|||
162004929|NCT01601535|585071828|FG003|Phase 2|Adverse Event|0|||
162004930|NCT01601535|585071829|FG004|Phase 2|Adverse Event|5|||
162004931|NCT01601535|585071830|FG005|Phase 2|Adverse Event|1|||
162004932|NCT01601535|585071825|FG000|Phase 2|Withdrawal by Subject|0|||
162004933|NCT01601535|585071826|FG001|Phase 2|Withdrawal by Subject|0|||
162004934|NCT01601535|585071827|FG002|Phase 2|Withdrawal by Subject|0|||
162004935|NCT01601535|585071828|FG003|Phase 2|Withdrawal by Subject|0|||
162004936|NCT01601535|585071829|FG004|Phase 2|Withdrawal by Subject|8|||
162004937|NCT01601535|585071830|FG005|Phase 2|Withdrawal by Subject|2|||
162004938|NCT01601535|585071825|FG000|Phase 2|Progressive Disease|0|||
162004939|NCT01601535|585071826|FG001|Phase 2|Progressive Disease|0|||
162004940|NCT01601535|585071827|FG002|Phase 2|Progressive Disease|0|||
162004941|NCT01601535|585071828|FG003|Phase 2|Progressive Disease|0|||
162004942|NCT01601535|585071829|FG004|Phase 2|Progressive Disease|5|||
162004943|NCT01601535|585071830|FG005|Phase 2|Progressive Disease|7|||
162004944|NCT01601535|585071825|FG000|Phase 2|Started Another Treatment|0|||
162004945|NCT01601535|585071826|FG001|Phase 2|Started Another Treatment|0|||
162004946|NCT01601535|585071827|FG002|Phase 2|Started Another Treatment|0|||
162004947|NCT01601535|585071828|FG003|Phase 2|Started Another Treatment|0|||
162004948|NCT01601535|585071829|FG004|Phase 2|Started Another Treatment|1|||
162004949|NCT01601535|585071830|FG005|Phase 2|Started Another Treatment|2|||
162004950|NCT03600909|585071833|FG000|Overall Study|Not treated|0|||
162043541|NCT01950169|585216360|FG002|Overall Study|Withdrawal by Subject|1|||
162043542|NCT01950169|585216358|FG000|Overall Study|Death|1|||
162043543|NCT01950169|585216359|FG001|Overall Study|Death|0|||
162043544|NCT01950169|585216360|FG002|Overall Study|Death|0|||
162043545|NCT00437320|585216361|FG000|Overall Study|Participant request|2|||
162043546|NCT00437320|585216362|FG001|Overall Study|Participant request|1|||
162043547|NCT00437320|585216363|FG002|Overall Study|Participant request|4|||
162043548|NCT00737438|585216364|FG000|Overall Study|Withdrawal by Subject|2|||
162043549|NCT00737438|585216364|FG000|Overall Study|Patient ineligible|1|||
162043550|NCT01739309|585216365|FG000|Overall Study|Adverse Event|1|||
162043551|NCT01739309|585216365|FG000|Overall Study|Withdrawal by Subject|1|||
162043552|NCT00178633|585216366|FG000|Overall Study|Lost to Follow-up|6|||
162043553|NCT04810481|585216368|FG000|Overall Study|Disqualified data sets|10|||
162043554|NCT04810481|585216369|FG001|Overall Study|Disqualified data sets|28|||
162043555|NCT01484132|585216373|FG000|Overall Study|Lost to Follow-up|8|||
162043556|NCT01484132|585216373|FG000|Overall Study|Difficulty with time commitment|2|||
162043557|NCT01484132|585216373|FG000|Overall Study|Ineligible|1|||
162043558|NCT01484132|585216373|FG000|Overall Study|No pre-treatment urine sample collected|1|||
162043559|NCT01484132|585216373|FG000|Overall Study|No post-treatment urine sample collected|10|||
162004951|NCT03600909|585071834|FG001|Overall Study|Not treated|3|||
162004952|NCT03600909|585071835|FG002|Overall Study|Not treated|0|||
162004953|NCT04576988|585071836|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
162004954|NCT04576988|585071837|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
162004955|NCT04576988|585071836|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
162004956|NCT04576988|585071837|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
162043560|NCT01631812|585216374|FG000|Overall Study|Adverse Event|25|||
162043561|NCT01631812|585216374|FG000|Overall Study|Lack of Efficacy|5|||
162004957|NCT04576988|585071836|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
162043562|NCT01631812|585216374|FG000|Overall Study|Withdrawal by Subject|4|||
162004958|NCT04576988|585071837|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
162004959|NCT04576988|585071836|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
162043563|NCT01631812|585216374|FG000|Overall Study|Physician Decision|3|||
162043564|NCT03698331|585216375|FG000|Overall Study|Adverse Event|2|||
162043565|NCT03698331|585216376|FG001|Overall Study|Adverse Event|3|||
162043566|NCT03698331|585216375|FG000|Overall Study|Withdrawal by Subject|1|||
162004960|NCT04576988|585071837|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
162004961|NCT04576988|585071836|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
162043567|NCT03698331|585216376|FG001|Overall Study|Withdrawal by Subject|1|||
162043568|NCT03698331|585216375|FG000|Overall Study|Lost to Follow-up|0|||
162043569|NCT03698331|585216376|FG001|Overall Study|Lost to Follow-up|2|||
162004962|NCT04576988|585071837|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
162004963|NCT04576988|585071836|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
162004964|NCT04576988|585071837|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
162004965|NCT04576988|585071836|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
162004966|NCT04576988|585071837|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
162004967|NCT04576988|585071836|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
162004968|NCT04576988|585071837|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
162004969|NCT04576988|585071836|FG000|Long Term Double Blind (LTDB)|Death|2|||
162004970|NCT04576988|585071837|FG001|Long Term Double Blind (LTDB)|Death|1|||
162004971|NCT04576988|585071836|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
162004972|NCT04576988|585071837|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
162004973|NCT02919761|585071843|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
162004974|NCT02919761|585071844|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
162004975|NCT02919761|585071845|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
162004976|NCT02919761|585071843|FG000|Part 1: Open Label|Adverse Event|1|||
162004977|NCT02919761|585071844|FG001|Part 1: Open Label|Adverse Event|0|||
162004978|NCT02919761|585071845|FG002|Part 1: Open Label|Adverse Event|0|||
162004979|NCT02919761|585071843|FG000|Part 1: Open Label|Lost to Follow-up|1|||
162004980|NCT02919761|585071844|FG001|Part 1: Open Label|Lost to Follow-up|0|||
162004981|NCT02919761|585071845|FG002|Part 1: Open Label|Lost to Follow-up|0|||
162004982|NCT02919761|585071843|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
162004983|NCT02919761|585071844|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
162004984|NCT02919761|585071845|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
162004985|NCT02919761|585071843|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
162004986|NCT02919761|585071844|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
162004987|NCT02919761|585071845|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
162004988|NCT02919761|585071843|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
162004989|NCT02919761|585071844|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
162004990|NCT02919761|585071845|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
162004991|NCT02919761|585071843|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
162004992|NCT02919761|585071844|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
162004993|NCT02919761|585071845|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
162004994|NCT02919761|585071843|FG000|Part 1: Open Label|Termination by Sponsor|1|||
162004995|NCT02919761|585071844|FG001|Part 1: Open Label|Termination by Sponsor|0|||
162004996|NCT02919761|585071845|FG002|Part 1: Open Label|Termination by Sponsor|0|||
162004997|NCT02919761|585071843|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
162004998|NCT02919761|585071844|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
162004999|NCT02919761|585071845|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
162005000|NCT02919761|585071843|FG000|Part 2: Double-blind|Adverse Event|0|||
162005001|NCT02919761|585071844|FG001|Part 2: Double-blind|Adverse Event|1|||
162005002|NCT02919761|585071845|FG002|Part 2: Double-blind|Adverse Event|0|||
162005003|NCT02919761|585071843|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
162005004|NCT02919761|585071844|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
162005005|NCT02919761|585071845|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
162005006|NCT02919761|585071843|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
162005007|NCT02919761|585071844|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
162005008|NCT02919761|585071845|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
162005009|NCT02919761|585071843|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
162005010|NCT02919761|585071844|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
162005011|NCT02919761|585071845|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
162005012|NCT02919761|585071843|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
162005013|NCT02919761|585071844|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
162005014|NCT02919761|585071845|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
162005015|NCT02919761|585071843|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
162005016|NCT02919761|585071844|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
162005017|NCT02919761|585071845|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
162005018|NCT02919761|585071843|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
162005019|NCT02919761|585071844|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
162005020|NCT02919761|585071845|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
162005021|NCT03724942|585071846|FG000|Overall Study|Adverse Event|20|||
162005022|NCT03724942|585071847|FG001|Overall Study|Adverse Event|14|||
162005023|NCT03724942|585071846|FG000|Overall Study|Lack of Efficacy|0|||
162005024|NCT03724942|585071847|FG001|Overall Study|Lack of Efficacy|1|||
162005025|NCT03724942|585071846|FG000|Overall Study|Physician Decision|5|||
162005026|NCT03724942|585071847|FG001|Overall Study|Physician Decision|2|||
162005027|NCT03724942|585071846|FG000|Overall Study|Protocol Violation|1|||
162005028|NCT03724942|585071847|FG001|Overall Study|Protocol Violation|0|||
162005029|NCT03724942|585071846|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
162005030|NCT03724942|585071847|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
162005031|NCT03724942|585071846|FG000|Overall Study|Withdrawal by Legal Representative|3|||
162005032|NCT03724942|585071847|FG001|Overall Study|Withdrawal by Legal Representative|0|||
162005033|NCT00474487|585073317|FG000|Overall Study|Withdrawal by Subject|6|||
162005034|NCT00474487|585073318|FG001|Overall Study|Withdrawal by Subject|0|||
162005035|NCT00474487|585073319|FG002|Overall Study|Withdrawal by Subject|0|||
162005036|NCT00474487|585073320|FG003|Overall Study|Withdrawal by Subject|0|||
162005037|NCT00474487|585073317|FG000|Overall Study|Lost to Follow-up|20|||
162005038|NCT00474487|585073318|FG001|Overall Study|Lost to Follow-up|1|||
162005039|NCT00474487|585073319|FG002|Overall Study|Lost to Follow-up|7|||
162005040|NCT00474487|585073320|FG003|Overall Study|Lost to Follow-up|0|||
162005041|NCT00474487|585073317|FG000|Overall Study|Inappropriate enrollment|4|||
162005042|NCT00474487|585073318|FG001|Overall Study|Inappropriate enrollment|0|||
162005043|NCT00474487|585073319|FG002|Overall Study|Inappropriate enrollment|7|||
162005044|NCT00474487|585073320|FG003|Overall Study|Inappropriate enrollment|0|||
162005045|NCT00474487|585073317|FG000|Overall Study|Death|0|||
162005046|NCT00474487|585073318|FG001|Overall Study|Death|1|||
162005047|NCT00474487|585073319|FG002|Overall Study|Death|0|||
162005048|NCT00474487|585073320|FG003|Overall Study|Death|0|||
162005049|NCT03924622|585073321|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
162005050|NCT03924622|585073322|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
162005051|NCT03924622|585073323|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
162005052|NCT03924622|585073324|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
162005053|NCT03924622|585073325|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
162005054|NCT03924622|585073326|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
162005055|NCT03085095|585073327|FG000|Overall Study|Adverse Event|23|||
162005056|NCT03085095|585073328|FG001|Overall Study|Adverse Event|8|||
162005057|NCT03085095|585073327|FG000|Overall Study|Protocol Violation|0|||
162005058|NCT03085095|585073328|FG001|Overall Study|Protocol Violation|1|||
162005059|NCT03085095|585073327|FG000|Overall Study|Lost to Follow-up|2|||
162005060|NCT03085095|585073328|FG001|Overall Study|Lost to Follow-up|1|||
162005061|NCT03085095|585073327|FG000|Overall Study|Withdrawal by Subject|17|||
162005062|NCT03085095|585073328|FG001|Overall Study|Withdrawal by Subject|6|||
162005063|NCT03085095|585073327|FG000|Overall Study|Physician Decision|9|||
162005064|NCT03085095|585073328|FG001|Overall Study|Physician Decision|3|||
162005065|NCT03085095|585073327|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
162005066|NCT03085095|585073328|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
162005067|NCT03085095|585073327|FG000|Overall Study|Did not Receive Study Drug|2|||
162005068|NCT03085095|585073328|FG001|Overall Study|Did not Receive Study Drug|2|||
162005069|NCT03085095|585073327|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
162005070|NCT03085095|585073328|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
162005071|NCT05176314|585073331|FG000|Overall Study|Lost to Follow-up|2|||
162005072|NCT05176314|585073331|FG000|Overall Study|Physician Decision|1|||
162005073|NCT05176314|585073331|FG000|Overall Study|Adverse Event|1|||
162005074|NCT05543265|585073333|FG000|Overall Study|Lost to Follow-up|3|||
162005075|NCT05543265|585073334|FG001|Overall Study|Lost to Follow-up|3|||
162005076|NCT05543265|585073333|FG000|Overall Study|Withdrawal by Subject|0|||
162005077|NCT05543265|585073334|FG001|Overall Study|Withdrawal by Subject|1|||
162005078|NCT02182895|585073335|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
162005079|NCT02182895|585073336|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
162005080|NCT01488045|585073346|FG000|Overall Study|Withdrawal by Subject|6|||
162005081|NCT01488045|585073347|FG001|Overall Study|Withdrawal by Subject|11|||
162005082|NCT01488045|585073346|FG000|Overall Study|Failure to present for colonoscopy|3|||
162005083|NCT01488045|585073347|FG001|Overall Study|Failure to present for colonoscopy|6|||
162005084|NCT01488045|585073346|FG000|Overall Study|Failure to report exclusion criteria|0|||
162005085|NCT01488045|585073347|FG001|Overall Study|Failure to report exclusion criteria|1|||
162005086|NCT00671658|585073349|FG000|Overall Study|Physician Decision|5|||
162005087|NCT03617172|585073352|FG000|Overall Study|Lost to Follow-up|1|||
162005088|NCT03617172|585073353|FG001|Overall Study|Lost to Follow-up|0|||
162005089|NCT01680341|585073354|FG000|Overall Study|Adverse Event|3|||
162005090|NCT01680341|585073355|FG001|Overall Study|Adverse Event|2|||
162005091|NCT01680341|585073354|FG000|Overall Study|Unclassified|18|||
162005092|NCT01680341|585073355|FG001|Overall Study|Unclassified|15|||
162005093|NCT02587221|585073357|FG000|Overall Study|Adverse Event|3|||
162005094|NCT02587221|585073358|FG001|Overall Study|Adverse Event|3|||
162005095|NCT02587221|585073357|FG000|Overall Study|Death|33|||
162005096|NCT02587221|585073358|FG001|Overall Study|Death|34|||
162005097|NCT02587221|585073357|FG000|Overall Study|Withdrawal by Subject|66|||
162005098|NCT02587221|585073358|FG001|Overall Study|Withdrawal by Subject|61|||
162005099|NCT02587221|585073357|FG000|Overall Study|Lost to Follow-up|21|||
162005100|NCT02587221|585073358|FG001|Overall Study|Lost to Follow-up|19|||
162005101|NCT02587221|585073357|FG000|Overall Study|Protocol Violation|6|||
162005102|NCT02587221|585073358|FG001|Overall Study|Protocol Violation|5|||
162005103|NCT02587221|585073357|FG000|Overall Study|Other Reason or Unspecified|2|||
162005104|NCT02587221|585073358|FG001|Overall Study|Other Reason or Unspecified|1|||
162005105|NCT03988400|585073359|FG000|Overall Study|Adverse Event|1|||
162005106|NCT03988400|585073360|FG001|Overall Study|Adverse Event|0|||
162005107|NCT03988400|585073359|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
162005108|NCT03988400|585073360|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
162005109|NCT03988400|585073359|FG000|Overall Study|Lost to Follow-up|0|||
162005110|NCT03988400|585073360|FG001|Overall Study|Lost to Follow-up|1|||
162005111|NCT04913610|585073361|FG000|Randomized Participants|Did Not Receive Treatment|0|||
162005112|NCT04913610|585073362|FG001|Randomized Participants|Did Not Receive Treatment|0|||
162005113|NCT04913610|585073363|FG002|Randomized Participants|Did Not Receive Treatment|1|||
162005114|NCT04913610|585073364|FG003|Randomized Participants|Did Not Receive Treatment|1|||
162005115|NCT04913610|585073365|FG004|Randomized Participants|Did Not Receive Treatment|0|||
162005116|NCT04913610|585073361|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
162005117|NCT04913610|585073362|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
162005118|NCT04913610|585073363|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
162005119|NCT04913610|585073364|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
162005120|NCT04913610|585073365|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
162005121|NCT03186209|585073366|FG000|Overall Study|Withdrawal by Subject|11|||
162005122|NCT03186209|585073367|FG001|Overall Study|Withdrawal by Subject|22|||
162005123|NCT03186209|585073366|FG000|Overall Study|Pregnancy|1|||
162005124|NCT03186209|585073367|FG001|Overall Study|Pregnancy|0|||
162005125|NCT03186209|585073366|FG000|Overall Study|Adverse Event|4|||
162005126|NCT03186209|585073367|FG001|Overall Study|Adverse Event|0|||
162005127|NCT03186209|585073366|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
162005128|NCT03186209|585073367|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
162005129|NCT03186209|585073366|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
162005130|NCT03186209|585073367|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
162005131|NCT03186209|585073366|FG000|Overall Study|Fail to meet randomization criteria|0|||
162005132|NCT03186209|585073367|FG001|Overall Study|Fail to meet randomization criteria|1|||
162005133|NCT03186209|585073366|FG000|Overall Study|Lost to Follow-up|0|||
162005134|NCT03186209|585073367|FG001|Overall Study|Lost to Follow-up|1|||
162005135|NCT00953667|585073370|FG000|Overall Study|Lost to Follow-up|11|||
162005136|NCT00953667|585073370|FG000|Overall Study|Physician Decision|35|||
162005137|NCT00953667|585073370|FG000|Overall Study|Withdrawal by Subject|63|||
162005138|NCT00953667|585073370|FG000|Overall Study|Adverse Event|10|||
162005139|NCT00953667|585073370|FG000|Overall Study|poor venous access,unable to draw blood|4|||
162005140|NCT00551759|585073371|FG000|Overall Study|Adverse Event|7|||
162005141|NCT00551759|585073371|FG000|Overall Study|Death|5|||
162005142|NCT00551759|585073371|FG000|Overall Study|Ineligible|1|||
162005143|NCT03521570|585073372|FG000|Overall Study|Not eligible|11|||
162005144|NCT00322881|585073374|FG000|Overall Study|Death|2|||
162005145|NCT00322881|585073374|FG000|Overall Study|Adverse Event|1|||
162005146|NCT00322881|585073374|FG000|Overall Study|Disease Progression|2|||
162005147|NCT02138890|585073381|FG000|Overall Study|Adverse Event|1|||
162005148|NCT02138890|585073382|FG001|Overall Study|Adverse Event|0|||
162005149|NCT00112736|585073383|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
162005150|NCT00112736|585073384|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
162005151|NCT05435339|585073385|FG000|Overall Study|Death|1|||
162005152|NCT05435339|585073386|FG001|Overall Study|Death|0|||
162005153|NCT05435339|585073387|FG002|Overall Study|Death|3|||
162005154|NCT05435339|585073388|FG003|Overall Study|Death|1|||
162005155|NCT05435339|585073389|FG004|Overall Study|Death|3|||
162005156|NCT05435339|585073390|FG005|Overall Study|Death|2|||
162005157|NCT05435339|585073391|FG006|Overall Study|Death|4|||
162005158|NCT05435339|585073392|FG007|Overall Study|Death|6|||
162005159|NCT05435339|585073385|FG000|Overall Study|Sponsor Decision|0|||
162005160|NCT05435339|585073386|FG001|Overall Study|Sponsor Decision|1|||
162005161|NCT05435339|585073387|FG002|Overall Study|Sponsor Decision|0|||
162005162|NCT05435339|585073388|FG003|Overall Study|Sponsor Decision|0|||
162005163|NCT05435339|585073389|FG004|Overall Study|Sponsor Decision|2|||
162005164|NCT05435339|585073390|FG005|Overall Study|Sponsor Decision|1|||
162005165|NCT05435339|585073391|FG006|Overall Study|Sponsor Decision|2|||
162005166|NCT05435339|585073392|FG007|Overall Study|Sponsor Decision|2|||
162005167|NCT05435339|585073385|FG000|Overall Study|Withdrawal by Subject|0|||
162005168|NCT05435339|585073386|FG001|Overall Study|Withdrawal by Subject|0|||
162005169|NCT05435339|585073387|FG002|Overall Study|Withdrawal by Subject|0|||
162005170|NCT05435339|585073388|FG003|Overall Study|Withdrawal by Subject|0|||
162005171|NCT05435339|585073389|FG004|Overall Study|Withdrawal by Subject|1|||
162005172|NCT05435339|585073390|FG005|Overall Study|Withdrawal by Subject|0|||
162005173|NCT05435339|585073391|FG006|Overall Study|Withdrawal by Subject|1|||
162005174|NCT05435339|585073392|FG007|Overall Study|Withdrawal by Subject|1|||
162005175|NCT01446159|585073394|FG000|Overall Study|Withdrawal by Subject|1|||
162005176|NCT01446159|585073395|FG001|Overall Study|Withdrawal by Subject|0|||
162005177|NCT01446159|585073396|FG002|Overall Study|Withdrawal by Subject|14|||
162005178|NCT01446159|585073397|FG003|Overall Study|Withdrawal by Subject|11|||
162005179|NCT01446159|585073394|FG000|Overall Study|Lost to Follow-up|0|||
162005180|NCT01446159|585073395|FG001|Overall Study|Lost to Follow-up|0|||
162005181|NCT01446159|585073396|FG002|Overall Study|Lost to Follow-up|1|||
162005182|NCT01446159|585073397|FG003|Overall Study|Lost to Follow-up|2|||
162043570|NCT03698331|585216375|FG000|Overall Study|Non-compliance with study drug|1|||
162043571|NCT03698331|585216376|FG001|Overall Study|Non-compliance with study drug|0|||
162043572|NCT02718300|585216377|FG000|Overall Study|Death|4|||
162043573|NCT02718300|585216378|FG001|Overall Study|Death|5|||
162043574|NCT02718300|585216379|FG002|Overall Study|Death|17|||
162043575|NCT02718300|585216377|FG000|Overall Study|Lost to Follow-up|1|||
162043576|NCT02718300|585216378|FG001|Overall Study|Lost to Follow-up|0|||
162043577|NCT02718300|585216379|FG002|Overall Study|Lost to Follow-up|2|||
162043578|NCT02718300|585216377|FG000|Overall Study|Physician Decision|1|||
162043579|NCT02718300|585216378|FG001|Overall Study|Physician Decision|0|||
162043580|NCT02718300|585216379|FG002|Overall Study|Physician Decision|2|||
162043581|NCT02718300|585216377|FG000|Overall Study|Study Terminated by Sponsor|6|||
162043582|NCT02718300|585216378|FG001|Overall Study|Study Terminated by Sponsor|3|||
162043583|NCT02718300|585216379|FG002|Overall Study|Study Terminated by Sponsor|4|||
162043584|NCT02718300|585216377|FG000|Overall Study|Withdrawal by Subject|0|||
162043585|NCT02718300|585216378|FG001|Overall Study|Withdrawal by Subject|4|||
162043586|NCT02718300|585216379|FG002|Overall Study|Withdrawal by Subject|3|||
162043587|NCT02718300|585216377|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
162043588|NCT02718300|585216378|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
162043589|NCT02718300|585216379|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
162043590|NCT05741528|585216380|FG000|Overall Study|Withdrawal by Subject|11|||
162043591|NCT05741528|585216380|FG000|Overall Study|Lost to Follow-up|3|||
162043592|NCT05741528|585216380|FG000|Overall Study|Adverse Event|2|||
162043593|NCT05741528|585216380|FG000|Overall Study|Non-Compliance With Study Drug|2|||
162043594|NCT05741528|585216380|FG000|Overall Study|Reason Not Specified|1|||
162043595|NCT04246372|585218031|FG000|Overall Study|Adverse Event|1|||
162043596|NCT04246372|585218031|FG000|Overall Study|Withdrawal by Subject|1|||
162043597|NCT04246372|585218031|FG000|Overall Study|Protocol Violation|2|||
162043598|NCT04246372|585218031|FG000|Overall Study|Physician Decision|1|||
162043599|NCT03673046|585218032|FG000|Overall Study|Adverse Event|1|||
162043600|NCT03673046|585218033|FG001|Overall Study|Adverse Event|1|||
162043601|NCT03673046|585218032|FG000|Overall Study|Withdrawal by Subject|8|||
162043602|NCT03673046|585218033|FG001|Overall Study|Withdrawal by Subject|2|||
162043603|NCT01896050|585218034|FG000|Overall Study|Adverse Event|37|||
162043604|NCT01896050|585218035|FG001|Overall Study|Adverse Event|2|||
162043605|NCT01896050|585218034|FG000|Overall Study|Death|1|||
162043606|NCT01896050|585218035|FG001|Overall Study|Death|0|||
162043607|NCT03693300|585218037|FG000|Overall Study|Withdrawal by Subject|6|||
162043608|NCT03693300|585218038|FG001|Overall Study|Withdrawal by Subject|0|||
162043609|NCT03693300|585218037|FG000|Overall Study|Death|50|||
162043610|NCT03693300|585218038|FG001|Overall Study|Death|2|||
162043611|NCT03693300|585218037|FG000|Overall Study|Lost to Follow-up|2|||
162043612|NCT03693300|585218038|FG001|Overall Study|Lost to Follow-up|0|||
162043613|NCT01824342|585218041|FG000|Overall Study|Withdrawal by Subject|0|||
162043614|NCT01824342|585218042|FG001|Overall Study|Withdrawal by Subject|3|||
162043615|NCT01824342|585218041|FG000|Overall Study|Adverse Event|1|||
162043616|NCT01824342|585218042|FG001|Overall Study|Adverse Event|1|||
162043617|NCT01824342|585218041|FG000|Overall Study|Disease Progression|1|||
162043618|NCT01824342|585218042|FG001|Overall Study|Disease Progression|1|||
162043619|NCT01824342|585218041|FG000|Overall Study|Physician Decision|5|||
162043620|NCT01824342|585218042|FG001|Overall Study|Physician Decision|0|||
162043621|NCT01824342|585218041|FG000|Overall Study|Death|2|||
162043622|NCT01824342|585218042|FG001|Overall Study|Death|0|||
162043623|NCT01926015|585218043|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162043624|NCT01926015|585218044|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162043625|NCT01926015|585218043|FG000|Overall Study|Randomized not treated|2|||
162005183|NCT01446159|585073394|FG000|Overall Study|Death|2|||
162005184|NCT01446159|585073395|FG001|Overall Study|Death|3|||
162005185|NCT01446159|585073396|FG002|Overall Study|Death|43|||
162005186|NCT01446159|585073397|FG003|Overall Study|Death|36|||
162005187|NCT01446159|585073394|FG000|Overall Study|Other|0|||
162005188|NCT01446159|585073395|FG001|Overall Study|Other|0|||
162005189|NCT01446159|585073396|FG002|Overall Study|Other|13|||
162005190|NCT01446159|585073397|FG003|Overall Study|Other|13|||
162043626|NCT01926015|585218044|FG001|Overall Study|Randomized not treated|0|||
162043627|NCT01364649|585218045|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
162043628|NCT01364649|585218046|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
162043629|NCT01364649|585218045|FG000|Overall Study|Lack of Efficacy|6|||
162043630|NCT01364649|585218046|FG001|Overall Study|Lack of Efficacy|0|||
162005191|NCT00004563|585073404|FG000|Overall Study|Withdrawal by Subject|20|||
162005192|NCT00004563|585073405|FG001|Overall Study|Withdrawal by Subject|16|||
162005193|NCT00004563|585073404|FG000|Overall Study|Lack of Efficacy|3|||
162043631|NCT01364649|585218045|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
162043632|NCT01364649|585218046|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
162043633|NCT01364649|585218045|FG000|Overall Study|Protocol Deviations|4|||
162043634|NCT01364649|585218046|FG001|Overall Study|Protocol Deviations|8|||
162043635|NCT01364649|585218045|FG000|Overall Study|Withdrawal of Consent|9|||
162043636|NCT01364649|585218046|FG001|Overall Study|Withdrawal of Consent|7|||
162043637|NCT01364649|585218045|FG000|Overall Study|Lost to Follow-up|12|||
162005194|NCT00004563|585073405|FG001|Overall Study|Lack of Efficacy|5|||
162005195|NCT00004563|585073404|FG000|Overall Study|Death|2|||
162005196|NCT00004563|585073405|FG001|Overall Study|Death|3|||
162005197|NCT05135871|585073408|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
162043638|NCT01364649|585218046|FG001|Overall Study|Lost to Follow-up|13|||
162043639|NCT01364649|585218045|FG000|Overall Study|Other|4|||
162043640|NCT01364649|585218046|FG001|Overall Study|Other|1|||
162043641|NCT01826604|585218047|FG000|Overall Study|Lost to Follow-up|8|||
162043642|NCT01826604|585218048|FG001|Overall Study|Lost to Follow-up|9|||
162043643|NCT06132659|585218049|FG000|Overall Study|Lost to Follow-up|0|||
162043644|NCT06132659|585218050|FG001|Overall Study|Lost to Follow-up|1|||
162043645|NCT06132659|585218051|FG002|Overall Study|Lost to Follow-up|0|||
162043646|NCT03615326|585218052|FG000|Overall Study|Death|266|||
162043647|NCT03615326|585218053|FG001|Overall Study|Death|286|||
162043648|NCT03615326|585218054|FG002|Overall Study|Death|14|||
162043649|NCT03615326|585218055|FG003|Overall Study|Death|17|||
162043650|NCT03615326|585218052|FG000|Overall Study|Lost to Follow-up|0|||
162043651|NCT03615326|585218053|FG001|Overall Study|Lost to Follow-up|1|||
162043652|NCT03615326|585218054|FG002|Overall Study|Lost to Follow-up|0|||
162043653|NCT03615326|585218055|FG003|Overall Study|Lost to Follow-up|0|||
162043654|NCT03615326|585218052|FG000|Overall Study|Withdrawal by Subject|1|||
162043655|NCT03615326|585218053|FG001|Overall Study|Withdrawal by Subject|3|||
162043656|NCT03615326|585218054|FG002|Overall Study|Withdrawal by Subject|0|||
162043657|NCT03615326|585218055|FG003|Overall Study|Withdrawal by Subject|0|||
162043658|NCT03615326|585218052|FG000|Overall Study|Participants Ongoing|83|||
162043659|NCT03615326|585218053|FG001|Overall Study|Participants Ongoing|58|||
162043660|NCT03615326|585218054|FG002|Overall Study|Participants Ongoing|6|||
162043661|NCT03615326|585218055|FG003|Overall Study|Participants Ongoing|3|||
162043662|NCT03794583|585218056|FG000|Overall Study|Death|8|||
162005198|NCT05135871|585073409|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
162005199|NCT05135871|585073410|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
162005200|NCT05135871|585073411|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
162005201|NCT04258423|585073412|FG000|Overall Study|Study Closure|2|||
162005202|NCT04258423|585073413|FG001|Overall Study|Study Closure|2|||
162005203|NCT03980730|585073414|FG000|Overall Study|Study Terminated by Sponsor|0|||
162005204|NCT03980730|585073415|FG001|Overall Study|Study Terminated by Sponsor|3|||
162005205|NCT03980730|585073414|FG000|Overall Study|Adverse Event|2|||
162005206|NCT03980730|585073415|FG001|Overall Study|Adverse Event|0|||
162005207|NCT03980730|585073414|FG000|Overall Study|Sponsor Request|0|||
162005208|NCT03980730|585073415|FG001|Overall Study|Sponsor Request|1|||
162005209|NCT00880620|585073416|FG000|Overall Study|Adverse Event|4|||
162005210|NCT00880620|585073417|FG001|Overall Study|Adverse Event|5|||
162005211|NCT00880620|585073418|FG002|Overall Study|Adverse Event|15|||
162005212|NCT00880620|585073419|FG003|Overall Study|Adverse Event|15|||
162005213|NCT00880620|585073416|FG000|Overall Study|Death|0|||
162005214|NCT00880620|585073417|FG001|Overall Study|Death|0|||
162005215|NCT00880620|585073418|FG002|Overall Study|Death|1|||
162005216|NCT00880620|585073419|FG003|Overall Study|Death|0|||
162005217|NCT00880620|585073416|FG000|Overall Study|Lack of Efficacy|12|||
162005218|NCT00880620|585073417|FG001|Overall Study|Lack of Efficacy|4|||
162005219|NCT00880620|585073418|FG002|Overall Study|Lack of Efficacy|0|||
162005220|NCT00880620|585073419|FG003|Overall Study|Lack of Efficacy|1|||
162005221|NCT00880620|585073416|FG000|Overall Study|Lost to Follow-up|0|||
162005222|NCT00880620|585073417|FG001|Overall Study|Lost to Follow-up|1|||
162005223|NCT00880620|585073418|FG002|Overall Study|Lost to Follow-up|1|||
162005224|NCT00880620|585073419|FG003|Overall Study|Lost to Follow-up|0|||
162005225|NCT00880620|585073416|FG000|Overall Study|Protocol Violation|0|||
162005226|NCT00880620|585073417|FG001|Overall Study|Protocol Violation|1|||
162005227|NCT00880620|585073418|FG002|Overall Study|Protocol Violation|0|||
162005228|NCT00880620|585073419|FG003|Overall Study|Protocol Violation|2|||
162005229|NCT00880620|585073416|FG000|Overall Study|Withdrawal by Subject|4|||
162005230|NCT00880620|585073417|FG001|Overall Study|Withdrawal by Subject|3|||
162005231|NCT00880620|585073418|FG002|Overall Study|Withdrawal by Subject|1|||
162043663|NCT03794583|585218056|FG000|Overall Study|Study Terminated by Sponsor|24|||
162043664|NCT03794583|585218056|FG000|Overall Study|Withdrawal by Subject|9|||
162043665|NCT02497612|585218057|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
162043666|NCT02497612|585218058|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
162043667|NCT02497612|585218059|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
162043668|NCT02497612|585218060|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
162043669|NCT02497612|585218057|FG000|Overall Study|Participant's request|2|||
162043670|NCT02497612|585218058|FG001|Overall Study|Participant's request|3|||
162005232|NCT00880620|585073419|FG003|Overall Study|Withdrawal by Subject|3|||
162005233|NCT00880620|585073416|FG000|Overall Study|Noncompliance|0|||
162005234|NCT00880620|585073417|FG001|Overall Study|Noncompliance|0|||
162005235|NCT00880620|585073418|FG002|Overall Study|Noncompliance|1|||
162005236|NCT00880620|585073419|FG003|Overall Study|Noncompliance|1|||
162043671|NCT02497612|585218059|FG002|Overall Study|Participant's request|4|||
162043672|NCT02497612|585218060|FG003|Overall Study|Participant's request|1|||
162043673|NCT02497612|585218057|FG000|Overall Study|Investigator's judgement|1|||
162043674|NCT02497612|585218058|FG001|Overall Study|Investigator's judgement|0|||
162043675|NCT02497612|585218059|FG002|Overall Study|Investigator's judgement|0|||
162043676|NCT02497612|585218060|FG003|Overall Study|Investigator's judgement|2|||
162043677|NCT02497612|585218057|FG000|Overall Study|Adverse Event|3|||
162043678|NCT02497612|585218058|FG001|Overall Study|Adverse Event|1|||
162043679|NCT02497612|585218059|FG002|Overall Study|Adverse Event|4|||
162043680|NCT02497612|585218060|FG003|Overall Study|Adverse Event|1|||
162043681|NCT02497612|585218057|FG000|Overall Study|Lost to Follow-up|1|||
162043682|NCT02497612|585218058|FG001|Overall Study|Lost to Follow-up|1|||
162043683|NCT02497612|585218059|FG002|Overall Study|Lost to Follow-up|0|||
162043684|NCT02497612|585218060|FG003|Overall Study|Lost to Follow-up|1|||
162043685|NCT02497612|585218057|FG000|Overall Study|Other unspecified|1|||
162043686|NCT02497612|585218058|FG001|Overall Study|Other unspecified|1|||
162043687|NCT02497612|585218059|FG002|Overall Study|Other unspecified|2|||
162043688|NCT02497612|585218060|FG003|Overall Study|Other unspecified|0|||
162043689|NCT02497612|585218057|FG000|Overall Study|Not eligible|1|||
162043690|NCT02497612|585218058|FG001|Overall Study|Not eligible|0|||
162043691|NCT02497612|585218059|FG002|Overall Study|Not eligible|0|||
162043692|NCT02497612|585218060|FG003|Overall Study|Not eligible|1|||
162043693|NCT02651467|585218061|FG000|Overall Study|Withdrawal by Subject|0|||
162043694|NCT02651467|585218062|FG001|Overall Study|Withdrawal by Subject|0|||
162043695|NCT02651467|585218063|FG002|Overall Study|Withdrawal by Subject|2|||
162043696|NCT02651467|585218061|FG000|Overall Study|Other (Not specified)|1|||
162043697|NCT02651467|585218062|FG001|Overall Study|Other (Not specified)|0|||
162043698|NCT02651467|585218063|FG002|Overall Study|Other (Not specified)|2|||
162043699|NCT01938573|585218064|FG000|Overall Study|Lack of Efficacy|1|||
162043700|NCT01938573|585218065|FG001|Overall Study|Lack of Efficacy|0|||
162043701|NCT01938573|585218064|FG000|Overall Study|Operation at other hospital|1|||
162043702|NCT01938573|585218065|FG001|Overall Study|Operation at other hospital|0|||
162043703|NCT02410551|585218066|FG000|Overall Study|Adverse Event|1|||
162043704|NCT02410551|585218066|FG000|Overall Study|Withdrawal by Subject|1|||
162043705|NCT02410551|585218066|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
162043706|NCT05469113|585218067|FG000|Period 2|Adverse Event|0|||
162043707|NCT05469113|585218068|FG001|Period 2|Adverse Event|3|||
162043708|NCT05447897|585218069|FG000|Overall Study|Did not participate in survey|2|||
162043709|NCT04553679|585218070|FG000|Overall Study|Withdrawal by Subject|2|||
162043710|NCT04553679|585218071|FG001|Overall Study|Withdrawal by Subject|0|||
162043711|NCT04553679|585218070|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
162043712|NCT04553679|585218071|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
162043713|NCT01230710|585218073|FG000|Overall Study|Disease Progression|41|||
162043714|NCT01230710|585218073|FG000|Overall Study|Lost to Follow-up|3|||
162043715|NCT01230710|585218073|FG000|Overall Study|Death|4|||
162043716|NCT01230710|585218073|FG000|Overall Study|Withdrawal of Consent|1|||
162043717|NCT02905149|585218074|FG000|Overall Study|Lost to Follow-up|2|||
162043718|NCT02905149|585218075|FG001|Overall Study|Lost to Follow-up|0|||
162043719|NCT00747812|585218076|FG000|Overall Study|Research Site Staff Relocation|5|||
162043720|NCT00747812|585218077|FG001|Overall Study|Research Site Staff Relocation|3|||
162043721|NCT01708161|585218080|FG000|Overall Study|Adverse Event|1|||
162043722|NCT01708161|585218081|FG001|Overall Study|Adverse Event|3|||
162043723|NCT01708161|585218082|FG002|Overall Study|Adverse Event|4|||
162043724|NCT01708161|585218083|FG003|Overall Study|Adverse Event|2|||
162043725|NCT01708161|585218084|FG004|Overall Study|Adverse Event|3|||
162043726|NCT01708161|585218085|FG005|Overall Study|Adverse Event|0|||
162043727|NCT01708161|585218080|FG000|Overall Study|Death|0|||
162043728|NCT01708161|585218081|FG001|Overall Study|Death|0|||
162043729|NCT01708161|585218082|FG002|Overall Study|Death|0|||
162043730|NCT01708161|585218083|FG003|Overall Study|Death|1|||
162043731|NCT01708161|585218084|FG004|Overall Study|Death|0|||
162043732|NCT01708161|585218085|FG005|Overall Study|Death|1|||
162043733|NCT01708161|585218080|FG000|Overall Study|Withdrawal by Subject|0|||
162043734|NCT01708161|585218081|FG001|Overall Study|Withdrawal by Subject|1|||
162043735|NCT01708161|585218082|FG002|Overall Study|Withdrawal by Subject|1|||
162043736|NCT01708161|585218083|FG003|Overall Study|Withdrawal by Subject|0|||
162043737|NCT01708161|585218084|FG004|Overall Study|Withdrawal by Subject|0|||
162043738|NCT01708161|585218085|FG005|Overall Study|Withdrawal by Subject|0|||
162043739|NCT01708161|585218080|FG000|Overall Study|Administrative problems|0|||
162043740|NCT01708161|585218081|FG001|Overall Study|Administrative problems|1|||
162043741|NCT01708161|585218082|FG002|Overall Study|Administrative problems|0|||
162043742|NCT01708161|585218083|FG003|Overall Study|Administrative problems|0|||
162043743|NCT01708161|585218084|FG004|Overall Study|Administrative problems|0|||
162043744|NCT01708161|585218085|FG005|Overall Study|Administrative problems|0|||
162043745|NCT01708161|585218080|FG000|Overall Study|Disease progression|3|||
162043746|NCT01708161|585218081|FG001|Overall Study|Disease progression|5|||
162043747|NCT01708161|585218082|FG002|Overall Study|Disease progression|5|||
162043748|NCT01708161|585218083|FG003|Overall Study|Disease progression|13|||
162043749|NCT01708161|585218084|FG004|Overall Study|Disease progression|3|||
162005237|NCT00880620|585073416|FG000|Overall Study|Other|1|||
162005238|NCT00880620|585073417|FG001|Overall Study|Other|1|||
162005239|NCT00880620|585073418|FG002|Overall Study|Other|2|||
162005240|NCT00880620|585073419|FG003|Overall Study|Other|2|||
162005241|NCT02016781|585073433|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
162005242|NCT02016781|585073434|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
162005243|NCT02016781|585073433|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
162005244|NCT02016781|585073434|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
162005245|NCT02016781|585073433|FG000|Final Database Lock|Withdrawal by Subject|2|||
162005246|NCT02016781|585073434|FG001|Final Database Lock|Withdrawal by Subject|1|||
162005247|NCT02016781|585073433|FG000|Final Database Lock|Lost to Follow-up|11|||
162005248|NCT02016781|585073434|FG001|Final Database Lock|Lost to Follow-up|4|||
162005249|NCT02016781|585073433|FG000|Final Database Lock|Missing data|0|||
162005250|NCT02016781|585073434|FG001|Final Database Lock|Missing data|3|||
162005251|NCT00945009|585073435|FG000|Overall Study|Lack of Efficacy|10|||
162005252|NCT00945009|585073436|FG001|Overall Study|Lack of Efficacy|0|||
162005253|NCT00945009|585073437|FG002|Overall Study|Lack of Efficacy|0|||
162005254|NCT00945009|585073435|FG000|Overall Study|Physician Decision|21|||
162005255|NCT00945009|585073436|FG001|Overall Study|Physician Decision|4|||
162005256|NCT00945009|585073437|FG002|Overall Study|Physician Decision|3|||
162005257|NCT00945009|585073435|FG000|Overall Study|Protocol Violation|6|||
162005258|NCT00945009|585073436|FG001|Overall Study|Protocol Violation|1|||
162005259|NCT00945009|585073437|FG002|Overall Study|Protocol Violation|0|||
162005260|NCT00945009|585073435|FG000|Overall Study|Withdrawal by Subject|1|||
162005261|NCT00945009|585073436|FG001|Overall Study|Withdrawal by Subject|0|||
162005262|NCT00945009|585073437|FG002|Overall Study|Withdrawal by Subject|0|||
162005263|NCT00945009|585073435|FG000|Overall Study|Ineligible|6|||
162005264|NCT00945009|585073436|FG001|Overall Study|Ineligible|1|||
162005265|NCT00945009|585073437|FG002|Overall Study|Ineligible|0|||
162005266|NCT00945009|585073435|FG000|Overall Study|Inevaluable|0|||
162005267|NCT00945009|585073436|FG001|Overall Study|Inevaluable|1|||
162005268|NCT00945009|585073437|FG002|Overall Study|Inevaluable|0|||
162005269|NCT00945009|585073435|FG000|Overall Study|Refusal of further protocol|1|||
162005270|NCT00945009|585073436|FG001|Overall Study|Refusal of further protocol|0|||
162005271|NCT00945009|585073437|FG002|Overall Study|Refusal of further protocol|0|||
162005272|NCT04875975|585073438|FG000|Overall Study|Adverse Event|1|||
162005273|NCT04875975|585073439|FG001|Overall Study|Adverse Event|2|||
162005274|NCT04875975|585073438|FG000|Overall Study|Lack of Efficacy|2|||
162005275|NCT04875975|585073439|FG001|Overall Study|Lack of Efficacy|2|||
162005276|NCT04875975|585073438|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
162005277|NCT04875975|585073439|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
162005278|NCT04875975|585073438|FG000|Overall Study|Relapse With Insults|0|||
162005279|NCT04875975|585073439|FG001|Overall Study|Relapse With Insults|1|||
162005280|NCT04875975|585073438|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
162005281|NCT04875975|585073439|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
162005282|NCT04972162|585073444|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
162005283|NCT04972162|585073445|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
162005284|NCT02429830|585073446|FG000|Overall Study|Lost to Follow-up|1|||
162005285|NCT02429830|585073446|FG000|Overall Study|Device Explant|2|||
162005286|NCT00385671|585075800|FG000|Overall Study|Adverse Event|14|||
162005287|NCT00385671|585075801|FG001|Overall Study|Adverse Event|27|||
162005288|NCT00385671|585075802|FG002|Overall Study|Adverse Event|18|||
162005289|NCT00385671|585075800|FG000|Overall Study|Lack of Efficacy|5|||
162005290|NCT00385671|585075801|FG001|Overall Study|Lack of Efficacy|9|||
162005291|NCT00385671|585075802|FG002|Overall Study|Lack of Efficacy|5|||
162005292|NCT00385671|585075800|FG000|Overall Study|Lost to Follow-up|6|||
162005293|NCT00385671|585075801|FG001|Overall Study|Lost to Follow-up|6|||
162005294|NCT00385671|585075802|FG002|Overall Study|Lost to Follow-up|5|||
162005295|NCT00385671|585075800|FG000|Overall Study|Physician Decision|2|||
162005296|NCT00385671|585075801|FG001|Overall Study|Physician Decision|1|||
162005297|NCT00385671|585075802|FG002|Overall Study|Physician Decision|2|||
162005298|NCT00385671|585075800|FG000|Overall Study|Protocol Violation|5|||
162005299|NCT00385671|585075801|FG001|Overall Study|Protocol Violation|2|||
162005300|NCT00385671|585075802|FG002|Overall Study|Protocol Violation|1|||
162005301|NCT00385671|585075800|FG000|Overall Study|Sponsor Decision|2|||
162005302|NCT00385671|585075801|FG001|Overall Study|Sponsor Decision|2|||
162005303|NCT00385671|585075802|FG002|Overall Study|Sponsor Decision|1|||
162005304|NCT00385671|585075800|FG000|Overall Study|Withdrawal by Subject|4|||
162005305|NCT00385671|585075801|FG001|Overall Study|Withdrawal by Subject|4|||
162005306|NCT00385671|585075802|FG002|Overall Study|Withdrawal by Subject|4|||
162005307|NCT01775501|585075805|FG000|Overall Study|Discontinued prior to treatment|1|||
162005308|NCT03037385|585075806|FG000|Overall Study|Adverse Event|0|||
162005309|NCT03037385|585075807|FG001|Overall Study|Adverse Event|0|||
162005310|NCT03037385|585075808|FG002|Overall Study|Adverse Event|1|||
162005311|NCT03037385|585075809|FG003|Overall Study|Adverse Event|0|||
162005312|NCT03037385|585075810|FG004|Overall Study|Adverse Event|0|||
162005313|NCT03037385|585075811|FG005|Overall Study|Adverse Event|0|||
162005314|NCT03037385|585075812|FG006|Overall Study|Adverse Event|0|||
162043750|NCT01708161|585218085|FG005|Overall Study|Disease progression|0|||
162043751|NCT02633501|585218087|FG000|Overall Study|Adverse Event|0|||
162043752|NCT02633501|585218088|FG001|Overall Study|Adverse Event|0|||
162043753|NCT02633501|585218089|FG002|Overall Study|Adverse Event|1|||
162043754|NCT02633501|585218090|FG003|Overall Study|Adverse Event|0|||
162043755|NCT02633501|585218091|FG004|Overall Study|Adverse Event|1|||
162043756|NCT02633501|585218092|FG005|Overall Study|Adverse Event|1|||
162043757|NCT02633501|585218087|FG000|Overall Study|Withdrawal by Subject|2|||
162043758|NCT02633501|585218088|FG001|Overall Study|Withdrawal by Subject|1|||
162043759|NCT02633501|585218089|FG002|Overall Study|Withdrawal by Subject|2|||
162043760|NCT02633501|585218090|FG003|Overall Study|Withdrawal by Subject|2|||
162043761|NCT02633501|585218091|FG004|Overall Study|Withdrawal by Subject|1|||
162043762|NCT02633501|585218092|FG005|Overall Study|Withdrawal by Subject|3|||
162043763|NCT02633501|585218087|FG000|Overall Study|Various other reasons|0|||
162043764|NCT02633501|585218088|FG001|Overall Study|Various other reasons|2|||
162043765|NCT02633501|585218089|FG002|Overall Study|Various other reasons|4|||
162043766|NCT02633501|585218090|FG003|Overall Study|Various other reasons|1|||
162043767|NCT02633501|585218091|FG004|Overall Study|Various other reasons|7|||
162043768|NCT02633501|585218092|FG005|Overall Study|Various other reasons|11|||
162043769|NCT02633501|585218087|FG000|Overall Study|Lost to Follow-up|0|||
162043770|NCT02633501|585218088|FG001|Overall Study|Lost to Follow-up|0|||
162043771|NCT02633501|585218089|FG002|Overall Study|Lost to Follow-up|0|||
162043772|NCT02633501|585218090|FG003|Overall Study|Lost to Follow-up|1|||
162043773|NCT02633501|585218091|FG004|Overall Study|Lost to Follow-up|2|||
162043774|NCT02633501|585218092|FG005|Overall Study|Lost to Follow-up|0|||
162005315|NCT03037385|585075813|FG007|Overall Study|Adverse Event|0|||
162043775|NCT01986140|585218094|FG000|Overall Study|Withdrawal by Subject|31|||
162043776|NCT01986140|585218095|FG001|Overall Study|Withdrawal by Subject|25|||
162043777|NCT01986140|585218094|FG000|Overall Study|alternative treatment|1|||
162043778|NCT01986140|585218095|FG001|Overall Study|alternative treatment|1|||
162043779|NCT01986140|585218094|FG000|Overall Study|found not eligible|3|||
162043780|NCT01986140|585218095|FG001|Overall Study|found not eligible|0|||
162043781|NCT01986140|585218094|FG000|Overall Study|Adverse Event|0|||
162043782|NCT01986140|585218095|FG001|Overall Study|Adverse Event|1|||
162043783|NCT01986140|585218094|FG000|Overall Study|progression disease|0|||
162043784|NCT01986140|585218095|FG001|Overall Study|progression disease|1|||
162043785|NCT01104155|585218100|FG000|Overall Study|Adverse Event|15|||
162043786|NCT01104155|585218101|FG001|Overall Study|Adverse Event|8|||
162043787|NCT01104155|585218100|FG000|Overall Study|Participant choice|6|||
162043788|NCT01104155|585218101|FG001|Overall Study|Participant choice|5|||
162043789|NCT01104155|585218100|FG000|Overall Study|Withdrawal of consent|1|||
162043790|NCT01104155|585218101|FG001|Overall Study|Withdrawal of consent|1|||
162043791|NCT01104155|585218100|FG000|Overall Study|Other|3|||
162005316|NCT03037385|585075814|FG008|Overall Study|Adverse Event|0|||
162005317|NCT03037385|585075815|FG009|Overall Study|Adverse Event|6|||
162005318|NCT03037385|585075806|FG000|Overall Study|Death|1|||
162005319|NCT03037385|585075807|FG001|Overall Study|Death|4|||
162005320|NCT03037385|585075808|FG002|Overall Study|Death|2|||
162005321|NCT03037385|585075809|FG003|Overall Study|Death|2|||
162005322|NCT03037385|585075810|FG004|Overall Study|Death|5|||
162005323|NCT03037385|585075811|FG005|Overall Study|Death|2|||
162005324|NCT03037385|585075812|FG006|Overall Study|Death|1|||
162005325|NCT03037385|585075813|FG007|Overall Study|Death|4|||
162005326|NCT03037385|585075814|FG008|Overall Study|Death|3|||
162005327|NCT03037385|585075815|FG009|Overall Study|Death|240|||
162005328|NCT03037385|585075806|FG000|Overall Study|Initiation of Another Therapy|1|||
162005329|NCT03037385|585075807|FG001|Overall Study|Initiation of Another Therapy|0|||
162043792|NCT01104155|585218101|FG001|Overall Study|Other|4|||
162043793|NCT01069627|585218113|FG000|Overall Study|Disease progression|7|||
162043794|NCT01069627|585218113|FG000|Overall Study|Adverse Event|12|||
162043795|NCT01069627|585218113|FG000|Overall Study|Protocol Violation|1|||
162043796|NCT02963935|585218116|FG000|Overall Study|Adverse Event|12|||
162043797|NCT02963935|585218117|FG001|Overall Study|Adverse Event|6|||
162043798|NCT02963935|585218116|FG000|Overall Study|Protocol Violation|2|||
162043799|NCT02963935|585218117|FG001|Overall Study|Protocol Violation|1|||
162043800|NCT02963935|585218116|FG000|Overall Study|Lack of Efficacy|0|||
162043801|NCT02963935|585218117|FG001|Overall Study|Lack of Efficacy|2|||
162043802|NCT02963935|585218116|FG000|Overall Study|Lost to Follow-up|1|||
162043803|NCT02963935|585218117|FG001|Overall Study|Lost to Follow-up|6|||
162005330|NCT03037385|585075808|FG002|Overall Study|Initiation of Another Therapy|0|||
162005331|NCT03037385|585075809|FG003|Overall Study|Initiation of Another Therapy|0|||
162005332|NCT03037385|585075810|FG004|Overall Study|Initiation of Another Therapy|0|||
162005333|NCT03037385|585075811|FG005|Overall Study|Initiation of Another Therapy|0|||
162005334|NCT03037385|585075812|FG006|Overall Study|Initiation of Another Therapy|0|||
162043804|NCT02963935|585218116|FG000|Overall Study|Unclassified|13|||
162043805|NCT02963935|585218117|FG001|Overall Study|Unclassified|22|||
162005335|NCT03037385|585075813|FG007|Overall Study|Initiation of Another Therapy|1|||
162005336|NCT03037385|585075814|FG008|Overall Study|Initiation of Another Therapy|0|||
162043806|NCT03911154|585218118|FG000|Overall Study|Withdrawal by Subject|1|||
162005337|NCT03037385|585075815|FG009|Overall Study|Initiation of Another Therapy|2|||
162005338|NCT03037385|585075806|FG000|Overall Study|Lost to Follow-up|0|||
162005339|NCT03037385|585075807|FG001|Overall Study|Lost to Follow-up|0|||
162005340|NCT03037385|585075808|FG002|Overall Study|Lost to Follow-up|0|||
162005341|NCT03037385|585075809|FG003|Overall Study|Lost to Follow-up|0|||
162005342|NCT03037385|585075810|FG004|Overall Study|Lost to Follow-up|0|||
162005343|NCT03037385|585075811|FG005|Overall Study|Lost to Follow-up|1|||
162005344|NCT03037385|585075812|FG006|Overall Study|Lost to Follow-up|0|||
162005345|NCT03037385|585075813|FG007|Overall Study|Lost to Follow-up|0|||
162005346|NCT03037385|585075814|FG008|Overall Study|Lost to Follow-up|0|||
162005347|NCT03037385|585075815|FG009|Overall Study|Lost to Follow-up|16|||
162005348|NCT03037385|585075806|FG000|Overall Study|Physician Decision|0|||
162005349|NCT03037385|585075807|FG001|Overall Study|Physician Decision|0|||
162005350|NCT03037385|585075808|FG002|Overall Study|Physician Decision|0|||
162005351|NCT03037385|585075809|FG003|Overall Study|Physician Decision|0|||
162005352|NCT03037385|585075810|FG004|Overall Study|Physician Decision|0|||
162005353|NCT03037385|585075811|FG005|Overall Study|Physician Decision|0|||
162005354|NCT03037385|585075812|FG006|Overall Study|Physician Decision|0|||
162005355|NCT03037385|585075813|FG007|Overall Study|Physician Decision|0|||
162005356|NCT03037385|585075814|FG008|Overall Study|Physician Decision|0|||
162005357|NCT03037385|585075815|FG009|Overall Study|Physician Decision|1|||
162005358|NCT03037385|585075806|FG000|Overall Study|Progressive Disease|0|||
162005359|NCT03037385|585075807|FG001|Overall Study|Progressive Disease|1|||
162005360|NCT03037385|585075808|FG002|Overall Study|Progressive Disease|1|||
162005361|NCT03037385|585075809|FG003|Overall Study|Progressive Disease|5|||
162005362|NCT03037385|585075810|FG004|Overall Study|Progressive Disease|2|||
162005363|NCT03037385|585075811|FG005|Overall Study|Progressive Disease|0|||
162005364|NCT03037385|585075812|FG006|Overall Study|Progressive Disease|1|||
162005365|NCT03037385|585075813|FG007|Overall Study|Progressive Disease|0|||
162005366|NCT03037385|585075814|FG008|Overall Study|Progressive Disease|0|||
162005367|NCT03037385|585075815|FG009|Overall Study|Progressive Disease|30|||
162005368|NCT03037385|585075806|FG000|Overall Study|Withdrawal by Subject|0|||
162005369|NCT03037385|585075807|FG001|Overall Study|Withdrawal by Subject|0|||
162005370|NCT03037385|585075808|FG002|Overall Study|Withdrawal by Subject|1|||
162005371|NCT03037385|585075809|FG003|Overall Study|Withdrawal by Subject|2|||
162005372|NCT03037385|585075810|FG004|Overall Study|Withdrawal by Subject|1|||
162005373|NCT03037385|585075811|FG005|Overall Study|Withdrawal by Subject|3|||
162005374|NCT03037385|585075812|FG006|Overall Study|Withdrawal by Subject|0|||
162005375|NCT03037385|585075813|FG007|Overall Study|Withdrawal by Subject|0|||
162005376|NCT03037385|585075814|FG008|Overall Study|Withdrawal by Subject|0|||
162005377|NCT03037385|585075815|FG009|Overall Study|Withdrawal by Subject|52|||
162005378|NCT03037385|585075806|FG000|Overall Study|Reason Not Specified|0|||
162005379|NCT03037385|585075807|FG001|Overall Study|Reason Not Specified|1|||
162005380|NCT03037385|585075808|FG002|Overall Study|Reason Not Specified|0|||
162005381|NCT03037385|585075809|FG003|Overall Study|Reason Not Specified|4|||
162005382|NCT03037385|585075810|FG004|Overall Study|Reason Not Specified|3|||
162005383|NCT03037385|585075811|FG005|Overall Study|Reason Not Specified|6|||
162005384|NCT03037385|585075812|FG006|Overall Study|Reason Not Specified|2|||
162005385|NCT03037385|585075813|FG007|Overall Study|Reason Not Specified|0|||
162005386|NCT03037385|585075814|FG008|Overall Study|Reason Not Specified|1|||
162005387|NCT03037385|585075815|FG009|Overall Study|Reason Not Specified|181|||
162005388|NCT02318706|585075816|FG000|Double-blind Phase|Adverse Event|7|||
162005389|NCT02318706|585075817|FG001|Double-blind Phase|Adverse Event|4|||
162005390|NCT02318706|585075818|FG002|Double-blind Phase|Adverse Event|3|||
162005391|NCT02318706|585075819|FG003|Double-blind Phase|Adverse Event|10|||
162005392|NCT02318706|585075820|FG004|Double-blind Phase|Adverse Event|0|||
162005393|NCT02318706|585075816|FG000|Double-blind Phase|Lost to Follow-up|1|||
162005394|NCT02318706|585075817|FG001|Double-blind Phase|Lost to Follow-up|0|||
162005395|NCT02318706|585075818|FG002|Double-blind Phase|Lost to Follow-up|0|||
162005396|NCT02318706|585075819|FG003|Double-blind Phase|Lost to Follow-up|0|||
162005397|NCT02318706|585075820|FG004|Double-blind Phase|Lost to Follow-up|0|||
162005398|NCT02318706|585075816|FG000|Double-blind Phase|Protocol Violation|4|||
162005399|NCT02318706|585075817|FG001|Double-blind Phase|Protocol Violation|2|||
162005400|NCT02318706|585075818|FG002|Double-blind Phase|Protocol Violation|4|||
162005401|NCT02318706|585075819|FG003|Double-blind Phase|Protocol Violation|3|||
162005402|NCT02318706|585075820|FG004|Double-blind Phase|Protocol Violation|0|||
162005403|NCT02318706|585075816|FG000|Double-blind Phase|Withdrawal by Subject|9|||
162005404|NCT02318706|585075817|FG001|Double-blind Phase|Withdrawal by Subject|5|||
162005405|NCT02318706|585075818|FG002|Double-blind Phase|Withdrawal by Subject|7|||
162005406|NCT02318706|585075819|FG003|Double-blind Phase|Withdrawal by Subject|10|||
162005407|NCT02318706|585075820|FG004|Double-blind Phase|Withdrawal by Subject|0|||
162005408|NCT02318706|585075816|FG000|Double-blind Phase|Other|4|||
162005409|NCT02318706|585075817|FG001|Double-blind Phase|Other|1|||
162005410|NCT02318706|585075818|FG002|Double-blind Phase|Other|2|||
162005411|NCT02318706|585075819|FG003|Double-blind Phase|Other|1|||
162005412|NCT02318706|585075820|FG004|Double-blind Phase|Other|0|||
162005413|NCT02318706|585075816|FG000|Double-blind Phase|Death|0|||
162005414|NCT02318706|585075817|FG001|Double-blind Phase|Death|0|||
162005415|NCT02318706|585075818|FG002|Double-blind Phase|Death|2|||
162043807|NCT05055128|585218119|FG000|Overall Study|Adverse Event|0|||
162043808|NCT05055128|585218120|FG001|Overall Study|Adverse Event|0|||
162043809|NCT05055128|585218121|FG002|Overall Study|Adverse Event|0|||
162043810|NCT05055128|585218122|FG003|Overall Study|Adverse Event|1|||
162043811|NCT05055128|585218123|FG004|Overall Study|Adverse Event|1|||
162043812|NCT05055128|585218119|FG000|Overall Study|Protocol Violation|0|||
162043813|NCT05055128|585218120|FG001|Overall Study|Protocol Violation|0|||
162043814|NCT05055128|585218121|FG002|Overall Study|Protocol Violation|0|||
162043815|NCT05055128|585218122|FG003|Overall Study|Protocol Violation|1|||
162043816|NCT05055128|585218123|FG004|Overall Study|Protocol Violation|0|||
162043817|NCT05055128|585218119|FG000|Overall Study|Withdrawal by Subject|5|||
162043818|NCT05055128|585218120|FG001|Overall Study|Withdrawal by Subject|2|||
162043819|NCT05055128|585218121|FG002|Overall Study|Withdrawal by Subject|2|||
162043820|NCT05055128|585218122|FG003|Overall Study|Withdrawal by Subject|4|||
162043821|NCT05055128|585218123|FG004|Overall Study|Withdrawal by Subject|2|||
162043822|NCT05055128|585218119|FG000|Overall Study|Randomized By Mistake|0|||
162043823|NCT05055128|585218120|FG001|Overall Study|Randomized By Mistake|1|||
162043824|NCT05055128|585218121|FG002|Overall Study|Randomized By Mistake|0|||
162043825|NCT05055128|585218122|FG003|Overall Study|Randomized By Mistake|0|||
162043826|NCT05055128|585218123|FG004|Overall Study|Randomized By Mistake|0|||
162043827|NCT05055128|585218119|FG000|Overall Study|Other|1|||
162043828|NCT05055128|585218120|FG001|Overall Study|Other|0|||
162043829|NCT05055128|585218121|FG002|Overall Study|Other|0|||
162043830|NCT05055128|585218122|FG003|Overall Study|Other|0|||
162043831|NCT05055128|585218123|FG004|Overall Study|Other|0|||
162043832|NCT00292318|585218125|FG000|Overall Study|Study terminated by officials|2|||
162043833|NCT00292318|585218126|FG001|Overall Study|Study terminated by officials|1|||
162043834|NCT01822496|585218127|FG000|Overall Study|Protocol Violation|2|||
162043835|NCT01822496|585218128|FG001|Overall Study|Protocol Violation|2|||
162043836|NCT01822496|585218129|FG002|Overall Study|Protocol Violation|0|||
162043837|NCT01822496|585218130|FG003|Overall Study|Protocol Violation|1|||
162043838|NCT01822496|585218127|FG000|Overall Study|Withdrawal by Subject|0|||
162043839|NCT01822496|585218128|FG001|Overall Study|Withdrawal by Subject|0|||
162043840|NCT01822496|585218129|FG002|Overall Study|Withdrawal by Subject|0|||
162043841|NCT01822496|585218130|FG003|Overall Study|Withdrawal by Subject|3|||
162043842|NCT03643159|585218131|FG000|Overall Study|Adverse Event|1|||
162043843|NCT03643159|585218131|FG000|Overall Study|Withdrawal by Subject|1|||
162043844|NCT00543543|585218132|FG000|Base Study|Adverse Event|1|||
162043845|NCT00543543|585218133|FG001|Base Study|Adverse Event|11|||
162043846|NCT00543543|585218134|FG002|Base Study|Adverse Event|0|||
162043847|NCT00543543|585218135|FG003|Base Study|Adverse Event|5|||
162043848|NCT00543543|585218132|FG000|Base Study|Lost to Follow-up|12|||
162043849|NCT00543543|585218133|FG001|Base Study|Lost to Follow-up|749|||
162043850|NCT00543543|585218134|FG002|Base Study|Lost to Follow-up|9|||
162043851|NCT00543543|585218135|FG003|Base Study|Lost to Follow-up|701|||
162043852|NCT00543543|585218132|FG000|Base Study|Physician Decision|0|||
162043853|NCT00543543|585218133|FG001|Base Study|Physician Decision|4|||
162043854|NCT00543543|585218134|FG002|Base Study|Physician Decision|0|||
162043855|NCT00543543|585218135|FG003|Base Study|Physician Decision|7|||
162043856|NCT00543543|585218132|FG000|Base Study|Protocol Violation|0|||
162043857|NCT00543543|585218133|FG001|Base Study|Protocol Violation|6|||
162043858|NCT00543543|585218134|FG002|Base Study|Protocol Violation|0|||
162043859|NCT00543543|585218135|FG003|Base Study|Protocol Violation|6|||
162043860|NCT00543543|585218132|FG000|Base Study|Withdrawal by Subject|7|||
162043861|NCT00543543|585218133|FG001|Base Study|Withdrawal by Subject|482|||
162043862|NCT00543543|585218134|FG002|Base Study|Withdrawal by Subject|5|||
162043863|NCT00543543|585218135|FG003|Base Study|Withdrawal by Subject|503|||
162043864|NCT00543543|585218132|FG000|Extension Study|Adverse Event|0|||
162043865|NCT00543543|585218133|FG001|Extension Study|Adverse Event|0|||
162043866|NCT00543543|585218134|FG002|Extension Study|Adverse Event|0|||
162043867|NCT00543543|585218135|FG003|Extension Study|Adverse Event|5|||
162043868|NCT00543543|585218132|FG000|Extension Study|Lost to Follow-up|0|||
162043869|NCT00543543|585218133|FG001|Extension Study|Lost to Follow-up|0|||
162043870|NCT00543543|585218134|FG002|Extension Study|Lost to Follow-up|0|||
162043871|NCT00543543|585218135|FG003|Extension Study|Lost to Follow-up|77|||
162043872|NCT00543543|585218132|FG000|Extension Study|Physician Decision|0|||
162043873|NCT00543543|585218133|FG001|Extension Study|Physician Decision|0|||
162043874|NCT00543543|585218134|FG002|Extension Study|Physician Decision|0|||
162043875|NCT00543543|585218135|FG003|Extension Study|Physician Decision|7|||
162043876|NCT00543543|585218132|FG000|Extension Study|Pregnancy|0|||
162043877|NCT00543543|585218133|FG001|Extension Study|Pregnancy|0|||
162043878|NCT00543543|585218134|FG002|Extension Study|Pregnancy|0|||
162043879|NCT00543543|585218135|FG003|Extension Study|Pregnancy|6|||
162043880|NCT00543543|585218132|FG000|Extension Study|Protocol Violation|0|||
162043881|NCT00543543|585218133|FG001|Extension Study|Protocol Violation|0|||
162043882|NCT00543543|585218134|FG002|Extension Study|Protocol Violation|0|||
162043883|NCT00543543|585218135|FG003|Extension Study|Protocol Violation|11|||
162043884|NCT00543543|585218132|FG000|Extension Study|Withdrawal by Subject|0|||
162043885|NCT00543543|585218133|FG001|Extension Study|Withdrawal by Subject|0|||
162043886|NCT00543543|585218134|FG002|Extension Study|Withdrawal by Subject|0|||
162043887|NCT00543543|585218135|FG003|Extension Study|Withdrawal by Subject|120|||
162043888|NCT00945555|585218136|FG000|Overall Study|Referred to another hospital|5|||
162043889|NCT00945555|585218136|FG000|Overall Study|Worsening condition, intensive care unit|1|||
162043890|NCT00945555|585218136|FG000|Overall Study|Withdrawal by Subject|2|||
162043891|NCT00945555|585218136|FG000|Overall Study|Participant continued treatment at home|1|||
162043892|NCT00945555|585218136|FG000|Overall Study|Death|18|||
162043893|NCT00945555|585218136|FG000|Overall Study|Other|1|||
162043894|NCT04502979|585218137|FG000|Overall Study|Lost to Follow-up|1|||
162043895|NCT04502979|585218138|FG001|Overall Study|Lost to Follow-up|3|||
162043896|NCT04502979|585218137|FG000|Overall Study|Withdrawal by Subject|2|||
162043897|NCT04502979|585218138|FG001|Overall Study|Withdrawal by Subject|1|||
162043898|NCT00586625|585218142|FG000|Overall Study|Adverse Event|6|||
162043899|NCT00586625|585218143|FG001|Overall Study|Adverse Event|6|||
162043900|NCT00586625|585218142|FG000|Overall Study|Protocol Violation|3|||
162043901|NCT00586625|585218143|FG001|Overall Study|Protocol Violation|0|||
162043902|NCT00586625|585218142|FG000|Overall Study|Withdrawal by Subject|32|||
162043903|NCT00586625|585218143|FG001|Overall Study|Withdrawal by Subject|10|||
162043904|NCT00586625|585218142|FG000|Overall Study|Subject non-compliance|0|||
162043905|NCT00586625|585218143|FG001|Overall Study|Subject non-compliance|1|||
162043906|NCT00586625|585218142|FG000|Overall Study|Subject unable to return for visit|2|||
162043907|NCT00586625|585218143|FG001|Overall Study|Subject unable to return for visit|0|||
162043908|NCT02906332|585218146|FG000|Overall Study|Withdrawal by Subject|1|||
162043909|NCT00165984|585218147|FG000|Overall Study|Death|15|||
162043910|NCT03945266|585218151|FG000|Overall Study|Withdrawal by Subject|1|||
162043911|NCT03945266|585218152|FG001|Overall Study|Withdrawal by Subject|0|||
162043912|NCT03945266|585218151|FG000|Overall Study|Miscarriage|0|||
162005416|NCT02318706|585075819|FG003|Double-blind Phase|Death|0|||
162005417|NCT02318706|585075820|FG004|Double-blind Phase|Death|0|||
162005418|NCT02318706|585075816|FG000|Open-label Extension Phase|Adverse Event|0|||
162005419|NCT02318706|585075817|FG001|Open-label Extension Phase|Adverse Event|0|||
162005420|NCT02318706|585075818|FG002|Open-label Extension Phase|Adverse Event|0|||
162005421|NCT02318706|585075819|FG003|Open-label Extension Phase|Adverse Event|0|||
162043913|NCT03945266|585218152|FG001|Overall Study|Miscarriage|2|||
162043914|NCT03945266|585218151|FG000|Overall Study|Lost to Follow-up|1|||
162043915|NCT03945266|585218152|FG001|Overall Study|Lost to Follow-up|0|||
162043916|NCT01686828|585218153|FG000|Overall Study|Physician Decision|1|||
162043917|NCT01686828|585218154|FG001|Overall Study|Physician Decision|0|||
162043918|NCT01686828|585218155|FG002|Overall Study|Physician Decision|0|||
162043919|NCT01686828|585218156|FG003|Overall Study|Physician Decision|0|||
162043920|NCT01686828|585218153|FG000|Overall Study|New Job|0|||
162043921|NCT01686828|585218154|FG001|Overall Study|New Job|1|||
162043922|NCT01686828|585218155|FG002|Overall Study|New Job|0|||
162043923|NCT01686828|585218156|FG003|Overall Study|New Job|0|||
162043924|NCT01686828|585218153|FG000|Overall Study|Weight Loss|0|||
162043925|NCT01686828|585218154|FG001|Overall Study|Weight Loss|0|||
162043926|NCT01686828|585218155|FG002|Overall Study|Weight Loss|1|||
162043927|NCT01686828|585218156|FG003|Overall Study|Weight Loss|0|||
162043928|NCT02734433|585218159|FG000|Overall Study|Disease progression|1|||
162043929|NCT02734433|585218160|FG001|Overall Study|Disease progression|5|||
162043930|NCT02734433|585218159|FG000|Overall Study|Clinical progression|0|||
162043931|NCT02734433|585218160|FG001|Overall Study|Clinical progression|1|||
162043932|NCT02734433|585218159|FG000|Overall Study|Withdrawal by Subject|1|||
162043933|NCT02734433|585218160|FG001|Overall Study|Withdrawal by Subject|2|||
162043934|NCT04916769|585218167|FG000|Period 1|Physician Decision|0|||
162043935|NCT04916769|585218168|FG001|Period 1|Physician Decision|0|||
162043936|NCT04916769|585218169|FG002|Period 1|Physician Decision|0|||
162043937|NCT04916769|585218170|FG003|Period 1|Physician Decision|0|||
162043938|NCT04916769|585218171|FG004|Period 1|Physician Decision|0|||
162043939|NCT04916769|585218172|FG005|Period 1|Physician Decision|1|||
162043940|NCT04916769|585218167|FG000|Period 2|Physician Decision|0|||
162005422|NCT02318706|585075820|FG004|Open-label Extension Phase|Adverse Event|21|||
162005423|NCT02318706|585075816|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
162005424|NCT02318706|585075817|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
162005425|NCT02318706|585075818|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
162043941|NCT04916769|585218168|FG001|Period 2|Physician Decision|1|||
162043942|NCT04916769|585218169|FG002|Period 2|Physician Decision|0|||
162043943|NCT04916769|585218170|FG003|Period 2|Physician Decision|0|||
162043944|NCT04916769|585218171|FG004|Period 2|Physician Decision|0|||
162043945|NCT04916769|585218172|FG005|Period 2|Physician Decision|0|||
162043946|NCT04941456|585218185|FG000|Overall Study|Withdrawal by Subject|1|||
162043947|NCT04941456|585218186|FG001|Overall Study|Withdrawal by Subject|0|||
162043948|NCT04941456|585218185|FG000|Overall Study|Protocol Violation|1|||
162043949|NCT04941456|585218186|FG001|Overall Study|Protocol Violation|0|||
162043950|NCT05628103|585218192|FG000|Overall Study|Adverse Event|7|||
162043951|NCT05628103|585218192|FG000|Overall Study|Withdrawal by Subject|3|||
162043952|NCT05628103|585218192|FG000|Overall Study|Lost to Follow-up|3|||
162043953|NCT05628103|585218192|FG000|Overall Study|Lack of Efficacy|1|||
162043954|NCT05628103|585218192|FG000|Overall Study|Non-Compliance With Study Drug|4|||
162043955|NCT04840888|585218193|FG000|Period 1|Withdrawal by Subject|0|||
162005426|NCT02318706|585075819|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
162005427|NCT02318706|585075820|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
162005428|NCT02318706|585075816|FG000|Open-label Extension Phase|Death|0|||
162043956|NCT04840888|585218194|FG001|Period 1|Withdrawal by Subject|0|||
162043957|NCT04840888|585218195|FG002|Period 1|Withdrawal by Subject|0|||
162043958|NCT04840888|585218196|FG003|Period 1|Withdrawal by Subject|0|||
162043959|NCT04840888|585218197|FG004|Period 1|Withdrawal by Subject|1|||
162043960|NCT04840888|585218198|FG005|Period 1|Withdrawal by Subject|0|||
162043961|NCT04840888|585218193|FG000|Period 1|Adverse Event|0|||
162043962|NCT04840888|585218194|FG001|Period 1|Adverse Event|0|||
162043963|NCT04840888|585218195|FG002|Period 1|Adverse Event|1|||
162043964|NCT04840888|585218196|FG003|Period 1|Adverse Event|1|||
162043965|NCT04840888|585218197|FG004|Period 1|Adverse Event|10|||
162043966|NCT04840888|585218198|FG005|Period 1|Adverse Event|1|||
162043967|NCT02719327|585218201|FG000|Overall Study|Withdrawal by Subject|11|||
162043968|NCT02719327|585218202|FG001|Overall Study|Withdrawal by Subject|8|||
162043969|NCT04340193|585218203|FG000|Overall Study|Other reason|0|||
162043970|NCT04340193|585218204|FG001|Overall Study|Other reason|0|||
162043971|NCT04340193|585218205|FG002|Overall Study|Other reason|1|||
162043972|NCT04340193|585218203|FG000|Overall Study|Disease recurrence|0|||
162043973|NCT04340193|585218204|FG001|Overall Study|Disease recurrence|1|||
162043974|NCT04340193|585218205|FG002|Overall Study|Disease recurrence|0|||
162043975|NCT04340193|585218203|FG000|Overall Study|Study drug toxicity|1|||
162043976|NCT04340193|585218204|FG001|Overall Study|Study drug toxicity|0|||
162043977|NCT04340193|585218205|FG002|Overall Study|Study drug toxicity|0|||
162043978|NCT04340193|585218203|FG000|Overall Study|Disease progression|1|||
162043979|NCT04340193|585218204|FG001|Overall Study|Disease progression|2|||
162043980|NCT04340193|585218205|FG002|Overall Study|Disease progression|3|||
162043981|NCT04340193|585218203|FG000|Overall Study|Administrative reasons by sponsor|0|||
162043982|NCT04340193|585218204|FG001|Overall Study|Administrative reasons by sponsor|1|||
162043983|NCT04340193|585218205|FG002|Overall Study|Administrative reasons by sponsor|0|||
162043984|NCT04340193|585218203|FG000|Overall Study|Adverse Event|1|||
162043985|NCT04340193|585218204|FG001|Overall Study|Adverse Event|1|||
162043986|NCT04340193|585218205|FG002|Overall Study|Adverse Event|0|||
162043987|NCT04063384|585219569|FG000|Overall Study|placebo manipulation issue|1|||
162043988|NCT04063384|585219570|FG001|Overall Study|placebo manipulation issue|2|||
162005429|NCT02318706|585075817|FG001|Open-label Extension Phase|Death|0|||
162005430|NCT02318706|585075818|FG002|Open-label Extension Phase|Death|0|||
162005431|NCT02318706|585075819|FG003|Open-label Extension Phase|Death|0|||
162005432|NCT02318706|585075820|FG004|Open-label Extension Phase|Death|1|||
162005433|NCT02318706|585075816|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
162005434|NCT02318706|585075817|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
162005435|NCT02318706|585075818|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
162005436|NCT02318706|585075819|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
162005437|NCT02318706|585075820|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
162005438|NCT04328077|585075821|FG000|Overall Study|Lost to Follow-up|0|||
162005439|NCT04328077|585075822|FG001|Overall Study|Lost to Follow-up|1|||
162005440|NCT04328077|585075823|FG002|Overall Study|Lost to Follow-up|0|||
162005441|NCT04328077|585075824|FG003|Overall Study|Lost to Follow-up|0|||
162005442|NCT04328077|585075821|FG000|Overall Study|Withdrawal by Subject|0|||
162005443|NCT04328077|585075822|FG001|Overall Study|Withdrawal by Subject|1|||
162005444|NCT04328077|585075823|FG002|Overall Study|Withdrawal by Subject|1|||
162005445|NCT04328077|585075824|FG003|Overall Study|Withdrawal by Subject|3|||
162005446|NCT01456039|585075825|FG000|Phase 1 (First Step)|Disease Progression|1|||
162005447|NCT01456039|585075826|FG001|Phase 1 (First Step)|Disease Progression|1|||
162005448|NCT01456039|585075827|FG002|Phase 1 (First Step)|Disease Progression|0|||
162005449|NCT01456039|585075825|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
162005450|NCT01456039|585075826|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
162005451|NCT01456039|585075827|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
162005452|NCT01456039|585075825|FG000|Phase 1 (First Step)|Adverse Event|0|||
162005453|NCT01456039|585075826|FG001|Phase 1 (First Step)|Adverse Event|3|||
162043989|NCT04063384|585219571|FG002|Overall Study|placebo manipulation issue|1|||
162043990|NCT04063384|585219572|FG003|Overall Study|placebo manipulation issue|1|||
162043991|NCT03894046|585219578|FG000|Overall Study|Protocol Violation|1|||
162043992|NCT03894046|585219579|FG001|Overall Study|Protocol Violation|0|||
162043993|NCT03894046|585219580|FG002|Overall Study|Protocol Violation|0|||
162043994|NCT03894046|585219578|FG000|Overall Study|Adverse Event|0|||
162043995|NCT03894046|585219579|FG001|Overall Study|Adverse Event|1|||
162043996|NCT03894046|585219580|FG002|Overall Study|Adverse Event|0|||
162043997|NCT03894046|585219578|FG000|Overall Study|Withdrawal by Subject|2|||
162005454|NCT01456039|585075827|FG002|Phase 1 (First Step)|Adverse Event|0|||
162005455|NCT01456039|585075825|FG000|Phase 1 (First Step)|Other|0|||
162005456|NCT01456039|585075826|FG001|Phase 1 (First Step)|Other|1|||
162043998|NCT03894046|585219579|FG001|Overall Study|Withdrawal by Subject|3|||
162043999|NCT03894046|585219580|FG002|Overall Study|Withdrawal by Subject|1|||
162044000|NCT03894046|585219578|FG000|Overall Study|Death|15|||
162044001|NCT03894046|585219579|FG001|Overall Study|Death|21|||
162044002|NCT03894046|585219580|FG002|Overall Study|Death|4|||
162005457|NCT01456039|585075827|FG002|Phase 1 (First Step)|Other|0|||
162005458|NCT01456039|585075825|FG000|Phase 2 (Second Step)|Disease Progression|0|||
162005459|NCT01456039|585075826|FG001|Phase 2 (Second Step)|Disease Progression|0|||
162005460|NCT01456039|585075827|FG002|Phase 2 (Second Step)|Disease Progression|17|||
162005461|NCT01456039|585075825|FG000|Phase 2 (Second Step)|Adverse Event|0|||
162005462|NCT01456039|585075826|FG001|Phase 2 (Second Step)|Adverse Event|0|||
162005463|NCT01456039|585075827|FG002|Phase 2 (Second Step)|Adverse Event|10|||
162005464|NCT01456039|585075825|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
162005465|NCT01456039|585075826|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
162005466|NCT01456039|585075827|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
162005467|NCT01456039|585075825|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
162005468|NCT01456039|585075826|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
162005469|NCT01456039|585075827|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
162005470|NCT01456039|585075825|FG000|Phase 2 (Second Step)|Other|0|||
162005471|NCT01456039|585075826|FG001|Phase 2 (Second Step)|Other|0|||
162005472|NCT01456039|585075827|FG002|Phase 2 (Second Step)|Other|1|||
162005473|NCT01702311|585075831|FG000|Overall Study|Withdrawal by Subject|3|||
162005474|NCT01702311|585075832|FG001|Overall Study|Withdrawal by Subject|2|||
162005475|NCT01702311|585075831|FG000|Overall Study|Discharge less than 24 hours|10|||
162005476|NCT01702311|585075832|FG001|Overall Study|Discharge less than 24 hours|7|||
162005477|NCT01702311|585075831|FG000|Overall Study|Physician Decision|3|||
162005478|NCT01702311|585075832|FG001|Overall Study|Physician Decision|4|||
162005479|NCT04106557|585075839|FG000|Overall Study|Physician Decision|0|||
162005480|NCT04106557|585075840|FG001|Overall Study|Physician Decision|1|||
162005481|NCT04106557|585075841|FG002|Overall Study|Physician Decision|0|||
162005482|NCT04106557|585075839|FG000|Overall Study|Protocol Violation|0|||
162005483|NCT04106557|585075840|FG001|Overall Study|Protocol Violation|1|||
162005484|NCT04106557|585075841|FG002|Overall Study|Protocol Violation|0|||
162005485|NCT02326155|585075842|FG000|Overall Study|Adverse Event|21|||
162005486|NCT02326155|585075843|FG001|Overall Study|Adverse Event|5|||
162005487|NCT02326155|585075842|FG000|Overall Study|Death|3|||
162005488|NCT02326155|585075843|FG001|Overall Study|Death|0|||
162005489|NCT02326155|585075842|FG000|Overall Study|Lack of Efficacy|49|||
162005490|NCT02326155|585075843|FG001|Overall Study|Lack of Efficacy|5|||
162005491|NCT02326155|585075842|FG000|Overall Study|Lost to Follow-up|14|||
162005492|NCT02326155|585075843|FG001|Overall Study|Lost to Follow-up|3|||
162005493|NCT02326155|585075842|FG000|Overall Study|Protocol Violation|2|||
162005494|NCT02326155|585075843|FG001|Overall Study|Protocol Violation|0|||
162005495|NCT02326155|585075842|FG000|Overall Study|Withdrawal by Subject|34|||
162005496|NCT02326155|585075843|FG001|Overall Study|Withdrawal by Subject|11|||
162005497|NCT02326155|585075842|FG000|Overall Study|Disease progression|37|||
162005498|NCT02326155|585075843|FG001|Overall Study|Disease progression|4|||
162005499|NCT02326155|585075842|FG000|Overall Study|Study close|188|||
162005500|NCT02326155|585075843|FG001|Overall Study|Study close|21|||
162005501|NCT02326155|585075842|FG000|Overall Study|except for study close|46|||
162005502|NCT02326155|585075843|FG001|Overall Study|except for study close|13|||
162005503|NCT00313014|585075844|FG000|Overall Study|Withdrawal by Subject|11|||
162005504|NCT00313014|585075845|FG001|Overall Study|Withdrawal by Subject|7|||
162005505|NCT00313014|585075846|FG002|Overall Study|Withdrawal by Subject|5|||
162005506|NCT00313014|585075844|FG000|Overall Study|Adverse Event|14|||
162005507|NCT00313014|585075845|FG001|Overall Study|Adverse Event|29|||
162005508|NCT00313014|585075846|FG002|Overall Study|Adverse Event|16|||
162005509|NCT00313014|585075844|FG000|Overall Study|Lost to Follow-up|7|||
162005510|NCT00313014|585075845|FG001|Overall Study|Lost to Follow-up|6|||
162005511|NCT00313014|585075846|FG002|Overall Study|Lost to Follow-up|10|||
162005512|NCT00313014|585075844|FG000|Overall Study|Administrative|9|||
162005513|NCT00313014|585075845|FG001|Overall Study|Administrative|6|||
162005514|NCT00313014|585075846|FG002|Overall Study|Administrative|14|||
162005515|NCT00313014|585075844|FG000|Overall Study|Lack of Efficacy|52|||
162005516|NCT00313014|585075845|FG001|Overall Study|Lack of Efficacy|25|||
162005517|NCT00313014|585075846|FG002|Overall Study|Lack of Efficacy|16|||
162005518|NCT01428258|585075852|FG000|Intervention 1|Withdrawal by Subject|2|||
162005519|NCT01428258|585075853|FG001|Intervention 1|Withdrawal by Subject|0|||
162005520|NCT02939287|585075859|FG000|Overall Study|met exclusion criteria|1|||
162005521|NCT02939287|585075860|FG001|Overall Study|met exclusion criteria|1|||
162005522|NCT02939287|585075861|FG002|Overall Study|met exclusion criteria|1|||
162005523|NCT02939287|585075859|FG000|Overall Study|Did not complete survey|2|||
162005524|NCT02939287|585075860|FG001|Overall Study|Did not complete survey|2|||
162005525|NCT02939287|585075861|FG002|Overall Study|Did not complete survey|0|||
162005526|NCT02939287|585075859|FG000|Overall Study|Withdrawal by Subject|1|||
162005527|NCT02939287|585075860|FG001|Overall Study|Withdrawal by Subject|1|||
162005528|NCT02939287|585075861|FG002|Overall Study|Withdrawal by Subject|0|||
162005529|NCT02476617|585075863|FG000|Overall Study|Adverse Event|1|||
162005530|NCT02476617|585075863|FG000|Overall Study|Lost to Follow-up|1|||
162005531|NCT01383928|585075864|FG000|Overall Study|Initiation of ASCT|2|||
162005532|NCT01383928|585075865|FG001|Overall Study|Initiation of ASCT|1|||
162005533|NCT01383928|585075866|FG002|Overall Study|Initiation of ASCT|18|||
162005534|NCT01383928|585075864|FG000|Overall Study|Adverse Event|1|||
162044003|NCT03894046|585219578|FG000|Overall Study|No growth of ABC|2|||
162044004|NCT03894046|585219579|FG001|Overall Study|No growth of ABC|1|||
162044005|NCT03894046|585219580|FG002|Overall Study|No growth of ABC|0|||
162044006|NCT03894046|585219578|FG000|Overall Study|Physician Decision|1|||
162044007|NCT03894046|585219579|FG001|Overall Study|Physician Decision|1|||
162044008|NCT03894046|585219580|FG002|Overall Study|Physician Decision|1|||
162044009|NCT03894046|585219578|FG000|Overall Study|Prohibited concomitant medication|1|||
162044010|NCT03894046|585219579|FG001|Overall Study|Prohibited concomitant medication|0|||
162044011|NCT03894046|585219580|FG002|Overall Study|Prohibited concomitant medication|0|||
162044012|NCT03894046|585219578|FG000|Overall Study|Transferred to other arm/group|1|||
162044013|NCT03894046|585219579|FG001|Overall Study|Transferred to other arm/group|1|||
162044014|NCT03894046|585219580|FG002|Overall Study|Transferred to other arm/group|0|||
162044015|NCT03270644|585219583|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
162044016|NCT03270644|585219583|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
162044017|NCT00004635|585219584|FG000|Period One|refused|2|||
162044018|NCT00004635|585219585|FG001|Period One|refused|1|||
162044019|NCT00004635|585219584|FG000|Period One|Withdrawal by Subject|1|||
162044020|NCT00004635|585219585|FG001|Period One|Withdrawal by Subject|1|||
162044021|NCT00004635|585219584|FG000|Period One|Protocol Violation|1|||
162044022|NCT00004635|585219585|FG001|Period One|Protocol Violation|0|||
162044023|NCT00004635|585219584|FG000|Period One|PSA did not go <5 ng/mL|1|||
162044024|NCT00004635|585219585|FG001|Period One|PSA did not go <5 ng/mL|0|||
162044025|NCT00004635|585219584|FG000|Period One|second malignancy|1|||
162044026|NCT00004635|585219585|FG001|Period One|second malignancy|0|||
162044027|NCT00004635|585219584|FG000|Period One|progressed|0|||
162044028|NCT00004635|585219585|FG001|Period One|progressed|2|||
162044029|NCT00004635|585219584|FG000|Period One|health problem|0|||
162044030|NCT00004635|585219585|FG001|Period One|health problem|1|||
162044031|NCT00004635|585219584|FG000|Period One|discrepancy in data entry|0|||
162044032|NCT00004635|585219585|FG001|Period One|discrepancy in data entry|1|||
162044033|NCT00004635|585219584|FG000|Period Two|progression|2|||
162044034|NCT00004635|585219585|FG001|Period Two|progression|3|||
162044035|NCT00004635|585219584|FG000|Period Two|Adverse Event|1|||
162044036|NCT00004635|585219585|FG001|Period Two|Adverse Event|0|||
162044037|NCT00004635|585219584|FG000|Period Two|refused|0|||
162044038|NCT00004635|585219585|FG001|Period Two|refused|2|||
162044039|NCT00004635|585219584|FG000|Period Two|health problem|1|||
162044040|NCT00004635|585219585|FG001|Period Two|health problem|1|||
162044041|NCT00004635|585219584|FG000|Period Two|travel issues|0|||
162044042|NCT00004635|585219585|FG001|Period Two|travel issues|1|||
162044043|NCT00004635|585219584|FG000|Period Two|secondary malignancy|1|||
162044044|NCT00004635|585219585|FG001|Period Two|secondary malignancy|1|||
162044045|NCT00004635|585219584|FG000|Period Two|Lost to Follow-up|1|||
162044046|NCT00004635|585219585|FG001|Period Two|Lost to Follow-up|0|||
162044047|NCT00004635|585219584|FG000|Period Two|discrepancy in data entry|0|||
162044048|NCT00004635|585219585|FG001|Period Two|discrepancy in data entry|1|||
162044049|NCT00191906|585219586|FG000|Study Period II|Adverse Event|0|||
162044050|NCT00191906|585219587|FG001|Study Period II|Adverse Event|1|||
162044051|NCT00191906|585219588|FG002|Study Period II|Adverse Event|0|||
162044052|NCT00191906|585219589|FG003|Study Period II|Adverse Event|0|||
162044053|NCT00191906|585219586|FG000|Study Period II|Withdrawal by Subject|0|||
162044054|NCT00191906|585219587|FG001|Study Period II|Withdrawal by Subject|3|||
162044055|NCT00191906|585219588|FG002|Study Period II|Withdrawal by Subject|0|||
162044056|NCT00191906|585219589|FG003|Study Period II|Withdrawal by Subject|0|||
162044057|NCT00191906|585219586|FG000|Study Period II|Parent/Caregiver Decision|0|||
162044058|NCT00191906|585219587|FG001|Study Period II|Parent/Caregiver Decision|1|||
162044059|NCT00191906|585219588|FG002|Study Period II|Parent/Caregiver Decision|0|||
162044060|NCT00191906|585219589|FG003|Study Period II|Parent/Caregiver Decision|0|||
162044061|NCT00191906|585219586|FG000|Study Period II|Entry Criteria Exclusion|0|||
162044062|NCT00191906|585219587|FG001|Study Period II|Entry Criteria Exclusion|0|||
162044063|NCT00191906|585219588|FG002|Study Period II|Entry Criteria Exclusion|1|||
162044064|NCT00191906|585219589|FG003|Study Period II|Entry Criteria Exclusion|0|||
162044065|NCT00191906|585219586|FG000|Study Period III|Adverse Event|1|||
162044066|NCT00191906|585219587|FG001|Study Period III|Adverse Event|0|||
162044067|NCT00191906|585219588|FG002|Study Period III|Adverse Event|0|||
162044068|NCT00191906|585219589|FG003|Study Period III|Adverse Event|0|||
162044069|NCT00191906|585219586|FG000|Study Period III|Lost to Follow-up|0|||
162044070|NCT00191906|585219587|FG001|Study Period III|Lost to Follow-up|1|||
162044071|NCT00191906|585219588|FG002|Study Period III|Lost to Follow-up|0|||
162044072|NCT00191906|585219589|FG003|Study Period III|Lost to Follow-up|0|||
162044073|NCT00191906|585219586|FG000|Study Period III|Parent/Caregiver Decision|1|||
162044074|NCT00191906|585219587|FG001|Study Period III|Parent/Caregiver Decision|0|||
162044075|NCT00191906|585219588|FG002|Study Period III|Parent/Caregiver Decision|0|||
162044076|NCT00191906|585219589|FG003|Study Period III|Parent/Caregiver Decision|0|||
162044077|NCT00191906|585219586|FG000|Study Period III|Lack of Efficacy|3|||
162044078|NCT00191906|585219587|FG001|Study Period III|Lack of Efficacy|3|||
162044079|NCT00191906|585219588|FG002|Study Period III|Lack of Efficacy|0|||
162044080|NCT00191906|585219589|FG003|Study Period III|Lack of Efficacy|0|||
162044081|NCT00573937|585219590|FG000|Overall Study|Study Terminated|0|||
162005535|NCT01383928|585075865|FG001|Overall Study|Adverse Event|2|||
162005536|NCT01383928|585075866|FG002|Overall Study|Adverse Event|8|||
162005537|NCT01383928|585075864|FG000|Overall Study|Other|1|||
162005538|NCT01383928|585075865|FG001|Overall Study|Other|3|||
162005539|NCT01383928|585075866|FG002|Overall Study|Other|4|||
162005540|NCT01383928|585075864|FG000|Overall Study|Progressive Disease|1|||
162005541|NCT01383928|585075865|FG001|Overall Study|Progressive Disease|1|||
162005542|NCT01383928|585075866|FG002|Overall Study|Progressive Disease|5|||
162005543|NCT01383928|585075864|FG000|Overall Study|Withdrawal by Subject|0|||
162005544|NCT01383928|585075865|FG001|Overall Study|Withdrawal by Subject|0|||
162005545|NCT01383928|585075866|FG002|Overall Study|Withdrawal by Subject|4|||
162005546|NCT01383928|585075864|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
162005547|NCT01383928|585075865|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
162005548|NCT01383928|585075866|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
162005549|NCT03486912|585075867|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
162005550|NCT03486912|585075868|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
162005551|NCT03486912|585075869|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
162005552|NCT03486912|585075870|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
162005553|NCT03486912|585075867|FG000|Treatment Period|Withdrawal by Subject|3|||
162005554|NCT03486912|585075868|FG001|Treatment Period|Withdrawal by Subject|3|||
162005555|NCT03486912|585075869|FG002|Treatment Period|Withdrawal by Subject|3|||
162005556|NCT03486912|585075870|FG003|Treatment Period|Withdrawal by Subject|2|||
162005557|NCT03486912|585075867|FG000|Treatment Period|Other Reasons|0|||
162005558|NCT03486912|585075868|FG001|Treatment Period|Other Reasons|2|||
162005559|NCT03486912|585075869|FG002|Treatment Period|Other Reasons|1|||
162005560|NCT03486912|585075870|FG003|Treatment Period|Other Reasons|1|||
162005561|NCT03486912|585075867|FG000|Treatment Period|Adverse Event|0|||
162005562|NCT03486912|585075868|FG001|Treatment Period|Adverse Event|1|||
162005563|NCT03486912|585075869|FG002|Treatment Period|Adverse Event|1|||
162005564|NCT03486912|585075870|FG003|Treatment Period|Adverse Event|0|||
162005565|NCT03486912|585075867|FG000|Treatment Period|Lost to Follow-up|1|||
162005566|NCT03486912|585075868|FG001|Treatment Period|Lost to Follow-up|0|||
162005567|NCT03486912|585075869|FG002|Treatment Period|Lost to Follow-up|0|||
162005568|NCT03486912|585075870|FG003|Treatment Period|Lost to Follow-up|2|||
162005569|NCT02491684|585075871|FG000|Treatment Phase|Adverse Event|2|||
162005570|NCT02491684|585075872|FG001|Treatment Phase|Adverse Event|2|||
162005571|NCT02491684|585075871|FG000|Treatment Phase|Incorrect randomisation|1|||
162005572|NCT02491684|585075872|FG001|Treatment Phase|Incorrect randomisation|0|||
162005573|NCT02491684|585075871|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
162005574|NCT02491684|585075872|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
162005575|NCT01499940|585075873|FG000|Overall Study|Study was withdrawn before completion.|9|||
162005576|NCT04739982|585075875|FG000|Overall Study|Lost to Follow-up|176|||
162005577|NCT04739982|585075876|FG001|Overall Study|Lost to Follow-up|65|||
162005578|NCT04739982|585075875|FG000|Overall Study|Withdrawal by Subject|19|||
162005579|NCT04739982|585075876|FG001|Overall Study|Withdrawal by Subject|0|||
162005580|NCT04739982|585075875|FG000|Overall Study|Protocol Violation|0|||
162005581|NCT04739982|585075876|FG001|Overall Study|Protocol Violation|5|||
162005582|NCT04914364|585075878|FG000|Overall Study|No longer eligible for study|1|||
162005583|NCT04914364|585075878|FG000|Overall Study|Lost to Follow-up|2|||
162005584|NCT00537394|585075879|FG000|First Year of Follow-up|Death|7|||
162005585|NCT00537394|585075880|FG001|First Year of Follow-up|Death|0|||
162005586|NCT00537394|585075881|FG002|First Year of Follow-up|Death|0|||
162005587|NCT00537394|585075879|FG000|First Year of Follow-up|Severe debilitation|1|||
162005588|NCT00537394|585075880|FG001|First Year of Follow-up|Severe debilitation|0|||
162005589|NCT00537394|585075881|FG002|First Year of Follow-up|Severe debilitation|1|||
162005590|NCT00537394|585075879|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
162005591|NCT00537394|585075880|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
162005592|NCT00537394|585075881|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
162005593|NCT00537394|585075879|FG000|First Year of Follow-up|Lost to Follow-up|1|||
162005594|NCT00537394|585075880|FG001|First Year of Follow-up|Lost to Follow-up|5|||
162005595|NCT00537394|585075881|FG002|First Year of Follow-up|Lost to Follow-up|1|||
162005596|NCT00537394|585075879|FG000|2nd Year of Follow-up|Death|4|||
162005597|NCT00537394|585075880|FG001|2nd Year of Follow-up|Death|1|||
162005598|NCT00537394|585075881|FG002|2nd Year of Follow-up|Death|2|||
162005599|NCT00537394|585075879|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
162005600|NCT00537394|585075880|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
162005601|NCT00537394|585075881|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
162005602|NCT00537394|585075879|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
162005603|NCT00537394|585075880|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
162044082|NCT00573937|585219591|FG001|Overall Study|Study Terminated|1|||
162044083|NCT02476201|585219592|FG000|Overall Study|Unable to program MPP|9|||
162005604|NCT00537394|585075881|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
162005605|NCT00537394|585075879|FG000|2nd Year of Follow-up|Clinic site closure|1|||
162005606|NCT00537394|585075880|FG001|2nd Year of Follow-up|Clinic site closure|0|||
162005607|NCT00537394|585075881|FG002|2nd Year of Follow-up|Clinic site closure|0|||
162005608|NCT01283139|585075882|FG000|Overall Study|Lost to Follow-up|5|||
162005609|NCT01283139|585075883|FG001|Overall Study|Lost to Follow-up|2|||
162005610|NCT01283139|585075884|FG002|Overall Study|Lost to Follow-up|3|||
162005611|NCT01283139|585075885|FG003|Overall Study|Lost to Follow-up|1|||
162005612|NCT01283139|585075882|FG000|Overall Study|Withdrawal by Subject|8|||
162005613|NCT01283139|585075883|FG001|Overall Study|Withdrawal by Subject|8|||
162005614|NCT01283139|585075884|FG002|Overall Study|Withdrawal by Subject|6|||
162005615|NCT01283139|585075885|FG003|Overall Study|Withdrawal by Subject|8|||
162005616|NCT01283139|585075882|FG000|Overall Study|Death|2|||
162005617|NCT01283139|585075883|FG001|Overall Study|Death|0|||
162005618|NCT01283139|585075884|FG002|Overall Study|Death|2|||
162005619|NCT01283139|585075885|FG003|Overall Study|Death|2|||
162005620|NCT01283139|585075882|FG000|Overall Study|Lack of Efficacy|1|||
162005621|NCT01283139|585075883|FG001|Overall Study|Lack of Efficacy|2|||
162005622|NCT01283139|585075884|FG002|Overall Study|Lack of Efficacy|2|||
162005623|NCT01283139|585075885|FG003|Overall Study|Lack of Efficacy|1|||
162005624|NCT01283139|585075882|FG000|Overall Study|Early termination due to AE/SAE|1|||
162005625|NCT01283139|585075883|FG001|Overall Study|Early termination due to AE/SAE|1|||
162005626|NCT01283139|585075884|FG002|Overall Study|Early termination due to AE/SAE|0|||
162005627|NCT01283139|585075885|FG003|Overall Study|Early termination due to AE/SAE|0|||
162005628|NCT01283139|585075882|FG000|Overall Study|Participant's refusal to continue|0|||
162005629|NCT01283139|585075883|FG001|Overall Study|Participant's refusal to continue|3|||
162005630|NCT01283139|585075884|FG002|Overall Study|Participant's refusal to continue|1|||
162005631|NCT01283139|585075885|FG003|Overall Study|Participant's refusal to continue|1|||
162005632|NCT01283139|585075882|FG000|Overall Study|Pregnancy|0|||
162005633|NCT01283139|585075883|FG001|Overall Study|Pregnancy|1|||
162005634|NCT01283139|585075884|FG002|Overall Study|Pregnancy|1|||
162005635|NCT01283139|585075885|FG003|Overall Study|Pregnancy|0|||
162005636|NCT01283139|585075882|FG000|Overall Study|Missed follow-up visit|0|||
162005637|NCT01283139|585075883|FG001|Overall Study|Missed follow-up visit|1|||
162005638|NCT01283139|585075884|FG002|Overall Study|Missed follow-up visit|2|||
162005639|NCT01283139|585075885|FG003|Overall Study|Missed follow-up visit|2|||
162005640|NCT01283139|585075882|FG000|Overall Study|Participant randomized in error|0|||
162005641|NCT01283139|585075883|FG001|Overall Study|Participant randomized in error|0|||
162005642|NCT01283139|585075884|FG002|Overall Study|Participant randomized in error|1|||
162005643|NCT01283139|585075885|FG003|Overall Study|Participant randomized in error|0|||
162005644|NCT01056822|585075890|FG000|Overall Study|Adverse Event|0|||
162005645|NCT01056822|585075891|FG001|Overall Study|Adverse Event|1|||
162005646|NCT01056822|585075890|FG000|Overall Study|Protocol Violation|6|||
162005647|NCT01056822|585075891|FG001|Overall Study|Protocol Violation|5|||
162005648|NCT01056822|585075890|FG000|Overall Study|Withdrawal by Subject|1|||
162005649|NCT01056822|585075891|FG001|Overall Study|Withdrawal by Subject|1|||
162005650|NCT01056822|585075890|FG000|Overall Study|Lost to Follow-up|1|||
162005651|NCT01056822|585075891|FG001|Overall Study|Lost to Follow-up|0|||
162005652|NCT01844765|585075897|FG000|Overall Study|Adverse Event|6|||
162005653|NCT01844765|585075898|FG001|Overall Study|Adverse Event|8|||
162005654|NCT01844765|585075897|FG000|Overall Study|Withdrawal by Subject|2|||
162005655|NCT01844765|585075898|FG001|Overall Study|Withdrawal by Subject|3|||
162005656|NCT01844765|585075897|FG000|Overall Study|Disease progression|1|||
162005657|NCT01844765|585075898|FG001|Overall Study|Disease progression|0|||
162005658|NCT01844765|585075897|FG000|Overall Study|Administrative problems|3|||
162005659|NCT01844765|585075898|FG001|Overall Study|Administrative problems|4|||
162005660|NCT01844765|585075897|FG000|Overall Study|Protocol deviation|2|||
162005661|NCT01844765|585075898|FG001|Overall Study|Protocol deviation|0|||
162005662|NCT01844765|585075897|FG000|Overall Study|Untreated|1|||
162005663|NCT01844765|585075898|FG001|Overall Study|Untreated|0|||
162005664|NCT02025179|585075899|FG000|Overall Study|Lost to Follow-up|0|||
162005665|NCT02025179|585075900|FG001|Overall Study|Lost to Follow-up|0|||
162005666|NCT02025179|585075901|FG002|Overall Study|Lost to Follow-up|1|||
162005667|NCT00556075|585075902|FG000|Overall Study|Lost to Follow-up|3|||
162005668|NCT00556075|585075903|FG001|Overall Study|Lost to Follow-up|0|||
162005669|NCT00556075|585075904|FG002|Overall Study|Lost to Follow-up|3|||
162005670|NCT00556075|585075902|FG000|Overall Study|Withdrawal by Subject|3|||
162005671|NCT00556075|585075903|FG001|Overall Study|Withdrawal by Subject|3|||
162005672|NCT00556075|585075904|FG002|Overall Study|Withdrawal by Subject|0|||
162005673|NCT00556075|585075902|FG000|Overall Study|Protocol Violation|1|||
162005674|NCT00556075|585075903|FG001|Overall Study|Protocol Violation|1|||
162005675|NCT00556075|585075904|FG002|Overall Study|Protocol Violation|3|||
162005676|NCT00556075|585075902|FG000|Overall Study|Not eligible|1|||
162005677|NCT00556075|585075903|FG001|Overall Study|Not eligible|1|||
162005678|NCT00556075|585075904|FG002|Overall Study|Not eligible|2|||
162005679|NCT00556075|585075902|FG000|Overall Study|Adverse Event|1|||
162005680|NCT00556075|585075903|FG001|Overall Study|Adverse Event|2|||
162005681|NCT00556075|585075904|FG002|Overall Study|Adverse Event|0|||
162005682|NCT00556075|585075902|FG000|Overall Study|Personal issues|4|||
162005683|NCT00556075|585075903|FG001|Overall Study|Personal issues|1|||
162005684|NCT00556075|585075904|FG002|Overall Study|Personal issues|0|||
162005685|NCT00556075|585075902|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
162005686|NCT00556075|585075903|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
162005687|NCT00556075|585075904|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
162005688|NCT00601835|585075905|FG000|Overall Study|Withdrawal by Subject|9|||
162005689|NCT00601835|585075906|FG001|Overall Study|Withdrawal by Subject|6|||
162005690|NCT00601835|585075905|FG000|Overall Study|Physician Decision|1|||
162005691|NCT00601835|585075906|FG001|Overall Study|Physician Decision|0|||
162005692|NCT00601835|585075905|FG000|Overall Study|Lost to Follow-up|37|||
162005693|NCT00601835|585075906|FG001|Overall Study|Lost to Follow-up|5|||
162005694|NCT00601835|585075905|FG000|Overall Study|Adverse Event|1|||
162005695|NCT00601835|585075906|FG001|Overall Study|Adverse Event|1|||
162005696|NCT00601835|585075905|FG000|Overall Study|Relocate|12|||
162005697|NCT00601835|585075906|FG001|Overall Study|Relocate|2|||
162005698|NCT01927497|585075907|FG000|Overall Study|Death|0|||
162005699|NCT01927497|585075908|FG001|Overall Study|Death|1|||
162005700|NCT01927497|585075907|FG000|Overall Study|Protocol Violation|2|||
162005701|NCT01927497|585075908|FG001|Overall Study|Protocol Violation|0|||
162005702|NCT00395746|585075909|FG000|Overall Study|Adverse Event|5|||
162005703|NCT00395746|585075910|FG001|Overall Study|Adverse Event|2|||
162005704|NCT00395746|585075911|FG002|Overall Study|Adverse Event|2|||
162005705|NCT00395746|585075909|FG000|Overall Study|Protocol Violation|0|||
162005706|NCT00395746|585075910|FG001|Overall Study|Protocol Violation|1|||
162005707|NCT00395746|585075911|FG002|Overall Study|Protocol Violation|0|||
162005708|NCT00395746|585075909|FG000|Overall Study|Lack of Efficacy|2|||
162005709|NCT00395746|585075910|FG001|Overall Study|Lack of Efficacy|0|||
162005710|NCT00395746|585075911|FG002|Overall Study|Lack of Efficacy|17|||
162005711|NCT00395746|585075909|FG000|Overall Study|Hypoglycaemia|2|||
162005712|NCT00395746|585075910|FG001|Overall Study|Hypoglycaemia|1|||
162005713|NCT00395746|585075911|FG002|Overall Study|Hypoglycaemia|0|||
162005714|NCT00395746|585075909|FG000|Overall Study|Subject decision|0|||
162005715|NCT00395746|585075910|FG001|Overall Study|Subject decision|0|||
162005716|NCT00395746|585075911|FG002|Overall Study|Subject decision|1|||
162005717|NCT00395746|585075909|FG000|Overall Study|Withdrawal of consent|0|||
162005718|NCT00395746|585075910|FG001|Overall Study|Withdrawal of consent|0|||
162005719|NCT00395746|585075911|FG002|Overall Study|Withdrawal of consent|1|||
162005720|NCT00395746|585075909|FG000|Overall Study|Difficultulty in use of device|0|||
162005721|NCT00395746|585075910|FG001|Overall Study|Difficultulty in use of device|0|||
162005722|NCT00395746|585075911|FG002|Overall Study|Difficultulty in use of device|1|||
162005723|NCT00395746|585075909|FG000|Overall Study|Unable to visit site on schedule|1|||
162005724|NCT00395746|585075910|FG001|Overall Study|Unable to visit site on schedule|0|||
162005725|NCT00395746|585075911|FG002|Overall Study|Unable to visit site on schedule|0|||
162005726|NCT04528641|585075912|FG000|Overall Study|Withdrawal by Subject|0|||
162005727|NCT04528641|585075913|FG001|Overall Study|Withdrawal by Subject|0|||
162005728|NCT04528641|585075914|FG002|Overall Study|Withdrawal by Subject|0|||
162005729|NCT04528641|585075915|FG003|Overall Study|Withdrawal by Subject|1|||
162005730|NCT04528641|585075916|FG004|Overall Study|Withdrawal by Subject|0|||
162005731|NCT04528641|585075917|FG005|Overall Study|Withdrawal by Subject|1|||
162005732|NCT03914417|585075918|FG000|Overall Study|Withdrawal by Subject|2|||
162005733|NCT00517296|585075923|FG000|Overall Study|Withdrawal by Subject|1|||
162005734|NCT00517296|585075924|FG001|Overall Study|Withdrawal by Subject|0|||
162005735|NCT04764162|585075927|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
162005736|NCT04764162|585075928|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
162005737|NCT00795704|585075929|FG000|Overall Study|Withdrawal by Subject|3|||
162005738|NCT00795704|585075930|FG001|Overall Study|Withdrawal by Subject|2|||
162005739|NCT00795704|585075929|FG000|Overall Study|Adverse Event|1|||
162005740|NCT00795704|585075930|FG001|Overall Study|Adverse Event|1|||
162005741|NCT01300728|585075931|FG000|Overall Study|Withdrawal by Subject|1|||
162005742|NCT01300728|585075932|FG001|Overall Study|Withdrawal by Subject|1|||
162005743|NCT01300728|585075931|FG000|Overall Study|Physician Decision|1|||
162005744|NCT01300728|585075932|FG001|Overall Study|Physician Decision|0|||
162005745|NCT01247324|585075933|FG000|Overall Study|Death|6|||
162005746|NCT01247324|585075934|FG001|Overall Study|Death|10|||
162005747|NCT01247324|585075933|FG000|Overall Study|Physician Decision|2|||
162005748|NCT01247324|585075934|FG001|Overall Study|Physician Decision|3|||
162005749|NCT01247324|585075933|FG000|Overall Study|Non-compliance with study drug|3|||
162005750|NCT01247324|585075934|FG001|Overall Study|Non-compliance with study drug|0|||
162005751|NCT01247324|585075933|FG000|Overall Study|Lack of Efficacy|24|||
162005752|NCT01247324|585075934|FG001|Overall Study|Lack of Efficacy|14|||
162005753|NCT01247324|585075933|FG000|Overall Study|Non-compliance|3|||
162005754|NCT01247324|585075934|FG001|Overall Study|Non-compliance|2|||
162005755|NCT01247324|585075933|FG000|Overall Study|Pregnancy|5|||
162005756|NCT01247324|585075934|FG001|Overall Study|Pregnancy|10|||
162005757|NCT01247324|585075933|FG000|Overall Study|Protocol Violation|1|||
162005758|NCT01247324|585075934|FG001|Overall Study|Protocol Violation|1|||
162005759|NCT01247324|585075933|FG000|Overall Study|Reason not specified|42|||
162005760|NCT01247324|585075934|FG001|Overall Study|Reason not specified|32|||
162005761|NCT01247324|585075933|FG000|Overall Study|Consent withdrawn by participant|41|||
162005762|NCT01247324|585075934|FG001|Overall Study|Consent withdrawn by participant|56|||
162005763|NCT01247324|585075933|FG000|Overall Study|Adverse Event|49|||
162005764|NCT01247324|585075934|FG001|Overall Study|Adverse Event|35|||
162005765|NCT01247324|585075933|FG000|Overall Study|Lost to Follow-up|3|||
162005766|NCT01247324|585075934|FG001|Overall Study|Lost to Follow-up|6|||
162005767|NCT01247324|585075933|FG000|Overall Study|Study Terminated by Sponsor|4|||
162005768|NCT01247324|585075934|FG001|Overall Study|Study Terminated by Sponsor|1|||
162005769|NCT01247324|585075933|FG000|Overall Study|Missing|2|||
162005770|NCT01247324|585075934|FG001|Overall Study|Missing|1|||
162005771|NCT00506350|585075935|FG000|Overall Study|Serious Adverse Event|1|||
162005772|NCT00506350|585075936|FG001|Overall Study|Serious Adverse Event|0|||
162005773|NCT00506350|585075937|FG002|Overall Study|Serious Adverse Event|0|||
162005774|NCT00506350|585075938|FG003|Overall Study|Serious Adverse Event|0|||
162005775|NCT00506350|585075939|FG004|Overall Study|Serious Adverse Event|0|||
162005776|NCT00506350|585075940|FG005|Overall Study|Serious Adverse Event|0|||
162005777|NCT00506350|585075941|FG006|Overall Study|Serious Adverse Event|0|||
162005778|NCT00506350|585075942|FG007|Overall Study|Serious Adverse Event|0|||
162005779|NCT00506350|585075943|FG008|Overall Study|Serious Adverse Event|0|||
162005780|NCT00506350|585075935|FG000|Overall Study|Adverse Event|0|||
162005781|NCT00506350|585075936|FG001|Overall Study|Adverse Event|0|||
162005782|NCT00506350|585075937|FG002|Overall Study|Adverse Event|0|||
162005783|NCT00506350|585075938|FG003|Overall Study|Adverse Event|0|||
162005784|NCT00506350|585075939|FG004|Overall Study|Adverse Event|0|||
162005785|NCT00506350|585075940|FG005|Overall Study|Adverse Event|0|||
162005786|NCT00506350|585075941|FG006|Overall Study|Adverse Event|0|||
162005787|NCT00506350|585075942|FG007|Overall Study|Adverse Event|1|||
162005788|NCT00506350|585075943|FG008|Overall Study|Adverse Event|1|||
162005789|NCT00506350|585075935|FG000|Overall Study|Protocol Violation|0|||
162005790|NCT00506350|585075936|FG001|Overall Study|Protocol Violation|0|||
162005791|NCT00506350|585075937|FG002|Overall Study|Protocol Violation|1|||
162005792|NCT00506350|585075938|FG003|Overall Study|Protocol Violation|0|||
162005793|NCT00506350|585075939|FG004|Overall Study|Protocol Violation|0|||
162005794|NCT00506350|585075940|FG005|Overall Study|Protocol Violation|0|||
162005795|NCT00506350|585075941|FG006|Overall Study|Protocol Violation|1|||
162005796|NCT00506350|585075942|FG007|Overall Study|Protocol Violation|0|||
162005797|NCT00506350|585075943|FG008|Overall Study|Protocol Violation|0|||
162005798|NCT00506350|585075935|FG000|Overall Study|Withdrawal by Subject|0|||
162005799|NCT00506350|585075936|FG001|Overall Study|Withdrawal by Subject|1|||
162005800|NCT00506350|585075937|FG002|Overall Study|Withdrawal by Subject|1|||
162005801|NCT00506350|585075938|FG003|Overall Study|Withdrawal by Subject|1|||
162005802|NCT00506350|585075939|FG004|Overall Study|Withdrawal by Subject|4|||
162005803|NCT00506350|585075940|FG005|Overall Study|Withdrawal by Subject|1|||
162005804|NCT00506350|585075941|FG006|Overall Study|Withdrawal by Subject|1|||
162005805|NCT00506350|585075942|FG007|Overall Study|Withdrawal by Subject|2|||
162005806|NCT00506350|585075943|FG008|Overall Study|Withdrawal by Subject|0|||
162005807|NCT00506350|585075935|FG000|Overall Study|Lost to Follow-up|1|||
162005808|NCT00506350|585075936|FG001|Overall Study|Lost to Follow-up|1|||
162005809|NCT00506350|585075937|FG002|Overall Study|Lost to Follow-up|1|||
162005810|NCT00506350|585075938|FG003|Overall Study|Lost to Follow-up|1|||
162005811|NCT00506350|585075939|FG004|Overall Study|Lost to Follow-up|2|||
162005812|NCT00506350|585075940|FG005|Overall Study|Lost to Follow-up|1|||
162005813|NCT00506350|585075941|FG006|Overall Study|Lost to Follow-up|0|||
162005814|NCT00506350|585075942|FG007|Overall Study|Lost to Follow-up|0|||
162005815|NCT00506350|585075943|FG008|Overall Study|Lost to Follow-up|2|||
162005816|NCT00506350|585075935|FG000|Overall Study|Medical Reason|0|||
162005817|NCT00506350|585075936|FG001|Overall Study|Medical Reason|0|||
162005818|NCT00506350|585075937|FG002|Overall Study|Medical Reason|0|||
162005819|NCT00506350|585075938|FG003|Overall Study|Medical Reason|0|||
162005820|NCT00506350|585075939|FG004|Overall Study|Medical Reason|1|||
162005821|NCT00506350|585075940|FG005|Overall Study|Medical Reason|0|||
162005822|NCT00506350|585075941|FG006|Overall Study|Medical Reason|0|||
162005823|NCT00506350|585075942|FG007|Overall Study|Medical Reason|0|||
162005824|NCT00506350|585075943|FG008|Overall Study|Medical Reason|0|||
162005825|NCT00506350|585075935|FG000|Overall Study|Other|1|||
162005826|NCT00506350|585075936|FG001|Overall Study|Other|1|||
162005827|NCT00506350|585075937|FG002|Overall Study|Other|3|||
162005828|NCT00506350|585075938|FG003|Overall Study|Other|0|||
162005829|NCT00506350|585075939|FG004|Overall Study|Other|3|||
162005830|NCT00506350|585075940|FG005|Overall Study|Other|0|||
162005831|NCT00506350|585075941|FG006|Overall Study|Other|0|||
162005832|NCT00506350|585075942|FG007|Overall Study|Other|2|||
162005833|NCT00506350|585075943|FG008|Overall Study|Other|2|||
162005834|NCT03474588|585075944|FG000|Overall Study|Withdrawal by Subject|4|||
162005835|NCT03474588|585075945|FG001|Overall Study|Withdrawal by Subject|3|||
162005836|NCT03474588|585075944|FG000|Overall Study|Death|0|||
162005837|NCT03474588|585075945|FG001|Overall Study|Death|1|||
162005838|NCT01607957|585075946|FG000|Overall Study|Not treated|1|||
162005839|NCT01607957|585075947|FG001|Overall Study|Not treated|1|||
162005840|NCT01607957|585075946|FG000|Overall Study|Death|367|||
162005841|NCT01607957|585075947|FG001|Overall Study|Death|211|||
162005842|NCT01607957|585075946|FG000|Overall Study|Lost to Follow-up|3|||
162005843|NCT01607957|585075947|FG001|Overall Study|Lost to Follow-up|3|||
162005844|NCT01607957|585075946|FG000|Overall Study|Participant refusal|1|||
162005845|NCT01607957|585075947|FG001|Overall Study|Participant refusal|0|||
162005846|NCT01691794|585075948|FG000|Overall Study|Poor/Non-Compliance|1|||
162005847|NCT01691794|585075949|FG001|Overall Study|Poor/Non-Compliance|4|||
162005848|NCT01691794|585075950|FG002|Overall Study|Poor/Non-Compliance|1|||
162005849|NCT01691794|585075948|FG000|Overall Study|Death|0|||
162005850|NCT01691794|585075949|FG001|Overall Study|Death|0|||
162005851|NCT01691794|585075950|FG002|Overall Study|Death|1|||
162005852|NCT01691794|585075948|FG000|Overall Study|Lack of Efficacy|0|||
162005853|NCT01691794|585075949|FG001|Overall Study|Lack of Efficacy|7|||
162005854|NCT01691794|585075950|FG002|Overall Study|Lack of Efficacy|1|||
162005855|NCT01691794|585075948|FG000|Overall Study|Participant request to discontinue|0|||
162005856|NCT01691794|585075949|FG001|Overall Study|Participant request to discontinue|1|||
162005857|NCT01691794|585075950|FG002|Overall Study|Participant request to discontinue|0|||
162005858|NCT01691794|585075948|FG000|Overall Study|Adverse Event|0|||
162005859|NCT01691794|585075949|FG001|Overall Study|Adverse Event|1|||
162005860|NCT01691794|585075950|FG002|Overall Study|Adverse Event|1|||
162005861|NCT01691794|585075948|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
162005862|NCT01691794|585075949|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
162005863|NCT01691794|585075950|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
162005864|NCT01691794|585075948|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
162005865|NCT01691794|585075949|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
162005866|NCT01691794|585075950|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
162005867|NCT04972786|585075951|FG000|First Intervention (1 Day)|Adverse Event|1|||
162005868|NCT04972786|585075952|FG001|First Intervention (1 Day)|Adverse Event|0|||
162005869|NCT03905096|585075953|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
162005870|NCT03905096|585075954|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
162005871|NCT04886154|585075956|FG000|Overall Study|Adverse Event|0|||
162005872|NCT04886154|585075957|FG001|Overall Study|Adverse Event|0|||
162005873|NCT04886154|585075958|FG002|Overall Study|Adverse Event|0|||
162005874|NCT04886154|585075959|FG003|Overall Study|Adverse Event|0|||
162005875|NCT04886154|585075960|FG004|Overall Study|Adverse Event|1|||
162005876|NCT04886154|585075961|FG005|Overall Study|Adverse Event|0|||
162005877|NCT04886154|585075962|FG006|Overall Study|Adverse Event|0|||
162005878|NCT04886154|585075963|FG007|Overall Study|Adverse Event|1|||
162005879|NCT04886154|585075964|FG008|Overall Study|Adverse Event|1|||
162005880|NCT04886154|585075965|FG009|Overall Study|Adverse Event|0|||
162005881|NCT04886154|585075966|FG010|Overall Study|Adverse Event|0|||
162005882|NCT04886154|585075967|FG011|Overall Study|Adverse Event|1|||
162005883|NCT04886154|585075968|FG012|Overall Study|Adverse Event|0|||
162005884|NCT04886154|585075969|FG013|Overall Study|Adverse Event|0|||
162005885|NCT04886154|585075970|FG014|Overall Study|Adverse Event|3|||
162005886|NCT04886154|585075956|FG000|Overall Study|Lost to Follow-up|1|||
162005887|NCT04886154|585075957|FG001|Overall Study|Lost to Follow-up|0|||
162005888|NCT04886154|585075958|FG002|Overall Study|Lost to Follow-up|2|||
162005889|NCT04886154|585075959|FG003|Overall Study|Lost to Follow-up|0|||
162005890|NCT04886154|585075960|FG004|Overall Study|Lost to Follow-up|17|||
162005891|NCT04886154|585075961|FG005|Overall Study|Lost to Follow-up|7|||
162005892|NCT04886154|585075962|FG006|Overall Study|Lost to Follow-up|8|||
162005893|NCT04886154|585075963|FG007|Overall Study|Lost to Follow-up|7|||
162005894|NCT04886154|585075964|FG008|Overall Study|Lost to Follow-up|8|||
162005895|NCT04886154|585075965|FG009|Overall Study|Lost to Follow-up|0|||
162005896|NCT04886154|585075966|FG010|Overall Study|Lost to Follow-up|2|||
162005897|NCT04886154|585075967|FG011|Overall Study|Lost to Follow-up|0|||
162005898|NCT04886154|585075968|FG012|Overall Study|Lost to Follow-up|0|||
162005899|NCT04886154|585075969|FG013|Overall Study|Lost to Follow-up|0|||
162005900|NCT04886154|585075970|FG014|Overall Study|Lost to Follow-up|0|||
162005901|NCT04886154|585075956|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005902|NCT04886154|585075957|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005903|NCT04886154|585075958|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005904|NCT04886154|585075959|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005905|NCT04886154|585075960|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005906|NCT04886154|585075961|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005907|NCT04886154|585075962|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
162005908|NCT04886154|585075963|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005909|NCT04886154|585075964|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005910|NCT04886154|585075965|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005911|NCT04886154|585075966|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005912|NCT04886154|585075967|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005913|NCT04886154|585075968|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005914|NCT04886154|585075969|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005915|NCT04886154|585075970|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
162005916|NCT04886154|585075956|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162005917|NCT04886154|585075957|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162005918|NCT04886154|585075958|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162005919|NCT04886154|585075959|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162005920|NCT04886154|585075960|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162005921|NCT04886154|585075961|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162005922|NCT04886154|585075962|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
162005923|NCT04886154|585075963|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162005924|NCT04886154|585075964|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162005925|NCT04886154|585075965|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162005926|NCT04886154|585075966|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162005927|NCT04886154|585075967|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162005928|NCT04886154|585075968|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162005929|NCT04886154|585075969|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162005930|NCT04886154|585075970|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162005931|NCT04886154|585075956|FG000|Overall Study|Other, Not Specified|0|||
162005932|NCT04886154|585075957|FG001|Overall Study|Other, Not Specified|0|||
162005933|NCT04886154|585075958|FG002|Overall Study|Other, Not Specified|0|||
162005934|NCT04886154|585075959|FG003|Overall Study|Other, Not Specified|0|||
162005935|NCT04886154|585075960|FG004|Overall Study|Other, Not Specified|11|||
162005936|NCT04886154|585075961|FG005|Overall Study|Other, Not Specified|8|||
162005937|NCT04886154|585075962|FG006|Overall Study|Other, Not Specified|9|||
162005938|NCT04886154|585075963|FG007|Overall Study|Other, Not Specified|10|||
162005939|NCT04886154|585075964|FG008|Overall Study|Other, Not Specified|6|||
162005940|NCT04886154|585075965|FG009|Overall Study|Other, Not Specified|1|||
162005941|NCT04886154|585075966|FG010|Overall Study|Other, Not Specified|1|||
162005942|NCT04886154|585075967|FG011|Overall Study|Other, Not Specified|2|||
162005943|NCT04886154|585075968|FG012|Overall Study|Other, Not Specified|1|||
162005944|NCT04886154|585075969|FG013|Overall Study|Other, Not Specified|2|||
162005945|NCT04886154|585075970|FG014|Overall Study|Other, Not Specified|3|||
162005946|NCT03919773|585075971|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
162005947|NCT03919773|585075972|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
162005948|NCT03919773|585075971|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
162005949|NCT03919773|585075972|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
162005950|NCT02702492|585075973|FG000|Overall Study|Disease progression|3|||
162005951|NCT02702492|585075974|FG001|Overall Study|Disease progression|3|||
162005952|NCT02702492|585075975|FG002|Overall Study|Disease progression|2|||
162005953|NCT02702492|585075976|FG003|Overall Study|Disease progression|4|||
162005954|NCT02702492|585075977|FG004|Overall Study|Disease progression|4|||
162005955|NCT02702492|585075978|FG005|Overall Study|Disease progression|1|||
162005956|NCT02702492|585075979|FG006|Overall Study|Disease progression|2|||
162005957|NCT02702492|585075980|FG007|Overall Study|Disease progression|8|||
162005958|NCT02702492|585075981|FG008|Overall Study|Disease progression|5|||
162005959|NCT02702492|585075982|FG009|Overall Study|Disease progression|1|||
162005960|NCT02702492|585075983|FG010|Overall Study|Disease progression|0|||
162005961|NCT02702492|585075984|FG011|Overall Study|Disease progression|3|||
162005962|NCT02702492|585075985|FG012|Overall Study|Disease progression|2|||
162005963|NCT02702492|585075973|FG000|Overall Study|Clinical progression|0|||
162005964|NCT02702492|585075974|FG001|Overall Study|Clinical progression|0|||
162005965|NCT02702492|585075975|FG002|Overall Study|Clinical progression|2|||
162005966|NCT02702492|585075976|FG003|Overall Study|Clinical progression|1|||
162005967|NCT02702492|585075977|FG004|Overall Study|Clinical progression|0|||
162005968|NCT02702492|585075978|FG005|Overall Study|Clinical progression|2|||
162005969|NCT02702492|585075979|FG006|Overall Study|Clinical progression|1|||
162005970|NCT02702492|585075980|FG007|Overall Study|Clinical progression|4|||
162005971|NCT02702492|585075981|FG008|Overall Study|Clinical progression|0|||
162005972|NCT02702492|585075982|FG009|Overall Study|Clinical progression|0|||
162005973|NCT02702492|585075983|FG010|Overall Study|Clinical progression|1|||
162005974|NCT02702492|585075984|FG011|Overall Study|Clinical progression|2|||
162005975|NCT02702492|585075985|FG012|Overall Study|Clinical progression|0|||
162005976|NCT02702492|585075973|FG000|Overall Study|Adverse Event|0|||
162005977|NCT02702492|585075974|FG001|Overall Study|Adverse Event|0|||
162005978|NCT02702492|585075975|FG002|Overall Study|Adverse Event|1|||
162005979|NCT02702492|585075976|FG003|Overall Study|Adverse Event|2|||
162005980|NCT02702492|585075977|FG004|Overall Study|Adverse Event|1|||
162005981|NCT02702492|585075978|FG005|Overall Study|Adverse Event|0|||
162005982|NCT02702492|585075979|FG006|Overall Study|Adverse Event|1|||
162005983|NCT02702492|585075980|FG007|Overall Study|Adverse Event|0|||
162005984|NCT02702492|585075981|FG008|Overall Study|Adverse Event|2|||
162005985|NCT02702492|585075982|FG009|Overall Study|Adverse Event|0|||
162005986|NCT02702492|585075983|FG010|Overall Study|Adverse Event|0|||
162005987|NCT02702492|585075984|FG011|Overall Study|Adverse Event|0|||
162005988|NCT02702492|585075985|FG012|Overall Study|Adverse Event|1|||
162005989|NCT02702492|585075973|FG000|Overall Study|Other|0|||
162005990|NCT02702492|585075974|FG001|Overall Study|Other|0|||
162005991|NCT02702492|585075975|FG002|Overall Study|Other|0|||
162005992|NCT02702492|585075976|FG003|Overall Study|Other|0|||
162005993|NCT02702492|585075977|FG004|Overall Study|Other|0|||
162005994|NCT02702492|585075978|FG005|Overall Study|Other|0|||
162005995|NCT02702492|585075979|FG006|Overall Study|Other|0|||
162005996|NCT02702492|585075980|FG007|Overall Study|Other|0|||
162005997|NCT02702492|585075981|FG008|Overall Study|Other|0|||
162005998|NCT02702492|585075982|FG009|Overall Study|Other|0|||
162005999|NCT02702492|585075983|FG010|Overall Study|Other|0|||
162006000|NCT02702492|585075984|FG011|Overall Study|Other|0|||
162006001|NCT02702492|585075985|FG012|Overall Study|Other|1|||
162006002|NCT00781768|585077434|FG000|Overall Study|Not transplanted.|0|||
162006003|NCT00781768|585077435|FG001|Overall Study|Not transplanted.|2|||
162006004|NCT00199381|585077442|FG000|Overall Study|Withdrawal by Subject|38|||
162006005|NCT00199381|585077442|FG000|Overall Study|Adverse Event|73|||
162006006|NCT00199381|585077442|FG000|Overall Study|Protocol Violation|6|||
162006007|NCT00199381|585077442|FG000|Overall Study|Lack of Efficacy|27|||
162006008|NCT00199381|585077442|FG000|Overall Study|Not including due to early termination|37|||
162006009|NCT00199381|585077442|FG000|Overall Study|Study termination by Sponsor|323|||
162006010|NCT02608684|585077444|FG000|Overall Study|Physician Decision|2|||
162006011|NCT02608684|585077444|FG000|Overall Study|Withdrawal by Subject|1|||
162006012|NCT00751296|585077445|FG000|Overall Study|Adverse Event|2|||
162006013|NCT01972217|585077446|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
162006014|NCT01972217|585077447|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
162006015|NCT01972217|585077448|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
162006016|NCT01972217|585077449|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
162006017|NCT01972217|585077446|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
162006018|NCT01972217|585077447|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
162006019|NCT01972217|585077448|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
162006020|NCT01972217|585077449|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
162006021|NCT01972217|585077446|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
162006022|NCT01972217|585077447|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
162006023|NCT01972217|585077448|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
162006024|NCT01972217|585077449|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
162006025|NCT01972217|585077446|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
162006026|NCT01972217|585077447|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
162006027|NCT01972217|585077448|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
162006028|NCT01972217|585077449|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
162006029|NCT01972217|585077446|FG000|Part B Double-blind, Randomised Period|Death|0|||
162006030|NCT01972217|585077447|FG001|Part B Double-blind, Randomised Period|Death|0|||
162006031|NCT01972217|585077448|FG002|Part B Double-blind, Randomised Period|Death|43|||
162006032|NCT01972217|585077449|FG003|Part B Double-blind, Randomised Period|Death|44|||
162006033|NCT01972217|585077446|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
162006034|NCT01972217|585077447|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
162006035|NCT01972217|585077448|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
162006036|NCT01972217|585077449|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
162006037|NCT01972217|585077446|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
162006038|NCT01972217|585077447|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
162006039|NCT01972217|585077448|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
162006040|NCT01972217|585077449|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
162006041|NCT01972217|585077446|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
162006042|NCT01972217|585077447|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
162006043|NCT01972217|585077448|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
162006044|NCT01972217|585077449|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
162006045|NCT01972217|585077446|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
162006046|NCT01972217|585077447|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
162006047|NCT01972217|585077448|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
162006048|NCT01972217|585077449|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
162006049|NCT03714672|585077450|FG000|Overall Study|Adverse Event|0|||
162006050|NCT03714672|585077451|FG001|Overall Study|Adverse Event|0|||
162006051|NCT03714672|585077452|FG002|Overall Study|Adverse Event|3|||
162006052|NCT03714672|585077453|FG003|Overall Study|Adverse Event|0|||
162006053|NCT03714672|585077450|FG000|Overall Study|Physician Decision|0|||
162006054|NCT03714672|585077451|FG001|Overall Study|Physician Decision|1|||
162006055|NCT03714672|585077452|FG002|Overall Study|Physician Decision|0|||
162006056|NCT03714672|585077453|FG003|Overall Study|Physician Decision|0|||
162006057|NCT03714672|585077450|FG000|Overall Study|Other Reason|1|||
162006058|NCT03714672|585077451|FG001|Overall Study|Other Reason|2|||
162006059|NCT03714672|585077452|FG002|Overall Study|Other Reason|1|||
162006060|NCT03714672|585077453|FG003|Overall Study|Other Reason|1|||
162006061|NCT03714672|585077450|FG000|Overall Study|Lost to Follow-up|1|||
162006062|NCT03714672|585077451|FG001|Overall Study|Lost to Follow-up|1|||
162006063|NCT03714672|585077452|FG002|Overall Study|Lost to Follow-up|0|||
162006064|NCT03714672|585077453|FG003|Overall Study|Lost to Follow-up|0|||
162006065|NCT00419393|585077454|FG000|Overall Study|Adverse Event|5|||
162006066|NCT00419393|585077454|FG000|Overall Study|Protocol Violation|5|||
162006067|NCT00419393|585077454|FG000|Overall Study|Withdrawal by Subject|7|||
162006068|NCT00419393|585077454|FG000|Overall Study|Other: Sponsor request|3|||
162006069|NCT00419393|585077454|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
162006070|NCT00419393|585077454|FG000|Overall Study|Other: Site closure|1|||
162006071|NCT00419393|585077454|FG000|Overall Study|Other: Other health problems|1|||
162006072|NCT00419393|585077454|FG000|Overall Study|Other: Investigator decision|1|||
162006073|NCT01074502|585077456|FG000|Overall Study|Withdrawal by Subject|1|||
162006074|NCT04945733|585077466|FG000|Overall Study|Physician Decision|1|||
162006075|NCT04945733|585077467|FG001|Overall Study|Physician Decision|3|||
162006076|NCT04945733|585077468|FG002|Overall Study|Physician Decision|0|||
162006077|NCT04945733|585077466|FG000|Overall Study|Withdrawal by Subject|3|||
162006078|NCT04945733|585077467|FG001|Overall Study|Withdrawal by Subject|3|||
162006079|NCT04945733|585077468|FG002|Overall Study|Withdrawal by Subject|0|||
162006080|NCT01231984|585077473|FG000|Study Period 1|Withdrawal by Subject|0|||
162006081|NCT01231984|585077474|FG001|Study Period 1|Withdrawal by Subject|0|||
162006082|NCT01231984|585077475|FG002|Study Period 1|Withdrawal by Subject|0|||
162006083|NCT01231984|585077476|FG003|Study Period 1|Withdrawal by Subject|1|||
162006084|NCT01231984|585077473|FG000|Study Period 1|Lost to Follow-up|1|||
162006085|NCT01231984|585077474|FG001|Study Period 1|Lost to Follow-up|1|||
162006086|NCT01231984|585077475|FG002|Study Period 1|Lost to Follow-up|1|||
162006087|NCT01231984|585077476|FG003|Study Period 1|Lost to Follow-up|0|||
162006088|NCT01231984|585077473|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
162006089|NCT01231984|585077474|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
162006090|NCT01231984|585077475|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
162006091|NCT01231984|585077476|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
162006092|NCT01231984|585077473|FG000|Study Period 1|Screen Failure|0|||
162006093|NCT01231984|585077474|FG001|Study Period 1|Screen Failure|0|||
162006094|NCT01231984|585077475|FG002|Study Period 1|Screen Failure|0|||
162006095|NCT01231984|585077476|FG003|Study Period 1|Screen Failure|1|||
162006096|NCT01231984|585077473|FG000|Study Period 1|Non-compliance with study requirements|5|||
162006097|NCT01231984|585077474|FG001|Study Period 1|Non-compliance with study requirements|0|||
162006098|NCT01231984|585077475|FG002|Study Period 1|Non-compliance with study requirements|2|||
162006099|NCT01231984|585077476|FG003|Study Period 1|Non-compliance with study requirements|1|||
162006100|NCT01231984|585077473|FG000|Study Period 1|Protocol Violation|3|||
162006101|NCT01231984|585077474|FG001|Study Period 1|Protocol Violation|4|||
162006102|NCT01231984|585077475|FG002|Study Period 1|Protocol Violation|2|||
162006103|NCT01231984|585077476|FG003|Study Period 1|Protocol Violation|3|||
162006104|NCT01231984|585077473|FG000|Study Period 1|Adverse Event|1|||
162006105|NCT01231984|585077474|FG001|Study Period 1|Adverse Event|0|||
162006106|NCT01231984|585077475|FG002|Study Period 1|Adverse Event|0|||
162006107|NCT01231984|585077476|FG003|Study Period 1|Adverse Event|0|||
162006108|NCT01231984|585077473|FG000|Study Period 1|Other|0|||
162006109|NCT01231984|585077474|FG001|Study Period 1|Other|0|||
162006110|NCT01231984|585077475|FG002|Study Period 1|Other|0|||
162006111|NCT01231984|585077476|FG003|Study Period 1|Other|1|||
162006112|NCT01231984|585077473|FG000|Study Period 2|Withdrawal by Subject|1|||
162006113|NCT01231984|585077474|FG001|Study Period 2|Withdrawal by Subject|1|||
162006114|NCT01231984|585077475|FG002|Study Period 2|Withdrawal by Subject|0|||
162006115|NCT01231984|585077476|FG003|Study Period 2|Withdrawal by Subject|0|||
162006116|NCT01231984|585077473|FG000|Study Period 2|Lost to Follow-up|1|||
162006117|NCT01231984|585077474|FG001|Study Period 2|Lost to Follow-up|0|||
162006118|NCT01231984|585077475|FG002|Study Period 2|Lost to Follow-up|0|||
162006119|NCT01231984|585077476|FG003|Study Period 2|Lost to Follow-up|3|||
162006120|NCT01231984|585077473|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
162006121|NCT01231984|585077474|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
162006122|NCT01231984|585077475|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
162006123|NCT01231984|585077476|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
162006124|NCT00499486|585077478|FG000|Overall Study|Withdrawal by Subject|16|||
162006125|NCT00333775|585077479|FG000|Overall Study|Death|144|||
162006126|NCT00333775|585077480|FG001|Overall Study|Death|149|||
162006127|NCT00333775|585077481|FG002|Overall Study|Death|143|||
162006128|NCT00333775|585077479|FG000|Overall Study|In Follow-up When Study Stopped|87|||
162006129|NCT00333775|585077480|FG001|Overall Study|In Follow-up When Study Stopped|92|||
162006130|NCT00333775|585077481|FG002|Overall Study|In Follow-up When Study Stopped|96|||
162006131|NCT00333775|585077479|FG000|Overall Study|Lost to Follow-up|10|||
162006132|NCT00333775|585077480|FG001|Overall Study|Lost to Follow-up|7|||
162006133|NCT00333775|585077481|FG002|Overall Study|Lost to Follow-up|8|||
162006134|NCT05236270|585077482|FG000|Overall Study|Lost to Follow-up|3|||
162006135|NCT05236270|585077483|FG001|Overall Study|Lost to Follow-up|2|||
162006136|NCT05236270|585077484|FG002|Overall Study|Lost to Follow-up|0|||
162006137|NCT05236270|585077485|FG003|Overall Study|Lost to Follow-up|0|||
162006138|NCT05236270|585077486|FG004|Overall Study|Lost to Follow-up|2|||
162006139|NCT05236270|585077487|FG005|Overall Study|Lost to Follow-up|0|||
162006140|NCT05236270|585077488|FG006|Overall Study|Lost to Follow-up|1|||
162006141|NCT05236270|585077489|FG007|Overall Study|Lost to Follow-up|3|||
162006142|NCT01149096|585077490|FG000|Overall Study|Lost to Follow-up|0|||
162006143|NCT01149096|585077491|FG001|Overall Study|Lost to Follow-up|1|||
162006144|NCT03651765|585077492|FG000|Overall Study|Adverse Event|6|||
162006145|NCT03651765|585077492|FG000|Overall Study|Lack of Efficacy|18|||
162006146|NCT03651765|585077492|FG000|Overall Study|Lost to Follow-up|5|||
162006147|NCT03651765|585077492|FG000|Overall Study|Non-Compliance with Study Drug|4|||
162006148|NCT03651765|585077492|FG000|Overall Study|Physician Decision|6|||
162006149|NCT03651765|585077492|FG000|Overall Study|Pregnancy|1|||
162006150|NCT03651765|585077492|FG000|Overall Study|Discontinued by Sponsor|40|||
162006151|NCT03651765|585077492|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
162006152|NCT03651765|585077492|FG000|Overall Study|Withdrawal by Subject|24|||
162006153|NCT03651765|585077492|FG000|Overall Study|Miscellaneous|6|||
162006154|NCT01263769|585077495|FG000|Overall Study|Non-Compliant with treatment|1|||
162006155|NCT03267277|585077496|FG000|Overall Study|Withdrawal by Subject|1|||
162006156|NCT00468169|585077497|FG000|Overall Study|Withdrawal by Subject|1|||
162006157|NCT00468169|585077498|FG001|Overall Study|Withdrawal by Subject|0|||
162006158|NCT01126749|585077503|FG000|Phase 1b|Other|0|||
162006159|NCT01126749|585077504|FG001|Phase 1b|Other|1|||
162006160|NCT01126749|585077505|FG002|Phase 1b|Other|0|||
162006161|NCT01126749|585077506|FG003|Phase 1b|Other|0|||
162006162|NCT01126749|585077503|FG000|Phase 1b|Withdrawal by Subject|0|||
162006163|NCT01126749|585077504|FG001|Phase 1b|Withdrawal by Subject|1|||
162006164|NCT01126749|585077505|FG002|Phase 1b|Withdrawal by Subject|0|||
162006165|NCT01126749|585077506|FG003|Phase 1b|Withdrawal by Subject|0|||
162006166|NCT01126749|585077503|FG000|Phase 1b|Death|3|||
162006167|NCT01126749|585077504|FG001|Phase 1b|Death|4|||
162006168|NCT01126749|585077505|FG002|Phase 1b|Death|0|||
162006169|NCT01126749|585077506|FG003|Phase 1b|Death|0|||
162006170|NCT01126749|585077503|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
162006171|NCT01126749|585077504|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
162006172|NCT01126749|585077505|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
162006173|NCT01126749|585077506|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
162006174|NCT01126749|585077503|FG000|Phase 2|Study Termination by Sponsor|0|||
162006175|NCT01126749|585077504|FG001|Phase 2|Study Termination by Sponsor|0|||
162006176|NCT01126749|585077505|FG002|Phase 2|Study Termination by Sponsor|12|||
162006177|NCT01126749|585077506|FG003|Phase 2|Study Termination by Sponsor|6|||
162006178|NCT01126749|585077503|FG000|Phase 2|Other|0|||
162006179|NCT01126749|585077504|FG001|Phase 2|Other|0|||
162006180|NCT01126749|585077505|FG002|Phase 2|Other|4|||
162006181|NCT01126749|585077506|FG003|Phase 2|Other|2|||
162006182|NCT01126749|585077503|FG000|Phase 2|Withdrawal by Subject|0|||
162006183|NCT01126749|585077504|FG001|Phase 2|Withdrawal by Subject|0|||
162006184|NCT01126749|585077505|FG002|Phase 2|Withdrawal by Subject|0|||
162006185|NCT01126749|585077506|FG003|Phase 2|Withdrawal by Subject|2|||
162006186|NCT01126749|585077503|FG000|Phase 2|Lost to Follow-up|0|||
162006187|NCT01126749|585077504|FG001|Phase 2|Lost to Follow-up|0|||
162006188|NCT01126749|585077505|FG002|Phase 2|Lost to Follow-up|0|||
162006189|NCT01126749|585077506|FG003|Phase 2|Lost to Follow-up|1|||
162006190|NCT01126749|585077503|FG000|Phase 2|Death|0|||
162006191|NCT01126749|585077504|FG001|Phase 2|Death|0|||
162006192|NCT01126749|585077505|FG002|Phase 2|Death|22|||
162006193|NCT01126749|585077506|FG003|Phase 2|Death|22|||
162006194|NCT01126749|585077503|FG000|Phase 2|Adverse Event|0|||
162006195|NCT01126749|585077504|FG001|Phase 2|Adverse Event|0|||
162006196|NCT01126749|585077505|FG002|Phase 2|Adverse Event|0|||
162006197|NCT01126749|585077506|FG003|Phase 2|Adverse Event|1|||
162006198|NCT03668873|585077507|FG000|Overall Study|Lost to Follow-up|6|||
162006199|NCT03668873|585077508|FG001|Overall Study|Lost to Follow-up|3|||
162044084|NCT02476201|585219592|FG000|Overall Study|Study echo not performed|5|||
162006200|NCT02183675|585077509|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
162006201|NCT02183675|585077510|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
162006202|NCT02183675|585077511|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
162006203|NCT02183675|585077512|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
162006204|NCT02183675|585077513|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
162006205|NCT02183675|585077514|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
162006206|NCT01521117|585077515|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
162006207|NCT01521117|585077516|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
162006208|NCT01521117|585077515|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
162006209|NCT01521117|585077516|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
162006210|NCT01521117|585077515|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
162006211|NCT01521117|585077516|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
162006212|NCT00784563|585077519|FG000|Years 1 & 2|Withdrawal by Subject|3|||
162006213|NCT00784563|585077520|FG001|Years 1 & 2|Withdrawal by Subject|2|||
162006214|NCT00784563|585077521|FG002|Years 1 & 2|Withdrawal by Subject|0|||
162006215|NCT00784563|585077519|FG000|Years 1 & 2|Adverse Event|0|||
162006216|NCT00784563|585077520|FG001|Years 1 & 2|Adverse Event|3|||
162006217|NCT00784563|585077521|FG002|Years 1 & 2|Adverse Event|0|||
162006218|NCT00784563|585077519|FG000|Year 3|Withdrawal by Subject|0|||
162006219|NCT00784563|585077520|FG001|Year 3|Withdrawal by Subject|0|||
162006220|NCT00784563|585077521|FG002|Year 3|Withdrawal by Subject|2|||
162006221|NCT00784563|585077519|FG000|Year 3|Adverse Event|0|||
162006222|NCT00784563|585077520|FG001|Year 3|Adverse Event|0|||
162006223|NCT00784563|585077521|FG002|Year 3|Adverse Event|1|||
162006224|NCT00762164|585077522|FG000|Overall Study|Lost to Follow-up|1|||
162006225|NCT00762164|585077523|FG001|Overall Study|Lost to Follow-up|1|||
162006226|NCT00762164|585077522|FG000|Overall Study|Discontinued medication|2|||
162006227|NCT00762164|585077523|FG001|Overall Study|Discontinued medication|0|||
162006228|NCT00762164|585077522|FG000|Overall Study|Withdrawal by Subject|0|||
162006229|NCT00762164|585077523|FG001|Overall Study|Withdrawal by Subject|1|||
162006230|NCT02657889|585077528|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
162006231|NCT02657889|585077529|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
162006232|NCT02657889|585077530|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
162006233|NCT02657889|585077531|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
162006234|NCT02657889|585077528|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
162006235|NCT02657889|585077529|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
162006236|NCT02657889|585077530|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
162006237|NCT02657889|585077531|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
162006238|NCT02657889|585077528|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
162006239|NCT02657889|585077529|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
162006240|NCT02657889|585077530|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
162006241|NCT02657889|585077531|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
162006242|NCT02657889|585077528|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
162006243|NCT02657889|585077529|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
162006244|NCT02657889|585077530|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
162006245|NCT02657889|585077531|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
162006246|NCT02657889|585077528|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
162006247|NCT02657889|585077529|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
162006248|NCT02657889|585077530|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
162006249|NCT02657889|585077531|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
162006250|NCT02657889|585077528|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
162006251|NCT02657889|585077529|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
162006252|NCT02657889|585077530|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
162006253|NCT02657889|585077531|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
162006254|NCT02657889|585077528|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
162006255|NCT02657889|585077529|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
162006256|NCT02657889|585077530|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
162006257|NCT02657889|585077531|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
162006258|NCT02657889|585077528|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
162006259|NCT02657889|585077529|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
162006260|NCT02657889|585077530|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
162006261|NCT02657889|585077531|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
162006262|NCT02657889|585077528|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
162006263|NCT02657889|585077529|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
162006264|NCT02657889|585077530|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
162006265|NCT02657889|585077531|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
162006266|NCT02657889|585077528|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
162006267|NCT02657889|585077529|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
162006268|NCT02657889|585077530|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
162006269|NCT02657889|585077531|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
162006270|NCT02657889|585077528|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
162006271|NCT02657889|585077529|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
162006272|NCT02657889|585077530|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
162006273|NCT02657889|585077531|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
162006274|NCT02657889|585077528|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
162006275|NCT02657889|585077529|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
162006276|NCT02657889|585077530|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
162006277|NCT02657889|585077531|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
162006278|NCT00685165|585077532|FG000|Washout Period of 14 Days|Adverse Event|1|||
162006279|NCT00685165|585077533|FG001|Washout Period of 14 Days|Adverse Event|0|||
162006280|NCT03155724|585077535|FG000|Overall Study|Death|3|||
162006281|NCT03155724|585077535|FG000|Overall Study|Physician Decision|1|||
162006282|NCT03155724|585077535|FG000|Overall Study|Study closure|7|||
162006283|NCT03050801|585077544|FG000|Experiment 1|Lost to Follow-up|0|||
162006284|NCT03050801|585077545|FG001|Experiment 1|Lost to Follow-up|1|||
162006285|NCT03050801|585077546|FG002|Experiment 1|Lost to Follow-up|0|||
162044085|NCT02476201|585219592|FG000|Overall Study|Adverse Event|4|||
162044086|NCT02476201|585219592|FG000|Overall Study|Death|2|||
162044087|NCT02476201|585219592|FG000|Overall Study|Lost to Follow-up|2|||
162044088|NCT02476201|585219592|FG000|Overall Study|MPP programmed to OFF|2|||
162044089|NCT02476201|585219592|FG000|Overall Study|Withdrawal by Subject|1|||
162044090|NCT02476201|585219592|FG000|Overall Study|Unsuccessful implant|1|||
162044091|NCT00333801|585219593|FG000|Overall Study|Moved to another state|5|||
162044092|NCT00333801|585219594|FG001|Overall Study|Moved to another state|3|||
162044093|NCT00333801|585219593|FG000|Overall Study|Lost to Follow-up|2|||
162044094|NCT00333801|585219594|FG001|Overall Study|Lost to Follow-up|0|||
162044095|NCT00333801|585219593|FG000|Overall Study|Incarcerated|1|||
162044096|NCT00333801|585219594|FG001|Overall Study|Incarcerated|2|||
162044097|NCT00333801|585219593|FG000|Overall Study|Withdrawal by Subject|0|||
162044098|NCT00333801|585219594|FG001|Overall Study|Withdrawal by Subject|1|||
162044099|NCT00777205|585219595|FG000|Overall Study|Lost to Follow-up|25|||
162044100|NCT00777205|585219596|FG001|Overall Study|Lost to Follow-up|9|||
162044101|NCT00777205|585219595|FG000|Overall Study|Withdrawal by Subject|6|||
162044102|NCT00777205|585219596|FG001|Overall Study|Withdrawal by Subject|4|||
162044103|NCT00777205|585219595|FG000|Overall Study|Death|0|||
162044104|NCT00777205|585219596|FG001|Overall Study|Death|2|||
162044105|NCT00777205|585219595|FG000|Overall Study|Protocol Violation|0|||
162044106|NCT00777205|585219596|FG001|Overall Study|Protocol Violation|56|||
162044107|NCT00722423|585219600|FG000|Overall Study|Protocol Violation|0|||
162044108|NCT00722423|585219601|FG001|Overall Study|Protocol Violation|1|||
162044109|NCT00464269|585219604|FG000|Overall Study|Lack of Efficacy|1|||
162044110|NCT00464269|585219605|FG001|Overall Study|Lack of Efficacy|0|||
162044111|NCT00464269|585219606|FG002|Overall Study|Lack of Efficacy|0|||
162044112|NCT00464269|585219607|FG003|Overall Study|Lack of Efficacy|0|||
162044113|NCT00464269|585219604|FG000|Overall Study|Lost to Follow-up|0|||
162044114|NCT00464269|585219605|FG001|Overall Study|Lost to Follow-up|4|||
162044115|NCT00464269|585219606|FG002|Overall Study|Lost to Follow-up|0|||
162044116|NCT00464269|585219607|FG003|Overall Study|Lost to Follow-up|1|||
162044117|NCT00464269|585219604|FG000|Overall Study|Withdrawal by Subject|0|||
162044118|NCT00464269|585219605|FG001|Overall Study|Withdrawal by Subject|2|||
162044119|NCT00464269|585219606|FG002|Overall Study|Withdrawal by Subject|1|||
162044120|NCT00464269|585219607|FG003|Overall Study|Withdrawal by Subject|1|||
162044121|NCT00464269|585219604|FG000|Overall Study|Other reason|3|||
162044122|NCT00464269|585219605|FG001|Overall Study|Other reason|3|||
162044123|NCT00464269|585219606|FG002|Overall Study|Other reason|1|||
162044124|NCT00464269|585219607|FG003|Overall Study|Other reason|1|||
162044125|NCT00464269|585219604|FG000|Overall Study|AE, serious fatal|0|||
162044126|NCT00464269|585219605|FG001|Overall Study|AE, serious fatal|0|||
162044127|NCT00464269|585219606|FG002|Overall Study|AE, serious fatal|1|||
162044128|NCT00464269|585219607|FG003|Overall Study|AE, serious fatal|1|||
162044129|NCT00464269|585219604|FG000|Overall Study|SAE, non-fatal|0|||
162044130|NCT00464269|585219605|FG001|Overall Study|SAE, non-fatal|0|||
162044131|NCT00464269|585219606|FG002|Overall Study|SAE, non-fatal|0|||
162044132|NCT00464269|585219607|FG003|Overall Study|SAE, non-fatal|1|||
162044133|NCT00464269|585219604|FG000|Overall Study|AE, non-serious non-fatal|2|||
162044134|NCT00464269|585219605|FG001|Overall Study|AE, non-serious non-fatal|8|||
162044135|NCT00464269|585219606|FG002|Overall Study|AE, non-serious non-fatal|3|||
162044136|NCT00464269|585219607|FG003|Overall Study|AE, non-serious non-fatal|4|||
162006286|NCT03050801|585077547|FG003|Experiment 1|Lost to Follow-up|0|||
162006287|NCT03050801|585077548|FG004|Experiment 1|Lost to Follow-up|0|||
162006288|NCT03050801|585077549|FG005|Experiment 1|Lost to Follow-up|0|||
162006289|NCT03050801|585077544|FG000|Experiment 1|Physician Decision|0|||
162006290|NCT03050801|585077545|FG001|Experiment 1|Physician Decision|3|||
162006291|NCT03050801|585077546|FG002|Experiment 1|Physician Decision|0|||
162006292|NCT03050801|585077547|FG003|Experiment 1|Physician Decision|0|||
162044137|NCT00464269|585219604|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
162044138|NCT00464269|585219605|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
162044139|NCT00464269|585219606|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
162044140|NCT00464269|585219607|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
162044141|NCT00747461|585219608|FG000|Overall Study|study terminated by sponsor|5|||
162044142|NCT02149875|585219609|FG000|Overall Study|Lost to Follow-up|3|||
162044143|NCT02149875|585219610|FG001|Overall Study|Lost to Follow-up|4|||
162044144|NCT02149875|585219611|FG002|Overall Study|Lost to Follow-up|5|||
162044145|NCT02149875|585219609|FG000|Overall Study|Withdrawal by Subject|3|||
162044146|NCT02149875|585219610|FG001|Overall Study|Withdrawal by Subject|2|||
162044147|NCT02149875|585219611|FG002|Overall Study|Withdrawal by Subject|2|||
162044148|NCT02149875|585219609|FG000|Overall Study|Physician Decision|1|||
162044149|NCT02149875|585219610|FG001|Overall Study|Physician Decision|2|||
162006293|NCT03050801|585077548|FG004|Experiment 1|Physician Decision|0|||
162044150|NCT02149875|585219611|FG002|Overall Study|Physician Decision|2|||
162044151|NCT00299182|585219613|FG000|Overall Study|Withdrawal by Subject|0|||
162044152|NCT00299182|585219614|FG001|Overall Study|Withdrawal by Subject|0|||
162044153|NCT00299182|585219615|FG002|Overall Study|Withdrawal by Subject|1|||
162044154|NCT00299182|585219616|FG003|Overall Study|Withdrawal by Subject|0|||
162044155|NCT00299182|585219617|FG004|Overall Study|Withdrawal by Subject|1|||
162044156|NCT00299182|585219618|FG005|Overall Study|Withdrawal by Subject|2|||
162044157|NCT00299182|585219619|FG006|Overall Study|Withdrawal by Subject|0|||
162044158|NCT00299182|585219613|FG000|Overall Study|Chemotherapy Changed|0|||
162044159|NCT00299182|585219614|FG001|Overall Study|Chemotherapy Changed|0|||
162044160|NCT00299182|585219615|FG002|Overall Study|Chemotherapy Changed|1|||
162044161|NCT00299182|585219616|FG003|Overall Study|Chemotherapy Changed|0|||
162044162|NCT00299182|585219617|FG004|Overall Study|Chemotherapy Changed|1|||
162044163|NCT00299182|585219618|FG005|Overall Study|Chemotherapy Changed|0|||
162044164|NCT00299182|585219619|FG006|Overall Study|Chemotherapy Changed|1|||
162044165|NCT00299182|585219613|FG000|Overall Study|Adverse Event|0|||
162044166|NCT00299182|585219614|FG001|Overall Study|Adverse Event|0|||
162044167|NCT00299182|585219615|FG002|Overall Study|Adverse Event|0|||
162044168|NCT00299182|585219616|FG003|Overall Study|Adverse Event|0|||
162044169|NCT00299182|585219617|FG004|Overall Study|Adverse Event|0|||
162044170|NCT00299182|585219618|FG005|Overall Study|Adverse Event|1|||
162044171|NCT00299182|585219619|FG006|Overall Study|Adverse Event|0|||
162044172|NCT00299182|585219613|FG000|Overall Study|Not Eligible|0|||
162044173|NCT00299182|585219614|FG001|Overall Study|Not Eligible|0|||
162044174|NCT00299182|585219615|FG002|Overall Study|Not Eligible|0|||
162044175|NCT00299182|585219616|FG003|Overall Study|Not Eligible|0|||
162044176|NCT00299182|585219617|FG004|Overall Study|Not Eligible|1|||
162044177|NCT00299182|585219618|FG005|Overall Study|Not Eligible|0|||
162044178|NCT00299182|585219619|FG006|Overall Study|Not Eligible|0|||
162044179|NCT00771316|585219630|FG000|Overall Study|Adverse Event|0|||
162044180|NCT00771316|585219631|FG001|Overall Study|Adverse Event|1|||
162044181|NCT00771316|585219630|FG000|Overall Study|Patient withdrew consent|1|||
162044182|NCT00771316|585219631|FG001|Overall Study|Patient withdrew consent|0|||
162044183|NCT00771316|585219630|FG000|Overall Study|Discontinued due to early termination|1|||
162044184|NCT00771316|585219631|FG001|Overall Study|Discontinued due to early termination|0|||
162044185|NCT04043728|585219634|FG000|Overall Study|Lost to Follow-up|1|||
162044186|NCT04043728|585219635|FG001|Overall Study|Lost to Follow-up|2|||
162044187|NCT04043728|585219636|FG002|Overall Study|Lost to Follow-up|0|||
162044188|NCT04308304|585219637|FG000|Overall Study|Withdrawal by Subject|4|||
162044189|NCT04308304|585219638|FG001|Overall Study|Withdrawal by Subject|0|||
162044190|NCT04308304|585219637|FG000|Overall Study|Protocol Violation|1|||
162044191|NCT04308304|585219638|FG001|Overall Study|Protocol Violation|0|||
162044192|NCT03659916|585219643|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
162044193|NCT03659916|585219644|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
162044194|NCT03659916|585219645|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
162044195|NCT03659916|585219643|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
162044196|NCT03659916|585219644|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
162044197|NCT03659916|585219645|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
162044198|NCT03659916|585219643|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
162044199|NCT03659916|585219644|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
162044200|NCT03659916|585219645|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
162044201|NCT03659916|585219643|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
162044202|NCT03659916|585219644|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
162044203|NCT03659916|585219645|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
162044204|NCT03659916|585219643|FG000|Treatment Period (72 Weeks)|Other|1|||
162044205|NCT03659916|585219644|FG001|Treatment Period (72 Weeks)|Other|3|||
162044206|NCT03659916|585219645|FG002|Treatment Period (72 Weeks)|Other|9|||
162044207|NCT03659916|585219643|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
162044208|NCT03659916|585219644|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
162044209|NCT03659916|585219645|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
162044210|NCT03659916|585219643|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
162044211|NCT03659916|585219644|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
162044212|NCT03659916|585219645|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
162044213|NCT03659916|585219643|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
162044214|NCT03659916|585219644|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
162044215|NCT03659916|585219645|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
162044216|NCT03659916|585219643|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
162044217|NCT03659916|585219644|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
162044218|NCT03659916|585219645|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
162044219|NCT03659916|585219643|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
162044220|NCT03659916|585219644|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
162044221|NCT03659916|585219645|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
162044222|NCT03659916|585219643|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
162044223|NCT03659916|585219644|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
162044224|NCT03659916|585219645|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
162044225|NCT03805646|585219646|FG000|Overall Study|Death|40|||
162044226|NCT03805646|585219647|FG001|Overall Study|Death|49|||
162044227|NCT03805646|585219646|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
162044228|NCT03805646|585219647|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
162044229|NCT04452344|585219648|FG000|Overall Study|Withdrawal by Subject|3|||
162044230|NCT04452344|585219649|FG001|Overall Study|Withdrawal by Subject|6|||
162044231|NCT04452344|585219648|FG000|Overall Study|Adverse Event|1|||
162044232|NCT04452344|585219649|FG001|Overall Study|Adverse Event|2|||
162044233|NCT04452344|585219648|FG000|Overall Study|Lost to Follow-up|2|||
162044234|NCT04452344|585219649|FG001|Overall Study|Lost to Follow-up|2|||
162044235|NCT04452344|585219648|FG000|Overall Study|No Post-Op Visit|6|||
162044236|NCT04452344|585219649|FG001|Overall Study|No Post-Op Visit|7|||
162044237|NCT05171777|585219650|FG000|Treatment Crossover Period|Adverse Event|9|||
162044238|NCT05171777|585219651|FG001|Treatment Crossover Period|Adverse Event|6|||
162044239|NCT05171777|585219652|FG002|Treatment Crossover Period|Adverse Event|0|||
162044240|NCT05171777|585219653|FG003|Treatment Crossover Period|Adverse Event|0|||
162044241|NCT05171777|585219650|FG000|Treatment Crossover Period|Death|5|||
162044242|NCT05171777|585219651|FG001|Treatment Crossover Period|Death|5|||
162044243|NCT05171777|585219652|FG002|Treatment Crossover Period|Death|0|||
162044244|NCT05171777|585219653|FG003|Treatment Crossover Period|Death|0|||
162044245|NCT05171777|585219650|FG000|Treatment Crossover Period|Disease Relapse|1|||
162044246|NCT05171777|585219651|FG001|Treatment Crossover Period|Disease Relapse|0|||
162044247|NCT05171777|585219652|FG002|Treatment Crossover Period|Disease Relapse|0|||
162044248|NCT05171777|585219653|FG003|Treatment Crossover Period|Disease Relapse|0|||
162044249|NCT05171777|585219650|FG000|Treatment Crossover Period|Reason not Specified|1|||
162044250|NCT05171777|585219651|FG001|Treatment Crossover Period|Reason not Specified|1|||
162044251|NCT05171777|585219652|FG002|Treatment Crossover Period|Reason not Specified|0|||
162044252|NCT05171777|585219653|FG003|Treatment Crossover Period|Reason not Specified|0|||
162044253|NCT05171777|585219650|FG000|Treatment Crossover Period|Physician Decision|0|||
162044254|NCT05171777|585219651|FG001|Treatment Crossover Period|Physician Decision|1|||
162044255|NCT05171777|585219652|FG002|Treatment Crossover Period|Physician Decision|0|||
162044256|NCT05171777|585219653|FG003|Treatment Crossover Period|Physician Decision|0|||
162044257|NCT05171777|585219650|FG000|Treatment Crossover Period|Progressive Disease|14|||
162044258|NCT05171777|585219651|FG001|Treatment Crossover Period|Progressive Disease|10|||
162044259|NCT05171777|585219652|FG002|Treatment Crossover Period|Progressive Disease|0|||
162044260|NCT05171777|585219653|FG003|Treatment Crossover Period|Progressive Disease|0|||
162044261|NCT05171777|585219650|FG000|Treatment Crossover Period|Protocol Violation|0|||
162044262|NCT05171777|585219651|FG001|Treatment Crossover Period|Protocol Violation|2|||
162044263|NCT05171777|585219652|FG002|Treatment Crossover Period|Protocol Violation|0|||
162044264|NCT05171777|585219653|FG003|Treatment Crossover Period|Protocol Violation|0|||
162044265|NCT05171777|585219650|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
162044266|NCT05171777|585219651|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
162044267|NCT05171777|585219652|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
162044268|NCT05171777|585219653|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
162044269|NCT05171777|585219650|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
162044270|NCT05171777|585219651|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
162044271|NCT05171777|585219652|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
162044272|NCT05171777|585219653|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
162044273|NCT05171777|585219650|FG000|Treatment Continuation Period|Adverse Event|0|||
162044274|NCT05171777|585219651|FG001|Treatment Continuation Period|Adverse Event|0|||
162044275|NCT05171777|585219652|FG002|Treatment Continuation Period|Adverse Event|3|||
162044276|NCT05171777|585219653|FG003|Treatment Continuation Period|Adverse Event|6|||
162044277|NCT05171777|585219650|FG000|Treatment Continuation Period|Death|0|||
162044278|NCT05171777|585219651|FG001|Treatment Continuation Period|Death|0|||
162044279|NCT05171777|585219652|FG002|Treatment Continuation Period|Death|1|||
162044280|NCT05171777|585219653|FG003|Treatment Continuation Period|Death|3|||
162044281|NCT05171777|585219650|FG000|Treatment Continuation Period|Disease Relapse|0|||
162044282|NCT05171777|585219651|FG001|Treatment Continuation Period|Disease Relapse|0|||
162044283|NCT05171777|585219652|FG002|Treatment Continuation Period|Disease Relapse|1|||
162044284|NCT05171777|585219653|FG003|Treatment Continuation Period|Disease Relapse|0|||
162044285|NCT05171777|585219650|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
162044286|NCT05171777|585219651|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
162044287|NCT05171777|585219652|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
162044288|NCT05171777|585219653|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
162044289|NCT05171777|585219650|FG000|Treatment Continuation Period|Physician Decision|0|||
162044290|NCT05171777|585219651|FG001|Treatment Continuation Period|Physician Decision|0|||
162044291|NCT05171777|585219652|FG002|Treatment Continuation Period|Physician Decision|0|||
162044292|NCT05171777|585219653|FG003|Treatment Continuation Period|Physician Decision|4|||
162044293|NCT05171777|585219650|FG000|Treatment Continuation Period|Progressive Disease|0|||
162044294|NCT05171777|585219651|FG001|Treatment Continuation Period|Progressive Disease|0|||
162044295|NCT05171777|585219652|FG002|Treatment Continuation Period|Progressive Disease|6|||
162044296|NCT05171777|585219653|FG003|Treatment Continuation Period|Progressive Disease|20|||
162044297|NCT05171777|585219650|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
162006294|NCT03050801|585077549|FG005|Experiment 1|Physician Decision|0|||
162006295|NCT03050801|585077544|FG000|Experiment 1|Change of experimental design|0|||
162006296|NCT03050801|585077545|FG001|Experiment 1|Change of experimental design|3|||
162006297|NCT03050801|585077546|FG002|Experiment 1|Change of experimental design|0|||
162006298|NCT03050801|585077547|FG003|Experiment 1|Change of experimental design|0|||
162006299|NCT03050801|585077548|FG004|Experiment 1|Change of experimental design|0|||
162006300|NCT03050801|585077549|FG005|Experiment 1|Change of experimental design|0|||
162006301|NCT03050801|585077544|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
162006302|NCT03050801|585077545|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
162006303|NCT03050801|585077546|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
162006304|NCT03050801|585077547|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
162006305|NCT03050801|585077548|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
162006306|NCT03050801|585077549|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
162006307|NCT03050801|585077544|FG000|Experiment 2|Lost to Follow-up|0|||
162006308|NCT03050801|585077545|FG001|Experiment 2|Lost to Follow-up|0|||
162006309|NCT03050801|585077546|FG002|Experiment 2|Lost to Follow-up|0|||
162006310|NCT03050801|585077547|FG003|Experiment 2|Lost to Follow-up|1|||
162006311|NCT03050801|585077548|FG004|Experiment 2|Lost to Follow-up|1|||
162006312|NCT03050801|585077549|FG005|Experiment 2|Lost to Follow-up|0|||
162006313|NCT03050801|585077544|FG000|Experiment 2|Physician Decision|0|||
162006314|NCT03050801|585077545|FG001|Experiment 2|Physician Decision|0|||
162006315|NCT03050801|585077546|FG002|Experiment 2|Physician Decision|0|||
162006316|NCT03050801|585077547|FG003|Experiment 2|Physician Decision|0|||
162006317|NCT03050801|585077548|FG004|Experiment 2|Physician Decision|1|||
162006318|NCT03050801|585077549|FG005|Experiment 2|Physician Decision|0|||
162006319|NCT03050801|585077544|FG000|Experiment 2|Pregnancy|0|||
162006320|NCT03050801|585077545|FG001|Experiment 2|Pregnancy|0|||
162006321|NCT03050801|585077546|FG002|Experiment 2|Pregnancy|0|||
162006322|NCT03050801|585077547|FG003|Experiment 2|Pregnancy|0|||
162006323|NCT03050801|585077548|FG004|Experiment 2|Pregnancy|1|||
162006324|NCT03050801|585077549|FG005|Experiment 2|Pregnancy|0|||
162006325|NCT03050801|585077544|FG000|Experiment 2|Withdrawal by Subject|0|||
162006326|NCT03050801|585077545|FG001|Experiment 2|Withdrawal by Subject|0|||
162006327|NCT03050801|585077546|FG002|Experiment 2|Withdrawal by Subject|0|||
162006328|NCT03050801|585077547|FG003|Experiment 2|Withdrawal by Subject|1|||
162006329|NCT03050801|585077548|FG004|Experiment 2|Withdrawal by Subject|0|||
162006330|NCT03050801|585077549|FG005|Experiment 2|Withdrawal by Subject|0|||
162006331|NCT03050801|585077544|FG000|Experiment 2|Poor data quality|0|||
162006332|NCT03050801|585077545|FG001|Experiment 2|Poor data quality|0|||
162006333|NCT03050801|585077546|FG002|Experiment 2|Poor data quality|0|||
162006334|NCT03050801|585077547|FG003|Experiment 2|Poor data quality|4|||
162006335|NCT03050801|585077548|FG004|Experiment 2|Poor data quality|1|||
162006336|NCT03050801|585077549|FG005|Experiment 2|Poor data quality|0|||
162006337|NCT03050801|585077544|FG000|Experiment 2|Discomfort during stimulation|0|||
162006338|NCT03050801|585077545|FG001|Experiment 2|Discomfort during stimulation|0|||
162006339|NCT03050801|585077546|FG002|Experiment 2|Discomfort during stimulation|0|||
162006340|NCT03050801|585077547|FG003|Experiment 2|Discomfort during stimulation|0|||
162006341|NCT03050801|585077548|FG004|Experiment 2|Discomfort during stimulation|0|||
162006342|NCT03050801|585077549|FG005|Experiment 2|Discomfort during stimulation|2|||
162006343|NCT01576341|585077550|FG000|Overall Study|Withdrawal by Subject|24|||
162006344|NCT01576341|585077550|FG000|Overall Study|Adverse Event|10|||
162006345|NCT01576341|585077550|FG000|Overall Study|Death|21|||
162006346|NCT01576341|585077550|FG000|Overall Study|Physician Decision|2|||
162006347|NCT01576341|585077550|FG000|Overall Study|Lost to Follow-up|2|||
162006348|NCT01576341|585077550|FG000|Overall Study|Kidney transplantation|10|||
162006349|NCT01576341|585077550|FG000|Overall Study|Protocol Violation|12|||
162006350|NCT01576341|585077550|FG000|Overall Study|Other|12|||
162006351|NCT03836625|585077551|FG000|Overall Study|Lost to Follow-up|9|||
162006352|NCT03836625|585077552|FG001|Overall Study|Lost to Follow-up|9|||
162006353|NCT03836625|585077551|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
162006354|NCT03836625|585077552|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
162006355|NCT03836625|585077551|FG000|Overall Study|Death|0|||
162006356|NCT03836625|585077552|FG001|Overall Study|Death|1|||
162006357|NCT03836625|585077551|FG000|Overall Study|Refused follow-up|0|||
162006358|NCT03836625|585077552|FG001|Overall Study|Refused follow-up|1|||
162006359|NCT03361137|585077555|FG000|Overall Study|Reason not specified|1|||
162006360|NCT03361137|585077556|FG001|Overall Study|Reason not specified|0|||
162006361|NCT03361137|585077557|FG002|Overall Study|Reason not specified|0|||
162006362|NCT03361137|585077558|FG003|Overall Study|Reason not specified|0|||
162006363|NCT03361137|585077559|FG004|Overall Study|Reason not specified|0|||
162006364|NCT00791934|585077560|FG000|Overall Study|Withdrawal by Subject|2|||
162006365|NCT00791934|585077560|FG000|Overall Study|Did not consent for extended follow-up|13|||
162006366|NCT03413891|585077562|FG000|Overall Study|Lost to Follow-up|2|||
162006367|NCT03413891|585077563|FG001|Overall Study|Lost to Follow-up|1|||
162006368|NCT03413891|585077562|FG000|Overall Study|Protocol Violation|0|||
162006369|NCT03413891|585077563|FG001|Overall Study|Protocol Violation|1|||
162006370|NCT03077542|585077568|FG000|Overall Study|Death|4|||
162044298|NCT05171777|585219651|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
162044299|NCT05171777|585219652|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
162044300|NCT05171777|585219653|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
162044301|NCT05171777|585219650|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
162044302|NCT05171777|585219651|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
162044303|NCT05171777|585219652|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
162044304|NCT05171777|585219653|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
162044305|NCT05171777|585219650|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
162044306|NCT05171777|585219651|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
162044307|NCT05171777|585219652|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
162044308|NCT05171777|585219653|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
162044309|NCT02364713|585219654|FG000|Overall Study|Ineligible|2|||
162044310|NCT02364713|585219655|FG001|Overall Study|Ineligible|2|||
162044311|NCT04686786|585219656|FG000|Overall Study|Adverse Event|9|||
162044312|NCT04686786|585219656|FG000|Overall Study|Death|1|||
162044313|NCT04686786|585219656|FG000|Overall Study|Lack of Efficacy|25|||
162044314|NCT04686786|585219656|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
162044315|NCT04686786|585219656|FG000|Overall Study|Study Terminated by Sponsor|14|||
162044316|NCT04686786|585219656|FG000|Overall Study|Withdrawal by Subject|15|||
162044317|NCT04686786|585219656|FG000|Overall Study|Other than specified|1|||
162044318|NCT03924869|585219657|FG000|Overall Study|Death|73|||
162044319|NCT03924869|585219658|FG001|Overall Study|Death|62|||
162044320|NCT03924869|585219657|FG000|Overall Study|Lost to Follow-up|3|||
162044321|NCT03924869|585219658|FG001|Overall Study|Lost to Follow-up|0|||
162044322|NCT03924869|585219657|FG000|Overall Study|Physician Decision|0|||
162044323|NCT03924869|585219658|FG001|Overall Study|Physician Decision|3|||
162044324|NCT03924869|585219657|FG000|Overall Study|Withdrawal by Subject|7|||
162044325|NCT03924869|585219658|FG001|Overall Study|Withdrawal by Subject|3|||
162044326|NCT03924869|585219657|FG000|Overall Study|Study Terminated By Sponsor|144|||
162044327|NCT03924869|585219658|FG001|Overall Study|Study Terminated By Sponsor|153|||
162044328|NCT03001882|585219661|FG000|Overall Study|Death|1|||
162044329|NCT03001882|585219662|FG001|Overall Study|Death|0|||
162006371|NCT03077542|585077569|FG001|Overall Study|Death|0|||
162006372|NCT03077542|585077568|FG000|Overall Study|Physician Decision|6|||
162006373|NCT03077542|585077569|FG001|Overall Study|Physician Decision|1|||
162006374|NCT03077542|585077568|FG000|Overall Study|Withdrawal by Subject|0|||
162006375|NCT03077542|585077569|FG001|Overall Study|Withdrawal by Subject|1|||
162006376|NCT00301808|585077570|FG000|Overall Study|Adverse Event|5|||
162006377|NCT00301808|585077570|FG000|Overall Study|Death|3|||
162006378|NCT00301808|585077570|FG000|Overall Study|Lack of Efficacy|4|||
162006379|NCT00844844|585077571|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
162006380|NCT00844844|585077571|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
162006381|NCT00844844|585077571|FG000|Extension Treatment Period|Adverse Event|2|||
162006382|NCT00844844|585077571|FG000|Post Treatment Period|Withdrawal by Subject|1|||
162006383|NCT04659044|585077584|FG000|Induction|Physician Decision|1|||
162006384|NCT04659044|585077584|FG000|Induction|Adverse Event|2|||
162006385|NCT04966013|585077586|FG000|Overall Study|Withdrawal by Subject|0|||
162006386|NCT04966013|585077587|FG001|Overall Study|Withdrawal by Subject|2|||
162006387|NCT04966013|585077588|FG002|Overall Study|Withdrawal by Subject|1|||
162006388|NCT04966013|585077586|FG000|Overall Study|Adverse Event|2|||
162006389|NCT04966013|585077587|FG001|Overall Study|Adverse Event|1|||
162006390|NCT04966013|585077588|FG002|Overall Study|Adverse Event|1|||
162006391|NCT01910298|585077592|FG000|Overall Study|Adverse Event|1|||
162006392|NCT01910298|585077593|FG001|Overall Study|Adverse Event|0|||
162006393|NCT01910298|585077592|FG000|Overall Study|Withdrawal by Subject|2|||
162006394|NCT01910298|585077593|FG001|Overall Study|Withdrawal by Subject|7|||
162006395|NCT01910298|585077592|FG000|Overall Study|Protocol Deviation|0|||
162006396|NCT01910298|585077593|FG001|Overall Study|Protocol Deviation|5|||
162006397|NCT01910298|585077592|FG000|Overall Study|Lost to Follow-up|1|||
162006398|NCT01910298|585077593|FG001|Overall Study|Lost to Follow-up|1|||
162006399|NCT01910298|585077592|FG000|Overall Study|Study Terminated by Sponsor|1|||
162006400|NCT01910298|585077593|FG001|Overall Study|Study Terminated by Sponsor|17|||
162006401|NCT01910298|585077592|FG000|Overall Study|Other Miscellaneous Reasons|0|||
162006402|NCT01910298|585077593|FG001|Overall Study|Other Miscellaneous Reasons|2|||
162006403|NCT00079417|585079160|FG000|Overall Study|Physician Decision|2|||
162006404|NCT00079417|585079160|FG000|Overall Study|Ineligible|7|||
162006405|NCT02458313|585079161|FG000|Overall Study|Withdrawal by Subject|6|||
162006406|NCT02458313|585079162|FG001|Overall Study|Withdrawal by Subject|8|||
162006407|NCT02458313|585079161|FG000|Overall Study|Excluded for motion during MRI|1|||
162044330|NCT03001882|585219663|FG002|Overall Study|Death|0|||
162044331|NCT03001882|585219664|FG003|Overall Study|Death|3|||
162044332|NCT03001882|585219661|FG000|Overall Study|Participant withdrew consent|0|||
162044333|NCT03001882|585219662|FG001|Overall Study|Participant withdrew consent|1|||
162006408|NCT02458313|585079162|FG001|Overall Study|Excluded for motion during MRI|2|||
162006409|NCT01615939|585079163|FG000|Overall Study|Lost to Follow-up|5|||
162006410|NCT01615939|585079164|FG001|Overall Study|Lost to Follow-up|0|||
162044334|NCT03001882|585219663|FG002|Overall Study|Participant withdrew consent|0|||
162044335|NCT03001882|585219664|FG003|Overall Study|Participant withdrew consent|5|||
162044336|NCT03001882|585219661|FG000|Overall Study|Other reasons|1|||
162044337|NCT03001882|585219662|FG001|Overall Study|Other reasons|2|||
162044338|NCT03001882|585219663|FG002|Overall Study|Other reasons|0|||
162044339|NCT03001882|585219664|FG003|Overall Study|Other reasons|5|||
162044340|NCT03001882|585219661|FG000|Overall Study|Administrative reason by sponsor|0|||
162044341|NCT03001882|585219662|FG001|Overall Study|Administrative reason by sponsor|0|||
162044342|NCT03001882|585219663|FG002|Overall Study|Administrative reason by sponsor|0|||
162044343|NCT03001882|585219664|FG003|Overall Study|Administrative reason by sponsor|1|||
162044344|NCT03001882|585219661|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
162044345|NCT03001882|585219662|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
162044346|NCT03001882|585219663|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
162044347|NCT03001882|585219664|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
162044348|NCT03001882|585219661|FG000|Overall Study|Not reported|0|||
162044349|NCT03001882|585219662|FG001|Overall Study|Not reported|0|||
162044350|NCT03001882|585219663|FG002|Overall Study|Not reported|0|||
162044351|NCT03001882|585219664|FG003|Overall Study|Not reported|6|||
162044352|NCT03001882|585219661|FG000|Overall Study|Maximum clinical benefit|2|||
162044353|NCT03001882|585219662|FG001|Overall Study|Maximum clinical benefit|3|||
162044354|NCT03001882|585219663|FG002|Overall Study|Maximum clinical benefit|0|||
162044355|NCT03001882|585219664|FG003|Overall Study|Maximum clinical benefit|10|||
162044356|NCT03001882|585219661|FG000|Overall Study|AE unrelated to study drug|3|||
162044357|NCT03001882|585219662|FG001|Overall Study|AE unrelated to study drug|3|||
162044358|NCT03001882|585219663|FG002|Overall Study|AE unrelated to study drug|0|||
162044359|NCT03001882|585219664|FG003|Overall Study|AE unrelated to study drug|11|||
162044360|NCT03001882|585219661|FG000|Overall Study|Study Drug Toxicity|8|||
162044361|NCT03001882|585219662|FG001|Overall Study|Study Drug Toxicity|5|||
162044362|NCT03001882|585219663|FG002|Overall Study|Study Drug Toxicity|0|||
162044363|NCT03001882|585219664|FG003|Overall Study|Study Drug Toxicity|37|||
162044364|NCT03001882|585219661|FG000|Overall Study|Disease progression|16|||
162044365|NCT03001882|585219662|FG001|Overall Study|Disease progression|14|||
162044366|NCT03001882|585219663|FG002|Overall Study|Disease progression|1|||
162044367|NCT03001882|585219664|FG003|Overall Study|Disease progression|90|||
162044368|NCT05268055|585219666|FG000|Overall Study|Lost to Follow-up|68|||
162044369|NCT05268055|585219667|FG001|Overall Study|Lost to Follow-up|68|||
162044370|NCT05268055|585219666|FG000|Overall Study|Withdrawal by Subject|12|||
162044371|NCT05268055|585219667|FG001|Overall Study|Withdrawal by Subject|8|||
162044372|NCT03507400|585219668|FG000|Overall Study|discontinued|5|||
162044373|NCT03507400|585219669|FG001|Overall Study|discontinued|1|||
162044374|NCT03507400|585219668|FG000|Overall Study|Lost to Follow-up|8|||
162044375|NCT03507400|585219669|FG001|Overall Study|Lost to Follow-up|6|||
162044376|NCT03507400|585219668|FG000|Overall Study|Protocol Violation|0|||
162044377|NCT03507400|585219669|FG001|Overall Study|Protocol Violation|1|||
162044378|NCT01555983|585219670|FG000|Overall Study|Withdrawal by Subject|1|||
162044379|NCT01555983|585219671|FG001|Overall Study|Withdrawal by Subject|0|||
162044380|NCT01555983|585219672|FG002|Overall Study|Withdrawal by Subject|0|||
162044381|NCT01555983|585219673|FG003|Overall Study|Withdrawal by Subject|0|||
162044382|NCT01555983|585219674|FG004|Overall Study|Withdrawal by Subject|1|||
162044383|NCT01555983|585219675|FG005|Overall Study|Withdrawal by Subject|1|||
162044384|NCT04026711|585219676|FG000|Overall Study|Withdrawal by Subject|1|||
162044385|NCT04026711|585219677|FG001|Overall Study|Withdrawal by Subject|0|||
162044386|NCT04026711|585219676|FG000|Overall Study|mental health crisis|1|||
162044387|NCT04026711|585219677|FG001|Overall Study|mental health crisis|0|||
162044388|NCT05985395|585219678|FG000|Overall Study|Physician Decision|2|||
162044389|NCT05985395|585219679|FG001|Overall Study|Physician Decision|1|||
162044390|NCT05985395|585219678|FG000|Overall Study|Withdrawal by Subject|1|||
162044391|NCT05985395|585219679|FG001|Overall Study|Withdrawal by Subject|0|||
162044392|NCT04823650|585219680|FG000|Overall Study|Withdrawal by Subject|0|||
162044393|NCT04823650|585219681|FG001|Overall Study|Withdrawal by Subject|0|||
162044394|NCT04823650|585219682|FG002|Overall Study|Withdrawal by Subject|0|||
162044395|NCT04823650|585219683|FG003|Overall Study|Withdrawal by Subject|0|||
162044396|NCT04823650|585219684|FG004|Overall Study|Withdrawal by Subject|1|||
162044397|NCT04823650|585219685|FG005|Overall Study|Withdrawal by Subject|0|||
162044398|NCT02699697|585220702|FG000|Overall Study|Death|18|||
162044399|NCT02699697|585220703|FG001|Overall Study|Death|15|||
162044400|NCT02699697|585220702|FG000|Overall Study|Physician Decision|0|||
162044401|NCT02699697|585220703|FG001|Overall Study|Physician Decision|1|||
162044402|NCT02699697|585220702|FG000|Overall Study|Lost to Follow-up|2|||
162044403|NCT02699697|585220703|FG001|Overall Study|Lost to Follow-up|3|||
162044404|NCT02699697|585220702|FG000|Overall Study|Refused to follow up|1|||
162044405|NCT02699697|585220703|FG001|Overall Study|Refused to follow up|1|||
162044406|NCT02699697|585220702|FG000|Overall Study|Entered hospice care|5|||
162044407|NCT02699697|585220703|FG001|Overall Study|Entered hospice care|2|||
162044408|NCT02699697|585220702|FG000|Overall Study|Missing reason for discontinuation|6|||
162044409|NCT02699697|585220703|FG001|Overall Study|Missing reason for discontinuation|5|||
162044410|NCT02362035|585220704|FG000|Overall Study|Death|67|||
162044411|NCT02362035|585220704|FG000|Overall Study|Lost to Follow-up|3|||
162044412|NCT02362035|585220704|FG000|Overall Study|Adverse Event|1|||
162044413|NCT02362035|585220704|FG000|Overall Study|Physician Decision|1|||
162044414|NCT02362035|585220704|FG000|Overall Study|Subject started another cancer therapy|10|||
162044415|NCT02362035|585220704|FG000|Overall Study|Study terminated by sponsor|45|||
162044416|NCT02362035|585220704|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
162044417|NCT02362035|585220704|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
162044418|NCT02362035|585220704|FG000|Overall Study|Disease progression|11|||
162044419|NCT02362035|585220704|FG000|Overall Study|Withdrawal by Subject|20|||
162044420|NCT00354614|585220705|FG000|Overall Study|Lack of Efficacy|28|||
162044421|NCT01426438|585220708|FG000|Overall Study|Lost to Follow-up|1|||
162044422|NCT01426438|585220709|FG001|Overall Study|Lost to Follow-up|3|||
162044423|NCT01426438|585220708|FG000|Overall Study|Off study Treatment|9|||
162044424|NCT01426438|585220709|FG001|Overall Study|Off study Treatment|3|||
162044425|NCT01426438|585220708|FG000|Overall Study|Poor scan quality|3|||
162044426|NCT01426438|585220709|FG001|Overall Study|Poor scan quality|2|||
162044427|NCT01426438|585220708|FG000|Overall Study|Missed Scan|2|||
162044428|NCT01426438|585220709|FG001|Overall Study|Missed Scan|2|||
162044429|NCT01788046|585220710|FG000|Overall Study|Withdrawal by Subject|12|||
162044430|NCT01788046|585220711|FG001|Overall Study|Withdrawal by Subject|12|||
162044431|NCT01788046|585220710|FG000|Overall Study|Lost to Follow-up|12|||
162044432|NCT01788046|585220711|FG001|Overall Study|Lost to Follow-up|19|||
162044433|NCT01788046|585220710|FG000|Overall Study|Death|7|||
162044434|NCT01788046|585220711|FG001|Overall Study|Death|5|||
162044435|NCT01788046|585220710|FG000|Overall Study|Protocol Specified Criteria|25|||
162044436|NCT01788046|585220711|FG001|Overall Study|Protocol Specified Criteria|1|||
162044437|NCT01797731|585220717|FG000|Overall Study|Didn't have proper radiographs required|3|||
162044438|NCT01797731|585220718|FG001|Overall Study|Didn't have proper radiographs required|3|||
162044439|NCT01604408|585220719|FG000|Treatment Period 1|Protocol Violation|0|||
162044440|NCT01604408|585220720|FG001|Treatment Period 1|Protocol Violation|1|||
162044441|NCT01604408|585220719|FG000|Treatment Period 2|Withdrawal by Subject|1|||
162044442|NCT01604408|585220720|FG001|Treatment Period 2|Withdrawal by Subject|1|||
162044443|NCT01604408|585220719|FG000|Treatment Period 2|Protocol Violation|1|||
162044444|NCT01604408|585220720|FG001|Treatment Period 2|Protocol Violation|0|||
162044445|NCT01604408|585220719|FG000|Treatment Period 2|Adverse Event|0|||
162044446|NCT01604408|585220720|FG001|Treatment Period 2|Adverse Event|1|||
162044447|NCT01604408|585220719|FG000|Treatment Period 3|Protocol Violation|1|||
162044448|NCT01604408|585220720|FG001|Treatment Period 3|Protocol Violation|1|||
162044449|NCT01604408|585220719|FG000|Treatment Period 3|Adverse Event|0|||
162044450|NCT01604408|585220720|FG001|Treatment Period 3|Adverse Event|3|||
162044451|NCT01604408|585220719|FG000|Treatment Period 3|Withdrawal by Subject|3|||
162044452|NCT01604408|585220720|FG001|Treatment Period 3|Withdrawal by Subject|1|||
162044453|NCT01604408|585220719|FG000|Treatment Period 3|Sponsor Decision|1|||
162044454|NCT01604408|585220720|FG001|Treatment Period 3|Sponsor Decision|0|||
162044455|NCT01604408|585220719|FG000|Treatment Period 4|Death|1|||
162044456|NCT01604408|585220720|FG001|Treatment Period 4|Death|0|||
162044457|NCT01604408|585220719|FG000|Treatment Period 4|Withdrawal by Subject|2|||
162044458|NCT01604408|585220720|FG001|Treatment Period 4|Withdrawal by Subject|1|||
162044459|NCT01604408|585220719|FG000|Treatment Period 4|Adverse Event|0|||
162044460|NCT01604408|585220720|FG001|Treatment Period 4|Adverse Event|1|||
162044461|NCT01604408|585220719|FG000|Treatment Period 5|Adverse Event|4|||
162044462|NCT01604408|585220720|FG001|Treatment Period 5|Adverse Event|0|||
162044463|NCT01604408|585220719|FG000|Treatment Period 6|Lost to Follow-up|0|||
162044464|NCT01604408|585220720|FG001|Treatment Period 6|Lost to Follow-up|1|||
162044465|NCT01604408|585220719|FG000|Treatment Period 6|Adverse Event|2|||
162044466|NCT01604408|585220720|FG001|Treatment Period 6|Adverse Event|0|||
162044467|NCT01604408|585220719|FG000|Treatment Period 6|Sponsor decision|0|||
162044468|NCT01604408|585220720|FG001|Treatment Period 6|Sponsor decision|1|||
162044469|NCT01604408|585220719|FG000|Observation Period|Adverse Event|1|||
162044470|NCT01604408|585220720|FG001|Observation Period|Adverse Event|1|||
162044471|NCT01604408|585220719|FG000|Observation Period|Withdrawal by Subject|0|||
162044472|NCT01604408|585220720|FG001|Observation Period|Withdrawal by Subject|2|||
162044473|NCT01189604|585220725|FG000|Overall Study|Impossible to visit|0|||
162044474|NCT01189604|585220726|FG001|Overall Study|Impossible to visit|0|||
162044475|NCT01189604|585220727|FG002|Overall Study|Impossible to visit|0|||
162044476|NCT01189604|585220728|FG003|Overall Study|Impossible to visit|0|||
162044477|NCT01189604|585220729|FG004|Overall Study|Impossible to visit|0|||
162044478|NCT01189604|585220730|FG005|Overall Study|Impossible to visit|1|||
162044479|NCT01189604|585220731|FG006|Overall Study|Impossible to visit|0|||
162044480|NCT01189604|585220725|FG000|Overall Study|Adverse Event|0|||
162044481|NCT01189604|585220726|FG001|Overall Study|Adverse Event|1|||
162044482|NCT01189604|585220727|FG002|Overall Study|Adverse Event|0|||
162044483|NCT01189604|585220728|FG003|Overall Study|Adverse Event|0|||
162044484|NCT01189604|585220729|FG004|Overall Study|Adverse Event|2|||
162044485|NCT01189604|585220730|FG005|Overall Study|Adverse Event|0|||
162044486|NCT01189604|585220731|FG006|Overall Study|Adverse Event|1|||
162044487|NCT01189604|585220725|FG000|Overall Study|Withdrawal by Subject|1|||
162006411|NCT03453164|585079171|FG000|Overall Study|Lack of Efficacy|16|||
162006412|NCT03453164|585079171|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
162006413|NCT03459079|585079173|FG000|Overall Study|Adverse Event|4|||
162006414|NCT03459079|585079174|FG001|Overall Study|Adverse Event|2|||
162006415|NCT03459079|585079175|FG002|Overall Study|Adverse Event|0|||
162006416|NCT03459079|585079173|FG000|Overall Study|Withdrawal by Subject|2|||
162006417|NCT03459079|585079174|FG001|Overall Study|Withdrawal by Subject|2|||
162006418|NCT03459079|585079175|FG002|Overall Study|Withdrawal by Subject|0|||
162006419|NCT00674817|585079176|FG000|Period 1|Withdrawal by Subject|2|||
162006420|NCT00674817|585079176|FG000|Period 1|Protocol Violation|1|||
162006421|NCT00674817|585079176|FG000|Period 3|Adverse Event|1|||
162006422|NCT00674817|585079176|FG000|Period 3|Protocol Violation|1|||
162006423|NCT00674817|585079176|FG000|Period 4|Adverse Event|1|||
162006424|NCT05660577|585079178|FG000|Overall Study|Discontinued|9|||
162006425|NCT03363841|585079179|FG000|Overall Study|Adverse Event|1|||
162006426|NCT03363841|585079179|FG000|Overall Study|Withdrawal by Subject|1|||
162006427|NCT03363841|585079179|FG000|Overall Study|Death|7|||
162006428|NCT03363841|585079179|FG000|Overall Study|Physician Decision|1|||
162006429|NCT02156076|585079184|FG000|Treatment Period|no longer meets study criteria|0|||
162006430|NCT02156076|585079185|FG001|Treatment Period|no longer meets study criteria|0|||
162006431|NCT02156076|585079186|FG002|Treatment Period|no longer meets study criteria|1|||
162006432|NCT02156076|585079187|FG003|Treatment Period|no longer meets study criteria|0|||
162006433|NCT02156076|585079184|FG000|Treatment Period|Poor/non-compliance|0|||
162006434|NCT02156076|585079185|FG001|Treatment Period|Poor/non-compliance|1|||
162006435|NCT02156076|585079186|FG002|Treatment Period|Poor/non-compliance|0|||
162006436|NCT02156076|585079187|FG003|Treatment Period|Poor/non-compliance|0|||
162006437|NCT02156076|585079184|FG000|Treatment Period|Lost to Follow-up|0|||
162006438|NCT02156076|585079185|FG001|Treatment Period|Lost to Follow-up|0|||
162006439|NCT02156076|585079186|FG002|Treatment Period|Lost to Follow-up|0|||
162006440|NCT02156076|585079187|FG003|Treatment Period|Lost to Follow-up|1|||
162006441|NCT02156076|585079184|FG000|Treatment Period|Withdrawal by Subject|0|||
162006442|NCT02156076|585079185|FG001|Treatment Period|Withdrawal by Subject|0|||
162006443|NCT02156076|585079186|FG002|Treatment Period|Withdrawal by Subject|1|||
162006444|NCT02156076|585079187|FG003|Treatment Period|Withdrawal by Subject|0|||
162006445|NCT02156076|585079184|FG000|Treatment Period|Subject request to discontinue treatment|0|||
162006446|NCT02156076|585079185|FG001|Treatment Period|Subject request to discontinue treatment|1|||
162006447|NCT02156076|585079186|FG002|Treatment Period|Subject request to discontinue treatment|0|||
162006448|NCT02156076|585079187|FG003|Treatment Period|Subject request to discontinue treatment|0|||
162006449|NCT02156076|585079184|FG000|Treatment Period|Adverse Event|0|||
162006450|NCT02156076|585079185|FG001|Treatment Period|Adverse Event|0|||
162006451|NCT02156076|585079186|FG002|Treatment Period|Adverse Event|0|||
162006452|NCT02156076|585079187|FG003|Treatment Period|Adverse Event|1|||
162006453|NCT02156076|585079184|FG000|Follow-up Period|Withdrawal by Subject|1|||
162006454|NCT02156076|585079185|FG001|Follow-up Period|Withdrawal by Subject|0|||
162006455|NCT02156076|585079186|FG002|Follow-up Period|Withdrawal by Subject|0|||
162006456|NCT02156076|585079187|FG003|Follow-up Period|Withdrawal by Subject|0|||
162006457|NCT03566511|585079191|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
162006458|NCT03566511|585079192|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
162006459|NCT00981656|585079198|FG000|Overall Study|Protocol Violation|1|||
162006460|NCT00981656|585079198|FG000|Overall Study|Did not start protocol treatment|2|||
162006461|NCT04026113|585079199|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
162006462|NCT04026113|585079200|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
162006463|NCT04026113|585079201|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
162006464|NCT04026113|585079202|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
162006465|NCT04026113|585079199|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
162006466|NCT04026113|585079200|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
162006467|NCT04026113|585079201|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
162006468|NCT04026113|585079202|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
162006469|NCT04026113|585079199|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
162006470|NCT04026113|585079200|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162006471|NCT04026113|585079201|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
162006472|NCT04026113|585079202|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162006473|NCT04026113|585079199|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
162006474|NCT04026113|585079200|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
162006475|NCT04026113|585079201|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
162006476|NCT04026113|585079202|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
162006477|NCT04026113|585079199|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
162006478|NCT04026113|585079200|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
162006479|NCT04026113|585079201|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
162044488|NCT01189604|585220726|FG001|Overall Study|Withdrawal by Subject|0|||
162044489|NCT01189604|585220727|FG002|Overall Study|Withdrawal by Subject|0|||
162006480|NCT04026113|585079202|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
162006481|NCT04026113|585079199|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
162006482|NCT04026113|585079200|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
162006483|NCT04026113|585079201|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
162006484|NCT04026113|585079202|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
162006485|NCT04026113|585079199|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
162006486|NCT04026113|585079200|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
162006487|NCT04026113|585079201|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
162006488|NCT04026113|585079202|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
162006489|NCT04026113|585079199|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
162006490|NCT04026113|585079200|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
162006491|NCT04026113|585079201|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
162006492|NCT04026113|585079202|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
162006493|NCT04026113|585079199|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
162006494|NCT04026113|585079200|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
162006495|NCT04026113|585079201|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
162006496|NCT04026113|585079202|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
162006497|NCT00687596|585079203|FG000|Overall Study|Adverse Event (AE)|10|||
162006498|NCT00687596|585079204|FG001|Overall Study|Adverse Event (AE)|3|||
162006499|NCT00687596|585079203|FG000|Overall Study|Radiological Disease Progression|6|||
162006500|NCT00687596|585079204|FG001|Overall Study|Radiological Disease Progression|2|||
162006501|NCT00687596|585079203|FG000|Overall Study|Clinical Disease Progression|1|||
162006502|NCT00687596|585079204|FG001|Overall Study|Clinical Disease Progression|3|||
162006503|NCT00687596|585079203|FG000|Overall Study|Investigator Discretion|3|||
162006504|NCT00687596|585079204|FG001|Overall Study|Investigator Discretion|1|||
162006505|NCT00687596|585079203|FG000|Overall Study|Sponsor Terminated Study|6|||
162006506|NCT00687596|585079204|FG001|Overall Study|Sponsor Terminated Study|17|||
162006507|NCT01527149|585079205|FG000|Overall Study|Death|2|||
162006508|NCT01709721|585079206|FG000|Open Label Phase|Withdrawal by Subject|0|||
162006509|NCT01709721|585079207|FG001|Open Label Phase|Withdrawal by Subject|0|||
162006510|NCT01709721|585079208|FG002|Open Label Phase|Withdrawal by Subject|5|||
162006511|NCT01709721|585079206|FG000|Open Label Phase|Adverse Event|0|||
162006512|NCT01709721|585079207|FG001|Open Label Phase|Adverse Event|0|||
162006513|NCT01709721|585079208|FG002|Open Label Phase|Adverse Event|8|||
162006514|NCT01709721|585079206|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
162006515|NCT01709721|585079207|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
162006516|NCT01709721|585079208|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
162006517|NCT01709721|585079206|FG000|Open Label Phase|Investigator Decision|0|||
162006518|NCT01709721|585079207|FG001|Open Label Phase|Investigator Decision|0|||
162006519|NCT01709721|585079208|FG002|Open Label Phase|Investigator Decision|1|||
162006520|NCT01709721|585079206|FG000|Open Label Phase|Sponsor Decision|0|||
162006521|NCT01709721|585079207|FG001|Open Label Phase|Sponsor Decision|0|||
162006522|NCT01709721|585079208|FG002|Open Label Phase|Sponsor Decision|2|||
162006523|NCT01709721|585079206|FG000|Open Label Phase|Protocol Violation|0|||
162006524|NCT01709721|585079207|FG001|Open Label Phase|Protocol Violation|0|||
162006525|NCT01709721|585079208|FG002|Open Label Phase|Protocol Violation|1|||
162006526|NCT01709721|585079206|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
162006527|NCT01709721|585079207|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
162006528|NCT01709721|585079208|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
162006529|NCT01709721|585079206|FG000|Open Label Phase|Inadequate Pain Control|0|||
162006530|NCT01709721|585079207|FG001|Open Label Phase|Inadequate Pain Control|0|||
162006531|NCT01709721|585079208|FG002|Open Label Phase|Inadequate Pain Control|37|||
162006532|NCT01709721|585079206|FG000|Open Label Phase|Other, Specify in text field in database|0|||
162006533|NCT01709721|585079207|FG001|Open Label Phase|Other, Specify in text field in database|0|||
162006534|NCT01709721|585079208|FG002|Open Label Phase|Other, Specify in text field in database|14|||
162006535|NCT01709721|585079206|FG000|Randomized Phase|Adverse Event|0|||
162006536|NCT01709721|585079207|FG001|Randomized Phase|Adverse Event|1|||
162006537|NCT01709721|585079208|FG002|Randomized Phase|Adverse Event|0|||
162006538|NCT01709721|585079206|FG000|Randomized Phase|Lost to Follow-up|1|||
162006539|NCT01709721|585079207|FG001|Randomized Phase|Lost to Follow-up|0|||
162006540|NCT01709721|585079208|FG002|Randomized Phase|Lost to Follow-up|0|||
162006541|NCT01709721|585079206|FG000|Randomized Phase|Inadequate Pain Control|1|||
162006542|NCT01709721|585079207|FG001|Randomized Phase|Inadequate Pain Control|2|||
162006543|NCT01709721|585079208|FG002|Randomized Phase|Inadequate Pain Control|0|||
162006544|NCT01709721|585079206|FG000|Randomized Phase|Other, Specify text field in database|1|||
162006545|NCT01709721|585079207|FG001|Randomized Phase|Other, Specify text field in database|3|||
162006546|NCT01709721|585079208|FG002|Randomized Phase|Other, Specify text field in database|0|||
162006547|NCT02230410|585079211|FG000|Overall Study|Screen Failure|3|||
162006548|NCT02558894|585079217|FG000|Overall Study|Death; any cause, entire study duration|28|||
162044490|NCT01189604|585220728|FG003|Overall Study|Withdrawal by Subject|0|||
162044491|NCT01189604|585220729|FG004|Overall Study|Withdrawal by Subject|0|||
162044492|NCT01189604|585220730|FG005|Overall Study|Withdrawal by Subject|0|||
162044493|NCT01189604|585220731|FG006|Overall Study|Withdrawal by Subject|0|||
162044494|NCT00808483|585220732|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
162044495|NCT00808483|585220733|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
162044496|NCT00808483|585220732|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
162044497|NCT00808483|585220733|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
162044498|NCT00808483|585220732|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
162044499|NCT00808483|585220733|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
162044500|NCT03945214|585220734|FG000|Overall Study|Lost to Follow-up|3|||
162044501|NCT03945214|585220735|FG001|Overall Study|Lost to Follow-up|4|||
162044502|NCT03945214|585220736|FG002|Overall Study|Lost to Follow-up|7|||
162044503|NCT03945214|585220737|FG003|Overall Study|Lost to Follow-up|4|||
162044504|NCT04102098|585220755|FG000|Main Study Period|Ongoing in study|302|||
162044505|NCT04102098|585220756|FG001|Main Study Period|Ongoing in study|291|||
162044506|NCT04102098|585220755|FG000|Main Study Period|Death|20|||
162044507|NCT04102098|585220756|FG001|Main Study Period|Death|27|||
162044508|NCT04102098|585220755|FG000|Main Study Period|Lost to Follow-up|1|||
162044509|NCT04102098|585220756|FG001|Main Study Period|Lost to Follow-up|1|||
162044510|NCT04102098|585220755|FG000|Main Study Period|Physician Decision|0|||
162044511|NCT04102098|585220756|FG001|Main Study Period|Physician Decision|1|||
162044512|NCT04102098|585220755|FG000|Main Study Period|Withdrawal by Subject|11|||
162044513|NCT04102098|585220756|FG001|Main Study Period|Withdrawal by Subject|14|||
162044514|NCT04102098|585220755|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
162044515|NCT04102098|585220756|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
162044516|NCT04102098|585220755|FG000|Crossover: AS Who Crossed Over|Death|11|||
162044517|NCT04102098|585220756|FG001|Crossover: AS Who Crossed Over|Death|0|||
162044518|NCT04102098|585220755|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
162044519|NCT04102098|585220756|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
162044520|NCT03150173|585220759|FG000|Overall Study|Lost to Follow-up|13|||
162044521|NCT03150173|585220760|FG001|Overall Study|Lost to Follow-up|5|||
162044522|NCT03755791|585220761|FG000|Overall Study|Did not receive any study treatment|3|||
162044523|NCT03755791|585220762|FG001|Overall Study|Did not receive any study treatment|0|||
162044524|NCT03755791|585220763|FG002|Overall Study|Did not receive any study treatment|10|||
162044525|NCT03755791|585220761|FG000|Overall Study|Radiographic progression|204|||
162044526|NCT03755791|585220762|FG001|Overall Study|Radiographic progression|92|||
162044527|NCT03755791|585220763|FG002|Overall Study|Radiographic progression|115|||
162044528|NCT03755791|585220761|FG000|Overall Study|Adverse Event|140|||
162044529|NCT03755791|585220762|FG001|Overall Study|Adverse Event|60|||
162044530|NCT03755791|585220763|FG002|Overall Study|Adverse Event|51|||
162044531|NCT03755791|585220761|FG000|Overall Study|Lack of Efficacy|12|||
162044532|NCT03755791|585220762|FG001|Overall Study|Lack of Efficacy|6|||
162044533|NCT03755791|585220763|FG002|Overall Study|Lack of Efficacy|6|||
162044534|NCT03755791|585220761|FG000|Overall Study|Withdrawal by Subject|26|||
162044535|NCT03755791|585220762|FG001|Overall Study|Withdrawal by Subject|23|||
162044536|NCT03755791|585220763|FG002|Overall Study|Withdrawal by Subject|24|||
162044537|NCT03755791|585220761|FG000|Overall Study|Sponsor decision,|41|||
162044538|NCT03755791|585220762|FG001|Overall Study|Sponsor decision,|5|||
162044539|NCT03755791|585220763|FG002|Overall Study|Sponsor decision,|7|||
162044540|NCT03755791|585220761|FG000|Overall Study|Lost to Follow-up|1|||
162044541|NCT03755791|585220762|FG001|Overall Study|Lost to Follow-up|0|||
162044542|NCT03755791|585220763|FG002|Overall Study|Lost to Follow-up|2|||
162044543|NCT03755791|585220761|FG000|Overall Study|Protocol Violation|0|||
162044544|NCT03755791|585220762|FG001|Overall Study|Protocol Violation|0|||
162044545|NCT03755791|585220763|FG002|Overall Study|Protocol Violation|2|||
162044546|NCT03755791|585220761|FG000|Overall Study|Other than specified|5|||
162044547|NCT03755791|585220762|FG001|Overall Study|Other than specified|2|||
162044548|NCT03755791|585220763|FG002|Overall Study|Other than specified|0|||
162044549|NCT01756053|585220767|FG000|Period 1 (10 Days)|Protocol Violation|1|||
162044550|NCT01756053|585220768|FG001|Period 1 (10 Days)|Protocol Violation|1|||
162044551|NCT01756053|585220767|FG000|Period 2 (10 Days)|Protocol Violation|0|||
162044552|NCT01756053|585220768|FG001|Period 2 (10 Days)|Protocol Violation|2|||
162044553|NCT03277690|585220769|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
162044554|NCT03277690|585220770|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
162044555|NCT03277690|585220769|FG000|Dose Titration and Maintenance|Physician Decision|1|||
162044556|NCT03277690|585220770|FG001|Dose Titration and Maintenance|Physician Decision|0|||
162044557|NCT03277690|585220769|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
162044558|NCT03277690|585220770|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
162044559|NCT03277690|585220769|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
162044560|NCT03277690|585220770|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
162044561|NCT03277690|585220769|FG000|Dose Titration and Maintenance|Adverse Event|15|||
162044562|NCT03277690|585220770|FG001|Dose Titration and Maintenance|Adverse Event|0|||
162044563|NCT03277690|585220769|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
162006549|NCT02558894|585079218|FG001|Overall Study|Death; any cause, entire study duration|31|||
162006550|NCT02558894|585079217|FG000|Overall Study|Withdrawal by Subject|2|||
162006551|NCT02558894|585079218|FG001|Overall Study|Withdrawal by Subject|1|||
162006552|NCT02558894|585079217|FG000|Overall Study|Closure of Part A|2|||
162006553|NCT02558894|585079218|FG001|Overall Study|Closure of Part A|1|||
162006554|NCT02992288|585079219|FG000|Overall Study|Adverse Event|8|||
162006555|NCT02992288|585079220|FG001|Overall Study|Adverse Event|2|||
162006556|NCT02992288|585079221|FG002|Overall Study|Adverse Event|2|||
162006557|NCT02992288|585079222|FG003|Overall Study|Adverse Event|2|||
162006558|NCT02992288|585079223|FG004|Overall Study|Adverse Event|2|||
162006559|NCT02992288|585079224|FG005|Overall Study|Adverse Event|7|||
162006560|NCT02992288|585079219|FG000|Overall Study|Non-compliance with study drug|0|||
162006561|NCT02992288|585079220|FG001|Overall Study|Non-compliance with study drug|1|||
162006562|NCT02992288|585079221|FG002|Overall Study|Non-compliance with study drug|1|||
162006563|NCT02992288|585079222|FG003|Overall Study|Non-compliance with study drug|0|||
162006564|NCT02992288|585079223|FG004|Overall Study|Non-compliance with study drug|1|||
162006565|NCT02992288|585079224|FG005|Overall Study|Non-compliance with study drug|0|||
162006566|NCT02992288|585079219|FG000|Overall Study|Physician Decision|3|||
162006567|NCT02992288|585079220|FG001|Overall Study|Physician Decision|0|||
162006568|NCT02992288|585079221|FG002|Overall Study|Physician Decision|1|||
162006569|NCT02992288|585079222|FG003|Overall Study|Physician Decision|0|||
162006570|NCT02992288|585079223|FG004|Overall Study|Physician Decision|0|||
162006571|NCT02992288|585079224|FG005|Overall Study|Physician Decision|1|||
162006572|NCT02992288|585079219|FG000|Overall Study|Death|2|||
162006573|NCT02992288|585079220|FG001|Overall Study|Death|0|||
162006574|NCT02992288|585079221|FG002|Overall Study|Death|2|||
162006575|NCT02992288|585079222|FG003|Overall Study|Death|1|||
162006576|NCT02992288|585079223|FG004|Overall Study|Death|2|||
162006577|NCT02992288|585079224|FG005|Overall Study|Death|0|||
162006578|NCT02992288|585079219|FG000|Overall Study|Lost to Follow-up|0|||
162006579|NCT02992288|585079220|FG001|Overall Study|Lost to Follow-up|0|||
162006580|NCT02992288|585079221|FG002|Overall Study|Lost to Follow-up|0|||
162006581|NCT02992288|585079222|FG003|Overall Study|Lost to Follow-up|1|||
162006582|NCT02992288|585079223|FG004|Overall Study|Lost to Follow-up|0|||
162006583|NCT02992288|585079224|FG005|Overall Study|Lost to Follow-up|0|||
162006584|NCT02992288|585079219|FG000|Overall Study|Protocol Violation|0|||
162006585|NCT02992288|585079220|FG001|Overall Study|Protocol Violation|0|||
162006586|NCT02992288|585079221|FG002|Overall Study|Protocol Violation|0|||
162006587|NCT02992288|585079222|FG003|Overall Study|Protocol Violation|0|||
162006588|NCT02992288|585079223|FG004|Overall Study|Protocol Violation|0|||
162006589|NCT02992288|585079224|FG005|Overall Study|Protocol Violation|1|||
162006590|NCT02992288|585079219|FG000|Overall Study|Withdrawal by Subject|4|||
162006591|NCT02992288|585079220|FG001|Overall Study|Withdrawal by Subject|2|||
162006592|NCT02992288|585079221|FG002|Overall Study|Withdrawal by Subject|1|||
162006593|NCT02992288|585079222|FG003|Overall Study|Withdrawal by Subject|5|||
162006594|NCT02992288|585079223|FG004|Overall Study|Withdrawal by Subject|3|||
162006595|NCT02992288|585079224|FG005|Overall Study|Withdrawal by Subject|4|||
162006596|NCT00656513|585079225|FG000|Overall Study|Protocol Violation|1|||
162006597|NCT00656513|585079226|FG001|Overall Study|Protocol Violation|0|||
162006598|NCT00656513|585079227|FG002|Overall Study|Protocol Violation|2|||
162006599|NCT00656513|585079225|FG000|Overall Study|Withdrawal by Subject|0|||
162006600|NCT00656513|585079226|FG001|Overall Study|Withdrawal by Subject|11|||
162006601|NCT00656513|585079227|FG002|Overall Study|Withdrawal by Subject|4|||
162006602|NCT00656513|585079225|FG000|Overall Study|Death|0|||
162006603|NCT00656513|585079226|FG001|Overall Study|Death|0|||
162006604|NCT00656513|585079227|FG002|Overall Study|Death|1|||
162006605|NCT00656513|585079225|FG000|Overall Study|Missing data|0|||
162006606|NCT00656513|585079226|FG001|Overall Study|Missing data|11|||
162006607|NCT00656513|585079227|FG002|Overall Study|Missing data|9|||
162006608|NCT00656513|585079225|FG000|Overall Study|Incomplete treatment|3|||
162006609|NCT00656513|585079226|FG001|Overall Study|Incomplete treatment|0|||
162006610|NCT00656513|585079227|FG002|Overall Study|Incomplete treatment|0|||
162006611|NCT00656513|585079225|FG000|Overall Study|Treatment completed outside of timeframe|0|||
162006612|NCT00656513|585079226|FG001|Overall Study|Treatment completed outside of timeframe|3|||
162006613|NCT00656513|585079227|FG002|Overall Study|Treatment completed outside of timeframe|1|||
162006614|NCT00656513|585079225|FG000|Overall Study|Missing baseline form|0|||
162006615|NCT00656513|585079226|FG001|Overall Study|Missing baseline form|5|||
162006616|NCT00656513|585079227|FG002|Overall Study|Missing baseline form|5|||
162006617|NCT03796728|585079232|FG000|Overall Study|Lost to Follow-up|8|||
162006618|NCT03796728|585079232|FG000|Overall Study|Reason not Specified|16|||
162006619|NCT00412984|585079237|FG000|Overall Study|Death|331|||
162006620|NCT00412984|585079238|FG001|Overall Study|Death|349|||
162006621|NCT00412984|585079237|FG000|Overall Study|Adverse Event|679|||
162006622|NCT00412984|585079238|FG001|Overall Study|Adverse Event|738|||
162006623|NCT00412984|585079237|FG000|Overall Study|Withdrawal by Subject|921|||
162006624|NCT00412984|585079238|FG001|Overall Study|Withdrawal by Subject|989|||
162006625|NCT00412984|585079237|FG000|Overall Study|Lost to Follow-up|51|||
162006626|NCT00412984|585079238|FG001|Overall Study|Lost to Follow-up|39|||
162006627|NCT00412984|585079237|FG000|Overall Study|Poor/Noncompliance|57|||
162006628|NCT00412984|585079238|FG001|Overall Study|Poor/Noncompliance|77|||
162006629|NCT00412984|585079237|FG000|Overall Study|Pregnancy|1|||
162006630|NCT00412984|585079238|FG001|Overall Study|Pregnancy|0|||
162006631|NCT00412984|585079237|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
162006632|NCT00412984|585079238|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
162006633|NCT00412984|585079237|FG000|Overall Study|Administrative Reason by Sponsor|11|||
162006634|NCT00412984|585079238|FG001|Overall Study|Administrative Reason by Sponsor|8|||
162006635|NCT00412984|585079237|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
162006636|NCT00412984|585079238|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
162006637|NCT00412984|585079237|FG000|Overall Study|Other Reason|80|||
162006638|NCT00412984|585079238|FG001|Overall Study|Other Reason|92|||
162006639|NCT00412984|585079237|FG000|Overall Study|Not Reported|11|||
162006640|NCT00412984|585079238|FG001|Overall Study|Not Reported|12|||
162006641|NCT04218240|585079240|FG000|Overall Study|Withdrawal by Subject|6|||
162006642|NCT04218240|585079241|FG001|Overall Study|Withdrawal by Subject|0|||
162006643|NCT04218240|585079240|FG000|Overall Study|Lack of Efficacy|24|||
162006644|NCT04218240|585079241|FG001|Overall Study|Lack of Efficacy|19|||
162006645|NCT04218240|585079240|FG000|Overall Study|Physician Decision|0|||
162006646|NCT04218240|585079241|FG001|Overall Study|Physician Decision|1|||
162006647|NCT04218240|585079240|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
162006648|NCT04218240|585079241|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
162006649|NCT04097678|585079242|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
162006650|NCT04097678|585079243|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
162006651|NCT03694678|585079244|FG000|Overall Study|Withdrawal by Subject|2|||
162006652|NCT03694678|585079245|FG001|Overall Study|Withdrawal by Subject|0|||
162006653|NCT03694678|585079244|FG000|Overall Study|Lost to Follow-up|2|||
162006654|NCT03694678|585079245|FG001|Overall Study|Lost to Follow-up|3|||
162006655|NCT02435212|585079246|FG000|Core Phase|Adverse Event|8|||
162006656|NCT02435212|585079247|FG001|Core Phase|Adverse Event|5|||
162006657|NCT02435212|585079246|FG000|Core Phase|Withdrawal by Subject|3|||
162006658|NCT02435212|585079247|FG001|Core Phase|Withdrawal by Subject|0|||
162006659|NCT02435212|585079246|FG000|Core Phase|Withdrawal by parent/guardian|9|||
162006660|NCT02435212|585079247|FG001|Core Phase|Withdrawal by parent/guardian|4|||
162006661|NCT02435212|585079246|FG000|Core Phase|Protocol Violation|1|||
162006662|NCT02435212|585079247|FG001|Core Phase|Protocol Violation|2|||
162006663|NCT02435212|585079246|FG000|Core Phase|Physician Decision|3|||
162006664|NCT02435212|585079247|FG001|Core Phase|Physician Decision|0|||
162006665|NCT02435212|585079246|FG000|Core Phase|Lost to Follow-up|0|||
162006666|NCT02435212|585079247|FG001|Core Phase|Lost to Follow-up|1|||
162006667|NCT02435212|585079246|FG000|Core Phase|Lack of Efficacy|0|||
162006668|NCT02435212|585079247|FG001|Core Phase|Lack of Efficacy|1|||
162006669|NCT02435212|585079246|FG000|Core Phase|Recovery|1|||
162006670|NCT02435212|585079247|FG001|Core Phase|Recovery|0|||
162006671|NCT02435212|585079246|FG000|Optional Extension Phase|Adverse Event|3|||
162006672|NCT02435212|585079247|FG001|Optional Extension Phase|Adverse Event|9|||
162006673|NCT02435212|585079246|FG000|Optional Extension Phase|Physician Decision|6|||
162006674|NCT02435212|585079247|FG001|Optional Extension Phase|Physician Decision|8|||
162006675|NCT02435212|585079246|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
162006676|NCT02435212|585079247|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
162006677|NCT02435212|585079246|FG000|Optional Extension Phase|Lack of Efficacy|2|||
162006678|NCT02435212|585079247|FG001|Optional Extension Phase|Lack of Efficacy|3|||
162006679|NCT02435212|585079246|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
162006680|NCT02435212|585079247|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
162006681|NCT02435212|585079246|FG000|Optional Extension Phase|Protocol Violation|0|||
162006682|NCT02435212|585079247|FG001|Optional Extension Phase|Protocol Violation|1|||
162006683|NCT02435212|585079246|FG000|Optional Extension Phase|Recovery|1|||
162006684|NCT02435212|585079247|FG001|Optional Extension Phase|Recovery|1|||
162006685|NCT02435212|585079246|FG000|Optional Extension Phase|Death|1|||
162006686|NCT02435212|585079247|FG001|Optional Extension Phase|Death|0|||
162006687|NCT02435212|585079246|FG000|Optional Extension Phase|Technical problems|2|||
162006688|NCT02435212|585079247|FG001|Optional Extension Phase|Technical problems|0|||
162006689|NCT01346358|585079248|FG000|Overall Study|Withdrawal by Subject|1|||
162006690|NCT01346358|585079249|FG001|Overall Study|Withdrawal by Subject|0|||
162006691|NCT01346358|585079250|FG002|Overall Study|Withdrawal by Subject|1|||
162006692|NCT01346358|585079251|FG003|Overall Study|Withdrawal by Subject|1|||
162006693|NCT01346358|585079252|FG004|Overall Study|Withdrawal by Subject|0|||
162006694|NCT01346358|585079253|FG005|Overall Study|Withdrawal by Subject|2|||
162006695|NCT01346358|585079254|FG006|Overall Study|Withdrawal by Subject|1|||
162006696|NCT01346358|585079255|FG007|Overall Study|Withdrawal by Subject|1|||
162006697|NCT01346358|585079256|FG008|Overall Study|Withdrawal by Subject|1|||
162006698|NCT01346358|585079248|FG000|Overall Study|Adverse Event|1|||
162044564|NCT03277690|585220770|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
162006699|NCT01346358|585079249|FG001|Overall Study|Adverse Event|0|||
162006700|NCT01346358|585079250|FG002|Overall Study|Adverse Event|0|||
162006701|NCT01346358|585079251|FG003|Overall Study|Adverse Event|0|||
162006702|NCT01346358|585079252|FG004|Overall Study|Adverse Event|1|||
162006703|NCT01346358|585079253|FG005|Overall Study|Adverse Event|0|||
162006704|NCT01346358|585079254|FG006|Overall Study|Adverse Event|0|||
162006705|NCT01346358|585079255|FG007|Overall Study|Adverse Event|0|||
162006706|NCT01346358|585079256|FG008|Overall Study|Adverse Event|1|||
162006707|NCT01346358|585079248|FG000|Overall Study|Non-Compliance|0|||
162006708|NCT01346358|585079249|FG001|Overall Study|Non-Compliance|0|||
162006709|NCT01346358|585079250|FG002|Overall Study|Non-Compliance|0|||
162006710|NCT01346358|585079251|FG003|Overall Study|Non-Compliance|0|||
162006711|NCT01346358|585079252|FG004|Overall Study|Non-Compliance|0|||
162006712|NCT01346358|585079253|FG005|Overall Study|Non-Compliance|0|||
162006713|NCT01346358|585079254|FG006|Overall Study|Non-Compliance|0|||
162006714|NCT01346358|585079255|FG007|Overall Study|Non-Compliance|2|||
162006715|NCT01346358|585079256|FG008|Overall Study|Non-Compliance|0|||
162006716|NCT01346358|585079248|FG000|Overall Study|Physician Decision|0|||
162006717|NCT01346358|585079249|FG001|Overall Study|Physician Decision|1|||
162006718|NCT01346358|585079250|FG002|Overall Study|Physician Decision|0|||
162006719|NCT01346358|585079251|FG003|Overall Study|Physician Decision|0|||
162006720|NCT01346358|585079252|FG004|Overall Study|Physician Decision|0|||
162006721|NCT01346358|585079253|FG005|Overall Study|Physician Decision|0|||
162006722|NCT01346358|585079254|FG006|Overall Study|Physician Decision|0|||
162006723|NCT01346358|585079255|FG007|Overall Study|Physician Decision|1|||
162006724|NCT01346358|585079256|FG008|Overall Study|Physician Decision|1|||
162006725|NCT05058365|585079259|FG000|Overall Study|Migration|1|||
162006726|NCT05058365|585079260|FG001|Overall Study|Migration|1|||
162006727|NCT00702702|585079261|FG000|Overall Study|Study prematurely terminated|56|||
162006728|NCT04819945|585079262|FG000|Overall Study|Lost to Follow-up|1|||
162006729|NCT04531176|585079265|FG000|Overall Study|Study was stopped early|24|||
162006730|NCT04531176|585079266|FG001|Overall Study|Study was stopped early|26|||
162006731|NCT04531176|585079267|FG002|Overall Study|Study was stopped early|24|||
162006732|NCT00561652|585079272|FG000|Overall Study|Withdrawal by Subject|0|||
162006733|NCT00561652|585079273|FG001|Overall Study|Withdrawal by Subject|1|||
162006734|NCT01451606|585079276|FG000|Overall Study|Withdrawal by Subject|4|||
162006735|NCT01451606|585079277|FG001|Overall Study|Withdrawal by Subject|3|||
162006736|NCT01614249|585079278|FG000|Overall Study|Lost to Follow-up|11|||
162006737|NCT01614249|585079279|FG001|Overall Study|Lost to Follow-up|23|||
162006738|NCT05498649|585079280|FG000|Overall Study|Lost to Follow-up|1|||
162006739|NCT03094416|585079281|FG000|Run-in|Screening failure|8|||
162006740|NCT03094416|585079281|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
162006741|NCT03094416|585079281|FG000|Run-in|Withdrawal by Subject|3|||
162006742|NCT03094416|585079281|FG000|Treatment Period|Withdrawal by Subject|2|||
162006743|NCT00321789|585079282|FG000|Overall Study|Lost to Follow-up|4|||
162006744|NCT00321789|585079283|FG001|Overall Study|Lost to Follow-up|7|||
162006745|NCT00321789|585079282|FG000|Overall Study|Withdrawal by Subject|6|||
162006746|NCT00321789|585079283|FG001|Overall Study|Withdrawal by Subject|6|||
162006747|NCT00321789|585079282|FG000|Overall Study|Protocol Violation|5|||
162006748|NCT00321789|585079283|FG001|Overall Study|Protocol Violation|3|||
162006749|NCT00005780|585079285|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
162006750|NCT02651675|585079286|FG000|Overall Study|Death|0|||
162006751|NCT02651675|585079287|FG001|Overall Study|Death|0|||
162006752|NCT02651675|585079288|FG002|Overall Study|Death|1|||
162006753|NCT00374140|585079289|FG000|Overall Study|Lost to Follow-up|1|||
162006754|NCT00374140|585079289|FG000|Overall Study|Protocol Violation|1|||
162006755|NCT02246530|585079290|FG000|Overall Study|Lost to Follow-up|4|||
162006756|NCT02246530|585079291|FG001|Overall Study|Lost to Follow-up|0|||
162006757|NCT00617734|585079292|FG000|Overall Study|Withdrew Consent|2|||
162006758|NCT00617734|585079293|FG001|Overall Study|Withdrew Consent|0|||
162006759|NCT00617734|585079292|FG000|Overall Study|Adverse Event|4|||
162006760|NCT00617734|585079293|FG001|Overall Study|Adverse Event|1|||
162006761|NCT00617734|585079292|FG000|Overall Study|Protocol Violation|1|||
162006762|NCT00617734|585079293|FG001|Overall Study|Protocol Violation|0|||
162006763|NCT00617734|585079292|FG000|Overall Study|Found Ineligible After Randomization|1|||
162006764|NCT00617734|585079293|FG001|Overall Study|Found Ineligible After Randomization|4|||
162006765|NCT00617734|585079292|FG000|Overall Study|Lost to Follow-up|0|||
162006766|NCT00617734|585079293|FG001|Overall Study|Lost to Follow-up|1|||
162006767|NCT02485691|585079294|FG000|Overall Study|Adverse Event|25|||
162006768|NCT02485691|585079295|FG001|Overall Study|Adverse Event|11|||
162006769|NCT02485691|585079294|FG000|Overall Study|Poor compliance to protocol|0|||
162006770|NCT02485691|585079295|FG001|Overall Study|Poor compliance to protocol|1|||
162006771|NCT02485691|585079294|FG000|Overall Study|Disease progression|57|||
162006772|NCT02485691|585079295|FG001|Overall Study|Disease progression|92|||
162006773|NCT02485691|585079294|FG000|Overall Study|Investigator's decision|23|||
162006774|NCT02485691|585079295|FG001|Overall Study|Investigator's decision|5|||
162006775|NCT02485691|585079294|FG000|Overall Study|Participant's request|13|||
162006776|NCT02485691|585079295|FG001|Overall Study|Participant's request|6|||
162006777|NCT02485691|585079294|FG000|Overall Study|Other reason|8|||
162006778|NCT02485691|585079295|FG001|Overall Study|Other reason|9|||
162006779|NCT02485691|585079294|FG000|Overall Study|Randomized and not treated|3|||
162006780|NCT02485691|585079295|FG001|Overall Study|Randomized and not treated|2|||
162044565|NCT03277690|585220769|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
162044566|NCT03277690|585220770|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
162044567|NCT02853344|585220771|FG000|Overall Study|Lost to Follow-up|1|||
162044568|NCT02853344|585220772|FG001|Overall Study|Lost to Follow-up|1|||
162044569|NCT02853344|585220771|FG000|Overall Study|Withdrawal by Subject|2|||
162044570|NCT02853344|585220772|FG001|Overall Study|Withdrawal by Subject|4|||
162044571|NCT02853344|585220771|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
162044572|NCT02853344|585220772|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
162044573|NCT02853344|585220771|FG000|Overall Study|Death|70|||
162044574|NCT02853344|585220772|FG001|Overall Study|Death|112|||
162044575|NCT02955797|585220773|FG000|Overall Study|Protocol Violation|1|||
162044576|NCT02955797|585220774|FG001|Overall Study|Protocol Violation|0|||
162044577|NCT02955797|585220775|FG002|Overall Study|Protocol Violation|0|||
162044578|NCT02955797|585220776|FG003|Overall Study|Protocol Violation|1|||
162044579|NCT02955797|585220773|FG000|Overall Study|Withdrawal by Subject|2|||
162044580|NCT02955797|585220774|FG001|Overall Study|Withdrawal by Subject|2|||
162044581|NCT02955797|585220775|FG002|Overall Study|Withdrawal by Subject|0|||
162044582|NCT02955797|585220776|FG003|Overall Study|Withdrawal by Subject|1|||
162044583|NCT02955797|585220773|FG000|Overall Study|Lost to Follow-up|0|||
162044584|NCT02955797|585220774|FG001|Overall Study|Lost to Follow-up|1|||
162044585|NCT02955797|585220775|FG002|Overall Study|Lost to Follow-up|0|||
162044586|NCT02955797|585220776|FG003|Overall Study|Lost to Follow-up|0|||
162044587|NCT03131453|585220778|FG000|Overall Study|Study terminated by Sponsor|424|||
162044588|NCT03131453|585220779|FG001|Overall Study|Study terminated by Sponsor|222|||
162044589|NCT03131453|585220780|FG002|Overall Study|Study terminated by Sponsor|438|||
162044590|NCT03131453|585220778|FG000|Overall Study|Withdrawal by Subject|18|||
162044591|NCT03131453|585220779|FG001|Overall Study|Withdrawal by Subject|7|||
162044592|NCT03131453|585220780|FG002|Overall Study|Withdrawal by Subject|13|||
162044593|NCT03131453|585220778|FG000|Overall Study|Adverse Event|10|||
162006781|NCT04292535|585079296|FG000|Overall Study|Withdrawal by Subject|0|||
162006782|NCT04292535|585079297|FG001|Overall Study|Withdrawal by Subject|0|||
162044594|NCT03131453|585220779|FG001|Overall Study|Adverse Event|3|||
162044595|NCT03131453|585220780|FG002|Overall Study|Adverse Event|3|||
162044596|NCT03131453|585220778|FG000|Overall Study|Lost to Follow-up|1|||
162044597|NCT03131453|585220779|FG001|Overall Study|Lost to Follow-up|0|||
162044598|NCT03131453|585220780|FG002|Overall Study|Lost to Follow-up|1|||
162044599|NCT03131453|585220778|FG000|Overall Study|Physician Decision|1|||
162044600|NCT03131453|585220779|FG001|Overall Study|Physician Decision|0|||
162044601|NCT03131453|585220780|FG002|Overall Study|Physician Decision|1|||
162044602|NCT03131453|585220778|FG000|Overall Study|Non-compliance with study treatment|1|||
162044603|NCT03131453|585220779|FG001|Overall Study|Non-compliance with study treatment|0|||
162044604|NCT03131453|585220780|FG002|Overall Study|Non-compliance with study treatment|0|||
162044605|NCT03131453|585220778|FG000|Overall Study|Technical problems|1|||
162044606|NCT03131453|585220779|FG001|Overall Study|Technical problems|0|||
162044607|NCT03131453|585220780|FG002|Overall Study|Technical problems|0|||
162044608|NCT03131453|585220778|FG000|Overall Study|Protocol deviation|0|||
162044609|NCT03131453|585220779|FG001|Overall Study|Protocol deviation|1|||
162044610|NCT03131453|585220780|FG002|Overall Study|Protocol deviation|0|||
162044611|NCT02081183|585220781|FG000|Overall Study|Lost to Follow-up|0|||
162044612|NCT02081183|585220782|FG001|Overall Study|Lost to Follow-up|1|||
162006783|NCT04292535|585079298|FG002|Overall Study|Withdrawal by Subject|0|||
162006784|NCT04292535|585079299|FG003|Overall Study|Withdrawal by Subject|0|||
162006785|NCT04292535|585079300|FG004|Overall Study|Withdrawal by Subject|0|||
162006786|NCT04292535|585079301|FG005|Overall Study|Withdrawal by Subject|0|||
162006787|NCT04292535|585079302|FG006|Overall Study|Withdrawal by Subject|0|||
162006788|NCT04292535|585079303|FG007|Overall Study|Withdrawal by Subject|1|||
162006789|NCT04292535|585079304|FG008|Overall Study|Withdrawal by Subject|0|||
162006790|NCT04292535|585079305|FG009|Overall Study|Withdrawal by Subject|0|||
162006791|NCT04292535|585079306|FG010|Overall Study|Withdrawal by Subject|0|||
162006792|NCT04292535|585079307|FG011|Overall Study|Withdrawal by Subject|0|||
162006793|NCT04292535|585079308|FG012|Overall Study|Withdrawal by Subject|0|||
162044613|NCT02081183|585220781|FG000|Overall Study|Protocol Violation|1|||
162044614|NCT02081183|585220782|FG001|Overall Study|Protocol Violation|0|||
162044615|NCT02081183|585220781|FG000|Overall Study|Other|3|||
162044616|NCT02081183|585220782|FG001|Overall Study|Other|3|||
162044617|NCT02840721|585220783|FG000|Treatment Period|Adverse Event|1|||
162044618|NCT02840721|585220783|FG000|Follow-Up|Lack of Efficacy|1|||
162006794|NCT04292535|585079309|FG013|Overall Study|Withdrawal by Subject|0|||
162006795|NCT04292535|585079296|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
162044619|NCT02840721|585220783|FG000|Follow-Up|Withdrawal by Subject|4|||
162044620|NCT02840721|585220783|FG000|Follow-Up|Withdrawal of Consent|2|||
162044621|NCT05535972|585220787|FG000|Overall Study|Withdrawal by Subject|31|||
162044622|NCT05535972|585220787|FG000|Overall Study|Lost to Follow-up|5|||
162044623|NCT05535972|585220787|FG000|Overall Study|Adverse Event|6|||
162044624|NCT05535972|585220787|FG000|Overall Study|Protocol Deviation|2|||
162044625|NCT02649894|585220788|FG000|Overall Study|Adverse Event|1|||
162044626|NCT02649894|585220789|FG001|Overall Study|Adverse Event|0|||
162044627|NCT02649894|585220788|FG000|Overall Study|Physician Decision|0|||
162006796|NCT04292535|585079297|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
162006797|NCT04292535|585079298|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
162006798|NCT04292535|585079299|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
162006799|NCT04292535|585079300|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
162006800|NCT04292535|585079301|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
162006801|NCT04292535|585079302|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
162006802|NCT04292535|585079303|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
162006803|NCT04292535|585079304|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
162006804|NCT04292535|585079305|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
162006805|NCT04292535|585079306|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
162006806|NCT04292535|585079307|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
162006807|NCT04292535|585079308|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
162006808|NCT04292535|585079309|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
162006809|NCT04292535|585079296|FG000|Overall Study|Report of Dizziness|0|||
162006810|NCT04292535|585079297|FG001|Overall Study|Report of Dizziness|0|||
162006811|NCT04292535|585079298|FG002|Overall Study|Report of Dizziness|0|||
162006812|NCT04292535|585079299|FG003|Overall Study|Report of Dizziness|0|||
162006813|NCT04292535|585079300|FG004|Overall Study|Report of Dizziness|0|||
162006814|NCT04292535|585079301|FG005|Overall Study|Report of Dizziness|0|||
162006815|NCT04292535|585079302|FG006|Overall Study|Report of Dizziness|0|||
162006816|NCT04292535|585079303|FG007|Overall Study|Report of Dizziness|0|||
162006817|NCT04292535|585079304|FG008|Overall Study|Report of Dizziness|0|||
162006818|NCT04292535|585079305|FG009|Overall Study|Report of Dizziness|0|||
162006819|NCT04292535|585079306|FG010|Overall Study|Report of Dizziness|0|||
162006820|NCT04292535|585079307|FG011|Overall Study|Report of Dizziness|0|||
162006821|NCT04292535|585079308|FG012|Overall Study|Report of Dizziness|0|||
162044628|NCT02649894|585220789|FG001|Overall Study|Physician Decision|1|||
162044629|NCT02649894|585220788|FG000|Overall Study|Withdrawal by Subject|5|||
162044630|NCT02649894|585220789|FG001|Overall Study|Withdrawal by Subject|2|||
162044631|NCT02649894|585220788|FG000|Overall Study|Lost to Follow-up|2|||
162044632|NCT02649894|585220789|FG001|Overall Study|Lost to Follow-up|1|||
162044633|NCT02649894|585220788|FG000|Overall Study|Death|30|||
162044634|NCT02649894|585220789|FG001|Overall Study|Death|7|||
162044635|NCT02649894|585220788|FG000|Overall Study|Other, not specified|6|||
162044636|NCT02649894|585220789|FG001|Overall Study|Other, not specified|0|||
162044637|NCT04590963|585220790|FG000|Overall Study|Death|118|||
162044638|NCT04590963|585220791|FG001|Overall Study|Death|59|||
162006822|NCT04292535|585079309|FG013|Overall Study|Report of Dizziness|1|||
162006823|NCT04292535|585079296|FG000|Overall Study|Equipment Failure|0|||
162006824|NCT04292535|585079297|FG001|Overall Study|Equipment Failure|0|||
162006825|NCT04292535|585079298|FG002|Overall Study|Equipment Failure|0|||
162006826|NCT04292535|585079299|FG003|Overall Study|Equipment Failure|0|||
162006827|NCT04292535|585079300|FG004|Overall Study|Equipment Failure|0|||
162006828|NCT04292535|585079301|FG005|Overall Study|Equipment Failure|0|||
162006829|NCT04292535|585079302|FG006|Overall Study|Equipment Failure|0|||
162006830|NCT04292535|585079303|FG007|Overall Study|Equipment Failure|0|||
162006831|NCT04292535|585079304|FG008|Overall Study|Equipment Failure|0|||
162006832|NCT04292535|585079305|FG009|Overall Study|Equipment Failure|0|||
162006833|NCT04292535|585079306|FG010|Overall Study|Equipment Failure|0|||
162006834|NCT04292535|585079307|FG011|Overall Study|Equipment Failure|1|||
162006835|NCT04292535|585079308|FG012|Overall Study|Equipment Failure|0|||
162006836|NCT04292535|585079309|FG013|Overall Study|Equipment Failure|0|||
162006837|NCT01420861|585079310|FG000|Overall Study|Adverse Event|2|||
162006838|NCT01420861|585079310|FG000|Overall Study|Study terminated by Sponsor|7|||
162006839|NCT01420861|585079310|FG000|Overall Study|Screen failure|7|||
162006840|NCT01420861|585079310|FG000|Overall Study|Randomized not Treated|2|||
162006841|NCT04905134|585079311|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
162006842|NCT04905134|585079311|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
162006843|NCT03009058|585079312|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
162006844|NCT05556265|585079313|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
162006845|NCT05556265|585079314|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
162006846|NCT05556265|585079315|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
162006847|NCT05556265|585079316|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
162006848|NCT05556265|585079317|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
162006849|NCT05556265|585079313|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
162006850|NCT05556265|585079314|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
162006851|NCT05556265|585079315|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
162044639|NCT04590963|585220790|FG000|Overall Study|Lost to Follow-up|1|||
162044640|NCT04590963|585220791|FG001|Overall Study|Lost to Follow-up|1|||
162044641|NCT04590963|585220790|FG000|Overall Study|Progressive disease|0|||
162044642|NCT04590963|585220791|FG001|Overall Study|Progressive disease|1|||
162044643|NCT04590963|585220790|FG000|Overall Study|Study terminated by sponsor|103|||
162006852|NCT05556265|585079316|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
162006853|NCT05556265|585079317|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
162006854|NCT05556265|585079313|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
162006855|NCT05556265|585079314|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
162006856|NCT05556265|585079315|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
162006857|NCT05556265|585079316|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
162006858|NCT05556265|585079317|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
162006859|NCT05556265|585079313|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
162006860|NCT05556265|585079314|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
162006861|NCT05556265|585079315|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
162006862|NCT05556265|585079316|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
162006863|NCT05556265|585079317|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
162006864|NCT05556265|585079313|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
162006865|NCT05556265|585079314|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
162006866|NCT05556265|585079315|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
162006867|NCT05556265|585079316|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
162006868|NCT05556265|585079317|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
162006869|NCT05556265|585079313|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
162006870|NCT05556265|585079314|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
162006871|NCT05556265|585079315|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
162006872|NCT05556265|585079316|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
162006873|NCT05556265|585079317|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
162006874|NCT05556265|585079313|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
162006875|NCT05556265|585079314|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
162006876|NCT05556265|585079315|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
162006877|NCT05556265|585079316|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
162006878|NCT05556265|585079317|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
162006879|NCT05556265|585079313|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
162006880|NCT05556265|585079314|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
162006881|NCT05556265|585079315|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
162006882|NCT05556265|585079316|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
162006883|NCT05556265|585079317|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
162006884|NCT05556265|585079313|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
162006885|NCT05556265|585079314|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
162006886|NCT05556265|585079315|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
162006887|NCT05556265|585079316|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
162006888|NCT05556265|585079317|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
162006889|NCT01586364|585081680|FG000|Overall Study|Withdrawal by Subject|40|||
162006890|NCT01586364|585081680|FG000|Overall Study|Adverse Event|37|||
162006891|NCT01586364|585081680|FG000|Overall Study|Lost to Follow-up|17|||
162006892|NCT01586364|585081680|FG000|Overall Study|Protocol Violation|16|||
162006893|NCT01586364|585081680|FG000|Overall Study|Lack of Efficacy|1|||
162006894|NCT01586364|585081680|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
162006895|NCT01586364|585081680|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
162006896|NCT01586364|585081680|FG000|Overall Study|Other-Site closure due to PI illness|1|||
162006897|NCT01586364|585081680|FG000|Overall Study|Other-PI discretion, site closing|2|||
162006898|NCT01586364|585081680|FG000|Overall Study|Other-Not specified|1|||
162006899|NCT02121535|585081681|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
162006900|NCT02121535|585081682|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
162006901|NCT02121535|585081681|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
162006902|NCT02121535|585081682|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
162006903|NCT04944992|585081683|FG000|Overall Study|Lost to Follow-up|1|||
162006904|NCT04944992|585081684|FG001|Overall Study|Lost to Follow-up|1|||
162006905|NCT04944992|585081683|FG000|Overall Study|Physician Decision|1|||
162006906|NCT04944992|585081684|FG001|Overall Study|Physician Decision|0|||
162006907|NCT04944992|585081683|FG000|Overall Study|Withdrawal by Subject|6|||
162006908|NCT04944992|585081684|FG001|Overall Study|Withdrawal by Subject|1|||
162006909|NCT05366738|585081685|FG000|Overall Study|Adverse Event|0|||
162006910|NCT05366738|585081686|FG001|Overall Study|Adverse Event|1|||
162006911|NCT05366738|585081687|FG002|Overall Study|Adverse Event|0|||
162006912|NCT05024032|585081694|FG000|Overall Study|Withdrawal by Subject|0|||
162006913|NCT05024032|585081695|FG001|Overall Study|Withdrawal by Subject|3|||
162006914|NCT05024032|585081696|FG002|Overall Study|Withdrawal by Subject|4|||
162006915|NCT05024032|585081694|FG000|Overall Study|Adverse Event|0|||
162006916|NCT05024032|585081695|FG001|Overall Study|Adverse Event|1|||
162006917|NCT05024032|585081696|FG002|Overall Study|Adverse Event|0|||
162006918|NCT05024032|585081694|FG000|Overall Study|Protocol Deviation|1|||
162006919|NCT05024032|585081695|FG001|Overall Study|Protocol Deviation|0|||
162006920|NCT05024032|585081696|FG002|Overall Study|Protocol Deviation|0|||
162006921|NCT00939393|585081697|FG000|Overall Study|Withdrawal by Subject|1|||
162006922|NCT00939393|585081698|FG001|Overall Study|Withdrawal by Subject|0|||
162006923|NCT00939393|585081697|FG000|Overall Study|Lost to Follow-up|3|||
162006924|NCT00939393|585081698|FG001|Overall Study|Lost to Follow-up|0|||
162006925|NCT01054885|585081699|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
162006926|NCT01054885|585081700|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162006927|NCT01054885|585081701|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162006928|NCT01054885|585081702|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162006929|NCT01054885|585081703|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162006930|NCT01054885|585081704|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162006931|NCT01054885|585081705|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
162006932|NCT01054885|585081699|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
162006933|NCT01054885|585081700|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
162006934|NCT01054885|585081701|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
162006935|NCT01054885|585081702|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
162006936|NCT01054885|585081703|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
162006937|NCT01054885|585081704|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
162006938|NCT01054885|585081705|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
162006939|NCT01054885|585081699|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
162006940|NCT01054885|585081700|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
162006941|NCT01054885|585081701|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
162006942|NCT01054885|585081702|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
162006943|NCT01054885|585081703|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
162006944|NCT01054885|585081704|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
162006945|NCT01054885|585081705|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
162006946|NCT01054885|585081699|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
162006947|NCT01054885|585081700|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162006948|NCT01054885|585081701|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162006949|NCT01054885|585081702|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162006950|NCT01054885|585081703|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162006951|NCT01054885|585081704|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162006952|NCT01054885|585081705|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
162006953|NCT01054885|585081699|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
162006954|NCT01054885|585081700|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
162006955|NCT01054885|585081701|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
162006956|NCT01054885|585081702|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
162006957|NCT01054885|585081703|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
162006958|NCT01054885|585081704|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
162006959|NCT01054885|585081705|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
162006960|NCT01054885|585081699|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
162006961|NCT01054885|585081700|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
162006962|NCT01054885|585081701|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
162006963|NCT01054885|585081702|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
162006964|NCT01054885|585081703|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
162044644|NCT04590963|585220791|FG001|Overall Study|Study terminated by sponsor|50|||
162044645|NCT04590963|585220790|FG000|Overall Study|Withdrawal by Subject|15|||
162044646|NCT04590963|585220791|FG001|Overall Study|Withdrawal by Subject|8|||
162044647|NCT04590963|585220790|FG000|Overall Study|Ongoing at data cut-off|9|||
162044648|NCT04590963|585220791|FG001|Overall Study|Ongoing at data cut-off|4|||
162044649|NCT04590963|585220790|FG000|Overall Study|Screen failure|1|||
162044650|NCT04590963|585220791|FG001|Overall Study|Screen failure|0|||
162044651|NCT04430738|585220792|FG000|Phase 1: Dose Escalation|Death|1|||
162044652|NCT04430738|585220793|FG001|Phase 1: Dose Escalation|Death|4|||
162044653|NCT04430738|585220794|FG002|Phase 1: Dose Escalation|Death|4|||
162044654|NCT04430738|585220795|FG003|Phase 1: Dose Escalation|Death|1|||
162044655|NCT04430738|585220796|FG004|Phase 1: Dose Escalation|Death|6|||
162044656|NCT04430738|585220797|FG005|Phase 1: Dose Escalation|Death|0|||
162044657|NCT04430738|585220792|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
162044658|NCT04430738|585220793|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
162044659|NCT04430738|585220794|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
162044660|NCT04430738|585220795|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
162044661|NCT04430738|585220796|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
162044662|NCT04430738|585220797|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
162044663|NCT04430738|585220792|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
162044664|NCT04430738|585220793|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
162006965|NCT01054885|585081704|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
162006966|NCT01054885|585081705|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
162006967|NCT01054885|585081699|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
162006968|NCT01054885|585081700|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
162006969|NCT01054885|585081701|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
162006970|NCT01054885|585081702|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
162006971|NCT01054885|585081703|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
162006972|NCT01054885|585081704|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
162006973|NCT01054885|585081705|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
162006974|NCT01054885|585081699|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
162006975|NCT01054885|585081700|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
162006976|NCT01054885|585081701|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
162006977|NCT01054885|585081702|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
162006978|NCT01054885|585081703|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
162006979|NCT01054885|585081704|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
162006980|NCT01054885|585081705|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
162006981|NCT01054885|585081699|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
162006982|NCT01054885|585081700|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
162006983|NCT01054885|585081701|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
162006984|NCT01054885|585081702|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
162006985|NCT01054885|585081703|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
162006986|NCT01054885|585081704|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
162006987|NCT01054885|585081705|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
162006988|NCT01054885|585081699|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
162006989|NCT01054885|585081700|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
162006990|NCT01054885|585081701|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
162006991|NCT01054885|585081702|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
162006992|NCT01054885|585081703|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
162006993|NCT01054885|585081704|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
162006994|NCT01054885|585081705|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
162006995|NCT01054885|585081699|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
162006996|NCT01054885|585081700|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
162006997|NCT01054885|585081701|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
162006998|NCT01054885|585081702|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
162006999|NCT01054885|585081703|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
162007000|NCT01054885|585081704|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
162007001|NCT01054885|585081705|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
162007002|NCT01054885|585081699|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
162007003|NCT01054885|585081700|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
162007004|NCT01054885|585081701|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
162007005|NCT01054885|585081702|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
162007006|NCT01054885|585081703|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
162007007|NCT01054885|585081704|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
162007008|NCT01054885|585081705|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
162007009|NCT01054885|585081699|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162007010|NCT01054885|585081700|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
162007011|NCT01054885|585081701|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
162007012|NCT01054885|585081702|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162007013|NCT01054885|585081703|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
162007014|NCT01054885|585081704|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
162007015|NCT01054885|585081705|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
162007016|NCT01054885|585081699|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
162007017|NCT01054885|585081700|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
162007018|NCT01054885|585081701|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
162007019|NCT01054885|585081702|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
162007020|NCT01054885|585081703|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
162007021|NCT01054885|585081704|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
162007022|NCT01054885|585081705|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
162007023|NCT01054885|585081699|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
162007024|NCT01054885|585081700|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
162007025|NCT01054885|585081701|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
162007026|NCT01054885|585081702|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
162007027|NCT01054885|585081703|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
162007028|NCT01054885|585081704|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
162007029|NCT01054885|585081705|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
162007030|NCT00804908|585081706|FG000|Overall Study|Other|115|||
162007031|NCT00804908|585081707|FG001|Overall Study|Other|116|||
162007032|NCT00804908|585081708|FG002|Overall Study|Other|114|||
162007033|NCT01280903|585081709|FG000|Overall Study|Lost to Follow-up|23|||
162007034|NCT01280903|585081710|FG001|Overall Study|Lost to Follow-up|16|||
162007035|NCT03829228|585081711|FG000|Overall Study|Protocol Violation|1|||
162007036|NCT02177695|585081712|FG000|ITT Analysis|Ineligible|5|||
162007037|NCT02177695|585081713|FG001|ITT Analysis|Ineligible|5|||
162007038|NCT02177695|585081712|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
162007039|NCT02177695|585081713|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
162007040|NCT02177695|585081712|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
162007041|NCT02177695|585081713|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
162007042|NCT02177695|585081712|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
162007043|NCT02177695|585081713|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
162007044|NCT00744497|585081716|FG000|Overall Study|Withdrawal by Subject|21|||
162007045|NCT00744497|585081717|FG001|Overall Study|Withdrawal by Subject|18|||
162007046|NCT00744497|585081716|FG000|Overall Study|Death|11|||
162007047|NCT00744497|585081717|FG001|Overall Study|Death|9|||
162007048|NCT00744497|585081716|FG000|Overall Study|Lost to Follow-up|4|||
162007049|NCT00744497|585081717|FG001|Overall Study|Lost to Follow-up|2|||
162007050|NCT00744497|585081716|FG000|Overall Study|Poor compliance/noncompliance|9|||
162007051|NCT00744497|585081717|FG001|Overall Study|Poor compliance/noncompliance|5|||
162007052|NCT00744497|585081716|FG000|Overall Study|No longer meets study criteria|7|||
162007053|NCT00744497|585081717|FG001|Overall Study|No longer meets study criteria|3|||
162007054|NCT00744497|585081716|FG000|Overall Study|Administrative Reason By Sponsor|25|||
162007055|NCT00744497|585081717|FG001|Overall Study|Administrative Reason By Sponsor|8|||
162007056|NCT00744497|585081716|FG000|Overall Study|Disease progression|312|||
162007057|NCT00744497|585081717|FG001|Overall Study|Disease progression|219|||
162007058|NCT00744497|585081716|FG000|Overall Study|Study drug toxicity|68|||
162007059|NCT00744497|585081717|FG001|Overall Study|Study drug toxicity|141|||
162007060|NCT00744497|585081716|FG000|Overall Study|Adverse event unrelated to study drug|78|||
162007061|NCT00744497|585081717|FG001|Overall Study|Adverse event unrelated to study drug|122|||
162007062|NCT00744497|585081716|FG000|Overall Study|Patient requested to stop study drug|65|||
162007063|NCT00744497|585081717|FG001|Overall Study|Patient requested to stop study drug|80|||
162007064|NCT00744497|585081716|FG000|Overall Study|Maximum clinical benefit|141|||
162007065|NCT00744497|585081717|FG001|Overall Study|Maximum clinical benefit|142|||
162007066|NCT00744497|585081716|FG000|Overall Study|Not defined|19|||
162007067|NCT00744497|585081717|FG001|Overall Study|Not defined|13|||
162007068|NCT02443688|585081718|FG000|Overall Study|Adverse Event|2|||
162007069|NCT02443688|585081719|FG001|Overall Study|Adverse Event|3|||
162007070|NCT02443688|585081720|FG002|Overall Study|Adverse Event|2|||
162007071|NCT02443688|585081718|FG000|Overall Study|Lost to Follow-up|1|||
162007072|NCT02443688|585081719|FG001|Overall Study|Lost to Follow-up|0|||
162007073|NCT02443688|585081720|FG002|Overall Study|Lost to Follow-up|0|||
162007074|NCT02443688|585081718|FG000|Overall Study|Physician Decision|3|||
162007075|NCT02443688|585081719|FG001|Overall Study|Physician Decision|0|||
162007076|NCT02443688|585081720|FG002|Overall Study|Physician Decision|1|||
162007077|NCT02443688|585081718|FG000|Overall Study|Pregnancy|0|||
162007078|NCT02443688|585081719|FG001|Overall Study|Pregnancy|0|||
162007079|NCT02443688|585081720|FG002|Overall Study|Pregnancy|1|||
162007080|NCT02443688|585081718|FG000|Overall Study|Withdrawal by Subject|3|||
162007081|NCT02443688|585081719|FG001|Overall Study|Withdrawal by Subject|3|||
162007082|NCT02443688|585081720|FG002|Overall Study|Withdrawal by Subject|4|||
162007083|NCT02443688|585081718|FG000|Overall Study|Non-compliance with study drug|1|||
162007084|NCT02443688|585081719|FG001|Overall Study|Non-compliance with study drug|2|||
162007085|NCT02443688|585081720|FG002|Overall Study|Non-compliance with study drug|4|||
162007086|NCT02443688|585081718|FG000|Overall Study|Sponsor Request|2|||
162007087|NCT02443688|585081719|FG001|Overall Study|Sponsor Request|1|||
162007088|NCT02443688|585081720|FG002|Overall Study|Sponsor Request|0|||
162007089|NCT00726063|585081722|FG000|Overall Study|Adverse Event|9|||
162007090|NCT00726063|585081723|FG001|Overall Study|Adverse Event|7|||
162007091|NCT02007096|585081724|FG000|Overall Study|medication not available|2|||
162007092|NCT02007096|585081725|FG001|Overall Study|medication not available|0|||
162007093|NCT02007096|585081724|FG000|Overall Study|did not inject saline|0|||
162007094|NCT02007096|585081725|FG001|Overall Study|did not inject saline|3|||
162007095|NCT02007096|585081724|FG000|Overall Study|did not follow postoperative protocol|8|||
162007096|NCT02007096|585081725|FG001|Overall Study|did not follow postoperative protocol|11|||
162007097|NCT02007096|585081724|FG000|Overall Study|converted to open surgery|1|||
162007098|NCT02007096|585081725|FG001|Overall Study|converted to open surgery|1|||
162007099|NCT02007096|585081724|FG000|Overall Study|no mesh placed|0|||
162007100|NCT02007096|585081725|FG001|Overall Study|no mesh placed|1|||
162007101|NCT00837434|585081727|FG000|Overall Study|Physician Decision|3|||
162044665|NCT04430738|585220794|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
162044666|NCT04430738|585220795|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
162044667|NCT04430738|585220796|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
162044668|NCT04430738|585220797|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
162044669|NCT04430738|585220792|FG000|Phase 1: Dose Escalation|Other|1|||
162044670|NCT04430738|585220793|FG001|Phase 1: Dose Escalation|Other|0|||
162044671|NCT04430738|585220794|FG002|Phase 1: Dose Escalation|Other|0|||
162044672|NCT04430738|585220795|FG003|Phase 1: Dose Escalation|Other|0|||
162044673|NCT04430738|585220796|FG004|Phase 1: Dose Escalation|Other|0|||
162044674|NCT04430738|585220797|FG005|Phase 1: Dose Escalation|Other|0|||
162044675|NCT04430738|585220792|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
162044676|NCT04430738|585220793|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
162044677|NCT04430738|585220794|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
162044678|NCT04430738|585220795|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
162044679|NCT04430738|585220796|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
162044680|NCT04430738|585220797|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
162044681|NCT04430738|585220792|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
162044682|NCT04430738|585220793|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
162044683|NCT04430738|585220794|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
162044684|NCT04430738|585220795|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
162044685|NCT04430738|585220796|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
162044686|NCT04430738|585220797|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
162044687|NCT01736124|585220798|FG000|Post-intervention Assessment|Death|2|||
162044688|NCT01736124|585220799|FG001|Post-intervention Assessment|Death|2|||
162044689|NCT01736124|585220798|FG000|Post-intervention Assessment|lost computer access|1|||
162044690|NCT01736124|585220799|FG001|Post-intervention Assessment|lost computer access|1|||
162044691|NCT01736124|585220798|FG000|Post-intervention Assessment|Moved away|3|||
162044692|NCT01736124|585220799|FG001|Post-intervention Assessment|Moved away|1|||
162044693|NCT01736124|585220798|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
162044694|NCT01736124|585220799|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
162044695|NCT01736124|585220798|FG000|Post-intervention Assessment|Illness|3|||
162044696|NCT01736124|585220799|FG001|Post-intervention Assessment|Illness|2|||
162044697|NCT01736124|585220798|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
162044698|NCT01736124|585220799|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
162044699|NCT01736124|585220798|FG000|Post-intervention Assessment|Temporarily away|3|||
162044700|NCT01736124|585220799|FG001|Post-intervention Assessment|Temporarily away|1|||
162044701|NCT01736124|585220798|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
162044702|NCT01736124|585220799|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
162044703|NCT01736124|585220798|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
162007102|NCT00837434|585081728|FG001|Overall Study|Physician Decision|0|||
162007103|NCT00837434|585081727|FG000|Overall Study|Lost to Follow-up|1|||
162007104|NCT00837434|585081728|FG001|Overall Study|Lost to Follow-up|1|||
162007105|NCT00837434|585081727|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
162007106|NCT00837434|585081728|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
162007107|NCT00837434|585081727|FG000|Overall Study|Noncompliant|2|||
162007108|NCT00837434|585081728|FG001|Overall Study|Noncompliant|0|||
162007109|NCT00837434|585081727|FG000|Overall Study|Baseline assessments not done in time|1|||
162007110|NCT00837434|585081728|FG001|Overall Study|Baseline assessments not done in time|0|||
162007111|NCT00837434|585081727|FG000|Overall Study|Unable to obtain study drug|1|||
162007112|NCT00837434|585081728|FG001|Overall Study|Unable to obtain study drug|0|||
162007113|NCT03044106|585081729|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
162007114|NCT03044106|585081730|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
162007115|NCT01207414|585081731|FG000|Overall Study|Adverse Event|25|||
162007116|NCT01207414|585081732|FG001|Overall Study|Adverse Event|39|||
162007117|NCT01207414|585081731|FG000|Overall Study|Abnormal test procedure results|0|||
162007118|NCT01207414|585081732|FG001|Overall Study|Abnormal test procedure results|1|||
162007119|NCT01207414|585081731|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
162007120|NCT01207414|585081732|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
162007121|NCT01207414|585081731|FG000|Overall Study|Patient withdrew consent|14|||
162007122|NCT01207414|585081732|FG001|Overall Study|Patient withdrew consent|11|||
162007123|NCT01207414|585081731|FG000|Overall Study|Lost to Follow-up|15|||
162007124|NCT01207414|585081732|FG001|Overall Study|Lost to Follow-up|17|||
162007125|NCT01207414|585081731|FG000|Overall Study|Administrative problems|1|||
162007126|NCT01207414|585081732|FG001|Overall Study|Administrative problems|1|||
162007127|NCT01207414|585081731|FG000|Overall Study|Protocol deviation|12|||
162044704|NCT01736124|585220799|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
162044705|NCT01736124|585220798|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
162044706|NCT01736124|585220799|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
162044707|NCT01736124|585220798|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
162044708|NCT01736124|585220799|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
162007128|NCT01207414|585081732|FG001|Overall Study|Protocol deviation|9|||
162007129|NCT01207414|585081731|FG000|Overall Study|Randomized in error|1|||
162007130|NCT01207414|585081732|FG001|Overall Study|Randomized in error|0|||
162007131|NCT01748292|585081733|FG000|Overall Study|Adverse Event|2|||
162007132|NCT01748292|585081734|FG001|Overall Study|Adverse Event|4|||
162007133|NCT01748292|585081733|FG000|Overall Study|Lost to Follow-up|0|||
162007134|NCT01748292|585081734|FG001|Overall Study|Lost to Follow-up|3|||
162007135|NCT01748292|585081733|FG000|Overall Study|Death|0|||
162007136|NCT01748292|585081734|FG001|Overall Study|Death|3|||
162007137|NCT01748292|585081733|FG000|Overall Study|Withdrawal by Subject|0|||
162007138|NCT01748292|585081734|FG001|Overall Study|Withdrawal by Subject|2|||
162007139|NCT02057250|585081735|FG000|AID Assessment Phase|Adverse Event|3|||
162007140|NCT02057250|585081736|FG001|AID Assessment Phase|Adverse Event|2|||
162007141|NCT02057250|585081737|FG002|AID Assessment Phase|Adverse Event|6|||
162007142|NCT02057250|585081738|FG003|AID Assessment Phase|Adverse Event|1|||
162007143|NCT02057250|585081739|FG004|AID Assessment Phase|Adverse Event|0|||
162007144|NCT02057250|585081735|FG000|AID Assessment Phase|Other than specified above|1|||
162007145|NCT02057250|585081736|FG001|AID Assessment Phase|Other than specified above|1|||
162007146|NCT02057250|585081737|FG002|AID Assessment Phase|Other than specified above|1|||
162007147|NCT02057250|585081738|FG003|AID Assessment Phase|Other than specified above|1|||
162007148|NCT02057250|585081739|FG004|AID Assessment Phase|Other than specified above|0|||
162007149|NCT02057250|585081735|FG000|Extension Phase|Adverse Event|0|||
162007150|NCT02057250|585081736|FG001|Extension Phase|Adverse Event|0|||
162007151|NCT02057250|585081737|FG002|Extension Phase|Adverse Event|0|||
162007152|NCT02057250|585081738|FG003|Extension Phase|Adverse Event|0|||
162007153|NCT02057250|585081739|FG004|Extension Phase|Adverse Event|15|||
162007154|NCT02057250|585081735|FG000|Extension Phase|Lack of Efficacy|0|||
162007155|NCT02057250|585081736|FG001|Extension Phase|Lack of Efficacy|0|||
162007156|NCT02057250|585081737|FG002|Extension Phase|Lack of Efficacy|0|||
162007157|NCT02057250|585081738|FG003|Extension Phase|Lack of Efficacy|0|||
162007158|NCT02057250|585081739|FG004|Extension Phase|Lack of Efficacy|10|||
162007159|NCT02057250|585081735|FG000|Extension Phase|Entered in this period but not treated|0|||
162007160|NCT02057250|585081736|FG001|Extension Phase|Entered in this period but not treated|0|||
162007161|NCT02057250|585081737|FG002|Extension Phase|Entered in this period but not treated|0|||
162007162|NCT02057250|585081738|FG003|Extension Phase|Entered in this period but not treated|0|||
162007163|NCT02057250|585081739|FG004|Extension Phase|Entered in this period but not treated|4|||
162007164|NCT02057250|585081735|FG000|Extension Phase|Other than specified above|0|||
162007165|NCT02057250|585081736|FG001|Extension Phase|Other than specified above|0|||
162007166|NCT02057250|585081737|FG002|Extension Phase|Other than specified above|0|||
162007167|NCT02057250|585081738|FG003|Extension Phase|Other than specified above|0|||
162007168|NCT02057250|585081739|FG004|Extension Phase|Other than specified above|7|||
162007169|NCT03367793|585081741|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
162007170|NCT03367793|585081742|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
162007171|NCT03367793|585081743|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
162007172|NCT03367793|585081744|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
162007173|NCT03367793|585081745|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
162007174|NCT03367793|585081746|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
162007175|NCT03199976|585081747|FG000|Overall Study|Lack of Efficacy|3|||
162007176|NCT03199976|585081748|FG001|Overall Study|Lack of Efficacy|6|||
162007177|NCT03199976|585081749|FG002|Overall Study|Lack of Efficacy|13|||
162007178|NCT03199976|585081747|FG000|Overall Study|Withdrawal by Subject|1|||
162007179|NCT03199976|585081748|FG001|Overall Study|Withdrawal by Subject|0|||
162007180|NCT03199976|585081749|FG002|Overall Study|Withdrawal by Subject|0|||
162007181|NCT03199976|585081747|FG000|Overall Study|Lost to Follow-up|0|||
162007182|NCT03199976|585081748|FG001|Overall Study|Lost to Follow-up|1|||
162007183|NCT03199976|585081749|FG002|Overall Study|Lost to Follow-up|1|||
162007184|NCT04852302|585081757|FG000|Overall Study|Withdrawal by Subject|2|||
162007185|NCT04852302|585081757|FG000|Overall Study|Did not complete CALM therapy.|2|||
162007186|NCT04711850|585081758|FG000|Overall Study|Graft loss|2|||
162007187|NCT04711850|585081759|FG001|Overall Study|Graft loss|1|||
162007188|NCT04711850|585081758|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
162007189|NCT04711850|585081759|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
162007190|NCT04711850|585081758|FG000|Overall Study|Study terminated by sponsor|5|||
162007191|NCT04711850|585081759|FG001|Overall Study|Study terminated by sponsor|3|||
162007192|NCT04711850|585081758|FG000|Overall Study|Sponsor decision|0|||
162007193|NCT04711850|585081759|FG001|Overall Study|Sponsor decision|2|||
162007194|NCT05249582|585081760|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
162007195|NCT05249582|585081761|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
162007196|NCT05249582|585081760|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
162007197|NCT05249582|585081761|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
162007198|NCT05249582|585081760|FG000|Overall Study|Declined to use virtual reality headset|1|||
162007199|NCT05249582|585081761|FG001|Overall Study|Declined to use virtual reality headset|0|||
162007200|NCT02738801|585081784|FG000|Overall Study|Adverse Event|1|||
162044709|NCT01736124|585220798|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
162044710|NCT01736124|585220799|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
162044711|NCT01736124|585220798|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
162044712|NCT01736124|585220799|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
162044713|NCT01736124|585220798|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
162044714|NCT01736124|585220799|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
162044715|NCT01736124|585220798|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
162044716|NCT01736124|585220799|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
162044717|NCT01736124|585220798|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
162044718|NCT01736124|585220799|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
162044719|NCT04176705|585220801|FG000|Overall Study|Withdrawal by Subject|4|||
162044720|NCT04176705|585220802|FG001|Overall Study|Withdrawal by Subject|4|||
162044721|NCT04176705|585220801|FG000|Overall Study|Death|1|||
162044722|NCT04176705|585220802|FG001|Overall Study|Death|1|||
162044723|NCT04176705|585220801|FG000|Overall Study|Lost to Follow-up|3|||
162044724|NCT04176705|585220802|FG001|Overall Study|Lost to Follow-up|3|||
162044725|NCT02628769|585220803|FG000|First Intervention|Adverse Event|1|||
162044726|NCT02628769|585220804|FG001|First Intervention|Adverse Event|0|||
162044727|NCT02628769|585220803|FG000|First Intervention|Withdrawal by Subject|0|||
162044728|NCT02628769|585220804|FG001|First Intervention|Withdrawal by Subject|1|||
162044729|NCT02628769|585220803|FG000|Second Intervention|Adverse Event|2|||
162044730|NCT02628769|585220804|FG001|Second Intervention|Adverse Event|0|||
162044731|NCT02628769|585220803|FG000|Second Intervention|Physician Decision|0|||
162044732|NCT02628769|585220804|FG001|Second Intervention|Physician Decision|1|||
162044733|NCT01467583|585220805|FG000|Overall Study|Death|1|||
162044734|NCT01467583|585220806|FG001|Overall Study|Death|1|||
162044735|NCT01467583|585220807|FG002|Overall Study|Death|0|||
162044736|NCT01467583|585220805|FG000|Overall Study|Withdrawal by Subject|1|||
162044737|NCT01467583|585220806|FG001|Overall Study|Withdrawal by Subject|0|||
162044738|NCT01467583|585220807|FG002|Overall Study|Withdrawal by Subject|0|||
162044739|NCT01467583|585220805|FG000|Overall Study|Protocol Violation|0|||
162044740|NCT01467583|585220806|FG001|Overall Study|Protocol Violation|0|||
162044741|NCT01467583|585220807|FG002|Overall Study|Protocol Violation|2|||
162044742|NCT05274165|585220808|FG000|Overall Study|Withdrawal by Subject|3|||
162044743|NCT05274165|585220809|FG001|Overall Study|Withdrawal by Subject|3|||
162044744|NCT00717093|585222506|FG000|Overall Study|Adverse Event|19|||
162044745|NCT00717093|585222507|FG001|Overall Study|Adverse Event|9|||
162044746|NCT00717093|585222506|FG000|Overall Study|Lack of Efficacy|3|||
162007201|NCT02738801|585081785|FG001|Overall Study|Adverse Event|1|||
162007202|NCT02738801|585081784|FG000|Overall Study|Withdrawal by Subject|0|||
162007203|NCT02738801|585081785|FG001|Overall Study|Withdrawal by Subject|1|||
162007204|NCT03279081|585081786|FG000|Overall Study|Withdrawal by Subject|12|||
162007205|NCT03279081|585081787|FG001|Overall Study|Withdrawal by Subject|20|||
162007206|NCT03279081|585081786|FG000|Overall Study|Physician Decision|4|||
162007207|NCT03279081|585081787|FG001|Overall Study|Physician Decision|1|||
162007208|NCT03279081|585081786|FG000|Overall Study|Lost to Follow-up|8|||
162007209|NCT03279081|585081787|FG001|Overall Study|Lost to Follow-up|8|||
162007210|NCT03279081|585081786|FG000|Overall Study|Death|0|||
162007211|NCT03279081|585081787|FG001|Overall Study|Death|1|||
162007212|NCT03279081|585081786|FG000|Overall Study|Adverse Event|1|||
162007213|NCT03279081|585081787|FG001|Overall Study|Adverse Event|0|||
162007214|NCT03279081|585081786|FG000|Overall Study|Reason not Specified|14|||
162007215|NCT03279081|585081787|FG001|Overall Study|Reason not Specified|4|||
162007216|NCT00771914|585081788|FG000|Overall Study|Physician Decision|0|||
162007217|NCT00771914|585081789|FG001|Overall Study|Physician Decision|0|||
162007218|NCT00771914|585081790|FG002|Overall Study|Physician Decision|0|||
162007219|NCT00771914|585081791|FG003|Overall Study|Physician Decision|1|||
162007220|NCT00771914|585081788|FG000|Overall Study|Lost to Follow-up|0|||
162007221|NCT00771914|585081789|FG001|Overall Study|Lost to Follow-up|0|||
162007222|NCT00771914|585081790|FG002|Overall Study|Lost to Follow-up|0|||
162007223|NCT00771914|585081791|FG003|Overall Study|Lost to Follow-up|1|||
162007224|NCT01743469|585081794|FG000|Active Treatment Phase|Adverse Event|10|||
162007225|NCT01743469|585081795|FG001|Active Treatment Phase|Adverse Event|5|||
162007226|NCT01743469|585081796|FG002|Active Treatment Phase|Adverse Event|8|||
162007227|NCT01743469|585081797|FG003|Active Treatment Phase|Adverse Event|1|||
162007228|NCT01743469|585081794|FG000|Active Treatment Phase|Disease Progression|40|||
162044747|NCT00717093|585222507|FG001|Overall Study|Lack of Efficacy|13|||
162044748|NCT00717093|585222506|FG000|Overall Study|Lost to Follow-up|9|||
162044749|NCT00717093|585222507|FG001|Overall Study|Lost to Follow-up|6|||
162044750|NCT00717093|585222506|FG000|Overall Study|Withdrawal by Subject|12|||
162044751|NCT00717093|585222507|FG001|Overall Study|Withdrawal by Subject|19|||
162044752|NCT00717093|585222506|FG000|Overall Study|Other|0|||
162044753|NCT00717093|585222507|FG001|Overall Study|Other|1|||
162044754|NCT00717093|585222506|FG000|Overall Study|Randomized but not treated|1|||
162044755|NCT00717093|585222507|FG001|Overall Study|Randomized but not treated|0|||
162007229|NCT01743469|585081795|FG001|Active Treatment Phase|Disease Progression|47|||
162007230|NCT01743469|585081796|FG002|Active Treatment Phase|Disease Progression|30|||
162044756|NCT00217620|585222508|FG000|Overall Study|Adverse Event|2|||
162007231|NCT01743469|585081797|FG003|Active Treatment Phase|Disease Progression|20|||
162007232|NCT01743469|585081794|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
162007233|NCT01743469|585081795|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
162007234|NCT01743469|585081796|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
162007235|NCT01743469|585081797|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
162007236|NCT01743469|585081794|FG000|Active Treatment Phase|Missing|1|||
162007237|NCT01743469|585081795|FG001|Active Treatment Phase|Missing|0|||
162007238|NCT01743469|585081796|FG002|Active Treatment Phase|Missing|0|||
162007239|NCT01743469|585081797|FG003|Active Treatment Phase|Missing|0|||
162007240|NCT01743469|585081794|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
162007241|NCT01743469|585081795|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
162007242|NCT01743469|585081796|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
162007243|NCT01743469|585081797|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
162007244|NCT01743469|585081794|FG000|Follow-up Period - Post-Treatment|Death|43|||
162007245|NCT01743469|585081795|FG001|Follow-up Period - Post-Treatment|Death|47|||
162007246|NCT01743469|585081796|FG002|Follow-up Period - Post-Treatment|Death|22|||
162007247|NCT01743469|585081797|FG003|Follow-up Period - Post-Treatment|Death|16|||
162007248|NCT01743469|585081794|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
162007249|NCT01743469|585081795|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
162007250|NCT01743469|585081796|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
162007251|NCT01743469|585081797|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
162007252|NCT02163538|585081802|FG000|Overall Study|Protocol Violation|1|||
162007253|NCT02163538|585081803|FG001|Overall Study|Protocol Violation|0|||
162007254|NCT02163538|585081802|FG000|Overall Study|Physician Decision|0|||
162007255|NCT02163538|585081803|FG001|Overall Study|Physician Decision|1|||
162007256|NCT04484961|585081806|FG000|Overall Study|Lost to Follow-up|9|||
162007257|NCT04484961|585081807|FG001|Overall Study|Lost to Follow-up|9|||
162007258|NCT00388349|585081808|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
162007259|NCT00388349|585081809|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
162007260|NCT01667900|585081814|FG000|Part B|Death|0|||
162007261|NCT01667900|585081815|FG001|Part B|Death|0|||
162007262|NCT01667900|585081816|FG002|Part B|Death|0|||
162007263|NCT01667900|585081817|FG003|Part B|Death|0|||
162007264|NCT01667900|585081818|FG004|Part B|Death|0|||
162007265|NCT01667900|585081819|FG005|Part B|Death|0|||
162007266|NCT01667900|585081820|FG006|Part B|Death|0|||
162007267|NCT01667900|585081821|FG007|Part B|Death|0|||
162007268|NCT01667900|585081822|FG008|Part B|Death|0|||
162007269|NCT01667900|585081823|FG009|Part B|Death|0|||
162007270|NCT01667900|585081824|FG010|Part B|Death|0|||
162044757|NCT00217620|585222508|FG000|Overall Study|Progression|31|||
162044758|NCT00217620|585222508|FG000|Overall Study|Not Protocol Specified|4|||
162044759|NCT00217620|585222508|FG000|Overall Study|Ineligible|13|||
162044760|NCT00217620|585222508|FG000|Overall Study|Never received treatment|1|||
162044761|NCT01314703|585222524|FG000|Overall Study|screen failure and closed enrollment|8|||
162044762|NCT04195906|585222528|FG000|Part 1|Adverse Event|3|||
162044763|NCT04195906|585222529|FG001|Part 1|Adverse Event|7|||
162044764|NCT04195906|585222528|FG000|Part 1|Withdrawal by Subject|0|||
162044765|NCT04195906|585222529|FG001|Part 1|Withdrawal by Subject|1|||
162044766|NCT04195906|585222528|FG000|Part 2|Adverse Event|1|||
162044767|NCT04195906|585222529|FG001|Part 2|Adverse Event|1|||
162044768|NCT04195906|585222528|FG000|Part 2|Withdrawal by Subject|0|||
162044769|NCT04195906|585222529|FG001|Part 2|Withdrawal by Subject|3|||
162044770|NCT04195906|585222528|FG000|Part 2|Other|1|||
162044771|NCT04195906|585222529|FG001|Part 2|Other|3|||
162044772|NCT02024529|585222531|FG000|Overall Study|Withdrawal by Subject|11|||
162044773|NCT02024529|585222532|FG001|Overall Study|Withdrawal by Subject|21|||
162044774|NCT02024529|585222531|FG000|Overall Study|Lost to Follow-up|2|||
162044775|NCT02024529|585222532|FG001|Overall Study|Lost to Follow-up|4|||
162044776|NCT00691301|585222533|FG000|Overall Study|Adverse Event|10|||
162044777|NCT00691301|585222533|FG000|Overall Study|Death|2|||
162044778|NCT00691301|585222533|FG000|Overall Study|Lack of Efficacy|32|||
162044779|NCT00691301|585222533|FG000|Overall Study|Withdrawal by Subject|4|||
162044780|NCT00691301|585222533|FG000|Overall Study|Concurrent illness|2|||
162044781|NCT00691301|585222533|FG000|Overall Study|other reason|3|||
162044782|NCT00691301|585222533|FG000|Overall Study|Did not initiate study treatment|1|||
162007271|NCT01667900|585081825|FG011|Part B|Death|0|||
162007272|NCT01667900|585081826|FG012|Part B|Death|0|||
162007273|NCT01667900|585081827|FG013|Part B|Death|0|||
162007274|NCT01667900|585081828|FG014|Part B|Death|0|||
162007275|NCT01667900|585081829|FG015|Part B|Death|0|||
162044783|NCT02642029|585222534|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
162044784|NCT02642029|585222535|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
162044785|NCT02642029|585222536|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
162044786|NCT02642029|585222537|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
162044787|NCT02642029|585222538|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
162044788|NCT02642029|585222539|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
162007276|NCT01667900|585081830|FG016|Part B|Death|1|||
162007277|NCT01667900|585081831|FG017|Part B|Death|0|||
162007278|NCT01667900|585081832|FG018|Part B|Death|0|||
162007279|NCT01667900|585081833|FG019|Part B|Death|0|||
162007280|NCT01345240|585081834|FG000|Overall Study|Adverse Event|3|||
162007281|NCT01345240|585081835|FG001|Overall Study|Adverse Event|5|||
162007282|NCT01345240|585081836|FG002|Overall Study|Adverse Event|4|||
162007283|NCT01345240|585081837|FG003|Overall Study|Adverse Event|2|||
162007284|NCT01345240|585081838|FG004|Overall Study|Adverse Event|1|||
162007285|NCT01345240|585081834|FG000|Overall Study|Lost to Follow-up|8|||
162007286|NCT01345240|585081835|FG001|Overall Study|Lost to Follow-up|9|||
162007287|NCT01345240|585081836|FG002|Overall Study|Lost to Follow-up|14|||
162007288|NCT01345240|585081837|FG003|Overall Study|Lost to Follow-up|7|||
162007289|NCT01345240|585081838|FG004|Overall Study|Lost to Follow-up|9|||
162007290|NCT00774046|585081841|FG000|Screening|Not eligible|56|||
162007291|NCT00774046|585081841|FG000|Enrollment|Desired other therapy/refused|28|||
162007292|NCT00774046|585081841|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
162007293|NCT00976274|585081842|FG000|Overall Study|Lost to Follow-up|5|||
162007294|NCT00976274|585081843|FG001|Overall Study|Lost to Follow-up|5|||
162007295|NCT00976274|585081842|FG000|Overall Study|Withdrawal by Subject|1|||
162007296|NCT00976274|585081843|FG001|Overall Study|Withdrawal by Subject|1|||
162007297|NCT00976274|585081842|FG000|Overall Study|Physician Decision|1|||
162007298|NCT00976274|585081843|FG001|Overall Study|Physician Decision|2|||
162007299|NCT02954536|585081845|FG000|Overall Study|Adverse Event|2|||
162007300|NCT02954536|585081845|FG000|Overall Study|Death|12|||
162007301|NCT02946580|585081846|FG000|Overall Study|Withdrawal by Subject|1|||
162007302|NCT02946580|585081847|FG001|Overall Study|Withdrawal by Subject|2|||
162007303|NCT02946580|585081846|FG000|Overall Study|Adverse Event|0|||
162007304|NCT02946580|585081847|FG001|Overall Study|Adverse Event|2|||
162007305|NCT02946580|585081846|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
162007306|NCT02946580|585081847|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
162007307|NCT02158442|585081848|FG000|Overall Study|Withdrawal by Subject|1|||
162007308|NCT02158442|585081849|FG001|Overall Study|Withdrawal by Subject|0|||
162007309|NCT02158442|585081848|FG000|Overall Study|Perfusion staff not available|1|||
162007310|NCT02158442|585081849|FG001|Overall Study|Perfusion staff not available|0|||
162007311|NCT02761330|585081850|FG000|Treatment Week 1|Withdrawal by Subject|0|||
162007312|NCT02761330|585081851|FG001|Treatment Week 1|Withdrawal by Subject|0|||
162007313|NCT02761330|585081852|FG002|Treatment Week 1|Withdrawal by Subject|0|||
162007314|NCT02761330|585081853|FG003|Treatment Week 1|Withdrawal by Subject|1|||
162007315|NCT02761330|585081854|FG004|Treatment Week 1|Withdrawal by Subject|0|||
162007316|NCT02761330|585081855|FG005|Treatment Week 1|Withdrawal by Subject|1|||
162007317|NCT05082857|585081860|FG000|Overall Study|participants relocated and could not continue|2|||
162007318|NCT05082857|585081861|FG001|Overall Study|participants relocated and could not continue|1|||
162007319|NCT05082857|585081860|FG000|Overall Study|Lost to Follow-up|1|||
162007320|NCT05082857|585081861|FG001|Overall Study|Lost to Follow-up|3|||
162007321|NCT03341299|585081862|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
162007322|NCT03341299|585081863|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
162007323|NCT03341299|585081864|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
162007324|NCT03341299|585081865|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
162007325|NCT01486966|585081878|FG000|Overall Study|Adverse Event|0|||
162007326|NCT01486966|585081879|FG001|Overall Study|Adverse Event|1|||
162007327|NCT01486966|585081878|FG000|Overall Study|Withdrawal by Subject|0|||
162007328|NCT01486966|585081879|FG001|Overall Study|Withdrawal by Subject|1|||
162007329|NCT03518086|585081882|FG000|Overall Study|Adverse Event|23|||
162007330|NCT03518086|585081883|FG001|Overall Study|Adverse Event|15|||
162007331|NCT03518086|585081884|FG002|Overall Study|Adverse Event|3|||
162007332|NCT03518086|585081885|FG003|Overall Study|Adverse Event|2|||
162007333|NCT03518086|585081882|FG000|Overall Study|Withdrawal by Subject|8|||
162007334|NCT03518086|585081883|FG001|Overall Study|Withdrawal by Subject|5|||
162007335|NCT03518086|585081884|FG002|Overall Study|Withdrawal by Subject|1|||
162044789|NCT02642029|585222534|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
162044790|NCT02642029|585222535|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
162044791|NCT02642029|585222536|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
162044792|NCT02642029|585222537|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
162044793|NCT02642029|585222538|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
162044794|NCT02642029|585222539|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
162044795|NCT02642029|585222534|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
162044796|NCT02642029|585222535|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
162007336|NCT03518086|585081885|FG003|Overall Study|Withdrawal by Subject|0|||
162007337|NCT03518086|585081882|FG000|Overall Study|Lack of Efficacy|5|||
162007338|NCT03518086|585081883|FG001|Overall Study|Lack of Efficacy|5|||
162044797|NCT02642029|585222536|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
162007339|NCT03518086|585081884|FG002|Overall Study|Lack of Efficacy|0|||
162007340|NCT03518086|585081885|FG003|Overall Study|Lack of Efficacy|2|||
162007341|NCT03518086|585081882|FG000|Overall Study|Protocol Violation|1|||
162007342|NCT03518086|585081883|FG001|Overall Study|Protocol Violation|5|||
162007343|NCT03518086|585081884|FG002|Overall Study|Protocol Violation|1|||
162007344|NCT03518086|585081885|FG003|Overall Study|Protocol Violation|3|||
162007345|NCT03518086|585081882|FG000|Overall Study|Lost to Follow-up|0|||
162007346|NCT03518086|585081883|FG001|Overall Study|Lost to Follow-up|3|||
162007347|NCT03518086|585081884|FG002|Overall Study|Lost to Follow-up|0|||
162007348|NCT03518086|585081885|FG003|Overall Study|Lost to Follow-up|0|||
162007349|NCT03518086|585081882|FG000|Overall Study|Insufficient Diary Data|0|||
162007350|NCT03518086|585081883|FG001|Overall Study|Insufficient Diary Data|2|||
162007351|NCT03518086|585081884|FG002|Overall Study|Insufficient Diary Data|0|||
162007352|NCT03518086|585081885|FG003|Overall Study|Insufficient Diary Data|0|||
162007353|NCT03518086|585081882|FG000|Overall Study|Non- compliance to Protocol|0|||
162007354|NCT03518086|585081883|FG001|Overall Study|Non- compliance to Protocol|1|||
162007355|NCT03518086|585081884|FG002|Overall Study|Non- compliance to Protocol|0|||
162007356|NCT03518086|585081885|FG003|Overall Study|Non- compliance to Protocol|0|||
162007357|NCT03518086|585081882|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
162007358|NCT03518086|585081883|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
162007359|NCT03518086|585081884|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
162007360|NCT03518086|585081885|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
162007361|NCT03518086|585081882|FG000|Overall Study|Site Terminated by Sponsor|0|||
162007362|NCT03518086|585081883|FG001|Overall Study|Site Terminated by Sponsor|1|||
162007363|NCT03518086|585081884|FG002|Overall Study|Site Terminated by Sponsor|0|||
162007364|NCT03518086|585081885|FG003|Overall Study|Site Terminated by Sponsor|0|||
162007365|NCT03518086|585081882|FG000|Overall Study|Pregnancy|0|||
162007366|NCT03518086|585081883|FG001|Overall Study|Pregnancy|0|||
162007367|NCT03518086|585081884|FG002|Overall Study|Pregnancy|0|||
162007368|NCT03518086|585081885|FG003|Overall Study|Pregnancy|2|||
162007369|NCT02336282|585081886|FG000|Overall Study|Unrelated illness|1|||
162007370|NCT02336282|585081886|FG000|Overall Study|Uncomfortable with technology|1|||
162007371|NCT02336282|585081886|FG000|Overall Study|Lost to Follow-up|1|||
162007372|NCT02336282|585081886|FG000|Overall Study|Not enough time to complete sessions|2|||
162007373|NCT05565742|585081888|FG000|Overall Study|Withdrawal by Subject|0|||
162007374|NCT05565742|585081889|FG001|Overall Study|Withdrawal by Subject|0|||
162007375|NCT05565742|585081890|FG002|Overall Study|Withdrawal by Subject|2|||
162007376|NCT05565742|585081891|FG003|Overall Study|Withdrawal by Subject|2|||
162007377|NCT05565742|585081892|FG004|Overall Study|Withdrawal by Subject|2|||
162007378|NCT05565742|585081888|FG000|Overall Study|Death|1|||
162007379|NCT05565742|585081889|FG001|Overall Study|Death|0|||
162007380|NCT05565742|585081890|FG002|Overall Study|Death|0|||
162007381|NCT05565742|585081891|FG003|Overall Study|Death|0|||
162007382|NCT05565742|585081892|FG004|Overall Study|Death|0|||
162007383|NCT05565742|585081888|FG000|Overall Study|Participant Travelled Abroad|0|||
162007384|NCT05565742|585081889|FG001|Overall Study|Participant Travelled Abroad|0|||
162007385|NCT05565742|585081890|FG002|Overall Study|Participant Travelled Abroad|0|||
162007386|NCT05565742|585081891|FG003|Overall Study|Participant Travelled Abroad|0|||
162007387|NCT05565742|585081892|FG004|Overall Study|Participant Travelled Abroad|1|||
162007388|NCT04163341|585081893|FG000|Overall Study|Withdrawal by Subject|2|||
162007389|NCT04163341|585081894|FG001|Overall Study|Withdrawal by Subject|0|||
162007390|NCT04163341|585081893|FG000|Overall Study|Lost to Follow-up|3|||
162007391|NCT04163341|585081894|FG001|Overall Study|Lost to Follow-up|4|||
162007392|NCT00668148|585081909|FG000|Overall Study|Adverse Event|5|||
162007393|NCT00668148|585081909|FG000|Overall Study|Subject Non-compliance|1|||
162007394|NCT00668148|585081909|FG000|Overall Study|Progressive Disease Before Treatment|2|||
162007395|NCT00668148|585081909|FG000|Overall Study|Withdrawal of Consent|2|||
162007396|NCT00303069|585083640|FG000|Overall Study|Lost to Follow-up|1|||
162007397|NCT00303069|585083641|FG001|Overall Study|Lost to Follow-up|0|||
162007398|NCT00303069|585083642|FG002|Overall Study|Lost to Follow-up|0|||
162007399|NCT00303069|585083643|FG003|Overall Study|Lost to Follow-up|2|||
162007400|NCT00303069|585083640|FG000|Overall Study|subject moved|1|||
162007401|NCT00303069|585083641|FG001|Overall Study|subject moved|0|||
162007402|NCT00303069|585083642|FG002|Overall Study|subject moved|0|||
162007403|NCT00303069|585083643|FG003|Overall Study|subject moved|0|||
162007404|NCT00303069|585083640|FG000|Overall Study|Recruitment into Army Reserves|0|||
162007405|NCT00303069|585083641|FG001|Overall Study|Recruitment into Army Reserves|0|||
162007406|NCT00303069|585083642|FG002|Overall Study|Recruitment into Army Reserves|1|||
162007407|NCT00303069|585083643|FG003|Overall Study|Recruitment into Army Reserves|0|||
162007408|NCT00092417|585083644|FG000|Overall Study|Lost to Follow-up|2|||
162007409|NCT00092417|585083645|FG001|Overall Study|Lost to Follow-up|0|||
162007410|NCT00092417|585083644|FG000|Overall Study|Withdrawal by Subject|2|||
162007411|NCT00092417|585083645|FG001|Overall Study|Withdrawal by Subject|1|||
162007412|NCT00092417|585083644|FG000|Overall Study|Other|1|||
162007413|NCT00092417|585083645|FG001|Overall Study|Other|0|||
162007414|NCT00425269|585083646|FG000|Overall Study|Pregnancy|5|||
162007415|NCT00425269|585083647|FG001|Overall Study|Pregnancy|7|||
162007416|NCT00425269|585083646|FG000|Overall Study|Lost to Follow-up|9|||
162007417|NCT00425269|585083647|FG001|Overall Study|Lost to Follow-up|9|||
162007418|NCT00425269|585083646|FG000|Overall Study|moved or medical reason|5|||
162007419|NCT00425269|585083647|FG001|Overall Study|moved or medical reason|4|||
162007420|NCT01084655|585083650|FG000|Overall Study|Radiographic disease progression|3|||
162007421|NCT01084655|585083651|FG001|Overall Study|Radiographic disease progression|2|||
162007422|NCT01084655|585083652|FG002|Overall Study|Radiographic disease progression|8|||
162007423|NCT01084655|585083650|FG000|Overall Study|Withdrawal by Subject|1|||
162007424|NCT01084655|585083651|FG001|Overall Study|Withdrawal by Subject|0|||
162007425|NCT01084655|585083652|FG002|Overall Study|Withdrawal by Subject|4|||
162007426|NCT01084655|585083650|FG000|Overall Study|Adverse Event|2|||
162007427|NCT01084655|585083651|FG001|Overall Study|Adverse Event|1|||
162007428|NCT01084655|585083652|FG002|Overall Study|Adverse Event|2|||
162007429|NCT01084655|585083650|FG000|Overall Study|Other|0|||
162007430|NCT01084655|585083651|FG001|Overall Study|Other|3|||
162007431|NCT01084655|585083652|FG002|Overall Study|Other|2|||
162007432|NCT01084655|585083650|FG000|Overall Study|Symptomatic deterioration|0|||
162007433|NCT01084655|585083651|FG001|Overall Study|Symptomatic deterioration|0|||
162007434|NCT01084655|585083652|FG002|Overall Study|Symptomatic deterioration|2|||
162007435|NCT01084655|585083650|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
162007436|NCT01084655|585083651|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
162007437|NCT01084655|585083652|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
162007438|NCT02345070|585083655|FG000|Overall Study|Adverse Event|12|||
162007439|NCT02345070|585083656|FG001|Overall Study|Adverse Event|8|||
162007440|NCT02345070|585083657|FG002|Overall Study|Adverse Event|16|||
162007441|NCT02345070|585083655|FG000|Overall Study|Poor compliance to protocol|2|||
162007442|NCT02345070|585083656|FG001|Overall Study|Poor compliance to protocol|0|||
162007443|NCT02345070|585083657|FG002|Overall Study|Poor compliance to protocol|0|||
162007444|NCT02345070|585083655|FG000|Overall Study|Other than specified above|6|||
162007445|NCT02345070|585083656|FG001|Overall Study|Other than specified above|3|||
162007446|NCT02345070|585083657|FG002|Overall Study|Other than specified above|7|||
162007447|NCT03337477|585083660|FG000|Overall Study|not categorized into the listed ones|11|||
162007448|NCT03337477|585083661|FG001|Overall Study|not categorized into the listed ones|9|||
162007449|NCT03337477|585083660|FG000|Overall Study|Withdrawal by Subject|0|||
162007450|NCT03337477|585083661|FG001|Overall Study|Withdrawal by Subject|1|||
162007451|NCT03337477|585083660|FG000|Overall Study|Death|0|||
162007452|NCT03337477|585083661|FG001|Overall Study|Death|1|||
162007453|NCT03337477|585083660|FG000|Overall Study|Lost to Follow-up|0|||
162007454|NCT03337477|585083661|FG001|Overall Study|Lost to Follow-up|2|||
162007455|NCT03182374|585083664|FG000|Overall Study|Lost to Follow-up|3|||
162007456|NCT03182374|585083665|FG001|Overall Study|Lost to Follow-up|2|||
162007457|NCT03182374|585083664|FG000|Overall Study|Lack of Efficacy|8|||
162007458|NCT03182374|585083665|FG001|Overall Study|Lack of Efficacy|14|||
162007459|NCT03182374|585083664|FG000|Overall Study|Withdrawal by Subject|1|||
162044798|NCT02642029|585222537|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
162007460|NCT03182374|585083665|FG001|Overall Study|Withdrawal by Subject|1|||
162007461|NCT03182374|585083664|FG000|Overall Study|exit for non-compliance|1|||
162007462|NCT03182374|585083665|FG001|Overall Study|exit for non-compliance|1|||
162007463|NCT03182374|585083664|FG000|Overall Study|one subject was randomized but not treated|1|||
162007464|NCT03182374|585083665|FG001|Overall Study|one subject was randomized but not treated|0|||
162007465|NCT03182374|585083664|FG000|Overall Study|Other reasons|0|||
162007466|NCT03182374|585083665|FG001|Overall Study|Other reasons|3|||
162007467|NCT01462370|585083666|FG000|Overall Study|Lack of Qualifying Event|1|||
162007468|NCT01462370|585083667|FG001|Overall Study|Lack of Qualifying Event|1|||
162007469|NCT01462370|585083666|FG000|Overall Study|Physician Decision|0|||
162007470|NCT01462370|585083667|FG001|Overall Study|Physician Decision|1|||
162007471|NCT01462370|585083666|FG000|Overall Study|Withdrawal by Subject|0|||
162007472|NCT01462370|585083667|FG001|Overall Study|Withdrawal by Subject|3|||
162007473|NCT00853307|585083670|FG000|Overall Study|Adverse Event|1|||
162007474|NCT00853307|585083671|FG001|Overall Study|Adverse Event|2|||
162007475|NCT00853307|585083670|FG000|Overall Study|Withdrawal by Subject|1|||
162007476|NCT00853307|585083671|FG001|Overall Study|Withdrawal by Subject|2|||
162007477|NCT00853307|585083670|FG000|Overall Study|Reason Not Specified|0|||
162007478|NCT00853307|585083671|FG001|Overall Study|Reason Not Specified|1|||
162007479|NCT00473564|585083672|FG000|Overall Study|robot surgery aborted in OR|23|||
162007480|NCT02379728|585083673|FG000|Overall Study|Lost to Follow-up|1|||
162007481|NCT02379728|585083674|FG001|Overall Study|Lost to Follow-up|0|||
162007482|NCT02379728|585083675|FG002|Overall Study|Lost to Follow-up|3|||
162007483|NCT02379728|585083676|FG003|Overall Study|Lost to Follow-up|0|||
162007484|NCT02379728|585083673|FG000|Overall Study|Withdrawal by Subject|5|||
162007485|NCT02379728|585083674|FG001|Overall Study|Withdrawal by Subject|0|||
162007486|NCT02379728|585083675|FG002|Overall Study|Withdrawal by Subject|5|||
162007487|NCT02379728|585083676|FG003|Overall Study|Withdrawal by Subject|3|||
162007488|NCT02379728|585083673|FG000|Overall Study|Protocol Violation|0|||
162007489|NCT02379728|585083674|FG001|Overall Study|Protocol Violation|0|||
162007490|NCT02379728|585083675|FG002|Overall Study|Protocol Violation|2|||
162007491|NCT02379728|585083676|FG003|Overall Study|Protocol Violation|0|||
162007492|NCT00914316|585083679|FG000|Phase 1|Physician Decision|4|||
162007493|NCT00914316|585083680|FG001|Phase 1|Physician Decision|0|||
162007494|NCT00914316|585083681|FG002|Phase 1|Physician Decision|1|||
162007495|NCT00914316|585083682|FG003|Phase 1|Physician Decision|2|||
162007496|NCT00914316|585083679|FG000|Phase 1|Withdrawal by Subject|0|||
162007497|NCT00914316|585083680|FG001|Phase 1|Withdrawal by Subject|2|||
162007498|NCT00914316|585083681|FG002|Phase 1|Withdrawal by Subject|4|||
162007499|NCT00914316|585083682|FG003|Phase 1|Withdrawal by Subject|0|||
162007500|NCT00914316|585083679|FG000|Phase 1|Adverse Event|1|||
162007501|NCT00914316|585083680|FG001|Phase 1|Adverse Event|0|||
162007502|NCT00914316|585083681|FG002|Phase 1|Adverse Event|0|||
162007503|NCT00914316|585083682|FG003|Phase 1|Adverse Event|0|||
162007504|NCT00914316|585083679|FG000|Phase 2|Withdrawal by Subject|1|||
162007505|NCT00914316|585083680|FG001|Phase 2|Withdrawal by Subject|0|||
162007506|NCT00914316|585083681|FG002|Phase 2|Withdrawal by Subject|1|||
162007507|NCT00914316|585083682|FG003|Phase 2|Withdrawal by Subject|0|||
162007508|NCT02177123|585083685|FG000|Overall Study|Lost to Follow-up|6|||
162007509|NCT02177123|585083685|FG000|Overall Study|Withdrawal by Subject|4|||
162007510|NCT02177123|585083685|FG000|Overall Study|Adverse Event|4|||
162007511|NCT02177123|585083685|FG000|Overall Study|Physician Decision|3|||
162007512|NCT02177123|585083685|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
162007513|NCT02177123|585083685|FG000|Overall Study|Excluded for medical reasons|2|||
162007514|NCT02177123|585083685|FG000|Overall Study|Death|1|||
162007515|NCT02177123|585083685|FG000|Overall Study|Other|1|||
162007516|NCT02177123|585083685|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
162007517|NCT01391546|585083686|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
162007518|NCT01391546|585083687|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
162007519|NCT06271993|585083689|FG000|Overall Study|Not reactive to histamine|5|||
162007520|NCT06271993|585083690|FG001|Overall Study|Not reactive to histamine|5|||
162007521|NCT06271993|585083691|FG002|Overall Study|Not reactive to histamine|5|||
162007522|NCT01980017|585083700|FG000|Overall Study|Lost to Follow-up|30|||
162007523|NCT01980017|585083701|FG001|Overall Study|Lost to Follow-up|21|||
162007524|NCT01980017|585083700|FG000|Overall Study|Death|0|||
162007525|NCT01980017|585083701|FG001|Overall Study|Death|1|||
162007526|NCT01435382|585083705|FG000|Overall Study|Lost to Follow-up|1|||
162007527|NCT01435382|585083706|FG001|Overall Study|Lost to Follow-up|0|||
162007528|NCT01435382|585083707|FG002|Overall Study|Lost to Follow-up|1|||
162007529|NCT01435382|585083708|FG003|Overall Study|Lost to Follow-up|0|||
162007530|NCT01435382|585083705|FG000|Overall Study|Withdrawal by Subject|0|||
162007531|NCT01435382|585083706|FG001|Overall Study|Withdrawal by Subject|2|||
162007532|NCT01435382|585083707|FG002|Overall Study|Withdrawal by Subject|0|||
162007533|NCT01435382|585083708|FG003|Overall Study|Withdrawal by Subject|1|||
162007534|NCT03379818|585083709|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
162007535|NCT03379818|585083710|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
162007536|NCT03379818|585083709|FG000|Overall Study|Withdrawal by Subject|2|||
162007537|NCT03379818|585083710|FG001|Overall Study|Withdrawal by Subject|3|||
162007538|NCT03379818|585083709|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
162007539|NCT03379818|585083710|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
162007540|NCT00910650|585083711|FG000|Overall Study|Death|2|||
162007541|NCT00423579|585083712|FG000|Overall Study|Lost to Follow-up|3|||
162007542|NCT00423579|585083713|FG001|Overall Study|Lost to Follow-up|0|||
162007543|NCT00423579|585083712|FG000|Overall Study|Protocol Violation|1|||
162007544|NCT00423579|585083713|FG001|Overall Study|Protocol Violation|3|||
162007545|NCT00423579|585083712|FG000|Overall Study|Diagnosis of diabetes|0|||
162007546|NCT00423579|585083713|FG001|Overall Study|Diagnosis of diabetes|1|||
162007547|NCT00260533|585083714|FG000|Overall Study|Other|3|||
162007548|NCT00260533|585083715|FG001|Overall Study|Other|3|||
162007549|NCT01761877|585083716|FG000|Overall Study|Adverse Event|7|||
162007550|NCT01761877|585083717|FG001|Overall Study|Adverse Event|0|||
162007551|NCT01761877|585083716|FG000|Overall Study|Withdrawal by Subject|6|||
162007552|NCT01761877|585083717|FG001|Overall Study|Withdrawal by Subject|4|||
162007553|NCT01761877|585083716|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
162007554|NCT01761877|585083717|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
162007555|NCT01761877|585083716|FG000|Overall Study|Death|0|||
162007556|NCT01761877|585083717|FG001|Overall Study|Death|1|||
162007557|NCT01761877|585083716|FG000|Overall Study|MRI intolerant|1|||
162007558|NCT01761877|585083717|FG001|Overall Study|MRI intolerant|6|||
162007559|NCT01310777|585083719|FG000|Overall Study|Adverse Event|23|||
162007560|NCT01310777|585083720|FG001|Overall Study|Adverse Event|1|||
162007561|NCT01310777|585083721|FG002|Overall Study|Adverse Event|15|||
162007562|NCT01310777|585083719|FG000|Overall Study|Lost to Follow-up|0|||
162007563|NCT01310777|585083720|FG001|Overall Study|Lost to Follow-up|4|||
162007564|NCT01310777|585083721|FG002|Overall Study|Lost to Follow-up|1|||
162007565|NCT01310777|585083719|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
162007566|NCT01310777|585083720|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
162007567|NCT01310777|585083721|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
162007568|NCT01310777|585083719|FG000|Overall Study|Inadequate Control of IOP|5|||
162007569|NCT01310777|585083720|FG001|Overall Study|Inadequate Control of IOP|7|||
162007570|NCT01310777|585083721|FG002|Overall Study|Inadequate Control of IOP|10|||
162007571|NCT01310777|585083719|FG000|Overall Study|Other|4|||
162007572|NCT01310777|585083720|FG001|Overall Study|Other|1|||
162007573|NCT01310777|585083721|FG002|Overall Study|Other|2|||
162007574|NCT00003475|585083722|FG000|Overall Study|Not evaluable|13|||
162007575|NCT03962491|585083723|FG000|Overall Study|Lost to Follow-up|4|||
162007576|NCT03962491|585083724|FG001|Overall Study|Lost to Follow-up|5|||
162007577|NCT03697252|585083731|FG000|Overall Study|Adverse Event|3|||
162007578|NCT03697252|585083732|FG001|Overall Study|Adverse Event|2|||
162007579|NCT03697252|585083731|FG000|Overall Study|Withdrawal by Subject|14|||
162007580|NCT03697252|585083732|FG001|Overall Study|Withdrawal by Subject|14|||
162007581|NCT03697252|585083731|FG000|Overall Study|Lost to Follow-up|0|||
162007582|NCT03697252|585083732|FG001|Overall Study|Lost to Follow-up|1|||
162007583|NCT03697252|585083731|FG000|Overall Study|Physician Decision|1|||
162007584|NCT03697252|585083732|FG001|Overall Study|Physician Decision|1|||
162007585|NCT03697252|585083731|FG000|Overall Study|Other|0|||
162007586|NCT03697252|585083732|FG001|Overall Study|Other|1|||
162007587|NCT00106704|585083733|FG000|Overall Study|Adverse Event|10|||
162007588|NCT00106704|585083734|FG001|Overall Study|Adverse Event|7|||
162007589|NCT00106704|585083733|FG000|Overall Study|Death|2|||
162007590|NCT00106704|585083734|FG001|Overall Study|Death|1|||
162007591|NCT00106704|585083733|FG000|Overall Study|Lack of Efficacy|67|||
162007592|NCT00106704|585083734|FG001|Overall Study|Lack of Efficacy|69|||
162007593|NCT00106704|585083733|FG000|Overall Study|Lost to Follow-up|7|||
162007594|NCT00106704|585083734|FG001|Overall Study|Lost to Follow-up|3|||
162007595|NCT00106704|585083733|FG000|Overall Study|Pregnancy|1|||
162007596|NCT00106704|585083734|FG001|Overall Study|Pregnancy|0|||
162007597|NCT00106704|585083733|FG000|Overall Study|Protocol Violation|4|||
162007598|NCT00106704|585083734|FG001|Overall Study|Protocol Violation|7|||
162007599|NCT00106704|585083733|FG000|Overall Study|Withdrawal by Subject|14|||
162007600|NCT00106704|585083734|FG001|Overall Study|Withdrawal by Subject|21|||
162007601|NCT00106704|585083733|FG000|Overall Study|Patient moved|1|||
162007602|NCT00106704|585083734|FG001|Overall Study|Patient moved|0|||
162007603|NCT00106704|585083733|FG000|Overall Study|Site terminated|0|||
162007604|NCT00106704|585083734|FG001|Overall Study|Site terminated|1|||
162007605|NCT00106704|585083733|FG000|Overall Study|Planned major surgery|1|||
162007606|NCT00106704|585083734|FG001|Overall Study|Planned major surgery|0|||
162007607|NCT00106704|585083733|FG000|Overall Study|Patient Received Glycemic Medication|22|||
162007608|NCT00106704|585083734|FG001|Overall Study|Patient Received Glycemic Medication|41|||
162007609|NCT00106704|585083733|FG000|Overall Study|Unable to re-enter US|1|||
162007610|NCT00106704|585083734|FG001|Overall Study|Unable to re-enter US|0|||
162007611|NCT00106704|585083733|FG000|Overall Study|Laboratory test|1|||
162007612|NCT00106704|585083734|FG001|Overall Study|Laboratory test|1|||
162007613|NCT01780506|585083735|FG000|Double-Blind Phase|Randomized but not Treated|3|||
162007614|NCT01780506|585083736|FG001|Double-Blind Phase|Randomized but not Treated|2|||
162007615|NCT01780506|585083735|FG000|Double-Blind Phase|Adverse Event|4|||
162007616|NCT01780506|585083736|FG001|Double-Blind Phase|Adverse Event|14|||
162007617|NCT01780506|585083735|FG000|Double-Blind Phase|Death|1|||
162007618|NCT01780506|585083736|FG001|Double-Blind Phase|Death|2|||
162007619|NCT01780506|585083735|FG000|Double-Blind Phase|Pregnancy|2|||
162007620|NCT01780506|585083736|FG001|Double-Blind Phase|Pregnancy|1|||
162007621|NCT01780506|585083735|FG000|Double-Blind Phase|Lack of Efficacy|1|||
162007622|NCT01780506|585083736|FG001|Double-Blind Phase|Lack of Efficacy|1|||
162007623|NCT01780506|585083735|FG000|Double-Blind Phase|Investigator's Discretion|5|||
162007624|NCT01780506|585083736|FG001|Double-Blind Phase|Investigator's Discretion|2|||
162007625|NCT01780506|585083735|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
162007626|NCT01780506|585083736|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
162007627|NCT01780506|585083735|FG000|Double-Blind Phase|Protocol Violation|4|||
162007628|NCT01780506|585083736|FG001|Double-Blind Phase|Protocol Violation|3|||
162007629|NCT01780506|585083735|FG000|Double-Blind Phase|Withdrew Consent|23|||
162007630|NCT01780506|585083736|FG001|Double-Blind Phase|Withdrew Consent|24|||
162007631|NCT01780506|585083735|FG000|Double-Blind Phase|Lost to Follow-up|23|||
162007632|NCT01780506|585083736|FG001|Double-Blind Phase|Lost to Follow-up|26|||
162007633|NCT01780506|585083735|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
162007634|NCT01780506|585083736|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
162007635|NCT01867671|585083740|FG000|Overall Study|Adverse Event|5|||
162007636|NCT01867671|585083741|FG001|Overall Study|Adverse Event|3|||
162007637|NCT01867671|585083740|FG000|Overall Study|Anaphylaxis|0|||
162007638|NCT01867671|585083741|FG001|Overall Study|Anaphylaxis|1|||
162007639|NCT01867671|585083740|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
162007640|NCT01867671|585083741|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
162007641|NCT01867671|585083740|FG000|Overall Study|Lost to Follow-up|0|||
162007642|NCT01867671|585083741|FG001|Overall Study|Lost to Follow-up|1|||
162007643|NCT01867671|585083740|FG000|Overall Study|Non-compliance with Study Drug|1|||
162007644|NCT01867671|585083741|FG001|Overall Study|Non-compliance with Study Drug|2|||
162007645|NCT01867671|585083740|FG000|Overall Study|Withdrawal by Subject|21|||
162007646|NCT01867671|585083741|FG001|Overall Study|Withdrawal by Subject|21|||
162007647|NCT00317473|585083742|FG000|Overall Study|Withdrawal by Subject|2|||
162007648|NCT00317473|585083743|FG001|Overall Study|Withdrawal by Subject|1|||
162007649|NCT00317473|585083744|FG002|Overall Study|Withdrawal by Subject|2|||
162007650|NCT00317473|585083745|FG003|Overall Study|Withdrawal by Subject|1|||
162007651|NCT00317473|585083746|FG004|Overall Study|Withdrawal by Subject|3|||
162044799|NCT02642029|585222538|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
162044800|NCT02642029|585222539|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
162044801|NCT02642029|585222534|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
162044802|NCT02642029|585222535|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
162007652|NCT00317473|585083747|FG005|Overall Study|Withdrawal by Subject|1|||
162007653|NCT00317473|585083742|FG000|Overall Study|Relocation|1|||
162007654|NCT00317473|585083743|FG001|Overall Study|Relocation|0|||
162007655|NCT00317473|585083744|FG002|Overall Study|Relocation|1|||
162007656|NCT00317473|585083745|FG003|Overall Study|Relocation|1|||
162007657|NCT00317473|585083746|FG004|Overall Study|Relocation|5|||
162007658|NCT00317473|585083747|FG005|Overall Study|Relocation|2|||
162007659|NCT00317473|585083742|FG000|Overall Study|Death|1|||
162007660|NCT00317473|585083743|FG001|Overall Study|Death|0|||
162007661|NCT00317473|585083744|FG002|Overall Study|Death|0|||
162007662|NCT00317473|585083745|FG003|Overall Study|Death|0|||
162007663|NCT00317473|585083746|FG004|Overall Study|Death|0|||
162007664|NCT00317473|585083747|FG005|Overall Study|Death|0|||
162007665|NCT00317473|585083742|FG000|Overall Study|Other|0|||
162007666|NCT00317473|585083743|FG001|Overall Study|Other|2|||
162007667|NCT00317473|585083744|FG002|Overall Study|Other|0|||
162007668|NCT00317473|585083745|FG003|Overall Study|Other|0|||
162007669|NCT00317473|585083746|FG004|Overall Study|Other|0|||
162007670|NCT00317473|585083747|FG005|Overall Study|Other|0|||
162007671|NCT02285855|585083748|FG000|Overall Study|Withdrawal by Subject|2|||
162007672|NCT02285855|585083749|FG001|Overall Study|Withdrawal by Subject|1|||
162007673|NCT03253796|585083750|FG000|Period 1: Run-In|Adverse Event|4|||
162007674|NCT03253796|585083751|FG001|Period 1: Run-In|Adverse Event|0|||
162007675|NCT03253796|585083752|FG002|Period 1: Run-In|Adverse Event|0|||
162007676|NCT03253796|585083753|FG003|Period 1: Run-In|Adverse Event|0|||
162007677|NCT03253796|585083754|FG004|Period 1: Run-In|Adverse Event|0|||
162007678|NCT03253796|585083750|FG000|Period 1: Run-In|Lack of Efficacy|1|||
162007679|NCT03253796|585083751|FG001|Period 1: Run-In|Lack of Efficacy|0|||
162007680|NCT03253796|585083752|FG002|Period 1: Run-In|Lack of Efficacy|0|||
162007681|NCT03253796|585083753|FG003|Period 1: Run-In|Lack of Efficacy|0|||
162007682|NCT03253796|585083754|FG004|Period 1: Run-In|Lack of Efficacy|0|||
162007683|NCT03253796|585083750|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
162007684|NCT03253796|585083751|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
162007685|NCT03253796|585083752|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
162007686|NCT03253796|585083753|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
162007687|NCT03253796|585083754|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
162007688|NCT03253796|585083750|FG000|Period 1: Run-In|Protocol Violation|5|||
162007689|NCT03253796|585083751|FG001|Period 1: Run-In|Protocol Violation|0|||
162007690|NCT03253796|585083752|FG002|Period 1: Run-In|Protocol Violation|0|||
162007691|NCT03253796|585083753|FG003|Period 1: Run-In|Protocol Violation|0|||
162007692|NCT03253796|585083754|FG004|Period 1: Run-In|Protocol Violation|0|||
162007693|NCT03253796|585083750|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
162007694|NCT03253796|585083751|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
162007695|NCT03253796|585083752|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
162007696|NCT03253796|585083753|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
162007697|NCT03253796|585083754|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
162007698|NCT03253796|585083750|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
162007699|NCT03253796|585083751|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
162007700|NCT03253796|585083752|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
162007701|NCT03253796|585083753|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
162007702|NCT03253796|585083754|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
162007703|NCT03253796|585083750|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
162007704|NCT03253796|585083751|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
162007705|NCT03253796|585083752|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
162007706|NCT03253796|585083753|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
162007707|NCT03253796|585083754|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
162007708|NCT03253796|585083750|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
162007709|NCT03253796|585083751|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
162007710|NCT03253796|585083752|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
162044803|NCT02642029|585222536|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
162007711|NCT03253796|585083753|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
162044804|NCT02642029|585222537|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
162044805|NCT02642029|585222538|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
162007712|NCT03253796|585083754|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
162007713|NCT03253796|585083750|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
162007714|NCT03253796|585083751|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
162007715|NCT03253796|585083752|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
162007716|NCT03253796|585083753|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
162007717|NCT03253796|585083754|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
162044806|NCT02642029|585222539|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
162044807|NCT02642029|585222534|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
162044808|NCT02642029|585222535|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
162044809|NCT02642029|585222536|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
162044810|NCT02642029|585222537|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
162044811|NCT02642029|585222538|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
162044812|NCT02642029|585222539|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
162044813|NCT02642029|585222534|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
162044814|NCT02642029|585222535|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
162044815|NCT02642029|585222536|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
162044816|NCT02642029|585222537|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
162044817|NCT02642029|585222538|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
162044818|NCT02642029|585222539|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
162044819|NCT01823146|585222540|FG000|Overall Study|Withdrawal by Subject|0|||
162044820|NCT01823146|585222541|FG001|Overall Study|Withdrawal by Subject|1|||
162044821|NCT01823146|585222540|FG000|Overall Study|Lost to Follow-up|2|||
162044822|NCT01823146|585222541|FG001|Overall Study|Lost to Follow-up|1|||
162044823|NCT00463580|585222542|FG000|Overall Study|Lost to Follow-up|1|||
162044824|NCT00463580|585222543|FG001|Overall Study|Lost to Follow-up|0|||
162044825|NCT00463580|585222542|FG000|Overall Study|Schedule conflict|2|||
162044826|NCT00463580|585222543|FG001|Overall Study|Schedule conflict|0|||
162044827|NCT00463580|585222542|FG000|Overall Study|Medical/psychiatric complications|0|||
162044828|NCT00463580|585222543|FG001|Overall Study|Medical/psychiatric complications|2|||
162044829|NCT01495975|585222545|FG000|Overall Study|Lost to Follow-up|1|||
162044830|NCT01495975|585222546|FG001|Overall Study|Lost to Follow-up|0|||
162044831|NCT02038881|585222549|FG000|Overall Study|Withdrawal by Subject|0|||
162044832|NCT02038881|585222550|FG001|Overall Study|Withdrawal by Subject|0|||
162044833|NCT02038881|585222551|FG002|Overall Study|Withdrawal by Subject|1|||
162044834|NCT02038881|585222549|FG000|Overall Study|Lost to Follow-up|2|||
162044835|NCT02038881|585222550|FG001|Overall Study|Lost to Follow-up|0|||
162044836|NCT02038881|585222551|FG002|Overall Study|Lost to Follow-up|0|||
162044837|NCT02038881|585222549|FG000|Overall Study|incarcerated|1|||
162044838|NCT02038881|585222550|FG001|Overall Study|incarcerated|0|||
162044839|NCT02038881|585222551|FG002|Overall Study|incarcerated|0|||
162044840|NCT00333840|585222552|FG000|First-line Treatment Period|Adverse Event|38|||
162044841|NCT00333840|585222553|FG001|First-line Treatment Period|Adverse Event|37|||
162044842|NCT00333840|585222554|FG002|First-line Treatment Period|Adverse Event|0|||
162044843|NCT00333840|585222555|FG003|First-line Treatment Period|Adverse Event|0|||
162044844|NCT00333840|585222552|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
162044845|NCT00333840|585222553|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
162044846|NCT00333840|585222554|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
162044847|NCT00333840|585222555|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
162044848|NCT00333840|585222552|FG000|First-line Treatment Period|Abnormal procedure|2|||
162044849|NCT00333840|585222553|FG001|First-line Treatment Period|Abnormal procedure|0|||
162044850|NCT00333840|585222554|FG002|First-line Treatment Period|Abnormal procedure|0|||
162044851|NCT00333840|585222555|FG003|First-line Treatment Period|Abnormal procedure|0|||
162044852|NCT00333840|585222552|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
162044853|NCT00333840|585222553|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
162044854|NCT00333840|585222554|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
162044855|NCT00333840|585222555|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
162044856|NCT00333840|585222552|FG000|First-line Treatment Period|No longer required study drug|21|||
162044857|NCT00333840|585222553|FG001|First-line Treatment Period|No longer required study drug|8|||
162044858|NCT00333840|585222554|FG002|First-line Treatment Period|No longer required study drug|0|||
162044859|NCT00333840|585222555|FG003|First-line Treatment Period|No longer required study drug|0|||
162044860|NCT00333840|585222552|FG000|First-line Treatment Period|Protocol Violation|17|||
162044861|NCT00333840|585222553|FG001|First-line Treatment Period|Protocol Violation|17|||
162044862|NCT00333840|585222554|FG002|First-line Treatment Period|Protocol Violation|0|||
162044863|NCT00333840|585222555|FG003|First-line Treatment Period|Protocol Violation|0|||
162044864|NCT00333840|585222552|FG000|First-line Treatment Period|Subject withdrew consent|57|||
162044865|NCT00333840|585222553|FG001|First-line Treatment Period|Subject withdrew consent|77|||
162044866|NCT00333840|585222554|FG002|First-line Treatment Period|Subject withdrew consent|0|||
162044867|NCT00333840|585222555|FG003|First-line Treatment Period|Subject withdrew consent|0|||
162044868|NCT00333840|585222552|FG000|First-line Treatment Period|Lost to Follow-up|15|||
162044869|NCT00333840|585222553|FG001|First-line Treatment Period|Lost to Follow-up|6|||
162044870|NCT00333840|585222554|FG002|First-line Treatment Period|Lost to Follow-up|0|||
162044871|NCT00333840|585222555|FG003|First-line Treatment Period|Lost to Follow-up|0|||
162044872|NCT00333840|585222552|FG000|First-line Treatment Period|Administrative problems|12|||
162044873|NCT00333840|585222553|FG001|First-line Treatment Period|Administrative problems|6|||
162044874|NCT00333840|585222554|FG002|First-line Treatment Period|Administrative problems|0|||
162044875|NCT00333840|585222555|FG003|First-line Treatment Period|Administrative problems|0|||
162044876|NCT00333840|585222552|FG000|First-line Treatment Period|Death|19|||
162044877|NCT00333840|585222553|FG001|First-line Treatment Period|Death|2|||
162044878|NCT00333840|585222554|FG002|First-line Treatment Period|Death|0|||
162044879|NCT00333840|585222555|FG003|First-line Treatment Period|Death|0|||
162044880|NCT00333840|585222552|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
162044881|NCT00333840|585222553|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
162044882|NCT00333840|585222554|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
162044883|NCT00333840|585222555|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
162044884|NCT00333840|585222552|FG000|Second-line Treatment Period|Adverse Event|0|||
162044885|NCT00333840|585222553|FG001|Second-line Treatment Period|Adverse Event|0|||
162044886|NCT00333840|585222554|FG002|Second-line Treatment Period|Adverse Event|3|||
162044887|NCT00333840|585222555|FG003|Second-line Treatment Period|Adverse Event|34|||
162007718|NCT03253796|585083750|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
162007719|NCT03253796|585083751|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
162007720|NCT03253796|585083752|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
162007721|NCT03253796|585083753|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
162007722|NCT03253796|585083754|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
162007723|NCT03253796|585083750|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
162007724|NCT03253796|585083751|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
162007725|NCT03253796|585083752|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
162007726|NCT03253796|585083753|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
162007727|NCT03253796|585083754|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
162007728|NCT00528112|585083755|FG000|Treatment up to 3 Years|Adverse Event|313|||
162007729|NCT00528112|585083756|FG001|Treatment up to 3 Years|Adverse Event|278|||
162007730|NCT00528112|585083755|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
162007731|NCT00528112|585083756|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
162007732|NCT00528112|585083755|FG000|Treatment up to 3 Years|Protocol Violation|16|||
162007733|NCT00528112|585083756|FG001|Treatment up to 3 Years|Protocol Violation|16|||
162007734|NCT00528112|585083755|FG000|Treatment up to 3 Years|Death|0|||
162007735|NCT00528112|585083756|FG001|Treatment up to 3 Years|Death|1|||
162007736|NCT00528112|585083755|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
162007737|NCT00528112|585083756|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
162007738|NCT00528112|585083755|FG000|Treatment up to 3 Years|Pregnancy|9|||
162007739|NCT00528112|585083756|FG001|Treatment up to 3 Years|Pregnancy|10|||
162007740|NCT00528112|585083755|FG000|Treatment up to 3 Years|Other reasons|186|||
162007741|NCT00528112|585083756|FG001|Treatment up to 3 Years|Other reasons|186|||
162007742|NCT00528112|585083755|FG000|Extension Phase|Withdrawal by Subject|0|||
162007743|NCT00528112|585083756|FG001|Extension Phase|Withdrawal by Subject|3|||
162007744|NCT00528112|585083755|FG000|Extension Phase|Other reasons|0|||
162007745|NCT00528112|585083756|FG001|Extension Phase|Other reasons|100|||
162007746|NCT00528112|585083755|FG000|Extension Phase|Pregnancy|0|||
162007747|NCT00528112|585083756|FG001|Extension Phase|Pregnancy|3|||
162007748|NCT00528112|585083755|FG000|Extension Phase|Lost to Follow-up|0|||
162007749|NCT00528112|585083756|FG001|Extension Phase|Lost to Follow-up|12|||
162007750|NCT00528112|585083755|FG000|Extension Phase|Death|0|||
162007751|NCT00528112|585083756|FG001|Extension Phase|Death|1|||
162007752|NCT00528112|585083755|FG000|Extension Phase|Adverse Event|0|||
162007753|NCT00528112|585083756|FG001|Extension Phase|Adverse Event|36|||
162007754|NCT00528112|585083755|FG000|Extension Phase|Protocol Violation|0|||
162007755|NCT00528112|585083756|FG001|Extension Phase|Protocol Violation|2|||
162007756|NCT02718898|585083759|FG000|Blinded Treatment Period|Adverse Event|5|||
162007757|NCT02718898|585083760|FG001|Blinded Treatment Period|Adverse Event|1|||
162007758|NCT02718898|585083761|FG002|Blinded Treatment Period|Adverse Event|0|||
162007759|NCT02718898|585083762|FG003|Blinded Treatment Period|Adverse Event|0|||
162007760|NCT02718898|585083763|FG004|Blinded Treatment Period|Adverse Event|0|||
162007761|NCT02718898|585083764|FG005|Blinded Treatment Period|Adverse Event|0|||
162007762|NCT02718898|585083765|FG006|Blinded Treatment Period|Adverse Event|0|||
162007763|NCT02718898|585083759|FG000|Blinded Treatment Period|Physician Decision|1|||
162007764|NCT02718898|585083760|FG001|Blinded Treatment Period|Physician Decision|0|||
162007765|NCT02718898|585083761|FG002|Blinded Treatment Period|Physician Decision|0|||
162007766|NCT02718898|585083762|FG003|Blinded Treatment Period|Physician Decision|0|||
162007767|NCT02718898|585083763|FG004|Blinded Treatment Period|Physician Decision|0|||
162007768|NCT02718898|585083764|FG005|Blinded Treatment Period|Physician Decision|0|||
162007769|NCT02718898|585083765|FG006|Blinded Treatment Period|Physician Decision|0|||
162007770|NCT02718898|585083759|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
162007771|NCT02718898|585083760|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
162007772|NCT02718898|585083761|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
162007773|NCT02718898|585083762|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
162007774|NCT02718898|585083763|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
162007775|NCT02718898|585083764|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
162044888|NCT00333840|585222552|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
162007776|NCT02718898|585083765|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
162007777|NCT02718898|585083759|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
162007778|NCT02718898|585083760|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
162007779|NCT02718898|585083761|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
162007780|NCT02718898|585083762|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
162007781|NCT02718898|585083763|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
162007782|NCT02718898|585083764|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
162007783|NCT02718898|585083765|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
162007784|NCT02718898|585083759|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
162007785|NCT02718898|585083760|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
162007786|NCT02718898|585083761|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
162007787|NCT02718898|585083762|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
162007788|NCT02718898|585083763|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
162007789|NCT02718898|585083764|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
162007790|NCT02718898|585083765|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
162007791|NCT02718898|585083759|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
162007792|NCT02718898|585083760|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
162007793|NCT02718898|585083761|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
162007794|NCT02718898|585083762|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
162007795|NCT02718898|585083763|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
162007796|NCT02718898|585083764|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
162007797|NCT02718898|585083765|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
162007798|NCT02718898|585083759|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
162007799|NCT02718898|585083760|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
162007800|NCT02718898|585083761|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
162007801|NCT02718898|585083762|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
162007802|NCT02718898|585083763|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
162007803|NCT02718898|585083764|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
162007804|NCT02718898|585083765|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
162007805|NCT02718898|585083759|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
162007806|NCT02718898|585083760|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
162007807|NCT02718898|585083761|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
162007808|NCT02718898|585083762|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
162007809|NCT02718898|585083763|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
162007810|NCT02718898|585083764|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
162007811|NCT02718898|585083765|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
162007812|NCT02718898|585083759|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
162007813|NCT02718898|585083760|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
162007814|NCT02718898|585083761|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
162007815|NCT02718898|585083762|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
162007816|NCT02718898|585083763|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
162007817|NCT02718898|585083764|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
162007818|NCT02718898|585083765|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
162007819|NCT02718898|585083759|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
162007820|NCT02718898|585083760|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
162007821|NCT02718898|585083761|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
162007822|NCT02718898|585083762|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
162007823|NCT02718898|585083763|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
162007824|NCT02718898|585083764|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
162007825|NCT02718898|585083765|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
162007826|NCT02718898|585083759|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
162007827|NCT02718898|585083760|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
162007828|NCT02718898|585083761|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
162007829|NCT02718898|585083762|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
162007830|NCT02718898|585083763|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
162007831|NCT02718898|585083764|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
162007832|NCT02718898|585083765|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
162007833|NCT02718898|585083759|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
162007834|NCT02718898|585083760|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
162007835|NCT02718898|585083761|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
162007836|NCT02718898|585083762|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
162007837|NCT02718898|585083763|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
162007838|NCT02718898|585083764|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
162007839|NCT02718898|585083765|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
162007840|NCT02718898|585083759|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162007841|NCT02718898|585083760|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162044889|NCT00333840|585222553|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
162044890|NCT00333840|585222554|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
162044891|NCT00333840|585222555|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
162044892|NCT00333840|585222552|FG000|Second-line Treatment Period|Abnormal procedure|0|||
162044893|NCT00333840|585222553|FG001|Second-line Treatment Period|Abnormal procedure|0|||
162044894|NCT00333840|585222554|FG002|Second-line Treatment Period|Abnormal procedure|0|||
162044895|NCT00333840|585222555|FG003|Second-line Treatment Period|Abnormal procedure|1|||
162044896|NCT00333840|585222552|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
162044897|NCT00333840|585222553|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
162044898|NCT00333840|585222554|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
162044899|NCT00333840|585222555|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
162044900|NCT00333840|585222552|FG000|Second-line Treatment Period|No longer required study drug|0|||
162044901|NCT00333840|585222553|FG001|Second-line Treatment Period|No longer required study drug|0|||
162044902|NCT00333840|585222554|FG002|Second-line Treatment Period|No longer required study drug|1|||
162044903|NCT00333840|585222555|FG003|Second-line Treatment Period|No longer required study drug|14|||
162044904|NCT00333840|585222552|FG000|Second-line Treatment Period|Protocol Violation|0|||
162007842|NCT02718898|585083761|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162007843|NCT02718898|585083762|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162007844|NCT02718898|585083763|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
162007845|NCT02718898|585083764|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
162007846|NCT02718898|585083765|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
162007847|NCT00231816|585083768|FG000|Overall Study|Adverse Event|1|||
162007848|NCT00231816|585083769|FG001|Overall Study|Adverse Event|0|||
162007849|NCT00231816|585083768|FG000|Overall Study|Lost to Follow-up|8|||
162007850|NCT00231816|585083769|FG001|Overall Study|Lost to Follow-up|5|||
162007851|NCT00231816|585083768|FG000|Overall Study|Protocol Violation|2|||
162007852|NCT00231816|585083769|FG001|Overall Study|Protocol Violation|3|||
162007853|NCT00231816|585083768|FG000|Overall Study|Withdrawal by Subject|3|||
162007854|NCT00231816|585083769|FG001|Overall Study|Withdrawal by Subject|3|||
162007855|NCT00231816|585083768|FG000|Overall Study|Other|2|||
162007856|NCT00231816|585083769|FG001|Overall Study|Other|1|||
162007857|NCT03043313|585083771|FG000|Overall Study|Withdrawal by Subject|5|||
162007858|NCT03043313|585083772|FG001|Overall Study|Withdrawal by Subject|1|||
162007859|NCT03043313|585083773|FG002|Overall Study|Withdrawal by Subject|1|||
162007860|NCT03043313|585083771|FG000|Overall Study|Lost to Follow-up|1|||
162007861|NCT03043313|585083772|FG001|Overall Study|Lost to Follow-up|1|||
162007862|NCT03043313|585083773|FG002|Overall Study|Lost to Follow-up|0|||
162007863|NCT03043313|585083771|FG000|Overall Study|Death|28|||
162007864|NCT03043313|585083772|FG001|Overall Study|Death|26|||
162007865|NCT03043313|585083773|FG002|Overall Study|Death|17|||
162007866|NCT03043313|585083771|FG000|Overall Study|Participation terminated by sponsor|11|||
162007867|NCT03043313|585083772|FG001|Overall Study|Participation terminated by sponsor|13|||
162007868|NCT03043313|585083773|FG002|Overall Study|Participation terminated by sponsor|13|||
162007869|NCT01506596|585083774|FG000|Overall Study|ineligible pathology|1|||
162007870|NCT05712460|585083776|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
162007871|NCT05712460|585083777|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
162007872|NCT05712460|585083778|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
162007873|NCT05712460|585083779|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
162007874|NCT05712460|585083780|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
162007875|NCT05712460|585083781|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
162007876|NCT05712460|585083782|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
162007877|NCT05712460|585083783|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
162007878|NCT05712460|585083784|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
162007879|NCT05712460|585083785|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
162007880|NCT05712460|585083786|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
162007881|NCT05712460|585083787|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
162007882|NCT05135767|585083791|FG000|Baseline|Lost to Follow-up|1|||
162007883|NCT05135767|585083792|FG001|Baseline|Lost to Follow-up|1|||
162007884|NCT05135767|585083791|FG000|Baseline|Withdrawal by Subject|0|||
162007885|NCT05135767|585083792|FG001|Baseline|Withdrawal by Subject|2|||
162007886|NCT05135767|585083791|FG000|Active Study Phase|Lost to Follow-up|2|||
162007887|NCT05135767|585083792|FG001|Active Study Phase|Lost to Follow-up|0|||
162007888|NCT02694185|585083793|FG000|Overall Study|Withdrawal by Subject|45|||
162007889|NCT02694185|585083794|FG001|Overall Study|Withdrawal by Subject|0|||
162007890|NCT04366349|585083795|FG000|Overall Study|Withdrawal by Subject|1|||
162007891|NCT04366349|585083796|FG001|Overall Study|Withdrawal by Subject|0|||
162007892|NCT04366349|585083797|FG002|Overall Study|Withdrawal by Subject|0|||
162007893|NCT04366349|585083798|FG003|Overall Study|Withdrawal by Subject|0|||
162007894|NCT04366349|585083799|FG004|Overall Study|Withdrawal by Subject|0|||
162007895|NCT04366349|585083800|FG005|Overall Study|Withdrawal by Subject|0|||
162007896|NCT02331134|585083801|FG000|Overall Study|Withdrawal by Subject|1|||
162007897|NCT04825574|585083805|FG000|Overall Study|Commercial treatment became available|1|||
162007898|NCT04825574|585083805|FG000|Overall Study|Disease progression|1|||
162007899|NCT05967260|585083806|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
162007900|NCT05967260|585083807|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
162044905|NCT00333840|585222553|FG001|Second-line Treatment Period|Protocol Violation|0|||
162044906|NCT00333840|585222554|FG002|Second-line Treatment Period|Protocol Violation|1|||
162044907|NCT00333840|585222555|FG003|Second-line Treatment Period|Protocol Violation|10|||
162044908|NCT00333840|585222552|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
162044909|NCT00333840|585222553|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
162044910|NCT00333840|585222554|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
162044911|NCT00333840|585222555|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
162044912|NCT00333840|585222552|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
162044913|NCT00333840|585222553|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
162044914|NCT00333840|585222554|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
162044915|NCT00333840|585222555|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
162044916|NCT00333840|585222552|FG000|Second-line Treatment Period|Administrative problems|0|||
162044917|NCT00333840|585222553|FG001|Second-line Treatment Period|Administrative problems|0|||
162044918|NCT00333840|585222554|FG002|Second-line Treatment Period|Administrative problems|0|||
162044919|NCT00333840|585222555|FG003|Second-line Treatment Period|Administrative problems|7|||
162044920|NCT00333840|585222552|FG000|Second-line Treatment Period|Death|0|||
162044921|NCT00333840|585222553|FG001|Second-line Treatment Period|Death|0|||
162044922|NCT00333840|585222554|FG002|Second-line Treatment Period|Death|0|||
162044923|NCT00333840|585222555|FG003|Second-line Treatment Period|Death|9|||
162044924|NCT02357979|585222556|FG000|Overall Study|Lost to Follow-up|5|||
162044925|NCT02357979|585222557|FG001|Overall Study|Lost to Follow-up|5|||
162044926|NCT01453725|585222558|FG000|Overall Study|Adverse Event|3|||
162044927|NCT01453725|585222559|FG001|Overall Study|Adverse Event|3|||
162044928|NCT01453725|585222558|FG000|Overall Study|Lost to Follow-up|4|||
162044929|NCT01453725|585222559|FG001|Overall Study|Lost to Follow-up|0|||
162044930|NCT01453725|585222558|FG000|Overall Study|Non-compliance With Protocol|1|||
162044931|NCT01453725|585222559|FG001|Overall Study|Non-compliance With Protocol|2|||
162044932|NCT01453725|585222558|FG000|Overall Study|Protocol Violation|1|||
162044933|NCT01453725|585222559|FG001|Overall Study|Protocol Violation|0|||
162044934|NCT01453725|585222558|FG000|Overall Study|Withdrawal by Subject|2|||
162007901|NCT05472090|585083809|FG000|Overall Study|Adverse Event|2|||
162007902|NCT05472090|585083810|FG001|Overall Study|Adverse Event|3|||
162007903|NCT05472090|585083809|FG000|Overall Study|Lack of Efficacy|1|||
162007904|NCT05472090|585083810|FG001|Overall Study|Lack of Efficacy|0|||
162007905|NCT05472090|585083809|FG000|Overall Study|Physician Decision|1|||
162007906|NCT05472090|585083810|FG001|Overall Study|Physician Decision|0|||
162007907|NCT05472090|585083809|FG000|Overall Study|Withdrawal by Subject|2|||
162007908|NCT05472090|585083810|FG001|Overall Study|Withdrawal by Subject|0|||
162007909|NCT05472090|585083809|FG000|Overall Study|Lost to Follow-up|0|||
162044935|NCT01453725|585222559|FG001|Overall Study|Withdrawal by Subject|3|||
162044936|NCT01453725|585222558|FG000|Overall Study|Pregnancy Wish|0|||
162044937|NCT01453725|585222559|FG001|Overall Study|Pregnancy Wish|2|||
162044938|NCT01453725|585222558|FG000|Overall Study|Pregnancy|1|||
162044939|NCT01453725|585222559|FG001|Overall Study|Pregnancy|0|||
162044940|NCT01453725|585222558|FG000|Overall Study|Physician Decision|1|||
162044941|NCT01453725|585222559|FG001|Overall Study|Physician Decision|1|||
162044942|NCT03449901|585222560|FG000|Overall Study|Progression|57|||
162044943|NCT03449901|585222561|FG001|Overall Study|Progression|12|||
162044944|NCT03449901|585222560|FG000|Overall Study|Adverse Event|3|||
162044945|NCT03449901|585222561|FG001|Overall Study|Adverse Event|0|||
162044946|NCT03449901|585222560|FG000|Overall Study|Death|6|||
162044947|NCT03449901|585222561|FG001|Overall Study|Death|2|||
162044948|NCT03449901|585222560|FG000|Overall Study|Withdrawal by Subject|12|||
162044949|NCT03449901|585222561|FG001|Overall Study|Withdrawal by Subject|1|||
162044950|NCT03449901|585222560|FG000|Overall Study|Physician Decision|1|||
162044951|NCT03449901|585222561|FG001|Overall Study|Physician Decision|0|||
162044952|NCT03449901|585222560|FG000|Overall Study|Patient elected for surgical intervention|1|||
162044953|NCT03449901|585222561|FG001|Overall Study|Patient elected for surgical intervention|0|||
162044954|NCT03449901|585222560|FG000|Overall Study|Patient off for other complicating disease|1|||
162044955|NCT03449901|585222561|FG001|Overall Study|Patient off for other complicating disease|0|||
162044956|NCT03605212|585222567|FG000|Treatment Period|Adverse Event|1|||
162044957|NCT03605212|585222568|FG001|Treatment Period|Adverse Event|0|||
162044958|NCT03605212|585222569|FG002|Treatment Period|Adverse Event|0|||
162044959|NCT03605212|585222570|FG003|Treatment Period|Adverse Event|0|||
162044960|NCT03605212|585222571|FG004|Treatment Period|Adverse Event|0|||
162044961|NCT03605212|585222567|FG000|Treatment Period|Physician Decision|0|||
162044962|NCT03605212|585222568|FG001|Treatment Period|Physician Decision|0|||
162044963|NCT03605212|585222569|FG002|Treatment Period|Physician Decision|0|||
162044964|NCT03605212|585222570|FG003|Treatment Period|Physician Decision|0|||
162044965|NCT03605212|585222571|FG004|Treatment Period|Physician Decision|1|||
162044966|NCT01254292|585222572|FG000|Comparative Phase|Adverse Event|25|||
162044967|NCT01254292|585222573|FG001|Comparative Phase|Adverse Event|25|||
162044968|NCT01254292|585222572|FG000|Comparative Phase|Lost to Follow-up|3|||
162044969|NCT01254292|585222573|FG001|Comparative Phase|Lost to Follow-up|21|||
162044970|NCT01254292|585222572|FG000|Comparative Phase|Pregnancy|2|||
162044971|NCT01254292|585222573|FG001|Comparative Phase|Pregnancy|6|||
162044972|NCT01254292|585222572|FG000|Comparative Phase|Withdrawal by Subject|20|||
162044973|NCT01254292|585222573|FG001|Comparative Phase|Withdrawal by Subject|21|||
162044974|NCT01254292|585222572|FG000|Comparative Phase|Protocol Violation|1|||
162044975|NCT01254292|585222573|FG001|Comparative Phase|Protocol Violation|2|||
162044976|NCT01254292|585222572|FG000|Comparative Phase|Wish for pregnancy|4|||
162044977|NCT01254292|585222573|FG001|Comparative Phase|Wish for pregnancy|6|||
162044978|NCT01254292|585222572|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
162044979|NCT01254292|585222573|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
162044980|NCT01254292|585222572|FG000|LCS12 Extension Phase|Adverse Event|9|||
162044981|NCT01254292|585222573|FG001|LCS12 Extension Phase|Adverse Event|0|||
162044982|NCT01254292|585222572|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
162044983|NCT01254292|585222573|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
162044984|NCT01254292|585222572|FG000|LCS12 Extension Phase|Other unknown|4|||
162044985|NCT01254292|585222573|FG001|LCS12 Extension Phase|Other unknown|0|||
162044986|NCT01254292|585222572|FG000|LCS12 Extension Phase|Pregnancy|2|||
162044987|NCT01254292|585222573|FG001|LCS12 Extension Phase|Pregnancy|0|||
162044988|NCT01254292|585222572|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
162044989|NCT01254292|585222573|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
162044990|NCT02083081|585222574|FG000|Overall Study|Lost to Follow-up|31|||
162044991|NCT02083081|585222575|FG001|Overall Study|Lost to Follow-up|9|||
162044992|NCT00285818|585222576|FG000|Overall Study|Withdrawal by Subject|3|||
162044993|NCT00285818|585222577|FG001|Overall Study|Withdrawal by Subject|2|||
162044994|NCT00285818|585222576|FG000|Overall Study|Lost to Follow-up|1|||
162044995|NCT00285818|585222577|FG001|Overall Study|Lost to Follow-up|0|||
162044996|NCT03109847|585222585|FG000|Overall Study|Withdrawal by Subject|1|||
162044997|NCT03109847|585222586|FG001|Overall Study|Withdrawal by Subject|0|||
162044998|NCT01268150|585222587|FG000|Treatment Phase|Progression of disease|18|||
162044999|NCT01268150|585222587|FG000|Treatment Phase|Adverse Event|3|||
162045000|NCT01268150|585222587|FG000|Treatment Phase|Withdrawal by Subject|3|||
162045001|NCT01268150|585222587|FG000|Treatment Phase|Other|4|||
162045002|NCT01268150|585222587|FG000|Extension Phase|Adverse Event|3|||
162045003|NCT01268150|585222587|FG000|Extension Phase|Disease progression|18|||
162045004|NCT01268150|585222587|FG000|Extension Phase|Other|6|||
162045005|NCT01672736|585222588|FG000|Overall Study|Available drug expired on 31 May 16|3|||
162045006|NCT04209348|585222589|FG000|Overall Study|Lost to Follow-up|1|||
162045007|NCT04209348|585222590|FG001|Overall Study|Lost to Follow-up|0|||
162045008|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
162045009|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
162045010|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|Death|1|||
162045011|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|Death|0|||
162045012|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
162045013|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
162045014|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
162045015|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
162045016|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
162045017|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
162045018|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
162045019|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
162045020|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
162045021|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
162045022|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
162045023|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
162045024|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
162045025|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
162045026|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
162045027|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
162045028|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
162045029|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
162045030|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
162045031|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
162045032|NCT02927262|585222591|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
162045033|NCT02927262|585222592|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
162045034|NCT02927262|585222591|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
162045035|NCT02927262|585222592|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
162045036|NCT02927262|585222591|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
162045037|NCT02927262|585222592|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
162045038|NCT02927262|585222591|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
162045039|NCT02927262|585222592|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
162045040|NCT02913612|585222593|FG000|Overall Study|Lost to Follow-up|6|||
162045041|NCT02913612|585222594|FG001|Overall Study|Lost to Follow-up|5|||
162045042|NCT02913612|585222595|FG002|Overall Study|Lost to Follow-up|2|||
162045043|NCT02913612|585222596|FG003|Overall Study|Lost to Follow-up|0|||
162045044|NCT02913612|585222593|FG000|Overall Study|Physician Decision|1|||
162045045|NCT02913612|585222594|FG001|Overall Study|Physician Decision|4|||
162045046|NCT02913612|585222595|FG002|Overall Study|Physician Decision|1|||
162045047|NCT02913612|585222596|FG003|Overall Study|Physician Decision|0|||
162045048|NCT02913612|585222593|FG000|Overall Study|Withdrawal by Subject|2|||
162045049|NCT02913612|585222594|FG001|Overall Study|Withdrawal by Subject|4|||
162045050|NCT02913612|585222595|FG002|Overall Study|Withdrawal by Subject|0|||
162045051|NCT02913612|585222596|FG003|Overall Study|Withdrawal by Subject|0|||
162045052|NCT02913612|585222593|FG000|Overall Study|Hemangioma resolved|1|||
162045053|NCT02913612|585222594|FG001|Overall Study|Hemangioma resolved|0|||
162045054|NCT02913612|585222595|FG002|Overall Study|Hemangioma resolved|0|||
162045055|NCT02913612|585222596|FG003|Overall Study|Hemangioma resolved|0|||
162045056|NCT02913612|585222593|FG000|Overall Study|Local IRB decision|1|||
162045057|NCT02913612|585222594|FG001|Overall Study|Local IRB decision|0|||
162045058|NCT02913612|585222595|FG002|Overall Study|Local IRB decision|0|||
162045059|NCT02913612|585222596|FG003|Overall Study|Local IRB decision|0|||
162045060|NCT02913612|585222593|FG000|Overall Study|Study drug non-compliance|1|||
162045061|NCT02913612|585222594|FG001|Overall Study|Study drug non-compliance|1|||
162045062|NCT02913612|585222595|FG002|Overall Study|Study drug non-compliance|0|||
162045063|NCT02913612|585222596|FG003|Overall Study|Study drug non-compliance|0|||
162045064|NCT02913612|585222593|FG000|Overall Study|Insurance issues|0|||
162045065|NCT02913612|585222594|FG001|Overall Study|Insurance issues|1|||
162045066|NCT02913612|585222595|FG002|Overall Study|Insurance issues|0|||
162045067|NCT02913612|585222596|FG003|Overall Study|Insurance issues|0|||
162045068|NCT02913612|585222593|FG000|Overall Study|Needed to treat second hemangioma|0|||
162045069|NCT02913612|585222594|FG001|Overall Study|Needed to treat second hemangioma|1|||
162045070|NCT02913612|585222595|FG002|Overall Study|Needed to treat second hemangioma|0|||
162045071|NCT02913612|585222596|FG003|Overall Study|Needed to treat second hemangioma|0|||
162045072|NCT02913612|585222593|FG000|Overall Study|Study completion criteria not met|0|||
162045073|NCT02913612|585222594|FG001|Overall Study|Study completion criteria not met|1|||
162045074|NCT02913612|585222595|FG002|Overall Study|Study completion criteria not met|0|||
162045075|NCT02913612|585222596|FG003|Overall Study|Study completion criteria not met|0|||
162045076|NCT02913612|585222593|FG000|Overall Study|Ineligible|0|||
162045077|NCT02913612|585222594|FG001|Overall Study|Ineligible|1|||
162045078|NCT02913612|585222595|FG002|Overall Study|Ineligible|0|||
162045079|NCT02913612|585222596|FG003|Overall Study|Ineligible|0|||
162045080|NCT04251273|585222597|FG000|Overall Study|Lost to Follow-up|331|||
162045081|NCT04251273|585222598|FG001|Overall Study|Lost to Follow-up|290|||
162045082|NCT04402060|585222599|FG000|Overall Study|Death|1|||
162045083|NCT04402060|585222600|FG001|Overall Study|Death|12|||
162045084|NCT04402060|585222601|FG002|Overall Study|Death|7|||
162045085|NCT04402060|585222599|FG000|Overall Study|Adverse Event|0|||
162045086|NCT04402060|585222600|FG001|Overall Study|Adverse Event|0|||
162045087|NCT04402060|585222601|FG002|Overall Study|Adverse Event|1|||
162045088|NCT04402060|585222599|FG000|Overall Study|Withdrawal by Subject|0|||
162045089|NCT04402060|585222600|FG001|Overall Study|Withdrawal by Subject|1|||
162045090|NCT04402060|585222601|FG002|Overall Study|Withdrawal by Subject|2|||
162045091|NCT04402060|585222599|FG000|Overall Study|Sponsor Request|0|||
162045092|NCT04402060|585222600|FG001|Overall Study|Sponsor Request|2|||
162045093|NCT04402060|585222601|FG002|Overall Study|Sponsor Request|0|||
162045094|NCT04402060|585222599|FG000|Overall Study|Physician Decision|0|||
162045095|NCT04402060|585222600|FG001|Overall Study|Physician Decision|0|||
162045096|NCT04402060|585222601|FG002|Overall Study|Physician Decision|1|||
162045097|NCT04402060|585222599|FG000|Overall Study|Other|0|||
162045098|NCT04402060|585222600|FG001|Overall Study|Other|1|||
162045099|NCT04402060|585222601|FG002|Overall Study|Other|0|||
162045100|NCT00936611|585222602|FG000|Overall Study|Progressive Disease|3|||
162045101|NCT00936611|585222602|FG000|Overall Study|New Systemic Therapy|22|||
162045102|NCT00936611|585222602|FG000|Overall Study|Lost to Follow-up|1|||
162045103|NCT00936611|585222602|FG000|Overall Study|Withdrawal by Subject|2|||
162045104|NCT00936611|585222602|FG000|Overall Study|Still on Follow-up|1|||
162045105|NCT00936611|585222602|FG000|Overall Study|Still on Active Therapy|7|||
162045106|NCT00936611|585222602|FG000|Overall Study|Ineligible for Study Drug|3|||
162045107|NCT02282358|585222611|FG000|Overall Study|Nonevaluable|1|||
162045108|NCT01898208|585222612|FG000|Overall Study|Positive blood culture|17|||
162045109|NCT01898208|585222613|FG001|Overall Study|Positive blood culture|23|||
162007910|NCT05472090|585083810|FG001|Overall Study|Lost to Follow-up|3|||
162045110|NCT01898208|585222614|FG002|Overall Study|Positive blood culture|15|||
162045111|NCT01898208|585222612|FG000|Overall Study|Death/comfort care within 24 hours|10|||
162045112|NCT01898208|585222613|FG001|Overall Study|Death/comfort care within 24 hours|9|||
162045113|NCT01898208|585222614|FG002|Overall Study|Death/comfort care within 24 hours|8|||
162045114|NCT01898208|585222612|FG000|Overall Study|Negative Gram Stain|6|||
162045115|NCT01898208|585222613|FG001|Overall Study|Negative Gram Stain|9|||
162045116|NCT01898208|585222614|FG002|Overall Study|Negative Gram Stain|6|||
162045117|NCT01898208|585222612|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
162045118|NCT01898208|585222613|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
162045119|NCT01898208|585222614|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
162045120|NCT01898208|585222612|FG000|Overall Study|System/Technical Error|1|||
162045121|NCT01898208|585222613|FG001|Overall Study|System/Technical Error|2|||
162045122|NCT01898208|585222614|FG002|Overall Study|System/Technical Error|3|||
162045123|NCT01898208|585222612|FG000|Overall Study|Lost to Follow-up|3|||
162045124|NCT01898208|585222613|FG001|Overall Study|Lost to Follow-up|1|||
162045125|NCT01898208|585222614|FG002|Overall Study|Lost to Follow-up|1|||
162045126|NCT00961649|585222615|FG000|Overall Study|Adverse Event|4|||
162045127|NCT00961649|585222616|FG001|Overall Study|Adverse Event|0|||
162045128|NCT00961649|585222617|FG002|Overall Study|Adverse Event|0|||
162045129|NCT00961649|585222618|FG003|Overall Study|Adverse Event|2|||
162045130|NCT00961649|585222615|FG000|Overall Study|Inadequate control of IOP|0|||
162045131|NCT00961649|585222616|FG001|Overall Study|Inadequate control of IOP|0|||
162045132|NCT00961649|585222617|FG002|Overall Study|Inadequate control of IOP|0|||
162045133|NCT00961649|585222618|FG003|Overall Study|Inadequate control of IOP|1|||
162045134|NCT00961649|585222615|FG000|Overall Study|Patient has travel plans during holidays|0|||
162045135|NCT00961649|585222616|FG001|Overall Study|Patient has travel plans during holidays|0|||
162045136|NCT00961649|585222617|FG002|Overall Study|Patient has travel plans during holidays|1|||
162045137|NCT00961649|585222618|FG003|Overall Study|Patient has travel plans during holidays|0|||
162045138|NCT00961649|585222615|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
162045139|NCT00961649|585222616|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
162045140|NCT00961649|585222617|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
162045141|NCT00961649|585222618|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
162045142|NCT00961649|585222615|FG000|Overall Study|Study terminated by sponsor|4|||
162045143|NCT00961649|585222616|FG001|Overall Study|Study terminated by sponsor|4|||
162045144|NCT00961649|585222617|FG002|Overall Study|Study terminated by sponsor|4|||
162045145|NCT00961649|585222618|FG003|Overall Study|Study terminated by sponsor|1|||
162045146|NCT02711345|585222619|FG000|Overall Study|Adverse Event|0|||
162045147|NCT02711345|585222620|FG001|Overall Study|Adverse Event|0|||
162045148|NCT02711345|585222621|FG002|Overall Study|Adverse Event|0|||
162045149|NCT02711345|585222622|FG003|Overall Study|Adverse Event|1|||
162045150|NCT02711345|585222623|FG004|Overall Study|Adverse Event|1|||
162045151|NCT02711345|585222624|FG005|Overall Study|Adverse Event|2|||
162045152|NCT02711345|585222625|FG006|Overall Study|Adverse Event|1|||
162045153|NCT02711345|585222626|FG007|Overall Study|Adverse Event|0|||
162045154|NCT02711345|585222627|FG008|Overall Study|Adverse Event|0|||
162045155|NCT02711345|585222628|FG009|Overall Study|Adverse Event|2|||
162045156|NCT02711345|585222619|FG000|Overall Study|Physician Decision|0|||
162045157|NCT02711345|585222620|FG001|Overall Study|Physician Decision|0|||
162045158|NCT02711345|585222621|FG002|Overall Study|Physician Decision|1|||
162045159|NCT02711345|585222622|FG003|Overall Study|Physician Decision|0|||
162045160|NCT02711345|585222623|FG004|Overall Study|Physician Decision|0|||
162045161|NCT02711345|585222624|FG005|Overall Study|Physician Decision|0|||
162045162|NCT02711345|585222625|FG006|Overall Study|Physician Decision|0|||
162045163|NCT02711345|585222626|FG007|Overall Study|Physician Decision|0|||
162045164|NCT02711345|585222627|FG008|Overall Study|Physician Decision|1|||
162045165|NCT02711345|585222628|FG009|Overall Study|Physician Decision|0|||
162045166|NCT02711345|585222619|FG000|Overall Study|Progressive disease|1|||
162045167|NCT02711345|585222620|FG001|Overall Study|Progressive disease|3|||
162045168|NCT02711345|585222621|FG002|Overall Study|Progressive disease|5|||
162045169|NCT02711345|585222622|FG003|Overall Study|Progressive disease|3|||
162045170|NCT02711345|585222623|FG004|Overall Study|Progressive disease|7|||
162045171|NCT02711345|585222624|FG005|Overall Study|Progressive disease|2|||
162045172|NCT02711345|585222625|FG006|Overall Study|Progressive disease|8|||
162045173|NCT02711345|585222626|FG007|Overall Study|Progressive disease|4|||
162045174|NCT02711345|585222627|FG008|Overall Study|Progressive disease|5|||
162045175|NCT02711345|585222628|FG009|Overall Study|Progressive disease|6|||
162045176|NCT02711345|585222619|FG000|Overall Study|Subject/guardian decision|0|||
162045177|NCT02711345|585222620|FG001|Overall Study|Subject/guardian decision|0|||
162045178|NCT02711345|585222621|FG002|Overall Study|Subject/guardian decision|0|||
162045179|NCT02711345|585222622|FG003|Overall Study|Subject/guardian decision|0|||
162045180|NCT02711345|585222623|FG004|Overall Study|Subject/guardian decision|0|||
162045181|NCT02711345|585222624|FG005|Overall Study|Subject/guardian decision|2|||
162045182|NCT02711345|585222625|FG006|Overall Study|Subject/guardian decision|3|||
162045183|NCT02711345|585222626|FG007|Overall Study|Subject/guardian decision|1|||
162045184|NCT02711345|585222627|FG008|Overall Study|Subject/guardian decision|0|||
162045185|NCT02711345|585222628|FG009|Overall Study|Subject/guardian decision|4|||
162045186|NCT02711345|585222619|FG000|Overall Study|Death|1|||
162045187|NCT02711345|585222620|FG001|Overall Study|Death|0|||
162045188|NCT02711345|585222621|FG002|Overall Study|Death|0|||
162045189|NCT02711345|585222622|FG003|Overall Study|Death|0|||
162045190|NCT02711345|585222623|FG004|Overall Study|Death|0|||
162045191|NCT02711345|585222624|FG005|Overall Study|Death|0|||
162045192|NCT02711345|585222625|FG006|Overall Study|Death|0|||
162045193|NCT02711345|585222626|FG007|Overall Study|Death|1|||
162045194|NCT02711345|585222627|FG008|Overall Study|Death|0|||
162045195|NCT02711345|585222628|FG009|Overall Study|Death|0|||
162045196|NCT02155881|585222629|FG000|Overall Study|Withdrawal by Subject|0|||
162045197|NCT02155881|585222630|FG001|Overall Study|Withdrawal by Subject|2|||
162045198|NCT02155881|585222629|FG000|Overall Study|Inappropriately randomized|2|||
162045199|NCT02155881|585222630|FG001|Overall Study|Inappropriately randomized|2|||
162045200|NCT04357782|585222631|FG000|Overall Study|Discharged from hospital|1|||
162045201|NCT04357782|585222632|FG001|Overall Study|Discharged from hospital|0|||
162045202|NCT04357782|585222631|FG000|Overall Study|Death|0|||
162045203|NCT04357782|585222632|FG001|Overall Study|Death|2|||
162045204|NCT01786148|585222633|FG000|Overall Study|Lost to Follow-up|21|||
162045205|NCT01786148|585222634|FG001|Overall Study|Lost to Follow-up|13|||
162045206|NCT01786148|585222633|FG000|Overall Study|Death|0|||
162045207|NCT01786148|585222634|FG001|Overall Study|Death|1|||
162045208|NCT01786148|585222633|FG000|Overall Study|Withdrawal by Subject|0|||
162045209|NCT01786148|585222634|FG001|Overall Study|Withdrawal by Subject|7|||
162045210|NCT01786148|585222633|FG000|Overall Study|Incarceration|1|||
162045211|NCT01786148|585222634|FG001|Overall Study|Incarceration|1|||
162045212|NCT03780543|585222636|FG000|Overall Study|Adverse Event|1|||
162045213|NCT03780543|585222637|FG001|Overall Study|Adverse Event|0|||
162045214|NCT03780543|585222638|FG002|Overall Study|Adverse Event|2|||
162045215|NCT03780543|585222636|FG000|Overall Study|Lost to Follow-up|2|||
162045216|NCT03780543|585222637|FG001|Overall Study|Lost to Follow-up|0|||
162045217|NCT03780543|585222638|FG002|Overall Study|Lost to Follow-up|1|||
162045218|NCT03780543|585222636|FG000|Overall Study|Study terminated by Sponsor|8|||
162045219|NCT03780543|585222637|FG001|Overall Study|Study terminated by Sponsor|7|||
162045220|NCT03780543|585222638|FG002|Overall Study|Study terminated by Sponsor|13|||
162045221|NCT03780543|585222636|FG000|Overall Study|Withdrawal by Subject|1|||
162045222|NCT03780543|585222637|FG001|Overall Study|Withdrawal by Subject|8|||
162045223|NCT03780543|585222638|FG002|Overall Study|Withdrawal by Subject|1|||
162045224|NCT03780543|585222636|FG000|Overall Study|Noncompliance with study drug|1|||
162045225|NCT03780543|585222637|FG001|Overall Study|Noncompliance with study drug|0|||
162045226|NCT03780543|585222638|FG002|Overall Study|Noncompliance with study drug|0|||
162045227|NCT01033851|585222639|FG000|Overall Study|Withdrawal by Subject|3|||
162045228|NCT01033851|585222640|FG001|Overall Study|Withdrawal by Subject|7|||
162045229|NCT00338104|585222641|FG000|Overall Study|Protocol Violation|2|||
162045230|NCT00338104|585222642|FG001|Overall Study|Protocol Violation|1|||
162045231|NCT00338104|585222643|FG002|Overall Study|Protocol Violation|3|||
162045232|NCT02362269|585222646|FG000|Overall Study|Moved|1|||
162045233|NCT02362269|585222647|FG001|Overall Study|Moved|0|||
162045234|NCT02362269|585222646|FG000|Overall Study|Lost to Follow-up|0|||
162045235|NCT02362269|585222647|FG001|Overall Study|Lost to Follow-up|6|||
162045236|NCT03841448|585222648|FG000|Double-blind Treatment (DBT) Period|Death|1|||
162045237|NCT03841448|585222649|FG001|Double-blind Treatment (DBT) Period|Death|1|||
162045238|NCT03841448|585222650|FG002|Double-blind Treatment (DBT) Period|Death|0|||
162045239|NCT03841448|585222651|FG003|Double-blind Treatment (DBT) Period|Death|0|||
162045240|NCT03841448|585222648|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
162045241|NCT03841448|585222649|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
162045242|NCT03841448|585222650|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
162045243|NCT03841448|585222651|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
162045244|NCT03841448|585222648|FG000|Open-Label Extension (OLE) Period|Death|0|||
162045245|NCT03841448|585222649|FG001|Open-Label Extension (OLE) Period|Death|0|||
162045246|NCT03841448|585222650|FG002|Open-Label Extension (OLE) Period|Death|0|||
162045247|NCT03841448|585222651|FG003|Open-Label Extension (OLE) Period|Death|1|||
162045248|NCT03841448|585222648|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
162045249|NCT03841448|585222649|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
162045250|NCT03841448|585222650|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
162045251|NCT03841448|585222651|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
162045252|NCT03841448|585222648|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
162045253|NCT03841448|585222649|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
162045254|NCT03841448|585222650|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
162045255|NCT03841448|585222651|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
162045256|NCT03841448|585222648|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
162045257|NCT03841448|585222649|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
162045258|NCT03841448|585222650|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
162045259|NCT03841448|585222651|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
162045260|NCT04068610|585222652|FG000|Overall Study|Death|4|||
162045261|NCT04068610|585222653|FG001|Overall Study|Death|8|||
162045262|NCT04068610|585222654|FG002|Overall Study|Death|13|||
162045263|NCT04068610|585222652|FG000|Overall Study|Lost to Follow-up|0|||
162045264|NCT04068610|585222653|FG001|Overall Study|Lost to Follow-up|2|||
162045265|NCT04068610|585222654|FG002|Overall Study|Lost to Follow-up|0|||
162045266|NCT04068610|585222652|FG000|Overall Study|Withdrawal by Subject|0|||
162045267|NCT04068610|585222653|FG001|Overall Study|Withdrawal by Subject|4|||
162045268|NCT04068610|585222654|FG002|Overall Study|Withdrawal by Subject|2|||
162045269|NCT04068610|585222652|FG000|Overall Study|Other|3|||
162045270|NCT04068610|585222653|FG001|Overall Study|Other|12|||
162045271|NCT04068610|585222654|FG002|Overall Study|Other|11|||
162045272|NCT00072176|585222655|FG000|Overall Study|Withdrawal by Subject|1|||
162045273|NCT00072176|585222656|FG001|Overall Study|Withdrawal by Subject|0|||
162045274|NCT00072176|585222655|FG000|Overall Study|Protocol Violation|0|||
162045275|NCT00072176|585222656|FG001|Overall Study|Protocol Violation|1|||
162045276|NCT02586064|585222657|FG000|Overall Study|Other Obligations|6|||
162045277|NCT02586064|585222658|FG001|Overall Study|Other Obligations|6|||
162045278|NCT02586064|585222657|FG000|Overall Study|Other|3|||
162045279|NCT02586064|585222658|FG001|Overall Study|Other|7|||
162045280|NCT02586064|585222657|FG000|Overall Study|Never Started|3|||
162045281|NCT02586064|585222658|FG001|Overall Study|Never Started|3|||
162045282|NCT02586064|585222657|FG000|Overall Study|Lost Interest|1|||
162045283|NCT02586064|585222658|FG001|Overall Study|Lost Interest|4|||
162045284|NCT02586064|585222657|FG000|Overall Study|Miscellaneous Life Issues|0|||
162045285|NCT02586064|585222658|FG001|Overall Study|Miscellaneous Life Issues|5|||
162045286|NCT02586064|585222657|FG000|Overall Study|Infrequent Attendance|2|||
162045287|NCT02586064|585222658|FG001|Overall Study|Infrequent Attendance|1|||
162045288|NCT02586064|585222657|FG000|Overall Study|Timed Out|2|||
162045289|NCT02586064|585222658|FG001|Overall Study|Timed Out|0|||
162045290|NCT02586064|585222657|FG000|Overall Study|AUD relapse|0|||
162045291|NCT02586064|585222658|FG001|Overall Study|AUD relapse|2|||
162045292|NCT02586064|585222657|FG000|Overall Study|Legal Issue|1|||
162045293|NCT02586064|585222658|FG001|Overall Study|Legal Issue|0|||
162045294|NCT02158975|585222659|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
162045295|NCT04815031|585222662|FG000|Overall Study|No adverse event information (missing information)|33|||
162045296|NCT02728596|585222663|FG000|Overall Study|Refusal unrelated to adverse event|3|||
162045297|NCT02728596|585222664|FG001|Overall Study|Refusal unrelated to adverse event|6|||
162045298|NCT02728596|585222665|FG002|Overall Study|Refusal unrelated to adverse event|7|||
162045299|NCT02728596|585222666|FG003|Overall Study|Refusal unrelated to adverse event|7|||
162045300|NCT02728596|585222663|FG000|Overall Study|Death|44|||
162045301|NCT02728596|585222664|FG001|Overall Study|Death|42|||
162045302|NCT02728596|585222665|FG002|Overall Study|Death|123|||
162045303|NCT02728596|585222666|FG003|Overall Study|Death|68|||
162045304|NCT03672643|585222667|FG000|Overall Study|Adverse Event|3|||
162045305|NCT03672643|585222667|FG000|Overall Study|Death|2|||
162045306|NCT03672643|585222667|FG000|Overall Study|Withdrawal by Subject|1|||
162045307|NCT03672643|585222667|FG000|Overall Study|Progressive disease|11|||
162045308|NCT03672643|585222667|FG000|Overall Study|Global deterioration of health status|1|||
162045309|NCT03672643|585222667|FG000|Overall Study|Refused further treatment|7|||
162045310|NCT03672643|585222667|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
162045311|NCT04102189|585222668|FG000|Overall Study|Withdrawal by Subject|1|||
162045312|NCT04102189|585222669|FG001|Overall Study|Withdrawal by Subject|2|||
162045313|NCT04102189|585222668|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162045314|NCT04102189|585222669|FG001|Overall Study|Withdrawal by parent/guardian|1|||
162045315|NCT04102189|585222668|FG000|Overall Study|Lost to Follow-up|1|||
162045316|NCT04102189|585222669|FG001|Overall Study|Lost to Follow-up|0|||
162045317|NCT01543698|585224222|FG000|Phase 1b|Disease progression|2|||
162045318|NCT01543698|585224223|FG001|Phase 1b|Disease progression|4|||
162045319|NCT01543698|585224224|FG002|Phase 1b|Disease progression|3|||
162045320|NCT01543698|585224225|FG003|Phase 1b|Disease progression|2|||
162045321|NCT01543698|585224226|FG004|Phase 1b|Disease progression|10|||
162045322|NCT01543698|585224227|FG005|Phase 1b|Disease progression|6|||
162045323|NCT01543698|585224228|FG006|Phase 1b|Disease progression|5|||
162045324|NCT01543698|585224229|FG007|Phase 1b|Disease progression|3|||
162045325|NCT01543698|585224230|FG008|Phase 1b|Disease progression|4|||
162045326|NCT01543698|585224231|FG009|Phase 1b|Disease progression|5|||
162045327|NCT01543698|585224232|FG010|Phase 1b|Disease progression|1|||
162045328|NCT01543698|585224233|FG011|Phase 1b|Disease progression|0|||
162045329|NCT01543698|585224234|FG012|Phase 1b|Disease progression|0|||
162045330|NCT01543698|585224235|FG013|Phase 1b|Disease progression|0|||
162045331|NCT01543698|585224236|FG014|Phase 1b|Disease progression|0|||
162045332|NCT01543698|585224222|FG000|Phase 1b|Death|0|||
162045333|NCT01543698|585224223|FG001|Phase 1b|Death|0|||
162045334|NCT01543698|585224224|FG002|Phase 1b|Death|1|||
162045335|NCT01543698|585224225|FG003|Phase 1b|Death|1|||
162045336|NCT01543698|585224226|FG004|Phase 1b|Death|0|||
162045337|NCT01543698|585224227|FG005|Phase 1b|Death|0|||
162045338|NCT01543698|585224228|FG006|Phase 1b|Death|0|||
162045339|NCT01543698|585224229|FG007|Phase 1b|Death|0|||
162045340|NCT01543698|585224230|FG008|Phase 1b|Death|0|||
162045341|NCT01543698|585224231|FG009|Phase 1b|Death|0|||
162045342|NCT01543698|585224232|FG010|Phase 1b|Death|1|||
162045343|NCT01543698|585224233|FG011|Phase 1b|Death|0|||
162045344|NCT01543698|585224234|FG012|Phase 1b|Death|0|||
162045345|NCT01543698|585224235|FG013|Phase 1b|Death|0|||
162045346|NCT01543698|585224236|FG014|Phase 1b|Death|0|||
162045347|NCT01543698|585224222|FG000|Phase 1b|Withdrawal by Subject|0|||
162045348|NCT01543698|585224223|FG001|Phase 1b|Withdrawal by Subject|1|||
162045349|NCT01543698|585224224|FG002|Phase 1b|Withdrawal by Subject|0|||
162045350|NCT01543698|585224225|FG003|Phase 1b|Withdrawal by Subject|1|||
162045351|NCT01543698|585224226|FG004|Phase 1b|Withdrawal by Subject|0|||
162045352|NCT01543698|585224227|FG005|Phase 1b|Withdrawal by Subject|0|||
162045353|NCT01543698|585224228|FG006|Phase 1b|Withdrawal by Subject|1|||
162045354|NCT01543698|585224229|FG007|Phase 1b|Withdrawal by Subject|0|||
162045355|NCT01543698|585224230|FG008|Phase 1b|Withdrawal by Subject|0|||
162045356|NCT01543698|585224231|FG009|Phase 1b|Withdrawal by Subject|0|||
162045357|NCT01543698|585224232|FG010|Phase 1b|Withdrawal by Subject|0|||
162045358|NCT01543698|585224233|FG011|Phase 1b|Withdrawal by Subject|0|||
162045359|NCT01543698|585224234|FG012|Phase 1b|Withdrawal by Subject|0|||
162045360|NCT01543698|585224235|FG013|Phase 1b|Withdrawal by Subject|0|||
162045361|NCT01543698|585224236|FG014|Phase 1b|Withdrawal by Subject|0|||
162045362|NCT01543698|585224222|FG000|Phase 1b|Adverse Event|1|||
162045363|NCT01543698|585224223|FG001|Phase 1b|Adverse Event|0|||
162045364|NCT01543698|585224224|FG002|Phase 1b|Adverse Event|0|||
162045365|NCT01543698|585224225|FG003|Phase 1b|Adverse Event|1|||
162045366|NCT01543698|585224226|FG004|Phase 1b|Adverse Event|2|||
162045367|NCT01543698|585224227|FG005|Phase 1b|Adverse Event|2|||
162045368|NCT01543698|585224228|FG006|Phase 1b|Adverse Event|0|||
162045369|NCT01543698|585224229|FG007|Phase 1b|Adverse Event|0|||
162045370|NCT01543698|585224230|FG008|Phase 1b|Adverse Event|1|||
162045371|NCT01543698|585224231|FG009|Phase 1b|Adverse Event|1|||
162045372|NCT01543698|585224232|FG010|Phase 1b|Adverse Event|2|||
162045373|NCT01543698|585224233|FG011|Phase 1b|Adverse Event|0|||
162045374|NCT01543698|585224234|FG012|Phase 1b|Adverse Event|0|||
162045375|NCT01543698|585224235|FG013|Phase 1b|Adverse Event|0|||
162045376|NCT01543698|585224236|FG014|Phase 1b|Adverse Event|0|||
162045377|NCT01543698|585224222|FG000|Phase 1b|Administrative problems|1|||
162045378|NCT01543698|585224223|FG001|Phase 1b|Administrative problems|0|||
162045379|NCT01543698|585224224|FG002|Phase 1b|Administrative problems|0|||
162045380|NCT01543698|585224225|FG003|Phase 1b|Administrative problems|0|||
162045381|NCT01543698|585224226|FG004|Phase 1b|Administrative problems|1|||
162045382|NCT01543698|585224227|FG005|Phase 1b|Administrative problems|0|||
162045383|NCT01543698|585224228|FG006|Phase 1b|Administrative problems|0|||
162045384|NCT01543698|585224229|FG007|Phase 1b|Administrative problems|1|||
162045385|NCT01543698|585224230|FG008|Phase 1b|Administrative problems|0|||
162045386|NCT01543698|585224231|FG009|Phase 1b|Administrative problems|0|||
162045387|NCT01543698|585224232|FG010|Phase 1b|Administrative problems|2|||
162045388|NCT01543698|585224233|FG011|Phase 1b|Administrative problems|0|||
162045389|NCT01543698|585224234|FG012|Phase 1b|Administrative problems|0|||
162045390|NCT01543698|585224235|FG013|Phase 1b|Administrative problems|0|||
162045391|NCT01543698|585224236|FG014|Phase 1b|Administrative problems|0|||
162045392|NCT01543698|585224222|FG000|Phase 1b|Protocol Violation|2|||
162045393|NCT01543698|585224223|FG001|Phase 1b|Protocol Violation|0|||
162045394|NCT01543698|585224224|FG002|Phase 1b|Protocol Violation|0|||
162045395|NCT01543698|585224225|FG003|Phase 1b|Protocol Violation|0|||
162045396|NCT01543698|585224226|FG004|Phase 1b|Protocol Violation|0|||
162045397|NCT01543698|585224227|FG005|Phase 1b|Protocol Violation|0|||
162045398|NCT01543698|585224228|FG006|Phase 1b|Protocol Violation|0|||
162045399|NCT01543698|585224229|FG007|Phase 1b|Protocol Violation|0|||
162045400|NCT01543698|585224230|FG008|Phase 1b|Protocol Violation|0|||
162045401|NCT01543698|585224231|FG009|Phase 1b|Protocol Violation|0|||
162045402|NCT01543698|585224232|FG010|Phase 1b|Protocol Violation|0|||
162045403|NCT01543698|585224233|FG011|Phase 1b|Protocol Violation|0|||
162045404|NCT01543698|585224234|FG012|Phase 1b|Protocol Violation|0|||
162045405|NCT01543698|585224235|FG013|Phase 1b|Protocol Violation|0|||
162045406|NCT01543698|585224236|FG014|Phase 1b|Protocol Violation|0|||
162045407|NCT01543698|585224222|FG000|Phase 2|Protocol Violation|0|||
162045408|NCT01543698|585224223|FG001|Phase 2|Protocol Violation|0|||
162045409|NCT01543698|585224224|FG002|Phase 2|Protocol Violation|0|||
162045410|NCT01543698|585224225|FG003|Phase 2|Protocol Violation|0|||
162045411|NCT01543698|585224226|FG004|Phase 2|Protocol Violation|0|||
162045412|NCT01543698|585224227|FG005|Phase 2|Protocol Violation|0|||
162045413|NCT01543698|585224228|FG006|Phase 2|Protocol Violation|0|||
162045414|NCT01543698|585224229|FG007|Phase 2|Protocol Violation|0|||
162045415|NCT01543698|585224230|FG008|Phase 2|Protocol Violation|0|||
162045416|NCT01543698|585224231|FG009|Phase 2|Protocol Violation|0|||
162045417|NCT01543698|585224232|FG010|Phase 2|Protocol Violation|0|||
162045418|NCT01543698|585224233|FG011|Phase 2|Protocol Violation|0|||
162045419|NCT01543698|585224234|FG012|Phase 2|Protocol Violation|1|||
162045420|NCT01543698|585224235|FG013|Phase 2|Protocol Violation|0|||
162045421|NCT01543698|585224236|FG014|Phase 2|Protocol Violation|0|||
162045422|NCT01543698|585224222|FG000|Phase 2|Disease progression|0|||
162045423|NCT01543698|585224223|FG001|Phase 2|Disease progression|0|||
162045424|NCT01543698|585224224|FG002|Phase 2|Disease progression|0|||
162045425|NCT01543698|585224225|FG003|Phase 2|Disease progression|0|||
162045426|NCT01543698|585224226|FG004|Phase 2|Disease progression|0|||
162045427|NCT01543698|585224227|FG005|Phase 2|Disease progression|0|||
162045428|NCT01543698|585224228|FG006|Phase 2|Disease progression|0|||
162045429|NCT01543698|585224229|FG007|Phase 2|Disease progression|0|||
162045430|NCT01543698|585224230|FG008|Phase 2|Disease progression|0|||
162045431|NCT01543698|585224231|FG009|Phase 2|Disease progression|0|||
162045432|NCT01543698|585224232|FG010|Phase 2|Disease progression|0|||
162045433|NCT01543698|585224233|FG011|Phase 2|Disease progression|10|||
162045434|NCT01543698|585224234|FG012|Phase 2|Disease progression|21|||
162045435|NCT01543698|585224235|FG013|Phase 2|Disease progression|30|||
162045436|NCT01543698|585224236|FG014|Phase 2|Disease progression|25|||
162045437|NCT01543698|585224222|FG000|Phase 2|Death|0|||
162045438|NCT01543698|585224223|FG001|Phase 2|Death|0|||
162045439|NCT01543698|585224224|FG002|Phase 2|Death|0|||
162045440|NCT01543698|585224225|FG003|Phase 2|Death|0|||
162045441|NCT01543698|585224226|FG004|Phase 2|Death|0|||
162045442|NCT01543698|585224227|FG005|Phase 2|Death|0|||
162045443|NCT01543698|585224228|FG006|Phase 2|Death|0|||
162045444|NCT01543698|585224229|FG007|Phase 2|Death|0|||
162045445|NCT01543698|585224230|FG008|Phase 2|Death|0|||
162045446|NCT01543698|585224231|FG009|Phase 2|Death|0|||
162045447|NCT01543698|585224232|FG010|Phase 2|Death|0|||
162045448|NCT01543698|585224233|FG011|Phase 2|Death|0|||
162045449|NCT01543698|585224234|FG012|Phase 2|Death|1|||
162045450|NCT01543698|585224235|FG013|Phase 2|Death|1|||
162045451|NCT01543698|585224236|FG014|Phase 2|Death|1|||
162045452|NCT01543698|585224222|FG000|Phase 2|Administrative problems|0|||
162045453|NCT01543698|585224223|FG001|Phase 2|Administrative problems|0|||
162045454|NCT01543698|585224224|FG002|Phase 2|Administrative problems|0|||
162045455|NCT01543698|585224225|FG003|Phase 2|Administrative problems|0|||
162045456|NCT01543698|585224226|FG004|Phase 2|Administrative problems|0|||
162045457|NCT01543698|585224227|FG005|Phase 2|Administrative problems|0|||
162045458|NCT01543698|585224228|FG006|Phase 2|Administrative problems|0|||
162045459|NCT01543698|585224229|FG007|Phase 2|Administrative problems|0|||
162045460|NCT01543698|585224230|FG008|Phase 2|Administrative problems|0|||
162045461|NCT01543698|585224231|FG009|Phase 2|Administrative problems|0|||
162045462|NCT01543698|585224232|FG010|Phase 2|Administrative problems|0|||
162045463|NCT01543698|585224233|FG011|Phase 2|Administrative problems|0|||
162045464|NCT01543698|585224234|FG012|Phase 2|Administrative problems|0|||
162045465|NCT01543698|585224235|FG013|Phase 2|Administrative problems|3|||
162045466|NCT01543698|585224236|FG014|Phase 2|Administrative problems|1|||
162045467|NCT01543698|585224222|FG000|Phase 2|Withdrawal by Subject|0|||
162045468|NCT01543698|585224223|FG001|Phase 2|Withdrawal by Subject|0|||
162045469|NCT01543698|585224224|FG002|Phase 2|Withdrawal by Subject|0|||
162045470|NCT01543698|585224225|FG003|Phase 2|Withdrawal by Subject|0|||
162045471|NCT01543698|585224226|FG004|Phase 2|Withdrawal by Subject|0|||
162045472|NCT01543698|585224227|FG005|Phase 2|Withdrawal by Subject|0|||
162045473|NCT01543698|585224228|FG006|Phase 2|Withdrawal by Subject|0|||
162045474|NCT01543698|585224229|FG007|Phase 2|Withdrawal by Subject|0|||
162045475|NCT01543698|585224230|FG008|Phase 2|Withdrawal by Subject|0|||
162045476|NCT01543698|585224231|FG009|Phase 2|Withdrawal by Subject|0|||
162045477|NCT01543698|585224232|FG010|Phase 2|Withdrawal by Subject|0|||
162045478|NCT01543698|585224233|FG011|Phase 2|Withdrawal by Subject|0|||
162045479|NCT01543698|585224234|FG012|Phase 2|Withdrawal by Subject|0|||
162045480|NCT01543698|585224235|FG013|Phase 2|Withdrawal by Subject|3|||
162045481|NCT01543698|585224236|FG014|Phase 2|Withdrawal by Subject|1|||
162045482|NCT01543698|585224222|FG000|Phase 2|Adverse Event|0|||
162045483|NCT01543698|585224223|FG001|Phase 2|Adverse Event|0|||
162045484|NCT01543698|585224224|FG002|Phase 2|Adverse Event|0|||
162045485|NCT01543698|585224225|FG003|Phase 2|Adverse Event|0|||
162045486|NCT01543698|585224226|FG004|Phase 2|Adverse Event|0|||
162045487|NCT01543698|585224227|FG005|Phase 2|Adverse Event|0|||
162045488|NCT01543698|585224228|FG006|Phase 2|Adverse Event|0|||
162045489|NCT01543698|585224229|FG007|Phase 2|Adverse Event|0|||
162045490|NCT01543698|585224230|FG008|Phase 2|Adverse Event|0|||
162045491|NCT01543698|585224231|FG009|Phase 2|Adverse Event|0|||
162045492|NCT01543698|585224232|FG010|Phase 2|Adverse Event|0|||
162045493|NCT01543698|585224233|FG011|Phase 2|Adverse Event|1|||
162045494|NCT01543698|585224234|FG012|Phase 2|Adverse Event|3|||
162045495|NCT01543698|585224235|FG013|Phase 2|Adverse Event|5|||
162045496|NCT01543698|585224236|FG014|Phase 2|Adverse Event|14|||
162045497|NCT00316719|585224237|FG000|Overall Study|Adverse Event|0|||
162045498|NCT00316719|585224238|FG001|Overall Study|Adverse Event|6|||
162045499|NCT00316719|585224237|FG000|Overall Study|Consent withdrawn|2|||
162045500|NCT00316719|585224238|FG001|Overall Study|Consent withdrawn|0|||
162045501|NCT01863953|585224239|FG000|Overall Study|Adverse Event|0|||
162045502|NCT01863953|585224240|FG001|Overall Study|Adverse Event|0|||
162045503|NCT01863953|585224241|FG002|Overall Study|Adverse Event|1|||
162045504|NCT00573183|585224242|FG000|Overall Study|Lost to Follow-up|52|||
162045505|NCT00573183|585224243|FG001|Overall Study|Lost to Follow-up|50|||
162045506|NCT00573183|585224242|FG000|Overall Study|Withdrawal by Subject|8|||
162045507|NCT00573183|585224243|FG001|Overall Study|Withdrawal by Subject|2|||
162045508|NCT00573183|585224242|FG000|Overall Study|Death|0|||
162045509|NCT00573183|585224243|FG001|Overall Study|Death|1|||
162045510|NCT00573183|585224242|FG000|Overall Study|Adverse Event|2|||
162045511|NCT00573183|585224243|FG001|Overall Study|Adverse Event|0|||
162045512|NCT00573183|585224242|FG000|Overall Study|Incarceration|5|||
162045513|NCT00573183|585224243|FG001|Overall Study|Incarceration|8|||
162045514|NCT00573183|585224242|FG000|Overall Study|Other|5|||
162045515|NCT00573183|585224243|FG001|Overall Study|Other|2|||
162045516|NCT05439941|585224244|FG000|Overall Study|Lack of Efficacy|8|||
162045517|NCT05439941|585224245|FG001|Overall Study|Lack of Efficacy|5|||
162045518|NCT05439941|585224246|FG002|Overall Study|Lack of Efficacy|3|||
162045519|NCT05439941|585224244|FG000|Overall Study|Treatment Failure|0|||
162045520|NCT05439941|585224245|FG001|Overall Study|Treatment Failure|1|||
162045521|NCT05439941|585224246|FG002|Overall Study|Treatment Failure|0|||
162045522|NCT05439941|585224244|FG000|Overall Study|Adverse Event|1|||
162045523|NCT05439941|585224245|FG001|Overall Study|Adverse Event|3|||
162045524|NCT05439941|585224246|FG002|Overall Study|Adverse Event|0|||
162045525|NCT05439941|585224244|FG000|Overall Study|Adverse Event - Parent Study|1|||
162045526|NCT05439941|585224245|FG001|Overall Study|Adverse Event - Parent Study|0|||
162045527|NCT05439941|585224246|FG002|Overall Study|Adverse Event - Parent Study|0|||
162045528|NCT05439941|585224244|FG000|Overall Study|Pregnancy|1|||
162045529|NCT05439941|585224245|FG001|Overall Study|Pregnancy|0|||
162045530|NCT05439941|585224246|FG002|Overall Study|Pregnancy|0|||
162045531|NCT05439941|585224244|FG000|Overall Study|Withdrawal by Subject|9|||
162045532|NCT05439941|585224245|FG001|Overall Study|Withdrawal by Subject|6|||
162045533|NCT05439941|585224246|FG002|Overall Study|Withdrawal by Subject|10|||
162045534|NCT05439941|585224244|FG000|Overall Study|Non-Compliance|1|||
162045535|NCT05439941|585224245|FG001|Overall Study|Non-Compliance|1|||
162045536|NCT05439941|585224246|FG002|Overall Study|Non-Compliance|1|||
162045537|NCT05439941|585224244|FG000|Overall Study|Lost to Follow-up|2|||
162045538|NCT05439941|585224245|FG001|Overall Study|Lost to Follow-up|2|||
162045539|NCT05439941|585224246|FG002|Overall Study|Lost to Follow-up|0|||
162045540|NCT05439941|585224244|FG000|Overall Study|Physician Decision|1|||
162045541|NCT05439941|585224245|FG001|Overall Study|Physician Decision|0|||
162045542|NCT05439941|585224246|FG002|Overall Study|Physician Decision|0|||
162045543|NCT05439941|585224244|FG000|Overall Study|Trial Termination by Sponsor|78|||
162045544|NCT05439941|585224245|FG001|Overall Study|Trial Termination by Sponsor|83|||
162045545|NCT05439941|585224246|FG002|Overall Study|Trial Termination by Sponsor|65|||
162045546|NCT05439941|585224244|FG000|Overall Study|Other than Reasons Listed|2|||
162045547|NCT05439941|585224245|FG001|Overall Study|Other than Reasons Listed|1|||
162045548|NCT05439941|585224246|FG002|Overall Study|Other than Reasons Listed|0|||
162045549|NCT02336373|585224249|FG000|Overall Study|Protocol closed early|4|||
162045550|NCT02336373|585224249|FG000|Overall Study|Physician Decision|14|||
162045551|NCT04798781|585224254|FG000|Overall Study|Withdrawal by Subject|1|||
162045552|NCT00615108|585224257|FG000|Overall Study|Adverse Event|122|||
162045553|NCT00615108|585224257|FG000|Overall Study|Other|370|||
162045554|NCT00615108|585224257|FG000|Overall Study|Lost to Follow-up|15|||
162045555|NCT00676338|585224258|FG000|Overall Study|Adverse Event|6|||
162045556|NCT00676338|585224259|FG001|Overall Study|Adverse Event|6|||
162045557|NCT00676338|585224260|FG002|Overall Study|Adverse Event|5|||
162045558|NCT00676338|585224261|FG003|Overall Study|Adverse Event|1|||
162045559|NCT00676338|585224258|FG000|Overall Study|Lost to Follow-up|4|||
162045560|NCT00676338|585224259|FG001|Overall Study|Lost to Follow-up|1|||
162045561|NCT00676338|585224260|FG002|Overall Study|Lost to Follow-up|3|||
162045562|NCT00676338|585224261|FG003|Overall Study|Lost to Follow-up|4|||
162045563|NCT00676338|585224258|FG000|Overall Study|Physician Decision|3|||
162045564|NCT00676338|585224259|FG001|Overall Study|Physician Decision|3|||
162045565|NCT00676338|585224260|FG002|Overall Study|Physician Decision|2|||
162045566|NCT00676338|585224261|FG003|Overall Study|Physician Decision|3|||
162045567|NCT00676338|585224258|FG000|Overall Study|Protocol Violation|5|||
162045568|NCT00676338|585224259|FG001|Overall Study|Protocol Violation|9|||
162045569|NCT00676338|585224260|FG002|Overall Study|Protocol Violation|2|||
162045570|NCT00676338|585224261|FG003|Overall Study|Protocol Violation|5|||
162045571|NCT00676338|585224258|FG000|Overall Study|Withdrawal by Subject|17|||
162045572|NCT00676338|585224259|FG001|Overall Study|Withdrawal by Subject|9|||
162045573|NCT00676338|585224260|FG002|Overall Study|Withdrawal by Subject|12|||
162045574|NCT00676338|585224261|FG003|Overall Study|Withdrawal by Subject|6|||
162045575|NCT00676338|585224258|FG000|Overall Study|Entry Criteria Not Met|0|||
162045576|NCT00676338|585224259|FG001|Overall Study|Entry Criteria Not Met|2|||
162045577|NCT00676338|585224260|FG002|Overall Study|Entry Criteria Not Met|1|||
162045578|NCT00676338|585224261|FG003|Overall Study|Entry Criteria Not Met|1|||
162045579|NCT00676338|585224258|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
162045580|NCT00676338|585224259|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
162045581|NCT00676338|585224260|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
162045582|NCT00676338|585224261|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
162045583|NCT02122458|585224262|FG000|Overall Study|Withdrawal by Subject|0|||
162045584|NCT02122458|585224263|FG001|Overall Study|Withdrawal by Subject|0|||
162045585|NCT02122458|585224264|FG002|Overall Study|Withdrawal by Subject|0|||
162045586|NCT02122458|585224265|FG003|Overall Study|Withdrawal by Subject|4|||
162045587|NCT02122458|585224266|FG004|Overall Study|Withdrawal by Subject|4|||
162045588|NCT02122458|585224267|FG005|Overall Study|Withdrawal by Subject|4|||
162045589|NCT02122458|585224268|FG006|Overall Study|Withdrawal by Subject|0|||
162045590|NCT02122458|585224262|FG000|Overall Study|Lost to Follow-up|1|||
162045591|NCT02122458|585224263|FG001|Overall Study|Lost to Follow-up|3|||
162045592|NCT02122458|585224264|FG002|Overall Study|Lost to Follow-up|0|||
162045593|NCT02122458|585224265|FG003|Overall Study|Lost to Follow-up|7|||
162045594|NCT02122458|585224266|FG004|Overall Study|Lost to Follow-up|5|||
162045595|NCT02122458|585224267|FG005|Overall Study|Lost to Follow-up|15|||
162045596|NCT02122458|585224268|FG006|Overall Study|Lost to Follow-up|1|||
162045597|NCT02122458|585224262|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
162045598|NCT02122458|585224263|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
162045599|NCT02122458|585224264|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
162045600|NCT02122458|585224265|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
162045601|NCT02122458|585224266|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
162045602|NCT02122458|585224267|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
162045603|NCT02122458|585224268|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
162045604|NCT02122458|585224262|FG000|Overall Study|Adverse Event|1|||
162045605|NCT02122458|585224263|FG001|Overall Study|Adverse Event|0|||
162045606|NCT02122458|585224264|FG002|Overall Study|Adverse Event|0|||
162045607|NCT02122458|585224265|FG003|Overall Study|Adverse Event|0|||
162045608|NCT02122458|585224266|FG004|Overall Study|Adverse Event|0|||
162045609|NCT02122458|585224267|FG005|Overall Study|Adverse Event|0|||
162045610|NCT02122458|585224268|FG006|Overall Study|Adverse Event|0|||
162045611|NCT02122458|585224262|FG000|Overall Study|Experimental Error|0|||
162045612|NCT02122458|585224263|FG001|Overall Study|Experimental Error|0|||
162045613|NCT02122458|585224264|FG002|Overall Study|Experimental Error|0|||
162045614|NCT02122458|585224265|FG003|Overall Study|Experimental Error|0|||
162045615|NCT02122458|585224266|FG004|Overall Study|Experimental Error|3|||
162045616|NCT02122458|585224267|FG005|Overall Study|Experimental Error|0|||
162045617|NCT02122458|585224268|FG006|Overall Study|Experimental Error|0|||
162045618|NCT02122458|585224262|FG000|Overall Study|Deployed or Moved|0|||
162045619|NCT02122458|585224263|FG001|Overall Study|Deployed or Moved|0|||
162045620|NCT02122458|585224264|FG002|Overall Study|Deployed or Moved|0|||
162045621|NCT02122458|585224265|FG003|Overall Study|Deployed or Moved|0|||
162045622|NCT02122458|585224266|FG004|Overall Study|Deployed or Moved|1|||
162045623|NCT02122458|585224267|FG005|Overall Study|Deployed or Moved|0|||
162045624|NCT02122458|585224268|FG006|Overall Study|Deployed or Moved|0|||
162045625|NCT02122458|585224262|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
162045626|NCT02122458|585224263|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
162045627|NCT02122458|585224264|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
162045628|NCT02122458|585224265|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
162045629|NCT02122458|585224266|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
162045630|NCT02122458|585224267|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
162045631|NCT02122458|585224268|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
162045632|NCT02122458|585224262|FG000|Overall Study|Noncompliance|0|||
162045633|NCT02122458|585224263|FG001|Overall Study|Noncompliance|1|||
162045634|NCT02122458|585224264|FG002|Overall Study|Noncompliance|0|||
162045635|NCT02122458|585224265|FG003|Overall Study|Noncompliance|0|||
162045636|NCT02122458|585224266|FG004|Overall Study|Noncompliance|0|||
162045637|NCT02122458|585224267|FG005|Overall Study|Noncompliance|0|||
162045638|NCT02122458|585224268|FG006|Overall Study|Noncompliance|0|||
162045639|NCT00412542|585224269|FG000|Overall Study|Withdrawal by Subject|0|||
162045640|NCT00412542|585224270|FG001|Overall Study|Withdrawal by Subject|2|||
162045641|NCT00412542|585224269|FG000|Overall Study|Not Eligible|0|||
162045642|NCT00412542|585224270|FG001|Overall Study|Not Eligible|1|||
162045643|NCT02833350|585224271|FG000|Overall Study|Adverse Event|0|||
162045644|NCT02833350|585224272|FG001|Overall Study|Adverse Event|3|||
162045645|NCT02833350|585224273|FG002|Overall Study|Adverse Event|4|||
162045646|NCT02833350|585224274|FG003|Overall Study|Adverse Event|4|||
162045647|NCT02833350|585224275|FG004|Overall Study|Adverse Event|1|||
162045648|NCT02833350|585224276|FG005|Overall Study|Adverse Event|0|||
162045649|NCT02833350|585224277|FG006|Overall Study|Adverse Event|1|||
162045650|NCT02833350|585224271|FG000|Overall Study|Death|0|||
162045651|NCT02833350|585224272|FG001|Overall Study|Death|0|||
162045652|NCT02833350|585224273|FG002|Overall Study|Death|1|||
162045653|NCT02833350|585224274|FG003|Overall Study|Death|0|||
162045654|NCT02833350|585224275|FG004|Overall Study|Death|0|||
162045655|NCT02833350|585224276|FG005|Overall Study|Death|0|||
162045656|NCT02833350|585224277|FG006|Overall Study|Death|0|||
162045657|NCT02833350|585224271|FG000|Overall Study|Lack of Efficacy|0|||
162045658|NCT02833350|585224272|FG001|Overall Study|Lack of Efficacy|2|||
162045659|NCT02833350|585224273|FG002|Overall Study|Lack of Efficacy|1|||
162045660|NCT02833350|585224274|FG003|Overall Study|Lack of Efficacy|4|||
162045661|NCT02833350|585224275|FG004|Overall Study|Lack of Efficacy|0|||
162045662|NCT02833350|585224276|FG005|Overall Study|Lack of Efficacy|1|||
162045663|NCT02833350|585224277|FG006|Overall Study|Lack of Efficacy|1|||
162045664|NCT02833350|585224271|FG000|Overall Study|Lost to Follow-up|0|||
162045665|NCT02833350|585224272|FG001|Overall Study|Lost to Follow-up|1|||
162045666|NCT02833350|585224273|FG002|Overall Study|Lost to Follow-up|0|||
162045667|NCT02833350|585224274|FG003|Overall Study|Lost to Follow-up|0|||
162045668|NCT02833350|585224275|FG004|Overall Study|Lost to Follow-up|0|||
162045669|NCT02833350|585224276|FG005|Overall Study|Lost to Follow-up|0|||
162045670|NCT02833350|585224277|FG006|Overall Study|Lost to Follow-up|1|||
162045671|NCT02833350|585224271|FG000|Overall Study|Withdrawal by Subject|3|||
162045672|NCT02833350|585224272|FG001|Overall Study|Withdrawal by Subject|3|||
162045673|NCT02833350|585224273|FG002|Overall Study|Withdrawal by Subject|2|||
162045674|NCT02833350|585224274|FG003|Overall Study|Withdrawal by Subject|0|||
162045675|NCT02833350|585224275|FG004|Overall Study|Withdrawal by Subject|2|||
162045676|NCT02833350|585224276|FG005|Overall Study|Withdrawal by Subject|0|||
162045677|NCT02833350|585224277|FG006|Overall Study|Withdrawal by Subject|2|||
162045678|NCT00075218|585224278|FG000|Double-Blind Treatment|Adverse Event|23|||
162045679|NCT00075218|585224279|FG001|Double-Blind Treatment|Adverse Event|4|||
162045680|NCT00075218|585224280|FG002|Double-Blind Treatment|Adverse Event|0|||
162045681|NCT00075218|585224278|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
162045682|NCT00075218|585224279|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
162045683|NCT00075218|585224280|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
162045684|NCT00075218|585224278|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
162045685|NCT00075218|585224279|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
162045686|NCT00075218|585224280|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
162045687|NCT00075218|585224278|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
162045688|NCT00075218|585224279|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
162045689|NCT00075218|585224280|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
162045690|NCT00075218|585224278|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
162045691|NCT00075218|585224279|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
162045692|NCT00075218|585224280|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
162045693|NCT00075218|585224278|FG000|Double-Blind Treatment|No study medication taken|2|||
162045694|NCT00075218|585224279|FG001|Double-Blind Treatment|No study medication taken|0|||
162045695|NCT00075218|585224280|FG002|Double-Blind Treatment|No study medication taken|0|||
162045696|NCT00075218|585224278|FG000|Open-Label Treatment|Lack of Efficacy|0|||
162045697|NCT00075218|585224279|FG001|Open-Label Treatment|Lack of Efficacy|0|||
162045698|NCT00075218|585224280|FG002|Open-Label Treatment|Lack of Efficacy|174|||
162045699|NCT00075218|585224278|FG000|Open-Label Treatment|Adverse Event|0|||
162045700|NCT00075218|585224279|FG001|Open-Label Treatment|Adverse Event|0|||
162045701|NCT00075218|585224280|FG002|Open-Label Treatment|Adverse Event|51|||
162045702|NCT00075218|585224278|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
162045703|NCT00075218|585224279|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
162045704|NCT00075218|585224280|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
162045705|NCT00075218|585224278|FG000|Open-Label Treatment|Decision of Sponsor|0|||
162045706|NCT00075218|585224279|FG001|Open-Label Treatment|Decision of Sponsor|0|||
162045707|NCT00075218|585224280|FG002|Open-Label Treatment|Decision of Sponsor|8|||
162045708|NCT00075218|585224278|FG000|Open-Label Treatment|Protocol Violation|0|||
162045709|NCT00075218|585224279|FG001|Open-Label Treatment|Protocol Violation|0|||
162045710|NCT00075218|585224280|FG002|Open-Label Treatment|Protocol Violation|1|||
162045711|NCT00075218|585224278|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
162045712|NCT00075218|585224279|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
162045713|NCT00075218|585224280|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
162045714|NCT00131508|585224281|FG000|Overall Study|Disease progression|0|||
162045715|NCT00131508|585224282|FG001|Overall Study|Disease progression|2|||
162045716|NCT00131508|585224281|FG000|Overall Study|Non-Compliance|2|||
162045717|NCT00131508|585224282|FG001|Overall Study|Non-Compliance|4|||
162045718|NCT00131508|585224281|FG000|Overall Study|Withdrawal by Subject|1|||
162045719|NCT00131508|585224282|FG001|Overall Study|Withdrawal by Subject|2|||
162045720|NCT03643575|585224283|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
162045721|NCT03643575|585224284|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
162045722|NCT03643575|585224285|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
162045723|NCT03643575|585224286|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
162045724|NCT03643575|585224287|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
162045725|NCT03643575|585224288|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
162045726|NCT03643575|585224283|FG000|Washout: 7 Days|Adverse Event|1|||
162045727|NCT03643575|585224284|FG001|Washout: 7 Days|Adverse Event|0|||
162045728|NCT03643575|585224285|FG002|Washout: 7 Days|Adverse Event|0|||
162045729|NCT03643575|585224286|FG003|Washout: 7 Days|Adverse Event|0|||
162045730|NCT03643575|585224287|FG004|Washout: 7 Days|Adverse Event|0|||
162045731|NCT03643575|585224288|FG005|Washout: 7 Days|Adverse Event|0|||
162045732|NCT03643575|585224283|FG000|Washout: 7 Days|Non compliance check in|0|||
162045733|NCT03643575|585224284|FG001|Washout: 7 Days|Non compliance check in|1|||
162045734|NCT03643575|585224285|FG002|Washout: 7 Days|Non compliance check in|0|||
162045735|NCT03643575|585224286|FG003|Washout: 7 Days|Non compliance check in|0|||
162045736|NCT03643575|585224287|FG004|Washout: 7 Days|Non compliance check in|0|||
162045737|NCT03643575|585224288|FG005|Washout: 7 Days|Non compliance check in|0|||
162045738|NCT00875979|585224289|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
162045739|NCT00875979|585224290|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
162045740|NCT00875979|585224289|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
162045741|NCT00875979|585224290|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
162045742|NCT00875979|585224289|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
162045743|NCT00875979|585224290|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
162045744|NCT00875979|585224289|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
162045745|NCT00875979|585224290|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
162045746|NCT00875979|585224289|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
162045747|NCT00875979|585224290|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
162045748|NCT00875979|585224289|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
162045749|NCT00875979|585224290|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
162045750|NCT00875979|585224289|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
162045751|NCT00875979|585224290|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
162045752|NCT00875979|585224289|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
162045753|NCT00875979|585224290|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
162045754|NCT00875979|585224289|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
162045755|NCT00875979|585224290|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
162045756|NCT01696695|585224292|FG000|Overall Study|Disease progression|373|||
162045757|NCT01696695|585224292|FG000|Overall Study|Death|29|||
162045758|NCT01696695|585224292|FG000|Overall Study|Adverse Event|74|||
162045759|NCT01696695|585224292|FG000|Overall Study|Withdrawal by Subject|92|||
162045760|NCT01696695|585224292|FG000|Overall Study|Lost to Follow-up|48|||
162045761|NCT01696695|585224292|FG000|Overall Study|Other|74|||
162045762|NCT01696695|585224292|FG000|Overall Study|Major Protocol Violation|192|||
162045763|NCT01904058|585224301|FG000|Overall Study|Adverse Event|2|||
162045764|NCT01904058|585224302|FG001|Overall Study|Adverse Event|0|||
162045765|NCT01904058|585224303|FG002|Overall Study|Adverse Event|0|||
162045766|NCT01904058|585224304|FG003|Overall Study|Adverse Event|0|||
162045767|NCT01904058|585224301|FG000|Overall Study|Withdrawal by Subject|1|||
162045768|NCT01904058|585224302|FG001|Overall Study|Withdrawal by Subject|0|||
162045769|NCT01904058|585224303|FG002|Overall Study|Withdrawal by Subject|1|||
162045770|NCT01904058|585224304|FG003|Overall Study|Withdrawal by Subject|0|||
162045771|NCT01904058|585224301|FG000|Overall Study|Pregnancy|0|||
162045772|NCT01904058|585224302|FG001|Overall Study|Pregnancy|0|||
162045773|NCT01904058|585224303|FG002|Overall Study|Pregnancy|0|||
162045774|NCT01904058|585224304|FG003|Overall Study|Pregnancy|1|||
162045775|NCT04041375|585224305|FG000|Intervention Phase|Withdrawal by Subject|2|||
162045776|NCT04041375|585224306|FG001|Intervention Phase|Withdrawal by Subject|2|||
162045777|NCT04041375|585224305|FG000|Follow-up Phase|Death|2|||
162045778|NCT04041375|585224306|FG001|Follow-up Phase|Death|0|||
162045779|NCT04041375|585224305|FG000|Follow-up Phase|Lost to Follow-up|2|||
162045780|NCT04041375|585224306|FG001|Follow-up Phase|Lost to Follow-up|1|||
162045781|NCT04041375|585224305|FG000|Follow-up Phase|Too ill|3|||
162045782|NCT04041375|585224306|FG001|Follow-up Phase|Too ill|0|||
162045783|NCT02404220|585224312|FG000|Overall Study|Adverse Event|0|||
162045784|NCT02404220|585224313|FG001|Overall Study|Adverse Event|0|||
162045785|NCT02404220|585224314|FG002|Overall Study|Adverse Event|1|||
162045786|NCT02404220|585224315|FG003|Overall Study|Adverse Event|0|||
162045787|NCT02404220|585224312|FG000|Overall Study|Death|5|||
162045788|NCT02404220|585224313|FG001|Overall Study|Death|5|||
162045789|NCT02404220|585224314|FG002|Overall Study|Death|3|||
162045790|NCT02404220|585224315|FG003|Overall Study|Death|8|||
162045791|NCT02404220|585224312|FG000|Overall Study|Progressive Disease|0|||
162045792|NCT02404220|585224313|FG001|Overall Study|Progressive Disease|0|||
162045793|NCT02404220|585224314|FG002|Overall Study|Progressive Disease|1|||
162045794|NCT02404220|585224315|FG003|Overall Study|Progressive Disease|1|||
162045795|NCT02404220|585224312|FG000|Overall Study|Study Terminated by Sponsor|0|||
162045796|NCT02404220|585224313|FG001|Overall Study|Study Terminated by Sponsor|0|||
162045797|NCT02404220|585224314|FG002|Overall Study|Study Terminated by Sponsor|2|||
162045798|NCT02404220|585224315|FG003|Overall Study|Study Terminated by Sponsor|1|||
162045799|NCT02404220|585224312|FG000|Overall Study|Withdrawal by Subject|0|||
162045800|NCT02404220|585224313|FG001|Overall Study|Withdrawal by Subject|1|||
162045801|NCT02404220|585224314|FG002|Overall Study|Withdrawal by Subject|0|||
162045802|NCT02404220|585224315|FG003|Overall Study|Withdrawal by Subject|0|||
162045803|NCT02404220|585224312|FG000|Overall Study|Enrolled but Never Treated|0|||
162045804|NCT02404220|585224313|FG001|Overall Study|Enrolled but Never Treated|2|||
162045805|NCT02404220|585224314|FG002|Overall Study|Enrolled but Never Treated|0|||
162045806|NCT02404220|585224315|FG003|Overall Study|Enrolled but Never Treated|0|||
162045807|NCT00395733|585224316|FG000|Period 2|Withdrawal by Subject|1|||
162045808|NCT00395733|585224317|FG001|Period 2|Withdrawal by Subject|2|||
162045809|NCT00395733|585224316|FG000|Period 2|Protocol Violation|0|||
162045810|NCT00395733|585224317|FG001|Period 2|Protocol Violation|1|||
162045811|NCT00395733|585224316|FG000|Period 2|Adverse Event|0|||
162045812|NCT00395733|585224317|FG001|Period 2|Adverse Event|2|||
162045813|NCT00395733|585224316|FG000|Period 2|Technical problems|1|||
162045814|NCT00395733|585224317|FG001|Period 2|Technical problems|0|||
162045815|NCT01147172|585224323|FG000|Overall Study|Withdrawal by Subject|2|||
162045816|NCT01147172|585224323|FG000|Overall Study|Lost to Follow-up|2|||
162045817|NCT01697358|585224324|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
162045818|NCT01697358|585224325|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
162045819|NCT01697358|585224324|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
162045820|NCT01697358|585224325|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
162045821|NCT01697358|585224324|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
162045822|NCT01697358|585224325|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
162045823|NCT01697358|585224324|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
162045824|NCT01697358|585224325|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
162045825|NCT01697358|585224324|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
162045826|NCT01697358|585224325|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
162045827|NCT01697358|585224324|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
162045828|NCT01697358|585224325|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
162045829|NCT01697358|585224324|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
162045830|NCT01697358|585224325|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
162045831|NCT01697358|585224324|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
162045832|NCT01697358|585224325|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
162045833|NCT01697358|585224324|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
162045834|NCT01697358|585224325|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
162045835|NCT01697358|585224324|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
162045836|NCT01697358|585224325|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
162045837|NCT02507973|585224328|FG000|Overall Study|Adverse Event|1|||
162045838|NCT03386474|585224331|FG000|Overall Study|Death|1|||
162045839|NCT03386474|585224332|FG001|Overall Study|Death|0|||
162045840|NCT03386474|585224331|FG000|Overall Study|Adverse Event|0|||
162045841|NCT03386474|585224332|FG001|Overall Study|Adverse Event|1|||
162045842|NCT02919696|585224335|FG000|Overall Study|Adverse Event|1|||
162045843|NCT02919696|585224336|FG001|Overall Study|Adverse Event|2|||
162045844|NCT02919696|585224335|FG000|Overall Study|Withdrawal by Subject|2|||
162045845|NCT02919696|585224336|FG001|Overall Study|Withdrawal by Subject|1|||
162045846|NCT02919696|585224335|FG000|Overall Study|Sponsor Decision|1|||
162045847|NCT02919696|585224336|FG001|Overall Study|Sponsor Decision|1|||
162045848|NCT02919696|585224335|FG000|Overall Study|Never Treated|0|||
162045849|NCT02919696|585224336|FG001|Overall Study|Never Treated|1|||
162045850|NCT03021304|585224338|FG000|Overall Study|Lack of Efficacy|1|||
162045851|NCT00484094|585224341|FG000|Overall Study|Discontinued|39|||
162045852|NCT00484094|585224341|FG000|Overall Study|Other|3|||
162045853|NCT03594994|585224342|FG000|Overall Study|Adverse Event|1|||
162045854|NCT03594994|585224343|FG001|Overall Study|Adverse Event|0|||
162045855|NCT03594994|585224342|FG000|Overall Study|Withdrawal by Subject|0|||
162045856|NCT03594994|585224343|FG001|Overall Study|Withdrawal by Subject|1|||
162045857|NCT00309985|585224347|FG000|Overall Study|Disease progression|12|||
162045858|NCT00309985|585224348|FG001|Overall Study|Disease progression|0|||
162045859|NCT00309985|585224347|FG000|Overall Study|Adverse Event|30|||
162045860|NCT00309985|585224348|FG001|Overall Study|Adverse Event|0|||
162045861|NCT00309985|585224347|FG000|Overall Study|Death|2|||
162045862|NCT00309985|585224348|FG001|Overall Study|Death|0|||
162045863|NCT00309985|585224347|FG000|Overall Study|Withdrawal by Subject|5|||
162045864|NCT00309985|585224348|FG001|Overall Study|Withdrawal by Subject|1|||
162045865|NCT00309985|585224347|FG000|Overall Study|Physician Decision|3|||
162045866|NCT00309985|585224348|FG001|Overall Study|Physician Decision|0|||
162045867|NCT00309985|585224347|FG000|Overall Study|Never started treatment|7|||
162045868|NCT00309985|585224348|FG001|Overall Study|Never started treatment|0|||
162045869|NCT00309985|585224347|FG000|Overall Study|Complicating disease|1|||
162045870|NCT00309985|585224348|FG001|Overall Study|Complicating disease|0|||
162045871|NCT00309985|585224347|FG000|Overall Study|Non-compliance|1|||
162045872|NCT00309985|585224348|FG001|Overall Study|Non-compliance|0|||
162045873|NCT00309985|585224347|FG000|Overall Study|Chemotherapy discontinued only|1|||
162045874|NCT00309985|585224348|FG001|Overall Study|Chemotherapy discontinued only|0|||
162045875|NCT03774082|585224351|FG000|Overall Study|Death|6|||
162045876|NCT03774082|585224352|FG001|Overall Study|Death|3|||
162045877|NCT03774082|585224353|FG002|Overall Study|Death|2|||
162045878|NCT03774082|585224351|FG000|Overall Study|Subject decision|0|||
162045879|NCT03774082|585224352|FG001|Overall Study|Subject decision|3|||
162045880|NCT03774082|585224353|FG002|Overall Study|Subject decision|0|||
162045881|NCT03774082|585224351|FG000|Overall Study|Lost to Follow-up|2|||
162045882|NCT03774082|585224352|FG001|Overall Study|Lost to Follow-up|0|||
162045883|NCT03774082|585224353|FG002|Overall Study|Lost to Follow-up|0|||
162045884|NCT03774082|585224351|FG000|Overall Study|Guardian decision|0|||
162045885|NCT03774082|585224352|FG001|Overall Study|Guardian decision|0|||
162045886|NCT03774082|585224353|FG002|Overall Study|Guardian decision|1|||
162045887|NCT03774082|585224351|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
162045888|NCT03774082|585224352|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
162045889|NCT03774082|585224353|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
162045890|NCT01950390|585224354|FG000|Overall Study|Never started treatment|3|||
162045891|NCT01950390|585224355|FG001|Overall Study|Never started treatment|2|||
162045892|NCT01950390|585224354|FG000|Overall Study|Disease progression|45|||
162045893|NCT01950390|585224355|FG001|Overall Study|Disease progression|52|||
162045894|NCT01950390|585224354|FG000|Overall Study|Adverse Event|22|||
162045895|NCT01950390|585224355|FG001|Overall Study|Adverse Event|16|||
162045896|NCT01950390|585224354|FG000|Overall Study|Death|5|||
162045897|NCT01950390|585224355|FG001|Overall Study|Death|3|||
162045898|NCT01950390|585224354|FG000|Overall Study|Withdrawal by Subject|5|||
162045899|NCT01950390|585224355|FG001|Overall Study|Withdrawal by Subject|1|||
162045900|NCT01950390|585224354|FG000|Overall Study|Alternative therapy|0|||
162045901|NCT01950390|585224355|FG001|Overall Study|Alternative therapy|3|||
162045902|NCT01950390|585224354|FG000|Overall Study|Complicating disease|1|||
162045903|NCT01950390|585224355|FG001|Overall Study|Complicating disease|0|||
162045904|NCT01950390|585224354|FG000|Overall Study|On treatment|1|||
162045905|NCT01950390|585224355|FG001|Overall Study|On treatment|0|||
162045906|NCT01950390|585224354|FG000|Overall Study|Symptomatic deterioration|2|||
162045907|NCT01950390|585224355|FG001|Overall Study|Symptomatic deterioration|1|||
162045908|NCT01950390|585224354|FG000|Overall Study|Physician Decision|0|||
162045909|NCT01950390|585224355|FG001|Overall Study|Physician Decision|4|||
162045910|NCT01950390|585224354|FG000|Overall Study|Lack of clinical benefit|0|||
162045911|NCT01950390|585224355|FG001|Overall Study|Lack of clinical benefit|1|||
162045912|NCT01950390|585224354|FG000|Overall Study|Maintained PR and moved to observation only|0|||
162045913|NCT01950390|585224355|FG001|Overall Study|Maintained PR and moved to observation only|1|||
162045914|NCT05938920|585224356|FG000|Overall Study|Adverse Event|1|||
162045915|NCT05938920|585224357|FG001|Overall Study|Adverse Event|3|||
162045916|NCT05938920|585224358|FG002|Overall Study|Adverse Event|2|||
162045917|NCT05938920|585224359|FG003|Overall Study|Adverse Event|1|||
162045918|NCT05938920|585224356|FG000|Overall Study|Death|0|||
162045919|NCT05938920|585224357|FG001|Overall Study|Death|1|||
162045920|NCT05938920|585224358|FG002|Overall Study|Death|0|||
162045921|NCT05938920|585224359|FG003|Overall Study|Death|0|||
162045922|NCT05938920|585224356|FG000|Overall Study|Lost to Follow-up|0|||
162045923|NCT05938920|585224357|FG001|Overall Study|Lost to Follow-up|0|||
162045924|NCT05938920|585224358|FG002|Overall Study|Lost to Follow-up|1|||
162045925|NCT05938920|585224359|FG003|Overall Study|Lost to Follow-up|0|||
162045926|NCT05938920|585224356|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
162045927|NCT05938920|585224357|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
162045928|NCT05938920|585224358|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
162045929|NCT05938920|585224359|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
162045930|NCT05938920|585224356|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
162045931|NCT05938920|585224357|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
162045932|NCT05938920|585224358|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
162045933|NCT05938920|585224359|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
162045934|NCT05938920|585224356|FG000|Overall Study|Participant Refused to Come In|0|||
162045935|NCT05938920|585224357|FG001|Overall Study|Participant Refused to Come In|0|||
162045936|NCT05938920|585224358|FG002|Overall Study|Participant Refused to Come In|1|||
162045937|NCT05938920|585224359|FG003|Overall Study|Participant Refused to Come In|0|||
162045938|NCT01251861|585224360|FG000|Overall Study|Disease progression|6|||
162045939|NCT01251861|585224361|FG001|Overall Study|Disease progression|6|||
162045940|NCT01251861|585224360|FG000|Overall Study|Adverse Event|2|||
162045941|NCT01251861|585224361|FG001|Overall Study|Adverse Event|17|||
162045942|NCT01251861|585224360|FG000|Overall Study|Withdrawal by Subject|2|||
162045943|NCT01251861|585224361|FG001|Overall Study|Withdrawal by Subject|2|||
162045944|NCT01251861|585224360|FG000|Overall Study|Alternative therapy|1|||
162045945|NCT01251861|585224361|FG001|Overall Study|Alternative therapy|0|||
162045946|NCT01251861|585224360|FG000|Overall Study|Other complicating disease|0|||
162045947|NCT01251861|585224361|FG001|Overall Study|Other complicating disease|1|||
162045948|NCT01251861|585224360|FG000|Overall Study|Physician Decision|1|||
162045949|NCT01251861|585224361|FG001|Overall Study|Physician Decision|0|||
162045950|NCT01251861|585224360|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
162045951|NCT01251861|585224361|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
162045952|NCT01251861|585224360|FG000|Overall Study|Other|1|||
162045953|NCT01251861|585224361|FG001|Overall Study|Other|0|||
162045954|NCT01251861|585224360|FG000|Overall Study|Never started therapy|4|||
162045955|NCT01251861|585224361|FG001|Overall Study|Never started therapy|1|||
162045956|NCT01251861|585224360|FG000|Overall Study|Potential interaction of drugs|0|||
162045957|NCT01251861|585224361|FG001|Overall Study|Potential interaction of drugs|1|||
162045958|NCT02975336|585225928|FG000|DBPC (52 Weeks)|Adverse Event|16|||
162045959|NCT02975336|585225929|FG001|DBPC (52 Weeks)|Adverse Event|17|||
162045960|NCT02975336|585225930|FG002|DBPC (52 Weeks)|Adverse Event|13|||
162045961|NCT02975336|585225931|FG003|DBPC (52 Weeks)|Adverse Event|18|||
162045962|NCT02975336|585225932|FG004|DBPC (52 Weeks)|Adverse Event|0|||
162045963|NCT02975336|585225933|FG005|DBPC (52 Weeks)|Adverse Event|0|||
162045964|NCT02975336|585225934|FG006|DBPC (52 Weeks)|Adverse Event|0|||
162045965|NCT02975336|585225935|FG007|DBPC (52 Weeks)|Adverse Event|0|||
162045966|NCT02975336|585225928|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
162045967|NCT02975336|585225929|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
162045968|NCT02975336|585225930|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
162045969|NCT02975336|585225931|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
162045970|NCT02975336|585225932|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
162045971|NCT02975336|585225933|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
162045972|NCT02975336|585225934|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
162045973|NCT02975336|585225935|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
162045974|NCT02975336|585225928|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
162045975|NCT02975336|585225929|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
162045976|NCT02975336|585225930|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
162045977|NCT02975336|585225931|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
162045978|NCT02975336|585225932|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
162045979|NCT02975336|585225933|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
162045980|NCT02975336|585225934|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
162045981|NCT02975336|585225935|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
162045982|NCT02975336|585225928|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
162045983|NCT02975336|585225929|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
162045984|NCT02975336|585225930|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
162045985|NCT02975336|585225931|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
162045986|NCT02975336|585225932|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
162045987|NCT02975336|585225933|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
162045988|NCT02975336|585225934|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
162045989|NCT02975336|585225935|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
162045990|NCT02975336|585225928|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
162045991|NCT02975336|585225929|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
162045992|NCT02975336|585225930|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
162045993|NCT02975336|585225931|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
162045994|NCT02975336|585225932|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
162045995|NCT02975336|585225933|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
162045996|NCT02975336|585225934|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
162045997|NCT02975336|585225935|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
162045998|NCT02975336|585225928|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
162045999|NCT02975336|585225929|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
162046000|NCT02975336|585225930|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
162046001|NCT02975336|585225931|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
162046002|NCT02975336|585225932|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
162046003|NCT02975336|585225933|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
162046004|NCT02975336|585225934|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
162046005|NCT02975336|585225935|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
162046006|NCT02975336|585225928|FG000|LTE (104 Weeks)|Adverse Event|0|||
162046007|NCT02975336|585225929|FG001|LTE (104 Weeks)|Adverse Event|0|||
162046008|NCT02975336|585225930|FG002|LTE (104 Weeks)|Adverse Event|0|||
162046009|NCT02975336|585225931|FG003|LTE (104 Weeks)|Adverse Event|0|||
162046010|NCT02975336|585225932|FG004|LTE (104 Weeks)|Adverse Event|7|||
162046011|NCT02975336|585225933|FG005|LTE (104 Weeks)|Adverse Event|4|||
162046012|NCT02975336|585225934|FG006|LTE (104 Weeks)|Adverse Event|2|||
162046013|NCT02975336|585225935|FG007|LTE (104 Weeks)|Adverse Event|0|||
162046014|NCT02975336|585225928|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
162046015|NCT02975336|585225929|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
162046016|NCT02975336|585225930|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
162046017|NCT02975336|585225931|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
162046018|NCT02975336|585225932|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
162046019|NCT02975336|585225933|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
162046020|NCT02975336|585225934|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
162046021|NCT02975336|585225935|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
162046022|NCT02975336|585225928|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
162046023|NCT02975336|585225929|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
162046024|NCT02975336|585225930|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
162046025|NCT02975336|585225931|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
162046026|NCT02975336|585225932|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
162046027|NCT02975336|585225933|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
162046028|NCT02975336|585225934|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
162046029|NCT02975336|585225935|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
162046030|NCT02975336|585225928|FG000|LTE (104 Weeks)|Other|0|||
162046031|NCT02975336|585225929|FG001|LTE (104 Weeks)|Other|0|||
162046032|NCT02975336|585225930|FG002|LTE (104 Weeks)|Other|0|||
162046033|NCT02975336|585225931|FG003|LTE (104 Weeks)|Other|0|||
162046034|NCT02975336|585225932|FG004|LTE (104 Weeks)|Other|55|||
162046035|NCT02975336|585225933|FG005|LTE (104 Weeks)|Other|63|||
162046036|NCT02975336|585225934|FG006|LTE (104 Weeks)|Other|76|||
162046037|NCT02975336|585225935|FG007|LTE (104 Weeks)|Other|72|||
162046038|NCT02008318|585225938|FG000|Overall Study|Adverse Event|4|||
162046039|NCT02008318|585225939|FG001|Overall Study|Adverse Event|0|||
162046040|NCT02008318|585225938|FG000|Overall Study|Physician Decision|2|||
162046041|NCT02008318|585225939|FG001|Overall Study|Physician Decision|0|||
162046042|NCT02008318|585225938|FG000|Overall Study|Progressive Disease|2|||
162046043|NCT02008318|585225939|FG001|Overall Study|Progressive Disease|0|||
162046044|NCT02008318|585225938|FG000|Overall Study|Protocol Violation|1|||
162046045|NCT02008318|585225939|FG001|Overall Study|Protocol Violation|1|||
162046046|NCT02008318|585225938|FG000|Overall Study|Withdrawal by Subject|3|||
162046047|NCT02008318|585225939|FG001|Overall Study|Withdrawal by Subject|0|||
162046048|NCT02281773|585225940|FG000|Overall Study|Adverse Event|6|||
162046049|NCT02281773|585225941|FG001|Overall Study|Adverse Event|1|||
162046050|NCT02281773|585225942|FG002|Overall Study|Adverse Event|4|||
162046051|NCT02281773|585225943|FG003|Overall Study|Adverse Event|8|||
162046052|NCT02281773|585225944|FG004|Overall Study|Adverse Event|9|||
162046053|NCT02281773|585225940|FG000|Overall Study|Protocol Violation|1|||
162046054|NCT02281773|585225941|FG001|Overall Study|Protocol Violation|0|||
162046055|NCT02281773|585225942|FG002|Overall Study|Protocol Violation|0|||
162046056|NCT02281773|585225943|FG003|Overall Study|Protocol Violation|2|||
162046057|NCT02281773|585225944|FG004|Overall Study|Protocol Violation|2|||
162046058|NCT02281773|585225940|FG000|Overall Study|Lost to Follow-up|2|||
162046059|NCT02281773|585225941|FG001|Overall Study|Lost to Follow-up|2|||
162046060|NCT02281773|585225942|FG002|Overall Study|Lost to Follow-up|6|||
162046061|NCT02281773|585225943|FG003|Overall Study|Lost to Follow-up|2|||
162046062|NCT02281773|585225944|FG004|Overall Study|Lost to Follow-up|10|||
162046063|NCT02281773|585225940|FG000|Overall Study|Withdrawal by Subject|2|||
162046064|NCT02281773|585225941|FG001|Overall Study|Withdrawal by Subject|8|||
162046065|NCT02281773|585225942|FG002|Overall Study|Withdrawal by Subject|6|||
162046066|NCT02281773|585225943|FG003|Overall Study|Withdrawal by Subject|6|||
162046067|NCT02281773|585225944|FG004|Overall Study|Withdrawal by Subject|8|||
162046068|NCT02281773|585225940|FG000|Overall Study|Other Reason|0|||
162046069|NCT02281773|585225941|FG001|Overall Study|Other Reason|4|||
162046070|NCT02281773|585225942|FG002|Overall Study|Other Reason|2|||
162046071|NCT02281773|585225943|FG003|Overall Study|Other Reason|3|||
162046072|NCT02281773|585225944|FG004|Overall Study|Other Reason|1|||
162046073|NCT00385762|585225945|FG000|Overall Study|Adverse Event|1|||
162046074|NCT00385762|585225945|FG000|Overall Study|Lost to Follow-up|1|||
162046075|NCT03355365|585225949|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
162046076|NCT03355365|585225950|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
162046077|NCT03355365|585225949|FG000|Year 1, First Intervention|Protocol Violation|1|||
162046078|NCT03355365|585225950|FG001|Year 1, First Intervention|Protocol Violation|0|||
162046079|NCT03355365|585225949|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
162046080|NCT03355365|585225950|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
162046081|NCT03355365|585225949|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
162046082|NCT03355365|585225950|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
162046083|NCT03355365|585225949|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
162046084|NCT03355365|585225950|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
162046085|NCT03355365|585225949|FG000|Year 2, Crossover Intervention|severe COVID|0|||
162046086|NCT03355365|585225950|FG001|Year 2, Crossover Intervention|severe COVID|1|||
162046087|NCT03355365|585225949|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
162046088|NCT03355365|585225950|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
162046089|NCT01147640|585225951|FG000|Overall Study|Adverse Event|2|||
162046090|NCT01147640|585225952|FG001|Overall Study|Adverse Event|0|||
162046091|NCT01147640|585225951|FG000|Overall Study|Physician Decision|1|||
162046092|NCT01147640|585225952|FG001|Overall Study|Physician Decision|0|||
162046093|NCT01147640|585225951|FG000|Overall Study|Withdrawal by Subject|1|||
162046094|NCT01147640|585225952|FG001|Overall Study|Withdrawal by Subject|0|||
162046095|NCT01147640|585225951|FG000|Overall Study|Lost to Follow-up|0|||
162046096|NCT01147640|585225952|FG001|Overall Study|Lost to Follow-up|1|||
162046097|NCT01147640|585225951|FG000|Overall Study|Didn't meet eligibility criteria|1|||
162046098|NCT01147640|585225952|FG001|Overall Study|Didn't meet eligibility criteria|0|||
162046099|NCT01856907|585225955|FG000|Overall Study|Pregnancy|0|||
162046100|NCT01856907|585225956|FG001|Overall Study|Pregnancy|1|||
162046101|NCT01856907|585225957|FG002|Overall Study|Pregnancy|0|||
162046102|NCT01856907|585225955|FG000|Overall Study|Pregnancy|0|||
162046103|NCT01856907|585225956|FG001|Overall Study|Pregnancy|1|||
162046104|NCT01856907|585225957|FG002|Overall Study|Pregnancy|0|||
162046105|NCT01856907|585225955|FG000|Overall Study|Withdrawal by Subject|0|||
162046106|NCT01856907|585225956|FG001|Overall Study|Withdrawal by Subject|1|||
162046107|NCT01856907|585225957|FG002|Overall Study|Withdrawal by Subject|0|||
162046108|NCT00986830|585225958|FG000|Overall Study|Death|1|||
162046109|NCT00986830|585225958|FG000|Overall Study|Lost to Follow-up|1|||
162046110|NCT00986830|585225958|FG000|Overall Study|Lack of Efficacy|1|||
162046111|NCT00986830|585225958|FG000|Overall Study|Unable to access sinus with device|5|||
162046112|NCT00845858|585225959|FG000|Overall Study|Withdrawal by Subject|5|||
162046113|NCT00845858|585225960|FG001|Overall Study|Withdrawal by Subject|1|||
162046114|NCT00845858|585225961|FG002|Overall Study|Withdrawal by Subject|1|||
162046115|NCT00845858|585225959|FG000|Overall Study|Adverse Event|3|||
162046116|NCT00845858|585225960|FG001|Overall Study|Adverse Event|8|||
162046117|NCT00845858|585225961|FG002|Overall Study|Adverse Event|4|||
162046118|NCT00845858|585225959|FG000|Overall Study|Protocol Violation|0|||
162046119|NCT00845858|585225960|FG001|Overall Study|Protocol Violation|0|||
162046120|NCT00845858|585225961|FG002|Overall Study|Protocol Violation|1|||
162046121|NCT00845858|585225959|FG000|Overall Study|not eligible|0|||
162046122|NCT00845858|585225960|FG001|Overall Study|not eligible|3|||
162046123|NCT00845858|585225961|FG002|Overall Study|not eligible|2|||
162046124|NCT01436396|585225962|FG000|Overall Study|Protocol Violation|7|||
162046125|NCT01436396|585225963|FG001|Overall Study|Protocol Violation|5|||
162046126|NCT01436396|585225962|FG000|Overall Study|Adverse Event|1|||
162046127|NCT01436396|585225963|FG001|Overall Study|Adverse Event|2|||
162046128|NCT01436396|585225962|FG000|Overall Study|Withdrawal by Subject|19|||
162046129|NCT01436396|585225963|FG001|Overall Study|Withdrawal by Subject|29|||
162046130|NCT01436396|585225962|FG000|Overall Study|Serious adverse event|2|||
162046131|NCT01436396|585225963|FG001|Overall Study|Serious adverse event|3|||
162046132|NCT01436396|585225962|FG000|Overall Study|Lost to Follow-up|3|||
162046133|NCT01436396|585225963|FG001|Overall Study|Lost to Follow-up|3|||
162046134|NCT01332331|585225965|FG000|Overall Study|Lost to Follow-up|0|||
162046135|NCT01332331|585225966|FG001|Overall Study|Lost to Follow-up|1|||
162046136|NCT01332331|585225965|FG000|Overall Study|Adverse Event|1|||
162046137|NCT01332331|585225966|FG001|Overall Study|Adverse Event|1|||
162046138|NCT01332331|585225965|FG000|Overall Study|Physician Decision|1|||
162046139|NCT01332331|585225966|FG001|Overall Study|Physician Decision|0|||
162046140|NCT00538291|585225967|FG000|Overall Study|Adverse Event|2|||
162046141|NCT00538291|585225967|FG000|Overall Study|Withdrawal by Subject|1|||
162046142|NCT00694707|585225968|FG000|Overall Study|Did Not Receive Treatment|0|||
162046143|NCT00694707|585225969|FG001|Overall Study|Did Not Receive Treatment|0|||
162046144|NCT00694707|585225970|FG002|Overall Study|Did Not Receive Treatment|1|||
162046145|NCT00694707|585225971|FG003|Overall Study|Did Not Receive Treatment|1|||
162046146|NCT00694707|585225972|FG004|Overall Study|Did Not Receive Treatment|1|||
162046147|NCT00694707|585225968|FG000|Overall Study|Adverse Event|22|||
162046148|NCT00694707|585225969|FG001|Overall Study|Adverse Event|14|||
162046149|NCT00694707|585225970|FG002|Overall Study|Adverse Event|8|||
162046150|NCT00694707|585225971|FG003|Overall Study|Adverse Event|12|||
162046151|NCT00694707|585225972|FG004|Overall Study|Adverse Event|13|||
162046152|NCT00694707|585225968|FG000|Overall Study|Insufficient Therapeutic Response|33|||
162046153|NCT00694707|585225969|FG001|Overall Study|Insufficient Therapeutic Response|18|||
162046154|NCT00694707|585225970|FG002|Overall Study|Insufficient Therapeutic Response|17|||
162046155|NCT00694707|585225971|FG003|Overall Study|Insufficient Therapeutic Response|15|||
162046156|NCT00694707|585225972|FG004|Overall Study|Insufficient Therapeutic Response|10|||
162046157|NCT00694707|585225968|FG000|Overall Study|Protocol Violation|1|||
162046158|NCT00694707|585225969|FG001|Overall Study|Protocol Violation|2|||
162046159|NCT00694707|585225970|FG002|Overall Study|Protocol Violation|1|||
162046160|NCT00694707|585225971|FG003|Overall Study|Protocol Violation|3|||
162046161|NCT00694707|585225972|FG004|Overall Study|Protocol Violation|1|||
162046162|NCT00694707|585225968|FG000|Overall Study|Withdrawal of Consent|14|||
162046163|NCT00694707|585225969|FG001|Overall Study|Withdrawal of Consent|18|||
162046164|NCT00694707|585225970|FG002|Overall Study|Withdrawal of Consent|22|||
162046165|NCT00694707|585225971|FG003|Overall Study|Withdrawal of Consent|16|||
162046166|NCT00694707|585225972|FG004|Overall Study|Withdrawal of Consent|15|||
162046167|NCT00694707|585225968|FG000|Overall Study|Lost to Follow-up|0|||
162046168|NCT00694707|585225969|FG001|Overall Study|Lost to Follow-up|1|||
162046169|NCT00694707|585225970|FG002|Overall Study|Lost to Follow-up|2|||
162046170|NCT00694707|585225971|FG003|Overall Study|Lost to Follow-up|0|||
162046171|NCT00694707|585225972|FG004|Overall Study|Lost to Follow-up|0|||
162046172|NCT00694707|585225968|FG000|Overall Study|Jeopardizing Parole Status|1|||
162046173|NCT00694707|585225969|FG001|Overall Study|Jeopardizing Parole Status|0|||
162046174|NCT00694707|585225970|FG002|Overall Study|Jeopardizing Parole Status|0|||
162046175|NCT00694707|585225971|FG003|Overall Study|Jeopardizing Parole Status|0|||
162046176|NCT00694707|585225972|FG004|Overall Study|Jeopardizing Parole Status|0|||
162046177|NCT00694707|585225968|FG000|Overall Study|Death in the Family|1|||
162046178|NCT00694707|585225969|FG001|Overall Study|Death in the Family|0|||
162046179|NCT00694707|585225970|FG002|Overall Study|Death in the Family|0|||
162046180|NCT00694707|585225971|FG003|Overall Study|Death in the Family|0|||
162046181|NCT00694707|585225972|FG004|Overall Study|Death in the Family|0|||
162046182|NCT00694707|585225968|FG000|Overall Study|Arrest by Police|0|||
162046183|NCT00694707|585225969|FG001|Overall Study|Arrest by Police|1|||
162046184|NCT00694707|585225970|FG002|Overall Study|Arrest by Police|0|||
162046185|NCT00694707|585225971|FG003|Overall Study|Arrest by Police|0|||
162046186|NCT00694707|585225972|FG004|Overall Study|Arrest by Police|0|||
162046187|NCT00694707|585225968|FG000|Overall Study|Administrative Reasons|0|||
162046188|NCT00694707|585225969|FG001|Overall Study|Administrative Reasons|1|||
162046189|NCT00694707|585225970|FG002|Overall Study|Administrative Reasons|0|||
162046190|NCT00694707|585225971|FG003|Overall Study|Administrative Reasons|2|||
162046191|NCT00694707|585225972|FG004|Overall Study|Administrative Reasons|0|||
162046192|NCT00694707|585225968|FG000|Overall Study|Notification of Past Head Injury|0|||
162046193|NCT00694707|585225969|FG001|Overall Study|Notification of Past Head Injury|0|||
162046194|NCT00694707|585225970|FG002|Overall Study|Notification of Past Head Injury|0|||
162046195|NCT00694707|585225971|FG003|Overall Study|Notification of Past Head Injury|1|||
162046196|NCT00694707|585225972|FG004|Overall Study|Notification of Past Head Injury|0|||
162046197|NCT04515394|585225982|FG000|Overall Study|Participant did not receive treatment|1|||
162046198|NCT04674644|585225983|FG000|Overall Study|with missing data|37|||
162046199|NCT00199875|585225984|FG000|Overall Study|Withdrawal by Subject|0|||
162046200|NCT00199875|585225985|FG001|Overall Study|Withdrawal by Subject|0|||
162046201|NCT00199875|585225986|FG002|Overall Study|Withdrawal by Subject|0|||
162046202|NCT00199875|585225987|FG003|Overall Study|Withdrawal by Subject|0|||
162046203|NCT00199875|585225988|FG004|Overall Study|Withdrawal by Subject|1|||
162046204|NCT03469934|585225989|FG000|Overall Study|Withdrawal by Subject|0|||
162046205|NCT03469934|585225990|FG001|Overall Study|Withdrawal by Subject|1|||
162046206|NCT01024231|585225992|FG000|Overall Study|Other Reasons|1|||
162046207|NCT01024231|585225993|FG001|Overall Study|Other Reasons|2|||
162046208|NCT01024231|585225994|FG002|Overall Study|Other Reasons|0|||
162046209|NCT01024231|585225995|FG003|Overall Study|Other Reasons|0|||
162046210|NCT01024231|585225996|FG004|Overall Study|Other Reasons|2|||
162046211|NCT01024231|585225997|FG005|Overall Study|Other Reasons|0|||
162046212|NCT01024231|585225998|FG006|Overall Study|Other Reasons|1|||
162046213|NCT01024231|585225992|FG000|Overall Study|Maximum Clinical Benefit|1|||
162046214|NCT01024231|585225993|FG001|Overall Study|Maximum Clinical Benefit|2|||
162046215|NCT01024231|585225994|FG002|Overall Study|Maximum Clinical Benefit|0|||
162046216|NCT01024231|585225995|FG003|Overall Study|Maximum Clinical Benefit|1|||
162046217|NCT01024231|585225996|FG004|Overall Study|Maximum Clinical Benefit|1|||
162046218|NCT01024231|585225997|FG005|Overall Study|Maximum Clinical Benefit|0|||
162046219|NCT01024231|585225998|FG006|Overall Study|Maximum Clinical Benefit|0|||
162046220|NCT01024231|585225992|FG000|Overall Study|Disease Progression|3|||
162046221|NCT01024231|585225993|FG001|Overall Study|Disease Progression|1|||
162046222|NCT01024231|585225994|FG002|Overall Study|Disease Progression|3|||
162046223|NCT01024231|585225995|FG003|Overall Study|Disease Progression|0|||
162046224|NCT01024231|585225996|FG004|Overall Study|Disease Progression|4|||
162046225|NCT01024231|585225997|FG005|Overall Study|Disease Progression|11|||
162046226|NCT01024231|585225998|FG006|Overall Study|Disease Progression|6|||
162046227|NCT01024231|585225992|FG000|Overall Study|AE unrelated to Study Drug|0|||
162046228|NCT01024231|585225993|FG001|Overall Study|AE unrelated to Study Drug|1|||
162046229|NCT01024231|585225994|FG002|Overall Study|AE unrelated to Study Drug|0|||
162046230|NCT01024231|585225995|FG003|Overall Study|AE unrelated to Study Drug|0|||
162046231|NCT01024231|585225996|FG004|Overall Study|AE unrelated to Study Drug|0|||
162046232|NCT01024231|585225997|FG005|Overall Study|AE unrelated to Study Drug|0|||
162046233|NCT01024231|585225998|FG006|Overall Study|AE unrelated to Study Drug|0|||
162046234|NCT01024231|585225992|FG000|Overall Study|No longer meets criteria|0|||
162046235|NCT01024231|585225993|FG001|Overall Study|No longer meets criteria|0|||
162046236|NCT01024231|585225994|FG002|Overall Study|No longer meets criteria|0|||
162046237|NCT01024231|585225995|FG003|Overall Study|No longer meets criteria|0|||
162046238|NCT01024231|585225996|FG004|Overall Study|No longer meets criteria|1|||
162046239|NCT01024231|585225997|FG005|Overall Study|No longer meets criteria|0|||
162046240|NCT01024231|585225998|FG006|Overall Study|No longer meets criteria|1|||
162046241|NCT01024231|585225992|FG000|Overall Study|Study Drug Toxicity|1|||
162046242|NCT01024231|585225993|FG001|Overall Study|Study Drug Toxicity|6|||
162046243|NCT01024231|585225994|FG002|Overall Study|Study Drug Toxicity|6|||
162046244|NCT01024231|585225995|FG003|Overall Study|Study Drug Toxicity|4|||
162046245|NCT01024231|585225996|FG004|Overall Study|Study Drug Toxicity|2|||
162046246|NCT01024231|585225997|FG005|Overall Study|Study Drug Toxicity|0|||
162046247|NCT01024231|585225998|FG006|Overall Study|Study Drug Toxicity|7|||
162046248|NCT01024231|585225992|FG000|Overall Study|Death|6|||
162046249|NCT01024231|585225993|FG001|Overall Study|Death|2|||
162046250|NCT01024231|585225994|FG002|Overall Study|Death|1|||
162046251|NCT01024231|585225995|FG003|Overall Study|Death|0|||
162046252|NCT01024231|585225996|FG004|Overall Study|Death|4|||
162046253|NCT01024231|585225997|FG005|Overall Study|Death|3|||
162046254|NCT01024231|585225998|FG006|Overall Study|Death|5|||
162046255|NCT01024231|585225992|FG000|Overall Study|Lost to Follow-up|0|||
162046256|NCT01024231|585225993|FG001|Overall Study|Lost to Follow-up|0|||
162046257|NCT01024231|585225994|FG002|Overall Study|Lost to Follow-up|0|||
162046258|NCT01024231|585225995|FG003|Overall Study|Lost to Follow-up|0|||
162046259|NCT01024231|585225996|FG004|Overall Study|Lost to Follow-up|0|||
162046260|NCT01024231|585225997|FG005|Overall Study|Lost to Follow-up|0|||
162046261|NCT01024231|585225998|FG006|Overall Study|Lost to Follow-up|1|||
162046262|NCT01024231|585225992|FG000|Overall Study|Withdrew Consent|0|||
162046263|NCT01024231|585225993|FG001|Overall Study|Withdrew Consent|1|||
162046264|NCT01024231|585225994|FG002|Overall Study|Withdrew Consent|0|||
162046265|NCT01024231|585225995|FG003|Overall Study|Withdrew Consent|0|||
162046266|NCT01024231|585225996|FG004|Overall Study|Withdrew Consent|0|||
162046267|NCT01024231|585225997|FG005|Overall Study|Withdrew Consent|0|||
162046268|NCT01024231|585225998|FG006|Overall Study|Withdrew Consent|0|||
162046269|NCT01024231|585225992|FG000|Overall Study|Continuing on Treatment|0|||
162046270|NCT01024231|585225993|FG001|Overall Study|Continuing on Treatment|0|||
162046271|NCT01024231|585225994|FG002|Overall Study|Continuing on Treatment|0|||
162046272|NCT01024231|585225995|FG003|Overall Study|Continuing on Treatment|0|||
162046273|NCT01024231|585225996|FG004|Overall Study|Continuing on Treatment|3|||
162046274|NCT01024231|585225997|FG005|Overall Study|Continuing on Treatment|2|||
162046275|NCT01024231|585225998|FG006|Overall Study|Continuing on Treatment|0|||
162046276|NCT02761733|585226000|FG000|Overall Study|Death|3|||
162046277|NCT02761733|585226001|FG001|Overall Study|Death|5|||
162046278|NCT02761733|585226002|FG002|Overall Study|Death|1|||
162046279|NCT02761733|585226003|FG003|Overall Study|Death|1|||
162046280|NCT02761733|585226000|FG000|Overall Study|Lost to Follow-up|6|||
162046281|NCT02761733|585226001|FG001|Overall Study|Lost to Follow-up|7|||
162046282|NCT02761733|585226002|FG002|Overall Study|Lost to Follow-up|0|||
162046283|NCT02761733|585226003|FG003|Overall Study|Lost to Follow-up|3|||
162046284|NCT02761733|585226000|FG000|Overall Study|Physician Decision|4|||
162046285|NCT02761733|585226001|FG001|Overall Study|Physician Decision|0|||
162046286|NCT02761733|585226002|FG002|Overall Study|Physician Decision|0|||
162046287|NCT02761733|585226003|FG003|Overall Study|Physician Decision|0|||
162046288|NCT02761733|585226000|FG000|Overall Study|Withdrawal by Subject|2|||
162046289|NCT02761733|585226001|FG001|Overall Study|Withdrawal by Subject|0|||
162046290|NCT02761733|585226002|FG002|Overall Study|Withdrawal by Subject|0|||
162046291|NCT02761733|585226003|FG003|Overall Study|Withdrawal by Subject|0|||
162046292|NCT02761733|585226000|FG000|Overall Study|Discharged from Study Site|10|||
162046293|NCT02761733|585226001|FG001|Overall Study|Discharged from Study Site|9|||
162046294|NCT02761733|585226002|FG002|Overall Study|Discharged from Study Site|25|||
162046295|NCT02761733|585226003|FG003|Overall Study|Discharged from Study Site|11|||
162046296|NCT02761733|585226000|FG000|Overall Study|Cognitive Impairment|5|||
162046297|NCT02761733|585226001|FG001|Overall Study|Cognitive Impairment|0|||
162046298|NCT02761733|585226002|FG002|Overall Study|Cognitive Impairment|1|||
162046299|NCT02761733|585226003|FG003|Overall Study|Cognitive Impairment|0|||
162046300|NCT00669396|585226004|FG000|Overall Study|Lost to Follow-up|10|||
162046301|NCT00669396|585226005|FG001|Overall Study|Lost to Follow-up|12|||
162046302|NCT01262573|585226006|FG000|Overall Study|Withdrawal by Subject|0|||
162046303|NCT01262573|585226007|FG001|Overall Study|Withdrawal by Subject|1|||
162046304|NCT00810693|585226008|FG000|Treatment Period|Adverse Event|8|||
162046305|NCT00810693|585226009|FG001|Treatment Period|Adverse Event|1|||
162046306|NCT00810693|585226010|FG002|Treatment Period|Adverse Event|7|||
162046307|NCT00810693|585226008|FG000|Treatment Period|Death|0|||
162046308|NCT00810693|585226009|FG001|Treatment Period|Death|1|||
162046309|NCT00810693|585226010|FG002|Treatment Period|Death|2|||
162046310|NCT00810693|585226008|FG000|Treatment Period|Lack of Efficacy|0|||
162046311|NCT00810693|585226009|FG001|Treatment Period|Lack of Efficacy|0|||
162046312|NCT00810693|585226010|FG002|Treatment Period|Lack of Efficacy|1|||
162046313|NCT00810693|585226008|FG000|Treatment Period|Lost to Follow-up|1|||
162046314|NCT00810693|585226009|FG001|Treatment Period|Lost to Follow-up|0|||
162046315|NCT00810693|585226010|FG002|Treatment Period|Lost to Follow-up|0|||
162046316|NCT00810693|585226008|FG000|Treatment Period|Non-compliance|1|||
162046317|NCT00810693|585226009|FG001|Treatment Period|Non-compliance|0|||
162046318|NCT00810693|585226010|FG002|Treatment Period|Non-compliance|0|||
162046319|NCT00810693|585226008|FG000|Treatment Period|Protocol Violation|1|||
162046320|NCT00810693|585226009|FG001|Treatment Period|Protocol Violation|2|||
162046321|NCT00810693|585226010|FG002|Treatment Period|Protocol Violation|2|||
162046322|NCT00810693|585226008|FG000|Treatment Period|Withdrawal by Subject|6|||
162046323|NCT00810693|585226009|FG001|Treatment Period|Withdrawal by Subject|2|||
162046324|NCT00810693|585226010|FG002|Treatment Period|Withdrawal by Subject|3|||
162046325|NCT00810693|585226008|FG000|Treatment Period|Not treated|0|||
162046326|NCT00810693|585226009|FG001|Treatment Period|Not treated|1|||
162046327|NCT00810693|585226010|FG002|Treatment Period|Not treated|1|||
162046328|NCT00810693|585226008|FG000|Follow-up Period (FUP)|Adverse Event|3|||
162046329|NCT00810693|585226009|FG001|Follow-up Period (FUP)|Adverse Event|1|||
162046330|NCT00810693|585226010|FG002|Follow-up Period (FUP)|Adverse Event|1|||
162046331|NCT00810693|585226008|FG000|Follow-up Period (FUP)|Death|2|||
162046332|NCT00810693|585226009|FG001|Follow-up Period (FUP)|Death|0|||
162046333|NCT00810693|585226010|FG002|Follow-up Period (FUP)|Death|1|||
162046334|NCT00810693|585226008|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
162046335|NCT00810693|585226009|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
162046336|NCT00810693|585226010|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
162046337|NCT00810693|585226008|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
162046338|NCT00810693|585226009|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
162046339|NCT00810693|585226010|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
162046340|NCT00810693|585226008|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
162046341|NCT00810693|585226009|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
162046342|NCT00810693|585226010|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
162046343|NCT04295772|585226011|FG000|Overall Study|Protocol Violation|1|||
162046344|NCT04295772|585226012|FG001|Overall Study|Protocol Violation|0|||
162046345|NCT04295772|585226011|FG000|Overall Study|Ongoing for safety monitoring|14|||
162046346|NCT04295772|585226012|FG001|Overall Study|Ongoing for safety monitoring|1|||
162046347|NCT04295772|585226011|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
162046348|NCT04295772|585226012|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
162046349|NCT00331422|585226013|FG000|Overall Study|Did not receive entire study regimen|5|||
162046350|NCT02345226|585226014|FG000|Double-Blind Phase|Adverse Event|5|||
162046351|NCT02345226|585226015|FG001|Double-Blind Phase|Adverse Event|6|||
162046352|NCT02345226|585226014|FG000|Double-Blind Phase|Death|3|||
162046353|NCT02345226|585226015|FG001|Double-Blind Phase|Death|0|||
162046354|NCT02345226|585226014|FG000|Double-Blind Phase|Pregnancy|0|||
162046355|NCT02345226|585226015|FG001|Double-Blind Phase|Pregnancy|1|||
162046356|NCT02345226|585226014|FG000|Double-Blind Phase|Lack of Efficacy|1|||
162046357|NCT02345226|585226015|FG001|Double-Blind Phase|Lack of Efficacy|0|||
162046358|NCT02345226|585226014|FG000|Double-Blind Phase|Investigator's Discretion|4|||
162046359|NCT02345226|585226015|FG001|Double-Blind Phase|Investigator's Discretion|3|||
162046360|NCT02345226|585226014|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
162046361|NCT02345226|585226015|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
162046362|NCT02345226|585226014|FG000|Double-Blind Phase|Withdrew Consent|41|||
162046363|NCT02345226|585226015|FG001|Double-Blind Phase|Withdrew Consent|39|||
162046364|NCT02345226|585226014|FG000|Double-Blind Phase|Lost to Follow-up|12|||
162046365|NCT02345226|585226015|FG001|Double-Blind Phase|Lost to Follow-up|16|||
162046366|NCT02345226|585226014|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
162046367|NCT02345226|585226015|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
162046368|NCT02345226|585226014|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
162046369|NCT02345226|585226015|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
162046370|NCT00066729|585226024|FG000|Overall Study|Lost to Follow-up|1|||
162046371|NCT00066729|585226024|FG000|Overall Study|Disease progression|1|||
162046372|NCT02349542|585226027|FG000|Overall Study|Withdrawal by Subject|5|||
162046373|NCT03896165|585226028|FG000|Overall Study|Withdrawal by Subject|2|||
162046374|NCT01163266|585226029|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
162046375|NCT01163266|585226030|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
162046376|NCT01163266|585226031|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
162046377|NCT01163266|585226029|FG000|Overall Study|Lack of Efficacy|1|||
162046378|NCT01163266|585226030|FG001|Overall Study|Lack of Efficacy|3|||
162046379|NCT01163266|585226031|FG002|Overall Study|Lack of Efficacy|1|||
162046380|NCT01163266|585226029|FG000|Overall Study|Noncompliance with Study Drug|0|||
162046381|NCT01163266|585226030|FG001|Overall Study|Noncompliance with Study Drug|2|||
162046382|NCT01163266|585226031|FG002|Overall Study|Noncompliance with Study Drug|0|||
162046383|NCT01163266|585226029|FG000|Overall Study|Protocol Deviations|2|||
162046384|NCT01163266|585226030|FG001|Overall Study|Protocol Deviations|2|||
162046385|NCT01163266|585226031|FG002|Overall Study|Protocol Deviations|5|||
162046386|NCT01163266|585226029|FG000|Overall Study|Withdrawal of Consent|5|||
162046387|NCT01163266|585226030|FG001|Overall Study|Withdrawal of Consent|7|||
162046388|NCT01163266|585226031|FG002|Overall Study|Withdrawal of Consent|3|||
162046389|NCT01163266|585226029|FG000|Overall Study|Lost to Follow-up|7|||
162046390|NCT01163266|585226030|FG001|Overall Study|Lost to Follow-up|7|||
162046391|NCT01163266|585226031|FG002|Overall Study|Lost to Follow-up|10|||
162046392|NCT01163266|585226029|FG000|Overall Study|Other|1|||
162046393|NCT01163266|585226030|FG001|Overall Study|Other|1|||
162046394|NCT01163266|585226031|FG002|Overall Study|Other|2|||
162046395|NCT03181893|585226032|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162046396|NCT03181893|585226033|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
162046397|NCT03181893|585226034|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162046398|NCT03181893|585226035|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162046399|NCT03181893|585226036|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162046400|NCT03181893|585226037|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162046401|NCT03181893|585226038|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162046402|NCT03181893|585226039|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162046403|NCT03181893|585226040|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162046404|NCT03181893|585226041|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162046405|NCT03181893|585226042|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
162046406|NCT03181893|585226032|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
162046407|NCT03181893|585226033|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
162046408|NCT03181893|585226034|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162046409|NCT03181893|585226035|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162046410|NCT03181893|585226036|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162046411|NCT03181893|585226037|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162046412|NCT03181893|585226038|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162046413|NCT03181893|585226039|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162046414|NCT03181893|585226040|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162046415|NCT03181893|585226041|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162046416|NCT03181893|585226042|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
162046417|NCT03181893|585226032|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162046418|NCT03181893|585226033|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162046419|NCT03181893|585226034|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162046420|NCT03181893|585226035|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162046421|NCT03181893|585226036|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162046422|NCT03181893|585226037|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162046423|NCT03181893|585226038|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162046424|NCT03181893|585226039|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
162046425|NCT03181893|585226040|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
162046426|NCT03181893|585226041|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162046427|NCT03181893|585226042|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
162046428|NCT03181893|585226032|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162046429|NCT03181893|585226033|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162046430|NCT03181893|585226034|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162046431|NCT03181893|585226035|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162046432|NCT03181893|585226036|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162046433|NCT03181893|585226037|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162046434|NCT03181893|585226038|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162046435|NCT03181893|585226039|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162046436|NCT03181893|585226040|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162046437|NCT03181893|585226041|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
162046438|NCT03181893|585226042|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
162046439|NCT03181893|585226032|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162046440|NCT03181893|585226033|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162046441|NCT03181893|585226034|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162046442|NCT03181893|585226035|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162046443|NCT03181893|585226036|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162046444|NCT03181893|585226037|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162046445|NCT03181893|585226038|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162046446|NCT03181893|585226039|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162046447|NCT03181893|585226040|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162046448|NCT03181893|585226041|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
162046449|NCT03181893|585226042|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
162046450|NCT04128371|585226043|FG000|Overall Study|Lack of Efficacy|1|||
162046451|NCT01361568|585226044|FG000|Overall Study|Adverse Event|0|||
162046452|NCT01361568|585226045|FG001|Overall Study|Adverse Event|0|||
162046453|NCT01361568|585226046|FG002|Overall Study|Adverse Event|0|||
162046454|NCT01361568|585226047|FG003|Overall Study|Adverse Event|0|||
162046455|NCT01361568|585226048|FG004|Overall Study|Adverse Event|1|||
162046456|NCT01361568|585226049|FG005|Overall Study|Adverse Event|0|||
162046457|NCT01361568|585226044|FG000|Overall Study|Physician Decision|0|||
162046458|NCT01361568|585226045|FG001|Overall Study|Physician Decision|0|||
162046459|NCT01361568|585226046|FG002|Overall Study|Physician Decision|0|||
162046460|NCT01361568|585226047|FG003|Overall Study|Physician Decision|0|||
162046461|NCT01361568|585226048|FG004|Overall Study|Physician Decision|0|||
162046462|NCT01361568|585226049|FG005|Overall Study|Physician Decision|1|||
162046463|NCT01361568|585226044|FG000|Overall Study|Withdrawal by Subject|2|||
162046464|NCT01361568|585226045|FG001|Overall Study|Withdrawal by Subject|1|||
162046465|NCT01361568|585226046|FG002|Overall Study|Withdrawal by Subject|0|||
162046466|NCT01361568|585226047|FG003|Overall Study|Withdrawal by Subject|0|||
162046467|NCT01361568|585226048|FG004|Overall Study|Withdrawal by Subject|0|||
162046468|NCT01361568|585226049|FG005|Overall Study|Withdrawal by Subject|1|||
162046469|NCT03308786|585226050|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
162046470|NCT00761631|585226051|FG000|Overall Study|Parent/legal guardian request|8|||
162046471|NCT00761631|585226052|FG001|Overall Study|Parent/legal guardian request|3|||
162046472|NCT00761631|585226053|FG002|Overall Study|Parent/legal guardian request|8|||
162046473|NCT00761631|585226054|FG003|Overall Study|Parent/legal guardian request|0|||
162046474|NCT00761631|585226055|FG004|Overall Study|Parent/legal guardian request|5|||
162046475|NCT00761631|585226056|FG005|Overall Study|Parent/legal guardian request|0|||
162046476|NCT00761631|585226051|FG000|Overall Study|Lost to Follow-up|2|||
162046477|NCT00761631|585226052|FG001|Overall Study|Lost to Follow-up|4|||
162046478|NCT00761631|585226053|FG002|Overall Study|Lost to Follow-up|7|||
162046479|NCT00761631|585226054|FG003|Overall Study|Lost to Follow-up|1|||
162046480|NCT00761631|585226055|FG004|Overall Study|Lost to Follow-up|6|||
162046481|NCT00761631|585226056|FG005|Overall Study|Lost to Follow-up|1|||
162046482|NCT00761631|585226051|FG000|Overall Study|Protocol Violation|2|||
162046483|NCT00761631|585226052|FG001|Overall Study|Protocol Violation|0|||
162046484|NCT00761631|585226053|FG002|Overall Study|Protocol Violation|0|||
162046485|NCT00761631|585226054|FG003|Overall Study|Protocol Violation|1|||
162046486|NCT00761631|585226055|FG004|Overall Study|Protocol Violation|5|||
162046487|NCT00761631|585226056|FG005|Overall Study|Protocol Violation|1|||
162046488|NCT00761631|585226051|FG000|Overall Study|Randomized, not treated|1|||
162046489|NCT00761631|585226052|FG001|Overall Study|Randomized, not treated|0|||
162046490|NCT00761631|585226053|FG002|Overall Study|Randomized, not treated|0|||
162046491|NCT00761631|585226054|FG003|Overall Study|Randomized, not treated|0|||
162046492|NCT00761631|585226055|FG004|Overall Study|Randomized, not treated|0|||
162046493|NCT00761631|585226056|FG005|Overall Study|Randomized, not treated|0|||
162046494|NCT00761631|585226051|FG000|Overall Study|Failed to return|1|||
162046495|NCT00761631|585226052|FG001|Overall Study|Failed to return|0|||
162046496|NCT00761631|585226053|FG002|Overall Study|Failed to return|1|||
162046497|NCT00761631|585226054|FG003|Overall Study|Failed to return|1|||
162046498|NCT00761631|585226055|FG004|Overall Study|Failed to return|5|||
162046499|NCT00761631|585226056|FG005|Overall Study|Failed to return|2|||
162046500|NCT00761631|585226051|FG000|Overall Study|Physician Decision|1|||
162046501|NCT00761631|585226052|FG001|Overall Study|Physician Decision|0|||
162046502|NCT00761631|585226053|FG002|Overall Study|Physician Decision|0|||
162046503|NCT00761631|585226054|FG003|Overall Study|Physician Decision|0|||
162046504|NCT00761631|585226055|FG004|Overall Study|Physician Decision|0|||
162046505|NCT00761631|585226056|FG005|Overall Study|Physician Decision|0|||
162046506|NCT00761631|585226051|FG000|Overall Study|Other|0|||
162046507|NCT00761631|585226052|FG001|Overall Study|Other|0|||
162046508|NCT00761631|585226053|FG002|Overall Study|Other|0|||
162046509|NCT00761631|585226054|FG003|Overall Study|Other|0|||
162046510|NCT00761631|585226055|FG004|Overall Study|Other|1|||
162046511|NCT00761631|585226056|FG005|Overall Study|Other|1|||
162046512|NCT01999868|585226057|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
162046513|NCT01999868|585226058|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
162046514|NCT01999868|585226059|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
162046515|NCT01999868|585226057|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
162046516|NCT01999868|585226058|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
162046517|NCT01999868|585226059|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
162046518|NCT01999868|585226057|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
162046519|NCT01999868|585226058|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
162046520|NCT01999868|585226059|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
162046521|NCT01999868|585226057|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
162046522|NCT01999868|585226058|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
162046523|NCT01999868|585226059|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
162046524|NCT01999868|585226057|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
162046525|NCT01999868|585226058|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
162046526|NCT01999868|585226059|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
162046527|NCT01999868|585226057|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
162046528|NCT01999868|585226058|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
162046529|NCT01999868|585226059|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
162046530|NCT01999868|585226057|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
162046531|NCT01999868|585226058|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
162046532|NCT01999868|585226059|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
162046533|NCT01999868|585226057|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
162046534|NCT01999868|585226058|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
162046535|NCT01999868|585226059|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
162046536|NCT01999868|585226057|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
162046537|NCT01999868|585226058|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
162046538|NCT01999868|585226059|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
162046539|NCT01999868|585226057|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
162046540|NCT01999868|585226058|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
162046541|NCT01999868|585226059|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
162046542|NCT01999868|585226057|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
162046543|NCT01999868|585226058|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
162046544|NCT01999868|585226059|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
162046545|NCT01999868|585226057|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
162046546|NCT01999868|585226058|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
162046547|NCT01999868|585226059|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
162046548|NCT01999868|585226057|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
162046549|NCT01999868|585226058|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
162046550|NCT01999868|585226059|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
162046551|NCT01999868|585226057|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
162046552|NCT01999868|585226058|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
162046553|NCT01999868|585226059|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
162046554|NCT01999868|585226057|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
162046555|NCT01999868|585226058|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
162046556|NCT01999868|585226059|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
162046557|NCT00289016|585226060|FG000|Overall Study|Disease Progression|29|||
162046558|NCT00289016|585226060|FG000|Overall Study|Death|2|||
162046559|NCT00289016|585226060|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
162046560|NCT00289016|585226060|FG000|Overall Study|Withdrawal by Subject|2|||
162046561|NCT00289016|585226060|FG000|Overall Study|Adverse Event|1|||
162046562|NCT00289016|585226060|FG000|Overall Study|Other|1|||
162046563|NCT03553927|585226061|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
162046564|NCT03553927|585226062|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
162046565|NCT03553927|585226061|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
162046566|NCT03553927|585226062|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
162046567|NCT03350620|585226064|FG000|Stage 2|Adverse Event|0|||
162046568|NCT03350620|585226065|FG001|Stage 2|Adverse Event|1|||
162046569|NCT03350620|585226066|FG002|Stage 2|Adverse Event|1|||
162046570|NCT03350620|585226064|FG000|Stage 2|Lack of Efficacy|0|||
162046571|NCT03350620|585226065|FG001|Stage 2|Lack of Efficacy|2|||
162046572|NCT03350620|585226066|FG002|Stage 2|Lack of Efficacy|0|||
162046573|NCT03350620|585226064|FG000|Stage 2|Lost to Follow-up|1|||
162046574|NCT03350620|585226065|FG001|Stage 2|Lost to Follow-up|2|||
162046575|NCT03350620|585226066|FG002|Stage 2|Lost to Follow-up|2|||
162046576|NCT03350620|585226064|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
162046577|NCT03350620|585226065|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
162046578|NCT03350620|585226066|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
162046579|NCT00566111|585226067|FG000|Overall Study|Adverse Event|0|||
162046580|NCT00566111|585226068|FG001|Overall Study|Adverse Event|2|||
162046581|NCT00531934|585227866|FG000|Overall Study|Adverse Event|4|||
162046582|NCT00531934|585227867|FG001|Overall Study|Adverse Event|8|||
162046583|NCT00531934|585227866|FG000|Overall Study|Progression|52|||
162046584|NCT00531934|585227867|FG001|Overall Study|Progression|42|||
162046585|NCT00531934|585227866|FG000|Overall Study|Death|7|||
162046586|NCT00531934|585227867|FG001|Overall Study|Death|10|||
162046587|NCT00531934|585227866|FG000|Overall Study|Withdrawal by Subject|1|||
162046588|NCT00531934|585227867|FG001|Overall Study|Withdrawal by Subject|1|||
162046589|NCT00531934|585227866|FG000|Overall Study|Other|2|||
162046590|NCT00531934|585227867|FG001|Overall Study|Other|2|||
162046591|NCT00150709|585227868|FG000|Overall Study|Protocol Violation|7|||
162046592|NCT00150709|585227869|FG001|Overall Study|Protocol Violation|8|||
162046593|NCT00150709|585227870|FG002|Overall Study|Protocol Violation|3|||
162046594|NCT00150709|585227871|FG003|Overall Study|Protocol Violation|1|||
162046595|NCT00150709|585227868|FG000|Overall Study|Adverse Event|8|||
162046596|NCT00150709|585227869|FG001|Overall Study|Adverse Event|2|||
162046597|NCT00150709|585227870|FG002|Overall Study|Adverse Event|2|||
162046598|NCT00150709|585227871|FG003|Overall Study|Adverse Event|3|||
162046599|NCT00150709|585227868|FG000|Overall Study|Lack of Efficacy|6|||
162046600|NCT00150709|585227869|FG001|Overall Study|Lack of Efficacy|11|||
162046601|NCT00150709|585227870|FG002|Overall Study|Lack of Efficacy|9|||
162046602|NCT00150709|585227871|FG003|Overall Study|Lack of Efficacy|0|||
162046603|NCT00150709|585227868|FG000|Overall Study|Withdrawal by Subject|7|||
162046604|NCT00150709|585227869|FG001|Overall Study|Withdrawal by Subject|10|||
162046605|NCT00150709|585227870|FG002|Overall Study|Withdrawal by Subject|5|||
162046606|NCT00150709|585227871|FG003|Overall Study|Withdrawal by Subject|0|||
162046607|NCT00150709|585227868|FG000|Overall Study|Lost to Follow-up|3|||
162046608|NCT00150709|585227869|FG001|Overall Study|Lost to Follow-up|2|||
162046609|NCT00150709|585227870|FG002|Overall Study|Lost to Follow-up|0|||
162046610|NCT00150709|585227871|FG003|Overall Study|Lost to Follow-up|0|||
162046611|NCT00150709|585227868|FG000|Overall Study|Sponsor decision|0|||
162046612|NCT00150709|585227869|FG001|Overall Study|Sponsor decision|0|||
162046613|NCT00150709|585227870|FG002|Overall Study|Sponsor decision|0|||
162046614|NCT00150709|585227871|FG003|Overall Study|Sponsor decision|1|||
162046615|NCT00150709|585227868|FG000|Overall Study|Site/Investigator discontinued the study|5|||
162046616|NCT00150709|585227869|FG001|Overall Study|Site/Investigator discontinued the study|5|||
162046617|NCT00150709|585227870|FG002|Overall Study|Site/Investigator discontinued the study|2|||
162046618|NCT00150709|585227871|FG003|Overall Study|Site/Investigator discontinued the study|0|||
162046619|NCT00150709|585227868|FG000|Overall Study|Decision of parent(s)|1|||
162046620|NCT00150709|585227869|FG001|Overall Study|Decision of parent(s)|2|||
162046621|NCT00150709|585227870|FG002|Overall Study|Decision of parent(s)|0|||
162046622|NCT00150709|585227871|FG003|Overall Study|Decision of parent(s)|0|||
162046623|NCT00150709|585227868|FG000|Overall Study|Decision of parent(s) and investigator|3|||
162046624|NCT00150709|585227869|FG001|Overall Study|Decision of parent(s) and investigator|0|||
162046625|NCT00150709|585227870|FG002|Overall Study|Decision of parent(s) and investigator|0|||
162046626|NCT00150709|585227871|FG003|Overall Study|Decision of parent(s) and investigator|0|||
162046627|NCT00150709|585227868|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
162046628|NCT00150709|585227869|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
162046629|NCT00150709|585227870|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
162046630|NCT00150709|585227871|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
162046631|NCT00150709|585227868|FG000|Overall Study|Investigator decision|1|||
162046632|NCT00150709|585227869|FG001|Overall Study|Investigator decision|0|||
162046633|NCT00150709|585227870|FG002|Overall Study|Investigator decision|0|||
162046634|NCT00150709|585227871|FG003|Overall Study|Investigator decision|1|||
162046635|NCT00150709|585227868|FG000|Overall Study|Subject relocated|2|||
162046636|NCT00150709|585227869|FG001|Overall Study|Subject relocated|2|||
162046637|NCT00150709|585227870|FG002|Overall Study|Subject relocated|1|||
162046638|NCT00150709|585227871|FG003|Overall Study|Subject relocated|0|||
162046639|NCT00150709|585227868|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
162046640|NCT00150709|585227869|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
162046641|NCT00150709|585227870|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
162046642|NCT00150709|585227871|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
162046643|NCT00150709|585227868|FG000|Overall Study|Convenience|0|||
162046644|NCT00150709|585227869|FG001|Overall Study|Convenience|1|||
162046645|NCT00150709|585227870|FG002|Overall Study|Convenience|0|||
162046646|NCT00150709|585227871|FG003|Overall Study|Convenience|0|||
162046647|NCT00150709|585227868|FG000|Overall Study|Subject entered new drug study|0|||
162046648|NCT00150709|585227869|FG001|Overall Study|Subject entered new drug study|1|||
162046649|NCT00150709|585227870|FG002|Overall Study|Subject entered new drug study|0|||
162046650|NCT00150709|585227871|FG003|Overall Study|Subject entered new drug study|0|||
162046651|NCT00150709|585227868|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
162046652|NCT00150709|585227869|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
162046653|NCT00150709|585227870|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
162046654|NCT00150709|585227871|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
162046655|NCT00150709|585227868|FG000|Overall Study|Lack of ease of swallowing|0|||
162046656|NCT00150709|585227869|FG001|Overall Study|Lack of ease of swallowing|1|||
162046657|NCT00150709|585227870|FG002|Overall Study|Lack of ease of swallowing|0|||
162046658|NCT00150709|585227871|FG003|Overall Study|Lack of ease of swallowing|0|||
162046659|NCT01816074|585227873|FG000|Phase 1|Time commitment issues|0|||
162046660|NCT01816074|585227874|FG001|Phase 1|Time commitment issues|0|||
162046661|NCT01816074|585227875|FG002|Phase 1|Time commitment issues|1|||
162046662|NCT01816074|585227876|FG003|Phase 1|Time commitment issues|0|||
162046663|NCT01816074|585227873|FG000|Phase 2|Time commitment Issues|0|||
162046664|NCT01816074|585227874|FG001|Phase 2|Time commitment Issues|2|||
162046665|NCT01816074|585227875|FG002|Phase 2|Time commitment Issues|0|||
162046666|NCT01816074|585227876|FG003|Phase 2|Time commitment Issues|0|||
162046667|NCT01816074|585227873|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
162046668|NCT01816074|585227874|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
162046669|NCT01816074|585227875|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
162046670|NCT01816074|585227876|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
162046671|NCT01816074|585227873|FG000|Phase 2|Physician Decision|0|||
162046672|NCT01816074|585227874|FG001|Phase 2|Physician Decision|0|||
162046673|NCT01816074|585227875|FG002|Phase 2|Physician Decision|0|||
162046674|NCT01816074|585227876|FG003|Phase 2|Physician Decision|1|||
162046675|NCT01816074|585227873|FG000|Phase 2|Withdrawal by Subject|1|||
162046676|NCT01816074|585227874|FG001|Phase 2|Withdrawal by Subject|0|||
162046677|NCT01816074|585227875|FG002|Phase 2|Withdrawal by Subject|0|||
162046678|NCT01816074|585227876|FG003|Phase 2|Withdrawal by Subject|0|||
162046679|NCT01303861|585227889|FG000|Overall Study|Lost to Follow-up|34|||
162046680|NCT01303861|585227890|FG001|Overall Study|Lost to Follow-up|14|||
162046681|NCT01303861|585227891|FG002|Overall Study|Lost to Follow-up|27|||
162046682|NCT01303861|585227892|FG003|Overall Study|Lost to Follow-up|31|||
162046683|NCT01303861|585227889|FG000|Overall Study|Lack of Efficacy|3|||
162046684|NCT01303861|585227890|FG001|Overall Study|Lack of Efficacy|2|||
162046685|NCT01303861|585227891|FG002|Overall Study|Lack of Efficacy|1|||
162046686|NCT01303861|585227892|FG003|Overall Study|Lack of Efficacy|0|||
162046687|NCT01303861|585227889|FG000|Overall Study|Withdrawal by Subject|16|||
162046688|NCT01303861|585227890|FG001|Overall Study|Withdrawal by Subject|8|||
162046689|NCT01303861|585227891|FG002|Overall Study|Withdrawal by Subject|8|||
162046690|NCT01303861|585227892|FG003|Overall Study|Withdrawal by Subject|23|||
162046691|NCT01303861|585227889|FG000|Overall Study|Adverse Event|4|||
162046692|NCT01303861|585227890|FG001|Overall Study|Adverse Event|1|||
162046693|NCT01303861|585227891|FG002|Overall Study|Adverse Event|0|||
162046694|NCT01303861|585227892|FG003|Overall Study|Adverse Event|5|||
162046695|NCT01303861|585227889|FG000|Overall Study|Pregnancy|1|||
162046696|NCT01303861|585227890|FG001|Overall Study|Pregnancy|0|||
162046697|NCT01303861|585227891|FG002|Overall Study|Pregnancy|0|||
162046698|NCT01303861|585227892|FG003|Overall Study|Pregnancy|0|||
162046699|NCT03650556|585227910|FG000|Overall Study|Death|2|||
162046700|NCT03650556|585227910|FG000|Overall Study|Withdrawal by Subject|20|||
162046701|NCT03650556|585227910|FG000|Overall Study|Physician Decision|2|||
162046702|NCT03650556|585227910|FG000|Overall Study|Lost to Follow-up|8|||
162046703|NCT03650556|585227910|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
162046704|NCT03650556|585227910|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
162046705|NCT03917459|585227912|FG000|Overall Study|Adverse Event|1|||
162046706|NCT03917459|585227913|FG001|Overall Study|Adverse Event|0|||
162046707|NCT03917459|585227912|FG000|Overall Study|Withdrawal by Subject|0|||
162046708|NCT03917459|585227913|FG001|Overall Study|Withdrawal by Subject|1|||
162046709|NCT00736944|585227914|FG000|Induction|Death|1|||
162046710|NCT00736944|585227914|FG000|Definitive Treatment|Physician Decision|1|||
162046711|NCT00894166|585227915|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
162046712|NCT00894166|585227916|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
162046713|NCT00894166|585227917|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
162046714|NCT00894166|585227918|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
162046715|NCT00894166|585227919|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
162046716|NCT00894166|585227920|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
162046717|NCT00894166|585227921|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
162046718|NCT00894166|585227922|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
162046719|NCT00894166|585227915|FG000|Overall Study|Death|0|||
162046720|NCT00894166|585227916|FG001|Overall Study|Death|0|||
162046721|NCT00894166|585227917|FG002|Overall Study|Death|0|||
162046722|NCT00894166|585227918|FG003|Overall Study|Death|1|||
162046723|NCT00894166|585227919|FG004|Overall Study|Death|0|||
162046724|NCT00894166|585227920|FG005|Overall Study|Death|0|||
162046725|NCT00894166|585227921|FG006|Overall Study|Death|0|||
162046726|NCT00894166|585227922|FG007|Overall Study|Death|0|||
162046727|NCT01601132|585227924|FG000|Overall Study|Patient withdrew consent|1|||
162046728|NCT01601132|585227924|FG000|Overall Study|Protocol deviation|1|||
162046729|NCT01500031|585227927|FG000|Overall Study|Death|1|||
162046730|NCT01500031|585227927|FG000|Overall Study|Withdrawal by Subject|4|||
162046731|NCT00091442|585227928|FG000|Overall Study|Progressive Disease|220|||
162046732|NCT00091442|585227929|FG001|Overall Study|Progressive Disease|189|||
162046733|NCT00091442|585227928|FG000|Overall Study|Physician Decision|61|||
162046734|NCT00091442|585227929|FG001|Overall Study|Physician Decision|58|||
162046735|NCT00091442|585227928|FG000|Overall Study|Withdrawal by Subject|38|||
162046736|NCT00091442|585227929|FG001|Overall Study|Withdrawal by Subject|46|||
162046737|NCT00091442|585227928|FG000|Overall Study|Adverse Event|29|||
162046738|NCT00091442|585227929|FG001|Overall Study|Adverse Event|48|||
162046739|NCT00091442|585227928|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
162046740|NCT00091442|585227929|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
162046741|NCT00091442|585227928|FG000|Overall Study|Death|9|||
162046742|NCT00091442|585227929|FG001|Overall Study|Death|7|||
162046743|NCT00091442|585227928|FG000|Overall Study|Lost to Follow-up|1|||
162046744|NCT00091442|585227929|FG001|Overall Study|Lost to Follow-up|3|||
162046745|NCT00091442|585227928|FG000|Overall Study|Other|2|||
162046746|NCT00091442|585227929|FG001|Overall Study|Other|6|||
162046747|NCT00917501|585227930|FG000|Overall Study|Lost to Follow-up|4|||
162046748|NCT00917501|585227931|FG001|Overall Study|Lost to Follow-up|1|||
162046749|NCT00917501|585227930|FG000|Overall Study|Withdrawal by Subject|3|||
162046750|NCT00917501|585227931|FG001|Overall Study|Withdrawal by Subject|1|||
162046751|NCT00917501|585227930|FG000|Overall Study|Lack of Efficacy|1|||
162046752|NCT00917501|585227931|FG001|Overall Study|Lack of Efficacy|2|||
162046753|NCT00917501|585227930|FG000|Overall Study|trouble swollowing capsules|0|||
162046754|NCT00917501|585227931|FG001|Overall Study|trouble swollowing capsules|1|||
162046755|NCT00850070|585227936|FG000|Overall Study|Lack of Efficacy|1|||
162046756|NCT00850070|585227937|FG001|Overall Study|Lack of Efficacy|1|||
162046757|NCT00850070|585227936|FG000|Overall Study|Adverse Event|2|||
162046758|NCT00850070|585227937|FG001|Overall Study|Adverse Event|0|||
162046759|NCT00216476|585227942|FG000|Overall Study|Withdrawal by Subject|59|||
162046760|NCT00216476|585227943|FG001|Overall Study|Withdrawal by Subject|72|||
162046761|NCT00216476|585227944|FG002|Overall Study|Withdrawal by Subject|9|||
162046762|NCT00216476|585227942|FG000|Overall Study|Lost to Follow-up|10|||
162046763|NCT00216476|585227943|FG001|Overall Study|Lost to Follow-up|9|||
162046764|NCT00216476|585227944|FG002|Overall Study|Lost to Follow-up|1|||
162046765|NCT00216476|585227942|FG000|Overall Study|Adverse Event|6|||
162046766|NCT00216476|585227943|FG001|Overall Study|Adverse Event|10|||
162046767|NCT00216476|585227944|FG002|Overall Study|Adverse Event|1|||
162046768|NCT00216476|585227942|FG000|Overall Study|Lack of Efficacy|4|||
162046769|NCT00216476|585227943|FG001|Overall Study|Lack of Efficacy|3|||
162046770|NCT00216476|585227944|FG002|Overall Study|Lack of Efficacy|0|||
162046771|NCT00216476|585227942|FG000|Overall Study|Death|2|||
162046772|NCT00216476|585227943|FG001|Overall Study|Death|0|||
162046773|NCT00216476|585227944|FG002|Overall Study|Death|0|||
162046774|NCT00216476|585227942|FG000|Overall Study|Pregnancy|0|||
162046775|NCT00216476|585227943|FG001|Overall Study|Pregnancy|1|||
162046776|NCT00216476|585227944|FG002|Overall Study|Pregnancy|1|||
162046777|NCT00216476|585227942|FG000|Overall Study|Other|0|||
162046778|NCT00216476|585227943|FG001|Overall Study|Other|0|||
162046779|NCT00216476|585227944|FG002|Overall Study|Other|1|||
162046780|NCT00216476|585227942|FG000|Overall Study|Refuses Injection|11|||
162046781|NCT00216476|585227943|FG001|Overall Study|Refuses Injection|0|||
162046782|NCT00216476|585227944|FG002|Overall Study|Refuses Injection|0|||
162046783|NCT00216476|585227942|FG000|Overall Study|No Further Need for Treatment|3|||
162046784|NCT00216476|585227943|FG001|Overall Study|No Further Need for Treatment|4|||
162046785|NCT00216476|585227944|FG002|Overall Study|No Further Need for Treatment|1|||
162046786|NCT00216476|585227942|FG000|Overall Study|Non-compliance|0|||
162046787|NCT00216476|585227943|FG001|Overall Study|Non-compliance|4|||
162046788|NCT00216476|585227944|FG002|Overall Study|Non-compliance|1|||
162046789|NCT00216476|585227942|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
162046790|NCT00216476|585227943|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
162046791|NCT00216476|585227944|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
162046792|NCT00216476|585227942|FG000|Overall Study|Administrative Reasons|1|||
162046793|NCT00216476|585227943|FG001|Overall Study|Administrative Reasons|1|||
162046794|NCT00216476|585227944|FG002|Overall Study|Administrative Reasons|0|||
162046795|NCT00216476|585227942|FG000|Overall Study|Protocol Deviation|5|||
162046796|NCT00216476|585227943|FG001|Overall Study|Protocol Deviation|1|||
162046797|NCT00216476|585227944|FG002|Overall Study|Protocol Deviation|0|||
162046798|NCT00216476|585227942|FG000|Overall Study|Patient Moved|2|||
162046799|NCT00216476|585227943|FG001|Overall Study|Patient Moved|2|||
162046800|NCT00216476|585227944|FG002|Overall Study|Patient Moved|0|||
162046801|NCT01522248|585227947|FG000|Overall Study|Lost to Follow-up|1|||
162046802|NCT01522248|585227948|FG001|Overall Study|Lost to Follow-up|0|||
162046803|NCT02191137|585227949|FG000|Treatment|Death|4|||
162046804|NCT02191137|585227949|FG000|Treatment|Withdrawal by Subject|3|||
162046805|NCT02191137|585227949|FG000|Treatment|Adverse Event|2|||
162046806|NCT02191137|585227949|FG000|Treatment|Other|1|||
162046807|NCT02191137|585227949|FG000|Follow-up|Lost to Follow-up|2|||
162046808|NCT02191137|585227949|FG000|Follow-up|Ongoing/unknown|2|||
162046809|NCT02191137|585227949|FG000|Follow-up|Adverse Event|1|||
162046810|NCT03096483|585227951|FG000|Overall Study|Withdrawal by site|1|||
162046811|NCT00369707|585227952|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
162046812|NCT00369707|585227952|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
162046813|NCT00369707|585227952|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
162046814|NCT00369707|585227952|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
162046815|NCT00369707|585227952|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
162046816|NCT00369707|585227952|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
162046817|NCT00369707|585227952|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
162046818|NCT00369707|585227952|FG000|Follow up for 2 Years After Treatment|Death|1|||
162046819|NCT00369707|585227952|FG000|Follow up for 2 Years After Treatment|Other|2|||
162046820|NCT05224141|585227953|FG000|Overall Study|Ongoing|75|||
162046821|NCT05224141|585227954|FG001|Overall Study|Ongoing|88|||
162046822|NCT05224141|585227953|FG000|Overall Study|Withdrawal by Subject|2|||
162046823|NCT05224141|585227954|FG001|Overall Study|Withdrawal by Subject|4|||
162046824|NCT05224141|585227953|FG000|Overall Study|Death|153|||
162046825|NCT05224141|585227954|FG001|Overall Study|Death|138|||
162046826|NCT02046733|585227955|FG000|Overall Study|never initiated 'treatment visits'|6|||
162046827|NCT02046733|585227956|FG001|Overall Study|never initiated 'treatment visits'|0|||
162046828|NCT01691898|585227960|FG000|Overall Study|Death|34|||
162046829|NCT01691898|585227961|FG001|Overall Study|Death|32|||
162046830|NCT01691898|585227962|FG002|Overall Study|Death|6|||
162046831|NCT01691898|585227963|FG003|Overall Study|Death|3|||
162046832|NCT01691898|585227964|FG004|Overall Study|Death|8|||
162046833|NCT01691898|585227965|FG005|Overall Study|Death|31|||
162046834|NCT01691898|585227960|FG000|Overall Study|Adverse Event|0|||
162046835|NCT01691898|585227961|FG001|Overall Study|Adverse Event|1|||
162046836|NCT01691898|585227962|FG002|Overall Study|Adverse Event|0|||
162046837|NCT01691898|585227963|FG003|Overall Study|Adverse Event|1|||
162046838|NCT01691898|585227964|FG004|Overall Study|Adverse Event|1|||
162046839|NCT01691898|585227965|FG005|Overall Study|Adverse Event|0|||
162046840|NCT01691898|585227960|FG000|Overall Study|Progression of Disease|1|||
162046841|NCT01691898|585227961|FG001|Overall Study|Progression of Disease|2|||
162046842|NCT01691898|585227962|FG002|Overall Study|Progression of Disease|1|||
162046843|NCT01691898|585227963|FG003|Overall Study|Progression of Disease|0|||
162046844|NCT01691898|585227964|FG004|Overall Study|Progression of Disease|0|||
162046845|NCT01691898|585227965|FG005|Overall Study|Progression of Disease|1|||
162046846|NCT01691898|585227960|FG000|Overall Study|Lost to Follow-up|3|||
162046847|NCT01691898|585227961|FG001|Overall Study|Lost to Follow-up|1|||
162046848|NCT01691898|585227962|FG002|Overall Study|Lost to Follow-up|0|||
162046849|NCT01691898|585227963|FG003|Overall Study|Lost to Follow-up|0|||
162046850|NCT01691898|585227964|FG004|Overall Study|Lost to Follow-up|1|||
162046851|NCT01691898|585227965|FG005|Overall Study|Lost to Follow-up|0|||
162046852|NCT01691898|585227960|FG000|Overall Study|Withdrawal by Subject|9|||
162046853|NCT01691898|585227961|FG001|Overall Study|Withdrawal by Subject|8|||
162046854|NCT01691898|585227962|FG002|Overall Study|Withdrawal by Subject|2|||
162046855|NCT01691898|585227963|FG003|Overall Study|Withdrawal by Subject|1|||
162046856|NCT01691898|585227964|FG004|Overall Study|Withdrawal by Subject|3|||
162046857|NCT01691898|585227965|FG005|Overall Study|Withdrawal by Subject|3|||
162046858|NCT01691898|585227960|FG000|Overall Study|Non-Compliance|0|||
162046859|NCT01691898|585227961|FG001|Overall Study|Non-Compliance|0|||
162046860|NCT01691898|585227962|FG002|Overall Study|Non-Compliance|0|||
162046861|NCT01691898|585227963|FG003|Overall Study|Non-Compliance|0|||
162046862|NCT01691898|585227964|FG004|Overall Study|Non-Compliance|1|||
162046863|NCT01691898|585227965|FG005|Overall Study|Non-Compliance|0|||
162046864|NCT01013350|585227966|FG000|Overall Study|Lost to Follow-up|15|||
162046865|NCT01013350|585227967|FG001|Overall Study|Lost to Follow-up|95|||
162046866|NCT01013350|585227966|FG000|Overall Study|Adverse Event|0|||
162046867|NCT01013350|585227967|FG001|Overall Study|Adverse Event|1|||
162046868|NCT01013350|585227966|FG000|Overall Study|Physician Decision|4|||
162046869|NCT01013350|585227967|FG001|Overall Study|Physician Decision|20|||
162046870|NCT01013350|585227966|FG000|Overall Study|Withdrawal by Subject|15|||
162046871|NCT01013350|585227967|FG001|Overall Study|Withdrawal by Subject|38|||
162046872|NCT01013350|585227966|FG000|Overall Study|Death|3|||
162046873|NCT01013350|585227967|FG001|Overall Study|Death|5|||
162046874|NCT01013350|585227966|FG000|Overall Study|Participant entered interventional study|0|||
162046875|NCT01013350|585227967|FG001|Overall Study|Participant entered interventional study|8|||
162046876|NCT01013350|585227966|FG000|Overall Study|Other|1|||
162046877|NCT01013350|585227967|FG001|Overall Study|Other|25|||
162046878|NCT02019277|585227968|FG000|Overall Study|Withdrawal by Subject|3|||
162046879|NCT02019277|585227968|FG000|Overall Study|Death|7|||
162046880|NCT02019277|585227968|FG000|Overall Study|Did no Cooperate|1|||
162046881|NCT02019277|585227968|FG000|Overall Study|Adverse Event|1|||
162046882|NCT03725852|585227969|FG000|Overall Study|Death|1|||
162046883|NCT03725852|585227970|FG001|Overall Study|Death|0|||
162046884|NCT03725852|585227969|FG000|Overall Study|Withdrawal by Subject|1|||
162046885|NCT03725852|585227970|FG001|Overall Study|Withdrawal by Subject|0|||
162046886|NCT03725852|585227969|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
162046887|NCT03725852|585227970|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
162046888|NCT04738734|585227972|FG000|Overall Study|Withdrawal by Subject|2|||
162046889|NCT04738734|585227973|FG001|Overall Study|Withdrawal by Subject|4|||
162046890|NCT04738734|585227972|FG000|Overall Study|Lost to Follow-up|5|||
162046891|NCT04738734|585227973|FG001|Overall Study|Lost to Follow-up|2|||
162046892|NCT04738734|585227972|FG000|Overall Study|Physician Decision|0|||
162046893|NCT04738734|585227973|FG001|Overall Study|Physician Decision|1|||
162046894|NCT04738734|585227972|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
162046895|NCT04738734|585227973|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
162046896|NCT04093414|585227976|FG000|3 Month Follow up|Physician Decision|0|||
162046897|NCT04093414|585227977|FG001|3 Month Follow up|Physician Decision|1|||
162046898|NCT04093414|585227976|FG000|6month Follow up|Physician Decision|1|||
162046899|NCT04093414|585227977|FG001|6month Follow up|Physician Decision|3|||
162046900|NCT03452228|585227978|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
162046901|NCT03452228|585227979|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
162046902|NCT03452228|585227980|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
162046903|NCT03452228|585227978|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
162046904|NCT03452228|585227979|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
162046905|NCT03452228|585227980|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
162046906|NCT03452228|585227978|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
162046907|NCT03452228|585227979|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
162046908|NCT03452228|585227980|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
162046909|NCT03452228|585227978|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162046910|NCT03452228|585227979|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
162046911|NCT03452228|585227980|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
162046912|NCT01297920|585227983|FG000|Overall Study|Adverse Event|42|||
162046913|NCT01297920|585227984|FG001|Overall Study|Adverse Event|10|||
162046914|NCT01297920|585227985|FG002|Overall Study|Adverse Event|38|||
162046915|NCT01297920|585227983|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
162046916|NCT01297920|585227984|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
162046917|NCT01297920|585227985|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
162046918|NCT01297920|585227983|FG000|Overall Study|Noncompliance|1|||
162046919|NCT01297920|585227984|FG001|Overall Study|Noncompliance|0|||
162046920|NCT01297920|585227985|FG002|Overall Study|Noncompliance|0|||
162046921|NCT01297920|585227983|FG000|Overall Study|Protocol Violation|1|||
162046922|NCT01297920|585227984|FG001|Overall Study|Protocol Violation|3|||
162046923|NCT01297920|585227985|FG002|Overall Study|Protocol Violation|0|||
162046924|NCT01297920|585227983|FG000|Overall Study|Inadequate Control of IOP|7|||
162046925|NCT01297920|585227984|FG001|Overall Study|Inadequate Control of IOP|9|||
162046926|NCT01297920|585227985|FG002|Overall Study|Inadequate Control of IOP|17|||
162046927|NCT01297920|585227983|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
162046928|NCT01297920|585227984|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
162046929|NCT01297920|585227985|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
162046930|NCT01710046|585227986|FG000|Overall Study|Lost to Follow-up|1|||
162046931|NCT01710046|585227987|FG001|Overall Study|Lost to Follow-up|0|||
162046932|NCT02215096|585227988|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
162046933|NCT02215096|585227989|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
162046934|NCT02215096|585227990|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
162046935|NCT02215096|585227991|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
162046936|NCT02215096|585227992|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
162046937|NCT02215096|585227988|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
162046938|NCT02215096|585227989|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
162046939|NCT02215096|585227990|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
162046940|NCT02215096|585227991|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
162046941|NCT02215096|585227992|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
162046942|NCT02215096|585227988|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
162046943|NCT02215096|585227989|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
162046944|NCT02215096|585227990|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
162046945|NCT02215096|585227991|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
162046946|NCT02215096|585227992|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
162046947|NCT02215096|585227988|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
162046948|NCT02215096|585227989|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
162046949|NCT02215096|585227990|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
162046950|NCT02215096|585227991|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
162046951|NCT02215096|585227992|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
162046952|NCT03439657|585227993|FG000|Overall Study|Adverse Event|2|||
162046953|NCT03439657|585227994|FG001|Overall Study|Adverse Event|3|||
162046954|NCT03439657|585227993|FG000|Overall Study|Lost to Follow-up|1|||
162046955|NCT03439657|585227994|FG001|Overall Study|Lost to Follow-up|0|||
162046956|NCT03439657|585227993|FG000|Overall Study|Protocol Violation|1|||
162046957|NCT03439657|585227994|FG001|Overall Study|Protocol Violation|1|||
162046958|NCT03439657|585227993|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
162046959|NCT03439657|585227994|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
162046960|NCT00370071|585227995|FG000|Overall Study|Withdrawal by Subject|2|||
162046961|NCT02004522|585227996|FG000|Overall Study|Adverse Event|55|||
162046962|NCT02004522|585227997|FG001|Overall Study|Adverse Event|6|||
162046963|NCT02004522|585227996|FG000|Overall Study|Withdrawal by Subject|13|||
162046964|NCT02004522|585227997|FG001|Overall Study|Withdrawal by Subject|7|||
162046965|NCT02004522|585227996|FG000|Overall Study|Death|12|||
162046966|NCT02004522|585227997|FG001|Overall Study|Death|3|||
162046967|NCT02004522|585227996|FG000|Overall Study|Physician Decision|3|||
162046968|NCT02004522|585227997|FG001|Overall Study|Physician Decision|4|||
162046969|NCT02004522|585227996|FG000|Overall Study|Protocol Violation|1|||
162046970|NCT02004522|585227997|FG001|Overall Study|Protocol Violation|0|||
162046971|NCT02004522|585227996|FG000|Overall Study|Other is reason listed by PI|4|||
162046972|NCT02004522|585227997|FG001|Overall Study|Other is reason listed by PI|1|||
162046973|NCT02004522|585227996|FG000|Overall Study|Never Dosed|2|||
162046974|NCT02004522|585227997|FG001|Overall Study|Never Dosed|4|||
162046975|NCT02004522|585227996|FG000|Overall Study|Disease Progression|35|||
162046976|NCT02004522|585227997|FG001|Overall Study|Disease Progression|31|||
162046977|NCT02004522|585227996|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
162046978|NCT02004522|585227997|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
162046979|NCT01787331|585227998|FG000|Overall Study|Physician Decision|1|||
162046980|NCT01787331|585227998|FG000|Overall Study|Withdrawal by Subject|1|||
162046981|NCT00319501|585228004|FG000|Double-blind Period|Withdrawal by Subject|0|||
162046982|NCT00319501|585228005|FG001|Double-blind Period|Withdrawal by Subject|3|||
162046983|NCT00319501|585228004|FG000|Double-blind Period|Sponsor Request|1|||
162046984|NCT00319501|585228005|FG001|Double-blind Period|Sponsor Request|0|||
162046985|NCT00319501|585228004|FG000|Double-blind Period|Did not receive treatment|42|||
162046986|NCT00319501|585228005|FG001|Double-blind Period|Did not receive treatment|29|||
162046987|NCT00319501|585228004|FG000|Open-label Period|Adverse Event|5|||
162046988|NCT00319501|585228005|FG001|Open-label Period|Adverse Event|0|||
162046989|NCT00319501|585228004|FG000|Open-label Period|Protocol Violation|6|||
162046990|NCT00319501|585228005|FG001|Open-label Period|Protocol Violation|0|||
162046991|NCT00319501|585228004|FG000|Open-label Period|Withdrawal by Subject|38|||
162046992|NCT00319501|585228005|FG001|Open-label Period|Withdrawal by Subject|0|||
162046993|NCT00319501|585228004|FG000|Open-label Period|Principal Investigator decision|6|||
162046994|NCT00319501|585228005|FG001|Open-label Period|Principal Investigator decision|0|||
162046995|NCT00319501|585228004|FG000|Open-label Period|Sponsor request|12|||
162046996|NCT00319501|585228005|FG001|Open-label Period|Sponsor request|0|||
162046997|NCT00319501|585228004|FG000|Open-label Period|Lost to Follow-up|5|||
162046998|NCT00319501|585228005|FG001|Open-label Period|Lost to Follow-up|0|||
162046999|NCT00319501|585228004|FG000|Open-label Period|Did not receive treatment|33|||
162047000|NCT00319501|585228005|FG001|Open-label Period|Did not receive treatment|0|||
162047001|NCT00319501|585228004|FG000|Open-label Period|Other|11|||
162047002|NCT00319501|585228005|FG001|Open-label Period|Other|0|||
162047003|NCT00319501|585228004|FG000|Open-label Extension Period|Adverse Event|2|||
162047004|NCT00319501|585228005|FG001|Open-label Extension Period|Adverse Event|0|||
162047005|NCT00319501|585228004|FG000|Open-label Extension Period|Did not receive treatment|18|||
162047006|NCT00319501|585228005|FG001|Open-label Extension Period|Did not receive treatment|0|||
162047007|NCT00319501|585228004|FG000|Open-label Extension Period|Other|1|||
162047008|NCT00319501|585228005|FG001|Open-label Extension Period|Other|0|||
162047009|NCT00319501|585228004|FG000|Open-label Extension Period|Principal investigator decision|2|||
162047010|NCT00319501|585228005|FG001|Open-label Extension Period|Principal investigator decision|0|||
162047011|NCT00319501|585228004|FG000|Open-label Extension Period|Sponsor request|26|||
162047012|NCT00319501|585228005|FG001|Open-label Extension Period|Sponsor request|0|||
162047013|NCT00319501|585228004|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
162047014|NCT00319501|585228005|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
162047015|NCT00667875|585228007|FG000|Overall Study|Adverse Event|0|||
162047016|NCT00667875|585228008|FG001|Overall Study|Adverse Event|2|||
162047017|NCT00667875|585228009|FG002|Overall Study|Adverse Event|6|||
162047018|NCT00667875|585228007|FG000|Overall Study|Withdrawal by Subject|10|||
162047019|NCT00667875|585228008|FG001|Overall Study|Withdrawal by Subject|9|||
162047020|NCT00667875|585228009|FG002|Overall Study|Withdrawal by Subject|7|||
162047021|NCT00450255|585228010|FG000|Overall Study|Prior RFA ablation of liver|1|||
162047022|NCT04092582|585229549|FG000|Overall Study|Death|1|||
162047023|NCT04092582|585229550|FG001|Overall Study|Death|1|||
162047024|NCT04092582|585229549|FG000|Overall Study|Withdrawal by Subject|4|||
162047025|NCT04092582|585229550|FG001|Overall Study|Withdrawal by Subject|1|||
162047026|NCT04092582|585229549|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
162047027|NCT04092582|585229550|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
162047028|NCT03019185|585229555|FG000|Overall Study|Lost to Follow-up|3|||
162047029|NCT03019185|585229556|FG001|Overall Study|Lost to Follow-up|0|||
162047030|NCT03019185|585229557|FG002|Overall Study|Lost to Follow-up|2|||
162047031|NCT03019185|585229555|FG000|Overall Study|Withdrawal by Subject|1|||
162047032|NCT03019185|585229556|FG001|Overall Study|Withdrawal by Subject|1|||
162047033|NCT03019185|585229557|FG002|Overall Study|Withdrawal by Subject|0|||
162047034|NCT03019185|585229555|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
162047035|NCT03019185|585229556|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
162047036|NCT03019185|585229557|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
162047037|NCT03019185|585229555|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
162047038|NCT03019185|585229556|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
162047039|NCT03019185|585229557|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
162047040|NCT02764333|585229558|FG000|Overall Study|Ineligible|1|||
162047041|NCT01200524|585229560|FG000|Overall Study|Withdrawal by Subject|1|||
162047042|NCT01200524|585229561|FG001|Overall Study|Withdrawal by Subject|1|||
162047043|NCT01200524|585229562|FG002|Overall Study|Withdrawal by Subject|3|||
162047044|NCT01200524|585229560|FG000|Overall Study|Adverse Event|1|||
162047045|NCT01200524|585229561|FG001|Overall Study|Adverse Event|0|||
162047046|NCT01200524|585229562|FG002|Overall Study|Adverse Event|0|||
162047047|NCT01200524|585229560|FG000|Overall Study|Non availability of study nurse|0|||
162047048|NCT01200524|585229561|FG001|Overall Study|Non availability of study nurse|0|||
162047049|NCT01200524|585229562|FG002|Overall Study|Non availability of study nurse|1|||
162047050|NCT01868503|585229563|FG000|Overall Study|Withdrawal by Subject|1|||
162047051|NCT01868503|585229563|FG000|Overall Study|Protocol Violation|1|||
162047052|NCT00491764|585229565|FG000|Overall Study|Adverse Event|1|||
162047053|NCT00491764|585229566|FG001|Overall Study|Adverse Event|2|||
162047054|NCT00491764|585229567|FG002|Overall Study|Adverse Event|4|||
162047055|NCT00491764|585229568|FG003|Overall Study|Adverse Event|4|||
162047056|NCT00491764|585229569|FG004|Overall Study|Adverse Event|0|||
162047057|NCT00491764|585229570|FG005|Overall Study|Adverse Event|1|||
162047058|NCT00491764|585229565|FG000|Overall Study|Lost to Follow-up|0|||
162047059|NCT00491764|585229566|FG001|Overall Study|Lost to Follow-up|1|||
162047060|NCT00491764|585229567|FG002|Overall Study|Lost to Follow-up|0|||
162047061|NCT00491764|585229568|FG003|Overall Study|Lost to Follow-up|1|||
162047062|NCT00491764|585229569|FG004|Overall Study|Lost to Follow-up|0|||
162047063|NCT00491764|585229570|FG005|Overall Study|Lost to Follow-up|3|||
162047064|NCT00491764|585229565|FG000|Overall Study|Withdrawal by Subject|2|||
162047065|NCT00491764|585229566|FG001|Overall Study|Withdrawal by Subject|3|||
162047066|NCT00491764|585229567|FG002|Overall Study|Withdrawal by Subject|1|||
162047067|NCT00491764|585229568|FG003|Overall Study|Withdrawal by Subject|2|||
162047068|NCT00491764|585229569|FG004|Overall Study|Withdrawal by Subject|2|||
162047069|NCT00491764|585229570|FG005|Overall Study|Withdrawal by Subject|4|||
162047070|NCT00491764|585229565|FG000|Overall Study|Non Compliance with the Protocol|1|||
162047071|NCT00491764|585229566|FG001|Overall Study|Non Compliance with the Protocol|0|||
162047072|NCT00491764|585229567|FG002|Overall Study|Non Compliance with the Protocol|0|||
162047073|NCT00491764|585229568|FG003|Overall Study|Non Compliance with the Protocol|0|||
162047074|NCT00491764|585229569|FG004|Overall Study|Non Compliance with the Protocol|0|||
162047075|NCT00491764|585229570|FG005|Overall Study|Non Compliance with the Protocol|0|||
162047076|NCT00491764|585229565|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
162047077|NCT00491764|585229566|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
162047078|NCT00491764|585229567|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
162047079|NCT00491764|585229568|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
162047080|NCT00491764|585229569|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
162047081|NCT00491764|585229570|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
162047082|NCT00491764|585229565|FG000|Overall Study|Administrative|1|||
162047083|NCT00491764|585229566|FG001|Overall Study|Administrative|0|||
162047084|NCT00491764|585229567|FG002|Overall Study|Administrative|2|||
162047085|NCT00491764|585229568|FG003|Overall Study|Administrative|1|||
162047086|NCT00491764|585229569|FG004|Overall Study|Administrative|0|||
162047087|NCT00491764|585229570|FG005|Overall Study|Administrative|0|||
162047088|NCT02110238|585229571|FG000|12 Week Pivotal Phase|Adverse Event|3|||
162047089|NCT02110238|585229572|FG001|12 Week Pivotal Phase|Adverse Event|0|||
162047090|NCT02110238|585229571|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
162047091|NCT02110238|585229572|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
162047092|NCT02110238|585229571|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
162047093|NCT02110238|585229572|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
162047094|NCT02110238|585229571|FG000|12 Week Pivotal Phase|Physician Decision|0|||
162047095|NCT02110238|585229572|FG001|12 Week Pivotal Phase|Physician Decision|2|||
162047096|NCT02110238|585229571|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
162047097|NCT02110238|585229572|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
162047098|NCT02110238|585229571|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
162047099|NCT02110238|585229572|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
162047100|NCT02110238|585229571|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
162047101|NCT02110238|585229572|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
162047102|NCT02110238|585229571|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
162047103|NCT02110238|585229572|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
162047104|NCT02110238|585229571|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
162047105|NCT02110238|585229572|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
162047106|NCT02110238|585229571|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
162047107|NCT02110238|585229572|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
162047108|NCT02110238|585229571|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
162047109|NCT02110238|585229572|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
162047110|NCT03228433|585229577|FG000|Overall Study|Lost to Follow-up|1|||
162047111|NCT03228433|585229578|FG001|Overall Study|Lost to Follow-up|0|||
162047112|NCT03228433|585229579|FG002|Overall Study|Lost to Follow-up|0|||
162047113|NCT03228433|585229580|FG003|Overall Study|Lost to Follow-up|0|||
162047114|NCT03228433|585229581|FG004|Overall Study|Lost to Follow-up|0|||
162047115|NCT03228433|585229582|FG005|Overall Study|Lost to Follow-up|0|||
162047116|NCT03228433|585229577|FG000|Overall Study|Positive alcohol test|0|||
162047117|NCT03228433|585229578|FG001|Overall Study|Positive alcohol test|0|||
162047118|NCT03228433|585229579|FG002|Overall Study|Positive alcohol test|0|||
162047119|NCT03228433|585229580|FG003|Overall Study|Positive alcohol test|1|||
162047120|NCT03228433|585229581|FG004|Overall Study|Positive alcohol test|0|||
162047121|NCT03228433|585229582|FG005|Overall Study|Positive alcohol test|0|||
162047122|NCT03626168|585229585|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
162047123|NCT03626168|585229586|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
162047124|NCT03626168|585229585|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
162047125|NCT03626168|585229586|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
162047126|NCT03626168|585229585|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
162047127|NCT03626168|585229586|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
162047128|NCT01419626|585229587|FG000|Overall Study|Protocol Violation|3|||
162047129|NCT01419626|585229588|FG001|Overall Study|Protocol Violation|2|||
162047130|NCT01419626|585229589|FG002|Overall Study|Protocol Violation|2|||
162047131|NCT01419626|585229587|FG000|Overall Study|Withdrawal by Subject|1|||
162047132|NCT01419626|585229588|FG001|Overall Study|Withdrawal by Subject|0|||
162047133|NCT01419626|585229589|FG002|Overall Study|Withdrawal by Subject|0|||
162047134|NCT01419626|585229587|FG000|Overall Study|Lost to Follow-up|0|||
162047135|NCT01419626|585229588|FG001|Overall Study|Lost to Follow-up|1|||
162047136|NCT01419626|585229589|FG002|Overall Study|Lost to Follow-up|1|||
162047137|NCT03212690|585229599|FG000|Overall Study|Protocol Violation|1|||
162047138|NCT03208127|585229601|FG000|Overall Study|Death|1|||
162047139|NCT01254331|585229606|FG000|Initial Phase|Adverse Event|3|||
162047140|NCT01254331|585229606|FG000|Initial Phase|Withdrawal by Subject|1|||
162047141|NCT01254331|585229606|FG000|Initial Phase|Pregnancy|1|||
162047142|NCT01254331|585229606|FG000|Extension Phase|Lack of Efficacy|1|||
162047143|NCT01254331|585229606|FG000|Extension Phase|Lost to Follow-up|3|||
162047144|NCT01011738|585229607|FG000|Overall Study|Death|12|||
162047145|NCT01011738|585229608|FG001|Overall Study|Death|3|||
162047146|NCT01011738|585229609|FG002|Overall Study|Death|0|||
162047147|NCT01011738|585229607|FG000|Overall Study|Unknown reasons|312|||
162047148|NCT01011738|585229608|FG001|Overall Study|Unknown reasons|291|||
162047149|NCT01011738|585229609|FG002|Overall Study|Unknown reasons|17|||
162047150|NCT00287365|585229610|FG000|Overall Study|sample not acquired|13|||
162047151|NCT00968864|585229611|FG000|Overall Study|Protocol exception/ not evaluable|1|||
162047152|NCT01346969|585229612|FG000|Overall Study|Withdrawal by Subject|0|||
162047153|NCT01346969|585229613|FG001|Overall Study|Withdrawal by Subject|0|||
162047154|NCT01346969|585229614|FG002|Overall Study|Withdrawal by Subject|1|||
162047155|NCT01346969|585229615|FG003|Overall Study|Withdrawal by Subject|0|||
162047156|NCT01346969|585229612|FG000|Overall Study|Lost to Follow-up|1|||
162047157|NCT01346969|585229613|FG001|Overall Study|Lost to Follow-up|0|||
162047158|NCT01346969|585229614|FG002|Overall Study|Lost to Follow-up|2|||
162047159|NCT01346969|585229615|FG003|Overall Study|Lost to Follow-up|0|||
162047160|NCT01346969|585229612|FG000|Overall Study|Physician Decision|0|||
162047161|NCT01346969|585229613|FG001|Overall Study|Physician Decision|0|||
162047162|NCT01346969|585229614|FG002|Overall Study|Physician Decision|0|||
162047163|NCT01346969|585229615|FG003|Overall Study|Physician Decision|1|||
162047164|NCT01346969|585229612|FG000|Overall Study|Randomized but not treated|1|||
162047165|NCT01346969|585229613|FG001|Overall Study|Randomized but not treated|0|||
162047166|NCT01346969|585229614|FG002|Overall Study|Randomized but not treated|0|||
162047167|NCT01346969|585229615|FG003|Overall Study|Randomized but not treated|0|||
162047168|NCT01967173|585229616|FG000|Overall Study|Lost to Follow-up|5|||
162047169|NCT01967173|585229617|FG001|Overall Study|Lost to Follow-up|3|||
162047170|NCT01967173|585229618|FG002|Overall Study|Lost to Follow-up|2|||
162047171|NCT01967173|585229619|FG003|Overall Study|Lost to Follow-up|4|||
162047172|NCT01967173|585229620|FG004|Overall Study|Lost to Follow-up|8|||
162047173|NCT01967173|585229621|FG005|Overall Study|Lost to Follow-up|12|||
162047174|NCT01967173|585229622|FG006|Overall Study|Lost to Follow-up|6|||
162047175|NCT01967173|585229623|FG007|Overall Study|Lost to Follow-up|8|||
162047176|NCT01967173|585229616|FG000|Overall Study|Physician Decision|2|||
162047177|NCT01967173|585229617|FG001|Overall Study|Physician Decision|0|||
162047178|NCT01967173|585229618|FG002|Overall Study|Physician Decision|2|||
162047179|NCT01967173|585229619|FG003|Overall Study|Physician Decision|1|||
162047180|NCT01967173|585229620|FG004|Overall Study|Physician Decision|1|||
162047181|NCT01967173|585229621|FG005|Overall Study|Physician Decision|1|||
162047182|NCT01967173|585229622|FG006|Overall Study|Physician Decision|1|||
162047183|NCT01967173|585229623|FG007|Overall Study|Physician Decision|0|||
162047184|NCT01967173|585229616|FG000|Overall Study|Lack of Efficacy|2|||
162047185|NCT01967173|585229617|FG001|Overall Study|Lack of Efficacy|0|||
162047186|NCT01967173|585229618|FG002|Overall Study|Lack of Efficacy|2|||
162047187|NCT01967173|585229619|FG003|Overall Study|Lack of Efficacy|2|||
162047188|NCT01967173|585229620|FG004|Overall Study|Lack of Efficacy|0|||
162047189|NCT01967173|585229621|FG005|Overall Study|Lack of Efficacy|1|||
162047190|NCT01967173|585229622|FG006|Overall Study|Lack of Efficacy|0|||
162047191|NCT01967173|585229623|FG007|Overall Study|Lack of Efficacy|2|||
162047192|NCT01967173|585229616|FG000|Overall Study|Pregnancy|0|||
162047193|NCT01967173|585229617|FG001|Overall Study|Pregnancy|0|||
162047194|NCT01967173|585229618|FG002|Overall Study|Pregnancy|0|||
162047195|NCT01967173|585229619|FG003|Overall Study|Pregnancy|0|||
162047196|NCT01967173|585229620|FG004|Overall Study|Pregnancy|0|||
162047197|NCT01967173|585229621|FG005|Overall Study|Pregnancy|0|||
162047198|NCT01967173|585229622|FG006|Overall Study|Pregnancy|1|||
162047199|NCT01967173|585229623|FG007|Overall Study|Pregnancy|1|||
162047200|NCT01967173|585229616|FG000|Overall Study|Adverse Event|0|||
162047201|NCT01967173|585229617|FG001|Overall Study|Adverse Event|0|||
162047202|NCT01967173|585229618|FG002|Overall Study|Adverse Event|0|||
162047203|NCT01967173|585229619|FG003|Overall Study|Adverse Event|0|||
162047204|NCT01967173|585229620|FG004|Overall Study|Adverse Event|0|||
162047205|NCT01967173|585229621|FG005|Overall Study|Adverse Event|0|||
162047206|NCT01967173|585229622|FG006|Overall Study|Adverse Event|0|||
162047207|NCT01967173|585229623|FG007|Overall Study|Adverse Event|1|||
162047208|NCT01967173|585229616|FG000|Overall Study|Withdrawal by Subject|15|||
162047209|NCT01967173|585229617|FG001|Overall Study|Withdrawal by Subject|14|||
162047210|NCT01967173|585229618|FG002|Overall Study|Withdrawal by Subject|10|||
162047211|NCT01967173|585229619|FG003|Overall Study|Withdrawal by Subject|7|||
162047212|NCT01967173|585229620|FG004|Overall Study|Withdrawal by Subject|8|||
162047213|NCT01967173|585229621|FG005|Overall Study|Withdrawal by Subject|9|||
162047214|NCT01967173|585229622|FG006|Overall Study|Withdrawal by Subject|10|||
162047215|NCT01967173|585229623|FG007|Overall Study|Withdrawal by Subject|12|||
162047216|NCT03666624|585229625|FG000|Overall Study|participant grieving over recent death of parent|1|||
162047217|NCT03666624|585229626|FG001|Overall Study|participant grieving over recent death of parent|0|||
162047218|NCT05213481|585229628|FG000|Overall Study|Adverse Event|3|||
162047219|NCT05213481|585229628|FG000|Overall Study|Lost to Follow-up|1|||
162047220|NCT00447005|585229630|FG000|Overall Study|Adverse Event|1|||
162047221|NCT00447005|585229630|FG000|Overall Study|Lack of Efficacy|11|||
162047222|NCT00397215|585229631|FG000|Month 0 (Day 0)|Adverse Event|0|||
162047223|NCT00397215|585229632|FG001|Month 0 (Day 0)|Adverse Event|1|||
162047224|NCT00397215|585229633|FG002|Month 0 (Day 0)|Adverse Event|0|||
162047225|NCT00397215|585229634|FG003|Month 0 (Day 0)|Adverse Event|0|||
162047226|NCT00397215|585229631|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
162047227|NCT00397215|585229632|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
162047228|NCT00397215|585229633|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
162047229|NCT00397215|585229634|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
162047230|NCT00397215|585229631|FG000|Month 0 (Day 0)|Other|4|||
162047231|NCT00397215|585229632|FG001|Month 0 (Day 0)|Other|1|||
162047232|NCT00397215|585229633|FG002|Month 0 (Day 0)|Other|3|||
162047233|NCT00397215|585229634|FG003|Month 0 (Day 0)|Other|3|||
162047234|NCT00397215|585229631|FG000|Month 6 (Day 180)|Adverse Event|0|||
162047235|NCT00397215|585229632|FG001|Month 6 (Day 180)|Adverse Event|3|||
162047236|NCT00397215|585229633|FG002|Month 6 (Day 180)|Adverse Event|2|||
162047237|NCT00397215|585229634|FG003|Month 6 (Day 180)|Adverse Event|0|||
162047238|NCT00397215|585229631|FG000|Month 6 (Day 180)|Other|2|||
162047239|NCT00397215|585229632|FG001|Month 6 (Day 180)|Other|0|||
162047240|NCT00397215|585229633|FG002|Month 6 (Day 180)|Other|3|||
162047241|NCT00397215|585229634|FG003|Month 6 (Day 180)|Other|0|||
162047242|NCT00423514|585229635|FG000|Overall Study|Ineligible|1|||
162047243|NCT00423514|585229636|FG001|Overall Study|Ineligible|0|||
162047244|NCT02128932|585229637|FG000|Overall Study|Withdrawal by Subject|11|||
162047245|NCT02128932|585229638|FG001|Overall Study|Withdrawal by Subject|7|||
162047246|NCT02128932|585229639|FG002|Overall Study|Withdrawal by Subject|8|||
162047247|NCT02128932|585229637|FG000|Overall Study|Death|2|||
162047248|NCT02128932|585229638|FG001|Overall Study|Death|0|||
162047249|NCT02128932|585229639|FG002|Overall Study|Death|2|||
162047250|NCT02128932|585229637|FG000|Overall Study|Lost to Follow-up|2|||
162047251|NCT02128932|585229638|FG001|Overall Study|Lost to Follow-up|1|||
162047252|NCT02128932|585229639|FG002|Overall Study|Lost to Follow-up|1|||
162047253|NCT02128932|585229637|FG000|Overall Study|No reason for withdrawal|12|||
162047254|NCT02128932|585229638|FG001|Overall Study|No reason for withdrawal|11|||
162047255|NCT02128932|585229639|FG002|Overall Study|No reason for withdrawal|7|||
162047256|NCT03685123|585229644|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
162047257|NCT03685123|585229645|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
162047258|NCT03685123|585229646|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
162047259|NCT03685123|585229644|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
162047260|NCT03685123|585229645|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
162047261|NCT03685123|585229646|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
162047262|NCT03685123|585229644|FG000|Weight Loss Phase|Lost to Follow-up|1|||
162047263|NCT03685123|585229645|FG001|Weight Loss Phase|Lost to Follow-up|0|||
162047264|NCT03685123|585229646|FG002|Weight Loss Phase|Lost to Follow-up|0|||
162047265|NCT03685123|585229644|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
162047266|NCT03685123|585229645|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
162047267|NCT03685123|585229646|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
162047268|NCT03685123|585229644|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
162047269|NCT03685123|585229645|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
162047270|NCT03685123|585229646|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
162047271|NCT03685123|585229644|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
162047272|NCT03685123|585229645|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
162047273|NCT03685123|585229646|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
162047274|NCT01254630|585229647|FG000|Overall Study|Adverse Event|36|||
162047275|NCT01254630|585229648|FG001|Overall Study|Adverse Event|15|||
162047276|NCT01254630|585229649|FG002|Overall Study|Adverse Event|40|||
162047277|NCT01254630|585229650|FG003|Overall Study|Adverse Event|8|||
162047278|NCT01254630|585229647|FG000|Overall Study|Death|461|||
162047279|NCT01254630|585229648|FG001|Overall Study|Death|151|||
162047280|NCT01254630|585229649|FG002|Overall Study|Death|478|||
162047281|NCT01254630|585229650|FG003|Overall Study|Death|139|||
162047282|NCT01254630|585229647|FG000|Overall Study|Lost to Follow-up|80|||
162047283|NCT01254630|585229648|FG001|Overall Study|Lost to Follow-up|26|||
162047284|NCT01254630|585229649|FG002|Overall Study|Lost to Follow-up|89|||
162047285|NCT01254630|585229650|FG003|Overall Study|Lost to Follow-up|32|||
162047286|NCT01254630|585229647|FG000|Overall Study|Physician Decision|24|||
162047287|NCT01254630|585229648|FG001|Overall Study|Physician Decision|8|||
162047288|NCT01254630|585229649|FG002|Overall Study|Physician Decision|16|||
162047289|NCT01254630|585229650|FG003|Overall Study|Physician Decision|7|||
162047290|NCT01254630|585229647|FG000|Overall Study|Withdrawal by Subject|201|||
162047291|NCT01254630|585229648|FG001|Overall Study|Withdrawal by Subject|94|||
162047292|NCT01254630|585229649|FG002|Overall Study|Withdrawal by Subject|188|||
162047293|NCT01254630|585229650|FG003|Overall Study|Withdrawal by Subject|89|||
162047294|NCT01254630|585229647|FG000|Overall Study|Study terminated by sponsor|0|||
162047295|NCT01254630|585229648|FG001|Overall Study|Study terminated by sponsor|994|||
162047296|NCT01254630|585229649|FG002|Overall Study|Study terminated by sponsor|0|||
162047297|NCT01254630|585229650|FG003|Overall Study|Study terminated by sponsor|1010|||
162047298|NCT01254630|585229647|FG000|Overall Study|Status not recorded|0|||
162047299|NCT01254630|585229648|FG001|Overall Study|Status not recorded|0|||
162047300|NCT01254630|585229649|FG002|Overall Study|Status not recorded|1|||
162047301|NCT01254630|585229650|FG003|Overall Study|Status not recorded|0|||
162047302|NCT02959983|585229651|FG000|Overall Study|Protocol Violation|0|||
162047303|NCT02959983|585229652|FG001|Overall Study|Protocol Violation|1|||
162047304|NCT02959983|585229651|FG000|Overall Study|Lack of Efficacy|0|||
162047305|NCT02959983|585229652|FG001|Overall Study|Lack of Efficacy|1|||
162047306|NCT02959983|585229651|FG000|Overall Study|Lost to Follow-up|12|||
162047307|NCT02959983|585229652|FG001|Overall Study|Lost to Follow-up|9|||
162047308|NCT02959983|585229651|FG000|Overall Study|Other|1|||
162047309|NCT02959983|585229652|FG001|Overall Study|Other|1|||
162047310|NCT02959983|585229651|FG000|Overall Study|Physician Decision|1|||
162047311|NCT02959983|585229652|FG001|Overall Study|Physician Decision|0|||
162047312|NCT02959983|585229651|FG000|Overall Study|Adverse Event|5|||
162047313|NCT02959983|585229652|FG001|Overall Study|Adverse Event|1|||
162047314|NCT02959983|585229651|FG000|Overall Study|Withdrawal by Subject|7|||
162047315|NCT02959983|585229652|FG001|Overall Study|Withdrawal by Subject|12|||
162047316|NCT02925117|585229658|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
162047317|NCT02925117|585229659|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
162047318|NCT02925117|585229660|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
162047319|NCT02925117|585229661|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
162047320|NCT02925117|585229662|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162047321|NCT02925117|585229663|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162047322|NCT02925117|585229664|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162047323|NCT02925117|585229665|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162047324|NCT02925117|585229666|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162047325|NCT02925117|585229667|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162047326|NCT02925117|585229668|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162047327|NCT02925117|585229669|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
162047328|NCT02925117|585229658|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
162047329|NCT02925117|585229659|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
162047330|NCT02925117|585229660|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
162047331|NCT02925117|585229661|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162047332|NCT02925117|585229662|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162047333|NCT02925117|585229663|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162047334|NCT02925117|585229664|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162047335|NCT02925117|585229665|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162047336|NCT02925117|585229666|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162047337|NCT02925117|585229667|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162047338|NCT02925117|585229668|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162047339|NCT02925117|585229669|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
162047340|NCT02925117|585229658|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
162047341|NCT02925117|585229659|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
162047342|NCT02925117|585229660|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162047343|NCT02925117|585229661|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162047344|NCT02925117|585229662|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162047345|NCT02925117|585229663|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162047346|NCT02925117|585229664|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162047347|NCT02925117|585229665|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162047348|NCT02925117|585229666|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162047349|NCT02925117|585229667|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162047350|NCT02925117|585229668|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162047351|NCT02925117|585229669|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
162047352|NCT02925117|585229658|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
162047353|NCT02925117|585229659|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
162047354|NCT02925117|585229660|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
162047355|NCT02925117|585229661|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
162047356|NCT02925117|585229662|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
162047357|NCT02925117|585229663|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
162047358|NCT02925117|585229664|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
162047359|NCT02925117|585229665|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
162047360|NCT02925117|585229666|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
162047361|NCT02925117|585229667|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
162047362|NCT02925117|585229668|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
162047363|NCT02925117|585229669|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
162047364|NCT02925117|585229658|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162047365|NCT02925117|585229659|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162047366|NCT02925117|585229660|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162047367|NCT02925117|585229661|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162047368|NCT02925117|585229662|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162047369|NCT02925117|585229663|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
162047370|NCT02925117|585229664|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162047371|NCT02925117|585229665|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162047372|NCT02925117|585229666|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162047373|NCT02925117|585229667|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
162047374|NCT02925117|585229668|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
162047375|NCT02925117|585229669|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
162047376|NCT02925117|585229658|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
162047377|NCT02925117|585229659|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
162047378|NCT02925117|585229660|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
162047379|NCT02925117|585229661|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
162047380|NCT02925117|585229662|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
162047381|NCT02925117|585229663|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
162047382|NCT02925117|585229664|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
162047383|NCT02925117|585229665|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
162047384|NCT02925117|585229666|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
162047385|NCT02925117|585229667|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
162047386|NCT02925117|585229668|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
162047387|NCT02925117|585229669|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
162047388|NCT02925117|585229658|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
162047389|NCT02925117|585229659|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
162047390|NCT02925117|585229660|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
162047391|NCT02925117|585229661|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
162047392|NCT02925117|585229662|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
162047393|NCT02925117|585229663|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
162047394|NCT02925117|585229664|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
162047395|NCT02925117|585229665|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
162047396|NCT02925117|585229666|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
162047397|NCT02925117|585229667|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
162047398|NCT02925117|585229668|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
162047399|NCT02925117|585229669|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
162047400|NCT02925117|585229658|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
162047401|NCT02925117|585229659|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
162047402|NCT02925117|585229660|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
162047403|NCT02925117|585229661|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
162047404|NCT02925117|585229662|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
162047405|NCT02925117|585229663|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
162047406|NCT02925117|585229664|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
162047407|NCT02925117|585229665|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
162047408|NCT02925117|585229666|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
162047409|NCT02925117|585229667|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
162047410|NCT02925117|585229668|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
162047411|NCT02925117|585229669|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
162047412|NCT04032652|585229670|FG000|Overall Study|The study was terminated and the PI has|1|||
162047413|NCT04032652|585229671|FG001|Overall Study|The study was terminated and the PI has|1|||
162047414|NCT02663908|585229672|FG000|Overall Study|Withdrawal by Subject|8|||
162047415|NCT02663908|585229673|FG001|Overall Study|Withdrawal by Subject|5|||
162047416|NCT02663908|585229672|FG000|Overall Study|Lost to Follow-up|1|||
162047417|NCT02663908|585229673|FG001|Overall Study|Lost to Follow-up|5|||
162047418|NCT02663908|585229672|FG000|Overall Study|Adverse Event|13|||
162047419|NCT02663908|585229673|FG001|Overall Study|Adverse Event|11|||
162047420|NCT02663908|585229672|FG000|Overall Study|Protocol Violation|1|||
162047421|NCT02663908|585229673|FG001|Overall Study|Protocol Violation|2|||
162047422|NCT02663908|585229672|FG000|Overall Study|Lack of therapeutic response|2|||
162047423|NCT02663908|585229673|FG001|Overall Study|Lack of therapeutic response|0|||
162047424|NCT02663908|585229672|FG000|Overall Study|COVID-19|1|||
162047425|NCT02663908|585229673|FG001|Overall Study|COVID-19|0|||
162047426|NCT02663908|585229672|FG000|Overall Study|Site closed|1|||
162047427|NCT02663908|585229673|FG001|Overall Study|Site closed|0|||
162047428|NCT02663908|585229672|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
162047429|NCT02663908|585229673|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
162047430|NCT02663908|585229672|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
162047431|NCT02663908|585229673|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
162047432|NCT02663908|585229672|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
162047433|NCT02663908|585229673|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
162047434|NCT02663908|585229672|FG000|Overall Study|Death|1|||
162047435|NCT02663908|585229673|FG001|Overall Study|Death|0|||
162047436|NCT02663908|585229672|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
162047437|NCT02663908|585229673|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
162047438|NCT02663908|585229672|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
162047439|NCT02663908|585229673|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
162047440|NCT02764697|585229674|FG000|Overall Study|Lack of Efficacy|3|||
162047441|NCT00302107|585229677|FG000|Overall Study|Lost to Follow-up|6|||
162047442|NCT00302107|585229678|FG001|Overall Study|Lost to Follow-up|5|||
162047443|NCT00302107|585229677|FG000|Overall Study|Protocol Violation|1|||
162047444|NCT00302107|585229678|FG001|Overall Study|Protocol Violation|0|||
162047445|NCT00302107|585229677|FG000|Overall Study|Relocation|0|||
162047446|NCT00302107|585229678|FG001|Overall Study|Relocation|1|||
162047447|NCT00302107|585229677|FG000|Overall Study|Withdrawal by Subject|0|||
162047448|NCT00302107|585229678|FG001|Overall Study|Withdrawal by Subject|3|||
162047449|NCT00302107|585229677|FG000|Overall Study|Adverse Event|1|||
162047450|NCT00302107|585229678|FG001|Overall Study|Adverse Event|0|||
162047451|NCT00437983|585229679|FG000|Overall Study|Adverse Event|6|||
162047452|NCT00437983|585229680|FG001|Overall Study|Adverse Event|6|||
162047453|NCT00437983|585229679|FG000|Overall Study|Protocol Violation|2|||
162047454|NCT00437983|585229680|FG001|Overall Study|Protocol Violation|1|||
162047455|NCT00437983|585229679|FG000|Overall Study|Withdrawal by Subject|5|||
162047456|NCT00437983|585229680|FG001|Overall Study|Withdrawal by Subject|6|||
162047457|NCT01790932|585229681|FG000|Overall Study|Disease Progression|41|||
162047458|NCT01790932|585229681|FG000|Overall Study|Adverse Event|7|||
162047459|NCT01790932|585229681|FG000|Overall Study|Physician Decision|1|||
162047460|NCT01790932|585229681|FG000|Overall Study|Withdrawal by Subject|1|||
162047461|NCT01441180|585229687|FG000|Overall Study|Lost to Follow-up|1|||
162047462|NCT01441180|585229688|FG001|Overall Study|Lost to Follow-up|1|||
162047463|NCT01441180|585229689|FG002|Overall Study|Lost to Follow-up|1|||
162047464|NCT01441180|585229687|FG000|Overall Study|Discontinued|0|||
162047465|NCT01441180|585229688|FG001|Overall Study|Discontinued|0|||
162047466|NCT01441180|585229689|FG002|Overall Study|Discontinued|2|||
162047467|NCT01558739|585229692|FG000|Overall Study|Adverse Event|7|||
162047468|NCT01558739|585229692|FG000|Overall Study|Withdrawal by Subject|2|||
162047469|NCT01558739|585229692|FG000|Overall Study|Death|3|||
162047470|NCT01558739|585229692|FG000|Overall Study|Disease Progression|4|||
162047471|NCT01558739|585229692|FG000|Overall Study|Protocol Violation|1|||
162047472|NCT02612129|585229697|FG000|Single Dose Treatment Period|Screening Failure|1|||
162047473|NCT02612129|585229698|FG001|Single Dose Treatment Period|Screening Failure|0|||
162047474|NCT02612129|585229699|FG002|Single Dose Treatment Period|Screening Failure|0|||
162047475|NCT02612129|585229697|FG000|Continuous Treatment Period|Early Escape|0|||
162047476|NCT02612129|585229698|FG001|Continuous Treatment Period|Early Escape|2|||
162047477|NCT02612129|585229699|FG002|Continuous Treatment Period|Early Escape|0|||
162047478|NCT02612129|585229697|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
162047479|NCT02612129|585229698|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
162047480|NCT02612129|585229699|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
162047481|NCT02612129|585229697|FG000|Continuous Treatment Period|Safety Reasons|0|||
162047482|NCT02612129|585229698|FG001|Continuous Treatment Period|Safety Reasons|3|||
162047483|NCT02612129|585229699|FG002|Continuous Treatment Period|Safety Reasons|0|||
162047484|NCT02612129|585229697|FG000|Continuous Treatment Period|Death|0|||
162047485|NCT02612129|585229698|FG001|Continuous Treatment Period|Death|1|||
162047486|NCT02612129|585229699|FG002|Continuous Treatment Period|Death|0|||
162047487|NCT02612129|585229697|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
162047488|NCT02612129|585229698|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
162047489|NCT02612129|585229699|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
162047490|NCT02557295|585229700|FG000|Overall Study|Withdrawal by Subject|9|||
162047491|NCT02557295|585229701|FG001|Overall Study|Withdrawal by Subject|2|||
162047492|NCT02557295|585229702|FG002|Overall Study|Withdrawal by Subject|4|||
162047493|NCT02557295|585229703|FG003|Overall Study|Withdrawal by Subject|0|||
162047494|NCT02557295|585229704|FG004|Overall Study|Withdrawal by Subject|0|||
162047495|NCT02557295|585229705|FG005|Overall Study|Withdrawal by Subject|0|||
162047496|NCT02557295|585229706|FG006|Overall Study|Withdrawal by Subject|15|||
162047497|NCT02557295|585229707|FG007|Overall Study|Withdrawal by Subject|1|||
162047498|NCT02557295|585229708|FG008|Overall Study|Withdrawal by Subject|3|||
162047499|NCT02557295|585229700|FG000|Overall Study|Disease Progression|0|||
162047500|NCT02557295|585229701|FG001|Overall Study|Disease Progression|0|||
162047501|NCT02557295|585229702|FG002|Overall Study|Disease Progression|0|||
162047502|NCT02557295|585229703|FG003|Overall Study|Disease Progression|0|||
162047503|NCT02557295|585229704|FG004|Overall Study|Disease Progression|0|||
162047504|NCT02557295|585229705|FG005|Overall Study|Disease Progression|0|||
162047505|NCT02557295|585229706|FG006|Overall Study|Disease Progression|1|||
162047506|NCT02557295|585229707|FG007|Overall Study|Disease Progression|0|||
162047507|NCT02557295|585229708|FG008|Overall Study|Disease Progression|0|||
162047508|NCT02557295|585229700|FG000|Overall Study|Lack of Efficacy|24|||
162047509|NCT02557295|585229701|FG001|Overall Study|Lack of Efficacy|1|||
162047510|NCT02557295|585229702|FG002|Overall Study|Lack of Efficacy|3|||
162047511|NCT02557295|585229703|FG003|Overall Study|Lack of Efficacy|0|||
162047512|NCT02557295|585229704|FG004|Overall Study|Lack of Efficacy|0|||
162047513|NCT02557295|585229705|FG005|Overall Study|Lack of Efficacy|0|||
162047514|NCT02557295|585229706|FG006|Overall Study|Lack of Efficacy|12|||
162047515|NCT02557295|585229707|FG007|Overall Study|Lack of Efficacy|1|||
162047516|NCT02557295|585229708|FG008|Overall Study|Lack of Efficacy|0|||
162047517|NCT02557295|585229700|FG000|Overall Study|Adverse Event|16|||
162047518|NCT02557295|585229701|FG001|Overall Study|Adverse Event|2|||
162047519|NCT02557295|585229702|FG002|Overall Study|Adverse Event|3|||
162047520|NCT02557295|585229703|FG003|Overall Study|Adverse Event|0|||
162047521|NCT02557295|585229704|FG004|Overall Study|Adverse Event|0|||
162047522|NCT02557295|585229705|FG005|Overall Study|Adverse Event|0|||
162047523|NCT02557295|585229706|FG006|Overall Study|Adverse Event|2|||
162047524|NCT02557295|585229707|FG007|Overall Study|Adverse Event|1|||
162047525|NCT02557295|585229708|FG008|Overall Study|Adverse Event|1|||
162047526|NCT02557295|585229700|FG000|Overall Study|Lost to Follow-up|4|||
162047527|NCT02557295|585229701|FG001|Overall Study|Lost to Follow-up|0|||
162047528|NCT02557295|585229702|FG002|Overall Study|Lost to Follow-up|0|||
162047529|NCT02557295|585229703|FG003|Overall Study|Lost to Follow-up|0|||
162047530|NCT02557295|585229704|FG004|Overall Study|Lost to Follow-up|0|||
162047531|NCT02557295|585229705|FG005|Overall Study|Lost to Follow-up|0|||
162047532|NCT02557295|585229706|FG006|Overall Study|Lost to Follow-up|9|||
162047533|NCT02557295|585229707|FG007|Overall Study|Lost to Follow-up|0|||
162047534|NCT02557295|585229708|FG008|Overall Study|Lost to Follow-up|0|||
162047535|NCT02557295|585229700|FG000|Overall Study|Study Close|54|||
162047536|NCT02557295|585229701|FG001|Overall Study|Study Close|3|||
162047537|NCT02557295|585229702|FG002|Overall Study|Study Close|5|||
162047538|NCT02557295|585229703|FG003|Overall Study|Study Close|3|||
162047539|NCT02557295|585229704|FG004|Overall Study|Study Close|0|||
162047540|NCT02557295|585229705|FG005|Overall Study|Study Close|0|||
162047541|NCT02557295|585229706|FG006|Overall Study|Study Close|37|||
162047542|NCT02557295|585229707|FG007|Overall Study|Study Close|3|||
162047543|NCT02557295|585229708|FG008|Overall Study|Study Close|19|||
162047544|NCT02557295|585229700|FG000|Overall Study|except for study close|4|||
162047545|NCT02557295|585229701|FG001|Overall Study|except for study close|0|||
162047546|NCT02557295|585229702|FG002|Overall Study|except for study close|0|||
162047547|NCT02557295|585229703|FG003|Overall Study|except for study close|0|||
162047548|NCT02557295|585229704|FG004|Overall Study|except for study close|0|||
162047549|NCT02557295|585229705|FG005|Overall Study|except for study close|0|||
162047550|NCT02557295|585229706|FG006|Overall Study|except for study close|5|||
162047551|NCT02557295|585229707|FG007|Overall Study|except for study close|1|||
162047552|NCT02557295|585229708|FG008|Overall Study|except for study close|0|||
162047553|NCT01066000|585229709|FG000|Overall Study|Protocol Violation|4|||
162047554|NCT01066000|585229709|FG000|Overall Study|Death|3|||
162047555|NCT01066000|585229709|FG000|Overall Study|Withdrawal by Subject|1|||
162047556|NCT01066000|585229709|FG000|Overall Study|Adverse Event|1|||
162047557|NCT01386008|585229710|FG000|Overall Study|exited w/o incident /study discontinued|17|||
162047558|NCT01386008|585229710|FG000|Overall Study|Adverse Event|3|||
162047559|NCT01067976|585229711|FG000|Overall Study|Study drug never administered|20|||
162047560|NCT01067976|585229711|FG000|Overall Study|Study prematurely discontinued|2|||
162047561|NCT04449861|585229712|FG000|Overall Study|Withdrawal by Subject|4|||
162047562|NCT04449861|585229712|FG000|Overall Study|Lost to Follow-up|5|||
162047563|NCT04449861|585229712|FG000|Overall Study|Death|112|||
162047564|NCT00976677|585229713|FG000|Overall Study|Adverse Event|1|||
162047565|NCT00976677|585229714|FG001|Overall Study|Adverse Event|0|||
162047566|NCT00976677|585229713|FG000|Overall Study|Withdrawal by Subject|0|||
162047567|NCT00976677|585229714|FG001|Overall Study|Withdrawal by Subject|2|||
162047568|NCT00976677|585229713|FG000|Overall Study|Disease progression|1|||
162047569|NCT00976677|585229714|FG001|Overall Study|Disease progression|1|||
162047570|NCT00976677|585229713|FG000|Overall Study|Trial unblinded|2|||
162047571|NCT00976677|585229714|FG001|Overall Study|Trial unblinded|2|||
162047572|NCT00976677|585229713|FG000|Overall Study|Unknown/Missing|1|||
162047573|NCT00976677|585229714|FG001|Overall Study|Unknown/Missing|0|||
162047574|NCT03487549|585229719|FG000|Overall Study|Protocol Violation|0|||
162047575|NCT03487549|585229720|FG001|Overall Study|Protocol Violation|1|||
162047576|NCT03487549|585229719|FG000|Overall Study|Lost to Follow-up|2|||
162047577|NCT03487549|585229720|FG001|Overall Study|Lost to Follow-up|1|||
162047578|NCT03487549|585229719|FG000|Overall Study|Withdrawal by Subject|2|||
162047579|NCT03487549|585229720|FG001|Overall Study|Withdrawal by Subject|0|||
162047580|NCT01798004|585231615|FG000|Overall Study|Death|2|||
162047581|NCT01798004|585231615|FG000|Overall Study|Lack of Efficacy|8|||
162047582|NCT01798004|585231615|FG000|Overall Study|Physician Decision|25|||
162047583|NCT01798004|585231615|FG000|Overall Study|Withdrawal by Subject|4|||
162047584|NCT01798004|585231615|FG000|Overall Study|Ineligible|4|||
162047585|NCT01798004|585231615|FG000|Overall Study|Patient/parent refusal|7|||
162047586|NCT01798004|585231615|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
162047587|NCT01798004|585231615|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
162047588|NCT03320057|585231616|FG000|Overall Study|Lost to Follow-up|4|||
162047589|NCT03320057|585231617|FG001|Overall Study|Lost to Follow-up|17|||
162047590|NCT03320057|585231616|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
162047591|NCT03320057|585231617|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
162047592|NCT06956170|585231618|FG000|Overall Study|Death|2|||
162047593|NCT06956170|585231619|FG001|Overall Study|Death|1|||
162047594|NCT06956170|585231618|FG000|Overall Study|Withdrawal by Subject|1|||
162047595|NCT06956170|585231619|FG001|Overall Study|Withdrawal by Subject|0|||
162047596|NCT06956170|585231618|FG000|Overall Study|Ongoing|7|||
162047597|NCT06956170|585231619|FG001|Overall Study|Ongoing|10|||
162047598|NCT02323113|585231620|FG000|Overall Study|Adverse Event|3|||
162047599|NCT02323113|585231621|FG001|Overall Study|Adverse Event|3|||
162047600|NCT02323113|585231622|FG002|Overall Study|Adverse Event|2|||
162047601|NCT02323113|585231623|FG003|Overall Study|Adverse Event|5|||
162047602|NCT02323113|585231624|FG004|Overall Study|Adverse Event|8|||
162047603|NCT02323113|585231625|FG005|Overall Study|Adverse Event|3|||
162047604|NCT02323113|585231626|FG006|Overall Study|Adverse Event|6|||
162047605|NCT02323113|585231627|FG007|Overall Study|Adverse Event|0|||
162047606|NCT02323113|585231620|FG000|Overall Study|Progressive Disease|0|||
162047607|NCT02323113|585231621|FG001|Overall Study|Progressive Disease|1|||
162047608|NCT02323113|585231622|FG002|Overall Study|Progressive Disease|1|||
162047609|NCT02323113|585231623|FG003|Overall Study|Progressive Disease|0|||
162047610|NCT02323113|585231624|FG004|Overall Study|Progressive Disease|0|||
162047611|NCT02323113|585231625|FG005|Overall Study|Progressive Disease|3|||
162047612|NCT02323113|585231626|FG006|Overall Study|Progressive Disease|0|||
162047613|NCT02323113|585231627|FG007|Overall Study|Progressive Disease|0|||
162047614|NCT02323113|585231620|FG000|Overall Study|Symptomatic Deterioration|0|||
162047615|NCT02323113|585231621|FG001|Overall Study|Symptomatic Deterioration|0|||
162047616|NCT02323113|585231622|FG002|Overall Study|Symptomatic Deterioration|1|||
162047617|NCT02323113|585231623|FG003|Overall Study|Symptomatic Deterioration|0|||
162047618|NCT02323113|585231624|FG004|Overall Study|Symptomatic Deterioration|1|||
162047619|NCT02323113|585231625|FG005|Overall Study|Symptomatic Deterioration|0|||
162047620|NCT02323113|585231626|FG006|Overall Study|Symptomatic Deterioration|0|||
162047621|NCT02323113|585231627|FG007|Overall Study|Symptomatic Deterioration|0|||
162047622|NCT02323113|585231620|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
162047623|NCT02323113|585231621|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
162047624|NCT02323113|585231622|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
162047625|NCT02323113|585231623|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
162047626|NCT02323113|585231624|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
162047627|NCT02323113|585231625|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
162047628|NCT02323113|585231626|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
162047629|NCT02323113|585231627|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
162047630|NCT02323113|585231620|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162047631|NCT02323113|585231621|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
162047632|NCT02323113|585231622|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162047633|NCT02323113|585231623|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162047634|NCT02323113|585231624|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162047635|NCT02323113|585231625|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162047636|NCT02323113|585231626|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162047637|NCT02323113|585231627|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
162047638|NCT02280304|585231632|FG000|Overall Study|Lost to Follow-up|7|||
162047639|NCT02280304|585231633|FG001|Overall Study|Lost to Follow-up|8|||
162047640|NCT04805541|585231634|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
162047641|NCT00713323|585231645|FG000|Overall Study|Adverse Event|75|||
162047642|NCT00713323|585231645|FG000|Overall Study|Withdrawal by Subject|15|||
162047643|NCT00713323|585231645|FG000|Overall Study|Lost to Follow-up|11|||
162047644|NCT00713323|585231645|FG000|Overall Study|Lack of Efficacy|36|||
162047645|NCT00713323|585231645|FG000|Overall Study|Low creatine clearance at screening|1|||
162047646|NCT00713323|585231645|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
162047647|NCT00713323|585231645|FG000|Overall Study|Surgery cured allodynic pain|1|||
162047648|NCT00713323|585231645|FG000|Overall Study|Pain free|1|||
162047649|NCT00713323|585231645|FG000|Overall Study|Non-compliance|1|||
162047650|NCT00713323|585231645|FG000|Overall Study|Pain resolved|1|||
162047651|NCT00713323|585231645|FG000|Overall Study|Subject travelling to USA|1|||
162047652|NCT00713323|585231645|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
162047653|NCT00713323|585231645|FG000|Overall Study|Treatment that may interact with Sativex|1|||
162047654|NCT05154578|585231646|FG000|Overall Study|Withdrawal by Subject|2|||
162047655|NCT05154578|585231647|FG001|Overall Study|Withdrawal by Subject|3|||
162047656|NCT05154578|585231648|FG002|Overall Study|Withdrawal by Subject|2|||
162047657|NCT05154578|585231649|FG003|Overall Study|Withdrawal by Subject|4|||
162047658|NCT05154578|585231650|FG004|Overall Study|Withdrawal by Subject|0|||
162047659|NCT05154578|585231646|FG000|Overall Study|Lost to Follow-up|0|||
162047660|NCT05154578|585231647|FG001|Overall Study|Lost to Follow-up|1|||
162047661|NCT05154578|585231648|FG002|Overall Study|Lost to Follow-up|0|||
162047662|NCT05154578|585231649|FG003|Overall Study|Lost to Follow-up|3|||
162047663|NCT05154578|585231650|FG004|Overall Study|Lost to Follow-up|0|||
162047664|NCT05154578|585231646|FG000|Overall Study|Adverse Event|0|||
162047665|NCT05154578|585231647|FG001|Overall Study|Adverse Event|0|||
162047666|NCT05154578|585231648|FG002|Overall Study|Adverse Event|0|||
162047667|NCT05154578|585231649|FG003|Overall Study|Adverse Event|1|||
162047668|NCT05154578|585231650|FG004|Overall Study|Adverse Event|0|||
162047669|NCT05154578|585231646|FG000|Overall Study|Relocated to another province|0|||
162047670|NCT05154578|585231647|FG001|Overall Study|Relocated to another province|0|||
162047671|NCT05154578|585231648|FG002|Overall Study|Relocated to another province|1|||
162047672|NCT05154578|585231649|FG003|Overall Study|Relocated to another province|0|||
162047673|NCT05154578|585231650|FG004|Overall Study|Relocated to another province|1|||
162047674|NCT05154578|585231646|FG000|Overall Study|Baby loss|0|||
162047675|NCT05154578|585231647|FG001|Overall Study|Baby loss|1|||
162047676|NCT05154578|585231648|FG002|Overall Study|Baby loss|0|||
162047677|NCT05154578|585231649|FG003|Overall Study|Baby loss|0|||
162047678|NCT05154578|585231650|FG004|Overall Study|Baby loss|0|||
162047679|NCT01146912|585231651|FG000|Overall Study|Already received influenza vaccination|817|||
162047680|NCT01146912|585231652|FG001|Overall Study|Already received influenza vaccination|822|||
162047681|NCT01146912|585231653|FG002|Overall Study|Already received influenza vaccination|13|||
162047682|NCT01146912|585231654|FG003|Overall Study|Already received influenza vaccination|15|||
162047683|NCT01146912|585231655|FG004|Overall Study|Already received influenza vaccination|41|||
162047684|NCT01146912|585231656|FG005|Overall Study|Already received influenza vaccination|61|||
162047685|NCT01146912|585231657|FG006|Overall Study|Already received influenza vaccination|56|||
162047686|NCT01146912|585231658|FG007|Overall Study|Already received influenza vaccination|0|||
162047687|NCT01146912|585231651|FG000|Overall Study|< 14 weeks gestational age|0|||
162047688|NCT01146912|585231652|FG001|Overall Study|< 14 weeks gestational age|0|||
162047689|NCT01146912|585231653|FG002|Overall Study|< 14 weeks gestational age|3|||
162047690|NCT01146912|585231654|FG003|Overall Study|< 14 weeks gestational age|2|||
162047691|NCT01146912|585231655|FG004|Overall Study|< 14 weeks gestational age|0|||
162047692|NCT01146912|585231656|FG005|Overall Study|< 14 weeks gestational age|0|||
162047693|NCT01146912|585231657|FG006|Overall Study|< 14 weeks gestational age|0|||
162047694|NCT01146912|585231658|FG007|Overall Study|< 14 weeks gestational age|0|||
162047695|NCT01146912|585231651|FG000|Overall Study|Duplicate patient|0|||
162047696|NCT01146912|585231652|FG001|Overall Study|Duplicate patient|0|||
162047697|NCT01146912|585231653|FG002|Overall Study|Duplicate patient|1|||
162047698|NCT01146912|585231654|FG003|Overall Study|Duplicate patient|0|||
162047699|NCT01146912|585231655|FG004|Overall Study|Duplicate patient|0|||
162047700|NCT01146912|585231656|FG005|Overall Study|Duplicate patient|0|||
162047701|NCT01146912|585231657|FG006|Overall Study|Duplicate patient|0|||
162047702|NCT01146912|585231658|FG007|Overall Study|Duplicate patient|0|||
162047703|NCT02980783|585231659|FG000|Overall Study|Lost to Follow-up|1|||
162047704|NCT00880542|585231660|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
162047705|NCT00880542|585231660|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
162047706|NCT00880542|585231660|FG000|REP: Surgical Resection|progressive disease|1|||
162047707|NCT05047770|585231661|FG000|Overall Study|Withdrawal by Subject|15|||
162047708|NCT05047770|585231662|FG001|Overall Study|Withdrawal by Subject|10|||
162047709|NCT05047770|585231663|FG002|Overall Study|Withdrawal by Subject|6|||
162047710|NCT05047770|585231664|FG003|Overall Study|Withdrawal by Subject|12|||
162047711|NCT05047770|585231661|FG000|Overall Study|Lost to Follow-up|7|||
162047712|NCT05047770|585231662|FG001|Overall Study|Lost to Follow-up|5|||
162047713|NCT05047770|585231663|FG002|Overall Study|Lost to Follow-up|12|||
162047714|NCT05047770|585231664|FG003|Overall Study|Lost to Follow-up|13|||
162047715|NCT05047770|585231661|FG000|Overall Study|Other|1|||
162047716|NCT05047770|585231662|FG001|Overall Study|Other|0|||
162047717|NCT05047770|585231663|FG002|Overall Study|Other|1|||
162047718|NCT05047770|585231664|FG003|Overall Study|Other|0|||
162047719|NCT01772160|585231665|FG000|Overall Study|Death|3|||
162047720|NCT01772160|585231665|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
162047721|NCT01772160|585231665|FG000|Overall Study|Consent withdrawal|3|||
162047722|NCT01772160|585231665|FG000|Overall Study|Migrated / moved from the study area|4|||
162047723|NCT01772160|585231665|FG000|Overall Study|Lost to Follow-up|30|||
162047724|NCT01772160|585231665|FG000|Overall Study|Other|5|||
162047725|NCT02202980|585231666|FG000|Overall Study|Lack of Efficacy|1|||
162047726|NCT02202980|585231667|FG001|Overall Study|Lack of Efficacy|0|||
162047727|NCT02202980|585231668|FG002|Overall Study|Lack of Efficacy|7|||
162047728|NCT02202980|585231669|FG003|Overall Study|Lack of Efficacy|0|||
162047729|NCT02202980|585231670|FG004|Overall Study|Lack of Efficacy|3|||
162047730|NCT02202980|585231671|FG005|Overall Study|Lack of Efficacy|1|||
162047731|NCT02202980|585231672|FG006|Overall Study|Lack of Efficacy|11|||
162047732|NCT02202980|585231673|FG007|Overall Study|Lack of Efficacy|2|||
162047733|NCT02202980|585231674|FG008|Overall Study|Lack of Efficacy|2|||
162047734|NCT02202980|585231675|FG009|Overall Study|Lack of Efficacy|0|||
162047735|NCT02202980|585231676|FG010|Overall Study|Lack of Efficacy|0|||
162047736|NCT02202980|585231677|FG011|Overall Study|Lack of Efficacy|3|||
162047737|NCT02202980|585231678|FG012|Overall Study|Lack of Efficacy|10|||
162047738|NCT02202980|585231679|FG013|Overall Study|Lack of Efficacy|0|||
162047739|NCT02202980|585231666|FG000|Overall Study|Protocol Violation|0|||
162047740|NCT02202980|585231667|FG001|Overall Study|Protocol Violation|0|||
162047741|NCT02202980|585231668|FG002|Overall Study|Protocol Violation|0|||
162047742|NCT02202980|585231669|FG003|Overall Study|Protocol Violation|3|||
162047743|NCT02202980|585231670|FG004|Overall Study|Protocol Violation|3|||
162047744|NCT02202980|585231671|FG005|Overall Study|Protocol Violation|0|||
162047745|NCT02202980|585231672|FG006|Overall Study|Protocol Violation|0|||
162047746|NCT02202980|585231673|FG007|Overall Study|Protocol Violation|0|||
162047747|NCT02202980|585231674|FG008|Overall Study|Protocol Violation|0|||
162047748|NCT02202980|585231675|FG009|Overall Study|Protocol Violation|0|||
162047749|NCT02202980|585231676|FG010|Overall Study|Protocol Violation|0|||
162047750|NCT02202980|585231677|FG011|Overall Study|Protocol Violation|0|||
162047751|NCT02202980|585231678|FG012|Overall Study|Protocol Violation|0|||
162047752|NCT02202980|585231679|FG013|Overall Study|Protocol Violation|0|||
162047753|NCT02202980|585231666|FG000|Overall Study|Lost to Follow-up|0|||
162047754|NCT02202980|585231667|FG001|Overall Study|Lost to Follow-up|1|||
162047755|NCT02202980|585231668|FG002|Overall Study|Lost to Follow-up|1|||
162047756|NCT02202980|585231669|FG003|Overall Study|Lost to Follow-up|1|||
162047757|NCT02202980|585231670|FG004|Overall Study|Lost to Follow-up|0|||
162047758|NCT02202980|585231671|FG005|Overall Study|Lost to Follow-up|0|||
162047759|NCT02202980|585231672|FG006|Overall Study|Lost to Follow-up|0|||
162047760|NCT02202980|585231673|FG007|Overall Study|Lost to Follow-up|1|||
162047761|NCT02202980|585231674|FG008|Overall Study|Lost to Follow-up|1|||
162047762|NCT02202980|585231675|FG009|Overall Study|Lost to Follow-up|0|||
162047763|NCT02202980|585231676|FG010|Overall Study|Lost to Follow-up|0|||
162047764|NCT02202980|585231677|FG011|Overall Study|Lost to Follow-up|0|||
162047765|NCT02202980|585231678|FG012|Overall Study|Lost to Follow-up|1|||
162047766|NCT02202980|585231679|FG013|Overall Study|Lost to Follow-up|0|||
162047767|NCT02202980|585231666|FG000|Overall Study|Withdrew Consent|0|||
162047768|NCT02202980|585231667|FG001|Overall Study|Withdrew Consent|1|||
162047769|NCT02202980|585231668|FG002|Overall Study|Withdrew Consent|2|||
162047770|NCT02202980|585231669|FG003|Overall Study|Withdrew Consent|0|||
162047771|NCT02202980|585231670|FG004|Overall Study|Withdrew Consent|0|||
162047772|NCT02202980|585231671|FG005|Overall Study|Withdrew Consent|0|||
162047773|NCT02202980|585231672|FG006|Overall Study|Withdrew Consent|0|||
162047774|NCT02202980|585231673|FG007|Overall Study|Withdrew Consent|0|||
162047775|NCT02202980|585231674|FG008|Overall Study|Withdrew Consent|1|||
162047776|NCT02202980|585231675|FG009|Overall Study|Withdrew Consent|0|||
162047777|NCT02202980|585231676|FG010|Overall Study|Withdrew Consent|0|||
162047778|NCT02202980|585231677|FG011|Overall Study|Withdrew Consent|0|||
162047779|NCT02202980|585231678|FG012|Overall Study|Withdrew Consent|0|||
162047780|NCT02202980|585231679|FG013|Overall Study|Withdrew Consent|0|||
162047781|NCT01952145|585231680|FG000|Overall Study|Protocol Violation|2|||
162047782|NCT01952145|585231681|FG001|Overall Study|Protocol Violation|1|||
162047783|NCT01952145|585231680|FG000|Overall Study|Death|0|||
162047784|NCT01952145|585231681|FG001|Overall Study|Death|1|||
162047785|NCT01952145|585231680|FG000|Overall Study|Adverse Event|9|||
162047786|NCT01952145|585231681|FG001|Overall Study|Adverse Event|0|||
162047787|NCT01952145|585231680|FG000|Overall Study|Withdrawal Criteria|16|||
162047788|NCT01952145|585231681|FG001|Overall Study|Withdrawal Criteria|11|||
162047789|NCT01952145|585231680|FG000|Overall Study|Unclassified|1|||
162047790|NCT01952145|585231681|FG001|Overall Study|Unclassified|1|||
162047791|NCT01540838|585231685|FG000|Overall Study|Open nasogastric tube|9|||
162047792|NCT01540838|585231686|FG001|Overall Study|Open nasogastric tube|7|||
162047793|NCT01540838|585231685|FG000|Overall Study|Treatment doses missing|8|||
162047794|NCT01540838|585231686|FG001|Overall Study|Treatment doses missing|12|||
162047795|NCT01540838|585231685|FG000|Overall Study|Additional antibiotic treatment|1|||
162047796|NCT01540838|585231686|FG001|Overall Study|Additional antibiotic treatment|2|||
162047797|NCT01540838|585231685|FG000|Overall Study|Died before treatment initiation|1|||
162047798|NCT01540838|585231686|FG001|Overall Study|Died before treatment initiation|1|||
162047799|NCT01540838|585231685|FG000|Overall Study|Not BM. Other treatment|3|||
162047800|NCT01540838|585231686|FG001|Overall Study|Not BM. Other treatment|1|||
162047801|NCT02130570|585231687|FG000|Overall Study|Death|3|||
162047802|NCT02130570|585231688|FG001|Overall Study|Death|5|||
162047803|NCT02130570|585231687|FG000|Overall Study|Withdrawal by Subject|6|||
162047804|NCT02130570|585231688|FG001|Overall Study|Withdrawal by Subject|3|||
162047805|NCT02130570|585231687|FG000|Overall Study|Part of practice that discontinued study|0|||
162047806|NCT02130570|585231688|FG001|Overall Study|Part of practice that discontinued study|5|||
162047807|NCT02808650|585231698|FG000|Overall Study|Death|0|||
162047808|NCT02808650|585231699|FG001|Overall Study|Death|0|||
162047809|NCT02808650|585231700|FG002|Overall Study|Death|0|||
162047810|NCT02808650|585231701|FG003|Overall Study|Death|0|||
162047811|NCT02808650|585231702|FG004|Overall Study|Death|1|||
162047812|NCT02808650|585231698|FG000|Overall Study|Lack of Efficacy|5|||
162047813|NCT02808650|585231699|FG001|Overall Study|Lack of Efficacy|5|||
162047814|NCT02808650|585231700|FG002|Overall Study|Lack of Efficacy|6|||
162047815|NCT02808650|585231701|FG003|Overall Study|Lack of Efficacy|5|||
162047816|NCT02808650|585231702|FG004|Overall Study|Lack of Efficacy|4|||
162047817|NCT02808650|585231698|FG000|Overall Study|Physician Decision|1|||
162047818|NCT02808650|585231699|FG001|Overall Study|Physician Decision|1|||
162047819|NCT02808650|585231700|FG002|Overall Study|Physician Decision|0|||
162047820|NCT02808650|585231701|FG003|Overall Study|Physician Decision|0|||
162047821|NCT02808650|585231702|FG004|Overall Study|Physician Decision|0|||
162047822|NCT02808650|585231698|FG000|Overall Study|Withdrawal by Subject|0|||
162047823|NCT02808650|585231699|FG001|Overall Study|Withdrawal by Subject|0|||
162047824|NCT02808650|585231700|FG002|Overall Study|Withdrawal by Subject|0|||
162047825|NCT02808650|585231701|FG003|Overall Study|Withdrawal by Subject|1|||
162047826|NCT02808650|585231702|FG004|Overall Study|Withdrawal by Subject|1|||
162047827|NCT04889222|585231708|FG000|Overall Study|Did not meet eligibility criteria|8|||
162047828|NCT04889222|585231708|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
162047829|NCT04889222|585231708|FG000|Overall Study|Did not proceed due to time constraints|5|||
162047830|NCT01180647|585231709|FG000|Overall Study|Lost to Follow-up|5|||
162047831|NCT01180647|585231710|FG001|Overall Study|Lost to Follow-up|6|||
162047832|NCT00071396|585231717|FG000|Overall Study|Withdrawal by Subject|1|||
162047833|NCT00071396|585231717|FG000|Overall Study|Physician Decision|2|||
162047834|NCT04545554|585231718|FG000|Overall Study|Withdrawal by Subject|0|||
162047835|NCT04545554|585231719|FG001|Overall Study|Withdrawal by Subject|0|||
162047836|NCT04545554|585231720|FG002|Overall Study|Withdrawal by Subject|0|||
162047837|NCT04545554|585231721|FG003|Overall Study|Withdrawal by Subject|1|||
162047838|NCT04545554|585231722|FG004|Overall Study|Withdrawal by Subject|0|||
162047839|NCT04545554|585231723|FG005|Overall Study|Withdrawal by Subject|0|||
162047840|NCT02639546|585231724|FG000|Overall Study|Death|2|||
162047841|NCT02639546|585231725|FG001|Overall Study|Death|2|||
162047842|NCT02639546|585231726|FG002|Overall Study|Death|1|||
162047843|NCT02639546|585231727|FG003|Overall Study|Death|2|||
162047844|NCT02639546|585231728|FG004|Overall Study|Death|2|||
162047845|NCT02639546|585231729|FG005|Overall Study|Death|2|||
162047846|NCT02639546|585231730|FG006|Overall Study|Death|0|||
162047847|NCT02639546|585231731|FG007|Overall Study|Death|0|||
162047848|NCT02639546|585231724|FG000|Overall Study|Lost to Follow-up|0|||
162047849|NCT02639546|585231725|FG001|Overall Study|Lost to Follow-up|0|||
162047850|NCT02639546|585231726|FG002|Overall Study|Lost to Follow-up|1|||
162047851|NCT02639546|585231727|FG003|Overall Study|Lost to Follow-up|0|||
162047852|NCT02639546|585231728|FG004|Overall Study|Lost to Follow-up|1|||
162047853|NCT02639546|585231729|FG005|Overall Study|Lost to Follow-up|1|||
162047854|NCT02639546|585231730|FG006|Overall Study|Lost to Follow-up|0|||
162047855|NCT02639546|585231731|FG007|Overall Study|Lost to Follow-up|1|||
162047856|NCT02639546|585231724|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
162047857|NCT02639546|585231725|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
162047858|NCT02639546|585231726|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
162047859|NCT02639546|585231727|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
162047860|NCT02639546|585231728|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
162047861|NCT02639546|585231729|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
162047862|NCT02639546|585231730|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
162047863|NCT02639546|585231731|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
162047864|NCT02639546|585231724|FG000|Overall Study|Study Terminated By Sponsor|0|||
162047865|NCT02639546|585231725|FG001|Overall Study|Study Terminated By Sponsor|2|||
162047866|NCT02639546|585231726|FG002|Overall Study|Study Terminated By Sponsor|3|||
162047867|NCT02639546|585231727|FG003|Overall Study|Study Terminated By Sponsor|4|||
162047868|NCT02639546|585231728|FG004|Overall Study|Study Terminated By Sponsor|4|||
162047869|NCT02639546|585231729|FG005|Overall Study|Study Terminated By Sponsor|3|||
162047870|NCT02639546|585231730|FG006|Overall Study|Study Terminated By Sponsor|3|||
162047871|NCT02639546|585231731|FG007|Overall Study|Study Terminated By Sponsor|9|||
162047872|NCT02639546|585231724|FG000|Overall Study|Withdrawal by Subject|2|||
162047873|NCT02639546|585231725|FG001|Overall Study|Withdrawal by Subject|2|||
162047874|NCT02639546|585231726|FG002|Overall Study|Withdrawal by Subject|1|||
162047875|NCT02639546|585231727|FG003|Overall Study|Withdrawal by Subject|0|||
162047876|NCT02639546|585231728|FG004|Overall Study|Withdrawal by Subject|0|||
162047877|NCT02639546|585231729|FG005|Overall Study|Withdrawal by Subject|1|||
162047878|NCT02639546|585231730|FG006|Overall Study|Withdrawal by Subject|2|||
162047879|NCT02639546|585231731|FG007|Overall Study|Withdrawal by Subject|1|||
162047880|NCT02478372|585231732|FG000|Overall Study|Protocol Violation|12|||
162047881|NCT02478372|585231733|FG001|Overall Study|Protocol Violation|8|||
162047882|NCT02478372|585231732|FG000|Overall Study|Lost to Follow-up|1|||
162047883|NCT02478372|585231733|FG001|Overall Study|Lost to Follow-up|4|||
162047884|NCT02478372|585231732|FG000|Overall Study|Death|0|||
162047885|NCT02478372|585231733|FG001|Overall Study|Death|2|||
162047886|NCT00116428|585231734|FG000|Overall Study|Withdrawal by Subject|2|||
162047887|NCT00116428|585231735|FG001|Overall Study|Withdrawal by Subject|5|||
162047888|NCT00116428|585231734|FG000|Overall Study|Did not meet inclusion criteria|1|||
162047889|NCT00116428|585231735|FG001|Overall Study|Did not meet inclusion criteria|0|||
162047890|NCT01032174|585231736|FG000|Overall Study|Adverse Event|0|||
162047891|NCT01032174|585231737|FG001|Overall Study|Adverse Event|1|||
162047892|NCT00113087|585231738|FG000|Overall Study|Death or Transplant|14|||
162047893|NCT00113087|585231739|FG001|Overall Study|Death or Transplant|16|||
162047894|NCT00113087|585231738|FG000|Overall Study|Family or MD withdrew subject|10|||
162047895|NCT00113087|585231739|FG001|Overall Study|Family or MD withdrew subject|5|||
162047896|NCT00386607|585231740|FG000|Core|Adverse Event|40|||
162047897|NCT00386607|585231741|FG001|Core|Adverse Event|0|||
162047898|NCT00386607|585231740|FG000|Core|Abnormal laboratory value(s)|3|||
162047899|NCT00386607|585231741|FG001|Core|Abnormal laboratory value(s)|0|||
162047900|NCT00386607|585231740|FG000|Core|Unsatisfactory therapeutic effect|23|||
162047901|NCT00386607|585231741|FG001|Core|Unsatisfactory therapeutic effect|0|||
162047902|NCT00386607|585231740|FG000|Core|Condition no longer requires study drug|4|||
162047903|NCT00386607|585231741|FG001|Core|Condition no longer requires study drug|0|||
162047904|NCT00386607|585231740|FG000|Core|Patient withdrew consent|15|||
162047905|NCT00386607|585231741|FG001|Core|Patient withdrew consent|0|||
162047906|NCT00386607|585231740|FG000|Core|Lost to Follow-up|23|||
162047907|NCT00386607|585231741|FG001|Core|Lost to Follow-up|0|||
162047908|NCT00386607|585231740|FG000|Core|Administrative problems|1|||
162047909|NCT00386607|585231741|FG001|Core|Administrative problems|0|||
162047910|NCT00386607|585231740|FG000|Core|Protocol Deviation|6|||
162047911|NCT00386607|585231741|FG001|Core|Protocol Deviation|0|||
162047912|NCT00386607|585231740|FG000|Extension|Adverse Event|0|||
162047913|NCT00386607|585231741|FG001|Extension|Adverse Event|6|||
162047914|NCT00386607|585231740|FG000|Extension|Abnormal laboratory value(s)|0|||
162047915|NCT00386607|585231741|FG001|Extension|Abnormal laboratory value(s)|1|||
162047916|NCT00386607|585231740|FG000|Extension|Administrative problems|0|||
162047917|NCT00386607|585231741|FG001|Extension|Administrative problems|1|||
162047918|NCT00386607|585231740|FG000|Extension|Lost to Follow-up|0|||
162047919|NCT00386607|585231741|FG001|Extension|Lost to Follow-up|3|||
162047920|NCT00386607|585231740|FG000|Extension|Patient withdrew consent|0|||
162047921|NCT00386607|585231741|FG001|Extension|Patient withdrew consent|5|||
162047922|NCT00386607|585231740|FG000|Extension|Unsatisfactory therapeutic effect|0|||
162047923|NCT00386607|585231741|FG001|Extension|Unsatisfactory therapeutic effect|1|||
162047924|NCT02713204|585231742|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
162047925|NCT02713204|585231743|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
162047926|NCT02713204|585231744|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
162047927|NCT02713204|585231745|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
162047928|NCT02713204|585231746|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
162047929|NCT02713204|585231747|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
162047930|NCT02713204|585231748|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
162047931|NCT02713204|585231749|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
162047932|NCT02713204|585231742|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162047933|NCT02713204|585231743|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162047934|NCT02713204|585231744|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
162047935|NCT02713204|585231745|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162047936|NCT02713204|585231746|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162047937|NCT02713204|585231747|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162047938|NCT02713204|585231748|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162047939|NCT02713204|585231749|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
162047940|NCT02713204|585231742|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162047941|NCT02713204|585231743|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
162047942|NCT02713204|585231744|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162047943|NCT02713204|585231745|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162047944|NCT02713204|585231746|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162047945|NCT02713204|585231747|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162047946|NCT02713204|585231748|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162047947|NCT02713204|585231749|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
162047948|NCT02713204|585231742|FG000|From Week 12 up to Week 36|Adverse Event|1|||
162047949|NCT02713204|585231743|FG001|From Week 12 up to Week 36|Adverse Event|0|||
162047950|NCT02713204|585231744|FG002|From Week 12 up to Week 36|Adverse Event|0|||
162047951|NCT02713204|585231745|FG003|From Week 12 up to Week 36|Adverse Event|1|||
162047952|NCT02713204|585231746|FG004|From Week 12 up to Week 36|Adverse Event|1|||
162047953|NCT02713204|585231747|FG005|From Week 12 up to Week 36|Adverse Event|0|||
162047954|NCT02713204|585231748|FG006|From Week 12 up to Week 36|Adverse Event|2|||
162047955|NCT02713204|585231749|FG007|From Week 12 up to Week 36|Adverse Event|1|||
162047956|NCT02713204|585231742|FG000|From Week 12 up to Week 36|Death|0|||
162047957|NCT02713204|585231743|FG001|From Week 12 up to Week 36|Death|0|||
162047958|NCT02713204|585231744|FG002|From Week 12 up to Week 36|Death|0|||
162047959|NCT02713204|585231745|FG003|From Week 12 up to Week 36|Death|1|||
162047960|NCT02713204|585231746|FG004|From Week 12 up to Week 36|Death|0|||
162047961|NCT02713204|585231747|FG005|From Week 12 up to Week 36|Death|1|||
162047962|NCT02713204|585231748|FG006|From Week 12 up to Week 36|Death|0|||
162047963|NCT02713204|585231749|FG007|From Week 12 up to Week 36|Death|3|||
162047964|NCT02713204|585231742|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
162047965|NCT02713204|585231743|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
162047966|NCT02713204|585231744|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
162047967|NCT02713204|585231745|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
162047968|NCT02713204|585231746|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
162047969|NCT02713204|585231747|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
162047970|NCT02713204|585231748|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
162047971|NCT02713204|585231749|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
162047972|NCT02713204|585231742|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
162047973|NCT02713204|585231743|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
162047974|NCT02713204|585231744|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
162047975|NCT02713204|585231745|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
162047976|NCT02713204|585231746|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
162047977|NCT02713204|585231747|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
162047978|NCT02713204|585231748|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
162047979|NCT02713204|585231749|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
162047980|NCT00474760|585231753|FG000|Overall Study|Death|0|||
162047981|NCT00474760|585231754|FG001|Overall Study|Death|0|||
162047982|NCT00474760|585231755|FG002|Overall Study|Death|0|||
162047983|NCT00474760|585231756|FG003|Overall Study|Death|0|||
162047984|NCT00474760|585231757|FG004|Overall Study|Death|2|||
162047985|NCT00474760|585231758|FG005|Overall Study|Death|0|||
162047986|NCT00474760|585231759|FG006|Overall Study|Death|0|||
162047987|NCT00474760|585231753|FG000|Overall Study|Adverse Event|0|||
162047988|NCT00474760|585231754|FG001|Overall Study|Adverse Event|0|||
162047989|NCT00474760|585231755|FG002|Overall Study|Adverse Event|0|||
162047990|NCT00474760|585231756|FG003|Overall Study|Adverse Event|0|||
162047991|NCT00474760|585231757|FG004|Overall Study|Adverse Event|1|||
162047992|NCT00474760|585231758|FG005|Overall Study|Adverse Event|7|||
162047993|NCT00474760|585231759|FG006|Overall Study|Adverse Event|0|||
162047994|NCT00474760|585231753|FG000|Overall Study|Laboratory abnormality|0|||
162047995|NCT00474760|585231754|FG001|Overall Study|Laboratory abnormality|0|||
162047996|NCT00474760|585231755|FG002|Overall Study|Laboratory abnormality|0|||
162047997|NCT00474760|585231756|FG003|Overall Study|Laboratory abnormality|0|||
162047998|NCT00474760|585231757|FG004|Overall Study|Laboratory abnormality|0|||
162047999|NCT00474760|585231758|FG005|Overall Study|Laboratory abnormality|1|||
162048000|NCT00474760|585231759|FG006|Overall Study|Laboratory abnormality|0|||
162048001|NCT00474760|585231753|FG000|Overall Study|Withdrawal by Subject|0|||
162048002|NCT00474760|585231754|FG001|Overall Study|Withdrawal by Subject|0|||
162048003|NCT00474760|585231755|FG002|Overall Study|Withdrawal by Subject|0|||
162048004|NCT00474760|585231756|FG003|Overall Study|Withdrawal by Subject|1|||
162048005|NCT00474760|585231757|FG004|Overall Study|Withdrawal by Subject|0|||
162048006|NCT00474760|585231758|FG005|Overall Study|Withdrawal by Subject|1|||
162048007|NCT00474760|585231759|FG006|Overall Study|Withdrawal by Subject|1|||
162048008|NCT00474760|585231753|FG000|Overall Study|Other|0|||
162048009|NCT00474760|585231754|FG001|Overall Study|Other|1|||
162048010|NCT00474760|585231755|FG002|Overall Study|Other|0|||
162048011|NCT00474760|585231756|FG003|Overall Study|Other|0|||
162048012|NCT00474760|585231757|FG004|Overall Study|Other|1|||
162048013|NCT00474760|585231758|FG005|Overall Study|Other|0|||
162048014|NCT00474760|585231759|FG006|Overall Study|Other|0|||
162048015|NCT00474760|585231753|FG000|Overall Study|Progressive disease|3|||
162048016|NCT00474760|585231754|FG001|Overall Study|Progressive disease|2|||
162048017|NCT00474760|585231755|FG002|Overall Study|Progressive disease|3|||
162048018|NCT00474760|585231756|FG003|Overall Study|Progressive disease|2|||
162048019|NCT00474760|585231757|FG004|Overall Study|Progressive disease|8|||
162048020|NCT00474760|585231758|FG005|Overall Study|Progressive disease|20|||
162048021|NCT00474760|585231759|FG006|Overall Study|Progressive disease|7|||
162048022|NCT00474760|585231753|FG000|Overall Study|Terminated by sponsor|0|||
162048023|NCT00474760|585231754|FG001|Overall Study|Terminated by sponsor|0|||
162048024|NCT00474760|585231755|FG002|Overall Study|Terminated by sponsor|0|||
162048025|NCT00474760|585231756|FG003|Overall Study|Terminated by sponsor|0|||
162048026|NCT00474760|585231757|FG004|Overall Study|Terminated by sponsor|0|||
162048027|NCT00474760|585231758|FG005|Overall Study|Terminated by sponsor|0|||
162048028|NCT00474760|585231759|FG006|Overall Study|Terminated by sponsor|2|||
162048029|NCT01927627|585231761|FG000|Overall Study|Adverse Event|3|||
162048030|NCT01927627|585231761|FG000|Overall Study|Lack of Efficacy|1|||
162048031|NCT01927627|585231761|FG000|Overall Study|Financial Concerns|1|||
162048032|NCT02635776|585231762|FG000|Overall Study|Physician Decision|1|||
162048033|NCT02635776|585231763|FG001|Overall Study|Physician Decision|0|||
162048034|NCT02635776|585231762|FG000|Overall Study|Adverse Event|51|||
162048035|NCT02635776|585231763|FG001|Overall Study|Adverse Event|3|||
162048036|NCT02635776|585231762|FG000|Overall Study|Withdrawal by Subject|41|||
162048037|NCT02635776|585231763|FG001|Overall Study|Withdrawal by Subject|7|||
162048038|NCT02635776|585231762|FG000|Overall Study|Lost to Follow-up|4|||
162048039|NCT02635776|585231763|FG001|Overall Study|Lost to Follow-up|0|||
162048040|NCT02635776|585231762|FG000|Overall Study|Other reasons|5|||
162048041|NCT02635776|585231763|FG001|Overall Study|Other reasons|1|||
162048042|NCT00660673|585231764|FG000|Overall Study|Adverse Event|84|||
162048043|NCT00660673|585231764|FG000|Overall Study|Lack of Efficacy|7|||
162048044|NCT00660673|585231764|FG000|Overall Study|Withdrawal by Subject|22|||
162048045|NCT00660673|585231764|FG000|Overall Study|Administrative|2|||
162048046|NCT00660673|585231764|FG000|Overall Study|Protocol Violation|2|||
162048047|NCT00579098|585231765|FG000|Overall Study|Lost to Follow-up|2|||
162048048|NCT00579098|585231766|FG001|Overall Study|Lost to Follow-up|0|||
162048049|NCT00579098|585231765|FG000|Overall Study|Adverse Event|2|||
162048050|NCT00579098|585231766|FG001|Overall Study|Adverse Event|3|||
162048051|NCT00579098|585231765|FG000|Overall Study|Withdrawal by Subject|2|||
162048052|NCT00579098|585231766|FG001|Overall Study|Withdrawal by Subject|3|||
162048053|NCT00579098|585231765|FG000|Overall Study|AF returned after ablation|3|||
162048054|NCT00579098|585231766|FG001|Overall Study|AF returned after ablation|2|||
162048055|NCT00633750|585231773|FG000|Overall Study|Adverse Event|2|||
162048056|NCT00633750|585231773|FG000|Overall Study|Withdrawal by Subject|3|||
162048057|NCT01903031|585231774|FG000|Overall Study|Not Able to Attend Clinic|1|||
162048058|NCT01903031|585231775|FG001|Overall Study|Not Able to Attend Clinic|1|||
162048059|NCT01903031|585231776|FG002|Overall Study|Not Able to Attend Clinic|0|||
162048060|NCT01903031|585231774|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
162048061|NCT01903031|585231775|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
162048062|NCT01903031|585231776|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
162048063|NCT01903031|585231774|FG000|Overall Study|Adverse Event|0|||
162048064|NCT01903031|585231775|FG001|Overall Study|Adverse Event|1|||
162048065|NCT01903031|585231776|FG002|Overall Study|Adverse Event|0|||
162048066|NCT01903031|585231774|FG000|Overall Study|Withdrawal by Subject|0|||
162048067|NCT01903031|585231775|FG001|Overall Study|Withdrawal by Subject|1|||
162048068|NCT01903031|585231776|FG002|Overall Study|Withdrawal by Subject|1|||
162048069|NCT01903031|585231774|FG000|Overall Study|Protocol Violation|0|||
162048070|NCT01903031|585231775|FG001|Overall Study|Protocol Violation|0|||
162048071|NCT01903031|585231776|FG002|Overall Study|Protocol Violation|2|||
162048072|NCT01903031|585231774|FG000|Overall Study|Lost to Follow-up|0|||
162048073|NCT01903031|585231775|FG001|Overall Study|Lost to Follow-up|0|||
162048074|NCT01903031|585231776|FG002|Overall Study|Lost to Follow-up|1|||
162048075|NCT01903031|585231774|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
162048076|NCT01903031|585231775|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
162048077|NCT01903031|585231776|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
162048078|NCT01811225|585231777|FG000|Treatment Period 1|Adverse Event|2|||
162048079|NCT01811225|585231778|FG001|Treatment Period 1|Adverse Event|3|||
162048080|NCT01811225|585231777|FG000|Treatment Period 1|Lost to Follow-up|12|||
162048081|NCT01811225|585231778|FG001|Treatment Period 1|Lost to Follow-up|8|||
162048082|NCT01811225|585231777|FG000|Treatment Period 1|transporation|1|||
162048083|NCT01811225|585231778|FG001|Treatment Period 1|transporation|0|||
162048084|NCT01811225|585231777|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
162048085|NCT01811225|585231778|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
162048086|NCT01811225|585231777|FG000|Treatment Period 2|Lost to Follow-up|1|||
162048087|NCT01811225|585231778|FG001|Treatment Period 2|Lost to Follow-up|2|||
162048088|NCT01811225|585231777|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
162048089|NCT01811225|585231778|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
162048090|NCT03000569|585231779|FG000|Overall Study|Withdrawal by Subject|1|||
162048091|NCT03000569|585231780|FG001|Overall Study|Withdrawal by Subject|0|||
162048092|NCT02298023|585231781|FG000|Overall Study|Withdrawal by Subject|1|||
162048093|NCT02298023|585231782|FG001|Overall Study|Withdrawal by Subject|0|||
162048094|NCT02298023|585231783|FG002|Overall Study|Withdrawal by Subject|0|||
162048095|NCT00492531|585231791|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
162048096|NCT00492531|585231792|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
162048097|NCT04122534|585231793|FG000|Overall Study|Lost to Follow-up|4|||
162048098|NCT01402011|585231799|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
162048099|NCT01402011|585231800|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
162048100|NCT01402011|585231801|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
162048101|NCT01402011|585231799|FG000|Active Treatment Period|Withdrawal by Subject|1|||
162048102|NCT01402011|585231800|FG001|Active Treatment Period|Withdrawal by Subject|3|||
162048103|NCT01402011|585231801|FG002|Active Treatment Period|Withdrawal by Subject|0|||
162048104|NCT01402011|585231799|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
162048105|NCT01402011|585231800|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
162048106|NCT01402011|585231801|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
162048107|NCT00594659|585231802|FG000|Overall Study|Lost to Follow-up|13|||
162048108|NCT00594659|585231803|FG001|Overall Study|Lost to Follow-up|9|||
162048109|NCT00594659|585231804|FG002|Overall Study|Lost to Follow-up|7|||
162048110|NCT00142298|585231806|FG000|Overall Study|Adverse Event|10|||
162048111|NCT00142298|585231807|FG001|Overall Study|Adverse Event|10|||
162048112|NCT00142298|585231808|FG002|Overall Study|Adverse Event|1|||
162048113|NCT00142298|585231809|FG003|Overall Study|Adverse Event|5|||
162048114|NCT00142298|585231810|FG004|Overall Study|Adverse Event|2|||
162048115|NCT00142298|585231811|FG005|Overall Study|Adverse Event|2|||
162048116|NCT00142298|585231812|FG006|Overall Study|Adverse Event|0|||
162048117|NCT00142298|585231813|FG007|Overall Study|Adverse Event|0|||
162048118|NCT00142298|585231814|FG008|Overall Study|Adverse Event|0|||
162048119|NCT00142298|585231815|FG009|Overall Study|Adverse Event|0|||
162048120|NCT00142298|585231806|FG000|Overall Study|Clinical disease progression|1|||
162048121|NCT00142298|585231807|FG001|Overall Study|Clinical disease progression|0|||
162048122|NCT00142298|585231808|FG002|Overall Study|Clinical disease progression|0|||
162048123|NCT00142298|585231809|FG003|Overall Study|Clinical disease progression|0|||
162048124|NCT00142298|585231810|FG004|Overall Study|Clinical disease progression|0|||
162048125|NCT00142298|585231811|FG005|Overall Study|Clinical disease progression|0|||
162048126|NCT00142298|585231812|FG006|Overall Study|Clinical disease progression|0|||
162048127|NCT00142298|585231813|FG007|Overall Study|Clinical disease progression|0|||
162048128|NCT00142298|585231814|FG008|Overall Study|Clinical disease progression|0|||
162048129|NCT00142298|585231815|FG009|Overall Study|Clinical disease progression|0|||
162048130|NCT00142298|585231806|FG000|Overall Study|Death|1|||
162048131|NCT00142298|585231807|FG001|Overall Study|Death|1|||
162048132|NCT00142298|585231808|FG002|Overall Study|Death|1|||
162048133|NCT00142298|585231809|FG003|Overall Study|Death|0|||
162048134|NCT00142298|585231810|FG004|Overall Study|Death|0|||
162048135|NCT00142298|585231811|FG005|Overall Study|Death|6|||
162048136|NCT00142298|585231812|FG006|Overall Study|Death|0|||
162048137|NCT00142298|585231813|FG007|Overall Study|Death|0|||
162048138|NCT00142298|585231814|FG008|Overall Study|Death|0|||
162048139|NCT00142298|585231815|FG009|Overall Study|Death|0|||
162048140|NCT00142298|585231806|FG000|Overall Study|Lack of Efficacy|44|||
162048141|NCT00142298|585231807|FG001|Overall Study|Lack of Efficacy|62|||
162048142|NCT00142298|585231808|FG002|Overall Study|Lack of Efficacy|9|||
162048143|NCT00142298|585231809|FG003|Overall Study|Lack of Efficacy|12|||
162048144|NCT00142298|585231810|FG004|Overall Study|Lack of Efficacy|1|||
162048145|NCT00142298|585231811|FG005|Overall Study|Lack of Efficacy|0|||
162048146|NCT00142298|585231812|FG006|Overall Study|Lack of Efficacy|0|||
162048147|NCT00142298|585231813|FG007|Overall Study|Lack of Efficacy|1|||
162048148|NCT00142298|585231814|FG008|Overall Study|Lack of Efficacy|0|||
162048149|NCT00142298|585231815|FG009|Overall Study|Lack of Efficacy|0|||
162048150|NCT00142298|585231806|FG000|Overall Study|Non-compliance|15|||
162048151|NCT00142298|585231807|FG001|Overall Study|Non-compliance|13|||
162048152|NCT00142298|585231808|FG002|Overall Study|Non-compliance|0|||
162048153|NCT00142298|585231809|FG003|Overall Study|Non-compliance|6|||
162048154|NCT00142298|585231810|FG004|Overall Study|Non-compliance|1|||
162048155|NCT00142298|585231811|FG005|Overall Study|Non-compliance|0|||
162048156|NCT00142298|585231812|FG006|Overall Study|Non-compliance|0|||
162048157|NCT00142298|585231813|FG007|Overall Study|Non-compliance|3|||
162048158|NCT00142298|585231814|FG008|Overall Study|Non-compliance|3|||
162048159|NCT00142298|585231815|FG009|Overall Study|Non-compliance|0|||
162048160|NCT00142298|585231806|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
162048161|NCT00142298|585231807|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
162048162|NCT00142298|585231808|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
162048163|NCT00142298|585231809|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
162048164|NCT00142298|585231810|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
162048165|NCT00142298|585231811|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
162048166|NCT00142298|585231812|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
162048167|NCT00142298|585231813|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
162048168|NCT00142298|585231814|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
162048169|NCT00142298|585231815|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
162048170|NCT00142298|585231806|FG000|Overall Study|Pregnancy|4|||
162048171|NCT00142298|585231807|FG001|Overall Study|Pregnancy|4|||
162048172|NCT00142298|585231808|FG002|Overall Study|Pregnancy|2|||
162048173|NCT00142298|585231809|FG003|Overall Study|Pregnancy|3|||
162048174|NCT00142298|585231810|FG004|Overall Study|Pregnancy|0|||
162048175|NCT00142298|585231811|FG005|Overall Study|Pregnancy|0|||
162048176|NCT00142298|585231812|FG006|Overall Study|Pregnancy|0|||
162048177|NCT00142298|585231813|FG007|Overall Study|Pregnancy|0|||
162048178|NCT00142298|585231814|FG008|Overall Study|Pregnancy|1|||
162048179|NCT00142298|585231815|FG009|Overall Study|Pregnancy|0|||
162048180|NCT00142298|585231806|FG000|Overall Study|Virologic breakthrough|19|||
162048181|NCT00142298|585231807|FG001|Overall Study|Virologic breakthrough|23|||
162048182|NCT00142298|585231808|FG002|Overall Study|Virologic breakthrough|9|||
162048183|NCT00142298|585231809|FG003|Overall Study|Virologic breakthrough|7|||
162048184|NCT00142298|585231810|FG004|Overall Study|Virologic breakthrough|2|||
162048185|NCT00142298|585231811|FG005|Overall Study|Virologic breakthrough|3|||
162048186|NCT00142298|585231812|FG006|Overall Study|Virologic breakthrough|3|||
162048187|NCT00142298|585231813|FG007|Overall Study|Virologic breakthrough|0|||
162048188|NCT00142298|585231814|FG008|Overall Study|Virologic breakthrough|0|||
162048189|NCT00142298|585231815|FG009|Overall Study|Virologic breakthrough|0|||
162048190|NCT00142298|585231806|FG000|Overall Study|Other- not specified|0|||
162048191|NCT00142298|585231807|FG001|Overall Study|Other- not specified|3|||
162048192|NCT00142298|585231808|FG002|Overall Study|Other- not specified|0|||
162048193|NCT00142298|585231809|FG003|Overall Study|Other- not specified|1|||
162048194|NCT00142298|585231810|FG004|Overall Study|Other- not specified|0|||
162048195|NCT00142298|585231811|FG005|Overall Study|Other- not specified|0|||
162048196|NCT00142298|585231812|FG006|Overall Study|Other- not specified|0|||
162048197|NCT00142298|585231813|FG007|Overall Study|Other- not specified|0|||
162048198|NCT00142298|585231814|FG008|Overall Study|Other- not specified|0|||
162048199|NCT00142298|585231815|FG009|Overall Study|Other- not specified|0|||
162048200|NCT00142298|585231806|FG000|Overall Study|Lost to Follow-up|0|||
162048201|NCT00142298|585231807|FG001|Overall Study|Lost to Follow-up|0|||
162048202|NCT00142298|585231808|FG002|Overall Study|Lost to Follow-up|0|||
162048203|NCT00142298|585231809|FG003|Overall Study|Lost to Follow-up|0|||
162048204|NCT00142298|585231810|FG004|Overall Study|Lost to Follow-up|0|||
162048205|NCT00142298|585231811|FG005|Overall Study|Lost to Follow-up|0|||
162048206|NCT00142298|585231812|FG006|Overall Study|Lost to Follow-up|2|||
162048207|NCT00142298|585231813|FG007|Overall Study|Lost to Follow-up|0|||
162048208|NCT00142298|585231814|FG008|Overall Study|Lost to Follow-up|0|||
162048209|NCT00142298|585231815|FG009|Overall Study|Lost to Follow-up|0|||
162048210|NCT00142298|585231806|FG000|Overall Study|Treatment Failure|0|||
162048211|NCT00142298|585231807|FG001|Overall Study|Treatment Failure|0|||
162048212|NCT00142298|585231808|FG002|Overall Study|Treatment Failure|0|||
162048213|NCT00142298|585231809|FG003|Overall Study|Treatment Failure|0|||
162048214|NCT00142298|585231810|FG004|Overall Study|Treatment Failure|0|||
162048215|NCT00142298|585231811|FG005|Overall Study|Treatment Failure|2|||
162048216|NCT00142298|585231812|FG006|Overall Study|Treatment Failure|2|||
162048217|NCT00142298|585231813|FG007|Overall Study|Treatment Failure|0|||
162048218|NCT00142298|585231814|FG008|Overall Study|Treatment Failure|0|||
162048219|NCT00142298|585231815|FG009|Overall Study|Treatment Failure|0|||
162048220|NCT02423772|585231818|FG000|Overall Study|Lost to Follow-up|3|||
162048221|NCT02423772|585231819|FG001|Overall Study|Lost to Follow-up|3|||
162048222|NCT02423772|585231818|FG000|Overall Study|Did not begin intervention|2|||
162048223|NCT02423772|585231819|FG001|Overall Study|Did not begin intervention|5|||
162048224|NCT06238362|585231820|FG000|Overall Study|Insufficient total sleep time|1|||
162048225|NCT06238362|585231821|FG001|Overall Study|Insufficient total sleep time|0|||
162048226|NCT06238362|585231820|FG000|Overall Study|Inadequate signal quality|1|||
162048227|NCT06238362|585231821|FG001|Overall Study|Inadequate signal quality|0|||
162048228|NCT01313858|585233293|FG000|Overall Study|Premature Treatment Termination|251|||
162048229|NCT01313858|585233294|FG001|Overall Study|Premature Treatment Termination|219|||
162048230|NCT01313858|585233295|FG002|Overall Study|Premature Treatment Termination|191|||
162048231|NCT01313858|585233293|FG000|Overall Study|Lost to Follow-up|35|||
162048232|NCT01313858|585233294|FG001|Overall Study|Lost to Follow-up|51|||
162048233|NCT01313858|585233295|FG002|Overall Study|Lost to Follow-up|47|||
162048234|NCT03689530|585233299|FG000|Overall Study|Withdrawal by Subject|53|||
162048235|NCT03689530|585233300|FG001|Overall Study|Withdrawal by Subject|16|||
162048236|NCT01392443|585233301|FG000|Overall Study|Disease progression|30|||
162048237|NCT01392443|585233301|FG000|Overall Study|Adverse Event|24|||
162048238|NCT01392443|585233301|FG000|Overall Study|Death|7|||
162048239|NCT01392443|585233301|FG000|Overall Study|Withdrawal by Subject|5|||
162048240|NCT01392443|585233301|FG000|Overall Study|Lost to Follow-up|1|||
162048241|NCT01392443|585233301|FG000|Overall Study|Protocol Violation|1|||
162048242|NCT01977794|585233302|FG000|Overall Study|Adverse Event|2|||
162048243|NCT01977794|585233303|FG001|Overall Study|Adverse Event|2|||
162048244|NCT01977794|585233302|FG000|Overall Study|Lost to Follow-up|2|||
162048245|NCT01977794|585233303|FG001|Overall Study|Lost to Follow-up|1|||
162048246|NCT01977794|585233302|FG000|Overall Study|Protocol Violation|1|||
162048247|NCT01977794|585233303|FG001|Overall Study|Protocol Violation|0|||
162048248|NCT01977794|585233302|FG000|Overall Study|Death|1|||
162048249|NCT01977794|585233303|FG001|Overall Study|Death|1|||
162048250|NCT01977794|585233302|FG000|Overall Study|Withdrew consent|2|||
162048251|NCT01977794|585233303|FG001|Overall Study|Withdrew consent|1|||
162048252|NCT01977794|585233302|FG000|Overall Study|Other|0|||
162048253|NCT01977794|585233303|FG001|Overall Study|Other|1|||
162048254|NCT00533897|585233306|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
162048255|NCT00533897|585233307|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
162048256|NCT00533897|585233308|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
162048257|NCT00533897|585233309|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
162048258|NCT00533897|585233310|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
162048259|NCT00533897|585233311|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
162048260|NCT00533897|585233312|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
162048261|NCT00533897|585233313|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
162048262|NCT00533897|585233306|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
162048263|NCT00533897|585233307|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162048264|NCT00533897|585233308|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162048265|NCT00533897|585233309|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162048266|NCT00533897|585233310|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162048267|NCT00533897|585233311|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162048268|NCT00533897|585233312|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162048269|NCT00533897|585233313|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
162048270|NCT00533897|585233306|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
162048271|NCT00533897|585233307|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162048272|NCT00533897|585233308|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162048273|NCT00533897|585233309|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162048274|NCT00533897|585233310|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162048275|NCT00533897|585233311|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162048276|NCT00533897|585233312|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162048277|NCT00533897|585233313|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
162048278|NCT00533897|585233306|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
162048279|NCT00533897|585233307|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162048280|NCT00533897|585233308|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162048281|NCT00533897|585233309|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162048282|NCT00533897|585233310|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162048283|NCT00533897|585233311|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162048284|NCT00533897|585233312|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162048285|NCT00533897|585233313|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
162048286|NCT00533897|585233306|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
162048287|NCT00533897|585233307|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162048288|NCT00533897|585233308|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162048289|NCT00533897|585233309|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162048290|NCT00533897|585233310|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162048291|NCT00533897|585233311|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162048292|NCT00533897|585233312|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162048293|NCT00533897|585233313|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
162048294|NCT00533897|585233306|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
162048295|NCT00533897|585233307|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162048296|NCT00533897|585233308|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162048297|NCT00533897|585233309|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162048298|NCT00533897|585233310|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162048299|NCT00533897|585233311|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162048300|NCT00533897|585233312|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162048301|NCT00533897|585233313|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
162048302|NCT00533897|585233306|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
162048303|NCT00533897|585233307|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
162048304|NCT00533897|585233308|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
162048305|NCT00533897|585233309|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
162048306|NCT00533897|585233310|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
162048307|NCT00533897|585233311|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
162048308|NCT00533897|585233312|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
162048309|NCT00533897|585233313|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
162048310|NCT00533897|585233306|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162048311|NCT00533897|585233307|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162048312|NCT00533897|585233308|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
162048313|NCT00533897|585233309|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162048314|NCT00533897|585233310|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162048315|NCT00533897|585233311|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162048316|NCT00533897|585233312|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162048317|NCT00533897|585233313|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
162048318|NCT00533897|585233306|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162048319|NCT00533897|585233307|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162048320|NCT00533897|585233308|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162048321|NCT00533897|585233309|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162048322|NCT00533897|585233310|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162048323|NCT00533897|585233311|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
162048324|NCT00533897|585233312|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162048325|NCT00533897|585233313|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
162048326|NCT00533897|585233306|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162048327|NCT00533897|585233307|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162048328|NCT00533897|585233308|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162048329|NCT00533897|585233309|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162048330|NCT00533897|585233310|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162048331|NCT00533897|585233311|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
162048332|NCT00533897|585233312|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162048333|NCT00533897|585233313|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
162048334|NCT00533897|585233306|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
162048335|NCT00533897|585233307|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
162048336|NCT00533897|585233308|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
162048337|NCT00533897|585233309|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
162048338|NCT00533897|585233310|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
162048339|NCT00533897|585233311|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
162048340|NCT00533897|585233312|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
162048341|NCT00533897|585233313|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
162048342|NCT00533897|585233306|FG000|Long Term Extension (LTE)|Death|0|||
162048343|NCT00533897|585233307|FG001|Long Term Extension (LTE)|Death|0|||
162048344|NCT00533897|585233308|FG002|Long Term Extension (LTE)|Death|0|||
162048345|NCT00533897|585233309|FG003|Long Term Extension (LTE)|Death|0|||
162048346|NCT00533897|585233310|FG004|Long Term Extension (LTE)|Death|0|||
162048347|NCT00533897|585233311|FG005|Long Term Extension (LTE)|Death|0|||
162048348|NCT00533897|585233312|FG006|Long Term Extension (LTE)|Death|1|||
162048349|NCT00533897|585233313|FG007|Long Term Extension (LTE)|Death|3|||
162048350|NCT00533897|585233306|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
162048351|NCT00533897|585233307|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
162048352|NCT00533897|585233308|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
162048353|NCT00533897|585233309|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
162048354|NCT00533897|585233310|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
162048355|NCT00533897|585233311|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
162048356|NCT00533897|585233312|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
162048357|NCT00533897|585233313|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
162048358|NCT00533897|585233306|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162048359|NCT00533897|585233307|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162048360|NCT00533897|585233308|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162048361|NCT00533897|585233309|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162048362|NCT00533897|585233310|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162048363|NCT00533897|585233311|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162048364|NCT00533897|585233312|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
162048365|NCT00533897|585233313|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
162048366|NCT00533897|585233306|FG000|Long Term Extension (LTE)|Adverse Event|0|||
162048367|NCT00533897|585233307|FG001|Long Term Extension (LTE)|Adverse Event|0|||
162048368|NCT00533897|585233308|FG002|Long Term Extension (LTE)|Adverse Event|0|||
162048369|NCT00533897|585233309|FG003|Long Term Extension (LTE)|Adverse Event|0|||
162048370|NCT00533897|585233310|FG004|Long Term Extension (LTE)|Adverse Event|0|||
162048371|NCT00533897|585233311|FG005|Long Term Extension (LTE)|Adverse Event|0|||
162048372|NCT00533897|585233312|FG006|Long Term Extension (LTE)|Adverse Event|2|||
162048373|NCT00533897|585233313|FG007|Long Term Extension (LTE)|Adverse Event|5|||
162048374|NCT00533897|585233306|FG000|Long Term Extension (LTE)|Pregnancy|0|||
162048375|NCT00533897|585233307|FG001|Long Term Extension (LTE)|Pregnancy|0|||
162048376|NCT00533897|585233308|FG002|Long Term Extension (LTE)|Pregnancy|0|||
162048377|NCT00533897|585233309|FG003|Long Term Extension (LTE)|Pregnancy|0|||
162048378|NCT00533897|585233310|FG004|Long Term Extension (LTE)|Pregnancy|0|||
162048379|NCT00533897|585233311|FG005|Long Term Extension (LTE)|Pregnancy|0|||
162048380|NCT00533897|585233312|FG006|Long Term Extension (LTE)|Pregnancy|0|||
162048381|NCT00533897|585233313|FG007|Long Term Extension (LTE)|Pregnancy|2|||
162048382|NCT00533897|585233306|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
162048383|NCT00533897|585233307|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
162048384|NCT00533897|585233308|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
162048385|NCT00533897|585233309|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
162048386|NCT00533897|585233310|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
162048387|NCT00533897|585233311|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
162048388|NCT00533897|585233312|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
162048389|NCT00533897|585233313|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
162048390|NCT00533897|585233306|FG000|Long Term Extension (LTE)|Other|0|||
162048391|NCT00533897|585233307|FG001|Long Term Extension (LTE)|Other|0|||
162048392|NCT00533897|585233308|FG002|Long Term Extension (LTE)|Other|0|||
162048393|NCT00533897|585233309|FG003|Long Term Extension (LTE)|Other|0|||
162048394|NCT00533897|585233310|FG004|Long Term Extension (LTE)|Other|0|||
162048395|NCT00533897|585233311|FG005|Long Term Extension (LTE)|Other|0|||
162048396|NCT00533897|585233312|FG006|Long Term Extension (LTE)|Other|1|||
162048397|NCT00533897|585233313|FG007|Long Term Extension (LTE)|Other|6|||
162048398|NCT01546207|585233316|FG000|Overall Study|Death|1|||
162048399|NCT01626456|585233317|FG000|Overall Study|Withdrawal by Subject|21|||
162048400|NCT01626456|585233318|FG001|Overall Study|Withdrawal by Subject|46|||
162048401|NCT01626456|585233317|FG000|Overall Study|Adverse Event|2|||
162048402|NCT01626456|585233318|FG001|Overall Study|Adverse Event|27|||
162048403|NCT01626456|585233317|FG000|Overall Study|Lost to Follow-up|2|||
162048404|NCT01626456|585233318|FG001|Overall Study|Lost to Follow-up|27|||
162048405|NCT01626456|585233317|FG000|Overall Study|Lack of Efficacy|6|||
162048406|NCT01626456|585233318|FG001|Overall Study|Lack of Efficacy|7|||
162048407|NCT01626456|585233317|FG000|Overall Study|Physician Decision|1|||
162048408|NCT01626456|585233318|FG001|Overall Study|Physician Decision|4|||
162048409|NCT01626456|585233317|FG000|Overall Study|Protocol Violation|1|||
162048410|NCT01626456|585233318|FG001|Overall Study|Protocol Violation|1|||
162048411|NCT01626456|585233317|FG000|Overall Study|Site Closure|2|||
162048412|NCT01626456|585233318|FG001|Overall Study|Site Closure|3|||
162048413|NCT01626456|585233317|FG000|Overall Study|Incarceration|0|||
162048414|NCT01626456|585233318|FG001|Overall Study|Incarceration|2|||
162048415|NCT00506662|585233319|FG000|Overall Study|Adverse Event|0|||
162048416|NCT00506662|585233320|FG001|Overall Study|Adverse Event|2|||
162048417|NCT00506662|585233319|FG000|Overall Study|Lack of Efficacy|1|||
162048418|NCT00506662|585233320|FG001|Overall Study|Lack of Efficacy|0|||
162048419|NCT00506662|585233319|FG000|Overall Study|Protocol Violation|2|||
162048420|NCT00506662|585233320|FG001|Overall Study|Protocol Violation|4|||
162048421|NCT00506662|585233319|FG000|Overall Study|Trial terminated|10|||
162048422|NCT00506662|585233320|FG001|Overall Study|Trial terminated|16|||
162048423|NCT00506662|585233319|FG000|Overall Study|Not recorded|4|||
162048424|NCT00506662|585233320|FG001|Overall Study|Not recorded|6|||
162048425|NCT04015336|585233322|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
162048426|NCT00491075|585233323|FG000|Overall Study|Withdrawal by Subject|1|||
162048427|NCT00491075|585233323|FG000|Overall Study|Physician Decision|1|||
162048428|NCT01603355|585233324|FG000|Overall Study|Lack of Efficacy|2|||
162048429|NCT00246753|585233325|FG000|Overall Study|Withdrawal by Subject|2|||
162048430|NCT00246753|585233325|FG000|Overall Study|Physician Decision|2|||
162048431|NCT00246753|585233325|FG000|Overall Study|Adverse Event|2|||
162048432|NCT00246753|585233325|FG000|Overall Study|Unacceptable toxicity|2|||
162048433|NCT01030536|585233328|FG000|Overall Study|Withdrawal by Subject|0|||
162048434|NCT01030536|585233329|FG001|Overall Study|Withdrawal by Subject|0|||
162048435|NCT01030536|585233330|FG002|Overall Study|Withdrawal by Subject|1|||
162048436|NCT01030536|585233331|FG003|Overall Study|Withdrawal by Subject|0|||
162048437|NCT01030536|585233332|FG004|Overall Study|Withdrawal by Subject|0|||
162048438|NCT01030536|585233328|FG000|Overall Study|undefined|1|||
162048439|NCT01030536|585233329|FG001|Overall Study|undefined|0|||
162048440|NCT01030536|585233330|FG002|Overall Study|undefined|1|||
162048441|NCT01030536|585233331|FG003|Overall Study|undefined|1|||
162048442|NCT01030536|585233332|FG004|Overall Study|undefined|0|||
162048443|NCT01030536|585233328|FG000|Overall Study|Adverse Event|0|||
162048444|NCT01030536|585233329|FG001|Overall Study|Adverse Event|3|||
162048445|NCT01030536|585233330|FG002|Overall Study|Adverse Event|1|||
162048446|NCT01030536|585233331|FG003|Overall Study|Adverse Event|0|||
162048447|NCT01030536|585233332|FG004|Overall Study|Adverse Event|1|||
162048448|NCT01030536|585233328|FG000|Overall Study|Progressive disease|6|||
162048449|NCT01030536|585233329|FG001|Overall Study|Progressive disease|2|||
162048450|NCT01030536|585233330|FG002|Overall Study|Progressive disease|3|||
162048451|NCT01030536|585233331|FG003|Overall Study|Progressive disease|2|||
162048452|NCT01030536|585233332|FG004|Overall Study|Progressive disease|0|||
162048453|NCT01030536|585233328|FG000|Overall Study|Death|0|||
162048454|NCT01030536|585233329|FG001|Overall Study|Death|1|||
162048455|NCT01030536|585233330|FG002|Overall Study|Death|0|||
162048456|NCT01030536|585233331|FG003|Overall Study|Death|0|||
162048457|NCT01030536|585233332|FG004|Overall Study|Death|0|||
162048458|NCT01065597|585233333|FG000|Overall Study|Adverse Event|1|||
162048459|NCT01781975|585233334|FG000|Overall Study|Death|1|||
162048460|NCT01781975|585233335|FG001|Overall Study|Death|0|||
162048502|NCT04545060|585233343|FG001|Overall Study|Withdrawal by Subject|22|||
162048503|NCT00619177|585233344|FG000|Overall Study|Adverse Event|18|||
162048504|NCT00619177|585233344|FG000|Overall Study|Lost to Follow-up|2|||
162048505|NCT00619177|585233344|FG000|Overall Study|Lack of Efficacy|1|||
162048506|NCT00619177|585233344|FG000|Overall Study|Missing termination information|481|||
162048507|NCT00619177|585233344|FG000|Overall Study|Not specified reasons|6|||
162048508|NCT01281137|585233349|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
162048509|NCT01281137|585233350|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
162048510|NCT01281137|585233349|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
162048511|NCT01281137|585233350|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
162048512|NCT01281137|585233349|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
162048513|NCT01281137|585233350|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
162048514|NCT01281137|585233349|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
162048515|NCT01281137|585233350|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
162048516|NCT01281137|585233349|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
162048517|NCT01281137|585233350|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
162048518|NCT00788073|585233353|FG000|STX209 Then Placebo|Adverse Event|1|||
162048519|NCT00788073|585233354|FG001|STX209 Then Placebo|Adverse Event|0|||
162048520|NCT00788073|585233353|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
162048521|NCT00788073|585233354|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
162048522|NCT00788073|585233353|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
162048523|NCT00788073|585233354|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
162048524|NCT00788073|585233353|FG000|STX209 Then Placebo|unable to return due to travel|0|||
162048525|NCT00788073|585233354|FG001|STX209 Then Placebo|unable to return due to travel|1|||
162048526|NCT00788073|585233353|FG000|Placebo Then STX209|Adverse Event|2|||
162048527|NCT00788073|585233354|FG001|Placebo Then STX209|Adverse Event|0|||
162048528|NCT00788073|585233353|FG000|Placebo Then STX209|Protocol Violation|0|||
162048529|NCT00788073|585233354|FG001|Placebo Then STX209|Protocol Violation|1|||
162048530|NCT03608254|585233355|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
162048531|NCT03608254|585233355|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
162048532|NCT00910273|585233356|FG000|Overall Study|Lack of Efficacy|6|||
162048533|NCT00910273|585233357|FG001|Overall Study|Lack of Efficacy|9|||
162048534|NCT00910273|585233356|FG000|Overall Study|Adverse Event|1|||
162048535|NCT00910273|585233357|FG001|Overall Study|Adverse Event|1|||
162048536|NCT00910273|585233356|FG000|Overall Study|Withdrawal by Subject|1|||
162048537|NCT00910273|585233357|FG001|Overall Study|Withdrawal by Subject|0|||
162048538|NCT00910273|585233356|FG000|Overall Study|Discontinuation of study by sponsor|8|||
162048539|NCT00910273|585233357|FG001|Overall Study|Discontinuation of study by sponsor|2|||
162048540|NCT00910273|585233356|FG000|Overall Study|Protocol Violation|1|||
162048541|NCT00910273|585233357|FG001|Overall Study|Protocol Violation|0|||
162048542|NCT00910273|585233356|FG000|Overall Study|Lost to Follow-up|1|||
162048543|NCT00910273|585233357|FG001|Overall Study|Lost to Follow-up|1|||
162048544|NCT03540030|585233358|FG000|Overall Study|Withdrawal by Subject|2|||
162048545|NCT03540030|585233359|FG001|Overall Study|Withdrawal by Subject|1|||
162048546|NCT03540030|585233358|FG000|Overall Study|screen fail|7|||
162048547|NCT03540030|585233359|FG001|Overall Study|screen fail|1|||
162048548|NCT03540030|585233358|FG000|Overall Study|never had surgery after signing consent|9|||
162048549|NCT03540030|585233359|FG001|Overall Study|never had surgery after signing consent|1|||
162048550|NCT00569270|585233360|FG000|Period: First Intervention|Protocol Violation|0|||
162048551|NCT00569270|585233361|FG001|Period: First Intervention|Protocol Violation|1|||
162048552|NCT00810355|585233372|FG000|Overall Study|Lost to Follow-up|13|||
162048553|NCT00810355|585233373|FG001|Overall Study|Lost to Follow-up|17|||
162048554|NCT00810355|585233374|FG002|Overall Study|Lost to Follow-up|11|||
162048555|NCT00810355|585233372|FG000|Overall Study|Withdrawal by Subject|1|||
162048556|NCT00810355|585233373|FG001|Overall Study|Withdrawal by Subject|0|||
162048557|NCT00810355|585233374|FG002|Overall Study|Withdrawal by Subject|0|||
162048558|NCT00657358|585233375|FG000|Overall Study|Lack of Efficacy|6|||
162048559|NCT04729621|585233377|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
162048560|NCT04729621|585233378|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
162048561|NCT04729621|585233379|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
162048562|NCT04729621|585233380|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
162048563|NCT04729621|585233381|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
162048564|NCT04729621|585233377|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
162048565|NCT04729621|585233378|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
162048566|NCT04729621|585233379|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
162048567|NCT04729621|585233380|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
162048568|NCT04729621|585233381|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
162048569|NCT04729621|585233377|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
162048570|NCT04729621|585233378|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
162048571|NCT04729621|585233379|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
162048572|NCT04729621|585233380|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
162048573|NCT04729621|585233381|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
162048574|NCT04729621|585233377|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
162048575|NCT04729621|585233378|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
162048576|NCT04729621|585233379|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
162048577|NCT04729621|585233380|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
162048578|NCT04729621|585233381|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
162048579|NCT04729621|585233377|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
162048580|NCT04729621|585233378|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
162048581|NCT04729621|585233379|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
162048582|NCT04729621|585233380|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
162048583|NCT04729621|585233381|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
162048584|NCT04729621|585233377|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
162048585|NCT04729621|585233378|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
162048586|NCT04729621|585233379|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
162048587|NCT04729621|585233380|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
162048588|NCT04729621|585233381|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
162048589|NCT01449539|585233385|FG000|Overall Study|Withdrawal by Subject|3|||
162048590|NCT01449539|585233385|FG000|Overall Study|Toxicity not study related|1|||
162048591|NCT01387789|585233386|FG000|Overall Study|Adverse Event|5|||
162048592|NCT01387789|585233386|FG000|Overall Study|Lack of Efficacy|2|||
162048593|NCT01387789|585233386|FG000|Overall Study|Lost to Follow-up|1|||
162048594|NCT00913380|585233389|FG000|Clinical Outcomes|Lost to Follow-up|6|||
162048595|NCT00913380|585233390|FG001|Clinical Outcomes|Lost to Follow-up|6|||
162048596|NCT01788228|585233395|FG000|Overall Study|Migrated/moved from study area|1|||
162048597|NCT01788228|585233396|FG001|Overall Study|Migrated/moved from study area|0|||
162048598|NCT02187744|585233397|FG000|Study|Participant refused further follow-up|1|||
162048599|NCT02187744|585233398|FG001|Study|Participant refused further follow-up|0|||
162048600|NCT02187744|585233397|FG000|Study|Other|2|||
162048601|NCT02187744|585233398|FG001|Study|Other|1|||
162048602|NCT02187744|585233397|FG000|Study|Lost to Follow-up|0|||
162048603|NCT02187744|585233398|FG001|Study|Lost to Follow-up|2|||
162048604|NCT02187744|585233397|FG000|Study|Related adverse event, not serious|0|||
162048605|NCT02187744|585233398|FG001|Study|Related adverse event, not serious|2|||
162048606|NCT02187744|585233397|FG000|Study|Death|1|||
162048607|NCT02187744|585233398|FG001|Study|Death|0|||
162048608|NCT02187744|585233397|FG000|Study|Related adverse event, serious non-fatal|0|||
162048609|NCT02187744|585233398|FG001|Study|Related adverse event, serious non-fatal|1|||
162048610|NCT02187744|585233397|FG000|Treatment|Death|1|||
162048611|NCT02187744|585233398|FG001|Treatment|Death|0|||
162048612|NCT02187744|585233397|FG000|Treatment|Related adverse event, serious non-fatal|0|||
162048613|NCT02187744|585233398|FG001|Treatment|Related adverse event, serious non-fatal|1|||
162048614|NCT02187744|585233397|FG000|Treatment|Related adverse event, not serious|0|||
162048615|NCT02187744|585233398|FG001|Treatment|Related adverse event, not serious|2|||
162048616|NCT02187744|585233397|FG000|Treatment|Lost to Follow-up|0|||
162048617|NCT02187744|585233398|FG001|Treatment|Lost to Follow-up|1|||
162048618|NCT02187744|585233397|FG000|Treatment|Other|2|||
162048619|NCT02187744|585233398|FG001|Treatment|Other|0|||
162048620|NCT02187744|585233397|FG000|Treatment|Participant refused continued treatment|1|||
162048621|NCT02187744|585233398|FG001|Treatment|Participant refused continued treatment|1|||
162048622|NCT01972568|585233399|FG000|Overall Study|Other events|3|||
162048623|NCT01972568|585233400|FG001|Overall Study|Other events|0|||
162048624|NCT01972568|585233401|FG002|Overall Study|Other events|0|||
162048625|NCT01972568|585233399|FG000|Overall Study|Lack of Efficacy|0|||
162048626|NCT01972568|585233400|FG001|Overall Study|Lack of Efficacy|1|||
162048627|NCT01972568|585233401|FG002|Overall Study|Lack of Efficacy|2|||
162048628|NCT01972568|585233399|FG000|Overall Study|Protocol Violation|1|||
162048629|NCT01972568|585233400|FG001|Overall Study|Protocol Violation|2|||
162048630|NCT01972568|585233401|FG002|Overall Study|Protocol Violation|2|||
162048631|NCT01972568|585233399|FG000|Overall Study|Withdrawal by Subject|6|||
162048632|NCT01972568|585233400|FG001|Overall Study|Withdrawal by Subject|3|||
162048633|NCT01972568|585233401|FG002|Overall Study|Withdrawal by Subject|7|||
162048634|NCT01972568|585233399|FG000|Overall Study|Lost to Follow-up|1|||
162048635|NCT01972568|585233400|FG001|Overall Study|Lost to Follow-up|0|||
162048636|NCT01972568|585233401|FG002|Overall Study|Lost to Follow-up|0|||
162048637|NCT01972568|585233399|FG000|Overall Study|Adverse Event|5|||
162048638|NCT01972568|585233400|FG001|Overall Study|Adverse Event|6|||
162048639|NCT01972568|585233401|FG002|Overall Study|Adverse Event|5|||
162048640|NCT02059408|585233405|FG000|Overall Study|Did not get tested|0|||
162048641|NCT02059408|585233406|FG001|Overall Study|Did not get tested|330|||
162048642|NCT02059408|585233407|FG002|Overall Study|Did not get tested|358|||
162048643|NCT04223973|585233413|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
162048644|NCT04223973|585233414|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
162048645|NCT04223973|585233413|FG000|Overall Study|Adverse Event|4|||
162048646|NCT04223973|585233414|FG001|Overall Study|Adverse Event|0|||
162048647|NCT04223973|585233413|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
162048648|NCT04223973|585233414|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
162048649|NCT04223973|585233413|FG000|Overall Study|Physician Decision|1|||
162048650|NCT04223973|585233414|FG001|Overall Study|Physician Decision|1|||
162048651|NCT04223973|585233413|FG000|Overall Study|Withdrawal by Subject|0|||
162048652|NCT04223973|585233414|FG001|Overall Study|Withdrawal by Subject|1|||
162048653|NCT01193842|585233415|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
162048654|NCT01193842|585233416|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
162048655|NCT01193842|585233417|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
162048656|NCT01193842|585233418|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
162048657|NCT01193842|585233419|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
162048658|NCT01193842|585233415|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
162048659|NCT01193842|585233416|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
162048660|NCT01193842|585233417|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
162048661|NCT01193842|585233418|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
162048662|NCT01193842|585233419|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
162048663|NCT01193842|585233415|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
162048664|NCT01193842|585233416|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
162048665|NCT01193842|585233417|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
162048666|NCT01193842|585233418|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
162048667|NCT01193842|585233419|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
162048668|NCT01193842|585233415|FG000|Phase II: Randomized Groups|Death|0|||
162048669|NCT01193842|585233416|FG001|Phase II: Randomized Groups|Death|0|||
162048670|NCT01193842|585233417|FG002|Phase II: Randomized Groups|Death|0|||
162048671|NCT01193842|585233418|FG003|Phase II: Randomized Groups|Death|1|||
162048672|NCT01193842|585233419|FG004|Phase II: Randomized Groups|Death|1|||
162048673|NCT01193842|585233415|FG000|Phase II: Randomized Groups|Adverse Event|0|||
162048674|NCT01193842|585233416|FG001|Phase II: Randomized Groups|Adverse Event|0|||
162048675|NCT01193842|585233417|FG002|Phase II: Randomized Groups|Adverse Event|0|||
162048676|NCT01193842|585233418|FG003|Phase II: Randomized Groups|Adverse Event|5|||
162048677|NCT01193842|585233419|FG004|Phase II: Randomized Groups|Adverse Event|3|||
162048678|NCT01193842|585233415|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
162048679|NCT01193842|585233416|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
162048680|NCT01193842|585233417|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
162048681|NCT01193842|585233418|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
162048682|NCT01193842|585233419|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
162048683|NCT01193842|585233415|FG000|Phase II: Randomized Groups|Ineligible|0|||
162048684|NCT01193842|585233416|FG001|Phase II: Randomized Groups|Ineligible|0|||
162048685|NCT01193842|585233417|FG002|Phase II: Randomized Groups|Ineligible|0|||
162048686|NCT01193842|585233418|FG003|Phase II: Randomized Groups|Ineligible|0|||
162048687|NCT01193842|585233419|FG004|Phase II: Randomized Groups|Ineligible|1|||
162048688|NCT01193842|585233415|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
162048689|NCT01193842|585233416|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
162048690|NCT01193842|585233417|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
162048691|NCT01193842|585233418|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
162048692|NCT01193842|585233419|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
162048693|NCT02569671|585233421|FG000|Overall Study|Lost to Follow-up|2|||
162048694|NCT02569671|585233422|FG001|Overall Study|Lost to Follow-up|1|||
162048695|NCT02569671|585233421|FG000|Overall Study|Withdrawal by Subject|1|||
162048696|NCT02569671|585233422|FG001|Overall Study|Withdrawal by Subject|3|||
162048697|NCT01995825|585235177|FG000|Overall Study|Withdrawal by Subject|1|||
162048698|NCT01995825|585235178|FG001|Overall Study|Withdrawal by Subject|0|||
162048699|NCT01367002|585235179|FG000|Overall Study|Withdrawal by Subject|1|||
162048700|NCT01367002|585235180|FG001|Overall Study|Withdrawal by Subject|0|||
162048701|NCT01367002|585235179|FG000|Overall Study|Physician Decision|0|||
162048702|NCT01367002|585235180|FG001|Overall Study|Physician Decision|2|||
162048703|NCT00354744|585235183|FG000|Overall Study|Adverse Event|2|||
162048704|NCT00354744|585235183|FG000|Overall Study|Death|2|||
162048705|NCT00354744|585235183|FG000|Overall Study|Lack of Efficacy|11|||
162048706|NCT00354744|585235183|FG000|Overall Study|Lost to Follow-up|2|||
162048707|NCT00354744|585235183|FG000|Overall Study|Physician Decision|11|||
162048708|NCT00354744|585235183|FG000|Overall Study|Withdrawal by Subject|14|||
162048709|NCT00541931|585235184|FG000|Overall Study|Adverse Event|1|||
162048710|NCT00541931|585235185|FG001|Overall Study|Adverse Event|0|||
162048711|NCT00541931|585235184|FG000|Overall Study|Lost to Follow-up|3|||
162048712|NCT00541931|585235185|FG001|Overall Study|Lost to Follow-up|3|||
162048713|NCT00541931|585235184|FG000|Overall Study|Withdrawal by Subject|1|||
162048714|NCT00541931|585235185|FG001|Overall Study|Withdrawal by Subject|0|||
162048715|NCT00541931|585235184|FG000|Overall Study|Transportation Issue|0|||
162048716|NCT00541931|585235185|FG001|Overall Study|Transportation Issue|1|||
162048717|NCT03094169|585235189|FG000|Overall Study|Lack of Efficacy|0|||
162048718|NCT03094169|585235190|FG001|Overall Study|Lack of Efficacy|0|||
162048719|NCT03094169|585235191|FG002|Overall Study|Lack of Efficacy|0|||
162048720|NCT03094169|585235192|FG003|Overall Study|Lack of Efficacy|0|||
162048721|NCT03094169|585235193|FG004|Overall Study|Lack of Efficacy|0|||
162048722|NCT03094169|585235194|FG005|Overall Study|Lack of Efficacy|0|||
162048723|NCT03094169|585235195|FG006|Overall Study|Lack of Efficacy|0|||
162048724|NCT03094169|585235196|FG007|Overall Study|Lack of Efficacy|21|||
162048725|NCT03094169|585235189|FG000|Overall Study|Adverse Event|0|||
162048726|NCT03094169|585235190|FG001|Overall Study|Adverse Event|0|||
162048727|NCT03094169|585235191|FG002|Overall Study|Adverse Event|0|||
162048728|NCT03094169|585235192|FG003|Overall Study|Adverse Event|0|||
162048729|NCT03094169|585235193|FG004|Overall Study|Adverse Event|0|||
162048730|NCT03094169|585235194|FG005|Overall Study|Adverse Event|0|||
162048731|NCT03094169|585235195|FG006|Overall Study|Adverse Event|0|||
162048732|NCT03094169|585235196|FG007|Overall Study|Adverse Event|2|||
162048733|NCT03094169|585235189|FG000|Overall Study|Withdrawal by Subject|0|||
162048734|NCT03094169|585235190|FG001|Overall Study|Withdrawal by Subject|0|||
162048735|NCT03094169|585235191|FG002|Overall Study|Withdrawal by Subject|0|||
162048736|NCT03094169|585235192|FG003|Overall Study|Withdrawal by Subject|0|||
162048737|NCT03094169|585235193|FG004|Overall Study|Withdrawal by Subject|0|||
162048738|NCT03094169|585235194|FG005|Overall Study|Withdrawal by Subject|0|||
162048739|NCT03094169|585235195|FG006|Overall Study|Withdrawal by Subject|1|||
162048740|NCT03094169|585235196|FG007|Overall Study|Withdrawal by Subject|1|||
162048741|NCT03094169|585235189|FG000|Overall Study|Trial Termination|0|||
162048742|NCT03094169|585235190|FG001|Overall Study|Trial Termination|0|||
162048743|NCT03094169|585235191|FG002|Overall Study|Trial Termination|0|||
162048744|NCT03094169|585235192|FG003|Overall Study|Trial Termination|0|||
162048745|NCT03094169|585235193|FG004|Overall Study|Trial Termination|0|||
162048746|NCT03094169|585235194|FG005|Overall Study|Trial Termination|0|||
162048747|NCT03094169|585235195|FG006|Overall Study|Trial Termination|0|||
162048748|NCT03094169|585235196|FG007|Overall Study|Trial Termination|1|||
162048749|NCT00617851|585235197|FG000|Overall Study|Death|0|||
162048750|NCT00617851|585235198|FG001|Overall Study|Death|0|||
162048751|NCT00617851|585235199|FG002|Overall Study|Death|0|||
162048752|NCT00617851|585235200|FG003|Overall Study|Death|1|||
162048753|NCT00617851|585235197|FG000|Overall Study|Withdrawal by Subject|14|||
162048754|NCT00617851|585235198|FG001|Overall Study|Withdrawal by Subject|7|||
162048755|NCT00617851|585235199|FG002|Overall Study|Withdrawal by Subject|12|||
162048756|NCT00617851|585235200|FG003|Overall Study|Withdrawal by Subject|4|||
162048757|NCT00617851|585235197|FG000|Overall Study|Lost to Follow-up|27|||
162048758|NCT00617851|585235198|FG001|Overall Study|Lost to Follow-up|29|||
162048759|NCT00617851|585235199|FG002|Overall Study|Lost to Follow-up|31|||
162048760|NCT00617851|585235200|FG003|Overall Study|Lost to Follow-up|19|||
162048761|NCT00617851|585235197|FG000|Overall Study|Inappropriate Enrollment|5|||
162048762|NCT00617851|585235198|FG001|Overall Study|Inappropriate Enrollment|4|||
162048763|NCT00617851|585235199|FG002|Overall Study|Inappropriate Enrollment|1|||
162048764|NCT00617851|585235200|FG003|Overall Study|Inappropriate Enrollment|1|||
162048765|NCT00617851|585235197|FG000|Overall Study|Unable to classify|1|||
162048766|NCT00617851|585235198|FG001|Overall Study|Unable to classify|0|||
162048767|NCT00617851|585235199|FG002|Overall Study|Unable to classify|1|||
162048768|NCT00617851|585235200|FG003|Overall Study|Unable to classify|0|||
162048769|NCT05350410|585235203|FG000|Overall Study|Withdrawal by Subject|1|||
162048770|NCT03750955|585235210|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
162048771|NCT03750955|585235211|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
162048772|NCT03750955|585235210|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
162048773|NCT03750955|585235211|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
162048774|NCT00697788|585235217|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162048775|NCT00697788|585235218|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
162048776|NCT00697788|585235219|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162048777|NCT00697788|585235220|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162048778|NCT00697788|585235221|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162048779|NCT00697788|585235222|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162048780|NCT00697788|585235223|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162048781|NCT00697788|585235224|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
162048782|NCT00697788|585235217|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162048783|NCT00697788|585235218|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162048784|NCT00697788|585235219|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162048785|NCT00697788|585235220|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162048786|NCT00697788|585235221|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
162048787|NCT00697788|585235222|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162048788|NCT00697788|585235223|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162048789|NCT00697788|585235224|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
162048790|NCT00142935|585235226|FG000|Overall Study|Other reason|1|||
162048791|NCT00142935|585235227|FG001|Overall Study|Other reason|1|||
162048792|NCT00142935|585235228|FG002|Overall Study|Other reason|1|||
162048793|NCT00142935|585235226|FG000|Overall Study|Lost to Follow-up|2|||
162048794|NCT00142935|585235227|FG001|Overall Study|Lost to Follow-up|5|||
162048795|NCT00142935|585235228|FG002|Overall Study|Lost to Follow-up|5|||
162048796|NCT00142935|585235226|FG000|Overall Study|Death|0|||
162048797|NCT00142935|585235227|FG001|Overall Study|Death|2|||
162048798|NCT00142935|585235228|FG002|Overall Study|Death|1|||
162048799|NCT01180985|585235233|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
162048800|NCT01180985|585235234|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
162048801|NCT00705289|585235235|FG000|Overall Study|Subject or treating physician's choice|131|||
162048802|NCT03345914|585235240|FG000|Overall Study|Transition to another study at week 16|80|||
162048803|NCT03345914|585235241|FG001|Overall Study|Transition to another study at week 16|86|||
162048804|NCT03345914|585235242|FG002|Overall Study|Transition to another study at week 16|78|||
162048805|NCT03345914|585235240|FG000|Overall Study|Transition to OLE during follow-up|37|||
162048806|NCT03345914|585235241|FG001|Overall Study|Transition to OLE during follow-up|33|||
162048807|NCT03345914|585235242|FG002|Overall Study|Transition to OLE during follow-up|39|||
162048808|NCT03345914|585235240|FG000|Overall Study|Physician Decision|0|||
162048809|NCT03345914|585235241|FG001|Overall Study|Physician Decision|1|||
162048810|NCT03345914|585235242|FG002|Overall Study|Physician Decision|1|||
162048811|NCT03345914|585235240|FG000|Overall Study|Withdrawal by Subject|5|||
162048812|NCT03345914|585235241|FG001|Overall Study|Withdrawal by Subject|1|||
162048813|NCT03345914|585235242|FG002|Overall Study|Withdrawal by Subject|2|||
162048814|NCT03345914|585235240|FG000|Overall Study|Other|1|||
162048815|NCT03345914|585235241|FG001|Overall Study|Other|1|||
162048816|NCT03345914|585235242|FG002|Overall Study|Other|1|||
162048817|NCT03345914|585235240|FG000|Overall Study|Ongoing|0|||
162048818|NCT03345914|585235241|FG001|Overall Study|Ongoing|0|||
162048819|NCT03345914|585235242|FG002|Overall Study|Ongoing|1|||
162048820|NCT02601027|585235245|FG000|Registration to Surgery|Withdrawal by Subject|20|||
162048821|NCT02601027|585235246|FG001|Registration to Surgery|Withdrawal by Subject|10|||
162048822|NCT01330030|585235247|FG000|Overall Study|Lost to Follow-up|16|||
162048823|NCT01330030|585235248|FG001|Overall Study|Lost to Follow-up|17|||
162048824|NCT01365052|585235249|FG000|Overall Study|Adverse Event|4|||
162048825|NCT01365052|585235250|FG001|Overall Study|Adverse Event|4|||
162048826|NCT02248701|585235253|FG000|Overall Study|Withdrawal by Subject|2|||
162048827|NCT02248701|585235254|FG001|Overall Study|Withdrawal by Subject|1|||
162048828|NCT02248701|585235253|FG000|Overall Study|Physician Decision|0|||
162048829|NCT02248701|585235254|FG001|Overall Study|Physician Decision|1|||
162048830|NCT02248701|585235253|FG000|Overall Study|Adverse Event|1|||
162048831|NCT02248701|585235254|FG001|Overall Study|Adverse Event|0|||
162048832|NCT02248701|585235253|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
162048833|NCT02248701|585235254|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
162048834|NCT00885846|585235257|FG000|Overall Study|Withdrawal by Subject|2|||
162048835|NCT00885846|585235258|FG001|Overall Study|Withdrawal by Subject|5|||
162048836|NCT00885846|585235259|FG002|Overall Study|Withdrawal by Subject|2|||
162048837|NCT00074984|585235260|FG000|Overall Study|Death|1|||
162048838|NCT00074984|585235261|FG001|Overall Study|Death|2|||
162048839|NCT00074984|585235260|FG000|Overall Study|Withdrawal by Subject|2|||
162048840|NCT00074984|585235261|FG001|Overall Study|Withdrawal by Subject|3|||
162048841|NCT00074984|585235260|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
162048842|NCT00074984|585235261|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
162048843|NCT03758443|585235262|FG000|Induction Period|Adverse Event|2|||
162048844|NCT03758443|585235263|FG001|Induction Period|Adverse Event|4|||
162048845|NCT03758443|585235264|FG002|Induction Period|Adverse Event|2|||
162048846|NCT03758443|585235265|FG003|Induction Period|Adverse Event|3|||
162048847|NCT03758443|585235262|FG000|Induction Period|Physician Decision|1|||
162048848|NCT03758443|585235263|FG001|Induction Period|Physician Decision|1|||
162048849|NCT03758443|585235264|FG002|Induction Period|Physician Decision|3|||
162048850|NCT03758443|585235265|FG003|Induction Period|Physician Decision|0|||
162048851|NCT03758443|585235262|FG000|Induction Period|Protocol Violation|0|||
162048852|NCT03758443|585235263|FG001|Induction Period|Protocol Violation|0|||
162048853|NCT03758443|585235264|FG002|Induction Period|Protocol Violation|0|||
162048854|NCT03758443|585235265|FG003|Induction Period|Protocol Violation|1|||
162048855|NCT03758443|585235262|FG000|Induction Period|Withdrawal by Subject|3|||
162048856|NCT03758443|585235263|FG001|Induction Period|Withdrawal by Subject|2|||
162048857|NCT03758443|585235264|FG002|Induction Period|Withdrawal by Subject|2|||
162048858|NCT03758443|585235265|FG003|Induction Period|Withdrawal by Subject|4|||
162048859|NCT03758443|585235262|FG000|Extended Induction Period|Adverse Event|1|||
162048860|NCT03758443|585235263|FG001|Extended Induction Period|Adverse Event|1|||
162048861|NCT03758443|585235264|FG002|Extended Induction Period|Adverse Event|0|||
162048862|NCT03758443|585235265|FG003|Extended Induction Period|Adverse Event|1|||
162048863|NCT03758443|585235262|FG000|Extended Induction Period|Lost to Follow-up|1|||
162048864|NCT03758443|585235263|FG001|Extended Induction Period|Lost to Follow-up|0|||
162048865|NCT03758443|585235264|FG002|Extended Induction Period|Lost to Follow-up|0|||
162048866|NCT03758443|585235265|FG003|Extended Induction Period|Lost to Follow-up|0|||
162048867|NCT03758443|585235262|FG000|Extended Induction Period|Physician Decision|2|||
162048868|NCT03758443|585235263|FG001|Extended Induction Period|Physician Decision|1|||
162048869|NCT03758443|585235264|FG002|Extended Induction Period|Physician Decision|2|||
162048870|NCT03758443|585235265|FG003|Extended Induction Period|Physician Decision|2|||
162048871|NCT03758443|585235262|FG000|Extended Induction Period|Protocol Violation|0|||
162048872|NCT03758443|585235263|FG001|Extended Induction Period|Protocol Violation|0|||
162048873|NCT03758443|585235264|FG002|Extended Induction Period|Protocol Violation|0|||
162048874|NCT03758443|585235265|FG003|Extended Induction Period|Protocol Violation|1|||
162048875|NCT03758443|585235262|FG000|Extended Induction Period|Withdrawal by Subject|8|||
162048876|NCT03758443|585235263|FG001|Extended Induction Period|Withdrawal by Subject|1|||
162048877|NCT03758443|585235264|FG002|Extended Induction Period|Withdrawal by Subject|7|||
162048878|NCT03758443|585235265|FG003|Extended Induction Period|Withdrawal by Subject|3|||
162048879|NCT03758443|585235262|FG000|Extended Induction Period|Miscellaneous|1|||
162048880|NCT03758443|585235263|FG001|Extended Induction Period|Miscellaneous|0|||
162048881|NCT03758443|585235264|FG002|Extended Induction Period|Miscellaneous|0|||
162048882|NCT03758443|585235265|FG003|Extended Induction Period|Miscellaneous|0|||
162048883|NCT03758443|585235262|FG000|Maintenance Period|Adverse Event|1|||
162048884|NCT03758443|585235263|FG001|Maintenance Period|Adverse Event|2|||
162048885|NCT03758443|585235264|FG002|Maintenance Period|Adverse Event|0|||
162048886|NCT03758443|585235265|FG003|Maintenance Period|Adverse Event|0|||
162048887|NCT03758443|585235262|FG000|Maintenance Period|Lost to Follow-up|0|||
162048888|NCT03758443|585235263|FG001|Maintenance Period|Lost to Follow-up|0|||
162048889|NCT03758443|585235264|FG002|Maintenance Period|Lost to Follow-up|0|||
162048890|NCT03758443|585235265|FG003|Maintenance Period|Lost to Follow-up|1|||
162048891|NCT03758443|585235262|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
162048892|NCT03758443|585235263|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
162048893|NCT03758443|585235264|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
162048894|NCT03758443|585235265|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
162048895|NCT03758443|585235262|FG000|Maintenance Period|Protocol Violation|0|||
162048896|NCT03758443|585235263|FG001|Maintenance Period|Protocol Violation|1|||
162048897|NCT03758443|585235264|FG002|Maintenance Period|Protocol Violation|0|||
162048898|NCT03758443|585235265|FG003|Maintenance Period|Protocol Violation|0|||
162048899|NCT03758443|585235262|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
162048900|NCT03758443|585235263|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
162048901|NCT03758443|585235264|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
162048902|NCT03758443|585235265|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
162048903|NCT03758443|585235262|FG000|Maintenance Period|Withdrawal by Subject|1|||
162048904|NCT03758443|585235263|FG001|Maintenance Period|Withdrawal by Subject|0|||
162048905|NCT03758443|585235264|FG002|Maintenance Period|Withdrawal by Subject|1|||
162048906|NCT03758443|585235265|FG003|Maintenance Period|Withdrawal by Subject|1|||
162048907|NCT03758443|585235262|FG000|Maintenance Period|Miscellaneous|0|||
162048908|NCT03758443|585235263|FG001|Maintenance Period|Miscellaneous|0|||
162048909|NCT03758443|585235264|FG002|Maintenance Period|Miscellaneous|1|||
162048910|NCT03758443|585235265|FG003|Maintenance Period|Miscellaneous|0|||
162048911|NCT03080454|585235266|FG000|Baseline|Adverse Event|2|||
162048912|NCT03080454|585235266|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
162048913|NCT03080454|585235266|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
162048914|NCT02747875|585235267|FG000|Overall Study|Physician Decision|1|||
162048915|NCT02747875|585235268|FG001|Overall Study|Physician Decision|0|||
162048916|NCT02747875|585235267|FG000|Overall Study|Adverse Event|0|||
162048917|NCT02747875|585235268|FG001|Overall Study|Adverse Event|1|||
162048918|NCT00762385|585235270|FG000|First Intervention|Lens Issue|1|||
162048919|NCT00762385|585235271|FG001|First Intervention|Lens Issue|1|||
162048920|NCT00762385|585235270|FG000|First Intervention|Lost to Follow-up|0|||
162048921|NCT00762385|585235271|FG001|First Intervention|Lost to Follow-up|2|||
162048922|NCT00762385|585235270|FG000|First Intervention|Ineligible|1|||
162048923|NCT00762385|585235271|FG001|First Intervention|Ineligible|0|||
162048924|NCT00762385|585235270|FG000|First Intervention|Protocol Violation|0|||
162048925|NCT00762385|585235271|FG001|First Intervention|Protocol Violation|1|||
162048926|NCT00762385|585235270|FG000|Second Intervention|Protocol Violation|3|||
162048927|NCT00762385|585235271|FG001|Second Intervention|Protocol Violation|3|||
162048928|NCT03863197|585235272|FG000|Overall Study|Lost to Follow-up|2|||
162048929|NCT03863197|585235273|FG001|Overall Study|Lost to Follow-up|3|||
162048930|NCT03863197|585235272|FG000|Overall Study|Withdrawal by Subject|4|||
162048931|NCT03863197|585235273|FG001|Overall Study|Withdrawal by Subject|0|||
162048932|NCT03863197|585235272|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
162048933|NCT03863197|585235273|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
162048934|NCT00973674|585235279|FG000|Overall Study|Protocol Violation|2|||
162048935|NCT00973674|585235280|FG001|Overall Study|Protocol Violation|0|||
162048936|NCT02846324|585235283|FG000|Overall Study|Other|1|||
162048937|NCT02846324|585235284|FG001|Overall Study|Other|0|||
162048938|NCT02846324|585235285|FG002|Overall Study|Other|0|||
162048939|NCT02846324|585235286|FG003|Overall Study|Other|0|||
162048940|NCT02846324|585235283|FG000|Overall Study|Withdrawal by Subject|1|||
162048941|NCT02846324|585235284|FG001|Overall Study|Withdrawal by Subject|0|||
162048942|NCT02846324|585235285|FG002|Overall Study|Withdrawal by Subject|4|||
162048943|NCT02846324|585235286|FG003|Overall Study|Withdrawal by Subject|0|||
162048944|NCT00400764|585235291|FG000|Phase Ib|Adverse Event|1|||
162048945|NCT00400764|585235292|FG001|Phase Ib|Adverse Event|0|||
162048946|NCT00400764|585235293|FG002|Phase Ib|Adverse Event|0|||
162048947|NCT00400764|585235294|FG003|Phase Ib|Adverse Event|0|||
162048948|NCT00400764|585235295|FG004|Phase Ib|Adverse Event|0|||
162048949|NCT00400764|585235291|FG000|Phase Ib|Death|1|||
162048950|NCT00400764|585235292|FG001|Phase Ib|Death|0|||
162048951|NCT00400764|585235293|FG002|Phase Ib|Death|0|||
162048952|NCT00400764|585235294|FG003|Phase Ib|Death|0|||
162048953|NCT00400764|585235295|FG004|Phase Ib|Death|0|||
162048954|NCT00400764|585235291|FG000|Phase Ib|Disease Progression|4|||
162048955|NCT00400764|585235292|FG001|Phase Ib|Disease Progression|4|||
162048956|NCT00400764|585235293|FG002|Phase Ib|Disease Progression|0|||
162048957|NCT00400764|585235294|FG003|Phase Ib|Disease Progression|0|||
162048958|NCT00400764|585235295|FG004|Phase Ib|Disease Progression|0|||
162048959|NCT00400764|585235291|FG000|Phase II|Death|0|||
162048960|NCT00400764|585235292|FG001|Phase II|Death|0|||
162048961|NCT00400764|585235293|FG002|Phase II|Death|1|||
162048962|NCT00400764|585235294|FG003|Phase II|Death|2|||
162048963|NCT00400764|585235295|FG004|Phase II|Death|0|||
162048964|NCT00400764|585235291|FG000|Phase II|Lost to Follow-up|0|||
162048965|NCT00400764|585235292|FG001|Phase II|Lost to Follow-up|0|||
162048966|NCT00400764|585235293|FG002|Phase II|Lost to Follow-up|1|||
162048967|NCT00400764|585235294|FG003|Phase II|Lost to Follow-up|0|||
162048968|NCT00400764|585235295|FG004|Phase II|Lost to Follow-up|0|||
162048969|NCT00400764|585235291|FG000|Phase II|Physician Decision|0|||
162048970|NCT00400764|585235292|FG001|Phase II|Physician Decision|0|||
162048971|NCT00400764|585235293|FG002|Phase II|Physician Decision|1|||
162048972|NCT00400764|585235294|FG003|Phase II|Physician Decision|1|||
162048973|NCT00400764|585235295|FG004|Phase II|Physician Decision|0|||
162048974|NCT00400764|585235291|FG000|Phase II|Sponsor's decision to terminate|0|||
162048975|NCT00400764|585235292|FG001|Phase II|Sponsor's decision to terminate|0|||
162048976|NCT00400764|585235293|FG002|Phase II|Sponsor's decision to terminate|18|||
162048977|NCT00400764|585235294|FG003|Phase II|Sponsor's decision to terminate|22|||
162048978|NCT00400764|585235295|FG004|Phase II|Sponsor's decision to terminate|11|||
162048979|NCT00400764|585235291|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
162048980|NCT00400764|585235292|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
162048981|NCT00400764|585235293|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
162048982|NCT00400764|585235294|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
162048983|NCT00400764|585235295|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
162048984|NCT00400764|585235291|FG000|Phase II|Withdrawal by Subject|0|||
162048985|NCT00400764|585235292|FG001|Phase II|Withdrawal by Subject|0|||
162048986|NCT00400764|585235293|FG002|Phase II|Withdrawal by Subject|1|||
162048987|NCT00400764|585235294|FG003|Phase II|Withdrawal by Subject|1|||
162048988|NCT00400764|585235295|FG004|Phase II|Withdrawal by Subject|0|||
162048989|NCT00722800|585235299|FG000|Overall Study|Withdrawal by Subject|1|||
162048990|NCT00722800|585235300|FG001|Overall Study|Withdrawal by Subject|0|||
162048991|NCT00722800|585235299|FG000|Overall Study|Physician Decision|1|||
162048992|NCT00722800|585235300|FG001|Overall Study|Physician Decision|0|||
162048993|NCT02130297|585235301|FG000|Overall Study|Lost to Follow-up|4|||
162048994|NCT00347360|585235304|FG000|Overall Study|Adverse Event|1|||
162048995|NCT00347360|585235305|FG001|Overall Study|Adverse Event|2|||
162048996|NCT00347360|585235306|FG002|Overall Study|Adverse Event|0|||
162048997|NCT00347360|585235307|FG003|Overall Study|Adverse Event|4|||
162048998|NCT00347360|585235308|FG004|Overall Study|Adverse Event|1|||
162048999|NCT00347360|585235309|FG005|Overall Study|Adverse Event|2|||
162049000|NCT00347360|585235310|FG006|Overall Study|Adverse Event|2|||
162049001|NCT00347360|585235311|FG007|Overall Study|Adverse Event|0|||
162049002|NCT00347360|585235312|FG008|Overall Study|Adverse Event|2|||
162049003|NCT00347360|585235313|FG009|Overall Study|Adverse Event|3|||
162049004|NCT00347360|585235314|FG010|Overall Study|Adverse Event|3|||
162049005|NCT00347360|585235315|FG011|Overall Study|Adverse Event|1|||
162049006|NCT00347360|585235316|FG012|Overall Study|Adverse Event|3|||
162049007|NCT00347360|585235317|FG013|Overall Study|Adverse Event|2|||
162049008|NCT00347360|585235318|FG014|Overall Study|Adverse Event|2|||
162049009|NCT00347360|585235304|FG000|Overall Study|Lost to Follow-up|0|||
162049010|NCT00347360|585235305|FG001|Overall Study|Lost to Follow-up|0|||
162049011|NCT00347360|585235306|FG002|Overall Study|Lost to Follow-up|0|||
162049012|NCT00347360|585235307|FG003|Overall Study|Lost to Follow-up|2|||
162049013|NCT00347360|585235308|FG004|Overall Study|Lost to Follow-up|1|||
162049014|NCT00347360|585235309|FG005|Overall Study|Lost to Follow-up|1|||
162049015|NCT00347360|585235310|FG006|Overall Study|Lost to Follow-up|0|||
162049016|NCT00347360|585235311|FG007|Overall Study|Lost to Follow-up|1|||
162049017|NCT00347360|585235312|FG008|Overall Study|Lost to Follow-up|1|||
162049018|NCT00347360|585235313|FG009|Overall Study|Lost to Follow-up|2|||
162049019|NCT00347360|585235314|FG010|Overall Study|Lost to Follow-up|0|||
162049020|NCT00347360|585235315|FG011|Overall Study|Lost to Follow-up|0|||
162049021|NCT00347360|585235316|FG012|Overall Study|Lost to Follow-up|1|||
162049022|NCT00347360|585235317|FG013|Overall Study|Lost to Follow-up|0|||
162049023|NCT00347360|585235318|FG014|Overall Study|Lost to Follow-up|0|||
162049024|NCT00347360|585235304|FG000|Overall Study|Protocol Violation|2|||
162049025|NCT00347360|585235305|FG001|Overall Study|Protocol Violation|3|||
162049026|NCT00347360|585235306|FG002|Overall Study|Protocol Violation|1|||
162049027|NCT00347360|585235307|FG003|Overall Study|Protocol Violation|2|||
162049028|NCT00347360|585235308|FG004|Overall Study|Protocol Violation|1|||
162049029|NCT00347360|585235309|FG005|Overall Study|Protocol Violation|2|||
162049030|NCT00347360|585235310|FG006|Overall Study|Protocol Violation|0|||
162049031|NCT00347360|585235311|FG007|Overall Study|Protocol Violation|0|||
162049032|NCT00347360|585235312|FG008|Overall Study|Protocol Violation|1|||
162049033|NCT00347360|585235313|FG009|Overall Study|Protocol Violation|2|||
162049034|NCT00347360|585235314|FG010|Overall Study|Protocol Violation|0|||
162049035|NCT00347360|585235315|FG011|Overall Study|Protocol Violation|0|||
162049036|NCT00347360|585235316|FG012|Overall Study|Protocol Violation|0|||
162049037|NCT00347360|585235317|FG013|Overall Study|Protocol Violation|1|||
162049038|NCT00347360|585235318|FG014|Overall Study|Protocol Violation|0|||
162049039|NCT00347360|585235304|FG000|Overall Study|Withdrawal by Subject|0|||
162049040|NCT00347360|585235305|FG001|Overall Study|Withdrawal by Subject|1|||
162049041|NCT00347360|585235306|FG002|Overall Study|Withdrawal by Subject|2|||
162049042|NCT00347360|585235307|FG003|Overall Study|Withdrawal by Subject|4|||
162049043|NCT00347360|585235308|FG004|Overall Study|Withdrawal by Subject|1|||
162049044|NCT00347360|585235309|FG005|Overall Study|Withdrawal by Subject|2|||
162049045|NCT00347360|585235310|FG006|Overall Study|Withdrawal by Subject|1|||
162049046|NCT00347360|585235311|FG007|Overall Study|Withdrawal by Subject|1|||
162049047|NCT00347360|585235312|FG008|Overall Study|Withdrawal by Subject|1|||
162049048|NCT00347360|585235313|FG009|Overall Study|Withdrawal by Subject|1|||
162049049|NCT00347360|585235314|FG010|Overall Study|Withdrawal by Subject|0|||
162049050|NCT00347360|585235315|FG011|Overall Study|Withdrawal by Subject|3|||
162049051|NCT00347360|585235316|FG012|Overall Study|Withdrawal by Subject|4|||
162049052|NCT00347360|585235317|FG013|Overall Study|Withdrawal by Subject|2|||
162049053|NCT00347360|585235318|FG014|Overall Study|Withdrawal by Subject|1|||
162049054|NCT00347360|585235304|FG000|Overall Study|Lack of Efficacy|1|||
162049055|NCT00347360|585235305|FG001|Overall Study|Lack of Efficacy|1|||
162049056|NCT00347360|585235306|FG002|Overall Study|Lack of Efficacy|3|||
162049057|NCT00347360|585235307|FG003|Overall Study|Lack of Efficacy|1|||
162049058|NCT00347360|585235308|FG004|Overall Study|Lack of Efficacy|0|||
162049059|NCT00347360|585235309|FG005|Overall Study|Lack of Efficacy|1|||
162049060|NCT00347360|585235310|FG006|Overall Study|Lack of Efficacy|0|||
162049061|NCT00347360|585235311|FG007|Overall Study|Lack of Efficacy|1|||
162049062|NCT00347360|585235312|FG008|Overall Study|Lack of Efficacy|1|||
162049063|NCT00347360|585235313|FG009|Overall Study|Lack of Efficacy|0|||
162049064|NCT00347360|585235314|FG010|Overall Study|Lack of Efficacy|0|||
162049065|NCT00347360|585235315|FG011|Overall Study|Lack of Efficacy|0|||
162049066|NCT00347360|585235316|FG012|Overall Study|Lack of Efficacy|0|||
162049067|NCT00347360|585235317|FG013|Overall Study|Lack of Efficacy|0|||
162049068|NCT00347360|585235318|FG014|Overall Study|Lack of Efficacy|0|||
162049069|NCT00347360|585235304|FG000|Overall Study|Reason not listed/blank|1|||
162049070|NCT00347360|585235305|FG001|Overall Study|Reason not listed/blank|0|||
162049071|NCT00347360|585235306|FG002|Overall Study|Reason not listed/blank|0|||
162049072|NCT00347360|585235307|FG003|Overall Study|Reason not listed/blank|0|||
162049073|NCT00347360|585235308|FG004|Overall Study|Reason not listed/blank|0|||
162049074|NCT00347360|585235309|FG005|Overall Study|Reason not listed/blank|0|||
162049075|NCT00347360|585235310|FG006|Overall Study|Reason not listed/blank|1|||
162049076|NCT00347360|585235311|FG007|Overall Study|Reason not listed/blank|0|||
162049077|NCT00347360|585235312|FG008|Overall Study|Reason not listed/blank|0|||
162049078|NCT00347360|585235313|FG009|Overall Study|Reason not listed/blank|0|||
162049079|NCT00347360|585235314|FG010|Overall Study|Reason not listed/blank|0|||
162049080|NCT00347360|585235315|FG011|Overall Study|Reason not listed/blank|0|||
162049081|NCT00347360|585235316|FG012|Overall Study|Reason not listed/blank|0|||
162049082|NCT00347360|585235317|FG013|Overall Study|Reason not listed/blank|1|||
162049083|NCT00347360|585235318|FG014|Overall Study|Reason not listed/blank|0|||
162049084|NCT00347360|585235304|FG000|Overall Study|Per sponsors instruction|0|||
162049085|NCT00347360|585235305|FG001|Overall Study|Per sponsors instruction|1|||
162049086|NCT00347360|585235306|FG002|Overall Study|Per sponsors instruction|0|||
162049087|NCT00347360|585235307|FG003|Overall Study|Per sponsors instruction|0|||
162049088|NCT00347360|585235308|FG004|Overall Study|Per sponsors instruction|0|||
162049089|NCT00347360|585235309|FG005|Overall Study|Per sponsors instruction|0|||
162049090|NCT00347360|585235310|FG006|Overall Study|Per sponsors instruction|0|||
162049091|NCT00347360|585235311|FG007|Overall Study|Per sponsors instruction|0|||
162049092|NCT00347360|585235312|FG008|Overall Study|Per sponsors instruction|0|||
162049093|NCT00347360|585235313|FG009|Overall Study|Per sponsors instruction|0|||
162049094|NCT00347360|585235314|FG010|Overall Study|Per sponsors instruction|0|||
162049095|NCT00347360|585235315|FG011|Overall Study|Per sponsors instruction|0|||
162049096|NCT00347360|585235316|FG012|Overall Study|Per sponsors instruction|0|||
162049097|NCT00347360|585235317|FG013|Overall Study|Per sponsors instruction|0|||
162049098|NCT00347360|585235318|FG014|Overall Study|Per sponsors instruction|0|||
162049099|NCT00347360|585235304|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
162049100|NCT00347360|585235305|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
162049101|NCT00347360|585235306|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
162049102|NCT00347360|585235307|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
162049103|NCT00347360|585235308|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
162049104|NCT00347360|585235309|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
162049105|NCT00347360|585235310|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
162049106|NCT00347360|585235311|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
162049107|NCT00347360|585235312|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
162049108|NCT00347360|585235313|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
162049109|NCT00347360|585235314|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
162049110|NCT00347360|585235315|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
162049111|NCT00347360|585235316|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
162049112|NCT00347360|585235317|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
162049113|NCT00347360|585235318|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
162049114|NCT00347360|585235304|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
162049115|NCT00347360|585235305|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
162049116|NCT00347360|585235306|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
162049117|NCT00347360|585235307|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
162049118|NCT00347360|585235308|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
162049119|NCT00347360|585235309|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
162049120|NCT00347360|585235310|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
162049121|NCT00347360|585235311|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
162049122|NCT00347360|585235312|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
162049123|NCT00347360|585235313|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
162049124|NCT00347360|585235314|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
162049125|NCT00347360|585235315|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
162049126|NCT00347360|585235316|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
162049127|NCT00347360|585235317|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
162049128|NCT00347360|585235318|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
162049129|NCT00347360|585235304|FG000|Overall Study|Abnormal lab values|0|||
162049130|NCT00347360|585235305|FG001|Overall Study|Abnormal lab values|0|||
162049131|NCT00347360|585235306|FG002|Overall Study|Abnormal lab values|0|||
162049132|NCT00347360|585235307|FG003|Overall Study|Abnormal lab values|0|||
162049133|NCT00347360|585235308|FG004|Overall Study|Abnormal lab values|0|||
162049134|NCT00347360|585235309|FG005|Overall Study|Abnormal lab values|0|||
162049135|NCT00347360|585235310|FG006|Overall Study|Abnormal lab values|1|||
162049136|NCT00347360|585235311|FG007|Overall Study|Abnormal lab values|0|||
162049137|NCT00347360|585235312|FG008|Overall Study|Abnormal lab values|0|||
162049138|NCT00347360|585235313|FG009|Overall Study|Abnormal lab values|0|||
162049139|NCT00347360|585235314|FG010|Overall Study|Abnormal lab values|0|||
162049140|NCT00347360|585235315|FG011|Overall Study|Abnormal lab values|0|||
162049141|NCT00347360|585235316|FG012|Overall Study|Abnormal lab values|0|||
162049142|NCT00347360|585235317|FG013|Overall Study|Abnormal lab values|0|||
162049143|NCT00347360|585235318|FG014|Overall Study|Abnormal lab values|0|||
162049144|NCT00347360|585235304|FG000|Overall Study|PI recommended early withdrawal|0|||
162049145|NCT00347360|585235305|FG001|Overall Study|PI recommended early withdrawal|0|||
162049146|NCT00347360|585235306|FG002|Overall Study|PI recommended early withdrawal|0|||
162049147|NCT00347360|585235307|FG003|Overall Study|PI recommended early withdrawal|0|||
162049148|NCT00347360|585235308|FG004|Overall Study|PI recommended early withdrawal|0|||
162049149|NCT00347360|585235309|FG005|Overall Study|PI recommended early withdrawal|0|||
162049150|NCT00347360|585235310|FG006|Overall Study|PI recommended early withdrawal|0|||
162049151|NCT00347360|585235311|FG007|Overall Study|PI recommended early withdrawal|0|||
162049152|NCT00347360|585235312|FG008|Overall Study|PI recommended early withdrawal|0|||
162049153|NCT00347360|585235313|FG009|Overall Study|PI recommended early withdrawal|1|||
162049154|NCT00347360|585235314|FG010|Overall Study|PI recommended early withdrawal|0|||
162049155|NCT00347360|585235315|FG011|Overall Study|PI recommended early withdrawal|0|||
162049156|NCT00347360|585235316|FG012|Overall Study|PI recommended early withdrawal|0|||
162049157|NCT00347360|585235317|FG013|Overall Study|PI recommended early withdrawal|0|||
162049158|NCT00347360|585235318|FG014|Overall Study|PI recommended early withdrawal|0|||
162049159|NCT00347360|585235304|FG000|Overall Study|Did not meet criteria before ABPM|0|||
162049160|NCT00347360|585235305|FG001|Overall Study|Did not meet criteria before ABPM|0|||
162049161|NCT00347360|585235306|FG002|Overall Study|Did not meet criteria before ABPM|0|||
162049162|NCT00347360|585235307|FG003|Overall Study|Did not meet criteria before ABPM|0|||
162049163|NCT00347360|585235308|FG004|Overall Study|Did not meet criteria before ABPM|0|||
162049164|NCT00347360|585235309|FG005|Overall Study|Did not meet criteria before ABPM|0|||
162049165|NCT00347360|585235310|FG006|Overall Study|Did not meet criteria before ABPM|0|||
162049166|NCT00347360|585235311|FG007|Overall Study|Did not meet criteria before ABPM|0|||
162049167|NCT00347360|585235312|FG008|Overall Study|Did not meet criteria before ABPM|0|||
162049168|NCT00347360|585235313|FG009|Overall Study|Did not meet criteria before ABPM|0|||
162049169|NCT00347360|585235314|FG010|Overall Study|Did not meet criteria before ABPM|1|||
162049170|NCT00347360|585235315|FG011|Overall Study|Did not meet criteria before ABPM|0|||
162049171|NCT00347360|585235316|FG012|Overall Study|Did not meet criteria before ABPM|0|||
162049172|NCT00347360|585235317|FG013|Overall Study|Did not meet criteria before ABPM|0|||
162049173|NCT00347360|585235318|FG014|Overall Study|Did not meet criteria before ABPM|0|||
162049174|NCT00347360|585235304|FG000|Overall Study|Randomized in error|0|||
162049175|NCT00347360|585235305|FG001|Overall Study|Randomized in error|0|||
162049176|NCT00347360|585235306|FG002|Overall Study|Randomized in error|0|||
162049177|NCT00347360|585235307|FG003|Overall Study|Randomized in error|0|||
162049178|NCT00347360|585235308|FG004|Overall Study|Randomized in error|0|||
162049179|NCT00347360|585235309|FG005|Overall Study|Randomized in error|0|||
162049180|NCT00347360|585235310|FG006|Overall Study|Randomized in error|0|||
162049181|NCT00347360|585235311|FG007|Overall Study|Randomized in error|0|||
162049182|NCT00347360|585235312|FG008|Overall Study|Randomized in error|0|||
162049183|NCT00347360|585235313|FG009|Overall Study|Randomized in error|0|||
162049184|NCT00347360|585235314|FG010|Overall Study|Randomized in error|0|||
162049185|NCT00347360|585235315|FG011|Overall Study|Randomized in error|1|||
162049186|NCT00347360|585235316|FG012|Overall Study|Randomized in error|0|||
162049187|NCT00347360|585235317|FG013|Overall Study|Randomized in error|0|||
162049188|NCT00347360|585235318|FG014|Overall Study|Randomized in error|0|||
162049189|NCT00347360|585235304|FG000|Overall Study|Failed inclusion criteria #4|0|||
162049190|NCT00347360|585235305|FG001|Overall Study|Failed inclusion criteria #4|0|||
162049191|NCT00347360|585235306|FG002|Overall Study|Failed inclusion criteria #4|0|||
162049192|NCT00347360|585235307|FG003|Overall Study|Failed inclusion criteria #4|0|||
162049193|NCT00347360|585235308|FG004|Overall Study|Failed inclusion criteria #4|0|||
162049194|NCT00347360|585235309|FG005|Overall Study|Failed inclusion criteria #4|0|||
162049195|NCT00347360|585235310|FG006|Overall Study|Failed inclusion criteria #4|0|||
162049196|NCT00347360|585235311|FG007|Overall Study|Failed inclusion criteria #4|0|||
162049197|NCT00347360|585235312|FG008|Overall Study|Failed inclusion criteria #4|0|||
162049198|NCT00347360|585235313|FG009|Overall Study|Failed inclusion criteria #4|0|||
162049199|NCT00347360|585235314|FG010|Overall Study|Failed inclusion criteria #4|0|||
162049200|NCT00347360|585235315|FG011|Overall Study|Failed inclusion criteria #4|1|||
162049201|NCT00347360|585235316|FG012|Overall Study|Failed inclusion criteria #4|0|||
162049202|NCT00347360|585235317|FG013|Overall Study|Failed inclusion criteria #4|0|||
162049203|NCT00347360|585235318|FG014|Overall Study|Failed inclusion criteria #4|0|||
162049204|NCT00347360|585235304|FG000|Overall Study|Prolonged duration between visits|0|||
162049205|NCT00347360|585235305|FG001|Overall Study|Prolonged duration between visits|0|||
162049206|NCT00347360|585235306|FG002|Overall Study|Prolonged duration between visits|0|||
162049207|NCT00347360|585235307|FG003|Overall Study|Prolonged duration between visits|0|||
162049208|NCT00347360|585235308|FG004|Overall Study|Prolonged duration between visits|0|||
162049209|NCT00347360|585235309|FG005|Overall Study|Prolonged duration between visits|0|||
162049210|NCT00347360|585235310|FG006|Overall Study|Prolonged duration between visits|0|||
162049211|NCT00347360|585235311|FG007|Overall Study|Prolonged duration between visits|0|||
162049212|NCT00347360|585235312|FG008|Overall Study|Prolonged duration between visits|0|||
162049213|NCT00347360|585235313|FG009|Overall Study|Prolonged duration between visits|0|||
162049214|NCT00347360|585235314|FG010|Overall Study|Prolonged duration between visits|0|||
162049215|NCT00347360|585235315|FG011|Overall Study|Prolonged duration between visits|0|||
162049216|NCT00347360|585235316|FG012|Overall Study|Prolonged duration between visits|1|||
162049217|NCT00347360|585235317|FG013|Overall Study|Prolonged duration between visits|0|||
162049218|NCT00347360|585235318|FG014|Overall Study|Prolonged duration between visits|0|||
162049219|NCT00347360|585235304|FG000|Overall Study|Subject left town, ran out of study drug|0|||
162049220|NCT00347360|585235305|FG001|Overall Study|Subject left town, ran out of study drug|0|||
162049221|NCT00347360|585235306|FG002|Overall Study|Subject left town, ran out of study drug|0|||
162049222|NCT00347360|585235307|FG003|Overall Study|Subject left town, ran out of study drug|0|||
162049223|NCT00347360|585235308|FG004|Overall Study|Subject left town, ran out of study drug|0|||
162049224|NCT00347360|585235309|FG005|Overall Study|Subject left town, ran out of study drug|0|||
162049225|NCT00347360|585235310|FG006|Overall Study|Subject left town, ran out of study drug|0|||
162049226|NCT00347360|585235311|FG007|Overall Study|Subject left town, ran out of study drug|0|||
162049227|NCT00347360|585235312|FG008|Overall Study|Subject left town, ran out of study drug|0|||
162049228|NCT00347360|585235313|FG009|Overall Study|Subject left town, ran out of study drug|0|||
162049229|NCT00347360|585235314|FG010|Overall Study|Subject left town, ran out of study drug|0|||
162049230|NCT00347360|585235315|FG011|Overall Study|Subject left town, ran out of study drug|0|||
162049231|NCT00347360|585235316|FG012|Overall Study|Subject left town, ran out of study drug|0|||
162049232|NCT00347360|585235317|FG013|Overall Study|Subject left town, ran out of study drug|1|||
162049233|NCT00347360|585235318|FG014|Overall Study|Subject left town, ran out of study drug|0|||
162049234|NCT00347360|585235304|FG000|Overall Study|Subject refuse to sign updated consent|0|||
162049235|NCT00347360|585235305|FG001|Overall Study|Subject refuse to sign updated consent|0|||
162049236|NCT00347360|585235306|FG002|Overall Study|Subject refuse to sign updated consent|0|||
162049237|NCT00347360|585235307|FG003|Overall Study|Subject refuse to sign updated consent|0|||
162049238|NCT00347360|585235308|FG004|Overall Study|Subject refuse to sign updated consent|0|||
162049239|NCT00347360|585235309|FG005|Overall Study|Subject refuse to sign updated consent|0|||
162049240|NCT00347360|585235310|FG006|Overall Study|Subject refuse to sign updated consent|0|||
162049241|NCT00347360|585235311|FG007|Overall Study|Subject refuse to sign updated consent|0|||
162049242|NCT00347360|585235312|FG008|Overall Study|Subject refuse to sign updated consent|0|||
162049243|NCT00347360|585235313|FG009|Overall Study|Subject refuse to sign updated consent|0|||
162049244|NCT00347360|585235314|FG010|Overall Study|Subject refuse to sign updated consent|0|||
162049245|NCT00347360|585235315|FG011|Overall Study|Subject refuse to sign updated consent|0|||
162049246|NCT00347360|585235316|FG012|Overall Study|Subject refuse to sign updated consent|0|||
162049247|NCT00347360|585235317|FG013|Overall Study|Subject refuse to sign updated consent|0|||
162049248|NCT00347360|585235318|FG014|Overall Study|Subject refuse to sign updated consent|1|||
162049249|NCT00347360|585235304|FG000|Overall Study|Visits conflicted with new job|0|||
162049250|NCT00347360|585235305|FG001|Overall Study|Visits conflicted with new job|0|||
162049251|NCT00347360|585235306|FG002|Overall Study|Visits conflicted with new job|0|||
162049252|NCT00347360|585235307|FG003|Overall Study|Visits conflicted with new job|0|||
162049253|NCT00347360|585235308|FG004|Overall Study|Visits conflicted with new job|0|||
162049254|NCT00347360|585235309|FG005|Overall Study|Visits conflicted with new job|0|||
162049255|NCT00347360|585235310|FG006|Overall Study|Visits conflicted with new job|1|||
162049256|NCT00347360|585235311|FG007|Overall Study|Visits conflicted with new job|0|||
162049257|NCT00347360|585235312|FG008|Overall Study|Visits conflicted with new job|0|||
162049258|NCT00347360|585235313|FG009|Overall Study|Visits conflicted with new job|0|||
162049259|NCT00347360|585235314|FG010|Overall Study|Visits conflicted with new job|0|||
162049260|NCT00347360|585235315|FG011|Overall Study|Visits conflicted with new job|0|||
162049261|NCT00347360|585235316|FG012|Overall Study|Visits conflicted with new job|0|||
162049262|NCT00347360|585235317|FG013|Overall Study|Visits conflicted with new job|0|||
162049263|NCT00347360|585235318|FG014|Overall Study|Visits conflicted with new job|0|||
162049264|NCT00508755|585235319|FG000|Overall Study|Withdrawal by Subject|1|||
162049265|NCT00957580|585235320|FG000|Overall Study|Ongoing at data cut-off|0|||
162049266|NCT00957580|585235321|FG001|Overall Study|Ongoing at data cut-off|1|||
162049267|NCT00957580|585235322|FG002|Overall Study|Ongoing at data cut-off|0|||
162049268|NCT00957580|585235320|FG000|Overall Study|Enrolled but not treated|0|||
162049269|NCT00957580|585235321|FG001|Overall Study|Enrolled but not treated|1|||
162049270|NCT00957580|585235322|FG002|Overall Study|Enrolled but not treated|0|||
162049271|NCT03113071|585235323|FG000|Overall Study|Withdrawal by Subject|1|||
162049272|NCT03113071|585235324|FG001|Overall Study|Withdrawal by Subject|0|||
162049273|NCT02369016|585235329|FG000|Overall Study|AE associated with clinical disease progression|2|||
162049274|NCT02369016|585235330|FG001|Overall Study|AE associated with clinical disease progression|1|||
162049275|NCT02369016|585235329|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
162049276|NCT02369016|585235330|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
162049277|NCT02369016|585235329|FG000|Overall Study|Progressive disease - clinical progression|1|||
162049278|NCT02369016|585235330|FG001|Overall Study|Progressive disease - clinical progression|4|||
162049279|NCT02369016|585235329|FG000|Overall Study|withdrawal by patient|4|||
162049280|NCT02369016|585235330|FG001|Overall Study|withdrawal by patient|0|||
162049281|NCT02369016|585235329|FG000|Overall Study|Progressive disease - radiological progression|6|||
162049282|NCT02369016|585235330|FG001|Overall Study|Progressive disease - radiological progression|2|||
162049283|NCT01187433|585235331|FG000|Overall Study|Protocol Violation|6|||
162049284|NCT01187433|585235332|FG001|Overall Study|Protocol Violation|2|||
162049285|NCT01187433|585235331|FG000|Overall Study|Withdrawal by Subject|5|||
162049286|NCT01187433|585235332|FG001|Overall Study|Withdrawal by Subject|2|||
162049287|NCT04203797|585235333|FG000|Overall Study|Adverse Event|1|||
162049288|NCT04203797|585235334|FG001|Overall Study|Adverse Event|0|||
162049289|NCT04203797|585235333|FG000|Overall Study|Did not complete End of Study follow-up|1|||
162049290|NCT04203797|585235334|FG001|Overall Study|Did not complete End of Study follow-up|0|||
162049291|NCT00621959|585235335|FG000|Overall Study|Adverse Event|4|||
162049292|NCT00621959|585235336|FG001|Overall Study|Adverse Event|2|||
162049293|NCT00621959|585235335|FG000|Overall Study|Lack of Efficacy|1|||
162049294|NCT00621959|585235336|FG001|Overall Study|Lack of Efficacy|1|||
162049295|NCT00621959|585235335|FG000|Overall Study|Lost to Follow-up|0|||
162049296|NCT00621959|585235336|FG001|Overall Study|Lost to Follow-up|2|||
162049297|NCT00621959|585235335|FG000|Overall Study|Withdrawal by Subject|1|||
162049298|NCT00621959|585235336|FG001|Overall Study|Withdrawal by Subject|1|||
162049299|NCT00621959|585235335|FG000|Overall Study|Other|1|||
162049300|NCT00621959|585235336|FG001|Overall Study|Other|3|||
162049301|NCT00242216|585235337|FG000|Overall Study|Lost to Follow-up|12|||
162049302|NCT00242216|585235338|FG001|Overall Study|Lost to Follow-up|17|||
162049303|NCT00242216|585235337|FG000|Overall Study|Death|4|||
162049304|NCT00242216|585235338|FG001|Overall Study|Death|2|||
162049305|NCT00242216|585235337|FG000|Overall Study|Lack of Efficacy|1|||
162049306|NCT00242216|585235338|FG001|Overall Study|Lack of Efficacy|2|||
162049307|NCT00242216|585235337|FG000|Overall Study|no medicaiton dispensed|1|||
162049308|NCT00242216|585235338|FG001|Overall Study|no medicaiton dispensed|1|||
162049309|NCT02484690|585235339|FG000|Overall Study|Adverse Event|1|||
162049310|NCT02484690|585235340|FG001|Overall Study|Adverse Event|3|||
162049311|NCT02484690|585235341|FG002|Overall Study|Adverse Event|0|||
162049312|NCT02484690|585235342|FG003|Overall Study|Adverse Event|0|||
162049313|NCT02484690|585235343|FG004|Overall Study|Adverse Event|5|||
162049314|NCT02484690|585235339|FG000|Overall Study|Death|0|||
162049315|NCT02484690|585235340|FG001|Overall Study|Death|0|||
162049316|NCT02484690|585235341|FG002|Overall Study|Death|0|||
162049317|NCT02484690|585235342|FG003|Overall Study|Death|0|||
162049318|NCT02484690|585235343|FG004|Overall Study|Death|1|||
162049319|NCT02484690|585235339|FG000|Overall Study|Withdrawal by Subject|1|||
162049320|NCT02484690|585235340|FG001|Overall Study|Withdrawal by Subject|3|||
162049321|NCT02484690|585235341|FG002|Overall Study|Withdrawal by Subject|1|||
162049322|NCT02484690|585235342|FG003|Overall Study|Withdrawal by Subject|2|||
162049323|NCT02484690|585235343|FG004|Overall Study|Withdrawal by Subject|0|||
162049324|NCT02484690|585235339|FG000|Overall Study|Physician Decision|2|||
162049325|NCT02484690|585235340|FG001|Overall Study|Physician Decision|0|||
162049326|NCT02484690|585235341|FG002|Overall Study|Physician Decision|1|||
162049327|NCT02484690|585235342|FG003|Overall Study|Physician Decision|0|||
162049328|NCT02484690|585235343|FG004|Overall Study|Physician Decision|0|||
162049329|NCT02484690|585235339|FG000|Overall Study|Lost to Follow-up|0|||
162049330|NCT02484690|585235340|FG001|Overall Study|Lost to Follow-up|0|||
162049331|NCT02484690|585235341|FG002|Overall Study|Lost to Follow-up|1|||
162049332|NCT02484690|585235342|FG003|Overall Study|Lost to Follow-up|0|||
162049333|NCT02484690|585235343|FG004|Overall Study|Lost to Follow-up|0|||
162049334|NCT03360747|585235344|FG000|Overall Study|Voluntary Withdrawal|1|||
162049335|NCT01759511|585235345|FG000|Overall Study|Adverse Event|4|||
162049336|NCT01759511|585235345|FG000|Overall Study|Death|2|||
162049337|NCT01759511|585235345|FG000|Overall Study|Lack of Efficacy|2|||
162049338|NCT01759511|585235345|FG000|Overall Study|Physician Decision|1|||
162049339|NCT01759511|585235345|FG000|Overall Study|Progressive Disease|5|||
162049340|NCT01759511|585235345|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
162049341|NCT01759511|585235345|FG000|Overall Study|Study Terminated by Sponsor|13|||
162049342|NCT01759511|585235345|FG000|Overall Study|Withdrawal by Subject|3|||
162049343|NCT01757535|585235353|FG000|Overall Study|Disease Relapse|151|||
162049344|NCT01757535|585235354|FG001|Overall Study|Disease Relapse|181|||
162049345|NCT01757535|585235353|FG000|Overall Study|Other Reasons|28|||
162049346|NCT01757535|585235354|FG001|Overall Study|Other Reasons|27|||
162049347|NCT01757535|585235353|FG000|Overall Study|Adverse Event|31|||
162049348|NCT01757535|585235354|FG001|Overall Study|Adverse Event|11|||
162049349|NCT01757535|585235353|FG000|Overall Study|Withdrew Consent|19|||
162049350|NCT01757535|585235354|FG001|Overall Study|Withdrew Consent|13|||
162049351|NCT01757535|585235353|FG000|Overall Study|Physician Decision|7|||
162049352|NCT01757535|585235354|FG001|Overall Study|Physician Decision|0|||
162049353|NCT01757535|585235353|FG000|Overall Study|Death|2|||
162049354|NCT01757535|585235354|FG001|Overall Study|Death|2|||
162049355|NCT00589290|585235355|FG000|Overall Study|Withdrawal by Subject|1|||
162049356|NCT03730012|585235357|FG000|Overall Study|Adverse Event|0|||
162049357|NCT03730012|585235358|FG001|Overall Study|Adverse Event|1|||
162049358|NCT03730012|585235357|FG000|Overall Study|Lack of Efficacy|1|||
162049359|NCT03730012|585235358|FG001|Overall Study|Lack of Efficacy|5|||
162049360|NCT03730012|585235357|FG000|Overall Study|Withdrawal by Subject|0|||
162049361|NCT03730012|585235358|FG001|Overall Study|Withdrawal by Subject|1|||
162049362|NCT03730012|585235357|FG000|Overall Study|Miscellaneous|2|||
162049363|NCT03730012|585235358|FG001|Overall Study|Miscellaneous|1|||
162049364|NCT01516437|585237013|FG000|Overall Study|Reason not specified|0|||
162049365|NCT01516437|585237014|FG001|Overall Study|Reason not specified|0|||
162049366|NCT01516437|585237015|FG002|Overall Study|Reason not specified|1|||
162049367|NCT01516437|585237016|FG003|Overall Study|Reason not specified|1|||
162049368|NCT00403234|585237017|FG000|Overall Study|Withdrawal by Subject|0|||
162049369|NCT00403234|585237018|FG001|Overall Study|Withdrawal by Subject|1|||
162049370|NCT00403234|585237019|FG002|Overall Study|Withdrawal by Subject|0|||
162049371|NCT00403234|585237020|FG003|Overall Study|Withdrawal by Subject|0|||
162049372|NCT00403234|585237017|FG000|Overall Study|Adverse Event|1|||
162049373|NCT00403234|585237018|FG001|Overall Study|Adverse Event|0|||
162049374|NCT00403234|585237019|FG002|Overall Study|Adverse Event|1|||
162049375|NCT00403234|585237020|FG003|Overall Study|Adverse Event|0|||
162049376|NCT00560105|585237023|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
162049377|NCT00560105|585237024|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
162049378|NCT01550289|585237025|FG000|Overall Study|Protocol Violation|1|||
162049379|NCT01550289|585237026|FG001|Overall Study|Protocol Violation|0|||
162049380|NCT01550289|585237025|FG000|Overall Study|Lost to Follow-up|1|||
162049381|NCT01550289|585237026|FG001|Overall Study|Lost to Follow-up|1|||
162049382|NCT01550289|585237025|FG000|Overall Study|Withdrawal by Subject|11|||
162049383|NCT01550289|585237026|FG001|Overall Study|Withdrawal by Subject|3|||
162049384|NCT03539081|585237027|FG000|Overall Study|Withdrawal by Subject|2|||
162049385|NCT03539081|585237028|FG001|Overall Study|Withdrawal by Subject|3|||
162049386|NCT03539081|585237029|FG002|Overall Study|Withdrawal by Subject|0|||
162049387|NCT03539081|585237027|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
162049388|NCT03539081|585237028|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
162049389|NCT03539081|585237029|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
162049390|NCT02555683|585237038|FG000|Overall Study|Physician Decision|1|||
162049391|NCT02555683|585237039|FG001|Overall Study|Physician Decision|0|||
162049392|NCT02555683|585237040|FG002|Overall Study|Physician Decision|2|||
162049393|NCT02555683|585237038|FG000|Overall Study|Lost to Follow-up|2|||
162049394|NCT02555683|585237039|FG001|Overall Study|Lost to Follow-up|1|||
162049395|NCT02555683|585237040|FG002|Overall Study|Lost to Follow-up|2|||
162049396|NCT02555683|585237038|FG000|Overall Study|Technical Problems|1|||
162049397|NCT02555683|585237039|FG001|Overall Study|Technical Problems|1|||
162049398|NCT02555683|585237040|FG002|Overall Study|Technical Problems|0|||
162049399|NCT02555683|585237038|FG000|Overall Study|Protocol deviation|0|||
162049400|NCT02555683|585237039|FG001|Overall Study|Protocol deviation|1|||
162049401|NCT02555683|585237040|FG002|Overall Study|Protocol deviation|0|||
162049402|NCT02555683|585237038|FG000|Overall Study|Lack of Efficacy|2|||
162049403|NCT02555683|585237039|FG001|Overall Study|Lack of Efficacy|0|||
162049404|NCT02555683|585237040|FG002|Overall Study|Lack of Efficacy|0|||
162049405|NCT02555683|585237038|FG000|Overall Study|Death|0|||
162049406|NCT02555683|585237039|FG001|Overall Study|Death|1|||
162049407|NCT02555683|585237040|FG002|Overall Study|Death|2|||
162049408|NCT02555683|585237038|FG000|Overall Study|Adverse Event|1|||
162049409|NCT02555683|585237039|FG001|Overall Study|Adverse Event|0|||
162049410|NCT02555683|585237040|FG002|Overall Study|Adverse Event|1|||
162049411|NCT02555683|585237038|FG000|Overall Study|Subject/guardian decision|12|||
162049412|NCT02555683|585237039|FG001|Overall Study|Subject/guardian decision|12|||
162049413|NCT02555683|585237040|FG002|Overall Study|Subject/guardian decision|22|||
162049414|NCT02555683|585237038|FG000|Overall Study|Death post Treatment/safety period|0|||
162049415|NCT02555683|585237039|FG001|Overall Study|Death post Treatment/safety period|1|||
162049416|NCT02555683|585237040|FG002|Overall Study|Death post Treatment/safety period|0|||
162049417|NCT04622306|585237050|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
162049418|NCT04622306|585237051|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
162049419|NCT04622306|585237052|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
162049420|NCT04622306|585237053|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
162049421|NCT04622306|585237054|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
162049422|NCT04622306|585237055|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
162049423|NCT04622306|585237050|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
162049424|NCT04622306|585237051|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
162049425|NCT04622306|585237052|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
162049426|NCT04622306|585237053|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
162049427|NCT04622306|585237054|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
162049428|NCT04622306|585237055|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
162049429|NCT02763462|585237057|FG000|Overall Study|Protocol Violation|6|||
162049430|NCT00129272|585237058|FG000|Overall Study|Lost to Follow-up|12|||
162049431|NCT00129272|585237059|FG001|Overall Study|Lost to Follow-up|11|||
162049432|NCT00129272|585237058|FG000|Overall Study|Withdrawal by Subject|5|||
162049433|NCT00129272|585237059|FG001|Overall Study|Withdrawal by Subject|11|||
162049434|NCT00675948|585237061|FG000|Overall Study|Adverse Event|23|||
162049435|NCT00675948|585237062|FG001|Overall Study|Adverse Event|1|||
162049436|NCT00675948|585237061|FG000|Overall Study|Lack of Efficacy|3|||
162049437|NCT00675948|585237062|FG001|Overall Study|Lack of Efficacy|0|||
162049438|NCT00675948|585237061|FG000|Overall Study|Withdrawal by Subject|7|||
162049439|NCT00675948|585237062|FG001|Overall Study|Withdrawal by Subject|0|||
162049440|NCT00675948|585237061|FG000|Overall Study|Lost to Follow-up|2|||
162049441|NCT00675948|585237062|FG001|Overall Study|Lost to Follow-up|0|||
162049442|NCT00675948|585237061|FG000|Overall Study|Protocol Violation|1|||
162049443|NCT00675948|585237062|FG001|Overall Study|Protocol Violation|0|||
162049444|NCT00675948|585237061|FG000|Overall Study|Pain under control|1|||
162049445|NCT00675948|585237062|FG001|Overall Study|Pain under control|0|||
162049446|NCT00675948|585237061|FG000|Overall Study|Sponsor decision|0|||
162049447|NCT00675948|585237062|FG001|Overall Study|Sponsor decision|1|||
162049448|NCT00675948|585237061|FG000|Overall Study|Patient died|1|||
162049449|NCT00675948|585237062|FG001|Overall Study|Patient died|0|||
162049450|NCT00675948|585237061|FG000|Overall Study|Patient unable to comply with diaries|1|||
162049451|NCT00675948|585237062|FG001|Overall Study|Patient unable to comply with diaries|0|||
162049452|NCT00675948|585237061|FG000|Overall Study|Patient feels unable to take medication|0|||
162049453|NCT00675948|585237062|FG001|Overall Study|Patient feels unable to take medication|1|||
162049454|NCT02100514|585237066|FG000|Treatment Period|Adverse Event|0|||
162049455|NCT02100514|585237067|FG001|Treatment Period|Adverse Event|5|||
162049456|NCT02100514|585237068|FG002|Treatment Period|Adverse Event|0|||
162049457|NCT02100514|585237069|FG003|Treatment Period|Adverse Event|0|||
162049458|NCT02100514|585237070|FG004|Treatment Period|Adverse Event|0|||
162049459|NCT02100514|585237066|FG000|Treatment Period|Death|2|||
162049460|NCT02100514|585237067|FG001|Treatment Period|Death|2|||
162049461|NCT02100514|585237068|FG002|Treatment Period|Death|0|||
162049462|NCT02100514|585237069|FG003|Treatment Period|Death|0|||
162049463|NCT02100514|585237070|FG004|Treatment Period|Death|0|||
162049464|NCT02100514|585237066|FG000|Treatment Period|Lost to Follow-up|5|||
162049465|NCT02100514|585237067|FG001|Treatment Period|Lost to Follow-up|17|||
162049466|NCT02100514|585237068|FG002|Treatment Period|Lost to Follow-up|0|||
162049467|NCT02100514|585237069|FG003|Treatment Period|Lost to Follow-up|0|||
162049468|NCT02100514|585237070|FG004|Treatment Period|Lost to Follow-up|0|||
162049469|NCT02100514|585237066|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
162049470|NCT02100514|585237067|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
162049471|NCT02100514|585237068|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
162049472|NCT02100514|585237069|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
162049473|NCT02100514|585237070|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
162049474|NCT02100514|585237066|FG000|Treatment Period|Protocol Violation|1|||
162049475|NCT02100514|585237067|FG001|Treatment Period|Protocol Violation|1|||
162049476|NCT02100514|585237068|FG002|Treatment Period|Protocol Violation|0|||
162049477|NCT02100514|585237069|FG003|Treatment Period|Protocol Violation|0|||
162049478|NCT02100514|585237070|FG004|Treatment Period|Protocol Violation|0|||
162049479|NCT02100514|585237066|FG000|Treatment Period|Withdrawal by Subject|12|||
162049480|NCT02100514|585237067|FG001|Treatment Period|Withdrawal by Subject|37|||
162049481|NCT02100514|585237068|FG002|Treatment Period|Withdrawal by Subject|0|||
162049482|NCT02100514|585237069|FG003|Treatment Period|Withdrawal by Subject|0|||
162049483|NCT02100514|585237070|FG004|Treatment Period|Withdrawal by Subject|0|||
162049484|NCT02100514|585237066|FG000|Treatment Period|Other|9|||
162049485|NCT02100514|585237067|FG001|Treatment Period|Other|11|||
162049486|NCT02100514|585237068|FG002|Treatment Period|Other|0|||
162049487|NCT02100514|585237069|FG003|Treatment Period|Other|0|||
162049488|NCT02100514|585237070|FG004|Treatment Period|Other|0|||
162049489|NCT02100514|585237066|FG000|Extension Period|Withdrew consent|0|||
162049490|NCT02100514|585237067|FG001|Extension Period|Withdrew consent|0|||
162049491|NCT02100514|585237068|FG002|Extension Period|Withdrew consent|2|||
162049492|NCT02100514|585237069|FG003|Extension Period|Withdrew consent|0|||
162049493|NCT02100514|585237070|FG004|Extension Period|Withdrew consent|0|||
162049494|NCT01896102|585237071|FG000|Overall Study|Death|1|||
162049495|NCT01896102|585237071|FG000|Overall Study|Participant to receive allogenic transplant|2|||
162049496|NCT01145625|585237072|FG000|Overall Study|Lost to Follow-up|8|||
162049497|NCT01145625|585237073|FG001|Overall Study|Lost to Follow-up|9|||
162049498|NCT01145625|585237072|FG000|Overall Study|Adverse Event|6|||
162049499|NCT01145625|585237073|FG001|Overall Study|Adverse Event|4|||
162049500|NCT01145625|585237072|FG000|Overall Study|Protocol Violation|3|||
162049501|NCT01145625|585237073|FG001|Overall Study|Protocol Violation|1|||
162049502|NCT01145625|585237072|FG000|Overall Study|Withdrawal by Subject|7|||
162049503|NCT01145625|585237073|FG001|Overall Study|Withdrawal by Subject|16|||
162049504|NCT01145625|585237072|FG000|Overall Study|Pregnancy|0|||
162049505|NCT01145625|585237073|FG001|Overall Study|Pregnancy|1|||
162049506|NCT01751178|585237075|FG000|Overall Study|Adverse Event|2|||
162049507|NCT01751178|585237076|FG001|Overall Study|Adverse Event|0|||
162049508|NCT01751178|585237077|FG002|Overall Study|Adverse Event|0|||
162049509|NCT01751178|585237075|FG000|Overall Study|Other Reason (unknown)|1|||
162049510|NCT01751178|585237076|FG001|Overall Study|Other Reason (unknown)|0|||
162049511|NCT01751178|585237077|FG002|Overall Study|Other Reason (unknown)|2|||
162049512|NCT04289623|585237078|FG000|Wave 1 Emails|Email was not delivered|268|||
162049513|NCT04289623|585237079|FG001|Wave 1 Emails|Email was not delivered|257|||
162049514|NCT04289623|585237080|FG002|Wave 1 Emails|Email was not delivered|0|||
162049515|NCT04289623|585237081|FG003|Wave 1 Emails|Email was not delivered|0|||
162049516|NCT04289623|585237082|FG004|Wave 1 Emails|Email was not delivered|0|||
162049517|NCT04289623|585237083|FG005|Wave 1 Emails|Email was not delivered|0|||
162049518|NCT04138810|585237090|FG000|Overall Study|Withdrawal by Subject|0|||
162049519|NCT04138810|585237091|FG001|Overall Study|Withdrawal by Subject|1|||
162049520|NCT04138810|585237090|FG000|Overall Study|Subject cancelled surgery|1|||
162049521|NCT04138810|585237091|FG001|Overall Study|Subject cancelled surgery|0|||
162049522|NCT00696800|585237092|FG000|Overall Study|Adverse Event|16|||
162049523|NCT00696800|585237093|FG001|Overall Study|Adverse Event|3|||
162049524|NCT00696800|585237092|FG000|Overall Study|Insufficient compliance with medication|2|||
162049525|NCT00696800|585237093|FG001|Overall Study|Insufficient compliance with medication|1|||
162049526|NCT00696800|585237092|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
162049527|NCT00696800|585237093|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
162049528|NCT00696800|585237092|FG000|Overall Study|Insufficient ovarian response|4|||
162049529|NCT00696800|585237093|FG001|Overall Study|Insufficient ovarian response|1|||
162049530|NCT00696800|585237092|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
162049531|NCT00696800|585237093|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
162049532|NCT00696800|585237092|FG000|Overall Study|Too high ovarian response|6|||
162049533|NCT00696800|585237093|FG001|Overall Study|Too high ovarian response|1|||
162049534|NCT00696800|585237092|FG000|Overall Study|No/too few/bad quality oocytes|4|||
162049535|NCT00696800|585237093|FG001|Overall Study|No/too few/bad quality oocytes|3|||
162049536|NCT00696800|585237092|FG000|Overall Study|No/abnormal fertilization|11|||
162049537|NCT00696800|585237093|FG001|Overall Study|No/abnormal fertilization|13|||
162049538|NCT00696800|585237092|FG000|Overall Study|No/too few/bad quality embryos|24|||
162049539|NCT00696800|585237093|FG001|Overall Study|No/too few/bad quality embryos|18|||
162049540|NCT00696800|585237092|FG000|Overall Study|Other Reasons|5|||
162049541|NCT00696800|585237093|FG001|Overall Study|Other Reasons|3|||
162049542|NCT00696800|585237092|FG000|Overall Study|Not treated|1|||
162049543|NCT00696800|585237093|FG001|Overall Study|Not treated|2|||
162049544|NCT00591344|585237096|FG000|Overall Study|Transportation issues|1|||
162049545|NCT00591344|585237097|FG001|Overall Study|Transportation issues|0|||
162049546|NCT00591344|585237096|FG000|Overall Study|Moved out of state|1|||
162049547|NCT00591344|585237097|FG001|Overall Study|Moved out of state|0|||
162049548|NCT00591344|585237096|FG000|Overall Study|Medical complications|1|||
162049549|NCT00591344|585237097|FG001|Overall Study|Medical complications|3|||
162049550|NCT00591344|585237096|FG000|Overall Study|Underwent DBS|2|||
162049551|NCT00591344|585237097|FG001|Overall Study|Underwent DBS|2|||
162049552|NCT00591344|585237096|FG000|Overall Study|Death|0|||
162049553|NCT00591344|585237097|FG001|Overall Study|Death|1|||
162049554|NCT00591344|585237096|FG000|Overall Study|Lost to Follow-up|0|||
162049555|NCT00591344|585237097|FG001|Overall Study|Lost to Follow-up|1|||
162049556|NCT00591344|585237096|FG000|Overall Study|Did not want to come off medication|0|||
162049557|NCT00591344|585237097|FG001|Overall Study|Did not want to come off medication|1|||
162049558|NCT00493025|585237098|FG000|Overall Study|Physician Decision|19|||
162049559|NCT02939079|585237100|FG000|Overall Study|Adverse Event|2|||
162049560|NCT02939079|585237101|FG001|Overall Study|Adverse Event|1|||
162049561|NCT02939079|585237100|FG000|Overall Study|Lost to Follow-up|0|||
162049562|NCT02939079|585237101|FG001|Overall Study|Lost to Follow-up|2|||
162049563|NCT02939079|585237100|FG000|Overall Study|Protocol Violation|1|||
162049564|NCT02939079|585237101|FG001|Overall Study|Protocol Violation|0|||
162049565|NCT02939079|585237100|FG000|Overall Study|Withdrawal by Subject|0|||
162049566|NCT02939079|585237101|FG001|Overall Study|Withdrawal by Subject|1|||
162049567|NCT02939079|585237100|FG000|Overall Study|relapse during the study|1|||
162049568|NCT02939079|585237101|FG001|Overall Study|relapse during the study|1|||
162049569|NCT01609231|585237102|FG000|Overall Study|Adverse Event|1|||
162049570|NCT01609231|585237103|FG001|Overall Study|Adverse Event|3|||
162049571|NCT01609231|585237102|FG000|Overall Study|Physician Decision|1|||
162049572|NCT01609231|585237103|FG001|Overall Study|Physician Decision|0|||
162049573|NCT01609231|585237102|FG000|Overall Study|Withdrawal by Subject|1|||
162049574|NCT01609231|585237103|FG001|Overall Study|Withdrawal by Subject|0|||
162049575|NCT00494299|585237110|FG000|Overall Study|Adverse Event|93|||
162049576|NCT00494299|585237111|FG001|Overall Study|Adverse Event|13|||
162049577|NCT00494299|585237110|FG000|Overall Study|Lost to Follow-up|1|||
162049578|NCT00494299|585237111|FG001|Overall Study|Lost to Follow-up|0|||
162049579|NCT00494299|585237110|FG000|Overall Study|Physician Decision|0|||
162049580|NCT00494299|585237111|FG001|Overall Study|Physician Decision|2|||
162049581|NCT00494299|585237110|FG000|Overall Study|Protocol Violation|1|||
162049582|NCT00494299|585237111|FG001|Overall Study|Protocol Violation|2|||
162049583|NCT00494299|585237110|FG000|Overall Study|Withdrawal by Subject|8|||
162049584|NCT00494299|585237111|FG001|Overall Study|Withdrawal by Subject|3|||
162049585|NCT00494299|585237110|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
162049586|NCT00494299|585237111|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
162049587|NCT00494299|585237110|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
162049588|NCT00494299|585237111|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
162049589|NCT00494299|585237110|FG000|Overall Study|Site Closed by Sponsor|6|||
162049590|NCT00494299|585237111|FG001|Overall Study|Site Closed by Sponsor|0|||
162049591|NCT00494299|585237110|FG000|Overall Study|Protocol Driven Decision Point|11|||
162049592|NCT00494299|585237111|FG001|Overall Study|Protocol Driven Decision Point|22|||
162049593|NCT00516074|585237114|FG000|Overall Study|Adverse Event|0|||
162049594|NCT00516074|585237115|FG001|Overall Study|Adverse Event|1|||
162049595|NCT00516074|585237114|FG000|Overall Study|Subject Decision|4|||
162049596|NCT00516074|585237115|FG001|Overall Study|Subject Decision|2|||
162049597|NCT00516074|585237114|FG000|Overall Study|Loss of Glucose Control|2|||
162049598|NCT00516074|585237115|FG001|Overall Study|Loss of Glucose Control|0|||
162049599|NCT03822182|585237118|FG000|Overall Study|Protocol Violation|0|||
162049600|NCT03822182|585237119|FG001|Overall Study|Protocol Violation|1|||
162049601|NCT03822182|585237120|FG002|Overall Study|Protocol Violation|1|||
162049602|NCT01484275|585237121|FG000|Overall Study|Study terminated by sponsor|28|||
162049603|NCT01484275|585237122|FG001|Overall Study|Study terminated by sponsor|32|||
162049604|NCT01484275|585237121|FG000|Overall Study|Other|10|||
162049605|NCT01484275|585237122|FG001|Overall Study|Other|0|||
162049606|NCT01484275|585237121|FG000|Overall Study|Death|3|||
162049607|NCT01484275|585237122|FG001|Overall Study|Death|4|||
162049608|NCT01484275|585237121|FG000|Overall Study|Withdrawal by Subject|1|||
162049609|NCT01484275|585237122|FG001|Overall Study|Withdrawal by Subject|5|||
162049610|NCT01484275|585237121|FG000|Overall Study|Lost to Follow-up|1|||
162049611|NCT01484275|585237122|FG001|Overall Study|Lost to Follow-up|1|||
162049612|NCT04154930|585237123|FG000|Overall Study|Withdrawal by Subject|15|||
162049613|NCT04154930|585237124|FG001|Overall Study|Withdrawal by Subject|6|||
162049614|NCT04154930|585237123|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
162049615|NCT04154930|585237124|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
162049616|NCT04154930|585237123|FG000|Overall Study|Lost to Follow-up|14|||
162049617|NCT04154930|585237124|FG001|Overall Study|Lost to Follow-up|6|||
162049618|NCT04154930|585237123|FG000|Overall Study|Other|6|||
162049619|NCT04154930|585237124|FG001|Overall Study|Other|0|||
162049620|NCT02020577|585237128|FG000|Overall Study|Progressive disease|3|||
162049621|NCT02020577|585237129|FG001|Overall Study|Progressive disease|38|||
162049622|NCT02020577|585237128|FG000|Overall Study|Other AE or clinical progression|0|||
162049623|NCT02020577|585237129|FG001|Overall Study|Other AE or clinical progression|15|||
162049624|NCT02020577|585237128|FG000|Overall Study|Withdrawal by Subject|0|||
162049625|NCT02020577|585237129|FG001|Overall Study|Withdrawal by Subject|1|||
162049626|NCT02020577|585237128|FG000|Overall Study|Other than stated above|0|||
162049627|NCT02020577|585237129|FG001|Overall Study|Other than stated above|1|||
162049628|NCT03113916|585237131|FG000|Overall Study|Withdrawal by Subject|9|||
162049629|NCT03113916|585237132|FG001|Overall Study|Withdrawal by Subject|7|||
162049630|NCT03113916|585237131|FG000|Overall Study|Pregnancy|1|||
162049631|NCT03113916|585237132|FG001|Overall Study|Pregnancy|3|||
162049632|NCT03113916|585237131|FG000|Overall Study|Lost to Follow-up|1|||
162049633|NCT03113916|585237132|FG001|Overall Study|Lost to Follow-up|2|||
162049634|NCT01758523|585237133|FG000|Overall Study|Adverse Event|2|||
162049635|NCT01758523|585237134|FG001|Overall Study|Adverse Event|1|||
162049636|NCT01758523|585237133|FG000|Overall Study|Lack of Efficacy|4|||
162049637|NCT01758523|585237134|FG001|Overall Study|Lack of Efficacy|2|||
162049638|NCT01758523|585237133|FG000|Overall Study|Lost to Follow-up|3|||
162049639|NCT01758523|585237134|FG001|Overall Study|Lost to Follow-up|4|||
162049640|NCT01758523|585237133|FG000|Overall Study|Withdrawal by Subject|12|||
162049641|NCT01758523|585237134|FG001|Overall Study|Withdrawal by Subject|7|||
162049642|NCT01893203|585237135|FG000|Overall Study|Withdrawal by Subject|1|||
162049643|NCT00945893|585237148|FG000|Overall Study|Lost to Follow-up|2|||
162049644|NCT00945893|585237149|FG001|Overall Study|Lost to Follow-up|8|||
162049645|NCT00945893|585237148|FG000|Overall Study|Withdrawal of consent|1|||
162049646|NCT00945893|585237149|FG001|Overall Study|Withdrawal of consent|2|||
162049647|NCT01611155|585237150|FG000|Overall Study|Adverse Event|1|||
162049648|NCT01611155|585237151|FG001|Overall Study|Adverse Event|1|||
162049649|NCT01611155|585237150|FG000|Overall Study|Refused further treatment|6|||
162049650|NCT01611155|585237151|FG001|Overall Study|Refused further treatment|4|||
162049651|NCT01611155|585237150|FG000|Overall Study|Disease progression|1|||
162049652|NCT01611155|585237151|FG001|Overall Study|Disease progression|0|||
162049653|NCT01611155|585237150|FG000|Overall Study|Withdrawal by Subject|1|||
162049654|NCT01611155|585237151|FG001|Overall Study|Withdrawal by Subject|0|||
162049655|NCT01611155|585237150|FG000|Overall Study|Alternative treatment|0|||
162049656|NCT01611155|585237151|FG001|Overall Study|Alternative treatment|1|||
162049657|NCT01611155|585237150|FG000|Overall Study|Ineligible patient|0|||
162049658|NCT01611155|585237151|FG001|Overall Study|Ineligible patient|1|||
162049659|NCT01602120|585237152|FG000|Overall Study|Adverse Event|3|||
162049660|NCT01602120|585237153|FG001|Overall Study|Adverse Event|6|||
162049661|NCT01602120|585237154|FG002|Overall Study|Adverse Event|0|||
162049662|NCT01602120|585237155|FG003|Overall Study|Adverse Event|2|||
162049663|NCT01602120|585237152|FG000|Overall Study|Death|0|||
162049664|NCT01602120|585237153|FG001|Overall Study|Death|4|||
162049665|NCT01602120|585237154|FG002|Overall Study|Death|0|||
162049666|NCT01602120|585237155|FG003|Overall Study|Death|0|||
162049667|NCT01602120|585237152|FG000|Overall Study|Lost to Follow-up|0|||
162049668|NCT01602120|585237153|FG001|Overall Study|Lost to Follow-up|1|||
162049669|NCT01602120|585237154|FG002|Overall Study|Lost to Follow-up|0|||
162049670|NCT01602120|585237155|FG003|Overall Study|Lost to Follow-up|1|||
162049671|NCT01602120|585237152|FG000|Overall Study|Protocol Violation|1|||
162049672|NCT01602120|585237153|FG001|Overall Study|Protocol Violation|1|||
162049673|NCT01602120|585237154|FG002|Overall Study|Protocol Violation|0|||
162049674|NCT01602120|585237155|FG003|Overall Study|Protocol Violation|0|||
162049675|NCT01602120|585237152|FG000|Overall Study|Non-compliance|0|||
162049676|NCT01602120|585237153|FG001|Overall Study|Non-compliance|3|||
162049677|NCT01602120|585237154|FG002|Overall Study|Non-compliance|0|||
162049678|NCT01602120|585237155|FG003|Overall Study|Non-compliance|1|||
162049679|NCT01602120|585237152|FG000|Overall Study|Withdrawal by Subject|8|||
162049680|NCT01602120|585237153|FG001|Overall Study|Withdrawal by Subject|17|||
162049681|NCT01602120|585237154|FG002|Overall Study|Withdrawal by Subject|0|||
162049682|NCT01602120|585237155|FG003|Overall Study|Withdrawal by Subject|3|||
162049683|NCT01602120|585237152|FG000|Overall Study|Study Terminated by Sponsor|12|||
162049684|NCT01602120|585237153|FG001|Overall Study|Study Terminated by Sponsor|24|||
162049685|NCT01602120|585237154|FG002|Overall Study|Study Terminated by Sponsor|17|||
162049686|NCT01602120|585237155|FG003|Overall Study|Study Terminated by Sponsor|44|||
162049687|NCT01602120|585237152|FG000|Overall Study|Physician Decision|2|||
162049688|NCT01602120|585237153|FG001|Overall Study|Physician Decision|3|||
162049689|NCT01602120|585237154|FG002|Overall Study|Physician Decision|0|||
162049690|NCT01602120|585237155|FG003|Overall Study|Physician Decision|0|||
162049691|NCT01602120|585237152|FG000|Overall Study|Unspecified Reason|3|||
162049692|NCT01602120|585237153|FG001|Overall Study|Unspecified Reason|1|||
162049693|NCT01602120|585237154|FG002|Overall Study|Unspecified Reason|0|||
162049694|NCT01602120|585237155|FG003|Overall Study|Unspecified Reason|2|||
162049695|NCT04502433|585237158|FG000|Overall Study|Death|2|||
162049696|NCT04502433|585237159|FG001|Overall Study|Death|4|||
162049697|NCT04502433|585237158|FG000|Overall Study|Lost to Follow-up|1|||
162049698|NCT04502433|585237159|FG001|Overall Study|Lost to Follow-up|0|||
162049699|NCT04502433|585237158|FG000|Overall Study|Physician Decision|0|||
162049700|NCT04502433|585237159|FG001|Overall Study|Physician Decision|1|||
162049701|NCT01681472|585237160|FG000|Overall Study|Adverse Event|0|||
162049702|NCT01681472|585237161|FG001|Overall Study|Adverse Event|1|||
162049703|NCT01681472|585237162|FG002|Overall Study|Adverse Event|0|||
162049704|NCT01681472|585237163|FG003|Overall Study|Adverse Event|0|||
162049705|NCT01696071|585237176|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
162049706|NCT01696071|585237177|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
162049707|NCT00300274|585237181|FG000|Overall Study|Withdrawal by Subject|12|||
162049708|NCT00300274|585237182|FG001|Overall Study|Withdrawal by Subject|3|||
162049709|NCT00300274|585237183|FG002|Overall Study|Withdrawal by Subject|14|||
162049710|NCT00300274|585237181|FG000|Overall Study|Lost to Follow-up|3|||
162049711|NCT00300274|585237182|FG001|Overall Study|Lost to Follow-up|4|||
162049712|NCT00300274|585237183|FG002|Overall Study|Lost to Follow-up|5|||
162049713|NCT00300274|585237181|FG000|Overall Study|Death|31|||
162049714|NCT00300274|585237182|FG001|Overall Study|Death|20|||
162049715|NCT00300274|585237183|FG002|Overall Study|Death|25|||
162049716|NCT00300274|585237181|FG000|Overall Study|Re-transplant|0|||
162049717|NCT00300274|585237182|FG001|Overall Study|Re-transplant|0|||
162049718|NCT00300274|585237183|FG002|Overall Study|Re-transplant|1|||
162049719|NCT00678080|585237184|FG000|Overall Study|Physician Decision|2|||
162049720|NCT00678080|585237185|FG001|Overall Study|Physician Decision|0|||
162049721|NCT00678080|585237184|FG000|Overall Study|Lost to Follow-up|1|||
162049722|NCT00678080|585237185|FG001|Overall Study|Lost to Follow-up|0|||
162049723|NCT00678080|585237184|FG000|Overall Study|Withdrawal by Subject|0|||
162049724|NCT00678080|585237185|FG001|Overall Study|Withdrawal by Subject|1|||
162049725|NCT04439201|585237188|FG000|Overall Study|Ineligible|2|||
162049726|NCT04439201|585237188|FG000|Overall Study|Never start protocol therapy|1|||
162049727|NCT04439201|585237188|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
162049728|NCT04439201|585237188|FG000|Overall Study|Mutation status not confirmed|4|||
162049729|NCT04439201|585237188|FG000|Overall Study|Adverse Event|1|||
162049730|NCT04439201|585237188|FG000|Overall Study|Death|7|||
162049731|NCT04439201|585237188|FG000|Overall Study|Withdrawal by Subject|2|||
162049732|NCT04439201|585237188|FG000|Overall Study|Disease progression|20|||
162049733|NCT04439201|585237188|FG000|Overall Study|Alternative therapy|1|||
162049734|NCT04439201|585237188|FG000|Overall Study|Physician Decision|1|||
162049735|NCT05136690|585237189|FG000|Period 1|Withdrawal by Subject|0|||
162049736|NCT05136690|585237190|FG001|Period 1|Withdrawal by Subject|1|||
162049737|NCT05136690|585237189|FG000|Period 2|Lost to Follow-up|0|||
162049738|NCT05136690|585237190|FG001|Period 2|Lost to Follow-up|3|||
162049739|NCT05136690|585237189|FG000|Period 2|Withdrawal by Subject|0|||
162049740|NCT05136690|585237190|FG001|Period 2|Withdrawal by Subject|1|||
162049741|NCT01453361|585237191|FG000|Overall Study|Disease Progression|6|||
162049742|NCT01453361|585237191|FG000|Overall Study|Screen-Failures|10|||
162049743|NCT01752985|585237192|FG000|Treatment Period|Subject request to discontinue treatment|1|||
162049744|NCT01752985|585237193|FG001|Treatment Period|Subject request to discontinue treatment|0|||
162049745|NCT01752985|585237194|FG002|Treatment Period|Subject request to discontinue treatment|1|||
162049746|NCT01752985|585237192|FG000|Treatment Period|Subject no longer meets study criteria|0|||
162049747|NCT01752985|585237193|FG001|Treatment Period|Subject no longer meets study criteria|1|||
162049748|NCT01752985|585237194|FG002|Treatment Period|Subject no longer meets study criteria|1|||
162049749|NCT01752985|585237192|FG000|Treatment Period|Adverse Event|2|||
162049750|NCT01752985|585237193|FG001|Treatment Period|Adverse Event|1|||
162049751|NCT01752985|585237194|FG002|Treatment Period|Adverse Event|2|||
162049752|NCT01752985|585237192|FG000|Treatment Period|Withdrawal by Subject|1|||
162049753|NCT01752985|585237193|FG001|Treatment Period|Withdrawal by Subject|1|||
162049754|NCT01752985|585237194|FG002|Treatment Period|Withdrawal by Subject|0|||
162049755|NCT01752985|585237192|FG000|Treatment Period|Lost to Follow-up|0|||
162049756|NCT01752985|585237193|FG001|Treatment Period|Lost to Follow-up|0|||
162049757|NCT01752985|585237194|FG002|Treatment Period|Lost to Follow-up|1|||
162049758|NCT02025621|585238451|FG000|Overall Study|Withdrawal by Subject|1|||
162049759|NCT02025621|585238452|FG001|Overall Study|Withdrawal by Subject|0|||
162049760|NCT02025621|585238451|FG000|Overall Study|Death|0|||
162049761|NCT02025621|585238452|FG001|Overall Study|Death|1|||
162049762|NCT02025621|585238451|FG000|Overall Study|No longer eligible|10|||
162049763|NCT02025621|585238452|FG001|Overall Study|No longer eligible|15|||
162049764|NCT02025621|585238451|FG000|Overall Study|Surgery initiated before infusion|3|||
162049765|NCT02025621|585238452|FG001|Overall Study|Surgery initiated before infusion|3|||
162049766|NCT00739674|585238453|FG000|Overall Study|Screening failures|19|||
162049767|NCT00739674|585238454|FG001|Overall Study|Screening failures|17|||
162049768|NCT00739674|585238453|FG000|Overall Study|Site 212 removal|19|||
162049769|NCT00739674|585238454|FG001|Overall Study|Site 212 removal|13|||
162049770|NCT00739674|585238453|FG000|Overall Study|No follow-up data|33|||
162049771|NCT00739674|585238454|FG001|Overall Study|No follow-up data|18|||
162049772|NCT00739674|585238453|FG000|Overall Study|Dietician consultation >30 days|1|||
162049773|NCT00739674|585238454|FG001|Overall Study|Dietician consultation >30 days|9|||
162049774|NCT00739674|585238453|FG000|Overall Study|Adverse Event|22|||
162049775|NCT00739674|585238454|FG001|Overall Study|Adverse Event|13|||
162049776|NCT00739674|585238453|FG000|Overall Study|Death|1|||
162049777|NCT00739674|585238454|FG001|Overall Study|Death|0|||
162049778|NCT00739674|585238453|FG000|Overall Study|Lack of Efficacy|1|||
162049779|NCT00739674|585238454|FG001|Overall Study|Lack of Efficacy|0|||
162049780|NCT00739674|585238453|FG000|Overall Study|Lost to Follow-up|52|||
162049781|NCT00739674|585238454|FG001|Overall Study|Lost to Follow-up|30|||
162049782|NCT00739674|585238453|FG000|Overall Study|Protocol Violation|5|||
162049783|NCT00739674|585238454|FG001|Overall Study|Protocol Violation|5|||
162049784|NCT00739674|585238453|FG000|Overall Study|Withdrawal by Subject|9|||
162049785|NCT00739674|585238454|FG001|Overall Study|Withdrawal by Subject|9|||
162049786|NCT00739674|585238453|FG000|Overall Study|Reason missing|2|||
162049787|NCT00739674|585238454|FG001|Overall Study|Reason missing|0|||
162049788|NCT00739674|585238453|FG000|Overall Study|Clinic closed|6|||
162049789|NCT00739674|585238454|FG001|Overall Study|Clinic closed|4|||
162049790|NCT00739674|585238453|FG000|Overall Study|Patient moved|3|||
162049791|NCT00739674|585238454|FG001|Overall Study|Patient moved|2|||
162049792|NCT00739674|585238453|FG000|Overall Study|Non compliant|4|||
162049793|NCT00739674|585238454|FG001|Overall Study|Non compliant|0|||
162049794|NCT00739674|585238453|FG000|Overall Study|Unable to attend visit|3|||
162049795|NCT00739674|585238454|FG001|Overall Study|Unable to attend visit|1|||
162049796|NCT00739674|585238453|FG000|Overall Study|Home monitoring off meds|1|||
162049797|NCT00739674|585238454|FG001|Overall Study|Home monitoring off meds|0|||
162049798|NCT00739674|585238453|FG000|Overall Study|Erectile dysfunction|0|||
162049799|NCT00739674|585238454|FG001|Overall Study|Erectile dysfunction|1|||
162049800|NCT01897454|585238455|FG000|Overall Study|Withdrawal by Subject|1|||
162049801|NCT02195583|585238457|FG000|Overall Study|Lost to Follow-up|1|||
162049802|NCT02195583|585238457|FG000|Overall Study|Withdrawal by Subject|4|||
162049803|NCT02195583|585238457|FG000|Overall Study|Adverse Event|2|||
162049804|NCT02195583|585238457|FG000|Overall Study|Other Reason|2|||
162049805|NCT01560403|585238458|FG000|Overall Study|Lost to Follow-up|0|||
162049806|NCT01560403|585238459|FG001|Overall Study|Lost to Follow-up|1|||
162049807|NCT00983437|585238461|FG000|Overall Study|Adverse Event|9|||
162049808|NCT00983437|585238461|FG000|Overall Study|Lack of Efficacy|1|||
162049809|NCT00983437|585238461|FG000|Overall Study|Withdrawal by Subject|8|||
162049810|NCT00983437|585238461|FG000|Overall Study|Noncompliance to Study Procedures|1|||
162049811|NCT00983437|585238461|FG000|Overall Study|Lost to Follow-up|2|||
162049812|NCT00983437|585238461|FG000|Overall Study|Other Reason|26|||
162049813|NCT04019288|585238462|FG000|Overall Study|Death|1|||
162049814|NCT04019288|585238463|FG001|Overall Study|Death|0|||
162049815|NCT04019288|585238464|FG002|Overall Study|Death|0|||
162049816|NCT00094172|585238465|FG000|Overall Study|Adverse Event|0|||
162049817|NCT00094172|585238466|FG001|Overall Study|Adverse Event|1|||
162049818|NCT00094172|585238465|FG000|Overall Study|Lost to Follow-up|2|||
162049819|NCT00094172|585238466|FG001|Overall Study|Lost to Follow-up|0|||
162049820|NCT00094172|585238465|FG000|Overall Study|Protocol Violation|0|||
162049821|NCT00094172|585238466|FG001|Overall Study|Protocol Violation|1|||
162049822|NCT00094172|585238465|FG000|Overall Study|Withdrawal by Subject|10|||
162049823|NCT00094172|585238466|FG001|Overall Study|Withdrawal by Subject|5|||
162049824|NCT00094172|585238465|FG000|Overall Study|Primary endpoint met.|1|||
162049825|NCT00094172|585238466|FG001|Overall Study|Primary endpoint met.|0|||
162049826|NCT00094172|585238465|FG000|Overall Study|Started other MS therapy due to disease|1|||
162049827|NCT00094172|585238466|FG001|Overall Study|Started other MS therapy due to disease|0|||
162049828|NCT01020981|585238470|FG000|Overall Study|Did not return mailed survey|74|||
162049829|NCT01020981|585238471|FG001|Overall Study|Did not return mailed survey|58|||
162049830|NCT01020981|585238470|FG000|Overall Study|Survey returned undeliverable|8|||
162049831|NCT01020981|585238471|FG001|Overall Study|Survey returned undeliverable|32|||
162049832|NCT01020981|585238470|FG000|Overall Study|Participant declined to complete survey|2|||
162049833|NCT01020981|585238471|FG001|Overall Study|Participant declined to complete survey|0|||
162049834|NCT00289133|585238478|FG000|Overall Study|Non-study device implanted|12|||
162049835|NCT00289133|585238479|FG001|Overall Study|Non-study device implanted|0|||
162049836|NCT00289133|585238478|FG000|Overall Study|Protocol Violation|32|||
162049837|NCT00289133|585238479|FG001|Overall Study|Protocol Violation|38|||
162049838|NCT00289133|585238478|FG000|Overall Study|Withdrawal by Subject|9|||
162049839|NCT00289133|585238479|FG001|Overall Study|Withdrawal by Subject|10|||
162049840|NCT00289133|585238478|FG000|Overall Study|Death|5|||
162049841|NCT00289133|585238479|FG001|Overall Study|Death|10|||
162049842|NCT00289133|585238478|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
162049843|NCT00289133|585238479|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
162049844|NCT00289133|585238478|FG000|Overall Study|Physician Decision|41|||
162049845|NCT00289133|585238479|FG001|Overall Study|Physician Decision|45|||
162049846|NCT00289133|585238478|FG000|Overall Study|Revision|8|||
162049847|NCT00289133|585238479|FG001|Overall Study|Revision|6|||
162049848|NCT00289133|585238478|FG000|Overall Study|Lost to Follow-up|92|||
162049849|NCT00289133|585238479|FG001|Overall Study|Lost to Follow-up|115|||
162049850|NCT03372096|585238481|FG000|Overall Study|Study Closed|8|||
162049851|NCT00040365|585238482|FG000|Overall Study|Death|1|||
162049852|NCT00040365|585238482|FG000|Overall Study|Progressive disease|7|||
162049853|NCT00040365|585238482|FG000|Overall Study|Lost to Follow-up|3|||
162049854|NCT01397890|585238485|FG000|Overall Study|Withdrawal by Subject|7|||
162049855|NCT01397890|585238486|FG001|Overall Study|Withdrawal by Subject|11|||
162049856|NCT01397890|585238485|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
162049857|NCT01397890|585238486|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
162049858|NCT01397890|585238485|FG000|Overall Study|Death|2|||
162049859|NCT01397890|585238486|FG001|Overall Study|Death|3|||
162049860|NCT01397890|585238485|FG000|Overall Study|Lost to Follow-up|1|||
162049861|NCT01397890|585238486|FG001|Overall Study|Lost to Follow-up|4|||
162049862|NCT01397890|585238485|FG000|Overall Study|Condition under Investigation Worsened|1|||
162049863|NCT01397890|585238486|FG001|Overall Study|Condition under Investigation Worsened|3|||
162049864|NCT01397890|585238485|FG000|Overall Study|Adverse Event|1|||
162049865|NCT01397890|585238486|FG001|Overall Study|Adverse Event|2|||
162049866|NCT01397890|585238485|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
162049867|NCT01397890|585238486|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
162049868|NCT01397890|585238485|FG000|Overall Study|Others|2|||
162049869|NCT01397890|585238486|FG001|Overall Study|Others|1|||
162049870|NCT00319553|585238489|FG000|Overall Study|Protocol Violation|1|||
162049871|NCT00319553|585238490|FG001|Overall Study|Protocol Violation|2|||
162049872|NCT00319553|585238489|FG000|Overall Study|Lost to Follow-up|2|||
162049873|NCT00319553|585238490|FG001|Overall Study|Lost to Follow-up|1|||
162049874|NCT00319553|585238489|FG000|Overall Study|Withdrawal by Subject|1|||
162049875|NCT00319553|585238490|FG001|Overall Study|Withdrawal by Subject|1|||
162049876|NCT03641339|585238493|FG000|Overall Study|Physician Decision|1|||
162049877|NCT03641339|585238494|FG001|Overall Study|Physician Decision|0|||
162049878|NCT03641339|585238495|FG002|Overall Study|Physician Decision|0|||
162049879|NCT03641339|585238496|FG003|Overall Study|Physician Decision|0|||
162049880|NCT03641339|585238497|FG004|Overall Study|Physician Decision|0|||
162049881|NCT03641339|585238498|FG005|Overall Study|Physician Decision|0|||
162049882|NCT03641339|585238493|FG000|Overall Study|Withdrawal by Subject|0|||
162049883|NCT03641339|585238494|FG001|Overall Study|Withdrawal by Subject|2|||
162049884|NCT03641339|585238495|FG002|Overall Study|Withdrawal by Subject|0|||
162049885|NCT03641339|585238496|FG003|Overall Study|Withdrawal by Subject|2|||
162049886|NCT03641339|585238497|FG004|Overall Study|Withdrawal by Subject|0|||
162049887|NCT03641339|585238498|FG005|Overall Study|Withdrawal by Subject|1|||
162049888|NCT02329080|585238499|FG000|Overall Study|Adverse Event|1|||
162049889|NCT02329080|585238499|FG000|Overall Study|Death|4|||
162049890|NCT02329080|585238499|FG000|Overall Study|Lack of Efficacy|22|||
162049891|NCT02329080|585238499|FG000|Overall Study|Lost to Follow-up|1|||
162049892|NCT02329080|585238499|FG000|Overall Study|Physician Decision|2|||
162049893|NCT02329080|585238499|FG000|Overall Study|Partial response|4|||
162049894|NCT02329080|585238499|FG000|Overall Study|Complete response|4|||
162049895|NCT00413244|585238501|FG000|Overall Study|Withdrawal by Subject|10|||
162049896|NCT00413244|585238502|FG001|Overall Study|Withdrawal by Subject|1|||
162049897|NCT02319837|585238505|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
162049898|NCT02319837|585238506|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
162049899|NCT02319837|585238507|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
162049900|NCT02319837|585238505|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
162049901|NCT02319837|585238506|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
162049902|NCT02319837|585238507|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
162049903|NCT02319837|585238505|FG000|Study Treatment Phase|Adverse Event|73|||
162049904|NCT02319837|585238506|FG001|Study Treatment Phase|Adverse Event|36|||
162049905|NCT02319837|585238507|FG002|Study Treatment Phase|Adverse Event|63|||
162049906|NCT02319837|585238505|FG000|Study Treatment Phase|Development of castration resistance|0|||
162049907|NCT02319837|585238506|FG001|Study Treatment Phase|Development of castration resistance|2|||
162049908|NCT02319837|585238507|FG002|Study Treatment Phase|Development of castration resistance|0|||
162049909|NCT02319837|585238505|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
162049910|NCT02319837|585238506|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
162049911|NCT02319837|585238507|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
162049912|NCT02319837|585238505|FG000|Study Treatment Phase|Protocol Violation|2|||
162049913|NCT02319837|585238506|FG001|Study Treatment Phase|Protocol Violation|2|||
162049914|NCT02319837|585238507|FG002|Study Treatment Phase|Protocol Violation|1|||
162049915|NCT02319837|585238505|FG000|Study Treatment Phase|Lost to Follow-up|0|||
162049916|NCT02319837|585238506|FG001|Study Treatment Phase|Lost to Follow-up|1|||
162049917|NCT02319837|585238507|FG002|Study Treatment Phase|Lost to Follow-up|0|||
162049918|NCT02319837|585238505|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
162237400|NCT00490724|585921088|FG002|Period II|Treatment Discontinuation|3|||
162049919|NCT02319837|585238506|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
162049920|NCT02319837|585238507|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
162049921|NCT02319837|585238505|FG000|Study Treatment Phase|Other|0|||
162049922|NCT02319837|585238506|FG001|Study Treatment Phase|Other|1|||
162049923|NCT02319837|585238507|FG002|Study Treatment Phase|Other|0|||
162049924|NCT02319837|585238505|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
162049925|NCT02319837|585238506|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
162049926|NCT02319837|585238507|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
162049927|NCT02319837|585238505|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
162049928|NCT02319837|585238506|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
162049929|NCT02319837|585238507|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
162049930|NCT02319837|585238505|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
162049931|NCT02319837|585238506|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
162049932|NCT02319837|585238507|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
162049933|NCT02319837|585238505|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
162049934|NCT02319837|585238506|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
162049935|NCT02319837|585238507|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
162049936|NCT02319837|585238505|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
162049937|NCT02319837|585238506|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
162049938|NCT02319837|585238507|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
162049939|NCT02319837|585238505|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
162049940|NCT02319837|585238506|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
162049941|NCT02319837|585238507|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
162049942|NCT02319837|585238505|FG000|Long-Term Follow-Up Phase|Death|33|||
162049943|NCT02319837|585238506|FG001|Long-Term Follow-Up Phase|Death|54|||
162049944|NCT02319837|585238507|FG002|Long-Term Follow-Up Phase|Death|42|||
162049945|NCT02435147|585238508|FG000|Overall Study|non-evaluable DXA scan|11|||
162049946|NCT00839852|585238511|FG000|Overall Study|Adverse Event|10|||
162049947|NCT00839852|585238511|FG000|Overall Study|Insufficient Therapeutic Response|3|||
162049948|NCT00839852|585238511|FG000|Overall Study|Protocol Violation|9|||
162049949|NCT00839852|585238511|FG000|Overall Study|Withdrawal of Consent|16|||
162049950|NCT00839852|585238511|FG000|Overall Study|Lost to Follow-up|7|||
162049951|NCT00839852|585238511|FG000|Overall Study|Lack of Compliance While in Jail|1|||
162049952|NCT00839852|585238511|FG000|Overall Study|Pregnancy|1|||
162049953|NCT03082261|585238512|FG000|Overall Study|Death|4|||
162049954|NCT03082261|585238512|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
162049955|NCT03082261|585238512|FG000|Overall Study|Insurance denial|1|||
162049956|NCT03082261|585238512|FG000|Overall Study|Peripheral lead added|1|||
162049957|NCT03082261|585238512|FG000|Overall Study|Withdrawal by Subject|40|||
162049958|NCT03082261|585238512|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
162049959|NCT03082261|585238512|FG000|Overall Study|Subject implanted with device other than study device|1|||
162049960|NCT03082261|585238512|FG000|Overall Study|Lost to Follow-up|14|||
162049961|NCT03082261|585238512|FG000|Overall Study|Subject moved to a different state|1|||
162049962|NCT03082261|585238512|FG000|Overall Study|Subject non-compliance|2|||
162049963|NCT03082261|585238512|FG000|Overall Study|Subject participation terminated by investigator|9|||
162049964|NCT03082261|585238512|FG000|Overall Study|Subject participation terminated by sponsor|4|||
162049965|NCT03082261|585238512|FG000|Overall Study|System explant|19|||
162049966|NCT03082261|585238512|FG000|Overall Study|Unable to place lead(s)|2|||
162049967|NCT03082261|585238512|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
162049968|NCT01313312|585238516|FG000|Overall Study|Adverse Event|5|||
162049969|NCT01313312|585238516|FG000|Overall Study|Withdrawal by Subject|18|||
162049970|NCT01313312|585238516|FG000|Overall Study|Lack of Efficacy|3|||
162049971|NCT01313312|585238516|FG000|Overall Study|Investigator Decision|1|||
162049972|NCT01313312|585238516|FG000|Overall Study|Observational Phase|1|||
162049973|NCT01313312|585238516|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
162049974|NCT01313312|585238516|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
162049975|NCT01206166|585238524|FG000|Overall Study|No evaluable data|2|||
162049976|NCT01206166|585238525|FG001|Overall Study|No evaluable data|3|||
162049977|NCT02716805|585238526|FG000|Overall Study|Progressive disease|2|||
162049978|NCT02716805|585238527|FG001|Overall Study|Progressive disease|0|||
162049979|NCT02716805|585238528|FG002|Overall Study|Progressive disease|0|||
162049980|NCT02716805|585238529|FG003|Overall Study|Progressive disease|0|||
162049981|NCT00066365|585238530|FG000|Overall Study|Adverse Event|1|||
162049982|NCT00066365|585238531|FG001|Overall Study|Adverse Event|0|||
162049983|NCT00066365|585238530|FG000|Overall Study|Lack of Efficacy|15|||
162049984|NCT00066365|585238531|FG001|Overall Study|Lack of Efficacy|12|||
162049985|NCT00066365|585238530|FG000|Overall Study|Physician Decision|1|||
162049986|NCT00066365|585238531|FG001|Overall Study|Physician Decision|0|||
162049987|NCT00066365|585238530|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
162049988|NCT00066365|585238531|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
162049989|NCT00066365|585238530|FG000|Overall Study|Ineligible|4|||
162049990|NCT00066365|585238531|FG001|Overall Study|Ineligible|2|||
162049991|NCT00467857|585238534|FG000|Overall Study|Adverse Event|1|||
162049992|NCT00467857|585238535|FG001|Overall Study|Adverse Event|0|||
162049993|NCT00467857|585238534|FG000|Overall Study|Withdrew consent|2|||
162049994|NCT00467857|585238535|FG001|Overall Study|Withdrew consent|0|||
162049995|NCT00467857|585238534|FG000|Overall Study|Death|0|||
162049996|NCT00467857|585238535|FG001|Overall Study|Death|1|||
162049997|NCT00467857|585238534|FG000|Overall Study|Discharged from court service|0|||
162049998|NCT00467857|585238535|FG001|Overall Study|Discharged from court service|1|||
162049999|NCT00467857|585238534|FG000|Overall Study|Emergency care required|0|||
162050000|NCT00467857|585238535|FG001|Overall Study|Emergency care required|1|||
162050001|NCT00467857|585238534|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
162050002|NCT00467857|585238535|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
162050003|NCT00467857|585238534|FG000|Overall Study|Discontinuation reason missing|0|||
162050004|NCT00467857|585238535|FG001|Overall Study|Discontinuation reason missing|3|||
162050005|NCT03576495|585238538|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
162050006|NCT03576495|585238539|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
162050007|NCT05306977|585238543|FG000|Overall Study|Withdrawal by Subject|1|||
162050008|NCT00369824|585238544|FG000|Overall Study|Adverse Event|0|||
162050009|NCT00369824|585238545|FG001|Overall Study|Adverse Event|2|||
162050010|NCT00369824|585238546|FG002|Overall Study|Adverse Event|0|||
162050011|NCT00369824|585238547|FG003|Overall Study|Adverse Event|0|||
162050012|NCT00369824|585238548|FG004|Overall Study|Adverse Event|1|||
162050013|NCT00369824|585238549|FG005|Overall Study|Adverse Event|0|||
162050014|NCT00369824|585238544|FG000|Overall Study|Protocol Violation|0|||
162050015|NCT00369824|585238545|FG001|Overall Study|Protocol Violation|1|||
162050016|NCT00369824|585238546|FG002|Overall Study|Protocol Violation|0|||
162050017|NCT00369824|585238547|FG003|Overall Study|Protocol Violation|1|||
162050018|NCT00369824|585238548|FG004|Overall Study|Protocol Violation|1|||
162050019|NCT00369824|585238549|FG005|Overall Study|Protocol Violation|0|||
162050020|NCT00369824|585238544|FG000|Overall Study|Withdrawal by Subject|9|||
162050021|NCT00369824|585238545|FG001|Overall Study|Withdrawal by Subject|5|||
162050022|NCT00369824|585238546|FG002|Overall Study|Withdrawal by Subject|5|||
162050023|NCT00369824|585238547|FG003|Overall Study|Withdrawal by Subject|4|||
162050024|NCT00369824|585238548|FG004|Overall Study|Withdrawal by Subject|6|||
162050025|NCT00369824|585238549|FG005|Overall Study|Withdrawal by Subject|2|||
162050026|NCT00369824|585238544|FG000|Overall Study|Lost to Follow-up|6|||
162050027|NCT00369824|585238545|FG001|Overall Study|Lost to Follow-up|11|||
162050028|NCT00369824|585238546|FG002|Overall Study|Lost to Follow-up|7|||
162050029|NCT00369824|585238547|FG003|Overall Study|Lost to Follow-up|8|||
162050030|NCT00369824|585238548|FG004|Overall Study|Lost to Follow-up|9|||
162050031|NCT00369824|585238549|FG005|Overall Study|Lost to Follow-up|6|||
162050032|NCT00369824|585238544|FG000|Overall Study|Other|0|||
162050033|NCT00369824|585238545|FG001|Overall Study|Other|0|||
162050034|NCT00369824|585238546|FG002|Overall Study|Other|0|||
162050035|NCT00369824|585238547|FG003|Overall Study|Other|2|||
162050036|NCT00369824|585238548|FG004|Overall Study|Other|1|||
162050037|NCT00369824|585238549|FG005|Overall Study|Other|3|||
162050038|NCT01443078|585238550|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
162050039|NCT01443078|585238550|FG000|Overall Study|Withdrawal by Subject|1|||
162050040|NCT01443078|585238550|FG000|Overall Study|Patient had brain mets|1|||
162050041|NCT01390649|585238551|FG000|Overall Study|Physician Decision|1|||
162050042|NCT00415168|585238555|FG000|Overall Study|Death|26|||
162050043|NCT00415168|585238555|FG000|Overall Study|Lost to Follow-up|3|||
162050044|NCT00415168|585238555|FG000|Overall Study|Physician Decision|13|||
162050045|NCT00415168|585238555|FG000|Overall Study|Sponsor Decision|4|||
162050046|NCT00415168|585238555|FG000|Overall Study|Withdrawal by Subject|6|||
162050047|NCT00003487|585238557|FG000|Overall Study|Not evaluable|2|||
162050048|NCT02628938|585238560|FG000|Overall Study|Did not attend the follow up recall|2|||
162050049|NCT02628938|585238561|FG001|Overall Study|Did not attend the follow up recall|2|||
162050050|NCT02628938|585238562|FG002|Overall Study|Did not attend the follow up recall|1|||
162050051|NCT02628938|585238560|FG000|Overall Study|Failure to comply with the instructions|3|||
162050052|NCT02628938|585238561|FG001|Overall Study|Failure to comply with the instructions|0|||
162050053|NCT02628938|585238562|FG002|Overall Study|Failure to comply with the instructions|3|||
162050054|NCT02058693|585238563|FG000|Phase 1|Withdrawal by Subject|3|||
162050055|NCT02058693|585238564|FG001|Phase 1|Withdrawal by Subject|2|||
162050056|NCT02058693|585238563|FG000|Phase 1|Adverse Event|0|||
162050057|NCT02058693|585238564|FG001|Phase 1|Adverse Event|1|||
162050058|NCT02058693|585238563|FG000|Phase 1|Lack of Efficacy|1|||
162050059|NCT02058693|585238564|FG001|Phase 1|Lack of Efficacy|0|||
162050060|NCT02058693|585238563|FG000|Phase 1|Physician Decision|1|||
162050061|NCT02058693|585238564|FG001|Phase 1|Physician Decision|1|||
162050062|NCT02058693|585238563|FG000|Phase 2|Withdrawal by Subject|0|||
162050063|NCT02058693|585238564|FG001|Phase 2|Withdrawal by Subject|2|||
162050064|NCT00241358|585238565|FG000|Overall Study|Determined to be not ineligible|0|||
162050065|NCT00241358|585238566|FG001|Overall Study|Determined to be not ineligible|1|||
162050066|NCT00241358|585238567|FG002|Overall Study|Determined to be not ineligible|1|||
162050067|NCT03855228|585238568|FG000|Overall Study|Adverse Event|2|||
162050068|NCT03855228|585238569|FG001|Overall Study|Adverse Event|4|||
162050069|NCT03855228|585238570|FG002|Overall Study|Adverse Event|4|||
162050070|NCT03855228|585238571|FG003|Overall Study|Adverse Event|8|||
162050071|NCT03855228|585238568|FG000|Overall Study|Treatment Failure|1|||
162050072|NCT03855228|585238569|FG001|Overall Study|Treatment Failure|2|||
162050073|NCT03855228|585238570|FG002|Overall Study|Treatment Failure|1|||
162050074|NCT03855228|585238571|FG003|Overall Study|Treatment Failure|8|||
162050075|NCT03855228|585238568|FG000|Overall Study|Lost to Follow-up|0|||
162050076|NCT03855228|585238569|FG001|Overall Study|Lost to Follow-up|0|||
162050077|NCT03855228|585238570|FG002|Overall Study|Lost to Follow-up|0|||
162050078|NCT03855228|585238571|FG003|Overall Study|Lost to Follow-up|1|||
162050079|NCT03855228|585238568|FG000|Overall Study|Protocol Violation|0|||
162050080|NCT03855228|585238569|FG001|Overall Study|Protocol Violation|1|||
162050081|NCT03855228|585238570|FG002|Overall Study|Protocol Violation|2|||
162050082|NCT03855228|585238571|FG003|Overall Study|Protocol Violation|1|||
162050083|NCT03855228|585238568|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
162050084|NCT03855228|585238569|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
162050085|NCT03855228|585238570|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
162050086|NCT03855228|585238571|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
162050087|NCT00590135|585238572|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
162050088|NCT02400333|585240008|FG000|Overall Study|Withdrawal by Subject|0|||
162050089|NCT02400333|585240009|FG001|Overall Study|Withdrawal by Subject|1|||
162050090|NCT02400333|585240010|FG002|Overall Study|Withdrawal by Subject|0|||
162050091|NCT02400333|585240011|FG003|Overall Study|Withdrawal by Subject|1|||
162050092|NCT02400333|585240008|FG000|Overall Study|Protocol Violation|1|||
162050093|NCT02400333|585240009|FG001|Overall Study|Protocol Violation|0|||
162050094|NCT02400333|585240010|FG002|Overall Study|Protocol Violation|2|||
162050095|NCT02400333|585240011|FG003|Overall Study|Protocol Violation|1|||
162050096|NCT02468674|585240012|FG000|Overall Study|Adverse Event|0|||
162050097|NCT02468674|585240013|FG001|Overall Study|Adverse Event|0|||
162050098|NCT02468674|585240014|FG002|Overall Study|Adverse Event|0|||
162050099|NCT02468674|585240015|FG003|Overall Study|Adverse Event|1|||
162050100|NCT02468674|585240016|FG004|Overall Study|Adverse Event|0|||
162050101|NCT02468674|585240017|FG005|Overall Study|Adverse Event|1|||
162050102|NCT02468674|585240018|FG006|Overall Study|Adverse Event|0|||
162050103|NCT02468674|585240019|FG007|Overall Study|Adverse Event|0|||
162050104|NCT02468674|585240020|FG008|Overall Study|Adverse Event|0|||
162050105|NCT02468674|585240012|FG000|Overall Study|Lost to Follow-up|1|||
162050106|NCT02468674|585240013|FG001|Overall Study|Lost to Follow-up|0|||
162050107|NCT02468674|585240014|FG002|Overall Study|Lost to Follow-up|0|||
162050108|NCT02468674|585240015|FG003|Overall Study|Lost to Follow-up|0|||
162050109|NCT02468674|585240016|FG004|Overall Study|Lost to Follow-up|0|||
162050110|NCT02468674|585240017|FG005|Overall Study|Lost to Follow-up|0|||
162050111|NCT02468674|585240018|FG006|Overall Study|Lost to Follow-up|0|||
162050112|NCT02468674|585240019|FG007|Overall Study|Lost to Follow-up|1|||
162050113|NCT02468674|585240020|FG008|Overall Study|Lost to Follow-up|1|||
162050114|NCT02468674|585240012|FG000|Overall Study|Physician Decision|0|||
162050115|NCT02468674|585240013|FG001|Overall Study|Physician Decision|0|||
162050116|NCT02468674|585240014|FG002|Overall Study|Physician Decision|0|||
162050117|NCT02468674|585240015|FG003|Overall Study|Physician Decision|0|||
162050118|NCT02468674|585240016|FG004|Overall Study|Physician Decision|0|||
162050119|NCT02468674|585240017|FG005|Overall Study|Physician Decision|0|||
162050120|NCT02468674|585240018|FG006|Overall Study|Physician Decision|1|||
162050121|NCT02468674|585240019|FG007|Overall Study|Physician Decision|0|||
162050122|NCT02468674|585240020|FG008|Overall Study|Physician Decision|0|||
162050123|NCT02468674|585240012|FG000|Overall Study|Patient/Guardian Decision|0|||
162050124|NCT02468674|585240013|FG001|Overall Study|Patient/Guardian Decision|0|||
162050125|NCT02468674|585240014|FG002|Overall Study|Patient/Guardian Decision|0|||
162050126|NCT02468674|585240015|FG003|Overall Study|Patient/Guardian Decision|0|||
162050127|NCT02468674|585240016|FG004|Overall Study|Patient/Guardian Decision|1|||
162050128|NCT02468674|585240017|FG005|Overall Study|Patient/Guardian Decision|0|||
162050129|NCT02468674|585240018|FG006|Overall Study|Patient/Guardian Decision|0|||
162050130|NCT02468674|585240019|FG007|Overall Study|Patient/Guardian Decision|2|||
162050131|NCT02468674|585240020|FG008|Overall Study|Patient/Guardian Decision|1|||
162050132|NCT02468674|585240012|FG000|Overall Study|Protocol Deviation|0|||
162050133|NCT02468674|585240013|FG001|Overall Study|Protocol Deviation|0|||
162050134|NCT02468674|585240014|FG002|Overall Study|Protocol Deviation|0|||
162050135|NCT02468674|585240015|FG003|Overall Study|Protocol Deviation|0|||
162050136|NCT02468674|585240016|FG004|Overall Study|Protocol Deviation|0|||
162050137|NCT02468674|585240017|FG005|Overall Study|Protocol Deviation|0|||
162050138|NCT02468674|585240018|FG006|Overall Study|Protocol Deviation|0|||
162050139|NCT02468674|585240019|FG007|Overall Study|Protocol Deviation|1|||
162050140|NCT02468674|585240020|FG008|Overall Study|Protocol Deviation|1|||
162050141|NCT01687998|585240028|FG000|Overall Study|Withdrawal by Subject|49|||
162050142|NCT01687998|585240029|FG001|Overall Study|Withdrawal by Subject|51|||
162050143|NCT01687998|585240028|FG000|Overall Study|Known to be Alive at Study End|54|||
162050144|NCT01687998|585240029|FG001|Overall Study|Known to be Alive at Study End|62|||
162050145|NCT01687998|585240028|FG000|Overall Study|Lost to Follow-up|9|||
162050146|NCT01687998|585240029|FG001|Overall Study|Lost to Follow-up|7|||
162050147|NCT00443261|585240032|FG000|Overall Study|Death|1|||
162050148|NCT01663532|585240033|FG000|Overall Study|Lost to Follow-up|9|||
162050149|NCT01663532|585240034|FG001|Overall Study|Lost to Follow-up|10|||
162050150|NCT01663532|585240033|FG000|Overall Study|Adverse Event|7|||
162050151|NCT01663532|585240034|FG001|Overall Study|Adverse Event|13|||
162050152|NCT01663532|585240033|FG000|Overall Study|Met Withdrawal Criteria|7|||
162050153|NCT01663532|585240034|FG001|Overall Study|Met Withdrawal Criteria|6|||
162050154|NCT01663532|585240033|FG000|Overall Study|Physician Decision|1|||
162050155|NCT01663532|585240034|FG001|Overall Study|Physician Decision|1|||
162050156|NCT01663532|585240033|FG000|Overall Study|Withdrawal by Subject|35|||
162050157|NCT01663532|585240034|FG001|Overall Study|Withdrawal by Subject|17|||
162050158|NCT01663532|585240033|FG000|Overall Study|Lack of Efficacy|15|||
162050159|NCT01663532|585240034|FG001|Overall Study|Lack of Efficacy|60|||
162050160|NCT01871532|585240040|FG000|Overall Study|Withdrawal by Subject|1|||
162050161|NCT01871532|585240041|FG001|Overall Study|Withdrawal by Subject|2|||
162050162|NCT00283400|585240042|FG000|Overall Study|Withdrawal by Subject|1|||
162050163|NCT00283400|585240043|FG001|Overall Study|Withdrawal by Subject|1|||
162050164|NCT00283400|585240044|FG002|Overall Study|Withdrawal by Subject|0|||
162050165|NCT00283400|585240045|FG003|Overall Study|Withdrawal by Subject|0|||
162050166|NCT00283400|585240042|FG000|Overall Study|Death|1|||
162050167|NCT00283400|585240043|FG001|Overall Study|Death|0|||
162050168|NCT00283400|585240044|FG002|Overall Study|Death|1|||
162050169|NCT00283400|585240045|FG003|Overall Study|Death|0|||
162050170|NCT00934089|585240049|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
162050171|NCT00934089|585240050|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
162050172|NCT00934089|585240049|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
162050173|NCT00934089|585240050|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
162050174|NCT00680017|585240051|FG000|Overall Study|Adverse Event|13|||
162050175|NCT00680017|585240052|FG001|Overall Study|Adverse Event|7|||
162050176|NCT00680017|585240051|FG000|Overall Study|Withdrawal by Subject|2|||
162050177|NCT00680017|585240052|FG001|Overall Study|Withdrawal by Subject|5|||
162050178|NCT00680017|585240051|FG000|Overall Study|Lost to Follow-up|2|||
162050179|NCT00680017|585240052|FG001|Overall Study|Lost to Follow-up|0|||
162050180|NCT01434667|585240053|FG000|Overall Study|Lost to Follow-up|5|||
162050181|NCT01434667|585240054|FG001|Overall Study|Lost to Follow-up|10|||
162050182|NCT02034110|585240057|FG000|Overall Study|Physician Decision|0|||
162050183|NCT02034110|585240058|FG001|Overall Study|Physician Decision|0|||
162050184|NCT02034110|585240059|FG002|Overall Study|Physician Decision|0|||
162050185|NCT02034110|585240060|FG003|Overall Study|Physician Decision|0|||
162050186|NCT02034110|585240061|FG004|Overall Study|Physician Decision|2|||
162050187|NCT02034110|585240062|FG005|Overall Study|Physician Decision|0|||
162050188|NCT02034110|585240063|FG006|Overall Study|Physician Decision|1|||
162050189|NCT02034110|585240064|FG007|Overall Study|Physician Decision|0|||
162050190|NCT02034110|585240057|FG000|Overall Study|Lost to Follow-up|1|||
162050191|NCT02034110|585240058|FG001|Overall Study|Lost to Follow-up|0|||
162050192|NCT02034110|585240059|FG002|Overall Study|Lost to Follow-up|0|||
162050193|NCT02034110|585240060|FG003|Overall Study|Lost to Follow-up|0|||
162050194|NCT02034110|585240061|FG004|Overall Study|Lost to Follow-up|1|||
162050195|NCT02034110|585240062|FG005|Overall Study|Lost to Follow-up|0|||
162050196|NCT02034110|585240063|FG006|Overall Study|Lost to Follow-up|1|||
162050197|NCT02034110|585240064|FG007|Overall Study|Lost to Follow-up|0|||
162050198|NCT02034110|585240057|FG000|Overall Study|Withdrawal by Subject|5|||
162050199|NCT02034110|585240058|FG001|Overall Study|Withdrawal by Subject|7|||
162050200|NCT02034110|585240059|FG002|Overall Study|Withdrawal by Subject|0|||
162050201|NCT02034110|585240060|FG003|Overall Study|Withdrawal by Subject|3|||
162050202|NCT02034110|585240061|FG004|Overall Study|Withdrawal by Subject|7|||
162050203|NCT02034110|585240062|FG005|Overall Study|Withdrawal by Subject|0|||
162050204|NCT02034110|585240063|FG006|Overall Study|Withdrawal by Subject|3|||
162050205|NCT02034110|585240064|FG007|Overall Study|Withdrawal by Subject|1|||
162050206|NCT02034110|585240057|FG000|Overall Study|Study closed by sponsor|6|||
162050207|NCT02034110|585240058|FG001|Overall Study|Study closed by sponsor|2|||
162050208|NCT02034110|585240059|FG002|Overall Study|Study closed by sponsor|0|||
162050209|NCT02034110|585240060|FG003|Overall Study|Study closed by sponsor|6|||
162050210|NCT02034110|585240061|FG004|Overall Study|Study closed by sponsor|7|||
162050211|NCT02034110|585240062|FG005|Overall Study|Study closed by sponsor|0|||
162050212|NCT02034110|585240063|FG006|Overall Study|Study closed by sponsor|42|||
162050213|NCT02034110|585240064|FG007|Overall Study|Study closed by sponsor|0|||
162050214|NCT00064337|585240065|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
162050215|NCT00064337|585240065|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
162050216|NCT00064337|585240065|FG000|PBSCC or Induction/PBSCC|Progression|3|||
162050217|NCT00064337|585240065|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
162050218|NCT00064337|585240065|FG000|PBSCC or Induction/PBSCC|Death|2|||
162050219|NCT00064337|585240065|FG000|Transplant|Adverse Event|9|||
162050220|NCT00064337|585240065|FG000|Transplant|Not protocol-specified|5|||
162050221|NCT00064337|585240065|FG000|Transplant|Death|3|||
162050222|NCT00064337|585240065|FG000|Transplant|Patient Refusal|2|||
162050223|NCT00064337|585240065|FG000|Transplant|Progression|2|||
162050224|NCT00064337|585240065|FG000|Maintenance|Adverse Event|3|||
162050225|NCT00064337|585240065|FG000|Maintenance|Progression|2|||
162050226|NCT00064337|585240065|FG000|Maintenance|On treatment at time of analysis|2|||
162050227|NCT00064337|585240065|FG000|Maintenance|Not protocol-specified|2|||
162050228|NCT00064337|585240065|FG000|Maintenance|Death|1|||
162050229|NCT02279420|585240066|FG000|Overall Study|Lost to Follow-up|23|||
162050230|NCT03535844|585240069|FG000|Overall Study|Withdrawal by Subject|0|||
162050231|NCT03535844|585240070|FG001|Overall Study|Withdrawal by Subject|1|||
162050232|NCT00612040|585240071|FG000|Overall Study|Adverse Event|0|||
162050233|NCT00612040|585240072|FG001|Overall Study|Adverse Event|2|||
162050234|NCT00612040|585240073|FG002|Overall Study|Adverse Event|1|||
162050235|NCT00612040|585240071|FG000|Overall Study|Protocol Violation|1|||
162050236|NCT00612040|585240072|FG001|Overall Study|Protocol Violation|2|||
162050237|NCT00612040|585240073|FG002|Overall Study|Protocol Violation|1|||
162050238|NCT00612040|585240071|FG000|Overall Study|Lack of Efficacy|2|||
162050239|NCT00612040|585240072|FG001|Overall Study|Lack of Efficacy|1|||
162050240|NCT00612040|585240073|FG002|Overall Study|Lack of Efficacy|0|||
162050241|NCT00612040|585240071|FG000|Overall Study|Unclassified|2|||
162050242|NCT00612040|585240072|FG001|Overall Study|Unclassified|2|||
162050243|NCT00612040|585240073|FG002|Overall Study|Unclassified|5|||
162050244|NCT00297830|585240074|FG000|6 Month Visit|Death|1|||
162050245|NCT00297830|585240075|FG001|6 Month Visit|Death|0|||
162050246|NCT00297830|585240076|FG002|6 Month Visit|Death|2|||
162050247|NCT00297830|585240074|FG000|6 Month Visit|Withdrawal by Subject|2|||
162050248|NCT00297830|585240075|FG001|6 Month Visit|Withdrawal by Subject|1|||
162050249|NCT00297830|585240076|FG002|6 Month Visit|Withdrawal by Subject|1|||
162050250|NCT00297830|585240074|FG000|6 Month Visit|Adverse Event|0|||
162050251|NCT00297830|585240075|FG001|6 Month Visit|Adverse Event|1|||
162050252|NCT00297830|585240076|FG002|6 Month Visit|Adverse Event|0|||
162050253|NCT00297830|585240074|FG000|12 Month Visit|Lost to Follow-up|1|||
162050254|NCT00297830|585240075|FG001|12 Month Visit|Lost to Follow-up|0|||
162050255|NCT00297830|585240076|FG002|12 Month Visit|Lost to Follow-up|0|||
162050256|NCT00297830|585240074|FG000|12 Month Visit|Adverse Event|0|||
162050257|NCT00297830|585240075|FG001|12 Month Visit|Adverse Event|3|||
162050258|NCT00297830|585240076|FG002|12 Month Visit|Adverse Event|0|||
162050259|NCT00297830|585240074|FG000|12 Month Visit|Withdrawal by Subject|0|||
162050260|NCT00297830|585240075|FG001|12 Month Visit|Withdrawal by Subject|3|||
162050261|NCT00297830|585240076|FG002|12 Month Visit|Withdrawal by Subject|0|||
162050262|NCT02835820|585240077|FG000|Overall Study|Baseline Screen Failure|0|||
162050263|NCT02835820|585240078|FG001|Overall Study|Baseline Screen Failure|3|||
162050264|NCT00827502|585240079|FG000|Overall Study|randomized but not treated|11|||
162050265|NCT00827502|585240079|FG000|Overall Study|Adverse Event|1|||
162050266|NCT00827502|585240079|FG000|Overall Study|Lost to Follow-up|4|||
162050267|NCT00827502|585240079|FG000|Overall Study|Withdrawal by Subject|5|||
162050268|NCT05096221|585240080|FG000|Part 2|Physician Decision|0|||
162050269|NCT05096221|585240081|FG001|Part 2|Physician Decision|1|||
162050270|NCT02478632|585240088|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
162050271|NCT02478632|585240089|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
162050272|NCT02478632|585240088|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
162050273|NCT02478632|585240089|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
162050274|NCT02478632|585240088|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
162050275|NCT02478632|585240089|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
162050276|NCT01867424|585240091|FG000|Overall Study|Patient noncompliance|2|||
162050277|NCT01867424|585240092|FG001|Overall Study|Patient noncompliance|1|||
162050278|NCT04645953|585240093|FG000|Overall Study|Lost to Follow-up|2|||
162050279|NCT04645953|585240094|FG001|Overall Study|Lost to Follow-up|1|||
162050280|NCT04645953|585240095|FG002|Overall Study|Lost to Follow-up|1|||
162050281|NCT04645953|585240093|FG000|Overall Study|Withdrawal by Subject|0|||
162050282|NCT04645953|585240094|FG001|Overall Study|Withdrawal by Subject|1|||
162050283|NCT04645953|585240095|FG002|Overall Study|Withdrawal by Subject|0|||
162050284|NCT04645953|585240093|FG000|Overall Study|Physician Decision|0|||
162050285|NCT04645953|585240094|FG001|Overall Study|Physician Decision|1|||
162050286|NCT04645953|585240095|FG002|Overall Study|Physician Decision|0|||
162050287|NCT04645953|585240093|FG000|Overall Study|Discontinued Prior to Dosing|0|||
162050288|NCT04645953|585240094|FG001|Overall Study|Discontinued Prior to Dosing|0|||
162050289|NCT04645953|585240095|FG002|Overall Study|Discontinued Prior to Dosing|2|||
162050290|NCT04613375|585240096|FG000|Overall Study|Death|198|||
162050291|NCT04613375|585240096|FG000|Overall Study|Withdrawal by Subject|3|||
162050292|NCT00434954|585240097|FG000|Overall Study|Adverse Event|17|||
162050293|NCT00434954|585240098|FG001|Overall Study|Adverse Event|2|||
162050294|NCT00434954|585240097|FG000|Overall Study|Entry criteria not met|14|||
162050295|NCT00434954|585240098|FG001|Overall Study|Entry criteria not met|16|||
162050296|NCT00434954|585240097|FG000|Overall Study|Lost to Follow-up|0|||
162050297|NCT00434954|585240098|FG001|Overall Study|Lost to Follow-up|1|||
162050298|NCT00434954|585240097|FG000|Overall Study|Physician Decision|6|||
162050299|NCT00434954|585240098|FG001|Overall Study|Physician Decision|3|||
162050300|NCT00434954|585240097|FG000|Overall Study|Protocol Violation|36|||
162050301|NCT00434954|585240098|FG001|Overall Study|Protocol Violation|27|||
162050302|NCT00434954|585240097|FG000|Overall Study|Sponsor decision|1|||
162050303|NCT00434954|585240098|FG001|Overall Study|Sponsor decision|0|||
162050304|NCT00434954|585240097|FG000|Overall Study|Subject decision|8|||
162050305|NCT00434954|585240098|FG001|Overall Study|Subject decision|22|||
162050306|NCT00002651|585240099|FG000|Induction|Adverse Event|44|||
162050307|NCT00002651|585240100|FG001|Induction|Adverse Event|0|||
162050308|NCT00002651|585240101|FG002|Induction|Adverse Event|0|||
162050309|NCT00002651|585240099|FG000|Induction|Refusal unrelated to adverse event|50|||
162050310|NCT00002651|585240100|FG001|Induction|Refusal unrelated to adverse event|0|||
162050311|NCT00002651|585240101|FG002|Induction|Refusal unrelated to adverse event|0|||
162050312|NCT00002651|585240099|FG000|Induction|Progression/relapse|274|||
162050313|NCT00002651|585240100|FG001|Induction|Progression/relapse|0|||
162050314|NCT00002651|585240101|FG002|Induction|Progression/relapse|0|||
162050315|NCT00002651|585240099|FG000|Induction|Death|62|||
162050316|NCT00002651|585240100|FG001|Induction|Death|0|||
162050317|NCT00002651|585240101|FG002|Induction|Death|0|||
162050318|NCT00002651|585240099|FG000|Induction|Other|823|||
162050319|NCT00002651|585240100|FG001|Induction|Other|0|||
162050320|NCT00002651|585240101|FG002|Induction|Other|0|||
162050321|NCT00002651|585240099|FG000|Induction|not eligible|90|||
162050322|NCT00002651|585240100|FG001|Induction|not eligible|0|||
162050323|NCT00002651|585240101|FG002|Induction|not eligible|0|||
162050324|NCT00002651|585240099|FG000|Consolidation and Randomization|Adverse Event|0|||
162050325|NCT00002651|585240100|FG001|Consolidation and Randomization|Adverse Event|36|||
162050326|NCT00002651|585240101|FG002|Consolidation and Randomization|Adverse Event|14|||
162050327|NCT00002651|585240099|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
162050328|NCT00002651|585240100|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
162050329|NCT00002651|585240101|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
162050330|NCT00002651|585240099|FG000|Consolidation and Randomization|Progression/relapse|0|||
162050331|NCT00002651|585240100|FG001|Consolidation and Randomization|Progression/relapse|295|||
162050332|NCT00002651|585240101|FG002|Consolidation and Randomization|Progression/relapse|298|||
162050333|NCT00002651|585240099|FG000|Consolidation and Randomization|Death|0|||
162050334|NCT00002651|585240100|FG001|Consolidation and Randomization|Death|38|||
162050335|NCT00002651|585240101|FG002|Consolidation and Randomization|Death|48|||
162050336|NCT00002651|585240099|FG000|Consolidation and Randomization|Other|0|||
162050337|NCT00002651|585240100|FG001|Consolidation and Randomization|Other|314|||
162050338|NCT00002651|585240101|FG002|Consolidation and Randomization|Other|313|||
162050339|NCT00002651|585240099|FG000|Consolidation and Randomization|not eligible|0|||
162050340|NCT00002651|585240100|FG001|Consolidation and Randomization|not eligible|102|||
162050341|NCT00002651|585240101|FG002|Consolidation and Randomization|not eligible|112|||
162050342|NCT03417219|585240102|FG000|Overall Study|Lost to Follow-up|0|||
162050343|NCT03417219|585240103|FG001|Overall Study|Lost to Follow-up|3|||
162050344|NCT02264639|585240108|FG000|Overall Study|Death (after completing single-dose phase)|1|||
162050345|NCT02264639|585240109|FG001|Overall Study|Death (after completing single-dose phase)|0|||
162050346|NCT02264639|585240110|FG002|Overall Study|Death (after completing single-dose phase)|0|||
162050347|NCT02264639|585240111|FG003|Overall Study|Death (after completing single-dose phase)|0|||
162050348|NCT02264639|585240112|FG004|Overall Study|Death (after completing single-dose phase)|0|||
162050349|NCT02264639|585240108|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
162050350|NCT02264639|585240109|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
162050351|NCT02264639|585240110|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
162050352|NCT02264639|585240111|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
162050353|NCT02264639|585240112|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
162050354|NCT02264639|585240108|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
162050355|NCT02264639|585240109|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
162050356|NCT02264639|585240110|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
162050357|NCT02264639|585240111|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
162050358|NCT02264639|585240112|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
162050359|NCT02264639|585240108|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
162050360|NCT02264639|585240109|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
162050361|NCT02264639|585240110|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
162050362|NCT02264639|585240111|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
162050363|NCT02264639|585240112|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
162050364|NCT01612858|585240113|FG000|Overall Study|Withdrawal by Subject|5|||
162050365|NCT01612858|585240114|FG001|Overall Study|Withdrawal by Subject|1|||
162050366|NCT00005044|585240115|FG000|Overall Study|Protocol Violation|37|||
162050367|NCT00005044|585240116|FG001|Overall Study|Protocol Violation|46|||
162050368|NCT00005044|585240115|FG000|Overall Study|Withdrawal by Subject|1|||
162050369|NCT00005044|585240116|FG001|Overall Study|Withdrawal by Subject|5|||
162050370|NCT00005044|585240115|FG000|Overall Study|No protocol treatment|0|||
162050371|NCT00005044|585240116|FG001|Overall Study|No protocol treatment|1|||
162050372|NCT00843856|585240117|FG000|Overall Study|Lost to Follow-up|1|||
162050373|NCT00843856|585240118|FG001|Overall Study|Lost to Follow-up|2|||
162050374|NCT02993757|585240123|FG000|Overall Study|Non compliance with the protocol|155|||
162050375|NCT02993757|585240124|FG001|Overall Study|Non compliance with the protocol|170|||
162050376|NCT02993757|585240123|FG000|Overall Study|Lost to Follow-up|1|||
162050377|NCT02993757|585240124|FG001|Overall Study|Lost to Follow-up|0|||
162050378|NCT02993757|585240123|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
162050379|NCT02993757|585240124|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
162050380|NCT00087607|585240133|FG000|Overall Study|Adverse Event|14|||
162050381|NCT00087607|585240134|FG001|Overall Study|Adverse Event|24|||
162050382|NCT00087607|585240133|FG000|Overall Study|Death|0|||
162050383|NCT00087607|585240134|FG001|Overall Study|Death|1|||
162050384|NCT00087607|585240133|FG000|Overall Study|Insufficient Therapeutic Response|53|||
162050385|NCT00087607|585240134|FG001|Overall Study|Insufficient Therapeutic Response|42|||
162050386|NCT00087607|585240133|FG000|Overall Study|Failure to return|21|||
162050387|NCT00087607|585240134|FG001|Overall Study|Failure to return|17|||
162050388|NCT00087607|585240133|FG000|Overall Study|Withdrew Consent|12|||
162050389|NCT00087607|585240134|FG001|Overall Study|Withdrew Consent|16|||
162050390|NCT00087607|585240133|FG000|Overall Study|Administrative|12|||
162050391|NCT00087607|585240134|FG001|Overall Study|Administrative|12|||
162050392|NCT00087607|585240133|FG000|Overall Study|Refused Treatment|5|||
162050393|NCT00087607|585240134|FG001|Overall Study|Refused Treatment|7|||
162050394|NCT00087607|585240133|FG000|Overall Study|Other Protocol Violation|5|||
162050395|NCT00087607|585240134|FG001|Overall Study|Other Protocol Violation|2|||
162050396|NCT00087607|585240133|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
162050397|NCT00087607|585240134|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
162050398|NCT00190671|585240135|FG000|Overall Study|Satisfactory Response|4|||
162050399|NCT00190671|585240136|FG001|Overall Study|Satisfactory Response|7|||
162050400|NCT00190671|585240135|FG000|Overall Study|Lack of Efficacy|19|||
162050401|NCT00190671|585240136|FG001|Overall Study|Lack of Efficacy|24|||
162050402|NCT00190671|585240135|FG000|Overall Study|Death from Study Disease|1|||
162050403|NCT00190671|585240136|FG001|Overall Study|Death from Study Disease|1|||
162050404|NCT00190671|585240135|FG000|Overall Study|Adverse Event|3|||
162050405|NCT00190671|585240136|FG001|Overall Study|Adverse Event|2|||
162050406|NCT00190671|585240135|FG000|Overall Study|Clinical Relapse|0|||
162050407|NCT00190671|585240136|FG001|Overall Study|Clinical Relapse|1|||
162050408|NCT00190671|585240135|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
162050409|NCT00190671|585240136|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
162050410|NCT00190671|585240135|FG000|Overall Study|Death from Other Causes|0|||
162050411|NCT00190671|585240136|FG001|Overall Study|Death from Other Causes|2|||
162050412|NCT00190671|585240135|FG000|Overall Study|Protocol Violation|0|||
162050413|NCT00190671|585240136|FG001|Overall Study|Protocol Violation|1|||
162050414|NCT00190671|585240135|FG000|Overall Study|Withdrawal by Subject|0|||
162050415|NCT00190671|585240136|FG001|Overall Study|Withdrawal by Subject|2|||
162050416|NCT02699593|585240137|FG000|Period 1|Unsatisfactory Visual Response|0|||
162050417|NCT02699593|585240138|FG001|Period 1|Unsatisfactory Visual Response|1|||
162050418|NCT02699593|585240137|FG000|Period 1|Torn Contact Len|4|||
162050419|NCT02699593|585240138|FG001|Period 1|Torn Contact Len|3|||
162050420|NCT02699593|585240137|FG000|Period 1|Protocol Violation|0|||
162050421|NCT02699593|585240138|FG001|Period 1|Protocol Violation|1|||
162050422|NCT02699593|585240137|FG000|Period 1|Withdrawal by Subject|0|||
162050423|NCT02699593|585240138|FG001|Period 1|Withdrawal by Subject|1|||
162050424|NCT02699593|585240137|FG000|Period 1|Adverse Event|1|||
162050425|NCT02699593|585240138|FG001|Period 1|Adverse Event|1|||
162050426|NCT02699593|585240137|FG000|Period 2|Adverse Event|1|||
162050427|NCT02699593|585240138|FG001|Period 2|Adverse Event|1|||
162050428|NCT02699593|585240137|FG000|Period 2|Lost Contact Lens|0|||
162050429|NCT02699593|585240138|FG001|Period 2|Lost Contact Lens|1|||
162050430|NCT02699593|585240137|FG000|Period 2|Torn Contact Lens|1|||
162050431|NCT02699593|585240138|FG001|Period 2|Torn Contact Lens|0|||
162050432|NCT02015754|585240139|FG000|Overall Study|Disease progression|5|||
162050433|NCT02015754|585240139|FG000|Overall Study|Change in treatment modality|5|||
162050434|NCT02015754|585240139|FG000|Overall Study|Lost to Follow-up|1|||
162050435|NCT02229383|585240142|FG000|Overall Study|Adverse Event|7|||
162050436|NCT02229383|585240143|FG001|Overall Study|Adverse Event|4|||
162050437|NCT02229383|585240142|FG000|Overall Study|Death|0|||
162050438|NCT02229383|585240143|FG001|Overall Study|Death|1|||
162050439|NCT02229383|585240142|FG000|Overall Study|Lost to Follow-up|5|||
162050440|NCT02229383|585240143|FG001|Overall Study|Lost to Follow-up|3|||
162050441|NCT02229383|585240142|FG000|Overall Study|Withdrawal by Subject|4|||
162050442|NCT02229383|585240143|FG001|Overall Study|Withdrawal by Subject|6|||
162050443|NCT02229383|585240142|FG000|Overall Study|Did not receive treatment|1|||
162050444|NCT02229383|585240143|FG001|Overall Study|Did not receive treatment|0|||
162050445|NCT02229383|585240142|FG000|Overall Study|Other|3|||
162050446|NCT02229383|585240143|FG001|Overall Study|Other|8|||
162050447|NCT00873015|585240147|FG000|Overall Study|Withdrawal by Subject|0|||
162050448|NCT00873015|585240148|FG001|Overall Study|Withdrawal by Subject|1|||
162050449|NCT00873015|585240149|FG002|Overall Study|Withdrawal by Subject|0|||
162050450|NCT00873015|585240150|FG003|Overall Study|Withdrawal by Subject|0|||
162050451|NCT03128411|585240151|FG000|Treatment Phase|Adverse Event|21|||
162050452|NCT03128411|585240151|FG000|Treatment Phase|Physician Decision|1|||
162050453|NCT03128411|585240151|FG000|Treatment Phase|Other|2|||
162050454|NCT03128411|585240151|FG000|Long Term Follow-up Phase|Death|2|||
162050455|NCT03298867|585240161|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
162050456|NCT03298867|585240162|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
162050457|NCT03298867|585240161|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
162050458|NCT03298867|585240162|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
162050459|NCT03298867|585240161|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
162050460|NCT03298867|585240162|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
162050461|NCT03298867|585240161|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
162050462|NCT03298867|585240162|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
162050463|NCT03298867|585240161|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
162050464|NCT03298867|585240162|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
162050465|NCT03298867|585240161|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
162050466|NCT03298867|585240162|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
162050467|NCT03298867|585240161|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
162050468|NCT03298867|585240162|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
162050469|NCT03298867|585240161|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
162050470|NCT03298867|585240162|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
162050471|NCT03298867|585240161|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
162050472|NCT03298867|585240162|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
162050473|NCT06934993|585240177|FG000|Overall Study|Withdrawal by Subject|29|||
162050474|NCT06934993|585240177|FG000|Overall Study|elevated postoperative creatinine level|11|||
162050475|NCT06934993|585240177|FG000|Overall Study|Death|3|||
162050476|NCT01218113|585242521|FG000|Overall Study|Withdrawal by Subject|1|||
162050477|NCT01218113|585242522|FG001|Overall Study|Withdrawal by Subject|0|||
162050478|NCT01218113|585242523|FG002|Overall Study|Withdrawal by Subject|1|||
162050479|NCT01218113|585242521|FG000|Overall Study|Lost to Follow-up|4|||
162050480|NCT01218113|585242522|FG001|Overall Study|Lost to Follow-up|1|||
162050481|NCT01218113|585242523|FG002|Overall Study|Lost to Follow-up|4|||
162050482|NCT01218113|585242521|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
162050483|NCT01218113|585242522|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
162050484|NCT01218113|585242523|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
162050485|NCT01385566|585242527|FG000|Overall Study|Lost to Follow-up|1|||
162050486|NCT01385566|585242528|FG001|Overall Study|Lost to Follow-up|0|||
162050487|NCT01385566|585242529|FG002|Overall Study|Lost to Follow-up|0|||
162050488|NCT01385566|585242530|FG003|Overall Study|Lost to Follow-up|0|||
162050489|NCT01385566|585242531|FG004|Overall Study|Lost to Follow-up|0|||
162050490|NCT01385566|585242532|FG005|Overall Study|Lost to Follow-up|0|||
162050491|NCT01385566|585242527|FG000|Overall Study|Withdrawal by Subject|0|||
162050492|NCT01385566|585242528|FG001|Overall Study|Withdrawal by Subject|0|||
162050493|NCT01385566|585242529|FG002|Overall Study|Withdrawal by Subject|0|||
162050494|NCT01385566|585242530|FG003|Overall Study|Withdrawal by Subject|1|||
162050495|NCT01385566|585242531|FG004|Overall Study|Withdrawal by Subject|0|||
162050496|NCT01385566|585242532|FG005|Overall Study|Withdrawal by Subject|0|||
162050497|NCT00967668|585242533|FG000|Overall Study|Withdrawal by Subject|13|||
162050498|NCT00967668|585242534|FG001|Overall Study|Withdrawal by Subject|8|||
162050499|NCT00967668|585242535|FG002|Overall Study|Withdrawal by Subject|8|||
162050500|NCT00967668|585242533|FG000|Overall Study|Death|0|||
162050501|NCT00967668|585242534|FG001|Overall Study|Death|2|||
162050502|NCT00967668|585242535|FG002|Overall Study|Death|4|||
162050503|NCT00967668|585242533|FG000|Overall Study|Removed due to behavior|1|||
162050504|NCT00967668|585242534|FG001|Overall Study|Removed due to behavior|1|||
162050505|NCT00967668|585242535|FG002|Overall Study|Removed due to behavior|2|||
162050506|NCT00967668|585242533|FG000|Overall Study|Refused Year 2|11|||
162050507|NCT00967668|585242534|FG001|Overall Study|Refused Year 2|6|||
162050508|NCT00967668|585242535|FG002|Overall Study|Refused Year 2|4|||
162050509|NCT00967668|585242533|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
162050510|NCT00967668|585242534|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
162050511|NCT00967668|585242535|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
162050512|NCT00967668|585242533|FG000|Overall Study|Lost to Follow-up|15|||
162050513|NCT00967668|585242534|FG001|Overall Study|Lost to Follow-up|9|||
162050514|NCT00967668|585242535|FG002|Overall Study|Lost to Follow-up|16|||
162050515|NCT00967668|585242533|FG000|Overall Study|Refused 12-mo assessment|3|||
162050516|NCT00967668|585242534|FG001|Overall Study|Refused 12-mo assessment|1|||
162050517|NCT00967668|585242535|FG002|Overall Study|Refused 12-mo assessment|9|||
162050518|NCT00967668|585242533|FG000|Overall Study|Pregnancy|1|||
162050519|NCT00967668|585242534|FG001|Overall Study|Pregnancy|0|||
162050520|NCT00967668|585242535|FG002|Overall Study|Pregnancy|0|||
162050521|NCT00825682|585242536|FG000|Overall Study|personal reasons/ inconvenience|13|||
162050522|NCT00825682|585242537|FG001|Overall Study|personal reasons/ inconvenience|5|||
162050523|NCT03281577|585242538|FG000|Overall Study|Adverse Event|0|||
162050524|NCT03281577|585242539|FG001|Overall Study|Adverse Event|0|||
162050525|NCT03281577|585242540|FG002|Overall Study|Adverse Event|0|||
162050526|NCT03281577|585242541|FG003|Overall Study|Adverse Event|1|||
162050527|NCT03281577|585242538|FG000|Overall Study|Withdrawal by Subject|1|||
162050528|NCT03281577|585242539|FG001|Overall Study|Withdrawal by Subject|0|||
162050529|NCT03281577|585242540|FG002|Overall Study|Withdrawal by Subject|0|||
162237401|NCT00903682|585921090|FG000|Overall Study|Adverse Event|6|||
162237402|NCT00903682|585921091|FG001|Overall Study|Adverse Event|13|||
162050530|NCT03281577|585242541|FG003|Overall Study|Withdrawal by Subject|0|||
162050531|NCT01644565|585242542|FG000|Overall Study|Undisclosed Medical History|1|||
162050532|NCT01644565|585242543|FG001|Overall Study|Undisclosed Medical History|0|||
162050533|NCT01644565|585242544|FG002|Overall Study|Undisclosed Medical History|0|||
162050534|NCT01644565|585242545|FG003|Overall Study|Undisclosed Medical History|0|||
162050535|NCT01644565|585242546|FG004|Overall Study|Undisclosed Medical History|0|||
162050536|NCT01644565|585242547|FG005|Overall Study|Undisclosed Medical History|0|||
162050537|NCT01644565|585242548|FG006|Overall Study|Undisclosed Medical History|0|||
162050538|NCT01644565|585242549|FG007|Overall Study|Undisclosed Medical History|0|||
162050539|NCT01644565|585242550|FG008|Overall Study|Undisclosed Medical History|0|||
162050540|NCT01644565|585242542|FG000|Overall Study|Lost to Follow-up|0|||
162050541|NCT01644565|585242543|FG001|Overall Study|Lost to Follow-up|0|||
162050542|NCT01644565|585242544|FG002|Overall Study|Lost to Follow-up|0|||
162050543|NCT01644565|585242545|FG003|Overall Study|Lost to Follow-up|1|||
162050544|NCT01644565|585242546|FG004|Overall Study|Lost to Follow-up|0|||
162050545|NCT01644565|585242547|FG005|Overall Study|Lost to Follow-up|0|||
162050546|NCT01644565|585242548|FG006|Overall Study|Lost to Follow-up|0|||
162050547|NCT01644565|585242549|FG007|Overall Study|Lost to Follow-up|2|||
162050548|NCT01644565|585242550|FG008|Overall Study|Lost to Follow-up|0|||
162050549|NCT01644565|585242542|FG000|Overall Study|Family emergency|0|||
162050550|NCT01644565|585242543|FG001|Overall Study|Family emergency|0|||
162050551|NCT01644565|585242544|FG002|Overall Study|Family emergency|0|||
162050552|NCT01644565|585242545|FG003|Overall Study|Family emergency|0|||
162050553|NCT01644565|585242546|FG004|Overall Study|Family emergency|1|||
162050554|NCT01644565|585242547|FG005|Overall Study|Family emergency|0|||
162050555|NCT01644565|585242548|FG006|Overall Study|Family emergency|0|||
162050556|NCT01644565|585242549|FG007|Overall Study|Family emergency|0|||
162050557|NCT01644565|585242550|FG008|Overall Study|Family emergency|0|||
162050558|NCT01644565|585242542|FG000|Overall Study|Relocation|0|||
162050559|NCT01644565|585242543|FG001|Overall Study|Relocation|0|||
162050560|NCT01644565|585242544|FG002|Overall Study|Relocation|0|||
162050561|NCT01644565|585242545|FG003|Overall Study|Relocation|0|||
162050562|NCT01644565|585242546|FG004|Overall Study|Relocation|0|||
162050563|NCT01644565|585242547|FG005|Overall Study|Relocation|0|||
162050564|NCT01644565|585242548|FG006|Overall Study|Relocation|0|||
162050565|NCT01644565|585242549|FG007|Overall Study|Relocation|0|||
162050566|NCT01644565|585242550|FG008|Overall Study|Relocation|1|||
162050567|NCT00787891|585242551|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
162050568|NCT00787891|585242552|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
162050569|NCT00787891|585242551|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
162050570|NCT00787891|585242552|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
162050571|NCT00787891|585242551|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
162050572|NCT00787891|585242552|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
162050573|NCT00787891|585242551|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
162050574|NCT00787891|585242552|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
162050575|NCT00787891|585242551|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
162050576|NCT00787891|585242552|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
162050577|NCT00787891|585242551|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
162050578|NCT00787891|585242552|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
162050579|NCT00787891|585242551|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
162050580|NCT00787891|585242552|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
162050581|NCT00787891|585242551|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
162050582|NCT00787891|585242552|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
162050583|NCT00787891|585242551|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
162050584|NCT00787891|585242552|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
162050585|NCT00787891|585242551|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
162050586|NCT00787891|585242552|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
162050587|NCT01594281|585242553|FG000|Interventional Core Phase|Protocol Deviation|1|||
162050588|NCT01594281|585242554|FG001|Interventional Core Phase|Protocol Deviation|0|||
162050589|NCT01594281|585242555|FG002|Interventional Core Phase|Protocol Deviation|0|||
162050590|NCT01594281|585242553|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
162050591|NCT01594281|585242554|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
162050592|NCT01594281|585242555|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
162050593|NCT01594281|585242553|FG000|Interventional Core Phase|Death|1|||
162050594|NCT01594281|585242554|FG001|Interventional Core Phase|Death|1|||
162050595|NCT01594281|585242555|FG002|Interventional Core Phase|Death|2|||
162050596|NCT01594281|585242553|FG000|Interventional Core Phase|Lost to Follow-up|1|||
162050597|NCT01594281|585242554|FG001|Interventional Core Phase|Lost to Follow-up|4|||
162050598|NCT01594281|585242555|FG002|Interventional Core Phase|Lost to Follow-up|1|||
162050599|NCT01594281|585242553|FG000|Interventional Core Phase|Adverse Event|4|||
162050600|NCT01594281|585242554|FG001|Interventional Core Phase|Adverse Event|4|||
162050601|NCT01594281|585242555|FG002|Interventional Core Phase|Adverse Event|4|||
162050602|NCT01594281|585242553|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
162050603|NCT01594281|585242554|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
162050604|NCT01594281|585242555|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
162050605|NCT01594281|585242553|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
162050606|NCT01594281|585242554|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
162050607|NCT01594281|585242555|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
162050608|NCT01594281|585242553|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
162050609|NCT01594281|585242554|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
162050610|NCT01594281|585242555|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
162050611|NCT02550106|585242557|FG000|Overall Study|Adverse Event|1|||
162050612|NCT02550106|585242557|FG000|Overall Study|Lack of Efficacy|3|||
162050613|NCT02550106|585242557|FG000|Overall Study|Protocol Violation|6|||
162050614|NCT02550106|585242557|FG000|Overall Study|Withdrawal by Subject|2|||
162050615|NCT01193530|585242560|FG000|Overall Study|Withdrawal by Subject|2|||
162050616|NCT01193530|585242561|FG001|Overall Study|Withdrawal by Subject|2|||
162050617|NCT01193530|585242560|FG000|Overall Study|Began Contraindicated Therapy|1|||
162050618|NCT01193530|585242561|FG001|Overall Study|Began Contraindicated Therapy|0|||
162050619|NCT01193530|585242560|FG000|Overall Study|Lost Light Box|0|||
162050620|NCT01193530|585242561|FG001|Overall Study|Lost Light Box|1|||
162050621|NCT01193530|585242560|FG000|Overall Study|Returned home - out of state|0|||
162050622|NCT01193530|585242561|FG001|Overall Study|Returned home - out of state|1|||
162050623|NCT01193530|585242560|FG000|Overall Study|Non-Compliance|0|||
162050624|NCT01193530|585242561|FG001|Overall Study|Non-Compliance|1|||
162050625|NCT01890473|585242562|FG000|Overall Study|Lost to Follow-up|1|||
162050626|NCT01890473|585242563|FG001|Overall Study|Lost to Follow-up|0|||
162050627|NCT01890473|585242562|FG000|Overall Study|Poor/non-compliance|1|||
162050628|NCT01890473|585242563|FG001|Overall Study|Poor/non-compliance|0|||
162050629|NCT03166735|585242564|FG000|Overall Study|Not Treated|1|||
162050630|NCT03166735|585242565|FG001|Overall Study|Not Treated|0|||
162050631|NCT03166735|585242566|FG002|Overall Study|Not Treated|0|||
162050632|NCT03166735|585242567|FG003|Overall Study|Not Treated|0|||
162050633|NCT03166735|585242568|FG004|Overall Study|Not Treated|0|||
162050634|NCT03166735|585242564|FG000|Overall Study|follow-up not completed as planned|0|||
162050635|NCT03166735|585242565|FG001|Overall Study|follow-up not completed as planned|1|||
162050636|NCT03166735|585242566|FG002|Overall Study|follow-up not completed as planned|1|||
162050637|NCT03166735|585242567|FG003|Overall Study|follow-up not completed as planned|0|||
162050638|NCT03166735|585242568|FG004|Overall Study|follow-up not completed as planned|1|||
162050639|NCT03166735|585242564|FG000|Overall Study|Withdrawal by Subject|0|||
162050640|NCT03166735|585242565|FG001|Overall Study|Withdrawal by Subject|0|||
162050641|NCT03166735|585242566|FG002|Overall Study|Withdrawal by Subject|1|||
162050642|NCT03166735|585242567|FG003|Overall Study|Withdrawal by Subject|1|||
162050643|NCT03166735|585242568|FG004|Overall Study|Withdrawal by Subject|2|||
162050644|NCT03166735|585242564|FG000|Overall Study|Lost to Follow-up|0|||
162050645|NCT03166735|585242565|FG001|Overall Study|Lost to Follow-up|2|||
162050646|NCT03166735|585242566|FG002|Overall Study|Lost to Follow-up|1|||
162050647|NCT03166735|585242567|FG003|Overall Study|Lost to Follow-up|0|||
162050648|NCT03166735|585242568|FG004|Overall Study|Lost to Follow-up|1|||
162050649|NCT01543958|585242569|FG000|Overall Study|Loss to follow-up|3|||
162050650|NCT01543958|585242569|FG000|Overall Study|ART initiation|1|||
162050651|NCT01945281|585242570|FG000|Overall Study|Adverse Event|1|||
162050652|NCT01945281|585242571|FG001|Overall Study|Adverse Event|0|||
162050653|NCT01945281|585242570|FG000|Overall Study|Death|3|||
162050654|NCT01945281|585242571|FG001|Overall Study|Death|3|||
162050655|NCT01945281|585242570|FG000|Overall Study|Physician Decision|1|||
162050656|NCT01945281|585242571|FG001|Overall Study|Physician Decision|1|||
162050657|NCT01945281|585242570|FG000|Overall Study|Technical Problems|1|||
162050658|NCT01945281|585242571|FG001|Overall Study|Technical Problems|0|||
162050659|NCT00926328|585242572|FG000|Overall Study|Lost to Follow-up|12|||
162050660|NCT00926328|585242573|FG001|Overall Study|Lost to Follow-up|14|||
162050661|NCT00726986|585242574|FG000|Induction Phase|Adverse Event|4|||
162050662|NCT00726986|585242574|FG000|Induction Phase|Withdrawal by Subject|2|||
162050663|NCT00726986|585242574|FG000|Induction Phase|Death|2|||
162050664|NCT00726986|585242574|FG000|Induction Phase|Lack of Efficacy|5|||
162050665|NCT00726986|585242574|FG000|Induction Phase|Secondary Disease|2|||
162050666|NCT00726986|585242574|FG000|Maintenance Phase|Adverse Event|1|||
162050667|NCT00726986|585242574|FG000|Maintenance Phase|Lack of Efficacy|2|||
162050668|NCT01819831|585242579|FG000|Overall Study|Withdrawal by Subject|1|||
162050669|NCT05074667|585242580|FG000|Overall Study|Death|1|||
162050670|NCT05074667|585242580|FG000|Overall Study|Withdrawal by Subject|4|||
162050671|NCT05074667|585242580|FG000|Overall Study|Lost to Follow-up|10|||
162050672|NCT02193867|585242581|FG000|Overall Study|Death|2|||
162050673|NCT02193867|585242581|FG000|Overall Study|Sponsor Study Termination|2|||
162050674|NCT02924571|585242582|FG000|Overall Study|Lost to Follow-up|1|||
162050675|NCT02924571|585242583|FG001|Overall Study|Lost to Follow-up|1|||
162050676|NCT02924571|585242584|FG002|Overall Study|Lost to Follow-up|0|||
162050677|NCT01705730|585242588|FG000|Overall Study|Lack of Efficacy|1|||
162050678|NCT01705730|585242588|FG000|Overall Study|Adverse Event|3|||
162050679|NCT01705730|585242588|FG000|Overall Study|Lost to Follow-up|1|||
162050680|NCT01705730|585242588|FG000|Overall Study|Reason not Specified|4|||
162050681|NCT04891978|585242594|FG000|Baseline|Protocol Violation|2|||
162050682|NCT04891978|585242595|FG001|Baseline|Protocol Violation|1|||
162050683|NCT04891978|585242596|FG002|Baseline|Protocol Violation|0|||
162050684|NCT04891978|585242594|FG000|Baseline|Missing AIRQ|1|||
162050685|NCT04891978|585242595|FG001|Baseline|Missing AIRQ|0|||
162050686|NCT04891978|585242596|FG002|Baseline|Missing AIRQ|0|||
162050687|NCT04891978|585242594|FG000|Baseline|Did not attend a baseline visit|0|||
162050688|NCT04891978|585242595|FG001|Baseline|Did not attend a baseline visit|0|||
162050689|NCT04891978|585242596|FG002|Baseline|Did not attend a baseline visit|9|||
162050690|NCT01776840|585242597|FG000|Overall Study|Lost to Follow-up|12|||
162050691|NCT01776840|585242598|FG001|Overall Study|Lost to Follow-up|7|||
162050692|NCT01776840|585242597|FG000|Overall Study|Withdrawal by Subject|32|||
162050693|NCT01776840|585242598|FG001|Overall Study|Withdrawal by Subject|48|||
162050694|NCT01776840|585242597|FG000|Overall Study|Sponsor decision|89|||
162050695|NCT01776840|585242598|FG001|Overall Study|Sponsor decision|87|||
162050696|NCT05338216|585242599|FG000|Overall Study|Withdrawal by Subject|1|||
162050697|NCT05338216|585242600|FG001|Overall Study|Withdrawal by Subject|1|||
162050698|NCT02589405|585242604|FG000|Overall Study|Adverse Event|3|||
162050699|NCT02589405|585242604|FG000|Overall Study|Withdrawal by Subject|1|||
162050700|NCT02693119|585242607|FG000|Open-Label Period|Withdrawal by Subject|0|||
162050701|NCT02693119|585242608|FG001|Open-Label Period|Withdrawal by Subject|1|||
162050702|NCT01719783|585242609|FG000|Dose 2|Physician Decision|1|||
162050703|NCT01719783|585242610|FG001|Dose 2|Physician Decision|0|||
162050704|NCT01350492|585242611|FG000|Intervention|Lost to Follow-up|2|||
162050705|NCT01350492|585242612|FG001|Intervention|Lost to Follow-up|5|||
162050706|NCT01350492|585242611|FG000|Intervention|Withdrawal by Subject|3|||
162050707|NCT01350492|585242612|FG001|Intervention|Withdrawal by Subject|1|||
162050708|NCT01350492|585242611|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
162050709|NCT01350492|585242612|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
162050710|NCT01350492|585242611|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
162050711|NCT01350492|585242612|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
162050712|NCT00753766|585242613|FG000|Overall Study|Physician Decision|1|||
162050713|NCT00753766|585242614|FG001|Overall Study|Physician Decision|0|||
162050714|NCT03800173|585242617|FG000|Overall Study|Lost to Follow-up|0|||
162050715|NCT03800173|585242618|FG001|Overall Study|Lost to Follow-up|0|||
162050716|NCT03800173|585242619|FG002|Overall Study|Lost to Follow-up|0|||
162050717|NCT03800173|585242620|FG003|Overall Study|Lost to Follow-up|0|||
162050718|NCT03800173|585242621|FG004|Overall Study|Lost to Follow-up|1|||
162050719|NCT00932126|585242624|FG000|Overall Study|Adverse Event|0|||
162050720|NCT00932126|585242625|FG001|Overall Study|Adverse Event|0|||
162050721|NCT00932126|585242626|FG002|Overall Study|Adverse Event|0|||
162050722|NCT00932126|585242627|FG003|Overall Study|Adverse Event|0|||
162050723|NCT00932126|585242628|FG004|Overall Study|Adverse Event|0|||
162050724|NCT00932126|585242629|FG005|Overall Study|Adverse Event|0|||
162050725|NCT00932126|585242630|FG006|Overall Study|Adverse Event|1|||
162050726|NCT00932126|585242631|FG007|Overall Study|Adverse Event|2|||
162050727|NCT00932126|585242624|FG000|Overall Study|Protocol Violation|0|||
162050728|NCT00932126|585242625|FG001|Overall Study|Protocol Violation|0|||
162050729|NCT00932126|585242626|FG002|Overall Study|Protocol Violation|0|||
162050730|NCT00932126|585242627|FG003|Overall Study|Protocol Violation|0|||
162050731|NCT00932126|585242628|FG004|Overall Study|Protocol Violation|1|||
162050732|NCT00932126|585242629|FG005|Overall Study|Protocol Violation|0|||
162050733|NCT00932126|585242630|FG006|Overall Study|Protocol Violation|0|||
162050734|NCT00932126|585242631|FG007|Overall Study|Protocol Violation|0|||
162050735|NCT00932126|585242624|FG000|Overall Study|Withdrawal by Subject|0|||
162050736|NCT00932126|585242625|FG001|Overall Study|Withdrawal by Subject|0|||
162050737|NCT00932126|585242626|FG002|Overall Study|Withdrawal by Subject|1|||
162050738|NCT00932126|585242627|FG003|Overall Study|Withdrawal by Subject|0|||
162050739|NCT00932126|585242628|FG004|Overall Study|Withdrawal by Subject|0|||
162050740|NCT00932126|585242629|FG005|Overall Study|Withdrawal by Subject|0|||
162050741|NCT00932126|585242630|FG006|Overall Study|Withdrawal by Subject|0|||
162050742|NCT00932126|585242631|FG007|Overall Study|Withdrawal by Subject|1|||
162050743|NCT00932126|585242624|FG000|Overall Study|Objective progression or relapse|3|||
162050744|NCT00932126|585242625|FG001|Overall Study|Objective progression or relapse|3|||
162050745|NCT00932126|585242626|FG002|Overall Study|Objective progression or relapse|2|||
162050746|NCT00932126|585242627|FG003|Overall Study|Objective progression or relapse|3|||
162050747|NCT00932126|585242628|FG004|Overall Study|Objective progression or relapse|3|||
162050748|NCT00932126|585242629|FG005|Overall Study|Objective progression or relapse|3|||
162050749|NCT00932126|585242630|FG006|Overall Study|Objective progression or relapse|3|||
162050750|NCT00932126|585242631|FG007|Overall Study|Objective progression or relapse|5|||
162050751|NCT00932126|585242624|FG000|Overall Study|Other|0|||
162050752|NCT00932126|585242625|FG001|Overall Study|Other|0|||
162050753|NCT00932126|585242626|FG002|Overall Study|Other|0|||
162050754|NCT00932126|585242627|FG003|Overall Study|Other|0|||
162050755|NCT00932126|585242628|FG004|Overall Study|Other|1|||
162050756|NCT00932126|585242629|FG005|Overall Study|Other|0|||
162050757|NCT00932126|585242630|FG006|Overall Study|Other|1|||
162050758|NCT00932126|585242631|FG007|Overall Study|Other|2|||
162050759|NCT02121522|585242639|FG000|Overall Study|Adverse Event|1|||
162050760|NCT01235689|585242640|FG000|Overall Study|Adverse Event|12|||
162050761|NCT01235689|585242641|FG001|Overall Study|Adverse Event|16|||
162050762|NCT01235689|585242640|FG000|Overall Study|Lack of Efficacy|12|||
162050763|NCT01235689|585242641|FG001|Overall Study|Lack of Efficacy|5|||
162050764|NCT01235689|585242640|FG000|Overall Study|Withdrawal by Subject|3|||
162050765|NCT01235689|585242641|FG001|Overall Study|Withdrawal by Subject|4|||
162050766|NCT01235689|585242640|FG000|Overall Study|Lost to Follow-up|1|||
162050767|NCT01235689|585242641|FG001|Overall Study|Lost to Follow-up|2|||
162050768|NCT01235689|585242640|FG000|Overall Study|Miscellaneous|1|||
162050769|NCT01235689|585242641|FG001|Overall Study|Miscellaneous|5|||
162050770|NCT02217878|585242642|FG000|Overall Study|required morphine due to chest pain|1|||
162050771|NCT02217878|585242643|FG001|Overall Study|required morphine due to chest pain|2|||
162050772|NCT02217878|585242642|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
162050773|NCT02217878|585242643|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
162050774|NCT00806351|585242646|FG000|Overall Study|Death|5|||
162050775|NCT00806351|585242647|FG001|Overall Study|Death|4|||
162050776|NCT02151110|585242649|FG000|Overall Study|Withdrawal by Subject|0|||
162050777|NCT02151110|585242650|FG001|Overall Study|Withdrawal by Subject|0|||
162050778|NCT02151110|585242651|FG002|Overall Study|Withdrawal by Subject|0|||
162050779|NCT02151110|585242652|FG003|Overall Study|Withdrawal by Subject|0|||
162050780|NCT02151110|585242653|FG004|Overall Study|Withdrawal by Subject|0|||
162050781|NCT02151110|585242654|FG005|Overall Study|Withdrawal by Subject|0|||
162050782|NCT02151110|585242655|FG006|Overall Study|Withdrawal by Subject|0|||
162050783|NCT02151110|585242656|FG007|Overall Study|Withdrawal by Subject|1|||
162050784|NCT02151110|585242649|FG000|Overall Study|Lost to Follow-up|0|||
162050785|NCT02151110|585242650|FG001|Overall Study|Lost to Follow-up|0|||
162050786|NCT02151110|585242651|FG002|Overall Study|Lost to Follow-up|0|||
162050787|NCT02151110|585242652|FG003|Overall Study|Lost to Follow-up|0|||
162050788|NCT02151110|585242653|FG004|Overall Study|Lost to Follow-up|0|||
162050789|NCT02151110|585242654|FG005|Overall Study|Lost to Follow-up|0|||
162050790|NCT02151110|585242655|FG006|Overall Study|Lost to Follow-up|0|||
162050791|NCT02151110|585242656|FG007|Overall Study|Lost to Follow-up|2|||
162050792|NCT00672646|585242660|FG000|Overall Study|Lost to Follow-up|0|||
162050793|NCT00672646|585242661|FG001|Overall Study|Lost to Follow-up|1|||
162050794|NCT00672646|585242662|FG002|Overall Study|Lost to Follow-up|2|||
162050795|NCT00672646|585242660|FG000|Overall Study|Withdrawal by Subject|0|||
162050796|NCT00672646|585242661|FG001|Overall Study|Withdrawal by Subject|0|||
162050797|NCT00672646|585242662|FG002|Overall Study|Withdrawal by Subject|1|||
162050798|NCT00289783|585242665|FG000|Primary Phase|Adverse Event|10|||
162050799|NCT00289783|585242666|FG001|Primary Phase|Adverse Event|1|||
162050800|NCT00289783|585242665|FG000|Primary Phase|Protocol Violation|27|||
162050801|NCT00289783|585242666|FG001|Primary Phase|Protocol Violation|6|||
162050802|NCT00289783|585242665|FG000|Primary Phase|Withdrawal by Subject|93|||
162050803|NCT00289783|585242666|FG001|Primary Phase|Withdrawal by Subject|40|||
162050804|NCT00289783|585242665|FG000|Primary Phase|Lost to Follow-up|60|||
162050805|NCT00289783|585242666|FG001|Primary Phase|Lost to Follow-up|14|||
162050806|NCT00289783|585242665|FG000|Primary Phase|Migration from the study area|26|||
162050807|NCT00289783|585242666|FG001|Primary Phase|Migration from the study area|10|||
162050808|NCT00289783|585242665|FG000|Primary Phase|Other|32|||
162050809|NCT00289783|585242666|FG001|Primary Phase|Other|12|||
162050810|NCT00289783|585242665|FG000|Fourth Dose Phase|Adverse Event|1|||
162050811|NCT00289783|585242666|FG001|Fourth Dose Phase|Adverse Event|0|||
162050812|NCT00289783|585242665|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
162050813|NCT00289783|585242666|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
162050814|NCT00289783|585242665|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
162050815|NCT00289783|585242666|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
162050816|NCT00289783|585242665|FG000|Fourth Dose Phase|Migration from the study area|1|||
162050817|NCT00289783|585242666|FG001|Fourth Dose Phase|Migration from the study area|1|||
162050818|NCT00289783|585242665|FG000|Fourth Dose Phase|Other|22|||
162050819|NCT00289783|585242666|FG001|Fourth Dose Phase|Other|10|||
162050820|NCT05248867|585242667|FG000|Double-blind Period|Lost to Follow-up|0|||
162050821|NCT05248867|585242668|FG001|Double-blind Period|Lost to Follow-up|3|||
162050822|NCT05248867|585242669|FG002|Double-blind Period|Lost to Follow-up|0|||
162050823|NCT05248867|585242670|FG003|Double-blind Period|Lost to Follow-up|0|||
162050824|NCT05248867|585242671|FG004|Double-blind Period|Lost to Follow-up|0|||
162050825|NCT05248867|585242672|FG005|Double-blind Period|Lost to Follow-up|0|||
162050826|NCT05248867|585242667|FG000|Double-blind Period|Withdrawal by Subject|5|||
162050827|NCT05248867|585242668|FG001|Double-blind Period|Withdrawal by Subject|14|||
162050828|NCT05248867|585242669|FG002|Double-blind Period|Withdrawal by Subject|0|||
162050829|NCT05248867|585242670|FG003|Double-blind Period|Withdrawal by Subject|0|||
162050830|NCT05248867|585242671|FG004|Double-blind Period|Withdrawal by Subject|0|||
162050831|NCT05248867|585242672|FG005|Double-blind Period|Withdrawal by Subject|0|||
162050832|NCT05248867|585242667|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
162050833|NCT05248867|585242668|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
162050834|NCT05248867|585242669|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
162050835|NCT05248867|585242670|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
162050836|NCT05248867|585242671|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
162050837|NCT05248867|585242672|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
162050838|NCT05248867|585242667|FG000|Double-blind Period|Other, not specified|3|||
162050839|NCT05248867|585242668|FG001|Double-blind Period|Other, not specified|8|||
162050840|NCT05248867|585242669|FG002|Double-blind Period|Other, not specified|0|||
162050841|NCT05248867|585242670|FG003|Double-blind Period|Other, not specified|0|||
162050842|NCT05248867|585242671|FG004|Double-blind Period|Other, not specified|0|||
162050843|NCT05248867|585242672|FG005|Double-blind Period|Other, not specified|0|||
162050844|NCT05248867|585242667|FG000|Open-label Period|Withdrawal by Subject|0|||
162050845|NCT05248867|585242668|FG001|Open-label Period|Withdrawal by Subject|0|||
162050846|NCT05248867|585242669|FG002|Open-label Period|Withdrawal by Subject|3|||
162050847|NCT05248867|585242670|FG003|Open-label Period|Withdrawal by Subject|1|||
162050848|NCT05248867|585242671|FG004|Open-label Period|Withdrawal by Subject|7|||
162050849|NCT05248867|585242672|FG005|Open-label Period|Withdrawal by Subject|9|||
162050850|NCT05248867|585242667|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
162050851|NCT05248867|585242668|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
162050852|NCT05248867|585242669|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
162050853|NCT05248867|585242670|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
162050854|NCT05248867|585242671|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
162050855|NCT05248867|585242672|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
162050856|NCT05248867|585242667|FG000|Open-label Period|Lost to Follow-up|0|||
162050857|NCT05248867|585242668|FG001|Open-label Period|Lost to Follow-up|0|||
162050858|NCT05248867|585242669|FG002|Open-label Period|Lost to Follow-up|0|||
162050859|NCT05248867|585242670|FG003|Open-label Period|Lost to Follow-up|0|||
162050860|NCT05248867|585242671|FG004|Open-label Period|Lost to Follow-up|5|||
162050861|NCT05248867|585242672|FG005|Open-label Period|Lost to Follow-up|2|||
162050862|NCT05248867|585242667|FG000|Open-label Period|COVID-19 Infection|0|||
162050863|NCT05248867|585242668|FG001|Open-label Period|COVID-19 Infection|0|||
162050864|NCT05248867|585242669|FG002|Open-label Period|COVID-19 Infection|0|||
162050865|NCT05248867|585242670|FG003|Open-label Period|COVID-19 Infection|0|||
162050866|NCT05248867|585242671|FG004|Open-label Period|COVID-19 Infection|1|||
162050867|NCT05248867|585242672|FG005|Open-label Period|COVID-19 Infection|0|||
162050868|NCT05248867|585242667|FG000|Open-label Period|Other, not specified|0|||
162050869|NCT05248867|585242668|FG001|Open-label Period|Other, not specified|0|||
162050870|NCT05248867|585242669|FG002|Open-label Period|Other, not specified|0|||
162050871|NCT05248867|585242670|FG003|Open-label Period|Other, not specified|0|||
162050872|NCT05248867|585242671|FG004|Open-label Period|Other, not specified|4|||
162050873|NCT05248867|585242672|FG005|Open-label Period|Other, not specified|0|||
162050874|NCT00345839|585242674|FG000|Overall Study|Withdrawal by Subject|91|||
162050875|NCT00345839|585242675|FG001|Overall Study|Withdrawal by Subject|98|||
162050876|NCT00345839|585242674|FG000|Overall Study|Lost to Follow-up|58|||
162050877|NCT00345839|585242675|FG001|Overall Study|Lost to Follow-up|61|||
162050878|NCT03749447|585244235|FG000|Overall Study|Adverse Event|11|||
162050879|NCT03749447|585244236|FG001|Overall Study|Adverse Event|3|||
162050880|NCT03749447|585244235|FG000|Overall Study|Death|1|||
162050881|NCT03749447|585244236|FG001|Overall Study|Death|1|||
162050882|NCT03749447|585244235|FG000|Overall Study|Lost to Follow-up|2|||
162050883|NCT03749447|585244236|FG001|Overall Study|Lost to Follow-up|2|||
162050884|NCT03749447|585244235|FG000|Overall Study|Reason Not Specified|0|||
162050885|NCT03749447|585244236|FG001|Overall Study|Reason Not Specified|3|||
162050886|NCT03749447|585244235|FG000|Overall Study|Physician Decision|4|||
162050887|NCT03749447|585244236|FG001|Overall Study|Physician Decision|3|||
162050888|NCT03749447|585244235|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
162050889|NCT03749447|585244236|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
162050890|NCT03749447|585244235|FG000|Overall Study|Study Terminated By Sponsor|112|||
162050891|NCT03749447|585244236|FG001|Overall Study|Study Terminated By Sponsor|105|||
162050892|NCT03749447|585244235|FG000|Overall Study|Withdrawal by Subject|12|||
162050893|NCT03749447|585244236|FG001|Overall Study|Withdrawal by Subject|6|||
162050894|NCT03749447|585244235|FG000|Overall Study|Non-compliance With Study Drug|0|||
162050895|NCT03749447|585244236|FG001|Overall Study|Non-compliance With Study Drug|1|||
162050896|NCT01575769|585244240|FG000|Overall Study|Adverse Event|1|||
162050897|NCT01575769|585244240|FG000|Overall Study|Study terminated by sponsor|40|||
162050898|NCT01673867|585244241|FG000|Randomization|Adverse event unrelated to study drug|1|||
162050899|NCT01673867|585244242|FG001|Randomization|Adverse event unrelated to study drug|0|||
162050900|NCT01673867|585244241|FG000|Randomization|Participant request to discontinue study treatment|0|||
162050901|NCT01673867|585244242|FG001|Randomization|Participant request to discontinue study treatment|4|||
162050902|NCT01673867|585244241|FG000|Randomization|Withdrawal by participant|0|||
162050903|NCT01673867|585244242|FG001|Randomization|Withdrawal by participant|12|||
162050904|NCT01673867|585244241|FG000|Randomization|Lost to Follow-up|0|||
162050905|NCT01673867|585244242|FG001|Randomization|Lost to Follow-up|1|||
162050906|NCT01673867|585244241|FG000|Randomization|Participant no longer meets study criteria|4|||
162050907|NCT01673867|585244242|FG001|Randomization|Participant no longer meets study criteria|5|||
162050908|NCT01673867|585244241|FG000|Treatment|Disease Progression|208|||
162050909|NCT01673867|585244242|FG001|Treatment|Disease Progression|178|||
162050910|NCT01673867|585244241|FG000|Treatment|Study Drug Toxicity|23|||
162050911|NCT01673867|585244242|FG001|Treatment|Study Drug Toxicity|43|||
162050912|NCT01673867|585244241|FG000|Treatment|Death|2|||
162050913|NCT01673867|585244242|FG001|Treatment|Death|3|||
162050914|NCT01673867|585244241|FG000|Treatment|Adverse event unrelated to study drug|23|||
162050915|NCT01673867|585244242|FG001|Treatment|Adverse event unrelated to study drug|10|||
162050916|NCT01673867|585244241|FG000|Treatment|Participant request to discontinue study treatment|7|||
162050917|NCT01673867|585244242|FG001|Treatment|Participant request to discontinue study treatment|17|||
162050918|NCT01673867|585244241|FG000|Treatment|Withdrawal by participant|5|||
162050919|NCT01673867|585244242|FG001|Treatment|Withdrawal by participant|5|||
162050920|NCT01673867|585244241|FG000|Treatment|Maximum clinical benefit|1|||
162050921|NCT01673867|585244242|FG001|Treatment|Maximum clinical benefit|10|||
162050922|NCT01673867|585244241|FG000|Treatment|Participant no longer meets study criteria|2|||
162050923|NCT01673867|585244242|FG001|Treatment|Participant no longer meets study criteria|0|||
162050924|NCT01673867|585244241|FG000|Treatment|Administrative reason by sponsor|3|||
162050925|NCT01673867|585244242|FG001|Treatment|Administrative reason by sponsor|0|||
162050926|NCT01673867|585244241|FG000|Treatment|Other reason|11|||
162050927|NCT01673867|585244242|FG001|Treatment|Other reason|2|||
162050928|NCT01473836|585244243|FG000|Overall Study|Adverse Event|4|||
162050929|NCT01473836|585244243|FG000|Overall Study|Lack of Efficacy|1|||
162050930|NCT01473836|585244243|FG000|Overall Study|Does not meet entrance criteria|1|||
162050931|NCT01709513|585244244|FG000|Overall Study|Randomized but not treated|0|||
162050932|NCT01709513|585244245|FG001|Overall Study|Randomized but not treated|1|||
162050933|NCT01709513|585244246|FG002|Overall Study|Randomized but not treated|0|||
162050934|NCT01709513|585244244|FG000|Overall Study|Adverse Event|16|||
162050935|NCT01709513|585244245|FG001|Overall Study|Adverse Event|31|||
162050936|NCT01709513|585244246|FG002|Overall Study|Adverse Event|23|||
162050937|NCT01709513|585244244|FG000|Overall Study|Poor compliance to protocol|2|||
162050938|NCT01709513|585244245|FG001|Overall Study|Poor compliance to protocol|0|||
162050939|NCT01709513|585244246|FG002|Overall Study|Poor compliance to protocol|0|||
162050940|NCT01709513|585244244|FG000|Overall Study|Other|3|||
162050941|NCT01709513|585244245|FG001|Overall Study|Other|11|||
162050942|NCT01709513|585244246|FG002|Overall Study|Other|7|||
162050943|NCT04218695|585244247|FG000|Overall Study|Adverse Event|1|||
162050944|NCT04218695|585244248|FG001|Overall Study|Adverse Event|0|||
162050945|NCT01513343|585244249|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
162050946|NCT01513343|585244250|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
162050947|NCT01513343|585244249|FG000|Post Data Collection|Dropped/withdrew from study|7|||
162050948|NCT01513343|585244250|FG001|Post Data Collection|Dropped/withdrew from study|1|||
162050949|NCT01513343|585244249|FG000|Post Data Collection|Lost to Follow-up|10|||
162050950|NCT01513343|585244250|FG001|Post Data Collection|Lost to Follow-up|23|||
162050951|NCT01513343|585244249|FG000|6-month Follow-up|Lost to Follow-up|28|||
162050952|NCT01513343|585244250|FG001|6-month Follow-up|Lost to Follow-up|17|||
162050953|NCT01513343|585244249|FG000|12-month Follow-up|Lost to Follow-up|10|||
162050954|NCT01513343|585244250|FG001|12-month Follow-up|Lost to Follow-up|3|||
162050955|NCT00599924|585244251|FG000|Overall Study|Lack of Efficacy|3|||
162050956|NCT00599924|585244252|FG001|Overall Study|Lack of Efficacy|5|||
162050957|NCT00599924|585244253|FG002|Overall Study|Lack of Efficacy|1|||
162050958|NCT00599924|585244254|FG003|Overall Study|Lack of Efficacy|2|||
162050959|NCT00599924|585244255|FG004|Overall Study|Lack of Efficacy|3|||
162050960|NCT00599924|585244256|FG005|Overall Study|Lack of Efficacy|2|||
162050961|NCT00599924|585244257|FG006|Overall Study|Lack of Efficacy|0|||
162050962|NCT00599924|585244251|FG000|Overall Study|Adverse Event|0|||
162050963|NCT00599924|585244252|FG001|Overall Study|Adverse Event|0|||
162050964|NCT00599924|585244253|FG002|Overall Study|Adverse Event|0|||
162050965|NCT00599924|585244254|FG003|Overall Study|Adverse Event|2|||
162050966|NCT00599924|585244255|FG004|Overall Study|Adverse Event|0|||
162050967|NCT00599924|585244256|FG005|Overall Study|Adverse Event|0|||
162050968|NCT00599924|585244257|FG006|Overall Study|Adverse Event|2|||
162050969|NCT00599924|585244251|FG000|Overall Study|Death|0|||
162050970|NCT00599924|585244252|FG001|Overall Study|Death|0|||
162050971|NCT00599924|585244253|FG002|Overall Study|Death|0|||
162050972|NCT00599924|585244254|FG003|Overall Study|Death|2|||
162050973|NCT00599924|585244255|FG004|Overall Study|Death|0|||
162050974|NCT00599924|585244256|FG005|Overall Study|Death|2|||
162050975|NCT00599924|585244257|FG006|Overall Study|Death|1|||
162050976|NCT00599924|585244251|FG000|Overall Study|Protocol Violation|0|||
162050977|NCT00599924|585244252|FG001|Overall Study|Protocol Violation|0|||
162050978|NCT00599924|585244253|FG002|Overall Study|Protocol Violation|0|||
162050979|NCT00599924|585244254|FG003|Overall Study|Protocol Violation|1|||
162050980|NCT00599924|585244255|FG004|Overall Study|Protocol Violation|0|||
162050981|NCT00599924|585244256|FG005|Overall Study|Protocol Violation|0|||
162050982|NCT00599924|585244257|FG006|Overall Study|Protocol Violation|0|||
162050983|NCT00599924|585244251|FG000|Overall Study|Withdrawal by Subject|0|||
162050984|NCT00599924|585244252|FG001|Overall Study|Withdrawal by Subject|0|||
162050985|NCT00599924|585244253|FG002|Overall Study|Withdrawal by Subject|1|||
162050986|NCT00599924|585244254|FG003|Overall Study|Withdrawal by Subject|0|||
162050987|NCT00599924|585244255|FG004|Overall Study|Withdrawal by Subject|1|||
162050988|NCT00599924|585244256|FG005|Overall Study|Withdrawal by Subject|0|||
162050989|NCT00599924|585244257|FG006|Overall Study|Withdrawal by Subject|0|||
162050990|NCT00599924|585244251|FG000|Overall Study|Other|0|||
162050991|NCT00599924|585244252|FG001|Overall Study|Other|0|||
162050992|NCT00599924|585244253|FG002|Overall Study|Other|0|||
162050993|NCT00599924|585244254|FG003|Overall Study|Other|1|||
162050994|NCT00599924|585244255|FG004|Overall Study|Other|2|||
162050995|NCT00599924|585244256|FG005|Overall Study|Other|0|||
162050996|NCT00599924|585244257|FG006|Overall Study|Other|2|||
162050997|NCT02587234|585244258|FG000|Overall Study|Withdrawal by Subject|1|||
162050998|NCT02587234|585244259|FG001|Overall Study|Withdrawal by Subject|1|||
162050999|NCT02587234|585244258|FG000|Overall Study|Lost to Follow-up|0|||
162051000|NCT02587234|585244259|FG001|Overall Study|Lost to Follow-up|2|||
162051001|NCT02165215|585244260|FG000|Induction Phase|Adverse Event|1|||
162051002|NCT02165215|585244261|FG001|Induction Phase|Adverse Event|0|||
162051003|NCT02165215|585244262|FG002|Induction Phase|Adverse Event|0|||
162051004|NCT02165215|585244260|FG000|Induction Phase|Withdrawal by Subject|10|||
162051005|NCT02165215|585244261|FG001|Induction Phase|Withdrawal by Subject|0|||
162051006|NCT02165215|585244262|FG002|Induction Phase|Withdrawal by Subject|0|||
162051007|NCT02165215|585244260|FG000|Induction Phase|Protocol Violation|1|||
162051008|NCT02165215|585244261|FG001|Induction Phase|Protocol Violation|0|||
162051009|NCT02165215|585244262|FG002|Induction Phase|Protocol Violation|0|||
162051010|NCT02165215|585244260|FG000|Induction Phase|Physician Decision|1|||
162051011|NCT02165215|585244261|FG001|Induction Phase|Physician Decision|0|||
162051012|NCT02165215|585244262|FG002|Induction Phase|Physician Decision|0|||
162051013|NCT02165215|585244260|FG000|Induction Phase|Lack of Efficacy|2|||
162051014|NCT02165215|585244261|FG001|Induction Phase|Lack of Efficacy|0|||
162051015|NCT02165215|585244262|FG002|Induction Phase|Lack of Efficacy|0|||
162051016|NCT02165215|585244260|FG000|Induction Phase|Non-Compliance|2|||
162051017|NCT02165215|585244261|FG001|Induction Phase|Non-Compliance|0|||
162051018|NCT02165215|585244262|FG002|Induction Phase|Non-Compliance|0|||
162051019|NCT02165215|585244260|FG000|Induction Phase|Lost to Follow-up|6|||
162051020|NCT02165215|585244261|FG001|Induction Phase|Lost to Follow-up|0|||
162051021|NCT02165215|585244262|FG002|Induction Phase|Lost to Follow-up|0|||
162051022|NCT02165215|585244260|FG000|Maintenance Phase|Withdrawal by Subject|0|||
162051023|NCT02165215|585244261|FG001|Maintenance Phase|Withdrawal by Subject|7|||
162051024|NCT02165215|585244262|FG002|Maintenance Phase|Withdrawal by Subject|3|||
162051025|NCT02165215|585244260|FG000|Maintenance Phase|Multiple reasons|0|||
162051026|NCT02165215|585244261|FG001|Maintenance Phase|Multiple reasons|2|||
162051027|NCT02165215|585244262|FG002|Maintenance Phase|Multiple reasons|1|||
162051028|NCT02165215|585244260|FG000|Maintenance Phase|Lost to Follow-up|0|||
162051029|NCT02165215|585244261|FG001|Maintenance Phase|Lost to Follow-up|2|||
162051030|NCT02165215|585244262|FG002|Maintenance Phase|Lost to Follow-up|0|||
162051031|NCT02165215|585244260|FG000|Maintenance Phase|Adverse Event|0|||
162051032|NCT02165215|585244261|FG001|Maintenance Phase|Adverse Event|1|||
162051033|NCT02165215|585244262|FG002|Maintenance Phase|Adverse Event|1|||
162051034|NCT01877265|585244263|FG000|Treatment Period 1|Sponsor Decision|0|||
162051035|NCT01877265|585244264|FG001|Treatment Period 1|Sponsor Decision|0|||
162051036|NCT01877265|585244265|FG002|Treatment Period 1|Sponsor Decision|1|||
162051037|NCT01877265|585244266|FG003|Treatment Period 1|Sponsor Decision|0|||
162051038|NCT01877265|585244267|FG004|Treatment Period 1|Sponsor Decision|0|||
162051039|NCT01877265|585244268|FG005|Treatment Period 1|Sponsor Decision|0|||
162051040|NCT01877265|585244263|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
162051041|NCT01877265|585244264|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
162051042|NCT01877265|585244265|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
162051043|NCT01877265|585244266|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
162051044|NCT01877265|585244267|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
162051045|NCT01877265|585244268|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
162051046|NCT01877265|585244263|FG000|Treatment Period 3|Lost to Follow-up|1|||
162051047|NCT01877265|585244264|FG001|Treatment Period 3|Lost to Follow-up|0|||
162051048|NCT01877265|585244265|FG002|Treatment Period 3|Lost to Follow-up|0|||
162051049|NCT01877265|585244266|FG003|Treatment Period 3|Lost to Follow-up|0|||
162051050|NCT01877265|585244267|FG004|Treatment Period 3|Lost to Follow-up|0|||
162051051|NCT01877265|585244268|FG005|Treatment Period 3|Lost to Follow-up|0|||
162051052|NCT01947582|585244269|FG000|Overall Study|Withdrawal by Subject|1|||
162051053|NCT00592384|585244270|FG000|Overall Study|Withdrawal by Subject|5|||
162051054|NCT00592384|585244271|FG001|Overall Study|Withdrawal by Subject|6|||
162051055|NCT01153347|585244275|FG000|Overall Study|Withdrawal by Subject|7|||
162051056|NCT01153347|585244276|FG001|Overall Study|Withdrawal by Subject|7|||
162051057|NCT01153347|585244277|FG002|Overall Study|Withdrawal by Subject|7|||
162051058|NCT01153347|585244278|FG003|Overall Study|Withdrawal by Subject|7|||
162051059|NCT01153347|585244275|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162051060|NCT01153347|585244276|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
162051061|NCT01153347|585244277|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
162051062|NCT01153347|585244278|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
162051063|NCT01153347|585244275|FG000|Overall Study|Adverse Event|3|||
162051064|NCT01153347|585244276|FG001|Overall Study|Adverse Event|9|||
162051065|NCT01153347|585244277|FG002|Overall Study|Adverse Event|21|||
162051066|NCT01153347|585244278|FG003|Overall Study|Adverse Event|7|||
162051067|NCT01153347|585244275|FG000|Overall Study|Severe non-compliance to protocol|6|||
162051068|NCT01153347|585244276|FG001|Overall Study|Severe non-compliance to protocol|7|||
162051069|NCT01153347|585244277|FG002|Overall Study|Severe non-compliance to protocol|4|||
162051070|NCT01153347|585244278|FG003|Overall Study|Severe non-compliance to protocol|3|||
162051071|NCT01153347|585244275|FG000|Overall Study|Condition under investigation worsened|1|||
162051072|NCT01153347|585244276|FG001|Overall Study|Condition under investigation worsened|1|||
162051073|NCT01153347|585244277|FG002|Overall Study|Condition under investigation worsened|0|||
162051074|NCT01153347|585244278|FG003|Overall Study|Condition under investigation worsened|0|||
162051075|NCT01153347|585244275|FG000|Overall Study|Lack of Efficacy|2|||
162051076|NCT01153347|585244276|FG001|Overall Study|Lack of Efficacy|2|||
162051077|NCT01153347|585244277|FG002|Overall Study|Lack of Efficacy|0|||
162051078|NCT01153347|585244278|FG003|Overall Study|Lack of Efficacy|4|||
162051079|NCT01153347|585244275|FG000|Overall Study|Study-specific withdrawal criteria|4|||
162051080|NCT01153347|585244276|FG001|Overall Study|Study-specific withdrawal criteria|3|||
162051081|NCT01153347|585244277|FG002|Overall Study|Study-specific withdrawal criteria|1|||
162051082|NCT01153347|585244278|FG003|Overall Study|Study-specific withdrawal criteria|2|||
162051083|NCT01153347|585244275|FG000|Overall Study|Lost to Follow-up|4|||
162051084|NCT01153347|585244276|FG001|Overall Study|Lost to Follow-up|9|||
162051085|NCT01153347|585244277|FG002|Overall Study|Lost to Follow-up|11|||
162051086|NCT01153347|585244278|FG003|Overall Study|Lost to Follow-up|8|||
162051087|NCT01153347|585244275|FG000|Overall Study|Other|5|||
162051088|NCT01153347|585244276|FG001|Overall Study|Other|5|||
162051089|NCT01153347|585244277|FG002|Overall Study|Other|4|||
162051090|NCT01153347|585244278|FG003|Overall Study|Other|0|||
162051091|NCT01153347|585244275|FG000|Overall Study|Death|1|||
162051092|NCT01153347|585244276|FG001|Overall Study|Death|0|||
162051093|NCT01153347|585244277|FG002|Overall Study|Death|0|||
162051094|NCT01153347|585244278|FG003|Overall Study|Death|0|||
162051095|NCT04401423|585244281|FG000|Overall Study|Withdrawal by Subject|3|||
162051096|NCT04401423|585244282|FG001|Overall Study|Withdrawal by Subject|1|||
162051097|NCT04401423|585244281|FG000|Overall Study|Physician Decision|2|||
162051098|NCT04401423|585244282|FG001|Overall Study|Physician Decision|1|||
162051099|NCT00003473|585244283|FG000|Overall Study|Three patients were not evaluable.|3|||
162051100|NCT04678661|585244284|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
162051101|NCT04678661|585244285|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
162051102|NCT04678661|585244284|FG000|Overall Study|Protocol Violation|2|||
162051103|NCT04678661|585244285|FG001|Overall Study|Protocol Violation|0|||
162051104|NCT04678661|585244284|FG000|Overall Study|Withdrawal by Subject|1|||
162051105|NCT04678661|585244285|FG001|Overall Study|Withdrawal by Subject|0|||
162051106|NCT04678661|585244284|FG000|Overall Study|Lost to Follow-up|2|||
162051107|NCT04678661|585244285|FG001|Overall Study|Lost to Follow-up|0|||
162051108|NCT04678661|585244284|FG000|Overall Study|Death|2|||
162051109|NCT04678661|585244285|FG001|Overall Study|Death|0|||
162051110|NCT03039283|585244288|FG000|Overall Study|Protocol Violation|2|||
162051111|NCT01086033|585244289|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
162051112|NCT01086033|585244289|FG000|Overall Study|Lost to Follow-up|86|||
162051113|NCT01086033|585244289|FG000|Overall Study|Adverse Event|42|||
162051114|NCT01086033|585244289|FG000|Overall Study|Withdrawal by Subject|41|||
162051115|NCT01086033|585244289|FG000|Overall Study|Other|14|||
162051116|NCT01086033|585244289|FG000|Overall Study|Other|13|||
162051117|NCT01086033|585244289|FG000|Overall Study|AE and Withdrew Consent|5|||
162051118|NCT01086033|585244289|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
162051119|NCT01086033|585244289|FG000|Overall Study|Withdrew consent and Other Reason|4|||
162051120|NCT01086033|585244289|FG000|Overall Study|AE and Lack of Efficacy|4|||
162051121|NCT01086033|585244289|FG000|Overall Study|Death|1|||
162051122|NCT01086033|585244289|FG000|Overall Study|AE and Lost to Follow-up|1|||
162051123|NCT01086033|585244289|FG000|Overall Study|AE and Other Reason|1|||
162051124|NCT01086033|585244289|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
162051125|NCT03639935|585244290|FG000|Overall Study|Death|3|||
162051126|NCT03639935|585244290|FG000|Overall Study|Adverse Event|1|||
162051127|NCT00864721|585244291|FG000|Overall Study|Patient request|11|||
162051128|NCT00864721|585244291|FG000|Overall Study|Hospitalized|1|||
162051129|NCT00864721|585244291|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
162051130|NCT00864721|585244291|FG000|Overall Study|Adverse Event|21|||
162051131|NCT01921387|585244294|FG000|Overall Study|Adverse Event|1|||
162051132|NCT01773733|585244295|FG000|Overall Study|Adverse Event|3286|||
162051133|NCT01773733|585244296|FG001|Overall Study|Adverse Event|540|||
162051134|NCT01773733|585244295|FG000|Overall Study|Pregnancy|28|||
162051135|NCT01773733|585244296|FG001|Overall Study|Pregnancy|0|||
162051136|NCT01773733|585244295|FG000|Overall Study|Other different categories of not compl|55415|||
162051137|NCT01773733|585244296|FG001|Overall Study|Other different categories of not compl|7781|||
162051138|NCT00261807|585244297|FG000|Overall Study|Lost to Follow-up|2|||
162051139|NCT00261807|585244297|FG000|Overall Study|Adverse Event|2|||
162051140|NCT00261807|585244297|FG000|Overall Study|Death|1|||
162051141|NCT00261807|585244297|FG000|Overall Study|Protocol Violation|2|||
162051142|NCT00762229|585244301|FG000|Overall Study|Lost to Follow-up|1|||
162051143|NCT00762229|585244302|FG001|Overall Study|Lost to Follow-up|1|||
162051144|NCT00762229|585244301|FG000|Overall Study|did not recveive intervention|0|||
162051145|NCT00762229|585244302|FG001|Overall Study|did not recveive intervention|1|||
162051146|NCT01081678|585244304|FG000|Overall Study|Ineligibility Determined|0|||
162051147|NCT01081678|585244305|FG001|Overall Study|Ineligibility Determined|0|||
162051148|NCT01081678|585244306|FG002|Overall Study|Ineligibility Determined|1|||
162051149|NCT01081678|585244307|FG003|Overall Study|Ineligibility Determined|1|||
162051150|NCT01081678|585244304|FG000|Overall Study|Noncompliance|3|||
162051151|NCT01081678|585244305|FG001|Overall Study|Noncompliance|4|||
162051152|NCT01081678|585244306|FG002|Overall Study|Noncompliance|5|||
162051153|NCT01081678|585244307|FG003|Overall Study|Noncompliance|2|||
162051154|NCT01081678|585244304|FG000|Overall Study|Adverse Event|2|||
162051155|NCT01081678|585244305|FG001|Overall Study|Adverse Event|1|||
162051156|NCT01081678|585244306|FG002|Overall Study|Adverse Event|2|||
162051157|NCT01081678|585244307|FG003|Overall Study|Adverse Event|2|||
162051158|NCT01081678|585244304|FG000|Overall Study|Withdrawal by Subject|15|||
162051159|NCT01081678|585244305|FG001|Overall Study|Withdrawal by Subject|7|||
162051160|NCT01081678|585244306|FG002|Overall Study|Withdrawal by Subject|17|||
162051161|NCT01081678|585244307|FG003|Overall Study|Withdrawal by Subject|14|||
162051162|NCT01081678|585244304|FG000|Overall Study|Administrative Decision|1|||
162051163|NCT01081678|585244305|FG001|Overall Study|Administrative Decision|0|||
162051164|NCT01081678|585244306|FG002|Overall Study|Administrative Decision|0|||
162051165|NCT01081678|585244307|FG003|Overall Study|Administrative Decision|1|||
162051166|NCT01081678|585244304|FG000|Overall Study|Lost to Follow-up|4|||
162051167|NCT01081678|585244305|FG001|Overall Study|Lost to Follow-up|1|||
162051168|NCT01081678|585244306|FG002|Overall Study|Lost to Follow-up|4|||
162051169|NCT01081678|585244307|FG003|Overall Study|Lost to Follow-up|3|||
162051170|NCT01081678|585244304|FG000|Overall Study|Death|2|||
162051171|NCT01081678|585244305|FG001|Overall Study|Death|2|||
162051172|NCT01081678|585244306|FG002|Overall Study|Death|2|||
162051173|NCT01081678|585244307|FG003|Overall Study|Death|6|||
162051174|NCT01081678|585244304|FG000|Overall Study|Other|0|||
162051175|NCT01081678|585244305|FG001|Overall Study|Other|1|||
162051176|NCT01081678|585244306|FG002|Overall Study|Other|0|||
162051177|NCT01081678|585244307|FG003|Overall Study|Other|0|||
162051178|NCT01619423|585244312|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
162051179|NCT01619423|585244313|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
162051180|NCT01619423|585244314|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
162051181|NCT01619423|585244315|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
162051182|NCT01281865|585244322|FG000|Overall Study|Adverse Event|1|||
162051183|NCT01281865|585244323|FG001|Overall Study|Adverse Event|1|||
162051184|NCT01281865|585244322|FG000|Overall Study|Withdrawal by Subject|1|||
162051185|NCT01281865|585244323|FG001|Overall Study|Withdrawal by Subject|0|||
162051186|NCT01281865|585244322|FG000|Overall Study|Lack of Efficacy|1|||
162051187|NCT01281865|585244323|FG001|Overall Study|Lack of Efficacy|0|||
162051188|NCT03478657|585244324|FG000|Overall Study|Withdrawal by Subject|0|||
162051189|NCT03478657|585244325|FG001|Overall Study|Withdrawal by Subject|1|||
162051190|NCT02590003|585244326|FG000|Overall Study|Death|1|||
162051191|NCT02590003|585244327|FG001|Overall Study|Death|2|||
162051192|NCT03733470|585244330|FG000|Overall Study|PI Decision|1|||
162051193|NCT03733470|585244331|FG001|Overall Study|PI Decision|1|||
162051194|NCT01786668|585244332|FG000|Overall Study|Adverse Event|0|||
162051195|NCT01786668|585244333|FG001|Overall Study|Adverse Event|1|||
162051196|NCT01786668|585244334|FG002|Overall Study|Adverse Event|1|||
162051197|NCT01786668|585244335|FG003|Overall Study|Adverse Event|2|||
162051198|NCT01786668|585244332|FG000|Overall Study|Withdrawal by Subject|0|||
162051199|NCT01786668|585244333|FG001|Overall Study|Withdrawal by Subject|0|||
162051200|NCT01786668|585244334|FG002|Overall Study|Withdrawal by Subject|3|||
162051201|NCT01786668|585244335|FG003|Overall Study|Withdrawal by Subject|1|||
162051202|NCT01786668|585244332|FG000|Overall Study|Pregnancy|0|||
162051203|NCT01786668|585244333|FG001|Overall Study|Pregnancy|0|||
162051204|NCT01786668|585244334|FG002|Overall Study|Pregnancy|0|||
162051205|NCT01786668|585244335|FG003|Overall Study|Pregnancy|1|||
162051206|NCT01786668|585244332|FG000|Overall Study|Lost to Follow-up|1|||
162051207|NCT01786668|585244333|FG001|Overall Study|Lost to Follow-up|0|||
162051208|NCT01786668|585244334|FG002|Overall Study|Lost to Follow-up|1|||
162051209|NCT01786668|585244335|FG003|Overall Study|Lost to Follow-up|0|||
162051210|NCT03068455|585244341|FG000|Pre-treatment Period|Disease progression|0|||
162051211|NCT03068455|585244342|FG001|Pre-treatment Period|Disease progression|1|||
162051212|NCT03068455|585244341|FG000|Pre-treatment Period|Participant withdrew consent|1|||
162051213|NCT03068455|585244342|FG001|Pre-treatment Period|Participant withdrew consent|1|||
162051214|NCT03068455|585244341|FG000|Pre-treatment Period|Poor/non-compliance|0|||
162051215|NCT03068455|585244342|FG001|Pre-treatment Period|Poor/non-compliance|1|||
162051216|NCT03068455|585244341|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
162051217|NCT03068455|585244342|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
162051218|NCT03068455|585244341|FG000|Pre-treatment Period|Not reported|2|||
162051219|NCT03068455|585244342|FG001|Pre-treatment Period|Not reported|1|||
162051220|NCT03068455|585244341|FG000|Treatment Period|Disease progression|166|||
162051221|NCT03068455|585244342|FG001|Treatment Period|Disease progression|208|||
162051222|NCT03068455|585244341|FG000|Treatment Period|Study drug toxicity|317|||
162051223|NCT03068455|585244342|FG001|Treatment Period|Study drug toxicity|104|||
162051224|NCT03068455|585244341|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
162051225|NCT03068455|585244342|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
162051226|NCT03068455|585244341|FG000|Treatment Period|Participant request to stop therapy|33|||
162051227|NCT03068455|585244342|FG001|Treatment Period|Participant request to stop therapy|20|||
162051228|NCT03068455|585244341|FG000|Treatment Period|Participant withdrew consent|5|||
162051229|NCT03068455|585244342|FG001|Treatment Period|Participant withdrew consent|10|||
162051230|NCT03068455|585244341|FG000|Treatment Period|Poor/non-compliance|3|||
162051231|NCT03068455|585244342|FG001|Treatment Period|Poor/non-compliance|0|||
162051232|NCT03068455|585244341|FG000|Treatment Period|Participant no longer meets study criteria|1|||
162051233|NCT03068455|585244342|FG001|Treatment Period|Participant no longer meets study criteria|3|||
162051234|NCT03068455|585244341|FG000|Treatment Period|Other reasons|12|||
162051235|NCT03068455|585244342|FG001|Treatment Period|Other reasons|4|||
162051236|NCT04457336|585244344|FG000|Period 2: Part A|Withdrawal by Subject|0|||
162051237|NCT04457336|585244345|FG001|Period 2: Part A|Withdrawal by Subject|1|||
162051238|NCT04457336|585244346|FG002|Period 2: Part A|Withdrawal by Subject|1|||
162051239|NCT04457336|585244347|FG003|Period 2: Part A|Withdrawal by Subject|1|||
162051240|NCT04457336|585244348|FG004|Period 2: Part A|Withdrawal by Subject|0|||
162051241|NCT04457336|585244349|FG005|Period 2: Part A|Withdrawal by Subject|0|||
162051242|NCT04457336|585244350|FG006|Period 2: Part A|Withdrawal by Subject|0|||
162051243|NCT04457336|585244351|FG007|Period 2: Part A|Withdrawal by Subject|0|||
162051244|NCT04457336|585244344|FG000|Period 2: Part A|Adverse Event|0|||
162051245|NCT04457336|585244345|FG001|Period 2: Part A|Adverse Event|0|||
162051246|NCT04457336|585244346|FG002|Period 2: Part A|Adverse Event|1|||
162051247|NCT04457336|585244347|FG003|Period 2: Part A|Adverse Event|1|||
162051248|NCT04457336|585244348|FG004|Period 2: Part A|Adverse Event|0|||
162051249|NCT04457336|585244349|FG005|Period 2: Part A|Adverse Event|0|||
162051250|NCT04457336|585244350|FG006|Period 2: Part A|Adverse Event|0|||
162051251|NCT04457336|585244351|FG007|Period 2: Part A|Adverse Event|0|||
162051252|NCT04457336|585244344|FG000|Period 2: Part A|Study Terminated|0|||
162051253|NCT04457336|585244345|FG001|Period 2: Part A|Study Terminated|0|||
162051254|NCT04457336|585244346|FG002|Period 2: Part A|Study Terminated|1|||
162051255|NCT04457336|585244347|FG003|Period 2: Part A|Study Terminated|0|||
162051256|NCT04457336|585244348|FG004|Period 2: Part A|Study Terminated|0|||
162051257|NCT04457336|585244349|FG005|Period 2: Part A|Study Terminated|0|||
162051258|NCT04457336|585244350|FG006|Period 2: Part A|Study Terminated|0|||
162051259|NCT04457336|585244351|FG007|Period 2: Part A|Study Terminated|0|||
162051260|NCT04457336|585244344|FG000|Period 2: Part A|Protocol Violation|0|||
162051261|NCT04457336|585244345|FG001|Period 2: Part A|Protocol Violation|1|||
162051262|NCT04457336|585244346|FG002|Period 2: Part A|Protocol Violation|0|||
162051263|NCT04457336|585244347|FG003|Period 2: Part A|Protocol Violation|0|||
162051264|NCT04457336|585244348|FG004|Period 2: Part A|Protocol Violation|0|||
162051265|NCT04457336|585244349|FG005|Period 2: Part A|Protocol Violation|0|||
162051266|NCT04457336|585244350|FG006|Period 2: Part A|Protocol Violation|0|||
162051267|NCT04457336|585244351|FG007|Period 2: Part A|Protocol Violation|0|||
162051268|NCT04457336|585244344|FG000|Period 2: Part A|Lost to Follow-up|0|||
162051269|NCT04457336|585244345|FG001|Period 2: Part A|Lost to Follow-up|1|||
162051270|NCT04457336|585244346|FG002|Period 2: Part A|Lost to Follow-up|0|||
162051271|NCT04457336|585244347|FG003|Period 2: Part A|Lost to Follow-up|0|||
162051272|NCT04457336|585244348|FG004|Period 2: Part A|Lost to Follow-up|0|||
162051273|NCT04457336|585244349|FG005|Period 2: Part A|Lost to Follow-up|0|||
162051274|NCT04457336|585244350|FG006|Period 2: Part A|Lost to Follow-up|0|||
162051275|NCT04457336|585244351|FG007|Period 2: Part A|Lost to Follow-up|0|||
162051276|NCT04457336|585244344|FG000|Period 2: Part A|Other|0|||
162051277|NCT04457336|585244345|FG001|Period 2: Part A|Other|1|||
162051278|NCT04457336|585244346|FG002|Period 2: Part A|Other|0|||
162051279|NCT04457336|585244347|FG003|Period 2: Part A|Other|0|||
162051280|NCT04457336|585244348|FG004|Period 2: Part A|Other|0|||
162051281|NCT04457336|585244349|FG005|Period 2: Part A|Other|0|||
162051282|NCT04457336|585244350|FG006|Period 2: Part A|Other|0|||
162051283|NCT04457336|585244351|FG007|Period 2: Part A|Other|0|||
162051284|NCT04457336|585244344|FG000|Period 2: Part A|Physician Decision|0|||
162051285|NCT04457336|585244345|FG001|Period 2: Part A|Physician Decision|0|||
162051286|NCT04457336|585244346|FG002|Period 2: Part A|Physician Decision|0|||
162051287|NCT04457336|585244347|FG003|Period 2: Part A|Physician Decision|1|||
162051288|NCT04457336|585244348|FG004|Period 2: Part A|Physician Decision|0|||
162051289|NCT04457336|585244349|FG005|Period 2: Part A|Physician Decision|0|||
162051290|NCT04457336|585244350|FG006|Period 2: Part A|Physician Decision|0|||
162051291|NCT04457336|585244351|FG007|Period 2: Part A|Physician Decision|0|||
162051292|NCT04457336|585244344|FG000|Period 3: Part B|Study Terminated|0|||
162051293|NCT04457336|585244345|FG001|Period 3: Part B|Study Terminated|0|||
162051294|NCT04457336|585244346|FG002|Period 3: Part B|Study Terminated|0|||
162051295|NCT04457336|585244347|FG003|Period 3: Part B|Study Terminated|0|||
162051296|NCT04457336|585244348|FG004|Period 3: Part B|Study Terminated|1|||
162051297|NCT04457336|585244349|FG005|Period 3: Part B|Study Terminated|10|||
162051298|NCT04457336|585244350|FG006|Period 3: Part B|Study Terminated|13|||
162051299|NCT04457336|585244351|FG007|Period 3: Part B|Study Terminated|0|||
162051300|NCT04457336|585244344|FG000|Period 3: Part B|Withdrawal by Subject|0|||
162051301|NCT04457336|585244345|FG001|Period 3: Part B|Withdrawal by Subject|0|||
162051302|NCT04457336|585244346|FG002|Period 3: Part B|Withdrawal by Subject|0|||
162051303|NCT04457336|585244347|FG003|Period 3: Part B|Withdrawal by Subject|0|||
162051304|NCT04457336|585244348|FG004|Period 3: Part B|Withdrawal by Subject|0|||
162051305|NCT04457336|585244349|FG005|Period 3: Part B|Withdrawal by Subject|1|||
162051306|NCT04457336|585244350|FG006|Period 3: Part B|Withdrawal by Subject|2|||
162051307|NCT04457336|585244351|FG007|Period 3: Part B|Withdrawal by Subject|0|||
162051308|NCT04457336|585244344|FG000|Period 4: Part C|Study Terminated|0|||
162051309|NCT04457336|585244345|FG001|Period 4: Part C|Study Terminated|0|||
162051310|NCT04457336|585244346|FG002|Period 4: Part C|Study Terminated|0|||
162051311|NCT04457336|585244347|FG003|Period 4: Part C|Study Terminated|0|||
162051312|NCT04457336|585244348|FG004|Period 4: Part C|Study Terminated|0|||
162051313|NCT04457336|585244349|FG005|Period 4: Part C|Study Terminated|0|||
162051314|NCT04457336|585244350|FG006|Period 4: Part C|Study Terminated|0|||
162051315|NCT04457336|585244351|FG007|Period 4: Part C|Study Terminated|30|||
162051316|NCT04457336|585244344|FG000|Period 4: Part C|Adverse Event|0|||
162051317|NCT04457336|585244345|FG001|Period 4: Part C|Adverse Event|0|||
162051318|NCT04457336|585244346|FG002|Period 4: Part C|Adverse Event|0|||
162051319|NCT04457336|585244347|FG003|Period 4: Part C|Adverse Event|0|||
162051320|NCT04457336|585244348|FG004|Period 4: Part C|Adverse Event|0|||
162051321|NCT04457336|585244349|FG005|Period 4: Part C|Adverse Event|0|||
162051322|NCT04457336|585244350|FG006|Period 4: Part C|Adverse Event|0|||
162051323|NCT04457336|585244351|FG007|Period 4: Part C|Adverse Event|2|||
162051324|NCT04457336|585244344|FG000|Period 4: Part C|Site Terminated|0|||
162051325|NCT04457336|585244345|FG001|Period 4: Part C|Site Terminated|0|||
162051326|NCT04457336|585244346|FG002|Period 4: Part C|Site Terminated|0|||
162051327|NCT04457336|585244347|FG003|Period 4: Part C|Site Terminated|0|||
162051328|NCT04457336|585244348|FG004|Period 4: Part C|Site Terminated|0|||
162051329|NCT04457336|585244349|FG005|Period 4: Part C|Site Terminated|0|||
162051330|NCT04457336|585244350|FG006|Period 4: Part C|Site Terminated|0|||
162051331|NCT04457336|585244351|FG007|Period 4: Part C|Site Terminated|1|||
162051332|NCT04457336|585244344|FG000|Period 4: Part C|Other|0|||
162051333|NCT04457336|585244345|FG001|Period 4: Part C|Other|0|||
162051334|NCT04457336|585244346|FG002|Period 4: Part C|Other|0|||
162051335|NCT04457336|585244347|FG003|Period 4: Part C|Other|0|||
162051336|NCT04457336|585244348|FG004|Period 4: Part C|Other|0|||
162051337|NCT04457336|585244349|FG005|Period 4: Part C|Other|0|||
162051338|NCT04457336|585244350|FG006|Period 4: Part C|Other|0|||
162051339|NCT04457336|585244351|FG007|Period 4: Part C|Other|2|||
162051340|NCT04457336|585244344|FG000|Period 4: Part C|Withdrawal by Subject|0|||
162051341|NCT04457336|585244345|FG001|Period 4: Part C|Withdrawal by Subject|0|||
162051342|NCT04457336|585244346|FG002|Period 4: Part C|Withdrawal by Subject|0|||
162051343|NCT04457336|585244347|FG003|Period 4: Part C|Withdrawal by Subject|0|||
162051344|NCT04457336|585244348|FG004|Period 4: Part C|Withdrawal by Subject|0|||
162051345|NCT04457336|585244349|FG005|Period 4: Part C|Withdrawal by Subject|0|||
162051346|NCT04457336|585244350|FG006|Period 4: Part C|Withdrawal by Subject|0|||
162051347|NCT04457336|585244351|FG007|Period 4: Part C|Withdrawal by Subject|3|||
162051348|NCT05379231|585244352|FG000|Home Visit|Withdrawal by Subject|2|||
162051349|NCT05379231|585244352|FG000|In-lab Visit|Withdrawal by Subject|2|||
162051350|NCT00446251|585244362|FG000|Overall Study|On-study Transplants|2|||
162051351|NCT00446251|585244362|FG000|Overall Study|Rituximab Infusion Reaction|2|||
162051352|NCT00446251|585244362|FG000|Overall Study|Lost to Follow-up|1|||
162051353|NCT01416272|585244366|FG000|Overall Study|Unacceptable distance visual acuity|2|||
162051354|NCT01416272|585244366|FG000|Overall Study|Lost to Follow-up|1|||
162051355|NCT01416272|585244366|FG000|Overall Study|Study related complaints|1|||
162051356|NCT00702689|585244367|FG000|Overall Study|Withdrawal by Subject|4|||
162051357|NCT00702689|585244367|FG000|Overall Study|Recurrent malignancy|1|||
162051358|NCT00702689|585244367|FG000|Overall Study|Adverse Event|1|||
162051359|NCT01986907|585244370|FG000|Overall Study|Adverse Event|11|||
162051360|NCT01986907|585244370|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
162051361|NCT01986907|585244370|FG000|Overall Study|Protocol Violation|4|||
162051362|NCT01986907|585244370|FG000|Overall Study|Withdrawal by Subject|76|||
162051363|NCT01986907|585244370|FG000|Overall Study|Lost to Follow-up|38|||
162051364|NCT01986907|585244370|FG000|Overall Study|Death|9|||
162051365|NCT00939640|585244374|FG000|Overall Study|Physician Decision|1|||
162051366|NCT00239590|585244375|FG000|Randomized|Lost to Follow-up|0|||
162051367|NCT00239590|585244376|FG001|Randomized|Lost to Follow-up|1|||
162051368|NCT00239590|585244375|FG000|Randomized|Withdrawal by Subject|0|||
162051369|NCT00239590|585244376|FG001|Randomized|Withdrawal by Subject|1|||
162051370|NCT00239590|585244375|FG000|Completed Study Protocol|Adverse Event|1|||
162051371|NCT00239590|585244376|FG001|Completed Study Protocol|Adverse Event|1|||
162051372|NCT00239590|585244375|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
162051373|NCT00239590|585244376|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
162051374|NCT00892047|585244381|FG000|Overall Study|Adverse Event|2|||
162051375|NCT00892047|585244382|FG001|Overall Study|Adverse Event|2|||
162051376|NCT00892047|585244381|FG000|Overall Study|subject burden|2|||
162051377|NCT00892047|585244382|FG001|Overall Study|subject burden|3|||
162051378|NCT00892047|585244381|FG000|Overall Study|Lack of Efficacy|0|||
162051379|NCT00892047|585244382|FG001|Overall Study|Lack of Efficacy|2|||
162051380|NCT01201785|585244383|FG000|Overall Study|Lost to Follow-up|16|||
162051381|NCT01999179|585244384|FG000|Overall Study|Adverse Event|1|||
162051382|NCT01999179|585244384|FG000|Overall Study|Lost to Follow-up|1|||
162051383|NCT01999179|585244384|FG000|Overall Study|Change in Therapy|3|||
162051384|NCT01999179|585244384|FG000|Overall Study|New catheter|2|||
162051385|NCT01146665|585244385|FG000|Overall Study|Withdrawal by Subject|10|||
162051386|NCT01146665|585244386|FG001|Overall Study|Withdrawal by Subject|16|||
162051387|NCT01064310|585244387|FG000|Period 1|Adverse Event|7|||
162051388|NCT01064310|585244388|FG001|Period 1|Adverse Event|10|||
162051389|NCT01064310|585244389|FG002|Period 1|Adverse Event|0|||
162051390|NCT01064310|585244387|FG000|Period 1|Physician Decision|1|||
162051391|NCT01064310|585244388|FG001|Period 1|Physician Decision|0|||
162051392|NCT01064310|585244389|FG002|Period 1|Physician Decision|0|||
162051393|NCT01064310|585244387|FG000|Period 1|Withdrawal by Subject|2|||
162051394|NCT01064310|585244388|FG001|Period 1|Withdrawal by Subject|2|||
162051395|NCT01064310|585244389|FG002|Period 1|Withdrawal by Subject|0|||
162051396|NCT01064310|585244387|FG000|Period 1|Lack of Efficacy|3|||
162051397|NCT01064310|585244388|FG001|Period 1|Lack of Efficacy|5|||
162051398|NCT01064310|585244389|FG002|Period 1|Lack of Efficacy|0|||
162051399|NCT01064310|585244387|FG000|Period 1|Entered Open-label Period|1|||
162051400|NCT01064310|585244388|FG001|Period 1|Entered Open-label Period|1|||
162051401|NCT01064310|585244389|FG002|Period 1|Entered Open-label Period|0|||
162051402|NCT01064310|585244387|FG000|Period 2|Adverse Event|2|||
162051403|NCT01064310|585244388|FG001|Period 2|Adverse Event|1|||
162051404|NCT01064310|585244389|FG002|Period 2|Adverse Event|0|||
162051405|NCT01064310|585244387|FG000|Period 2|Physician Decision|0|||
162051406|NCT01064310|585244388|FG001|Period 2|Physician Decision|1|||
162051407|NCT01064310|585244389|FG002|Period 2|Physician Decision|0|||
162051408|NCT01064310|585244387|FG000|Period 2|Entered Open-label Period|1|||
162051409|NCT01064310|585244388|FG001|Period 2|Entered Open-label Period|0|||
162051410|NCT01064310|585244389|FG002|Period 2|Entered Open-label Period|0|||
162051411|NCT01064310|585244387|FG000|Period 2|Lack of Efficacy|1|||
162051412|NCT01064310|585244388|FG001|Period 2|Lack of Efficacy|4|||
162051413|NCT01064310|585244389|FG002|Period 2|Lack of Efficacy|0|||
162051414|NCT01064310|585244387|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
162051415|NCT01064310|585244388|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
162051416|NCT01064310|585244389|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
162051417|NCT01064310|585244387|FG000|Open Label Pazopinib|Adverse Event|0|||
162051418|NCT01064310|585244388|FG001|Open Label Pazopinib|Adverse Event|0|||
162051419|NCT01064310|585244389|FG002|Open Label Pazopinib|Adverse Event|12|||
162051420|NCT01064310|585244387|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
162051421|NCT01064310|585244388|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
162051422|NCT01064310|585244389|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
162051423|NCT01064310|585244387|FG000|Open Label Pazopinib|Physician Decision|0|||
162051424|NCT01064310|585244388|FG001|Open Label Pazopinib|Physician Decision|0|||
162051425|NCT01064310|585244389|FG002|Open Label Pazopinib|Physician Decision|20|||
162051426|NCT00001880|585244390|FG000|Overall Study|Death|14|||
162051427|NCT02639065|585244391|FG000|Study Treatment|Disease Progression|13|||
162051428|NCT02639065|585244391|FG000|Study Treatment|Adverse Event|9|||
162051429|NCT02639065|585244391|FG000|Study Treatment|Withdrawal by Subject|1|||
162051430|NCT02639065|585244391|FG000|Follow up|Subject refused to follow up|1|||
162051431|NCT02639065|585244391|FG000|Follow up|Symptomatic Deterioration|2|||
162051432|NCT02639065|585244391|FG000|Follow up|Death|2|||
162051433|NCT02639065|585244391|FG000|Follow up|Study Terminated|1|||
162051434|NCT02639065|585244391|FG000|Follow up|Disease Progression|3|||
162051435|NCT00660699|585244392|FG000|Overall Study|Withdrawal by Subject|2|||
162051436|NCT05147428|585244393|FG000|Overall Study|Removed prior to mailing|289|||
162051437|NCT05147428|585244394|FG001|Overall Study|Removed prior to mailing|306|||
162051438|NCT05147428|585244395|FG002|Overall Study|Removed prior to mailing|270|||
162051439|NCT05147428|585244393|FG000|Overall Study|Died or disenrolled during blackout period|239|||
162051440|NCT05147428|585244394|FG001|Overall Study|Died or disenrolled during blackout period|278|||
162051441|NCT05147428|585244395|FG002|Overall Study|Died or disenrolled during blackout period|273|||
162051442|NCT03128047|585244396|FG000|Overall Study|Withdrawal by Subject|1|||
162051443|NCT01713686|585245761|FG000|Overall Study|Lost to Follow-up|9|||
162051444|NCT01713686|585245761|FG000|Overall Study|Withdrawal by Subject|6|||
162051445|NCT02385045|585245762|FG000|Overall Study|Endoscopy could not be completed|4|||
162051446|NCT00381485|585245764|FG000|Open-Label Run-In Period|Adverse Event|9|||
162051447|NCT00381485|585245765|FG001|Open-Label Run-In Period|Adverse Event|0|||
162051448|NCT00381485|585245766|FG002|Open-Label Run-In Period|Adverse Event|0|||
162051449|NCT00381485|585245767|FG003|Open-Label Run-In Period|Adverse Event|0|||
162051450|NCT00381485|585245764|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
162051451|NCT00381485|585245765|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
162051452|NCT00381485|585245766|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
162051453|NCT00381485|585245767|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
162051454|NCT00381485|585245764|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
162051455|NCT00381485|585245765|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
162051456|NCT00381485|585245766|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
162051457|NCT00381485|585245767|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
162051458|NCT00381485|585245764|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
162051459|NCT00381485|585245765|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
162051460|NCT00381485|585245766|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
162051461|NCT00381485|585245767|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
162051462|NCT00381485|585245764|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
162051463|NCT00381485|585245765|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
162051464|NCT00381485|585245766|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
162051465|NCT00381485|585245767|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
162051466|NCT00381485|585245764|FG000|Open-Label Run-In Period|Treatment failure|1|||
162051467|NCT00381485|585245765|FG001|Open-Label Run-In Period|Treatment failure|0|||
162051468|NCT00381485|585245766|FG002|Open-Label Run-In Period|Treatment failure|0|||
162051469|NCT00381485|585245767|FG003|Open-Label Run-In Period|Treatment failure|0|||
162051470|NCT00381485|585245764|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162051471|NCT00381485|585245765|FG001|Double-Blind Treatment Period|Adverse Event|2|||
162051472|NCT00381485|585245766|FG002|Double-Blind Treatment Period|Adverse Event|2|||
162051473|NCT00381485|585245767|FG003|Double-Blind Treatment Period|Adverse Event|5|||
162051474|NCT00381485|585245764|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
162051475|NCT00381485|585245765|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
162051476|NCT00381485|585245766|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
162051477|NCT00381485|585245767|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
162051478|NCT00381485|585245764|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162051479|NCT00381485|585245765|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
162051480|NCT00381485|585245766|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
162051481|NCT00381485|585245767|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
162051482|NCT00381485|585245764|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
162051483|NCT00381485|585245765|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
162051484|NCT00381485|585245766|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
162051485|NCT00381485|585245767|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
162051486|NCT00381485|585245764|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
162051487|NCT00381485|585245765|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
162051488|NCT00381485|585245766|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
162051489|NCT00381485|585245767|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
162051490|NCT00381485|585245764|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
162051491|NCT00381485|585245765|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
162051492|NCT00381485|585245766|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
162051493|NCT00381485|585245767|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
162051494|NCT00381485|585245764|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
162051495|NCT00381485|585245765|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
162051496|NCT00381485|585245766|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
162051497|NCT00381485|585245767|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
162051498|NCT00381485|585245764|FG000|Double-Blind Treatment Period|Administrative|0|||
162051499|NCT00381485|585245765|FG001|Double-Blind Treatment Period|Administrative|1|||
162051500|NCT00381485|585245766|FG002|Double-Blind Treatment Period|Administrative|0|||
162051501|NCT00381485|585245767|FG003|Double-Blind Treatment Period|Administrative|1|||
162051502|NCT01235351|585245768|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
162051503|NCT01235351|585245769|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
162051504|NCT00745823|585245770|FG000|Overall Study|Adverse Event|5|||
162051505|NCT00745823|585245771|FG001|Overall Study|Adverse Event|3|||
162051506|NCT00745823|585245770|FG000|Overall Study|Lack of Efficacy|20|||
162051507|NCT00745823|585245771|FG001|Overall Study|Lack of Efficacy|6|||
162051508|NCT00745823|585245770|FG000|Overall Study|Lost to Follow-up|10|||
162051509|NCT00745823|585245771|FG001|Overall Study|Lost to Follow-up|11|||
162051510|NCT00745823|585245770|FG000|Overall Study|Physician Decision|10|||
162051511|NCT00745823|585245771|FG001|Overall Study|Physician Decision|5|||
162051512|NCT00745823|585245770|FG000|Overall Study|Pregnancy|0|||
162051513|NCT00745823|585245771|FG001|Overall Study|Pregnancy|4|||
162051514|NCT00745823|585245770|FG000|Overall Study|Withdrawal by Subject|14|||
162051515|NCT00745823|585245771|FG001|Overall Study|Withdrawal by Subject|8|||
162051516|NCT00745823|585245770|FG000|Overall Study|Study Terminated by Sponsor|326|||
162051517|NCT00745823|585245771|FG001|Overall Study|Study Terminated by Sponsor|349|||
162051518|NCT02980601|585245781|FG000|Overall Study|Lost to Follow-up|2|||
162051519|NCT02980601|585245782|FG001|Overall Study|Lost to Follow-up|2|||
162051520|NCT02980601|585245781|FG000|Overall Study|Death|0|||
162051521|NCT02980601|585245782|FG001|Overall Study|Death|1|||
162051522|NCT02980601|585245781|FG000|Overall Study|Graft loss|1|||
162051523|NCT02980601|585245782|FG001|Overall Study|Graft loss|0|||
162051524|NCT02980601|585245781|FG000|Overall Study|Failed to sign consent|2|||
162051525|NCT02980601|585245782|FG001|Overall Study|Failed to sign consent|0|||
162051526|NCT00290888|585245783|FG000|Overall Study|Physician Decision|3|||
162051527|NCT00290888|585245784|FG001|Overall Study|Physician Decision|1|||
162051528|NCT01034631|585245785|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
162051529|NCT01034631|585245786|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
162051530|NCT01034631|585245787|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
162051531|NCT01034631|585245785|FG000|Phase II|Not Evaluable per protocol|0|||
162051532|NCT01034631|585245786|FG001|Phase II|Not Evaluable per protocol|0|||
162051533|NCT01034631|585245787|FG002|Phase II|Not Evaluable per protocol|2|||
162051534|NCT01034631|585245785|FG000|Phase II|Determined Ineligible per protocol|0|||
162051535|NCT01034631|585245786|FG001|Phase II|Determined Ineligible per protocol|1|||
162051536|NCT01034631|585245787|FG002|Phase II|Determined Ineligible per protocol|0|||
162051537|NCT00799383|585245788|FG000|Overall Study|Protocol Violation|1|||
162051538|NCT00799383|585245789|FG001|Overall Study|Protocol Violation|1|||
162051539|NCT00799383|585245788|FG000|Overall Study|Adverse Event|0|||
162051540|NCT00799383|585245789|FG001|Overall Study|Adverse Event|1|||
162051541|NCT00799383|585245788|FG000|Overall Study|Lost to Follow-up|1|||
162051542|NCT00799383|585245789|FG001|Overall Study|Lost to Follow-up|2|||
162051543|NCT00799383|585245788|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
162051544|NCT00799383|585245789|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
162051545|NCT00799383|585245788|FG000|Overall Study|Withdrawal by Subject|0|||
162051546|NCT00799383|585245789|FG001|Overall Study|Withdrawal by Subject|1|||
162051547|NCT03486223|585245799|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
162051548|NCT03486223|585245800|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
162051549|NCT03068130|585245813|FG000|Overall Study|Adverse Event|19|||
162051550|NCT03068130|585245813|FG000|Overall Study|Death|14|||
162051551|NCT03068130|585245813|FG000|Overall Study|Lost to Follow-up|4|||
162051552|NCT03068130|585245813|FG000|Overall Study|Withdrawal by Subject|26|||
162051553|NCT03068130|585245813|FG000|Overall Study|Administrative Reasons|3|||
162051554|NCT03068130|585245813|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
162051555|NCT03068130|585245813|FG000|Overall Study|Study terminated by sponsor|194|||
162051556|NCT00590720|585245814|FG000|Overall Study|Lost to Follow-up|1|||
162051557|NCT00590720|585245815|FG001|Overall Study|Lost to Follow-up|0|||
162051558|NCT00590720|585245814|FG000|Overall Study|Withdrawal by Subject|0|||
162051559|NCT00590720|585245815|FG001|Overall Study|Withdrawal by Subject|1|||
162051560|NCT03741062|585245820|FG000|Overall Study|Protocol Violation|1|||
162051561|NCT03741062|585245821|FG001|Overall Study|Protocol Violation|0|||
162051562|NCT02527161|585245822|FG000|Overall Study|Failed MRI|52|||
162051563|NCT02527161|585245822|FG000|Overall Study|Withdrawal by Subject|19|||
162051564|NCT02527161|585245822|FG000|Overall Study|Delay in or unfit for surgery|16|||
162051565|NCT02527161|585245822|FG000|Overall Study|MRI contraindication|6|||
162051566|NCT02527161|585245822|FG000|Overall Study|Consent violation|4|||
162051567|NCT02527161|585245822|FG000|Overall Study|Only Recruited to Part A|27|||
162051568|NCT02527161|585245822|FG000|Overall Study|Physician Decision|1|||
162051569|NCT02527161|585245822|FG000|Overall Study|Adverse Event|1|||
162051570|NCT02527161|585245822|FG000|Overall Study|Lost to Follow-up|6|||
162051571|NCT02609828|585245823|FG000|Overall Study|Adverse Event|8|||
162051572|NCT02609828|585245824|FG001|Overall Study|Adverse Event|1|||
162051573|NCT02609828|585245825|FG002|Overall Study|Adverse Event|0|||
162051574|NCT02609828|585245826|FG003|Overall Study|Adverse Event|6|||
162051575|NCT02609828|585245823|FG000|Overall Study|Death|15|||
162051576|NCT02609828|585245824|FG001|Overall Study|Death|1|||
162051577|NCT02609828|585245825|FG002|Overall Study|Death|1|||
162051578|NCT02609828|585245826|FG003|Overall Study|Death|19|||
162051579|NCT02609828|585245823|FG000|Overall Study|Insufficient clinical response|2|||
162051580|NCT02609828|585245824|FG001|Overall Study|Insufficient clinical response|1|||
162051581|NCT02609828|585245825|FG002|Overall Study|Insufficient clinical response|0|||
162051582|NCT02609828|585245826|FG003|Overall Study|Insufficient clinical response|0|||
162051583|NCT02609828|585245823|FG000|Overall Study|Lost to Follow-up|0|||
162051584|NCT02609828|585245824|FG001|Overall Study|Lost to Follow-up|0|||
162051585|NCT02609828|585245825|FG002|Overall Study|Lost to Follow-up|0|||
162051586|NCT02609828|585245826|FG003|Overall Study|Lost to Follow-up|1|||
162051587|NCT02609828|585245823|FG000|Overall Study|Protocol Violation|2|||
162051588|NCT02609828|585245824|FG001|Overall Study|Protocol Violation|0|||
162051589|NCT02609828|585245825|FG002|Overall Study|Protocol Violation|0|||
162051590|NCT02609828|585245826|FG003|Overall Study|Protocol Violation|1|||
162051591|NCT02609828|585245823|FG000|Overall Study|Withdrawal by Subject|12|||
162051592|NCT02609828|585245824|FG001|Overall Study|Withdrawal by Subject|1|||
162051593|NCT02609828|585245825|FG002|Overall Study|Withdrawal by Subject|0|||
162051594|NCT02609828|585245826|FG003|Overall Study|Withdrawal by Subject|10|||
162051595|NCT02609828|585245823|FG000|Overall Study|Other|3|||
162051596|NCT02609828|585245824|FG001|Overall Study|Other|0|||
162051597|NCT02609828|585245825|FG002|Overall Study|Other|0|||
162051598|NCT02609828|585245826|FG003|Overall Study|Other|6|||
162051599|NCT02609828|585245823|FG000|Overall Study|Randomized but not treated|1|||
162051600|NCT02609828|585245824|FG001|Overall Study|Randomized but not treated|0|||
162051601|NCT02609828|585245825|FG002|Overall Study|Randomized but not treated|0|||
162051602|NCT02609828|585245826|FG003|Overall Study|Randomized but not treated|0|||
162051603|NCT02805972|585245827|FG000|Washout Period|Lost to Follow-up|3|||
162051604|NCT02805972|585245828|FG001|Washout Period|Lost to Follow-up|0|||
162051605|NCT00389597|585245835|FG000|Overall Study|Lost to Follow-up|8|||
162051606|NCT00389597|585245836|FG001|Overall Study|Lost to Follow-up|6|||
162051607|NCT00389597|585245837|FG002|Overall Study|Lost to Follow-up|4|||
162051608|NCT00389597|585245838|FG003|Overall Study|Lost to Follow-up|6|||
162051609|NCT00306189|585245839|FG000|Overall Study|Physician Decision|0|||
162051610|NCT00306189|585245840|FG001|Overall Study|Physician Decision|0|||
162051611|NCT00306189|585245841|FG002|Overall Study|Physician Decision|0|||
162051612|NCT00306189|585245842|FG003|Overall Study|Physician Decision|1|||
162051613|NCT00306189|585245839|FG000|Overall Study|Adverse Event|3|||
162051614|NCT00306189|585245840|FG001|Overall Study|Adverse Event|3|||
162051615|NCT00306189|585245841|FG002|Overall Study|Adverse Event|2|||
162051616|NCT00306189|585245842|FG003|Overall Study|Adverse Event|2|||
162051617|NCT00306189|585245839|FG000|Overall Study|Withdrawal by Subject|4|||
162051618|NCT00306189|585245840|FG001|Overall Study|Withdrawal by Subject|2|||
162051619|NCT00306189|585245841|FG002|Overall Study|Withdrawal by Subject|8|||
162051620|NCT00306189|585245842|FG003|Overall Study|Withdrawal by Subject|1|||
162051621|NCT00306189|585245839|FG000|Overall Study|Ineligibility determined|1|||
162051622|NCT00306189|585245840|FG001|Overall Study|Ineligibility determined|1|||
162051623|NCT00306189|585245841|FG002|Overall Study|Ineligibility determined|1|||
162051624|NCT00306189|585245842|FG003|Overall Study|Ineligibility determined|1|||
162051625|NCT00306189|585245839|FG000|Overall Study|Other|1|||
162051626|NCT00306189|585245840|FG001|Overall Study|Other|0|||
162051627|NCT00306189|585245841|FG002|Overall Study|Other|0|||
162051628|NCT00306189|585245842|FG003|Overall Study|Other|0|||
162051629|NCT00259610|585245843|FG000|Overall Study|Withdrawal by Subject|33|||
162051630|NCT00259610|585245844|FG001|Overall Study|Withdrawal by Subject|25|||
162051631|NCT00259610|585245845|FG002|Overall Study|Withdrawal by Subject|29|||
162051632|NCT00259610|585245846|FG003|Overall Study|Withdrawal by Subject|19|||
162051633|NCT00259610|585245843|FG000|Overall Study|Lost to Follow-up|19|||
162051634|NCT00259610|585245844|FG001|Overall Study|Lost to Follow-up|8|||
162051635|NCT00259610|585245845|FG002|Overall Study|Lost to Follow-up|18|||
162051636|NCT00259610|585245846|FG003|Overall Study|Lost to Follow-up|15|||
162051637|NCT00259610|585245843|FG000|Overall Study|Physician Decision|6|||
162051638|NCT00259610|585245844|FG001|Overall Study|Physician Decision|4|||
162051639|NCT00259610|585245845|FG002|Overall Study|Physician Decision|7|||
162051640|NCT00259610|585245846|FG003|Overall Study|Physician Decision|2|||
162051641|NCT00259610|585245843|FG000|Overall Study|Death|1|||
162051642|NCT00259610|585245844|FG001|Overall Study|Death|1|||
162051643|NCT00259610|585245845|FG002|Overall Study|Death|2|||
162051644|NCT00259610|585245846|FG003|Overall Study|Death|0|||
162051645|NCT00259610|585245843|FG000|Overall Study|non medical reason|6|||
162051646|NCT00259610|585245844|FG001|Overall Study|non medical reason|2|||
162051647|NCT00259610|585245845|FG002|Overall Study|non medical reason|10|||
162051648|NCT00259610|585245846|FG003|Overall Study|non medical reason|3|||
162051649|NCT00259610|585245843|FG000|Overall Study|Adverse Event|3|||
162051650|NCT00259610|585245844|FG001|Overall Study|Adverse Event|4|||
162051651|NCT00259610|585245845|FG002|Overall Study|Adverse Event|5|||
162051652|NCT00259610|585245846|FG003|Overall Study|Adverse Event|2|||
162051653|NCT00259610|585245843|FG000|Overall Study|Serious Adverse Event|8|||
162051654|NCT00259610|585245844|FG001|Overall Study|Serious Adverse Event|2|||
162051655|NCT00259610|585245845|FG002|Overall Study|Serious Adverse Event|2|||
162051656|NCT00259610|585245846|FG003|Overall Study|Serious Adverse Event|2|||
162051657|NCT00282984|585245850|FG000|Overall Study|Death|2|||
162051658|NCT00282984|585245851|FG001|Overall Study|Death|5|||
162051659|NCT00282984|585245850|FG000|Overall Study|Adverse Event|8|||
162051660|NCT00282984|585245851|FG001|Overall Study|Adverse Event|5|||
162051661|NCT00282984|585245850|FG000|Overall Study|Lack of Efficacy|0|||
162051662|NCT00282984|585245851|FG001|Overall Study|Lack of Efficacy|2|||
162051663|NCT00282984|585245850|FG000|Overall Study|Lost to Follow-up|14|||
162051664|NCT00282984|585245851|FG001|Overall Study|Lost to Follow-up|10|||
162051665|NCT00282984|585245850|FG000|Overall Study|Withdrawal by Participant|22|||
162051666|NCT00282984|585245851|FG001|Overall Study|Withdrawal by Participant|34|||
162051667|NCT00282984|585245850|FG000|Overall Study|Participant stopped study medication|2|||
162051668|NCT00282984|585245851|FG001|Overall Study|Participant stopped study medication|2|||
162051669|NCT00282984|585245850|FG000|Overall Study|Participant only allowed phone follow-up|0|||
162051670|NCT00282984|585245851|FG001|Overall Study|Participant only allowed phone follow-up|1|||
162051671|NCT00282984|585245850|FG000|Overall Study|Participant used antipsychosis meds|0|||
162051672|NCT00282984|585245851|FG001|Overall Study|Participant used antipsychosis meds|1|||
162051673|NCT00282984|585245850|FG000|Overall Study|lack of motivation|1|||
162051674|NCT00282984|585245851|FG001|Overall Study|lack of motivation|0|||
162051675|NCT00282984|585245850|FG000|Overall Study|in prison|0|||
162051676|NCT00282984|585245851|FG001|Overall Study|in prison|1|||
162051677|NCT00282984|585245850|FG000|Overall Study|Protocol Violation|2|||
162051678|NCT00282984|585245851|FG001|Overall Study|Protocol Violation|0|||
162051679|NCT00868608|585245852|FG000|Overall Study|Withdrawal by Subject|3|||
162051680|NCT00868608|585245853|FG001|Overall Study|Withdrawal by Subject|1|||
162051681|NCT00868608|585245854|FG002|Overall Study|Withdrawal by Subject|0|||
162051682|NCT00868608|585245852|FG000|Overall Study|Lost to Follow-up|3|||
162051683|NCT00868608|585245853|FG001|Overall Study|Lost to Follow-up|0|||
162051684|NCT00868608|585245854|FG002|Overall Study|Lost to Follow-up|1|||
162051685|NCT00868608|585245852|FG000|Overall Study|Death|16|||
162051686|NCT00868608|585245853|FG001|Overall Study|Death|2|||
162051687|NCT00868608|585245854|FG002|Overall Study|Death|4|||
162051688|NCT00868608|585245852|FG000|Overall Study|Other - Unspecified|1|||
162051689|NCT00868608|585245853|FG001|Overall Study|Other - Unspecified|0|||
162051690|NCT00868608|585245854|FG002|Overall Study|Other - Unspecified|0|||
162051691|NCT00457301|585245855|FG000|Overall Study|Withdrawal by Subject|3|||
162051692|NCT00457301|585245856|FG001|Overall Study|Withdrawal by Subject|3|||
162051693|NCT00457301|585245855|FG000|Overall Study|Censored out of the study|15|||
162051694|NCT00457301|585245856|FG001|Overall Study|Censored out of the study|14|||
162051695|NCT00457301|585245855|FG000|Overall Study|Death|5|||
162051696|NCT00457301|585245856|FG001|Overall Study|Death|7|||
162051697|NCT00191269|585245857|FG000|Overall Study|Protocol Violation|0|||
162051698|NCT00191269|585245858|FG001|Overall Study|Protocol Violation|2|||
162051699|NCT00191269|585245857|FG000|Overall Study|Adverse Event|1|||
162051700|NCT00191269|585245858|FG001|Overall Study|Adverse Event|4|||
162051701|NCT00191269|585245857|FG000|Overall Study|Progression of Disease|4|||
162051702|NCT00191269|585245858|FG001|Overall Study|Progression of Disease|42|||
162051703|NCT00191269|585245857|FG000|Overall Study|Lack of Efficacy|1|||
162051704|NCT00191269|585245858|FG001|Overall Study|Lack of Efficacy|5|||
162051705|NCT00191269|585245857|FG000|Overall Study|Withdrawal by Subject|0|||
162051706|NCT00191269|585245858|FG001|Overall Study|Withdrawal by Subject|1|||
162051707|NCT00191269|585245857|FG000|Overall Study|Pathologic Aggrevation|0|||
162051708|NCT00191269|585245858|FG001|Overall Study|Pathologic Aggrevation|1|||
162051709|NCT00191269|585245857|FG000|Overall Study|Physician Decision|0|||
162051710|NCT00191269|585245858|FG001|Overall Study|Physician Decision|3|||
162051711|NCT00674362|585245859|FG000|Double Blind|Adverse Event|6|||
162051712|NCT00674362|585245860|FG001|Double Blind|Adverse Event|6|||
162051713|NCT00674362|585245859|FG000|Double Blind|Lack of Efficacy|2|||
162051714|NCT00674362|585245860|FG001|Double Blind|Lack of Efficacy|6|||
162051715|NCT00674362|585245859|FG000|Double Blind|Loss of efficacy|0|||
162051716|NCT00674362|585245860|FG001|Double Blind|Loss of efficacy|1|||
162051717|NCT00674362|585245859|FG000|Double Blind|Withdrawal by Subject|4|||
162051718|NCT00674362|585245860|FG001|Double Blind|Withdrawal by Subject|3|||
162051719|NCT00674362|585245859|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
162051720|NCT00674362|585245860|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
162051721|NCT00674362|585245859|FG000|Double Blind|Other: Surgery|0|||
162051722|NCT00674362|585245860|FG001|Double Blind|Other: Surgery|1|||
162051723|NCT00674362|585245859|FG000|Open Label|Adverse Event|1|||
162051724|NCT00674362|585245860|FG001|Open Label|Adverse Event|0|||
162051725|NCT00674362|585245859|FG000|Open Label|Other: Subject moved to extension study|1|||
162051726|NCT00674362|585245860|FG001|Open Label|Other: Subject moved to extension study|0|||
162051727|NCT00939770|585245863|FG000|Overall Study|Adverse Event|1|||
162051728|NCT00939770|585245864|FG001|Overall Study|Adverse Event|1|||
162051729|NCT00939770|585245865|FG002|Overall Study|Adverse Event|0|||
162051730|NCT00939770|585245866|FG003|Overall Study|Adverse Event|0|||
162051731|NCT00939770|585245867|FG004|Overall Study|Adverse Event|6|||
162051732|NCT00939770|585245868|FG005|Overall Study|Adverse Event|2|||
162051733|NCT00939770|585245869|FG006|Overall Study|Adverse Event|1|||
162051734|NCT00939770|585245870|FG007|Overall Study|Adverse Event|1|||
162051735|NCT00939770|585245863|FG000|Overall Study|Lack of Efficacy|4|||
162051736|NCT00939770|585245864|FG001|Overall Study|Lack of Efficacy|6|||
162051737|NCT00939770|585245865|FG002|Overall Study|Lack of Efficacy|13|||
162051738|NCT00939770|585245866|FG003|Overall Study|Lack of Efficacy|9|||
162051739|NCT00939770|585245867|FG004|Overall Study|Lack of Efficacy|16|||
162051740|NCT00939770|585245868|FG005|Overall Study|Lack of Efficacy|8|||
162051741|NCT00939770|585245869|FG006|Overall Study|Lack of Efficacy|11|||
162051742|NCT00939770|585245870|FG007|Overall Study|Lack of Efficacy|1|||
162051743|NCT00939770|585245863|FG000|Overall Study|Lost to Follow-up|0|||
162051744|NCT00939770|585245864|FG001|Overall Study|Lost to Follow-up|0|||
162051745|NCT00939770|585245865|FG002|Overall Study|Lost to Follow-up|0|||
162051746|NCT00939770|585245866|FG003|Overall Study|Lost to Follow-up|0|||
162051747|NCT00939770|585245867|FG004|Overall Study|Lost to Follow-up|1|||
162051748|NCT00939770|585245868|FG005|Overall Study|Lost to Follow-up|0|||
162051749|NCT00939770|585245869|FG006|Overall Study|Lost to Follow-up|0|||
162051750|NCT00939770|585245870|FG007|Overall Study|Lost to Follow-up|0|||
162051751|NCT00939770|585245863|FG000|Overall Study|Physician Decision|0|||
162051752|NCT00939770|585245864|FG001|Overall Study|Physician Decision|0|||
162051753|NCT00939770|585245865|FG002|Overall Study|Physician Decision|2|||
162051754|NCT00939770|585245866|FG003|Overall Study|Physician Decision|0|||
162051755|NCT00939770|585245867|FG004|Overall Study|Physician Decision|7|||
162051756|NCT00939770|585245868|FG005|Overall Study|Physician Decision|1|||
162051757|NCT00939770|585245869|FG006|Overall Study|Physician Decision|0|||
162051758|NCT00939770|585245870|FG007|Overall Study|Physician Decision|6|||
162051759|NCT00939770|585245863|FG000|Overall Study|Protocol Violation|0|||
162051760|NCT00939770|585245864|FG001|Overall Study|Protocol Violation|0|||
162051761|NCT00939770|585245865|FG002|Overall Study|Protocol Violation|0|||
162051762|NCT00939770|585245866|FG003|Overall Study|Protocol Violation|0|||
162051763|NCT00939770|585245867|FG004|Overall Study|Protocol Violation|1|||
162051764|NCT00939770|585245868|FG005|Overall Study|Protocol Violation|0|||
162051765|NCT00939770|585245869|FG006|Overall Study|Protocol Violation|0|||
162051766|NCT00939770|585245870|FG007|Overall Study|Protocol Violation|0|||
162051767|NCT00939770|585245863|FG000|Overall Study|Withdrawal by Subject|0|||
162051768|NCT00939770|585245864|FG001|Overall Study|Withdrawal by Subject|1|||
162051769|NCT00939770|585245865|FG002|Overall Study|Withdrawal by Subject|5|||
162051770|NCT00939770|585245866|FG003|Overall Study|Withdrawal by Subject|2|||
162051771|NCT00939770|585245867|FG004|Overall Study|Withdrawal by Subject|6|||
162051772|NCT00939770|585245868|FG005|Overall Study|Withdrawal by Subject|0|||
162051773|NCT00939770|585245869|FG006|Overall Study|Withdrawal by Subject|2|||
162051774|NCT00939770|585245870|FG007|Overall Study|Withdrawal by Subject|2|||
162051775|NCT04665856|585245871|FG000|Overall Study|Site Terminated by Sponsor|1|||
162051776|NCT04665856|585245872|FG001|Overall Study|Site Terminated by Sponsor|0|||
162051777|NCT04665856|585245871|FG000|Overall Study|Withdrawal by Subject|2|||
162051778|NCT04665856|585245872|FG001|Overall Study|Withdrawal by Subject|0|||
162051779|NCT04665856|585245871|FG000|Overall Study|Lost to Follow-up|3|||
162051780|NCT04665856|585245872|FG001|Overall Study|Lost to Follow-up|2|||
162051781|NCT04665856|585245871|FG000|Overall Study|Death|39|||
162051782|NCT04665856|585245872|FG001|Overall Study|Death|44|||
162051783|NCT04665856|585245871|FG000|Overall Study|Ongoing in study|17|||
162051784|NCT04665856|585245872|FG001|Overall Study|Ongoing in study|15|||
162051785|NCT03386448|585245873|FG000|Overall Study|Adverse Event|0|||
162051786|NCT03386448|585245874|FG001|Overall Study|Adverse Event|2|||
162051787|NCT02564796|585245875|FG000|Overall Study|Physician Decision|2|||
162051788|NCT02564796|585245876|FG001|Overall Study|Physician Decision|2|||
162051789|NCT00114530|585245877|FG000|Overall Study|Death|3|||
162051790|NCT00114530|585245878|FG001|Overall Study|Death|11|||
162051791|NCT00114530|585245877|FG000|Overall Study|Lost to Follow-up|1|||
162051792|NCT00114530|585245878|FG001|Overall Study|Lost to Follow-up|1|||
162051793|NCT00114530|585245877|FG000|Overall Study|Physician Decision|1|||
162051794|NCT00114530|585245878|FG001|Overall Study|Physician Decision|1|||
162051795|NCT00114530|585245877|FG000|Overall Study|Withdrawal by Subject|2|||
162051796|NCT00114530|585245878|FG001|Overall Study|Withdrawal by Subject|6|||
162051797|NCT00114530|585245877|FG000|Overall Study|Breast Cancer|1|||
162051798|NCT00114530|585245878|FG001|Overall Study|Breast Cancer|0|||
162051799|NCT00114530|585245877|FG000|Overall Study|Subject decision after endpoint failure|0|||
162051800|NCT00114530|585245878|FG001|Overall Study|Subject decision after endpoint failure|1|||
162051801|NCT00114530|585245877|FG000|Overall Study|Ineligible|1|||
162051802|NCT00114530|585245878|FG001|Overall Study|Ineligible|0|||
162051803|NCT02538029|585245881|FG000|Overall Study|unable to complete cognitive assessments|1|||
162051804|NCT02538029|585245882|FG001|Overall Study|unable to complete cognitive assessments|0|||
162051805|NCT02538029|585245883|FG002|Overall Study|unable to complete cognitive assessments|1|||
162051806|NCT01466153|585245884|FG000|Overall Study|Disease Progression|2|||
162051807|NCT01466153|585245885|FG001|Overall Study|Disease Progression|2|||
162051808|NCT01466153|585245886|FG002|Overall Study|Disease Progression|0|||
162051809|NCT01466153|585245884|FG000|Overall Study|Adverse Event|14|||
162051810|NCT01466153|585245885|FG001|Overall Study|Adverse Event|13|||
162051811|NCT01466153|585245886|FG002|Overall Study|Adverse Event|17|||
162051812|NCT01466153|585245884|FG000|Overall Study|Withdrawal of Consent|2|||
162051813|NCT01466153|585245885|FG001|Overall Study|Withdrawal of Consent|0|||
162051814|NCT01466153|585245886|FG002|Overall Study|Withdrawal of Consent|0|||
162051815|NCT01466153|585245884|FG000|Overall Study|Investigator Discretion|3|||
162051816|NCT01466153|585245885|FG001|Overall Study|Investigator Discretion|2|||
162051817|NCT01466153|585245886|FG002|Overall Study|Investigator Discretion|2|||
162051818|NCT01466153|585245884|FG000|Overall Study|Randomized-Not Treated|2|||
162051819|NCT01466153|585245885|FG001|Overall Study|Randomized-Not Treated|3|||
162051820|NCT01466153|585245886|FG002|Overall Study|Randomized-Not Treated|4|||
162051821|NCT01466153|585245884|FG000|Overall Study|Other-Unspecified|6|||
162051822|NCT01466153|585245885|FG001|Overall Study|Other-Unspecified|4|||
162051823|NCT01466153|585245886|FG002|Overall Study|Other-Unspecified|2|||
162051824|NCT01088997|585245889|FG000|Overall Study|Physician Decision|1|||
162051825|NCT01088997|585245890|FG001|Overall Study|Physician Decision|1|||
162051826|NCT01088997|585245889|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
162051827|NCT01088997|585245890|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
162051828|NCT01088997|585245889|FG000|Overall Study|Excluded prior to receiving drug|1|||
162051829|NCT01088997|585245890|FG001|Overall Study|Excluded prior to receiving drug|1|||
162051830|NCT01095731|585245895|FG000|Overall Study|Protocol Violation|1|||
162051831|NCT01095731|585245896|FG001|Overall Study|Protocol Violation|1|||
162051832|NCT01095731|585245895|FG000|Overall Study|Withdrawal by Subject|0|||
162051833|NCT01095731|585245896|FG001|Overall Study|Withdrawal by Subject|1|||
162051834|NCT02302807|585245899|FG000|Overall Study|Withdrawal by Subject|28|||
162051835|NCT02302807|585245900|FG001|Overall Study|Withdrawal by Subject|11|||
162051836|NCT02302807|585245899|FG000|Overall Study|Lost to Follow-up|4|||
162051837|NCT02302807|585245900|FG001|Overall Study|Lost to Follow-up|6|||
162051838|NCT02302807|585245899|FG000|Overall Study|Death|397|||
162051839|NCT02302807|585245900|FG001|Overall Study|Death|385|||
162051840|NCT02302807|585245899|FG000|Overall Study|Study Terminated By Sponsor|35|||
162051841|NCT02302807|585245900|FG001|Overall Study|Study Terminated By Sponsor|64|||
162051842|NCT02302807|585245899|FG000|Overall Study|Physician Decision|0|||
162051843|NCT02302807|585245900|FG001|Overall Study|Physician Decision|1|||
162051844|NCT01980940|585245902|FG000|Overall Study|Protocol Violation|0|||
162051845|NCT01980940|585245903|FG001|Overall Study|Protocol Violation|0|||
162051846|NCT01980940|585245904|FG002|Overall Study|Protocol Violation|0|||
162051847|NCT01980940|585245905|FG003|Overall Study|Protocol Violation|0|||
162051848|NCT01980940|585245906|FG004|Overall Study|Protocol Violation|0|||
162051849|NCT01980940|585245907|FG005|Overall Study|Protocol Violation|2|||
162051850|NCT01980940|585245908|FG006|Overall Study|Protocol Violation|0|||
162051851|NCT01980940|585245909|FG007|Overall Study|Protocol Violation|0|||
162051852|NCT00688753|585247532|FG000|Overall Study|Disease progression|55|||
162051853|NCT00688753|585247532|FG000|Overall Study|Missing|1|||
162051854|NCT00688753|585247532|FG000|Overall Study|Death|9|||
162051855|NCT00688753|585247532|FG000|Overall Study|Withdrawal by Subject|3|||
162051856|NCT00688753|585247532|FG000|Overall Study|Adverse Event|20|||
162051857|NCT00688753|585247532|FG000|Overall Study|Protocol Violation|1|||
162051858|NCT00688753|585247532|FG000|Overall Study|Lost to Follow-up|3|||
162051859|NCT03192462|585247539|FG000|Overall Study|Death|13|||
162051860|NCT03192462|585247540|FG001|Overall Study|Death|11|||
162051861|NCT03192462|585247541|FG002|Overall Study|Death|10|||
162051862|NCT03192462|585247539|FG000|Overall Study|Lost to Follow-up|0|||
162051863|NCT03192462|585247540|FG001|Overall Study|Lost to Follow-up|1|||
162051864|NCT03192462|585247541|FG002|Overall Study|Lost to Follow-up|0|||
162051865|NCT05996718|585247542|FG000|Overall Study|Lost to Follow-up|3|||
162051866|NCT03187197|585247544|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
162051867|NCT03187197|585247545|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
162051868|NCT03187197|585247546|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
162051869|NCT03187197|585247544|FG000|Overall Study|Withdrawal by Subject|8|||
162051870|NCT03187197|585247545|FG001|Overall Study|Withdrawal by Subject|63|||
162051871|NCT03187197|585247546|FG002|Overall Study|Withdrawal by Subject|4|||
162051872|NCT03187197|585247544|FG000|Overall Study|Lost to Follow-up|1|||
162051873|NCT03187197|585247545|FG001|Overall Study|Lost to Follow-up|60|||
162051874|NCT03187197|585247546|FG002|Overall Study|Lost to Follow-up|7|||
162051875|NCT03187197|585247544|FG000|Overall Study|Adverse Event|6|||
162051876|NCT03187197|585247545|FG001|Overall Study|Adverse Event|29|||
162051877|NCT03187197|585247546|FG002|Overall Study|Adverse Event|0|||
162051878|NCT03187197|585247544|FG000|Overall Study|Death|0|||
162051879|NCT03187197|585247545|FG001|Overall Study|Death|11|||
162051880|NCT03187197|585247546|FG002|Overall Study|Death|0|||
162051881|NCT03187197|585247544|FG000|Overall Study|Administrative problem|1|||
162051882|NCT03187197|585247545|FG001|Overall Study|Administrative problem|1|||
162051883|NCT03187197|585247546|FG002|Overall Study|Administrative problem|0|||
162051884|NCT03187197|585247544|FG000|Overall Study|Reason not listed|2|||
162051885|NCT03187197|585247545|FG001|Overall Study|Reason not listed|54|||
162051886|NCT03187197|585247546|FG002|Overall Study|Reason not listed|1|||
162051887|NCT03187197|585247544|FG000|Overall Study|Missing|1|||
162051888|NCT03187197|585247545|FG001|Overall Study|Missing|32|||
162051889|NCT03187197|585247546|FG002|Overall Study|Missing|3|||
162051890|NCT03187197|585247544|FG000|Overall Study|Status missing|2|||
162051891|NCT03187197|585247545|FG001|Overall Study|Status missing|33|||
162051892|NCT03187197|585247546|FG002|Overall Study|Status missing|3|||
162051893|NCT03187197|585247544|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
162051894|NCT03187197|585247545|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
162051895|NCT03187197|585247546|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
162051896|NCT04840615|585247547|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
162051897|NCT04840615|585247548|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
162051898|NCT04840615|585247549|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
162051899|NCT00115739|585247550|FG000|Overall Study|Lost to Follow-up|3|||
162051900|NCT00259649|585247553|FG000|Overall Study|Lost to Follow-up|7|||
162051901|NCT00259649|585247553|FG000|Overall Study|irregular menses|3|||
162051902|NCT02200211|585247554|FG000|Overall Study|Lost to Follow-up|7|||
162051903|NCT02200211|585247555|FG001|Overall Study|Lost to Follow-up|7|||
162051904|NCT02200211|585247556|FG002|Overall Study|Lost to Follow-up|1|||
162051905|NCT02200211|585247557|FG003|Overall Study|Lost to Follow-up|2|||
162051906|NCT02200211|585247554|FG000|Overall Study|Withdrawal by Subject|1|||
162051907|NCT02200211|585247555|FG001|Overall Study|Withdrawal by Subject|0|||
162051908|NCT02200211|585247556|FG002|Overall Study|Withdrawal by Subject|0|||
162051909|NCT02200211|585247557|FG003|Overall Study|Withdrawal by Subject|0|||
162051910|NCT02501473|585247558|FG000|Overall Study|Study Terminated|2|||
162051911|NCT02501473|585247559|FG001|Overall Study|Study Terminated|3|||
162051912|NCT02501473|585247560|FG002|Overall Study|Study Terminated|7|||
162051913|NCT02501473|585247561|FG003|Overall Study|Study Terminated|9|||
162051914|NCT02501473|585247562|FG004|Overall Study|Study Terminated|2|||
162051915|NCT02501473|585247563|FG005|Overall Study|Study Terminated|10|||
162051916|NCT02501473|585247564|FG006|Overall Study|Study Terminated|1|||
162051917|NCT02501473|585247565|FG007|Overall Study|Study Terminated|0|||
162051918|NCT02501473|585247558|FG000|Overall Study|Withdrawal by Subject|0|||
162051919|NCT02501473|585247559|FG001|Overall Study|Withdrawal by Subject|0|||
162051920|NCT02501473|585247560|FG002|Overall Study|Withdrawal by Subject|3|||
162051921|NCT02501473|585247561|FG003|Overall Study|Withdrawal by Subject|3|||
162051922|NCT02501473|585247562|FG004|Overall Study|Withdrawal by Subject|2|||
162051923|NCT02501473|585247563|FG005|Overall Study|Withdrawal by Subject|2|||
162051924|NCT02501473|585247564|FG006|Overall Study|Withdrawal by Subject|0|||
162051925|NCT02501473|585247565|FG007|Overall Study|Withdrawal by Subject|0|||
162051926|NCT02501473|585247558|FG000|Overall Study|Death|0|||
162051927|NCT02501473|585247559|FG001|Overall Study|Death|0|||
162051928|NCT02501473|585247560|FG002|Overall Study|Death|1|||
162051929|NCT02501473|585247561|FG003|Overall Study|Death|1|||
162051930|NCT02501473|585247562|FG004|Overall Study|Death|0|||
162051931|NCT02501473|585247563|FG005|Overall Study|Death|1|||
162051932|NCT02501473|585247564|FG006|Overall Study|Death|0|||
162051933|NCT02501473|585247565|FG007|Overall Study|Death|0|||
162051934|NCT02501473|585247558|FG000|Overall Study|Lost to Follow-up|1|||
162051935|NCT02501473|585247559|FG001|Overall Study|Lost to Follow-up|0|||
162051936|NCT02501473|585247560|FG002|Overall Study|Lost to Follow-up|1|||
162051937|NCT02501473|585247561|FG003|Overall Study|Lost to Follow-up|0|||
162051938|NCT02501473|585247562|FG004|Overall Study|Lost to Follow-up|0|||
162051939|NCT02501473|585247563|FG005|Overall Study|Lost to Follow-up|1|||
162051940|NCT02501473|585247564|FG006|Overall Study|Lost to Follow-up|0|||
162051941|NCT02501473|585247565|FG007|Overall Study|Lost to Follow-up|0|||
162051942|NCT02501473|585247558|FG000|Overall Study|Reason not specified|0|||
162051943|NCT02501473|585247559|FG001|Overall Study|Reason not specified|0|||
162051944|NCT02501473|585247560|FG002|Overall Study|Reason not specified|1|||
162051945|NCT02501473|585247561|FG003|Overall Study|Reason not specified|1|||
162051946|NCT02501473|585247562|FG004|Overall Study|Reason not specified|0|||
162051947|NCT02501473|585247563|FG005|Overall Study|Reason not specified|0|||
162051948|NCT02501473|585247564|FG006|Overall Study|Reason not specified|0|||
162051949|NCT02501473|585247565|FG007|Overall Study|Reason not specified|0|||
162051950|NCT02954237|585247566|FG000|Overall Study|Withdrawal by Subject|25|||
162051951|NCT02954237|585247566|FG000|Overall Study|Missed visit|16|||
162051952|NCT02954237|585247566|FG000|Overall Study|Death|2|||
162051953|NCT00621985|585247573|FG000|Dexamethasone Admission|Adverse Event|1|||
162051954|NCT01806298|585247574|FG000|Overall Study|Adverse Event|3|||
162051955|NCT01806298|585247574|FG000|Overall Study|Protocol Non-compliance|1|||
162051956|NCT01806298|585247574|FG000|Overall Study|Withdrawal by Subject|1|||
162051957|NCT01806298|585247574|FG000|Overall Study|Other|5|||
162051958|NCT01001377|585247577|FG000|Overall Study|Ineligibility determined|2|||
162051959|NCT01001377|585247578|FG001|Overall Study|Ineligibility determined|0|||
162051960|NCT01001377|585247577|FG000|Overall Study|Withdrawal by Subject|19|||
162051961|NCT01001377|585247578|FG001|Overall Study|Withdrawal by Subject|20|||
162051962|NCT01001377|585247577|FG000|Overall Study|Lost to Follow-up|14|||
162051963|NCT01001377|585247578|FG001|Overall Study|Lost to Follow-up|17|||
162051964|NCT01001377|585247577|FG000|Overall Study|Death|391|||
162051965|NCT01001377|585247578|FG001|Overall Study|Death|384|||
162051966|NCT02732119|585247579|FG000|Phase I|Adverse Event|1|||
162051967|NCT02732119|585247580|FG001|Phase I|Adverse Event|3|||
162051968|NCT02732119|585247581|FG002|Phase I|Adverse Event|1|||
162051969|NCT02732119|585247582|FG003|Phase I|Adverse Event|0|||
162051970|NCT02732119|585247583|FG004|Phase I|Adverse Event|0|||
162051971|NCT02732119|585247579|FG000|Phase I|Progressive disease|7|||
162051972|NCT02732119|585247580|FG001|Phase I|Progressive disease|3|||
162051973|NCT02732119|585247581|FG002|Phase I|Progressive disease|2|||
162051974|NCT02732119|585247582|FG003|Phase I|Progressive disease|0|||
162051975|NCT02732119|585247583|FG004|Phase I|Progressive disease|0|||
162051976|NCT02732119|585247579|FG000|Phase I|Protocol deviation|0|||
162051977|NCT02732119|585247580|FG001|Phase I|Protocol deviation|1|||
162051978|NCT02732119|585247581|FG002|Phase I|Protocol deviation|0|||
162051979|NCT02732119|585247582|FG003|Phase I|Protocol deviation|0|||
162051980|NCT02732119|585247583|FG004|Phase I|Protocol deviation|0|||
162051981|NCT02732119|585247579|FG000|Phase I|Physician Decision|0|||
162051982|NCT02732119|585247580|FG001|Phase I|Physician Decision|3|||
162051983|NCT02732119|585247581|FG002|Phase I|Physician Decision|4|||
162051984|NCT02732119|585247582|FG003|Phase I|Physician Decision|0|||
162051985|NCT02732119|585247583|FG004|Phase I|Physician Decision|0|||
162051986|NCT02732119|585247579|FG000|Phase II|Adverse Event|0|||
162051987|NCT02732119|585247580|FG001|Phase II|Adverse Event|0|||
162051988|NCT02732119|585247581|FG002|Phase II|Adverse Event|0|||
162051989|NCT02732119|585247582|FG003|Phase II|Adverse Event|3|||
162051990|NCT02732119|585247583|FG004|Phase II|Adverse Event|3|||
162051991|NCT02732119|585247579|FG000|Phase II|Death|0|||
162051992|NCT02732119|585247580|FG001|Phase II|Death|0|||
162051993|NCT02732119|585247581|FG002|Phase II|Death|0|||
162051994|NCT02732119|585247582|FG003|Phase II|Death|1|||
162051995|NCT02732119|585247583|FG004|Phase II|Death|0|||
162051996|NCT02732119|585247579|FG000|Phase II|Progressive dissease|0|||
162051997|NCT02732119|585247580|FG001|Phase II|Progressive dissease|0|||
162051998|NCT02732119|585247581|FG002|Phase II|Progressive dissease|0|||
162051999|NCT02732119|585247582|FG003|Phase II|Progressive dissease|30|||
162052000|NCT02732119|585247583|FG004|Phase II|Progressive dissease|23|||
162052001|NCT02732119|585247579|FG000|Phase II|Study terminated by sponsor|0|||
162052002|NCT02732119|585247580|FG001|Phase II|Study terminated by sponsor|0|||
162052003|NCT02732119|585247581|FG002|Phase II|Study terminated by sponsor|0|||
162052004|NCT02732119|585247582|FG003|Phase II|Study terminated by sponsor|2|||
162052005|NCT02732119|585247583|FG004|Phase II|Study terminated by sponsor|2|||
162052006|NCT02732119|585247579|FG000|Phase II|Other|0|||
162052007|NCT02732119|585247580|FG001|Phase II|Other|0|||
162052008|NCT02732119|585247581|FG002|Phase II|Other|0|||
162052009|NCT02732119|585247582|FG003|Phase II|Other|2|||
162052010|NCT02732119|585247583|FG004|Phase II|Other|0|||
162052011|NCT02732119|585247579|FG000|Phase II|Physician Decision|0|||
162052012|NCT02732119|585247580|FG001|Phase II|Physician Decision|0|||
162052013|NCT02732119|585247581|FG002|Phase II|Physician Decision|0|||
162052014|NCT02732119|585247582|FG003|Phase II|Physician Decision|8|||
162052015|NCT02732119|585247583|FG004|Phase II|Physician Decision|5|||
162052016|NCT00964860|585247584|FG000|Overall Study|Withdrawal by Subject|0|||
162052017|NCT00964860|585247585|FG001|Overall Study|Withdrawal by Subject|1|||
162052018|NCT04343261|585247586|FG000|Overall Study|Adverse Event|1|||
162052019|NCT04343261|585247586|FG000|Overall Study|received inadequate amount of antibodies|7|||
162052020|NCT00134082|585247589|FG000|Overall Study|Adverse Event|2|||
162052021|NCT00134082|585247589|FG000|Overall Study|Death|1|||
162052022|NCT00724932|585247590|FG000|Overall Study|Lost to Follow-up|1|||
162052023|NCT00724932|585247591|FG001|Overall Study|Lost to Follow-up|0|||
162052024|NCT00724932|585247590|FG000|Overall Study|Not treated|4|||
162052025|NCT00724932|585247591|FG001|Overall Study|Not treated|3|||
162052026|NCT02849678|585247592|FG000|Overall Study|Protocol Violation|3|||
162052027|NCT02849678|585247593|FG001|Overall Study|Protocol Violation|6|||
162052028|NCT00288054|585247599|FG000|Overall Study|Protocol Violation|2|||
162052029|NCT00288054|585247599|FG000|Overall Study|Lack of Efficacy|16|||
162052030|NCT00288054|585247599|FG000|Overall Study|Adverse Event|3|||
162052031|NCT00288054|585247599|FG000|Overall Study|Withdrawal by Subject|1|||
162052032|NCT00288054|585247599|FG000|Overall Study|Not protocol specified|2|||
162052033|NCT00289991|585247600|FG000|Overall Study|Death|35|||
162052034|NCT00289991|585247601|FG001|Overall Study|Death|38|||
162052035|NCT00289991|585247600|FG000|Overall Study|Adverse Event|15|||
162052036|NCT00289991|585247601|FG001|Overall Study|Adverse Event|13|||
162052037|NCT00289991|585247600|FG000|Overall Study|Failure of prophylaxis|1|||
162052038|NCT00289991|585247601|FG001|Overall Study|Failure of prophylaxis|1|||
162052039|NCT00289991|585247600|FG000|Overall Study|Fungal breakthrough infection|0|||
162052040|NCT00289991|585247601|FG001|Overall Study|Fungal breakthrough infection|1|||
162052041|NCT00289991|585247600|FG000|Overall Study|Lost to Follow-up|0|||
162052042|NCT00289991|585247601|FG001|Overall Study|Lost to Follow-up|1|||
162052043|NCT00289991|585247600|FG000|Overall Study|Withdrawal by Subject|2|||
162052044|NCT00289991|585247601|FG001|Overall Study|Withdrawal by Subject|12|||
162052045|NCT00289991|585247600|FG000|Overall Study|Other|5|||
162052046|NCT00289991|585247601|FG001|Overall Study|Other|14|||
162052047|NCT01091974|585247602|FG000|Overall Study|Did not start intervention|3|||
162052048|NCT01091974|585247603|FG001|Overall Study|Did not start intervention|1|||
162052049|NCT01091974|585247604|FG002|Overall Study|Did not start intervention|3|||
162052050|NCT01091974|585247605|FG003|Overall Study|Did not start intervention|1|||
162052051|NCT01091974|585247602|FG000|Overall Study|resumed sleep medication|0|||
162052052|NCT01091974|585247603|FG001|Overall Study|resumed sleep medication|0|||
162052053|NCT01091974|585247604|FG002|Overall Study|resumed sleep medication|1|||
162052054|NCT01091974|585247605|FG003|Overall Study|resumed sleep medication|2|||
162052055|NCT01091974|585247602|FG000|Overall Study|Withdrawal by Subject|1|||
162052056|NCT01091974|585247603|FG001|Overall Study|Withdrawal by Subject|3|||
162052057|NCT01091974|585247604|FG002|Overall Study|Withdrawal by Subject|2|||
162052058|NCT01091974|585247605|FG003|Overall Study|Withdrawal by Subject|2|||
162052059|NCT01091974|585247602|FG000|Overall Study|side-effects|1|||
162052060|NCT01091974|585247603|FG001|Overall Study|side-effects|1|||
162052061|NCT01091974|585247604|FG002|Overall Study|side-effects|0|||
162052062|NCT01091974|585247605|FG003|Overall Study|side-effects|2|||
162052063|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
162052064|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
162052065|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
162052066|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
162052067|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
162052068|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
162052069|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
162052070|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
162052071|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
162052072|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
162052073|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
162052074|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
162052075|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
162052076|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
162052077|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
162052078|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
162052079|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
162052080|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
162052081|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
162052082|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
162052083|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
162052084|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
162052085|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
162052086|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
162052087|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
162052088|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
162052089|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
162052090|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
162052091|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
162052092|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
162052093|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
162052094|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
162052095|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
162052096|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
162052097|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
162052098|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
162052099|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
162052100|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
162052101|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
162052102|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
162052103|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
162052104|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
162052105|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
162052106|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
162052107|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
162052108|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
162052109|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
162052110|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
162052111|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
162052112|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
162052113|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
162052114|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
162052115|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
162052116|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
162052117|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
162052118|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
162052119|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
162052120|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
162052121|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
162052122|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
162052123|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
162052124|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
162052125|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
162052126|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
162052127|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
162052128|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
162052129|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
162052130|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
162052131|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
162052132|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
162052133|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Change of location|0|||
162052134|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Change of location|0|||
162052135|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Change of location|0|||
162052136|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Change of location|1|||
162052137|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Change of location|0|||
162052138|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
162052139|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
162052140|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
162052141|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
162052142|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
162052143|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
162052144|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
162052145|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
162052146|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
162052147|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
162052148|NCT00730405|585247609|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
162052149|NCT00730405|585247610|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
162052150|NCT00730405|585247611|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
162052151|NCT00730405|585247612|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
162052152|NCT00730405|585247613|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
162052153|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
162052154|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
162052155|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
162052156|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
162052157|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
162052158|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
162052159|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
162052160|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
162052161|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
162052162|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
162052163|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
162052164|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
162052165|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
162052166|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
162052167|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
162052168|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Death|0|||
162052169|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Death|1|||
162052170|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Death|0|||
162052171|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Death|1|||
162052172|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Death|0|||
162052173|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Change of location|1|||
162052174|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Change of location|1|||
162052175|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Change of location|0|||
162052176|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Change of location|1|||
162052177|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Change of location|0|||
162052178|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
162052179|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
162052180|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
162052181|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
162052182|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
162052183|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
162052184|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
162052185|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
162052186|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
162052187|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
162052188|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
162052189|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
162052190|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
162052191|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
162052192|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
162052193|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
162052194|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
162052195|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
162052196|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
162052197|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
162052198|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
162052199|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
162052200|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
162122661|NCT00406419|585500294|FG002|Overall Study|Adverse Event|16|||
162052201|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
162052202|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
162052203|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
162052204|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
162052205|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
162052206|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
162052207|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
162052208|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
162052209|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
162052210|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
162052211|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
162052212|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
162052213|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
162052214|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
162052215|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
162052216|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
162052217|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
162052218|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
162052219|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
162052220|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
162052221|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
162052222|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
162052223|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
162052224|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
162052225|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
162052226|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
162052227|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
162052228|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Missing|0|||
162052229|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Missing|0|||
162052230|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Missing|2|||
162052231|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Missing|0|||
162052232|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Missing|0|||
162052233|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
162052234|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
162052235|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
162052236|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
162052237|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
162052238|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
162052239|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
162052240|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
162052241|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
162052242|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
162052243|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
162052244|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
162052245|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
162052246|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
162052247|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
162052248|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
162052249|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
162052250|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
162052251|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
162052252|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
162052253|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
162052254|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
162052255|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
162052256|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
162052257|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
162052258|NCT00730405|585247609|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
162052259|NCT00730405|585247610|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
162052260|NCT00730405|585247611|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
162052261|NCT00730405|585247612|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
162052262|NCT00730405|585247613|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
162052263|NCT01496807|585247614|FG000|Overall Study|Progressive Disease|21|||
162052264|NCT01496807|585247614|FG000|Overall Study|Participant preference/toxicity|8|||
162052265|NCT01496807|585247614|FG000|Overall Study|Change in diagnosis|1|||
162052266|NCT03330288|585247617|FG000|Overall Study|Other reason|1|||
162052267|NCT03330288|585247618|FG001|Overall Study|Other reason|1|||
162052268|NCT03330288|585247617|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
162052269|NCT03330288|585247618|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
162052270|NCT03330288|585247617|FG000|Overall Study|Adverse Event|1|||
162052271|NCT03330288|585247618|FG001|Overall Study|Adverse Event|0|||
162052272|NCT03330288|585247617|FG000|Overall Study|Withdrawal by Subject|1|||
162052273|NCT03330288|585247618|FG001|Overall Study|Withdrawal by Subject|0|||
162052274|NCT03330288|585247617|FG000|Overall Study|Lost to Follow-up|26|||
162052275|NCT03330288|585247618|FG001|Overall Study|Lost to Follow-up|7|||
162052276|NCT04447794|585247619|FG000|Overall Study|Lost to Follow-up|2|||
162052277|NCT04447794|585247620|FG001|Overall Study|Lost to Follow-up|3|||
162052278|NCT04447794|585247621|FG002|Overall Study|Lost to Follow-up|8|||
162052279|NCT04447794|585247619|FG000|Overall Study|Withdrawal by Subject|1|||
162052280|NCT04447794|585247620|FG001|Overall Study|Withdrawal by Subject|1|||
162052281|NCT04447794|585247621|FG002|Overall Study|Withdrawal by Subject|0|||
162052282|NCT00205881|585247626|FG000|Overall Study|Withdrawal by Subject|16|||
162052283|NCT04203498|585247629|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
162052284|NCT04203498|585247630|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
162052285|NCT04203498|585247629|FG000|Overall Study|Withdrawal of patient consent|7|||
162052286|NCT04203498|585247630|FG001|Overall Study|Withdrawal of patient consent|2|||
162052287|NCT04203498|585247629|FG000|Overall Study|Adverse Event|4|||
162052288|NCT04203498|585247630|FG001|Overall Study|Adverse Event|1|||
162052289|NCT04203498|585247629|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
162052290|NCT04203498|585247630|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
162052291|NCT04203498|585247629|FG000|Overall Study|Did not receive IMP|2|||
162052292|NCT04203498|585247630|FG001|Overall Study|Did not receive IMP|0|||
162052293|NCT00334958|585247632|FG000|Overall Study|Medication Noncompliance|0|||
162052294|NCT00334958|585247633|FG001|Overall Study|Medication Noncompliance|3|||
162052295|NCT00334958|585247632|FG000|Overall Study|Protocol Violation|2|||
162052296|NCT00334958|585247633|FG001|Overall Study|Protocol Violation|2|||
162052297|NCT00334958|585247632|FG000|Overall Study|Request of the investigator or sponsor|0|||
162052298|NCT00334958|585247633|FG001|Overall Study|Request of the investigator or sponsor|1|||
162052299|NCT00334958|585247632|FG000|Overall Study|Withdrawal by Subject|7|||
162052300|NCT00334958|585247633|FG001|Overall Study|Withdrawal by Subject|4|||
162052301|NCT00334958|585247632|FG000|Overall Study|Adverse Event|27|||
162052302|NCT00334958|585247633|FG001|Overall Study|Adverse Event|12|||
162052303|NCT00334958|585247632|FG000|Overall Study|Other|1|||
162052304|NCT00334958|585247633|FG001|Overall Study|Other|2|||
162052305|NCT01548287|585247634|FG000|Screening|No reason provided|0|||
162052306|NCT01548287|585247635|FG001|Screening|No reason provided|0|||
162052307|NCT01548287|585247636|FG002|Screening|No reason provided|0|||
162052308|NCT01548287|585247637|FG003|Screening|No reason provided|0|||
162052309|NCT01548287|585247638|FG004|Screening|No reason provided|9|||
162052310|NCT01548287|585247634|FG000|Screening|Did not meet eligibility criteria|0|||
162052311|NCT01548287|585247635|FG001|Screening|Did not meet eligibility criteria|0|||
162052312|NCT01548287|585247636|FG002|Screening|Did not meet eligibility criteria|0|||
162052313|NCT01548287|585247637|FG003|Screening|Did not meet eligibility criteria|0|||
162052314|NCT01548287|585247638|FG004|Screening|Did not meet eligibility criteria|74|||
162052315|NCT01548287|585247634|FG000|Randomized Period|Did not meet inclusion criteria|0|||
162052316|NCT01548287|585247635|FG001|Randomized Period|Did not meet inclusion criteria|0|||
162052317|NCT01548287|585247636|FG002|Randomized Period|Did not meet inclusion criteria|2|||
162052318|NCT01548287|585247637|FG003|Randomized Period|Did not meet inclusion criteria|0|||
162052319|NCT01548287|585247638|FG004|Randomized Period|Did not meet inclusion criteria|0|||
162052320|NCT01548287|585247634|FG000|Randomized Period|Adverse Event|0|||
162052321|NCT01548287|585247635|FG001|Randomized Period|Adverse Event|2|||
162052322|NCT01548287|585247636|FG002|Randomized Period|Adverse Event|5|||
162052323|NCT01548287|585247637|FG003|Randomized Period|Adverse Event|0|||
162052324|NCT01548287|585247638|FG004|Randomized Period|Adverse Event|0|||
162052325|NCT02762578|585247643|FG000|Overall Study|Adverse Event|1|||
162052326|NCT02762578|585247644|FG001|Overall Study|Adverse Event|6|||
162052327|NCT02762578|585247643|FG000|Overall Study|Protocol Violation|4|||
162052328|NCT02762578|585247644|FG001|Overall Study|Protocol Violation|2|||
162052329|NCT02762578|585247643|FG000|Overall Study|Withdrawal by Subject|4|||
162052330|NCT02762578|585247644|FG001|Overall Study|Withdrawal by Subject|2|||
162052331|NCT02762578|585247643|FG000|Overall Study|Unclassified|6|||
162052332|NCT02762578|585247644|FG001|Overall Study|Unclassified|0|||
162052333|NCT01090492|585247645|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
162052334|NCT01090492|585247646|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
162052335|NCT01090492|585247647|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
162052336|NCT01090492|585247648|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
162052337|NCT01090492|585247649|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
162052338|NCT01090492|585247650|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
162052339|NCT01090492|585247651|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
162052340|NCT01090492|585247652|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
162052341|NCT01090492|585247645|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
162052342|NCT01090492|585247646|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
162052343|NCT01090492|585247647|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
162052344|NCT01090492|585247648|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
162052345|NCT01090492|585247649|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
162052346|NCT01090492|585247650|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
162052347|NCT01090492|585247651|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
162052348|NCT01090492|585247652|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
162052349|NCT01090492|585247645|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052350|NCT01090492|585247646|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052351|NCT01090492|585247647|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
162052352|NCT01090492|585247648|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052353|NCT01090492|585247649|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052354|NCT01090492|585247650|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052355|NCT01090492|585247651|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052356|NCT01090492|585247652|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052357|NCT01090492|585247645|FG000|First Intervention Period (4 Weeks)|Other|0|||
162052358|NCT01090492|585247646|FG001|First Intervention Period (4 Weeks)|Other|0|||
162052359|NCT01090492|585247647|FG002|First Intervention Period (4 Weeks)|Other|1|||
162052360|NCT01090492|585247648|FG003|First Intervention Period (4 Weeks)|Other|1|||
162052361|NCT01090492|585247649|FG004|First Intervention Period (4 Weeks)|Other|2|||
162052362|NCT01090492|585247650|FG005|First Intervention Period (4 Weeks)|Other|0|||
162052363|NCT01090492|585247651|FG006|First Intervention Period (4 Weeks)|Other|0|||
162052364|NCT01090492|585247652|FG007|First Intervention Period (4 Weeks)|Other|0|||
162052365|NCT01090492|585247645|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
162052366|NCT01090492|585247646|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
162052367|NCT01090492|585247647|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
162052368|NCT01090492|585247648|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
162052369|NCT01090492|585247649|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
162052370|NCT01090492|585247650|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
162052371|NCT01090492|585247651|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
162052372|NCT01090492|585247652|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
162052373|NCT01090492|585247645|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
162052374|NCT01090492|585247646|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
162052375|NCT01090492|585247647|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
162052376|NCT01090492|585247648|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
162052377|NCT01090492|585247649|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
162052378|NCT01090492|585247650|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
162052379|NCT01090492|585247651|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
162052380|NCT01090492|585247652|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
162052381|NCT01090492|585247645|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
162052382|NCT01090492|585247646|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
162052383|NCT01090492|585247647|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
162052384|NCT01090492|585247648|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
162052385|NCT01090492|585247649|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
162052386|NCT01090492|585247650|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
162052387|NCT01090492|585247651|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
162052388|NCT01090492|585247652|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
162052389|NCT01090492|585247645|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162052390|NCT01090492|585247646|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
162052391|NCT01090492|585247647|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162052392|NCT01090492|585247648|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162052393|NCT01090492|585247649|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162052394|NCT01090492|585247650|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162052395|NCT01090492|585247651|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162052396|NCT01090492|585247652|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
162052397|NCT01090492|585247645|FG000|Second Intervention Period (4 Weeks)|Other|0|||
162052398|NCT01090492|585247646|FG001|Second Intervention Period (4 Weeks)|Other|1|||
162052399|NCT01090492|585247647|FG002|Second Intervention Period (4 Weeks)|Other|1|||
162052400|NCT01090492|585247648|FG003|Second Intervention Period (4 Weeks)|Other|0|||
162052401|NCT01090492|585247649|FG004|Second Intervention Period (4 Weeks)|Other|0|||
162052402|NCT01090492|585247650|FG005|Second Intervention Period (4 Weeks)|Other|0|||
162052403|NCT01090492|585247651|FG006|Second Intervention Period (4 Weeks)|Other|0|||
162052404|NCT01090492|585247652|FG007|Second Intervention Period (4 Weeks)|Other|0|||
162052405|NCT01090492|585247645|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
162052406|NCT01090492|585247646|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
162052407|NCT01090492|585247647|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
162052408|NCT01090492|585247648|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
162052409|NCT01090492|585247649|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
162052410|NCT01090492|585247650|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
162052411|NCT01090492|585247651|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
162052412|NCT01090492|585247652|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
162052413|NCT01090492|585247645|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052414|NCT01090492|585247646|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052415|NCT01090492|585247647|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052416|NCT01090492|585247648|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052417|NCT01090492|585247649|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052418|NCT01090492|585247650|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052419|NCT01090492|585247651|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
162052420|NCT01090492|585247652|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
162052421|NCT02083965|585247653|FG000|Treatment Period|Other|1|||
162052422|NCT02083965|585247654|FG001|Treatment Period|Other|0|||
162052423|NCT00911547|585247656|FG000|Overall Study|Adverse Event|8|||
162052424|NCT00911547|585247657|FG001|Overall Study|Adverse Event|27|||
162052425|NCT00911547|585247658|FG002|Overall Study|Adverse Event|11|||
162052426|NCT00911547|585247659|FG003|Overall Study|Adverse Event|6|||
162052427|NCT00911547|585247656|FG000|Overall Study|Lost to Follow-up|0|||
162052428|NCT00911547|585247657|FG001|Overall Study|Lost to Follow-up|0|||
162052429|NCT00911547|585247658|FG002|Overall Study|Lost to Follow-up|2|||
162052430|NCT00911547|585247659|FG003|Overall Study|Lost to Follow-up|1|||
162052431|NCT00911547|585247656|FG000|Overall Study|Protocol Violation|0|||
162052432|NCT00911547|585247657|FG001|Overall Study|Protocol Violation|5|||
162052433|NCT00911547|585247658|FG002|Overall Study|Protocol Violation|5|||
162052434|NCT00911547|585247659|FG003|Overall Study|Protocol Violation|1|||
162052435|NCT00911547|585247656|FG000|Overall Study|Withdrawal by Subject|3|||
162052436|NCT00911547|585247657|FG001|Overall Study|Withdrawal by Subject|10|||
162052437|NCT00911547|585247658|FG002|Overall Study|Withdrawal by Subject|4|||
162052438|NCT00911547|585247659|FG003|Overall Study|Withdrawal by Subject|8|||
162052439|NCT03583697|585247662|FG000|Overall Study|Withdrawal by Subject|0|||
162052440|NCT03583697|585247663|FG001|Overall Study|Withdrawal by Subject|0|||
162052441|NCT03583697|585247664|FG002|Overall Study|Withdrawal by Subject|1|||
162052442|NCT03583697|585247662|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
162052443|NCT03583697|585247663|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
162052444|NCT03583697|585247664|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
162052445|NCT00365508|585247665|FG000|Overall Study|Lost to Follow-up|139|||
162052446|NCT00365508|585247666|FG001|Overall Study|Lost to Follow-up|154|||
162052447|NCT00404235|585247669|FG000|Overall Study|Withdrawal by Subject|1|||
162052448|NCT00404235|585247670|FG001|Overall Study|Withdrawal by Subject|2|||
162052449|NCT00679432|585247671|FG000|Overall Study|Adverse Event|5|||
162052450|NCT00679432|585247672|FG001|Overall Study|Adverse Event|6|||
162052451|NCT00679432|585247673|FG002|Overall Study|Adverse Event|10|||
162052452|NCT00679432|585247674|FG003|Overall Study|Adverse Event|7|||
162052453|NCT00679432|585247671|FG000|Overall Study|Protocol Violation|1|||
162052454|NCT00679432|585247672|FG001|Overall Study|Protocol Violation|1|||
162052455|NCT00679432|585247673|FG002|Overall Study|Protocol Violation|2|||
162052456|NCT00679432|585247674|FG003|Overall Study|Protocol Violation|1|||
162052457|NCT00679432|585247671|FG000|Overall Study|Withdrawal by Subject|8|||
162052458|NCT00679432|585247672|FG001|Overall Study|Withdrawal by Subject|11|||
162052459|NCT00679432|585247673|FG002|Overall Study|Withdrawal by Subject|10|||
162052460|NCT00679432|585247674|FG003|Overall Study|Withdrawal by Subject|9|||
162052461|NCT00679432|585247671|FG000|Overall Study|Lost to Follow-up|1|||
162052462|NCT00679432|585247672|FG001|Overall Study|Lost to Follow-up|5|||
162052463|NCT00679432|585247673|FG002|Overall Study|Lost to Follow-up|4|||
162052464|NCT00679432|585247674|FG003|Overall Study|Lost to Follow-up|2|||
162052465|NCT00679432|585247671|FG000|Overall Study|Physician Decision|3|||
162052466|NCT00679432|585247672|FG001|Overall Study|Physician Decision|2|||
162052467|NCT00679432|585247673|FG002|Overall Study|Physician Decision|2|||
162052468|NCT00679432|585247674|FG003|Overall Study|Physician Decision|2|||
162052469|NCT00679432|585247671|FG000|Overall Study|Sponsor decision|1|||
162052470|NCT00679432|585247672|FG001|Overall Study|Sponsor decision|0|||
162052471|NCT00679432|585247673|FG002|Overall Study|Sponsor decision|0|||
162052472|NCT00679432|585247674|FG003|Overall Study|Sponsor decision|0|||
162052473|NCT00679432|585247671|FG000|Overall Study|Lack of Efficacy|13|||
162052474|NCT00679432|585247672|FG001|Overall Study|Lack of Efficacy|9|||
162052475|NCT00679432|585247673|FG002|Overall Study|Lack of Efficacy|14|||
162052476|NCT00679432|585247674|FG003|Overall Study|Lack of Efficacy|8|||
162052477|NCT00679432|585247671|FG000|Overall Study|Infectious colitis, normal histology|5|||
162052478|NCT00679432|585247672|FG001|Overall Study|Infectious colitis, normal histology|4|||
162052479|NCT00679432|585247673|FG002|Overall Study|Infectious colitis, normal histology|8|||
162052480|NCT00679432|585247674|FG003|Overall Study|Infectious colitis, normal histology|3|||
162052481|NCT00679432|585247671|FG000|Overall Study|Randomization error, return to prior Rx|0|||
162052482|NCT00679432|585247672|FG001|Overall Study|Randomization error, return to prior Rx|0|||
162052483|NCT00679432|585247673|FG002|Overall Study|Randomization error, return to prior Rx|3|||
162052484|NCT00679432|585247674|FG003|Overall Study|Randomization error, return to prior Rx|0|||
162052485|NCT00824720|585247675|FG000|Overall Study|failed plug insertion|3|||
162052486|NCT00824720|585247676|FG001|Overall Study|failed plug insertion|1|||
162052487|NCT00824720|585247677|FG002|Overall Study|failed plug insertion|0|||
162052488|NCT00824720|585247675|FG000|Overall Study|Protocol Violation|0|||
162052489|NCT00824720|585247676|FG001|Overall Study|Protocol Violation|0|||
162052490|NCT00824720|585247677|FG002|Overall Study|Protocol Violation|1|||
162052491|NCT01558271|585247680|FG000|Overall Study|Adverse Event|6|||
162052492|NCT01558271|585247681|FG001|Overall Study|Adverse Event|3|||
162052493|NCT01558271|585247682|FG002|Overall Study|Adverse Event|4|||
162052494|NCT01558271|585247680|FG000|Overall Study|Lost to Follow-up|1|||
162052495|NCT01558271|585247681|FG001|Overall Study|Lost to Follow-up|0|||
162052496|NCT01558271|585247682|FG002|Overall Study|Lost to Follow-up|0|||
162052497|NCT01558271|585247680|FG000|Overall Study|Protocol Violation|1|||
162052498|NCT01558271|585247681|FG001|Overall Study|Protocol Violation|0|||
162052499|NCT01558271|585247682|FG002|Overall Study|Protocol Violation|0|||
162052500|NCT01558271|585247680|FG000|Overall Study|Withdrawal by Subject|10|||
162052501|NCT01558271|585247681|FG001|Overall Study|Withdrawal by Subject|6|||
162052502|NCT01558271|585247682|FG002|Overall Study|Withdrawal by Subject|12|||
162052503|NCT01558271|585247680|FG000|Overall Study|Physician Decision|0|||
162052504|NCT01558271|585247681|FG001|Overall Study|Physician Decision|2|||
162052505|NCT01558271|585247682|FG002|Overall Study|Physician Decision|1|||
162052506|NCT02610725|585247683|FG000|Overall Study|Lost to Follow-up|197|||
162052507|NCT02610725|585247683|FG000|Overall Study|self-reported contraindication|9|||
162052508|NCT04094883|585247684|FG000|Overall Study|Withdrawal by Subject|1|||
162052509|NCT00743483|585247685|FG000|Baseline Period|Physician Decision|1|||
162052510|NCT00743483|585247685|FG000|Treatment Period|Adverse Event|1|||
162052511|NCT01084083|585247686|FG000|Overall Study|Adverse Event|5|||
162052512|NCT01084083|585247686|FG000|Overall Study|Death|1|||
162052513|NCT01084083|585247686|FG000|Overall Study|Withdrawal by Subject|2|||
162052514|NCT01084083|585247686|FG000|Overall Study|Complicating disease|1|||
162052515|NCT01084083|585247686|FG000|Overall Study|Other|2|||
162052516|NCT01084083|585247686|FG000|Overall Study|Never started assigned therapy|1|||
162052517|NCT00873912|585247688|FG000|Overall Study|Withdrawal by Subject|1|||
162052518|NCT00873912|585247689|FG001|Overall Study|Withdrawal by Subject|0|||
162052519|NCT00873912|585247688|FG000|Overall Study|Lost to Follow-up|2|||
162052520|NCT00873912|585247689|FG001|Overall Study|Lost to Follow-up|0|||
162052521|NCT05570500|585247692|FG000|Overall Study|Lost to Follow-up|7|||
162052522|NCT05570500|585247693|FG001|Overall Study|Lost to Follow-up|5|||
162052523|NCT04731363|585247697|FG000|Overall Study|Could not obtain samples|0|||
162052524|NCT04731363|585247698|FG001|Overall Study|Could not obtain samples|1|||
162052525|NCT04731363|585247699|FG002|Overall Study|Could not obtain samples|0|||
162052526|NCT04731363|585247700|FG003|Overall Study|Could not obtain samples|0|||
162052527|NCT04731363|585247697|FG000|Overall Study|Physician Decision|0|||
162052528|NCT04731363|585247698|FG001|Overall Study|Physician Decision|1|||
162052529|NCT04731363|585247699|FG002|Overall Study|Physician Decision|0|||
162052530|NCT04731363|585247700|FG003|Overall Study|Physician Decision|0|||
162052531|NCT00982137|585249455|FG000|Overall Study|Lost to Follow-up|0|||
162052532|NCT00982137|585249456|FG001|Overall Study|Lost to Follow-up|0|||
162052533|NCT00982137|585249457|FG002|Overall Study|Lost to Follow-up|0|||
162052534|NCT00982137|585249458|FG003|Overall Study|Lost to Follow-up|1|||
162052535|NCT00982137|585249455|FG000|Overall Study|Withdrawal by Subject|0|||
162052536|NCT00982137|585249456|FG001|Overall Study|Withdrawal by Subject|1|||
162052537|NCT00982137|585249457|FG002|Overall Study|Withdrawal by Subject|0|||
162052538|NCT00982137|585249458|FG003|Overall Study|Withdrawal by Subject|0|||
162052539|NCT00126191|585249459|FG000|Overall Study|Physician Decision|0|||
162052540|NCT00126191|585249460|FG001|Overall Study|Physician Decision|1|||
162052541|NCT00126191|585249459|FG000|Overall Study|Death|0|||
162052542|NCT00126191|585249460|FG001|Overall Study|Death|1|||
162052543|NCT00674700|585249472|FG000|Year 1|Adverse Event|17|||
162052544|NCT00674700|585249473|FG001|Year 1|Adverse Event|20|||
162052545|NCT00674700|585249474|FG002|Year 1|Adverse Event|5|||
162052546|NCT00674700|585249472|FG000|Year 1|Withdrawal by Subject|7|||
162052547|NCT00674700|585249473|FG001|Year 1|Withdrawal by Subject|7|||
162052548|NCT00674700|585249474|FG002|Year 1|Withdrawal by Subject|6|||
162052549|NCT00674700|585249472|FG000|Year 1|Any other reason not above-mentioned|7|||
162052550|NCT00674700|585249473|FG001|Year 1|Any other reason not above-mentioned|7|||
162052551|NCT00674700|585249474|FG002|Year 1|Any other reason not above-mentioned|6|||
162052552|NCT00674700|585249472|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
162052553|NCT00674700|585249473|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
162052554|NCT00674700|585249474|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
162052555|NCT00674700|585249472|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
162052556|NCT00674700|585249473|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
162052557|NCT00674700|585249474|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
162052558|NCT00674700|585249472|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
162052559|NCT00674700|585249473|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
162052560|NCT00674700|585249474|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
162052561|NCT00691015|585249479|FG000|Overall Study|Refused further treatment|1|||
162052562|NCT00867568|585249480|FG000|Overall Study|Lack of Efficacy|10|||
162052563|NCT00867568|585249480|FG000|Overall Study|Adverse Event|4|||
162052564|NCT00867568|585249480|FG000|Overall Study|Withdrawal by Subject|1|||
162052565|NCT01056653|585249481|FG000|Overall Study|Lost to Follow-up|0|||
162052566|NCT01056653|585249482|FG001|Overall Study|Lost to Follow-up|0|||
162052567|NCT01056653|585249483|FG002|Overall Study|Lost to Follow-up|2|||
162052568|NCT05275400|585249484|FG000|Treatment Period|Adverse Event|7|||
162052569|NCT05275400|585249485|FG001|Treatment Period|Adverse Event|1|||
162052570|NCT05275400|585249484|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
162052571|NCT05275400|585249485|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
162052572|NCT05275400|585249484|FG000|Treatment Period|Death|5|||
162052573|NCT05275400|585249485|FG001|Treatment Period|Death|2|||
162052574|NCT05275400|585249484|FG000|Treatment Period|Protocol Violation|1|||
162052575|NCT05275400|585249485|FG001|Treatment Period|Protocol Violation|0|||
162052576|NCT05275400|585249484|FG000|Treatment Period|Physician Decision|5|||
162052577|NCT05275400|585249485|FG001|Treatment Period|Physician Decision|4|||
162052578|NCT05275400|585249484|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
162052579|NCT05275400|585249485|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
162052580|NCT05275400|585249484|FG000|Treatment Period|Withdrawal by Subject|30|||
162052581|NCT05275400|585249485|FG001|Treatment Period|Withdrawal by Subject|12|||
162052582|NCT05275400|585249484|FG000|Treatment Period|Lost to Follow-up|1|||
162052583|NCT05275400|585249485|FG001|Treatment Period|Lost to Follow-up|5|||
162052584|NCT05275400|585249484|FG000|Treatment Period|Lack of Efficacy|1|||
162052585|NCT05275400|585249485|FG001|Treatment Period|Lack of Efficacy|0|||
162052586|NCT05275400|585249484|FG000|Treatment Period|Sponsor Decision|1|||
162052587|NCT05275400|585249485|FG001|Treatment Period|Sponsor Decision|0|||
162052588|NCT05275400|585249484|FG000|Follow-Up Period|Death|2|||
162052589|NCT05275400|585249485|FG001|Follow-Up Period|Death|0|||
162052590|NCT05275400|585249484|FG000|Follow-Up Period|Protocol Violation|1|||
162052591|NCT05275400|585249485|FG001|Follow-Up Period|Protocol Violation|0|||
162052592|NCT05275400|585249484|FG000|Follow-Up Period|Withdrawal by Subject|3|||
162052593|NCT05275400|585249485|FG001|Follow-Up Period|Withdrawal by Subject|0|||
162052594|NCT02585960|585249486|FG000|PK/Safety Assessment Period|Physician Decision|0|||
162052595|NCT02585960|585249487|FG001|PK/Safety Assessment Period|Physician Decision|1|||
162052596|NCT02585960|585249488|FG002|PK/Safety Assessment Period|Physician Decision|0|||
162052597|NCT02585960|585249486|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
162052598|NCT02585960|585249487|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
162052599|NCT02585960|585249488|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
162052600|NCT02585960|585249486|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
162052601|NCT02585960|585249487|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
162052602|NCT02585960|585249488|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
162052603|NCT02585960|585249486|FG000|PK/Safety Assessment Period|Other|4|||
162052604|NCT02585960|585249487|FG001|PK/Safety Assessment Period|Other|4|||
162052605|NCT02585960|585249488|FG002|PK/Safety Assessment Period|Other|0|||
162052606|NCT02585960|585249486|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
162052607|NCT02585960|585249487|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
162052608|NCT02585960|585249488|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
162052609|NCT02585960|585249486|FG000|PK/Safety Assessment Period|Screen Failure|0|||
162052610|NCT02585960|585249487|FG001|PK/Safety Assessment Period|Screen Failure|0|||
162052611|NCT02585960|585249488|FG002|PK/Safety Assessment Period|Screen Failure|1|||
162052612|NCT02585960|585249486|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
162052613|NCT02585960|585249487|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
162052614|NCT02585960|585249488|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
162052615|NCT02585960|585249486|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
162052616|NCT02585960|585249487|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
162052617|NCT02585960|585249488|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
162052618|NCT06333613|585249489|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
162052619|NCT01847274|585249490|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
162052620|NCT01847274|585249491|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
162052621|NCT01847274|585249492|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
162052622|NCT01847274|585249493|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
162052623|NCT01847274|585249494|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162052624|NCT01847274|585249495|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162052625|NCT01847274|585249496|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162052626|NCT01847274|585249497|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162052627|NCT01847274|585249498|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162052628|NCT01847274|585249499|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162052629|NCT01847274|585249500|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
162052630|NCT01847274|585249490|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
162052631|NCT01847274|585249491|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
162052632|NCT01847274|585249492|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
162052633|NCT01847274|585249493|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
162052634|NCT01847274|585249494|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162052635|NCT01847274|585249495|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162052636|NCT01847274|585249496|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162052637|NCT01847274|585249497|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162052638|NCT01847274|585249498|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162052639|NCT01847274|585249499|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162052640|NCT01847274|585249500|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
162052641|NCT01847274|585249490|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
162052642|NCT01847274|585249491|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
162052643|NCT01847274|585249492|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
162052644|NCT01847274|585249493|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
162052645|NCT01847274|585249494|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162052646|NCT01847274|585249495|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162052647|NCT01847274|585249496|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162052648|NCT01847274|585249497|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162052649|NCT01847274|585249498|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162052650|NCT01847274|585249499|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162052651|NCT01847274|585249500|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
162052652|NCT01847274|585249490|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162052653|NCT01847274|585249491|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162052654|NCT01847274|585249492|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162052655|NCT01847274|585249493|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
162052656|NCT01847274|585249494|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162052657|NCT01847274|585249495|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162052658|NCT01847274|585249496|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162052659|NCT01847274|585249497|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162052660|NCT01847274|585249498|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162052661|NCT01847274|585249499|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162052662|NCT01847274|585249500|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
162052663|NCT01847274|585249490|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
162052664|NCT01847274|585249491|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
162052665|NCT01847274|585249492|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
162052666|NCT01847274|585249493|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
162052667|NCT01847274|585249494|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162052668|NCT01847274|585249495|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162052669|NCT01847274|585249496|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162052670|NCT01847274|585249497|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162052671|NCT01847274|585249498|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162052672|NCT01847274|585249499|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162052673|NCT01847274|585249500|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
162052674|NCT01847274|585249490|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
162052675|NCT01847274|585249491|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
162052676|NCT01847274|585249492|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
162052677|NCT01847274|585249493|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
162052678|NCT01847274|585249494|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162052679|NCT01847274|585249495|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162052680|NCT01847274|585249496|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162052681|NCT01847274|585249497|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162052682|NCT01847274|585249498|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162052683|NCT01847274|585249499|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162052684|NCT01847274|585249500|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
162052685|NCT01847274|585249490|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
162052686|NCT01847274|585249491|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
162052687|NCT01847274|585249492|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
162052688|NCT01847274|585249493|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
162052689|NCT01847274|585249494|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162052690|NCT01847274|585249495|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162052691|NCT01847274|585249496|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162052692|NCT01847274|585249497|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162052693|NCT01847274|585249498|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162052694|NCT01847274|585249499|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162052695|NCT01847274|585249500|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
162052696|NCT01847274|585249490|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162052697|NCT01847274|585249491|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162052698|NCT01847274|585249492|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162052699|NCT01847274|585249493|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162052700|NCT01847274|585249494|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162052701|NCT01847274|585249495|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
162052702|NCT01847274|585249496|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162052703|NCT01847274|585249497|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162052704|NCT01847274|585249498|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162052705|NCT01847274|585249499|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162052706|NCT01847274|585249500|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
162052707|NCT01847274|585249490|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162052708|NCT01847274|585249491|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162052709|NCT01847274|585249492|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162052710|NCT01847274|585249493|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162052711|NCT01847274|585249494|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
162052712|NCT01847274|585249495|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162052713|NCT01847274|585249496|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162052714|NCT01847274|585249497|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162052715|NCT01847274|585249498|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162052716|NCT01847274|585249499|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162052717|NCT01847274|585249500|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
162052718|NCT01847274|585249490|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162052719|NCT01847274|585249491|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162052720|NCT01847274|585249492|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162052721|NCT01847274|585249493|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162052722|NCT01847274|585249494|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162052723|NCT01847274|585249495|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162052724|NCT01847274|585249496|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
162052725|NCT01847274|585249497|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162052726|NCT01847274|585249498|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162052727|NCT01847274|585249499|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162052728|NCT01847274|585249500|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
162052729|NCT01847274|585249490|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162052730|NCT01847274|585249491|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162052731|NCT01847274|585249492|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162052732|NCT01847274|585249493|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162052733|NCT01847274|585249494|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162052734|NCT01847274|585249495|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162052735|NCT01847274|585249496|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
162052736|NCT01847274|585249497|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162052737|NCT01847274|585249498|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162052738|NCT01847274|585249499|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162052739|NCT01847274|585249500|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
162052740|NCT01847274|585249490|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162052741|NCT01847274|585249491|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162052742|NCT01847274|585249492|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162052743|NCT01847274|585249493|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162052744|NCT01847274|585249494|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162052745|NCT01847274|585249495|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162052746|NCT01847274|585249496|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
162052747|NCT01847274|585249497|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162052748|NCT01847274|585249498|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162052749|NCT01847274|585249499|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162052750|NCT01847274|585249500|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
162052751|NCT01847274|585249490|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162052752|NCT01847274|585249491|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162052753|NCT01847274|585249492|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162052754|NCT01847274|585249493|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162052755|NCT01847274|585249494|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162052756|NCT01847274|585249495|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162052757|NCT01847274|585249496|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
162052758|NCT01847274|585249497|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
162052759|NCT01847274|585249498|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
162052760|NCT01847274|585249499|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
162052761|NCT01847274|585249500|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
162052762|NCT01847274|585249490|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162052763|NCT01847274|585249491|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162052764|NCT01847274|585249492|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162052765|NCT01847274|585249493|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162052766|NCT01847274|585249494|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162052767|NCT01847274|585249495|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162052768|NCT01847274|585249496|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162052769|NCT01847274|585249497|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
162052770|NCT01847274|585249498|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162052771|NCT01847274|585249499|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
162052772|NCT01847274|585249500|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
162052773|NCT01847274|585249490|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162052774|NCT01847274|585249491|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162052775|NCT01847274|585249492|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162052776|NCT01847274|585249493|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162052777|NCT01847274|585249494|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162052778|NCT01847274|585249495|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162052779|NCT01847274|585249496|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162052780|NCT01847274|585249497|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
162052781|NCT01847274|585249498|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
162052782|NCT01847274|585249499|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
162052783|NCT01847274|585249500|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
162052784|NCT01847274|585249490|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162052785|NCT01847274|585249491|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162052786|NCT01847274|585249492|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162052787|NCT01847274|585249493|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162052788|NCT01847274|585249494|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162052789|NCT01847274|585249495|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162052790|NCT01847274|585249496|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162052791|NCT01847274|585249497|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162052792|NCT01847274|585249498|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162052793|NCT01847274|585249499|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
162052794|NCT01847274|585249500|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
162052795|NCT03727230|585249501|FG000|Overall Study|Lost to Follow-up|12|||
162052796|NCT01706146|585249502|FG000|Overall Study|Withdrawal by Subject|1|||
162052797|NCT01706146|585249502|FG000|Overall Study|Adverse Event|3|||
162052798|NCT01706146|585249502|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
162052799|NCT02059395|585249504|FG000|Overall Study|Lost to Follow-up|2|||
162052800|NCT02059395|585249505|FG001|Overall Study|Lost to Follow-up|4|||
162052801|NCT05209360|585249506|FG000|Overall Study|Withdrawal by Subject|0|||
162052802|NCT05209360|585249507|FG001|Overall Study|Withdrawal by Subject|0|||
162052803|NCT05209360|585249508|FG002|Overall Study|Withdrawal by Subject|1|||
162052804|NCT05209360|585249509|FG003|Overall Study|Withdrawal by Subject|0|||
162052805|NCT05209360|585249510|FG004|Overall Study|Withdrawal by Subject|0|||
162052806|NCT05209360|585249511|FG005|Overall Study|Withdrawal by Subject|0|||
162052807|NCT02021331|585249514|FG000|Overall Study|Adverse Event|0|||
162052808|NCT02021331|585249515|FG001|Overall Study|Adverse Event|2|||
162052809|NCT01488370|585249516|FG000|Overall Study|Protocol Violation|0|||
162052810|NCT01488370|585249517|FG001|Overall Study|Protocol Violation|1|||
162052811|NCT01488370|585249518|FG002|Overall Study|Protocol Violation|1|||
162052812|NCT02340975|585249532|FG000|Overall Study|Death|6|||
162052813|NCT02340975|585249533|FG001|Overall Study|Death|23|||
162052814|NCT02340975|585249534|FG002|Overall Study|Death|21|||
162052815|NCT02340975|585249535|FG003|Overall Study|Death|7|||
162052816|NCT02340975|585249536|FG004|Overall Study|Death|21|||
162052817|NCT02340975|585249537|FG005|Overall Study|Death|13|||
162052818|NCT02340975|585249532|FG000|Overall Study|Lost to Follow-up|0|||
162052819|NCT02340975|585249533|FG001|Overall Study|Lost to Follow-up|0|||
162052820|NCT02340975|585249534|FG002|Overall Study|Lost to Follow-up|0|||
162052821|NCT02340975|585249535|FG003|Overall Study|Lost to Follow-up|0|||
162052822|NCT02340975|585249536|FG004|Overall Study|Lost to Follow-up|2|||
162052823|NCT02340975|585249537|FG005|Overall Study|Lost to Follow-up|0|||
162052824|NCT02340975|585249532|FG000|Overall Study|Withdrawal by Subject|0|||
162052825|NCT02340975|585249533|FG001|Overall Study|Withdrawal by Subject|0|||
162052826|NCT02340975|585249534|FG002|Overall Study|Withdrawal by Subject|3|||
162052827|NCT02340975|585249535|FG003|Overall Study|Withdrawal by Subject|3|||
162052828|NCT02340975|585249536|FG004|Overall Study|Withdrawal by Subject|2|||
162052829|NCT02340975|585249537|FG005|Overall Study|Withdrawal by Subject|0|||
162052830|NCT02340975|585249532|FG000|Overall Study|Other|0|||
162052831|NCT02340975|585249533|FG001|Overall Study|Other|4|||
162052832|NCT02340975|585249534|FG002|Overall Study|Other|0|||
162052833|NCT02340975|585249535|FG003|Overall Study|Other|2|||
162052834|NCT02340975|585249536|FG004|Overall Study|Other|0|||
162052835|NCT02340975|585249537|FG005|Overall Study|Other|6|||
162052836|NCT01007812|585249540|FG000|Period 1, One Week|Lost to Follow-up|0|||
162052837|NCT01007812|585249541|FG001|Period 1, One Week|Lost to Follow-up|1|||
162052838|NCT01007812|585249540|FG000|Period 1, One Week|Discomfort|1|||
162052839|NCT01007812|585249541|FG001|Period 1, One Week|Discomfort|0|||
162052840|NCT03948581|585249542|FG000|Overall Study|Lost to Follow-up|0|||
162052841|NCT03948581|585249543|FG001|Overall Study|Lost to Follow-up|1|||
162052842|NCT03173313|585249544|FG000|Overall Study|Lost to Follow-up|2|||
162052843|NCT03173313|585249545|FG001|Overall Study|Lost to Follow-up|3|||
162052844|NCT03173313|585249544|FG000|Overall Study|Withdrawal by Subject|0|||
162052845|NCT03173313|585249545|FG001|Overall Study|Withdrawal by Subject|1|||
162052846|NCT03173313|585249544|FG000|Overall Study|Death|5|||
162052847|NCT03173313|585249545|FG001|Overall Study|Death|0|||
162052848|NCT03173313|585249544|FG000|Overall Study|Physician Decision|1|||
162052849|NCT03173313|585249545|FG001|Overall Study|Physician Decision|0|||
162052850|NCT03173313|585249544|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
162052851|NCT03173313|585249545|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
162052852|NCT03173313|585249544|FG000|Overall Study|Bone Fracture|1|||
162052853|NCT03173313|585249545|FG001|Overall Study|Bone Fracture|0|||
162052854|NCT01876420|585249546|FG000|Overall Study|Missed 30 day visit|1|||
162052855|NCT00963937|585249549|FG000|Overall Study|Protocol Violation|1|||
162052856|NCT00963937|585249550|FG001|Overall Study|Protocol Violation|1|||
162052857|NCT00963937|585249551|FG002|Overall Study|Protocol Violation|0|||
162052858|NCT00963937|585249549|FG000|Overall Study|Physician Decision|18|||
162052859|NCT00963937|585249550|FG001|Overall Study|Physician Decision|10|||
162052860|NCT00963937|585249551|FG002|Overall Study|Physician Decision|4|||
162052861|NCT02106975|585249552|FG000|Overall Study|Death|25|||
162052862|NCT02106975|585249553|FG001|Overall Study|Death|39|||
162052863|NCT00622401|585249554|FG000|Overall Study|Disease progression prior to treatment|3|||
162052864|NCT00622401|585249555|FG001|Overall Study|Disease progression prior to treatment|2|||
162052865|NCT00622401|585249556|FG002|Overall Study|Disease progression prior to treatment|0|||
162052866|NCT03546062|585249557|FG000|Overall Study|Adverse Event|6|||
162052867|NCT03546062|585249558|FG001|Overall Study|Adverse Event|5|||
162052868|NCT03546062|585249559|FG002|Overall Study|Adverse Event|8|||
162052869|NCT00181155|585249560|FG000|Overall Study|Physician Decision|1|||
162052870|NCT00181155|585249561|FG001|Overall Study|Physician Decision|0|||
162052871|NCT00181155|585249560|FG000|Overall Study|Withdrawal by Subject|1|||
162052872|NCT00181155|585249561|FG001|Overall Study|Withdrawal by Subject|0|||
162052873|NCT02572401|585249562|FG000|Overall Study|Lost to Follow-up|5|||
162052874|NCT02572401|585249563|FG001|Overall Study|Lost to Follow-up|8|||
162052875|NCT02572401|585249564|FG002|Overall Study|Lost to Follow-up|9|||
162052876|NCT02572401|585249565|FG003|Overall Study|Lost to Follow-up|9|||
162052877|NCT02572401|585249562|FG000|Overall Study|Death|0|||
162052878|NCT02572401|585249563|FG001|Overall Study|Death|0|||
162052879|NCT02572401|585249564|FG002|Overall Study|Death|0|||
162052880|NCT02572401|585249565|FG003|Overall Study|Death|1|||
162052881|NCT01768286|585249571|FG000|Overall Study|Randomized But Not Treated|0|||
162052882|NCT01768286|585249572|FG001|Overall Study|Randomized But Not Treated|0|||
162052883|NCT01768286|585249573|FG002|Overall Study|Randomized But Not Treated|1|||
162052884|NCT01768286|585249574|FG003|Overall Study|Randomized But Not Treated|0|||
162052885|NCT01768286|585249571|FG000|Overall Study|Lack of Efficacy|7|||
162052886|NCT01768286|585249572|FG001|Overall Study|Lack of Efficacy|4|||
162052887|NCT01768286|585249573|FG002|Overall Study|Lack of Efficacy|0|||
162052888|NCT01768286|585249574|FG003|Overall Study|Lack of Efficacy|1|||
162052889|NCT01768286|585249571|FG000|Overall Study|Withdrew Consent|0|||
162052890|NCT01768286|585249572|FG001|Overall Study|Withdrew Consent|0|||
162052891|NCT01768286|585249573|FG002|Overall Study|Withdrew Consent|1|||
162052892|NCT01768286|585249574|FG003|Overall Study|Withdrew Consent|0|||
162052893|NCT02243696|585249575|FG000|Overall Study|Death|282|||
162052894|NCT02243696|585249575|FG000|Overall Study|Withdrawal by Subject|79|||
162052895|NCT02243696|585249575|FG000|Overall Study|Lost to Follow-up|57|||
162052896|NCT02243696|585249575|FG000|Overall Study|Subject No Longer has Study System|42|||
162052897|NCT02243696|585249575|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
162052898|NCT02243696|585249575|FG000|Overall Study|Study Terminated for EP PASSION|961|||
162052899|NCT00622284|585249576|FG000|Overall Study|Lack of Efficacy|45|||
162052900|NCT00622284|585249577|FG001|Overall Study|Lack of Efficacy|15|||
162052901|NCT00622284|585249576|FG000|Overall Study|Adverse Event|61|||
162052902|NCT00622284|585249577|FG001|Overall Study|Adverse Event|90|||
162052903|NCT00622284|585249576|FG000|Overall Study|Protocol Violation|12|||
162052904|NCT00622284|585249577|FG001|Overall Study|Protocol Violation|5|||
162052905|NCT00622284|585249576|FG000|Overall Study|Lost to Follow-up|11|||
162052906|NCT00622284|585249577|FG001|Overall Study|Lost to Follow-up|13|||
162052907|NCT00622284|585249576|FG000|Overall Study|Withdrawal by Subject|27|||
162052908|NCT00622284|585249577|FG001|Overall Study|Withdrawal by Subject|24|||
162052909|NCT00622284|585249576|FG000|Overall Study|Other reason (not specified)|33|||
162052910|NCT00622284|585249577|FG001|Overall Study|Other reason (not specified)|24|||
162052911|NCT02935842|585249578|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
162052912|NCT02935842|585249579|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
162052913|NCT02935842|585249580|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
162052914|NCT02935842|585249581|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
162052915|NCT02935842|585249578|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
162052916|NCT02935842|585249579|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
162052917|NCT02935842|585249580|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
162052918|NCT02935842|585249581|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
162052919|NCT02935842|585249578|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
162052920|NCT02935842|585249579|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
162052921|NCT02935842|585249580|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
162052922|NCT02935842|585249581|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
162052923|NCT02935842|585249578|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
162052924|NCT02935842|585249579|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
162052925|NCT02935842|585249580|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
162052926|NCT02935842|585249581|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
162052927|NCT02935842|585249578|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
162052928|NCT02935842|585249579|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
162052929|NCT02935842|585249580|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
162052930|NCT02935842|585249581|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
162052931|NCT03344796|585249584|FG000|Overall Study|Lost to Follow-up|0|||
162052932|NCT03344796|585249585|FG001|Overall Study|Lost to Follow-up|0|||
162052933|NCT03344796|585249586|FG002|Overall Study|Lost to Follow-up|0|||
162052934|NCT03344796|585249587|FG003|Overall Study|Lost to Follow-up|0|||
162052935|NCT03344796|585249588|FG004|Overall Study|Lost to Follow-up|0|||
162052936|NCT03344796|585249589|FG005|Overall Study|Lost to Follow-up|2|||
162052937|NCT00915278|585249590|FG000|Overall Study|Death|1|||
162052938|NCT00915278|585249591|FG001|Overall Study|Death|0|||
162052939|NCT00915278|585249592|FG002|Overall Study|Death|0|||
162052940|NCT00915278|585249593|FG003|Overall Study|Death|0|||
162052941|NCT00915278|585249594|FG004|Overall Study|Death|0|||
162052942|NCT00915278|585249595|FG005|Overall Study|Death|0|||
162052943|NCT00915278|585249590|FG000|Overall Study|Lost to Follow-up|0|||
162052944|NCT00915278|585249591|FG001|Overall Study|Lost to Follow-up|1|||
162052945|NCT00915278|585249592|FG002|Overall Study|Lost to Follow-up|0|||
162052946|NCT00915278|585249593|FG003|Overall Study|Lost to Follow-up|0|||
162052947|NCT00915278|585249594|FG004|Overall Study|Lost to Follow-up|0|||
162052948|NCT00915278|585249595|FG005|Overall Study|Lost to Follow-up|0|||
162052949|NCT00915278|585249590|FG000|Overall Study|Withdrawal by Subject|0|||
162052950|NCT00915278|585249591|FG001|Overall Study|Withdrawal by Subject|1|||
162052951|NCT00915278|585249592|FG002|Overall Study|Withdrawal by Subject|0|||
162052952|NCT00915278|585249593|FG003|Overall Study|Withdrawal by Subject|0|||
162052953|NCT00915278|585249594|FG004|Overall Study|Withdrawal by Subject|1|||
162052954|NCT00915278|585249595|FG005|Overall Study|Withdrawal by Subject|4|||
162052955|NCT00915278|585249590|FG000|Overall Study|Adverse Event|4|||
162052956|NCT00915278|585249591|FG001|Overall Study|Adverse Event|1|||
162052957|NCT00915278|585249592|FG002|Overall Study|Adverse Event|0|||
162052958|NCT00915278|585249593|FG003|Overall Study|Adverse Event|0|||
162052959|NCT00915278|585249594|FG004|Overall Study|Adverse Event|0|||
162052960|NCT00915278|585249595|FG005|Overall Study|Adverse Event|0|||
162052961|NCT00915278|585249590|FG000|Overall Study|Progressive disease/clinical progression|0|||
162052962|NCT00915278|585249591|FG001|Overall Study|Progressive disease/clinical progression|0|||
162052963|NCT00915278|585249592|FG002|Overall Study|Progressive disease/clinical progression|0|||
162052964|NCT00915278|585249593|FG003|Overall Study|Progressive disease/clinical progression|3|||
162052965|NCT00915278|585249594|FG004|Overall Study|Progressive disease/clinical progression|1|||
162052966|NCT00915278|585249595|FG005|Overall Study|Progressive disease/clinical progression|2|||
162052967|NCT00915278|585249590|FG000|Overall Study|Infusion related AEs|0|||
162052968|NCT00915278|585249591|FG001|Overall Study|Infusion related AEs|0|||
162052969|NCT00915278|585249592|FG002|Overall Study|Infusion related AEs|0|||
162052970|NCT00915278|585249593|FG003|Overall Study|Infusion related AEs|0|||
162052971|NCT00915278|585249594|FG004|Overall Study|Infusion related AEs|0|||
162052972|NCT00915278|585249595|FG005|Overall Study|Infusion related AEs|2|||
162052973|NCT00915278|585249590|FG000|Overall Study|Admission to hospice|0|||
162052974|NCT00915278|585249591|FG001|Overall Study|Admission to hospice|0|||
162052975|NCT00915278|585249592|FG002|Overall Study|Admission to hospice|1|||
162052976|NCT00915278|585249593|FG003|Overall Study|Admission to hospice|0|||
162052977|NCT00915278|585249594|FG004|Overall Study|Admission to hospice|0|||
162052978|NCT00915278|585249595|FG005|Overall Study|Admission to hospice|0|||
162052979|NCT02412618|585249596|FG000|Overall Study|Withdrawal by Subject|1|||
162052980|NCT02412618|585249597|FG001|Overall Study|Withdrawal by Subject|1|||
162052981|NCT02412618|585249596|FG000|Overall Study|Expulsion|1|||
162052982|NCT02412618|585249597|FG001|Overall Study|Expulsion|1|||
162052983|NCT01201850|585249599|FG000|Overall Study|Tumor progression|4|||
162052984|NCT03137537|585249600|FG000|Overall Study|Adverse Event|0|||
162052985|NCT03137537|585249601|FG001|Overall Study|Adverse Event|1|||
162052986|NCT04066023|585249602|FG000|Overall Study|Adverse Event|0|||
162052987|NCT04066023|585249603|FG001|Overall Study|Adverse Event|0|||
162052988|NCT04066023|585249604|FG002|Overall Study|Adverse Event|1|||
162052989|NCT04066023|585249602|FG000|Overall Study|Sponsor decision|3|||
162052990|NCT04066023|585249603|FG001|Overall Study|Sponsor decision|6|||
162052991|NCT04066023|585249604|FG002|Overall Study|Sponsor decision|2|||
162052992|NCT04066023|585249602|FG000|Overall Study|Physician Decision|0|||
162052993|NCT04066023|585249603|FG001|Overall Study|Physician Decision|0|||
162052994|NCT04066023|585249604|FG002|Overall Study|Physician Decision|1|||
162052995|NCT04066023|585249602|FG000|Overall Study|Lost to Follow-up|0|||
162052996|NCT04066023|585249603|FG001|Overall Study|Lost to Follow-up|1|||
162052997|NCT04066023|585249604|FG002|Overall Study|Lost to Follow-up|1|||
162052998|NCT04066023|585249602|FG000|Overall Study|Noncompliance|0|||
162052999|NCT04066023|585249603|FG001|Overall Study|Noncompliance|1|||
162053000|NCT04066023|585249604|FG002|Overall Study|Noncompliance|1|||
162053001|NCT01552694|585249605|FG000|Overall Study|Lost to Follow-up|0|||
162053002|NCT01552694|585249606|FG001|Overall Study|Lost to Follow-up|1|||
162053003|NCT01552694|585249605|FG000|Overall Study|Protocol Violation|0|||
162053004|NCT01552694|585249606|FG001|Overall Study|Protocol Violation|1|||
162053005|NCT03338010|585249608|FG000|Overall Study|Withdrawal by Subject|14|||
162053006|NCT03338010|585249609|FG001|Overall Study|Withdrawal by Subject|8|||
162053007|NCT03338010|585249608|FG000|Overall Study|Lost to Follow-up|4|||
162053008|NCT03338010|585249609|FG001|Overall Study|Lost to Follow-up|2|||
162053009|NCT03338010|585249608|FG000|Overall Study|Adverse Event|3|||
162053010|NCT03338010|585249609|FG001|Overall Study|Adverse Event|2|||
162053011|NCT03338010|585249608|FG000|Overall Study|Physician Decision|2|||
162053012|NCT03338010|585249609|FG001|Overall Study|Physician Decision|2|||
162053013|NCT03338010|585249608|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162053014|NCT03338010|585249609|FG001|Overall Study|Non-Compliance with Study Drug|3|||
162053015|NCT03338010|585249608|FG000|Overall Study|Protocol Violation|0|||
162053016|NCT03338010|585249609|FG001|Overall Study|Protocol Violation|1|||
162053017|NCT00629707|585249614|FG000|Overall Study|Withdrawal by Subject|0|||
162053018|NCT00629707|585249615|FG001|Overall Study|Withdrawal by Subject|1|||
162053019|NCT00629707|585249614|FG000|Overall Study|Physician Decision|0|||
162053020|NCT00629707|585249615|FG001|Overall Study|Physician Decision|1|||
162053021|NCT00293033|585249616|FG000|Open-label Titration Period|Adverse Event|10|||
162053022|NCT00293033|585249616|FG000|Open-label Titration Period|Death|3|||
162053023|NCT00293033|585249616|FG000|Open-label Titration Period|Lack of Efficacy|5|||
162053024|NCT00293033|585249616|FG000|Open-label Titration Period|Protocol Violation|2|||
162053025|NCT00293033|585249616|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
162053026|NCT00293033|585249616|FG000|Open-label Titration Period|Noncompliance and other|27|||
162053027|NCT00293033|585249616|FG000|Double-blind Treatment Period|Adverse Event|3|||
162053028|NCT00293033|585249616|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
162053029|NCT00293033|585249616|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
162053030|NCT00293033|585249616|FG000|Double-blind Treatment Period|Noncompliance|4|||
162053031|NCT00453063|585249617|FG000|Overall Study|Adverse Event|1|||
162053032|NCT00453063|585249618|FG001|Overall Study|Adverse Event|2|||
162053033|NCT00453063|585249617|FG000|Overall Study|Withdrawal by Subject|1|||
162053034|NCT00453063|585249618|FG001|Overall Study|Withdrawal by Subject|1|||
162053035|NCT00453063|585249617|FG000|Overall Study|Protocol Violation|1|||
162053036|NCT00453063|585249618|FG001|Overall Study|Protocol Violation|0|||
162053037|NCT00837811|585249619|FG000|Overall Study|Adverse Event|4|||
162053038|NCT00837811|585249620|FG001|Overall Study|Adverse Event|6|||
162053039|NCT00837811|585249621|FG002|Overall Study|Adverse Event|0|||
162053040|NCT00837811|585249619|FG000|Overall Study|Death|1|||
162053041|NCT00837811|585249620|FG001|Overall Study|Death|1|||
162053042|NCT00837811|585249621|FG002|Overall Study|Death|0|||
162053043|NCT00837811|585249619|FG000|Overall Study|Lack of Efficacy|0|||
162053044|NCT00837811|585249620|FG001|Overall Study|Lack of Efficacy|11|||
162053045|NCT00837811|585249621|FG002|Overall Study|Lack of Efficacy|0|||
162053046|NCT00837811|585249619|FG000|Overall Study|Lost to Follow-up|1|||
162053047|NCT00837811|585249620|FG001|Overall Study|Lost to Follow-up|3|||
162053048|NCT00837811|585249621|FG002|Overall Study|Lost to Follow-up|0|||
162053049|NCT00837811|585249619|FG000|Overall Study|Physician Decision|0|||
162053050|NCT00837811|585249620|FG001|Overall Study|Physician Decision|2|||
162053051|NCT00837811|585249621|FG002|Overall Study|Physician Decision|1|||
162053052|NCT00837811|585249619|FG000|Overall Study|Withdrawal by Subject|1|||
162053053|NCT00837811|585249620|FG001|Overall Study|Withdrawal by Subject|9|||
162053054|NCT00837811|585249621|FG002|Overall Study|Withdrawal by Subject|0|||
162053055|NCT00837811|585249619|FG000|Overall Study|Sponsor Decision|0|||
162053056|NCT00837811|585249620|FG001|Overall Study|Sponsor Decision|2|||
162053057|NCT00837811|585249621|FG002|Overall Study|Sponsor Decision|0|||
162053058|NCT00717197|585251502|FG000|Overall Study|Unable to purchase study drug|5|||
162053059|NCT00717197|585251502|FG000|Overall Study|Tumor Progression|1|||
162053060|NCT00717197|585251502|FG000|Overall Study|Physician Decision|1|||
162053061|NCT01898806|585251505|FG000|Overall Study|Withdrawal by Subject|2|||
162053062|NCT01898806|585251505|FG000|Overall Study|Physician Decision|1|||
162053063|NCT03003390|585251506|FG000|Overall Study|Physician Decision|2|||
162053064|NCT03003390|585251507|FG001|Overall Study|Physician Decision|0|||
162053065|NCT03003390|585251506|FG000|Overall Study|Parent refused intervention|2|||
162053066|NCT03003390|585251507|FG001|Overall Study|Parent refused intervention|0|||
162053067|NCT01648101|585251508|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
162053068|NCT01648101|585251509|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
162053069|NCT01648101|585251510|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
162053070|NCT01648101|585251508|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
162053071|NCT01648101|585251509|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
162053072|NCT01648101|585251510|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
162053073|NCT01648101|585251508|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
162053074|NCT01648101|585251509|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
162053075|NCT01648101|585251510|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
162053076|NCT01648101|585251508|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
162053077|NCT01648101|585251509|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
162053078|NCT01648101|585251510|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
162053079|NCT01648101|585251508|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
162053080|NCT01648101|585251509|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
162053081|NCT01648101|585251510|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
162053082|NCT01648101|585251508|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
162053083|NCT01648101|585251509|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
162053084|NCT01648101|585251510|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
162053085|NCT01648101|585251508|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
162053086|NCT01648101|585251509|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
162053087|NCT01648101|585251510|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
162053088|NCT01648101|585251508|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
162053089|NCT01648101|585251509|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
162053090|NCT01648101|585251510|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
162053091|NCT01648101|585251508|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
162053092|NCT01648101|585251509|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
162053093|NCT01648101|585251510|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
162053094|NCT01648101|585251508|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
162053095|NCT01648101|585251509|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
162053096|NCT01648101|585251510|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
162053097|NCT01648101|585251508|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
162053098|NCT01648101|585251509|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
162053099|NCT01648101|585251510|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
162053100|NCT02469298|585251523|FG000|Overall Study|Protocol Violation|0|||
162053101|NCT02469298|585251524|FG001|Overall Study|Protocol Violation|1|||
162053102|NCT02469298|585251525|FG002|Overall Study|Protocol Violation|1|||
162053103|NCT02469298|585251526|FG003|Overall Study|Protocol Violation|0|||
162053104|NCT02469298|585251523|FG000|Overall Study|Lost to Follow-up|1|||
162053105|NCT02469298|585251524|FG001|Overall Study|Lost to Follow-up|0|||
162053106|NCT02469298|585251525|FG002|Overall Study|Lost to Follow-up|1|||
162053107|NCT02469298|585251526|FG003|Overall Study|Lost to Follow-up|0|||
162053108|NCT02469298|585251523|FG000|Overall Study|Physician Decision|0|||
162053109|NCT02469298|585251524|FG001|Overall Study|Physician Decision|0|||
162053110|NCT02469298|585251525|FG002|Overall Study|Physician Decision|0|||
162053111|NCT02469298|585251526|FG003|Overall Study|Physician Decision|1|||
162053112|NCT02469298|585251523|FG000|Overall Study|Withdrawal by Subject|0|||
162053113|NCT02469298|585251524|FG001|Overall Study|Withdrawal by Subject|0|||
162053114|NCT02469298|585251525|FG002|Overall Study|Withdrawal by Subject|0|||
162053115|NCT02469298|585251526|FG003|Overall Study|Withdrawal by Subject|1|||
162053116|NCT00307294|585251527|FG000|Overall Study|Withdrawal by Subject|1|||
162053117|NCT03311724|585251528|FG000|Overall Study|Physician Decision|0|||
162053118|NCT03311724|585251529|FG001|Overall Study|Physician Decision|0|||
162053119|NCT03311724|585251530|FG002|Overall Study|Physician Decision|0|||
162053120|NCT03311724|585251531|FG003|Overall Study|Physician Decision|1|||
162053121|NCT03311724|585251528|FG000|Overall Study|Protocol Violation|1|||
162053122|NCT03311724|585251529|FG001|Overall Study|Protocol Violation|0|||
162053123|NCT03311724|585251530|FG002|Overall Study|Protocol Violation|1|||
162053124|NCT03311724|585251531|FG003|Overall Study|Protocol Violation|0|||
162053125|NCT03311724|585251528|FG000|Overall Study|Withdrawal by Subject|1|||
162053126|NCT03311724|585251529|FG001|Overall Study|Withdrawal by Subject|1|||
162053127|NCT03311724|585251530|FG002|Overall Study|Withdrawal by Subject|0|||
162053128|NCT03311724|585251531|FG003|Overall Study|Withdrawal by Subject|0|||
162053129|NCT03311724|585251528|FG000|Overall Study|Lost to Follow-up|1|||
162053130|NCT03311724|585251529|FG001|Overall Study|Lost to Follow-up|0|||
162053131|NCT03311724|585251530|FG002|Overall Study|Lost to Follow-up|0|||
162053132|NCT03311724|585251531|FG003|Overall Study|Lost to Follow-up|0|||
162053133|NCT03311724|585251528|FG000|Overall Study|Sponsor Decision|0|||
162053134|NCT03311724|585251529|FG001|Overall Study|Sponsor Decision|0|||
162053135|NCT03311724|585251530|FG002|Overall Study|Sponsor Decision|1|||
162053136|NCT03311724|585251531|FG003|Overall Study|Sponsor Decision|0|||
162053137|NCT01433991|585251532|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
162053138|NCT01433991|585251533|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
162053139|NCT01433991|585251534|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
162053140|NCT01433991|585251535|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
162053141|NCT01433991|585251532|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
162053142|NCT01433991|585251533|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
162053143|NCT01433991|585251534|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
162053144|NCT01433991|585251535|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
162053145|NCT01433991|585251532|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
162053146|NCT01433991|585251533|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
162053147|NCT01433991|585251534|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
162053148|NCT01433991|585251535|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
162053149|NCT01433991|585251532|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
162053150|NCT01433991|585251533|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
162053151|NCT01433991|585251534|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
162053152|NCT01433991|585251535|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
162053153|NCT01433991|585251532|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
162053154|NCT01433991|585251533|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
162053155|NCT01433991|585251534|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
162053156|NCT01433991|585251535|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
162053157|NCT01433991|585251532|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
162053158|NCT01433991|585251533|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
162053159|NCT01433991|585251534|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
162053160|NCT01433991|585251535|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
162053161|NCT01433991|585251532|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
162053162|NCT01433991|585251533|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
162053163|NCT01433991|585251534|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
162053164|NCT01433991|585251535|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
162053165|NCT02955602|585251536|FG000|Overall Study|Adverse Event|0|||
162053166|NCT02955602|585251537|FG001|Overall Study|Adverse Event|3|||
162053167|NCT02955602|585251538|FG002|Overall Study|Adverse Event|0|||
162053168|NCT02955602|585251536|FG000|Overall Study|Withdrawal of informed consent|1|||
162053169|NCT02955602|585251537|FG001|Overall Study|Withdrawal of informed consent|3|||
162053170|NCT02955602|585251538|FG002|Overall Study|Withdrawal of informed consent|2|||
162053171|NCT02955602|585251536|FG000|Overall Study|Lost to Follow-up|0|||
162053172|NCT02955602|585251537|FG001|Overall Study|Lost to Follow-up|0|||
162053173|NCT02955602|585251538|FG002|Overall Study|Lost to Follow-up|1|||
162053174|NCT02955602|585251536|FG000|Overall Study|Other|0|||
162053175|NCT02955602|585251537|FG001|Overall Study|Other|1|||
162053176|NCT02955602|585251538|FG002|Overall Study|Other|3|||
162053177|NCT03000439|585251541|FG000|Open Label Part 1|Adverse Event|6|||
162053178|NCT03000439|585251542|FG001|Open Label Part 1|Adverse Event|0|||
162053179|NCT03000439|585251543|FG002|Open Label Part 1|Adverse Event|0|||
162053180|NCT03000439|585251544|FG003|Open Label Part 1|Adverse Event|0|||
162053181|NCT03000439|585251541|FG000|Open Label Part 1|Other|2|||
162053182|NCT03000439|585251542|FG001|Open Label Part 1|Other|0|||
162053183|NCT03000439|585251543|FG002|Open Label Part 1|Other|0|||
162053184|NCT03000439|585251544|FG003|Open Label Part 1|Other|0|||
162053185|NCT03000439|585251541|FG000|Open Label Part 1|Insufficient clinical response|16|||
162053186|NCT03000439|585251542|FG001|Open Label Part 1|Insufficient clinical response|0|||
162053187|NCT03000439|585251543|FG002|Open Label Part 1|Insufficient clinical response|0|||
162053188|NCT03000439|585251544|FG003|Open Label Part 1|Insufficient clinical response|0|||
162053189|NCT03000439|585251541|FG000|Open Label Part 2|Other|0|||
162053190|NCT03000439|585251542|FG001|Open Label Part 2|Other|5|||
162053191|NCT03000439|585251543|FG002|Open Label Part 2|Other|0|||
162053192|NCT03000439|585251544|FG003|Open Label Part 2|Other|0|||
162053193|NCT03000439|585251541|FG000|Open Label Part 2|Insufficient clinical response|0|||
162053194|NCT03000439|585251542|FG001|Open Label Part 2|Insufficient clinical response|12|||
162053195|NCT03000439|585251543|FG002|Open Label Part 2|Insufficient clinical response|0|||
162053196|NCT03000439|585251544|FG003|Open Label Part 2|Insufficient clinical response|0|||
162053197|NCT03000439|585251541|FG000|Double Blind Phase|Adverse Event|0|||
162053198|NCT03000439|585251542|FG001|Double Blind Phase|Adverse Event|0|||
162053199|NCT03000439|585251543|FG002|Double Blind Phase|Adverse Event|2|||
162053200|NCT03000439|585251544|FG003|Double Blind Phase|Adverse Event|1|||
162053201|NCT03000439|585251541|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
162053202|NCT03000439|585251542|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
162053203|NCT03000439|585251543|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
162053204|NCT03000439|585251544|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
162053205|NCT03000439|585251541|FG000|Double Blind Phase|Other|0|||
162053206|NCT03000439|585251542|FG001|Double Blind Phase|Other|0|||
162053207|NCT03000439|585251543|FG002|Double Blind Phase|Other|10|||
162053208|NCT03000439|585251544|FG003|Double Blind Phase|Other|11|||
162053209|NCT03000439|585251541|FG000|Double Blind Phase|Insufficient clinical response|0|||
162053210|NCT03000439|585251542|FG001|Double Blind Phase|Insufficient clinical response|0|||
162053211|NCT03000439|585251543|FG002|Double Blind Phase|Insufficient clinical response|0|||
162053212|NCT03000439|585251544|FG003|Double Blind Phase|Insufficient clinical response|2|||
162053213|NCT01581931|585251549|FG000|Washout|Adverse Event|0|||
162053214|NCT01581931|585251550|FG001|Washout|Adverse Event|1|||
162053215|NCT00395304|585251557|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162053216|NCT00395304|585251558|FG001|Treatment Period 1|Withdrawal by Subject|3|||
162053217|NCT00395304|585251559|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162053218|NCT00395304|585251560|FG003|Treatment Period 1|Withdrawal by Subject|2|||
162053219|NCT00395304|585251561|FG004|Treatment Period 1|Withdrawal by Subject|1|||
162053220|NCT00395304|585251562|FG005|Treatment Period 1|Withdrawal by Subject|1|||
162053221|NCT00395304|585251557|FG000|Treatment Period 1|Lost to Follow-up|1|||
162053222|NCT00395304|585251558|FG001|Treatment Period 1|Lost to Follow-up|0|||
162053223|NCT00395304|585251559|FG002|Treatment Period 1|Lost to Follow-up|0|||
162053224|NCT00395304|585251560|FG003|Treatment Period 1|Lost to Follow-up|1|||
162053225|NCT00395304|585251561|FG004|Treatment Period 1|Lost to Follow-up|0|||
162053226|NCT00395304|585251562|FG005|Treatment Period 1|Lost to Follow-up|1|||
162053227|NCT00395304|585251557|FG000|Treatment Period 1|Physician Decision|0|||
162053228|NCT00395304|585251558|FG001|Treatment Period 1|Physician Decision|1|||
162053229|NCT00395304|585251559|FG002|Treatment Period 1|Physician Decision|0|||
162053230|NCT00395304|585251560|FG003|Treatment Period 1|Physician Decision|0|||
162053231|NCT00395304|585251561|FG004|Treatment Period 1|Physician Decision|0|||
162053232|NCT00395304|585251562|FG005|Treatment Period 1|Physician Decision|0|||
162053233|NCT00395304|585251557|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162053234|NCT00395304|585251558|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162053235|NCT00395304|585251559|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162053236|NCT00395304|585251560|FG003|Treatment Period 2|Withdrawal by Subject|1|||
162053237|NCT00395304|585251561|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162053238|NCT00395304|585251562|FG005|Treatment Period 2|Withdrawal by Subject|2|||
162053239|NCT00395304|585251557|FG000|Treatment Period 2|Lost to Follow-up|0|||
162053240|NCT00395304|585251558|FG001|Treatment Period 2|Lost to Follow-up|3|||
162053241|NCT00395304|585251559|FG002|Treatment Period 2|Lost to Follow-up|0|||
162053242|NCT00395304|585251560|FG003|Treatment Period 2|Lost to Follow-up|0|||
162053243|NCT00395304|585251561|FG004|Treatment Period 2|Lost to Follow-up|0|||
162053244|NCT00395304|585251562|FG005|Treatment Period 2|Lost to Follow-up|0|||
162053245|NCT00395304|585251557|FG000|Treatment Period 2|Physician Decision|0|||
162053246|NCT00395304|585251558|FG001|Treatment Period 2|Physician Decision|0|||
162053247|NCT00395304|585251559|FG002|Treatment Period 2|Physician Decision|1|||
162053248|NCT00395304|585251560|FG003|Treatment Period 2|Physician Decision|0|||
162053249|NCT00395304|585251561|FG004|Treatment Period 2|Physician Decision|0|||
162053250|NCT00395304|585251562|FG005|Treatment Period 2|Physician Decision|0|||
162053251|NCT00395304|585251557|FG000|Treatment Period 2|Other|0|||
162053252|NCT00395304|585251558|FG001|Treatment Period 2|Other|1|||
162053253|NCT00395304|585251559|FG002|Treatment Period 2|Other|0|||
162053254|NCT00395304|585251560|FG003|Treatment Period 2|Other|0|||
162053255|NCT00395304|585251561|FG004|Treatment Period 2|Other|0|||
162053256|NCT00395304|585251562|FG005|Treatment Period 2|Other|0|||
162053257|NCT00395304|585251557|FG000|Treatment Period 3|Withdrawal by Subject|0|||
162053258|NCT00395304|585251558|FG001|Treatment Period 3|Withdrawal by Subject|0|||
162053259|NCT00395304|585251559|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162053260|NCT00395304|585251560|FG003|Treatment Period 3|Withdrawal by Subject|1|||
162053261|NCT00395304|585251561|FG004|Treatment Period 3|Withdrawal by Subject|0|||
162053262|NCT00395304|585251562|FG005|Treatment Period 3|Withdrawal by Subject|1|||
162053263|NCT00395304|585251557|FG000|Treatment Period 3|Lost to Follow-up|1|||
162053264|NCT00395304|585251558|FG001|Treatment Period 3|Lost to Follow-up|1|||
162053265|NCT00395304|585251559|FG002|Treatment Period 3|Lost to Follow-up|0|||
162053266|NCT00395304|585251560|FG003|Treatment Period 3|Lost to Follow-up|0|||
162053267|NCT00395304|585251561|FG004|Treatment Period 3|Lost to Follow-up|0|||
162053268|NCT00395304|585251562|FG005|Treatment Period 3|Lost to Follow-up|0|||
162053269|NCT00395304|585251557|FG000|Treatment Period 3|Physician Decision|0|||
162053270|NCT00395304|585251558|FG001|Treatment Period 3|Physician Decision|1|||
162053271|NCT00395304|585251559|FG002|Treatment Period 3|Physician Decision|0|||
162053272|NCT00395304|585251560|FG003|Treatment Period 3|Physician Decision|0|||
162053273|NCT00395304|585251561|FG004|Treatment Period 3|Physician Decision|0|||
162053274|NCT00395304|585251562|FG005|Treatment Period 3|Physician Decision|0|||
162053275|NCT00395304|585251557|FG000|Treatment Period 3|Other|0|||
162053276|NCT00395304|585251558|FG001|Treatment Period 3|Other|0|||
162053277|NCT00395304|585251559|FG002|Treatment Period 3|Other|0|||
162053278|NCT00395304|585251560|FG003|Treatment Period 3|Other|1|||
162053279|NCT00395304|585251561|FG004|Treatment Period 3|Other|0|||
162053280|NCT00395304|585251562|FG005|Treatment Period 3|Other|0|||
162053281|NCT00980057|585251567|FG000|Overall Study|Death|13|||
162053282|NCT00980057|585251568|FG001|Overall Study|Death|3|||
162053283|NCT00980057|585251567|FG000|Overall Study|Adverse Event|0|||
162053284|NCT00980057|585251568|FG001|Overall Study|Adverse Event|1|||
162053285|NCT00980057|585251567|FG000|Overall Study|Physician Decision|4|||
162053286|NCT00980057|585251568|FG001|Overall Study|Physician Decision|0|||
162053287|NCT00980057|585251567|FG000|Overall Study|Lost to Follow-up|1|||
162053288|NCT00980057|585251568|FG001|Overall Study|Lost to Follow-up|0|||
162053289|NCT00980057|585251567|FG000|Overall Study|Withdrawal by Subject|1|||
162053290|NCT00980057|585251568|FG001|Overall Study|Withdrawal by Subject|1|||
162053291|NCT01397084|585251572|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
162053292|NCT01397084|585251572|FG000|Overall Study|Protocol Violation|2|||
162053293|NCT01397084|585251572|FG000|Overall Study|Adverse Event|2|||
162053294|NCT01397084|585251572|FG000|Overall Study|Withdrawal by Subject|1|||
162053295|NCT01397084|585251572|FG000|Overall Study|Lost to Follow-up|1|||
162053296|NCT01397084|585251572|FG000|Overall Study|Used other proton pump inhibitor|1|||
162053297|NCT04160195|585251575|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
162053298|NCT04160195|585251576|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
162053299|NCT03766581|585251579|FG000|Randomization|Other reasons|2|||
162053300|NCT03766581|585251580|FG001|Randomization|Other reasons|1|||
162053301|NCT03766581|585251581|FG002|Randomization|Other reasons|0|||
162053302|NCT03766581|585251582|FG003|Randomization|Other reasons|1|||
162053303|NCT03766581|585251583|FG004|Randomization|Other reasons|0|||
162053304|NCT03766581|585251584|FG005|Randomization|Other reasons|0|||
162053305|NCT03766581|585251585|FG006|Randomization|Other reasons|0|||
162053306|NCT03766581|585251586|FG007|Randomization|Other reasons|0|||
162053307|NCT03766581|585251579|FG000|Randomization|Participant no longer meets study criteria|5|||
162053308|NCT03766581|585251580|FG001|Randomization|Participant no longer meets study criteria|3|||
162053309|NCT03766581|585251581|FG002|Randomization|Participant no longer meets study criteria|4|||
162053310|NCT03766581|585251582|FG003|Randomization|Participant no longer meets study criteria|0|||
162053311|NCT03766581|585251583|FG004|Randomization|Participant no longer meets study criteria|2|||
162053312|NCT03766581|585251584|FG005|Randomization|Participant no longer meets study criteria|3|||
162053313|NCT03766581|585251585|FG006|Randomization|Participant no longer meets study criteria|0|||
162053314|NCT03766581|585251586|FG007|Randomization|Participant no longer meets study criteria|1|||
162053315|NCT03766581|585251579|FG000|Randomization|Participant request to discontinue study treatment|1|||
162053316|NCT03766581|585251580|FG001|Randomization|Participant request to discontinue study treatment|0|||
162053317|NCT03766581|585251581|FG002|Randomization|Participant request to discontinue study treatment|0|||
162053318|NCT03766581|585251582|FG003|Randomization|Participant request to discontinue study treatment|0|||
162053319|NCT03766581|585251583|FG004|Randomization|Participant request to discontinue study treatment|1|||
162053320|NCT03766581|585251584|FG005|Randomization|Participant request to discontinue study treatment|2|||
162053321|NCT03766581|585251585|FG006|Randomization|Participant request to discontinue study treatment|0|||
162053322|NCT03766581|585251586|FG007|Randomization|Participant request to discontinue study treatment|0|||
162053323|NCT03766581|585251579|FG000|Randomization|Participant withdrew consent|1|||
162053324|NCT03766581|585251580|FG001|Randomization|Participant withdrew consent|0|||
162053325|NCT03766581|585251581|FG002|Randomization|Participant withdrew consent|1|||
162053326|NCT03766581|585251582|FG003|Randomization|Participant withdrew consent|2|||
162053327|NCT03766581|585251583|FG004|Randomization|Participant withdrew consent|1|||
162053328|NCT03766581|585251584|FG005|Randomization|Participant withdrew consent|1|||
162053329|NCT03766581|585251585|FG006|Randomization|Participant withdrew consent|0|||
162053330|NCT03766581|585251586|FG007|Randomization|Participant withdrew consent|0|||
162053331|NCT03766581|585251579|FG000|Treatment|Adverse Event|82|||
162053332|NCT03766581|585251580|FG001|Treatment|Adverse Event|44|||
162053333|NCT03766581|585251581|FG002|Treatment|Adverse Event|47|||
162053334|NCT03766581|585251582|FG003|Treatment|Adverse Event|46|||
162053335|NCT03766581|585251583|FG004|Treatment|Adverse Event|50|||
162053336|NCT03766581|585251584|FG005|Treatment|Adverse Event|77|||
162053337|NCT03766581|585251585|FG006|Treatment|Adverse Event|5|||
162053338|NCT03766581|585251586|FG007|Treatment|Adverse Event|2|||
162053339|NCT03766581|585251579|FG000|Treatment|Participant request to discontinue treatment|34|||
162053340|NCT03766581|585251580|FG001|Treatment|Participant request to discontinue treatment|6|||
162053341|NCT03766581|585251581|FG002|Treatment|Participant request to discontinue treatment|10|||
162053342|NCT03766581|585251582|FG003|Treatment|Participant request to discontinue treatment|10|||
162053343|NCT03766581|585251583|FG004|Treatment|Participant request to discontinue treatment|14|||
162053344|NCT03766581|585251584|FG005|Treatment|Participant request to discontinue treatment|15|||
162053345|NCT03766581|585251585|FG006|Treatment|Participant request to discontinue treatment|0|||
162053346|NCT03766581|585251586|FG007|Treatment|Participant request to discontinue treatment|1|||
162053347|NCT03766581|585251579|FG000|Treatment|Participant withdrew consent|11|||
162053348|NCT03766581|585251580|FG001|Treatment|Participant withdrew consent|4|||
162053349|NCT03766581|585251581|FG002|Treatment|Participant withdrew consent|5|||
162053350|NCT03766581|585251582|FG003|Treatment|Participant withdrew consent|5|||
162053351|NCT03766581|585251583|FG004|Treatment|Participant withdrew consent|4|||
162053352|NCT03766581|585251584|FG005|Treatment|Participant withdrew consent|4|||
162053353|NCT03766581|585251585|FG006|Treatment|Participant withdrew consent|0|||
162053354|NCT03766581|585251586|FG007|Treatment|Participant withdrew consent|0|||
162053355|NCT03766581|585251579|FG000|Treatment|Death|1|||
162053356|NCT03766581|585251580|FG001|Treatment|Death|0|||
162053357|NCT03766581|585251581|FG002|Treatment|Death|0|||
162053358|NCT03766581|585251582|FG003|Treatment|Death|0|||
162053359|NCT03766581|585251583|FG004|Treatment|Death|0|||
162053360|NCT03766581|585251584|FG005|Treatment|Death|0|||
162053361|NCT03766581|585251585|FG006|Treatment|Death|0|||
162053362|NCT03766581|585251586|FG007|Treatment|Death|0|||
162053363|NCT03766581|585251579|FG000|Treatment|Lost to Follow-up|1|||
162053364|NCT03766581|585251580|FG001|Treatment|Lost to Follow-up|0|||
162053365|NCT03766581|585251581|FG002|Treatment|Lost to Follow-up|0|||
162053366|NCT03766581|585251582|FG003|Treatment|Lost to Follow-up|1|||
162053367|NCT03766581|585251583|FG004|Treatment|Lost to Follow-up|0|||
162053368|NCT03766581|585251584|FG005|Treatment|Lost to Follow-up|0|||
162053369|NCT03766581|585251585|FG006|Treatment|Lost to Follow-up|0|||
162053370|NCT03766581|585251586|FG007|Treatment|Lost to Follow-up|0|||
162053371|NCT03766581|585251579|FG000|Treatment|Poor/Non compliance|2|||
162053372|NCT03766581|585251580|FG001|Treatment|Poor/Non compliance|2|||
162053373|NCT03766581|585251581|FG002|Treatment|Poor/Non compliance|1|||
162053374|NCT03766581|585251582|FG003|Treatment|Poor/Non compliance|1|||
162053375|NCT03766581|585251583|FG004|Treatment|Poor/Non compliance|1|||
162053376|NCT03766581|585251584|FG005|Treatment|Poor/Non compliance|1|||
162053377|NCT03766581|585251585|FG006|Treatment|Poor/Non compliance|0|||
162053378|NCT03766581|585251586|FG007|Treatment|Poor/Non compliance|0|||
162053379|NCT03766581|585251579|FG000|Treatment|Participant no longer meets study criteria|9|||
162053380|NCT03766581|585251580|FG001|Treatment|Participant no longer meets study criteria|1|||
162053381|NCT03766581|585251581|FG002|Treatment|Participant no longer meets study criteria|5|||
162053382|NCT03766581|585251582|FG003|Treatment|Participant no longer meets study criteria|4|||
162053383|NCT03766581|585251583|FG004|Treatment|Participant no longer meets study criteria|4|||
162053384|NCT03766581|585251584|FG005|Treatment|Participant no longer meets study criteria|4|||
162053385|NCT03766581|585251585|FG006|Treatment|Participant no longer meets study criteria|2|||
162053386|NCT03766581|585251586|FG007|Treatment|Participant no longer meets study criteria|0|||
162053387|NCT03766581|585251579|FG000|Treatment|Other reasons|13|||
162053388|NCT03766581|585251580|FG001|Treatment|Other reasons|8|||
162053389|NCT03766581|585251581|FG002|Treatment|Other reasons|3|||
162053390|NCT03766581|585251582|FG003|Treatment|Other reasons|7|||
162053391|NCT03766581|585251583|FG004|Treatment|Other reasons|3|||
162053392|NCT03766581|585251584|FG005|Treatment|Other reasons|3|||
162053393|NCT03766581|585251585|FG006|Treatment|Other reasons|0|||
162053394|NCT03766581|585251586|FG007|Treatment|Other reasons|0|||
162053395|NCT03716024|585251587|FG000|Overall Study|Randomized, not Treated|7|||
162053396|NCT03716024|585251588|FG001|Overall Study|Randomized, not Treated|8|||
162053397|NCT03716024|585251587|FG000|Overall Study|Adverse Event|1|||
162053398|NCT03716024|585251588|FG001|Overall Study|Adverse Event|2|||
162053399|NCT03716024|585251587|FG000|Overall Study|Treatment Failure|1|||
162053400|NCT03716024|585251588|FG001|Overall Study|Treatment Failure|0|||
162053401|NCT03716024|585251587|FG000|Overall Study|Lost to Follow-up|2|||
162053402|NCT03716024|585251588|FG001|Overall Study|Lost to Follow-up|6|||
162053403|NCT03716024|585251587|FG000|Overall Study|Withdrawal by Subject|0|||
162053404|NCT03716024|585251588|FG001|Overall Study|Withdrawal by Subject|1|||
162053405|NCT03716024|585251587|FG000|Overall Study|Missing Reason|0|||
162053406|NCT03716024|585251588|FG001|Overall Study|Missing Reason|1|||
162053407|NCT01651039|585251590|FG000|Overall Study|Non-evaluables|5|||
162053408|NCT01651039|585251590|FG000|Overall Study|Physician Decision|2|||
162053409|NCT01651039|585251590|FG000|Overall Study|Withdrawal by Subject|1|||
162053410|NCT01651039|585251590|FG000|Overall Study|Progressive Disease|22|||
162053411|NCT03600818|585251592|FG000|Overall Study|Adverse Event|4|||
162053412|NCT03600818|585251593|FG001|Overall Study|Adverse Event|7|||
162053413|NCT03600818|585251592|FG000|Overall Study|Lack of Efficacy|9|||
162053414|NCT03600818|585251593|FG001|Overall Study|Lack of Efficacy|4|||
162053415|NCT03600818|585251592|FG000|Overall Study|Withdrawal by Subject|4|||
162053416|NCT03600818|585251593|FG001|Overall Study|Withdrawal by Subject|3|||
162053417|NCT03600818|585251592|FG000|Overall Study|Other-unspecified|5|||
162053418|NCT03600818|585251593|FG001|Overall Study|Other-unspecified|3|||
162053419|NCT03600818|585251592|FG000|Overall Study|Randomized and not treated|0|||
162053420|NCT03600818|585251593|FG001|Overall Study|Randomized and not treated|1|||
162053421|NCT02582983|585251596|FG000|Overall Study|Death|3|||
162053422|NCT02582983|585251596|FG000|Overall Study|Withdrawal by Subject|2|||
162053423|NCT02582983|585251596|FG000|Overall Study|Adverse Event|1|||
162053424|NCT04377620|585251597|FG000|Overall Study|Death|42|||
162053425|NCT04377620|585251598|FG001|Overall Study|Death|48|||
162053426|NCT04377620|585251599|FG002|Overall Study|Death|36|||
162053427|NCT04377620|585251597|FG000|Overall Study|Withdrawal by Subject|0|||
162053428|NCT04377620|585251598|FG001|Overall Study|Withdrawal by Subject|2|||
162053429|NCT04377620|585251599|FG002|Overall Study|Withdrawal by Subject|0|||
162053430|NCT04930965|585251600|FG000|Overall Study|Lost to Follow-up|7|||
162053431|NCT04930965|585251601|FG001|Overall Study|Lost to Follow-up|5|||
162053432|NCT04189081|585251603|FG000|Overall Study|Lost to Follow-up|1|||
162053433|NCT04189081|585251604|FG001|Overall Study|Lost to Follow-up|0|||
162053434|NCT04189081|585251605|FG002|Overall Study|Lost to Follow-up|0|||
162053435|NCT04189081|585251603|FG000|Overall Study|Withdrawal by Subject|0|||
162053436|NCT04189081|585251604|FG001|Overall Study|Withdrawal by Subject|0|||
162053437|NCT04189081|585251605|FG002|Overall Study|Withdrawal by Subject|1|||
162053438|NCT00044083|585251606|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
162053439|NCT00044083|585251607|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
162053440|NCT00044083|585251606|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
162053441|NCT00044083|585251607|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
162053442|NCT00044083|585251606|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
162053443|NCT00044083|585251607|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
162053444|NCT00044083|585251606|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
162053445|NCT00044083|585251607|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
162053446|NCT00044083|585251606|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
162053447|NCT00044083|585251607|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
162053448|NCT00044083|585251606|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
162053449|NCT00044083|585251607|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
162053450|NCT00044083|585251606|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
162053451|NCT00044083|585251607|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
162053452|NCT00044083|585251606|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
162053453|NCT00044083|585251607|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
162053454|NCT00044083|585251606|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
162053455|NCT00044083|585251607|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
162053456|NCT00044083|585251606|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
162053457|NCT00044083|585251607|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
162053458|NCT00444912|585251608|FG000|Overall Study|Death|1|||
162053459|NCT00444912|585251609|FG001|Overall Study|Death|2|||
162053460|NCT00444912|585251608|FG000|Overall Study|Lost to Follow-up|1|||
162053461|NCT00444912|585251609|FG001|Overall Study|Lost to Follow-up|0|||
162053462|NCT00444912|585251608|FG000|Overall Study|Participant Failed Mobilization|1|||
162053463|NCT00444912|585251609|FG001|Overall Study|Participant Failed Mobilization|0|||
162053464|NCT03758066|585251610|FG000|Overall Study|Lost to Follow-up|14|||
162053465|NCT03706079|585251616|FG000|Predecessor Study|Death|0|||
162053466|NCT03706079|585251617|FG001|Predecessor Study|Death|2|||
162053467|NCT03706079|585251618|FG002|Predecessor Study|Death|0|||
162053468|NCT03706079|585251619|FG003|Predecessor Study|Death|1|||
162053469|NCT03706079|585251620|FG004|Predecessor Study|Death|0|||
162053470|NCT03706079|585251621|FG005|Predecessor Study|Death|0|||
162053471|NCT03706079|585251616|FG000|Predecessor Study|Lost to Follow-up|5|||
162053472|NCT03706079|585251617|FG001|Predecessor Study|Lost to Follow-up|2|||
162053473|NCT03706079|585251618|FG002|Predecessor Study|Lost to Follow-up|0|||
162053474|NCT03706079|585251619|FG003|Predecessor Study|Lost to Follow-up|0|||
162053475|NCT03706079|585251620|FG004|Predecessor Study|Lost to Follow-up|1|||
162053476|NCT03706079|585251621|FG005|Predecessor Study|Lost to Follow-up|0|||
162053477|NCT03706079|585251616|FG000|Predecessor Study|Withdrawal by Subject|8|||
162053478|NCT03706079|585251617|FG001|Predecessor Study|Withdrawal by Subject|15|||
162053479|NCT03706079|585251618|FG002|Predecessor Study|Withdrawal by Subject|0|||
162053480|NCT03706079|585251619|FG003|Predecessor Study|Withdrawal by Subject|5|||
162053481|NCT03706079|585251620|FG004|Predecessor Study|Withdrawal by Subject|2|||
162053482|NCT03706079|585251621|FG005|Predecessor Study|Withdrawal by Subject|0|||
162053483|NCT03706079|585251616|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
162053484|NCT03706079|585251617|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
162053485|NCT03706079|585251618|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
162053486|NCT03706079|585251619|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
162053487|NCT03706079|585251620|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
162053488|NCT03706079|585251621|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
162053489|NCT03706079|585251616|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
162053490|NCT03706079|585251617|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
162053491|NCT03706079|585251618|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
162053492|NCT03706079|585251619|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
162053493|NCT03706079|585251620|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
162053494|NCT03706079|585251621|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
162053495|NCT03706079|585251616|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
162053496|NCT03706079|585251617|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
162053497|NCT03706079|585251618|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
162122662|NCT00406419|585500292|FG000|Overall Study|Lost to Follow-up|11|||
162053498|NCT03706079|585251619|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
162053499|NCT03706079|585251620|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
162053500|NCT03706079|585251621|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
162053501|NCT03706079|585251616|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
162053502|NCT03706079|585251617|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
162053503|NCT03706079|585251618|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
162053504|NCT03706079|585251619|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
162053505|NCT03706079|585251620|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
162053506|NCT03706079|585251621|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
162053507|NCT03706079|585251616|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
162053508|NCT03706079|585251617|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
162053509|NCT03706079|585251618|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
162053510|NCT03706079|585251619|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
162053511|NCT03706079|585251620|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
162053512|NCT03706079|585251621|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
162053513|NCT03706079|585251616|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
162053514|NCT03706079|585251617|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
162053515|NCT03706079|585251618|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
162053516|NCT03706079|585251619|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
162053517|NCT03706079|585251620|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
162053518|NCT03706079|585251621|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
162053519|NCT03706079|585251616|FG000|Long Term Extension (DESTINATION)|Death|8|||
162053520|NCT03706079|585251617|FG001|Long Term Extension (DESTINATION)|Death|2|||
162053521|NCT03706079|585251618|FG002|Long Term Extension (DESTINATION)|Death|2|||
162053522|NCT03706079|585251619|FG003|Long Term Extension (DESTINATION)|Death|1|||
162053523|NCT03706079|585251620|FG004|Long Term Extension (DESTINATION)|Death|0|||
162053524|NCT03706079|585251621|FG005|Long Term Extension (DESTINATION)|Death|0|||
162053525|NCT00329238|585251622|FG000|Overall Study|Adverse Event|147|||
162053526|NCT00329238|585251623|FG001|Overall Study|Adverse Event|129|||
162053527|NCT00329238|585251622|FG000|Overall Study|Protocol Violation|23|||
162053528|NCT00329238|585251623|FG001|Overall Study|Protocol Violation|34|||
162053529|NCT00329238|585251622|FG000|Overall Study|Lost to Follow-up|2|||
162053530|NCT00329238|585251623|FG001|Overall Study|Lost to Follow-up|6|||
162053531|NCT00329238|585251622|FG000|Overall Study|Withdrawal by Subject|64|||
162053532|NCT00329238|585251623|FG001|Overall Study|Withdrawal by Subject|58|||
162053533|NCT00329238|585251622|FG000|Overall Study|Other reason (not specified)|40|||
162053534|NCT00329238|585251623|FG001|Overall Study|Other reason (not specified)|54|||
162053535|NCT01306942|585251634|FG000|Phase I|Adverse Event|2|||
162053536|NCT01306942|585251635|FG001|Phase I|Adverse Event|2|||
162053537|NCT01306942|585251636|FG002|Phase I|Adverse Event|0|||
162053538|NCT01306942|585251637|FG003|Phase I|Adverse Event|0|||
162053539|NCT01306942|585251634|FG000|Phase I|Physician Decision|3|||
162053540|NCT01306942|585251635|FG001|Phase I|Physician Decision|1|||
162053541|NCT01306942|585251636|FG002|Phase I|Physician Decision|0|||
162053542|NCT01306942|585251637|FG003|Phase I|Physician Decision|0|||
162053543|NCT01306942|585251634|FG000|Phase II|Adverse Event|0|||
162053544|NCT01306942|585251635|FG001|Phase II|Adverse Event|0|||
162053545|NCT01306942|585251636|FG002|Phase II|Adverse Event|0|||
162053546|NCT01306942|585251637|FG003|Phase II|Adverse Event|6|||
162053547|NCT01306942|585251634|FG000|Phase II|Physician Decision|2|||
162053548|NCT01306942|585251635|FG001|Phase II|Physician Decision|0|||
162053549|NCT01306942|585251636|FG002|Phase II|Physician Decision|0|||
162053550|NCT01306942|585251637|FG003|Phase II|Physician Decision|5|||
162053551|NCT01306942|585251634|FG000|Phase II|Withdrawal by Subject|0|||
162053552|NCT01306942|585251635|FG001|Phase II|Withdrawal by Subject|0|||
162053553|NCT01306942|585251636|FG002|Phase II|Withdrawal by Subject|0|||
162053554|NCT01306942|585251637|FG003|Phase II|Withdrawal by Subject|2|||
162053555|NCT01306942|585251634|FG000|Phase II|Death|0|||
162053556|NCT01306942|585251635|FG001|Phase II|Death|0|||
162053557|NCT01306942|585251636|FG002|Phase II|Death|0|||
162053558|NCT01306942|585251637|FG003|Phase II|Death|1|||
162053559|NCT01306942|585251634|FG000|Phase II|Not finished treatment|0|||
162053560|NCT01306942|585251635|FG001|Phase II|Not finished treatment|0|||
162053561|NCT01306942|585251636|FG002|Phase II|Not finished treatment|0|||
162053562|NCT01306942|585251637|FG003|Phase II|Not finished treatment|1|||
162053563|NCT01306942|585251634|FG000|Phase II|Protocol Violation|0|||
162053564|NCT01306942|585251635|FG001|Phase II|Protocol Violation|0|||
162053565|NCT01306942|585251636|FG002|Phase II|Protocol Violation|0|||
162053566|NCT01306942|585251637|FG003|Phase II|Protocol Violation|1|||
162053567|NCT03190915|585251638|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
162053568|NCT03190915|585251638|FG000|Overall Study|Progressive Disease|3|||
162053569|NCT03988088|585251642|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
162053570|NCT03988088|585251643|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
162053571|NCT03988088|585251644|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
162053572|NCT03988088|585251645|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
162053573|NCT03988088|585251642|FG000|Open-Label Addendum|Lost to Follow-up|0|||
162053574|NCT03988088|585251643|FG001|Open-Label Addendum|Lost to Follow-up|0|||
162053575|NCT03988088|585251644|FG002|Open-Label Addendum|Lost to Follow-up|1|||
162053576|NCT03988088|585251645|FG003|Open-Label Addendum|Lost to Follow-up|0|||
162053577|NCT01546883|585251646|FG000|Overall Study|Withdrawal by Subject|3|||
162053578|NCT01546883|585251646|FG000|Overall Study|Adverse Event|4|||
162053579|NCT01546883|585251646|FG000|Overall Study|Lost to Follow-up|2|||
162053580|NCT01546883|585251646|FG000|Overall Study|early closure of study|2|||
162053581|NCT01546883|585251646|FG000|Overall Study|other unrelated illness|1|||
162053582|NCT00923156|585251649|FG000|Overall Study|Adverse Event|0|||
162053583|NCT00923156|585251650|FG001|Overall Study|Adverse Event|2|||
162053584|NCT00923156|585251651|FG002|Overall Study|Adverse Event|1|||
162053585|NCT00923156|585251649|FG000|Overall Study|Abnormal laboratory values|0|||
162053586|NCT00923156|585251650|FG001|Overall Study|Abnormal laboratory values|0|||
162053587|NCT00923156|585251651|FG002|Overall Study|Abnormal laboratory values|1|||
162053588|NCT00923156|585251649|FG000|Overall Study|Withdrawal by Subject|0|||
162053589|NCT00923156|585251650|FG001|Overall Study|Withdrawal by Subject|1|||
162053590|NCT00923156|585251651|FG002|Overall Study|Withdrawal by Subject|0|||
162053591|NCT00923156|585251649|FG000|Overall Study|Death|0|||
162053592|NCT00923156|585251650|FG001|Overall Study|Death|1|||
162053593|NCT00923156|585251651|FG002|Overall Study|Death|0|||
162053594|NCT00923156|585251649|FG000|Overall Study|Lack of Efficacy|0|||
162053595|NCT00923156|585251650|FG001|Overall Study|Lack of Efficacy|0|||
162053596|NCT00923156|585251651|FG002|Overall Study|Lack of Efficacy|1|||
162053597|NCT00191139|585251654|FG000|Overall Study|Adverse Event|2|||
162053598|NCT00191139|585251655|FG001|Overall Study|Adverse Event|6|||
162053599|NCT00191139|585251654|FG000|Overall Study|Death|2|||
162053600|NCT00191139|585251655|FG001|Overall Study|Death|0|||
162053601|NCT00191139|585251654|FG000|Overall Study|Withdrawal by Subject|0|||
162053602|NCT00191139|585251655|FG001|Overall Study|Withdrawal by Subject|3|||
162053603|NCT00191139|585251654|FG000|Overall Study|Disease Progression|0|||
162053604|NCT00191139|585251655|FG001|Overall Study|Disease Progression|1|||
162053605|NCT00191139|585251654|FG000|Overall Study|Other|1|||
162053606|NCT00191139|585251655|FG001|Overall Study|Other|2|||
162053607|NCT02465515|585251658|FG000|Overall Study|Investigator site closed|4|||
162053608|NCT02465515|585251659|FG001|Overall Study|Investigator site closed|5|||
162053609|NCT02465515|585251658|FG000|Overall Study|Withdrawal by Subject|74|||
162053610|NCT02465515|585251659|FG001|Overall Study|Withdrawal by Subject|43|||
162053611|NCT02465515|585251658|FG000|Overall Study|Physician Decision|8|||
162053612|NCT02465515|585251659|FG001|Overall Study|Physician Decision|12|||
162053613|NCT02465515|585251658|FG000|Overall Study|Lost to Follow-up|68|||
162053614|NCT02465515|585251659|FG001|Overall Study|Lost to Follow-up|51|||
162053615|NCT00816595|585251660|FG000|Overall Study|Withdrawal by Subject|2|||
162053616|NCT00816595|585251661|FG001|Overall Study|Withdrawal by Subject|0|||
162053617|NCT00481078|585251665|FG000|Overall Study|Progression of disease|11|||
162053618|NCT00481078|585251666|FG001|Overall Study|Progression of disease|11|||
162053619|NCT00481078|585251665|FG000|Overall Study|Adverse Event|15|||
162053620|NCT00481078|585251666|FG001|Overall Study|Adverse Event|3|||
162053621|NCT00481078|585251665|FG000|Overall Study|Death|5|||
162053622|NCT00481078|585251666|FG001|Overall Study|Death|3|||
162053623|NCT00481078|585251665|FG000|Overall Study|Intercurrent illness|1|||
162053624|NCT00481078|585251666|FG001|Overall Study|Intercurrent illness|0|||
162053625|NCT00481078|585251665|FG000|Overall Study|Withdrawal by Subject|7|||
162053626|NCT00481078|585251666|FG001|Overall Study|Withdrawal by Subject|1|||
162053627|NCT00481078|585251665|FG000|Overall Study|Information not available|1|||
162053628|NCT00481078|585251666|FG001|Overall Study|Information not available|0|||
162053629|NCT00481078|585251665|FG000|Overall Study|Received other treatment|2|||
162053630|NCT00481078|585251666|FG001|Overall Study|Received other treatment|1|||
162053631|NCT00481078|585251665|FG000|Overall Study|Brain metastasis|0|||
162053632|NCT00481078|585251666|FG001|Overall Study|Brain metastasis|1|||
162053633|NCT00228384|585251667|FG000|Overall Study|Death|9|||
162053634|NCT00228384|585251668|FG001|Overall Study|Death|3|||
162053635|NCT00228384|585251667|FG000|Overall Study|Lost to Follow-up|6|||
162053636|NCT00228384|585251668|FG001|Overall Study|Lost to Follow-up|10|||
162053637|NCT00228384|585251667|FG000|Overall Study|Surgical Intervention (bypass)|5|||
162053638|NCT00228384|585251668|FG001|Overall Study|Surgical Intervention (bypass)|5|||
162053639|NCT00228384|585251667|FG000|Overall Study|Withdrawal by Subject|9|||
162053640|NCT00228384|585251668|FG001|Overall Study|Withdrawal by Subject|10|||
162053641|NCT00228384|585251667|FG000|Overall Study|Physician Decision|0|||
162053642|NCT00228384|585251668|FG001|Overall Study|Physician Decision|1|||
162053643|NCT01918774|585253473|FG000|Overall Study|Lost prior to first CBTw session|4|||
162053644|NCT01918774|585253473|FG000|Overall Study|Lost to Follow-up|1|||
162053645|NCT01389817|585253474|FG000|Overall Study|Physician Decision|1|||
162053646|NCT01389817|585253475|FG001|Overall Study|Physician Decision|0|||
162053647|NCT01389817|585253474|FG000|Overall Study|Lost to Follow-up|1|||
162053648|NCT01389817|585253475|FG001|Overall Study|Lost to Follow-up|0|||
162053649|NCT01389817|585253474|FG000|Overall Study|Withdrawal by Subject|2|||
162053650|NCT01389817|585253475|FG001|Overall Study|Withdrawal by Subject|0|||
162053651|NCT01749137|585253476|FG000|Overall Study|Adverse Event|4|||
162053652|NCT01749137|585253477|FG001|Overall Study|Adverse Event|4|||
162053653|NCT01749137|585253476|FG000|Overall Study|Lost to Follow-up|2|||
162053654|NCT01749137|585253477|FG001|Overall Study|Lost to Follow-up|3|||
162053655|NCT01749137|585253476|FG000|Overall Study|Physician Decision|1|||
162053656|NCT01749137|585253477|FG001|Overall Study|Physician Decision|0|||
162053657|NCT01749137|585253476|FG000|Overall Study|Withdrawal by Subject|8|||
162053658|NCT01749137|585253477|FG001|Overall Study|Withdrawal by Subject|4|||
162053659|NCT04980040|585253479|FG000|Overall Study|Violated the Inclusion Criteria|260|||
162053660|NCT04980040|585253479|FG000|Overall Study|Violated the Administration & Dosage|225|||
162053661|NCT04980040|585253479|FG000|Overall Study|Lost to Safety-Follow-up|4|||
162053662|NCT04980040|585253479|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
162053663|NCT03130257|585253480|FG000|Overall Study|Withdrawal by Subject|1|||
162053664|NCT03130257|585253481|FG001|Overall Study|Withdrawal by Subject|0|||
162053665|NCT03130257|585253482|FG002|Overall Study|Withdrawal by Subject|2|||
162053666|NCT01508650|585253483|FG000|Overall Study|Lost to Follow-up|0|||
162053667|NCT01508650|585253484|FG001|Overall Study|Lost to Follow-up|3|||
162053668|NCT02064894|585253485|FG000|Overall Study|Withdrawal by Subject|43|||
162053669|NCT02064894|585253486|FG001|Overall Study|Withdrawal by Subject|102|||
162053670|NCT02064894|585253487|FG002|Overall Study|Withdrawal by Subject|115|||
162053671|NCT01976338|585253488|FG000|Overall Study|Physician Decision|0|||
162053672|NCT01976338|585253489|FG001|Overall Study|Physician Decision|1|||
162053673|NCT01976338|585253488|FG000|Overall Study|Lost to Follow-up|3|||
162053674|NCT01976338|585253489|FG001|Overall Study|Lost to Follow-up|0|||
162053675|NCT01976338|585253488|FG000|Overall Study|Withdrawal by Subject|5|||
162053676|NCT01976338|585253489|FG001|Overall Study|Withdrawal by Subject|2|||
162053677|NCT01976338|585253488|FG000|Overall Study|Adverse Event|5|||
162053678|NCT01976338|585253489|FG001|Overall Study|Adverse Event|1|||
162053679|NCT00705484|585253492|FG000|Overall Study|Adverse Event|28|||
162053680|NCT00705484|585253493|FG001|Overall Study|Adverse Event|27|||
162053681|NCT00705484|585253492|FG000|Overall Study|Lost to Follow-up|169|||
162053682|NCT00705484|585253493|FG001|Overall Study|Lost to Follow-up|250|||
162053683|NCT00705484|585253492|FG000|Overall Study|Withdrawal by Subject|96|||
162053684|NCT00705484|585253493|FG001|Overall Study|Withdrawal by Subject|72|||
162053685|NCT00705484|585253492|FG000|Overall Study|Administrative|89|||
162053686|NCT00705484|585253493|FG001|Overall Study|Administrative|59|||
162053687|NCT02197247|585253494|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
162053688|NCT02197247|585253494|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
162053689|NCT02197247|585253494|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
162053690|NCT02197247|585253494|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
162053691|NCT02197247|585253494|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
162053692|NCT02197247|585253494|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
162053693|NCT02197247|585253494|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
162053694|NCT02197247|585253494|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
162053695|NCT01606007|585253495|FG000|Overall Study|Reason 'Other' in the protocol|0|||
162053696|NCT01606007|585253496|FG001|Overall Study|Reason 'Other' in the protocol|1|||
162053697|NCT01606007|585253497|FG002|Overall Study|Reason 'Other' in the protocol|1|||
162053698|NCT01606007|585253495|FG000|Overall Study|Pregnancy|0|||
162053699|NCT01606007|585253496|FG001|Overall Study|Pregnancy|1|||
162053700|NCT01606007|585253497|FG002|Overall Study|Pregnancy|1|||
162053701|NCT01606007|585253495|FG000|Overall Study|Withdrawal by Subject|8|||
162053702|NCT01606007|585253496|FG001|Overall Study|Withdrawal by Subject|6|||
162053703|NCT01606007|585253497|FG002|Overall Study|Withdrawal by Subject|1|||
162053704|NCT01606007|585253495|FG000|Overall Study|Adverse Event|0|||
162053705|NCT01606007|585253496|FG001|Overall Study|Adverse Event|1|||
162053706|NCT01606007|585253497|FG002|Overall Study|Adverse Event|1|||
162053707|NCT01606007|585253495|FG000|Overall Study|discontinue study treatment|0|||
162053708|NCT01606007|585253496|FG001|Overall Study|discontinue study treatment|2|||
162053709|NCT01606007|585253497|FG002|Overall Study|discontinue study treatment|1|||
162053710|NCT01606007|585253495|FG000|Overall Study|Lost to Follow-up|6|||
162053711|NCT01606007|585253496|FG001|Overall Study|Lost to Follow-up|8|||
162053712|NCT01606007|585253497|FG002|Overall Study|Lost to Follow-up|5|||
162053713|NCT01606007|585253495|FG000|Overall Study|Poor/Non-compliance|1|||
162053714|NCT01606007|585253496|FG001|Overall Study|Poor/Non-compliance|0|||
162053715|NCT01606007|585253497|FG002|Overall Study|Poor/Non-compliance|0|||
162053716|NCT00851747|585253499|FG000|Overall Study|Physician Decision|6|||
162053717|NCT00851747|585253500|FG001|Overall Study|Physician Decision|6|||
162053718|NCT00851747|585253501|FG002|Overall Study|Physician Decision|6|||
162053719|NCT02499783|585253504|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
162053720|NCT02499783|585253505|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
162053721|NCT02499783|585253506|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
162053722|NCT02499783|585253504|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
162053723|NCT02499783|585253505|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
162053724|NCT02499783|585253506|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
162053725|NCT02499783|585253504|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
162053726|NCT02499783|585253505|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
162053727|NCT02499783|585253506|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
162053728|NCT02499783|585253504|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
162053729|NCT02499783|585253505|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
162053730|NCT02499783|585253506|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
162053731|NCT02499783|585253504|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
162053732|NCT02499783|585253505|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
162053733|NCT02499783|585253506|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
162053734|NCT02499783|585253504|FG000|DB Period: Weeks 0-8|Other|1|||
162053735|NCT02499783|585253505|FG001|DB Period: Weeks 0-8|Other|1|||
162053736|NCT02499783|585253506|FG002|DB Period: Weeks 0-8|Other|0|||
162053737|NCT02499783|585253504|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
162053738|NCT02499783|585253505|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
162053739|NCT02499783|585253506|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
162053740|NCT02499783|585253504|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
162053741|NCT02499783|585253505|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
162053742|NCT02499783|585253506|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
162053743|NCT02499783|585253504|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
162053744|NCT02499783|585253505|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
162053745|NCT02499783|585253506|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
162053746|NCT02499783|585253504|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
162053747|NCT02499783|585253505|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
162053748|NCT02499783|585253506|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
162053749|NCT02228460|585253507|FG000|Overall Study|Adverse Event|1|||
162053750|NCT02228460|585253507|FG000|Overall Study|Lost to Follow-up|1|||
162053751|NCT01243892|585253508|FG000|Overall Study|Did not meet eligibility criteria|2|||
162053752|NCT01243892|585253509|FG001|Overall Study|Did not meet eligibility criteria|0|||
162053753|NCT00119106|585253514|FG000|Overall Study|HIV infected at baseline|179|||
162053754|NCT00119106|585253515|FG001|Overall Study|HIV infected at baseline|178|||
162053755|NCT01866293|585253516|FG000|Overall Study|Adverse Event|2|||
162053756|NCT01010061|585253517|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
162053757|NCT01010061|585253518|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
162053758|NCT01010061|585253517|FG000|Overall Study|Disease Progression|2|||
162053759|NCT01010061|585253518|FG001|Overall Study|Disease Progression|8|||
162053760|NCT01010061|585253517|FG000|Overall Study|Withdrew Consent|5|||
162053761|NCT01010061|585253518|FG001|Overall Study|Withdrew Consent|1|||
162053762|NCT01010061|585253517|FG000|Overall Study|Death|3|||
162053763|NCT01010061|585253518|FG001|Overall Study|Death|6|||
162053764|NCT01010061|585253517|FG000|Overall Study|Administrative/Other|0|||
162053765|NCT01010061|585253518|FG001|Overall Study|Administrative/Other|1|||
162053766|NCT01010061|585253517|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
162053767|NCT01010061|585253518|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
162053768|NCT01010061|585253517|FG000|Overall Study|Insufficient Therapeutic Response|1|||
162053769|NCT01010061|585253518|FG001|Overall Study|Insufficient Therapeutic Response|5|||
162053770|NCT01010061|585253517|FG000|Overall Study|Violation of Selection Criteria|0|||
162053771|NCT01010061|585253518|FG001|Overall Study|Violation of Selection Criteria|1|||
162053772|NCT01010061|585253517|FG000|Overall Study|Did Not Receive Treatment|2|||
162053773|NCT01010061|585253518|FG001|Overall Study|Did Not Receive Treatment|2|||
162053774|NCT03066804|585253519|FG000|Overall Study|Physician Decision|0|||
162053775|NCT03066804|585253520|FG001|Overall Study|Physician Decision|4|||
162053776|NCT03066804|585253519|FG000|Overall Study|Death|23|||
162053777|NCT03066804|585253520|FG001|Overall Study|Death|17|||
162053778|NCT03066804|585253519|FG000|Overall Study|Withdrawal by Subject|19|||
162053779|NCT03066804|585253520|FG001|Overall Study|Withdrawal by Subject|25|||
162053780|NCT03066804|585253519|FG000|Overall Study|Lost to Follow-up|2|||
162053781|NCT03066804|585253520|FG001|Overall Study|Lost to Follow-up|0|||
162053782|NCT03066804|585253519|FG000|Overall Study|Adverse Event|2|||
162053783|NCT03066804|585253520|FG001|Overall Study|Adverse Event|3|||
162053784|NCT03066804|585253519|FG000|Overall Study|Technical problems|5|||
162053785|NCT03066804|585253520|FG001|Overall Study|Technical problems|1|||
162053786|NCT03982368|585253525|FG000|Overall Study|Adverse Event|6|||
162053787|NCT03982368|585253526|FG001|Overall Study|Adverse Event|4|||
162053788|NCT03982368|585253527|FG002|Overall Study|Adverse Event|3|||
162053789|NCT03982368|585253525|FG000|Overall Study|Lost to Follow-up|2|||
162053790|NCT03982368|585253526|FG001|Overall Study|Lost to Follow-up|1|||
162053791|NCT03982368|585253527|FG002|Overall Study|Lost to Follow-up|0|||
162053792|NCT03982368|585253525|FG000|Overall Study|Withdrawal by Subject|1|||
162053793|NCT03982368|585253526|FG001|Overall Study|Withdrawal by Subject|2|||
162053794|NCT03982368|585253527|FG002|Overall Study|Withdrawal by Subject|0|||
162053795|NCT03982368|585253525|FG000|Overall Study|unknow|4|||
162053796|NCT03982368|585253526|FG001|Overall Study|unknow|0|||
162053797|NCT03982368|585253527|FG002|Overall Study|unknow|2|||
162053798|NCT03570697|585253528|FG000|Overall Study|Lost to Follow-up|0|||
162053799|NCT03570697|585253529|FG001|Overall Study|Lost to Follow-up|1|||
162053800|NCT03570697|585253528|FG000|Overall Study|Death|2|||
162053801|NCT03570697|585253529|FG001|Overall Study|Death|0|||
162053802|NCT03570697|585253528|FG000|Overall Study|Withdrawal by Subject|4|||
162053803|NCT03570697|585253529|FG001|Overall Study|Withdrawal by Subject|2|||
162053804|NCT00518284|585253530|FG000|Overall Study|Adverse Event|0|||
162053805|NCT00518284|585253531|FG001|Overall Study|Adverse Event|1|||
162053806|NCT00518284|585253532|FG002|Overall Study|Adverse Event|0|||
162053807|NCT00518284|585253533|FG003|Overall Study|Adverse Event|0|||
162053808|NCT00518284|585253530|FG000|Overall Study|Study Termination|0|||
162053809|NCT00518284|585253531|FG001|Overall Study|Study Termination|2|||
162053810|NCT00518284|585253532|FG002|Overall Study|Study Termination|1|||
162053811|NCT00518284|585253533|FG003|Overall Study|Study Termination|2|||
162053812|NCT01849783|585253534|FG000|Overall Study|Adverse Event|5|||
162053813|NCT01849783|585253534|FG000|Overall Study|Death|2|||
162053814|NCT01849783|585253534|FG000|Overall Study|Physician Decision|1|||
162053815|NCT01849783|585253534|FG000|Overall Study|Withdrawal by Subject|1|||
162053816|NCT01849783|585253534|FG000|Overall Study|Unable to comply|2|||
162053817|NCT01849783|585253534|FG000|Overall Study|Disease progression|11|||
162053818|NCT02571777|585253535|FG000|Overall Study|Subject/guardian decision|34|||
162053819|NCT02571777|585253536|FG001|Overall Study|Subject/guardian decision|26|||
162053820|NCT02571777|585253537|FG002|Overall Study|Subject/guardian decision|26|||
162053821|NCT02571777|585253538|FG003|Overall Study|Subject/guardian decision|25|||
162053822|NCT02571777|585253539|FG004|Overall Study|Subject/guardian decision|27|||
162053823|NCT02571777|585253535|FG000|Overall Study|Protocol Deviation|2|||
162053824|NCT02571777|585253536|FG001|Overall Study|Protocol Deviation|3|||
162053825|NCT02571777|585253537|FG002|Overall Study|Protocol Deviation|4|||
162053826|NCT02571777|585253538|FG003|Overall Study|Protocol Deviation|8|||
162053827|NCT02571777|585253539|FG004|Overall Study|Protocol Deviation|4|||
162053828|NCT02571777|585253535|FG000|Overall Study|Death|1|||
162053829|NCT02571777|585253536|FG001|Overall Study|Death|1|||
162053830|NCT02571777|585253537|FG002|Overall Study|Death|4|||
162053831|NCT02571777|585253538|FG003|Overall Study|Death|0|||
162053832|NCT02571777|585253539|FG004|Overall Study|Death|0|||
162053833|NCT02571777|585253535|FG000|Overall Study|Lost to Follow-up|1|||
162053834|NCT02571777|585253536|FG001|Overall Study|Lost to Follow-up|1|||
162053835|NCT02571777|585253537|FG002|Overall Study|Lost to Follow-up|2|||
162053836|NCT02571777|585253538|FG003|Overall Study|Lost to Follow-up|0|||
162053837|NCT02571777|585253539|FG004|Overall Study|Lost to Follow-up|1|||
162053838|NCT02571777|585253535|FG000|Overall Study|Physician Decision|1|||
162053839|NCT02571777|585253536|FG001|Overall Study|Physician Decision|7|||
162053840|NCT02571777|585253537|FG002|Overall Study|Physician Decision|5|||
162053841|NCT02571777|585253538|FG003|Overall Study|Physician Decision|2|||
162053842|NCT02571777|585253539|FG004|Overall Study|Physician Decision|4|||
162053843|NCT02571777|585253535|FG000|Overall Study|Pregnancy|0|||
162053844|NCT02571777|585253536|FG001|Overall Study|Pregnancy|0|||
162053845|NCT02571777|585253537|FG002|Overall Study|Pregnancy|0|||
162053846|NCT02571777|585253538|FG003|Overall Study|Pregnancy|2|||
162053847|NCT02571777|585253539|FG004|Overall Study|Pregnancy|0|||
162053848|NCT00801632|585253540|FG000|Overall Study|Re-transplant|1|||
162053849|NCT05393895|585253544|FG000|Overall Study|Adverse Event|2|||
162053850|NCT05393895|585253545|FG001|Overall Study|Adverse Event|3|||
162053851|NCT05393895|585253544|FG000|Overall Study|Lost to Follow-up|4|||
162053852|NCT05393895|585253545|FG001|Overall Study|Lost to Follow-up|3|||
162053853|NCT05393895|585253544|FG000|Overall Study|Protocol Violation|1|||
162053854|NCT05393895|585253545|FG001|Overall Study|Protocol Violation|0|||
162053855|NCT05393895|585253544|FG000|Overall Study|Withdrawal by Subject|1|||
162053856|NCT05393895|585253545|FG001|Overall Study|Withdrawal by Subject|4|||
162053857|NCT01203098|585253552|FG000|Overall Study|Adverse Event|3|||
162053858|NCT01203098|585253553|FG001|Overall Study|Adverse Event|1|||
162053859|NCT01203098|585253554|FG002|Overall Study|Adverse Event|7|||
162053860|NCT01203098|585253552|FG000|Overall Study|Lost to Follow-up|0|||
162053861|NCT01203098|585253553|FG001|Overall Study|Lost to Follow-up|0|||
162053862|NCT01203098|585253554|FG002|Overall Study|Lost to Follow-up|1|||
162053863|NCT01203098|585253552|FG000|Overall Study|Physician Decision|2|||
162053864|NCT01203098|585253553|FG001|Overall Study|Physician Decision|2|||
162053865|NCT01203098|585253554|FG002|Overall Study|Physician Decision|0|||
162053866|NCT01203098|585253552|FG000|Overall Study|Withdrawal by Subject|1|||
162053867|NCT01203098|585253553|FG001|Overall Study|Withdrawal by Subject|1|||
162053868|NCT01203098|585253554|FG002|Overall Study|Withdrawal by Subject|3|||
162053869|NCT03851705|585253559|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
162053870|NCT03851705|585253560|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
162053871|NCT03851705|585253561|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
162053872|NCT03851705|585253562|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
162053873|NCT03851705|585253559|FG000|Part 1: Double-Blind Period|Other reason|1|||
162053874|NCT03851705|585253560|FG001|Part 1: Double-Blind Period|Other reason|0|||
162053875|NCT03851705|585253561|FG002|Part 1: Double-Blind Period|Other reason|0|||
162053876|NCT03851705|585253562|FG003|Part 1: Double-Blind Period|Other reason|0|||
162053877|NCT03851705|585253559|FG000|Part 2: Open-Label Period|Other reason|0|||
162053878|NCT03851705|585253560|FG001|Part 2: Open-Label Period|Other reason|0|||
162053879|NCT03851705|585253561|FG002|Part 2: Open-Label Period|Other reason|0|||
162053880|NCT03851705|585253562|FG003|Part 2: Open-Label Period|Other reason|1|||
162053881|NCT03851705|585253559|FG000|Part 2: Open-Label Period|Death|0|||
162053882|NCT03851705|585253560|FG001|Part 2: Open-Label Period|Death|0|||
162053883|NCT03851705|585253561|FG002|Part 2: Open-Label Period|Death|3|||
162053884|NCT03851705|585253562|FG003|Part 2: Open-Label Period|Death|0|||
162053885|NCT03851705|585253559|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
162053886|NCT03851705|585253560|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
162053887|NCT03851705|585253561|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
162053888|NCT03851705|585253562|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
162053889|NCT03095612|585253563|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
162053890|NCT03095612|585253564|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
162053891|NCT03095612|585253565|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
162053892|NCT03095612|585253566|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
162053893|NCT03095612|585253567|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
162053894|NCT03095612|585253568|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
162053895|NCT03095612|585253569|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
162053896|NCT00621582|585253570|FG000|Overall Study|Adverse Event|7|||
162053897|NCT00621582|585253570|FG000|Overall Study|Protocol Violation|57|||
162053898|NCT00621582|585253570|FG000|Overall Study|Lost to Follow-up|24|||
162053899|NCT00621582|585253570|FG000|Overall Study|issues not identified by investigators|18|||
162053900|NCT01042678|585253571|FG000|Overall Study|Physician Decision|1|||
162053901|NCT01042678|585253572|FG001|Overall Study|Physician Decision|0|||
162053902|NCT01042678|585253573|FG002|Overall Study|Physician Decision|0|||
162053903|NCT01042678|585253574|FG003|Overall Study|Physician Decision|0|||
162053904|NCT01042678|585253575|FG004|Overall Study|Physician Decision|0|||
162053905|NCT01042678|585253576|FG005|Overall Study|Physician Decision|0|||
162053906|NCT03617185|585253577|FG000|Baseline|Lost to Follow-up|0|||
162053907|NCT03617185|585253578|FG001|Baseline|Lost to Follow-up|2|||
162053908|NCT03617185|585253579|FG002|Baseline|Lost to Follow-up|1|||
162053909|NCT03617185|585253580|FG003|Baseline|Lost to Follow-up|1|||
162053910|NCT03617185|585253577|FG000|Baseline|Withdrawal by Subject|0|||
162053911|NCT03617185|585253578|FG001|Baseline|Withdrawal by Subject|1|||
162053912|NCT03617185|585253579|FG002|Baseline|Withdrawal by Subject|0|||
162053913|NCT03617185|585253580|FG003|Baseline|Withdrawal by Subject|1|||
162053914|NCT03617185|585253577|FG000|Baseline|Driving Distance/Travel|0|||
162053915|NCT03617185|585253578|FG001|Baseline|Driving Distance/Travel|0|||
162053916|NCT03617185|585253579|FG002|Baseline|Driving Distance/Travel|2|||
162053917|NCT03617185|585253580|FG003|Baseline|Driving Distance/Travel|0|||
162053918|NCT03617185|585253577|FG000|Baseline|Family Obligations|0|||
162053919|NCT03617185|585253578|FG001|Baseline|Family Obligations|0|||
162053920|NCT03617185|585253579|FG002|Baseline|Family Obligations|0|||
162053921|NCT03617185|585253580|FG003|Baseline|Family Obligations|1|||
162053922|NCT03617185|585253577|FG000|3 Months|Lost to Follow-up|4|||
162053923|NCT03617185|585253578|FG001|3 Months|Lost to Follow-up|1|||
162053924|NCT03617185|585253579|FG002|3 Months|Lost to Follow-up|0|||
162053925|NCT03617185|585253580|FG003|3 Months|Lost to Follow-up|2|||
162053926|NCT03617185|585253577|FG000|3 Months|Withdrawal by Subject|1|||
162053927|NCT03617185|585253578|FG001|3 Months|Withdrawal by Subject|3|||
162053928|NCT03617185|585253579|FG002|3 Months|Withdrawal by Subject|0|||
162053929|NCT03617185|585253580|FG003|3 Months|Withdrawal by Subject|0|||
162053930|NCT03617185|585253577|FG000|3 Months|Driving Distance/Travel|1|||
162053931|NCT03617185|585253578|FG001|3 Months|Driving Distance/Travel|0|||
162053932|NCT03617185|585253579|FG002|3 Months|Driving Distance/Travel|0|||
162053933|NCT03617185|585253580|FG003|3 Months|Driving Distance/Travel|0|||
162053934|NCT03617185|585253577|FG000|3 Months|Family Obligations|0|||
162053935|NCT03617185|585253578|FG001|3 Months|Family Obligations|0|||
162053936|NCT03617185|585253579|FG002|3 Months|Family Obligations|0|||
162053937|NCT03617185|585253580|FG003|3 Months|Family Obligations|1|||
162053938|NCT03617185|585253577|FG000|12 Months|Lost to Follow-up|3|||
162053939|NCT03617185|585253578|FG001|12 Months|Lost to Follow-up|1|||
162053940|NCT03617185|585253579|FG002|12 Months|Lost to Follow-up|3|||
162053941|NCT03617185|585253580|FG003|12 Months|Lost to Follow-up|0|||
162053942|NCT03617185|585253577|FG000|12 Months|Withdrawal by Subject|0|||
162053943|NCT03617185|585253578|FG001|12 Months|Withdrawal by Subject|0|||
162053944|NCT03617185|585253579|FG002|12 Months|Withdrawal by Subject|0|||
162053945|NCT03617185|585253580|FG003|12 Months|Withdrawal by Subject|1|||
162053946|NCT03617185|585253577|FG000|12 Months|Driving Distance/Travel|0|||
162053947|NCT03617185|585253578|FG001|12 Months|Driving Distance/Travel|0|||
162053948|NCT03617185|585253579|FG002|12 Months|Driving Distance/Travel|1|||
162053949|NCT03617185|585253580|FG003|12 Months|Driving Distance/Travel|0|||
162053950|NCT01387932|585253582|FG000|Randomized and Treated|Physician Decision|3|||
162053951|NCT01387932|585253583|FG001|Randomized and Treated|Physician Decision|2|||
162053952|NCT01387932|585253582|FG000|Randomized and Treated|Withdrawal by Subject|4|||
162053953|NCT01387932|585253583|FG001|Randomized and Treated|Withdrawal by Subject|2|||
162053954|NCT01387932|585253582|FG000|Survival Follow-up|Liver Transplant|24|||
162053955|NCT01387932|585253583|FG001|Survival Follow-up|Liver Transplant|28|||
162053956|NCT01387932|585253582|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
162053957|NCT01387932|585253583|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
162053958|NCT01387932|585253582|FG000|Survival Follow-up|Withdrawal by Subject|2|||
162053959|NCT01387932|585253583|FG001|Survival Follow-up|Withdrawal by Subject|4|||
162053960|NCT01387932|585253582|FG000|Survival Follow-up|Lost to Follow-up|6|||
162053961|NCT01387932|585253583|FG001|Survival Follow-up|Lost to Follow-up|5|||
162053962|NCT01964430|585253584|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
162053963|NCT01964430|585253585|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
162053964|NCT01964430|585253584|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
162053965|NCT01964430|585253585|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
162053966|NCT01964430|585253584|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
162053967|NCT01964430|585253585|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
162053968|NCT01964430|585253584|FG000|Treatment Period|Adverse Event|71|||
162053969|NCT01964430|585253585|FG001|Treatment Period|Adverse Event|37|||
162053970|NCT01964430|585253584|FG000|Treatment Period|Withdrawal by Subject|36|||
162053971|NCT01964430|585253585|FG001|Treatment Period|Withdrawal by Subject|27|||
162053972|NCT01964430|585253584|FG000|Treatment Period|Death|1|||
162053973|NCT01964430|585253585|FG001|Treatment Period|Death|3|||
162053974|NCT01964430|585253584|FG000|Treatment Period|Protocol Deviation|0|||
162053975|NCT01964430|585253585|FG001|Treatment Period|Protocol Deviation|1|||
162053976|NCT01964430|585253584|FG000|Treatment Period|Physician Decision|5|||
162053977|NCT01964430|585253585|FG001|Treatment Period|Physician Decision|4|||
162053978|NCT01964430|585253584|FG000|Treatment Period|Disease Relapse|28|||
162053979|NCT01964430|585253585|FG001|Treatment Period|Disease Relapse|38|||
162053980|NCT01964430|585253584|FG000|Treatment Period|Other reasons|1|||
162053981|NCT01964430|585253585|FG001|Treatment Period|Other reasons|3|||
162053982|NCT02591290|585253586|FG000|Overall Study|Withdrawal by Subject|2|||
162053983|NCT02571075|585253589|FG000|Overall Study|Lost to Follow-up|20|||
162053984|NCT02571075|585253590|FG001|Overall Study|Lost to Follow-up|24|||
162053985|NCT02197520|585253593|FG000|Period 1|Withdrawal by Subject|1|||
162053986|NCT02197520|585253594|FG001|Period 1|Withdrawal by Subject|0|||
162053987|NCT02197520|585253593|FG000|Period 2|Adverse Event|0|||
162053988|NCT02197520|585253594|FG001|Period 2|Adverse Event|2|||
162053989|NCT02197520|585253593|FG000|Period 2|Withdrawal by Subject|1|||
162053990|NCT02197520|585253594|FG001|Period 2|Withdrawal by Subject|0|||
162053991|NCT00913497|585253595|FG000|Overall Study|Adverse Event|1|||
162053992|NCT00913497|585253595|FG000|Overall Study|Withdrawal by Subject|2|||
162053993|NCT02021773|585253610|FG000|Overall Study|Adverse Event|1|||
162053994|NCT02021773|585253611|FG001|Overall Study|Adverse Event|4|||
162053995|NCT02021773|585253612|FG002|Overall Study|Adverse Event|3|||
162053996|NCT02021773|585253610|FG000|Overall Study|Lack of Efficacy|2|||
162053997|NCT02021773|585253611|FG001|Overall Study|Lack of Efficacy|2|||
162053998|NCT02021773|585253612|FG002|Overall Study|Lack of Efficacy|2|||
162053999|NCT02021773|585253610|FG000|Overall Study|Protocol Violation|2|||
162054000|NCT02021773|585253611|FG001|Overall Study|Protocol Violation|3|||
162054001|NCT02021773|585253612|FG002|Overall Study|Protocol Violation|1|||
162054002|NCT02021773|585253610|FG000|Overall Study|Withdrawal by Subject|3|||
162054003|NCT02021773|585253611|FG001|Overall Study|Withdrawal by Subject|4|||
162054004|NCT02021773|585253612|FG002|Overall Study|Withdrawal by Subject|5|||
162054005|NCT02021773|585253610|FG000|Overall Study|Lost to Follow-up|1|||
162054006|NCT02021773|585253611|FG001|Overall Study|Lost to Follow-up|3|||
162054007|NCT02021773|585253612|FG002|Overall Study|Lost to Follow-up|0|||
162054008|NCT02021773|585253610|FG000|Overall Study|Reason not specified|3|||
162054009|NCT02021773|585253611|FG001|Overall Study|Reason not specified|0|||
162054010|NCT02021773|585253612|FG002|Overall Study|Reason not specified|0|||
162054011|NCT01253408|585253616|FG000|Overall Study|Adverse Event|0|||
162054012|NCT01253408|585253617|FG001|Overall Study|Adverse Event|1|||
162054013|NCT01253408|585253618|FG002|Overall Study|Adverse Event|0|||
162054014|NCT03408483|585253619|FG000|Overall Study|Physician Decision|3|||
162054015|NCT03408483|585253620|FG001|Overall Study|Physician Decision|3|||
162054016|NCT03408483|585253619|FG000|Overall Study|Lost to Follow-up|3|||
162054017|NCT03408483|585253620|FG001|Overall Study|Lost to Follow-up|0|||
162054018|NCT00478231|585253621|FG000|Overall Study|Death|7|||
162054019|NCT00478231|585253621|FG000|Overall Study|Lack of Efficacy|47|||
162054020|NCT00478231|585253621|FG000|Overall Study|Lost to Follow-up|7|||
162054021|NCT00478231|585253621|FG000|Overall Study|Withdrawal by Subject|6|||
162054022|NCT00478231|585253621|FG000|Overall Study|Other|9|||
162054023|NCT00478231|585253621|FG000|Overall Study|Adverse Event|5|||
162054024|NCT00478231|585253621|FG000|Overall Study|Randomized, not treated|3|||
162054025|NCT01817530|585253622|FG000|Overall Study|Exclusionary Medication Received|0|||
162054026|NCT01817530|585253623|FG001|Overall Study|Exclusionary Medication Received|0|||
162054027|NCT01817530|585253624|FG002|Overall Study|Exclusionary Medication Received|0|||
162054028|NCT01817530|585253625|FG003|Overall Study|Exclusionary Medication Received|0|||
162054029|NCT01817530|585253626|FG004|Overall Study|Exclusionary Medication Received|1|||
162054030|NCT01817530|585253627|FG005|Overall Study|Exclusionary Medication Received|0|||
162054031|NCT01817530|585253628|FG006|Overall Study|Exclusionary Medication Received|0|||
162054032|NCT01817530|585253629|FG007|Overall Study|Exclusionary Medication Received|0|||
162054033|NCT01817530|585253622|FG000|Overall Study|Adverse Event|6|||
162054034|NCT01817530|585253623|FG001|Overall Study|Adverse Event|3|||
162054035|NCT01817530|585253624|FG002|Overall Study|Adverse Event|2|||
162054036|NCT01817530|585253625|FG003|Overall Study|Adverse Event|5|||
162054037|NCT01817530|585253626|FG004|Overall Study|Adverse Event|0|||
162054038|NCT01817530|585253627|FG005|Overall Study|Adverse Event|10|||
162054039|NCT01817530|585253628|FG006|Overall Study|Adverse Event|5|||
162054040|NCT01817530|585253629|FG007|Overall Study|Adverse Event|8|||
162054041|NCT01817530|585253622|FG000|Overall Study|Subject Noncompliant|3|||
162054042|NCT01817530|585253623|FG001|Overall Study|Subject Noncompliant|1|||
162054043|NCT01817530|585253624|FG002|Overall Study|Subject Noncompliant|0|||
162054044|NCT01817530|585253625|FG003|Overall Study|Subject Noncompliant|4|||
162054045|NCT01817530|585253626|FG004|Overall Study|Subject Noncompliant|0|||
162054046|NCT01817530|585253627|FG005|Overall Study|Subject Noncompliant|1|||
162054047|NCT01817530|585253628|FG006|Overall Study|Subject Noncompliant|1|||
162054048|NCT01817530|585253629|FG007|Overall Study|Subject Noncompliant|1|||
162054049|NCT01817530|585253622|FG000|Overall Study|Lack of Efficacy|1|||
162054050|NCT01817530|585253623|FG001|Overall Study|Lack of Efficacy|0|||
162054051|NCT01817530|585253624|FG002|Overall Study|Lack of Efficacy|0|||
162054052|NCT01817530|585253625|FG003|Overall Study|Lack of Efficacy|0|||
162054053|NCT01817530|585253626|FG004|Overall Study|Lack of Efficacy|0|||
162054054|NCT01817530|585253627|FG005|Overall Study|Lack of Efficacy|1|||
162054055|NCT01817530|585253628|FG006|Overall Study|Lack of Efficacy|0|||
162054056|NCT01817530|585253629|FG007|Overall Study|Lack of Efficacy|1|||
162054057|NCT01817530|585253622|FG000|Overall Study|Pregnancy|0|||
162054058|NCT01817530|585253623|FG001|Overall Study|Pregnancy|0|||
162054059|NCT01817530|585253624|FG002|Overall Study|Pregnancy|0|||
162054060|NCT01817530|585253625|FG003|Overall Study|Pregnancy|0|||
162054061|NCT01817530|585253626|FG004|Overall Study|Pregnancy|0|||
162054062|NCT01817530|585253627|FG005|Overall Study|Pregnancy|1|||
162054063|NCT01817530|585253628|FG006|Overall Study|Pregnancy|0|||
162054064|NCT01817530|585253629|FG007|Overall Study|Pregnancy|0|||
162054065|NCT01817530|585253622|FG000|Overall Study|Other|0|||
162054066|NCT01817530|585253623|FG001|Overall Study|Other|1|||
162054067|NCT01817530|585253624|FG002|Overall Study|Other|0|||
162054068|NCT01817530|585253625|FG003|Overall Study|Other|0|||
162054069|NCT01817530|585253626|FG004|Overall Study|Other|1|||
162054070|NCT01817530|585253627|FG005|Overall Study|Other|0|||
162054071|NCT01817530|585253628|FG006|Overall Study|Other|5|||
162054072|NCT01817530|585253629|FG007|Overall Study|Other|0|||
162054073|NCT01817530|585253622|FG000|Overall Study|Surgery or Invasive Intervention|1|||
162054074|NCT01817530|585253623|FG001|Overall Study|Surgery or Invasive Intervention|0|||
162054075|NCT01817530|585253624|FG002|Overall Study|Surgery or Invasive Intervention|0|||
162054076|NCT01817530|585253625|FG003|Overall Study|Surgery or Invasive Intervention|0|||
162054077|NCT01817530|585253626|FG004|Overall Study|Surgery or Invasive Intervention|1|||
162054078|NCT01817530|585253627|FG005|Overall Study|Surgery or Invasive Intervention|1|||
162054079|NCT01817530|585253628|FG006|Overall Study|Surgery or Invasive Intervention|1|||
162054080|NCT01817530|585253629|FG007|Overall Study|Surgery or Invasive Intervention|0|||
162054081|NCT01817530|585253622|FG000|Overall Study|Consent Withdrawn by Subject|3|||
162054082|NCT01817530|585253623|FG001|Overall Study|Consent Withdrawn by Subject|4|||
162054083|NCT01817530|585253624|FG002|Overall Study|Consent Withdrawn by Subject|7|||
162054084|NCT01817530|585253625|FG003|Overall Study|Consent Withdrawn by Subject|3|||
162054085|NCT01817530|585253626|FG004|Overall Study|Consent Withdrawn by Subject|5|||
162054086|NCT01817530|585253627|FG005|Overall Study|Consent Withdrawn by Subject|3|||
162054087|NCT01817530|585253628|FG006|Overall Study|Consent Withdrawn by Subject|3|||
162054088|NCT01817530|585253629|FG007|Overall Study|Consent Withdrawn by Subject|10|||
162054089|NCT01817530|585253622|FG000|Overall Study|Lost to Follow-up|1|||
162054090|NCT01817530|585253623|FG001|Overall Study|Lost to Follow-up|4|||
162054091|NCT01817530|585253624|FG002|Overall Study|Lost to Follow-up|2|||
162054092|NCT01817530|585253625|FG003|Overall Study|Lost to Follow-up|1|||
162054093|NCT01817530|585253626|FG004|Overall Study|Lost to Follow-up|3|||
162054094|NCT01817530|585253627|FG005|Overall Study|Lost to Follow-up|2|||
162054095|NCT01817530|585253628|FG006|Overall Study|Lost to Follow-up|8|||
162054096|NCT01817530|585253629|FG007|Overall Study|Lost to Follow-up|4|||
162054097|NCT00566995|585253630|FG000|Overall Study|Toxicity|4|||
162054098|NCT00566995|585253630|FG000|Overall Study|Withdrew consent|3|||
162054099|NCT02657369|585253631|FG000|Overall Study|Death|27|||
162054100|NCT02657369|585253631|FG000|Overall Study|Study terminated by sponsor|7|||
162054101|NCT00074152|585253632|FG000|Overall Study|Death|21|||
162054102|NCT00074152|585253633|FG001|Overall Study|Death|9|||
162054103|NCT00074152|585253632|FG000|Overall Study|Lack of Efficacy|34|||
162054104|NCT00074152|585253633|FG001|Overall Study|Lack of Efficacy|24|||
162054105|NCT01785069|585253634|FG000|Overall Study|Implanted with nonstudy device|1|||
162054106|NCT01785069|585253635|FG001|Overall Study|Implanted with nonstudy device|2|||
162054107|NCT01785069|585253636|FG002|Overall Study|Implanted with nonstudy device|1|||
162054108|NCT01785069|585253637|FG003|Overall Study|Implanted with nonstudy device|0|||
162054109|NCT01785069|585253634|FG000|Overall Study|Death|0|||
162054110|NCT01785069|585253635|FG001|Overall Study|Death|0|||
162054111|NCT01785069|585253636|FG002|Overall Study|Death|2|||
162054112|NCT01785069|585253637|FG003|Overall Study|Death|0|||
162054113|NCT01785069|585253634|FG000|Overall Study|Subject choice|2|||
162054114|NCT01785069|585253635|FG001|Overall Study|Subject choice|2|||
162054115|NCT01785069|585253636|FG002|Overall Study|Subject choice|0|||
162054116|NCT01785069|585253637|FG003|Overall Study|Subject choice|1|||
162054117|NCT01785069|585253634|FG000|Overall Study|Lost to Follow-up|1|||
162054118|NCT01785069|585253635|FG001|Overall Study|Lost to Follow-up|2|||
162054119|NCT01785069|585253636|FG002|Overall Study|Lost to Follow-up|4|||
162054120|NCT01785069|585253637|FG003|Overall Study|Lost to Follow-up|1|||
162054121|NCT01785069|585253634|FG000|Overall Study|Reason not Specified|1|||
162054122|NCT01785069|585253635|FG001|Overall Study|Reason not Specified|2|||
162054123|NCT01785069|585253636|FG002|Overall Study|Reason not Specified|1|||
162054124|NCT01785069|585253637|FG003|Overall Study|Reason not Specified|4|||
162054125|NCT01785069|585253634|FG000|Overall Study|Not evaluable|7|||
162054126|NCT01785069|585253635|FG001|Overall Study|Not evaluable|4|||
162054127|NCT01785069|585253636|FG002|Overall Study|Not evaluable|5|||
162054128|NCT01785069|585253637|FG003|Overall Study|Not evaluable|8|||
162054129|NCT03288129|585253638|FG000|Overall Study|Adverse Event|10|||
162054130|NCT03288129|585253638|FG000|Overall Study|Lost to Follow-up|3|||
162054131|NCT03288129|585253638|FG000|Overall Study|Withdrawal by Subject|3|||
162054132|NCT03288129|585253638|FG000|Overall Study|Withdrawal of consent/assent|1|||
162054133|NCT03288129|585253638|FG000|Overall Study|Other|5|||
162054134|NCT01744197|585253641|FG000|Overall Study|Received 1 patch|2|||
162054135|NCT01744197|585253642|FG001|Overall Study|Received 1 patch|1|||
162054136|NCT01744197|585253641|FG000|Overall Study|No patch received|2|||
162054137|NCT01744197|585253642|FG001|Overall Study|No patch received|2|||
162054138|NCT02777333|585253643|FG000|Overall Study|Withdrawal by Subject|0|||
162054139|NCT02777333|585253644|FG001|Overall Study|Withdrawal by Subject|1|||
162054140|NCT02777333|585253643|FG000|Overall Study|Lost to Follow-up|0|||
162054141|NCT02777333|585253644|FG001|Overall Study|Lost to Follow-up|1|||
162054142|NCT01606800|585255506|FG000|Overall Study|Adverse Event|3|||
162054143|NCT01606800|585255507|FG001|Overall Study|Adverse Event|1|||
162054144|NCT01606800|585255506|FG000|Overall Study|Participant withdrew consent|0|||
162054145|NCT01606800|585255507|FG001|Overall Study|Participant withdrew consent|1|||
162054146|NCT01606800|585255506|FG000|Overall Study|Missing completion status|2|||
162054147|NCT01606800|585255507|FG001|Overall Study|Missing completion status|0|||
162054148|NCT02370160|585255511|FG000|Overall Study|Death|3|||
162054149|NCT02370160|585255512|FG001|Overall Study|Death|4|||
162054150|NCT02370160|585255513|FG002|Overall Study|Death|1|||
162054151|NCT04487730|585255514|FG000|Overall Study|Withdrawal by Subject|3|||
162054152|NCT04487730|585255515|FG001|Overall Study|Withdrawal by Subject|1|||
162054153|NCT04487730|585255514|FG000|Overall Study|Lost to Follow-up|0|||
162054154|NCT04487730|585255515|FG001|Overall Study|Lost to Follow-up|1|||
162054155|NCT04487730|585255514|FG000|Overall Study|Physician Decision|0|||
162054156|NCT04487730|585255515|FG001|Overall Study|Physician Decision|1|||
162054157|NCT01970397|585255518|FG000|Overall Study|Adverse Event|0|||
162054158|NCT01970397|585255519|FG001|Overall Study|Adverse Event|1|||
162054159|NCT01970397|585255518|FG000|Overall Study|Lost to Follow-up|0|||
162054160|NCT01970397|585255519|FG001|Overall Study|Lost to Follow-up|1|||
162054161|NCT01970397|585255518|FG000|Overall Study|Personal Reasons|1|||
162054162|NCT01970397|585255519|FG001|Overall Study|Personal Reasons|2|||
162054163|NCT01970397|585255518|FG000|Overall Study|Protocol Violation|1|||
162054164|NCT01970397|585255519|FG001|Overall Study|Protocol Violation|1|||
162054165|NCT03305575|585255520|FG000|Overall Study|Physician Decision|1|||
162054166|NCT03305575|585255521|FG001|Overall Study|Physician Decision|0|||
162054167|NCT02871297|585255529|FG000|Overall Study|Adverse Event|34|||
162054168|NCT02871297|585255529|FG000|Overall Study|Lack of Efficacy|10|||
162054169|NCT02871297|585255529|FG000|Overall Study|Non-compliance with study drug|15|||
162054170|NCT02871297|585255529|FG000|Overall Study|Protocol Violation|3|||
162054171|NCT02871297|585255529|FG000|Overall Study|Withdrawal by Subject|20|||
162054172|NCT02871297|585255529|FG000|Overall Study|Lost to Follow-up|13|||
162054173|NCT02871297|585255529|FG000|Overall Study|Rolled over to 13546A|2|||
162054174|NCT02871297|585255529|FG000|Overall Study|Other than specified|39|||
162054175|NCT02966028|585255530|FG000|Overall Study|Adverse Event|7|||
162054176|NCT02966028|585255531|FG001|Overall Study|Adverse Event|13|||
162054177|NCT02966028|585255532|FG002|Overall Study|Adverse Event|10|||
162054178|NCT02966028|585255530|FG000|Overall Study|Physician Decision|1|||
162054179|NCT02966028|585255531|FG001|Overall Study|Physician Decision|0|||
162054180|NCT02966028|585255532|FG002|Overall Study|Physician Decision|2|||
162054181|NCT02966028|585255530|FG000|Overall Study|Withdrawal by Subject|7|||
162054182|NCT02966028|585255531|FG001|Overall Study|Withdrawal by Subject|5|||
162054183|NCT02966028|585255532|FG002|Overall Study|Withdrawal by Subject|5|||
162054184|NCT02966028|585255530|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
162054185|NCT02966028|585255531|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
162054186|NCT02966028|585255532|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
162054187|NCT04115839|585255533|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
162054188|NCT04115839|585255534|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
162054189|NCT04115839|585255535|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
162054190|NCT04115839|585255536|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
162054191|NCT04115839|585255537|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
162054192|NCT04115839|585255538|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
162054193|NCT04115839|585255539|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
162054194|NCT04115839|585255533|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
162054195|NCT04115839|585255534|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
162054196|NCT04115839|585255535|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
162054197|NCT04115839|585255536|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
162054198|NCT04115839|585255537|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
162054199|NCT04115839|585255538|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
162054200|NCT04115839|585255539|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
162054201|NCT04115839|585255533|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
162054202|NCT04115839|585255534|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
162054203|NCT04115839|585255535|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
162054204|NCT04115839|585255536|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
162054205|NCT04115839|585255537|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
162054206|NCT04115839|585255538|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
162054207|NCT04115839|585255539|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
162054208|NCT04115839|585255533|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
162054209|NCT04115839|585255534|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
162054210|NCT04115839|585255535|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
162054211|NCT04115839|585255536|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
162054212|NCT04115839|585255537|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
162054213|NCT04115839|585255538|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
162054214|NCT04115839|585255539|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
162054215|NCT04115839|585255533|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
162054216|NCT04115839|585255534|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
162054217|NCT04115839|585255535|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
162054218|NCT04115839|585255536|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
162054219|NCT04115839|585255537|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
162054220|NCT04115839|585255538|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
162054221|NCT04115839|585255539|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
162054222|NCT04115839|585255533|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
162054223|NCT04115839|585255534|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
162054224|NCT04115839|585255535|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
162054225|NCT04115839|585255536|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
162054226|NCT04115839|585255537|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
162054227|NCT04115839|585255538|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
162054228|NCT04115839|585255539|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
162054229|NCT01408485|585255540|FG000|Overall Study|Withdrawal by Subject|21|||
162054230|NCT02151591|585255541|FG000|Overall Study|Lost to Follow-up|6|||
162054231|NCT02151591|585255542|FG001|Overall Study|Lost to Follow-up|3|||
162054232|NCT01342796|585255543|FG000|Overall Study|Withdrawal by Subject|2|||
162054233|NCT01342796|585255544|FG001|Overall Study|Withdrawal by Subject|0|||
162054234|NCT01342796|585255543|FG000|Overall Study|Lost to Follow-up|0|||
162054235|NCT01342796|585255544|FG001|Overall Study|Lost to Follow-up|3|||
162054236|NCT01342796|585255543|FG000|Overall Study|Inappropriate enrollment|1|||
162054237|NCT01342796|585255544|FG001|Overall Study|Inappropriate enrollment|0|||
162054238|NCT01751867|585255545|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
162054239|NCT01751867|585255546|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
162054240|NCT01751867|585255545|FG000|Overall Study|Diease Progression|4|||
162054241|NCT01751867|585255546|FG001|Overall Study|Diease Progression|18|||
162054242|NCT01751867|585255545|FG000|Overall Study|Adverse Event|8|||
162054243|NCT01751867|585255546|FG001|Overall Study|Adverse Event|15|||
162054244|NCT01751867|585255545|FG000|Overall Study|Poor Compliance|0|||
162054245|NCT01751867|585255546|FG001|Overall Study|Poor Compliance|5|||
162054246|NCT01751867|585255545|FG000|Overall Study|Withdrawal by Subject|3|||
162054247|NCT01751867|585255546|FG001|Overall Study|Withdrawal by Subject|1|||
162054248|NCT01751867|585255545|FG000|Overall Study|Physician Decision|4|||
162054249|NCT01751867|585255546|FG001|Overall Study|Physician Decision|7|||
162054250|NCT01751867|585255545|FG000|Overall Study|Protocol Violation|0|||
162054251|NCT01751867|585255546|FG001|Overall Study|Protocol Violation|2|||
162054252|NCT01751867|585255545|FG000|Overall Study|Death|0|||
162054253|NCT01751867|585255546|FG001|Overall Study|Death|5|||
162054254|NCT01751867|585255545|FG000|Overall Study|Other|11|||
162054255|NCT01751867|585255546|FG001|Overall Study|Other|37|||
162054256|NCT01751867|585255545|FG000|Overall Study|Randomized but not treated.|2|||
162054257|NCT01751867|585255546|FG001|Overall Study|Randomized but not treated.|1|||
162054258|NCT01396148|585255547|FG000|Overall Study|Patient Decision|1|||
162054259|NCT00224042|585255556|FG000|Overall Study|Adverse Event|2|||
162054260|NCT00224042|585255557|FG001|Overall Study|Adverse Event|1|||
162054261|NCT00224042|585255556|FG000|Overall Study|Protocol Violation|0|||
162054262|NCT00224042|585255557|FG001|Overall Study|Protocol Violation|1|||
162054263|NCT00224042|585255556|FG000|Overall Study|Physician Decision|0|||
162054264|NCT00224042|585255557|FG001|Overall Study|Physician Decision|1|||
162054265|NCT00224042|585255556|FG000|Overall Study|Did not meet lab incusion criteria|2|||
162054266|NCT00224042|585255557|FG001|Overall Study|Did not meet lab incusion criteria|3|||
162054267|NCT00224042|585255556|FG000|Overall Study|Other|2|||
162054268|NCT00224042|585255557|FG001|Overall Study|Other|0|||
162054269|NCT00840450|585255558|FG000|Overall Study|Adverse Event|1|||
162054270|NCT00840450|585255558|FG000|Overall Study|Lack of Efficacy|2|||
162054271|NCT03095066|585255559|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
162054272|NCT03095066|585255560|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
162054273|NCT03095066|585255561|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
162054274|NCT03095066|585255562|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
162054275|NCT03095066|585255563|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
162054276|NCT03095066|585255564|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
162054277|NCT03095066|585255565|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
162054278|NCT03095066|585255566|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
162054279|NCT03095066|585255559|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
162054280|NCT03095066|585255560|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
162054281|NCT03095066|585255561|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
162054282|NCT03095066|585255562|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
162054283|NCT03095066|585255563|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
162054284|NCT03095066|585255564|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
162054285|NCT03095066|585255565|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
162054286|NCT03095066|585255566|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
162054287|NCT03095066|585255559|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
162054288|NCT03095066|585255560|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
162054289|NCT03095066|585255561|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
162054290|NCT03095066|585255562|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
162054291|NCT03095066|585255563|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
162054292|NCT03095066|585255564|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
162054293|NCT03095066|585255565|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
162054294|NCT03095066|585255566|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
162054295|NCT03095066|585255559|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162054296|NCT03095066|585255560|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
162054297|NCT03095066|585255561|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162054298|NCT03095066|585255562|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162054299|NCT03095066|585255563|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162054300|NCT03095066|585255564|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162054301|NCT03095066|585255565|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162054302|NCT03095066|585255566|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
162054303|NCT03095066|585255559|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
162054304|NCT03095066|585255560|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
162054305|NCT03095066|585255561|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
162054306|NCT03095066|585255562|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
162054307|NCT03095066|585255563|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
162054308|NCT03095066|585255564|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
162054309|NCT03095066|585255565|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
162054310|NCT03095066|585255566|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
162054311|NCT03095066|585255559|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
162054312|NCT03095066|585255560|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162054313|NCT03095066|585255561|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162054314|NCT03095066|585255562|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162054315|NCT03095066|585255563|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162054316|NCT03095066|585255564|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162054317|NCT03095066|585255565|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162054318|NCT03095066|585255566|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
162054319|NCT03095066|585255559|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
162054320|NCT03095066|585255560|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
162054321|NCT03095066|585255561|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
162054322|NCT03095066|585255562|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
162054323|NCT03095066|585255563|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
162054324|NCT03095066|585255564|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
162054325|NCT03095066|585255565|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
162054326|NCT03095066|585255566|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
162054327|NCT03095066|585255559|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
162054328|NCT03095066|585255560|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
162054329|NCT03095066|585255561|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162054330|NCT03095066|585255562|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162054331|NCT03095066|585255563|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162054332|NCT03095066|585255564|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162054333|NCT03095066|585255565|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162054334|NCT03095066|585255566|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
162054335|NCT03095066|585255559|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
162054336|NCT03095066|585255560|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
162054337|NCT03095066|585255561|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
162054338|NCT03095066|585255562|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
162054339|NCT03095066|585255563|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
162054340|NCT03095066|585255564|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
162054341|NCT03095066|585255565|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
162054342|NCT03095066|585255566|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
162054343|NCT03095066|585255559|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
162054344|NCT03095066|585255560|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
162054345|NCT03095066|585255561|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
162054346|NCT03095066|585255562|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
162054347|NCT03095066|585255563|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
162054348|NCT03095066|585255564|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
162054349|NCT03095066|585255565|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
162054350|NCT03095066|585255566|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
162054351|NCT03095066|585255559|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
162054352|NCT03095066|585255560|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
162054353|NCT03095066|585255561|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
162054354|NCT03095066|585255562|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
162054355|NCT03095066|585255563|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
162054356|NCT03095066|585255564|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
162054357|NCT03095066|585255565|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
162054358|NCT03095066|585255566|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
162054359|NCT03095066|585255559|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
162054360|NCT03095066|585255560|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
162054361|NCT03095066|585255561|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
162054362|NCT03095066|585255562|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
162054363|NCT03095066|585255563|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
162054364|NCT03095066|585255564|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
162054365|NCT03095066|585255565|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
162054366|NCT03095066|585255566|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
162054367|NCT03095066|585255559|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162054368|NCT03095066|585255560|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162054369|NCT03095066|585255561|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
162054370|NCT03095066|585255562|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162054371|NCT03095066|585255563|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162054372|NCT03095066|585255564|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162054373|NCT03095066|585255565|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162054374|NCT03095066|585255566|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
162054375|NCT03095066|585255559|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
162054376|NCT03095066|585255560|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
162054377|NCT03095066|585255561|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
162054378|NCT03095066|585255562|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
162054379|NCT03095066|585255563|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
162054380|NCT03095066|585255564|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
162054381|NCT03095066|585255565|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
162054382|NCT03095066|585255566|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
162054383|NCT03095066|585255559|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162054384|NCT03095066|585255560|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162054385|NCT03095066|585255561|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162054386|NCT03095066|585255562|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162054387|NCT03095066|585255563|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162054388|NCT03095066|585255564|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162054389|NCT03095066|585255565|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
162054390|NCT03095066|585255566|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
162054391|NCT03095066|585255559|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162054392|NCT03095066|585255560|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162054393|NCT03095066|585255561|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162054394|NCT03095066|585255562|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162054395|NCT03095066|585255563|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162054396|NCT03095066|585255564|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
162054397|NCT03095066|585255565|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162054398|NCT03095066|585255566|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
162054399|NCT03095066|585255559|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162054400|NCT03095066|585255560|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162054401|NCT03095066|585255561|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162054402|NCT03095066|585255562|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162054403|NCT03095066|585255563|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
162054404|NCT03095066|585255564|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162054405|NCT03095066|585255565|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
162054406|NCT03095066|585255566|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
162054407|NCT03095066|585255559|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
162054408|NCT03095066|585255560|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
162054409|NCT03095066|585255561|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
162054410|NCT03095066|585255562|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
162054411|NCT03095066|585255563|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
162054412|NCT03095066|585255564|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
162054413|NCT03095066|585255565|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
162054414|NCT03095066|585255566|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
162054415|NCT03095066|585255559|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
162054416|NCT03095066|585255560|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
162054417|NCT03095066|585255561|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
162054418|NCT03095066|585255562|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
162054419|NCT03095066|585255563|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
162054420|NCT03095066|585255564|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
162054421|NCT03095066|585255565|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
162054422|NCT03095066|585255566|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
162054423|NCT03095066|585255559|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
162054424|NCT03095066|585255560|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
162054425|NCT03095066|585255561|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
162054426|NCT03095066|585255562|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
162054427|NCT03095066|585255563|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
162054428|NCT03095066|585255564|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
162054429|NCT03095066|585255565|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
162054430|NCT03095066|585255566|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
162054431|NCT00160693|585255567|FG000|Overall Study|Adverse Event|97|||
162054432|NCT00160693|585255567|FG000|Overall Study|Lack of Efficacy|30|||
162054433|NCT00160693|585255567|FG000|Overall Study|Protocol Violation|24|||
162054434|NCT00160693|585255567|FG000|Overall Study|Lost to Follow-up|15|||
162054435|NCT00160693|585255567|FG000|Overall Study|Withdrawal by Subject|54|||
162054436|NCT00160693|585255567|FG000|Overall Study|Study terminated by sponsor|15|||
162054437|NCT03052725|585255568|FG000|Overall Study|Adverse Event|2|||
162054438|NCT03052725|585255569|FG001|Overall Study|Adverse Event|0|||
162054439|NCT03052725|585255568|FG000|Overall Study|Withdrawal by Subject|3|||
162054440|NCT03052725|585255569|FG001|Overall Study|Withdrawal by Subject|4|||
162054441|NCT03052725|585255568|FG000|Overall Study|Pregnancy|0|||
162054442|NCT03052725|585255569|FG001|Overall Study|Pregnancy|1|||
162054443|NCT03052725|585255568|FG000|Overall Study|Site closure|0|||
162054444|NCT03052725|585255569|FG001|Overall Study|Site closure|1|||
162054445|NCT03052725|585255568|FG000|Overall Study|Study terminated by sponsor|143|||
162054446|NCT03052725|585255569|FG001|Overall Study|Study terminated by sponsor|144|||
162054447|NCT00777608|585255571|FG000|Overall Study|Lost to Follow-up|1|||
162054448|NCT00777608|585255572|FG001|Overall Study|Lost to Follow-up|1|||
162054449|NCT00777608|585255571|FG000|Overall Study|Withdrawal by Subject|1|||
162054450|NCT00777608|585255572|FG001|Overall Study|Withdrawal by Subject|3|||
162054451|NCT00777608|585255571|FG000|Overall Study|Protocol Violation|1|||
162054452|NCT00777608|585255572|FG001|Overall Study|Protocol Violation|0|||
162054453|NCT00777608|585255571|FG000|Overall Study|Investigator Decision|1|||
162054454|NCT00777608|585255572|FG001|Overall Study|Investigator Decision|2|||
162054455|NCT00520936|585255574|FG000|Overall Study|Physician Decision|0|||
162054456|NCT00520936|585255575|FG001|Overall Study|Physician Decision|2|||
162054457|NCT00520936|585255576|FG002|Overall Study|Physician Decision|1|||
162054458|NCT00520936|585255577|FG003|Overall Study|Physician Decision|0|||
162054459|NCT00520936|585255578|FG004|Overall Study|Physician Decision|0|||
162054460|NCT00520936|585255579|FG005|Overall Study|Physician Decision|0|||
162054461|NCT00520936|585255580|FG006|Overall Study|Physician Decision|0|||
162054462|NCT00520936|585255581|FG007|Overall Study|Physician Decision|0|||
162054463|NCT00520936|585255574|FG000|Overall Study|Withdrawal by Subject|0|||
162054464|NCT00520936|585255575|FG001|Overall Study|Withdrawal by Subject|0|||
162054465|NCT00520936|585255576|FG002|Overall Study|Withdrawal by Subject|0|||
162054466|NCT00520936|585255577|FG003|Overall Study|Withdrawal by Subject|0|||
162054467|NCT00520936|585255578|FG004|Overall Study|Withdrawal by Subject|0|||
162054468|NCT00520936|585255579|FG005|Overall Study|Withdrawal by Subject|0|||
162054469|NCT00520936|585255580|FG006|Overall Study|Withdrawal by Subject|0|||
162054470|NCT00520936|585255581|FG007|Overall Study|Withdrawal by Subject|1|||
162122663|NCT00406419|585500293|FG001|Overall Study|Lost to Follow-up|10|||
162054471|NCT00520936|585255574|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
162054472|NCT00520936|585255575|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
162054473|NCT00520936|585255576|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
162054474|NCT00520936|585255577|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
162054475|NCT00520936|585255578|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
162054476|NCT00520936|585255579|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
162054477|NCT00520936|585255580|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
162054478|NCT00520936|585255581|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
162054479|NCT00520936|585255574|FG000|Overall Study|Death|0|||
162054480|NCT00520936|585255575|FG001|Overall Study|Death|0|||
162054481|NCT00520936|585255576|FG002|Overall Study|Death|0|||
162054482|NCT00520936|585255577|FG003|Overall Study|Death|0|||
162054483|NCT00520936|585255578|FG004|Overall Study|Death|0|||
162054484|NCT00520936|585255579|FG005|Overall Study|Death|0|||
162054485|NCT00520936|585255580|FG006|Overall Study|Death|1|||
162054486|NCT00520936|585255581|FG007|Overall Study|Death|0|||
162054487|NCT00520936|585255574|FG000|Overall Study|Protocol Violation|0|||
162054488|NCT00520936|585255575|FG001|Overall Study|Protocol Violation|1|||
162054489|NCT00520936|585255576|FG002|Overall Study|Protocol Violation|1|||
162054490|NCT00520936|585255577|FG003|Overall Study|Protocol Violation|0|||
162054491|NCT00520936|585255578|FG004|Overall Study|Protocol Violation|1|||
162054492|NCT00520936|585255579|FG005|Overall Study|Protocol Violation|0|||
162054493|NCT00520936|585255580|FG006|Overall Study|Protocol Violation|1|||
162054494|NCT00520936|585255581|FG007|Overall Study|Protocol Violation|0|||
162054495|NCT05988619|585255582|FG000|Overall Study|Lost to Follow-up|1|||
162054496|NCT05988619|585255583|FG001|Overall Study|Lost to Follow-up|4|||
162054497|NCT05988619|585255582|FG000|Overall Study|Withdrawal by Subject|2|||
162054498|NCT05988619|585255583|FG001|Overall Study|Withdrawal by Subject|9|||
162054499|NCT00726232|585255586|FG000|Initial Phase (Dose-finding)|Death|0|||
162054500|NCT00726232|585255587|FG001|Initial Phase (Dose-finding)|Death|0|||
162054501|NCT00726232|585255588|FG002|Initial Phase (Dose-finding)|Death|0|||
162054502|NCT00726232|585255589|FG003|Initial Phase (Dose-finding)|Death|0|||
162054503|NCT00726232|585255590|FG004|Initial Phase (Dose-finding)|Death|1|||
162054504|NCT00726232|585255591|FG005|Initial Phase (Dose-finding)|Death|0|||
162054505|NCT00726232|585255592|FG006|Initial Phase (Dose-finding)|Death|0|||
162054506|NCT00726232|585255593|FG007|Initial Phase (Dose-finding)|Death|0|||
162054507|NCT00726232|585255586|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
162054508|NCT00726232|585255587|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
162054509|NCT00726232|585255588|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
162054510|NCT00726232|585255589|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
162054511|NCT00726232|585255590|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
162054512|NCT00726232|585255591|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
162054513|NCT00726232|585255592|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
162054514|NCT00726232|585255593|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
162054515|NCT00726232|585255586|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
162054516|NCT00726232|585255587|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
162054517|NCT00726232|585255588|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
162054518|NCT00726232|585255589|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
162054519|NCT00726232|585255590|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
162054520|NCT00726232|585255591|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
162054521|NCT00726232|585255592|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
162054522|NCT00726232|585255593|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
162054523|NCT00726232|585255586|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
162054524|NCT00726232|585255587|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
162054525|NCT00726232|585255588|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
162054526|NCT00726232|585255589|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
162054527|NCT00726232|585255590|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
162054528|NCT00726232|585255591|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
162054529|NCT00726232|585255592|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
162054530|NCT00726232|585255593|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
162054531|NCT00726232|585255586|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
162054532|NCT00726232|585255587|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
162054533|NCT00726232|585255588|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
162054534|NCT00726232|585255589|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
162054535|NCT00726232|585255590|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
162054536|NCT00726232|585255591|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
162054537|NCT00726232|585255592|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
162054538|NCT00726232|585255593|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
162054539|NCT00726232|585255586|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
162054540|NCT00726232|585255587|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
162054541|NCT00726232|585255588|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
162054542|NCT00726232|585255589|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
162054543|NCT00726232|585255590|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
162054544|NCT00726232|585255591|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
162054545|NCT00726232|585255592|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
162054546|NCT00726232|585255593|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
162054547|NCT00726232|585255586|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
162054548|NCT00726232|585255587|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
162054549|NCT00726232|585255588|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
162054550|NCT00726232|585255589|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
162054551|NCT00726232|585255590|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
162054552|NCT00726232|585255591|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
162054553|NCT00726232|585255592|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
162054554|NCT00726232|585255593|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
162054555|NCT00726232|585255586|FG000|Expansion Phase|Death|0|||
162054556|NCT00726232|585255587|FG001|Expansion Phase|Death|0|||
162054557|NCT00726232|585255588|FG002|Expansion Phase|Death|0|||
162054558|NCT00726232|585255589|FG003|Expansion Phase|Death|0|||
162054559|NCT00726232|585255590|FG004|Expansion Phase|Death|0|||
162054560|NCT00726232|585255591|FG005|Expansion Phase|Death|0|||
162054561|NCT00726232|585255592|FG006|Expansion Phase|Death|0|||
162054562|NCT00726232|585255593|FG007|Expansion Phase|Death|1|||
162054563|NCT00726232|585255586|FG000|Expansion Phase|Adverse Event|0|||
162054564|NCT00726232|585255587|FG001|Expansion Phase|Adverse Event|0|||
162054565|NCT00726232|585255588|FG002|Expansion Phase|Adverse Event|0|||
162054566|NCT00726232|585255589|FG003|Expansion Phase|Adverse Event|0|||
162054567|NCT00726232|585255590|FG004|Expansion Phase|Adverse Event|0|||
162054568|NCT00726232|585255591|FG005|Expansion Phase|Adverse Event|0|||
162054569|NCT00726232|585255592|FG006|Expansion Phase|Adverse Event|6|||
162054570|NCT00726232|585255593|FG007|Expansion Phase|Adverse Event|11|||
162054571|NCT00726232|585255586|FG000|Expansion Phase|Withdrawal by Subject|0|||
162054572|NCT00726232|585255587|FG001|Expansion Phase|Withdrawal by Subject|0|||
162054573|NCT00726232|585255588|FG002|Expansion Phase|Withdrawal by Subject|0|||
162054574|NCT00726232|585255589|FG003|Expansion Phase|Withdrawal by Subject|0|||
162054575|NCT00726232|585255590|FG004|Expansion Phase|Withdrawal by Subject|0|||
162054576|NCT00726232|585255591|FG005|Expansion Phase|Withdrawal by Subject|0|||
162054577|NCT00726232|585255592|FG006|Expansion Phase|Withdrawal by Subject|2|||
162054578|NCT00726232|585255593|FG007|Expansion Phase|Withdrawal by Subject|3|||
162054579|NCT00726232|585255586|FG000|Expansion Phase|Disease progression|0|||
162054580|NCT00726232|585255587|FG001|Expansion Phase|Disease progression|0|||
162054581|NCT00726232|585255588|FG002|Expansion Phase|Disease progression|0|||
162054582|NCT00726232|585255589|FG003|Expansion Phase|Disease progression|0|||
162054583|NCT00726232|585255590|FG004|Expansion Phase|Disease progression|0|||
162054584|NCT00726232|585255591|FG005|Expansion Phase|Disease progression|0|||
162054585|NCT00726232|585255592|FG006|Expansion Phase|Disease progression|4|||
162054586|NCT00726232|585255593|FG007|Expansion Phase|Disease progression|0|||
162054587|NCT00726232|585255586|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
162054588|NCT00726232|585255587|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
162054589|NCT00726232|585255588|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
162054590|NCT00726232|585255589|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
162054591|NCT00726232|585255590|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
162054592|NCT00726232|585255591|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
162054593|NCT00726232|585255592|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
162054594|NCT00726232|585255593|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
162054595|NCT00726232|585255586|FG000|Expansion Phase|Per Investigator: lack of response|0|||
162054596|NCT00726232|585255587|FG001|Expansion Phase|Per Investigator: lack of response|0|||
162054597|NCT00726232|585255588|FG002|Expansion Phase|Per Investigator: lack of response|0|||
162054598|NCT00726232|585255589|FG003|Expansion Phase|Per Investigator: lack of response|0|||
162054599|NCT00726232|585255590|FG004|Expansion Phase|Per Investigator: lack of response|0|||
162054600|NCT00726232|585255591|FG005|Expansion Phase|Per Investigator: lack of response|0|||
162054601|NCT00726232|585255592|FG006|Expansion Phase|Per Investigator: lack of response|1|||
162054602|NCT00726232|585255593|FG007|Expansion Phase|Per Investigator: lack of response|7|||
162054603|NCT00726232|585255586|FG000|Expansion Phase|Unspecified reason|0|||
162054604|NCT00726232|585255587|FG001|Expansion Phase|Unspecified reason|0|||
162054605|NCT00726232|585255588|FG002|Expansion Phase|Unspecified reason|0|||
162054606|NCT00726232|585255589|FG003|Expansion Phase|Unspecified reason|0|||
162054607|NCT00726232|585255590|FG004|Expansion Phase|Unspecified reason|0|||
162054608|NCT00726232|585255591|FG005|Expansion Phase|Unspecified reason|0|||
162054609|NCT00726232|585255592|FG006|Expansion Phase|Unspecified reason|1|||
162054610|NCT00726232|585255593|FG007|Expansion Phase|Unspecified reason|0|||
162054611|NCT01471171|585255594|FG000|Treatment Period 1|Adverse Event|4|||
162054612|NCT01471171|585255595|FG001|Treatment Period 1|Adverse Event|1|||
162054613|NCT01471171|585255594|FG000|Treatment Period 2|Adverse Event|1|||
162054614|NCT01471171|585255595|FG001|Treatment Period 2|Adverse Event|0|||
162054615|NCT02864498|585255596|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
162054616|NCT02864498|585255597|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
162054617|NCT02864498|585255598|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
162054618|NCT02864498|585255596|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
162054619|NCT02864498|585255597|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
162054620|NCT02864498|585255598|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
162054621|NCT02864498|585255596|FG000|Overall Study|Investigator Discretion|0|||
162054622|NCT02864498|585255597|FG001|Overall Study|Investigator Discretion|2|||
162054623|NCT02864498|585255598|FG002|Overall Study|Investigator Discretion|1|||
162054624|NCT02864498|585255596|FG000|Overall Study|Lost to Follow-up|8|||
162054625|NCT02864498|585255597|FG001|Overall Study|Lost to Follow-up|6|||
162054626|NCT02864498|585255598|FG002|Overall Study|Lost to Follow-up|3|||
162054627|NCT02864498|585255596|FG000|Overall Study|Lack of Efficacy|5|||
162054628|NCT02864498|585255597|FG001|Overall Study|Lack of Efficacy|3|||
162054629|NCT02864498|585255598|FG002|Overall Study|Lack of Efficacy|3|||
162054630|NCT02864498|585255596|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
162054631|NCT02864498|585255597|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
162054632|NCT02864498|585255598|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
162054633|NCT02864498|585255596|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
162054634|NCT02864498|585255597|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
162054635|NCT02864498|585255598|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
162054636|NCT02864498|585255596|FG000|Overall Study|Subject moved out of the country.|0|||
162054637|NCT02864498|585255597|FG001|Overall Study|Subject moved out of the country.|0|||
162054638|NCT02864498|585255598|FG002|Overall Study|Subject moved out of the country.|1|||
162054639|NCT00730132|585255601|FG000|Overall Study|Protocol Violation|154|||
162054640|NCT00730132|585255601|FG000|Overall Study|Death|1|||
162054641|NCT00370032|585255602|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
162054642|NCT00370032|585255603|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
162054643|NCT00370032|585255602|FG000|Washout Period|Withdrawal by Subject|0|||
162054644|NCT00370032|585255603|FG001|Washout Period|Withdrawal by Subject|1|||
162054645|NCT00370032|585255602|FG000|Washout Period|Lost to Follow-up|0|||
162054646|NCT00370032|585255603|FG001|Washout Period|Lost to Follow-up|1|||
162054647|NCT00370032|585255602|FG000|Washout Period|Adverse Event|1|||
162054648|NCT00370032|585255603|FG001|Washout Period|Adverse Event|0|||
162054649|NCT00370032|585255602|FG000|Follow-up Period|Withdrawal by Subject|1|||
162054650|NCT00370032|585255603|FG001|Follow-up Period|Withdrawal by Subject|0|||
162054651|NCT03208244|585255607|FG000|Overall Study|Death|1|||
162054652|NCT04431453|585255608|FG000|Overall Study|Withdrew Consent|0|||
162054653|NCT04431453|585255609|FG001|Overall Study|Withdrew Consent|1|||
162054654|NCT04431453|585255610|FG002|Overall Study|Withdrew Consent|0|||
162054655|NCT04431453|585255611|FG003|Overall Study|Withdrew Consent|2|||
162054656|NCT04431453|585255612|FG004|Overall Study|Withdrew Consent|0|||
162054657|NCT04431453|585255613|FG005|Overall Study|Withdrew Consent|0|||
162054658|NCT04431453|585255614|FG006|Overall Study|Withdrew Consent|0|||
162054659|NCT04431453|585255615|FG007|Overall Study|Withdrew Consent|0|||
162054660|NCT04431453|585255608|FG000|Overall Study|Death|1|||
162054661|NCT04431453|585255609|FG001|Overall Study|Death|0|||
162054662|NCT04431453|585255610|FG002|Overall Study|Death|0|||
162054663|NCT04431453|585255611|FG003|Overall Study|Death|0|||
162054664|NCT04431453|585255612|FG004|Overall Study|Death|0|||
162054665|NCT04431453|585255613|FG005|Overall Study|Death|0|||
162054666|NCT04431453|585255614|FG006|Overall Study|Death|0|||
162054667|NCT04431453|585255615|FG007|Overall Study|Death|1|||
162054668|NCT04431453|585255608|FG000|Overall Study|Lost to Follow-up|0|||
162054669|NCT04431453|585255609|FG001|Overall Study|Lost to Follow-up|0|||
162054670|NCT04431453|585255610|FG002|Overall Study|Lost to Follow-up|1|||
162054671|NCT04431453|585255611|FG003|Overall Study|Lost to Follow-up|1|||
162054672|NCT04431453|585255612|FG004|Overall Study|Lost to Follow-up|0|||
162054673|NCT04431453|585255613|FG005|Overall Study|Lost to Follow-up|0|||
162054674|NCT04431453|585255614|FG006|Overall Study|Lost to Follow-up|0|||
162054675|NCT04431453|585255615|FG007|Overall Study|Lost to Follow-up|0|||
162054676|NCT04431453|585255608|FG000|Overall Study|Enrolled but Never Treated|0|||
162054677|NCT04431453|585255609|FG001|Overall Study|Enrolled but Never Treated|0|||
162054678|NCT04431453|585255610|FG002|Overall Study|Enrolled but Never Treated|0|||
162054679|NCT04431453|585255611|FG003|Overall Study|Enrolled but Never Treated|0|||
162054680|NCT04431453|585255612|FG004|Overall Study|Enrolled but Never Treated|1|||
162054681|NCT04431453|585255613|FG005|Overall Study|Enrolled but Never Treated|0|||
162054682|NCT04431453|585255614|FG006|Overall Study|Enrolled but Never Treated|0|||
162054683|NCT04431453|585255615|FG007|Overall Study|Enrolled but Never Treated|0|||
162054684|NCT03385564|585255616|FG000|Overall Study|Adverse Event|0|||
162054685|NCT03385564|585255617|FG001|Overall Study|Adverse Event|0|||
162054686|NCT03385564|585255618|FG002|Overall Study|Adverse Event|3|||
162054687|NCT03385564|585255619|FG003|Overall Study|Adverse Event|3|||
162054688|NCT03385564|585255616|FG000|Overall Study|Other than listed|0|||
162054689|NCT03385564|585255617|FG001|Overall Study|Other than listed|0|||
162054690|NCT03385564|585255618|FG002|Overall Study|Other than listed|0|||
162054691|NCT03385564|585255619|FG003|Overall Study|Other than listed|5|||
162054692|NCT03385564|585255616|FG000|Overall Study|Withdrawal by Subject|0|||
162054693|NCT03385564|585255617|FG001|Overall Study|Withdrawal by Subject|1|||
162054694|NCT03385564|585255618|FG002|Overall Study|Withdrawal by Subject|1|||
162054695|NCT03385564|585255619|FG003|Overall Study|Withdrawal by Subject|0|||
162054696|NCT03385564|585255616|FG000|Overall Study|Lack of Efficacy|0|||
162054697|NCT03385564|585255617|FG001|Overall Study|Lack of Efficacy|0|||
162054698|NCT03385564|585255618|FG002|Overall Study|Lack of Efficacy|0|||
162054699|NCT03385564|585255619|FG003|Overall Study|Lack of Efficacy|1|||
162054700|NCT03385564|585255616|FG000|Overall Study|Death|0|||
162054701|NCT03385564|585255617|FG001|Overall Study|Death|0|||
162054702|NCT03385564|585255618|FG002|Overall Study|Death|1|||
162054703|NCT03385564|585255619|FG003|Overall Study|Death|0|||
162054704|NCT01702961|585255626|FG000|Overall Study|Additional treatment|3|||
162054705|NCT01702961|585255626|FG000|Overall Study|Progressive disease|5|||
162054706|NCT01702961|585255626|FG000|Overall Study|Relapse|20|||
162054707|NCT01702961|585255626|FG000|Overall Study|Death|6|||
162054708|NCT01702961|585255626|FG000|Overall Study|Lost to Follow-up|2|||
162054709|NCT01702961|585255626|FG000|Overall Study|Ongoing|11|||
162054710|NCT03724032|585255629|FG000|Overall Study|Physician Decision|1|||
162054711|NCT03724032|585255630|FG001|Overall Study|Physician Decision|0|||
162054712|NCT03724032|585255631|FG002|Overall Study|Physician Decision|0|||
162054713|NCT03724032|585255629|FG000|Overall Study|Protocol Violation|2|||
162054714|NCT03724032|585255630|FG001|Overall Study|Protocol Violation|2|||
162054715|NCT03724032|585255631|FG002|Overall Study|Protocol Violation|1|||
162054716|NCT00751933|585255632|FG000|Overall Study|Withdrawal by Subject|0|||
162054717|NCT00751933|585255633|FG001|Overall Study|Withdrawal by Subject|1|||
162054718|NCT00751933|585255634|FG002|Overall Study|Withdrawal by Subject|0|||
162054719|NCT00751933|585255635|FG003|Overall Study|Withdrawal by Subject|0|||
162054720|NCT00751933|585255632|FG000|Overall Study|Physician Decision|0|||
162054721|NCT00751933|585255633|FG001|Overall Study|Physician Decision|0|||
162054722|NCT00751933|585255634|FG002|Overall Study|Physician Decision|1|||
162054723|NCT00751933|585255635|FG003|Overall Study|Physician Decision|1|||
162054724|NCT00361569|585255637|FG000|Overall Study|Protocol Violation|3|||
162054725|NCT00361569|585255638|FG001|Overall Study|Protocol Violation|2|||
162054726|NCT00361569|585255639|FG002|Overall Study|Protocol Violation|4|||
162054727|NCT00361569|585255640|FG003|Overall Study|Protocol Violation|2|||
162054728|NCT00361569|585255637|FG000|Overall Study|Withdrawal by Subject|2|||
162054729|NCT00361569|585255638|FG001|Overall Study|Withdrawal by Subject|1|||
162054730|NCT00361569|585255639|FG002|Overall Study|Withdrawal by Subject|9|||
162054731|NCT00361569|585255640|FG003|Overall Study|Withdrawal by Subject|14|||
162054732|NCT00361569|585255637|FG000|Overall Study|Adverse Event|3|||
162054733|NCT00361569|585255638|FG001|Overall Study|Adverse Event|5|||
162054734|NCT00361569|585255639|FG002|Overall Study|Adverse Event|2|||
162054735|NCT00361569|585255640|FG003|Overall Study|Adverse Event|2|||
162054736|NCT00361569|585255637|FG000|Overall Study|Lost to Follow-up|2|||
162054737|NCT00361569|585255638|FG001|Overall Study|Lost to Follow-up|3|||
162054738|NCT00361569|585255639|FG002|Overall Study|Lost to Follow-up|3|||
162054739|NCT00361569|585255640|FG003|Overall Study|Lost to Follow-up|2|||
162054740|NCT00361569|585255637|FG000|Overall Study|Not specified by investigator|2|||
162054741|NCT00361569|585255638|FG001|Overall Study|Not specified by investigator|0|||
162054742|NCT00361569|585255639|FG002|Overall Study|Not specified by investigator|0|||
162054743|NCT00361569|585255640|FG003|Overall Study|Not specified by investigator|1|||
162054744|NCT02605824|585255641|FG000|Overall Study|Physician Decision|1|||
162054745|NCT02605824|585255642|FG001|Overall Study|Physician Decision|0|||
162054746|NCT04875195|585255643|FG000|Overall Study|Death|9|||
162054747|NCT04875195|585255644|FG001|Overall Study|Death|3|||
162054748|NCT04875195|585255643|FG000|Overall Study|Withdrawal by Subject|2|||
162054749|NCT04875195|585255644|FG001|Overall Study|Withdrawal by Subject|1|||
162054750|NCT04875195|585255643|FG000|Overall Study|Ongoing in study|49|||
162054751|NCT04875195|585255644|FG001|Overall Study|Ongoing in study|2|||
162054752|NCT02339584|585255645|FG000|Overall Study|Adverse Event|11|||
162054753|NCT02339584|585255646|FG001|Overall Study|Adverse Event|7|||
162054754|NCT02339584|585255645|FG000|Overall Study|Lack of Efficacy|0|||
162054755|NCT02339584|585255646|FG001|Overall Study|Lack of Efficacy|1|||
162054756|NCT02339584|585255645|FG000|Overall Study|Physician Decision|1|||
162054757|NCT02339584|585255646|FG001|Overall Study|Physician Decision|2|||
162054758|NCT02339584|585255645|FG000|Overall Study|Protocol Violation|1|||
162054759|NCT02339584|585255646|FG001|Overall Study|Protocol Violation|1|||
162054760|NCT02339584|585255645|FG000|Overall Study|Withdrawal by Subject|2|||
162054761|NCT02339584|585255646|FG001|Overall Study|Withdrawal by Subject|4|||
162054762|NCT00826943|585255647|FG000|Overall Study|Withdrawal by Subject|0|||
162054763|NCT00826943|585255648|FG001|Overall Study|Withdrawal by Subject|0|||
162054764|NCT00826943|585255649|FG002|Overall Study|Withdrawal by Subject|0|||
162054765|NCT00826943|585255650|FG003|Overall Study|Withdrawal by Subject|0|||
162054766|NCT00826943|585255651|FG004|Overall Study|Withdrawal by Subject|1|||
162054767|NCT00826943|585255652|FG005|Overall Study|Withdrawal by Subject|0|||
162054768|NCT03715530|585255653|FG000|Overall Study|Lost to Follow-up|3|||
162054769|NCT03715530|585255654|FG001|Overall Study|Lost to Follow-up|1|||
162054770|NCT03715530|585255655|FG002|Overall Study|Lost to Follow-up|2|||
162054771|NCT01594762|585255656|FG000|Overall Study|Withdrawal by Subject|1|||
162054772|NCT01594762|585255657|FG001|Overall Study|Withdrawal by Subject|0|||
162054773|NCT01594762|585255656|FG000|Overall Study|Lost to Follow-up|10|||
162054774|NCT01594762|585255657|FG001|Overall Study|Lost to Follow-up|10|||
162054775|NCT03338998|585255661|FG000|Treatment Period|Withdrawal by Subject|1|||
162054776|NCT03338998|585255662|FG001|Treatment Period|Withdrawal by Subject|1|||
162054777|NCT03338998|585255661|FG000|Treatment Period|Adverse Event|0|||
162054778|NCT03338998|585255662|FG001|Treatment Period|Adverse Event|2|||
162054779|NCT03338998|585255661|FG000|Treatment Period|Protocol deviation|1|||
162054780|NCT03338998|585255662|FG001|Treatment Period|Protocol deviation|0|||
162054781|NCT03338998|585255661|FG000|Treatment Period|Physician Decision|2|||
162054782|NCT03338998|585255662|FG001|Treatment Period|Physician Decision|0|||
162054783|NCT03338998|585255661|FG000|Treatment Period|Subject failed swallow test|4|||
162054784|NCT03338998|585255662|FG001|Treatment Period|Subject failed swallow test|0|||
162054785|NCT03338998|585255661|FG000|Safety Follow-Up Period|Adverse Event|0|||
162054786|NCT03338998|585255662|FG001|Safety Follow-Up Period|Adverse Event|1|||
162054787|NCT03338998|585255661|FG000|Safety Follow-Up Period|Protocol deviation|1|||
162054788|NCT03338998|585255662|FG001|Safety Follow-Up Period|Protocol deviation|0|||
162054789|NCT03338998|585255661|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
162054790|NCT03338998|585255662|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
162054791|NCT04706091|585255665|FG000|Treatment 2|Withdrawal by Subject|1|||
162054792|NCT04706091|585255666|FG001|Treatment 2|Withdrawal by Subject|0|||
162054793|NCT03329573|585255667|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
162054794|NCT03329573|585255668|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
162054795|NCT03329573|585255669|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
162054796|NCT03329573|585255670|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
162054797|NCT03329573|585255667|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
162054798|NCT03329573|585255668|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
162054799|NCT03329573|585255669|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162054800|NCT03329573|585255670|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
162054801|NCT03329573|585255667|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
162054802|NCT03329573|585255668|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
162054803|NCT03329573|585255669|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
162054804|NCT03329573|585255670|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
162054805|NCT03329573|585255667|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
162054806|NCT03329573|585255668|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
162054807|NCT03329573|585255669|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
162054808|NCT03329573|585255670|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
162054809|NCT05695209|585255680|FG000|3-months|Withdrawal by Subject|2|||
162054810|NCT05695209|585255681|FG001|3-months|Withdrawal by Subject|0|||
162054811|NCT05695209|585255680|FG000|3-months|Unable to contact for 3-month data collection|0|||
162054812|NCT05695209|585255681|FG001|3-months|Unable to contact for 3-month data collection|1|||
162054813|NCT05695209|585255680|FG000|6-months|Lost to Follow-up|1|||
162054814|NCT05695209|585255681|FG001|6-months|Lost to Follow-up|1|||
162054815|NCT04698187|585255684|FG000|Overall Study|Withdrawal by Subject|7|||
162054816|NCT04698187|585255684|FG000|Overall Study|Death|21|||
162054817|NCT04698187|585255684|FG000|Overall Study|Sponsor Decision|15|||
162054818|NCT04698187|585255684|FG000|Overall Study|In-transit Disease|1|||
162054819|NCT03069378|585255685|FG000|Overall Study|Withdrawal by Subject|1|||
162054820|NCT02993146|585255686|FG000|Overall Study|Withdrawal by Subject|0|||
162054821|NCT02993146|585255687|FG001|Overall Study|Withdrawal by Subject|0|||
162054822|NCT02993146|585255688|FG002|Overall Study|Withdrawal by Subject|1|||
162054823|NCT02993146|585255689|FG003|Overall Study|Withdrawal by Subject|1|||
162054824|NCT01397708|585255690|FG000|Overall Study|Withdrawal by Subject|0|||
162054825|NCT01397708|585255691|FG001|Overall Study|Withdrawal by Subject|0|||
162054826|NCT01397708|585255692|FG002|Overall Study|Withdrawal by Subject|1|||
162054827|NCT01397708|585255693|FG003|Overall Study|Withdrawal by Subject|0|||
162054828|NCT01397708|585255694|FG004|Overall Study|Withdrawal by Subject|0|||
162054829|NCT01397708|585255695|FG005|Overall Study|Withdrawal by Subject|0|||
162054830|NCT01397708|585255696|FG006|Overall Study|Withdrawal by Subject|0|||
162054831|NCT01397708|585255697|FG007|Overall Study|Withdrawal by Subject|1|||
162054832|NCT01397708|585255690|FG000|Overall Study|Death|0|||
162054833|NCT01397708|585255691|FG001|Overall Study|Death|0|||
162054834|NCT01397708|585255692|FG002|Overall Study|Death|1|||
162054835|NCT01397708|585255693|FG003|Overall Study|Death|1|||
162054836|NCT01397708|585255694|FG004|Overall Study|Death|0|||
162054837|NCT01397708|585255695|FG005|Overall Study|Death|0|||
162054838|NCT01397708|585255696|FG006|Overall Study|Death|0|||
162054839|NCT01397708|585255697|FG007|Overall Study|Death|0|||
162054840|NCT01397708|585255690|FG000|Overall Study|Lost to Follow-up|0|||
162054841|NCT01397708|585255691|FG001|Overall Study|Lost to Follow-up|0|||
162054842|NCT01397708|585255692|FG002|Overall Study|Lost to Follow-up|0|||
162054843|NCT01397708|585255693|FG003|Overall Study|Lost to Follow-up|0|||
162054844|NCT01397708|585255694|FG004|Overall Study|Lost to Follow-up|1|||
162054845|NCT01397708|585255695|FG005|Overall Study|Lost to Follow-up|0|||
162054846|NCT01397708|585255696|FG006|Overall Study|Lost to Follow-up|0|||
162054847|NCT01397708|585255697|FG007|Overall Study|Lost to Follow-up|0|||
162054848|NCT01397708|585255690|FG000|Overall Study|Other|0|||
162054849|NCT01397708|585255691|FG001|Overall Study|Other|0|||
162054850|NCT01397708|585255692|FG002|Overall Study|Other|0|||
162054851|NCT01397708|585255693|FG003|Overall Study|Other|0|||
162054852|NCT01397708|585255694|FG004|Overall Study|Other|0|||
162054853|NCT01397708|585255695|FG005|Overall Study|Other|0|||
162054854|NCT01397708|585255696|FG006|Overall Study|Other|1|||
162054855|NCT01397708|585255697|FG007|Overall Study|Other|0|||
162054856|NCT01133522|585255698|FG000|Overall Study|Withdrawal by Subject|0|||
162054857|NCT01133522|585255699|FG001|Overall Study|Withdrawal by Subject|1|||
162054858|NCT01133522|585255700|FG002|Overall Study|Withdrawal by Subject|0|||
162054859|NCT01133522|585255701|FG003|Overall Study|Withdrawal by Subject|1|||
162054860|NCT01133522|585255702|FG004|Overall Study|Withdrawal by Subject|0|||
162054861|NCT01133522|585255703|FG005|Overall Study|Withdrawal by Subject|0|||
162054862|NCT01133522|585255704|FG006|Overall Study|Withdrawal by Subject|0|||
162054863|NCT01133522|585255705|FG007|Overall Study|Withdrawal by Subject|0|||
162054864|NCT01133522|585255706|FG008|Overall Study|Withdrawal by Subject|0|||
162054865|NCT01133522|585255707|FG009|Overall Study|Withdrawal by Subject|0|||
162054866|NCT01133522|585255698|FG000|Overall Study|Physician Decision|0|||
162054867|NCT01133522|585255699|FG001|Overall Study|Physician Decision|0|||
162054868|NCT01133522|585255700|FG002|Overall Study|Physician Decision|0|||
162054869|NCT01133522|585255701|FG003|Overall Study|Physician Decision|0|||
162054870|NCT01133522|585255702|FG004|Overall Study|Physician Decision|1|||
162054871|NCT01133522|585255703|FG005|Overall Study|Physician Decision|0|||
162054872|NCT01133522|585255704|FG006|Overall Study|Physician Decision|0|||
162054873|NCT01133522|585255705|FG007|Overall Study|Physician Decision|0|||
162054874|NCT01133522|585255706|FG008|Overall Study|Physician Decision|0|||
162054875|NCT01133522|585255707|FG009|Overall Study|Physician Decision|0|||
162054876|NCT04997304|585255708|FG000|Overall Study|Lost to Follow-up|11|||
162054877|NCT04997304|585255708|FG000|Overall Study|Death|1|||
162054878|NCT04997304|585255708|FG000|Overall Study|Withdrawal by Subject|14|||
162054879|NCT00612690|585257365|FG000|Overall Study|Lost to Follow-up|72|||
162054880|NCT00612690|585257366|FG001|Overall Study|Lost to Follow-up|98|||
162054881|NCT00612690|585257365|FG000|Overall Study|Withdrawal by Subject|32|||
162054882|NCT00612690|585257366|FG001|Overall Study|Withdrawal by Subject|20|||
162054883|NCT00612690|585257365|FG000|Overall Study|Withdrawal by Site|11|||
162054884|NCT00612690|585257366|FG001|Overall Study|Withdrawal by Site|0|||
162054885|NCT00907777|585257369|FG000|Overall Study|Withdrawal by Subject|0|||
162054886|NCT00907777|585257370|FG001|Overall Study|Withdrawal by Subject|1|||
162054887|NCT03291808|585257371|FG000|Overall Study|Lost to Follow-up|6|||
162054888|NCT03291808|585257371|FG000|Overall Study|Research burden|4|||
162054889|NCT00638378|585257372|FG000|Overall Study|Death|2|||
162054890|NCT00638378|585257372|FG000|Overall Study|Adverse Event|1|||
162054891|NCT00638378|585257372|FG000|Overall Study|Disease progression|15|||
162054892|NCT00638378|585257372|FG000|Overall Study|Physician Decision|4|||
162054893|NCT03364023|585257375|FG000|Overall Study|Lost to Follow-up|3|||
162054894|NCT03364023|585257375|FG000|Overall Study|Death|14|||
162054895|NCT02891850|585257376|FG000|Overall Study|Adverse Event|3|||
162054896|NCT02891850|585257377|FG001|Overall Study|Adverse Event|0|||
162054897|NCT02891850|585257376|FG000|Overall Study|Death|0|||
162054898|NCT02891850|585257377|FG001|Overall Study|Death|4|||
162054899|NCT02891850|585257376|FG000|Overall Study|Physician Decision|1|||
162054900|NCT02891850|585257377|FG001|Overall Study|Physician Decision|0|||
162054901|NCT02891850|585257376|FG000|Overall Study|Pregnancy|1|||
162054902|NCT02891850|585257377|FG001|Overall Study|Pregnancy|0|||
162054903|NCT02891850|585257376|FG000|Overall Study|Withdrawal by Subject|2|||
162054904|NCT02891850|585257377|FG001|Overall Study|Withdrawal by Subject|3|||
162054905|NCT03797014|585257378|FG000|Overall Study|Withdrawal by Subject|1|||
162054906|NCT03797014|585257378|FG000|Overall Study|Lost to Follow-up|1|||
162054907|NCT03797014|585257378|FG000|Overall Study|Protocol Violation|1|||
162054908|NCT00105469|585257383|FG000|Overall Study|Adverse Event|9|||
162054909|NCT00105469|585257384|FG001|Overall Study|Adverse Event|8|||
162054910|NCT00105469|585257383|FG000|Overall Study|Protocol Violation|4|||
162054911|NCT00105469|585257384|FG001|Overall Study|Protocol Violation|0|||
162054912|NCT00105469|585257383|FG000|Overall Study|Withdrawal by Subject|2|||
162054913|NCT00105469|585257384|FG001|Overall Study|Withdrawal by Subject|3|||
162054914|NCT00105469|585257383|FG000|Overall Study|Lost to Follow-up|1|||
162054915|NCT00105469|585257384|FG001|Overall Study|Lost to Follow-up|0|||
162054916|NCT00105469|585257383|FG000|Overall Study|Lack of Efficacy|2|||
162054917|NCT00105469|585257384|FG001|Overall Study|Lack of Efficacy|0|||
162054918|NCT00105469|585257383|FG000|Overall Study|Other Reason|4|||
162054919|NCT00105469|585257384|FG001|Overall Study|Other Reason|0|||
162054920|NCT02820753|585257389|FG000|2 Month|Withdrawal by Subject|3|||
162054921|NCT02820753|585257390|FG001|2 Month|Withdrawal by Subject|3|||
162054922|NCT02820753|585257389|FG000|2 Month|Lost to Follow-up|24|||
162054923|NCT02820753|585257390|FG001|2 Month|Lost to Follow-up|26|||
162054924|NCT02820753|585257389|FG000|2 Month|Stopped per NIH Hold|51|||
162054925|NCT02820753|585257390|FG001|2 Month|Stopped per NIH Hold|13|||
162054926|NCT02820753|585257389|FG000|6 Month|Withdrawal by Subject|2|||
162054927|NCT02820753|585257390|FG001|6 Month|Withdrawal by Subject|2|||
162054928|NCT02820753|585257389|FG000|6 Month|Lost to Follow-up|20|||
162054929|NCT02820753|585257390|FG001|6 Month|Lost to Follow-up|27|||
162054930|NCT02820753|585257389|FG000|6 Month|Stopped per NIH Hold|81|||
162054931|NCT02820753|585257390|FG001|6 Month|Stopped per NIH Hold|81|||
162054932|NCT02820753|585257389|FG000|6 Month|Death|0|||
162054933|NCT02820753|585257390|FG001|6 Month|Death|1|||
162054934|NCT00790023|585257391|FG000|Overall Study|Adverse Event|2|||
162054935|NCT00790023|585257392|FG001|Overall Study|Adverse Event|1|||
162054936|NCT00790023|585257393|FG002|Overall Study|Adverse Event|4|||
162054937|NCT00790023|585257391|FG000|Overall Study|Protocol Violation|2|||
162054938|NCT00790023|585257392|FG001|Overall Study|Protocol Violation|4|||
162054939|NCT00790023|585257393|FG002|Overall Study|Protocol Violation|2|||
162054940|NCT00790023|585257391|FG000|Overall Study|Withdrawal by Subject|2|||
162054941|NCT00790023|585257392|FG001|Overall Study|Withdrawal by Subject|0|||
162054942|NCT00790023|585257393|FG002|Overall Study|Withdrawal by Subject|6|||
162054943|NCT00790023|585257391|FG000|Overall Study|Lost to Follow-up|0|||
162054944|NCT00790023|585257392|FG001|Overall Study|Lost to Follow-up|0|||
162054945|NCT00790023|585257393|FG002|Overall Study|Lost to Follow-up|1|||
162054946|NCT00790023|585257391|FG000|Overall Study|Other|5|||
162054947|NCT00790023|585257392|FG001|Overall Study|Other|5|||
162054948|NCT00790023|585257393|FG002|Overall Study|Other|8|||
162054949|NCT02468414|585257394|FG000|Overall Study|Early Study Termination by Sponsor|1|||
162054950|NCT02468414|585257395|FG001|Overall Study|Early Study Termination by Sponsor|0|||
162054951|NCT02468414|585257394|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
162054952|NCT02468414|585257395|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
162054953|NCT02468414|585257394|FG000|Overall Study|Screen Failure|1|||
162054954|NCT02468414|585257395|FG001|Overall Study|Screen Failure|0|||
162054955|NCT01338792|585257396|FG000|Overall Study|Adverse Event|2|||
162054956|NCT01338792|585257396|FG000|Overall Study|Death|1|||
162054957|NCT01338792|585257396|FG000|Overall Study|Withdrawal by Subject|1|||
162054958|NCT01652703|585257397|FG000|Overall Study|Withdrawal by Subject|0|||
162054959|NCT01652703|585257398|FG001|Overall Study|Withdrawal by Subject|1|||
162054960|NCT01652703|585257399|FG002|Overall Study|Withdrawal by Subject|3|||
162054961|NCT01652703|585257400|FG003|Overall Study|Withdrawal by Subject|1|||
162054962|NCT01652703|585257401|FG004|Overall Study|Withdrawal by Subject|0|||
162054963|NCT01652703|585257402|FG005|Overall Study|Withdrawal by Subject|1|||
162054964|NCT01652703|585257397|FG000|Overall Study|Other|0|||
162054965|NCT01652703|585257398|FG001|Overall Study|Other|0|||
162054966|NCT01652703|585257399|FG002|Overall Study|Other|0|||
162054967|NCT01652703|585257400|FG003|Overall Study|Other|1|||
162054968|NCT01652703|585257401|FG004|Overall Study|Other|1|||
162054969|NCT01652703|585257402|FG005|Overall Study|Other|1|||
162054970|NCT00062374|585257403|FG000|Overall Study|Not treated|12|||
162054971|NCT03555591|585257404|FG000|Overall Study|Protocol Violation|77|||
162054972|NCT02380677|585257412|FG000|Overall Study|Adverse Event|0|||
162054973|NCT02380677|585257413|FG001|Overall Study|Adverse Event|0|||
162054974|NCT02380677|585257414|FG002|Overall Study|Adverse Event|0|||
162054975|NCT02380677|585257415|FG003|Overall Study|Adverse Event|1|||
162054976|NCT02380677|585257416|FG004|Overall Study|Adverse Event|1|||
162054977|NCT02380677|585257417|FG005|Overall Study|Adverse Event|4|||
162054978|NCT02380677|585257418|FG006|Overall Study|Adverse Event|2|||
162054979|NCT02380677|585257419|FG007|Overall Study|Adverse Event|2|||
162054980|NCT02380677|585257420|FG008|Overall Study|Adverse Event|2|||
162054981|NCT02380677|585257421|FG009|Overall Study|Adverse Event|1|||
162054982|NCT02380677|585257422|FG010|Overall Study|Adverse Event|2|||
162054983|NCT02380677|585257423|FG011|Overall Study|Adverse Event|1|||
162054984|NCT02380677|585257412|FG000|Overall Study|Physician Decision|1|||
162054985|NCT02380677|585257413|FG001|Overall Study|Physician Decision|0|||
162054986|NCT02380677|585257414|FG002|Overall Study|Physician Decision|1|||
162054987|NCT02380677|585257415|FG003|Overall Study|Physician Decision|1|||
162054988|NCT02380677|585257416|FG004|Overall Study|Physician Decision|0|||
162054989|NCT02380677|585257417|FG005|Overall Study|Physician Decision|0|||
162054990|NCT02380677|585257418|FG006|Overall Study|Physician Decision|0|||
162054991|NCT02380677|585257419|FG007|Overall Study|Physician Decision|0|||
162054992|NCT02380677|585257420|FG008|Overall Study|Physician Decision|0|||
162054993|NCT02380677|585257421|FG009|Overall Study|Physician Decision|0|||
162054994|NCT02380677|585257422|FG010|Overall Study|Physician Decision|0|||
162054995|NCT02380677|585257423|FG011|Overall Study|Physician Decision|0|||
162054996|NCT02380677|585257412|FG000|Overall Study|Lack of Efficacy|0|||
162054997|NCT02380677|585257413|FG001|Overall Study|Lack of Efficacy|1|||
162054998|NCT02380677|585257414|FG002|Overall Study|Lack of Efficacy|2|||
162054999|NCT02380677|585257415|FG003|Overall Study|Lack of Efficacy|0|||
162055000|NCT02380677|585257416|FG004|Overall Study|Lack of Efficacy|4|||
162055001|NCT02380677|585257417|FG005|Overall Study|Lack of Efficacy|1|||
162055002|NCT02380677|585257418|FG006|Overall Study|Lack of Efficacy|1|||
162055003|NCT02380677|585257419|FG007|Overall Study|Lack of Efficacy|2|||
162055004|NCT02380677|585257420|FG008|Overall Study|Lack of Efficacy|2|||
162055005|NCT02380677|585257421|FG009|Overall Study|Lack of Efficacy|0|||
162055006|NCT02380677|585257422|FG010|Overall Study|Lack of Efficacy|2|||
162055007|NCT02380677|585257423|FG011|Overall Study|Lack of Efficacy|1|||
162055008|NCT02380677|585257412|FG000|Overall Study|Withdrawal by Subject|0|||
162055009|NCT02380677|585257413|FG001|Overall Study|Withdrawal by Subject|0|||
162055010|NCT02380677|585257414|FG002|Overall Study|Withdrawal by Subject|0|||
162055011|NCT02380677|585257415|FG003|Overall Study|Withdrawal by Subject|0|||
162055012|NCT02380677|585257416|FG004|Overall Study|Withdrawal by Subject|0|||
162055013|NCT02380677|585257417|FG005|Overall Study|Withdrawal by Subject|0|||
162055014|NCT02380677|585257418|FG006|Overall Study|Withdrawal by Subject|0|||
162055015|NCT02380677|585257419|FG007|Overall Study|Withdrawal by Subject|0|||
162055016|NCT02380677|585257420|FG008|Overall Study|Withdrawal by Subject|0|||
162055017|NCT02380677|585257421|FG009|Overall Study|Withdrawal by Subject|1|||
162055018|NCT02380677|585257422|FG010|Overall Study|Withdrawal by Subject|0|||
162055019|NCT02380677|585257423|FG011|Overall Study|Withdrawal by Subject|3|||
162055020|NCT02380677|585257412|FG000|Overall Study|Other|0|||
162055021|NCT02380677|585257413|FG001|Overall Study|Other|0|||
162055022|NCT02380677|585257414|FG002|Overall Study|Other|0|||
162055023|NCT02380677|585257415|FG003|Overall Study|Other|1|||
162055024|NCT02380677|585257416|FG004|Overall Study|Other|1|||
162055025|NCT02380677|585257417|FG005|Overall Study|Other|1|||
162055026|NCT02380677|585257418|FG006|Overall Study|Other|0|||
162055027|NCT02380677|585257419|FG007|Overall Study|Other|0|||
162055028|NCT02380677|585257420|FG008|Overall Study|Other|0|||
162055029|NCT02380677|585257421|FG009|Overall Study|Other|0|||
162055030|NCT02380677|585257422|FG010|Overall Study|Other|0|||
162055031|NCT02380677|585257423|FG011|Overall Study|Other|0|||
162055032|NCT05035550|585257431|FG000|Overall Study|Withdrawal by Subject|3|||
162055033|NCT05035550|585257432|FG001|Overall Study|Withdrawal by Subject|0|||
162055034|NCT00617123|585257435|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
162055035|NCT00617123|585257436|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
162055036|NCT00617123|585257435|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
162055037|NCT00617123|585257436|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
162055038|NCT00617123|585257435|FG000|Referral Screening Period|Adverse Event|0|||
162055039|NCT00617123|585257436|FG001|Referral Screening Period|Adverse Event|1|||
162055040|NCT00617123|585257435|FG000|Study Treatment Period|Withdrawal by Subject|8|||
162055041|NCT00617123|585257436|FG001|Study Treatment Period|Withdrawal by Subject|12|||
162055042|NCT00617123|585257435|FG000|Study Treatment Period|Adverse Event|7|||
162055043|NCT00617123|585257436|FG001|Study Treatment Period|Adverse Event|3|||
162055044|NCT00617123|585257435|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
162055045|NCT00617123|585257436|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
162055046|NCT00617123|585257435|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
162055047|NCT00617123|585257436|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
162055048|NCT04213079|585257437|FG000|Overall Study|Lost to Follow-up|0|||
162055049|NCT04213079|585257438|FG001|Overall Study|Lost to Follow-up|2|||
162055050|NCT01061177|585257442|FG000|Overall Study|Adverse Event|117|||
162055051|NCT01061177|585257442|FG000|Overall Study|Withdrawal by Subject|27|||
162055052|NCT01061177|585257442|FG000|Overall Study|Disease progression|17|||
162055053|NCT01061177|585257442|FG000|Overall Study|Protocol Violation|11|||
162055054|NCT01061177|585257442|FG000|Overall Study|Lost to Follow-up|9|||
162055055|NCT01061177|585257442|FG000|Overall Study|New cancer therapy|9|||
162055056|NCT01061177|585257442|FG000|Overall Study|Abnormal laboratory values|6|||
162055057|NCT01061177|585257442|FG000|Overall Study|Abnormal test procedure results|4|||
162055058|NCT01061177|585257442|FG000|Overall Study|Administratie problems|4|||
162055059|NCT01061177|585257442|FG000|Overall Study|Death|4|||
162055060|NCT03616600|585257443|FG000|Overall Study|Withdrawal by Subject|1|||
162055061|NCT03616600|585257444|FG001|Overall Study|Withdrawal by Subject|0|||
162055062|NCT00587054|585257445|FG000|Overall Study|Patient not treated|9|||
162055063|NCT03984994|585257446|FG000|Overall Study|Withdrawal by Subject|2|||
162055064|NCT03984994|585257447|FG001|Overall Study|Withdrawal by Subject|1|||
162055065|NCT03010176|585257449|FG000|Overall Study|Death|21|||
162055066|NCT03010176|585257450|FG001|Overall Study|Death|35|||
162055067|NCT03010176|585257451|FG002|Overall Study|Death|19|||
162055068|NCT03010176|585257452|FG003|Overall Study|Death|19|||
162055069|NCT03010176|585257453|FG004|Overall Study|Death|14|||
162055070|NCT03010176|585257454|FG005|Overall Study|Death|0|||
162055071|NCT03010176|585257449|FG000|Overall Study|Lost to Follow-up|0|||
162055072|NCT03010176|585257450|FG001|Overall Study|Lost to Follow-up|0|||
162055073|NCT03010176|585257451|FG002|Overall Study|Lost to Follow-up|0|||
162055074|NCT03010176|585257452|FG003|Overall Study|Lost to Follow-up|0|||
162055075|NCT03010176|585257453|FG004|Overall Study|Lost to Follow-up|1|||
162055076|NCT03010176|585257454|FG005|Overall Study|Lost to Follow-up|0|||
162055077|NCT03010176|585257449|FG000|Overall Study|Physician Decision|0|||
162055078|NCT03010176|585257450|FG001|Overall Study|Physician Decision|4|||
162055079|NCT03010176|585257451|FG002|Overall Study|Physician Decision|0|||
162055080|NCT03010176|585257452|FG003|Overall Study|Physician Decision|1|||
162055081|NCT03010176|585257453|FG004|Overall Study|Physician Decision|0|||
162055082|NCT03010176|585257454|FG005|Overall Study|Physician Decision|0|||
162055083|NCT03010176|585257449|FG000|Overall Study|Sponsor Decision|0|||
162055084|NCT03010176|585257450|FG001|Overall Study|Sponsor Decision|4|||
162055085|NCT03010176|585257451|FG002|Overall Study|Sponsor Decision|4|||
162055086|NCT03010176|585257452|FG003|Overall Study|Sponsor Decision|1|||
162055087|NCT03010176|585257453|FG004|Overall Study|Sponsor Decision|6|||
162055088|NCT03010176|585257454|FG005|Overall Study|Sponsor Decision|0|||
162055089|NCT03010176|585257449|FG000|Overall Study|Withdrawal by Subject|11|||
162055090|NCT03010176|585257450|FG001|Overall Study|Withdrawal by Subject|9|||
162055091|NCT03010176|585257451|FG002|Overall Study|Withdrawal by Subject|3|||
162055092|NCT03010176|585257452|FG003|Overall Study|Withdrawal by Subject|0|||
162055093|NCT03010176|585257453|FG004|Overall Study|Withdrawal by Subject|4|||
162055094|NCT03010176|585257454|FG005|Overall Study|Withdrawal by Subject|0|||
162055095|NCT04220866|585257455|FG000|Overall Study|Death|4|||
162055096|NCT04220866|585257456|FG001|Overall Study|Death|5|||
162055097|NCT04220866|585257455|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
162055098|NCT04220866|585257456|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
162055099|NCT04220866|585257455|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
162055100|NCT04220866|585257456|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
162055101|NCT04220866|585257455|FG000|Overall Study|Withdrawal by Subject|0|||
162055102|NCT04220866|585257456|FG001|Overall Study|Withdrawal by Subject|1|||
162055103|NCT03858309|585257457|FG000|Overall Study|Withdrawal by Subject|2|||
162055104|NCT03858309|585257458|FG001|Overall Study|Withdrawal by Subject|3|||
162055105|NCT00709761|585257459|FG000|Overall Study|Withdrawal by Subject|8|||
162055106|NCT00709761|585257459|FG000|Overall Study|study closed/terminated|17|||
162055107|NCT00709761|585257459|FG000|Overall Study|Lost to Follow-up|2|||
162055108|NCT03478930|585257460|FG000|Overall Study|Adverse Event|0|||
162055109|NCT03478930|585257461|FG001|Overall Study|Adverse Event|1|||
162055110|NCT03478930|585257460|FG000|Overall Study|Lack of Efficacy|3|||
162055111|NCT03478930|585257461|FG001|Overall Study|Lack of Efficacy|3|||
162055112|NCT03478930|585257460|FG000|Overall Study|Withdrawal by Subject|6|||
162055113|NCT03478930|585257461|FG001|Overall Study|Withdrawal by Subject|5|||
162055114|NCT01812174|585257462|FG000|Overall Study|Death|1|||
162055115|NCT01812174|585257463|FG001|Overall Study|Death|0|||
162055116|NCT01812174|585257462|FG000|Overall Study|Protocol Violation|2|||
162055117|NCT01812174|585257463|FG001|Overall Study|Protocol Violation|0|||
162055118|NCT00553644|585257466|FG000|Overall Study|Adverse Event|17|||
162055119|NCT00553644|585257466|FG000|Overall Study|Withdrawal by Subject|4|||
162055120|NCT00553644|585257466|FG000|Overall Study|Physician Decision|1|||
162055121|NCT00553644|585257466|FG000|Overall Study|Alternative therapy|6|||
162055122|NCT01336764|585257469|FG000|Overall Study|Withdrawal by Subject|5|||
162055123|NCT01336764|585257470|FG001|Overall Study|Withdrawal by Subject|5|||
162055124|NCT01051323|585257471|FG000|Overall Study|Discontinuation of treatment|103|||
162055125|NCT01051323|585257471|FG000|Overall Study|Transplantation|28|||
162055126|NCT01051323|585257471|FG000|Overall Study|Dialysis dependency|22|||
162055127|NCT01051323|585257471|FG000|Overall Study|Withdrawal by Subject|13|||
162055128|NCT01051323|585257471|FG000|Overall Study|Lost to Follow-up|31|||
162055129|NCT01051323|585257471|FG000|Overall Study|Death|129|||
162055130|NCT01051323|585257471|FG000|Overall Study|Hospitalization|28|||
162055131|NCT01051323|585257471|FG000|Overall Study|Other|148|||
162055132|NCT01051323|585257471|FG000|Overall Study|Missing|37|||
162055133|NCT00555971|585257472|FG000|Overall Study|Adverse Event|1|||
162055134|NCT00555971|585257473|FG001|Overall Study|Adverse Event|1|||
162055135|NCT01626391|585257474|FG000|Overall Study|Physician Decision|1|||
162055136|NCT01626391|585257475|FG001|Overall Study|Physician Decision|0|||
162055137|NCT01626391|585257474|FG000|Overall Study|Withdrawal by Subject|1|||
162055138|NCT01626391|585257475|FG001|Overall Study|Withdrawal by Subject|0|||
162055139|NCT05469178|585257476|FG000|Overall Study|Death|1|||
162055140|NCT05469178|585257477|FG001|Overall Study|Death|1|||
162055141|NCT05469178|585257478|FG002|Overall Study|Death|3|||
162055142|NCT05469178|585257479|FG003|Overall Study|Death|6|||
162055143|NCT05469178|585257476|FG000|Overall Study|Lack of Efficacy|2|||
162055144|NCT05469178|585257477|FG001|Overall Study|Lack of Efficacy|2|||
162055145|NCT05469178|585257478|FG002|Overall Study|Lack of Efficacy|1|||
162055146|NCT05469178|585257479|FG003|Overall Study|Lack of Efficacy|10|||
162055147|NCT00968513|585257480|FG000|Overall Study|Death|4|||
162055148|NCT00968513|585257481|FG001|Overall Study|Death|10|||
162055149|NCT00968513|585257482|FG002|Overall Study|Death|15|||
162055150|NCT05466682|585257485|FG000|Overall Study|Withdrawal by Subject|0|||
162055151|NCT05466682|585257486|FG001|Overall Study|Withdrawal by Subject|2|||
162055152|NCT05466682|585257485|FG000|Overall Study|Lost to Follow-up|2|||
162055153|NCT05466682|585257486|FG001|Overall Study|Lost to Follow-up|1|||
162055154|NCT02801396|585257487|FG000|Period 1|Withdrawal by Subject|0|||
162055155|NCT02801396|585257488|FG001|Period 1|Withdrawal by Subject|0|||
162055156|NCT02801396|585257489|FG002|Period 1|Withdrawal by Subject|0|||
162055157|NCT02801396|585257490|FG003|Period 1|Withdrawal by Subject|0|||
162055158|NCT02801396|585257491|FG004|Period 1|Withdrawal by Subject|1|||
162055159|NCT02801396|585257492|FG005|Period 1|Withdrawal by Subject|0|||
162055160|NCT03087643|585257499|FG000|Overall Study|Withdrawal by Subject|2|||
162055161|NCT03087643|585257500|FG001|Overall Study|Withdrawal by Subject|4|||
162055162|NCT03087643|585257499|FG000|Overall Study|Death|2|||
162055163|NCT03087643|585257500|FG001|Overall Study|Death|2|||
162055164|NCT02083783|585257501|FG000|Overall Study|Withdrawal by Subject|1|||
162055165|NCT02083783|585257502|FG001|Overall Study|Withdrawal by Subject|0|||
162055166|NCT04528732|585257503|FG000|Overall Study|Death|1|||
162055167|NCT04528732|585257504|FG001|Overall Study|Death|0|||
162055168|NCT04528732|585257505|FG002|Overall Study|Death|1|||
162055169|NCT04528732|585257503|FG000|Overall Study|Lost to Follow-up|0|||
162055170|NCT04528732|585257504|FG001|Overall Study|Lost to Follow-up|1|||
162055171|NCT04528732|585257505|FG002|Overall Study|Lost to Follow-up|2|||
162055172|NCT02405780|585257517|FG000|Period I|Adverse Event|8|||
162055173|NCT02405780|585257518|FG001|Period I|Adverse Event|0|||
162055174|NCT02405780|585257519|FG002|Period I|Adverse Event|3|||
162055175|NCT02405780|585257520|FG003|Period I|Adverse Event|7|||
162055176|NCT02405780|585257517|FG000|Period I|Medical reasons|1|||
162055177|NCT02405780|585257518|FG001|Period I|Medical reasons|1|||
162055178|NCT02405780|585257519|FG002|Period I|Medical reasons|0|||
162055179|NCT02405780|585257520|FG003|Period I|Medical reasons|1|||
162055180|NCT02405780|585257517|FG000|Period I|Screening Failure|1|||
162055181|NCT02405780|585257518|FG001|Period I|Screening Failure|0|||
162055182|NCT02405780|585257519|FG002|Period I|Screening Failure|1|||
162055183|NCT02405780|585257520|FG003|Period I|Screening Failure|0|||
162055184|NCT02405780|585257517|FG000|Period I|Withdrawal by Subject|9|||
162055185|NCT02405780|585257518|FG001|Period I|Withdrawal by Subject|1|||
162055186|NCT02405780|585257519|FG002|Period I|Withdrawal by Subject|3|||
162055187|NCT02405780|585257520|FG003|Period I|Withdrawal by Subject|4|||
162055188|NCT02405780|585257517|FG000|Period I|Non-compliance with study procedures|8|||
162055189|NCT02405780|585257518|FG001|Period I|Non-compliance with study procedures|6|||
162055190|NCT02405780|585257519|FG002|Period I|Non-compliance with study procedures|8|||
162055191|NCT02405780|585257520|FG003|Period I|Non-compliance with study procedures|11|||
162055192|NCT02405780|585257517|FG000|Period II|Adverse Event|3|||
162055193|NCT02405780|585257518|FG001|Period II|Adverse Event|5|||
162055194|NCT02405780|585257519|FG002|Period II|Adverse Event|4|||
162055195|NCT02405780|585257520|FG003|Period II|Adverse Event|11|||
162055196|NCT02405780|585257517|FG000|Period II|Medical reason|0|||
162055197|NCT02405780|585257518|FG001|Period II|Medical reason|1|||
162055198|NCT02405780|585257519|FG002|Period II|Medical reason|0|||
162055199|NCT02405780|585257520|FG003|Period II|Medical reason|0|||
162055200|NCT02405780|585257517|FG000|Period II|Pregnancy|0|||
162055201|NCT02405780|585257518|FG001|Period II|Pregnancy|0|||
162055202|NCT02405780|585257519|FG002|Period II|Pregnancy|1|||
162055203|NCT02405780|585257520|FG003|Period II|Pregnancy|0|||
162055204|NCT02405780|585257517|FG000|Period II|Withdrawal by Subject|7|||
162055205|NCT02405780|585257518|FG001|Period II|Withdrawal by Subject|4|||
162055206|NCT02405780|585257519|FG002|Period II|Withdrawal by Subject|0|||
162055207|NCT02405780|585257520|FG003|Period II|Withdrawal by Subject|3|||
162055208|NCT02405780|585257517|FG000|Period II|Non-compliance with study procedures|5|||
162055209|NCT02405780|585257518|FG001|Period II|Non-compliance with study procedures|2|||
162055210|NCT02405780|585257519|FG002|Period II|Non-compliance with study procedures|7|||
162055211|NCT02405780|585257520|FG003|Period II|Non-compliance with study procedures|4|||
162055212|NCT01654536|585257521|FG000|Overall Study|Lost to Follow-up|5|||
162055213|NCT01654536|585257522|FG001|Overall Study|Lost to Follow-up|5|||
162055214|NCT01654536|585257521|FG000|Overall Study|Physician Decision|12|||
162055215|NCT01654536|585257522|FG001|Overall Study|Physician Decision|8|||
162055216|NCT01654536|585257521|FG000|Overall Study|Withdrawal by Subject|27|||
162055217|NCT01654536|585257522|FG001|Overall Study|Withdrawal by Subject|25|||
162055218|NCT00668707|585257523|FG000|Overall Study|Cancer Recurrence|58|||
162055219|NCT00668707|585257524|FG001|Overall Study|Cancer Recurrence|58|||
162055220|NCT00668707|585257523|FG000|Overall Study|Withdrawal by Subject|117|||
162055221|NCT00668707|585257524|FG001|Overall Study|Withdrawal by Subject|100|||
162055222|NCT00668707|585257523|FG000|Overall Study|Lost to Follow-up|3|||
162055223|NCT00668707|585257524|FG001|Overall Study|Lost to Follow-up|6|||
162055224|NCT00668707|585257523|FG000|Overall Study|Protocol Violation|10|||
162055225|NCT00668707|585257524|FG001|Overall Study|Protocol Violation|12|||
162055226|NCT00668707|585257523|FG000|Overall Study|Death|11|||
162055227|NCT00668707|585257524|FG001|Overall Study|Death|4|||
162055228|NCT03846804|585257529|FG000|Overall Study|Refused blood draw|1|||
162055229|NCT03846804|585257529|FG000|Overall Study|Protocol Violation|1|||
162055230|NCT04362072|585257530|FG000|Treatment|Adverse Event|1|||
162055231|NCT04362072|585257530|FG000|Treatment|Death|9|||
162055232|NCT04362072|585257530|FG000|Treatment|Physician Decision|2|||
162055233|NCT04362072|585257530|FG000|Treatment|Progressive disease|27|||
162055234|NCT04362072|585257530|FG000|Treatment|Withdrawal by Subject|4|||
162055235|NCT04362072|585257530|FG000|Treatment|Global deterioration of health status|1|||
162055236|NCT04362072|585257530|FG000|Treatment|Switched to commercial Lorlatinib|13|||
162055237|NCT04362072|585257530|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
162055238|NCT04362072|585257530|FG000|Treatment|Other|3|||
162055239|NCT04362072|585257530|FG000|Follow up|Death|2|||
162055240|NCT04362072|585257530|FG000|Follow up|Other|2|||
162055241|NCT04524689|585257531|FG000|Overall Study|Withdrawal by Subject|1|||
162055242|NCT04524689|585257532|FG001|Overall Study|Withdrawal by Subject|1|||
162055243|NCT04524689|585257533|FG002|Overall Study|Withdrawal by Subject|0|||
162122664|NCT00406419|585500294|FG002|Overall Study|Lost to Follow-up|5|||
162055244|NCT04524689|585257534|FG003|Overall Study|Withdrawal by Subject|0|||
162055245|NCT04524689|585257535|FG004|Overall Study|Withdrawal by Subject|2|||
162055246|NCT04524689|585257536|FG005|Overall Study|Withdrawal by Subject|0|||
162055247|NCT04524689|585257531|FG000|Overall Study|Study terminated by Sponsor|6|||
162055248|NCT04524689|585257532|FG001|Overall Study|Study terminated by Sponsor|0|||
162055249|NCT04524689|585257533|FG002|Overall Study|Study terminated by Sponsor|1|||
162055250|NCT04524689|585257534|FG003|Overall Study|Study terminated by Sponsor|0|||
162055251|NCT04524689|585257535|FG004|Overall Study|Study terminated by Sponsor|4|||
162055252|NCT04524689|585257536|FG005|Overall Study|Study terminated by Sponsor|0|||
162055253|NCT04524689|585257531|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
162055254|NCT04524689|585257532|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
162055255|NCT04524689|585257533|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
162055256|NCT04524689|585257534|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
162055257|NCT04524689|585257535|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
162055258|NCT04524689|585257536|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
162055259|NCT01664533|585259417|FG000|Overall Study|Death|42|||
162055260|NCT01664533|585259417|FG000|Overall Study|Lost to Follow-up|3|||
162055261|NCT01664533|585259417|FG000|Overall Study|Study termination|9|||
162055262|NCT01664533|585259417|FG000|Overall Study|Protocol Violation|3|||
162055263|NCT00844831|585259419|FG000|Overall Study|Withdrawal by Subject|4|||
162055264|NCT00844831|585259419|FG000|Overall Study|Adverse Event|1|||
162055265|NCT00844831|585259419|FG000|Overall Study|Physician Decision|1|||
162055266|NCT05255068|585259420|FG000|Overall Study|Lost to Follow-up|0|||
162055267|NCT05255068|585259421|FG001|Overall Study|Lost to Follow-up|1|||
162055268|NCT03156543|585259423|FG000|Overall Study|Withdrawal by Subject|1|||
162055269|NCT03156543|585259424|FG001|Overall Study|Withdrawal by Subject|0|||
162055270|NCT02397278|585259425|FG000|Overall Study|Withdrawal by Subject|0|||
162055271|NCT02397278|585259426|FG001|Overall Study|Withdrawal by Subject|2|||
162055272|NCT02397278|585259425|FG000|Overall Study|Deemed ineligible following surgery|1|||
162055273|NCT02397278|585259426|FG001|Overall Study|Deemed ineligible following surgery|1|||
162055274|NCT02601469|585259428|FG000|Overall Study|Enrolled in Error|1|||
162055275|NCT02601469|585259429|FG001|Overall Study|Enrolled in Error|0|||
162055276|NCT00056316|585259430|FG000|Overall Study|Withdrawal by Subject|2|||
162055277|NCT00056316|585259431|FG001|Overall Study|Withdrawal by Subject|2|||
162055278|NCT00056316|585259430|FG000|Overall Study|Death/NH placement of pt|1|||
162055279|NCT00056316|585259431|FG001|Overall Study|Death/NH placement of pt|1|||
162055280|NCT02161731|585259432|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
162055281|NCT02161731|585259433|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
162055282|NCT02161731|585259432|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
162055283|NCT02161731|585259433|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
162055284|NCT01315678|585259438|FG000|Overall Study|Withdrawal by Subject|7|||
162055285|NCT01315678|585259439|FG001|Overall Study|Withdrawal by Subject|3|||
162055286|NCT01315678|585259438|FG000|Overall Study|Adverse Event|3|||
162055287|NCT01315678|585259439|FG001|Overall Study|Adverse Event|1|||
162055288|NCT01315678|585259438|FG000|Overall Study|Lost to Follow-up|1|||
162055289|NCT01315678|585259439|FG001|Overall Study|Lost to Follow-up|0|||
162055290|NCT01315678|585259438|FG000|Overall Study|similar reason to those listed above|3|||
162055291|NCT01315678|585259439|FG001|Overall Study|similar reason to those listed above|2|||
162055292|NCT00573469|585259443|FG000|Overall Study|Adverse Event|1|||
162055293|NCT00573469|585259444|FG001|Overall Study|Adverse Event|1|||
162055294|NCT00573469|585259445|FG002|Overall Study|Adverse Event|1|||
162055295|NCT00573469|585259443|FG000|Overall Study|Withdrawal by Subject|0|||
162055296|NCT00573469|585259444|FG001|Overall Study|Withdrawal by Subject|2|||
162055297|NCT00573469|585259445|FG002|Overall Study|Withdrawal by Subject|0|||
162055298|NCT00573469|585259443|FG000|Overall Study|Other|5|||
162055299|NCT00573469|585259444|FG001|Overall Study|Other|1|||
162055300|NCT00573469|585259445|FG002|Overall Study|Other|3|||
162055301|NCT00004978|585259446|FG000|Overall Study|Death|107|||
162055302|NCT00004978|585259447|FG001|Overall Study|Death|116|||
162055303|NCT00004978|585259446|FG000|Overall Study|Lost to Follow-up|101|||
162055304|NCT00004978|585259447|FG001|Overall Study|Lost to Follow-up|108|||
162055305|NCT00004978|585259446|FG000|Overall Study|Withdrawal by Subject|17|||
162055306|NCT00004978|585259447|FG001|Overall Study|Withdrawal by Subject|26|||
162055307|NCT00004978|585259446|FG000|Overall Study|site closure - not in analysis cohort|19|||
162055308|NCT00004978|585259447|FG001|Overall Study|site closure - not in analysis cohort|20|||
162055309|NCT02155608|585259454|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
162055310|NCT02155608|585259455|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
162055311|NCT02155608|585259454|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
162055312|NCT02155608|585259455|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
162055313|NCT03633695|585259456|FG000|Overall Study|Lost to Follow-up|4|||
162055314|NCT03633695|585259457|FG001|Overall Study|Lost to Follow-up|5|||
162055315|NCT03633695|585259456|FG000|Overall Study|Discontinued|8|||
162055316|NCT03633695|585259457|FG001|Overall Study|Discontinued|4|||
162055317|NCT01532414|585259458|FG000|Overall Study|Lost to Follow-up|3|||
162055318|NCT01532414|585259459|FG001|Overall Study|Lost to Follow-up|0|||
162055319|NCT01532414|585259460|FG002|Overall Study|Lost to Follow-up|1|||
162055320|NCT01532414|585259458|FG000|Overall Study|Withdrawal by Subject|3|||
162055321|NCT01532414|585259459|FG001|Overall Study|Withdrawal by Subject|0|||
162055322|NCT01532414|585259460|FG002|Overall Study|Withdrawal by Subject|0|||
162055323|NCT01532414|585259458|FG000|Overall Study|No V6 semen sample|0|||
162055324|NCT01532414|585259459|FG001|Overall Study|No V6 semen sample|1|||
162055325|NCT01532414|585259460|FG002|Overall Study|No V6 semen sample|0|||
162055326|NCT01532414|585259458|FG000|Overall Study|Adverse Event|0|||
162055327|NCT01532414|585259459|FG001|Overall Study|Adverse Event|1|||
162055328|NCT01532414|585259460|FG002|Overall Study|Adverse Event|1|||
162055329|NCT01532414|585259458|FG000|Overall Study|Unable to complete 24 hour PK|0|||
162055330|NCT01532414|585259459|FG001|Overall Study|Unable to complete 24 hour PK|0|||
162055331|NCT01532414|585259460|FG002|Overall Study|Unable to complete 24 hour PK|1|||
162055332|NCT01532414|585259458|FG000|Overall Study|Withdrawn by sponsor|1|||
162055333|NCT01532414|585259459|FG001|Overall Study|Withdrawn by sponsor|0|||
162055334|NCT01532414|585259460|FG002|Overall Study|Withdrawn by sponsor|0|||
162055335|NCT00684593|585259463|FG000|Overall Study|Adverse Event|0|||
162055336|NCT00684593|585259464|FG001|Overall Study|Adverse Event|2|||
162055337|NCT02599129|585259465|FG000|Overall Study|Lack of Efficacy|2|||
162055338|NCT02599129|585259466|FG001|Overall Study|Lack of Efficacy|2|||
162055339|NCT02599129|585259465|FG000|Overall Study|Lost to Follow-up|1|||
162055340|NCT02599129|585259466|FG001|Overall Study|Lost to Follow-up|0|||
162055341|NCT02599129|585259465|FG000|Overall Study|Withdrawal by Subject|2|||
162055342|NCT02599129|585259466|FG001|Overall Study|Withdrawal by Subject|1|||
162055343|NCT00617773|585259467|FG000|Overall Study|Physician Decision|1|||
162055344|NCT00617773|585259467|FG000|Overall Study|Lack of compliance with the protocol|1|||
162055345|NCT00617773|585259467|FG000|Overall Study|Withdrawal by Subject|1|||
162055346|NCT00617773|585259467|FG000|Overall Study|Death|1|||
162055347|NCT00617773|585259467|FG000|Overall Study|Progressive disease|19|||
162055348|NCT00617773|585259467|FG000|Overall Study|Protocol Violation|1|||
162055349|NCT01029795|585259468|FG000|Overall Study|Entry Criteria Not Met|2|||
162055350|NCT01029795|585259469|FG001|Overall Study|Entry Criteria Not Met|1|||
162055351|NCT01029795|585259468|FG000|Overall Study|Physician Decision|2|||
162055352|NCT01029795|585259469|FG001|Overall Study|Physician Decision|1|||
162055353|NCT01029795|585259468|FG000|Overall Study|Sponsor Decision|11|||
162055354|NCT01029795|585259469|FG001|Overall Study|Sponsor Decision|17|||
162055355|NCT01029795|585259468|FG000|Overall Study|Withdrawal by Subject|1|||
162055356|NCT01029795|585259469|FG001|Overall Study|Withdrawal by Subject|3|||
162055357|NCT02573311|585259479|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
162055358|NCT02573311|585259480|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
162055359|NCT02573311|585259479|FG000|Disposition for Part 2|Physician Decision|25|||
162055360|NCT02573311|585259480|FG001|Disposition for Part 2|Physician Decision|7|||
162055361|NCT02573311|585259479|FG000|Disposition for Part 2|Adverse Event|36|||
162055362|NCT02573311|585259480|FG001|Disposition for Part 2|Adverse Event|5|||
162055363|NCT02573311|585259479|FG000|Disposition for Part 2|Lost to Follow-up|76|||
162055364|NCT02573311|585259480|FG001|Disposition for Part 2|Lost to Follow-up|7|||
162055365|NCT02573311|585259479|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
162055366|NCT02573311|585259480|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
162055367|NCT02573311|585259479|FG000|Disposition for Part 2|Investigator decision|0|||
162055368|NCT02573311|585259480|FG001|Disposition for Part 2|Investigator decision|1|||
162055369|NCT02573311|585259479|FG000|Disposition for Part 2|Other than specified above|13|||
162055370|NCT02573311|585259480|FG001|Disposition for Part 2|Other than specified above|3|||
162055371|NCT05683249|585259481|FG000|Overall Study|Adverse Event|3|||
162055372|NCT05683249|585259482|FG001|Overall Study|Adverse Event|1|||
162055373|NCT05683249|585259481|FG000|Overall Study|Lack of Efficacy|0|||
162055374|NCT05683249|585259482|FG001|Overall Study|Lack of Efficacy|2|||
162055375|NCT05683249|585259481|FG000|Overall Study|Lost to Follow-up|6|||
162055376|NCT05683249|585259482|FG001|Overall Study|Lost to Follow-up|5|||
162055377|NCT05683249|585259481|FG000|Overall Study|Non-compliance with Study Drug|2|||
162055378|NCT05683249|585259482|FG001|Overall Study|Non-compliance with Study Drug|0|||
162055379|NCT05683249|585259481|FG000|Overall Study|Protocol Violation|6|||
162055380|NCT05683249|585259482|FG001|Overall Study|Protocol Violation|3|||
162055381|NCT05683249|585259481|FG000|Overall Study|Withdrawal by Subject|9|||
162055382|NCT05683249|585259482|FG001|Overall Study|Withdrawal by Subject|8|||
162055383|NCT05683249|585259481|FG000|Overall Study|Other|0|||
162055384|NCT05683249|585259482|FG001|Overall Study|Other|2|||
162055385|NCT01328431|585259483|FG000|Baseline|Protocol Violation|0|||
162055386|NCT01328431|585259484|FG001|Baseline|Protocol Violation|2|||
162055387|NCT01328431|585259483|FG000|1 Month (1M)|Lost to Follow-up|55|||
162055388|NCT01328431|585259484|FG001|1 Month (1M)|Lost to Follow-up|58|||
162055389|NCT01328431|585259483|FG000|3 Month (3M)|Death|2|||
162055390|NCT01328431|585259484|FG001|3 Month (3M)|Death|2|||
162055391|NCT01328431|585259483|FG000|3 Month (3M)|Lost to Follow-up|75|||
162055392|NCT01328431|585259484|FG001|3 Month (3M)|Lost to Follow-up|70|||
162055393|NCT01328431|585259483|FG000|12 Month (12M)|Death|2|||
162055394|NCT01328431|585259484|FG001|12 Month (12M)|Death|6|||
162055395|NCT01328431|585259483|FG000|12 Month (12M)|Lost to Follow-up|82|||
162055396|NCT01328431|585259484|FG001|12 Month (12M)|Lost to Follow-up|91|||
162055397|NCT02256631|585259487|FG000|Overall Study|Lost to Follow-up|1|||
162055398|NCT02256631|585259488|FG001|Overall Study|Lost to Follow-up|1|||
162055399|NCT02256631|585259489|FG002|Overall Study|Lost to Follow-up|0|||
162055400|NCT02256631|585259490|FG003|Overall Study|Lost to Follow-up|2|||
162055401|NCT02256631|585259491|FG004|Overall Study|Lost to Follow-up|0|||
162055402|NCT02256631|585259492|FG005|Overall Study|Lost to Follow-up|4|||
162055403|NCT02256631|585259493|FG006|Overall Study|Lost to Follow-up|1|||
162055404|NCT02256631|585259487|FG000|Overall Study|Withdrawal by Subject|0|||
162055405|NCT02256631|585259488|FG001|Overall Study|Withdrawal by Subject|0|||
162055406|NCT02256631|585259489|FG002|Overall Study|Withdrawal by Subject|0|||
162055407|NCT02256631|585259490|FG003|Overall Study|Withdrawal by Subject|1|||
162055408|NCT02256631|585259491|FG004|Overall Study|Withdrawal by Subject|1|||
162055409|NCT02256631|585259492|FG005|Overall Study|Withdrawal by Subject|0|||
162055410|NCT02256631|585259493|FG006|Overall Study|Withdrawal by Subject|1|||
162055411|NCT02256631|585259487|FG000|Overall Study|Unable to get to clinic|0|||
162055412|NCT02256631|585259488|FG001|Overall Study|Unable to get to clinic|2|||
162055413|NCT02256631|585259489|FG002|Overall Study|Unable to get to clinic|0|||
162055414|NCT02256631|585259490|FG003|Overall Study|Unable to get to clinic|1|||
162055415|NCT02256631|585259491|FG004|Overall Study|Unable to get to clinic|0|||
162055416|NCT02256631|585259492|FG005|Overall Study|Unable to get to clinic|1|||
162055417|NCT02256631|585259493|FG006|Overall Study|Unable to get to clinic|2|||
162055418|NCT01427972|585259494|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162055419|NCT01427972|585259495|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162055420|NCT01427972|585259496|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162055421|NCT01427972|585259497|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162055422|NCT01427972|585259498|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162055423|NCT01427972|585259499|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162055424|NCT01427972|585259500|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162055425|NCT01427972|585259501|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
162055426|NCT01427972|585259502|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162055427|NCT01427972|585259503|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162055428|NCT01427972|585259504|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162055429|NCT01427972|585259505|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
162055430|NCT01427972|585259494|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162055431|NCT01427972|585259495|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162055432|NCT01427972|585259496|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162055433|NCT01427972|585259497|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162055434|NCT01427972|585259498|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162055435|NCT01427972|585259499|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
162055436|NCT01427972|585259500|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162055437|NCT01427972|585259501|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162055438|NCT01427972|585259502|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162055439|NCT01427972|585259503|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162055440|NCT01427972|585259504|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162055441|NCT01427972|585259505|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
162055442|NCT01427972|585259494|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162055443|NCT01427972|585259495|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
162055444|NCT01427972|585259496|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162055445|NCT01427972|585259497|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162055446|NCT01427972|585259498|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162055447|NCT01427972|585259499|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162055448|NCT01427972|585259500|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162055449|NCT01427972|585259501|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162055450|NCT01427972|585259502|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162055451|NCT01427972|585259503|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162055452|NCT01427972|585259504|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162055453|NCT01427972|585259505|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
162055454|NCT02094677|585259506|FG000|Overall Study|Screening|3|||
162055455|NCT02094677|585259507|FG001|Overall Study|Screening|1|||
162055456|NCT04967443|585259511|FG000|Open Label Treatment|Death|1|||
162055457|NCT04967443|585259512|FG001|Open Label Treatment|Death|0|||
162055458|NCT04967443|585259513|FG002|Open Label Treatment|Death|0|||
162055459|NCT04967443|585259514|FG003|Open Label Treatment|Death|0|||
162055460|NCT04967443|585259515|FG004|Open Label Treatment|Death|0|||
162055461|NCT04967443|585259516|FG005|Open Label Treatment|Death|0|||
162055462|NCT04967443|585259517|FG006|Open Label Treatment|Death|0|||
162055463|NCT04967443|585259518|FG007|Open Label Treatment|Death|0|||
162055464|NCT04967443|585259511|FG000|Open Label Treatment|Lost to Follow-up|0|||
162055465|NCT04967443|585259512|FG001|Open Label Treatment|Lost to Follow-up|0|||
162055466|NCT04967443|585259513|FG002|Open Label Treatment|Lost to Follow-up|1|||
162055467|NCT04967443|585259514|FG003|Open Label Treatment|Lost to Follow-up|0|||
162055468|NCT04967443|585259515|FG004|Open Label Treatment|Lost to Follow-up|0|||
162055469|NCT04967443|585259516|FG005|Open Label Treatment|Lost to Follow-up|0|||
162055470|NCT04967443|585259517|FG006|Open Label Treatment|Lost to Follow-up|0|||
162055471|NCT04967443|585259518|FG007|Open Label Treatment|Lost to Follow-up|0|||
162055472|NCT04967443|585259511|FG000|Open Label Treatment|Withdrawal by Subject|0|||
162055473|NCT04967443|585259512|FG001|Open Label Treatment|Withdrawal by Subject|1|||
162055474|NCT04967443|585259513|FG002|Open Label Treatment|Withdrawal by Subject|0|||
162055475|NCT04967443|585259514|FG003|Open Label Treatment|Withdrawal by Subject|1|||
162055476|NCT04967443|585259515|FG004|Open Label Treatment|Withdrawal by Subject|0|||
162055477|NCT04967443|585259516|FG005|Open Label Treatment|Withdrawal by Subject|1|||
162055478|NCT04967443|585259517|FG006|Open Label Treatment|Withdrawal by Subject|2|||
162055479|NCT04967443|585259518|FG007|Open Label Treatment|Withdrawal by Subject|3|||
162055480|NCT04967443|585259511|FG000|Follow-Up|Death|1|||
162055481|NCT04967443|585259512|FG001|Follow-Up|Death|0|||
162055482|NCT04967443|585259513|FG002|Follow-Up|Death|0|||
162055483|NCT04967443|585259514|FG003|Follow-Up|Death|0|||
162055484|NCT04967443|585259515|FG004|Follow-Up|Death|0|||
162055485|NCT04967443|585259516|FG005|Follow-Up|Death|0|||
162055486|NCT04967443|585259517|FG006|Follow-Up|Death|0|||
162055487|NCT04967443|585259518|FG007|Follow-Up|Death|0|||
162055488|NCT04967443|585259511|FG000|Follow-Up|Lost to Follow-up|0|||
162055489|NCT04967443|585259512|FG001|Follow-Up|Lost to Follow-up|0|||
162055490|NCT04967443|585259513|FG002|Follow-Up|Lost to Follow-up|1|||
162055491|NCT04967443|585259514|FG003|Follow-Up|Lost to Follow-up|1|||
162055492|NCT04967443|585259515|FG004|Follow-Up|Lost to Follow-up|0|||
162055493|NCT04967443|585259516|FG005|Follow-Up|Lost to Follow-up|0|||
162055494|NCT04967443|585259517|FG006|Follow-Up|Lost to Follow-up|0|||
162055495|NCT04967443|585259518|FG007|Follow-Up|Lost to Follow-up|0|||
162055496|NCT04967443|585259511|FG000|Follow-Up|Withdrawal by Subject|0|||
162055497|NCT04967443|585259512|FG001|Follow-Up|Withdrawal by Subject|1|||
162055498|NCT04967443|585259513|FG002|Follow-Up|Withdrawal by Subject|0|||
162055499|NCT04967443|585259514|FG003|Follow-Up|Withdrawal by Subject|1|||
162055500|NCT04967443|585259515|FG004|Follow-Up|Withdrawal by Subject|0|||
162055501|NCT04967443|585259516|FG005|Follow-Up|Withdrawal by Subject|1|||
162055502|NCT04967443|585259517|FG006|Follow-Up|Withdrawal by Subject|2|||
162055503|NCT04967443|585259518|FG007|Follow-Up|Withdrawal by Subject|3|||
162055504|NCT04502693|585259519|FG000|Overall Study|Adverse Event|7|||
162055505|NCT04502693|585259520|FG001|Overall Study|Adverse Event|6|||
162055506|NCT04502693|585259521|FG002|Overall Study|Adverse Event|11|||
162055507|NCT04502693|585259522|FG003|Overall Study|Adverse Event|1|||
162055508|NCT04502693|585259519|FG000|Overall Study|Lost to Follow-up|32|||
162055509|NCT04502693|585259520|FG001|Overall Study|Lost to Follow-up|36|||
162055510|NCT04502693|585259521|FG002|Overall Study|Lost to Follow-up|69|||
162055511|NCT04502693|585259522|FG003|Overall Study|Lost to Follow-up|4|||
162055512|NCT04502693|585259519|FG000|Overall Study|Protocol Violation|8|||
162055513|NCT04502693|585259520|FG001|Overall Study|Protocol Violation|8|||
162055514|NCT04502693|585259521|FG002|Overall Study|Protocol Violation|16|||
162055515|NCT04502693|585259522|FG003|Overall Study|Protocol Violation|1|||
162055516|NCT04502693|585259519|FG000|Overall Study|Withdrawal by Subject|46|||
162055517|NCT04502693|585259520|FG001|Overall Study|Withdrawal by Subject|38|||
162055518|NCT04502693|585259521|FG002|Overall Study|Withdrawal by Subject|54|||
162055519|NCT04502693|585259522|FG003|Overall Study|Withdrawal by Subject|7|||
162055520|NCT04502693|585259519|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
162055521|NCT04502693|585259520|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
162055522|NCT04502693|585259521|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
162055523|NCT04502693|585259522|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162055524|NCT04502693|585259519|FG000|Overall Study|Other|1|||
162055525|NCT04502693|585259520|FG001|Overall Study|Other|0|||
162055526|NCT04502693|585259521|FG002|Overall Study|Other|1|||
162055527|NCT04502693|585259522|FG003|Overall Study|Other|1|||
162055528|NCT00602797|585259523|FG000|Overall Study|Adverse Event|1|||
162055529|NCT02784431|585259524|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
162055530|NCT02784431|585259524|FG000|Overall Study|Early Study Termination|19|||
162055531|NCT01273597|585259527|FG000|Overall Study|Adverse Event|5|||
162055532|NCT01273597|585259527|FG000|Overall Study|Underwent Kidney Transplantation|2|||
162055533|NCT01273597|585259527|FG000|Overall Study|Reason Not Reported|1|||
162055534|NCT00393029|585259528|FG000|Overall Study|Not treated|0|||
162055535|NCT00393029|585259529|FG001|Overall Study|Not treated|1|||
162055536|NCT03547583|585259530|FG000|Overall Study|Adverse Event|16|||
162055537|NCT03547583|585259531|FG001|Overall Study|Adverse Event|11|||
162055538|NCT03547583|585259532|FG002|Overall Study|Adverse Event|10|||
162055539|NCT03547583|585259530|FG000|Overall Study|Death|11|||
162055540|NCT03547583|585259531|FG001|Overall Study|Death|7|||
162055541|NCT03547583|585259532|FG002|Overall Study|Death|4|||
162055542|NCT03547583|585259530|FG000|Overall Study|Lost to Follow-up|1|||
162055543|NCT03547583|585259531|FG001|Overall Study|Lost to Follow-up|0|||
162055544|NCT03547583|585259532|FG002|Overall Study|Lost to Follow-up|0|||
162055545|NCT03547583|585259530|FG000|Overall Study|Non-compliance with study drug|0|||
162055546|NCT03547583|585259531|FG001|Overall Study|Non-compliance with study drug|0|||
162055547|NCT03547583|585259532|FG002|Overall Study|Non-compliance with study drug|1|||
162055548|NCT03547583|585259530|FG000|Overall Study|Physician Decision|1|||
162055549|NCT03547583|585259531|FG001|Overall Study|Physician Decision|0|||
162055550|NCT03547583|585259532|FG002|Overall Study|Physician Decision|3|||
162055551|NCT03547583|585259530|FG000|Overall Study|Protocol Violation|2|||
162055552|NCT03547583|585259531|FG001|Overall Study|Protocol Violation|1|||
162055553|NCT03547583|585259532|FG002|Overall Study|Protocol Violation|1|||
162055554|NCT03547583|585259530|FG000|Overall Study|Withdrawal by Subject|12|||
162055555|NCT03547583|585259531|FG001|Overall Study|Withdrawal by Subject|19|||
162055556|NCT03547583|585259532|FG002|Overall Study|Withdrawal by Subject|10|||
162055557|NCT03547583|585259530|FG000|Overall Study|Other|2|||
162055558|NCT03547583|585259531|FG001|Overall Study|Other|2|||
162055559|NCT03547583|585259532|FG002|Overall Study|Other|3|||
162055560|NCT00279305|585259533|FG000|Overall Study|Pregnancy|1|||
162055561|NCT00279305|585259534|FG001|Overall Study|Pregnancy|0|||
162055562|NCT00279305|585259533|FG000|Overall Study|Withdrawal by Subject|2|||
162055563|NCT00279305|585259534|FG001|Overall Study|Withdrawal by Subject|0|||
162055564|NCT00279305|585259533|FG000|Overall Study|Dificulting establishing IV|1|||
162055565|NCT00279305|585259534|FG001|Overall Study|Dificulting establishing IV|0|||
162055566|NCT00279305|585259533|FG000|Overall Study|FDA Safety Alert|4|||
162055567|NCT00279305|585259534|FG001|Overall Study|FDA Safety Alert|1|||
162055568|NCT04404361|585259535|FG000|Overall Study|Death|12|||
162055569|NCT04404361|585259536|FG001|Overall Study|Death|12|||
162055570|NCT04404361|585259535|FG000|Overall Study|Withdrawal by Subject|13|||
162055571|NCT04404361|585259536|FG001|Overall Study|Withdrawal by Subject|5|||
162055572|NCT04404361|585259535|FG000|Overall Study|Lost to Follow-up|6|||
162055573|NCT04404361|585259536|FG001|Overall Study|Lost to Follow-up|3|||
162055574|NCT04404361|585259535|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
162055575|NCT04404361|585259536|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
162055576|NCT01063868|585259543|FG000|Overall Study|Adverse Event|9|||
162055577|NCT01063868|585259544|FG001|Overall Study|Adverse Event|7|||
162055578|NCT01063868|585259543|FG000|Overall Study|Withdrawal by Subject|3|||
162055579|NCT01063868|585259544|FG001|Overall Study|Withdrawal by Subject|1|||
162055580|NCT01063868|585259543|FG000|Overall Study|Study Terminated By Sponsor|23|||
162055581|NCT01063868|585259544|FG001|Overall Study|Study Terminated By Sponsor|4|||
162055582|NCT01949506|585259545|FG000|Overall Study|Physician Decision|1|||
162055583|NCT01446289|585259546|FG000|Overall Study|Withdrawal by Subject|1|||
162055584|NCT01446289|585259547|FG001|Overall Study|Withdrawal by Subject|0|||
162055585|NCT01446289|585259548|FG002|Overall Study|Withdrawal by Subject|1|||
162055586|NCT01446289|585259549|FG003|Overall Study|Withdrawal by Subject|0|||
162055587|NCT03307967|585259550|FG000|Overall Study|Lost to Follow-up|4|||
162055588|NCT02915016|585259551|FG000|Overall Study|Lost to Follow-up|4|||
162055589|NCT02915016|585259552|FG001|Overall Study|Lost to Follow-up|2|||
162055590|NCT02915016|585259553|FG002|Overall Study|Lost to Follow-up|5|||
162055591|NCT02915016|585259554|FG003|Overall Study|Lost to Follow-up|3|||
162055592|NCT02915016|585259555|FG004|Overall Study|Lost to Follow-up|5|||
162055593|NCT02915016|585259556|FG005|Overall Study|Lost to Follow-up|2|||
162055594|NCT02915016|585259557|FG006|Overall Study|Lost to Follow-up|8|||
162055595|NCT02915016|585259558|FG007|Overall Study|Lost to Follow-up|2|||
162055596|NCT02915016|585259551|FG000|Overall Study|Physician Decision|0|||
162055597|NCT02915016|585259552|FG001|Overall Study|Physician Decision|0|||
162055598|NCT02915016|585259553|FG002|Overall Study|Physician Decision|1|||
162055599|NCT02915016|585259554|FG003|Overall Study|Physician Decision|0|||
162055600|NCT02915016|585259555|FG004|Overall Study|Physician Decision|0|||
162055601|NCT02915016|585259556|FG005|Overall Study|Physician Decision|1|||
162055602|NCT02915016|585259557|FG006|Overall Study|Physician Decision|2|||
162055603|NCT02915016|585259558|FG007|Overall Study|Physician Decision|0|||
162055604|NCT02915016|585259551|FG000|Overall Study|Withdrawal by Subject|2|||
162055605|NCT02915016|585259552|FG001|Overall Study|Withdrawal by Subject|0|||
162055606|NCT02915016|585259553|FG002|Overall Study|Withdrawal by Subject|1|||
162055607|NCT02915016|585259554|FG003|Overall Study|Withdrawal by Subject|0|||
162055608|NCT02915016|585259555|FG004|Overall Study|Withdrawal by Subject|1|||
162055609|NCT02915016|585259556|FG005|Overall Study|Withdrawal by Subject|3|||
162055610|NCT02915016|585259557|FG006|Overall Study|Withdrawal by Subject|1|||
162055611|NCT02915016|585259558|FG007|Overall Study|Withdrawal by Subject|1|||
162055612|NCT02915016|585259551|FG000|Overall Study|Elected not to continue|0|||
162055613|NCT02915016|585259552|FG001|Overall Study|Elected not to continue|0|||
162055614|NCT02915016|585259553|FG002|Overall Study|Elected not to continue|0|||
162055615|NCT02915016|585259554|FG003|Overall Study|Elected not to continue|1|||
162055616|NCT02915016|585259555|FG004|Overall Study|Elected not to continue|0|||
162055617|NCT02915016|585259556|FG005|Overall Study|Elected not to continue|0|||
162055618|NCT02915016|585259557|FG006|Overall Study|Elected not to continue|1|||
162055619|NCT02915016|585259558|FG007|Overall Study|Elected not to continue|0|||
162055620|NCT02915016|585259551|FG000|Overall Study|HIV infection|1|||
162055621|NCT02915016|585259552|FG001|Overall Study|HIV infection|1|||
162055622|NCT02915016|585259553|FG002|Overall Study|HIV infection|1|||
162055623|NCT02915016|585259554|FG003|Overall Study|HIV infection|0|||
162055624|NCT02915016|585259555|FG004|Overall Study|HIV infection|1|||
162055625|NCT02915016|585259556|FG005|Overall Study|HIV infection|0|||
162055626|NCT02915016|585259557|FG006|Overall Study|HIV infection|0|||
162055627|NCT02915016|585259558|FG007|Overall Study|HIV infection|0|||
162055628|NCT02915016|585259551|FG000|Overall Study|Participant unable to adhere|0|||
162055629|NCT02915016|585259552|FG001|Overall Study|Participant unable to adhere|0|||
162055630|NCT02915016|585259553|FG002|Overall Study|Participant unable to adhere|0|||
162055631|NCT02915016|585259554|FG003|Overall Study|Participant unable to adhere|0|||
162055632|NCT02915016|585259555|FG004|Overall Study|Participant unable to adhere|0|||
162055633|NCT02915016|585259556|FG005|Overall Study|Participant unable to adhere|0|||
162055634|NCT02915016|585259557|FG006|Overall Study|Participant unable to adhere|0|||
162055635|NCT02915016|585259558|FG007|Overall Study|Participant unable to adhere|1|||
162055636|NCT02578316|585259559|FG000|Extension Phase|Progression of disease|6|||
162055637|NCT02166905|585259560|FG000|Overall Study|Withdrawal by Subject|1|||
162055638|NCT02166905|585259561|FG001|Overall Study|Withdrawal by Subject|0|||
162055639|NCT02166905|585259562|FG002|Overall Study|Withdrawal by Subject|0|||
162055640|NCT02166905|585259563|FG003|Overall Study|Withdrawal by Subject|0|||
162055641|NCT02617628|585259564|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
162055642|NCT02617628|585259565|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
162055643|NCT03278873|585259570|FG000|Overall Study|Withdrawal by Subject|0|||
162055644|NCT03278873|585259571|FG001|Overall Study|Withdrawal by Subject|1|||
162055645|NCT03278873|585259572|FG002|Overall Study|Withdrawal by Subject|0|||
162055646|NCT03278873|585259573|FG003|Overall Study|Withdrawal by Subject|0|||
162055647|NCT03278873|585259570|FG000|Overall Study|Sponsor's decision|0|||
162055648|NCT03278873|585259571|FG001|Overall Study|Sponsor's decision|1|||
162055649|NCT03278873|585259572|FG002|Overall Study|Sponsor's decision|0|||
162055650|NCT03278873|585259573|FG003|Overall Study|Sponsor's decision|0|||
162055651|NCT03278873|585259570|FG000|Overall Study|Early Termination|2|||
162055652|NCT03278873|585259571|FG001|Overall Study|Early Termination|6|||
162055653|NCT03278873|585259572|FG002|Overall Study|Early Termination|0|||
162055654|NCT03278873|585259573|FG003|Overall Study|Early Termination|4|||
162055655|NCT03278873|585259570|FG000|Overall Study|Lost to Follow-up|0|||
162055656|NCT03278873|585259571|FG001|Overall Study|Lost to Follow-up|0|||
162055657|NCT03278873|585259572|FG002|Overall Study|Lost to Follow-up|2|||
162055658|NCT03278873|585259573|FG003|Overall Study|Lost to Follow-up|0|||
162055659|NCT03278873|585259570|FG000|Overall Study|The patient decided to withdraw via email|1|||
162055660|NCT03278873|585259571|FG001|Overall Study|The patient decided to withdraw via email|0|||
162055661|NCT03278873|585259572|FG002|Overall Study|The patient decided to withdraw via email|0|||
162055662|NCT03278873|585259573|FG003|Overall Study|The patient decided to withdraw via email|0|||
162055663|NCT03278873|585259570|FG000|Overall Study|The patient was unresponsive to contact|0|||
162055664|NCT03278873|585259571|FG001|Overall Study|The patient was unresponsive to contact|0|||
162055665|NCT03278873|585259572|FG002|Overall Study|The patient was unresponsive to contact|0|||
162055666|NCT03278873|585259573|FG003|Overall Study|The patient was unresponsive to contact|4|||
162055667|NCT03278873|585259570|FG000|Overall Study|The patient wished to participate no longer|0|||
162055668|NCT03278873|585259571|FG001|Overall Study|The patient wished to participate no longer|1|||
162055669|NCT03278873|585259572|FG002|Overall Study|The patient wished to participate no longer|0|||
162055670|NCT03278873|585259573|FG003|Overall Study|The patient wished to participate no longer|0|||
162055671|NCT03278873|585259570|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
162055672|NCT03278873|585259571|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
162055673|NCT03278873|585259572|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
162055674|NCT03278873|585259573|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
162055675|NCT05243641|585259574|FG000|Overall Study|Adverse Event|3|||
162055676|NCT05243641|585259575|FG001|Overall Study|Adverse Event|0|||
162055677|NCT05243641|585259576|FG002|Overall Study|Adverse Event|0|||
162055678|NCT05243641|585259577|FG003|Overall Study|Adverse Event|1|||
162055679|NCT05243641|585259578|FG004|Overall Study|Adverse Event|0|||
162055680|NCT05243641|585259579|FG005|Overall Study|Adverse Event|0|||
162055681|NCT05243641|585259574|FG000|Overall Study|Disease progression|4|||
162055682|NCT05243641|585259575|FG001|Overall Study|Disease progression|0|||
162055683|NCT05243641|585259576|FG002|Overall Study|Disease progression|0|||
162055684|NCT05243641|585259577|FG003|Overall Study|Disease progression|2|||
162055685|NCT05243641|585259578|FG004|Overall Study|Disease progression|0|||
162055686|NCT05243641|585259579|FG005|Overall Study|Disease progression|0|||
162055687|NCT04518306|585259588|FG000|Double-Blind Period|Run in failure|0|||
162055688|NCT04518306|585259589|FG001|Double-Blind Period|Run in failure|0|||
162055689|NCT04518306|585259590|FG002|Double-Blind Period|Run in failure|1|||
162055690|NCT04518306|585259588|FG000|Double-Blind Period|Adverse Event|0|||
162055691|NCT04518306|585259589|FG001|Double-Blind Period|Adverse Event|2|||
162055692|NCT04518306|585259590|FG002|Double-Blind Period|Adverse Event|2|||
162055693|NCT04518306|585259588|FG000|Double-Blind Period|Lost to Follow-up|1|||
162055694|NCT04518306|585259589|FG001|Double-Blind Period|Lost to Follow-up|2|||
162055695|NCT04518306|585259590|FG002|Double-Blind Period|Lost to Follow-up|2|||
162055696|NCT04518306|585259588|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
162055697|NCT04518306|585259589|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
162055698|NCT04518306|585259590|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
162055699|NCT04518306|585259588|FG000|Double-Blind Period|Other|0|||
162055700|NCT04518306|585259589|FG001|Double-Blind Period|Other|2|||
162055701|NCT04518306|585259590|FG002|Double-Blind Period|Other|0|||
162055702|NCT04518306|585259588|FG000|Double-Blind Period|Missing|0|||
162055703|NCT04518306|585259589|FG001|Double-Blind Period|Missing|1|||
162055704|NCT04518306|585259590|FG002|Double-Blind Period|Missing|0|||
162055705|NCT03268954|585259594|FG000|Overall Study|Withdrawal by Subject|27|||
162055706|NCT03268954|585259595|FG001|Overall Study|Withdrawal by Subject|17|||
162055707|NCT03268954|585259594|FG000|Overall Study|Lost to Follow-up|2|||
162055708|NCT03268954|585259595|FG001|Overall Study|Lost to Follow-up|3|||
162055709|NCT03268954|585259594|FG000|Overall Study|Reason Not Specified|3|||
162055710|NCT03268954|585259595|FG001|Overall Study|Reason Not Specified|8|||
162055711|NCT05372419|585259598|FG000|Overall Study|Protocol Deviation|1|||
162055712|NCT05372419|585259598|FG000|Overall Study|Withdrawal by Subject|5|||
162055713|NCT05372419|585259598|FG000|Overall Study|Lost to Follow-up|7|||
162055714|NCT05358444|585259599|FG000|Overall Study|Withdrawal by Subject|0|||
162055715|NCT05358444|585259600|FG001|Overall Study|Withdrawal by Subject|1|||
162055716|NCT05358444|585259599|FG000|Overall Study|Lost to Follow-up|0|||
162055717|NCT05358444|585259600|FG001|Overall Study|Lost to Follow-up|3|||
162055718|NCT02801331|585259601|FG000|Overall Study|Transferred to another hospital|8|||
162055719|NCT02801331|585259602|FG001|Overall Study|Transferred to another hospital|7|||
162055720|NCT02801331|585259601|FG000|Overall Study|Withdrawal by Subject|0|||
162055721|NCT02801331|585259602|FG001|Overall Study|Withdrawal by Subject|4|||
162055722|NCT02801331|585259601|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
162055723|NCT02801331|585259602|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
162055724|NCT02443987|585259603|FG000|Overall Study|Bladder injury|1|||
162055725|NCT02443987|585259604|FG001|Overall Study|Bladder injury|1|||
162055726|NCT02443987|585259603|FG000|Overall Study|Other|0|||
162055727|NCT02443987|585259604|FG001|Overall Study|Other|1|||
162055728|NCT02513394|585259606|FG000|Overall Study|Withdrawal by Subject|11|||
162055729|NCT02513394|585259607|FG001|Overall Study|Withdrawal by Subject|23|||
162055730|NCT02513394|585259606|FG000|Overall Study|Ineligible|1|||
162055731|NCT02513394|585259607|FG001|Overall Study|Ineligible|0|||
162055732|NCT03217175|585261323|FG000|Overall Study|Physician Decision|4|||
162055733|NCT03217175|585261324|FG001|Overall Study|Physician Decision|1|||
162055734|NCT00429273|585261325|FG000|Overall Study|Lost to Follow-up|1|||
162055735|NCT00429273|585261326|FG001|Overall Study|Lost to Follow-up|2|||
162055736|NCT00429273|585261327|FG002|Overall Study|Lost to Follow-up|2|||
162055737|NCT00429273|585261325|FG000|Overall Study|Physician Decision|6|||
162055738|NCT00429273|585261326|FG001|Overall Study|Physician Decision|5|||
162055739|NCT00429273|585261327|FG002|Overall Study|Physician Decision|5|||
162055740|NCT00429273|585261325|FG000|Overall Study|Adverse Event|1|||
162055741|NCT00429273|585261326|FG001|Overall Study|Adverse Event|1|||
162055742|NCT00429273|585261327|FG002|Overall Study|Adverse Event|2|||
162055743|NCT01218204|585261332|FG000|Part B Washout|Adverse Event|0|||
162055744|NCT01218204|585261333|FG001|Part B Washout|Adverse Event|1|||
162055745|NCT01218204|585261334|FG002|Part B Washout|Adverse Event|0|||
162055746|NCT01218204|585261335|FG003|Part B Washout|Adverse Event|0|||
162055747|NCT01218204|585261332|FG000|Part B Washout|Lost to Follow-up|0|||
162055748|NCT01218204|585261333|FG001|Part B Washout|Lost to Follow-up|2|||
162055749|NCT01218204|585261334|FG002|Part B Washout|Lost to Follow-up|0|||
162055750|NCT01218204|585261335|FG003|Part B Washout|Lost to Follow-up|0|||
162055751|NCT01218204|585261332|FG000|Part B Washout|Physician Decision|0|||
162055752|NCT01218204|585261333|FG001|Part B Washout|Physician Decision|14|||
162055753|NCT01218204|585261334|FG002|Part B Washout|Physician Decision|0|||
162055754|NCT01218204|585261335|FG003|Part B Washout|Physician Decision|0|||
162055755|NCT01218204|585261332|FG000|Part B Washout|Withdrawal by Subject|0|||
162055756|NCT01218204|585261333|FG001|Part B Washout|Withdrawal by Subject|14|||
162055757|NCT01218204|585261334|FG002|Part B Washout|Withdrawal by Subject|0|||
162055758|NCT01218204|585261335|FG003|Part B Washout|Withdrawal by Subject|0|||
162055759|NCT01218204|585261332|FG000|Part B Washout|Reached defined stopping criteria|0|||
162055760|NCT01218204|585261333|FG001|Part B Washout|Reached defined stopping criteria|2|||
162055761|NCT01218204|585261334|FG002|Part B Washout|Reached defined stopping criteria|0|||
162055762|NCT01218204|585261335|FG003|Part B Washout|Reached defined stopping criteria|0|||
162055763|NCT01218204|585261332|FG000|Part B Washout|Did not meet continuation criteria|0|||
162055764|NCT01218204|585261333|FG001|Part B Washout|Did not meet continuation criteria|112|||
162055765|NCT01218204|585261334|FG002|Part B Washout|Did not meet continuation criteria|0|||
162055766|NCT01218204|585261335|FG003|Part B Washout|Did not meet continuation criteria|0|||
162055767|NCT01218204|585261332|FG000|Part B Run-in|Adverse Event|0|||
162055768|NCT01218204|585261333|FG001|Part B Run-in|Adverse Event|0|||
162055769|NCT01218204|585261334|FG002|Part B Run-in|Adverse Event|1|||
162055770|NCT01218204|585261335|FG003|Part B Run-in|Adverse Event|0|||
162055771|NCT01218204|585261332|FG000|Part B Run-in|Protocol Violation|0|||
162055772|NCT01218204|585261333|FG001|Part B Run-in|Protocol Violation|0|||
162055773|NCT01218204|585261334|FG002|Part B Run-in|Protocol Violation|2|||
162055774|NCT01218204|585261335|FG003|Part B Run-in|Protocol Violation|0|||
162055775|NCT01218204|585261332|FG000|Part B Run-in|Withdrawal by Subject|0|||
162055776|NCT01218204|585261333|FG001|Part B Run-in|Withdrawal by Subject|0|||
162055777|NCT01218204|585261334|FG002|Part B Run-in|Withdrawal by Subject|3|||
162055778|NCT01218204|585261335|FG003|Part B Run-in|Withdrawal by Subject|0|||
162055779|NCT01218204|585261332|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
162055780|NCT01218204|585261333|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
162055781|NCT01218204|585261334|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
162055782|NCT01218204|585261335|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
162055783|NCT01218204|585261332|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
162055784|NCT01218204|585261333|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
162055785|NCT01218204|585261334|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
162055786|NCT01218204|585261335|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
162055787|NCT00407797|585261343|FG000|Overall Study|Lost to Follow-up|2|||
162055788|NCT00407797|585261343|FG000|Overall Study|Adverse Event|6|||
162055789|NCT00407797|585261343|FG000|Overall Study|Other|7|||
162055790|NCT00407797|585261343|FG000|Overall Study|Withdrawal by Subject|3|||
162055791|NCT01402492|585261347|FG000|Overall Study|Withdrawal by Subject|17|||
162055792|NCT01402492|585261348|FG001|Overall Study|Withdrawal by Subject|11|||
162055793|NCT01402492|585261349|FG002|Overall Study|Withdrawal by Subject|11|||
162055794|NCT01402492|585261347|FG000|Overall Study|Adverse Event|2|||
162055795|NCT01402492|585261348|FG001|Overall Study|Adverse Event|3|||
162055796|NCT01402492|585261349|FG002|Overall Study|Adverse Event|4|||
162055797|NCT01402492|585261347|FG000|Overall Study|Physician Decision|0|||
162055798|NCT01402492|585261348|FG001|Overall Study|Physician Decision|3|||
162055799|NCT01402492|585261349|FG002|Overall Study|Physician Decision|0|||
162055800|NCT01402492|585261347|FG000|Overall Study|Incarcerated (N=3)|2|||
162055801|NCT01402492|585261348|FG001|Overall Study|Incarcerated (N=3)|0|||
162055802|NCT01402492|585261349|FG002|Overall Study|Incarcerated (N=3)|1|||
162055803|NCT00518986|585261361|FG000|Overall Study|Adverse Event|12|||
162055804|NCT00518986|585261362|FG001|Overall Study|Adverse Event|7|||
162055805|NCT00518986|585261361|FG000|Overall Study|Lack of Efficacy|0|||
162055806|NCT00518986|585261362|FG001|Overall Study|Lack of Efficacy|2|||
162055807|NCT00518986|585261361|FG000|Overall Study|Lost to Follow-up|3|||
162055808|NCT00518986|585261362|FG001|Overall Study|Lost to Follow-up|2|||
162055809|NCT00518986|585261361|FG000|Overall Study|Physician Decision|0|||
162055810|NCT00518986|585261362|FG001|Overall Study|Physician Decision|3|||
162055811|NCT00518986|585261361|FG000|Overall Study|Protocol Violation|5|||
162055812|NCT00518986|585261362|FG001|Overall Study|Protocol Violation|7|||
162055813|NCT00518986|585261361|FG000|Overall Study|Withdrawal by Subject|4|||
162055814|NCT00518986|585261362|FG001|Overall Study|Withdrawal by Subject|4|||
162055815|NCT00518986|585261361|FG000|Overall Study|Non-Specific|2|||
162055816|NCT00518986|585261362|FG001|Overall Study|Non-Specific|1|||
162055817|NCT04862585|585261365|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
162055818|NCT04862585|585261366|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
162055819|NCT04862585|585261365|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
162055820|NCT04862585|585261366|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
162055821|NCT04862585|585261365|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
162055822|NCT04862585|585261366|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
162055823|NCT04862585|585261365|FG000|Overall Study|one withdrew without providing a reason|0|||
162055824|NCT04862585|585261366|FG001|Overall Study|one withdrew without providing a reason|1|||
162055825|NCT02099708|585261368|FG000|Overall Study|Data Not Available|30|||
162055826|NCT02099708|585261368|FG000|Overall Study|Lost to Follow-up|141|||
162055827|NCT02099708|585261368|FG000|Overall Study|Other|29|||
162055828|NCT05229406|585261369|FG000|Overall Study|Withdrawal by Subject|1|||
162055829|NCT05229406|585261370|FG001|Overall Study|Withdrawal by Subject|2|||
162055830|NCT01930123|585261371|FG000|Overall Study|Adverse Event|1|||
162055831|NCT01930123|585261372|FG001|Overall Study|Adverse Event|0|||
162055832|NCT01930123|585261371|FG000|Overall Study|Physician Decision|21|||
162055833|NCT01930123|585261372|FG001|Overall Study|Physician Decision|8|||
162055834|NCT01930123|585261371|FG000|Overall Study|Withdrawal by Subject|1|||
162055835|NCT01930123|585261372|FG001|Overall Study|Withdrawal by Subject|0|||
162055836|NCT03310021|585261374|FG000|Overall Study|Withdrawal by Subject|0|||
162055837|NCT03310021|585261375|FG001|Overall Study|Withdrawal by Subject|0|||
162055838|NCT03310021|585261376|FG002|Overall Study|Withdrawal by Subject|0|||
162055839|NCT03310021|585261377|FG003|Overall Study|Withdrawal by Subject|0|||
162055840|NCT03310021|585261378|FG004|Overall Study|Withdrawal by Subject|0|||
162055841|NCT03310021|585261379|FG005|Overall Study|Withdrawal by Subject|0|||
162055842|NCT03310021|585261380|FG006|Overall Study|Withdrawal by Subject|1|||
162055843|NCT03310021|585261381|FG007|Overall Study|Withdrawal by Subject|0|||
162055844|NCT03310021|585261382|FG008|Overall Study|Withdrawal by Subject|0|||
162055845|NCT03310021|585261383|FG009|Overall Study|Withdrawal by Subject|0|||
162055846|NCT03310021|585261384|FG010|Overall Study|Withdrawal by Subject|0|||
162055847|NCT03310021|585261385|FG011|Overall Study|Withdrawal by Subject|0|||
162055848|NCT03310021|585261386|FG012|Overall Study|Withdrawal by Subject|0|||
162055849|NCT03310021|585261387|FG013|Overall Study|Withdrawal by Subject|0|||
162055850|NCT03310021|585261388|FG014|Overall Study|Withdrawal by Subject|0|||
162055851|NCT03310021|585261389|FG015|Overall Study|Withdrawal by Subject|0|||
162055852|NCT03310021|585261390|FG016|Overall Study|Withdrawal by Subject|0|||
162055853|NCT03310021|585261391|FG017|Overall Study|Withdrawal by Subject|0|||
162055854|NCT03310021|585261392|FG018|Overall Study|Withdrawal by Subject|0|||
162055855|NCT03310021|585261393|FG019|Overall Study|Withdrawal by Subject|0|||
162055856|NCT03310021|585261374|FG000|Overall Study|Lost to Follow-up|0|||
162055857|NCT03310021|585261375|FG001|Overall Study|Lost to Follow-up|0|||
162055858|NCT03310021|585261376|FG002|Overall Study|Lost to Follow-up|0|||
162055859|NCT03310021|585261377|FG003|Overall Study|Lost to Follow-up|0|||
162055860|NCT03310021|585261378|FG004|Overall Study|Lost to Follow-up|0|||
162055861|NCT03310021|585261379|FG005|Overall Study|Lost to Follow-up|0|||
162055862|NCT03310021|585261380|FG006|Overall Study|Lost to Follow-up|0|||
162055863|NCT03310021|585261381|FG007|Overall Study|Lost to Follow-up|0|||
162055864|NCT03310021|585261382|FG008|Overall Study|Lost to Follow-up|0|||
162055865|NCT03310021|585261383|FG009|Overall Study|Lost to Follow-up|0|||
162055866|NCT03310021|585261384|FG010|Overall Study|Lost to Follow-up|1|||
162055867|NCT03310021|585261385|FG011|Overall Study|Lost to Follow-up|0|||
162055868|NCT03310021|585261386|FG012|Overall Study|Lost to Follow-up|0|||
162055869|NCT03310021|585261387|FG013|Overall Study|Lost to Follow-up|0|||
162055870|NCT03310021|585261388|FG014|Overall Study|Lost to Follow-up|0|||
162055871|NCT03310021|585261389|FG015|Overall Study|Lost to Follow-up|0|||
162055872|NCT03310021|585261390|FG016|Overall Study|Lost to Follow-up|0|||
162055873|NCT03310021|585261391|FG017|Overall Study|Lost to Follow-up|0|||
162055874|NCT03310021|585261392|FG018|Overall Study|Lost to Follow-up|0|||
162055875|NCT03310021|585261393|FG019|Overall Study|Lost to Follow-up|0|||
162055876|NCT00702923|585261394|FG000|Overall Study|Adverse Event|1|||
162055877|NCT02002091|585261395|FG000|Screening|Lost to Follow-up|10|||
162055878|NCT02002091|585261396|FG001|Screening|Lost to Follow-up|12|||
162055879|NCT02002091|585261395|FG000|Screening|Death|3|||
162055880|NCT02002091|585261396|FG001|Screening|Death|2|||
162055881|NCT01233258|585261399|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
162055882|NCT01233258|585261400|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
162055883|NCT01233258|585261401|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
162055884|NCT01233258|585261402|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
162055885|NCT01233258|585261403|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
162055886|NCT01233258|585261404|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
162055887|NCT01233258|585261399|FG000|First Intervention (6 Months)|Protocol Violation|0|||
162055888|NCT01233258|585261400|FG001|First Intervention (6 Months)|Protocol Violation|0|||
162055889|NCT01233258|585261401|FG002|First Intervention (6 Months)|Protocol Violation|1|||
162055890|NCT01233258|585261402|FG003|First Intervention (6 Months)|Protocol Violation|0|||
162055891|NCT01233258|585261403|FG004|First Intervention (6 Months)|Protocol Violation|0|||
162055892|NCT01233258|585261404|FG005|First Intervention (6 Months)|Protocol Violation|0|||
162055893|NCT01233258|585261399|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
162055894|NCT01233258|585261400|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
162055895|NCT01233258|585261401|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
162055896|NCT01233258|585261402|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
162055897|NCT01233258|585261403|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
162055898|NCT01233258|585261404|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
162055899|NCT00530946|585261408|FG000|Overall Study|Adverse Event|1|||
162055900|NCT00530946|585261409|FG001|Overall Study|Adverse Event|2|||
162055901|NCT00530946|585261410|FG002|Overall Study|Adverse Event|1|||
162055902|NCT00530946|585261411|FG003|Overall Study|Adverse Event|1|||
162055903|NCT00530946|585261408|FG000|Overall Study|Protocol Violation|0|||
162055904|NCT00530946|585261409|FG001|Overall Study|Protocol Violation|0|||
162055905|NCT00530946|585261410|FG002|Overall Study|Protocol Violation|0|||
162055906|NCT00530946|585261411|FG003|Overall Study|Protocol Violation|1|||
162055907|NCT00530946|585261408|FG000|Overall Study|Noncompliance|1|||
162055908|NCT00530946|585261409|FG001|Overall Study|Noncompliance|0|||
162055909|NCT00530946|585261410|FG002|Overall Study|Noncompliance|0|||
162055910|NCT00530946|585261411|FG003|Overall Study|Noncompliance|0|||
162055911|NCT03322631|585261416|FG000|Overall Study|Withdrawal by Subject|0|||
162055912|NCT03322631|585261417|FG001|Overall Study|Withdrawal by Subject|1|||
162055913|NCT03322631|585261418|FG002|Overall Study|Withdrawal by Subject|0|||
162055914|NCT03322631|585261419|FG003|Overall Study|Withdrawal by Subject|0|||
162055915|NCT03322631|585261416|FG000|Overall Study|Adverse Event|0|||
162055916|NCT03322631|585261417|FG001|Overall Study|Adverse Event|0|||
162055917|NCT03322631|585261418|FG002|Overall Study|Adverse Event|1|||
162055918|NCT03322631|585261419|FG003|Overall Study|Adverse Event|0|||
162055919|NCT01300650|585261421|FG000|Overall Study|Adverse Event|1|||
162055920|NCT03943147|585261422|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
162055921|NCT03943147|585261423|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
162055922|NCT03943147|585261422|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
162055923|NCT03943147|585261423|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
162055924|NCT03943147|585261422|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
162055925|NCT03943147|585261423|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
162122665|NCT01115491|585500297|FG000|Overall Study|Death|22|||
162055926|NCT03943147|585261422|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
162055927|NCT03943147|585261423|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
162055928|NCT03943147|585261422|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
162055929|NCT03943147|585261423|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
162055930|NCT03943147|585261422|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
162055931|NCT03943147|585261423|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
162055932|NCT01318993|585261424|FG000|Overall Study|Adverse Event|53|||
162055933|NCT01318993|585261424|FG000|Overall Study|Lack of Efficacy|121|||
162055934|NCT01318993|585261424|FG000|Overall Study|Protocol Violation|3|||
162055935|NCT01318993|585261424|FG000|Overall Study|Protocol based stopping criteria|6|||
162055936|NCT01318993|585261424|FG000|Overall Study|Study closed or terminated|174|||
162055937|NCT01318993|585261424|FG000|Overall Study|Lost to Follow-up|4|||
162055938|NCT01318993|585261424|FG000|Overall Study|Physician Decision|13|||
162055939|NCT01318993|585261424|FG000|Overall Study|Withdrawal by Subject|24|||
162055940|NCT03736447|585261428|FG000|Overall Study|Adverse Event|5|||
162055941|NCT03736447|585261429|FG001|Overall Study|Adverse Event|1|||
162055942|NCT03736447|585261428|FG000|Overall Study|Withdrawal by Subject|5|||
162055943|NCT03736447|585261429|FG001|Overall Study|Withdrawal by Subject|1|||
162055944|NCT03736447|585261428|FG000|Overall Study|Lost to Follow-up|1|||
162055945|NCT03736447|585261429|FG001|Overall Study|Lost to Follow-up|0|||
162055946|NCT03736447|585261428|FG000|Overall Study|Physician Decision|1|||
162055947|NCT03736447|585261429|FG001|Overall Study|Physician Decision|0|||
162055948|NCT03736447|585261428|FG000|Overall Study|Continued commitment to study treatment|3|||
162055949|NCT03736447|585261429|FG001|Overall Study|Continued commitment to study treatment|0|||
162055950|NCT03736447|585261428|FG000|Overall Study|Taste aversion to study product|0|||
162055951|NCT03736447|585261429|FG001|Overall Study|Taste aversion to study product|1|||
162055952|NCT02619175|585261430|FG000|Overall Study|Withdrawal by Subject|1|||
162055953|NCT02619175|585261431|FG001|Overall Study|Withdrawal by Subject|0|||
162055954|NCT02619175|585261430|FG000|Overall Study|foot pain|1|||
162055955|NCT02619175|585261431|FG001|Overall Study|foot pain|0|||
162055956|NCT02795832|585261435|FG000|Overall Study|Adverse Event|0|||
162055957|NCT02795832|585261436|FG001|Overall Study|Adverse Event|0|||
162055958|NCT02795832|585261437|FG002|Overall Study|Adverse Event|0|||
162055959|NCT02795832|585261438|FG003|Overall Study|Adverse Event|0|||
162055960|NCT02795832|585261439|FG004|Overall Study|Adverse Event|0|||
162055961|NCT02795832|585261440|FG005|Overall Study|Adverse Event|3|||
162055962|NCT02695329|585261441|FG000|Overall Study|Adverse Event|1|||
162055963|NCT02695329|585261442|FG001|Overall Study|Adverse Event|0|||
162055964|NCT02695329|585261441|FG000|Overall Study|Poor X-ray quality for measurement|4|||
162055965|NCT02695329|585261442|FG001|Overall Study|Poor X-ray quality for measurement|5|||
162055966|NCT01382212|585261443|FG000|Overall Study|Kidney transplant|1|||
162055967|NCT01382212|585261443|FG000|Overall Study|Withdrew consent|1|||
162055968|NCT01846416|585261445|FG000|Treatment Phase|Death|2|||
162055969|NCT01846416|585261446|FG001|Treatment Phase|Death|9|||
162055970|NCT01846416|585261447|FG002|Treatment Phase|Death|1|||
162055971|NCT01846416|585261445|FG000|Treatment Phase|Withdrawal by Subject|2|||
162055972|NCT01846416|585261446|FG001|Treatment Phase|Withdrawal by Subject|4|||
162055973|NCT01846416|585261447|FG002|Treatment Phase|Withdrawal by Subject|2|||
162055974|NCT01846416|585261445|FG000|Treatment Phase|Other|1|||
162055975|NCT01846416|585261446|FG001|Treatment Phase|Other|5|||
162055976|NCT01846416|585261447|FG002|Treatment Phase|Other|1|||
162055977|NCT01846416|585261445|FG000|Treatment Phase|Physician Decision|1|||
162055978|NCT01846416|585261446|FG001|Treatment Phase|Physician Decision|2|||
162055979|NCT01846416|585261447|FG002|Treatment Phase|Physician Decision|0|||
162055980|NCT01846416|585261445|FG000|Treatment Phase|Adverse Event|3|||
162055981|NCT01846416|585261446|FG001|Treatment Phase|Adverse Event|4|||
162055982|NCT01846416|585261447|FG002|Treatment Phase|Adverse Event|0|||
162055983|NCT01846416|585261445|FG000|Treatment Phase|Non-compliance|0|||
162055984|NCT01846416|585261446|FG001|Treatment Phase|Non-compliance|2|||
162055985|NCT01846416|585261447|FG002|Treatment Phase|Non-compliance|0|||
162055986|NCT01846416|585261445|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
162055987|NCT01846416|585261446|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
162055988|NCT01846416|585261447|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
162055989|NCT01846416|585261445|FG000|Treatment Phase|Progressive Disease|21|||
162055990|NCT01846416|585261446|FG001|Treatment Phase|Progressive Disease|63|||
162055991|NCT01846416|585261447|FG002|Treatment Phase|Progressive Disease|9|||
162055992|NCT01846416|585261445|FG000|Survival Follow-up|Death|21|||
162055993|NCT01846416|585261446|FG001|Survival Follow-up|Death|62|||
162055994|NCT01846416|585261447|FG002|Survival Follow-up|Death|9|||
162055995|NCT01846416|585261445|FG000|Survival Follow-up|Lost to Follow-up|0|||
162055996|NCT01846416|585261446|FG001|Survival Follow-up|Lost to Follow-up|2|||
162055997|NCT01846416|585261447|FG002|Survival Follow-up|Lost to Follow-up|2|||
162055998|NCT01846416|585261445|FG000|Survival Follow-up|Withdrawal by Subject|2|||
162055999|NCT01846416|585261446|FG001|Survival Follow-up|Withdrawal by Subject|7|||
162056000|NCT01846416|585261447|FG002|Survival Follow-up|Withdrawal by Subject|0|||
162056001|NCT01846416|585261445|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
162056002|NCT01846416|585261446|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
162056003|NCT01846416|585261447|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
162056004|NCT01846416|585261445|FG000|Survival Follow-up|Other|3|||
162056005|NCT01846416|585261446|FG001|Survival Follow-up|Other|1|||
162056006|NCT01846416|585261447|FG002|Survival Follow-up|Other|1|||
162056007|NCT00382252|585261448|FG000|Overall Study|Death|4|||
162056008|NCT00382252|585261448|FG000|Overall Study|Protocol Violation|8|||
162056009|NCT00382252|585261448|FG000|Overall Study|Not treated by RFA|1|||
162056010|NCT00833794|585261449|FG000|Open-label Phase|Adverse Event|225|||
162056011|NCT00833794|585261450|FG001|Open-label Phase|Adverse Event|0|||
162056012|NCT00833794|585261449|FG000|Open-label Phase|Lack of Efficacy|28|||
162056013|NCT00833794|585261450|FG001|Open-label Phase|Lack of Efficacy|0|||
162056014|NCT00833794|585261449|FG000|Open-label Phase|Withdrawal by Subject|48|||
162056015|NCT00833794|585261450|FG001|Open-label Phase|Withdrawal by Subject|0|||
162056016|NCT00833794|585261449|FG000|Open-label Phase|Physician Decision|20|||
162056017|NCT00833794|585261450|FG001|Open-label Phase|Physician Decision|0|||
162056018|NCT00833794|585261449|FG000|Open-label Phase|Administrative reason|1|||
162056019|NCT00833794|585261450|FG001|Open-label Phase|Administrative reason|0|||
162056020|NCT00833794|585261449|FG000|Open-label Phase|Protocol Violation|47|||
162056021|NCT00833794|585261450|FG001|Open-label Phase|Protocol Violation|0|||
162056022|NCT00833794|585261449|FG000|Open-label Phase|Did not complete wash-out period|12|||
162056023|NCT00833794|585261450|FG001|Open-label Phase|Did not complete wash-out period|0|||
162056024|NCT00833794|585261449|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
162056025|NCT00833794|585261450|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
162056026|NCT00833794|585261449|FG000|Double-blind Phase|Adverse Event|44|||
162056027|NCT00833794|585261450|FG001|Double-blind Phase|Adverse Event|11|||
162056028|NCT00833794|585261449|FG000|Double-blind Phase|Lack of Efficacy|34|||
162056029|NCT00833794|585261450|FG001|Double-blind Phase|Lack of Efficacy|22|||
162056030|NCT00833794|585261449|FG000|Double-blind Phase|Withdrawal by Subject|23|||
162056031|NCT00833794|585261450|FG001|Double-blind Phase|Withdrawal by Subject|6|||
162056032|NCT00833794|585261449|FG000|Double-blind Phase|Physician Decision|4|||
162056033|NCT00833794|585261450|FG001|Double-blind Phase|Physician Decision|7|||
162056034|NCT00833794|585261449|FG000|Double-blind Phase|Administrative reason|1|||
162056035|NCT00833794|585261450|FG001|Double-blind Phase|Administrative reason|3|||
162056036|NCT00039130|585261453|FG000|Overall Study|Adverse Event|11|||
162056037|NCT00039130|585261453|FG000|Overall Study|Death|9|||
162056038|NCT00039130|585261453|FG000|Overall Study|Withdrawal by Subject|3|||
162056039|NCT00039130|585261453|FG000|Overall Study|Progression|2|||
162056040|NCT00039130|585261453|FG000|Overall Study|Subsequent treatment|2|||
162056041|NCT00039130|585261453|FG000|Overall Study|Physician Decision|3|||
162056042|NCT01269463|585261454|FG000|First Intervention|Withdrawal by Subject|1|||
162056043|NCT01269463|585261455|FG001|First Intervention|Withdrawal by Subject|0|||
162056044|NCT01269463|585261454|FG000|First Intervention|Adverse Event|1|||
162056045|NCT01269463|585261455|FG001|First Intervention|Adverse Event|0|||
162056046|NCT01269463|585261454|FG000|First Intervention|Lack of Efficacy|0|||
162056047|NCT01269463|585261455|FG001|First Intervention|Lack of Efficacy|1|||
162056048|NCT01269463|585261454|FG000|First Intervention|Physician Decision|0|||
162056049|NCT01269463|585261455|FG001|First Intervention|Physician Decision|1|||
162056050|NCT02612727|585261457|FG000|Overall Study|Parent request|4|||
162056051|NCT02612727|585261458|FG001|Overall Study|Parent request|1|||
162056052|NCT02612727|585261457|FG000|Overall Study|Needed treatment incompatible with PT|1|||
162056053|NCT02612727|585261458|FG001|Overall Study|Needed treatment incompatible with PT|1|||
162056054|NCT02612727|585261457|FG000|Overall Study|Direct hyperbilirubinemia|0|||
162056055|NCT02612727|585261458|FG001|Overall Study|Direct hyperbilirubinemia|2|||
162056056|NCT03820986|585261462|FG000|Overall Study|Death|201|||
162056057|NCT03820986|585261463|FG001|Overall Study|Death|175|||
162056058|NCT03820986|585261462|FG000|Overall Study|Lost to Follow-up|1|||
162056059|NCT03820986|585261463|FG001|Overall Study|Lost to Follow-up|1|||
162056060|NCT03820986|585261462|FG000|Overall Study|Physician Decision|1|||
162056061|NCT03820986|585261463|FG001|Overall Study|Physician Decision|0|||
162056062|NCT03820986|585261462|FG000|Overall Study|Sponsor Decision|122|||
162056063|NCT03820986|585261463|FG001|Overall Study|Sponsor Decision|160|||
162056064|NCT03820986|585261462|FG000|Overall Study|Withdrawal by Subject|9|||
162056065|NCT03820986|585261463|FG001|Overall Study|Withdrawal by Subject|4|||
162056066|NCT01638546|585261474|FG000|Overall Study|Adverse Event|1|||
162056067|NCT01638546|585261475|FG001|Overall Study|Adverse Event|3|||
162056068|NCT05766423|585261480|FG000|Overall Study|Withdrawal by Subject|1|||
162056069|NCT05766423|585261481|FG001|Overall Study|Withdrawal by Subject|0|||
162056070|NCT05766423|585261480|FG000|Overall Study|Consented, not scheduled|3|||
162056071|NCT05766423|585261481|FG001|Overall Study|Consented, not scheduled|5|||
162056072|NCT00540514|585263172|FG000|Overall Study|Still on treatment|3|||
162056073|NCT00540514|585263173|FG001|Overall Study|Still on treatment|0|||
162056074|NCT00540514|585263172|FG000|Overall Study|Unacceptable Toxicity|61|||
162056075|NCT00540514|585263173|FG001|Overall Study|Unacceptable Toxicity|62|||
162056076|NCT00540514|585263172|FG000|Overall Study|Adverse Event|20|||
162056077|NCT00540514|585263173|FG001|Overall Study|Adverse Event|24|||
162056078|NCT00540514|585263172|FG000|Overall Study|Physician Decision|86|||
162056079|NCT00540514|585263173|FG001|Overall Study|Physician Decision|99|||
162056080|NCT00540514|585263172|FG000|Overall Study|Protocol Deviation|3|||
162056081|NCT00540514|585263173|FG001|Overall Study|Protocol Deviation|4|||
162056082|NCT00540514|585263172|FG000|Overall Study|Lost to Follow-up|1|||
162056083|NCT00540514|585263173|FG001|Overall Study|Lost to Follow-up|1|||
162056084|NCT00540514|585263172|FG000|Overall Study|Withdrawal by Subject|65|||
162056085|NCT00540514|585263173|FG001|Overall Study|Withdrawal by Subject|67|||
162056086|NCT00540514|585263172|FG000|Overall Study|Excluded prior to treatment|7|||
162056087|NCT00540514|585263173|FG001|Overall Study|Excluded prior to treatment|7|||
162056088|NCT00540514|585263172|FG000|Overall Study|Paclitaxel not available|0|||
162056089|NCT00540514|585263173|FG001|Overall Study|Paclitaxel not available|2|||
162056090|NCT01892293|585263184|FG000|Overall Study|Apheresed but not treated|4|||
162056091|NCT03602482|585263187|FG000|Overall Study|Withdrawal by Subject|6|||
162056092|NCT03602482|585263188|FG001|Overall Study|Withdrawal by Subject|7|||
162056093|NCT03602482|585263189|FG002|Overall Study|Withdrawal by Subject|0|||
162056094|NCT03602482|585263190|FG003|Overall Study|Withdrawal by Subject|0|||
162056095|NCT03808545|585263202|FG000|Overall Study|Withdrawal by Subject|1|||
162056096|NCT03808545|585263203|FG001|Overall Study|Withdrawal by Subject|1|||
162056097|NCT00618072|585263212|FG000|Overall Study|Lost to Follow-up|2|||
162056098|NCT00618072|585263213|FG001|Overall Study|Lost to Follow-up|0|||
162056099|NCT00618072|585263214|FG002|Overall Study|Lost to Follow-up|3|||
162056100|NCT00618072|585263212|FG000|Overall Study|Physician Decision|0|||
162056101|NCT00618072|585263213|FG001|Overall Study|Physician Decision|1|||
162056102|NCT00618072|585263214|FG002|Overall Study|Physician Decision|1|||
162056103|NCT00684307|585263215|FG000|Overall Study|Adverse Event|11|||
162056104|NCT00684307|585263216|FG001|Overall Study|Adverse Event|6|||
162056105|NCT00684307|585263217|FG002|Overall Study|Adverse Event|15|||
162056106|NCT00684307|585263218|FG003|Overall Study|Adverse Event|16|||
162056107|NCT00684307|585263219|FG004|Overall Study|Adverse Event|8|||
162056108|NCT00684307|585263215|FG000|Overall Study|Development of increasing Liver Function|0|||
162056109|NCT00684307|585263216|FG001|Overall Study|Development of increasing Liver Function|2|||
162056110|NCT00684307|585263217|FG002|Overall Study|Development of increasing Liver Function|0|||
162056111|NCT00684307|585263218|FG003|Overall Study|Development of increasing Liver Function|1|||
162056112|NCT00684307|585263219|FG004|Overall Study|Development of increasing Liver Function|0|||
162056113|NCT00684307|585263215|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
162056114|NCT00684307|585263216|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
162056115|NCT00684307|585263217|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
162056116|NCT00684307|585263218|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
162056117|NCT00684307|585263219|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
162056118|NCT00684307|585263215|FG000|Overall Study|Incorrect enrolment or randomization|4|||
162056119|NCT00684307|585263216|FG001|Overall Study|Incorrect enrolment or randomization|0|||
162056120|NCT00684307|585263217|FG002|Overall Study|Incorrect enrolment or randomization|0|||
162056121|NCT00684307|585263218|FG003|Overall Study|Incorrect enrolment or randomization|0|||
162056122|NCT00684307|585263219|FG004|Overall Study|Incorrect enrolment or randomization|0|||
162056123|NCT00684307|585263215|FG000|Overall Study|Interupted IP for more than 7 days|0|||
162056124|NCT00684307|585263216|FG001|Overall Study|Interupted IP for more than 7 days|4|||
162056125|NCT00684307|585263217|FG002|Overall Study|Interupted IP for more than 7 days|1|||
162056126|NCT00684307|585263218|FG003|Overall Study|Interupted IP for more than 7 days|3|||
162056127|NCT00684307|585263219|FG004|Overall Study|Interupted IP for more than 7 days|3|||
162056128|NCT00684307|585263215|FG000|Overall Study|Severe non compliance to protocol|1|||
162056129|NCT00684307|585263216|FG001|Overall Study|Severe non compliance to protocol|0|||
162056130|NCT00684307|585263217|FG002|Overall Study|Severe non compliance to protocol|0|||
162056131|NCT00684307|585263218|FG003|Overall Study|Severe non compliance to protocol|1|||
162056132|NCT00684307|585263219|FG004|Overall Study|Severe non compliance to protocol|2|||
162056133|NCT00684307|585263215|FG000|Overall Study|Participant not willing to continue|7|||
162056134|NCT00684307|585263216|FG001|Overall Study|Participant not willing to continue|10|||
162056135|NCT00684307|585263217|FG002|Overall Study|Participant not willing to continue|11|||
162056136|NCT00684307|585263218|FG003|Overall Study|Participant not willing to continue|5|||
162056137|NCT00684307|585263219|FG004|Overall Study|Participant not willing to continue|8|||
162056138|NCT00684307|585263215|FG000|Overall Study|Criteria from the CSR|0|||
162056139|NCT00684307|585263216|FG001|Overall Study|Criteria from the CSR|0|||
162056140|NCT00684307|585263217|FG002|Overall Study|Criteria from the CSR|1|||
162056141|NCT00684307|585263218|FG003|Overall Study|Criteria from the CSR|3|||
162056142|NCT00684307|585263219|FG004|Overall Study|Criteria from the CSR|3|||
162056143|NCT00133952|585263221|FG000|Overall Study|Adverse Event|1|||
162056144|NCT00133952|585263222|FG001|Overall Study|Adverse Event|2|||
162056145|NCT00133952|585263221|FG000|Overall Study|Death|3|||
162056146|NCT00133952|585263222|FG001|Overall Study|Death|2|||
162056147|NCT00133952|585263221|FG000|Overall Study|Lost to Follow-up|9|||
162056148|NCT00133952|585263222|FG001|Overall Study|Lost to Follow-up|14|||
162056149|NCT00133952|585263221|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
162056150|NCT00133952|585263222|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
162056151|NCT00133952|585263221|FG000|Overall Study|Protocol Violation|1|||
162056152|NCT00133952|585263222|FG001|Overall Study|Protocol Violation|1|||
162056153|NCT00133952|585263221|FG000|Overall Study|Withdrawal by Subject|20|||
162056154|NCT00133952|585263222|FG001|Overall Study|Withdrawal by Subject|4|||
162056155|NCT00133952|585263221|FG000|Overall Study|Physician Decision|4|||
162056156|NCT00133952|585263222|FG001|Overall Study|Physician Decision|3|||
162056157|NCT00133952|585263221|FG000|Overall Study|Sponsor Decision|0|||
162056158|NCT00133952|585263222|FG001|Overall Study|Sponsor Decision|1|||
162056159|NCT02170298|585263225|FG000|Overall Study|Withdrawal by Subject|0|||
162056160|NCT02170298|585263226|FG001|Overall Study|Withdrawal by Subject|1|||
162056161|NCT02170298|585263225|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
162056162|NCT02170298|585263226|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
162056163|NCT05048784|585263229|FG000|Period 1|Adverse Event|3|||
162056164|NCT05048784|585263230|FG001|Period 1|Adverse Event|1|||
162056165|NCT05048784|585263231|FG002|Period 1|Adverse Event|0|||
162056166|NCT05048784|585263232|FG003|Period 1|Adverse Event|0|||
162056167|NCT05048784|585263229|FG000|Period 2|Lost to Follow-up|0|||
162056168|NCT05048784|585263230|FG001|Period 2|Lost to Follow-up|1|||
162056169|NCT05048784|585263231|FG002|Period 2|Lost to Follow-up|0|||
162056170|NCT05048784|585263232|FG003|Period 2|Lost to Follow-up|0|||
162056171|NCT02853604|585263237|FG000|Overall Study|Withdrawal by Subject|12|||
162056172|NCT02853604|585263238|FG001|Overall Study|Withdrawal by Subject|35|||
162056173|NCT02853604|585263237|FG000|Overall Study|Lost to Follow-up|4|||
162056174|NCT02853604|585263238|FG001|Overall Study|Lost to Follow-up|8|||
162056175|NCT02853604|585263237|FG000|Overall Study|Death|1|||
162056176|NCT02853604|585263238|FG001|Overall Study|Death|5|||
162056177|NCT02853604|585263237|FG000|Overall Study|Miscellaneous|11|||
162056178|NCT02853604|585263238|FG001|Overall Study|Miscellaneous|2|||
162056179|NCT02853604|585263237|FG000|Overall Study|Progressive Disease|0|||
162056180|NCT02853604|585263238|FG001|Overall Study|Progressive Disease|2|||
162056181|NCT00727025|585263239|FG000|Overall Study|Physician Decision|23|||
162056182|NCT02269241|585263240|FG000|Overall Study|Lost to Follow-up|269|||
162056183|NCT02269241|585263240|FG000|Overall Study|Withdrawal by Subject|155|||
162056184|NCT02269241|585263240|FG000|Overall Study|Protocol Violation|1|||
162056185|NCT02269241|585263240|FG000|Overall Study|Physician Decision|7|||
162056186|NCT02269241|585263240|FG000|Overall Study|Pregnancy|15|||
162056187|NCT02269241|585263240|FG000|Overall Study|Wish for pregnancy|5|||
162056188|NCT02269241|585263240|FG000|Overall Study|Development of an exclusion criteria|16|||
162056189|NCT02269241|585263240|FG000|Overall Study|Adverse Event|113|||
162056190|NCT02269241|585263240|FG000|Overall Study|At the specific request of the sponsor|20|||
162056191|NCT02269241|585263240|FG000|Overall Study|Several reasons not classified|53|||
162056192|NCT02269241|585263240|FG000|Overall Study|Screening failures|546|||
162056193|NCT03020160|585263241|FG000|Overall Study|Withdrawal by Subject|1|||
162056194|NCT03020160|585263242|FG001|Overall Study|Withdrawal by Subject|0|||
162056195|NCT02270957|585263243|FG000|Overall Study|Lack of Efficacy|2|||
162056196|NCT02270957|585263244|FG001|Overall Study|Lack of Efficacy|4|||
162056197|NCT02270957|585263243|FG000|Overall Study|Adverse Event|2|||
162056198|NCT02270957|585263244|FG001|Overall Study|Adverse Event|0|||
162056199|NCT01539538|585263252|FG000|Overall Study|Adverse Event|13|||
162056200|NCT01539538|585263253|FG001|Overall Study|Adverse Event|18|||
162056201|NCT01539538|585263252|FG000|Overall Study|Lack of Efficacy|13|||
162056202|NCT01539538|585263253|FG001|Overall Study|Lack of Efficacy|16|||
162056203|NCT01539538|585263252|FG000|Overall Study|Withdrawal by Subject|2|||
162056204|NCT01539538|585263253|FG001|Overall Study|Withdrawal by Subject|3|||
162056205|NCT01539538|585263252|FG000|Overall Study|PCA no longer required or PCA problem|3|||
162056206|NCT01539538|585263253|FG001|Overall Study|PCA no longer required or PCA problem|7|||
162056207|NCT03897465|585263254|FG000|Overall Study|Lost to Follow-up|2|||
162056208|NCT03897465|585263255|FG001|Overall Study|Lost to Follow-up|1|||
162056209|NCT03897465|585263254|FG000|Overall Study|Adverse Event|2|||
162056210|NCT03897465|585263255|FG001|Overall Study|Adverse Event|0|||
162056211|NCT03897465|585263254|FG000|Overall Study|complete healing by V2|1|||
162056212|NCT03897465|585263255|FG001|Overall Study|complete healing by V2|0|||
162056213|NCT03897465|585263254|FG000|Overall Study|occurence of exclusion criterion|1|||
162056214|NCT03897465|585263255|FG001|Overall Study|occurence of exclusion criterion|1|||
162056215|NCT03897465|585263254|FG000|Overall Study|Other|1|||
162056216|NCT03897465|585263255|FG001|Overall Study|Other|0|||
162056217|NCT00847379|585263256|FG000|Overall Study|Study terminated by Sponsor|59|||
162056218|NCT00847379|585263257|FG001|Overall Study|Study terminated by Sponsor|57|||
162056219|NCT00847379|585263258|FG002|Overall Study|Study terminated by Sponsor|57|||
162056220|NCT00521014|585263259|FG000|Overall Study|Inevaluable, not treated|1|||
162056221|NCT04390191|585263260|FG000|Overall Study|Withdrawal by Subject|1|||
162056222|NCT04390191|585263261|FG001|Overall Study|Withdrawal by Subject|0|||
162056223|NCT03978832|585263264|FG000|Overall Study|Adverse Event|1|||
162056224|NCT03978832|585263264|FG000|Overall Study|Lost to Follow-up|1|||
162056225|NCT03978832|585263264|FG000|Overall Study|Withdrawal by Subject|6|||
162056226|NCT03978832|585263264|FG000|Overall Study|Physician Decision|2|||
162056227|NCT03978832|585263264|FG000|Overall Study|did not pass screening criteria|44|||
162056228|NCT00003499|585263265|FG000|Overall Study|Not evaluable|8|||
162056229|NCT02042183|585263270|FG000|Overall Study|Physician Decision|7|||
162056230|NCT02042183|585263271|FG001|Overall Study|Physician Decision|2|||
162056231|NCT02042183|585263270|FG000|Overall Study|Lack of Efficacy|4|||
162056232|NCT02042183|585263271|FG001|Overall Study|Lack of Efficacy|3|||
162056233|NCT02042183|585263270|FG000|Overall Study|Non-compliance with Study Drug|2|||
162056234|NCT02042183|585263271|FG001|Overall Study|Non-compliance with Study Drug|3|||
162056235|NCT02042183|585263270|FG000|Overall Study|Adverse Event|17|||
162056236|NCT02042183|585263271|FG001|Overall Study|Adverse Event|6|||
162056237|NCT02042183|585263270|FG000|Overall Study|Other|3|||
162056238|NCT02042183|585263271|FG001|Overall Study|Other|3|||
162056239|NCT02042183|585263270|FG000|Overall Study|Withdrawal by Subject|21|||
162056240|NCT02042183|585263271|FG001|Overall Study|Withdrawal by Subject|16|||
162056241|NCT02042183|585263270|FG000|Overall Study|Site Terminated by Sponsor|2|||
162056242|NCT02042183|585263271|FG001|Overall Study|Site Terminated by Sponsor|1|||
162056243|NCT02042183|585263270|FG000|Overall Study|Lost to Follow-up|9|||
162056244|NCT02042183|585263271|FG001|Overall Study|Lost to Follow-up|2|||
162056245|NCT01256008|585263272|FG000|Overall Study|Lost to Follow-up|6|||
162056246|NCT01256008|585263273|FG001|Overall Study|Lost to Follow-up|4|||
162056247|NCT01256008|585263274|FG002|Overall Study|Lost to Follow-up|11|||
162056248|NCT01256008|585263272|FG000|Overall Study|Withdrawal by Subject|2|||
162056249|NCT01256008|585263273|FG001|Overall Study|Withdrawal by Subject|3|||
162056250|NCT01256008|585263274|FG002|Overall Study|Withdrawal by Subject|10|||
162056251|NCT00378378|585263277|FG000|Overall Study|Withdrawal by Subject|0|||
162056252|NCT00378378|585263278|FG001|Overall Study|Withdrawal by Subject|1|||
162056253|NCT00378378|585263279|FG002|Overall Study|Withdrawal by Subject|0|||
162056254|NCT00378378|585263277|FG000|Overall Study|Treatment Failure|0|||
162056255|NCT00378378|585263278|FG001|Overall Study|Treatment Failure|0|||
162056256|NCT00378378|585263279|FG002|Overall Study|Treatment Failure|1|||
162056257|NCT00378378|585263277|FG000|Overall Study|Non-compliance with protocol|0|||
162056258|NCT00378378|585263278|FG001|Overall Study|Non-compliance with protocol|0|||
162056259|NCT00378378|585263279|FG002|Overall Study|Non-compliance with protocol|1|||
162056260|NCT01854710|585263280|FG000|Overall Study|Withdrawal by Subject|2|||
162056261|NCT01854710|585263281|FG001|Overall Study|Withdrawal by Subject|1|||
162056262|NCT01854710|585263282|FG002|Overall Study|Withdrawal by Subject|0|||
162056263|NCT01854710|585263283|FG003|Overall Study|Withdrawal by Subject|0|||
162056264|NCT01854710|585263284|FG004|Overall Study|Withdrawal by Subject|0|||
162056265|NCT01854710|585263285|FG005|Overall Study|Withdrawal by Subject|0|||
162056266|NCT01854710|585263280|FG000|Overall Study|CRI procedural error|2|||
162056267|NCT01854710|585263281|FG001|Overall Study|CRI procedural error|2|||
162056268|NCT01854710|585263282|FG002|Overall Study|CRI procedural error|2|||
162056269|NCT01854710|585263283|FG003|Overall Study|CRI procedural error|2|||
162056270|NCT01854710|585263284|FG004|Overall Study|CRI procedural error|2|||
162056271|NCT01854710|585263285|FG005|Overall Study|CRI procedural error|2|||
162056272|NCT03132220|585263290|FG000|Overall Study|Lost to Follow-up|17|||
162056273|NCT03132220|585263291|FG001|Overall Study|Lost to Follow-up|8|||
162056274|NCT03132220|585263290|FG000|Overall Study|Withdrawal by Subject|1|||
162056275|NCT03132220|585263291|FG001|Overall Study|Withdrawal by Subject|4|||
162056276|NCT00601458|585263293|FG000|Overall Study|Dosing Error|1|||
162056277|NCT00601458|585263294|FG001|Overall Study|Dosing Error|0|||
162056278|NCT00601458|585263295|FG002|Overall Study|Dosing Error|0|||
162056279|NCT00601458|585263293|FG000|Overall Study|Incomplete Data|0|||
162056280|NCT00601458|585263294|FG001|Overall Study|Incomplete Data|2|||
162056281|NCT00601458|585263295|FG002|Overall Study|Incomplete Data|0|||
162056282|NCT00601458|585263293|FG000|Overall Study|Protocol Violation|3|||
162056283|NCT00601458|585263294|FG001|Overall Study|Protocol Violation|2|||
162056284|NCT00601458|585263295|FG002|Overall Study|Protocol Violation|1|||
162056285|NCT00601458|585263293|FG000|Overall Study|Early Termination|0|||
162056286|NCT00601458|585263294|FG001|Overall Study|Early Termination|1|||
162056287|NCT00601458|585263295|FG002|Overall Study|Early Termination|1|||
162056288|NCT04171531|585263299|FG000|Overall Study|Lost to Follow-up|4|||
162056289|NCT04171531|585263300|FG001|Overall Study|Lost to Follow-up|5|||
162056290|NCT04171531|585263299|FG000|Overall Study|Consent only through 6 months|1|||
162056291|NCT04171531|585263300|FG001|Overall Study|Consent only through 6 months|1|||
162056292|NCT04171531|585263299|FG000|Overall Study|Insurance did not cover procedure|0|||
162056293|NCT04171531|585263300|FG001|Overall Study|Insurance did not cover procedure|1|||
162056294|NCT04171531|585263299|FG000|Overall Study|Physician Decision|0|||
162056295|NCT04171531|585263300|FG001|Overall Study|Physician Decision|3|||
162056296|NCT04171531|585263299|FG000|Overall Study|Withdrawal by Subject|1|||
162056297|NCT04171531|585263300|FG001|Overall Study|Withdrawal by Subject|5|||
162056298|NCT05537883|585263303|FG000|Overall Study|revisional surgery|4|||
162056299|NCT05537883|585263304|FG001|Overall Study|revisional surgery|2|||
162056300|NCT05537883|585263303|FG000|Overall Study|surgeries were cancelled|0|||
162056301|NCT05537883|585263304|FG001|Overall Study|surgeries were cancelled|2|||
162056302|NCT05537883|585263303|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
162056303|NCT05537883|585263304|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
162056304|NCT05288062|585263305|FG000|Overall Study|Ineligible|0|||
162056305|NCT05288062|585263306|FG001|Overall Study|Ineligible|0|||
162056306|NCT05288062|585263307|FG002|Overall Study|Ineligible|1|||
162056307|NCT05288062|585263308|FG003|Overall Study|Ineligible|0|||
162056308|NCT05288062|585263305|FG000|Overall Study|Withdrawal by Subject|0|||
162056309|NCT05288062|585263306|FG001|Overall Study|Withdrawal by Subject|0|||
162056310|NCT05288062|585263307|FG002|Overall Study|Withdrawal by Subject|1|||
162056311|NCT05288062|585263308|FG003|Overall Study|Withdrawal by Subject|0|||
162056312|NCT02296320|585263310|FG000|Overall Study|Withdrawal by Subject|4|||
162056313|NCT02296320|585263311|FG001|Overall Study|Withdrawal by Subject|0|||
162056314|NCT02296320|585263312|FG002|Overall Study|Withdrawal by Subject|2|||
162056315|NCT02296320|585263310|FG000|Overall Study|Death|24|||
162056316|NCT02296320|585263311|FG001|Overall Study|Death|3|||
162056317|NCT02296320|585263312|FG002|Overall Study|Death|27|||
162056318|NCT02296320|585263310|FG000|Overall Study|Lost to Follow-up|5|||
162056319|NCT02296320|585263311|FG001|Overall Study|Lost to Follow-up|2|||
162056320|NCT02296320|585263312|FG002|Overall Study|Lost to Follow-up|7|||
162056321|NCT02296320|585263310|FG000|Overall Study|Not treated|2|||
162056322|NCT02296320|585263311|FG001|Overall Study|Not treated|0|||
162056323|NCT02296320|585263312|FG002|Overall Study|Not treated|0|||
162056324|NCT02296320|585263310|FG000|Overall Study|Not - specified|0|||
162056325|NCT02296320|585263311|FG001|Overall Study|Not - specified|0|||
162056326|NCT02296320|585263312|FG002|Overall Study|Not - specified|1|||
162056327|NCT00729651|585263316|FG000|Overall Study|Withdrawal by Subject|5|||
162056328|NCT00729651|585263317|FG001|Overall Study|Withdrawal by Subject|6|||
162056329|NCT00729651|585263316|FG000|Overall Study|Lost to Follow-up|5|||
162056330|NCT00729651|585263317|FG001|Overall Study|Lost to Follow-up|4|||
162056331|NCT00729651|585263316|FG000|Overall Study|Protocol Violation|0|||
162056332|NCT00729651|585263317|FG001|Overall Study|Protocol Violation|1|||
162056333|NCT00729651|585263316|FG000|Overall Study|Adverse Event|7|||
162056334|NCT00729651|585263317|FG001|Overall Study|Adverse Event|3|||
162056335|NCT00729651|585263316|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
162056336|NCT00729651|585263317|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
162056337|NCT00729651|585263316|FG000|Overall Study|Subject's private reason|2|||
162056338|NCT00729651|585263317|FG001|Overall Study|Subject's private reason|0|||
162056339|NCT01874054|585263318|FG000|Overall Study|Withdrawal by Subject|3|||
162056340|NCT01874054|585263318|FG000|Overall Study|Study Termination by Sponsor|42|||
162056341|NCT01874054|585263318|FG000|Overall Study|Lost to Follow-up|5|||
162056342|NCT01874054|585263318|FG000|Overall Study|Death|5|||
162056343|NCT03953820|585263321|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
162056344|NCT03953820|585263322|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
162056345|NCT03953820|585263323|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
162056346|NCT03953820|585263321|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
162056347|NCT03953820|585263322|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
162056348|NCT03953820|585263323|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
162056349|NCT01534962|585263324|FG000|Overall Study|Randomized but did not start treatment|2|||
162056350|NCT01534962|585263325|FG001|Overall Study|Randomized but did not start treatment|0|||
162056351|NCT01534962|585263326|FG002|Overall Study|Randomized but did not start treatment|0|||
162056352|NCT01534962|585263327|FG003|Overall Study|Randomized but did not start treatment|1|||
162056353|NCT01534962|585263324|FG000|Overall Study|Discontinued at AF recurrence|35|||
162056354|NCT01534962|585263325|FG001|Overall Study|Discontinued at AF recurrence|26|||
162056355|NCT01534962|585263326|FG002|Overall Study|Discontinued at AF recurrence|24|||
162056356|NCT01534962|585263327|FG003|Overall Study|Discontinued at AF recurrence|31|||
162056357|NCT00880009|585263328|FG000|Overall Study|Study terminated by sponsor|14|||
162056358|NCT00880009|585263328|FG000|Overall Study|Withdrawal by Subject|1|||
162056359|NCT00880009|585263328|FG000|Overall Study|Protocol Violation|1|||
162056360|NCT04545385|585263329|FG000|Overall Study|Withdrawal by Subject|2|||
162056361|NCT04545385|585263330|FG001|Overall Study|Withdrawal by Subject|0|||
162056362|NCT04545385|585263329|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
162056363|NCT04545385|585263330|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
162056364|NCT04545385|585263329|FG000|Overall Study|Study termination|10|||
162056365|NCT04545385|585263330|FG001|Overall Study|Study termination|10|||
162056366|NCT04545385|585263329|FG000|Overall Study|Sponsor decision|2|||
162056367|NCT04545385|585263330|FG001|Overall Study|Sponsor decision|2|||
162056368|NCT04545385|585263329|FG000|Overall Study|Other than specified|1|||
162056369|NCT04545385|585263330|FG001|Overall Study|Other than specified|0|||
162056370|NCT01128842|585263335|FG000|Overall Study|Adverse Event|1|||
162056371|NCT01128842|585263335|FG000|Overall Study|Disease Progression|6|||
162056372|NCT02378961|585263336|FG000|Overall Study|Lack of Efficacy|4|||
162056373|NCT02378961|585263337|FG001|Overall Study|Lack of Efficacy|2|||
162056374|NCT02378961|585263338|FG002|Overall Study|Lack of Efficacy|0|||
162056375|NCT02378961|585263339|FG003|Overall Study|Lack of Efficacy|1|||
162056376|NCT02378961|585263336|FG000|Overall Study|Death|0|||
162056377|NCT02378961|585263337|FG001|Overall Study|Death|0|||
162056378|NCT02378961|585263338|FG002|Overall Study|Death|1|||
162056379|NCT02378961|585263339|FG003|Overall Study|Death|0|||
162056380|NCT05399641|585263346|FG000|Overall Study|Adverse Event|0|||
162056381|NCT05399641|585263347|FG001|Overall Study|Adverse Event|1|||
162056382|NCT05399641|585263348|FG002|Overall Study|Adverse Event|1|||
162056383|NCT05399641|585263346|FG000|Overall Study|Lost to Follow-up|1|||
162056384|NCT05399641|585263347|FG001|Overall Study|Lost to Follow-up|2|||
162056385|NCT05399641|585263348|FG002|Overall Study|Lost to Follow-up|2|||
162056386|NCT05399641|585263346|FG000|Overall Study|Physician Decision|1|||
162056387|NCT05399641|585263347|FG001|Overall Study|Physician Decision|3|||
162056388|NCT05399641|585263348|FG002|Overall Study|Physician Decision|3|||
162056389|NCT05399641|585263346|FG000|Overall Study|Withdrawal by Subject|4|||
162056390|NCT05399641|585263347|FG001|Overall Study|Withdrawal by Subject|11|||
162056391|NCT05399641|585263348|FG002|Overall Study|Withdrawal by Subject|7|||
162056392|NCT05399641|585263346|FG000|Overall Study|Reason not defined|3|||
162056393|NCT05399641|585263347|FG001|Overall Study|Reason not defined|5|||
162056394|NCT05399641|585263348|FG002|Overall Study|Reason not defined|6|||
162056395|NCT00390468|585263349|FG000|Overall Study|Protocol Violation|2|||
162056396|NCT00390468|585263349|FG000|Overall Study|Lack of Efficacy|1|||
162056397|NCT01049308|585263350|FG000|Pill Counts|Withdrawal by Subject|83|||
162056398|NCT01348165|585263352|FG000|Overall Study|Adverse Event|0|||
162056399|NCT01348165|585263353|FG001|Overall Study|Adverse Event|0|||
162056400|NCT01348165|585263354|FG002|Overall Study|Adverse Event|0|||
162056401|NCT01348165|585263355|FG003|Overall Study|Adverse Event|0|||
162056402|NCT01348165|585263356|FG004|Overall Study|Adverse Event|0|||
162056403|NCT01348165|585263357|FG005|Overall Study|Adverse Event|0|||
162056404|NCT01348165|585263358|FG006|Overall Study|Adverse Event|1|||
162056405|NCT00911820|585265622|FG000|Overall Study|RECIST progression|12|||
162056406|NCT00911820|585265623|FG001|Overall Study|RECIST progression|8|||
162056407|NCT00911820|585265622|FG000|Overall Study|Adverse Event|8|||
162056408|NCT00911820|585265623|FG001|Overall Study|Adverse Event|8|||
162056409|NCT00911820|585265622|FG000|Overall Study|Clinical Progression|7|||
162056410|NCT00911820|585265623|FG001|Overall Study|Clinical Progression|5|||
162056411|NCT00911820|585265622|FG000|Overall Study|Physician Decision|5|||
162056412|NCT00911820|585265623|FG001|Overall Study|Physician Decision|9|||
162056413|NCT00911820|585265622|FG000|Overall Study|Decline in Performance Status|4|||
162056414|NCT00911820|585265623|FG001|Overall Study|Decline in Performance Status|2|||
162056415|NCT00911820|585265622|FG000|Overall Study|Withdrawal by Subject|3|||
162056416|NCT00911820|585265623|FG001|Overall Study|Withdrawal by Subject|4|||
162056417|NCT00911820|585265622|FG000|Overall Study|Death|1|||
162056418|NCT00911820|585265623|FG001|Overall Study|Death|2|||
162056419|NCT00911820|585265622|FG000|Overall Study|Pursue surgery|1|||
162056420|NCT00911820|585265623|FG001|Overall Study|Pursue surgery|1|||
162056421|NCT00911820|585265622|FG000|Overall Study|Pursue Radiation|1|||
162056422|NCT00911820|585265623|FG001|Overall Study|Pursue Radiation|0|||
162056423|NCT00911820|585265622|FG000|Overall Study|Still on Therapy|2|||
162056424|NCT00911820|585265623|FG001|Overall Study|Still on Therapy|2|||
162056425|NCT00911820|585265622|FG000|Overall Study|Pathology Not Confirmed|1|||
162056426|NCT00911820|585265623|FG001|Overall Study|Pathology Not Confirmed|0|||
162056427|NCT00911820|585265622|FG000|Overall Study|Withdraw before Receive Treatment|0|||
162056428|NCT00911820|585265623|FG001|Overall Study|Withdraw before Receive Treatment|2|||
162056429|NCT00996216|585265624|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
162056430|NCT00996216|585265624|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
162056431|NCT00996216|585265624|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
162056432|NCT01411774|585265625|FG000|Overall Study|Withdrawal by Subject|0|||
162056433|NCT01411774|585265626|FG001|Overall Study|Withdrawal by Subject|3|||
162056434|NCT03292588|585265627|FG000|Overall Study|Death|1|||
162056435|NCT03292588|585265628|FG001|Overall Study|Death|0|||
162056436|NCT03292588|585265627|FG000|Overall Study|Lost to Follow-up|12|||
162056437|NCT03292588|585265628|FG001|Overall Study|Lost to Follow-up|16|||
162056438|NCT03292588|585265627|FG000|Overall Study|Physician Decision|0|||
162056439|NCT03292588|585265628|FG001|Overall Study|Physician Decision|1|||
162056440|NCT03292588|585265627|FG000|Overall Study|Withdrawal by Subject|4|||
162056441|NCT03292588|585265628|FG001|Overall Study|Withdrawal by Subject|4|||
162056442|NCT03292588|585265627|FG000|Overall Study|Move out of town|1|||
162056443|NCT03292588|585265628|FG001|Overall Study|Move out of town|0|||
162056444|NCT03292588|585265627|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
162056445|NCT03292588|585265628|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
162056446|NCT05526716|585265634|FG000|Overall Study|Death|1|||
162056447|NCT05526716|585265635|FG001|Overall Study|Death|2|||
162056448|NCT05526716|585265634|FG000|Overall Study|Lost to Follow-up|17|||
162056449|NCT05526716|585265635|FG001|Overall Study|Lost to Follow-up|15|||
162056450|NCT05526716|585265634|FG000|Overall Study|Physician Decision|0|||
162056451|NCT05526716|585265635|FG001|Overall Study|Physician Decision|1|||
162056452|NCT05526716|585265634|FG000|Overall Study|Randomized by mistake without study treatment|0|||
162056453|NCT05526716|585265635|FG001|Overall Study|Randomized by mistake without study treatment|1|||
162056454|NCT05526716|585265634|FG000|Overall Study|Withdrawal by Subject|12|||
162056455|NCT05526716|585265635|FG001|Overall Study|Withdrawal by Subject|12|||
162056456|NCT05526716|585265634|FG000|Overall Study|Not reported|0|||
162056457|NCT05526716|585265635|FG001|Overall Study|Not reported|2|||
162056458|NCT04932096|585265638|FG000|Overall Study|Withdrawal by Subject|1|||
162056459|NCT04932096|585265639|FG001|Overall Study|Withdrawal by Subject|1|||
162056460|NCT04932096|585265638|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
162056461|NCT04932096|585265639|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
162056462|NCT01438957|585265640|FG000|Overall Study|Physician Decision|1|||
162056463|NCT01438957|585265641|FG001|Overall Study|Physician Decision|1|||
162056464|NCT01438957|585265642|FG002|Overall Study|Physician Decision|0|||
162056465|NCT01438957|585265643|FG003|Overall Study|Physician Decision|1|||
162056466|NCT01438957|585265644|FG004|Overall Study|Physician Decision|0|||
162056467|NCT03902574|585265646|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
162056468|NCT03902574|585265647|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
162056469|NCT03902574|585265648|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
162056470|NCT02101060|585265654|FG000|Overall Study|Adverse Event|1|||
162056471|NCT02101060|585265655|FG001|Overall Study|Adverse Event|0|||
162056472|NCT02101060|585265654|FG000|Overall Study|Withdrawal by Subject|1|||
162056473|NCT02101060|585265655|FG001|Overall Study|Withdrawal by Subject|1|||
162056474|NCT02101060|585265654|FG000|Overall Study|Lost to Follow-up|3|||
162056475|NCT02101060|585265655|FG001|Overall Study|Lost to Follow-up|3|||
162056476|NCT00545168|585265662|FG000|Overall Study|Lost to Follow-up|5|||
162056477|NCT00545168|585265663|FG001|Overall Study|Lost to Follow-up|5|||
162056478|NCT00545168|585265664|FG002|Overall Study|Lost to Follow-up|5|||
162056479|NCT00545168|585265662|FG000|Overall Study|Withdrawal by Subject|9|||
162056480|NCT00545168|585265663|FG001|Overall Study|Withdrawal by Subject|0|||
162056481|NCT00545168|585265664|FG002|Overall Study|Withdrawal by Subject|13|||
162056482|NCT00545168|585265662|FG000|Overall Study|Protocol Violation|1|||
162056483|NCT00545168|585265663|FG001|Overall Study|Protocol Violation|0|||
162056484|NCT00545168|585265664|FG002|Overall Study|Protocol Violation|1|||
162056485|NCT00545168|585265662|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
162056486|NCT00545168|585265663|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
162056487|NCT00545168|585265664|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
162056488|NCT01833520|585265667|FG000|Overall Study|Lack of Efficacy|3|||
162056489|NCT01833520|585265668|FG001|Overall Study|Lack of Efficacy|3|||
162056490|NCT01833520|585265669|FG002|Overall Study|Lack of Efficacy|8|||
162056491|NCT01833520|585265670|FG003|Overall Study|Lack of Efficacy|3|||
162056492|NCT04182763|585265680|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
162056493|NCT04182763|585265681|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
162056494|NCT04182763|585265682|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
162056495|NCT04182763|585265683|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
162056496|NCT04182763|585265684|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
162056497|NCT04182763|585265680|FG000|Double-Blind Period, initial 6 months|Death|0|||
162056498|NCT04182763|585265681|FG001|Double-Blind Period, initial 6 months|Death|1|||
162056499|NCT04182763|585265682|FG002|Double-Blind Period, initial 6 months|Death|0|||
162056500|NCT04182763|585265683|FG003|Double-Blind Period, initial 6 months|Death|0|||
162056501|NCT04182763|585265684|FG004|Double-Blind Period, initial 6 months|Death|0|||
162056502|NCT04182763|585265680|FG000|Open-Label Period, subsequent 18 months|Death|3|||
162056503|NCT04182763|585265681|FG001|Open-Label Period, subsequent 18 months|Death|2|||
162056504|NCT04182763|585265682|FG002|Open-Label Period, subsequent 18 months|Death|2|||
162056505|NCT04182763|585265683|FG003|Open-Label Period, subsequent 18 months|Death|0|||
162056506|NCT04182763|585265684|FG004|Open-Label Period, subsequent 18 months|Death|1|||
162056507|NCT04182763|585265680|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
162056508|NCT04182763|585265681|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
162056509|NCT04182763|585265682|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
162056510|NCT04182763|585265683|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
162056511|NCT04182763|585265684|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
162056512|NCT04182763|585265680|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
162056513|NCT04182763|585265681|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
162056514|NCT04182763|585265682|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
162056515|NCT04182763|585265683|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
162056516|NCT04182763|585265684|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
162056517|NCT00003479|585265688|FG000|Overall Study|Not evaluable|3|||
162056518|NCT01484197|585265701|FG000|Treatment Period 1|Adverse Event|1|||
162056519|NCT01484197|585265702|FG001|Treatment Period 1|Adverse Event|0|||
162056520|NCT01484197|585265703|FG002|Treatment Period 1|Adverse Event|0|||
162056521|NCT01484197|585265704|FG003|Treatment Period 1|Adverse Event|0|||
162056522|NCT01484197|585265701|FG000|Treatment Period 2|Subject withdrew consent|0|||
162056523|NCT01484197|585265702|FG001|Treatment Period 2|Subject withdrew consent|0|||
162056524|NCT01484197|585265703|FG002|Treatment Period 2|Subject withdrew consent|0|||
162056525|NCT01484197|585265704|FG003|Treatment Period 2|Subject withdrew consent|1|||
162056526|NCT01727297|585265705|FG000|Overall Study|Death|13|||
162056527|NCT01727297|585265706|FG001|Overall Study|Death|0|||
162056528|NCT01727297|585265705|FG000|Overall Study|Protocol Violation|1|||
162056529|NCT01727297|585265706|FG001|Overall Study|Protocol Violation|10|||
162056530|NCT01727297|585265705|FG000|Overall Study|Adverse Event|3|||
162056531|NCT01727297|585265706|FG001|Overall Study|Adverse Event|1|||
162056532|NCT01727297|585265705|FG000|Overall Study|Lost to Follow-up|11|||
162056533|NCT01727297|585265706|FG001|Overall Study|Lost to Follow-up|0|||
162056534|NCT01727297|585265705|FG000|Overall Study|Withdrawal by Subject|26|||
162056535|NCT01727297|585265706|FG001|Overall Study|Withdrawal by Subject|27|||
162056536|NCT01727297|585265705|FG000|Overall Study|Physician Decision|19|||
162056537|NCT01727297|585265706|FG001|Overall Study|Physician Decision|5|||
162056538|NCT01727297|585265705|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
162056539|NCT01727297|585265706|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
162056540|NCT02244606|585265707|FG000|Overall Study|Adverse Event|0|||
162056541|NCT02244606|585265708|FG001|Overall Study|Adverse Event|1|||
162056542|NCT02244606|585265709|FG002|Overall Study|Adverse Event|1|||
162056543|NCT02244606|585265710|FG003|Overall Study|Adverse Event|0|||
162056544|NCT02244606|585265707|FG000|Overall Study|Lost to Follow-up|2|||
162056545|NCT02244606|585265708|FG001|Overall Study|Lost to Follow-up|2|||
162056546|NCT02244606|585265709|FG002|Overall Study|Lost to Follow-up|1|||
162056547|NCT02244606|585265710|FG003|Overall Study|Lost to Follow-up|0|||
162056548|NCT02244606|585265707|FG000|Overall Study|Protocol Violation|0|||
162056549|NCT02244606|585265708|FG001|Overall Study|Protocol Violation|0|||
162056550|NCT02244606|585265709|FG002|Overall Study|Protocol Violation|0|||
162056551|NCT02244606|585265710|FG003|Overall Study|Protocol Violation|1|||
162056552|NCT02244606|585265707|FG000|Overall Study|Withdrawal by Subject|1|||
162056553|NCT02244606|585265708|FG001|Overall Study|Withdrawal by Subject|1|||
162056554|NCT02244606|585265709|FG002|Overall Study|Withdrawal by Subject|0|||
162056555|NCT02244606|585265710|FG003|Overall Study|Withdrawal by Subject|0|||
162056556|NCT02244606|585265707|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
162056557|NCT02244606|585265708|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
162056558|NCT02244606|585265709|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
162056559|NCT02244606|585265710|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
162056560|NCT02321800|585265716|FG000|Overall Study|Withdrawal by Subject|3|||
162056561|NCT02321800|585265717|FG001|Overall Study|Withdrawal by Subject|3|||
162056562|NCT02321800|585265716|FG000|Overall Study|Death|1|||
162056563|NCT02321800|585265717|FG001|Overall Study|Death|0|||
162056564|NCT02321800|585265716|FG000|Overall Study|Protocol Violation|1|||
162056565|NCT02321800|585265717|FG001|Overall Study|Protocol Violation|0|||
162056566|NCT02321800|585265716|FG000|Overall Study|Lost to Follow-up|10|||
162056567|NCT02321800|585265717|FG001|Overall Study|Lost to Follow-up|4|||
162056568|NCT02321800|585265716|FG000|Overall Study|Adverse Event|2|||
162056569|NCT02321800|585265717|FG001|Overall Study|Adverse Event|3|||
162056570|NCT02321800|585265716|FG000|Overall Study|Other, Miscellaneous|3|||
162056571|NCT02321800|585265717|FG001|Overall Study|Other, Miscellaneous|1|||
162056572|NCT00982878|585265721|FG000|Overall Study|Physician Decision|1|||
162056573|NCT00642460|585265726|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
162056574|NCT00642460|585265727|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
162056575|NCT00642460|585265728|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
162056576|NCT00642460|585265729|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
162056577|NCT00642460|585265730|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
162056578|NCT00642460|585265731|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
162056579|NCT00642460|585265726|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
162056580|NCT00642460|585265727|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
162056581|NCT00642460|585265728|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
162056582|NCT00642460|585265729|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
162056583|NCT00642460|585265730|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
162056584|NCT00642460|585265731|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
162056585|NCT00642460|585265726|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
162056586|NCT00642460|585265727|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
162056587|NCT00642460|585265728|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
162056588|NCT00642460|585265729|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
162056589|NCT00642460|585265730|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
162056590|NCT00642460|585265731|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
162056591|NCT00642460|585265726|FG000|Part II: Open-Label Up to Week 92|Death|0|||
162056592|NCT00642460|585265727|FG001|Part II: Open-Label Up to Week 92|Death|1|||
162056593|NCT00642460|585265728|FG002|Part II: Open-Label Up to Week 92|Death|0|||
162056594|NCT00642460|585265729|FG003|Part II: Open-Label Up to Week 92|Death|2|||
162056595|NCT00642460|585265730|FG004|Part II: Open-Label Up to Week 92|Death|0|||
162056596|NCT00642460|585265731|FG005|Part II: Open-Label Up to Week 92|Death|0|||
162056597|NCT00642460|585265726|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
162056598|NCT00642460|585265727|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
162056599|NCT00642460|585265728|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
162056600|NCT00642460|585265729|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
162056601|NCT00642460|585265730|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
162056602|NCT00642460|585265731|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
162056603|NCT00642460|585265726|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
162056604|NCT00642460|585265727|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
162056605|NCT00642460|585265728|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
162056606|NCT00642460|585265729|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
162056607|NCT00642460|585265730|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
162056608|NCT00642460|585265731|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
162056609|NCT00642460|585265726|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
162056610|NCT00642460|585265727|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
162056611|NCT00642460|585265728|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
162056612|NCT00642460|585265729|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
162056613|NCT00642460|585265730|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
162056614|NCT00642460|585265731|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
162056615|NCT00642460|585265726|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
162056616|NCT00642460|585265727|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
162056617|NCT00642460|585265728|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
162056618|NCT00642460|585265729|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
162056619|NCT00642460|585265730|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
162056620|NCT00642460|585265731|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
162056621|NCT00642460|585265726|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
162056622|NCT00642460|585265727|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
162056623|NCT00642460|585265728|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
162056624|NCT00642460|585265729|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
162056625|NCT00642460|585265730|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
162056626|NCT00642460|585265731|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
162056627|NCT00642460|585265726|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
162056628|NCT00642460|585265727|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
162056629|NCT00642460|585265728|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
162056630|NCT00642460|585265729|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
162056631|NCT00642460|585265730|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
162056632|NCT00642460|585265731|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
162056633|NCT00642460|585265726|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
162056634|NCT00642460|585265727|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
162056635|NCT00642460|585265728|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
162056636|NCT00642460|585265729|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
162056637|NCT00642460|585265730|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
162056638|NCT00642460|585265731|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
162056639|NCT00642460|585265726|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
162056640|NCT00642460|585265727|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
162056641|NCT00642460|585265728|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
162056642|NCT00642460|585265729|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
162056643|NCT00642460|585265730|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
162056644|NCT00642460|585265731|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
162056645|NCT00642460|585265726|FG000|Part III: Open-Label Up to Week 260|Other|0|||
162056646|NCT00642460|585265727|FG001|Part III: Open-Label Up to Week 260|Other|0|||
162056647|NCT00642460|585265728|FG002|Part III: Open-Label Up to Week 260|Other|0|||
162056648|NCT00642460|585265729|FG003|Part III: Open-Label Up to Week 260|Other|0|||
162056649|NCT00642460|585265730|FG004|Part III: Open-Label Up to Week 260|Other|2|||
162056650|NCT00642460|585265731|FG005|Part III: Open-Label Up to Week 260|Other|2|||
162056651|NCT00642460|585265726|FG000|Part III: Open-Label Up to Week 260|Death|0|||
162056652|NCT00642460|585265727|FG001|Part III: Open-Label Up to Week 260|Death|0|||
162056653|NCT00642460|585265728|FG002|Part III: Open-Label Up to Week 260|Death|0|||
162056654|NCT00642460|585265729|FG003|Part III: Open-Label Up to Week 260|Death|0|||
162056655|NCT00642460|585265730|FG004|Part III: Open-Label Up to Week 260|Death|0|||
162056656|NCT00642460|585265731|FG005|Part III: Open-Label Up to Week 260|Death|3|||
162056657|NCT00642460|585265726|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
162056658|NCT00642460|585265727|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
162056659|NCT00642460|585265728|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
162056660|NCT00642460|585265729|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
162056661|NCT00642460|585265730|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
162056662|NCT00642460|585265731|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
162056663|NCT00642460|585265726|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
162056664|NCT00642460|585265727|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
162056665|NCT00642460|585265728|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
162056666|NCT00642460|585265729|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
162056667|NCT00642460|585265730|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
162056668|NCT00642460|585265731|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
162056669|NCT04605484|585265735|FG000|Overall Study|Lost to Follow-up|0|||
162056670|NCT04605484|585265736|FG001|Overall Study|Lost to Follow-up|1|||
162056671|NCT04605484|585265737|FG002|Overall Study|Lost to Follow-up|1|||
162056672|NCT04605484|585265735|FG000|Overall Study|Other|0|||
162056673|NCT04605484|585265736|FG001|Overall Study|Other|1|||
162056674|NCT04605484|585265737|FG002|Overall Study|Other|0|||
162056675|NCT03366337|585265738|FG000|Overall Study|Lost to Follow-up|1|||
162056676|NCT03366337|585265739|FG001|Overall Study|Lost to Follow-up|0|||
162056677|NCT03366337|585265740|FG002|Overall Study|Lost to Follow-up|1|||
162056678|NCT03366337|585265741|FG003|Overall Study|Lost to Follow-up|0|||
162056679|NCT03366337|585265738|FG000|Overall Study|Withdrawal by Subject|2|||
162056680|NCT03366337|585265739|FG001|Overall Study|Withdrawal by Subject|0|||
162056681|NCT03366337|585265740|FG002|Overall Study|Withdrawal by Subject|1|||
162056682|NCT03366337|585265741|FG003|Overall Study|Withdrawal by Subject|1|||
162056683|NCT01697566|585265750|FG000|Overall Study|Withdrawal by Subject|0|||
162056684|NCT01697566|585265751|FG001|Overall Study|Withdrawal by Subject|0|||
162056685|NCT01697566|585265752|FG002|Overall Study|Withdrawal by Subject|1|||
162056686|NCT01697566|585265753|FG003|Overall Study|Withdrawal by Subject|1|||
162056687|NCT01697566|585265750|FG000|Overall Study|Final biopsy not obtained|0|||
162056688|NCT01697566|585265751|FG001|Overall Study|Final biopsy not obtained|0|||
162056689|NCT01697566|585265752|FG002|Overall Study|Final biopsy not obtained|1|||
162056690|NCT01697566|585265753|FG003|Overall Study|Final biopsy not obtained|0|||
162056691|NCT01447433|585265754|FG000|Overall Study|Lost to Follow-up|0|||
162056692|NCT01447433|585265755|FG001|Overall Study|Lost to Follow-up|2|||
162056693|NCT01447433|585265754|FG000|Overall Study|Withdrawal by Subject|3|||
162056694|NCT01447433|585265755|FG001|Overall Study|Withdrawal by Subject|3|||
162056695|NCT01447433|585265754|FG000|Overall Study|Protocol Violation|1|||
162056696|NCT01447433|585265755|FG001|Overall Study|Protocol Violation|1|||
162056697|NCT01578187|585265756|FG000|Usability Phase|Withdrawal by Subject|1|||
162056698|NCT02516163|585265761|FG000|Overall Study|Withdrawal by Subject|1|||
162056699|NCT02516163|585265761|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
162056700|NCT02516163|585265761|FG000|Overall Study|Unfit/delay in surgery|3|||
162056701|NCT02516163|585265761|FG000|Overall Study|Use of incorrect measurement technique|5|||
162056702|NCT02516163|585265761|FG000|Overall Study|Data not recorded|2|||
162056703|NCT02516163|585265761|FG000|Overall Study|MRI contraindication exclusion|6|||
162056704|NCT01217814|585265762|FG000|Overall Study|Adverse Event|1|||
162056705|NCT01217814|585265763|FG001|Overall Study|Adverse Event|1|||
162056706|NCT01217814|585265764|FG002|Overall Study|Adverse Event|0|||
162056707|NCT01217814|585265762|FG000|Overall Study|Lack of Efficacy|0|||
162056708|NCT01217814|585265763|FG001|Overall Study|Lack of Efficacy|0|||
162056709|NCT01217814|585265764|FG002|Overall Study|Lack of Efficacy|1|||
162056710|NCT01658072|585265765|FG000|Overall Study|Protocol Violation|4|||
162056711|NCT01658072|585265766|FG001|Overall Study|Protocol Violation|2|||
162056712|NCT00040664|585265767|FG000|Overall Study|Adverse Event|12|||
162056713|NCT00040664|585265768|FG001|Overall Study|Adverse Event|3|||
162056714|NCT00040664|585265769|FG002|Overall Study|Adverse Event|2|||
162056715|NCT00040664|585265770|FG003|Overall Study|Adverse Event|7|||
162056716|NCT00040664|585265767|FG000|Overall Study|Lack of Efficacy|9|||
162056717|NCT00040664|585265768|FG001|Overall Study|Lack of Efficacy|2|||
162056718|NCT00040664|585265769|FG002|Overall Study|Lack of Efficacy|3|||
162056719|NCT00040664|585265770|FG003|Overall Study|Lack of Efficacy|4|||
162056720|NCT00040664|585265767|FG000|Overall Study|Insufficient CD4 response|1|||
162056721|NCT00040664|585265768|FG001|Overall Study|Insufficient CD4 response|0|||
162056722|NCT00040664|585265769|FG002|Overall Study|Insufficient CD4 response|1|||
162056723|NCT00040664|585265770|FG003|Overall Study|Insufficient CD4 response|0|||
162056724|NCT00040664|585265767|FG000|Overall Study|Lost to Follow-up|4|||
162056725|NCT00040664|585265768|FG001|Overall Study|Lost to Follow-up|2|||
162056726|NCT00040664|585265769|FG002|Overall Study|Lost to Follow-up|0|||
162056727|NCT00040664|585265770|FG003|Overall Study|Lost to Follow-up|2|||
162056728|NCT00040664|585265767|FG000|Overall Study|Protocol Violation|2|||
162056729|NCT00040664|585265768|FG001|Overall Study|Protocol Violation|1|||
162056730|NCT00040664|585265769|FG002|Overall Study|Protocol Violation|0|||
162056731|NCT00040664|585265770|FG003|Overall Study|Protocol Violation|1|||
162056732|NCT00040664|585265767|FG000|Overall Study|Withdrawal by Subject|7|||
162056733|NCT00040664|585265768|FG001|Overall Study|Withdrawal by Subject|0|||
162056734|NCT00040664|585265769|FG002|Overall Study|Withdrawal by Subject|3|||
162056735|NCT00040664|585265770|FG003|Overall Study|Withdrawal by Subject|4|||
162056736|NCT00040664|585265767|FG000|Overall Study|Pregnancy|3|||
162056737|NCT00040664|585265768|FG001|Overall Study|Pregnancy|0|||
162056738|NCT00040664|585265769|FG002|Overall Study|Pregnancy|0|||
162056739|NCT00040664|585265770|FG003|Overall Study|Pregnancy|3|||
162056740|NCT00040664|585265767|FG000|Overall Study|Medication adherence/compliance problems|8|||
162056741|NCT00040664|585265768|FG001|Overall Study|Medication adherence/compliance problems|2|||
162056742|NCT00040664|585265769|FG002|Overall Study|Medication adherence/compliance problems|1|||
162056743|NCT00040664|585265770|FG003|Overall Study|Medication adherence/compliance problems|5|||
162056744|NCT00040664|585265767|FG000|Overall Study|Poor taste|2|||
162056745|NCT00040664|585265768|FG001|Overall Study|Poor taste|0|||
162056746|NCT00040664|585265769|FG002|Overall Study|Poor taste|2|||
162056747|NCT00040664|585265770|FG003|Overall Study|Poor taste|0|||
162056748|NCT00040664|585265767|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
162056749|NCT00040664|585265768|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
162056750|NCT00040664|585265769|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
162056751|NCT00040664|585265770|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
162056752|NCT00040664|585265767|FG000|Overall Study|Change of formulation|2|||
162056753|NCT00040664|585265768|FG001|Overall Study|Change of formulation|2|||
162056754|NCT00040664|585265769|FG002|Overall Study|Change of formulation|0|||
162056755|NCT00040664|585265770|FG003|Overall Study|Change of formulation|0|||
162056756|NCT00040664|585265767|FG000|Overall Study|Non-viability of oral suspension|1|||
162056757|NCT00040664|585265768|FG001|Overall Study|Non-viability of oral suspension|0|||
162056758|NCT00040664|585265769|FG002|Overall Study|Non-viability of oral suspension|1|||
162056759|NCT00040664|585265770|FG003|Overall Study|Non-viability of oral suspension|0|||
162056760|NCT01709162|585265771|FG000|Overall Study|Disease progression|3|||
162056761|NCT01709162|585265772|FG001|Overall Study|Disease progression|3|||
162056762|NCT01709162|585265771|FG000|Overall Study|Study drug toxicity|2|||
162056763|NCT01709162|585265772|FG001|Overall Study|Study drug toxicity|0|||
162056764|NCT01709162|585265771|FG000|Overall Study|Administrative reason by sponsor|0|||
162056765|NCT01709162|585265772|FG001|Overall Study|Administrative reason by sponsor|1|||
162056766|NCT01709162|585265771|FG000|Overall Study|Other|1|||
162056767|NCT01709162|585265772|FG001|Overall Study|Other|0|||
162056768|NCT01709162|585265771|FG000|Overall Study|Withdrawal by Subject|0|||
162056769|NCT01709162|585265772|FG001|Overall Study|Withdrawal by Subject|1|||
162056770|NCT01637272|585265776|FG000|Overall Study|Adverse Event|6|||
162056771|NCT01637272|585265776|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162056772|NCT01637272|585265776|FG000|Overall Study|Withdrawal by Subject|3|||
162056773|NCT01637272|585265776|FG000|Overall Study|Lost to Follow-up|2|||
162056774|NCT01637272|585265776|FG000|Overall Study|completed core, did not enter ext. phase|4|||
162056775|NCT01637272|585265776|FG000|Overall Study|Administrative problems|1|||
162056776|NCT01637272|585265776|FG000|Overall Study|Protocol Violation|2|||
162056777|NCT01844518|585265777|FG000|Overall Study|Adverse Event|7|||
162056778|NCT01844518|585265778|FG001|Overall Study|Adverse Event|1|||
162056779|NCT01844518|585265777|FG000|Overall Study|Lack of Efficacy|17|||
162056780|NCT01844518|585265778|FG001|Overall Study|Lack of Efficacy|5|||
162056781|NCT01844518|585265777|FG000|Overall Study|Participant's request to discontinue|4|||
162056782|NCT01844518|585265778|FG001|Overall Study|Participant's request to discontinue|1|||
162056783|NCT01844518|585265777|FG000|Overall Study|Poor/Non-compliance|1|||
162056784|NCT01844518|585265778|FG001|Overall Study|Poor/Non-compliance|0|||
162056785|NCT01844518|585265777|FG000|Overall Study|No Longer Met Study Criteria|2|||
162056786|NCT01844518|585265778|FG001|Overall Study|No Longer Met Study Criteria|0|||
162056787|NCT01844518|585265777|FG000|Overall Study|Withdrawal by Subject|9|||
162056788|NCT01844518|585265778|FG001|Overall Study|Withdrawal by Subject|0|||
162056789|NCT01844518|585265777|FG000|Overall Study|Pregnancy|1|||
162056790|NCT01844518|585265778|FG001|Overall Study|Pregnancy|0|||
162056791|NCT03334539|585265783|FG000|Overall Study|Adverse Event|3|||
162056792|NCT03334539|585265784|FG001|Overall Study|Adverse Event|5|||
162056793|NCT03334539|585265785|FG002|Overall Study|Adverse Event|0|||
162056794|NCT03334539|585265783|FG000|Overall Study|Withdrawal by Subject|0|||
162056795|NCT03334539|585265784|FG001|Overall Study|Withdrawal by Subject|1|||
162056796|NCT03334539|585265785|FG002|Overall Study|Withdrawal by Subject|1|||
162056797|NCT03334539|585265783|FG000|Overall Study|Administrative Reasons|1|||
162056798|NCT03334539|585265784|FG001|Overall Study|Administrative Reasons|0|||
162056799|NCT03334539|585265785|FG002|Overall Study|Administrative Reasons|0|||
162056800|NCT03334539|585265783|FG000|Overall Study|Hypertension Not Controlled|0|||
162056801|NCT03334539|585265784|FG001|Overall Study|Hypertension Not Controlled|1|||
162056802|NCT03334539|585265785|FG002|Overall Study|Hypertension Not Controlled|0|||
162056803|NCT03706456|585265789|FG000|Overall Study|Adverse Event|1|||
162056804|NCT03706456|585265789|FG000|Overall Study|Lack of Efficacy|2|||
162056805|NCT04523220|585265790|FG000|Main Treatment Period|Physician Decision|1|||
162056806|NCT04523220|585265791|FG001|Main Treatment Period|Physician Decision|1|||
162056807|NCT04523220|585265792|FG002|Main Treatment Period|Physician Decision|0|||
162056808|NCT04523220|585265790|FG000|Main Treatment Period|Other|5|||
162056809|NCT04523220|585265791|FG001|Main Treatment Period|Other|2|||
162056810|NCT04523220|585265792|FG002|Main Treatment Period|Other|4|||
162056811|NCT04523220|585265790|FG000|Main Treatment Period|Subject Decision|5|||
162056812|NCT04523220|585265791|FG001|Main Treatment Period|Subject Decision|7|||
162056813|NCT04523220|585265792|FG002|Main Treatment Period|Subject Decision|3|||
162056814|NCT04523220|585265790|FG000|Main Treatment Period|Death|5|||
162056815|NCT04523220|585265791|FG001|Main Treatment Period|Death|11|||
162056816|NCT04523220|585265792|FG002|Main Treatment Period|Death|4|||
162056817|NCT04523220|585265790|FG000|Main Treatment Period|Adverse Event|11|||
162056818|NCT04523220|585265791|FG001|Main Treatment Period|Adverse Event|9|||
162056819|NCT04523220|585265792|FG002|Main Treatment Period|Adverse Event|9|||
162056820|NCT04523220|585265790|FG000|Main Treatment Period|Withdrawal by Subject|3|||
162056821|NCT04523220|585265791|FG001|Main Treatment Period|Withdrawal by Subject|3|||
162056822|NCT04523220|585265792|FG002|Main Treatment Period|Withdrawal by Subject|4|||
162056823|NCT04523220|585265790|FG000|Main Treatment Period|Study drug never adminstered|10|||
162056824|NCT04523220|585265791|FG001|Main Treatment Period|Study drug never adminstered|3|||
162056825|NCT04523220|585265792|FG002|Main Treatment Period|Study drug never adminstered|5|||
162056826|NCT04523220|585265790|FG000|Extension Treatment Period|Physician Decision|1|||
162056827|NCT04523220|585265791|FG001|Extension Treatment Period|Physician Decision|0|||
162056828|NCT04523220|585265792|FG002|Extension Treatment Period|Physician Decision|3|||
162056829|NCT04523220|585265790|FG000|Extension Treatment Period|Other|2|||
162056830|NCT04523220|585265791|FG001|Extension Treatment Period|Other|6|||
162056831|NCT04523220|585265792|FG002|Extension Treatment Period|Other|6|||
162056832|NCT04523220|585265790|FG000|Extension Treatment Period|Subject Decision|5|||
162056833|NCT04523220|585265791|FG001|Extension Treatment Period|Subject Decision|2|||
162056834|NCT04523220|585265792|FG002|Extension Treatment Period|Subject Decision|4|||
162056835|NCT04523220|585265790|FG000|Extension Treatment Period|Death|6|||
162056836|NCT04523220|585265791|FG001|Extension Treatment Period|Death|4|||
162056837|NCT04523220|585265792|FG002|Extension Treatment Period|Death|7|||
162056838|NCT04523220|585265790|FG000|Extension Treatment Period|Adverse Event|6|||
162056839|NCT04523220|585265791|FG001|Extension Treatment Period|Adverse Event|7|||
162056840|NCT04523220|585265792|FG002|Extension Treatment Period|Adverse Event|9|||
162056841|NCT04523220|585265790|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
162056842|NCT04523220|585265791|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
162056843|NCT04523220|585265792|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
162056844|NCT04523220|585265790|FG000|Extension Treatment Period|Study drug never administered|0|||
162056845|NCT04523220|585265791|FG001|Extension Treatment Period|Study drug never administered|1|||
162056846|NCT04523220|585265792|FG002|Extension Treatment Period|Study drug never administered|0|||
162056847|NCT00256750|585265794|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
162056848|NCT00256750|585265795|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
162056849|NCT00256750|585265796|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
162056850|NCT00256750|585265794|FG000|Transplanted Pre-Treatment|Other|2|||
162056851|NCT00256750|585265795|FG001|Transplanted Pre-Treatment|Other|0|||
162056852|NCT00256750|585265796|FG002|Transplanted Pre-Treatment|Other|0|||
162056853|NCT00256750|585265794|FG000|Transplanted Pre-Treatment|Death|1|||
162056854|NCT00256750|585265795|FG001|Transplanted Pre-Treatment|Death|0|||
162056855|NCT00256750|585265796|FG002|Transplanted Pre-Treatment|Death|0|||
162056856|NCT00256750|585265794|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
162056857|NCT00256750|585265795|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
162056858|NCT00256750|585265796|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
162056859|NCT00256750|585265794|FG000|Post-Transplant Treated (12 Months)|Death|3|||
162056860|NCT00256750|585265795|FG001|Post-Transplant Treated (12 Months)|Death|2|||
162056861|NCT00256750|585265796|FG002|Post-Transplant Treated (12 Months)|Death|4|||
162056862|NCT00256750|585265794|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
162056863|NCT00256750|585265795|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
162056864|NCT00256750|585265796|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
162056865|NCT00256750|585265794|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
162056866|NCT00256750|585265795|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
162056867|NCT00256750|585265796|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
162056868|NCT00256750|585265794|FG000|Post-Transplant Treated (12 Months)|Other|5|||
162056869|NCT00256750|585265795|FG001|Post-Transplant Treated (12 Months)|Other|4|||
162056870|NCT00256750|585265796|FG002|Post-Transplant Treated (12 Months)|Other|2|||
162056871|NCT00256750|585265794|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
162056872|NCT00256750|585265795|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
162056873|NCT00256750|585265796|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
162056874|NCT00256750|585265794|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
162056875|NCT00256750|585265795|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
162056876|NCT00256750|585265796|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
162056877|NCT00256750|585265794|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
162056878|NCT00256750|585265795|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
162056879|NCT00256750|585265796|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
162056880|NCT00256750|585265794|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
162056881|NCT00256750|585265795|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
162056882|NCT00256750|585265796|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
162056883|NCT00256750|585265794|FG000|Post-Transplant Treated (24 Months)|Death|3|||
162056884|NCT00256750|585265795|FG001|Post-Transplant Treated (24 Months)|Death|0|||
162056885|NCT00256750|585265796|FG002|Post-Transplant Treated (24 Months)|Death|0|||
162056886|NCT00256750|585265794|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
162056887|NCT00256750|585265795|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
162056888|NCT00256750|585265796|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
162056889|NCT00256750|585265794|FG000|Post-Transplant Treated (24 Months)|Other|2|||
162056890|NCT00256750|585265795|FG001|Post-Transplant Treated (24 Months)|Other|0|||
162056891|NCT00256750|585265796|FG002|Post-Transplant Treated (24 Months)|Other|1|||
162056892|NCT00256750|585265794|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
162056893|NCT00256750|585265795|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
162056894|NCT00256750|585265796|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
162056895|NCT00256750|585265794|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
162056896|NCT00256750|585265795|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
162056897|NCT00256750|585265796|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
162056898|NCT00256750|585265794|FG000|Post-Transplant Treated (36 Months)|Death|0|||
162056899|NCT00256750|585265795|FG001|Post-Transplant Treated (36 Months)|Death|2|||
162056900|NCT00256750|585265796|FG002|Post-Transplant Treated (36 Months)|Death|1|||
162056901|NCT00256750|585265794|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
162056902|NCT00256750|585265795|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
162056903|NCT00256750|585265796|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
162056904|NCT00256750|585265794|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
162056905|NCT00256750|585265795|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
162056906|NCT00256750|585265796|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
162056907|NCT00256750|585265794|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
162056908|NCT00256750|585265795|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
162056909|NCT00256750|585265796|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
162056910|NCT00256750|585265794|FG000|Post-Transplant Treated (36 Months)|Other|0|||
162056911|NCT00256750|585265795|FG001|Post-Transplant Treated (36 Months)|Other|1|||
162056912|NCT00256750|585265796|FG002|Post-Transplant Treated (36 Months)|Other|1|||
162056913|NCT00256750|585265794|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
162056914|NCT00256750|585265795|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
162056915|NCT00256750|585265796|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
162056916|NCT00256750|585265794|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
162056917|NCT00256750|585265795|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
162056918|NCT00256750|585265796|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
162056919|NCT00256750|585265794|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
162056920|NCT00256750|585265795|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
162056921|NCT00256750|585265796|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
162056922|NCT00256750|585265794|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
162056923|NCT00256750|585265795|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
162056924|NCT00256750|585265796|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
162056925|NCT00256750|585265794|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
162056926|NCT00256750|585265795|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
162056927|NCT00256750|585265796|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
162056928|NCT00256750|585265794|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
162056929|NCT00256750|585265795|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
162056930|NCT00256750|585265796|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
162056931|NCT00256750|585265794|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
162056932|NCT00256750|585265795|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
162056933|NCT00256750|585265796|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
162056934|NCT00256750|585265794|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
162056935|NCT00256750|585265795|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
162056936|NCT00256750|585265796|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
162056937|NCT00256750|585265794|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
162056938|NCT00256750|585265795|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
162056939|NCT00256750|585265796|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
162056940|NCT02439138|585265801|FG000|Overall Study|Adverse Event|1|||
162056941|NCT02439138|585265801|FG000|Overall Study|PI decision to terminate the study|2|||
162056942|NCT04659161|585265802|FG000|Overall Study|Adverse Event|10|||
162056943|NCT04659161|585265803|FG001|Overall Study|Adverse Event|6|||
162056944|NCT04659161|585265802|FG000|Overall Study|Withdrawal by Subject|13|||
162056945|NCT04659161|585265803|FG001|Overall Study|Withdrawal by Subject|12|||
162056946|NCT04659161|585265802|FG000|Overall Study|Other|9|||
162056947|NCT04659161|585265803|FG001|Overall Study|Other|8|||
162056948|NCT01929343|585265804|FG000|Overall Study|Physician Decision|0|||
162056949|NCT01929343|585265805|FG001|Overall Study|Physician Decision|2|||
162056950|NCT01929343|585265806|FG002|Overall Study|Physician Decision|0|||
162056951|NCT01929343|585265804|FG000|Overall Study|Withdrawal by Subject|1|||
162056952|NCT01929343|585265805|FG001|Overall Study|Withdrawal by Subject|0|||
162056953|NCT01929343|585265806|FG002|Overall Study|Withdrawal by Subject|0|||
162056954|NCT02197130|585265809|FG000|Overall Study|Adverse Event|13|||
162056955|NCT02197130|585265810|FG001|Overall Study|Adverse Event|4|||
162056956|NCT02197130|585265811|FG002|Overall Study|Adverse Event|23|||
162056957|NCT02197130|585265809|FG000|Overall Study|Death|0|||
162056958|NCT02197130|585265810|FG001|Overall Study|Death|1|||
162056959|NCT02197130|585265811|FG002|Overall Study|Death|0|||
162056960|NCT02197130|585265809|FG000|Overall Study|Lost to Follow-up|2|||
162056961|NCT02197130|585265810|FG001|Overall Study|Lost to Follow-up|0|||
162056962|NCT02197130|585265811|FG002|Overall Study|Lost to Follow-up|1|||
162056963|NCT02197130|585265809|FG000|Overall Study|Does not meet entrance criteria|0|||
162056964|NCT02197130|585265810|FG001|Overall Study|Does not meet entrance criteria|0|||
162056965|NCT02197130|585265811|FG002|Overall Study|Does not meet entrance criteria|1|||
162056966|NCT02197130|585265809|FG000|Overall Study|Withdrawal by Subject|0|||
162056967|NCT02197130|585265810|FG001|Overall Study|Withdrawal by Subject|3|||
162056968|NCT02197130|585265811|FG002|Overall Study|Withdrawal by Subject|4|||
162056969|NCT02197130|585265809|FG000|Overall Study|Other|1|||
162056970|NCT02197130|585265810|FG001|Overall Study|Other|0|||
162056971|NCT02197130|585265811|FG002|Overall Study|Other|3|||
162056972|NCT02615145|585265812|FG000|Overall Study|Did Not Start Treatment|0|||
162056973|NCT02615145|585265813|FG001|Overall Study|Did Not Start Treatment|0|||
162056974|NCT02615145|585265814|FG002|Overall Study|Did Not Start Treatment|1|||
162056975|NCT02615145|585265815|FG003|Overall Study|Did Not Start Treatment|1|||
162056976|NCT02615145|585265812|FG000|Overall Study|Failure to Return|20|||
162056977|NCT02615145|585265813|FG001|Overall Study|Failure to Return|10|||
162056978|NCT02615145|585265814|FG002|Overall Study|Failure to Return|7|||
162056979|NCT02615145|585265815|FG003|Overall Study|Failure to Return|0|||
162056980|NCT02615145|585265812|FG000|Overall Study|Death|2|||
162056981|NCT02615145|585265813|FG001|Overall Study|Death|3|||
162056982|NCT02615145|585265814|FG002|Overall Study|Death|0|||
162056983|NCT02615145|585265815|FG003|Overall Study|Death|0|||
162056984|NCT02615145|585265812|FG000|Overall Study|Other, Not Specified|5|||
162056985|NCT02615145|585265813|FG001|Overall Study|Other, Not Specified|2|||
162056986|NCT02615145|585265814|FG002|Overall Study|Other, Not Specified|0|||
162056987|NCT02615145|585265815|FG003|Overall Study|Other, Not Specified|0|||
162056988|NCT00006237|585265816|FG000|Overall Study|Adverse Event|39|||
162056989|NCT00006237|585265817|FG001|Overall Study|Adverse Event|29|||
162056990|NCT00006237|585265816|FG000|Overall Study|Death|1|||
162056991|NCT00006237|585265817|FG001|Overall Study|Death|0|||
162056992|NCT00006237|585265816|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
162056993|NCT00006237|585265817|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
162056994|NCT00006237|585265816|FG000|Overall Study|Progression/relapse|54|||
162056995|NCT00006237|585265817|FG001|Overall Study|Progression/relapse|2|||
162056996|NCT00006237|585265816|FG000|Overall Study|Not eligible|9|||
162056997|NCT00006237|585265817|FG001|Overall Study|Not eligible|20|||
162056998|NCT00006237|585265816|FG000|Overall Study|Withdrawal by Subject|0|||
162056999|NCT00006237|585265817|FG001|Overall Study|Withdrawal by Subject|1|||
162057000|NCT00006237|585265816|FG000|Overall Study|Not protocol specified|14|||
162057001|NCT00006237|585265817|FG001|Overall Study|Not protocol specified|5|||
162057002|NCT03648983|585265827|FG000|Overall Study|Study was terminated due to PI departure|95|||
162057003|NCT01943292|585267298|FG000|Overall Study|Withdrawal by Subject|1|||
162057004|NCT01943292|585267299|FG001|Overall Study|Withdrawal by Subject|0|||
162057005|NCT01943292|585267300|FG002|Overall Study|Withdrawal by Subject|0|||
162057006|NCT00187486|585267307|FG000|Overall Study|Protocol Violation|1|||
162057007|NCT02483520|585267308|FG000|Overall Study|Lost to Follow-up|3|||
162057008|NCT02483520|585267309|FG001|Overall Study|Lost to Follow-up|4|||
162057009|NCT02483520|585267308|FG000|Overall Study|Withdrawal by Subject|4|||
162057010|NCT02483520|585267309|FG001|Overall Study|Withdrawal by Subject|14|||
162057011|NCT02483520|585267308|FG000|Overall Study|Hospitalized|2|||
162057012|NCT02483520|585267309|FG001|Overall Study|Hospitalized|3|||
162057013|NCT02483520|585267308|FG000|Overall Study|Moved to LTC|2|||
162057014|NCT02483520|585267309|FG001|Overall Study|Moved to LTC|3|||
162057015|NCT01104493|585267312|FG000|Overall Study|Lost to Follow-up|0|||
162057016|NCT01104493|585267313|FG001|Overall Study|Lost to Follow-up|2|||
162057017|NCT03489720|585267315|FG000|Overall Study|Withdrawal by Subject|2|||
162057018|NCT03489720|585267316|FG001|Overall Study|Withdrawal by Subject|0|||
162057019|NCT02511184|585267317|FG000|Overall Study|Death|1|||
162057020|NCT02511184|585267318|FG001|Overall Study|Death|0|||
162057021|NCT02511184|585267317|FG000|Overall Study|Lost to Follow-up|0|||
162057022|NCT02511184|585267318|FG001|Overall Study|Lost to Follow-up|1|||
162057023|NCT02511184|585267317|FG000|Overall Study|Study terminated by sponsor|1|||
162057024|NCT02511184|585267318|FG001|Overall Study|Study terminated by sponsor|5|||
162057025|NCT02511184|585267317|FG000|Overall Study|Withdrawal by Subject|0|||
162057026|NCT02511184|585267318|FG001|Overall Study|Withdrawal by Subject|1|||
162057027|NCT01806545|585267319|FG000|Overall Study|Adverse Event|2|||
162057028|NCT01806545|585267320|FG001|Overall Study|Adverse Event|3|||
162057029|NCT01806545|585267319|FG000|Overall Study|Lost to Follow-up|1|||
162057030|NCT01806545|585267320|FG001|Overall Study|Lost to Follow-up|0|||
162057031|NCT01806545|585267319|FG000|Overall Study|Withdrawal by Subject|3|||
162057032|NCT01806545|585267320|FG001|Overall Study|Withdrawal by Subject|2|||
162057033|NCT00884312|585267321|FG000|Overall Study|Non-fatal Progressive Disease|0|||
162057034|NCT00884312|585267322|FG001|Overall Study|Non-fatal Progressive Disease|8|||
162057035|NCT00884312|585267321|FG000|Overall Study|Fatal Progressive Disease|0|||
162057036|NCT00884312|585267322|FG001|Overall Study|Fatal Progressive Disease|1|||
162057037|NCT00884312|585267321|FG000|Overall Study|Non-fatal Adverse Event|1|||
162057038|NCT00884312|585267322|FG001|Overall Study|Non-fatal Adverse Event|0|||
162057039|NCT00884312|585267321|FG000|Overall Study|Fatal Adverse Event|1|||
162057040|NCT00884312|585267322|FG001|Overall Study|Fatal Adverse Event|4|||
162057041|NCT00884312|585267321|FG000|Overall Study|Withdrawal by Subject|0|||
162057042|NCT00884312|585267322|FG001|Overall Study|Withdrawal by Subject|6|||
162057043|NCT00884312|585267321|FG000|Overall Study|Physician Decision|0|||
162057044|NCT00884312|585267322|FG001|Overall Study|Physician Decision|1|||
162057045|NCT00884312|585267321|FG000|Overall Study|Other|0|||
162057046|NCT00884312|585267322|FG001|Overall Study|Other|4|||
162057047|NCT00884312|585267321|FG000|Overall Study|Did Not Receive Study Drug|0|||
162057048|NCT00884312|585267322|FG001|Overall Study|Did Not Receive Study Drug|1|||
162057049|NCT03521934|585267332|FG000|Overall Study|Death|65|||
162057050|NCT03521934|585267333|FG001|Overall Study|Death|73|||
162057051|NCT03521934|585267332|FG000|Overall Study|Withdrawal by Subject|18|||
162057052|NCT03521934|585267333|FG001|Overall Study|Withdrawal by Subject|23|||
162057053|NCT03521934|585267332|FG000|Overall Study|Site Terminated by Sponsor|39|||
162057054|NCT03521934|585267333|FG001|Overall Study|Site Terminated by Sponsor|35|||
162057055|NCT03521934|585267332|FG000|Overall Study|Study Terminated by Sponsor|483|||
162057056|NCT03521934|585267333|FG001|Overall Study|Study Terminated by Sponsor|477|||
162057057|NCT03521934|585267332|FG000|Overall Study|Reason not Specified|3|||
162057058|NCT03521934|585267333|FG001|Overall Study|Reason not Specified|6|||
162057059|NCT00284050|585267336|FG000|Overall Study|Adverse Event|1|||
162057060|NCT00284050|585267337|FG001|Overall Study|Adverse Event|1|||
162057061|NCT00284050|585267338|FG002|Overall Study|Adverse Event|1|||
162057062|NCT00284050|585267336|FG000|Overall Study|Lack of Efficacy|0|||
162057063|NCT00284050|585267337|FG001|Overall Study|Lack of Efficacy|1|||
162057064|NCT00284050|585267338|FG002|Overall Study|Lack of Efficacy|3|||
162057065|NCT00284050|585267336|FG000|Overall Study|Protocol Violation|0|||
162057066|NCT00284050|585267337|FG001|Overall Study|Protocol Violation|1|||
162057067|NCT00284050|585267338|FG002|Overall Study|Protocol Violation|2|||
162057068|NCT00284050|585267336|FG000|Overall Study|Withdrawal by Subject|2|||
162057069|NCT00284050|585267337|FG001|Overall Study|Withdrawal by Subject|2|||
162057070|NCT00284050|585267338|FG002|Overall Study|Withdrawal by Subject|2|||
162057071|NCT00284050|585267336|FG000|Overall Study|Lost to Follow-up|1|||
162057072|NCT00284050|585267337|FG001|Overall Study|Lost to Follow-up|0|||
162057073|NCT00284050|585267338|FG002|Overall Study|Lost to Follow-up|1|||
162057074|NCT00284050|585267336|FG000|Overall Study|Death|1|||
162057075|NCT00284050|585267337|FG001|Overall Study|Death|0|||
162057076|NCT00284050|585267338|FG002|Overall Study|Death|0|||
162057077|NCT00489541|585267341|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
162057078|NCT00489541|585267342|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
162057079|NCT00489541|585267341|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
162057080|NCT00489541|585267342|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
162057081|NCT00489541|585267341|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
162057082|NCT00489541|585267342|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
162057083|NCT00489541|585267341|FG000|12-Month Clinical Follow-up|Death|3|||
162057084|NCT00489541|585267342|FG001|12-Month Clinical Follow-up|Death|2|||
162057085|NCT00489541|585267341|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
162057086|NCT00489541|585267342|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
162057087|NCT00489541|585267341|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
162057088|NCT00489541|585267342|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
162057089|NCT02551731|585267343|FG000|Overall Study|Withdrawal by Subject|2|||
162057090|NCT01192516|585267345|FG000|Overall Study|Lost to Follow-up|7|||
162057091|NCT01192516|585267346|FG001|Overall Study|Lost to Follow-up|10|||
162057092|NCT01192516|585267347|FG002|Overall Study|Lost to Follow-up|7|||
162057093|NCT01192516|585267345|FG000|Overall Study|Withdrawal by Subject|4|||
162057094|NCT01192516|585267346|FG001|Overall Study|Withdrawal by Subject|4|||
162057095|NCT01192516|585267347|FG002|Overall Study|Withdrawal by Subject|1|||
162057096|NCT01192516|585267345|FG000|Overall Study|started new treatment|5|||
162057097|NCT01192516|585267346|FG001|Overall Study|started new treatment|1|||
162057098|NCT01192516|585267347|FG002|Overall Study|started new treatment|0|||
162057099|NCT01192516|585267345|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
162057100|NCT01192516|585267346|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
162057101|NCT01192516|585267347|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
162057102|NCT05228132|585267352|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
162057103|NCT05228132|585267352|FG000|Overall Study|Adverse Event|3|||
162057104|NCT05228132|585267352|FG000|Overall Study|Lost to Follow-up|1|||
162057105|NCT05228132|585267352|FG000|Overall Study|Arteriovenous-fistula mature|1|||
162057106|NCT02627144|585267353|FG000|Overall Study|Serious adverse event|32|||
162057107|NCT02627144|585267353|FG000|Overall Study|Cancer progression|171|||
162057108|NCT02627144|585267353|FG000|Overall Study|Death from cancer|20|||
162057109|NCT02627144|585267353|FG000|Overall Study|Death from other cause|8|||
162057110|NCT02627144|585267353|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
162057111|NCT02627144|585267353|FG000|Overall Study|Administrative reasons|65|||
162057112|NCT02627144|585267353|FG000|Overall Study|Lost to Follow-up|8|||
162057113|NCT02627144|585267353|FG000|Overall Study|Enrolled, not treated|6|||
162057114|NCT02627144|585267353|FG000|Overall Study|Other|17|||
162057115|NCT00496470|585267360|FG000|Overall Study|Adverse Event|8|||
162057116|NCT00496470|585267361|FG001|Overall Study|Adverse Event|10|||
162057117|NCT00496470|585267360|FG000|Overall Study|Withdrawal by Subject|5|||
162057118|NCT00496470|585267361|FG001|Overall Study|Withdrawal by Subject|12|||
162057119|NCT00496470|585267360|FG000|Overall Study|Incorrectly enrolled|13|||
162057120|NCT00496470|585267361|FG001|Overall Study|Incorrectly enrolled|5|||
162057121|NCT00496470|585267360|FG000|Overall Study|Other reason|0|||
162057122|NCT00496470|585267361|FG001|Overall Study|Other reason|2|||
162057123|NCT01217801|585267367|FG000|Period 1|Protocol Violation|1|||
162057124|NCT01217801|585267368|FG001|Period 1|Protocol Violation|1|||
162057125|NCT01217801|585267367|FG000|Period 1|Withdrawal by Subject|0|||
162057126|NCT01217801|585267368|FG001|Period 1|Withdrawal by Subject|1|||
162057127|NCT00291577|585267370|FG000|Overall Study|Adverse Event|1|||
162057128|NCT00291577|585267370|FG000|Overall Study|Other|4|||
162057129|NCT00291577|585267370|FG000|Overall Study|Withdrawal by Subject|2|||
162057130|NCT00291577|585267370|FG000|Overall Study|Lack of Efficacy|14|||
162057131|NCT04584645|585267371|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
162057132|NCT04584645|585267372|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
162057133|NCT03845985|585267379|FG000|Overall Study|Lost to Follow-up|2|||
162057134|NCT03845985|585267380|FG001|Overall Study|Lost to Follow-up|1|||
162057135|NCT03845985|585267379|FG000|Overall Study|Physician Decision|1|||
162057136|NCT03845985|585267380|FG001|Overall Study|Physician Decision|0|||
162057137|NCT03845985|585267379|FG000|Overall Study|Withdrawal by Subject|4|||
162057138|NCT03845985|585267380|FG001|Overall Study|Withdrawal by Subject|1|||
162057139|NCT02756013|585267381|FG000|Overall Study|Adverse Event|1|||
162057140|NCT02756013|585267381|FG000|Overall Study|Hypersensitivity|1|||
162057141|NCT03926169|585267382|FG000|Period A|Adverse Event|2|||
162057142|NCT03926169|585267383|FG001|Period A|Adverse Event|2|||
162057143|NCT03926169|585267384|FG002|Period A|Adverse Event|1|||
162057144|NCT03926169|585267382|FG000|Period A|Withdrawal by Subject|2|||
162057145|NCT03926169|585267383|FG001|Period A|Withdrawal by Subject|2|||
162057146|NCT03926169|585267384|FG002|Period A|Withdrawal by Subject|2|||
162057147|NCT03926169|585267382|FG000|Period A|Lost to Follow-up|3|||
162057148|NCT03926169|585267383|FG001|Period A|Lost to Follow-up|1|||
162057149|NCT03926169|585267384|FG002|Period A|Lost to Follow-up|0|||
162057150|NCT03926169|585267382|FG000|Period A|Lack of Efficacy|0|||
162057151|NCT03926169|585267383|FG001|Period A|Lack of Efficacy|2|||
162057152|NCT03926169|585267384|FG002|Period A|Lack of Efficacy|2|||
162057153|NCT03926169|585267382|FG000|Period A|COVID-19 Infection|0|||
162057154|NCT03926169|585267383|FG001|Period A|COVID-19 Infection|1|||
162057155|NCT03926169|585267384|FG002|Period A|COVID-19 Infection|0|||
162057156|NCT03926169|585267382|FG000|Period A|COVID-19 Logistical Restrictions|0|||
162057157|NCT03926169|585267383|FG001|Period A|COVID-19 Logistical Restrictions|2|||
162057158|NCT03926169|585267384|FG002|Period A|COVID-19 Logistical Restrictions|1|||
162057159|NCT03926169|585267382|FG000|Period A|Other, Not Specified|1|||
162057160|NCT03926169|585267383|FG001|Period A|Other, Not Specified|0|||
162057161|NCT03926169|585267384|FG002|Period A|Other, Not Specified|0|||
162057162|NCT03926169|585267382|FG000|Period B|Adverse Event|3|||
162057163|NCT03926169|585267383|FG001|Period B|Adverse Event|1|||
162057164|NCT03926169|585267384|FG002|Period B|Adverse Event|1|||
162057165|NCT03926169|585267382|FG000|Period B|Withdrawal by Subject|1|||
162057166|NCT03926169|585267383|FG001|Period B|Withdrawal by Subject|3|||
162057167|NCT03926169|585267384|FG002|Period B|Withdrawal by Subject|0|||
162057168|NCT03926169|585267382|FG000|Period B|Lack of Efficacy|3|||
162057169|NCT03926169|585267383|FG001|Period B|Lack of Efficacy|1|||
162057170|NCT03926169|585267384|FG002|Period B|Lack of Efficacy|1|||
162057171|NCT03926169|585267382|FG000|Period B|Lost to Follow-up|1|||
162057172|NCT03926169|585267383|FG001|Period B|Lost to Follow-up|1|||
162057173|NCT03926169|585267384|FG002|Period B|Lost to Follow-up|4|||
162057174|NCT03926169|585267382|FG000|Period B|Other, Not Specified|62|||
162057175|NCT03926169|585267383|FG001|Period B|Other, Not Specified|57|||
162057176|NCT03926169|585267384|FG002|Period B|Other, Not Specified|65|||
162057177|NCT00968201|585267385|FG000|Base Study - (Period II)|Adverse Event|8|||
162057178|NCT00968201|585267386|FG001|Base Study - (Period II)|Adverse Event|0|||
162057179|NCT00968201|585267387|FG002|Base Study - (Period II)|Adverse Event|16|||
162057180|NCT00968201|585267385|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
162057181|NCT00968201|585267386|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
162057182|NCT00968201|585267387|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
162057183|NCT00968201|585267385|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
162057184|NCT00968201|585267386|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
162057185|NCT00968201|585267387|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
162057186|NCT00968201|585267385|FG000|Base Study - (Period II)|Protocol Violation|12|||
162057187|NCT00968201|585267386|FG001|Base Study - (Period II)|Protocol Violation|0|||
162057188|NCT00968201|585267387|FG002|Base Study - (Period II)|Protocol Violation|12|||
162057189|NCT00968201|585267385|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
162057190|NCT00968201|585267386|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
162057191|NCT00968201|585267387|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
162057192|NCT00968201|585267385|FG000|Base Study - (Period II)|Site Error|0|||
162057193|NCT00968201|585267386|FG001|Base Study - (Period II)|Site Error|0|||
162057194|NCT00968201|585267387|FG002|Base Study - (Period II)|Site Error|1|||
162057195|NCT00968201|585267385|FG000|Extension Study - (Period III)|Adverse Event|0|||
162057196|NCT00968201|585267386|FG001|Extension Study - (Period III)|Adverse Event|5|||
162057197|NCT00968201|585267387|FG002|Extension Study - (Period III)|Adverse Event|22|||
162122666|NCT01115491|585500297|FG000|Overall Study|Adverse Event|3|||
162057198|NCT00968201|585267385|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
162057199|NCT00968201|585267386|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
162057200|NCT00968201|585267387|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
162057201|NCT00968201|585267385|FG000|Extension Study - (Period III)|Protocol Violation|0|||
162057202|NCT00968201|585267386|FG001|Extension Study - (Period III)|Protocol Violation|17|||
162057203|NCT00968201|585267387|FG002|Extension Study - (Period III)|Protocol Violation|14|||
162057204|NCT00968201|585267385|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
162057205|NCT00968201|585267386|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
162057206|NCT00968201|585267387|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
162057207|NCT00968201|585267385|FG000|Extension Study - (Period III)|Patient Relocated|0|||
162057208|NCT00968201|585267386|FG001|Extension Study - (Period III)|Patient Relocated|1|||
162057209|NCT00968201|585267387|FG002|Extension Study - (Period III)|Patient Relocated|1|||
162057210|NCT00968201|585267385|FG000|Extension Study - (Period III)|Noncompliance|0|||
162057211|NCT00968201|585267386|FG001|Extension Study - (Period III)|Noncompliance|0|||
162057212|NCT00968201|585267387|FG002|Extension Study - (Period III)|Noncompliance|3|||
162057213|NCT00968201|585267385|FG000|Extension Study - (Period III)|Other|0|||
162057214|NCT00968201|585267386|FG001|Extension Study - (Period III)|Other|0|||
162057215|NCT00968201|585267387|FG002|Extension Study - (Period III)|Other|2|||
162057216|NCT00968201|585267385|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
162057217|NCT00968201|585267386|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
162057218|NCT00968201|585267387|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
162057219|NCT04974697|585267388|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
162057220|NCT04974697|585267388|FG000|Overall Study|Lens discomfort|1|||
162057221|NCT03302234|585267389|FG000|Overall Study|Death|191|||
162057222|NCT03302234|585267390|FG001|Overall Study|Death|192|||
162057223|NCT03302234|585267389|FG000|Overall Study|Withdrawal by Subject|2|||
162057224|NCT03302234|585267390|FG001|Overall Study|Withdrawal by Subject|2|||
162057225|NCT03302234|585267389|FG000|Overall Study|Sponsor Decision|90|||
162057226|NCT03302234|585267390|FG001|Overall Study|Sponsor Decision|89|||
162057227|NCT03302234|585267389|FG000|Overall Study|Laryngeal carcinoma|0|||
162057228|NCT03302234|585267390|FG001|Overall Study|Laryngeal carcinoma|1|||
162057229|NCT03302234|585267389|FG000|Overall Study|Not Reported|1|||
162057230|NCT03302234|585267390|FG001|Overall Study|Not Reported|0|||
162057231|NCT04112784|585267392|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
162057232|NCT04112784|585267392|FG000|Overall Study|Screen Failures|4|||
162057233|NCT00221403|585267393|FG000|Overall Study|Protocol Violation|1|||
162057234|NCT00221403|585267394|FG001|Overall Study|Protocol Violation|0|||
162057235|NCT00221403|585267395|FG002|Overall Study|Protocol Violation|0|||
162057236|NCT00221403|585267393|FG000|Overall Study|Physician Decision|1|||
162057237|NCT00221403|585267394|FG001|Overall Study|Physician Decision|0|||
162057238|NCT00221403|585267395|FG002|Overall Study|Physician Decision|0|||
162057239|NCT00221403|585267393|FG000|Overall Study|Withdrawal by Subject|0|||
162057240|NCT00221403|585267394|FG001|Overall Study|Withdrawal by Subject|3|||
162057241|NCT00221403|585267395|FG002|Overall Study|Withdrawal by Subject|0|||
162057242|NCT00221403|585267393|FG000|Overall Study|Lack of Efficacy|0|||
162057243|NCT00221403|585267394|FG001|Overall Study|Lack of Efficacy|1|||
162057244|NCT00221403|585267395|FG002|Overall Study|Lack of Efficacy|0|||
162057245|NCT00221403|585267393|FG000|Overall Study|Adverse Event|0|||
162057246|NCT00221403|585267394|FG001|Overall Study|Adverse Event|1|||
162057247|NCT00221403|585267395|FG002|Overall Study|Adverse Event|0|||
162057248|NCT00496054|585267401|FG000|Overall Study|Adverse Event|1|||
162057249|NCT00496054|585267401|FG000|Overall Study|Lost to Follow-up|7|||
162057250|NCT01737697|585267402|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162057251|NCT01737697|585267403|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
162057252|NCT01737697|585267404|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162057253|NCT01737697|585267405|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
162057254|NCT01737697|585267406|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
162057255|NCT01737697|585267407|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162057256|NCT01737697|585267408|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162057257|NCT01737697|585267409|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162057258|NCT01737697|585267410|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162057259|NCT01737697|585267411|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162057260|NCT01737697|585267412|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162057261|NCT01737697|585267413|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162057262|NCT01737697|585267414|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162057263|NCT01737697|585267415|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162057264|NCT01737697|585267416|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
162057265|NCT01737697|585267402|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
162057266|NCT01737697|585267403|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
162057267|NCT01737697|585267404|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
162057268|NCT01737697|585267405|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162057269|NCT01737697|585267406|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162057270|NCT01737697|585267407|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162057271|NCT01737697|585267408|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162057272|NCT01737697|585267409|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162057273|NCT01737697|585267410|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162057274|NCT01737697|585267411|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162057275|NCT01737697|585267412|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162057276|NCT01737697|585267413|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162057277|NCT01737697|585267414|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162057278|NCT01737697|585267415|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162057279|NCT01737697|585267416|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
162057280|NCT01737697|585267402|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057281|NCT01737697|585267403|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057282|NCT01737697|585267404|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057283|NCT01737697|585267405|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
162057284|NCT01737697|585267406|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057285|NCT01737697|585267407|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057286|NCT01737697|585267408|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057287|NCT01737697|585267409|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057288|NCT01737697|585267410|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057289|NCT01737697|585267411|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057290|NCT01737697|585267412|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057291|NCT01737697|585267413|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057292|NCT01737697|585267414|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057293|NCT01737697|585267415|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057294|NCT01737697|585267416|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
162057295|NCT01737697|585267402|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057296|NCT01737697|585267403|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
162057297|NCT01737697|585267404|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057298|NCT01737697|585267405|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057299|NCT01737697|585267406|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057300|NCT01737697|585267407|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057301|NCT01737697|585267408|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057302|NCT01737697|585267409|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057303|NCT01737697|585267410|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057304|NCT01737697|585267411|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057305|NCT01737697|585267412|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057306|NCT01737697|585267413|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057307|NCT01737697|585267414|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057308|NCT01737697|585267415|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057309|NCT01737697|585267416|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
162057310|NCT01737697|585267402|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057311|NCT01737697|585267403|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057312|NCT01737697|585267404|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057313|NCT01737697|585267405|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057314|NCT01737697|585267406|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
162057315|NCT01737697|585267407|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057316|NCT01737697|585267408|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057317|NCT01737697|585267409|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057318|NCT01737697|585267410|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057319|NCT01737697|585267411|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057320|NCT01737697|585267412|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057321|NCT01737697|585267413|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057322|NCT01737697|585267414|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057323|NCT01737697|585267415|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057324|NCT01737697|585267416|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
162057325|NCT01737697|585267402|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162057326|NCT01737697|585267403|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
162057327|NCT01737697|585267404|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
162057328|NCT01737697|585267405|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
162057329|NCT01737697|585267406|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
162057330|NCT01737697|585267407|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162057331|NCT01737697|585267408|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162057332|NCT01737697|585267409|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162057333|NCT01737697|585267410|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162057334|NCT01737697|585267411|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162057335|NCT01737697|585267412|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162057336|NCT01737697|585267413|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162057337|NCT01737697|585267414|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162057338|NCT01737697|585267415|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162057339|NCT01737697|585267416|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
162057340|NCT01737697|585267402|FG000|Subacute Phase|Adverse Event|0|||
162057341|NCT01737697|585267403|FG001|Subacute Phase|Adverse Event|0|||
162057342|NCT01737697|585267404|FG002|Subacute Phase|Adverse Event|0|||
162057343|NCT01737697|585267405|FG003|Subacute Phase|Adverse Event|0|||
162057344|NCT01737697|585267406|FG004|Subacute Phase|Adverse Event|0|||
162057345|NCT01737697|585267407|FG005|Subacute Phase|Adverse Event|1|||
162057346|NCT01737697|585267408|FG006|Subacute Phase|Adverse Event|1|||
162057347|NCT01737697|585267409|FG007|Subacute Phase|Adverse Event|1|||
162057348|NCT01737697|585267410|FG008|Subacute Phase|Adverse Event|1|||
162057349|NCT01737697|585267411|FG009|Subacute Phase|Adverse Event|1|||
162057350|NCT01737697|585267412|FG010|Subacute Phase|Adverse Event|4|||
162057351|NCT01737697|585267413|FG011|Subacute Phase|Adverse Event|1|||
162057352|NCT01737697|585267414|FG012|Subacute Phase|Adverse Event|1|||
162057353|NCT01737697|585267415|FG013|Subacute Phase|Adverse Event|0|||
162057354|NCT01737697|585267416|FG014|Subacute Phase|Adverse Event|0|||
162057355|NCT01737697|585267402|FG000|Subacute Phase|Withdrawal by Subject|0|||
162057356|NCT01737697|585267403|FG001|Subacute Phase|Withdrawal by Subject|0|||
162057357|NCT01737697|585267404|FG002|Subacute Phase|Withdrawal by Subject|0|||
162057358|NCT01737697|585267405|FG003|Subacute Phase|Withdrawal by Subject|0|||
162057359|NCT01737697|585267406|FG004|Subacute Phase|Withdrawal by Subject|0|||
162057360|NCT01737697|585267407|FG005|Subacute Phase|Withdrawal by Subject|1|||
162057361|NCT01737697|585267408|FG006|Subacute Phase|Withdrawal by Subject|0|||
162057362|NCT01737697|585267409|FG007|Subacute Phase|Withdrawal by Subject|2|||
162057363|NCT01737697|585267410|FG008|Subacute Phase|Withdrawal by Subject|0|||
162057364|NCT01737697|585267411|FG009|Subacute Phase|Withdrawal by Subject|1|||
162057365|NCT01737697|585267412|FG010|Subacute Phase|Withdrawal by Subject|0|||
162057366|NCT01737697|585267413|FG011|Subacute Phase|Withdrawal by Subject|1|||
162057367|NCT01737697|585267414|FG012|Subacute Phase|Withdrawal by Subject|1|||
162057368|NCT01737697|585267415|FG013|Subacute Phase|Withdrawal by Subject|1|||
162057369|NCT01737697|585267416|FG014|Subacute Phase|Withdrawal by Subject|0|||
162057370|NCT01737697|585267402|FG000|Subacute Phase|Lost to Follow-up|0|||
162057371|NCT01737697|585267403|FG001|Subacute Phase|Lost to Follow-up|0|||
162057372|NCT01737697|585267404|FG002|Subacute Phase|Lost to Follow-up|0|||
162057373|NCT01737697|585267405|FG003|Subacute Phase|Lost to Follow-up|0|||
162057374|NCT01737697|585267406|FG004|Subacute Phase|Lost to Follow-up|0|||
162057375|NCT01737697|585267407|FG005|Subacute Phase|Lost to Follow-up|0|||
162057376|NCT01737697|585267408|FG006|Subacute Phase|Lost to Follow-up|0|||
162057377|NCT01737697|585267409|FG007|Subacute Phase|Lost to Follow-up|0|||
162057378|NCT01737697|585267410|FG008|Subacute Phase|Lost to Follow-up|0|||
162057379|NCT01737697|585267411|FG009|Subacute Phase|Lost to Follow-up|0|||
162057380|NCT01737697|585267412|FG010|Subacute Phase|Lost to Follow-up|0|||
162057381|NCT01737697|585267413|FG011|Subacute Phase|Lost to Follow-up|0|||
162057382|NCT01737697|585267414|FG012|Subacute Phase|Lost to Follow-up|0|||
162057383|NCT01737697|585267415|FG013|Subacute Phase|Lost to Follow-up|0|||
162057384|NCT01737697|585267416|FG014|Subacute Phase|Lost to Follow-up|1|||
162057385|NCT01737697|585267402|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
162057386|NCT01737697|585267403|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
162057387|NCT01737697|585267404|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
162057388|NCT01737697|585267405|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
162057389|NCT01737697|585267406|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
162057390|NCT01737697|585267407|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
162057391|NCT01737697|585267408|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
162057392|NCT01737697|585267409|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
162057393|NCT01737697|585267410|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
162057394|NCT01737697|585267411|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
162057395|NCT01737697|585267412|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
162057396|NCT01737697|585267413|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
162057397|NCT01737697|585267414|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
162057398|NCT01737697|585267415|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
162057399|NCT01737697|585267416|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
162057400|NCT01737697|585267402|FG000|Subacute Phase|Protocol Violation|0|||
162057401|NCT01737697|585267403|FG001|Subacute Phase|Protocol Violation|0|||
162057402|NCT01737697|585267404|FG002|Subacute Phase|Protocol Violation|0|||
162057403|NCT01737697|585267405|FG003|Subacute Phase|Protocol Violation|0|||
162057404|NCT01737697|585267406|FG004|Subacute Phase|Protocol Violation|0|||
162057405|NCT01737697|585267407|FG005|Subacute Phase|Protocol Violation|1|||
162057406|NCT01737697|585267408|FG006|Subacute Phase|Protocol Violation|0|||
162057407|NCT01737697|585267409|FG007|Subacute Phase|Protocol Violation|0|||
162057408|NCT01737697|585267410|FG008|Subacute Phase|Protocol Violation|0|||
162057409|NCT01737697|585267411|FG009|Subacute Phase|Protocol Violation|0|||
162057410|NCT01737697|585267412|FG010|Subacute Phase|Protocol Violation|1|||
162057411|NCT01737697|585267413|FG011|Subacute Phase|Protocol Violation|0|||
162057412|NCT01737697|585267414|FG012|Subacute Phase|Protocol Violation|0|||
162057413|NCT01737697|585267415|FG013|Subacute Phase|Protocol Violation|0|||
162057414|NCT01737697|585267416|FG014|Subacute Phase|Protocol Violation|0|||
162057415|NCT01737697|585267402|FG000|Subacute Phase|Physician Decision|0|||
162057416|NCT01737697|585267403|FG001|Subacute Phase|Physician Decision|0|||
162057417|NCT01737697|585267404|FG002|Subacute Phase|Physician Decision|0|||
162057418|NCT01737697|585267405|FG003|Subacute Phase|Physician Decision|0|||
162057419|NCT01737697|585267406|FG004|Subacute Phase|Physician Decision|0|||
162057420|NCT01737697|585267407|FG005|Subacute Phase|Physician Decision|0|||
162057421|NCT01737697|585267408|FG006|Subacute Phase|Physician Decision|0|||
162057422|NCT01737697|585267409|FG007|Subacute Phase|Physician Decision|0|||
162057423|NCT01737697|585267410|FG008|Subacute Phase|Physician Decision|1|||
162057424|NCT01737697|585267411|FG009|Subacute Phase|Physician Decision|0|||
162057425|NCT01737697|585267412|FG010|Subacute Phase|Physician Decision|0|||
162057426|NCT01737697|585267413|FG011|Subacute Phase|Physician Decision|0|||
162057427|NCT01737697|585267414|FG012|Subacute Phase|Physician Decision|0|||
162057428|NCT01737697|585267415|FG013|Subacute Phase|Physician Decision|0|||
162057429|NCT01737697|585267416|FG014|Subacute Phase|Physician Decision|0|||
162057430|NCT01737697|585267402|FG000|Subacute Phase|Death|0|||
162057431|NCT01737697|585267403|FG001|Subacute Phase|Death|0|||
162057432|NCT01737697|585267404|FG002|Subacute Phase|Death|0|||
162057433|NCT01737697|585267405|FG003|Subacute Phase|Death|0|||
162057434|NCT01737697|585267406|FG004|Subacute Phase|Death|0|||
162057435|NCT01737697|585267407|FG005|Subacute Phase|Death|0|||
162057436|NCT01737697|585267408|FG006|Subacute Phase|Death|0|||
162057437|NCT01737697|585267409|FG007|Subacute Phase|Death|0|||
162057438|NCT01737697|585267410|FG008|Subacute Phase|Death|0|||
162057439|NCT01737697|585267411|FG009|Subacute Phase|Death|0|||
162057440|NCT01737697|585267412|FG010|Subacute Phase|Death|1|||
162057441|NCT01737697|585267413|FG011|Subacute Phase|Death|0|||
162057442|NCT01737697|585267414|FG012|Subacute Phase|Death|0|||
162057443|NCT01737697|585267415|FG013|Subacute Phase|Death|0|||
162057444|NCT01737697|585267416|FG014|Subacute Phase|Death|0|||
162057445|NCT02216591|585267417|FG000|Overall Study|Lost to Follow-up|0|||
162057446|NCT02216591|585267418|FG001|Overall Study|Lost to Follow-up|1|||
162057447|NCT01950741|585267420|FG000|Overall Study|Lost to Follow-up|1|||
162057448|NCT01950741|585267420|FG000|Overall Study|Death|1|||
162057449|NCT01950741|585267420|FG000|Overall Study|Withdrawal by Subject|1|||
162057450|NCT00558558|585267423|FG000|Overall Study|Unable to swallow|1|||
162057451|NCT00558558|585267423|FG000|Overall Study|Withdrawal by Subject|1|||
162057452|NCT00558558|585267423|FG000|Overall Study|Lack of Efficacy|4|||
162057453|NCT02549937|585267425|FG000|Overall Study|Death|0|||
162057454|NCT02549937|585267426|FG001|Overall Study|Death|1|||
162057455|NCT02549937|585267427|FG002|Overall Study|Death|0|||
162057456|NCT02549937|585267428|FG003|Overall Study|Death|1|||
162057457|NCT02549937|585267429|FG004|Overall Study|Death|0|||
162057458|NCT02549937|585267430|FG005|Overall Study|Death|8|||
162057459|NCT02549937|585267431|FG006|Overall Study|Death|0|||
162057460|NCT02549937|585267432|FG007|Overall Study|Death|0|||
162057461|NCT02549937|585267433|FG008|Overall Study|Death|19|||
162057462|NCT02549937|585267425|FG000|Overall Study|No follow up required|3|||
162057463|NCT02549937|585267426|FG001|Overall Study|No follow up required|6|||
162057464|NCT02549937|585267427|FG002|Overall Study|No follow up required|3|||
162057465|NCT02549937|585267428|FG003|Overall Study|No follow up required|8|||
162057466|NCT02549937|585267429|FG004|Overall Study|No follow up required|12|||
162057467|NCT02549937|585267430|FG005|Overall Study|No follow up required|21|||
162057468|NCT02549937|585267431|FG006|Overall Study|No follow up required|9|||
162057469|NCT02549937|585267432|FG007|Overall Study|No follow up required|11|||
162057470|NCT02549937|585267433|FG008|Overall Study|No follow up required|0|||
162057471|NCT02549937|585267425|FG000|Overall Study|Other|0|||
162057472|NCT02549937|585267426|FG001|Overall Study|Other|0|||
162057473|NCT02549937|585267427|FG002|Overall Study|Other|0|||
162057474|NCT02549937|585267428|FG003|Overall Study|Other|0|||
162057475|NCT02549937|585267429|FG004|Overall Study|Other|1|||
162057476|NCT02549937|585267430|FG005|Overall Study|Other|0|||
162057477|NCT02549937|585267431|FG006|Overall Study|Other|3|||
162057478|NCT02549937|585267432|FG007|Overall Study|Other|2|||
162057479|NCT02549937|585267433|FG008|Overall Study|Other|3|||
162057480|NCT02549937|585267425|FG000|Overall Study|Lost to Follow-up|0|||
162057481|NCT02549937|585267426|FG001|Overall Study|Lost to Follow-up|0|||
162057482|NCT02549937|585267427|FG002|Overall Study|Lost to Follow-up|0|||
162057483|NCT02549937|585267428|FG003|Overall Study|Lost to Follow-up|0|||
162057484|NCT02549937|585267429|FG004|Overall Study|Lost to Follow-up|0|||
162057485|NCT02549937|585267430|FG005|Overall Study|Lost to Follow-up|0|||
162057486|NCT02549937|585267431|FG006|Overall Study|Lost to Follow-up|0|||
162057487|NCT02549937|585267432|FG007|Overall Study|Lost to Follow-up|0|||
162057488|NCT02549937|585267433|FG008|Overall Study|Lost to Follow-up|3|||
162057489|NCT02549937|585267425|FG000|Overall Study|Withdrawal by Subject|0|||
162057490|NCT02549937|585267426|FG001|Overall Study|Withdrawal by Subject|0|||
162057491|NCT02549937|585267427|FG002|Overall Study|Withdrawal by Subject|0|||
162057492|NCT02549937|585267428|FG003|Overall Study|Withdrawal by Subject|0|||
162057493|NCT02549937|585267429|FG004|Overall Study|Withdrawal by Subject|0|||
162057494|NCT02549937|585267430|FG005|Overall Study|Withdrawal by Subject|1|||
162057495|NCT02549937|585267431|FG006|Overall Study|Withdrawal by Subject|4|||
162057496|NCT02549937|585267432|FG007|Overall Study|Withdrawal by Subject|3|||
162057497|NCT02549937|585267433|FG008|Overall Study|Withdrawal by Subject|2|||
162057498|NCT02549937|585267425|FG000|Overall Study|Sponsor Decision|0|||
162057499|NCT02549937|585267426|FG001|Overall Study|Sponsor Decision|0|||
162057500|NCT02549937|585267427|FG002|Overall Study|Sponsor Decision|0|||
162057501|NCT02549937|585267428|FG003|Overall Study|Sponsor Decision|0|||
162057502|NCT02549937|585267429|FG004|Overall Study|Sponsor Decision|0|||
162057503|NCT02549937|585267430|FG005|Overall Study|Sponsor Decision|0|||
162057504|NCT02549937|585267431|FG006|Overall Study|Sponsor Decision|0|||
162057505|NCT02549937|585267432|FG007|Overall Study|Sponsor Decision|0|||
162057506|NCT02549937|585267433|FG008|Overall Study|Sponsor Decision|6|||
162057507|NCT02144012|585267436|FG000|Overall Study|Adverse Event|1|||
162057508|NCT02144012|585267437|FG001|Overall Study|Adverse Event|0|||
162057509|NCT02144012|585267436|FG000|Overall Study|Death|1|||
162057510|NCT02144012|585267437|FG001|Overall Study|Death|0|||
162057511|NCT02144012|585267436|FG000|Overall Study|Withdrawal by Subject|11|||
162057512|NCT02144012|585267437|FG001|Overall Study|Withdrawal by Subject|3|||
162057513|NCT02144012|585267436|FG000|Overall Study|Study Terminated by Sponsor|18|||
162057514|NCT02144012|585267437|FG001|Overall Study|Study Terminated by Sponsor|12|||
162057515|NCT02144012|585267436|FG000|Overall Study|Other|3|||
162057516|NCT02144012|585267437|FG001|Overall Study|Other|0|||
162057517|NCT00317356|585267438|FG000|Overall Study|Adverse Event|0|||
162057518|NCT00317356|585267439|FG001|Overall Study|Adverse Event|0|||
162057519|NCT00317356|585267440|FG002|Overall Study|Adverse Event|1|||
162057520|NCT00317356|585267441|FG003|Overall Study|Adverse Event|0|||
162057521|NCT00317356|585267438|FG000|Overall Study|Lack of Efficacy|1|||
162057522|NCT00317356|585267439|FG001|Overall Study|Lack of Efficacy|1|||
162057523|NCT00317356|585267440|FG002|Overall Study|Lack of Efficacy|0|||
162057524|NCT00317356|585267441|FG003|Overall Study|Lack of Efficacy|3|||
162057525|NCT00317356|585267438|FG000|Overall Study|Physician Decision|0|||
162057526|NCT00317356|585267439|FG001|Overall Study|Physician Decision|1|||
162057527|NCT00317356|585267440|FG002|Overall Study|Physician Decision|0|||
162057528|NCT00317356|585267441|FG003|Overall Study|Physician Decision|0|||
162057529|NCT04342897|585267442|FG000|Overall Study|Death|7|||
162057530|NCT04342897|585267443|FG001|Overall Study|Death|4|||
162057531|NCT04342897|585267442|FG000|Overall Study|Lost to Follow-up|6|||
162057532|NCT04342897|585267443|FG001|Overall Study|Lost to Follow-up|6|||
162057533|NCT04342897|585267442|FG000|Overall Study|Withdrawal by Subject|1|||
162057534|NCT04342897|585267443|FG001|Overall Study|Withdrawal by Subject|2|||
162057535|NCT03727347|585267445|FG000|Overall Study|Withdrawal by Subject|2|||
162057536|NCT03727347|585267445|FG000|Overall Study|Lost to Follow-up|1|||
162057537|NCT04292743|585267446|FG000|Overall Study|Physician Decision|1|||
162057538|NCT04292743|585267447|FG001|Overall Study|Physician Decision|3|||
162057539|NCT04292743|585267448|FG002|Overall Study|Physician Decision|0|||
162057540|NCT04292743|585267449|FG003|Overall Study|Physician Decision|0|||
162057541|NCT04292743|585267446|FG000|Overall Study|Withdrawal by Subject|0|||
162057542|NCT04292743|585267447|FG001|Overall Study|Withdrawal by Subject|5|||
162057543|NCT04292743|585267448|FG002|Overall Study|Withdrawal by Subject|0|||
162057544|NCT04292743|585267449|FG003|Overall Study|Withdrawal by Subject|0|||
162057545|NCT04292743|585267446|FG000|Overall Study|Death|0|||
162057546|NCT04292743|585267447|FG001|Overall Study|Death|1|||
162057547|NCT04292743|585267448|FG002|Overall Study|Death|0|||
162057548|NCT04292743|585267449|FG003|Overall Study|Death|0|||
162057549|NCT04292743|585267446|FG000|Overall Study|Progression of Disease|2|||
162057550|NCT04292743|585267447|FG001|Overall Study|Progression of Disease|5|||
162057551|NCT04292743|585267448|FG002|Overall Study|Progression of Disease|0|||
162057552|NCT04292743|585267449|FG003|Overall Study|Progression of Disease|0|||
162057553|NCT04292743|585267446|FG000|Overall Study|No Treatment per protocol|0|||
162057554|NCT04292743|585267447|FG001|Overall Study|No Treatment per protocol|2|||
162057555|NCT04292743|585267448|FG002|Overall Study|No Treatment per protocol|0|||
162057556|NCT04292743|585267449|FG003|Overall Study|No Treatment per protocol|0|||
162057557|NCT05330702|585267450|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
162057558|NCT05330702|585267451|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
162057559|NCT05330702|585267452|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
162057560|NCT02674529|585269751|FG000|Overall Study|Lost to Follow-up|1|||
162057561|NCT02674529|585269752|FG001|Overall Study|Lost to Follow-up|2|||
162057562|NCT02674529|585269751|FG000|Overall Study|Withdrawal by Subject|2|||
162057563|NCT02674529|585269752|FG001|Overall Study|Withdrawal by Subject|1|||
162057564|NCT02674529|585269751|FG000|Overall Study|Physician Decision|0|||
162057565|NCT02674529|585269752|FG001|Overall Study|Physician Decision|1|||
162057566|NCT02674529|585269751|FG000|Overall Study|Protocol Violation|0|||
162057567|NCT02674529|585269752|FG001|Overall Study|Protocol Violation|1|||
162057568|NCT02141282|585269754|FG000|Overall Study|Adverse event, not related to progression|8|||
162057569|NCT02141282|585269755|FG001|Overall Study|Adverse event, not related to progression|1|||
162057570|NCT02141282|585269756|FG002|Overall Study|Adverse event, not related to progression|3|||
162057571|NCT02141282|585269757|FG003|Overall Study|Adverse event, not related to progression|1|||
162057572|NCT02141282|585269754|FG000|Overall Study|Adverse event, related to progression|1|||
162057573|NCT02141282|585269755|FG001|Overall Study|Adverse event, related to progression|0|||
162057574|NCT02141282|585269756|FG002|Overall Study|Adverse event, related to progression|2|||
162237403|NCT00903682|585921090|FG000|Overall Study|Lost to Follow-up|1|||
162057575|NCT02141282|585269757|FG003|Overall Study|Adverse event, related to progression|0|||
162057576|NCT02141282|585269754|FG000|Overall Study|COVID-19 infection|1|||
162057577|NCT02141282|585269755|FG001|Overall Study|COVID-19 infection|0|||
162057578|NCT02141282|585269756|FG002|Overall Study|COVID-19 infection|0|||
162057579|NCT02141282|585269757|FG003|Overall Study|COVID-19 infection|0|||
162057580|NCT02141282|585269754|FG000|Overall Study|Lost to Follow-up|0|||
162057581|NCT02141282|585269755|FG001|Overall Study|Lost to Follow-up|0|||
162057582|NCT02141282|585269756|FG002|Overall Study|Lost to Follow-up|4|||
162057583|NCT02141282|585269757|FG003|Overall Study|Lost to Follow-up|2|||
162057584|NCT02141282|585269754|FG000|Overall Study|Other, not specified|14|||
162057585|NCT02141282|585269755|FG001|Overall Study|Other, not specified|11|||
162057586|NCT02141282|585269756|FG002|Overall Study|Other, not specified|23|||
162057587|NCT02141282|585269757|FG003|Overall Study|Other, not specified|9|||
162057588|NCT02141282|585269754|FG000|Overall Study|Progressive disease, Richter's|4|||
162057589|NCT02141282|585269755|FG001|Overall Study|Progressive disease, Richter's|1|||
162057590|NCT02141282|585269756|FG002|Overall Study|Progressive disease, Richter's|1|||
162057591|NCT02141282|585269757|FG003|Overall Study|Progressive disease, Richter's|1|||
162057592|NCT02141282|585269754|FG000|Overall Study|Progressive disease per protocol|12|||
162057593|NCT02141282|585269755|FG001|Overall Study|Progressive disease per protocol|7|||
162057594|NCT02141282|585269756|FG002|Overall Study|Progressive disease per protocol|9|||
162057595|NCT02141282|585269757|FG003|Overall Study|Progressive disease per protocol|2|||
162057596|NCT02141282|585269754|FG000|Overall Study|Stem cell transplant|1|||
162057597|NCT02141282|585269755|FG001|Overall Study|Stem cell transplant|0|||
162057598|NCT02141282|585269756|FG002|Overall Study|Stem cell transplant|1|||
162057599|NCT02141282|585269757|FG003|Overall Study|Stem cell transplant|0|||
162057600|NCT02141282|585269754|FG000|Overall Study|Study terminated by Sponsor|0|||
162057601|NCT02141282|585269755|FG001|Overall Study|Study terminated by Sponsor|1|||
162057602|NCT02141282|585269756|FG002|Overall Study|Study terminated by Sponsor|0|||
162057603|NCT02141282|585269757|FG003|Overall Study|Study terminated by Sponsor|0|||
162057604|NCT02141282|585269754|FG000|Overall Study|Subject non-compliance|0|||
162057605|NCT02141282|585269755|FG001|Overall Study|Subject non-compliance|0|||
162057606|NCT02141282|585269756|FG002|Overall Study|Subject non-compliance|1|||
162057607|NCT02141282|585269757|FG003|Overall Study|Subject non-compliance|0|||
162057608|NCT02141282|585269754|FG000|Overall Study|Withdrew consent|2|||
162057609|NCT02141282|585269755|FG001|Overall Study|Withdrew consent|0|||
162057610|NCT02141282|585269756|FG002|Overall Study|Withdrew consent|4|||
162057611|NCT02141282|585269757|FG003|Overall Study|Withdrew consent|0|||
162057612|NCT00963547|585269760|FG000|Overall Study|Adverse Event|0|||
162057613|NCT00963547|585269761|FG001|Overall Study|Adverse Event|1|||
162057614|NCT00963547|585269762|FG002|Overall Study|Adverse Event|0|||
162057615|NCT00963547|585269763|FG003|Overall Study|Adverse Event|1|||
162057616|NCT00963547|585269764|FG004|Overall Study|Adverse Event|0|||
162057617|NCT00963547|585269765|FG005|Overall Study|Adverse Event|0|||
162057618|NCT00963547|585269766|FG006|Overall Study|Adverse Event|0|||
162057619|NCT00963547|585269760|FG000|Overall Study|Physician Decision|1|||
162057620|NCT00963547|585269761|FG001|Overall Study|Physician Decision|1|||
162057621|NCT00963547|585269762|FG002|Overall Study|Physician Decision|0|||
162057622|NCT00963547|585269763|FG003|Overall Study|Physician Decision|0|||
162057623|NCT00963547|585269764|FG004|Overall Study|Physician Decision|0|||
162057624|NCT00963547|585269765|FG005|Overall Study|Physician Decision|0|||
162057625|NCT00963547|585269766|FG006|Overall Study|Physician Decision|0|||
162057626|NCT00963547|585269760|FG000|Overall Study|Progressive Disease|3|||
162057627|NCT00963547|585269761|FG001|Overall Study|Progressive Disease|8|||
162057628|NCT00963547|585269762|FG002|Overall Study|Progressive Disease|9|||
162057629|NCT00963547|585269763|FG003|Overall Study|Progressive Disease|5|||
162057630|NCT00963547|585269764|FG004|Overall Study|Progressive Disease|0|||
162057631|NCT00963547|585269765|FG005|Overall Study|Progressive Disease|0|||
162057632|NCT00963547|585269766|FG006|Overall Study|Progressive Disease|0|||
162057633|NCT00963547|585269760|FG000|Overall Study|Withdrawal by Subject|0|||
162057634|NCT00963547|585269761|FG001|Overall Study|Withdrawal by Subject|0|||
162057635|NCT00963547|585269762|FG002|Overall Study|Withdrawal by Subject|3|||
162057636|NCT00963547|585269763|FG003|Overall Study|Withdrawal by Subject|0|||
162057637|NCT00963547|585269764|FG004|Overall Study|Withdrawal by Subject|0|||
162057638|NCT00963547|585269765|FG005|Overall Study|Withdrawal by Subject|0|||
162057639|NCT00963547|585269766|FG006|Overall Study|Withdrawal by Subject|0|||
162057640|NCT00963547|585269760|FG000|Overall Study|Reason Unknown|0|||
162057641|NCT00963547|585269761|FG001|Overall Study|Reason Unknown|1|||
162057642|NCT00963547|585269762|FG002|Overall Study|Reason Unknown|0|||
162057643|NCT00963547|585269763|FG003|Overall Study|Reason Unknown|0|||
162057644|NCT00963547|585269764|FG004|Overall Study|Reason Unknown|0|||
162057645|NCT00963547|585269765|FG005|Overall Study|Reason Unknown|0|||
162057646|NCT00963547|585269766|FG006|Overall Study|Reason Unknown|0|||
162057647|NCT00331682|585269767|FG000|Overall Study|Adverse Event|1|||
162057648|NCT03761277|585269768|FG000|Enrollment to Implant|Screen Failure|17|||
162057649|NCT03761277|585269768|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
162057650|NCT03761277|585269768|FG000|Enrollment to Implant|Physician Decision|2|||
162057651|NCT03761277|585269768|FG000|Enrollment to Implant|Site Closure|3|||
162057652|NCT03761277|585269768|FG000|Enrollment to Implant|Sponsor Request|2|||
162057653|NCT03761277|585269768|FG000|Post-Implant to 6 Months|Adverse Event|2|||
162057654|NCT03761277|585269768|FG000|Post-Implant to 6 Months|Death|1|||
162057655|NCT03761277|585269768|FG000|Post-Implant to 6 Months|Site Closure|2|||
162057656|NCT03761277|585269768|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
162057657|NCT03761277|585269768|FG000|6 Months to 12 Months|Physician Decision|2|||
162057658|NCT03761277|585269768|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
162057659|NCT00759031|585269769|FG000|First Intervention (1 Day)|Physician Decision|1|||
162057660|NCT00759031|585269770|FG001|First Intervention (1 Day)|Physician Decision|0|||
162057661|NCT00759031|585269769|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
162057662|NCT00759031|585269770|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
162057663|NCT00759031|585269769|FG000|First Intervention (1 Day)|Screening failure|1|||
162057664|NCT00759031|585269770|FG001|First Intervention (1 Day)|Screening failure|0|||
162057665|NCT00543140|585269771|FG000|Overall Study|Lost to Follow-up|33|||
162057666|NCT00543140|585269771|FG000|Overall Study|Withdrawal by Subject|13|||
162057667|NCT00543140|585269771|FG000|Overall Study|Protocol Violation|10|||
162057668|NCT00543140|585269771|FG000|Overall Study|Insufficient weight loss|10|||
162057669|NCT00543140|585269771|FG000|Overall Study|SAE leading to explant of SAGB|3|||
162057670|NCT00543140|585269771|FG000|Overall Study|Death|1|||
162057671|NCT00543140|585269771|FG000|Overall Study|Subject moved|1|||
162057672|NCT00543140|585269771|FG000|Overall Study|Conversion to different procedure|1|||
162057673|NCT04532164|585269772|FG000|Overall Study|Adverse Event|1|||
162057674|NCT04532164|585269772|FG000|Overall Study|Protocol Violation|5|||
162057675|NCT04532164|585269772|FG000|Overall Study|Lost to Follow-up|1|||
162057676|NCT04532164|585269772|FG000|Overall Study|Found to be Ineligible|3|||
162057677|NCT04532164|585269772|FG000|Overall Study|Withdrawal by Subject|14|||
162057678|NCT01599234|585269773|FG000|Overall Study|Adverse Event|9|||
162057679|NCT01599234|585269774|FG001|Overall Study|Adverse Event|5|||
162057680|NCT01599234|585269773|FG000|Overall Study|Withdrawal by Subject|2|||
162057681|NCT01599234|585269774|FG001|Overall Study|Withdrawal by Subject|1|||
162057682|NCT01599234|585269773|FG000|Overall Study|Lost to Follow-up|1|||
162057683|NCT01599234|585269774|FG001|Overall Study|Lost to Follow-up|2|||
162057684|NCT01599234|585269773|FG000|Overall Study|Lack of Efficacy|2|||
162057685|NCT01599234|585269774|FG001|Overall Study|Lack of Efficacy|4|||
162057686|NCT01599234|585269773|FG000|Overall Study|Unable to operate spray|1|||
162057687|NCT01599234|585269774|FG001|Overall Study|Unable to operate spray|0|||
162057688|NCT01599234|585269773|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
162057689|NCT01599234|585269774|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
162057690|NCT01599234|585269773|FG000|Overall Study|Death|1|||
162057691|NCT01599234|585269774|FG001|Overall Study|Death|0|||
162057692|NCT01599234|585269773|FG000|Overall Study|Patient would not stop driving|1|||
162057693|NCT01599234|585269774|FG001|Overall Study|Patient would not stop driving|0|||
162057694|NCT01599234|585269773|FG000|Overall Study|Contra-indication discovered|0|||
162057695|NCT01599234|585269774|FG001|Overall Study|Contra-indication discovered|1|||
162057696|NCT01599234|585269773|FG000|Overall Study|Pregnancy|0|||
162057697|NCT01599234|585269774|FG001|Overall Study|Pregnancy|1|||
162057698|NCT00743340|585269779|FG000|Overall Study|Study medication non-compliance|1|||
162057699|NCT00743340|585269779|FG000|Overall Study|Lost to Follow-up|1|||
162057700|NCT00743340|585269779|FG000|Overall Study|Withdrawal from the Study|5|||
162057701|NCT00743340|585269779|FG000|Overall Study|Protocol Violation|1|||
162057702|NCT00743340|585269779|FG000|Overall Study|Virologic failure|8|||
162057703|NCT00743340|585269779|FG000|Overall Study|Pregnancy|1|||
162057704|NCT00743340|585269779|FG000|Overall Study|Rolled over to other Gilead Study|23|||
162057705|NCT00743340|585269779|FG000|Overall Study|Participant Relocated|1|||
162057706|NCT02708121|585269780|FG000|Overall Study|Withdrawn by Study Team|1|||
162057707|NCT02708121|585269781|FG001|Overall Study|Withdrawn by Study Team|1|||
162057708|NCT02708121|585269780|FG000|Overall Study|Withdrawal by Subject|0|||
162057709|NCT02708121|585269781|FG001|Overall Study|Withdrawal by Subject|4|||
162057710|NCT00127660|585269784|FG000|Overall Study|Protocol Violation|3|||
162057711|NCT00127660|585269785|FG001|Overall Study|Protocol Violation|3|||
162057712|NCT00127660|585269786|FG002|Overall Study|Protocol Violation|5|||
162057713|NCT00127660|585269787|FG003|Overall Study|Protocol Violation|0|||
162057714|NCT01987505|585269788|FG000|Overall Study|Other|9|||
162057715|NCT01987505|585269788|FG000|Overall Study|Withdrawal by Subject|2|||
162057716|NCT01987505|585269788|FG000|Overall Study|Other Reason|2|||
162057717|NCT01987505|585269788|FG000|Overall Study|Lost to Follow-up|15|||
162057718|NCT01987505|585269788|FG000|Overall Study|Investigator Decision|2|||
162057719|NCT01987505|585269788|FG000|Overall Study|Death|4|||
162057720|NCT01425281|585269789|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
162057721|NCT01425281|585269790|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
162057722|NCT01425281|585269789|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
162057723|NCT01425281|585269790|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
162057724|NCT01425281|585269789|FG000|At 180-day Clinical Follow-up|Death|0|||
162057725|NCT01425281|585269790|FG001|At 180-day Clinical Follow-up|Death|1|||
162057726|NCT01425281|585269789|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
162057727|NCT01425281|585269790|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
162057728|NCT01425281|585269789|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
162057729|NCT01425281|585269790|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
162057730|NCT01425281|585269789|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
162057731|NCT01425281|585269790|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
162057732|NCT01425281|585269789|FG000|At 2-year Clinical Follow-up|Death|2|||
162057733|NCT01425281|585269790|FG001|At 2-year Clinical Follow-up|Death|0|||
162057734|NCT01425281|585269789|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
162057735|NCT01425281|585269790|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
162057736|NCT01425281|585269789|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
162057737|NCT01425281|585269790|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
162057738|NCT01425281|585269789|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
162057739|NCT01425281|585269790|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
162057740|NCT01425281|585269789|FG000|At 3-year Clinical Follow-up|Death|2|||
162057741|NCT01425281|585269790|FG001|At 3-year Clinical Follow-up|Death|3|||
162057742|NCT01425281|585269789|FG000|At 4-year Clinical Follow-up|Death|7|||
162057743|NCT01425281|585269790|FG001|At 4-year Clinical Follow-up|Death|3|||
162057744|NCT01425281|585269789|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
162057745|NCT01425281|585269790|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
162057746|NCT01425281|585269789|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
162057747|NCT01425281|585269790|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
162057748|NCT01425281|585269789|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
162057749|NCT01425281|585269790|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
162057750|NCT01425281|585269789|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
162057751|NCT01425281|585269790|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
162057752|NCT01425281|585269789|FG000|At 5-year Clinical Follow-up|Death|2|||
162057753|NCT01425281|585269790|FG001|At 5-year Clinical Follow-up|Death|0|||
162057754|NCT01425281|585269789|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
162057755|NCT01425281|585269790|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
162057756|NCT01425281|585269789|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
162057757|NCT01425281|585269790|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
162057758|NCT01425281|585269789|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
162057759|NCT01425281|585269790|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
162057760|NCT01749514|585269791|FG000|Overall Study|Lost to Follow-up|0|||
162057761|NCT01749514|585269792|FG001|Overall Study|Lost to Follow-up|0|||
162057762|NCT01749514|585269793|FG002|Overall Study|Lost to Follow-up|0|||
162057763|NCT01749514|585269794|FG003|Overall Study|Lost to Follow-up|0|||
162057764|NCT01749514|585269795|FG004|Overall Study|Lost to Follow-up|0|||
162057765|NCT01749514|585269796|FG005|Overall Study|Lost to Follow-up|0|||
162057766|NCT01749514|585269797|FG006|Overall Study|Lost to Follow-up|0|||
162057767|NCT01749514|585269798|FG007|Overall Study|Lost to Follow-up|1|||
162057768|NCT01749514|585269791|FG000|Overall Study|Withdrawal by Subject|0|||
162057769|NCT01749514|585269792|FG001|Overall Study|Withdrawal by Subject|0|||
162057770|NCT01749514|585269793|FG002|Overall Study|Withdrawal by Subject|0|||
162057771|NCT01749514|585269794|FG003|Overall Study|Withdrawal by Subject|0|||
162057772|NCT01749514|585269795|FG004|Overall Study|Withdrawal by Subject|0|||
162057773|NCT01749514|585269796|FG005|Overall Study|Withdrawal by Subject|1|||
162057774|NCT01749514|585269797|FG006|Overall Study|Withdrawal by Subject|0|||
162057775|NCT01749514|585269798|FG007|Overall Study|Withdrawal by Subject|1|||
162057776|NCT01749514|585269791|FG000|Overall Study|Not Reported|0|||
162057777|NCT01749514|585269792|FG001|Overall Study|Not Reported|0|||
162057778|NCT01749514|585269793|FG002|Overall Study|Not Reported|0|||
162057779|NCT01749514|585269794|FG003|Overall Study|Not Reported|0|||
162057780|NCT01749514|585269795|FG004|Overall Study|Not Reported|0|||
162057781|NCT01749514|585269796|FG005|Overall Study|Not Reported|0|||
162057782|NCT01749514|585269797|FG006|Overall Study|Not Reported|0|||
162057783|NCT01749514|585269798|FG007|Overall Study|Not Reported|5|||
162057784|NCT02509156|585269799|FG000|Randomized Phase|Death|1|||
162057785|NCT02509156|585269800|FG001|Randomized Phase|Death|0|||
162057786|NCT02509156|585269799|FG000|Randomized Phase|Withdrawal by Subject|1|||
162057787|NCT02509156|585269800|FG001|Randomized Phase|Withdrawal by Subject|1|||
162057788|NCT05131646|585269801|FG000|Overall Study|Withdrawal by Subject|1|||
162057789|NCT05131646|585269802|FG001|Overall Study|Withdrawal by Subject|0|||
162057790|NCT05131646|585269803|FG002|Overall Study|Withdrawal by Subject|0|||
162057791|NCT02128113|585269804|FG000|Overall Study|Withdrawal by Subject|3|||
162057792|NCT02128113|585269805|FG001|Overall Study|Withdrawal by Subject|1|||
162057793|NCT02128113|585269806|FG002|Overall Study|Withdrawal by Subject|0|||
162057794|NCT02128113|585269804|FG000|Overall Study|Protocol Violation|0|||
162057795|NCT02128113|585269805|FG001|Overall Study|Protocol Violation|1|||
162057796|NCT02128113|585269806|FG002|Overall Study|Protocol Violation|0|||
162057797|NCT02128113|585269804|FG000|Overall Study|Surgery cancelled|0|||
162057798|NCT02128113|585269805|FG001|Overall Study|Surgery cancelled|1|||
162057799|NCT02128113|585269806|FG002|Overall Study|Surgery cancelled|0|||
162057800|NCT02128113|585269804|FG000|Overall Study|Adverse Event|0|||
162057801|NCT02128113|585269805|FG001|Overall Study|Adverse Event|0|||
162057802|NCT02128113|585269806|FG002|Overall Study|Adverse Event|1|||
162057803|NCT01750242|585269807|FG000|Overall Study|Unreadable Images|3|||
162057804|NCT03765918|585269808|FG000|Overall Study|Death|109|||
162057805|NCT03765918|585269809|FG001|Overall Study|Death|127|||
162057806|NCT03765918|585269808|FG000|Overall Study|Lost to Follow-up|2|||
162057807|NCT03765918|585269809|FG001|Overall Study|Lost to Follow-up|3|||
162057808|NCT03765918|585269808|FG000|Overall Study|Withdrawal by Subject|12|||
162057809|NCT03765918|585269809|FG001|Overall Study|Withdrawal by Subject|16|||
162057810|NCT03765918|585269808|FG000|Overall Study|Participants Ongoing|240|||
162057811|NCT03765918|585269809|FG001|Overall Study|Participants Ongoing|205|||
162057812|NCT04202965|585269810|FG000|Overall Study|Adverse Event|3|||
162057813|NCT04202965|585269810|FG000|Overall Study|Did not meet inclusion criteria|1|||
162057814|NCT02969369|585269811|FG000|Study|Adverse Event|1|||
162057815|NCT02969369|585269812|FG001|Study|Adverse Event|6|||
162057816|NCT02969369|585269811|FG000|Study|Lack of Efficacy|0|||
162057817|NCT02969369|585269812|FG001|Study|Lack of Efficacy|1|||
162057818|NCT02969369|585269811|FG000|Study|Lost to Follow-up|0|||
162057819|NCT02969369|585269812|FG001|Study|Lost to Follow-up|1|||
162057820|NCT02969369|585269811|FG000|Study|Withdrawal by Subject|3|||
162057821|NCT02969369|585269812|FG001|Study|Withdrawal by Subject|5|||
162057822|NCT02969369|585269811|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
162057823|NCT02969369|585269812|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
162057824|NCT02969369|585269811|FG000|Double-blind Period|Adverse Event|1|||
162057825|NCT02969369|585269812|FG001|Double-blind Period|Adverse Event|5|||
162057826|NCT02969369|585269811|FG000|Double-blind Period|Lost to Follow-up|0|||
162057827|NCT02969369|585269812|FG001|Double-blind Period|Lost to Follow-up|1|||
162057828|NCT02969369|585269811|FG000|Double-blind Period|Withdrawal by Subject|2|||
162057829|NCT02969369|585269812|FG001|Double-blind Period|Withdrawal by Subject|3|||
162057830|NCT02969369|585269811|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
162057831|NCT02969369|585269812|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
162057832|NCT02969369|585269811|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
162057833|NCT02969369|585269812|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
162057834|NCT02969369|585269811|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
162057835|NCT02969369|585269812|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
162057836|NCT02969369|585269811|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
162057837|NCT02969369|585269812|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
162057838|NCT01980992|585269815|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
162057839|NCT01980992|585269816|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
162057840|NCT01980992|585269815|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
162057841|NCT01980992|585269816|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
162057842|NCT01980992|585269815|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
162057843|NCT01980992|585269816|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
162057844|NCT01980992|585269815|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
162057845|NCT01980992|585269816|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
162057846|NCT01980992|585269815|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
162057847|NCT01980992|585269816|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
162057848|NCT01980992|585269815|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
162057849|NCT01980992|585269816|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
162057850|NCT00299975|585269817|FG000|Overall Study|Adverse Event|1|||
162057851|NCT00299975|585269818|FG001|Overall Study|Adverse Event|0|||
162057852|NCT00299975|585269819|FG002|Overall Study|Adverse Event|2|||
162057853|NCT00299975|585269817|FG000|Overall Study|Pregnancy|0|||
162057854|NCT00299975|585269818|FG001|Overall Study|Pregnancy|0|||
162057855|NCT00299975|585269819|FG002|Overall Study|Pregnancy|1|||
162057856|NCT00299975|585269817|FG000|Overall Study|Lack of Efficacy|1|||
162057857|NCT00299975|585269818|FG001|Overall Study|Lack of Efficacy|0|||
162057858|NCT00299975|585269819|FG002|Overall Study|Lack of Efficacy|1|||
162057859|NCT00299975|585269817|FG000|Overall Study|Lost to Follow-up|1|||
162057860|NCT00299975|585269818|FG001|Overall Study|Lost to Follow-up|0|||
162057861|NCT00299975|585269819|FG002|Overall Study|Lost to Follow-up|0|||
162057862|NCT00299975|585269817|FG000|Overall Study|Withdrawal by Subject|0|||
162057863|NCT00299975|585269818|FG001|Overall Study|Withdrawal by Subject|1|||
162057864|NCT00299975|585269819|FG002|Overall Study|Withdrawal by Subject|3|||
162057865|NCT00299975|585269817|FG000|Overall Study|Physician Decision|0|||
162057866|NCT00299975|585269818|FG001|Overall Study|Physician Decision|0|||
162057867|NCT00299975|585269819|FG002|Overall Study|Physician Decision|1|||
162057868|NCT01169493|585269823|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
162057869|NCT01169493|585269824|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
162057870|NCT01169493|585269825|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
162057871|NCT01169493|585269826|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
162057872|NCT01169493|585269827|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
162057873|NCT01169493|585269828|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
162057874|NCT01169493|585269823|FG000|Period 3 (6 Months)|Adverse Event|0|||
162057875|NCT01169493|585269824|FG001|Period 3 (6 Months)|Adverse Event|1|||
162057876|NCT01169493|585269825|FG002|Period 3 (6 Months)|Adverse Event|0|||
162057877|NCT01169493|585269826|FG003|Period 3 (6 Months)|Adverse Event|0|||
162057878|NCT01169493|585269827|FG004|Period 3 (6 Months)|Adverse Event|0|||
162057879|NCT01169493|585269828|FG005|Period 3 (6 Months)|Adverse Event|0|||
162057880|NCT01169493|585269823|FG000|Period 3 (6 Months)|Physician Decision|0|||
162057881|NCT01169493|585269824|FG001|Period 3 (6 Months)|Physician Decision|1|||
162057882|NCT01169493|585269825|FG002|Period 3 (6 Months)|Physician Decision|1|||
162057883|NCT01169493|585269826|FG003|Period 3 (6 Months)|Physician Decision|0|||
162057884|NCT01169493|585269827|FG004|Period 3 (6 Months)|Physician Decision|0|||
162057885|NCT01169493|585269828|FG005|Period 3 (6 Months)|Physician Decision|0|||
162057886|NCT00211809|585269835|FG000|Overall Study|Lack of Efficacy|1|||
162057887|NCT00211809|585269835|FG000|Overall Study|Lost to Follow-up|2|||
162057888|NCT00211809|585269835|FG000|Overall Study|Pregnancy|1|||
162057889|NCT00211809|585269835|FG000|Overall Study|side effects|2|||
162057890|NCT00036270|585269837|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
162057891|NCT00036270|585269838|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
162057892|NCT00036270|585269837|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
162057893|NCT00036270|585269838|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
162057894|NCT00036270|585269837|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
162057895|NCT00036270|585269838|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
162057896|NCT00036270|585269837|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
162057897|NCT00036270|585269838|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
162057898|NCT00036270|585269837|FG000|Study Treatment to 5 Year Report|Other|277|||
162057899|NCT00036270|585269838|FG001|Study Treatment to 5 Year Report|Other|288|||
162057900|NCT00036270|585269837|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
162057901|NCT00036270|585269838|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
162057902|NCT00036270|585269837|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
162057903|NCT00036270|585269838|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
162057904|NCT00036270|585269837|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
162057905|NCT00036270|585269838|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
162057906|NCT00036270|585269837|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
162057907|NCT00036270|585269838|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
162057908|NCT00036270|585269837|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
162057909|NCT00036270|585269838|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
162057910|NCT00036270|585269837|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
162057911|NCT00036270|585269838|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
162057912|NCT01370356|585269839|FG000|Overall Study|Death|1|||
162057913|NCT01370356|585269840|FG001|Overall Study|Death|0|||
162057914|NCT01370356|585269839|FG000|Overall Study|Lack of Efficacy|6|||
162057915|NCT01370356|585269840|FG001|Overall Study|Lack of Efficacy|28|||
162057916|NCT01370356|585269839|FG000|Overall Study|Lost to Follow-up|76|||
162057917|NCT01370356|585269840|FG001|Overall Study|Lost to Follow-up|81|||
162057918|NCT01370356|585269839|FG000|Overall Study|Withdrawal by Subject|54|||
162057919|NCT01370356|585269840|FG001|Overall Study|Withdrawal by Subject|59|||
162057920|NCT01370356|585269839|FG000|Overall Study|Reason not specified|39|||
162057921|NCT01370356|585269840|FG001|Overall Study|Reason not specified|43|||
162057922|NCT01370356|585269839|FG000|Overall Study|Protocol Violation|3|||
162057923|NCT01370356|585269840|FG001|Overall Study|Protocol Violation|3|||
162057924|NCT01370356|585269839|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
162057925|NCT01370356|585269840|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
162057926|NCT01370356|585269839|FG000|Overall Study|AE Not Related to Study Drug|1|||
162057927|NCT01370356|585269840|FG001|Overall Study|AE Not Related to Study Drug|4|||
162057928|NCT01218243|585269842|FG000|Overall Study|Lack of Efficacy|1|||
162057929|NCT01218243|585269843|FG001|Overall Study|Lack of Efficacy|1|||
162057930|NCT01218243|585269842|FG000|Overall Study|Lost to Follow-up|3|||
162057931|NCT01218243|585269843|FG001|Overall Study|Lost to Follow-up|3|||
162057932|NCT01218243|585269842|FG000|Overall Study|Protocol Violation|5|||
162057933|NCT01218243|585269843|FG001|Overall Study|Protocol Violation|10|||
162057934|NCT00799422|585269847|FG000|First Week of Wear|Lost to Follow-up|0|||
162057935|NCT00799422|585269848|FG001|First Week of Wear|Lost to Follow-up|0|||
162057936|NCT00799422|585269849|FG002|First Week of Wear|Lost to Follow-up|1|||
162057937|NCT00799422|585269850|FG003|First Week of Wear|Lost to Follow-up|0|||
162057938|NCT00799422|585269851|FG004|First Week of Wear|Lost to Follow-up|0|||
162057939|NCT00799422|585269852|FG005|First Week of Wear|Lost to Follow-up|0|||
162057940|NCT00799422|585269847|FG000|First Week of Wear|Adverse Event|0|||
162057941|NCT00799422|585269848|FG001|First Week of Wear|Adverse Event|0|||
162057942|NCT00799422|585269849|FG002|First Week of Wear|Adverse Event|0|||
162057943|NCT00799422|585269850|FG003|First Week of Wear|Adverse Event|1|||
162057944|NCT00799422|585269851|FG004|First Week of Wear|Adverse Event|0|||
162057945|NCT00799422|585269852|FG005|First Week of Wear|Adverse Event|0|||
162057946|NCT01496612|585269853|FG000|1st Intervention|Adverse Event|1|||
162057947|NCT01496612|585269854|FG001|1st Intervention|Adverse Event|0|||
162057948|NCT01496612|585269853|FG000|1st Intervention|Withdrawal by Subject|1|||
162057949|NCT01496612|585269854|FG001|1st Intervention|Withdrawal by Subject|0|||
162057950|NCT03129100|585269856|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
162057951|NCT03129100|585269857|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
162057952|NCT03129100|585269858|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
162057953|NCT03129100|585269859|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
162057954|NCT03129100|585269860|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
162057955|NCT03129100|585269861|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
162057956|NCT03129100|585269862|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
162057957|NCT03129100|585269863|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
162057958|NCT03129100|585269864|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
162057959|NCT03129100|585269865|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
162057960|NCT03129100|585269866|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
162057961|NCT03129100|585269867|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
162057962|NCT03129100|585269868|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
162057963|NCT03129100|585269869|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
162057964|NCT03129100|585269870|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
162057965|NCT03129100|585269871|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
162057966|NCT03129100|585269872|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
162057967|NCT03129100|585269873|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
162057968|NCT03129100|585269874|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
162057969|NCT03129100|585269875|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
162057970|NCT03129100|585269876|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
162057971|NCT03129100|585269877|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
162057972|NCT03129100|585269878|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
162057973|NCT03129100|585269879|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
162057974|NCT03129100|585269880|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
162057975|NCT03129100|585269881|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
162057976|NCT03129100|585269856|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
162057977|NCT03129100|585269857|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057978|NCT03129100|585269858|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057979|NCT03129100|585269859|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057980|NCT03129100|585269860|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057981|NCT03129100|585269861|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057982|NCT03129100|585269862|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057983|NCT03129100|585269863|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057984|NCT03129100|585269864|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057985|NCT03129100|585269865|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057986|NCT03129100|585269866|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057987|NCT03129100|585269867|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057988|NCT03129100|585269868|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057989|NCT03129100|585269869|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057990|NCT03129100|585269870|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057991|NCT03129100|585269871|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057992|NCT03129100|585269872|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057993|NCT03129100|585269873|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057994|NCT03129100|585269874|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057995|NCT03129100|585269875|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057996|NCT03129100|585269876|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057997|NCT03129100|585269877|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057998|NCT03129100|585269878|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162057999|NCT03129100|585269879|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162058000|NCT03129100|585269880|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162058001|NCT03129100|585269881|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
162058002|NCT03129100|585269856|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
162058003|NCT03129100|585269857|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
162058004|NCT03129100|585269858|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058005|NCT03129100|585269859|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058006|NCT03129100|585269860|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058007|NCT03129100|585269861|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058008|NCT03129100|585269862|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058009|NCT03129100|585269863|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058010|NCT03129100|585269864|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058011|NCT03129100|585269865|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058012|NCT03129100|585269866|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058013|NCT03129100|585269867|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058014|NCT03129100|585269868|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058015|NCT03129100|585269869|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058016|NCT03129100|585269870|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058017|NCT03129100|585269871|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058018|NCT03129100|585269872|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058019|NCT03129100|585269873|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058020|NCT03129100|585269874|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058021|NCT03129100|585269875|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058022|NCT03129100|585269876|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058023|NCT03129100|585269877|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058024|NCT03129100|585269878|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162122667|NCT01115491|585500297|FG000|Overall Study|Lost to Follow-up|3|||
162058025|NCT03129100|585269879|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058026|NCT03129100|585269880|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058027|NCT03129100|585269881|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
162058028|NCT03129100|585269856|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
162058029|NCT03129100|585269857|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
162058030|NCT03129100|585269858|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058031|NCT03129100|585269859|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058032|NCT03129100|585269860|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058033|NCT03129100|585269861|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058034|NCT03129100|585269862|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058035|NCT03129100|585269863|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058036|NCT03129100|585269864|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058037|NCT03129100|585269865|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058038|NCT03129100|585269866|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058039|NCT03129100|585269867|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058040|NCT03129100|585269868|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058041|NCT03129100|585269869|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058042|NCT03129100|585269870|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058043|NCT03129100|585269871|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058044|NCT03129100|585269872|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058045|NCT03129100|585269873|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058046|NCT03129100|585269874|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058047|NCT03129100|585269875|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058048|NCT03129100|585269876|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058049|NCT03129100|585269877|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058050|NCT03129100|585269878|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058051|NCT03129100|585269879|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058052|NCT03129100|585269880|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058053|NCT03129100|585269881|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
162058054|NCT03129100|585269856|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058055|NCT03129100|585269857|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
162058056|NCT03129100|585269858|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058057|NCT03129100|585269859|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058058|NCT03129100|585269860|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058059|NCT03129100|585269861|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058060|NCT03129100|585269862|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058061|NCT03129100|585269863|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058062|NCT03129100|585269864|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058063|NCT03129100|585269865|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058064|NCT03129100|585269866|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058065|NCT03129100|585269867|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058066|NCT03129100|585269868|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058067|NCT03129100|585269869|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058068|NCT03129100|585269870|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058069|NCT03129100|585269871|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058070|NCT03129100|585269872|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058071|NCT03129100|585269873|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058072|NCT03129100|585269874|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058073|NCT03129100|585269875|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058074|NCT03129100|585269876|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058075|NCT03129100|585269877|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058076|NCT03129100|585269878|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058077|NCT03129100|585269879|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058078|NCT03129100|585269880|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058079|NCT03129100|585269881|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
162058080|NCT03129100|585269856|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058081|NCT03129100|585269857|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058082|NCT03129100|585269858|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
162058083|NCT03129100|585269859|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
162058084|NCT03129100|585269860|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058085|NCT03129100|585269861|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
162058086|NCT03129100|585269862|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058087|NCT03129100|585269863|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058088|NCT03129100|585269864|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058089|NCT03129100|585269865|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058090|NCT03129100|585269866|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058091|NCT03129100|585269867|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058092|NCT03129100|585269868|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058093|NCT03129100|585269869|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058094|NCT03129100|585269870|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058095|NCT03129100|585269871|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058096|NCT03129100|585269872|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058097|NCT03129100|585269873|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058098|NCT03129100|585269874|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058099|NCT03129100|585269875|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058100|NCT03129100|585269876|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058101|NCT03129100|585269877|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058102|NCT03129100|585269878|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058103|NCT03129100|585269879|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058104|NCT03129100|585269880|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058105|NCT03129100|585269881|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
162058106|NCT03129100|585269856|FG000|Period2 Extension Period (Group A and B)|Death|0|||
162058107|NCT03129100|585269857|FG001|Period2 Extension Period (Group A and B)|Death|0|||
162058108|NCT03129100|585269858|FG002|Period2 Extension Period (Group A and B)|Death|1|||
162058109|NCT03129100|585269859|FG003|Period2 Extension Period (Group A and B)|Death|0|||
162058110|NCT03129100|585269860|FG004|Period2 Extension Period (Group A and B)|Death|0|||
162058111|NCT03129100|585269861|FG005|Period2 Extension Period (Group A and B)|Death|0|||
162058112|NCT03129100|585269862|FG006|Period2 Extension Period (Group A and B)|Death|0|||
162058113|NCT03129100|585269863|FG007|Period2 Extension Period (Group A and B)|Death|0|||
162058114|NCT03129100|585269864|FG008|Period2 Extension Period (Group A and B)|Death|0|||
162058115|NCT03129100|585269865|FG009|Period2 Extension Period (Group A and B)|Death|0|||
162058116|NCT03129100|585269866|FG010|Period2 Extension Period (Group A and B)|Death|0|||
162058117|NCT03129100|585269867|FG011|Period2 Extension Period (Group A and B)|Death|0|||
162058118|NCT03129100|585269868|FG012|Period2 Extension Period (Group A and B)|Death|0|||
162058119|NCT03129100|585269869|FG013|Period2 Extension Period (Group A and B)|Death|0|||
162058120|NCT03129100|585269870|FG014|Period2 Extension Period (Group A and B)|Death|0|||
162058121|NCT03129100|585269871|FG015|Period2 Extension Period (Group A and B)|Death|0|||
162058122|NCT03129100|585269872|FG016|Period2 Extension Period (Group A and B)|Death|0|||
162058123|NCT03129100|585269873|FG017|Period2 Extension Period (Group A and B)|Death|0|||
162058124|NCT03129100|585269874|FG018|Period2 Extension Period (Group A and B)|Death|0|||
162058125|NCT03129100|585269875|FG019|Period2 Extension Period (Group A and B)|Death|0|||
162058126|NCT03129100|585269876|FG020|Period2 Extension Period (Group A and B)|Death|0|||
162058127|NCT03129100|585269877|FG021|Period2 Extension Period (Group A and B)|Death|0|||
162058128|NCT03129100|585269878|FG022|Period2 Extension Period (Group A and B)|Death|0|||
162058129|NCT03129100|585269879|FG023|Period2 Extension Period (Group A and B)|Death|0|||
162058130|NCT03129100|585269880|FG024|Period2 Extension Period (Group A and B)|Death|0|||
162058131|NCT03129100|585269881|FG025|Period2 Extension Period (Group A and B)|Death|0|||
162058132|NCT03129100|585269856|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058133|NCT03129100|585269857|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058134|NCT03129100|585269858|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
162058135|NCT03129100|585269859|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
162058136|NCT03129100|585269860|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
162058137|NCT03129100|585269861|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
162058138|NCT03129100|585269862|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
162058139|NCT03129100|585269863|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058140|NCT03129100|585269864|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058141|NCT03129100|585269865|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058142|NCT03129100|585269866|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058143|NCT03129100|585269867|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058144|NCT03129100|585269868|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058145|NCT03129100|585269869|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058146|NCT03129100|585269870|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058147|NCT03129100|585269871|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058148|NCT03129100|585269872|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058149|NCT03129100|585269873|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058150|NCT03129100|585269874|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058151|NCT03129100|585269875|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058152|NCT03129100|585269876|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058153|NCT03129100|585269877|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058154|NCT03129100|585269878|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058155|NCT03129100|585269879|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058156|NCT03129100|585269880|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058157|NCT03129100|585269881|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
162058158|NCT03129100|585269856|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162237404|NCT00903682|585921091|FG001|Overall Study|Lost to Follow-up|0|||
162058159|NCT03129100|585269857|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058160|NCT03129100|585269858|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
162058161|NCT03129100|585269859|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058162|NCT03129100|585269860|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058163|NCT03129100|585269861|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058164|NCT03129100|585269862|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058165|NCT03129100|585269863|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058166|NCT03129100|585269864|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058167|NCT03129100|585269865|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058168|NCT03129100|585269866|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058169|NCT03129100|585269867|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058170|NCT03129100|585269868|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058171|NCT03129100|585269869|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058172|NCT03129100|585269870|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058173|NCT03129100|585269871|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058174|NCT03129100|585269872|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058175|NCT03129100|585269873|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058176|NCT03129100|585269874|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058177|NCT03129100|585269875|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058178|NCT03129100|585269876|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058179|NCT03129100|585269877|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058180|NCT03129100|585269878|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058181|NCT03129100|585269879|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058182|NCT03129100|585269880|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058183|NCT03129100|585269881|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
162058184|NCT03129100|585269856|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058185|NCT03129100|585269857|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058186|NCT03129100|585269858|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
162058187|NCT03129100|585269859|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058188|NCT03129100|585269860|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058189|NCT03129100|585269861|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058190|NCT03129100|585269862|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058191|NCT03129100|585269863|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058192|NCT03129100|585269864|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058193|NCT03129100|585269865|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058194|NCT03129100|585269866|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058195|NCT03129100|585269867|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058196|NCT03129100|585269868|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058197|NCT03129100|585269869|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058198|NCT03129100|585269870|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058199|NCT03129100|585269871|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058200|NCT03129100|585269872|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058201|NCT03129100|585269873|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058202|NCT03129100|585269874|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058203|NCT03129100|585269875|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058204|NCT03129100|585269876|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058205|NCT03129100|585269877|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058206|NCT03129100|585269878|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058207|NCT03129100|585269879|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058208|NCT03129100|585269880|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058209|NCT03129100|585269881|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
162058210|NCT03129100|585269856|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058211|NCT03129100|585269857|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058212|NCT03129100|585269858|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
162058213|NCT03129100|585269859|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058214|NCT03129100|585269860|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058215|NCT03129100|585269861|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058216|NCT03129100|585269862|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058217|NCT03129100|585269863|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058218|NCT03129100|585269864|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058219|NCT03129100|585269865|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058220|NCT03129100|585269866|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058221|NCT03129100|585269867|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058222|NCT03129100|585269868|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058223|NCT03129100|585269869|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058224|NCT03129100|585269870|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058225|NCT03129100|585269871|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058226|NCT03129100|585269872|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058227|NCT03129100|585269873|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058228|NCT03129100|585269874|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058229|NCT03129100|585269875|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058230|NCT03129100|585269876|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058231|NCT03129100|585269877|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058232|NCT03129100|585269878|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058233|NCT03129100|585269879|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058234|NCT03129100|585269880|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058235|NCT03129100|585269881|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
162058236|NCT03129100|585269856|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058237|NCT03129100|585269857|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058238|NCT03129100|585269858|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058239|NCT03129100|585269859|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058240|NCT03129100|585269860|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
162058241|NCT03129100|585269861|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
162058242|NCT03129100|585269862|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
162058243|NCT03129100|585269863|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058244|NCT03129100|585269864|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058245|NCT03129100|585269865|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058246|NCT03129100|585269866|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058247|NCT03129100|585269867|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058248|NCT03129100|585269868|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058249|NCT03129100|585269869|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058250|NCT03129100|585269870|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058251|NCT03129100|585269871|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058252|NCT03129100|585269872|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058253|NCT03129100|585269873|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058254|NCT03129100|585269874|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058255|NCT03129100|585269875|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058256|NCT03129100|585269876|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058257|NCT03129100|585269877|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058258|NCT03129100|585269878|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058259|NCT03129100|585269879|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058260|NCT03129100|585269880|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058261|NCT03129100|585269881|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
162058262|NCT03129100|585269856|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058263|NCT03129100|585269857|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058264|NCT03129100|585269858|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058265|NCT03129100|585269859|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058266|NCT03129100|585269860|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058267|NCT03129100|585269861|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058268|NCT03129100|585269862|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058269|NCT03129100|585269863|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058270|NCT03129100|585269864|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058271|NCT03129100|585269865|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
162058272|NCT03129100|585269866|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058273|NCT03129100|585269867|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058274|NCT03129100|585269868|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058275|NCT03129100|585269869|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058276|NCT03129100|585269870|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058277|NCT03129100|585269871|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058278|NCT03129100|585269872|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058279|NCT03129100|585269873|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058280|NCT03129100|585269874|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058281|NCT03129100|585269875|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058282|NCT03129100|585269876|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058283|NCT03129100|585269877|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058284|NCT03129100|585269878|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058285|NCT03129100|585269879|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058286|NCT03129100|585269880|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058287|NCT03129100|585269881|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
162058288|NCT03129100|585269856|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058289|NCT03129100|585269857|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058290|NCT03129100|585269858|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058291|NCT03129100|585269859|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058292|NCT03129100|585269860|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058293|NCT03129100|585269861|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058294|NCT03129100|585269862|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058295|NCT03129100|585269863|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058296|NCT03129100|585269864|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058297|NCT03129100|585269865|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058298|NCT03129100|585269866|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058299|NCT03129100|585269867|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
162058300|NCT03129100|585269868|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058301|NCT03129100|585269869|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058302|NCT03129100|585269870|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058303|NCT03129100|585269871|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058304|NCT03129100|585269872|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058305|NCT03129100|585269873|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058306|NCT03129100|585269874|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058307|NCT03129100|585269875|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058308|NCT03129100|585269876|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058309|NCT03129100|585269877|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058310|NCT03129100|585269878|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058311|NCT03129100|585269879|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058312|NCT03129100|585269880|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058313|NCT03129100|585269881|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
162058314|NCT03129100|585269856|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058315|NCT03129100|585269857|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058316|NCT03129100|585269858|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058317|NCT03129100|585269859|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058318|NCT03129100|585269860|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058319|NCT03129100|585269861|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058320|NCT03129100|585269862|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058321|NCT03129100|585269863|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058322|NCT03129100|585269864|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058323|NCT03129100|585269865|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058324|NCT03129100|585269866|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058325|NCT03129100|585269867|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
162058326|NCT03129100|585269868|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
162058327|NCT03129100|585269869|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
162058328|NCT03129100|585269870|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
162058329|NCT03129100|585269871|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058330|NCT03129100|585269872|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058331|NCT03129100|585269873|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058332|NCT03129100|585269874|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058333|NCT03129100|585269875|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058334|NCT03129100|585269876|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058335|NCT03129100|585269877|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058336|NCT03129100|585269878|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058337|NCT03129100|585269879|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058338|NCT03129100|585269880|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058339|NCT03129100|585269881|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
162058340|NCT03129100|585269856|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058341|NCT03129100|585269857|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058342|NCT03129100|585269858|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058343|NCT03129100|585269859|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058344|NCT03129100|585269860|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058345|NCT03129100|585269861|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058346|NCT03129100|585269862|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058347|NCT03129100|585269863|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058348|NCT03129100|585269864|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058349|NCT03129100|585269865|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058350|NCT03129100|585269866|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058351|NCT03129100|585269867|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
162058352|NCT03129100|585269868|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058353|NCT03129100|585269869|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
162058354|NCT03129100|585269870|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
162058355|NCT03129100|585269871|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058356|NCT03129100|585269872|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058357|NCT03129100|585269873|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058358|NCT03129100|585269874|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058359|NCT03129100|585269875|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058360|NCT03129100|585269876|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058361|NCT03129100|585269877|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058362|NCT03129100|585269878|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058363|NCT03129100|585269879|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058364|NCT03129100|585269880|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058365|NCT03129100|585269881|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
162058366|NCT03129100|585269856|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058367|NCT03129100|585269857|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058368|NCT03129100|585269858|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058369|NCT03129100|585269859|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058370|NCT03129100|585269860|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058371|NCT03129100|585269861|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058372|NCT03129100|585269862|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058373|NCT03129100|585269863|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058374|NCT03129100|585269864|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058375|NCT03129100|585269865|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058376|NCT03129100|585269866|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058377|NCT03129100|585269867|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058378|NCT03129100|585269868|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058379|NCT03129100|585269869|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058380|NCT03129100|585269870|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058381|NCT03129100|585269871|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
162058382|NCT03129100|585269872|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058383|NCT03129100|585269873|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058384|NCT03129100|585269874|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058385|NCT03129100|585269875|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058386|NCT03129100|585269876|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058387|NCT03129100|585269877|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058388|NCT03129100|585269878|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058389|NCT03129100|585269879|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058390|NCT03129100|585269880|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058391|NCT03129100|585269881|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
162058392|NCT03129100|585269856|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058393|NCT03129100|585269857|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058394|NCT03129100|585269858|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058395|NCT03129100|585269859|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058396|NCT03129100|585269860|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058397|NCT03129100|585269861|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058398|NCT03129100|585269862|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058399|NCT03129100|585269863|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058400|NCT03129100|585269864|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058401|NCT03129100|585269865|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058402|NCT03129100|585269866|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058403|NCT03129100|585269867|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058404|NCT03129100|585269868|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
162058405|NCT03129100|585269869|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058406|NCT03129100|585269870|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
162058407|NCT03129100|585269871|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
162058408|NCT03129100|585269872|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058409|NCT03129100|585269873|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058410|NCT03129100|585269874|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058411|NCT03129100|585269875|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058412|NCT03129100|585269876|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058413|NCT03129100|585269877|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058414|NCT03129100|585269878|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058415|NCT03129100|585269879|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058416|NCT03129100|585269880|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058417|NCT03129100|585269881|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
162058418|NCT03129100|585269856|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058419|NCT03129100|585269857|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058420|NCT03129100|585269858|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058421|NCT03129100|585269859|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058422|NCT03129100|585269860|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058423|NCT03129100|585269861|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058424|NCT03129100|585269862|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058425|NCT03129100|585269863|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058426|NCT03129100|585269864|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058427|NCT03129100|585269865|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058428|NCT03129100|585269866|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058429|NCT03129100|585269867|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058430|NCT03129100|585269868|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058431|NCT03129100|585269869|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058432|NCT03129100|585269870|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058433|NCT03129100|585269871|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058434|NCT03129100|585269872|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058435|NCT03129100|585269873|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
162058436|NCT03129100|585269874|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058437|NCT03129100|585269875|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
162058438|NCT03129100|585269876|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058439|NCT03129100|585269877|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058440|NCT03129100|585269878|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058441|NCT03129100|585269879|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058442|NCT03129100|585269880|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058443|NCT03129100|585269881|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
162058444|NCT03129100|585269856|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058445|NCT03129100|585269857|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058446|NCT03129100|585269858|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058447|NCT03129100|585269859|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058448|NCT03129100|585269860|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058449|NCT03129100|585269861|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058450|NCT03129100|585269862|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058451|NCT03129100|585269863|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058452|NCT03129100|585269864|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058453|NCT03129100|585269865|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058454|NCT03129100|585269866|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058455|NCT03129100|585269867|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058456|NCT03129100|585269868|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058457|NCT03129100|585269869|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058458|NCT03129100|585269870|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058459|NCT03129100|585269871|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058460|NCT03129100|585269872|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058461|NCT03129100|585269873|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058462|NCT03129100|585269874|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058463|NCT03129100|585269875|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058464|NCT03129100|585269876|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
162058465|NCT03129100|585269877|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058466|NCT03129100|585269878|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058467|NCT03129100|585269879|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058468|NCT03129100|585269880|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058469|NCT03129100|585269881|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
162058470|NCT03129100|585269856|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
162058471|NCT03129100|585269857|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
162058472|NCT03129100|585269858|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
162058473|NCT03129100|585269859|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
162058474|NCT03129100|585269860|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
162058475|NCT03129100|585269861|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
162058476|NCT03129100|585269862|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
162058477|NCT03129100|585269863|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
162058478|NCT03129100|585269864|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
162058479|NCT03129100|585269865|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
162058480|NCT03129100|585269866|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
162058481|NCT03129100|585269867|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
162058482|NCT03129100|585269868|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
162058483|NCT03129100|585269869|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
162058484|NCT03129100|585269870|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
162058485|NCT03129100|585269871|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
162058486|NCT03129100|585269872|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
162058487|NCT03129100|585269873|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
162058488|NCT03129100|585269874|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
162058489|NCT03129100|585269875|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
162058490|NCT03129100|585269876|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
162058491|NCT03129100|585269877|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
162058492|NCT03129100|585269878|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
162058493|NCT03129100|585269879|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
162058494|NCT03129100|585269880|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
162058495|NCT03129100|585269881|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
162058496|NCT03129100|585269856|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058497|NCT03129100|585269857|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058498|NCT03129100|585269858|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058499|NCT03129100|585269859|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058500|NCT03129100|585269860|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058501|NCT03129100|585269861|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058502|NCT03129100|585269862|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058503|NCT03129100|585269863|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058504|NCT03129100|585269864|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058505|NCT03129100|585269865|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058506|NCT03129100|585269866|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058507|NCT03129100|585269867|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058508|NCT03129100|585269868|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058509|NCT03129100|585269869|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058510|NCT03129100|585269870|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058511|NCT03129100|585269871|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058512|NCT03129100|585269872|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058513|NCT03129100|585269873|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058514|NCT03129100|585269874|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058515|NCT03129100|585269875|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058516|NCT03129100|585269876|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
162058517|NCT03129100|585269877|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058518|NCT03129100|585269878|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058519|NCT03129100|585269879|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058520|NCT03129100|585269880|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058521|NCT03129100|585269881|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
162058522|NCT03129100|585269856|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
162058523|NCT03129100|585269857|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
162058524|NCT03129100|585269858|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
162058525|NCT03129100|585269859|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
162058526|NCT03129100|585269860|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
162058527|NCT03129100|585269861|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
162058528|NCT03129100|585269862|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
162058529|NCT03129100|585269863|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
162058530|NCT03129100|585269864|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
162058531|NCT03129100|585269865|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
162058532|NCT03129100|585269866|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
162058533|NCT03129100|585269867|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
162058534|NCT03129100|585269868|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
162058535|NCT03129100|585269869|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
162058536|NCT03129100|585269870|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
162058537|NCT03129100|585269871|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
162058538|NCT03129100|585269872|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
162058539|NCT03129100|585269873|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
162058540|NCT03129100|585269874|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
162058541|NCT03129100|585269875|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
162058542|NCT03129100|585269876|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
162058543|NCT03129100|585269877|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
162058544|NCT03129100|585269878|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
162058545|NCT03129100|585269879|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
162058546|NCT03129100|585269880|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
162058547|NCT03129100|585269881|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
162058548|NCT03129100|585269856|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058549|NCT03129100|585269857|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058550|NCT03129100|585269858|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058551|NCT03129100|585269859|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058552|NCT03129100|585269860|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058553|NCT03129100|585269861|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058554|NCT03129100|585269862|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058555|NCT03129100|585269863|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058556|NCT03129100|585269864|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058557|NCT03129100|585269865|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058558|NCT03129100|585269866|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058559|NCT03129100|585269867|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058560|NCT03129100|585269868|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058561|NCT03129100|585269869|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058562|NCT03129100|585269870|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058563|NCT03129100|585269871|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058564|NCT03129100|585269872|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058565|NCT03129100|585269873|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058566|NCT03129100|585269874|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058567|NCT03129100|585269875|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058568|NCT03129100|585269876|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058569|NCT03129100|585269877|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058570|NCT03129100|585269878|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058571|NCT03129100|585269879|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
162058572|NCT03129100|585269880|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
162058573|NCT03129100|585269881|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
162058574|NCT03129100|585269856|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058575|NCT03129100|585269857|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058576|NCT03129100|585269858|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058577|NCT03129100|585269859|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058578|NCT03129100|585269860|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058579|NCT03129100|585269861|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058580|NCT03129100|585269862|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058581|NCT03129100|585269863|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058582|NCT03129100|585269864|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058583|NCT03129100|585269865|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058584|NCT03129100|585269866|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058585|NCT03129100|585269867|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058586|NCT03129100|585269868|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058587|NCT03129100|585269869|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058588|NCT03129100|585269870|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058589|NCT03129100|585269871|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058590|NCT03129100|585269872|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058591|NCT03129100|585269873|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058592|NCT03129100|585269874|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058593|NCT03129100|585269875|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058594|NCT03129100|585269876|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058595|NCT03129100|585269877|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058596|NCT03129100|585269878|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
162058597|NCT03129100|585269879|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
162058598|NCT03129100|585269880|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
162058599|NCT03129100|585269881|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
162058600|NCT03129100|585269856|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058601|NCT03129100|585269857|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058602|NCT03129100|585269858|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058603|NCT03129100|585269859|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058604|NCT03129100|585269860|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058605|NCT03129100|585269861|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058606|NCT03129100|585269862|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058607|NCT03129100|585269863|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058608|NCT03129100|585269864|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058609|NCT03129100|585269865|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058610|NCT03129100|585269866|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058611|NCT03129100|585269867|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058612|NCT03129100|585269868|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058613|NCT03129100|585269869|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058614|NCT03129100|585269870|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058615|NCT03129100|585269871|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058616|NCT03129100|585269872|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058617|NCT03129100|585269873|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058618|NCT03129100|585269874|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058619|NCT03129100|585269875|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058620|NCT03129100|585269876|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058621|NCT03129100|585269877|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058622|NCT03129100|585269878|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058623|NCT03129100|585269879|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058624|NCT03129100|585269880|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
162058625|NCT03129100|585269881|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
162058626|NCT03129100|585269856|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058627|NCT03129100|585269857|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058628|NCT03129100|585269858|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058629|NCT03129100|585269859|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058630|NCT03129100|585269860|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058631|NCT03129100|585269861|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058632|NCT03129100|585269862|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058633|NCT03129100|585269863|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058634|NCT03129100|585269864|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058635|NCT03129100|585269865|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058636|NCT03129100|585269866|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058637|NCT03129100|585269867|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058638|NCT03129100|585269868|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058639|NCT03129100|585269869|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058640|NCT03129100|585269870|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058641|NCT03129100|585269871|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058642|NCT03129100|585269872|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058643|NCT03129100|585269873|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058644|NCT03129100|585269874|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058645|NCT03129100|585269875|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058646|NCT03129100|585269876|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058647|NCT03129100|585269877|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058648|NCT03129100|585269878|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058649|NCT03129100|585269879|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058650|NCT03129100|585269880|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
162058651|NCT03129100|585269881|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
162058652|NCT03129100|585269856|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
162058653|NCT03129100|585269857|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
162058654|NCT03129100|585269858|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
162058655|NCT03129100|585269859|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
162058656|NCT03129100|585269860|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
162058657|NCT03129100|585269861|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
162058658|NCT03129100|585269862|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
162058659|NCT03129100|585269863|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
162058660|NCT03129100|585269864|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
162058661|NCT03129100|585269865|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
162058662|NCT03129100|585269866|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
162058663|NCT03129100|585269867|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
162058664|NCT03129100|585269868|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
162058665|NCT03129100|585269869|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
162058666|NCT03129100|585269870|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
162058667|NCT03129100|585269871|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
162058668|NCT03129100|585269872|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
162058669|NCT03129100|585269873|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
162058670|NCT03129100|585269874|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
162058671|NCT03129100|585269875|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
162058672|NCT03129100|585269876|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
162058673|NCT03129100|585269877|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
162058674|NCT03129100|585269878|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
162058675|NCT03129100|585269879|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
162058676|NCT03129100|585269880|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
162058677|NCT03129100|585269881|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
162058678|NCT03708328|585269884|FG000|Overall Study|Death|3|||
162058679|NCT03708328|585269885|FG001|Overall Study|Death|3|||
162058680|NCT03708328|585269886|FG002|Overall Study|Death|4|||
162058681|NCT03708328|585269887|FG003|Overall Study|Death|2|||
162058682|NCT03708328|585269888|FG004|Overall Study|Death|2|||
162058683|NCT03708328|585269889|FG005|Overall Study|Death|13|||
162058684|NCT03708328|585269890|FG006|Overall Study|Death|26|||
162058685|NCT03708328|585269891|FG007|Overall Study|Death|18|||
162058686|NCT03708328|585269892|FG008|Overall Study|Death|13|||
162058687|NCT03708328|585269893|FG009|Overall Study|Death|8|||
162058688|NCT03708328|585269884|FG000|Overall Study|Lost to Follow-up|0|||
162058689|NCT03708328|585269885|FG001|Overall Study|Lost to Follow-up|1|||
162058690|NCT03708328|585269886|FG002|Overall Study|Lost to Follow-up|0|||
162058691|NCT03708328|585269887|FG003|Overall Study|Lost to Follow-up|1|||
162058692|NCT03708328|585269888|FG004|Overall Study|Lost to Follow-up|0|||
162058693|NCT03708328|585269889|FG005|Overall Study|Lost to Follow-up|3|||
162058694|NCT03708328|585269890|FG006|Overall Study|Lost to Follow-up|3|||
162058695|NCT03708328|585269891|FG007|Overall Study|Lost to Follow-up|0|||
162058696|NCT03708328|585269892|FG008|Overall Study|Lost to Follow-up|0|||
162058697|NCT03708328|585269893|FG009|Overall Study|Lost to Follow-up|1|||
162058698|NCT03708328|585269884|FG000|Overall Study|Physician Decision|0|||
162058699|NCT03708328|585269885|FG001|Overall Study|Physician Decision|0|||
162058700|NCT03708328|585269886|FG002|Overall Study|Physician Decision|0|||
162058701|NCT03708328|585269887|FG003|Overall Study|Physician Decision|0|||
162058702|NCT03708328|585269888|FG004|Overall Study|Physician Decision|0|||
162058703|NCT03708328|585269889|FG005|Overall Study|Physician Decision|1|||
162058704|NCT03708328|585269890|FG006|Overall Study|Physician Decision|0|||
162058705|NCT03708328|585269891|FG007|Overall Study|Physician Decision|0|||
162058706|NCT03708328|585269892|FG008|Overall Study|Physician Decision|0|||
162058707|NCT03708328|585269893|FG009|Overall Study|Physician Decision|0|||
162058708|NCT03708328|585269884|FG000|Overall Study|Withdrawal by Subject|0|||
162058709|NCT03708328|585269885|FG001|Overall Study|Withdrawal by Subject|0|||
162058710|NCT03708328|585269886|FG002|Overall Study|Withdrawal by Subject|0|||
162058711|NCT03708328|585269887|FG003|Overall Study|Withdrawal by Subject|0|||
162058712|NCT03708328|585269888|FG004|Overall Study|Withdrawal by Subject|1|||
162058713|NCT03708328|585269889|FG005|Overall Study|Withdrawal by Subject|0|||
162058714|NCT03708328|585269890|FG006|Overall Study|Withdrawal by Subject|2|||
162058715|NCT03708328|585269891|FG007|Overall Study|Withdrawal by Subject|4|||
162058716|NCT03708328|585269892|FG008|Overall Study|Withdrawal by Subject|1|||
162058717|NCT03708328|585269893|FG009|Overall Study|Withdrawal by Subject|5|||
162058718|NCT03708328|585269884|FG000|Overall Study|Study Closed Locally|0|||
162058719|NCT03708328|585269885|FG001|Overall Study|Study Closed Locally|0|||
162058720|NCT03708328|585269886|FG002|Overall Study|Study Closed Locally|0|||
162058721|NCT03708328|585269887|FG003|Overall Study|Study Closed Locally|0|||
162058722|NCT03708328|585269888|FG004|Overall Study|Study Closed Locally|0|||
162058723|NCT03708328|585269889|FG005|Overall Study|Study Closed Locally|0|||
162058724|NCT03708328|585269890|FG006|Overall Study|Study Closed Locally|0|||
162058725|NCT03708328|585269891|FG007|Overall Study|Study Closed Locally|1|||
162058726|NCT03708328|585269892|FG008|Overall Study|Study Closed Locally|0|||
162058727|NCT03708328|585269893|FG009|Overall Study|Study Closed Locally|0|||
162058728|NCT03708328|585269884|FG000|Overall Study|Study Ended By Sponsor|0|||
162058729|NCT03708328|585269885|FG001|Overall Study|Study Ended By Sponsor|0|||
162058730|NCT03708328|585269886|FG002|Overall Study|Study Ended By Sponsor|0|||
162058731|NCT03708328|585269887|FG003|Overall Study|Study Ended By Sponsor|0|||
162058732|NCT03708328|585269888|FG004|Overall Study|Study Ended By Sponsor|0|||
162058733|NCT03708328|585269889|FG005|Overall Study|Study Ended By Sponsor|1|||
162058734|NCT03708328|585269890|FG006|Overall Study|Study Ended By Sponsor|0|||
162058735|NCT03708328|585269891|FG007|Overall Study|Study Ended By Sponsor|1|||
162058736|NCT03708328|585269892|FG008|Overall Study|Study Ended By Sponsor|0|||
162058737|NCT03708328|585269893|FG009|Overall Study|Study Ended By Sponsor|0|||
162058738|NCT03708328|585269884|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162058739|NCT03708328|585269885|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162058740|NCT03708328|585269886|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162058741|NCT03708328|585269887|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162058742|NCT03708328|585269888|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162058743|NCT03708328|585269889|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162058744|NCT03708328|585269890|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162058745|NCT03708328|585269891|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162058746|NCT03708328|585269892|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
162058747|NCT03708328|585269893|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
162058748|NCT00571948|585269894|FG000|Overall Study|Lost to Follow-up|2|||
162058749|NCT00571948|585269895|FG001|Overall Study|Lost to Follow-up|0|||
162058750|NCT00571948|585269894|FG000|Overall Study|Withdrawal by Subject|1|||
162058751|NCT00571948|585269895|FG001|Overall Study|Withdrawal by Subject|2|||
162058752|NCT00571948|585269894|FG000|Overall Study|Protocol Violation|3|||
162058753|NCT00571948|585269895|FG001|Overall Study|Protocol Violation|3|||
162058754|NCT00571948|585269894|FG000|Overall Study|infant refused study meal|3|||
162058755|NCT00571948|585269895|FG001|Overall Study|infant refused study meal|4|||
162058756|NCT00571948|585269894|FG000|Overall Study|Parent were afraid of blood colection|2|||
162058757|NCT00571948|585269895|FG001|Overall Study|Parent were afraid of blood colection|5|||
162058758|NCT01845831|585269897|FG000|Inpatient Phase|Withdrawal by Subject|1|||
162058759|NCT01845831|585269898|FG001|Inpatient Phase|Withdrawal by Subject|1|||
162058760|NCT01845831|585269899|FG002|Inpatient Phase|Withdrawal by Subject|0|||
162058761|NCT01845831|585269900|FG003|Inpatient Phase|Withdrawal by Subject|0|||
162058762|NCT01845831|585269901|FG004|Inpatient Phase|Withdrawal by Subject|0|||
162058763|NCT02010775|585269902|FG000|Overall Study|Adverse Event|0|||
162058764|NCT02010775|585269903|FG001|Overall Study|Adverse Event|0|||
162058765|NCT02010775|585269904|FG002|Overall Study|Adverse Event|0|||
162058766|NCT02010775|585269905|FG003|Overall Study|Adverse Event|0|||
162058767|NCT02010775|585269906|FG004|Overall Study|Adverse Event|1|||
162058768|NCT02010775|585269902|FG000|Overall Study|Pregnancy|0|||
162058769|NCT02010775|585269903|FG001|Overall Study|Pregnancy|0|||
162058770|NCT02010775|585269904|FG002|Overall Study|Pregnancy|2|||
162058771|NCT02010775|585269905|FG003|Overall Study|Pregnancy|0|||
162058772|NCT02010775|585269906|FG004|Overall Study|Pregnancy|0|||
162058773|NCT02010775|585269902|FG000|Overall Study|Lost to Follow-up|2|||
162058774|NCT02010775|585269903|FG001|Overall Study|Lost to Follow-up|0|||
162058775|NCT02010775|585269904|FG002|Overall Study|Lost to Follow-up|0|||
162058776|NCT02010775|585269905|FG003|Overall Study|Lost to Follow-up|1|||
162058777|NCT02010775|585269906|FG004|Overall Study|Lost to Follow-up|1|||
162058778|NCT02010775|585269902|FG000|Overall Study|Personal Reasons|3|||
162058779|NCT02010775|585269903|FG001|Overall Study|Personal Reasons|3|||
162058780|NCT02010775|585269904|FG002|Overall Study|Personal Reasons|1|||
162058781|NCT02010775|585269905|FG003|Overall Study|Personal Reasons|2|||
162058782|NCT02010775|585269906|FG004|Overall Study|Personal Reasons|4|||
162058783|NCT02030041|585269907|FG000|Overall Study|Withdrawal by Subject|2|||
162058784|NCT02030041|585269908|FG001|Overall Study|Withdrawal by Subject|2|||
162058785|NCT02030041|585269909|FG002|Overall Study|Withdrawal by Subject|1|||
162058786|NCT02006719|585269911|FG000|Overall Study|Withdrawal by Subject|10|||
162058787|NCT02006719|585269912|FG001|Overall Study|Withdrawal by Subject|2|||
162058788|NCT02006719|585269911|FG000|Overall Study|Lost to Follow-up|5|||
162058789|NCT02006719|585269912|FG001|Overall Study|Lost to Follow-up|1|||
162058790|NCT02006719|585269911|FG000|Overall Study|Protocol Violation|2|||
162058791|NCT02006719|585269912|FG001|Overall Study|Protocol Violation|0|||
162058792|NCT02006719|585269911|FG000|Overall Study|Adverse Event|1|||
162058793|NCT02006719|585269912|FG001|Overall Study|Adverse Event|1|||
162058794|NCT02006719|585269911|FG000|Overall Study|Other/Unknown|0|||
162058795|NCT02006719|585269912|FG001|Overall Study|Other/Unknown|1|||
162058796|NCT02207244|585269913|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
162058797|NCT02207244|585269914|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
162058798|NCT02207244|585269915|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
162058799|NCT02207244|585269916|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162058800|NCT02207244|585269917|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162058801|NCT02207244|585269918|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162058802|NCT02207244|585269919|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162058803|NCT02207244|585269920|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162058804|NCT02207244|585269921|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162058805|NCT02207244|585269922|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162058806|NCT02207244|585269923|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
162058807|NCT02207244|585269913|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
162058808|NCT02207244|585269914|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162058809|NCT02207244|585269915|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
162058810|NCT02207244|585269916|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162058811|NCT02207244|585269917|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162058812|NCT02207244|585269918|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162058813|NCT02207244|585269919|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162058814|NCT02207244|585269920|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162058815|NCT02207244|585269921|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162058816|NCT02207244|585269922|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162058817|NCT02207244|585269923|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
162058818|NCT02207244|585269913|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
162058819|NCT02207244|585269914|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
162058820|NCT02207244|585269915|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
162058821|NCT02207244|585269916|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162058822|NCT02207244|585269917|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162058823|NCT02207244|585269918|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162058824|NCT02207244|585269919|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162058825|NCT02207244|585269920|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162058826|NCT02207244|585269921|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162058827|NCT02207244|585269922|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162058828|NCT02207244|585269923|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
162058829|NCT02207244|585269913|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
162058830|NCT02207244|585269914|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
162058831|NCT02207244|585269915|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162058832|NCT02207244|585269916|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162058833|NCT02207244|585269917|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162058834|NCT02207244|585269918|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162058835|NCT02207244|585269919|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162058836|NCT02207244|585269920|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162058837|NCT02207244|585269921|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162058838|NCT02207244|585269922|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162058839|NCT02207244|585269923|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
162058840|NCT02207244|585269913|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
162058841|NCT02207244|585269914|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
162058842|NCT02207244|585269915|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
162058843|NCT02207244|585269916|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162058844|NCT02207244|585269917|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162058845|NCT02207244|585269918|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162058846|NCT02207244|585269919|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162058847|NCT02207244|585269920|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162058848|NCT02207244|585269921|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162058849|NCT02207244|585269922|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162058850|NCT02207244|585269923|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
162058851|NCT02207244|585269913|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162058852|NCT02207244|585269914|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
162058853|NCT02207244|585269915|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
162058854|NCT02207244|585269916|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162058855|NCT02207244|585269917|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162058856|NCT02207244|585269918|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162058857|NCT02207244|585269919|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162058858|NCT02207244|585269920|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162058859|NCT02207244|585269921|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162058860|NCT02207244|585269922|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162058861|NCT02207244|585269923|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
162058862|NCT02207244|585269913|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
162058863|NCT02207244|585269914|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
162058864|NCT02207244|585269915|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
162058865|NCT02207244|585269916|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
162058866|NCT02207244|585269917|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
162058867|NCT02207244|585269918|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
162058868|NCT02207244|585269919|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
162058869|NCT02207244|585269920|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
162058870|NCT02207244|585269921|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
162058871|NCT02207244|585269922|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
162058872|NCT02207244|585269923|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
162058873|NCT02207244|585269913|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162058874|NCT02207244|585269914|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162058875|NCT02207244|585269915|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162058876|NCT02207244|585269916|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162058877|NCT02207244|585269917|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
162058878|NCT02207244|585269918|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
162058879|NCT02207244|585269919|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162058880|NCT02207244|585269920|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162058881|NCT02207244|585269921|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162058882|NCT02207244|585269922|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162058883|NCT02207244|585269923|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
162058884|NCT02207244|585269913|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162058885|NCT02207244|585269914|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162058886|NCT02207244|585269915|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162058887|NCT02207244|585269916|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162058888|NCT02207244|585269917|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162058889|NCT02207244|585269918|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
162058890|NCT02207244|585269919|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162058891|NCT02207244|585269920|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162058892|NCT02207244|585269921|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162058893|NCT02207244|585269922|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162058894|NCT02207244|585269923|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
162058895|NCT02207244|585269913|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162058896|NCT02207244|585269914|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162058897|NCT02207244|585269915|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162058898|NCT02207244|585269916|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
162058899|NCT02207244|585269917|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
162058900|NCT02207244|585269918|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
162058901|NCT02207244|585269919|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162058902|NCT02207244|585269920|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162058903|NCT02207244|585269921|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162058904|NCT02207244|585269922|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162058905|NCT02207244|585269923|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
162058906|NCT02207244|585269913|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162058907|NCT02207244|585269914|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162058908|NCT02207244|585269915|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162058909|NCT02207244|585269916|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
162058910|NCT02207244|585269917|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
162058911|NCT02207244|585269918|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
162058912|NCT02207244|585269919|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162058913|NCT02207244|585269920|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162058914|NCT02207244|585269921|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162058915|NCT02207244|585269922|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162058916|NCT02207244|585269923|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
162058917|NCT02207244|585269913|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162058918|NCT02207244|585269914|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162058919|NCT02207244|585269915|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162058920|NCT02207244|585269916|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
162058921|NCT02207244|585269917|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162058922|NCT02207244|585269918|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
162058923|NCT02207244|585269919|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162058924|NCT02207244|585269920|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162058925|NCT02207244|585269921|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162058926|NCT02207244|585269922|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162058927|NCT02207244|585269923|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
162058928|NCT02207244|585269913|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
162058929|NCT02207244|585269914|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
162058930|NCT02207244|585269915|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
162058931|NCT02207244|585269916|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
162058932|NCT02207244|585269917|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
162058933|NCT02207244|585269918|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
162058934|NCT02207244|585269919|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
162058935|NCT02207244|585269920|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
162058936|NCT02207244|585269921|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
162058937|NCT02207244|585269922|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
162058938|NCT02207244|585269923|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
162058939|NCT02207244|585269913|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162058940|NCT02207244|585269914|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162058941|NCT02207244|585269915|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162058942|NCT02207244|585269916|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162058943|NCT02207244|585269917|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162058944|NCT02207244|585269918|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162058945|NCT02207244|585269919|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
162058946|NCT02207244|585269920|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
162058947|NCT02207244|585269921|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
162058948|NCT02207244|585269922|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
162058949|NCT02207244|585269923|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
162058950|NCT02207244|585269913|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162058951|NCT02207244|585269914|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162058952|NCT02207244|585269915|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162058953|NCT02207244|585269916|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162058954|NCT02207244|585269917|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162058955|NCT02207244|585269918|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162058956|NCT02207244|585269919|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162058957|NCT02207244|585269920|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
162058958|NCT02207244|585269921|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162058959|NCT02207244|585269922|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162058960|NCT02207244|585269923|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
162058961|NCT02207244|585269913|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162058962|NCT02207244|585269914|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162058963|NCT02207244|585269915|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162058964|NCT02207244|585269916|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162058965|NCT02207244|585269917|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162058966|NCT02207244|585269918|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162058967|NCT02207244|585269919|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
162058968|NCT02207244|585269920|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
162058969|NCT02207244|585269921|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
162058970|NCT02207244|585269922|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
162058971|NCT02207244|585269923|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
162058972|NCT02207244|585269913|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162058973|NCT02207244|585269914|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162058974|NCT02207244|585269915|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162058975|NCT02207244|585269916|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162058976|NCT02207244|585269917|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162058977|NCT02207244|585269918|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162058978|NCT02207244|585269919|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
162058979|NCT02207244|585269920|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
162058980|NCT02207244|585269921|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162058981|NCT02207244|585269922|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
162058982|NCT02207244|585269923|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
162058983|NCT02207244|585269913|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162058984|NCT02207244|585269914|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162058985|NCT02207244|585269915|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162058986|NCT02207244|585269916|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162058987|NCT02207244|585269917|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162058988|NCT02207244|585269918|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162058989|NCT02207244|585269919|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
162058990|NCT02207244|585269920|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
162058991|NCT02207244|585269921|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
162058992|NCT02207244|585269922|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
162058993|NCT02207244|585269923|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
162058994|NCT02207244|585269913|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162058995|NCT02207244|585269914|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162058996|NCT02207244|585269915|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162058997|NCT02207244|585269916|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162058998|NCT02207244|585269917|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162058999|NCT02207244|585269918|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162059000|NCT02207244|585269919|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162059001|NCT02207244|585269920|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
162059002|NCT02207244|585269921|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
162059003|NCT02207244|585269922|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162059004|NCT02207244|585269923|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
162059005|NCT02207244|585269913|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162059006|NCT02207244|585269914|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162059007|NCT02207244|585269915|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162059008|NCT02207244|585269916|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162059009|NCT02207244|585269917|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162059010|NCT02207244|585269918|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162059011|NCT02207244|585269919|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162059012|NCT02207244|585269920|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162059013|NCT02207244|585269921|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
162059014|NCT02207244|585269922|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162059015|NCT02207244|585269923|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
162059016|NCT02207244|585269913|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162059017|NCT02207244|585269914|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162059018|NCT02207244|585269915|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162059019|NCT02207244|585269916|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162059020|NCT02207244|585269917|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162059021|NCT02207244|585269918|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162059022|NCT02207244|585269919|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162059023|NCT02207244|585269920|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
162059024|NCT02207244|585269921|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162059025|NCT02207244|585269922|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162059026|NCT02207244|585269923|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
162059027|NCT02207244|585269913|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162059028|NCT02207244|585269914|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162059029|NCT02207244|585269915|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162059030|NCT02207244|585269916|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162059031|NCT02207244|585269917|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162059032|NCT02207244|585269918|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162059033|NCT02207244|585269919|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
162059034|NCT02207244|585269920|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162059035|NCT02207244|585269921|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162059036|NCT02207244|585269922|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162059037|NCT02207244|585269923|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
162059038|NCT02207244|585269913|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162059039|NCT02207244|585269914|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162059040|NCT02207244|585269915|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162059041|NCT02207244|585269916|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162059042|NCT02207244|585269917|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162059043|NCT02207244|585269918|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162059044|NCT02207244|585269919|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162059045|NCT02207244|585269920|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162059046|NCT02207244|585269921|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
162059047|NCT02207244|585269922|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
162059048|NCT02207244|585269923|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
162059049|NCT02207244|585269913|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162059050|NCT02207244|585269914|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162059051|NCT02207244|585269915|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162059052|NCT02207244|585269916|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162059053|NCT02207244|585269917|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162059054|NCT02207244|585269918|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162059055|NCT02207244|585269919|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162059056|NCT02207244|585269920|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162059057|NCT02207244|585269921|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
162059058|NCT02207244|585269922|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
162059059|NCT02207244|585269923|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
162059060|NCT02207244|585269913|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162059061|NCT02207244|585269914|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162059062|NCT02207244|585269915|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162059063|NCT02207244|585269916|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162059064|NCT02207244|585269917|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162059065|NCT02207244|585269918|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162059066|NCT02207244|585269919|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162059067|NCT02207244|585269920|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162059068|NCT02207244|585269921|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
162059069|NCT02207244|585269922|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
162059070|NCT02207244|585269923|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
162059071|NCT02207244|585269913|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162059072|NCT02207244|585269914|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162059073|NCT02207244|585269915|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162059074|NCT02207244|585269916|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162059075|NCT02207244|585269917|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162059076|NCT02207244|585269918|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162059077|NCT02207244|585269919|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162059078|NCT02207244|585269920|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162059079|NCT02207244|585269921|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
162059080|NCT02207244|585269922|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
162059081|NCT02207244|585269923|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
162059082|NCT02207244|585269913|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
162059083|NCT02207244|585269914|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
162059084|NCT02207244|585269915|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
162059085|NCT02207244|585269916|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
162059086|NCT02207244|585269917|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
162059087|NCT02207244|585269918|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
162059088|NCT02207244|585269919|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
162059089|NCT02207244|585269920|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
162059090|NCT02207244|585269921|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
162059091|NCT02207244|585269922|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
162059092|NCT02207244|585269923|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
162059093|NCT02207244|585269913|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
162059094|NCT02207244|585269914|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
162059095|NCT02207244|585269915|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
162059096|NCT02207244|585269916|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
162059097|NCT02207244|585269917|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
162059098|NCT02207244|585269918|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
162059099|NCT02207244|585269919|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
162059100|NCT02207244|585269920|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
162059101|NCT02207244|585269921|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
162059102|NCT02207244|585269922|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
162059103|NCT02207244|585269923|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
162059104|NCT02207244|585269913|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162059105|NCT02207244|585269914|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162059106|NCT02207244|585269915|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162059107|NCT02207244|585269916|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162059108|NCT02207244|585269917|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162059109|NCT02207244|585269918|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162059110|NCT02207244|585269919|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162059111|NCT02207244|585269920|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162059112|NCT02207244|585269921|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162059113|NCT02207244|585269922|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
162059114|NCT02207244|585269923|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
162059115|NCT01866930|585269929|FG000|Treatment Period|Other|1|||
162059116|NCT01866930|585269930|FG001|Treatment Period|Other|0|||
162059117|NCT01866930|585269929|FG000|Treatment Period|Death|0|||
162059118|NCT01866930|585269930|FG001|Treatment Period|Death|2|||
162059119|NCT01866930|585269929|FG000|Treatment Period|Poor/non compliance|0|||
162059120|NCT01866930|585269930|FG001|Treatment Period|Poor/non compliance|2|||
162059121|NCT01866930|585269929|FG000|Treatment Period|No longer meets study criteria|0|||
162059122|NCT01866930|585269930|FG001|Treatment Period|No longer meets study criteria|1|||
162059123|NCT01866930|585269929|FG000|Treatment Period|Withdrawal by Subject|2|||
162059124|NCT01866930|585269930|FG001|Treatment Period|Withdrawal by Subject|8|||
162059125|NCT01866930|585269929|FG000|Treatment Period|Lack of Efficacy|1|||
162059126|NCT01866930|585269930|FG001|Treatment Period|Lack of Efficacy|9|||
162059127|NCT01866930|585269929|FG000|Treatment Period|Adverse Event|4|||
162059128|NCT01866930|585269930|FG001|Treatment Period|Adverse Event|12|||
162059129|NCT01866930|585269929|FG000|Treatment Period|Lost to Follow-up|1|||
162059130|NCT01866930|585269930|FG001|Treatment Period|Lost to Follow-up|1|||
162059131|NCT01866930|585269929|FG000|Follow-up Period|Lost to Follow-up|1|||
162059132|NCT01866930|585269930|FG001|Follow-up Period|Lost to Follow-up|1|||
162059133|NCT01866930|585269929|FG000|Follow-up Period|Other|1|||
162059134|NCT01866930|585269930|FG001|Follow-up Period|Other|5|||
162059135|NCT01866930|585269929|FG000|Follow-up Period|No longer required per protocol|1|||
162059136|NCT01866930|585269930|FG001|Follow-up Period|No longer required per protocol|0|||
162059137|NCT01866930|585269929|FG000|Follow-up Period|Withdrawal by Subject|3|||
162059138|NCT01866930|585269930|FG001|Follow-up Period|Withdrawal by Subject|3|||
162059139|NCT02521870|585269935|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162059140|NCT02521870|585269936|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
162059141|NCT02521870|585269937|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162059142|NCT02521870|585269938|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162059143|NCT02521870|585269939|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162059144|NCT02521870|585269940|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162059145|NCT02521870|585269941|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162059146|NCT02521870|585269942|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162059147|NCT02521870|585269943|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162059148|NCT02521870|585269944|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162059149|NCT02521870|585269945|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162059150|NCT02521870|585269946|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162059151|NCT02521870|585269935|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
162059152|NCT02521870|585269936|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
162059153|NCT02521870|585269937|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
162059154|NCT02521870|585269938|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
162059155|NCT02521870|585269939|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
162059156|NCT02521870|585269940|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
162059157|NCT02521870|585269941|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
162059158|NCT02521870|585269942|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
162059159|NCT02521870|585269943|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
162059160|NCT02521870|585269944|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
162059161|NCT02521870|585269945|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
162059162|NCT02521870|585269946|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
162059163|NCT02521870|585269935|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
162059164|NCT02521870|585269936|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
162059165|NCT02521870|585269937|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
162059166|NCT02521870|585269938|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
162059167|NCT02521870|585269939|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
162059168|NCT02521870|585269940|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
162059169|NCT02521870|585269941|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
162059170|NCT02521870|585269942|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
162059171|NCT02521870|585269943|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
162059172|NCT02521870|585269944|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
162059173|NCT02521870|585269945|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
162059174|NCT02521870|585269946|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
162059175|NCT02521870|585269935|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162059176|NCT02521870|585269936|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162059177|NCT02521870|585269937|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162059178|NCT02521870|585269938|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162059179|NCT02521870|585269939|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
162059180|NCT02521870|585269940|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
162059181|NCT02521870|585269941|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
162059182|NCT02521870|585269942|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162059183|NCT02521870|585269943|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
162059184|NCT02521870|585269944|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
162059185|NCT02521870|585269945|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
162059186|NCT02521870|585269946|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162059187|NCT02521870|585269935|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
162059188|NCT02521870|585269936|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
162059189|NCT02521870|585269937|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
162059190|NCT02521870|585269938|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
162059191|NCT02521870|585269939|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
162059192|NCT02521870|585269940|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
162059193|NCT02521870|585269941|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
162059194|NCT02521870|585269942|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
162059195|NCT02521870|585269943|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
162059196|NCT02521870|585269944|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
162059197|NCT02521870|585269945|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
162059198|NCT02521870|585269946|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
162059199|NCT02521870|585269935|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
162059200|NCT02521870|585269936|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
162059201|NCT02521870|585269937|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
162059202|NCT02521870|585269938|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
162059203|NCT02521870|585269939|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
162059204|NCT02521870|585269940|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
162059205|NCT02521870|585269941|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
162059206|NCT02521870|585269942|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
162059207|NCT02521870|585269943|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
162059208|NCT02521870|585269944|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
162059209|NCT02521870|585269945|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
162059210|NCT02521870|585269946|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
162059211|NCT02521870|585269935|FG000|Phase 2: Dose Expansion|Death|0|||
162059212|NCT02521870|585269936|FG001|Phase 2: Dose Expansion|Death|0|||
162059213|NCT02521870|585269937|FG002|Phase 2: Dose Expansion|Death|0|||
162059214|NCT02521870|585269938|FG003|Phase 2: Dose Expansion|Death|0|||
162059215|NCT02521870|585269939|FG004|Phase 2: Dose Expansion|Death|1|||
162059216|NCT02521870|585269940|FG005|Phase 2: Dose Expansion|Death|1|||
162059217|NCT02521870|585269941|FG006|Phase 2: Dose Expansion|Death|3|||
162059218|NCT02521870|585269942|FG007|Phase 2: Dose Expansion|Death|1|||
162059219|NCT02521870|585269943|FG008|Phase 2: Dose Expansion|Death|1|||
162059220|NCT02521870|585269944|FG009|Phase 2: Dose Expansion|Death|5|||
162059221|NCT02521870|585269945|FG010|Phase 2: Dose Expansion|Death|2|||
162059222|NCT02521870|585269946|FG011|Phase 2: Dose Expansion|Death|2|||
162059223|NCT02521870|585269935|FG000|Phase 2: Dose Expansion|Other|0|||
162059224|NCT02521870|585269936|FG001|Phase 2: Dose Expansion|Other|0|||
162059225|NCT02521870|585269937|FG002|Phase 2: Dose Expansion|Other|0|||
162059226|NCT02521870|585269938|FG003|Phase 2: Dose Expansion|Other|0|||
162059227|NCT02521870|585269939|FG004|Phase 2: Dose Expansion|Other|10|||
162059228|NCT02521870|585269940|FG005|Phase 2: Dose Expansion|Other|3|||
162059229|NCT02521870|585269941|FG006|Phase 2: Dose Expansion|Other|2|||
162059230|NCT02521870|585269942|FG007|Phase 2: Dose Expansion|Other|0|||
162059231|NCT02521870|585269943|FG008|Phase 2: Dose Expansion|Other|10|||
162059232|NCT02521870|585269944|FG009|Phase 2: Dose Expansion|Other|5|||
162059233|NCT02521870|585269945|FG010|Phase 2: Dose Expansion|Other|1|||
162059234|NCT02521870|585269946|FG011|Phase 2: Dose Expansion|Other|7|||
162059235|NCT02521870|585269935|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162059236|NCT02521870|585269936|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162059237|NCT02521870|585269937|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162059238|NCT02521870|585269938|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162059239|NCT02521870|585269939|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
162059240|NCT02521870|585269940|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162059241|NCT02521870|585269941|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162059242|NCT02521870|585269942|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162059243|NCT02521870|585269943|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162059244|NCT02521870|585269944|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162059245|NCT02521870|585269945|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162059246|NCT02521870|585269946|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162059247|NCT02521870|585269935|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162059248|NCT02521870|585269936|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162059249|NCT02521870|585269937|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162059250|NCT02521870|585269938|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162059251|NCT02521870|585269939|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
162059252|NCT02521870|585269940|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162059253|NCT02521870|585269941|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162059254|NCT02521870|585269942|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162059255|NCT02521870|585269943|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162059256|NCT02521870|585269944|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162059257|NCT02521870|585269945|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162059258|NCT02521870|585269946|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
162059259|NCT00471328|585269947|FG000|Core Phase|Adverse Event|18|||
162059260|NCT00471328|585269948|FG001|Core Phase|Adverse Event|6|||
162059261|NCT00471328|585269947|FG000|Core Phase|Death|8|||
162059262|NCT00471328|585269948|FG001|Core Phase|Death|4|||
162059263|NCT00471328|585269947|FG000|Core Phase|Withdrawal by Subject|2|||
162059264|NCT00471328|585269948|FG001|Core Phase|Withdrawal by Subject|2|||
162059265|NCT00471328|585269947|FG000|Core Phase|Abnormal laboratory value|1|||
162059266|NCT00471328|585269948|FG001|Core Phase|Abnormal laboratory value|0|||
162059267|NCT00471328|585269947|FG000|Core Phase|Disease Progression|78|||
162059268|NCT00471328|585269948|FG001|Core Phase|Disease Progression|53|||
162059269|NCT00471328|585269947|FG000|Core Phase|Administrative Problem|0|||
162059270|NCT00471328|585269948|FG001|Core Phase|Administrative Problem|1|||
162059271|NCT00471328|585269947|FG000|Core Phase|Protocol Deviation|0|||
162059272|NCT00471328|585269948|FG001|Core Phase|Protocol Deviation|1|||
162059273|NCT00471328|585269947|FG000|Extension Phase|Adverse Event|3|||
162059274|NCT00471328|585269948|FG001|Extension Phase|Adverse Event|12|||
162059275|NCT00471328|585269947|FG000|Extension Phase|Withdrawal by Subject|0|||
162059276|NCT00471328|585269948|FG001|Extension Phase|Withdrawal by Subject|2|||
162059277|NCT00471328|585269947|FG000|Extension Phase|Death|1|||
162059278|NCT00471328|585269948|FG001|Extension Phase|Death|7|||
162059279|NCT00471328|585269947|FG000|Extension Phase|Protocol Deviation|3|||
162059280|NCT00471328|585269948|FG001|Extension Phase|Protocol Deviation|1|||
162059281|NCT00471328|585269947|FG000|Extension Phase|Treatment duration as per protocol|0|||
162059282|NCT00471328|585269948|FG001|Extension Phase|Treatment duration as per protocol|1|||
162059283|NCT00471328|585269947|FG000|Extension Phase|Disease Progression|32|||
162059284|NCT00471328|585269948|FG001|Extension Phase|Disease Progression|44|||
162059285|NCT00471328|585269947|FG000|Extension Phase|New cancer Therapy|1|||
162059286|NCT00471328|585269948|FG001|Extension Phase|New cancer Therapy|0|||
162059287|NCT00471328|585269947|FG000|Extension Phase|Administrative Problem|1|||
162059288|NCT00471328|585269948|FG001|Extension Phase|Administrative Problem|0|||
162059289|NCT00519831|585269949|FG000|Overall Study|Adverse Event|3|||
162059290|NCT02854631|585269950|FG000|Overall Study|Adverse Event|1|||
162059291|NCT02854631|585269951|FG001|Overall Study|Adverse Event|2|||
162059292|NCT02854631|585269950|FG000|Overall Study|Withdrew Consent|3|||
162059293|NCT02854631|585269951|FG001|Overall Study|Withdrew Consent|2|||
162059294|NCT02854631|585269950|FG000|Overall Study|Investigator's Discretion|2|||
162059295|NCT02854631|585269951|FG001|Overall Study|Investigator's Discretion|0|||
162059296|NCT02854631|585269950|FG000|Overall Study|Death|12|||
162059297|NCT02854631|585269951|FG001|Overall Study|Death|8|||
162059298|NCT02854631|585269950|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
162059299|NCT02854631|585269951|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
162059300|NCT02854631|585269950|FG000|Overall Study|Protocol Violation|0|||
162059301|NCT02854631|585269951|FG001|Overall Study|Protocol Violation|1|||
162059302|NCT02854631|585269950|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
162059303|NCT02854631|585269951|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
162059304|NCT02854631|585269950|FG000|Overall Study|Lost to Follow-up|4|||
162059305|NCT02854631|585269951|FG001|Overall Study|Lost to Follow-up|2|||
162059306|NCT03930797|585269952|FG000|Overall Study|Lost to Follow-up|3|||
162059307|NCT03930797|585269953|FG001|Overall Study|Lost to Follow-up|10|||
162059308|NCT01962896|585269954|FG000|Overall Study|Lack of Efficacy|4|||
162059309|NCT00621153|585269955|FG000|Overall Study|Safety Reason|8|||
162059310|NCT00621153|585269956|FG001|Overall Study|Safety Reason|7|||
162059311|NCT00621153|585269955|FG000|Overall Study|Adverse Event|3|||
162059312|NCT00621153|585269956|FG001|Overall Study|Adverse Event|2|||
162059313|NCT00621153|585269955|FG000|Overall Study|Lost to Follow-up|5|||
162059314|NCT00621153|585269956|FG001|Overall Study|Lost to Follow-up|1|||
162059315|NCT00621153|585269955|FG000|Overall Study|Withdrawal by Subject|4|||
162059316|NCT00621153|585269956|FG001|Overall Study|Withdrawal by Subject|5|||
162059317|NCT00753415|585269957|FG000|Part A|Disease progression|1|||
162059318|NCT00753415|585269958|FG001|Part A|Disease progression|0|||
162059319|NCT00753415|585269959|FG002|Part A|Disease progression|1|||
162059320|NCT00753415|585269960|FG003|Part A|Disease progression|2|||
162059321|NCT00753415|585269961|FG004|Part A|Disease progression|0|||
162059322|NCT00753415|585269962|FG005|Part A|Disease progression|0|||
162059323|NCT00753415|585269963|FG006|Part A|Disease progression|0|||
162059324|NCT00753415|585269964|FG007|Part A|Disease progression|0|||
162059325|NCT00753415|585269965|FG008|Part A|Disease progression|0|||
162059326|NCT00753415|585269966|FG009|Part A|Disease progression|0|||
162059327|NCT00753415|585269957|FG000|Part A|Withdrawal by Subject|0|||
162059328|NCT00753415|585269958|FG001|Part A|Withdrawal by Subject|0|||
162059329|NCT00753415|585269959|FG002|Part A|Withdrawal by Subject|1|||
162059330|NCT00753415|585269960|FG003|Part A|Withdrawal by Subject|0|||
162059331|NCT00753415|585269961|FG004|Part A|Withdrawal by Subject|0|||
162059332|NCT00753415|585269962|FG005|Part A|Withdrawal by Subject|0|||
162059333|NCT00753415|585269963|FG006|Part A|Withdrawal by Subject|0|||
162059334|NCT00753415|585269964|FG007|Part A|Withdrawal by Subject|0|||
162059335|NCT00753415|585269965|FG008|Part A|Withdrawal by Subject|0|||
162059336|NCT00753415|585269966|FG009|Part A|Withdrawal by Subject|0|||
162059337|NCT00753415|585269957|FG000|Part B|Lost to Follow-up|0|||
162059338|NCT00753415|585269958|FG001|Part B|Lost to Follow-up|0|||
162059339|NCT00753415|585269959|FG002|Part B|Lost to Follow-up|0|||
162059340|NCT00753415|585269960|FG003|Part B|Lost to Follow-up|0|||
162059341|NCT00753415|585269961|FG004|Part B|Lost to Follow-up|0|||
162059342|NCT00753415|585269962|FG005|Part B|Lost to Follow-up|0|||
162059343|NCT00753415|585269963|FG006|Part B|Lost to Follow-up|0|||
162059344|NCT00753415|585269964|FG007|Part B|Lost to Follow-up|1|||
162059345|NCT00753415|585269965|FG008|Part B|Lost to Follow-up|1|||
162059346|NCT00753415|585269966|FG009|Part B|Lost to Follow-up|0|||
162059347|NCT00753415|585269957|FG000|Part B|Disease progression|0|||
162059348|NCT00753415|585269958|FG001|Part B|Disease progression|0|||
162059349|NCT00753415|585269959|FG002|Part B|Disease progression|0|||
162059350|NCT00753415|585269960|FG003|Part B|Disease progression|0|||
162059351|NCT00753415|585269961|FG004|Part B|Disease progression|0|||
162059352|NCT00753415|585269962|FG005|Part B|Disease progression|0|||
162059353|NCT00753415|585269963|FG006|Part B|Disease progression|0|||
162059354|NCT00753415|585269964|FG007|Part B|Disease progression|0|||
162059355|NCT00753415|585269965|FG008|Part B|Disease progression|2|||
162059356|NCT00753415|585269966|FG009|Part B|Disease progression|1|||
162059357|NCT02881554|585269975|FG000|Overall Study|Withdrawal by Subject|2|||
162059358|NCT02881554|585269976|FG001|Overall Study|Withdrawal by Subject|0|||
162059359|NCT01852110|585271941|FG000|Overall Study|Adverse Event|12|||
162059360|NCT01852110|585271942|FG001|Overall Study|Adverse Event|5|||
162059361|NCT01852110|585271943|FG002|Overall Study|Adverse Event|0|||
162059362|NCT01852110|585271944|FG003|Overall Study|Adverse Event|0|||
162059363|NCT01852110|585271945|FG004|Overall Study|Adverse Event|0|||
162059364|NCT01852110|585271946|FG005|Overall Study|Adverse Event|0|||
162059365|NCT01852110|585271941|FG000|Overall Study|Lost to Follow-up|1|||
162059366|NCT01852110|585271942|FG001|Overall Study|Lost to Follow-up|3|||
162059367|NCT01852110|585271943|FG002|Overall Study|Lost to Follow-up|0|||
162059368|NCT01852110|585271944|FG003|Overall Study|Lost to Follow-up|0|||
162059369|NCT01852110|585271945|FG004|Overall Study|Lost to Follow-up|0|||
162059370|NCT01852110|585271946|FG005|Overall Study|Lost to Follow-up|0|||
162059371|NCT01852110|585271941|FG000|Overall Study|Non-compliance with Study Drug|2|||
162059372|NCT01852110|585271942|FG001|Overall Study|Non-compliance with Study Drug|1|||
162059373|NCT01852110|585271943|FG002|Overall Study|Non-compliance with Study Drug|0|||
162059374|NCT01852110|585271944|FG003|Overall Study|Non-compliance with Study Drug|0|||
162059375|NCT01852110|585271945|FG004|Overall Study|Non-compliance with Study Drug|0|||
162059376|NCT01852110|585271946|FG005|Overall Study|Non-compliance with Study Drug|0|||
162059377|NCT01852110|585271941|FG000|Overall Study|Physician Decision|1|||
162059378|NCT01852110|585271942|FG001|Overall Study|Physician Decision|0|||
162059379|NCT01852110|585271943|FG002|Overall Study|Physician Decision|0|||
162059380|NCT01852110|585271944|FG003|Overall Study|Physician Decision|0|||
162059381|NCT01852110|585271945|FG004|Overall Study|Physician Decision|0|||
162059382|NCT01852110|585271946|FG005|Overall Study|Physician Decision|0|||
162059383|NCT01852110|585271941|FG000|Overall Study|Protocol Violation|0|||
162059384|NCT01852110|585271942|FG001|Overall Study|Protocol Violation|1|||
162059385|NCT01852110|585271943|FG002|Overall Study|Protocol Violation|0|||
162059386|NCT01852110|585271944|FG003|Overall Study|Protocol Violation|0|||
162059387|NCT01852110|585271945|FG004|Overall Study|Protocol Violation|0|||
162059388|NCT01852110|585271946|FG005|Overall Study|Protocol Violation|0|||
162059389|NCT01852110|585271941|FG000|Overall Study|Study Terminated by Sponsor|30|||
162059390|NCT01852110|585271942|FG001|Overall Study|Study Terminated by Sponsor|32|||
162059391|NCT01852110|585271943|FG002|Overall Study|Study Terminated by Sponsor|0|||
162059392|NCT01852110|585271944|FG003|Overall Study|Study Terminated by Sponsor|0|||
162059393|NCT01852110|585271945|FG004|Overall Study|Study Terminated by Sponsor|0|||
162059394|NCT01852110|585271946|FG005|Overall Study|Study Terminated by Sponsor|0|||
162059395|NCT01852110|585271941|FG000|Overall Study|Withdrawal by Subject|4|||
162059396|NCT01852110|585271942|FG001|Overall Study|Withdrawal by Subject|4|||
162059397|NCT01852110|585271943|FG002|Overall Study|Withdrawal by Subject|0|||
162059398|NCT01852110|585271944|FG003|Overall Study|Withdrawal by Subject|0|||
162059399|NCT01852110|585271945|FG004|Overall Study|Withdrawal by Subject|0|||
162059400|NCT01852110|585271946|FG005|Overall Study|Withdrawal by Subject|0|||
162059401|NCT02961751|585271957|FG000|Overall Study|Lost to Follow-up|11|||
162059402|NCT02961751|585271957|FG000|Overall Study|Physician Decision|2|||
162059403|NCT02961751|585271957|FG000|Overall Study|Not Eligible at Enrollment|1|||
162059404|NCT02961751|585271957|FG000|Overall Study|Protocol Violation|1|||
162059405|NCT00842712|585271958|FG000|Safety Run-in Part|Adverse Event|0|||
162059406|NCT00842712|585271959|FG001|Safety Run-in Part|Adverse Event|1|||
162059407|NCT00842712|585271960|FG002|Safety Run-in Part|Adverse Event|0|||
162059408|NCT00842712|585271961|FG003|Safety Run-in Part|Adverse Event|0|||
162059409|NCT00842712|585271962|FG004|Safety Run-in Part|Adverse Event|0|||
162059410|NCT00842712|585271963|FG005|Safety Run-in Part|Adverse Event|0|||
162059411|NCT00842712|585271964|FG006|Safety Run-in Part|Adverse Event|0|||
162059412|NCT00842712|585271958|FG000|Safety Run-in Part|Progressive disease|3|||
162059413|NCT00842712|585271959|FG001|Safety Run-in Part|Progressive disease|1|||
162059414|NCT00842712|585271960|FG002|Safety Run-in Part|Progressive disease|0|||
162059415|NCT00842712|585271961|FG003|Safety Run-in Part|Progressive disease|1|||
162059416|NCT00842712|585271962|FG004|Safety Run-in Part|Progressive disease|0|||
162059417|NCT00842712|585271963|FG005|Safety Run-in Part|Progressive disease|0|||
162059418|NCT00842712|585271964|FG006|Safety Run-in Part|Progressive disease|0|||
162059419|NCT00842712|585271958|FG000|Randomized Part|Randomized but not treated|0|||
162059420|NCT00842712|585271959|FG001|Randomized Part|Randomized but not treated|0|||
162059421|NCT00842712|585271960|FG002|Randomized Part|Randomized but not treated|0|||
162059422|NCT00842712|585271961|FG003|Randomized Part|Randomized but not treated|0|||
162059423|NCT00842712|585271962|FG004|Randomized Part|Randomized but not treated|0|||
162059424|NCT00842712|585271963|FG005|Randomized Part|Randomized but not treated|1|||
162059425|NCT00842712|585271964|FG006|Randomized Part|Randomized but not treated|4|||
162059426|NCT00842712|585271958|FG000|Randomized Part|Ongoing at cut-off date|0|||
162059427|NCT00842712|585271959|FG001|Randomized Part|Ongoing at cut-off date|0|||
162059428|NCT00842712|585271960|FG002|Randomized Part|Ongoing at cut-off date|0|||
162059429|NCT00842712|585271961|FG003|Randomized Part|Ongoing at cut-off date|0|||
162059430|NCT00842712|585271962|FG004|Randomized Part|Ongoing at cut-off date|0|||
162059431|NCT00842712|585271963|FG005|Randomized Part|Ongoing at cut-off date|0|||
162059432|NCT00842712|585271964|FG006|Randomized Part|Ongoing at cut-off date|2|||
162059433|NCT01384760|585271971|FG000|Overall Study|Lost to Follow-up|0|||
162059434|NCT01384760|585271972|FG001|Overall Study|Lost to Follow-up|6|||
162059435|NCT01384760|585271971|FG000|Overall Study|Protocol Violation|16|||
162059436|NCT01384760|585271972|FG001|Overall Study|Protocol Violation|0|||
162059437|NCT00903695|585271976|FG000|Overall Study|medical exclusion after 1st testing|1|||
162059438|NCT00903695|585271977|FG001|Overall Study|medical exclusion after 1st testing|0|||
162059439|NCT00903695|585271976|FG000|Overall Study|lung cancer|1|||
162059440|NCT00903695|585271977|FG001|Overall Study|lung cancer|0|||
162059441|NCT01549860|585271978|FG000|Overall Study|Withdrawal by Subject|1|||
162059442|NCT01549860|585271979|FG001|Overall Study|Withdrawal by Subject|0|||
162059443|NCT01549860|585271978|FG000|Overall Study|Physician Decision|1|||
162059444|NCT01549860|585271979|FG001|Overall Study|Physician Decision|1|||
162059445|NCT01366521|585271981|FG000|Overall Study|Adverse Event|1|||
162059446|NCT01366521|585271982|FG001|Overall Study|Adverse Event|0|||
162059447|NCT01366521|585271983|FG002|Overall Study|Adverse Event|0|||
162059448|NCT01366521|585271984|FG003|Overall Study|Adverse Event|0|||
162059449|NCT01366521|585271981|FG000|Overall Study|Protocol Violation|0|||
162059450|NCT01366521|585271982|FG001|Overall Study|Protocol Violation|0|||
162059451|NCT01366521|585271983|FG002|Overall Study|Protocol Violation|1|||
162059452|NCT01366521|585271984|FG003|Overall Study|Protocol Violation|0|||
162059453|NCT01366521|585271981|FG000|Overall Study|Physician Decision|0|||
162059454|NCT01366521|585271982|FG001|Overall Study|Physician Decision|0|||
162059455|NCT01366521|585271983|FG002|Overall Study|Physician Decision|1|||
162059456|NCT01366521|585271984|FG003|Overall Study|Physician Decision|0|||
162059457|NCT01366521|585271981|FG000|Overall Study|Withdrawal by Subject|0|||
162059458|NCT01366521|585271982|FG001|Overall Study|Withdrawal by Subject|1|||
162059459|NCT01366521|585271983|FG002|Overall Study|Withdrawal by Subject|0|||
162059460|NCT01366521|585271984|FG003|Overall Study|Withdrawal by Subject|0|||
162059461|NCT02430311|585271985|FG000|Part A|Adverse Event|0|||
162059462|NCT02430311|585271986|FG001|Part A|Adverse Event|1|||
162059463|NCT02430311|585271985|FG000|Part A|Withdrawal by Subject|1|||
162059464|NCT02430311|585271986|FG001|Part A|Withdrawal by Subject|0|||
162059465|NCT02430311|585271985|FG000|Part B|Meet study-specific withdrawal criteria|6|||
162059466|NCT02430311|585271986|FG001|Part B|Meet study-specific withdrawal criteria|6|||
162059467|NCT02430311|585271985|FG000|Part B|Withdrawal by Subject|2|||
162059468|NCT02430311|585271986|FG001|Part B|Withdrawal by Subject|2|||
162059469|NCT02430311|585271985|FG000|Part B|Adverse Event|1|||
162059470|NCT02430311|585271986|FG001|Part B|Adverse Event|0|||
162059471|NCT02430311|585271985|FG000|Part B|Death|1|||
162059472|NCT02430311|585271986|FG001|Part B|Death|0|||
162059473|NCT00578812|585271987|FG000|Overall Study|Not treated|6|||
162059474|NCT00578812|585271988|FG001|Overall Study|Not treated|7|||
162059475|NCT00085631|585272011|FG000|Overall Study|Missing Data|4|||
162059476|NCT00085631|585272012|FG001|Overall Study|Missing Data|11|||
162059477|NCT00085631|585272013|FG002|Overall Study|Missing Data|7|||
162059478|NCT01513473|585272014|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
162059479|NCT01513473|585272015|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
162059480|NCT01513473|585272014|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
162059481|NCT01513473|585272015|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
162059482|NCT01513473|585272014|FG000|Main Trial (26 Weeks)|Unclassified|0|||
162059483|NCT01513473|585272015|FG001|Main Trial (26 Weeks)|Unclassified|2|||
162059484|NCT01513473|585272014|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
162059485|NCT01513473|585272015|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
162059486|NCT01513473|585272014|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
162059487|NCT01513473|585272015|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
162059488|NCT04016285|585272016|FG000|Overall Study|Did not progress to surgery|2|||
162059489|NCT04016285|585272017|FG001|Overall Study|Did not progress to surgery|5|||
162059490|NCT04016285|585272016|FG000|Overall Study|Failed to collect outcome data|5|||
162059491|NCT04016285|585272017|FG001|Overall Study|Failed to collect outcome data|3|||
162059492|NCT04166435|585272018|FG000|Overall Study|2 patients ineligible for response|2|||
162059493|NCT03462082|585272019|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
162059494|NCT03462082|585272020|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
162059495|NCT03462082|585272021|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
162059496|NCT03462082|585272022|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
162059497|NCT03462082|585272023|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
162059498|NCT03462082|585272024|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
162059499|NCT03462082|585272025|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
162059500|NCT03462082|585272026|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
162059501|NCT00166114|585272029|FG000|Overall Study|Protocol Violation|2|||
162059502|NCT00166114|585272030|FG001|Overall Study|Protocol Violation|1|||
162059503|NCT00166114|585272029|FG000|Overall Study|Withdrawal by Subject|10|||
162059504|NCT00166114|585272030|FG001|Overall Study|Withdrawal by Subject|4|||
162059505|NCT00166114|585272029|FG000|Overall Study|Adverse Event|2|||
162059506|NCT00166114|585272030|FG001|Overall Study|Adverse Event|1|||
162059507|NCT03266107|585272035|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
162059508|NCT03266107|585272035|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
162059509|NCT03266107|585272035|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
162059510|NCT03266107|585272035|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
162059511|NCT02548650|585272038|FG000|Triple Therapy|Adverse Event|1|||
162059512|NCT02548650|585272039|FG001|Triple Therapy|Adverse Event|0|||
162059513|NCT02548650|585272038|FG000|Triple Therapy|Withdrawal by Subject|0|||
162059514|NCT02548650|585272039|FG001|Triple Therapy|Withdrawal by Subject|4|||
162059515|NCT02548650|585272038|FG000|Double Therapy|Adverse Event|1|||
162059516|NCT02548650|585272039|FG001|Double Therapy|Adverse Event|1|||
162059517|NCT02548650|585272038|FG000|Double Therapy|Withdrawal by Subject|0|||
162059518|NCT02548650|585272039|FG001|Double Therapy|Withdrawal by Subject|1|||
162059519|NCT01191801|585272040|FG000|Overall Study|Death|36|||
162059520|NCT01191801|585272041|FG001|Overall Study|Death|12|||
162059521|NCT01191801|585272040|FG000|Overall Study|Lack of Efficacy|176|||
162059522|NCT01191801|585272041|FG001|Overall Study|Lack of Efficacy|258|||
162059523|NCT01191801|585272040|FG000|Overall Study|Adverse Event|9|||
162059524|NCT01191801|585272041|FG001|Overall Study|Adverse Event|8|||
162059525|NCT01191801|585272040|FG000|Overall Study|Protocol Violation|2|||
162059526|NCT01191801|585272041|FG001|Overall Study|Protocol Violation|4|||
162059527|NCT01191801|585272040|FG000|Overall Study|Physician Decision|47|||
162059528|NCT01191801|585272041|FG001|Overall Study|Physician Decision|24|||
162059529|NCT01191801|585272040|FG000|Overall Study|Withdrawal by Subject|1|||
162059530|NCT01191801|585272041|FG001|Overall Study|Withdrawal by Subject|4|||
162059531|NCT01191801|585272040|FG000|Overall Study|Not Provided|45|||
162059532|NCT01191801|585272041|FG001|Overall Study|Not Provided|27|||
162059533|NCT00299104|585272042|FG000|Treatment Period|Adverse Event|14|||
162059534|NCT00299104|585272043|FG001|Treatment Period|Adverse Event|9|||
162059535|NCT00299104|585272044|FG002|Treatment Period|Adverse Event|7|||
162059536|NCT00299104|585272042|FG000|Treatment Period|Death|1|||
162059537|NCT00299104|585272043|FG001|Treatment Period|Death|1|||
162059538|NCT00299104|585272044|FG002|Treatment Period|Death|1|||
162059539|NCT00299104|585272042|FG000|Treatment Period|Insufficient therapeutic response|34|||
162059540|NCT00299104|585272043|FG001|Treatment Period|Insufficient therapeutic response|13|||
162059541|NCT00299104|585272044|FG002|Treatment Period|Insufficient therapeutic response|8|||
162059542|NCT00299104|585272042|FG000|Treatment Period|Failure to return|9|||
162059543|NCT00299104|585272043|FG001|Treatment Period|Failure to return|8|||
162059544|NCT00299104|585272044|FG002|Treatment Period|Failure to return|8|||
162059545|NCT00299104|585272042|FG000|Treatment Period|Violation of selection criteria|1|||
162059546|NCT00299104|585272043|FG001|Treatment Period|Violation of selection criteria|2|||
162059547|NCT00299104|585272044|FG002|Treatment Period|Violation of selection criteria|0|||
162059548|NCT00299104|585272042|FG000|Treatment Period|Protocol Violation|1|||
162059549|NCT00299104|585272043|FG001|Treatment Period|Protocol Violation|1|||
162059550|NCT00299104|585272044|FG002|Treatment Period|Protocol Violation|0|||
162059551|NCT00299104|585272042|FG000|Treatment Period|Refused treatment|9|||
162059552|NCT00299104|585272043|FG001|Treatment Period|Refused treatment|2|||
162059553|NCT00299104|585272044|FG002|Treatment Period|Refused treatment|2|||
162059554|NCT00299104|585272042|FG000|Treatment Period|Withdrew consent|14|||
162059555|NCT00299104|585272043|FG001|Treatment Period|Withdrew consent|19|||
162059556|NCT00299104|585272044|FG002|Treatment Period|Withdrew consent|9|||
162059557|NCT00299104|585272042|FG000|Treatment Period|Administrative reasons|106|||
162059558|NCT00299104|585272043|FG001|Treatment Period|Administrative reasons|120|||
162059559|NCT00299104|585272044|FG002|Treatment Period|Administrative reasons|137|||
162059560|NCT00299104|585272042|FG000|Safety Follow-Up (SFU) Period|Death|3|||
162059561|NCT00299104|585272043|FG001|Safety Follow-Up (SFU) Period|Death|2|||
162059562|NCT00299104|585272044|FG002|Safety Follow-Up (SFU) Period|Death|1|||
162059563|NCT00299104|585272042|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
162059564|NCT00299104|585272043|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
162059565|NCT00299104|585272044|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
162059566|NCT00299104|585272042|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
162059567|NCT00299104|585272043|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
162059568|NCT00299104|585272044|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
162059569|NCT00299104|585272042|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
162059570|NCT00299104|585272043|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
162059571|NCT00299104|585272044|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
162059572|NCT00299104|585272042|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
162059573|NCT00299104|585272043|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
162059574|NCT00299104|585272044|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
162059575|NCT00299104|585272042|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
162059576|NCT00299104|585272043|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
162059577|NCT00299104|585272044|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
162059578|NCT00299104|585272042|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
162059579|NCT00299104|585272043|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
162059580|NCT00299104|585272044|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
162059581|NCT00299104|585272042|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
162059582|NCT00299104|585272043|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
162059583|NCT00299104|585272044|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
162059584|NCT02651922|585272048|FG000|Overall Study|due to exclusion criteria|2|||
162059585|NCT01366209|585272049|FG000|Overall Study|Adverse Event|6|||
162059586|NCT01366209|585272050|FG001|Overall Study|Adverse Event|7|||
162059587|NCT01366209|585272049|FG000|Overall Study|Withdrawal by Subject|4|||
162059588|NCT01366209|585272050|FG001|Overall Study|Withdrawal by Subject|4|||
162059589|NCT01366209|585272049|FG000|Overall Study|Death|12|||
162059590|NCT01366209|585272050|FG001|Overall Study|Death|19|||
162059591|NCT01366209|585272049|FG000|Overall Study|Lung transplantation|6|||
162059592|NCT01366209|585272050|FG001|Overall Study|Lung transplantation|1|||
162059593|NCT01366209|585272049|FG000|Overall Study|Lost to Follow-up|2|||
162059594|NCT01366209|585272050|FG001|Overall Study|Lost to Follow-up|1|||
162059595|NCT01366209|585272049|FG000|Overall Study|Physician Decision|1|||
162059596|NCT01366209|585272050|FG001|Overall Study|Physician Decision|0|||
162059597|NCT01366209|585272049|FG000|Overall Study|Sponsors decision|0|||
162059598|NCT01366209|585272050|FG001|Overall Study|Sponsors decision|1|||
162059599|NCT01366209|585272049|FG000|Overall Study|Withdrew consent|4|||
162059600|NCT01366209|585272050|FG001|Overall Study|Withdrew consent|3|||
162059601|NCT01053221|585272051|FG000|Overall Study|The study was closed prematurely|5|||
162059602|NCT01053221|585272052|FG001|Overall Study|The study was closed prematurely|9|||
162059603|NCT03018704|585272053|FG000|Overall Study|Lost to Follow-up|1|||
162059604|NCT03018704|585272054|FG001|Overall Study|Lost to Follow-up|1|||
162059605|NCT00320411|585272055|FG000|Overall Study|No investigational product admin.|4|||
162059606|NCT02088047|585272058|FG000|Overall Study|Withdrawal by Subject|1|||
162059607|NCT02088047|585272059|FG001|Overall Study|Withdrawal by Subject|0|||
162059608|NCT01025752|585272060|FG000|Overall Study|Lost to Follow-up|7|||
162059609|NCT01025752|585272061|FG001|Overall Study|Lost to Follow-up|10|||
162059610|NCT01025752|585272060|FG000|Overall Study|Physician Decision|1|||
162059611|NCT01025752|585272061|FG001|Overall Study|Physician Decision|3|||
162059612|NCT01417234|585272062|FG000|Overall Study|Subject non-compliant|3|||
162059613|NCT00023764|585272063|FG000|Overall Study|Other|1|||
162059614|NCT00023764|585272063|FG000|Overall Study|Adverse Event|4|||
162059615|NCT00023764|585272063|FG000|Overall Study|Withdrawal by Subject|1|||
162059616|NCT00023764|585272063|FG000|Overall Study|Progression of disease|6|||
162059617|NCT00023764|585272063|FG000|Overall Study|patient received other treatment|1|||
162059618|NCT00023764|585272063|FG000|Overall Study|delay in obtaining staging images|1|||
162059619|NCT01537393|585272064|FG000|Overall Study|Exclude prior to study|32|||
162059620|NCT01537393|585272065|FG001|Overall Study|Exclude prior to study|44|||
162059621|NCT01537393|585272064|FG000|Overall Study|Death|20|||
162059622|NCT01537393|585272065|FG001|Overall Study|Death|32|||
162059623|NCT01537393|585272064|FG000|Overall Study|Withdrawal by Subject|18|||
162059624|NCT01537393|585272065|FG001|Overall Study|Withdrawal by Subject|17|||
162059625|NCT01537393|585272064|FG000|Overall Study|Lost to Follow-up|53|||
162059626|NCT01537393|585272065|FG001|Overall Study|Lost to Follow-up|48|||
162059627|NCT01537393|585272064|FG000|Overall Study|Failure - Regrafted|28|||
162059628|NCT01537393|585272065|FG001|Overall Study|Failure - Regrafted|43|||
162059629|NCT01537393|585272064|FG000|Overall Study|Failure - Not regrafted|2|||
162059630|NCT01537393|585272065|FG001|Overall Study|Failure - Not regrafted|6|||
162059631|NCT01537393|585272064|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
162059632|NCT01537393|585272065|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
162059633|NCT00459953|585272066|FG000|Overall Study|not analyzed-household member in study|1|||
162059634|NCT00459953|585272067|FG001|Overall Study|not analyzed-household member in study|1|||
162059635|NCT01197560|585272068|FG000|Overall Study|Adverse Event|6|||
162059636|NCT01197560|585272069|FG001|Overall Study|Adverse Event|8|||
162059637|NCT01197560|585272068|FG000|Overall Study|Death|3|||
162059638|NCT01197560|585272069|FG001|Overall Study|Death|5|||
162059639|NCT01197560|585272068|FG000|Overall Study|Withdrawal by Subject|1|||
162059640|NCT01197560|585272069|FG001|Overall Study|Withdrawal by Subject|1|||
162059641|NCT01197560|585272068|FG000|Overall Study|Disease progression|40|||
162059642|NCT01197560|585272069|FG001|Overall Study|Disease progression|35|||
162059643|NCT01197560|585272068|FG000|Overall Study|Miscellaneous|4|||
162059644|NCT01197560|585272069|FG001|Overall Study|Miscellaneous|3|||
162059645|NCT01197560|585272068|FG000|Overall Study|Missing|0|||
162059646|NCT01197560|585272069|FG001|Overall Study|Missing|1|||
162059647|NCT00211510|585272072|FG000|Overall Study|Physician Decision|3|||
162059648|NCT00211510|585272073|FG001|Overall Study|Physician Decision|1|||
162059649|NCT00211510|585272072|FG000|Overall Study|Withdrawal by Subject|3|||
162059650|NCT00211510|585272073|FG001|Overall Study|Withdrawal by Subject|1|||
162059651|NCT01487200|585272074|FG000|Overall Study|Withdrawal by Subject|0|||
162059652|NCT01487200|585272075|FG001|Overall Study|Withdrawal by Subject|1|||
162059653|NCT01487200|585272076|FG002|Overall Study|Withdrawal by Subject|0|||
162059654|NCT01487200|585272077|FG003|Overall Study|Withdrawal by Subject|0|||
162059655|NCT04051008|585272082|FG000|Overall Study|Withdrawal by Subject|2|||
162059656|NCT04051008|585272083|FG001|Overall Study|Withdrawal by Subject|0|||
162059657|NCT04051008|585272084|FG002|Overall Study|Withdrawal by Subject|1|||
162059658|NCT02862171|585272085|FG000|Overall Study|Death|1|||
162059659|NCT02862171|585272085|FG000|Overall Study|Lost to Follow-up|13|||
162059660|NCT02862171|585272085|FG000|Overall Study|Withdrawal by Subject|57|||
162059661|NCT02862171|585272085|FG000|Overall Study|Non-compliance|4|||
162059662|NCT02862171|585272085|FG000|Overall Study|HIV-1 seroconversion|18|||
162059663|NCT00662012|585272086|FG000|Overall Study|Lost to Follow-up|85|||
162059664|NCT00662012|585272086|FG000|Overall Study|Death|1|||
162059665|NCT00662012|585272086|FG000|Overall Study|Withdrawal by Subject|1|||
162059666|NCT04212650|585272090|FG000|Overall Study|Withdrawal by Subject|1|||
162059667|NCT04212650|585272091|FG001|Overall Study|Withdrawal by Subject|0|||
162059668|NCT00838578|585272092|FG000|Overall Study|Protocol Violation|2|||
162059669|NCT00598832|585272093|FG000|Overall Study|Lack of Efficacy|3|||
162059670|NCT00598832|585272094|FG001|Overall Study|Lack of Efficacy|7|||
162059671|NCT00598832|585272093|FG000|Overall Study|Adverse Event|6|||
162059672|NCT00598832|585272094|FG001|Overall Study|Adverse Event|2|||
162059673|NCT00598832|585272093|FG000|Overall Study|Withdrawal by Subject|25|||
162059674|NCT00598832|585272094|FG001|Overall Study|Withdrawal by Subject|36|||
162059675|NCT00598832|585272093|FG000|Overall Study|Protocol Violation|0|||
162059676|NCT00598832|585272094|FG001|Overall Study|Protocol Violation|2|||
162059677|NCT00598832|585272093|FG000|Overall Study|Lost to Follow-up|24|||
162059678|NCT00598832|585272094|FG001|Overall Study|Lost to Follow-up|29|||
162059679|NCT00598832|585272093|FG000|Overall Study|Pregnancy|2|||
162059680|NCT00598832|585272094|FG001|Overall Study|Pregnancy|2|||
162059681|NCT00598832|585272093|FG000|Overall Study|Physician Decision|1|||
162059682|NCT00598832|585272094|FG001|Overall Study|Physician Decision|4|||
162059683|NCT00598832|585272093|FG000|Overall Study|Non compliance|1|||
162059684|NCT00598832|585272094|FG001|Overall Study|Non compliance|0|||
162059685|NCT00357968|585272099|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
162059686|NCT00357968|585272100|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
162059687|NCT00357968|585272099|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
162059688|NCT00357968|585272100|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
162059689|NCT03919799|585272101|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
162059690|NCT03919799|585272102|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
162059691|NCT03919799|585272103|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
162059692|NCT03919799|585272104|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
162059693|NCT03919799|585272105|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
162059694|NCT03919799|585272101|FG000|DB Period (28 Weeks)|Adverse Event|1|||
162059695|NCT03919799|585272102|FG001|DB Period (28 Weeks)|Adverse Event|1|||
162059696|NCT03919799|585272103|FG002|DB Period (28 Weeks)|Adverse Event|1|||
162059697|NCT03919799|585272104|FG003|DB Period (28 Weeks)|Adverse Event|0|||
162059698|NCT03919799|585272105|FG004|DB Period (28 Weeks)|Adverse Event|0|||
162059699|NCT03919799|585272101|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
162059700|NCT03919799|585272102|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
162059701|NCT03919799|585272103|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
162059702|NCT03919799|585272104|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
162059703|NCT03919799|585272105|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
162059704|NCT03919799|585272101|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
162059705|NCT03919799|585272102|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
162059706|NCT03919799|585272103|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
162059707|NCT03919799|585272104|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
162059708|NCT03919799|585272105|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
162059709|NCT03919799|585272101|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
162059710|NCT03919799|585272102|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
162059711|NCT03919799|585272103|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
162059712|NCT03919799|585272104|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
162059713|NCT03919799|585272105|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
162059714|NCT02142959|585272106|FG000|Overall Study|Adverse Event|1|||
162059715|NCT02142959|585272107|FG001|Overall Study|Adverse Event|0|||
162059716|NCT02142959|585272108|FG002|Overall Study|Adverse Event|0|||
162059717|NCT02142959|585272106|FG000|Overall Study|Death|0|||
162059718|NCT02142959|585272107|FG001|Overall Study|Death|1|||
162059719|NCT02142959|585272108|FG002|Overall Study|Death|0|||
162059720|NCT02142959|585272106|FG000|Overall Study|Withdrawal by Subject|3|||
162059721|NCT02142959|585272107|FG001|Overall Study|Withdrawal by Subject|1|||
162059722|NCT02142959|585272108|FG002|Overall Study|Withdrawal by Subject|3|||
162059723|NCT02142959|585272106|FG000|Overall Study|Administrative Reasons|1|||
162059724|NCT02142959|585272107|FG001|Overall Study|Administrative Reasons|0|||
162059725|NCT02142959|585272108|FG002|Overall Study|Administrative Reasons|1|||
162059726|NCT02142959|585272106|FG000|Overall Study|Missing|0|||
162059727|NCT02142959|585272107|FG001|Overall Study|Missing|1|||
162059728|NCT02142959|585272108|FG002|Overall Study|Missing|0|||
162059729|NCT02142959|585272106|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
162059730|NCT02142959|585272107|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
162059731|NCT02142959|585272108|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
162059732|NCT02142959|585272106|FG000|Overall Study|Patient didn't complete end of study visit|0|||
162059733|NCT02142959|585272107|FG001|Overall Study|Patient didn't complete end of study visit|0|||
162059734|NCT02142959|585272108|FG002|Overall Study|Patient didn't complete end of study visit|1|||
162059735|NCT03547687|585272110|FG000|Overall Study|Withdrawal by Subject|1|||
162059736|NCT03547687|585272110|FG000|Overall Study|Death|1|||
162059737|NCT00646776|585272111|FG000|Overall Study|Adverse Event|1|||
162059738|NCT00646776|585272112|FG001|Overall Study|Adverse Event|9|||
162059739|NCT00646776|585272111|FG000|Overall Study|Investigator discretion|0|||
162059740|NCT00646776|585272112|FG001|Overall Study|Investigator discretion|4|||
162059741|NCT01753856|585272117|FG000|Overall Study|Adverse Event|1|||
162059742|NCT01753856|585272118|FG001|Overall Study|Adverse Event|0|||
162059743|NCT01753856|585272117|FG000|Overall Study|Withdrawal by Subject|0|||
162059744|NCT01753856|585272118|FG001|Overall Study|Withdrawal by Subject|2|||
162059745|NCT01753856|585272117|FG000|Overall Study|Sponsor Decision|2|||
162059746|NCT01753856|585272118|FG001|Overall Study|Sponsor Decision|0|||
162059747|NCT05980182|585272119|FG000|Overall Study|Lost to Follow-up|10|||
162059748|NCT04600921|585272124|FG000|Overall Study|Withdrawal by Subject|3|||
162059749|NCT04600921|585272125|FG001|Overall Study|Withdrawal by Subject|5|||
162059750|NCT04600921|585272124|FG000|Overall Study|Death|0|||
162059751|NCT04600921|585272125|FG001|Overall Study|Death|1|||
162059752|NCT04419714|585272126|FG000|Overall Study|Technical Fault|5|||
162059753|NCT04419714|585272126|FG000|Overall Study|Protocol Deviation|2|||
162059754|NCT04419714|585272126|FG000|Overall Study|Withdrawal by Subject|1|||
162059755|NCT02700815|585273549|FG000|Overall Study|Adverse Event|0|||
162059756|NCT02700815|585273550|FG001|Overall Study|Adverse Event|6|||
162059757|NCT02700815|585273551|FG002|Overall Study|Adverse Event|2|||
162059758|NCT02700815|585273552|FG003|Overall Study|Adverse Event|3|||
162059759|NCT02700815|585273549|FG000|Overall Study|Lack of Efficacy|0|||
162059760|NCT02700815|585273550|FG001|Overall Study|Lack of Efficacy|0|||
162059761|NCT02700815|585273551|FG002|Overall Study|Lack of Efficacy|1|||
162059762|NCT02700815|585273552|FG003|Overall Study|Lack of Efficacy|2|||
162059763|NCT02700815|585273549|FG000|Overall Study|Lost to Follow-up|1|||
162059764|NCT02700815|585273550|FG001|Overall Study|Lost to Follow-up|0|||
162059765|NCT02700815|585273551|FG002|Overall Study|Lost to Follow-up|0|||
162059766|NCT02700815|585273552|FG003|Overall Study|Lost to Follow-up|1|||
162059767|NCT02700815|585273549|FG000|Overall Study|Refusal to continue medication|0|||
162059768|NCT02700815|585273550|FG001|Overall Study|Refusal to continue medication|1|||
162059769|NCT02700815|585273551|FG002|Overall Study|Refusal to continue medication|0|||
162059770|NCT02700815|585273552|FG003|Overall Study|Refusal to continue medication|1|||
162059771|NCT02700815|585273549|FG000|Overall Study|Withdrawal by Subject|0|||
162059772|NCT02700815|585273550|FG001|Overall Study|Withdrawal by Subject|0|||
162059773|NCT02700815|585273551|FG002|Overall Study|Withdrawal by Subject|1|||
162059774|NCT02700815|585273552|FG003|Overall Study|Withdrawal by Subject|0|||
162059775|NCT04023526|585273553|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
162059776|NCT04023526|585273554|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
162059777|NCT04023526|585273553|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
162059778|NCT04023526|585273554|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
162059779|NCT01955733|585273558|FG000|Period 1|Lost to Follow-up|1|||
162059780|NCT01955733|585273559|FG001|Period 1|Lost to Follow-up|0|||
162059781|NCT01955733|585273560|FG002|Period 1|Lost to Follow-up|0|||
162059782|NCT01955733|585273558|FG000|Period 2|Adverse Event|1|||
162059783|NCT01955733|585273559|FG001|Period 2|Adverse Event|0|||
162059784|NCT01955733|585273560|FG002|Period 2|Adverse Event|0|||
162059785|NCT01955733|585273558|FG000|Period 2|Physician Decision|0|||
162059786|NCT01955733|585273559|FG001|Period 2|Physician Decision|0|||
162059787|NCT01955733|585273560|FG002|Period 2|Physician Decision|1|||
162059788|NCT01955733|585273558|FG000|Period 2|Withdrawal by Subject|1|||
162059789|NCT01955733|585273559|FG001|Period 2|Withdrawal by Subject|3|||
162059790|NCT01955733|585273560|FG002|Period 2|Withdrawal by Subject|2|||
162059791|NCT01955733|585273558|FG000|Period 2|Study terminated by sponsor|8|||
162059792|NCT01955733|585273559|FG001|Period 2|Study terminated by sponsor|14|||
162059793|NCT01955733|585273560|FG002|Period 2|Study terminated by sponsor|16|||
162059794|NCT01955733|585273558|FG000|Period 2|Lost to Follow-up|2|||
162059795|NCT01955733|585273559|FG001|Period 2|Lost to Follow-up|0|||
162059796|NCT01955733|585273560|FG002|Period 2|Lost to Follow-up|0|||
162059797|NCT01955733|585273558|FG000|Period 2|Other not defined above|0|||
162059798|NCT01955733|585273559|FG001|Period 2|Other not defined above|2|||
162059799|NCT01955733|585273560|FG002|Period 2|Other not defined above|2|||
162059800|NCT02324569|585273570|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
162059801|NCT02324569|585273571|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
162059802|NCT02324569|585273570|FG000|Overall Study|Voluntary Withdrawal|3|||
162059803|NCT02324569|585273571|FG001|Overall Study|Voluntary Withdrawal|6|||
162059804|NCT02324569|585273570|FG000|Overall Study|Lack of Efficacy|2|||
162059805|NCT02324569|585273571|FG001|Overall Study|Lack of Efficacy|3|||
162059806|NCT02324569|585273570|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
162059807|NCT02324569|585273571|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
162059808|NCT02324569|585273570|FG000|Overall Study|Inconvenient Schedule|2|||
162059809|NCT02324569|585273571|FG001|Overall Study|Inconvenient Schedule|0|||
162059810|NCT00793403|585273580|FG000|Overall Study|Other|73|||
162059811|NCT00309387|585273591|FG000|Overall Study|Death|72|||
162059812|NCT00309387|585273592|FG001|Overall Study|Death|73|||
162059813|NCT00309387|585273591|FG000|Overall Study|Lost to Follow-up|70|||
162059814|NCT00309387|585273592|FG001|Overall Study|Lost to Follow-up|86|||
162059815|NCT00381095|585273593|FG000|Overall Study|Death|3|||
162059816|NCT00381095|585273594|FG001|Overall Study|Death|4|||
162059817|NCT00381095|585273593|FG000|Overall Study|Lack of Efficacy|2|||
162059818|NCT00381095|585273594|FG001|Overall Study|Lack of Efficacy|4|||
162059819|NCT00381095|585273593|FG000|Overall Study|Other|2|||
162059820|NCT00381095|585273594|FG001|Overall Study|Other|2|||
162059821|NCT00381095|585273593|FG000|Overall Study|Protocol Violation|1|||
162059822|NCT00381095|585273594|FG001|Overall Study|Protocol Violation|1|||
162059823|NCT00381095|585273593|FG000|Overall Study|Withdrawal by Subject|3|||
162059824|NCT00381095|585273594|FG001|Overall Study|Withdrawal by Subject|3|||
162059825|NCT00381095|585273593|FG000|Overall Study|Adverse Event|2|||
162059826|NCT00381095|585273594|FG001|Overall Study|Adverse Event|7|||
162059827|NCT02899988|585273596|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
162059828|NCT02899988|585273597|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
162059829|NCT02899988|585273598|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162059830|NCT02899988|585273599|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162059831|NCT02899988|585273600|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162059832|NCT02899988|585273601|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162059833|NCT02899988|585273602|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162059834|NCT02899988|585273603|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162059835|NCT02899988|585273604|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162059836|NCT02899988|585273605|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162059837|NCT02899988|585273606|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
162059838|NCT02899988|585273596|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
162059839|NCT02899988|585273597|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
162059840|NCT02899988|585273598|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
162059841|NCT02899988|585273599|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
162059842|NCT02899988|585273600|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
162059843|NCT02899988|585273601|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
162059844|NCT02899988|585273602|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
162059845|NCT02899988|585273603|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
162059846|NCT02899988|585273604|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
162059847|NCT02899988|585273605|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
162059848|NCT02899988|585273606|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
162059849|NCT02899988|585273596|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
162059850|NCT02899988|585273597|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
162059851|NCT02899988|585273598|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
162059852|NCT02899988|585273599|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
162059853|NCT02899988|585273600|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
162059854|NCT02899988|585273601|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
162059855|NCT02899988|585273602|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
162059856|NCT02899988|585273603|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
162059857|NCT02899988|585273604|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
162059858|NCT02899988|585273605|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
162059859|NCT02899988|585273606|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
162059860|NCT02899988|585273596|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
162059861|NCT02899988|585273597|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
162059862|NCT02899988|585273598|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
162059863|NCT02899988|585273599|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
162059864|NCT02899988|585273600|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
162059865|NCT02899988|585273601|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
162059866|NCT02899988|585273602|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
162059867|NCT02899988|585273603|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
162059868|NCT02899988|585273604|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
162059869|NCT02899988|585273605|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
162059870|NCT02899988|585273606|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
162059871|NCT02899988|585273596|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162059872|NCT02899988|585273597|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162059873|NCT02899988|585273598|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162059874|NCT02899988|585273599|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162059875|NCT02899988|585273600|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162059876|NCT02899988|585273601|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
162059877|NCT02899988|585273602|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162059878|NCT02899988|585273603|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
162059879|NCT02899988|585273604|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162059880|NCT02899988|585273605|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162059881|NCT02899988|585273606|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
162059882|NCT02899988|585273596|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
162059883|NCT02899988|585273597|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
162059884|NCT02899988|585273598|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
162059885|NCT02899988|585273599|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
162059886|NCT02899988|585273600|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
162059887|NCT02899988|585273601|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
162059888|NCT02899988|585273602|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
162059889|NCT02899988|585273603|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
162059890|NCT02899988|585273604|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
162059891|NCT02899988|585273605|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
162059892|NCT02899988|585273606|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
162059893|NCT00856284|585273608|FG000|Overall Study|Hyperglycemic rescue|231|||
162059894|NCT00856284|585273609|FG001|Overall Study|Hyperglycemic rescue|201|||
162059895|NCT00856284|585273610|FG002|Overall Study|Hyperglycemic rescue|235|||
162059896|NCT00856284|585273608|FG000|Overall Study|Adverse Event|60|||
162059897|NCT00856284|585273609|FG001|Overall Study|Adverse Event|74|||
162059898|NCT00856284|585273610|FG002|Overall Study|Adverse Event|82|||
162059899|NCT00856284|585273608|FG000|Overall Study|Major protocol deviation|24|||
162059900|NCT00856284|585273609|FG001|Overall Study|Major protocol deviation|16|||
162059901|NCT00856284|585273610|FG002|Overall Study|Major protocol deviation|15|||
162059902|NCT00856284|585273608|FG000|Overall Study|Lost to Follow-up|20|||
162059903|NCT00856284|585273609|FG001|Overall Study|Lost to Follow-up|22|||
162059904|NCT00856284|585273610|FG002|Overall Study|Lost to Follow-up|28|||
162059905|NCT00856284|585273608|FG000|Overall Study|Voluntary withdrawal|48|||
162059906|NCT00856284|585273609|FG001|Overall Study|Voluntary withdrawal|52|||
162059907|NCT00856284|585273610|FG002|Overall Study|Voluntary withdrawal|62|||
162059908|NCT00856284|585273608|FG000|Overall Study|Pregnancy|1|||
162059909|NCT00856284|585273609|FG001|Overall Study|Pregnancy|2|||
162059910|NCT00856284|585273610|FG002|Overall Study|Pregnancy|0|||
162059911|NCT00856284|585273608|FG000|Overall Study|Investigator discretion|9|||
162059912|NCT00856284|585273609|FG001|Overall Study|Investigator discretion|8|||
162059913|NCT00856284|585273610|FG002|Overall Study|Investigator discretion|10|||
162059914|NCT00856284|585273608|FG000|Overall Study|Other|15|||
162059915|NCT00856284|585273609|FG001|Overall Study|Other|17|||
162059916|NCT00856284|585273610|FG002|Overall Study|Other|14|||
162059917|NCT00856284|585273608|FG000|Overall Study|Randomized in error|0|||
162059918|NCT00856284|585273609|FG001|Overall Study|Randomized in error|0|||
162059919|NCT00856284|585273610|FG002|Overall Study|Randomized in error|1|||
162059920|NCT02485301|585273611|FG000|Overall Study|Serious Adverse Events|2|||
162059921|NCT02485301|585273612|FG001|Overall Study|Serious Adverse Events|1|||
162059922|NCT02485301|585273611|FG000|Overall Study|Protocol Violation|0|||
162059923|NCT02485301|585273612|FG001|Overall Study|Protocol Violation|1|||
162059924|NCT02485301|585273611|FG000|Overall Study|Withdrawal by Subject|6|||
162059925|NCT02485301|585273612|FG001|Overall Study|Withdrawal by Subject|7|||
162059926|NCT02485301|585273611|FG000|Overall Study|Migrated/moved from study area|10|||
162059927|NCT02485301|585273612|FG001|Overall Study|Migrated/moved from study area|19|||
162059928|NCT02485301|585273611|FG000|Overall Study|Lost to Follow-up|17|||
162059929|NCT02485301|585273612|FG001|Overall Study|Lost to Follow-up|17|||
162059930|NCT02485301|585273611|FG000|Overall Study|Other|3|||
162059931|NCT02485301|585273612|FG001|Overall Study|Other|4|||
162059932|NCT02041286|585273614|FG000|Overall Study|Adverse Event|1|||
162059933|NCT03138889|585273618|FG000|Overall Study|Withdrawal by Subject|5|||
162059934|NCT03138889|585273619|FG001|Overall Study|Withdrawal by Subject|5|||
162059935|NCT03138889|585273620|FG002|Overall Study|Withdrawal by Subject|0|||
162059936|NCT03138889|585273621|FG003|Overall Study|Withdrawal by Subject|2|||
162059937|NCT03138889|585273622|FG004|Overall Study|Withdrawal by Subject|1|||
162059938|NCT03138889|585273623|FG005|Overall Study|Withdrawal by Subject|3|||
162059939|NCT03138889|585273624|FG006|Overall Study|Withdrawal by Subject|0|||
162059940|NCT03138889|585273625|FG007|Overall Study|Withdrawal by Subject|1|||
162059941|NCT00411645|585273626|FG000|Overall Study|Consent Withdrawn|13|||
162059942|NCT00411645|585273627|FG001|Overall Study|Consent Withdrawn|22|||
162059943|NCT00411645|585273626|FG000|Overall Study|Death|56|||
162059944|NCT00411645|585273627|FG001|Overall Study|Death|135|||
162059945|NCT00411645|585273626|FG000|Overall Study|Investigator/Sponsor Decision|10|||
162059946|NCT00411645|585273627|FG001|Overall Study|Investigator/Sponsor Decision|7|||
162059947|NCT00411645|585273626|FG000|Overall Study|Lost to Follow-up|2|||
162059948|NCT00411645|585273627|FG001|Overall Study|Lost to Follow-up|0|||
162059949|NCT01349790|585273628|FG000|Overall Study|Investigator Judgement|3|||
162059950|NCT01349790|585273628|FG000|Overall Study|Death|2|||
162059951|NCT01349790|585273628|FG000|Overall Study|Withdrawal by Patient|2|||
162059952|NCT01349790|585273628|FG000|Overall Study|Adverse Event|1|||
162059953|NCT01349790|585273628|FG000|Overall Study|Lost to Follow-up|1|||
162059954|NCT02289690|585273629|FG000|Overall Study|Adverse Event Related to Progression|0|||
162059955|NCT02289690|585273630|FG001|Overall Study|Adverse Event Related to Progression|1|||
162059956|NCT02289690|585273631|FG002|Overall Study|Adverse Event Related to Progression|1|||
162059957|NCT02289690|585273632|FG003|Overall Study|Adverse Event Related to Progression|0|||
162059958|NCT02289690|585273633|FG004|Overall Study|Adverse Event Related to Progression|1|||
162059959|NCT02289690|585273634|FG005|Overall Study|Adverse Event Related to Progression|0|||
162059960|NCT02289690|585273635|FG006|Overall Study|Adverse Event Related to Progression|1|||
162059961|NCT02289690|585273636|FG007|Overall Study|Adverse Event Related to Progression|0|||
162059962|NCT02289690|585273637|FG008|Overall Study|Adverse Event Related to Progression|0|||
162059963|NCT02289690|585273638|FG009|Overall Study|Adverse Event Related to Progression|0|||
162059964|NCT02289690|585273629|FG000|Overall Study|Withdrawal by Subject|1|||
162059965|NCT02289690|585273630|FG001|Overall Study|Withdrawal by Subject|0|||
162059966|NCT02289690|585273631|FG002|Overall Study|Withdrawal by Subject|0|||
162059967|NCT02289690|585273632|FG003|Overall Study|Withdrawal by Subject|0|||
162059968|NCT02289690|585273633|FG004|Overall Study|Withdrawal by Subject|1|||
162059969|NCT02289690|585273634|FG005|Overall Study|Withdrawal by Subject|1|||
162059970|NCT02289690|585273635|FG006|Overall Study|Withdrawal by Subject|0|||
162059971|NCT02289690|585273636|FG007|Overall Study|Withdrawal by Subject|0|||
162059972|NCT02289690|585273637|FG008|Overall Study|Withdrawal by Subject|4|||
162059973|NCT02289690|585273638|FG009|Overall Study|Withdrawal by Subject|2|||
162059974|NCT02289690|585273629|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
162059975|NCT02289690|585273630|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
162059976|NCT02289690|585273631|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
162059977|NCT02289690|585273632|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
162059978|NCT02289690|585273633|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
162059979|NCT02289690|585273634|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
162059980|NCT02289690|585273635|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
162059981|NCT02289690|585273636|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
162059982|NCT02289690|585273637|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
162059983|NCT02289690|585273638|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
162059984|NCT02289690|585273629|FG000|Overall Study|Lost to Follow-up|0|||
162059985|NCT02289690|585273630|FG001|Overall Study|Lost to Follow-up|0|||
162059986|NCT02289690|585273631|FG002|Overall Study|Lost to Follow-up|0|||
162059987|NCT02289690|585273632|FG003|Overall Study|Lost to Follow-up|0|||
162059988|NCT02289690|585273633|FG004|Overall Study|Lost to Follow-up|0|||
162059989|NCT02289690|585273634|FG005|Overall Study|Lost to Follow-up|0|||
162059990|NCT02289690|585273635|FG006|Overall Study|Lost to Follow-up|0|||
162059991|NCT02289690|585273636|FG007|Overall Study|Lost to Follow-up|1|||
162059992|NCT02289690|585273637|FG008|Overall Study|Lost to Follow-up|0|||
162059993|NCT02289690|585273638|FG009|Overall Study|Lost to Follow-up|2|||
162059994|NCT02289690|585273629|FG000|Overall Study|Death|0|||
162059995|NCT02289690|585273630|FG001|Overall Study|Death|0|||
162059996|NCT02289690|585273631|FG002|Overall Study|Death|0|||
162059997|NCT02289690|585273632|FG003|Overall Study|Death|0|||
162059998|NCT02289690|585273633|FG004|Overall Study|Death|0|||
162059999|NCT02289690|585273634|FG005|Overall Study|Death|0|||
162060000|NCT02289690|585273635|FG006|Overall Study|Death|0|||
162060001|NCT02289690|585273636|FG007|Overall Study|Death|49|||
162060002|NCT02289690|585273637|FG008|Overall Study|Death|45|||
162060003|NCT02289690|585273638|FG009|Overall Study|Death|41|||
162060004|NCT02289690|585273629|FG000|Overall Study|Sponsor Discontinued Study|0|||
162060005|NCT02289690|585273630|FG001|Overall Study|Sponsor Discontinued Study|0|||
162060006|NCT02289690|585273631|FG002|Overall Study|Sponsor Discontinued Study|0|||
162060007|NCT02289690|585273632|FG003|Overall Study|Sponsor Discontinued Study|0|||
162060008|NCT02289690|585273633|FG004|Overall Study|Sponsor Discontinued Study|0|||
162060009|NCT02289690|585273634|FG005|Overall Study|Sponsor Discontinued Study|0|||
162060010|NCT02289690|585273635|FG006|Overall Study|Sponsor Discontinued Study|0|||
162060011|NCT02289690|585273636|FG007|Overall Study|Sponsor Discontinued Study|9|||
162060012|NCT02289690|585273637|FG008|Overall Study|Sponsor Discontinued Study|7|||
162060013|NCT02289690|585273638|FG009|Overall Study|Sponsor Discontinued Study|15|||
162060014|NCT02289690|585273629|FG000|Overall Study|Other|0|||
162060015|NCT02289690|585273630|FG001|Overall Study|Other|0|||
162060016|NCT02289690|585273631|FG002|Overall Study|Other|0|||
162060017|NCT02289690|585273632|FG003|Overall Study|Other|1|||
162060018|NCT02289690|585273633|FG004|Overall Study|Other|1|||
162060019|NCT02289690|585273634|FG005|Overall Study|Other|0|||
162060020|NCT02289690|585273635|FG006|Overall Study|Other|1|||
162060021|NCT02289690|585273636|FG007|Overall Study|Other|2|||
162060022|NCT02289690|585273637|FG008|Overall Study|Other|3|||
162060023|NCT02289690|585273638|FG009|Overall Study|Other|1|||
162060024|NCT03042533|585273641|FG000|Overall Study|MD left program|1|||
162060025|NCT03042533|585273642|FG001|Overall Study|MD left program|4|||
162060026|NCT03042533|585273643|FG002|Overall Study|MD left program|1|||
162060027|NCT00814164|585273647|FG000|Overall Study|Progression|7|||
162060028|NCT00814164|585273647|FG000|Overall Study|not stated|7|||
162060029|NCT00814164|585273647|FG000|Overall Study|Death|5|||
162060030|NCT03167411|585273648|FG000|Overall Study|Adverse Event|0|||
162060031|NCT03167411|585273649|FG001|Overall Study|Adverse Event|1|||
162060032|NCT00420927|585273650|FG000|Period 1|Adverse Event|19|||
162060033|NCT00420927|585273651|FG001|Period 1|Adverse Event|15|||
162060034|NCT00420927|585273652|FG002|Period 1|Adverse Event|0|||
162060035|NCT00420927|585273653|FG003|Period 1|Adverse Event|0|||
162060036|NCT00420927|585273654|FG004|Period 1|Adverse Event|0|||
162060037|NCT00420927|585273655|FG005|Period 1|Adverse Event|0|||
162060038|NCT00420927|585273656|FG006|Period 1|Adverse Event|0|||
162060039|NCT00420927|585273650|FG000|Period 1|Withdrawal by Subject|7|||
162060040|NCT00420927|585273651|FG001|Period 1|Withdrawal by Subject|12|||
162060041|NCT00420927|585273652|FG002|Period 1|Withdrawal by Subject|0|||
162060042|NCT00420927|585273653|FG003|Period 1|Withdrawal by Subject|0|||
162060043|NCT00420927|585273654|FG004|Period 1|Withdrawal by Subject|0|||
162060044|NCT00420927|585273655|FG005|Period 1|Withdrawal by Subject|0|||
162060045|NCT00420927|585273656|FG006|Period 1|Withdrawal by Subject|0|||
162060046|NCT00420927|585273650|FG000|Period 1|Lost to Follow-up|8|||
162060047|NCT00420927|585273651|FG001|Period 1|Lost to Follow-up|6|||
162060048|NCT00420927|585273652|FG002|Period 1|Lost to Follow-up|0|||
162060049|NCT00420927|585273653|FG003|Period 1|Lost to Follow-up|0|||
162060050|NCT00420927|585273654|FG004|Period 1|Lost to Follow-up|0|||
162060051|NCT00420927|585273655|FG005|Period 1|Lost to Follow-up|0|||
162060052|NCT00420927|585273656|FG006|Period 1|Lost to Follow-up|0|||
162060053|NCT00420927|585273650|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
162060054|NCT00420927|585273651|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
162060055|NCT00420927|585273652|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
162060056|NCT00420927|585273653|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
162060057|NCT00420927|585273654|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
162060058|NCT00420927|585273655|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
162060059|NCT00420927|585273656|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
162060060|NCT00420927|585273650|FG000|Period 1|Death|2|||
162060061|NCT00420927|585273651|FG001|Period 1|Death|0|||
162060062|NCT00420927|585273652|FG002|Period 1|Death|0|||
162060063|NCT00420927|585273653|FG003|Period 1|Death|0|||
162060064|NCT00420927|585273654|FG004|Period 1|Death|0|||
162060065|NCT00420927|585273655|FG005|Period 1|Death|0|||
162060066|NCT00420927|585273656|FG006|Period 1|Death|0|||
162060067|NCT00420927|585273650|FG000|Period 1|Subject moved/relocated|0|||
162060068|NCT00420927|585273651|FG001|Period 1|Subject moved/relocated|2|||
162060069|NCT00420927|585273652|FG002|Period 1|Subject moved/relocated|0|||
162060070|NCT00420927|585273653|FG003|Period 1|Subject moved/relocated|0|||
162060071|NCT00420927|585273654|FG004|Period 1|Subject moved/relocated|0|||
162060072|NCT00420927|585273655|FG005|Period 1|Subject moved/relocated|0|||
162060073|NCT00420927|585273656|FG006|Period 1|Subject moved/relocated|0|||
162060074|NCT00420927|585273650|FG000|Period 1|Noncompliant with study drug|1|||
162060075|NCT00420927|585273651|FG001|Period 1|Noncompliant with study drug|1|||
162060076|NCT00420927|585273652|FG002|Period 1|Noncompliant with study drug|0|||
162060077|NCT00420927|585273653|FG003|Period 1|Noncompliant with study drug|0|||
162060078|NCT00420927|585273654|FG004|Period 1|Noncompliant with study drug|0|||
162060079|NCT00420927|585273655|FG005|Period 1|Noncompliant with study drug|0|||
162060080|NCT00420927|585273656|FG006|Period 1|Noncompliant with study drug|0|||
162060081|NCT00420927|585273650|FG000|Period 1|Randomization error|1|||
162060082|NCT00420927|585273651|FG001|Period 1|Randomization error|0|||
162060083|NCT00420927|585273652|FG002|Period 1|Randomization error|0|||
162060084|NCT00420927|585273653|FG003|Period 1|Randomization error|0|||
162060085|NCT00420927|585273654|FG004|Period 1|Randomization error|0|||
162060086|NCT00420927|585273655|FG005|Period 1|Randomization error|0|||
162060087|NCT00420927|585273656|FG006|Period 1|Randomization error|0|||
162060088|NCT00420927|585273650|FG000|Period 1|Suspected tuberculosis/positive test|1|||
162060089|NCT00420927|585273651|FG001|Period 1|Suspected tuberculosis/positive test|1|||
162060090|NCT00420927|585273652|FG002|Period 1|Suspected tuberculosis/positive test|0|||
162060091|NCT00420927|585273653|FG003|Period 1|Suspected tuberculosis/positive test|0|||
162060092|NCT00420927|585273654|FG004|Period 1|Suspected tuberculosis/positive test|0|||
162060093|NCT00420927|585273655|FG005|Period 1|Suspected tuberculosis/positive test|0|||
162060094|NCT00420927|585273656|FG006|Period 1|Suspected tuberculosis/positive test|0|||
162060095|NCT00420927|585273650|FG000|Period 1|Study site closure|0|||
162060096|NCT00420927|585273651|FG001|Period 1|Study site closure|1|||
162060097|NCT00420927|585273652|FG002|Period 1|Study site closure|0|||
162060098|NCT00420927|585273653|FG003|Period 1|Study site closure|0|||
162060099|NCT00420927|585273654|FG004|Period 1|Study site closure|0|||
162060100|NCT00420927|585273655|FG005|Period 1|Study site closure|0|||
162060101|NCT00420927|585273656|FG006|Period 1|Study site closure|0|||
162060102|NCT00420927|585273650|FG000|Period 1|Subject received new diagnosis|0|||
162060103|NCT00420927|585273651|FG001|Period 1|Subject received new diagnosis|2|||
162060104|NCT00420927|585273652|FG002|Period 1|Subject received new diagnosis|0|||
162060105|NCT00420927|585273653|FG003|Period 1|Subject received new diagnosis|0|||
162060106|NCT00420927|585273654|FG004|Period 1|Subject received new diagnosis|0|||
162060107|NCT00420927|585273655|FG005|Period 1|Subject received new diagnosis|0|||
162060108|NCT00420927|585273656|FG006|Period 1|Subject received new diagnosis|0|||
162060109|NCT00420927|585273650|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
162060110|NCT00420927|585273651|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
162060111|NCT00420927|585273652|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
162060112|NCT00420927|585273653|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
162060113|NCT00420927|585273654|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
162060114|NCT00420927|585273655|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
162060115|NCT00420927|585273656|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
162060116|NCT00420927|585273650|FG000|Period 1|Failed to meet entry criteria|8|||
162060117|NCT00420927|585273651|FG001|Period 1|Failed to meet entry criteria|7|||
162060118|NCT00420927|585273652|FG002|Period 1|Failed to meet entry criteria|0|||
162060119|NCT00420927|585273653|FG003|Period 1|Failed to meet entry criteria|0|||
162060120|NCT00420927|585273654|FG004|Period 1|Failed to meet entry criteria|0|||
162060121|NCT00420927|585273655|FG005|Period 1|Failed to meet entry criteria|0|||
162060122|NCT00420927|585273656|FG006|Period 1|Failed to meet entry criteria|0|||
162060123|NCT00420927|585273650|FG000|Period 1|Took prohibited medication|1|||
162060124|NCT00420927|585273651|FG001|Period 1|Took prohibited medication|3|||
162060125|NCT00420927|585273652|FG002|Period 1|Took prohibited medication|0|||
162060126|NCT00420927|585273653|FG003|Period 1|Took prohibited medication|0|||
162060127|NCT00420927|585273654|FG004|Period 1|Took prohibited medication|0|||
162060128|NCT00420927|585273655|FG005|Period 1|Took prohibited medication|0|||
162060129|NCT00420927|585273656|FG006|Period 1|Took prohibited medication|0|||
162060130|NCT00420927|585273650|FG000|Period 2|Adverse Event|0|||
162060131|NCT00420927|585273651|FG001|Period 2|Adverse Event|0|||
162060132|NCT00420927|585273652|FG002|Period 2|Adverse Event|7|||
162060133|NCT00420927|585273653|FG003|Period 2|Adverse Event|3|||
162060134|NCT00420927|585273654|FG004|Period 2|Adverse Event|17|||
162060135|NCT00420927|585273655|FG005|Period 2|Adverse Event|6|||
162060136|NCT00420927|585273656|FG006|Period 2|Adverse Event|20|||
162060137|NCT00420927|585273650|FG000|Period 2|Withdrawal by Subject|0|||
162060138|NCT00420927|585273651|FG001|Period 2|Withdrawal by Subject|0|||
162060139|NCT00420927|585273652|FG002|Period 2|Withdrawal by Subject|1|||
162060140|NCT00420927|585273653|FG003|Period 2|Withdrawal by Subject|3|||
162060141|NCT00420927|585273654|FG004|Period 2|Withdrawal by Subject|11|||
162060142|NCT00420927|585273655|FG005|Period 2|Withdrawal by Subject|2|||
162060143|NCT00420927|585273656|FG006|Period 2|Withdrawal by Subject|12|||
162060144|NCT00420927|585273650|FG000|Period 2|Lost to Follow-up|0|||
162060145|NCT00420927|585273651|FG001|Period 2|Lost to Follow-up|0|||
162060146|NCT00420927|585273652|FG002|Period 2|Lost to Follow-up|2|||
162060147|NCT00420927|585273653|FG003|Period 2|Lost to Follow-up|2|||
162060148|NCT00420927|585273654|FG004|Period 2|Lost to Follow-up|6|||
162060149|NCT00420927|585273655|FG005|Period 2|Lost to Follow-up|3|||
162060150|NCT00420927|585273656|FG006|Period 2|Lost to Follow-up|9|||
162060151|NCT00420927|585273650|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
162060152|NCT00420927|585273651|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
162060153|NCT00420927|585273652|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
162060154|NCT00420927|585273653|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
162060155|NCT00420927|585273654|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
162060156|NCT00420927|585273655|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
162060157|NCT00420927|585273656|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
162060158|NCT00420927|585273650|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
162060159|NCT00420927|585273651|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
162060160|NCT00420927|585273652|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
162060161|NCT00420927|585273653|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
162060162|NCT00420927|585273654|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
162060163|NCT00420927|585273655|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
162060164|NCT00420927|585273656|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
162060165|NCT00420927|585273650|FG000|Period 2|Subject unable to find transportation|0|||
162060166|NCT00420927|585273651|FG001|Period 2|Subject unable to find transportation|0|||
162060167|NCT00420927|585273652|FG002|Period 2|Subject unable to find transportation|0|||
162060168|NCT00420927|585273653|FG003|Period 2|Subject unable to find transportation|0|||
162060169|NCT00420927|585273654|FG004|Period 2|Subject unable to find transportation|0|||
162060170|NCT00420927|585273655|FG005|Period 2|Subject unable to find transportation|0|||
162060171|NCT00420927|585273656|FG006|Period 2|Subject unable to find transportation|1|||
162060172|NCT00420927|585273650|FG000|Period 2|Physician Decision|0|||
162060173|NCT00420927|585273651|FG001|Period 2|Physician Decision|0|||
162060174|NCT00420927|585273652|FG002|Period 2|Physician Decision|0|||
162060175|NCT00420927|585273653|FG003|Period 2|Physician Decision|0|||
162060176|NCT00420927|585273654|FG004|Period 2|Physician Decision|1|||
162060177|NCT00420927|585273655|FG005|Period 2|Physician Decision|1|||
162060178|NCT00420927|585273656|FG006|Period 2|Physician Decision|0|||
162060179|NCT00420927|585273650|FG000|Period 2|Sponsor decision|0|||
162060180|NCT00420927|585273651|FG001|Period 2|Sponsor decision|0|||
162060181|NCT00420927|585273652|FG002|Period 2|Sponsor decision|1|||
162060182|NCT00420927|585273653|FG003|Period 2|Sponsor decision|0|||
162060183|NCT00420927|585273654|FG004|Period 2|Sponsor decision|0|||
162060184|NCT00420927|585273655|FG005|Period 2|Sponsor decision|0|||
162060185|NCT00420927|585273656|FG006|Period 2|Sponsor decision|1|||
162060186|NCT00420927|585273650|FG000|Period 2|Randomization error|0|||
162060187|NCT00420927|585273651|FG001|Period 2|Randomization error|0|||
162060188|NCT00420927|585273652|FG002|Period 2|Randomization error|0|||
162060189|NCT00420927|585273653|FG003|Period 2|Randomization error|0|||
162060190|NCT00420927|585273654|FG004|Period 2|Randomization error|1|||
162060191|NCT00420927|585273655|FG005|Period 2|Randomization error|1|||
162060192|NCT00420927|585273656|FG006|Period 2|Randomization error|0|||
162060193|NCT00420927|585273650|FG000|Period 2|Noncompliant with study drug|0|||
162060194|NCT00420927|585273651|FG001|Period 2|Noncompliant with study drug|0|||
162060195|NCT00420927|585273652|FG002|Period 2|Noncompliant with study drug|0|||
162060196|NCT00420927|585273653|FG003|Period 2|Noncompliant with study drug|1|||
162060197|NCT00420927|585273654|FG004|Period 2|Noncompliant with study drug|0|||
162060198|NCT00420927|585273655|FG005|Period 2|Noncompliant with study drug|0|||
162060199|NCT00420927|585273656|FG006|Period 2|Noncompliant with study drug|2|||
162060200|NCT00420927|585273650|FG000|Period 2|Methotrexate intolerance|0|||
162060201|NCT00420927|585273651|FG001|Period 2|Methotrexate intolerance|0|||
162060202|NCT00420927|585273652|FG002|Period 2|Methotrexate intolerance|0|||
162060203|NCT00420927|585273653|FG003|Period 2|Methotrexate intolerance|0|||
162060204|NCT00420927|585273654|FG004|Period 2|Methotrexate intolerance|0|||
162060205|NCT00420927|585273655|FG005|Period 2|Methotrexate intolerance|0|||
162060206|NCT00420927|585273656|FG006|Period 2|Methotrexate intolerance|1|||
162060207|NCT00420927|585273650|FG000|Period 2|Took prohibited medication|0|||
162060208|NCT00420927|585273651|FG001|Period 2|Took prohibited medication|0|||
162060209|NCT00420927|585273652|FG002|Period 2|Took prohibited medication|0|||
162060210|NCT00420927|585273653|FG003|Period 2|Took prohibited medication|0|||
162060211|NCT00420927|585273654|FG004|Period 2|Took prohibited medication|1|||
162060212|NCT00420927|585273655|FG005|Period 2|Took prohibited medication|0|||
162060213|NCT00420927|585273656|FG006|Period 2|Took prohibited medication|0|||
162060214|NCT04448171|585273657|FG000|Overall Study|Procedure Cancelled|1|||
162060215|NCT04448171|585273658|FG001|Overall Study|Procedure Cancelled|0|||
162060216|NCT04448171|585273657|FG000|Overall Study|Protocol Violation|1|||
162060217|NCT04448171|585273658|FG001|Overall Study|Protocol Violation|0|||
162060218|NCT00855920|585273659|FG000|Overall Study|Protocol Violation|0|||
162060219|NCT00855920|585273660|FG001|Overall Study|Protocol Violation|0|||
162060220|NCT00855920|585273661|FG002|Overall Study|Protocol Violation|2|||
162060221|NCT00855920|585273659|FG000|Overall Study|Adverse Event|2|||
162060222|NCT00855920|585273660|FG001|Overall Study|Adverse Event|1|||
162060223|NCT00855920|585273661|FG002|Overall Study|Adverse Event|1|||
162060224|NCT00855920|585273659|FG000|Overall Study|Lack of Efficacy|2|||
162060225|NCT00855920|585273660|FG001|Overall Study|Lack of Efficacy|2|||
162060226|NCT00855920|585273661|FG002|Overall Study|Lack of Efficacy|2|||
162060227|NCT00855920|585273659|FG000|Overall Study|Withdrawal by Subject|2|||
162060228|NCT00855920|585273660|FG001|Overall Study|Withdrawal by Subject|3|||
162060229|NCT00855920|585273661|FG002|Overall Study|Withdrawal by Subject|2|||
162060230|NCT00855920|585273659|FG000|Overall Study|Lost to Follow-up|1|||
162060231|NCT00855920|585273660|FG001|Overall Study|Lost to Follow-up|0|||
162060232|NCT00855920|585273661|FG002|Overall Study|Lost to Follow-up|2|||
162060233|NCT00855920|585273659|FG000|Overall Study|Death|0|||
162060234|NCT00855920|585273660|FG001|Overall Study|Death|1|||
162060235|NCT00855920|585273661|FG002|Overall Study|Death|0|||
162060236|NCT00855920|585273659|FG000|Overall Study|Decision by the sponsor|0|||
162060237|NCT00855920|585273660|FG001|Overall Study|Decision by the sponsor|1|||
162060238|NCT00855920|585273661|FG002|Overall Study|Decision by the sponsor|1|||
162060239|NCT00855920|585273659|FG000|Overall Study|Other than specified above|1|||
162060240|NCT00855920|585273660|FG001|Overall Study|Other than specified above|1|||
162060241|NCT00855920|585273661|FG002|Overall Study|Other than specified above|1|||
162060242|NCT01032837|585273664|FG000|Overall Study|Adverse event/internal illness|0|||
162060243|NCT01032837|585273665|FG001|Overall Study|Adverse event/internal illness|1|||
162060244|NCT01032837|585273666|FG002|Overall Study|Adverse event/internal illness|0|||
162060245|NCT01032837|585273667|FG003|Overall Study|Adverse event/internal illness|1|||
162060246|NCT01032837|585273664|FG000|Overall Study|Withdrew consent|0|||
162060247|NCT01032837|585273665|FG001|Overall Study|Withdrew consent|2|||
162060248|NCT01032837|585273666|FG002|Overall Study|Withdrew consent|0|||
162060249|NCT01032837|585273667|FG003|Overall Study|Withdrew consent|1|||
162060250|NCT01032837|585273664|FG000|Overall Study|Failed to return|0|||
162060251|NCT01032837|585273665|FG001|Overall Study|Failed to return|0|||
162060252|NCT01032837|585273666|FG002|Overall Study|Failed to return|1|||
162060253|NCT01032837|585273667|FG003|Overall Study|Failed to return|0|||
162060254|NCT01032837|585273664|FG000|Overall Study|Refused treatment|0|||
162060255|NCT01032837|585273665|FG001|Overall Study|Refused treatment|0|||
162060256|NCT01032837|585273666|FG002|Overall Study|Refused treatment|0|||
162060257|NCT01032837|585273667|FG003|Overall Study|Refused treatment|1|||
162060258|NCT00843024|585273668|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
162060259|NCT00843024|585273669|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
162060260|NCT00843024|585273670|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
162060261|NCT00843024|585273671|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
162060262|NCT00843024|585273672|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
162060263|NCT00843024|585273673|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
162060264|NCT00843024|585273668|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
162060265|NCT00843024|585273669|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
162060266|NCT00843024|585273670|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
162060267|NCT00843024|585273671|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
162060268|NCT00843024|585273672|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
162060269|NCT00843024|585273673|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
162060270|NCT00843024|585273668|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
162060271|NCT00843024|585273669|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
162060272|NCT00843024|585273670|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
162060273|NCT00843024|585273671|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
162060274|NCT00843024|585273672|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
162060275|NCT00843024|585273673|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
162060276|NCT00843024|585273668|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
162060277|NCT00843024|585273669|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
162060278|NCT00843024|585273670|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
162060279|NCT00843024|585273671|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
162060280|NCT00843024|585273672|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
162060281|NCT00843024|585273673|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
162060282|NCT00843024|585273668|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
162060283|NCT00843024|585273669|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
162060284|NCT00843024|585273670|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
162060285|NCT00843024|585273671|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
162060286|NCT00843024|585273672|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
162060287|NCT00843024|585273673|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
162060288|NCT00843024|585273668|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
162060289|NCT00843024|585273669|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
162060290|NCT00843024|585273670|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
162060291|NCT00843024|585273671|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
162060292|NCT00843024|585273672|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
162060293|NCT00843024|585273673|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
162060294|NCT00843024|585273668|FG000|Single-blind Placebo Run-In Phase|Other|0|||
162060295|NCT00843024|585273669|FG001|Single-blind Placebo Run-In Phase|Other|1|||
162060296|NCT00843024|585273670|FG002|Single-blind Placebo Run-In Phase|Other|0|||
162060297|NCT00843024|585273671|FG003|Single-blind Placebo Run-In Phase|Other|0|||
162060298|NCT00843024|585273672|FG004|Single-blind Placebo Run-In Phase|Other|0|||
162060299|NCT00843024|585273673|FG005|Single-blind Placebo Run-In Phase|Other|0|||
162060300|NCT00843024|585273668|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
162060301|NCT00843024|585273669|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
162060302|NCT00843024|585273670|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
162060303|NCT00843024|585273671|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
162060304|NCT00843024|585273672|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
162060305|NCT00843024|585273673|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
162060306|NCT00843024|585273668|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
162060307|NCT00843024|585273669|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
162060308|NCT00843024|585273670|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
162060309|NCT00843024|585273671|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
162060310|NCT00843024|585273672|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
162060311|NCT00843024|585273673|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
162060312|NCT00843024|585273668|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162060313|NCT00843024|585273669|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162060314|NCT00843024|585273670|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162060315|NCT00843024|585273671|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
162060316|NCT00843024|585273672|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162060317|NCT00843024|585273673|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
162060318|NCT00843024|585273668|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
162060319|NCT00843024|585273669|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
162060320|NCT00843024|585273670|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
162060321|NCT00843024|585273671|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
162060322|NCT00843024|585273672|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
162060323|NCT00843024|585273673|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
162060324|NCT00843024|585273668|FG000|Double-blind Treatment Phase|Physician Decision|0|||
162060325|NCT00843024|585273669|FG001|Double-blind Treatment Phase|Physician Decision|0|||
162060326|NCT00843024|585273670|FG002|Double-blind Treatment Phase|Physician Decision|0|||
162060327|NCT00843024|585273671|FG003|Double-blind Treatment Phase|Physician Decision|3|||
162060328|NCT00843024|585273672|FG004|Double-blind Treatment Phase|Physician Decision|1|||
162060329|NCT00843024|585273673|FG005|Double-blind Treatment Phase|Physician Decision|1|||
162060330|NCT00843024|585273668|FG000|Double-blind Treatment Phase|Adverse Event|0|||
162060331|NCT00843024|585273669|FG001|Double-blind Treatment Phase|Adverse Event|0|||
162060332|NCT00843024|585273670|FG002|Double-blind Treatment Phase|Adverse Event|0|||
162060333|NCT00843024|585273671|FG003|Double-blind Treatment Phase|Adverse Event|0|||
162060334|NCT00843024|585273672|FG004|Double-blind Treatment Phase|Adverse Event|1|||
162060335|NCT00843024|585273673|FG005|Double-blind Treatment Phase|Adverse Event|1|||
162060336|NCT00843024|585273668|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
162060337|NCT00843024|585273669|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
162060338|NCT00843024|585273670|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
162060339|NCT00843024|585273671|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
162060340|NCT00843024|585273672|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
162060341|NCT00843024|585273673|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
162060342|NCT05201703|585273674|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
162060343|NCT05201703|585273675|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
162060344|NCT05201703|585273674|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
162060345|NCT05201703|585273675|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
162060346|NCT00844896|585273676|FG000|Overall Study|Lost to Follow-up|12|||
162060347|NCT00844896|585273677|FG001|Overall Study|Lost to Follow-up|16|||
162060348|NCT00844896|585273676|FG000|Overall Study|Parents did not have time to complete|0|||
162060349|NCT00844896|585273677|FG001|Overall Study|Parents did not have time to complete|1|||
162060350|NCT02233647|585273678|FG000|Overall Study|Adverse Event|1|||
162060351|NCT00458211|585273679|FG000|Overall Study|Lack of Efficacy|12|||
162060352|NCT00458211|585273679|FG000|Overall Study|Withdrawal by Subject|2|||
162060353|NCT00458211|585273679|FG000|Overall Study|Protocol Violation|2|||
162060354|NCT02132130|585273680|FG000|Overall Study|Lost to Follow-up|0|||
162060355|NCT02132130|585273681|FG001|Overall Study|Lost to Follow-up|2|||
162060356|NCT02132130|585273682|FG002|Overall Study|Lost to Follow-up|0|||
162060357|NCT02132130|585273683|FG003|Overall Study|Lost to Follow-up|0|||
162060358|NCT02132130|585273680|FG000|Overall Study|Withdrawal by Subject|0|||
162060359|NCT02132130|585273681|FG001|Overall Study|Withdrawal by Subject|0|||
162060360|NCT02132130|585273682|FG002|Overall Study|Withdrawal by Subject|0|||
162060361|NCT02132130|585273683|FG003|Overall Study|Withdrawal by Subject|1|||
162060362|NCT00679302|585273684|FG000|Overall Study|Lost to Follow-up|8|||
162060363|NCT00679302|585273685|FG001|Overall Study|Lost to Follow-up|4|||
162060364|NCT04656691|585273686|FG000|Overall Study|Adverse Event|1|||
162060365|NCT00439244|585273689|FG000|Overall Study|Adverse Event|5|||
162060366|NCT00439244|585273690|FG001|Overall Study|Adverse Event|2|||
162060367|NCT00439244|585273691|FG002|Overall Study|Adverse Event|3|||
162060368|NCT00439244|585273689|FG000|Overall Study|Withdrawal by Subject|3|||
162060369|NCT00439244|585273690|FG001|Overall Study|Withdrawal by Subject|1|||
162060370|NCT00439244|585273691|FG002|Overall Study|Withdrawal by Subject|2|||
162060371|NCT00439244|585273689|FG000|Overall Study|Lost to Follow-up|2|||
162060372|NCT00439244|585273690|FG001|Overall Study|Lost to Follow-up|1|||
162060373|NCT00439244|585273691|FG002|Overall Study|Lost to Follow-up|2|||
162060374|NCT00439244|585273689|FG000|Overall Study|Death|0|||
162060375|NCT00439244|585273690|FG001|Overall Study|Death|1|||
162060376|NCT00439244|585273691|FG002|Overall Study|Death|0|||
162060377|NCT00439244|585273689|FG000|Overall Study|Protocol Violation|0|||
162060378|NCT00439244|585273690|FG001|Overall Study|Protocol Violation|1|||
162060379|NCT00439244|585273691|FG002|Overall Study|Protocol Violation|0|||
162060380|NCT00439244|585273689|FG000|Overall Study|Administrative problems|1|||
162060381|NCT00439244|585273690|FG001|Overall Study|Administrative problems|0|||
162060382|NCT00439244|585273691|FG002|Overall Study|Administrative problems|0|||
162060383|NCT05425745|585273695|FG000|Overall Study|Withdrawal of Consent|3|||
162060384|NCT05425745|585273696|FG001|Overall Study|Withdrawal of Consent|3|||
162060385|NCT05425745|585273695|FG000|Overall Study|Death|2|||
162060386|NCT05425745|585273696|FG001|Overall Study|Death|3|||
162060387|NCT05425745|585273695|FG000|Overall Study|Lost to Follow-up|1|||
162060388|NCT05425745|585273696|FG001|Overall Study|Lost to Follow-up|2|||
162060389|NCT05425745|585273695|FG000|Overall Study|Adverse Event|0|||
162060390|NCT05425745|585273696|FG001|Overall Study|Adverse Event|1|||
162060391|NCT05425745|585273695|FG000|Overall Study|Did not return for end of study visit|0|||
162060392|NCT05425745|585273696|FG001|Overall Study|Did not return for end of study visit|1|||
162060393|NCT05425745|585273695|FG000|Overall Study|End of study visit completed by phone|1|||
162060394|NCT05425745|585273696|FG001|Overall Study|End of study visit completed by phone|0|||
162060395|NCT05425745|585273695|FG000|Overall Study|Subject decision|1|||
162060396|NCT05425745|585273696|FG001|Overall Study|Subject decision|0|||
162060397|NCT02239978|585275239|FG000|Overall Study|Withdrawal by Subject|2|||
162060398|NCT02239978|585275240|FG001|Overall Study|Withdrawal by Subject|0|||
162060399|NCT03010254|585275244|FG000|Overall Study|Adverse Event|0|||
162060400|NCT03010254|585275245|FG001|Overall Study|Adverse Event|1|||
162060401|NCT03010254|585275244|FG000|Overall Study|Lost to Follow-up|4|||
162060402|NCT03010254|585275245|FG001|Overall Study|Lost to Follow-up|0|||
162060403|NCT03010254|585275244|FG000|Overall Study|Withdrawal by Subject|1|||
162060404|NCT03010254|585275245|FG001|Overall Study|Withdrawal by Subject|1|||
162060405|NCT03010254|585275244|FG000|Overall Study|Other|2|||
162060406|NCT03010254|585275245|FG001|Overall Study|Other|3|||
162060407|NCT01404325|585275252|FG000|Overall Study|Lost to Follow-up|1|||
162060408|NCT01404325|585275253|FG001|Overall Study|Lost to Follow-up|0|||
162060409|NCT01404325|585275252|FG000|Overall Study|Death|2|||
162060410|NCT01404325|585275253|FG001|Overall Study|Death|0|||
162060411|NCT01404325|585275252|FG000|Overall Study|Graft loss/Retransplantation|1|||
162060412|NCT01404325|585275253|FG001|Overall Study|Graft loss/Retransplantation|0|||
162060413|NCT01404325|585275252|FG000|Overall Study|non-specified reason|0|||
162060414|NCT01404325|585275253|FG001|Overall Study|non-specified reason|2|||
162060415|NCT03909295|585275257|FG000|Overall Study|Adverse Event|2|||
162060416|NCT03909295|585275257|FG000|Overall Study|Study terminated by sponsor|50|||
162060417|NCT03312933|585275261|FG000|Overall Study|Protocol Violation|15|||
162060418|NCT03312933|585275261|FG000|Overall Study|Lost to Follow-up|36|||
162060419|NCT03312933|585275261|FG000|Overall Study|Withdrawal by Subject|3|||
162060420|NCT00848081|585275263|FG000|Overall Study|Adverse Event|6|||
162060421|NCT00848081|585275264|FG001|Overall Study|Adverse Event|7|||
162060422|NCT00848081|585275263|FG000|Overall Study|Protocol Violation|8|||
162060423|NCT00848081|585275264|FG001|Overall Study|Protocol Violation|5|||
162060424|NCT00848081|585275263|FG000|Overall Study|Lost to Follow-up|1|||
162060425|NCT00848081|585275264|FG001|Overall Study|Lost to Follow-up|0|||
162060426|NCT00848081|585275263|FG000|Overall Study|Physician Decision|0|||
162060427|NCT00848081|585275264|FG001|Overall Study|Physician Decision|3|||
162060428|NCT00848081|585275263|FG000|Overall Study|Withdrawal by Subject|5|||
162060429|NCT00848081|585275264|FG001|Overall Study|Withdrawal by Subject|3|||
162060430|NCT01752907|585275265|FG000|Overall Study|Withdrawal by Subject|4|||
162060431|NCT01752907|585275266|FG001|Overall Study|Withdrawal by Subject|10|||
162060432|NCT01752907|585275265|FG000|Overall Study|Lost to Follow-up|2|||
162060433|NCT01752907|585275266|FG001|Overall Study|Lost to Follow-up|1|||
162060434|NCT01752907|585275265|FG000|Overall Study|Decision by Sponsor|6|||
162060435|NCT01752907|585275266|FG001|Overall Study|Decision by Sponsor|9|||
162060436|NCT03098550|585275267|FG000|Overall Study|Disease Progression|30|||
162060437|NCT03098550|585275268|FG001|Overall Study|Disease Progression|19|||
162060438|NCT03098550|585275269|FG002|Overall Study|Disease Progression|41|||
162060439|NCT03098550|585275267|FG000|Overall Study|Study Drug Toxicity|2|||
162060440|NCT03098550|585275268|FG001|Overall Study|Study Drug Toxicity|1|||
162060441|NCT03098550|585275269|FG002|Overall Study|Study Drug Toxicity|0|||
162060442|NCT03098550|585275267|FG000|Overall Study|Death|1|||
162060443|NCT03098550|585275268|FG001|Overall Study|Death|0|||
162060444|NCT03098550|585275269|FG002|Overall Study|Death|0|||
162060445|NCT03098550|585275267|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
162060446|NCT03098550|585275268|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
162060447|NCT03098550|585275269|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
162060448|NCT03098550|585275267|FG000|Overall Study|Administrative reason by sponsor|0|||
162060449|NCT03098550|585275268|FG001|Overall Study|Administrative reason by sponsor|0|||
162060450|NCT03098550|585275269|FG002|Overall Study|Administrative reason by sponsor|1|||
162060451|NCT03098550|585275267|FG000|Overall Study|Other reasons|2|||
162060452|NCT03098550|585275268|FG001|Overall Study|Other reasons|0|||
162060453|NCT03098550|585275269|FG002|Overall Study|Other reasons|0|||
162060454|NCT00630396|585275273|FG000|Overall Study|Death|4|||
162060455|NCT00630396|585275273|FG000|Overall Study|Lost to Follow-up|3|||
162060456|NCT02990910|585275277|FG000|Overall Study|Lack of Efficacy|6|||
162060457|NCT02990910|585275278|FG001|Overall Study|Lack of Efficacy|10|||
162060458|NCT02064868|585275280|FG000|Overall Study|Lost to Follow-up|14|||
162060459|NCT02064868|585275281|FG001|Overall Study|Lost to Follow-up|8|||
162060460|NCT02064868|585275280|FG000|Overall Study|Physician Decision|1|||
162060461|NCT02064868|585275281|FG001|Overall Study|Physician Decision|0|||
162060462|NCT02064868|585275280|FG000|Overall Study|Withdrawal by Subject|14|||
162060463|NCT02064868|585275281|FG001|Overall Study|Withdrawal by Subject|3|||
162060464|NCT02064868|585275280|FG000|Overall Study|Technical Problems or Missing|5|||
162060465|NCT02064868|585275281|FG001|Overall Study|Technical Problems or Missing|2|||
162060466|NCT00482612|585275282|FG000|In-treatment Period|No study medication administered|0|||
162060467|NCT00482612|585275283|FG001|In-treatment Period|No study medication administered|0|||
162060468|NCT00482612|585275284|FG002|In-treatment Period|No study medication administered|1|||
162060469|NCT00482612|585275285|FG003|In-treatment Period|No study medication administered|0|||
162060470|NCT00482612|585275282|FG000|Follow-up Period|Other|4|||
162060471|NCT00482612|585275283|FG001|Follow-up Period|Other|2|||
162060472|NCT00482612|585275284|FG002|Follow-up Period|Other|1|||
162060473|NCT00482612|585275285|FG003|Follow-up Period|Other|2|||
162060474|NCT00482612|585275282|FG000|Follow-up Period|Lack of compliance|0|||
162060475|NCT00482612|585275283|FG001|Follow-up Period|Lack of compliance|0|||
162060476|NCT00482612|585275284|FG002|Follow-up Period|Lack of compliance|1|||
162060477|NCT00482612|585275285|FG003|Follow-up Period|Lack of compliance|0|||
162060478|NCT00482612|585275282|FG000|Follow-up Period|Lost to Follow-up|0|||
162060479|NCT00482612|585275283|FG001|Follow-up Period|Lost to Follow-up|4|||
162060480|NCT00482612|585275284|FG002|Follow-up Period|Lost to Follow-up|2|||
162060481|NCT00482612|585275285|FG003|Follow-up Period|Lost to Follow-up|1|||
162060482|NCT00482612|585275282|FG000|Follow-up Period|Adverse Event|4|||
162060483|NCT00482612|585275283|FG001|Follow-up Period|Adverse Event|7|||
162060484|NCT00482612|585275284|FG002|Follow-up Period|Adverse Event|9|||
162060485|NCT00482612|585275285|FG003|Follow-up Period|Adverse Event|0|||
162060486|NCT00482612|585275282|FG000|Follow-up Period|Lack of Efficacy|2|||
162060487|NCT00482612|585275283|FG001|Follow-up Period|Lack of Efficacy|0|||
162060488|NCT00482612|585275284|FG002|Follow-up Period|Lack of Efficacy|1|||
162060489|NCT00482612|585275285|FG003|Follow-up Period|Lack of Efficacy|0|||
162060490|NCT00482612|585275282|FG000|Follow-up Period|Withdrawal by Subject|3|||
162060491|NCT00482612|585275283|FG001|Follow-up Period|Withdrawal by Subject|5|||
162060492|NCT00482612|585275284|FG002|Follow-up Period|Withdrawal by Subject|7|||
162060493|NCT00482612|585275285|FG003|Follow-up Period|Withdrawal by Subject|2|||
162060494|NCT00482612|585275282|FG000|Follow-up Period|Reasons not related to trial|1|||
162060495|NCT00482612|585275283|FG001|Follow-up Period|Reasons not related to trial|0|||
162060496|NCT00482612|585275284|FG002|Follow-up Period|Reasons not related to trial|1|||
162060497|NCT00482612|585275285|FG003|Follow-up Period|Reasons not related to trial|3|||
162060498|NCT00660023|585275286|FG000|Overall Study|Adverse Event|2|||
162060499|NCT00660023|585275286|FG000|Overall Study|Death|8|||
162060500|NCT00660023|585275286|FG000|Overall Study|Blood Transfusion|5|||
162060501|NCT00660023|585275286|FG000|Overall Study|Renal Transplantation|3|||
162060502|NCT00660023|585275286|FG000|Overall Study|Withdrawal by Subject|1|||
162060503|NCT00660023|585275286|FG000|Overall Study|Missed Pregnancy Test|1|||
162060504|NCT00660023|585275286|FG000|Overall Study|Other Screening Failure|9|||
162060505|NCT04180488|585275288|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
162060506|NCT04180488|585275289|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
162060507|NCT04180488|585275290|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
162060508|NCT04180488|585275291|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
162060509|NCT04180488|585275292|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
162060510|NCT04180488|585275293|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
162060511|NCT04180488|585275288|FG000|Overall Study|Withdrawal by Subject|8|||
162060512|NCT04180488|585275289|FG001|Overall Study|Withdrawal by Subject|4|||
162060513|NCT04180488|585275290|FG002|Overall Study|Withdrawal by Subject|5|||
162060514|NCT04180488|585275291|FG003|Overall Study|Withdrawal by Subject|2|||
162060515|NCT04180488|585275292|FG004|Overall Study|Withdrawal by Subject|8|||
162060516|NCT04180488|585275293|FG005|Overall Study|Withdrawal by Subject|6|||
162060517|NCT04180488|585275288|FG000|Overall Study|Adverse Event|3|||
162060518|NCT04180488|585275289|FG001|Overall Study|Adverse Event|2|||
162060519|NCT04180488|585275290|FG002|Overall Study|Adverse Event|0|||
162060520|NCT04180488|585275291|FG003|Overall Study|Adverse Event|0|||
162060521|NCT04180488|585275292|FG004|Overall Study|Adverse Event|0|||
162060522|NCT04180488|585275293|FG005|Overall Study|Adverse Event|0|||
162060523|NCT04180488|585275288|FG000|Overall Study|Poor compliance to protocol|0|||
162060524|NCT04180488|585275289|FG001|Overall Study|Poor compliance to protocol|0|||
162060525|NCT04180488|585275290|FG002|Overall Study|Poor compliance to protocol|1|||
162060526|NCT04180488|585275291|FG003|Overall Study|Poor compliance to protocol|0|||
162060527|NCT04180488|585275292|FG004|Overall Study|Poor compliance to protocol|0|||
162060528|NCT04180488|585275293|FG005|Overall Study|Poor compliance to protocol|0|||
162060529|NCT03506815|585275294|FG000|Overall Study|Adverse Event|8|||
162060530|NCT03506815|585275295|FG001|Overall Study|Adverse Event|0|||
162060531|NCT03506815|585275294|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
162060532|NCT03506815|585275295|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
162060533|NCT03506815|585275294|FG000|Overall Study|Protocol Violation|1|||
162060534|NCT03506815|585275295|FG001|Overall Study|Protocol Violation|0|||
162060535|NCT03506815|585275294|FG000|Overall Study|Elective Surgery|1|||
162060536|NCT03506815|585275295|FG001|Overall Study|Elective Surgery|0|||
162060537|NCT04492618|585275299|FG000|Overall Study|Withdrawal by Subject|1|||
162060538|NCT03562481|585275300|FG000|First Intervention|Lost to Follow-up|1|||
162060539|NCT03562481|585275301|FG001|First Intervention|Lost to Follow-up|0|||
162060540|NCT01401283|585275302|FG000|Overall Study|surgery cancelled|5|||
162060541|NCT01401283|585275303|FG001|Overall Study|surgery cancelled|8|||
162060542|NCT01401283|585275302|FG000|Overall Study|preoperative arrhythmia|5|||
162060543|NCT01401283|585275303|FG001|Overall Study|preoperative arrhythmia|0|||
162060544|NCT01401283|585275302|FG000|Overall Study|no central venous access|0|||
162060545|NCT01401283|585275303|FG001|Overall Study|no central venous access|1|||
162060546|NCT01401283|585275302|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
162060547|NCT01401283|585275303|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
162060548|NCT01327885|585275308|FG000|Overall Study|Disease progression-according to RECIST|173|||
162060549|NCT01327885|585275309|FG001|Overall Study|Disease progression-according to RECIST|165|||
162060550|NCT01327885|585275308|FG000|Overall Study|Clinical progression|24|||
162060551|NCT01327885|585275309|FG001|Overall Study|Clinical progression|27|||
162060552|NCT01327885|585275308|FG000|Overall Study|Adverse Event|14|||
162060553|NCT01327885|585275309|FG001|Overall Study|Adverse Event|10|||
162060554|NCT01327885|585275308|FG000|Overall Study|Subject choice|5|||
162060555|NCT01327885|585275309|FG001|Overall Study|Subject choice|10|||
162060556|NCT01327885|585275308|FG000|Overall Study|Other|8|||
162060557|NCT01327885|585275309|FG001|Overall Study|Other|6|||
162060558|NCT01327885|585275308|FG000|Overall Study|Withdrawal of consent from study|3|||
162060559|NCT01327885|585275309|FG001|Overall Study|Withdrawal of consent from study|4|||
162060560|NCT01327885|585275308|FG000|Overall Study|Not treated|1|||
162060561|NCT01327885|585275309|FG001|Overall Study|Not treated|1|||
162060562|NCT01327885|585275308|FG000|Overall Study|Administrative decision|0|||
162060563|NCT01327885|585275309|FG001|Overall Study|Administrative decision|1|||
162060564|NCT03824912|585275315|FG000|Overall Study|Lost to Follow-up|18|||
162060565|NCT03824912|585275316|FG001|Overall Study|Lost to Follow-up|15|||
162060566|NCT03824912|585275317|FG002|Overall Study|Lost to Follow-up|8|||
162060567|NCT03824912|585275315|FG000|Overall Study|Negative Baseline Culture Result|118|||
162060568|NCT03824912|585275316|FG001|Overall Study|Negative Baseline Culture Result|112|||
162060569|NCT03824912|585275317|FG002|Overall Study|Negative Baseline Culture Result|57|||
162060570|NCT03824912|585275315|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162060571|NCT03824912|585275316|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162060572|NCT03824912|585275317|FG002|Overall Study|Non-Compliance with Study Drug|1|||
162060573|NCT03824912|585275315|FG000|Overall Study|Protocol Violation|1|||
162060574|NCT03824912|585275316|FG001|Overall Study|Protocol Violation|4|||
162060575|NCT03824912|585275317|FG002|Overall Study|Protocol Violation|1|||
162060576|NCT03824912|585275315|FG000|Overall Study|Withdrawal by Subject|3|||
162060577|NCT03824912|585275316|FG001|Overall Study|Withdrawal by Subject|2|||
162060578|NCT03824912|585275317|FG002|Overall Study|Withdrawal by Subject|1|||
162060579|NCT03824912|585275315|FG000|Overall Study|Participation in another study|0|||
162060580|NCT03824912|585275316|FG001|Overall Study|Participation in another study|1|||
162060581|NCT03824912|585275317|FG002|Overall Study|Participation in another study|0|||
162060582|NCT04271605|585275318|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
162060583|NCT01059825|585275321|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
162060584|NCT01059825|585275322|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
162060585|NCT01059825|585275323|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
162060586|NCT01059825|585275324|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
162060587|NCT01059825|585275325|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
162060588|NCT01059825|585275326|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
162060589|NCT01059825|585275327|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
162060590|NCT01059825|585275321|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
162060591|NCT01059825|585275322|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
162060592|NCT01059825|585275323|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
162060593|NCT01059825|585275324|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
162060594|NCT01059825|585275325|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
162060595|NCT01059825|585275326|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
162060596|NCT01059825|585275327|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
162060597|NCT01059825|585275321|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
162060598|NCT01059825|585275322|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
162060599|NCT01059825|585275323|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
162060600|NCT01059825|585275324|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
162060601|NCT01059825|585275325|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
162060602|NCT01059825|585275326|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
162060603|NCT01059825|585275327|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
162060604|NCT01059825|585275321|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
162060605|NCT01059825|585275322|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
162060606|NCT01059825|585275323|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
162060607|NCT01059825|585275324|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
162060608|NCT01059825|585275325|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
162060609|NCT01059825|585275326|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
162060610|NCT01059825|585275327|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
162060611|NCT01059825|585275321|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
162060612|NCT01059825|585275322|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
162060613|NCT01059825|585275323|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
162060614|NCT01059825|585275324|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
162060615|NCT01059825|585275325|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
162060616|NCT01059825|585275326|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
162060617|NCT01059825|585275327|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
162060618|NCT01059825|585275321|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
162060619|NCT01059825|585275322|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
162060620|NCT01059825|585275323|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
162060621|NCT01059825|585275324|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
162060622|NCT01059825|585275325|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
162060623|NCT01059825|585275326|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
162060624|NCT01059825|585275327|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
162060625|NCT01059825|585275321|FG000|Treatment Period|Lost to Follow-up|2|||
162060626|NCT01059825|585275322|FG001|Treatment Period|Lost to Follow-up|1|||
162060627|NCT01059825|585275323|FG002|Treatment Period|Lost to Follow-up|0|||
162060628|NCT01059825|585275324|FG003|Treatment Period|Lost to Follow-up|1|||
162060629|NCT01059825|585275325|FG004|Treatment Period|Lost to Follow-up|2|||
162060630|NCT01059825|585275326|FG005|Treatment Period|Lost to Follow-up|0|||
162060631|NCT01059825|585275327|FG006|Treatment Period|Lost to Follow-up|0|||
162060632|NCT01059825|585275321|FG000|Treatment Period|Withdrawal by Subject|3|||
162060633|NCT01059825|585275322|FG001|Treatment Period|Withdrawal by Subject|0|||
162060634|NCT01059825|585275323|FG002|Treatment Period|Withdrawal by Subject|1|||
162060635|NCT01059825|585275324|FG003|Treatment Period|Withdrawal by Subject|5|||
162060636|NCT01059825|585275325|FG004|Treatment Period|Withdrawal by Subject|4|||
162060637|NCT01059825|585275326|FG005|Treatment Period|Withdrawal by Subject|1|||
162060638|NCT01059825|585275327|FG006|Treatment Period|Withdrawal by Subject|0|||
162060639|NCT01059825|585275321|FG000|Treatment Period|Other reason not specified|1|||
162060640|NCT01059825|585275322|FG001|Treatment Period|Other reason not specified|2|||
162060641|NCT01059825|585275323|FG002|Treatment Period|Other reason not specified|1|||
162060642|NCT01059825|585275324|FG003|Treatment Period|Other reason not specified|2|||
162060643|NCT01059825|585275325|FG004|Treatment Period|Other reason not specified|0|||
162060644|NCT01059825|585275326|FG005|Treatment Period|Other reason not specified|0|||
162060645|NCT01059825|585275327|FG006|Treatment Period|Other reason not specified|0|||
162060646|NCT01059825|585275321|FG000|Treatment Period|Protocol Violation|0|||
162060647|NCT01059825|585275322|FG001|Treatment Period|Protocol Violation|0|||
162060648|NCT01059825|585275323|FG002|Treatment Period|Protocol Violation|1|||
162060649|NCT01059825|585275324|FG003|Treatment Period|Protocol Violation|1|||
162060650|NCT01059825|585275325|FG004|Treatment Period|Protocol Violation|1|||
162060651|NCT01059825|585275326|FG005|Treatment Period|Protocol Violation|1|||
162060652|NCT01059825|585275327|FG006|Treatment Period|Protocol Violation|0|||
162060653|NCT01059825|585275321|FG000|Treatment Period|Adverse event related to study drug|1|||
162060654|NCT01059825|585275322|FG001|Treatment Period|Adverse event related to study drug|0|||
162060655|NCT01059825|585275323|FG002|Treatment Period|Adverse event related to study drug|1|||
162060656|NCT01059825|585275324|FG003|Treatment Period|Adverse event related to study drug|1|||
162060657|NCT01059825|585275325|FG004|Treatment Period|Adverse event related to study drug|0|||
162060658|NCT01059825|585275326|FG005|Treatment Period|Adverse event related to study drug|0|||
162060659|NCT01059825|585275327|FG006|Treatment Period|Adverse event related to study drug|0|||
162060660|NCT01059825|585275321|FG000|Treatment Period|Insufficient clinical response|3|||
162060661|NCT01059825|585275322|FG001|Treatment Period|Insufficient clinical response|0|||
162060662|NCT01059825|585275323|FG002|Treatment Period|Insufficient clinical response|0|||
162060663|NCT01059825|585275324|FG003|Treatment Period|Insufficient clinical response|0|||
162060664|NCT01059825|585275325|FG004|Treatment Period|Insufficient clinical response|0|||
162060665|NCT01059825|585275326|FG005|Treatment Period|Insufficient clinical response|0|||
162060666|NCT01059825|585275327|FG006|Treatment Period|Insufficient clinical response|0|||
162060667|NCT01059825|585275321|FG000|Treatment Period|Adverse event not related to study drug|0|||
162060668|NCT01059825|585275322|FG001|Treatment Period|Adverse event not related to study drug|1|||
162060669|NCT01059825|585275323|FG002|Treatment Period|Adverse event not related to study drug|2|||
162060670|NCT01059825|585275324|FG003|Treatment Period|Adverse event not related to study drug|1|||
162060671|NCT01059825|585275325|FG004|Treatment Period|Adverse event not related to study drug|1|||
162060672|NCT01059825|585275326|FG005|Treatment Period|Adverse event not related to study drug|1|||
162060673|NCT01059825|585275327|FG006|Treatment Period|Adverse event not related to study drug|0|||
162060674|NCT03342690|585275330|FG000|Overall Study|Missing Information|9|||
162060675|NCT03342690|585275330|FG000|Overall Study|Protocol Violation|16|||
162060676|NCT00105482|585275341|FG000|Overall Study|Adverse Event|1|||
162060677|NCT00105482|585275342|FG001|Overall Study|Adverse Event|1|||
162060678|NCT00105482|585275341|FG000|Overall Study|Lost to Follow-up|26|||
162060679|NCT00105482|585275342|FG001|Overall Study|Lost to Follow-up|17|||
162060680|NCT00105482|585275341|FG000|Overall Study|Withdrawal by Subject|0|||
162060681|NCT00105482|585275342|FG001|Overall Study|Withdrawal by Subject|1|||
162060682|NCT00105482|585275341|FG000|Overall Study|Lost Interest|29|||
162060683|NCT00105482|585275342|FG001|Overall Study|Lost Interest|32|||
162060684|NCT00105482|585275341|FG000|Overall Study|Scheduling Conflict|2|||
162060685|NCT00105482|585275342|FG001|Overall Study|Scheduling Conflict|3|||
162060686|NCT00105482|585275341|FG000|Overall Study|Withdrawn by PI|1|||
162060687|NCT00105482|585275342|FG001|Overall Study|Withdrawn by PI|1|||
162060688|NCT02495168|585275348|FG000|Overall Study|Other than Specified|18|||
162060689|NCT02495168|585275349|FG001|Overall Study|Other than Specified|22|||
162060690|NCT02495168|585275350|FG002|Overall Study|Other than Specified|5|||
162060691|NCT02495168|585275348|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
162060692|NCT02495168|585275349|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
162060693|NCT02495168|585275350|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
162060694|NCT02495168|585275348|FG000|Overall Study|Physician Decision|1|||
162060695|NCT02495168|585275349|FG001|Overall Study|Physician Decision|1|||
162060696|NCT02495168|585275350|FG002|Overall Study|Physician Decision|0|||
162060697|NCT02495168|585275348|FG000|Overall Study|Lost to Follow-up|10|||
162060698|NCT02495168|585275349|FG001|Overall Study|Lost to Follow-up|6|||
162060699|NCT02495168|585275350|FG002|Overall Study|Lost to Follow-up|1|||
162060700|NCT02495168|585275348|FG000|Overall Study|Withdrawal by Subject|1|||
162060701|NCT02495168|585275349|FG001|Overall Study|Withdrawal by Subject|4|||
162060702|NCT02495168|585275350|FG002|Overall Study|Withdrawal by Subject|2|||
162060703|NCT02495168|585275348|FG000|Overall Study|Protocol Violation|0|||
162060704|NCT02495168|585275349|FG001|Overall Study|Protocol Violation|10|||
162060705|NCT02495168|585275350|FG002|Overall Study|Protocol Violation|1|||
162060706|NCT02495168|585275348|FG000|Overall Study|Adverse Event|4|||
162060707|NCT02495168|585275349|FG001|Overall Study|Adverse Event|8|||
162060708|NCT02495168|585275350|FG002|Overall Study|Adverse Event|3|||
162060709|NCT02495168|585275348|FG000|Overall Study|Lack of Efficacy|0|||
162060710|NCT02495168|585275349|FG001|Overall Study|Lack of Efficacy|0|||
162060711|NCT02495168|585275350|FG002|Overall Study|Lack of Efficacy|3|||
162060712|NCT00644995|585275351|FG000|Overall Study|Lost to Follow-up|1|||
162060713|NCT00644995|585275352|FG001|Overall Study|Lost to Follow-up|4|||
162060714|NCT00644995|585275351|FG000|Overall Study|Refused|1|||
162060715|NCT00644995|585275352|FG001|Overall Study|Refused|0|||
162060716|NCT03247530|585275353|FG000|Overall Study|Withdrawal by caregiver|19|||
162060717|NCT03247530|585275354|FG001|Overall Study|Withdrawal by caregiver|8|||
162060718|NCT03247530|585275355|FG002|Overall Study|Withdrawal by caregiver|10|||
162060719|NCT03247530|585275353|FG000|Overall Study|Lost to Follow-up|3|||
162060720|NCT03247530|585275354|FG001|Overall Study|Lost to Follow-up|9|||
162060721|NCT03247530|585275355|FG002|Overall Study|Lost to Follow-up|6|||
162060722|NCT03247530|585275353|FG000|Overall Study|Adverse Event|2|||
162060723|NCT03247530|585275354|FG001|Overall Study|Adverse Event|5|||
162060724|NCT03247530|585275355|FG002|Overall Study|Adverse Event|2|||
162060725|NCT03247530|585275353|FG000|Overall Study|Failure to follow procedure|1|||
162060726|NCT03247530|585275354|FG001|Overall Study|Failure to follow procedure|1|||
162060727|NCT03247530|585275355|FG002|Overall Study|Failure to follow procedure|1|||
162060728|NCT03247530|585275353|FG000|Overall Study|Withdrawal by Subject|1|||
162060729|NCT03247530|585275354|FG001|Overall Study|Withdrawal by Subject|1|||
162060730|NCT03247530|585275355|FG002|Overall Study|Withdrawal by Subject|0|||
162060731|NCT03247530|585275353|FG000|Overall Study|Study medication misuse|0|||
162060732|NCT03247530|585275354|FG001|Overall Study|Study medication misuse|1|||
162060733|NCT03247530|585275355|FG002|Overall Study|Study medication misuse|0|||
162060734|NCT03247530|585275353|FG000|Overall Study|Other, multiple categories|1|||
162060735|NCT03247530|585275354|FG001|Overall Study|Other, multiple categories|3|||
162060736|NCT03247530|585275355|FG002|Overall Study|Other, multiple categories|1|||
162060737|NCT01587001|585275356|FG000|Overall Study|Lost to Follow-up|2|||
162060738|NCT01587001|585275357|FG001|Overall Study|Lost to Follow-up|0|||
162060739|NCT01587001|585275356|FG000|Overall Study|Insufficient samples to complete testing|4|||
162060740|NCT01587001|585275357|FG001|Overall Study|Insufficient samples to complete testing|1|||
162060741|NCT04786990|585275358|FG000|Overall Study|Withdrawal by Subject|1|||
162060742|NCT04786990|585275358|FG000|Overall Study|Adverse Event|1|||
162060743|NCT04786990|585275358|FG000|Overall Study|Lost to Follow-up|1|||
162060744|NCT04786990|585275358|FG000|Overall Study|Noncompliance|1|||
162060745|NCT04786990|585275358|FG000|Overall Study|Unable to complete site visits|1|||
162060746|NCT04786990|585275358|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
162060747|NCT02846779|585275362|FG000|Overall Study|Lost Enrollment|83|||
162060748|NCT02846779|585275363|FG001|Overall Study|Lost Enrollment|82|||
162060749|NCT02846779|585275364|FG002|Overall Study|Lost Enrollment|86|||
162060750|NCT02846779|585275362|FG000|Overall Study|Less than 31 days of follow-up|56|||
162060751|NCT02846779|585275363|FG001|Overall Study|Less than 31 days of follow-up|45|||
162060752|NCT02846779|585275364|FG002|Overall Study|Less than 31 days of follow-up|52|||
162060753|NCT00887978|585275367|FG000|Overall Study|Adverse Event|18|||
162060754|NCT00887978|585275368|FG001|Overall Study|Adverse Event|5|||
162060755|NCT00887978|585275367|FG000|Overall Study|Clinical Worsening|4|||
162060756|NCT00887978|585275368|FG001|Overall Study|Clinical Worsening|4|||
162060757|NCT00887978|585275367|FG000|Overall Study|Death|2|||
162060758|NCT00887978|585275368|FG001|Overall Study|Death|3|||
162060759|NCT00887978|585275367|FG000|Overall Study|Withdrawal by Subject|1|||
162060760|NCT00887978|585275368|FG001|Overall Study|Withdrawal by Subject|2|||
162060761|NCT00887978|585275367|FG000|Overall Study|Lost to Follow-up|0|||
162060762|NCT00887978|585275368|FG001|Overall Study|Lost to Follow-up|1|||
162060763|NCT05353985|585275371|FG000|Overall Study|Adverse Event|5|||
162060764|NCT05353985|585275372|FG001|Overall Study|Adverse Event|7|||
162060765|NCT05353985|585275371|FG000|Overall Study|Lost to Follow-up|1|||
162060766|NCT05353985|585275372|FG001|Overall Study|Lost to Follow-up|1|||
162060767|NCT05353985|585275371|FG000|Overall Study|Protocol Violation|1|||
162060768|NCT05353985|585275372|FG001|Overall Study|Protocol Violation|0|||
162060769|NCT05353985|585275371|FG000|Overall Study|Withdrawal by Subject|13|||
162060770|NCT05353985|585275372|FG001|Overall Study|Withdrawal by Subject|17|||
162060771|NCT05353985|585275371|FG000|Overall Study|Reason Not Specified|1|||
162060772|NCT05353985|585275372|FG001|Overall Study|Reason Not Specified|0|||
162060773|NCT05353985|585275371|FG000|Overall Study|Randomized in Error & Not Treated|0|||
162060774|NCT05353985|585275372|FG001|Overall Study|Randomized in Error & Not Treated|1|||
162060775|NCT00524368|585276829|FG000|Overall Study|Adverse Event|10|||
162060776|NCT00524368|585276830|FG001|Overall Study|Adverse Event|12|||
162060777|NCT00524368|585276829|FG000|Overall Study|Lost to Follow-up|9|||
162060778|NCT00524368|585276830|FG001|Overall Study|Lost to Follow-up|13|||
162060779|NCT00524368|585276829|FG000|Overall Study|Withdrawal by Subject|4|||
162060780|NCT00524368|585276830|FG001|Overall Study|Withdrawal by Subject|5|||
162060781|NCT00524368|585276829|FG000|Overall Study|Non-compliant|8|||
162060782|NCT00524368|585276830|FG001|Overall Study|Non-compliant|9|||
162060783|NCT00524368|585276829|FG000|Overall Study|Reached a Virologic Endpoint|3|||
162060784|NCT00524368|585276830|FG001|Overall Study|Reached a Virologic Endpoint|2|||
162060785|NCT00524368|585276829|FG000|Overall Study|Sponsor's Decision|2|||
162060786|NCT00524368|585276830|FG001|Overall Study|Sponsor's Decision|0|||
162060787|NCT00524368|585276829|FG000|Overall Study|Ineligible to Continue the study|2|||
162060788|NCT00524368|585276830|FG001|Overall Study|Ineligible to Continue the study|5|||
162060789|NCT00524368|585276829|FG000|Overall Study|Other|3|||
162060790|NCT00524368|585276830|FG001|Overall Study|Other|2|||
162060791|NCT04221009|585276833|FG000|Overall Study|Withdrawal by Subject|4|||
162060792|NCT00793598|585276834|FG000|Overall Study|Patient Request|0|||
162060793|NCT00793598|585276835|FG001|Overall Study|Patient Request|1|||
162060794|NCT00793598|585276836|FG002|Overall Study|Patient Request|0|||
162060795|NCT00793598|585276837|FG003|Overall Study|Patient Request|0|||
162060796|NCT00793598|585276838|FG004|Overall Study|Patient Request|0|||
162060797|NCT00793598|585276839|FG005|Overall Study|Patient Request|0|||
162060798|NCT00793598|585276840|FG006|Overall Study|Patient Request|0|||
162060799|NCT00793598|585276841|FG007|Overall Study|Patient Request|0|||
162060800|NCT00793598|585276834|FG000|Overall Study|Protocol Violation|0|||
162060801|NCT00793598|585276835|FG001|Overall Study|Protocol Violation|0|||
162060802|NCT00793598|585276836|FG002|Overall Study|Protocol Violation|0|||
162060803|NCT00793598|585276837|FG003|Overall Study|Protocol Violation|0|||
162060804|NCT00793598|585276838|FG004|Overall Study|Protocol Violation|0|||
162060805|NCT00793598|585276839|FG005|Overall Study|Protocol Violation|0|||
162060806|NCT00793598|585276840|FG006|Overall Study|Protocol Violation|0|||
162060807|NCT00793598|585276841|FG007|Overall Study|Protocol Violation|1|||
162060808|NCT00793598|585276834|FG000|Overall Study|Subject not dosed|0|||
162060809|NCT00793598|585276835|FG001|Overall Study|Subject not dosed|0|||
162060810|NCT00793598|585276836|FG002|Overall Study|Subject not dosed|0|||
162060811|NCT00793598|585276837|FG003|Overall Study|Subject not dosed|0|||
162060812|NCT00793598|585276838|FG004|Overall Study|Subject not dosed|0|||
162060813|NCT00793598|585276839|FG005|Overall Study|Subject not dosed|1|||
162060814|NCT00793598|585276840|FG006|Overall Study|Subject not dosed|0|||
162060815|NCT00793598|585276841|FG007|Overall Study|Subject not dosed|0|||
162060816|NCT02762266|585276842|FG000|Overall Study|Physician Decision|2|||
162060817|NCT02762266|585276843|FG001|Overall Study|Physician Decision|0|||
162060818|NCT02373202|585276846|FG000|Overall Study|Adverse Event|2|||
162060819|NCT02373202|585276847|FG001|Overall Study|Adverse Event|5|||
162060820|NCT02373202|585276848|FG002|Overall Study|Adverse Event|2|||
162060821|NCT02373202|585276849|FG003|Overall Study|Adverse Event|1|||
162060822|NCT02373202|585276846|FG000|Overall Study|Lack of Efficacy|0|||
162060823|NCT02373202|585276847|FG001|Overall Study|Lack of Efficacy|0|||
162060824|NCT02373202|585276848|FG002|Overall Study|Lack of Efficacy|1|||
162060825|NCT02373202|585276849|FG003|Overall Study|Lack of Efficacy|0|||
162060826|NCT02373202|585276846|FG000|Overall Study|Other|0|||
162060827|NCT02373202|585276847|FG001|Overall Study|Other|1|||
162060828|NCT02373202|585276848|FG002|Overall Study|Other|0|||
162060829|NCT02373202|585276849|FG003|Overall Study|Other|0|||
162060830|NCT00410046|585276850|FG000|Overall Study|Adverse Event|3|||
162060831|NCT00410046|585276850|FG000|Overall Study|Withdrawal by Subject|1|||
162060832|NCT00410046|585276850|FG000|Overall Study|Lost to Follow-up|1|||
162060833|NCT02310568|585276853|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
162060834|NCT02310568|585276854|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
162060835|NCT02310568|585276855|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
162060836|NCT02310568|585276856|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
162060837|NCT02310568|585276857|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
162060838|NCT02310568|585276853|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
162060839|NCT02310568|585276854|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
162060840|NCT02310568|585276855|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
162060841|NCT02310568|585276856|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
162060842|NCT02310568|585276857|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
162060843|NCT02310568|585276853|FG000|Stage 1 ( 4 Weeks)|Other|1|||
162060844|NCT02310568|585276854|FG001|Stage 1 ( 4 Weeks)|Other|1|||
162060845|NCT02310568|585276855|FG002|Stage 1 ( 4 Weeks)|Other|0|||
162060846|NCT02310568|585276856|FG003|Stage 1 ( 4 Weeks)|Other|0|||
162060847|NCT02310568|585276857|FG004|Stage 1 ( 4 Weeks)|Other|0|||
162060848|NCT02310568|585276853|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
162060849|NCT02310568|585276854|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
162060850|NCT02310568|585276855|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
162060851|NCT02310568|585276856|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
162060852|NCT02310568|585276857|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
162060853|NCT02310568|585276853|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
162060854|NCT02310568|585276854|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
162060855|NCT02310568|585276855|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
162060856|NCT02310568|585276856|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
162060857|NCT02310568|585276857|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
162060858|NCT02310568|585276853|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
162060859|NCT02310568|585276854|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
162060860|NCT02310568|585276855|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
162060861|NCT02310568|585276856|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
162060862|NCT02310568|585276857|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
162060863|NCT02310568|585276853|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
162060864|NCT02310568|585276854|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
162060865|NCT02310568|585276855|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
162060866|NCT02310568|585276856|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
162060867|NCT02310568|585276857|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
162060868|NCT02310568|585276853|FG000|Stage 2 (4 Weeks)|Other|0|||
162060869|NCT02310568|585276854|FG001|Stage 2 (4 Weeks)|Other|1|||
162060870|NCT02310568|585276855|FG002|Stage 2 (4 Weeks)|Other|1|||
162060871|NCT02310568|585276856|FG003|Stage 2 (4 Weeks)|Other|0|||
162060872|NCT02310568|585276857|FG004|Stage 2 (4 Weeks)|Other|0|||
162060873|NCT02310568|585276853|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
162060874|NCT02310568|585276854|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
162060875|NCT02310568|585276855|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
162060876|NCT02310568|585276856|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
162060877|NCT02310568|585276857|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
162060878|NCT02310568|585276853|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
162060879|NCT02310568|585276854|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
162060880|NCT02310568|585276855|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
162060881|NCT02310568|585276856|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
162060882|NCT02310568|585276857|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
162060883|NCT02310568|585276853|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
162060884|NCT02310568|585276854|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
162060885|NCT02310568|585276855|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
162060886|NCT02310568|585276856|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
162060887|NCT02310568|585276857|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
162060888|NCT02989194|585276862|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
162060889|NCT02989194|585276863|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
162060890|NCT02989194|585276864|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
162060891|NCT02989194|585276862|FG000|Overall Study|Lost to Follow-up|0|||
162060892|NCT02989194|585276863|FG001|Overall Study|Lost to Follow-up|1|||
162060893|NCT02989194|585276864|FG002|Overall Study|Lost to Follow-up|0|||
162060894|NCT02989194|585276862|FG000|Overall Study|Withdrawal by Subject|0|||
162060895|NCT02989194|585276863|FG001|Overall Study|Withdrawal by Subject|1|||
162060896|NCT02989194|585276864|FG002|Overall Study|Withdrawal by Subject|0|||
162060897|NCT04160091|585276867|FG000|Overall Study|Terminated by Sponsor|7|||
162060898|NCT04160091|585276868|FG001|Overall Study|Terminated by Sponsor|3|||
162060899|NCT04160091|585276869|FG002|Overall Study|Terminated by Sponsor|5|||
162060900|NCT04160091|585276870|FG003|Overall Study|Terminated by Sponsor|2|||
162060901|NCT04160091|585276867|FG000|Overall Study|Noncompliance|0|||
162060902|NCT04160091|585276868|FG001|Overall Study|Noncompliance|0|||
162060903|NCT04160091|585276869|FG002|Overall Study|Noncompliance|0|||
162060904|NCT04160091|585276870|FG003|Overall Study|Noncompliance|1|||
162060905|NCT04160091|585276867|FG000|Overall Study|Withdrawal by Subject|0|||
162060906|NCT04160091|585276868|FG001|Overall Study|Withdrawal by Subject|0|||
162060907|NCT04160091|585276869|FG002|Overall Study|Withdrawal by Subject|0|||
162060908|NCT04160091|585276870|FG003|Overall Study|Withdrawal by Subject|1|||
162060909|NCT00609492|585276873|FG000|Overall Study|Withdrawal by Subject|0|||
162060910|NCT00609492|585276874|FG001|Overall Study|Withdrawal by Subject|2|||
162060911|NCT00609492|585276875|FG002|Overall Study|Withdrawal by Subject|3|||
162060912|NCT00609492|585276873|FG000|Overall Study|Lost to Follow-up|1|||
162060913|NCT00609492|585276874|FG001|Overall Study|Lost to Follow-up|1|||
162060914|NCT00609492|585276875|FG002|Overall Study|Lost to Follow-up|4|||
162060915|NCT02057406|585276876|FG000|Overall Study|Physician Decision|0|||
162060916|NCT02057406|585276877|FG001|Overall Study|Physician Decision|0|||
162060917|NCT02057406|585276878|FG002|Overall Study|Physician Decision|2|||
162060918|NCT02057406|585276876|FG000|Overall Study|Withdrawal by Subject|0|||
162060919|NCT02057406|585276877|FG001|Overall Study|Withdrawal by Subject|2|||
162060920|NCT02057406|585276878|FG002|Overall Study|Withdrawal by Subject|0|||
162060921|NCT02057406|585276876|FG000|Overall Study|Lost to Follow-up|0|||
162060922|NCT02057406|585276877|FG001|Overall Study|Lost to Follow-up|0|||
162060923|NCT02057406|585276878|FG002|Overall Study|Lost to Follow-up|1|||
162060924|NCT02057406|585276876|FG000|Overall Study|Death|1|||
162060925|NCT02057406|585276877|FG001|Overall Study|Death|0|||
162060926|NCT02057406|585276878|FG002|Overall Study|Death|0|||
162060927|NCT02057406|585276876|FG000|Overall Study|Protocol Violation|0|||
162060928|NCT02057406|585276877|FG001|Overall Study|Protocol Violation|1|||
162060929|NCT02057406|585276878|FG002|Overall Study|Protocol Violation|0|||
162060930|NCT02057406|585276876|FG000|Overall Study|Patient transportation issues|0|||
162060931|NCT02057406|585276877|FG001|Overall Study|Patient transportation issues|0|||
162060932|NCT02057406|585276878|FG002|Overall Study|Patient transportation issues|1|||
162060933|NCT01224431|585276879|FG000|Overall Study|not randomized|0|||
162060934|NCT01224431|585276880|FG001|Overall Study|not randomized|4|||
162060935|NCT01224431|585276879|FG000|Overall Study|no video record|0|||
162060936|NCT01224431|585276880|FG001|Overall Study|no video record|1|||
162060937|NCT02433483|585276881|FG000|Overall Study|Unacceptable toxicity|1|||
162060938|NCT02433483|585276881|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
162060939|NCT00549302|585276890|FG000|Double-Blind|Death|2|||
162060940|NCT00549302|585276891|FG001|Double-Blind|Death|9|||
162060941|NCT00549302|585276892|FG002|Double-Blind|Death|0|||
162060942|NCT00549302|585276890|FG000|Double-Blind|Adverse Event|3|||
162060943|NCT00549302|585276891|FG001|Double-Blind|Adverse Event|16|||
162060944|NCT00549302|585276892|FG002|Double-Blind|Adverse Event|0|||
162060945|NCT00549302|585276890|FG000|Double-Blind|Withdrawal by Subject|3|||
162060946|NCT00549302|585276891|FG001|Double-Blind|Withdrawal by Subject|8|||
162060947|NCT00549302|585276892|FG002|Double-Blind|Withdrawal by Subject|0|||
162060948|NCT00549302|585276890|FG000|Double-Blind|Investigator Decision|1|||
162060949|NCT00549302|585276891|FG001|Double-Blind|Investigator Decision|5|||
162060950|NCT00549302|585276892|FG002|Double-Blind|Investigator Decision|0|||
162060951|NCT00549302|585276890|FG000|Double-Blind|Sponsor Decision|0|||
162060952|NCT00549302|585276891|FG001|Double-Blind|Sponsor Decision|1|||
162060953|NCT00549302|585276892|FG002|Double-Blind|Sponsor Decision|0|||
162060954|NCT00549302|585276890|FG000|Double-Blind|Lost to Follow-up|1|||
162060955|NCT00549302|585276891|FG001|Double-Blind|Lost to Follow-up|2|||
162060956|NCT00549302|585276892|FG002|Double-Blind|Lost to Follow-up|0|||
162060957|NCT00549302|585276890|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
162060958|NCT00549302|585276891|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
162060959|NCT00549302|585276892|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
162060960|NCT00549302|585276890|FG000|Double-Blind|New condition or starts new therapy|0|||
162060961|NCT00549302|585276891|FG001|Double-Blind|New condition or starts new therapy|2|||
162060962|NCT00549302|585276892|FG002|Double-Blind|New condition or starts new therapy|0|||
162060963|NCT00549302|585276890|FG000|Open-Label|Adverse Event|0|||
162060964|NCT00549302|585276891|FG001|Open-Label|Adverse Event|0|||
162060965|NCT00549302|585276892|FG002|Open-Label|Adverse Event|11|||
162060966|NCT00549302|585276890|FG000|Open-Label|Death|0|||
162060967|NCT00549302|585276891|FG001|Open-Label|Death|0|||
162060968|NCT00549302|585276892|FG002|Open-Label|Death|40|||
162060969|NCT00549302|585276890|FG000|Open-Label|Investigator Decision|0|||
162060970|NCT00549302|585276891|FG001|Open-Label|Investigator Decision|0|||
162060971|NCT00549302|585276892|FG002|Open-Label|Investigator Decision|5|||
162060972|NCT00549302|585276890|FG000|Open-Label|Lost to Follow-up|0|||
162060973|NCT00549302|585276891|FG001|Open-Label|Lost to Follow-up|0|||
162060974|NCT00549302|585276892|FG002|Open-Label|Lost to Follow-up|2|||
162060975|NCT00549302|585276890|FG000|Open-Label|Other|0|||
162060976|NCT00549302|585276891|FG001|Open-Label|Other|0|||
162060977|NCT00549302|585276892|FG002|Open-Label|Other|3|||
162060978|NCT00549302|585276890|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
162060979|NCT00549302|585276891|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
162060980|NCT00549302|585276892|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
162060981|NCT00549302|585276890|FG000|Open-Label|Withdrawal by Subject|0|||
162060982|NCT00549302|585276891|FG001|Open-Label|Withdrawal by Subject|0|||
162060983|NCT00549302|585276892|FG002|Open-Label|Withdrawal by Subject|6|||
162060984|NCT01414114|585276893|FG000|Overall Study|Adverse Event|2|||
162060985|NCT01414114|585276893|FG000|Overall Study|Withdrawal by Subject|1|||
162060986|NCT01414114|585276893|FG000|Overall Study|Other|2|||
162060987|NCT05620563|585276894|FG000|Overall Study|Adverse Event|3|||
162060988|NCT05620563|585276895|FG001|Overall Study|Adverse Event|1|||
162060989|NCT05620563|585276894|FG000|Overall Study|Lost to Follow-up|0|||
162060990|NCT05620563|585276895|FG001|Overall Study|Lost to Follow-up|2|||
162060991|NCT05620563|585276894|FG000|Overall Study|Protocol Deviation|1|||
162060992|NCT05620563|585276895|FG001|Overall Study|Protocol Deviation|2|||
162060993|NCT05620563|585276894|FG000|Overall Study|Withdrawal by Subject|3|||
162060994|NCT05620563|585276895|FG001|Overall Study|Withdrawal by Subject|3|||
162060995|NCT05620563|585276894|FG000|Overall Study|Physician Decision|0|||
162060996|NCT05620563|585276895|FG001|Overall Study|Physician Decision|1|||
162060997|NCT00865124|585276896|FG000|Overall Study|Physician Decision|2|||
162060998|NCT00865124|585276897|FG001|Overall Study|Physician Decision|1|||
162060999|NCT00865124|585276898|FG002|Overall Study|Physician Decision|0|||
162061000|NCT00865124|585276896|FG000|Overall Study|Withdrawn consent|2|||
162061001|NCT00865124|585276897|FG001|Overall Study|Withdrawn consent|0|||
162061002|NCT00865124|585276898|FG002|Overall Study|Withdrawn consent|0|||
162061003|NCT02743520|585276899|FG000|Overall Study|Withdrawal by Subject|1|||
162061004|NCT02547649|585276903|FG000|Overall Study|Lost to Follow-up|3|||
162061005|NCT02547649|585276904|FG001|Overall Study|Lost to Follow-up|1|||
162061006|NCT02547649|585276905|FG002|Overall Study|Lost to Follow-up|1|||
162061007|NCT02547649|585276903|FG000|Overall Study|Not vaccinated|0|||
162061008|NCT02547649|585276904|FG001|Overall Study|Not vaccinated|0|||
162061009|NCT02547649|585276905|FG002|Overall Study|Not vaccinated|1|||
162061010|NCT02547649|585276903|FG000|Overall Study|Withdrawal by Subject|0|||
162061011|NCT02547649|585276904|FG001|Overall Study|Withdrawal by Subject|4|||
162061012|NCT02547649|585276905|FG002|Overall Study|Withdrawal by Subject|2|||
162061013|NCT03454997|585276906|FG000|Overall Study|Staff Coach - Left Oranization|1|||
162061014|NCT03454997|585276907|FG001|Overall Study|Staff Coach - Left Oranization|1|||
162061015|NCT03454997|585276906|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
162061016|NCT03454997|585276907|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
162061017|NCT03454997|585276906|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
162061018|NCT03454997|585276907|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
162061019|NCT03454997|585276906|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
162061020|NCT03454997|585276907|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
162061021|NCT03454997|585276906|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
162061022|NCT03454997|585276907|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
162061023|NCT03454997|585276906|FG000|Overall Study|Client with SMI - Left organization|0|||
162061024|NCT03454997|585276907|FG001|Overall Study|Client with SMI - Left organization|1|||
162061025|NCT03454997|585276906|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
162061026|NCT03454997|585276907|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
162061027|NCT01111149|585276912|FG000|Overall Study|Protocol Violation|1|||
162061028|NCT01111149|585276913|FG001|Overall Study|Protocol Violation|1|||
162061029|NCT01111149|585276914|FG002|Overall Study|Protocol Violation|2|||
162061030|NCT01111149|585276912|FG000|Overall Study|Withdrawal by Subject|1|||
162061031|NCT01111149|585276913|FG001|Overall Study|Withdrawal by Subject|0|||
162061032|NCT01111149|585276914|FG002|Overall Study|Withdrawal by Subject|2|||
162061033|NCT00006903|585276919|FG000|Overall Study|Still receiving treatment|0|||
162061034|NCT00006903|585276920|FG001|Overall Study|Still receiving treatment|0|||
162061035|NCT00006903|585276921|FG002|Overall Study|Still receiving treatment|1|||
162061036|NCT00006903|585276919|FG000|Overall Study|Refused further treatment|0|||
162061037|NCT00006903|585276920|FG001|Overall Study|Refused further treatment|2|||
162061038|NCT00006903|585276921|FG002|Overall Study|Refused further treatment|1|||
162061039|NCT00006903|585276919|FG000|Overall Study|Adverse Event|0|||
162061040|NCT00006903|585276920|FG001|Overall Study|Adverse Event|0|||
162061041|NCT00006903|585276921|FG002|Overall Study|Adverse Event|1|||
162061042|NCT00006903|585276919|FG000|Overall Study|Death|0|||
162061043|NCT00006903|585276920|FG001|Overall Study|Death|1|||
162061044|NCT00006903|585276921|FG002|Overall Study|Death|0|||
162061045|NCT00006903|585276919|FG000|Overall Study|Patient never treated|0|||
162061046|NCT00006903|585276920|FG001|Overall Study|Patient never treated|0|||
162061047|NCT00006903|585276921|FG002|Overall Study|Patient never treated|1|||
162061048|NCT00006903|585276919|FG000|Overall Study|Ineligible|10|||
162061049|NCT00006903|585276920|FG001|Overall Study|Ineligible|1|||
162061050|NCT00006903|585276921|FG002|Overall Study|Ineligible|2|||
162061051|NCT01909674|585276922|FG000|Overall Study|Withdrawal by Subject|5|||
162061052|NCT01909674|585276923|FG001|Overall Study|Withdrawal by Subject|2|||
162061053|NCT02794883|585276924|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
162061054|NCT02794883|585276925|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
162061055|NCT02794883|585276926|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
162061056|NCT02794883|585276924|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
162061057|NCT02794883|585276925|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
162061058|NCT02794883|585276926|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
162061059|NCT02794883|585276924|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
162061060|NCT02794883|585276925|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
162061061|NCT02794883|585276926|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
162061062|NCT02794883|585276924|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
162061063|NCT02794883|585276925|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
162061064|NCT02794883|585276926|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
162061065|NCT02794883|585276924|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
162061066|NCT02794883|585276925|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
162061067|NCT02794883|585276926|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
162061068|NCT02794883|585276924|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
162061069|NCT02794883|585276925|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
162061070|NCT02794883|585276926|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
162061071|NCT02794883|585276924|FG000|Follow-up Period (up to 2 Years)|Death|12|||
162061072|NCT02794883|585276925|FG001|Follow-up Period (up to 2 Years)|Death|10|||
162061073|NCT02794883|585276926|FG002|Follow-up Period (up to 2 Years)|Death|10|||
162061074|NCT01678911|585276930|FG000|Second Intervention|Lost to Follow-up|2|||
162061075|NCT01678911|585276931|FG001|Second Intervention|Lost to Follow-up|0|||
162061076|NCT01906008|585276932|FG000|Overall Study|Lost to Follow-up|2|||
162061077|NCT01906008|585276933|FG001|Overall Study|Lost to Follow-up|0|||
162061078|NCT01906008|585276932|FG000|Overall Study|Oxaliplatin toxicity|2|||
162061079|NCT01906008|585276933|FG001|Overall Study|Oxaliplatin toxicity|0|||
162061080|NCT01906008|585276932|FG000|Overall Study|Protocol Violation|0|||
162061081|NCT01906008|585276933|FG001|Overall Study|Protocol Violation|1|||
162061082|NCT01906008|585276932|FG000|Overall Study|Withdrawal by Subject|1|||
162061083|NCT01906008|585276933|FG001|Overall Study|Withdrawal by Subject|5|||
162061084|NCT01906008|585276932|FG000|Overall Study|Did not start study med|3|||
162061085|NCT01906008|585276933|FG001|Overall Study|Did not start study med|4|||
162061086|NCT01906008|585276932|FG000|Overall Study|Oxaliplatin stops|10|||
162061087|NCT01906008|585276933|FG001|Overall Study|Oxaliplatin stops|8|||
162061088|NCT01906008|585276932|FG000|Overall Study|Hospice|1|||
162061089|NCT01906008|585276933|FG001|Overall Study|Hospice|0|||
162061090|NCT01906008|585276932|FG000|Overall Study|Physician Decision|3|||
162061091|NCT01906008|585276933|FG001|Overall Study|Physician Decision|3|||
162061092|NCT01906008|585276932|FG000|Overall Study|Lack of compliance of study med|5|||
162061093|NCT01906008|585276933|FG001|Overall Study|Lack of compliance of study med|3|||
162061094|NCT01906008|585276932|FG000|Overall Study|Adverse Event|0|||
162061095|NCT01906008|585276933|FG001|Overall Study|Adverse Event|3|||
162061096|NCT02117648|585276934|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
162061097|NCT02117648|585276934|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
162061098|NCT02117648|585276934|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
162061099|NCT02117648|585276934|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
162061100|NCT02117648|585276934|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
162061101|NCT02117648|585276934|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
162061102|NCT02117648|585276934|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
162061103|NCT02117648|585276934|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
162061104|NCT02117648|585276934|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
162061105|NCT02117648|585276934|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
162061106|NCT02117648|585276934|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
162061107|NCT05025241|585276936|FG000|Screening|Failed Screening|5|||
162061108|NCT05025241|585276936|FG000|Treatment and Follow Up|Adverse Event|3|||
162061109|NCT02670837|585276937|FG000|Overall Study|Death|2|||
162061110|NCT02670837|585276938|FG001|Overall Study|Death|0|||
162061111|NCT02670837|585276939|FG002|Overall Study|Death|0|||
162061112|NCT02220205|585276940|FG000|Overall Study|Withdrawal by Subject|1|||
162061113|NCT02220205|585276941|FG001|Overall Study|Withdrawal by Subject|0|||
162061114|NCT02266225|585276942|FG000|Overall Study|Lost to Follow-up|2|||
162061115|NCT02266225|585276942|FG000|Overall Study|Death|1|||
162061116|NCT02266225|585276942|FG000|Overall Study|Withdrawal by Subject|13|||
162061117|NCT01574326|585276943|FG000|Overall Study|Randomized but not treated|0|||
162061118|NCT01574326|585276944|FG001|Overall Study|Randomized but not treated|1|||
162061119|NCT01574326|585276943|FG000|Overall Study|Withdrawal by Participant|2|||
162061120|NCT01574326|585276944|FG001|Overall Study|Withdrawal by Participant|4|||
162061121|NCT01574326|585276943|FG000|Overall Study|Physician Decision|5|||
162061122|NCT01574326|585276944|FG001|Overall Study|Physician Decision|3|||
162061123|NCT01574326|585276943|FG000|Overall Study|Adverse Event|1|||
162061124|NCT01574326|585276944|FG001|Overall Study|Adverse Event|3|||
162061125|NCT01574326|585276943|FG000|Overall Study|Other: Mainly kidney transplant|8|||
162061126|NCT01574326|585276944|FG001|Overall Study|Other: Mainly kidney transplant|8|||
162061127|NCT00137046|585276945|FG000|Overall Study|Death|2|||
162061128|NCT00137046|585276946|FG001|Overall Study|Death|1|||
162061129|NCT00137046|585276945|FG000|Overall Study|Adverse Event|16|||
162061130|NCT00137046|585276946|FG001|Overall Study|Adverse Event|5|||
162061131|NCT00137046|585276945|FG000|Overall Study|Laboratory Abnormality|2|||
162061132|NCT00137046|585276946|FG001|Overall Study|Laboratory Abnormality|0|||
162061133|NCT00137046|585276945|FG000|Overall Study|Lack of Efficacy|13|||
162061134|NCT00137046|585276946|FG001|Overall Study|Lack of Efficacy|1|||
162061135|NCT00137046|585276945|FG000|Overall Study|Lost to Follow-up|8|||
162061136|NCT00137046|585276946|FG001|Overall Study|Lost to Follow-up|24|||
162061137|NCT00137046|585276945|FG000|Overall Study|Other|23|||
162061138|NCT00137046|585276946|FG001|Overall Study|Other|19|||
162061139|NCT00137046|585276945|FG000|Overall Study|Withdrawal by Subject|33|||
162061140|NCT00137046|585276946|FG001|Overall Study|Withdrawal by Subject|42|||
162061141|NCT00137046|585276945|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
162061142|NCT00137046|585276946|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
162061143|NCT00137046|585276945|FG000|Overall Study|Withdrew prior to study treatment|1|||
162061144|NCT00137046|585276946|FG001|Overall Study|Withdrew prior to study treatment|1|||
162061145|NCT02268084|585276953|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
162061146|NCT02268084|585276954|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
162061147|NCT02268084|585276953|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
162061148|NCT02268084|585276954|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
162061149|NCT05227027|585276955|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
162061150|NCT05227027|585276956|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
162061151|NCT06149247|585276957|FG000|Overall Study|Adverse Event|0|||
162061152|NCT06149247|585276958|FG001|Overall Study|Adverse Event|1|||
162061153|NCT00371137|585276965|FG000|Overall Study|Adverse Event|20|||
162061154|NCT00371137|585276966|FG001|Overall Study|Adverse Event|35|||
162061155|NCT00371137|585276967|FG002|Overall Study|Adverse Event|42|||
162061156|NCT00371137|585276965|FG000|Overall Study|Withdrawal by Subject|11|||
162061157|NCT00371137|585276966|FG001|Overall Study|Withdrawal by Subject|10|||
162061158|NCT00371137|585276967|FG002|Overall Study|Withdrawal by Subject|15|||
162061159|NCT00371137|585276965|FG000|Overall Study|Lost to Follow-up|6|||
162061160|NCT00371137|585276966|FG001|Overall Study|Lost to Follow-up|3|||
162061161|NCT00371137|585276967|FG002|Overall Study|Lost to Follow-up|5|||
162061162|NCT00371137|585276965|FG000|Overall Study|Lack of Efficacy|30|||
162061163|NCT00371137|585276966|FG001|Overall Study|Lack of Efficacy|12|||
162061164|NCT00371137|585276967|FG002|Overall Study|Lack of Efficacy|13|||
162061165|NCT00371137|585276965|FG000|Overall Study|Sponsor Decision|2|||
162061166|NCT00371137|585276966|FG001|Overall Study|Sponsor Decision|1|||
162061167|NCT00371137|585276967|FG002|Overall Study|Sponsor Decision|2|||
162061168|NCT00371137|585276965|FG000|Overall Study|Physician Decision|1|||
162061169|NCT00371137|585276966|FG001|Overall Study|Physician Decision|1|||
162061170|NCT00371137|585276967|FG002|Overall Study|Physician Decision|1|||
162061171|NCT00371137|585276965|FG000|Overall Study|Protocol Violation|2|||
162061172|NCT00371137|585276966|FG001|Overall Study|Protocol Violation|1|||
162061173|NCT00371137|585276967|FG002|Overall Study|Protocol Violation|1|||
162061174|NCT01756898|585276968|FG000|Overall Study|Adverse Event|7|||
162061175|NCT01756898|585276969|FG001|Overall Study|Adverse Event|1|||
162061176|NCT01756898|585276970|FG002|Overall Study|Adverse Event|0|||
162061177|NCT01756898|585276971|FG003|Overall Study|Adverse Event|0|||
162061178|NCT01756898|585276968|FG000|Overall Study|Lack of Efficacy|4|||
162061179|NCT01756898|585276969|FG001|Overall Study|Lack of Efficacy|7|||
162061180|NCT01756898|585276970|FG002|Overall Study|Lack of Efficacy|6|||
162061181|NCT01756898|585276971|FG003|Overall Study|Lack of Efficacy|6|||
162061182|NCT01756898|585276968|FG000|Overall Study|Lost to Follow-up|2|||
162061183|NCT01756898|585276969|FG001|Overall Study|Lost to Follow-up|4|||
162061184|NCT01756898|585276970|FG002|Overall Study|Lost to Follow-up|2|||
162061185|NCT01756898|585276971|FG003|Overall Study|Lost to Follow-up|3|||
162061186|NCT01756898|585276968|FG000|Overall Study|Protocol Violation|1|||
162061187|NCT01756898|585276969|FG001|Overall Study|Protocol Violation|2|||
162061188|NCT01756898|585276970|FG002|Overall Study|Protocol Violation|2|||
162061189|NCT01756898|585276971|FG003|Overall Study|Protocol Violation|1|||
162061190|NCT01756898|585276968|FG000|Overall Study|Withdrew Consent|5|||
162061191|NCT01756898|585276969|FG001|Overall Study|Withdrew Consent|3|||
162061192|NCT01756898|585276970|FG002|Overall Study|Withdrew Consent|5|||
162061193|NCT01756898|585276971|FG003|Overall Study|Withdrew Consent|6|||
162061194|NCT01756898|585276968|FG000|Overall Study|Other|0|||
162061195|NCT01756898|585276969|FG001|Overall Study|Other|2|||
162061196|NCT01756898|585276970|FG002|Overall Study|Other|2|||
162061197|NCT01756898|585276971|FG003|Overall Study|Other|0|||
162061198|NCT01500694|585276972|FG000|Overall Study|Adverse Event|4|||
162061199|NCT01500694|585276973|FG001|Overall Study|Adverse Event|3|||
162061200|NCT01500694|585276972|FG000|Overall Study|Protocol Violation|0|||
162061201|NCT01500694|585276973|FG001|Overall Study|Protocol Violation|1|||
162061202|NCT01500694|585276972|FG000|Overall Study|Withdrawal by Subject|23|||
162061203|NCT01500694|585276973|FG001|Overall Study|Withdrawal by Subject|14|||
162061204|NCT01500694|585276972|FG000|Overall Study|Lost to Follow-up|2|||
162061205|NCT01500694|585276973|FG001|Overall Study|Lost to Follow-up|3|||
162061206|NCT01500694|585276972|FG000|Overall Study|Lack of Efficacy|14|||
162061207|NCT01500694|585276973|FG001|Overall Study|Lack of Efficacy|5|||
162061208|NCT01500694|585276972|FG000|Overall Study|Other|9|||
162061209|NCT01500694|585276973|FG001|Overall Study|Other|3|||
162061210|NCT02837783|585276974|FG000|Overall Study|Adverse Event|1|||
162061211|NCT02837783|585276975|FG001|Overall Study|Adverse Event|0|||
162061212|NCT02837783|585276974|FG000|Overall Study|Other, Not Specified|1|||
162061213|NCT02837783|585276975|FG001|Overall Study|Other, Not Specified|2|||
162061214|NCT01438424|585278803|FG000|Overall Study|Continuing treatment|29|||
162061215|NCT01438424|585278803|FG000|Overall Study|Minimal virologic response|95|||
162061216|NCT01438424|585278803|FG000|Overall Study|Not identified|55|||
162061217|NCT01438424|585278803|FG000|Overall Study|Withdrawal by Subject|104|||
162061218|NCT01438424|585278803|FG000|Overall Study|Progression of chronic hepatitis B|22|||
162061219|NCT01438424|585278803|FG000|Overall Study|Death|22|||
162061220|NCT01438424|585278803|FG000|Overall Study|Adverse Event|17|||
162061221|NCT01438424|585278803|FG000|Overall Study|Lost to Follow-up|17|||
162061222|NCT01438424|585278803|FG000|Overall Study|Abnormal laboratory test result|14|||
162061223|NCT01438424|585278803|FG000|Overall Study|Need for drug prohibited by protocol|14|||
162061224|NCT01438424|585278803|FG000|Overall Study|Pregnancy|7|||
162061225|NCT01438424|585278803|FG000|Overall Study|No longer met inclusion criteria|1|||
162061226|NCT01438424|585278803|FG000|Overall Study|Participant noncompliance|20|||
162061227|NCT02927080|585278804|FG000|Overall Study|Withdrawal by Subject|0|||
162061228|NCT02927080|585278805|FG001|Overall Study|Withdrawal by Subject|0|||
162061229|NCT02927080|585278806|FG002|Overall Study|Withdrawal by Subject|0|||
162061230|NCT02927080|585278807|FG003|Overall Study|Withdrawal by Subject|0|||
162061231|NCT02927080|585278808|FG004|Overall Study|Withdrawal by Subject|1|||
162061232|NCT02927080|585278809|FG005|Overall Study|Withdrawal by Subject|0|||
162061233|NCT02927080|585278810|FG006|Overall Study|Withdrawal by Subject|1|||
162061234|NCT02927080|585278811|FG007|Overall Study|Withdrawal by Subject|1|||
162061235|NCT02927080|585278812|FG008|Overall Study|Withdrawal by Subject|0|||
162061236|NCT02927080|585278813|FG009|Overall Study|Withdrawal by Subject|2|||
162061237|NCT02927080|585278804|FG000|Overall Study|Willingness to comply with protocol|0|||
162061238|NCT02927080|585278805|FG001|Overall Study|Willingness to comply with protocol|0|||
162061239|NCT02927080|585278806|FG002|Overall Study|Willingness to comply with protocol|0|||
162061240|NCT02927080|585278807|FG003|Overall Study|Willingness to comply with protocol|0|||
162061241|NCT02927080|585278808|FG004|Overall Study|Willingness to comply with protocol|0|||
162061242|NCT02927080|585278809|FG005|Overall Study|Willingness to comply with protocol|0|||
162061243|NCT02927080|585278810|FG006|Overall Study|Willingness to comply with protocol|0|||
162061244|NCT02927080|585278811|FG007|Overall Study|Willingness to comply with protocol|0|||
162061245|NCT02927080|585278812|FG008|Overall Study|Willingness to comply with protocol|0|||
162061246|NCT02927080|585278813|FG009|Overall Study|Willingness to comply with protocol|1|||
162061247|NCT02927080|585278804|FG000|Overall Study|Study terminated by Sponsor|0|||
162061248|NCT02927080|585278805|FG001|Overall Study|Study terminated by Sponsor|0|||
162061249|NCT02927080|585278806|FG002|Overall Study|Study terminated by Sponsor|0|||
162061250|NCT02927080|585278807|FG003|Overall Study|Study terminated by Sponsor|0|||
162061251|NCT02927080|585278808|FG004|Overall Study|Study terminated by Sponsor|0|||
162061252|NCT02927080|585278809|FG005|Overall Study|Study terminated by Sponsor|0|||
162061253|NCT02927080|585278810|FG006|Overall Study|Study terminated by Sponsor|6|||
162061254|NCT02927080|585278811|FG007|Overall Study|Study terminated by Sponsor|7|||
162061255|NCT02927080|585278812|FG008|Overall Study|Study terminated by Sponsor|2|||
162061256|NCT02927080|585278813|FG009|Overall Study|Study terminated by Sponsor|3|||
162061257|NCT02927080|585278804|FG000|Overall Study|Adverse Event|0|||
162061258|NCT02927080|585278805|FG001|Overall Study|Adverse Event|1|||
162061259|NCT02927080|585278806|FG002|Overall Study|Adverse Event|0|||
162061260|NCT02927080|585278807|FG003|Overall Study|Adverse Event|0|||
162061261|NCT02927080|585278808|FG004|Overall Study|Adverse Event|0|||
162061262|NCT02927080|585278809|FG005|Overall Study|Adverse Event|0|||
162061263|NCT02927080|585278810|FG006|Overall Study|Adverse Event|0|||
162061264|NCT02927080|585278811|FG007|Overall Study|Adverse Event|1|||
162061265|NCT02927080|585278812|FG008|Overall Study|Adverse Event|0|||
162061266|NCT02927080|585278813|FG009|Overall Study|Adverse Event|1|||
162061267|NCT02927080|585278804|FG000|Overall Study|Other|0|||
162061268|NCT02927080|585278805|FG001|Overall Study|Other|0|||
162061269|NCT02927080|585278806|FG002|Overall Study|Other|0|||
162061270|NCT02927080|585278807|FG003|Overall Study|Other|0|||
162061271|NCT02927080|585278808|FG004|Overall Study|Other|0|||
162061272|NCT02927080|585278809|FG005|Overall Study|Other|0|||
162061273|NCT02927080|585278810|FG006|Overall Study|Other|1|||
162061274|NCT02927080|585278811|FG007|Overall Study|Other|0|||
162061275|NCT02927080|585278812|FG008|Overall Study|Other|1|||
162061276|NCT02927080|585278813|FG009|Overall Study|Other|0|||
162061277|NCT01411228|585278815|FG000|Overall Study|Lost to Follow-up|0|||
162061278|NCT01411228|585278816|FG001|Overall Study|Lost to Follow-up|0|||
162061279|NCT01411228|585278817|FG002|Overall Study|Lost to Follow-up|1|||
162061280|NCT01411228|585278815|FG000|Overall Study|Withdrawal by Subject|1|||
162061281|NCT01411228|585278816|FG001|Overall Study|Withdrawal by Subject|0|||
162061282|NCT01411228|585278817|FG002|Overall Study|Withdrawal by Subject|0|||
162061283|NCT00664742|585278818|FG000|Overall Study|Withdrawn due to adverse events|3|||
162061284|NCT00664742|585278818|FG000|Overall Study|Withdrawal by Subject|31|||
162061285|NCT00664742|585278818|FG000|Overall Study|Lost to Follow-up|92|||
162061286|NCT02670083|585278819|FG000|Overall Study|Adverse Event|16|||
162061287|NCT02670083|585278820|FG001|Overall Study|Adverse Event|13|||
162061288|NCT02670083|585278819|FG000|Overall Study|Death|4|||
162061289|NCT02670083|585278820|FG001|Overall Study|Death|6|||
162061290|NCT02670083|585278819|FG000|Overall Study|Lost to Follow-up|2|||
162061291|NCT02670083|585278820|FG001|Overall Study|Lost to Follow-up|2|||
162061292|NCT02670083|585278819|FG000|Overall Study|Multiple Reasons|9|||
162061293|NCT02670083|585278820|FG001|Overall Study|Multiple Reasons|9|||
162061294|NCT02670083|585278819|FG000|Overall Study|Physician Decision|0|||
162061295|NCT02670083|585278820|FG001|Overall Study|Physician Decision|2|||
162061296|NCT02670083|585278819|FG000|Overall Study|Study Terminated By Sponsor|257|||
162061297|NCT02670083|585278820|FG001|Overall Study|Study Terminated By Sponsor|254|||
162061298|NCT02670083|585278819|FG000|Overall Study|Symptomatic Deterioration|0|||
162061299|NCT02670083|585278820|FG001|Overall Study|Symptomatic Deterioration|2|||
162061300|NCT02670083|585278819|FG000|Overall Study|Withdrawal by Subject|32|||
162061301|NCT02670083|585278820|FG001|Overall Study|Withdrawal by Subject|31|||
162061302|NCT02670083|585278819|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162061303|NCT02670083|585278820|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162061304|NCT02825992|585278821|FG000|Overall Study|Withdrawal by Subject|4|||
162061305|NCT02825992|585278821|FG000|Overall Study|Lost to Follow-up|2|||
162061306|NCT02825992|585278821|FG000|Overall Study|Procedure terminated|2|||
162061307|NCT02904512|585278826|FG000|Overall Study|Withdrawal by Subject|1|||
162061308|NCT02904512|585278827|FG001|Overall Study|Withdrawal by Subject|0|||
162061309|NCT02904512|585278826|FG000|Overall Study|Transferred to ICU|1|||
162061310|NCT02904512|585278827|FG001|Overall Study|Transferred to ICU|0|||
162061311|NCT02904512|585278826|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
162061312|NCT02904512|585278827|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
162061313|NCT01963403|585278828|FG000|Overall Study|Lost to Follow-up|2|||
162061314|NCT01963403|585278829|FG001|Overall Study|Lost to Follow-up|3|||
162061315|NCT01963403|585278828|FG000|Overall Study|Implant removal|0|||
162061316|NCT01963403|585278829|FG001|Overall Study|Implant removal|1|||
162061317|NCT00779467|585278830|FG000|Overall Study|Lack of Efficacy|11|||
162061318|NCT00779467|585278831|FG001|Overall Study|Lack of Efficacy|2|||
162061319|NCT00779467|585278832|FG002|Overall Study|Lack of Efficacy|6|||
162061320|NCT00779467|585278833|FG003|Overall Study|Lack of Efficacy|11|||
162061321|NCT00779467|585278830|FG000|Overall Study|failed inclusion criteria|3|||
162061322|NCT00779467|585278831|FG001|Overall Study|failed inclusion criteria|3|||
162061323|NCT00779467|585278832|FG002|Overall Study|failed inclusion criteria|1|||
162061324|NCT00779467|585278833|FG003|Overall Study|failed inclusion criteria|2|||
162061325|NCT00779467|585278830|FG000|Overall Study|missing data|1|||
162061326|NCT00779467|585278831|FG001|Overall Study|missing data|0|||
162061327|NCT00779467|585278832|FG002|Overall Study|missing data|1|||
162061328|NCT00779467|585278833|FG003|Overall Study|missing data|4|||
162061329|NCT00779467|585278830|FG000|Overall Study|technical issue|0|||
162061330|NCT00779467|585278831|FG001|Overall Study|technical issue|0|||
162061331|NCT00779467|585278832|FG002|Overall Study|technical issue|2|||
162061332|NCT00779467|585278833|FG003|Overall Study|technical issue|1|||
162061333|NCT00779467|585278830|FG000|Overall Study|unavailable research staff|0|||
162061334|NCT00779467|585278831|FG001|Overall Study|unavailable research staff|0|||
162061335|NCT00779467|585278832|FG002|Overall Study|unavailable research staff|0|||
162061336|NCT00779467|585278833|FG003|Overall Study|unavailable research staff|1|||
162061337|NCT00460408|585278840|FG000|Overall Study|Adverse Event|1|||
162061338|NCT00460408|585278841|FG001|Overall Study|Adverse Event|0|||
162061339|NCT00460408|585278842|FG002|Overall Study|Adverse Event|0|||
162061340|NCT00460408|585278843|FG003|Overall Study|Adverse Event|0|||
162061341|NCT00460408|585278840|FG000|Overall Study|Death|7|||
162061342|NCT00460408|585278841|FG001|Overall Study|Death|0|||
162061343|NCT00460408|585278842|FG002|Overall Study|Death|0|||
162061344|NCT00460408|585278843|FG003|Overall Study|Death|0|||
162061345|NCT00460408|585278840|FG000|Overall Study|Lost to Follow-up|11|||
162061346|NCT00460408|585278841|FG001|Overall Study|Lost to Follow-up|0|||
162061347|NCT00460408|585278842|FG002|Overall Study|Lost to Follow-up|1|||
162061348|NCT00460408|585278843|FG003|Overall Study|Lost to Follow-up|0|||
162061349|NCT00460408|585278840|FG000|Overall Study|Withdrawal by Subject|31|||
162061350|NCT00460408|585278841|FG001|Overall Study|Withdrawal by Subject|0|||
162061351|NCT00460408|585278842|FG002|Overall Study|Withdrawal by Subject|0|||
162061352|NCT00460408|585278843|FG003|Overall Study|Withdrawal by Subject|0|||
162061353|NCT00460408|585278840|FG000|Overall Study|Insufficient clinical response|5|||
162061354|NCT00460408|585278841|FG001|Overall Study|Insufficient clinical response|1|||
162061355|NCT00460408|585278842|FG002|Overall Study|Insufficient clinical response|5|||
162061356|NCT00460408|585278843|FG003|Overall Study|Insufficient clinical response|0|||
162061357|NCT00460408|585278840|FG000|Overall Study|Other|12|||
162061358|NCT00460408|585278841|FG001|Overall Study|Other|2|||
162061359|NCT00460408|585278842|FG002|Overall Study|Other|0|||
162061360|NCT00460408|585278843|FG003|Overall Study|Other|0|||
162061361|NCT02573350|585278844|FG000|Overall Study|Lost to Follow-up|2|||
162061362|NCT02573350|585278845|FG001|Overall Study|Lost to Follow-up|1|||
162061363|NCT02573350|585278844|FG000|Overall Study|Adverse Event|3|||
162061364|NCT02573350|585278845|FG001|Overall Study|Adverse Event|4|||
162061365|NCT02573350|585278844|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
162061366|NCT02573350|585278845|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
162061367|NCT02573350|585278844|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
162061368|NCT02573350|585278845|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
162061369|NCT02573350|585278844|FG000|Overall Study|Subject withdrew consent to participate|6|||
162061370|NCT02573350|585278845|FG001|Overall Study|Subject withdrew consent to participate|1|||
162061371|NCT02573350|585278844|FG000|Overall Study|Protocol Deviation|1|||
162061372|NCT02573350|585278845|FG001|Overall Study|Protocol Deviation|1|||
162061373|NCT01442493|585278846|FG000|Overall Study|withdrawn from study|3|||
162061374|NCT01442493|585278847|FG001|Overall Study|withdrawn from study|2|||
162061375|NCT00938639|585278848|FG000|Overall Study|Moved away from study area|0|||
162061376|NCT00938639|585278849|FG001|Overall Study|Moved away from study area|1|||
162061377|NCT00938639|585278848|FG000|Overall Study|Lost to Follow-up|1|||
162061378|NCT00938639|585278849|FG001|Overall Study|Lost to Follow-up|2|||
162061379|NCT00938639|585278848|FG000|Overall Study|Family issues|1|||
162061380|NCT00938639|585278849|FG001|Overall Study|Family issues|1|||
162061381|NCT00938639|585278848|FG000|Overall Study|Participant noncompliance|1|||
162061382|NCT00938639|585278849|FG001|Overall Study|Participant noncompliance|0|||
162061383|NCT04326231|585278852|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
162061384|NCT03303079|585278853|FG000|Overall Study|Adverse Event|0|||
162061385|NCT03303079|585278854|FG001|Overall Study|Adverse Event|1|||
162061386|NCT03303079|585278855|FG002|Overall Study|Adverse Event|3|||
162061387|NCT03303079|585278853|FG000|Overall Study|Protocol Violation|5|||
162061388|NCT03303079|585278854|FG001|Overall Study|Protocol Violation|4|||
162061389|NCT03303079|585278855|FG002|Overall Study|Protocol Violation|7|||
162061390|NCT03303079|585278853|FG000|Overall Study|Withdrawal by Subject|2|||
162061391|NCT03303079|585278854|FG001|Overall Study|Withdrawal by Subject|4|||
162061392|NCT03303079|585278855|FG002|Overall Study|Withdrawal by Subject|2|||
162061393|NCT03303079|585278853|FG000|Overall Study|Other than specified|0|||
162061394|NCT03303079|585278854|FG001|Overall Study|Other than specified|2|||
162061395|NCT03303079|585278855|FG002|Overall Study|Other than specified|0|||
162061396|NCT01830972|585278862|FG000|Part II|Withdrawal by Subject|2|||
162061397|NCT01830972|585278863|FG001|Part II|Withdrawal by Subject|2|||
162061398|NCT01830972|585278862|FG000|Part III|Withdrawal by Subject|1|||
162061399|NCT01830972|585278863|FG001|Part III|Withdrawal by Subject|0|||
162061400|NCT01830972|585278862|FG000|Part III|Noncompliance|1|||
162061401|NCT01830972|585278863|FG001|Part III|Noncompliance|0|||
162061402|NCT01830972|585278862|FG000|Part IV|Withdrawal by Subject|2|||
162061403|NCT01830972|585278863|FG001|Part IV|Withdrawal by Subject|1|||
162061404|NCT01830972|585278862|FG000|Part IV|Non-Compliance|1|||
162061405|NCT01830972|585278863|FG001|Part IV|Non-Compliance|0|||
162061406|NCT00660309|585278866|FG000|Overall Study|Adverse Event|2|||
162061407|NCT00660309|585278867|FG001|Overall Study|Adverse Event|0|||
162061408|NCT00660309|585278866|FG000|Overall Study|Withdrawal by Subject|0|||
162061409|NCT00660309|585278867|FG001|Overall Study|Withdrawal by Subject|3|||
162061410|NCT02532972|585278871|FG000|Overall Study|Withdrawal by Subject|1|||
162061411|NCT00110149|585278872|FG000|Overall Study|Physician Decision|3|||
162061412|NCT00748033|585278873|FG000|Overall Study|Adverse Event|0|||
162061413|NCT00748033|585278874|FG001|Overall Study|Adverse Event|1|||
162061414|NCT01018186|585278875|FG000|2-week Run-in Period|Protocol Violation|1|||
162061415|NCT01018186|585278876|FG001|2-week Run-in Period|Protocol Violation|0|||
162061416|NCT01018186|585278877|FG002|2-week Run-in Period|Protocol Violation|0|||
162061417|NCT01018186|585278878|FG003|2-week Run-in Period|Protocol Violation|0|||
162061418|NCT01018186|585278875|FG000|2-week Run-in Period|Lost to Follow-up|2|||
162061419|NCT01018186|585278876|FG001|2-week Run-in Period|Lost to Follow-up|0|||
162061420|NCT01018186|585278877|FG002|2-week Run-in Period|Lost to Follow-up|0|||
162061421|NCT01018186|585278878|FG003|2-week Run-in Period|Lost to Follow-up|0|||
162061422|NCT01018186|585278875|FG000|2-week Run-in Period|Physician Decision|3|||
162061423|NCT01018186|585278876|FG001|2-week Run-in Period|Physician Decision|0|||
162061424|NCT01018186|585278877|FG002|2-week Run-in Period|Physician Decision|0|||
162061425|NCT01018186|585278878|FG003|2-week Run-in Period|Physician Decision|0|||
162061426|NCT01018186|585278875|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
162061427|NCT01018186|585278876|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
162061428|NCT01018186|585278877|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
162061429|NCT01018186|585278878|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
162061430|NCT01018186|585278875|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
162061431|NCT01018186|585278876|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
162061432|NCT01018186|585278877|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
162061433|NCT01018186|585278878|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
162061434|NCT01018186|585278875|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
162061435|NCT01018186|585278876|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
162061436|NCT01018186|585278877|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
162061437|NCT01018186|585278878|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
162061438|NCT01018186|585278875|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
162061439|NCT01018186|585278876|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
162061440|NCT01018186|585278877|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
162061441|NCT01018186|585278878|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
162061442|NCT01018186|585278875|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
162061443|NCT01018186|585278876|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
162061444|NCT01018186|585278877|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
162061445|NCT01018186|585278878|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
162061446|NCT01018186|585278875|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
162061447|NCT01018186|585278876|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
162061448|NCT01018186|585278877|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
162061449|NCT01018186|585278878|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
162061450|NCT01018186|585278875|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
162061451|NCT01018186|585278876|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
162061452|NCT01018186|585278877|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
162061453|NCT01018186|585278878|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
162061454|NCT01018186|585278875|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
162061455|NCT01018186|585278876|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
162061456|NCT01018186|585278877|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
162061457|NCT01018186|585278878|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
162061458|NCT01018186|585278875|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
162061459|NCT01018186|585278876|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
162061460|NCT01018186|585278877|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
162061461|NCT01018186|585278878|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
162061462|NCT02603419|585278879|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
162061463|NCT02603419|585278880|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
162061464|NCT02603419|585278881|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
162061465|NCT02603419|585278882|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
162061466|NCT02603419|585278883|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
162061467|NCT02603419|585278884|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
162061468|NCT02603419|585278879|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
162061469|NCT02603419|585278880|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
162061470|NCT02603419|585278881|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
162061471|NCT02603419|585278882|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
162061472|NCT02603419|585278883|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
162061473|NCT02603419|585278884|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
162061474|NCT02603419|585278879|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
162061475|NCT02603419|585278880|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
162061476|NCT02603419|585278881|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
162061477|NCT02603419|585278882|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
162061478|NCT02603419|585278883|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
162061479|NCT02603419|585278884|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
162061480|NCT02603419|585278879|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
162061481|NCT02603419|585278880|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
162061482|NCT02603419|585278881|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
162061483|NCT02603419|585278882|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
162061484|NCT02603419|585278883|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
162061485|NCT02603419|585278884|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
162061486|NCT02603419|585278879|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
162061487|NCT02603419|585278880|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
162061488|NCT02603419|585278881|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
162061489|NCT02603419|585278882|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
162061490|NCT02603419|585278883|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
162061491|NCT02603419|585278884|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
162061492|NCT02603419|585278879|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
162061493|NCT02603419|585278880|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
162061494|NCT02603419|585278881|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
162061495|NCT02603419|585278882|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
162061496|NCT02603419|585278883|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
162061497|NCT02603419|585278884|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
162061498|NCT02603419|585278879|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
162061499|NCT02603419|585278880|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
162061500|NCT02603419|585278881|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
162061501|NCT02603419|585278882|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
162061502|NCT02603419|585278883|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
162061503|NCT02603419|585278884|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
162061504|NCT02603419|585278879|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
162061505|NCT02603419|585278880|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
162061506|NCT02603419|585278881|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
162061507|NCT02603419|585278882|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
162061508|NCT02603419|585278883|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
162061509|NCT02603419|585278884|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
162061510|NCT02603419|585278879|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
162061511|NCT02603419|585278880|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
162061512|NCT02603419|585278881|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
162061513|NCT02603419|585278882|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
162061514|NCT02603419|585278883|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
162061515|NCT02603419|585278884|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
162061516|NCT02603419|585278879|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
162061517|NCT02603419|585278880|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
162061518|NCT02603419|585278881|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
162061519|NCT02603419|585278882|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
162061520|NCT02603419|585278883|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
162061521|NCT02603419|585278884|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
162061522|NCT03552198|585278885|FG000|Overall Study|Lost to Follow-up|42|||
162061523|NCT03552198|585278886|FG001|Overall Study|Lost to Follow-up|48|||
162061524|NCT03552198|585278887|FG002|Overall Study|Lost to Follow-up|15|||
162061525|NCT03552198|585278888|FG003|Overall Study|Lost to Follow-up|19|||
162061526|NCT03552198|585278885|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
162061527|NCT03552198|585278886|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
162061528|NCT03552198|585278887|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
162061529|NCT03552198|585278888|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
162061530|NCT03552198|585278885|FG000|Overall Study|Did not receive air alerts|1|||
162061531|NCT03552198|585278886|FG001|Overall Study|Did not receive air alerts|0|||
162061532|NCT03552198|585278887|FG002|Overall Study|Did not receive air alerts|0|||
162061533|NCT03552198|585278888|FG003|Overall Study|Did not receive air alerts|1|||
162061534|NCT02925494|585278889|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
162061535|NCT02925494|585278890|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
162061536|NCT02925494|585278891|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
162061537|NCT02925494|585278892|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
162061538|NCT02925494|585278889|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
162061539|NCT02925494|585278890|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
162061540|NCT02925494|585278891|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
162061541|NCT02925494|585278892|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
162061542|NCT02925494|585278889|FG000|Post-Treatment Follow-Up Period|Other|1|||
162061543|NCT02925494|585278890|FG001|Post-Treatment Follow-Up Period|Other|4|||
162061544|NCT02925494|585278891|FG002|Post-Treatment Follow-Up Period|Other|3|||
162061545|NCT02925494|585278892|FG003|Post-Treatment Follow-Up Period|Other|6|||
162061546|NCT02925494|585278889|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
162061547|NCT02925494|585278890|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
162061548|NCT02925494|585278891|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
162061549|NCT02925494|585278892|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
162061550|NCT02925494|585278889|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
162061551|NCT02925494|585278890|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
162061552|NCT02925494|585278891|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
162061553|NCT02925494|585278892|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
162061554|NCT02925494|585278889|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
162061555|NCT02925494|585278890|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
162061556|NCT02925494|585278891|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
162061557|NCT02925494|585278892|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
162061558|NCT02925494|585278889|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
162061559|NCT02925494|585278890|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
162061560|NCT02925494|585278891|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
162061561|NCT02925494|585278892|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
162061562|NCT01666782|585278898|FG000|Overall Study|Received 2 doses of vaccine|0|||
162061563|NCT01666782|585278899|FG001|Overall Study|Received 2 doses of vaccine|1|||
162061564|NCT01666782|585278898|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
162061565|NCT01666782|585278899|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
162061566|NCT02007109|585278902|FG000|Overall Study|Diary not returned or excluded|102|||
162061567|NCT02007109|585278902|FG000|Overall Study|Excluded - Age<7yo|9|||
162061568|NCT03572062|585278903|FG000|Overall Study|Adverse Event|0|||
162061569|NCT03572062|585278904|FG001|Overall Study|Adverse Event|0|||
162061570|NCT03572062|585278905|FG002|Overall Study|Adverse Event|0|||
162061571|NCT03572062|585278906|FG003|Overall Study|Adverse Event|0|||
162061572|NCT03572062|585278907|FG004|Overall Study|Adverse Event|0|||
162061573|NCT03572062|585278908|FG005|Overall Study|Adverse Event|0|||
162061574|NCT03572062|585278909|FG006|Overall Study|Adverse Event|0|||
162061575|NCT03572062|585278910|FG007|Overall Study|Adverse Event|0|||
162061576|NCT03572062|585278911|FG008|Overall Study|Adverse Event|1|||
162061577|NCT03572062|585278912|FG009|Overall Study|Adverse Event|3|||
162061578|NCT03572062|585278903|FG000|Overall Study|Death|0|||
162061579|NCT03572062|585278904|FG001|Overall Study|Death|0|||
162061580|NCT03572062|585278905|FG002|Overall Study|Death|0|||
162061581|NCT03572062|585278906|FG003|Overall Study|Death|0|||
162061582|NCT03572062|585278907|FG004|Overall Study|Death|0|||
162061583|NCT03572062|585278908|FG005|Overall Study|Death|1|||
162061584|NCT03572062|585278909|FG006|Overall Study|Death|0|||
162061585|NCT03572062|585278910|FG007|Overall Study|Death|0|||
162061586|NCT03572062|585278911|FG008|Overall Study|Death|0|||
162061587|NCT03572062|585278912|FG009|Overall Study|Death|0|||
162061588|NCT03572062|585278903|FG000|Overall Study|Lost to Follow-up|0|||
162061589|NCT03572062|585278904|FG001|Overall Study|Lost to Follow-up|0|||
162061590|NCT03572062|585278905|FG002|Overall Study|Lost to Follow-up|0|||
162061591|NCT03572062|585278906|FG003|Overall Study|Lost to Follow-up|0|||
162061592|NCT03572062|585278907|FG004|Overall Study|Lost to Follow-up|0|||
162061593|NCT03572062|585278908|FG005|Overall Study|Lost to Follow-up|1|||
162061594|NCT03572062|585278909|FG006|Overall Study|Lost to Follow-up|1|||
162061595|NCT03572062|585278910|FG007|Overall Study|Lost to Follow-up|0|||
162061596|NCT03572062|585278911|FG008|Overall Study|Lost to Follow-up|0|||
162061597|NCT03572062|585278912|FG009|Overall Study|Lost to Follow-up|0|||
162061598|NCT03572062|585278903|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
162061599|NCT03572062|585278904|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
162061600|NCT03572062|585278905|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
162061601|NCT03572062|585278906|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
162061602|NCT03572062|585278907|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
162061603|NCT03572062|585278908|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
162061604|NCT03572062|585278909|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
162061605|NCT03572062|585278910|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
162061606|NCT03572062|585278911|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
162061607|NCT03572062|585278912|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
162061608|NCT03572062|585278903|FG000|Overall Study|Study Terminated By Sponsor|0|||
162061609|NCT03572062|585278904|FG001|Overall Study|Study Terminated By Sponsor|0|||
162061610|NCT03572062|585278905|FG002|Overall Study|Study Terminated By Sponsor|0|||
162061611|NCT03572062|585278906|FG003|Overall Study|Study Terminated By Sponsor|0|||
162061612|NCT03572062|585278907|FG004|Overall Study|Study Terminated By Sponsor|0|||
162061613|NCT03572062|585278908|FG005|Overall Study|Study Terminated By Sponsor|0|||
162061614|NCT03572062|585278909|FG006|Overall Study|Study Terminated By Sponsor|0|||
162061615|NCT03572062|585278910|FG007|Overall Study|Study Terminated By Sponsor|0|||
162061616|NCT03572062|585278911|FG008|Overall Study|Study Terminated By Sponsor|29|||
162061617|NCT03572062|585278912|FG009|Overall Study|Study Terminated By Sponsor|27|||
162061618|NCT03572062|585278903|FG000|Overall Study|Physician Decision|0|||
162061619|NCT03572062|585278904|FG001|Overall Study|Physician Decision|0|||
162061620|NCT03572062|585278905|FG002|Overall Study|Physician Decision|0|||
162061621|NCT03572062|585278906|FG003|Overall Study|Physician Decision|0|||
162061622|NCT03572062|585278907|FG004|Overall Study|Physician Decision|0|||
162061623|NCT03572062|585278908|FG005|Overall Study|Physician Decision|0|||
162061624|NCT03572062|585278909|FG006|Overall Study|Physician Decision|0|||
162061625|NCT03572062|585278910|FG007|Overall Study|Physician Decision|0|||
162061626|NCT03572062|585278911|FG008|Overall Study|Physician Decision|1|||
162061627|NCT03572062|585278912|FG009|Overall Study|Physician Decision|0|||
162061628|NCT03572062|585278903|FG000|Overall Study|Withdrawal by Subject|0|||
162061629|NCT03572062|585278904|FG001|Overall Study|Withdrawal by Subject|0|||
162061630|NCT03572062|585278905|FG002|Overall Study|Withdrawal by Subject|0|||
162061631|NCT03572062|585278906|FG003|Overall Study|Withdrawal by Subject|0|||
162061632|NCT03572062|585278907|FG004|Overall Study|Withdrawal by Subject|0|||
162061633|NCT03572062|585278908|FG005|Overall Study|Withdrawal by Subject|0|||
162061634|NCT03572062|585278909|FG006|Overall Study|Withdrawal by Subject|0|||
162061635|NCT03572062|585278910|FG007|Overall Study|Withdrawal by Subject|0|||
162061636|NCT03572062|585278911|FG008|Overall Study|Withdrawal by Subject|0|||
162061637|NCT03572062|585278912|FG009|Overall Study|Withdrawal by Subject|1|||
162061638|NCT03572062|585278903|FG000|Overall Study|Randomized But Not Treated|0|||
162061639|NCT03572062|585278904|FG001|Overall Study|Randomized But Not Treated|0|||
162061640|NCT03572062|585278905|FG002|Overall Study|Randomized But Not Treated|0|||
162061641|NCT03572062|585278906|FG003|Overall Study|Randomized But Not Treated|0|||
162061642|NCT03572062|585278907|FG004|Overall Study|Randomized But Not Treated|1|||
162061643|NCT03572062|585278908|FG005|Overall Study|Randomized But Not Treated|2|||
162061644|NCT03572062|585278909|FG006|Overall Study|Randomized But Not Treated|0|||
162061645|NCT03572062|585278910|FG007|Overall Study|Randomized But Not Treated|1|||
162061646|NCT03572062|585278911|FG008|Overall Study|Randomized But Not Treated|0|||
162061647|NCT03572062|585278912|FG009|Overall Study|Randomized But Not Treated|0|||
162061648|NCT01858389|585278913|FG000|Overall Study|Death|1|||
162061649|NCT01858389|585278914|FG001|Overall Study|Death|3|||
162061650|NCT01858389|585278913|FG000|Overall Study|Study terminated by sponsor|0|||
162061651|NCT01858389|585278914|FG001|Overall Study|Study terminated by sponsor|2|||
162061652|NCT01858389|585278913|FG000|Overall Study|Withdrawal by Subject|0|||
162061653|NCT01858389|585278914|FG001|Overall Study|Withdrawal by Subject|1|||
162061654|NCT01858389|585278913|FG000|Overall Study|Progressive disease|10|||
162061655|NCT01858389|585278914|FG001|Overall Study|Progressive disease|11|||
162061656|NCT01858389|585278913|FG000|Overall Study|Other|2|||
162061657|NCT01858389|585278914|FG001|Overall Study|Other|4|||
162061658|NCT01858389|585278913|FG000|Overall Study|Adverse Event|3|||
162061659|NCT01858389|585278914|FG001|Overall Study|Adverse Event|1|||
162061660|NCT01858389|585278913|FG000|Overall Study|Did not receive treatment|0|||
162061661|NCT01858389|585278914|FG001|Overall Study|Did not receive treatment|3|||
162061662|NCT01691781|585278915|FG000|Overall Study|Withdrawal by Subject|4|||
162061663|NCT01691781|585278916|FG001|Overall Study|Withdrawal by Subject|3|||
162061664|NCT01691781|585278915|FG000|Overall Study|Physician Decision|1|||
162061665|NCT01691781|585278916|FG001|Overall Study|Physician Decision|1|||
162061666|NCT01691781|585278915|FG000|Overall Study|Protocol Violation|2|||
162061667|NCT01691781|585278916|FG001|Overall Study|Protocol Violation|2|||
162061668|NCT01691781|585278915|FG000|Overall Study|Adverse Event|0|||
162061669|NCT01691781|585278916|FG001|Overall Study|Adverse Event|1|||
162061670|NCT03978520|585278917|FG000|Overall Study|Adverse Event|2|||
162061671|NCT03978520|585278918|FG001|Overall Study|Adverse Event|5|||
162061672|NCT03978520|585278919|FG002|Overall Study|Adverse Event|3|||
162061673|NCT03978520|585278920|FG003|Overall Study|Adverse Event|5|||
162061674|NCT03978520|585278921|FG004|Overall Study|Adverse Event|6|||
162061675|NCT03978520|585278917|FG000|Overall Study|Withdrawal by Subject|10|||
162061676|NCT03978520|585278918|FG001|Overall Study|Withdrawal by Subject|4|||
162061677|NCT03978520|585278919|FG002|Overall Study|Withdrawal by Subject|5|||
162061678|NCT03978520|585278920|FG003|Overall Study|Withdrawal by Subject|6|||
162061679|NCT03978520|585278921|FG004|Overall Study|Withdrawal by Subject|5|||
162061680|NCT03978520|585278917|FG000|Overall Study|Lost to Follow-up|2|||
162061681|NCT03978520|585278918|FG001|Overall Study|Lost to Follow-up|2|||
162061682|NCT03978520|585278919|FG002|Overall Study|Lost to Follow-up|2|||
162061683|NCT03978520|585278920|FG003|Overall Study|Lost to Follow-up|0|||
162061684|NCT03978520|585278921|FG004|Overall Study|Lost to Follow-up|1|||
162061685|NCT03978520|585278917|FG000|Overall Study|COVID-19 infection|0|||
162061686|NCT03978520|585278918|FG001|Overall Study|COVID-19 infection|1|||
162061687|NCT03978520|585278919|FG002|Overall Study|COVID-19 infection|0|||
162061688|NCT03978520|585278920|FG003|Overall Study|COVID-19 infection|0|||
162061689|NCT03978520|585278921|FG004|Overall Study|COVID-19 infection|0|||
162061690|NCT03978520|585278917|FG000|Overall Study|Other, not specified|9|||
162061691|NCT03978520|585278918|FG001|Overall Study|Other, not specified|4|||
162061692|NCT03978520|585278919|FG002|Overall Study|Other, not specified|1|||
162061693|NCT03978520|585278920|FG003|Overall Study|Other, not specified|1|||
162061694|NCT03978520|585278921|FG004|Overall Study|Other, not specified|2|||
162061695|NCT03978520|585278917|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
162061696|NCT03978520|585278918|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
162061697|NCT03978520|585278919|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
162061698|NCT03978520|585278920|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
162061699|NCT03978520|585278921|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
162061700|NCT03200860|585278922|FG000|Overall Study|Withdrawal by Subject|1|||
162061701|NCT03200860|585278923|FG001|Overall Study|Withdrawal by Subject|0|||
162061702|NCT02634320|585278929|FG000|Overall Study|Adverse Event|2|||
162061703|NCT02634320|585278929|FG000|Overall Study|Lost to Follow-up|3|||
162061704|NCT02634320|585278929|FG000|Overall Study|Moved out of area|2|||
162061705|NCT02634320|585278929|FG000|Overall Study|Out of window for study visits|1|||
162061706|NCT02634320|585278929|FG000|Overall Study|Protocol Violation|1|||
162061707|NCT02634320|585278929|FG000|Overall Study|Withdrawal by Subject|5|||
162061708|NCT02634320|585278929|FG000|Overall Study|Lack of Efficacy|2|||
162061709|NCT02760069|585278930|FG000|Overall Study|Withdrawal by Subject|0|||
162061710|NCT02760069|585278931|FG001|Overall Study|Withdrawal by Subject|1|||
162061711|NCT02760069|585278932|FG002|Overall Study|Withdrawal by Subject|1|||
162061712|NCT00600483|585278937|FG000|Overall Study|Lost to Follow-up|26|||
162061713|NCT00600483|585278938|FG001|Overall Study|Lost to Follow-up|47|||
162061714|NCT00600483|585278937|FG000|Overall Study|Randomized but not treated|10|||
162061715|NCT00600483|585278938|FG001|Overall Study|Randomized but not treated|0|||
162061716|NCT03031678|585278944|FG000|Overall Study|Study closed prior to completion|1|||
162061717|NCT03694821|585278945|FG000|Overall Study|Study terminated|4|||
162061718|NCT03694821|585278946|FG001|Overall Study|Study terminated|8|||
162061719|NCT03694821|585278947|FG002|Overall Study|Study terminated|4|||
162061720|NCT05109442|585278952|FG000|Overall Study|Withdrawal by Subject|0|||
162061721|NCT05109442|585278953|FG001|Overall Study|Withdrawal by Subject|0|||
162061722|NCT05109442|585278954|FG002|Overall Study|Withdrawal by Subject|1|||
162061723|NCT05109442|585278955|FG003|Overall Study|Withdrawal by Subject|0|||
162061724|NCT05109442|585278956|FG004|Overall Study|Withdrawal by Subject|0|||
162061725|NCT05109442|585278957|FG005|Overall Study|Withdrawal by Subject|0|||
162061726|NCT05109442|585278952|FG000|Overall Study|Adverse Event|0|||
162061727|NCT05109442|585278953|FG001|Overall Study|Adverse Event|1|||
162061728|NCT05109442|585278954|FG002|Overall Study|Adverse Event|5|||
162061729|NCT05109442|585278955|FG003|Overall Study|Adverse Event|0|||
162061730|NCT05109442|585278956|FG004|Overall Study|Adverse Event|0|||
162061731|NCT05109442|585278957|FG005|Overall Study|Adverse Event|2|||
162061732|NCT05109442|585278952|FG000|Overall Study|Death|0|||
162061733|NCT05109442|585278953|FG001|Overall Study|Death|0|||
162061734|NCT05109442|585278954|FG002|Overall Study|Death|4|||
162061735|NCT05109442|585278955|FG003|Overall Study|Death|0|||
162061736|NCT05109442|585278956|FG004|Overall Study|Death|0|||
162061737|NCT05109442|585278957|FG005|Overall Study|Death|1|||
162061738|NCT05109442|585278952|FG000|Overall Study|Physician Decision|1|||
162061739|NCT05109442|585278953|FG001|Overall Study|Physician Decision|0|||
162061740|NCT05109442|585278954|FG002|Overall Study|Physician Decision|1|||
162061741|NCT05109442|585278955|FG003|Overall Study|Physician Decision|0|||
162061742|NCT05109442|585278956|FG004|Overall Study|Physician Decision|0|||
162061743|NCT05109442|585278957|FG005|Overall Study|Physician Decision|2|||
162061744|NCT05109442|585278952|FG000|Overall Study|Other than listed|0|||
162061745|NCT05109442|585278953|FG001|Overall Study|Other than listed|0|||
162061746|NCT05109442|585278954|FG002|Overall Study|Other than listed|9|||
162061747|NCT05109442|585278955|FG003|Overall Study|Other than listed|2|||
162061748|NCT05109442|585278956|FG004|Overall Study|Other than listed|0|||
162061749|NCT05109442|585278957|FG005|Overall Study|Other than listed|8|||
162061750|NCT05109442|585278952|FG000|Overall Study|Lack of Efficacy|3|||
162061751|NCT05109442|585278953|FG001|Overall Study|Lack of Efficacy|5|||
162061752|NCT05109442|585278954|FG002|Overall Study|Lack of Efficacy|29|||
162061753|NCT05109442|585278955|FG003|Overall Study|Lack of Efficacy|10|||
162061754|NCT05109442|585278956|FG004|Overall Study|Lack of Efficacy|11|||
162061755|NCT05109442|585278957|FG005|Overall Study|Lack of Efficacy|17|||
162061756|NCT03278613|585278967|FG000|Overall Study|Lost to Follow-up|3|||
162061757|NCT03278613|585278968|FG001|Overall Study|Lost to Follow-up|1|||
162061758|NCT01405456|585278969|FG000|Overall Study|Lost to Follow-up|2|||
162061759|NCT01405456|585278970|FG001|Overall Study|Lost to Follow-up|1|||
162061760|NCT01405456|585278969|FG000|Overall Study|Physician Decision|1|||
162061761|NCT01405456|585278970|FG001|Overall Study|Physician Decision|0|||
162061762|NCT05475236|585278972|FG000|Overall Study|Withdrawal by Subject|0|||
162061763|NCT05475236|585278973|FG001|Overall Study|Withdrawal by Subject|1|||
162061764|NCT02154490|585281166|FG000|Overall Study|No tissue submitted|23|||
162061765|NCT02154490|585281166|FG000|Overall Study|No biomarker results|167|||
162061766|NCT02154490|585281166|FG000|Overall Study|Not assigned to a sub-study|270|||
162061767|NCT02154490|585281166|FG000|Overall Study|Did not register to a sub-study|749|||
162061768|NCT02692716|585281168|FG000|Overall Study|Lost to Follow-up|2|||
162061769|NCT02692716|585281169|FG001|Overall Study|Lost to Follow-up|5|||
162061770|NCT02692716|585281168|FG000|Overall Study|Withdrawal by Subject|3|||
162061771|NCT02692716|585281169|FG001|Overall Study|Withdrawal by Subject|1|||
162061772|NCT02564042|585281185|FG000|Overall Study|Adverse Event|4|||
162061773|NCT02564042|585281186|FG001|Overall Study|Adverse Event|4|||
162061774|NCT02564042|585281187|FG002|Overall Study|Adverse Event|3|||
162061775|NCT02564042|585281188|FG003|Overall Study|Adverse Event|0|||
162061776|NCT02564042|585281189|FG004|Overall Study|Adverse Event|0|||
162061777|NCT02564042|585281190|FG005|Overall Study|Adverse Event|1|||
162061778|NCT02564042|585281185|FG000|Overall Study|Lost to Follow-up|1|||
162061779|NCT02564042|585281186|FG001|Overall Study|Lost to Follow-up|1|||
162061780|NCT02564042|585281187|FG002|Overall Study|Lost to Follow-up|1|||
162061781|NCT02564042|585281188|FG003|Overall Study|Lost to Follow-up|0|||
162061782|NCT02564042|585281189|FG004|Overall Study|Lost to Follow-up|1|||
162061783|NCT02564042|585281190|FG005|Overall Study|Lost to Follow-up|1|||
162061784|NCT02564042|585281185|FG000|Overall Study|Physician Decision|1|||
162061785|NCT02564042|585281186|FG001|Overall Study|Physician Decision|0|||
162061786|NCT02564042|585281187|FG002|Overall Study|Physician Decision|0|||
162061787|NCT02564042|585281188|FG003|Overall Study|Physician Decision|1|||
162061788|NCT02564042|585281189|FG004|Overall Study|Physician Decision|0|||
162061789|NCT02564042|585281190|FG005|Overall Study|Physician Decision|0|||
162061790|NCT02564042|585281185|FG000|Overall Study|Withdrawal by Subject|5|||
162061791|NCT02564042|585281186|FG001|Overall Study|Withdrawal by Subject|3|||
162061792|NCT02564042|585281187|FG002|Overall Study|Withdrawal by Subject|2|||
162061793|NCT02564042|585281188|FG003|Overall Study|Withdrawal by Subject|2|||
162061794|NCT02564042|585281189|FG004|Overall Study|Withdrawal by Subject|10|||
162061795|NCT02564042|585281190|FG005|Overall Study|Withdrawal by Subject|12|||
162061796|NCT01356966|585281191|FG000|Overall Study|Withdrawal by Subject|1|||
162061797|NCT01356966|585281192|FG001|Overall Study|Withdrawal by Subject|2|||
162061798|NCT01356966|585281191|FG000|Overall Study|Physician Decision|1|||
162061799|NCT01356966|585281192|FG001|Overall Study|Physician Decision|0|||
162061800|NCT02743806|585281193|FG000|Overall Study|Adverse Event|9|||
162061801|NCT02743806|585281193|FG000|Overall Study|Lost to Follow-up|8|||
162061802|NCT02743806|585281193|FG000|Overall Study|Voluntary Withdrawal|54|||
162061803|NCT02743806|585281193|FG000|Overall Study|Study Termination|65|||
162061804|NCT02743806|585281193|FG000|Overall Study|Pregnancy|6|||
162061805|NCT02743806|585281193|FG000|Overall Study|No Longer Clinically Benefiting|27|||
162061806|NCT02743806|585281193|FG000|Overall Study|Reason Not Specified|12|||
162061807|NCT02085785|585281199|FG000|Overall Study|Withdrawal by Subject|2|||
162061808|NCT02085785|585281200|FG001|Overall Study|Withdrawal by Subject|1|||
162061809|NCT02085785|585281199|FG000|Overall Study|Lost to Follow-up|0|||
162061810|NCT02085785|585281200|FG001|Overall Study|Lost to Follow-up|1|||
162061811|NCT03590041|585281201|FG000|Overall Study|Protocol Violation|4|||
162061812|NCT03590041|585281202|FG001|Overall Study|Protocol Violation|3|||
162061813|NCT03590041|585281201|FG000|Overall Study|No session data recorded|14|||
162061814|NCT03590041|585281202|FG001|Overall Study|No session data recorded|2|||
162061815|NCT02692703|585281203|FG000|Overall Study|Lost to Follow-up|1|||
162061816|NCT02692703|585281203|FG000|Overall Study|Other|1|||
162061817|NCT00267046|585281204|FG000|Overall Study|Disease progression|4|||
162061818|NCT00267046|585281205|FG001|Overall Study|Disease progression|2|||
162061819|NCT00267046|585281204|FG000|Overall Study|Chemotoxicity|2|||
162061820|NCT00267046|585281205|FG001|Overall Study|Chemotoxicity|0|||
162061821|NCT00267046|585281204|FG000|Overall Study|Open-label palifermin|2|||
162061822|NCT00267046|585281205|FG001|Overall Study|Open-label palifermin|7|||
162061823|NCT00267046|585281204|FG000|Overall Study|Surgery|3|||
162061824|NCT00267046|585281205|FG001|Overall Study|Surgery|1|||
162061825|NCT00267046|585281204|FG000|Overall Study|Withdrawal by Subject|1|||
162061826|NCT00267046|585281205|FG001|Overall Study|Withdrawal by Subject|0|||
162061827|NCT00267046|585281204|FG000|Overall Study|Radiation|0|||
162061828|NCT00267046|585281205|FG001|Overall Study|Radiation|1|||
162061829|NCT00103142|585281206|FG000|Overall Study|Adverse Event|1|||
162061830|NCT00103142|585281207|FG001|Overall Study|Adverse Event|0|||
162061831|NCT00103142|585281206|FG000|Overall Study|Progression of disease|2|||
162061832|NCT00103142|585281207|FG001|Overall Study|Progression of disease|1|||
162061833|NCT01979016|585281215|FG000|Overall Study|Withdrawal by Subject|2|||
162061834|NCT01979016|585281216|FG001|Overall Study|Withdrawal by Subject|0|||
162061835|NCT01979016|585281215|FG000|Overall Study|Adverse Event|0|||
162061836|NCT01979016|585281216|FG001|Overall Study|Adverse Event|1|||
162061837|NCT01741701|585281218|FG000|Overall Study|Adverse Event|5|||
162061838|NCT01741701|585281219|FG001|Overall Study|Adverse Event|1|||
162061839|NCT01741701|585281218|FG000|Overall Study|Withdrawal by Subject|0|||
162061840|NCT01741701|585281219|FG001|Overall Study|Withdrawal by Subject|1|||
162061841|NCT00372112|585281226|FG000|Overall Study|Adverse Event|0|||
162061842|NCT00372112|585281227|FG001|Overall Study|Adverse Event|1|||
162061843|NCT00372112|585281228|FG002|Overall Study|Adverse Event|1|||
162061844|NCT00372112|585281229|FG003|Overall Study|Adverse Event|1|||
162061845|NCT00372112|585281226|FG000|Overall Study|Withdrawal by Subject|0|||
162061846|NCT00372112|585281227|FG001|Overall Study|Withdrawal by Subject|0|||
162061847|NCT00372112|585281228|FG002|Overall Study|Withdrawal by Subject|2|||
162061848|NCT00372112|585281229|FG003|Overall Study|Withdrawal by Subject|1|||
162061849|NCT00372112|585281226|FG000|Overall Study|Exacerbation|0|||
162061850|NCT00372112|585281227|FG001|Overall Study|Exacerbation|0|||
162061851|NCT00372112|585281228|FG002|Overall Study|Exacerbation|0|||
162061852|NCT00372112|585281229|FG003|Overall Study|Exacerbation|1|||
162061853|NCT00372112|585281226|FG000|Overall Study|PR >240 at Visit 3|0|||
162061854|NCT00372112|585281227|FG001|Overall Study|PR >240 at Visit 3|0|||
162061855|NCT00372112|585281228|FG002|Overall Study|PR >240 at Visit 3|0|||
162061856|NCT00372112|585281229|FG003|Overall Study|PR >240 at Visit 3|1|||
162061857|NCT00372112|585281226|FG000|Overall Study|Hepatitis B|1|||
162061858|NCT00372112|585281227|FG001|Overall Study|Hepatitis B|0|||
162061859|NCT00372112|585281228|FG002|Overall Study|Hepatitis B|0|||
162061860|NCT00372112|585281229|FG003|Overall Study|Hepatitis B|0|||
162061861|NCT00372112|585281226|FG000|Overall Study|Other-protocol violation|0|||
162061862|NCT00372112|585281227|FG001|Overall Study|Other-protocol violation|0|||
162061863|NCT00372112|585281228|FG002|Overall Study|Other-protocol violation|1|||
162061864|NCT00372112|585281229|FG003|Overall Study|Other-protocol violation|0|||
162061865|NCT04649060|585281230|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
162061866|NCT04649060|585281231|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
162061867|NCT04649060|585281230|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
162061868|NCT04649060|585281231|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
162061869|NCT04649060|585281230|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
162061870|NCT04649060|585281231|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
162061871|NCT04649060|585281230|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
162061872|NCT04649060|585281231|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
162061873|NCT04649060|585281230|FG000|Arm A/Arm B Treatment|Patient Request|1|||
162061874|NCT04649060|585281231|FG001|Arm A/Arm B Treatment|Patient Request|0|||
162061875|NCT04649060|585281230|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
162061876|NCT04649060|585281231|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
162061877|NCT04649060|585281230|FG000|Arm A/Arm B Treatment|Other|1|||
162061878|NCT04649060|585281231|FG001|Arm A/Arm B Treatment|Other|0|||
162061879|NCT04649060|585281230|FG000|Crossover (Arm B)|Adverse Event|0|||
162061880|NCT04649060|585281231|FG001|Crossover (Arm B)|Adverse Event|1|||
162061881|NCT04649060|585281230|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
162061882|NCT04649060|585281231|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
162061883|NCT02706691|585281232|FG000|Overall Study|Adverse Event|1|||
162061884|NCT00171730|585281238|FG000|Overall Study|Adverse Event|3|||
162061885|NCT00171730|585281238|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
162061886|NCT00171730|585281238|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
162061887|NCT00171730|585281238|FG000|Overall Study|Withdrawal by Subject|3|||
162061888|NCT01985867|585281239|FG000|Overall Study|Lost to Follow-up|3|||
162061889|NCT01985867|585281240|FG001|Overall Study|Lost to Follow-up|4|||
162061890|NCT01985867|585281239|FG000|Overall Study|Adverse Event|3|||
162061891|NCT01985867|585281240|FG001|Overall Study|Adverse Event|2|||
162061892|NCT01985867|585281239|FG000|Overall Study|Lack of Efficacy|1|||
162061893|NCT01985867|585281240|FG001|Overall Study|Lack of Efficacy|0|||
162061894|NCT01829191|585281241|FG000|Overall Study|Relocation|0|||
162061895|NCT01829191|585281242|FG001|Overall Study|Relocation|1|||
162061896|NCT01829191|585281241|FG000|Overall Study|Lens discomfort|0|||
162061897|NCT01829191|585281242|FG001|Overall Study|Lens discomfort|3|||
162061898|NCT01829191|585281241|FG000|Overall Study|Lens handling difficulty|1|||
162061899|NCT01829191|585281242|FG001|Overall Study|Lens handling difficulty|4|||
162061900|NCT01829191|585281241|FG000|Overall Study|Protocol Violation|4|||
162061901|NCT01829191|585281242|FG001|Overall Study|Protocol Violation|1|||
162061902|NCT01829191|585281241|FG000|Overall Study|Withdrawal by Subject|2|||
162061903|NCT01829191|585281242|FG001|Overall Study|Withdrawal by Subject|3|||
162061904|NCT01829191|585281241|FG000|Overall Study|Lost to Follow-up|0|||
162061905|NCT01829191|585281242|FG001|Overall Study|Lost to Follow-up|1|||
162061906|NCT01829191|585281241|FG000|Overall Study|Subject was fit for ortho - k|0|||
162061907|NCT01829191|585281242|FG001|Overall Study|Subject was fit for ortho - k|1|||
162061908|NCT01276353|585281245|FG000|Double-blind|Adverse Event|2|||
162061909|NCT01276353|585281246|FG001|Double-blind|Adverse Event|0|||
162061910|NCT01276353|585281245|FG000|Double-blind|Withdrawal by Subject|1|||
162061911|NCT01276353|585281246|FG001|Double-blind|Withdrawal by Subject|0|||
162061912|NCT01276353|585281245|FG000|Extension|Adverse Event|2|||
162061913|NCT01276353|585281246|FG001|Extension|Adverse Event|5|||
162061914|NCT01276353|585281245|FG000|Extension|Withdrawal by Subject|1|||
162061915|NCT01276353|585281246|FG001|Extension|Withdrawal by Subject|2|||
162061916|NCT01276353|585281245|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
162061917|NCT01276353|585281246|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
162061918|NCT01276353|585281245|FG000|Extension|Physician Decision|1|||
162061919|NCT01276353|585281246|FG001|Extension|Physician Decision|0|||
162061920|NCT01276353|585281245|FG000|Extension|Prohibited concomitant medications|0|||
162061921|NCT01276353|585281246|FG001|Extension|Prohibited concomitant medications|1|||
162061922|NCT00553514|585281250|FG000|Overall Study|Protocol deviation|0|||
162061923|NCT00553514|585281251|FG001|Overall Study|Protocol deviation|0|||
162061924|NCT00553514|585281252|FG002|Overall Study|Protocol deviation|0|||
162061925|NCT00553514|585281253|FG003|Overall Study|Protocol deviation|1|||
162061926|NCT00553514|585281254|FG004|Overall Study|Protocol deviation|0|||
162061927|NCT00553514|585281250|FG000|Overall Study|Lack of ovarian response|4|||
162061928|NCT00553514|585281251|FG001|Overall Study|Lack of ovarian response|5|||
162061929|NCT00553514|585281252|FG002|Overall Study|Lack of ovarian response|5|||
162061930|NCT00553514|585281253|FG003|Overall Study|Lack of ovarian response|5|||
162061931|NCT00553514|585281254|FG004|Overall Study|Lack of ovarian response|6|||
162061932|NCT00553514|585281250|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
162061933|NCT00553514|585281251|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
162061934|NCT00553514|585281252|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
162061935|NCT00553514|585281253|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
162061936|NCT00553514|585281254|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
162061937|NCT00553514|585281250|FG000|Overall Study|Risk of multiple pregnancy|0|||
162061938|NCT00553514|585281251|FG001|Overall Study|Risk of multiple pregnancy|2|||
162061939|NCT00553514|585281252|FG002|Overall Study|Risk of multiple pregnancy|0|||
162061940|NCT00553514|585281253|FG003|Overall Study|Risk of multiple pregnancy|1|||
162061941|NCT00553514|585281254|FG004|Overall Study|Risk of multiple pregnancy|0|||
162061942|NCT00553514|585281250|FG000|Overall Study|Other|1|||
162061943|NCT00553514|585281251|FG001|Overall Study|Other|1|||
162061944|NCT00553514|585281252|FG002|Overall Study|Other|0|||
162061945|NCT00553514|585281253|FG003|Overall Study|Other|0|||
162061946|NCT00553514|585281254|FG004|Overall Study|Other|1|||
162061947|NCT01465997|585281255|FG000|Overall Study|Adverse Event|12|||
162061948|NCT01465997|585281256|FG001|Overall Study|Adverse Event|22|||
162061949|NCT01465997|585281255|FG000|Overall Study|Lack of Efficacy|13|||
162061950|NCT01465997|585281256|FG001|Overall Study|Lack of Efficacy|1|||
162061951|NCT01465997|585281255|FG000|Overall Study|Protocol Violation|1|||
162061952|NCT01465997|585281256|FG001|Overall Study|Protocol Violation|4|||
162061953|NCT01465997|585281255|FG000|Overall Study|Lost to Follow-up|6|||
162061954|NCT01465997|585281256|FG001|Overall Study|Lost to Follow-up|9|||
162061955|NCT01465997|585281255|FG000|Overall Study|Withdrawal by Subject|32|||
162061956|NCT01465997|585281256|FG001|Overall Study|Withdrawal by Subject|35|||
162061957|NCT01465997|585281255|FG000|Overall Study|investigator's decision|1|||
162061958|NCT01465997|585281256|FG001|Overall Study|investigator's decision|1|||
162061959|NCT01465997|585281255|FG000|Overall Study|Death|0|||
162061960|NCT01465997|585281256|FG001|Overall Study|Death|1|||
162061961|NCT01465997|585281255|FG000|Overall Study|sponsor's decision|1|||
162061962|NCT01465997|585281256|FG001|Overall Study|sponsor's decision|1|||
162061963|NCT01465997|585281255|FG000|Overall Study|subject withdrew consent|1|||
162061964|NCT01465997|585281256|FG001|Overall Study|subject withdrew consent|0|||
162061965|NCT01465997|585281255|FG000|Overall Study|local lab unblinded site|1|||
162061966|NCT01465997|585281256|FG001|Overall Study|local lab unblinded site|0|||
162061967|NCT01465997|585281255|FG000|Overall Study|withdrew before follow-up|0|||
162061968|NCT01465997|585281256|FG001|Overall Study|withdrew before follow-up|13|||
162061969|NCT01465997|585281255|FG000|Overall Study|decision by site staff|0|||
162061970|NCT01465997|585281256|FG001|Overall Study|decision by site staff|1|||
162061971|NCT01465997|585281255|FG000|Overall Study|subject left participation SP0993|0|||
162061972|NCT01465997|585281256|FG001|Overall Study|subject left participation SP0993|1|||
162061973|NCT02205814|585281257|FG000|Overall Study|Lost to Follow-up|0|||
162061974|NCT02205814|585281258|FG001|Overall Study|Lost to Follow-up|0|||
162061975|NCT02205814|585281259|FG002|Overall Study|Lost to Follow-up|0|||
162061976|NCT02205814|585281260|FG003|Overall Study|Lost to Follow-up|1|||
162061977|NCT02205814|585281257|FG000|Overall Study|Lack of Efficacy|1|||
162061978|NCT02205814|585281258|FG001|Overall Study|Lack of Efficacy|0|||
162061979|NCT02205814|585281259|FG002|Overall Study|Lack of Efficacy|1|||
162061980|NCT02205814|585281260|FG003|Overall Study|Lack of Efficacy|1|||
162061981|NCT02205814|585281257|FG000|Overall Study|Physician Decision|0|||
162061982|NCT02205814|585281258|FG001|Overall Study|Physician Decision|0|||
162061983|NCT02205814|585281259|FG002|Overall Study|Physician Decision|1|||
162061984|NCT02205814|585281260|FG003|Overall Study|Physician Decision|0|||
162061985|NCT02205814|585281257|FG000|Overall Study|Protocol Violation|1|||
162061986|NCT02205814|585281258|FG001|Overall Study|Protocol Violation|0|||
162061987|NCT02205814|585281259|FG002|Overall Study|Protocol Violation|0|||
162061988|NCT02205814|585281260|FG003|Overall Study|Protocol Violation|1|||
162061989|NCT02205814|585281257|FG000|Overall Study|Withdrawal by Subject|0|||
162061990|NCT02205814|585281258|FG001|Overall Study|Withdrawal by Subject|1|||
162061991|NCT02205814|585281259|FG002|Overall Study|Withdrawal by Subject|2|||
162061992|NCT02205814|585281260|FG003|Overall Study|Withdrawal by Subject|1|||
162061993|NCT02205814|585281257|FG000|Overall Study|not compliant with study procedures|0|||
162061994|NCT02205814|585281258|FG001|Overall Study|not compliant with study procedures|0|||
162061995|NCT02205814|585281259|FG002|Overall Study|not compliant with study procedures|1|||
162061996|NCT02205814|585281260|FG003|Overall Study|not compliant with study procedures|0|||
162061997|NCT01426373|585281261|FG000|Overall Study|Adverse Event|6|||
162061998|NCT01426373|585281261|FG000|Overall Study|Lost to Follow-up|14|||
162061999|NCT01426373|585281261|FG000|Overall Study|Participant Convenience|10|||
162062000|NCT01426373|585281261|FG000|Overall Study|Miscellaneous Reasons|4|||
162062001|NCT00726661|585281264|FG000|Overall Study|Lost to Follow-up|36|||
162062002|NCT00726661|585281265|FG001|Overall Study|Lost to Follow-up|11|||
162062003|NCT00726661|585281264|FG000|Overall Study|Withdrawal by Subject|17|||
162062004|NCT00726661|585281265|FG001|Overall Study|Withdrawal by Subject|13|||
162062005|NCT00726661|585281264|FG000|Overall Study|Trial terminated by sponsor|214|||
162062006|NCT00726661|585281265|FG001|Overall Study|Trial terminated by sponsor|187|||
162062007|NCT00726661|585281264|FG000|Overall Study|Death|475|||
162062008|NCT00726661|585281265|FG001|Overall Study|Death|159|||
162062009|NCT00726661|585281264|FG000|Overall Study|Physician Decision|25|||
162062010|NCT00726661|585281265|FG001|Overall Study|Physician Decision|13|||
162062011|NCT00726661|585281264|FG000|Overall Study|Other|47|||
162062012|NCT00726661|585281265|FG001|Overall Study|Other|35|||
162062013|NCT02557646|585281268|FG000|Overall Study|Adverse Event|40|||
162062014|NCT02557646|585281268|FG000|Overall Study|Death|1|||
162062015|NCT02557646|585281268|FG000|Overall Study|Lack of Efficacy|186|||
162062016|NCT02557646|585281268|FG000|Overall Study|Withdrawal by Subject|18|||
162062017|NCT02557646|585281268|FG000|Overall Study|Lost to Follow-up|17|||
162062018|NCT02557646|585281268|FG000|Overall Study|Other|14|||
162062019|NCT00005937|585281274|FG000|Overall Study|Lack of Efficacy|5|||
162062020|NCT00160251|585281275|FG000|Prior to Amendment 2|Adverse Event|2|||
162062021|NCT00160251|585281276|FG001|Prior to Amendment 2|Adverse Event|1|||
162062022|NCT00160251|585281277|FG002|Prior to Amendment 2|Adverse Event|3|||
162062023|NCT00160251|585281278|FG003|Prior to Amendment 2|Adverse Event|1|||
162062024|NCT00160251|585281279|FG004|Prior to Amendment 2|Adverse Event|1|||
162062025|NCT00160251|585281280|FG005|Prior to Amendment 2|Adverse Event|1|||
162062026|NCT00160251|585281281|FG006|Prior to Amendment 2|Adverse Event|1|||
162062027|NCT00160251|585281282|FG007|Prior to Amendment 2|Adverse Event|0|||
162062028|NCT00160251|585281275|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
162062029|NCT00160251|585281276|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
162062030|NCT00160251|585281277|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
162062031|NCT00160251|585281278|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
162062032|NCT00160251|585281279|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
162062033|NCT00160251|585281280|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
162062034|NCT00160251|585281281|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
162062035|NCT00160251|585281282|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
162062036|NCT00160251|585281275|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
162062037|NCT00160251|585281276|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
162062038|NCT00160251|585281277|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
162062039|NCT00160251|585281278|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
162062040|NCT00160251|585281279|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
162062041|NCT00160251|585281280|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
162062042|NCT00160251|585281281|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
162062043|NCT00160251|585281282|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
162062044|NCT00160251|585281275|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
162062045|NCT00160251|585281276|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
162062046|NCT00160251|585281277|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
162062047|NCT00160251|585281278|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
162062048|NCT00160251|585281279|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
162062049|NCT00160251|585281280|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
162062050|NCT00160251|585281281|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
162062051|NCT00160251|585281282|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
162062052|NCT00160251|585281275|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
162062053|NCT00160251|585281276|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
162062054|NCT00160251|585281277|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
162062055|NCT00160251|585281278|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
162062056|NCT00160251|585281279|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
162062057|NCT00160251|585281280|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
162062058|NCT00160251|585281281|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
162062059|NCT00160251|585281282|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
162062060|NCT00160251|585281275|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
162062061|NCT00160251|585281276|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
162062062|NCT00160251|585281277|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
162062063|NCT00160251|585281278|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
162062064|NCT00160251|585281279|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
162062065|NCT00160251|585281280|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
162062066|NCT00160251|585281281|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
162062067|NCT00160251|585281282|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
162062068|NCT00160251|585281275|FG000|Post-amendment 2|Adverse Event|0|||
162062069|NCT00160251|585281276|FG001|Post-amendment 2|Adverse Event|0|||
162062070|NCT00160251|585281277|FG002|Post-amendment 2|Adverse Event|0|||
162062071|NCT00160251|585281278|FG003|Post-amendment 2|Adverse Event|0|||
162062072|NCT00160251|585281279|FG004|Post-amendment 2|Adverse Event|0|||
162062073|NCT00160251|585281280|FG005|Post-amendment 2|Adverse Event|0|||
162062074|NCT00160251|585281281|FG006|Post-amendment 2|Adverse Event|0|||
162062075|NCT00160251|585281282|FG007|Post-amendment 2|Adverse Event|20|||
162062076|NCT00160251|585281275|FG000|Post-amendment 2|Lack of Efficacy|0|||
162062077|NCT00160251|585281276|FG001|Post-amendment 2|Lack of Efficacy|0|||
162062078|NCT00160251|585281277|FG002|Post-amendment 2|Lack of Efficacy|0|||
162062079|NCT00160251|585281278|FG003|Post-amendment 2|Lack of Efficacy|0|||
162062080|NCT00160251|585281279|FG004|Post-amendment 2|Lack of Efficacy|0|||
162062081|NCT00160251|585281280|FG005|Post-amendment 2|Lack of Efficacy|0|||
162062082|NCT00160251|585281281|FG006|Post-amendment 2|Lack of Efficacy|0|||
162062083|NCT00160251|585281282|FG007|Post-amendment 2|Lack of Efficacy|24|||
162062084|NCT00160251|585281275|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162062085|NCT00160251|585281276|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162062086|NCT00160251|585281277|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162062087|NCT00160251|585281278|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162062088|NCT00160251|585281279|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162062089|NCT00160251|585281280|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162062090|NCT00160251|585281281|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
162062091|NCT00160251|585281282|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
162062092|NCT01288469|585281283|FG000|Overall Study|Adverse Event|4|||
162062093|NCT01288469|585281284|FG001|Overall Study|Adverse Event|1|||
162062094|NCT01288469|585281285|FG002|Overall Study|Adverse Event|1|||
162062095|NCT01288469|585281283|FG000|Overall Study|Poor compliance to protocol|0|||
162062096|NCT01288469|585281284|FG001|Overall Study|Poor compliance to protocol|1|||
162062097|NCT01288469|585281285|FG002|Overall Study|Poor compliance to protocol|0|||
162062098|NCT01288469|585281283|FG000|Overall Study|Participant Moved|1|||
162062099|NCT01288469|585281284|FG001|Overall Study|Participant Moved|0|||
162062100|NCT01288469|585281285|FG002|Overall Study|Participant Moved|0|||
162062101|NCT01288469|585281283|FG000|Overall Study|Consent withdrawn by subject|1|||
162062102|NCT01288469|585281284|FG001|Overall Study|Consent withdrawn by subject|1|||
162062103|NCT01288469|585281285|FG002|Overall Study|Consent withdrawn by subject|1|||
162062104|NCT01288469|585281283|FG000|Overall Study|Exclusion criteria finally met|1|||
162062105|NCT01288469|585281284|FG001|Overall Study|Exclusion criteria finally met|0|||
162062106|NCT01288469|585281285|FG002|Overall Study|Exclusion criteria finally met|0|||
162062107|NCT01574612|585281286|FG000|Overall Study|Adverse Event|3|||
162062108|NCT01574612|585281286|FG000|Overall Study|non compliant with drug|2|||
162062109|NCT01574612|585281286|FG000|Overall Study|Withdrawal by Subject|1|||
162062110|NCT01574612|585281286|FG000|Overall Study|Lost to Follow-up|2|||
162062111|NCT00582166|585281287|FG000|Overall Study|Death|1|||
162062112|NCT00582166|585281287|FG000|Overall Study|Ineligible pathology|1|||
162062113|NCT01606436|585281290|FG000|Overall Study|Withdrawal by Subject|0|||
162062114|NCT01606436|585281291|FG001|Overall Study|Withdrawal by Subject|0|||
162062115|NCT01606436|585281292|FG002|Overall Study|Withdrawal by Subject|1|||
162062116|NCT01606436|585281293|FG003|Overall Study|Withdrawal by Subject|1|||
162062117|NCT01606436|585281294|FG004|Overall Study|Withdrawal by Subject|1|||
162062118|NCT01606436|585281295|FG005|Overall Study|Withdrawal by Subject|0|||
162062119|NCT01606436|585281290|FG000|Overall Study|Adverse Event|0|||
162062120|NCT01606436|585281291|FG001|Overall Study|Adverse Event|0|||
162062121|NCT01606436|585281292|FG002|Overall Study|Adverse Event|1|||
162062122|NCT01606436|585281293|FG003|Overall Study|Adverse Event|0|||
162062123|NCT01606436|585281294|FG004|Overall Study|Adverse Event|0|||
162062124|NCT01606436|585281295|FG005|Overall Study|Adverse Event|0|||
162062125|NCT01606436|585281290|FG000|Overall Study|Sponsor Decision|0|||
162062126|NCT01606436|585281291|FG001|Overall Study|Sponsor Decision|0|||
162062127|NCT01606436|585281292|FG002|Overall Study|Sponsor Decision|0|||
162062128|NCT01606436|585281293|FG003|Overall Study|Sponsor Decision|1|||
162062129|NCT01606436|585281294|FG004|Overall Study|Sponsor Decision|0|||
162062130|NCT01606436|585281295|FG005|Overall Study|Sponsor Decision|0|||
162062131|NCT02859454|585281296|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
162062132|NCT02452398|585281301|FG000|Overall Study|Adverse Event|1|||
162062133|NCT02452398|585281301|FG000|Overall Study|Lost to Follow-up|28|||
162062134|NCT02452398|585281301|FG000|Overall Study|Physician Decision|2|||
162062135|NCT02452398|585281301|FG000|Overall Study|Withdrawal by Subject|6|||
162062136|NCT02452398|585281301|FG000|Overall Study|Moved away|4|||
162062137|NCT03334448|585281302|FG000|Washout|Personal Reason|0|||
162062138|NCT03334448|585281303|FG001|Washout|Personal Reason|1|||
162062139|NCT03334448|585281304|FG002|Washout|Personal Reason|0|||
162062140|NCT03334448|585281305|FG003|Washout|Personal Reason|0|||
162062141|NCT03334448|585281302|FG000|Washout|Protocol Violation|0|||
162062142|NCT03334448|585281303|FG001|Washout|Protocol Violation|0|||
162062143|NCT03334448|585281304|FG002|Washout|Protocol Violation|0|||
162062144|NCT03334448|585281305|FG003|Washout|Protocol Violation|1|||
162062145|NCT02326025|585281306|FG000|Overall Study|Adverse Event|3|||
162062146|NCT02326025|585281307|FG001|Overall Study|Adverse Event|0|||
162062147|NCT02326025|585281306|FG000|Overall Study|Physician Decision|1|||
162062148|NCT02326025|585281307|FG001|Overall Study|Physician Decision|2|||
162062149|NCT02326025|585281306|FG000|Overall Study|Physician and Participant Decision|1|||
162062150|NCT02326025|585281307|FG001|Overall Study|Physician and Participant Decision|0|||
162062151|NCT02326025|585281306|FG000|Overall Study|Withdrawal by Subject|0|||
162062152|NCT02326025|585281307|FG001|Overall Study|Withdrawal by Subject|2|||
162062153|NCT02326025|585281306|FG000|Overall Study|Protocol Violation|0|||
162062154|NCT02326025|585281307|FG001|Overall Study|Protocol Violation|1|||
162062155|NCT01365910|585281308|FG000|Overall Study|Withdrawal by Subject|7|||
162062156|NCT01365910|585281308|FG000|Overall Study|disease progression|18|||
162062157|NCT01365910|585281308|FG000|Overall Study|Adverse Event|3|||
162062158|NCT01365910|585281308|FG000|Overall Study|other complicating disease|1|||
162062159|NCT01365910|585281308|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
162062160|NCT02013791|585281309|FG000|Period 1|Lost to Follow-up|0|||
162062161|NCT02013791|585281310|FG001|Period 1|Lost to Follow-up|0|||
162062162|NCT02013791|585281311|FG002|Period 1|Lost to Follow-up|0|||
162062163|NCT02013791|585281312|FG003|Period 1|Lost to Follow-up|1|||
162062164|NCT02013791|585281313|FG004|Period 1|Lost to Follow-up|0|||
162062165|NCT02013791|585281314|FG005|Period 1|Lost to Follow-up|0|||
162062166|NCT02013791|585281315|FG006|Period 1|Lost to Follow-up|1|||
162062167|NCT02013791|585281316|FG007|Period 1|Lost to Follow-up|1|||
162062168|NCT02013791|585281317|FG008|Period 1|Lost to Follow-up|0|||
162062169|NCT02013791|585281309|FG000|Period 1|Other Miscellaneous Reasons|0|||
162062170|NCT02013791|585281310|FG001|Period 1|Other Miscellaneous Reasons|2|||
162062171|NCT02013791|585281311|FG002|Period 1|Other Miscellaneous Reasons|0|||
162062172|NCT02013791|585281312|FG003|Period 1|Other Miscellaneous Reasons|0|||
162062173|NCT02013791|585281313|FG004|Period 1|Other Miscellaneous Reasons|0|||
162062174|NCT02013791|585281314|FG005|Period 1|Other Miscellaneous Reasons|0|||
162062175|NCT02013791|585281315|FG006|Period 1|Other Miscellaneous Reasons|0|||
162062176|NCT02013791|585281316|FG007|Period 1|Other Miscellaneous Reasons|0|||
162062177|NCT02013791|585281317|FG008|Period 1|Other Miscellaneous Reasons|0|||
162062178|NCT03798483|585281318|FG000|Overall Study|Lost to Follow-up|2|||
162062179|NCT02643082|585281319|FG000|Period 1|Adverse Event|1|||
162062180|NCT02643082|585281320|FG001|Period 1|Adverse Event|0|||
162062181|NCT02289417|585281321|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
162062182|NCT02289417|585281322|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162062183|NCT02289417|585281323|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
162062184|NCT02289417|585281324|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162062185|NCT02289417|585281325|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162062186|NCT02289417|585281326|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162062187|NCT02289417|585281327|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162062188|NCT02289417|585281328|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162062189|NCT02289417|585281329|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
162062190|NCT02289417|585281321|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
162062191|NCT02289417|585281322|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
162062192|NCT02289417|585281323|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
162062193|NCT02289417|585281324|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
162062194|NCT02289417|585281325|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
162062195|NCT02289417|585281326|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
162062196|NCT02289417|585281327|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
162062197|NCT02289417|585281328|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
162062198|NCT02289417|585281329|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
162062199|NCT02289417|585281321|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162062200|NCT02289417|585281322|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
162062201|NCT02289417|585281323|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162062202|NCT02289417|585281324|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162062203|NCT02289417|585281325|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162062204|NCT02289417|585281326|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162062205|NCT02289417|585281327|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162062206|NCT02289417|585281328|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162062207|NCT02289417|585281329|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
162062208|NCT02289417|585281321|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
162062209|NCT02289417|585281322|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162062210|NCT02289417|585281323|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162062211|NCT02289417|585281324|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162062212|NCT02289417|585281325|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162062213|NCT02289417|585281326|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162062214|NCT02289417|585281327|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162062215|NCT02289417|585281328|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162062216|NCT02289417|585281329|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
162062217|NCT02289417|585281321|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
162062218|NCT02289417|585281322|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
162062219|NCT02289417|585281323|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
162062220|NCT02289417|585281324|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
162062221|NCT02289417|585281325|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
162062222|NCT02289417|585281326|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
162062223|NCT02289417|585281327|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
162062224|NCT02289417|585281328|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
162062225|NCT02289417|585281329|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
162062226|NCT02289417|585281321|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162062227|NCT02289417|585281322|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162062228|NCT02289417|585281323|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
162062229|NCT02289417|585281324|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162062230|NCT02289417|585281325|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162062231|NCT02289417|585281326|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162062232|NCT02289417|585281327|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162062233|NCT02289417|585281328|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162062234|NCT02289417|585281329|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
162062235|NCT02289417|585281321|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
162062236|NCT02289417|585281322|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
162062237|NCT02289417|585281323|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
162062238|NCT02289417|585281324|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
162062239|NCT02289417|585281325|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
162062240|NCT02289417|585281326|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
162062241|NCT02289417|585281327|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
162062242|NCT02289417|585281328|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
162062243|NCT02289417|585281329|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
162062244|NCT02289417|585281321|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
162062245|NCT02289417|585281322|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
162062246|NCT02289417|585281323|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
162062247|NCT02289417|585281324|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
162062248|NCT02289417|585281325|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
162062249|NCT02289417|585281326|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
162062250|NCT02289417|585281327|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
162062251|NCT02289417|585281328|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
162062252|NCT02289417|585281329|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
162062253|NCT02289417|585281321|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162062254|NCT02289417|585281322|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162062255|NCT02289417|585281323|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162062256|NCT02289417|585281324|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162062257|NCT02289417|585281325|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162062258|NCT02289417|585281326|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162062259|NCT02289417|585281327|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
162062260|NCT02289417|585281328|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162062261|NCT02289417|585281329|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
162062262|NCT02289417|585281321|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162062263|NCT02289417|585281322|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162062264|NCT02289417|585281323|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162062265|NCT02289417|585281324|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
162062266|NCT02289417|585281325|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162062267|NCT02289417|585281326|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162062268|NCT02289417|585281327|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
162062269|NCT02289417|585281328|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162062270|NCT02289417|585281329|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
162062271|NCT02289417|585281321|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
162062272|NCT02289417|585281322|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
162062273|NCT02289417|585281323|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
162062274|NCT02289417|585281324|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
162062275|NCT02289417|585281325|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
162062276|NCT02289417|585281326|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
162062277|NCT02289417|585281327|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
162062278|NCT02289417|585281328|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
162062279|NCT02289417|585281329|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
162062280|NCT02289417|585281321|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162062281|NCT02289417|585281322|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162062282|NCT02289417|585281323|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162062283|NCT02289417|585281324|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162062284|NCT02289417|585281325|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162062285|NCT02289417|585281326|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162062286|NCT02289417|585281327|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
162062287|NCT02289417|585281328|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
162062288|NCT02289417|585281329|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
162062289|NCT02289417|585281321|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162062290|NCT02289417|585281322|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162062291|NCT02289417|585281323|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162062292|NCT02289417|585281324|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162062293|NCT02289417|585281325|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162062294|NCT02289417|585281326|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162062295|NCT02289417|585281327|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
162062296|NCT02289417|585281328|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
162062297|NCT02289417|585281329|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
162062298|NCT02289417|585281321|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
162062299|NCT02289417|585281322|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
162062300|NCT02289417|585281323|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
162062301|NCT02289417|585281324|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
162062302|NCT02289417|585281325|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
162062303|NCT02289417|585281326|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
162062304|NCT02289417|585281327|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
162062305|NCT02289417|585281328|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
162062306|NCT02289417|585281329|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
162062307|NCT02725710|585281330|FG000|Overall Study|Lost to Follow-up|1|||
162062308|NCT02725710|585281331|FG001|Overall Study|Lost to Follow-up|0|||
162062309|NCT02505867|585281332|FG000|Overall Study|Lack of Efficacy|6|||
162062310|NCT02505867|585281333|FG001|Overall Study|Lack of Efficacy|6|||
162062311|NCT01782222|585281334|FG000|Overall Study|Adverse Event|4|||
162062312|NCT01782222|585281335|FG001|Overall Study|Adverse Event|5|||
162062313|NCT01782222|585281336|FG002|Overall Study|Adverse Event|3|||
162062314|NCT01782222|585281334|FG000|Overall Study|Lack of Efficacy|2|||
162062315|NCT01782222|585281335|FG001|Overall Study|Lack of Efficacy|1|||
162062316|NCT01782222|585281336|FG002|Overall Study|Lack of Efficacy|0|||
162062317|NCT01782222|585281334|FG000|Overall Study|Protocol Violation|1|||
162062318|NCT01782222|585281335|FG001|Overall Study|Protocol Violation|0|||
162062319|NCT01782222|585281336|FG002|Overall Study|Protocol Violation|0|||
162062320|NCT01782222|585281334|FG000|Overall Study|Withdrawal by Subject|1|||
162062321|NCT01782222|585281335|FG001|Overall Study|Withdrawal by Subject|4|||
162062322|NCT01782222|585281336|FG002|Overall Study|Withdrawal by Subject|1|||
162062323|NCT01782222|585281334|FG000|Overall Study|Moved to other state|0|||
162062324|NCT01782222|585281335|FG001|Overall Study|Moved to other state|1|||
162062325|NCT01782222|585281336|FG002|Overall Study|Moved to other state|0|||
162062326|NCT01605877|585281337|FG000|Overall Study|Withdrawal by Subject|1|||
162062327|NCT01918085|585281340|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
162062328|NCT01918085|585281341|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
162062329|NCT00687323|585281342|FG000|Overall Study|Death|25|||
162062330|NCT00687323|585281342|FG000|Overall Study|Withdrawal by Subject|1|||
162062331|NCT00687323|585281342|FG000|Overall Study|Excluded from efficacy evaluations|6|||
162062332|NCT00687323|585281342|FG000|Overall Study|Screen failure|148|||
162062333|NCT03655691|585281348|FG000|Overall Study|Adverse Event|0|||
162062334|NCT03655691|585281349|FG001|Overall Study|Adverse Event|0|||
162062335|NCT03655691|585281350|FG002|Overall Study|Adverse Event|1|||
162062336|NCT03655691|585281348|FG000|Overall Study|Lost to Follow-up|1|||
162062337|NCT03655691|585281349|FG001|Overall Study|Lost to Follow-up|1|||
162062338|NCT03655691|585281350|FG002|Overall Study|Lost to Follow-up|2|||
162062339|NCT03655691|585281348|FG000|Overall Study|Protocol Violation|0|||
162062340|NCT03655691|585281349|FG001|Overall Study|Protocol Violation|1|||
162062341|NCT03655691|585281350|FG002|Overall Study|Protocol Violation|0|||
162062342|NCT03655691|585281348|FG000|Overall Study|Withdrawal by Subject|1|||
162062343|NCT03655691|585281349|FG001|Overall Study|Withdrawal by Subject|1|||
162062344|NCT03655691|585281350|FG002|Overall Study|Withdrawal by Subject|0|||
162062345|NCT04557371|585281351|FG000|Overall Study|Covid-19-related|0|||
162062346|NCT04557371|585281352|FG001|Overall Study|Covid-19-related|1|||
162062347|NCT04557371|585281353|FG002|Overall Study|Covid-19-related|0|||
162062348|NCT04557371|585281351|FG000|Overall Study|Withdrawal by Subject|0|||
162062349|NCT04557371|585281352|FG001|Overall Study|Withdrawal by Subject|1|||
162062350|NCT04557371|585281353|FG002|Overall Study|Withdrawal by Subject|0|||
162062351|NCT04557371|585281351|FG000|Overall Study|Adverse Event|1|||
162062352|NCT04557371|585281352|FG001|Overall Study|Adverse Event|0|||
162062353|NCT04557371|585281353|FG002|Overall Study|Adverse Event|0|||
162062354|NCT01428453|585281356|FG000|Overall Study|Adverse Event|2|||
162062355|NCT01428453|585281357|FG001|Overall Study|Adverse Event|7|||
162062356|NCT01428453|585281356|FG000|Overall Study|Protocol Violation|1|||
162062357|NCT01428453|585281357|FG001|Overall Study|Protocol Violation|0|||
162062358|NCT01428453|585281356|FG000|Overall Study|Lost to Follow-up|0|||
162062359|NCT01428453|585281357|FG001|Overall Study|Lost to Follow-up|1|||
162062360|NCT01428453|585281356|FG000|Overall Study|Withdrawal by Subject|3|||
162062361|NCT01428453|585281357|FG001|Overall Study|Withdrawal by Subject|1|||
162062362|NCT01996709|585281358|FG000|Overall Study|Withdrawal by Subject|1|||
162062363|NCT01996709|585281359|FG001|Overall Study|Withdrawal by Subject|0|||
162062364|NCT01996709|585281358|FG000|Overall Study|Lost to Follow-up|3|||
162062365|NCT01996709|585281359|FG001|Overall Study|Lost to Follow-up|0|||
162062366|NCT01996709|585281358|FG000|Overall Study|Subject Non-Compliant|1|||
162062367|NCT01996709|585281359|FG001|Overall Study|Subject Non-Compliant|0|||
162062368|NCT01996709|585281358|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
162062369|NCT01996709|585281359|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
162062370|NCT03918447|585281360|FG000|Overall Study|Death|1|||
162062371|NCT03918447|585281361|FG001|Overall Study|Death|0|||
162062372|NCT03918447|585281360|FG000|Overall Study|Lost to Follow-up|13|||
162062373|NCT03918447|585281361|FG001|Overall Study|Lost to Follow-up|6|||
162062374|NCT03918447|585281360|FG000|Overall Study|Withdrawal by Subject|19|||
162062375|NCT03918447|585281361|FG001|Overall Study|Withdrawal by Subject|17|||
162062376|NCT03918447|585281360|FG000|Overall Study|Study Terminated by Sponsor|195|||
162062377|NCT03918447|585281361|FG001|Overall Study|Study Terminated by Sponsor|197|||
162062378|NCT03918447|585281360|FG000|Overall Study|Reason not Specified|0|||
162062379|NCT03918447|585281361|FG001|Overall Study|Reason not Specified|1|||
162062380|NCT00477971|585281362|FG000|Overall Study|Disease progression|6|||
162062381|NCT00477971|585281363|FG001|Overall Study|Disease progression|0|||
162062382|NCT00477971|585281362|FG000|Overall Study|Withdrawal by Subject|3|||
162062383|NCT00477971|585281363|FG001|Overall Study|Withdrawal by Subject|1|||
162062384|NCT00477971|585281362|FG000|Overall Study|Adverse Event|3|||
162062385|NCT00477971|585281363|FG001|Overall Study|Adverse Event|0|||
162062386|NCT00477971|585281362|FG000|Overall Study|Death|2|||
162062387|NCT00477971|585281363|FG001|Overall Study|Death|4|||
162062388|NCT00477971|585281362|FG000|Overall Study|Alternative treatment|3|||
162062389|NCT00477971|585281363|FG001|Overall Study|Alternative treatment|1|||
162062390|NCT01774968|585281364|FG000|Overall Study|Adverse Event|4|||
162062391|NCT01774968|585281365|FG001|Overall Study|Adverse Event|4|||
162062392|NCT01774968|585281364|FG000|Overall Study|Death|0|||
162062393|NCT01774968|585281365|FG001|Overall Study|Death|1|||
162062394|NCT01774968|585281364|FG000|Overall Study|Lost to Follow-up|1|||
162062395|NCT01774968|585281365|FG001|Overall Study|Lost to Follow-up|3|||
162062396|NCT01774968|585281364|FG000|Overall Study|Physician Decision|5|||
162062397|NCT01774968|585281365|FG001|Overall Study|Physician Decision|1|||
162062398|NCT01774968|585281364|FG000|Overall Study|Protocol Violation|14|||
162062399|NCT01774968|585281365|FG001|Overall Study|Protocol Violation|13|||
162062400|NCT01774968|585281364|FG000|Overall Study|Sponsor Decision|0|||
162062401|NCT01774968|585281365|FG001|Overall Study|Sponsor Decision|2|||
162062402|NCT01774968|585281364|FG000|Overall Study|Withdrawal by Subject|6|||
162062403|NCT01774968|585281365|FG001|Overall Study|Withdrawal by Subject|11|||
162062404|NCT05355805|585281366|FG000|Overall Study|Lost to Follow-up|6|||
162062405|NCT05355805|585281367|FG001|Overall Study|Lost to Follow-up|11|||
162062406|NCT05355805|585281368|FG002|Overall Study|Lost to Follow-up|10|||
162062407|NCT05355805|585281369|FG003|Overall Study|Lost to Follow-up|6|||
162062408|NCT05355805|585281366|FG000|Overall Study|Decision by Sponsor|0|||
162062409|NCT05355805|585281367|FG001|Overall Study|Decision by Sponsor|0|||
162062410|NCT05355805|585281368|FG002|Overall Study|Decision by Sponsor|1|||
162062411|NCT05355805|585281369|FG003|Overall Study|Decision by Sponsor|0|||
162062412|NCT05355805|585281366|FG000|Overall Study|Withdrawal by Subject|7|||
162062413|NCT05355805|585281367|FG001|Overall Study|Withdrawal by Subject|14|||
162062414|NCT05355805|585281368|FG002|Overall Study|Withdrawal by Subject|15|||
162062415|NCT05355805|585281369|FG003|Overall Study|Withdrawal by Subject|13|||
162062416|NCT04232124|585282668|FG000|Overall Study|Lost to Follow-up|3|||
162062417|NCT01986855|585282671|FG000|Overall Study|Adverse Event|1|||
162062418|NCT01986855|585282672|FG001|Overall Study|Adverse Event|0|||
162062419|NCT01986855|585282673|FG002|Overall Study|Adverse Event|0|||
162062420|NCT01986855|585282671|FG000|Overall Study|Death|3|||
162062421|NCT01986855|585282672|FG001|Overall Study|Death|4|||
162062422|NCT01986855|585282673|FG002|Overall Study|Death|4|||
162062423|NCT01986855|585282671|FG000|Overall Study|Lost to Follow-up|2|||
162062424|NCT01986855|585282672|FG001|Overall Study|Lost to Follow-up|1|||
162062425|NCT01986855|585282673|FG002|Overall Study|Lost to Follow-up|0|||
162062426|NCT01986855|585282671|FG000|Overall Study|Screen Failure|0|||
162062427|NCT01986855|585282672|FG001|Overall Study|Screen Failure|1|||
162062428|NCT01986855|585282673|FG002|Overall Study|Screen Failure|0|||
162062429|NCT01986855|585282671|FG000|Overall Study|Participant Moved|0|||
162062430|NCT01986855|585282672|FG001|Overall Study|Participant Moved|0|||
162062431|NCT01986855|585282673|FG002|Overall Study|Participant Moved|2|||
162062432|NCT01986855|585282671|FG000|Overall Study|Withdrawal by Subject|7|||
162062433|NCT01986855|585282672|FG001|Overall Study|Withdrawal by Subject|8|||
162062434|NCT01986855|585282673|FG002|Overall Study|Withdrawal by Subject|5|||
162062435|NCT04317066|585282674|FG000|Overall Study|Sponsor decision|5|||
162062436|NCT04317066|585282674|FG000|Overall Study|Death|2|||
162062437|NCT02014597|585282678|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
162062438|NCT02014597|585282679|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
162062439|NCT02279173|585282681|FG000|Overall Study|Protocol-specified Criteria|67|||
162062440|NCT02279173|585282681|FG000|Overall Study|Withdrawal by Subject|20|||
162062441|NCT02279173|585282681|FG000|Overall Study|Decision by Sponsor|4|||
162062442|NCT02279173|585282681|FG000|Overall Study|Lost to Follow-up|3|||
162062443|NCT00464087|585282683|FG000|Overall Study|No PCI per inclusion criteria|0|||
162062444|NCT00464087|585282684|FG001|Overall Study|No PCI per inclusion criteria|0|||
162062445|NCT00464087|585282685|FG002|Overall Study|No PCI per inclusion criteria|29|||
162062446|NCT01164956|585282686|FG000|Overall Study|Side Effects|1|||
162062447|NCT01164956|585282687|FG001|Overall Study|Side Effects|0|||
162062448|NCT01164956|585282688|FG002|Overall Study|Side Effects|1|||
162062449|NCT00754624|585282689|FG000|Overall Study|Adverse Event|16|||
162062450|NCT00754624|585282689|FG000|Overall Study|Death|1|||
162062451|NCT00754624|585282689|FG000|Overall Study|Physician Decision|8|||
162062452|NCT00754624|585282689|FG000|Overall Study|Protocol Violation|1|||
162062453|NCT00754624|585282689|FG000|Overall Study|Withdrawal by Subject|28|||
162062454|NCT00754624|585282689|FG000|Overall Study|Various|12|||
162062455|NCT00754624|585282689|FG000|Overall Study|Lost to Follow-up|3|||
162062456|NCT00720434|585282690|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
162062457|NCT00720434|585282691|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
162062458|NCT00720434|585282692|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
162062459|NCT00720434|585282693|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
162062460|NCT00720434|585282690|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
162062461|NCT00720434|585282691|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
162062462|NCT00720434|585282692|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
162062463|NCT00720434|585282693|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
162062464|NCT00720434|585282690|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
162062465|NCT00720434|585282691|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
162062466|NCT00720434|585282692|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
162062467|NCT00720434|585282693|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
162062468|NCT00720434|585282690|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
162062469|NCT00720434|585282691|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
162062470|NCT00720434|585282692|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
162062471|NCT00720434|585282693|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
162062472|NCT00720434|585282690|FG000|Open-Label Period (Week 5-72)|Other|4|||
162062473|NCT00720434|585282691|FG001|Open-Label Period (Week 5-72)|Other|3|||
162062474|NCT00720434|585282692|FG002|Open-Label Period (Week 5-72)|Other|3|||
162062475|NCT00720434|585282693|FG003|Open-Label Period (Week 5-72)|Other|2|||
162062476|NCT00418314|585282694|FG000|Overall Study|Withdrawal by Subject|1|||
162062477|NCT00418314|585282695|FG001|Overall Study|Withdrawal by Subject|2|||
162062478|NCT00967798|585282696|FG000|Overall Study|Withdrawal by Subject|5|||
162062479|NCT00967798|585282697|FG001|Overall Study|Withdrawal by Subject|2|||
162062480|NCT00967798|585282696|FG000|Overall Study|Lost to Follow-up|4|||
162062481|NCT00967798|585282697|FG001|Overall Study|Lost to Follow-up|1|||
162062482|NCT02425046|585282698|FG000|Overall Study|Lost to Follow-up|52|||
162062483|NCT02425046|585282699|FG001|Overall Study|Lost to Follow-up|50|||
162062484|NCT02425046|585282700|FG002|Overall Study|Lost to Follow-up|56|||
162062485|NCT02425046|585282698|FG000|Overall Study|Withdrawal by Subject|16|||
162062486|NCT02425046|585282699|FG001|Overall Study|Withdrawal by Subject|12|||
162062487|NCT02425046|585282700|FG002|Overall Study|Withdrawal by Subject|0|||
162062488|NCT02782780|585282701|FG000|Overall Study|dropped out after randomization.|7|||
162062489|NCT02782780|585282702|FG001|Overall Study|dropped out after randomization.|5|||
162062490|NCT02782780|585282701|FG000|Overall Study|Protocol Violation|0|||
162062491|NCT02782780|585282702|FG001|Overall Study|Protocol Violation|2|||
162062492|NCT01413191|585282703|FG000|Overall Study|Lost to Follow-up|5|||
162062493|NCT01413191|585282703|FG000|Overall Study|Disease Progression|5|||
162062494|NCT01413191|585282703|FG000|Overall Study|Death|1|||
162062495|NCT03654651|585282704|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
162062496|NCT03654651|585282705|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
162062497|NCT03045328|585282706|FG000|Overall Study|Withdrawal by Subject|2|||
162062498|NCT00589914|585282709|FG000|Overall Study|Adverse Event|19|||
162062499|NCT00589914|585282710|FG001|Overall Study|Adverse Event|10|||
162062500|NCT00589914|585282709|FG000|Overall Study|Death|2|||
162062501|NCT00589914|585282710|FG001|Overall Study|Death|0|||
162062502|NCT00589914|585282709|FG000|Overall Study|Lack of Efficacy|40|||
162062503|NCT00589914|585282710|FG001|Overall Study|Lack of Efficacy|43|||
162062504|NCT00589914|585282709|FG000|Overall Study|Lost to Follow-up|11|||
162062505|NCT00589914|585282710|FG001|Overall Study|Lost to Follow-up|18|||
162062506|NCT00589914|585282709|FG000|Overall Study|Pregnancy|1|||
162062507|NCT00589914|585282710|FG001|Overall Study|Pregnancy|0|||
162062508|NCT00589914|585282709|FG000|Overall Study|Withdrawal by Subject|55|||
162062509|NCT00589914|585282710|FG001|Overall Study|Withdrawal by Subject|49|||
162062510|NCT00589914|585282709|FG000|Overall Study|Other|22|||
162062511|NCT00589914|585282710|FG001|Overall Study|Other|17|||
162062512|NCT03585504|585282711|FG000|Overall Study|Lost to Follow-up|26|||
162062513|NCT03585504|585282712|FG001|Overall Study|Lost to Follow-up|29|||
162062514|NCT00849381|585282714|FG000|Overall Study|Adverse Event|1|||
162062515|NCT00849381|585282714|FG000|Overall Study|Lost to Follow-up|129|||
162062516|NCT00849381|585282714|FG000|Overall Study|Protocol Violation|5|||
162062517|NCT00849381|585282714|FG000|Overall Study|Withdrawal by Subject|6|||
162062518|NCT00849381|585282714|FG000|Overall Study|Other|4|||
162062519|NCT04429061|585282715|FG000|Overall Study|Lost to Follow-up|62|||
162062520|NCT04429061|585282716|FG001|Overall Study|Lost to Follow-up|87|||
162062521|NCT04429061|585282715|FG000|Overall Study|Withdrawal by Subject|3|||
162062522|NCT04429061|585282716|FG001|Overall Study|Withdrawal by Subject|4|||
162062523|NCT02289898|585282723|FG000|Overall Study|Death|5|||
162062524|NCT02289898|585282724|FG001|Overall Study|Death|4|||
162062525|NCT02289898|585282725|FG002|Overall Study|Death|3|||
162062526|NCT02289898|585282723|FG000|Overall Study|Physician Decision|2|||
162062527|NCT02289898|585282724|FG001|Overall Study|Physician Decision|5|||
162062528|NCT02289898|585282725|FG002|Overall Study|Physician Decision|2|||
162062529|NCT02289898|585282723|FG000|Overall Study|Withdrawal by Subject|0|||
162062530|NCT02289898|585282724|FG001|Overall Study|Withdrawal by Subject|4|||
162062531|NCT02289898|585282725|FG002|Overall Study|Withdrawal by Subject|1|||
162062532|NCT02289898|585282723|FG000|Overall Study|Adverse Event|3|||
162062533|NCT02289898|585282724|FG001|Overall Study|Adverse Event|5|||
162062534|NCT02289898|585282725|FG002|Overall Study|Adverse Event|5|||
162062535|NCT02289898|585282723|FG000|Overall Study|Disease progression|34|||
162062536|NCT02289898|585282724|FG001|Overall Study|Disease progression|28|||
162062537|NCT02289898|585282725|FG002|Overall Study|Disease progression|34|||
162062538|NCT02289898|585282723|FG000|Overall Study|Use of another anticancer therapy|0|||
162062539|NCT02289898|585282724|FG001|Overall Study|Use of another anticancer therapy|0|||
162062540|NCT02289898|585282725|FG002|Overall Study|Use of another anticancer therapy|1|||
162062541|NCT02289898|585282723|FG000|Overall Study|Other|8|||
162062542|NCT02289898|585282724|FG001|Overall Study|Other|7|||
162062543|NCT02289898|585282725|FG002|Overall Study|Other|10|||
162062544|NCT04118166|585282726|FG000|Overall Study|Adverse Event|1|||
162062545|NCT00885105|585282729|FG000|Overall Study|Withdrawal by Subject|0|||
162062546|NCT00885105|585282730|FG001|Overall Study|Withdrawal by Subject|8|||
162062547|NCT00885105|585282729|FG000|Overall Study|Adverse Event|1|||
162062548|NCT00885105|585282730|FG001|Overall Study|Adverse Event|0|||
162062549|NCT00885105|585282729|FG000|Overall Study|Protocol Violation|0|||
162062550|NCT00885105|585282730|FG001|Overall Study|Protocol Violation|2|||
162062551|NCT03519932|585282731|FG000|First Intervention|Adverse Event|1|||
162062552|NCT03519932|585282732|FG001|First Intervention|Adverse Event|3|||
162062553|NCT02254486|585282733|FG000|Overall Study|Adverse Event|1|||
162062554|NCT02254486|585282734|FG001|Overall Study|Adverse Event|1|||
162062555|NCT02254486|585282733|FG000|Overall Study|Lack of Efficacy|1|||
162062556|NCT02254486|585282734|FG001|Overall Study|Lack of Efficacy|0|||
162062557|NCT02254486|585282733|FG000|Overall Study|Lost to Follow-up|2|||
162062558|NCT02254486|585282734|FG001|Overall Study|Lost to Follow-up|4|||
162062559|NCT02254486|585282733|FG000|Overall Study|Protocol Violation|1|||
162062560|NCT02254486|585282734|FG001|Overall Study|Protocol Violation|2|||
162062561|NCT02254486|585282733|FG000|Overall Study|Withdrawal by Subject|17|||
162062562|NCT02254486|585282734|FG001|Overall Study|Withdrawal by Subject|15|||
162062563|NCT02254486|585282733|FG000|Overall Study|GFR<60mL/min|16|||
162062564|NCT02254486|585282734|FG001|Overall Study|GFR<60mL/min|21|||
162062565|NCT02254486|585282733|FG000|Overall Study|Various|12|||
162062566|NCT02254486|585282734|FG001|Overall Study|Various|12|||
162062567|NCT01350414|585282735|FG000|Overall Study|Lost to Follow-up|13|||
162062568|NCT01350414|585282735|FG000|Overall Study|Withdrawal by Subject|4|||
162062569|NCT01350414|585282735|FG000|Overall Study|Physician Decision|2|||
162062570|NCT02772081|585282741|FG000|Overall Study|Physician Decision|1|||
162062571|NCT02772081|585282742|FG001|Overall Study|Physician Decision|1|||
162062572|NCT02772081|585282741|FG000|Overall Study|Death|1|||
162062573|NCT02772081|585282742|FG001|Overall Study|Death|1|||
162062574|NCT00759954|585282745|FG000|Overall Study|Personal reason|1|||
162062575|NCT00759954|585282746|FG001|Overall Study|Personal reason|0|||
162062576|NCT00759954|585282745|FG000|Overall Study|Adverse Event|1|||
162062577|NCT00759954|585282746|FG001|Overall Study|Adverse Event|2|||
162062578|NCT00022633|585282750|FG000|Overall Study|Adverse Event|11|||
162062579|NCT00022633|585282751|FG001|Overall Study|Adverse Event|1|||
162062580|NCT00022633|585282750|FG000|Overall Study|Refusal unrelated to adverse event|1|||
162062581|NCT00022633|585282751|FG001|Overall Study|Refusal unrelated to adverse event|0|||
162062582|NCT00022633|585282750|FG000|Overall Study|Progression/relapse|9|||
162062583|NCT00022633|585282751|FG001|Overall Study|Progression/relapse|2|||
162062584|NCT00022633|585282750|FG000|Overall Study|Death|4|||
162062585|NCT00022633|585282751|FG001|Overall Study|Death|0|||
162062586|NCT00022633|585282750|FG000|Overall Study|Other - not protocol specified|3|||
162062587|NCT00022633|585282751|FG001|Overall Study|Other - not protocol specified|2|||
162062588|NCT00022633|585282750|FG000|Overall Study|Ineligible|4|||
162062589|NCT00022633|585282751|FG001|Overall Study|Ineligible|0|||
162062590|NCT03033394|585282756|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
162062591|NCT03033394|585282756|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
162062592|NCT03033394|585282756|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
162062593|NCT03033394|585282756|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
162062594|NCT03033394|585282756|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
162062595|NCT02927431|585282757|FG000|Overall Study|Withdrawal by Subject|0|||
162062596|NCT02927431|585282758|FG001|Overall Study|Withdrawal by Subject|0|||
162062597|NCT02927431|585282759|FG002|Overall Study|Withdrawal by Subject|1|||
162062598|NCT02246660|585282760|FG000|Overall Study|Withdrawal by Subject|0|||
162062599|NCT02246660|585282761|FG001|Overall Study|Withdrawal by Subject|1|||
162062600|NCT02246660|585282762|FG002|Overall Study|Withdrawal by Subject|0|||
162062601|NCT02246660|585282760|FG000|Overall Study|Death|0|||
162062602|NCT02246660|585282761|FG001|Overall Study|Death|0|||
162062603|NCT02246660|585282762|FG002|Overall Study|Death|1|||
162062604|NCT04952402|585282763|FG000|Overall Study|Lost to Follow-up|1|||
162062605|NCT04952402|585282764|FG001|Overall Study|Lost to Follow-up|3|||
162062606|NCT04952402|585282763|FG000|Overall Study|Lack Of Venous Access|0|||
162062607|NCT04952402|585282764|FG001|Overall Study|Lack Of Venous Access|1|||
162062608|NCT00143403|585282765|FG000|Overall Study|Adverse Event|3|||
162062609|NCT00143403|585282766|FG001|Overall Study|Adverse Event|8|||
162062610|NCT00143403|585282765|FG000|Overall Study|Death|1|||
162062611|NCT00143403|585282766|FG001|Overall Study|Death|0|||
162062612|NCT00143403|585282765|FG000|Overall Study|Withdrawal by Subject|3|||
162062613|NCT00143403|585282766|FG001|Overall Study|Withdrawal by Subject|12|||
162062614|NCT00143403|585282765|FG000|Overall Study|Relapse|15|||
162062615|NCT00143403|585282766|FG001|Overall Study|Relapse|7|||
162062616|NCT00143403|585282765|FG000|Overall Study|Protocol Violation|2|||
162062617|NCT00143403|585282766|FG001|Overall Study|Protocol Violation|2|||
162062618|NCT00143403|585282765|FG000|Overall Study|specified by site|4|||
162062619|NCT00143403|585282766|FG001|Overall Study|specified by site|9|||
162062620|NCT00143403|585282765|FG000|Overall Study|Randomized Not Treated|7|||
162062621|NCT00143403|585282766|FG001|Overall Study|Randomized Not Treated|8|||
162062622|NCT00587639|585282767|FG000|Overall Study|Withdrawal by Subject|1|||
162062623|NCT01442675|585282768|FG000|Overall Study|Protocol Violation|6|||
162062624|NCT01442675|585282768|FG000|Overall Study|Lost to Follow-up|2|||
162062625|NCT01442675|585282768|FG000|Overall Study|Withdrawal by Subject|4|||
162062626|NCT03944954|585282773|FG000|Overall Study|Withdrawal by Subject|22|||
162062627|NCT03944954|585282774|FG001|Overall Study|Withdrawal by Subject|4|||
162062628|NCT03944954|585282773|FG000|Overall Study|Lost to Follow-up|18|||
162062629|NCT03944954|585282774|FG001|Overall Study|Lost to Follow-up|0|||
162062630|NCT03944954|585282773|FG000|Overall Study|Failed Medical Screening|7|||
162062631|NCT03944954|585282774|FG001|Overall Study|Failed Medical Screening|0|||
162062632|NCT03235154|585282778|FG000|Overall Study|Withdrawal by Subject|1|||
162062633|NCT03235154|585282778|FG000|Overall Study|Adverse Event|1|||
162062634|NCT03235154|585282778|FG000|Overall Study|Lost to Follow-up|2|||
162062635|NCT00536198|585282779|FG000|Overall Study|Lost to Follow-up|15|||
162062636|NCT00536198|585282780|FG001|Overall Study|Lost to Follow-up|14|||
162062637|NCT00536198|585282779|FG000|Overall Study|Withdrawal by Subject|16|||
162062638|NCT00536198|585282780|FG001|Overall Study|Withdrawal by Subject|12|||
162062639|NCT00536198|585282779|FG000|Overall Study|Adverse Event|2|||
162062640|NCT00536198|585282780|FG001|Overall Study|Adverse Event|2|||
162062641|NCT00536198|585282779|FG000|Overall Study|Rescue|3|||
162062642|NCT00536198|585282780|FG001|Overall Study|Rescue|9|||
162062643|NCT00536198|585282779|FG000|Overall Study|Pregnancy|1|||
162062644|NCT00536198|585282780|FG001|Overall Study|Pregnancy|1|||
162062645|NCT00536198|585282779|FG000|Overall Study|Protocol Violation|0|||
162062646|NCT00536198|585282780|FG001|Overall Study|Protocol Violation|1|||
162062647|NCT00881712|585282781|FG000|Overall Study|Death|1|||
162062648|NCT00881712|585282782|FG001|Overall Study|Death|0|||
162062649|NCT00881712|585282783|FG002|Overall Study|Death|0|||
162062650|NCT00881712|585282781|FG000|Overall Study|Withdrawal by Subject|1|||
162062651|NCT00881712|585282782|FG001|Overall Study|Withdrawal by Subject|0|||
162062652|NCT00881712|585282783|FG002|Overall Study|Withdrawal by Subject|0|||
162062653|NCT00276744|585282784|FG000|PART A|Reason unknown|98|||
162062654|NCT00965718|585282803|FG000|Overall Study|Withdrawal by Subject|4|||
162062655|NCT03667924|585282804|FG000|Baseline Completed|Lost to Follow-up|0|||
162062656|NCT03667924|585282805|FG001|Baseline Completed|Lost to Follow-up|2|||
162062657|NCT03667924|585282806|FG002|Baseline Completed|Lost to Follow-up|0|||
162062658|NCT03667924|585282804|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
162062659|NCT03667924|585282805|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
162062660|NCT03667924|585282806|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
162062661|NCT03667924|585282804|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
162062662|NCT03667924|585282805|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
162062663|NCT03667924|585282806|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
162062664|NCT03667924|585282804|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
162062665|NCT03667924|585282805|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
162062666|NCT03667924|585282806|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
162062667|NCT03667924|585282804|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
162062668|NCT03667924|585282805|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
162062669|NCT03667924|585282806|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
162062670|NCT03667924|585282804|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
162062671|NCT03667924|585282805|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
162062672|NCT03667924|585282806|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
162062673|NCT03667924|585282804|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
162062674|NCT03667924|585282805|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
162062675|NCT03667924|585282806|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
162062676|NCT00126568|585282807|FG000|Overall Study|Death|2|||
162062677|NCT01244425|585282808|FG000|Overall Study|Withdrawal by Subject|2|||
162062678|NCT01244425|585282809|FG001|Overall Study|Withdrawal by Subject|2|||
162062679|NCT01244425|585282808|FG000|Overall Study|Adverse Event|1|||
162062680|NCT01244425|585282809|FG001|Overall Study|Adverse Event|1|||
162062681|NCT02547454|585282810|FG000|Overall Study|Due to hemodialysis|53|||
162062682|NCT02547454|585282810|FG000|Overall Study|Due to transplantation|1|||
162062683|NCT02547454|585282810|FG000|Overall Study|Due to no further need to treat|4|||
162062684|NCT02547454|585282810|FG000|Overall Study|Death|38|||
162062685|NCT02547454|585282810|FG000|Overall Study|Lost to Follow-up|26|||
162062686|NCT02547454|585282810|FG000|Overall Study|Other|39|||
162062687|NCT02547454|585282810|FG000|Overall Study|No data|11|||
162062688|NCT00407563|585284312|FG000|Overall Study|Patient continues on treatment|1|||
162062689|NCT01409564|585284313|FG000|Overall Study|low medication compliance|4|||
162062690|NCT01409564|585284314|FG001|Overall Study|low medication compliance|3|||
162062691|NCT01409564|585284313|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
162062692|NCT01409564|585284314|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
162062693|NCT05040386|585284315|FG000|Overall Study|Withdrawal by Subject|1|||
162062694|NCT05040386|585284316|FG001|Overall Study|Withdrawal by Subject|0|||
162062695|NCT05040386|585284317|FG002|Overall Study|Withdrawal by Subject|1|||
162062696|NCT05040386|585284318|FG003|Overall Study|Withdrawal by Subject|0|||
162062697|NCT05040386|585284315|FG000|Overall Study|Lost to Follow-up|0|||
162062698|NCT05040386|585284316|FG001|Overall Study|Lost to Follow-up|0|||
162062699|NCT05040386|585284317|FG002|Overall Study|Lost to Follow-up|1|||
162062700|NCT05040386|585284318|FG003|Overall Study|Lost to Follow-up|0|||
162062701|NCT02618434|585284321|FG000|Overall Study|Withdrawal by Subject|0|||
162062702|NCT02618434|585284322|FG001|Overall Study|Withdrawal by Subject|2|||
162062703|NCT02618434|585284323|FG002|Overall Study|Withdrawal by Subject|3|||
162062704|NCT02618434|585284321|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
162062705|NCT02618434|585284322|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
162062706|NCT02618434|585284323|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
162062707|NCT02618434|585284321|FG000|Overall Study|Lost to Follow-up|3|||
162062708|NCT02618434|585284322|FG001|Overall Study|Lost to Follow-up|1|||
162062709|NCT02618434|585284323|FG002|Overall Study|Lost to Follow-up|3|||
162062710|NCT02618434|585284321|FG000|Overall Study|Adverse Event|1|||
162062711|NCT02618434|585284322|FG001|Overall Study|Adverse Event|0|||
162062712|NCT02618434|585284323|FG002|Overall Study|Adverse Event|12|||
162062713|NCT02618434|585284321|FG000|Overall Study|Physician Decision|0|||
162062714|NCT02618434|585284322|FG001|Overall Study|Physician Decision|1|||
162062715|NCT02618434|585284323|FG002|Overall Study|Physician Decision|0|||
162062716|NCT02618434|585284321|FG000|Overall Study|Protocol Violation|0|||
162062717|NCT02618434|585284322|FG001|Overall Study|Protocol Violation|0|||
162062718|NCT02618434|585284323|FG002|Overall Study|Protocol Violation|1|||
162062719|NCT02618434|585284321|FG000|Overall Study|Other, Multiple categories|1|||
162062720|NCT02618434|585284322|FG001|Overall Study|Other, Multiple categories|1|||
162062721|NCT02618434|585284323|FG002|Overall Study|Other, Multiple categories|1|||
162062722|NCT04626297|585284327|FG000|Overall Study|Adverse Event|5|||
162062723|NCT04626297|585284328|FG001|Overall Study|Adverse Event|3|||
162062724|NCT04626297|585284327|FG000|Overall Study|Lost to Follow-up|7|||
162062725|NCT04626297|585284328|FG001|Overall Study|Lost to Follow-up|3|||
162062726|NCT04626297|585284327|FG000|Overall Study|Protocol Violation|5|||
162062727|NCT04626297|585284328|FG001|Overall Study|Protocol Violation|1|||
162062728|NCT04626297|585284327|FG000|Overall Study|Withdrawal by Subject|20|||
162062729|NCT04626297|585284328|FG001|Overall Study|Withdrawal by Subject|6|||
162062730|NCT04626297|585284327|FG000|Overall Study|Sponsor decision|2|||
162062731|NCT04626297|585284328|FG001|Overall Study|Sponsor decision|1|||
162062732|NCT02066233|585284329|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
162062733|NCT02066233|585284330|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
162062734|NCT02598076|585284331|FG000|Overall Study|Lost to Follow-up|2|||
162062735|NCT02598076|585284332|FG001|Overall Study|Lost to Follow-up|3|||
162062736|NCT02005445|585284333|FG000|Overall Study|Dual study enrollment|0|||
162062737|NCT02005445|585284334|FG001|Overall Study|Dual study enrollment|1|||
162062738|NCT00010374|585284335|FG000|Overall Study|False positive phrenic nerve test|1|||
162062739|NCT00533845|585284342|FG000|Overall Study|Physician Decision|1|||
162062740|NCT00533845|585284343|FG001|Overall Study|Physician Decision|0|||
162062741|NCT04294472|585284351|FG000|Overall Study|Adverse Event|0|||
162062742|NCT04294472|585284352|FG001|Overall Study|Adverse Event|1|||
162062743|NCT04294472|585284353|FG002|Overall Study|Adverse Event|1|||
162062744|NCT04294472|585284351|FG000|Overall Study|Randomized but not treated|0|||
162062745|NCT04294472|585284352|FG001|Overall Study|Randomized but not treated|1|||
162062746|NCT04294472|585284353|FG002|Overall Study|Randomized but not treated|1|||
162062747|NCT00563381|585284355|FG000|Overall Study|Adverse Event|264|||
162062748|NCT00563381|585284356|FG001|Overall Study|Adverse Event|292|||
162062749|NCT00563381|585284355|FG000|Overall Study|Protocol Violation|66|||
162062750|NCT00563381|585284356|FG001|Overall Study|Protocol Violation|74|||
162062751|NCT00563381|585284355|FG000|Overall Study|Lost to Follow-up|7|||
162062752|NCT00563381|585284356|FG001|Overall Study|Lost to Follow-up|15|||
162062753|NCT00563381|585284355|FG000|Overall Study|Withdrawal by Subject|192|||
162062754|NCT00563381|585284356|FG001|Overall Study|Withdrawal by Subject|209|||
162062755|NCT00563381|585284355|FG000|Overall Study|Lack of Efficacy|32|||
162062756|NCT00563381|585284356|FG001|Overall Study|Lack of Efficacy|24|||
162062757|NCT00563381|585284355|FG000|Overall Study|Individual different reasons|24|||
162062758|NCT00563381|585284356|FG001|Overall Study|Individual different reasons|34|||
162062759|NCT00667368|585284357|FG000|Overall Study|Lost to Follow-up|176|||
162062760|NCT00667368|585284358|FG001|Overall Study|Lost to Follow-up|155|||
162062761|NCT00667368|585284357|FG000|Overall Study|Discontinued early|24|||
162062762|NCT00667368|585284358|FG001|Overall Study|Discontinued early|17|||
162062763|NCT02407704|585284359|FG000|Overall Study|Lost to Follow-up|0|||
162062764|NCT02407704|585284360|FG001|Overall Study|Lost to Follow-up|0|||
162062765|NCT02407704|585284361|FG002|Overall Study|Lost to Follow-up|0|||
162062766|NCT02407704|585284362|FG003|Overall Study|Lost to Follow-up|2|||
162062767|NCT02407704|585284359|FG000|Overall Study|Protocol Violation|0|||
162062768|NCT02407704|585284360|FG001|Overall Study|Protocol Violation|0|||
162062769|NCT02407704|585284361|FG002|Overall Study|Protocol Violation|0|||
162062770|NCT02407704|585284362|FG003|Overall Study|Protocol Violation|1|||
162062771|NCT02407704|585284359|FG000|Overall Study|Withdrawal by Subject|0|||
162062772|NCT02407704|585284360|FG001|Overall Study|Withdrawal by Subject|0|||
162062773|NCT02407704|585284361|FG002|Overall Study|Withdrawal by Subject|1|||
162062774|NCT02407704|585284362|FG003|Overall Study|Withdrawal by Subject|0|||
162062775|NCT01957553|585284363|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
162062776|NCT01957553|585284364|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
162062777|NCT01957553|585284363|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
162062778|NCT01957553|585284364|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
162062779|NCT01957553|585284363|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
162062780|NCT01957553|585284364|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
162062781|NCT01957553|585284363|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
162062782|NCT01957553|585284364|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
162062783|NCT01957553|585284363|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
162062784|NCT01957553|585284364|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
162062785|NCT01957553|585284363|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
162062786|NCT01957553|585284364|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
162062787|NCT01957553|585284363|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
162062788|NCT01957553|585284364|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
162062789|NCT01957553|585284363|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
162062790|NCT01957553|585284364|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
162062791|NCT01957553|585284363|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
162062792|NCT01957553|585284364|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
162062793|NCT01683383|585284369|FG000|Overall Study|Infant was not transported|1|||
162062794|NCT01683383|585284370|FG001|Overall Study|Infant was not transported|0|||
162062795|NCT02496611|585284371|FG000|Overall Study|Lost to Follow-up|2|||
162062796|NCT02496611|585284372|FG001|Overall Study|Lost to Follow-up|1|||
162062797|NCT02496611|585284371|FG000|Overall Study|Withdrawal by Subject|5|||
162062798|NCT02496611|585284372|FG001|Overall Study|Withdrawal by Subject|2|||
162062799|NCT02850965|585284373|FG000|Overall Study|Other than listed|3|||
162062800|NCT02850965|585284374|FG001|Overall Study|Other than listed|4|||
162062801|NCT02850965|585284373|FG000|Overall Study|Protocol Violation|0|||
162062802|NCT02850965|585284374|FG001|Overall Study|Protocol Violation|2|||
162062803|NCT02850965|585284373|FG000|Overall Study|Lost to Follow-up|5|||
162062804|NCT02850965|585284374|FG001|Overall Study|Lost to Follow-up|3|||
162062805|NCT02850965|585284373|FG000|Overall Study|Lack of Efficacy|4|||
162062806|NCT02850965|585284374|FG001|Overall Study|Lack of Efficacy|8|||
162062807|NCT02850965|585284373|FG000|Overall Study|Adverse Event|3|||
162062808|NCT02850965|585284374|FG001|Overall Study|Adverse Event|2|||
162062809|NCT02850965|585284373|FG000|Overall Study|Withdrawal by Subject|3|||
162062810|NCT02850965|585284374|FG001|Overall Study|Withdrawal by Subject|4|||
162062811|NCT02850965|585284373|FG000|Overall Study|Physician Decision|0|||
162062812|NCT02850965|585284374|FG001|Overall Study|Physician Decision|1|||
162062813|NCT02850965|585284373|FG000|Overall Study|Randomized but not treated|0|||
162062814|NCT02850965|585284374|FG001|Overall Study|Randomized but not treated|1|||
162062815|NCT00230607|585284383|FG000|Overall Study|Other|3|||
162062816|NCT03672747|585284384|FG000|Overall Study|Lost to Follow-up|1|||
162062817|NCT03672747|585284385|FG001|Overall Study|Lost to Follow-up|1|||
162062818|NCT03672747|585284386|FG002|Overall Study|Lost to Follow-up|2|||
162062819|NCT03672747|585284387|FG003|Overall Study|Lost to Follow-up|2|||
162062820|NCT03672747|585284388|FG004|Overall Study|Lost to Follow-up|2|||
162062821|NCT03672747|585284389|FG005|Overall Study|Lost to Follow-up|1|||
162062822|NCT03228537|585284392|FG000|Neoadjuvant|Adverse Event|2|||
162062823|NCT03228537|585284392|FG000|Neoadjuvant|Progression/Relapse|4|||
162062824|NCT03228537|585284392|FG000|Neoadjuvant|Death|1|||
162062825|NCT03228537|585284392|FG000|Surgery|Death|1|||
162062826|NCT03228537|585284392|FG000|Surgery|Other - Not Protocol Specified|2|||
162062827|NCT03228537|585284392|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
162062828|NCT03228537|585284392|FG000|Maintenance|Progression/Relapse|10|||
162062829|NCT01648205|585284395|FG000|Placebo|Pregnancy|1|||
162062830|NCT01648205|585284395|FG000|Placebo|Withdrawal by Subject|1|||
162062831|NCT01648205|585284395|FG000|Placebo|Protocol Violation|2|||
162062832|NCT01648205|585284395|FG000|Ranolazine|Death|1|||
162062833|NCT01648205|585284395|FG000|Ranolazine|Withdrawal by Subject|1|||
162062834|NCT01648205|585284395|FG000|Ranolazine|Protocol Violation|3|||
162062835|NCT00580606|585284406|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
162062836|NCT00580606|585284407|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
162062837|NCT00580606|585284406|FG000|Open Label (OL)|Withdrawal by Subject|4|||
162062838|NCT00580606|585284407|FG001|Open Label (OL)|Withdrawal by Subject|6|||
162062839|NCT00580606|585284406|FG000|Open Label (OL)|Dosing Symptoms|0|||
162062840|NCT00580606|585284407|FG001|Open Label (OL)|Dosing Symptoms|1|||
162062841|NCT00580606|585284406|FG000|Open Label (OL)|Lost to Follow-up|0|||
162062842|NCT00580606|585284407|FG001|Open Label (OL)|Lost to Follow-up|1|||
162062843|NCT00580606|585284406|FG000|Open Label (OL)|Pregnancy|0|||
162062844|NCT00580606|585284407|FG001|Open Label (OL)|Pregnancy|1|||
162062845|NCT00580606|585284406|FG000|Open Label (OL)|Non-compliance|2|||
162062846|NCT00580606|585284407|FG001|Open Label (OL)|Non-compliance|0|||
162062847|NCT00580606|585284406|FG000|Open Label (OL)|Physician Decision|1|||
162062848|NCT00580606|585284407|FG001|Open Label (OL)|Physician Decision|1|||
162062849|NCT00580606|585284406|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
162062850|NCT00580606|585284407|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
162062851|NCT03358290|585284409|FG000|Overall Study|Study discontinued by Sponsor|0|||
162062852|NCT03358290|585284410|FG001|Overall Study|Study discontinued by Sponsor|1|||
162062853|NCT03358290|585284411|FG002|Overall Study|Study discontinued by Sponsor|1|||
162062854|NCT03358290|585284412|FG003|Overall Study|Study discontinued by Sponsor|0|||
162062855|NCT03358290|585284413|FG004|Overall Study|Study discontinued by Sponsor|0|||
162062856|NCT03358290|585284409|FG000|Overall Study|Adverse Event|0|||
162062857|NCT03358290|585284410|FG001|Overall Study|Adverse Event|0|||
162062858|NCT03358290|585284411|FG002|Overall Study|Adverse Event|1|||
162062859|NCT03358290|585284412|FG003|Overall Study|Adverse Event|2|||
162062860|NCT03358290|585284413|FG004|Overall Study|Adverse Event|0|||
162062861|NCT03358290|585284409|FG000|Overall Study|Withdrawal by Subject|0|||
162062862|NCT03358290|585284410|FG001|Overall Study|Withdrawal by Subject|0|||
162062863|NCT03358290|585284411|FG002|Overall Study|Withdrawal by Subject|0|||
162062864|NCT03358290|585284412|FG003|Overall Study|Withdrawal by Subject|0|||
162062865|NCT03358290|585284413|FG004|Overall Study|Withdrawal by Subject|1|||
162062866|NCT01482884|585284414|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
162062867|NCT01482884|585284415|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
162062868|NCT01482884|585284414|FG000|Overall Study|Protocol Violation|1|||
162062869|NCT01482884|585284415|FG001|Overall Study|Protocol Violation|0|||
162062870|NCT01482884|585284414|FG000|Overall Study|Lost to Follow-up|2|||
162062871|NCT01482884|585284415|FG001|Overall Study|Lost to Follow-up|2|||
162062872|NCT01482884|585284414|FG000|Overall Study|Lack of Efficacy|0|||
162062873|NCT01482884|585284415|FG001|Overall Study|Lack of Efficacy|1|||
162062874|NCT01482884|585284414|FG000|Overall Study|Adverse Event|2|||
162062875|NCT01482884|585284415|FG001|Overall Study|Adverse Event|1|||
162062876|NCT01482884|585284414|FG000|Overall Study|Withdrawal by Subject|8|||
162062877|NCT01482884|585284415|FG001|Overall Study|Withdrawal by Subject|13|||
162062878|NCT04102020|585284416|FG000|Overall Study|Adverse Event|1|||
162062879|NCT04102020|585284417|FG001|Overall Study|Adverse Event|0|||
162062880|NCT04102020|585284418|FG002|Overall Study|Adverse Event|0|||
162062881|NCT04102020|585284419|FG003|Overall Study|Adverse Event|1|||
162062882|NCT04102020|585284420|FG004|Overall Study|Adverse Event|0|||
162062883|NCT04102020|585284416|FG000|Overall Study|Withdrawal by Subject|0|||
162062884|NCT04102020|585284417|FG001|Overall Study|Withdrawal by Subject|1|||
162062885|NCT04102020|585284418|FG002|Overall Study|Withdrawal by Subject|1|||
162062886|NCT04102020|585284419|FG003|Overall Study|Withdrawal by Subject|1|||
162062887|NCT04102020|585284420|FG004|Overall Study|Withdrawal by Subject|1|||
162062888|NCT04102020|585284416|FG000|Overall Study|Death|1|||
162062889|NCT04102020|585284417|FG001|Overall Study|Death|4|||
162062890|NCT04102020|585284418|FG002|Overall Study|Death|1|||
162062891|NCT04102020|585284419|FG003|Overall Study|Death|1|||
162062892|NCT04102020|585284420|FG004|Overall Study|Death|0|||
162062893|NCT04102020|585284416|FG000|Overall Study|Physician Decision|1|||
162062894|NCT04102020|585284417|FG001|Overall Study|Physician Decision|2|||
162062895|NCT04102020|585284418|FG002|Overall Study|Physician Decision|2|||
162062896|NCT04102020|585284419|FG003|Overall Study|Physician Decision|0|||
162062897|NCT04102020|585284420|FG004|Overall Study|Physician Decision|1|||
162062898|NCT04102020|585284416|FG000|Overall Study|COVID-19 Infection|1|||
162062899|NCT04102020|585284417|FG001|Overall Study|COVID-19 Infection|0|||
162062900|NCT04102020|585284418|FG002|Overall Study|COVID-19 Infection|0|||
162062901|NCT04102020|585284419|FG003|Overall Study|COVID-19 Infection|0|||
162062902|NCT04102020|585284420|FG004|Overall Study|COVID-19 Infection|0|||
162062903|NCT04102020|585284416|FG000|Overall Study|Not disclosed|5|||
162062904|NCT04102020|585284417|FG001|Overall Study|Not disclosed|3|||
162062905|NCT04102020|585284418|FG002|Overall Study|Not disclosed|8|||
162062906|NCT04102020|585284419|FG003|Overall Study|Not disclosed|0|||
162062907|NCT04102020|585284420|FG004|Overall Study|Not disclosed|1|||
162062908|NCT04102020|585284416|FG000|Overall Study|MIssing|1|||
162062909|NCT04102020|585284417|FG001|Overall Study|MIssing|0|||
162062910|NCT04102020|585284418|FG002|Overall Study|MIssing|1|||
162062911|NCT04102020|585284419|FG003|Overall Study|MIssing|1|||
162062912|NCT04102020|585284420|FG004|Overall Study|MIssing|1|||
162062913|NCT04102020|585284416|FG000|Overall Study|Continuing in ongoing study|13|||
162062914|NCT04102020|585284417|FG001|Overall Study|Continuing in ongoing study|13|||
162062915|NCT04102020|585284418|FG002|Overall Study|Continuing in ongoing study|7|||
162062916|NCT04102020|585284419|FG003|Overall Study|Continuing in ongoing study|26|||
162062917|NCT04102020|585284420|FG004|Overall Study|Continuing in ongoing study|12|||
162062918|NCT04853225|585284421|FG000|Overall Study|Withdrawal by Subject|81|||
162062919|NCT04853225|585284422|FG001|Overall Study|Withdrawal by Subject|4|||
162062920|NCT04853225|585284423|FG002|Overall Study|Withdrawal by Subject|1|||
162062921|NCT04853225|585284421|FG000|Overall Study|Physician Decision|12|||
162062922|NCT04853225|585284422|FG001|Overall Study|Physician Decision|4|||
162062923|NCT04853225|585284423|FG002|Overall Study|Physician Decision|1|||
162062924|NCT04853225|585284421|FG000|Overall Study|Lost to Follow-up|50|||
162062925|NCT04853225|585284422|FG001|Overall Study|Lost to Follow-up|0|||
162062926|NCT04853225|585284423|FG002|Overall Study|Lost to Follow-up|0|||
162062927|NCT04853225|585284421|FG000|Overall Study|Other|102|||
162062928|NCT04853225|585284422|FG001|Overall Study|Other|11|||
162062929|NCT04853225|585284423|FG002|Overall Study|Other|5|||
162062930|NCT04853225|585284421|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
162062931|NCT04853225|585284422|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
162062932|NCT04853225|585284423|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
162062933|NCT04853225|585284421|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
162062934|NCT04853225|585284422|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
162062935|NCT04853225|585284423|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
162062936|NCT03789318|585284424|FG000|Overall Study|Adverse Event|0|||
162062937|NCT03789318|585284425|FG001|Overall Study|Adverse Event|0|||
162062938|NCT03789318|585284426|FG002|Overall Study|Adverse Event|1|||
162062939|NCT03789318|585284427|FG003|Overall Study|Adverse Event|1|||
162062940|NCT03789318|585284428|FG004|Overall Study|Adverse Event|0|||
162062941|NCT03789318|585284424|FG000|Overall Study|Lost to Follow-up|0|||
162062942|NCT03789318|585284425|FG001|Overall Study|Lost to Follow-up|0|||
162062943|NCT03789318|585284426|FG002|Overall Study|Lost to Follow-up|1|||
162062944|NCT03789318|585284427|FG003|Overall Study|Lost to Follow-up|0|||
162062945|NCT03789318|585284428|FG004|Overall Study|Lost to Follow-up|0|||
162062946|NCT03789318|585284424|FG000|Overall Study|Withdrawal by Subject|0|||
162062947|NCT03789318|585284425|FG001|Overall Study|Withdrawal by Subject|0|||
162062948|NCT03789318|585284426|FG002|Overall Study|Withdrawal by Subject|1|||
162062949|NCT03789318|585284427|FG003|Overall Study|Withdrawal by Subject|0|||
162062950|NCT03789318|585284428|FG004|Overall Study|Withdrawal by Subject|0|||
162062951|NCT02167893|585284429|FG000|Overall Study|Investigator transferred|85|||
162062952|NCT02167893|585284429|FG000|Overall Study|Investigator health reasons|10|||
162062953|NCT02167893|585284429|FG000|Overall Study|Case report forms not collected|68|||
162062954|NCT04847557|585284430|FG000|Overall Study|Adverse Event|1|||
162062955|NCT04847557|585284431|FG001|Overall Study|Adverse Event|0|||
162062956|NCT04847557|585284430|FG000|Overall Study|Death|19|||
162062957|NCT04847557|585284431|FG001|Overall Study|Death|15|||
162062958|NCT04847557|585284430|FG000|Overall Study|Lost to Follow-up|3|||
162062959|NCT04847557|585284431|FG001|Overall Study|Lost to Follow-up|6|||
162062960|NCT04847557|585284430|FG000|Overall Study|Physician Decision|1|||
162062961|NCT04847557|585284431|FG001|Overall Study|Physician Decision|0|||
162062962|NCT04847557|585284430|FG000|Overall Study|Protocol Violation|0|||
162062963|NCT04847557|585284431|FG001|Overall Study|Protocol Violation|1|||
162062964|NCT04847557|585284430|FG000|Overall Study|Withdrawal by Subject|8|||
162062965|NCT04847557|585284431|FG001|Overall Study|Withdrawal by Subject|14|||
162062966|NCT01325584|585284432|FG000|Overall Study|Death|1|||
162062967|NCT00733408|585286188|FG000|Overall Study|Adverse Event|4|||
162062968|NCT01134783|585286189|FG000|Overall Study|Pregnancy|16|||
162062969|NCT01134783|585286190|FG001|Overall Study|Pregnancy|8|||
162062970|NCT01134783|585286189|FG000|Overall Study|Withdrawal by Subject|15|||
162062971|NCT01134783|585286190|FG001|Overall Study|Withdrawal by Subject|9|||
162062972|NCT01134783|585286189|FG000|Overall Study|Lost to Follow-up|5|||
162062973|NCT01134783|585286190|FG001|Overall Study|Lost to Follow-up|20|||
162062974|NCT00531232|585286193|FG000|Overall Study|Investigator decision|0|||
162062975|NCT00531232|585286194|FG001|Overall Study|Investigator decision|0|||
162062976|NCT00531232|585286195|FG002|Overall Study|Investigator decision|4|||
162062977|NCT00531232|585286193|FG000|Overall Study|Participants refused further treatment|0|||
162062978|NCT00531232|585286194|FG001|Overall Study|Participants refused further treatment|1|||
162062979|NCT00531232|585286195|FG002|Overall Study|Participants refused further treatment|2|||
162062980|NCT00531232|585286193|FG000|Overall Study|Adverse events (AEs)|1|||
162062981|NCT00531232|585286194|FG001|Overall Study|Adverse events (AEs)|2|||
162062982|NCT00531232|585286195|FG002|Overall Study|Adverse events (AEs)|2|||
162062983|NCT00531232|585286193|FG000|Overall Study|Treatment failure|1|||
162062984|NCT00531232|585286194|FG001|Overall Study|Treatment failure|3|||
162062985|NCT00531232|585286195|FG002|Overall Study|Treatment failure|7|||
162062986|NCT00531232|585286193|FG000|Overall Study|Disease recurrence|0|||
162062987|NCT00531232|585286194|FG001|Overall Study|Disease recurrence|0|||
162062988|NCT00531232|585286195|FG002|Overall Study|Disease recurrence|1|||
162062989|NCT00531232|585286193|FG000|Overall Study|Deceased|2|||
162062990|NCT00531232|585286194|FG001|Overall Study|Deceased|2|||
162062991|NCT00531232|585286195|FG002|Overall Study|Deceased|2|||
162062992|NCT00531232|585286193|FG000|Overall Study|Withdrawal by Subject|0|||
162062993|NCT00531232|585286194|FG001|Overall Study|Withdrawal by Subject|1|||
162062994|NCT00531232|585286195|FG002|Overall Study|Withdrawal by Subject|2|||
162062995|NCT00531232|585286193|FG000|Overall Study|Other|0|||
162062996|NCT00531232|585286194|FG001|Overall Study|Other|0|||
162062997|NCT00531232|585286195|FG002|Overall Study|Other|5|||
162062998|NCT00463346|585286196|FG000|Overall Study|Withdrawal by Subject|3|||
162062999|NCT00463346|585286197|FG001|Overall Study|Withdrawal by Subject|3|||
162063000|NCT03641651|585286198|FG000|Overall Study|organizational issues at one study site|1|||
162063001|NCT01991067|585286200|FG000|Overall Study|Lost to Follow-up|6|||
162063002|NCT01991067|585286201|FG001|Overall Study|Lost to Follow-up|5|||
162063003|NCT00224055|585286203|FG000|Overall Study|Adverse Event|9|||
162063004|NCT00224055|585286204|FG001|Overall Study|Adverse Event|3|||
162063005|NCT00224055|585286203|FG000|Overall Study|Lost to Follow-up|1|||
162063006|NCT00224055|585286204|FG001|Overall Study|Lost to Follow-up|2|||
162063007|NCT00224055|585286203|FG000|Overall Study|Protocol Violation|1|||
162063008|NCT00224055|585286204|FG001|Overall Study|Protocol Violation|1|||
162063009|NCT00224055|585286203|FG000|Overall Study|Inclusion Violation|3|||
162063010|NCT00224055|585286204|FG001|Overall Study|Inclusion Violation|6|||
162063011|NCT00224055|585286203|FG000|Overall Study|Withdrawal by Subject|0|||
162063012|NCT00224055|585286204|FG001|Overall Study|Withdrawal by Subject|2|||
162063013|NCT00224055|585286203|FG000|Overall Study|Other|1|||
162063014|NCT00224055|585286204|FG001|Overall Study|Other|0|||
162063015|NCT00127712|585286205|FG000|Overall Study|Adverse Event|3|||
162063016|NCT00127712|585286206|FG001|Overall Study|Adverse Event|0|||
162063017|NCT00127712|585286205|FG000|Overall Study|Lack of GI access to continue|2|||
162063018|NCT00127712|585286206|FG001|Overall Study|Lack of GI access to continue|0|||
162063019|NCT03055260|585286207|FG000|Overall Study|Withdrawal by Subject|1|||
162063020|NCT03055260|585286208|FG001|Overall Study|Withdrawal by Subject|0|||
162063021|NCT02450903|585286209|FG000|Overall Study|Adverse Event|3|||
162063022|NCT02450903|585286209|FG000|Overall Study|Progressive disease|15|||
162063023|NCT02450903|585286209|FG000|Overall Study|Switched to commercial drug|1|||
162063024|NCT02450903|585286209|FG000|Overall Study|Subject/guardian decision|1|||
162063025|NCT00592839|585286210|FG000|Overall Study|Withdrawal by Subject|1|||
162063026|NCT00592839|585286211|FG001|Overall Study|Withdrawal by Subject|1|||
162063027|NCT00592839|585286212|FG002|Overall Study|Withdrawal by Subject|3|||
162063028|NCT00592839|585286210|FG000|Overall Study|Protocol Violation|1|||
162063029|NCT00592839|585286211|FG001|Overall Study|Protocol Violation|1|||
162063030|NCT00592839|585286212|FG002|Overall Study|Protocol Violation|2|||
162063031|NCT00592839|585286210|FG000|Overall Study|Adverse Event|0|||
162063032|NCT00592839|585286211|FG001|Overall Study|Adverse Event|1|||
162063033|NCT00592839|585286212|FG002|Overall Study|Adverse Event|0|||
162063034|NCT00592839|585286210|FG000|Overall Study|Lost to Follow-up|0|||
162063035|NCT00592839|585286211|FG001|Overall Study|Lost to Follow-up|1|||
162063036|NCT00592839|585286212|FG002|Overall Study|Lost to Follow-up|1|||
162063037|NCT00799487|585286214|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
162063038|NCT00799487|585286215|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
162063039|NCT00799487|585286216|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
162063040|NCT00799487|585286214|FG000|Dose Adjustment Period|Adverse Event|2|||
162063041|NCT00799487|585286215|FG001|Dose Adjustment Period|Adverse Event|0|||
162063042|NCT00799487|585286216|FG002|Dose Adjustment Period|Adverse Event|0|||
162063043|NCT00799487|585286214|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
162063044|NCT00799487|585286215|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
162063045|NCT00799487|585286216|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
162063046|NCT00799487|585286214|FG000|Dose Adjustment Period|Investigator Discretion|2|||
162063047|NCT00799487|585286215|FG001|Dose Adjustment Period|Investigator Discretion|0|||
162063048|NCT00799487|585286216|FG002|Dose Adjustment Period|Investigator Discretion|0|||
162063049|NCT00799487|585286214|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
162063050|NCT00799487|585286215|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
162063051|NCT00799487|585286216|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
162063052|NCT00799487|585286214|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
162063053|NCT00799487|585286215|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
162063054|NCT00799487|585286216|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
162063055|NCT00799487|585286214|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
162063056|NCT00799487|585286215|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
162063057|NCT00799487|585286216|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
162063058|NCT00799487|585286214|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
162063059|NCT00799487|585286215|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
162063060|NCT00799487|585286216|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
162063061|NCT00799487|585286214|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
162063062|NCT00799487|585286215|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
162063063|NCT00799487|585286216|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
162063064|NCT00799487|585286214|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
162063065|NCT00799487|585286215|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
162063066|NCT00799487|585286216|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
162063067|NCT00799487|585286214|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
162063068|NCT00799487|585286215|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
162063069|NCT00799487|585286216|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
162063070|NCT00799487|585286214|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
162063071|NCT00799487|585286215|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
162063072|NCT00799487|585286216|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
162063073|NCT01463878|585286217|FG000|Overall Study|no longer met criteria for tube feed|2|||
162063074|NCT01463878|585286218|FG001|Overall Study|no longer met criteria for tube feed|2|||
162063075|NCT02051608|585286223|FG000|Part 1: Double Blind Treatment|Death|3|||
162063076|NCT02051608|585286224|FG001|Part 1: Double Blind Treatment|Death|3|||
162063077|NCT02051608|585286225|FG002|Part 1: Double Blind Treatment|Death|0|||
162063078|NCT02051608|585286226|FG003|Part 1: Double Blind Treatment|Death|0|||
162063079|NCT02051608|585286223|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
162063080|NCT02051608|585286224|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
162063081|NCT02051608|585286225|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
162063082|NCT02051608|585286226|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
162063083|NCT02051608|585286223|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
162063084|NCT02051608|585286224|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
162063085|NCT02051608|585286225|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
162063086|NCT02051608|585286226|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
162063087|NCT02051608|585286223|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
162063088|NCT02051608|585286224|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
162063089|NCT02051608|585286225|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
162063090|NCT02051608|585286226|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
162063091|NCT02051608|585286223|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
162063092|NCT02051608|585286224|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
162063093|NCT02051608|585286225|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
162063094|NCT02051608|585286226|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
162063095|NCT02051608|585286223|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
162063096|NCT02051608|585286224|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
162063097|NCT02051608|585286225|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
162063098|NCT02051608|585286226|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
162063099|NCT02051608|585286223|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
162063100|NCT02051608|585286224|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
162063101|NCT02051608|585286225|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
162063102|NCT02051608|585286226|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
162063103|NCT02051608|585286223|FG000|Part 1: Double Blind Treatment|Other|6|||
162063104|NCT02051608|585286224|FG001|Part 1: Double Blind Treatment|Other|3|||
162063105|NCT02051608|585286225|FG002|Part 1: Double Blind Treatment|Other|0|||
162063106|NCT02051608|585286226|FG003|Part 1: Double Blind Treatment|Other|0|||
162063107|NCT02051608|585286223|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
162063108|NCT02051608|585286224|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
162063109|NCT02051608|585286225|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
162063110|NCT02051608|585286226|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
162063111|NCT02051608|585286223|FG000|Part 2: Open-label Extension|Adverse Event|0|||
162063112|NCT02051608|585286224|FG001|Part 2: Open-label Extension|Adverse Event|0|||
162063113|NCT02051608|585286225|FG002|Part 2: Open-label Extension|Adverse Event|6|||
162063114|NCT02051608|585286226|FG003|Part 2: Open-label Extension|Adverse Event|8|||
162063115|NCT02051608|585286223|FG000|Part 2: Open-label Extension|Death|0|||
162063116|NCT02051608|585286224|FG001|Part 2: Open-label Extension|Death|0|||
162063117|NCT02051608|585286225|FG002|Part 2: Open-label Extension|Death|7|||
162063118|NCT02051608|585286226|FG003|Part 2: Open-label Extension|Death|4|||
162063119|NCT02051608|585286223|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
162063120|NCT02051608|585286224|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
162063121|NCT02051608|585286225|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
162063122|NCT02051608|585286226|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
162063123|NCT02051608|585286223|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
162063124|NCT02051608|585286224|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
162063125|NCT02051608|585286225|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
162063126|NCT02051608|585286226|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
162063127|NCT02051608|585286223|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
162063128|NCT02051608|585286224|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
162063129|NCT02051608|585286225|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
162063130|NCT02051608|585286226|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
162063131|NCT02051608|585286223|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
162063132|NCT02051608|585286224|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
162063133|NCT02051608|585286225|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
162063134|NCT02051608|585286226|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
162063135|NCT02051608|585286223|FG000|Part 2: Open-label Extension|Physician Decision|0|||
162063136|NCT02051608|585286224|FG001|Part 2: Open-label Extension|Physician Decision|0|||
162063137|NCT02051608|585286225|FG002|Part 2: Open-label Extension|Physician Decision|8|||
162063138|NCT02051608|585286226|FG003|Part 2: Open-label Extension|Physician Decision|5|||
162063139|NCT02051608|585286223|FG000|Part 2: Open-label Extension|Other|0|||
162063140|NCT02051608|585286224|FG001|Part 2: Open-label Extension|Other|0|||
162063141|NCT02051608|585286225|FG002|Part 2: Open-label Extension|Other|9|||
162063142|NCT02051608|585286226|FG003|Part 2: Open-label Extension|Other|9|||
162063143|NCT00142584|585286227|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
162063144|NCT00142584|585286228|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
162063145|NCT00142584|585286227|FG000|Overall Study|Withdrawal by Subject|30|||
162063146|NCT00142584|585286228|FG001|Overall Study|Withdrawal by Subject|16|||
162063147|NCT00142584|585286227|FG000|Overall Study|Lost to Follow-up|22|||
162063148|NCT00142584|585286228|FG001|Overall Study|Lost to Follow-up|12|||
162063149|NCT00142584|585286227|FG000|Overall Study|Adverse Event|14|||
162063150|NCT00142584|585286228|FG001|Overall Study|Adverse Event|5|||
162063151|NCT00142584|585286227|FG000|Overall Study|Protocol Violation|4|||
162063152|NCT00142584|585286228|FG001|Overall Study|Protocol Violation|7|||
162063153|NCT00142584|585286227|FG000|Overall Study|Treatment Failure|2|||
162063154|NCT00142584|585286228|FG001|Overall Study|Treatment Failure|0|||
162063155|NCT01083576|585286231|FG000|Overall Study|Treatment Failure|6|||
162063156|NCT01083576|585286232|FG001|Overall Study|Treatment Failure|1|||
162063157|NCT01986985|585286233|FG000|Overall Study|Withdrawal by Subject|4|||
162063158|NCT01986985|585286233|FG000|Overall Study|Scan not completed due to malfunction|3|||
162063159|NCT00449540|585286234|FG000|Pretreatment Phase|No migraine experienced|66|||
162063160|NCT00449540|585286235|FG001|Pretreatment Phase|No migraine experienced|0|||
162063161|NCT00449540|585286236|FG002|Pretreatment Phase|No migraine experienced|0|||
162063162|NCT00449540|585286234|FG000|Treatment Phase|did not experience or treat migraine|0|||
162063163|NCT00449540|585286235|FG001|Treatment Phase|did not experience or treat migraine|20|||
162063164|NCT00449540|585286236|FG002|Treatment Phase|did not experience or treat migraine|17|||
162063165|NCT04577118|585286237|FG000|Overall Study|Withdrawal by Subject|4|||
162063166|NCT00356369|585286238|FG000|Active Phase|Withdrawal by Subject|2|||
162063167|NCT00356369|585286239|FG001|Active Phase|Withdrawal by Subject|1|||
162063168|NCT00673465|585286240|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
162063169|NCT00673465|585286241|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
162063170|NCT00673465|585286242|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
162063171|NCT00673465|585286243|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
162063172|NCT00673465|585286244|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
162063173|NCT00673465|585286245|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
162063174|NCT00673465|585286246|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
162063175|NCT00673465|585286247|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
162063176|NCT00673465|585286248|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
162063177|NCT00673465|585286249|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
162063178|NCT00673465|585286250|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
162063179|NCT00673465|585286251|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
162063180|NCT00673465|585286240|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
162063181|NCT00673465|585286241|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
162063182|NCT00673465|585286242|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
162063183|NCT00673465|585286243|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
162063184|NCT00673465|585286244|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
162063185|NCT00673465|585286245|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
162063186|NCT00673465|585286246|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
162063187|NCT00673465|585286247|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
162063188|NCT00673465|585286248|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
162063189|NCT00673465|585286249|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
162063190|NCT00673465|585286250|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
162063191|NCT00673465|585286251|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
162063192|NCT01996982|585286254|FG000|Overall Study|PI/team left institution|7|||
162063193|NCT01195415|585286273|FG000|Overall Study|No repeat biopsy due to progression|2|||
162063194|NCT01919723|585286274|FG000|Overall Study|Blood Samples Hemolyzed|2|||
162063195|NCT01919723|585286275|FG001|Overall Study|Blood Samples Hemolyzed|2|||
162063196|NCT01957644|585286276|FG000|Overall Study|Adverse Event|4|||
162063197|NCT01957644|585286277|FG001|Overall Study|Adverse Event|2|||
162063198|NCT01957644|585286278|FG002|Overall Study|Adverse Event|0|||
162063199|NCT01957644|585286279|FG003|Overall Study|Adverse Event|0|||
162063200|NCT01957644|585286280|FG004|Overall Study|Adverse Event|1|||
162063201|NCT01957644|585286276|FG000|Overall Study|Progressive disease / relapse|0|||
162063202|NCT01957644|585286277|FG001|Overall Study|Progressive disease / relapse|1|||
162063203|NCT01957644|585286278|FG002|Overall Study|Progressive disease / relapse|0|||
162063204|NCT01957644|585286279|FG003|Overall Study|Progressive disease / relapse|1|||
162063205|NCT01957644|585286280|FG004|Overall Study|Progressive disease / relapse|0|||
162063206|NCT01957644|585286276|FG000|Overall Study|Other reason|1|||
162063207|NCT01957644|585286277|FG001|Overall Study|Other reason|2|||
162063208|NCT01957644|585286278|FG002|Overall Study|Other reason|1|||
162063209|NCT01957644|585286279|FG003|Overall Study|Other reason|1|||
162063210|NCT01957644|585286280|FG004|Overall Study|Other reason|0|||
162063211|NCT01957644|585286276|FG000|Overall Study|Withdrawal by Subject|1|||
162063212|NCT01957644|585286277|FG001|Overall Study|Withdrawal by Subject|0|||
162063213|NCT01957644|585286278|FG002|Overall Study|Withdrawal by Subject|0|||
162063214|NCT01957644|585286279|FG003|Overall Study|Withdrawal by Subject|0|||
162063215|NCT01957644|585286280|FG004|Overall Study|Withdrawal by Subject|0|||
162063216|NCT01957644|585286276|FG000|Overall Study|Protocol Violation|0|||
162063217|NCT01957644|585286277|FG001|Overall Study|Protocol Violation|1|||
162063218|NCT01957644|585286278|FG002|Overall Study|Protocol Violation|0|||
162063219|NCT01957644|585286279|FG003|Overall Study|Protocol Violation|0|||
162063220|NCT01957644|585286280|FG004|Overall Study|Protocol Violation|0|||
162063221|NCT04044716|585286281|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
162063222|NCT04044716|585286282|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
162063223|NCT04044716|585286283|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
162063224|NCT04044716|585286281|FG000|Overall Study|Lost to Follow-up|2|||
162063225|NCT04044716|585286282|FG001|Overall Study|Lost to Follow-up|3|||
162063226|NCT04044716|585286283|FG002|Overall Study|Lost to Follow-up|0|||
162063227|NCT00996307|585286286|FG000|Overall Study|Adverse Event|0|||
162063228|NCT00996307|585286287|FG001|Overall Study|Adverse Event|1|||
162063229|NCT00996307|585286288|FG002|Overall Study|Adverse Event|0|||
162063230|NCT00996307|585286289|FG003|Overall Study|Adverse Event|0|||
162063231|NCT00996307|585286286|FG000|Overall Study|Withdrawal by Subject|3|||
162063232|NCT00996307|585286287|FG001|Overall Study|Withdrawal by Subject|2|||
162063233|NCT00996307|585286288|FG002|Overall Study|Withdrawal by Subject|5|||
162063234|NCT00996307|585286289|FG003|Overall Study|Withdrawal by Subject|5|||
162063235|NCT00996307|585286286|FG000|Overall Study|Lost to Follow-up|13|||
162063236|NCT00996307|585286287|FG001|Overall Study|Lost to Follow-up|13|||
162063237|NCT00996307|585286288|FG002|Overall Study|Lost to Follow-up|7|||
162063238|NCT00996307|585286289|FG003|Overall Study|Lost to Follow-up|15|||
162063239|NCT00996307|585286286|FG000|Overall Study|Administrative reason|0|||
162063240|NCT00996307|585286287|FG001|Overall Study|Administrative reason|1|||
162063241|NCT00996307|585286288|FG002|Overall Study|Administrative reason|0|||
162063242|NCT00996307|585286289|FG003|Overall Study|Administrative reason|0|||
162063243|NCT00996307|585286286|FG000|Overall Study|Unable to classify|4|||
162063244|NCT00996307|585286287|FG001|Overall Study|Unable to classify|0|||
162063245|NCT00996307|585286288|FG002|Overall Study|Unable to classify|2|||
162063246|NCT00996307|585286289|FG003|Overall Study|Unable to classify|1|||
162063247|NCT02788357|585286290|FG000|Overall Study|Lost to Follow-up|3|||
162063248|NCT02788357|585286291|FG001|Overall Study|Lost to Follow-up|0|||
162063249|NCT00640601|585286292|FG000|Overall Study|Adverse Event|43|||
162063250|NCT00640601|585286292|FG000|Overall Study|Withdrawal by Subject|20|||
162063251|NCT00640601|585286292|FG000|Overall Study|Protocol Violation|6|||
162063252|NCT00640601|585286292|FG000|Overall Study|Lack of Efficacy|16|||
162063253|NCT00640601|585286292|FG000|Overall Study|Lost to Follow-up|9|||
162063254|NCT00640601|585286292|FG000|Overall Study|Physician Decision|8|||
162063255|NCT00640601|585286292|FG000|Overall Study|treatment naive, combination therapy|10|||
162063256|NCT03198234|585286293|FG000|Overall Study|Relapse of primary disease|0|||
162063257|NCT03198234|585286294|FG001|Overall Study|Relapse of primary disease|1|||
162063258|NCT03198234|585286295|FG002|Overall Study|Relapse of primary disease|0|||
162063259|NCT00165776|585286297|FG000|Overall Study|Lack of Efficacy|0|||
162063260|NCT00165776|585286298|FG001|Overall Study|Lack of Efficacy|0|||
162063261|NCT00165776|585286299|FG002|Overall Study|Lack of Efficacy|0|||
162063262|NCT00165776|585286300|FG003|Overall Study|Lack of Efficacy|1|||
162063263|NCT00165776|585286297|FG000|Overall Study|Withdrawal by Subject|4|||
162063264|NCT00165776|585286298|FG001|Overall Study|Withdrawal by Subject|1|||
162063265|NCT00165776|585286299|FG002|Overall Study|Withdrawal by Subject|2|||
162063266|NCT00165776|585286300|FG003|Overall Study|Withdrawal by Subject|0|||
162063267|NCT00165776|585286297|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
162063268|NCT00165776|585286298|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
162063269|NCT00165776|585286299|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
162063270|NCT00165776|585286300|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
162063271|NCT04285879|585286301|FG000|Overall Study|Lost to Follow-up|1|||
162063272|NCT04285879|585286302|FG001|Overall Study|Lost to Follow-up|8|||
162063273|NCT04285879|585286301|FG000|Overall Study|medical/surgical exclusion|16|||
162063274|NCT04285879|585286302|FG001|Overall Study|medical/surgical exclusion|0|||
162063275|NCT01835587|585286305|FG000|Overall Study|Disease Recurrence or Relapse|0|||
162063276|NCT01835587|585286306|FG001|Overall Study|Disease Recurrence or Relapse|3|||
162063277|NCT01835587|585286307|FG002|Overall Study|Disease Recurrence or Relapse|0|||
162063278|NCT01835587|585286308|FG003|Overall Study|Disease Recurrence or Relapse|3|||
162063279|NCT01835587|585286305|FG000|Overall Study|Withdrawal by Subject|2|||
162063280|NCT01835587|585286306|FG001|Overall Study|Withdrawal by Subject|0|||
162063281|NCT01835587|585286307|FG002|Overall Study|Withdrawal by Subject|0|||
162063282|NCT01835587|585286308|FG003|Overall Study|Withdrawal by Subject|3|||
162063283|NCT01835587|585286305|FG000|Overall Study|Adverse Event|0|||
162063284|NCT01835587|585286306|FG001|Overall Study|Adverse Event|0|||
162063285|NCT01835587|585286307|FG002|Overall Study|Adverse Event|2|||
162063286|NCT01835587|585286308|FG003|Overall Study|Adverse Event|2|||
162063287|NCT01835587|585286305|FG000|Overall Study|Death|0|||
162063288|NCT01835587|585286306|FG001|Overall Study|Death|0|||
162063289|NCT01835587|585286307|FG002|Overall Study|Death|0|||
162063290|NCT01835587|585286308|FG003|Overall Study|Death|1|||
162063291|NCT01835587|585286305|FG000|Overall Study|Miscellaneous|0|||
162063292|NCT01835587|585286306|FG001|Overall Study|Miscellaneous|1|||
162063293|NCT01835587|585286307|FG002|Overall Study|Miscellaneous|0|||
162063294|NCT01835587|585286308|FG003|Overall Study|Miscellaneous|0|||
162063295|NCT03310775|585286315|FG000|Overall Study|Lost to Follow-up|2|||
162063296|NCT03310775|585286316|FG001|Overall Study|Lost to Follow-up|3|||
162063297|NCT03310775|585286315|FG000|Overall Study|aggravation of depression|0|||
162063298|NCT03310775|585286316|FG001|Overall Study|aggravation of depression|1|||
162063299|NCT02260921|585286324|FG000|Overall Study|Adverse Event|1|||
162063300|NCT02260921|585286325|FG001|Overall Study|Adverse Event|0|||
162063301|NCT02260921|585286324|FG000|Overall Study|Lost to Follow-up|4|||
162063302|NCT02260921|585286325|FG001|Overall Study|Lost to Follow-up|3|||
162063303|NCT02260921|585286324|FG000|Overall Study|Withdraw Consent|4|||
162063304|NCT02260921|585286325|FG001|Overall Study|Withdraw Consent|1|||
162063305|NCT02260921|585286324|FG000|Overall Study|Death|1|||
162063306|NCT02260921|585286325|FG001|Overall Study|Death|0|||
162063307|NCT02260921|585286324|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
162063308|NCT02260921|585286325|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
162063309|NCT02999854|585286326|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
162063310|NCT02999854|585286327|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
162063311|NCT02999854|585286326|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
162063312|NCT02999854|585286327|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
162063313|NCT02999854|585286326|FG000|Active Study Phase (up to 18 Months)|Death|7|||
162063314|NCT02999854|585286327|FG001|Active Study Phase (up to 18 Months)|Death|5|||
162063315|NCT02999854|585286326|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
162063316|NCT02999854|585286327|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
162063317|NCT02999854|585286326|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
162063318|NCT02999854|585286327|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
162063319|NCT02999854|585286326|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
162063320|NCT02999854|585286327|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
162063321|NCT02999854|585286326|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
162063322|NCT02999854|585286327|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
162063323|NCT02999854|585286326|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
162063324|NCT02999854|585286327|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
162063325|NCT00203996|585286328|FG000|Overall Study|Lost to Follow-up|0|||
162063326|NCT00203996|585286329|FG001|Overall Study|Lost to Follow-up|0|||
162063327|NCT00203996|585286330|FG002|Overall Study|Lost to Follow-up|0|||
162063328|NCT00203996|585286331|FG003|Overall Study|Lost to Follow-up|1|||
162063329|NCT00203996|585286332|FG004|Overall Study|Lost to Follow-up|0|||
162063330|NCT00203996|585286333|FG005|Overall Study|Lost to Follow-up|0|||
162063331|NCT00203996|585286334|FG006|Overall Study|Lost to Follow-up|0|||
162063332|NCT00203996|585286335|FG007|Overall Study|Lost to Follow-up|0|||
162063333|NCT00203996|585286336|FG008|Overall Study|Lost to Follow-up|0|||
162063334|NCT00203996|585286337|FG009|Overall Study|Lost to Follow-up|0|||
162063335|NCT00203996|585286328|FG000|Overall Study|Protocol Violation|0|||
162063336|NCT00203996|585286329|FG001|Overall Study|Protocol Violation|0|||
162063337|NCT00203996|585286330|FG002|Overall Study|Protocol Violation|0|||
162063338|NCT00203996|585286331|FG003|Overall Study|Protocol Violation|6|||
162063339|NCT00203996|585286332|FG004|Overall Study|Protocol Violation|1|||
162063340|NCT00203996|585286333|FG005|Overall Study|Protocol Violation|0|||
162063341|NCT00203996|585286334|FG006|Overall Study|Protocol Violation|0|||
162063342|NCT00203996|585286335|FG007|Overall Study|Protocol Violation|0|||
162063343|NCT00203996|585286336|FG008|Overall Study|Protocol Violation|0|||
162063344|NCT00203996|585286337|FG009|Overall Study|Protocol Violation|0|||
162063345|NCT00203996|585286328|FG000|Overall Study|Physician Decision|0|||
162063346|NCT00203996|585286329|FG001|Overall Study|Physician Decision|0|||
162063347|NCT00203996|585286330|FG002|Overall Study|Physician Decision|0|||
162063348|NCT00203996|585286331|FG003|Overall Study|Physician Decision|2|||
162063349|NCT00203996|585286332|FG004|Overall Study|Physician Decision|0|||
162063350|NCT00203996|585286333|FG005|Overall Study|Physician Decision|0|||
162063351|NCT00203996|585286334|FG006|Overall Study|Physician Decision|0|||
162063352|NCT00203996|585286335|FG007|Overall Study|Physician Decision|0|||
162063353|NCT00203996|585286336|FG008|Overall Study|Physician Decision|0|||
162063354|NCT00203996|585286337|FG009|Overall Study|Physician Decision|1|||
162063355|NCT00203996|585286328|FG000|Overall Study|CPAP machine malfunction|0|||
162063356|NCT00203996|585286329|FG001|Overall Study|CPAP machine malfunction|0|||
162063357|NCT00203996|585286330|FG002|Overall Study|CPAP machine malfunction|0|||
162063358|NCT00203996|585286331|FG003|Overall Study|CPAP machine malfunction|1|||
162063359|NCT00203996|585286332|FG004|Overall Study|CPAP machine malfunction|0|||
162063360|NCT00203996|585286333|FG005|Overall Study|CPAP machine malfunction|0|||
162063361|NCT00203996|585286334|FG006|Overall Study|CPAP machine malfunction|0|||
162063362|NCT00203996|585286335|FG007|Overall Study|CPAP machine malfunction|0|||
162063363|NCT00203996|585286336|FG008|Overall Study|CPAP machine malfunction|0|||
162063364|NCT00203996|585286337|FG009|Overall Study|CPAP machine malfunction|0|||
162063365|NCT00203996|585286328|FG000|Overall Study|Scheduling issue|0|||
162063366|NCT00203996|585286329|FG001|Overall Study|Scheduling issue|0|||
162063367|NCT00203996|585286330|FG002|Overall Study|Scheduling issue|0|||
162063368|NCT00203996|585286331|FG003|Overall Study|Scheduling issue|0|||
162063369|NCT00203996|585286332|FG004|Overall Study|Scheduling issue|0|||
162063370|NCT00203996|585286333|FG005|Overall Study|Scheduling issue|0|||
162063371|NCT00203996|585286334|FG006|Overall Study|Scheduling issue|0|||
162063372|NCT00203996|585286335|FG007|Overall Study|Scheduling issue|2|||
162063373|NCT00203996|585286336|FG008|Overall Study|Scheduling issue|0|||
162063374|NCT00203996|585286337|FG009|Overall Study|Scheduling issue|0|||
162063375|NCT03064451|585286338|FG000|Overall Study|Lost to Follow-up|1|||
162063376|NCT03064451|585286338|FG000|Overall Study|Mapping Failure|4|||
162063377|NCT03064451|585286338|FG000|Overall Study|Exited prior to procedure|8|||
162063378|NCT03064451|585286338|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
162063379|NCT00897104|585286339|FG000|Overall Study|Lost to Follow-up|12|||
162063380|NCT00897104|585286340|FG001|Overall Study|Lost to Follow-up|17|||
162063381|NCT00897104|585286341|FG002|Overall Study|Lost to Follow-up|2|||
162063382|NCT00897104|585286339|FG000|Overall Study|Pregnancy|0|||
162063383|NCT00897104|585286340|FG001|Overall Study|Pregnancy|1|||
162063384|NCT00897104|585286341|FG002|Overall Study|Pregnancy|0|||
162063385|NCT00897104|585286339|FG000|Overall Study|Protocol Violation|0|||
162063386|NCT00897104|585286340|FG001|Overall Study|Protocol Violation|1|||
162063387|NCT00897104|585286341|FG002|Overall Study|Protocol Violation|0|||
162063388|NCT00897104|585286339|FG000|Overall Study|Withdrawal by Subject|23|||
162063389|NCT00897104|585286340|FG001|Overall Study|Withdrawal by Subject|27|||
162063390|NCT00897104|585286341|FG002|Overall Study|Withdrawal by Subject|3|||
162063391|NCT00897104|585286339|FG000|Overall Study|Abnormal Prestudy Labs|2|||
162063392|NCT00897104|585286340|FG001|Overall Study|Abnormal Prestudy Labs|0|||
162063393|NCT00897104|585286341|FG002|Overall Study|Abnormal Prestudy Labs|0|||
162063394|NCT00897104|585286339|FG000|Overall Study|Abnormal Baseline ECG|2|||
162063395|NCT00897104|585286340|FG001|Overall Study|Abnormal Baseline ECG|2|||
162063396|NCT00897104|585286341|FG002|Overall Study|Abnormal Baseline ECG|0|||
162063397|NCT00897104|585286339|FG000|Overall Study|Need for Concom. Med.|0|||
162063398|NCT00897104|585286340|FG001|Overall Study|Need for Concom. Med.|1|||
162063399|NCT00897104|585286341|FG002|Overall Study|Need for Concom. Med.|1|||
162063400|NCT00897104|585286339|FG000|Overall Study|Lack of Migraine Attack|20|||
162063401|NCT00897104|585286340|FG001|Overall Study|Lack of Migraine Attack|22|||
162063402|NCT00897104|585286341|FG002|Overall Study|Lack of Migraine Attack|1|||
162063403|NCT00897104|585286339|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
162063404|NCT00897104|585286340|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162063405|NCT00897104|585286341|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
162063406|NCT00897104|585286339|FG000|Overall Study|Other|3|||
162063407|NCT00897104|585286340|FG001|Overall Study|Other|0|||
162063408|NCT00897104|585286341|FG002|Overall Study|Other|0|||
162063409|NCT00897104|585286339|FG000|Overall Study|Protocol Violation|1|||
162063410|NCT00897104|585286340|FG001|Overall Study|Protocol Violation|0|||
162063411|NCT00897104|585286341|FG002|Overall Study|Protocol Violation|0|||
162063412|NCT00897104|585286339|FG000|Overall Study|Withdrawal by Subject|0|||
162063413|NCT00897104|585286340|FG001|Overall Study|Withdrawal by Subject|0|||
162063414|NCT00897104|585286341|FG002|Overall Study|Withdrawal by Subject|1|||
162063415|NCT00750204|585286342|FG000|Overall Study|study halted prematurely|1|||
162063416|NCT00750204|585286343|FG001|Overall Study|study halted prematurely|1|||
162063417|NCT00434330|585286344|FG000|Overall Study|Adverse Event|0|||
162063418|NCT00434330|585286345|FG001|Overall Study|Adverse Event|0|||
162063419|NCT00434330|585286346|FG002|Overall Study|Adverse Event|1|||
162063420|NCT00434330|585286347|FG003|Overall Study|Adverse Event|0|||
162063421|NCT00434330|585286348|FG004|Overall Study|Adverse Event|0|||
162063422|NCT00434330|585286349|FG005|Overall Study|Adverse Event|0|||
162063423|NCT00434330|585286344|FG000|Overall Study|Death|1|||
162063424|NCT00434330|585286345|FG001|Overall Study|Death|0|||
162063425|NCT00434330|585286346|FG002|Overall Study|Death|0|||
162063426|NCT00434330|585286347|FG003|Overall Study|Death|0|||
162063427|NCT00434330|585286348|FG004|Overall Study|Death|1|||
162063428|NCT00434330|585286349|FG005|Overall Study|Death|1|||
162063429|NCT00434330|585286344|FG000|Overall Study|Withdrawal by Subject|0|||
162063430|NCT00434330|585286345|FG001|Overall Study|Withdrawal by Subject|0|||
162063431|NCT00434330|585286346|FG002|Overall Study|Withdrawal by Subject|1|||
162063432|NCT00434330|585286347|FG003|Overall Study|Withdrawal by Subject|1|||
162063433|NCT00434330|585286348|FG004|Overall Study|Withdrawal by Subject|0|||
162063434|NCT00434330|585286349|FG005|Overall Study|Withdrawal by Subject|0|||
162063435|NCT00434330|585286344|FG000|Overall Study|Renal transplant|0|||
162063436|NCT00434330|585286345|FG001|Overall Study|Renal transplant|0|||
162063437|NCT00434330|585286346|FG002|Overall Study|Renal transplant|0|||
162063438|NCT00434330|585286347|FG003|Overall Study|Renal transplant|1|||
162063439|NCT00434330|585286348|FG004|Overall Study|Renal transplant|0|||
162063440|NCT00434330|585286349|FG005|Overall Study|Renal transplant|0|||
162063441|NCT00434330|585286344|FG000|Overall Study|Subject Not Compliant With Study|0|||
162063442|NCT00434330|585286345|FG001|Overall Study|Subject Not Compliant With Study|0|||
162063443|NCT00434330|585286346|FG002|Overall Study|Subject Not Compliant With Study|1|||
162063444|NCT00434330|585286347|FG003|Overall Study|Subject Not Compliant With Study|0|||
162063445|NCT00434330|585286348|FG004|Overall Study|Subject Not Compliant With Study|0|||
162063446|NCT00434330|585286349|FG005|Overall Study|Subject Not Compliant With Study|0|||
162063447|NCT00850564|585286352|FG000|Overall Study|Withdrawal by Subject|2|||
162063448|NCT03032705|585286353|FG000|Overall Study|Lost to Follow-up|16|||
162063449|NCT03032705|585286354|FG001|Overall Study|Lost to Follow-up|17|||
162063450|NCT03032705|585286353|FG000|Overall Study|did not quality|6|||
162063451|NCT03032705|585286354|FG001|Overall Study|did not quality|6|||
162063452|NCT01937559|585286357|FG000|Overall Study|Physician Decision|3|||
162063453|NCT01937559|585286358|FG001|Overall Study|Physician Decision|3|||
162063454|NCT01937559|585286359|FG002|Overall Study|Physician Decision|0|||
162063455|NCT01937559|585286357|FG000|Overall Study|Withdrawal by Subject|6|||
162063456|NCT01937559|585286358|FG001|Overall Study|Withdrawal by Subject|4|||
162063457|NCT01937559|585286359|FG002|Overall Study|Withdrawal by Subject|0|||
162063458|NCT01937559|585286357|FG000|Overall Study|screen fail|2|||
162063459|NCT01937559|585286358|FG001|Overall Study|screen fail|4|||
162063460|NCT01937559|585286359|FG002|Overall Study|screen fail|0|||
162063461|NCT04818840|585286360|FG000|Overall Study|Lost to Follow-up|0|||
162063462|NCT04818840|585286361|FG001|Overall Study|Lost to Follow-up|5|||
162063463|NCT04818840|585286360|FG000|Overall Study|Physician Decision|1|||
162063464|NCT04818840|585286361|FG001|Overall Study|Physician Decision|0|||
162063465|NCT04818840|585286360|FG000|Overall Study|Site Terminated by Sponsor|0|||
162063466|NCT04818840|585286361|FG001|Overall Study|Site Terminated by Sponsor|3|||
162063467|NCT04818840|585286360|FG000|Overall Study|Study Terminated by Sponsor|43|||
162063468|NCT04818840|585286361|FG001|Overall Study|Study Terminated by Sponsor|7|||
162063469|NCT04818840|585286360|FG000|Overall Study|Withdrawal by Subject|0|||
162063470|NCT04818840|585286361|FG001|Overall Study|Withdrawal by Subject|1|||
162063471|NCT00397982|585288845|FG000|Overall Study|Withdrawal by Subject|1|||
162063472|NCT00397982|585288845|FG000|Overall Study|Adverse Event|1|||
162063473|NCT00397982|585288845|FG000|Overall Study|noncompliance|1|||
162063474|NCT00397982|585288845|FG000|Overall Study|Unrelated health issues|1|||
162063475|NCT02329730|585288846|FG000|Overall Study|Protocol Violation|0|||
162063476|NCT02329730|585288847|FG001|Overall Study|Protocol Violation|0|||
162063477|NCT02329730|585288848|FG002|Overall Study|Protocol Violation|0|||
162063478|NCT02329730|585288849|FG003|Overall Study|Protocol Violation|0|||
162063479|NCT02329730|585288850|FG004|Overall Study|Protocol Violation|2|||
162063480|NCT02329730|585288851|FG005|Overall Study|Protocol Violation|2|||
162063481|NCT02329730|585288852|FG006|Overall Study|Protocol Violation|0|||
162063482|NCT02329730|585288853|FG007|Overall Study|Protocol Violation|0|||
162063483|NCT02329730|585288854|FG008|Overall Study|Protocol Violation|0|||
162063484|NCT02329730|585288855|FG009|Overall Study|Protocol Violation|0|||
162063485|NCT02329730|585288856|FG010|Overall Study|Protocol Violation|0|||
162063486|NCT02329730|585288857|FG011|Overall Study|Protocol Violation|0|||
162063487|NCT02329730|585288846|FG000|Overall Study|Withdrawal by Subject|0|||
162063488|NCT02329730|585288847|FG001|Overall Study|Withdrawal by Subject|0|||
162063489|NCT02329730|585288848|FG002|Overall Study|Withdrawal by Subject|0|||
162063490|NCT02329730|585288849|FG003|Overall Study|Withdrawal by Subject|0|||
162063491|NCT02329730|585288850|FG004|Overall Study|Withdrawal by Subject|1|||
162063492|NCT02329730|585288851|FG005|Overall Study|Withdrawal by Subject|0|||
162063493|NCT02329730|585288852|FG006|Overall Study|Withdrawal by Subject|1|||
162063494|NCT02329730|585288853|FG007|Overall Study|Withdrawal by Subject|1|||
162063495|NCT02329730|585288854|FG008|Overall Study|Withdrawal by Subject|1|||
162063496|NCT02329730|585288855|FG009|Overall Study|Withdrawal by Subject|1|||
162063497|NCT02329730|585288856|FG010|Overall Study|Withdrawal by Subject|0|||
162063498|NCT02329730|585288857|FG011|Overall Study|Withdrawal by Subject|0|||
162063499|NCT02345850|585288858|FG000|Overall Study|Not transplanted|10|||
162063500|NCT02345850|585288859|FG001|Overall Study|Not transplanted|5|||
162063501|NCT02345850|585288860|FG002|Overall Study|Not transplanted|4|||
162063502|NCT02345850|585288858|FG000|Overall Study|Lost to Follow-up|2|||
162063503|NCT02345850|585288859|FG001|Overall Study|Lost to Follow-up|3|||
162063504|NCT02345850|585288860|FG002|Overall Study|Lost to Follow-up|2|||
162063505|NCT02345850|585288858|FG000|Overall Study|Withdrawal by Subject|1|||
162063506|NCT02345850|585288859|FG001|Overall Study|Withdrawal by Subject|0|||
162063507|NCT02345850|585288860|FG002|Overall Study|Withdrawal by Subject|0|||
162063508|NCT02392247|585288862|FG000|Overall Study|Withdrawal by Subject|1|||
162063509|NCT02392247|585288862|FG000|Overall Study|Surgery cancelled; no data|1|||
162063510|NCT00951665|585288863|FG000|Phase 1b|Adverse Event|2|||
162063511|NCT00951665|585288864|FG001|Phase 1b|Adverse Event|1|||
162063512|NCT00951665|585288865|FG002|Phase 1b|Adverse Event|0|||
162063513|NCT00951665|585288866|FG003|Phase 1b|Adverse Event|1|||
162063514|NCT00951665|585288867|FG004|Phase 1b|Adverse Event|0|||
162063515|NCT00951665|585288868|FG005|Phase 1b|Adverse Event|0|||
162063516|NCT00951665|585288863|FG000|Phase 1b|Death|1|||
162063517|NCT00951665|585288864|FG001|Phase 1b|Death|0|||
162063518|NCT00951665|585288865|FG002|Phase 1b|Death|2|||
162063519|NCT00951665|585288866|FG003|Phase 1b|Death|0|||
162063520|NCT00951665|585288867|FG004|Phase 1b|Death|0|||
162063521|NCT00951665|585288868|FG005|Phase 1b|Death|0|||
162063522|NCT00951665|585288863|FG000|Phase 1b|Physician Decision|4|||
162063523|NCT00951665|585288864|FG001|Phase 1b|Physician Decision|0|||
162063524|NCT00951665|585288865|FG002|Phase 1b|Physician Decision|1|||
162063525|NCT00951665|585288866|FG003|Phase 1b|Physician Decision|0|||
162063526|NCT00951665|585288867|FG004|Phase 1b|Physician Decision|0|||
162063527|NCT00951665|585288868|FG005|Phase 1b|Physician Decision|0|||
162063528|NCT00951665|585288863|FG000|Phase 1b|Withdrawal by Subject|0|||
162063529|NCT00951665|585288864|FG001|Phase 1b|Withdrawal by Subject|1|||
162063530|NCT00951665|585288865|FG002|Phase 1b|Withdrawal by Subject|0|||
162063531|NCT00951665|585288866|FG003|Phase 1b|Withdrawal by Subject|0|||
162063532|NCT00951665|585288867|FG004|Phase 1b|Withdrawal by Subject|0|||
162063533|NCT00951665|585288868|FG005|Phase 1b|Withdrawal by Subject|0|||
162063534|NCT00951665|585288863|FG000|Phase 1b|Disease Progression|13|||
162063535|NCT00951665|585288864|FG001|Phase 1b|Disease Progression|2|||
162063536|NCT00951665|585288865|FG002|Phase 1b|Disease Progression|14|||
162063537|NCT00951665|585288866|FG003|Phase 1b|Disease Progression|0|||
162063538|NCT00951665|585288867|FG004|Phase 1b|Disease Progression|0|||
162063539|NCT00951665|585288868|FG005|Phase 1b|Disease Progression|0|||
162063540|NCT00951665|585288863|FG000|Phase 1b|Protocol Violation|2|||
162063541|NCT00951665|585288864|FG001|Phase 1b|Protocol Violation|0|||
162063542|NCT00951665|585288865|FG002|Phase 1b|Protocol Violation|0|||
162063543|NCT00951665|585288866|FG003|Phase 1b|Protocol Violation|0|||
162063544|NCT00951665|585288867|FG004|Phase 1b|Protocol Violation|0|||
162063545|NCT00951665|585288868|FG005|Phase 1b|Protocol Violation|0|||
162063546|NCT00951665|585288863|FG000|Phase 2a|Adverse Event|0|||
162063547|NCT00951665|585288864|FG001|Phase 2a|Adverse Event|0|||
162063548|NCT00951665|585288865|FG002|Phase 2a|Adverse Event|0|||
162063549|NCT00951665|585288866|FG003|Phase 2a|Adverse Event|0|||
162063550|NCT00951665|585288867|FG004|Phase 2a|Adverse Event|2|||
162063551|NCT00951665|585288868|FG005|Phase 2a|Adverse Event|0|||
162063552|NCT00951665|585288863|FG000|Phase 2a|Death|0|||
162063553|NCT00951665|585288864|FG001|Phase 2a|Death|0|||
162063554|NCT00951665|585288865|FG002|Phase 2a|Death|0|||
162063555|NCT00951665|585288866|FG003|Phase 2a|Death|0|||
162063556|NCT00951665|585288867|FG004|Phase 2a|Death|1|||
162063557|NCT00951665|585288868|FG005|Phase 2a|Death|1|||
162063558|NCT00951665|585288863|FG000|Phase 2a|Lost to Follow-up|0|||
162063559|NCT00951665|585288864|FG001|Phase 2a|Lost to Follow-up|0|||
162063560|NCT00951665|585288865|FG002|Phase 2a|Lost to Follow-up|0|||
162063561|NCT00951665|585288866|FG003|Phase 2a|Lost to Follow-up|0|||
162063562|NCT00951665|585288867|FG004|Phase 2a|Lost to Follow-up|1|||
162063563|NCT00951665|585288868|FG005|Phase 2a|Lost to Follow-up|0|||
162063564|NCT00951665|585288863|FG000|Phase 2a|Physician Decision|0|||
162063565|NCT00951665|585288864|FG001|Phase 2a|Physician Decision|0|||
162063566|NCT00951665|585288865|FG002|Phase 2a|Physician Decision|0|||
162063567|NCT00951665|585288866|FG003|Phase 2a|Physician Decision|0|||
162063568|NCT00951665|585288867|FG004|Phase 2a|Physician Decision|0|||
162063569|NCT00951665|585288868|FG005|Phase 2a|Physician Decision|1|||
162063570|NCT00951665|585288863|FG000|Phase 2a|Withdrawal by Subject|0|||
162063571|NCT00951665|585288864|FG001|Phase 2a|Withdrawal by Subject|0|||
162063572|NCT00951665|585288865|FG002|Phase 2a|Withdrawal by Subject|0|||
162063573|NCT00951665|585288866|FG003|Phase 2a|Withdrawal by Subject|0|||
162063574|NCT00951665|585288867|FG004|Phase 2a|Withdrawal by Subject|2|||
162063575|NCT00951665|585288868|FG005|Phase 2a|Withdrawal by Subject|0|||
162063576|NCT00951665|585288863|FG000|Phase 2a|Disease Progression|0|||
162063577|NCT00951665|585288864|FG001|Phase 2a|Disease Progression|0|||
162063578|NCT00951665|585288865|FG002|Phase 2a|Disease Progression|0|||
162063579|NCT00951665|585288866|FG003|Phase 2a|Disease Progression|0|||
162063580|NCT00951665|585288867|FG004|Phase 2a|Disease Progression|6|||
162063581|NCT00951665|585288868|FG005|Phase 2a|Disease Progression|5|||
162063582|NCT00254540|585288871|FG000|Overall Study|Adverse Event|6|||
162063583|NCT00254540|585288872|FG001|Overall Study|Adverse Event|7|||
162063584|NCT00254540|585288871|FG000|Overall Study|Lack of Efficacy|13|||
162063585|NCT00254540|585288872|FG001|Overall Study|Lack of Efficacy|13|||
162063586|NCT00254540|585288871|FG000|Overall Study|Death|0|||
162063587|NCT00254540|585288872|FG001|Overall Study|Death|1|||
162063588|NCT00254540|585288871|FG000|Overall Study|Laboratory Test Abnormality|0|||
162063589|NCT00254540|585288872|FG001|Overall Study|Laboratory Test Abnormality|1|||
162063590|NCT01313767|585288873|FG000|Overall Study|Adverse Event|1|||
162063591|NCT01313767|585288874|FG001|Overall Study|Adverse Event|0|||
162063592|NCT01313767|585288873|FG000|Overall Study|Lost to Follow-up|1|||
162063593|NCT01313767|585288874|FG001|Overall Study|Lost to Follow-up|0|||
162063594|NCT01313767|585288873|FG000|Overall Study|Withdrawal by Subject|2|||
162063595|NCT01313767|585288874|FG001|Overall Study|Withdrawal by Subject|1|||
162063596|NCT01313767|585288873|FG000|Overall Study|Protocol Violation|3|||
162063597|NCT01313767|585288874|FG001|Overall Study|Protocol Violation|1|||
162063598|NCT00249444|585288875|FG000|Overall Study|Lost to Follow-up|2|||
162063599|NCT00249444|585288876|FG001|Overall Study|Lost to Follow-up|2|||
162063600|NCT00249444|585288875|FG000|Overall Study|non-compliant|9|||
162063601|NCT00249444|585288876|FG001|Overall Study|non-compliant|11|||
162063602|NCT00249444|585288875|FG000|Overall Study|Adverse Event|1|||
162063603|NCT00249444|585288876|FG001|Overall Study|Adverse Event|1|||
162063604|NCT00249444|585288875|FG000|Overall Study|life event|0|||
162063605|NCT00249444|585288876|FG001|Overall Study|life event|1|||
162063606|NCT00232817|585288877|FG000|Overall Study|Protocol Violation|2|||
162063607|NCT00232817|585288878|FG001|Overall Study|Protocol Violation|1|||
162063608|NCT01084174|585288882|FG000|Overall Study|gastrointestinal symptoms|1|||
162063609|NCT01084174|585288883|FG001|Overall Study|gastrointestinal symptoms|1|||
162063610|NCT01084174|585288882|FG000|Overall Study|Eosinophilic esophagitis|0|||
162063611|NCT01084174|585288883|FG001|Overall Study|Eosinophilic esophagitis|1|||
162063612|NCT01084174|585288882|FG000|Overall Study|Anaphylaxis|0|||
162063613|NCT01084174|585288883|FG001|Overall Study|Anaphylaxis|1|||
162063614|NCT01084174|585288882|FG000|Overall Study|Participant noncompliance|0|||
162063615|NCT01084174|585288883|FG001|Overall Study|Participant noncompliance|1|||
162063616|NCT04273217|585288884|FG000|Overall Study|Lost to Follow-up|0|||
162063617|NCT04273217|585288885|FG001|Overall Study|Lost to Follow-up|0|||
162063618|NCT04273217|585288886|FG002|Overall Study|Lost to Follow-up|0|||
162063619|NCT04273217|585288887|FG003|Overall Study|Lost to Follow-up|0|||
162063620|NCT04273217|585288888|FG004|Overall Study|Lost to Follow-up|0|||
162063621|NCT04273217|585288889|FG005|Overall Study|Lost to Follow-up|1|||
162063622|NCT04273217|585288884|FG000|Overall Study|Participant non-compliance|0|||
162063623|NCT04273217|585288885|FG001|Overall Study|Participant non-compliance|0|||
162063624|NCT04273217|585288886|FG002|Overall Study|Participant non-compliance|0|||
162063625|NCT04273217|585288887|FG003|Overall Study|Participant non-compliance|0|||
162063626|NCT04273217|585288888|FG004|Overall Study|Participant non-compliance|1|||
162063627|NCT04273217|585288889|FG005|Overall Study|Participant non-compliance|0|||
162063628|NCT04273217|585288884|FG000|Overall Study|Positive urine drug screen|1|||
162063629|NCT04273217|585288885|FG001|Overall Study|Positive urine drug screen|0|||
162063630|NCT04273217|585288886|FG002|Overall Study|Positive urine drug screen|1|||
162063631|NCT04273217|585288887|FG003|Overall Study|Positive urine drug screen|0|||
162063632|NCT04273217|585288888|FG004|Overall Study|Positive urine drug screen|0|||
162063633|NCT04273217|585288889|FG005|Overall Study|Positive urine drug screen|1|||
162063634|NCT04532099|585288890|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
162063635|NCT04532099|585288891|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
162063636|NCT04532099|585288892|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
162063637|NCT05492942|585288893|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
162063638|NCT05492942|585288894|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
162063639|NCT05492942|585288895|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
162063640|NCT05492942|585288896|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
162063641|NCT02506153|585288897|FG000|Overall Study|Adverse Event|359|||
162063642|NCT02506153|585288898|FG001|Overall Study|Adverse Event|114|||
162063643|NCT02506153|585288897|FG000|Overall Study|Refused unrelated to adverse event|127|||
162063644|NCT02506153|585288898|FG001|Overall Study|Refused unrelated to adverse event|18|||
162063645|NCT02506153|585288897|FG000|Overall Study|Progression/relapse|91|||
162063646|NCT02506153|585288898|FG001|Overall Study|Progression/relapse|136|||
162063647|NCT02506153|585288897|FG000|Overall Study|Death|2|||
162063648|NCT02506153|585288898|FG001|Overall Study|Death|1|||
162063649|NCT02506153|585288897|FG000|Overall Study|Other - not protocol specified|23|||
162063650|NCT02506153|585288898|FG001|Overall Study|Other - not protocol specified|12|||
162063651|NCT00311623|585288899|FG000|Overall Study|Physician Decision|0|||
162063652|NCT00311623|585288900|FG001|Overall Study|Physician Decision|0|||
162063653|NCT00311623|585288901|FG002|Overall Study|Physician Decision|2|||
162063654|NCT03103919|585288902|FG000|Overall Study|Adverse Event|2|||
162063655|NCT03103919|585288903|FG001|Overall Study|Adverse Event|2|||
162063656|NCT03998189|585288904|FG000|Overall Study|Lack of Efficacy|0|||
162063657|NCT03998189|585288905|FG001|Overall Study|Lack of Efficacy|1|||
162063658|NCT04983264|585288906|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
162063659|NCT04983264|585288907|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
162063660|NCT04983264|585288908|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
162063661|NCT04983264|585288906|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
162063662|NCT04983264|585288907|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
162063663|NCT04983264|585288908|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
162063664|NCT01828281|585288909|FG000|Overall Study|Withdrawal by Subject|1|||
162063665|NCT01828281|585288910|FG001|Overall Study|Withdrawal by Subject|0|||
162063666|NCT01124422|585288911|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
162063667|NCT01124422|585288912|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
162063668|NCT01124422|585288913|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
162063669|NCT01124422|585288911|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
162063670|NCT01124422|585288912|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
162063671|NCT01124422|585288913|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
162063672|NCT01124422|585288911|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
162063673|NCT01124422|585288912|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
162063674|NCT01124422|585288913|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
162063675|NCT01124422|585288911|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
162063676|NCT01124422|585288912|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
162063677|NCT01124422|585288913|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
162063678|NCT01124422|585288911|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
162063679|NCT01124422|585288912|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
162063680|NCT01124422|585288913|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
162063681|NCT01124422|585288911|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
162063682|NCT01124422|585288912|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
162063683|NCT01124422|585288913|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
162063684|NCT01124422|585288911|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
162063685|NCT01124422|585288912|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
162063686|NCT01124422|585288913|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
162063687|NCT01124422|585288911|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
162063688|NCT01124422|585288912|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
162063689|NCT01124422|585288913|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
162063690|NCT01124422|585288911|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
162063691|NCT01124422|585288912|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
162063692|NCT01124422|585288913|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
162063693|NCT01124422|585288911|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
162063694|NCT01124422|585288912|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
162063695|NCT01124422|585288913|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
162063696|NCT03454893|585288914|FG000|Overall Study|Study Terminated by the Sponsor|5|||
162063697|NCT03454893|585288914|FG000|Overall Study|Did not pass screening|4|||
162063698|NCT04876274|585288915|FG000|Overall Study|Lost to Follow-up|9|||
162063699|NCT04876274|585288916|FG001|Overall Study|Lost to Follow-up|12|||
162063700|NCT03070782|585288917|FG000|Overall Study|Adverse Event|3|||
162063701|NCT03070782|585288918|FG001|Overall Study|Adverse Event|0|||
162063702|NCT03070782|585288919|FG002|Overall Study|Adverse Event|3|||
162063703|NCT03070782|585288920|FG003|Overall Study|Adverse Event|1|||
162063704|NCT03070782|585288921|FG004|Overall Study|Adverse Event|6|||
162063705|NCT03070782|585288922|FG005|Overall Study|Adverse Event|2|||
162063706|NCT03070782|585288917|FG000|Overall Study|Withdrawal by Subject|2|||
162063707|NCT03070782|585288918|FG001|Overall Study|Withdrawal by Subject|1|||
162063708|NCT03070782|585288919|FG002|Overall Study|Withdrawal by Subject|1|||
162063709|NCT03070782|585288920|FG003|Overall Study|Withdrawal by Subject|0|||
162063710|NCT03070782|585288921|FG004|Overall Study|Withdrawal by Subject|4|||
162063711|NCT03070782|585288922|FG005|Overall Study|Withdrawal by Subject|3|||
162063712|NCT03070782|585288917|FG000|Overall Study|Reason Not Specified|2|||
162063713|NCT03070782|585288918|FG001|Overall Study|Reason Not Specified|0|||
162063714|NCT03070782|585288919|FG002|Overall Study|Reason Not Specified|0|||
162063715|NCT03070782|585288920|FG003|Overall Study|Reason Not Specified|1|||
162063716|NCT03070782|585288921|FG004|Overall Study|Reason Not Specified|2|||
162063717|NCT03070782|585288922|FG005|Overall Study|Reason Not Specified|1|||
162063718|NCT03070782|585288917|FG000|Overall Study|Ineligibility|0|||
162063719|NCT03070782|585288918|FG001|Overall Study|Ineligibility|0|||
162063720|NCT03070782|585288919|FG002|Overall Study|Ineligibility|0|||
162063721|NCT03070782|585288920|FG003|Overall Study|Ineligibility|1|||
162063722|NCT03070782|585288921|FG004|Overall Study|Ineligibility|0|||
162063723|NCT03070782|585288922|FG005|Overall Study|Ineligibility|1|||
162063724|NCT03070782|585288917|FG000|Overall Study|Pregnancy|0|||
162063725|NCT03070782|585288918|FG001|Overall Study|Pregnancy|0|||
162063726|NCT03070782|585288919|FG002|Overall Study|Pregnancy|0|||
162063727|NCT03070782|585288920|FG003|Overall Study|Pregnancy|1|||
162063728|NCT03070782|585288921|FG004|Overall Study|Pregnancy|0|||
162063729|NCT03070782|585288922|FG005|Overall Study|Pregnancy|0|||
162063730|NCT03070782|585288917|FG000|Overall Study|Investigator Judgement|0|||
162063731|NCT03070782|585288918|FG001|Overall Study|Investigator Judgement|0|||
162063732|NCT03070782|585288919|FG002|Overall Study|Investigator Judgement|0|||
162063733|NCT03070782|585288920|FG003|Overall Study|Investigator Judgement|1|||
162063734|NCT03070782|585288921|FG004|Overall Study|Investigator Judgement|0|||
162063735|NCT03070782|585288922|FG005|Overall Study|Investigator Judgement|0|||
162063736|NCT03527966|585288927|FG000|Overall Study|Lost to Follow-up|3|||
162063737|NCT03527966|585288928|FG001|Overall Study|Lost to Follow-up|0|||
162063738|NCT01948050|585288929|FG000|Overall Study|Withdrawal by Subject|0|||
162063739|NCT01948050|585288930|FG001|Overall Study|Withdrawal by Subject|1|||
162063740|NCT00558025|585288931|FG000|Overall Study|Adverse Event|1|||
162063741|NCT00558025|585288932|FG001|Overall Study|Adverse Event|1|||
162063742|NCT00558025|585288931|FG000|Overall Study|Withdrawal by Subject|2|||
162063743|NCT00558025|585288932|FG001|Overall Study|Withdrawal by Subject|2|||
162063744|NCT00558025|585288931|FG000|Overall Study|Protocol Violation|1|||
162063745|NCT00558025|585288932|FG001|Overall Study|Protocol Violation|0|||
162063746|NCT02288559|585288933|FG000|Overall Study|Adverse Event|1|||
162063747|NCT02288559|585288934|FG001|Overall Study|Adverse Event|1|||
162063748|NCT02288559|585288935|FG002|Overall Study|Adverse Event|5|||
162063749|NCT02288559|585288936|FG003|Overall Study|Adverse Event|0|||
162063750|NCT02288559|585288933|FG000|Overall Study|Death|0|||
162063751|NCT02288559|585288934|FG001|Overall Study|Death|0|||
162063752|NCT02288559|585288935|FG002|Overall Study|Death|1|||
162063753|NCT02288559|585288936|FG003|Overall Study|Death|0|||
162063754|NCT02288559|585288933|FG000|Overall Study|Lost to Follow-up|0|||
162063755|NCT02288559|585288934|FG001|Overall Study|Lost to Follow-up|0|||
162063756|NCT02288559|585288935|FG002|Overall Study|Lost to Follow-up|0|||
162063757|NCT02288559|585288936|FG003|Overall Study|Lost to Follow-up|1|||
162063758|NCT02288559|585288933|FG000|Overall Study|Withdrawal by Subject|0|||
162063759|NCT02288559|585288934|FG001|Overall Study|Withdrawal by Subject|0|||
162063760|NCT02288559|585288935|FG002|Overall Study|Withdrawal by Subject|2|||
162063761|NCT02288559|585288936|FG003|Overall Study|Withdrawal by Subject|1|||
162063762|NCT02288559|585288933|FG000|Overall Study|Reason Not Specified|0|||
162063763|NCT02288559|585288934|FG001|Overall Study|Reason Not Specified|0|||
162063764|NCT02288559|585288935|FG002|Overall Study|Reason Not Specified|3|||
162063765|NCT02288559|585288936|FG003|Overall Study|Reason Not Specified|0|||
162063766|NCT02709785|585288939|FG000|Overall Study|Withdrawal by Subject|1|||
162063767|NCT02709785|585288940|FG001|Overall Study|Withdrawal by Subject|2|||
162063768|NCT02709785|585288941|FG002|Overall Study|Withdrawal by Subject|1|||
162063769|NCT01961323|585288944|FG000|Overall Study|Withdrawal by Subject|7|||
162063770|NCT01961323|585288944|FG000|Overall Study|Lost to Follow-up|8|||
162063771|NCT01961323|585288944|FG000|Overall Study|screen failure|34|||
162063772|NCT00810407|585288945|FG000|Overall Study|Protocol Violation|3|||
162063773|NCT00810407|585288945|FG000|Overall Study|No Visit After First Day of Treatment|3|||
162063774|NCT03315208|585288946|FG000|Overall Study|Lost to Follow-up|11|||
162063775|NCT03315208|585288947|FG001|Overall Study|Lost to Follow-up|6|||
162063776|NCT03315208|585288946|FG000|Overall Study|Withdrawal by Subject|2|||
162063777|NCT03315208|585288947|FG001|Overall Study|Withdrawal by Subject|0|||
162063778|NCT02320149|585288951|FG000|Overall Study|Adverse Event|3|||
162063779|NCT02320149|585288952|FG001|Overall Study|Adverse Event|7|||
162063780|NCT02320149|585288951|FG000|Overall Study|Withdrawal of Consent|28|||
162063781|NCT02320149|585288952|FG001|Overall Study|Withdrawal of Consent|32|||
162063782|NCT02320149|585288951|FG000|Overall Study|Lost to Follow-up|21|||
162063783|NCT02320149|585288952|FG001|Overall Study|Lost to Follow-up|34|||
162063784|NCT02320149|585288951|FG000|Overall Study|Protocol Violation|2|||
162063785|NCT02320149|585288952|FG001|Overall Study|Protocol Violation|1|||
162063786|NCT02320149|585288951|FG000|Overall Study|Noncompliance with Study Treatment|7|||
162063787|NCT02320149|585288952|FG001|Overall Study|Noncompliance with Study Treatment|2|||
162063788|NCT02320149|585288951|FG000|Overall Study|Lack of Efficacy|0|||
162063789|NCT02320149|585288952|FG001|Overall Study|Lack of Efficacy|1|||
162063790|NCT02320149|585288951|FG000|Overall Study|Other Miscellaneous Reasons|2|||
162063791|NCT02320149|585288952|FG001|Overall Study|Other Miscellaneous Reasons|3|||
162063792|NCT06133348|585288955|FG000|Overall Study|Death|3|||
162063793|NCT06133348|585288955|FG000|Overall Study|Lost to Follow-up|1|||
162063794|NCT06133348|585288955|FG000|Overall Study|Physician Decision|1|||
162063795|NCT06133348|585288955|FG000|Overall Study|Withdrawal by Subject|5|||
162063796|NCT00276159|585288956|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
162063797|NCT00333866|585288959|FG000|Overall Study|Adverse Event|23|||
162063798|NCT00333866|585288960|FG001|Overall Study|Adverse Event|37|||
162063799|NCT00333866|585288961|FG002|Overall Study|Adverse Event|38|||
162063800|NCT00333866|585288962|FG003|Overall Study|Adverse Event|47|||
162063801|NCT00333866|585288959|FG000|Overall Study|Other|3|||
162063802|NCT00333866|585288960|FG001|Overall Study|Other|2|||
162063803|NCT00333866|585288961|FG002|Overall Study|Other|2|||
162063804|NCT00333866|585288962|FG003|Overall Study|Other|2|||
162063805|NCT00333866|585288959|FG000|Overall Study|Lack of Efficacy|8|||
162063806|NCT00333866|585288960|FG001|Overall Study|Lack of Efficacy|6|||
162063807|NCT00333866|585288961|FG002|Overall Study|Lack of Efficacy|3|||
162063808|NCT00333866|585288962|FG003|Overall Study|Lack of Efficacy|5|||
162063809|NCT00333866|585288959|FG000|Overall Study|Lost to Follow-up|1|||
162063810|NCT00333866|585288960|FG001|Overall Study|Lost to Follow-up|2|||
162063811|NCT00333866|585288961|FG002|Overall Study|Lost to Follow-up|2|||
162063812|NCT00333866|585288962|FG003|Overall Study|Lost to Follow-up|2|||
162063813|NCT00333866|585288959|FG000|Overall Study|Withdrawal by Subject|8|||
162063814|NCT00333866|585288960|FG001|Overall Study|Withdrawal by Subject|14|||
162063815|NCT00333866|585288961|FG002|Overall Study|Withdrawal by Subject|4|||
162063816|NCT00333866|585288962|FG003|Overall Study|Withdrawal by Subject|9|||
162063817|NCT00333866|585288959|FG000|Overall Study|Randomized but not Treated|5|||
162063818|NCT00333866|585288960|FG001|Overall Study|Randomized but not Treated|3|||
162063819|NCT00333866|585288961|FG002|Overall Study|Randomized but not Treated|2|||
162063820|NCT00333866|585288962|FG003|Overall Study|Randomized but not Treated|1|||
162063821|NCT06073119|585288963|FG000|Overall Study|Adverse Event|1|||
162063822|NCT06073119|585288964|FG001|Overall Study|Adverse Event|3|||
162063823|NCT06073119|585288965|FG002|Overall Study|Adverse Event|0|||
162063824|NCT06073119|585288966|FG003|Overall Study|Adverse Event|0|||
162063825|NCT06073119|585288967|FG004|Overall Study|Adverse Event|1|||
162063826|NCT06073119|585288968|FG005|Overall Study|Adverse Event|0|||
162063827|NCT06073119|585288963|FG000|Overall Study|Non-compliance with study schedule|1|||
162063828|NCT06073119|585288964|FG001|Overall Study|Non-compliance with study schedule|0|||
162063829|NCT06073119|585288965|FG002|Overall Study|Non-compliance with study schedule|0|||
162063830|NCT06073119|585288966|FG003|Overall Study|Non-compliance with study schedule|0|||
162063831|NCT06073119|585288967|FG004|Overall Study|Non-compliance with study schedule|1|||
162063832|NCT06073119|585288968|FG005|Overall Study|Non-compliance with study schedule|0|||
162063833|NCT06073119|585288963|FG000|Overall Study|Withdrawal by Subject|4|||
162063834|NCT06073119|585288964|FG001|Overall Study|Withdrawal by Subject|4|||
162063835|NCT06073119|585288965|FG002|Overall Study|Withdrawal by Subject|3|||
162063836|NCT06073119|585288966|FG003|Overall Study|Withdrawal by Subject|5|||
162063837|NCT06073119|585288967|FG004|Overall Study|Withdrawal by Subject|3|||
162063838|NCT06073119|585288968|FG005|Overall Study|Withdrawal by Subject|1|||
162063839|NCT06073119|585288963|FG000|Overall Study|Other|2|||
162063840|NCT06073119|585288964|FG001|Overall Study|Other|4|||
162063841|NCT06073119|585288965|FG002|Overall Study|Other|1|||
162063842|NCT06073119|585288966|FG003|Overall Study|Other|0|||
162063843|NCT06073119|585288967|FG004|Overall Study|Other|1|||
162063844|NCT06073119|585288968|FG005|Overall Study|Other|0|||
162063845|NCT01359449|585288971|FG000|Overall Study|Lost to Follow-up|1|||
162063846|NCT01359449|585288972|FG001|Overall Study|Lost to Follow-up|0|||
162063847|NCT01359449|585288971|FG000|Overall Study|Protocol Violation|0|||
162063848|NCT01359449|585288972|FG001|Overall Study|Protocol Violation|2|||
162063849|NCT01359449|585288971|FG000|Overall Study|Withdrawal by Subject|3|||
162063850|NCT01359449|585288972|FG001|Overall Study|Withdrawal by Subject|2|||
162063851|NCT02036294|585288974|FG000|Overall Study|Death|7|||
162063852|NCT02036294|585288975|FG001|Overall Study|Death|8|||
162063853|NCT02036294|585288974|FG000|Overall Study|Withdrawal by Subject|2|||
162063854|NCT02036294|585288975|FG001|Overall Study|Withdrawal by Subject|3|||
162063855|NCT00429104|585288980|FG000|Overall Study|Protocol Violation|1|||
162063856|NCT01907815|585288981|FG000|Overall Study|Withdrawal by Subject|1|||
162063857|NCT01907815|585288982|FG001|Overall Study|Withdrawal by Subject|0|||
162063858|NCT01285310|585288983|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
162063859|NCT01285310|585288984|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
162063860|NCT01285310|585288985|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
162063861|NCT01285310|585288986|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
162063862|NCT01285310|585288987|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
162063863|NCT01285310|585288983|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
162063864|NCT01285310|585288984|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
162063865|NCT01285310|585288985|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
162063866|NCT01285310|585288986|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
162063867|NCT01285310|585288987|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
162063868|NCT01285310|585288983|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
162063869|NCT01285310|585288984|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
162063870|NCT01285310|585288985|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
162063871|NCT01285310|585288986|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
162063872|NCT01285310|585288987|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
162063873|NCT01285310|585288983|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
162063874|NCT01285310|585288984|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
162063875|NCT01285310|585288985|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
162063876|NCT01285310|585288986|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
162063877|NCT01285310|585288987|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
162063878|NCT01285310|585288983|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
162063879|NCT01285310|585288984|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
162063880|NCT01285310|585288985|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
162063881|NCT01285310|585288986|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
162063882|NCT01285310|585288987|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
162063883|NCT01285310|585288983|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
162063884|NCT01285310|585288984|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
162063885|NCT01285310|585288985|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
162063886|NCT01285310|585288986|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
162063887|NCT01285310|585288987|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
162063888|NCT01285310|585288983|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
162063889|NCT01285310|585288984|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
162063890|NCT01285310|585288985|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
162063891|NCT01285310|585288986|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
162063892|NCT01285310|585288987|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
162063893|NCT01285310|585288983|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
162063894|NCT01285310|585288984|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
162063895|NCT01285310|585288985|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
162063896|NCT01285310|585288986|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
162063897|NCT01285310|585288987|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
162063898|NCT01285310|585288983|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
162063899|NCT01285310|585288984|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
162063900|NCT01285310|585288985|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
162063901|NCT01285310|585288986|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
162063902|NCT01285310|585288987|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
162063903|NCT01285310|585288983|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
162063904|NCT01285310|585288984|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
162063905|NCT01285310|585288985|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
162063906|NCT01285310|585288986|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
162063907|NCT01285310|585288987|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
162063908|NCT01285310|585288983|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
162063909|NCT01285310|585288984|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
162063910|NCT01285310|585288985|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
162063911|NCT01285310|585288986|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
162063912|NCT01285310|585288987|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
162063913|NCT01285310|585288983|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
162063914|NCT01285310|585288984|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
162063915|NCT01285310|585288985|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
162063916|NCT01285310|585288986|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
162063917|NCT01285310|585288987|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
162063918|NCT00514540|585288988|FG000|First-Line Chemo|Withdrawal by Subject|1|||
162063919|NCT00514540|585288988|FG000|First-Line Chemo|Protocol Violation|7|||
162063920|NCT00514540|585288988|FG000|Second-Line|Physician/Patient Decision|31|||
162063921|NCT00555321|585288995|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
162063922|NCT00555321|585288996|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
162063923|NCT00555321|585288997|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
162063924|NCT00555321|585288998|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
162063925|NCT00555321|585288999|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
162063926|NCT00555321|585288995|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
162063927|NCT00555321|585288996|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
162063928|NCT00555321|585288997|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
162063929|NCT00555321|585288998|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
162063930|NCT00555321|585288999|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
162063931|NCT00555321|585288995|FG000|Treatment Phase up to 12-months|Death|2|||
162063932|NCT00555321|585288996|FG001|Treatment Phase up to 12-months|Death|1|||
162063933|NCT00555321|585288997|FG002|Treatment Phase up to 12-months|Death|4|||
162063934|NCT00555321|585288998|FG003|Treatment Phase up to 12-months|Death|0|||
162063935|NCT00555321|585288999|FG004|Treatment Phase up to 12-months|Death|0|||
162063936|NCT00555321|585288995|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
162063937|NCT00555321|585288996|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
162063938|NCT00555321|585288997|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
162063939|NCT00555321|585288998|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
162063940|NCT00555321|585288999|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
162063941|NCT00555321|585288995|FG000|Treatment Phase up to 12-months|Other Reason|1|||
162063942|NCT00555321|585288996|FG001|Treatment Phase up to 12-months|Other Reason|3|||
162063943|NCT00555321|585288997|FG002|Treatment Phase up to 12-months|Other Reason|2|||
162063944|NCT00555321|585288998|FG003|Treatment Phase up to 12-months|Other Reason|0|||
162063945|NCT00555321|585288999|FG004|Treatment Phase up to 12-months|Other Reason|0|||
162063946|NCT00555321|585288995|FG000|Treatment Phase up to 12-months|Never treated|2|||
162063947|NCT00555321|585288996|FG001|Treatment Phase up to 12-months|Never treated|3|||
162063948|NCT00555321|585288997|FG002|Treatment Phase up to 12-months|Never treated|1|||
162063949|NCT00555321|585288998|FG003|Treatment Phase up to 12-months|Never treated|0|||
162063950|NCT00555321|585288999|FG004|Treatment Phase up to 12-months|Never treated|4|||
162063951|NCT00555321|585288995|FG000|Long-term Extension Phase|Adverse Event|2|||
162063952|NCT00555321|585288996|FG001|Long-term Extension Phase|Adverse Event|5|||
162063953|NCT00555321|585288997|FG002|Long-term Extension Phase|Adverse Event|2|||
162063954|NCT00555321|585288998|FG003|Long-term Extension Phase|Adverse Event|1|||
162063955|NCT00555321|585288999|FG004|Long-term Extension Phase|Adverse Event|0|||
162063956|NCT00555321|585288995|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
162063957|NCT00555321|585288996|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
162063958|NCT00555321|585288997|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
162063959|NCT00555321|585288998|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
162063960|NCT00555321|585288999|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
162063961|NCT00555321|585288995|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
162063962|NCT00555321|585288996|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
162063963|NCT00555321|585288997|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
162063964|NCT00555321|585288998|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
162063965|NCT00555321|585288999|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
162063966|NCT00555321|585288995|FG000|Long-term Extension Phase|Death|2|||
162063967|NCT00555321|585288996|FG001|Long-term Extension Phase|Death|0|||
162063968|NCT00555321|585288997|FG002|Long-term Extension Phase|Death|0|||
162063969|NCT00555321|585288998|FG003|Long-term Extension Phase|Death|3|||
162063970|NCT00555321|585288999|FG004|Long-term Extension Phase|Death|0|||
162063971|NCT00555321|585288995|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
162063972|NCT00555321|585288996|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
162063973|NCT00555321|585288997|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
162063974|NCT00555321|585288998|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
162063975|NCT00555321|585288999|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
162063976|NCT00555321|585288995|FG000|Long-term Extension Phase|Other Reason|1|||
162063977|NCT00555321|585288996|FG001|Long-term Extension Phase|Other Reason|0|||
162063978|NCT00555321|585288997|FG002|Long-term Extension Phase|Other Reason|2|||
162063979|NCT00555321|585288998|FG003|Long-term Extension Phase|Other Reason|0|||
162063980|NCT00555321|585288999|FG004|Long-term Extension Phase|Other Reason|0|||
162063981|NCT01348347|585289000|FG000|Overall Study|Withdrawal by Subject|1|||
162063982|NCT01348347|585289001|FG001|Overall Study|Withdrawal by Subject|1|||
162063983|NCT01348347|585289002|FG002|Overall Study|Withdrawal by Subject|1|||
162063984|NCT01348347|585289000|FG000|Overall Study|Progressive disease|2|||
162063985|NCT01348347|585289001|FG001|Overall Study|Progressive disease|5|||
162063986|NCT01348347|585289002|FG002|Overall Study|Progressive disease|5|||
162063987|NCT00191789|585289006|FG000|Overall Study|Adverse Event|5|||
162063988|NCT00191789|585289006|FG000|Overall Study|Patient: Satisfactory Response|5|||
162063989|NCT00191789|585289006|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
162063990|NCT00191789|585289006|FG000|Overall Study|Withdrawal by Subject|4|||
162063991|NCT00191789|585289006|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
162063992|NCT00191789|585289006|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
162063993|NCT00191789|585289006|FG000|Overall Study|Death - Not Study-Drug Related|1|||
162063994|NCT02860169|585289013|FG000|Part A|Withdrawal by Subject|1|||
162063995|NCT02860169|585289013|FG000|Part A|Other (Screening failure)|6|||
162063996|NCT02860169|585289013|FG000|Part A|Other (Survey not completed)|3|||
162063997|NCT02860169|585289013|FG000|Part A|Other (did not completed consent)|1|||
162063998|NCT02860169|585289013|FG000|Part B|Other (Screening failure)|10|||
162063999|NCT02860169|585289013|FG000|Part B|Withdrawal by Subject|1|||
162064000|NCT02860169|585289013|FG000|Part C|Other (Screening failure)|1|||
162064001|NCT01782495|585289014|FG000|Overall Study|Adverse Event|0|||
162064002|NCT01782495|585289015|FG001|Overall Study|Adverse Event|0|||
162064003|NCT01782495|585289016|FG002|Overall Study|Adverse Event|0|||
162064004|NCT01782495|585289017|FG003|Overall Study|Adverse Event|0|||
162064005|NCT01782495|585289018|FG004|Overall Study|Adverse Event|0|||
162064006|NCT01782495|585289019|FG005|Overall Study|Adverse Event|0|||
162064007|NCT01782495|585289020|FG006|Overall Study|Adverse Event|0|||
162064008|NCT01782495|585289021|FG007|Overall Study|Adverse Event|2|||
162064009|NCT01782495|585289022|FG008|Overall Study|Adverse Event|0|||
162064010|NCT01782495|585289023|FG009|Overall Study|Adverse Event|0|||
162064011|NCT01782495|585289024|FG010|Overall Study|Adverse Event|0|||
162064012|NCT01782495|585289014|FG000|Overall Study|Withdrew Consent|0|||
162064013|NCT01782495|585289015|FG001|Overall Study|Withdrew Consent|1|||
162064014|NCT01782495|585289016|FG002|Overall Study|Withdrew Consent|0|||
162064015|NCT01782495|585289017|FG003|Overall Study|Withdrew Consent|0|||
162064016|NCT01782495|585289018|FG004|Overall Study|Withdrew Consent|0|||
162064017|NCT01782495|585289019|FG005|Overall Study|Withdrew Consent|0|||
162064018|NCT01782495|585289020|FG006|Overall Study|Withdrew Consent|0|||
162064019|NCT01782495|585289021|FG007|Overall Study|Withdrew Consent|1|||
162064020|NCT01782495|585289022|FG008|Overall Study|Withdrew Consent|0|||
162064021|NCT01782495|585289023|FG009|Overall Study|Withdrew Consent|0|||
162064022|NCT01782495|585289024|FG010|Overall Study|Withdrew Consent|0|||
162064023|NCT02622321|585289027|FG000|Overall Study|Withdrawal by Subject|2|||
162064024|NCT02622321|585289028|FG001|Overall Study|Withdrawal by Subject|0|||
162064025|NCT02622321|585289029|FG002|Overall Study|Withdrawal by Subject|0|||
162064026|NCT02622321|585289030|FG003|Overall Study|Withdrawal by Subject|0|||
162064027|NCT02622321|585289027|FG000|Overall Study|Death|0|||
162064028|NCT02622321|585289028|FG001|Overall Study|Death|0|||
162064029|NCT02622321|585289029|FG002|Overall Study|Death|1|||
162064030|NCT02622321|585289030|FG003|Overall Study|Death|0|||
162064031|NCT02622321|585289027|FG000|Overall Study|Physician Decision|1|||
162064032|NCT02622321|585289028|FG001|Overall Study|Physician Decision|0|||
162064033|NCT02622321|585289029|FG002|Overall Study|Physician Decision|0|||
162064034|NCT02622321|585289030|FG003|Overall Study|Physician Decision|0|||
162064035|NCT00241280|585289031|FG000|Overall Study|Adverse Event|2|||
162064036|NCT00241280|585289032|FG001|Overall Study|Adverse Event|6|||
162064037|NCT00241280|585289031|FG000|Overall Study|Discomfort|11|||
162064038|NCT00241280|585289032|FG001|Overall Study|Discomfort|16|||
162064039|NCT00241280|585289031|FG000|Overall Study|Pregnancy|1|||
162064040|NCT00241280|585289032|FG001|Overall Study|Pregnancy|5|||
162064041|NCT00241280|585289031|FG000|Overall Study|Lost to Follow-up|5|||
162064042|NCT00241280|585289032|FG001|Overall Study|Lost to Follow-up|8|||
162064043|NCT00241280|585289031|FG000|Overall Study|Withdrawal by Subject|7|||
162064044|NCT00241280|585289032|FG001|Overall Study|Withdrawal by Subject|4|||
162064045|NCT00241280|585289031|FG000|Overall Study|Protocol Violation|4|||
162064046|NCT00241280|585289032|FG001|Overall Study|Protocol Violation|10|||
162064047|NCT00241280|585289031|FG000|Overall Study|Relocation|4|||
162064048|NCT00241280|585289032|FG001|Overall Study|Relocation|4|||
162064049|NCT00241280|585289031|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
162064050|NCT00241280|585289032|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
162064051|NCT00241280|585289031|FG000|Overall Study|Unsatisfactory Visual Response|1|||
162064052|NCT00241280|585289032|FG001|Overall Study|Unsatisfactory Visual Response|1|||
162064053|NCT00241280|585289031|FG000|Overall Study|Diabetic|1|||
162064054|NCT00241280|585289032|FG001|Overall Study|Diabetic|0|||
162064055|NCT00241280|585289031|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
162064056|NCT00241280|585289032|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
162064057|NCT00241280|585289031|FG000|Overall Study|Dispensed incorrect test article|1|||
162064058|NCT00241280|585289032|FG001|Overall Study|Dispensed incorrect test article|2|||
162064059|NCT00241280|585289031|FG000|Overall Study|Unacceptable Fit|0|||
162064060|NCT00241280|585289032|FG001|Overall Study|Unacceptable Fit|1|||
162064061|NCT00241280|585289031|FG000|Overall Study|Scheduling Conflict|0|||
162064062|NCT00241280|585289032|FG001|Overall Study|Scheduling Conflict|2|||
162064063|NCT00241280|585289031|FG000|Overall Study|History of Ocular Surgery|0|||
162064064|NCT00241280|585289032|FG001|Overall Study|History of Ocular Surgery|1|||
162064065|NCT00241280|585289031|FG000|Overall Study|Coating on Lens|1|||
162064066|NCT00241280|585289032|FG001|Overall Study|Coating on Lens|0|||
162064067|NCT00241280|585289031|FG000|Overall Study|Excessive Dryness|0|||
162064068|NCT00241280|585289032|FG001|Overall Study|Excessive Dryness|1|||
162064069|NCT01958008|585289033|FG000|Overall Study|Worsening of disease under study|0|||
162064070|NCT01958008|585289034|FG001|Overall Study|Worsening of disease under study|0|||
162064071|NCT01958008|585289035|FG002|Overall Study|Worsening of disease under study|1|||
162064072|NCT01958008|585289036|FG003|Overall Study|Worsening of disease under study|0|||
162064073|NCT01958008|585289033|FG000|Overall Study|Other adverse event|1|||
162064074|NCT01958008|585289034|FG001|Overall Study|Other adverse event|0|||
162064075|NCT01958008|585289035|FG002|Overall Study|Other adverse event|0|||
162064076|NCT01958008|585289036|FG003|Overall Study|Other adverse event|0|||
162064077|NCT01414855|585289037|FG000|Overall Study|Death|17|||
162064078|NCT01414855|585289037|FG000|Overall Study|Lost to Follow-up|5|||
162064079|NCT01414855|585289037|FG000|Overall Study|Withdrawal by Subject|7|||
162064080|NCT01853826|585290808|FG000|Overall Study|Patients who switched to commercial drug|11|||
162064081|NCT01853826|585290808|FG000|Overall Study|Patient refused to continue medication|21|||
162064082|NCT01853826|585290808|FG000|Overall Study|Lost to Follow-up|2|||
162064083|NCT01853826|585290808|FG000|Overall Study|Non-compliant with protocol|4|||
162064084|NCT01853826|585290808|FG000|Overall Study|Other adverse events (AE)|62|||
162064085|NCT01853826|585290808|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
162064086|NCT01853826|585290808|FG000|Overall Study|Progressive disease|342|||
162064087|NCT01853826|585290808|FG000|Overall Study|Other than listed|13|||
162064088|NCT01853826|585290808|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
162064089|NCT04779489|585290819|FG000|Overall Study|Physician Decision|1|||
162064090|NCT02068443|585290820|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162064091|NCT02068443|585290821|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
162064092|NCT02068443|585290822|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
162064093|NCT02068443|585290820|FG000|Overall Study|Voluntary Withdrawal|4|||
162064094|NCT02068443|585290821|FG001|Overall Study|Voluntary Withdrawal|0|||
162064095|NCT02068443|585290822|FG002|Overall Study|Voluntary Withdrawal|1|||
162064096|NCT02068443|585290820|FG000|Overall Study|Lack of Efficacy|2|||
162064097|NCT02068443|585290821|FG001|Overall Study|Lack of Efficacy|1|||
162064098|NCT02068443|585290822|FG002|Overall Study|Lack of Efficacy|0|||
162064099|NCT02068443|585290820|FG000|Overall Study|Other Reason Not Specified|1|||
162064100|NCT02068443|585290821|FG001|Overall Study|Other Reason Not Specified|0|||
162064101|NCT02068443|585290822|FG002|Overall Study|Other Reason Not Specified|0|||
162064102|NCT02723084|585290824|FG000|Overall Study|Withdrawal by Subject|1|||
162064103|NCT02723084|585290825|FG001|Overall Study|Withdrawal by Subject|1|||
162064104|NCT02723084|585290824|FG000|Overall Study|Lost to Follow-up|3|||
162064105|NCT02723084|585290825|FG001|Overall Study|Lost to Follow-up|0|||
162064106|NCT05126901|585290830|FG000|Overall Study|Withdrawal by Subject|1|||
162064107|NCT05126901|585290831|FG001|Overall Study|Withdrawal by Subject|1|||
162064108|NCT05126901|585290832|FG002|Overall Study|Withdrawal by Subject|4|||
162064109|NCT05126901|585290830|FG000|Overall Study|Adverse Event|0|||
162064110|NCT05126901|585290831|FG001|Overall Study|Adverse Event|0|||
162064111|NCT05126901|585290832|FG002|Overall Study|Adverse Event|1|||
162064112|NCT05126901|585290830|FG000|Overall Study|Lost to Follow-up|0|||
162064113|NCT05126901|585290831|FG001|Overall Study|Lost to Follow-up|2|||
162064114|NCT05126901|585290832|FG002|Overall Study|Lost to Follow-up|0|||
162064115|NCT04067544|585290833|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
162064116|NCT01320085|585290834|FG000|Overall Study|Disease Progression|26|||
162064117|NCT01320085|585290835|FG001|Overall Study|Disease Progression|93|||
162064118|NCT01320085|585290836|FG002|Overall Study|Disease Progression|17|||
162064119|NCT01320085|585290834|FG000|Overall Study|Adverse Event|12|||
162064120|NCT01320085|585290835|FG001|Overall Study|Adverse Event|20|||
162064121|NCT01320085|585290836|FG002|Overall Study|Adverse Event|5|||
162064122|NCT01320085|585290834|FG000|Overall Study|Withdrawal by Subject|2|||
162064123|NCT01320085|585290835|FG001|Overall Study|Withdrawal by Subject|4|||
162064124|NCT01320085|585290836|FG002|Overall Study|Withdrawal by Subject|1|||
162064125|NCT01320085|585290834|FG000|Overall Study|Protocol Deviation|1|||
162064126|NCT01320085|585290835|FG001|Overall Study|Protocol Deviation|0|||
162064127|NCT01320085|585290836|FG002|Overall Study|Protocol Deviation|1|||
162064128|NCT01320085|585290834|FG000|Overall Study|Administrative problems|0|||
162064129|NCT01320085|585290835|FG001|Overall Study|Administrative problems|0|||
162064130|NCT01320085|585290836|FG002|Overall Study|Administrative problems|1|||
162064131|NCT00225251|585290839|FG000|Overall Study|Withdrawal by Subject|1|||
162064132|NCT00225251|585290840|FG001|Overall Study|Withdrawal by Subject|1|||
162064133|NCT00710710|585290841|FG000|Overall Study|Consent withdrawn|2|||
162064134|NCT00710710|585290842|FG001|Overall Study|Consent withdrawn|2|||
162064135|NCT00710710|585290841|FG000|Overall Study|Protocol Violation|0|||
162064136|NCT00710710|585290842|FG001|Overall Study|Protocol Violation|1|||
162064137|NCT00710710|585290841|FG000|Overall Study|Adverse Event|3|||
162064138|NCT00710710|585290842|FG001|Overall Study|Adverse Event|3|||
162064139|NCT00710710|585290841|FG000|Overall Study|Progressive disease|40|||
162064140|NCT00710710|585290842|FG001|Overall Study|Progressive disease|38|||
162064141|NCT00715078|585290843|FG000|Overall Study|Death|29|||
162064142|NCT00715078|585290844|FG001|Overall Study|Death|36|||
162064143|NCT00715078|585290845|FG002|Overall Study|Death|36|||
162064144|NCT00715078|585290843|FG000|Overall Study|Withdrawal by Subject|1|||
162064145|NCT00715078|585290844|FG001|Overall Study|Withdrawal by Subject|0|||
162064146|NCT00715078|585290845|FG002|Overall Study|Withdrawal by Subject|1|||
162064147|NCT00715078|585290843|FG000|Overall Study|Unable to start due to disease prog.|0|||
162064148|NCT00715078|585290844|FG001|Overall Study|Unable to start due to disease prog.|0|||
162064149|NCT00715078|585290845|FG002|Overall Study|Unable to start due to disease prog.|1|||
162064150|NCT01529346|585290846|FG000|Overall Study|Lost to Follow-up|2|||
162064151|NCT01529346|585290847|FG001|Overall Study|Lost to Follow-up|0|||
162064152|NCT01529346|585290848|FG002|Overall Study|Lost to Follow-up|1|||
162064153|NCT01529346|585290849|FG003|Overall Study|Lost to Follow-up|0|||
162064154|NCT01529346|585290850|FG004|Overall Study|Lost to Follow-up|0|||
162064155|NCT01529346|585290846|FG000|Overall Study|Other|0|||
162064156|NCT01529346|585290847|FG001|Overall Study|Other|1|||
162064157|NCT01529346|585290848|FG002|Overall Study|Other|1|||
162064158|NCT01529346|585290849|FG003|Overall Study|Other|0|||
162064159|NCT01529346|585290850|FG004|Overall Study|Other|0|||
162064160|NCT02282020|585290857|FG000|Overall Study|Objective Disease Progression|128|||
162064161|NCT02282020|585290858|FG001|Overall Study|Objective Disease Progression|30|||
162064162|NCT02282020|585290857|FG000|Overall Study|Adverse Event|18|||
162064163|NCT02282020|585290858|FG001|Overall Study|Adverse Event|15|||
162064164|NCT02282020|585290857|FG000|Overall Study|Withdrawal by Subject|7|||
162064165|NCT02282020|585290858|FG001|Overall Study|Withdrawal by Subject|10|||
162064166|NCT02282020|585290857|FG000|Overall Study|Miscellaneous|5|||
162064167|NCT02282020|585290858|FG001|Overall Study|Miscellaneous|19|||
162064168|NCT02282020|585290857|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
162064169|NCT02282020|585290858|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
162064170|NCT02282020|585290857|FG000|Overall Study|Developed Discontinuation Criteria|0|||
162064171|NCT02282020|585290858|FG001|Overall Study|Developed Discontinuation Criteria|2|||
162064172|NCT02282020|585290857|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
162064173|NCT02282020|585290858|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
162064174|NCT00588848|585290859|FG000|Overall Study|Physician Decision|0|||
162064175|NCT00588848|585290860|FG001|Overall Study|Physician Decision|3|||
162064176|NCT01499667|585290861|FG000|Overall Study|administrative problems|4|||
162064177|NCT01499667|585290862|FG001|Overall Study|administrative problems|5|||
162064178|NCT01499667|585290863|FG002|Overall Study|administrative problems|5|||
162064179|NCT01499667|585290861|FG000|Overall Study|Protocol Violation|1|||
162064180|NCT01499667|585290862|FG001|Overall Study|Protocol Violation|3|||
162064181|NCT01499667|585290863|FG002|Overall Study|Protocol Violation|2|||
162064182|NCT01499667|585290861|FG000|Overall Study|Adverse Event|0|||
162064183|NCT01499667|585290862|FG001|Overall Study|Adverse Event|2|||
162064184|NCT01499667|585290863|FG002|Overall Study|Adverse Event|2|||
162064185|NCT01499667|585290861|FG000|Overall Study|Withdrawal by Subject|2|||
162064186|NCT01499667|585290862|FG001|Overall Study|Withdrawal by Subject|1|||
162064187|NCT01499667|585290863|FG002|Overall Study|Withdrawal by Subject|1|||
162064188|NCT01499667|585290861|FG000|Overall Study|Lack of Efficacy|2|||
162064189|NCT01499667|585290862|FG001|Overall Study|Lack of Efficacy|0|||
162064190|NCT01499667|585290863|FG002|Overall Study|Lack of Efficacy|0|||
162064191|NCT02673489|585290864|FG000|Treatment Period|Lost to Follow-up|3|||
162064192|NCT02673489|585290865|FG001|Treatment Period|Lost to Follow-up|0|||
162064193|NCT02673489|585290864|FG000|Treatment Period|Participant request to discontinue|1|||
162064194|NCT02673489|585290865|FG001|Treatment Period|Participant request to discontinue|1|||
162064195|NCT02673489|585290864|FG000|Treatment Period|Participant moved to another province|1|||
162064196|NCT02673489|585290865|FG001|Treatment Period|Participant moved to another province|0|||
162064197|NCT02673489|585290864|FG000|Treatment Period|Participant was incarcerated|0|||
162064198|NCT02673489|585290865|FG001|Treatment Period|Participant was incarcerated|1|||
162064199|NCT02673489|585290864|FG000|Treatment Period|Adverse Event|0|||
162064200|NCT02673489|585290865|FG001|Treatment Period|Adverse Event|1|||
162064201|NCT02673489|585290864|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
162064202|NCT02673489|585290865|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
162064203|NCT02673489|585290864|FG000|Follow Up Period|Unable to return for follow-up|0|||
162064204|NCT02673489|585290865|FG001|Follow Up Period|Unable to return for follow-up|1|||
162064205|NCT00082355|585290866|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
162064206|NCT00082355|585290866|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
162064207|NCT00082355|585290866|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
162064208|NCT02233309|585290868|FG000|Overall Study|Physician Decision|5|||
162064209|NCT01506479|585290872|FG000|Overall Study|Lost to Follow-up|1|||
162064210|NCT01506479|585290873|FG001|Overall Study|Lost to Follow-up|2|||
162064211|NCT01506479|585290874|FG002|Overall Study|Lost to Follow-up|2|||
162064212|NCT01506479|585290872|FG000|Overall Study|Withdrawal by Subject|1|||
162064213|NCT01506479|585290873|FG001|Overall Study|Withdrawal by Subject|2|||
162064214|NCT01506479|585290874|FG002|Overall Study|Withdrawal by Subject|1|||
162064215|NCT01506479|585290872|FG000|Overall Study|Missing assessment|1|||
162064216|NCT01506479|585290873|FG001|Overall Study|Missing assessment|0|||
162064217|NCT01506479|585290874|FG002|Overall Study|Missing assessment|0|||
162064218|NCT01506479|585290872|FG000|Overall Study|Adverse Event|0|||
162064219|NCT01506479|585290873|FG001|Overall Study|Adverse Event|1|||
162064220|NCT01506479|585290874|FG002|Overall Study|Adverse Event|0|||
162064221|NCT05247866|585290876|FG000|Overall Study|Adverse Event|2|||
162064222|NCT05247866|585290876|FG000|Overall Study|Lack of Efficacy|1|||
162064223|NCT05247866|585290876|FG000|Overall Study|Protocol Violation|1|||
162064224|NCT05247866|585290876|FG000|Overall Study|Withdrawal by Subject|3|||
162064225|NCT04463719|585290879|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
162064226|NCT04463719|585290880|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
162064227|NCT04463719|585290881|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
162064228|NCT02746874|585290882|FG000|Overall Study|Withdrawal by Subject|0|||
162064229|NCT02746874|585290883|FG001|Overall Study|Withdrawal by Subject|1|||
162064230|NCT02746874|585290882|FG000|Overall Study|Surgery Date Changed|0|||
162064231|NCT02746874|585290883|FG001|Overall Study|Surgery Date Changed|2|||
162064232|NCT01156311|585290887|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
162064233|NCT01156311|585290888|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
162064234|NCT01156311|585290889|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
162064235|NCT01156311|585290890|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
162064236|NCT01156311|585290887|FG000|2-Month Monotherapy Period|Physician Decision|0|||
162064237|NCT01156311|585290888|FG001|2-Month Monotherapy Period|Physician Decision|1|||
162064238|NCT01156311|585290889|FG002|2-Month Monotherapy Period|Physician Decision|0|||
162064239|NCT01156311|585290890|FG003|2-Month Monotherapy Period|Physician Decision|0|||
162064240|NCT01156311|585290887|FG000|2-Month Monotherapy Period|Other|1|||
162064241|NCT01156311|585290888|FG001|2-Month Monotherapy Period|Other|0|||
162064242|NCT01156311|585290889|FG002|2-Month Monotherapy Period|Other|0|||
162064243|NCT01156311|585290890|FG003|2-Month Monotherapy Period|Other|0|||
162064244|NCT01156311|585290887|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
162064245|NCT01156311|585290888|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
162064246|NCT01156311|585290889|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
162064247|NCT01156311|585290890|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
162064248|NCT01156311|585290887|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
162064249|NCT01156311|585290888|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
162064250|NCT01156311|585290889|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
162064251|NCT01156311|585290890|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
162064252|NCT01156311|585290887|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
162064253|NCT01156311|585290888|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
162064254|NCT01156311|585290889|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
162064255|NCT01156311|585290890|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
162064256|NCT01156311|585290887|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
162064257|NCT01156311|585290888|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
162064258|NCT01156311|585290889|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
162064259|NCT01156311|585290890|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
162064260|NCT01156311|585290887|FG000|6-month Add-on Therapy Period|Other|0|||
162064261|NCT01156311|585290888|FG001|6-month Add-on Therapy Period|Other|0|||
162064262|NCT01156311|585290889|FG002|6-month Add-on Therapy Period|Other|1|||
162064263|NCT01156311|585290890|FG003|6-month Add-on Therapy Period|Other|2|||
162064264|NCT02393547|585290893|FG000|Overall Study|Adverse Event|2|||
162064265|NCT02393547|585290893|FG000|Overall Study|Withdrawal by Subject|3|||
162064266|NCT02393547|585290893|FG000|Overall Study|Lost to Follow-up|1|||
162064267|NCT04997161|585290907|FG000|Overall Study|Study terminated by sponsor|3|||
162064268|NCT00752232|585290908|FG000|Overall Study|Protocol Violation|0|||
162064269|NCT00752232|585290909|FG001|Overall Study|Protocol Violation|0|||
162064270|NCT00752232|585290910|FG002|Overall Study|Protocol Violation|0|||
162064271|NCT00752232|585290911|FG003|Overall Study|Protocol Violation|0|||
162064272|NCT00752232|585290912|FG004|Overall Study|Protocol Violation|0|||
162064273|NCT00752232|585290913|FG005|Overall Study|Protocol Violation|1|||
162064274|NCT00752232|585290914|FG006|Overall Study|Protocol Violation|0|||
162064275|NCT00752232|585290908|FG000|Overall Study|Caregiver request|2|||
162064276|NCT00752232|585290909|FG001|Overall Study|Caregiver request|0|||
162064277|NCT00752232|585290910|FG002|Overall Study|Caregiver request|0|||
162064278|NCT00752232|585290911|FG003|Overall Study|Caregiver request|0|||
162064279|NCT00752232|585290912|FG004|Overall Study|Caregiver request|1|||
162064280|NCT00752232|585290913|FG005|Overall Study|Caregiver request|0|||
162064281|NCT00752232|585290914|FG006|Overall Study|Caregiver request|0|||
162064282|NCT00752232|585290908|FG000|Overall Study|Investigator request|0|||
162064283|NCT00752232|585290909|FG001|Overall Study|Investigator request|0|||
162064284|NCT00752232|585290910|FG002|Overall Study|Investigator request|0|||
162064285|NCT00752232|585290911|FG003|Overall Study|Investigator request|0|||
162064286|NCT00752232|585290912|FG004|Overall Study|Investigator request|1|||
162064287|NCT00752232|585290913|FG005|Overall Study|Investigator request|0|||
162064288|NCT00752232|585290914|FG006|Overall Study|Investigator request|0|||
162064289|NCT00752232|585290908|FG000|Overall Study|Subject request|0|||
162064290|NCT00752232|585290909|FG001|Overall Study|Subject request|0|||
162064291|NCT00752232|585290910|FG002|Overall Study|Subject request|1|||
162064292|NCT00752232|585290911|FG003|Overall Study|Subject request|0|||
162064293|NCT00752232|585290912|FG004|Overall Study|Subject request|0|||
162064294|NCT00752232|585290913|FG005|Overall Study|Subject request|0|||
162064295|NCT00752232|585290914|FG006|Overall Study|Subject request|0|||
162064296|NCT00752232|585290908|FG000|Overall Study|Group home admission|0|||
162064297|NCT00752232|585290909|FG001|Overall Study|Group home admission|0|||
162064298|NCT00752232|585290910|FG002|Overall Study|Group home admission|0|||
162064299|NCT00752232|585290911|FG003|Overall Study|Group home admission|1|||
162064300|NCT00752232|585290912|FG004|Overall Study|Group home admission|0|||
162064301|NCT00752232|585290913|FG005|Overall Study|Group home admission|0|||
162064302|NCT00752232|585290914|FG006|Overall Study|Group home admission|0|||
162064303|NCT00752232|585290908|FG000|Overall Study|Caregiver could not attend the subject|0|||
162064304|NCT00752232|585290909|FG001|Overall Study|Caregiver could not attend the subject|0|||
162064305|NCT00752232|585290910|FG002|Overall Study|Caregiver could not attend the subject|0|||
162064306|NCT00752232|585290911|FG003|Overall Study|Caregiver could not attend the subject|0|||
162064307|NCT00752232|585290912|FG004|Overall Study|Caregiver could not attend the subject|1|||
162064308|NCT00752232|585290913|FG005|Overall Study|Caregiver could not attend the subject|0|||
162064309|NCT00752232|585290914|FG006|Overall Study|Caregiver could not attend the subject|0|||
162064310|NCT04502589|585290915|FG000|Overall Study|Physician Decision|1|||
162064311|NCT04502589|585290916|FG001|Overall Study|Physician Decision|0|||
162064312|NCT02730455|585290918|FG000|Overall Study|Death|5|||
162064313|NCT02730455|585290919|FG001|Overall Study|Death|6|||
162064314|NCT02730455|585290920|FG002|Overall Study|Death|4|||
162064315|NCT02730455|585290918|FG000|Overall Study|Consent withdrawn|2|||
162064316|NCT02730455|585290919|FG001|Overall Study|Consent withdrawn|4|||
162064317|NCT02730455|585290920|FG002|Overall Study|Consent withdrawn|1|||
162064318|NCT02730455|585290918|FG000|Overall Study|Lost to Follow-up|3|||
162064319|NCT02730455|585290919|FG001|Overall Study|Lost to Follow-up|1|||
162064320|NCT02730455|585290920|FG002|Overall Study|Lost to Follow-up|4|||
162064321|NCT02730455|585290918|FG000|Overall Study|Other|1|||
162064322|NCT02730455|585290919|FG001|Overall Study|Other|1|||
162064323|NCT02730455|585290920|FG002|Overall Study|Other|2|||
162064324|NCT02730455|585290918|FG000|Overall Study|Other|2|||
162064325|NCT02730455|585290919|FG001|Overall Study|Other|2|||
162064326|NCT02730455|585290920|FG002|Overall Study|Other|0|||
162064327|NCT02733367|585290921|FG000|Overall Study|Withdrawal by Subject|6|||
162064328|NCT01922089|585290924|FG000|Overall Study|Adverse Event|18|||
162064329|NCT01922089|585290925|FG001|Overall Study|Adverse Event|13|||
162064330|NCT01922089|585290924|FG000|Overall Study|Protocol Deviation|10|||
162064331|NCT01922089|585290925|FG001|Overall Study|Protocol Deviation|7|||
162064332|NCT01922089|585290924|FG000|Overall Study|Withdrawal by Subject|3|||
162064333|NCT01922089|585290925|FG001|Overall Study|Withdrawal by Subject|4|||
162064334|NCT01922089|585290924|FG000|Overall Study|administrative problems|4|||
162064335|NCT01922089|585290925|FG001|Overall Study|administrative problems|1|||
162064336|NCT01922089|585290924|FG000|Overall Study|Physician Decision|2|||
162064337|NCT01922089|585290925|FG001|Overall Study|Physician Decision|3|||
162064338|NCT01922089|585290924|FG000|Overall Study|Death|2|||
162064339|NCT01922089|585290925|FG001|Overall Study|Death|1|||
162064340|NCT01922089|585290924|FG000|Overall Study|Lost to Follow-up|0|||
162064341|NCT01922089|585290925|FG001|Overall Study|Lost to Follow-up|1|||
162064342|NCT05582889|585290926|FG000|Overall Study|Health event|3|||
162064343|NCT05582889|585290927|FG001|Overall Study|Health event|2|||
162064344|NCT05582889|585290926|FG000|Overall Study|Lost to Follow-up|2|||
162064345|NCT05582889|585290927|FG001|Overall Study|Lost to Follow-up|4|||
162064346|NCT00001723|585290928|FG000|Overall Study|Lack of Efficacy|6|||
162064347|NCT00001723|585290929|FG001|Overall Study|Lack of Efficacy|7|||
162064348|NCT00001723|585290928|FG000|Overall Study|Lack of family interest|4|||
162064349|NCT00001723|585290929|FG001|Overall Study|Lack of family interest|5|||
162064350|NCT00001723|585290928|FG000|Overall Study|Lost to Follow-up|2|||
162064351|NCT00001723|585290929|FG001|Overall Study|Lost to Follow-up|2|||
162064352|NCT00001723|585290928|FG000|Overall Study|medication intolerance|1|||
162064353|NCT00001723|585290929|FG001|Overall Study|medication intolerance|2|||
162064354|NCT02170051|585290930|FG000|Overall Study|Withdrawal by Subject|10|||
162064355|NCT02170051|585290931|FG001|Overall Study|Withdrawal by Subject|10|||
162064356|NCT02170051|585290930|FG000|Overall Study|Lost to Follow-up|1|||
162064357|NCT02170051|585290931|FG001|Overall Study|Lost to Follow-up|3|||
162064358|NCT04551092|585290932|FG000|Overall Study|Lost to Follow-up|7|||
162064359|NCT04551092|585290932|FG000|Overall Study|Withdrawal by Subject|4|||
162064360|NCT01324999|585290933|FG000|Overall Study|Adverse Event|3|||
162064361|NCT01324999|585290933|FG000|Overall Study|Withdrawal by Subject|2|||
162064362|NCT01712490|585290934|FG000|Overall Study|Ongoing|601|||
162064363|NCT01712490|585290935|FG001|Overall Study|Ongoing|586|||
162064364|NCT01712490|585290934|FG000|Overall Study|Other|11|||
162064365|NCT01712490|585290935|FG001|Overall Study|Other|11|||
162064366|NCT01712490|585290934|FG000|Overall Study|Withdrawal by Subject|36|||
162064367|NCT01712490|585290935|FG001|Overall Study|Withdrawal by Subject|44|||
162064368|NCT01712490|585290934|FG000|Overall Study|Lost to Follow-up|16|||
162064369|NCT01712490|585290935|FG001|Overall Study|Lost to Follow-up|29|||
162064370|NCT01714635|585290943|FG000|Overall Study|Discontinued|1|||
162064371|NCT01714635|585290944|FG001|Overall Study|Discontinued|0|||
162064372|NCT01714635|585290945|FG002|Overall Study|Discontinued|2|||
162064373|NCT01714635|585290943|FG000|Overall Study|Missed 6-month exam|1|||
162064374|NCT01714635|585290944|FG001|Overall Study|Missed 6-month exam|0|||
162064375|NCT01714635|585290945|FG002|Overall Study|Missed 6-month exam|0|||
162064376|NCT01129960|585290946|FG000|Overall Study|Withdrawal by Subject|3|||
162064377|NCT01129960|585290947|FG001|Overall Study|Withdrawal by Subject|0|||
162064378|NCT01129960|585290948|FG002|Overall Study|Withdrawal by Subject|3|||
162064379|NCT01129960|585290949|FG003|Overall Study|Withdrawal by Subject|2|||
162064380|NCT01129960|585290946|FG000|Overall Study|Lack of Efficacy|1|||
162064381|NCT01129960|585290947|FG001|Overall Study|Lack of Efficacy|1|||
162064382|NCT01129960|585290948|FG002|Overall Study|Lack of Efficacy|1|||
162064383|NCT01129960|585290949|FG003|Overall Study|Lack of Efficacy|1|||
162064384|NCT01129960|585290946|FG000|Overall Study|Adverse Event|23|||
162064385|NCT01129960|585290947|FG001|Overall Study|Adverse Event|16|||
162064386|NCT01129960|585290948|FG002|Overall Study|Adverse Event|16|||
162064387|NCT01129960|585290949|FG003|Overall Study|Adverse Event|7|||
162064388|NCT01129960|585290946|FG000|Overall Study|Protocol Violation|1|||
162064389|NCT01129960|585290947|FG001|Overall Study|Protocol Violation|2|||
162064390|NCT01129960|585290948|FG002|Overall Study|Protocol Violation|3|||
162064391|NCT01129960|585290949|FG003|Overall Study|Protocol Violation|0|||
162064392|NCT01129960|585290946|FG000|Overall Study|Lost to Follow-up|0|||
162064393|NCT01129960|585290947|FG001|Overall Study|Lost to Follow-up|2|||
162064394|NCT01129960|585290948|FG002|Overall Study|Lost to Follow-up|3|||
162064395|NCT01129960|585290949|FG003|Overall Study|Lost to Follow-up|3|||
162064396|NCT01129960|585290946|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
162064397|NCT01129960|585290947|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
162064398|NCT01129960|585290948|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
162064399|NCT01129960|585290949|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
162064400|NCT01129960|585290946|FG000|Overall Study|Physician Decision|1|||
162064401|NCT01129960|585290947|FG001|Overall Study|Physician Decision|0|||
162064402|NCT01129960|585290948|FG002|Overall Study|Physician Decision|0|||
162064403|NCT01129960|585290949|FG003|Overall Study|Physician Decision|0|||
162064404|NCT01129960|585290946|FG000|Overall Study|Pregnancy|1|||
162064405|NCT01129960|585290947|FG001|Overall Study|Pregnancy|0|||
162064406|NCT01129960|585290948|FG002|Overall Study|Pregnancy|0|||
162064407|NCT01129960|585290949|FG003|Overall Study|Pregnancy|0|||
162064408|NCT01927367|585290952|FG000|Overall Study|Withdrawal by Subject|7|||
162064409|NCT01927367|585290953|FG001|Overall Study|Withdrawal by Subject|4|||
162064410|NCT01927367|585290952|FG000|Overall Study|No baseline data|0|||
162064411|NCT01927367|585290953|FG001|Overall Study|No baseline data|1|||
162064412|NCT00071513|585290954|FG000|Intervention Component|Withdrawal by Subject|2|||
162064413|NCT00071513|585290955|FG001|Intervention Component|Withdrawal by Subject|3|||
162064414|NCT00071513|585290954|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
162064415|NCT00071513|585290955|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
162064416|NCT01634360|585290956|FG000|Overall Study|Adverse Event|10|||
162064417|NCT01634360|585290957|FG001|Overall Study|Adverse Event|34|||
162064418|NCT01634360|585290956|FG000|Overall Study|subject withdrew consent|13|||
162064419|NCT01634360|585290957|FG001|Overall Study|subject withdrew consent|23|||
162064420|NCT01634360|585290956|FG000|Overall Study|Protocol Violation|1|||
162064421|NCT01634360|585290957|FG001|Overall Study|Protocol Violation|1|||
162064422|NCT01634360|585290956|FG000|Overall Study|Lack of Efficacy|4|||
162064423|NCT01634360|585290957|FG001|Overall Study|Lack of Efficacy|14|||
162064424|NCT01634360|585290956|FG000|Overall Study|Other|3|||
162064425|NCT01634360|585290957|FG001|Overall Study|Other|20|||
162064426|NCT01634360|585290956|FG000|Overall Study|Study termination by sponsor|18|||
162064427|NCT01634360|585290957|FG001|Overall Study|Study termination by sponsor|44|||
162064428|NCT02743871|585290958|FG000|Overall Study|Lost to Follow-up|0|||
162064429|NCT02743871|585290959|FG001|Overall Study|Lost to Follow-up|0|||
162064430|NCT02743871|585290960|FG002|Overall Study|Lost to Follow-up|0|||
162064431|NCT02743871|585290961|FG003|Overall Study|Lost to Follow-up|1|||
162064432|NCT02743871|585290962|FG004|Overall Study|Lost to Follow-up|0|||
162064433|NCT02743871|585290963|FG005|Overall Study|Lost to Follow-up|0|||
162064434|NCT02743871|585290964|FG006|Overall Study|Lost to Follow-up|1|||
162064435|NCT02743871|585290965|FG007|Overall Study|Lost to Follow-up|0|||
162064436|NCT02743871|585290966|FG008|Overall Study|Lost to Follow-up|0|||
162064437|NCT02743871|585290967|FG009|Overall Study|Lost to Follow-up|0|||
162064438|NCT02743871|585290968|FG010|Overall Study|Lost to Follow-up|0|||
162064439|NCT02743871|585290969|FG011|Overall Study|Lost to Follow-up|2|||
162064440|NCT02743871|585290970|FG012|Overall Study|Lost to Follow-up|0|||
162064441|NCT02743871|585290971|FG013|Overall Study|Lost to Follow-up|0|||
162064442|NCT02743871|585290958|FG000|Overall Study|Withdrawal by Subject|0|||
162064443|NCT02743871|585290959|FG001|Overall Study|Withdrawal by Subject|0|||
162064444|NCT02743871|585290960|FG002|Overall Study|Withdrawal by Subject|0|||
162064445|NCT02743871|585290961|FG003|Overall Study|Withdrawal by Subject|0|||
162064446|NCT02743871|585290962|FG004|Overall Study|Withdrawal by Subject|0|||
162064447|NCT02743871|585290963|FG005|Overall Study|Withdrawal by Subject|0|||
162064448|NCT02743871|585290964|FG006|Overall Study|Withdrawal by Subject|0|||
162064449|NCT02743871|585290965|FG007|Overall Study|Withdrawal by Subject|0|||
162064450|NCT02743871|585290966|FG008|Overall Study|Withdrawal by Subject|0|||
162064451|NCT02743871|585290967|FG009|Overall Study|Withdrawal by Subject|0|||
162064452|NCT02743871|585290968|FG010|Overall Study|Withdrawal by Subject|1|||
162064453|NCT02743871|585290969|FG011|Overall Study|Withdrawal by Subject|0|||
162064454|NCT02743871|585290970|FG012|Overall Study|Withdrawal by Subject|12|||
162064455|NCT02743871|585290971|FG013|Overall Study|Withdrawal by Subject|6|||
162064456|NCT02743871|585290958|FG000|Overall Study|Adverse Event|1|||
162064457|NCT02743871|585290959|FG001|Overall Study|Adverse Event|0|||
162064458|NCT02743871|585290960|FG002|Overall Study|Adverse Event|0|||
162064459|NCT02743871|585290961|FG003|Overall Study|Adverse Event|0|||
162064460|NCT02743871|585290962|FG004|Overall Study|Adverse Event|0|||
162064461|NCT02743871|585290963|FG005|Overall Study|Adverse Event|0|||
162064462|NCT02743871|585290964|FG006|Overall Study|Adverse Event|0|||
162064463|NCT02743871|585290965|FG007|Overall Study|Adverse Event|0|||
162064464|NCT02743871|585290966|FG008|Overall Study|Adverse Event|0|||
162064465|NCT02743871|585290967|FG009|Overall Study|Adverse Event|0|||
162064466|NCT02743871|585290968|FG010|Overall Study|Adverse Event|0|||
162064467|NCT02743871|585290969|FG011|Overall Study|Adverse Event|0|||
162064468|NCT02743871|585290970|FG012|Overall Study|Adverse Event|0|||
162064469|NCT02743871|585290971|FG013|Overall Study|Adverse Event|0|||
162064470|NCT02743871|585290958|FG000|Overall Study|Other|0|||
162064471|NCT02743871|585290959|FG001|Overall Study|Other|0|||
162064472|NCT02743871|585290960|FG002|Overall Study|Other|0|||
162064473|NCT02743871|585290961|FG003|Overall Study|Other|0|||
162064474|NCT02743871|585290962|FG004|Overall Study|Other|0|||
162064475|NCT02743871|585290963|FG005|Overall Study|Other|0|||
162064476|NCT02743871|585290964|FG006|Overall Study|Other|0|||
162064477|NCT02743871|585290965|FG007|Overall Study|Other|0|||
162064478|NCT02743871|585290966|FG008|Overall Study|Other|0|||
162064479|NCT02743871|585290967|FG009|Overall Study|Other|0|||
162064480|NCT02743871|585290968|FG010|Overall Study|Other|0|||
162064481|NCT02743871|585290969|FG011|Overall Study|Other|1|||
162064482|NCT02743871|585290970|FG012|Overall Study|Other|1|||
162064483|NCT02743871|585290971|FG013|Overall Study|Other|1|||
162064484|NCT02743871|585290958|FG000|Overall Study|Protocol Violation|0|||
162064485|NCT02743871|585290959|FG001|Overall Study|Protocol Violation|0|||
162064486|NCT02743871|585290960|FG002|Overall Study|Protocol Violation|0|||
162064487|NCT02743871|585290961|FG003|Overall Study|Protocol Violation|0|||
162064488|NCT02743871|585290962|FG004|Overall Study|Protocol Violation|0|||
162064489|NCT02743871|585290963|FG005|Overall Study|Protocol Violation|0|||
162064490|NCT02743871|585290964|FG006|Overall Study|Protocol Violation|0|||
162064491|NCT02743871|585290965|FG007|Overall Study|Protocol Violation|0|||
162064492|NCT02743871|585290966|FG008|Overall Study|Protocol Violation|0|||
162064493|NCT02743871|585290967|FG009|Overall Study|Protocol Violation|0|||
162064494|NCT02743871|585290968|FG010|Overall Study|Protocol Violation|0|||
162064495|NCT02743871|585290969|FG011|Overall Study|Protocol Violation|0|||
162064496|NCT02743871|585290970|FG012|Overall Study|Protocol Violation|2|||
162064497|NCT02743871|585290971|FG013|Overall Study|Protocol Violation|0|||
162064498|NCT02848651|585290977|FG000|Overall Study|Death|85|||
162064499|NCT02848651|585290977|FG000|Overall Study|Lost to Follow-up|1|||
162064500|NCT02848651|585290977|FG000|Overall Study|Non-Compliance|1|||
162064501|NCT02848651|585290977|FG000|Overall Study|Symptomatic Deterioration|1|||
162064502|NCT02848651|585290977|FG000|Overall Study|Physician Decision|4|||
162064503|NCT02848651|585290977|FG000|Overall Study|Withdrawal by Subject|14|||
162064504|NCT00396591|585290978|FG000|Overall Study|Disease Progression|13|||
162064505|NCT00396591|585290978|FG000|Overall Study|Adverse Event|2|||
162064506|NCT00396591|585290978|FG000|Overall Study|Participant request|1|||
162064507|NCT01535053|585290981|FG000|Overall Study|Ineligible|1|||
162064508|NCT01535053|585290982|FG001|Overall Study|Ineligible|2|||
162064509|NCT00512707|585290983|FG000|Overall Study|Lost to Follow-up|5|||
162064510|NCT00512707|585290984|FG001|Overall Study|Lost to Follow-up|11|||
162064511|NCT00512707|585290983|FG000|Overall Study|Developed skin irritation|2|||
162064512|NCT00512707|585290984|FG001|Overall Study|Developed skin irritation|1|||
162064513|NCT00512707|585290983|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
162064514|NCT00512707|585290984|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
162064515|NCT00512707|585290983|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
162064516|NCT00512707|585290984|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
162064517|NCT03653637|585293455|FG000|Overall Study|Death|1|||
162064518|NCT03653637|585293456|FG001|Overall Study|Death|3|||
162064519|NCT03653637|585293455|FG000|Overall Study|Lost to Follow-up|29|||
162064520|NCT03653637|585293456|FG001|Overall Study|Lost to Follow-up|30|||
162064521|NCT03653637|585293455|FG000|Overall Study|Physician Decision|1|||
162064522|NCT03653637|585293456|FG001|Overall Study|Physician Decision|1|||
162064523|NCT03653637|585293455|FG000|Overall Study|Withdrawal by Subject|7|||
162064524|NCT03653637|585293456|FG001|Overall Study|Withdrawal by Subject|4|||
162064525|NCT01702454|585293459|FG000|Overall Study|Consent withdrawal|0|||
162064526|NCT01702454|585293460|FG001|Overall Study|Consent withdrawal|1|||
162064527|NCT01702454|585293459|FG000|Overall Study|Migrated/moved from study area|0|||
162064528|NCT01702454|585293460|FG001|Overall Study|Migrated/moved from study area|1|||
162064529|NCT01702454|585293459|FG000|Overall Study|Lost to Follow-up|3|||
162064530|NCT01702454|585293460|FG001|Overall Study|Lost to Follow-up|6|||
162064531|NCT03510884|585293461|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
162064532|NCT03510884|585293462|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
162064533|NCT03510884|585293463|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
162064534|NCT03510884|585293464|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
162064535|NCT03510884|585293461|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
162064536|NCT03510884|585293462|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
162064537|NCT03510884|585293463|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
162064538|NCT03510884|585293464|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
162064539|NCT03510884|585293461|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
162064540|NCT03510884|585293462|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
162064541|NCT03510884|585293463|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
162064542|NCT03510884|585293464|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
162064543|NCT03510884|585293461|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
162064544|NCT03510884|585293462|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
162064545|NCT03510884|585293463|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
162064546|NCT03510884|585293464|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
162064547|NCT03510884|585293461|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
162064548|NCT03510884|585293462|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
162064549|NCT03510884|585293463|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
162064550|NCT03510884|585293464|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
162064551|NCT03510884|585293461|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
162064552|NCT03510884|585293462|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
162064553|NCT03510884|585293463|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
162064554|NCT03510884|585293464|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
162064555|NCT03510884|585293461|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
162064556|NCT03510884|585293462|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
162064557|NCT03510884|585293463|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
162064558|NCT03510884|585293464|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
162064559|NCT03510884|585293461|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
162064560|NCT03510884|585293462|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
162064561|NCT03510884|585293463|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
162064562|NCT03510884|585293464|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
162064563|NCT03510884|585293461|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
162064564|NCT03510884|585293462|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
162064565|NCT03510884|585293463|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
162064566|NCT03510884|585293464|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
162064567|NCT03510884|585293461|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
162064568|NCT03510884|585293462|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
162064569|NCT03510884|585293463|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
162064570|NCT03510884|585293464|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
162064571|NCT00157950|585293465|FG000|Overall Study|Death|1|||
162064572|NCT00157950|585293466|FG001|Overall Study|Death|0|||
162064573|NCT01287897|585293470|FG000|Overall Study|Adverse Event|5|||
162064574|NCT01287897|585293471|FG001|Overall Study|Adverse Event|3|||
162064575|NCT01287897|585293472|FG002|Overall Study|Adverse Event|6|||
162064576|NCT01287897|585293473|FG003|Overall Study|Adverse Event|4|||
162064577|NCT01287897|585293470|FG000|Overall Study|Lack of Efficacy|2|||
162064578|NCT01287897|585293471|FG001|Overall Study|Lack of Efficacy|0|||
162064579|NCT01287897|585293472|FG002|Overall Study|Lack of Efficacy|0|||
162064580|NCT01287897|585293473|FG003|Overall Study|Lack of Efficacy|0|||
162064581|NCT01287897|585293470|FG000|Overall Study|Protocol Violation|1|||
162064582|NCT01287897|585293471|FG001|Overall Study|Protocol Violation|1|||
162064583|NCT01287897|585293472|FG002|Overall Study|Protocol Violation|0|||
162064584|NCT01287897|585293473|FG003|Overall Study|Protocol Violation|1|||
162064585|NCT01287897|585293470|FG000|Overall Study|Lost to Follow-up|0|||
162064586|NCT01287897|585293471|FG001|Overall Study|Lost to Follow-up|0|||
162064587|NCT01287897|585293472|FG002|Overall Study|Lost to Follow-up|2|||
162064588|NCT01287897|585293473|FG003|Overall Study|Lost to Follow-up|0|||
162064589|NCT01287897|585293470|FG000|Overall Study|Withdrawal by Subject|1|||
162064590|NCT01287897|585293471|FG001|Overall Study|Withdrawal by Subject|5|||
162064591|NCT01287897|585293472|FG002|Overall Study|Withdrawal by Subject|3|||
162064592|NCT01287897|585293473|FG003|Overall Study|Withdrawal by Subject|2|||
162064593|NCT01287897|585293470|FG000|Overall Study|Not consented properly|0|||
162064594|NCT01287897|585293471|FG001|Overall Study|Not consented properly|1|||
162064595|NCT01287897|585293472|FG002|Overall Study|Not consented properly|0|||
162064596|NCT01287897|585293473|FG003|Overall Study|Not consented properly|0|||
162064597|NCT01287897|585293470|FG000|Overall Study|Not meeting entrance criteria|1|||
162064598|NCT01287897|585293471|FG001|Overall Study|Not meeting entrance criteria|1|||
162064599|NCT01287897|585293472|FG002|Overall Study|Not meeting entrance criteria|0|||
162064600|NCT01287897|585293473|FG003|Overall Study|Not meeting entrance criteria|0|||
162064601|NCT01287897|585293470|FG000|Overall Study|Other|1|||
162064602|NCT01287897|585293471|FG001|Overall Study|Other|0|||
162064603|NCT01287897|585293472|FG002|Overall Study|Other|1|||
162064604|NCT01287897|585293473|FG003|Overall Study|Other|0|||
162064605|NCT02892760|585293474|FG000|Overall Study|Withdrawal by Subject|3|||
162064606|NCT00386776|585293475|FG000|Overall Study|Withdrawal by Subject|8|||
162064607|NCT01500629|585293476|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
162064608|NCT01500629|585293477|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
162064609|NCT02902965|585293478|FG000|Overall Study|Withdrawal by Subject|10|||
162064610|NCT00293254|585293479|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
162064611|NCT00293254|585293480|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
162064612|NCT00293254|585293479|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
162064613|NCT00293254|585293480|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
162064614|NCT00293254|585293479|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
162064615|NCT00293254|585293480|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
162064616|NCT00293254|585293479|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
162064617|NCT00293254|585293480|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
162064618|NCT00293254|585293479|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
162064619|NCT00293254|585293480|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
162064620|NCT00293254|585293479|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
162064621|NCT00293254|585293480|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
162064622|NCT00293254|585293479|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
162064623|NCT00293254|585293480|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
162064624|NCT00293254|585293479|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
162064625|NCT00293254|585293480|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
162064626|NCT00293254|585293479|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
162064627|NCT00293254|585293480|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
162064628|NCT00293254|585293479|FG000|Extension - Double-Blind Week 49-156|Death|4|||
162064629|NCT00293254|585293480|FG001|Extension - Double-Blind Week 49-156|Death|1|||
162064630|NCT00293254|585293479|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
162064631|NCT00293254|585293480|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
162064632|NCT00293254|585293479|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
162064633|NCT00293254|585293480|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
162064634|NCT00293254|585293479|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
162064635|NCT00293254|585293480|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
162064636|NCT00293254|585293479|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
162064637|NCT00293254|585293480|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
162064638|NCT00293254|585293479|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
162064639|NCT00293254|585293480|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
162064640|NCT00293254|585293479|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
162064641|NCT00293254|585293480|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
162064642|NCT00293254|585293479|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
162064643|NCT00293254|585293480|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
162064644|NCT00293254|585293479|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
162064645|NCT00293254|585293480|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
162064646|NCT00293254|585293479|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
162064647|NCT00293254|585293480|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
162064648|NCT00293254|585293479|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
162064649|NCT00293254|585293480|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
162064650|NCT00293254|585293479|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
162064651|NCT00293254|585293480|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
162064652|NCT00293254|585293479|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
162064653|NCT00293254|585293480|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
162064654|NCT00293254|585293479|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
162064655|NCT00293254|585293480|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
162064656|NCT00293254|585293479|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
162064657|NCT00293254|585293480|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
162064658|NCT00293254|585293479|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
162064659|NCT00293254|585293480|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
162064660|NCT00293254|585293479|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
162064661|NCT00293254|585293480|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
162064662|NCT00293254|585293479|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
162064663|NCT00293254|585293480|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
162064664|NCT00531050|585293481|FG000|Part 1: Period 1|Adverse Event|0|||
162064665|NCT00531050|585293482|FG001|Part 1: Period 1|Adverse Event|1|||
162064666|NCT00531050|585293483|FG002|Part 1: Period 1|Adverse Event|0|||
162064667|NCT00531050|585293484|FG003|Part 1: Period 1|Adverse Event|0|||
162064668|NCT00531050|585293485|FG004|Part 1: Period 1|Adverse Event|0|||
162064669|NCT00531050|585293486|FG005|Part 1: Period 1|Adverse Event|0|||
162064670|NCT00531050|585293481|FG000|Part 1: Period 1|Protocol Deviation|0|||
162064671|NCT00531050|585293482|FG001|Part 1: Period 1|Protocol Deviation|0|||
162064672|NCT00531050|585293483|FG002|Part 1: Period 1|Protocol Deviation|0|||
162064673|NCT00531050|585293484|FG003|Part 1: Period 1|Protocol Deviation|1|||
162064674|NCT00531050|585293485|FG004|Part 1: Period 1|Protocol Deviation|0|||
162064675|NCT00531050|585293486|FG005|Part 1: Period 1|Protocol Deviation|0|||
162064676|NCT00531050|585293481|FG000|Part 1: Period 3|Adverse Event|1|||
162064677|NCT00531050|585293482|FG001|Part 1: Period 3|Adverse Event|0|||
162064678|NCT00531050|585293483|FG002|Part 1: Period 3|Adverse Event|0|||
162064679|NCT00531050|585293484|FG003|Part 1: Period 3|Adverse Event|0|||
162064680|NCT00531050|585293485|FG004|Part 1: Period 3|Adverse Event|0|||
162064681|NCT00531050|585293486|FG005|Part 1: Period 3|Adverse Event|0|||
162064682|NCT00531050|585293481|FG000|Part 2: Period 1|Adverse Event|0|||
162064683|NCT00531050|585293482|FG001|Part 2: Period 1|Adverse Event|0|||
162064684|NCT00531050|585293483|FG002|Part 2: Period 1|Adverse Event|0|||
162064685|NCT00531050|585293484|FG003|Part 2: Period 1|Adverse Event|0|||
162064686|NCT00531050|585293485|FG004|Part 2: Period 1|Adverse Event|0|||
162064687|NCT00531050|585293486|FG005|Part 2: Period 1|Adverse Event|1|||
162064688|NCT00531050|585293481|FG000|Part 2: Period 3|Abnormal test procedure|1|||
162064689|NCT00531050|585293482|FG001|Part 2: Period 3|Abnormal test procedure|0|||
162064690|NCT00531050|585293483|FG002|Part 2: Period 3|Abnormal test procedure|0|||
162064691|NCT00531050|585293484|FG003|Part 2: Period 3|Abnormal test procedure|0|||
162064692|NCT00531050|585293485|FG004|Part 2: Period 3|Abnormal test procedure|0|||
162064693|NCT00531050|585293486|FG005|Part 2: Period 3|Abnormal test procedure|1|||
162064694|NCT00475176|585293489|FG000|Overall Study|Adverse Event|2|||
162064695|NCT00475176|585293489|FG000|Overall Study|Withdrawal by Subject|1|||
162064696|NCT00475176|585293489|FG000|Overall Study|Protocol Violation|1|||
162064697|NCT01484873|585293490|FG000|Overall Study|Withdrawal by Subject|2|||
162064698|NCT01549392|585293491|FG000|Overall Study|Withdrawal by Subject|1|||
162064699|NCT01549392|585293492|FG001|Overall Study|Withdrawal by Subject|0|||
162064700|NCT00227903|585293493|FG000|Overall Study|Withdrawal by Subject|2|||
162064701|NCT00227903|585293494|FG001|Overall Study|Withdrawal by Subject|5|||
162064702|NCT00227903|585293493|FG000|Overall Study|Subject moved out of area|1|||
162064703|NCT00227903|585293494|FG001|Overall Study|Subject moved out of area|2|||
162064704|NCT00227903|585293493|FG000|Overall Study|Lost to Follow-up|1|||
162064705|NCT00227903|585293494|FG001|Overall Study|Lost to Follow-up|3|||
162064706|NCT00227903|585293493|FG000|Overall Study|Miscarriage|1|||
162064707|NCT00227903|585293494|FG001|Overall Study|Miscarriage|0|||
162064708|NCT01475331|585293495|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
162064709|NCT01475331|585293496|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
162064710|NCT01475331|585293495|FG000|Overall Study|excessive main duct communication|1|||
162064711|NCT01475331|585293496|FG001|Overall Study|excessive main duct communication|1|||
162064712|NCT01475331|585293495|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
162064713|NCT01475331|585293496|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
162064714|NCT01475331|585293495|FG000|Overall Study|Sign of malignancy during the procedure|2|||
162064715|NCT01475331|585293496|FG001|Overall Study|Sign of malignancy during the procedure|0|||
162064716|NCT01475331|585293495|FG000|Overall Study|cyst found to be prohibitively small|0|||
162064717|NCT01475331|585293496|FG001|Overall Study|cyst found to be prohibitively small|1|||
162064718|NCT00462761|585293497|FG000|Overall Study|Adverse Event|6|||
162064719|NCT00462761|585293497|FG000|Overall Study|Withdrawal by Subject|9|||
162064720|NCT00462761|585293497|FG000|Overall Study|Physician Decision|5|||
162064721|NCT00462761|585293497|FG000|Overall Study|Disease progression|43|||
162064722|NCT00462761|585293497|FG000|Overall Study|Death|12|||
162064723|NCT00462761|585293497|FG000|Overall Study|Other|1|||
162064724|NCT02877082|585293498|FG000|Overall Study|Trial was closed early|5|||
162064725|NCT03720470|585293503|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
162064726|NCT03720470|585293504|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
162064727|NCT03720470|585293505|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
162064728|NCT03720470|585293506|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
162064729|NCT03720470|585293507|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
162064730|NCT03720470|585293508|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
162064731|NCT03720470|585293503|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
162064732|NCT03720470|585293504|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
162064733|NCT03720470|585293505|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
162064734|NCT03720470|585293506|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
162064735|NCT03720470|585293507|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
162064736|NCT03720470|585293508|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
162064737|NCT03720470|585293503|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
162064738|NCT03720470|585293504|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
162064739|NCT03720470|585293505|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
162064740|NCT03720470|585293506|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
162064741|NCT03720470|585293507|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
162064742|NCT03720470|585293508|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
162064743|NCT03720470|585293503|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
162064744|NCT03720470|585293504|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
162064745|NCT03720470|585293505|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
162064746|NCT03720470|585293506|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
162064747|NCT03720470|585293507|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
162064748|NCT03720470|585293508|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
162064749|NCT03720470|585293503|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
162064750|NCT03720470|585293504|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
162064751|NCT03720470|585293505|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
162064752|NCT03720470|585293506|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
162064753|NCT03720470|585293507|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
162064754|NCT03720470|585293508|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
162064755|NCT03720470|585293503|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
162064756|NCT03720470|585293504|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
162064757|NCT03720470|585293505|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
162064758|NCT03720470|585293506|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
162064759|NCT03720470|585293507|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
162064760|NCT03720470|585293508|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
162064761|NCT03720470|585293503|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
162064762|NCT03720470|585293504|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
162064763|NCT03720470|585293505|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
162064764|NCT03720470|585293506|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
162064765|NCT03720470|585293507|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
162064766|NCT03720470|585293508|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
162064767|NCT03720470|585293503|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
162064768|NCT03720470|585293504|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
162064769|NCT03720470|585293505|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
162064770|NCT03720470|585293506|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
162064771|NCT03720470|585293507|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
162064772|NCT03720470|585293508|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
162064773|NCT03720470|585293503|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
162064774|NCT03720470|585293504|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
162064775|NCT03720470|585293505|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
162064776|NCT03720470|585293506|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
162064777|NCT03720470|585293507|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
162064778|NCT03720470|585293508|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
162064779|NCT03720470|585293503|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
162064780|NCT03720470|585293504|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
162064781|NCT03720470|585293505|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
162064782|NCT03720470|585293506|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
162064783|NCT03720470|585293507|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
162064784|NCT03720470|585293508|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
162064785|NCT03720470|585293503|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
162064786|NCT03720470|585293504|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
162064787|NCT03720470|585293505|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
162064788|NCT03720470|585293506|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
162064789|NCT03720470|585293507|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
162064790|NCT03720470|585293508|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
162064791|NCT03720470|585293503|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
162064792|NCT03720470|585293504|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
162064793|NCT03720470|585293505|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
162064794|NCT03720470|585293506|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
162064795|NCT03720470|585293507|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
162064796|NCT03720470|585293508|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
162064797|NCT03720470|585293503|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
162064798|NCT03720470|585293504|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
162064799|NCT03720470|585293505|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
162064800|NCT03720470|585293506|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
162064801|NCT03720470|585293507|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
162064802|NCT03720470|585293508|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
162064803|NCT03720470|585293503|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
162064804|NCT03720470|585293504|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
162064805|NCT03720470|585293505|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
162064806|NCT03720470|585293506|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
162064807|NCT03720470|585293507|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
162064808|NCT03720470|585293508|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
162064809|NCT03720470|585293503|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
162064810|NCT03720470|585293504|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
162064811|NCT03720470|585293505|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
162064812|NCT03720470|585293506|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
162064813|NCT03720470|585293507|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
162064814|NCT03720470|585293508|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
162064815|NCT03720470|585293503|FG000|Treatment Period: Final 4 Weeks|Other|0|||
162064816|NCT03720470|585293504|FG001|Treatment Period: Final 4 Weeks|Other|1|||
162064817|NCT03720470|585293505|FG002|Treatment Period: Final 4 Weeks|Other|0|||
162064818|NCT03720470|585293506|FG003|Treatment Period: Final 4 Weeks|Other|2|||
162064819|NCT03720470|585293507|FG004|Treatment Period: Final 4 Weeks|Other|1|||
162064820|NCT03720470|585293508|FG005|Treatment Period: Final 4 Weeks|Other|0|||
162064821|NCT00460031|585293509|FG000|Overall Study|Adverse Event|5|||
162064822|NCT00460031|585293509|FG000|Overall Study|Withdrawal by Subject|5|||
162064823|NCT00460031|585293509|FG000|Overall Study|Death|1|||
162064824|NCT01988103|585293514|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
162064825|NCT01988103|585293515|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
162064826|NCT01988103|585293516|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
162064827|NCT01988103|585293517|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
162064828|NCT01988103|585293518|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
162064829|NCT01988103|585293514|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
162064830|NCT01988103|585293515|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
162064831|NCT01988103|585293516|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
162064832|NCT01988103|585293517|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
162064833|NCT01988103|585293518|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
162064834|NCT01988103|585293514|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
162064835|NCT01988103|585293515|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
162064836|NCT01988103|585293516|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
162064837|NCT01988103|585293517|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
162064838|NCT01988103|585293518|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
162064839|NCT01988103|585293514|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
162064840|NCT01988103|585293515|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
162064841|NCT01988103|585293516|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
162064842|NCT01988103|585293517|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
162064843|NCT01988103|585293518|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
162064844|NCT01988103|585293514|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
162064845|NCT01988103|585293515|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
162064846|NCT01988103|585293516|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
162064847|NCT01988103|585293517|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
162064848|NCT01988103|585293518|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
162064849|NCT01988103|585293514|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
162064850|NCT01988103|585293515|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
162064851|NCT01988103|585293516|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
162064852|NCT01988103|585293517|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
162064853|NCT01988103|585293518|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
162064854|NCT01988103|585293514|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
162064855|NCT01988103|585293515|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
162064856|NCT01988103|585293516|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
162064857|NCT01988103|585293517|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
162064858|NCT01988103|585293518|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
162064859|NCT01946425|585293522|FG000|Overall Study|Protocol Violation|1|||
162064860|NCT01946425|585293523|FG001|Overall Study|Protocol Violation|0|||
162064861|NCT01946425|585293522|FG000|Overall Study|Withdrawal by Subject|1|||
162064862|NCT01946425|585293523|FG001|Overall Study|Withdrawal by Subject|0|||
162064863|NCT05682326|585293529|FG000|Overall Study|Withdrawal by Subject|1|||
162064864|NCT05682326|585293530|FG001|Overall Study|Withdrawal by Subject|0|||
162064865|NCT01402544|585293531|FG000|Overall Study|Withdrawal by Subject|6|||
162064866|NCT01113801|585293532|FG000|Overall Study|Adverse Event|4|||
162064867|NCT01113801|585293533|FG001|Overall Study|Adverse Event|0|||
162064868|NCT01113801|585293534|FG002|Overall Study|Adverse Event|2|||
162064869|NCT01113801|585293535|FG003|Overall Study|Adverse Event|6|||
162064870|NCT01113801|585293532|FG000|Overall Study|Death|4|||
162064871|NCT01113801|585293533|FG001|Overall Study|Death|5|||
162064872|NCT01113801|585293534|FG002|Overall Study|Death|3|||
162064873|NCT01113801|585293535|FG003|Overall Study|Death|4|||
162064874|NCT01113801|585293532|FG000|Overall Study|Protocol Violation|0|||
162064875|NCT01113801|585293533|FG001|Overall Study|Protocol Violation|1|||
162064876|NCT01113801|585293534|FG002|Overall Study|Protocol Violation|0|||
162064877|NCT01113801|585293535|FG003|Overall Study|Protocol Violation|0|||
162064878|NCT01113801|585293532|FG000|Overall Study|Withdrawal by Subject|9|||
162064879|NCT01113801|585293533|FG001|Overall Study|Withdrawal by Subject|7|||
162064880|NCT01113801|585293534|FG002|Overall Study|Withdrawal by Subject|7|||
162064881|NCT01113801|585293535|FG003|Overall Study|Withdrawal by Subject|8|||
162064882|NCT01113801|585293532|FG000|Overall Study|Physician Decision|2|||
162064883|NCT01113801|585293533|FG001|Overall Study|Physician Decision|2|||
162064884|NCT01113801|585293534|FG002|Overall Study|Physician Decision|3|||
162064885|NCT01113801|585293535|FG003|Overall Study|Physician Decision|3|||
162064886|NCT01113801|585293532|FG000|Overall Study|Sponsor Decision|15|||
162064887|NCT01113801|585293533|FG001|Overall Study|Sponsor Decision|21|||
162064888|NCT01113801|585293534|FG002|Overall Study|Sponsor Decision|20|||
162064889|NCT01113801|585293535|FG003|Overall Study|Sponsor Decision|15|||
162064890|NCT01113801|585293532|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
162064891|NCT01113801|585293533|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
162064892|NCT01113801|585293534|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
162064893|NCT01113801|585293535|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
162064894|NCT01949051|585293539|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
162064895|NCT01949051|585293540|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
162064896|NCT01949051|585293541|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
162064897|NCT01949051|585293542|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
162064898|NCT01949051|585293543|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
162064899|NCT01949051|585293544|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
162064900|NCT01949051|585293539|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
162064901|NCT01949051|585293540|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162064902|NCT01949051|585293541|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162064903|NCT01949051|585293542|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162064904|NCT01949051|585293543|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162064905|NCT01949051|585293544|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
162064906|NCT01949051|585293539|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
162064907|NCT01949051|585293540|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
162064908|NCT01949051|585293541|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
162064909|NCT01949051|585293542|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
162064910|NCT01949051|585293543|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
162064911|NCT01949051|585293544|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
162064912|NCT01949051|585293539|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
162064913|NCT01949051|585293540|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
162064914|NCT01949051|585293541|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
162064915|NCT01949051|585293542|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
162064916|NCT01949051|585293543|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
162064917|NCT01949051|585293544|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
162064918|NCT01949051|585293539|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
162064919|NCT01949051|585293540|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
162064920|NCT01949051|585293541|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
162064921|NCT01949051|585293542|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
162064922|NCT01949051|585293543|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
162064923|NCT01949051|585293544|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
162064924|NCT01846507|585293546|FG000|Overall Study|Lost to Follow-up|4|||
162064925|NCT01846507|585293546|FG000|Overall Study|Protocol Violation|1|||
162064926|NCT01846507|585293546|FG000|Overall Study|Missing data|2|||
162064927|NCT01314443|585293547|FG000|Overall Study|Withdrawal by Subject|2|||
162064928|NCT01314443|585293548|FG001|Overall Study|Withdrawal by Subject|1|||
162064929|NCT01314443|585293549|FG002|Overall Study|Withdrawal by Subject|1|||
162064930|NCT01314443|585293550|FG003|Overall Study|Withdrawal by Subject|1|||
162064931|NCT01314443|585293547|FG000|Overall Study|Protocol Violation|2|||
162064932|NCT01314443|585293548|FG001|Overall Study|Protocol Violation|2|||
162064933|NCT01314443|585293549|FG002|Overall Study|Protocol Violation|1|||
162064934|NCT01314443|585293550|FG003|Overall Study|Protocol Violation|1|||
162064935|NCT01782859|585293551|FG000|Overall Study|Protocol Violation|6|||
162064936|NCT01782859|585293552|FG001|Overall Study|Protocol Violation|6|||
162064937|NCT01782859|585293551|FG000|Overall Study|Withdrawal by Subject|0|||
162064938|NCT01782859|585293552|FG001|Overall Study|Withdrawal by Subject|1|||
162064939|NCT04545866|585293553|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
162064940|NCT04545866|585293554|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
162064941|NCT04545866|585293553|FG000|Overall Study|Withdrawal by Physician|1|||
162064942|NCT04545866|585293554|FG001|Overall Study|Withdrawal by Physician|0|||
162064943|NCT02436356|585293557|FG000|Overall Study|Excluded by MRI Screening|0|||
162064944|NCT02436356|585293558|FG001|Overall Study|Excluded by MRI Screening|0|||
162064945|NCT02436356|585293559|FG002|Overall Study|Excluded by MRI Screening|2|||
162064946|NCT02436356|585293557|FG000|Overall Study|Lost to Follow-up|0|||
162064947|NCT02436356|585293558|FG001|Overall Study|Lost to Follow-up|1|||
162064948|NCT02436356|585293559|FG002|Overall Study|Lost to Follow-up|0|||
162064949|NCT02436356|585293557|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
162064950|NCT02436356|585293558|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
162064951|NCT02436356|585293559|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
162064952|NCT02436356|585293557|FG000|Overall Study|Excluded due to other medical conditions|3|||
162064953|NCT02436356|585293558|FG001|Overall Study|Excluded due to other medical conditions|0|||
162064954|NCT02436356|585293559|FG002|Overall Study|Excluded due to other medical conditions|0|||
162064955|NCT02436356|585293557|FG000|Overall Study|Withdrawal by Subject|1|||
162064956|NCT02436356|585293558|FG001|Overall Study|Withdrawal by Subject|0|||
162064957|NCT02436356|585293559|FG002|Overall Study|Withdrawal by Subject|0|||
162064958|NCT02875860|585293560|FG000|Overall Study|Withdrawal by Subject|0|||
162064959|NCT02875860|585293561|FG001|Overall Study|Withdrawal by Subject|1|||
162064960|NCT03287804|585293562|FG000|Overall Study|Death|1|||
162064961|NCT03287804|585293562|FG000|Overall Study|Physician Decision|2|||
162064962|NCT03287804|585293562|FG000|Overall Study|Progressive disease|8|||
162064963|NCT01881776|585293563|FG000|Overall Study|Lost to Follow-up|1|||
162064964|NCT01881776|585293564|FG001|Overall Study|Lost to Follow-up|2|||
162064965|NCT01881776|585293565|FG002|Overall Study|Lost to Follow-up|1|||
162064966|NCT01881776|585293563|FG000|Overall Study|Protocol Violation|0|||
162064967|NCT01881776|585293564|FG001|Overall Study|Protocol Violation|2|||
162064968|NCT01881776|585293565|FG002|Overall Study|Protocol Violation|1|||
162064969|NCT00487747|585293566|FG000|Overall Study|Adverse Event|1|||
162064970|NCT00487747|585293566|FG000|Overall Study|Lost to Follow-up|9|||
162064971|NCT00487747|585293566|FG000|Overall Study|Lack of Efficacy|1|||
162064972|NCT04483011|585293567|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
162064973|NCT04483011|585293568|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
162064974|NCT02979522|585293594|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
162064975|NCT02979522|585293595|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
162064976|NCT02979522|585293594|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
162064977|NCT02979522|585293595|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
162064978|NCT01896531|585293598|FG000|Overall Study|Death|57|||
162064979|NCT01896531|585293599|FG001|Overall Study|Death|59|||
162064980|NCT01896531|585293598|FG000|Overall Study|Lost to Follow-up|3|||
162064981|NCT01896531|585293599|FG001|Overall Study|Lost to Follow-up|0|||
162064982|NCT01896531|585293598|FG000|Overall Study|Non-compliance|0|||
162064983|NCT01896531|585293599|FG001|Overall Study|Non-compliance|1|||
162064984|NCT01896531|585293598|FG000|Overall Study|Study Ended by Sponsor|7|||
162064985|NCT01896531|585293599|FG001|Overall Study|Study Ended by Sponsor|20|||
162064986|NCT01896531|585293598|FG000|Overall Study|Withdrawal by Subject|3|||
162064987|NCT01896531|585293599|FG001|Overall Study|Withdrawal by Subject|2|||
162064988|NCT01896531|585293598|FG000|Overall Study|Death Prior to Treatment|1|||
162064989|NCT01896531|585293599|FG001|Overall Study|Death Prior to Treatment|0|||
162064990|NCT05185089|585293600|FG000|First Intervention (4 weeks)|Adverse Event|0|||
162064991|NCT05185089|585293601|FG001|First Intervention (4 weeks)|Adverse Event|0|||
162064992|NCT05185089|585293602|FG002|First Intervention (4 weeks)|Adverse Event|0|||
162064993|NCT05185089|585293603|FG003|First Intervention (4 weeks)|Adverse Event|1|||
162064994|NCT05185089|585293600|FG000|Second Intervention (4 weeks)|Death|0|||
162064995|NCT05185089|585293601|FG001|Second Intervention (4 weeks)|Death|1|||
162064996|NCT05185089|585293602|FG002|Second Intervention (4 weeks)|Death|0|||
162064997|NCT05185089|585293603|FG003|Second Intervention (4 weeks)|Death|0|||
162064998|NCT05185089|585293600|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
162064999|NCT05185089|585293601|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
162065000|NCT05185089|585293602|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
162065001|NCT05185089|585293603|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
162065002|NCT00770289|585293604|FG000|Overall Study|Other|6|||
162065003|NCT02733991|585293605|FG000|Overall Study|Adverse Event|1|||
162065004|NCT02733991|585293606|FG001|Overall Study|Adverse Event|0|||
162065005|NCT02733991|585293605|FG000|Overall Study|Withdrawal by Subject|0|||
162065006|NCT02733991|585293606|FG001|Overall Study|Withdrawal by Subject|5|||
162065007|NCT02956486|585293609|FG000|Core Phase|Adverse Event|51|||
162065008|NCT02956486|585293610|FG001|Core Phase|Adverse Event|88|||
162065009|NCT02956486|585293611|FG002|Core Phase|Adverse Event|0|||
162065010|NCT02956486|585293609|FG000|Core Phase|Lost to Follow-up|8|||
162065011|NCT02956486|585293610|FG001|Core Phase|Lost to Follow-up|6|||
162065012|NCT02956486|585293611|FG002|Core Phase|Lost to Follow-up|0|||
162065013|NCT02956486|585293609|FG000|Core Phase|Inadequate therapeutic effect|4|||
162065014|NCT02956486|585293610|FG001|Core Phase|Inadequate therapeutic effect|5|||
162065015|NCT02956486|585293611|FG002|Core Phase|Inadequate therapeutic effect|0|||
162065016|NCT02956486|585293609|FG000|Core Phase|Withdrawal by Subject|101|||
162065017|NCT02956486|585293610|FG001|Core Phase|Withdrawal by Subject|104|||
162065018|NCT02956486|585293611|FG002|Core Phase|Withdrawal by Subject|0|||
162065019|NCT02956486|585293609|FG000|Core Phase|Study terminated by sponsor|888|||
162065020|NCT02956486|585293610|FG001|Core Phase|Study terminated by sponsor|848|||
162065021|NCT02956486|585293611|FG002|Core Phase|Study terminated by sponsor|0|||
162065022|NCT02956486|585293609|FG000|Core Phase|Other|27|||
162065023|NCT02956486|585293610|FG001|Core Phase|Other|18|||
162065024|NCT02956486|585293611|FG002|Core Phase|Other|0|||
162065025|NCT02956486|585293609|FG000|Core Phase|Not treated|0|||
162065026|NCT02956486|585293610|FG001|Core Phase|Not treated|3|||
162065027|NCT02956486|585293611|FG002|Core Phase|Not treated|0|||
162065028|NCT02956486|585293609|FG000|Extension Phase|Adverse Event|0|||
162065029|NCT02956486|585293610|FG001|Extension Phase|Adverse Event|0|||
162065030|NCT02956486|585293611|FG002|Extension Phase|Adverse Event|2|||
162065031|NCT02956486|585293609|FG000|Extension Phase|Study terminated by sponsor|0|||
162065032|NCT02956486|585293610|FG001|Extension Phase|Study terminated by sponsor|0|||
162065033|NCT02956486|585293611|FG002|Extension Phase|Study terminated by sponsor|16|||
162065034|NCT02956486|585293609|FG000|Extension Phase|Not Treated|0|||
162065035|NCT02956486|585293610|FG001|Extension Phase|Not Treated|0|||
162065036|NCT02956486|585293611|FG002|Extension Phase|Not Treated|1|||
162065037|NCT00680745|585293614|FG000|Overall Study|Withdrawal by Subject|8|||
162065038|NCT00680745|585293615|FG001|Overall Study|Withdrawal by Subject|3|||
162065039|NCT00680745|585293616|FG002|Overall Study|Withdrawal by Subject|2|||
162065040|NCT00680745|585293617|FG003|Overall Study|Withdrawal by Subject|8|||
162065041|NCT00680745|585293614|FG000|Overall Study|Lost to Follow-up|0|||
162065042|NCT00680745|585293615|FG001|Overall Study|Lost to Follow-up|1|||
162065043|NCT00680745|585293616|FG002|Overall Study|Lost to Follow-up|1|||
162065044|NCT00680745|585293617|FG003|Overall Study|Lost to Follow-up|0|||
162065045|NCT00680745|585293614|FG000|Overall Study|Death|1|||
162065046|NCT00680745|585293615|FG001|Overall Study|Death|0|||
162065047|NCT00680745|585293616|FG002|Overall Study|Death|1|||
162065048|NCT00680745|585293617|FG003|Overall Study|Death|0|||
162065049|NCT00680745|585293614|FG000|Overall Study|Adverse Event|5|||
162065050|NCT00680745|585293615|FG001|Overall Study|Adverse Event|3|||
162065051|NCT00680745|585293616|FG002|Overall Study|Adverse Event|3|||
162065052|NCT00680745|585293617|FG003|Overall Study|Adverse Event|3|||
162065053|NCT00680745|585293614|FG000|Overall Study|Poor/Non-compliance|0|||
162065054|NCT00680745|585293615|FG001|Overall Study|Poor/Non-compliance|3|||
162065055|NCT00680745|585293616|FG002|Overall Study|Poor/Non-compliance|0|||
162065056|NCT00680745|585293617|FG003|Overall Study|Poor/Non-compliance|0|||
162065057|NCT00680745|585293614|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
162065058|NCT00680745|585293615|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
162065059|NCT00680745|585293616|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
162065060|NCT00680745|585293617|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
162065061|NCT00680745|585293614|FG000|Overall Study|False Treatment|0|||
162065062|NCT00680745|585293615|FG001|Overall Study|False Treatment|1|||
162065063|NCT00680745|585293616|FG002|Overall Study|False Treatment|3|||
162065064|NCT00680745|585293617|FG003|Overall Study|False Treatment|0|||
162065065|NCT02485574|585293622|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
162065066|NCT00255047|585293624|FG000|Overall Study|Serious Adverse Events|2|||
162065067|NCT00255047|585293625|FG001|Overall Study|Serious Adverse Events|1|||
162065068|NCT00255047|585293626|FG002|Overall Study|Serious Adverse Events|2|||
162065069|NCT00255047|585293627|FG003|Overall Study|Serious Adverse Events|1|||
162065070|NCT00255047|585293624|FG000|Overall Study|Adverse Event|0|||
162065071|NCT00255047|585293625|FG001|Overall Study|Adverse Event|3|||
162065072|NCT00255047|585293626|FG002|Overall Study|Adverse Event|2|||
162065073|NCT00255047|585293627|FG003|Overall Study|Adverse Event|1|||
162065074|NCT00255047|585293624|FG000|Overall Study|Protocol Violation|13|||
162065075|NCT00255047|585293625|FG001|Overall Study|Protocol Violation|13|||
162065076|NCT00255047|585293626|FG002|Overall Study|Protocol Violation|16|||
162065077|NCT00255047|585293627|FG003|Overall Study|Protocol Violation|20|||
162065078|NCT00255047|585293624|FG000|Overall Study|Lost to Follow-up|9|||
162065079|NCT00255047|585293625|FG001|Overall Study|Lost to Follow-up|8|||
162065080|NCT00255047|585293626|FG002|Overall Study|Lost to Follow-up|5|||
162065081|NCT00255047|585293627|FG003|Overall Study|Lost to Follow-up|6|||
162065082|NCT00255047|585293624|FG000|Overall Study|Withdrawal by Subject|24|||
162065083|NCT00255047|585293625|FG001|Overall Study|Withdrawal by Subject|23|||
162065084|NCT00255047|585293626|FG002|Overall Study|Withdrawal by Subject|25|||
162065085|NCT00255047|585293627|FG003|Overall Study|Withdrawal by Subject|18|||
162065086|NCT00003492|585293634|FG000|Overall Study|Not evaluable|6|||
162065087|NCT03049280|585293640|FG000|Overall Study|Physician Decision|1|||
162065088|NCT01867021|585293641|FG000|Overall Study|Adverse Event|0|||
162065089|NCT01867021|585293642|FG001|Overall Study|Adverse Event|1|||
162065090|NCT01867021|585293641|FG000|Overall Study|Not Eligible|0|||
162065091|NCT01867021|585293642|FG001|Overall Study|Not Eligible|1|||
162065092|NCT01867021|585293641|FG000|Overall Study|Death|1|||
162065093|NCT01867021|585293642|FG001|Overall Study|Death|0|||
162065094|NCT01867021|585293641|FG000|Overall Study|Lost to Follow-up|0|||
162065095|NCT01867021|585293642|FG001|Overall Study|Lost to Follow-up|2|||
162065096|NCT01867021|585293641|FG000|Overall Study|Withdrawal by Subject|1|||
162065097|NCT01867021|585293642|FG001|Overall Study|Withdrawal by Subject|6|||
162065098|NCT03171415|585293646|FG000|Overall Study|Lost to Follow-up|0|||
162065099|NCT03171415|585293647|FG001|Overall Study|Lost to Follow-up|0|||
162065100|NCT03171415|585293648|FG002|Overall Study|Lost to Follow-up|0|||
162065101|NCT03171415|585293649|FG003|Overall Study|Lost to Follow-up|0|||
162065102|NCT03171415|585293650|FG004|Overall Study|Lost to Follow-up|2|||
162065103|NCT04140292|585293651|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
162065104|NCT04140292|585293652|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
162065105|NCT01962207|585293654|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
162065106|NCT01962207|585293655|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
162065107|NCT01962207|585293656|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
162065108|NCT01962207|585293657|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
162065109|NCT01962207|585293654|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
162065110|NCT01962207|585293655|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
162065111|NCT01962207|585293656|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
162065112|NCT01962207|585293657|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
162065113|NCT01962207|585293654|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
162065114|NCT01962207|585293655|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
162065115|NCT01962207|585293656|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
162065116|NCT01962207|585293657|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
162065117|NCT01962207|585293654|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
162065118|NCT01962207|585293655|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
162065119|NCT01962207|585293656|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
162065120|NCT01962207|585293657|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
162065121|NCT01962207|585293654|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
162065122|NCT01962207|585293655|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
162065123|NCT01962207|585293656|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
162065124|NCT01962207|585293657|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
162065125|NCT01962207|585293654|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
162065126|NCT01962207|585293655|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
162065127|NCT01962207|585293656|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
162065128|NCT01962207|585293657|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
162065129|NCT00680043|585293658|FG000|Overall Study|Withdrawal by Subject|1|||
162065130|NCT00680043|585293659|FG001|Overall Study|Withdrawal by Subject|0|||
162065131|NCT00680043|585293660|FG002|Overall Study|Withdrawal by Subject|0|||
162065132|NCT00680043|585293658|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
162065133|NCT00680043|585293659|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
162065134|NCT00680043|585293660|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
162065135|NCT00680043|585293658|FG000|Overall Study|Renal Transplant|1|||
162065136|NCT00680043|585293659|FG001|Overall Study|Renal Transplant|0|||
162065137|NCT00680043|585293660|FG002|Overall Study|Renal Transplant|4|||
162065138|NCT02480114|585293661|FG000|Overall Study|Not completing surveys|3|||
162065139|NCT02480114|585293662|FG001|Overall Study|Not completing surveys|2|||
162065140|NCT02480114|585293661|FG000|Overall Study|Withdrawal by Subject|2|||
162065141|NCT02480114|585293662|FG001|Overall Study|Withdrawal by Subject|4|||
162065142|NCT02480114|585293661|FG000|Overall Study|Disease progression|3|||
162065143|NCT02480114|585293662|FG001|Overall Study|Disease progression|0|||
162065144|NCT02480114|585293661|FG000|Overall Study|Improper completion of survey|1|||
162065145|NCT02480114|585293662|FG001|Overall Study|Improper completion of survey|1|||
162065146|NCT02480114|585293661|FG000|Overall Study|Not eligible|0|||
162065147|NCT02480114|585293662|FG001|Overall Study|Not eligible|1|||
162065148|NCT02081690|585295385|FG000|Overall Study|Death|3|||
162065149|NCT02081690|585295385|FG000|Overall Study|Physician Decision|3|||
162065150|NCT02081690|585295385|FG000|Overall Study|Withdrawal by Subject|1|||
162065151|NCT00982488|585295388|FG000|Overall Study|Administrative reason by sponsor|81|||
162065152|NCT00982488|585295389|FG001|Overall Study|Administrative reason by sponsor|3|||
162065153|NCT00982488|585295390|FG002|Overall Study|Administrative reason by sponsor|11|||
162065154|NCT00982488|585295391|FG003|Overall Study|Administrative reason by sponsor|0|||
162065155|NCT00982488|585295392|FG004|Overall Study|Administrative reason by sponsor|0|||
162065156|NCT00982488|585295388|FG000|Overall Study|Adverse event unrelated to study drug|5|||
162065157|NCT00982488|585295389|FG001|Overall Study|Adverse event unrelated to study drug|1|||
162065158|NCT00982488|585295390|FG002|Overall Study|Adverse event unrelated to study drug|0|||
162065159|NCT00982488|585295391|FG003|Overall Study|Adverse event unrelated to study drug|0|||
162065160|NCT00982488|585295392|FG004|Overall Study|Adverse event unrelated to study drug|0|||
162065161|NCT00982488|585295388|FG000|Overall Study|Death|11|||
162065162|NCT00982488|585295389|FG001|Overall Study|Death|0|||
162065163|NCT00982488|585295390|FG002|Overall Study|Death|2|||
162065164|NCT00982488|585295391|FG003|Overall Study|Death|0|||
162065165|NCT00982488|585295392|FG004|Overall Study|Death|0|||
162065166|NCT00982488|585295388|FG000|Overall Study|Disease progression|30|||
162065167|NCT00982488|585295389|FG001|Overall Study|Disease progression|5|||
162065168|NCT00982488|585295390|FG002|Overall Study|Disease progression|10|||
162065169|NCT00982488|585295391|FG003|Overall Study|Disease progression|1|||
162065170|NCT00982488|585295392|FG004|Overall Study|Disease progression|1|||
162065171|NCT00982488|585295388|FG000|Overall Study|Lost to Follow-up|1|||
162065172|NCT00982488|585295389|FG001|Overall Study|Lost to Follow-up|0|||
162065173|NCT00982488|585295390|FG002|Overall Study|Lost to Follow-up|0|||
162065174|NCT00982488|585295391|FG003|Overall Study|Lost to Follow-up|0|||
162065175|NCT00982488|585295392|FG004|Overall Study|Lost to Follow-up|0|||
162065176|NCT00982488|585295388|FG000|Overall Study|Maximum clinical benefit|1|||
162065177|NCT00982488|585295389|FG001|Overall Study|Maximum clinical benefit|1|||
162065178|NCT00982488|585295390|FG002|Overall Study|Maximum clinical benefit|1|||
162065179|NCT00982488|585295391|FG003|Overall Study|Maximum clinical benefit|0|||
162065180|NCT00982488|585295392|FG004|Overall Study|Maximum clinical benefit|0|||
162065181|NCT00982488|585295388|FG000|Overall Study|Other|15|||
162065182|NCT00982488|585295389|FG001|Overall Study|Other|1|||
162065183|NCT00982488|585295390|FG002|Overall Study|Other|3|||
162065184|NCT00982488|585295391|FG003|Overall Study|Other|1|||
162065185|NCT00982488|585295392|FG004|Overall Study|Other|0|||
162065186|NCT00982488|585295388|FG000|Overall Study|Poor compliance/noncompliance|0|||
162065187|NCT00982488|585295389|FG001|Overall Study|Poor compliance/noncompliance|1|||
162065188|NCT00982488|585295390|FG002|Overall Study|Poor compliance/noncompliance|0|||
162065189|NCT00982488|585295391|FG003|Overall Study|Poor compliance/noncompliance|0|||
162065190|NCT00982488|585295392|FG004|Overall Study|Poor compliance/noncompliance|0|||
162065191|NCT00982488|585295388|FG000|Overall Study|Stem cell transplant|2|||
162065192|NCT00982488|585295389|FG001|Overall Study|Stem cell transplant|0|||
162065193|NCT00982488|585295390|FG002|Overall Study|Stem cell transplant|0|||
162065194|NCT00982488|585295391|FG003|Overall Study|Stem cell transplant|1|||
162065195|NCT00982488|585295392|FG004|Overall Study|Stem cell transplant|0|||
162065196|NCT00982488|585295388|FG000|Overall Study|Study drug toxicity|34|||
162065197|NCT00982488|585295389|FG001|Overall Study|Study drug toxicity|1|||
162065198|NCT00982488|585295390|FG002|Overall Study|Study drug toxicity|6|||
162065199|NCT00982488|585295391|FG003|Overall Study|Study drug toxicity|0|||
162065200|NCT00982488|585295392|FG004|Overall Study|Study drug toxicity|0|||
162065201|NCT00982488|585295388|FG000|Overall Study|Withdrawal by Subject|5|||
162065202|NCT00982488|585295389|FG001|Overall Study|Withdrawal by Subject|1|||
162065203|NCT00982488|585295390|FG002|Overall Study|Withdrawal by Subject|1|||
162065204|NCT00982488|585295391|FG003|Overall Study|Withdrawal by Subject|0|||
162065205|NCT00982488|585295392|FG004|Overall Study|Withdrawal by Subject|0|||
162065206|NCT03204981|585295393|FG000|Overall Study|Physician Decision|2|||
162065207|NCT03204981|585295393|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
162065208|NCT04203238|585295394|FG000|Overall Study|Withdrawal by Subject|1|||
162065209|NCT04203238|585295395|FG001|Overall Study|Withdrawal by Subject|1|||
162065210|NCT04203238|585295394|FG000|Overall Study|Covid-19|3|||
162065211|NCT04203238|585295395|FG001|Overall Study|Covid-19|0|||
162065212|NCT04244786|585295398|FG000|Overall Study|Adverse Event|0|||
162065213|NCT04244786|585295399|FG001|Overall Study|Adverse Event|0|||
162065214|NCT04244786|585295400|FG002|Overall Study|Adverse Event|2|||
162065215|NCT04244786|585295398|FG000|Overall Study|Withdrawal by Subject|0|||
162065216|NCT04244786|585295399|FG001|Overall Study|Withdrawal by Subject|0|||
162065217|NCT04244786|585295400|FG002|Overall Study|Withdrawal by Subject|5|||
162065218|NCT00415909|585295401|FG000|Overall Study|Withdrawal by Subject|2|||
162065219|NCT00415909|585295401|FG000|Overall Study|Death|1|||
162065220|NCT05024058|585295402|FG000|Treatment|Study terminated by sponsor|5|||
162065221|NCT05024058|585295403|FG001|Treatment|Study terminated by sponsor|6|||
162065222|NCT05024058|585295404|FG002|Treatment|Study terminated by sponsor|4|||
162065223|NCT05024058|585295405|FG003|Treatment|Study terminated by sponsor|2|||
162065224|NCT05024058|585295406|FG004|Treatment|Study terminated by sponsor|3|||
162065225|NCT05024058|585295407|FG005|Treatment|Study terminated by sponsor|3|||
162065226|NCT05024058|585295408|FG006|Treatment|Study terminated by sponsor|1|||
162065227|NCT05024058|585295409|FG007|Treatment|Study terminated by sponsor|3|||
162065228|NCT05024058|585295410|FG008|Treatment|Study terminated by sponsor|6|||
162065229|NCT05024058|585295411|FG009|Treatment|Study terminated by sponsor|6|||
162065230|NCT05024058|585295402|FG000|Follow-up|Withdrawal by Subject|1|||
162065231|NCT05024058|585295403|FG001|Follow-up|Withdrawal by Subject|0|||
162065232|NCT05024058|585295404|FG002|Follow-up|Withdrawal by Subject|1|||
162065233|NCT05024058|585295405|FG003|Follow-up|Withdrawal by Subject|0|||
162065234|NCT05024058|585295406|FG004|Follow-up|Withdrawal by Subject|0|||
162065235|NCT05024058|585295407|FG005|Follow-up|Withdrawal by Subject|0|||
162065236|NCT05024058|585295408|FG006|Follow-up|Withdrawal by Subject|0|||
162065237|NCT05024058|585295409|FG007|Follow-up|Withdrawal by Subject|1|||
162065238|NCT05024058|585295410|FG008|Follow-up|Withdrawal by Subject|0|||
162065239|NCT05024058|585295411|FG009|Follow-up|Withdrawal by Subject|1|||
162065240|NCT02734810|585295412|FG000|Overall Study|Adverse Event|1|||
162065241|NCT02734810|585295413|FG001|Overall Study|Adverse Event|0|||
162065242|NCT02734810|585295412|FG000|Overall Study|Lack of Efficacy|1|||
162065243|NCT02734810|585295413|FG001|Overall Study|Lack of Efficacy|0|||
162065244|NCT02507505|585295414|FG000|Overall Study|Withdrawal by Subject|13|||
162065245|NCT02507505|585295415|FG001|Overall Study|Withdrawal by Subject|11|||
162065246|NCT02507505|585295414|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
162065247|NCT02507505|585295415|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
162065248|NCT02507505|585295414|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
162065249|NCT02507505|585295415|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
162065250|NCT02507505|585295414|FG000|Overall Study|Death before receipt of anesthesia|0|||
162065251|NCT02507505|585295415|FG001|Overall Study|Death before receipt of anesthesia|1|||
162065252|NCT00931762|585295416|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
162065253|NCT00931762|585295416|FG000|Overall Study|Administrative Problems|5|||
162065254|NCT00931762|585295416|FG000|Overall Study|Death|1|||
162065255|NCT00931762|585295416|FG000|Overall Study|Disease Progression|3|||
162065256|NCT00931762|585295416|FG000|Overall Study|Adverse Event (s)|11|||
162065257|NCT00931762|585295416|FG000|Overall Study|Subject withdrew consent|13|||
162065258|NCT03182829|585295417|FG000|Overall Study|Protocol Violation|12|||
162065259|NCT03182829|585295418|FG001|Overall Study|Protocol Violation|12|||
162065260|NCT03182829|585295417|FG000|Overall Study|Other|4|||
162065261|NCT03182829|585295418|FG001|Overall Study|Other|3|||
162065262|NCT02664441|585295419|FG000|Randomization|Withdrawal by Subject|0|||
162065263|NCT02664441|585295420|FG001|Randomization|Withdrawal by Subject|1|||
162065264|NCT02664441|585295419|FG000|36-week Randomized Trial|Adverse Event|2|||
162065265|NCT02664441|585295420|FG001|36-week Randomized Trial|Adverse Event|0|||
162065266|NCT02664441|585295419|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
162065267|NCT02664441|585295420|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
162065268|NCT02664441|585295419|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
162065269|NCT02664441|585295420|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
162065270|NCT02664441|585295419|FG000|18-week Open Label Extension|Adverse Event|1|||
162065271|NCT02664441|585295420|FG001|18-week Open Label Extension|Adverse Event|0|||
162065272|NCT02664441|585295419|FG000|18-week Open Label Extension|Physician Decision|1|||
162065273|NCT02664441|585295420|FG001|18-week Open Label Extension|Physician Decision|0|||
162065274|NCT02664441|585295419|FG000|18-week Open Label Extension|Death|1|||
162065275|NCT02664441|585295420|FG001|18-week Open Label Extension|Death|0|||
162065276|NCT02664441|585295419|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
162065277|NCT02664441|585295420|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
162065278|NCT02335489|585295425|FG000|Overall Study|Sponsor terminated study|4|||
162065279|NCT02335489|585295425|FG000|Overall Study|Lost to Follow-up|1|||
162065280|NCT02335489|585295425|FG000|Overall Study|Withdrawal by Subject|2|||
162065281|NCT02335489|585295425|FG000|Overall Study|Physician Decision|2|||
162065282|NCT02335489|585295425|FG000|Overall Study|Lack of Efficacy|1|||
162065283|NCT02259582|585295426|FG000|Overall Study|Physician Decision|0|||
162065284|NCT02259582|585295427|FG001|Overall Study|Physician Decision|1|||
162065285|NCT02259582|585295428|FG002|Overall Study|Physician Decision|0|||
162065286|NCT02259582|585295426|FG000|Overall Study|Death|0|||
162065287|NCT02259582|585295427|FG001|Overall Study|Death|0|||
162065288|NCT02259582|585295428|FG002|Overall Study|Death|1|||
162065289|NCT02259582|585295426|FG000|Overall Study|Adverse Event|1|||
162065290|NCT02259582|585295427|FG001|Overall Study|Adverse Event|0|||
162065291|NCT02259582|585295428|FG002|Overall Study|Adverse Event|1|||
162065292|NCT02259582|585295426|FG000|Overall Study|Withdrawal by Subject|0|||
162065293|NCT02259582|585295427|FG001|Overall Study|Withdrawal by Subject|0|||
162065294|NCT02259582|585295428|FG002|Overall Study|Withdrawal by Subject|1|||
162065295|NCT02259582|585295426|FG000|Overall Study|Disease progression|14|||
162065296|NCT02259582|585295427|FG001|Overall Study|Disease progression|15|||
162065297|NCT02259582|585295428|FG002|Overall Study|Disease progression|17|||
162065298|NCT02259582|585295426|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
162065299|NCT02259582|585295427|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
162065300|NCT02259582|585295428|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
162065301|NCT00759863|585295431|FG000|Overall Study|Death, moved, or lost contact|20|||
162065302|NCT00759863|585295432|FG001|Overall Study|Death, moved, or lost contact|18|||
162065303|NCT00412854|585295436|FG000|Overall Study|Withdrawn due to adverse events|1|||
162065304|NCT00412854|585295437|FG001|Overall Study|Withdrawn due to adverse events|5|||
162065305|NCT00412854|585295436|FG000|Overall Study|Withdrawn for other reasons|13|||
162065306|NCT00412854|585295437|FG001|Overall Study|Withdrawn for other reasons|11|||
162065307|NCT00503308|585295438|FG000|Overall Study|Protocol Violation|2|||
162065308|NCT00503308|585295439|FG001|Overall Study|Protocol Violation|1|||
162065309|NCT03263442|585295441|FG000|Inpatient Phase|Death|1|||
162065310|NCT03263442|585295442|FG001|Inpatient Phase|Death|0|||
162065311|NCT03263442|585295441|FG000|Inpatient Phase|Withdrawal by Subject|1|||
162065312|NCT03263442|585295442|FG001|Inpatient Phase|Withdrawal by Subject|0|||
162065313|NCT03263442|585295441|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
162065314|NCT03263442|585295442|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
162065315|NCT03263442|585295441|FG000|1-month Follow-Up|Lost to Follow-up|1|||
162065316|NCT03263442|585295442|FG001|1-month Follow-Up|Lost to Follow-up|0|||
162237405|NCT00903682|585921090|FG000|Overall Study|Withdrawal by Subject|5|||
162237406|NCT00903682|585921091|FG001|Overall Study|Withdrawal by Subject|0|||
162237407|NCT00903682|585921090|FG000|Overall Study|Pregnancy|0|||
162237408|NCT00903682|585921091|FG001|Overall Study|Pregnancy|1|||
162237409|NCT00903682|585921090|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
162237410|NCT00903682|585921091|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
162237411|NCT00903682|585921090|FG000|Overall Study|Subject Non-Compliant|1|||
162237412|NCT00903682|585921091|FG001|Overall Study|Subject Non-Compliant|0|||
162237413|NCT00903682|585921090|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
162237414|NCT00903682|585921091|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
162237415|NCT00903682|585921090|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
162237416|NCT00903682|585921091|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
162237417|NCT03866473|585921092|FG000|Phase 1|Death|1|||
162237418|NCT03866473|585921093|FG001|Phase 1|Death|0|||
162237419|NCT03866473|585921092|FG000|Phase 2|Death|0|||
162237420|NCT03866473|585921093|FG001|Phase 2|Death|2|||
162237421|NCT03866473|585921092|FG000|Phase 2|Dropped|1|||
162237422|NCT03866473|585921093|FG001|Phase 2|Dropped|1|||
162237423|NCT03866473|585921092|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
162237424|NCT03866473|585921093|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
162237425|NCT03110185|585921094|FG000|Overall Study|Death|0|||
162237426|NCT03110185|585921095|FG001|Overall Study|Death|1|||
162237427|NCT03110185|585921094|FG000|Overall Study|Withdrawal by Subject|2|||
162237428|NCT03110185|585921095|FG001|Overall Study|Withdrawal by Subject|7|||
162237429|NCT03110185|585921094|FG000|Overall Study|Time Constraints|0|||
162237430|NCT03110185|585921095|FG001|Overall Study|Time Constraints|6|||
162237431|NCT03110185|585921094|FG000|Overall Study|Conflict with care|5|||
162237432|NCT03110185|585921095|FG001|Overall Study|Conflict with care|12|||
162237433|NCT03110185|585921094|FG000|Overall Study|Protocol Violation|1|||
162237434|NCT03110185|585921095|FG001|Overall Study|Protocol Violation|4|||
162237435|NCT03110185|585921094|FG000|Overall Study|MRI Incompatible|2|||
162237436|NCT03110185|585921095|FG001|Overall Study|MRI Incompatible|0|||
162237437|NCT03110185|585921094|FG000|Overall Study|Patient Refusal|0|||
162065317|NCT03263442|585295441|FG000|3-month Follow-Up|Lost to Follow-up|1|||
162065318|NCT03263442|585295442|FG001|3-month Follow-Up|Lost to Follow-up|3|||
162065319|NCT03263442|585295441|FG000|6-month Follow-Up|Lost to Follow-up|2|||
162065320|NCT03263442|585295442|FG001|6-month Follow-Up|Lost to Follow-up|2|||
162065321|NCT03804879|585295443|FG000|Overall Study|Adverse Event|3|||
162065322|NCT03804879|585295444|FG001|Overall Study|Adverse Event|0|||
162065323|NCT03804879|585295443|FG000|Overall Study|Study Terminated By Sponsor|10|||
162065324|NCT03804879|585295444|FG001|Overall Study|Study Terminated By Sponsor|12|||
162065325|NCT03804879|585295443|FG000|Overall Study|Withdrawal by Subject|3|||
162065326|NCT03804879|585295444|FG001|Overall Study|Withdrawal by Subject|1|||
162065327|NCT02436889|585295445|FG000|Overall Study|No improvement in symptoms|1|||
162065328|NCT02436889|585295446|FG001|Overall Study|No improvement in symptoms|0|||
162065329|NCT02436889|585295445|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
162065330|NCT02436889|585295446|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
162065331|NCT01034462|585295447|FG000|Overall Study|Adverse Event|7|||
162065332|NCT01034462|585295448|FG001|Overall Study|Adverse Event|17|||
162065333|NCT01034462|585295447|FG000|Overall Study|Lack of Efficacy|4|||
162065334|NCT01034462|585295448|FG001|Overall Study|Lack of Efficacy|4|||
162065335|NCT01034462|585295447|FG000|Overall Study|Protocol Violation|10|||
162065336|NCT01034462|585295448|FG001|Overall Study|Protocol Violation|7|||
162065337|NCT01034462|585295447|FG000|Overall Study|Withdrawal by Subject|9|||
162065338|NCT01034462|585295448|FG001|Overall Study|Withdrawal by Subject|8|||
162065339|NCT01034462|585295447|FG000|Overall Study|Lost to Follow-up|14|||
162065340|NCT01034462|585295448|FG001|Overall Study|Lost to Follow-up|16|||
162065341|NCT01034462|585295447|FG000|Overall Study|Other reasons|1|||
162065342|NCT01034462|585295448|FG001|Overall Study|Other reasons|2|||
162065343|NCT01594125|585295449|FG000|Overall Study|Withdrawal by Subject|1|||
162065344|NCT01594125|585295450|FG001|Overall Study|Withdrawal by Subject|0|||
162065345|NCT01594125|585295451|FG002|Overall Study|Withdrawal by Subject|0|||
162065346|NCT01594125|585295452|FG003|Overall Study|Withdrawal by Subject|1|||
162065347|NCT01594125|585295453|FG004|Overall Study|Withdrawal by Subject|0|||
162065348|NCT01594125|585295449|FG000|Overall Study|Progressive Disease|3|||
162065349|NCT01594125|585295450|FG001|Overall Study|Progressive Disease|12|||
162065350|NCT01594125|585295451|FG002|Overall Study|Progressive Disease|3|||
162065351|NCT01594125|585295452|FG003|Overall Study|Progressive Disease|3|||
162065352|NCT01594125|585295453|FG004|Overall Study|Progressive Disease|7|||
162065353|NCT00708643|585295454|FG000|Overall Study|Adverse Event|0|||
162065354|NCT00708643|585295455|FG001|Overall Study|Adverse Event|1|||
162065355|NCT03635957|585295458|FG000|Run-In Period|Lost to Follow-up|1|||
162065356|NCT03635957|585295458|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
162065357|NCT01710033|585295459|FG000|Stage 2|Adverse Event|0|||
162065358|NCT01710033|585295460|FG001|Stage 2|Adverse Event|0|||
162065359|NCT01710033|585295461|FG002|Stage 2|Adverse Event|0|||
162065360|NCT01710033|585295462|FG003|Stage 2|Adverse Event|0|||
162065361|NCT01710033|585295463|FG004|Stage 2|Adverse Event|1|||
162065362|NCT01525550|585295465|FG000|Overall Study|Lost to Follow-up|8|||
162065363|NCT01525550|585295466|FG001|Overall Study|Lost to Follow-up|2|||
162065364|NCT01525550|585295465|FG000|Overall Study|Death|19|||
162065365|NCT01525550|585295466|FG001|Overall Study|Death|28|||
162065366|NCT01525550|585295465|FG000|Overall Study|Other|0|||
162065367|NCT01525550|585295466|FG001|Overall Study|Other|4|||
162065368|NCT01525550|585295465|FG000|Overall Study|Sponsor's Decision|30|||
162065369|NCT01525550|585295466|FG001|Overall Study|Sponsor's Decision|11|||
162065370|NCT01525550|585295465|FG000|Overall Study|Withdrawal by Subject|4|||
162065371|NCT01525550|585295466|FG001|Overall Study|Withdrawal by Subject|0|||
162065372|NCT03045887|585295469|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
162065373|NCT03045887|585295470|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162065374|NCT03045887|585295471|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162065375|NCT03045887|585295472|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162065376|NCT03045887|585295473|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162065377|NCT03045887|585295474|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162065378|NCT03045887|585295475|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162065379|NCT03045887|585295476|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162065380|NCT03045887|585295477|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162065381|NCT03045887|585295478|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
162065382|NCT03045887|585295469|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162065383|NCT03045887|585295470|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162065384|NCT03045887|585295471|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162065385|NCT03045887|585295472|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
162065386|NCT03045887|585295473|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162065387|NCT03045887|585295474|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162065388|NCT03045887|585295475|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162065389|NCT03045887|585295476|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162065390|NCT03045887|585295477|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162065391|NCT03045887|585295478|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
162065392|NCT03045887|585295469|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
162065393|NCT03045887|585295470|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
162065394|NCT03045887|585295471|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
162065395|NCT03045887|585295472|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
162065396|NCT03045887|585295473|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
162065397|NCT03045887|585295474|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
162065398|NCT03045887|585295475|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
162065399|NCT03045887|585295476|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
162065400|NCT03045887|585295477|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
162065401|NCT03045887|585295478|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
162065402|NCT03045887|585295469|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162065403|NCT03045887|585295470|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162065404|NCT03045887|585295471|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
162065405|NCT03045887|585295472|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
162065406|NCT03045887|585295473|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162065407|NCT03045887|585295474|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162065408|NCT03045887|585295475|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162065409|NCT03045887|585295476|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162065410|NCT03045887|585295477|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162065411|NCT03045887|585295478|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
162065412|NCT03045887|585295469|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162065413|NCT03045887|585295470|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162065414|NCT03045887|585295471|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162065415|NCT03045887|585295472|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
162065416|NCT03045887|585295473|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162065417|NCT03045887|585295474|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162065418|NCT03045887|585295475|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162065419|NCT03045887|585295476|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162065420|NCT03045887|585295477|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162065421|NCT03045887|585295478|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
162065422|NCT03414424|585295479|FG000|Overall Study|Screened out after consent|0|||
162065423|NCT03414424|585295480|FG001|Overall Study|Screened out after consent|2|||
162065424|NCT03414424|585295479|FG000|Overall Study|Lost to Follow-up|0|||
162065425|NCT03414424|585295480|FG001|Overall Study|Lost to Follow-up|1|||
162065426|NCT01408914|585295481|FG000|Overall Study|Could not complete tx in protocol period|5|||
162065427|NCT01408914|585295482|FG001|Overall Study|Could not complete tx in protocol period|5|||
162065428|NCT01408914|585295483|FG002|Overall Study|Could not complete tx in protocol period|6|||
162065429|NCT01408914|585295481|FG000|Overall Study|Lost to Follow-up|4|||
162065430|NCT01408914|585295482|FG001|Overall Study|Lost to Follow-up|1|||
162065431|NCT01408914|585295483|FG002|Overall Study|Lost to Follow-up|2|||
162065432|NCT01408914|585295481|FG000|Overall Study|Physician Decision|1|||
162065433|NCT01408914|585295482|FG001|Overall Study|Physician Decision|1|||
162065434|NCT01408914|585295483|FG002|Overall Study|Physician Decision|0|||
162065435|NCT01408914|585295481|FG000|Overall Study|Withdrawal by Subject|1|||
162065436|NCT01408914|585295482|FG001|Overall Study|Withdrawal by Subject|0|||
162065437|NCT01408914|585295483|FG002|Overall Study|Withdrawal by Subject|1|||
162065438|NCT01408914|585295481|FG000|Overall Study|Moved out of study jurisdiction|1|||
162065439|NCT01408914|585295482|FG001|Overall Study|Moved out of study jurisdiction|1|||
162065440|NCT01408914|585295483|FG002|Overall Study|Moved out of study jurisdiction|0|||
162065441|NCT01408914|585295481|FG000|Overall Study|Late exclusion|0|||
162065442|NCT01408914|585295482|FG001|Overall Study|Late exclusion|3|||
162065443|NCT01408914|585295483|FG002|Overall Study|Late exclusion|3|||
162065444|NCT01408914|585295481|FG000|Overall Study|Change in local TB/HIV norms|0|||
162065445|NCT01408914|585295482|FG001|Overall Study|Change in local TB/HIV norms|1|||
162065446|NCT01408914|585295483|FG002|Overall Study|Change in local TB/HIV norms|1|||
162065447|NCT01585194|585295484|FG000|Overall Study|Withdrawal by Subject|1|||
162065448|NCT01585194|585295484|FG000|Overall Study|Physician Decision|2|||
162065449|NCT01585194|585295484|FG000|Overall Study|Lack of insurance|1|||
162065450|NCT00993291|585295485|FG000|Overall Study|Withdrawal by Subject|1|||
162065451|NCT04446377|585295487|FG000|Overall Study|Withdrawal by Subject|6|||
162065452|NCT04446377|585295488|FG001|Overall Study|Withdrawal by Subject|1|||
162065453|NCT04446377|585295487|FG000|Overall Study|Physician Decision|1|||
162065454|NCT04446377|585295488|FG001|Overall Study|Physician Decision|1|||
162065455|NCT04446377|585295487|FG000|Overall Study|Lost to Follow-up|0|||
162065456|NCT04446377|585295488|FG001|Overall Study|Lost to Follow-up|2|||
162065457|NCT04446377|585295487|FG000|Overall Study|Not eligible|0|||
162065458|NCT04446377|585295488|FG001|Overall Study|Not eligible|1|||
162065459|NCT01414075|585295493|FG000|Overall Study|Adverse Event|1|||
162065460|NCT01414075|585295494|FG001|Overall Study|Adverse Event|0|||
162065461|NCT01414075|585295495|FG002|Overall Study|Adverse Event|1|||
162237438|NCT03110185|585921095|FG001|Overall Study|Patient Refusal|1|||
162065462|NCT01414075|585295496|FG003|Overall Study|Adverse Event|0|||
162065463|NCT01414075|585295493|FG000|Overall Study|Death|1|||
162065464|NCT01414075|585295494|FG001|Overall Study|Death|0|||
162065465|NCT01414075|585295495|FG002|Overall Study|Death|0|||
162065466|NCT01414075|585295496|FG003|Overall Study|Death|1|||
162065467|NCT01414075|585295493|FG000|Overall Study|Withdrawal by Subject|0|||
162065468|NCT01414075|585295494|FG001|Overall Study|Withdrawal by Subject|0|||
162065469|NCT01414075|585295495|FG002|Overall Study|Withdrawal by Subject|0|||
162065470|NCT01414075|585295496|FG003|Overall Study|Withdrawal by Subject|1|||
162065471|NCT01414075|585295493|FG000|Overall Study|Other than specified|1|||
162065472|NCT01414075|585295494|FG001|Overall Study|Other than specified|0|||
162065473|NCT01414075|585295495|FG002|Overall Study|Other than specified|1|||
162065474|NCT01414075|585295496|FG003|Overall Study|Other than specified|0|||
162065475|NCT04903626|585295498|FG000|Overall Study|Lost to Follow-up|6|||
162065476|NCT04903626|585295498|FG000|Overall Study|Withdrawal by Subject|1|||
162065477|NCT04903626|585295498|FG000|Overall Study|Other, Not Specified|1|||
162065478|NCT06112756|585295501|FG000|Overall Study|Withdrawal by Subject|0|||
162065479|NCT06112756|585295502|FG001|Overall Study|Withdrawal by Subject|2|||
162065480|NCT06112756|585295501|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
162065481|NCT06112756|585295502|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
162065482|NCT06112756|585295501|FG000|Overall Study|Adverse Event|2|||
162065483|NCT06112756|585295502|FG001|Overall Study|Adverse Event|2|||
162065484|NCT03060629|585295503|FG000|Overall Study|Death|4|||
162065485|NCT03060629|585295504|FG001|Overall Study|Death|5|||
162065486|NCT03060629|585295503|FG000|Overall Study|Withdrawal by Subject|50|||
162065487|NCT03060629|585295504|FG001|Overall Study|Withdrawal by Subject|35|||
162065488|NCT03060629|585295503|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
162065489|NCT03060629|585295504|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
162065490|NCT03060629|585295503|FG000|Overall Study|Participant Relocate|15|||
162065491|NCT03060629|585295504|FG001|Overall Study|Participant Relocate|15|||
162065492|NCT03060629|585295503|FG000|Overall Study|Unable to Contact Participant|34|||
162065493|NCT03060629|585295504|FG001|Overall Study|Unable to Contact Participant|23|||
162065494|NCT03060629|585295503|FG000|Overall Study|Investigator Decision|7|||
162065495|NCT03060629|585295504|FG001|Overall Study|Investigator Decision|7|||
162065496|NCT03060629|585295503|FG000|Overall Study|Study Terminated by Sponsor|1100|||
162065497|NCT03060629|585295504|FG001|Overall Study|Study Terminated by Sponsor|1123|||
162065498|NCT03060629|585295503|FG000|Overall Study|Other|4|||
162065499|NCT03060629|585295504|FG001|Overall Study|Other|4|||
162065500|NCT01862874|585295505|FG000|Overall Study|Randomized not treated|1|||
162065501|NCT01862874|585295506|FG001|Overall Study|Randomized not treated|0|||
162065502|NCT01862874|585295505|FG000|Overall Study|Adverse Event|0|||
162065503|NCT01862874|585295506|FG001|Overall Study|Adverse Event|3|||
162065504|NCT01862874|585295505|FG000|Overall Study|Lost to Follow-up|26|||
162065505|NCT01862874|585295506|FG001|Overall Study|Lost to Follow-up|29|||
162065506|NCT01862874|585295505|FG000|Overall Study|Physician Decision|5|||
162065507|NCT01862874|585295506|FG001|Overall Study|Physician Decision|3|||
162065508|NCT01862874|585295505|FG000|Overall Study|Withdrawn by parent/guardian|1|||
162065509|NCT01862874|585295506|FG001|Overall Study|Withdrawn by parent/guardian|1|||
162065510|NCT01862874|585295505|FG000|Overall Study|Withdrawal by Subject|46|||
162065511|NCT01862874|585295506|FG001|Overall Study|Withdrawal by Subject|40|||
162065512|NCT01862874|585295505|FG000|Overall Study|Death|0|||
162065513|NCT01862874|585295506|FG001|Overall Study|Death|1|||
162065514|NCT03681405|585295507|FG000|Overall Study|Found to be ineligible after randomized|1|||
162065515|NCT03681405|585295508|FG001|Overall Study|Found to be ineligible after randomized|0|||
162065516|NCT02056340|585295510|FG000|Overall Study|Lost to Follow-up|5|||
162065517|NCT02056340|585295511|FG001|Overall Study|Lost to Follow-up|5|||
162065518|NCT02056340|585295510|FG000|Overall Study|Withdrawal by Subject|2|||
162065519|NCT02056340|585295511|FG001|Overall Study|Withdrawal by Subject|6|||
162065520|NCT04851314|585295516|FG000|Overall Study|Unable to complete research set-up procedures|0|||
162065521|NCT04851314|585295517|FG001|Overall Study|Unable to complete research set-up procedures|2|||
162065522|NCT04851314|585295516|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
162065523|NCT04851314|585295517|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
162065524|NCT00867009|585295518|FG000|Induction Period|Nonserious Adverse Event|5|||
162065525|NCT00867009|585295518|FG000|Induction Period|Serious Adverse Event|10|||
162065526|NCT00867009|585295518|FG000|Induction Period|Death due to serious adverse event|6|||
162065527|NCT00867009|585295518|FG000|Induction Period|Death due to Study Disease|4|||
162065528|NCT00867009|585295518|FG000|Induction Period|Protocol Violation|1|||
162065529|NCT00867009|585295518|FG000|Induction Period|Withdrawal by Subject|8|||
162065530|NCT00867009|585295518|FG000|Induction Period|Physician Decision|3|||
162065531|NCT00867009|585295518|FG000|Induction Period|Progressive Disease (PD)|25|||
162065532|NCT00867009|585295518|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
162065533|NCT03266094|585295521|FG000|Overall Study|Lost to Follow-up|1|||
162065534|NCT03266094|585295521|FG000|Overall Study|Withdrawal by Subject|1|||
162065535|NCT00883116|585295524|FG000|Overall Study|Adverse event unrelated to study drug|5|||
162065536|NCT00883116|585295525|FG001|Overall Study|Adverse event unrelated to study drug|10|||
162065537|NCT00883116|585295524|FG000|Overall Study|Death|6|||
162065538|NCT00883116|585295525|FG001|Overall Study|Death|2|||
162065539|NCT00883116|585295524|FG000|Overall Study|Disease progression|130|||
162065540|NCT00883116|585295525|FG001|Overall Study|Disease progression|128|||
162065541|NCT00883116|585295524|FG000|Overall Study|Lost to Follow-up|0|||
162065542|NCT00883116|585295525|FG001|Overall Study|Lost to Follow-up|1|||
162065543|NCT00883116|585295524|FG000|Overall Study|Maximum clinical benefit|13|||
162065544|NCT00883116|585295525|FG001|Overall Study|Maximum clinical benefit|46|||
162065545|NCT00883116|585295524|FG000|Overall Study|Not identified|3|||
162065546|NCT00883116|585295525|FG001|Overall Study|Not identified|6|||
162065547|NCT00883116|585295524|FG000|Overall Study|Study drug toxicity|36|||
162065548|NCT00883116|585295525|FG001|Overall Study|Study drug toxicity|16|||
162065549|NCT00883116|585295524|FG000|Overall Study|Withdrawal by Subject|14|||
162065550|NCT00883116|585295525|FG001|Overall Study|Withdrawal by Subject|8|||
162065551|NCT00883116|585295524|FG000|Overall Study|No longer meets study criteria|2|||
162065552|NCT00883116|585295525|FG001|Overall Study|No longer meets study criteria|2|||
162065553|NCT03036072|585295526|FG000|Overall Study|Death|0|||
162065554|NCT03036072|585295527|FG001|Overall Study|Death|1|||
162065555|NCT03036072|585295526|FG000|Overall Study|Withdrawal by Subject|0|||
162065556|NCT03036072|585295527|FG001|Overall Study|Withdrawal by Subject|1|||
162065557|NCT03036072|585295526|FG000|Overall Study|Physician Decision|0|||
162065558|NCT03036072|585295527|FG001|Overall Study|Physician Decision|1|||
162065559|NCT02484729|585295528|FG000|Overall Study|Failure of IntelliCap Error|0|||
162065560|NCT02484729|585295529|FG001|Overall Study|Failure of IntelliCap Error|0|||
162065561|NCT02484729|585295530|FG002|Overall Study|Failure of IntelliCap Error|0|||
162065562|NCT02484729|585295531|FG003|Overall Study|Failure of IntelliCap Error|0|||
162065563|NCT02484729|585295532|FG004|Overall Study|Failure of IntelliCap Error|0|||
162065564|NCT02484729|585295533|FG005|Overall Study|Failure of IntelliCap Error|0|||
162065565|NCT02484729|585295534|FG006|Overall Study|Failure of IntelliCap Error|0|||
162065566|NCT02484729|585295535|FG007|Overall Study|Failure of IntelliCap Error|0|||
162065567|NCT02484729|585295536|FG008|Overall Study|Failure of IntelliCap Error|0|||
162065568|NCT02484729|585295537|FG009|Overall Study|Failure of IntelliCap Error|1|||
162065569|NCT01031069|585295538|FG000|Overall Study|Serious Adverse Event|0|||
162065570|NCT01031069|585295539|FG001|Overall Study|Serious Adverse Event|1|||
162065571|NCT01031069|585295540|FG002|Overall Study|Serious Adverse Event|0|||
162065572|NCT01031069|585295541|FG003|Overall Study|Serious Adverse Event|0|||
162065573|NCT01031069|585295538|FG000|Overall Study|Withdrawal by Subject|2|||
162065574|NCT01031069|585295539|FG001|Overall Study|Withdrawal by Subject|3|||
162065575|NCT01031069|585295540|FG002|Overall Study|Withdrawal by Subject|18|||
162065576|NCT01031069|585295541|FG003|Overall Study|Withdrawal by Subject|18|||
162065577|NCT01031069|585295538|FG000|Overall Study|Migrated/moved from study area|1|||
162065578|NCT01031069|585295539|FG001|Overall Study|Migrated/moved from study area|2|||
162065579|NCT01031069|585295540|FG002|Overall Study|Migrated/moved from study area|1|||
162065580|NCT01031069|585295541|FG003|Overall Study|Migrated/moved from study area|1|||
162065581|NCT01031069|585295538|FG000|Overall Study|Lost to Follow-up|9|||
162065582|NCT01031069|585295539|FG001|Overall Study|Lost to Follow-up|5|||
162065583|NCT01031069|585295540|FG002|Overall Study|Lost to Follow-up|21|||
162065584|NCT01031069|585295541|FG003|Overall Study|Lost to Follow-up|15|||
162065585|NCT01031069|585295538|FG000|Overall Study|Other|0|||
162065586|NCT01031069|585295539|FG001|Overall Study|Other|0|||
162065587|NCT01031069|585295540|FG002|Overall Study|Other|1|||
162065588|NCT01031069|585295541|FG003|Overall Study|Other|0|||
162065589|NCT01317160|585295542|FG000|Overall Study|Incorrect inclusion|1|||
162065590|NCT01317160|585295543|FG001|Overall Study|Incorrect inclusion|1|||
162065591|NCT01317160|585295542|FG000|Overall Study|Lost to Follow-up|3|||
162065592|NCT01317160|585295543|FG001|Overall Study|Lost to Follow-up|3|||
162065593|NCT01317160|585295542|FG000|Overall Study|Withdrawal by Subject|0|||
162065594|NCT01317160|585295543|FG001|Overall Study|Withdrawal by Subject|2|||
162065595|NCT03578367|585295545|FG000|Overall Study|Adverse Event|0|||
162065596|NCT03578367|585295546|FG001|Overall Study|Adverse Event|3|||
162065597|NCT03578367|585295547|FG002|Overall Study|Adverse Event|0|||
162065598|NCT03578367|585295548|FG003|Overall Study|Adverse Event|5|||
162065599|NCT03578367|585295545|FG000|Overall Study|Withdrawal by Subject|2|||
162065600|NCT03578367|585295546|FG001|Overall Study|Withdrawal by Subject|2|||
162065601|NCT03578367|585295547|FG002|Overall Study|Withdrawal by Subject|1|||
162065602|NCT03578367|585295548|FG003|Overall Study|Withdrawal by Subject|3|||
162065603|NCT03578367|585295545|FG000|Overall Study|Physician Decision|0|||
162065604|NCT03578367|585295546|FG001|Overall Study|Physician Decision|0|||
162065605|NCT03578367|585295547|FG002|Overall Study|Physician Decision|14|||
162065606|NCT03578367|585295548|FG003|Overall Study|Physician Decision|0|||
162065607|NCT03578367|585295545|FG000|Overall Study|Death|1|||
162065608|NCT03578367|585295546|FG001|Overall Study|Death|0|||
162065609|NCT03578367|585295547|FG002|Overall Study|Death|0|||
162065610|NCT03578367|585295548|FG003|Overall Study|Death|0|||
162065611|NCT03578367|585295545|FG000|Overall Study|Not treated|0|||
162065612|NCT03578367|585295546|FG001|Overall Study|Not treated|0|||
162065613|NCT03578367|585295547|FG002|Overall Study|Not treated|1|||
162065614|NCT03578367|585295548|FG003|Overall Study|Not treated|0|||
162065615|NCT00670800|585297282|FG000|Overall Study|2 controls were insulin resistant|0|||
162065616|NCT00670800|585297283|FG001|Overall Study|2 controls were insulin resistant|2|||
162065617|NCT00587561|585297284|FG000|Overall Study|Lost to Follow-up|6|||
162065618|NCT00587561|585297285|FG001|Overall Study|Lost to Follow-up|4|||
162065619|NCT05661942|585297286|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
162065620|NCT05661942|585297287|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
162065621|NCT00001596|585297298|FG000|Overall Study|Death|1|||
162065622|NCT00001596|585297299|FG001|Overall Study|Death|0|||
162065623|NCT00001596|585297298|FG000|Overall Study|Withdrawal by Subject|3|||
162065624|NCT00001596|585297299|FG001|Overall Study|Withdrawal by Subject|1|||
162065625|NCT00001596|585297298|FG000|Overall Study|Study Termination|12|||
162065626|NCT00001596|585297299|FG001|Overall Study|Study Termination|9|||
162065627|NCT00001596|585297298|FG000|Overall Study|Adverse Event|1|||
162065628|NCT00001596|585297299|FG001|Overall Study|Adverse Event|0|||
162065629|NCT03274687|585297300|FG000|Overall Study|Protocol Violation|1|||
162065630|NCT03274687|585297301|FG001|Overall Study|Protocol Violation|1|||
162065631|NCT01572909|585297304|FG000|Overall Study|Adverse Event|7|||
162065632|NCT01572909|585297305|FG001|Overall Study|Adverse Event|2|||
162065633|NCT01572909|585297304|FG000|Overall Study|Death|3|||
162065634|NCT01572909|585297305|FG001|Overall Study|Death|1|||
162065635|NCT01572909|585297304|FG000|Overall Study|Lost to Follow-up|8|||
162065636|NCT01572909|585297305|FG001|Overall Study|Lost to Follow-up|7|||
162065637|NCT01572909|585297304|FG000|Overall Study|Physician Decision|1|||
162065638|NCT01572909|585297305|FG001|Overall Study|Physician Decision|1|||
162065639|NCT01572909|585297304|FG000|Overall Study|Technical Issues|1|||
162065640|NCT01572909|585297305|FG001|Overall Study|Technical Issues|0|||
162065641|NCT01572909|585297304|FG000|Overall Study|Withdrawal by Subject|12|||
162065642|NCT01572909|585297305|FG001|Overall Study|Withdrawal by Subject|11|||
162065643|NCT01572909|585297304|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
162065644|NCT01572909|585297305|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
162065645|NCT01199289|585297306|FG000|Overall Study|Ineligibility determined|2|||
162065646|NCT01199289|585297307|FG001|Overall Study|Ineligibility determined|1|||
162065647|NCT01199289|585297308|FG002|Overall Study|Ineligibility determined|0|||
162065648|NCT01199289|585297309|FG003|Overall Study|Ineligibility determined|0|||
162065649|NCT01199289|585297306|FG000|Overall Study|Protocol Violation|1|||
162065650|NCT01199289|585297307|FG001|Overall Study|Protocol Violation|0|||
162065651|NCT01199289|585297308|FG002|Overall Study|Protocol Violation|0|||
162065652|NCT01199289|585297309|FG003|Overall Study|Protocol Violation|1|||
162065653|NCT01199289|585297306|FG000|Overall Study|Noncompliance|1|||
162065654|NCT01199289|585297307|FG001|Overall Study|Noncompliance|0|||
162065655|NCT01199289|585297308|FG002|Overall Study|Noncompliance|2|||
162065656|NCT01199289|585297309|FG003|Overall Study|Noncompliance|0|||
162065657|NCT01199289|585297306|FG000|Overall Study|Adverse Event|0|||
162065658|NCT01199289|585297307|FG001|Overall Study|Adverse Event|3|||
162065659|NCT01199289|585297308|FG002|Overall Study|Adverse Event|1|||
162065660|NCT01199289|585297309|FG003|Overall Study|Adverse Event|4|||
162065661|NCT01199289|585297306|FG000|Overall Study|Full consent withdrawn|2|||
162065662|NCT01199289|585297307|FG001|Overall Study|Full consent withdrawn|2|||
162065663|NCT01199289|585297308|FG002|Overall Study|Full consent withdrawn|2|||
162065664|NCT01199289|585297309|FG003|Overall Study|Full consent withdrawn|3|||
162065665|NCT01199289|585297306|FG000|Overall Study|Administrative decision|0|||
162065666|NCT01199289|585297307|FG001|Overall Study|Administrative decision|0|||
162065667|NCT01199289|585297308|FG002|Overall Study|Administrative decision|0|||
162065668|NCT01199289|585297309|FG003|Overall Study|Administrative decision|1|||
162065669|NCT01199289|585297306|FG000|Overall Study|Lost to Follow-up|0|||
162065670|NCT01199289|585297307|FG001|Overall Study|Lost to Follow-up|0|||
162065671|NCT01199289|585297308|FG002|Overall Study|Lost to Follow-up|0|||
162065672|NCT01199289|585297309|FG003|Overall Study|Lost to Follow-up|1|||
162065673|NCT01199289|585297306|FG000|Overall Study|Protocol-specified criteria|3|||
162065674|NCT01199289|585297307|FG001|Overall Study|Protocol-specified criteria|0|||
162065675|NCT01199289|585297308|FG002|Overall Study|Protocol-specified criteria|0|||
162065676|NCT01199289|585297309|FG003|Overall Study|Protocol-specified criteria|1|||
162065677|NCT01199289|585297306|FG000|Overall Study|Pregnancy|0|||
162065678|NCT01199289|585297307|FG001|Overall Study|Pregnancy|1|||
162065679|NCT01199289|585297308|FG002|Overall Study|Pregnancy|0|||
162065680|NCT01199289|585297309|FG003|Overall Study|Pregnancy|1|||
162065681|NCT02636868|585297310|FG000|Overall Study|Death|0|||
162065682|NCT02636868|585297311|FG001|Overall Study|Death|1|||
162065683|NCT02636868|585297312|FG002|Overall Study|Death|2|||
162065684|NCT00903617|585297318|FG000|Overall Study|Adverse Event|0|||
162065685|NCT00903617|585297319|FG001|Overall Study|Adverse Event|1|||
162065686|NCT00903617|585297320|FG002|Overall Study|Adverse Event|1|||
162065687|NCT00903617|585297321|FG003|Overall Study|Adverse Event|0|||
162065688|NCT00903617|585297318|FG000|Overall Study|Protocol-defined stopping criteria|0|||
162065689|NCT00903617|585297319|FG001|Overall Study|Protocol-defined stopping criteria|2|||
162065690|NCT00903617|585297320|FG002|Overall Study|Protocol-defined stopping criteria|0|||
162065691|NCT00903617|585297321|FG003|Overall Study|Protocol-defined stopping criteria|0|||
162065692|NCT00903617|585297318|FG000|Overall Study|Lost to Follow-up|2|||
162065693|NCT00903617|585297319|FG001|Overall Study|Lost to Follow-up|0|||
162065694|NCT00903617|585297320|FG002|Overall Study|Lost to Follow-up|1|||
162065695|NCT00903617|585297321|FG003|Overall Study|Lost to Follow-up|1|||
162065696|NCT00903617|585297318|FG000|Overall Study|Withdrawal by Subject|1|||
162065697|NCT00903617|585297319|FG001|Overall Study|Withdrawal by Subject|2|||
162065698|NCT00903617|585297320|FG002|Overall Study|Withdrawal by Subject|3|||
162065699|NCT00903617|585297321|FG003|Overall Study|Withdrawal by Subject|0|||
162065700|NCT01104636|585297322|FG000|Overall Study|Lack of Efficacy|43|||
162065701|NCT01104636|585297322|FG000|Overall Study|Lost to Follow-up|24|||
162065702|NCT01104636|585297322|FG000|Overall Study|Withdrawal by Subject|4|||
162065703|NCT01104636|585297322|FG000|Overall Study|Other|43|||
162065704|NCT01104636|585297322|FG000|Overall Study|Study terminated by sponsor|1|||
162065705|NCT01104636|585297322|FG000|Overall Study|Pregnancy|2|||
162065706|NCT01104636|585297322|FG000|Overall Study|Adverse Event|40|||
162065707|NCT01104636|585297322|FG000|Overall Study|Ongoing|21|||
162065708|NCT01706003|585297323|FG000|Overall Study|Withdrawal by Subject|2|||
162065709|NCT01706003|585297324|FG001|Overall Study|Withdrawal by Subject|0|||
162065710|NCT01706003|585297323|FG000|Overall Study|Not scheduled|3|||
162065711|NCT01706003|585297324|FG001|Overall Study|Not scheduled|0|||
162065712|NCT01706003|585297323|FG000|Overall Study|Lost to Follow-up|6|||
162065713|NCT01706003|585297324|FG001|Overall Study|Lost to Follow-up|4|||
162065714|NCT03316131|585297325|FG000|Treatment Period 2|Protocol deviation|1|||
162065715|NCT03316131|585297326|FG001|Treatment Period 2|Protocol deviation|0|||
162065716|NCT05608005|585297328|FG000|Overall Study|Adverse Event|2|||
162065717|NCT05608005|585297329|FG001|Overall Study|Adverse Event|1|||
162065718|NCT05608005|585297330|FG002|Overall Study|Adverse Event|3|||
162065719|NCT05608005|585297328|FG000|Overall Study|Protocol Violation|2|||
162065720|NCT05608005|585297329|FG001|Overall Study|Protocol Violation|3|||
162065721|NCT05608005|585297330|FG002|Overall Study|Protocol Violation|0|||
162065722|NCT05608005|585297328|FG000|Overall Study|Withdrawal by Subject|10|||
162065723|NCT05608005|585297329|FG001|Overall Study|Withdrawal by Subject|12|||
162065724|NCT05608005|585297330|FG002|Overall Study|Withdrawal by Subject|4|||
162065725|NCT05608005|585297328|FG000|Overall Study|Lost to Follow-up|25|||
162065726|NCT05608005|585297329|FG001|Overall Study|Lost to Follow-up|27|||
162065727|NCT05608005|585297330|FG002|Overall Study|Lost to Follow-up|15|||
162065728|NCT05608005|585297328|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
162065729|NCT05608005|585297329|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
162065730|NCT05608005|585297330|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
162065731|NCT03518073|585297331|FG000|Overall Study|Adverse Event|2|||
162065732|NCT03518073|585297332|FG001|Overall Study|Adverse Event|4|||
162065733|NCT03518073|585297333|FG002|Overall Study|Adverse Event|2|||
162065734|NCT03518073|585297331|FG000|Overall Study|Death|2|||
162065735|NCT03518073|585297332|FG001|Overall Study|Death|1|||
162065736|NCT03518073|585297333|FG002|Overall Study|Death|3|||
162065737|NCT03518073|585297331|FG000|Overall Study|Lost to Follow-up|1|||
162065738|NCT03518073|585297332|FG001|Overall Study|Lost to Follow-up|0|||
162065739|NCT03518073|585297333|FG002|Overall Study|Lost to Follow-up|1|||
162065740|NCT03518073|585297331|FG000|Overall Study|Physician Decision|5|||
162065741|NCT03518073|585297332|FG001|Overall Study|Physician Decision|0|||
162065742|NCT03518073|585297333|FG002|Overall Study|Physician Decision|2|||
162065743|NCT03518073|585297331|FG000|Overall Study|Progressive disease|1|||
162065744|NCT03518073|585297332|FG001|Overall Study|Progressive disease|1|||
162065745|NCT03518073|585297333|FG002|Overall Study|Progressive disease|1|||
162065746|NCT03518073|585297331|FG000|Overall Study|Protocol Violation|1|||
162065747|NCT03518073|585297332|FG001|Overall Study|Protocol Violation|0|||
162065748|NCT03518073|585297333|FG002|Overall Study|Protocol Violation|0|||
162065749|NCT03518073|585297331|FG000|Overall Study|Withdrawal by Subject|30|||
162065750|NCT03518073|585297332|FG001|Overall Study|Withdrawal by Subject|34|||
162065751|NCT03518073|585297333|FG002|Overall Study|Withdrawal by Subject|29|||
162065752|NCT03518073|585297331|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
162065753|NCT03518073|585297332|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
162065754|NCT03518073|585297333|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
162065755|NCT03518073|585297331|FG000|Overall Study|Covid-19|1|||
162065756|NCT03518073|585297332|FG001|Overall Study|Covid-19|2|||
162065757|NCT03518073|585297333|FG002|Overall Study|Covid-19|1|||
162065758|NCT03045081|585297334|FG000|Overall Study|Withdrawal by Subject|6|||
162065759|NCT03045081|585297335|FG001|Overall Study|Withdrawal by Subject|11|||
162065760|NCT02169739|585297337|FG000|Overall Study|Lost to Follow-up|0|||
162065761|NCT02169739|585297338|FG001|Overall Study|Lost to Follow-up|4|||
162065762|NCT01244906|585297340|FG000|Overall Study|Death|2|||
162065763|NCT01244906|585297340|FG000|Overall Study|Progression of disease post treatment|6|||
162065764|NCT03480750|585297341|FG000|Overall Study|Withdrawal by Subject|0|||
162065765|NCT03480750|585297342|FG001|Overall Study|Withdrawal by Subject|1|||
162065766|NCT03480750|585297343|FG002|Overall Study|Withdrawal by Subject|0|||
162065767|NCT03480750|585297344|FG003|Overall Study|Withdrawal by Subject|0|||
162065768|NCT03480750|585297345|FG004|Overall Study|Withdrawal by Subject|0|||
162065769|NCT03480750|585297346|FG005|Overall Study|Withdrawal by Subject|0|||
162065770|NCT03480750|585297341|FG000|Overall Study|The interruption in Trientine shippment|0|||
162065771|NCT03480750|585297342|FG001|Overall Study|The interruption in Trientine shippment|0|||
162065772|NCT03480750|585297343|FG002|Overall Study|The interruption in Trientine shippment|0|||
162065773|NCT03480750|585297344|FG003|Overall Study|The interruption in Trientine shippment|0|||
162065774|NCT03480750|585297345|FG004|Overall Study|The interruption in Trientine shippment|0|||
162065775|NCT03480750|585297346|FG005|Overall Study|The interruption in Trientine shippment|1|||
162065776|NCT00723892|585297353|FG000|Overall Study|Participant not tracked|33|||
162065777|NCT00723892|585297354|FG001|Overall Study|Participant not tracked|35|||
162065778|NCT00723892|585297353|FG000|Overall Study|Virological criterion|24|||
162065779|NCT00723892|585297354|FG001|Overall Study|Virological criterion|9|||
162065780|NCT00723892|585297353|FG000|Overall Study|Withdrawal by Subject|6|||
162065781|NCT00723892|585297354|FG001|Overall Study|Withdrawal by Subject|9|||
162065782|NCT00723892|585297353|FG000|Overall Study|End planned|11|||
162065783|NCT00723892|585297354|FG001|Overall Study|End planned|7|||
162065784|NCT00723892|585297353|FG000|Overall Study|Bad tolerance|5|||
162065785|NCT00723892|585297354|FG001|Overall Study|Bad tolerance|5|||
162065786|NCT00723892|585297353|FG000|Overall Study|Multiple reasons|17|||
162065787|NCT00723892|585297354|FG001|Overall Study|Multiple reasons|12|||
162065788|NCT00723892|585297353|FG000|Overall Study|Other|6|||
162065789|NCT00723892|585297354|FG001|Overall Study|Other|3|||
162065790|NCT00723892|585297353|FG000|Overall Study|Study end|1|||
162065791|NCT00723892|585297354|FG001|Overall Study|Study end|3|||
162065792|NCT00723892|585297353|FG000|Overall Study|Weight loss|1|||
162065793|NCT00723892|585297354|FG001|Overall Study|Weight loss|3|||
162065794|NCT00723892|585297353|FG000|Overall Study|Alcohol abuse|0|||
162065795|NCT00723892|585297354|FG001|Overall Study|Alcohol abuse|1|||
162065796|NCT00723892|585297353|FG000|Overall Study|Intercurrent infection|2|||
162065797|NCT00723892|585297354|FG001|Overall Study|Intercurrent infection|0|||
162065798|NCT00723892|585297353|FG000|Overall Study|Drug addiction|1|||
162065799|NCT00723892|585297354|FG001|Overall Study|Drug addiction|0|||
162065800|NCT03683758|585297355|FG000|Overall Study|Non-study commitment conflict|1|||
162065801|NCT03683758|585297356|FG001|Overall Study|Non-study commitment conflict|3|||
162065802|NCT03683758|585297355|FG000|Overall Study|Illness preventing participation|1|||
162065803|NCT03683758|585297356|FG001|Overall Study|Illness preventing participation|0|||
162065804|NCT03683758|585297355|FG000|Overall Study|Adverse Event|1|||
162065805|NCT03683758|585297356|FG001|Overall Study|Adverse Event|0|||
162065806|NCT02411292|585297357|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
162065807|NCT02411292|585297357|FG000|Overall Study|Death|2|||
162065808|NCT02411292|585297357|FG000|Overall Study|Lost to Follow-up|3|||
162065809|NCT00303498|585297358|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
162065810|NCT00303498|585297359|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
162065811|NCT00303498|585297358|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
162065812|NCT00303498|585297359|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
162065813|NCT00303498|585297358|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
162065814|NCT00303498|585297359|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
162065815|NCT00303498|585297358|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
162065816|NCT00303498|585297359|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
162065817|NCT00303498|585297358|FG000|Run-In-Phase (10 Weeks)|Other|4|||
162065818|NCT00303498|585297359|FG001|Run-In-Phase (10 Weeks)|Other|1|||
162065819|NCT00303498|585297358|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
162065820|NCT00303498|585297359|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
162065821|NCT00303498|585297358|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
162065822|NCT00303498|585297359|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
162065823|NCT00303498|585297358|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
162065824|NCT00303498|585297359|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
162065825|NCT00303498|585297358|FG000|Maintenance Phase (24 Weeks)|Death|1|||
162065826|NCT00303498|585297359|FG001|Maintenance Phase (24 Weeks)|Death|0|||
162065827|NCT00303498|585297358|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
162065828|NCT00303498|585297359|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
162065829|NCT00303498|585297358|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
162065830|NCT00303498|585297359|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
162065831|NCT00303498|585297358|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
162065832|NCT00303498|585297359|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
162065833|NCT00303498|585297358|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
162065834|NCT00303498|585297359|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
162065835|NCT00303498|585297358|FG000|Maintenance Phase (24 Weeks)|Other|1|||
162065836|NCT00303498|585297359|FG001|Maintenance Phase (24 Weeks)|Other|0|||
162065837|NCT00303498|585297358|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
162065838|NCT00303498|585297359|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
162065839|NCT00303498|585297358|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
162065840|NCT00303498|585297359|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
162065841|NCT00453921|585297360|FG000|Overall Study|Withdrawal by Subject|1|||
162065842|NCT00453921|585297361|FG001|Overall Study|Withdrawal by Subject|1|||
162065843|NCT00453921|585297362|FG002|Overall Study|Withdrawal by Subject|1|||
162065844|NCT00453921|585297363|FG003|Overall Study|Withdrawal by Subject|1|||
162065845|NCT00453921|585297360|FG000|Overall Study|Lost to Follow-up|0|||
162065846|NCT00453921|585297361|FG001|Overall Study|Lost to Follow-up|0|||
162065847|NCT00453921|585297362|FG002|Overall Study|Lost to Follow-up|1|||
162065848|NCT00453921|585297363|FG003|Overall Study|Lost to Follow-up|0|||
162065849|NCT00174915|585297364|FG000|Overall Study|Lost to Follow-up|19|||
162065850|NCT00174915|585297365|FG001|Overall Study|Lost to Follow-up|17|||
162065851|NCT00174915|585297366|FG002|Overall Study|Lost to Follow-up|9|||
162065852|NCT00174915|585297367|FG003|Overall Study|Lost to Follow-up|17|||
162065853|NCT00174915|585297368|FG004|Overall Study|Lost to Follow-up|10|||
162065854|NCT00174915|585297364|FG000|Overall Study|Adverse Event|18|||
162065855|NCT00174915|585297365|FG001|Overall Study|Adverse Event|16|||
162065856|NCT00174915|585297366|FG002|Overall Study|Adverse Event|11|||
162065857|NCT00174915|585297367|FG003|Overall Study|Adverse Event|18|||
162065858|NCT00174915|585297368|FG004|Overall Study|Adverse Event|5|||
162065859|NCT00174915|585297364|FG000|Overall Study|Personal Reason(s)|16|||
162065860|NCT00174915|585297365|FG001|Overall Study|Personal Reason(s)|16|||
162065861|NCT00174915|585297366|FG002|Overall Study|Personal Reason(s)|9|||
162065862|NCT00174915|585297367|FG003|Overall Study|Personal Reason(s)|9|||
162065863|NCT00174915|585297368|FG004|Overall Study|Personal Reason(s)|9|||
162065864|NCT00174915|585297364|FG000|Overall Study|Other|15|||
162065865|NCT00174915|585297365|FG001|Overall Study|Other|8|||
162065866|NCT00174915|585297366|FG002|Overall Study|Other|6|||
162065867|NCT00174915|585297367|FG003|Overall Study|Other|5|||
162065868|NCT00174915|585297368|FG004|Overall Study|Other|3|||
162065869|NCT00174915|585297364|FG000|Overall Study|Gout Flare|13|||
162065870|NCT00174915|585297365|FG001|Overall Study|Gout Flare|6|||
162065871|NCT00174915|585297366|FG002|Overall Study|Gout Flare|8|||
162065872|NCT00174915|585297367|FG003|Overall Study|Gout Flare|1|||
162065873|NCT00174915|585297368|FG004|Overall Study|Gout Flare|0|||
162065874|NCT00174915|585297364|FG000|Overall Study|Protocol Violation|6|||
162065875|NCT00174915|585297365|FG001|Overall Study|Protocol Violation|3|||
162065876|NCT00174915|585297366|FG002|Overall Study|Protocol Violation|3|||
162065877|NCT00174915|585297367|FG003|Overall Study|Protocol Violation|6|||
162065878|NCT00174915|585297368|FG004|Overall Study|Protocol Violation|3|||
162065879|NCT00174915|585297364|FG000|Overall Study|Therapeutic Failure|6|||
162065880|NCT00174915|585297365|FG001|Overall Study|Therapeutic Failure|3|||
162065881|NCT00174915|585297366|FG002|Overall Study|Therapeutic Failure|2|||
162065882|NCT00174915|585297367|FG003|Overall Study|Therapeutic Failure|1|||
162065883|NCT00174915|585297368|FG004|Overall Study|Therapeutic Failure|3|||
162065884|NCT02232425|585297369|FG000|Overall Study|Lost to Follow-up|6|||
162065885|NCT02232425|585297370|FG001|Overall Study|Lost to Follow-up|2|||
162065886|NCT02232425|585297369|FG000|Overall Study|Adverse Event|2|||
162065887|NCT02232425|585297370|FG001|Overall Study|Adverse Event|0|||
162065888|NCT02232425|585297369|FG000|Overall Study|Withdrawal by Subject|5|||
162065889|NCT02232425|585297370|FG001|Overall Study|Withdrawal by Subject|6|||
162065890|NCT02232425|585297369|FG000|Overall Study|Lack of Efficacy|1|||
162065891|NCT02232425|585297370|FG001|Overall Study|Lack of Efficacy|0|||
162065892|NCT03060447|585297371|FG000|Overall Study|Withdrawal by Subject|2|||
162065893|NCT03060447|585297372|FG001|Overall Study|Withdrawal by Subject|0|||
162065894|NCT01601626|585297375|FG000|Overall Study|Death|1|||
162065895|NCT01601626|585297376|FG001|Overall Study|Death|1|||
162065896|NCT01601626|585297377|FG002|Overall Study|Death|1|||
162065897|NCT01601626|585297375|FG000|Overall Study|Lost to Follow-up|1|||
162065898|NCT01601626|585297376|FG001|Overall Study|Lost to Follow-up|2|||
162065899|NCT01601626|585297377|FG002|Overall Study|Lost to Follow-up|0|||
162065900|NCT01601626|585297375|FG000|Overall Study|Unable to Get to Clinic|0|||
162065901|NCT01601626|585297376|FG001|Overall Study|Unable to Get to Clinic|1|||
162065902|NCT01601626|585297377|FG002|Overall Study|Unable to Get to Clinic|0|||
162065903|NCT01601626|585297375|FG000|Overall Study|Withdrawal by Subject|0|||
162065904|NCT01601626|585297376|FG001|Overall Study|Withdrawal by Subject|1|||
162065905|NCT01601626|585297377|FG002|Overall Study|Withdrawal by Subject|1|||
162065906|NCT01601626|585297375|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
162065907|NCT01601626|585297376|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
162065908|NCT01601626|585297377|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
162065909|NCT00546637|585297378|FG000|Overall Study|Adverse Event|46|||
162065910|NCT00546637|585297379|FG001|Overall Study|Adverse Event|20|||
162065911|NCT00546637|585297378|FG000|Overall Study|Lack of Efficacy|5|||
162065912|NCT00546637|585297379|FG001|Overall Study|Lack of Efficacy|5|||
162065913|NCT00546637|585297378|FG000|Overall Study|Lost to Follow-up|2|||
162065914|NCT00546637|585297379|FG001|Overall Study|Lost to Follow-up|2|||
162065915|NCT00546637|585297378|FG000|Overall Study|Other|10|||
162065916|NCT00546637|585297379|FG001|Overall Study|Other|12|||
162065917|NCT00546637|585297378|FG000|Overall Study|Withdrawal by Subject|7|||
162065918|NCT00546637|585297379|FG001|Overall Study|Withdrawal by Subject|9|||
162065919|NCT00546637|585297378|FG000|Overall Study|Randomized, but not treated|3|||
162065920|NCT00546637|585297379|FG001|Overall Study|Randomized, but not treated|1|||
162065921|NCT04984993|585297383|FG000|Overall Study|Withdrawal by Subject|8|||
162065922|NCT04984993|585297384|FG001|Overall Study|Withdrawal by Subject|2|||
162065923|NCT04984993|585297383|FG000|Overall Study|Lost to Follow-up|2|||
162065924|NCT04984993|585297384|FG001|Overall Study|Lost to Follow-up|2|||
162065925|NCT04984993|585297383|FG000|Overall Study|Both patients moved to another country|4|||
162065926|NCT04984993|585297384|FG001|Overall Study|Both patients moved to another country|0|||
162065927|NCT01110707|585297385|FG000|Overall Study|Protocol Violation|0|||
162065928|NCT01110707|585297386|FG001|Overall Study|Protocol Violation|3|||
162065929|NCT03108027|585297391|FG000|Period 1|Subject/Guardian Decision|0|||
162065930|NCT03108027|585297392|FG001|Period 1|Subject/Guardian Decision|0|||
162065931|NCT03108027|585297393|FG002|Period 1|Subject/Guardian Decision|0|||
162065932|NCT03108027|585297394|FG003|Period 1|Subject/Guardian Decision|2|||
162065933|NCT03108027|585297395|FG004|Period 1|Subject/Guardian Decision|0|||
162065934|NCT03108027|585297396|FG005|Period 1|Subject/Guardian Decision|0|||
162065935|NCT03108027|585297391|FG000|Period 3|Adverse Event|0|||
162065936|NCT03108027|585297392|FG001|Period 3|Adverse Event|1|||
162065937|NCT03108027|585297393|FG002|Period 3|Adverse Event|0|||
162065938|NCT03108027|585297394|FG003|Period 3|Adverse Event|0|||
162065939|NCT03108027|585297395|FG004|Period 3|Adverse Event|0|||
162065940|NCT03108027|585297396|FG005|Period 3|Adverse Event|0|||
162065941|NCT02426892|585297397|FG000|Overall Study|Adverse Event|2|||
162065942|NCT02426892|585297397|FG000|Overall Study|Lack of Efficacy|17|||
162065943|NCT02426892|585297397|FG000|Overall Study|Withdrawal by Subject|1|||
162065944|NCT03178773|585297398|FG000|Overall Study|Death|0|||
162065945|NCT03178773|585297399|FG001|Overall Study|Death|1|||
162065946|NCT03178773|585297398|FG000|Overall Study|Lost to Follow-up|29|||
162065947|NCT03178773|585297399|FG001|Overall Study|Lost to Follow-up|25|||
162065948|NCT03178773|585297398|FG000|Overall Study|Withdrawal by Subject|10|||
162065949|NCT03178773|585297399|FG001|Overall Study|Withdrawal by Subject|14|||
162065950|NCT01382446|585297400|FG000|Overall Study|Withdrawal by Subject|0|||
162065951|NCT01382446|585297401|FG001|Overall Study|Withdrawal by Subject|1|||
162065952|NCT01382446|585297400|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
162065953|NCT01382446|585297401|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
162065954|NCT00003901|585297402|FG000|Overall Study|Adverse Event|1|||
162065955|NCT00003901|585297402|FG000|Overall Study|Withdrawal by Subject|1|||
162065956|NCT00003901|585297402|FG000|Overall Study|Ineligible|6|||
162065957|NCT00003901|585297402|FG000|Overall Study|CT Scan not within protocol requirement|2|||
162065958|NCT00003901|585297402|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
162065959|NCT00003901|585297402|FG000|Overall Study|Medical problems|6|||
162065960|NCT00268996|585297405|FG000|Overall Study|Adverse Event|11|||
162065961|NCT00268996|585297406|FG001|Overall Study|Adverse Event|7|||
162065962|NCT00268996|585297405|FG000|Overall Study|Lost to Follow-up|3|||
162065963|NCT00268996|585297406|FG001|Overall Study|Lost to Follow-up|1|||
162065964|NCT00268996|585297405|FG000|Overall Study|Withdrawal by Subject|5|||
162065965|NCT00268996|585297406|FG001|Overall Study|Withdrawal by Subject|11|||
162065966|NCT00268996|585297405|FG000|Overall Study|Non-compliance|1|||
162065967|NCT00268996|585297406|FG001|Overall Study|Non-compliance|0|||
162065968|NCT00268996|585297405|FG000|Overall Study|Other|1|||
162065969|NCT00268996|585297406|FG001|Overall Study|Other|1|||
162065970|NCT03325075|585297409|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
162065971|NCT03325075|585297410|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
162065972|NCT03325075|585297411|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
162065973|NCT03325075|585297412|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
162065974|NCT03325075|585297409|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
162065975|NCT03325075|585297410|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
162065976|NCT03325075|585297411|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
162065977|NCT03325075|585297412|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
162065978|NCT03325075|585297409|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
162065979|NCT03325075|585297410|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
162065980|NCT03325075|585297411|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
162065981|NCT03325075|585297412|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
162065982|NCT00422591|585297413|FG000|Overall Study|Physician Decision|4|||
162065983|NCT00422591|585297413|FG000|Overall Study|Withdrawal by Subject|2|||
162065984|NCT03241342|585297418|FG000|Overall Study|Adverse Event|5|||
162065985|NCT03241342|585297419|FG001|Overall Study|Adverse Event|8|||
162065986|NCT03241342|585297420|FG002|Overall Study|Adverse Event|4|||
162065987|NCT03241342|585297418|FG000|Overall Study|Lack of Efficacy|0|||
162065988|NCT03241342|585297419|FG001|Overall Study|Lack of Efficacy|0|||
162065989|NCT03241342|585297420|FG002|Overall Study|Lack of Efficacy|1|||
162065990|NCT03241342|585297418|FG000|Overall Study|noncompliance with study drug|2|||
162065991|NCT03241342|585297419|FG001|Overall Study|noncompliance with study drug|1|||
162065992|NCT03241342|585297420|FG002|Overall Study|noncompliance with study drug|1|||
162065993|NCT03241342|585297418|FG000|Overall Study|sponsor decision|0|||
162065994|NCT03241342|585297419|FG001|Overall Study|sponsor decision|1|||
162065995|NCT03241342|585297420|FG002|Overall Study|sponsor decision|2|||
162065996|NCT03241342|585297418|FG000|Overall Study|not reported|15|||
162065997|NCT03241342|585297419|FG001|Overall Study|not reported|21|||
162065998|NCT03241342|585297420|FG002|Overall Study|not reported|19|||
162065999|NCT00541034|585297424|FG000|Overall Study|Non-Compliance|3|||
162066000|NCT03334903|585297425|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
162066001|NCT03334903|585297426|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
162066002|NCT03334903|585297425|FG000|Overall Study|Protocol Violation|1|||
162066003|NCT03334903|585297426|FG001|Overall Study|Protocol Violation|3|||
162066004|NCT03334903|585297425|FG000|Overall Study|Surgery postponed|1|||
162066005|NCT03334903|585297426|FG001|Overall Study|Surgery postponed|0|||
162066006|NCT03334903|585297425|FG000|Overall Study|Adverse Event|1|||
162066007|NCT03334903|585297426|FG001|Overall Study|Adverse Event|1|||
162066008|NCT03334903|585297425|FG000|Overall Study|Withdrawal by Subject|0|||
162066009|NCT03334903|585297426|FG001|Overall Study|Withdrawal by Subject|1|||
162066010|NCT00501293|585298861|FG000|Optimization Period|Enrolled in error|1|||
162066011|NCT00501293|585298862|FG001|Optimization Period|Enrolled in error|0|||
162066012|NCT00501293|585298861|FG000|Maintenance Period|Withdrawal by Subject|14|||
162066013|NCT00501293|585298862|FG001|Maintenance Period|Withdrawal by Subject|13|||
162066014|NCT00501293|585298861|FG000|Maintenance Period|Lost to Follow-up|12|||
162066015|NCT00501293|585298862|FG001|Maintenance Period|Lost to Follow-up|7|||
162066016|NCT00501293|585298861|FG000|Maintenance Period|Adverse Event|6|||
162066017|NCT00501293|585298862|FG001|Maintenance Period|Adverse Event|6|||
162066018|NCT00501293|585298861|FG000|Maintenance Period|Protocol Violation|2|||
162066019|NCT00501293|585298862|FG001|Maintenance Period|Protocol Violation|1|||
162066020|NCT00501293|585298861|FG000|Maintenance Period|Lack of Efficacy|4|||
162066021|NCT00501293|585298862|FG001|Maintenance Period|Lack of Efficacy|1|||
162066022|NCT00501293|585298861|FG000|Maintenance Period|Noncompliant with study medication|5|||
162066023|NCT00501293|585298862|FG001|Maintenance Period|Noncompliant with study medication|0|||
162066024|NCT00501293|585298861|FG000|Maintenance Period|Went into rehabilitation|1|||
162066025|NCT00501293|585298862|FG001|Maintenance Period|Went into rehabilitation|0|||
162066026|NCT00501293|585298861|FG000|Maintenance Period|Would not wear patch|1|||
162066027|NCT00501293|585298862|FG001|Maintenance Period|Would not wear patch|0|||
162066028|NCT00501293|585298861|FG000|Maintenance Period|Application site reaction|1|||
162066029|NCT00501293|585298862|FG001|Maintenance Period|Application site reaction|0|||
162066030|NCT00498602|585298867|FG000|Overall Study|Death|0|||
162066031|NCT00498602|585298868|FG001|Overall Study|Death|0|||
162066032|NCT00498602|585298869|FG002|Overall Study|Death|0|||
162066033|NCT00498602|585298870|FG003|Overall Study|Death|0|||
162066034|NCT00498602|585298871|FG004|Overall Study|Death|0|||
162066035|NCT00498602|585298872|FG005|Overall Study|Death|1|||
162066036|NCT00498602|585298873|FG006|Overall Study|Death|0|||
162066037|NCT00498602|585298867|FG000|Overall Study|Lack of Efficacy|1|||
162066038|NCT00498602|585298868|FG001|Overall Study|Lack of Efficacy|0|||
162066039|NCT00498602|585298869|FG002|Overall Study|Lack of Efficacy|0|||
162066040|NCT00498602|585298870|FG003|Overall Study|Lack of Efficacy|0|||
162066041|NCT00498602|585298871|FG004|Overall Study|Lack of Efficacy|0|||
162066042|NCT00498602|585298872|FG005|Overall Study|Lack of Efficacy|0|||
162066043|NCT00498602|585298873|FG006|Overall Study|Lack of Efficacy|0|||
162066044|NCT00498602|585298867|FG000|Overall Study|Lost to Follow-up|0|||
162066045|NCT00498602|585298868|FG001|Overall Study|Lost to Follow-up|2|||
162066046|NCT00498602|585298869|FG002|Overall Study|Lost to Follow-up|0|||
162066047|NCT00498602|585298870|FG003|Overall Study|Lost to Follow-up|2|||
162066048|NCT00498602|585298871|FG004|Overall Study|Lost to Follow-up|0|||
162066049|NCT00498602|585298872|FG005|Overall Study|Lost to Follow-up|0|||
162066050|NCT00498602|585298873|FG006|Overall Study|Lost to Follow-up|0|||
162066051|NCT00498602|585298867|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
162066052|NCT00498602|585298868|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
162066053|NCT00498602|585298869|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
162066054|NCT00498602|585298870|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
162066055|NCT00498602|585298871|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
162066056|NCT00498602|585298872|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
162066057|NCT00498602|585298873|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
162066058|NCT00498602|585298867|FG000|Overall Study|AE not related to Study Drug|1|||
162066059|NCT00498602|585298868|FG001|Overall Study|AE not related to Study Drug|3|||
162066060|NCT00498602|585298869|FG002|Overall Study|AE not related to Study Drug|0|||
162066061|NCT00498602|585298870|FG003|Overall Study|AE not related to Study Drug|0|||
162066062|NCT00498602|585298871|FG004|Overall Study|AE not related to Study Drug|2|||
162066063|NCT00498602|585298872|FG005|Overall Study|AE not related to Study Drug|2|||
162066064|NCT00498602|585298873|FG006|Overall Study|AE not related to Study Drug|1|||
162066065|NCT00498602|585298867|FG000|Overall Study|Caregiver Request|2|||
162066066|NCT00498602|585298868|FG001|Overall Study|Caregiver Request|2|||
162066067|NCT00498602|585298869|FG002|Overall Study|Caregiver Request|2|||
162066068|NCT00498602|585298870|FG003|Overall Study|Caregiver Request|0|||
162066069|NCT00498602|585298871|FG004|Overall Study|Caregiver Request|1|||
162066070|NCT00498602|585298872|FG005|Overall Study|Caregiver Request|2|||
162066071|NCT00498602|585298873|FG006|Overall Study|Caregiver Request|0|||
162066072|NCT00498602|585298867|FG000|Overall Study|Investigator Request|0|||
162066073|NCT00498602|585298868|FG001|Overall Study|Investigator Request|0|||
162066074|NCT00498602|585298869|FG002|Overall Study|Investigator Request|1|||
162066075|NCT00498602|585298870|FG003|Overall Study|Investigator Request|0|||
162066076|NCT00498602|585298871|FG004|Overall Study|Investigator Request|0|||
162066077|NCT00498602|585298872|FG005|Overall Study|Investigator Request|0|||
162066078|NCT00498602|585298873|FG006|Overall Study|Investigator Request|0|||
162066079|NCT00498602|585298867|FG000|Overall Study|Subject Request|3|||
162066080|NCT00498602|585298868|FG001|Overall Study|Subject Request|0|||
162066081|NCT00498602|585298869|FG002|Overall Study|Subject Request|1|||
162066082|NCT00498602|585298870|FG003|Overall Study|Subject Request|1|||
162066083|NCT00498602|585298871|FG004|Overall Study|Subject Request|1|||
162066084|NCT00498602|585298872|FG005|Overall Study|Subject Request|4|||
162066085|NCT00498602|585298873|FG006|Overall Study|Subject Request|1|||
162066086|NCT00498602|585298867|FG000|Overall Study|Other|2|||
162066087|NCT00498602|585298868|FG001|Overall Study|Other|3|||
162066088|NCT00498602|585298869|FG002|Overall Study|Other|1|||
162066089|NCT00498602|585298870|FG003|Overall Study|Other|0|||
162066090|NCT00498602|585298871|FG004|Overall Study|Other|0|||
162066091|NCT00498602|585298872|FG005|Overall Study|Other|3|||
162066092|NCT00498602|585298873|FG006|Overall Study|Other|0|||
162066093|NCT03318315|585298877|FG000|Overall Study|Lost to Follow-up|3|||
162066094|NCT03318315|585298878|FG001|Overall Study|Lost to Follow-up|2|||
162066095|NCT03318315|585298879|FG002|Overall Study|Lost to Follow-up|1|||
162066096|NCT03318315|585298877|FG000|Overall Study|Protocol Violation|1|||
162066097|NCT03318315|585298878|FG001|Overall Study|Protocol Violation|1|||
162066098|NCT03318315|585298879|FG002|Overall Study|Protocol Violation|1|||
162066099|NCT03318315|585298877|FG000|Overall Study|Withdrawal by Subject|0|||
162066100|NCT03318315|585298878|FG001|Overall Study|Withdrawal by Subject|0|||
162066101|NCT03318315|585298879|FG002|Overall Study|Withdrawal by Subject|2|||
162066102|NCT02617511|585298890|FG000|Overall Study|Withdrawal by Subject|1|||
162066103|NCT02617511|585298891|FG001|Overall Study|Withdrawal by Subject|0|||
162066104|NCT00811473|585298892|FG000|Overall Study|Adverse Event|3|||
162066105|NCT00811473|585298893|FG001|Overall Study|Adverse Event|12|||
162066106|NCT00811473|585298892|FG000|Overall Study|Lost to Follow-up|5|||
162066107|NCT00811473|585298893|FG001|Overall Study|Lost to Follow-up|1|||
162066108|NCT00811473|585298892|FG000|Overall Study|Withdrawal by Subject|2|||
162066109|NCT00811473|585298893|FG001|Overall Study|Withdrawal by Subject|4|||
162066110|NCT00811473|585298892|FG000|Overall Study|Severe non-compliance to protocol|2|||
162066111|NCT00811473|585298893|FG001|Overall Study|Severe non-compliance to protocol|4|||
162066112|NCT00811473|585298892|FG000|Overall Study|Lack of therapeutic response|4|||
162066113|NCT00811473|585298893|FG001|Overall Study|Lack of therapeutic response|1|||
162066114|NCT00811473|585298892|FG000|Overall Study|Condition under investigation worsened|1|||
162066115|NCT00811473|585298893|FG001|Overall Study|Condition under investigation worsened|3|||
162066116|NCT00811473|585298892|FG000|Overall Study|Other 2|4|||
162066117|NCT00811473|585298893|FG001|Overall Study|Other 2|1|||
162066118|NCT00811473|585298892|FG000|Overall Study|Incorrect Enrollment|1|||
162066119|NCT00811473|585298893|FG001|Overall Study|Incorrect Enrollment|0|||
162066120|NCT00811473|585298892|FG000|Overall Study|Safety Reasons|1|||
162066121|NCT00811473|585298893|FG001|Overall Study|Safety Reasons|0|||
162066122|NCT01119131|585298897|FG000|Overall Study|Adverse Event|1|||
162066123|NCT01119131|585298898|FG001|Overall Study|Adverse Event|1|||
162066124|NCT01119131|585298899|FG002|Overall Study|Adverse Event|1|||
162066125|NCT01119131|585298897|FG000|Overall Study|Non-Compliance|1|||
162066126|NCT01119131|585298898|FG001|Overall Study|Non-Compliance|0|||
162066127|NCT01119131|585298899|FG002|Overall Study|Non-Compliance|4|||
162066128|NCT01119131|585298897|FG000|Overall Study|Physician Decision|0|||
162066129|NCT01119131|585298898|FG001|Overall Study|Physician Decision|0|||
162066130|NCT01119131|585298899|FG002|Overall Study|Physician Decision|1|||
162066131|NCT01187043|585298901|FG000|Overall Study|Adverse Event|0|||
162066132|NCT01187043|585298902|FG001|Overall Study|Adverse Event|0|||
162066133|NCT01187043|585298903|FG002|Overall Study|Adverse Event|0|||
162066134|NCT01187043|585298904|FG003|Overall Study|Adverse Event|0|||
162066135|NCT01187043|585298905|FG004|Overall Study|Adverse Event|1|||
162066136|NCT01187043|585298901|FG000|Overall Study|Unable to make scheduled visits|1|||
162066137|NCT01187043|585298902|FG001|Overall Study|Unable to make scheduled visits|0|||
162066138|NCT01187043|585298903|FG002|Overall Study|Unable to make scheduled visits|4|||
162066139|NCT01187043|585298904|FG003|Overall Study|Unable to make scheduled visits|0|||
162066140|NCT01187043|585298905|FG004|Overall Study|Unable to make scheduled visits|1|||
162066141|NCT00573534|585298906|FG000|Overall Study|oppositional behavior|3|||
162066142|NCT03035409|585298907|FG000|Overall Study|Adverse Event|5|||
162066143|NCT03035409|585298907|FG000|Overall Study|Death|2|||
162066144|NCT03035409|585298907|FG000|Overall Study|Withdrawal by Subject|2|||
162066145|NCT03035409|585298907|FG000|Overall Study|Non compliance|4|||
162066146|NCT03035409|585298907|FG000|Overall Study|Patient was jittery|1|||
162066147|NCT03035409|585298907|FG000|Overall Study|Did not like Questionnaire|1|||
162066148|NCT03035409|585298907|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
162066149|NCT03035409|585298907|FG000|Overall Study|Did not like taking drugs|1|||
162066150|NCT00927784|585298910|FG000|Overall Study|Death|1|||
162066151|NCT00927784|585298911|FG001|Overall Study|Death|0|||
162066152|NCT00927784|585298910|FG000|Overall Study|Withdrawal by Subject|1|||
162066153|NCT00927784|585298911|FG001|Overall Study|Withdrawal by Subject|0|||
162066154|NCT02457910|585298912|FG000|Overall Study|Withdrawal by Subject|0|||
162066155|NCT02457910|585298913|FG001|Overall Study|Withdrawal by Subject|0|||
162066156|NCT02457910|585298914|FG002|Overall Study|Withdrawal by Subject|0|||
162066157|NCT02457910|585298915|FG003|Overall Study|Withdrawal by Subject|0|||
162066158|NCT02457910|585298916|FG004|Overall Study|Withdrawal by Subject|0|||
162066159|NCT02457910|585298917|FG005|Overall Study|Withdrawal by Subject|1|||
162066160|NCT02457910|585298912|FG000|Overall Study|Adverse Event|0|||
162066161|NCT02457910|585298913|FG001|Overall Study|Adverse Event|2|||
162066162|NCT02457910|585298914|FG002|Overall Study|Adverse Event|1|||
162066163|NCT02457910|585298915|FG003|Overall Study|Adverse Event|1|||
162066164|NCT02457910|585298916|FG004|Overall Study|Adverse Event|1|||
162066165|NCT02457910|585298917|FG005|Overall Study|Adverse Event|3|||
162066166|NCT02457910|585298912|FG000|Overall Study|Disease progression|3|||
162066167|NCT02457910|585298913|FG001|Overall Study|Disease progression|3|||
162066168|NCT02457910|585298914|FG002|Overall Study|Disease progression|1|||
162066169|NCT02457910|585298915|FG003|Overall Study|Disease progression|1|||
162066170|NCT02457910|585298916|FG004|Overall Study|Disease progression|4|||
162066171|NCT02457910|585298917|FG005|Overall Study|Disease progression|6|||
162066172|NCT02457910|585298912|FG000|Overall Study|Other complicating illness|0|||
162066173|NCT02457910|585298913|FG001|Overall Study|Other complicating illness|0|||
162066174|NCT02457910|585298914|FG002|Overall Study|Other complicating illness|0|||
162066175|NCT02457910|585298915|FG003|Overall Study|Other complicating illness|0|||
162066176|NCT02457910|585298916|FG004|Overall Study|Other complicating illness|0|||
162066177|NCT02457910|585298917|FG005|Overall Study|Other complicating illness|1|||
162066178|NCT02457910|585298912|FG000|Overall Study|Death|0|||
162066179|NCT02457910|585298913|FG001|Overall Study|Death|0|||
162066180|NCT02457910|585298914|FG002|Overall Study|Death|1|||
162066181|NCT02457910|585298915|FG003|Overall Study|Death|0|||
162066182|NCT02457910|585298916|FG004|Overall Study|Death|0|||
162066183|NCT02457910|585298917|FG005|Overall Study|Death|0|||
162066184|NCT00467259|585298918|FG000|Overall Study|Adverse Event|24|||
162066185|NCT00467259|585298919|FG001|Overall Study|Adverse Event|90|||
162066186|NCT00467259|585298918|FG000|Overall Study|Protocol Violation|1|||
162066187|NCT00467259|585298919|FG001|Overall Study|Protocol Violation|7|||
162066188|NCT00467259|585298918|FG000|Overall Study|Withdrawal by Subject|34|||
162066189|NCT00467259|585298919|FG001|Overall Study|Withdrawal by Subject|108|||
162066190|NCT00467259|585298918|FG000|Overall Study|Physician Decision|0|||
162066191|NCT00467259|585298919|FG001|Overall Study|Physician Decision|2|||
162066192|NCT00467259|585298918|FG000|Overall Study|Lost to Follow-up|14|||
162066193|NCT00467259|585298919|FG001|Overall Study|Lost to Follow-up|34|||
162066194|NCT00467259|585298918|FG000|Overall Study|Site Closed|2|||
162066195|NCT00467259|585298919|FG001|Overall Study|Site Closed|1|||
162066196|NCT01339429|585298920|FG000|Overall Study|Withdrawal by Subject|1|||
162066197|NCT01339429|585298920|FG000|Overall Study|Physician Decision|3|||
162066198|NCT00459667|585298923|FG000|Overall Study|Adverse Event|9|||
162066199|NCT00459667|585298924|FG001|Overall Study|Adverse Event|12|||
162066200|NCT00459667|585298925|FG002|Overall Study|Adverse Event|8|||
162066201|NCT00459667|585298923|FG000|Overall Study|Lost to Follow-up|5|||
162066202|NCT00459667|585298924|FG001|Overall Study|Lost to Follow-up|9|||
162066203|NCT00459667|585298925|FG002|Overall Study|Lost to Follow-up|3|||
162066204|NCT00459667|585298923|FG000|Overall Study|Pregnancy|1|||
162066205|NCT00459667|585298924|FG001|Overall Study|Pregnancy|1|||
162066206|NCT00459667|585298925|FG002|Overall Study|Pregnancy|1|||
162066207|NCT00459667|585298923|FG000|Overall Study|Protocol Violation|1|||
162066208|NCT00459667|585298924|FG001|Overall Study|Protocol Violation|0|||
162066209|NCT00459667|585298925|FG002|Overall Study|Protocol Violation|0|||
162066210|NCT00459667|585298923|FG000|Overall Study|Withdrawal by Subject|3|||
162066211|NCT00459667|585298924|FG001|Overall Study|Withdrawal by Subject|5|||
162066212|NCT00459667|585298925|FG002|Overall Study|Withdrawal by Subject|5|||
162066213|NCT00459667|585298923|FG000|Overall Study|Other disease modifying treatment|1|||
162066214|NCT00459667|585298924|FG001|Overall Study|Other disease modifying treatment|2|||
162066215|NCT00459667|585298925|FG002|Overall Study|Other disease modifying treatment|1|||
162066216|NCT00459667|585298923|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
162066217|NCT00459667|585298924|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
162066218|NCT00459667|585298925|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
162066219|NCT00459667|585298923|FG000|Overall Study|No treatment administered|6|||
162066220|NCT00459667|585298924|FG001|Overall Study|No treatment administered|3|||
162066221|NCT00459667|585298925|FG002|Overall Study|No treatment administered|1|||
162066222|NCT01013701|585298926|FG000|Overall Study|study prematurely terminated|7|||
162066223|NCT00556712|585298930|FG000|Overall Study|Adverse Event|7|||
162066224|NCT00556712|585298931|FG001|Overall Study|Adverse Event|19|||
162066225|NCT00556712|585298930|FG000|Overall Study|Death|5|||
162066226|NCT00556712|585298931|FG001|Overall Study|Death|10|||
162066227|NCT00556712|585298930|FG000|Overall Study|Progressive Disease|383|||
162066228|NCT00556712|585298931|FG001|Overall Study|Progressive Disease|320|||
162066229|NCT00556712|585298930|FG000|Overall Study|Protocol Violation|3|||
162066230|NCT00556712|585298931|FG001|Overall Study|Protocol Violation|2|||
162066231|NCT00556712|585298930|FG000|Overall Study|Refused Treatment|17|||
162066232|NCT00556712|585298931|FG001|Overall Study|Refused Treatment|16|||
162066233|NCT00556712|585298930|FG000|Overall Study|Failure to Return|2|||
162066234|NCT00556712|585298931|FG001|Overall Study|Failure to Return|3|||
162066235|NCT00556712|585298930|FG000|Overall Study|Other|2|||
162066236|NCT00556712|585298931|FG001|Overall Study|Other|2|||
162066237|NCT00556712|585298930|FG000|Overall Study|Ongoing at Data Cutoff|32|||
162066238|NCT00556712|585298931|FG001|Overall Study|Ongoing at Data Cutoff|66|||
162066239|NCT01059799|585298933|FG000|Overall Study|Adverse Event|2|||
162066240|NCT01059799|585298934|FG001|Overall Study|Adverse Event|3|||
162066241|NCT01059799|585298933|FG000|Overall Study|Lack of Efficacy|1|||
162066242|NCT01059799|585298934|FG001|Overall Study|Lack of Efficacy|0|||
162066243|NCT01059799|585298933|FG000|Overall Study|Protocol Violation|3|||
162066244|NCT01059799|585298934|FG001|Overall Study|Protocol Violation|2|||
162066245|NCT01059799|585298933|FG000|Overall Study|Withdrawal criteria|13|||
162066246|NCT01059799|585298934|FG001|Overall Study|Withdrawal criteria|2|||
162066247|NCT01059799|585298933|FG000|Overall Study|Other|12|||
162066248|NCT01059799|585298934|FG001|Overall Study|Other|3|||
162066249|NCT01361464|585298935|FG000|Overall Study|Death|1|||
162066250|NCT01361464|585298935|FG000|Overall Study|Withdrawal by Subject|2|||
162066251|NCT00818662|585298940|FG000|Overall Study|Adverse Event|5|||
162066252|NCT00818662|585298941|FG001|Overall Study|Adverse Event|14|||
162066253|NCT00818662|585298942|FG002|Overall Study|Adverse Event|4|||
162066254|NCT00818662|585298943|FG003|Overall Study|Adverse Event|3|||
162066255|NCT00818662|585298940|FG000|Overall Study|Withdrawal by Subject|5|||
162066256|NCT00818662|585298941|FG001|Overall Study|Withdrawal by Subject|4|||
162066257|NCT00818662|585298942|FG002|Overall Study|Withdrawal by Subject|2|||
162066258|NCT00818662|585298943|FG003|Overall Study|Withdrawal by Subject|2|||
162066259|NCT00818662|585298940|FG000|Overall Study|Death|1|||
162066260|NCT00818662|585298941|FG001|Overall Study|Death|3|||
162066261|NCT00818662|585298942|FG002|Overall Study|Death|0|||
162066262|NCT00818662|585298943|FG003|Overall Study|Death|0|||
162066263|NCT00818662|585298940|FG000|Overall Study|Physician Decision|1|||
162066264|NCT00818662|585298941|FG001|Overall Study|Physician Decision|0|||
162066265|NCT00818662|585298942|FG002|Overall Study|Physician Decision|0|||
162066266|NCT00818662|585298943|FG003|Overall Study|Physician Decision|0|||
162066267|NCT00818662|585298940|FG000|Overall Study|Lost to Follow-up|0|||
162066268|NCT00818662|585298941|FG001|Overall Study|Lost to Follow-up|0|||
162066269|NCT00818662|585298942|FG002|Overall Study|Lost to Follow-up|0|||
162066270|NCT00818662|585298943|FG003|Overall Study|Lost to Follow-up|1|||
162066271|NCT00818662|585298940|FG000|Overall Study|Unwilling or Unable to Participate|4|||
162066272|NCT00818662|585298941|FG001|Overall Study|Unwilling or Unable to Participate|6|||
162066273|NCT00818662|585298942|FG002|Overall Study|Unwilling or Unable to Participate|2|||
162066274|NCT00818662|585298943|FG003|Overall Study|Unwilling or Unable to Participate|4|||
162066275|NCT00818662|585298940|FG000|Overall Study|Protocol Violation|1|||
162066276|NCT00818662|585298941|FG001|Overall Study|Protocol Violation|1|||
162066277|NCT00818662|585298942|FG002|Overall Study|Protocol Violation|0|||
162066278|NCT00818662|585298943|FG003|Overall Study|Protocol Violation|0|||
162066279|NCT00818662|585298940|FG000|Overall Study|Requires a Prohibited Medication|1|||
162066280|NCT00818662|585298941|FG001|Overall Study|Requires a Prohibited Medication|0|||
162066281|NCT00818662|585298942|FG002|Overall Study|Requires a Prohibited Medication|0|||
162066282|NCT00818662|585298943|FG003|Overall Study|Requires a Prohibited Medication|0|||
162066283|NCT00818662|585298940|FG000|Overall Study|Safety Risk|1|||
162066284|NCT00818662|585298941|FG001|Overall Study|Safety Risk|1|||
162066285|NCT00818662|585298942|FG002|Overall Study|Safety Risk|0|||
162066286|NCT00818662|585298943|FG003|Overall Study|Safety Risk|1|||
162066287|NCT00818662|585298940|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
162066288|NCT00818662|585298941|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
162066289|NCT00818662|585298942|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
162066290|NCT00818662|585298943|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
162066291|NCT00818662|585298940|FG000|Overall Study|Participant's health declined|0|||
162066292|NCT00818662|585298941|FG001|Overall Study|Participant's health declined|0|||
162066293|NCT00818662|585298942|FG002|Overall Study|Participant's health declined|0|||
162066294|NCT00818662|585298943|FG003|Overall Study|Participant's health declined|1|||
162066295|NCT00818662|585298940|FG000|Overall Study|Caregiver to pursue other treatment|0|||
162066296|NCT00818662|585298941|FG001|Overall Study|Caregiver to pursue other treatment|1|||
162066297|NCT00818662|585298942|FG002|Overall Study|Caregiver to pursue other treatment|0|||
162066298|NCT00818662|585298943|FG003|Overall Study|Caregiver to pursue other treatment|0|||
162066299|NCT00818662|585298940|FG000|Overall Study|Moving out of state|0|||
162066300|NCT00818662|585298941|FG001|Overall Study|Moving out of state|0|||
162066301|NCT00818662|585298942|FG002|Overall Study|Moving out of state|0|||
162066302|NCT00818662|585298943|FG003|Overall Study|Moving out of state|1|||
162066303|NCT00818662|585298940|FG000|Overall Study|Declined move to another study site|1|||
162066304|NCT00818662|585298941|FG001|Overall Study|Declined move to another study site|0|||
162066305|NCT00818662|585298942|FG002|Overall Study|Declined move to another study site|0|||
162066306|NCT00818662|585298943|FG003|Overall Study|Declined move to another study site|0|||
162066307|NCT00818662|585298940|FG000|Overall Study|Change in living situation|0|||
162066308|NCT00818662|585298941|FG001|Overall Study|Change in living situation|0|||
162066309|NCT00818662|585298942|FG002|Overall Study|Change in living situation|0|||
162066310|NCT00818662|585298943|FG003|Overall Study|Change in living situation|1|||
162066311|NCT00818662|585298940|FG000|Overall Study|Study partner decision|0|||
162066312|NCT00818662|585298941|FG001|Overall Study|Study partner decision|0|||
162066313|NCT00818662|585298942|FG002|Overall Study|Study partner decision|0|||
162066314|NCT00818662|585298943|FG003|Overall Study|Study partner decision|1|||
162066315|NCT00818662|585298940|FG000|Overall Study|Admitted to long term nursing care|0|||
162066316|NCT00818662|585298941|FG001|Overall Study|Admitted to long term nursing care|1|||
162066317|NCT00818662|585298942|FG002|Overall Study|Admitted to long term nursing care|0|||
162066318|NCT00818662|585298943|FG003|Overall Study|Admitted to long term nursing care|0|||
162066319|NCT03021265|585298944|FG000|Overall Study|Adverse Event|29|||
162066320|NCT03021265|585298944|FG000|Overall Study|Lack of Efficacy|3|||
162066321|NCT03021265|585298944|FG000|Overall Study|Improved|17|||
162066322|NCT03021265|585298944|FG000|Overall Study|Lost to Follow-up|67|||
162066323|NCT03021265|585298944|FG000|Overall Study|No reason given|2|||
162066324|NCT03021265|585298944|FG000|Overall Study|No visit since the first visit|4|||
162066325|NCT01722071|585298945|FG000|Overall Study|Protocol Violation|1|||
162066326|NCT01722071|585298946|FG001|Overall Study|Protocol Violation|0|||
162066327|NCT01106898|585298947|FG000|Overall Study|Adverse Event|6|||
162066328|NCT01338493|585298948|FG000|Enrolled|Withdrawal by Subject|1|||
162066329|NCT01338493|585298948|FG000|Enrolled|Patient not implanted|4|||
162066330|NCT01338493|585298948|FG000|Discharge|Death|1|||
162066331|NCT01338493|585298948|FG000|Discharge|Missed visit|1|||
162066332|NCT01338493|585298948|FG000|6 Months Follow up|Lost to Follow-up|11|||
162066333|NCT01338493|585298948|FG000|6 Months Follow up|Missed visit|8|||
162066334|NCT01338493|585298948|FG000|12 Months Follow up|Lost to Follow-up|9|||
162066335|NCT01846611|585298949|FG000|Overall Study|Lost to Follow-up|4|||
162066336|NCT01846611|585298950|FG001|Overall Study|Lost to Follow-up|6|||
162066337|NCT01846611|585298949|FG000|Overall Study|Withdrawal by Subject|15|||
162066338|NCT01846611|585298950|FG001|Overall Study|Withdrawal by Subject|19|||
162066339|NCT01846611|585298949|FG000|Overall Study|Other|19|||
162066340|NCT01846611|585298950|FG001|Overall Study|Other|18|||
162066341|NCT00847704|585298951|FG000|Overall Study|Withdrawal by Subject|1|||
162066342|NCT01614067|585298952|FG000|Overall Study|Pregnancy|1|||
162066343|NCT01614067|585298953|FG001|Overall Study|Pregnancy|0|||
162066344|NCT01614067|585298952|FG000|Overall Study|Physician Decision|6|||
162066345|NCT01614067|585298953|FG001|Overall Study|Physician Decision|5|||
162066346|NCT01614067|585298952|FG000|Overall Study|Withdrawal by Subject|0|||
162066347|NCT01614067|585298953|FG001|Overall Study|Withdrawal by Subject|1|||
162066348|NCT01614067|585298952|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
162066349|NCT01614067|585298953|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
162066350|NCT02289079|585298959|FG000|Overall Study|Physician Decision|2|||
162066351|NCT02289079|585298960|FG001|Overall Study|Physician Decision|0|||
162066352|NCT02289079|585298959|FG000|Overall Study|Lost to Follow-up|0|||
162066353|NCT02289079|585298960|FG001|Overall Study|Lost to Follow-up|1|||
162066354|NCT02671422|585298961|FG000|Overall Study|Lost to Follow-up|1|||
162066355|NCT02671422|585298961|FG000|Overall Study|Adverse Event|68|||
162066356|NCT02671422|585298961|FG000|Overall Study|Lack of Efficacy|1|||
162066357|NCT02671422|585298961|FG000|Overall Study|Lost to Follow-up|4|||
162066358|NCT02671422|585298961|FG000|Overall Study|Withdrawal by Subject|7|||
162066359|NCT02671422|585298961|FG000|Overall Study|Progressive Disease|156|||
162066360|NCT02671422|585298961|FG000|Overall Study|Worsening of Disease|4|||
162066361|NCT02671422|585298961|FG000|Overall Study|Sponsor decision|5|||
162066362|NCT02671422|585298961|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
162066363|NCT02671422|585298961|FG000|Overall Study|Not treated with Vargatef®|3|||
162066364|NCT02671422|585298961|FG000|Overall Study|Other not defined above|3|||
162066365|NCT02111850|585298962|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162066366|NCT02111850|585298963|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162066367|NCT02111850|585298964|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162066368|NCT02111850|585298965|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162066369|NCT02111850|585298966|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
162066370|NCT02111850|585298967|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162066371|NCT02111850|585298968|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162066372|NCT02111850|585298969|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162066373|NCT02111850|585298970|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162066374|NCT02111850|585298971|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162066375|NCT02111850|585298972|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
162066376|NCT03061331|585298973|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
162066377|NCT03061331|585298974|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
162066378|NCT02625259|585298975|FG000|First Intervention (Day 1)|Other|0|||
162066379|NCT02625259|585298976|FG001|First Intervention (Day 1)|Other|0|||
162066380|NCT02625259|585298977|FG002|First Intervention (Day 1)|Other|1|||
162066381|NCT02625259|585298978|FG003|First Intervention (Day 1)|Other|0|||
162066382|NCT02625259|585298979|FG004|First Intervention (Day 1)|Other|0|||
162066383|NCT02625259|585298975|FG000|First Intervention (Day 1)|Adverse Event|2|||
162066384|NCT02625259|585298976|FG001|First Intervention (Day 1)|Adverse Event|1|||
162066385|NCT02625259|585298977|FG002|First Intervention (Day 1)|Adverse Event|0|||
162066386|NCT02625259|585298978|FG003|First Intervention (Day 1)|Adverse Event|0|||
162066387|NCT02625259|585298979|FG004|First Intervention (Day 1)|Adverse Event|0|||
162066388|NCT02625259|585298975|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
162066389|NCT02625259|585298976|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
162066390|NCT02625259|585298977|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
162066391|NCT02625259|585298978|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
162066392|NCT02625259|585298979|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
162066393|NCT01980875|585298980|FG000|Overall Study|Withdrew Consent|1|||
162066394|NCT01980875|585298981|FG001|Overall Study|Withdrew Consent|1|||
162066395|NCT01980875|585298982|FG002|Overall Study|Withdrew Consent|1|||
162066396|NCT01980875|585298980|FG000|Overall Study|Study Terminated by Sponsor|7|||
162066397|NCT01980875|585298981|FG001|Overall Study|Study Terminated by Sponsor|24|||
162066398|NCT01980875|585298982|FG002|Overall Study|Study Terminated by Sponsor|22|||
162066399|NCT01980875|585298980|FG000|Overall Study|Lost to Follow-up|0|||
162066400|NCT01980875|585298981|FG001|Overall Study|Lost to Follow-up|0|||
162066401|NCT01980875|585298982|FG002|Overall Study|Lost to Follow-up|1|||
162066402|NCT00513474|585298983|FG000|Overall Study|Death|6|||
162066403|NCT00513474|585298984|FG001|Overall Study|Death|9|||
162066404|NCT00513474|585298983|FG000|Overall Study|Participant Withdrew Consent|1|||
162066405|NCT00513474|585298984|FG001|Overall Study|Participant Withdrew Consent|0|||
162066406|NCT04772755|585298985|FG000|Overall Study|Withdrawal by Subject|1|||
162066407|NCT04772755|585298986|FG001|Overall Study|Withdrawal by Subject|0|||
162066408|NCT04772755|585298985|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
162066409|NCT04772755|585298986|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
162066410|NCT00662363|585298988|FG000|Overall Study|Withdrawal by Subject|6|||
162066411|NCT00662363|585298989|FG001|Overall Study|Withdrawal by Subject|5|||
162066412|NCT00662363|585298988|FG000|Overall Study|Adverse Event|0|||
162066413|NCT00662363|585298989|FG001|Overall Study|Adverse Event|3|||
162066414|NCT00662363|585298988|FG000|Overall Study|Discharged early from rehab|4|||
162066415|NCT00662363|585298989|FG001|Overall Study|Discharged early from rehab|1|||
162066416|NCT00662363|585298988|FG000|Overall Study|Protocol Violation|1|||
162066417|NCT00662363|585298989|FG001|Overall Study|Protocol Violation|1|||
162066418|NCT00195676|585298990|FG000|Period O - Open-label Treatment|Adverse Event|82|||
162066419|NCT00195676|585298990|FG000|Period O - Open-label Treatment|Death|6|||
162066420|NCT00195676|585298990|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
162066421|NCT00195676|585298990|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
162066422|NCT00195676|585298990|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
162066423|NCT00195676|585298990|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
162066424|NCT00195676|585298990|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
162066425|NCT00195676|585298990|FG000|Period O - Open-label Treatment|Other reasons|68|||
162066426|NCT00195676|585298990|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
162066427|NCT00195676|585298990|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
162066428|NCT00195676|585298990|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
162066429|NCT00195676|585298990|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
162066430|NCT00195676|585298990|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
162066431|NCT00195676|585298990|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
162066432|NCT00195676|585298990|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
162066433|NCT00195676|585298990|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
162066434|NCT00195676|585298990|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
162066435|NCT00195676|585298990|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
162066436|NCT00195676|585298990|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
162066437|NCT00195676|585298990|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
162066438|NCT00195676|585298990|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
162066439|NCT01189812|585298991|FG000|Overall Study|Withdrawal by Subject|2|||
162066440|NCT01189812|585298992|FG001|Overall Study|Withdrawal by Subject|3|||
162066441|NCT01189812|585298991|FG000|Overall Study|Adverse Event|1|||
162066442|NCT01189812|585298992|FG001|Overall Study|Adverse Event|0|||
162066443|NCT01189812|585298991|FG000|Overall Study|Out of Window|4|||
162066444|NCT01189812|585298992|FG001|Overall Study|Out of Window|3|||
162066445|NCT01189812|585298991|FG000|Overall Study|Moved out of State|1|||
162066446|NCT01189812|585298992|FG001|Overall Study|Moved out of State|2|||
162066447|NCT01905657|585298993|FG000|Overall Study|Adverse Event|23|||
162066448|NCT01905657|585298994|FG001|Overall Study|Adverse Event|17|||
162066449|NCT01905657|585298995|FG002|Overall Study|Adverse Event|18|||
162066450|NCT01905657|585298993|FG000|Overall Study|Clinical Progression|103|||
162237439|NCT00600886|585921096|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
162066451|NCT01905657|585298994|FG001|Overall Study|Clinical Progression|78|||
162066452|NCT01905657|585298995|FG002|Overall Study|Clinical Progression|59|||
162066453|NCT01905657|585298993|FG000|Overall Study|Death|40|||
162066454|NCT01905657|585298994|FG001|Overall Study|Death|43|||
162066455|NCT01905657|585298995|FG002|Overall Study|Death|47|||
162066456|NCT01905657|585298993|FG000|Overall Study|Excluded Medication|13|||
162066457|NCT01905657|585298994|FG001|Overall Study|Excluded Medication|16|||
162066458|NCT01905657|585298995|FG002|Overall Study|Excluded Medication|9|||
162066459|NCT01905657|585298993|FG000|Overall Study|Lost to Follow-up|1|||
162066460|NCT01905657|585298994|FG001|Overall Study|Lost to Follow-up|2|||
162066461|NCT01905657|585298995|FG002|Overall Study|Lost to Follow-up|1|||
162066462|NCT01905657|585298993|FG000|Overall Study|Physician Decision|5|||
162066463|NCT01905657|585298994|FG001|Overall Study|Physician Decision|8|||
162066464|NCT01905657|585298995|FG002|Overall Study|Physician Decision|12|||
162066465|NCT01905657|585298993|FG000|Overall Study|Protocol Violation|2|||
162066466|NCT01905657|585298994|FG001|Overall Study|Protocol Violation|1|||
162066467|NCT01905657|585298995|FG002|Overall Study|Protocol Violation|1|||
162066468|NCT01905657|585298993|FG000|Overall Study|Screen Failure|0|||
162066469|NCT01905657|585298994|FG001|Overall Study|Screen Failure|1|||
162066470|NCT01905657|585298995|FG002|Overall Study|Screen Failure|0|||
162066471|NCT01905657|585298993|FG000|Overall Study|Withdrawal by Subject|15|||
162066472|NCT01905657|585298994|FG001|Overall Study|Withdrawal by Subject|21|||
162066473|NCT01905657|585298995|FG002|Overall Study|Withdrawal by Subject|53|||
162066474|NCT01905657|585298993|FG000|Overall Study|Sponsor Decision|1|||
162066475|NCT01905657|585298994|FG001|Overall Study|Sponsor Decision|0|||
162066476|NCT01905657|585298995|FG002|Overall Study|Sponsor Decision|0|||
162066477|NCT03761147|585298997|FG000|Overall Study|Withdrawal by Subject|6|||
162066478|NCT03761147|585298998|FG001|Overall Study|Withdrawal by Subject|1|||
162066479|NCT03761147|585298997|FG000|Overall Study|Adverse Event|1|||
162066480|NCT03761147|585298998|FG001|Overall Study|Adverse Event|3|||
162066481|NCT04080297|585298999|FG000|Overall Study|Adverse Event|1|||
162066482|NCT04080297|585299000|FG001|Overall Study|Adverse Event|3|||
162066483|NCT04080297|585298999|FG000|Overall Study|concurrent illness|1|||
162066484|NCT04080297|585299000|FG001|Overall Study|concurrent illness|0|||
162066485|NCT02744391|585299001|FG000|Overall Study|Lost to Follow-up|9|||
162066486|NCT02744391|585299001|FG000|Overall Study|Physician Decision|2|||
162066487|NCT02744391|585299001|FG000|Overall Study|Withdrawal by Subject|3|||
162066488|NCT05838742|585299002|FG000|Overall Study|Adverse Event|2|||
162066489|NCT05838742|585299003|FG001|Overall Study|Adverse Event|0|||
162066490|NCT05838742|585299004|FG002|Overall Study|Adverse Event|1|||
162066491|NCT05838742|585299005|FG003|Overall Study|Adverse Event|0|||
162066492|NCT05838742|585299006|FG004|Overall Study|Adverse Event|1|||
162066493|NCT05838742|585299002|FG000|Overall Study|Lost to Follow-up|1|||
162066494|NCT05838742|585299003|FG001|Overall Study|Lost to Follow-up|1|||
162066495|NCT05838742|585299004|FG002|Overall Study|Lost to Follow-up|1|||
162066496|NCT05838742|585299005|FG003|Overall Study|Lost to Follow-up|0|||
162066497|NCT05838742|585299006|FG004|Overall Study|Lost to Follow-up|0|||
162066498|NCT05838742|585299002|FG000|Overall Study|Physician Decision|0|||
162066499|NCT05838742|585299003|FG001|Overall Study|Physician Decision|0|||
162066500|NCT05838742|585299004|FG002|Overall Study|Physician Decision|0|||
162066501|NCT05838742|585299005|FG003|Overall Study|Physician Decision|0|||
162066502|NCT05838742|585299006|FG004|Overall Study|Physician Decision|1|||
162066503|NCT05838742|585299002|FG000|Overall Study|Withdrawal by Subject|8|||
162066504|NCT05838742|585299003|FG001|Overall Study|Withdrawal by Subject|3|||
162066505|NCT05838742|585299004|FG002|Overall Study|Withdrawal by Subject|3|||
162066506|NCT05838742|585299005|FG003|Overall Study|Withdrawal by Subject|1|||
162066507|NCT05838742|585299006|FG004|Overall Study|Withdrawal by Subject|4|||
162066508|NCT05838742|585299002|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
162066509|NCT05838742|585299003|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
162066510|NCT05838742|585299004|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
162066511|NCT05838742|585299005|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
162066512|NCT05838742|585299006|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
162066513|NCT05838742|585299002|FG000|Overall Study|Lack of Efficacy|0|||
162066514|NCT05838742|585299003|FG001|Overall Study|Lack of Efficacy|0|||
162066515|NCT05838742|585299004|FG002|Overall Study|Lack of Efficacy|0|||
162066516|NCT05838742|585299005|FG003|Overall Study|Lack of Efficacy|1|||
162066517|NCT05838742|585299006|FG004|Overall Study|Lack of Efficacy|0|||
162066518|NCT05838742|585299002|FG000|Overall Study|Randomized, not treated|2|||
162066519|NCT05838742|585299003|FG001|Overall Study|Randomized, not treated|1|||
162066520|NCT05838742|585299004|FG002|Overall Study|Randomized, not treated|0|||
162066521|NCT05838742|585299005|FG003|Overall Study|Randomized, not treated|1|||
162066522|NCT05838742|585299006|FG004|Overall Study|Randomized, not treated|0|||
162066523|NCT02045797|585299007|FG000|Overall Study|Adverse Event|3|||
162066524|NCT02045797|585299008|FG001|Overall Study|Adverse Event|1|||
162066525|NCT02045797|585299009|FG002|Overall Study|Adverse Event|0|||
162066526|NCT02045797|585299007|FG000|Overall Study|Lack of Efficacy|1|||
162066527|NCT02045797|585299008|FG001|Overall Study|Lack of Efficacy|0|||
162066528|NCT02045797|585299009|FG002|Overall Study|Lack of Efficacy|0|||
162066529|NCT02045797|585299007|FG000|Overall Study|Lost to Follow-up|2|||
162066530|NCT02045797|585299008|FG001|Overall Study|Lost to Follow-up|3|||
162066531|NCT02045797|585299009|FG002|Overall Study|Lost to Follow-up|1|||
162066532|NCT02045797|585299007|FG000|Overall Study|Physician Decision|0|||
162066533|NCT02045797|585299008|FG001|Overall Study|Physician Decision|1|||
162066534|NCT02045797|585299009|FG002|Overall Study|Physician Decision|0|||
162066535|NCT02045797|585299007|FG000|Overall Study|Withdrawal by Subject|1|||
162066536|NCT02045797|585299008|FG001|Overall Study|Withdrawal by Subject|2|||
162066537|NCT02045797|585299009|FG002|Overall Study|Withdrawal by Subject|0|||
162066538|NCT03851302|585299010|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
162066539|NCT03851302|585299011|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
162066540|NCT03851302|585299012|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
162066541|NCT03851302|585299013|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
162066542|NCT03851302|585299014|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
162066543|NCT03851302|585299015|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
162066544|NCT03851302|585299010|FG000|Screening (1 Day)|Screened out|0|||
162066545|NCT03851302|585299011|FG001|Screening (1 Day)|Screened out|0|||
162066546|NCT03851302|585299012|FG002|Screening (1 Day)|Screened out|1|||
162066547|NCT03851302|585299013|FG003|Screening (1 Day)|Screened out|1|||
162066548|NCT03851302|585299014|FG004|Screening (1 Day)|Screened out|0|||
162066549|NCT03851302|585299015|FG005|Screening (1 Day)|Screened out|0|||
162066550|NCT03851302|585299010|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
162066551|NCT03851302|585299011|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
162066552|NCT03851302|585299012|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
162066553|NCT03851302|585299013|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
162066554|NCT03851302|585299014|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
162066555|NCT03851302|585299015|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
162066556|NCT04405037|585299016|FG000|Overall Study|Withdrawal by Subject|1|||
162066557|NCT04405037|585299017|FG001|Overall Study|Withdrawal by Subject|0|||
162066558|NCT04405037|585299016|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
162066559|NCT04405037|585299017|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
162122668|NCT01115491|585500297|FG000|Overall Study|Withdrawal by Subject|1|||
162122669|NCT01115491|585500297|FG000|Overall Study|Physician Decision|1|||
162122670|NCT01461993|585500298|FG000|Overall Study|Withdrawal by Subject|60|||
162122671|NCT01461993|585500299|FG001|Overall Study|Withdrawal by Subject|53|||
162122672|NCT01461993|585500300|FG002|Overall Study|Withdrawal by Subject|16|||
162122673|NCT01461993|585500298|FG000|Overall Study|Lost to Follow-up|44|||
162122674|NCT01461993|585500299|FG001|Overall Study|Lost to Follow-up|48|||
162122675|NCT01461993|585500300|FG002|Overall Study|Lost to Follow-up|22|||
162122676|NCT01461993|585500298|FG000|Overall Study|Protocol Violation|10|||
162122677|NCT01461993|585500299|FG001|Overall Study|Protocol Violation|9|||
162122678|NCT01461993|585500300|FG002|Overall Study|Protocol Violation|7|||
162122679|NCT01461993|585500298|FG000|Overall Study|Adverse Event|9|||
162122680|NCT01461993|585500299|FG001|Overall Study|Adverse Event|11|||
162122681|NCT01461993|585500300|FG002|Overall Study|Adverse Event|3|||
162122682|NCT01461993|585500298|FG000|Overall Study|No longer met eligibility criteria|13|||
162122683|NCT01461993|585500299|FG001|Overall Study|No longer met eligibility criteria|18|||
162122684|NCT01461993|585500300|FG002|Overall Study|No longer met eligibility criteria|10|||
162122685|NCT01461993|585500298|FG000|Overall Study|Did not meet entrance criteria|2|||
162122686|NCT01461993|585500299|FG001|Overall Study|Did not meet entrance criteria|3|||
162122687|NCT01461993|585500300|FG002|Overall Study|Did not meet entrance criteria|0|||
162122688|NCT01461993|585500298|FG000|Overall Study|Other|13|||
162122689|NCT01461993|585500299|FG001|Overall Study|Other|15|||
162122690|NCT01461993|585500300|FG002|Overall Study|Other|6|||
162122691|NCT01821898|585500302|FG000|Overall Study|Withdrawal by Subject|2|||
162122692|NCT01821898|585500303|FG001|Overall Study|Withdrawal by Subject|1|||
162122693|NCT01121484|585500304|FG000|Overall Study|Adverse Event|12|||
162122694|NCT01121484|585500305|FG001|Overall Study|Adverse Event|5|||
162122695|NCT01121484|585500304|FG000|Overall Study|Lack of Efficacy|3|||
162122696|NCT01121484|585500305|FG001|Overall Study|Lack of Efficacy|11|||
162122697|NCT01121484|585500304|FG000|Overall Study|Lost to Follow-up|5|||
162122698|NCT01121484|585500305|FG001|Overall Study|Lost to Follow-up|9|||
162122699|NCT01121484|585500304|FG000|Overall Study|Physician Decision|0|||
162122700|NCT01121484|585500305|FG001|Overall Study|Physician Decision|3|||
162122701|NCT01121484|585500304|FG000|Overall Study|Protocol Violation|1|||
162122702|NCT01121484|585500305|FG001|Overall Study|Protocol Violation|0|||
162122703|NCT01121484|585500304|FG000|Overall Study|Withdrawal by Subject|8|||
162122704|NCT01121484|585500305|FG001|Overall Study|Withdrawal by Subject|7|||
162122705|NCT01121484|585500304|FG000|Overall Study|Discontinuation of study by sponsor|0|||
162122706|NCT01121484|585500305|FG001|Overall Study|Discontinuation of study by sponsor|1|||
162122707|NCT01121484|585500304|FG000|Overall Study|Other|3|||
162122708|NCT01121484|585500305|FG001|Overall Study|Other|3|||
162122709|NCT01121484|585500304|FG000|Overall Study|Randomized, not treated|1|||
162122710|NCT01121484|585500305|FG001|Overall Study|Randomized, not treated|4|||
162122711|NCT06390826|585500308|FG000|Overall Study|Never Start Protocol Therapy|1|||
162122712|NCT06390826|585500308|FG000|Overall Study|Adverse Event|1|||
162122713|NCT06390826|585500308|FG000|Overall Study|Disease Progression|8|||
162122714|NCT03915951|585500309|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
162122715|NCT03915951|585500310|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
162122716|NCT03915951|585500309|FG000|Overall Study|Adverse Event|12|||
162122717|NCT03915951|585500310|FG001|Overall Study|Adverse Event|6|||
162122718|NCT03915951|585500309|FG000|Overall Study|Disease progression (radiological)|17|||
162122719|NCT03915951|585500310|FG001|Overall Study|Disease progression (radiological)|15|||
162066560|NCT03220217|585300848|FG000|Overall Study|Withdrawal by Subject|0|||
162066561|NCT03220217|585300849|FG001|Overall Study|Withdrawal by Subject|1|||
162066562|NCT03220217|585300850|FG002|Overall Study|Withdrawal by Subject|0|||
162066563|NCT03220217|585300848|FG000|Overall Study|Subject Missed Procedure|0|||
162066564|NCT03220217|585300849|FG001|Overall Study|Subject Missed Procedure|0|||
162066565|NCT03220217|585300850|FG002|Overall Study|Subject Missed Procedure|1|||
162066566|NCT00312494|585300851|FG000|Overall Study|Randomized; not treated with study drug|9|||
162066567|NCT00312494|585300852|FG001|Overall Study|Randomized; not treated with study drug|10|||
162066568|NCT00312494|585300853|FG002|Overall Study|Randomized; not treated with study drug|5|||
162066569|NCT00312494|585300851|FG000|Overall Study|Adverse Event|33|||
162066570|NCT00312494|585300852|FG001|Overall Study|Adverse Event|15|||
162066571|NCT00312494|585300853|FG002|Overall Study|Adverse Event|11|||
162066572|NCT00312494|585300851|FG000|Overall Study|Lack of Efficacy|4|||
162066573|NCT00312494|585300852|FG001|Overall Study|Lack of Efficacy|6|||
162066574|NCT00312494|585300853|FG002|Overall Study|Lack of Efficacy|8|||
162066575|NCT00312494|585300851|FG000|Overall Study|Laboratory abnormality|1|||
162066576|NCT00312494|585300852|FG001|Overall Study|Laboratory abnormality|0|||
162066577|NCT00312494|585300853|FG002|Overall Study|Laboratory abnormality|0|||
162066578|NCT00312494|585300851|FG000|Overall Study|Lost to Follow-up|8|||
162066579|NCT00312494|585300852|FG001|Overall Study|Lost to Follow-up|8|||
162066580|NCT00312494|585300853|FG002|Overall Study|Lost to Follow-up|8|||
162066581|NCT00312494|585300851|FG000|Overall Study|Withdrawal by Subject|6|||
162066582|NCT00312494|585300852|FG001|Overall Study|Withdrawal by Subject|9|||
162066583|NCT00312494|585300853|FG002|Overall Study|Withdrawal by Subject|10|||
162066584|NCT00312494|585300851|FG000|Overall Study|Other|10|||
162066585|NCT00312494|585300852|FG001|Overall Study|Other|10|||
162066586|NCT00312494|585300853|FG002|Overall Study|Other|1|||
162066587|NCT02355691|585300854|FG000|Overall Study|Loss of Research Personnel|7|||
162066588|NCT02355691|585300855|FG001|Overall Study|Loss of Research Personnel|9|||
162066589|NCT00065507|585300856|FG000|Overall Study|Death|16|||
162066590|NCT00065507|585300857|FG001|Overall Study|Death|17|||
162066591|NCT00065507|585300856|FG000|Overall Study|Adverse Event|4|||
162066592|NCT00065507|585300857|FG001|Overall Study|Adverse Event|3|||
162066593|NCT00065507|585300856|FG000|Overall Study|Lack of Efficacy|0|||
162066594|NCT00065507|585300857|FG001|Overall Study|Lack of Efficacy|6|||
162066595|NCT00065507|585300856|FG000|Overall Study|Poor/Non-compliance|3|||
162066596|NCT00065507|585300857|FG001|Overall Study|Poor/Non-compliance|2|||
162066597|NCT00065507|585300856|FG000|Overall Study|Lost to Follow-up|3|||
162066598|NCT00065507|585300857|FG001|Overall Study|Lost to Follow-up|0|||
162066599|NCT00065507|585300856|FG000|Overall Study|Subject Withdrew Consent|2|||
162066600|NCT00065507|585300857|FG001|Overall Study|Subject Withdrew Consent|1|||
162066601|NCT00065507|585300856|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
162066602|NCT00065507|585300857|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
162066603|NCT00350636|585300858|FG000|Overall Study|Adverse Event|19|||
162066604|NCT00350636|585300859|FG001|Overall Study|Adverse Event|13|||
162066605|NCT00350636|585300858|FG000|Overall Study|Protocol Violation|1|||
162066606|NCT00350636|585300859|FG001|Overall Study|Protocol Violation|3|||
162066607|NCT00350636|585300858|FG000|Overall Study|Withdrawal by Subject|13|||
162066608|NCT00350636|585300859|FG001|Overall Study|Withdrawal by Subject|17|||
162066609|NCT00350636|585300858|FG000|Overall Study|Lost to Follow-up|9|||
162066610|NCT00350636|585300859|FG001|Overall Study|Lost to Follow-up|8|||
162066611|NCT00350636|585300858|FG000|Overall Study|Physician Decision|0|||
162066612|NCT00350636|585300859|FG001|Overall Study|Physician Decision|2|||
162066613|NCT00350636|585300858|FG000|Overall Study|Other|1|||
162066614|NCT00350636|585300859|FG001|Overall Study|Other|2|||
162066615|NCT00100815|585300860|FG000|Overall Study|Progression|24|||
162066616|NCT00100815|585300860|FG000|Overall Study|Adverse Event|18|||
162066617|NCT00100815|585300860|FG000|Overall Study|Death|4|||
162066618|NCT00100815|585300860|FG000|Overall Study|Other|3|||
162066619|NCT01647282|585300866|FG000|Overall Study|Physician Decision|7|||
162066620|NCT01647282|585300867|FG001|Overall Study|Physician Decision|5|||
162066621|NCT01042236|585300868|FG000|Treatment Period 1|Adverse Event|0|||
162066622|NCT01042236|585300869|FG001|Treatment Period 1|Adverse Event|1|||
162066623|NCT01042236|585300870|FG002|Treatment Period 1|Adverse Event|0|||
162066624|NCT01042236|585300871|FG003|Treatment Period 1|Adverse Event|0|||
162066625|NCT01042236|585300872|FG004|Treatment Period 1|Adverse Event|1|||
162066626|NCT01042236|585300873|FG005|Treatment Period 1|Adverse Event|0|||
162066627|NCT01042236|585300868|FG000|Treatment Period 3|Adverse Event|0|||
162066628|NCT01042236|585300869|FG001|Treatment Period 3|Adverse Event|0|||
162066629|NCT01042236|585300870|FG002|Treatment Period 3|Adverse Event|0|||
162066630|NCT01042236|585300871|FG003|Treatment Period 3|Adverse Event|1|||
162066631|NCT01042236|585300872|FG004|Treatment Period 3|Adverse Event|0|||
162066632|NCT01042236|585300873|FG005|Treatment Period 3|Adverse Event|0|||
162066633|NCT01042236|585300868|FG000|Treatment Period 3|Protocol Violation|0|||
162066634|NCT01042236|585300869|FG001|Treatment Period 3|Protocol Violation|0|||
162066635|NCT01042236|585300870|FG002|Treatment Period 3|Protocol Violation|0|||
162066636|NCT01042236|585300871|FG003|Treatment Period 3|Protocol Violation|1|||
162066637|NCT01042236|585300872|FG004|Treatment Period 3|Protocol Violation|0|||
162066638|NCT01042236|585300873|FG005|Treatment Period 3|Protocol Violation|0|||
162066639|NCT01172847|585300876|FG000|Overall Study|Withdrawal by Subject|3|||
162066640|NCT00665353|585300881|FG000|Study Step 1|Adverse Event|1|||
162066641|NCT00665353|585300881|FG000|Study Step 1|Withdrawal by Subject|2|||
162066642|NCT00665353|585300881|FG000|Study Step 2|Lost to Follow-up|2|||
162066643|NCT00665353|585300881|FG000|Study Step 2|Lack of Efficacy|12|||
162066644|NCT01851720|585300882|FG000|Overall Study|Lost to Follow-up|0|||
162066645|NCT01851720|585300883|FG001|Overall Study|Lost to Follow-up|1|||
162066646|NCT02132767|585300888|FG000|Overall Study|Death|3|||
162066647|NCT02132767|585300889|FG001|Overall Study|Death|2|||
162066648|NCT02132767|585300888|FG000|Overall Study|Withdrawal by Subject|10|||
162066649|NCT02132767|585300889|FG001|Overall Study|Withdrawal by Subject|9|||
162066650|NCT02132767|585300888|FG000|Overall Study|Lost to Follow-up|4|||
162066651|NCT02132767|585300889|FG001|Overall Study|Lost to Follow-up|4|||
162066652|NCT00390858|585300890|FG000|Overall Study|Adverse Event|6|||
162066653|NCT00390858|585300891|FG001|Overall Study|Adverse Event|2|||
162066654|NCT00390858|585300890|FG000|Overall Study|Lack of Efficacy|0|||
162066655|NCT00390858|585300891|FG001|Overall Study|Lack of Efficacy|1|||
162066656|NCT00390858|585300890|FG000|Overall Study|Withdrawal by Subject|3|||
162066657|NCT00390858|585300891|FG001|Overall Study|Withdrawal by Subject|4|||
162066658|NCT00937157|585300892|FG000|Overall Study|Pregnancy|1|||
162066659|NCT00937157|585300892|FG000|Overall Study|Lost to Follow-up|3|||
162066660|NCT02865187|585300893|FG000|Overall Study|Lost to Follow-up|12|||
162066661|NCT02865187|585300894|FG001|Overall Study|Lost to Follow-up|7|||
162066662|NCT02865187|585300893|FG000|Overall Study|Adverse Event|1|||
162066663|NCT02865187|585300894|FG001|Overall Study|Adverse Event|0|||
162066664|NCT04267133|585300895|FG000|Overall Study|Withdrawal by Subject|1|||
162066665|NCT04267133|585300895|FG000|Overall Study|Adverse Event|4|||
162066666|NCT02968563|585300896|FG000|Overall Study|Adverse Event|0|||
162066667|NCT02968563|585300897|FG001|Overall Study|Adverse Event|6|||
162066668|NCT02968563|585300896|FG000|Overall Study|Death|1|||
162066669|NCT02968563|585300897|FG001|Overall Study|Death|1|||
162066670|NCT02968563|585300896|FG000|Overall Study|Lost to Follow-up|0|||
162066671|NCT02968563|585300897|FG001|Overall Study|Lost to Follow-up|1|||
162066672|NCT00674661|585300898|FG000|Overall Study|Other|5|||
162066673|NCT00674661|585300899|FG001|Overall Study|Other|7|||
162066674|NCT00674661|585300898|FG000|Overall Study|Lost to Follow-up|6|||
162066675|NCT00674661|585300899|FG001|Overall Study|Lost to Follow-up|3|||
162066676|NCT00674661|585300898|FG000|Overall Study|Withdrawal by Subject|0|||
162066677|NCT00674661|585300899|FG001|Overall Study|Withdrawal by Subject|5|||
162066678|NCT02377466|585300904|FG000|Overall Study|Other: Randomized and not treated|0|||
162066679|NCT02377466|585300905|FG001|Overall Study|Other: Randomized and not treated|2|||
162066680|NCT04210310|585300906|FG000|Overall Study|Lost to Follow-up|32|||
162066681|NCT04210310|585300907|FG001|Overall Study|Lost to Follow-up|1|||
162066682|NCT03566823|585300909|FG000|Overall Study|Lack of Efficacy|0|||
162066683|NCT03566823|585300910|FG001|Overall Study|Lack of Efficacy|1|||
162066684|NCT03566823|585300911|FG002|Overall Study|Lack of Efficacy|0|||
162066685|NCT03566823|585300909|FG000|Overall Study|Withdrawal by Subject|1|||
162066686|NCT03566823|585300910|FG001|Overall Study|Withdrawal by Subject|2|||
162066687|NCT03566823|585300911|FG002|Overall Study|Withdrawal by Subject|0|||
162066688|NCT03566823|585300909|FG000|Overall Study|Adverse Event|1|||
162066689|NCT03566823|585300910|FG001|Overall Study|Adverse Event|0|||
162066690|NCT03566823|585300911|FG002|Overall Study|Adverse Event|2|||
162066691|NCT01909479|585300912|FG000|From Baseline to Week 26|Adverse Event|3|||
162066692|NCT01909479|585300913|FG001|From Baseline to Week 26|Adverse Event|2|||
162066693|NCT01909479|585300912|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
162066694|NCT01909479|585300913|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
162066695|NCT01909479|585300912|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
162066696|NCT01909479|585300913|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
162066697|NCT01909479|585300912|FG000|26 - 52 Weeks|Adverse Event|0|||
162066698|NCT01909479|585300913|FG001|26 - 52 Weeks|Adverse Event|1|||
162066699|NCT01909479|585300912|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
162066700|NCT01909479|585300913|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
162066701|NCT01909479|585300912|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
162066702|NCT01909479|585300913|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
162066703|NCT01909479|585300912|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
162066704|NCT01909479|585300913|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
162066705|NCT01909479|585300912|FG000|52 Weeks to End of Study|Adverse Event|2|||
162066706|NCT01909479|585300913|FG001|52 Weeks to End of Study|Adverse Event|1|||
162066707|NCT01909479|585300912|FG000|52 Weeks to End of Study|Death|0|||
162066708|NCT01909479|585300913|FG001|52 Weeks to End of Study|Death|1|||
162066709|NCT01909479|585300912|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
162066710|NCT01909479|585300913|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
162066711|NCT01909479|585300912|FG000|52 Weeks to End of Study|Protocol Violation|1|||
162066712|NCT01909479|585300913|FG001|52 Weeks to End of Study|Protocol Violation|0|||
162066713|NCT01909479|585300912|FG000|52 Weeks to End of Study|Progressive disease|1|||
162066714|NCT01909479|585300913|FG001|52 Weeks to End of Study|Progressive disease|1|||
162066715|NCT01909479|585300912|FG000|52 Weeks to End of Study|Personal reasons|2|||
162066716|NCT01909479|585300913|FG001|52 Weeks to End of Study|Personal reasons|1|||
162066717|NCT01909479|585300912|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
162066718|NCT01909479|585300913|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
162066719|NCT01909479|585300912|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
162066720|NCT01909479|585300913|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
162066721|NCT01909479|585300912|FG000|52 Weeks to End of Study|Lack of contact|1|||
162066722|NCT01909479|585300913|FG001|52 Weeks to End of Study|Lack of contact|0|||
162066723|NCT01909479|585300912|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
162066724|NCT01909479|585300913|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
162066725|NCT01909479|585300912|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
162066726|NCT01909479|585300913|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
162066727|NCT03557151|585300915|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
162066728|NCT03557151|585300916|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
162066729|NCT03557151|585300915|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
162066730|NCT03557151|585300916|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
162066731|NCT03557151|585300915|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
162066732|NCT03557151|585300916|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
162066733|NCT02810392|585300917|FG000|Overall Study|Subject too ill to continue|1|||
162066734|NCT02810392|585300918|FG001|Overall Study|Subject too ill to continue|0|||
162066735|NCT02810392|585300917|FG000|Overall Study|COVID 19 research restrictions|0|||
162066736|NCT02810392|585300918|FG001|Overall Study|COVID 19 research restrictions|1|||
162066737|NCT06079320|585300921|FG000|Follow up Phase|Lost to Follow-up|1|||
162066738|NCT06079320|585300922|FG001|Follow up Phase|Lost to Follow-up|0|||
162066739|NCT02196558|585300923|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
162066740|NCT02196558|585300924|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
162066741|NCT02196558|585300925|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
162066742|NCT02196558|585300923|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
162066743|NCT02196558|585300924|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
162066744|NCT02196558|585300925|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
162066745|NCT02196558|585300923|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
162066746|NCT02196558|585300924|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
162066747|NCT02196558|585300925|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
162066748|NCT02196558|585300923|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
162066749|NCT02196558|585300924|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
162066750|NCT02196558|585300925|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
162066751|NCT02196558|585300923|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
162066752|NCT02196558|585300924|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
162066753|NCT02196558|585300925|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
162066754|NCT02107482|585300930|FG000|Overall Study|inconveinence|2|||
162066755|NCT02107482|585300930|FG000|Overall Study|Lost to Follow-up|1|||
162066756|NCT02107482|585300930|FG000|Overall Study|Lack of Efficacy|1|||
162066757|NCT03128892|585300931|FG000|Overall Study|Withdrawal by Subject|2|||
162066758|NCT03128892|585300931|FG000|Overall Study|Physician Decision|1|||
162066759|NCT00368355|585300933|FG000|Overall Study|Adverse Event|1|||
162066760|NCT00368355|585300934|FG001|Overall Study|Adverse Event|0|||
162066761|NCT00368355|585300933|FG000|Overall Study|Death|2|||
162066762|NCT00368355|585300934|FG001|Overall Study|Death|4|||
162066763|NCT00368355|585300933|FG000|Overall Study|Relapse|6|||
162066764|NCT00368355|585300934|FG001|Overall Study|Relapse|10|||
162066765|NCT00368355|585300933|FG000|Overall Study|Subsequent transplant|0|||
162066766|NCT00368355|585300934|FG001|Overall Study|Subsequent transplant|3|||
162066767|NCT00368355|585300933|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
162066768|NCT00368355|585300934|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
162066769|NCT03473808|585300943|FG000|Overall Study|Withdrawal by Subject|1|||
162066770|NCT02157298|585300946|FG000|Overall Study|Adverse Event|1|||
162066771|NCT02157298|585300947|FG001|Overall Study|Adverse Event|0|||
162066772|NCT02157298|585300946|FG000|Overall Study|Subject no longer meets study criteria|1|||
162066773|NCT02157298|585300947|FG001|Overall Study|Subject no longer meets study criteria|2|||
162066774|NCT02157298|585300946|FG000|Overall Study|Poor/Non-compliance|1|||
162066775|NCT02157298|585300947|FG001|Overall Study|Poor/Non-compliance|0|||
162066776|NCT02157298|585300946|FG000|Overall Study|Withdrawal by Subject|1|||
162066777|NCT02157298|585300947|FG001|Overall Study|Withdrawal by Subject|0|||
162066778|NCT04059094|585300948|FG000|Overall Study|Adverse Event|0|||
162066779|NCT04059094|585300949|FG001|Overall Study|Adverse Event|0|||
162066780|NCT04059094|585300950|FG002|Overall Study|Adverse Event|0|||
162066781|NCT04059094|585300951|FG003|Overall Study|Adverse Event|0|||
162066782|NCT04059094|585300952|FG004|Overall Study|Adverse Event|1|||
162066783|NCT04059094|585300948|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
162066784|NCT04059094|585300949|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
162066785|NCT04059094|585300950|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
162066786|NCT04059094|585300951|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
162066787|NCT04059094|585300952|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
162066788|NCT01085591|585300953|FG000|Overall Study|Adverse Event|0|||
162066789|NCT01085591|585300954|FG001|Overall Study|Adverse Event|1|||
162066790|NCT01085591|585300955|FG002|Overall Study|Adverse Event|3|||
162066791|NCT01085591|585300953|FG000|Overall Study|Physician Decision|1|||
162066792|NCT01085591|585300954|FG001|Overall Study|Physician Decision|0|||
162066793|NCT01085591|585300955|FG002|Overall Study|Physician Decision|1|||
162066794|NCT01085591|585300953|FG000|Overall Study|Withdrawal by Subject|0|||
162066795|NCT01085591|585300954|FG001|Overall Study|Withdrawal by Subject|2|||
162066796|NCT01085591|585300955|FG002|Overall Study|Withdrawal by Subject|1|||
162066797|NCT01085591|585300953|FG000|Overall Study|Lost to Follow-up|0|||
162066798|NCT01085591|585300954|FG001|Overall Study|Lost to Follow-up|1|||
162066799|NCT01085591|585300955|FG002|Overall Study|Lost to Follow-up|1|||
162066800|NCT01085591|585300953|FG000|Overall Study|Protocol Violation|1|||
162066801|NCT01085591|585300954|FG001|Overall Study|Protocol Violation|1|||
162066802|NCT01085591|585300955|FG002|Overall Study|Protocol Violation|1|||
162066803|NCT01085591|585300953|FG000|Overall Study|Other|0|||
162066804|NCT01085591|585300954|FG001|Overall Study|Other|1|||
162066805|NCT01085591|585300955|FG002|Overall Study|Other|0|||
162066806|NCT01085591|585300953|FG000|Overall Study|Not Properly Consented|1|||
162066807|NCT01085591|585300954|FG001|Overall Study|Not Properly Consented|0|||
162066808|NCT01085591|585300955|FG002|Overall Study|Not Properly Consented|0|||
162066809|NCT03715764|585300960|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
162066810|NCT03715764|585300961|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
162066811|NCT03715764|585300960|FG000|3 Month Follow-up|Lost to Follow-up|2|||
162066812|NCT03715764|585300961|FG001|3 Month Follow-up|Lost to Follow-up|2|||
162066813|NCT03715764|585300960|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
162066814|NCT03715764|585300961|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
162066815|NCT03715764|585300960|FG000|6 Month Follow-up|Lost to Follow-up|3|||
162066816|NCT03715764|585300961|FG001|6 Month Follow-up|Lost to Follow-up|0|||
162066817|NCT03715764|585300960|FG000|12 Month Follow-up|Lost to Follow-up|2|||
162066818|NCT03715764|585300961|FG001|12 Month Follow-up|Lost to Follow-up|3|||
162066819|NCT03715764|585300960|FG000|12 Month Follow-up|Pregnancy|0|||
162066820|NCT03715764|585300961|FG001|12 Month Follow-up|Pregnancy|1|||
162066821|NCT03715764|585300960|FG000|12 Month Follow-up|Surgery|2|||
162066822|NCT03715764|585300961|FG001|12 Month Follow-up|Surgery|0|||
162066823|NCT03715764|585300960|FG000|12 Month Follow-up|Wrong address|1|||
162066824|NCT03715764|585300961|FG001|12 Month Follow-up|Wrong address|0|||
162066825|NCT03715764|585300960|FG000|12 Month Follow-up|No symptoms|1|||
162066826|NCT03715764|585300961|FG001|12 Month Follow-up|No symptoms|0|||
162066827|NCT03715764|585300960|FG000|12 Month Follow-up|Changed primary care centre|0|||
162066828|NCT03715764|585300961|FG001|12 Month Follow-up|Changed primary care centre|1|||
162066829|NCT05119569|585300965|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
162066830|NCT05119569|585300966|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
162066831|NCT05119569|585300967|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
162066832|NCT05119569|585300968|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
162066833|NCT05119569|585300965|FG000|Double Blind Treatment Phase|Adverse Event|6|||
162066834|NCT05119569|585300966|FG001|Double Blind Treatment Phase|Adverse Event|0|||
162066835|NCT05119569|585300967|FG002|Double Blind Treatment Phase|Adverse Event|0|||
162066836|NCT05119569|585300968|FG003|Double Blind Treatment Phase|Adverse Event|0|||
162066837|NCT05119569|585300965|FG000|Open Label Extension Phase|Ongoing in the study|0|||
162066838|NCT05119569|585300966|FG001|Open Label Extension Phase|Ongoing in the study|0|||
162066839|NCT05119569|585300967|FG002|Open Label Extension Phase|Ongoing in the study|65|||
162066840|NCT05119569|585300968|FG003|Open Label Extension Phase|Ongoing in the study|34|||
162066841|NCT02623439|585300971|FG000|Overall Study|Withdrawal by Subject|1|||
162066842|NCT02623439|585300971|FG000|Overall Study|Screen Failure|1|||
162066843|NCT02200445|585300975|FG000|Overall Study|Lack of Efficacy|1|||
162066844|NCT02200445|585300976|FG001|Overall Study|Lack of Efficacy|2|||
162066845|NCT02200445|585300977|FG002|Overall Study|Lack of Efficacy|2|||
162066846|NCT02200445|585300975|FG000|Overall Study|Adverse Event|0|||
162066847|NCT02200445|585300976|FG001|Overall Study|Adverse Event|2|||
162066848|NCT02200445|585300977|FG002|Overall Study|Adverse Event|0|||
162066849|NCT04484142|585300978|FG000|Overall Study|Adverse Event|13|||
162066850|NCT04484142|585300978|FG000|Overall Study|Progressive Disease|87|||
162066851|NCT04484142|585300978|FG000|Overall Study|Clinical Progression|10|||
162066852|NCT04484142|585300978|FG000|Overall Study|Withdrawal by Subject|6|||
162066853|NCT04484142|585300978|FG000|Overall Study|Physician Decision|1|||
162066854|NCT03700671|585300979|FG000|Overall Study|Lack of Efficacy|1|||
162066855|NCT03700671|585300980|FG001|Overall Study|Lack of Efficacy|2|||
162066856|NCT05371509|585300981|FG000|Overall Study|Physician Decision|1|||
162066857|NCT05371509|585300982|FG001|Overall Study|Physician Decision|0|||
162066858|NCT04434092|585300989|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
162066859|NCT04434092|585300990|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
162066860|NCT04434092|585300991|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
162066861|NCT04434092|585300989|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
162066862|NCT04434092|585300990|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
162066863|NCT04434092|585300991|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
162066864|NCT04434092|585300989|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
162066865|NCT04434092|585300990|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
162066866|NCT04434092|585300991|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
162066867|NCT04434092|585300989|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
162066868|NCT04434092|585300990|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
162066869|NCT04434092|585300991|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
162066870|NCT04434092|585300989|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
162066871|NCT04434092|585300990|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
162066872|NCT04434092|585300991|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
162066873|NCT04434092|585300989|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
162066874|NCT04434092|585300990|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
162066875|NCT04434092|585300991|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
162066876|NCT04434092|585300989|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
162066877|NCT04434092|585300990|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
162066878|NCT04434092|585300991|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
162066879|NCT02554812|585300992|FG000|Overall Study|Adverse Event|2|||
162066880|NCT02554812|585300993|FG001|Overall Study|Adverse Event|5|||
162066881|NCT02554812|585300994|FG002|Overall Study|Adverse Event|3|||
162066882|NCT02554812|585300995|FG003|Overall Study|Adverse Event|0|||
162066883|NCT02554812|585300996|FG004|Overall Study|Adverse Event|5|||
162066884|NCT02554812|585300997|FG005|Overall Study|Adverse Event|0|||
162066885|NCT02554812|585300998|FG006|Overall Study|Adverse Event|1|||
162066886|NCT02554812|585300999|FG007|Overall Study|Adverse Event|6|||
162066887|NCT02554812|585301000|FG008|Overall Study|Adverse Event|2|||
162066888|NCT02554812|585301001|FG009|Overall Study|Adverse Event|2|||
162066889|NCT02554812|585301002|FG010|Overall Study|Adverse Event|1|||
162066890|NCT02554812|585301003|FG011|Overall Study|Adverse Event|2|||
162066891|NCT02554812|585301004|FG012|Overall Study|Adverse Event|0|||
162066892|NCT02554812|585301005|FG013|Overall Study|Adverse Event|3|||
162066893|NCT02554812|585301006|FG014|Overall Study|Adverse Event|2|||
162066894|NCT02554812|585301007|FG015|Overall Study|Adverse Event|1|||
162066895|NCT02554812|585301008|FG016|Overall Study|Adverse Event|0|||
162066896|NCT02554812|585301009|FG017|Overall Study|Adverse Event|1|||
162066897|NCT02554812|585301010|FG018|Overall Study|Adverse Event|0|||
162066898|NCT02554812|585301011|FG019|Overall Study|Adverse Event|0|||
162066899|NCT02554812|585301012|FG020|Overall Study|Adverse Event|0|||
162066900|NCT02554812|585301013|FG021|Overall Study|Adverse Event|2|||
162066901|NCT02554812|585301014|FG022|Overall Study|Adverse Event|1|||
162066902|NCT02554812|585301015|FG023|Overall Study|Adverse Event|1|||
162066903|NCT02554812|585301016|FG024|Overall Study|Adverse Event|1|||
162066904|NCT02554812|585301017|FG025|Overall Study|Adverse Event|2|||
162066905|NCT02554812|585301018|FG026|Overall Study|Adverse Event|1|||
162066906|NCT02554812|585300992|FG000|Overall Study|Death|1|||
162066907|NCT02554812|585300993|FG001|Overall Study|Death|2|||
162066908|NCT02554812|585300994|FG002|Overall Study|Death|2|||
162066909|NCT02554812|585300995|FG003|Overall Study|Death|2|||
162066910|NCT02554812|585300996|FG004|Overall Study|Death|0|||
162066911|NCT02554812|585300997|FG005|Overall Study|Death|1|||
162066912|NCT02554812|585300998|FG006|Overall Study|Death|1|||
162066913|NCT02554812|585300999|FG007|Overall Study|Death|1|||
162066914|NCT02554812|585301000|FG008|Overall Study|Death|0|||
162066915|NCT02554812|585301001|FG009|Overall Study|Death|0|||
162066916|NCT02554812|585301002|FG010|Overall Study|Death|0|||
162066917|NCT02554812|585301003|FG011|Overall Study|Death|0|||
162066918|NCT02554812|585301004|FG012|Overall Study|Death|0|||
162066919|NCT02554812|585301005|FG013|Overall Study|Death|0|||
162066920|NCT02554812|585301006|FG014|Overall Study|Death|1|||
162066921|NCT02554812|585301007|FG015|Overall Study|Death|1|||
162066922|NCT02554812|585301008|FG016|Overall Study|Death|1|||
162066923|NCT02554812|585301009|FG017|Overall Study|Death|0|||
162066924|NCT02554812|585301010|FG018|Overall Study|Death|1|||
162066925|NCT02554812|585301011|FG019|Overall Study|Death|2|||
162066926|NCT02554812|585301012|FG020|Overall Study|Death|0|||
162066927|NCT02554812|585301013|FG021|Overall Study|Death|1|||
162066928|NCT02554812|585301014|FG022|Overall Study|Death|1|||
162066929|NCT02554812|585301015|FG023|Overall Study|Death|0|||
162066930|NCT02554812|585301016|FG024|Overall Study|Death|0|||
162066931|NCT02554812|585301017|FG025|Overall Study|Death|0|||
162066932|NCT02554812|585301018|FG026|Overall Study|Death|0|||
162066933|NCT02554812|585300992|FG000|Overall Study|Lost to Follow-up|0|||
162066934|NCT02554812|585300993|FG001|Overall Study|Lost to Follow-up|1|||
162066935|NCT02554812|585300994|FG002|Overall Study|Lost to Follow-up|0|||
162066936|NCT02554812|585300995|FG003|Overall Study|Lost to Follow-up|0|||
162066937|NCT02554812|585300996|FG004|Overall Study|Lost to Follow-up|0|||
162066938|NCT02554812|585300997|FG005|Overall Study|Lost to Follow-up|0|||
162066939|NCT02554812|585300998|FG006|Overall Study|Lost to Follow-up|0|||
162066940|NCT02554812|585300999|FG007|Overall Study|Lost to Follow-up|0|||
162066941|NCT02554812|585301000|FG008|Overall Study|Lost to Follow-up|0|||
162066942|NCT02554812|585301001|FG009|Overall Study|Lost to Follow-up|0|||
162066943|NCT02554812|585301002|FG010|Overall Study|Lost to Follow-up|0|||
162066944|NCT02554812|585301003|FG011|Overall Study|Lost to Follow-up|0|||
162066945|NCT02554812|585301004|FG012|Overall Study|Lost to Follow-up|0|||
162066946|NCT02554812|585301005|FG013|Overall Study|Lost to Follow-up|0|||
162066947|NCT02554812|585301006|FG014|Overall Study|Lost to Follow-up|0|||
162066948|NCT02554812|585301007|FG015|Overall Study|Lost to Follow-up|0|||
162066949|NCT02554812|585301008|FG016|Overall Study|Lost to Follow-up|0|||
162066950|NCT02554812|585301009|FG017|Overall Study|Lost to Follow-up|0|||
162066951|NCT02554812|585301010|FG018|Overall Study|Lost to Follow-up|0|||
162066952|NCT02554812|585301011|FG019|Overall Study|Lost to Follow-up|0|||
162066953|NCT02554812|585301012|FG020|Overall Study|Lost to Follow-up|0|||
162066954|NCT02554812|585301013|FG021|Overall Study|Lost to Follow-up|0|||
162066955|NCT02554812|585301014|FG022|Overall Study|Lost to Follow-up|0|||
162066956|NCT02554812|585301015|FG023|Overall Study|Lost to Follow-up|0|||
162066957|NCT02554812|585301016|FG024|Overall Study|Lost to Follow-up|0|||
162066958|NCT02554812|585301017|FG025|Overall Study|Lost to Follow-up|0|||
162066959|NCT02554812|585301018|FG026|Overall Study|Lost to Follow-up|0|||
162066960|NCT02554812|585300992|FG000|Overall Study|Global deterioration of health status|4|||
162066961|NCT02554812|585300993|FG001|Overall Study|Global deterioration of health status|3|||
162066962|NCT02554812|585300994|FG002|Overall Study|Global deterioration of health status|3|||
162066963|NCT02554812|585300995|FG003|Overall Study|Global deterioration of health status|2|||
162066964|NCT02554812|585300996|FG004|Overall Study|Global deterioration of health status|5|||
162066965|NCT02554812|585300997|FG005|Overall Study|Global deterioration of health status|0|||
162066966|NCT02554812|585300998|FG006|Overall Study|Global deterioration of health status|2|||
162066967|NCT02554812|585300999|FG007|Overall Study|Global deterioration of health status|1|||
162066968|NCT02554812|585301000|FG008|Overall Study|Global deterioration of health status|1|||
162066969|NCT02554812|585301001|FG009|Overall Study|Global deterioration of health status|1|||
162066970|NCT02554812|585301002|FG010|Overall Study|Global deterioration of health status|2|||
162066971|NCT02554812|585301003|FG011|Overall Study|Global deterioration of health status|1|||
162066972|NCT02554812|585301004|FG012|Overall Study|Global deterioration of health status|0|||
162066973|NCT02554812|585301005|FG013|Overall Study|Global deterioration of health status|0|||
162066974|NCT02554812|585301006|FG014|Overall Study|Global deterioration of health status|0|||
162066975|NCT02554812|585301007|FG015|Overall Study|Global deterioration of health status|1|||
162066976|NCT02554812|585301008|FG016|Overall Study|Global deterioration of health status|0|||
162066977|NCT02554812|585301009|FG017|Overall Study|Global deterioration of health status|0|||
162066978|NCT02554812|585301010|FG018|Overall Study|Global deterioration of health status|0|||
162066979|NCT02554812|585301011|FG019|Overall Study|Global deterioration of health status|0|||
162066980|NCT02554812|585301012|FG020|Overall Study|Global deterioration of health status|0|||
162066981|NCT02554812|585301013|FG021|Overall Study|Global deterioration of health status|0|||
162066982|NCT02554812|585301014|FG022|Overall Study|Global deterioration of health status|0|||
162066983|NCT02554812|585301015|FG023|Overall Study|Global deterioration of health status|0|||
162066984|NCT02554812|585301016|FG024|Overall Study|Global deterioration of health status|0|||
162066985|NCT02554812|585301017|FG025|Overall Study|Global deterioration of health status|0|||
162066986|NCT02554812|585301018|FG026|Overall Study|Global deterioration of health status|0|||
162066987|NCT02554812|585300992|FG000|Overall Study|Progressive disease|20|||
162066988|NCT02554812|585300993|FG001|Overall Study|Progressive disease|16|||
162066989|NCT02554812|585300994|FG002|Overall Study|Progressive disease|19|||
162066990|NCT02554812|585300995|FG003|Overall Study|Progressive disease|18|||
162066991|NCT02554812|585300996|FG004|Overall Study|Progressive disease|21|||
162066992|NCT02554812|585300997|FG005|Overall Study|Progressive disease|15|||
162066993|NCT02554812|585300998|FG006|Overall Study|Progressive disease|6|||
162066994|NCT02554812|585300999|FG007|Overall Study|Progressive disease|13|||
162066995|NCT02554812|585301000|FG008|Overall Study|Progressive disease|6|||
162066996|NCT02554812|585301001|FG009|Overall Study|Progressive disease|6|||
162066997|NCT02554812|585301002|FG010|Overall Study|Progressive disease|8|||
162066998|NCT02554812|585301003|FG011|Overall Study|Progressive disease|8|||
162066999|NCT02554812|585301004|FG012|Overall Study|Progressive disease|6|||
162067000|NCT02554812|585301005|FG013|Overall Study|Progressive disease|10|||
162067001|NCT02554812|585301006|FG014|Overall Study|Progressive disease|20|||
162067002|NCT02554812|585301007|FG015|Overall Study|Progressive disease|6|||
162067003|NCT02554812|585301008|FG016|Overall Study|Progressive disease|3|||
162067004|NCT02554812|585301009|FG017|Overall Study|Progressive disease|3|||
162067005|NCT02554812|585301010|FG018|Overall Study|Progressive disease|11|||
162067006|NCT02554812|585301011|FG019|Overall Study|Progressive disease|7|||
162067007|NCT02554812|585301012|FG020|Overall Study|Progressive disease|11|||
162067008|NCT02554812|585301013|FG021|Overall Study|Progressive disease|6|||
162067009|NCT02554812|585301014|FG022|Overall Study|Progressive disease|9|||
162067010|NCT02554812|585301015|FG023|Overall Study|Progressive disease|9|||
162067011|NCT02554812|585301016|FG024|Overall Study|Progressive disease|4|||
162067012|NCT02554812|585301017|FG025|Overall Study|Progressive disease|5|||
162067013|NCT02554812|585301018|FG026|Overall Study|Progressive disease|5|||
162067014|NCT02554812|585300992|FG000|Overall Study|Other|0|||
162067015|NCT02554812|585300993|FG001|Overall Study|Other|0|||
162067016|NCT02554812|585300994|FG002|Overall Study|Other|2|||
162067017|NCT02554812|585300995|FG003|Overall Study|Other|3|||
162067018|NCT02554812|585300996|FG004|Overall Study|Other|2|||
162067019|NCT02554812|585300997|FG005|Overall Study|Other|1|||
162067020|NCT02554812|585300998|FG006|Overall Study|Other|0|||
162067021|NCT02554812|585300999|FG007|Overall Study|Other|0|||
162067022|NCT02554812|585301000|FG008|Overall Study|Other|1|||
162067023|NCT02554812|585301001|FG009|Overall Study|Other|1|||
162067024|NCT02554812|585301002|FG010|Overall Study|Other|0|||
162067025|NCT02554812|585301003|FG011|Overall Study|Other|0|||
162067026|NCT02554812|585301004|FG012|Overall Study|Other|1|||
162067027|NCT02554812|585301005|FG013|Overall Study|Other|0|||
162067028|NCT02554812|585301006|FG014|Overall Study|Other|1|||
162067029|NCT02554812|585301007|FG015|Overall Study|Other|0|||
162067030|NCT02554812|585301008|FG016|Overall Study|Other|0|||
162067031|NCT02554812|585301009|FG017|Overall Study|Other|0|||
162067032|NCT02554812|585301010|FG018|Overall Study|Other|0|||
162067033|NCT02554812|585301011|FG019|Overall Study|Other|0|||
162067034|NCT02554812|585301012|FG020|Overall Study|Other|0|||
162067035|NCT02554812|585301013|FG021|Overall Study|Other|2|||
162067036|NCT02554812|585301014|FG022|Overall Study|Other|0|||
162067037|NCT02554812|585301015|FG023|Overall Study|Other|0|||
162067038|NCT02554812|585301016|FG024|Overall Study|Other|0|||
162067039|NCT02554812|585301017|FG025|Overall Study|Other|0|||
162067040|NCT02554812|585301018|FG026|Overall Study|Other|0|||
162067041|NCT02554812|585300992|FG000|Overall Study|Withdrawal by Subject|1|||
162067042|NCT02554812|585300993|FG001|Overall Study|Withdrawal by Subject|0|||
162067043|NCT02554812|585300994|FG002|Overall Study|Withdrawal by Subject|0|||
162067044|NCT02554812|585300995|FG003|Overall Study|Withdrawal by Subject|2|||
162067045|NCT02554812|585300996|FG004|Overall Study|Withdrawal by Subject|2|||
162067046|NCT02554812|585300997|FG005|Overall Study|Withdrawal by Subject|3|||
162067047|NCT02554812|585300998|FG006|Overall Study|Withdrawal by Subject|0|||
162067048|NCT02554812|585300999|FG007|Overall Study|Withdrawal by Subject|0|||
162067049|NCT02554812|585301000|FG008|Overall Study|Withdrawal by Subject|1|||
162067050|NCT02554812|585301001|FG009|Overall Study|Withdrawal by Subject|1|||
162067051|NCT02554812|585301002|FG010|Overall Study|Withdrawal by Subject|0|||
162067052|NCT02554812|585301003|FG011|Overall Study|Withdrawal by Subject|1|||
162067053|NCT02554812|585301004|FG012|Overall Study|Withdrawal by Subject|1|||
162067054|NCT02554812|585301005|FG013|Overall Study|Withdrawal by Subject|1|||
162067055|NCT02554812|585301006|FG014|Overall Study|Withdrawal by Subject|1|||
162067056|NCT02554812|585301007|FG015|Overall Study|Withdrawal by Subject|1|||
162067057|NCT02554812|585301008|FG016|Overall Study|Withdrawal by Subject|3|||
162067058|NCT02554812|585301009|FG017|Overall Study|Withdrawal by Subject|1|||
162067059|NCT02554812|585301010|FG018|Overall Study|Withdrawal by Subject|0|||
162067060|NCT02554812|585301011|FG019|Overall Study|Withdrawal by Subject|2|||
162067061|NCT02554812|585301012|FG020|Overall Study|Withdrawal by Subject|0|||
162067062|NCT02554812|585301013|FG021|Overall Study|Withdrawal by Subject|1|||
162067063|NCT02554812|585301014|FG022|Overall Study|Withdrawal by Subject|0|||
162067064|NCT02554812|585301015|FG023|Overall Study|Withdrawal by Subject|1|||
162067065|NCT02554812|585301016|FG024|Overall Study|Withdrawal by Subject|0|||
162067066|NCT02554812|585301017|FG025|Overall Study|Withdrawal by Subject|0|||
162067067|NCT02554812|585301018|FG026|Overall Study|Withdrawal by Subject|1|||
162067068|NCT02554812|585300992|FG000|Overall Study|Physician Decision|1|||
162067069|NCT02554812|585300993|FG001|Overall Study|Physician Decision|0|||
162067070|NCT02554812|585300994|FG002|Overall Study|Physician Decision|0|||
162067071|NCT02554812|585300995|FG003|Overall Study|Physician Decision|1|||
162067072|NCT02554812|585300996|FG004|Overall Study|Physician Decision|0|||
162067073|NCT02554812|585300997|FG005|Overall Study|Physician Decision|1|||
162067074|NCT02554812|585300998|FG006|Overall Study|Physician Decision|0|||
162067075|NCT02554812|585300999|FG007|Overall Study|Physician Decision|0|||
162067076|NCT02554812|585301000|FG008|Overall Study|Physician Decision|0|||
162067077|NCT02554812|585301001|FG009|Overall Study|Physician Decision|0|||
162067078|NCT02554812|585301002|FG010|Overall Study|Physician Decision|1|||
162067079|NCT02554812|585301003|FG011|Overall Study|Physician Decision|0|||
162067080|NCT02554812|585301004|FG012|Overall Study|Physician Decision|0|||
162067081|NCT02554812|585301005|FG013|Overall Study|Physician Decision|0|||
162067082|NCT02554812|585301006|FG014|Overall Study|Physician Decision|0|||
162067083|NCT02554812|585301007|FG015|Overall Study|Physician Decision|0|||
162067084|NCT02554812|585301008|FG016|Overall Study|Physician Decision|1|||
162067085|NCT02554812|585301009|FG017|Overall Study|Physician Decision|1|||
162067086|NCT02554812|585301010|FG018|Overall Study|Physician Decision|0|||
162067087|NCT02554812|585301011|FG019|Overall Study|Physician Decision|1|||
162067088|NCT02554812|585301012|FG020|Overall Study|Physician Decision|1|||
162067089|NCT02554812|585301013|FG021|Overall Study|Physician Decision|0|||
162067090|NCT02554812|585301014|FG022|Overall Study|Physician Decision|1|||
162067091|NCT02554812|585301015|FG023|Overall Study|Physician Decision|0|||
162067092|NCT02554812|585301016|FG024|Overall Study|Physician Decision|0|||
162067093|NCT02554812|585301017|FG025|Overall Study|Physician Decision|0|||
162067094|NCT02554812|585301018|FG026|Overall Study|Physician Decision|0|||
162067095|NCT02554812|585300992|FG000|Overall Study|Study terminated by sponsor|0|||
162067096|NCT02554812|585300993|FG001|Overall Study|Study terminated by sponsor|0|||
162067097|NCT02554812|585300994|FG002|Overall Study|Study terminated by sponsor|0|||
162067098|NCT02554812|585300995|FG003|Overall Study|Study terminated by sponsor|0|||
162067099|NCT02554812|585300996|FG004|Overall Study|Study terminated by sponsor|0|||
162067100|NCT02554812|585300997|FG005|Overall Study|Study terminated by sponsor|0|||
162067101|NCT02554812|585300998|FG006|Overall Study|Study terminated by sponsor|0|||
162067102|NCT02554812|585300999|FG007|Overall Study|Study terminated by sponsor|0|||
162067103|NCT02554812|585301000|FG008|Overall Study|Study terminated by sponsor|0|||
162067104|NCT02554812|585301001|FG009|Overall Study|Study terminated by sponsor|0|||
162067105|NCT02554812|585301002|FG010|Overall Study|Study terminated by sponsor|0|||
162067106|NCT02554812|585301003|FG011|Overall Study|Study terminated by sponsor|0|||
162067107|NCT02554812|585301004|FG012|Overall Study|Study terminated by sponsor|0|||
162067108|NCT02554812|585301005|FG013|Overall Study|Study terminated by sponsor|0|||
162067109|NCT02554812|585301006|FG014|Overall Study|Study terminated by sponsor|0|||
162067110|NCT02554812|585301007|FG015|Overall Study|Study terminated by sponsor|0|||
162067111|NCT02554812|585301008|FG016|Overall Study|Study terminated by sponsor|0|||
162067112|NCT02554812|585301009|FG017|Overall Study|Study terminated by sponsor|0|||
162067113|NCT02554812|585301010|FG018|Overall Study|Study terminated by sponsor|0|||
162067114|NCT02554812|585301011|FG019|Overall Study|Study terminated by sponsor|0|||
162067115|NCT02554812|585301012|FG020|Overall Study|Study terminated by sponsor|0|||
162067116|NCT02554812|585301013|FG021|Overall Study|Study terminated by sponsor|0|||
162067117|NCT02554812|585301014|FG022|Overall Study|Study terminated by sponsor|0|||
162067118|NCT02554812|585301015|FG023|Overall Study|Study terminated by sponsor|0|||
162067119|NCT02554812|585301016|FG024|Overall Study|Study terminated by sponsor|1|||
162067120|NCT02554812|585301017|FG025|Overall Study|Study terminated by sponsor|0|||
162067121|NCT02554812|585301018|FG026|Overall Study|Study terminated by sponsor|0|||
162067122|NCT02554812|585300992|FG000|Overall Study|No longer meets eligibility criteria|0|||
162067123|NCT02554812|585300993|FG001|Overall Study|No longer meets eligibility criteria|1|||
162067124|NCT02554812|585300994|FG002|Overall Study|No longer meets eligibility criteria|0|||
162067125|NCT02554812|585300995|FG003|Overall Study|No longer meets eligibility criteria|0|||
162067126|NCT02554812|585300996|FG004|Overall Study|No longer meets eligibility criteria|0|||
162067127|NCT02554812|585300997|FG005|Overall Study|No longer meets eligibility criteria|0|||
162067128|NCT02554812|585300998|FG006|Overall Study|No longer meets eligibility criteria|0|||
162067129|NCT02554812|585300999|FG007|Overall Study|No longer meets eligibility criteria|0|||
162067130|NCT02554812|585301000|FG008|Overall Study|No longer meets eligibility criteria|0|||
162067131|NCT02554812|585301001|FG009|Overall Study|No longer meets eligibility criteria|0|||
162067132|NCT02554812|585301002|FG010|Overall Study|No longer meets eligibility criteria|0|||
162067133|NCT02554812|585301003|FG011|Overall Study|No longer meets eligibility criteria|0|||
162067134|NCT02554812|585301004|FG012|Overall Study|No longer meets eligibility criteria|0|||
162067135|NCT02554812|585301005|FG013|Overall Study|No longer meets eligibility criteria|0|||
162067136|NCT02554812|585301006|FG014|Overall Study|No longer meets eligibility criteria|0|||
162067137|NCT02554812|585301007|FG015|Overall Study|No longer meets eligibility criteria|0|||
162067138|NCT02554812|585301008|FG016|Overall Study|No longer meets eligibility criteria|0|||
162067139|NCT02554812|585301009|FG017|Overall Study|No longer meets eligibility criteria|0|||
162067140|NCT02554812|585301010|FG018|Overall Study|No longer meets eligibility criteria|0|||
162067141|NCT02554812|585301011|FG019|Overall Study|No longer meets eligibility criteria|0|||
162067142|NCT02554812|585301012|FG020|Overall Study|No longer meets eligibility criteria|0|||
162067143|NCT02554812|585301013|FG021|Overall Study|No longer meets eligibility criteria|0|||
162067144|NCT02554812|585301014|FG022|Overall Study|No longer meets eligibility criteria|0|||
162067145|NCT02554812|585301015|FG023|Overall Study|No longer meets eligibility criteria|0|||
162067146|NCT02554812|585301016|FG024|Overall Study|No longer meets eligibility criteria|0|||
162067147|NCT02554812|585301017|FG025|Overall Study|No longer meets eligibility criteria|0|||
162067148|NCT02554812|585301018|FG026|Overall Study|No longer meets eligibility criteria|0|||
162067149|NCT02879305|585301019|FG000|Overall Study|Investigator Site Closed|55|||
162067150|NCT02879305|585301020|FG001|Overall Study|Investigator Site Closed|57|||
162067151|NCT02879305|585301019|FG000|Overall Study|Withdrawal by Subject|44|||
162067152|NCT02879305|585301020|FG001|Overall Study|Withdrawal by Subject|42|||
162067153|NCT02879305|585301019|FG000|Overall Study|Lost to Follow-up|17|||
162067154|NCT02879305|585301020|FG001|Overall Study|Lost to Follow-up|12|||
162067155|NCT02879305|585301019|FG000|Overall Study|Other|1|||
162067156|NCT02879305|585301020|FG001|Overall Study|Other|0|||
162067157|NCT01786629|585302851|FG000|Overall Study|Lack of Efficacy|0|||
162067158|NCT01786629|585302852|FG001|Overall Study|Lack of Efficacy|4|||
162067159|NCT01786629|585302851|FG000|Overall Study|Adverse Event|0|||
162067160|NCT01786629|585302852|FG001|Overall Study|Adverse Event|1|||
162067161|NCT00180414|585302853|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
162067162|NCT00180414|585302854|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
162067163|NCT00613938|585302855|FG000|Overall Study|Withdrawal by Subject|2|||
162067164|NCT00613938|585302856|FG001|Overall Study|Withdrawal by Subject|4|||
162067165|NCT00613938|585302857|FG002|Overall Study|Withdrawal by Subject|9|||
162067166|NCT00613938|585302858|FG003|Overall Study|Withdrawal by Subject|9|||
162067167|NCT00613938|585302855|FG000|Overall Study|Adverse Event|1|||
162067168|NCT00613938|585302856|FG001|Overall Study|Adverse Event|4|||
162067169|NCT00613938|585302857|FG002|Overall Study|Adverse Event|8|||
162067170|NCT00613938|585302858|FG003|Overall Study|Adverse Event|5|||
162067171|NCT00613938|585302855|FG000|Overall Study|Lack of Efficacy|16|||
162067172|NCT00613938|585302856|FG001|Overall Study|Lack of Efficacy|18|||
162067173|NCT00613938|585302857|FG002|Overall Study|Lack of Efficacy|5|||
162067174|NCT00613938|585302858|FG003|Overall Study|Lack of Efficacy|9|||
162067175|NCT00613938|585302855|FG000|Overall Study|Other|1|||
162067176|NCT00613938|585302856|FG001|Overall Study|Other|2|||
162067177|NCT00613938|585302857|FG002|Overall Study|Other|1|||
162067178|NCT00613938|585302858|FG003|Overall Study|Other|3|||
162067179|NCT03025542|585302859|FG000|Overall Study|Adverse Event|0|||
162067180|NCT03025542|585302860|FG001|Overall Study|Adverse Event|2|||
162067181|NCT03025542|585302859|FG000|Overall Study|Lost to Follow-up|1|||
162067182|NCT03025542|585302860|FG001|Overall Study|Lost to Follow-up|0|||
162067183|NCT03025542|585302859|FG000|Overall Study|Withdrawal by Subject|1|||
162067184|NCT03025542|585302860|FG001|Overall Study|Withdrawal by Subject|0|||
162067185|NCT00488345|585302861|FG000|Overall Study|Adverse Event|0|||
162067186|NCT00488345|585302862|FG001|Overall Study|Adverse Event|1|||
162067187|NCT00488345|585302863|FG002|Overall Study|Adverse Event|1|||
162067188|NCT00488345|585302861|FG000|Overall Study|Unable to administer antibiotics at home|0|||
162067189|NCT00488345|585302862|FG001|Overall Study|Unable to administer antibiotics at home|1|||
162067190|NCT00488345|585302863|FG002|Overall Study|Unable to administer antibiotics at home|0|||
162067191|NCT00488345|585302861|FG000|Overall Study|Institutional Review Board review|0|||
162067192|NCT00488345|585302862|FG001|Overall Study|Institutional Review Board review|0|||
162067193|NCT00488345|585302863|FG002|Overall Study|Institutional Review Board review|1|||
162067194|NCT00488345|585302861|FG000|Overall Study|Surgical team recommendation|0|||
162067195|NCT00488345|585302862|FG001|Overall Study|Surgical team recommendation|1|||
162067196|NCT00488345|585302863|FG002|Overall Study|Surgical team recommendation|0|||
162067197|NCT00488345|585302861|FG000|Overall Study|Parent/legal guardian request|0|||
162067198|NCT00488345|585302862|FG001|Overall Study|Parent/legal guardian request|1|||
162067199|NCT00488345|585302863|FG002|Overall Study|Parent/legal guardian request|1|||
162067200|NCT04708886|585302867|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
162067201|NCT04708886|585302867|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
162067202|NCT01853046|585302868|FG000|Overall Study|Withdrawal by Subject|1|||
162067203|NCT01853046|585302869|FG001|Overall Study|Withdrawal by Subject|1|||
162067204|NCT01853046|585302868|FG000|Overall Study|Adverse Event|4|||
162067205|NCT01853046|585302869|FG001|Overall Study|Adverse Event|2|||
162067206|NCT01853046|585302868|FG000|Overall Study|Disease progression|13|||
162067207|NCT01853046|585302869|FG001|Overall Study|Disease progression|3|||
162067208|NCT03020407|585302871|FG000|Overall Study|Withdrawal by Subject|2|||
162067209|NCT03020407|585302872|FG001|Overall Study|Withdrawal by Subject|1|||
162067210|NCT03020407|585302871|FG000|Overall Study|Lost to Follow-up|2|||
162067211|NCT03020407|585302872|FG001|Overall Study|Lost to Follow-up|3|||
162067212|NCT03020407|585302871|FG000|Overall Study|Protocol Violation|0|||
162067213|NCT03020407|585302872|FG001|Overall Study|Protocol Violation|1|||
162067214|NCT01585428|585302873|FG000|Overall Study|Death during treatment|1|||
162067215|NCT01585428|585302874|FG001|Overall Study|Death during treatment|0|||
162067216|NCT02699554|585302875|FG000|Overall Study|Lost to Follow-up|9|||
162067217|NCT00788151|585302876|FG000|Overall Study|Other adverse event|0|||
162067218|NCT00788151|585302877|FG001|Overall Study|Other adverse event|2|||
162067219|NCT00788151|585302876|FG000|Overall Study|Protocol Violation|0|||
162067220|NCT00788151|585302877|FG001|Overall Study|Protocol Violation|1|||
162067221|NCT00788151|585302876|FG000|Overall Study|Withdrawal by Subject|13|||
162067222|NCT00788151|585302877|FG001|Overall Study|Withdrawal by Subject|6|||
162067223|NCT00788151|585302876|FG000|Overall Study|Enrolled but not treated|1|||
162067224|NCT00788151|585302877|FG001|Overall Study|Enrolled but not treated|1|||
162067225|NCT02057198|585302878|FG000|Overall Study|Death|0|||
162067226|NCT02057198|585302879|FG001|Overall Study|Death|0|||
162067227|NCT02057198|585302880|FG002|Overall Study|Death|1|||
162067228|NCT02057198|585302878|FG000|Overall Study|Discharged early; lost to followup|0|||
162067229|NCT02057198|585302879|FG001|Overall Study|Discharged early; lost to followup|1|||
162067230|NCT02057198|585302880|FG002|Overall Study|Discharged early; lost to followup|0|||
162067231|NCT00503009|585302881|FG000|Overall Study|Protocol Violation|1|||
162067232|NCT00503009|585302882|FG001|Overall Study|Protocol Violation|0|||
162067233|NCT00503009|585302883|FG002|Overall Study|Protocol Violation|1|||
162067234|NCT00503009|585302881|FG000|Overall Study|Withdrawal by Subject|0|||
162067235|NCT00503009|585302882|FG001|Overall Study|Withdrawal by Subject|1|||
162067236|NCT00503009|585302883|FG002|Overall Study|Withdrawal by Subject|1|||
162067237|NCT00503009|585302881|FG000|Overall Study|Physician Decision|0|||
162067238|NCT00503009|585302882|FG001|Overall Study|Physician Decision|1|||
162067239|NCT00503009|585302883|FG002|Overall Study|Physician Decision|1|||
162067240|NCT02632552|585302887|FG000|Overall Study|Lost to Follow-up|14|||
162067241|NCT02632552|585302888|FG001|Overall Study|Lost to Follow-up|8|||
162067242|NCT02632552|585302887|FG000|Overall Study|Withdrawal by Subject|2|||
162067243|NCT02632552|585302888|FG001|Overall Study|Withdrawal by Subject|0|||
162067244|NCT02632552|585302887|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
162067245|NCT02632552|585302888|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
162067246|NCT00495170|585302897|FG000|Overall Study|Lost to Follow-up|9|||
162067247|NCT00495170|585302897|FG000|Overall Study|Withdrawal by Subject|3|||
162067248|NCT00495170|585302897|FG000|Overall Study|Inappropriate staging|8|||
162067249|NCT00330616|585302898|FG000|Overall Study|Adverse Event|13|||
162067250|NCT00330616|585302898|FG000|Overall Study|Lack of Efficacy|1|||
162067251|NCT00330616|585302898|FG000|Overall Study|Lost to Follow-up|2|||
162067252|NCT00330616|585302898|FG000|Overall Study|Withdrawal by Subject|4|||
162067253|NCT00330616|585302898|FG000|Overall Study|Other|1|||
162067254|NCT02141997|585302903|FG000|Overall Study|Adverse Event|0|||
162067255|NCT02141997|585302904|FG001|Overall Study|Adverse Event|2|||
162067256|NCT02141997|585302905|FG002|Overall Study|Adverse Event|0|||
162067257|NCT02141997|585302906|FG003|Overall Study|Adverse Event|1|||
162067258|NCT02141997|585302903|FG000|Overall Study|Participant noncompliance|1|||
162067259|NCT02141997|585302904|FG001|Overall Study|Participant noncompliance|0|||
162067260|NCT02141997|585302905|FG002|Overall Study|Participant noncompliance|0|||
162067261|NCT02141997|585302906|FG003|Overall Study|Participant noncompliance|0|||
162067262|NCT02141997|585302903|FG000|Overall Study|Withdrew consent|1|||
162067263|NCT02141997|585302904|FG001|Overall Study|Withdrew consent|0|||
162067264|NCT02141997|585302905|FG002|Overall Study|Withdrew consent|3|||
162067265|NCT02141997|585302906|FG003|Overall Study|Withdrew consent|0|||
162067266|NCT02141997|585302903|FG000|Overall Study|Other|1|||
162067267|NCT02141997|585302904|FG001|Overall Study|Other|4|||
162067268|NCT02141997|585302905|FG002|Overall Study|Other|0|||
162067269|NCT02141997|585302906|FG003|Overall Study|Other|0|||
162067270|NCT00451321|585302908|FG000|Overall Study|Lost to Follow-up|3|||
162067271|NCT00451321|585302909|FG001|Overall Study|Lost to Follow-up|3|||
162067272|NCT00451321|585302910|FG002|Overall Study|Lost to Follow-up|1|||
162067273|NCT00451321|585302911|FG003|Overall Study|Lost to Follow-up|3|||
162067274|NCT00451321|585302912|FG004|Overall Study|Lost to Follow-up|0|||
162067275|NCT00451321|585302913|FG005|Overall Study|Lost to Follow-up|1|||
162067276|NCT00451321|585302914|FG006|Overall Study|Lost to Follow-up|0|||
162067277|NCT00451321|585302915|FG007|Overall Study|Lost to Follow-up|0|||
162067278|NCT00451321|585302908|FG000|Overall Study|Withdrawal by Subject|3|||
162067279|NCT00451321|585302909|FG001|Overall Study|Withdrawal by Subject|1|||
162067280|NCT00451321|585302910|FG002|Overall Study|Withdrawal by Subject|0|||
162067281|NCT00451321|585302911|FG003|Overall Study|Withdrawal by Subject|4|||
162067282|NCT00451321|585302912|FG004|Overall Study|Withdrawal by Subject|0|||
162067283|NCT00451321|585302913|FG005|Overall Study|Withdrawal by Subject|0|||
162067284|NCT00451321|585302914|FG006|Overall Study|Withdrawal by Subject|0|||
162067285|NCT00451321|585302915|FG007|Overall Study|Withdrawal by Subject|0|||
162067286|NCT00451321|585302908|FG000|Overall Study|Study closed/terminated|1|||
162067287|NCT00451321|585302909|FG001|Overall Study|Study closed/terminated|1|||
162067288|NCT00451321|585302910|FG002|Overall Study|Study closed/terminated|17|||
162067289|NCT00451321|585302911|FG003|Overall Study|Study closed/terminated|5|||
162067290|NCT00451321|585302912|FG004|Overall Study|Study closed/terminated|7|||
162067291|NCT00451321|585302913|FG005|Overall Study|Study closed/terminated|7|||
162067292|NCT00451321|585302914|FG006|Overall Study|Study closed/terminated|5|||
162067293|NCT00451321|585302915|FG007|Overall Study|Study closed/terminated|3|||
162067294|NCT00451321|585302908|FG000|Overall Study|Sponsor decision to amend protocol|0|||
162067295|NCT00451321|585302909|FG001|Overall Study|Sponsor decision to amend protocol|0|||
162067296|NCT00451321|585302910|FG002|Overall Study|Sponsor decision to amend protocol|0|||
162067297|NCT00451321|585302911|FG003|Overall Study|Sponsor decision to amend protocol|0|||
162067298|NCT00451321|585302912|FG004|Overall Study|Sponsor decision to amend protocol|0|||
162067299|NCT00451321|585302913|FG005|Overall Study|Sponsor decision to amend protocol|1|||
162067300|NCT00451321|585302914|FG006|Overall Study|Sponsor decision to amend protocol|1|||
162067301|NCT00451321|585302915|FG007|Overall Study|Sponsor decision to amend protocol|3|||
162067302|NCT00732615|585302920|FG000|Overall Study|Withdrawal by Subject|3|||
162067303|NCT00732615|585302921|FG001|Overall Study|Withdrawal by Subject|1|||
162067304|NCT00732615|585302920|FG000|Overall Study|Lost to Follow-up|0|||
162067305|NCT00732615|585302921|FG001|Overall Study|Lost to Follow-up|1|||
162067306|NCT00732615|585302920|FG000|Overall Study|Adverse Event|0|||
162067307|NCT00732615|585302921|FG001|Overall Study|Adverse Event|2|||
162067308|NCT00732615|585302920|FG000|Overall Study|Physician Decision|3|||
162067309|NCT00732615|585302921|FG001|Overall Study|Physician Decision|0|||
162067310|NCT00732615|585302920|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
162067311|NCT00732615|585302921|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
162067312|NCT00909389|585302925|FG000|Overall Study|Adverse Event|6|||
162067313|NCT00909389|585302925|FG000|Overall Study|Death|4|||
162067314|NCT00909389|585302925|FG000|Overall Study|Poor Compliance|16|||
162067315|NCT00909389|585302925|FG000|Overall Study|Lost to Follow-up|4|||
162067316|NCT00909389|585302925|FG000|Overall Study|No Information|103|||
162067317|NCT00597766|585302928|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
162067318|NCT00597766|585302929|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
162067319|NCT00597766|585302930|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
162067320|NCT00597766|585302928|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
162067321|NCT00597766|585302929|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
162067322|NCT00597766|585302930|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
162067323|NCT01333059|585302931|FG000|Overall Study|Physician Decision|3|||
162067324|NCT01333059|585302932|FG001|Overall Study|Physician Decision|3|||
162067325|NCT01333059|585302931|FG000|Overall Study|Protocol Violation|3|||
162067326|NCT01333059|585302932|FG001|Overall Study|Protocol Violation|0|||
162067327|NCT01166763|585302933|FG000|Overall Study|Withdrawal by Subject|3|||
162067328|NCT00737282|585302934|FG000|Overall Study|Study prematurely terminated|175|||
162067329|NCT02763189|585302935|FG000|Overall Study|Device failure|0|||
162067330|NCT02763189|585302936|FG001|Overall Study|Device failure|2|||
162067331|NCT02049957|585302941|FG000|Overall Study|Progressive Disease|5|||
162067332|NCT02049957|585302942|FG001|Overall Study|Progressive Disease|4|||
162067333|NCT02049957|585302943|FG002|Overall Study|Progressive Disease|2|||
162067334|NCT02049957|585302944|FG003|Overall Study|Progressive Disease|2|||
162067335|NCT02049957|585302945|FG004|Overall Study|Progressive Disease|6|||
162067336|NCT02049957|585302946|FG005|Overall Study|Progressive Disease|35|||
162067337|NCT02049957|585302947|FG006|Overall Study|Progressive Disease|7|||
162067338|NCT02049957|585302948|FG007|Overall Study|Progressive Disease|26|||
162067339|NCT02049957|585302949|FG008|Overall Study|Progressive Disease|6|||
162067340|NCT02049957|585302941|FG000|Overall Study|Adverse Event|1|||
162067341|NCT02049957|585302942|FG001|Overall Study|Adverse Event|1|||
162067342|NCT02049957|585302943|FG002|Overall Study|Adverse Event|1|||
162067343|NCT02049957|585302944|FG003|Overall Study|Adverse Event|0|||
162067344|NCT02049957|585302945|FG004|Overall Study|Adverse Event|0|||
162067345|NCT02049957|585302946|FG005|Overall Study|Adverse Event|5|||
162067346|NCT02049957|585302947|FG006|Overall Study|Adverse Event|0|||
162067347|NCT02049957|585302948|FG007|Overall Study|Adverse Event|6|||
162067348|NCT02049957|585302949|FG008|Overall Study|Adverse Event|1|||
162067349|NCT02049957|585302941|FG000|Overall Study|Study Terminated by Sponsor|0|||
162067350|NCT02049957|585302942|FG001|Overall Study|Study Terminated by Sponsor|1|||
162067351|NCT02049957|585302943|FG002|Overall Study|Study Terminated by Sponsor|0|||
162067352|NCT02049957|585302944|FG003|Overall Study|Study Terminated by Sponsor|0|||
162067353|NCT02049957|585302945|FG004|Overall Study|Study Terminated by Sponsor|0|||
162067354|NCT02049957|585302946|FG005|Overall Study|Study Terminated by Sponsor|0|||
162067355|NCT02049957|585302947|FG006|Overall Study|Study Terminated by Sponsor|1|||
162067356|NCT02049957|585302948|FG007|Overall Study|Study Terminated by Sponsor|0|||
162067357|NCT02049957|585302949|FG008|Overall Study|Study Terminated by Sponsor|0|||
162067358|NCT02049957|585302941|FG000|Overall Study|Withdrawal by Subject|0|||
162067359|NCT02049957|585302942|FG001|Overall Study|Withdrawal by Subject|0|||
162067360|NCT02049957|585302943|FG002|Overall Study|Withdrawal by Subject|0|||
162067361|NCT02049957|585302944|FG003|Overall Study|Withdrawal by Subject|1|||
162067362|NCT02049957|585302945|FG004|Overall Study|Withdrawal by Subject|0|||
162067363|NCT02049957|585302946|FG005|Overall Study|Withdrawal by Subject|2|||
162067364|NCT02049957|585302947|FG006|Overall Study|Withdrawal by Subject|0|||
162067365|NCT02049957|585302948|FG007|Overall Study|Withdrawal by Subject|3|||
162067366|NCT02049957|585302949|FG008|Overall Study|Withdrawal by Subject|1|||
162067367|NCT02049957|585302941|FG000|Overall Study|Physician Decision|0|||
162067368|NCT02049957|585302942|FG001|Overall Study|Physician Decision|0|||
162067369|NCT02049957|585302943|FG002|Overall Study|Physician Decision|0|||
162067370|NCT02049957|585302944|FG003|Overall Study|Physician Decision|0|||
162067371|NCT02049957|585302945|FG004|Overall Study|Physician Decision|0|||
162067372|NCT02049957|585302946|FG005|Overall Study|Physician Decision|1|||
162067373|NCT02049957|585302947|FG006|Overall Study|Physician Decision|0|||
162067374|NCT02049957|585302948|FG007|Overall Study|Physician Decision|0|||
162067375|NCT02049957|585302949|FG008|Overall Study|Physician Decision|0|||
162067376|NCT04447755|585302950|FG000|Overall Study|Death|9|||
162067377|NCT04447755|585302951|FG001|Overall Study|Death|16|||
162067378|NCT04447755|585302952|FG002|Overall Study|Death|8|||
162067379|NCT04447755|585302953|FG003|Overall Study|Death|9|||
162067380|NCT04447755|585302954|FG004|Overall Study|Death|8|||
162067381|NCT04447755|585302955|FG005|Overall Study|Death|9|||
162067382|NCT04447755|585302956|FG006|Overall Study|Death|55|||
162067383|NCT04447755|585302950|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162067384|NCT04447755|585302951|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162067385|NCT04447755|585302952|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
162067386|NCT04447755|585302953|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
162067387|NCT04447755|585302954|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
162067388|NCT04447755|585302955|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
162067389|NCT04447755|585302956|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
162067390|NCT04447755|585302950|FG000|Overall Study|Sponsor Decision|0|||
162067391|NCT04447755|585302951|FG001|Overall Study|Sponsor Decision|0|||
162067392|NCT04447755|585302952|FG002|Overall Study|Sponsor Decision|0|||
162067393|NCT04447755|585302953|FG003|Overall Study|Sponsor Decision|0|||
162067394|NCT04447755|585302954|FG004|Overall Study|Sponsor Decision|1|||
162067395|NCT04447755|585302955|FG005|Overall Study|Sponsor Decision|0|||
162067396|NCT04447755|585302956|FG006|Overall Study|Sponsor Decision|10|||
162067397|NCT04447755|585302950|FG000|Overall Study|Lost to Follow-up|0|||
162067398|NCT04447755|585302951|FG001|Overall Study|Lost to Follow-up|0|||
162067399|NCT04447755|585302952|FG002|Overall Study|Lost to Follow-up|0|||
162067400|NCT04447755|585302953|FG003|Overall Study|Lost to Follow-up|0|||
162067401|NCT04447755|585302954|FG004|Overall Study|Lost to Follow-up|0|||
162067402|NCT04447755|585302955|FG005|Overall Study|Lost to Follow-up|0|||
162067403|NCT04447755|585302956|FG006|Overall Study|Lost to Follow-up|1|||
162067404|NCT00840294|585302957|FG000|Overall Study|Withdrawal by Subject|2|||
162067405|NCT00840294|585302958|FG001|Overall Study|Withdrawal by Subject|1|||
162067406|NCT00840294|585302957|FG000|Overall Study|Protocol Violation|1|||
162067407|NCT00840294|585302958|FG001|Overall Study|Protocol Violation|3|||
162067408|NCT00840294|585302957|FG000|Overall Study|Illness|0|||
162067409|NCT00840294|585302958|FG001|Overall Study|Illness|1|||
162067410|NCT00383149|585302960|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
162067411|NCT00383149|585302960|FG000|Overall Study|Death|2|||
162067412|NCT00383149|585302960|FG000|Overall Study|Disease Progression|38|||
162067413|NCT00383149|585302960|FG000|Overall Study|Lost to Follow-up|1|||
162067414|NCT00383149|585302960|FG000|Overall Study|Other|1|||
162067415|NCT00383149|585302960|FG000|Overall Study|Study Drug Toxicity|4|||
162067416|NCT00383149|585302960|FG000|Overall Study|Request to Discontinue Treatment|4|||
162067417|NCT00383149|585302960|FG000|Overall Study|Participant Withdrew Consent|1|||
162067418|NCT03721276|585302961|FG000|Overall Study|Lost to Follow-up|5|||
162067419|NCT03721276|585302962|FG001|Overall Study|Lost to Follow-up|3|||
162067420|NCT03721276|585302961|FG000|Overall Study|Adverse Event|0|||
162067421|NCT03721276|585302962|FG001|Overall Study|Adverse Event|1|||
162067422|NCT01405742|585302967|FG000|Overall Study|Lost to Follow-up|1|||
162067423|NCT01405742|585302968|FG001|Overall Study|Lost to Follow-up|0|||
162067424|NCT01340898|585302969|FG000|Primary Phase|Serious Adverse Events|0|||
162067425|NCT01340898|585302970|FG001|Primary Phase|Serious Adverse Events|0|||
162067426|NCT01340898|585302971|FG002|Primary Phase|Serious Adverse Events|1|||
162067427|NCT01340898|585302969|FG000|Primary Phase|Withdrawal by Subject|8|||
162067428|NCT01340898|585302970|FG001|Primary Phase|Withdrawal by Subject|7|||
162067429|NCT01340898|585302971|FG002|Primary Phase|Withdrawal by Subject|5|||
162067430|NCT01340898|585302969|FG000|Primary Phase|Migrated/moved from study area|4|||
162067431|NCT01340898|585302970|FG001|Primary Phase|Migrated/moved from study area|1|||
162067432|NCT01340898|585302971|FG002|Primary Phase|Migrated/moved from study area|0|||
162067433|NCT01340898|585302969|FG000|Primary Phase|Lost to Follow-up|4|||
162067434|NCT01340898|585302970|FG001|Primary Phase|Lost to Follow-up|1|||
162067435|NCT01340898|585302971|FG002|Primary Phase|Lost to Follow-up|0|||
162067436|NCT01340898|585302969|FG000|Booster Phase|Withdrawal by Subject|3|||
162067437|NCT01340898|585302970|FG001|Booster Phase|Withdrawal by Subject|0|||
162067438|NCT01340898|585302971|FG002|Booster Phase|Withdrawal by Subject|4|||
162067439|NCT01340898|585302969|FG000|Booster Phase|Migrated/moved from study area|3|||
162067440|NCT01340898|585302970|FG001|Booster Phase|Migrated/moved from study area|0|||
162067441|NCT01340898|585302971|FG002|Booster Phase|Migrated/moved from study area|0|||
162067442|NCT01340898|585302969|FG000|Booster Phase|Lost to Follow-up|4|||
162067443|NCT01340898|585302970|FG001|Booster Phase|Lost to Follow-up|2|||
162067444|NCT01340898|585302971|FG002|Booster Phase|Lost to Follow-up|3|||
162067445|NCT04900220|585302972|FG000|Overall Study|Lost to Follow-up|1|||
162067446|NCT04900220|585302973|FG001|Overall Study|Lost to Follow-up|1|||
162067447|NCT03428360|585302974|FG000|Overall Study|Informed consent withdrawn|5|||
162067448|NCT03428360|585302974|FG000|Overall Study|Withdrawal by Subject|4|||
162067449|NCT03428360|585302974|FG000|Overall Study|Lost to Follow-up|5|||
162067450|NCT03428360|585302974|FG000|Overall Study|Physician Decision|2|||
162067451|NCT03428360|585302974|FG000|Overall Study|Informed consent withdrawn|5|||
162067452|NCT03428360|585302974|FG000|Overall Study|Study terminated by sponsor|10|||
162067453|NCT03428360|585302974|FG000|Overall Study|Non-compliant with study|1|||
162067454|NCT03428360|585302974|FG000|Overall Study|Non-compliant with study drug|3|||
162067455|NCT03428360|585302974|FG000|Overall Study|Death|3|||
162067456|NCT03428360|585302974|FG000|Overall Study|Adverse Event|1|||
162067457|NCT03428360|585302974|FG000|Overall Study|Not on antiepileptic drug|1|||
162067458|NCT02028065|585302975|FG000|Randomization Through Start Treatment|Not treated|1|||
162067459|NCT02028065|585302976|FG001|Randomization Through Start Treatment|Not treated|3|||
162067460|NCT02028065|585302977|FG002|Randomization Through Start Treatment|Not treated|3|||
162067461|NCT02028065|585302975|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
162067462|NCT02028065|585302976|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
162067463|NCT02028065|585302977|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
162067464|NCT02028065|585302975|FG000|Treatment Through Study Completion|Physician Decision|1|||
162067465|NCT02028065|585302976|FG001|Treatment Through Study Completion|Physician Decision|0|||
162067466|NCT02028065|585302977|FG002|Treatment Through Study Completion|Physician Decision|0|||
162067467|NCT02028065|585302975|FG000|Treatment Through Study Completion|Protocol Violation|1|||
162067468|NCT02028065|585302976|FG001|Treatment Through Study Completion|Protocol Violation|4|||
162067469|NCT02028065|585302977|FG002|Treatment Through Study Completion|Protocol Violation|0|||
162067470|NCT02028065|585302975|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
162067471|NCT02028065|585302976|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
162067472|NCT02028065|585302977|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
162067473|NCT02028065|585302975|FG000|Treatment Through Study Completion|Adverse Event|3|||
162067474|NCT02028065|585302976|FG001|Treatment Through Study Completion|Adverse Event|3|||
162067475|NCT02028065|585302977|FG002|Treatment Through Study Completion|Adverse Event|5|||
162067476|NCT04868890|585302980|FG000|Overall Study|Death|2|||
162067477|NCT04868890|585302981|FG001|Overall Study|Death|1|||
162067478|NCT04868890|585302980|FG000|Overall Study|Withdrawal by Subject|1|||
162067479|NCT04868890|585302981|FG001|Overall Study|Withdrawal by Subject|5|||
162067480|NCT02669433|585302986|FG000|Overall Study|Protocol Violation|0|||
162067481|NCT02669433|585302987|FG001|Overall Study|Protocol Violation|4|||
162067482|NCT02669433|585302988|FG002|Overall Study|Protocol Violation|1|||
162067483|NCT02669433|585302986|FG000|Overall Study|Disease Progression|1|||
162067484|NCT02669433|585302987|FG001|Overall Study|Disease Progression|0|||
162067485|NCT02669433|585302988|FG002|Overall Study|Disease Progression|0|||
162067486|NCT02669433|585302986|FG000|Overall Study|Physician Decision|1|||
162067487|NCT02669433|585302987|FG001|Overall Study|Physician Decision|1|||
162067488|NCT02669433|585302988|FG002|Overall Study|Physician Decision|0|||
162067489|NCT02669433|585302986|FG000|Overall Study|Adverse Event|6|||
162067490|NCT02669433|585302987|FG001|Overall Study|Adverse Event|7|||
162067491|NCT02669433|585302988|FG002|Overall Study|Adverse Event|10|||
162067492|NCT02669433|585302986|FG000|Overall Study|Sponsor Termination|1|||
162067493|NCT02669433|585302987|FG001|Overall Study|Sponsor Termination|0|||
162067494|NCT02669433|585302988|FG002|Overall Study|Sponsor Termination|1|||
162067495|NCT02669433|585302986|FG000|Overall Study|Withdrawal by Subject|5|||
162067496|NCT02669433|585302987|FG001|Overall Study|Withdrawal by Subject|1|||
162067497|NCT02669433|585302988|FG002|Overall Study|Withdrawal by Subject|0|||
162067498|NCT02669433|585302986|FG000|Overall Study|Withdrawal by Caregiver|1|||
162067499|NCT02669433|585302987|FG001|Overall Study|Withdrawal by Caregiver|0|||
162067500|NCT02669433|585302988|FG002|Overall Study|Withdrawal by Caregiver|2|||
162067501|NCT02669433|585302986|FG000|Overall Study|Death|0|||
162067502|NCT02669433|585302987|FG001|Overall Study|Death|1|||
162067503|NCT02669433|585302988|FG002|Overall Study|Death|1|||
162067504|NCT00576927|585302989|FG000|Clinical Assessment|Lack of Efficacy|24|||
162067505|NCT00576927|585302989|FG000|Clinical Assessment|Death|1|||
162067506|NCT00576927|585302989|FG000|Clinical Assessment|Withdrawal by Subject|10|||
162067507|NCT00576927|585302989|FG000|Clinical Assessment|Physician Decision|1|||
162067508|NCT00576927|585302989|FG000|Baseline|Physician Decision|9|||
162067509|NCT00576927|585302989|FG000|Baseline|Medication Change by PCP of subject|1|||
162067510|NCT00576927|585302989|FG000|Baseline|Withdrawal by Subject|3|||
162067511|NCT00576927|585302989|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
162067512|NCT00576927|585302989|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
162067513|NCT00576927|585302989|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
162067514|NCT00576927|585302989|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
162067515|NCT00576927|585302989|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
162067516|NCT01850524|585302993|FG000|Overall Study|Lost to Follow-up|5|||
162067517|NCT01850524|585302994|FG001|Overall Study|Lost to Follow-up|10|||
162067518|NCT01850524|585302993|FG000|Overall Study|Withdrawal by Subject|24|||
162067519|NCT01850524|585302994|FG001|Overall Study|Withdrawal by Subject|22|||
162067520|NCT01850524|585302993|FG000|Overall Study|Reason not Specified|142|||
162067521|NCT01850524|585302994|FG001|Overall Study|Reason not Specified|141|||
162067522|NCT01698801|585302995|FG000|Treatment Phase|Adverse Event|4|||
162067523|NCT01698801|585302995|FG000|Treatment Phase|Protocol Violation|1|||
162067524|NCT01698801|585302995|FG000|Treatment Phase|Other|4|||
162067525|NCT01698801|585302995|FG000|Treatment Phase|Withdrawal by Subject|1|||
162067526|NCT01698801|585302995|FG000|Treatment Phase|Disease progression|1|||
162067527|NCT01698801|585302995|FG000|Follow Up Phase|Withdrawal by Subject|1|||
162067528|NCT01698801|585302995|FG000|Follow Up Phase|Death|4|||
162067529|NCT00656474|585302996|FG000|Overall Study|Other Reason|1|||
162067530|NCT02062879|585302997|FG000|Overall Study|Withdrawal by Subject|4|||
162067531|NCT02062879|585302998|FG001|Overall Study|Withdrawal by Subject|1|||
162067532|NCT02998840|585302999|FG000|Overall Study|Lost to Follow-up|1|||
162067533|NCT02998840|585303000|FG001|Overall Study|Lost to Follow-up|1|||
162067534|NCT02998840|585303001|FG002|Overall Study|Lost to Follow-up|2|||
162067535|NCT02998840|585303002|FG003|Overall Study|Lost to Follow-up|3|||
162067536|NCT02998840|585302999|FG000|Overall Study|Withdrawal by Subject|1|||
162067537|NCT02998840|585303000|FG001|Overall Study|Withdrawal by Subject|1|||
162067538|NCT02998840|585303001|FG002|Overall Study|Withdrawal by Subject|0|||
162067539|NCT02998840|585303002|FG003|Overall Study|Withdrawal by Subject|1|||
162067540|NCT02998840|585302999|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
162067541|NCT02998840|585303000|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
162067542|NCT02998840|585303001|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
162067543|NCT02998840|585303002|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
162067544|NCT00665847|585303006|FG000|Overall Study|Adverse Event|8|||
162067545|NCT00665847|585303006|FG000|Overall Study|Withdrawal by Subject|2|||
162067546|NCT00665847|585303006|FG000|Overall Study|Subject non-compliant|8|||
162067547|NCT00665847|585303006|FG000|Overall Study|Subject reached a virologic endpoint|4|||
162067548|NCT00665847|585303006|FG000|Overall Study|Resistance to TMC125|1|||
162067549|NCT00665847|585303006|FG000|Overall Study|Subject ineligible to continue the trial|1|||
162067550|NCT00665847|585303006|FG000|Overall Study|Switch to Commercial Medication|1|||
162067551|NCT01686633|585303007|FG000|Overall Study|Lack of Efficacy|33|||
162067552|NCT01686633|585303008|FG001|Overall Study|Lack of Efficacy|13|||
162067553|NCT01686633|585303009|FG002|Overall Study|Lack of Efficacy|11|||
162067554|NCT01686633|585303007|FG000|Overall Study|Withdrawal by Subject|8|||
162067555|NCT01686633|585303008|FG001|Overall Study|Withdrawal by Subject|8|||
162067556|NCT01686633|585303009|FG002|Overall Study|Withdrawal by Subject|5|||
162067557|NCT01686633|585303007|FG000|Overall Study|Physician Decision|3|||
162067558|NCT01686633|585303008|FG001|Overall Study|Physician Decision|4|||
162067559|NCT01686633|585303009|FG002|Overall Study|Physician Decision|4|||
162067560|NCT01686633|585303007|FG000|Overall Study|Adverse Event|4|||
162067561|NCT01686633|585303008|FG001|Overall Study|Adverse Event|3|||
162067562|NCT01686633|585303009|FG002|Overall Study|Adverse Event|3|||
162067563|NCT01686633|585303007|FG000|Overall Study|Protocol Violation|2|||
162067564|NCT01686633|585303008|FG001|Overall Study|Protocol Violation|3|||
162067565|NCT01686633|585303009|FG002|Overall Study|Protocol Violation|0|||
162067566|NCT01686633|585303007|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
162067567|NCT01686633|585303008|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
162067568|NCT01686633|585303009|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
162067569|NCT01686633|585303007|FG000|Overall Study|Lost to Follow-up|0|||
162067570|NCT01686633|585303008|FG001|Overall Study|Lost to Follow-up|1|||
162067571|NCT01686633|585303009|FG002|Overall Study|Lost to Follow-up|1|||
162067572|NCT00511667|585303014|FG000|Overall Study|Adverse Event|1|||
162067573|NCT00511667|585303015|FG001|Overall Study|Adverse Event|0|||
162067574|NCT00511667|585303014|FG000|Overall Study|Protocol Violation|1|||
162067575|NCT00511667|585303015|FG001|Overall Study|Protocol Violation|1|||
162067576|NCT00511667|585303014|FG000|Overall Study|Withdrawal by Subject|2|||
162067577|NCT00511667|585303015|FG001|Overall Study|Withdrawal by Subject|0|||
162067578|NCT00511667|585303014|FG000|Overall Study|Site terminated|6|||
162067579|NCT00511667|585303015|FG001|Overall Study|Site terminated|1|||
162067580|NCT00511667|585303014|FG000|Overall Study|Other|2|||
162067581|NCT00511667|585303015|FG001|Overall Study|Other|1|||
162067582|NCT00623727|585304682|FG000|Double Blind (DB)|Adverse Event|1|||
162067583|NCT00623727|585304683|FG001|Double Blind (DB)|Adverse Event|3|||
162067584|NCT00623727|585304682|FG000|Double Blind (DB)|Physician Decision|0|||
162067585|NCT00623727|585304683|FG001|Double Blind (DB)|Physician Decision|1|||
162067586|NCT00623727|585304682|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
162067587|NCT00623727|585304683|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
162067588|NCT00623727|585304682|FG000|Double Blind (DB)|Lack of Efficacy|2|||
162067589|NCT00623727|585304683|FG001|Double Blind (DB)|Lack of Efficacy|2|||
162067590|NCT00623727|585304682|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
162067591|NCT00623727|585304683|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
162067592|NCT00623727|585304682|FG000|Double Blind (DB)|Lost to Follow-up|1|||
162067593|NCT00623727|585304683|FG001|Double Blind (DB)|Lost to Follow-up|1|||
162067594|NCT00623727|585304682|FG000|Double Blind (DB)|Protocol Violation|2|||
162067595|NCT00623727|585304683|FG001|Double Blind (DB)|Protocol Violation|2|||
162067596|NCT00623727|585304682|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
162067597|NCT00623727|585304683|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
162067598|NCT00623727|585304682|FG000|Open Label Follow-up|Study termination|0|||
162067599|NCT00623727|585304683|FG001|Open Label Follow-up|Study termination|6|||
162067600|NCT00623727|585304682|FG000|Open Label Follow-up|Participant convenience|0|||
162067601|NCT00623727|585304683|FG001|Open Label Follow-up|Participant convenience|1|||
162067602|NCT01852942|585304684|FG000|Overall Study|Physician Decision|1|||
162067603|NCT01852942|585304685|FG001|Overall Study|Physician Decision|0|||
162067604|NCT01852942|585304684|FG000|Overall Study|Death|1|||
162067605|NCT01852942|585304685|FG001|Overall Study|Death|1|||
162067606|NCT01852942|585304684|FG000|Overall Study|Withdrawal by Subject|2|||
162067607|NCT01852942|585304685|FG001|Overall Study|Withdrawal by Subject|3|||
162067608|NCT01852942|585304684|FG000|Overall Study|Lost to Follow-up|1|||
162067609|NCT01852942|585304685|FG001|Overall Study|Lost to Follow-up|2|||
162067610|NCT00696696|585304689|FG000|Overall Study|Adverse Event|5|||
162067611|NCT00696696|585304689|FG000|Overall Study|Withdrawal by Subject|8|||
162067612|NCT00696696|585304689|FG000|Overall Study|Physician Decision|2|||
162067613|NCT00696696|585304689|FG000|Overall Study|Death|3|||
162067614|NCT02642614|585304690|FG000|Overall Study|Adverse Event|1|||
162067615|NCT02642614|585304691|FG001|Overall Study|Adverse Event|1|||
162067616|NCT02642614|585304692|FG002|Overall Study|Adverse Event|2|||
162067617|NCT02642614|585304693|FG003|Overall Study|Adverse Event|2|||
162067618|NCT02642614|585304690|FG000|Overall Study|Lost to Follow-up|1|||
162067619|NCT02642614|585304691|FG001|Overall Study|Lost to Follow-up|0|||
162067620|NCT02642614|585304692|FG002|Overall Study|Lost to Follow-up|0|||
162067621|NCT02642614|585304693|FG003|Overall Study|Lost to Follow-up|0|||
162067622|NCT02642614|585304690|FG000|Overall Study|Withdrawal by Subject|1|||
162067623|NCT02642614|585304691|FG001|Overall Study|Withdrawal by Subject|1|||
162067624|NCT02642614|585304692|FG002|Overall Study|Withdrawal by Subject|0|||
162067625|NCT02642614|585304693|FG003|Overall Study|Withdrawal by Subject|0|||
162067626|NCT00936910|585304698|FG000|Overall Study|Lack of Efficacy|3|||
162067627|NCT01729754|585304699|FG000|Part 1|Adverse Event|2|||
162067628|NCT01729754|585304700|FG001|Part 1|Adverse Event|0|||
162067629|NCT01729754|585304701|FG002|Part 1|Adverse Event|0|||
162067630|NCT01729754|585304702|FG003|Part 1|Adverse Event|1|||
162067631|NCT01729754|585304703|FG004|Part 1|Adverse Event|0|||
162067632|NCT01729754|585304704|FG005|Part 1|Adverse Event|0|||
162067633|NCT01729754|585304705|FG006|Part 1|Adverse Event|2|||
162067634|NCT01729754|585304706|FG007|Part 1|Adverse Event|0|||
162067635|NCT01729754|585304707|FG008|Part 1|Adverse Event|0|||
162067636|NCT01729754|585304708|FG009|Part 1|Adverse Event|5|||
162067637|NCT01729754|585304699|FG000|Part 1|Lack of Efficacy|1|||
162067638|NCT01729754|585304700|FG001|Part 1|Lack of Efficacy|0|||
162067639|NCT01729754|585304701|FG002|Part 1|Lack of Efficacy|0|||
162067640|NCT01729754|585304702|FG003|Part 1|Lack of Efficacy|0|||
162067641|NCT01729754|585304703|FG004|Part 1|Lack of Efficacy|0|||
162067642|NCT01729754|585304704|FG005|Part 1|Lack of Efficacy|0|||
162067643|NCT01729754|585304705|FG006|Part 1|Lack of Efficacy|2|||
162067644|NCT01729754|585304706|FG007|Part 1|Lack of Efficacy|0|||
162067645|NCT01729754|585304707|FG008|Part 1|Lack of Efficacy|0|||
162067646|NCT01729754|585304708|FG009|Part 1|Lack of Efficacy|0|||
162067647|NCT01729754|585304699|FG000|Part 1|Lost to Follow-up|1|||
162067648|NCT01729754|585304700|FG001|Part 1|Lost to Follow-up|0|||
162067649|NCT01729754|585304701|FG002|Part 1|Lost to Follow-up|0|||
162067650|NCT01729754|585304702|FG003|Part 1|Lost to Follow-up|2|||
162067651|NCT01729754|585304703|FG004|Part 1|Lost to Follow-up|0|||
162067652|NCT01729754|585304704|FG005|Part 1|Lost to Follow-up|0|||
162067653|NCT01729754|585304705|FG006|Part 1|Lost to Follow-up|3|||
162067654|NCT01729754|585304706|FG007|Part 1|Lost to Follow-up|0|||
162067655|NCT01729754|585304707|FG008|Part 1|Lost to Follow-up|0|||
162067656|NCT01729754|585304708|FG009|Part 1|Lost to Follow-up|3|||
162067657|NCT01729754|585304699|FG000|Part 1|Non-compliance with Study Drug|1|||
162067658|NCT01729754|585304700|FG001|Part 1|Non-compliance with Study Drug|0|||
162067659|NCT01729754|585304701|FG002|Part 1|Non-compliance with Study Drug|0|||
162067660|NCT01729754|585304702|FG003|Part 1|Non-compliance with Study Drug|0|||
162067661|NCT01729754|585304703|FG004|Part 1|Non-compliance with Study Drug|0|||
162067662|NCT01729754|585304704|FG005|Part 1|Non-compliance with Study Drug|0|||
162067663|NCT01729754|585304705|FG006|Part 1|Non-compliance with Study Drug|0|||
162067664|NCT01729754|585304706|FG007|Part 1|Non-compliance with Study Drug|0|||
162067665|NCT01729754|585304707|FG008|Part 1|Non-compliance with Study Drug|0|||
162067666|NCT01729754|585304708|FG009|Part 1|Non-compliance with Study Drug|0|||
162067667|NCT01729754|585304699|FG000|Part 1|Physician Decision|0|||
162067668|NCT01729754|585304700|FG001|Part 1|Physician Decision|0|||
162067669|NCT01729754|585304701|FG002|Part 1|Physician Decision|0|||
162067670|NCT01729754|585304702|FG003|Part 1|Physician Decision|0|||
162067671|NCT01729754|585304703|FG004|Part 1|Physician Decision|0|||
162067672|NCT01729754|585304704|FG005|Part 1|Physician Decision|0|||
162067673|NCT01729754|585304705|FG006|Part 1|Physician Decision|0|||
162067674|NCT01729754|585304706|FG007|Part 1|Physician Decision|0|||
162067675|NCT01729754|585304707|FG008|Part 1|Physician Decision|0|||
162067676|NCT01729754|585304708|FG009|Part 1|Physician Decision|4|||
162067677|NCT01729754|585304699|FG000|Part 1|Pregnancy|0|||
162067678|NCT01729754|585304700|FG001|Part 1|Pregnancy|0|||
162067679|NCT01729754|585304701|FG002|Part 1|Pregnancy|0|||
162067680|NCT01729754|585304702|FG003|Part 1|Pregnancy|1|||
162067681|NCT01729754|585304703|FG004|Part 1|Pregnancy|0|||
162067682|NCT01729754|585304704|FG005|Part 1|Pregnancy|0|||
162067683|NCT01729754|585304705|FG006|Part 1|Pregnancy|0|||
162067684|NCT01729754|585304706|FG007|Part 1|Pregnancy|0|||
162067685|NCT01729754|585304707|FG008|Part 1|Pregnancy|0|||
162067686|NCT01729754|585304708|FG009|Part 1|Pregnancy|1|||
162067687|NCT01729754|585304699|FG000|Part 1|Progressive Disease|0|||
162067688|NCT01729754|585304700|FG001|Part 1|Progressive Disease|0|||
162067689|NCT01729754|585304701|FG002|Part 1|Progressive Disease|0|||
162067690|NCT01729754|585304702|FG003|Part 1|Progressive Disease|0|||
162067691|NCT01729754|585304703|FG004|Part 1|Progressive Disease|0|||
162067692|NCT01729754|585304704|FG005|Part 1|Progressive Disease|0|||
162067693|NCT01729754|585304705|FG006|Part 1|Progressive Disease|0|||
162067694|NCT01729754|585304706|FG007|Part 1|Progressive Disease|0|||
162067695|NCT01729754|585304707|FG008|Part 1|Progressive Disease|0|||
162067696|NCT01729754|585304708|FG009|Part 1|Progressive Disease|1|||
162067697|NCT01729754|585304699|FG000|Part 1|Protocol Violation|2|||
162067698|NCT01729754|585304700|FG001|Part 1|Protocol Violation|0|||
162067699|NCT01729754|585304701|FG002|Part 1|Protocol Violation|0|||
162067700|NCT01729754|585304702|FG003|Part 1|Protocol Violation|1|||
162067701|NCT01729754|585304703|FG004|Part 1|Protocol Violation|0|||
162067702|NCT01729754|585304704|FG005|Part 1|Protocol Violation|0|||
162067703|NCT01729754|585304705|FG006|Part 1|Protocol Violation|1|||
162067704|NCT01729754|585304706|FG007|Part 1|Protocol Violation|0|||
162067705|NCT01729754|585304707|FG008|Part 1|Protocol Violation|0|||
162067706|NCT01729754|585304708|FG009|Part 1|Protocol Violation|0|||
162067707|NCT01729754|585304699|FG000|Part 1|Withdrawal by Subject|5|||
162067708|NCT01729754|585304700|FG001|Part 1|Withdrawal by Subject|0|||
162067709|NCT01729754|585304701|FG002|Part 1|Withdrawal by Subject|0|||
162067710|NCT01729754|585304702|FG003|Part 1|Withdrawal by Subject|7|||
162067711|NCT01729754|585304703|FG004|Part 1|Withdrawal by Subject|0|||
162067712|NCT01729754|585304704|FG005|Part 1|Withdrawal by Subject|0|||
162067713|NCT01729754|585304705|FG006|Part 1|Withdrawal by Subject|5|||
162067714|NCT01729754|585304706|FG007|Part 1|Withdrawal by Subject|0|||
162067715|NCT01729754|585304707|FG008|Part 1|Withdrawal by Subject|0|||
162067716|NCT01729754|585304708|FG009|Part 1|Withdrawal by Subject|6|||
162067717|NCT01729754|585304699|FG000|Part 1|Other Protocol Specified Criteria|2|||
162067718|NCT01729754|585304700|FG001|Part 1|Other Protocol Specified Criteria|0|||
162067719|NCT01729754|585304701|FG002|Part 1|Other Protocol Specified Criteria|0|||
162067720|NCT01729754|585304702|FG003|Part 1|Other Protocol Specified Criteria|0|||
162067721|NCT01729754|585304703|FG004|Part 1|Other Protocol Specified Criteria|0|||
162067722|NCT01729754|585304704|FG005|Part 1|Other Protocol Specified Criteria|0|||
162067723|NCT01729754|585304705|FG006|Part 1|Other Protocol Specified Criteria|1|||
162067724|NCT01729754|585304706|FG007|Part 1|Other Protocol Specified Criteria|0|||
162067725|NCT01729754|585304707|FG008|Part 1|Other Protocol Specified Criteria|0|||
162067726|NCT01729754|585304708|FG009|Part 1|Other Protocol Specified Criteria|4|||
162067727|NCT01729754|585304699|FG000|Part 2|Adverse Event|2|||
162067728|NCT01729754|585304700|FG001|Part 2|Adverse Event|0|||
162067729|NCT01729754|585304701|FG002|Part 2|Adverse Event|0|||
162067730|NCT01729754|585304702|FG003|Part 2|Adverse Event|0|||
162067731|NCT01729754|585304703|FG004|Part 2|Adverse Event|0|||
162067732|NCT01729754|585304704|FG005|Part 2|Adverse Event|0|||
162067733|NCT01729754|585304705|FG006|Part 2|Adverse Event|0|||
162067734|NCT01729754|585304706|FG007|Part 2|Adverse Event|0|||
162067735|NCT01729754|585304707|FG008|Part 2|Adverse Event|1|||
162067736|NCT01729754|585304708|FG009|Part 2|Adverse Event|2|||
162067737|NCT01729754|585304699|FG000|Part 2|Lack of Efficacy|0|||
162067738|NCT01729754|585304700|FG001|Part 2|Lack of Efficacy|0|||
162067739|NCT01729754|585304701|FG002|Part 2|Lack of Efficacy|0|||
162067740|NCT01729754|585304702|FG003|Part 2|Lack of Efficacy|0|||
162067741|NCT01729754|585304703|FG004|Part 2|Lack of Efficacy|0|||
162067742|NCT01729754|585304704|FG005|Part 2|Lack of Efficacy|0|||
162067743|NCT01729754|585304705|FG006|Part 2|Lack of Efficacy|0|||
162067744|NCT01729754|585304706|FG007|Part 2|Lack of Efficacy|0|||
162067745|NCT01729754|585304707|FG008|Part 2|Lack of Efficacy|2|||
162067746|NCT01729754|585304708|FG009|Part 2|Lack of Efficacy|2|||
162067747|NCT01729754|585304699|FG000|Part 2|Lost to Follow-up|0|||
162067748|NCT01729754|585304700|FG001|Part 2|Lost to Follow-up|0|||
162067749|NCT01729754|585304701|FG002|Part 2|Lost to Follow-up|0|||
162067750|NCT01729754|585304702|FG003|Part 2|Lost to Follow-up|2|||
162067751|NCT01729754|585304703|FG004|Part 2|Lost to Follow-up|0|||
162067752|NCT01729754|585304704|FG005|Part 2|Lost to Follow-up|0|||
162067753|NCT01729754|585304705|FG006|Part 2|Lost to Follow-up|0|||
162067754|NCT01729754|585304706|FG007|Part 2|Lost to Follow-up|1|||
162067755|NCT01729754|585304707|FG008|Part 2|Lost to Follow-up|0|||
162067756|NCT01729754|585304708|FG009|Part 2|Lost to Follow-up|2|||
162067757|NCT01729754|585304699|FG000|Part 2|Non-Compliance with Study Drug|0|||
162067758|NCT01729754|585304700|FG001|Part 2|Non-Compliance with Study Drug|0|||
162067759|NCT01729754|585304701|FG002|Part 2|Non-Compliance with Study Drug|0|||
162067760|NCT01729754|585304702|FG003|Part 2|Non-Compliance with Study Drug|0|||
162067761|NCT01729754|585304703|FG004|Part 2|Non-Compliance with Study Drug|0|||
162067762|NCT01729754|585304704|FG005|Part 2|Non-Compliance with Study Drug|0|||
162067763|NCT01729754|585304705|FG006|Part 2|Non-Compliance with Study Drug|0|||
162067764|NCT01729754|585304706|FG007|Part 2|Non-Compliance with Study Drug|0|||
162067765|NCT01729754|585304707|FG008|Part 2|Non-Compliance with Study Drug|0|||
162067766|NCT01729754|585304708|FG009|Part 2|Non-Compliance with Study Drug|1|||
162067767|NCT01729754|585304699|FG000|Part 2|Pregnancy|0|||
162067768|NCT01729754|585304700|FG001|Part 2|Pregnancy|0|||
162067769|NCT01729754|585304701|FG002|Part 2|Pregnancy|0|||
162067770|NCT01729754|585304702|FG003|Part 2|Pregnancy|1|||
162067771|NCT01729754|585304703|FG004|Part 2|Pregnancy|0|||
162067772|NCT01729754|585304704|FG005|Part 2|Pregnancy|0|||
162067773|NCT01729754|585304705|FG006|Part 2|Pregnancy|0|||
162067774|NCT01729754|585304706|FG007|Part 2|Pregnancy|0|||
162067775|NCT01729754|585304707|FG008|Part 2|Pregnancy|0|||
162067776|NCT01729754|585304708|FG009|Part 2|Pregnancy|1|||
162067777|NCT01729754|585304699|FG000|Part 2|Withdrawal by Subject|3|||
162067778|NCT01729754|585304700|FG001|Part 2|Withdrawal by Subject|0|||
162067779|NCT01729754|585304701|FG002|Part 2|Withdrawal by Subject|0|||
162067780|NCT01729754|585304702|FG003|Part 2|Withdrawal by Subject|2|||
162067781|NCT01729754|585304703|FG004|Part 2|Withdrawal by Subject|0|||
162067782|NCT01729754|585304704|FG005|Part 2|Withdrawal by Subject|0|||
162067783|NCT01729754|585304705|FG006|Part 2|Withdrawal by Subject|0|||
162067784|NCT01729754|585304706|FG007|Part 2|Withdrawal by Subject|1|||
162067785|NCT01729754|585304707|FG008|Part 2|Withdrawal by Subject|1|||
162067786|NCT01729754|585304708|FG009|Part 2|Withdrawal by Subject|4|||
162067787|NCT01729754|585304699|FG000|Part 2|Other Protocol Specified Criteria|1|||
162067788|NCT01729754|585304700|FG001|Part 2|Other Protocol Specified Criteria|0|||
162067789|NCT01729754|585304701|FG002|Part 2|Other Protocol Specified Criteria|0|||
162067790|NCT01729754|585304702|FG003|Part 2|Other Protocol Specified Criteria|0|||
162067791|NCT01729754|585304703|FG004|Part 2|Other Protocol Specified Criteria|0|||
162067792|NCT01729754|585304704|FG005|Part 2|Other Protocol Specified Criteria|0|||
162067793|NCT01729754|585304705|FG006|Part 2|Other Protocol Specified Criteria|0|||
162067794|NCT01729754|585304706|FG007|Part 2|Other Protocol Specified Criteria|1|||
162067795|NCT01729754|585304707|FG008|Part 2|Other Protocol Specified Criteria|0|||
162067796|NCT01729754|585304708|FG009|Part 2|Other Protocol Specified Criteria|0|||
162067797|NCT01729754|585304699|FG000|Part 3|Adverse Event|0|||
162067798|NCT01729754|585304700|FG001|Part 3|Adverse Event|0|||
162067799|NCT01729754|585304701|FG002|Part 3|Adverse Event|1|||
162067800|NCT01729754|585304702|FG003|Part 3|Adverse Event|0|||
162067801|NCT01729754|585304703|FG004|Part 3|Adverse Event|0|||
162067802|NCT01729754|585304704|FG005|Part 3|Adverse Event|5|||
162067803|NCT01729754|585304705|FG006|Part 3|Adverse Event|0|||
162067804|NCT01729754|585304706|FG007|Part 3|Adverse Event|0|||
162067805|NCT01729754|585304707|FG008|Part 3|Adverse Event|0|||
162067806|NCT01729754|585304708|FG009|Part 3|Adverse Event|3|||
162067807|NCT01729754|585304699|FG000|Part 3|Death|0|||
162067808|NCT01729754|585304700|FG001|Part 3|Death|0|||
162067809|NCT01729754|585304701|FG002|Part 3|Death|0|||
162067810|NCT01729754|585304702|FG003|Part 3|Death|0|||
162067811|NCT01729754|585304703|FG004|Part 3|Death|0|||
162067812|NCT01729754|585304704|FG005|Part 3|Death|2|||
162067813|NCT01729754|585304705|FG006|Part 3|Death|0|||
162067814|NCT01729754|585304706|FG007|Part 3|Death|0|||
162067815|NCT01729754|585304707|FG008|Part 3|Death|0|||
162067816|NCT01729754|585304708|FG009|Part 3|Death|0|||
162067817|NCT01729754|585304699|FG000|Part 3|Lack of Efficacy|0|||
162067818|NCT01729754|585304700|FG001|Part 3|Lack of Efficacy|0|||
162067819|NCT01729754|585304701|FG002|Part 3|Lack of Efficacy|0|||
162067820|NCT01729754|585304702|FG003|Part 3|Lack of Efficacy|0|||
162067821|NCT01729754|585304703|FG004|Part 3|Lack of Efficacy|2|||
162067822|NCT01729754|585304704|FG005|Part 3|Lack of Efficacy|0|||
162067823|NCT01729754|585304705|FG006|Part 3|Lack of Efficacy|0|||
162067824|NCT01729754|585304706|FG007|Part 3|Lack of Efficacy|0|||
162067825|NCT01729754|585304707|FG008|Part 3|Lack of Efficacy|0|||
162067826|NCT01729754|585304708|FG009|Part 3|Lack of Efficacy|4|||
162067827|NCT01729754|585304699|FG000|Part 3|Lost to Follow-up|0|||
162067828|NCT01729754|585304700|FG001|Part 3|Lost to Follow-up|1|||
162067829|NCT01729754|585304701|FG002|Part 3|Lost to Follow-up|2|||
162067830|NCT01729754|585304702|FG003|Part 3|Lost to Follow-up|0|||
162067831|NCT01729754|585304703|FG004|Part 3|Lost to Follow-up|0|||
162067832|NCT01729754|585304704|FG005|Part 3|Lost to Follow-up|3|||
162067833|NCT01729754|585304705|FG006|Part 3|Lost to Follow-up|0|||
162067834|NCT01729754|585304706|FG007|Part 3|Lost to Follow-up|0|||
162067835|NCT01729754|585304707|FG008|Part 3|Lost to Follow-up|1|||
162067836|NCT01729754|585304708|FG009|Part 3|Lost to Follow-up|0|||
162067837|NCT01729754|585304699|FG000|Part 3|Physician Decision|0|||
162067838|NCT01729754|585304700|FG001|Part 3|Physician Decision|0|||
162067839|NCT01729754|585304701|FG002|Part 3|Physician Decision|1|||
162067840|NCT01729754|585304702|FG003|Part 3|Physician Decision|0|||
162067841|NCT01729754|585304703|FG004|Part 3|Physician Decision|0|||
162067842|NCT01729754|585304704|FG005|Part 3|Physician Decision|0|||
162067843|NCT01729754|585304705|FG006|Part 3|Physician Decision|0|||
162067844|NCT01729754|585304706|FG007|Part 3|Physician Decision|0|||
162067845|NCT01729754|585304707|FG008|Part 3|Physician Decision|0|||
162067846|NCT01729754|585304708|FG009|Part 3|Physician Decision|0|||
162067847|NCT01729754|585304699|FG000|Part 3|Withdrawal by Subject|0|||
162067848|NCT01729754|585304700|FG001|Part 3|Withdrawal by Subject|4|||
162067849|NCT01729754|585304701|FG002|Part 3|Withdrawal by Subject|1|||
162067850|NCT01729754|585304702|FG003|Part 3|Withdrawal by Subject|0|||
162067851|NCT01729754|585304703|FG004|Part 3|Withdrawal by Subject|2|||
162067852|NCT01729754|585304704|FG005|Part 3|Withdrawal by Subject|1|||
162067853|NCT01729754|585304705|FG006|Part 3|Withdrawal by Subject|0|||
162067854|NCT01729754|585304706|FG007|Part 3|Withdrawal by Subject|2|||
162067855|NCT01729754|585304707|FG008|Part 3|Withdrawal by Subject|0|||
162067856|NCT01729754|585304708|FG009|Part 3|Withdrawal by Subject|0|||
162067857|NCT01729754|585304699|FG000|Part 3|Other Protocol Specified Criteria|0|||
162067858|NCT01729754|585304700|FG001|Part 3|Other Protocol Specified Criteria|0|||
162067859|NCT01729754|585304701|FG002|Part 3|Other Protocol Specified Criteria|0|||
162067860|NCT01729754|585304702|FG003|Part 3|Other Protocol Specified Criteria|0|||
162067861|NCT01729754|585304703|FG004|Part 3|Other Protocol Specified Criteria|0|||
162067862|NCT01729754|585304704|FG005|Part 3|Other Protocol Specified Criteria|2|||
162067863|NCT01729754|585304705|FG006|Part 3|Other Protocol Specified Criteria|0|||
162067864|NCT01729754|585304706|FG007|Part 3|Other Protocol Specified Criteria|1|||
162067865|NCT01729754|585304707|FG008|Part 3|Other Protocol Specified Criteria|0|||
162067866|NCT01729754|585304708|FG009|Part 3|Other Protocol Specified Criteria|0|||
162067867|NCT00708162|585304709|FG000|Randomized Phase|Randomized but Not Treated|7|||
162067868|NCT00708162|585304710|FG001|Randomized Phase|Randomized but Not Treated|5|||
162067869|NCT00708162|585304709|FG000|Randomized Phase|Participant Noncompliance|40|||
162067870|NCT00708162|585304710|FG001|Randomized Phase|Participant Noncompliance|32|||
162067871|NCT00708162|585304709|FG000|Randomized Phase|Lost to Follow-up|34|||
162067872|NCT00708162|585304710|FG001|Randomized Phase|Lost to Follow-up|34|||
162067873|NCT00708162|585304709|FG000|Randomized Phase|Withdrew Consent|31|||
162067874|NCT00708162|585304710|FG001|Randomized Phase|Withdrew Consent|22|||
162067875|NCT00708162|585304709|FG000|Randomized Phase|Lack of Efficacy|14|||
162067876|NCT00708162|585304710|FG001|Randomized Phase|Lack of Efficacy|19|||
162067877|NCT00708162|585304709|FG000|Randomized Phase|Protocol Violation|10|||
162067878|NCT00708162|585304710|FG001|Randomized Phase|Protocol Violation|11|||
162067879|NCT00708162|585304709|FG000|Randomized Phase|Adverse Event|8|||
162067880|NCT00708162|585304710|FG001|Randomized Phase|Adverse Event|12|||
162067881|NCT00708162|585304709|FG000|Randomized Phase|Investigator's Discretion|7|||
162067882|NCT00708162|585304710|FG001|Randomized Phase|Investigator's Discretion|10|||
162067883|NCT00708162|585304709|FG000|Randomized Phase|Death|2|||
162067884|NCT00708162|585304710|FG001|Randomized Phase|Death|9|||
162067885|NCT00708162|585304709|FG000|Randomized Phase|Pregnancy|3|||
162067886|NCT00708162|585304710|FG001|Randomized Phase|Pregnancy|0|||
162067887|NCT00708162|585304709|FG000|Open-Label Phase|Lost to Follow-up|10|||
162067888|NCT00708162|585304710|FG001|Open-Label Phase|Lost to Follow-up|8|||
162067889|NCT00708162|585304709|FG000|Open-Label Phase|Withdrew Consent|12|||
162067890|NCT00708162|585304710|FG001|Open-Label Phase|Withdrew Consent|6|||
162067891|NCT00708162|585304709|FG000|Open-Label Phase|Participant Noncompliance|7|||
162067892|NCT00708162|585304710|FG001|Open-Label Phase|Participant Noncompliance|7|||
162067893|NCT00708162|585304709|FG000|Open-Label Phase|Lack of Efficacy|7|||
162067894|NCT00708162|585304710|FG001|Open-Label Phase|Lack of Efficacy|4|||
162067895|NCT00708162|585304709|FG000|Open-Label Phase|Investigator's Discretion|3|||
162067896|NCT00708162|585304710|FG001|Open-Label Phase|Investigator's Discretion|2|||
162067897|NCT00708162|585304709|FG000|Open-Label Phase|Death|3|||
162067898|NCT00708162|585304710|FG001|Open-Label Phase|Death|1|||
162067899|NCT00708162|585304709|FG000|Open-Label Phase|Adverse Event|1|||
162067900|NCT00708162|585304710|FG001|Open-Label Phase|Adverse Event|2|||
162067901|NCT00708162|585304709|FG000|Open-Label Phase|Other|1|||
162067902|NCT00708162|585304710|FG001|Open-Label Phase|Other|0|||
162067903|NCT01349803|585304712|FG000|Overall Study|Adverse Event|0|||
162067904|NCT01349803|585304713|FG001|Overall Study|Adverse Event|0|||
162067905|NCT01349803|585304714|FG002|Overall Study|Adverse Event|0|||
162067906|NCT01349803|585304715|FG003|Overall Study|Adverse Event|2|||
162067907|NCT01349803|585304712|FG000|Overall Study|Withdrawal by Subject|1|||
162067908|NCT01349803|585304713|FG001|Overall Study|Withdrawal by Subject|0|||
162067909|NCT01349803|585304714|FG002|Overall Study|Withdrawal by Subject|0|||
162067910|NCT01349803|585304715|FG003|Overall Study|Withdrawal by Subject|0|||
162067911|NCT01349803|585304712|FG000|Overall Study|Protocol-specified criteria|0|||
162067912|NCT01349803|585304713|FG001|Overall Study|Protocol-specified criteria|1|||
162067913|NCT01349803|585304714|FG002|Overall Study|Protocol-specified criteria|3|||
162067914|NCT01349803|585304715|FG003|Overall Study|Protocol-specified criteria|0|||
162067915|NCT02345811|585304716|FG000|First Intervention|Withdrawal by Subject|1|||
162067916|NCT02345811|585304717|FG001|First Intervention|Withdrawal by Subject|1|||
162067917|NCT02522286|585304718|FG000|Overall Study|Withdrawal by Subject|3|||
162067918|NCT02522286|585304719|FG001|Overall Study|Withdrawal by Subject|0|||
162067919|NCT02522286|585304720|FG002|Overall Study|Withdrawal by Subject|0|||
162067920|NCT02522286|585304721|FG003|Overall Study|Withdrawal by Subject|3|||
162067921|NCT00605813|585304723|FG000|Overall Study|Protocol Violation|25|||
162067922|NCT01163279|585304725|FG000|Overall Study|Withdrawal by Subject|2|||
162067923|NCT01163279|585304726|FG001|Overall Study|Withdrawal by Subject|0|||
162067924|NCT01870583|585304727|FG000|Overall Study|Protocol Violation|0|||
162067925|NCT01870583|585304728|FG001|Overall Study|Protocol Violation|5|||
162067926|NCT01870583|585304729|FG002|Overall Study|Protocol Violation|3|||
162067927|NCT01870583|585304727|FG000|Overall Study|Lost to Follow-up|11|||
162067928|NCT01870583|585304728|FG001|Overall Study|Lost to Follow-up|13|||
162067929|NCT01870583|585304729|FG002|Overall Study|Lost to Follow-up|5|||
162067930|NCT01394523|585304730|FG000|Overall Study|Unable to place block|1|||
162067931|NCT01394523|585304731|FG001|Overall Study|Unable to place block|0|||
162067932|NCT01394523|585304732|FG002|Overall Study|Unable to place block|0|||
162067933|NCT02389998|585304736|FG000|Overall Study|car accident|1|||
162067934|NCT02389998|585304737|FG001|Overall Study|car accident|0|||
162067935|NCT04741074|585304740|FG000|Overall Study|Withdrawal by Subject|1|||
162067936|NCT04741074|585304741|FG001|Overall Study|Withdrawal by Subject|1|||
162067937|NCT04741074|585304740|FG000|Overall Study|Study terminated prematurely|1|||
162067938|NCT04741074|585304741|FG001|Overall Study|Study terminated prematurely|0|||
162067939|NCT01770379|585304743|FG000|Overall Study|Technical issues|1|||
162067940|NCT01770379|585304744|FG001|Overall Study|Technical issues|0|||
162067941|NCT01770379|585304745|FG002|Overall Study|Technical issues|0|||
162067942|NCT01770379|585304743|FG000|Overall Study|Withdrawal by Subject|7|||
162067943|NCT01770379|585304744|FG001|Overall Study|Withdrawal by Subject|10|||
162067944|NCT01770379|585304745|FG002|Overall Study|Withdrawal by Subject|7|||
162067945|NCT01770379|585304743|FG000|Overall Study|study terminated by sponsor|22|||
162067946|NCT01770379|585304744|FG001|Overall Study|study terminated by sponsor|23|||
162067947|NCT01770379|585304745|FG002|Overall Study|study terminated by sponsor|22|||
162067948|NCT01770379|585304743|FG000|Overall Study|Protocol Violation|0|||
162067949|NCT01770379|585304744|FG001|Overall Study|Protocol Violation|1|||
162067950|NCT01770379|585304745|FG002|Overall Study|Protocol Violation|1|||
162067951|NCT01770379|585304743|FG000|Overall Study|Physician Decision|0|||
162067952|NCT01770379|585304744|FG001|Overall Study|Physician Decision|1|||
162067953|NCT01770379|585304745|FG002|Overall Study|Physician Decision|2|||
162067954|NCT01770379|585304743|FG000|Overall Study|Lost to Follow-up|0|||
162067955|NCT01770379|585304744|FG001|Overall Study|Lost to Follow-up|0|||
162067956|NCT01770379|585304745|FG002|Overall Study|Lost to Follow-up|2|||
162067957|NCT01770379|585304743|FG000|Overall Study|Lack of Efficacy|8|||
162067958|NCT01770379|585304744|FG001|Overall Study|Lack of Efficacy|6|||
162067959|NCT01770379|585304745|FG002|Overall Study|Lack of Efficacy|6|||
162067960|NCT01770379|585304743|FG000|Overall Study|Adverse Event|1|||
162067961|NCT01770379|585304744|FG001|Overall Study|Adverse Event|3|||
162067962|NCT01770379|585304745|FG002|Overall Study|Adverse Event|2|||
162067963|NCT00778700|585304746|FG000|Overall Study|Adverse Event|6|||
162067964|NCT00778700|585304747|FG001|Overall Study|Adverse Event|1|||
162067965|NCT00778700|585304748|FG002|Overall Study|Adverse Event|3|||
162067966|NCT00778700|585304749|FG003|Overall Study|Adverse Event|5|||
162067967|NCT00778700|585304746|FG000|Overall Study|Protocol Violation|1|||
162067968|NCT00778700|585304747|FG001|Overall Study|Protocol Violation|1|||
162067969|NCT00778700|585304748|FG002|Overall Study|Protocol Violation|0|||
162067970|NCT00778700|585304749|FG003|Overall Study|Protocol Violation|0|||
162067971|NCT00778700|585304746|FG000|Overall Study|Subject Withdrew Consent|6|||
162067972|NCT00778700|585304747|FG001|Overall Study|Subject Withdrew Consent|4|||
162067973|NCT00778700|585304748|FG002|Overall Study|Subject Withdrew Consent|1|||
162067974|NCT00778700|585304749|FG003|Overall Study|Subject Withdrew Consent|4|||
162067975|NCT00778700|585304746|FG000|Overall Study|Lost to Follow-up|3|||
162067976|NCT00778700|585304747|FG001|Overall Study|Lost to Follow-up|1|||
162067977|NCT00778700|585304748|FG002|Overall Study|Lost to Follow-up|0|||
162067978|NCT00778700|585304749|FG003|Overall Study|Lost to Follow-up|1|||
162067979|NCT00778700|585304746|FG000|Overall Study|Reason not Specified|2|||
162067980|NCT00778700|585304747|FG001|Overall Study|Reason not Specified|0|||
162067981|NCT00778700|585304748|FG002|Overall Study|Reason not Specified|1|||
162067982|NCT00778700|585304749|FG003|Overall Study|Reason not Specified|3|||
162067983|NCT00778700|585304746|FG000|Overall Study|Other|0|||
162067984|NCT00778700|585304747|FG001|Overall Study|Other|0|||
162067985|NCT00778700|585304748|FG002|Overall Study|Other|1|||
162067986|NCT00778700|585304749|FG003|Overall Study|Other|0|||
162067987|NCT03274440|585304752|FG000|Overall Study|Time commitment too great|1|||
162067988|NCT03274440|585304753|FG001|Overall Study|Time commitment too great|0|||
162067989|NCT03274440|585304754|FG002|Overall Study|Time commitment too great|0|||
162067990|NCT03274440|585304755|FG003|Overall Study|Time commitment too great|1|||
162067991|NCT03274440|585304756|FG004|Overall Study|Time commitment too great|0|||
162067992|NCT03274440|585304757|FG005|Overall Study|Time commitment too great|0|||
162067993|NCT00450450|585304758|FG000|Overall Study|Death|1|||
162067994|NCT00450450|585304759|FG001|Overall Study|Death|3|||
162067995|NCT00450450|585304758|FG000|Overall Study|Relapse|2|||
162067996|NCT00450450|585304759|FG001|Overall Study|Relapse|0|||
162067997|NCT00450450|585304758|FG000|Overall Study|Missing Data|2|||
162067998|NCT00450450|585304759|FG001|Overall Study|Missing Data|0|||
162067999|NCT02150954|585304762|FG000|Overall Study|Protocol Violation|1|||
162068000|NCT02150954|585304763|FG001|Overall Study|Protocol Violation|0|||
162068001|NCT02611778|585304769|FG000|Overall Study|Withdrawal by Subject|2|||
162068002|NCT02611778|585304770|FG001|Overall Study|Withdrawal by Subject|8|||
162068003|NCT02611778|585304769|FG000|Overall Study|Adverse Event|1|||
162068004|NCT02611778|585304770|FG001|Overall Study|Adverse Event|2|||
162068005|NCT02611778|585304769|FG000|Overall Study|Death|2|||
162068006|NCT02611778|585304770|FG001|Overall Study|Death|1|||
162068007|NCT02611778|585304769|FG000|Overall Study|Protocol Violation|1|||
162068008|NCT02611778|585304770|FG001|Overall Study|Protocol Violation|0|||
162068009|NCT02611778|585304769|FG000|Overall Study|Lost to Follow-up|3|||
162068010|NCT02611778|585304770|FG001|Overall Study|Lost to Follow-up|1|||
162068011|NCT02611778|585304769|FG000|Overall Study|Need for alternative treatment|1|||
162068012|NCT02611778|585304770|FG001|Overall Study|Need for alternative treatment|0|||
162068013|NCT02611778|585304769|FG000|Overall Study|Other Reason|2|||
162068014|NCT02611778|585304770|FG001|Overall Study|Other Reason|1|||
162068015|NCT04008030|585304772|FG000|Pre-Treatment|Withdrawal by Subject|0|||
162068016|NCT04008030|585304773|FG001|Pre-Treatment|Withdrawal by Subject|0|||
162068017|NCT04008030|585304774|FG002|Pre-Treatment|Withdrawal by Subject|9|||
162068018|NCT04008030|585304772|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
162068019|NCT04008030|585304773|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
162068020|NCT04008030|585304774|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
162068021|NCT04008030|585304772|FG000|Pre-Treatment|Other reasons|0|||
162068022|NCT04008030|585304773|FG001|Pre-Treatment|Other reasons|1|||
162068023|NCT04008030|585304774|FG002|Pre-Treatment|Other reasons|6|||
162068024|NCT04008030|585304772|FG000|Treatment|Withdrawal by Subject|1|||
162068025|NCT04008030|585304773|FG001|Treatment|Withdrawal by Subject|1|||
162068026|NCT04008030|585304774|FG002|Treatment|Withdrawal by Subject|1|||
162068027|NCT04008030|585304772|FG000|Treatment|Death|2|||
162068028|NCT04008030|585304773|FG001|Treatment|Death|4|||
162068029|NCT04008030|585304774|FG002|Treatment|Death|0|||
162068030|NCT04008030|585304772|FG000|Treatment|Pregnancy|0|||
162068031|NCT04008030|585304773|FG001|Treatment|Pregnancy|1|||
162068032|NCT04008030|585304774|FG002|Treatment|Pregnancy|0|||
162068033|NCT04008030|585304772|FG000|Treatment|Participant no longer meets study criteria|0|||
162068034|NCT04008030|585304773|FG001|Treatment|Participant no longer meets study criteria|1|||
162068035|NCT04008030|585304774|FG002|Treatment|Participant no longer meets study criteria|0|||
162068036|NCT04008030|585304772|FG000|Treatment|Other reasons|5|||
162068037|NCT04008030|585304773|FG001|Treatment|Other reasons|13|||
162068038|NCT04008030|585304774|FG002|Treatment|Other reasons|6|||
162068039|NCT04008030|585304772|FG000|Treatment|Disease Progression|137|||
162068040|NCT04008030|585304773|FG001|Treatment|Disease Progression|82|||
162068041|NCT04008030|585304774|FG002|Treatment|Disease Progression|85|||
162068042|NCT04008030|585304772|FG000|Treatment|Study drug toxicity|28|||
162068043|NCT04008030|585304773|FG001|Treatment|Study drug toxicity|48|||
162068044|NCT04008030|585304774|FG002|Treatment|Study drug toxicity|8|||
162068045|NCT04008030|585304772|FG000|Treatment|Adverse Event unrelated to study drug|28|||
162068046|NCT04008030|585304773|FG001|Treatment|Adverse Event unrelated to study drug|22|||
162068047|NCT04008030|585304774|FG002|Treatment|Adverse Event unrelated to study drug|6|||
162068048|NCT04008030|585304772|FG000|Treatment|Maximum Clinical Benefit|0|||
162068049|NCT04008030|585304773|FG001|Treatment|Maximum Clinical Benefit|1|||
162068050|NCT04008030|585304774|FG002|Treatment|Maximum Clinical Benefit|9|||
162068051|NCT04008030|585304772|FG000|Treatment|On-going treatment|13|||
162068052|NCT04008030|585304773|FG001|Treatment|On-going treatment|20|||
162068053|NCT04008030|585304774|FG002|Treatment|On-going treatment|0|||
162068054|NCT02574247|585304781|FG000|Overall Study|Withdrawal by Subject|1|||
162068055|NCT02574247|585304782|FG001|Overall Study|Withdrawal by Subject|0|||
162068056|NCT02574247|585304783|FG002|Overall Study|Withdrawal by Subject|0|||
162068057|NCT02574247|585304781|FG000|Overall Study|Did not meet inclusion criteria|4|||
162068058|NCT02574247|585304782|FG001|Overall Study|Did not meet inclusion criteria|3|||
162068059|NCT02574247|585304783|FG002|Overall Study|Did not meet inclusion criteria|5|||
162068060|NCT02268864|585304784|FG000|Overall Study|Withdrawal by Subject|2|||
162068061|NCT02268864|585304785|FG001|Overall Study|Withdrawal by Subject|0|||
162068062|NCT02268864|585304786|FG002|Overall Study|Withdrawal by Subject|0|||
162068063|NCT02268864|585304784|FG000|Overall Study|Death|0|||
162068064|NCT02268864|585304785|FG001|Overall Study|Death|1|||
162068065|NCT02268864|585304786|FG002|Overall Study|Death|0|||
162068066|NCT02659631|585304789|FG000|Overall Study|Lost to Follow-up|0|||
162068067|NCT02659631|585304790|FG001|Overall Study|Lost to Follow-up|0|||
162068068|NCT02659631|585304791|FG002|Overall Study|Lost to Follow-up|2|||
162068069|NCT02659631|585304792|FG003|Overall Study|Lost to Follow-up|0|||
162068070|NCT02659631|585304793|FG004|Overall Study|Lost to Follow-up|0|||
162068071|NCT02659631|585304794|FG005|Overall Study|Lost to Follow-up|1|||
162068072|NCT02659631|585304795|FG006|Overall Study|Lost to Follow-up|0|||
162068073|NCT02659631|585304796|FG007|Overall Study|Lost to Follow-up|0|||
162068074|NCT02659631|585304797|FG008|Overall Study|Lost to Follow-up|0|||
162068075|NCT02659631|585304798|FG009|Overall Study|Lost to Follow-up|0|||
162068076|NCT02659631|585304789|FG000|Overall Study|Withdrawal prior to treatment|0|||
162068077|NCT02659631|585304790|FG001|Overall Study|Withdrawal prior to treatment|0|||
162068078|NCT02659631|585304791|FG002|Overall Study|Withdrawal prior to treatment|0|||
162068079|NCT02659631|585304792|FG003|Overall Study|Withdrawal prior to treatment|0|||
162068080|NCT02659631|585304793|FG004|Overall Study|Withdrawal prior to treatment|1|||
162068081|NCT02659631|585304794|FG005|Overall Study|Withdrawal prior to treatment|0|||
162068082|NCT02659631|585304795|FG006|Overall Study|Withdrawal prior to treatment|0|||
162068083|NCT02659631|585304796|FG007|Overall Study|Withdrawal prior to treatment|0|||
162068084|NCT02659631|585304797|FG008|Overall Study|Withdrawal prior to treatment|0|||
162068085|NCT02659631|585304798|FG009|Overall Study|Withdrawal prior to treatment|0|||
162068086|NCT02659631|585304789|FG000|Overall Study|Participant refused further follow-up|0|||
162068087|NCT02659631|585304790|FG001|Overall Study|Participant refused further follow-up|0|||
162068088|NCT02659631|585304791|FG002|Overall Study|Participant refused further follow-up|0|||
162068089|NCT02659631|585304792|FG003|Overall Study|Participant refused further follow-up|1|||
162068090|NCT02659631|585304793|FG004|Overall Study|Participant refused further follow-up|0|||
162068091|NCT02659631|585304794|FG005|Overall Study|Participant refused further follow-up|0|||
162068092|NCT02659631|585304795|FG006|Overall Study|Participant refused further follow-up|0|||
162068093|NCT02659631|585304796|FG007|Overall Study|Participant refused further follow-up|0|||
162068094|NCT02659631|585304797|FG008|Overall Study|Participant refused further follow-up|1|||
162068095|NCT02659631|585304798|FG009|Overall Study|Participant refused further follow-up|0|||
162068096|NCT02659631|585304789|FG000|Overall Study|Death (follow-up phase)|1|||
162068097|NCT02659631|585304790|FG001|Overall Study|Death (follow-up phase)|2|||
162068098|NCT02659631|585304791|FG002|Overall Study|Death (follow-up phase)|1|||
162068099|NCT02659631|585304792|FG003|Overall Study|Death (follow-up phase)|1|||
162068100|NCT02659631|585304793|FG004|Overall Study|Death (follow-up phase)|3|||
162068101|NCT02659631|585304794|FG005|Overall Study|Death (follow-up phase)|2|||
162068102|NCT02659631|585304795|FG006|Overall Study|Death (follow-up phase)|0|||
162068103|NCT02659631|585304796|FG007|Overall Study|Death (follow-up phase)|3|||
162068104|NCT02659631|585304797|FG008|Overall Study|Death (follow-up phase)|1|||
162068105|NCT02659631|585304798|FG009|Overall Study|Death (follow-up phase)|0|||
162068106|NCT02659631|585304789|FG000|Overall Study|Death (treatment phase)|0|||
162068107|NCT02659631|585304790|FG001|Overall Study|Death (treatment phase)|0|||
162068108|NCT02659631|585304791|FG002|Overall Study|Death (treatment phase)|0|||
162068109|NCT02659631|585304792|FG003|Overall Study|Death (treatment phase)|0|||
162068110|NCT02659631|585304793|FG004|Overall Study|Death (treatment phase)|1|||
162068111|NCT02659631|585304794|FG005|Overall Study|Death (treatment phase)|0|||
162068112|NCT02659631|585304795|FG006|Overall Study|Death (treatment phase)|1|||
162068113|NCT02659631|585304796|FG007|Overall Study|Death (treatment phase)|0|||
162068114|NCT02659631|585304797|FG008|Overall Study|Death (treatment phase)|0|||
162068115|NCT02659631|585304798|FG009|Overall Study|Death (treatment phase)|0|||
162068116|NCT01928329|585304799|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
162068117|NCT01928329|585304800|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
162068118|NCT01928329|585304799|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
162068119|NCT01928329|585304800|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
162068120|NCT01928329|585304799|FG000|Overall Study|Adverse Event|5|||
162068121|NCT01928329|585304800|FG001|Overall Study|Adverse Event|3|||
162068122|NCT01928329|585304799|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
162068123|NCT01928329|585304800|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
162068124|NCT01928329|585304799|FG000|Overall Study|Withdrawal by Subject|1|||
162068125|NCT01928329|585304800|FG001|Overall Study|Withdrawal by Subject|5|||
162068126|NCT01928329|585304799|FG000|Overall Study|Physician Decision|1|||
162068127|NCT01928329|585304800|FG001|Overall Study|Physician Decision|1|||
162068128|NCT01496313|585304801|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
162068129|NCT01496313|585304802|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
162068130|NCT01496313|585304803|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
162068131|NCT01496313|585304804|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
162068132|NCT01496313|585304805|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
162068133|NCT01496313|585304806|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
162068134|NCT01496313|585304801|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
162068135|NCT01496313|585304802|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
162068136|NCT01496313|585304803|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
162068137|NCT01496313|585304804|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
162068138|NCT01496313|585304805|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
162068139|NCT01496313|585304806|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
162068140|NCT01496313|585304801|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
162068141|NCT01496313|585304802|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
162068142|NCT01496313|585304803|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
162068143|NCT01496313|585304804|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
162068144|NCT01496313|585304805|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
162068145|NCT01496313|585304806|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
162068146|NCT01496313|585304801|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
162068147|NCT01496313|585304802|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
162068148|NCT01496313|585304803|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
162068149|NCT01496313|585304804|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
162068150|NCT01496313|585304805|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
162068151|NCT01496313|585304806|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
162068152|NCT01496313|585304801|FG000|Randomized Period (up to 14 Months)|Other|1|||
162068153|NCT01496313|585304802|FG001|Randomized Period (up to 14 Months)|Other|2|||
162068154|NCT01496313|585304803|FG002|Randomized Period (up to 14 Months)|Other|0|||
162068155|NCT01496313|585304804|FG003|Randomized Period (up to 14 Months)|Other|0|||
162068156|NCT01496313|585304805|FG004|Randomized Period (up to 14 Months)|Other|0|||
162068157|NCT01496313|585304806|FG005|Randomized Period (up to 14 Months)|Other|0|||
162068158|NCT01496313|585304801|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
162068159|NCT01496313|585304802|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
162068160|NCT01496313|585304803|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
162068161|NCT01496313|585304804|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
162068162|NCT01496313|585304805|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
162068163|NCT01496313|585304806|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
162068164|NCT01496313|585304801|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
162068165|NCT01496313|585304802|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
162068166|NCT01496313|585304803|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
162068167|NCT01496313|585304804|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
162068168|NCT01496313|585304805|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
162068169|NCT01496313|585304806|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
162068170|NCT01496313|585304801|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
162068171|NCT01496313|585304802|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
162068172|NCT01496313|585304803|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
162068173|NCT01496313|585304804|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
162068174|NCT01496313|585304805|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
162068175|NCT01496313|585304806|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
162068176|NCT00171223|585304813|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
162068177|NCT00171223|585304814|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
162068178|NCT00171223|585304815|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
162068179|NCT00171223|585304813|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
162068180|NCT00171223|585304814|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
162068181|NCT00171223|585304815|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
162068182|NCT00171223|585304813|FG000|Overall Study|Abnormal Procedure|1|||
162068183|NCT00171223|585304814|FG001|Overall Study|Abnormal Procedure|0|||
162068184|NCT00171223|585304815|FG002|Overall Study|Abnormal Procedure|0|||
162068185|NCT00171223|585304813|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
162068186|NCT00171223|585304814|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
162068187|NCT00171223|585304815|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
162068188|NCT00171223|585304813|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
162068189|NCT00171223|585304814|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
162068190|NCT00171223|585304815|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
162068191|NCT00171223|585304813|FG000|Overall Study|Protocol Violation|2|||
162068192|NCT00171223|585304814|FG001|Overall Study|Protocol Violation|2|||
162068193|NCT00171223|585304815|FG002|Overall Study|Protocol Violation|3|||
162068194|NCT00171223|585304813|FG000|Overall Study|Participant Withdrew Consent|12|||
162068195|NCT00171223|585304814|FG001|Overall Study|Participant Withdrew Consent|21|||
162068196|NCT00171223|585304815|FG002|Overall Study|Participant Withdrew Consent|15|||
162068197|NCT00171223|585304813|FG000|Overall Study|Lost to Follow-up|5|||
162068198|NCT00171223|585304814|FG001|Overall Study|Lost to Follow-up|2|||
162068199|NCT00171223|585304815|FG002|Overall Study|Lost to Follow-up|3|||
162068200|NCT00171223|585304813|FG000|Overall Study|Administrative Problems|4|||
162068201|NCT00171223|585304814|FG001|Overall Study|Administrative Problems|7|||
162068202|NCT00171223|585304815|FG002|Overall Study|Administrative Problems|6|||
162068203|NCT00171223|585304813|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
162068204|NCT00171223|585304814|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
162068205|NCT00171223|585304815|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
162068206|NCT00171223|585304813|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
162068207|NCT00171223|585304814|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
162068208|NCT00171223|585304815|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
162068209|NCT02064166|585304816|FG000|Overall Study|Adverse Event|1|||
162068210|NCT02064166|585304817|FG001|Overall Study|Adverse Event|0|||
162068211|NCT01528254|585304820|FG000|Overall Study|Administrative problems|96|||
162068212|NCT01528254|585304821|FG001|Overall Study|Administrative problems|94|||
162068213|NCT01528254|585304820|FG000|Overall Study|Adverse Event|28|||
162068214|NCT01528254|585304821|FG001|Overall Study|Adverse Event|44|||
162068215|NCT01528254|585304820|FG000|Overall Study|Lost to Follow-up|17|||
162068216|NCT01528254|585304821|FG001|Overall Study|Lost to Follow-up|24|||
162068217|NCT01528254|585304820|FG000|Overall Study|Death|13|||
162068218|NCT01528254|585304821|FG001|Overall Study|Death|9|||
162068219|NCT01528254|585304820|FG000|Overall Study|Protocol deviation|9|||
162068220|NCT01528254|585304821|FG001|Overall Study|Protocol deviation|19|||
162068221|NCT01528254|585304820|FG000|Overall Study|New therapy for study indication|8|||
162068222|NCT01528254|585304821|FG001|Overall Study|New therapy for study indication|6|||
162068223|NCT01528254|585304820|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
162068224|NCT01528254|585304821|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
162068225|NCT01528254|585304820|FG000|Overall Study|Withdrawal by Subject|5|||
162068226|NCT01528254|585304821|FG001|Overall Study|Withdrawal by Subject|4|||
162068227|NCT01528254|585304820|FG000|Overall Study|Abnormal laboratory value(s)|3|||
162068228|NCT01528254|585304821|FG001|Overall Study|Abnormal laboratory value(s)|7|||
162068229|NCT01528254|585304820|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162068230|NCT01528254|585304821|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162068231|NCT01528254|585304820|FG000|Overall Study|No longer requires study drug|1|||
162068232|NCT01528254|585304821|FG001|Overall Study|No longer requires study drug|1|||
162068233|NCT00416078|585304824|FG000|Overall Study|Death|3|||
162068234|NCT00416078|585304825|FG001|Overall Study|Death|4|||
162068235|NCT00416078|585304824|FG000|Overall Study|Withdrawal by Subject|3|||
162068236|NCT00416078|585304825|FG001|Overall Study|Withdrawal by Subject|2|||
162068237|NCT00416078|585304824|FG000|Overall Study|Physician Decision|1|||
162068238|NCT00416078|585304825|FG001|Overall Study|Physician Decision|0|||
162068239|NCT00416078|585304824|FG000|Overall Study|Lost to Follow-up|4|||
162068240|NCT00416078|585304825|FG001|Overall Study|Lost to Follow-up|2|||
162068241|NCT03564145|585304834|FG000|Overall Study|Adverse Event|4|||
162068242|NCT03564145|585304834|FG000|Overall Study|Lost to Follow-up|21|||
162068243|NCT03564145|585304834|FG000|Overall Study|Protocol Violation|2|||
162068244|NCT03564145|585304834|FG000|Overall Study|Withdrawal by Subject|48|||
162068245|NCT03564145|585304834|FG000|Overall Study|Study Terminated by Sponsor|146|||
162068246|NCT03564145|585304834|FG000|Overall Study|Physician Decision|1|||
162068247|NCT03564145|585304834|FG000|Overall Study|Other Than Specified|1|||
162068248|NCT03564145|585304834|FG000|Overall Study|Pregnancy|1|||
162068249|NCT04219891|585304837|FG000|Overall Study|Lost to Follow-up|3|||
162068250|NCT04219891|585304837|FG000|Overall Study|Withdrawal by Subject|2|||
162068251|NCT00410761|585306653|FG000|Randomized Treatment Period|Adverse Event|34|||
162068252|NCT00410761|585306654|FG001|Randomized Treatment Period|Adverse Event|3|||
162068253|NCT00410761|585306653|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
162068254|NCT00410761|585306654|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
162068255|NCT00410761|585306653|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
162068256|NCT00410761|585306654|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
162068257|NCT00410761|585306653|FG000|Randomized Treatment Period|Other|69|||
162068258|NCT00410761|585306654|FG001|Randomized Treatment Period|Other|21|||
162068259|NCT00410761|585306653|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
162068260|NCT00410761|585306654|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
162068261|NCT00410761|585306653|FG000|Open-Label Treatment Period|Adverse Event|13|||
162068262|NCT00410761|585306654|FG001|Open-Label Treatment Period|Adverse Event|15|||
162068263|NCT00410761|585306653|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
162068264|NCT00410761|585306654|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
162068265|NCT00410761|585306653|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
162068266|NCT00410761|585306654|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
162068267|NCT00410761|585306653|FG000|Open-Label Treatment Period|Other|18|||
162068268|NCT00410761|585306654|FG001|Open-Label Treatment Period|Other|9|||
162068269|NCT00773292|585306658|FG000|Treatment 48 Weeks|Adverse Event|1|||
162068270|NCT00773292|585306658|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
162068271|NCT00573755|585306659|FG000|Overall Study|Still receiving treatment|1|||
162068272|NCT00573755|585306660|FG001|Overall Study|Still receiving treatment|0|||
162068273|NCT03724812|585306661|FG000|Overall Study|Missed Visit|1|||
162068274|NCT03724812|585306661|FG000|Overall Study|Death|2|||
162068275|NCT03724812|585306661|FG000|Overall Study|Withdrawal by Subject|1|||
162068276|NCT03525574|585306665|FG000|Overall Study|Adverse Event|15|||
162068277|NCT03525574|585306666|FG001|Overall Study|Adverse Event|0|||
162068278|NCT03525574|585306665|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
162068279|NCT03525574|585306666|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
162068280|NCT03525574|585306665|FG000|Overall Study|Lost to Follow-up|4|||
162068281|NCT03525574|585306666|FG001|Overall Study|Lost to Follow-up|0|||
162068282|NCT03525574|585306665|FG000|Overall Study|Commercial drug is Available for participant|48|||
162068283|NCT03525574|585306666|FG001|Overall Study|Commercial drug is Available for participant|0|||
162068284|NCT03525574|585306665|FG000|Overall Study|Death|1|||
162068285|NCT03525574|585306666|FG001|Overall Study|Death|0|||
162068286|NCT03525574|585306665|FG000|Overall Study|Other non-compliance|2|||
162068287|NCT03525574|585306666|FG001|Overall Study|Other non-compliance|0|||
162068288|NCT03525574|585306665|FG000|Overall Study|Physician Decision|6|||
162068289|NCT03525574|585306666|FG001|Overall Study|Physician Decision|0|||
162068290|NCT03525574|585306665|FG000|Overall Study|Other|58|||
162068291|NCT03525574|585306666|FG001|Overall Study|Other|0|||
162068292|NCT03525574|585306665|FG000|Overall Study|Enrolled but never dosed|1|||
162068293|NCT03525574|585306666|FG001|Overall Study|Enrolled but never dosed|0|||
162068294|NCT03525574|585306665|FG000|Overall Study|Not enrolled in 105 study|0|||
162068295|NCT03525574|585306666|FG001|Overall Study|Not enrolled in 105 study|3|||
162068296|NCT03227029|585306672|FG000|Overall Study|Child Wheezed (no treatment)|0|||
162068297|NCT03227029|585306673|FG001|Overall Study|Child Wheezed (no treatment)|1|||
162068298|NCT03227029|585306674|FG002|Overall Study|Child Wheezed (no treatment)|0|||
162068299|NCT03227029|585306672|FG000|Overall Study|No post RSV season visit due to COVID|3|||
162068300|NCT03227029|585306673|FG001|Overall Study|No post RSV season visit due to COVID|3|||
162068301|NCT03227029|585306674|FG002|Overall Study|No post RSV season visit due to COVID|2|||
162068302|NCT03227029|585306672|FG000|Overall Study|Not able to get to clinic|0|||
162068303|NCT03227029|585306673|FG001|Overall Study|Not able to get to clinic|0|||
162068304|NCT03227029|585306674|FG002|Overall Study|Not able to get to clinic|1|||
162068305|NCT03227029|585306672|FG000|Overall Study|Withdrawal by Subject|1|||
162068306|NCT03227029|585306673|FG001|Overall Study|Withdrawal by Subject|0|||
162068307|NCT03227029|585306674|FG002|Overall Study|Withdrawal by Subject|0|||
162068308|NCT03227029|585306672|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
162068309|NCT03227029|585306673|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
162068310|NCT03227029|585306674|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
162068311|NCT01291173|585306675|FG000|Overall Study|Adverse Event|0|||
162068312|NCT01291173|585306676|FG001|Overall Study|Adverse Event|3|||
162068313|NCT01291173|585306677|FG002|Overall Study|Adverse Event|1|||
162068314|NCT01291173|585306678|FG003|Overall Study|Adverse Event|3|||
162068315|NCT01291173|585306675|FG000|Overall Study|Protocol Violation|7|||
162068316|NCT01291173|585306676|FG001|Overall Study|Protocol Violation|2|||
162068317|NCT01291173|585306677|FG002|Overall Study|Protocol Violation|2|||
162068318|NCT01291173|585306678|FG003|Overall Study|Protocol Violation|5|||
162237440|NCT00600886|585921097|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
162068319|NCT01291173|585306675|FG000|Overall Study|Withdrawal by Subject|6|||
162068320|NCT01291173|585306676|FG001|Overall Study|Withdrawal by Subject|4|||
162068321|NCT01291173|585306677|FG002|Overall Study|Withdrawal by Subject|4|||
162068322|NCT01291173|585306678|FG003|Overall Study|Withdrawal by Subject|2|||
162068323|NCT01291173|585306675|FG000|Overall Study|Lost to Follow-up|4|||
162068324|NCT01291173|585306676|FG001|Overall Study|Lost to Follow-up|6|||
162068325|NCT01291173|585306677|FG002|Overall Study|Lost to Follow-up|3|||
162068326|NCT01291173|585306678|FG003|Overall Study|Lost to Follow-up|2|||
162068327|NCT01291173|585306675|FG000|Overall Study|Unable to meet visit schedule|0|||
162068328|NCT01291173|585306676|FG001|Overall Study|Unable to meet visit schedule|0|||
162068329|NCT01291173|585306677|FG002|Overall Study|Unable to meet visit schedule|1|||
162068330|NCT01291173|585306678|FG003|Overall Study|Unable to meet visit schedule|0|||
162068331|NCT01291173|585306675|FG000|Overall Study|Lack of compliance|0|||
162068332|NCT01291173|585306676|FG001|Overall Study|Lack of compliance|0|||
162068333|NCT01291173|585306677|FG002|Overall Study|Lack of compliance|0|||
162068334|NCT01291173|585306678|FG003|Overall Study|Lack of compliance|1|||
162068335|NCT01291173|585306675|FG000|Overall Study|Subject was unblinded|0|||
162068336|NCT01291173|585306676|FG001|Overall Study|Subject was unblinded|0|||
162068337|NCT01291173|585306677|FG002|Overall Study|Subject was unblinded|1|||
162068338|NCT01291173|585306678|FG003|Overall Study|Subject was unblinded|0|||
162068339|NCT01291173|585306675|FG000|Overall Study|Excluded therapy|0|||
162068340|NCT01291173|585306676|FG001|Overall Study|Excluded therapy|0|||
162068341|NCT01291173|585306677|FG002|Overall Study|Excluded therapy|1|||
162068342|NCT01291173|585306678|FG003|Overall Study|Excluded therapy|0|||
162068343|NCT01074450|585306684|FG000|First Intervention|Emesis in Dosing Interval|0|||
162068344|NCT01074450|585306685|FG001|First Intervention|Emesis in Dosing Interval|2|||
162068345|NCT01074450|585306684|FG000|Second Intervention|Protocol Violation|1|||
162068346|NCT01074450|585306685|FG001|Second Intervention|Protocol Violation|0|||
162068347|NCT01074450|585306684|FG000|Second Intervention|Physician Decision|0|||
162068348|NCT01074450|585306685|FG001|Second Intervention|Physician Decision|1|||
162068349|NCT02728895|585306686|FG000|Overall Study|Other|1|||
162068350|NCT02728895|585306687|FG001|Overall Study|Other|2|||
162068351|NCT02728895|585306686|FG000|Overall Study|Withdrawal by Subject|0|||
162068352|NCT02728895|585306687|FG001|Overall Study|Withdrawal by Subject|3|||
162068353|NCT02769247|585306688|FG000|Overall Study|Withdrawal by Subject|1|||
162068354|NCT02769247|585306689|FG001|Overall Study|Withdrawal by Subject|0|||
162068355|NCT02769247|585306690|FG002|Overall Study|Withdrawal by Subject|0|||
162068356|NCT02769247|585306691|FG003|Overall Study|Withdrawal by Subject|1|||
162068357|NCT02769247|585306688|FG000|Overall Study|Protocol Violation|0|||
162068358|NCT02769247|585306689|FG001|Overall Study|Protocol Violation|0|||
162068359|NCT02769247|585306690|FG002|Overall Study|Protocol Violation|1|||
162068360|NCT02769247|585306691|FG003|Overall Study|Protocol Violation|0|||
162068361|NCT02769247|585306688|FG000|Overall Study|Physician Decision|1|||
162068362|NCT02769247|585306689|FG001|Overall Study|Physician Decision|0|||
162068363|NCT02769247|585306690|FG002|Overall Study|Physician Decision|0|||
162068364|NCT02769247|585306691|FG003|Overall Study|Physician Decision|0|||
162068365|NCT04788953|585306692|FG000|Overall Study|Adverse Event|1|||
162068366|NCT04788953|585306693|FG001|Overall Study|Adverse Event|1|||
162068367|NCT04788953|585306692|FG000|Overall Study|Withdrawal by Subject|1|||
162068368|NCT04788953|585306693|FG001|Overall Study|Withdrawal by Subject|0|||
162068369|NCT04788953|585306692|FG000|Overall Study|Protocol Violation|0|||
162068370|NCT04788953|585306693|FG001|Overall Study|Protocol Violation|1|||
162068371|NCT00469092|585306694|FG000|Overall Study|Adverse Event|5|||
162068372|NCT00469092|585306695|FG001|Overall Study|Adverse Event|4|||
162068373|NCT00469092|585306694|FG000|Overall Study|Lack of Efficacy|1|||
162068374|NCT00469092|585306695|FG001|Overall Study|Lack of Efficacy|0|||
162068375|NCT00469092|585306694|FG000|Overall Study|Lost to Follow-up|1|||
162068376|NCT00469092|585306695|FG001|Overall Study|Lost to Follow-up|2|||
162068377|NCT00469092|585306694|FG000|Overall Study|Protocol Violation|3|||
162068378|NCT00469092|585306695|FG001|Overall Study|Protocol Violation|3|||
162068379|NCT00469092|585306694|FG000|Overall Study|Withdrawal by Subject|4|||
162068380|NCT00469092|585306695|FG001|Overall Study|Withdrawal by Subject|4|||
162068381|NCT00469092|585306694|FG000|Overall Study|Withdrawal Criteria|3|||
162068382|NCT00469092|585306695|FG001|Overall Study|Withdrawal Criteria|4|||
162068383|NCT00469092|585306694|FG000|Overall Study|Incorrectly Randomised|4|||
162068384|NCT00469092|585306695|FG001|Overall Study|Incorrectly Randomised|3|||
162068385|NCT00469092|585306694|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
162068386|NCT00469092|585306695|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
162068387|NCT00469092|585306694|FG000|Overall Study|Use of lipid lowering drug|1|||
162068388|NCT00469092|585306695|FG001|Overall Study|Use of lipid lowering drug|0|||
162068389|NCT00469092|585306694|FG000|Overall Study|Hypoglycaemic Episodes|1|||
162068390|NCT00469092|585306695|FG001|Overall Study|Hypoglycaemic Episodes|1|||
162068391|NCT00469092|585306694|FG000|Overall Study|Abnormal lab value|1|||
162068392|NCT00469092|585306695|FG001|Overall Study|Abnormal lab value|0|||
162068393|NCT00469092|585306694|FG000|Overall Study|Use of Corticosteroid|1|||
162068394|NCT00469092|585306695|FG001|Overall Study|Use of Corticosteroid|0|||
162068395|NCT02024867|585306696|FG000|Overall Study|Protocol Violation|3|||
162068396|NCT02024867|585306697|FG001|Overall Study|Protocol Violation|3|||
162068397|NCT02024867|585306696|FG000|Overall Study|Lost to Follow-up|6|||
162068398|NCT02024867|585306697|FG001|Overall Study|Lost to Follow-up|4|||
162068399|NCT02369341|585306700|FG000|Overall Study|Migrated/moved from study area|1|||
162068400|NCT02369341|585306701|FG001|Overall Study|Migrated/moved from study area|0|||
162068401|NCT01086540|585306702|FG000|Overall Study|Death|3|||
162068402|NCT01086540|585306703|FG001|Overall Study|Death|1|||
162068403|NCT01086540|585306702|FG000|Overall Study|Physician Decision|2|||
162068404|NCT01086540|585306703|FG001|Overall Study|Physician Decision|1|||
162068405|NCT01086540|585306702|FG000|Overall Study|Addition of new therapy for PAH|1|||
162068406|NCT01086540|585306703|FG001|Overall Study|Addition of new therapy for PAH|0|||
162068407|NCT02707991|585306704|FG000|Overall Study|Protocol Violation|1|||
162068408|NCT02707991|585306705|FG001|Overall Study|Protocol Violation|0|||
162068409|NCT02707991|585306704|FG000|Overall Study|Became ineligible|0|||
162068410|NCT02707991|585306705|FG001|Overall Study|Became ineligible|1|||
162068411|NCT05407675|585306708|FG000|Overall Study|Withdrawal by Subject|0|||
162068412|NCT05407675|585306709|FG001|Overall Study|Withdrawal by Subject|2|||
162068413|NCT05407675|585306710|FG002|Overall Study|Withdrawal by Subject|3|||
162068414|NCT05407675|585306711|FG003|Overall Study|Withdrawal by Subject|5|||
162068415|NCT05407675|585306712|FG004|Overall Study|Withdrawal by Subject|0|||
162068416|NCT05407675|585306713|FG005|Overall Study|Withdrawal by Subject|2|||
162068417|NCT05407675|585306714|FG006|Overall Study|Withdrawal by Subject|0|||
162068418|NCT05407675|585306715|FG007|Overall Study|Withdrawal by Subject|0|||
162068419|NCT05407675|585306716|FG008|Overall Study|Withdrawal by Subject|2|||
162068420|NCT05407675|585306717|FG009|Overall Study|Withdrawal by Subject|0|||
162068421|NCT05407675|585306718|FG010|Overall Study|Withdrawal by Subject|1|||
162068422|NCT05407675|585306719|FG011|Overall Study|Withdrawal by Subject|0|||
162068423|NCT05407675|585306720|FG012|Overall Study|Withdrawal by Subject|0|||
162068424|NCT05407675|585306708|FG000|Overall Study|Site terminated by sponsor|0|||
162068425|NCT05407675|585306709|FG001|Overall Study|Site terminated by sponsor|0|||
162068426|NCT05407675|585306710|FG002|Overall Study|Site terminated by sponsor|1|||
162068427|NCT05407675|585306711|FG003|Overall Study|Site terminated by sponsor|0|||
162068428|NCT05407675|585306712|FG004|Overall Study|Site terminated by sponsor|2|||
162068429|NCT05407675|585306713|FG005|Overall Study|Site terminated by sponsor|0|||
162068430|NCT05407675|585306714|FG006|Overall Study|Site terminated by sponsor|1|||
162068431|NCT05407675|585306715|FG007|Overall Study|Site terminated by sponsor|0|||
162068432|NCT05407675|585306716|FG008|Overall Study|Site terminated by sponsor|0|||
162068433|NCT05407675|585306717|FG009|Overall Study|Site terminated by sponsor|2|||
162068434|NCT05407675|585306718|FG010|Overall Study|Site terminated by sponsor|2|||
162068435|NCT05407675|585306719|FG011|Overall Study|Site terminated by sponsor|2|||
162068436|NCT05407675|585306720|FG012|Overall Study|Site terminated by sponsor|1|||
162068437|NCT05407675|585306708|FG000|Overall Study|Disease Progression|0|||
162068438|NCT05407675|585306709|FG001|Overall Study|Disease Progression|0|||
162068439|NCT05407675|585306710|FG002|Overall Study|Disease Progression|0|||
162068440|NCT05407675|585306711|FG003|Overall Study|Disease Progression|0|||
162068441|NCT05407675|585306712|FG004|Overall Study|Disease Progression|0|||
162068442|NCT05407675|585306713|FG005|Overall Study|Disease Progression|0|||
162068443|NCT05407675|585306714|FG006|Overall Study|Disease Progression|0|||
162068444|NCT05407675|585306715|FG007|Overall Study|Disease Progression|0|||
162068445|NCT05407675|585306716|FG008|Overall Study|Disease Progression|0|||
162068446|NCT05407675|585306717|FG009|Overall Study|Disease Progression|0|||
162068447|NCT05407675|585306718|FG010|Overall Study|Disease Progression|1|||
162068448|NCT05407675|585306719|FG011|Overall Study|Disease Progression|0|||
162068449|NCT05407675|585306720|FG012|Overall Study|Disease Progression|0|||
162068450|NCT05407675|585306708|FG000|Overall Study|Physician Decision|0|||
162068451|NCT05407675|585306709|FG001|Overall Study|Physician Decision|0|||
162068452|NCT05407675|585306710|FG002|Overall Study|Physician Decision|0|||
162068453|NCT05407675|585306711|FG003|Overall Study|Physician Decision|0|||
162068454|NCT05407675|585306712|FG004|Overall Study|Physician Decision|0|||
162068455|NCT05407675|585306713|FG005|Overall Study|Physician Decision|0|||
162068456|NCT05407675|585306714|FG006|Overall Study|Physician Decision|0|||
162068457|NCT05407675|585306715|FG007|Overall Study|Physician Decision|0|||
162068458|NCT05407675|585306716|FG008|Overall Study|Physician Decision|0|||
162068459|NCT05407675|585306717|FG009|Overall Study|Physician Decision|0|||
162068460|NCT05407675|585306718|FG010|Overall Study|Physician Decision|1|||
162068461|NCT05407675|585306719|FG011|Overall Study|Physician Decision|0|||
162068462|NCT05407675|585306720|FG012|Overall Study|Physician Decision|0|||
162068463|NCT05407675|585306708|FG000|Overall Study|Other reasons|0|||
162068464|NCT05407675|585306709|FG001|Overall Study|Other reasons|0|||
162068465|NCT05407675|585306710|FG002|Overall Study|Other reasons|0|||
162068466|NCT05407675|585306711|FG003|Overall Study|Other reasons|0|||
162237441|NCT00600886|585921096|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
162068467|NCT05407675|585306712|FG004|Overall Study|Other reasons|0|||
162068468|NCT05407675|585306713|FG005|Overall Study|Other reasons|0|||
162068469|NCT05407675|585306714|FG006|Overall Study|Other reasons|0|||
162068470|NCT05407675|585306715|FG007|Overall Study|Other reasons|0|||
162068471|NCT05407675|585306716|FG008|Overall Study|Other reasons|1|||
162068472|NCT05407675|585306717|FG009|Overall Study|Other reasons|1|||
162068473|NCT05407675|585306718|FG010|Overall Study|Other reasons|1|||
162068474|NCT05407675|585306719|FG011|Overall Study|Other reasons|1|||
162068475|NCT05407675|585306720|FG012|Overall Study|Other reasons|0|||
162068476|NCT05407675|585306708|FG000|Overall Study|Death|3|||
162068477|NCT05407675|585306709|FG001|Overall Study|Death|4|||
162068478|NCT05407675|585306710|FG002|Overall Study|Death|3|||
162068479|NCT05407675|585306711|FG003|Overall Study|Death|6|||
162068480|NCT05407675|585306712|FG004|Overall Study|Death|0|||
162068481|NCT05407675|585306713|FG005|Overall Study|Death|2|||
162068482|NCT05407675|585306714|FG006|Overall Study|Death|4|||
162068483|NCT05407675|585306715|FG007|Overall Study|Death|2|||
162068484|NCT05407675|585306716|FG008|Overall Study|Death|2|||
162068485|NCT05407675|585306717|FG009|Overall Study|Death|4|||
162068486|NCT05407675|585306718|FG010|Overall Study|Death|2|||
162068487|NCT05407675|585306719|FG011|Overall Study|Death|1|||
162068488|NCT05407675|585306720|FG012|Overall Study|Death|0|||
162068489|NCT05407675|585306708|FG000|Overall Study|Adverse Event|0|||
162068490|NCT05407675|585306709|FG001|Overall Study|Adverse Event|0|||
162068491|NCT05407675|585306710|FG002|Overall Study|Adverse Event|0|||
162068492|NCT05407675|585306711|FG003|Overall Study|Adverse Event|0|||
162068493|NCT05407675|585306712|FG004|Overall Study|Adverse Event|1|||
162068494|NCT05407675|585306713|FG005|Overall Study|Adverse Event|0|||
162068495|NCT05407675|585306714|FG006|Overall Study|Adverse Event|0|||
162068496|NCT05407675|585306715|FG007|Overall Study|Adverse Event|0|||
162068497|NCT05407675|585306716|FG008|Overall Study|Adverse Event|0|||
162068498|NCT05407675|585306717|FG009|Overall Study|Adverse Event|0|||
162068499|NCT05407675|585306718|FG010|Overall Study|Adverse Event|0|||
162068500|NCT05407675|585306719|FG011|Overall Study|Adverse Event|1|||
162068501|NCT05407675|585306720|FG012|Overall Study|Adverse Event|0|||
162068502|NCT05407675|585306708|FG000|Overall Study|Ongoing Treatment|0|||
162068503|NCT05407675|585306709|FG001|Overall Study|Ongoing Treatment|0|||
162068504|NCT05407675|585306710|FG002|Overall Study|Ongoing Treatment|0|||
162068505|NCT05407675|585306711|FG003|Overall Study|Ongoing Treatment|0|||
162068506|NCT05407675|585306712|FG004|Overall Study|Ongoing Treatment|0|||
162068507|NCT05407675|585306713|FG005|Overall Study|Ongoing Treatment|0|||
162068508|NCT05407675|585306714|FG006|Overall Study|Ongoing Treatment|0|||
162068509|NCT05407675|585306715|FG007|Overall Study|Ongoing Treatment|0|||
162068510|NCT05407675|585306716|FG008|Overall Study|Ongoing Treatment|1|||
162068511|NCT05407675|585306717|FG009|Overall Study|Ongoing Treatment|0|||
162068512|NCT05407675|585306718|FG010|Overall Study|Ongoing Treatment|0|||
162068513|NCT05407675|585306719|FG011|Overall Study|Ongoing Treatment|0|||
162068514|NCT05407675|585306720|FG012|Overall Study|Ongoing Treatment|0|||
162068515|NCT00857220|585306721|FG000|Overall Study|Adverse Event|35|||
162068516|NCT00857220|585306721|FG000|Overall Study|Death|1|||
162068517|NCT00857220|585306721|FG000|Overall Study|Lack of Efficacy|11|||
162068518|NCT00857220|585306721|FG000|Overall Study|Lost to Follow-up|30|||
162068519|NCT00857220|585306721|FG000|Overall Study|Physician Decision|4|||
162068520|NCT00857220|585306721|FG000|Overall Study|Protocol Violation|16|||
162068521|NCT00857220|585306721|FG000|Overall Study|Withdrawal by Subject|67|||
162068522|NCT00857220|585306721|FG000|Overall Study|Clinical Hold|6|||
162068523|NCT00857220|585306721|FG000|Overall Study|Site Closed|5|||
162068524|NCT00857220|585306721|FG000|Overall Study|Miscellaneous|8|||
162068525|NCT02612428|585306722|FG000|VTL-308|Death|14|||
162068526|NCT02612428|585306723|FG001|VTL-308|Death|16|||
162068527|NCT02612428|585306722|FG000|VTL-308|Withdrawal by Subject|0|||
162068528|NCT02612428|585306723|FG001|VTL-308|Withdrawal by Subject|1|||
162068529|NCT02612428|585306722|FG000|VTL-308E|Death|9|||
162068530|NCT02612428|585306723|FG001|VTL-308E|Death|7|||
162068531|NCT02612428|585306722|FG000|VTL-308E|Lost to Follow-up|2|||
162068532|NCT02612428|585306723|FG001|VTL-308E|Lost to Follow-up|0|||
162068533|NCT00742001|585306726|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
162068534|NCT00742001|585306727|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
162068535|NCT00742001|585306728|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
162068536|NCT00137423|585306729|FG000|Overall Study|Adverse Event|7|||
162068537|NCT00137423|585306730|FG001|Overall Study|Adverse Event|9|||
162068538|NCT00137423|585306729|FG000|Overall Study|consent withdrawn|1|||
162068539|NCT00137423|585306730|FG001|Overall Study|consent withdrawn|1|||
162068540|NCT00137423|585306729|FG000|Overall Study|Lack of Efficacy|31|||
162068541|NCT00137423|585306730|FG001|Overall Study|Lack of Efficacy|33|||
162068542|NCT00137423|585306729|FG000|Overall Study|Death|0|||
162068543|NCT00137423|585306730|FG001|Overall Study|Death|1|||
162068544|NCT03187262|585306731|FG000|Induction|Lack of Efficacy|2|||
162068545|NCT03187262|585306731|FG000|Induction|Progressive Disease|4|||
162068546|NCT03187262|585306731|FG000|Consolidation|Progressive Disease|5|||
162068547|NCT01050257|585306734|FG000|Overall Study|Adverse Event|4|||
162068548|NCT01050257|585306735|FG001|Overall Study|Adverse Event|4|||
162068549|NCT01050257|585306736|FG002|Overall Study|Adverse Event|2|||
162068550|NCT01050257|585306734|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
162068551|NCT01050257|585306735|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
162068552|NCT01050257|585306736|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
162068553|NCT01050257|585306734|FG000|Overall Study|Withdrawal by Subject|0|||
162068554|NCT01050257|585306735|FG001|Overall Study|Withdrawal by Subject|3|||
162068555|NCT01050257|585306736|FG002|Overall Study|Withdrawal by Subject|0|||
162068556|NCT01050257|585306734|FG000|Overall Study|No reason specified|0|||
162068557|NCT01050257|585306735|FG001|Overall Study|No reason specified|0|||
162068558|NCT01050257|585306736|FG002|Overall Study|No reason specified|2|||
162068559|NCT01050257|585306734|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
162068560|NCT01050257|585306735|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
162068561|NCT01050257|585306736|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
162068562|NCT01050257|585306734|FG000|Overall Study|Violation criteria|0|||
162068563|NCT01050257|585306735|FG001|Overall Study|Violation criteria|1|||
162068564|NCT01050257|585306736|FG002|Overall Study|Violation criteria|0|||
162068565|NCT01050257|585306734|FG000|Overall Study|Failure to return|0|||
162068566|NCT01050257|585306735|FG001|Overall Study|Failure to return|2|||
162068567|NCT01050257|585306736|FG002|Overall Study|Failure to return|0|||
162068568|NCT01050257|585306734|FG000|Overall Study|Death|0|||
162068569|NCT01050257|585306735|FG001|Overall Study|Death|0|||
162068570|NCT01050257|585306736|FG002|Overall Study|Death|1|||
162068571|NCT02580357|585306737|FG000|Overall Study|Lost to Follow-up|2|||
162068572|NCT02580357|585306738|FG001|Overall Study|Lost to Follow-up|0|||
162068573|NCT02580357|585306739|FG002|Overall Study|Lost to Follow-up|0|||
162068574|NCT02580357|585306737|FG000|Overall Study|Protocol Violation|1|||
162068575|NCT02580357|585306738|FG001|Overall Study|Protocol Violation|0|||
162068576|NCT02580357|585306739|FG002|Overall Study|Protocol Violation|0|||
162068577|NCT03742037|585306741|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
162068578|NCT03742037|585306742|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
162068579|NCT03742037|585306743|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
162068580|NCT03742037|585306744|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
162068581|NCT03742037|585306745|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
162068582|NCT03742037|585306746|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
162068583|NCT03742037|585306747|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
162068584|NCT03742037|585306741|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
162068585|NCT03742037|585306742|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
162068586|NCT03742037|585306743|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
162068587|NCT03742037|585306744|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
162068588|NCT03742037|585306745|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
162068589|NCT03742037|585306746|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
162068590|NCT03742037|585306747|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
162068591|NCT03742037|585306741|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
162068592|NCT03742037|585306742|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
162068593|NCT03742037|585306743|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
162068594|NCT03742037|585306744|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
162068595|NCT03742037|585306745|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
162068596|NCT03742037|585306746|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
162068597|NCT03742037|585306747|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
162068598|NCT03742037|585306741|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
162068599|NCT03742037|585306742|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
162068600|NCT03742037|585306743|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
162068601|NCT03742037|585306744|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
162068602|NCT03742037|585306745|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
162068603|NCT03742037|585306746|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
162068604|NCT03742037|585306747|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
162068605|NCT03742037|585306741|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
162068606|NCT03742037|585306742|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
162068607|NCT03742037|585306743|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
162068608|NCT03742037|585306744|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
162068609|NCT03742037|585306745|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
162068610|NCT03742037|585306746|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
162068611|NCT03742037|585306747|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
162068612|NCT03742037|585306741|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
162068613|NCT03742037|585306742|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
162068614|NCT03742037|585306743|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
162068615|NCT03742037|585306744|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
162068616|NCT03742037|585306745|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
162068617|NCT03742037|585306746|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
162068618|NCT03742037|585306747|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
162068619|NCT03742037|585306741|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
162068620|NCT03742037|585306742|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
162068621|NCT03742037|585306743|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
162068622|NCT03742037|585306744|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
162068623|NCT03742037|585306745|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
162068624|NCT03742037|585306746|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
162068625|NCT03742037|585306747|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
162068626|NCT03742037|585306741|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
162068627|NCT03742037|585306742|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
162068628|NCT03742037|585306743|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
162068629|NCT03742037|585306744|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
162068630|NCT03742037|585306745|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
162068631|NCT03742037|585306746|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
162068632|NCT03742037|585306747|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
162068633|NCT03742037|585306741|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
162068634|NCT03742037|585306742|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
162068635|NCT03742037|585306743|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
162068636|NCT03742037|585306744|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
162068637|NCT03742037|585306745|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
162068638|NCT03742037|585306746|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
162068639|NCT03742037|585306747|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
162068640|NCT03742037|585306741|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
162068641|NCT03742037|585306742|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
162068642|NCT03742037|585306743|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
162068643|NCT03742037|585306744|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
162068644|NCT03742037|585306745|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
162068645|NCT03742037|585306746|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
162068646|NCT03742037|585306747|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
162068647|NCT03742037|585306741|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
162068648|NCT03742037|585306742|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
162068649|NCT03742037|585306743|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
162068650|NCT03742037|585306744|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
162068651|NCT03742037|585306745|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
162068652|NCT03742037|585306746|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
162068653|NCT03742037|585306747|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
162068654|NCT03742037|585306741|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
162068655|NCT03742037|585306742|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
162068656|NCT03742037|585306743|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
162068657|NCT03742037|585306744|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
162068658|NCT03742037|585306745|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
162068659|NCT03742037|585306746|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
162068660|NCT03742037|585306747|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
162068661|NCT03742037|585306741|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
162068662|NCT03742037|585306742|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
162068663|NCT03742037|585306743|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
162068664|NCT03742037|585306744|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
162068665|NCT03742037|585306745|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
162068666|NCT03742037|585306746|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
162068667|NCT03742037|585306747|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
162068668|NCT03742037|585306741|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
162068669|NCT03742037|585306742|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
162068670|NCT03742037|585306743|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
162068671|NCT03742037|585306744|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
162068672|NCT03742037|585306745|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
162068673|NCT03742037|585306746|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
162068674|NCT03742037|585306747|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
162068675|NCT03742037|585306741|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
162068676|NCT03742037|585306742|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
162068677|NCT03742037|585306743|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
162068678|NCT03742037|585306744|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
162068679|NCT03742037|585306745|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
162068680|NCT03742037|585306746|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
162068681|NCT03742037|585306747|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
162068682|NCT04128267|585306750|FG000|Overall Study|Withdrawal by Subject|6|||
162068683|NCT04128267|585306750|FG000|Overall Study|Death|2|||
162068684|NCT04128267|585306750|FG000|Overall Study|Disease progression|1|||
162068685|NCT04128267|585306750|FG000|Overall Study|Participant had other medical issues|4|||
162068686|NCT04128267|585306750|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
162068687|NCT01705652|585306751|FG000|Overall Study|Adverse Event|1|||
162068688|NCT01705652|585306752|FG001|Overall Study|Adverse Event|0|||
162237442|NCT00600886|585921097|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
162237443|NCT00600886|585921096|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
162068689|NCT01705652|585306751|FG000|Overall Study|Withdrawal by Subject|1|||
162068690|NCT01705652|585306752|FG001|Overall Study|Withdrawal by Subject|2|||
162068691|NCT01705652|585306751|FG000|Overall Study|non-compliance|1|||
162068692|NCT01705652|585306752|FG001|Overall Study|non-compliance|1|||
162068693|NCT00056407|585306755|FG000|Overall Study|Adverse Event|282|||
162068694|NCT00056407|585306756|FG001|Overall Study|Adverse Event|364|||
162068695|NCT00056407|585306755|FG000|Overall Study|Withdrawal by Subject|377|||
162068696|NCT00056407|585306756|FG001|Overall Study|Withdrawal by Subject|361|||
162068697|NCT00056407|585306755|FG000|Overall Study|Lost to Follow-up|123|||
162068698|NCT00056407|585306756|FG001|Overall Study|Lost to Follow-up|113|||
162068699|NCT00056407|585306755|FG000|Overall Study|Protocol Violation|104|||
162068700|NCT00056407|585306756|FG001|Overall Study|Protocol Violation|95|||
162068701|NCT00056407|585306755|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
162068702|NCT00056407|585306756|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
162068703|NCT00056407|585306755|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
162068704|NCT00056407|585306756|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
162068705|NCT00056407|585306755|FG000|Overall Study|Missing|25|||
162068706|NCT00056407|585306756|FG001|Overall Study|Missing|34|||
162068707|NCT00616655|585306757|FG000|Overall Study|Adverse Event|10|||
162068708|NCT00616655|585306758|FG001|Overall Study|Adverse Event|7|||
162068709|NCT00616655|585306759|FG002|Overall Study|Adverse Event|12|||
162068710|NCT00616655|585306757|FG000|Overall Study|Lack of Efficacy|5|||
162068711|NCT00616655|585306758|FG001|Overall Study|Lack of Efficacy|5|||
162068712|NCT00616655|585306759|FG002|Overall Study|Lack of Efficacy|5|||
162068713|NCT00616655|585306757|FG000|Overall Study|Lost to Follow-up|3|||
162068714|NCT00616655|585306758|FG001|Overall Study|Lost to Follow-up|12|||
162068715|NCT00616655|585306759|FG002|Overall Study|Lost to Follow-up|10|||
162068716|NCT00616655|585306757|FG000|Overall Study|Protocol Violation|2|||
162068717|NCT00616655|585306758|FG001|Overall Study|Protocol Violation|4|||
162068718|NCT00616655|585306759|FG002|Overall Study|Protocol Violation|3|||
162068719|NCT00616655|585306757|FG000|Overall Study|Withdrawal by Subject|9|||
162068720|NCT00616655|585306758|FG001|Overall Study|Withdrawal by Subject|7|||
162068721|NCT00616655|585306759|FG002|Overall Study|Withdrawal by Subject|11|||
162068722|NCT00616655|585306757|FG000|Overall Study|Does not meet in/ex criteria|0|||
162068723|NCT00616655|585306758|FG001|Overall Study|Does not meet in/ex criteria|0|||
162068724|NCT00616655|585306759|FG002|Overall Study|Does not meet in/ex criteria|2|||
162068725|NCT00616655|585306757|FG000|Overall Study|Other|6|||
162068726|NCT00616655|585306758|FG001|Overall Study|Other|6|||
162068727|NCT00616655|585306759|FG002|Overall Study|Other|5|||
162068728|NCT00309842|585306760|FG000|Overall Study|Lost to Follow-up|1|||
162068729|NCT01026792|585306761|FG000|Overall Study|Protocol Violation|1|||
162068730|NCT02335099|585306764|FG000|Treatment|Withdrawal by Subject|1|||
162068731|NCT02335099|585306765|FG001|Treatment|Withdrawal by Subject|3|||
162068732|NCT02335099|585306764|FG000|Treatment|Lost to Follow-up|2|||
162068733|NCT02335099|585306765|FG001|Treatment|Lost to Follow-up|0|||
162068734|NCT02335099|585306764|FG000|Treatment|Death|1|||
162068735|NCT02335099|585306765|FG001|Treatment|Death|0|||
162068736|NCT02335099|585306764|FG000|Treatment|Adverse Event|1|||
162068737|NCT02335099|585306765|FG001|Treatment|Adverse Event|2|||
162068738|NCT02335099|585306764|FG000|Follow-up|Death|0|||
162068739|NCT02335099|585306765|FG001|Follow-up|Death|1|||
162068740|NCT01472081|585306766|FG000|Overall Study|Continuing treatment at time of analysis|1|||
162068741|NCT01472081|585306767|FG001|Overall Study|Continuing treatment at time of analysis|4|||
162068742|NCT01472081|585306768|FG002|Overall Study|Continuing treatment at time of analysis|1|||
162068743|NCT01472081|585306769|FG003|Overall Study|Continuing treatment at time of analysis|8|||
162068744|NCT01472081|585306770|FG004|Overall Study|Continuing treatment at time of analysis|9|||
162068745|NCT01472081|585306771|FG005|Overall Study|Continuing treatment at time of analysis|0|||
162068746|NCT01472081|585306766|FG000|Overall Study|Disease Progression|4|||
162068747|NCT01472081|585306767|FG001|Overall Study|Disease Progression|10|||
162068748|NCT01472081|585306768|FG002|Overall Study|Disease Progression|12|||
162068749|NCT01472081|585306769|FG003|Overall Study|Disease Progression|31|||
162068750|NCT01472081|585306770|FG004|Overall Study|Disease Progression|22|||
162068751|NCT01472081|585306771|FG005|Overall Study|Disease Progression|3|||
162068752|NCT01472081|585306766|FG000|Overall Study|Study drug toxicity|2|||
162068753|NCT01472081|585306767|FG001|Overall Study|Study drug toxicity|9|||
162068754|NCT01472081|585306768|FG002|Overall Study|Study drug toxicity|4|||
162068755|NCT01472081|585306769|FG003|Overall Study|Study drug toxicity|6|||
162068756|NCT01472081|585306770|FG004|Overall Study|Study drug toxicity|13|||
162068757|NCT01472081|585306771|FG005|Overall Study|Study drug toxicity|2|||
162068758|NCT01472081|585306766|FG000|Overall Study|Death|0|||
162068759|NCT01472081|585306767|FG001|Overall Study|Death|0|||
162068760|NCT01472081|585306768|FG002|Overall Study|Death|0|||
162068761|NCT01472081|585306769|FG003|Overall Study|Death|0|||
162068762|NCT01472081|585306770|FG004|Overall Study|Death|1|||
162068763|NCT01472081|585306771|FG005|Overall Study|Death|0|||
162068764|NCT01472081|585306766|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
162068765|NCT01472081|585306767|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
162068766|NCT01472081|585306768|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
162068767|NCT01472081|585306769|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
162068768|NCT01472081|585306770|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
162068769|NCT01472081|585306771|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
162068770|NCT01472081|585306766|FG000|Overall Study|Withdrawal by Subject|0|||
162068771|NCT01472081|585306767|FG001|Overall Study|Withdrawal by Subject|0|||
162068772|NCT01472081|585306768|FG002|Overall Study|Withdrawal by Subject|0|||
162068773|NCT01472081|585306769|FG003|Overall Study|Withdrawal by Subject|0|||
162068774|NCT01472081|585306770|FG004|Overall Study|Withdrawal by Subject|0|||
162068775|NCT01472081|585306771|FG005|Overall Study|Withdrawal by Subject|1|||
162068776|NCT01472081|585306766|FG000|Overall Study|Poor/non-compliance|0|||
162068777|NCT01472081|585306767|FG001|Overall Study|Poor/non-compliance|0|||
162068778|NCT01472081|585306768|FG002|Overall Study|Poor/non-compliance|1|||
162068779|NCT01472081|585306769|FG003|Overall Study|Poor/non-compliance|0|||
162068780|NCT01472081|585306770|FG004|Overall Study|Poor/non-compliance|1|||
162068781|NCT01472081|585306771|FG005|Overall Study|Poor/non-compliance|0|||
162068782|NCT01472081|585306766|FG000|Overall Study|No longer meets study criteria|0|||
162068783|NCT01472081|585306767|FG001|Overall Study|No longer meets study criteria|0|||
162068784|NCT01472081|585306768|FG002|Overall Study|No longer meets study criteria|1|||
162068785|NCT01472081|585306769|FG003|Overall Study|No longer meets study criteria|0|||
162068786|NCT01472081|585306770|FG004|Overall Study|No longer meets study criteria|0|||
162068787|NCT01472081|585306771|FG005|Overall Study|No longer meets study criteria|0|||
162068788|NCT01472081|585306766|FG000|Overall Study|Subject request to discontinue treatment|0|||
162068789|NCT01472081|585306767|FG001|Overall Study|Subject request to discontinue treatment|3|||
162068790|NCT01472081|585306768|FG002|Overall Study|Subject request to discontinue treatment|1|||
162068791|NCT01472081|585306769|FG003|Overall Study|Subject request to discontinue treatment|1|||
162068792|NCT01472081|585306770|FG004|Overall Study|Subject request to discontinue treatment|0|||
162068793|NCT01472081|585306771|FG005|Overall Study|Subject request to discontinue treatment|0|||
162068794|NCT01367158|585306772|FG000|Overall Study|Withdrew consent|0|||
162068795|NCT01367158|585306773|FG001|Overall Study|Withdrew consent|2|||
162068796|NCT01367158|585306774|FG002|Overall Study|Withdrew consent|1|||
162068797|NCT01367158|585306775|FG003|Overall Study|Withdrew consent|0|||
162068798|NCT01367158|585306776|FG004|Overall Study|Withdrew consent|2|||
162068799|NCT01367158|585306777|FG005|Overall Study|Withdrew consent|0|||
162068800|NCT01367158|585306778|FG006|Overall Study|Withdrew consent|0|||
162068801|NCT01367158|585306779|FG007|Overall Study|Withdrew consent|1|||
162068802|NCT01367158|585306780|FG008|Overall Study|Withdrew consent|0|||
162068803|NCT01367158|585306781|FG009|Overall Study|Withdrew consent|0|||
162068804|NCT01367158|585306782|FG010|Overall Study|Withdrew consent|0|||
162068805|NCT01367158|585306772|FG000|Overall Study|Lost to Follow-up|0|||
162068806|NCT01367158|585306773|FG001|Overall Study|Lost to Follow-up|0|||
162068807|NCT01367158|585306774|FG002|Overall Study|Lost to Follow-up|0|||
162068808|NCT01367158|585306775|FG003|Overall Study|Lost to Follow-up|1|||
162068809|NCT01367158|585306776|FG004|Overall Study|Lost to Follow-up|0|||
162068810|NCT01367158|585306777|FG005|Overall Study|Lost to Follow-up|2|||
162068811|NCT01367158|585306778|FG006|Overall Study|Lost to Follow-up|0|||
162068812|NCT01367158|585306779|FG007|Overall Study|Lost to Follow-up|1|||
162068813|NCT01367158|585306780|FG008|Overall Study|Lost to Follow-up|0|||
162068814|NCT01367158|585306781|FG009|Overall Study|Lost to Follow-up|0|||
162068815|NCT01367158|585306782|FG010|Overall Study|Lost to Follow-up|1|||
162068816|NCT01367158|585306772|FG000|Overall Study|Protocol Violation|0|||
162068817|NCT01367158|585306773|FG001|Overall Study|Protocol Violation|1|||
162068818|NCT01367158|585306774|FG002|Overall Study|Protocol Violation|0|||
162068819|NCT01367158|585306775|FG003|Overall Study|Protocol Violation|0|||
162068820|NCT01367158|585306776|FG004|Overall Study|Protocol Violation|0|||
162068821|NCT01367158|585306777|FG005|Overall Study|Protocol Violation|0|||
162068822|NCT01367158|585306778|FG006|Overall Study|Protocol Violation|0|||
162068823|NCT01367158|585306779|FG007|Overall Study|Protocol Violation|0|||
162068824|NCT01367158|585306780|FG008|Overall Study|Protocol Violation|0|||
162068825|NCT01367158|585306781|FG009|Overall Study|Protocol Violation|0|||
162068826|NCT01367158|585306782|FG010|Overall Study|Protocol Violation|0|||
162068827|NCT01765153|585306783|FG000|Training Phase 1|Format of intervention differed|1|||
162068828|NCT01765153|585306784|FG001|Training Phase 1|Format of intervention differed|0|||
162068829|NCT01765153|585306783|FG000|Training Phase 1|Poor participation in intervention|0|||
162068830|NCT01765153|585306784|FG001|Training Phase 1|Poor participation in intervention|1|||
162068831|NCT01765153|585306783|FG000|Rest Phase 1|Withdrawal by Subject|0|||
162068832|NCT01765153|585306784|FG001|Rest Phase 1|Withdrawal by Subject|1|||
162068833|NCT01765153|585306783|FG000|Training Phase 2|Withdrawal by Subject|0|||
162068834|NCT01765153|585306784|FG001|Training Phase 2|Withdrawal by Subject|1|||
162068835|NCT01765153|585306783|FG000|Rest Phase 2|Lost to Follow-up|2|||
162068836|NCT01765153|585306784|FG001|Rest Phase 2|Lost to Follow-up|1|||
162068837|NCT04702997|585306785|FG000|Overall Study|Withdrawal by Subject|1|||
162068838|NCT04702997|585306786|FG001|Overall Study|Withdrawal by Subject|1|||
162068839|NCT03915496|585306787|FG000|Overall Study|Adverse Event|2|||
162068840|NCT03915496|585306788|FG001|Overall Study|Adverse Event|1|||
162068841|NCT03915496|585306789|FG002|Overall Study|Adverse Event|2|||
162068842|NCT02663674|585306790|FG000|Overall Study|Lost to Follow-up|5|||
162068843|NCT02663674|585306791|FG001|Overall Study|Lost to Follow-up|4|||
162068844|NCT02663674|585306790|FG000|Overall Study|Withdrawal by Subject|1|||
162068845|NCT02663674|585306791|FG001|Overall Study|Withdrawal by Subject|4|||
162068846|NCT02663674|585306790|FG000|Overall Study|Physician Decision|1|||
162068847|NCT02663674|585306791|FG001|Overall Study|Physician Decision|1|||
162068848|NCT02663674|585306790|FG000|Overall Study|Other Event (Health Related)|0|||
162068849|NCT02663674|585306791|FG001|Overall Study|Other Event (Health Related)|1|||
162068850|NCT01386554|585306794|FG000|Overall Study|Lost to Follow-up|0|||
162068851|NCT01386554|585306795|FG001|Overall Study|Lost to Follow-up|0|||
162068852|NCT01386554|585306796|FG002|Overall Study|Lost to Follow-up|1|||
162068853|NCT01386554|585306794|FG000|Overall Study|Adverse Event|2|||
162068854|NCT01386554|585306795|FG001|Overall Study|Adverse Event|5|||
162068855|NCT01386554|585306796|FG002|Overall Study|Adverse Event|2|||
162068856|NCT01386554|585306794|FG000|Overall Study|Progressive disease|1|||
162068857|NCT01386554|585306795|FG001|Overall Study|Progressive disease|2|||
162068858|NCT01386554|585306796|FG002|Overall Study|Progressive disease|2|||
162068859|NCT01386554|585306794|FG000|Overall Study|Administration of live vaccines|0|||
162068860|NCT01386554|585306795|FG001|Overall Study|Administration of live vaccines|1|||
162068861|NCT01386554|585306796|FG002|Overall Study|Administration of live vaccines|0|||
162068862|NCT01386554|585306794|FG000|Overall Study|Investigator discretion|0|||
162068863|NCT01386554|585306795|FG001|Overall Study|Investigator discretion|0|||
162068864|NCT01386554|585306796|FG002|Overall Study|Investigator discretion|1|||
162068865|NCT01386554|585306794|FG000|Overall Study|Reason not collected|0|||
162068866|NCT01386554|585306795|FG001|Overall Study|Reason not collected|1|||
162068867|NCT01386554|585306796|FG002|Overall Study|Reason not collected|0|||
162068868|NCT00353262|585306797|FG000|Overall Study|Adverse Event|8|||
162068869|NCT00353262|585306797|FG000|Overall Study|Withdrawal by Subject|2|||
162068870|NCT00353262|585306797|FG000|Overall Study|Insufficient Therapeutic Response|13|||
162068871|NCT00353262|585306797|FG000|Overall Study|Progression|1|||
162068872|NCT00353262|585306797|FG000|Overall Study|Surgery|4|||
162068873|NCT00353262|585306797|FG000|Overall Study|Break from Chemotherapy|1|||
162068874|NCT04166513|585306798|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
162068875|NCT04166513|585306799|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
162068876|NCT04166513|585306800|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
162068877|NCT04166513|585306801|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
162068878|NCT04166513|585306798|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
162068879|NCT04166513|585306799|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
162068880|NCT04166513|585306800|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
162068881|NCT04166513|585306801|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
162068882|NCT04166513|585306798|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
162068883|NCT04166513|585306799|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
162068884|NCT04166513|585306800|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
162068885|NCT04166513|585306801|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
162068886|NCT04166513|585306798|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
162068887|NCT04166513|585306799|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
162068888|NCT04166513|585306800|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
162068889|NCT04166513|585306801|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
162068890|NCT04166513|585306798|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
162068891|NCT04166513|585306799|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
162068892|NCT04166513|585306800|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
162068893|NCT04166513|585306801|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
162068894|NCT05286307|585306802|FG000|Overall Study|Incomplete outcome assessments|2|||
162068895|NCT05286307|585306803|FG001|Overall Study|Incomplete outcome assessments|1|||
162068896|NCT05286307|585306802|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
162068897|NCT05286307|585306803|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
162068898|NCT05286307|585306802|FG000|Overall Study|Lost to follow up at 6 months|25|||
162068899|NCT05286307|585306803|FG001|Overall Study|Lost to follow up at 6 months|35|||
162068900|NCT05286307|585306802|FG000|Overall Study|Study medication not available|1|||
162068901|NCT05286307|585306803|FG001|Overall Study|Study medication not available|1|||
162068902|NCT02759471|585306804|FG000|Overall Study|discomfort|2|||
162068903|NCT01103284|585306805|FG000|Overall Study|Death|2|||
162068904|NCT01103284|585306806|FG001|Overall Study|Death|0|||
162068905|NCT01103284|585306805|FG000|Overall Study|Lost to Follow-up|9|||
162068906|NCT01103284|585306806|FG001|Overall Study|Lost to Follow-up|10|||
162068907|NCT01103284|585306805|FG000|Overall Study|Pregnancy|3|||
162068908|NCT01103284|585306806|FG001|Overall Study|Pregnancy|1|||
162068909|NCT01103284|585306805|FG000|Overall Study|Protocol Violation|12|||
162068910|NCT01103284|585306806|FG001|Overall Study|Protocol Violation|5|||
162068911|NCT01103284|585306805|FG000|Overall Study|Adverse Event|0|||
162068912|NCT01103284|585306806|FG001|Overall Study|Adverse Event|5|||
162068913|NCT01103284|585306805|FG000|Overall Study|Withdrawal by Subject|14|||
162068914|NCT01103284|585306806|FG001|Overall Study|Withdrawal by Subject|18|||
162068915|NCT01103284|585306805|FG000|Overall Study|Dermal Hypersensitivity|0|||
162068916|NCT01103284|585306806|FG001|Overall Study|Dermal Hypersensitivity|1|||
162068917|NCT01103284|585306805|FG000|Overall Study|Termination by the Sponsor|0|||
162068918|NCT01103284|585306806|FG001|Overall Study|Termination by the Sponsor|1|||
162068919|NCT01103284|585306805|FG000|Overall Study|Not described|2|||
162068920|NCT01103284|585306806|FG001|Overall Study|Not described|1|||
162068921|NCT01103284|585306805|FG000|Overall Study|Missing CRF entries for study completion|0|||
162068922|NCT01103284|585306806|FG001|Overall Study|Missing CRF entries for study completion|2|||
162068923|NCT03712904|585307765|FG000|Overall Study|Death|0|||
162068924|NCT03712904|585307766|FG001|Overall Study|Death|1|||
162068925|NCT03712904|585307765|FG000|Overall Study|Withdrawal by Subject|0|||
162068926|NCT03712904|585307766|FG001|Overall Study|Withdrawal by Subject|1|||
162068927|NCT03712904|585307765|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
162068928|NCT03712904|585307766|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
162068929|NCT04568590|585307769|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
162068930|NCT03745937|585307770|FG000|Overall Study|Withdrawal by Subject|0|||
162068931|NCT03745937|585307771|FG001|Overall Study|Withdrawal by Subject|0|||
162068932|NCT03745937|585307772|FG002|Overall Study|Withdrawal by Subject|0|||
162068933|NCT03745937|585307773|FG003|Overall Study|Withdrawal by Subject|1|||
162068934|NCT03745937|585307770|FG000|Overall Study|Not-specifed|0|||
162068935|NCT03745937|585307771|FG001|Overall Study|Not-specifed|1|||
162068936|NCT03745937|585307772|FG002|Overall Study|Not-specifed|0|||
162068937|NCT03745937|585307773|FG003|Overall Study|Not-specifed|1|||
162068938|NCT01190254|585307776|FG000|Overall Study|Adverse Event|3|||
162068939|NCT01190254|585307777|FG001|Overall Study|Adverse Event|6|||
162068940|NCT01190254|585307778|FG002|Overall Study|Adverse Event|8|||
162068941|NCT01190254|585307776|FG000|Overall Study|Lack of Efficacy|7|||
162068942|NCT01190254|585307777|FG001|Overall Study|Lack of Efficacy|4|||
162068943|NCT01190254|585307778|FG002|Overall Study|Lack of Efficacy|5|||
162068944|NCT01190254|585307776|FG000|Overall Study|Lost to Follow-up|4|||
162068945|NCT01190254|585307777|FG001|Overall Study|Lost to Follow-up|2|||
162068946|NCT01190254|585307778|FG002|Overall Study|Lost to Follow-up|0|||
162068947|NCT01190254|585307776|FG000|Overall Study|Withdrawal by Subject|4|||
162068948|NCT01190254|585307777|FG001|Overall Study|Withdrawal by Subject|5|||
162068949|NCT01190254|585307778|FG002|Overall Study|Withdrawal by Subject|7|||
162068950|NCT01190254|585307776|FG000|Overall Study|Protocol Violation|2|||
162068951|NCT01190254|585307777|FG001|Overall Study|Protocol Violation|0|||
162068952|NCT01190254|585307778|FG002|Overall Study|Protocol Violation|2|||
162068953|NCT01190254|585307776|FG000|Overall Study|Did not meet protocol eligibility|1|||
162068954|NCT01190254|585307777|FG001|Overall Study|Did not meet protocol eligibility|0|||
162068955|NCT01190254|585307778|FG002|Overall Study|Did not meet protocol eligibility|0|||
162068956|NCT02356783|585307779|FG000|Overall Study|Lost to Follow-up|1|||
162068957|NCT02356783|585307780|FG001|Overall Study|Lost to Follow-up|3|||
162068958|NCT01485640|585307781|FG000|Overall Study|Adverse Event|10|||
162068959|NCT01485640|585307781|FG000|Overall Study|Lack of Efficacy|2|||
162068960|NCT01485640|585307781|FG000|Overall Study|Protocol Violation|1|||
162068961|NCT01485640|585307781|FG000|Overall Study|Withdrawal by Subject|14|||
162068962|NCT01485640|585307781|FG000|Overall Study|Terminated by Sponsor|95|||
162068963|NCT00202644|585307784|FG000|Overall Study|Adverse Event|12|||
162068964|NCT00202644|585307785|FG001|Overall Study|Adverse Event|13|||
162068965|NCT00202644|585307784|FG000|Overall Study|Withdrawal by Subject|8|||
162068966|NCT00202644|585307785|FG001|Overall Study|Withdrawal by Subject|6|||
162068967|NCT00202644|585307784|FG000|Overall Study|Lack of Efficacy|6|||
162068968|NCT00202644|585307785|FG001|Overall Study|Lack of Efficacy|6|||
162068969|NCT00202644|585307784|FG000|Overall Study|Lost to Follow-up|0|||
162068970|NCT00202644|585307785|FG001|Overall Study|Lost to Follow-up|1|||
162068971|NCT00202644|585307784|FG000|Overall Study|Other|9|||
162068972|NCT00202644|585307785|FG001|Overall Study|Other|1|||
162068973|NCT03232281|585307791|FG000|Overall Study|Adverse Event|1|||
162068974|NCT03232281|585307792|FG001|Overall Study|Adverse Event|1|||
162068975|NCT03232281|585307791|FG000|Overall Study|Withdrawal by Subject|5|||
162068976|NCT03232281|585307792|FG001|Overall Study|Withdrawal by Subject|4|||
162068977|NCT03232281|585307791|FG000|Overall Study|Protocol Deviation|1|||
162068978|NCT03232281|585307792|FG001|Overall Study|Protocol Deviation|1|||
162068979|NCT01372501|585307796|FG000|Overall Study|Adverse Event|4|||
162068980|NCT01372501|585307796|FG000|Overall Study|Device migration|1|||
162068981|NCT02489344|585307797|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
162068982|NCT02489344|585307797|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
162068983|NCT02489344|585307797|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
162068984|NCT02489344|585307797|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
162068985|NCT01132482|585307798|FG000|Overall Study|Adverse Event|1|||
162068986|NCT01132482|585307799|FG001|Overall Study|Adverse Event|0|||
162068987|NCT05333900|585307800|FG000|Overall Study|Protocol Violation|0|||
162068988|NCT05333900|585307801|FG001|Overall Study|Protocol Violation|1|||
162068989|NCT05333900|585307800|FG000|Overall Study|Withdrawal by Subject|0|||
162068990|NCT05333900|585307801|FG001|Overall Study|Withdrawal by Subject|1|||
162068991|NCT05333900|585307800|FG000|Overall Study|COVID-19 Pandemic|1|||
162068992|NCT05333900|585307801|FG001|Overall Study|COVID-19 Pandemic|1|||
162068993|NCT01462084|585307802|FG000|Overall Study|Withdrawal by Subject|1|||
162068994|NCT01462084|585307803|FG001|Overall Study|Withdrawal by Subject|0|||
162068995|NCT01462084|585307802|FG000|Overall Study|Protocol Violation|1|||
162068996|NCT01462084|585307803|FG001|Overall Study|Protocol Violation|1|||
162068997|NCT02278263|585307806|FG000|Overall Study|Protocol Violation|7|||
162068998|NCT02278263|585307807|FG001|Overall Study|Protocol Violation|0|||
162068999|NCT02278263|585307808|FG002|Overall Study|Protocol Violation|9|||
162069000|NCT01998737|585307809|FG000|Overall Study|Corrupted database|23|||
162069001|NCT01998737|585307810|FG001|Overall Study|Corrupted database|0|||
162069002|NCT02092662|585307812|FG000|Overall Study|Lost to Follow-up|13|||
162069003|NCT02092662|585307813|FG001|Overall Study|Lost to Follow-up|0|||
162069004|NCT00772707|585307814|FG000|Overall Study|Withdrawn|3|||
162069005|NCT01266460|585307816|FG000|Overall Study|Adverse Event|3|||
162069006|NCT01266460|585307816|FG000|Overall Study|Withdrawal by Subject|5|||
162069007|NCT01266460|585307816|FG000|Overall Study|Disease Progression|18|||
162069008|NCT01266460|585307816|FG000|Overall Study|Not otherwise specified|8|||
162069009|NCT01132547|585307817|FG000|Overall Study|Withdrawal by Subject|3|||
162069010|NCT01132547|585307818|FG001|Overall Study|Withdrawal by Subject|1|||
162069011|NCT01132547|585307817|FG000|Overall Study|Death|1|||
162069012|NCT01132547|585307818|FG001|Overall Study|Death|0|||
162069013|NCT05811234|585307819|FG000|Overall Study|Loss of Effectiveness|2|||
162069014|NCT05811234|585307819|FG000|Overall Study|Adverse Event|4|||
162069015|NCT05811234|585307819|FG000|Overall Study|Pregnancy|1|||
162069016|NCT05811234|585307819|FG000|Overall Study|Disease progression|1|||
162069017|NCT05811234|585307819|FG000|Overall Study|Withdrawal by Subject|4|||
162069018|NCT05811234|585307819|FG000|Overall Study|Lost to Follow-up|13|||
162069019|NCT05811234|585307819|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
162069020|NCT02710045|585307820|FG000|Overall Study|Death|1|||
162069021|NCT02710045|585307821|FG001|Overall Study|Death|2|||
162069022|NCT02710045|585307822|FG002|Overall Study|Death|0|||
162069023|NCT02710045|585307820|FG000|Overall Study|Withdrawal by Subject|6|||
162069024|NCT02710045|585307821|FG001|Overall Study|Withdrawal by Subject|6|||
162069025|NCT02710045|585307822|FG002|Overall Study|Withdrawal by Subject|2|||
162069026|NCT02710045|585307820|FG000|Overall Study|Protocol Violation|1|||
162069027|NCT02710045|585307821|FG001|Overall Study|Protocol Violation|2|||
162069028|NCT02710045|585307822|FG002|Overall Study|Protocol Violation|3|||
162069029|NCT02710045|585307820|FG000|Overall Study|Lost to Follow-up|3|||
162069030|NCT02710045|585307821|FG001|Overall Study|Lost to Follow-up|6|||
162069031|NCT02710045|585307822|FG002|Overall Study|Lost to Follow-up|7|||
162069032|NCT02710045|585307820|FG000|Overall Study|Physician Decision|0|||
162069033|NCT02710045|585307821|FG001|Overall Study|Physician Decision|0|||
162069034|NCT02710045|585307822|FG002|Overall Study|Physician Decision|1|||
162069035|NCT02710045|585307820|FG000|Overall Study|Poor Attendance|0|||
162069036|NCT02710045|585307821|FG001|Overall Study|Poor Attendance|1|||
162069037|NCT02710045|585307822|FG002|Overall Study|Poor Attendance|0|||
162069038|NCT04499781|585307823|FG000|Overall Study|Lost to Follow-up|2|||
162069039|NCT04499781|585307824|FG001|Overall Study|Lost to Follow-up|3|||
162069040|NCT04499781|585307823|FG000|Overall Study|Withdrawal by Subject|2|||
162069041|NCT04499781|585307824|FG001|Overall Study|Withdrawal by Subject|0|||
162069042|NCT00227305|585307829|FG000|Overall Study|Adverse Event|40|||
162069043|NCT00227305|585307829|FG000|Overall Study|Withdrawal by Subject|42|||
162069044|NCT00227305|585307829|FG000|Overall Study|Lost to Follow-up|33|||
162069045|NCT00227305|585307829|FG000|Overall Study|Study specific discontinuation|13|||
162069046|NCT00227305|585307829|FG000|Overall Study|MOVED OUT OF AREA|3|||
162069047|NCT00227305|585307829|FG000|Overall Study|Lack of Efficacy|7|||
162069048|NCT00227305|585307829|FG000|Overall Study|Physician Decision|3|||
162069049|NCT00227305|585307829|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
162069050|NCT00227305|585307829|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
162069051|NCT00227305|585307829|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
162069052|NCT00278109|585307831|FG000|Overall Study|Adverse Event|3|||
162069053|NCT00278109|585307831|FG000|Overall Study|social circumstances|1|||
162069054|NCT04339296|585307837|FG000|Overall Study|Refuse to participate after allocation|1|||
162069055|NCT04339296|585307838|FG001|Overall Study|Refuse to participate after allocation|1|||
162069056|NCT04339296|585307837|FG000|Overall Study|Withdrew after completion of baseline|2|||
162069057|NCT04339296|585307838|FG001|Overall Study|Withdrew after completion of baseline|1|||
162069058|NCT04339296|585307837|FG000|Overall Study|Lost to Follow-up|0|||
162069059|NCT04339296|585307838|FG001|Overall Study|Lost to Follow-up|4|||
162069060|NCT04339296|585307837|FG000|Overall Study|Discontinued intervention|5|||
162069061|NCT04339296|585307838|FG001|Overall Study|Discontinued intervention|3|||
162069062|NCT03424265|585307839|FG000|Overall Study|screening failure|1|||
162069063|NCT03424265|585307840|FG001|Overall Study|screening failure|0|||
162069064|NCT03424265|585307839|FG000|Overall Study|Withdrawal by Subject|0|||
162069065|NCT03424265|585307840|FG001|Overall Study|Withdrawal by Subject|2|||
162069066|NCT00453544|585307841|FG000|Overall Study|Withdrawal by Subject|1|||
162069067|NCT00453544|585307842|FG001|Overall Study|Withdrawal by Subject|0|||
162069068|NCT00453544|585307843|FG002|Overall Study|Withdrawal by Subject|0|||
162069069|NCT00453544|585307844|FG003|Overall Study|Withdrawal by Subject|0|||
162069070|NCT00453544|585307841|FG000|Overall Study|Primary outcome measure not completed|1|||
162069071|NCT00453544|585307842|FG001|Overall Study|Primary outcome measure not completed|1|||
162069072|NCT00453544|585307843|FG002|Overall Study|Primary outcome measure not completed|0|||
162069073|NCT00453544|585307844|FG003|Overall Study|Primary outcome measure not completed|1|||
162069074|NCT01558752|585307845|FG000|Overall Study|Physician Decision|2|||
162069075|NCT01558752|585307846|FG001|Overall Study|Physician Decision|0|||
162069076|NCT01829230|585307847|FG000|Overall Study|Protocol Violation|0|||
162069077|NCT01829230|585307848|FG001|Overall Study|Protocol Violation|2|||
162069078|NCT01829230|585307847|FG000|Overall Study|Withdrawal by Subject|0|||
162069079|NCT01829230|585307848|FG001|Overall Study|Withdrawal by Subject|1|||
162069080|NCT01829230|585307847|FG000|Overall Study|Lost to Follow-up|1|||
162069081|NCT01829230|585307848|FG001|Overall Study|Lost to Follow-up|1|||
162069082|NCT00969150|585307849|FG000|Overall Study|Adverse Event|4|||
162069083|NCT00969150|585307850|FG001|Overall Study|Adverse Event|14|||
162069084|NCT00969150|585307849|FG000|Overall Study|Lack of Efficacy|1|||
162069085|NCT00969150|585307850|FG001|Overall Study|Lack of Efficacy|1|||
162069086|NCT00969150|585307849|FG000|Overall Study|Protocol Violation|9|||
162069087|NCT00969150|585307850|FG001|Overall Study|Protocol Violation|12|||
162069088|NCT00969150|585307849|FG000|Overall Study|Withdrawal by Subject|13|||
162069089|NCT00969150|585307850|FG001|Overall Study|Withdrawal by Subject|9|||
162069090|NCT00969150|585307849|FG000|Overall Study|Lost to Follow-up|5|||
162069091|NCT00969150|585307850|FG001|Overall Study|Lost to Follow-up|4|||
162069092|NCT00969150|585307849|FG000|Overall Study|Other reasons|1|||
162069093|NCT00969150|585307850|FG001|Overall Study|Other reasons|0|||
162069094|NCT00461682|585307851|FG000|Overall Study|Protocol Violation|1|||
162069095|NCT04105998|585308979|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
162069096|NCT04105998|585308980|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
162069097|NCT00613015|585308982|FG000|Overall Study|Lost to Follow-up|0|||
162069098|NCT00613015|585308983|FG001|Overall Study|Lost to Follow-up|1|||
162069099|NCT00613015|585308984|FG002|Overall Study|Lost to Follow-up|3|||
162069100|NCT00613015|585308985|FG003|Overall Study|Lost to Follow-up|3|||
162069101|NCT00613015|585308986|FG004|Overall Study|Lost to Follow-up|2|||
162069102|NCT00613015|585308987|FG005|Overall Study|Lost to Follow-up|3|||
162069103|NCT00071760|585308990|FG000|Overall Study|Adverse Event|2|||
162069104|NCT00071760|585308991|FG001|Overall Study|Adverse Event|1|||
162069105|NCT00071760|585308990|FG000|Overall Study|Lost to Follow-up|0|||
162069106|NCT00071760|585308991|FG001|Overall Study|Lost to Follow-up|3|||
162069107|NCT00071760|585308990|FG000|Overall Study|Protocol Violation|1|||
162069108|NCT00071760|585308991|FG001|Overall Study|Protocol Violation|0|||
162069109|NCT00071760|585308990|FG000|Overall Study|Withdrawal by Subject|0|||
162069110|NCT00071760|585308991|FG001|Overall Study|Withdrawal by Subject|1|||
162069111|NCT00071760|585308990|FG000|Overall Study|Insufficient Viral Load Response|1|||
162069112|NCT00071760|585308991|FG001|Overall Study|Insufficient Viral Load Response|1|||
162069113|NCT00071760|585308990|FG000|Overall Study|Lack of availability of RTV|1|||
162069114|NCT00071760|585308991|FG001|Overall Study|Lack of availability of RTV|0|||
162069115|NCT00071760|585308990|FG000|Overall Study|Physician Decision|2|||
162069116|NCT00071760|585308991|FG001|Overall Study|Physician Decision|1|||
162069117|NCT00071760|585308990|FG000|Overall Study|Relocation|0|||
162069118|NCT00071760|585308991|FG001|Overall Study|Relocation|1|||
162069119|NCT02073279|585308992|FG000|Double-blind Period|Adverse Event|1|||
162069120|NCT02073279|585308993|FG001|Double-blind Period|Adverse Event|1|||
162069121|NCT02073279|585308992|FG000|Double-blind Period|Switched to another treatment|1|||
162069122|NCT02073279|585308993|FG001|Double-blind Period|Switched to another treatment|2|||
162069123|NCT02073279|585308992|FG000|Double-blind Period|Protocol Violation|0|||
162069124|NCT02073279|585308993|FG001|Double-blind Period|Protocol Violation|1|||
162069125|NCT02073279|585308992|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
162069126|NCT02073279|585308993|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
162069127|NCT02073279|585308992|FG000|Double-blind Period|Withdrawal by Subject|2|||
162069128|NCT02073279|585308993|FG001|Double-blind Period|Withdrawal by Subject|2|||
162069129|NCT02073279|585308992|FG000|Open-label Extension Period|Adverse Event|1|||
162069130|NCT02073279|585308993|FG001|Open-label Extension Period|Adverse Event|0|||
162069131|NCT02073279|585308992|FG000|Open-label Extension Period|Lack of Efficacy|1|||
162069132|NCT02073279|585308993|FG001|Open-label Extension Period|Lack of Efficacy|0|||
162069133|NCT02073279|585308992|FG000|Open-label Extension Period|Lost to Follow-up|0|||
162069134|NCT02073279|585308993|FG001|Open-label Extension Period|Lost to Follow-up|4|||
162069135|NCT02073279|585308992|FG000|Open-label Extension Period|Switched to another treatment|1|||
162069136|NCT02073279|585308993|FG001|Open-label Extension Period|Switched to another treatment|4|||
162069137|NCT02073279|585308992|FG000|Open-label Extension Period|Protocol Violation|0|||
162069138|NCT02073279|585308993|FG001|Open-label Extension Period|Protocol Violation|1|||
162069139|NCT02073279|585308992|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
162069140|NCT02073279|585308993|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
162069141|NCT02073279|585308992|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
162069142|NCT02073279|585308993|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
162069143|NCT01994629|585308994|FG000|Overall Study|Withdrawal by Subject|1|||
162069144|NCT01994629|585308995|FG001|Overall Study|Withdrawal by Subject|0|||
162069145|NCT01994629|585308994|FG000|Overall Study|Lost to Follow-up|0|||
162069146|NCT01994629|585308995|FG001|Overall Study|Lost to Follow-up|3|||
162069147|NCT03338062|585308998|FG000|Overall Study|Alternative Therapy|1|||
162069148|NCT03338062|585308999|FG001|Overall Study|Alternative Therapy|0|||
162069149|NCT04340362|585309000|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
162069150|NCT02375113|585309004|FG000|Overall Study|Undisclosed Reason(s).|1|||
162069151|NCT02375113|585309005|FG001|Overall Study|Undisclosed Reason(s).|1|||
162069152|NCT02375113|585309004|FG000|Overall Study|Poor adherence (<70%).|1|||
162069153|NCT02375113|585309005|FG001|Overall Study|Poor adherence (<70%).|0|||
162069154|NCT02375113|585309004|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
162069155|NCT02375113|585309005|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
162069156|NCT01214629|585309006|FG000|Overall Study|Progressive Disease|1|||
162069157|NCT01214629|585309007|FG001|Overall Study|Progressive Disease|1|||
162069158|NCT01214629|585309008|FG002|Overall Study|Progressive Disease|0|||
162069159|NCT01214629|585309009|FG003|Overall Study|Progressive Disease|1|||
162069160|NCT01214629|585309010|FG004|Overall Study|Progressive Disease|2|||
162069161|NCT01214629|585309011|FG005|Overall Study|Progressive Disease|3|||
162069162|NCT01214629|585309012|FG006|Overall Study|Progressive Disease|1|||
162069163|NCT01214629|585309013|FG007|Overall Study|Progressive Disease|1|||
162069164|NCT01214629|585309014|FG008|Overall Study|Progressive Disease|1|||
162069165|NCT01214629|585309015|FG009|Overall Study|Progressive Disease|5|||
162069166|NCT01214629|585309016|FG010|Overall Study|Progressive Disease|1|||
162069167|NCT01214629|585309006|FG000|Overall Study|Adverse Event|0|||
162069168|NCT01214629|585309007|FG001|Overall Study|Adverse Event|0|||
162069169|NCT01214629|585309008|FG002|Overall Study|Adverse Event|0|||
162069170|NCT01214629|585309009|FG003|Overall Study|Adverse Event|1|||
162069171|NCT01214629|585309010|FG004|Overall Study|Adverse Event|0|||
162069172|NCT01214629|585309011|FG005|Overall Study|Adverse Event|1|||
162069173|NCT01214629|585309012|FG006|Overall Study|Adverse Event|0|||
162069174|NCT01214629|585309013|FG007|Overall Study|Adverse Event|0|||
162069175|NCT01214629|585309014|FG008|Overall Study|Adverse Event|0|||
162069176|NCT01214629|585309015|FG009|Overall Study|Adverse Event|1|||
162069177|NCT01214629|585309016|FG010|Overall Study|Adverse Event|0|||
162069178|NCT01214629|585309006|FG000|Overall Study|Physician Decision|0|||
162069179|NCT01214629|585309007|FG001|Overall Study|Physician Decision|0|||
162069180|NCT01214629|585309008|FG002|Overall Study|Physician Decision|0|||
162069181|NCT01214629|585309009|FG003|Overall Study|Physician Decision|0|||
162069182|NCT01214629|585309010|FG004|Overall Study|Physician Decision|0|||
162069183|NCT01214629|585309011|FG005|Overall Study|Physician Decision|0|||
162069184|NCT01214629|585309012|FG006|Overall Study|Physician Decision|0|||
162069185|NCT01214629|585309013|FG007|Overall Study|Physician Decision|0|||
162069186|NCT01214629|585309014|FG008|Overall Study|Physician Decision|0|||
162069187|NCT01214629|585309015|FG009|Overall Study|Physician Decision|0|||
162069188|NCT01214629|585309016|FG010|Overall Study|Physician Decision|1|||
162069189|NCT01214629|585309006|FG000|Overall Study|Withdrawal by Subject|0|||
162069190|NCT01214629|585309007|FG001|Overall Study|Withdrawal by Subject|0|||
162069191|NCT01214629|585309008|FG002|Overall Study|Withdrawal by Subject|0|||
162069192|NCT01214629|585309009|FG003|Overall Study|Withdrawal by Subject|0|||
162069193|NCT01214629|585309010|FG004|Overall Study|Withdrawal by Subject|0|||
162069194|NCT01214629|585309011|FG005|Overall Study|Withdrawal by Subject|0|||
162069195|NCT01214629|585309012|FG006|Overall Study|Withdrawal by Subject|0|||
162069196|NCT01214629|585309013|FG007|Overall Study|Withdrawal by Subject|0|||
162069197|NCT01214629|585309014|FG008|Overall Study|Withdrawal by Subject|0|||
162069198|NCT01214629|585309015|FG009|Overall Study|Withdrawal by Subject|1|||
162069199|NCT01214629|585309016|FG010|Overall Study|Withdrawal by Subject|0|||
162069200|NCT00877383|585309019|FG000|Overall Study|Adverse Event|13|||
162069201|NCT00877383|585309020|FG001|Overall Study|Adverse Event|14|||
162069202|NCT00877383|585309019|FG000|Overall Study|Lost to Follow-up|5|||
162069203|NCT00877383|585309020|FG001|Overall Study|Lost to Follow-up|3|||
162069204|NCT00877383|585309019|FG000|Overall Study|Subject withdrew consent|3|||
162069205|NCT00877383|585309020|FG001|Overall Study|Subject withdrew consent|12|||
162069206|NCT00877383|585309019|FG000|Overall Study|Subject no longer requires study drug|2|||
162069207|NCT00877383|585309020|FG001|Overall Study|Subject no longer requires study drug|0|||
162069208|NCT00877383|585309019|FG000|Overall Study|Administrative problems|2|||
162069209|NCT00877383|585309020|FG001|Overall Study|Administrative problems|0|||
162069210|NCT00877383|585309019|FG000|Overall Study|Protocol deviation|2|||
162069211|NCT00877383|585309020|FG001|Overall Study|Protocol deviation|6|||
162069212|NCT00877383|585309019|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
162069213|NCT00877383|585309020|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162069214|NCT00877383|585309019|FG000|Overall Study|Death|1|||
162069215|NCT00877383|585309020|FG001|Overall Study|Death|2|||
162069216|NCT00459108|585309022|FG000|Overall Study|Withdrawal by Subject|5|||
162069217|NCT00459108|585309022|FG000|Overall Study|Adverse Event|3|||
162069218|NCT00459108|585309022|FG000|Overall Study|Death|2|||
162069219|NCT00459108|585309022|FG000|Overall Study|Progression|1|||
162069220|NCT04387435|585309031|FG000|Overall Study|Physician Decision|1|||
162069221|NCT00391274|585309037|FG000|Overall Study|Death Due to Study Disease|55|||
162069222|NCT00391274|585309038|FG001|Overall Study|Death Due to Study Disease|45|||
162069223|NCT00391274|585309037|FG000|Overall Study|Lost to Follow-up|0|||
162069224|NCT00391274|585309038|FG001|Overall Study|Lost to Follow-up|3|||
162069225|NCT00391274|585309037|FG000|Overall Study|Physician Decision|4|||
162069226|NCT00391274|585309038|FG001|Overall Study|Physician Decision|2|||
162069227|NCT00391274|585309037|FG000|Overall Study|Withdrawal by Subject|0|||
162069228|NCT00391274|585309038|FG001|Overall Study|Withdrawal by Subject|3|||
162069229|NCT00391274|585309037|FG000|Overall Study|Death Due to Adverse Event|1|||
162069230|NCT00391274|585309038|FG001|Overall Study|Death Due to Adverse Event|3|||
162069231|NCT00391274|585309037|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
162069232|NCT00391274|585309038|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
162069233|NCT00391274|585309037|FG000|Overall Study|Death Not Study Related|0|||
162069234|NCT00391274|585309038|FG001|Overall Study|Death Not Study Related|1|||
162069235|NCT04501666|585309042|FG000|Overall Study|Physician Decision|0|||
162069236|NCT04501666|585309043|FG001|Overall Study|Physician Decision|1|||
162069237|NCT04501666|585309042|FG000|Overall Study|Adverse Event|12|||
162069238|NCT04501666|585309043|FG001|Overall Study|Adverse Event|4|||
162069239|NCT04501666|585309042|FG000|Overall Study|Subject's request|10|||
162069240|NCT04501666|585309043|FG001|Overall Study|Subject's request|6|||
162069241|NCT04501666|585309042|FG000|Overall Study|Protocol Deviation|2|||
162069242|NCT04501666|585309043|FG001|Overall Study|Protocol Deviation|1|||
162069243|NCT04501666|585309042|FG000|Overall Study|Other-- site permanently closing|0|||
162069244|NCT04501666|585309043|FG001|Overall Study|Other-- site permanently closing|1|||
162069245|NCT00642941|585309044|FG000|Overall Study|Physician Decision|3|||
162069246|NCT00642941|585309045|FG001|Overall Study|Physician Decision|1|||
162069247|NCT00642941|585309046|FG002|Overall Study|Physician Decision|0|||
162069248|NCT00642941|585309047|FG003|Overall Study|Physician Decision|0|||
162069249|NCT00642941|585309048|FG004|Overall Study|Physician Decision|0|||
162069250|NCT00642941|585309049|FG005|Overall Study|Physician Decision|0|||
162069251|NCT00642941|585309050|FG006|Overall Study|Physician Decision|1|||
162069252|NCT00642941|585309051|FG007|Overall Study|Physician Decision|0|||
162069253|NCT00642941|585309052|FG008|Overall Study|Physician Decision|0|||
162069254|NCT00642941|585309053|FG009|Overall Study|Physician Decision|1|||
162069255|NCT00642941|585309054|FG010|Overall Study|Physician Decision|0|||
162069256|NCT00642941|585309055|FG011|Overall Study|Physician Decision|1|||
162069257|NCT00642941|585309044|FG000|Overall Study|Death|4|||
162069258|NCT00642941|585309045|FG001|Overall Study|Death|0|||
162069259|NCT00642941|585309046|FG002|Overall Study|Death|1|||
162069260|NCT00642941|585309047|FG003|Overall Study|Death|1|||
162069261|NCT00642941|585309048|FG004|Overall Study|Death|2|||
162069262|NCT00642941|585309049|FG005|Overall Study|Death|1|||
162069263|NCT00642941|585309050|FG006|Overall Study|Death|0|||
162069264|NCT00642941|585309051|FG007|Overall Study|Death|0|||
162069265|NCT00642941|585309052|FG008|Overall Study|Death|0|||
162069266|NCT00642941|585309053|FG009|Overall Study|Death|0|||
162069267|NCT00642941|585309054|FG010|Overall Study|Death|0|||
162069268|NCT00642941|585309055|FG011|Overall Study|Death|1|||
162069269|NCT00642941|585309044|FG000|Overall Study|Study closed by Sponsor|0|||
162069270|NCT00642941|585309045|FG001|Overall Study|Study closed by Sponsor|1|||
162069271|NCT00642941|585309046|FG002|Overall Study|Study closed by Sponsor|0|||
162069272|NCT00642941|585309047|FG003|Overall Study|Study closed by Sponsor|0|||
162069273|NCT00642941|585309048|FG004|Overall Study|Study closed by Sponsor|0|||
162069274|NCT00642941|585309049|FG005|Overall Study|Study closed by Sponsor|0|||
162069275|NCT00642941|585309050|FG006|Overall Study|Study closed by Sponsor|0|||
162069276|NCT00642941|585309051|FG007|Overall Study|Study closed by Sponsor|0|||
162069277|NCT00642941|585309052|FG008|Overall Study|Study closed by Sponsor|0|||
162069278|NCT00642941|585309053|FG009|Overall Study|Study closed by Sponsor|0|||
162069279|NCT00642941|585309054|FG010|Overall Study|Study closed by Sponsor|0|||
162069280|NCT00642941|585309055|FG011|Overall Study|Study closed by Sponsor|0|||
162069281|NCT00642941|585309044|FG000|Overall Study|Withdrawal by Subject|1|||
162069282|NCT00642941|585309045|FG001|Overall Study|Withdrawal by Subject|0|||
162069283|NCT00642941|585309046|FG002|Overall Study|Withdrawal by Subject|0|||
162069284|NCT00642941|585309047|FG003|Overall Study|Withdrawal by Subject|2|||
162069285|NCT00642941|585309048|FG004|Overall Study|Withdrawal by Subject|0|||
162069286|NCT00642941|585309049|FG005|Overall Study|Withdrawal by Subject|0|||
162069287|NCT00642941|585309050|FG006|Overall Study|Withdrawal by Subject|2|||
162069288|NCT00642941|585309051|FG007|Overall Study|Withdrawal by Subject|0|||
162069289|NCT00642941|585309052|FG008|Overall Study|Withdrawal by Subject|1|||
162069290|NCT00642941|585309053|FG009|Overall Study|Withdrawal by Subject|0|||
162069291|NCT00642941|585309054|FG010|Overall Study|Withdrawal by Subject|0|||
162069292|NCT00642941|585309055|FG011|Overall Study|Withdrawal by Subject|1|||
162069293|NCT00642941|585309044|FG000|Overall Study|Protocol Violation|0|||
162069294|NCT00642941|585309045|FG001|Overall Study|Protocol Violation|0|||
162069295|NCT00642941|585309046|FG002|Overall Study|Protocol Violation|0|||
162069296|NCT00642941|585309047|FG003|Overall Study|Protocol Violation|0|||
162069297|NCT00642941|585309048|FG004|Overall Study|Protocol Violation|0|||
162069298|NCT00642941|585309049|FG005|Overall Study|Protocol Violation|0|||
162069299|NCT00642941|585309050|FG006|Overall Study|Protocol Violation|1|||
162069300|NCT00642941|585309051|FG007|Overall Study|Protocol Violation|0|||
162069301|NCT00642941|585309052|FG008|Overall Study|Protocol Violation|0|||
162069302|NCT00642941|585309053|FG009|Overall Study|Protocol Violation|0|||
162069303|NCT00642941|585309054|FG010|Overall Study|Protocol Violation|0|||
162069304|NCT00642941|585309055|FG011|Overall Study|Protocol Violation|0|||
162069305|NCT00642941|585309044|FG000|Overall Study|Adverse Event|1|||
162069306|NCT00642941|585309045|FG001|Overall Study|Adverse Event|1|||
162069307|NCT00642941|585309046|FG002|Overall Study|Adverse Event|0|||
162069308|NCT00642941|585309047|FG003|Overall Study|Adverse Event|0|||
162069309|NCT00642941|585309048|FG004|Overall Study|Adverse Event|0|||
162069310|NCT00642941|585309049|FG005|Overall Study|Adverse Event|0|||
162069311|NCT00642941|585309050|FG006|Overall Study|Adverse Event|1|||
162069312|NCT00642941|585309051|FG007|Overall Study|Adverse Event|1|||
162069313|NCT00642941|585309052|FG008|Overall Study|Adverse Event|0|||
162069314|NCT00642941|585309053|FG009|Overall Study|Adverse Event|1|||
162069315|NCT00642941|585309054|FG010|Overall Study|Adverse Event|0|||
162069316|NCT00642941|585309055|FG011|Overall Study|Adverse Event|0|||
162069317|NCT00642941|585309044|FG000|Overall Study|Other|1|||
162069318|NCT00642941|585309045|FG001|Overall Study|Other|1|||
162069319|NCT00642941|585309046|FG002|Overall Study|Other|1|||
162069320|NCT00642941|585309047|FG003|Overall Study|Other|1|||
162069321|NCT00642941|585309048|FG004|Overall Study|Other|0|||
162069322|NCT00642941|585309049|FG005|Overall Study|Other|1|||
162069323|NCT00642941|585309050|FG006|Overall Study|Other|0|||
162069324|NCT00642941|585309051|FG007|Overall Study|Other|1|||
162069325|NCT00642941|585309052|FG008|Overall Study|Other|0|||
162069326|NCT00642941|585309053|FG009|Overall Study|Other|0|||
162069327|NCT00642941|585309054|FG010|Overall Study|Other|0|||
162069328|NCT00642941|585309055|FG011|Overall Study|Other|1|||
162069329|NCT00642941|585309044|FG000|Overall Study|Disease progression|60|||
162069330|NCT00642941|585309045|FG001|Overall Study|Disease progression|50|||
162069331|NCT00642941|585309046|FG002|Overall Study|Disease progression|5|||
162069332|NCT00642941|585309047|FG003|Overall Study|Disease progression|36|||
162069333|NCT00642941|585309048|FG004|Overall Study|Disease progression|23|||
162069334|NCT00642941|585309049|FG005|Overall Study|Disease progression|39|||
162069335|NCT00642941|585309050|FG006|Overall Study|Disease progression|18|||
162069336|NCT00642941|585309051|FG007|Overall Study|Disease progression|12|||
162069337|NCT00642941|585309052|FG008|Overall Study|Disease progression|10|||
162069338|NCT00642941|585309053|FG009|Overall Study|Disease progression|7|||
162069339|NCT00642941|585309054|FG010|Overall Study|Disease progression|12|||
162069340|NCT00642941|585309055|FG011|Overall Study|Disease progression|7|||
162069341|NCT03051607|585309057|FG000|Overall Study|Adverse Event|66|||
162069342|NCT01505868|585309058|FG000|Overall Study|Withdrawal by Subject|1|||
162069343|NCT01505868|585309059|FG001|Overall Study|Withdrawal by Subject|0|||
162069344|NCT01505868|585309060|FG002|Overall Study|Withdrawal by Subject|0|||
162069345|NCT01505868|585309061|FG003|Overall Study|Withdrawal by Subject|0|||
162069346|NCT01505868|585309062|FG004|Overall Study|Withdrawal by Subject|0|||
162069347|NCT00894322|585309063|FG000|Overall Study|Withdrawal by Subject|1|||
162069348|NCT00894322|585309064|FG001|Overall Study|Withdrawal by Subject|0|||
162069349|NCT00894322|585309065|FG002|Overall Study|Withdrawal by Subject|0|||
162069350|NCT00553150|585309066|FG000|Overall Study|Withdrawal by Subject|0|||
162069351|NCT00553150|585309067|FG001|Overall Study|Withdrawal by Subject|0|||
162069352|NCT00553150|585309068|FG002|Overall Study|Withdrawal by Subject|0|||
162069353|NCT00553150|585309069|FG003|Overall Study|Withdrawal by Subject|2|||
162069354|NCT00553150|585309066|FG000|Overall Study|Protocol Violation|0|||
162069355|NCT00553150|585309067|FG001|Overall Study|Protocol Violation|0|||
162069356|NCT00553150|585309068|FG002|Overall Study|Protocol Violation|0|||
162069357|NCT00553150|585309069|FG003|Overall Study|Protocol Violation|1|||
162069358|NCT00553150|585309066|FG000|Overall Study|Ineligible|0|||
162069359|NCT00553150|585309067|FG001|Overall Study|Ineligible|0|||
162069360|NCT00553150|585309068|FG002|Overall Study|Ineligible|0|||
162069361|NCT00553150|585309069|FG003|Overall Study|Ineligible|1|||
162069362|NCT03338855|585309070|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
162069363|NCT03338855|585309071|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
162069364|NCT03605303|585309080|FG000|Period 1|Study Terminated|2|||
162069365|NCT03605303|585309081|FG001|Period 1|Study Terminated|1|||
162069366|NCT00399360|585309082|FG000|Overall Study|Lost to Follow-up|2|||
162069367|NCT00399360|585309083|FG001|Overall Study|Lost to Follow-up|1|||
162069368|NCT00399360|585309084|FG002|Overall Study|Lost to Follow-up|2|||
162069369|NCT00399360|585309085|FG003|Overall Study|Lost to Follow-up|4|||
162069370|NCT00399360|585309082|FG000|Overall Study|Adverse Event|0|||
162069371|NCT00399360|585309083|FG001|Overall Study|Adverse Event|0|||
162069372|NCT00399360|585309084|FG002|Overall Study|Adverse Event|1|||
162069373|NCT00399360|585309085|FG003|Overall Study|Adverse Event|0|||
162069374|NCT00399360|585309082|FG000|Overall Study|Withdrawal by Subject|0|||
162069375|NCT00399360|585309083|FG001|Overall Study|Withdrawal by Subject|2|||
162069376|NCT00399360|585309084|FG002|Overall Study|Withdrawal by Subject|0|||
162069377|NCT00399360|585309085|FG003|Overall Study|Withdrawal by Subject|2|||
162069378|NCT02626520|585309087|FG000|Overall Study|Physician Decision|1|||
162069379|NCT02626520|585309088|FG001|Overall Study|Physician Decision|1|||
162069380|NCT02626520|585309087|FG000|Overall Study|Adverse Event|0|||
162069381|NCT02626520|585309088|FG001|Overall Study|Adverse Event|4|||
162069382|NCT02626520|585309087|FG000|Overall Study|Lack of Efficacy|0|||
162069383|NCT02626520|585309088|FG001|Overall Study|Lack of Efficacy|2|||
162069384|NCT02626520|585309087|FG000|Overall Study|Did not start protocol therapy|0|||
162069385|NCT02626520|585309088|FG001|Overall Study|Did not start protocol therapy|2|||
162069386|NCT02626520|585309087|FG000|Overall Study|Study terminated|0|||
162069387|NCT02626520|585309088|FG001|Overall Study|Study terminated|1|||
162069388|NCT00679263|585309094|FG000|Visit 2/Dose 1|Adverse Event|1|||
162069389|NCT00679263|585309095|FG001|Visit 2/Dose 1|Adverse Event|0|||
162069390|NCT00679263|585309096|FG002|Visit 2/Dose 1|Adverse Event|0|||
162069391|NCT00679263|585309094|FG000|Visit 2/Dose 1|subject not compliance|1|||
162069392|NCT00679263|585309095|FG001|Visit 2/Dose 1|subject not compliance|1|||
162069393|NCT00679263|585309096|FG002|Visit 2/Dose 1|subject not compliance|0|||
162069394|NCT00733746|585309097|FG000|Overall Study|Ineligible|5|||
162069395|NCT02472795|585309100|FG000|Overall Study|Adverse Event|0|||
162069396|NCT02472795|585309101|FG001|Overall Study|Adverse Event|1|||
162069397|NCT02472795|585309102|FG002|Overall Study|Adverse Event|0|||
162069398|NCT02472795|585309103|FG003|Overall Study|Adverse Event|0|||
162069399|NCT02472795|585309104|FG004|Overall Study|Adverse Event|2|||
162069400|NCT02472795|585309100|FG000|Overall Study|Withdrawal by Subject|0|||
162069401|NCT02472795|585309101|FG001|Overall Study|Withdrawal by Subject|0|||
162069402|NCT02472795|585309102|FG002|Overall Study|Withdrawal by Subject|0|||
162069403|NCT02472795|585309103|FG003|Overall Study|Withdrawal by Subject|0|||
162069404|NCT02472795|585309104|FG004|Overall Study|Withdrawal by Subject|1|||
162069405|NCT00597012|585309107|FG000|Overall Study|Death|1|||
162069406|NCT00597012|585309108|FG001|Overall Study|Death|1|||
162069407|NCT00597012|585309107|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
162069408|NCT00597012|585309108|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
162069409|NCT00597012|585309107|FG000|Overall Study|Withdrawal by Subject|7|||
162069410|NCT00597012|585309108|FG001|Overall Study|Withdrawal by Subject|4|||
162069411|NCT00597012|585309107|FG000|Overall Study|Ineligible|2|||
162069412|NCT00597012|585309108|FG001|Overall Study|Ineligible|0|||
162069413|NCT00597012|585309107|FG000|Overall Study|Lost to Follow-up|0|||
162069414|NCT00597012|585309108|FG001|Overall Study|Lost to Follow-up|2|||
162069415|NCT04318080|585311481|FG000|Overall Study|Study closed by sponsor|10|||
162069416|NCT04318080|585311482|FG001|Overall Study|Study closed by sponsor|22|||
162069417|NCT04318080|585311481|FG000|Overall Study|Death|3|||
162069418|NCT04318080|585311482|FG001|Overall Study|Death|9|||
162069419|NCT04318080|585311481|FG000|Overall Study|Withdrawal by Subject|1|||
162069420|NCT04318080|585311482|FG001|Overall Study|Withdrawal by Subject|0|||
162069421|NCT04318080|585311481|FG000|Overall Study|Protocol Deviation|1|||
162069422|NCT04318080|585311482|FG001|Overall Study|Protocol Deviation|0|||
162069423|NCT06308822|585311483|FG000|Overall Study|Mutation Status Not Confirmed|17|||
162069424|NCT06308822|585311483|FG000|Overall Study|Adverse Event|1|||
162069425|NCT06308822|585311483|FG000|Overall Study|Death|5|||
162069426|NCT06308822|585311483|FG000|Overall Study|Disease progression|8|||
162069427|NCT06308822|585311483|FG000|Overall Study|Withdrawal by Subject|1|||
162069428|NCT06308822|585311483|FG000|Overall Study|Physician Decision|3|||
162069429|NCT01536379|585311484|FG000|Overall Study|Adverse Event|1|||
162069430|NCT01536379|585311485|FG001|Overall Study|Adverse Event|2|||
162069431|NCT01536379|585311484|FG000|Overall Study|Withdrawal by Subject|1|||
162069432|NCT01536379|585311485|FG001|Overall Study|Withdrawal by Subject|1|||
162069433|NCT04734652|585311494|FG000|Overall Study|Withdrawal by Subject|2|||
162069434|NCT04734652|585311495|FG001|Overall Study|Withdrawal by Subject|0|||
162069435|NCT04734652|585311494|FG000|Overall Study|Death|0|||
162069436|NCT04734652|585311495|FG001|Overall Study|Death|1|||
162069437|NCT04729127|585311497|FG000|Overall Study|Suspended/Terminated EI Services|4|||
162069438|NCT04729127|585311498|FG001|Overall Study|Suspended/Terminated EI Services|0|||
162069439|NCT04729127|585311499|FG002|Overall Study|Suspended/Terminated EI Services|4|||
162069440|NCT04729127|585311500|FG003|Overall Study|Suspended/Terminated EI Services|6|||
162069441|NCT04729127|585311501|FG004|Overall Study|Suspended/Terminated EI Services|0|||
162069442|NCT04729127|585311502|FG005|Overall Study|Suspended/Terminated EI Services|6|||
162069443|NCT04729127|585311503|FG006|Overall Study|Suspended/Terminated EI Services|2|||
162069444|NCT04729127|585311504|FG007|Overall Study|Suspended/Terminated EI Services|0|||
162069445|NCT04729127|585311505|FG008|Overall Study|Suspended/Terminated EI Services|2|||
162069446|NCT04729127|585311497|FG000|Overall Study|Withdrawal by Subject|1|||
162069447|NCT04729127|585311498|FG001|Overall Study|Withdrawal by Subject|0|||
162069448|NCT04729127|585311499|FG002|Overall Study|Withdrawal by Subject|1|||
162069449|NCT04729127|585311500|FG003|Overall Study|Withdrawal by Subject|0|||
162069450|NCT04729127|585311501|FG004|Overall Study|Withdrawal by Subject|0|||
162069451|NCT04729127|585311502|FG005|Overall Study|Withdrawal by Subject|0|||
162069452|NCT04729127|585311503|FG006|Overall Study|Withdrawal by Subject|0|||
162069453|NCT04729127|585311504|FG007|Overall Study|Withdrawal by Subject|0|||
162069454|NCT04729127|585311505|FG008|Overall Study|Withdrawal by Subject|0|||
162069455|NCT04729127|585311497|FG000|Overall Study|Switched Agency/Setting|1|||
162069456|NCT04729127|585311498|FG001|Overall Study|Switched Agency/Setting|0|||
162069457|NCT04729127|585311499|FG002|Overall Study|Switched Agency/Setting|1|||
162069458|NCT04729127|585311500|FG003|Overall Study|Switched Agency/Setting|1|||
162069459|NCT04729127|585311501|FG004|Overall Study|Switched Agency/Setting|0|||
162069460|NCT04729127|585311502|FG005|Overall Study|Switched Agency/Setting|1|||
162069461|NCT04729127|585311503|FG006|Overall Study|Switched Agency/Setting|1|||
162069462|NCT04729127|585311504|FG007|Overall Study|Switched Agency/Setting|0|||
162069463|NCT04729127|585311505|FG008|Overall Study|Switched Agency/Setting|1|||
162069464|NCT03662542|585311508|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
162069465|NCT03662542|585311509|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162069466|NCT03662542|585311510|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162069467|NCT03662542|585311511|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162069468|NCT03662542|585311512|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162069469|NCT03662542|585311513|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162069470|NCT03662542|585311514|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162069471|NCT03662542|585311515|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162069472|NCT03662542|585311516|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
162069473|NCT03662542|585311508|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162069474|NCT03662542|585311509|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
162069475|NCT03662542|585311510|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162069476|NCT03662542|585311511|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162069477|NCT03662542|585311512|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162069478|NCT03662542|585311513|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162069479|NCT03662542|585311514|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162069480|NCT03662542|585311515|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162069481|NCT03662542|585311516|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
162069482|NCT03662542|585311508|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
162069483|NCT03662542|585311509|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
162069484|NCT03662542|585311510|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
162069485|NCT03662542|585311511|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
162069486|NCT03662542|585311512|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
162069487|NCT03662542|585311513|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
162069488|NCT03662542|585311514|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
162069489|NCT03662542|585311515|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
162069490|NCT03662542|585311516|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
162069491|NCT03662542|585311508|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
162069492|NCT03662542|585311509|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162069493|NCT03662542|585311510|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162069494|NCT03662542|585311511|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162069495|NCT03662542|585311512|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162069496|NCT03662542|585311513|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162069497|NCT03662542|585311514|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162069498|NCT03662542|585311515|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162069499|NCT03662542|585311516|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
162069500|NCT03662542|585311508|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162069501|NCT03662542|585311509|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162069502|NCT03662542|585311510|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162069503|NCT03662542|585311511|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162069504|NCT03662542|585311512|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162069505|NCT03662542|585311513|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
162069506|NCT03662542|585311514|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162069507|NCT03662542|585311515|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162069508|NCT03662542|585311516|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
162069509|NCT03662542|585311508|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
162069510|NCT03662542|585311509|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
162069511|NCT03662542|585311510|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
162069512|NCT03662542|585311511|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
162069513|NCT03662542|585311512|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
162069514|NCT03662542|585311513|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
162069515|NCT03662542|585311514|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
162069516|NCT03662542|585311515|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
162069517|NCT03662542|585311516|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
162069518|NCT03662542|585311508|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
162069519|NCT03662542|585311509|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
162069520|NCT03662542|585311510|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
162069521|NCT03662542|585311511|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
162069522|NCT03662542|585311512|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
162069523|NCT03662542|585311513|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
162069524|NCT03662542|585311514|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
162069525|NCT03662542|585311515|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
162069526|NCT03662542|585311516|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
162069527|NCT03662542|585311508|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162069528|NCT03662542|585311509|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162069529|NCT03662542|585311510|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162069530|NCT03662542|585311511|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162069531|NCT03662542|585311512|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
162069532|NCT03662542|585311513|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
162069533|NCT03662542|585311514|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162069534|NCT03662542|585311515|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162069535|NCT03662542|585311516|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
162069536|NCT03662542|585311508|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162069537|NCT03662542|585311509|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162069538|NCT03662542|585311510|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162069539|NCT03662542|585311511|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162069540|NCT03662542|585311512|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162069541|NCT03662542|585311513|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
162069542|NCT03662542|585311514|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162069543|NCT03662542|585311515|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162069544|NCT03662542|585311516|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
162069545|NCT03662542|585311508|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
162069546|NCT03662542|585311509|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
162069547|NCT03662542|585311510|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
162069548|NCT03662542|585311511|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
162069549|NCT03662542|585311512|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
162069550|NCT03662542|585311513|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
162069551|NCT03662542|585311514|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
162069552|NCT03662542|585311515|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
162069553|NCT03662542|585311516|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
162069554|NCT03662542|585311508|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162069555|NCT03662542|585311509|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162069556|NCT03662542|585311510|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162069557|NCT03662542|585311511|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162069558|NCT03662542|585311512|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162069559|NCT03662542|585311513|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162069560|NCT03662542|585311514|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
162069561|NCT03662542|585311515|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
162069562|NCT03662542|585311516|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
162069563|NCT03662542|585311508|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162069564|NCT03662542|585311509|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162069565|NCT03662542|585311510|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162069566|NCT03662542|585311511|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162069567|NCT03662542|585311512|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162069568|NCT03662542|585311513|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162069569|NCT03662542|585311514|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
162069570|NCT03662542|585311515|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
162069571|NCT03662542|585311516|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
162069572|NCT03662542|585311508|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
162069573|NCT03662542|585311509|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
162069574|NCT03662542|585311510|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
162069575|NCT03662542|585311511|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
162069576|NCT03662542|585311512|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
162069577|NCT03662542|585311513|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
162069578|NCT03662542|585311514|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
162069579|NCT03662542|585311515|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
162069580|NCT03662542|585311516|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
162069581|NCT01217060|585311518|FG000|Overall Study|Withdrawal by Subject|1|||
162069582|NCT03388138|585311519|FG000|Overall Study|Protocol Violation|1|||
162069583|NCT03388138|585311520|FG001|Overall Study|Protocol Violation|0|||
162069584|NCT01528072|585311521|FG000|Overall Study|Withdrawal by Subject|5|||
162069585|NCT01528072|585311521|FG000|Overall Study|Physician Decision|1|||
162069586|NCT01528072|585311521|FG000|Overall Study|Determined not eligible by AEAC|1|||
162069587|NCT01528072|585311521|FG000|Overall Study|Missed Visit|2|||
162069588|NCT01528072|585311521|FG000|Overall Study|Lost to Follow-up|5|||
162069589|NCT01528072|585311521|FG000|Overall Study|Explanted|2|||
162069590|NCT01528072|585311521|FG000|Overall Study|Site Closure|4|||
162069591|NCT01528072|585311521|FG000|Overall Study|Death|2|||
162069592|NCT01528072|585311521|FG000|Overall Study|Early Termination of Study|52|||
162069593|NCT02436759|585311528|FG000|Overall Study|Adverse Event|3|||
162069594|NCT02436759|585311529|FG001|Overall Study|Adverse Event|0|||
162069595|NCT02436759|585311528|FG000|Overall Study|Protocol Violation|1|||
162069596|NCT02436759|585311529|FG001|Overall Study|Protocol Violation|0|||
162069597|NCT02436759|585311528|FG000|Overall Study|Withdrawal by Subject|0|||
162069598|NCT02436759|585311529|FG001|Overall Study|Withdrawal by Subject|1|||
162069599|NCT04014075|585311530|FG000|Overall Study|Progressive Disease|53|||
162069600|NCT04014075|585311530|FG000|Overall Study|Adverse Event|15|||
162069601|NCT04014075|585311530|FG000|Overall Study|Clinical Progression|4|||
162069602|NCT04014075|585311530|FG000|Overall Study|Death|2|||
162069603|NCT04014075|585311530|FG000|Overall Study|Withdrawal by Subject|2|||
162069604|NCT04014075|585311530|FG000|Overall Study|Miscellaneous|2|||
162069605|NCT04014075|585311530|FG000|Overall Study|Physician Decision|1|||
162069606|NCT01912287|585311531|FG000|Overall Study|Ineligible|1|||
162069607|NCT01912287|585311532|FG001|Overall Study|Ineligible|0|||
162069608|NCT01912287|585311533|FG002|Overall Study|Ineligible|1|||
162069609|NCT01912287|585311531|FG000|Overall Study|No-show|0|||
162069610|NCT01912287|585311532|FG001|Overall Study|No-show|0|||
162069611|NCT01912287|585311533|FG002|Overall Study|No-show|1|||
162069612|NCT01912287|585311531|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
162069613|NCT01912287|585311532|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
162069614|NCT01912287|585311533|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
162069615|NCT01912287|585311531|FG000|Overall Study|Felt treatment no longer needed|0|||
162069616|NCT01912287|585311532|FG001|Overall Study|Felt treatment no longer needed|1|||
162069617|NCT01912287|585311533|FG002|Overall Study|Felt treatment no longer needed|0|||
162069618|NCT01912287|585311531|FG000|Overall Study|Life circumstances|4|||
162069619|NCT01912287|585311532|FG001|Overall Study|Life circumstances|2|||
162069620|NCT01912287|585311533|FG002|Overall Study|Life circumstances|0|||
162069621|NCT01912287|585311531|FG000|Overall Study|Lost Interest|1|||
162069622|NCT01912287|585311532|FG001|Overall Study|Lost Interest|0|||
162069623|NCT01912287|585311533|FG002|Overall Study|Lost Interest|0|||
162069624|NCT01912287|585311531|FG000|Overall Study|Uknown reason - subject drop out|5|||
162069625|NCT01912287|585311532|FG001|Overall Study|Uknown reason - subject drop out|7|||
162069626|NCT01912287|585311533|FG002|Overall Study|Uknown reason - subject drop out|3|||
162069627|NCT01912287|585311531|FG000|Overall Study|Missed Assesment|1|||
162069628|NCT01912287|585311532|FG001|Overall Study|Missed Assesment|1|||
162069629|NCT01912287|585311533|FG002|Overall Study|Missed Assesment|1|||
162069630|NCT01912287|585311531|FG000|Overall Study|Scheduling/change in availability|17|||
162069631|NCT01912287|585311532|FG001|Overall Study|Scheduling/change in availability|10|||
162069632|NCT01912287|585311533|FG002|Overall Study|Scheduling/change in availability|8|||
162069633|NCT02631850|585311534|FG000|Treatment Period|Lost to Follow-up|0|||
162069634|NCT02631850|585311535|FG001|Treatment Period|Lost to Follow-up|1|||
162069635|NCT02631850|585311536|FG002|Treatment Period|Lost to Follow-up|0|||
162069636|NCT02631850|585311537|FG003|Treatment Period|Lost to Follow-up|0|||
162069637|NCT02631850|585311534|FG000|Treatment Period|Protocol Violation|1|||
162069638|NCT02631850|585311535|FG001|Treatment Period|Protocol Violation|0|||
162069639|NCT02631850|585311536|FG002|Treatment Period|Protocol Violation|0|||
162069640|NCT02631850|585311537|FG003|Treatment Period|Protocol Violation|0|||
162069641|NCT02631850|585311534|FG000|Treatment Period|Withdrawal by Subject|0|||
162069642|NCT02631850|585311535|FG001|Treatment Period|Withdrawal by Subject|5|||
162069643|NCT02631850|585311536|FG002|Treatment Period|Withdrawal by Subject|2|||
162069644|NCT02631850|585311537|FG003|Treatment Period|Withdrawal by Subject|2|||
162069645|NCT02631850|585311534|FG000|Treatment Period|Adverse Event|1|||
162069646|NCT02631850|585311535|FG001|Treatment Period|Adverse Event|0|||
162069647|NCT02631850|585311536|FG002|Treatment Period|Adverse Event|2|||
162069648|NCT02631850|585311537|FG003|Treatment Period|Adverse Event|3|||
162069649|NCT02631850|585311534|FG000|Treatment Period|Family medical issue|1|||
162069650|NCT02631850|585311535|FG001|Treatment Period|Family medical issue|0|||
162069651|NCT02631850|585311536|FG002|Treatment Period|Family medical issue|0|||
162069652|NCT02631850|585311537|FG003|Treatment Period|Family medical issue|0|||
162069653|NCT02631850|585311534|FG000|6 Month Follow up|Lost to Follow-up|5|||
162069654|NCT02631850|585311535|FG001|6 Month Follow up|Lost to Follow-up|8|||
162069655|NCT02631850|585311536|FG002|6 Month Follow up|Lost to Follow-up|3|||
162069656|NCT02631850|585311537|FG003|6 Month Follow up|Lost to Follow-up|5|||
162069657|NCT02631850|585311534|FG000|6 Month Follow up|Withdrawal by Subject|1|||
162069658|NCT02631850|585311535|FG001|6 Month Follow up|Withdrawal by Subject|0|||
162069659|NCT02631850|585311536|FG002|6 Month Follow up|Withdrawal by Subject|0|||
162069660|NCT02631850|585311537|FG003|6 Month Follow up|Withdrawal by Subject|2|||
162069661|NCT02631850|585311534|FG000|6 Month Follow up|Adverse Event|1|||
162069662|NCT02631850|585311535|FG001|6 Month Follow up|Adverse Event|4|||
162069663|NCT02631850|585311536|FG002|6 Month Follow up|Adverse Event|1|||
162069664|NCT02631850|585311537|FG003|6 Month Follow up|Adverse Event|3|||
162069665|NCT02631850|585311534|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
162069666|NCT02631850|585311535|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
162069667|NCT02631850|585311536|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
162069668|NCT02631850|585311537|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
162069669|NCT00326950|585311539|FG000|Overall Study|Progressive Disease|1|||
162069670|NCT01514760|585311540|FG000|Overall Study|Lost to Follow-up|2|||
162069671|NCT00619801|585311561|FG000|Overall Study|Lack of Efficacy|0|||
162069672|NCT00619801|585311562|FG001|Overall Study|Lack of Efficacy|1|||
162069673|NCT00619801|585311561|FG000|Overall Study|Withdrawal by Subject|1|||
162069674|NCT00619801|585311562|FG001|Overall Study|Withdrawal by Subject|1|||
162069675|NCT00619801|585311561|FG000|Overall Study|Loss of efficacy|0|||
162069676|NCT00619801|585311562|FG001|Overall Study|Loss of efficacy|1|||
162069677|NCT00975481|585311571|FG000|Second Intervention Period|Adverse Event|2|||
162069678|NCT00975481|585311572|FG001|Second Intervention Period|Adverse Event|1|||
162069679|NCT00975481|585311573|FG002|Second Intervention Period|Adverse Event|0|||
162069680|NCT00975481|585311574|FG003|Second Intervention Period|Adverse Event|0|||
162069681|NCT00975481|585311575|FG004|Second Intervention Period|Adverse Event|0|||
162069682|NCT00975481|585311576|FG005|Second Intervention Period|Adverse Event|0|||
162069683|NCT00975481|585311571|FG000|Second Intervention Period|Withdrawal by Subject|0|||
162069684|NCT00975481|585311572|FG001|Second Intervention Period|Withdrawal by Subject|0|||
162069685|NCT00975481|585311573|FG002|Second Intervention Period|Withdrawal by Subject|1|||
162069686|NCT00975481|585311574|FG003|Second Intervention Period|Withdrawal by Subject|0|||
162069687|NCT00975481|585311575|FG004|Second Intervention Period|Withdrawal by Subject|0|||
162069688|NCT00975481|585311576|FG005|Second Intervention Period|Withdrawal by Subject|0|||
162069689|NCT00975481|585311571|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
162069690|NCT00975481|585311572|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
162069691|NCT00975481|585311573|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
162069692|NCT00975481|585311574|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
162069693|NCT00975481|585311575|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
162069694|NCT00975481|585311576|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
162069695|NCT00975481|585311571|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
162069696|NCT00975481|585311572|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
162069697|NCT00975481|585311573|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
162069698|NCT00975481|585311574|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
162069699|NCT00975481|585311575|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
162069700|NCT00975481|585311576|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
162069701|NCT03559257|585311579|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
162069702|NCT03559257|585311580|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
162069703|NCT03559257|585311579|FG000|Double Blind Treatment Period|Protocol Violation|1|||
162069704|NCT03559257|585311580|FG001|Double Blind Treatment Period|Protocol Violation|4|||
162069705|NCT03559257|585311579|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
162069706|NCT03559257|585311580|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
162069707|NCT03559257|585311579|FG000|Double Blind Treatment Period|Adverse Event|0|||
162069708|NCT03559257|585311580|FG001|Double Blind Treatment Period|Adverse Event|1|||
162069709|NCT03559257|585311579|FG000|Double Blind Treatment Period|Screen Failure|0|||
162069710|NCT03559257|585311580|FG001|Double Blind Treatment Period|Screen Failure|1|||
162069711|NCT03559257|585311579|FG000|Open-label Treatment Period|Adverse Event|1|||
162069712|NCT03559257|585311580|FG001|Open-label Treatment Period|Adverse Event|4|||
162069713|NCT03559257|585311579|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
162069714|NCT03559257|585311580|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
162069715|NCT03559257|585311579|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
162069716|NCT03559257|585311580|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
162069717|NCT03559257|585311579|FG000|Open-label Treatment Period|Protocol Violation|2|||
162069718|NCT03559257|585311580|FG001|Open-label Treatment Period|Protocol Violation|0|||
162069719|NCT03559257|585311579|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
162069720|NCT03559257|585311580|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
162069721|NCT03559257|585311579|FG000|Open-label Treatment Period|Physician Decision|0|||
162069722|NCT03559257|585311580|FG001|Open-label Treatment Period|Physician Decision|1|||
162069723|NCT02738450|585311581|FG000|Overall Study|Withdrawal by Subject|0|||
162069724|NCT02738450|585311582|FG001|Overall Study|Withdrawal by Subject|2|||
162069725|NCT02738450|585311583|FG002|Overall Study|Withdrawal by Subject|0|||
162069726|NCT03630120|585311584|FG000|Overall Study|Disease progression|0|||
162069727|NCT03630120|585311585|FG001|Overall Study|Disease progression|1|||
162069728|NCT03630120|585311586|FG002|Overall Study|Disease progression|1|||
162069729|NCT03630120|585311587|FG003|Overall Study|Disease progression|1|||
162069730|NCT01387347|585311588|FG000|Overall Study|Lost to Follow-up|2|||
162069731|NCT01387347|585311589|FG001|Overall Study|Lost to Follow-up|1|||
162069732|NCT01519960|585311590|FG000|Overall Study|Withdrawal from the study|26|||
162069733|NCT01519960|585311591|FG001|Overall Study|Withdrawal from the study|22|||
162069734|NCT01519960|585311592|FG002|Overall Study|Withdrawal from the study|5|||
162069735|NCT03251079|585311593|FG000|Overall Study|Withdrawal by Subject|1|||
162069736|NCT03204305|585311604|FG000|Overall Study|Lost to Follow-up|6|||
162069737|NCT03204305|585311605|FG001|Overall Study|Lost to Follow-up|4|||
162069738|NCT03204305|585311606|FG002|Overall Study|Lost to Follow-up|0|||
162069739|NCT03204305|585311607|FG003|Overall Study|Lost to Follow-up|0|||
162069740|NCT03204305|585311604|FG000|Overall Study|Physician Decision|1|||
162069741|NCT03204305|585311605|FG001|Overall Study|Physician Decision|0|||
162069742|NCT03204305|585311606|FG002|Overall Study|Physician Decision|0|||
162069743|NCT03204305|585311607|FG003|Overall Study|Physician Decision|0|||
162069744|NCT03204305|585311604|FG000|Overall Study|failure to place arterial line|2|||
162069745|NCT03204305|585311605|FG001|Overall Study|failure to place arterial line|1|||
162069746|NCT03204305|585311606|FG002|Overall Study|failure to place arterial line|0|||
162069747|NCT03204305|585311607|FG003|Overall Study|failure to place arterial line|0|||
162069748|NCT03204305|585311604|FG000|Overall Study|Withdrawal by Subject|2|||
162069749|NCT03204305|585311605|FG001|Overall Study|Withdrawal by Subject|0|||
162069750|NCT03204305|585311606|FG002|Overall Study|Withdrawal by Subject|0|||
162069751|NCT03204305|585311607|FG003|Overall Study|Withdrawal by Subject|0|||
162069752|NCT01165554|585311614|FG000|Overall Study|Withdrawal by Subject|23|||
162069753|NCT02951156|585311615|FG000|Overall Study|Death|3|||
162069754|NCT02951156|585311616|FG001|Overall Study|Death|8|||
162069755|NCT02951156|585311617|FG002|Overall Study|Death|5|||
162069756|NCT02951156|585311615|FG000|Overall Study|Progressive disease|1|||
162069757|NCT02951156|585311616|FG001|Overall Study|Progressive disease|0|||
162069758|NCT02951156|585311617|FG002|Overall Study|Progressive disease|1|||
162069759|NCT02951156|585311615|FG000|Overall Study|Withdrawal by Subject|0|||
162069760|NCT02951156|585311616|FG001|Overall Study|Withdrawal by Subject|0|||
162069761|NCT02951156|585311617|FG002|Overall Study|Withdrawal by Subject|1|||
162069762|NCT02951156|585311615|FG000|Overall Study|Study terminated by sponsor|0|||
162069763|NCT02951156|585311616|FG001|Overall Study|Study terminated by sponsor|0|||
162069764|NCT02951156|585311617|FG002|Overall Study|Study terminated by sponsor|1|||
162069765|NCT02951156|585311615|FG000|Overall Study|Other|5|||
162069766|NCT02951156|585311616|FG001|Overall Study|Other|1|||
162069767|NCT02951156|585311617|FG002|Overall Study|Other|2|||
162069768|NCT01603459|585311620|FG000|Overall Study|Adverse Event|5|||
162069769|NCT01603459|585311620|FG000|Overall Study|Withdrawal by Subject|5|||
162069770|NCT01603459|585311620|FG000|Overall Study|Lost to Follow-up|3|||
162069771|NCT01603459|585311620|FG000|Overall Study|Predefined discontinuation criteria|3|||
162069772|NCT01603459|585311620|FG000|Overall Study|Non-compliance|1|||
162069773|NCT01603459|585311620|FG000|Overall Study|Administrative reason|1|||
162069774|NCT02953314|585311624|FG000|Overall Study|Adverse Event|0|||
162069775|NCT02953314|585311625|FG001|Overall Study|Adverse Event|1|||
162069776|NCT02953314|585311624|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
162069777|NCT02953314|585311625|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
162069778|NCT00535223|585311626|FG000|Overall Study|Withdrawal by Subject|4|||
162069779|NCT00535223|585311627|FG001|Overall Study|Withdrawal by Subject|1|||
162069780|NCT00492115|585311628|FG000|Overall Study|Withdrawal by Subject|3|||
162069781|NCT00492115|585311629|FG001|Overall Study|Withdrawal by Subject|4|||
162069782|NCT01288287|585311630|FG000|Overall Study|Lost to Follow-up|8|||
162069783|NCT01288287|585311630|FG000|Overall Study|Withdrawal by Subject|4|||
162069784|NCT01288287|585311630|FG000|Overall Study|Lack of Efficacy|13|||
162069785|NCT01288287|585311630|FG000|Overall Study|Other Reason|13|||
162069786|NCT01288287|585311630|FG000|Overall Study|Unknown Reason|1|||
162069787|NCT01288287|585311630|FG000|Overall Study|Unknown Status|7|||
162069788|NCT02515045|585311641|FG000|Overall Study|Adverse Event|0|||
162069789|NCT02515045|585311642|FG001|Overall Study|Adverse Event|3|||
162069790|NCT02515045|585311643|FG002|Overall Study|Adverse Event|3|||
162069791|NCT02515045|585311641|FG000|Overall Study|Lost to Follow-up|0|||
162069792|NCT02515045|585311642|FG001|Overall Study|Lost to Follow-up|1|||
162069793|NCT02515045|585311643|FG002|Overall Study|Lost to Follow-up|1|||
162069794|NCT03255382|585311644|FG000|Overall Study|Adverse Event|3|||
162069795|NCT03255382|585311645|FG001|Overall Study|Adverse Event|0|||
162069796|NCT03255382|585311644|FG000|Overall Study|Lost to Follow-up|2|||
162069797|NCT03255382|585311645|FG001|Overall Study|Lost to Follow-up|0|||
162069798|NCT03255382|585311644|FG000|Overall Study|Withdrawal by Subject|2|||
162069799|NCT03255382|585311645|FG001|Overall Study|Withdrawal by Subject|0|||
162069800|NCT03255382|585311644|FG000|Overall Study|Other|6|||
162069801|NCT03255382|585311645|FG001|Overall Study|Other|0|||
162069802|NCT00238121|585311646|FG000|Overall Study|Withdrawal by Subject|1|||
162069803|NCT00238121|585311647|FG001|Overall Study|Withdrawal by Subject|1|||
162069804|NCT00238121|585311646|FG000|Overall Study|Adverse Event|2|||
162069805|NCT00238121|585311647|FG001|Overall Study|Adverse Event|1|||
162069806|NCT02221284|585311648|FG000|Overall Study|Case Report Forms Uncollected|56|||
162069807|NCT02221284|585311648|FG000|Overall Study|Protocol Deviation|5|||
162069808|NCT01166178|585311649|FG000|Overall Study|Withdrawal by Subject|1|||
162069809|NCT01166178|585311650|FG001|Overall Study|Withdrawal by Subject|0|||
162069810|NCT01166178|585311649|FG000|Overall Study|Study was terminated|20|||
162069811|NCT01166178|585311650|FG001|Overall Study|Study was terminated|8|||
162069812|NCT04948450|585311651|FG000|Overall Study|Return home|1|||
162069813|NCT04948450|585311652|FG001|Overall Study|Return home|3|||
162069814|NCT00101907|585311656|FG000|Overall Study|Adverse Event|1|||
162069815|NCT00101907|585311657|FG001|Overall Study|Adverse Event|0|||
162069816|NCT00101907|585311658|FG002|Overall Study|Adverse Event|0|||
162069817|NCT00101907|585311659|FG003|Overall Study|Adverse Event|0|||
162069818|NCT00101907|585311660|FG004|Overall Study|Adverse Event|0|||
162069819|NCT00101907|585311661|FG005|Overall Study|Adverse Event|0|||
162069820|NCT00101907|585311656|FG000|Overall Study|Death|0|||
162069821|NCT00101907|585311657|FG001|Overall Study|Death|1|||
162069822|NCT00101907|585311658|FG002|Overall Study|Death|0|||
162069823|NCT00101907|585311659|FG003|Overall Study|Death|0|||
162069824|NCT00101907|585311660|FG004|Overall Study|Death|3|||
162069825|NCT00101907|585311661|FG005|Overall Study|Death|0|||
162069826|NCT00101907|585311656|FG000|Overall Study|Physician Decision|0|||
162069827|NCT00101907|585311657|FG001|Overall Study|Physician Decision|0|||
162069828|NCT00101907|585311658|FG002|Overall Study|Physician Decision|0|||
162069829|NCT00101907|585311659|FG003|Overall Study|Physician Decision|1|||
162069830|NCT00101907|585311660|FG004|Overall Study|Physician Decision|1|||
162069831|NCT00101907|585311661|FG005|Overall Study|Physician Decision|0|||
162069832|NCT00101907|585311656|FG000|Overall Study|Withdrawal by Subject|1|||
162069833|NCT00101907|585311657|FG001|Overall Study|Withdrawal by Subject|0|||
162069834|NCT00101907|585311658|FG002|Overall Study|Withdrawal by Subject|1|||
162069835|NCT00101907|585311659|FG003|Overall Study|Withdrawal by Subject|0|||
162069836|NCT00101907|585311660|FG004|Overall Study|Withdrawal by Subject|1|||
162069837|NCT00101907|585311661|FG005|Overall Study|Withdrawal by Subject|0|||
162069838|NCT00624052|585311662|FG000|Overall Study|Adverse Event|7|||
162069839|NCT00624052|585311663|FG001|Overall Study|Adverse Event|6|||
162069840|NCT00624052|585311664|FG002|Overall Study|Adverse Event|0|||
162069841|NCT00624052|585311665|FG003|Overall Study|Adverse Event|3|||
162069842|NCT00624052|585311662|FG000|Overall Study|Lack of Efficacy|1|||
162069843|NCT00624052|585311663|FG001|Overall Study|Lack of Efficacy|1|||
162069844|NCT00624052|585311664|FG002|Overall Study|Lack of Efficacy|0|||
162069845|NCT00624052|585311665|FG003|Overall Study|Lack of Efficacy|0|||
162069846|NCT00624052|585311662|FG000|Overall Study|Lost to Follow-up|2|||
162069847|NCT00624052|585311663|FG001|Overall Study|Lost to Follow-up|3|||
162069848|NCT00624052|585311664|FG002|Overall Study|Lost to Follow-up|1|||
162069849|NCT00624052|585311665|FG003|Overall Study|Lost to Follow-up|0|||
162069850|NCT00624052|585311662|FG000|Overall Study|Non compliant with the protocol|2|||
162069851|NCT00624052|585311663|FG001|Overall Study|Non compliant with the protocol|1|||
162069852|NCT00624052|585311664|FG002|Overall Study|Non compliant with the protocol|1|||
162069853|NCT00624052|585311665|FG003|Overall Study|Non compliant with the protocol|1|||
162069854|NCT00624052|585311662|FG000|Overall Study|Consent withdrawn|3|||
162069855|NCT00624052|585311663|FG001|Overall Study|Consent withdrawn|1|||
162069856|NCT00624052|585311664|FG002|Overall Study|Consent withdrawn|1|||
162069857|NCT00624052|585311665|FG003|Overall Study|Consent withdrawn|0|||
162069858|NCT00624052|585311662|FG000|Overall Study|Changed job/ran out if meds|0|||
162069859|NCT00624052|585311663|FG001|Overall Study|Changed job/ran out if meds|2|||
162069860|NCT00624052|585311664|FG002|Overall Study|Changed job/ran out if meds|0|||
162069861|NCT00624052|585311665|FG003|Overall Study|Changed job/ran out if meds|0|||
162069862|NCT01474876|585311672|FG000|Overall Study|Adverse Event|11|||
162069863|NCT01474876|585311673|FG001|Overall Study|Adverse Event|5|||
162069864|NCT01474876|585311674|FG002|Overall Study|Adverse Event|0|||
162069865|NCT01474876|585311672|FG000|Overall Study|Serious Adverse Event|2|||
162069866|NCT01474876|585311673|FG001|Overall Study|Serious Adverse Event|3|||
162069867|NCT01474876|585311674|FG002|Overall Study|Serious Adverse Event|0|||
162069868|NCT01474876|585311672|FG000|Overall Study|Lost to Follow-up|5|||
162069869|NCT01474876|585311673|FG001|Overall Study|Lost to Follow-up|4|||
162069870|NCT01474876|585311674|FG002|Overall Study|Lost to Follow-up|0|||
162069871|NCT01474876|585311672|FG000|Overall Study|Investigator's decision|28|||
162069872|NCT01474876|585311673|FG001|Overall Study|Investigator's decision|6|||
162069873|NCT01474876|585311674|FG002|Overall Study|Investigator's decision|0|||
162069874|NCT01474876|585311672|FG000|Overall Study|Patient's request|19|||
162069875|NCT01474876|585311673|FG001|Overall Study|Patient's request|5|||
162069876|NCT01474876|585311674|FG002|Overall Study|Patient's request|0|||
162069877|NCT01474876|585311672|FG000|Overall Study|Investigator's decision and pt request|1|||
162069878|NCT01474876|585311673|FG001|Overall Study|Investigator's decision and pt request|0|||
162069879|NCT01474876|585311674|FG002|Overall Study|Investigator's decision and pt request|0|||
162069880|NCT02291055|585311677|FG000|Overall Study|Death|2|||
162069881|NCT02291055|585311678|FG001|Overall Study|Death|2|||
162069882|NCT02291055|585311679|FG002|Overall Study|Death|5|||
162069883|NCT02291055|585311680|FG003|Overall Study|Death|8|||
162069884|NCT02291055|585311681|FG004|Overall Study|Death|12|||
162069885|NCT02291055|585311677|FG000|Overall Study|Lost to Follow-up|0|||
162069886|NCT02291055|585311678|FG001|Overall Study|Lost to Follow-up|0|||
162069887|NCT02291055|585311679|FG002|Overall Study|Lost to Follow-up|0|||
162069888|NCT02291055|585311680|FG003|Overall Study|Lost to Follow-up|1|||
162069889|NCT02291055|585311681|FG004|Overall Study|Lost to Follow-up|2|||
162069890|NCT02291055|585311677|FG000|Overall Study|Withdrawal by Subject|3|||
162069891|NCT02291055|585311678|FG001|Overall Study|Withdrawal by Subject|1|||
162069892|NCT02291055|585311679|FG002|Overall Study|Withdrawal by Subject|1|||
162069893|NCT02291055|585311680|FG003|Overall Study|Withdrawal by Subject|5|||
162069894|NCT02291055|585311681|FG004|Overall Study|Withdrawal by Subject|10|||
162069895|NCT02291055|585311677|FG000|Overall Study|Progressive Disease|0|||
162069896|NCT02291055|585311678|FG001|Overall Study|Progressive Disease|0|||
162069897|NCT02291055|585311679|FG002|Overall Study|Progressive Disease|1|||
162069898|NCT02291055|585311680|FG003|Overall Study|Progressive Disease|4|||
162069899|NCT02291055|585311681|FG004|Overall Study|Progressive Disease|2|||
162069900|NCT02291055|585311677|FG000|Overall Study|Study Terminated by Sponsor|0|||
162069901|NCT02291055|585311678|FG001|Overall Study|Study Terminated by Sponsor|0|||
162069902|NCT02291055|585311679|FG002|Overall Study|Study Terminated by Sponsor|0|||
162069903|NCT02291055|585311680|FG003|Overall Study|Study Terminated by Sponsor|5|||
162069904|NCT02291055|585311681|FG004|Overall Study|Study Terminated by Sponsor|1|||
162069905|NCT02291055|585311677|FG000|Overall Study|Other|0|||
162069906|NCT02291055|585311678|FG001|Overall Study|Other|2|||
162069907|NCT02291055|585311679|FG002|Overall Study|Other|1|||
162069908|NCT02291055|585311680|FG003|Overall Study|Other|4|||
162069909|NCT02291055|585311681|FG004|Overall Study|Other|0|||
162069910|NCT01523886|585311683|FG000|Overall Study|surgery cancelled|0|||
162069911|NCT01523886|585311684|FG001|Overall Study|surgery cancelled|1|||
162069912|NCT03839212|585311685|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
162069913|NCT01173718|585311697|FG000|Overall Study|Death|17|||
162069914|NCT01173718|585311697|FG000|Overall Study|Abandonment of study graft|27|||
162069915|NCT02113956|585311698|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
162069916|NCT02113956|585311699|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
162069917|NCT02113956|585311698|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
162069918|NCT02113956|585311699|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
162069919|NCT02113956|585311698|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
162069920|NCT02113956|585311699|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
162069921|NCT01499563|585311702|FG000|Overall Study|Withdrawal by Subject|10|||
162069922|NCT01499563|585311703|FG001|Overall Study|Withdrawal by Subject|11|||
162069923|NCT01499563|585311704|FG002|Overall Study|Withdrawal by Subject|7|||
162069924|NCT01499563|585311705|FG003|Overall Study|Withdrawal by Subject|8|||
162069925|NCT01499563|585311702|FG000|Overall Study|Physician Decision|2|||
162069926|NCT01499563|585311703|FG001|Overall Study|Physician Decision|1|||
162069927|NCT01499563|585311704|FG002|Overall Study|Physician Decision|3|||
162069928|NCT01499563|585311705|FG003|Overall Study|Physician Decision|0|||
162069929|NCT01499563|585311702|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
162069930|NCT01499563|585311703|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
162069931|NCT01499563|585311704|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
162069932|NCT01499563|585311705|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
162069933|NCT01499563|585311702|FG000|Overall Study|Adverse Event|2|||
162069934|NCT01499563|585311703|FG001|Overall Study|Adverse Event|0|||
162069935|NCT01499563|585311704|FG002|Overall Study|Adverse Event|1|||
162069936|NCT01499563|585311705|FG003|Overall Study|Adverse Event|3|||
162069937|NCT01499563|585311702|FG000|Overall Study|Lack of Efficacy|0|||
162069938|NCT01499563|585311703|FG001|Overall Study|Lack of Efficacy|1|||
162069939|NCT01499563|585311704|FG002|Overall Study|Lack of Efficacy|6|||
162069940|NCT01499563|585311705|FG003|Overall Study|Lack of Efficacy|3|||
162069941|NCT01499563|585311702|FG000|Overall Study|Other|8|||
162069942|NCT01499563|585311703|FG001|Overall Study|Other|6|||
162069943|NCT01499563|585311704|FG002|Overall Study|Other|6|||
162069944|NCT01499563|585311705|FG003|Overall Study|Other|4|||
162069945|NCT03658538|585311706|FG000|Overall Study|Death|2|||
162069946|NCT03658538|585311707|FG001|Overall Study|Death|1|||
162069947|NCT03658538|585311706|FG000|Overall Study|Cancer diagnosis|1|||
162069948|NCT03658538|585311707|FG001|Overall Study|Cancer diagnosis|0|||
162069949|NCT03658538|585311706|FG000|Overall Study|Change residence|1|||
162069950|NCT03658538|585311707|FG001|Overall Study|Change residence|2|||
162069951|NCT03658538|585311706|FG000|Overall Study|Lost to Follow-up|3|||
162069952|NCT03658538|585311707|FG001|Overall Study|Lost to Follow-up|3|||
162069953|NCT03658538|585311706|FG000|Overall Study|Unblinded|2|||
162069954|NCT03658538|585311707|FG001|Overall Study|Unblinded|3|||
162069955|NCT03658538|585311706|FG000|Overall Study|Physician Decision|0|||
162069956|NCT03658538|585311707|FG001|Overall Study|Physician Decision|1|||
162069957|NCT03658538|585311706|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
162069958|NCT03658538|585311707|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
162069959|NCT03658538|585311706|FG000|Overall Study|Evicted from home|1|||
162069960|NCT03658538|585311707|FG001|Overall Study|Evicted from home|0|||
162069961|NCT02926924|585314792|FG000|Overall Study|withdrawal - reason unknown|0|||
162069962|NCT02926924|585314793|FG001|Overall Study|withdrawal - reason unknown|1|||
162069963|NCT00939809|585314798|FG000|Overall Study|Adverse Event|2|||
162069964|NCT00939809|585314798|FG000|Overall Study|Death|1|||
162069965|NCT01921179|585314799|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
162069966|NCT01921179|585314800|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
162069967|NCT01921179|585314799|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
162069968|NCT01921179|585314800|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
162069969|NCT02603809|585314802|FG000|Overall Study|Withdrawal by Subject|4|||
162069970|NCT02603809|585314803|FG001|Overall Study|Withdrawal by Subject|1|||
162069971|NCT02603809|585314804|FG002|Overall Study|Withdrawal by Subject|2|||
162069972|NCT02603809|585314805|FG003|Overall Study|Withdrawal by Subject|3|||
162237444|NCT00600886|585921097|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
162069973|NCT02603809|585314806|FG004|Overall Study|Withdrawal by Subject|3|||
162069974|NCT02603809|585314807|FG005|Overall Study|Withdrawal by Subject|4|||
162069975|NCT02603809|585314802|FG000|Overall Study|Lost to Follow-up|2|||
162069976|NCT02603809|585314803|FG001|Overall Study|Lost to Follow-up|3|||
162069977|NCT02603809|585314804|FG002|Overall Study|Lost to Follow-up|1|||
162069978|NCT02603809|585314805|FG003|Overall Study|Lost to Follow-up|4|||
162069979|NCT02603809|585314806|FG004|Overall Study|Lost to Follow-up|2|||
162069980|NCT02603809|585314807|FG005|Overall Study|Lost to Follow-up|2|||
162069981|NCT02603809|585314802|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
162069982|NCT02603809|585314803|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
162069983|NCT02603809|585314804|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
162069984|NCT02603809|585314805|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
162069985|NCT02603809|585314806|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
162069986|NCT02603809|585314807|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
162069987|NCT02603809|585314802|FG000|Overall Study|Physician Decision|0|||
162069988|NCT02603809|585314803|FG001|Overall Study|Physician Decision|0|||
162069989|NCT02603809|585314804|FG002|Overall Study|Physician Decision|0|||
162069990|NCT02603809|585314805|FG003|Overall Study|Physician Decision|1|||
162069991|NCT02603809|585314806|FG004|Overall Study|Physician Decision|2|||
162069992|NCT02603809|585314807|FG005|Overall Study|Physician Decision|1|||
162069993|NCT02603809|585314802|FG000|Overall Study|Adverse Event|3|||
162069994|NCT02603809|585314803|FG001|Overall Study|Adverse Event|0|||
162069995|NCT02603809|585314804|FG002|Overall Study|Adverse Event|2|||
162069996|NCT02603809|585314805|FG003|Overall Study|Adverse Event|2|||
162069997|NCT02603809|585314806|FG004|Overall Study|Adverse Event|1|||
162069998|NCT02603809|585314807|FG005|Overall Study|Adverse Event|1|||
162069999|NCT02603809|585314802|FG000|Overall Study|Lack of Efficacy|0|||
162070000|NCT02603809|585314803|FG001|Overall Study|Lack of Efficacy|1|||
162070001|NCT02603809|585314804|FG002|Overall Study|Lack of Efficacy|0|||
162070002|NCT02603809|585314805|FG003|Overall Study|Lack of Efficacy|0|||
162070003|NCT02603809|585314806|FG004|Overall Study|Lack of Efficacy|0|||
162070004|NCT02603809|585314807|FG005|Overall Study|Lack of Efficacy|1|||
162070005|NCT00380978|585314808|FG000|Overall Study|Refused allocated intervention|0|||
162070006|NCT00380978|585314809|FG001|Overall Study|Refused allocated intervention|6|||
162070007|NCT00380978|585314808|FG000|Overall Study|Wrong study envelope|0|||
162070008|NCT00380978|585314809|FG001|Overall Study|Wrong study envelope|2|||
162070009|NCT00380978|585314808|FG000|Overall Study|Allocation prior to analgesia request|1|||
162070010|NCT00380978|585314809|FG001|Overall Study|Allocation prior to analgesia request|2|||
162070011|NCT00380978|585314808|FG000|Overall Study|Parous patient|1|||
162070012|NCT00380978|585314809|FG001|Overall Study|Parous patient|0|||
162070013|NCT04146545|585314810|FG000|Overall Study|deemed ineligible after randomization|1|||
162070014|NCT04146545|585314811|FG001|Overall Study|deemed ineligible after randomization|0|||
162070015|NCT01254227|585314812|FG000|Overall Study|Withdrawal by Subject|6|||
162070016|NCT01254227|585314812|FG000|Overall Study|Lost to Follow-up|6|||
162070017|NCT01254227|585314812|FG000|Overall Study|Adverse Event|5|||
162070018|NCT01254227|585314812|FG000|Overall Study|Abnormal test procedure result|5|||
162070019|NCT01254227|585314812|FG000|Overall Study|Administrative problems|2|||
162070020|NCT01254227|585314812|FG000|Overall Study|Death|1|||
162070021|NCT01254227|585314812|FG000|Overall Study|Protocol deviation|1|||
162070022|NCT02750592|585314813|FG000|Overall Study|Adverse Event|3|||
162070023|NCT02750592|585314813|FG000|Overall Study|Lack of Efficacy|2|||
162070024|NCT02981342|585314814|FG000|Overall Study|Adverse Event|0|||
162070025|NCT02981342|585314815|FG001|Overall Study|Adverse Event|0|||
162070026|NCT02981342|585314816|FG002|Overall Study|Adverse Event|0|||
162070027|NCT02981342|585314817|FG003|Overall Study|Adverse Event|1|||
162070028|NCT02981342|585314814|FG000|Overall Study|Death|0|||
162070029|NCT02981342|585314815|FG001|Overall Study|Death|9|||
162070030|NCT02981342|585314816|FG002|Overall Study|Death|9|||
162070031|NCT02981342|585314817|FG003|Overall Study|Death|4|||
162070032|NCT02981342|585314814|FG000|Overall Study|Withdrawal by Subject|0|||
162070033|NCT02981342|585314815|FG001|Overall Study|Withdrawal by Subject|0|||
162070034|NCT02981342|585314816|FG002|Overall Study|Withdrawal by Subject|3|||
162070035|NCT02981342|585314817|FG003|Overall Study|Withdrawal by Subject|1|||
162070036|NCT02981342|585314814|FG000|Overall Study|Study closed by sponsor|0|||
162070037|NCT02981342|585314815|FG001|Overall Study|Study closed by sponsor|0|||
162070038|NCT02981342|585314816|FG002|Overall Study|Study closed by sponsor|1|||
162070039|NCT02981342|585314817|FG003|Overall Study|Study closed by sponsor|1|||
162070040|NCT02981342|585314814|FG000|Overall Study|Randomized, Never Treated|0|||
162070041|NCT02981342|585314815|FG001|Overall Study|Randomized, Never Treated|1|||
162070042|NCT02981342|585314816|FG002|Overall Study|Randomized, Never Treated|0|||
162070043|NCT02981342|585314817|FG003|Overall Study|Randomized, Never Treated|7|||
162070044|NCT02981342|585314814|FG000|Overall Study|Lost to Follow-up|0|||
162070045|NCT02981342|585314815|FG001|Overall Study|Lost to Follow-up|1|||
162070046|NCT02981342|585314816|FG002|Overall Study|Lost to Follow-up|0|||
162070047|NCT02981342|585314817|FG003|Overall Study|Lost to Follow-up|0|||
162070048|NCT01277523|585314820|FG000|Overall Study|Adverse Event|1|||
162070049|NCT01277523|585314821|FG001|Overall Study|Adverse Event|0|||
162070050|NCT01277523|585314822|FG002|Overall Study|Adverse Event|0|||
162070051|NCT01277523|585314820|FG000|Overall Study|Protocol Violation|2|||
162070052|NCT01277523|585314821|FG001|Overall Study|Protocol Violation|0|||
162070053|NCT01277523|585314822|FG002|Overall Study|Protocol Violation|0|||
162070054|NCT01277523|585314820|FG000|Overall Study|Other Reason not Defined|0|||
162070055|NCT01277523|585314821|FG001|Overall Study|Other Reason not Defined|1|||
162070056|NCT01277523|585314822|FG002|Overall Study|Other Reason not Defined|0|||
162070057|NCT00112502|585314825|FG000|Overall Study|Withdrawal by Subject|0|||
162070058|NCT00112502|585314826|FG001|Overall Study|Withdrawal by Subject|1|||
162070059|NCT00112502|585314827|FG002|Overall Study|Withdrawal by Subject|1|||
162070060|NCT00112502|585314828|FG003|Overall Study|Withdrawal by Subject|4|||
162070061|NCT00112502|585314829|FG004|Overall Study|Withdrawal by Subject|2|||
162070062|NCT00112502|585314830|FG005|Overall Study|Withdrawal by Subject|5|||
162070063|NCT00112502|585314831|FG006|Overall Study|Withdrawal by Subject|3|||
162070064|NCT00112502|585314832|FG007|Overall Study|Withdrawal by Subject|7|||
162070065|NCT00265343|585314833|FG000|Overall Study|Adverse Event|10|||
162070066|NCT00265343|585314834|FG001|Overall Study|Adverse Event|7|||
162070067|NCT00265343|585314833|FG000|Overall Study|Withdrawal by Subject|3|||
162070068|NCT00265343|585314834|FG001|Overall Study|Withdrawal by Subject|9|||
162070069|NCT00265343|585314833|FG000|Overall Study|Other|8|||
162070070|NCT00265343|585314834|FG001|Overall Study|Other|3|||
162070071|NCT02608268|585314835|FG000|Overall Study|Adverse Event|0|||
162070072|NCT02608268|585314836|FG001|Overall Study|Adverse Event|0|||
162070073|NCT02608268|585314837|FG002|Overall Study|Adverse Event|1|||
162070074|NCT02608268|585314838|FG003|Overall Study|Adverse Event|0|||
162070075|NCT02608268|585314839|FG004|Overall Study|Adverse Event|0|||
162070076|NCT02608268|585314840|FG005|Overall Study|Adverse Event|0|||
162070077|NCT02608268|585314841|FG006|Overall Study|Adverse Event|0|||
162070078|NCT02608268|585314842|FG007|Overall Study|Adverse Event|0|||
162070079|NCT02608268|585314843|FG008|Overall Study|Adverse Event|0|||
162070080|NCT02608268|585314844|FG009|Overall Study|Adverse Event|0|||
162070081|NCT02608268|585314845|FG010|Overall Study|Adverse Event|0|||
162070082|NCT02608268|585314846|FG011|Overall Study|Adverse Event|0|||
162070083|NCT02608268|585314847|FG012|Overall Study|Adverse Event|2|||
162070084|NCT02608268|585314848|FG013|Overall Study|Adverse Event|0|||
162070085|NCT02608268|585314849|FG014|Overall Study|Adverse Event|0|||
162070086|NCT02608268|585314850|FG015|Overall Study|Adverse Event|0|||
162070087|NCT02608268|585314851|FG016|Overall Study|Adverse Event|0|||
162070088|NCT02608268|585314852|FG017|Overall Study|Adverse Event|0|||
162070089|NCT02608268|585314853|FG018|Overall Study|Adverse Event|0|||
162070090|NCT02608268|585314854|FG019|Overall Study|Adverse Event|0|||
162070091|NCT02608268|585314855|FG020|Overall Study|Adverse Event|1|||
162070092|NCT02608268|585314856|FG021|Overall Study|Adverse Event|1|||
162070093|NCT02608268|585314857|FG022|Overall Study|Adverse Event|0|||
162070094|NCT02608268|585314858|FG023|Overall Study|Adverse Event|0|||
162070095|NCT02608268|585314859|FG024|Overall Study|Adverse Event|1|||
162070096|NCT02608268|585314860|FG025|Overall Study|Adverse Event|0|||
162070097|NCT02608268|585314861|FG026|Overall Study|Adverse Event|0|||
162070098|NCT02608268|585314862|FG027|Overall Study|Adverse Event|0|||
162070099|NCT02608268|585314863|FG028|Overall Study|Adverse Event|1|||
162070100|NCT02608268|585314864|FG029|Overall Study|Adverse Event|0|||
162070101|NCT02608268|585314835|FG000|Overall Study|Death|1|||
162070102|NCT02608268|585314836|FG001|Overall Study|Death|0|||
162070103|NCT02608268|585314837|FG002|Overall Study|Death|0|||
162070104|NCT02608268|585314838|FG003|Overall Study|Death|0|||
162070105|NCT02608268|585314839|FG004|Overall Study|Death|0|||
162070106|NCT02608268|585314840|FG005|Overall Study|Death|0|||
162070107|NCT02608268|585314841|FG006|Overall Study|Death|0|||
162070108|NCT02608268|585314842|FG007|Overall Study|Death|0|||
162070109|NCT02608268|585314843|FG008|Overall Study|Death|1|||
162070110|NCT02608268|585314844|FG009|Overall Study|Death|1|||
162070111|NCT02608268|585314845|FG010|Overall Study|Death|0|||
162070112|NCT02608268|585314846|FG011|Overall Study|Death|0|||
162070113|NCT02608268|585314847|FG012|Overall Study|Death|0|||
162070114|NCT02608268|585314848|FG013|Overall Study|Death|0|||
162070115|NCT02608268|585314849|FG014|Overall Study|Death|0|||
162070116|NCT02608268|585314850|FG015|Overall Study|Death|1|||
162070117|NCT02608268|585314851|FG016|Overall Study|Death|0|||
162070118|NCT02608268|585314852|FG017|Overall Study|Death|1|||
162070119|NCT02608268|585314853|FG018|Overall Study|Death|0|||
162070120|NCT02608268|585314854|FG019|Overall Study|Death|1|||
162070121|NCT02608268|585314855|FG020|Overall Study|Death|1|||
162070122|NCT02608268|585314856|FG021|Overall Study|Death|0|||
162070123|NCT02608268|585314857|FG022|Overall Study|Death|0|||
162070124|NCT02608268|585314858|FG023|Overall Study|Death|0|||
162070125|NCT02608268|585314859|FG024|Overall Study|Death|1|||
162070126|NCT02608268|585314860|FG025|Overall Study|Death|2|||
162070127|NCT02608268|585314861|FG026|Overall Study|Death|0|||
162070128|NCT02608268|585314862|FG027|Overall Study|Death|1|||
162070129|NCT02608268|585314863|FG028|Overall Study|Death|4|||
162070130|NCT02608268|585314864|FG029|Overall Study|Death|0|||
162070131|NCT02608268|585314835|FG000|Overall Study|Physician Decision|0|||
162070132|NCT02608268|585314836|FG001|Overall Study|Physician Decision|0|||
162070133|NCT02608268|585314837|FG002|Overall Study|Physician Decision|0|||
162070134|NCT02608268|585314838|FG003|Overall Study|Physician Decision|0|||
162070135|NCT02608268|585314839|FG004|Overall Study|Physician Decision|0|||
162070136|NCT02608268|585314840|FG005|Overall Study|Physician Decision|0|||
162070137|NCT02608268|585314841|FG006|Overall Study|Physician Decision|0|||
162070138|NCT02608268|585314842|FG007|Overall Study|Physician Decision|0|||
162070139|NCT02608268|585314843|FG008|Overall Study|Physician Decision|0|||
162070140|NCT02608268|585314844|FG009|Overall Study|Physician Decision|0|||
162070141|NCT02608268|585314845|FG010|Overall Study|Physician Decision|1|||
162070142|NCT02608268|585314846|FG011|Overall Study|Physician Decision|0|||
162070143|NCT02608268|585314847|FG012|Overall Study|Physician Decision|0|||
162070144|NCT02608268|585314848|FG013|Overall Study|Physician Decision|1|||
162070145|NCT02608268|585314849|FG014|Overall Study|Physician Decision|0|||
162070146|NCT02608268|585314850|FG015|Overall Study|Physician Decision|0|||
162070147|NCT02608268|585314851|FG016|Overall Study|Physician Decision|0|||
162070148|NCT02608268|585314852|FG017|Overall Study|Physician Decision|0|||
162070149|NCT02608268|585314853|FG018|Overall Study|Physician Decision|0|||
162070150|NCT02608268|585314854|FG019|Overall Study|Physician Decision|0|||
162070151|NCT02608268|585314855|FG020|Overall Study|Physician Decision|0|||
162070152|NCT02608268|585314856|FG021|Overall Study|Physician Decision|0|||
162070153|NCT02608268|585314857|FG022|Overall Study|Physician Decision|1|||
162070154|NCT02608268|585314858|FG023|Overall Study|Physician Decision|1|||
162070155|NCT02608268|585314859|FG024|Overall Study|Physician Decision|1|||
162070156|NCT02608268|585314860|FG025|Overall Study|Physician Decision|0|||
162070157|NCT02608268|585314861|FG026|Overall Study|Physician Decision|0|||
162070158|NCT02608268|585314862|FG027|Overall Study|Physician Decision|2|||
162070159|NCT02608268|585314863|FG028|Overall Study|Physician Decision|1|||
162070160|NCT02608268|585314864|FG029|Overall Study|Physician Decision|1|||
162070161|NCT02608268|585314835|FG000|Overall Study|Progressive disease|12|||
162070162|NCT02608268|585314836|FG001|Overall Study|Progressive disease|8|||
162070163|NCT02608268|585314837|FG002|Overall Study|Progressive disease|13|||
162070164|NCT02608268|585314838|FG003|Overall Study|Progressive disease|5|||
162070165|NCT02608268|585314839|FG004|Overall Study|Progressive disease|2|||
162070166|NCT02608268|585314840|FG005|Overall Study|Progressive disease|4|||
162070167|NCT02608268|585314841|FG006|Overall Study|Progressive disease|6|||
162070168|NCT02608268|585314842|FG007|Overall Study|Progressive disease|2|||
162070169|NCT02608268|585314843|FG008|Overall Study|Progressive disease|5|||
162070170|NCT02608268|585314844|FG009|Overall Study|Progressive disease|6|||
162070171|NCT02608268|585314845|FG010|Overall Study|Progressive disease|5|||
162070172|NCT02608268|585314846|FG011|Overall Study|Progressive disease|5|||
162070173|NCT02608268|585314847|FG012|Overall Study|Progressive disease|4|||
162070174|NCT02608268|585314848|FG013|Overall Study|Progressive disease|11|||
162070175|NCT02608268|585314849|FG014|Overall Study|Progressive disease|6|||
162070176|NCT02608268|585314850|FG015|Overall Study|Progressive disease|3|||
162070177|NCT02608268|585314851|FG016|Overall Study|Progressive disease|5|||
162070178|NCT02608268|585314852|FG017|Overall Study|Progressive disease|5|||
162070179|NCT02608268|585314853|FG018|Overall Study|Progressive disease|5|||
162070180|NCT02608268|585314854|FG019|Overall Study|Progressive disease|2|||
162070181|NCT02608268|585314855|FG020|Overall Study|Progressive disease|10|||
162070182|NCT02608268|585314856|FG021|Overall Study|Progressive disease|4|||
162070183|NCT02608268|585314857|FG022|Overall Study|Progressive disease|5|||
162070184|NCT02608268|585314858|FG023|Overall Study|Progressive disease|5|||
162070185|NCT02608268|585314859|FG024|Overall Study|Progressive disease|3|||
162070186|NCT02608268|585314860|FG025|Overall Study|Progressive disease|11|||
162070187|NCT02608268|585314861|FG026|Overall Study|Progressive disease|16|||
162070188|NCT02608268|585314862|FG027|Overall Study|Progressive disease|11|||
162070189|NCT02608268|585314863|FG028|Overall Study|Progressive disease|10|||
162070190|NCT02608268|585314864|FG029|Overall Study|Progressive disease|15|||
162070191|NCT02608268|585314835|FG000|Overall Study|Subject/guardian decision|1|||
162070192|NCT02608268|585314836|FG001|Overall Study|Subject/guardian decision|1|||
162070193|NCT02608268|585314837|FG002|Overall Study|Subject/guardian decision|2|||
162070194|NCT02608268|585314838|FG003|Overall Study|Subject/guardian decision|0|||
162070195|NCT02608268|585314839|FG004|Overall Study|Subject/guardian decision|0|||
162070196|NCT02608268|585314840|FG005|Overall Study|Subject/guardian decision|0|||
162070197|NCT02608268|585314841|FG006|Overall Study|Subject/guardian decision|0|||
162070198|NCT02608268|585314842|FG007|Overall Study|Subject/guardian decision|0|||
162070199|NCT02608268|585314843|FG008|Overall Study|Subject/guardian decision|2|||
162070200|NCT02608268|585314844|FG009|Overall Study|Subject/guardian decision|2|||
162070201|NCT02608268|585314845|FG010|Overall Study|Subject/guardian decision|0|||
162070202|NCT02608268|585314846|FG011|Overall Study|Subject/guardian decision|1|||
162070203|NCT02608268|585314847|FG012|Overall Study|Subject/guardian decision|0|||
162070204|NCT02608268|585314848|FG013|Overall Study|Subject/guardian decision|1|||
162070205|NCT02608268|585314849|FG014|Overall Study|Subject/guardian decision|0|||
162070206|NCT02608268|585314850|FG015|Overall Study|Subject/guardian decision|1|||
162070207|NCT02608268|585314851|FG016|Overall Study|Subject/guardian decision|0|||
162070208|NCT02608268|585314852|FG017|Overall Study|Subject/guardian decision|0|||
162070209|NCT02608268|585314853|FG018|Overall Study|Subject/guardian decision|1|||
162070210|NCT02608268|585314854|FG019|Overall Study|Subject/guardian decision|0|||
162070211|NCT02608268|585314855|FG020|Overall Study|Subject/guardian decision|0|||
162070212|NCT02608268|585314856|FG021|Overall Study|Subject/guardian decision|0|||
162070213|NCT02608268|585314857|FG022|Overall Study|Subject/guardian decision|1|||
162070214|NCT02608268|585314858|FG023|Overall Study|Subject/guardian decision|0|||
162070215|NCT02608268|585314859|FG024|Overall Study|Subject/guardian decision|0|||
162070216|NCT02608268|585314860|FG025|Overall Study|Subject/guardian decision|1|||
162070217|NCT02608268|585314861|FG026|Overall Study|Subject/guardian decision|1|||
162070218|NCT02608268|585314862|FG027|Overall Study|Subject/guardian decision|1|||
162070219|NCT02608268|585314863|FG028|Overall Study|Subject/guardian decision|1|||
162070220|NCT02608268|585314864|FG029|Overall Study|Subject/guardian decision|0|||
162070221|NCT04762680|585314873|FG000|Phase 2|Adverse Event|0|||
162070222|NCT04762680|585314874|FG001|Phase 2|Adverse Event|1|||
162070223|NCT04762680|585314875|FG002|Phase 2|Adverse Event|0|||
162070224|NCT04762680|585314876|FG003|Phase 2|Adverse Event|0|||
162070225|NCT04762680|585314877|FG004|Phase 2|Adverse Event|0|||
162070226|NCT04762680|585314878|FG005|Phase 2|Adverse Event|0|||
162070227|NCT04762680|585314879|FG006|Phase 2|Adverse Event|0|||
162070228|NCT04762680|585314880|FG007|Phase 2|Adverse Event|0|||
162070229|NCT04762680|585314881|FG008|Phase 2|Adverse Event|0|||
162070230|NCT04762680|585314882|FG009|Phase 2|Adverse Event|0|||
162070231|NCT04762680|585314883|FG010|Phase 2|Adverse Event|0|||
162070232|NCT04762680|585314884|FG011|Phase 2|Adverse Event|0|||
162070233|NCT04762680|585314885|FG012|Phase 2|Adverse Event|0|||
162070234|NCT04762680|585314886|FG013|Phase 2|Adverse Event|0|||
162070235|NCT04762680|585314887|FG014|Phase 2|Adverse Event|0|||
162070236|NCT04762680|585314888|FG015|Phase 2|Adverse Event|0|||
162070237|NCT04762680|585314889|FG016|Phase 2|Adverse Event|0|||
162070238|NCT04762680|585314890|FG017|Phase 2|Adverse Event|0|||
162070239|NCT04762680|585314891|FG018|Phase 2|Adverse Event|0|||
162070240|NCT04762680|585314892|FG019|Phase 2|Adverse Event|0|||
162070241|NCT04762680|585314893|FG020|Phase 2|Adverse Event|0|||
162070242|NCT04762680|585314894|FG021|Phase 2|Adverse Event|0|||
162070243|NCT04762680|585314873|FG000|Phase 2|Protocol Violation|5|||
162070244|NCT04762680|585314874|FG001|Phase 2|Protocol Violation|5|||
162070245|NCT04762680|585314875|FG002|Phase 2|Protocol Violation|1|||
162070246|NCT04762680|585314876|FG003|Phase 2|Protocol Violation|0|||
162070247|NCT04762680|585314877|FG004|Phase 2|Protocol Violation|0|||
162070248|NCT04762680|585314878|FG005|Phase 2|Protocol Violation|0|||
162070249|NCT04762680|585314879|FG006|Phase 2|Protocol Violation|0|||
162070250|NCT04762680|585314880|FG007|Phase 2|Protocol Violation|0|||
162070251|NCT04762680|585314881|FG008|Phase 2|Protocol Violation|0|||
162070252|NCT04762680|585314882|FG009|Phase 2|Protocol Violation|0|||
162070253|NCT04762680|585314883|FG010|Phase 2|Protocol Violation|0|||
162070254|NCT04762680|585314884|FG011|Phase 2|Protocol Violation|0|||
162070255|NCT04762680|585314885|FG012|Phase 2|Protocol Violation|0|||
162070256|NCT04762680|585314886|FG013|Phase 2|Protocol Violation|0|||
162070257|NCT04762680|585314887|FG014|Phase 2|Protocol Violation|0|||
162070258|NCT04762680|585314888|FG015|Phase 2|Protocol Violation|0|||
162070259|NCT04762680|585314889|FG016|Phase 2|Protocol Violation|0|||
162070260|NCT04762680|585314890|FG017|Phase 2|Protocol Violation|0|||
162070261|NCT04762680|585314891|FG018|Phase 2|Protocol Violation|0|||
162070262|NCT04762680|585314892|FG019|Phase 2|Protocol Violation|0|||
162070263|NCT04762680|585314893|FG020|Phase 2|Protocol Violation|0|||
162070264|NCT04762680|585314894|FG021|Phase 2|Protocol Violation|0|||
162070265|NCT04762680|585314873|FG000|Phase 2|Withdrawal by Subject|23|||
162070266|NCT04762680|585314874|FG001|Phase 2|Withdrawal by Subject|21|||
162070267|NCT04762680|585314875|FG002|Phase 2|Withdrawal by Subject|28|||
162070268|NCT04762680|585314876|FG003|Phase 2|Withdrawal by Subject|0|||
162070269|NCT04762680|585314877|FG004|Phase 2|Withdrawal by Subject|0|||
162070270|NCT04762680|585314878|FG005|Phase 2|Withdrawal by Subject|0|||
162070271|NCT04762680|585314879|FG006|Phase 2|Withdrawal by Subject|0|||
162070272|NCT04762680|585314880|FG007|Phase 2|Withdrawal by Subject|0|||
162070273|NCT04762680|585314881|FG008|Phase 2|Withdrawal by Subject|0|||
162070274|NCT04762680|585314882|FG009|Phase 2|Withdrawal by Subject|0|||
162070275|NCT04762680|585314883|FG010|Phase 2|Withdrawal by Subject|0|||
162070276|NCT04762680|585314884|FG011|Phase 2|Withdrawal by Subject|0|||
162070277|NCT04762680|585314885|FG012|Phase 2|Withdrawal by Subject|0|||
162070278|NCT04762680|585314886|FG013|Phase 2|Withdrawal by Subject|0|||
162070279|NCT04762680|585314887|FG014|Phase 2|Withdrawal by Subject|0|||
162070280|NCT04762680|585314888|FG015|Phase 2|Withdrawal by Subject|0|||
162070281|NCT04762680|585314889|FG016|Phase 2|Withdrawal by Subject|0|||
162070282|NCT04762680|585314890|FG017|Phase 2|Withdrawal by Subject|0|||
162070283|NCT04762680|585314891|FG018|Phase 2|Withdrawal by Subject|0|||
162070284|NCT04762680|585314892|FG019|Phase 2|Withdrawal by Subject|0|||
162070285|NCT04762680|585314893|FG020|Phase 2|Withdrawal by Subject|0|||
162070286|NCT04762680|585314894|FG021|Phase 2|Withdrawal by Subject|0|||
162070287|NCT04762680|585314873|FG000|Phase 2|Lost to Follow-up|14|||
162070288|NCT04762680|585314874|FG001|Phase 2|Lost to Follow-up|8|||
162070289|NCT04762680|585314875|FG002|Phase 2|Lost to Follow-up|9|||
162070290|NCT04762680|585314876|FG003|Phase 2|Lost to Follow-up|0|||
162070291|NCT04762680|585314877|FG004|Phase 2|Lost to Follow-up|0|||
162070292|NCT04762680|585314878|FG005|Phase 2|Lost to Follow-up|0|||
162070293|NCT04762680|585314879|FG006|Phase 2|Lost to Follow-up|0|||
162070294|NCT04762680|585314880|FG007|Phase 2|Lost to Follow-up|0|||
162070295|NCT04762680|585314881|FG008|Phase 2|Lost to Follow-up|0|||
162070296|NCT04762680|585314882|FG009|Phase 2|Lost to Follow-up|0|||
162070297|NCT04762680|585314883|FG010|Phase 2|Lost to Follow-up|0|||
162070298|NCT04762680|585314884|FG011|Phase 2|Lost to Follow-up|0|||
162070299|NCT04762680|585314885|FG012|Phase 2|Lost to Follow-up|0|||
162070300|NCT04762680|585314886|FG013|Phase 2|Lost to Follow-up|0|||
162070301|NCT04762680|585314887|FG014|Phase 2|Lost to Follow-up|0|||
162070302|NCT04762680|585314888|FG015|Phase 2|Lost to Follow-up|0|||
162070303|NCT04762680|585314889|FG016|Phase 2|Lost to Follow-up|0|||
162070304|NCT04762680|585314890|FG017|Phase 2|Lost to Follow-up|0|||
162070305|NCT04762680|585314891|FG018|Phase 2|Lost to Follow-up|0|||
162070306|NCT04762680|585314892|FG019|Phase 2|Lost to Follow-up|0|||
162070307|NCT04762680|585314893|FG020|Phase 2|Lost to Follow-up|0|||
162070308|NCT04762680|585314894|FG021|Phase 2|Lost to Follow-up|0|||
162070309|NCT04762680|585314873|FG000|Phase 3|Adverse Event|0|||
162070310|NCT04762680|585314874|FG001|Phase 3|Adverse Event|0|||
162070311|NCT04762680|585314875|FG002|Phase 3|Adverse Event|0|||
162070312|NCT04762680|585314876|FG003|Phase 3|Adverse Event|1|||
162070313|NCT04762680|585314877|FG004|Phase 3|Adverse Event|0|||
162070314|NCT04762680|585314878|FG005|Phase 3|Adverse Event|0|||
162070315|NCT04762680|585314879|FG006|Phase 3|Adverse Event|0|||
162070316|NCT04762680|585314880|FG007|Phase 3|Adverse Event|0|||
162070317|NCT04762680|585314881|FG008|Phase 3|Adverse Event|0|||
162070318|NCT04762680|585314882|FG009|Phase 3|Adverse Event|0|||
162070319|NCT04762680|585314883|FG010|Phase 3|Adverse Event|0|||
162070320|NCT04762680|585314884|FG011|Phase 3|Adverse Event|0|||
162070321|NCT04762680|585314885|FG012|Phase 3|Adverse Event|0|||
162070322|NCT04762680|585314886|FG013|Phase 3|Adverse Event|0|||
162070323|NCT04762680|585314887|FG014|Phase 3|Adverse Event|0|||
162070324|NCT04762680|585314888|FG015|Phase 3|Adverse Event|0|||
162070325|NCT04762680|585314889|FG016|Phase 3|Adverse Event|0|||
162070326|NCT04762680|585314890|FG017|Phase 3|Adverse Event|3|||
162070327|NCT04762680|585314891|FG018|Phase 3|Adverse Event|0|||
162070328|NCT04762680|585314892|FG019|Phase 3|Adverse Event|0|||
162070329|NCT04762680|585314893|FG020|Phase 3|Adverse Event|0|||
162070330|NCT04762680|585314894|FG021|Phase 3|Adverse Event|0|||
162070331|NCT04762680|585314873|FG000|Phase 3|Protocol Violation|0|||
162070332|NCT04762680|585314874|FG001|Phase 3|Protocol Violation|0|||
162070333|NCT04762680|585314875|FG002|Phase 3|Protocol Violation|0|||
162070334|NCT04762680|585314876|FG003|Phase 3|Protocol Violation|4|||
162070335|NCT04762680|585314877|FG004|Phase 3|Protocol Violation|1|||
162070336|NCT04762680|585314878|FG005|Phase 3|Protocol Violation|5|||
162070337|NCT04762680|585314879|FG006|Phase 3|Protocol Violation|1|||
162070338|NCT04762680|585314880|FG007|Phase 3|Protocol Violation|0|||
162070339|NCT04762680|585314881|FG008|Phase 3|Protocol Violation|0|||
162070340|NCT04762680|585314882|FG009|Phase 3|Protocol Violation|0|||
162070341|NCT04762680|585314883|FG010|Phase 3|Protocol Violation|0|||
162070342|NCT04762680|585314884|FG011|Phase 3|Protocol Violation|2|||
162070343|NCT04762680|585314885|FG012|Phase 3|Protocol Violation|3|||
162070344|NCT04762680|585314886|FG013|Phase 3|Protocol Violation|0|||
162070345|NCT04762680|585314887|FG014|Phase 3|Protocol Violation|0|||
162070346|NCT04762680|585314888|FG015|Phase 3|Protocol Violation|1|||
162070347|NCT04762680|585314889|FG016|Phase 3|Protocol Violation|0|||
162070348|NCT04762680|585314890|FG017|Phase 3|Protocol Violation|10|||
162070349|NCT04762680|585314891|FG018|Phase 3|Protocol Violation|0|||
162070350|NCT04762680|585314892|FG019|Phase 3|Protocol Violation|0|||
162070351|NCT04762680|585314893|FG020|Phase 3|Protocol Violation|0|||
162070352|NCT04762680|585314894|FG021|Phase 3|Protocol Violation|0|||
162070353|NCT04762680|585314873|FG000|Phase 3|Withdrawal by Subject|0|||
162070354|NCT04762680|585314874|FG001|Phase 3|Withdrawal by Subject|0|||
162070355|NCT04762680|585314875|FG002|Phase 3|Withdrawal by Subject|0|||
162070356|NCT04762680|585314876|FG003|Phase 3|Withdrawal by Subject|13|||
162070357|NCT04762680|585314877|FG004|Phase 3|Withdrawal by Subject|17|||
162070358|NCT04762680|585314878|FG005|Phase 3|Withdrawal by Subject|12|||
162070359|NCT04762680|585314879|FG006|Phase 3|Withdrawal by Subject|8|||
162070360|NCT04762680|585314880|FG007|Phase 3|Withdrawal by Subject|3|||
162070361|NCT04762680|585314881|FG008|Phase 3|Withdrawal by Subject|2|||
162070362|NCT04762680|585314882|FG009|Phase 3|Withdrawal by Subject|4|||
162070363|NCT04762680|585314883|FG010|Phase 3|Withdrawal by Subject|3|||
162070364|NCT04762680|585314884|FG011|Phase 3|Withdrawal by Subject|1|||
162070365|NCT04762680|585314885|FG012|Phase 3|Withdrawal by Subject|3|||
162070366|NCT04762680|585314886|FG013|Phase 3|Withdrawal by Subject|2|||
162070367|NCT04762680|585314887|FG014|Phase 3|Withdrawal by Subject|1|||
162070368|NCT04762680|585314888|FG015|Phase 3|Withdrawal by Subject|4|||
162070369|NCT04762680|585314889|FG016|Phase 3|Withdrawal by Subject|6|||
162070370|NCT04762680|585314890|FG017|Phase 3|Withdrawal by Subject|32|||
162070371|NCT04762680|585314891|FG018|Phase 3|Withdrawal by Subject|0|||
162070372|NCT04762680|585314892|FG019|Phase 3|Withdrawal by Subject|0|||
162070373|NCT04762680|585314893|FG020|Phase 3|Withdrawal by Subject|0|||
162070374|NCT04762680|585314894|FG021|Phase 3|Withdrawal by Subject|0|||
162070375|NCT04762680|585314873|FG000|Phase 3|Lost to Follow-up|0|||
162070376|NCT04762680|585314874|FG001|Phase 3|Lost to Follow-up|0|||
162070377|NCT04762680|585314875|FG002|Phase 3|Lost to Follow-up|0|||
162070378|NCT04762680|585314876|FG003|Phase 3|Lost to Follow-up|9|||
162070379|NCT04762680|585314877|FG004|Phase 3|Lost to Follow-up|22|||
162070380|NCT04762680|585314878|FG005|Phase 3|Lost to Follow-up|24|||
162070381|NCT04762680|585314879|FG006|Phase 3|Lost to Follow-up|2|||
162070382|NCT04762680|585314880|FG007|Phase 3|Lost to Follow-up|4|||
162070383|NCT04762680|585314881|FG008|Phase 3|Lost to Follow-up|6|||
162070384|NCT04762680|585314882|FG009|Phase 3|Lost to Follow-up|4|||
162070385|NCT04762680|585314883|FG010|Phase 3|Lost to Follow-up|3|||
162070386|NCT04762680|585314884|FG011|Phase 3|Lost to Follow-up|0|||
162070387|NCT04762680|585314885|FG012|Phase 3|Lost to Follow-up|5|||
162070388|NCT04762680|585314886|FG013|Phase 3|Lost to Follow-up|4|||
162070389|NCT04762680|585314887|FG014|Phase 3|Lost to Follow-up|6|||
162070390|NCT04762680|585314888|FG015|Phase 3|Lost to Follow-up|1|||
162070391|NCT04762680|585314889|FG016|Phase 3|Lost to Follow-up|1|||
162070392|NCT04762680|585314890|FG017|Phase 3|Lost to Follow-up|66|||
162070393|NCT04762680|585314891|FG018|Phase 3|Lost to Follow-up|0|||
162070394|NCT04762680|585314892|FG019|Phase 3|Lost to Follow-up|0|||
162070395|NCT04762680|585314893|FG020|Phase 3|Lost to Follow-up|0|||
162070396|NCT04762680|585314894|FG021|Phase 3|Lost to Follow-up|0|||
162070397|NCT04762680|585314873|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070398|NCT04762680|585314874|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070399|NCT04762680|585314875|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070400|NCT04762680|585314876|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070401|NCT04762680|585314877|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070402|NCT04762680|585314878|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070403|NCT04762680|585314879|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070404|NCT04762680|585314880|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070405|NCT04762680|585314881|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070406|NCT04762680|585314882|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070407|NCT04762680|585314883|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070408|NCT04762680|585314884|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070409|NCT04762680|585314885|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070410|NCT04762680|585314886|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070411|NCT04762680|585314887|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070412|NCT04762680|585314888|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070413|NCT04762680|585314889|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070414|NCT04762680|585314890|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070415|NCT04762680|585314891|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070416|NCT04762680|585314892|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070417|NCT04762680|585314893|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
162070418|NCT04762680|585314894|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
162070419|NCT04762680|585314873|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070420|NCT04762680|585314874|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070421|NCT04762680|585314875|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070422|NCT04762680|585314876|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070423|NCT04762680|585314877|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070424|NCT04762680|585314878|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070425|NCT04762680|585314879|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070426|NCT04762680|585314880|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070427|NCT04762680|585314881|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070428|NCT04762680|585314882|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070429|NCT04762680|585314883|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070430|NCT04762680|585314884|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070431|NCT04762680|585314885|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070432|NCT04762680|585314886|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070433|NCT04762680|585314887|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070434|NCT04762680|585314888|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070435|NCT04762680|585314889|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070436|NCT04762680|585314890|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070437|NCT04762680|585314891|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070438|NCT04762680|585314892|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
162070439|NCT04762680|585314893|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070440|NCT04762680|585314894|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
162070441|NCT02584504|585314897|FG000|Double-blind Treatment|Participant withdrew consent|0|||
162070442|NCT02584504|585314898|FG001|Double-blind Treatment|Participant withdrew consent|0|||
162070443|NCT02584504|585314899|FG002|Double-blind Treatment|Participant withdrew consent|1|||
162070444|NCT02584504|585314897|FG000|Double-blind Treatment|Adverse Event|0|||
162070445|NCT02584504|585314898|FG001|Double-blind Treatment|Adverse Event|1|||
162070446|NCT02584504|585314899|FG002|Double-blind Treatment|Adverse Event|0|||
162070447|NCT02584504|585314897|FG000|Double-blind Treatment|Family Matter|0|||
162070448|NCT02584504|585314898|FG001|Double-blind Treatment|Family Matter|1|||
162070449|NCT02584504|585314899|FG002|Double-blind Treatment|Family Matter|0|||
162070450|NCT02584504|585314897|FG000|Open-label Treatment|Participant withdrew consent|0|||
162070451|NCT02584504|585314898|FG001|Open-label Treatment|Participant withdrew consent|0|||
162070452|NCT02584504|585314899|FG002|Open-label Treatment|Participant withdrew consent|4|||
162070453|NCT02584504|585314897|FG000|Open-label Treatment|Adverse Event|2|||
162070454|NCT02584504|585314898|FG001|Open-label Treatment|Adverse Event|2|||
162070455|NCT02584504|585314899|FG002|Open-label Treatment|Adverse Event|3|||
162070456|NCT02584504|585314897|FG000|Open-label Treatment|Physician Decision|0|||
162070457|NCT02584504|585314898|FG001|Open-label Treatment|Physician Decision|1|||
162070458|NCT02584504|585314899|FG002|Open-label Treatment|Physician Decision|0|||
162070459|NCT02584504|585314897|FG000|Open-label Treatment|Entered but not treated|0|||
162070460|NCT02584504|585314898|FG001|Open-label Treatment|Entered but not treated|1|||
162070461|NCT02584504|585314899|FG002|Open-label Treatment|Entered but not treated|1|||
162070462|NCT02432846|585314900|FG000|Overall Study (4 Arms/Strata)|Death|3|||
162070463|NCT02432846|585314901|FG001|Overall Study (4 Arms/Strata)|Death|2|||
162070464|NCT02432846|585314902|FG002|Overall Study (4 Arms/Strata)|Death|4|||
162070465|NCT02432846|585314903|FG003|Overall Study (4 Arms/Strata)|Death|3|||
162070466|NCT02432846|585314904|FG004|Overall Study (4 Arms/Strata)|Death|0|||
162070467|NCT02432846|585314905|FG005|Overall Study (4 Arms/Strata)|Death|0|||
162070468|NCT02432846|585314900|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
162070469|NCT02432846|585314901|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
162070470|NCT02432846|585314902|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
162070471|NCT02432846|585314903|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
162070472|NCT02432846|585314904|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
162070473|NCT02432846|585314905|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
162070474|NCT02432846|585314900|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
162070475|NCT02432846|585314901|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
162070476|NCT02432846|585314902|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
162070477|NCT02432846|585314903|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
162070478|NCT02432846|585314904|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
162070479|NCT02432846|585314905|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
162070480|NCT02432846|585314900|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
162070481|NCT02432846|585314901|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
162070482|NCT02432846|585314902|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
162070483|NCT02432846|585314903|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
162070484|NCT02432846|585314904|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
162070485|NCT02432846|585314905|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
162070486|NCT02432846|585314900|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
162070487|NCT02432846|585314901|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
162070488|NCT02432846|585314902|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
162070489|NCT02432846|585314903|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
162070490|NCT02432846|585314904|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
162070491|NCT02432846|585314905|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
162070492|NCT02432846|585314900|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
162070493|NCT02432846|585314901|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
162070494|NCT02432846|585314902|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
162070495|NCT02432846|585314903|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
162070496|NCT02432846|585314904|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
162070497|NCT02432846|585314905|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
162070498|NCT02432846|585314900|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
162070499|NCT02432846|585314901|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
162070500|NCT02432846|585314902|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
162070501|NCT02432846|585314903|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
162070502|NCT02432846|585314904|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
162070503|NCT02432846|585314905|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
162070504|NCT02432846|585314900|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
162070505|NCT02432846|585314901|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
162070506|NCT02432846|585314902|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
162070507|NCT02432846|585314903|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
162070508|NCT02432846|585314904|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
162070509|NCT02432846|585314905|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
162070510|NCT02432846|585314900|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
162070511|NCT02432846|585314901|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
162070512|NCT02432846|585314902|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
162070513|NCT02432846|585314903|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
162070514|NCT02432846|585314904|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
162070515|NCT02432846|585314905|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
162070516|NCT02432846|585314900|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
162070517|NCT02432846|585314901|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
162070518|NCT02432846|585314902|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
162070519|NCT02432846|585314903|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
162070520|NCT02432846|585314904|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
162070521|NCT02432846|585314905|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
162070522|NCT02432846|585314900|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
162070523|NCT02432846|585314901|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
162070524|NCT02432846|585314902|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
162070525|NCT02432846|585314903|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
162070526|NCT02432846|585314904|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
162070527|NCT02432846|585314905|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
162070528|NCT02432846|585314900|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
162070529|NCT02432846|585314901|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
162070530|NCT02432846|585314902|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
162070531|NCT02432846|585314903|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
162070532|NCT02432846|585314904|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
162070533|NCT02432846|585314905|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
162070534|NCT02432846|585314900|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
162070535|NCT02432846|585314901|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
162070536|NCT02432846|585314902|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
162070537|NCT02432846|585314903|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
162070538|NCT02432846|585314904|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
162070539|NCT02432846|585314905|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
162070540|NCT02432846|585314900|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
162070541|NCT02432846|585314901|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
162070542|NCT02432846|585314902|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
162070543|NCT02432846|585314903|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
162070544|NCT02432846|585314904|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
162070545|NCT02432846|585314905|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
162070546|NCT01998633|585314906|FG000|Overall Study|Death|1|||
162070547|NCT00413192|585314907|FG000|Overall Study|Disease progression|26|||
162070548|NCT00413192|585314908|FG001|Overall Study|Disease progression|31|||
162070549|NCT00413192|585314909|FG002|Overall Study|Disease progression|16|||
162070550|NCT00413192|585314910|FG003|Overall Study|Disease progression|25|||
162070551|NCT00413192|585314907|FG000|Overall Study|Toxicity|3|||
162070552|NCT00413192|585314908|FG001|Overall Study|Toxicity|2|||
162070553|NCT00413192|585314909|FG002|Overall Study|Toxicity|2|||
162070554|NCT00413192|585314910|FG003|Overall Study|Toxicity|2|||
162070555|NCT00413192|585314907|FG000|Overall Study|Withdrawal by Subject|3|||
162070556|NCT00413192|585314908|FG001|Overall Study|Withdrawal by Subject|5|||
162070557|NCT00413192|585314909|FG002|Overall Study|Withdrawal by Subject|0|||
162070558|NCT00413192|585314910|FG003|Overall Study|Withdrawal by Subject|1|||
162070559|NCT00413192|585314907|FG000|Overall Study|Intercurrent illness|0|||
162070560|NCT00413192|585314908|FG001|Overall Study|Intercurrent illness|0|||
162070561|NCT00413192|585314909|FG002|Overall Study|Intercurrent illness|0|||
162070562|NCT00413192|585314910|FG003|Overall Study|Intercurrent illness|1|||
162070563|NCT00413192|585314907|FG000|Overall Study|Intercurrent death|0|||
162070564|NCT00413192|585314908|FG001|Overall Study|Intercurrent death|1|||
162070565|NCT00413192|585314909|FG002|Overall Study|Intercurrent death|0|||
162070566|NCT00413192|585314910|FG003|Overall Study|Intercurrent death|0|||
162070567|NCT00413192|585314907|FG000|Overall Study|Other|5|||
162070568|NCT00413192|585314908|FG001|Overall Study|Other|1|||
162070569|NCT00413192|585314909|FG002|Overall Study|Other|1|||
162070570|NCT00413192|585314910|FG003|Overall Study|Other|2|||
162070571|NCT00413192|585314907|FG000|Overall Study|Not treated|0|||
162070572|NCT00413192|585314908|FG001|Overall Study|Not treated|0|||
162070573|NCT00413192|585314909|FG002|Overall Study|Not treated|0|||
162070574|NCT00413192|585314910|FG003|Overall Study|Not treated|1|||
162070575|NCT03992781|585314911|FG000|Overall Study|Lost to Follow-up|5|||
162070576|NCT03992781|585314911|FG000|Overall Study|Adverse Event|1|||
162070577|NCT03992781|585314911|FG000|Overall Study|Lack of Efficacy|5|||
162070578|NCT01996826|585314912|FG000|Overall Study|Lost to Follow-up|6|||
162070579|NCT01996826|585314913|FG001|Overall Study|Lost to Follow-up|2|||
162070580|NCT01996826|585314912|FG000|Overall Study|Physician Decision|1|||
162070581|NCT01996826|585314913|FG001|Overall Study|Physician Decision|1|||
162070582|NCT00695396|585314914|FG000|Overall Study|Study Closed Prematurely|5|||
162070583|NCT00695396|585314915|FG001|Overall Study|Study Closed Prematurely|6|||
162070584|NCT00695396|585314916|FG002|Overall Study|Study Closed Prematurely|8|||
162070585|NCT00695396|585314914|FG000|Overall Study|Withdrawal by Subject|2|||
162070586|NCT00695396|585314915|FG001|Overall Study|Withdrawal by Subject|2|||
162070587|NCT00695396|585314916|FG002|Overall Study|Withdrawal by Subject|0|||
162070588|NCT00518323|585314918|FG000|Overall Study|Lack of Efficacy|14|||
162070589|NCT00518323|585314919|FG001|Overall Study|Lack of Efficacy|2|||
162070590|NCT00518323|585314920|FG002|Overall Study|Lack of Efficacy|4|||
162070591|NCT00518323|585314921|FG003|Overall Study|Lack of Efficacy|20|||
162070592|NCT00518323|585314918|FG000|Overall Study|Withdrawal by Subject|1|||
162070593|NCT00518323|585314919|FG001|Overall Study|Withdrawal by Subject|2|||
162070594|NCT00518323|585314920|FG002|Overall Study|Withdrawal by Subject|4|||
162070595|NCT00518323|585314921|FG003|Overall Study|Withdrawal by Subject|2|||
162070596|NCT00518323|585314918|FG000|Overall Study|Lost to Follow-up|0|||
162070597|NCT00518323|585314919|FG001|Overall Study|Lost to Follow-up|2|||
162070598|NCT00518323|585314920|FG002|Overall Study|Lost to Follow-up|1|||
162070599|NCT00518323|585314921|FG003|Overall Study|Lost to Follow-up|3|||
162070600|NCT00518323|585314918|FG000|Overall Study|Adverse Event|1|||
162070601|NCT00518323|585314919|FG001|Overall Study|Adverse Event|1|||
162070602|NCT00518323|585314920|FG002|Overall Study|Adverse Event|1|||
162070603|NCT00518323|585314921|FG003|Overall Study|Adverse Event|0|||
162070604|NCT00518323|585314918|FG000|Overall Study|Prohibited medication and others|3|||
162070605|NCT00518323|585314919|FG001|Overall Study|Prohibited medication and others|1|||
162070606|NCT00518323|585314920|FG002|Overall Study|Prohibited medication and others|1|||
162070607|NCT00518323|585314921|FG003|Overall Study|Prohibited medication and others|0|||
162070608|NCT03164928|585314923|FG000|Overall Study|Lost to Follow-up|1|||
162070609|NCT03164928|585314924|FG001|Overall Study|Lost to Follow-up|0|||
162070610|NCT01275833|585314927|FG000|Overall Study|Study terminated|1|||
162070611|NCT01275833|585314928|FG001|Overall Study|Study terminated|1|||
162070612|NCT02118012|585314930|FG000|Overall Study|Adverse Event|0|||
162070613|NCT02118012|585314931|FG001|Overall Study|Adverse Event|1|||
162070614|NCT02118012|585314930|FG000|Overall Study|Physician Decision|0|||
162070615|NCT02118012|585314931|FG001|Overall Study|Physician Decision|1|||
162070616|NCT00536107|585314932|FG000|Overall Study|Death|5|||
162070617|NCT00536107|585314933|FG001|Overall Study|Death|1|||
162070618|NCT00536107|585314932|FG000|Overall Study|Incorrect enrolment|1|||
162070619|NCT00536107|585314933|FG001|Overall Study|Incorrect enrolment|0|||
162070620|NCT00536107|585314932|FG000|Overall Study|Withdrawal by Subject|0|||
162070621|NCT00536107|585314933|FG001|Overall Study|Withdrawal by Subject|1|||
162070622|NCT00536107|585314932|FG000|Overall Study|Study Termination|2|||
162070623|NCT00536107|585314933|FG001|Overall Study|Study Termination|4|||
162070624|NCT03329690|585314934|FG000|Overall Study|Progressive disease per RECIST|85|||
162070625|NCT03329690|585314935|FG001|Overall Study|Progressive disease per RECIST|44|||
162070626|NCT03329690|585314936|FG002|Overall Study|Progressive disease per RECIST|6|||
162070627|NCT03329690|585314937|FG003|Overall Study|Progressive disease per RECIST|16|||
162070628|NCT03329690|585314938|FG004|Overall Study|Progressive disease per RECIST|20|||
162070629|NCT03329690|585314934|FG000|Overall Study|Clinical progression|7|||
162070630|NCT03329690|585314935|FG001|Overall Study|Clinical progression|4|||
162070631|NCT03329690|585314936|FG002|Overall Study|Clinical progression|1|||
162070632|NCT03329690|585314937|FG003|Overall Study|Clinical progression|1|||
162070633|NCT03329690|585314938|FG004|Overall Study|Clinical progression|1|||
162070634|NCT03329690|585314934|FG000|Overall Study|Adverse Event|22|||
162070635|NCT03329690|585314935|FG001|Overall Study|Adverse Event|4|||
162070636|NCT03329690|585314936|FG002|Overall Study|Adverse Event|0|||
162070637|NCT03329690|585314937|FG003|Overall Study|Adverse Event|1|||
162070638|NCT03329690|585314938|FG004|Overall Study|Adverse Event|2|||
162070639|NCT03329690|585314934|FG000|Overall Study|Death|2|||
162070640|NCT03329690|585314935|FG001|Overall Study|Death|0|||
162070641|NCT03329690|585314936|FG002|Overall Study|Death|0|||
162070642|NCT03329690|585314937|FG003|Overall Study|Death|1|||
162070643|NCT03329690|585314938|FG004|Overall Study|Death|0|||
162070644|NCT03329690|585314934|FG000|Overall Study|Withdrawal by Subject|2|||
162070645|NCT03329690|585314935|FG001|Overall Study|Withdrawal by Subject|3|||
162070646|NCT03329690|585314936|FG002|Overall Study|Withdrawal by Subject|0|||
162070647|NCT03329690|585314937|FG003|Overall Study|Withdrawal by Subject|1|||
162070648|NCT03329690|585314938|FG004|Overall Study|Withdrawal by Subject|0|||
162070649|NCT03329690|585314934|FG000|Overall Study|Physician Decision|1|||
162070650|NCT03329690|585314935|FG001|Overall Study|Physician Decision|0|||
162070651|NCT03329690|585314936|FG002|Overall Study|Physician Decision|0|||
162070652|NCT03329690|585314937|FG003|Overall Study|Physician Decision|0|||
162070653|NCT03329690|585314938|FG004|Overall Study|Physician Decision|1|||
162070654|NCT03329690|585314934|FG000|Overall Study|Miscellaneous|6|||
162070655|NCT03329690|585314935|FG001|Overall Study|Miscellaneous|0|||
162070656|NCT03329690|585314936|FG002|Overall Study|Miscellaneous|0|||
162070657|NCT03329690|585314937|FG003|Overall Study|Miscellaneous|0|||
162070658|NCT03329690|585314938|FG004|Overall Study|Miscellaneous|0|||
162070659|NCT03329690|585314934|FG000|Overall Study|Did not receive treatment|1|||
162070660|NCT03329690|585314935|FG001|Overall Study|Did not receive treatment|0|||
162070661|NCT03329690|585314936|FG002|Overall Study|Did not receive treatment|0|||
162070662|NCT03329690|585314937|FG003|Overall Study|Did not receive treatment|1|||
162070663|NCT03329690|585314938|FG004|Overall Study|Did not receive treatment|0|||
162070664|NCT00450333|585314941|FG000|Overall Study|Study terminated|47|||
162070665|NCT00450333|585314942|FG001|Overall Study|Study terminated|54|||
162070666|NCT00450333|585314943|FG002|Overall Study|Study terminated|16|||
162070667|NCT00450333|585314944|FG003|Overall Study|Study terminated|21|||
162070668|NCT00450333|585314941|FG000|Overall Study|Adverse Event|1|||
162070669|NCT00450333|585314942|FG001|Overall Study|Adverse Event|7|||
162070670|NCT00450333|585314943|FG002|Overall Study|Adverse Event|2|||
162070671|NCT00450333|585314944|FG003|Overall Study|Adverse Event|2|||
162070672|NCT00450333|585314941|FG000|Overall Study|Protocol Violation|1|||
162070673|NCT00450333|585314942|FG001|Overall Study|Protocol Violation|0|||
162070674|NCT00450333|585314943|FG002|Overall Study|Protocol Violation|1|||
162070675|NCT00450333|585314944|FG003|Overall Study|Protocol Violation|0|||
162070676|NCT00450333|585314941|FG000|Overall Study|Withdrawal by Subject|1|||
162070677|NCT00450333|585314942|FG001|Overall Study|Withdrawal by Subject|0|||
162070678|NCT00450333|585314943|FG002|Overall Study|Withdrawal by Subject|3|||
162070679|NCT00450333|585314944|FG003|Overall Study|Withdrawal by Subject|0|||
162070680|NCT00450333|585314941|FG000|Overall Study|Kidney transplant|1|||
162070681|NCT00450333|585314942|FG001|Overall Study|Kidney transplant|0|||
162070682|NCT00450333|585314943|FG002|Overall Study|Kidney transplant|1|||
162070683|NCT00450333|585314944|FG003|Overall Study|Kidney transplant|3|||
162070684|NCT00450333|585314941|FG000|Overall Study|Death|3|||
162070685|NCT00450333|585314942|FG001|Overall Study|Death|2|||
162070686|NCT00450333|585314943|FG002|Overall Study|Death|2|||
162070687|NCT00450333|585314944|FG003|Overall Study|Death|2|||
162070688|NCT03855280|585314950|FG000|Treatment Phase|Adverse Event|1|||
162070689|NCT03855280|585314950|FG000|Treatment Phase|Withdrawal by Subject|1|||
162070690|NCT03855280|585314950|FG000|Continuation Phase|Protocol Violation|1|||
162070691|NCT03855280|585314950|FG000|Continuation Phase|Adverse Event|1|||
162070692|NCT03855280|585314950|FG000|Continuation Phase|Sponsor Concluded Study|1|||
162070693|NCT01092182|585314953|FG000|Overall Study|Death|0|||
162070694|NCT01092182|585314954|FG001|Overall Study|Death|5|||
162070695|NCT01092182|585314955|FG002|Overall Study|Death|3|||
162070696|NCT01092182|585314953|FG000|Overall Study|participant safety|1|||
162070697|NCT01092182|585314954|FG001|Overall Study|participant safety|2|||
162070698|NCT01092182|585314955|FG002|Overall Study|participant safety|0|||
162070699|NCT01092182|585314953|FG000|Overall Study|Physician Decision|0|||
162070700|NCT01092182|585314954|FG001|Overall Study|Physician Decision|6|||
162070701|NCT01092182|585314955|FG002|Overall Study|Physician Decision|0|||
162070702|NCT01092182|585314953|FG000|Overall Study|Did not meet criteria|0|||
162070703|NCT01092182|585314954|FG001|Overall Study|Did not meet criteria|0|||
162070704|NCT01092182|585314955|FG002|Overall Study|Did not meet criteria|25|||
162070705|NCT01092182|585314953|FG000|Overall Study|Non-compliance|0|||
162070706|NCT01092182|585314954|FG001|Overall Study|Non-compliance|3|||
162070707|NCT01092182|585314955|FG002|Overall Study|Non-compliance|0|||
162070708|NCT01092182|585314953|FG000|Overall Study|Participant refused follow-up|0|||
162070709|NCT01092182|585314954|FG001|Overall Study|Participant refused follow-up|2|||
162070710|NCT01092182|585314955|FG002|Overall Study|Participant refused follow-up|0|||
162070711|NCT01641692|585314956|FG000|Treatment Period 1|Adverse Event|1|||
162070712|NCT01641692|585314957|FG001|Treatment Period 1|Adverse Event|0|||
162070713|NCT01641692|585314958|FG002|Treatment Period 1|Adverse Event|0|||
162070714|NCT01641692|585314959|FG003|Treatment Period 1|Adverse Event|0|||
162070715|NCT01641692|585314960|FG004|Treatment Period 1|Adverse Event|0|||
162070716|NCT01641692|585314961|FG005|Treatment Period 1|Adverse Event|0|||
162070717|NCT01641692|585314962|FG006|Treatment Period 1|Adverse Event|0|||
162070718|NCT01641692|585314963|FG007|Treatment Period 1|Adverse Event|0|||
162070719|NCT01641692|585314956|FG000|Treatment Period 1|Lack of Efficacy|0|||
162070720|NCT01641692|585314957|FG001|Treatment Period 1|Lack of Efficacy|0|||
162070721|NCT01641692|585314958|FG002|Treatment Period 1|Lack of Efficacy|0|||
162070722|NCT01641692|585314959|FG003|Treatment Period 1|Lack of Efficacy|0|||
162070723|NCT01641692|585314960|FG004|Treatment Period 1|Lack of Efficacy|0|||
162070724|NCT01641692|585314961|FG005|Treatment Period 1|Lack of Efficacy|0|||
162070725|NCT01641692|585314962|FG006|Treatment Period 1|Lack of Efficacy|0|||
162070726|NCT01641692|585314963|FG007|Treatment Period 1|Lack of Efficacy|1|||
162070727|NCT01641692|585314956|FG000|Treatment Period 1|Protocol Violation|1|||
162070728|NCT01641692|585314957|FG001|Treatment Period 1|Protocol Violation|0|||
162070729|NCT01641692|585314958|FG002|Treatment Period 1|Protocol Violation|0|||
162070730|NCT01641692|585314959|FG003|Treatment Period 1|Protocol Violation|0|||
162070731|NCT01641692|585314960|FG004|Treatment Period 1|Protocol Violation|2|||
162070732|NCT01641692|585314961|FG005|Treatment Period 1|Protocol Violation|0|||
162070733|NCT01641692|585314962|FG006|Treatment Period 1|Protocol Violation|0|||
162070734|NCT01641692|585314963|FG007|Treatment Period 1|Protocol Violation|0|||
162070735|NCT01641692|585314956|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
162070736|NCT01641692|585314957|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
162070737|NCT01641692|585314958|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
162070738|NCT01641692|585314959|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
162070739|NCT01641692|585314960|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
162070740|NCT01641692|585314961|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
162070741|NCT01641692|585314962|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
162070742|NCT01641692|585314963|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
162070743|NCT01641692|585314956|FG000|Treatment Period 1|Lost to Follow-up|0|||
162070744|NCT01641692|585314957|FG001|Treatment Period 1|Lost to Follow-up|0|||
162070745|NCT01641692|585314958|FG002|Treatment Period 1|Lost to Follow-up|1|||
162070746|NCT01641692|585314959|FG003|Treatment Period 1|Lost to Follow-up|0|||
162070747|NCT01641692|585314960|FG004|Treatment Period 1|Lost to Follow-up|0|||
162070748|NCT01641692|585314961|FG005|Treatment Period 1|Lost to Follow-up|0|||
162070749|NCT01641692|585314962|FG006|Treatment Period 1|Lost to Follow-up|0|||
162070750|NCT01641692|585314963|FG007|Treatment Period 1|Lost to Follow-up|0|||
162070751|NCT01641692|585314956|FG000|Treatment Period 1|Physician Decision|0|||
162070752|NCT01641692|585314957|FG001|Treatment Period 1|Physician Decision|0|||
162070753|NCT01641692|585314958|FG002|Treatment Period 1|Physician Decision|0|||
162070754|NCT01641692|585314959|FG003|Treatment Period 1|Physician Decision|0|||
162070755|NCT01641692|585314960|FG004|Treatment Period 1|Physician Decision|1|||
162070756|NCT01641692|585314961|FG005|Treatment Period 1|Physician Decision|0|||
162070757|NCT01641692|585314962|FG006|Treatment Period 1|Physician Decision|0|||
162070758|NCT01641692|585314963|FG007|Treatment Period 1|Physician Decision|0|||
162070759|NCT01641692|585314956|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162070760|NCT01641692|585314957|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162070761|NCT01641692|585314958|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162070762|NCT01641692|585314959|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162070763|NCT01641692|585314960|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162070764|NCT01641692|585314961|FG005|Treatment Period 1|Withdrawal by Subject|2|||
162070765|NCT01641692|585314962|FG006|Treatment Period 1|Withdrawal by Subject|0|||
162070766|NCT01641692|585314963|FG007|Treatment Period 1|Withdrawal by Subject|1|||
162070767|NCT01641692|585314956|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
162070768|NCT01641692|585314957|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162070769|NCT01641692|585314958|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162070770|NCT01641692|585314959|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162070771|NCT01641692|585314960|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162070772|NCT01641692|585314961|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162070773|NCT01641692|585314962|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162070774|NCT01641692|585314963|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
162070775|NCT01641692|585314956|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162070776|NCT01641692|585314957|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162070777|NCT01641692|585314958|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162070778|NCT01641692|585314959|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162070779|NCT01641692|585314960|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162070780|NCT01641692|585314961|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162070781|NCT01641692|585314962|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
162070782|NCT01641692|585314963|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162070783|NCT01641692|585314956|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
162070784|NCT01641692|585314957|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162070785|NCT01641692|585314958|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
162070786|NCT01641692|585314959|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
162070787|NCT01641692|585314960|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
162070788|NCT01641692|585314961|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162070789|NCT01641692|585314962|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162070790|NCT01641692|585314963|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
162070791|NCT01641692|585314956|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
162070792|NCT01641692|585314957|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
162070793|NCT01641692|585314958|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162070794|NCT01641692|585314959|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
162070795|NCT01641692|585314960|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
162070796|NCT01641692|585314961|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162070797|NCT01641692|585314962|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
162070798|NCT01641692|585314963|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162070799|NCT01641692|585314956|FG000|Treatment Period 2|Lack of Efficacy|1|||
162070800|NCT01641692|585314957|FG001|Treatment Period 2|Lack of Efficacy|0|||
162070801|NCT01641692|585314958|FG002|Treatment Period 2|Lack of Efficacy|0|||
162070802|NCT01641692|585314959|FG003|Treatment Period 2|Lack of Efficacy|0|||
162070803|NCT01641692|585314960|FG004|Treatment Period 2|Lack of Efficacy|0|||
162070804|NCT01641692|585314961|FG005|Treatment Period 2|Lack of Efficacy|0|||
162070805|NCT01641692|585314962|FG006|Treatment Period 2|Lack of Efficacy|0|||
162070806|NCT01641692|585314963|FG007|Treatment Period 2|Lack of Efficacy|0|||
162070807|NCT01641692|585314956|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
162070808|NCT01641692|585314957|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162070809|NCT01641692|585314958|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162070810|NCT01641692|585314959|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162070811|NCT01641692|585314960|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162070812|NCT01641692|585314961|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162070813|NCT01641692|585314962|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162070814|NCT01641692|585314963|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
162070815|NCT01641692|585314956|FG000|Treatment Period 2|Lost to Follow-up|0|||
162070816|NCT01641692|585314957|FG001|Treatment Period 2|Lost to Follow-up|0|||
162070817|NCT01641692|585314958|FG002|Treatment Period 2|Lost to Follow-up|0|||
162070818|NCT01641692|585314959|FG003|Treatment Period 2|Lost to Follow-up|0|||
162070819|NCT01641692|585314960|FG004|Treatment Period 2|Lost to Follow-up|0|||
162070820|NCT01641692|585314961|FG005|Treatment Period 2|Lost to Follow-up|1|||
162070821|NCT01641692|585314962|FG006|Treatment Period 2|Lost to Follow-up|0|||
162070822|NCT01641692|585314963|FG007|Treatment Period 2|Lost to Follow-up|0|||
162070823|NCT01641692|585314956|FG000|Treatment Period 2|Withdrawal by Subject|1|||
162070824|NCT01641692|585314957|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162070825|NCT01641692|585314958|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162070826|NCT01641692|585314959|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162070827|NCT01641692|585314960|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162070828|NCT01641692|585314961|FG005|Treatment Period 2|Withdrawal by Subject|1|||
162070829|NCT01641692|585314962|FG006|Treatment Period 2|Withdrawal by Subject|0|||
162070830|NCT01641692|585314963|FG007|Treatment Period 2|Withdrawal by Subject|1|||
162070831|NCT01641692|585314956|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162070832|NCT01641692|585314957|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162070833|NCT01641692|585314958|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162070834|NCT01641692|585314959|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162070835|NCT01641692|585314960|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
162070836|NCT01641692|585314961|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162070837|NCT01641692|585314962|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
162070838|NCT01641692|585314963|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
162070839|NCT01641692|585314956|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162070840|NCT01641692|585314957|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162070841|NCT01641692|585314958|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
162070842|NCT01641692|585314959|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162070843|NCT01641692|585314960|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162070844|NCT01641692|585314961|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
162070845|NCT01641692|585314962|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162070846|NCT01641692|585314963|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
162070847|NCT01641692|585314956|FG000|Treatment Period 3|Adverse Event|0|||
162070848|NCT01641692|585314957|FG001|Treatment Period 3|Adverse Event|0|||
162070849|NCT01641692|585314958|FG002|Treatment Period 3|Adverse Event|0|||
162070850|NCT01641692|585314959|FG003|Treatment Period 3|Adverse Event|0|||
162070851|NCT01641692|585314960|FG004|Treatment Period 3|Adverse Event|0|||
162070852|NCT01641692|585314961|FG005|Treatment Period 3|Adverse Event|0|||
162070853|NCT01641692|585314962|FG006|Treatment Period 3|Adverse Event|1|||
162070854|NCT01641692|585314963|FG007|Treatment Period 3|Adverse Event|0|||
162070855|NCT01641692|585314956|FG000|Treatment Period 3|Protocol Violation|0|||
162070856|NCT01641692|585314957|FG001|Treatment Period 3|Protocol Violation|0|||
162070857|NCT01641692|585314958|FG002|Treatment Period 3|Protocol Violation|1|||
162070858|NCT01641692|585314959|FG003|Treatment Period 3|Protocol Violation|0|||
162070859|NCT01641692|585314960|FG004|Treatment Period 3|Protocol Violation|0|||
162070860|NCT01641692|585314961|FG005|Treatment Period 3|Protocol Violation|0|||
162070861|NCT01641692|585314962|FG006|Treatment Period 3|Protocol Violation|0|||
162070862|NCT01641692|585314963|FG007|Treatment Period 3|Protocol Violation|0|||
162070863|NCT01641692|585314956|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162070864|NCT01641692|585314957|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162070865|NCT01641692|585314958|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162070866|NCT01641692|585314959|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162070867|NCT01641692|585314960|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162070868|NCT01641692|585314961|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162070869|NCT01641692|585314962|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
162070870|NCT01641692|585314963|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
162070871|NCT01641692|585314956|FG000|Treatment Period 3|Lost to Follow-up|0|||
162070872|NCT01641692|585314957|FG001|Treatment Period 3|Lost to Follow-up|1|||
162070873|NCT01641692|585314958|FG002|Treatment Period 3|Lost to Follow-up|0|||
162070874|NCT01641692|585314959|FG003|Treatment Period 3|Lost to Follow-up|0|||
162070875|NCT01641692|585314960|FG004|Treatment Period 3|Lost to Follow-up|0|||
162070876|NCT01641692|585314961|FG005|Treatment Period 3|Lost to Follow-up|0|||
162070877|NCT01641692|585314962|FG006|Treatment Period 3|Lost to Follow-up|0|||
162070878|NCT01641692|585314963|FG007|Treatment Period 3|Lost to Follow-up|0|||
162070879|NCT01641692|585314956|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
162070880|NCT01641692|585314957|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
162070881|NCT01641692|585314958|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
162070882|NCT01641692|585314959|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
162070883|NCT01641692|585314960|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
162070884|NCT01641692|585314961|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
162070885|NCT01641692|585314962|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
162070886|NCT01641692|585314963|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
162070887|NCT01641692|585314956|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
162070888|NCT01641692|585314957|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
162070889|NCT01641692|585314958|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
162070890|NCT01641692|585314959|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
162070891|NCT01641692|585314960|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
162070892|NCT01641692|585314961|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
162070893|NCT01641692|585314962|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
162070894|NCT01641692|585314963|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
162070895|NCT02738151|585314964|FG000|Overall Study|Randomized but not treated|4|||
162070896|NCT02738151|585314965|FG001|Overall Study|Randomized but not treated|1|||
162070897|NCT02738151|585314964|FG000|Overall Study|Adverse Event|4|||
162070898|NCT02738151|585314965|FG001|Overall Study|Adverse Event|5|||
162070899|NCT02738151|585314964|FG000|Overall Study|Hypoglycemia|0|||
162070900|NCT02738151|585314965|FG001|Overall Study|Hypoglycemia|1|||
162070901|NCT02738151|585314964|FG000|Overall Study|Poor Compliance to Protocol|4|||
162070902|NCT02738151|585314965|FG001|Overall Study|Poor Compliance to Protocol|3|||
162070903|NCT02738151|585314964|FG000|Overall Study|Other than specified above|11|||
162070904|NCT02738151|585314965|FG001|Overall Study|Other than specified above|21|||
162070905|NCT03333044|585314970|FG000|Overall Study|Pregnancy|1|||
162070906|NCT03333044|585314971|FG001|Overall Study|Pregnancy|0|||
162070907|NCT03333044|585314972|FG002|Overall Study|Pregnancy|0|||
162070908|NCT03333044|585314970|FG000|Overall Study|Lost to Follow-up|0|||
162070909|NCT03333044|585314971|FG001|Overall Study|Lost to Follow-up|14|||
162070910|NCT03333044|585314972|FG002|Overall Study|Lost to Follow-up|6|||
162070911|NCT04007094|585314980|FG000|Overall Study|Lost to Follow-up|1|||
162070912|NCT04007094|585314981|FG001|Overall Study|Lost to Follow-up|1|||
162070913|NCT02921776|585314982|FG000|Overall Study|patient deterioration, fatigue|2|||
162070914|NCT02921776|585314983|FG001|Overall Study|patient deterioration, fatigue|6|||
162070915|NCT02921776|585314984|FG002|Overall Study|patient deterioration, fatigue|0|||
162070916|NCT02921776|585314985|FG003|Overall Study|patient deterioration, fatigue|0|||
162070917|NCT02921776|585314986|FG004|Overall Study|patient deterioration, fatigue|0|||
162070918|NCT02921776|585314987|FG005|Overall Study|patient deterioration, fatigue|0|||
162070919|NCT02921776|585314988|FG006|Overall Study|patient deterioration, fatigue|0|||
162070920|NCT02921776|585314989|FG007|Overall Study|patient deterioration, fatigue|0|||
162070921|NCT02921776|585314982|FG000|Overall Study|Withdrawal by Subject|0|||
162070922|NCT02921776|585314983|FG001|Overall Study|Withdrawal by Subject|2|||
162070923|NCT02921776|585314984|FG002|Overall Study|Withdrawal by Subject|0|||
162070924|NCT02921776|585314985|FG003|Overall Study|Withdrawal by Subject|1|||
162070925|NCT02921776|585314986|FG004|Overall Study|Withdrawal by Subject|1|||
162070926|NCT02921776|585314987|FG005|Overall Study|Withdrawal by Subject|0|||
162070927|NCT02921776|585314988|FG006|Overall Study|Withdrawal by Subject|8|||
162070928|NCT02921776|585314989|FG007|Overall Study|Withdrawal by Subject|1|||
162070929|NCT02921776|585314982|FG000|Overall Study|Death|0|||
162070930|NCT02921776|585314983|FG001|Overall Study|Death|0|||
162070931|NCT02921776|585314984|FG002|Overall Study|Death|0|||
162070932|NCT02921776|585314985|FG003|Overall Study|Death|2|||
162070933|NCT02921776|585314986|FG004|Overall Study|Death|0|||
162070934|NCT02921776|585314987|FG005|Overall Study|Death|0|||
162070935|NCT02921776|585314988|FG006|Overall Study|Death|0|||
162070936|NCT02921776|585314989|FG007|Overall Study|Death|0|||
162070937|NCT02921776|585314982|FG000|Overall Study|extubation or early discharge|0|||
162070938|NCT02921776|585314983|FG001|Overall Study|extubation or early discharge|0|||
162070939|NCT02921776|585314984|FG002|Overall Study|extubation or early discharge|0|||
162070940|NCT02921776|585314985|FG003|Overall Study|extubation or early discharge|5|||
162070941|NCT02921776|585314986|FG004|Overall Study|extubation or early discharge|5|||
162070942|NCT02921776|585314987|FG005|Overall Study|extubation or early discharge|0|||
162070943|NCT02921776|585314988|FG006|Overall Study|extubation or early discharge|0|||
162070944|NCT02921776|585314989|FG007|Overall Study|extubation or early discharge|0|||
162070945|NCT02921776|585314982|FG000|Overall Study|Lost to Follow-up|0|||
162070946|NCT02921776|585314983|FG001|Overall Study|Lost to Follow-up|0|||
162070947|NCT02921776|585314984|FG002|Overall Study|Lost to Follow-up|0|||
162070948|NCT02921776|585314985|FG003|Overall Study|Lost to Follow-up|0|||
162070949|NCT02921776|585314986|FG004|Overall Study|Lost to Follow-up|0|||
162070950|NCT02921776|585314987|FG005|Overall Study|Lost to Follow-up|2|||
162070951|NCT02921776|585314988|FG006|Overall Study|Lost to Follow-up|3|||
162070952|NCT02921776|585314989|FG007|Overall Study|Lost to Follow-up|6|||
162070953|NCT04537234|585314998|FG000|Overall Study|Withdrawal by Subject|2|||
162070954|NCT04537234|585314999|FG001|Overall Study|Withdrawal by Subject|0|||
162070955|NCT01239368|585316284|FG000|Overall Study|Principal investigator discretion|1|||
162070956|NCT01239368|585316285|FG001|Overall Study|Principal investigator discretion|0|||
162070957|NCT01239368|585316286|FG002|Overall Study|Principal investigator discretion|0|||
162070958|NCT01239368|585316287|FG003|Overall Study|Principal investigator discretion|0|||
162070959|NCT01239368|585316288|FG004|Overall Study|Principal investigator discretion|1|||
162070960|NCT01239368|585316289|FG005|Overall Study|Principal investigator discretion|2|||
162070961|NCT01239368|585316290|FG006|Overall Study|Principal investigator discretion|0|||
162070962|NCT01239368|585316291|FG007|Overall Study|Principal investigator discretion|0|||
162070963|NCT01239368|585316292|FG008|Overall Study|Principal investigator discretion|0|||
162070964|NCT01239368|585316293|FG009|Overall Study|Principal investigator discretion|1|||
162070965|NCT01239368|585316284|FG000|Overall Study|Disease progression on study|1|||
162070966|NCT01239368|585316285|FG001|Overall Study|Disease progression on study|1|||
162070967|NCT01239368|585316286|FG002|Overall Study|Disease progression on study|1|||
162070968|NCT01239368|585316287|FG003|Overall Study|Disease progression on study|1|||
162070969|NCT01239368|585316288|FG004|Overall Study|Disease progression on study|4|||
162070970|NCT01239368|585316289|FG005|Overall Study|Disease progression on study|2|||
162070971|NCT01239368|585316290|FG006|Overall Study|Disease progression on study|5|||
162070972|NCT01239368|585316291|FG007|Overall Study|Disease progression on study|0|||
162070973|NCT01239368|585316292|FG008|Overall Study|Disease progression on study|0|||
162070974|NCT01239368|585316293|FG009|Overall Study|Disease progression on study|2|||
162070975|NCT01239368|585316284|FG000|Overall Study|Refused further treatment|0|||
162070976|NCT01239368|585316285|FG001|Overall Study|Refused further treatment|0|||
162070977|NCT01239368|585316286|FG002|Overall Study|Refused further treatment|0|||
162070978|NCT01239368|585316287|FG003|Overall Study|Refused further treatment|0|||
162070979|NCT01239368|585316288|FG004|Overall Study|Refused further treatment|0|||
162070980|NCT01239368|585316289|FG005|Overall Study|Refused further treatment|0|||
162070981|NCT01239368|585316290|FG006|Overall Study|Refused further treatment|0|||
162070982|NCT01239368|585316291|FG007|Overall Study|Refused further treatment|0|||
162070983|NCT01239368|585316292|FG008|Overall Study|Refused further treatment|0|||
162070984|NCT01239368|585316293|FG009|Overall Study|Refused further treatment|1|||
162070985|NCT01239368|585316284|FG000|Overall Study|Death|0|||
162070986|NCT01239368|585316285|FG001|Overall Study|Death|0|||
162070987|NCT01239368|585316286|FG002|Overall Study|Death|0|||
162070988|NCT01239368|585316287|FG003|Overall Study|Death|0|||
162070989|NCT01239368|585316288|FG004|Overall Study|Death|0|||
162070990|NCT01239368|585316289|FG005|Overall Study|Death|0|||
162070991|NCT01239368|585316290|FG006|Overall Study|Death|1|||
162070992|NCT01239368|585316291|FG007|Overall Study|Death|0|||
162070993|NCT01239368|585316292|FG008|Overall Study|Death|0|||
162070994|NCT01239368|585316293|FG009|Overall Study|Death|0|||
162070995|NCT04709575|585316294|FG000|Overall Study|Withdrawal by Subject|6|||
162070996|NCT04709575|585316295|FG001|Overall Study|Withdrawal by Subject|2|||
162070997|NCT04709575|585316294|FG000|Overall Study|Lost to Follow-up|2|||
162070998|NCT04709575|585316295|FG001|Overall Study|Lost to Follow-up|2|||
162070999|NCT04709575|585316294|FG000|Overall Study|Adverse Event|1|||
162071000|NCT04709575|585316295|FG001|Overall Study|Adverse Event|0|||
162071001|NCT04709575|585316294|FG000|Overall Study|Protocol Violation|1|||
162071002|NCT04709575|585316295|FG001|Overall Study|Protocol Violation|1|||
162071003|NCT03181399|585316297|FG000|6 Months on Treatment|Protocol non-compliance|7|||
162071004|NCT03181399|585316297|FG000|6 Months on Treatment|Adverse Event|4|||
162071005|NCT03181399|585316297|FG000|6 Months on Treatment|Tried alternative treatment|2|||
162071006|NCT03181399|585316297|FG000|6 Months on Treatment|Lost to Follow-up|2|||
162071007|NCT03181399|585316297|FG000|6 Months on Treatment|Personal reasons|1|||
162071008|NCT03181399|585316297|FG000|3 Months Off-treatment|Parent unable to travel|1|||
162071009|NCT00858442|585316300|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
162071010|NCT00858442|585316301|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
162071011|NCT02016625|585316302|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
162071012|NCT02016625|585316303|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
162071013|NCT02016625|585316302|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
162071014|NCT02016625|585316303|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
162071015|NCT02016625|585316302|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
162071016|NCT02016625|585316303|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
162071017|NCT03970733|585316307|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
162071018|NCT03970733|585316308|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
162071019|NCT03970733|585316309|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
162071020|NCT03970733|585316310|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
162071021|NCT03970733|585316311|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
162071022|NCT03970733|585316307|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
162071023|NCT03970733|585316308|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
162071024|NCT03970733|585316309|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
162071025|NCT03970733|585316310|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
162071026|NCT03970733|585316311|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
162071027|NCT03970733|585316307|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
162071028|NCT03970733|585316308|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
162071029|NCT03970733|585316309|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
162071030|NCT03970733|585316310|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
162071031|NCT03970733|585316311|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
162071032|NCT03970733|585316307|FG000|Main Study Phase (18 Months)|Other|1|||
162071033|NCT03970733|585316308|FG001|Main Study Phase (18 Months)|Other|1|||
162071034|NCT03970733|585316309|FG002|Main Study Phase (18 Months)|Other|0|||
162071035|NCT03970733|585316310|FG003|Main Study Phase (18 Months)|Other|0|||
162071036|NCT03970733|585316311|FG004|Main Study Phase (18 Months)|Other|0|||
162071037|NCT03970733|585316307|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
162071038|NCT03970733|585316308|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
162071039|NCT03970733|585316309|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
162071040|NCT03970733|585316310|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
162071041|NCT03970733|585316311|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
162071042|NCT02784821|585316315|FG000|Overall Study|Death|0|||
162071043|NCT02784821|585316316|FG001|Overall Study|Death|5|||
162071044|NCT02784821|585316317|FG002|Overall Study|Death|4|||
162071045|NCT02784821|585316318|FG003|Overall Study|Death|5|||
162071046|NCT02794103|585316319|FG000|Overall Study|Loss to follow up due to high sedation|3|||
162071047|NCT01139450|585316320|FG000|Overall Study|Withdrawal by Subject|7|||
162071048|NCT01139450|585316321|FG001|Overall Study|Withdrawal by Subject|10|||
162071049|NCT01139450|585316322|FG002|Overall Study|Withdrawal by Subject|13|||
162071050|NCT01139450|585316320|FG000|Overall Study|Lack of Efficacy|3|||
162071051|NCT01139450|585316321|FG001|Overall Study|Lack of Efficacy|1|||
162071052|NCT01139450|585316322|FG002|Overall Study|Lack of Efficacy|8|||
162071053|NCT01139450|585316320|FG000|Overall Study|Protocol Violation|6|||
162071054|NCT01139450|585316321|FG001|Overall Study|Protocol Violation|5|||
162071055|NCT01139450|585316322|FG002|Overall Study|Protocol Violation|2|||
162071056|NCT01139450|585316320|FG000|Overall Study|Lost to Follow-up|9|||
162071057|NCT01139450|585316321|FG001|Overall Study|Lost to Follow-up|7|||
162071058|NCT01139450|585316322|FG002|Overall Study|Lost to Follow-up|11|||
162071059|NCT01139450|585316320|FG000|Overall Study|Administrative|0|||
162071060|NCT01139450|585316321|FG001|Overall Study|Administrative|0|||
162071061|NCT01139450|585316322|FG002|Overall Study|Administrative|1|||
162071062|NCT01139450|585316320|FG000|Overall Study|Adverse Event|2|||
162071063|NCT01139450|585316321|FG001|Overall Study|Adverse Event|2|||
162071064|NCT01139450|585316322|FG002|Overall Study|Adverse Event|3|||
162071065|NCT02082210|585316327|FG000|Overall Study|Death|0|||
162071066|NCT02082210|585316328|FG001|Overall Study|Death|0|||
162071067|NCT02082210|585316329|FG002|Overall Study|Death|1|||
162071068|NCT02082210|585316330|FG003|Overall Study|Death|1|||
162071069|NCT02082210|585316331|FG004|Overall Study|Death|1|||
162071070|NCT02082210|585316332|FG005|Overall Study|Death|0|||
162071071|NCT02082210|585316327|FG000|Overall Study|Withdrawal by Subject|0|||
162071072|NCT02082210|585316328|FG001|Overall Study|Withdrawal by Subject|0|||
162071073|NCT02082210|585316329|FG002|Overall Study|Withdrawal by Subject|0|||
162071074|NCT02082210|585316330|FG003|Overall Study|Withdrawal by Subject|1|||
162071075|NCT02082210|585316331|FG004|Overall Study|Withdrawal by Subject|2|||
162071076|NCT02082210|585316332|FG005|Overall Study|Withdrawal by Subject|2|||
162071077|NCT02082210|585316327|FG000|Overall Study|Clinical Progression|0|||
162071078|NCT02082210|585316328|FG001|Overall Study|Clinical Progression|0|||
162071079|NCT02082210|585316329|FG002|Overall Study|Clinical Progression|0|||
162071080|NCT02082210|585316330|FG003|Overall Study|Clinical Progression|1|||
162071081|NCT02082210|585316331|FG004|Overall Study|Clinical Progression|0|||
162071082|NCT02082210|585316332|FG005|Overall Study|Clinical Progression|0|||
162071083|NCT02082210|585316327|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
162071084|NCT02082210|585316328|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
162071085|NCT02082210|585316329|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
162071086|NCT02082210|585316330|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
162071087|NCT02082210|585316331|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
162071088|NCT02082210|585316332|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
162071089|NCT02082210|585316327|FG000|Overall Study|Physician Decision|0|||
162071090|NCT02082210|585316328|FG001|Overall Study|Physician Decision|0|||
162071091|NCT02082210|585316329|FG002|Overall Study|Physician Decision|1|||
162071092|NCT02082210|585316330|FG003|Overall Study|Physician Decision|1|||
162071093|NCT02082210|585316331|FG004|Overall Study|Physician Decision|0|||
162071094|NCT02082210|585316332|FG005|Overall Study|Physician Decision|0|||
162071095|NCT01859494|585316344|FG000|Overall Study|Adverse Event|1|||
162071096|NCT01290666|585316350|FG000|Overall Study|Lost to Follow-up|11|||
162071097|NCT01290666|585316350|FG000|Overall Study|Withdrawal by Subject|23|||
162071098|NCT01290666|585316350|FG000|Overall Study|Early Termination of Study|4|||
162071099|NCT00297037|585316353|FG000|Overall Study|Withdrawal by Subject|2|||
162071100|NCT00297037|585316354|FG001|Overall Study|Withdrawal by Subject|0|||
162071101|NCT03814746|585316361|FG000|Overall Study|Participant decision|9|||
162071102|NCT03814746|585316362|FG001|Overall Study|Participant decision|6|||
162071103|NCT03814746|585316363|FG002|Overall Study|Participant decision|15|||
162071104|NCT03814746|585316361|FG000|Overall Study|Physician Decision|2|||
162071105|NCT03814746|585316362|FG001|Overall Study|Physician Decision|2|||
162071106|NCT03814746|585316363|FG002|Overall Study|Physician Decision|4|||
162071107|NCT03814746|585316361|FG000|Overall Study|Death|2|||
162071108|NCT03814746|585316362|FG001|Overall Study|Death|2|||
162071109|NCT03814746|585316363|FG002|Overall Study|Death|2|||
162071110|NCT03814746|585316361|FG000|Overall Study|Adverse Event|2|||
162071111|NCT03814746|585316362|FG001|Overall Study|Adverse Event|2|||
162071112|NCT03814746|585316363|FG002|Overall Study|Adverse Event|1|||
162071113|NCT03814746|585316361|FG000|Overall Study|Lost to Follow-up|2|||
162071114|NCT03814746|585316362|FG001|Overall Study|Lost to Follow-up|1|||
162071115|NCT03814746|585316363|FG002|Overall Study|Lost to Follow-up|2|||
162071116|NCT03814746|585316361|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
162071117|NCT03814746|585316362|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
162071118|NCT03814746|585316363|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
162071119|NCT03814746|585316361|FG000|Overall Study|Pregnancy|0|||
162071120|NCT03814746|585316362|FG001|Overall Study|Pregnancy|1|||
162071121|NCT03814746|585316363|FG002|Overall Study|Pregnancy|1|||
162071122|NCT03814746|585316361|FG000|Overall Study|Protocol Violation|1|||
162071123|NCT03814746|585316362|FG001|Overall Study|Protocol Violation|0|||
162071124|NCT03814746|585316363|FG002|Overall Study|Protocol Violation|0|||
162071125|NCT05089682|585316364|FG000|Overall Study|Withdrawal by Subject|2|||
162071126|NCT00483379|585316369|FG000|Treatment Period|Adverse Event|1|||
162071127|NCT00483379|585316370|FG001|Treatment Period|Adverse Event|0|||
162071128|NCT00483379|585316369|FG000|Treatment Period|Withdrawal by Subject|1|||
162071129|NCT00483379|585316370|FG001|Treatment Period|Withdrawal by Subject|0|||
162071130|NCT00371254|585316372|FG000|Overall Study|Disease progression|13|||
162071131|NCT00371254|585316373|FG001|Overall Study|Disease progression|13|||
162071132|NCT00371254|585316372|FG000|Overall Study|Study drug toxicity|3|||
162071133|NCT00371254|585316373|FG001|Overall Study|Study drug toxicity|5|||
162071134|NCT00371254|585316372|FG000|Overall Study|Subject request|5|||
162071135|NCT00371254|585316373|FG001|Overall Study|Subject request|0|||
162071136|NCT00371254|585316372|FG000|Overall Study|Investigator Decision|2|||
162071137|NCT00371254|585316373|FG001|Overall Study|Investigator Decision|0|||
162071138|NCT00371254|585316372|FG000|Overall Study|Adverse event unrelated to study drug|0|||
162071139|NCT00371254|585316373|FG001|Overall Study|Adverse event unrelated to study drug|1|||
162071140|NCT00371254|585316372|FG000|Overall Study|Lost to Follow-up|0|||
162071141|NCT00371254|585316373|FG001|Overall Study|Lost to Follow-up|1|||
162071142|NCT00371254|585316372|FG000|Overall Study|Withdrawal by Subject|0|||
162071143|NCT00371254|585316373|FG001|Overall Study|Withdrawal by Subject|1|||
162071144|NCT01817725|585316374|FG000|Overall Study|Withdrawal by Subject|1|||
162071145|NCT02337907|585316375|FG000|Overall Study|Other than listed|1|||
162071146|NCT02337907|585316376|FG001|Overall Study|Other than listed|0|||
162071147|NCT02337907|585316377|FG002|Overall Study|Other than listed|0|||
162071148|NCT02337907|585316378|FG003|Overall Study|Other than listed|1|||
162071149|NCT02337907|585316379|FG004|Overall Study|Other than listed|1|||
162071150|NCT02337907|585316380|FG005|Overall Study|Other than listed|0|||
162071151|NCT02337907|585316375|FG000|Overall Study|Withdrawal by Subject|2|||
162071152|NCT02337907|585316376|FG001|Overall Study|Withdrawal by Subject|3|||
162071153|NCT02337907|585316377|FG002|Overall Study|Withdrawal by Subject|0|||
162071154|NCT02337907|585316378|FG003|Overall Study|Withdrawal by Subject|2|||
162071155|NCT02337907|585316379|FG004|Overall Study|Withdrawal by Subject|5|||
162071156|NCT02337907|585316380|FG005|Overall Study|Withdrawal by Subject|0|||
162071157|NCT02337907|585316375|FG000|Overall Study|Lost to Follow-up|0|||
162071158|NCT02337907|585316376|FG001|Overall Study|Lost to Follow-up|0|||
162071159|NCT02337907|585316377|FG002|Overall Study|Lost to Follow-up|0|||
162071160|NCT02337907|585316378|FG003|Overall Study|Lost to Follow-up|0|||
162071161|NCT02337907|585316379|FG004|Overall Study|Lost to Follow-up|0|||
162071162|NCT02337907|585316380|FG005|Overall Study|Lost to Follow-up|1|||
162071163|NCT02337907|585316375|FG000|Overall Study|Adverse Event|1|||
162071164|NCT02337907|585316376|FG001|Overall Study|Adverse Event|1|||
162071165|NCT02337907|585316377|FG002|Overall Study|Adverse Event|1|||
162071166|NCT02337907|585316378|FG003|Overall Study|Adverse Event|1|||
162071167|NCT02337907|585316379|FG004|Overall Study|Adverse Event|4|||
162071168|NCT02337907|585316380|FG005|Overall Study|Adverse Event|0|||
162071169|NCT00909779|585316381|FG000|Overall Study|Adverse Event|53|||
162071170|NCT00909779|585316382|FG001|Overall Study|Adverse Event|55|||
162071171|NCT00909779|585316381|FG000|Overall Study|Lack of Efficacy|7|||
162071172|NCT00909779|585316382|FG001|Overall Study|Lack of Efficacy|4|||
162071173|NCT00909779|585316381|FG000|Overall Study|Lost to Follow-up|19|||
162071174|NCT00909779|585316382|FG001|Overall Study|Lost to Follow-up|15|||
162071175|NCT00909779|585316381|FG000|Overall Study|Physician Decision|8|||
162071176|NCT00909779|585316382|FG001|Overall Study|Physician Decision|2|||
162071177|NCT00909779|585316381|FG000|Overall Study|Protocol Violation|2|||
162071178|NCT00909779|585316382|FG001|Overall Study|Protocol Violation|5|||
162071179|NCT00909779|585316381|FG000|Overall Study|Withdrawal by Subject|116|||
162071180|NCT00909779|585316382|FG001|Overall Study|Withdrawal by Subject|80|||
162071181|NCT00909779|585316381|FG000|Overall Study|Site Ceasing Operation|2|||
162071182|NCT00909779|585316382|FG001|Overall Study|Site Ceasing Operation|2|||
162071183|NCT00909779|585316381|FG000|Overall Study|Medical Monitor Decision|1|||
162071184|NCT00909779|585316382|FG001|Overall Study|Medical Monitor Decision|0|||
162071185|NCT00909779|585316381|FG000|Overall Study|Noncompliance|1|||
162071186|NCT00909779|585316382|FG001|Overall Study|Noncompliance|1|||
162071187|NCT00909779|585316381|FG000|Overall Study|Randomized in error|1|||
162071188|NCT00909779|585316382|FG001|Overall Study|Randomized in error|1|||
162071189|NCT00099437|585316383|FG000|Overall Study|Lost to Follow-up|30|||
162071190|NCT00099437|585316384|FG001|Overall Study|Lost to Follow-up|33|||
162071191|NCT00099437|585316383|FG000|Overall Study|Death|293|||
162071192|NCT00099437|585316384|FG001|Overall Study|Death|261|||
162071193|NCT00099437|585316383|FG000|Overall Study|Withdrawal by Subject|6|||
162071194|NCT00099437|585316384|FG001|Overall Study|Withdrawal by Subject|10|||
162071195|NCT00099437|585316383|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
162071196|NCT00099437|585316384|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
162071197|NCT02809677|585316385|FG000|Overall Study|Withdrawal by Subject|8|||
162071198|NCT05172544|585316388|FG000|Overall Study|Withdrawal by Subject|1|||
162071199|NCT05172544|585316389|FG001|Overall Study|Withdrawal by Subject|0|||
162071200|NCT05172544|585316390|FG002|Overall Study|Withdrawal by Subject|0|||
162071201|NCT05172544|585316388|FG000|Overall Study|Physician Decision|0|||
162071202|NCT05172544|585316389|FG001|Overall Study|Physician Decision|0|||
162071203|NCT05172544|585316390|FG002|Overall Study|Physician Decision|1|||
162071204|NCT00423150|585316395|FG000|Overall Study|Adverse Event|11|||
162071205|NCT00423150|585316395|FG000|Overall Study|Progression of disease being studied|69|||
162071206|NCT00423150|585316395|FG000|Overall Study|Withdrawal by Subject|1|||
162071207|NCT00423150|585316395|FG000|Overall Study|Non-compliance with protocol|1|||
162071208|NCT00423150|585316395|FG000|Overall Study|Administrative|4|||
162071209|NCT00561080|585316396|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
162071210|NCT00561080|585316397|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
162071211|NCT00561080|585316398|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
162071212|NCT00561080|585316396|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
162071213|NCT00561080|585316397|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
162071214|NCT00561080|585316398|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
162071215|NCT00561080|585316396|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
162071216|NCT00561080|585316397|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
162071217|NCT00561080|585316398|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
162071218|NCT00561080|585316396|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
162071219|NCT00561080|585316397|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
162071220|NCT00561080|585316398|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
162071221|NCT00561080|585316396|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
162071222|NCT00561080|585316397|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
162071223|NCT00561080|585316398|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
162071224|NCT00561080|585316396|FG000|Vaccination Period (up to Month 4)|Other|0|||
162071225|NCT00561080|585316397|FG001|Vaccination Period (up to Month 4)|Other|2|||
162071226|NCT00561080|585316398|FG002|Vaccination Period (up to Month 4)|Other|1|||
162071227|NCT00561080|585316396|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
162071228|NCT00561080|585316397|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
162071229|NCT00561080|585316398|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
162071230|NCT00561080|585316396|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
162071231|NCT00561080|585316397|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
162071232|NCT00561080|585316398|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
162071233|NCT00561080|585316396|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
162071234|NCT00561080|585316397|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
162071235|NCT00561080|585316398|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
162071236|NCT00561080|585316396|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
162071237|NCT00561080|585316397|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
162071238|NCT00561080|585316398|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
162071239|NCT02295995|585316399|FG000|Overall Study|Lost to Follow-up|5|||
162071240|NCT02295995|585316400|FG001|Overall Study|Lost to Follow-up|1|||
162071241|NCT03649711|585316401|FG000|Overall Study|Adverse Event|0|||
162071242|NCT03649711|585316402|FG001|Overall Study|Adverse Event|1|||
162071243|NCT03649711|585316403|FG002|Overall Study|Adverse Event|0|||
162071244|NCT03649711|585316401|FG000|Overall Study|Kidney Transplant|1|||
162071245|NCT03649711|585316402|FG001|Overall Study|Kidney Transplant|0|||
162071246|NCT03649711|585316403|FG002|Overall Study|Kidney Transplant|0|||
162071247|NCT04350788|585316408|FG000|Overall Study|Lost to Follow-up|6|||
162071248|NCT04350788|585316409|FG001|Overall Study|Lost to Follow-up|2|||
162071249|NCT04350788|585316408|FG000|Overall Study|Withdrawal by Subject|2|||
162071250|NCT04350788|585316409|FG001|Overall Study|Withdrawal by Subject|4|||
162071251|NCT04350788|585316408|FG000|Overall Study|Protocol Violation|4|||
162071252|NCT04350788|585316409|FG001|Overall Study|Protocol Violation|0|||
162071253|NCT01581307|585316410|FG000|Overall Study|Withdrawal by Subject|1|||
162071254|NCT00378209|585316411|FG000|Overall Study|Progressive disease|11|||
162071255|NCT00378209|585316411|FG000|Overall Study|Adverse Event|3|||
162071256|NCT00378209|585316411|FG000|Overall Study|Initiation of non-protocol therapy|3|||
162071257|NCT00378209|585316411|FG000|Overall Study|Physician Decision|3|||
162071258|NCT00378209|585316411|FG000|Overall Study|Death|1|||
162071259|NCT00378209|585316411|FG000|Overall Study|Treatment delay|1|||
162071260|NCT02070744|585316412|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
162071261|NCT02070744|585316413|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
162071262|NCT02070744|585316414|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
162071263|NCT02070744|585316415|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
162071264|NCT02070744|585316416|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
162071265|NCT02070744|585316412|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
162071266|NCT02070744|585316413|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
162071267|NCT02070744|585316414|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
162071268|NCT02070744|585316415|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
162071269|NCT02070744|585316416|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
162071270|NCT02070744|585316412|FG000|OLE Phase (48 Weeks)|Other|0|||
162071271|NCT02070744|585316413|FG001|OLE Phase (48 Weeks)|Other|0|||
162071272|NCT02070744|585316414|FG002|OLE Phase (48 Weeks)|Other|0|||
162071273|NCT02070744|585316415|FG003|OLE Phase (48 Weeks)|Other|0|||
162071274|NCT02070744|585316416|FG004|OLE Phase (48 Weeks)|Other|1|||
162071275|NCT07114198|585316420|FG000|Overall Study|Protocol Violation|1|||
162071276|NCT07114198|585316421|FG001|Overall Study|Protocol Violation|1|||
162071277|NCT02967692|585317980|FG000|Overall Study|Progressive disease|3|||
162071278|NCT02967692|585317981|FG001|Overall Study|Progressive disease|15|||
162071279|NCT02967692|585317982|FG002|Overall Study|Progressive disease|114|||
162071280|NCT02967692|585317983|FG003|Overall Study|Progressive disease|151|||
162071281|NCT02967692|585317980|FG000|Overall Study|Subject/guardian decision|1|||
162071282|NCT02967692|585317981|FG001|Overall Study|Subject/guardian decision|1|||
162071283|NCT02967692|585317982|FG002|Overall Study|Subject/guardian decision|14|||
162071284|NCT02967692|585317983|FG003|Overall Study|Subject/guardian decision|22|||
162071285|NCT02967692|585317980|FG000|Overall Study|Death|0|||
162071286|NCT02967692|585317981|FG001|Overall Study|Death|1|||
162071287|NCT02967692|585317982|FG002|Overall Study|Death|13|||
162071288|NCT02967692|585317983|FG003|Overall Study|Death|13|||
162071289|NCT02967692|585317980|FG000|Overall Study|Protocol deviation|1|||
162071290|NCT02967692|585317981|FG001|Overall Study|Protocol deviation|0|||
162071291|NCT02967692|585317982|FG002|Overall Study|Protocol deviation|1|||
162071292|NCT02967692|585317983|FG003|Overall Study|Protocol deviation|1|||
162071293|NCT02967692|585317980|FG000|Overall Study|Lost to Follow-up|0|||
162071294|NCT02967692|585317981|FG001|Overall Study|Lost to Follow-up|0|||
162071295|NCT02967692|585317982|FG002|Overall Study|Lost to Follow-up|1|||
162071296|NCT02967692|585317983|FG003|Overall Study|Lost to Follow-up|0|||
162071297|NCT02967692|585317980|FG000|Overall Study|Physician Decision|0|||
162071298|NCT02967692|585317981|FG001|Overall Study|Physician Decision|0|||
162071299|NCT02967692|585317982|FG002|Overall Study|Physician Decision|22|||
162071300|NCT02967692|585317983|FG003|Overall Study|Physician Decision|13|||
162071301|NCT02967692|585317980|FG000|Overall Study|Adverse Event|2|||
162071302|NCT02967692|585317981|FG001|Overall Study|Adverse Event|9|||
162071303|NCT02967692|585317982|FG002|Overall Study|Adverse Event|60|||
162071304|NCT02967692|585317983|FG003|Overall Study|Adverse Event|28|||
162071305|NCT02967692|585317980|FG000|Overall Study|Study terminated by sponsor|2|||
162071306|NCT02967692|585317981|FG001|Overall Study|Study terminated by sponsor|1|||
162071307|NCT02967692|585317982|FG002|Overall Study|Study terminated by sponsor|42|||
162071308|NCT02967692|585317983|FG003|Overall Study|Study terminated by sponsor|37|||
162071309|NCT04439253|585317987|FG000|Overall Study|Adverse Event|1|||
162071310|NCT04439253|585317987|FG000|Overall Study|Disease progression|2|||
162071311|NCT04439253|585317987|FG000|Overall Study|Complicating disease|1|||
162071312|NCT04447417|585317988|FG000|Overall Study|Withdrawal by Subject|1|||
162071313|NCT04447417|585317989|FG001|Overall Study|Withdrawal by Subject|0|||
162071314|NCT04447417|585317988|FG000|Overall Study|Failure to meet inclusion criteria|1|||
162071315|NCT04447417|585317989|FG001|Overall Study|Failure to meet inclusion criteria|0|||
162071316|NCT04447417|585317988|FG000|Overall Study|Lost to Follow-up|1|||
162071317|NCT04447417|585317989|FG001|Overall Study|Lost to Follow-up|0|||
162071318|NCT00066066|585317990|FG000|Overall Study|Lost to Follow-up|6|||
162071319|NCT00066066|585317991|FG001|Overall Study|Lost to Follow-up|4|||
162071320|NCT00066066|585317992|FG002|Overall Study|Lost to Follow-up|7|||
162071321|NCT00066066|585317993|FG003|Overall Study|Lost to Follow-up|4|||
162071322|NCT00066066|585317994|FG004|Overall Study|Lost to Follow-up|3|||
162071323|NCT00066066|585317995|FG005|Overall Study|Lost to Follow-up|5|||
162071324|NCT02155738|585317998|FG000|Overall Study|Missing critical information|1|||
162071325|NCT02155738|585317999|FG001|Overall Study|Missing critical information|0|||
162071326|NCT02155738|585318000|FG002|Overall Study|Missing critical information|0|||
162071327|NCT02155738|585318001|FG003|Overall Study|Missing critical information|1|||
162071328|NCT01466348|585318004|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
162071329|NCT01466348|585318005|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
162071330|NCT02189473|585318010|FG000|Overall Study|Death|22|||
162071331|NCT02189473|585318011|FG001|Overall Study|Death|23|||
162071332|NCT02189473|585318010|FG000|Overall Study|Lost to Follow-up|1|||
162071333|NCT02189473|585318011|FG001|Overall Study|Lost to Follow-up|2|||
162071334|NCT02385266|585318017|FG000|Overall Study|Withdrawal by Subject|1|||
162071335|NCT02385266|585318018|FG001|Overall Study|Withdrawal by Subject|3|||
162071336|NCT00914810|585318019|FG000|Overall Study|Withdrawal by Subject|1|||
162071337|NCT00914810|585318020|FG001|Overall Study|Withdrawal by Subject|0|||
162071338|NCT00914810|585318019|FG000|Overall Study|Relocated out of state|1|||
162071339|NCT00914810|585318020|FG001|Overall Study|Relocated out of state|0|||
162071340|NCT00914810|585318019|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
162071341|NCT00914810|585318020|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
162071342|NCT00952341|585318022|FG000|Cycle 1|Adverse Event|4|||
162071343|NCT00952341|585318023|FG001|Cycle 1|Adverse Event|1|||
162071344|NCT00952341|585318022|FG000|Cycle 1|Withdrawal by Subject|3|||
162071345|NCT00952341|585318023|FG001|Cycle 1|Withdrawal by Subject|8|||
162071346|NCT00952341|585318022|FG000|Cycle 1|Protocol Violation|2|||
162071347|NCT00952341|585318023|FG001|Cycle 1|Protocol Violation|1|||
162071348|NCT00952341|585318022|FG000|Cycle 1|Lost to Follow-up|11|||
162071349|NCT00952341|585318023|FG001|Cycle 1|Lost to Follow-up|2|||
162071350|NCT00952341|585318022|FG000|Cycle 1|Physician Decision|0|||
162071351|NCT00952341|585318023|FG001|Cycle 1|Physician Decision|1|||
162071352|NCT00952341|585318022|FG000|Cycle 2|Withdrawal by Subject|1|||
162071353|NCT00952341|585318023|FG001|Cycle 2|Withdrawal by Subject|1|||
162071354|NCT00952341|585318022|FG000|Cycle 2|Protocol Violation|1|||
162071355|NCT00952341|585318023|FG001|Cycle 2|Protocol Violation|0|||
162071356|NCT00952341|585318022|FG000|Cycle 2|Lost to Follow-up|6|||
162071357|NCT00952341|585318023|FG001|Cycle 2|Lost to Follow-up|9|||
162071358|NCT00952341|585318022|FG000|Cycle 2|Physician Decision|1|||
162071359|NCT00952341|585318023|FG001|Cycle 2|Physician Decision|1|||
162071360|NCT00952341|585318022|FG000|Cycle 2|Progressive Disease|0|||
162071361|NCT00952341|585318023|FG001|Cycle 2|Progressive Disease|1|||
162071362|NCT02066467|585318028|FG000|Overall Study|Did not undergo implant procedure|24|||
162071363|NCT02066467|585318028|FG000|Overall Study|Attempted to implant withoput success|43|||
162071364|NCT02066467|585318028|FG000|Overall Study|Consent ineligible|1|||
162071365|NCT02066467|585318028|FG000|Overall Study|Death|54|||
162071366|NCT02066467|585318028|FG000|Overall Study|Lost to Follow-up|51|||
162071367|NCT02066467|585318028|FG000|Overall Study|Adverse Event|20|||
162071368|NCT02066467|585318028|FG000|Overall Study|Withdrawal by Subject|16|||
162071369|NCT02066467|585318028|FG000|Overall Study|Physician Decision|2|||
162071370|NCT02066467|585318028|FG000|Overall Study|Not defined|4|||
162071371|NCT01652664|585318029|FG000|Overall Study|Treatment Failure|5|||
162071372|NCT01652664|585318030|FG001|Overall Study|Treatment Failure|1|||
162071373|NCT01652664|585318029|FG000|Overall Study|Inadequate IOP control|1|||
162071374|NCT01652664|585318030|FG001|Overall Study|Inadequate IOP control|0|||
162071375|NCT00491387|585318031|FG000|Overall Study|study terminated|20|||
162071376|NCT02418468|585318036|FG000|Overall Study|Adverse Event|1|||
162071377|NCT02418468|585318037|FG001|Overall Study|Adverse Event|0|||
162071378|NCT02418468|585318036|FG000|Overall Study|Withdrawal of informed consent|1|||
162071379|NCT02418468|585318037|FG001|Overall Study|Withdrawal of informed consent|1|||
162071380|NCT02914769|585318038|FG000|Overall Study|Protocol Violation|3|||
162071381|NCT02914769|585318039|FG001|Overall Study|Protocol Violation|2|||
162071382|NCT02914769|585318038|FG000|Overall Study|Withdrawal by Subject|0|||
162071383|NCT02914769|585318039|FG001|Overall Study|Withdrawal by Subject|1|||
162071384|NCT01592344|585318040|FG000|Overall Study|Adverse Event|1|||
162071385|NCT01592344|585318041|FG001|Overall Study|Adverse Event|1|||
162071386|NCT01592344|585318040|FG000|Overall Study|Lack of Efficacy|1|||
162071387|NCT01592344|585318041|FG001|Overall Study|Lack of Efficacy|0|||
162071388|NCT01592344|585318040|FG000|Overall Study|not available at primary outcome visit|2|||
162071389|NCT01592344|585318041|FG001|Overall Study|not available at primary outcome visit|4|||
162071390|NCT02738333|585318042|FG000|Overall Study|Death|1|||
162071391|NCT02738333|585318043|FG001|Overall Study|Death|0|||
162071392|NCT02738333|585318044|FG002|Overall Study|Death|0|||
162071393|NCT02738333|585318042|FG000|Overall Study|Lost to Follow-up|1|||
162071394|NCT02738333|585318043|FG001|Overall Study|Lost to Follow-up|0|||
162071395|NCT02738333|585318044|FG002|Overall Study|Lost to Follow-up|0|||
162071396|NCT00949325|585318045|FG000|Overall Study|Adverse Event|0|||
162071397|NCT00949325|585318046|FG001|Overall Study|Adverse Event|2|||
162071398|NCT00949325|585318047|FG002|Overall Study|Adverse Event|0|||
162071399|NCT03311659|585318054|FG000|Overall Study|Protocol Violation|1|||
162071400|NCT04327388|585318057|FG000|Overall Study|Adverse Event|17|||
162071401|NCT04327388|585318058|FG001|Overall Study|Adverse Event|18|||
162071402|NCT04327388|585318059|FG002|Overall Study|Adverse Event|9|||
162071403|NCT04327388|585318057|FG000|Overall Study|Other|1|||
162071404|NCT04327388|585318058|FG001|Overall Study|Other|2|||
162071405|NCT04327388|585318059|FG002|Overall Study|Other|0|||
162071406|NCT04327388|585318057|FG000|Overall Study|Randomized and not treated|2|||
162071407|NCT04327388|585318058|FG001|Overall Study|Randomized and not treated|0|||
162071408|NCT04327388|585318059|FG002|Overall Study|Randomized and not treated|2|||
162071409|NCT04829318|585318060|FG000|Overall Study|Adverse Event|6|||
162071410|NCT04829318|585318060|FG000|Overall Study|Death|1|||
162071411|NCT04829318|585318060|FG000|Overall Study|Lost to Follow-up|1|||
162071412|NCT04829318|585318060|FG000|Overall Study|Physician Decision|1|||
162071413|NCT04829318|585318060|FG000|Overall Study|Withdrawal by Subject|19|||
162071414|NCT04829318|585318060|FG000|Overall Study|Site terminated by sponsor|1|||
162071415|NCT04829318|585318060|FG000|Overall Study|Sponsor decision|5|||
162071416|NCT04829318|585318060|FG000|Overall Study|Other|1|||
162071417|NCT00728130|585318061|FG000|Overall Study|Withdrawal by Subject|1|||
162071418|NCT00728130|585318061|FG000|Overall Study|Paperwork not completed in time|1|||
162071419|NCT00728130|585318061|FG000|Overall Study|Physician Decision|1|||
162071420|NCT04053023|585318064|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
162071421|NCT04053023|585318065|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
162071422|NCT03447990|585318066|FG000|Overall Study|Withdrawal by Subject|0|||
162071423|NCT03447990|585318067|FG001|Overall Study|Withdrawal by Subject|0|||
162071424|NCT03447990|585318068|FG002|Overall Study|Withdrawal by Subject|0|||
162071425|NCT03447990|585318069|FG003|Overall Study|Withdrawal by Subject|0|||
162071426|NCT03447990|585318070|FG004|Overall Study|Withdrawal by Subject|0|||
162071427|NCT03447990|585318071|FG005|Overall Study|Withdrawal by Subject|0|||
162071428|NCT03447990|585318072|FG006|Overall Study|Withdrawal by Subject|1|||
162071429|NCT05104567|585318075|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
162071430|NCT05104567|585318076|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
162071431|NCT05104567|585318077|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
162071432|NCT05104567|585318078|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
162071433|NCT05104567|585318079|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
162071434|NCT05104567|585318080|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
162071435|NCT05104567|585318081|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
162071436|NCT05104567|585318075|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
162071437|NCT05104567|585318076|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
162071438|NCT05104567|585318077|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
162071439|NCT05104567|585318078|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
162071440|NCT05104567|585318079|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
162071441|NCT05104567|585318080|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
162071442|NCT05104567|585318081|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
162071443|NCT05104567|585318075|FG000|Overall Study|Progressive disease|3|||
162071444|NCT05104567|585318076|FG001|Overall Study|Progressive disease|13|||
162071445|NCT05104567|585318077|FG002|Overall Study|Progressive disease|13|||
162071446|NCT05104567|585318078|FG003|Overall Study|Progressive disease|17|||
162071447|NCT05104567|585318079|FG004|Overall Study|Progressive disease|17|||
162071448|NCT05104567|585318080|FG005|Overall Study|Progressive disease|28|||
162071449|NCT05104567|585318081|FG006|Overall Study|Progressive disease|24|||
162071450|NCT05104567|585318075|FG000|Overall Study|Withdrawal by Subject|1|||
162071451|NCT05104567|585318076|FG001|Overall Study|Withdrawal by Subject|1|||
162071452|NCT05104567|585318077|FG002|Overall Study|Withdrawal by Subject|2|||
162071453|NCT05104567|585318078|FG003|Overall Study|Withdrawal by Subject|0|||
162071454|NCT05104567|585318079|FG004|Overall Study|Withdrawal by Subject|0|||
162071455|NCT05104567|585318080|FG005|Overall Study|Withdrawal by Subject|0|||
162071456|NCT05104567|585318081|FG006|Overall Study|Withdrawal by Subject|0|||
162071457|NCT05104567|585318075|FG000|Overall Study|Other|1|||
162071458|NCT05104567|585318076|FG001|Overall Study|Other|1|||
162071459|NCT05104567|585318077|FG002|Overall Study|Other|1|||
162071460|NCT05104567|585318078|FG003|Overall Study|Other|0|||
162071461|NCT05104567|585318079|FG004|Overall Study|Other|0|||
162071462|NCT05104567|585318080|FG005|Overall Study|Other|0|||
162071463|NCT05104567|585318081|FG006|Overall Study|Other|0|||
162071464|NCT01464346|585318082|FG000|Overall Study|Withdrawal by Subject|0|||
162071465|NCT01464346|585318083|FG001|Overall Study|Withdrawal by Subject|0|||
162071466|NCT01464346|585318084|FG002|Overall Study|Withdrawal by Subject|1|||
162071467|NCT03999892|585318085|FG000|Overall Study|Lost to Follow-up|1|||
162071468|NCT01848756|585318086|FG000|Overall Study|Adverse Event|1|||
162071469|NCT01848756|585318086|FG000|Overall Study|Withdrawal by Subject|1|||
162071470|NCT01848756|585318086|FG000|Overall Study|Enrolled in Error|1|||
162071471|NCT01286012|585318087|FG000|Overall Study|Adverse Event|3|||
162071472|NCT01286012|585318088|FG001|Overall Study|Adverse Event|3|||
162071473|NCT01286012|585318087|FG000|Overall Study|Death|2|||
162071474|NCT01286012|585318088|FG001|Overall Study|Death|3|||
162071475|NCT01286012|585318087|FG000|Overall Study|Protocol Violation|1|||
162071476|NCT01286012|585318088|FG001|Overall Study|Protocol Violation|1|||
162071477|NCT01286012|585318087|FG000|Overall Study|Withdrawal by Subject|4|||
162071478|NCT01286012|585318088|FG001|Overall Study|Withdrawal by Subject|4|||
162071479|NCT01286012|585318087|FG000|Overall Study|Physician Decision|2|||
162071480|NCT01286012|585318088|FG001|Overall Study|Physician Decision|0|||
162071481|NCT01286012|585318087|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
162071482|NCT01286012|585318088|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
162071483|NCT04056195|585318091|FG000|Overall Study|Adverse Event|1|||
162071484|NCT04056195|585318092|FG001|Overall Study|Adverse Event|0|||
162071485|NCT04056195|585318093|FG002|Overall Study|Adverse Event|0|||
162071486|NCT04056195|585318091|FG000|Overall Study|Withdrawal by Subject|0|||
162071487|NCT04056195|585318092|FG001|Overall Study|Withdrawal by Subject|1|||
162071488|NCT04056195|585318093|FG002|Overall Study|Withdrawal by Subject|1|||
162071489|NCT04056195|585318091|FG000|Overall Study|Physician Decision|1|||
162071490|NCT04056195|585318092|FG001|Overall Study|Physician Decision|1|||
162071491|NCT04056195|585318093|FG002|Overall Study|Physician Decision|1|||
162071492|NCT01498458|585318094|FG000|Overall Study|Adverse Event|4|||
162071493|NCT01498458|585318094|FG000|Overall Study|Physician Decision|3|||
162071494|NCT02226003|585318095|FG000|Overall Study|Lost to Follow-up|2|||
162071495|NCT02226003|585318096|FG001|Overall Study|Lost to Follow-up|1|||
162071496|NCT02226003|585318097|FG002|Overall Study|Lost to Follow-up|3|||
162071497|NCT02226003|585318095|FG000|Overall Study|Withdrawal by Subject|0|||
162071498|NCT02226003|585318096|FG001|Overall Study|Withdrawal by Subject|0|||
162071499|NCT02226003|585318097|FG002|Overall Study|Withdrawal by Subject|3|||
162071500|NCT02865915|585318098|FG000|Overall Study|Pregnancy|1|||
162071501|NCT02865915|585318099|FG001|Overall Study|Pregnancy|0|||
162071502|NCT02865915|585318098|FG000|Overall Study|Withdrawal by Subject|1|||
162071503|NCT02865915|585318099|FG001|Overall Study|Withdrawal by Subject|1|||
162071504|NCT02865915|585318098|FG000|Overall Study|Adverse Event|0|||
162071505|NCT02865915|585318099|FG001|Overall Study|Adverse Event|4|||
162071506|NCT02865915|585318098|FG000|Overall Study|Lost to Follow-up|0|||
162071507|NCT02865915|585318099|FG001|Overall Study|Lost to Follow-up|1|||
162071508|NCT02865915|585318098|FG000|Overall Study|Protocol Violation|0|||
162071509|NCT02865915|585318099|FG001|Overall Study|Protocol Violation|1|||
162071510|NCT02865915|585318098|FG000|Overall Study|Study terminated by sponsor|23|||
162071511|NCT02865915|585318099|FG001|Overall Study|Study terminated by sponsor|18|||
162071512|NCT02865915|585318098|FG000|Overall Study|Dosing group discontinued|0|||
162071513|NCT02865915|585318099|FG001|Overall Study|Dosing group discontinued|5|||
162071514|NCT05760300|585318107|FG000|Overall Study|Adverse Event|0|||
162071515|NCT05760300|585318108|FG001|Overall Study|Adverse Event|0|||
162071516|NCT05760300|585318109|FG002|Overall Study|Adverse Event|1|||
162071517|NCT05760300|585318110|FG003|Overall Study|Adverse Event|0|||
162071518|NCT05760300|585318107|FG000|Overall Study|Participant Decision|1|||
162071519|NCT05760300|585318108|FG001|Overall Study|Participant Decision|0|||
162071520|NCT05760300|585318109|FG002|Overall Study|Participant Decision|0|||
162071521|NCT05760300|585318110|FG003|Overall Study|Participant Decision|0|||
162071522|NCT03279692|585318111|FG000|Overall Study|Withdrawal by Subject|1|||
162071523|NCT02446990|585318114|FG000|Overall Study|Death|485|||
162071524|NCT02446990|585318115|FG001|Overall Study|Death|458|||
162071525|NCT02446990|585318114|FG000|Overall Study|Lost to Follow-up|3|||
162071526|NCT02446990|585318115|FG001|Overall Study|Lost to Follow-up|1|||
162071527|NCT02446990|585318114|FG000|Overall Study|Physician Decision|1|||
162071528|NCT02446990|585318115|FG001|Overall Study|Physician Decision|0|||
162071529|NCT02446990|585318114|FG000|Overall Study|Withdrawal by Subject|231|||
162071530|NCT02446990|585318115|FG001|Overall Study|Withdrawal by Subject|199|||
162071531|NCT01064401|585318116|FG000|Overall Study|Adverse Event|47|||
162071532|NCT01064401|585318117|FG001|Overall Study|Adverse Event|56|||
162071533|NCT01064401|585318116|FG000|Overall Study|Lack of Efficacy|46|||
162071534|NCT01064401|585318117|FG001|Overall Study|Lack of Efficacy|23|||
162071535|NCT01064401|585318116|FG000|Overall Study|Lost to Follow-up|12|||
162071536|NCT01064401|585318117|FG001|Overall Study|Lost to Follow-up|9|||
162071537|NCT01064401|585318116|FG000|Overall Study|Consent Withdrawn|98|||
162071538|NCT01064401|585318117|FG001|Overall Study|Consent Withdrawn|80|||
162071539|NCT01064401|585318116|FG000|Overall Study|Investigator Decision|4|||
162071540|NCT01064401|585318117|FG001|Overall Study|Investigator Decision|6|||
162071541|NCT01064401|585318116|FG000|Overall Study|Death|4|||
162071542|NCT01064401|585318117|FG001|Overall Study|Death|0|||
162071543|NCT01064401|585318116|FG000|Overall Study|Pregnancy|4|||
162071544|NCT01064401|585318117|FG001|Overall Study|Pregnancy|7|||
162071545|NCT01064401|585318116|FG000|Overall Study|Noncompliance|7|||
162071546|NCT01064401|585318117|FG001|Overall Study|Noncompliance|8|||
162071547|NCT01064401|585318116|FG000|Overall Study|Site Closure|4|||
162071548|NCT01064401|585318117|FG001|Overall Study|Site Closure|5|||
162071549|NCT01064401|585318116|FG000|Overall Study|Other|2|||
162071550|NCT01064401|585318117|FG001|Overall Study|Other|1|||
162071551|NCT03158051|585318118|FG000|Overall Study|Lost to Follow-up|41|||
162071552|NCT03158051|585318119|FG001|Overall Study|Lost to Follow-up|47|||
162071553|NCT03158051|585318118|FG000|Overall Study|Physician Decision|6|||
162071554|NCT03158051|585318119|FG001|Overall Study|Physician Decision|7|||
162071555|NCT03158051|585318118|FG000|Overall Study|Withdrawal by Subject|24|||
162071556|NCT03158051|585318119|FG001|Overall Study|Withdrawal by Subject|15|||
162071557|NCT03158051|585318118|FG000|Overall Study|Death|0|||
162071558|NCT03158051|585318119|FG001|Overall Study|Death|1|||
162071559|NCT02005250|585318120|FG000|Overall Study|Lost to Follow-up|15|||
162071560|NCT02005250|585318121|FG001|Overall Study|Lost to Follow-up|5|||
162071561|NCT02588833|585318122|FG000|Part 1|Withdrawal by Subject|1|||
162071562|NCT02588833|585318123|FG001|Part 1|Withdrawal by Subject|0|||
162071563|NCT02588833|585318122|FG000|Part 2A|Physician Decision|0|||
162071564|NCT02588833|585318123|FG001|Part 2A|Physician Decision|1|||
162071565|NCT02588833|585318122|FG000|Part 2A|Withdrawal by Subject|0|||
162071566|NCT02588833|585318123|FG001|Part 2A|Withdrawal by Subject|1|||
162071567|NCT02588833|585318122|FG000|Part 2B|Adverse Event|0|||
162071568|NCT02588833|585318123|FG001|Part 2B|Adverse Event|1|||
162071569|NCT02588833|585318122|FG000|Part 2C|Adverse Event|0|||
162071570|NCT02588833|585318123|FG001|Part 2C|Adverse Event|1|||
162071571|NCT02588833|585318122|FG000|Part 2C|Withdrawal by Subject|0|||
162071572|NCT02588833|585318123|FG001|Part 2C|Withdrawal by Subject|1|||
162071573|NCT02588833|585318122|FG000|Part 3 (Safety Follow-up)|Other|0|||
162071574|NCT02588833|585318123|FG001|Part 3 (Safety Follow-up)|Other|2|||
162071575|NCT00702403|585320630|FG000|From Consent to Engraftment|Progressive leukemia|6|||
162071576|NCT00702403|585320630|FG000|From Consent to Engraftment|Critically ill|2|||
162071577|NCT00702403|585320630|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
162071578|NCT00702403|585320630|FG000|From Consent to Engraftment|Myocardial infarction|1|||
162071579|NCT00702403|585320630|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
162071580|NCT00702403|585320630|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
162071581|NCT00702403|585320630|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
162071582|NCT00702403|585320630|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
162071583|NCT00702403|585320630|FG000|From Engraftment to Study Completion|Non-compliance|2|||
162071584|NCT00702403|585320630|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
162071585|NCT00702403|585320630|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
162071586|NCT00702403|585320630|FG000|From Engraftment to Study Completion|Suicide|1|||
162071587|NCT00702403|585320630|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
162071588|NCT00702403|585320630|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
162071589|NCT00702403|585320630|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
162071590|NCT00887354|585320638|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
162071591|NCT00887354|585320639|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
162071592|NCT00887354|585320638|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
162071593|NCT00887354|585320639|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
162071594|NCT00887354|585320638|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
162071595|NCT00887354|585320639|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
162071596|NCT00887354|585320638|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
162071597|NCT00887354|585320639|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
162071598|NCT00887354|585320638|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
162071599|NCT00887354|585320639|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
162071600|NCT00887354|585320638|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
162071601|NCT00887354|585320639|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
162071602|NCT00887354|585320638|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
162071603|NCT00887354|585320639|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
162071604|NCT00887354|585320638|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
162071605|NCT00887354|585320639|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
162071606|NCT00887354|585320638|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
162071607|NCT00887354|585320639|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
162071608|NCT00887354|585320638|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
162071609|NCT00887354|585320639|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
162071610|NCT00887354|585320638|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
162071611|NCT00887354|585320639|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
162071612|NCT00887354|585320638|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
162071613|NCT00887354|585320639|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
162071614|NCT00887354|585320638|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
162071615|NCT00887354|585320639|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
162071616|NCT00887354|585320638|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
162071617|NCT00887354|585320639|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
162071618|NCT00887354|585320638|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
162071619|NCT00887354|585320639|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
162071620|NCT00192504|585320642|FG000|Overall Study|Lost to Follow-up|1|||
162071621|NCT00192504|585320643|FG001|Overall Study|Lost to Follow-up|0|||
162071622|NCT00192504|585320644|FG002|Overall Study|Lost to Follow-up|0|||
162071623|NCT00192504|585320645|FG003|Overall Study|Lost to Follow-up|0|||
162071624|NCT00192504|585320642|FG000|Overall Study|Dosing window missed|0|||
162071625|NCT00192504|585320643|FG001|Overall Study|Dosing window missed|0|||
162071626|NCT00192504|585320644|FG002|Overall Study|Dosing window missed|1|||
162071627|NCT00192504|585320645|FG003|Overall Study|Dosing window missed|0|||
162071628|NCT03989440|585320646|FG000|Overall Study|COVID-19 travel restrictions|0|||
162071629|NCT03989440|585320647|FG001|Overall Study|COVID-19 travel restrictions|0|||
162071630|NCT03989440|585320648|FG002|Overall Study|COVID-19 travel restrictions|1|||
162071631|NCT03989440|585320649|FG003|Overall Study|COVID-19 travel restrictions|0|||
162071632|NCT03989440|585320650|FG004|Overall Study|COVID-19 travel restrictions|0|||
162071633|NCT03989440|585320651|FG005|Overall Study|COVID-19 travel restrictions|0|||
162071634|NCT03989440|585320646|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
162071635|NCT03989440|585320647|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
162071636|NCT03989440|585320648|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
162071637|NCT03989440|585320649|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
162071638|NCT03989440|585320650|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
162071639|NCT03989440|585320651|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
162071640|NCT01955161|585320652|FG000|Overall Study|Withdrawal before treatment|2|||
162071641|NCT01955161|585320653|FG001|Overall Study|Withdrawal before treatment|0|||
162071642|NCT01955161|585320654|FG002|Overall Study|Withdrawal before treatment|1|||
162071643|NCT01955161|585320652|FG000|Overall Study|Adverse Event|10|||
162071644|NCT01955161|585320653|FG001|Overall Study|Adverse Event|14|||
162071645|NCT01955161|585320654|FG002|Overall Study|Adverse Event|15|||
162071646|NCT01955161|585320652|FG000|Overall Study|Death|1|||
162071647|NCT01955161|585320653|FG001|Overall Study|Death|1|||
162071648|NCT01955161|585320654|FG002|Overall Study|Death|3|||
162071649|NCT01955161|585320652|FG000|Overall Study|Withdrawal by Subject|9|||
162071650|NCT01955161|585320653|FG001|Overall Study|Withdrawal by Subject|8|||
162071651|NCT01955161|585320654|FG002|Overall Study|Withdrawal by Subject|12|||
162071652|NCT01955161|585320652|FG000|Overall Study|Protocol Violation|2|||
162071653|NCT01955161|585320653|FG001|Overall Study|Protocol Violation|0|||
162071654|NCT01955161|585320654|FG002|Overall Study|Protocol Violation|0|||
162071655|NCT01955161|585320652|FG000|Overall Study|Other reason: physician decision|0|||
162071656|NCT01955161|585320653|FG001|Overall Study|Other reason: physician decision|1|||
162071657|NCT01955161|585320654|FG002|Overall Study|Other reason: physician decision|1|||
162071658|NCT01955161|585320652|FG000|Overall Study|Other reason: disallowed medication|1|||
162071659|NCT01955161|585320653|FG001|Overall Study|Other reason: disallowed medication|0|||
162071660|NCT01955161|585320654|FG002|Overall Study|Other reason: disallowed medication|1|||
162071661|NCT01955161|585320652|FG000|Overall Study|Other reason: caregiver unavailable|1|||
162071662|NCT01955161|585320653|FG001|Overall Study|Other reason: caregiver unavailable|0|||
162071663|NCT01955161|585320654|FG002|Overall Study|Other reason: caregiver unavailable|0|||
162071664|NCT01955161|585320652|FG000|Overall Study|Other reason: moved to nursing home|0|||
162071665|NCT01955161|585320653|FG001|Overall Study|Other reason: moved to nursing home|1|||
162071666|NCT01955161|585320654|FG002|Overall Study|Other reason: moved to nursing home|0|||
162071667|NCT01955161|585320652|FG000|Overall Study|Other reason: insufficient compliance|0|||
162071668|NCT01955161|585320653|FG001|Overall Study|Other reason: insufficient compliance|0|||
162071669|NCT01955161|585320654|FG002|Overall Study|Other reason: insufficient compliance|1|||
162071670|NCT01955161|585320652|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
162071671|NCT01955161|585320653|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
162071672|NCT01955161|585320654|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
162071673|NCT01955161|585320652|FG000|Overall Study|Other reason: patient's will|0|||
162071674|NCT01955161|585320653|FG001|Overall Study|Other reason: patient's will|0|||
162071675|NCT01955161|585320654|FG002|Overall Study|Other reason: patient's will|1|||
162071676|NCT04608500|585320655|FG000|Overall Study|Adverse Event|2|||
162071677|NCT04608500|585320656|FG001|Overall Study|Adverse Event|0|||
162071678|NCT04608500|585320655|FG000|Overall Study|Lost to Follow-up|15|||
162071679|NCT04608500|585320656|FG001|Overall Study|Lost to Follow-up|9|||
162071680|NCT04608500|585320655|FG000|Overall Study|Participant request|11|||
162071681|NCT04608500|585320656|FG001|Overall Study|Participant request|7|||
162071682|NCT04608500|585320655|FG000|Overall Study|Protocol Violation|1|||
162071683|NCT04608500|585320656|FG001|Overall Study|Protocol Violation|0|||
162071684|NCT04608500|585320655|FG000|Overall Study|Other|6|||
162071685|NCT04608500|585320656|FG001|Overall Study|Other|2|||
162071686|NCT00542919|585320657|FG000|Overall Study|Adverse Event|1|||
162071687|NCT00542919|585320658|FG001|Overall Study|Adverse Event|5|||
162071688|NCT00542919|585320659|FG002|Overall Study|Adverse Event|1|||
162071689|NCT00542919|585320657|FG000|Overall Study|Withdrawal by Subject|1|||
162071690|NCT00542919|585320658|FG001|Overall Study|Withdrawal by Subject|0|||
162071691|NCT00542919|585320659|FG002|Overall Study|Withdrawal by Subject|3|||
162071692|NCT00542919|585320657|FG000|Overall Study|Physician Decision|2|||
162071693|NCT00542919|585320658|FG001|Overall Study|Physician Decision|2|||
162071694|NCT00542919|585320659|FG002|Overall Study|Physician Decision|1|||
162071695|NCT00542919|585320657|FG000|Overall Study|Sponsor Decision|1|||
162071696|NCT00542919|585320658|FG001|Overall Study|Sponsor Decision|0|||
162071697|NCT00542919|585320659|FG002|Overall Study|Sponsor Decision|0|||
162071698|NCT00542919|585320657|FG000|Overall Study|Lost to Follow-up|2|||
162071699|NCT00542919|585320658|FG001|Overall Study|Lost to Follow-up|0|||
162071700|NCT00542919|585320659|FG002|Overall Study|Lost to Follow-up|1|||
162071701|NCT05123222|585320666|FG000|Overall Study|Lost to Follow-up|2|||
162071702|NCT05123222|585320667|FG001|Overall Study|Lost to Follow-up|0|||
162071703|NCT05123222|585320668|FG002|Overall Study|Lost to Follow-up|0|||
162071704|NCT05123222|585320669|FG003|Overall Study|Lost to Follow-up|0|||
162071705|NCT05123222|585320666|FG000|Overall Study|Protocol Violation|0|||
162071706|NCT05123222|585320667|FG001|Overall Study|Protocol Violation|0|||
162071707|NCT05123222|585320668|FG002|Overall Study|Protocol Violation|1|||
162071708|NCT05123222|585320669|FG003|Overall Study|Protocol Violation|0|||
162071709|NCT02535741|585320670|FG000|Overall Study|Adverse Event|3|||
162071710|NCT02535741|585320670|FG000|Overall Study|Withdrawal by Subject|9|||
162071711|NCT02535741|585320670|FG000|Overall Study|Lost to Follow-up|10|||
162071712|NCT02535741|585320670|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
162071713|NCT02535741|585320670|FG000|Overall Study|Missing data|6|||
162071714|NCT03020823|585320673|FG000|Overall Study|Physician Decision|4|||
162071715|NCT03020823|585320673|FG000|Overall Study|Lack of Efficacy|4|||
162071716|NCT03020823|585320673|FG000|Overall Study|Adverse Event|2|||
162071717|NCT03739112|585320674|FG000|Overall Study|Adverse Event|2|||
162071718|NCT03739112|585320675|FG001|Overall Study|Adverse Event|2|||
162071719|NCT03739112|585320674|FG000|Overall Study|Withdrawal by Subject|38|||
162071720|NCT03739112|585320675|FG001|Overall Study|Withdrawal by Subject|19|||
162071721|NCT03739112|585320674|FG000|Overall Study|Lost to Follow-up|31|||
162071722|NCT03739112|585320675|FG001|Overall Study|Lost to Follow-up|33|||
162071723|NCT03739112|585320674|FG000|Overall Study|Protocol Deviation|12|||
162071724|NCT03739112|585320675|FG001|Overall Study|Protocol Deviation|9|||
162071725|NCT03739112|585320674|FG000|Overall Study|Physician Decision|1|||
162071726|NCT03739112|585320675|FG001|Overall Study|Physician Decision|0|||
162071727|NCT03739112|585320674|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
162071728|NCT03739112|585320675|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
162071729|NCT03739112|585320674|FG000|Overall Study|Site went on hold|65|||
162071730|NCT03739112|585320675|FG001|Overall Study|Site went on hold|67|||
162071731|NCT03739112|585320674|FG000|Overall Study|Other than specified|8|||
162071732|NCT03739112|585320675|FG001|Overall Study|Other than specified|5|||
162071733|NCT03739112|585320674|FG000|Overall Study|Randomized but not vaccinated|31|||
162071734|NCT03739112|585320675|FG001|Overall Study|Randomized but not vaccinated|25|||
162071735|NCT00588822|585320677|FG000|Overall Study|progression of disease|8|||
162071736|NCT01727141|585320679|FG000|Overall Study|Physician Decision|0|||
162071737|NCT01727141|585320680|FG001|Overall Study|Physician Decision|1|||
162071738|NCT01727141|585320681|FG002|Overall Study|Physician Decision|0|||
162071739|NCT01727141|585320682|FG003|Overall Study|Physician Decision|2|||
162071740|NCT01727141|585320679|FG000|Overall Study|Lost to Follow-up|0|||
162071741|NCT01727141|585320680|FG001|Overall Study|Lost to Follow-up|2|||
162071742|NCT01727141|585320681|FG002|Overall Study|Lost to Follow-up|0|||
162071743|NCT01727141|585320682|FG003|Overall Study|Lost to Follow-up|0|||
162071744|NCT01727141|585320679|FG000|Overall Study|Death|0|||
162071745|NCT01727141|585320680|FG001|Overall Study|Death|1|||
162071746|NCT01727141|585320681|FG002|Overall Study|Death|1|||
162071747|NCT01727141|585320682|FG003|Overall Study|Death|1|||
162071748|NCT01727141|585320679|FG000|Overall Study|Protocol deviation|1|||
162071749|NCT01727141|585320680|FG001|Overall Study|Protocol deviation|1|||
162071750|NCT01727141|585320681|FG002|Overall Study|Protocol deviation|0|||
162071751|NCT01727141|585320682|FG003|Overall Study|Protocol deviation|1|||
162071752|NCT01727141|585320679|FG000|Overall Study|Withdrawal by Subject|4|||
162071753|NCT01727141|585320680|FG001|Overall Study|Withdrawal by Subject|4|||
162071754|NCT01727141|585320681|FG002|Overall Study|Withdrawal by Subject|2|||
162071755|NCT01727141|585320682|FG003|Overall Study|Withdrawal by Subject|11|||
162071756|NCT02529137|585320685|FG000|Overall Study|Discontinuation for different reasons|8|||
162071757|NCT02731729|585320688|FG000|Overall Study|Death|2|||
162071758|NCT02731729|585320689|FG001|Overall Study|Death|2|||
162071759|NCT02731729|585320688|FG000|Overall Study|Study terminated by Sponsor|6|||
162071760|NCT02731729|585320689|FG001|Overall Study|Study terminated by Sponsor|6|||
162071761|NCT02731729|585320688|FG000|Overall Study|Withdrawal by Subject|1|||
162071762|NCT02731729|585320689|FG001|Overall Study|Withdrawal by Subject|0|||
162071763|NCT01344447|585320690|FG000|Overall Study|Adverse Event|1|||
162071764|NCT01344447|585320690|FG000|Overall Study|Protocol Violation|1|||
162071765|NCT01344447|585320690|FG000|Overall Study|Withdrawal by Subject|1|||
162071766|NCT01344447|585320690|FG000|Overall Study|The contrast was not seen|1|||
162071767|NCT01344447|585320690|FG000|Overall Study|Physician Decision|1|||
162071768|NCT01344447|585320690|FG000|Overall Study|MRA unsuccessful|1|||
162071769|NCT01344447|585320690|FG000|Overall Study|Bolus tracking failed|1|||
162071770|NCT01344447|585320690|FG000|Overall Study|Error of power injector|1|||
162071771|NCT01660711|585320691|FG000|Overall Study|Adverse Event|7|||
162071772|NCT01660711|585320691|FG000|Overall Study|Withdrawal by Subject|1|||
162071773|NCT00581776|585320695|FG000|Overall Study|Disease progression or no response|3|||
162071774|NCT02357901|585320696|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
162071775|NCT02357901|585320697|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
162071776|NCT02357901|585320698|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
162071777|NCT02357901|585320699|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
162071778|NCT02357901|585320696|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
162071779|NCT02357901|585320697|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
162071780|NCT02357901|585320698|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
162071781|NCT02357901|585320699|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
162071782|NCT02357901|585320696|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
162071783|NCT02357901|585320697|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
162071784|NCT02357901|585320698|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
162071785|NCT02357901|585320699|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
162071786|NCT02357901|585320696|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
162071787|NCT02357901|585320697|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
162071788|NCT02357901|585320698|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
162071789|NCT02357901|585320699|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
162071790|NCT02357901|585320696|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
162071791|NCT02357901|585320697|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
162071792|NCT02357901|585320698|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
162071793|NCT02357901|585320699|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
162071794|NCT02357901|585320696|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
162071795|NCT02357901|585320697|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
162071796|NCT02357901|585320698|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
162071797|NCT02357901|585320699|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
162071798|NCT02357901|585320696|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
162071799|NCT02357901|585320697|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
162071800|NCT02357901|585320698|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
162071801|NCT02357901|585320699|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
162071802|NCT02357901|585320696|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
162071803|NCT02357901|585320697|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
162071804|NCT02357901|585320698|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
162071805|NCT02357901|585320699|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
162071806|NCT02357901|585320696|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
162071807|NCT02357901|585320697|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
162071808|NCT02357901|585320698|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
162071809|NCT02357901|585320699|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
162071810|NCT02357901|585320696|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
162071811|NCT02357901|585320697|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
162071812|NCT02357901|585320698|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
162071813|NCT02357901|585320699|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
162071814|NCT02357901|585320696|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
162071815|NCT02357901|585320697|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
162071816|NCT02357901|585320698|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
162071817|NCT02357901|585320699|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
162071818|NCT02759120|585320702|FG000|Overall Study|Death|34|||
162071819|NCT02759120|585320703|FG001|Overall Study|Death|36|||
162071820|NCT02759120|585320702|FG000|Overall Study|Lost to Follow-up|4|||
162071821|NCT02759120|585320703|FG001|Overall Study|Lost to Follow-up|7|||
162071822|NCT02759120|585320702|FG000|Overall Study|Physician Decision|3|||
162071823|NCT02759120|585320703|FG001|Overall Study|Physician Decision|0|||
162071824|NCT02759120|585320702|FG000|Overall Study|Withdrawal by Subject|28|||
162071825|NCT02759120|585320703|FG001|Overall Study|Withdrawal by Subject|15|||
162071826|NCT02759120|585320702|FG000|Overall Study|Moved out of area|3|||
162071827|NCT02759120|585320703|FG001|Overall Study|Moved out of area|4|||
162071828|NCT02759120|585320702|FG000|Overall Study|Lung transplant|3|||
162071829|NCT02759120|585320703|FG001|Overall Study|Lung transplant|5|||
162071830|NCT02759120|585320702|FG000|Overall Study|Other reason not completed|10|||
162071831|NCT02759120|585320703|FG001|Overall Study|Other reason not completed|12|||
162071832|NCT04461015|585320707|FG000|Overall Study|IV access lost during the study|0|||
162071833|NCT04461015|585320708|FG001|Overall Study|IV access lost during the study|1|||
162071834|NCT04461015|585320707|FG000|Overall Study|Withdrawal by Subject|0|||
162071835|NCT04461015|585320708|FG001|Overall Study|Withdrawal by Subject|1|||
162071836|NCT02063854|585320716|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
162071837|NCT02063854|585320717|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
162071838|NCT02063854|585320718|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
162071839|NCT02063854|585320719|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
162071840|NCT02063854|585320720|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
162071841|NCT02063854|585320721|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
162071842|NCT02063854|585320722|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
162071843|NCT02063854|585320716|FG000|Overall Study|Major Protocol Deviation|0|||
162071844|NCT02063854|585320717|FG001|Overall Study|Major Protocol Deviation|0|||
162071845|NCT02063854|585320718|FG002|Overall Study|Major Protocol Deviation|3|||
162071846|NCT02063854|585320719|FG003|Overall Study|Major Protocol Deviation|0|||
162071847|NCT02063854|585320720|FG004|Overall Study|Major Protocol Deviation|0|||
162071848|NCT02063854|585320721|FG005|Overall Study|Major Protocol Deviation|0|||
162071849|NCT02063854|585320722|FG006|Overall Study|Major Protocol Deviation|0|||
162071850|NCT02063854|585320716|FG000|Overall Study|Voluntary Withdrawal|2|||
162071851|NCT02063854|585320717|FG001|Overall Study|Voluntary Withdrawal|0|||
162071852|NCT02063854|585320718|FG002|Overall Study|Voluntary Withdrawal|8|||
162071853|NCT02063854|585320719|FG003|Overall Study|Voluntary Withdrawal|1|||
162071854|NCT02063854|585320720|FG004|Overall Study|Voluntary Withdrawal|3|||
162071855|NCT02063854|585320721|FG005|Overall Study|Voluntary Withdrawal|6|||
162071856|NCT02063854|585320722|FG006|Overall Study|Voluntary Withdrawal|1|||
162071857|NCT02063854|585320716|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
162071858|NCT02063854|585320717|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
162071859|NCT02063854|585320718|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
162071860|NCT02063854|585320719|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
162071861|NCT02063854|585320720|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
162071862|NCT02063854|585320721|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
162071863|NCT02063854|585320722|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
162071864|NCT02063854|585320716|FG000|Overall Study|Reason Not Specified|1|||
162071865|NCT02063854|585320717|FG001|Overall Study|Reason Not Specified|0|||
162071866|NCT02063854|585320718|FG002|Overall Study|Reason Not Specified|0|||
162071867|NCT02063854|585320719|FG003|Overall Study|Reason Not Specified|0|||
162071868|NCT02063854|585320720|FG004|Overall Study|Reason Not Specified|0|||
162071869|NCT02063854|585320721|FG005|Overall Study|Reason Not Specified|0|||
162071870|NCT02063854|585320722|FG006|Overall Study|Reason Not Specified|0|||
162071871|NCT02063854|585320716|FG000|Overall Study|Did Not Receive Study Drug|0|||
162071872|NCT02063854|585320717|FG001|Overall Study|Did Not Receive Study Drug|0|||
162071873|NCT02063854|585320718|FG002|Overall Study|Did Not Receive Study Drug|0|||
162071874|NCT02063854|585320719|FG003|Overall Study|Did Not Receive Study Drug|0|||
162071875|NCT02063854|585320720|FG004|Overall Study|Did Not Receive Study Drug|0|||
162071876|NCT02063854|585320721|FG005|Overall Study|Did Not Receive Study Drug|1|||
162071877|NCT02063854|585320722|FG006|Overall Study|Did Not Receive Study Drug|0|||
162071878|NCT01413360|585320727|FG000|Overall Study|Lost to Follow-up|2|||
162071879|NCT01413360|585320727|FG000|Overall Study|Adverse Event|1|||
162071880|NCT02246673|585320731|FG000|Overall Study|Sponsor Decision|1|||
162071881|NCT02246673|585320732|FG001|Overall Study|Sponsor Decision|0|||
162071882|NCT02246673|585320733|FG002|Overall Study|Sponsor Decision|0|||
162071883|NCT02246673|585320734|FG003|Overall Study|Sponsor Decision|0|||
162071884|NCT02246673|585320735|FG004|Overall Study|Sponsor Decision|0|||
162071885|NCT02246673|585320731|FG000|Overall Study|Withdrawal by Subject|0|||
162071886|NCT02246673|585320732|FG001|Overall Study|Withdrawal by Subject|0|||
162071887|NCT02246673|585320733|FG002|Overall Study|Withdrawal by Subject|0|||
162071888|NCT02246673|585320734|FG003|Overall Study|Withdrawal by Subject|0|||
162071889|NCT02246673|585320735|FG004|Overall Study|Withdrawal by Subject|1|||
162071890|NCT02246673|585320731|FG000|Overall Study|Lost to Follow-up|0|||
162071891|NCT02246673|585320732|FG001|Overall Study|Lost to Follow-up|0|||
162071892|NCT02246673|585320733|FG002|Overall Study|Lost to Follow-up|0|||
162071893|NCT02246673|585320734|FG003|Overall Study|Lost to Follow-up|1|||
162071894|NCT02246673|585320735|FG004|Overall Study|Lost to Follow-up|0|||
162071895|NCT02246673|585320731|FG000|Overall Study|Protocol Violation|0|||
162071896|NCT02246673|585320732|FG001|Overall Study|Protocol Violation|0|||
162071897|NCT02246673|585320733|FG002|Overall Study|Protocol Violation|0|||
162071898|NCT02246673|585320734|FG003|Overall Study|Protocol Violation|1|||
162071899|NCT02246673|585320735|FG004|Overall Study|Protocol Violation|0|||
162071900|NCT05413369|585320736|FG000|Overall Study|Adverse Event|1|||
162071901|NCT05413369|585320737|FG001|Overall Study|Adverse Event|1|||
162071902|NCT05413369|585320736|FG000|Overall Study|Withdrawal by Subject|13|||
162071903|NCT05413369|585320737|FG001|Overall Study|Withdrawal by Subject|4|||
162071904|NCT05413369|585320736|FG000|Overall Study|Non-compliance with study schedule|2|||
162071905|NCT05413369|585320737|FG001|Overall Study|Non-compliance with study schedule|1|||
162071906|NCT05413369|585320736|FG000|Overall Study|Other|1|||
162071907|NCT05413369|585320737|FG001|Overall Study|Other|1|||
162071908|NCT04519645|585320742|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
162071909|NCT04519645|585320743|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
162071910|NCT04519645|585320744|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
162071911|NCT04519645|585320742|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
162071912|NCT04519645|585320743|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
162071913|NCT04519645|585320744|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
162071914|NCT04519645|585320742|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
162071915|NCT04519645|585320743|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
162071916|NCT04519645|585320744|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
162071917|NCT04519645|585320742|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
162071918|NCT04519645|585320743|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
162071919|NCT04519645|585320744|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
162071920|NCT01679002|585320745|FG000|Overall Study|Adverse Event|1|||
162071921|NCT01679002|585320746|FG001|Overall Study|Adverse Event|1|||
162071922|NCT01679002|585320747|FG002|Overall Study|Adverse Event|0|||
162071923|NCT00730912|585320750|FG000|Overall Study|Discontinued|0|||
162071924|NCT00730912|585320751|FG001|Overall Study|Discontinued|0|||
162071925|NCT00730912|585320752|FG002|Overall Study|Discontinued|1|||
162071926|NCT02205333|585320756|FG000|Overall Study|Death|5|||
162071927|NCT02205333|585320757|FG001|Overall Study|Death|6|||
162071928|NCT02205333|585320758|FG002|Overall Study|Death|2|||
162071929|NCT02205333|585320759|FG003|Overall Study|Death|6|||
162071930|NCT02205333|585320760|FG004|Overall Study|Death|5|||
162071931|NCT02205333|585320761|FG005|Overall Study|Death|3|||
162071932|NCT02205333|585320762|FG006|Overall Study|Death|3|||
162071933|NCT02205333|585320763|FG007|Overall Study|Death|2|||
162071934|NCT02205333|585320764|FG008|Overall Study|Death|0|||
162071935|NCT02205333|585320756|FG000|Overall Study|Withdrawal by Subject|1|||
162071936|NCT02205333|585320757|FG001|Overall Study|Withdrawal by Subject|0|||
162071937|NCT02205333|585320758|FG002|Overall Study|Withdrawal by Subject|0|||
162071938|NCT02205333|585320759|FG003|Overall Study|Withdrawal by Subject|1|||
162071939|NCT02205333|585320760|FG004|Overall Study|Withdrawal by Subject|0|||
162071940|NCT02205333|585320761|FG005|Overall Study|Withdrawal by Subject|0|||
162071941|NCT02205333|585320762|FG006|Overall Study|Withdrawal by Subject|2|||
162071942|NCT02205333|585320763|FG007|Overall Study|Withdrawal by Subject|0|||
162071943|NCT02205333|585320764|FG008|Overall Study|Withdrawal by Subject|0|||
162071944|NCT01176266|585320765|FG000|Overall Study|Death|6|||
162071945|NCT01176266|585320765|FG000|Overall Study|Withdrawal by Subject|3|||
162071946|NCT01179477|585320766|FG000|Overall Study|Death|542|||
162071947|NCT01179477|585320766|FG000|Overall Study|Unsuccessful implant|80|||
162071948|NCT01179477|585320766|FG000|Overall Study|Non-death withdrawal|438|||
162071949|NCT01179477|585320766|FG000|Overall Study|Did not complete final visit|27|||
162071950|NCT03755414|585320768|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
162071951|NCT03755414|585320769|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
162071952|NCT03755414|585320770|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
162071953|NCT03755414|585320768|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
162071954|NCT03755414|585320769|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
162071955|NCT03755414|585320770|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
162071956|NCT03755414|585320768|FG000|Overall Study|Non-compliance|0|||
162071957|NCT03755414|585320769|FG001|Overall Study|Non-compliance|1|||
162071958|NCT03755414|585320770|FG002|Overall Study|Non-compliance|0|||
162071959|NCT02153112|585320771|FG000|Overall Study|Adverse Event|0|||
162071960|NCT02153112|585320772|FG001|Overall Study|Adverse Event|0|||
162071961|NCT02153112|585320773|FG002|Overall Study|Adverse Event|1|||
162071962|NCT02153112|585320774|FG003|Overall Study|Adverse Event|0|||
162071963|NCT02153112|585320775|FG004|Overall Study|Adverse Event|0|||
162071964|NCT02153112|585320776|FG005|Overall Study|Adverse Event|0|||
162071965|NCT02153112|585320777|FG006|Overall Study|Adverse Event|0|||
162071966|NCT02153112|585320778|FG007|Overall Study|Adverse Event|0|||
162071967|NCT02153112|585320779|FG008|Overall Study|Adverse Event|0|||
162071968|NCT02153112|585320780|FG009|Overall Study|Adverse Event|0|||
162071969|NCT02153112|585320771|FG000|Overall Study|Lost to Follow-up|1|||
162071970|NCT02153112|585320772|FG001|Overall Study|Lost to Follow-up|1|||
162071971|NCT02153112|585320773|FG002|Overall Study|Lost to Follow-up|0|||
162071972|NCT02153112|585320774|FG003|Overall Study|Lost to Follow-up|0|||
162071973|NCT02153112|585320775|FG004|Overall Study|Lost to Follow-up|2|||
162071974|NCT02153112|585320776|FG005|Overall Study|Lost to Follow-up|1|||
162071975|NCT02153112|585320777|FG006|Overall Study|Lost to Follow-up|1|||
162071976|NCT02153112|585320778|FG007|Overall Study|Lost to Follow-up|0|||
162071977|NCT02153112|585320779|FG008|Overall Study|Lost to Follow-up|1|||
162071978|NCT02153112|585320780|FG009|Overall Study|Lost to Follow-up|1|||
162071979|NCT02153112|585320771|FG000|Overall Study|Withdrawal by Subject|3|||
162071980|NCT02153112|585320772|FG001|Overall Study|Withdrawal by Subject|1|||
162071981|NCT02153112|585320773|FG002|Overall Study|Withdrawal by Subject|2|||
162071982|NCT02153112|585320774|FG003|Overall Study|Withdrawal by Subject|2|||
162071983|NCT02153112|585320775|FG004|Overall Study|Withdrawal by Subject|1|||
162071984|NCT02153112|585320776|FG005|Overall Study|Withdrawal by Subject|1|||
162071985|NCT02153112|585320777|FG006|Overall Study|Withdrawal by Subject|7|||
162071986|NCT02153112|585320778|FG007|Overall Study|Withdrawal by Subject|2|||
162071987|NCT02153112|585320779|FG008|Overall Study|Withdrawal by Subject|13|||
162071988|NCT02153112|585320780|FG009|Overall Study|Withdrawal by Subject|12|||
162071989|NCT02153112|585320771|FG000|Overall Study|Reason not Specified|0|||
162071990|NCT02153112|585320772|FG001|Overall Study|Reason not Specified|0|||
162071991|NCT02153112|585320773|FG002|Overall Study|Reason not Specified|0|||
162071992|NCT02153112|585320774|FG003|Overall Study|Reason not Specified|0|||
162071993|NCT02153112|585320775|FG004|Overall Study|Reason not Specified|0|||
162071994|NCT02153112|585320776|FG005|Overall Study|Reason not Specified|0|||
162071995|NCT02153112|585320777|FG006|Overall Study|Reason not Specified|0|||
162071996|NCT02153112|585320778|FG007|Overall Study|Reason not Specified|0|||
162071997|NCT02153112|585320779|FG008|Overall Study|Reason not Specified|1|||
162071998|NCT02153112|585320780|FG009|Overall Study|Reason not Specified|1|||
162071999|NCT00455429|585320781|FG000|Overall Study|Study Terminated by Sponsor|0|||
162072000|NCT00455429|585320782|FG001|Overall Study|Study Terminated by Sponsor|0|||
162072001|NCT00455429|585320783|FG002|Overall Study|Study Terminated by Sponsor|0|||
162072002|NCT00455429|585320784|FG003|Overall Study|Study Terminated by Sponsor|3|||
162072003|NCT00455429|585320781|FG000|Overall Study|Lost to Follow-up|1|||
162072004|NCT00455429|585320782|FG001|Overall Study|Lost to Follow-up|0|||
162072005|NCT00455429|585320783|FG002|Overall Study|Lost to Follow-up|0|||
162072006|NCT00455429|585320784|FG003|Overall Study|Lost to Follow-up|3|||
162072007|NCT00455429|585320781|FG000|Overall Study|Withdrawal by Subject|0|||
162072008|NCT00455429|585320782|FG001|Overall Study|Withdrawal by Subject|1|||
162072009|NCT00455429|585320783|FG002|Overall Study|Withdrawal by Subject|1|||
162072010|NCT00455429|585320784|FG003|Overall Study|Withdrawal by Subject|0|||
162072011|NCT00455429|585320781|FG000|Overall Study|Lack of Efficacy|0|||
162072012|NCT00455429|585320782|FG001|Overall Study|Lack of Efficacy|1|||
162072013|NCT00455429|585320783|FG002|Overall Study|Lack of Efficacy|0|||
162072014|NCT00455429|585320784|FG003|Overall Study|Lack of Efficacy|1|||
162072015|NCT00455429|585320781|FG000|Overall Study|Adverse Event|0|||
162072016|NCT00455429|585320782|FG001|Overall Study|Adverse Event|1|||
162072017|NCT00455429|585320783|FG002|Overall Study|Adverse Event|0|||
162072018|NCT00455429|585320784|FG003|Overall Study|Adverse Event|3|||
162072019|NCT00455429|585320781|FG000|Overall Study|Randomly assigned but not treated|0|||
162072020|NCT00455429|585320782|FG001|Overall Study|Randomly assigned but not treated|0|||
162072021|NCT00455429|585320783|FG002|Overall Study|Randomly assigned but not treated|0|||
162072022|NCT00455429|585320784|FG003|Overall Study|Randomly assigned but not treated|2|||
162072023|NCT00455429|585320781|FG000|Overall Study|Personal Reason|1|||
162072024|NCT00455429|585320782|FG001|Overall Study|Personal Reason|0|||
162072025|NCT00455429|585320783|FG002|Overall Study|Personal Reason|0|||
162072026|NCT00455429|585320784|FG003|Overall Study|Personal Reason|0|||
162072027|NCT00455429|585320781|FG000|Overall Study|Non-compliance|0|||
162072028|NCT00455429|585320782|FG001|Overall Study|Non-compliance|0|||
162072029|NCT00455429|585320783|FG002|Overall Study|Non-compliance|0|||
162072030|NCT00455429|585320784|FG003|Overall Study|Non-compliance|1|||
162072031|NCT00455429|585320781|FG000|Overall Study|Other|0|||
162072032|NCT00455429|585320782|FG001|Overall Study|Other|2|||
162072033|NCT00455429|585320783|FG002|Overall Study|Other|0|||
162072034|NCT00455429|585320784|FG003|Overall Study|Other|1|||
162072035|NCT04351087|585320785|FG000|Overall Study|Lost to Follow-up|7|||
162072036|NCT04351087|585320786|FG001|Overall Study|Lost to Follow-up|3|||
162072037|NCT04351087|585320785|FG000|Overall Study|Withdrawal by Subject|3|||
162072038|NCT04351087|585320786|FG001|Overall Study|Withdrawal by Subject|4|||
162072039|NCT04351087|585320785|FG000|Overall Study|Lack of Efficacy|3|||
162072040|NCT04351087|585320786|FG001|Overall Study|Lack of Efficacy|2|||
162072041|NCT03519347|585320787|FG000|Interventional Crossover Period 1|Death|0|||
162072042|NCT03519347|585320788|FG001|Interventional Crossover Period 1|Death|0|||
162072043|NCT03519347|585320789|FG002|Interventional Crossover Period 1|Death|0|||
162072044|NCT03519347|585320790|FG003|Interventional Crossover Period 1|Death|1|||
162072045|NCT01412021|585320791|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
162072046|NCT01412021|585320791|FG000|Overall Study|Treatment Prior to Approval|3|||
162072047|NCT01412021|585320791|FG000|Overall Study|Transferred to Other Hospital|9|||
162072048|NCT00484939|585320794|FG000|Overall Study|Death|9|||
162072049|NCT00484939|585320795|FG001|Overall Study|Death|13|||
162072050|NCT00484939|585320794|FG000|Overall Study|Adverse Event|22|||
162072051|NCT00484939|585320795|FG001|Overall Study|Adverse Event|12|||
162072052|NCT00484939|585320794|FG000|Overall Study|Patient Withdrew Consent|19|||
162072053|NCT00484939|585320795|FG001|Overall Study|Patient Withdrew Consent|10|||
162072054|NCT00484939|585320794|FG000|Overall Study|Protocol Violation|3|||
162072055|NCT00484939|585320795|FG001|Overall Study|Protocol Violation|3|||
162072056|NCT00484939|585320794|FG000|Overall Study|Lost to Follow-up|0|||
162072057|NCT00484939|585320795|FG001|Overall Study|Lost to Follow-up|3|||
162072058|NCT00484939|585320794|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
162072059|NCT00484939|585320795|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
162072060|NCT00484939|585320794|FG000|Overall Study|Disease progression|67|||
162072061|NCT00484939|585320795|FG001|Overall Study|Disease progression|88|||
162072062|NCT00484939|585320794|FG000|Overall Study|Screen Failure|2|||
162072063|NCT00484939|585320795|FG001|Overall Study|Screen Failure|2|||
162072064|NCT00484939|585320794|FG000|Overall Study|Reason Not Specified|11|||
162072065|NCT00484939|585320795|FG001|Overall Study|Reason Not Specified|6|||
162072066|NCT01522365|585320796|FG000|Overall Study|Withdrawal by Subject|1|||
162072067|NCT01522365|585320797|FG001|Overall Study|Withdrawal by Subject|1|||
162072068|NCT01522365|585320796|FG000|Overall Study|Lost to Follow-up|1|||
162072069|NCT01522365|585320797|FG001|Overall Study|Lost to Follow-up|1|||
162072070|NCT02466555|585320800|FG000|Overall Study|Lost to Follow-up|2|||
162072071|NCT01120756|585320801|FG000|Overall Study|Withdrawal by Subject|1|||
162072072|NCT01120756|585320802|FG001|Overall Study|Withdrawal by Subject|1|||
162072073|NCT00698581|585320803|FG000|Overall Study|Lack of Efficacy|23|||
162072074|NCT00698581|585320804|FG001|Overall Study|Lack of Efficacy|11|||
162072075|NCT00698581|585320803|FG000|Overall Study|Withdrawal by Subject|6|||
162072076|NCT00698581|585320804|FG001|Overall Study|Withdrawal by Subject|0|||
162072077|NCT00698581|585320803|FG000|Overall Study|Other reason|9|||
162072078|NCT00698581|585320804|FG001|Overall Study|Other reason|1|||
162072079|NCT00698581|585320803|FG000|Overall Study|SAE, non-fatal|1|||
162072080|NCT00698581|585320804|FG001|Overall Study|SAE, non-fatal|0|||
162072081|NCT00698581|585320803|FG000|Overall Study|AE, non-serious non-fatal|4|||
162072082|NCT00698581|585320804|FG001|Overall Study|AE, non-serious non-fatal|0|||
162072083|NCT00698581|585320803|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162072084|NCT00698581|585320804|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
162072085|NCT00698581|585320803|FG000|Overall Study|AE of unknown type|1|||
162072086|NCT00698581|585320804|FG001|Overall Study|AE of unknown type|0|||
162072087|NCT03760146|585320805|FG000|Overall Study|Adverse Event|11|||
162072088|NCT03760146|585320806|FG001|Overall Study|Adverse Event|8|||
162072089|NCT03760146|585320807|FG002|Overall Study|Adverse Event|0|||
162072090|NCT03760146|585320808|FG003|Overall Study|Adverse Event|0|||
162072091|NCT03760146|585320809|FG004|Overall Study|Adverse Event|0|||
162072092|NCT03760146|585320810|FG005|Overall Study|Adverse Event|0|||
162072093|NCT03760146|585320805|FG000|Overall Study|Death|1|||
162072094|NCT03760146|585320806|FG001|Overall Study|Death|0|||
162072095|NCT03760146|585320807|FG002|Overall Study|Death|0|||
162072096|NCT03760146|585320808|FG003|Overall Study|Death|0|||
162072097|NCT03760146|585320809|FG004|Overall Study|Death|0|||
162072098|NCT03760146|585320810|FG005|Overall Study|Death|0|||
162072099|NCT03760146|585320805|FG000|Overall Study|Lost to Follow-up|41|||
162072100|NCT03760146|585320806|FG001|Overall Study|Lost to Follow-up|28|||
162072101|NCT03760146|585320807|FG002|Overall Study|Lost to Follow-up|9|||
162072102|NCT03760146|585320808|FG003|Overall Study|Lost to Follow-up|2|||
162072103|NCT03760146|585320809|FG004|Overall Study|Lost to Follow-up|14|||
162072104|NCT03760146|585320810|FG005|Overall Study|Lost to Follow-up|8|||
162072105|NCT03760146|585320805|FG000|Overall Study|No longer met eligibility criteria|3|||
162072106|NCT03760146|585320806|FG001|Overall Study|No longer met eligibility criteria|9|||
162072107|NCT03760146|585320807|FG002|Overall Study|No longer met eligibility criteria|0|||
162072108|NCT03760146|585320808|FG003|Overall Study|No longer met eligibility criteria|0|||
162072109|NCT03760146|585320809|FG004|Overall Study|No longer met eligibility criteria|1|||
162072110|NCT03760146|585320810|FG005|Overall Study|No longer met eligibility criteria|0|||
162072111|NCT03760146|585320805|FG000|Overall Study|Protocol Violation|21|||
162072112|NCT03760146|585320806|FG001|Overall Study|Protocol Violation|13|||
162072113|NCT03760146|585320807|FG002|Overall Study|Protocol Violation|1|||
162072114|NCT03760146|585320808|FG003|Overall Study|Protocol Violation|0|||
162072115|NCT03760146|585320809|FG004|Overall Study|Protocol Violation|1|||
162072116|NCT03760146|585320810|FG005|Overall Study|Protocol Violation|0|||
162072117|NCT03760146|585320805|FG000|Overall Study|Withdrawal by Subject|19|||
162072118|NCT03760146|585320806|FG001|Overall Study|Withdrawal by Subject|20|||
162072119|NCT03760146|585320807|FG002|Overall Study|Withdrawal by Subject|1|||
162072120|NCT03760146|585320808|FG003|Overall Study|Withdrawal by Subject|0|||
162072121|NCT03760146|585320809|FG004|Overall Study|Withdrawal by Subject|1|||
162072122|NCT03760146|585320810|FG005|Overall Study|Withdrawal by Subject|0|||
162072123|NCT00449644|585320811|FG000|Overall Study|Adverse Event|0|||
162072124|NCT00449644|585320812|FG001|Overall Study|Adverse Event|0|||
162072125|NCT00449644|585320813|FG002|Overall Study|Adverse Event|3|||
162072126|NCT00449644|585320814|FG003|Overall Study|Adverse Event|5|||
162072127|NCT00449644|585320811|FG000|Overall Study|Death|1|||
162072128|NCT00449644|585320812|FG001|Overall Study|Death|0|||
162072129|NCT00449644|585320813|FG002|Overall Study|Death|6|||
162072130|NCT00449644|585320814|FG003|Overall Study|Death|1|||
162072131|NCT00449644|585320811|FG000|Overall Study|Lost to Follow-up|1|||
162072132|NCT00449644|585320812|FG001|Overall Study|Lost to Follow-up|1|||
162072133|NCT00449644|585320813|FG002|Overall Study|Lost to Follow-up|5|||
162072134|NCT00449644|585320814|FG003|Overall Study|Lost to Follow-up|3|||
162072135|NCT00449644|585320811|FG000|Overall Study|Pregnancy|0|||
162072136|NCT00449644|585320812|FG001|Overall Study|Pregnancy|0|||
162072137|NCT00449644|585320813|FG002|Overall Study|Pregnancy|3|||
162072138|NCT00449644|585320814|FG003|Overall Study|Pregnancy|2|||
162072139|NCT00449644|585320811|FG000|Overall Study|Protocol Violation|4|||
162072140|NCT00449644|585320812|FG001|Overall Study|Protocol Violation|4|||
162072141|NCT00449644|585320813|FG002|Overall Study|Protocol Violation|3|||
162072142|NCT00449644|585320814|FG003|Overall Study|Protocol Violation|7|||
162072143|NCT00449644|585320811|FG000|Overall Study|Withdrawal by Subject|3|||
162072144|NCT00449644|585320812|FG001|Overall Study|Withdrawal by Subject|4|||
162072145|NCT00449644|585320813|FG002|Overall Study|Withdrawal by Subject|6|||
162072146|NCT00449644|585320814|FG003|Overall Study|Withdrawal by Subject|7|||
162072147|NCT00449644|585320811|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
162072148|NCT00449644|585320812|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
162072149|NCT00449644|585320813|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
162072150|NCT00449644|585320814|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
162072151|NCT00449644|585320811|FG000|Overall Study|Other|1|||
162072152|NCT00449644|585320812|FG001|Overall Study|Other|4|||
162072153|NCT00449644|585320813|FG002|Overall Study|Other|1|||
162072154|NCT00449644|585320814|FG003|Overall Study|Other|0|||
162072155|NCT00449644|585320811|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
162072156|NCT00449644|585320812|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
162072157|NCT00449644|585320813|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
162072158|NCT00449644|585320814|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
162072159|NCT00529542|585320815|FG000|Overall Study|Withdrawal by Subject|1|||
162072160|NCT00529542|585320816|FG001|Overall Study|Withdrawal by Subject|0|||
162072161|NCT00529542|585320815|FG000|Overall Study|Lost to Follow-up|0|||
162072162|NCT00529542|585320816|FG001|Overall Study|Lost to Follow-up|1|||
162072163|NCT02406651|585320828|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
162072164|NCT00718328|585320832|FG000|Overall Study|Lost to Follow-up|1|||
162072165|NCT00718328|585320833|FG001|Overall Study|Lost to Follow-up|0|||
162072166|NCT00663052|585320834|FG000|Overall Study|Adverse Event|6|||
162072167|NCT00663052|585320835|FG001|Overall Study|Adverse Event|3|||
162072168|NCT00663052|585320834|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
162072169|NCT00663052|585320835|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
162072170|NCT00663052|585320834|FG000|Overall Study|Protocol Violation|1|||
162072171|NCT00663052|585320835|FG001|Overall Study|Protocol Violation|0|||
162072172|NCT00663052|585320834|FG000|Overall Study|Withdrawal by Subject|2|||
162072173|NCT00663052|585320835|FG001|Overall Study|Withdrawal by Subject|5|||
162072174|NCT00663052|585320834|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
162072175|NCT00663052|585320835|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
162072176|NCT00663052|585320834|FG000|Overall Study|Other|0|||
162072177|NCT00663052|585320835|FG001|Overall Study|Other|1|||
162072178|NCT01030523|585322248|FG000|Initial Study (5 Years)|Death|1|||
162072179|NCT01030523|585322249|FG001|Initial Study (5 Years)|Death|0|||
162072180|NCT01030523|585322248|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
162072181|NCT01030523|585322249|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
162072182|NCT01030523|585322248|FG000|Initial Study (5 Years)|Implant failure|1|||
162072183|NCT01030523|585322249|FG001|Initial Study (5 Years)|Implant failure|0|||
162072184|NCT01030523|585322248|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
162072185|NCT01030523|585322249|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
162072186|NCT01030523|585322248|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
162072187|NCT01030523|585322249|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
162072188|NCT01030523|585322248|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
162072189|NCT01030523|585322249|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
162072190|NCT01063764|585322252|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
162072191|NCT01063764|585322252|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
162072192|NCT01063764|585322252|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
162072193|NCT01063764|585322252|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
162072194|NCT01063764|585322252|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
162072195|NCT01063764|585322252|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
162072196|NCT01063764|585322252|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
162072197|NCT00697515|585322253|FG000|Dose Optimization Period|Adverse Event|4|||
162072198|NCT00697515|585322254|FG001|Dose Optimization Period|Adverse Event|0|||
162072199|NCT00697515|585322253|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
162072200|NCT00697515|585322254|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
162072201|NCT00697515|585322253|FG000|Dose Optimization Period|Lost to Follow-up|2|||
162072202|NCT00697515|585322254|FG001|Dose Optimization Period|Lost to Follow-up|0|||
162072203|NCT00697515|585322253|FG000|Dose Optimization Period|sponsor request|2|||
162072204|NCT00697515|585322254|FG001|Dose Optimization Period|sponsor request|0|||
162072205|NCT00697515|585322253|FG000|Dose Optimization Period|called to active duty|1|||
162072206|NCT00697515|585322254|FG001|Dose Optimization Period|called to active duty|0|||
162072207|NCT00697515|585322253|FG000|Dose Optimization Period|elevated QTc|1|||
162072208|NCT00697515|585322254|FG001|Dose Optimization Period|elevated QTc|0|||
162072209|NCT00697515|585322253|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
162072210|NCT00697515|585322254|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
162072211|NCT00697515|585322253|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
162072212|NCT00697515|585322254|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
162072213|NCT00697515|585322253|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
162072214|NCT00697515|585322254|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
162072215|NCT00697515|585322253|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
162072216|NCT00697515|585322254|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
162072217|NCT01957462|585322255|FG000|Test Period 1|Withdrawal by Subject|1|||
162072218|NCT01957462|585322256|FG001|Test Period 1|Withdrawal by Subject|0|||
162072219|NCT01957462|585322255|FG000|Test Period 1|Adverse Event|1|||
162072220|NCT01957462|585322256|FG001|Test Period 1|Adverse Event|0|||
162072221|NCT05954052|585322257|FG000|Overall Study|Adverse Event|1|||
162072222|NCT03102918|585322258|FG000|Overall Study|Protocol Violation|1|||
162072223|NCT03102918|585322259|FG001|Overall Study|Protocol Violation|0|||
162072224|NCT05517382|585322268|FG000|Overall Study|Lost to Follow-up|0|||
162072225|NCT05517382|585322269|FG001|Overall Study|Lost to Follow-up|1|||
162072226|NCT03886220|585322270|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
162072227|NCT03886220|585322271|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
162072228|NCT03886220|585322270|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
162072229|NCT03886220|585322271|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
162072230|NCT03886220|585322270|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
162072231|NCT03886220|585322271|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
162072232|NCT01675128|585322278|FG000|Overall Study|Disease progression on study|1|||
162072233|NCT01675128|585322279|FG001|Overall Study|Disease progression on study|1|||
162072234|NCT01675128|585322280|FG002|Overall Study|Disease progression on study|1|||
162072235|NCT01675128|585322278|FG000|Overall Study|Refused further treatment|1|||
162072236|NCT01675128|585322279|FG001|Overall Study|Refused further treatment|0|||
162072237|NCT01675128|585322280|FG002|Overall Study|Refused further treatment|0|||
162072238|NCT01675128|585322278|FG000|Overall Study|Pulmonary complication; off study|0|||
162072239|NCT01675128|585322279|FG001|Overall Study|Pulmonary complication; off study|1|||
162072240|NCT01675128|585322280|FG002|Overall Study|Pulmonary complication; off study|0|||
162072241|NCT03526458|585322286|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
162072242|NCT03526458|585322287|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
162072243|NCT03526458|585322286|FG000|Overall Study|Stone passed, surgery cancelled|2|||
162072244|NCT03526458|585322287|FG001|Overall Study|Stone passed, surgery cancelled|1|||
162072245|NCT03526458|585322286|FG000|Overall Study|Withdrawal by Subject|1|||
162072246|NCT03526458|585322287|FG001|Overall Study|Withdrawal by Subject|0|||
162072247|NCT03526458|585322286|FG000|Overall Study|Physician Decision|2|||
162072248|NCT03526458|585322287|FG001|Overall Study|Physician Decision|1|||
162072249|NCT03526458|585322286|FG000|Overall Study|Lack of equipment|1|||
162072250|NCT03526458|585322287|FG001|Overall Study|Lack of equipment|1|||
162072251|NCT00271947|585322288|FG000|Overall Study|Lost to Follow-up|1|||
162072252|NCT04404855|585322289|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
162072253|NCT04404855|585322290|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
162072254|NCT00735878|585322291|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
162072255|NCT00735878|585322292|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
162072256|NCT00735878|585322293|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
162072257|NCT00651755|585322296|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
162072258|NCT00651755|585322297|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
162072259|NCT00651755|585322296|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
162072260|NCT00651755|585322297|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
162072261|NCT03642717|585322302|FG000|Overall Study|Lost to Follow-up|2|||
162072262|NCT03642717|585322302|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
162072263|NCT03642717|585322302|FG000|Overall Study|Taken study drug prior to contract date|3|||
162072264|NCT02587065|585322303|FG000|Overall Study|Adverse Event|14|||
162072265|NCT02587065|585322303|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
162072266|NCT02587065|585322303|FG000|Overall Study|Non-adherence to the Protocol|3|||
162072267|NCT02587065|585322303|FG000|Overall Study|Discontinuation of Study Medication|2|||
162072268|NCT02587065|585322303|FG000|Overall Study|Reason not Specified|3|||
162072269|NCT01559012|585322304|FG000|Overall Study|Withdrawal by Subject|0|||
162072270|NCT01559012|585322305|FG001|Overall Study|Withdrawal by Subject|1|||
162072271|NCT00302458|585322306|FG000|Overall Study|Lost to Follow-up|1|||
162072272|NCT00302458|585322306|FG000|Overall Study|Ineligible after screening|1|||
162072273|NCT00302458|585322306|FG000|Overall Study|Withdrawal by Subject|1|||
162072274|NCT00946712|585322307|FG000|Overall Study|Adverse Event|118|||
162072275|NCT00946712|585322308|FG001|Overall Study|Adverse Event|124|||
162072276|NCT00946712|585322307|FG000|Overall Study|Disease progression|308|||
162072277|NCT00946712|585322308|FG001|Overall Study|Disease progression|404|||
162072278|NCT00946712|585322307|FG000|Overall Study|Death|21|||
162072279|NCT00946712|585322308|FG001|Overall Study|Death|22|||
162072280|NCT00946712|585322307|FG000|Overall Study|No treatment given|25|||
162072281|NCT00946712|585322308|FG001|Overall Study|No treatment given|29|||
162072282|NCT00946712|585322307|FG000|Overall Study|Other reasons|61|||
162072283|NCT00946712|585322308|FG001|Overall Study|Other reasons|73|||
162072284|NCT00946712|585322307|FG000|Overall Study|On Treatment|0|||
162072285|NCT00946712|585322308|FG001|Overall Study|On Treatment|4|||
162072286|NCT00946712|585322307|FG000|Overall Study|Ineligible|14|||
162072287|NCT00946712|585322308|FG001|Overall Study|Ineligible|6|||
162072288|NCT00853723|585322311|FG000|Overall Study|Adverse Event|3|||
162072289|NCT00853723|585322312|FG001|Overall Study|Adverse Event|4|||
162072290|NCT00853723|585322313|FG002|Overall Study|Adverse Event|1|||
162072291|NCT00853723|585322311|FG000|Overall Study|Withdrawal by Subject|2|||
162072292|NCT00853723|585322312|FG001|Overall Study|Withdrawal by Subject|1|||
162072293|NCT00853723|585322313|FG002|Overall Study|Withdrawal by Subject|0|||
162072294|NCT00853723|585322311|FG000|Overall Study|Protocol Violation|1|||
162072295|NCT00853723|585322312|FG001|Overall Study|Protocol Violation|2|||
162072296|NCT00853723|585322313|FG002|Overall Study|Protocol Violation|1|||
162072297|NCT04248933|585322314|FG000|Overall Study|Lost to Follow-up|9|||
162072298|NCT04248933|585322314|FG000|Overall Study|Withdrawal by Subject|2|||
162072299|NCT00445965|585322317|FG000|Overall Study|Adverse Event|2|||
162072300|NCT00445965|585322317|FG000|Overall Study|Physician Decision|1|||
162072301|NCT00445965|585322317|FG000|Overall Study|Enrolled but not treated|1|||
162072302|NCT00445965|585322317|FG000|Overall Study|Removed due to progressive disease|29|||
162072303|NCT02642432|585322318|FG000|Overall Study|Adverse Event|2|||
162072304|NCT02642432|585322318|FG000|Overall Study|Withdrew Consent|1|||
162072305|NCT02642432|585322318|FG000|Overall Study|Lost to Follow-up|2|||
162072306|NCT02642432|585322318|FG000|Overall Study|Other|3|||
162072307|NCT02447081|585322319|FG000|Overall Study|Death|161|||
162072308|NCT02447081|585322319|FG000|Overall Study|Lost to Follow-up|36|||
162072309|NCT02447081|585322319|FG000|Overall Study|Visit not completed|17|||
162072310|NCT02447081|585322319|FG000|Overall Study|unsuccessful implant procedure|10|||
162072311|NCT05778786|585322320|FG000|Period 1|COVID-19 Related|3|||
162072312|NCT05778786|585322321|FG001|Period 1|COVID-19 Related|3|||
162072313|NCT05778786|585322320|FG000|Period 1|Withdrew Consent during Study|1|||
162072314|NCT05778786|585322321|FG001|Period 1|Withdrew Consent during Study|0|||
162072315|NCT05778786|585322320|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
162072316|NCT05778786|585322321|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
162072317|NCT05778786|585322320|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
162072318|NCT05778786|585322321|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
162072319|NCT02867709|585322324|FG000|Treatment Period|Adverse Event|1|||
162072320|NCT02867709|585322325|FG001|Treatment Period|Adverse Event|1|||
162072321|NCT02867709|585322326|FG002|Treatment Period|Adverse Event|2|||
162072322|NCT02867709|585322324|FG000|Treatment Period|Withdrawal of Consent|7|||
162072323|NCT02867709|585322325|FG001|Treatment Period|Withdrawal of Consent|9|||
162072324|NCT02867709|585322326|FG002|Treatment Period|Withdrawal of Consent|8|||
162072325|NCT02867709|585322324|FG000|Treatment Period|Lost to Follow-up|17|||
162072326|NCT02867709|585322325|FG001|Treatment Period|Lost to Follow-up|20|||
162072327|NCT02867709|585322326|FG002|Treatment Period|Lost to Follow-up|20|||
162072328|NCT02867709|585322324|FG000|Treatment Period|Lack of Qualifying Event|42|||
162072329|NCT02867709|585322325|FG001|Treatment Period|Lack of Qualifying Event|55|||
162072330|NCT02867709|585322326|FG002|Treatment Period|Lack of Qualifying Event|42|||
162072331|NCT02867709|585322324|FG000|Treatment Period|Protocol Violation|3|||
162072332|NCT02867709|585322325|FG001|Treatment Period|Protocol Violation|2|||
162072333|NCT02867709|585322326|FG002|Treatment Period|Protocol Violation|3|||
162072334|NCT02867709|585322324|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
162072335|NCT02867709|585322325|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
162072336|NCT02867709|585322326|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
162072337|NCT02867709|585322324|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
162072338|NCT02867709|585322325|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
162072339|NCT02867709|585322326|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
162072340|NCT02867709|585322324|FG000|Safety Follow-up Period|Pregnancy|0|||
162072341|NCT02867709|585322325|FG001|Safety Follow-up Period|Pregnancy|1|||
162072342|NCT02867709|585322326|FG002|Safety Follow-up Period|Pregnancy|0|||
162072343|NCT02867709|585322324|FG000|Safety Follow-up Period|Protocol Violation|0|||
162072344|NCT02867709|585322325|FG001|Safety Follow-up Period|Protocol Violation|1|||
162072345|NCT02867709|585322326|FG002|Safety Follow-up Period|Protocol Violation|1|||
162072346|NCT02075658|585322327|FG000|Overall Study|Physician Decision|2|||
162072347|NCT02075658|585322328|FG001|Overall Study|Physician Decision|2|||
162072348|NCT02946047|585322330|FG000|Overall Study|Adverse Event|1|||
162072349|NCT02946047|585322331|FG001|Overall Study|Adverse Event|0|||
162072350|NCT02946047|585322332|FG002|Overall Study|Adverse Event|0|||
162072351|NCT02946047|585322333|FG003|Overall Study|Adverse Event|0|||
162072352|NCT03615105|585322334|FG000|Overall Study|Protocol Violation|1|||
162072353|NCT03615105|585322335|FG001|Overall Study|Protocol Violation|0|||
162072354|NCT03615105|585322336|FG002|Overall Study|Protocol Violation|0|||
162072355|NCT03615105|585322334|FG000|Overall Study|Death|0|||
162072356|NCT03615105|585322335|FG001|Overall Study|Death|2|||
162072357|NCT03615105|585322336|FG002|Overall Study|Death|0|||
162072358|NCT05041322|585322337|FG000|Baseline|Withdrawal by Subject|1|||
162072359|NCT05041322|585322338|FG001|Baseline|Withdrawal by Subject|0|||
162072360|NCT05041322|585322337|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
162072361|NCT05041322|585322338|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
162072362|NCT05041322|585322337|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
162072363|NCT05041322|585322338|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
162072364|NCT01894581|585322339|FG000|Overall Study|Withdrawal by Subject|2|||
162072365|NCT01894581|585322340|FG001|Overall Study|Withdrawal by Subject|3|||
162072366|NCT01894581|585322339|FG000|Overall Study|Screen Failure|3|||
162072367|NCT01894581|585322340|FG001|Overall Study|Screen Failure|4|||
162072368|NCT03313804|585322341|FG000|Treatment|Death|5|||
162072369|NCT03313804|585322341|FG000|Treatment|still on treatment|2|||
162072370|NCT03313804|585322341|FG000|Follow Up|still on follow up|3|||
162072371|NCT03795298|585322342|FG000|Overall Study|Death|34|||
162072372|NCT03795298|585322343|FG001|Overall Study|Death|29|||
162072373|NCT03795298|585322342|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
162072374|NCT03795298|585322343|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
162072375|NCT03795298|585322342|FG000|Overall Study|Lost to Follow-up|28|||
162072376|NCT03795298|585322343|FG001|Overall Study|Lost to Follow-up|17|||
162072377|NCT03795298|585322342|FG000|Overall Study|Physician Decision|5|||
162072378|NCT03795298|585322343|FG001|Overall Study|Physician Decision|4|||
162072379|NCT03795298|585322342|FG000|Overall Study|Withdrawal by Subject|43|||
162072380|NCT03795298|585322343|FG001|Overall Study|Withdrawal by Subject|28|||
162072381|NCT03795298|585322342|FG000|Overall Study|Reason not reported|7|||
162072382|NCT03795298|585322343|FG001|Overall Study|Reason not reported|9|||
162072383|NCT01252940|585322344|FG000|Main Study Phase|Randomized but not treated|4|||
162072384|NCT01252940|585322345|FG001|Main Study Phase|Randomized but not treated|2|||
162072385|NCT01252940|585322344|FG000|Main Study Phase|Adverse Event|3|||
162072386|NCT01252940|585322345|FG001|Main Study Phase|Adverse Event|1|||
162072387|NCT01252940|585322344|FG000|Main Study Phase|Lack of Efficacy|1|||
162072388|NCT01252940|585322345|FG001|Main Study Phase|Lack of Efficacy|0|||
162072389|NCT01252940|585322344|FG000|Main Study Phase|Lost to Follow-up|6|||
162072390|NCT01252940|585322345|FG001|Main Study Phase|Lost to Follow-up|1|||
162072391|NCT01252940|585322344|FG000|Main Study Phase|Physician Decision|1|||
162072392|NCT01252940|585322345|FG001|Main Study Phase|Physician Decision|0|||
162072393|NCT01252940|585322344|FG000|Main Study Phase|Protocol Violation|4|||
162072394|NCT01252940|585322345|FG001|Main Study Phase|Protocol Violation|2|||
162072395|NCT01252940|585322344|FG000|Main Study Phase|Withdrawal by Subject|6|||
162072396|NCT01252940|585322345|FG001|Main Study Phase|Withdrawal by Subject|5|||
162072397|NCT01252940|585322344|FG000|Main Study Phase|Subject Non-compliance|1|||
162072398|NCT01252940|585322345|FG001|Main Study Phase|Subject Non-compliance|1|||
162072399|NCT01252940|585322344|FG000|Extension Phase|Adverse Event|2|||
162072400|NCT01252940|585322345|FG001|Extension Phase|Adverse Event|1|||
162072401|NCT01252940|585322344|FG000|Extension Phase|Lack of Efficacy|1|||
162072402|NCT01252940|585322345|FG001|Extension Phase|Lack of Efficacy|0|||
162072403|NCT01252940|585322344|FG000|Extension Phase|Lost to Follow-up|5|||
162072404|NCT01252940|585322345|FG001|Extension Phase|Lost to Follow-up|0|||
162072405|NCT01252940|585322344|FG000|Extension Phase|Physician Decision|0|||
162072406|NCT01252940|585322345|FG001|Extension Phase|Physician Decision|1|||
162072407|NCT01252940|585322344|FG000|Extension Phase|Subject Non-compliance|1|||
162072408|NCT01252940|585322345|FG001|Extension Phase|Subject Non-compliance|0|||
162072409|NCT01252940|585322344|FG000|Extension Phase|Withdrawal by Subject|1|||
162072410|NCT01252940|585322345|FG001|Extension Phase|Withdrawal by Subject|1|||
162072411|NCT01502423|585322346|FG000|Overall Study|Withdrawal by Subject|0|||
162072412|NCT01502423|585322347|FG001|Overall Study|Withdrawal by Subject|1|||
162072413|NCT04199117|585322348|FG000|Overall Study|Withdrawal by Subject|3|||
162072414|NCT04199117|585322349|FG001|Overall Study|Withdrawal by Subject|0|||
162072415|NCT04199117|585322350|FG002|Overall Study|Withdrawal by Subject|0|||
162072416|NCT04199117|585322351|FG003|Overall Study|Withdrawal by Subject|1|||
162072417|NCT04199117|585322352|FG004|Overall Study|Withdrawal by Subject|1|||
162072418|NCT04199117|585322353|FG005|Overall Study|Withdrawal by Subject|0|||
162072419|NCT04199117|585322354|FG006|Overall Study|Withdrawal by Subject|0|||
162072420|NCT04199117|585322355|FG007|Overall Study|Withdrawal by Subject|2|||
162072421|NCT04199117|585322356|FG008|Overall Study|Withdrawal by Subject|0|||
162072422|NCT04199117|585322357|FG009|Overall Study|Withdrawal by Subject|0|||
162072423|NCT04199117|585322358|FG010|Overall Study|Withdrawal by Subject|1|||
162072424|NCT04199117|585322359|FG011|Overall Study|Withdrawal by Subject|1|||
162072425|NCT04199117|585322360|FG012|Overall Study|Withdrawal by Subject|2|||
162072426|NCT04199117|585322361|FG013|Overall Study|Withdrawal by Subject|1|||
162072427|NCT04199117|585322362|FG014|Overall Study|Withdrawal by Subject|1|||
162072428|NCT04199117|585322363|FG015|Overall Study|Withdrawal by Subject|1|||
162072429|NCT04199117|585322348|FG000|Overall Study|Death|1|||
162072430|NCT04199117|585322349|FG001|Overall Study|Death|1|||
162072431|NCT04199117|585322350|FG002|Overall Study|Death|0|||
162072432|NCT04199117|585322351|FG003|Overall Study|Death|0|||
162072433|NCT04199117|585322352|FG004|Overall Study|Death|0|||
162072434|NCT04199117|585322353|FG005|Overall Study|Death|0|||
162072435|NCT04199117|585322354|FG006|Overall Study|Death|0|||
162072436|NCT04199117|585322355|FG007|Overall Study|Death|0|||
162072437|NCT04199117|585322356|FG008|Overall Study|Death|0|||
162072438|NCT04199117|585322357|FG009|Overall Study|Death|0|||
162072439|NCT04199117|585322358|FG010|Overall Study|Death|0|||
162072440|NCT04199117|585322359|FG011|Overall Study|Death|1|||
162072441|NCT04199117|585322360|FG012|Overall Study|Death|0|||
162072442|NCT04199117|585322361|FG013|Overall Study|Death|1|||
162072443|NCT04199117|585322362|FG014|Overall Study|Death|0|||
162072444|NCT04199117|585322363|FG015|Overall Study|Death|0|||
162072445|NCT04199117|585322348|FG000|Overall Study|Withdrawal by PI|0|||
162072446|NCT04199117|585322349|FG001|Overall Study|Withdrawal by PI|0|||
162072447|NCT04199117|585322350|FG002|Overall Study|Withdrawal by PI|0|||
162072448|NCT04199117|585322351|FG003|Overall Study|Withdrawal by PI|0|||
162072449|NCT04199117|585322352|FG004|Overall Study|Withdrawal by PI|0|||
162072450|NCT04199117|585322353|FG005|Overall Study|Withdrawal by PI|0|||
162072451|NCT04199117|585322354|FG006|Overall Study|Withdrawal by PI|0|||
162072452|NCT04199117|585322355|FG007|Overall Study|Withdrawal by PI|0|||
162072453|NCT04199117|585322356|FG008|Overall Study|Withdrawal by PI|0|||
162072454|NCT04199117|585322357|FG009|Overall Study|Withdrawal by PI|0|||
162072455|NCT04199117|585322358|FG010|Overall Study|Withdrawal by PI|0|||
162072456|NCT04199117|585322359|FG011|Overall Study|Withdrawal by PI|0|||
162072457|NCT04199117|585322360|FG012|Overall Study|Withdrawal by PI|1|||
162072458|NCT04199117|585322361|FG013|Overall Study|Withdrawal by PI|0|||
162072459|NCT04199117|585322362|FG014|Overall Study|Withdrawal by PI|0|||
162072460|NCT04199117|585322363|FG015|Overall Study|Withdrawal by PI|0|||
162072461|NCT04383743|585322364|FG000|Overall Study|Withdrawal by Subject|1|||
162072462|NCT04383743|585322364|FG000|Overall Study|Adverse Event|1|||
162072463|NCT04814433|585322367|FG000|Overall Study|Survey not returned|4|||
162072464|NCT04814433|585322368|FG001|Overall Study|Survey not returned|8|||
162072465|NCT04814433|585322369|FG002|Overall Study|Survey not returned|4|||
162072466|NCT04814433|585322370|FG003|Overall Study|Survey not returned|5|||
162072467|NCT03482791|585322375|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
162072468|NCT03482791|585322376|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
162072469|NCT00296374|585322378|FG000|Overall Study|Adverse Event|14|||
162072470|NCT00296374|585322379|FG001|Overall Study|Adverse Event|10|||
162072471|NCT00296374|585322380|FG002|Overall Study|Adverse Event|7|||
162072472|NCT00296374|585322378|FG000|Overall Study|Withdrawal by Subject|3|||
162072473|NCT00296374|585322379|FG001|Overall Study|Withdrawal by Subject|5|||
162072474|NCT00296374|585322380|FG002|Overall Study|Withdrawal by Subject|11|||
162072475|NCT00296374|585322378|FG000|Overall Study|Incorrect enrollment|3|||
162072476|NCT00296374|585322379|FG001|Overall Study|Incorrect enrollment|3|||
162072477|NCT00296374|585322380|FG002|Overall Study|Incorrect enrollment|4|||
162072478|NCT00296374|585322378|FG000|Overall Study|Protocol Violation|1|||
162072479|NCT00296374|585322379|FG001|Overall Study|Protocol Violation|2|||
162072480|NCT00296374|585322380|FG002|Overall Study|Protocol Violation|3|||
162072481|NCT00296374|585322378|FG000|Overall Study|Lost to Follow-up|3|||
162072482|NCT00296374|585322379|FG001|Overall Study|Lost to Follow-up|1|||
162072483|NCT00296374|585322380|FG002|Overall Study|Lost to Follow-up|1|||
162072484|NCT00296374|585322378|FG000|Overall Study|Relocated to another state|1|||
162072485|NCT00296374|585322379|FG001|Overall Study|Relocated to another state|0|||
162072486|NCT00296374|585322380|FG002|Overall Study|Relocated to another state|0|||
162072487|NCT00296374|585322378|FG000|Overall Study|Stopped drug before end of study visit|0|||
162072488|NCT00296374|585322379|FG001|Overall Study|Stopped drug before end of study visit|1|||
162072489|NCT00296374|585322380|FG002|Overall Study|Stopped drug before end of study visit|0|||
162072490|NCT00296374|585322378|FG000|Overall Study|Nephrologist introduced ACE|0|||
162072491|NCT00296374|585322379|FG001|Overall Study|Nephrologist introduced ACE|1|||
162072492|NCT00296374|585322380|FG002|Overall Study|Nephrologist introduced ACE|0|||
162072493|NCT00296374|585322378|FG000|Overall Study|Pregnancy|0|||
162072494|NCT00296374|585322379|FG001|Overall Study|Pregnancy|0|||
162072495|NCT00296374|585322380|FG002|Overall Study|Pregnancy|2|||
162072496|NCT00296374|585322378|FG000|Overall Study|Other|0|||
162072497|NCT00296374|585322379|FG001|Overall Study|Other|0|||
162072498|NCT00296374|585322380|FG002|Overall Study|Other|1|||
162072499|NCT01721330|585322381|FG000|Overall Study|Withdrawal by Subject|0|||
162072500|NCT01721330|585322382|FG001|Overall Study|Withdrawal by Subject|1|||
162072501|NCT01816893|585322383|FG000|Washout Period|Withdrawal by Subject|2|||
162072502|NCT01816893|585322384|FG001|Washout Period|Withdrawal by Subject|0|||
162072503|NCT00699972|585323886|FG000|Overall Study|Adverse Event|7|||
162072504|NCT00699972|585323887|FG001|Overall Study|Adverse Event|9|||
162072505|NCT00699972|585323888|FG002|Overall Study|Adverse Event|24|||
162072506|NCT00699972|585323886|FG000|Overall Study|Lost to Follow-up|0|||
162072507|NCT00699972|585323887|FG001|Overall Study|Lost to Follow-up|2|||
162072508|NCT00699972|585323888|FG002|Overall Study|Lost to Follow-up|0|||
162072509|NCT00699972|585323886|FG000|Overall Study|Withdrawal by Subject|3|||
162072510|NCT00699972|585323887|FG001|Overall Study|Withdrawal by Subject|7|||
162072511|NCT00699972|585323888|FG002|Overall Study|Withdrawal by Subject|4|||
162072512|NCT00699972|585323886|FG000|Overall Study|Lack of Efficacy|2|||
162072513|NCT00699972|585323887|FG001|Overall Study|Lack of Efficacy|0|||
162072514|NCT00699972|585323888|FG002|Overall Study|Lack of Efficacy|2|||
162072515|NCT00699972|585323886|FG000|Overall Study|Administrative/Other|3|||
162072516|NCT00699972|585323887|FG001|Overall Study|Administrative/Other|1|||
162072517|NCT00699972|585323888|FG002|Overall Study|Administrative/Other|4|||
162072518|NCT00699972|585323886|FG000|Overall Study|Randomized, Not Treated|1|||
162072519|NCT00699972|585323887|FG001|Overall Study|Randomized, Not Treated|0|||
162072520|NCT00699972|585323888|FG002|Overall Study|Randomized, Not Treated|1|||
162072521|NCT01545817|585323889|FG000|Pazopanib|Disease progression|51|||
162072522|NCT01545817|585323890|FG001|Pazopanib|Disease progression|0|||
162072523|NCT01545817|585323889|FG000|Pazopanib|Adverse Event|19|||
162072524|NCT01545817|585323890|FG001|Pazopanib|Adverse Event|0|||
162072525|NCT01545817|585323889|FG000|Pazopanib|Other reason|4|||
162072526|NCT01545817|585323890|FG001|Pazopanib|Other reason|0|||
162072527|NCT01545817|585323889|FG000|Everolimus|Other reason|0|||
162072528|NCT01545817|585323890|FG001|Everolimus|Other reason|7|||
162072529|NCT01545817|585323889|FG000|Everolimus|Disease progression|0|||
162072530|NCT01545817|585323890|FG001|Everolimus|Disease progression|25|||
162072531|NCT01545817|585323889|FG000|Everolimus|Adverse Event|0|||
162072532|NCT01545817|585323890|FG001|Everolimus|Adverse Event|6|||
162072533|NCT03971695|585323894|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162072534|NCT03971695|585323895|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162072535|NCT03971695|585323896|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162072536|NCT03971695|585323897|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
162072537|NCT03971695|585323898|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
162072538|NCT03971695|585323899|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162072539|NCT03971695|585323900|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162072540|NCT03971695|585323901|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162072541|NCT03971695|585323902|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
162072542|NCT03971695|585323903|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
162072543|NCT03971695|585323904|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
162072544|NCT03971695|585323905|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
162072545|NCT03971695|585323906|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
162072546|NCT00156533|585323907|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
162072547|NCT00156533|585323908|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
162072548|NCT00156533|585323909|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
162072549|NCT00156533|585323910|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
162072550|NCT00156533|585323907|FG000|Overall Study|Withdrawal by Subject|1|||
162072551|NCT00156533|585323908|FG001|Overall Study|Withdrawal by Subject|0|||
162072552|NCT00156533|585323909|FG002|Overall Study|Withdrawal by Subject|0|||
162072553|NCT00156533|585323910|FG003|Overall Study|Withdrawal by Subject|1|||
162072554|NCT00156533|585323907|FG000|Overall Study|Failed Screening|1|||
162072555|NCT00156533|585323908|FG001|Overall Study|Failed Screening|0|||
162072556|NCT00156533|585323909|FG002|Overall Study|Failed Screening|1|||
162072557|NCT00156533|585323910|FG003|Overall Study|Failed Screening|1|||
162072558|NCT01881230|585323911|FG000|Overall Study|Death|2|||
162072559|NCT01881230|585323912|FG001|Overall Study|Death|0|||
162072560|NCT01881230|585323913|FG002|Overall Study|Death|1|||
162072561|NCT01881230|585323911|FG000|Overall Study|Adverse Event|9|||
162072562|NCT01881230|585323912|FG001|Overall Study|Adverse Event|13|||
162072563|NCT01881230|585323913|FG002|Overall Study|Adverse Event|12|||
162072564|NCT01881230|585323911|FG000|Overall Study|Progressive Disease|31|||
162072565|NCT01881230|585323912|FG001|Overall Study|Progressive Disease|35|||
162072566|NCT01881230|585323913|FG002|Overall Study|Progressive Disease|36|||
162072567|NCT01881230|585323911|FG000|Overall Study|Symptomatic Deterioration|3|||
162072568|NCT01881230|585323912|FG001|Overall Study|Symptomatic Deterioration|3|||
162072569|NCT01881230|585323913|FG002|Overall Study|Symptomatic Deterioration|1|||
162072570|NCT01881230|585323911|FG000|Overall Study|Withdrawal by Subject|6|||
162072571|NCT01881230|585323912|FG001|Overall Study|Withdrawal by Subject|4|||
162072572|NCT01881230|585323913|FG002|Overall Study|Withdrawal by Subject|6|||
162072573|NCT01881230|585323911|FG000|Overall Study|Physician Decision|4|||
162072574|NCT01881230|585323912|FG001|Overall Study|Physician Decision|3|||
162072575|NCT01881230|585323913|FG002|Overall Study|Physician Decision|6|||
162072576|NCT01881230|585323911|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162072577|NCT01881230|585323912|FG001|Overall Study|Non-Compliance with Study Drug|2|||
162072578|NCT01881230|585323913|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162072579|NCT01881230|585323911|FG000|Overall Study|Given Commercially Available Drug|0|||
162072580|NCT01881230|585323912|FG001|Overall Study|Given Commercially Available Drug|0|||
162072581|NCT01881230|585323913|FG002|Overall Study|Given Commercially Available Drug|2|||
162072582|NCT01881230|585323911|FG000|Overall Study|Protocol Violation|1|||
162072583|NCT01881230|585323912|FG001|Overall Study|Protocol Violation|1|||
162072584|NCT01881230|585323913|FG002|Overall Study|Protocol Violation|0|||
162072585|NCT01881230|585323911|FG000|Overall Study|Miscellaneous|3|||
162072586|NCT01881230|585323912|FG001|Overall Study|Miscellaneous|3|||
162072587|NCT01881230|585323913|FG002|Overall Study|Miscellaneous|0|||
162072588|NCT01881230|585323911|FG000|Overall Study|Untreated: Other|0|||
162072589|NCT01881230|585323912|FG001|Overall Study|Untreated: Other|0|||
162072590|NCT01881230|585323913|FG002|Overall Study|Untreated: Other|1|||
162072591|NCT01881230|585323911|FG000|Overall Study|Untreated: Death|0|||
162072592|NCT01881230|585323912|FG001|Overall Study|Untreated: Death|0|||
162072593|NCT01881230|585323913|FG002|Overall Study|Untreated: Death|1|||
162072594|NCT01881230|585323911|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
162072595|NCT01881230|585323912|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
162072596|NCT01881230|585323913|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
162072597|NCT02747420|585323914|FG000|Overall Study|Lost to Follow-up|4|||
162072598|NCT02747420|585323915|FG001|Overall Study|Lost to Follow-up|2|||
162072599|NCT02747420|585323914|FG000|Overall Study|Withdrawal by Subject|3|||
162072600|NCT02747420|585323915|FG001|Overall Study|Withdrawal by Subject|2|||
162072601|NCT05129488|585323916|FG000|Overall Study|Protocol Violation|3|||
162072602|NCT00706641|585323921|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
162072603|NCT00706641|585323921|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
162072604|NCT00706641|585323921|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
162072605|NCT04782856|585323922|FG000|Overall Study|Withdrawal by Subject|0|||
162072606|NCT04782856|585323923|FG001|Overall Study|Withdrawal by Subject|1|||
162072607|NCT00798369|585323924|FG000|Overall Study|Subject withdrew consent|0|||
162072608|NCT00798369|585323925|FG001|Overall Study|Subject withdrew consent|0|||
162072609|NCT00798369|585323926|FG002|Overall Study|Subject withdrew consent|1|||
162072610|NCT00798369|585323927|FG003|Overall Study|Subject withdrew consent|1|||
162072611|NCT00798369|585323928|FG004|Overall Study|Subject withdrew consent|0|||
162072612|NCT00798369|585323929|FG005|Overall Study|Subject withdrew consent|2|||
162072613|NCT00798369|585323924|FG000|Overall Study|Lost to Follow-up|1|||
162072614|NCT00798369|585323925|FG001|Overall Study|Lost to Follow-up|1|||
162072615|NCT00798369|585323926|FG002|Overall Study|Lost to Follow-up|1|||
162072616|NCT00798369|585323927|FG003|Overall Study|Lost to Follow-up|0|||
162072617|NCT00798369|585323928|FG004|Overall Study|Lost to Follow-up|1|||
162072618|NCT00798369|585323929|FG005|Overall Study|Lost to Follow-up|0|||
162072619|NCT00798369|585323924|FG000|Overall Study|Adminstrative problems|0|||
162072620|NCT00798369|585323925|FG001|Overall Study|Adminstrative problems|0|||
162072621|NCT00798369|585323926|FG002|Overall Study|Adminstrative problems|0|||
162072622|NCT00798369|585323927|FG003|Overall Study|Adminstrative problems|0|||
162072623|NCT00798369|585323928|FG004|Overall Study|Adminstrative problems|0|||
162072624|NCT00798369|585323929|FG005|Overall Study|Adminstrative problems|1|||
162072625|NCT04475588|585323930|FG000|Overall Study|Adverse Event|2|||
162072626|NCT04475588|585323931|FG001|Overall Study|Adverse Event|0|||
162072627|NCT01327300|585323932|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
162072628|NCT01327300|585323933|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
162072629|NCT02603432|585323934|FG000|Overall Study|Adverse Event|1|||
162072630|NCT02603432|585323935|FG001|Overall Study|Adverse Event|0|||
162072631|NCT02603432|585323934|FG000|Overall Study|Death|221|||
162072632|NCT02603432|585323935|FG001|Overall Study|Death|242|||
162072633|NCT02603432|585323934|FG000|Overall Study|Lost to Follow-up|3|||
162072634|NCT02603432|585323935|FG001|Overall Study|Lost to Follow-up|9|||
162072635|NCT02603432|585323934|FG000|Overall Study|Progressive Disease|7|||
162072636|NCT02603432|585323935|FG001|Overall Study|Progressive Disease|5|||
162072637|NCT02603432|585323934|FG000|Overall Study|Withdrawal by Subject|12|||
162072638|NCT02603432|585323935|FG001|Overall Study|Withdrawal by Subject|18|||
162072639|NCT02603432|585323934|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
162072640|NCT02603432|585323935|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
162072641|NCT02603432|585323934|FG000|Overall Study|Study terminated by sponsor|74|||
162072642|NCT02603432|585323935|FG001|Overall Study|Study terminated by sponsor|75|||
162072643|NCT02603432|585323934|FG000|Overall Study|Other|13|||
162072644|NCT02603432|585323935|FG001|Overall Study|Other|0|||
162072645|NCT00666757|585323939|FG000|Overall Study|Lost to Follow-up|39|||
162072646|NCT00666757|585323940|FG001|Overall Study|Lost to Follow-up|35|||
162072647|NCT00666757|585323939|FG000|Overall Study|Protocol Violation|23|||
162072648|NCT00666757|585323940|FG001|Overall Study|Protocol Violation|24|||
162072649|NCT00666757|585323939|FG000|Overall Study|Adverse Event|22|||
162072650|NCT00666757|585323940|FG001|Overall Study|Adverse Event|12|||
162072651|NCT00666757|585323939|FG000|Overall Study|Withdrawal by Subject|13|||
162072652|NCT00666757|585323940|FG001|Overall Study|Withdrawal by Subject|17|||
162072653|NCT00666757|585323939|FG000|Overall Study|Lack of Efficacy|3|||
162072654|NCT00666757|585323940|FG001|Overall Study|Lack of Efficacy|6|||
162072655|NCT00666757|585323939|FG000|Overall Study|Physician Decision|0|||
162072656|NCT00666757|585323940|FG001|Overall Study|Physician Decision|2|||
162072657|NCT00666757|585323939|FG000|Overall Study|Sponsor decision|0|||
162072658|NCT00666757|585323940|FG001|Overall Study|Sponsor decision|1|||
162072659|NCT01231581|585323941|FG000|Overall Study|Lost to Follow-up|2|||
162072660|NCT01231581|585323942|FG001|Overall Study|Lost to Follow-up|2|||
162072661|NCT01231581|585323941|FG000|Overall Study|Withdrawal by Subject|6|||
162072662|NCT01231581|585323942|FG001|Overall Study|Withdrawal by Subject|9|||
162072663|NCT01231581|585323941|FG000|Overall Study|Study Closed/Terminated|6|||
162072664|NCT01231581|585323942|FG001|Overall Study|Study Closed/Terminated|5|||
162072665|NCT01231581|585323941|FG000|Overall Study|Death|65|||
162072666|NCT01231581|585323942|FG001|Overall Study|Death|64|||
162072667|NCT01231581|585323941|FG000|Overall Study|Ongoing|1|||
162072668|NCT01231581|585323942|FG001|Overall Study|Ongoing|0|||
162072669|NCT01723163|585323945|FG000|Treatment Phase|Withdrawal by Subject|14|||
162072670|NCT01723163|585323946|FG001|Treatment Phase|Withdrawal by Subject|6|||
162072671|NCT01723163|585323945|FG000|Treatment Phase|Withdrawal by PI|5|||
162072672|NCT01723163|585323946|FG001|Treatment Phase|Withdrawal by PI|1|||
162072673|NCT01723163|585323945|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
162072674|NCT01723163|585323946|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
162072675|NCT01723163|585323945|FG000|3-Month Follow-up|Unable to Contact|12|||
162072676|NCT01723163|585323946|FG001|3-Month Follow-up|Unable to Contact|19|||
162072677|NCT01723163|585323945|FG000|6-Month Follow-up|Death|1|||
162072678|NCT01723163|585323946|FG001|6-Month Follow-up|Death|0|||
162072679|NCT01723163|585323945|FG000|6-Month Follow-up|Unable to Contact|17|||
162072680|NCT01723163|585323946|FG001|6-Month Follow-up|Unable to Contact|15|||
162072681|NCT01723163|585323945|FG000|12-Month Follow-up|Death|1|||
162072682|NCT01723163|585323946|FG001|12-Month Follow-up|Death|0|||
162072683|NCT01723163|585323945|FG000|12-Month Follow-up|Unable to Contact|23|||
162072684|NCT01723163|585323946|FG001|12-Month Follow-up|Unable to Contact|28|||
162072685|NCT02510794|585323947|FG000|Overall Study|Adverse Event|0|||
162072686|NCT02510794|585323948|FG001|Overall Study|Adverse Event|1|||
162072687|NCT02510794|585323949|FG002|Overall Study|Adverse Event|0|||
162072688|NCT02510794|585323950|FG003|Overall Study|Adverse Event|0|||
162072689|NCT02510794|585323947|FG000|Overall Study|Death|1|||
162072690|NCT02510794|585323948|FG001|Overall Study|Death|2|||
162072691|NCT02510794|585323949|FG002|Overall Study|Death|1|||
162072692|NCT02510794|585323950|FG003|Overall Study|Death|1|||
162072693|NCT02510794|585323947|FG000|Overall Study|Lack of Efficacy|3|||
162072694|NCT02510794|585323948|FG001|Overall Study|Lack of Efficacy|1|||
162072695|NCT02510794|585323949|FG002|Overall Study|Lack of Efficacy|1|||
162072696|NCT02510794|585323950|FG003|Overall Study|Lack of Efficacy|0|||
162072697|NCT02510794|585323947|FG000|Overall Study|Participant moved out of the area|0|||
162072698|NCT02510794|585323948|FG001|Overall Study|Participant moved out of the area|0|||
162072699|NCT02510794|585323949|FG002|Overall Study|Participant moved out of the area|0|||
162072700|NCT02510794|585323950|FG003|Overall Study|Participant moved out of the area|1|||
162072701|NCT02510794|585323947|FG000|Overall Study|Physician Decision|3|||
162072702|NCT02510794|585323948|FG001|Overall Study|Physician Decision|0|||
162072703|NCT02510794|585323949|FG002|Overall Study|Physician Decision|0|||
162072704|NCT02510794|585323950|FG003|Overall Study|Physician Decision|0|||
162072705|NCT02510794|585323947|FG000|Overall Study|Protocol Violation|0|||
162072706|NCT02510794|585323948|FG001|Overall Study|Protocol Violation|0|||
162072707|NCT02510794|585323949|FG002|Overall Study|Protocol Violation|1|||
162072708|NCT02510794|585323950|FG003|Overall Study|Protocol Violation|0|||
162072709|NCT02510794|585323947|FG000|Overall Study|Withdrawal by Subject|1|||
162072710|NCT02510794|585323948|FG001|Overall Study|Withdrawal by Subject|2|||
162072711|NCT02510794|585323949|FG002|Overall Study|Withdrawal by Subject|4|||
162072712|NCT02510794|585323950|FG003|Overall Study|Withdrawal by Subject|3|||
162072713|NCT01649375|585323951|FG000|Up to Week 16|Adverse Event|2|||
162072714|NCT01649375|585323952|FG001|Up to Week 16|Adverse Event|5|||
162072715|NCT01649375|585323953|FG002|Up to Week 16|Adverse Event|4|||
162072716|NCT01649375|585323954|FG003|Up to Week 16|Adverse Event|0|||
162072717|NCT01649375|585323955|FG004|Up to Week 16|Adverse Event|0|||
162072718|NCT01649375|585323951|FG000|Up to Week 16|Lack of Efficacy|0|||
162072719|NCT01649375|585323952|FG001|Up to Week 16|Lack of Efficacy|0|||
162072720|NCT01649375|585323953|FG002|Up to Week 16|Lack of Efficacy|1|||
162072721|NCT01649375|585323954|FG003|Up to Week 16|Lack of Efficacy|0|||
162072722|NCT01649375|585323955|FG004|Up to Week 16|Lack of Efficacy|0|||
162072723|NCT01649375|585323951|FG000|Up to Week 16|Physician Decision|0|||
162072724|NCT01649375|585323952|FG001|Up to Week 16|Physician Decision|0|||
162072725|NCT01649375|585323953|FG002|Up to Week 16|Physician Decision|1|||
162072726|NCT01649375|585323954|FG003|Up to Week 16|Physician Decision|0|||
162072727|NCT01649375|585323955|FG004|Up to Week 16|Physician Decision|0|||
162072728|NCT01649375|585323951|FG000|Up to Week 16|Withdrawal by Subject|2|||
162072729|NCT01649375|585323952|FG001|Up to Week 16|Withdrawal by Subject|1|||
162072730|NCT01649375|585323953|FG002|Up to Week 16|Withdrawal by Subject|2|||
162072731|NCT01649375|585323954|FG003|Up to Week 16|Withdrawal by Subject|0|||
162072732|NCT01649375|585323955|FG004|Up to Week 16|Withdrawal by Subject|0|||
162072733|NCT01649375|585323951|FG000|Up to Week 16|Death|1|||
162072734|NCT01649375|585323952|FG001|Up to Week 16|Death|0|||
162072735|NCT01649375|585323953|FG002|Up to Week 16|Death|0|||
162072736|NCT01649375|585323954|FG003|Up to Week 16|Death|0|||
162072737|NCT01649375|585323955|FG004|Up to Week 16|Death|0|||
162072738|NCT01649375|585323951|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
162072739|NCT01649375|585323952|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
162072740|NCT01649375|585323953|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
162072741|NCT01649375|585323954|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
162072742|NCT01649375|585323955|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
162072743|NCT01649375|585323951|FG000|Week 16 up to Week 260|Non-compliance|0|||
162072744|NCT01649375|585323952|FG001|Week 16 up to Week 260|Non-compliance|1|||
162072745|NCT01649375|585323953|FG002|Week 16 up to Week 260|Non-compliance|0|||
162072746|NCT01649375|585323954|FG003|Week 16 up to Week 260|Non-compliance|1|||
162072747|NCT01649375|585323955|FG004|Week 16 up to Week 260|Non-compliance|0|||
162072748|NCT01649375|585323951|FG000|Week 16 up to Week 260|Physician Decision|0|||
162072749|NCT01649375|585323952|FG001|Week 16 up to Week 260|Physician Decision|2|||
162072750|NCT01649375|585323953|FG002|Week 16 up to Week 260|Physician Decision|0|||
162072751|NCT01649375|585323954|FG003|Week 16 up to Week 260|Physician Decision|0|||
162072752|NCT01649375|585323955|FG004|Week 16 up to Week 260|Physician Decision|0|||
162072753|NCT01649375|585323951|FG000|Week 16 up to Week 260|Technical issues|0|||
162072754|NCT01649375|585323952|FG001|Week 16 up to Week 260|Technical issues|1|||
162072755|NCT01649375|585323953|FG002|Week 16 up to Week 260|Technical issues|0|||
162072756|NCT01649375|585323954|FG003|Week 16 up to Week 260|Technical issues|1|||
162072757|NCT01649375|585323955|FG004|Week 16 up to Week 260|Technical issues|0|||
162072758|NCT01649375|585323951|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
162072759|NCT01649375|585323952|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
162072760|NCT01649375|585323953|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
162072761|NCT01649375|585323954|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
162072762|NCT01649375|585323955|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
162072763|NCT01649375|585323951|FG000|Week 16 up to Week 260|Death|1|||
162072764|NCT01649375|585323952|FG001|Week 16 up to Week 260|Death|1|||
162072765|NCT01649375|585323953|FG002|Week 16 up to Week 260|Death|0|||
162072766|NCT01649375|585323954|FG003|Week 16 up to Week 260|Death|0|||
162072767|NCT01649375|585323955|FG004|Week 16 up to Week 260|Death|0|||
162072768|NCT01649375|585323951|FG000|Week 16 up to Week 260|Adverse Event|5|||
162072769|NCT01649375|585323952|FG001|Week 16 up to Week 260|Adverse Event|2|||
162072770|NCT01649375|585323953|FG002|Week 16 up to Week 260|Adverse Event|0|||
162072771|NCT01649375|585323954|FG003|Week 16 up to Week 260|Adverse Event|3|||
162072772|NCT01649375|585323955|FG004|Week 16 up to Week 260|Adverse Event|2|||
162072773|NCT01856790|585323956|FG000|Closed Loop Control|Withdrawal by Subject|2|||
162072774|NCT01856790|585323956|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
162072775|NCT04091646|585323959|FG000|Overall Study|Adverse Event|2|||
162072776|NCT04091646|585323960|FG001|Overall Study|Adverse Event|1|||
162072777|NCT04091646|585323959|FG000|Overall Study|Lost to Follow-up|6|||
162072778|NCT04091646|585323960|FG001|Overall Study|Lost to Follow-up|2|||
162072779|NCT04091646|585323959|FG000|Overall Study|Protocol Violation|0|||
162072780|NCT04091646|585323960|FG001|Overall Study|Protocol Violation|1|||
162072781|NCT04091646|585323959|FG000|Overall Study|Withdrawal by Subject|4|||
162072782|NCT04091646|585323960|FG001|Overall Study|Withdrawal by Subject|1|||
162072783|NCT04091646|585323959|FG000|Overall Study|Participant Incarcerated|1|||
162072784|NCT04091646|585323960|FG001|Overall Study|Participant Incarcerated|0|||
162072785|NCT01921829|585323961|FG000|Overall Study|Withdrawal by Subject|0|||
162072786|NCT01921829|585323962|FG001|Overall Study|Withdrawal by Subject|1|||
162072787|NCT04765358|585323967|FG000|Overall Study|Withdrawal by Subject|1|||
162072788|NCT01316276|585323968|FG000|Overall Study|Death|1|||
162072789|NCT01316276|585323968|FG000|Overall Study|Adverse Event|19|||
162072790|NCT01316276|585323968|FG000|Overall Study|Withdrawal of consent|24|||
162072791|NCT01316276|585323968|FG000|Overall Study|Lost to Follow-up|1|||
162072792|NCT01316276|585323968|FG000|Overall Study|Other|22|||
162072793|NCT00605475|585323969|FG000|Overall Study|Abnormal Laboratory Values|0|||
162072794|NCT00605475|585323970|FG001|Overall Study|Abnormal Laboratory Values|0|||
162072795|NCT00605475|585323971|FG002|Overall Study|Abnormal Laboratory Values|0|||
162072796|NCT00605475|585323972|FG003|Overall Study|Abnormal Laboratory Values|0|||
162072797|NCT00605475|585323973|FG004|Overall Study|Abnormal Laboratory Values|0|||
162072798|NCT00605475|585323974|FG005|Overall Study|Abnormal Laboratory Values|0|||
162072799|NCT00605475|585323975|FG006|Overall Study|Abnormal Laboratory Values|0|||
162072800|NCT00605475|585323976|FG007|Overall Study|Abnormal Laboratory Values|0|||
162072801|NCT00605475|585323977|FG008|Overall Study|Abnormal Laboratory Values|1|||
162072802|NCT00605475|585323978|FG009|Overall Study|Abnormal Laboratory Values|0|||
162072803|NCT00605475|585323969|FG000|Overall Study|Administrative problems|0|||
162072804|NCT00605475|585323970|FG001|Overall Study|Administrative problems|0|||
162072805|NCT00605475|585323971|FG002|Overall Study|Administrative problems|0|||
162072806|NCT00605475|585323972|FG003|Overall Study|Administrative problems|0|||
162072807|NCT00605475|585323973|FG004|Overall Study|Administrative problems|0|||
162072808|NCT00605475|585323974|FG005|Overall Study|Administrative problems|0|||
162072809|NCT00605475|585323975|FG006|Overall Study|Administrative problems|1|||
162072810|NCT00605475|585323976|FG007|Overall Study|Administrative problems|0|||
162072811|NCT00605475|585323977|FG008|Overall Study|Administrative problems|0|||
162072812|NCT00605475|585323978|FG009|Overall Study|Administrative problems|0|||
162072813|NCT00605475|585323969|FG000|Overall Study|Lost to Follow-up|0|||
162072814|NCT00605475|585323970|FG001|Overall Study|Lost to Follow-up|0|||
162072815|NCT00605475|585323971|FG002|Overall Study|Lost to Follow-up|0|||
162072816|NCT00605475|585323972|FG003|Overall Study|Lost to Follow-up|0|||
162072817|NCT00605475|585323973|FG004|Overall Study|Lost to Follow-up|0|||
162072818|NCT00605475|585323974|FG005|Overall Study|Lost to Follow-up|0|||
162072819|NCT00605475|585323975|FG006|Overall Study|Lost to Follow-up|0|||
162072820|NCT00605475|585323976|FG007|Overall Study|Lost to Follow-up|0|||
162072821|NCT00605475|585323977|FG008|Overall Study|Lost to Follow-up|1|||
162072822|NCT00605475|585323978|FG009|Overall Study|Lost to Follow-up|1|||
162072823|NCT00605475|585323969|FG000|Overall Study|Protocol Violation|0|||
162072824|NCT00605475|585323970|FG001|Overall Study|Protocol Violation|0|||
162072825|NCT00605475|585323971|FG002|Overall Study|Protocol Violation|0|||
162072826|NCT00605475|585323972|FG003|Overall Study|Protocol Violation|0|||
162072827|NCT00605475|585323973|FG004|Overall Study|Protocol Violation|1|||
162072828|NCT00605475|585323974|FG005|Overall Study|Protocol Violation|0|||
162072829|NCT00605475|585323975|FG006|Overall Study|Protocol Violation|0|||
162072830|NCT00605475|585323976|FG007|Overall Study|Protocol Violation|0|||
162072831|NCT00605475|585323977|FG008|Overall Study|Protocol Violation|0|||
162072832|NCT00605475|585323978|FG009|Overall Study|Protocol Violation|0|||
162072833|NCT00605475|585323969|FG000|Overall Study|Withdrawal by Subject|0|||
162072834|NCT00605475|585323970|FG001|Overall Study|Withdrawal by Subject|0|||
162072835|NCT00605475|585323971|FG002|Overall Study|Withdrawal by Subject|0|||
162072836|NCT00605475|585323972|FG003|Overall Study|Withdrawal by Subject|0|||
162072837|NCT00605475|585323973|FG004|Overall Study|Withdrawal by Subject|0|||
162072838|NCT00605475|585323974|FG005|Overall Study|Withdrawal by Subject|2|||
162072839|NCT00605475|585323975|FG006|Overall Study|Withdrawal by Subject|0|||
162072840|NCT00605475|585323976|FG007|Overall Study|Withdrawal by Subject|0|||
162072841|NCT00605475|585323977|FG008|Overall Study|Withdrawal by Subject|0|||
162072842|NCT00605475|585323978|FG009|Overall Study|Withdrawal by Subject|1|||
162072843|NCT03538158|585323984|FG000|Overall Study|Lost to Follow-up|13|||
162072844|NCT03538158|585323985|FG001|Overall Study|Lost to Follow-up|7|||
162072845|NCT03538158|585323984|FG000|Overall Study|Withdrawal by Subject|2|||
162072846|NCT03538158|585323985|FG001|Overall Study|Withdrawal by Subject|1|||
162072847|NCT02419742|585323988|FG000|Overall Study|Adverse Event|2|||
162072848|NCT02419742|585323989|FG001|Overall Study|Adverse Event|0|||
162072849|NCT02419742|585323988|FG000|Overall Study|Disease Progression|0|||
162072850|NCT02419742|585323989|FG001|Overall Study|Disease Progression|1|||
162072851|NCT02419742|585323988|FG000|Overall Study|Withdrew Consent|2|||
162072852|NCT02419742|585323989|FG001|Overall Study|Withdrew Consent|1|||
162072853|NCT02419742|585323988|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
162072854|NCT02419742|585323989|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
162072855|NCT02255981|585323990|FG000|Overall Study|Lost to Follow-up|3|||
162072856|NCT02255981|585323990|FG000|Overall Study|Withdrawal by Subject|1|||
162072857|NCT04649164|585323995|FG000|Overall Study|Withdrawal by Subject|1|||
162072858|NCT04649164|585323996|FG001|Overall Study|Withdrawal by Subject|1|||
162072859|NCT04649164|585323997|FG002|Overall Study|Withdrawal by Subject|2|||
162072860|NCT04649164|585323995|FG000|Overall Study|Participant's care recipient expired|0|||
162072861|NCT04649164|585323996|FG001|Overall Study|Participant's care recipient expired|0|||
162072862|NCT04649164|585323997|FG002|Overall Study|Participant's care recipient expired|2|||
162072863|NCT04356963|585324003|FG000|First Session|Withdrawal by Subject|1|||
162072864|NCT04356963|585324003|FG000|Second Session|Withdrawal by Subject|3|||
162072865|NCT04356963|585324003|FG000|Second Session|Lost to Follow-up|1|||
162072866|NCT04356963|585324003|FG000|Third Session|Lost to Follow-up|6|||
162072867|NCT04356963|585324003|FG000|Third Session|Withdrawal by Subject|1|||
162072868|NCT02410954|585324006|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
162072869|NCT02410954|585324007|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
162072870|NCT02410954|585324006|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
162072871|NCT02410954|585324007|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
162072872|NCT00791518|585324009|FG000|Overall Study|Protocol Violation|93|||
162072873|NCT02488681|585324010|FG000|Overall Study|Implant unsuccessful|7|||
162072874|NCT00720057|585324013|FG000|Overall Study|Lost to Follow-up|0|||
162072875|NCT00720057|585324014|FG001|Overall Study|Lost to Follow-up|2|||
162072876|NCT00720057|585324013|FG000|Overall Study|Protocol Violation|1|||
162072877|NCT00720057|585324014|FG001|Overall Study|Protocol Violation|0|||
162072878|NCT00720057|585324013|FG000|Overall Study|Withdrawal by Subject|0|||
162072879|NCT00720057|585324014|FG001|Overall Study|Withdrawal by Subject|1|||
162072880|NCT00271609|585324024|FG000|Overall Study|Adverse Event|11|||
162072881|NCT00271609|585324025|FG001|Overall Study|Adverse Event|3|||
162072882|NCT00271609|585324024|FG000|Overall Study|Withdrawal by Subject|2|||
162072883|NCT00271609|585324025|FG001|Overall Study|Withdrawal by Subject|0|||
162072884|NCT03341533|585324026|FG000|Overall Study|Withdrawal by Subject|1|||
162072885|NCT03341533|585324027|FG001|Overall Study|Withdrawal by Subject|1|||
162072886|NCT03341533|585324026|FG000|Overall Study|Not eligible after randomization|2|||
162072887|NCT03341533|585324027|FG001|Overall Study|Not eligible after randomization|1|||
162072888|NCT00643682|585324028|FG000|Overall Study|did not keep appointment|522|||
162072889|NCT00643682|585324029|FG001|Overall Study|did not keep appointment|509|||
162072890|NCT01782664|585324031|FG000|Overall Study|Adverse Event|2|||
162072891|NCT01782664|585324032|FG001|Overall Study|Adverse Event|2|||
162072892|NCT01782664|585324033|FG002|Overall Study|Adverse Event|2|||
162072893|NCT01782664|585324034|FG003|Overall Study|Adverse Event|2|||
162072894|NCT01782664|585324035|FG004|Overall Study|Adverse Event|0|||
162072895|NCT01782664|585324036|FG005|Overall Study|Adverse Event|0|||
162072896|NCT01782664|585324031|FG000|Overall Study|Lack of Efficacy|2|||
162072897|NCT01782664|585324032|FG001|Overall Study|Lack of Efficacy|0|||
162072898|NCT01782664|585324033|FG002|Overall Study|Lack of Efficacy|2|||
162072899|NCT01782664|585324034|FG003|Overall Study|Lack of Efficacy|2|||
162072900|NCT01782664|585324035|FG004|Overall Study|Lack of Efficacy|0|||
162072901|NCT01782664|585324036|FG005|Overall Study|Lack of Efficacy|0|||
162072902|NCT01782664|585324031|FG000|Overall Study|Protocol Violation|0|||
162072903|NCT01782664|585324032|FG001|Overall Study|Protocol Violation|1|||
162072904|NCT01782664|585324033|FG002|Overall Study|Protocol Violation|0|||
162072905|NCT01782664|585324034|FG003|Overall Study|Protocol Violation|1|||
162072906|NCT01782664|585324035|FG004|Overall Study|Protocol Violation|0|||
162072907|NCT01782664|585324036|FG005|Overall Study|Protocol Violation|0|||
162072908|NCT01782664|585324031|FG000|Overall Study|Withdrawal by Subject|2|||
162072909|NCT01782664|585324032|FG001|Overall Study|Withdrawal by Subject|2|||
162072910|NCT01782664|585324033|FG002|Overall Study|Withdrawal by Subject|0|||
162072911|NCT01782664|585324034|FG003|Overall Study|Withdrawal by Subject|0|||
162072912|NCT01782664|585324035|FG004|Overall Study|Withdrawal by Subject|0|||
162072913|NCT01782664|585324036|FG005|Overall Study|Withdrawal by Subject|0|||
162072914|NCT04170348|585324037|FG000|Overall Study|Lost to Follow-up|2|||
162072915|NCT04170348|585324038|FG001|Overall Study|Lost to Follow-up|2|||
162072916|NCT04170348|585324037|FG000|Overall Study|Withdrawal by Subject|1|||
162072917|NCT04170348|585324038|FG001|Overall Study|Withdrawal by Subject|5|||
162072918|NCT04170348|585324037|FG000|Overall Study|Non-adherence|1|||
162072919|NCT04170348|585324038|FG001|Overall Study|Non-adherence|1|||
162072920|NCT04170348|585324037|FG000|Overall Study|Adverse Event|1|||
162072921|NCT04170348|585324038|FG001|Overall Study|Adverse Event|0|||
162072922|NCT01082965|585324040|FG000|Overall Study|Protocol Violation|0|||
162072923|NCT01082965|585324041|FG001|Overall Study|Protocol Violation|1|||
162072924|NCT01082965|585324040|FG000|Overall Study|Other|1|||
162072925|NCT01082965|585324041|FG001|Overall Study|Other|1|||
162072926|NCT05198843|585324043|FG000|Overall Study|Lack of Efficacy|1|||
162072927|NCT03188094|585324046|FG000|Overall Study|Screen failure|1|||
162072928|NCT03188094|585324047|FG001|Overall Study|Screen failure|0|||
162072929|NCT03188094|585324048|FG002|Overall Study|Screen failure|0|||
162072930|NCT03188094|585324046|FG000|Overall Study|Pregnancy|3|||
162072931|NCT03188094|585324047|FG001|Overall Study|Pregnancy|0|||
162072932|NCT03188094|585324048|FG002|Overall Study|Pregnancy|0|||
162072933|NCT03188094|585324046|FG000|Overall Study|Ineligible|1|||
162072934|NCT03188094|585324047|FG001|Overall Study|Ineligible|0|||
162072935|NCT03188094|585324048|FG002|Overall Study|Ineligible|0|||
162072936|NCT03188094|585324046|FG000|Overall Study|Lost to Follow-up|0|||
162072937|NCT03188094|585324047|FG001|Overall Study|Lost to Follow-up|0|||
162072938|NCT03188094|585324048|FG002|Overall Study|Lost to Follow-up|17|||
162072939|NCT04307446|585325970|FG000|Overall Study|Lost to Follow-up|2|||
162072940|NCT04307446|585325971|FG001|Overall Study|Lost to Follow-up|0|||
162072941|NCT02515942|585325972|FG000|Overall Study|Adverse Event|5|||
162072942|NCT02515942|585325973|FG001|Overall Study|Adverse Event|0|||
162072943|NCT02515942|585325974|FG002|Overall Study|Adverse Event|0|||
162072944|NCT02515942|585325972|FG000|Overall Study|Death|0|||
162072945|NCT02515942|585325973|FG001|Overall Study|Death|0|||
162072946|NCT02515942|585325974|FG002|Overall Study|Death|1|||
162072947|NCT02515942|585325972|FG000|Overall Study|Lack of Efficacy|0|||
162072948|NCT02515942|585325973|FG001|Overall Study|Lack of Efficacy|0|||
162072949|NCT02515942|585325974|FG002|Overall Study|Lack of Efficacy|1|||
162072950|NCT02515942|585325972|FG000|Overall Study|Lost to Follow-up|2|||
162072951|NCT02515942|585325973|FG001|Overall Study|Lost to Follow-up|0|||
162072952|NCT02515942|585325974|FG002|Overall Study|Lost to Follow-up|0|||
162072953|NCT02515942|585325972|FG000|Overall Study|Withdrawal by Subject|0|||
162072954|NCT02515942|585325973|FG001|Overall Study|Withdrawal by Subject|3|||
162072955|NCT02515942|585325974|FG002|Overall Study|Withdrawal by Subject|2|||
162072956|NCT05620576|585325975|FG000|Overall Study|Adverse Event|1|||
162072957|NCT05620576|585325976|FG001|Overall Study|Adverse Event|1|||
162072958|NCT05620576|585325975|FG000|Overall Study|Lost to Follow-up|3|||
162072959|NCT05620576|585325976|FG001|Overall Study|Lost to Follow-up|1|||
162072960|NCT05620576|585325975|FG000|Overall Study|Physician Decision|0|||
162072961|NCT05620576|585325976|FG001|Overall Study|Physician Decision|1|||
162072962|NCT05620576|585325975|FG000|Overall Study|Protocol Deviation|1|||
162072963|NCT05620576|585325976|FG001|Overall Study|Protocol Deviation|1|||
162072964|NCT05620576|585325975|FG000|Overall Study|Withdrawal by Subject|2|||
162072965|NCT05620576|585325976|FG001|Overall Study|Withdrawal by Subject|3|||
162072966|NCT02622828|585325977|FG000|Overall Study|participant withdrew|3|||
162072967|NCT03616912|585325978|FG000|Overall Study|Adverse Event|17|||
162072968|NCT03616912|585325979|FG001|Overall Study|Adverse Event|21|||
162072969|NCT03616912|585325980|FG002|Overall Study|Adverse Event|9|||
162072970|NCT03616912|585325981|FG003|Overall Study|Adverse Event|0|||
162072971|NCT03616912|585325982|FG004|Overall Study|Adverse Event|0|||
162072972|NCT03616912|585325983|FG005|Overall Study|Adverse Event|0|||
162072973|NCT03616912|585325978|FG000|Overall Study|Death|1|||
162072974|NCT03616912|585325979|FG001|Overall Study|Death|1|||
162072975|NCT03616912|585325980|FG002|Overall Study|Death|0|||
162072976|NCT03616912|585325981|FG003|Overall Study|Death|0|||
162072977|NCT03616912|585325982|FG004|Overall Study|Death|0|||
162072978|NCT03616912|585325983|FG005|Overall Study|Death|0|||
162072979|NCT03616912|585325978|FG000|Overall Study|Lack of Efficacy|13|||
162072980|NCT03616912|585325979|FG001|Overall Study|Lack of Efficacy|6|||
162072981|NCT03616912|585325980|FG002|Overall Study|Lack of Efficacy|8|||
162072982|NCT03616912|585325981|FG003|Overall Study|Lack of Efficacy|4|||
162072983|NCT03616912|585325982|FG004|Overall Study|Lack of Efficacy|5|||
162072984|NCT03616912|585325983|FG005|Overall Study|Lack of Efficacy|1|||
162072985|NCT03616912|585325978|FG000|Overall Study|Lost to Follow-up|1|||
162072986|NCT03616912|585325979|FG001|Overall Study|Lost to Follow-up|2|||
162072987|NCT03616912|585325980|FG002|Overall Study|Lost to Follow-up|3|||
162072988|NCT03616912|585325981|FG003|Overall Study|Lost to Follow-up|0|||
162072989|NCT03616912|585325982|FG004|Overall Study|Lost to Follow-up|0|||
162072990|NCT03616912|585325983|FG005|Overall Study|Lost to Follow-up|0|||
162072991|NCT03616912|585325978|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
162072992|NCT03616912|585325979|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
162072993|NCT03616912|585325980|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
162072994|NCT03616912|585325981|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
162072995|NCT03616912|585325982|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
162072996|NCT03616912|585325983|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
162072997|NCT03616912|585325978|FG000|Overall Study|Withdrawal by Subject|12|||
162072998|NCT03616912|585325979|FG001|Overall Study|Withdrawal by Subject|12|||
162072999|NCT03616912|585325980|FG002|Overall Study|Withdrawal by Subject|15|||
162073000|NCT03616912|585325981|FG003|Overall Study|Withdrawal by Subject|2|||
162073001|NCT03616912|585325982|FG004|Overall Study|Withdrawal by Subject|0|||
162073002|NCT03616912|585325983|FG005|Overall Study|Withdrawal by Subject|2|||
162073003|NCT03616912|585325978|FG000|Overall Study|Study Terminated by Sponsor|0|||
162073004|NCT03616912|585325979|FG001|Overall Study|Study Terminated by Sponsor|0|||
162073005|NCT03616912|585325980|FG002|Overall Study|Study Terminated by Sponsor|0|||
162073006|NCT03616912|585325981|FG003|Overall Study|Study Terminated by Sponsor|10|||
162073007|NCT03616912|585325982|FG004|Overall Study|Study Terminated by Sponsor|9|||
162073008|NCT03616912|585325983|FG005|Overall Study|Study Terminated by Sponsor|11|||
162073009|NCT03616912|585325978|FG000|Overall Study|Protocol Deviation|1|||
162073010|NCT03616912|585325979|FG001|Overall Study|Protocol Deviation|1|||
162073011|NCT03616912|585325980|FG002|Overall Study|Protocol Deviation|0|||
162073012|NCT03616912|585325981|FG003|Overall Study|Protocol Deviation|0|||
162073013|NCT03616912|585325982|FG004|Overall Study|Protocol Deviation|0|||
162073014|NCT03616912|585325983|FG005|Overall Study|Protocol Deviation|0|||
162073015|NCT03616912|585325978|FG000|Overall Study|Pregnancy|1|||
162073016|NCT03616912|585325979|FG001|Overall Study|Pregnancy|0|||
162073017|NCT03616912|585325980|FG002|Overall Study|Pregnancy|4|||
162073018|NCT03616912|585325981|FG003|Overall Study|Pregnancy|0|||
162073019|NCT03616912|585325982|FG004|Overall Study|Pregnancy|0|||
162073020|NCT03616912|585325983|FG005|Overall Study|Pregnancy|0|||
162073021|NCT03616912|585325978|FG000|Overall Study|Protocol Violation|1|||
162073022|NCT03616912|585325979|FG001|Overall Study|Protocol Violation|0|||
162073023|NCT03616912|585325980|FG002|Overall Study|Protocol Violation|2|||
162073024|NCT03616912|585325981|FG003|Overall Study|Protocol Violation|0|||
162073025|NCT03616912|585325982|FG004|Overall Study|Protocol Violation|0|||
162073026|NCT03616912|585325983|FG005|Overall Study|Protocol Violation|0|||
162073027|NCT03616912|585325978|FG000|Overall Study|Physician Decision|2|||
162073028|NCT03616912|585325979|FG001|Overall Study|Physician Decision|0|||
162073029|NCT03616912|585325980|FG002|Overall Study|Physician Decision|0|||
162073030|NCT03616912|585325981|FG003|Overall Study|Physician Decision|0|||
162073031|NCT03616912|585325982|FG004|Overall Study|Physician Decision|1|||
162073032|NCT03616912|585325983|FG005|Overall Study|Physician Decision|0|||
162073033|NCT03616912|585325978|FG000|Overall Study|Randomized But Never Treated|0|||
162073034|NCT03616912|585325979|FG001|Overall Study|Randomized But Never Treated|2|||
162073035|NCT03616912|585325980|FG002|Overall Study|Randomized But Never Treated|0|||
162073036|NCT03616912|585325981|FG003|Overall Study|Randomized But Never Treated|0|||
162073037|NCT03616912|585325982|FG004|Overall Study|Randomized But Never Treated|0|||
162073038|NCT03616912|585325983|FG005|Overall Study|Randomized But Never Treated|0|||
162073039|NCT01124604|585325984|FG000|Overall Study|Adverse Event|10|||
162073040|NCT01124604|585325985|FG001|Overall Study|Adverse Event|1|||
162073041|NCT01124604|585325984|FG000|Overall Study|Lack of Efficacy|1|||
162073042|NCT01124604|585325985|FG001|Overall Study|Lack of Efficacy|0|||
162073043|NCT01124604|585325984|FG000|Overall Study|Withdrawal by Subject|4|||
162073044|NCT01124604|585325985|FG001|Overall Study|Withdrawal by Subject|0|||
162073045|NCT01124604|585325984|FG000|Overall Study|Disease Progression|0|||
162073046|NCT01124604|585325985|FG001|Overall Study|Disease Progression|1|||
162073047|NCT01859507|585325986|FG000|Overall Study|left the country|4|||
162073048|NCT01762943|585325987|FG000|Overall Study|Physician Decision|1|||
162073049|NCT01762943|585325988|FG001|Overall Study|Physician Decision|1|||
162073050|NCT01762943|585325987|FG000|Overall Study|Protocol Violation|1|||
162073051|NCT01762943|585325988|FG001|Overall Study|Protocol Violation|0|||
162073052|NCT01762943|585325987|FG000|Overall Study|Withdrawal by Subject|2|||
162073053|NCT01762943|585325988|FG001|Overall Study|Withdrawal by Subject|1|||
162073054|NCT00539838|585325989|FG000|Overall Study|Fail to return|2|||
162073055|NCT00539838|585325990|FG001|Overall Study|Fail to return|0|||
162073056|NCT00539838|585325991|FG002|Overall Study|Fail to return|0|||
162073057|NCT00539838|585325989|FG000|Overall Study|Withdrawal by Subject|0|||
162073058|NCT00539838|585325990|FG001|Overall Study|Withdrawal by Subject|4|||
162073059|NCT00539838|585325991|FG002|Overall Study|Withdrawal by Subject|0|||
162073060|NCT00539838|585325989|FG000|Overall Study|Death|0|||
162073061|NCT00539838|585325990|FG001|Overall Study|Death|2|||
162073062|NCT00539838|585325991|FG002|Overall Study|Death|0|||
162073063|NCT00539838|585325989|FG000|Overall Study|Did not cooperate|1|||
162073064|NCT00539838|585325990|FG001|Overall Study|Did not cooperate|0|||
162073065|NCT00539838|585325991|FG002|Overall Study|Did not cooperate|1|||
162073066|NCT00539838|585325989|FG000|Overall Study|Administrative|4|||
162073067|NCT00539838|585325990|FG001|Overall Study|Administrative|0|||
162073068|NCT00539838|585325991|FG002|Overall Study|Administrative|8|||
162073069|NCT02474199|585325995|FG000|Overall Study|Lost to Follow-up|1|||
162073070|NCT02474199|585325996|FG001|Overall Study|Lost to Follow-up|0|||
162073071|NCT02474199|585325997|FG002|Overall Study|Lost to Follow-up|0|||
162073072|NCT02474199|585325998|FG003|Overall Study|Lost to Follow-up|0|||
162073073|NCT02474199|585325995|FG000|Overall Study|Withdrawal by Subject|1|||
162073074|NCT02474199|585325996|FG001|Overall Study|Withdrawal by Subject|2|||
162073075|NCT02474199|585325997|FG002|Overall Study|Withdrawal by Subject|0|||
162073076|NCT02474199|585325998|FG003|Overall Study|Withdrawal by Subject|1|||
162073077|NCT02474199|585325995|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
162073078|NCT02474199|585325996|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
162073079|NCT02474199|585325997|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
162073080|NCT02474199|585325998|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
162073081|NCT02474199|585325995|FG000|Overall Study|Did not meet eligibility criteria|0|||
162073082|NCT02474199|585325996|FG001|Overall Study|Did not meet eligibility criteria|0|||
162073083|NCT02474199|585325997|FG002|Overall Study|Did not meet eligibility criteria|2|||
162073084|NCT02474199|585325998|FG003|Overall Study|Did not meet eligibility criteria|2|||
162073085|NCT03090100|585325999|FG000|Overall Study|Adverse Event|9|||
162073086|NCT03090100|585326000|FG001|Overall Study|Adverse Event|11|||
162073087|NCT03090100|585325999|FG000|Overall Study|Pregnancy|1|||
162073088|NCT03090100|585326000|FG001|Overall Study|Pregnancy|1|||
162073089|NCT03090100|585325999|FG000|Overall Study|Lack of Efficacy|2|||
162073090|NCT03090100|585326000|FG001|Overall Study|Lack of Efficacy|7|||
162073091|NCT03090100|585325999|FG000|Overall Study|Lost to Follow-up|2|||
162073092|NCT03090100|585326000|FG001|Overall Study|Lost to Follow-up|2|||
162073093|NCT03090100|585325999|FG000|Overall Study|Withdrawal by Subject|7|||
162073094|NCT03090100|585326000|FG001|Overall Study|Withdrawal by Subject|19|||
162073095|NCT03090100|585325999|FG000|Overall Study|Protocol Violation|2|||
162073096|NCT03090100|585326000|FG001|Overall Study|Protocol Violation|6|||
162073097|NCT03090100|585325999|FG000|Overall Study|Non-compliance|2|||
162073098|NCT03090100|585326000|FG001|Overall Study|Non-compliance|0|||
162073099|NCT03090100|585325999|FG000|Overall Study|Other|2|||
162073100|NCT03090100|585326000|FG001|Overall Study|Other|2|||
162073101|NCT03446040|585326003|FG000|Overall Study|Disease progression|3|||
162073102|NCT03446040|585326004|FG001|Overall Study|Disease progression|3|||
162073103|NCT03446040|585326005|FG002|Overall Study|Disease progression|3|||
162073104|NCT03446040|585326006|FG003|Overall Study|Disease progression|4|||
162073105|NCT03446040|585326007|FG004|Overall Study|Disease progression|4|||
162073106|NCT03446040|585326008|FG005|Overall Study|Disease progression|6|||
162073107|NCT03446040|585326009|FG006|Overall Study|Disease progression|3|||
162073108|NCT03446040|585326010|FG007|Overall Study|Disease progression|4|||
162073109|NCT03446040|585326011|FG008|Overall Study|Disease progression|2|||
162073110|NCT03446040|585326012|FG009|Overall Study|Disease progression|4|||
162073111|NCT03446040|585326013|FG010|Overall Study|Disease progression|9|||
162073112|NCT03446040|585326014|FG011|Overall Study|Disease progression|3|||
162073113|NCT03446040|585326015|FG012|Overall Study|Disease progression|7|||
162073114|NCT03446040|585326016|FG013|Overall Study|Disease progression|7|||
162073115|NCT03446040|585326003|FG000|Overall Study|Study drug toxicity|0|||
162073116|NCT03446040|585326004|FG001|Overall Study|Study drug toxicity|0|||
162073117|NCT03446040|585326005|FG002|Overall Study|Study drug toxicity|0|||
162073118|NCT03446040|585326006|FG003|Overall Study|Study drug toxicity|0|||
162073119|NCT03446040|585326007|FG004|Overall Study|Study drug toxicity|0|||
162073120|NCT03446040|585326008|FG005|Overall Study|Study drug toxicity|0|||
162073121|NCT03446040|585326009|FG006|Overall Study|Study drug toxicity|0|||
162073122|NCT03446040|585326010|FG007|Overall Study|Study drug toxicity|0|||
162073123|NCT03446040|585326011|FG008|Overall Study|Study drug toxicity|1|||
162073124|NCT03446040|585326012|FG009|Overall Study|Study drug toxicity|0|||
162073125|NCT03446040|585326013|FG010|Overall Study|Study drug toxicity|0|||
162073126|NCT03446040|585326014|FG011|Overall Study|Study drug toxicity|0|||
162073127|NCT03446040|585326015|FG012|Overall Study|Study drug toxicity|0|||
162073128|NCT03446040|585326016|FG013|Overall Study|Study drug toxicity|0|||
162073129|NCT03446040|585326003|FG000|Overall Study|Adverse Event|0|||
162073130|NCT03446040|585326004|FG001|Overall Study|Adverse Event|0|||
162073131|NCT03446040|585326005|FG002|Overall Study|Adverse Event|0|||
162073132|NCT03446040|585326006|FG003|Overall Study|Adverse Event|0|||
162073133|NCT03446040|585326007|FG004|Overall Study|Adverse Event|0|||
162073134|NCT03446040|585326008|FG005|Overall Study|Adverse Event|2|||
162073135|NCT03446040|585326009|FG006|Overall Study|Adverse Event|0|||
162073136|NCT03446040|585326010|FG007|Overall Study|Adverse Event|0|||
162073137|NCT03446040|585326011|FG008|Overall Study|Adverse Event|1|||
162073138|NCT03446040|585326012|FG009|Overall Study|Adverse Event|0|||
162073139|NCT03446040|585326013|FG010|Overall Study|Adverse Event|0|||
162073140|NCT03446040|585326014|FG011|Overall Study|Adverse Event|0|||
162073141|NCT03446040|585326015|FG012|Overall Study|Adverse Event|0|||
162073142|NCT03446040|585326016|FG013|Overall Study|Adverse Event|0|||
162073143|NCT03446040|585326003|FG000|Overall Study|Death|0|||
162073144|NCT03446040|585326004|FG001|Overall Study|Death|0|||
162073145|NCT03446040|585326005|FG002|Overall Study|Death|0|||
162073146|NCT03446040|585326006|FG003|Overall Study|Death|0|||
162073147|NCT03446040|585326007|FG004|Overall Study|Death|0|||
162073148|NCT03446040|585326008|FG005|Overall Study|Death|0|||
162073149|NCT03446040|585326009|FG006|Overall Study|Death|0|||
162073150|NCT03446040|585326010|FG007|Overall Study|Death|0|||
162073151|NCT03446040|585326011|FG008|Overall Study|Death|0|||
162073152|NCT03446040|585326012|FG009|Overall Study|Death|0|||
162073153|NCT03446040|585326013|FG010|Overall Study|Death|1|||
162073154|NCT03446040|585326014|FG011|Overall Study|Death|0|||
162073155|NCT03446040|585326015|FG012|Overall Study|Death|0|||
162073156|NCT03446040|585326016|FG013|Overall Study|Death|2|||
162073157|NCT03446040|585326003|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
162073158|NCT03446040|585326004|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
162073159|NCT03446040|585326005|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
162073160|NCT03446040|585326006|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
162073161|NCT03446040|585326007|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
162073162|NCT03446040|585326008|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
162073163|NCT03446040|585326009|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
162073164|NCT03446040|585326010|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
162073165|NCT03446040|585326011|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
162073166|NCT03446040|585326012|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
162073167|NCT03446040|585326013|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
162073168|NCT03446040|585326014|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
162073169|NCT03446040|585326015|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
162073170|NCT03446040|585326016|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
162073171|NCT03446040|585326003|FG000|Overall Study|Participant withdrew consent|0|||
162073172|NCT03446040|585326004|FG001|Overall Study|Participant withdrew consent|0|||
162073173|NCT03446040|585326005|FG002|Overall Study|Participant withdrew consent|0|||
162073174|NCT03446040|585326006|FG003|Overall Study|Participant withdrew consent|0|||
162073175|NCT03446040|585326007|FG004|Overall Study|Participant withdrew consent|0|||
162073176|NCT03446040|585326008|FG005|Overall Study|Participant withdrew consent|1|||
162073177|NCT03446040|585326009|FG006|Overall Study|Participant withdrew consent|0|||
162073178|NCT03446040|585326010|FG007|Overall Study|Participant withdrew consent|1|||
162073179|NCT03446040|585326011|FG008|Overall Study|Participant withdrew consent|0|||
162073180|NCT03446040|585326012|FG009|Overall Study|Participant withdrew consent|0|||
162073181|NCT03446040|585326013|FG010|Overall Study|Participant withdrew consent|0|||
162073182|NCT03446040|585326014|FG011|Overall Study|Participant withdrew consent|0|||
162073183|NCT03446040|585326015|FG012|Overall Study|Participant withdrew consent|0|||
162073184|NCT03446040|585326016|FG013|Overall Study|Participant withdrew consent|0|||
162073185|NCT03446040|585326003|FG000|Overall Study|Not reported|0|||
162073186|NCT03446040|585326004|FG001|Overall Study|Not reported|0|||
162073187|NCT03446040|585326005|FG002|Overall Study|Not reported|1|||
162073188|NCT03446040|585326006|FG003|Overall Study|Not reported|0|||
162073189|NCT03446040|585326007|FG004|Overall Study|Not reported|0|||
162073190|NCT03446040|585326008|FG005|Overall Study|Not reported|0|||
162073191|NCT03446040|585326009|FG006|Overall Study|Not reported|0|||
162073192|NCT03446040|585326010|FG007|Overall Study|Not reported|0|||
162073193|NCT03446040|585326011|FG008|Overall Study|Not reported|0|||
162073194|NCT03446040|585326012|FG009|Overall Study|Not reported|0|||
162073195|NCT03446040|585326013|FG010|Overall Study|Not reported|0|||
162073196|NCT03446040|585326014|FG011|Overall Study|Not reported|0|||
162073197|NCT03446040|585326015|FG012|Overall Study|Not reported|0|||
162073198|NCT03446040|585326016|FG013|Overall Study|Not reported|0|||
162073199|NCT00456521|585326017|FG000|Overall Study|Adverse Event|150|||
162073200|NCT00456521|585326018|FG001|Overall Study|Adverse Event|25|||
162073201|NCT00456521|585326017|FG000|Overall Study|Withdrawal by Subject|43|||
162073202|NCT00456521|585326018|FG001|Overall Study|Withdrawal by Subject|24|||
162073203|NCT00456521|585326017|FG000|Overall Study|Lost to Follow-up|22|||
162073204|NCT00456521|585326018|FG001|Overall Study|Lost to Follow-up|17|||
162073205|NCT00456521|585326017|FG000|Overall Study|Lack of Efficacy|3|||
162073206|NCT00456521|585326018|FG001|Overall Study|Lack of Efficacy|6|||
162073207|NCT00456521|585326017|FG000|Overall Study|Protocol Violation|4|||
162073208|NCT00456521|585326018|FG001|Overall Study|Protocol Violation|0|||
162073209|NCT00456521|585326017|FG000|Overall Study|Pregnancy|1|||
162073210|NCT00456521|585326018|FG001|Overall Study|Pregnancy|1|||
162073211|NCT00456521|585326017|FG000|Overall Study|Drug non-compliance, moved, other|26|||
162073212|NCT00456521|585326018|FG001|Overall Study|Drug non-compliance, moved, other|11|||
162073213|NCT02596854|585326019|FG000|Overall Study|Withdrawn|8|||
162073214|NCT00464568|585326022|FG000|Overall Study|Adverse Event|2|||
162073215|NCT00405587|585326023|FG000|Overall Study|Death|0|||
162073216|NCT00405587|585326024|FG001|Overall Study|Death|0|||
162073217|NCT00405587|585326025|FG002|Overall Study|Death|0|||
162073218|NCT00405587|585326026|FG003|Overall Study|Death|1|||
162073219|NCT00405587|585326023|FG000|Overall Study|Disease Progression|22|||
162073220|NCT00405587|585326024|FG001|Overall Study|Disease Progression|23|||
162073221|NCT00405587|585326025|FG002|Overall Study|Disease Progression|21|||
162073222|NCT00405587|585326026|FG003|Overall Study|Disease Progression|17|||
162073223|NCT00405587|585326023|FG000|Overall Study|Physician Decision|3|||
162073224|NCT00405587|585326024|FG001|Overall Study|Physician Decision|2|||
162073225|NCT00405587|585326025|FG002|Overall Study|Physician Decision|0|||
162073226|NCT00405587|585326026|FG003|Overall Study|Physician Decision|0|||
162073227|NCT00405587|585326023|FG000|Overall Study|Adverse Event|1|||
162073228|NCT00405587|585326024|FG001|Overall Study|Adverse Event|0|||
162073229|NCT00405587|585326025|FG002|Overall Study|Adverse Event|0|||
162073230|NCT00405587|585326026|FG003|Overall Study|Adverse Event|0|||
162073231|NCT00405587|585326023|FG000|Overall Study|Lost to Follow-up|0|||
162073232|NCT00405587|585326024|FG001|Overall Study|Lost to Follow-up|1|||
162073233|NCT00405587|585326025|FG002|Overall Study|Lost to Follow-up|1|||
162073234|NCT00405587|585326026|FG003|Overall Study|Lost to Follow-up|0|||
162073235|NCT00405587|585326023|FG000|Overall Study|Radiation induced necrosis|0|||
162073236|NCT00405587|585326024|FG001|Overall Study|Radiation induced necrosis|1|||
162073237|NCT00405587|585326025|FG002|Overall Study|Radiation induced necrosis|0|||
162073238|NCT00405587|585326026|FG003|Overall Study|Radiation induced necrosis|0|||
162073239|NCT00405587|585326023|FG000|Overall Study|Withdrawal by Subject|0|||
162073240|NCT00405587|585326024|FG001|Overall Study|Withdrawal by Subject|0|||
162073241|NCT00405587|585326025|FG002|Overall Study|Withdrawal by Subject|0|||
162073242|NCT00405587|585326026|FG003|Overall Study|Withdrawal by Subject|2|||
162073243|NCT00405587|585326023|FG000|Overall Study|Participant not dosed|0|||
162073244|NCT00405587|585326024|FG001|Overall Study|Participant not dosed|1|||
162073245|NCT00405587|585326025|FG002|Overall Study|Participant not dosed|0|||
162073246|NCT00405587|585326026|FG003|Overall Study|Participant not dosed|0|||
162073247|NCT00507442|585326031|FG000|Overall Study|Adverse Event|8|||
162073248|NCT00507442|585326032|FG001|Overall Study|Adverse Event|11|||
162073249|NCT00507442|585326033|FG002|Overall Study|Adverse Event|4|||
162073250|NCT00507442|585326034|FG003|Overall Study|Adverse Event|1|||
162073251|NCT00507442|585326031|FG000|Overall Study|Protocol Violation|0|||
162073252|NCT00507442|585326032|FG001|Overall Study|Protocol Violation|1|||
162073253|NCT00507442|585326033|FG002|Overall Study|Protocol Violation|0|||
162073254|NCT00507442|585326034|FG003|Overall Study|Protocol Violation|0|||
162073255|NCT00507442|585326031|FG000|Overall Study|Lost to Follow-up|0|||
162073256|NCT00507442|585326032|FG001|Overall Study|Lost to Follow-up|0|||
162073257|NCT00507442|585326033|FG002|Overall Study|Lost to Follow-up|1|||
162073258|NCT00507442|585326034|FG003|Overall Study|Lost to Follow-up|0|||
162073259|NCT00507442|585326031|FG000|Overall Study|Physician Decision|0|||
162073260|NCT00507442|585326032|FG001|Overall Study|Physician Decision|2|||
162073261|NCT00507442|585326033|FG002|Overall Study|Physician Decision|4|||
162073262|NCT00507442|585326034|FG003|Overall Study|Physician Decision|1|||
162073263|NCT00507442|585326031|FG000|Overall Study|Progressive Disease|2|||
162073264|NCT00507442|585326032|FG001|Overall Study|Progressive Disease|4|||
162073265|NCT00507442|585326033|FG002|Overall Study|Progressive Disease|2|||
162073266|NCT00507442|585326034|FG003|Overall Study|Progressive Disease|0|||
162073267|NCT00507442|585326031|FG000|Overall Study|Withdrawal by Subject|4|||
162073268|NCT00507442|585326032|FG001|Overall Study|Withdrawal by Subject|4|||
162073269|NCT00507442|585326033|FG002|Overall Study|Withdrawal by Subject|2|||
162073270|NCT00507442|585326034|FG003|Overall Study|Withdrawal by Subject|1|||
162073271|NCT00507442|585326031|FG000|Overall Study|Other|2|||
162073272|NCT00507442|585326032|FG001|Overall Study|Other|5|||
162073273|NCT00507442|585326033|FG002|Overall Study|Other|2|||
162073274|NCT00507442|585326034|FG003|Overall Study|Other|2|||
162073275|NCT02672423|585326036|FG000|Period 1|Adverse Event|0|||
162073276|NCT02672423|585326037|FG001|Period 1|Adverse Event|0|||
162073277|NCT02672423|585326038|FG002|Period 1|Adverse Event|0|||
162073278|NCT02672423|585326039|FG003|Period 1|Adverse Event|0|||
162073279|NCT02672423|585326040|FG004|Period 1|Adverse Event|1|||
162073280|NCT02672423|585326041|FG005|Period 1|Adverse Event|0|||
162073281|NCT02672423|585326042|FG006|Period 1|Adverse Event|0|||
162073282|NCT02672423|585326043|FG007|Period 1|Adverse Event|0|||
162073283|NCT02672423|585326044|FG008|Period 1|Adverse Event|0|||
162073284|NCT02672423|585326045|FG009|Period 1|Adverse Event|0|||
162073285|NCT02672423|585326036|FG000|Period 2|Withdrawal by Subject|0|||
162073286|NCT02672423|585326037|FG001|Period 2|Withdrawal by Subject|0|||
162073287|NCT02672423|585326038|FG002|Period 2|Withdrawal by Subject|1|||
162073288|NCT02672423|585326039|FG003|Period 2|Withdrawal by Subject|0|||
162073289|NCT02672423|585326040|FG004|Period 2|Withdrawal by Subject|0|||
162073290|NCT02672423|585326041|FG005|Period 2|Withdrawal by Subject|0|||
162073291|NCT02672423|585326042|FG006|Period 2|Withdrawal by Subject|0|||
162073292|NCT02672423|585326043|FG007|Period 2|Withdrawal by Subject|0|||
162073293|NCT02672423|585326044|FG008|Period 2|Withdrawal by Subject|0|||
162073294|NCT02672423|585326045|FG009|Period 2|Withdrawal by Subject|0|||
162073295|NCT02672423|585326036|FG000|Period 3|Withdrawal by Subject|0|||
162073296|NCT02672423|585326037|FG001|Period 3|Withdrawal by Subject|0|||
162073297|NCT02672423|585326038|FG002|Period 3|Withdrawal by Subject|0|||
162073298|NCT02672423|585326039|FG003|Period 3|Withdrawal by Subject|0|||
162073299|NCT02672423|585326040|FG004|Period 3|Withdrawal by Subject|0|||
162073300|NCT02672423|585326041|FG005|Period 3|Withdrawal by Subject|0|||
162073301|NCT02672423|585326042|FG006|Period 3|Withdrawal by Subject|0|||
162073302|NCT02672423|585326043|FG007|Period 3|Withdrawal by Subject|1|||
162073303|NCT02672423|585326044|FG008|Period 3|Withdrawal by Subject|0|||
162073304|NCT02672423|585326045|FG009|Period 3|Withdrawal by Subject|0|||
162073305|NCT02672423|585326036|FG000|Period 3|Physician Decision|0|||
162073306|NCT02672423|585326037|FG001|Period 3|Physician Decision|0|||
162073307|NCT02672423|585326038|FG002|Period 3|Physician Decision|0|||
162073308|NCT02672423|585326039|FG003|Period 3|Physician Decision|0|||
162073309|NCT02672423|585326040|FG004|Period 3|Physician Decision|0|||
162073310|NCT02672423|585326041|FG005|Period 3|Physician Decision|1|||
162073311|NCT02672423|585326042|FG006|Period 3|Physician Decision|0|||
162073312|NCT02672423|585326043|FG007|Period 3|Physician Decision|0|||
162073313|NCT02672423|585326044|FG008|Period 3|Physician Decision|0|||
162073314|NCT02672423|585326045|FG009|Period 3|Physician Decision|0|||
162073315|NCT01454570|585326052|FG000|Overall Study|Withdrawal by Subject|2|||
162073316|NCT01454570|585326052|FG000|Overall Study|Screen Failure|7|||
162073317|NCT00885755|585326053|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
162073318|NCT00885755|585326054|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
162073319|NCT00885755|585326055|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
162073320|NCT00885755|585326053|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
162073321|NCT00885755|585326054|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
162073322|NCT00885755|585326055|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
162073323|NCT00885755|585326053|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
162073324|NCT00885755|585326054|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
162073325|NCT00885755|585326055|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
162073326|NCT00885755|585326053|FG000|Part I: Trastuzumab+Taxane|Death|0|||
162073327|NCT00885755|585326054|FG001|Part I: Trastuzumab+Taxane|Death|0|||
162073328|NCT00885755|585326055|FG002|Part I: Trastuzumab+Taxane|Death|1|||
162073329|NCT00885755|585326053|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
162073330|NCT00885755|585326054|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
162073331|NCT00885755|585326055|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
162073332|NCT00325754|585326056|FG000|Overall Study|Adverse Event|4|||
162073333|NCT00325754|585326057|FG001|Overall Study|Adverse Event|1|||
162073334|NCT01852812|585326061|FG000|Overall Study|Adverse Event|0|||
162073335|NCT01852812|585326062|FG001|Overall Study|Adverse Event|0|||
162073336|NCT01852812|585326063|FG002|Overall Study|Adverse Event|1|||
162073337|NCT01852812|585326061|FG000|Overall Study|Non-compliance With Study Drug|0|||
162073338|NCT01852812|585326062|FG001|Overall Study|Non-compliance With Study Drug|1|||
162073339|NCT01852812|585326063|FG002|Overall Study|Non-compliance With Study Drug|0|||
162073340|NCT02625090|585326068|FG000|Overall Study|Participant wants to be pregnant|2|||
162073341|NCT02625090|585326068|FG000|Overall Study|For the Promoter|1|||
162073342|NCT02625090|585326068|FG000|Overall Study|Sponsor's Decision|9|||
162073343|NCT02625090|585326068|FG000|Overall Study|Somnolence|1|||
162073344|NCT02625090|585326068|FG000|Overall Study|Study terminated by Sponsor|7|||
162073345|NCT02625090|585326068|FG000|Overall Study|Negative Benefit/Risk|1|||
162073346|NCT02625090|585326068|FG000|Overall Study|Protocol Deviation|2|||
162073347|NCT02625090|585326068|FG000|Overall Study|Lack of Efficacy|16|||
162073348|NCT02625090|585326068|FG000|Overall Study|Adverse Event|3|||
162073349|NCT02250443|585326069|FG000|Overall Study|Administrative problems|7|||
162073350|NCT02250443|585326069|FG000|Overall Study|Adverse Event|3|||
162073351|NCT03168464|585326070|FG000|Overall Study|Death|9|||
162073352|NCT03168464|585326070|FG000|Overall Study|Progression of disease|6|||
162073353|NCT01549964|585326071|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
162073354|NCT01549964|585326072|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
162073355|NCT01549964|585326073|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
162073356|NCT01549964|585326074|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
162073357|NCT01549964|585326071|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
162073358|NCT01549964|585326072|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
162073359|NCT01549964|585326073|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
162073360|NCT01549964|585326074|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
162073361|NCT01549964|585326071|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
162073362|NCT01549964|585326072|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
162073363|NCT01549964|585326073|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
162073364|NCT01549964|585326074|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
162073365|NCT01549964|585326071|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
162073366|NCT01549964|585326072|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
162073367|NCT01549964|585326073|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
162073368|NCT01549964|585326074|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
162073369|NCT01549964|585326071|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
162073370|NCT01549964|585326072|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
162073371|NCT01549964|585326073|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
162073372|NCT01549964|585326074|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
162073373|NCT01549964|585326071|FG000|24-Week Treatment Period|Other|1|||
162073374|NCT01549964|585326072|FG001|24-Week Treatment Period|Other|0|||
162073375|NCT01549964|585326073|FG002|24-Week Treatment Period|Other|1|||
162073376|NCT01549964|585326074|FG003|24-Week Treatment Period|Other|0|||
162073377|NCT01549964|585326071|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
162073378|NCT01549964|585326072|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
162073379|NCT01549964|585326073|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
162073380|NCT01549964|585326074|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
162073381|NCT01549964|585326071|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
162073382|NCT01549964|585326072|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
162073383|NCT01549964|585326073|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
162073384|NCT01549964|585326074|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
162073385|NCT01549964|585326071|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
162073386|NCT01549964|585326072|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
162073387|NCT01549964|585326073|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
162073388|NCT01549964|585326074|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
162073389|NCT01549964|585326071|FG000|80-Week Extension Period|Pregnancy|0|||
162073390|NCT01549964|585326072|FG001|80-Week Extension Period|Pregnancy|0|||
162073391|NCT01549964|585326073|FG002|80-Week Extension Period|Pregnancy|1|||
162073392|NCT01549964|585326074|FG003|80-Week Extension Period|Pregnancy|0|||
162073393|NCT01549964|585326071|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
162073394|NCT01549964|585326072|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
162073395|NCT01549964|585326073|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
162073396|NCT01549964|585326074|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
162073397|NCT01549964|585326071|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
162073398|NCT01549964|585326072|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
162073399|NCT01549964|585326073|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
162073400|NCT01549964|585326074|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
162073401|NCT01549964|585326071|FG000|80-Week Extension Period|Lost to Follow-up|1|||
162073402|NCT01549964|585326072|FG001|80-Week Extension Period|Lost to Follow-up|0|||
162073403|NCT01549964|585326073|FG002|80-Week Extension Period|Lost to Follow-up|2|||
162073404|NCT01549964|585326074|FG003|80-Week Extension Period|Lost to Follow-up|1|||
162073405|NCT01549964|585326071|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
162073406|NCT01549964|585326072|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
162073407|NCT01549964|585326073|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
162073408|NCT01549964|585326074|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
162073409|NCT00634088|585326077|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
162073410|NCT00634088|585326078|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
162073411|NCT00634088|585326079|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
162073412|NCT00634088|585326080|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
162073413|NCT00634088|585326077|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
162073414|NCT00634088|585326078|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
162073415|NCT00634088|585326079|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
162073416|NCT00634088|585326080|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
162073417|NCT00634088|585326077|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
162073418|NCT00634088|585326078|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
162073419|NCT00634088|585326079|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
162073420|NCT00634088|585326080|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
162073421|NCT00634088|585326077|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
162073422|NCT00634088|585326078|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
162073423|NCT00634088|585326079|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
162073424|NCT00634088|585326080|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
162073425|NCT00634088|585326077|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
162073426|NCT00634088|585326078|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
162073427|NCT00634088|585326079|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
162073428|NCT00634088|585326080|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
162073429|NCT00634088|585326077|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
162073430|NCT00634088|585326078|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
162073431|NCT00634088|585326079|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
162073432|NCT00634088|585326080|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
162073433|NCT02290821|585326081|FG000|Overall Study|Withdrawal by Subject|1|||
162073434|NCT02290821|585326082|FG001|Overall Study|Withdrawal by Subject|1|||
162073435|NCT02290821|585326081|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
162073436|NCT02290821|585326082|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
162073437|NCT02290821|585326081|FG000|Overall Study|Lost to Follow-up|3|||
162073438|NCT02290821|585326082|FG001|Overall Study|Lost to Follow-up|2|||
162073439|NCT02438722|585326088|FG000|Overall Study|Adverse Event|12|||
162073440|NCT02438722|585326089|FG001|Overall Study|Adverse Event|9|||
162073441|NCT02438722|585326088|FG000|Overall Study|Refusal unrelated to AE|2|||
162073442|NCT02438722|585326089|FG001|Overall Study|Refusal unrelated to AE|5|||
162073443|NCT02438722|585326088|FG000|Overall Study|Disease progression/relapse|46|||
162073444|NCT02438722|585326089|FG001|Overall Study|Disease progression/relapse|51|||
162073445|NCT02438722|585326088|FG000|Overall Study|Death|0|||
162073446|NCT02438722|585326089|FG001|Overall Study|Death|3|||
162073447|NCT02438722|585326088|FG000|Overall Study|Physician Decision|2|||
162073448|NCT02438722|585326089|FG001|Overall Study|Physician Decision|2|||
162073449|NCT02438722|585326088|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
162073450|NCT02438722|585326089|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
162073451|NCT02438722|585326088|FG000|Overall Study|Withdrawal by Subject|0|||
162073452|NCT02438722|585326089|FG001|Overall Study|Withdrawal by Subject|1|||
162073453|NCT02438722|585326088|FG000|Overall Study|On protocol treatment|15|||
162073454|NCT02438722|585326089|FG001|Overall Study|On protocol treatment|14|||
162073455|NCT02438722|585326088|FG000|Overall Study|Did not receive protocol treatment|5|||
162073456|NCT02438722|585326089|FG001|Overall Study|Did not receive protocol treatment|0|||
162073457|NCT03343483|585326090|FG000|Overall Study|Death|0|||
162073458|NCT03343483|585326091|FG001|Overall Study|Death|3|||
162073459|NCT03343483|585326090|FG000|Overall Study|Lost to Follow-up|9|||
162073460|NCT03343483|585326091|FG001|Overall Study|Lost to Follow-up|13|||
162073461|NCT03343483|585326090|FG000|Overall Study|Withdrawal by Subject|8|||
162073462|NCT03343483|585326091|FG001|Overall Study|Withdrawal by Subject|17|||
162073463|NCT01488097|585326094|FG000|Overall Study|Lost to Follow-up|1|||
162073464|NCT01577758|585326095|FG000|Dose Escalation Phase|Adverse Event|0|||
162073465|NCT01577758|585326096|FG001|Dose Escalation Phase|Adverse Event|0|||
162073466|NCT01577758|585326097|FG002|Dose Escalation Phase|Adverse Event|0|||
162073467|NCT01577758|585326098|FG003|Dose Escalation Phase|Adverse Event|0|||
162073468|NCT01577758|585326099|FG004|Dose Escalation Phase|Adverse Event|0|||
162073469|NCT01577758|585326100|FG005|Dose Escalation Phase|Adverse Event|2|||
162073470|NCT01577758|585326101|FG006|Dose Escalation Phase|Adverse Event|1|||
162073471|NCT01577758|585326102|FG007|Dose Escalation Phase|Adverse Event|0|||
162073472|NCT01577758|585326095|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
162073473|NCT01577758|585326096|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
162073474|NCT01577758|585326097|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
162073475|NCT01577758|585326098|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
162073476|NCT01577758|585326099|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
162073477|NCT01577758|585326100|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
162073478|NCT01577758|585326101|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
162073479|NCT01577758|585326102|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
162073480|NCT01577758|585326095|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
162073481|NCT01577758|585326096|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
162073482|NCT01577758|585326097|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
162073483|NCT01577758|585326098|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
162073484|NCT01577758|585326099|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
162073485|NCT01577758|585326100|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
162073486|NCT01577758|585326101|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
162073487|NCT01577758|585326102|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
162073488|NCT01577758|585326095|FG000|Dose Escalation Phase|Progression Disease|2|||
162073489|NCT01577758|585326096|FG001|Dose Escalation Phase|Progression Disease|2|||
162073490|NCT01577758|585326097|FG002|Dose Escalation Phase|Progression Disease|1|||
162073491|NCT01577758|585326098|FG003|Dose Escalation Phase|Progression Disease|2|||
162073492|NCT01577758|585326099|FG004|Dose Escalation Phase|Progression Disease|5|||
162073493|NCT01577758|585326100|FG005|Dose Escalation Phase|Progression Disease|0|||
162073494|NCT01577758|585326101|FG006|Dose Escalation Phase|Progression Disease|0|||
162073495|NCT01577758|585326102|FG007|Dose Escalation Phase|Progression Disease|0|||
162073496|NCT01577758|585326095|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162073497|NCT01577758|585326096|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162073498|NCT01577758|585326097|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162073499|NCT01577758|585326098|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162073500|NCT01577758|585326099|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162073501|NCT01577758|585326100|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162073502|NCT01577758|585326101|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
162073503|NCT01577758|585326102|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
162073504|NCT01577758|585326095|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
162073505|NCT01577758|585326096|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
162073506|NCT01577758|585326097|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
162073507|NCT01577758|585326098|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
162073508|NCT01577758|585326099|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
162073509|NCT01577758|585326100|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
162073510|NCT01577758|585326101|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
162073511|NCT01577758|585326102|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
162073512|NCT01577758|585326095|FG000|mCRC Expansion Phase|Progression Disease|0|||
162073513|NCT01577758|585326096|FG001|mCRC Expansion Phase|Progression Disease|0|||
162073514|NCT01577758|585326097|FG002|mCRC Expansion Phase|Progression Disease|0|||
162073515|NCT01577758|585326098|FG003|mCRC Expansion Phase|Progression Disease|0|||
162073516|NCT01577758|585326099|FG004|mCRC Expansion Phase|Progression Disease|0|||
162073517|NCT01577758|585326100|FG005|mCRC Expansion Phase|Progression Disease|0|||
162073518|NCT01577758|585326101|FG006|mCRC Expansion Phase|Progression Disease|0|||
162073519|NCT01577758|585326102|FG007|mCRC Expansion Phase|Progression Disease|19|||
162073520|NCT04969224|585326109|FG000|Overall Study|Adverse Event|1|||
162073521|NCT04969224|585326109|FG000|Overall Study|Enrolled but never dosed|1|||
162073522|NCT03165110|585326113|FG000|Overall Study|Anroid phone software incompatibility|1|||
162073523|NCT05533632|585326114|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
162073524|NCT05533632|585326114|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
162073525|NCT05533632|585326114|FG000|Overall Study|Lost to Follow-up|1|||
162073526|NCT05533632|585326114|FG000|Overall Study|Withdrawal by Subject|4|||
162073527|NCT05533632|585326114|FG000|Overall Study|Adverse Event|4|||
162073528|NCT02726074|585326115|FG000|Overall Study|Withdrawal by Subject|4|||
162073529|NCT02726074|585326115|FG000|Overall Study|Adverse Event|14|||
162073530|NCT02726074|585326115|FG000|Overall Study|Protocol Violation|3|||
162073531|NCT02726074|585326115|FG000|Overall Study|Lost to Follow-up|2|||
162073532|NCT02726074|585326115|FG000|Overall Study|Others|3|||
162073533|NCT00579826|585326116|FG000|Overall Study|Withdrawal by Subject|5|||
162073534|NCT00579826|585326117|FG001|Overall Study|Withdrawal by Subject|3|||
162073535|NCT04191382|585326118|FG000|Overall Study|Withdrawal by Subject|1|||
162073536|NCT04191382|585326119|FG001|Overall Study|Withdrawal by Subject|0|||
162073537|NCT04191382|585326120|FG002|Overall Study|Withdrawal by Subject|0|||
162073538|NCT00454987|585326123|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
162073539|NCT00454987|585326124|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
162073540|NCT00454987|585326125|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
162073541|NCT00454987|585326123|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
162073542|NCT00454987|585326124|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
162073543|NCT00454987|585326125|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
162073544|NCT00454987|585326123|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
162073545|NCT00454987|585326124|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
162073546|NCT00454987|585326125|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
162073547|NCT03054870|585326127|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
162073548|NCT03054870|585326127|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
162073549|NCT02009046|585326128|FG000|Overall Study|Lost to Follow-up|256|||
162073550|NCT02009046|585326129|FG001|Overall Study|Lost to Follow-up|206|||
162073551|NCT00973479|585326133|FG000|Overall Study|Lost to Follow-up|0|||
162073552|NCT00973479|585326134|FG001|Overall Study|Lost to Follow-up|3|||
162073553|NCT00973479|585326133|FG000|Overall Study|Death|2|||
162073554|NCT00973479|585326134|FG001|Overall Study|Death|2|||
162073555|NCT00973479|585326133|FG000|Overall Study|Withdrawal by Subject|15|||
162073556|NCT00973479|585326134|FG001|Overall Study|Withdrawal by Subject|16|||
162073557|NCT00973479|585326133|FG000|Overall Study|Lack of Efficacy|5|||
162073558|NCT00973479|585326134|FG001|Overall Study|Lack of Efficacy|7|||
162073559|NCT00973479|585326133|FG000|Overall Study|Adverse Event|12|||
162073560|NCT00973479|585326134|FG001|Overall Study|Adverse Event|32|||
162073561|NCT00973479|585326133|FG000|Overall Study|Protocol Violation|2|||
162073562|NCT00973479|585326134|FG001|Overall Study|Protocol Violation|2|||
162073563|NCT00973479|585326133|FG000|Overall Study|Other|1|||
162073564|NCT00973479|585326134|FG001|Overall Study|Other|7|||
162073565|NCT05075850|585326135|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
162073566|NCT00362115|585326136|FG000|Overall Study|Adverse Event|0|||
162073567|NCT00362115|585326137|FG001|Overall Study|Adverse Event|1|||
162073568|NCT00362115|585326138|FG002|Overall Study|Adverse Event|1|||
162073569|NCT00362115|585326139|FG003|Overall Study|Adverse Event|1|||
162073570|NCT00362115|585326140|FG004|Overall Study|Adverse Event|2|||
162073571|NCT00362115|585326141|FG005|Overall Study|Adverse Event|2|||
162073572|NCT00362115|585326142|FG006|Overall Study|Adverse Event|1|||
162073573|NCT00362115|585326136|FG000|Overall Study|Protocol Violation|0|||
162073574|NCT00362115|585326137|FG001|Overall Study|Protocol Violation|0|||
162073575|NCT00362115|585326138|FG002|Overall Study|Protocol Violation|0|||
162073576|NCT00362115|585326139|FG003|Overall Study|Protocol Violation|0|||
162073577|NCT00362115|585326140|FG004|Overall Study|Protocol Violation|0|||
162073578|NCT00362115|585326141|FG005|Overall Study|Protocol Violation|1|||
162073579|NCT00362115|585326142|FG006|Overall Study|Protocol Violation|0|||
162073580|NCT00362115|585326136|FG000|Overall Study|Lost to Follow-up|0|||
162073581|NCT00362115|585326137|FG001|Overall Study|Lost to Follow-up|1|||
162073582|NCT00362115|585326138|FG002|Overall Study|Lost to Follow-up|0|||
162073583|NCT00362115|585326139|FG003|Overall Study|Lost to Follow-up|0|||
162073584|NCT00362115|585326140|FG004|Overall Study|Lost to Follow-up|2|||
162073585|NCT00362115|585326141|FG005|Overall Study|Lost to Follow-up|0|||
162073586|NCT00362115|585326142|FG006|Overall Study|Lost to Follow-up|1|||
162073587|NCT00362115|585326136|FG000|Overall Study|Withdrawal by Subject|1|||
162073588|NCT00362115|585326137|FG001|Overall Study|Withdrawal by Subject|3|||
162073589|NCT00362115|585326138|FG002|Overall Study|Withdrawal by Subject|1|||
162073590|NCT00362115|585326139|FG003|Overall Study|Withdrawal by Subject|0|||
162073591|NCT00362115|585326140|FG004|Overall Study|Withdrawal by Subject|1|||
162073592|NCT00362115|585326141|FG005|Overall Study|Withdrawal by Subject|3|||
162073593|NCT00362115|585326142|FG006|Overall Study|Withdrawal by Subject|4|||
162073594|NCT00362115|585326136|FG000|Overall Study|Lack of Efficacy|1|||
162073595|NCT00362115|585326137|FG001|Overall Study|Lack of Efficacy|0|||
162073596|NCT00362115|585326138|FG002|Overall Study|Lack of Efficacy|5|||
162073597|NCT00362115|585326139|FG003|Overall Study|Lack of Efficacy|2|||
162073598|NCT00362115|585326140|FG004|Overall Study|Lack of Efficacy|2|||
162073599|NCT00362115|585326141|FG005|Overall Study|Lack of Efficacy|0|||
162073600|NCT00362115|585326142|FG006|Overall Study|Lack of Efficacy|3|||
162073601|NCT00362115|585326136|FG000|Overall Study|Physician Decision|0|||
162073602|NCT00362115|585326137|FG001|Overall Study|Physician Decision|0|||
162073603|NCT00362115|585326138|FG002|Overall Study|Physician Decision|0|||
162073604|NCT00362115|585326139|FG003|Overall Study|Physician Decision|0|||
162073605|NCT00362115|585326140|FG004|Overall Study|Physician Decision|0|||
162073606|NCT00362115|585326141|FG005|Overall Study|Physician Decision|0|||
162073607|NCT00362115|585326142|FG006|Overall Study|Physician Decision|3|||
162073608|NCT00362115|585326136|FG000|Overall Study|Other|0|||
162073609|NCT00362115|585326137|FG001|Overall Study|Other|1|||
162073610|NCT00362115|585326138|FG002|Overall Study|Other|0|||
162073611|NCT00362115|585326139|FG003|Overall Study|Other|1|||
162073612|NCT00362115|585326140|FG004|Overall Study|Other|0|||
162073613|NCT00362115|585326141|FG005|Overall Study|Other|1|||
162073614|NCT00362115|585326142|FG006|Overall Study|Other|0|||
162073615|NCT01170091|585326143|FG000|Overall Study|Missing efficacy evaluation|3|||
162073616|NCT01170091|585326143|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
162073617|NCT02188589|585326144|FG000|Overall Study|Withdrawal by Subject|5|||
162073618|NCT00003641|585326145|FG000|Overall Study|Withdrawal by Subject|0|||
162073619|NCT00003641|585326146|FG001|Overall Study|Withdrawal by Subject|100|||
162073620|NCT00003641|585326145|FG000|Overall Study|Adverse Event|0|||
162073621|NCT00003641|585326146|FG001|Overall Study|Adverse Event|38|||
162073622|NCT00003641|585326145|FG000|Overall Study|Disease progression|0|||
162073623|NCT00003641|585326146|FG001|Overall Study|Disease progression|2|||
162073624|NCT00003641|585326145|FG000|Overall Study|Unknown/missing|0|||
162073625|NCT00003641|585326146|FG001|Overall Study|Unknown/missing|22|||
162073626|NCT00003641|585326145|FG000|Overall Study|Should not receive interferon therapy|2|||
162073627|NCT00003641|585326146|FG001|Overall Study|Should not receive interferon therapy|0|||
162073628|NCT00003641|585326145|FG000|Overall Study|Never started interferon|567|||
162073629|NCT00003641|585326146|FG001|Overall Study|Never started interferon|12|||
162073630|NCT00741039|585326150|FG000|Overall Study|Patient non-compliance|2|||
162073631|NCT00741039|585326151|FG001|Overall Study|Patient non-compliance|0|||
162073632|NCT00878709|585326152|FG000|Overall Study|Withdrawal by Subject|197|||
162073633|NCT00878709|585326153|FG001|Overall Study|Withdrawal by Subject|120|||
162073634|NCT00878709|585326152|FG000|Overall Study|Lost to Follow-up|35|||
162073635|NCT00878709|585326153|FG001|Overall Study|Lost to Follow-up|33|||
162073636|NCT00878709|585326152|FG000|Overall Study|Other Reasons|93|||
162073637|NCT00878709|585326153|FG001|Overall Study|Other Reasons|84|||
162073638|NCT00768300|585326154|FG000|Overall Study|Randomized but not treated|1|||
162073639|NCT00768300|585326155|FG001|Overall Study|Randomized but not treated|1|||
162073640|NCT00768300|585326154|FG000|Overall Study|Adverse Event|10|||
162073641|NCT00768300|585326155|FG001|Overall Study|Adverse Event|2|||
162073642|NCT00768300|585326154|FG000|Overall Study|Protocol Violation|6|||
162073643|NCT00768300|585326155|FG001|Overall Study|Protocol Violation|1|||
162073644|NCT00768300|585326154|FG000|Overall Study|Withdrawal by Subject|13|||
162073645|NCT00768300|585326155|FG001|Overall Study|Withdrawal by Subject|7|||
162073646|NCT00768300|585326154|FG000|Overall Study|Physician Decision|2|||
162073647|NCT00768300|585326155|FG001|Overall Study|Physician Decision|3|||
162073648|NCT00768300|585326154|FG000|Overall Study|Study discontinued by Sponsor|271|||
162073649|NCT00768300|585326155|FG001|Overall Study|Study discontinued by Sponsor|140|||
162073650|NCT00768300|585326154|FG000|Overall Study|Death|21|||
162073651|NCT00768300|585326155|FG001|Overall Study|Death|5|||
162073652|NCT00768300|585326154|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
162073653|NCT00768300|585326155|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
162073654|NCT00768300|585326154|FG000|Overall Study|Screen failure following randomization|1|||
162073655|NCT00768300|585326155|FG001|Overall Study|Screen failure following randomization|0|||
162073656|NCT00768300|585326154|FG000|Overall Study|Received lung transplant|1|||
162073657|NCT00768300|585326155|FG001|Overall Study|Received lung transplant|1|||
162073658|NCT00768300|585326154|FG000|Overall Study|Lost to Follow-up|0|||
162073659|NCT00768300|585326155|FG001|Overall Study|Lost to Follow-up|1|||
162073660|NCT00768300|585326154|FG000|Overall Study|Began prohibited concomitant medication|0|||
162073661|NCT00768300|585326155|FG001|Overall Study|Began prohibited concomitant medication|1|||
162073662|NCT00768300|585326154|FG000|Overall Study|Treated but never dosed with Study drug|1|||
162073663|NCT00768300|585326155|FG001|Overall Study|Treated but never dosed with Study drug|0|||
162073664|NCT00768300|585326154|FG000|Overall Study|Missing data|1|||
162073665|NCT00768300|585326155|FG001|Overall Study|Missing data|0|||
162073666|NCT02068222|585326156|FG000|Overall Study|Lost to Follow-up|1|||
162073667|NCT04254978|585327569|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
162073668|NCT04254978|585327569|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
162073669|NCT04254978|585327569|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
162073670|NCT04254978|585327569|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
162073671|NCT04254978|585327569|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
162073672|NCT04254978|585327569|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
162073673|NCT03257631|585327570|FG000|Overall Study|Death|1|||
162073674|NCT03257631|585327571|FG001|Overall Study|Death|0|||
162073675|NCT03257631|585327572|FG002|Overall Study|Death|1|||
162073676|NCT03257631|585327573|FG003|Overall Study|Death|1|||
162073677|NCT03257631|585327570|FG000|Overall Study|Progressive Disease|10|||
162073678|NCT03257631|585327571|FG001|Overall Study|Progressive Disease|9|||
162073679|NCT03257631|585327572|FG002|Overall Study|Progressive Disease|17|||
162073680|NCT03257631|585327573|FG003|Overall Study|Progressive Disease|8|||
162073681|NCT03257631|585327570|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162073682|NCT03257631|585327571|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162073683|NCT03257631|585327572|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
162073684|NCT03257631|585327573|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
162073685|NCT03257631|585327570|FG000|Overall Study|Adverse Event|0|||
162073686|NCT03257631|585327571|FG001|Overall Study|Adverse Event|0|||
162073687|NCT03257631|585327572|FG002|Overall Study|Adverse Event|2|||
162073688|NCT03257631|585327573|FG003|Overall Study|Adverse Event|0|||
162073689|NCT00277212|585327575|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
162073690|NCT00277212|585327576|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
162073691|NCT00277212|585327577|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
162073692|NCT00277212|585327575|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
162073693|NCT00277212|585327576|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
162073694|NCT00277212|585327577|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
162073695|NCT00277212|585327575|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
162073696|NCT00277212|585327576|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
162073697|NCT00277212|585327577|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
162073698|NCT00277212|585327575|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
162073699|NCT00277212|585327576|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
162073700|NCT00277212|585327577|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
162073701|NCT00277212|585327575|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
162073702|NCT00277212|585327576|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
162073703|NCT00277212|585327577|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
162073704|NCT00277212|585327575|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
162073705|NCT00277212|585327576|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
162073706|NCT00277212|585327577|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
162073707|NCT00277212|585327575|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
162073708|NCT00277212|585327576|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
162073709|NCT00277212|585327577|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
162073710|NCT00277212|585327575|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
162073711|NCT00277212|585327576|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
162073712|NCT00277212|585327577|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
162073713|NCT00277212|585327575|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
162073714|NCT00277212|585327576|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
162073715|NCT00277212|585327577|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
162073716|NCT00277212|585327575|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
162073717|NCT00277212|585327576|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
162073718|NCT00277212|585327577|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
162073719|NCT00277212|585327575|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
162073720|NCT00277212|585327576|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
162073721|NCT00277212|585327577|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
162073722|NCT00277212|585327575|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
162073723|NCT00277212|585327576|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
162073724|NCT00277212|585327577|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
162073725|NCT00277212|585327575|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
162073726|NCT00277212|585327576|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
162073727|NCT00277212|585327577|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
162073728|NCT00277212|585327575|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
162073729|NCT00277212|585327576|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
162073730|NCT00277212|585327577|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
162073731|NCT00277212|585327575|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
162073732|NCT00277212|585327576|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
162073733|NCT00277212|585327577|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
162073734|NCT00277212|585327575|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
162073735|NCT00277212|585327576|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
162073736|NCT00277212|585327577|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
162073737|NCT00277212|585327575|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
162073738|NCT00277212|585327576|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
162073739|NCT00277212|585327577|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
162073740|NCT00277212|585327575|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
162073741|NCT00277212|585327576|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
162073742|NCT00277212|585327577|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
162073743|NCT00902564|585327578|FG000|Overall Study|Withdrawal by Subject|2|||
162073744|NCT03336216|585327579|FG000|Randomization|Not reported|2|||
162073745|NCT03336216|585327580|FG001|Randomization|Not reported|0|||
162073746|NCT03336216|585327581|FG002|Randomization|Not reported|1|||
162073747|NCT03336216|585327582|FG003|Randomization|Not reported|0|||
162073748|NCT03336216|585327579|FG000|Randomization|Other reasons|1|||
162073749|NCT03336216|585327580|FG001|Randomization|Other reasons|1|||
162073750|NCT03336216|585327581|FG002|Randomization|Other reasons|1|||
162073751|NCT03336216|585327582|FG003|Randomization|Other reasons|0|||
162073752|NCT03336216|585327579|FG000|Randomization|Participant no longer meets study criteria|0|||
162073753|NCT03336216|585327580|FG001|Randomization|Participant no longer meets study criteria|2|||
162073754|NCT03336216|585327581|FG002|Randomization|Participant no longer meets study criteria|4|||
162073755|NCT03336216|585327582|FG003|Randomization|Participant no longer meets study criteria|1|||
162073756|NCT03336216|585327579|FG000|Randomization|Lost to Follow-up|1|||
162073757|NCT03336216|585327580|FG001|Randomization|Lost to Follow-up|0|||
162073758|NCT03336216|585327581|FG002|Randomization|Lost to Follow-up|0|||
162073759|NCT03336216|585327582|FG003|Randomization|Lost to Follow-up|0|||
162073760|NCT03336216|585327579|FG000|Randomization|Participant withdrew consent|9|||
162073761|NCT03336216|585327580|FG001|Randomization|Participant withdrew consent|1|||
162073762|NCT03336216|585327581|FG002|Randomization|Participant withdrew consent|0|||
162073763|NCT03336216|585327582|FG003|Randomization|Participant withdrew consent|0|||
162073764|NCT03336216|585327579|FG000|Randomization|Adverse Event|1|||
162073765|NCT03336216|585327580|FG001|Randomization|Adverse Event|1|||
162073766|NCT03336216|585327581|FG002|Randomization|Adverse Event|0|||
162073767|NCT03336216|585327582|FG003|Randomization|Adverse Event|0|||
162073768|NCT03336216|585327579|FG000|Treatment|Adverse Event|2|||
162073769|NCT03336216|585327580|FG001|Treatment|Adverse Event|3|||
162073770|NCT03336216|585327581|FG002|Treatment|Adverse Event|4|||
162073771|NCT03336216|585327582|FG003|Treatment|Adverse Event|4|||
162073772|NCT03336216|585327579|FG000|Treatment|Participant request to discontinue treatment|2|||
162073773|NCT03336216|585327580|FG001|Treatment|Participant request to discontinue treatment|1|||
162073774|NCT03336216|585327581|FG002|Treatment|Participant request to discontinue treatment|2|||
162073775|NCT03336216|585327582|FG003|Treatment|Participant request to discontinue treatment|2|||
162073776|NCT03336216|585327579|FG000|Treatment|Participant withdrew consent|7|||
162073777|NCT03336216|585327580|FG001|Treatment|Participant withdrew consent|2|||
162073778|NCT03336216|585327581|FG002|Treatment|Participant withdrew consent|3|||
162073779|NCT03336216|585327582|FG003|Treatment|Participant withdrew consent|2|||
162073780|NCT03336216|585327579|FG000|Treatment|Death|2|||
162073781|NCT03336216|585327580|FG001|Treatment|Death|3|||
162073782|NCT03336216|585327581|FG002|Treatment|Death|3|||
162073783|NCT03336216|585327582|FG003|Treatment|Death|4|||
162073784|NCT03336216|585327579|FG000|Treatment|Participant no longer meets study criteria|0|||
162073785|NCT03336216|585327580|FG001|Treatment|Participant no longer meets study criteria|1|||
162073786|NCT03336216|585327581|FG002|Treatment|Participant no longer meets study criteria|0|||
162073787|NCT03336216|585327582|FG003|Treatment|Participant no longer meets study criteria|0|||
162073788|NCT03336216|585327579|FG000|Treatment|Other reasons|2|||
162073789|NCT03336216|585327580|FG001|Treatment|Other reasons|0|||
162073790|NCT03336216|585327581|FG002|Treatment|Other reasons|0|||
162073791|NCT03336216|585327582|FG003|Treatment|Other reasons|3|||
162073792|NCT03336216|585327579|FG000|Treatment|Disease progression|23|||
162073793|NCT03336216|585327580|FG001|Treatment|Disease progression|34|||
162073794|NCT03336216|585327581|FG002|Treatment|Disease progression|33|||
162073795|NCT03336216|585327582|FG003|Treatment|Disease progression|26|||
162073796|NCT03336216|585327579|FG000|Treatment|Study drug toxicity|0|||
162073797|NCT03336216|585327580|FG001|Treatment|Study drug toxicity|3|||
162073798|NCT03336216|585327581|FG002|Treatment|Study drug toxicity|2|||
162073799|NCT03336216|585327582|FG003|Treatment|Study drug toxicity|0|||
162073800|NCT03336216|585327579|FG000|Treatment|Adverse Event unrelated to study drug|1|||
162073801|NCT03336216|585327580|FG001|Treatment|Adverse Event unrelated to study drug|1|||
162073802|NCT03336216|585327581|FG002|Treatment|Adverse Event unrelated to study drug|1|||
162073803|NCT03336216|585327582|FG003|Treatment|Adverse Event unrelated to study drug|0|||
162073804|NCT03336216|585327579|FG000|Treatment|Disease Recurrence|1|||
162073805|NCT03336216|585327580|FG001|Treatment|Disease Recurrence|0|||
162073806|NCT03336216|585327581|FG002|Treatment|Disease Recurrence|0|||
162073807|NCT03336216|585327582|FG003|Treatment|Disease Recurrence|0|||
162073808|NCT00922766|585327585|FG000|Overall Study|Death|3|||
162073809|NCT00922766|585327585|FG000|Overall Study|Withdrawal by Subject|2|||
162073810|NCT00922766|585327585|FG000|Overall Study|Other|1|||
162073811|NCT00922766|585327585|FG000|Overall Study|Adverse Event|1|||
162073812|NCT02404311|585327587|FG000|Part A: Month 0-18|Death|2|||
162073813|NCT02404311|585327588|FG001|Part A: Month 0-18|Death|0|||
162073814|NCT02404311|585327589|FG002|Part A: Month 0-18|Death|0|||
162073815|NCT02404311|585327590|FG003|Part A: Month 0-18|Death|0|||
162073816|NCT02404311|585327591|FG004|Part A: Month 0-18|Death|0|||
162073817|NCT02404311|585327587|FG000|Part A: Month 0-18|Physician Decision|1|||
162073818|NCT02404311|585327588|FG001|Part A: Month 0-18|Physician Decision|0|||
162073819|NCT02404311|585327589|FG002|Part A: Month 0-18|Physician Decision|0|||
162073820|NCT02404311|585327590|FG003|Part A: Month 0-18|Physician Decision|0|||
162073821|NCT02404311|585327591|FG004|Part A: Month 0-18|Physician Decision|0|||
162073822|NCT02404311|585327587|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
162073823|NCT02404311|585327588|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
162073824|NCT02404311|585327589|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
162073825|NCT02404311|585327590|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
162073826|NCT02404311|585327591|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
162073827|NCT02404311|585327587|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
162073828|NCT02404311|585327588|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
162073829|NCT02404311|585327589|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
162073830|NCT02404311|585327590|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
162073831|NCT02404311|585327591|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
162073832|NCT02404311|585327587|FG000|Part A: Month 0-18|HIV Infection|6|||
162073833|NCT02404311|585327588|FG001|Part A: Month 0-18|HIV Infection|2|||
162073834|NCT02404311|585327589|FG002|Part A: Month 0-18|HIV Infection|0|||
162073835|NCT02404311|585327590|FG003|Part A: Month 0-18|HIV Infection|0|||
162073836|NCT02404311|585327591|FG004|Part A: Month 0-18|HIV Infection|0|||
162073837|NCT02404311|585327587|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
162073838|NCT02404311|585327588|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
162073839|NCT02404311|585327589|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
162073840|NCT02404311|585327590|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
162073841|NCT02404311|585327591|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
162073842|NCT00159588|585327592|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
162073843|NCT00159588|585327593|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
162073844|NCT00159588|585327594|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
162073845|NCT03314584|585327601|FG000|Overall Study|Withdrawal by Subject|3|||
162073846|NCT03314584|585327602|FG001|Overall Study|Withdrawal by Subject|3|||
162073847|NCT03314584|585327601|FG000|Overall Study|Lost to Follow-up|4|||
162073848|NCT03314584|585327602|FG001|Overall Study|Lost to Follow-up|0|||
162073849|NCT06134817|585327603|FG000|Overall Study|Physician Departure - termination of study|1|||
162073850|NCT03406858|585327610|FG000|Overall Study|Failure to receive treatment drug.|1|||
162073851|NCT03406858|585327610|FG000|Overall Study|ineligible|1|||
162073852|NCT06027866|585327611|FG000|Overall Study|Withdrawal by Subject|2|||
162073853|NCT00930579|585327612|FG000|Overall Study|Withdrawal by Subject|1|||
162073854|NCT00930579|585327612|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
162073855|NCT01046682|585327621|FG000|Overall Study|Adverse Event|2|||
162073856|NCT01046682|585327622|FG001|Overall Study|Adverse Event|0|||
162073857|NCT05071183|585327623|FG000|Overall Study|Death|1|||
162073858|NCT05071183|585327624|FG001|Overall Study|Death|2|||
162073859|NCT05071183|585327625|FG002|Overall Study|Death|0|||
162073860|NCT05071183|585327623|FG000|Overall Study|Other Reasons|1|||
162073861|NCT05071183|585327624|FG001|Overall Study|Other Reasons|3|||
162073862|NCT05071183|585327625|FG002|Overall Study|Other Reasons|2|||
162073863|NCT02046148|585327626|FG000|Overall Study|Lost to Follow-up|1|||
162073864|NCT02046148|585327627|FG001|Overall Study|Lost to Follow-up|1|||
162073865|NCT02046148|585327626|FG000|Overall Study|Withdrawal by Subject|0|||
162073866|NCT02046148|585327627|FG001|Overall Study|Withdrawal by Subject|2|||
162073867|NCT03506373|585327629|FG000|Overall Study|Adverse Event|6|||
162073868|NCT03506373|585327629|FG000|Overall Study|Withdrawal by Subject|2|||
162073869|NCT03506373|585327629|FG000|Overall Study|Disease progression|5|||
162073870|NCT03506373|585327629|FG000|Overall Study|Other|3|||
162073871|NCT02939560|585327639|FG000|Overall Study|Withdrawal by Subject|2|||
162073872|NCT02939560|585327639|FG000|Overall Study|Protocol Violation|1|||
162073873|NCT03340025|585327640|FG000|Overall Study|Lost to Follow-up|2|||
162073874|NCT03340025|585327641|FG001|Overall Study|Lost to Follow-up|2|||
162073875|NCT02420691|585327642|FG000|Overall Study|Adverse Event|3|||
162073876|NCT02420691|585327642|FG000|Overall Study|Withdrawal by Subject|3|||
162073877|NCT01293240|585327643|FG000|Overall Study|Noncompliance|2|||
162073878|NCT01520363|585327644|FG000|Overall Study|Withdrawal by Subject|2|||
162073879|NCT01520363|585327645|FG001|Overall Study|Withdrawal by Subject|0|||
162073880|NCT01498952|585327649|FG000|Overall Study|Death|2|||
162073881|NCT01498952|585327650|FG001|Overall Study|Death|2|||
162073882|NCT01498952|585327651|FG002|Overall Study|Death|0|||
162073883|NCT01498952|585327652|FG003|Overall Study|Death|0|||
162073884|NCT01498952|585327653|FG004|Overall Study|Death|0|||
162073885|NCT00304356|585327654|FG000|Nitazoxanide|Physician Decision|5|||
162073886|NCT00304356|585327654|FG000|Nitazoxanide|Physician Decision|1|||
162073887|NCT00304356|585327654|FG000|Nitazoxanide|number is 0|1|||
162073888|NCT00304356|585327654|FG000|Nitazoxanide|Physician Decision|1|||
162073889|NCT00304356|585327654|FG000|Nitazoxanide|Physician Decision|1|||
162073890|NCT00304356|585327654|FG000|Nitazoxanide|Physician Decision|1|||
162073891|NCT04256785|585327657|FG000|Overall Study|Adverse Event|8|||
162073892|NCT04256785|585327658|FG001|Overall Study|Adverse Event|6|||
162073893|NCT04256785|585327657|FG000|Overall Study|Lack of Efficacy|3|||
162073894|NCT04256785|585327658|FG001|Overall Study|Lack of Efficacy|4|||
162073895|NCT04256785|585327657|FG000|Overall Study|Lost to Follow-up|7|||
162073896|NCT04256785|585327658|FG001|Overall Study|Lost to Follow-up|7|||
162073897|NCT04256785|585327657|FG000|Overall Study|Protocol Violation|1|||
162073898|NCT04256785|585327658|FG001|Overall Study|Protocol Violation|0|||
162073899|NCT04256785|585327657|FG000|Overall Study|Withdrawal by Subject|4|||
162073900|NCT04256785|585327658|FG001|Overall Study|Withdrawal by Subject|1|||
162073901|NCT04256785|585327657|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
162073902|NCT04256785|585327658|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
162073903|NCT01265849|585327659|FG000|Overall Study|Randomized//Treatment not initiated|1|||
162073904|NCT01265849|585327660|FG001|Overall Study|Randomized//Treatment not initiated|4|||
162073905|NCT01265849|585327661|FG002|Overall Study|Randomized//Treatment not initiated|0|||
162073906|NCT01265849|585327659|FG000|Overall Study|Physician Decision|1|||
162073907|NCT01265849|585327660|FG001|Overall Study|Physician Decision|2|||
162073908|NCT01265849|585327661|FG002|Overall Study|Physician Decision|0|||
162073909|NCT01265849|585327659|FG000|Overall Study|Lost to Follow-up|18|||
162073910|NCT01265849|585327660|FG001|Overall Study|Lost to Follow-up|15|||
162073911|NCT01265849|585327661|FG002|Overall Study|Lost to Follow-up|5|||
162073912|NCT01265849|585327659|FG000|Overall Study|Not otherwise specified|1|||
162073913|NCT01265849|585327660|FG001|Overall Study|Not otherwise specified|6|||
162073914|NCT01265849|585327661|FG002|Overall Study|Not otherwise specified|1|||
162073915|NCT01265849|585327659|FG000|Overall Study|Withdrawal by Subject|25|||
162073916|NCT01265849|585327660|FG001|Overall Study|Withdrawal by Subject|34|||
162073917|NCT01265849|585327661|FG002|Overall Study|Withdrawal by Subject|13|||
162073918|NCT01154218|585327662|FG000|Third Intervention Period|Adverse Event|0|||
162073919|NCT01154218|585327663|FG001|Third Intervention Period|Adverse Event|1|||
162073920|NCT01154218|585327664|FG002|Third Intervention Period|Adverse Event|0|||
162073921|NCT01154218|585327665|FG003|Third Intervention Period|Adverse Event|0|||
162073922|NCT01154218|585327662|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
162073923|NCT01154218|585327663|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
162073924|NCT01154218|585327664|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
162073925|NCT01154218|585327665|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
162073926|NCT01154218|585327662|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
162073927|NCT01154218|585327663|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
162073928|NCT01154218|585327664|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
162073929|NCT01154218|585327665|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
162073930|NCT03194321|585327666|FG000|Overall Study|Withdrawal by Subject|1|||
162073931|NCT03194321|585327666|FG000|Overall Study|Lost to Follow-up|1|||
162073932|NCT03194321|585327666|FG000|Overall Study|Travel for Follow-up|1|||
162073933|NCT01374087|585327674|FG000|Overall Study|Adverse Event|1|||
162073934|NCT01374087|585327675|FG001|Overall Study|Adverse Event|0|||
162073935|NCT01374087|585327674|FG000|Overall Study|Disease progression|2|||
162073936|NCT01374087|585327675|FG001|Overall Study|Disease progression|2|||
162073937|NCT01374087|585327674|FG000|Overall Study|Study discontinued|13|||
162073938|NCT01374087|585327675|FG001|Overall Study|Study discontinued|13|||
162073939|NCT03011307|585327676|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
162073940|NCT03011307|585327677|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
162073941|NCT03011307|585327676|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
162073942|NCT03011307|585327677|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
162073943|NCT03011307|585327676|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
162073944|NCT03011307|585327677|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
162073945|NCT00567892|585327681|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
162073946|NCT00567892|585327682|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
162073947|NCT00567892|585327683|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
162073948|NCT00567892|585327684|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
162073949|NCT00567892|585327681|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
162073950|NCT00567892|585327682|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
162073951|NCT00567892|585327683|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
162073952|NCT00567892|585327684|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
162073953|NCT04690751|585327686|FG000|Overall Study|Protocol Violation|0|||
162073954|NCT04690751|585327687|FG001|Overall Study|Protocol Violation|1|||
162073955|NCT04690751|585327688|FG002|Overall Study|Protocol Violation|0|||
162073956|NCT04690751|585327689|FG003|Overall Study|Protocol Violation|1|||
162073957|NCT04690751|585327690|FG004|Overall Study|Protocol Violation|2|||
162073958|NCT04690751|585327691|FG005|Overall Study|Protocol Violation|0|||
162073959|NCT04690751|585327686|FG000|Overall Study|Adverse Event|0|||
162073960|NCT04690751|585327687|FG001|Overall Study|Adverse Event|0|||
162073961|NCT04690751|585327688|FG002|Overall Study|Adverse Event|1|||
162073962|NCT04690751|585327689|FG003|Overall Study|Adverse Event|0|||
162073963|NCT04690751|585327690|FG004|Overall Study|Adverse Event|0|||
162073964|NCT04690751|585327691|FG005|Overall Study|Adverse Event|0|||
162073965|NCT04690751|585327686|FG000|Overall Study|Positive urine drug screen test|0|||
162073966|NCT04690751|585327687|FG001|Overall Study|Positive urine drug screen test|0|||
162073967|NCT04690751|585327688|FG002|Overall Study|Positive urine drug screen test|0|||
162073968|NCT04690751|585327689|FG003|Overall Study|Positive urine drug screen test|0|||
162073969|NCT04690751|585327690|FG004|Overall Study|Positive urine drug screen test|1|||
162073970|NCT04690751|585327691|FG005|Overall Study|Positive urine drug screen test|0|||
162073971|NCT01344161|585327692|FG000|Overall Study|Lost to Follow-up|4|||
162073972|NCT01344161|585327693|FG001|Overall Study|Lost to Follow-up|1|||
162073973|NCT01344161|585327692|FG000|Overall Study|Pregnancy|0|||
162073974|NCT01344161|585327693|FG001|Overall Study|Pregnancy|1|||
162073975|NCT01344161|585327692|FG000|Overall Study|Protocol Violation|1|||
162073976|NCT01344161|585327693|FG001|Overall Study|Protocol Violation|1|||
162073977|NCT04364620|585327694|FG000|Overall Study|Disease Progression|20|||
162073978|NCT04364620|585327694|FG000|Overall Study|Adverse Event|5|||
162073979|NCT04364620|585327694|FG000|Overall Study|Physician Decision|4|||
162073980|NCT04364620|585327694|FG000|Overall Study|Death|3|||
162073981|NCT04364620|585327694|FG000|Overall Study|Other|2|||
162073982|NCT04364620|585327694|FG000|Overall Study|Withdrawal by Subject|1|||
162073983|NCT01541969|585329397|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
162073984|NCT01541969|585329398|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
162073985|NCT01541969|585329397|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
162073986|NCT01541969|585329398|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
162073987|NCT01541969|585329397|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
162073988|NCT01541969|585329398|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
162073989|NCT01541969|585329397|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
162073990|NCT01541969|585329398|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
162073991|NCT01541969|585329397|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
162073992|NCT01541969|585329398|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
162073993|NCT01541969|585329397|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
162073994|NCT01541969|585329398|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
162073995|NCT01541969|585329397|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
162073996|NCT01541969|585329398|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
162073997|NCT01541969|585329397|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
162073998|NCT01541969|585329398|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
162073999|NCT01541969|585329397|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
162074000|NCT01541969|585329398|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
162074001|NCT01541969|585329397|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
162074002|NCT01541969|585329398|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
162074003|NCT01365507|585329399|FG000|Overall Study|Withdrawal Criteria|8|||
162074004|NCT01365507|585329400|FG001|Overall Study|Withdrawal Criteria|5|||
162074005|NCT01365507|585329399|FG000|Overall Study|Unclassified|1|||
162074006|NCT01365507|585329400|FG001|Overall Study|Unclassified|4|||
162074007|NCT01614990|585329401|FG000|Overall Study|Protocol Violation|1|||
162074008|NCT01614990|585329402|FG001|Overall Study|Protocol Violation|1|||
162074009|NCT02255500|585329409|FG000|Overall Study|Withdrawal by Subject|1|||
162074010|NCT02255500|585329410|FG001|Overall Study|Withdrawal by Subject|0|||
162074011|NCT02449239|585329413|FG000|Induction Phase|Lack of Efficacy|64|||
162074012|NCT02449239|585329413|FG000|Induction Phase|Adverse Event|1|||
162074013|NCT02449239|585329413|FG000|Induction Phase|Lost to Follow-up|1|||
162074014|NCT02449239|585329413|FG000|Induction Phase|Protocol Violation|1|||
162074015|NCT02449239|585329413|FG000|Induction Phase|Physician Decision|1|||
162074016|NCT02449239|585329413|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
162074017|NCT02449239|585329413|FG000|Induction Phase|Withdrawal by Subject|1|||
162074018|NCT02449239|585329413|FG000|Maintenance Month 3|Lack of Efficacy|14|||
162074019|NCT02449239|585329413|FG000|Maintenance Month 6|Lack of Efficacy|10|||
162074020|NCT02449239|585329413|FG000|Maintenance Month 6|Adverse Event|2|||
162074021|NCT02449239|585329413|FG000|Maintenance Month 6|Physician Decision|1|||
162074022|NCT02449239|585329413|FG000|Maintenance Month 9|Lack of Efficacy|2|||
162074023|NCT02449239|585329413|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
162074024|NCT02449239|585329413|FG000|Maintenance Month 12|Lack of Efficacy|5|||
162074025|NCT02449239|585329413|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
162074026|NCT02449239|585329413|FG000|Maintenance Month 12|Subject moved from area|1|||
162074027|NCT02449239|585329413|FG000|Maintenance Month 15|Lack of Efficacy|1|||
162074028|NCT02449239|585329413|FG000|Maintenance Month 21|Lack of Efficacy|1|||
162074029|NCT02449239|585329413|FG000|Maintenance Month 21|Sponsor decision|1|||
162074030|NCT03509675|585329416|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
162074031|NCT03509675|585329417|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
162074032|NCT03509675|585329416|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
162074033|NCT03509675|585329417|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
162074034|NCT03509675|585329416|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
162074035|NCT03509675|585329417|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
162074036|NCT03509675|585329416|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
162074037|NCT03509675|585329417|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
162074038|NCT03239470|585329420|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
162074039|NCT03239470|585329421|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
162074040|NCT01023581|585329422|FG000|Overall Study|Adverse Event|4|||
162074041|NCT01023581|585329423|FG001|Overall Study|Adverse Event|4|||
162074042|NCT01023581|585329424|FG002|Overall Study|Adverse Event|7|||
162074043|NCT01023581|585329425|FG003|Overall Study|Adverse Event|3|||
162074044|NCT01023581|585329426|FG004|Overall Study|Adverse Event|2|||
162074045|NCT01023581|585329427|FG005|Overall Study|Adverse Event|5|||
162074046|NCT01023581|585329428|FG006|Overall Study|Adverse Event|11|||
162074047|NCT01023581|585329422|FG000|Overall Study|Major protocol deviation|2|||
162074048|NCT01023581|585329423|FG001|Overall Study|Major protocol deviation|0|||
162074049|NCT01023581|585329424|FG002|Overall Study|Major protocol deviation|3|||
162074050|NCT01023581|585329425|FG003|Overall Study|Major protocol deviation|0|||
162074051|NCT01023581|585329426|FG004|Overall Study|Major protocol deviation|0|||
162074052|NCT01023581|585329427|FG005|Overall Study|Major protocol deviation|0|||
162074053|NCT01023581|585329428|FG006|Overall Study|Major protocol deviation|0|||
162074054|NCT01023581|585329422|FG000|Overall Study|Lost to Follow-up|4|||
162074055|NCT01023581|585329423|FG001|Overall Study|Lost to Follow-up|8|||
162074056|NCT01023581|585329424|FG002|Overall Study|Lost to Follow-up|7|||
162074057|NCT01023581|585329425|FG003|Overall Study|Lost to Follow-up|2|||
162074058|NCT01023581|585329426|FG004|Overall Study|Lost to Follow-up|5|||
162074059|NCT01023581|585329427|FG005|Overall Study|Lost to Follow-up|2|||
162074060|NCT01023581|585329428|FG006|Overall Study|Lost to Follow-up|2|||
162074061|NCT01023581|585329422|FG000|Overall Study|Withdrawal by Subject|13|||
162074062|NCT01023581|585329423|FG001|Overall Study|Withdrawal by Subject|8|||
162074063|NCT01023581|585329424|FG002|Overall Study|Withdrawal by Subject|16|||
162074064|NCT01023581|585329425|FG003|Overall Study|Withdrawal by Subject|10|||
162074065|NCT01023581|585329426|FG004|Overall Study|Withdrawal by Subject|6|||
162074066|NCT01023581|585329427|FG005|Overall Study|Withdrawal by Subject|8|||
162074067|NCT01023581|585329428|FG006|Overall Study|Withdrawal by Subject|5|||
162074068|NCT01023581|585329422|FG000|Overall Study|Pregnancy|0|||
162074069|NCT01023581|585329423|FG001|Overall Study|Pregnancy|0|||
162074070|NCT01023581|585329424|FG002|Overall Study|Pregnancy|0|||
162074071|NCT01023581|585329425|FG003|Overall Study|Pregnancy|2|||
162074072|NCT01023581|585329426|FG004|Overall Study|Pregnancy|0|||
162074073|NCT01023581|585329427|FG005|Overall Study|Pregnancy|1|||
162074074|NCT01023581|585329428|FG006|Overall Study|Pregnancy|0|||
162074075|NCT01023581|585329422|FG000|Overall Study|Lack of Efficacy|9|||
162074076|NCT01023581|585329423|FG001|Overall Study|Lack of Efficacy|3|||
162074077|NCT01023581|585329424|FG002|Overall Study|Lack of Efficacy|6|||
162074078|NCT01023581|585329425|FG003|Overall Study|Lack of Efficacy|2|||
162074079|NCT01023581|585329426|FG004|Overall Study|Lack of Efficacy|1|||
162074080|NCT01023581|585329427|FG005|Overall Study|Lack of Efficacy|2|||
162074081|NCT01023581|585329428|FG006|Overall Study|Lack of Efficacy|1|||
162074082|NCT01023581|585329422|FG000|Overall Study|Physician Decision|2|||
162074083|NCT01023581|585329423|FG001|Overall Study|Physician Decision|0|||
162074084|NCT01023581|585329424|FG002|Overall Study|Physician Decision|2|||
162074085|NCT01023581|585329425|FG003|Overall Study|Physician Decision|1|||
162074086|NCT01023581|585329426|FG004|Overall Study|Physician Decision|1|||
162074087|NCT01023581|585329427|FG005|Overall Study|Physician Decision|1|||
162074088|NCT01023581|585329428|FG006|Overall Study|Physician Decision|1|||
162074089|NCT01023581|585329422|FG000|Overall Study|Other|1|||
162074090|NCT01023581|585329423|FG001|Overall Study|Other|0|||
162074091|NCT01023581|585329424|FG002|Overall Study|Other|1|||
162074092|NCT01023581|585329425|FG003|Overall Study|Other|0|||
162074093|NCT01023581|585329426|FG004|Overall Study|Other|1|||
162074094|NCT01023581|585329427|FG005|Overall Study|Other|0|||
162074095|NCT01023581|585329428|FG006|Overall Study|Other|0|||
162074096|NCT02658890|585329436|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074097|NCT02658890|585329437|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074098|NCT02658890|585329438|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074099|NCT02658890|585329439|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074100|NCT02658890|585329440|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074101|NCT02658890|585329441|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074102|NCT02658890|585329442|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074103|NCT02658890|585329443|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074104|NCT02658890|585329444|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
162074105|NCT02658890|585329445|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074106|NCT02658890|585329446|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074107|NCT02658890|585329447|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074108|NCT02658890|585329448|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074109|NCT02658890|585329449|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074110|NCT02658890|585329450|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074111|NCT02658890|585329451|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074112|NCT02658890|585329452|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074113|NCT02658890|585329453|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074114|NCT02658890|585329454|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074115|NCT02658890|585329455|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074116|NCT02658890|585329456|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074117|NCT02658890|585329457|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074118|NCT02658890|585329458|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074119|NCT02658890|585329459|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074120|NCT02658890|585329460|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074121|NCT02658890|585329461|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074122|NCT02658890|585329462|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074123|NCT02658890|585329436|FG000|Treatment Phase|Adverse Event|0|||
162074124|NCT02658890|585329437|FG001|Treatment Phase|Adverse Event|1|||
162074125|NCT02658890|585329438|FG002|Treatment Phase|Adverse Event|2|||
162074126|NCT02658890|585329439|FG003|Treatment Phase|Adverse Event|2|||
162074127|NCT02658890|585329440|FG004|Treatment Phase|Adverse Event|1|||
162074128|NCT02658890|585329441|FG005|Treatment Phase|Adverse Event|0|||
162074129|NCT02658890|585329442|FG006|Treatment Phase|Adverse Event|0|||
162074130|NCT02658890|585329443|FG007|Treatment Phase|Adverse Event|2|||
162074131|NCT02658890|585329444|FG008|Treatment Phase|Adverse Event|1|||
162074132|NCT02658890|585329445|FG009|Treatment Phase|Adverse Event|2|||
162074133|NCT02658890|585329446|FG010|Treatment Phase|Adverse Event|3|||
162074134|NCT02658890|585329447|FG011|Treatment Phase|Adverse Event|0|||
162074135|NCT02658890|585329448|FG012|Treatment Phase|Adverse Event|1|||
162074136|NCT02658890|585329449|FG013|Treatment Phase|Adverse Event|4|||
162074137|NCT02658890|585329450|FG014|Treatment Phase|Adverse Event|0|||
162074138|NCT02658890|585329451|FG015|Treatment Phase|Adverse Event|0|||
162074139|NCT02658890|585329452|FG016|Treatment Phase|Adverse Event|0|||
162074140|NCT02658890|585329453|FG017|Treatment Phase|Adverse Event|0|||
162074141|NCT02658890|585329454|FG018|Treatment Phase|Adverse Event|5|||
162074142|NCT02658890|585329455|FG019|Treatment Phase|Adverse Event|1|||
162074143|NCT02658890|585329456|FG020|Treatment Phase|Adverse Event|3|||
162074144|NCT02658890|585329457|FG021|Treatment Phase|Adverse Event|0|||
162074145|NCT02658890|585329458|FG022|Treatment Phase|Adverse Event|5|||
162074146|NCT02658890|585329459|FG023|Treatment Phase|Adverse Event|0|||
162074147|NCT02658890|585329460|FG024|Treatment Phase|Adverse Event|0|||
162074148|NCT02658890|585329461|FG025|Treatment Phase|Adverse Event|2|||
162074149|NCT02658890|585329462|FG026|Treatment Phase|Adverse Event|1|||
162074150|NCT02658890|585329436|FG000|Treatment Phase|Death|0|||
162074151|NCT02658890|585329437|FG001|Treatment Phase|Death|0|||
162074152|NCT02658890|585329438|FG002|Treatment Phase|Death|0|||
162074153|NCT02658890|585329439|FG003|Treatment Phase|Death|0|||
162074154|NCT02658890|585329440|FG004|Treatment Phase|Death|0|||
162074155|NCT02658890|585329441|FG005|Treatment Phase|Death|0|||
162074156|NCT02658890|585329442|FG006|Treatment Phase|Death|0|||
162074157|NCT02658890|585329443|FG007|Treatment Phase|Death|0|||
162074158|NCT02658890|585329444|FG008|Treatment Phase|Death|0|||
162074159|NCT02658890|585329445|FG009|Treatment Phase|Death|0|||
162074160|NCT02658890|585329446|FG010|Treatment Phase|Death|0|||
162074161|NCT02658890|585329447|FG011|Treatment Phase|Death|0|||
162074162|NCT02658890|585329448|FG012|Treatment Phase|Death|0|||
162074163|NCT02658890|585329449|FG013|Treatment Phase|Death|0|||
162074164|NCT02658890|585329450|FG014|Treatment Phase|Death|0|||
162074165|NCT02658890|585329451|FG015|Treatment Phase|Death|0|||
162074166|NCT02658890|585329452|FG016|Treatment Phase|Death|0|||
162074167|NCT02658890|585329453|FG017|Treatment Phase|Death|0|||
162074168|NCT02658890|585329454|FG018|Treatment Phase|Death|1|||
162074169|NCT02658890|585329455|FG019|Treatment Phase|Death|0|||
162074170|NCT02658890|585329456|FG020|Treatment Phase|Death|0|||
162074171|NCT02658890|585329457|FG021|Treatment Phase|Death|0|||
162074172|NCT02658890|585329458|FG022|Treatment Phase|Death|0|||
162074173|NCT02658890|585329459|FG023|Treatment Phase|Death|0|||
162074174|NCT02658890|585329460|FG024|Treatment Phase|Death|0|||
162074175|NCT02658890|585329461|FG025|Treatment Phase|Death|0|||
162074176|NCT02658890|585329462|FG026|Treatment Phase|Death|0|||
162074177|NCT02658890|585329436|FG000|Treatment Phase|Lost to Follow-up|0|||
162074178|NCT02658890|585329437|FG001|Treatment Phase|Lost to Follow-up|0|||
162074179|NCT02658890|585329438|FG002|Treatment Phase|Lost to Follow-up|0|||
162074180|NCT02658890|585329439|FG003|Treatment Phase|Lost to Follow-up|0|||
162074181|NCT02658890|585329440|FG004|Treatment Phase|Lost to Follow-up|0|||
162074182|NCT02658890|585329441|FG005|Treatment Phase|Lost to Follow-up|0|||
162074183|NCT02658890|585329442|FG006|Treatment Phase|Lost to Follow-up|1|||
162074184|NCT02658890|585329443|FG007|Treatment Phase|Lost to Follow-up|0|||
162074185|NCT02658890|585329444|FG008|Treatment Phase|Lost to Follow-up|0|||
162074186|NCT02658890|585329445|FG009|Treatment Phase|Lost to Follow-up|0|||
162074187|NCT02658890|585329446|FG010|Treatment Phase|Lost to Follow-up|0|||
162074188|NCT02658890|585329447|FG011|Treatment Phase|Lost to Follow-up|0|||
162074189|NCT02658890|585329448|FG012|Treatment Phase|Lost to Follow-up|0|||
162074190|NCT02658890|585329449|FG013|Treatment Phase|Lost to Follow-up|0|||
162074191|NCT02658890|585329450|FG014|Treatment Phase|Lost to Follow-up|0|||
162074192|NCT02658890|585329451|FG015|Treatment Phase|Lost to Follow-up|0|||
162074193|NCT02658890|585329452|FG016|Treatment Phase|Lost to Follow-up|0|||
162074194|NCT02658890|585329453|FG017|Treatment Phase|Lost to Follow-up|0|||
162074195|NCT02658890|585329454|FG018|Treatment Phase|Lost to Follow-up|0|||
162074196|NCT02658890|585329455|FG019|Treatment Phase|Lost to Follow-up|0|||
162074197|NCT02658890|585329456|FG020|Treatment Phase|Lost to Follow-up|0|||
162074198|NCT02658890|585329457|FG021|Treatment Phase|Lost to Follow-up|0|||
162074199|NCT02658890|585329458|FG022|Treatment Phase|Lost to Follow-up|0|||
162074200|NCT02658890|585329459|FG023|Treatment Phase|Lost to Follow-up|0|||
162074201|NCT02658890|585329460|FG024|Treatment Phase|Lost to Follow-up|0|||
162074202|NCT02658890|585329461|FG025|Treatment Phase|Lost to Follow-up|0|||
162074203|NCT02658890|585329462|FG026|Treatment Phase|Lost to Follow-up|0|||
162074204|NCT02658890|585329436|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
162074205|NCT02658890|585329437|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
162074206|NCT02658890|585329438|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
162074207|NCT02658890|585329439|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
162074208|NCT02658890|585329440|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
162074209|NCT02658890|585329441|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
162074210|NCT02658890|585329442|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
162074211|NCT02658890|585329443|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
162074212|NCT02658890|585329444|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
162074213|NCT02658890|585329445|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
162074214|NCT02658890|585329446|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
162074215|NCT02658890|585329447|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
162074216|NCT02658890|585329448|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
162074217|NCT02658890|585329449|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
162074218|NCT02658890|585329450|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
162074219|NCT02658890|585329451|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
162074220|NCT02658890|585329452|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
162074221|NCT02658890|585329453|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
162074222|NCT02658890|585329454|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
162074223|NCT02658890|585329455|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
162074224|NCT02658890|585329456|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
162074225|NCT02658890|585329457|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
162074226|NCT02658890|585329458|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
162074227|NCT02658890|585329459|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
162074228|NCT02658890|585329460|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
162074229|NCT02658890|585329461|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
162074230|NCT02658890|585329462|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
162074231|NCT02658890|585329436|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
162074232|NCT02658890|585329437|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
162074233|NCT02658890|585329438|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
162074234|NCT02658890|585329439|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
162074235|NCT02658890|585329440|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
162074236|NCT02658890|585329441|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
162074237|NCT02658890|585329442|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
162074238|NCT02658890|585329443|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
162074239|NCT02658890|585329444|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
162074240|NCT02658890|585329445|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
162074241|NCT02658890|585329446|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
162074242|NCT02658890|585329447|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
162074243|NCT02658890|585329448|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
162074244|NCT02658890|585329449|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
162074245|NCT02658890|585329450|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
162074246|NCT02658890|585329451|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
162074247|NCT02658890|585329452|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
162074248|NCT02658890|585329453|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
162074249|NCT02658890|585329454|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
162074250|NCT02658890|585329455|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
162074251|NCT02658890|585329456|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
162074252|NCT02658890|585329457|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
162074253|NCT02658890|585329458|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
162074254|NCT02658890|585329459|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
162074255|NCT02658890|585329460|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
162074256|NCT02658890|585329461|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
162074257|NCT02658890|585329462|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
162074258|NCT02658890|585329436|FG000|Treatment Phase|Other Reasons|0|||
162074259|NCT02658890|585329437|FG001|Treatment Phase|Other Reasons|0|||
162074260|NCT02658890|585329438|FG002|Treatment Phase|Other Reasons|0|||
162074261|NCT02658890|585329439|FG003|Treatment Phase|Other Reasons|0|||
162074262|NCT02658890|585329440|FG004|Treatment Phase|Other Reasons|0|||
162074263|NCT02658890|585329441|FG005|Treatment Phase|Other Reasons|0|||
162074264|NCT02658890|585329442|FG006|Treatment Phase|Other Reasons|1|||
162074265|NCT02658890|585329443|FG007|Treatment Phase|Other Reasons|0|||
162074266|NCT02658890|585329444|FG008|Treatment Phase|Other Reasons|1|||
162074267|NCT02658890|585329445|FG009|Treatment Phase|Other Reasons|0|||
162074268|NCT02658890|585329446|FG010|Treatment Phase|Other Reasons|0|||
162074269|NCT02658890|585329447|FG011|Treatment Phase|Other Reasons|0|||
162074270|NCT02658890|585329448|FG012|Treatment Phase|Other Reasons|0|||
162074271|NCT02658890|585329449|FG013|Treatment Phase|Other Reasons|2|||
162074272|NCT02658890|585329450|FG014|Treatment Phase|Other Reasons|0|||
162074273|NCT02658890|585329451|FG015|Treatment Phase|Other Reasons|0|||
162074274|NCT02658890|585329452|FG016|Treatment Phase|Other Reasons|0|||
162074275|NCT02658890|585329453|FG017|Treatment Phase|Other Reasons|0|||
162074276|NCT02658890|585329454|FG018|Treatment Phase|Other Reasons|1|||
162074277|NCT02658890|585329455|FG019|Treatment Phase|Other Reasons|0|||
162074278|NCT02658890|585329456|FG020|Treatment Phase|Other Reasons|0|||
162074279|NCT02658890|585329457|FG021|Treatment Phase|Other Reasons|0|||
162074280|NCT02658890|585329458|FG022|Treatment Phase|Other Reasons|0|||
162074281|NCT02658890|585329459|FG023|Treatment Phase|Other Reasons|0|||
162074282|NCT02658890|585329460|FG024|Treatment Phase|Other Reasons|1|||
162074283|NCT02658890|585329461|FG025|Treatment Phase|Other Reasons|0|||
162074284|NCT02658890|585329462|FG026|Treatment Phase|Other Reasons|1|||
162074285|NCT02658890|585329436|FG000|Treatment Phase|Progressive Disease|6|||
162074286|NCT02658890|585329437|FG001|Treatment Phase|Progressive Disease|7|||
162074287|NCT02658890|585329438|FG002|Treatment Phase|Progressive Disease|6|||
162074288|NCT02658890|585329439|FG003|Treatment Phase|Progressive Disease|12|||
162074289|NCT02658890|585329440|FG004|Treatment Phase|Progressive Disease|6|||
162074290|NCT02658890|585329441|FG005|Treatment Phase|Progressive Disease|18|||
162074291|NCT02658890|585329442|FG006|Treatment Phase|Progressive Disease|12|||
162074292|NCT02658890|585329443|FG007|Treatment Phase|Progressive Disease|19|||
162074293|NCT02658890|585329444|FG008|Treatment Phase|Progressive Disease|26|||
162074294|NCT02658890|585329445|FG009|Treatment Phase|Progressive Disease|8|||
162074295|NCT02658890|585329446|FG010|Treatment Phase|Progressive Disease|7|||
162074296|NCT02658890|585329447|FG011|Treatment Phase|Progressive Disease|9|||
162074297|NCT02658890|585329448|FG012|Treatment Phase|Progressive Disease|8|||
162074298|NCT02658890|585329449|FG013|Treatment Phase|Progressive Disease|29|||
162074299|NCT02658890|585329450|FG014|Treatment Phase|Progressive Disease|6|||
162074300|NCT02658890|585329451|FG015|Treatment Phase|Progressive Disease|2|||
162074301|NCT02658890|585329452|FG016|Treatment Phase|Progressive Disease|32|||
162074302|NCT02658890|585329453|FG017|Treatment Phase|Progressive Disease|14|||
162074303|NCT02658890|585329454|FG018|Treatment Phase|Progressive Disease|40|||
162074304|NCT02658890|585329455|FG019|Treatment Phase|Progressive Disease|32|||
162074305|NCT02658890|585329456|FG020|Treatment Phase|Progressive Disease|19|||
162074306|NCT02658890|585329457|FG021|Treatment Phase|Progressive Disease|30|||
162074307|NCT02658890|585329458|FG022|Treatment Phase|Progressive Disease|15|||
162074308|NCT02658890|585329459|FG023|Treatment Phase|Progressive Disease|0|||
162074309|NCT02658890|585329460|FG024|Treatment Phase|Progressive Disease|0|||
162074310|NCT02658890|585329461|FG025|Treatment Phase|Progressive Disease|14|||
162074311|NCT02658890|585329462|FG026|Treatment Phase|Progressive Disease|11|||
162074312|NCT02658890|585329436|FG000|Treatment Phase|Study Drug Toxicity|0|||
162074313|NCT02658890|585329437|FG001|Treatment Phase|Study Drug Toxicity|0|||
162074314|NCT02658890|585329438|FG002|Treatment Phase|Study Drug Toxicity|2|||
162074315|NCT02658890|585329439|FG003|Treatment Phase|Study Drug Toxicity|0|||
162074316|NCT02658890|585329440|FG004|Treatment Phase|Study Drug Toxicity|0|||
162074317|NCT02658890|585329441|FG005|Treatment Phase|Study Drug Toxicity|0|||
162074318|NCT02658890|585329442|FG006|Treatment Phase|Study Drug Toxicity|0|||
162074319|NCT02658890|585329443|FG007|Treatment Phase|Study Drug Toxicity|0|||
162074320|NCT02658890|585329444|FG008|Treatment Phase|Study Drug Toxicity|3|||
162074321|NCT02658890|585329445|FG009|Treatment Phase|Study Drug Toxicity|0|||
162074322|NCT02658890|585329446|FG010|Treatment Phase|Study Drug Toxicity|1|||
162074323|NCT02658890|585329447|FG011|Treatment Phase|Study Drug Toxicity|1|||
162074324|NCT02658890|585329448|FG012|Treatment Phase|Study Drug Toxicity|2|||
162074325|NCT02658890|585329449|FG013|Treatment Phase|Study Drug Toxicity|9|||
162074326|NCT02658890|585329450|FG014|Treatment Phase|Study Drug Toxicity|0|||
162074327|NCT02658890|585329451|FG015|Treatment Phase|Study Drug Toxicity|1|||
162074328|NCT02658890|585329452|FG016|Treatment Phase|Study Drug Toxicity|1|||
162074329|NCT02658890|585329453|FG017|Treatment Phase|Study Drug Toxicity|0|||
162074330|NCT02658890|585329454|FG018|Treatment Phase|Study Drug Toxicity|8|||
162074331|NCT02658890|585329455|FG019|Treatment Phase|Study Drug Toxicity|3|||
162074332|NCT02658890|585329456|FG020|Treatment Phase|Study Drug Toxicity|2|||
162074333|NCT02658890|585329457|FG021|Treatment Phase|Study Drug Toxicity|0|||
162074334|NCT02658890|585329458|FG022|Treatment Phase|Study Drug Toxicity|8|||
162074335|NCT02658890|585329459|FG023|Treatment Phase|Study Drug Toxicity|0|||
162074336|NCT02658890|585329460|FG024|Treatment Phase|Study Drug Toxicity|0|||
162074337|NCT02658890|585329461|FG025|Treatment Phase|Study Drug Toxicity|2|||
162074338|NCT02658890|585329462|FG026|Treatment Phase|Study Drug Toxicity|0|||
162074339|NCT02658890|585329436|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074340|NCT02658890|585329437|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074341|NCT02658890|585329438|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074342|NCT02658890|585329439|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
162074343|NCT02658890|585329440|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074344|NCT02658890|585329441|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074345|NCT02658890|585329442|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074346|NCT02658890|585329443|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074347|NCT02658890|585329444|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074348|NCT02658890|585329445|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
162074349|NCT02658890|585329446|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074350|NCT02658890|585329447|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074351|NCT02658890|585329448|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074352|NCT02658890|585329449|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074353|NCT02658890|585329450|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074354|NCT02658890|585329451|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074355|NCT02658890|585329452|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074356|NCT02658890|585329453|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074357|NCT02658890|585329454|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
162074358|NCT02658890|585329455|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074359|NCT02658890|585329456|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074360|NCT02658890|585329457|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074361|NCT02658890|585329458|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
162074362|NCT02658890|585329459|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074363|NCT02658890|585329460|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074364|NCT02658890|585329461|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074365|NCT02658890|585329462|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
162074366|NCT02658890|585329436|FG000|Treatment Phase|Withdrawal by Subject|0|||
162074367|NCT02658890|585329437|FG001|Treatment Phase|Withdrawal by Subject|1|||
162074368|NCT02658890|585329438|FG002|Treatment Phase|Withdrawal by Subject|0|||
162074369|NCT02658890|585329439|FG003|Treatment Phase|Withdrawal by Subject|0|||
162074370|NCT02658890|585329440|FG004|Treatment Phase|Withdrawal by Subject|0|||
162074371|NCT02658890|585329441|FG005|Treatment Phase|Withdrawal by Subject|0|||
162074372|NCT02658890|585329442|FG006|Treatment Phase|Withdrawal by Subject|1|||
162074373|NCT02658890|585329443|FG007|Treatment Phase|Withdrawal by Subject|0|||
162074374|NCT02658890|585329444|FG008|Treatment Phase|Withdrawal by Subject|0|||
162074375|NCT02658890|585329445|FG009|Treatment Phase|Withdrawal by Subject|1|||
162074376|NCT02658890|585329446|FG010|Treatment Phase|Withdrawal by Subject|0|||
162074377|NCT02658890|585329447|FG011|Treatment Phase|Withdrawal by Subject|0|||
162074378|NCT02658890|585329448|FG012|Treatment Phase|Withdrawal by Subject|1|||
162074379|NCT02658890|585329449|FG013|Treatment Phase|Withdrawal by Subject|3|||
162074380|NCT02658890|585329450|FG014|Treatment Phase|Withdrawal by Subject|0|||
162074381|NCT02658890|585329451|FG015|Treatment Phase|Withdrawal by Subject|0|||
162074382|NCT02658890|585329452|FG016|Treatment Phase|Withdrawal by Subject|1|||
162074383|NCT02658890|585329453|FG017|Treatment Phase|Withdrawal by Subject|0|||
162074384|NCT02658890|585329454|FG018|Treatment Phase|Withdrawal by Subject|4|||
162074385|NCT02658890|585329455|FG019|Treatment Phase|Withdrawal by Subject|3|||
162074386|NCT02658890|585329456|FG020|Treatment Phase|Withdrawal by Subject|0|||
162074387|NCT02658890|585329457|FG021|Treatment Phase|Withdrawal by Subject|4|||
162074388|NCT02658890|585329458|FG022|Treatment Phase|Withdrawal by Subject|1|||
162074389|NCT02658890|585329459|FG023|Treatment Phase|Withdrawal by Subject|1|||
162074390|NCT02658890|585329460|FG024|Treatment Phase|Withdrawal by Subject|0|||
162074391|NCT02658890|585329461|FG025|Treatment Phase|Withdrawal by Subject|0|||
162074392|NCT02658890|585329462|FG026|Treatment Phase|Withdrawal by Subject|0|||
162074393|NCT00076011|585329465|FG000|Overall Study|Death|1|||
162074394|NCT00076011|585329465|FG000|Overall Study|Adverse Event|10|||
162074395|NCT00076011|585329465|FG000|Overall Study|Lack of Efficacy|25|||
162074396|NCT00076011|585329465|FG000|Overall Study|Withdrawal by Subject|1|||
162074397|NCT00076011|585329465|FG000|Overall Study|Study terminated by sponsor|3|||
162074398|NCT00076011|585329465|FG000|Overall Study|Other|11|||
162074399|NCT00076011|585329465|FG000|Overall Study|Ongoing|1|||
162074400|NCT02864251|585329472|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
162074401|NCT02864251|585329473|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
162074402|NCT02864251|585329474|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
162074403|NCT02864251|585329472|FG000|Pre-Treatment|Withdrawal by Participant|0|||
162074404|NCT02864251|585329473|FG001|Pre-Treatment|Withdrawal by Participant|0|||
162074405|NCT02864251|585329474|FG002|Pre-Treatment|Withdrawal by Participant|4|||
162074406|NCT02864251|585329472|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
162074407|NCT02864251|585329473|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
162074408|NCT02864251|585329474|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
162074409|NCT02864251|585329472|FG000|Pre-Treatment|Other Reasons|0|||
162074410|NCT02864251|585329473|FG001|Pre-Treatment|Other Reasons|1|||
162074411|NCT02864251|585329474|FG002|Pre-Treatment|Other Reasons|1|||
162074412|NCT02864251|585329472|FG000|Treatment|Disease Progression|109|||
162074413|NCT02864251|585329473|FG001|Treatment|Disease Progression|52|||
162074414|NCT02864251|585329474|FG002|Treatment|Disease Progression|101|||
162074415|NCT02864251|585329472|FG000|Treatment|Study Drug Toxicity|9|||
162074416|NCT02864251|585329473|FG001|Treatment|Study Drug Toxicity|4|||
162074417|NCT02864251|585329474|FG002|Treatment|Study Drug Toxicity|10|||
162074418|NCT02864251|585329472|FG000|Treatment|Death|0|||
162074419|NCT02864251|585329473|FG001|Treatment|Death|2|||
162074420|NCT02864251|585329474|FG002|Treatment|Death|3|||
162074421|NCT02864251|585329472|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
162074422|NCT02864251|585329473|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
162074423|NCT02864251|585329474|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
162074424|NCT02864251|585329472|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
162074425|NCT02864251|585329473|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
162074426|NCT02864251|585329474|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
162074427|NCT02864251|585329472|FG000|Treatment|Withdrawal by Participant|8|||
162074428|NCT02864251|585329473|FG001|Treatment|Withdrawal by Participant|5|||
162074429|NCT02864251|585329474|FG002|Treatment|Withdrawal by Participant|13|||
162074430|NCT02864251|585329472|FG000|Treatment|Maximum Clinical Benefit|1|||
162074431|NCT02864251|585329473|FG001|Treatment|Maximum Clinical Benefit|0|||
162074432|NCT02864251|585329474|FG002|Treatment|Maximum Clinical Benefit|1|||
162074433|NCT02864251|585329472|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
162074434|NCT02864251|585329473|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
162074435|NCT02864251|585329474|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
162074436|NCT02864251|585329472|FG000|Treatment|Other Reasons|1|||
162074437|NCT02864251|585329473|FG001|Treatment|Other Reasons|1|||
162074438|NCT02864251|585329474|FG002|Treatment|Other Reasons|4|||
162074439|NCT02864251|585329472|FG000|Treatment|Administrative Reason by Sponsor|1|||
162074440|NCT02864251|585329473|FG001|Treatment|Administrative Reason by Sponsor|0|||
162074441|NCT02864251|585329474|FG002|Treatment|Administrative Reason by Sponsor|0|||
162074442|NCT04343521|585329475|FG000|Overall Study|Adverse Event|0|||
162074443|NCT04343521|585329476|FG001|Overall Study|Adverse Event|2|||
162074444|NCT04343521|585329475|FG000|Overall Study|Death|1|||
162074445|NCT04343521|585329476|FG001|Overall Study|Death|2|||
162074446|NCT04343521|585329475|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
162074447|NCT04343521|585329476|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
162074448|NCT04343521|585329475|FG000|Overall Study|Withdrawal by Subject|70|||
162074449|NCT04343521|585329476|FG001|Overall Study|Withdrawal by Subject|95|||
162074450|NCT04343521|585329475|FG000|Overall Study|Withdrawal by study team|6|||
162074451|NCT04343521|585329476|FG001|Overall Study|Withdrawal by study team|12|||
162074452|NCT00107198|585329477|FG000|Overall Study|Lack of Efficacy|28|||
162074453|NCT00107198|585329477|FG000|Overall Study|Lost to Follow-up|12|||
162074454|NCT00107198|585329477|FG000|Overall Study|Protocol Violation|1|||
162074455|NCT00107198|585329477|FG000|Overall Study|Withdrawal by Subject|6|||
162074456|NCT00107198|585329477|FG000|Overall Study|Ineligible|5|||
162074457|NCT02532647|585329478|FG000|Overall Study|Did not receive trial medication|1|||
162074458|NCT02532647|585329479|FG001|Overall Study|Did not receive trial medication|0|||
162074459|NCT02532647|585329480|FG002|Overall Study|Did not receive trial medication|1|||
162074460|NCT03897179|585329490|FG000|Overall Study|Withdrawal by Subject|1|||
162074461|NCT01480076|585329491|FG000|Overall Study|Run-in Failure|52|||
162074462|NCT01480076|585329491|FG000|Overall Study|Adverse Event|39|||
162074463|NCT01480076|585329491|FG000|Overall Study|Death|2|||
162074464|NCT01480076|585329491|FG000|Overall Study|Disease Progression|5|||
162074465|NCT01480076|585329491|FG000|Overall Study|Non-compliance With Study Protocol|15|||
162074466|NCT01480076|585329491|FG000|Overall Study|Withdrawal by Subject|105|||
162074467|NCT01480076|585329491|FG000|Overall Study|Lost to Follow-up|7|||
162074468|NCT01480076|585329491|FG000|Overall Study|Investigator Decision|13|||
162074469|NCT01480076|585329491|FG000|Overall Study|Other|52|||
162074470|NCT02503332|585329493|FG000|Overall Study|Adverse Event|17|||
162074471|NCT02503332|585329494|FG001|Overall Study|Adverse Event|5|||
162074472|NCT02503332|585329495|FG002|Overall Study|Adverse Event|3|||
162074473|NCT02503332|585329496|FG003|Overall Study|Adverse Event|1|||
162074474|NCT02503332|585329493|FG000|Overall Study|Investigator's Decision|5|||
162074475|NCT02503332|585329494|FG001|Overall Study|Investigator's Decision|1|||
162074476|NCT02503332|585329495|FG002|Overall Study|Investigator's Decision|0|||
162074477|NCT02503332|585329496|FG003|Overall Study|Investigator's Decision|0|||
162074478|NCT02503332|585329493|FG000|Overall Study|Sponsor's Decision|1|||
162074479|NCT02503332|585329494|FG001|Overall Study|Sponsor's Decision|0|||
162074480|NCT02503332|585329495|FG002|Overall Study|Sponsor's Decision|0|||
162074481|NCT02503332|585329496|FG003|Overall Study|Sponsor's Decision|1|||
162074482|NCT02503332|585329493|FG000|Overall Study|Subject Request|6|||
162074483|NCT02503332|585329494|FG001|Overall Study|Subject Request|5|||
162074484|NCT02503332|585329495|FG002|Overall Study|Subject Request|2|||
162074485|NCT02503332|585329496|FG003|Overall Study|Subject Request|1|||
162074486|NCT02503332|585329493|FG000|Overall Study|Death|0|||
162074487|NCT02503332|585329494|FG001|Overall Study|Death|2|||
162074488|NCT02503332|585329495|FG002|Overall Study|Death|2|||
162074489|NCT02503332|585329496|FG003|Overall Study|Death|0|||
162074490|NCT02503332|585329493|FG000|Overall Study|Other|5|||
162074491|NCT02503332|585329494|FG001|Overall Study|Other|6|||
162074492|NCT02503332|585329495|FG002|Overall Study|Other|1|||
162074493|NCT02503332|585329496|FG003|Overall Study|Other|1|||
162074494|NCT05694546|585329497|FG000|Overall Study|Lost to Follow-up|11|||
162074495|NCT02120950|585329498|FG000|Overall Study|Adverse Event|5|||
162074496|NCT02120950|585329499|FG001|Overall Study|Adverse Event|4|||
162074497|NCT02120950|585329500|FG002|Overall Study|Adverse Event|3|||
162074498|NCT02120950|585329498|FG000|Overall Study|Death|3|||
162074499|NCT02120950|585329499|FG001|Overall Study|Death|0|||
162074500|NCT02120950|585329500|FG002|Overall Study|Death|1|||
162074501|NCT02120950|585329498|FG000|Overall Study|Withdrawal by Subject|6|||
162074502|NCT02120950|585329499|FG001|Overall Study|Withdrawal by Subject|3|||
162074503|NCT02120950|585329500|FG002|Overall Study|Withdrawal by Subject|2|||
162074504|NCT02120950|585329498|FG000|Overall Study|Protocol Violation|1|||
162074505|NCT02120950|585329499|FG001|Overall Study|Protocol Violation|1|||
162074506|NCT02120950|585329500|FG002|Overall Study|Protocol Violation|7|||
162074507|NCT02120950|585329498|FG000|Overall Study|Other reasons|5|||
162074508|NCT02120950|585329499|FG001|Overall Study|Other reasons|4|||
162074509|NCT02120950|585329500|FG002|Overall Study|Other reasons|1|||
162074510|NCT02120950|585329498|FG000|Overall Study|Lost to Follow-up|0|||
162074511|NCT02120950|585329499|FG001|Overall Study|Lost to Follow-up|2|||
162074512|NCT02120950|585329500|FG002|Overall Study|Lost to Follow-up|1|||
162074513|NCT02424383|585329501|FG000|Overall Study|Withdrawal by Subject|32|||
162074514|NCT02424383|585329501|FG000|Overall Study|Death|170|||
162074515|NCT02424383|585329501|FG000|Overall Study|Sponsor's decision|3|||
162074516|NCT02424383|585329501|FG000|Overall Study|Investigator's decision|44|||
162074517|NCT02424383|585329501|FG000|Overall Study|Lost to Follow-up|81|||
162074518|NCT02424383|585329501|FG000|Overall Study|Other|7|||
162074519|NCT02424383|585329501|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
162074520|NCT03412084|585329505|FG000|Overall Study|Withdrawal by Subject|2|||
162074521|NCT03412084|585329506|FG001|Overall Study|Withdrawal by Subject|0|||
162074522|NCT03412084|585329505|FG000|Overall Study|Participant moved|1|||
162074523|NCT03412084|585329506|FG001|Overall Study|Participant moved|0|||
162074524|NCT03412084|585329505|FG000|Overall Study|Lost to Follow-up|1|||
162074525|NCT03412084|585329506|FG001|Overall Study|Lost to Follow-up|1|||
162074526|NCT01928862|585329510|FG000|Overall Study|Lost to Follow-up|1|||
162074527|NCT01928862|585329511|FG001|Overall Study|Lost to Follow-up|0|||
162074528|NCT01928862|585329512|FG002|Overall Study|Lost to Follow-up|0|||
162074529|NCT01928862|585329513|FG003|Overall Study|Lost to Follow-up|0|||
162074530|NCT01928862|585329514|FG004|Overall Study|Lost to Follow-up|1|||
162074531|NCT01752855|585329518|FG000|Overall Study|Adverse Event|1|||
162074532|NCT01752855|585329519|FG001|Overall Study|Adverse Event|0|||
162074533|NCT01752855|585329518|FG000|Overall Study|Withdrew Consent|0|||
162074534|NCT01752855|585329519|FG001|Overall Study|Withdrew Consent|2|||
162074535|NCT01752855|585329518|FG000|Overall Study|Lack of Efficacy|0|||
162074536|NCT01752855|585329519|FG001|Overall Study|Lack of Efficacy|2|||
162074537|NCT01478321|585329521|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
162074538|NCT01478321|585329521|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
162074539|NCT01478321|585329521|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
162074540|NCT01478321|585329521|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
162074541|NCT01478321|585329521|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
162074542|NCT01478321|585329521|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
162074543|NCT01478321|585329521|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
162074544|NCT01478321|585329521|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
162074545|NCT02053753|585329522|FG000|Overall Study|Withdrawal by Subject|2|||
162074546|NCT02053753|585329523|FG001|Overall Study|Withdrawal by Subject|4|||
162074547|NCT02053753|585329522|FG000|Overall Study|Decision by Sponsor|1|||
162074548|NCT02053753|585329523|FG001|Overall Study|Decision by Sponsor|1|||
162074549|NCT02053753|585329522|FG000|Overall Study|Lost to Follow-up|4|||
162074550|NCT02053753|585329523|FG001|Overall Study|Lost to Follow-up|3|||
162074551|NCT02439320|585329524|FG000|Overall Study|Adverse Event|0|||
162074552|NCT02439320|585329525|FG001|Overall Study|Adverse Event|2|||
162074553|NCT02439320|585329526|FG002|Overall Study|Adverse Event|0|||
162074554|NCT02439320|585329524|FG000|Overall Study|Lost to Follow-up|37|||
162074555|NCT02439320|585329525|FG001|Overall Study|Lost to Follow-up|34|||
162074556|NCT02439320|585329526|FG002|Overall Study|Lost to Follow-up|42|||
162074557|NCT02439320|585329524|FG000|Overall Study|Death|0|||
162074558|NCT02439320|585329525|FG001|Overall Study|Death|1|||
162074559|NCT02439320|585329526|FG002|Overall Study|Death|0|||
162074560|NCT02439320|585329524|FG000|Overall Study|Noncompliance with Protocol|10|||
162074561|NCT02439320|585329525|FG001|Overall Study|Noncompliance with Protocol|11|||
162074562|NCT02439320|585329526|FG002|Overall Study|Noncompliance with Protocol|7|||
162074563|NCT02439320|585329524|FG000|Overall Study|Pregnancy|0|||
162074564|NCT02439320|585329525|FG001|Overall Study|Pregnancy|1|||
162074565|NCT02439320|585329526|FG002|Overall Study|Pregnancy|1|||
162074566|NCT02439320|585329524|FG000|Overall Study|Withdrawal by Subject|12|||
162074567|NCT02439320|585329525|FG001|Overall Study|Withdrawal by Subject|16|||
162074568|NCT02439320|585329526|FG002|Overall Study|Withdrawal by Subject|14|||
162074569|NCT02439320|585329524|FG000|Overall Study|Physician Decision|2|||
162074570|NCT02439320|585329525|FG001|Overall Study|Physician Decision|1|||
162074571|NCT02439320|585329526|FG002|Overall Study|Physician Decision|0|||
162074572|NCT02439320|585329524|FG000|Overall Study|Sponsor Request|0|||
162074573|NCT02439320|585329525|FG001|Overall Study|Sponsor Request|2|||
162074574|NCT02439320|585329526|FG002|Overall Study|Sponsor Request|1|||
162074575|NCT02439320|585329524|FG000|Overall Study|Randomization Failure|35|||
162074576|NCT02439320|585329525|FG001|Overall Study|Randomization Failure|46|||
162074577|NCT02439320|585329526|FG002|Overall Study|Randomization Failure|34|||
162074578|NCT01505608|585329527|FG000|Phase I|Lack of Efficacy|0|||
162074579|NCT01505608|585329528|FG001|Phase I|Lack of Efficacy|4|||
162074580|NCT01505608|585329527|FG000|Phase I|Adverse Event|0|||
162074581|NCT01505608|585329528|FG001|Phase I|Adverse Event|1|||
162074582|NCT01505608|585329527|FG000|Phase I|Withdrawal by Subject|0|||
162074583|NCT01505608|585329528|FG001|Phase I|Withdrawal by Subject|1|||
162074584|NCT01505608|585329527|FG000|Phase II|Lack of Efficacy|2|||
162074585|NCT01505608|585329528|FG001|Phase II|Lack of Efficacy|1|||
162074586|NCT01505608|585329527|FG000|Phase II|Protocol Violation|0|||
162074587|NCT01505608|585329528|FG001|Phase II|Protocol Violation|1|||
162074588|NCT01251380|585329531|FG000|Overall Study|Other (Not otherwise specified)|12|||
162074589|NCT01251380|585329531|FG000|Overall Study|Withdrawal by Subject|6|||
162074590|NCT01251380|585329531|FG000|Overall Study|Lack of Efficacy|1|||
162074591|NCT01251380|585329531|FG000|Overall Study|Adverse Event|1|||
162074592|NCT01251380|585329531|FG000|Overall Study|Lost to Follow-up|2|||
162074593|NCT02404350|585329535|FG000|Overall Study|Adverse Event|2|||
162074594|NCT02404350|585329536|FG001|Overall Study|Adverse Event|2|||
162074595|NCT02404350|585329537|FG002|Overall Study|Adverse Event|3|||
162074596|NCT02404350|585329538|FG003|Overall Study|Adverse Event|9|||
162074597|NCT02404350|585329535|FG000|Overall Study|Lack of Efficacy|3|||
162074598|NCT02404350|585329536|FG001|Overall Study|Lack of Efficacy|1|||
162074599|NCT02404350|585329537|FG002|Overall Study|Lack of Efficacy|0|||
162074600|NCT02404350|585329538|FG003|Overall Study|Lack of Efficacy|3|||
162074601|NCT02404350|585329535|FG000|Overall Study|Lost to Follow-up|2|||
162074602|NCT02404350|585329536|FG001|Overall Study|Lost to Follow-up|0|||
162074603|NCT02404350|585329537|FG002|Overall Study|Lost to Follow-up|0|||
162074604|NCT02404350|585329538|FG003|Overall Study|Lost to Follow-up|1|||
162074605|NCT02404350|585329535|FG000|Overall Study|Physician Decision|1|||
162074606|NCT02404350|585329536|FG001|Overall Study|Physician Decision|0|||
162074607|NCT02404350|585329537|FG002|Overall Study|Physician Decision|0|||
162074608|NCT02404350|585329538|FG003|Overall Study|Physician Decision|2|||
162074609|NCT02404350|585329535|FG000|Overall Study|Pregnancy|0|||
162074610|NCT02404350|585329536|FG001|Overall Study|Pregnancy|0|||
162074611|NCT02404350|585329537|FG002|Overall Study|Pregnancy|0|||
162074612|NCT02404350|585329538|FG003|Overall Study|Pregnancy|1|||
162074613|NCT02404350|585329535|FG000|Overall Study|Withdrawal by Subject|7|||
162074614|NCT02404350|585329536|FG001|Overall Study|Withdrawal by Subject|3|||
162074615|NCT02404350|585329537|FG002|Overall Study|Withdrawal by Subject|3|||
162074616|NCT02404350|585329538|FG003|Overall Study|Withdrawal by Subject|19|||
162074617|NCT02404350|585329535|FG000|Overall Study|Due to Non-compliance with treatment|0|||
162074618|NCT02404350|585329536|FG001|Overall Study|Due to Non-compliance with treatment|0|||
162074619|NCT02404350|585329537|FG002|Overall Study|Due to Non-compliance with treatment|0|||
162074620|NCT02404350|585329538|FG003|Overall Study|Due to Non-compliance with treatment|1|||
162074621|NCT02404350|585329535|FG000|Overall Study|Due to Technical problems|0|||
162074622|NCT02404350|585329536|FG001|Overall Study|Due to Technical problems|0|||
162074623|NCT02404350|585329537|FG002|Overall Study|Due to Technical problems|0|||
162074624|NCT02404350|585329538|FG003|Overall Study|Due to Technical problems|1|||
162074625|NCT05389657|585329539|FG000|Overall Study|Lost to Follow-up|7|||
162074626|NCT05389657|585329540|FG001|Overall Study|Lost to Follow-up|8|||
162074627|NCT05237206|585329542|FG000|Overall Study|screen failure-did not receive treatment|8|||
162074628|NCT05237206|585329542|FG000|Overall Study|did not receive treatment|3|||
162074629|NCT03261947|585329543|FG000|Overall Study|Death|10|||
162074630|NCT03261947|585329544|FG001|Overall Study|Death|13|||
162074631|NCT03261947|585329545|FG002|Overall Study|Death|17|||
162074632|NCT03261947|585329546|FG003|Overall Study|Death|12|||
162074633|NCT03261947|585329547|FG004|Overall Study|Death|8|||
162074634|NCT03261947|585329543|FG000|Overall Study|Lost to Follow-up|0|||
162074635|NCT03261947|585329544|FG001|Overall Study|Lost to Follow-up|0|||
162074636|NCT03261947|585329545|FG002|Overall Study|Lost to Follow-up|2|||
162074637|NCT03261947|585329546|FG003|Overall Study|Lost to Follow-up|1|||
162074638|NCT03261947|585329547|FG004|Overall Study|Lost to Follow-up|0|||
162074639|NCT03261947|585329543|FG000|Overall Study|Withdrawal by Subject|0|||
162074640|NCT03261947|585329544|FG001|Overall Study|Withdrawal by Subject|0|||
162074641|NCT03261947|585329545|FG002|Overall Study|Withdrawal by Subject|3|||
162074642|NCT03261947|585329546|FG003|Overall Study|Withdrawal by Subject|0|||
162074643|NCT03261947|585329547|FG004|Overall Study|Withdrawal by Subject|1|||
162074644|NCT03261947|585329543|FG000|Overall Study|Site Terminated by Sponsor|0|||
162074645|NCT03261947|585329544|FG001|Overall Study|Site Terminated by Sponsor|0|||
162074646|NCT03261947|585329545|FG002|Overall Study|Site Terminated by Sponsor|4|||
162074647|NCT03261947|585329546|FG003|Overall Study|Site Terminated by Sponsor|7|||
162074648|NCT03261947|585329547|FG004|Overall Study|Site Terminated by Sponsor|5|||
162074649|NCT03261947|585329543|FG000|Overall Study|Reason not Specified|2|||
162074650|NCT03261947|585329544|FG001|Overall Study|Reason not Specified|0|||
162074651|NCT03261947|585329545|FG002|Overall Study|Reason not Specified|4|||
162074652|NCT03261947|585329546|FG003|Overall Study|Reason not Specified|1|||
162074653|NCT03261947|585329547|FG004|Overall Study|Reason not Specified|3|||
162074654|NCT03969992|585329548|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
162074655|NCT03969992|585329549|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
162074656|NCT03969992|585329550|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
162074657|NCT03969992|585329548|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
162074658|NCT03969992|585329549|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
162074659|NCT03969992|585329550|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
162074660|NCT03969992|585329548|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
162074661|NCT03969992|585329549|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
162074662|NCT03969992|585329550|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
162074663|NCT03969992|585329548|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
162074664|NCT03969992|585329549|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
162074665|NCT03969992|585329550|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
162074666|NCT03969992|585329548|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
162074667|NCT03969992|585329549|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
162074668|NCT03969992|585329550|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
162074669|NCT04120974|585329551|FG000|Overall Study|Death|1|||
162074670|NCT04120974|585329551|FG000|Overall Study|Physician Decision|1|||
162074671|NCT04120974|585329551|FG000|Overall Study|Lost to Follow-up|6|||
162074672|NCT02154581|585329555|FG000|Overall Study|Lost to Follow-up|7|||
162074673|NCT02154581|585329556|FG001|Overall Study|Lost to Follow-up|8|||
162074674|NCT00314574|585331331|FG000|Overall Study|Death|3|||
162074675|NCT00314574|585331332|FG001|Overall Study|Death|0|||
162074676|NCT00314574|585331331|FG000|Overall Study|Adverse Event|11|||
162074677|NCT00314574|585331332|FG001|Overall Study|Adverse Event|16|||
162074678|NCT00314574|585331331|FG000|Overall Study|Lost to Follow-up|19|||
162074679|NCT00314574|585331332|FG001|Overall Study|Lost to Follow-up|25|||
162074680|NCT00314574|585331331|FG000|Overall Study|Withdrawal by Subject|33|||
162074681|NCT00314574|585331332|FG001|Overall Study|Withdrawal by Subject|22|||
162074682|NCT00314574|585331331|FG000|Overall Study|Physician Decision|22|||
162074683|NCT00314574|585331332|FG001|Overall Study|Physician Decision|15|||
162074684|NCT00314574|585331331|FG000|Overall Study|Pregnancy|6|||
162074685|NCT00314574|585331332|FG001|Overall Study|Pregnancy|4|||
162074686|NCT00314574|585331331|FG000|Overall Study|Data unknown at database lock|0|||
162074687|NCT00314574|585331332|FG001|Overall Study|Data unknown at database lock|1|||
162074688|NCT02932904|585331337|FG000|Overall Study|Reason not Specified|1|||
162074689|NCT02932904|585331338|FG001|Overall Study|Reason not Specified|0|||
162074690|NCT02932904|585331339|FG002|Overall Study|Reason not Specified|2|||
162074691|NCT02932904|585331340|FG003|Overall Study|Reason not Specified|2|||
162074692|NCT02932904|585331337|FG000|Overall Study|Noncompliance with Study Drug|2|||
162074693|NCT02932904|585331338|FG001|Overall Study|Noncompliance with Study Drug|3|||
162074694|NCT02932904|585331339|FG002|Overall Study|Noncompliance with Study Drug|3|||
162074695|NCT02932904|585331340|FG003|Overall Study|Noncompliance with Study Drug|4|||
162074696|NCT02932904|585331337|FG000|Overall Study|Pregnancy|0|||
162074697|NCT02932904|585331338|FG001|Overall Study|Pregnancy|1|||
162074698|NCT02932904|585331339|FG002|Overall Study|Pregnancy|1|||
162074699|NCT02932904|585331340|FG003|Overall Study|Pregnancy|0|||
162074700|NCT02932904|585331337|FG000|Overall Study|Study Termination|0|||
162074701|NCT02932904|585331338|FG001|Overall Study|Study Termination|1|||
162074702|NCT02932904|585331339|FG002|Overall Study|Study Termination|0|||
162074703|NCT02932904|585331340|FG003|Overall Study|Study Termination|0|||
162074704|NCT02932904|585331337|FG000|Overall Study|Voluntary Withdrawal|2|||
162074705|NCT02932904|585331338|FG001|Overall Study|Voluntary Withdrawal|1|||
162074706|NCT02932904|585331339|FG002|Overall Study|Voluntary Withdrawal|4|||
162074707|NCT02932904|585331340|FG003|Overall Study|Voluntary Withdrawal|2|||
162074708|NCT02932904|585331337|FG000|Overall Study|Lost to Follow-up|5|||
162074709|NCT02932904|585331338|FG001|Overall Study|Lost to Follow-up|3|||
162074710|NCT02932904|585331339|FG002|Overall Study|Lost to Follow-up|6|||
162074711|NCT02932904|585331340|FG003|Overall Study|Lost to Follow-up|0|||
162074712|NCT02932904|585331337|FG000|Overall Study|Significant Protocol Deviation|2|||
162074713|NCT02932904|585331338|FG001|Overall Study|Significant Protocol Deviation|3|||
162074714|NCT02932904|585331339|FG002|Overall Study|Significant Protocol Deviation|6|||
162074715|NCT02932904|585331340|FG003|Overall Study|Significant Protocol Deviation|1|||
162074716|NCT02932904|585331337|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
162074717|NCT02932904|585331338|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
162074718|NCT02932904|585331339|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
162074719|NCT02932904|585331340|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
162074720|NCT02932904|585331337|FG000|Overall Study|Randomized But Not Treated|1|||
162074721|NCT02932904|585331338|FG001|Overall Study|Randomized But Not Treated|1|||
162074722|NCT02932904|585331339|FG002|Overall Study|Randomized But Not Treated|0|||
162074723|NCT02932904|585331340|FG003|Overall Study|Randomized But Not Treated|2|||
162074724|NCT03144180|585331344|FG000|Overall Study|STAT Delivery|1|||
162074725|NCT03144180|585331345|FG001|Overall Study|STAT Delivery|1|||
162074726|NCT03144180|585331344|FG000|Overall Study|Provider forgot to fill out forms|1|||
162074727|NCT03144180|585331345|FG001|Overall Study|Provider forgot to fill out forms|3|||
162074728|NCT03144180|585331344|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
162074729|NCT03144180|585331345|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
162074730|NCT03144180|585331344|FG000|Overall Study|Scrub tech removed tube cap|0|||
162074731|NCT03144180|585331345|FG001|Overall Study|Scrub tech removed tube cap|1|||
162074732|NCT00751348|585331350|FG000|Overall Study|Withdrawal by Subject|5|||
162074733|NCT00751348|585331351|FG001|Overall Study|Withdrawal by Subject|2|||
162074734|NCT00751348|585331350|FG000|Overall Study|Migration from study area|1|||
162074735|NCT00751348|585331351|FG001|Overall Study|Migration from study area|0|||
162074736|NCT00743652|585331357|FG000|Overall Study|Parent/Legal Guardian Request|3|||
162074737|NCT00743652|585331358|FG001|Overall Study|Parent/Legal Guardian Request|2|||
162074738|NCT00743652|585331359|FG002|Overall Study|Parent/Legal Guardian Request|2|||
162074739|NCT00743652|585331360|FG003|Overall Study|Parent/Legal Guardian Request|2|||
162074740|NCT00743652|585331361|FG004|Overall Study|Parent/Legal Guardian Request|0|||
162074741|NCT00743652|585331357|FG000|Overall Study|Adverse Event|3|||
162074742|NCT00743652|585331358|FG001|Overall Study|Adverse Event|0|||
162074743|NCT00743652|585331359|FG002|Overall Study|Adverse Event|0|||
162074744|NCT00743652|585331360|FG003|Overall Study|Adverse Event|0|||
162074745|NCT00743652|585331361|FG004|Overall Study|Adverse Event|0|||
162074746|NCT00743652|585331357|FG000|Overall Study|Death|2|||
162074747|NCT00743652|585331358|FG001|Overall Study|Death|0|||
162074748|NCT00743652|585331359|FG002|Overall Study|Death|0|||
162074749|NCT00743652|585331360|FG003|Overall Study|Death|0|||
162074750|NCT00743652|585331361|FG004|Overall Study|Death|0|||
162074751|NCT00743652|585331357|FG000|Overall Study|Investigator Request|0|||
162074752|NCT00743652|585331358|FG001|Overall Study|Investigator Request|0|||
162074753|NCT00743652|585331359|FG002|Overall Study|Investigator Request|0|||
162074754|NCT00743652|585331360|FG003|Overall Study|Investigator Request|2|||
162074755|NCT00743652|585331361|FG004|Overall Study|Investigator Request|0|||
162074756|NCT00743652|585331357|FG000|Overall Study|Other|1|||
162074757|NCT00743652|585331358|FG001|Overall Study|Other|1|||
162074758|NCT00743652|585331359|FG002|Overall Study|Other|0|||
162074759|NCT00743652|585331360|FG003|Overall Study|Other|0|||
162074760|NCT00743652|585331361|FG004|Overall Study|Other|0|||
162074761|NCT00743652|585331357|FG000|Overall Study|Lost to Follow-up|1|||
162074762|NCT00743652|585331358|FG001|Overall Study|Lost to Follow-up|0|||
162074763|NCT00743652|585331359|FG002|Overall Study|Lost to Follow-up|0|||
162074764|NCT00743652|585331360|FG003|Overall Study|Lost to Follow-up|0|||
162074765|NCT00743652|585331361|FG004|Overall Study|Lost to Follow-up|0|||
162074766|NCT00228917|585331362|FG000|Overall Study|Migrated/moved from study area|0|||
162074767|NCT00228917|585331363|FG001|Overall Study|Migrated/moved from study area|0|||
162074768|NCT00228917|585331364|FG002|Overall Study|Migrated/moved from study area|0|||
162074769|NCT00228917|585331365|FG003|Overall Study|Migrated/moved from study area|0|||
162074770|NCT00228917|585331366|FG004|Overall Study|Migrated/moved from study area|0|||
162074771|NCT00228917|585331367|FG005|Overall Study|Migrated/moved from study area|2|||
162074772|NCT00228917|585331368|FG006|Overall Study|Migrated/moved from study area|0|||
162074773|NCT00228917|585331369|FG007|Overall Study|Migrated/moved from study area|0|||
162074774|NCT01476696|585331370|FG000|Overall Study|Sponsor decision|2|||
162074775|NCT01476696|585331371|FG001|Overall Study|Sponsor decision|1|||
162074776|NCT01476696|585331372|FG002|Overall Study|Sponsor decision|0|||
162074777|NCT01476696|585331370|FG000|Overall Study|Withdrawal by Subject|1|||
162074778|NCT01476696|585331371|FG001|Overall Study|Withdrawal by Subject|0|||
162074779|NCT01476696|585331372|FG002|Overall Study|Withdrawal by Subject|0|||
162074780|NCT02063737|585331375|FG000|Overall Study|Lost to Follow-up|11|||
162074781|NCT02063737|585331376|FG001|Overall Study|Lost to Follow-up|4|||
162074782|NCT04372602|585331379|FG000|Overall Study|Withdrawal by Subject|1|||
162074783|NCT04372602|585331380|FG001|Overall Study|Withdrawal by Subject|1|||
162074784|NCT04372602|585331379|FG000|Overall Study|Adverse Event|0|||
162074785|NCT04372602|585331380|FG001|Overall Study|Adverse Event|1|||
162074786|NCT04372602|585331379|FG000|Overall Study|Transitioned to comfort care|0|||
162074787|NCT04372602|585331380|FG001|Overall Study|Transitioned to comfort care|1|||
162074788|NCT01085097|585331384|FG000|Overall Study|Adverse Event|0|||
162074789|NCT01085097|585331385|FG001|Overall Study|Adverse Event|0|||
162074790|NCT01085097|585331386|FG002|Overall Study|Adverse Event|2|||
162074791|NCT01085097|585331384|FG000|Overall Study|Treatment failure|2|||
162074792|NCT01085097|585331385|FG001|Overall Study|Treatment failure|0|||
162074793|NCT01085097|585331386|FG002|Overall Study|Treatment failure|0|||
162074794|NCT06049043|585331387|FG000|Overall Study|Lost to Follow-up|11|||
162074795|NCT06049043|585331388|FG001|Overall Study|Lost to Follow-up|9|||
162074796|NCT00129129|585331389|FG000|Primary Phase|Adverse Event|2|||
162074797|NCT00129129|585331390|FG001|Primary Phase|Adverse Event|1|||
162074798|NCT00129129|585331391|FG002|Primary Phase|Adverse Event|0|||
162074799|NCT00129129|585331392|FG003|Primary Phase|Adverse Event|0|||
162074800|NCT00129129|585331393|FG004|Primary Phase|Adverse Event|0|||
162074801|NCT00129129|585331389|FG000|Primary Phase|Withdrawal by Subject|12|||
162074802|NCT00129129|585331390|FG001|Primary Phase|Withdrawal by Subject|10|||
162074803|NCT00129129|585331391|FG002|Primary Phase|Withdrawal by Subject|0|||
162074804|NCT00129129|585331392|FG003|Primary Phase|Withdrawal by Subject|0|||
162074805|NCT00129129|585331393|FG004|Primary Phase|Withdrawal by Subject|0|||
162074806|NCT00129129|585331389|FG000|Primary Phase|Migration from study area|1|||
162074807|NCT00129129|585331390|FG001|Primary Phase|Migration from study area|3|||
162074808|NCT00129129|585331391|FG002|Primary Phase|Migration from study area|0|||
162074809|NCT00129129|585331392|FG003|Primary Phase|Migration from study area|0|||
162074810|NCT00129129|585331393|FG004|Primary Phase|Migration from study area|0|||
162074811|NCT00129129|585331389|FG000|Primary Phase|Lost to Follow-up|8|||
162074812|NCT00129129|585331390|FG001|Primary Phase|Lost to Follow-up|6|||
162074813|NCT00129129|585331391|FG002|Primary Phase|Lost to Follow-up|0|||
162074814|NCT00129129|585331392|FG003|Primary Phase|Lost to Follow-up|0|||
162074815|NCT00129129|585331393|FG004|Primary Phase|Lost to Follow-up|0|||
162074816|NCT00129129|585331389|FG000|Primary Phase|Other|2|||
162074817|NCT00129129|585331390|FG001|Primary Phase|Other|5|||
162074818|NCT00129129|585331391|FG002|Primary Phase|Other|0|||
162074819|NCT00129129|585331392|FG003|Primary Phase|Other|0|||
162074820|NCT00129129|585331393|FG004|Primary Phase|Other|0|||
162074821|NCT00129129|585331389|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
162074822|NCT00129129|585331390|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
162074823|NCT00129129|585331391|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
162074824|NCT00129129|585331392|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
162074825|NCT00129129|585331393|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
162074826|NCT00129129|585331389|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
162074827|NCT00129129|585331390|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
162074828|NCT00129129|585331391|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
162074829|NCT00129129|585331392|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
162074830|NCT00129129|585331393|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
162074831|NCT00129129|585331389|FG000|Fourth Dose Phase|Migration from study area|0|||
162074832|NCT00129129|585331390|FG001|Fourth Dose Phase|Migration from study area|0|||
162074833|NCT00129129|585331391|FG002|Fourth Dose Phase|Migration from study area|0|||
162074834|NCT00129129|585331392|FG003|Fourth Dose Phase|Migration from study area|0|||
162074835|NCT00129129|585331393|FG004|Fourth Dose Phase|Migration from study area|2|||
162074836|NCT00129129|585331389|FG000|Fourth Dose Phase|Other|0|||
162074837|NCT00129129|585331390|FG001|Fourth Dose Phase|Other|0|||
162074838|NCT00129129|585331391|FG002|Fourth Dose Phase|Other|0|||
162074839|NCT00129129|585331392|FG003|Fourth Dose Phase|Other|1|||
162074840|NCT00129129|585331393|FG004|Fourth Dose Phase|Other|1|||
162074841|NCT00129129|585331389|FG000|Fourth Dose Phase|Protocol Violation|0|||
162074842|NCT00129129|585331390|FG001|Fourth Dose Phase|Protocol Violation|0|||
162074843|NCT00129129|585331391|FG002|Fourth Dose Phase|Protocol Violation|0|||
162074844|NCT00129129|585331392|FG003|Fourth Dose Phase|Protocol Violation|1|||
162074845|NCT00129129|585331393|FG004|Fourth Dose Phase|Protocol Violation|0|||
162074846|NCT03089606|585331396|FG000|Overall Study|Progression after Cycle 1|1|||
162074847|NCT00335972|585331397|FG000|Overall Study|not given treatments|0|||
162074848|NCT00335972|585331398|FG001|Overall Study|not given treatments|3|||
162074849|NCT03965962|585331400|FG000|Overall Study|Adverse Event|1|||
162074850|NCT03965962|585331401|FG001|Overall Study|Adverse Event|0|||
162074851|NCT03965962|585331402|FG002|Overall Study|Adverse Event|0|||
162074852|NCT03965962|585331403|FG003|Overall Study|Adverse Event|0|||
162074853|NCT03965962|585331400|FG000|Overall Study|Protocol Violation|21|||
162074854|NCT03965962|585331401|FG001|Overall Study|Protocol Violation|4|||
162074855|NCT03965962|585331402|FG002|Overall Study|Protocol Violation|10|||
162074856|NCT03965962|585331403|FG003|Overall Study|Protocol Violation|5|||
162074857|NCT03965962|585331400|FG000|Overall Study|Lost to Follow-up|0|||
162074858|NCT03965962|585331401|FG001|Overall Study|Lost to Follow-up|1|||
162074859|NCT03965962|585331402|FG002|Overall Study|Lost to Follow-up|0|||
162074860|NCT03965962|585331403|FG003|Overall Study|Lost to Follow-up|0|||
162074861|NCT03965962|585331400|FG000|Overall Study|Withdrawal by Subject|3|||
162074862|NCT03965962|585331401|FG001|Overall Study|Withdrawal by Subject|0|||
162074863|NCT03965962|585331402|FG002|Overall Study|Withdrawal by Subject|0|||
162074864|NCT03965962|585331403|FG003|Overall Study|Withdrawal by Subject|1|||
162074865|NCT03190889|585331408|FG000|Overall Study|Lost to Follow-up|7|||
162074866|NCT03190889|585331409|FG001|Overall Study|Lost to Follow-up|7|||
162074867|NCT03190889|585331410|FG002|Overall Study|Lost to Follow-up|3|||
162074868|NCT03190889|585331408|FG000|Overall Study|Withdrawal by Subject|1|||
162074869|NCT03190889|585331409|FG001|Overall Study|Withdrawal by Subject|1|||
162074870|NCT03190889|585331410|FG002|Overall Study|Withdrawal by Subject|2|||
162074871|NCT03190889|585331408|FG000|Overall Study|Did not complete protocol|4|||
162074872|NCT03190889|585331409|FG001|Overall Study|Did not complete protocol|9|||
162074873|NCT03190889|585331410|FG002|Overall Study|Did not complete protocol|0|||
162074874|NCT03190889|585331408|FG000|Overall Study|COVID-19|1|||
162074875|NCT03190889|585331409|FG001|Overall Study|COVID-19|0|||
162074876|NCT03190889|585331410|FG002|Overall Study|COVID-19|2|||
162074877|NCT02140567|585331412|FG000|Overall Study|Problems with recording equipment|6|||
162074878|NCT02882854|585331415|FG000|Overall Study|Lost to Follow-up|1|||
162074879|NCT02882854|585331416|FG001|Overall Study|Lost to Follow-up|2|||
162074880|NCT02882854|585331415|FG000|Overall Study|Physician Decision|0|||
162074881|NCT02882854|585331416|FG001|Overall Study|Physician Decision|1|||
162074882|NCT02039674|585331417|FG000|Overall Study|Adverse Event|0|||
162074883|NCT02039674|585331418|FG001|Overall Study|Adverse Event|0|||
162074884|NCT02039674|585331419|FG002|Overall Study|Adverse Event|0|||
162074885|NCT02039674|585331420|FG003|Overall Study|Adverse Event|1|||
162074886|NCT02039674|585331421|FG004|Overall Study|Adverse Event|0|||
162074887|NCT02039674|585331422|FG005|Overall Study|Adverse Event|0|||
162074888|NCT02039674|585331423|FG006|Overall Study|Adverse Event|0|||
162074889|NCT02039674|585331424|FG007|Overall Study|Adverse Event|0|||
162074890|NCT02039674|585331425|FG008|Overall Study|Adverse Event|2|||
162074891|NCT02039674|585331426|FG009|Overall Study|Adverse Event|1|||
162074892|NCT02039674|585331427|FG010|Overall Study|Adverse Event|0|||
162074893|NCT02039674|585331428|FG011|Overall Study|Adverse Event|2|||
162074894|NCT02039674|585331429|FG012|Overall Study|Adverse Event|3|||
162074895|NCT02039674|585331430|FG013|Overall Study|Adverse Event|1|||
162074896|NCT02039674|585331417|FG000|Overall Study|Death|2|||
162074897|NCT02039674|585331418|FG001|Overall Study|Death|0|||
162074898|NCT02039674|585331419|FG002|Overall Study|Death|2|||
162074899|NCT02039674|585331420|FG003|Overall Study|Death|3|||
162074900|NCT02039674|585331421|FG004|Overall Study|Death|0|||
162074901|NCT02039674|585331422|FG005|Overall Study|Death|0|||
162074902|NCT02039674|585331423|FG006|Overall Study|Death|1|||
162074903|NCT02039674|585331424|FG007|Overall Study|Death|0|||
162074904|NCT02039674|585331425|FG008|Overall Study|Death|2|||
162074905|NCT02039674|585331426|FG009|Overall Study|Death|0|||
162074906|NCT02039674|585331427|FG010|Overall Study|Death|1|||
162074907|NCT02039674|585331428|FG011|Overall Study|Death|3|||
162074908|NCT02039674|585331429|FG012|Overall Study|Death|2|||
162074909|NCT02039674|585331430|FG013|Overall Study|Death|8|||
162074910|NCT02039674|585331417|FG000|Overall Study|Excluded Medication|1|||
162074911|NCT02039674|585331418|FG001|Overall Study|Excluded Medication|1|||
162074912|NCT02039674|585331419|FG002|Overall Study|Excluded Medication|0|||
162074913|NCT02039674|585331420|FG003|Overall Study|Excluded Medication|1|||
162074914|NCT02039674|585331421|FG004|Overall Study|Excluded Medication|0|||
162074915|NCT02039674|585331422|FG005|Overall Study|Excluded Medication|1|||
162074916|NCT02039674|585331423|FG006|Overall Study|Excluded Medication|0|||
162074917|NCT02039674|585331424|FG007|Overall Study|Excluded Medication|0|||
162074918|NCT02039674|585331425|FG008|Overall Study|Excluded Medication|2|||
162074919|NCT02039674|585331426|FG009|Overall Study|Excluded Medication|3|||
162074920|NCT02039674|585331427|FG010|Overall Study|Excluded Medication|5|||
162074921|NCT02039674|585331428|FG011|Overall Study|Excluded Medication|6|||
162074922|NCT02039674|585331429|FG012|Overall Study|Excluded Medication|8|||
162074923|NCT02039674|585331430|FG013|Overall Study|Excluded Medication|3|||
162074924|NCT02039674|585331417|FG000|Overall Study|Lost to Follow-up|0|||
162074925|NCT02039674|585331418|FG001|Overall Study|Lost to Follow-up|0|||
162074926|NCT02039674|585331419|FG002|Overall Study|Lost to Follow-up|0|||
162074927|NCT02039674|585331420|FG003|Overall Study|Lost to Follow-up|0|||
162074928|NCT02039674|585331421|FG004|Overall Study|Lost to Follow-up|1|||
162074929|NCT02039674|585331422|FG005|Overall Study|Lost to Follow-up|1|||
162074930|NCT02039674|585331423|FG006|Overall Study|Lost to Follow-up|0|||
162074931|NCT02039674|585331424|FG007|Overall Study|Lost to Follow-up|0|||
162074932|NCT02039674|585331425|FG008|Overall Study|Lost to Follow-up|0|||
162074933|NCT02039674|585331426|FG009|Overall Study|Lost to Follow-up|0|||
162074934|NCT02039674|585331427|FG010|Overall Study|Lost to Follow-up|0|||
162074935|NCT02039674|585331428|FG011|Overall Study|Lost to Follow-up|2|||
162074936|NCT02039674|585331429|FG012|Overall Study|Lost to Follow-up|2|||
162074937|NCT02039674|585331430|FG013|Overall Study|Lost to Follow-up|1|||
162074938|NCT02039674|585331417|FG000|Overall Study|Physician Decision|0|||
162074939|NCT02039674|585331418|FG001|Overall Study|Physician Decision|0|||
162074940|NCT02039674|585331419|FG002|Overall Study|Physician Decision|0|||
162074941|NCT02039674|585331420|FG003|Overall Study|Physician Decision|0|||
162074942|NCT02039674|585331421|FG004|Overall Study|Physician Decision|0|||
162074943|NCT02039674|585331422|FG005|Overall Study|Physician Decision|0|||
162074944|NCT02039674|585331423|FG006|Overall Study|Physician Decision|0|||
162074945|NCT02039674|585331424|FG007|Overall Study|Physician Decision|0|||
162074946|NCT02039674|585331425|FG008|Overall Study|Physician Decision|0|||
162074947|NCT02039674|585331426|FG009|Overall Study|Physician Decision|0|||
162074948|NCT02039674|585331427|FG010|Overall Study|Physician Decision|0|||
162074949|NCT02039674|585331428|FG011|Overall Study|Physician Decision|1|||
162074950|NCT02039674|585331429|FG012|Overall Study|Physician Decision|1|||
162074951|NCT02039674|585331430|FG013|Overall Study|Physician Decision|0|||
162074952|NCT02039674|585331417|FG000|Overall Study|Progressive Disease|8|||
162074953|NCT02039674|585331418|FG001|Overall Study|Progressive Disease|8|||
162074954|NCT02039674|585331419|FG002|Overall Study|Progressive Disease|6|||
162074955|NCT02039674|585331420|FG003|Overall Study|Progressive Disease|7|||
162074956|NCT02039674|585331421|FG004|Overall Study|Progressive Disease|9|||
162074957|NCT02039674|585331422|FG005|Overall Study|Progressive Disease|10|||
162074958|NCT02039674|585331423|FG006|Overall Study|Progressive Disease|1|||
162074959|NCT02039674|585331424|FG007|Overall Study|Progressive Disease|3|||
162074960|NCT02039674|585331425|FG008|Overall Study|Progressive Disease|6|||
162074961|NCT02039674|585331426|FG009|Overall Study|Progressive Disease|4|||
162074962|NCT02039674|585331427|FG010|Overall Study|Progressive Disease|0|||
162074963|NCT02039674|585331428|FG011|Overall Study|Progressive Disease|34|||
162074964|NCT02039674|585331429|FG012|Overall Study|Progressive Disease|34|||
162074965|NCT02039674|585331430|FG013|Overall Study|Progressive Disease|18|||
162074966|NCT02039674|585331417|FG000|Overall Study|Withdrawal by Subject|1|||
162074967|NCT02039674|585331418|FG001|Overall Study|Withdrawal by Subject|2|||
162074968|NCT02039674|585331419|FG002|Overall Study|Withdrawal by Subject|3|||
162074969|NCT02039674|585331420|FG003|Overall Study|Withdrawal by Subject|0|||
162074970|NCT02039674|585331421|FG004|Overall Study|Withdrawal by Subject|1|||
162074971|NCT02039674|585331422|FG005|Overall Study|Withdrawal by Subject|0|||
162074972|NCT02039674|585331423|FG006|Overall Study|Withdrawal by Subject|0|||
162074973|NCT02039674|585331424|FG007|Overall Study|Withdrawal by Subject|0|||
162074974|NCT02039674|585331425|FG008|Overall Study|Withdrawal by Subject|0|||
162074975|NCT02039674|585331426|FG009|Overall Study|Withdrawal by Subject|1|||
162074976|NCT02039674|585331427|FG010|Overall Study|Withdrawal by Subject|1|||
162074977|NCT02039674|585331428|FG011|Overall Study|Withdrawal by Subject|4|||
162074978|NCT02039674|585331429|FG012|Overall Study|Withdrawal by Subject|6|||
162074979|NCT02039674|585331430|FG013|Overall Study|Withdrawal by Subject|2|||
162074980|NCT02039674|585331417|FG000|Overall Study|Clinical Progression|0|||
162074981|NCT02039674|585331418|FG001|Overall Study|Clinical Progression|0|||
162074982|NCT02039674|585331419|FG002|Overall Study|Clinical Progression|0|||
162074983|NCT02039674|585331420|FG003|Overall Study|Clinical Progression|0|||
162074984|NCT02039674|585331421|FG004|Overall Study|Clinical Progression|0|||
162074985|NCT02039674|585331422|FG005|Overall Study|Clinical Progression|0|||
162074986|NCT02039674|585331423|FG006|Overall Study|Clinical Progression|1|||
162074987|NCT02039674|585331424|FG007|Overall Study|Clinical Progression|0|||
162074988|NCT02039674|585331425|FG008|Overall Study|Clinical Progression|0|||
162074989|NCT02039674|585331426|FG009|Overall Study|Clinical Progression|0|||
162074990|NCT02039674|585331427|FG010|Overall Study|Clinical Progression|0|||
162074991|NCT02039674|585331428|FG011|Overall Study|Clinical Progression|0|||
162074992|NCT02039674|585331429|FG012|Overall Study|Clinical Progression|1|||
162074993|NCT02039674|585331430|FG013|Overall Study|Clinical Progression|0|||
162074994|NCT02039674|585331417|FG000|Overall Study|Sponsor Decision|1|||
162074995|NCT02039674|585331418|FG001|Overall Study|Sponsor Decision|1|||
162074996|NCT02039674|585331419|FG002|Overall Study|Sponsor Decision|1|||
162074997|NCT02039674|585331420|FG003|Overall Study|Sponsor Decision|1|||
162074998|NCT02039674|585331421|FG004|Overall Study|Sponsor Decision|1|||
162074999|NCT02039674|585331422|FG005|Overall Study|Sponsor Decision|0|||
162075000|NCT02039674|585331423|FG006|Overall Study|Sponsor Decision|0|||
162075001|NCT02039674|585331424|FG007|Overall Study|Sponsor Decision|0|||
162075002|NCT02039674|585331425|FG008|Overall Study|Sponsor Decision|0|||
162075003|NCT02039674|585331426|FG009|Overall Study|Sponsor Decision|3|||
162075004|NCT02039674|585331427|FG010|Overall Study|Sponsor Decision|0|||
162075005|NCT02039674|585331428|FG011|Overall Study|Sponsor Decision|8|||
162075006|NCT02039674|585331429|FG012|Overall Study|Sponsor Decision|5|||
162075007|NCT02039674|585331430|FG013|Overall Study|Sponsor Decision|0|||
162075008|NCT02039674|585331417|FG000|Overall Study|Other|0|||
162075009|NCT02039674|585331418|FG001|Overall Study|Other|0|||
162075010|NCT02039674|585331419|FG002|Overall Study|Other|0|||
162075011|NCT02039674|585331420|FG003|Overall Study|Other|0|||
162075012|NCT02039674|585331421|FG004|Overall Study|Other|0|||
162075013|NCT02039674|585331422|FG005|Overall Study|Other|0|||
162075014|NCT02039674|585331423|FG006|Overall Study|Other|0|||
162075015|NCT02039674|585331424|FG007|Overall Study|Other|0|||
162075016|NCT02039674|585331425|FG008|Overall Study|Other|0|||
162075017|NCT02039674|585331426|FG009|Overall Study|Other|0|||
162075018|NCT02039674|585331427|FG010|Overall Study|Other|0|||
162075019|NCT02039674|585331428|FG011|Overall Study|Other|0|||
162075020|NCT02039674|585331429|FG012|Overall Study|Other|1|||
162075021|NCT02039674|585331430|FG013|Overall Study|Other|0|||
162075022|NCT01358357|585331431|FG000|Open Label Phase|Adverse Event|0|||
162075023|NCT01358357|585331432|FG001|Open Label Phase|Adverse Event|0|||
162075024|NCT01358357|585331433|FG002|Open Label Phase|Adverse Event|59|||
162075025|NCT01358357|585331431|FG000|Open Label Phase|Lack of Efficacy|0|||
162075026|NCT01358357|585331432|FG001|Open Label Phase|Lack of Efficacy|0|||
162075027|NCT01358357|585331433|FG002|Open Label Phase|Lack of Efficacy|107|||
162075028|NCT01358357|585331431|FG000|Open Label Phase|Lost to Follow-up|0|||
162075029|NCT01358357|585331432|FG001|Open Label Phase|Lost to Follow-up|0|||
162075030|NCT01358357|585331433|FG002|Open Label Phase|Lost to Follow-up|76|||
162075031|NCT01358357|585331431|FG000|Open Label Phase|Protocol Violation|0|||
162075032|NCT01358357|585331432|FG001|Open Label Phase|Protocol Violation|0|||
162075033|NCT01358357|585331433|FG002|Open Label Phase|Protocol Violation|45|||
162075034|NCT01358357|585331431|FG000|Open Label Phase|Withdrawal by Subject|0|||
162075035|NCT01358357|585331432|FG001|Open Label Phase|Withdrawal by Subject|0|||
162075036|NCT01358357|585331433|FG002|Open Label Phase|Withdrawal by Subject|112|||
162075037|NCT01358357|585331431|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
162075038|NCT01358357|585331432|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
162075039|NCT01358357|585331433|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
162075040|NCT01358357|585331431|FG000|Open Label Phase|Terminated at study completion|0|||
162075041|NCT01358357|585331432|FG001|Open Label Phase|Terminated at study completion|0|||
162075042|NCT01358357|585331433|FG002|Open Label Phase|Terminated at study completion|5|||
162075043|NCT01358357|585331431|FG000|Open Label Phase|Mood episode|0|||
162075044|NCT01358357|585331432|FG001|Open Label Phase|Mood episode|0|||
162075045|NCT01358357|585331433|FG002|Open Label Phase|Mood episode|42|||
162075046|NCT01358357|585331431|FG000|Double-Blind Phase|Adverse Event|8|||
162075047|NCT01358357|585331432|FG001|Double-Blind Phase|Adverse Event|5|||
162075048|NCT01358357|585331433|FG002|Double-Blind Phase|Adverse Event|0|||
162075049|NCT01358357|585331431|FG000|Double-Blind Phase|Lost to Follow-up|5|||
162075050|NCT01358357|585331432|FG001|Double-Blind Phase|Lost to Follow-up|7|||
162075051|NCT01358357|585331433|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162075052|NCT01358357|585331431|FG000|Double-Blind Phase|Protocol Violation|1|||
162075053|NCT01358357|585331432|FG001|Double-Blind Phase|Protocol Violation|11|||
162075054|NCT01358357|585331433|FG002|Double-Blind Phase|Protocol Violation|0|||
162075055|NCT01358357|585331431|FG000|Double-Blind Phase|Protocol Violation|16|||
162075056|NCT01358357|585331432|FG001|Double-Blind Phase|Protocol Violation|12|||
162075057|NCT01358357|585331433|FG002|Double-Blind Phase|Protocol Violation|0|||
162075058|NCT01358357|585331431|FG000|Double-Blind Phase|Terminated at study completion|2|||
162075059|NCT01358357|585331432|FG001|Double-Blind Phase|Terminated at study completion|0|||
162075060|NCT01358357|585331433|FG002|Double-Blind Phase|Terminated at study completion|0|||
162075061|NCT01358357|585331431|FG000|Double-Blind Phase|Recurrence of mood event|48|||
162075062|NCT01358357|585331432|FG001|Double-Blind Phase|Recurrence of mood event|64|||
162075063|NCT01358357|585331433|FG002|Double-Blind Phase|Recurrence of mood event|0|||
162075064|NCT01358357|585331431|FG000|Double-Blind Phase|Administrative|0|||
162075065|NCT01358357|585331432|FG001|Double-Blind Phase|Administrative|1|||
162075066|NCT01358357|585331433|FG002|Double-Blind Phase|Administrative|0|||
162075067|NCT02590939|585331434|FG000|Overall Study|Withdrawal by Subject|3|||
162075068|NCT02590939|585331435|FG001|Overall Study|Withdrawal by Subject|1|||
162075069|NCT02590939|585331434|FG000|Overall Study|Failed the nociceptive test|2|||
162075070|NCT02590939|585331435|FG001|Overall Study|Failed the nociceptive test|1|||
162075071|NCT03774433|585331440|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
162075072|NCT00108160|585331441|FG000|Overall Study|Lost to Follow-up|25|||
162075073|NCT00108160|585331442|FG001|Overall Study|Lost to Follow-up|12|||
162075074|NCT00108160|585331441|FG000|Overall Study|Death|1|||
162075075|NCT00108160|585331442|FG001|Overall Study|Death|2|||
162075076|NCT00108160|585331441|FG000|Overall Study|Withdrawal by Subject|4|||
162075077|NCT00108160|585331442|FG001|Overall Study|Withdrawal by Subject|2|||
162075078|NCT00108160|585331441|FG000|Overall Study|Protocol Violation|9|||
162075079|NCT00108160|585331442|FG001|Overall Study|Protocol Violation|5|||
162075080|NCT02081079|585331443|FG000|Overall Study|Lack of Efficacy|3|||
162075081|NCT02081079|585331444|FG001|Overall Study|Lack of Efficacy|2|||
162075082|NCT02081079|585331443|FG000|Overall Study|Lost to Follow-up|1|||
162075083|NCT02081079|585331444|FG001|Overall Study|Lost to Follow-up|0|||
162075084|NCT01712854|585331445|FG000|Overall Study|Physician Decision|1|||
162075085|NCT00768144|585331446|FG000|Overall Study|Adverse Event|13|||
162075086|NCT00768144|585331446|FG000|Overall Study|Progressive Disease|21|||
162075087|NCT00768144|585331446|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
162075088|NCT00768144|585331446|FG000|Overall Study|Pt Withdrew Consent|1|||
162075089|NCT01150123|585331447|FG000|Overall Study|Withdrawal by Subject|1|||
162075090|NCT01150123|585331448|FG001|Overall Study|Withdrawal by Subject|1|||
162075091|NCT01150123|585331449|FG002|Overall Study|Withdrawal by Subject|2|||
162075092|NCT01150123|585331450|FG003|Overall Study|Withdrawal by Subject|1|||
162075093|NCT01150123|585331451|FG004|Overall Study|Withdrawal by Subject|1|||
162075094|NCT01150123|585331452|FG005|Overall Study|Withdrawal by Subject|1|||
162075095|NCT01150123|585331453|FG006|Overall Study|Withdrawal by Subject|0|||
162075096|NCT01150123|585331454|FG007|Overall Study|Withdrawal by Subject|3|||
162075097|NCT01150123|585331455|FG008|Overall Study|Withdrawal by Subject|2|||
162075098|NCT01150123|585331456|FG009|Overall Study|Withdrawal by Subject|0|||
162075099|NCT01150123|585331457|FG010|Overall Study|Withdrawal by Subject|1|||
162075100|NCT01150123|585331458|FG011|Overall Study|Withdrawal by Subject|0|||
162075101|NCT01150123|585331459|FG012|Overall Study|Withdrawal by Subject|1|||
162075102|NCT01150123|585331460|FG013|Overall Study|Withdrawal by Subject|0|||
162075103|NCT01150123|585331461|FG014|Overall Study|Withdrawal by Subject|0|||
162075104|NCT01150123|585331462|FG015|Overall Study|Withdrawal by Subject|1|||
162075105|NCT01150123|585331463|FG016|Overall Study|Withdrawal by Subject|0|||
162075106|NCT01150123|585331464|FG017|Overall Study|Withdrawal by Subject|1|||
162075107|NCT01150123|585331447|FG000|Overall Study|Lost to Follow-up|2|||
162075108|NCT01150123|585331448|FG001|Overall Study|Lost to Follow-up|1|||
162075109|NCT01150123|585331449|FG002|Overall Study|Lost to Follow-up|2|||
162075110|NCT01150123|585331450|FG003|Overall Study|Lost to Follow-up|2|||
162075111|NCT01150123|585331451|FG004|Overall Study|Lost to Follow-up|2|||
162075112|NCT01150123|585331452|FG005|Overall Study|Lost to Follow-up|5|||
162075113|NCT01150123|585331453|FG006|Overall Study|Lost to Follow-up|0|||
162075114|NCT01150123|585331454|FG007|Overall Study|Lost to Follow-up|0|||
162075115|NCT01150123|585331455|FG008|Overall Study|Lost to Follow-up|3|||
162075116|NCT01150123|585331456|FG009|Overall Study|Lost to Follow-up|1|||
162075117|NCT01150123|585331457|FG010|Overall Study|Lost to Follow-up|1|||
162075118|NCT01150123|585331458|FG011|Overall Study|Lost to Follow-up|1|||
162075119|NCT01150123|585331459|FG012|Overall Study|Lost to Follow-up|2|||
162075120|NCT01150123|585331460|FG013|Overall Study|Lost to Follow-up|0|||
162075121|NCT01150123|585331461|FG014|Overall Study|Lost to Follow-up|0|||
162075122|NCT01150123|585331462|FG015|Overall Study|Lost to Follow-up|0|||
162075123|NCT01150123|585331463|FG016|Overall Study|Lost to Follow-up|0|||
162075124|NCT01150123|585331464|FG017|Overall Study|Lost to Follow-up|0|||
162075125|NCT02225743|585331465|FG000|Overall Study|Withdrawal by Subject|18|||
162075126|NCT02171260|585331468|FG000|Overall Study|Death|0|||
162075127|NCT02171260|585331469|FG001|Overall Study|Death|0|||
162075128|NCT02171260|585331470|FG002|Overall Study|Death|0|||
162075129|NCT02171260|585331471|FG003|Overall Study|Death|1|||
162075130|NCT02171260|585331468|FG000|Overall Study|Physician Decision|1|||
162075131|NCT02171260|585331469|FG001|Overall Study|Physician Decision|0|||
162075132|NCT02171260|585331470|FG002|Overall Study|Physician Decision|1|||
162075133|NCT02171260|585331471|FG003|Overall Study|Physician Decision|0|||
162075134|NCT02171260|585331468|FG000|Overall Study|Withdrawal by Subject|1|||
162075135|NCT02171260|585331469|FG001|Overall Study|Withdrawal by Subject|0|||
162075136|NCT02171260|585331470|FG002|Overall Study|Withdrawal by Subject|0|||
162075137|NCT02171260|585331471|FG003|Overall Study|Withdrawal by Subject|0|||
162075138|NCT02171260|585331468|FG000|Overall Study|Evidence of progressive disease|4|||
162075139|NCT02171260|585331469|FG001|Overall Study|Evidence of progressive disease|6|||
162075140|NCT02171260|585331470|FG002|Overall Study|Evidence of progressive disease|4|||
162075141|NCT02171260|585331471|FG003|Overall Study|Evidence of progressive disease|4|||
162075142|NCT00322842|585331474|FG000|Overall Study|Withdrawal by Subject|0|||
162075143|NCT00322842|585331475|FG001|Overall Study|Withdrawal by Subject|1|||
162075144|NCT00322842|585331474|FG000|Overall Study|Lost to Follow-up|0|||
162075145|NCT00322842|585331475|FG001|Overall Study|Lost to Follow-up|1|||
162075146|NCT00322842|585331474|FG000|Overall Study|Refused transplant|1|||
162075147|NCT00322842|585331475|FG001|Overall Study|Refused transplant|0|||
162075148|NCT00322842|585331474|FG000|Overall Study|Death|1|||
162075149|NCT00322842|585331475|FG001|Overall Study|Death|0|||
162075150|NCT00323492|585331478|FG000|Study Phase 1|Adverse Event|2|||
162075151|NCT00323492|585331479|FG001|Study Phase 1|Adverse Event|0|||
162075152|NCT00323492|585331480|FG002|Study Phase 1|Adverse Event|0|||
162075153|NCT00323492|585331478|FG000|Study Phase 2|Adverse Event|1|||
162075154|NCT00323492|585331479|FG001|Study Phase 2|Adverse Event|0|||
162075155|NCT00323492|585331480|FG002|Study Phase 2|Adverse Event|0|||
162075156|NCT00323492|585331478|FG000|Study Phase 2|Physician Decision|1|||
162075157|NCT00323492|585331479|FG001|Study Phase 2|Physician Decision|0|||
162075158|NCT00323492|585331480|FG002|Study Phase 2|Physician Decision|0|||
162075159|NCT00323492|585331478|FG000|Study Phase 2|Lost to Follow-up|1|||
162075160|NCT00323492|585331479|FG001|Study Phase 2|Lost to Follow-up|0|||
162075161|NCT00323492|585331480|FG002|Study Phase 2|Lost to Follow-up|0|||
162075162|NCT00323492|585331478|FG000|Study Phase 2|Withdrawal by Subject|0|||
162075163|NCT00323492|585331479|FG001|Study Phase 2|Withdrawal by Subject|1|||
162075164|NCT00323492|585331480|FG002|Study Phase 2|Withdrawal by Subject|0|||
162075165|NCT00323492|585331478|FG000|Study Phase 2|Noncompliance with study schedule|0|||
162075166|NCT00323492|585331479|FG001|Study Phase 2|Noncompliance with study schedule|0|||
162075167|NCT00323492|585331480|FG002|Study Phase 2|Noncompliance with study schedule|1|||
162075168|NCT00323492|585331478|FG000|Study Phase 2|Protocol Violation|1|||
162075169|NCT00323492|585331479|FG001|Study Phase 2|Protocol Violation|0|||
162075170|NCT00323492|585331480|FG002|Study Phase 2|Protocol Violation|0|||
162075171|NCT03082599|585331481|FG000|Overall Study|Lost to Follow-up|1|||
162075172|NCT03082599|585331482|FG001|Overall Study|Lost to Follow-up|0|||
162075173|NCT02486042|585331483|FG000|Overall Study|Physician Decision|1|||
162075174|NCT02486042|585331484|FG001|Overall Study|Physician Decision|7|||
162075175|NCT02486042|585331483|FG000|Overall Study|Hospital transfer|2|||
162075176|NCT02486042|585331484|FG001|Overall Study|Hospital transfer|2|||
162075177|NCT02486042|585331483|FG000|Overall Study|Withdrawal by Subject|0|||
162075178|NCT02486042|585331484|FG001|Overall Study|Withdrawal by Subject|2|||
162075179|NCT01466387|585331487|FG000|Overall Study|Adverse Event|0|||
162075180|NCT01466387|585331488|FG001|Overall Study|Adverse Event|0|||
162075181|NCT01466387|585331489|FG002|Overall Study|Adverse Event|1|||
162075182|NCT01466387|585331490|FG003|Overall Study|Adverse Event|1|||
162075183|NCT01466387|585331491|FG004|Overall Study|Adverse Event|0|||
162075184|NCT01466387|585331492|FG005|Overall Study|Adverse Event|0|||
162075185|NCT01466387|585331487|FG000|Overall Study|Lost to Follow-up|0|||
162075186|NCT01466387|585331488|FG001|Overall Study|Lost to Follow-up|0|||
162075187|NCT01466387|585331489|FG002|Overall Study|Lost to Follow-up|0|||
162075188|NCT01466387|585331490|FG003|Overall Study|Lost to Follow-up|0|||
162075189|NCT01466387|585331491|FG004|Overall Study|Lost to Follow-up|0|||
162075190|NCT01466387|585331492|FG005|Overall Study|Lost to Follow-up|1|||
162075191|NCT01466387|585331487|FG000|Overall Study|Protocol Violation|1|||
162075192|NCT01466387|585331488|FG001|Overall Study|Protocol Violation|0|||
162075193|NCT01466387|585331489|FG002|Overall Study|Protocol Violation|0|||
162075194|NCT01466387|585331490|FG003|Overall Study|Protocol Violation|1|||
162075195|NCT01466387|585331491|FG004|Overall Study|Protocol Violation|0|||
162075196|NCT01466387|585331492|FG005|Overall Study|Protocol Violation|0|||
162075197|NCT00832585|585331504|FG000|Overall Study|Withdrawal by Subject|1|||
162075198|NCT00832585|585331504|FG000|Overall Study|Lost to Follow-up|1|||
162075199|NCT00673179|585331506|FG000|Overall Study|Toxicity/Complications|3|||
162075200|NCT00673179|585331507|FG001|Overall Study|Toxicity/Complications|0|||
162075201|NCT00352846|585331508|FG000|Overall Study|Disease progression|0|||
162075202|NCT00352846|585331509|FG001|Overall Study|Disease progression|2|||
162075203|NCT00352846|585331508|FG000|Overall Study|Withdrawal by Subject|3|||
162075204|NCT00352846|585331509|FG001|Overall Study|Withdrawal by Subject|8|||
162075205|NCT00352846|585331508|FG000|Overall Study|Ineligible|3|||
162075206|NCT00352846|585331509|FG001|Overall Study|Ineligible|2|||
162075207|NCT00352846|585331508|FG000|Overall Study|Non-compliance|2|||
162075208|NCT00352846|585331509|FG001|Overall Study|Non-compliance|0|||
162075209|NCT00352846|585331508|FG000|Overall Study|Death|0|||
162075210|NCT00352846|585331509|FG001|Overall Study|Death|1|||
162075211|NCT00281684|585331510|FG000|Overall Study|Lost to Follow-up|0|||
162075212|NCT00281684|585331511|FG001|Overall Study|Lost to Follow-up|0|||
162075213|NCT00281684|585331512|FG002|Overall Study|Lost to Follow-up|1|||
162075214|NCT00281684|585331513|FG003|Overall Study|Lost to Follow-up|0|||
162075215|NCT00281684|585331510|FG000|Overall Study|Withdrawal by Subject|1|||
162075216|NCT00281684|585331511|FG001|Overall Study|Withdrawal by Subject|0|||
162075217|NCT00281684|585331512|FG002|Overall Study|Withdrawal by Subject|0|||
162075218|NCT00281684|585331513|FG003|Overall Study|Withdrawal by Subject|0|||
162075219|NCT01527682|585331514|FG000|Overall Study|Protocol Violation|8|||
162075220|NCT04668950|585331516|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
162075221|NCT04668950|585331517|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
162075222|NCT04668950|585331516|FG000|Overall Study|Could not confirm started study medication|15|||
162075223|NCT04668950|585331517|FG001|Overall Study|Could not confirm started study medication|15|||
162075224|NCT04668950|585331516|FG000|Overall Study|Could not confirm baseline status|6|||
162075225|NCT04668950|585331517|FG001|Overall Study|Could not confirm baseline status|2|||
162075226|NCT04668950|585331516|FG000|Overall Study|Drop out and did not start medication|15|||
162075227|NCT04668950|585331517|FG001|Overall Study|Drop out and did not start medication|17|||
162075228|NCT04668950|585331516|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
162075229|NCT04668950|585331517|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
162075230|NCT04668950|585331516|FG000|Overall Study|Other|2|||
162075231|NCT04668950|585331517|FG001|Overall Study|Other|4|||
162075232|NCT03979638|585331520|FG000|Period 1|Physician Decision|1|||
162075233|NCT03979638|585331521|FG001|Period 1|Physician Decision|1|||
162075234|NCT03979638|585331520|FG000|Period 1|Withdrawal by Subject|4|||
162075235|NCT03979638|585331521|FG001|Period 1|Withdrawal by Subject|3|||
162075236|NCT03979638|585331520|FG000|Period 1|Study terminated by Sponsor|1|||
162075237|NCT03979638|585331521|FG001|Period 1|Study terminated by Sponsor|3|||
162075238|NCT03979638|585331520|FG000|Period 1|Protocol Violation|1|||
162075239|NCT03979638|585331521|FG001|Period 1|Protocol Violation|0|||
162075240|NCT03979638|585331520|FG000|Period 2|Study terminated by Sponsor|1|||
162075241|NCT03979638|585331521|FG001|Period 2|Study terminated by Sponsor|1|||
162075242|NCT01531387|585331522|FG000|Overall Study|Early termination of study|11|||
162075243|NCT01531387|585331523|FG001|Overall Study|Early termination of study|11|||
162075244|NCT00578942|585331524|FG000|Overall Study|Lost to Follow-up|1|||
162075245|NCT01124643|585331527|FG000|Overall Study|Death|1|||
162075246|NCT04220411|585331528|FG000|Overall Study|Adverse Event|0|||
162075247|NCT04220411|585331529|FG001|Overall Study|Adverse Event|0|||
162075248|NCT04220411|585331530|FG002|Overall Study|Adverse Event|0|||
162075249|NCT04220411|585331531|FG003|Overall Study|Adverse Event|1|||
162075250|NCT00403273|585333012|FG000|Overall Study|Lost to Follow-up|3|||
162075251|NCT00403273|585333013|FG001|Overall Study|Lost to Follow-up|2|||
162075252|NCT00403273|585333012|FG000|Overall Study|Physician Decision|0|||
162075253|NCT00403273|585333013|FG001|Overall Study|Physician Decision|1|||
162075254|NCT00403273|585333012|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
162075255|NCT00403273|585333013|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
162075256|NCT00502697|585333019|FG000|Overall Study|Withdrawal by Subject|3|||
162075257|NCT00502697|585333020|FG001|Overall Study|Withdrawal by Subject|1|||
162075258|NCT00502697|585333019|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
162075259|NCT00502697|585333020|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
162075260|NCT00502697|585333019|FG000|Overall Study|found not to meet eligibility criteria|3|||
162075261|NCT00502697|585333020|FG001|Overall Study|found not to meet eligibility criteria|4|||
162075262|NCT00502697|585333019|FG000|Overall Study|did not meet assignment criteria|4|||
162075263|NCT00502697|585333020|FG001|Overall Study|did not meet assignment criteria|2|||
162075264|NCT03256552|585333025|FG000|Overall Study|Protocol Violation|1|||
162075265|NCT03256552|585333025|FG000|Overall Study|Physician Decision|1|||
162075266|NCT03256552|585333025|FG000|Overall Study|Adverse Event|1|||
162075267|NCT03256552|585333025|FG000|Overall Study|Withdrawal by Subject|2|||
162075268|NCT02268409|585333032|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
162075269|NCT02268409|585333032|FG000|Overall Study|Death|1|||
162075270|NCT02268409|585333032|FG000|Overall Study|Lost to Follow-up|1|||
162075271|NCT02268409|585333032|FG000|Overall Study|Protocol Violation|3|||
162075272|NCT02268409|585333032|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
162075273|NCT02268409|585333032|FG000|Overall Study|Withdrawal by Subject|5|||
162075274|NCT00489853|585333033|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
162075275|NCT00489853|585333034|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
162075276|NCT00489853|585333035|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
162075277|NCT00489853|585333033|FG000|Wash-out Period 1|Adverse Event|0|||
162075278|NCT00489853|585333034|FG001|Wash-out Period 1|Adverse Event|1|||
162075279|NCT00489853|585333035|FG002|Wash-out Period 1|Adverse Event|1|||
162075280|NCT00489853|585333033|FG000|Wash-out Period 1|Protocol Violation|0|||
162075281|NCT00489853|585333034|FG001|Wash-out Period 1|Protocol Violation|1|||
162075282|NCT00489853|585333035|FG002|Wash-out Period 1|Protocol Violation|1|||
162075283|NCT00489853|585333033|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
162075284|NCT00489853|585333034|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
162075285|NCT00489853|585333035|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
162075286|NCT00489853|585333033|FG000|Wash-out Period 2|Adverse Event|1|||
162075287|NCT00489853|585333034|FG001|Wash-out Period 2|Adverse Event|1|||
162075288|NCT00489853|585333035|FG002|Wash-out Period 2|Adverse Event|0|||
162075289|NCT00489853|585333033|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
162075290|NCT00489853|585333034|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
162075291|NCT00489853|585333035|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
162075292|NCT00489853|585333033|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
162075293|NCT00489853|585333034|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
162075294|NCT00489853|585333035|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
162075295|NCT03265249|585333040|FG000|Overall Study|Withdrawal by Subject|0|||
162075296|NCT03265249|585333041|FG001|Overall Study|Withdrawal by Subject|1|||
162075297|NCT01012622|585333045|FG000|Overall Study|Withdrawal by Subject|6|||
162075298|NCT01012622|585333045|FG000|Overall Study|Lost to Follow-up|5|||
162075299|NCT01012622|585333045|FG000|Overall Study|Adverse Event|7|||
162075300|NCT01012622|585333045|FG000|Overall Study|non-compliance with the drug|9|||
162075301|NCT01012622|585333045|FG000|Overall Study|Other|1|||
162075302|NCT01012622|585333045|FG000|Overall Study|screening failure|1|||
162075303|NCT01012622|585333045|FG000|Overall Study|withdrawal of consent by a parent|2|||
162075304|NCT01176292|585333046|FG000|Overall Study|Lost to Follow-up|2|||
162075305|NCT01176292|585333047|FG001|Overall Study|Lost to Follow-up|4|||
162075306|NCT01176292|585333046|FG000|Overall Study|Adverse Event|1|||
162075307|NCT01176292|585333047|FG001|Overall Study|Adverse Event|1|||
162075308|NCT01176292|585333046|FG000|Overall Study|Physician Decision|0|||
162075309|NCT01176292|585333047|FG001|Overall Study|Physician Decision|2|||
162075310|NCT01176292|585333046|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
162075311|NCT01176292|585333047|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
162075312|NCT00380393|585333048|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
162075313|NCT00380393|585333049|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
162075314|NCT00380393|585333048|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
162075315|NCT00380393|585333049|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
162075316|NCT00380393|585333048|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
162075317|NCT00380393|585333049|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
162075318|NCT00380393|585333048|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
162075319|NCT00380393|585333049|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
162075320|NCT00380393|585333048|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
162075321|NCT00380393|585333049|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
162075322|NCT00380393|585333048|FG000|Month 14|Withdrawal by Subject|9|||
162075323|NCT00380393|585333049|FG001|Month 14|Withdrawal by Subject|7|||
162075324|NCT00380393|585333048|FG000|Month 14|Death|1|||
162075325|NCT00380393|585333049|FG001|Month 14|Death|0|||
162075326|NCT00380393|585333048|FG000|Month 14|Lost to Follow-up|0|||
162075327|NCT00380393|585333049|FG001|Month 14|Lost to Follow-up|1|||
162075328|NCT00380393|585333048|FG000|Month 14|Migrated/moved from study area|39|||
162075329|NCT00380393|585333049|FG001|Month 14|Migrated/moved from study area|42|||
162075330|NCT00380393|585333048|FG000|Month 14|Protocol Violation|2|||
162075331|NCT00380393|585333049|FG001|Month 14|Protocol Violation|0|||
162075332|NCT00380393|585333048|FG000|Month 14|Others|6|||
162075333|NCT00380393|585333049|FG001|Month 14|Others|6|||
162075334|NCT00278954|585333060|FG000|Overall Study|Adverse Event|3|||
162075335|NCT00278954|585333060|FG000|Overall Study|Lost to Follow-up|1|||
162075336|NCT00278954|585333060|FG000|Overall Study|Withdrawal by Subject|1|||
162075337|NCT02211131|585333064|FG000|Overall Study|Death|26|||
162075338|NCT02211131|585333065|FG001|Overall Study|Death|16|||
162075339|NCT02211131|585333064|FG000|Overall Study|Lost to Follow-up|4|||
162075340|NCT02211131|585333065|FG001|Overall Study|Lost to Follow-up|3|||
162075341|NCT02211131|585333064|FG000|Overall Study|Decision by Sponsor|1|||
162075342|NCT02211131|585333065|FG001|Overall Study|Decision by Sponsor|1|||
162075343|NCT02211131|585333064|FG000|Overall Study|Withdrawal by Subject|3|||
162075344|NCT02211131|585333065|FG001|Overall Study|Withdrawal by Subject|8|||
162075345|NCT05664490|585333066|FG000|Overall Study|Withdrawal by Subject|0|||
162075346|NCT05664490|585333067|FG001|Overall Study|Withdrawal by Subject|1|||
162075347|NCT05664490|585333066|FG000|Overall Study|Lost to Follow-up|14|||
162075348|NCT05664490|585333067|FG001|Overall Study|Lost to Follow-up|22|||
162075349|NCT01589445|585333070|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
162075350|NCT01589445|585333070|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
162075351|NCT01589445|585333070|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
162075352|NCT01589445|585333070|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
162075353|NCT01589445|585333070|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
162075354|NCT01589445|585333070|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
162075355|NCT01589445|585333070|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
162075356|NCT01589445|585333070|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
162075357|NCT01589445|585333070|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
162075358|NCT01589445|585333070|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
162075359|NCT00481195|585333075|FG000|Overall Study|Adverse Event|16|||
162075360|NCT00481195|585333076|FG001|Overall Study|Adverse Event|11|||
162075361|NCT00481195|585333075|FG000|Overall Study|Lack of Efficacy|1|||
162075362|NCT00481195|585333076|FG001|Overall Study|Lack of Efficacy|3|||
162075363|NCT00481195|585333075|FG000|Overall Study|Lost to Follow-up|4|||
162075364|NCT00481195|585333076|FG001|Overall Study|Lost to Follow-up|6|||
162075365|NCT00481195|585333075|FG000|Overall Study|Physician Decision|3|||
162075366|NCT00481195|585333076|FG001|Overall Study|Physician Decision|1|||
162075367|NCT00481195|585333075|FG000|Overall Study|Protocol Violation|10|||
162075368|NCT00481195|585333076|FG001|Overall Study|Protocol Violation|7|||
162075369|NCT00481195|585333075|FG000|Overall Study|Withdrawal by Subject|3|||
162075370|NCT00481195|585333076|FG001|Overall Study|Withdrawal by Subject|9|||
162075371|NCT00481195|585333075|FG000|Overall Study|Miscellaneous|2|||
162075372|NCT00481195|585333076|FG001|Overall Study|Miscellaneous|2|||
162075373|NCT01498640|585333077|FG000|Overall Study|Lost to Follow-up|1|||
162075374|NCT01498640|585333077|FG000|Overall Study|Death|1|||
162075375|NCT01498640|585333077|FG000|Overall Study|Other|3|||
162075376|NCT01319877|585333078|FG000|Overall Study|Lost to Follow-up|100|||
162075377|NCT01319877|585333079|FG001|Overall Study|Lost to Follow-up|37|||
162075378|NCT01319877|585333078|FG000|Overall Study|Physician Decision|2|||
162075379|NCT01319877|585333079|FG001|Overall Study|Physician Decision|0|||
162075380|NCT01319877|585333078|FG000|Overall Study|Disease Progression|2|||
162075381|NCT01319877|585333079|FG001|Overall Study|Disease Progression|2|||
162075382|NCT01319877|585333078|FG000|Overall Study|Withdrawal by Subject|0|||
162075383|NCT01319877|585333079|FG001|Overall Study|Withdrawal by Subject|1|||
162075384|NCT01319877|585333078|FG000|Overall Study|Reason Not Specified|4|||
162075385|NCT01319877|585333079|FG001|Overall Study|Reason Not Specified|5|||
162075386|NCT02347189|585333082|FG000|Overall Study|No implant attempted of study device|9|||
162075387|NCT02347189|585333082|FG000|Overall Study|No primary outcome data available|2|||
162075388|NCT02677987|585333083|FG000|Overall Study|Withdrawal by Subject|3|||
162075389|NCT02677987|585333084|FG001|Overall Study|Withdrawal by Subject|0|||
162075390|NCT02677987|585333083|FG000|Overall Study|Lost to Follow-up|1|||
162075391|NCT02677987|585333084|FG001|Overall Study|Lost to Follow-up|0|||
162075392|NCT03320564|585333085|FG000|Overall Study|Protocol Violation|1|||
162075393|NCT00600938|585333086|FG000|Core Study|Abnormal test procedure result(s)|3|||
162075394|NCT00600938|585333087|FG001|Core Study|Abnormal test procedure result(s)|2|||
162075395|NCT00600938|585333088|FG002|Core Study|Abnormal test procedure result(s)|0|||
162075396|NCT00600938|585333089|FG003|Core Study|Abnormal test procedure result(s)|0|||
162075397|NCT00600938|585333086|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
162075398|NCT00600938|585333087|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
162075399|NCT00600938|585333088|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
162075400|NCT00600938|585333089|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
162075401|NCT00600938|585333086|FG000|Core Study|Patient withdrew consent|7|||
162075402|NCT00600938|585333087|FG001|Core Study|Patient withdrew consent|12|||
162075403|NCT00600938|585333088|FG002|Core Study|Patient withdrew consent|0|||
162075404|NCT00600938|585333089|FG003|Core Study|Patient withdrew consent|0|||
162075405|NCT00600938|585333086|FG000|Core Study|Lost to Follow-up|3|||
162075406|NCT00600938|585333087|FG001|Core Study|Lost to Follow-up|2|||
162075407|NCT00600938|585333088|FG002|Core Study|Lost to Follow-up|0|||
162075408|NCT00600938|585333089|FG003|Core Study|Lost to Follow-up|0|||
162075409|NCT00600938|585333086|FG000|Core Study|Death|1|||
162075410|NCT00600938|585333087|FG001|Core Study|Death|1|||
162075411|NCT00600938|585333088|FG002|Core Study|Death|0|||
162075412|NCT00600938|585333089|FG003|Core Study|Death|0|||
162075413|NCT00600938|585333086|FG000|Core Study|Protocol Violation|1|||
162075414|NCT00600938|585333087|FG001|Core Study|Protocol Violation|2|||
162075415|NCT00600938|585333088|FG002|Core Study|Protocol Violation|0|||
162075416|NCT00600938|585333089|FG003|Core Study|Protocol Violation|0|||
162075417|NCT00600938|585333086|FG000|Extension Study|Adverse Event|1|||
162075418|NCT00600938|585333087|FG001|Extension Study|Adverse Event|0|||
162075419|NCT00600938|585333088|FG002|Extension Study|Adverse Event|2|||
162075420|NCT00600938|585333089|FG003|Extension Study|Adverse Event|0|||
162075421|NCT00600938|585333086|FG000|Extension Study|Abnormal test procedure results|0|||
162075422|NCT00600938|585333087|FG001|Extension Study|Abnormal test procedure results|1|||
162075423|NCT00600938|585333088|FG002|Extension Study|Abnormal test procedure results|1|||
162075424|NCT00600938|585333089|FG003|Extension Study|Abnormal test procedure results|1|||
162075425|NCT00600938|585333086|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
162075426|NCT00600938|585333087|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
162075427|NCT00600938|585333088|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
162075428|NCT00600938|585333089|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
162075429|NCT00600938|585333086|FG000|Extension Study|Withdrawal by Subject|2|||
162075430|NCT00600938|585333087|FG001|Extension Study|Withdrawal by Subject|2|||
162075431|NCT00600938|585333088|FG002|Extension Study|Withdrawal by Subject|3|||
162075432|NCT00600938|585333089|FG003|Extension Study|Withdrawal by Subject|0|||
162075433|NCT00600938|585333086|FG000|Extension Study|Lost to Follow-up|1|||
162075434|NCT00600938|585333087|FG001|Extension Study|Lost to Follow-up|1|||
162075435|NCT00600938|585333088|FG002|Extension Study|Lost to Follow-up|2|||
162075436|NCT00600938|585333089|FG003|Extension Study|Lost to Follow-up|0|||
162075437|NCT00600938|585333086|FG000|Extension Study|Death|1|||
162075438|NCT00600938|585333087|FG001|Extension Study|Death|0|||
162075439|NCT00600938|585333088|FG002|Extension Study|Death|0|||
162075440|NCT00600938|585333089|FG003|Extension Study|Death|0|||
162075441|NCT02680639|585333090|FG000|Screening Period|Screen Failure|7|||
162075442|NCT02680639|585333091|FG001|Screening Period|Screen Failure|0|||
162075443|NCT02680639|585333092|FG002|Screening Period|Screen Failure|0|||
162075444|NCT02678676|585333093|FG000|Overall Study|Death|619|||
162075445|NCT02678676|585333094|FG001|Overall Study|Death|649|||
162075446|NCT02678676|585333093|FG000|Overall Study|Withdrawal by Subject|13|||
162075447|NCT02678676|585333094|FG001|Overall Study|Withdrawal by Subject|5|||
162075448|NCT02678676|585333093|FG000|Overall Study|Lost to Follow-up|171|||
162075449|NCT02678676|585333094|FG001|Overall Study|Lost to Follow-up|151|||
162075450|NCT02678676|585333093|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
162075451|NCT02678676|585333094|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
162075452|NCT03200899|585333095|FG000|Overall Study|Lost to Follow-up|10|||
162075453|NCT03200899|585333096|FG001|Overall Study|Lost to Follow-up|23|||
162075454|NCT01342510|585333111|FG000|Overall Study|Protocol Violation|12|||
162075455|NCT01342510|585333112|FG001|Overall Study|Protocol Violation|6|||
162075456|NCT01342510|585333113|FG002|Overall Study|Protocol Violation|13|||
162075457|NCT01342510|585333114|FG003|Overall Study|Protocol Violation|11|||
162075458|NCT01400516|585333116|FG000|Primary Trial|Withdrawal by Subject|0|||
162075459|NCT01400516|585333117|FG001|Primary Trial|Withdrawal by Subject|2|||
162075460|NCT00549562|585333118|FG000|Overall Study|Adverse Event|1|||
162075461|NCT00549562|585333118|FG000|Overall Study|Lack of Efficacy|1|||
162075462|NCT00323115|585333124|FG000|Vaccine Administration|Adverse Event|1|||
162075463|NCT00323115|585333124|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
162075464|NCT04837131|585333125|FG000|Overall Study|Death|1|||
162075465|NCT04837131|585333125|FG000|Overall Study|Withdrawal by Subject|1|||
162075466|NCT04837131|585333125|FG000|Overall Study|Adverse Event|1|||
162075467|NCT04837131|585333125|FG000|Overall Study|Protocol Violation|1|||
162075468|NCT02496533|585333126|FG000|Overall Study|Lack of data on outcome|3|||
162075469|NCT02496533|585333127|FG001|Overall Study|Lack of data on outcome|0|||
162075470|NCT02496533|585333126|FG000|Overall Study|Patient did not complete all measures|0|||
162075471|NCT02496533|585333127|FG001|Overall Study|Patient did not complete all measures|4|||
162075472|NCT02496533|585333126|FG000|Overall Study|Late for radiologic testing|0|||
162075473|NCT02496533|585333127|FG001|Overall Study|Late for radiologic testing|2|||
162075474|NCT05756790|585333128|FG000|Overall Study|Withdrawal by Subject|1|||
162075475|NCT05756790|585333129|FG001|Overall Study|Withdrawal by Subject|1|||
162075476|NCT05756790|585333130|FG002|Overall Study|Withdrawal by Subject|1|||
162075477|NCT05756790|585333131|FG003|Overall Study|Withdrawal by Subject|1|||
162075478|NCT05756790|585333132|FG004|Overall Study|Withdrawal by Subject|0|||
162075479|NCT05756790|585333133|FG005|Overall Study|Withdrawal by Subject|0|||
162075480|NCT05756790|585333128|FG000|Overall Study|Protocol Violation|0|||
162075481|NCT05756790|585333129|FG001|Overall Study|Protocol Violation|0|||
162075482|NCT05756790|585333130|FG002|Overall Study|Protocol Violation|1|||
162075483|NCT05756790|585333131|FG003|Overall Study|Protocol Violation|1|||
162075484|NCT05756790|585333132|FG004|Overall Study|Protocol Violation|0|||
162075485|NCT05756790|585333133|FG005|Overall Study|Protocol Violation|0|||
162075486|NCT05756790|585333128|FG000|Overall Study|Ineligible|0|||
162075487|NCT05756790|585333129|FG001|Overall Study|Ineligible|0|||
162075488|NCT05756790|585333130|FG002|Overall Study|Ineligible|0|||
162075489|NCT05756790|585333131|FG003|Overall Study|Ineligible|0|||
162075490|NCT05756790|585333132|FG004|Overall Study|Ineligible|2|||
162075491|NCT05756790|585333133|FG005|Overall Study|Ineligible|2|||
162075492|NCT00589108|585334337|FG000|Overall Study|Lost to Follow-up|1|||
162075493|NCT00589108|585334338|FG001|Overall Study|Lost to Follow-up|1|||
162075494|NCT00589108|585334339|FG002|Overall Study|Lost to Follow-up|1|||
162075495|NCT00589108|585334337|FG000|Overall Study|Death|3|||
162075496|NCT00589108|585334338|FG001|Overall Study|Death|3|||
162075497|NCT00589108|585334339|FG002|Overall Study|Death|4|||
162075498|NCT03026257|585334342|FG000|Overall Study|Adverse Event|3|||
162075499|NCT03026257|585334343|FG001|Overall Study|Adverse Event|0|||
162075500|NCT03026257|585334344|FG002|Overall Study|Adverse Event|0|||
162075501|NCT03026257|585334345|FG003|Overall Study|Adverse Event|0|||
162075502|NCT03026257|585334346|FG004|Overall Study|Adverse Event|0|||
162075503|NCT03026257|585334347|FG005|Overall Study|Adverse Event|0|||
162075504|NCT03026257|585334342|FG000|Overall Study|Lost to Follow-up|1|||
162075505|NCT03026257|585334343|FG001|Overall Study|Lost to Follow-up|0|||
162075506|NCT03026257|585334344|FG002|Overall Study|Lost to Follow-up|0|||
162075507|NCT03026257|585334345|FG003|Overall Study|Lost to Follow-up|0|||
162075508|NCT03026257|585334346|FG004|Overall Study|Lost to Follow-up|0|||
162075509|NCT03026257|585334347|FG005|Overall Study|Lost to Follow-up|0|||
162075510|NCT03026257|585334342|FG000|Overall Study|Protocol Violation|1|||
162075511|NCT03026257|585334343|FG001|Overall Study|Protocol Violation|0|||
162075512|NCT03026257|585334344|FG002|Overall Study|Protocol Violation|0|||
162075513|NCT03026257|585334345|FG003|Overall Study|Protocol Violation|1|||
162075514|NCT03026257|585334346|FG004|Overall Study|Protocol Violation|1|||
162075515|NCT03026257|585334347|FG005|Overall Study|Protocol Violation|0|||
162075516|NCT03026257|585334342|FG000|Overall Study|Withdrawal by Subject|1|||
162075517|NCT03026257|585334343|FG001|Overall Study|Withdrawal by Subject|1|||
162075518|NCT03026257|585334344|FG002|Overall Study|Withdrawal by Subject|0|||
162075519|NCT03026257|585334345|FG003|Overall Study|Withdrawal by Subject|0|||
162075520|NCT03026257|585334346|FG004|Overall Study|Withdrawal by Subject|0|||
162075521|NCT03026257|585334347|FG005|Overall Study|Withdrawal by Subject|0|||
162075522|NCT02181556|585334349|FG000|Overall Study|Withdrawal by Subject|1|||
162075523|NCT00427635|585334350|FG000|Treatment Phase|Withdrawal by Subject|1|||
162075524|NCT00427635|585334351|FG001|Treatment Phase|Withdrawal by Subject|0|||
162075525|NCT00427635|585334350|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
162075526|NCT00427635|585334351|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
162075527|NCT00838201|585334354|FG000|Overall Study|Investigator decision, or other reasons|2|||
162075528|NCT00838201|585334355|FG001|Overall Study|Investigator decision, or other reasons|3|||
162075529|NCT00838201|585334354|FG000|Overall Study|Noncompliance|0|||
162075530|NCT00838201|585334355|FG001|Overall Study|Noncompliance|1|||
162075531|NCT00838201|585334354|FG000|Overall Study|Administrative decision|1|||
162075532|NCT00838201|585334355|FG001|Overall Study|Administrative decision|2|||
162075533|NCT00838201|585334354|FG000|Overall Study|Disease progression|3|||
162075534|NCT00838201|585334355|FG001|Overall Study|Disease progression|3|||
162075535|NCT00838201|585334354|FG000|Overall Study|Consent withdrawn|16|||
162075536|NCT00838201|585334355|FG001|Overall Study|Consent withdrawn|19|||
162075537|NCT00838201|585334354|FG000|Overall Study|Lost to Follow-up|4|||
162075538|NCT00838201|585334355|FG001|Overall Study|Lost to Follow-up|3|||
162075539|NCT00838201|585334354|FG000|Overall Study|Adverse Event|5|||
162075540|NCT00838201|585334355|FG001|Overall Study|Adverse Event|9|||
162075541|NCT00838201|585334354|FG000|Overall Study|Death|11|||
162075542|NCT00838201|585334355|FG001|Overall Study|Death|13|||
162075543|NCT02520011|585334357|FG000|Overall Study|Adverse Event|0|||
162075544|NCT02520011|585334358|FG001|Overall Study|Adverse Event|1|||
162075545|NCT02520011|585334359|FG002|Overall Study|Adverse Event|2|||
162075546|NCT02520011|585334357|FG000|Overall Study|Death|0|||
162075547|NCT02520011|585334358|FG001|Overall Study|Death|8|||
162075548|NCT02520011|585334359|FG002|Overall Study|Death|1|||
162075549|NCT02520011|585334357|FG000|Overall Study|Lack of Efficacy|4|||
162075550|NCT02520011|585334358|FG001|Overall Study|Lack of Efficacy|26|||
162075551|NCT02520011|585334359|FG002|Overall Study|Lack of Efficacy|4|||
162075552|NCT02520011|585334357|FG000|Overall Study|Physician Decision|0|||
162075553|NCT02520011|585334358|FG001|Overall Study|Physician Decision|2|||
162075554|NCT02520011|585334359|FG002|Overall Study|Physician Decision|0|||
162075555|NCT02520011|585334357|FG000|Overall Study|Withdrawal by Subject|1|||
162075556|NCT02520011|585334358|FG001|Overall Study|Withdrawal by Subject|3|||
162075557|NCT02520011|585334359|FG002|Overall Study|Withdrawal by Subject|0|||
162075558|NCT02520011|585334357|FG000|Overall Study|Protocol Deviation|0|||
162075559|NCT02520011|585334358|FG001|Overall Study|Protocol Deviation|1|||
162075560|NCT02520011|585334359|FG002|Overall Study|Protocol Deviation|0|||
162075561|NCT02520011|585334357|FG000|Overall Study|Patient went to hospice|0|||
162075562|NCT02520011|585334358|FG001|Overall Study|Patient went to hospice|1|||
162075563|NCT02520011|585334359|FG002|Overall Study|Patient went to hospice|0|||
162075564|NCT02520011|585334357|FG000|Overall Study|Progressive disease following response|0|||
162075565|NCT02520011|585334358|FG001|Overall Study|Progressive disease following response|4|||
162075566|NCT02520011|585334359|FG002|Overall Study|Progressive disease following response|2|||
162075567|NCT00644969|585334360|FG000|Treatment Phase|Randomized, not treated|1|||
162075568|NCT00644969|585334361|FG001|Treatment Phase|Randomized, not treated|0|||
162075569|NCT00644969|585334360|FG000|Treatment Phase|Adverse Event|3|||
162075570|NCT00644969|585334361|FG001|Treatment Phase|Adverse Event|0|||
162075571|NCT00644969|585334360|FG000|Treatment Phase|Withdrawal by Subject|4|||
162075572|NCT00644969|585334361|FG001|Treatment Phase|Withdrawal by Subject|0|||
162075573|NCT00644969|585334360|FG000|Treatment Phase|Lost to Follow-up|2|||
162075574|NCT00644969|585334361|FG001|Treatment Phase|Lost to Follow-up|2|||
162075575|NCT00644969|585334360|FG000|Treatment Phase|Other|4|||
162075576|NCT00644969|585334361|FG001|Treatment Phase|Other|1|||
162075577|NCT00644969|585334360|FG000|Post Treatment Phase|Death|1|||
162075578|NCT00644969|585334361|FG001|Post Treatment Phase|Death|0|||
162075579|NCT00644969|585334360|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
162075580|NCT00644969|585334361|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
162075581|NCT00644969|585334360|FG000|Post Treatment Phase|Lost to Follow-up|4|||
162075582|NCT00644969|585334361|FG001|Post Treatment Phase|Lost to Follow-up|1|||
162075583|NCT00644969|585334360|FG000|Post Treatment Phase|Other|1|||
162075584|NCT00644969|585334361|FG001|Post Treatment Phase|Other|0|||
162075585|NCT01933048|585334362|FG000|Overall Study|Lost to Follow-up|15|||
162075586|NCT01933048|585334363|FG001|Overall Study|Lost to Follow-up|18|||
162075587|NCT01933048|585334362|FG000|Overall Study|personal reasons|1|||
162075588|NCT01933048|585334363|FG001|Overall Study|personal reasons|1|||
162075589|NCT01933048|585334362|FG000|Overall Study|Protocol Violation|7|||
162075590|NCT01933048|585334363|FG001|Overall Study|Protocol Violation|8|||
162075591|NCT01933048|585334362|FG000|Overall Study|Physician Decision|1|||
162075592|NCT01933048|585334363|FG001|Overall Study|Physician Decision|0|||
162075593|NCT01933048|585334362|FG000|Overall Study|unknown reasons|1|||
162075594|NCT01933048|585334363|FG001|Overall Study|unknown reasons|1|||
162075595|NCT02780804|585334364|FG000|Overall Study|Death|1|||
162075596|NCT02780804|585334365|FG001|Overall Study|Death|0|||
162075597|NCT02780804|585334366|FG002|Overall Study|Death|0|||
162075598|NCT02780804|585334364|FG000|Overall Study|Lack of Efficacy|5|||
162075599|NCT02780804|585334365|FG001|Overall Study|Lack of Efficacy|8|||
162075600|NCT02780804|585334366|FG002|Overall Study|Lack of Efficacy|4|||
162075601|NCT02780804|585334364|FG000|Overall Study|Physician Decision|0|||
162075602|NCT02780804|585334365|FG001|Overall Study|Physician Decision|0|||
162075603|NCT02780804|585334366|FG002|Overall Study|Physician Decision|2|||
162075604|NCT02780804|585334364|FG000|Overall Study|Withdrawal by Subject|0|||
162075605|NCT02780804|585334365|FG001|Overall Study|Withdrawal by Subject|1|||
162075606|NCT02780804|585334366|FG002|Overall Study|Withdrawal by Subject|0|||
162075607|NCT02476968|585334367|FG000|Overall Study|Other|0|||
162075608|NCT02476968|585334368|FG001|Overall Study|Other|2|||
162075609|NCT02476968|585334369|FG002|Overall Study|Other|0|||
162075610|NCT02476968|585334367|FG000|Overall Study|Lost to Follow-up|10|||
162075611|NCT02476968|585334368|FG001|Overall Study|Lost to Follow-up|0|||
162075612|NCT02476968|585334369|FG002|Overall Study|Lost to Follow-up|1|||
162075613|NCT02476968|585334367|FG000|Overall Study|Death|48|||
162075614|NCT02476968|585334368|FG001|Overall Study|Death|8|||
162075615|NCT02476968|585334369|FG002|Overall Study|Death|1|||
162075616|NCT02476968|585334367|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162075617|NCT02476968|585334368|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162075618|NCT02476968|585334369|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
162075619|NCT02476968|585334367|FG000|Overall Study|Patient decision|37|||
162075620|NCT02476968|585334368|FG001|Overall Study|Patient decision|8|||
162075621|NCT02476968|585334369|FG002|Overall Study|Patient decision|0|||
162075622|NCT04171414|585334374|FG000|Overall Study|Death|1|||
162075623|NCT04171414|585334374|FG000|Overall Study|Withdrawal by Subject|1|||
162075624|NCT01714310|585334375|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
162075625|NCT01714310|585334376|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
162075626|NCT01714310|585334377|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
162075627|NCT01714310|585334375|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
162075628|NCT01714310|585334376|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
162075629|NCT01714310|585334377|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
162075630|NCT01714310|585334375|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
162075631|NCT01714310|585334376|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
162075632|NCT01714310|585334377|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
162075633|NCT01714310|585334375|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
162075634|NCT01714310|585334376|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
162075635|NCT01714310|585334377|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
162075636|NCT02487394|585334378|FG000|Phase 1|Withdrawal by Subject|0|||
162075637|NCT02487394|585334379|FG001|Phase 1|Withdrawal by Subject|1|||
162075638|NCT00704535|585334380|FG000|Overall Study|Adverse Event|2|||
162075639|NCT00704535|585334380|FG000|Overall Study|Death|2|||
162075640|NCT00704535|585334380|FG000|Overall Study|Lost to Follow-up|8|||
162075641|NCT00704535|585334380|FG000|Overall Study|Protocol Violation|10|||
162075642|NCT00704535|585334380|FG000|Overall Study|Completed status not on Case Report Form|124|||
162075643|NCT04064294|585334385|FG000|Overall Study|Adverse Event|1|||
162075644|NCT04064294|585334386|FG001|Overall Study|Adverse Event|0|||
162075645|NCT04064294|585334387|FG002|Overall Study|Adverse Event|0|||
162075646|NCT01289847|585334388|FG000|Overall Study|Patient could not comply with visits|1|||
162075647|NCT00006478|585334399|FG000|Overall Study|Vaccine could not be produced|1|||
162075648|NCT00006478|585334399|FG000|Overall Study|Physician Decision|6|||
162075649|NCT03161483|585334400|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
162075650|NCT03161483|585334401|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
162075651|NCT03161483|585334402|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
162075652|NCT03161483|585334403|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
162075653|NCT03161483|585334400|FG000|Treatment Period|Death|1|||
162075654|NCT03161483|585334401|FG001|Treatment Period|Death|0|||
162075655|NCT03161483|585334402|FG002|Treatment Period|Death|0|||
162075656|NCT03161483|585334403|FG003|Treatment Period|Death|0|||
162075657|NCT03161483|585334400|FG000|Treatment Period|Adverse Event|5|||
162075658|NCT03161483|585334401|FG001|Treatment Period|Adverse Event|2|||
162075659|NCT03161483|585334402|FG002|Treatment Period|Adverse Event|1|||
162075660|NCT03161483|585334403|FG003|Treatment Period|Adverse Event|11|||
162075661|NCT03161483|585334400|FG000|Treatment Period|Pregnancy|1|||
162075662|NCT03161483|585334401|FG001|Treatment Period|Pregnancy|0|||
162075663|NCT03161483|585334402|FG002|Treatment Period|Pregnancy|0|||
162075664|NCT03161483|585334403|FG003|Treatment Period|Pregnancy|0|||
162075665|NCT03161483|585334400|FG000|Treatment Period|Lack of Efficacy|0|||
162075666|NCT03161483|585334401|FG001|Treatment Period|Lack of Efficacy|0|||
162075667|NCT03161483|585334402|FG002|Treatment Period|Lack of Efficacy|0|||
162075668|NCT03161483|585334403|FG003|Treatment Period|Lack of Efficacy|1|||
162075669|NCT03161483|585334400|FG000|Treatment Period|Withdrawal by Subject|2|||
162075670|NCT03161483|585334401|FG001|Treatment Period|Withdrawal by Subject|5|||
162075671|NCT03161483|585334402|FG002|Treatment Period|Withdrawal by Subject|2|||
162075672|NCT03161483|585334403|FG003|Treatment Period|Withdrawal by Subject|6|||
162075673|NCT03161483|585334400|FG000|Treatment Period|Lost to Follow-up|0|||
162075674|NCT03161483|585334401|FG001|Treatment Period|Lost to Follow-up|0|||
162075675|NCT03161483|585334402|FG002|Treatment Period|Lost to Follow-up|0|||
162075676|NCT03161483|585334403|FG003|Treatment Period|Lost to Follow-up|1|||
162075677|NCT03161483|585334400|FG000|Treatment Period|Protocol Violation|0|||
162075678|NCT03161483|585334401|FG001|Treatment Period|Protocol Violation|0|||
162075679|NCT03161483|585334402|FG002|Treatment Period|Protocol Violation|0|||
162075680|NCT03161483|585334403|FG003|Treatment Period|Protocol Violation|1|||
162075681|NCT03161483|585334400|FG000|Treatment Period|Other reasons|1|||
162075682|NCT03161483|585334401|FG001|Treatment Period|Other reasons|1|||
162075683|NCT03161483|585334402|FG002|Treatment Period|Other reasons|0|||
162075684|NCT03161483|585334403|FG003|Treatment Period|Other reasons|0|||
162075685|NCT00600756|585334406|FG000|Analysis After 6 Months|Adverse Event|43|||
162075686|NCT00600756|585334407|FG001|Analysis After 6 Months|Adverse Event|33|||
162075687|NCT00600756|585334406|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
162075688|NCT00600756|585334407|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
162075689|NCT00600756|585334406|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
162075690|NCT00600756|585334407|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
162075691|NCT00600756|585334406|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
162075692|NCT00600756|585334407|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
162075693|NCT00600756|585334406|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
162075694|NCT00600756|585334407|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
162075695|NCT00600756|585334406|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
162075696|NCT00600756|585334407|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
162075697|NCT00600756|585334406|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
162075698|NCT00600756|585334407|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
162075699|NCT00600756|585334406|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
162075700|NCT00600756|585334407|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
162075701|NCT00600756|585334406|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
162075702|NCT00600756|585334407|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
162075703|NCT00600756|585334406|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
162075704|NCT00600756|585334407|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
162075705|NCT00600756|585334406|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
162075706|NCT00600756|585334407|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
162075707|NCT00600756|585334406|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
162075708|NCT00600756|585334407|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
162075709|NCT00600756|585334406|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
162075710|NCT00600756|585334407|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
162075711|NCT00600756|585334406|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
162075712|NCT00600756|585334407|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
162075713|NCT04753164|585334408|FG000|Overall Study|Adverse Event|0|||
162075714|NCT04753164|585334409|FG001|Overall Study|Adverse Event|2|||
162075715|NCT04753164|585334408|FG000|Overall Study|Withdrawal by Subject|9|||
162075716|NCT04753164|585334409|FG001|Overall Study|Withdrawal by Subject|7|||
162075717|NCT04753164|585334408|FG000|Overall Study|Lost to Follow-up|6|||
162075718|NCT04753164|585334409|FG001|Overall Study|Lost to Follow-up|6|||
162075719|NCT04753164|585334408|FG000|Overall Study|Other|12|||
162075720|NCT04753164|585334409|FG001|Overall Study|Other|5|||
162075721|NCT00694369|585334410|FG000|Overall Study|Adverse Event|0|||
162075722|NCT00694369|585334411|FG001|Overall Study|Adverse Event|1|||
162075723|NCT00694369|585334412|FG002|Overall Study|Adverse Event|0|||
162075724|NCT00694369|585334413|FG003|Overall Study|Adverse Event|1|||
162075725|NCT00694369|585334414|FG004|Overall Study|Adverse Event|3|||
162075726|NCT00694369|585334410|FG000|Overall Study|Lost to Follow-up|0|||
162075727|NCT00694369|585334411|FG001|Overall Study|Lost to Follow-up|0|||
162075728|NCT00694369|585334412|FG002|Overall Study|Lost to Follow-up|1|||
162075729|NCT00694369|585334413|FG003|Overall Study|Lost to Follow-up|1|||
162075730|NCT00694369|585334414|FG004|Overall Study|Lost to Follow-up|0|||
162075731|NCT00694369|585334410|FG000|Overall Study|Physician Decision|0|||
162075732|NCT00694369|585334411|FG001|Overall Study|Physician Decision|0|||
162075733|NCT00694369|585334412|FG002|Overall Study|Physician Decision|0|||
162075734|NCT00694369|585334413|FG003|Overall Study|Physician Decision|0|||
162075735|NCT00694369|585334414|FG004|Overall Study|Physician Decision|1|||
162075736|NCT00694369|585334410|FG000|Overall Study|Protocol Violation|0|||
162075737|NCT00694369|585334411|FG001|Overall Study|Protocol Violation|1|||
162075738|NCT00694369|585334412|FG002|Overall Study|Protocol Violation|0|||
162075739|NCT00694369|585334413|FG003|Overall Study|Protocol Violation|0|||
162075740|NCT00694369|585334414|FG004|Overall Study|Protocol Violation|0|||
162075741|NCT00694369|585334410|FG000|Overall Study|Withdrawal by Subject|1|||
162075742|NCT00694369|585334411|FG001|Overall Study|Withdrawal by Subject|1|||
162075743|NCT00694369|585334412|FG002|Overall Study|Withdrawal by Subject|1|||
162075744|NCT00694369|585334413|FG003|Overall Study|Withdrawal by Subject|1|||
162075745|NCT00694369|585334414|FG004|Overall Study|Withdrawal by Subject|2|||
162075746|NCT00439556|585334415|FG000|Overall Study|Patient was taken off study for non-comp|0|||
162075747|NCT00439556|585334416|FG001|Overall Study|Patient was taken off study for non-comp|1|||
162075748|NCT00439556|585334417|FG002|Overall Study|Patient was taken off study for non-comp|0|||
162075749|NCT02871739|585334418|FG000|Overall Study|Lost to Follow-up|3|||
162075750|NCT02871739|585334419|FG001|Overall Study|Lost to Follow-up|2|||
162075751|NCT02871739|585334420|FG002|Overall Study|Lost to Follow-up|0|||
162075752|NCT02871739|585334421|FG003|Overall Study|Lost to Follow-up|2|||
162075753|NCT01324388|585334424|FG000|Part 1 of Study|Adverse Event|2|||
162075754|NCT01324388|585334425|FG001|Part 1 of Study|Adverse Event|0|||
162075755|NCT01324388|585334426|FG002|Part 1 of Study|Adverse Event|0|||
162075756|NCT01324388|585334427|FG003|Part 1 of Study|Adverse Event|0|||
162075757|NCT01324388|585334424|FG000|Part 1 of Study|Protocol Violation|1|||
162075758|NCT01324388|585334425|FG001|Part 1 of Study|Protocol Violation|2|||
162075759|NCT01324388|585334426|FG002|Part 1 of Study|Protocol Violation|0|||
162075760|NCT01324388|585334427|FG003|Part 1 of Study|Protocol Violation|0|||
162075761|NCT01324388|585334424|FG000|Part 1 of Study|Physician Decision|1|||
162075762|NCT01324388|585334425|FG001|Part 1 of Study|Physician Decision|0|||
162075763|NCT01324388|585334426|FG002|Part 1 of Study|Physician Decision|0|||
162075764|NCT01324388|585334427|FG003|Part 1 of Study|Physician Decision|0|||
162075765|NCT01324388|585334424|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
162075766|NCT01324388|585334425|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
162075767|NCT01324388|585334426|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
162075768|NCT01324388|585334427|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
162075769|NCT01324388|585334424|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
162075770|NCT01324388|585334425|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
162075771|NCT01324388|585334426|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
162075772|NCT01324388|585334427|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
162075773|NCT01405963|585334428|FG000|Overall Study|Moved Away|2|||
162075774|NCT01405963|585334429|FG001|Overall Study|Moved Away|0|||
162075775|NCT01405963|585334428|FG000|Overall Study|Adverse Event|0|||
162075776|NCT01405963|585334429|FG001|Overall Study|Adverse Event|1|||
162075777|NCT01405963|585334428|FG000|Overall Study|Lost to Follow-up|0|||
162075778|NCT01405963|585334429|FG001|Overall Study|Lost to Follow-up|1|||
162075779|NCT00850395|585334436|FG000|Overall Study|Death|1|||
162075780|NCT00850395|585334436|FG000|Overall Study|Adverse Event|1|||
162075781|NCT00850395|585334436|FG000|Overall Study|Insufficient clinical response|3|||
162075782|NCT00850395|585334436|FG000|Overall Study|Other|5|||
162075783|NCT01737047|585334437|FG000|Overall Study|Death|10|||
162075784|NCT01737047|585334438|FG001|Overall Study|Death|0|||
162075785|NCT01737047|585334439|FG002|Overall Study|Death|1|||
162075786|NCT01737047|585334437|FG000|Overall Study|Withdrawal by Subject|17|||
162075787|NCT01737047|585334438|FG001|Overall Study|Withdrawal by Subject|11|||
162075788|NCT01737047|585334439|FG002|Overall Study|Withdrawal by Subject|4|||
162075789|NCT02802592|585334440|FG000|Overall Study|Study terminated due to loss of funding|4|||
162075790|NCT04007523|585334441|FG000|Overall Study|Withdrawal by Subject|0|||
162075791|NCT04007523|585334442|FG001|Overall Study|Withdrawal by Subject|1|||
162075792|NCT04007523|585334443|FG002|Overall Study|Withdrawal by Subject|1|||
162075793|NCT04007523|585334444|FG003|Overall Study|Withdrawal by Subject|0|||
162075794|NCT04007523|585334441|FG000|Overall Study|ICU Transfer|0|||
162075795|NCT04007523|585334442|FG001|Overall Study|ICU Transfer|1|||
162075796|NCT04007523|585334443|FG002|Overall Study|ICU Transfer|0|||
162075797|NCT04007523|585334444|FG003|Overall Study|ICU Transfer|0|||
162075798|NCT04007523|585334441|FG000|Overall Study|COVID hospital closure|0|||
162075799|NCT04007523|585334442|FG001|Overall Study|COVID hospital closure|0|||
162075800|NCT04007523|585334443|FG002|Overall Study|COVID hospital closure|1|||
162075801|NCT04007523|585334444|FG003|Overall Study|COVID hospital closure|2|||
162075802|NCT04007523|585334441|FG000|Overall Study|Surgery cancelled|0|||
162075803|NCT04007523|585334442|FG001|Overall Study|Surgery cancelled|0|||
162075804|NCT04007523|585334443|FG002|Overall Study|Surgery cancelled|1|||
162075805|NCT04007523|585334444|FG003|Overall Study|Surgery cancelled|1|||
162075806|NCT01826487|585334445|FG000|Overall Study|Adverse Event|1|||
162075807|NCT01826487|585334446|FG001|Overall Study|Adverse Event|1|||
162075808|NCT01826487|585334445|FG000|Overall Study|Lost to Follow-up|1|||
162075809|NCT01826487|585334446|FG001|Overall Study|Lost to Follow-up|0|||
162075810|NCT01826487|585334445|FG000|Overall Study|Withdrawal by Subject|1|||
162075811|NCT01826487|585334446|FG001|Overall Study|Withdrawal by Subject|3|||
162075812|NCT01826487|585334445|FG000|Overall Study|Protocol Violation|1|||
162075813|NCT01826487|585334446|FG001|Overall Study|Protocol Violation|1|||
162075814|NCT01408030|585334447|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
162075815|NCT01408030|585334448|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
162075816|NCT01408030|585334449|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
162075817|NCT01408030|585334450|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
162075818|NCT01408030|585334447|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
162075819|NCT01408030|585334448|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
162075820|NCT01408030|585334449|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
162075821|NCT01408030|585334450|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
162075822|NCT01408030|585334447|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
162075823|NCT01408030|585334448|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
162075824|NCT01408030|585334449|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
162075825|NCT01408030|585334450|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
162075826|NCT01408030|585334447|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
162075827|NCT01408030|585334448|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
162075828|NCT01408030|585334449|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
162075829|NCT01408030|585334450|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
162075830|NCT01408030|585334447|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
162075831|NCT01408030|585334448|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
162075832|NCT01408030|585334449|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
162075833|NCT01408030|585334450|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
162075834|NCT01408030|585334447|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
162075835|NCT01408030|585334448|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
162075836|NCT01408030|585334449|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
162075837|NCT01408030|585334450|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
162075838|NCT01408030|585334447|FG000|Observation Phase (Off Drug)|Other|1|||
162075839|NCT01408030|585334448|FG001|Observation Phase (Off Drug)|Other|1|||
162075840|NCT01408030|585334449|FG002|Observation Phase (Off Drug)|Other|1|||
162075841|NCT01408030|585334450|FG003|Observation Phase (Off Drug)|Other|1|||
162075842|NCT02965703|585334451|FG000|Overall Study|Withdrawal by Subject|6|||
162075843|NCT02965703|585334452|FG001|Overall Study|Withdrawal by Subject|3|||
162075844|NCT02965703|585334453|FG002|Overall Study|Withdrawal by Subject|1|||
162075845|NCT02965703|585334451|FG000|Overall Study|Protocol Violation|1|||
162075846|NCT02965703|585334452|FG001|Overall Study|Protocol Violation|0|||
162075847|NCT02965703|585334453|FG002|Overall Study|Protocol Violation|0|||
162075848|NCT02965703|585334451|FG000|Overall Study|Adverse Event|1|||
162075849|NCT02965703|585334452|FG001|Overall Study|Adverse Event|1|||
162075850|NCT02965703|585334453|FG002|Overall Study|Adverse Event|0|||
162075851|NCT02965703|585334451|FG000|Overall Study|Lost to Follow-up|2|||
162075852|NCT02965703|585334452|FG001|Overall Study|Lost to Follow-up|1|||
162075853|NCT02965703|585334453|FG002|Overall Study|Lost to Follow-up|1|||
162075854|NCT00788827|585334459|FG000|Overall Study|Lack of Efficacy|2|||
162075855|NCT03608774|585334460|FG000|Overall Study|Lost to Follow-up|5|||
162075856|NCT03608774|585334461|FG001|Overall Study|Lost to Follow-up|5|||
162075857|NCT03608774|585334460|FG000|Overall Study|Withdrawal by Subject|1|||
162075858|NCT03608774|585334461|FG001|Overall Study|Withdrawal by Subject|0|||
162075859|NCT03608774|585334460|FG000|Overall Study|Protocol Violation|1|||
162075860|NCT03608774|585334461|FG001|Overall Study|Protocol Violation|0|||
162075861|NCT03608774|585334460|FG000|Overall Study|Not eligible at enrollment|0|||
162075862|NCT03608774|585334461|FG001|Overall Study|Not eligible at enrollment|1|||
162075863|NCT03608774|585334460|FG000|Overall Study|Health related event|0|||
162075864|NCT03608774|585334461|FG001|Overall Study|Health related event|1|||
162075865|NCT01586819|585334462|FG000|Overall Study|Withdrawal by Subject|1|||
162075866|NCT01586819|585334463|FG001|Overall Study|Withdrawal by Subject|0|||
162075867|NCT01359254|585334464|FG000|Overall Study|Death|1|||
162075868|NCT01359254|585334465|FG001|Overall Study|Death|0|||
162075869|NCT02028988|585334471|FG000|Overall Study|Withdrawal by Subject|2|||
162075870|NCT00851799|585334474|FG000|Overall Study|Death|1|||
162075871|NCT00851799|585334475|FG001|Overall Study|Death|0|||
162075872|NCT00851799|585334476|FG002|Overall Study|Death|1|||
162075873|NCT00851799|585334474|FG000|Overall Study|Lost to Follow-up|5|||
162075874|NCT00851799|585334475|FG001|Overall Study|Lost to Follow-up|3|||
162075875|NCT00851799|585334476|FG002|Overall Study|Lost to Follow-up|10|||
162075876|NCT00851799|585334474|FG000|Overall Study|Not able to get to clinic|8|||
162075877|NCT00851799|585334475|FG001|Overall Study|Not able to get to clinic|5|||
162075878|NCT00851799|585334476|FG002|Overall Study|Not able to get to clinic|9|||
162075879|NCT00851799|585334474|FG000|Overall Study|Not willing to adhere to requirements|1|||
162075880|NCT00851799|585334475|FG001|Overall Study|Not willing to adhere to requirements|2|||
162075881|NCT00851799|585334476|FG002|Overall Study|Not willing to adhere to requirements|2|||
162075882|NCT00851799|585334474|FG000|Overall Study|Withdrew consent prior study completion|1|||
162075883|NCT00851799|585334475|FG001|Overall Study|Withdrew consent prior study completion|2|||
162075884|NCT00851799|585334476|FG002|Overall Study|Withdrew consent prior study completion|1|||
162075885|NCT00851799|585334474|FG000|Overall Study|Severe Debilitation|0|||
162075886|NCT00851799|585334475|FG001|Overall Study|Severe Debilitation|1|||
162075887|NCT00851799|585334476|FG002|Overall Study|Severe Debilitation|0|||
162075888|NCT00851799|585334474|FG000|Overall Study|Completed protocol due to pregnancy|0|||
162075889|NCT00851799|585334475|FG001|Overall Study|Completed protocol due to pregnancy|0|||
162075890|NCT00851799|585334476|FG002|Overall Study|Completed protocol due to pregnancy|1|||
162075891|NCT04365556|585334479|FG000|Overall Study|No longer eligible due to treatment plan|1|||
162075892|NCT04365556|585334480|FG001|Overall Study|No longer eligible due to treatment plan|0|||
162075893|NCT04365556|585334479|FG000|Overall Study|Lost to Follow-up|3|||
162075894|NCT04365556|585334480|FG001|Overall Study|Lost to Follow-up|2|||
162075895|NCT03873987|585335758|FG000|Overall Study|Adverse Event|1|||
162075896|NCT03873987|585335759|FG001|Overall Study|Adverse Event|0|||
162075897|NCT03873987|585335758|FG000|Overall Study|staff was unable to start a new IV line|1|||
162075898|NCT03873987|585335759|FG001|Overall Study|staff was unable to start a new IV line|0|||
162075899|NCT03873987|585335758|FG000|Overall Study|Lost to Follow-up|0|||
162075900|NCT03873987|585335759|FG001|Overall Study|Lost to Follow-up|1|||
162075901|NCT01465022|585335760|FG000|Overall Study|Lost to Follow-up|15|||
162075902|NCT01465022|585335761|FG001|Overall Study|Lost to Follow-up|14|||
162075903|NCT01465022|585335762|FG002|Overall Study|Lost to Follow-up|0|||
162075904|NCT01465022|585335760|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
162075905|NCT01465022|585335761|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
162075906|NCT01465022|585335762|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
162075907|NCT01465022|585335760|FG000|Overall Study|Not Randomized|0|||
162075908|NCT01465022|585335761|FG001|Overall Study|Not Randomized|0|||
162075909|NCT01465022|585335762|FG002|Overall Study|Not Randomized|70|||
162075910|NCT00004888|585335763|FG000|Overall Study|Adverse Event|5|||
162075911|NCT00004888|585335764|FG001|Overall Study|Adverse Event|10|||
162075912|NCT00004888|585335763|FG000|Overall Study|Withdrawal by Subject|0|||
162075913|NCT00004888|585335764|FG001|Overall Study|Withdrawal by Subject|3|||
162075914|NCT00004888|585335763|FG000|Overall Study|Physician Decision|1|||
162075915|NCT00004888|585335764|FG001|Overall Study|Physician Decision|1|||
162075916|NCT00004888|585335763|FG000|Overall Study|Progressive Disease|4|||
162075917|NCT00004888|585335764|FG001|Overall Study|Progressive Disease|9|||
162075918|NCT00004888|585335763|FG000|Overall Study|Death without progressive disease|0|||
162075919|NCT00004888|585335764|FG001|Overall Study|Death without progressive disease|1|||
162075920|NCT00004888|585335763|FG000|Overall Study|Toxic death|1|||
162075921|NCT00004888|585335764|FG001|Overall Study|Toxic death|0|||
162075922|NCT00136084|585335765|FG000|Overall Study|Death|12|||
162075923|NCT00136084|585335766|FG001|Overall Study|Death|5|||
162075924|NCT00136084|585335765|FG000|Overall Study|Unacceptable toxicity|8|||
162075925|NCT00136084|585335766|FG001|Overall Study|Unacceptable toxicity|11|||
162075926|NCT00136084|585335765|FG000|Overall Study|Relapse|20|||
162075927|NCT00136084|585335766|FG001|Overall Study|Relapse|23|||
162075928|NCT00136084|585335765|FG000|Overall Study|Lost to Follow-up|2|||
162075929|NCT00136084|585335766|FG001|Overall Study|Lost to Follow-up|0|||
162075930|NCT00136084|585335765|FG000|Overall Study|No Response|1|||
162075931|NCT00136084|585335766|FG001|Overall Study|No Response|2|||
162075932|NCT00136084|585335765|FG000|Overall Study|Withdrawal by Subject|5|||
162075933|NCT00136084|585335766|FG001|Overall Study|Withdrawal by Subject|1|||
162075934|NCT02579265|585335767|FG000|Overall Study|Weaned off earlier than 28 days|44|||
162075935|NCT02579265|585335768|FG001|Overall Study|Weaned off earlier than 28 days|43|||
162075936|NCT02579265|585335767|FG000|Overall Study|Adverse Event|2|||
162075937|NCT02579265|585335768|FG001|Overall Study|Adverse Event|0|||
162075938|NCT02579265|585335767|FG000|Overall Study|Any other reason not specified|0|||
162075939|NCT02579265|585335768|FG001|Overall Study|Any other reason not specified|2|||
162075940|NCT02579265|585335767|FG000|Overall Study|Withdrawal by Subject|2|||
162075941|NCT02579265|585335768|FG001|Overall Study|Withdrawal by Subject|0|||
162075942|NCT02579265|585335767|FG000|Overall Study|Physician Decision|1|||
162075943|NCT02579265|585335768|FG001|Overall Study|Physician Decision|0|||
162075944|NCT02579265|585335767|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
162075945|NCT02579265|585335768|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
162075946|NCT02174848|585335769|FG000|Overall Study|Adverse Event|2|||
162075947|NCT02174848|585335770|FG001|Overall Study|Adverse Event|1|||
162075948|NCT02174848|585335769|FG000|Overall Study|Withdrawal by Subject|3|||
162075949|NCT02174848|585335770|FG001|Overall Study|Withdrawal by Subject|3|||
162075950|NCT02174848|585335769|FG000|Overall Study|Lost to Follow-up|0|||
162075951|NCT02174848|585335770|FG001|Overall Study|Lost to Follow-up|1|||
162075952|NCT02174848|585335769|FG000|Overall Study|Worsening of disease|1|||
162075953|NCT02174848|585335770|FG001|Overall Study|Worsening of disease|1|||
162075954|NCT02174848|585335769|FG000|Overall Study|Unable to comply with study requirements|1|||
162075955|NCT02174848|585335770|FG001|Overall Study|Unable to comply with study requirements|0|||
162075956|NCT00997503|585335776|FG000|Overall Study|Death|53|||
162075957|NCT00997503|585335776|FG000|Overall Study|Withdrawal by Subject|76|||
162075958|NCT00997503|585335776|FG000|Overall Study|Lost to Follow-up|33|||
162075959|NCT00997503|585335776|FG000|Overall Study|Adverse Event|3|||
162075960|NCT00997503|585335776|FG000|Overall Study|Physician Decision|10|||
162075961|NCT00997503|585335776|FG000|Overall Study|Missed 12-month follow-up|85|||
162075962|NCT00997503|585335776|FG000|Overall Study|Other reason|13|||
162075963|NCT01641367|585335785|FG000|Cohorts|Death|18|||
162075964|NCT01641367|585335786|FG001|Cohorts|Death|1|||
162075965|NCT01641367|585335787|FG002|Cohorts|Death|2|||
162075966|NCT01641367|585335788|FG003|Cohorts|Death|0|||
162075967|NCT01641367|585335789|FG004|Cohorts|Death|1|||
162075968|NCT01641367|585335790|FG005|Cohorts|Death|1|||
162075969|NCT01641367|585335791|FG006|Cohorts|Death|0|||
162075970|NCT01641367|585335792|FG007|Cohorts|Death|0|||
162075971|NCT01641367|585335785|FG000|Cohorts|Lost to Follow-up|16|||
162075972|NCT01641367|585335786|FG001|Cohorts|Lost to Follow-up|0|||
162075973|NCT01641367|585335787|FG002|Cohorts|Lost to Follow-up|2|||
162075974|NCT01641367|585335788|FG003|Cohorts|Lost to Follow-up|0|||
162075975|NCT01641367|585335789|FG004|Cohorts|Lost to Follow-up|2|||
162075976|NCT01641367|585335790|FG005|Cohorts|Lost to Follow-up|0|||
162075977|NCT01641367|585335791|FG006|Cohorts|Lost to Follow-up|0|||
162075978|NCT01641367|585335792|FG007|Cohorts|Lost to Follow-up|0|||
162075979|NCT01641367|585335785|FG000|Randomized Adherence Intervention|Death|0|||
162075980|NCT01641367|585335786|FG001|Randomized Adherence Intervention|Death|0|||
162075981|NCT01641367|585335787|FG002|Randomized Adherence Intervention|Death|0|||
162075982|NCT01641367|585335788|FG003|Randomized Adherence Intervention|Death|0|||
162075983|NCT01641367|585335789|FG004|Randomized Adherence Intervention|Death|0|||
162075984|NCT01641367|585335790|FG005|Randomized Adherence Intervention|Death|0|||
162075985|NCT01641367|585335791|FG006|Randomized Adherence Intervention|Death|11|||
162075986|NCT01641367|585335792|FG007|Randomized Adherence Intervention|Death|12|||
162075987|NCT01641367|585335785|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
162075988|NCT01641367|585335786|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
162075989|NCT01641367|585335787|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
162075990|NCT01641367|585335788|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
162075991|NCT01641367|585335789|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
162075992|NCT01641367|585335790|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
162075993|NCT01641367|585335791|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
162075994|NCT01641367|585335792|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
162075995|NCT04920123|585335795|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
162075996|NCT04920123|585335796|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
162075997|NCT04920123|585335797|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
162075998|NCT00218296|585335803|FG000|Overall Study|Lost to Follow-up|9|||
162075999|NCT00218296|585335804|FG001|Overall Study|Lost to Follow-up|7|||
162076000|NCT00218296|585335803|FG000|Overall Study|Withdrawal by Subject|36|||
162076001|NCT00218296|585335804|FG001|Overall Study|Withdrawal by Subject|47|||
162076002|NCT00218296|585335803|FG000|Overall Study|Randomized but did not enter treatment|66|||
162076003|NCT00218296|585335804|FG001|Overall Study|Randomized but did not enter treatment|67|||
162076004|NCT00449956|585335817|FG000|Overall Study|Adverse Event|7|||
162076005|NCT00449956|585335818|FG001|Overall Study|Adverse Event|1|||
162076006|NCT00449956|585335819|FG002|Overall Study|Adverse Event|6|||
162076007|NCT00449956|585335817|FG000|Overall Study|Lack of Efficacy|0|||
162076008|NCT00449956|585335818|FG001|Overall Study|Lack of Efficacy|0|||
162076009|NCT00449956|585335819|FG002|Overall Study|Lack of Efficacy|1|||
162076010|NCT00449956|585335817|FG000|Overall Study|Protocol Violation|1|||
162076011|NCT00449956|585335818|FG001|Overall Study|Protocol Violation|1|||
162076012|NCT00449956|585335819|FG002|Overall Study|Protocol Violation|1|||
162076013|NCT00449956|585335817|FG000|Overall Study|Withdrawal by Subject|0|||
162076014|NCT00449956|585335818|FG001|Overall Study|Withdrawal by Subject|1|||
162076015|NCT00449956|585335819|FG002|Overall Study|Withdrawal by Subject|0|||
162076016|NCT00449956|585335817|FG000|Overall Study|Physician Decision|2|||
162076017|NCT00449956|585335818|FG001|Overall Study|Physician Decision|1|||
162076018|NCT00449956|585335819|FG002|Overall Study|Physician Decision|1|||
162076019|NCT01988571|585335824|FG000|Overall Study|Death|3|||
162076020|NCT01988571|585335825|FG001|Overall Study|Death|1|||
162076021|NCT01988571|585335824|FG000|Overall Study|Physician Decision|2|||
162076022|NCT01988571|585335825|FG001|Overall Study|Physician Decision|1|||
162076023|NCT01988571|585335824|FG000|Overall Study|Lost to Follow-up|3|||
162076024|NCT01988571|585335825|FG001|Overall Study|Lost to Follow-up|0|||
162076025|NCT01988571|585335824|FG000|Overall Study|Withdrawal by Subject|31|||
162076026|NCT01988571|585335825|FG001|Overall Study|Withdrawal by Subject|33|||
162076027|NCT00409617|585335836|FG000|Overall Study|Adverse Event|57|||
162076028|NCT00409617|585335836|FG000|Overall Study|Lack of Efficacy|54|||
162076029|NCT00409617|585335836|FG000|Overall Study|Lost to Follow-up|2|||
162076030|NCT00409617|585335836|FG000|Overall Study|Protocol Violation|24|||
162076031|NCT00409617|585335836|FG000|Overall Study|Withdrawal by Subject|8|||
162076032|NCT00409617|585335836|FG000|Overall Study|Administrative reasons|1|||
162076033|NCT00409617|585335836|FG000|Overall Study|Not described|14|||
162076034|NCT02159521|585335837|FG000|Overall Study|Enrolled but not treated|3|||
162076035|NCT02159521|585335837|FG000|Overall Study|Withdrawal by Subject|7|||
162076036|NCT02159521|585335837|FG000|Overall Study|Lost to Follow-up|6|||
162076037|NCT02159521|585335837|FG000|Overall Study|Death|1|||
162076038|NCT02159521|585335837|FG000|Overall Study|Other than specified|1|||
162076039|NCT00907374|585335840|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
162076040|NCT00907374|585335841|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
162076041|NCT03818516|585335842|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
162076042|NCT03742141|585335848|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
162076043|NCT01524692|585335851|FG000|Overall Study|Withdrawal by Subject|3|||
162076044|NCT01709695|585335853|FG000|Overall Study|Withdrawal by Subject|1|||
162076045|NCT01709695|585335854|FG001|Overall Study|Withdrawal by Subject|1|||
162076046|NCT03065244|585335858|FG000|Overall Study|Lost to Follow-up|1|||
162076047|NCT03065244|585335859|FG001|Overall Study|Lost to Follow-up|1|||
162076048|NCT03065244|585335858|FG000|Overall Study|Diagnosed with a different disease|1|||
162076049|NCT03065244|585335859|FG001|Overall Study|Diagnosed with a different disease|1|||
162076050|NCT03065244|585335858|FG000|Overall Study|Protocol Violation|0|||
162076051|NCT03065244|585335859|FG001|Overall Study|Protocol Violation|1|||
162076052|NCT03065244|585335858|FG000|Overall Study|Withdrawal by Subject|1|||
162076053|NCT03065244|585335859|FG001|Overall Study|Withdrawal by Subject|1|||
162076054|NCT03717480|585335860|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
162076055|NCT01894152|585335861|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
162076056|NCT01774786|585335863|FG000|Overall Study|Death|300|||
162076057|NCT01774786|585335864|FG001|Overall Study|Death|319|||
162076058|NCT01774786|585335863|FG000|Overall Study|Lost to Follow-up|6|||
162076059|NCT01774786|585335864|FG001|Overall Study|Lost to Follow-up|7|||
162076060|NCT01774786|585335863|FG000|Overall Study|Withdrawal by Subject|18|||
162076061|NCT01774786|585335864|FG001|Overall Study|Withdrawal by Subject|14|||
162076062|NCT01774786|585335863|FG000|Overall Study|Physician Decision|2|||
162076063|NCT01774786|585335864|FG001|Overall Study|Physician Decision|0|||
162076064|NCT01774786|585335863|FG000|Overall Study|Non-compliance|0|||
162076065|NCT01774786|585335864|FG001|Overall Study|Non-compliance|1|||
162076066|NCT01774786|585335863|FG000|Overall Study|Reason Not Specified|2|||
162076067|NCT01774786|585335864|FG001|Overall Study|Reason Not Specified|5|||
162076068|NCT04544293|585335865|FG000|Double-blind|Adverse Event|2|||
162076069|NCT04544293|585335866|FG001|Double-blind|Adverse Event|1|||
162076070|NCT04544293|585335865|FG000|Double-blind|Pregnancy|0|||
162076071|NCT04544293|585335866|FG001|Double-blind|Pregnancy|1|||
162076072|NCT04544293|585335865|FG000|Double-blind|Lost to Follow-up|0|||
162076073|NCT04544293|585335866|FG001|Double-blind|Lost to Follow-up|1|||
162076074|NCT04544293|585335865|FG000|Open-Label Extension|Study ongoing|79|||
162076075|NCT04544293|585335866|FG001|Open-Label Extension|Study ongoing|81|||
162076076|NCT01062555|585335871|FG000|Phase 1|Death|10|||
162076077|NCT01062555|585335872|FG001|Phase 1|Death|17|||
162076078|NCT01062555|585335873|FG002|Phase 1|Death|0|||
162076079|NCT01062555|585335874|FG003|Phase 1|Death|0|||
162076080|NCT01062555|585335871|FG000|Phase 1|Graft Failure|12|||
162076081|NCT01062555|585335872|FG001|Phase 1|Graft Failure|8|||
162076082|NCT01062555|585335873|FG002|Phase 1|Graft Failure|0|||
162076083|NCT01062555|585335874|FG003|Phase 1|Graft Failure|0|||
162076084|NCT01062555|585335871|FG000|Phase 1|Withdrawal by Subject|1|||
162076085|NCT01062555|585335872|FG001|Phase 1|Withdrawal by Subject|1|||
162076086|NCT01062555|585335873|FG002|Phase 1|Withdrawal by Subject|0|||
162076087|NCT01062555|585335874|FG003|Phase 1|Withdrawal by Subject|0|||
162076088|NCT01062555|585335871|FG000|Phase 2|Death|0|||
162076089|NCT01062555|585335872|FG001|Phase 2|Death|0|||
162076090|NCT01062555|585335873|FG002|Phase 2|Death|8|||
162076091|NCT01062555|585335874|FG003|Phase 2|Death|3|||
162076092|NCT01062555|585335871|FG000|Phase 2|Graft failure|0|||
162076093|NCT01062555|585335872|FG001|Phase 2|Graft failure|0|||
162076094|NCT01062555|585335873|FG002|Phase 2|Graft failure|7|||
162076095|NCT01062555|585335874|FG003|Phase 2|Graft failure|4|||
162076096|NCT01062555|585335871|FG000|Phase 2|Withdrawal by Subject|0|||
162076097|NCT01062555|585335872|FG001|Phase 2|Withdrawal by Subject|0|||
162076098|NCT01062555|585335873|FG002|Phase 2|Withdrawal by Subject|0|||
162076099|NCT01062555|585335874|FG003|Phase 2|Withdrawal by Subject|7|||
162076100|NCT01062555|585335871|FG000|Phase 2|Protocol Violation|0|||
162076101|NCT01062555|585335872|FG001|Phase 2|Protocol Violation|0|||
162076102|NCT01062555|585335873|FG002|Phase 2|Protocol Violation|0|||
162076103|NCT01062555|585335874|FG003|Phase 2|Protocol Violation|3|||
162076104|NCT01062555|585335871|FG000|Phase 2|Physician Decision|0|||
162076105|NCT01062555|585335872|FG001|Phase 2|Physician Decision|0|||
162076106|NCT01062555|585335873|FG002|Phase 2|Physician Decision|0|||
162076107|NCT01062555|585335874|FG003|Phase 2|Physician Decision|17|||
162076108|NCT02818777|585335881|FG000|Overall Study|Adverse Event|3|||
162076109|NCT00747435|585335882|FG000|Overall Study|Lost to Follow-up|2|||
162076110|NCT00747435|585335882|FG000|Overall Study|Withdrawal by Subject|3|||
162076111|NCT00747435|585335882|FG000|Overall Study|Still undergoing follow up|1|||
162076112|NCT01324349|585335883|FG000|Overall Study|Death|1|||
162076113|NCT01324349|585335884|FG001|Overall Study|Death|1|||
162076114|NCT01324349|585335883|FG000|Overall Study|Withdrawal by Subject|0|||
162076115|NCT01324349|585335884|FG001|Overall Study|Withdrawal by Subject|1|||
162076116|NCT02276612|585335885|FG000|Overall Study|Death|1|||
162076117|NCT02276612|585335886|FG001|Overall Study|Death|0|||
162076118|NCT02276612|585335885|FG000|Overall Study|Pregnancy|1|||
162076119|NCT02276612|585335886|FG001|Overall Study|Pregnancy|0|||
162076120|NCT02276612|585335885|FG000|Overall Study|Withdrew Consent|1|||
162076121|NCT02276612|585335886|FG001|Overall Study|Withdrew Consent|0|||
162076122|NCT02276612|585335885|FG000|Overall Study|Lost to Follow-up|1|||
162076123|NCT02276612|585335886|FG001|Overall Study|Lost to Follow-up|0|||
162076124|NCT04439318|585335887|FG000|Overall Study|Ineligible|1|||
162076125|NCT04439318|585335887|FG000|Overall Study|Never Started Treatment|3|||
162076126|NCT04439318|585335887|FG000|Overall Study|Adverse Event|10|||
162076127|NCT04439318|585335887|FG000|Overall Study|Death|2|||
162076128|NCT04439318|585335887|FG000|Overall Study|Disease Progression|25|||
162076129|NCT04439318|585335887|FG000|Overall Study|Other Complicating Disease|2|||
162076130|NCT04439318|585335887|FG000|Overall Study|Withdrawal by Subject|4|||
162076131|NCT04439318|585335887|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
162076132|NCT04439318|585335887|FG000|Overall Study|Non-Compliance|1|||
162076133|NCT04439318|585335887|FG000|Overall Study|Still on Treatment|1|||
162076134|NCT00826267|585337808|FG000|Overall Study|Other Adverse Event|1|||
162076135|NCT00826267|585337809|FG001|Overall Study|Other Adverse Event|0|||
162076136|NCT00826267|585337810|FG002|Overall Study|Other Adverse Event|0|||
162076137|NCT02586493|585337817|FG000|Overall Study|Adverse Event|4|||
162076138|NCT02586493|585337817|FG000|Overall Study|Protocol Violation|6|||
162076139|NCT02586493|585337817|FG000|Overall Study|Lost to Follow-up|1|||
162076140|NCT02586493|585337817|FG000|Overall Study|Withdrawal by Subject|1|||
162076141|NCT01604343|585337825|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
162076142|NCT01604343|585337826|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
162076143|NCT01604343|585337827|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
162076144|NCT01604343|585337828|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
162076145|NCT01604343|585337829|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
162076146|NCT01604343|585337825|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
162076147|NCT01604343|585337826|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
162076148|NCT01604343|585337827|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
162076149|NCT01604343|585337828|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
162076150|NCT01604343|585337829|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
162076151|NCT01604343|585337825|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
162076152|NCT01604343|585337826|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
162076153|NCT01604343|585337827|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
162076154|NCT01604343|585337828|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
162076155|NCT01604343|585337829|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
162076156|NCT01604343|585337825|FG000|Prior to W52 Administration(Through W52)|Death|5|||
162076157|NCT01604343|585337826|FG001|Prior to W52 Administration(Through W52)|Death|0|||
162076158|NCT01604343|585337827|FG002|Prior to W52 Administration(Through W52)|Death|2|||
162076159|NCT01604343|585337828|FG003|Prior to W52 Administration(Through W52)|Death|0|||
162076160|NCT01604343|585337829|FG004|Prior to W52 Administration(Through W52)|Death|4|||
162076161|NCT01604343|585337825|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
162076162|NCT01604343|585337826|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
162076163|NCT01604343|585337827|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
162076164|NCT01604343|585337828|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
162076165|NCT01604343|585337829|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
162076166|NCT01604343|585337825|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
162076167|NCT01604343|585337826|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
162076168|NCT01604343|585337827|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
162076169|NCT01604343|585337828|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
162076170|NCT01604343|585337829|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
162076171|NCT01604343|585337825|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
162076172|NCT01604343|585337826|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
162076173|NCT01604343|585337827|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
162076174|NCT01604343|585337828|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
162076175|NCT01604343|585337829|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
162076176|NCT01604343|585337825|FG000|Prior to W52 Administration(Through W52)|Other|15|||
162076177|NCT01604343|585337826|FG001|Prior to W52 Administration(Through W52)|Other|0|||
162076178|NCT01604343|585337827|FG002|Prior to W52 Administration(Through W52)|Other|10|||
162076179|NCT01604343|585337828|FG003|Prior to W52 Administration(Through W52)|Other|0|||
162076180|NCT01604343|585337829|FG004|Prior to W52 Administration(Through W52)|Other|6|||
162076181|NCT01604343|585337825|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
162076182|NCT01604343|585337826|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
162076183|NCT01604343|585337827|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
162076184|NCT01604343|585337828|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
162076185|NCT01604343|585337829|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
162076186|NCT01604343|585337825|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
162076187|NCT01604343|585337826|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
162076188|NCT01604343|585337827|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
162076189|NCT01604343|585337828|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
162076190|NCT01604343|585337829|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
162076191|NCT01604343|585337825|FG000|Week 52 to Week 104|Adverse Event|0|||
162076192|NCT01604343|585337826|FG001|Week 52 to Week 104|Adverse Event|12|||
162076193|NCT01604343|585337827|FG002|Week 52 to Week 104|Adverse Event|26|||
162076194|NCT01604343|585337828|FG003|Week 52 to Week 104|Adverse Event|21|||
162076195|NCT01604343|585337829|FG004|Week 52 to Week 104|Adverse Event|27|||
162076196|NCT01604343|585337825|FG000|Week 52 to Week 104|Death|0|||
162076197|NCT01604343|585337826|FG001|Week 52 to Week 104|Death|4|||
162076198|NCT01604343|585337827|FG002|Week 52 to Week 104|Death|2|||
162076199|NCT01604343|585337828|FG003|Week 52 to Week 104|Death|5|||
162076200|NCT01604343|585337829|FG004|Week 52 to Week 104|Death|0|||
162076201|NCT01604343|585337825|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
162076202|NCT01604343|585337826|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
162076203|NCT01604343|585337827|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
162076204|NCT01604343|585337828|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
162076205|NCT01604343|585337829|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
162076206|NCT01604343|585337825|FG000|Week 52 to Week 104|Physician Decision|0|||
162076207|NCT01604343|585337826|FG001|Week 52 to Week 104|Physician Decision|1|||
162076208|NCT01604343|585337827|FG002|Week 52 to Week 104|Physician Decision|0|||
162076209|NCT01604343|585337828|FG003|Week 52 to Week 104|Physician Decision|0|||
162076210|NCT01604343|585337829|FG004|Week 52 to Week 104|Physician Decision|2|||
162076211|NCT01604343|585337825|FG000|Week 52 to Week 104|Pregnancy|0|||
162076212|NCT01604343|585337826|FG001|Week 52 to Week 104|Pregnancy|0|||
162076213|NCT01604343|585337827|FG002|Week 52 to Week 104|Pregnancy|1|||
162076214|NCT01604343|585337828|FG003|Week 52 to Week 104|Pregnancy|2|||
162076215|NCT01604343|585337829|FG004|Week 52 to Week 104|Pregnancy|1|||
162076216|NCT01604343|585337825|FG000|Week 52 to Week 104|Other|0|||
162076217|NCT01604343|585337826|FG001|Week 52 to Week 104|Other|11|||
162076218|NCT01604343|585337827|FG002|Week 52 to Week 104|Other|11|||
162076219|NCT01604343|585337828|FG003|Week 52 to Week 104|Other|6|||
162076220|NCT01604343|585337829|FG004|Week 52 to Week 104|Other|3|||
162076221|NCT01604343|585337825|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
162076222|NCT01604343|585337826|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
162076223|NCT01604343|585337827|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
162076224|NCT01604343|585337828|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
162076225|NCT01604343|585337829|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
162076226|NCT01604343|585337825|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
162076227|NCT01604343|585337826|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
162076228|NCT01604343|585337827|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
162076229|NCT01604343|585337828|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
162076230|NCT01604343|585337829|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
162076231|NCT01604343|585337825|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
162076232|NCT01604343|585337826|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
162076233|NCT01604343|585337827|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
162076234|NCT01604343|585337828|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
162076235|NCT01604343|585337829|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
162076236|NCT00436748|585337830|FG000|Overall Study|Ineligibility Determined|1|||
162076237|NCT00436748|585337831|FG001|Overall Study|Ineligibility Determined|1|||
162076238|NCT00436748|585337830|FG000|Overall Study|Adverse Event|0|||
162076239|NCT00436748|585337831|FG001|Overall Study|Adverse Event|2|||
162076240|NCT00436748|585337830|FG000|Overall Study|Consent Withdrawn|1|||
162076241|NCT00436748|585337831|FG001|Overall Study|Consent Withdrawn|4|||
162076242|NCT00436748|585337830|FG000|Overall Study|Administrative Decision|1|||
162076243|NCT00436748|585337831|FG001|Overall Study|Administrative Decision|0|||
162076244|NCT00436748|585337830|FG000|Overall Study|Lost to Follow-up|0|||
162076245|NCT00436748|585337831|FG001|Overall Study|Lost to Follow-up|1|||
162076246|NCT00436748|585337830|FG000|Overall Study|Protocol-specified Criteria|5|||
162076247|NCT00436748|585337831|FG001|Overall Study|Protocol-specified Criteria|4|||
162076248|NCT00436748|585337830|FG000|Overall Study|Other|3|||
162076249|NCT00436748|585337831|FG001|Overall Study|Other|0|||
162076250|NCT00850200|585337832|FG000|Overall Study|Physician Decision|2|||
162076251|NCT00850200|585337832|FG000|Overall Study|Did not recieve treatment|2|||
162076252|NCT00850200|585337832|FG000|Overall Study|Withdrawal by Subject|1|||
162076253|NCT02711800|585337833|FG000|Overall Study|Lost to Follow-up|1|||
162076254|NCT02711800|585337833|FG000|Overall Study|Withdrawal by Subject|1|||
162076255|NCT05442554|585337835|FG000|Overall Study|Adverse Event|1|||
162076256|NCT01990495|585337843|FG000|Overall Study|Physician Decision|5|||
162076257|NCT01990495|585337844|FG001|Overall Study|Physician Decision|4|||
162076258|NCT00097721|585337845|FG000|Overall Study|Adverse Event|8|||
162076259|NCT00097721|585337846|FG001|Overall Study|Adverse Event|1|||
162076260|NCT00097721|585337845|FG000|Overall Study|Withdrawal by Subject|6|||
162076261|NCT00097721|585337846|FG001|Overall Study|Withdrawal by Subject|1|||
162076262|NCT00097721|585337845|FG000|Overall Study|Progressive Disease|55|||
162076263|NCT00097721|585337846|FG001|Overall Study|Progressive Disease|27|||
162076264|NCT00097721|585337845|FG000|Overall Study|Physician Decision|1|||
162076265|NCT00097721|585337846|FG001|Overall Study|Physician Decision|3|||
162076266|NCT00097721|585337845|FG000|Overall Study|Reason not given|1|||
162076267|NCT00097721|585337846|FG001|Overall Study|Reason not given|1|||
162076268|NCT02972632|585337852|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
162076269|NCT02972632|585337852|FG000|Overall Study|Lost to Follow-up|4|||
162076270|NCT02972632|585337852|FG000|Overall Study|Voluntary Withdrawal|10|||
162076271|NCT02126969|585337853|FG000|Overall Study|Withdrawal by Subject|1|||
162076272|NCT02126969|585337854|FG001|Overall Study|Withdrawal by Subject|2|||
162076273|NCT00354172|585337855|FG000|Overall Study|Did not receive transplant|1|||
162076274|NCT01828034|585337856|FG000|Overall Study|Withdrawal by Subject|0|||
162076275|NCT01828034|585337857|FG001|Overall Study|Withdrawal by Subject|0|||
162076276|NCT01828034|585337858|FG002|Overall Study|Withdrawal by Subject|0|||
162076277|NCT01828034|585337859|FG003|Overall Study|Withdrawal by Subject|1|||
162076278|NCT02023151|585337860|FG000|Overall Study|Lost to Follow-up|4|||
162076279|NCT03450707|585337861|FG000|Overall Study|Outside enrollment window|4|||
162076280|NCT03450707|585337862|FG001|Overall Study|Outside enrollment window|1|||
162076281|NCT03450707|585337861|FG000|Overall Study|Death|1|||
162076282|NCT03450707|585337862|FG001|Overall Study|Death|0|||
162076283|NCT03450707|585337861|FG000|Overall Study|Indication for thiamine|1|||
162076284|NCT03450707|585337862|FG001|Overall Study|Indication for thiamine|1|||
162076285|NCT03450707|585337861|FG000|Overall Study|Evidence of traumatic brain injury|1|||
162076286|NCT03450707|585337862|FG001|Overall Study|Evidence of traumatic brain injury|0|||
162076287|NCT03450707|585337861|FG000|Overall Study|Following commands|0|||
162076288|NCT03450707|585337862|FG001|Overall Study|Following commands|3|||
162076289|NCT03450707|585337861|FG000|Overall Study|Lactate < 3.5|0|||
162076290|NCT03450707|585337862|FG001|Overall Study|Lactate < 3.5|2|||
162076291|NCT03450707|585337861|FG000|Overall Study|Rearrest with ECMO|0|||
162076292|NCT03450707|585337862|FG001|Overall Study|Rearrest with ECMO|1|||
162076293|NCT03450707|585337861|FG000|Overall Study|Indication for thiamine + head CT results|0|||
162076294|NCT03450707|585337862|FG001|Overall Study|Indication for thiamine + head CT results|1|||
162076295|NCT03450707|585337861|FG000|Overall Study|Family/patient goals of care|0|||
162076296|NCT03450707|585337862|FG001|Overall Study|Family/patient goals of care|1|||
162076297|NCT02871375|585337863|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
162076298|NCT02871375|585337864|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
162076299|NCT00004412|585337867|FG000|Randomized Period|Moved to Crossover Period|3|||
162076300|NCT00004412|585337868|FG001|Randomized Period|Moved to Crossover Period|0|||
162076301|NCT00004412|585337869|FG002|Randomized Period|Moved to Crossover Period|0|||
162076302|NCT00337103|585337870|FG000|Overall Study|Progressive Disease|414|||
162076303|NCT00337103|585337871|FG001|Overall Study|Progressive Disease|410|||
162076304|NCT00337103|585337870|FG000|Overall Study|Adverse Event|45|||
162076305|NCT00337103|585337871|FG001|Overall Study|Adverse Event|59|||
162076306|NCT00337103|585337870|FG000|Overall Study|Subject Choice|34|||
162076307|NCT00337103|585337871|FG001|Overall Study|Subject Choice|27|||
162076308|NCT00337103|585337870|FG000|Overall Study|Clinical Progression|27|||
162076309|NCT00337103|585337871|FG001|Overall Study|Clinical Progression|24|||
162076310|NCT00337103|585337870|FG000|Overall Study|Physician Decision|15|||
162076311|NCT00337103|585337871|FG001|Overall Study|Physician Decision|14|||
162076312|NCT00337103|585337870|FG000|Overall Study|Withdrawal by Subject|8|||
162076313|NCT00337103|585337871|FG001|Overall Study|Withdrawal by Subject|5|||
162076314|NCT00337103|585337870|FG000|Overall Study|Other|5|||
162076315|NCT00337103|585337871|FG001|Overall Study|Other|6|||
162076316|NCT00337103|585337870|FG000|Overall Study|Entry Criteria Not Met|4|||
162076317|NCT00337103|585337871|FG001|Overall Study|Entry Criteria Not Met|1|||
162076318|NCT00337103|585337870|FG000|Overall Study|Lost to Follow-up|1|||
162076319|NCT00337103|585337871|FG001|Overall Study|Lost to Follow-up|2|||
162076320|NCT00337103|585337870|FG000|Overall Study|Death|1|||
162076321|NCT00337103|585337871|FG001|Overall Study|Death|0|||
162076322|NCT00149747|585337886|FG000|Overall Study|Death|1|||
162076323|NCT00149747|585337887|FG001|Overall Study|Death|0|||
162076324|NCT00149747|585337886|FG000|Overall Study|Withdrawal by Subject|3|||
162076325|NCT00149747|585337887|FG001|Overall Study|Withdrawal by Subject|3|||
162076326|NCT03373383|585337888|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
162076327|NCT03373383|585337889|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
162076328|NCT03373383|585337890|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
162076329|NCT03373383|585337891|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
162076330|NCT03373383|585337892|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
162076331|NCT03373383|585337888|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
162076332|NCT03373383|585337889|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
162076333|NCT03373383|585337890|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
162076334|NCT03373383|585337891|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
162076335|NCT03373383|585337892|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
162076336|NCT03373383|585337888|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
162076337|NCT03373383|585337889|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
162076338|NCT03373383|585337890|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
162076339|NCT03373383|585337891|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
162076340|NCT03373383|585337892|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
162076341|NCT03373383|585337888|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
162076342|NCT03373383|585337889|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
162076343|NCT03373383|585337890|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
162076344|NCT03373383|585337891|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
162076345|NCT03373383|585337892|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
162076346|NCT03373383|585337888|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
162076347|NCT03373383|585337889|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
162076348|NCT03373383|585337890|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
162076349|NCT03373383|585337891|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
162076350|NCT03373383|585337892|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
162076351|NCT03373383|585337888|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
162076352|NCT03373383|585337889|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
162076353|NCT03373383|585337890|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
162076354|NCT03373383|585337891|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
162076355|NCT03373383|585337892|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
162076356|NCT03373383|585337888|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
162076357|NCT03373383|585337889|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
162076358|NCT03373383|585337890|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
162076359|NCT03373383|585337891|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
162076360|NCT03373383|585337892|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
162076361|NCT03373383|585337888|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
162076362|NCT03373383|585337889|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
162076363|NCT03373383|585337890|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
162076364|NCT03373383|585337891|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
162076365|NCT03373383|585337892|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
162076366|NCT03373383|585337888|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
162076367|NCT03373383|585337889|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
162076368|NCT03373383|585337890|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
162076369|NCT03373383|585337891|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
162076370|NCT03373383|585337892|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
162076371|NCT02689258|585337893|FG000|Overall Study|Subject Non-Compliance|0|||
162076372|NCT02689258|585337894|FG001|Overall Study|Subject Non-Compliance|1|||
162076373|NCT02689258|585337895|FG002|Overall Study|Subject Non-Compliance|0|||
162076374|NCT02689258|585337896|FG003|Overall Study|Subject Non-Compliance|0|||
162076375|NCT02689258|585337897|FG004|Overall Study|Subject Non-Compliance|0|||
162076376|NCT02689258|585337898|FG005|Overall Study|Subject Non-Compliance|0|||
162076377|NCT02689258|585337899|FG006|Overall Study|Subject Non-Compliance|0|||
162076378|NCT02689258|585337900|FG007|Overall Study|Subject Non-Compliance|0|||
162076379|NCT02689258|585337901|FG008|Overall Study|Subject Non-Compliance|0|||
162076380|NCT02689258|585337902|FG009|Overall Study|Subject Non-Compliance|0|||
162076381|NCT02689258|585337903|FG010|Overall Study|Subject Non-Compliance|0|||
162076382|NCT02689258|585337904|FG011|Overall Study|Subject Non-Compliance|0|||
162076383|NCT02689258|585337893|FG000|Overall Study|Subject Refusal to Continue|0|||
162076384|NCT02689258|585337894|FG001|Overall Study|Subject Refusal to Continue|1|||
162076385|NCT02689258|585337895|FG002|Overall Study|Subject Refusal to Continue|0|||
162076386|NCT02689258|585337896|FG003|Overall Study|Subject Refusal to Continue|0|||
162076387|NCT02689258|585337897|FG004|Overall Study|Subject Refusal to Continue|0|||
162076388|NCT02689258|585337898|FG005|Overall Study|Subject Refusal to Continue|0|||
162076389|NCT02689258|585337899|FG006|Overall Study|Subject Refusal to Continue|0|||
162076390|NCT02689258|585337900|FG007|Overall Study|Subject Refusal to Continue|0|||
162076391|NCT02689258|585337901|FG008|Overall Study|Subject Refusal to Continue|1|||
162076392|NCT02689258|585337902|FG009|Overall Study|Subject Refusal to Continue|0|||
162076393|NCT02689258|585337903|FG010|Overall Study|Subject Refusal to Continue|0|||
162076394|NCT02689258|585337904|FG011|Overall Study|Subject Refusal to Continue|1|||
162076395|NCT02689258|585337893|FG000|Overall Study|Other|0|||
162076396|NCT02689258|585337894|FG001|Overall Study|Other|2|||
162076397|NCT02689258|585337895|FG002|Overall Study|Other|0|||
162076398|NCT02689258|585337896|FG003|Overall Study|Other|0|||
162076399|NCT02689258|585337897|FG004|Overall Study|Other|1|||
162076400|NCT02689258|585337898|FG005|Overall Study|Other|0|||
162076401|NCT02689258|585337899|FG006|Overall Study|Other|0|||
162076402|NCT02689258|585337900|FG007|Overall Study|Other|0|||
162076403|NCT02689258|585337901|FG008|Overall Study|Other|1|||
162076404|NCT02689258|585337902|FG009|Overall Study|Other|0|||
162076405|NCT02689258|585337903|FG010|Overall Study|Other|0|||
162076406|NCT02689258|585337904|FG011|Overall Study|Other|0|||
162076407|NCT00594464|585337906|FG000|Overall Study|Withdrawal by Subject|1|||
162076408|NCT00594464|585337906|FG000|Overall Study|Delay in operation|2|||
162076409|NCT00785486|585337907|FG000|Midazolam Alone|Withdrawal by Subject|1|||
162076410|NCT02907359|585337914|FG000|Overall Study|Death|234|||
162076411|NCT02907359|585337915|FG001|Overall Study|Death|117|||
162076412|NCT02907359|585337914|FG000|Overall Study|Withdrawal by Subject|6|||
162076413|NCT02907359|585337915|FG001|Overall Study|Withdrawal by Subject|11|||
162076414|NCT02907359|585337914|FG000|Overall Study|Lost to Follow-up|1|||
162076415|NCT02907359|585337915|FG001|Overall Study|Lost to Follow-up|0|||
162076416|NCT03131440|585337916|FG000|Overall Study|Withdrawal by Subject|1|||
162076417|NCT03131440|585337917|FG001|Overall Study|Withdrawal by Subject|3|||
162076418|NCT03131440|585337918|FG002|Overall Study|Withdrawal by Subject|0|||
162076419|NCT03131440|585337919|FG003|Overall Study|Withdrawal by Subject|0|||
162076420|NCT03131440|585337920|FG004|Overall Study|Withdrawal by Subject|1|||
162076421|NCT03131440|585337921|FG005|Overall Study|Withdrawal by Subject|0|||
162076422|NCT03131440|585337922|FG006|Overall Study|Withdrawal by Subject|0|||
162076423|NCT03131440|585337923|FG007|Overall Study|Withdrawal by Subject|1|||
162076424|NCT03131440|585337924|FG008|Overall Study|Withdrawal by Subject|1|||
162076425|NCT03131440|585337925|FG009|Overall Study|Withdrawal by Subject|1|||
162076426|NCT03131440|585337926|FG010|Overall Study|Withdrawal by Subject|0|||
162076427|NCT03131440|585337927|FG011|Overall Study|Withdrawal by Subject|1|||
162076428|NCT03131440|585337928|FG012|Overall Study|Withdrawal by Subject|1|||
162076429|NCT03131440|585337929|FG013|Overall Study|Withdrawal by Subject|0|||
162076430|NCT03131440|585337930|FG014|Overall Study|Withdrawal by Subject|1|||
162076431|NCT03131440|585337931|FG015|Overall Study|Withdrawal by Subject|0|||
162076432|NCT03131440|585337932|FG016|Overall Study|Withdrawal by Subject|0|||
162076433|NCT03131440|585337933|FG017|Overall Study|Withdrawal by Subject|0|||
162076434|NCT03131440|585337934|FG018|Overall Study|Withdrawal by Subject|1|||
162076435|NCT03131440|585337935|FG019|Overall Study|Withdrawal by Subject|0|||
162076436|NCT03131440|585337936|FG020|Overall Study|Withdrawal by Subject|1|||
162076437|NCT03131440|585337937|FG021|Overall Study|Withdrawal by Subject|1|||
162076438|NCT03131440|585337938|FG022|Overall Study|Withdrawal by Subject|1|||
162076439|NCT03131440|585337939|FG023|Overall Study|Withdrawal by Subject|0|||
162076440|NCT03131440|585337940|FG024|Overall Study|Withdrawal by Subject|0|||
162076441|NCT03131440|585337941|FG025|Overall Study|Withdrawal by Subject|0|||
162076442|NCT03131440|585337942|FG026|Overall Study|Withdrawal by Subject|0|||
162076443|NCT03131440|585337943|FG027|Overall Study|Withdrawal by Subject|0|||
162076444|NCT03131440|585337944|FG028|Overall Study|Withdrawal by Subject|0|||
162076445|NCT03131440|585337945|FG029|Overall Study|Withdrawal by Subject|0|||
162076446|NCT03131440|585337946|FG030|Overall Study|Withdrawal by Subject|1|||
162076447|NCT03131440|585337947|FG031|Overall Study|Withdrawal by Subject|0|||
162076448|NCT03131440|585337916|FG000|Overall Study|Lost to Follow-up|0|||
162076449|NCT03131440|585337917|FG001|Overall Study|Lost to Follow-up|0|||
162076450|NCT03131440|585337918|FG002|Overall Study|Lost to Follow-up|0|||
162076451|NCT03131440|585337919|FG003|Overall Study|Lost to Follow-up|0|||
162076452|NCT03131440|585337920|FG004|Overall Study|Lost to Follow-up|0|||
162076453|NCT03131440|585337921|FG005|Overall Study|Lost to Follow-up|1|||
162076454|NCT03131440|585337922|FG006|Overall Study|Lost to Follow-up|0|||
162076455|NCT03131440|585337923|FG007|Overall Study|Lost to Follow-up|0|||
162076456|NCT03131440|585337924|FG008|Overall Study|Lost to Follow-up|0|||
162076457|NCT03131440|585337925|FG009|Overall Study|Lost to Follow-up|0|||
162076458|NCT03131440|585337926|FG010|Overall Study|Lost to Follow-up|0|||
162076459|NCT03131440|585337927|FG011|Overall Study|Lost to Follow-up|0|||
162076460|NCT03131440|585337928|FG012|Overall Study|Lost to Follow-up|0|||
162076461|NCT03131440|585337929|FG013|Overall Study|Lost to Follow-up|0|||
162076462|NCT03131440|585337930|FG014|Overall Study|Lost to Follow-up|0|||
162076463|NCT03131440|585337931|FG015|Overall Study|Lost to Follow-up|0|||
162076464|NCT03131440|585337932|FG016|Overall Study|Lost to Follow-up|0|||
162076465|NCT03131440|585337933|FG017|Overall Study|Lost to Follow-up|0|||
162076466|NCT03131440|585337934|FG018|Overall Study|Lost to Follow-up|0|||
162076467|NCT03131440|585337935|FG019|Overall Study|Lost to Follow-up|2|||
162076468|NCT03131440|585337936|FG020|Overall Study|Lost to Follow-up|1|||
162076469|NCT03131440|585337937|FG021|Overall Study|Lost to Follow-up|0|||
162076470|NCT03131440|585337938|FG022|Overall Study|Lost to Follow-up|1|||
162076471|NCT03131440|585337939|FG023|Overall Study|Lost to Follow-up|0|||
162076472|NCT03131440|585337940|FG024|Overall Study|Lost to Follow-up|1|||
162076473|NCT03131440|585337941|FG025|Overall Study|Lost to Follow-up|0|||
162076474|NCT03131440|585337942|FG026|Overall Study|Lost to Follow-up|0|||
162076475|NCT03131440|585337943|FG027|Overall Study|Lost to Follow-up|2|||
162076476|NCT03131440|585337944|FG028|Overall Study|Lost to Follow-up|0|||
162076477|NCT03131440|585337945|FG029|Overall Study|Lost to Follow-up|2|||
162076478|NCT03131440|585337946|FG030|Overall Study|Lost to Follow-up|0|||
162076479|NCT03131440|585337947|FG031|Overall Study|Lost to Follow-up|0|||
162076480|NCT03131440|585337916|FG000|Overall Study|Death|0|||
162076481|NCT03131440|585337917|FG001|Overall Study|Death|0|||
162076482|NCT03131440|585337918|FG002|Overall Study|Death|0|||
162076483|NCT03131440|585337919|FG003|Overall Study|Death|0|||
162076484|NCT03131440|585337920|FG004|Overall Study|Death|0|||
162076485|NCT03131440|585337921|FG005|Overall Study|Death|0|||
162076486|NCT03131440|585337922|FG006|Overall Study|Death|0|||
162076487|NCT03131440|585337923|FG007|Overall Study|Death|0|||
162076488|NCT03131440|585337924|FG008|Overall Study|Death|0|||
162076489|NCT03131440|585337925|FG009|Overall Study|Death|0|||
162076490|NCT03131440|585337926|FG010|Overall Study|Death|0|||
162076491|NCT03131440|585337927|FG011|Overall Study|Death|0|||
162076492|NCT03131440|585337928|FG012|Overall Study|Death|0|||
162076493|NCT03131440|585337929|FG013|Overall Study|Death|0|||
162076494|NCT03131440|585337930|FG014|Overall Study|Death|0|||
162076495|NCT03131440|585337931|FG015|Overall Study|Death|0|||
162076496|NCT03131440|585337932|FG016|Overall Study|Death|0|||
162076497|NCT03131440|585337933|FG017|Overall Study|Death|0|||
162076498|NCT03131440|585337934|FG018|Overall Study|Death|0|||
162076499|NCT03131440|585337935|FG019|Overall Study|Death|0|||
162076500|NCT03131440|585337936|FG020|Overall Study|Death|0|||
162076501|NCT03131440|585337937|FG021|Overall Study|Death|0|||
162076502|NCT03131440|585337938|FG022|Overall Study|Death|0|||
162076503|NCT03131440|585337939|FG023|Overall Study|Death|0|||
162076504|NCT03131440|585337940|FG024|Overall Study|Death|0|||
162076505|NCT03131440|585337941|FG025|Overall Study|Death|1|||
162076506|NCT03131440|585337942|FG026|Overall Study|Death|0|||
162076507|NCT03131440|585337943|FG027|Overall Study|Death|0|||
162076508|NCT03131440|585337944|FG028|Overall Study|Death|0|||
162076509|NCT03131440|585337945|FG029|Overall Study|Death|0|||
162076510|NCT03131440|585337946|FG030|Overall Study|Death|0|||
162076511|NCT03131440|585337947|FG031|Overall Study|Death|0|||
162076512|NCT00746941|585337950|FG000|Overall Study|Death|2|||
162076513|NCT00746941|585337951|FG001|Overall Study|Death|0|||
162076514|NCT00746941|585337952|FG002|Overall Study|Death|0|||
162076515|NCT00746941|585337953|FG003|Overall Study|Death|6|||
162076516|NCT00746941|585337950|FG000|Overall Study|Physician Decision|0|||
162076517|NCT00746941|585337951|FG001|Overall Study|Physician Decision|0|||
162076518|NCT00746941|585337952|FG002|Overall Study|Physician Decision|2|||
162076519|NCT00746941|585337953|FG003|Overall Study|Physician Decision|0|||
162076520|NCT00746941|585337950|FG000|Overall Study|Withdrawal by Subject|3|||
162076521|NCT00746941|585337951|FG001|Overall Study|Withdrawal by Subject|0|||
162076522|NCT00746941|585337952|FG002|Overall Study|Withdrawal by Subject|0|||
162076523|NCT00746941|585337953|FG003|Overall Study|Withdrawal by Subject|2|||
162076524|NCT00746941|585337950|FG000|Overall Study|Other, reason not provided|2|||
162076525|NCT00746941|585337951|FG001|Overall Study|Other, reason not provided|4|||
162076526|NCT00746941|585337952|FG002|Overall Study|Other, reason not provided|0|||
162076527|NCT00746941|585337953|FG003|Overall Study|Other, reason not provided|4|||
162076528|NCT00746941|585337950|FG000|Overall Study|Adverse Event|0|||
162076529|NCT00746941|585337951|FG001|Overall Study|Adverse Event|0|||
162076530|NCT00746941|585337952|FG002|Overall Study|Adverse Event|0|||
162076531|NCT00746941|585337953|FG003|Overall Study|Adverse Event|1|||
162076532|NCT01354496|585337961|FG000|Period 1|Adverse Event|0|||
162076533|NCT01354496|585337962|FG001|Period 1|Adverse Event|0|||
162076534|NCT01354496|585337963|FG002|Period 1|Adverse Event|1|||
162076535|NCT01354496|585337964|FG003|Period 1|Adverse Event|0|||
162076536|NCT01354496|585337965|FG004|Period 1|Adverse Event|0|||
162076537|NCT01354496|585337966|FG005|Period 1|Adverse Event|0|||
162076538|NCT01354496|585337961|FG000|Period 1|Physician Decision|0|||
162076539|NCT01354496|585337962|FG001|Period 1|Physician Decision|0|||
162076540|NCT01354496|585337963|FG002|Period 1|Physician Decision|1|||
162076541|NCT01354496|585337964|FG003|Period 1|Physician Decision|0|||
162076542|NCT01354496|585337965|FG004|Period 1|Physician Decision|0|||
162076543|NCT01354496|585337966|FG005|Period 1|Physician Decision|0|||
162076544|NCT01354496|585337961|FG000|Period 2|Adverse Event|0|||
162076545|NCT01354496|585337962|FG001|Period 2|Adverse Event|0|||
162076546|NCT01354496|585337963|FG002|Period 2|Adverse Event|0|||
162076547|NCT01354496|585337964|FG003|Period 2|Adverse Event|1|||
162076548|NCT01354496|585337965|FG004|Period 2|Adverse Event|0|||
162076549|NCT01354496|585337966|FG005|Period 2|Adverse Event|0|||
162076550|NCT01354496|585337961|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
162076551|NCT01354496|585337962|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
162076552|NCT01354496|585337963|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
162076553|NCT01354496|585337964|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
162076554|NCT01354496|585337965|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
162076555|NCT01354496|585337966|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
162076556|NCT00500292|585337968|FG000|Overall Study|Adverse Event|3|||
162076557|NCT00500292|585337969|FG001|Overall Study|Adverse Event|6|||
162076558|NCT00500292|585337970|FG002|Overall Study|Adverse Event|4|||
162076559|NCT00500292|585337968|FG000|Overall Study|Condition under investigation worsened|21|||
162076560|NCT00500292|585337969|FG001|Overall Study|Condition under investigation worsened|23|||
162076561|NCT00500292|585337970|FG002|Overall Study|Condition under investigation worsened|19|||
162076562|NCT00500292|585337968|FG000|Overall Study|Withdrawal by Subject|0|||
162076563|NCT00500292|585337969|FG001|Overall Study|Withdrawal by Subject|1|||
162076564|NCT00500292|585337970|FG002|Overall Study|Withdrawal by Subject|0|||
162076565|NCT00500292|585337968|FG000|Overall Study|Other|1|||
162076566|NCT00500292|585337969|FG001|Overall Study|Other|1|||
162076567|NCT00500292|585337970|FG002|Overall Study|Other|4|||
162076568|NCT02741700|585337971|FG000|Overall Study|Lost to Follow-up|17|||
162076569|NCT02741700|585337972|FG001|Overall Study|Lost to Follow-up|8|||
162076570|NCT02741700|585337971|FG000|Overall Study|Withdrawal by Subject|2|||
162076571|NCT02741700|585337972|FG001|Overall Study|Withdrawal by Subject|5|||
162076572|NCT02741700|585337971|FG000|Overall Study|Physician Decision|3|||
162076573|NCT02741700|585337972|FG001|Overall Study|Physician Decision|0|||
162076574|NCT02741700|585337971|FG000|Overall Study|Moved out of State|0|||
162076575|NCT02741700|585337972|FG001|Overall Study|Moved out of State|1|||
162076576|NCT02741700|585337971|FG000|Overall Study|Death|4|||
162076577|NCT02741700|585337972|FG001|Overall Study|Death|5|||
162076578|NCT00075582|585337973|FG000|Overall Study|Adverse Event|3|||
162076579|NCT00075582|585337974|FG001|Overall Study|Adverse Event|1|||
162076580|NCT00075582|585337973|FG000|Overall Study|Lack of Efficacy|4|||
162076581|NCT00075582|585337974|FG001|Overall Study|Lack of Efficacy|8|||
162076582|NCT00075582|585337973|FG000|Overall Study|Physician Decision|5|||
162076583|NCT00075582|585337974|FG001|Overall Study|Physician Decision|8|||
162076584|NCT00075582|585337973|FG000|Overall Study|Withdrawal by Subject|2|||
162076585|NCT00075582|585337974|FG001|Overall Study|Withdrawal by Subject|2|||
162076586|NCT00075582|585337973|FG000|Overall Study|Ineligible for study|36|||
162076587|NCT00075582|585337974|FG001|Overall Study|Ineligible for study|16|||
162076588|NCT02385084|585337975|FG000|Period 2|Protocol Violation|0|||
162076589|NCT02385084|585337976|FG001|Period 2|Protocol Violation|0|||
162076590|NCT02385084|585337977|FG002|Period 2|Protocol Violation|1|||
162076591|NCT02385084|585337978|FG003|Period 2|Protocol Violation|0|||
162076592|NCT02385084|585337979|FG004|Period 2|Protocol Violation|0|||
162076593|NCT02385084|585337980|FG005|Period 2|Protocol Violation|0|||
162076594|NCT05045144|585337981|FG000|Overall Study|Lost to Follow-up|3|||
162076595|NCT05045144|585337982|FG001|Overall Study|Lost to Follow-up|2|||
162076596|NCT05045144|585337983|FG002|Overall Study|Lost to Follow-up|3|||
162076597|NCT05045144|585337984|FG003|Overall Study|Lost to Follow-up|5|||
162076598|NCT05045144|585337985|FG004|Overall Study|Lost to Follow-up|13|||
162076599|NCT05045144|585337981|FG000|Overall Study|Withdrawal by Subject|0|||
162076600|NCT05045144|585337982|FG001|Overall Study|Withdrawal by Subject|1|||
162076601|NCT05045144|585337983|FG002|Overall Study|Withdrawal by Subject|0|||
162076602|NCT05045144|585337984|FG003|Overall Study|Withdrawal by Subject|0|||
162076603|NCT05045144|585337985|FG004|Overall Study|Withdrawal by Subject|0|||
162076604|NCT05045144|585337981|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162076605|NCT05045144|585337982|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162076606|NCT05045144|585337983|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162076607|NCT05045144|585337984|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162076608|NCT05045144|585337985|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
162076609|NCT00744627|585337986|FG000|Overall Study|Adverse Event|6|||
162076610|NCT00744627|585337987|FG001|Overall Study|Adverse Event|9|||
162076611|NCT00744627|585337986|FG000|Overall Study|Lack of Efficacy|7|||
162076612|NCT00744627|585337987|FG001|Overall Study|Lack of Efficacy|3|||
162076613|NCT00744627|585337986|FG000|Overall Study|Noncompliance|0|||
162076614|NCT00744627|585337987|FG001|Overall Study|Noncompliance|1|||
162076615|NCT00744627|585337986|FG000|Overall Study|Protocol Deviations|0|||
162076616|NCT00744627|585337987|FG001|Overall Study|Protocol Deviations|2|||
162076617|NCT00744627|585337986|FG000|Overall Study|Voluntary Withdrawal|9|||
162076618|NCT00744627|585337987|FG001|Overall Study|Voluntary Withdrawal|6|||
162076619|NCT00744627|585337986|FG000|Overall Study|Lost to Follow-up|2|||
162076620|NCT00744627|585337987|FG001|Overall Study|Lost to Follow-up|1|||
162076621|NCT00744627|585337986|FG000|Overall Study|Other|1|||
162076622|NCT00744627|585337987|FG001|Overall Study|Other|0|||
162076623|NCT02268786|585337988|FG000|Overall Study|No Euploid Embryos available|42|||
162076624|NCT02268786|585337989|FG001|Overall Study|No Euploid Embryos available|0|||
162076625|NCT02268786|585337988|FG000|Overall Study|Withdrawal by Subject|7|||
162076626|NCT02268786|585337989|FG001|Overall Study|Withdrawal by Subject|14|||
162076627|NCT02268786|585337988|FG000|Overall Study|Thaw Failure|6|||
162076628|NCT02268786|585337989|FG001|Overall Study|Thaw Failure|4|||
162076629|NCT02268786|585337988|FG000|Overall Study|Protocol Violation|1|||
162076630|NCT02268786|585337989|FG001|Overall Study|Protocol Violation|0|||
162076631|NCT04809220|585337992|FG000|Overall Study|Adverse Event|4|||
162076632|NCT04809220|585337993|FG001|Overall Study|Adverse Event|0|||
162076633|NCT04809220|585337992|FG000|Overall Study|Death|1|||
162076634|NCT04809220|585337993|FG001|Overall Study|Death|0|||
162076635|NCT04809220|585337992|FG000|Overall Study|Lost to Follow-up|3|||
162076636|NCT04809220|585337993|FG001|Overall Study|Lost to Follow-up|0|||
162076637|NCT04809220|585337992|FG000|Overall Study|Physician Decision|0|||
162076638|NCT04809220|585337993|FG001|Overall Study|Physician Decision|1|||
162076639|NCT04809220|585337992|FG000|Overall Study|Withdrawal by Subject|9|||
162076640|NCT04809220|585337993|FG001|Overall Study|Withdrawal by Subject|5|||
162076641|NCT04809220|585337992|FG000|Overall Study|Due to long-term overseas business trips|1|||
162076642|NCT04809220|585337993|FG001|Overall Study|Due to long-term overseas business trips|0|||
162076643|NCT03560531|585337998|FG000|Overall Study|Death|4|||
162076644|NCT03560531|585337999|FG001|Overall Study|Death|1|||
162076645|NCT03560531|585338000|FG002|Overall Study|Death|1|||
162076646|NCT03560531|585338001|FG003|Overall Study|Death|2|||
162076647|NCT03560531|585338002|FG004|Overall Study|Death|6|||
162076648|NCT03560531|585338003|FG005|Overall Study|Death|1|||
162076649|NCT03560531|585338004|FG006|Overall Study|Death|4|||
162076650|NCT03560531|585338005|FG007|Overall Study|Death|8|||
162076651|NCT03560531|585338006|FG008|Overall Study|Death|1|||
162076652|NCT03560531|585338007|FG009|Overall Study|Death|3|||
162076653|NCT03560531|585338008|FG010|Overall Study|Death|2|||
162076654|NCT03560531|585338009|FG011|Overall Study|Death|0|||
162076655|NCT03560531|585338010|FG012|Overall Study|Death|4|||
162076656|NCT03560531|585338011|FG013|Overall Study|Death|1|||
162076657|NCT03560531|585337998|FG000|Overall Study|Lost to Follow-up|1|||
162076658|NCT03560531|585337999|FG001|Overall Study|Lost to Follow-up|1|||
162076659|NCT03560531|585338000|FG002|Overall Study|Lost to Follow-up|0|||
162076660|NCT03560531|585338001|FG003|Overall Study|Lost to Follow-up|0|||
162076661|NCT03560531|585338002|FG004|Overall Study|Lost to Follow-up|0|||
162076662|NCT03560531|585338003|FG005|Overall Study|Lost to Follow-up|0|||
162076663|NCT03560531|585338004|FG006|Overall Study|Lost to Follow-up|1|||
162076664|NCT03560531|585338005|FG007|Overall Study|Lost to Follow-up|0|||
162076665|NCT03560531|585338006|FG008|Overall Study|Lost to Follow-up|0|||
162076666|NCT03560531|585338007|FG009|Overall Study|Lost to Follow-up|0|||
162076667|NCT03560531|585338008|FG010|Overall Study|Lost to Follow-up|0|||
162076668|NCT03560531|585338009|FG011|Overall Study|Lost to Follow-up|0|||
162076669|NCT03560531|585338010|FG012|Overall Study|Lost to Follow-up|0|||
162076670|NCT03560531|585338011|FG013|Overall Study|Lost to Follow-up|0|||
162076671|NCT03560531|585337998|FG000|Overall Study|Withdrawal by Subject|1|||
162076672|NCT03560531|585337999|FG001|Overall Study|Withdrawal by Subject|0|||
162076673|NCT03560531|585338000|FG002|Overall Study|Withdrawal by Subject|0|||
162076674|NCT03560531|585338001|FG003|Overall Study|Withdrawal by Subject|0|||
162076675|NCT03560531|585338002|FG004|Overall Study|Withdrawal by Subject|0|||
162076676|NCT03560531|585338003|FG005|Overall Study|Withdrawal by Subject|0|||
162076677|NCT03560531|585338004|FG006|Overall Study|Withdrawal by Subject|0|||
162076678|NCT03560531|585338005|FG007|Overall Study|Withdrawal by Subject|3|||
162076679|NCT03560531|585338006|FG008|Overall Study|Withdrawal by Subject|2|||
162076680|NCT03560531|585338007|FG009|Overall Study|Withdrawal by Subject|0|||
162076681|NCT03560531|585338008|FG010|Overall Study|Withdrawal by Subject|0|||
162076682|NCT03560531|585338009|FG011|Overall Study|Withdrawal by Subject|0|||
162076683|NCT03560531|585338010|FG012|Overall Study|Withdrawal by Subject|2|||
162076684|NCT03560531|585338011|FG013|Overall Study|Withdrawal by Subject|0|||
162076685|NCT03560531|585337998|FG000|Overall Study|Study end per-protocol|1|||
162076686|NCT03560531|585337999|FG001|Overall Study|Study end per-protocol|1|||
162076687|NCT03560531|585338000|FG002|Overall Study|Study end per-protocol|2|||
162076688|NCT03560531|585338001|FG003|Overall Study|Study end per-protocol|0|||
162076689|NCT03560531|585338002|FG004|Overall Study|Study end per-protocol|1|||
162076690|NCT03560531|585338003|FG005|Overall Study|Study end per-protocol|0|||
162076691|NCT03560531|585338004|FG006|Overall Study|Study end per-protocol|0|||
162076692|NCT03560531|585338005|FG007|Overall Study|Study end per-protocol|0|||
162076693|NCT03560531|585338006|FG008|Overall Study|Study end per-protocol|0|||
162076694|NCT03560531|585338007|FG009|Overall Study|Study end per-protocol|0|||
162076695|NCT03560531|585338008|FG010|Overall Study|Study end per-protocol|0|||
162076696|NCT03560531|585338009|FG011|Overall Study|Study end per-protocol|0|||
162076697|NCT03560531|585338010|FG012|Overall Study|Study end per-protocol|0|||
162076698|NCT03560531|585338011|FG013|Overall Study|Study end per-protocol|0|||
162076699|NCT03560531|585337998|FG000|Overall Study|Early study termination by sponsor|9|||
162076700|NCT03560531|585337999|FG001|Overall Study|Early study termination by sponsor|0|||
162076701|NCT03560531|585338000|FG002|Overall Study|Early study termination by sponsor|0|||
162076702|NCT03560531|585338001|FG003|Overall Study|Early study termination by sponsor|4|||
162076703|NCT03560531|585338002|FG004|Overall Study|Early study termination by sponsor|8|||
162076704|NCT03560531|585338003|FG005|Overall Study|Early study termination by sponsor|2|||
162076705|NCT03560531|585338004|FG006|Overall Study|Early study termination by sponsor|5|||
162076706|NCT03560531|585338005|FG007|Overall Study|Early study termination by sponsor|64|||
162076707|NCT03560531|585338006|FG008|Overall Study|Early study termination by sponsor|7|||
162076708|NCT03560531|585338007|FG009|Overall Study|Early study termination by sponsor|2|||
162076709|NCT03560531|585338008|FG010|Overall Study|Early study termination by sponsor|16|||
162076710|NCT03560531|585338009|FG011|Overall Study|Early study termination by sponsor|2|||
162076711|NCT03560531|585338010|FG012|Overall Study|Early study termination by sponsor|6|||
162076712|NCT03560531|585338011|FG013|Overall Study|Early study termination by sponsor|2|||
162076713|NCT02968979|585338012|FG000|Overall Study|Protocol Violation|7|||
162076714|NCT02968979|585338012|FG000|Overall Study|Withdrawal by Subject|1|||
162076715|NCT01471379|585338013|FG000|Overall Study|Adverse Event|1|||
162076716|NCT01471379|585338014|FG001|Overall Study|Adverse Event|0|||
162076717|NCT01471379|585338015|FG002|Overall Study|Adverse Event|0|||
162076718|NCT01471379|585338013|FG000|Overall Study|Study terminated|0|||
162076719|NCT01471379|585338014|FG001|Overall Study|Study terminated|1|||
162076720|NCT01471379|585338015|FG002|Overall Study|Study terminated|0|||
162076721|NCT00729183|585338016|FG000|Overall Study|Adverse Event|11|||
162076722|NCT00729183|585338017|FG001|Overall Study|Adverse Event|5|||
162076723|NCT00729183|585338016|FG000|Overall Study|Lack of Efficacy|0|||
162076724|NCT00729183|585338017|FG001|Overall Study|Lack of Efficacy|1|||
162076725|NCT00729183|585338016|FG000|Overall Study|Lost to Follow-up|3|||
162076726|NCT00729183|585338017|FG001|Overall Study|Lost to Follow-up|1|||
162076727|NCT00729183|585338016|FG000|Overall Study|Physician Decision|1|||
162076728|NCT00729183|585338017|FG001|Overall Study|Physician Decision|1|||
162076729|NCT00729183|585338016|FG000|Overall Study|Protocol Violation|1|||
162076730|NCT00729183|585338017|FG001|Overall Study|Protocol Violation|0|||
162076731|NCT00729183|585338016|FG000|Overall Study|Withdrawal by Subject|9|||
162076732|NCT00729183|585338017|FG001|Overall Study|Withdrawal by Subject|7|||
162076733|NCT01200797|585338026|FG000|Overall Study|symptomatic deterioration|2|||
162076734|NCT01200797|585338026|FG000|Overall Study|Adverse Event|4|||
162076735|NCT01200797|585338026|FG000|Overall Study|Disease Progression|13|||
162076736|NCT03745144|585338029|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
162076737|NCT03745144|585338030|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
162076738|NCT03745144|585338031|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
162076739|NCT03745144|585338029|FG000|Period 1|Other|0|||
162076740|NCT03745144|585338030|FG001|Period 1|Other|0|||
162076741|NCT03745144|585338031|FG002|Period 1|Other|1|||
162076742|NCT00642668|585338036|FG000|Overall Study|Lost to Follow-up|1|||
162076743|NCT00642668|585338036|FG000|Overall Study|Adverse Event|2|||
162076744|NCT00642668|585338036|FG000|Overall Study|Death|2|||
162076745|NCT00642668|585338036|FG000|Overall Study|Insufficient Therapeutic Response|1|||
162076746|NCT00642668|585338036|FG000|Overall Study|Failure to Return|1|||
162076747|NCT00642668|585338036|FG000|Overall Study|Dialysis Initiation|5|||
162076748|NCT00642668|585338036|FG000|Overall Study|Blood Transfusion|2|||
162076749|NCT00896337|585338037|FG000|Overall Study|Death|7|||
162076750|NCT00896337|585338037|FG000|Overall Study|Withdrawal by Subject|7|||
162076751|NCT00896337|585338037|FG000|Overall Study|Lost to Follow-up|11|||
162076752|NCT04151290|585338042|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
162076753|NCT04380857|585339801|FG000|Overall Study|Lost to Follow-up|3|||
162076754|NCT04380857|585339802|FG001|Overall Study|Lost to Follow-up|3|||
162076755|NCT02558790|585339803|FG000|Overall Study|Lost to Follow-up|2|||
162076756|NCT02558790|585339803|FG000|Overall Study|Physician Decision|1|||
162076757|NCT02558790|585339803|FG000|Overall Study|Withdrawal by Subject|1|||
162076758|NCT02558790|585339803|FG000|Overall Study|Screen Fail|3|||
162076759|NCT05083442|585339804|FG000|Overall Study|Lost to Follow-up|1|||
162076760|NCT05083442|585339805|FG001|Overall Study|Lost to Follow-up|0|||
162076761|NCT05083442|585339804|FG000|Overall Study|Lack of Efficacy|0|||
162076762|NCT05083442|585339805|FG001|Overall Study|Lack of Efficacy|1|||
162076763|NCT05083442|585339804|FG000|Overall Study|Withdrawal by Subject|1|||
162076764|NCT05083442|585339805|FG001|Overall Study|Withdrawal by Subject|3|||
162076765|NCT05083442|585339804|FG000|Overall Study|scheduling difficulties|1|||
162076766|NCT05083442|585339805|FG001|Overall Study|scheduling difficulties|2|||
162076767|NCT04865354|585339813|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
162076768|NCT04865354|585339814|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
162076769|NCT04865354|585339813|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
162076770|NCT04865354|585339814|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
162076771|NCT04865354|585339813|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
162076772|NCT04865354|585339814|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
162076773|NCT02945410|585339815|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
162076774|NCT02945410|585339816|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
162076775|NCT02945410|585339817|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
162076776|NCT02945410|585339818|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
162076777|NCT02945410|585339819|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
162076778|NCT02945410|585339820|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
162076779|NCT02945410|585339815|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
162076780|NCT02945410|585339816|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
162076781|NCT02945410|585339817|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
162076782|NCT02945410|585339818|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
162076783|NCT02945410|585339819|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
162076784|NCT02945410|585339820|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
162076785|NCT02945410|585339815|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
162076786|NCT02945410|585339816|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
162076787|NCT02945410|585339817|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
162076788|NCT02945410|585339818|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
162076789|NCT02945410|585339819|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
162076790|NCT02945410|585339820|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
162076791|NCT00110812|585339821|FG000|Main Study|Death|0|||
162076792|NCT00110812|585339822|FG001|Main Study|Death|0|||
162076793|NCT00110812|585339823|FG002|Main Study|Death|2|||
162076794|NCT00110812|585339821|FG000|Main Study|Withdrawal by Subject|0|||
162076795|NCT00110812|585339822|FG001|Main Study|Withdrawal by Subject|0|||
162076796|NCT00110812|585339823|FG002|Main Study|Withdrawal by Subject|1|||
162076797|NCT00110812|585339821|FG000|Main Study|Lost to Follow-up|8|||
162076798|NCT00110812|585339822|FG001|Main Study|Lost to Follow-up|11|||
162076799|NCT00110812|585339823|FG002|Main Study|Lost to Follow-up|10|||
162076800|NCT00110812|585339821|FG000|Extended Follow-up|Death|1|||
162076801|NCT00110812|585339822|FG001|Extended Follow-up|Death|0|||
162076802|NCT00110812|585339823|FG002|Extended Follow-up|Death|3|||
162076803|NCT00110812|585339821|FG000|Extended Follow-up|Withdrawal by Subject|0|||
162076804|NCT00110812|585339822|FG001|Extended Follow-up|Withdrawal by Subject|1|||
162076805|NCT00110812|585339823|FG002|Extended Follow-up|Withdrawal by Subject|0|||
162076806|NCT00110812|585339821|FG000|Extended Follow-up|Lost to Follow-up|1|||
162076807|NCT00110812|585339822|FG001|Extended Follow-up|Lost to Follow-up|3|||
162076808|NCT00110812|585339823|FG002|Extended Follow-up|Lost to Follow-up|1|||
162076809|NCT01886833|585339824|FG000|Overall Study|IgA not available from both periods|204|||
162076810|NCT04200248|585339825|FG000|Overall Study|Personal reasons|0|||
162076811|NCT04200248|585339826|FG001|Overall Study|Personal reasons|0|||
162076812|NCT04200248|585339827|FG002|Overall Study|Personal reasons|1|||
162076813|NCT04200248|585339825|FG000|Overall Study|Discontinued prior to treatment|3|||
162076814|NCT04200248|585339826|FG001|Overall Study|Discontinued prior to treatment|3|||
162076815|NCT04200248|585339827|FG002|Overall Study|Discontinued prior to treatment|2|||
162076816|NCT01454726|585339828|FG000|Overall Study|Withdrawal by Subject|0|||
162076817|NCT01454726|585339829|FG001|Overall Study|Withdrawal by Subject|1|||
162076818|NCT04476030|585339830|FG000|Overall Study|Withdrawal by Subject|20|||
162076819|NCT04476030|585339831|FG001|Overall Study|Withdrawal by Subject|16|||
162076820|NCT04476030|585339830|FG000|Overall Study|Adverse Event|10|||
162076821|NCT04476030|585339831|FG001|Overall Study|Adverse Event|11|||
162076822|NCT04476030|585339830|FG000|Overall Study|Lost to Follow-up|7|||
162076823|NCT04476030|585339831|FG001|Overall Study|Lost to Follow-up|4|||
162076824|NCT04476030|585339830|FG000|Overall Study|Physician Decision|1|||
162076825|NCT04476030|585339831|FG001|Overall Study|Physician Decision|1|||
162076826|NCT04476030|585339830|FG000|Overall Study|Protocol Deviation|2|||
162076827|NCT04476030|585339831|FG001|Overall Study|Protocol Deviation|0|||
162076828|NCT04476030|585339830|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
162076829|NCT04476030|585339831|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
162076830|NCT04476030|585339830|FG000|Overall Study|Randomized but not Dosed|2|||
162076831|NCT04476030|585339831|FG001|Overall Study|Randomized but not Dosed|8|||
162076832|NCT02342704|585339832|FG000|Overall Study|Physician Decision|0|||
162076833|NCT02342704|585339833|FG001|Overall Study|Physician Decision|3|||
162076834|NCT02342704|585339832|FG000|Overall Study|Sponsor Termination|49|||
162076835|NCT02342704|585339833|FG001|Overall Study|Sponsor Termination|43|||
162076836|NCT02342704|585339832|FG000|Overall Study|Other|0|||
162076837|NCT02342704|585339833|FG001|Overall Study|Other|1|||
162076838|NCT02342704|585339832|FG000|Overall Study|Withdrawal by Subject|1|||
162076839|NCT02342704|585339833|FG001|Overall Study|Withdrawal by Subject|0|||
162076840|NCT02342704|585339832|FG000|Overall Study|Lost to Follow-up|2|||
162076841|NCT02342704|585339833|FG001|Overall Study|Lost to Follow-up|1|||
162076842|NCT02342704|585339832|FG000|Overall Study|Adverse Event|1|||
162076843|NCT02342704|585339833|FG001|Overall Study|Adverse Event|3|||
162076844|NCT00302003|585339834|FG000|Overall Study|Lack of Efficacy|62|||
162076845|NCT00302003|585339834|FG000|Overall Study|Lost to Follow-up|1|||
162076846|NCT00302003|585339834|FG000|Overall Study|Physician Decision|2|||
162076847|NCT00302003|585339834|FG000|Overall Study|Withdrawal by Subject|5|||
162076848|NCT00302003|585339834|FG000|Overall Study|Ineligible|9|||
162076849|NCT00302003|585339834|FG000|Overall Study|Protocol Violation|1|||
162076850|NCT02042924|585339835|FG000|Overall Study|Early Death|1|||
162076851|NCT04033003|585339836|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
162076852|NCT04033003|585339837|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
162076853|NCT04033003|585339836|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
162076854|NCT04033003|585339837|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
162076855|NCT04033003|585339836|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
162076856|NCT04033003|585339837|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
162076857|NCT04033003|585339836|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
162076858|NCT04033003|585339837|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
162076859|NCT04033003|585339836|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
162076860|NCT04033003|585339837|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
162076861|NCT04033003|585339836|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
162076862|NCT04033003|585339837|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
162076863|NCT04033003|585339836|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
162076864|NCT04033003|585339837|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
162076865|NCT04033003|585339836|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
162076866|NCT04033003|585339837|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
162076867|NCT04033003|585339836|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
162076868|NCT04033003|585339837|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
162076869|NCT04033003|585339836|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
162076870|NCT04033003|585339837|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
162076871|NCT04033003|585339836|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
162076872|NCT04033003|585339837|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
162076873|NCT04033003|585339836|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
162076874|NCT04033003|585339837|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
162076875|NCT04033003|585339836|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
162076876|NCT04033003|585339837|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
162076877|NCT02919670|585339838|FG000|Overall Study|Only 17 participants met compliance|43|||
162076878|NCT02919670|585339839|FG001|Overall Study|Only 17 participants met compliance|39|||
162076879|NCT02256891|585339840|FG000|Overall Study|Death|0|||
162076880|NCT02256891|585339841|FG001|Overall Study|Death|2|||
162076881|NCT02256891|585339840|FG000|Overall Study|Lost to Follow-up|0|||
162076882|NCT02256891|585339841|FG001|Overall Study|Lost to Follow-up|3|||
162076883|NCT02256891|585339840|FG000|Overall Study|Physician Decision|7|||
162076884|NCT02256891|585339841|FG001|Overall Study|Physician Decision|3|||
162076885|NCT02256891|585339840|FG000|Overall Study|Screen Fail|5|||
162076886|NCT02256891|585339841|FG001|Overall Study|Screen Fail|4|||
162076887|NCT02256891|585339840|FG000|Overall Study|Equipment Malfunction|0|||
162076888|NCT02256891|585339841|FG001|Overall Study|Equipment Malfunction|1|||
162076889|NCT01675882|585339844|FG000|Overall Study|Adverse Event|0|||
162076890|NCT01675882|585339845|FG001|Overall Study|Adverse Event|2|||
162076891|NCT01675882|585339846|FG002|Overall Study|Adverse Event|1|||
162076892|NCT01675882|585339847|FG003|Overall Study|Adverse Event|0|||
162076893|NCT01675882|585339844|FG000|Overall Study|Participant unwilling to continue|2|||
162076894|NCT01675882|585339845|FG001|Overall Study|Participant unwilling to continue|4|||
162076895|NCT01675882|585339846|FG002|Overall Study|Participant unwilling to continue|2|||
162076896|NCT01675882|585339847|FG003|Overall Study|Participant unwilling to continue|1|||
162076897|NCT01675882|585339844|FG000|Overall Study|Lost to Follow-up|0|||
162076898|NCT01675882|585339845|FG001|Overall Study|Lost to Follow-up|1|||
162076899|NCT01675882|585339846|FG002|Overall Study|Lost to Follow-up|0|||
162076900|NCT01675882|585339847|FG003|Overall Study|Lost to Follow-up|0|||
162076901|NCT01675882|585339844|FG000|Overall Study|Non-compliance|0|||
162076902|NCT01675882|585339845|FG001|Overall Study|Non-compliance|0|||
162076903|NCT01675882|585339846|FG002|Overall Study|Non-compliance|0|||
162076904|NCT01675882|585339847|FG003|Overall Study|Non-compliance|1|||
162076905|NCT01446965|585339850|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
162076906|NCT01446965|585339851|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
162076907|NCT01446965|585339850|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
162076908|NCT01446965|585339851|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
162076909|NCT02016482|585339861|FG000|Period A|Adverse Event|3|||
162076910|NCT02016482|585339862|FG001|Period A|Adverse Event|5|||
162076911|NCT02016482|585339861|FG000|Period A|Withdrawal by Subject|3|||
162076912|NCT02016482|585339862|FG001|Period A|Withdrawal by Subject|4|||
162076913|NCT02016482|585339861|FG000|Period A|Lost to Follow-up|3|||
162076914|NCT02016482|585339862|FG001|Period A|Lost to Follow-up|3|||
162076915|NCT02016482|585339861|FG000|Period A|Lack of Efficacy|2|||
162076916|NCT02016482|585339862|FG001|Period A|Lack of Efficacy|1|||
162076917|NCT02016482|585339861|FG000|Period A|Other|3|||
162076918|NCT02016482|585339862|FG001|Period A|Other|0|||
162076919|NCT02016482|585339861|FG000|Period A|Protocol Violation|0|||
162076920|NCT02016482|585339862|FG001|Period A|Protocol Violation|1|||
162076921|NCT02016482|585339861|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
162076922|NCT02016482|585339862|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
162076923|NCT02016482|585339861|FG000|Period B|Withdrawal by Subject|1|||
162076924|NCT02016482|585339862|FG001|Period B|Withdrawal by Subject|1|||
162076925|NCT02016482|585339861|FG000|Period B|Lost to Follow-up|2|||
162076926|NCT02016482|585339862|FG001|Period B|Lost to Follow-up|0|||
162076927|NCT02016482|585339861|FG000|Period B|Lack of Efficacy|6|||
162076928|NCT02016482|585339862|FG001|Period B|Lack of Efficacy|4|||
162076929|NCT02016482|585339861|FG000|Period B|Other|4|||
162076930|NCT02016482|585339862|FG001|Period B|Other|0|||
162076931|NCT02016482|585339861|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
162076932|NCT02016482|585339862|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
162076933|NCT03387813|585339863|FG000|Overall Study|Death|40|||
162076934|NCT03387813|585339864|FG001|Overall Study|Death|37|||
162076935|NCT03387813|585339865|FG002|Overall Study|Death|190|||
162076936|NCT03387813|585339863|FG000|Overall Study|Withdrawal by Subject|9|||
162076937|NCT03387813|585339864|FG001|Overall Study|Withdrawal by Subject|19|||
162076938|NCT03387813|585339865|FG002|Overall Study|Withdrawal by Subject|32|||
162076939|NCT03387813|585339863|FG000|Overall Study|Lost to Follow-up|3|||
162076940|NCT03387813|585339864|FG001|Overall Study|Lost to Follow-up|9|||
162076941|NCT03387813|585339865|FG002|Overall Study|Lost to Follow-up|15|||
162076942|NCT03387813|585339863|FG000|Overall Study|Non-Compliance|6|||
162076943|NCT03387813|585339864|FG001|Overall Study|Non-Compliance|6|||
162076944|NCT03387813|585339865|FG002|Overall Study|Non-Compliance|31|||
162076945|NCT03387813|585339863|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
162076946|NCT03387813|585339864|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
162076947|NCT03387813|585339865|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
162076948|NCT00606892|585339866|FG000|First Intervention|Protocol Violation|1|||
162076949|NCT00606892|585339867|FG001|First Intervention|Protocol Violation|4|||
162076950|NCT00855309|585339869|FG000|Overall Study|patient never recieved drug|1|||
162076951|NCT00855309|585339870|FG001|Overall Study|patient never recieved drug|0|||
162076952|NCT00829296|585339871|FG000|Overall Study|Adverse Event|5|||
162076953|NCT00829296|585339872|FG001|Overall Study|Adverse Event|4|||
162076954|NCT04960228|585339878|FG000|Overall Study|Withdrawal by Subject|216|||
162076955|NCT04960228|585339879|FG001|Overall Study|Withdrawal by Subject|35|||
162076956|NCT04960228|585339878|FG000|Overall Study|Failed attention check|69|||
162076957|NCT04960228|585339879|FG001|Overall Study|Failed attention check|148|||
162076958|NCT04960228|585339878|FG000|Overall Study|Flagged for response quality by Dynata|3|||
162076959|NCT04960228|585339879|FG001|Overall Study|Flagged for response quality by Dynata|3|||
162076960|NCT01987427|585339880|FG000|Overall Study|Adverse Event|4|||
162076961|NCT01987427|585339881|FG001|Overall Study|Adverse Event|2|||
162076962|NCT01987427|585339882|FG002|Overall Study|Adverse Event|8|||
162076963|NCT01987427|585339880|FG000|Overall Study|Lost to Follow-up|6|||
162076964|NCT01987427|585339881|FG001|Overall Study|Lost to Follow-up|6|||
162076965|NCT01987427|585339882|FG002|Overall Study|Lost to Follow-up|9|||
162076966|NCT01987427|585339880|FG000|Overall Study|Withdrawal by Subject|2|||
162076967|NCT01987427|585339881|FG001|Overall Study|Withdrawal by Subject|1|||
162076968|NCT01987427|585339882|FG002|Overall Study|Withdrawal by Subject|3|||
162076969|NCT01987427|585339880|FG000|Overall Study|Lack of Efficacy|1|||
162076970|NCT01987427|585339881|FG001|Overall Study|Lack of Efficacy|0|||
162076971|NCT01987427|585339882|FG002|Overall Study|Lack of Efficacy|0|||
162076972|NCT01987427|585339880|FG000|Overall Study|Other|1|||
162076973|NCT01987427|585339881|FG001|Overall Study|Other|1|||
162076974|NCT01987427|585339882|FG002|Overall Study|Other|0|||
162076975|NCT02547129|585339887|FG000|Overall Study|Difficulty with ongoing infection|1|||
162076976|NCT02547129|585339888|FG001|Overall Study|Difficulty with ongoing infection|0|||
162076977|NCT00794196|585339890|FG000|Overall Study|Lost to Follow-up|5|||
162076978|NCT00794196|585339891|FG001|Overall Study|Lost to Follow-up|23|||
162076979|NCT02129803|585339892|FG000|Overall Study|Protocol Violation|4|||
162076980|NCT02129803|585339893|FG001|Overall Study|Protocol Violation|0|||
162076981|NCT02129803|585339892|FG000|Overall Study|Physician Decision|0|||
162076982|NCT02129803|585339893|FG001|Overall Study|Physician Decision|1|||
162076983|NCT02129803|585339892|FG000|Overall Study|Difficulty sleeping|1|||
162076984|NCT02129803|585339893|FG001|Overall Study|Difficulty sleeping|0|||
162076985|NCT02129803|585339892|FG000|Overall Study|Morning headache|0|||
162076986|NCT02129803|585339893|FG001|Overall Study|Morning headache|1|||
162076987|NCT02129803|585339892|FG000|Overall Study|Withdrawal by Subject|1|||
162076988|NCT02129803|585339893|FG001|Overall Study|Withdrawal by Subject|1|||
162076989|NCT02319031|585339894|FG000|Treatment Period|Death|1|||
162076990|NCT02319031|585339895|FG001|Treatment Period|Death|0|||
162076991|NCT01640366|585339900|FG000|Overall Study|Withdrawal by Subject|1|||
162076992|NCT01640366|585339900|FG000|Overall Study|Protocol Violation|16|||
162076993|NCT01640366|585339900|FG000|Overall Study|Lost to Follow-up|5|||
162076994|NCT02739269|585339901|FG000|Overall Study|Protocol Violation|5|||
162076995|NCT02739269|585339902|FG001|Overall Study|Protocol Violation|0|||
162076996|NCT02739269|585339901|FG000|Overall Study|Cycle cancellation|2|||
162076997|NCT02739269|585339902|FG001|Overall Study|Cycle cancellation|2|||
162076998|NCT02739269|585339901|FG000|Overall Study|Withdrawal by Subject|0|||
162076999|NCT02739269|585339902|FG001|Overall Study|Withdrawal by Subject|2|||
162077000|NCT01070316|585339906|FG000|Extension Phase|Lack of Efficacy|3|||
162077001|NCT01070316|585339906|FG000|Extension Phase|Withdrawal by Subject|1|||
162077002|NCT02013167|585339907|FG000|Overall Study|Withdrawal by Subject|15|||
162077003|NCT02013167|585339908|FG001|Overall Study|Withdrawal by Subject|14|||
162077004|NCT02013167|585339907|FG000|Overall Study|Sponsor Decision|1|||
162077005|NCT02013167|585339908|FG001|Overall Study|Sponsor Decision|3|||
162077006|NCT02013167|585339907|FG000|Overall Study|Lost to Follow-up|0|||
162077007|NCT02013167|585339908|FG001|Overall Study|Lost to Follow-up|1|||
162077008|NCT02013167|585339907|FG000|Overall Study|Death|85|||
162077009|NCT02013167|585339908|FG001|Overall Study|Death|160|||
162077010|NCT01113879|585339913|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
162077011|NCT01113879|585339914|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
162077012|NCT00082433|585339918|FG000|Overall Study|Adverse Event|12|||
162077013|NCT00082433|585339919|FG001|Overall Study|Adverse Event|17|||
162077014|NCT00082433|585339918|FG000|Overall Study|Death|8|||
162077015|NCT00082433|585339919|FG001|Overall Study|Death|18|||
162077016|NCT00082433|585339918|FG000|Overall Study|Disease Progression/Relapse|270|||
162077017|NCT00082433|585339919|FG001|Overall Study|Disease Progression/Relapse|388|||
162077018|NCT00082433|585339918|FG000|Overall Study|Physician Decision|50|||
162077019|NCT00082433|585339919|FG001|Overall Study|Physician Decision|61|||
162077020|NCT00082433|585339918|FG000|Overall Study|Lost to Follow-up|1|||
162077021|NCT00082433|585339919|FG001|Overall Study|Lost to Follow-up|2|||
162077022|NCT00082433|585339918|FG000|Overall Study|Study Drug Toxicity|179|||
162077023|NCT00082433|585339919|FG001|Overall Study|Study Drug Toxicity|66|||
162077024|NCT00082433|585339918|FG000|Overall Study|Withdrawal by Subject|55|||
162077025|NCT00082433|585339919|FG001|Overall Study|Withdrawal by Subject|30|||
162077026|NCT00082433|585339918|FG000|Overall Study|Still On Treatment|2|||
162077027|NCT00082433|585339919|FG001|Overall Study|Still On Treatment|1|||
162077028|NCT00082433|585339918|FG000|Overall Study|Not Treated|12|||
162077029|NCT00082433|585339919|FG001|Overall Study|Not Treated|11|||
162077030|NCT00082433|585339918|FG000|Overall Study|Ineligible|2|||
162077031|NCT00082433|585339919|FG001|Overall Study|Ineligible|1|||
162077032|NCT00082433|585339918|FG000|Overall Study|Noncompliance|2|||
162077033|NCT00082433|585339919|FG001|Overall Study|Noncompliance|1|||
162077034|NCT00082433|585339918|FG000|Overall Study|New primary cancer|1|||
162077035|NCT00082433|585339919|FG001|Overall Study|New primary cancer|0|||
162077036|NCT00082433|585339918|FG000|Overall Study|Impending surgery|0|||
162077037|NCT00082433|585339919|FG001|Overall Study|Impending surgery|1|||
162077038|NCT01796197|585339922|FG000|Overall Study|Lost to Follow-up|1|||
162077039|NCT01796197|585339922|FG000|Overall Study|Lack of Efficacy|1|||
162077040|NCT04097821|585339923|FG000|Overall Study|Subject Decision|0|||
162077041|NCT04097821|585339924|FG001|Overall Study|Subject Decision|0|||
162077042|NCT04097821|585339925|FG002|Overall Study|Subject Decision|0|||
162077043|NCT04097821|585339926|FG003|Overall Study|Subject Decision|1|||
162077044|NCT04097821|585339927|FG004|Overall Study|Subject Decision|2|||
162077045|NCT04097821|585339928|FG005|Overall Study|Subject Decision|2|||
162077046|NCT04097821|585339929|FG006|Overall Study|Subject Decision|0|||
162077047|NCT04097821|585339930|FG007|Overall Study|Subject Decision|1|||
162077048|NCT04097821|585339923|FG000|Overall Study|Death|0|||
162077049|NCT04097821|585339924|FG001|Overall Study|Death|0|||
162077050|NCT04097821|585339925|FG002|Overall Study|Death|3|||
162077051|NCT04097821|585339926|FG003|Overall Study|Death|1|||
162077052|NCT04097821|585339927|FG004|Overall Study|Death|0|||
162077053|NCT04097821|585339928|FG005|Overall Study|Death|0|||
162077054|NCT04097821|585339929|FG006|Overall Study|Death|0|||
162077055|NCT04097821|585339930|FG007|Overall Study|Death|0|||
162077056|NCT04097821|585339923|FG000|Overall Study|Physician Decision|1|||
162077057|NCT04097821|585339924|FG001|Overall Study|Physician Decision|2|||
162077058|NCT04097821|585339925|FG002|Overall Study|Physician Decision|0|||
162077059|NCT04097821|585339926|FG003|Overall Study|Physician Decision|0|||
162077060|NCT04097821|585339927|FG004|Overall Study|Physician Decision|0|||
162077061|NCT04097821|585339928|FG005|Overall Study|Physician Decision|0|||
162077062|NCT04097821|585339929|FG006|Overall Study|Physician Decision|0|||
162077063|NCT04097821|585339930|FG007|Overall Study|Physician Decision|0|||
162077064|NCT04097821|585339923|FG000|Overall Study|Adverse Event|0|||
162077065|NCT04097821|585339924|FG001|Overall Study|Adverse Event|0|||
162077066|NCT04097821|585339925|FG002|Overall Study|Adverse Event|1|||
162077067|NCT04097821|585339926|FG003|Overall Study|Adverse Event|1|||
162077068|NCT04097821|585339927|FG004|Overall Study|Adverse Event|0|||
162077069|NCT04097821|585339928|FG005|Overall Study|Adverse Event|0|||
162077070|NCT04097821|585339929|FG006|Overall Study|Adverse Event|0|||
162077071|NCT04097821|585339930|FG007|Overall Study|Adverse Event|0|||
162077072|NCT04097821|585339923|FG000|Overall Study|New Therapy For Study Indication|0|||
162077073|NCT04097821|585339924|FG001|Overall Study|New Therapy For Study Indication|0|||
162077074|NCT04097821|585339925|FG002|Overall Study|New Therapy For Study Indication|0|||
162077075|NCT04097821|585339926|FG003|Overall Study|New Therapy For Study Indication|0|||
162077076|NCT04097821|585339927|FG004|Overall Study|New Therapy For Study Indication|0|||
162077077|NCT04097821|585339928|FG005|Overall Study|New Therapy For Study Indication|0|||
162077078|NCT04097821|585339929|FG006|Overall Study|New Therapy For Study Indication|1|||
162077079|NCT04097821|585339930|FG007|Overall Study|New Therapy For Study Indication|0|||
162077080|NCT00244712|585339934|FG000|Overall Study|Adverse Event|20|||
162077081|NCT00244712|585339935|FG001|Overall Study|Adverse Event|21|||
162077082|NCT00244712|585339934|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
162077083|NCT00244712|585339935|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
162077084|NCT00244712|585339934|FG000|Overall Study|Lack of Compliance|10|||
162077085|NCT00244712|585339935|FG001|Overall Study|Lack of Compliance|11|||
162077086|NCT00244712|585339934|FG000|Overall Study|Lost to Follow-up|45|||
162077087|NCT00244712|585339935|FG001|Overall Study|Lost to Follow-up|52|||
162077088|NCT00244712|585339934|FG000|Overall Study|Withdrawal by Subject|13|||
162077089|NCT00244712|585339935|FG001|Overall Study|Withdrawal by Subject|23|||
162077090|NCT00244712|585339934|FG000|Overall Study|Protocol Violation, disease progression|13|||
162077091|NCT00244712|585339935|FG001|Overall Study|Protocol Violation, disease progression|11|||
162077092|NCT01077804|585339938|FG000|Overall Study|Unreachable|102|||
162077093|NCT01077804|585339938|FG000|Overall Study|Refused to continue|79|||
162077094|NCT01077804|585339938|FG000|Overall Study|Other|18|||
162077095|NCT02776917|585339939|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
162077096|NCT02620046|585339941|FG000|Overall Study|Adverse Event|22|||
162077097|NCT02620046|585339942|FG001|Overall Study|Adverse Event|42|||
162077098|NCT02620046|585339941|FG000|Overall Study|Lost to Follow-up|4|||
162077099|NCT02620046|585339942|FG001|Overall Study|Lost to Follow-up|10|||
162077100|NCT02620046|585339941|FG000|Overall Study|Withdrawal by Subject|36|||
162077101|NCT02620046|585339942|FG001|Overall Study|Withdrawal by Subject|66|||
162077102|NCT02620046|585339941|FG000|Overall Study|Site Termination|3|||
162077103|NCT02620046|585339942|FG001|Overall Study|Site Termination|3|||
162077104|NCT02620046|585339941|FG000|Overall Study|Pregnancy|3|||
162077105|NCT02620046|585339942|FG001|Overall Study|Pregnancy|7|||
162077106|NCT02620046|585339941|FG000|Overall Study|Lack of Efficacy|81|||
162077107|NCT02620046|585339942|FG001|Overall Study|Lack of Efficacy|146|||
162077108|NCT02620046|585339941|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
162077109|NCT02620046|585339942|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
162077110|NCT02620046|585339941|FG000|Overall Study|Reason Not Specified|13|||
162077111|NCT02620046|585339942|FG001|Overall Study|Reason Not Specified|21|||
162077112|NCT02620046|585339941|FG000|Overall Study|Significant Protocol Deviation|0|||
162077113|NCT02620046|585339942|FG001|Overall Study|Significant Protocol Deviation|1|||
162077114|NCT00560950|585339945|FG000|Overall Study|Lost to Follow-up|1|||
162077115|NCT00560950|585339946|FG001|Overall Study|Lost to Follow-up|0|||
162077116|NCT00574405|585341545|FG000|Overall Study|Withdrawal by Subject|3|||
162077117|NCT00574405|585341546|FG001|Overall Study|Withdrawal by Subject|2|||
162077118|NCT01336738|585341547|FG000|Overall Study|Adverse Event|0|||
162077119|NCT01336738|585341548|FG001|Overall Study|Adverse Event|3|||
162077120|NCT01336738|585341549|FG002|Overall Study|Adverse Event|2|||
162077121|NCT01336738|585341550|FG003|Overall Study|Adverse Event|1|||
162077122|NCT01336738|585341551|FG004|Overall Study|Adverse Event|3|||
162077123|NCT01336738|585341547|FG000|Overall Study|Lost to Follow-up|2|||
162077124|NCT01336738|585341548|FG001|Overall Study|Lost to Follow-up|1|||
162077125|NCT01336738|585341549|FG002|Overall Study|Lost to Follow-up|2|||
162077126|NCT01336738|585341550|FG003|Overall Study|Lost to Follow-up|2|||
162077127|NCT01336738|585341551|FG004|Overall Study|Lost to Follow-up|2|||
162077128|NCT01336738|585341547|FG000|Overall Study|Did not meet entrance criteria|0|||
162077129|NCT01336738|585341548|FG001|Overall Study|Did not meet entrance criteria|1|||
162077130|NCT01336738|585341549|FG002|Overall Study|Did not meet entrance criteria|0|||
162077131|NCT01336738|585341550|FG003|Overall Study|Did not meet entrance criteria|0|||
162077132|NCT01336738|585341551|FG004|Overall Study|Did not meet entrance criteria|0|||
162077133|NCT01336738|585341547|FG000|Overall Study|Protocol Violation|0|||
162077134|NCT01336738|585341548|FG001|Overall Study|Protocol Violation|1|||
162077135|NCT01336738|585341549|FG002|Overall Study|Protocol Violation|0|||
162077136|NCT01336738|585341550|FG003|Overall Study|Protocol Violation|0|||
162077137|NCT01336738|585341551|FG004|Overall Study|Protocol Violation|0|||
162077138|NCT01336738|585341547|FG000|Overall Study|Withdrawal by Subject|2|||
162077139|NCT01336738|585341548|FG001|Overall Study|Withdrawal by Subject|0|||
162077140|NCT01336738|585341549|FG002|Overall Study|Withdrawal by Subject|2|||
162077141|NCT01336738|585341550|FG003|Overall Study|Withdrawal by Subject|1|||
162077142|NCT01336738|585341551|FG004|Overall Study|Withdrawal by Subject|1|||
162077143|NCT01336738|585341547|FG000|Overall Study|Other|3|||
162077144|NCT01336738|585341548|FG001|Overall Study|Other|3|||
162077145|NCT01336738|585341549|FG002|Overall Study|Other|2|||
162077146|NCT01336738|585341550|FG003|Overall Study|Other|3|||
162077147|NCT01336738|585341551|FG004|Overall Study|Other|4|||
162077148|NCT01083433|585341552|FG000|Overall Study|Lost to Follow-up|2|||
162077149|NCT01083433|585341553|FG001|Overall Study|Lost to Follow-up|1|||
162077150|NCT01083433|585341554|FG002|Overall Study|Lost to Follow-up|1|||
162077151|NCT01083433|585341552|FG000|Overall Study|Withdrawal by Subject|0|||
162077152|NCT01083433|585341553|FG001|Overall Study|Withdrawal by Subject|5|||
162077153|NCT01083433|585341554|FG002|Overall Study|Withdrawal by Subject|3|||
162077154|NCT01083433|585341552|FG000|Overall Study|Pregnancy|0|||
162077155|NCT01083433|585341553|FG001|Overall Study|Pregnancy|0|||
162077156|NCT01083433|585341554|FG002|Overall Study|Pregnancy|1|||
162077157|NCT02970968|585341556|FG000|Overall Study|Withdrawal by Subject|3|||
162077158|NCT02970968|585341557|FG001|Overall Study|Withdrawal by Subject|3|||
162077159|NCT02970968|585341556|FG000|Overall Study|Adverse Event|1|||
162077160|NCT02970968|585341557|FG001|Overall Study|Adverse Event|2|||
162077161|NCT02970968|585341556|FG000|Overall Study|Lost to Follow-up|1|||
162077162|NCT02970968|585341557|FG001|Overall Study|Lost to Follow-up|1|||
162077163|NCT02970968|585341556|FG000|Overall Study|Non-Compliance|0|||
162077164|NCT02970968|585341557|FG001|Overall Study|Non-Compliance|1|||
162077165|NCT03003520|585341558|FG000|Overall Study|Adverse Event|9|||
162077166|NCT03003520|585341559|FG001|Overall Study|Adverse Event|0|||
162077167|NCT03003520|585341558|FG000|Overall Study|Death|1|||
162077168|NCT03003520|585341559|FG001|Overall Study|Death|0|||
162077169|NCT03003520|585341558|FG000|Overall Study|Other reasons|4|||
162077170|NCT03003520|585341559|FG001|Overall Study|Other reasons|0|||
162077171|NCT03003520|585341558|FG000|Overall Study|Withdrawal by Subject|6|||
162077172|NCT03003520|585341559|FG001|Overall Study|Withdrawal by Subject|0|||
162077173|NCT03003520|585341558|FG000|Overall Study|Progressive disease|9|||
162077174|NCT03003520|585341559|FG001|Overall Study|Progressive disease|1|||
162077175|NCT01332149|585341560|FG000|Overall Study|Adverse Event|11|||
162077176|NCT01332149|585341561|FG001|Overall Study|Adverse Event|9|||
162077177|NCT01332149|585341560|FG000|Overall Study|Other unspecified|5|||
162077178|NCT01332149|585341561|FG001|Overall Study|Other unspecified|7|||
162077179|NCT01332149|585341560|FG000|Overall Study|Protocol Violation|1|||
162077180|NCT01332149|585341561|FG001|Overall Study|Protocol Violation|3|||
162077181|NCT01332149|585341560|FG000|Overall Study|Withdrawal by Subject|4|||
162077182|NCT01332149|585341561|FG001|Overall Study|Withdrawal by Subject|5|||
162077183|NCT01332149|585341560|FG000|Overall Study|Lost to Follow-up|1|||
162077184|NCT01332149|585341561|FG001|Overall Study|Lost to Follow-up|1|||
162077185|NCT01332149|585341560|FG000|Overall Study|Insufficient clinical response|4|||
162077186|NCT01332149|585341561|FG001|Overall Study|Insufficient clinical response|7|||
162077187|NCT01332149|585341560|FG000|Overall Study|Did not meet entrance criteria|3|||
162077188|NCT01332149|585341561|FG001|Overall Study|Did not meet entrance criteria|4|||
162077189|NCT01332149|585341560|FG000|Overall Study|Randomized but not treated|1|||
162077190|NCT01332149|585341561|FG001|Overall Study|Randomized but not treated|2|||
162077191|NCT04982029|585341562|FG000|Overall Study|Lost to Follow-up|2|||
162077192|NCT04982029|585341563|FG001|Overall Study|Lost to Follow-up|3|||
162077193|NCT03264404|585341564|FG000|Overall Study|Death|2|||
162077194|NCT03264404|585341564|FG000|Overall Study|Physician Decision|1|||
162077195|NCT03264404|585341564|FG000|Overall Study|Disease Progression|28|||
162077196|NCT03264404|585341564|FG000|Overall Study|Adverse Event|1|||
162077197|NCT03264404|585341564|FG000|Overall Study|Off study prior to treatment|2|||
162077198|NCT02565381|585341565|FG000|Overall Study|Lost to Follow-up|1|||
162077199|NCT02565381|585341566|FG001|Overall Study|Lost to Follow-up|0|||
162077200|NCT02565381|585341567|FG002|Overall Study|Lost to Follow-up|1|||
162077201|NCT04615949|585341570|FG000|Overall Study|Withdrawal by Subject|2|||
162077202|NCT04615949|585341571|FG001|Overall Study|Withdrawal by Subject|4|||
162077203|NCT04615949|585341570|FG000|Overall Study|Lost to Follow-up|2|||
162077204|NCT04615949|585341571|FG001|Overall Study|Lost to Follow-up|2|||
162077205|NCT04615949|585341570|FG000|Overall Study|Death|0|||
162077206|NCT04615949|585341571|FG001|Overall Study|Death|2|||
162077207|NCT03036566|585341572|FG000|Overall Study|Lost to Follow-up|3|||
162077208|NCT05458856|585341573|FG000|Overall Study|Withdrawal by Subject|5|||
162077209|NCT05458856|585341573|FG000|Overall Study|Death|4|||
162077210|NCT05458856|585341573|FG000|Overall Study|Protocol Deviation|3|||
162077211|NCT05458856|585341573|FG000|Overall Study|Physician Decision|1|||
162077212|NCT01852292|585341577|FG000|Overall Study|Untreated - did not receive study drug|3|||
162077213|NCT01852292|585341578|FG001|Overall Study|Untreated - did not receive study drug|1|||
162077214|NCT01852292|585341577|FG000|Overall Study|Death|9|||
162077215|NCT01852292|585341578|FG001|Overall Study|Death|8|||
162077216|NCT01852292|585341577|FG000|Overall Study|Patient/guardian decision|8|||
162077217|NCT01852292|585341578|FG001|Overall Study|Patient/guardian decision|4|||
162077218|NCT01852292|585341577|FG000|Overall Study|Adverse Event|8|||
162077219|NCT01852292|585341578|FG001|Overall Study|Adverse Event|11|||
162077220|NCT01852292|585341577|FG000|Overall Study|Physician Decision|6|||
162077221|NCT01852292|585341578|FG001|Overall Study|Physician Decision|2|||
162077222|NCT01852292|585341577|FG000|Overall Study|Protocol Violation|2|||
162077223|NCT01852292|585341578|FG001|Overall Study|Protocol Violation|0|||
162077224|NCT01852292|585341577|FG000|Overall Study|Non-compliance with study treatment|1|||
162077225|NCT01852292|585341578|FG001|Overall Study|Non-compliance with study treatment|0|||
162077226|NCT01852292|585341577|FG000|Overall Study|Study terminated by Sponsor|0|||
162077227|NCT01852292|585341578|FG001|Overall Study|Study terminated by Sponsor|1|||
162077228|NCT01852292|585341577|FG000|Overall Study|Progressive disease|42|||
162077229|NCT01852292|585341578|FG001|Overall Study|Progressive disease|52|||
162077230|NCT01914666|585341581|FG000|Treatment Period|Lack of Efficacy|0|||
162077231|NCT01914666|585341582|FG001|Treatment Period|Lack of Efficacy|0|||
162077232|NCT01914666|585341583|FG002|Treatment Period|Lack of Efficacy|2|||
162077233|NCT01914666|585341581|FG000|Treatment Period|Adverse Event|10|||
162077234|NCT01914666|585341582|FG001|Treatment Period|Adverse Event|4|||
162077235|NCT01914666|585341583|FG002|Treatment Period|Adverse Event|2|||
162077236|NCT01914666|585341581|FG000|Treatment Period|Withdrawal by Subject|3|||
162077237|NCT01914666|585341582|FG001|Treatment Period|Withdrawal by Subject|2|||
162077238|NCT01914666|585341583|FG002|Treatment Period|Withdrawal by Subject|2|||
162077239|NCT01914666|585341581|FG000|Treatment Period|Physician Decision|0|||
162077240|NCT01914666|585341582|FG001|Treatment Period|Physician Decision|0|||
162077241|NCT01914666|585341583|FG002|Treatment Period|Physician Decision|2|||
162077242|NCT02388737|585341585|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
162077243|NCT02388737|585341586|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
162077244|NCT02388737|585341587|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
162077245|NCT02388737|585341585|FG000|Overall Study|Major Protocol Deviation|18|||
162077246|NCT02388737|585341586|FG001|Overall Study|Major Protocol Deviation|25|||
162077247|NCT02388737|585341587|FG002|Overall Study|Major Protocol Deviation|22|||
162077248|NCT02388737|585341585|FG000|Overall Study|Lost to Follow-up|5|||
162077249|NCT02388737|585341586|FG001|Overall Study|Lost to Follow-up|1|||
162077250|NCT02388737|585341587|FG002|Overall Study|Lost to Follow-up|4|||
162077251|NCT02388737|585341585|FG000|Overall Study|Voluntary Withdrawal|10|||
162077252|NCT02388737|585341586|FG001|Overall Study|Voluntary Withdrawal|18|||
162077253|NCT02388737|585341587|FG002|Overall Study|Voluntary Withdrawal|17|||
162077254|NCT02388737|585341585|FG000|Overall Study|Lack of Efficacy|3|||
162077255|NCT02388737|585341586|FG001|Overall Study|Lack of Efficacy|0|||
162077256|NCT02388737|585341587|FG002|Overall Study|Lack of Efficacy|3|||
162077257|NCT02388737|585341585|FG000|Overall Study|Reason Not Specified|5|||
162077258|NCT02388737|585341586|FG001|Overall Study|Reason Not Specified|5|||
162077259|NCT02388737|585341587|FG002|Overall Study|Reason Not Specified|4|||
162077260|NCT03252522|585341588|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
162077261|NCT03252522|585341589|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
162077262|NCT03252522|585341590|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
162077263|NCT03252522|585341588|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
162077264|NCT03252522|585341589|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
162077265|NCT03252522|585341590|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
162077266|NCT03252522|585341588|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
162077267|NCT03252522|585341589|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
162077268|NCT03252522|585341590|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
162077269|NCT03252522|585341588|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
162077270|NCT03252522|585341589|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
162077271|NCT03252522|585341590|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
162077272|NCT03252522|585341588|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
162077273|NCT03252522|585341589|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
162077274|NCT03252522|585341590|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
162077275|NCT03252522|585341588|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
162077276|NCT03252522|585341589|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
162077277|NCT03252522|585341590|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
162077278|NCT03252522|585341588|FG000|Phase 2: Open Label|Adverse Event|0|||
162077279|NCT03252522|585341589|FG001|Phase 2: Open Label|Adverse Event|0|||
162077280|NCT03252522|585341590|FG002|Phase 2: Open Label|Adverse Event|2|||
162077281|NCT03252522|585341588|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
162077282|NCT03252522|585341589|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
162077283|NCT03252522|585341590|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
162077284|NCT03299842|585341592|FG000|Overall Study|Caregiver withdrew consent|2|||
162077285|NCT03299842|585341592|FG000|Overall Study|Child would not keep the watch on|3|||
162077286|NCT00071812|585341593|FG000|24-Week Double-Blind Period|Adverse Event|2|||
162077287|NCT00071812|585341594|FG001|24-Week Double-Blind Period|Adverse Event|3|||
162077288|NCT00071812|585341595|FG002|24-Week Double-Blind Period|Adverse Event|4|||
162077289|NCT00071812|585341596|FG003|24-Week Double-Blind Period|Adverse Event|4|||
162077290|NCT00071812|585341593|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
162077291|NCT00071812|585341594|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
162077292|NCT00071812|585341595|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
162077293|NCT00071812|585341596|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
162077294|NCT00071812|585341593|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
162077295|NCT00071812|585341594|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
162077296|NCT00071812|585341595|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
162077297|NCT00071812|585341596|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
162077298|NCT00071812|585341593|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
162077299|NCT00071812|585341594|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
162077300|NCT00071812|585341595|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
162077301|NCT00071812|585341596|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
162077302|NCT00071812|585341593|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
162077303|NCT00071812|585341594|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
162077304|NCT00071812|585341595|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
162077305|NCT00071812|585341596|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
162077306|NCT00071812|585341593|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
162077307|NCT00071812|585341594|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
162077308|NCT00071812|585341595|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
162077309|NCT00071812|585341596|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
162077310|NCT00071812|585341593|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
162077311|NCT00071812|585341594|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
162077312|NCT00071812|585341595|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
162077313|NCT00071812|585341596|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
162077314|NCT00071812|585341593|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
162077315|NCT00071812|585341594|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
162077316|NCT00071812|585341595|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
162077317|NCT00071812|585341596|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
162077318|NCT00071812|585341593|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162077319|NCT00071812|585341594|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162077320|NCT00071812|585341595|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162077321|NCT00071812|585341596|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
162077322|NCT00071812|585341593|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
162077323|NCT00071812|585341594|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
162077324|NCT00071812|585341595|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
162077325|NCT00071812|585341596|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
162077326|NCT01940120|585341599|FG000|Overall Study|Death|40|||
162077327|NCT01940120|585341599|FG000|Overall Study|Withdrawal by Subject|8|||
162077328|NCT03711162|585341601|FG000|Overall Study|Adverse Event|5|||
162077329|NCT03711162|585341602|FG001|Overall Study|Adverse Event|2|||
162077330|NCT03711162|585341603|FG002|Overall Study|Adverse Event|4|||
162077331|NCT03711162|585341601|FG000|Overall Study|Death|11|||
162077332|NCT03711162|585341602|FG001|Overall Study|Death|7|||
162077333|NCT03711162|585341603|FG002|Overall Study|Death|8|||
162077334|NCT03711162|585341601|FG000|Overall Study|Lost to Follow-up|1|||
162077335|NCT03711162|585341602|FG001|Overall Study|Lost to Follow-up|0|||
162077336|NCT03711162|585341603|FG002|Overall Study|Lost to Follow-up|1|||
162077337|NCT03711162|585341601|FG000|Overall Study|Study Terminated by Sponsor|139|||
162077338|NCT03711162|585341602|FG001|Overall Study|Study Terminated by Sponsor|152|||
162077339|NCT03711162|585341603|FG002|Overall Study|Study Terminated by Sponsor|146|||
162077340|NCT03711162|585341601|FG000|Overall Study|Withdrawal by Subject|17|||
162077341|NCT03711162|585341602|FG001|Overall Study|Withdrawal by Subject|10|||
162077342|NCT03711162|585341603|FG002|Overall Study|Withdrawal by Subject|10|||
162077343|NCT03711162|585341601|FG000|Overall Study|Miscellaneous|1|||
162077344|NCT03711162|585341602|FG001|Overall Study|Miscellaneous|2|||
162077345|NCT03711162|585341603|FG002|Overall Study|Miscellaneous|2|||
162077346|NCT03711162|585341601|FG000|Overall Study|Not Treated|1|||
162077347|NCT03711162|585341602|FG001|Overall Study|Not Treated|0|||
162077348|NCT03711162|585341603|FG002|Overall Study|Not Treated|1|||
162077349|NCT03711162|585341601|FG000|Overall Study|Physician Decision|0|||
162077350|NCT03711162|585341602|FG001|Overall Study|Physician Decision|2|||
162077351|NCT03711162|585341603|FG002|Overall Study|Physician Decision|0|||
162077352|NCT03711162|585341601|FG000|Overall Study|Lack of Efficacy|0|||
162077353|NCT03711162|585341602|FG001|Overall Study|Lack of Efficacy|0|||
162077354|NCT03711162|585341603|FG002|Overall Study|Lack of Efficacy|2|||
162077355|NCT03711162|585341601|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
162077356|NCT03711162|585341602|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
162077357|NCT03711162|585341603|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
162077358|NCT01275066|585341606|FG000|Overall Study|Withdrawal by Subject|0|||
162077359|NCT01275066|585341607|FG001|Overall Study|Withdrawal by Subject|0|||
162077360|NCT01275066|585341608|FG002|Overall Study|Withdrawal by Subject|1|||
162077361|NCT01275066|585341606|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
162077362|NCT01275066|585341607|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
162077363|NCT01275066|585341608|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
162077364|NCT03240133|585341609|FG000|Overall Study|Withdrawal by Subject|0|||
162077365|NCT03240133|585341610|FG001|Overall Study|Withdrawal by Subject|1|||
162077366|NCT03240133|585341611|FG002|Overall Study|Withdrawal by Subject|0|||
162077367|NCT03240133|585341609|FG000|Overall Study|Adverse Event|1|||
162077368|NCT03240133|585341610|FG001|Overall Study|Adverse Event|1|||
162077369|NCT03240133|585341611|FG002|Overall Study|Adverse Event|0|||
162077370|NCT03240133|585341609|FG000|Overall Study|Rash|1|||
162077371|NCT03240133|585341610|FG001|Overall Study|Rash|0|||
162077372|NCT03240133|585341611|FG002|Overall Study|Rash|0|||
162077373|NCT03240133|585341609|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
162077374|NCT03240133|585341610|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
162077375|NCT03240133|585341611|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
162077376|NCT03240133|585341609|FG000|Overall Study|Intercurrent illness.|0|||
162077377|NCT03240133|585341610|FG001|Overall Study|Intercurrent illness.|1|||
162077378|NCT03240133|585341611|FG002|Overall Study|Intercurrent illness.|0|||
162077379|NCT03240133|585341609|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
162077380|NCT03240133|585341610|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
162077381|NCT03240133|585341611|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
162077382|NCT00749463|585341612|FG000|Overall Study|Adverse Event|0|||
162077383|NCT00749463|585341613|FG001|Overall Study|Adverse Event|4|||
162077384|NCT00749463|585341614|FG002|Overall Study|Adverse Event|1|||
162077385|NCT00749463|585341612|FG000|Overall Study|Withdrawal by Subject|1|||
162077386|NCT00749463|585341613|FG001|Overall Study|Withdrawal by Subject|0|||
162077387|NCT00749463|585341614|FG002|Overall Study|Withdrawal by Subject|0|||
162077388|NCT00116831|585341615|FG000|Overall Study|Adverse Event|14|||
162077389|NCT00116831|585341616|FG001|Overall Study|Adverse Event|16|||
162077390|NCT00116831|585341615|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
162077391|NCT00116831|585341616|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
162077392|NCT00116831|585341615|FG000|Overall Study|Lost to Follow-up|8|||
162077393|NCT00116831|585341616|FG001|Overall Study|Lost to Follow-up|6|||
162077394|NCT00116831|585341615|FG000|Overall Study|Protocol Violation|3|||
162077395|NCT00116831|585341616|FG001|Overall Study|Protocol Violation|6|||
162077396|NCT00116831|585341615|FG000|Overall Study|Hypoglycaemic events|1|||
162077397|NCT00116831|585341616|FG001|Overall Study|Hypoglycaemic events|0|||
162077398|NCT00116831|585341615|FG000|Overall Study|Low haemoglobin on screening|1|||
162077399|NCT00116831|585341616|FG001|Overall Study|Low haemoglobin on screening|0|||
162077400|NCT00116831|585341615|FG000|Overall Study|Withdrawn investigational product|1|||
162077401|NCT00116831|585341616|FG001|Overall Study|Withdrawn investigational product|0|||
162077402|NCT00116831|585341615|FG000|Overall Study|Withdrawal by Subject|32|||
162077403|NCT00116831|585341616|FG001|Overall Study|Withdrawal by Subject|32|||
162077404|NCT00116831|585341615|FG000|Overall Study|Insufficient therapeutic effect|0|||
162077405|NCT00116831|585341616|FG001|Overall Study|Insufficient therapeutic effect|1|||
162077406|NCT00116831|585341615|FG000|Overall Study|Missing data for participant|1|||
162077407|NCT00116831|585341616|FG001|Overall Study|Missing data for participant|0|||
162077408|NCT04904185|585341617|FG000|Overall Study|Expansion failure|1|||
162077409|NCT04904185|585341618|FG001|Overall Study|Expansion failure|0|||
162077410|NCT04904185|585341617|FG000|Overall Study|Late response on prior treatment|1|||
162077411|NCT04904185|585341618|FG001|Overall Study|Late response on prior treatment|0|||
162077412|NCT01344369|585341621|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
162077413|NCT01344369|585341622|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
162077414|NCT01344369|585341621|FG000|Washout of 28 Days|Physician Decision|0|||
162077415|NCT01344369|585341622|FG001|Washout of 28 Days|Physician Decision|1|||
162077416|NCT01344369|585341621|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
162077417|NCT01344369|585341622|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
162077418|NCT00735371|585341634|FG000|Overall Study|Adverse Event|3|||
162077419|NCT00735371|585341635|FG001|Overall Study|Adverse Event|3|||
162077420|NCT00735371|585341636|FG002|Overall Study|Adverse Event|4|||
162077421|NCT00735371|585341637|FG003|Overall Study|Adverse Event|1|||
162077422|NCT00735371|585341634|FG000|Overall Study|Protocol Violation|2|||
162077423|NCT00735371|585341635|FG001|Overall Study|Protocol Violation|2|||
162077424|NCT00735371|585341636|FG002|Overall Study|Protocol Violation|0|||
162077425|NCT00735371|585341637|FG003|Overall Study|Protocol Violation|3|||
162077426|NCT00735371|585341634|FG000|Overall Study|Withdrawal by Subject|0|||
162077427|NCT00735371|585341635|FG001|Overall Study|Withdrawal by Subject|2|||
162077428|NCT00735371|585341636|FG002|Overall Study|Withdrawal by Subject|2|||
162077429|NCT00735371|585341637|FG003|Overall Study|Withdrawal by Subject|0|||
162077430|NCT00735371|585341634|FG000|Overall Study|Lost to Follow-up|1|||
162077431|NCT00735371|585341635|FG001|Overall Study|Lost to Follow-up|1|||
162077432|NCT00735371|585341636|FG002|Overall Study|Lost to Follow-up|3|||
162077433|NCT00735371|585341637|FG003|Overall Study|Lost to Follow-up|1|||
162077434|NCT00735371|585341634|FG000|Overall Study|Lack of Efficacy|4|||
162077435|NCT00735371|585341635|FG001|Overall Study|Lack of Efficacy|2|||
162077436|NCT00735371|585341636|FG002|Overall Study|Lack of Efficacy|0|||
162077437|NCT00735371|585341637|FG003|Overall Study|Lack of Efficacy|4|||
162077438|NCT00735371|585341634|FG000|Overall Study|Sponsor Decision|3|||
162077439|NCT00735371|585341635|FG001|Overall Study|Sponsor Decision|1|||
162077440|NCT00735371|585341636|FG002|Overall Study|Sponsor Decision|0|||
162077441|NCT00735371|585341637|FG003|Overall Study|Sponsor Decision|1|||
162077442|NCT00735371|585341634|FG000|Overall Study|Protocol Violation|0|||
162077443|NCT00735371|585341635|FG001|Overall Study|Protocol Violation|1|||
162077444|NCT00735371|585341636|FG002|Overall Study|Protocol Violation|2|||
162077445|NCT00735371|585341637|FG003|Overall Study|Protocol Violation|0|||
162077446|NCT00735371|585341634|FG000|Overall Study|Prior Vyvanse Exposure|1|||
162077447|NCT00735371|585341635|FG001|Overall Study|Prior Vyvanse Exposure|1|||
162077448|NCT00735371|585341636|FG002|Overall Study|Prior Vyvanse Exposure|0|||
162077449|NCT00735371|585341637|FG003|Overall Study|Prior Vyvanse Exposure|0|||
162077450|NCT00735371|585341634|FG000|Overall Study|Exclusion criteria|1|||
162077451|NCT00735371|585341635|FG001|Overall Study|Exclusion criteria|0|||
162077452|NCT00735371|585341636|FG002|Overall Study|Exclusion criteria|0|||
162077453|NCT00735371|585341637|FG003|Overall Study|Exclusion criteria|0|||
162077454|NCT01533246|585341640|FG000|Overall Study|Adverse Event|1|||
162077455|NCT01533246|585341640|FG000|Overall Study|Withdrawal by Subject|1|||
162077456|NCT01465464|585341654|FG000|Overall Study|Adverse Event|96|||
162077457|NCT01465464|585341655|FG001|Overall Study|Adverse Event|49|||
162077458|NCT01465464|585341654|FG000|Overall Study|Lack of Efficacy|139|||
162077459|NCT01465464|585341655|FG001|Overall Study|Lack of Efficacy|190|||
162077460|NCT01465464|585341654|FG000|Overall Study|Physician Decision|13|||
162077461|NCT01465464|585341655|FG001|Overall Study|Physician Decision|5|||
162077462|NCT01465464|585341654|FG000|Overall Study|Protocol Violation|1|||
162077463|NCT01465464|585341655|FG001|Overall Study|Protocol Violation|1|||
162077464|NCT01465464|585341654|FG000|Overall Study|Withdrawal by Subject|46|||
162077465|NCT01465464|585341655|FG001|Overall Study|Withdrawal by Subject|30|||
162077466|NCT01465464|585341654|FG000|Overall Study|Other|9|||
162077467|NCT01465464|585341655|FG001|Overall Study|Other|3|||
162077468|NCT01465464|585341654|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
162077469|NCT01465464|585341655|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
162077470|NCT01183975|585341658|FG000|Overall Study|Lost to Follow-up|73|||
162077471|NCT02244580|585341666|FG000|Overall Study|No cancer tissues available|241|||
162077472|NCT02136576|585341668|FG000|Overall Study|Lost to Follow-up|2|||
162077473|NCT02136576|585341669|FG001|Overall Study|Lost to Follow-up|0|||
162077474|NCT02136576|585341670|FG002|Overall Study|Lost to Follow-up|0|||
162077475|NCT01708174|585341671|FG000|Treatment Period|Withdrawal by Subject|1|||
162077476|NCT01708174|585341672|FG001|Treatment Period|Withdrawal by Subject|0|||
162077477|NCT01708174|585341673|FG002|Treatment Period|Withdrawal by Subject|0|||
162077478|NCT01708174|585341671|FG000|Treatment Period|Progressive disease|0|||
162077479|NCT01708174|585341672|FG001|Treatment Period|Progressive disease|1|||
162077480|NCT01708174|585341673|FG002|Treatment Period|Progressive disease|0|||
162077481|NCT01708174|585341671|FG000|Treatment Period|Death|0|||
162077482|NCT01708174|585341672|FG001|Treatment Period|Death|0|||
162077483|NCT01708174|585341673|FG002|Treatment Period|Death|1|||
162077484|NCT01708174|585341671|FG000|Treatment Period|Adverse Event|0|||
162077485|NCT01708174|585341672|FG001|Treatment Period|Adverse Event|1|||
162077486|NCT01708174|585341673|FG002|Treatment Period|Adverse Event|0|||
162077487|NCT00923559|585341674|FG000|Overall Study|Lost to Follow-up|2|||
162077488|NCT00923559|585341675|FG001|Overall Study|Lost to Follow-up|3|||
162077489|NCT02268812|585341676|FG000|Overall Study|Adverse Event|8|||
162077490|NCT02268812|585341677|FG001|Overall Study|Adverse Event|26|||
162077491|NCT02268812|585341678|FG002|Overall Study|Adverse Event|7|||
162077492|NCT02268812|585341679|FG003|Overall Study|Adverse Event|10|||
162077493|NCT02268812|585341676|FG000|Overall Study|Protocol deviation|0|||
162077494|NCT02268812|585341677|FG001|Overall Study|Protocol deviation|0|||
162077495|NCT02268812|585341678|FG002|Overall Study|Protocol deviation|1|||
162077496|NCT02268812|585341679|FG003|Overall Study|Protocol deviation|0|||
162077497|NCT02268812|585341676|FG000|Overall Study|Withdrawal by Subject|0|||
162077498|NCT02268812|585341677|FG001|Overall Study|Withdrawal by Subject|1|||
162077499|NCT02268812|585341678|FG002|Overall Study|Withdrawal by Subject|0|||
162077500|NCT02268812|585341679|FG003|Overall Study|Withdrawal by Subject|0|||
162077501|NCT02268812|585341676|FG000|Overall Study|Physician Decision|3|||
162077502|NCT02268812|585341677|FG001|Overall Study|Physician Decision|1|||
162077503|NCT02268812|585341678|FG002|Overall Study|Physician Decision|0|||
162077504|NCT02268812|585341679|FG003|Overall Study|Physician Decision|1|||
162077505|NCT02268812|585341676|FG000|Overall Study|Other|5|||
162077506|NCT02268812|585341677|FG001|Overall Study|Other|4|||
162077507|NCT02268812|585341678|FG002|Overall Study|Other|1|||
162077508|NCT02268812|585341679|FG003|Overall Study|Other|3|||
162077509|NCT01951157|585341681|FG000|Overall Study|Progressive Disease|12|||
162077510|NCT01951157|585341682|FG001|Overall Study|Progressive Disease|13|||
162077511|NCT01951157|585341683|FG002|Overall Study|Progressive Disease|10|||
162077512|NCT01951157|585341681|FG000|Overall Study|Treatment-unrelated AE|1|||
162077513|NCT01951157|585341682|FG001|Overall Study|Treatment-unrelated AE|0|||
162077514|NCT01951157|585341683|FG002|Overall Study|Treatment-unrelated AE|3|||
162077515|NCT01951157|585341681|FG000|Overall Study|Study Termination|0|||
162077516|NCT01951157|585341682|FG001|Overall Study|Study Termination|0|||
162077517|NCT01951157|585341683|FG002|Overall Study|Study Termination|1|||
162077518|NCT01951157|585341681|FG000|Overall Study|Physician Decision|5|||
162077519|NCT01951157|585341682|FG001|Overall Study|Physician Decision|3|||
162077520|NCT01951157|585341683|FG002|Overall Study|Physician Decision|2|||
162077521|NCT01951157|585341681|FG000|Overall Study|Non-treatmentrelated death|2|||
162077522|NCT01951157|585341682|FG001|Overall Study|Non-treatmentrelated death|2|||
162077523|NCT01951157|585341683|FG002|Overall Study|Non-treatmentrelated death|2|||
162077524|NCT01951157|585341681|FG000|Overall Study|No treated|0|||
162077525|NCT01951157|585341682|FG001|Overall Study|No treated|1|||
162077526|NCT01951157|585341683|FG002|Overall Study|No treated|0|||
162077527|NCT01951157|585341681|FG000|Overall Study|Treatment-related AE|2|||
162077528|NCT01951157|585341682|FG001|Overall Study|Treatment-related AE|0|||
162077529|NCT01951157|585341683|FG002|Overall Study|Treatment-related AE|4|||
162077530|NCT01951157|585341681|FG000|Overall Study|Consent withdrawn by subject|0|||
162077531|NCT01951157|585341682|FG001|Overall Study|Consent withdrawn by subject|1|||
162077532|NCT01951157|585341683|FG002|Overall Study|Consent withdrawn by subject|3|||
162077533|NCT01951157|585341681|FG000|Overall Study|Treatment-related death|0|||
162077534|NCT01951157|585341682|FG001|Overall Study|Treatment-related death|2|||
162077535|NCT01951157|585341683|FG002|Overall Study|Treatment-related death|0|||
162077536|NCT04964128|585341686|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
162077537|NCT04964128|585341686|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
162077538|NCT00994240|585341688|FG000|Overall Study|Lost to Follow-up|3|||
162077539|NCT00994240|585341689|FG001|Overall Study|Lost to Follow-up|2|||
162077540|NCT00994240|585341688|FG000|Overall Study|Withdrawal by Subject|1|||
162077541|NCT00994240|585341689|FG001|Overall Study|Withdrawal by Subject|0|||
162077542|NCT00994240|585341688|FG000|Overall Study|study termination|2|||
162077543|NCT00994240|585341689|FG001|Overall Study|study termination|3|||
162077544|NCT01177540|585341690|FG000|Overall Study|Adverse Event|1|||
162077545|NCT01177540|585341691|FG001|Overall Study|Adverse Event|0|||
162077546|NCT00748215|585341700|FG000|Overall Study|Withdrawal by Subject|7|||
162077547|NCT00748215|585341701|FG001|Overall Study|Withdrawal by Subject|7|||
162077548|NCT00748215|585341700|FG000|Overall Study|Treatment change|2|||
162077549|NCT00748215|585341701|FG001|Overall Study|Treatment change|1|||
162077550|NCT00748215|585341700|FG000|Overall Study|Change in patient condition|0|||
162077551|NCT00748215|585341701|FG001|Overall Study|Change in patient condition|3|||
162077552|NCT00748215|585341700|FG000|Overall Study|Non-compliant|0|||
162077553|NCT00748215|585341701|FG001|Overall Study|Non-compliant|2|||
162077554|NCT00748215|585341700|FG000|Overall Study|Adverse Event|0|||
162077555|NCT00748215|585341701|FG001|Overall Study|Adverse Event|5|||
162077556|NCT04152447|585343518|FG000|Overall Study|Lost to Follow-up|1|||
162077557|NCT04152447|585343519|FG001|Overall Study|Lost to Follow-up|0|||
162077558|NCT04152447|585343518|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
162077559|NCT04152447|585343519|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
162077560|NCT04152447|585343518|FG000|Overall Study|Withdrawal by Subject|0|||
162077561|NCT04152447|585343519|FG001|Overall Study|Withdrawal by Subject|1|||
162077562|NCT04152447|585343518|FG000|Overall Study|Found ineligible after enrolling|1|||
162077563|NCT04152447|585343519|FG001|Overall Study|Found ineligible after enrolling|1|||
162077564|NCT04152447|585343518|FG000|Overall Study|Did not receive VR headset in time.|0|||
162077565|NCT04152447|585343519|FG001|Overall Study|Did not receive VR headset in time.|2|||
162077566|NCT03240575|585343520|FG000|Overall Study|Adverse Event|0|||
162077567|NCT03240575|585343521|FG001|Overall Study|Adverse Event|2|||
162077568|NCT03240575|585343522|FG002|Overall Study|Adverse Event|0|||
162077569|NCT03240575|585343523|FG003|Overall Study|Adverse Event|1|||
162077570|NCT03240575|585343520|FG000|Overall Study|Withdrawal by Subject|2|||
162077571|NCT03240575|585343521|FG001|Overall Study|Withdrawal by Subject|11|||
162077572|NCT03240575|585343522|FG002|Overall Study|Withdrawal by Subject|0|||
162077573|NCT03240575|585343523|FG003|Overall Study|Withdrawal by Subject|1|||
162077574|NCT03240575|585343520|FG000|Overall Study|Other|0|||
162077575|NCT03240575|585343521|FG001|Overall Study|Other|1|||
162077576|NCT03240575|585343522|FG002|Overall Study|Other|0|||
162077577|NCT03240575|585343523|FG003|Overall Study|Other|0|||
162077578|NCT04482179|585343524|FG000|Overall Study|Death|1|||
162077579|NCT04482179|585343525|FG001|Overall Study|Death|0|||
162077580|NCT04482179|585343524|FG000|Overall Study|Withdrawal by Subject|1|||
162077581|NCT04482179|585343525|FG001|Overall Study|Withdrawal by Subject|0|||
162077582|NCT03034954|585343528|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
162077583|NCT03034954|585343529|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
162077584|NCT03568942|585343532|FG000|Overall Study|Family emergency|1|||
162077585|NCT03568942|585343532|FG000|Overall Study|Lost to Follow-up|1|||
162077586|NCT04145895|585343536|FG000|Overall Study|Physician Decision|2|||
162077587|NCT04145895|585343537|FG001|Overall Study|Physician Decision|0|||
162077588|NCT04145895|585343536|FG000|Overall Study|Withdrawal by Subject|0|||
162077589|NCT04145895|585343537|FG001|Overall Study|Withdrawal by Subject|2|||
162077590|NCT00913744|585343538|FG000|Overall Study|Adverse Event|2|||
162077591|NCT00913744|585343539|FG001|Overall Study|Adverse Event|0|||
162077592|NCT00913744|585343538|FG000|Overall Study|Withdrawal by Subject|2|||
162077593|NCT00913744|585343539|FG001|Overall Study|Withdrawal by Subject|1|||
162077594|NCT00913744|585343538|FG000|Overall Study|Death|1|||
162077595|NCT00913744|585343539|FG001|Overall Study|Death|0|||
162077596|NCT00805935|585343540|FG000|Overall Study|Stimulation Failure|1|||
162077597|NCT00805935|585343541|FG001|Overall Study|Stimulation Failure|5|||
162077598|NCT00805935|585343542|FG002|Overall Study|Stimulation Failure|2|||
162077599|NCT00805935|585343543|FG003|Overall Study|Stimulation Failure|2|||
162077600|NCT00805935|585343540|FG000|Overall Study|Cycle cancelled|0|||
162077601|NCT00805935|585343541|FG001|Overall Study|Cycle cancelled|0|||
162077602|NCT00805935|585343542|FG002|Overall Study|Cycle cancelled|2|||
162077603|NCT00805935|585343543|FG003|Overall Study|Cycle cancelled|0|||
162077604|NCT00805935|585343540|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
162077605|NCT00805935|585343541|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
162077606|NCT00805935|585343542|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
162077607|NCT00805935|585343543|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
162077608|NCT00805935|585343540|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
162077609|NCT00805935|585343541|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
162077610|NCT00805935|585343542|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
162077611|NCT00805935|585343543|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
162077612|NCT00805935|585343540|FG000|Overall Study|Lost to Follow-up|1|||
162077613|NCT00805935|585343541|FG001|Overall Study|Lost to Follow-up|0|||
162077614|NCT00805935|585343542|FG002|Overall Study|Lost to Follow-up|0|||
162077615|NCT00805935|585343543|FG003|Overall Study|Lost to Follow-up|0|||
162077616|NCT00805935|585343540|FG000|Overall Study|No positive serum pregnancy|8|||
162077617|NCT00805935|585343541|FG001|Overall Study|No positive serum pregnancy|7|||
162077618|NCT00805935|585343542|FG002|Overall Study|No positive serum pregnancy|6|||
162077619|NCT00805935|585343543|FG003|Overall Study|No positive serum pregnancy|5|||
162077620|NCT00805935|585343540|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
162077621|NCT00805935|585343541|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
162077622|NCT00805935|585343542|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
162077623|NCT00805935|585343543|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
162077624|NCT00805935|585343540|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
162077625|NCT00805935|585343541|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
162077626|NCT00805935|585343542|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
162077627|NCT00805935|585343543|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
162077628|NCT00805935|585343540|FG000|Overall Study|Biochemical pregnancy|0|||
162077629|NCT00805935|585343541|FG001|Overall Study|Biochemical pregnancy|1|||
162077630|NCT00805935|585343542|FG002|Overall Study|Biochemical pregnancy|0|||
162077631|NCT00805935|585343543|FG003|Overall Study|Biochemical pregnancy|0|||
162077632|NCT00805935|585343540|FG000|Overall Study|Chemical pregnancy|0|||
162077633|NCT00805935|585343541|FG001|Overall Study|Chemical pregnancy|5|||
162077634|NCT00805935|585343542|FG002|Overall Study|Chemical pregnancy|3|||
162077635|NCT00805935|585343543|FG003|Overall Study|Chemical pregnancy|2|||
162077636|NCT00805935|585343540|FG000|Overall Study|Ectopic pregnancy|0|||
162077637|NCT00805935|585343541|FG001|Overall Study|Ectopic pregnancy|0|||
162077638|NCT00805935|585343542|FG002|Overall Study|Ectopic pregnancy|1|||
162077639|NCT00805935|585343543|FG003|Overall Study|Ectopic pregnancy|0|||
162077640|NCT00805935|585343540|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
162077641|NCT00805935|585343541|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
162077642|NCT00805935|585343542|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
162077643|NCT00805935|585343543|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
162077644|NCT01218516|585343544|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
162077645|NCT01218516|585343545|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
162077646|NCT01218516|585343546|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
162077647|NCT01218516|585343547|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
162077648|NCT01218516|585343544|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
162077649|NCT01218516|585343545|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
162077650|NCT01218516|585343546|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
162077651|NCT01218516|585343547|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
162077652|NCT01218516|585343544|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
162077653|NCT01218516|585343545|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
162077654|NCT01218516|585343546|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
162077655|NCT01218516|585343547|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
162077656|NCT01218516|585343544|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
162077657|NCT01218516|585343545|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
162077658|NCT01218516|585343546|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
162077659|NCT01218516|585343547|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
162077660|NCT01218516|585343544|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
162077661|NCT01218516|585343545|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
162077662|NCT01218516|585343546|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
162077663|NCT01218516|585343547|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
162077664|NCT01218516|585343544|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
162077665|NCT01218516|585343545|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
162077666|NCT01218516|585343546|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
162077667|NCT01218516|585343547|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
162077668|NCT01218516|585343544|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
162077669|NCT01218516|585343545|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
162077670|NCT01218516|585343546|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
162077671|NCT01218516|585343547|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
162077672|NCT01218516|585343544|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
162077673|NCT01218516|585343545|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
162077674|NCT01218516|585343546|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
162077675|NCT01218516|585343547|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
162077676|NCT01218516|585343544|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
162077677|NCT01218516|585343545|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
162077678|NCT01218516|585343546|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
162077679|NCT01218516|585343547|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
162077680|NCT01218516|585343544|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
162077681|NCT01218516|585343545|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
162077682|NCT01218516|585343546|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
162077683|NCT01218516|585343547|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
162077684|NCT01218516|585343544|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
162077685|NCT01218516|585343545|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
162077686|NCT01218516|585343546|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
162077687|NCT01218516|585343547|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
162077688|NCT01218516|585343544|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
162077689|NCT01218516|585343545|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
162077690|NCT01218516|585343546|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
162077691|NCT01218516|585343547|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
162077692|NCT00283439|585343548|FG000|Overall Study|Adverse Event|0|||
162077693|NCT00283439|585343549|FG001|Overall Study|Adverse Event|0|||
162077694|NCT00283439|585343550|FG002|Overall Study|Adverse Event|0|||
162077695|NCT00283439|585343551|FG003|Overall Study|Adverse Event|1|||
162077696|NCT00283439|585343548|FG000|Overall Study|Death|0|||
162077697|NCT00283439|585343549|FG001|Overall Study|Death|0|||
162077698|NCT00283439|585343550|FG002|Overall Study|Death|1|||
162077699|NCT00283439|585343551|FG003|Overall Study|Death|0|||
162077700|NCT00283439|585343548|FG000|Overall Study|Disease progression|0|||
162077701|NCT00283439|585343549|FG001|Overall Study|Disease progression|1|||
162077702|NCT00283439|585343550|FG002|Overall Study|Disease progression|0|||
162077703|NCT00283439|585343551|FG003|Overall Study|Disease progression|0|||
162077704|NCT00283439|585343548|FG000|Overall Study|Requirement for alternative therapy|1|||
162077705|NCT00283439|585343549|FG001|Overall Study|Requirement for alternative therapy|2|||
162077706|NCT00283439|585343550|FG002|Overall Study|Requirement for alternative therapy|5|||
162077707|NCT00283439|585343551|FG003|Overall Study|Requirement for alternative therapy|2|||
162077708|NCT00283439|585343548|FG000|Overall Study|Stem cell transplant|6|||
162077709|NCT00283439|585343549|FG001|Overall Study|Stem cell transplant|6|||
162077710|NCT00283439|585343550|FG002|Overall Study|Stem cell transplant|4|||
162077711|NCT00283439|585343551|FG003|Overall Study|Stem cell transplant|3|||
162077712|NCT00283439|585343548|FG000|Overall Study|Treatment discontinued|0|||
162077713|NCT00283439|585343549|FG001|Overall Study|Treatment discontinued|2|||
162077714|NCT00283439|585343550|FG002|Overall Study|Treatment discontinued|1|||
162077715|NCT00283439|585343551|FG003|Overall Study|Treatment discontinued|3|||
162077716|NCT00283439|585343548|FG000|Overall Study|Other|1|||
162077717|NCT00283439|585343549|FG001|Overall Study|Other|0|||
162077718|NCT00283439|585343550|FG002|Overall Study|Other|0|||
162077719|NCT00283439|585343551|FG003|Overall Study|Other|0|||
162077720|NCT01539226|585343552|FG000|Overall Study|Withdrawal by Subject|24|||
162077721|NCT01539226|585343553|FG001|Overall Study|Withdrawal by Subject|54|||
162077722|NCT01539226|585343552|FG000|Overall Study|Lost to Follow-up|20|||
162077723|NCT01539226|585343553|FG001|Overall Study|Lost to Follow-up|54|||
162077724|NCT01539226|585343552|FG000|Overall Study|Death|1|||
162077725|NCT01539226|585343553|FG001|Overall Study|Death|2|||
162077726|NCT01539226|585343552|FG000|Overall Study|Adverse Event|2|||
162077727|NCT01539226|585343553|FG001|Overall Study|Adverse Event|0|||
162077728|NCT01539226|585343552|FG000|Overall Study|Pregnancy|13|||
162077729|NCT01539226|585343553|FG001|Overall Study|Pregnancy|29|||
162077730|NCT01539226|585343552|FG000|Overall Study|inappropriate enrollment|0|||
162077731|NCT01539226|585343553|FG001|Overall Study|inappropriate enrollment|1|||
162077732|NCT01539226|585343552|FG000|Overall Study|Multiple Reasons|3|||
162077733|NCT01539226|585343553|FG001|Overall Study|Multiple Reasons|1|||
162077734|NCT01539226|585343552|FG000|Overall Study|not HIV seroconversion-related|93|||
162077735|NCT01539226|585343553|FG001|Overall Study|not HIV seroconversion-related|176|||
162077736|NCT01539226|585343552|FG000|Overall Study|HIV seroconversion-related|55|||
162077737|NCT01539226|585343553|FG001|Overall Study|HIV seroconversion-related|80|||
162077738|NCT01539226|585343552|FG000|Overall Study|Non-compliance|6|||
162077739|NCT01539226|585343553|FG001|Overall Study|Non-compliance|8|||
162077740|NCT01632891|585343554|FG000|Overall Study|Lost to Follow-up|0|||
162077741|NCT01632891|585343555|FG001|Overall Study|Lost to Follow-up|1|||
162077742|NCT01632891|585343554|FG000|Overall Study|Withdrawal by Subject|1|||
162077743|NCT01632891|585343555|FG001|Overall Study|Withdrawal by Subject|0|||
162077744|NCT00333229|585343556|FG000|Overall Study|Lack of Efficacy|0|||
162077745|NCT00333229|585343557|FG001|Overall Study|Lack of Efficacy|1|||
162077746|NCT00240071|585343559|FG000|Overall Study|Withdrawal by Subject|3|||
162077747|NCT02821962|585343560|FG000|Overall Study|Lost to Follow-up|2|||
162077748|NCT02821962|585343561|FG001|Overall Study|Lost to Follow-up|0|||
162077749|NCT04206293|585343574|FG000|Overall Study|Consent withdrawal|1|||
162077750|NCT01610791|585343582|FG000|Overall Study|Lost to Follow-up|7|||
162077751|NCT01610791|585343582|FG000|Overall Study|Adverse Event|6|||
162077752|NCT01610791|585343582|FG000|Overall Study|Physician Decision|1|||
162077753|NCT01610791|585343582|FG000|Overall Study|Adverse event and Investigator decision|1|||
162077754|NCT01610791|585343582|FG000|Overall Study|Death|1|||
162077755|NCT01610791|585343582|FG000|Overall Study|Not determined|5|||
162077756|NCT04304001|585343583|FG000|Overall Study|Lost to Follow-up|13|||
162077757|NCT04304001|585343584|FG001|Overall Study|Lost to Follow-up|9|||
162077758|NCT04164901|585343585|FG000|Overall Study|Withdrawal by Subject|4|||
162077759|NCT04164901|585343586|FG001|Overall Study|Withdrawal by Subject|4|||
162077760|NCT02465528|585343587|FG000|Overall Study|Progressive disease|0|||
162077761|NCT02465528|585343588|FG001|Overall Study|Progressive disease|2|||
162077762|NCT02465528|585343589|FG002|Overall Study|Progressive disease|9|||
162077763|NCT02465528|585343590|FG003|Overall Study|Progressive disease|4|||
162077764|NCT02465528|585343587|FG000|Overall Study|Study terminated by sponsor|1|||
162077765|NCT02465528|585343588|FG001|Overall Study|Study terminated by sponsor|2|||
162077766|NCT02465528|585343589|FG002|Overall Study|Study terminated by sponsor|0|||
162077767|NCT02465528|585343590|FG003|Overall Study|Study terminated by sponsor|0|||
162077768|NCT02465528|585343587|FG000|Overall Study|Withdrawal by Subject|0|||
162077769|NCT02465528|585343588|FG001|Overall Study|Withdrawal by Subject|0|||
162077770|NCT02465528|585343589|FG002|Overall Study|Withdrawal by Subject|2|||
162077771|NCT02465528|585343590|FG003|Overall Study|Withdrawal by Subject|0|||
162077772|NCT02465528|585343587|FG000|Overall Study|Adverse Event|0|||
162077773|NCT02465528|585343588|FG001|Overall Study|Adverse Event|0|||
162077774|NCT02465528|585343589|FG002|Overall Study|Adverse Event|0|||
162077775|NCT02465528|585343590|FG003|Overall Study|Adverse Event|1|||
162077776|NCT02465528|585343587|FG000|Overall Study|Physician Decision|0|||
162077777|NCT02465528|585343588|FG001|Overall Study|Physician Decision|0|||
162077778|NCT02465528|585343589|FG002|Overall Study|Physician Decision|1|||
162077779|NCT02465528|585343590|FG003|Overall Study|Physician Decision|0|||
162077780|NCT05358821|585343591|FG000|Overall Study|Withdrawal by Subject|0|||
162077781|NCT05358821|585343592|FG001|Overall Study|Withdrawal by Subject|1|||
162077782|NCT05358821|585343593|FG002|Overall Study|Withdrawal by Subject|0|||
162077783|NCT05358821|585343591|FG000|Overall Study|Withdrawal of Consent|0|||
162077784|NCT05358821|585343592|FG001|Overall Study|Withdrawal of Consent|0|||
162077785|NCT05358821|585343593|FG002|Overall Study|Withdrawal of Consent|1|||
162077786|NCT04627064|585343597|FG000|Overall Study|Progressive disease|8|||
162077787|NCT04627064|585343598|FG001|Overall Study|Progressive disease|0|||
162077788|NCT04627064|585343597|FG000|Overall Study|Withdrawal by Subject|2|||
162077789|NCT04627064|585343598|FG001|Overall Study|Withdrawal by Subject|0|||
162077790|NCT04627064|585343597|FG000|Overall Study|Physician Decision|1|||
162077791|NCT04627064|585343598|FG001|Overall Study|Physician Decision|0|||
162077792|NCT02086110|585343604|FG000|Overall Study|Withdrawal by Subject|1|||
162077793|NCT02086110|585343605|FG001|Overall Study|Withdrawal by Subject|1|||
162077794|NCT01869192|585343606|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
162077795|NCT01869192|585343607|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
162077796|NCT01869192|585343606|FG000|Postoperative Chemotherapy|Physician Decision|0|||
162077797|NCT01869192|585343607|FG001|Postoperative Chemotherapy|Physician Decision|2|||
162077798|NCT02286193|585343610|FG000|Overall Study|Referred: CRS unable to make contact|62|||
162077799|NCT02286193|585343610|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
162077800|NCT02286193|585343610|FG000|Overall Study|Referred: Declined service|38|||
162077801|NCT00423891|585343611|FG000|Enrolled|Withdrawal by Subject|0|||
162077802|NCT00423891|585343612|FG001|Enrolled|Withdrawal by Subject|0|||
162077803|NCT00423891|585343613|FG002|Enrolled|Withdrawal by Subject|1|||
162077804|NCT00423891|585343611|FG000|Enrolled|Lost to Follow-up|0|||
162077805|NCT00423891|585343612|FG001|Enrolled|Lost to Follow-up|0|||
162077806|NCT00423891|585343613|FG002|Enrolled|Lost to Follow-up|1|||
162077807|NCT00423891|585343611|FG000|Enrolled|No longer met criteria|11|||
162077808|NCT00423891|585343612|FG001|Enrolled|No longer met criteria|2|||
162077809|NCT00423891|585343613|FG002|Enrolled|No longer met criteria|1|||
162077810|NCT00423891|585343611|FG000|Treatment|Withdrawal by Subject|1|||
162077811|NCT00423891|585343612|FG001|Treatment|Withdrawal by Subject|0|||
162077812|NCT00423891|585343613|FG002|Treatment|Withdrawal by Subject|0|||
162077813|NCT00423891|585343611|FG000|Treatment|Lost to Follow-up|1|||
162077814|NCT00423891|585343612|FG001|Treatment|Lost to Follow-up|0|||
162077815|NCT00423891|585343613|FG002|Treatment|Lost to Follow-up|0|||
162077816|NCT00423891|585343611|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
162077817|NCT00423891|585343612|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
162077818|NCT00423891|585343613|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
162077819|NCT00423891|585343611|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
162077820|NCT00423891|585343612|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
162077821|NCT00423891|585343613|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
162077822|NCT01585766|585343630|FG000|Overall Study|Withdrawal by Subject|0|||
162077823|NCT01585766|585343631|FG001|Overall Study|Withdrawal by Subject|1|||
162077824|NCT01585766|585343632|FG002|Overall Study|Withdrawal by Subject|1|||
162077825|NCT01585766|585343633|FG003|Overall Study|Withdrawal by Subject|0|||
162077826|NCT01585766|585343634|FG004|Overall Study|Withdrawal by Subject|0|||
162077827|NCT01585766|585343635|FG005|Overall Study|Withdrawal by Subject|0|||
162077828|NCT01585766|585343630|FG000|Overall Study|Death|0|||
162077829|NCT01585766|585343631|FG001|Overall Study|Death|1|||
162077830|NCT01585766|585343632|FG002|Overall Study|Death|0|||
162077831|NCT01585766|585343633|FG003|Overall Study|Death|0|||
162077832|NCT01585766|585343634|FG004|Overall Study|Death|0|||
162077833|NCT01585766|585343635|FG005|Overall Study|Death|0|||
162077834|NCT01585766|585343630|FG000|Overall Study|Physician Decision|0|||
162077835|NCT01585766|585343631|FG001|Overall Study|Physician Decision|0|||
162077836|NCT01585766|585343632|FG002|Overall Study|Physician Decision|1|||
162077837|NCT01585766|585343633|FG003|Overall Study|Physician Decision|0|||
162077838|NCT01585766|585343634|FG004|Overall Study|Physician Decision|0|||
162077839|NCT01585766|585343635|FG005|Overall Study|Physician Decision|0|||
162077840|NCT01364428|585343636|FG000|Overall Study|Adverse Event|1|||
162077841|NCT01364428|585343637|FG001|Overall Study|Adverse Event|2|||
162077842|NCT01364428|585343636|FG000|Overall Study|Protocol Violation|2|||
162077843|NCT01364428|585343637|FG001|Overall Study|Protocol Violation|0|||
162077844|NCT01364428|585343636|FG000|Overall Study|Withdrawal Criteria|14|||
162077845|NCT01364428|585343637|FG001|Overall Study|Withdrawal Criteria|10|||
162077846|NCT01364428|585343636|FG000|Overall Study|Other|3|||
162077847|NCT01364428|585343637|FG001|Overall Study|Other|3|||
162077848|NCT01073865|585343638|FG000|Overall Study|Reasons other than below|19|||
162077849|NCT01073865|585343639|FG001|Overall Study|Reasons other than below|31|||
162077850|NCT01073865|585343638|FG000|Overall Study|Lost to Follow-up|1|||
162077851|NCT01073865|585343639|FG001|Overall Study|Lost to Follow-up|1|||
162077852|NCT01073865|585343638|FG000|Overall Study|Death|3|||
162077853|NCT01073865|585343639|FG001|Overall Study|Death|2|||
162077854|NCT01073865|585343638|FG000|Overall Study|Withdrawal by Subject|5|||
162077855|NCT01073865|585343639|FG001|Overall Study|Withdrawal by Subject|5|||
162077856|NCT03925324|585343640|FG000|Overall Study|Death|1|||
162077857|NCT03925324|585343641|FG001|Overall Study|Death|1|||
162077858|NCT04414553|585343642|FG000|Overall Study|Lost to Follow-up|20|||
162077859|NCT00696137|585343646|FG000|Overall Study|Withdrawal by Subject|2|||
162077860|NCT04371380|585343650|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
162077861|NCT04371380|585343651|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
162077862|NCT04371380|585343652|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
162077863|NCT02376166|585343653|FG000|Overall Study|Adverse Event|1|||
162077864|NCT02376166|585343653|FG000|Overall Study|Discontinued metformin early|2|||
162077865|NCT02197806|585343656|FG000|Overall Study|Adverse Event|0|||
162077866|NCT02197806|585343657|FG001|Overall Study|Adverse Event|1|||
162077867|NCT02197806|585343658|FG002|Overall Study|Adverse Event|0|||
162077868|NCT02197806|585343659|FG003|Overall Study|Adverse Event|1|||
162077869|NCT00537381|585343660|FG000|Overall Study|Adverse Event|13|||
162077870|NCT00537381|585343661|FG001|Overall Study|Adverse Event|9|||
162077871|NCT00537381|585343660|FG000|Overall Study|Death|3|||
162077872|NCT00537381|585343661|FG001|Overall Study|Death|3|||
162077873|NCT00537381|585343660|FG000|Overall Study|Withdrawal by Subject|5|||
162077874|NCT00537381|585343661|FG001|Overall Study|Withdrawal by Subject|14|||
162077875|NCT00537381|585343660|FG000|Overall Study|Physician Decision|7|||
162077876|NCT00537381|585343661|FG001|Overall Study|Physician Decision|6|||
162077877|NCT00537381|585343660|FG000|Overall Study|Disease Progression|9|||
162077878|NCT00537381|585343661|FG001|Overall Study|Disease Progression|18|||
162077879|NCT00537381|585343660|FG000|Overall Study|Sponsor decision|14|||
162077880|NCT00537381|585343661|FG001|Overall Study|Sponsor decision|9|||
162077881|NCT00537381|585343660|FG000|Overall Study|Other|5|||
162077882|NCT00537381|585343661|FG001|Overall Study|Other|3|||
162077883|NCT00680901|585343662|FG000|Overall Study|Ongoing: On Study Treatment|1|||
162077884|NCT00680901|585343663|FG001|Overall Study|Ongoing: On Study Treatment|0|||
162077885|NCT00680901|585343662|FG000|Overall Study|Ongoing: In Follow Up|1|||
162077886|NCT00680901|585343663|FG001|Overall Study|Ongoing: In Follow Up|0|||
162077887|NCT00680901|585343662|FG000|Overall Study|Adverse Event|1|||
162077888|NCT00680901|585343663|FG001|Overall Study|Adverse Event|1|||
162077889|NCT00680901|585343662|FG000|Overall Study|Lost to Follow-up|3|||
162077890|NCT00680901|585343663|FG001|Overall Study|Lost to Follow-up|5|||
162077891|NCT00680901|585343662|FG000|Overall Study|Subject decided to withdraw from the study|4|||
162077892|NCT00680901|585343663|FG001|Overall Study|Subject decided to withdraw from the study|15|||
162077893|NCT00680901|585343662|FG000|Overall Study|Sponsor decision|1|||
162077894|NCT00680901|585343663|FG001|Overall Study|Sponsor decision|0|||
162077895|NCT00680901|585343662|FG000|Overall Study|Physician Decision|0|||
162077896|NCT00680901|585343663|FG001|Overall Study|Physician Decision|2|||
162077897|NCT00680901|585343662|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
162077898|NCT00680901|585343663|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
162077899|NCT00680901|585343662|FG000|Overall Study|Other protocol defined stopping criteria|17|||
162077900|NCT00680901|585343663|FG001|Overall Study|Other protocol defined stopping criteria|17|||
162077901|NCT04251221|585343672|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
162077902|NCT04251221|585343673|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
162077903|NCT02120794|585343676|FG000|Overall Study|Withdrawal by Subject|43|||
162077904|NCT02120794|585343676|FG000|Overall Study|Adverse Event|10|||
162077905|NCT02120794|585343676|FG000|Overall Study|Physician Decision|4|||
162077906|NCT02120794|585343676|FG000|Overall Study|Due to insurance coverage|1|||
162077907|NCT01148511|585343677|FG000|Exposed to Study Drug|Protocol Violation|2|||
162077908|NCT01148511|585343678|FG001|Exposed to Study Drug|Protocol Violation|0|||
162077909|NCT01148511|585343679|FG002|Exposed to Study Drug|Protocol Violation|0|||
162077910|NCT01148511|585343677|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
162077911|NCT01148511|585343678|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
162077912|NCT01148511|585343679|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
162077913|NCT01148511|585343677|FG000|Randomized|Adverse Event|0|||
162077914|NCT01148511|585343678|FG001|Randomized|Adverse Event|1|||
162077915|NCT01148511|585343679|FG002|Randomized|Adverse Event|0|||
162077916|NCT01148511|585343677|FG000|Randomized|Protocol Violation|0|||
162077917|NCT01148511|585343678|FG001|Randomized|Protocol Violation|2|||
162077918|NCT01148511|585343679|FG002|Randomized|Protocol Violation|1|||
162077919|NCT01148511|585343677|FG000|Randomized|Lost to Follow-up|0|||
162077920|NCT01148511|585343678|FG001|Randomized|Lost to Follow-up|1|||
162077921|NCT01148511|585343679|FG002|Randomized|Lost to Follow-up|1|||
162077922|NCT01148511|585343677|FG000|Randomized|Consent withdrawal|0|||
162077923|NCT01148511|585343678|FG001|Randomized|Consent withdrawal|5|||
162077924|NCT01148511|585343679|FG002|Randomized|Consent withdrawal|3|||
162077925|NCT01148511|585343677|FG000|Randomized|Other|0|||
162077926|NCT01148511|585343678|FG001|Randomized|Other|1|||
162077927|NCT01148511|585343679|FG002|Randomized|Other|1|||
162077928|NCT00969553|585343688|FG000|Overall Study|Progressive disease (PD)|2|||
162077929|NCT00969553|585343689|FG001|Overall Study|Progressive disease (PD)|2|||
162077930|NCT00969553|585343690|FG002|Overall Study|Progressive disease (PD)|6|||
162077931|NCT00969553|585343691|FG003|Overall Study|Progressive disease (PD)|9|||
162077932|NCT00969553|585343692|FG004|Overall Study|Progressive disease (PD)|2|||
162077933|NCT00969553|585343693|FG005|Overall Study|Progressive disease (PD)|4|||
162077934|NCT00969553|585343694|FG006|Overall Study|Progressive disease (PD)|2|||
162077935|NCT00969553|585343695|FG007|Overall Study|Progressive disease (PD)|12|||
162077936|NCT00969553|585343696|FG008|Overall Study|Progressive disease (PD)|3|||
162077937|NCT00969553|585343688|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
162077938|NCT00969553|585343689|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
162077939|NCT00969553|585343690|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
162077940|NCT00969553|585343691|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
162077941|NCT00969553|585343692|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
162077942|NCT00969553|585343693|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
162077943|NCT00969553|585343694|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
162077944|NCT00969553|585343695|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
162077945|NCT00969553|585343696|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
162077946|NCT00969553|585343688|FG000|Overall Study|Other Adverse Event|0|||
162077947|NCT00969553|585343689|FG001|Overall Study|Other Adverse Event|0|||
162077948|NCT00969553|585343690|FG002|Overall Study|Other Adverse Event|0|||
162077949|NCT00969553|585343691|FG003|Overall Study|Other Adverse Event|1|||
162077950|NCT00969553|585343692|FG004|Overall Study|Other Adverse Event|0|||
162077951|NCT00969553|585343693|FG005|Overall Study|Other Adverse Event|0|||
162077952|NCT00969553|585343694|FG006|Overall Study|Other Adverse Event|1|||
162077953|NCT00969553|585343695|FG007|Overall Study|Other Adverse Event|0|||
162077954|NCT00969553|585343696|FG008|Overall Study|Other Adverse Event|0|||
162077955|NCT00969553|585343688|FG000|Overall Study|Refused cont. medication|1|||
162077956|NCT00969553|585343689|FG001|Overall Study|Refused cont. medication|1|||
162077957|NCT00969553|585343690|FG002|Overall Study|Refused cont. medication|0|||
162077958|NCT00969553|585343691|FG003|Overall Study|Refused cont. medication|2|||
162077959|NCT00969553|585343692|FG004|Overall Study|Refused cont. medication|0|||
162077960|NCT00969553|585343693|FG005|Overall Study|Refused cont. medication|0|||
162077961|NCT00969553|585343694|FG006|Overall Study|Refused cont. medication|0|||
162077962|NCT00969553|585343695|FG007|Overall Study|Refused cont. medication|1|||
162077963|NCT00969553|585343696|FG008|Overall Study|Refused cont. medication|0|||
162077964|NCT00969553|585343688|FG000|Overall Study|Not specified above|0|||
162077965|NCT00969553|585343689|FG001|Overall Study|Not specified above|0|||
162077966|NCT00969553|585343690|FG002|Overall Study|Not specified above|0|||
162077967|NCT00969553|585343691|FG003|Overall Study|Not specified above|4|||
162077968|NCT00969553|585343692|FG004|Overall Study|Not specified above|0|||
162077969|NCT00969553|585343693|FG005|Overall Study|Not specified above|0|||
162077970|NCT00969553|585343694|FG006|Overall Study|Not specified above|1|||
162077971|NCT00969553|585343695|FG007|Overall Study|Not specified above|1|||
162077972|NCT00969553|585343696|FG008|Overall Study|Not specified above|0|||
162077973|NCT04243538|585343697|FG000|Overall Study|Withdrawal by Subject|0|||
162077974|NCT04243538|585343698|FG001|Overall Study|Withdrawal by Subject|2|||
162077975|NCT04243538|585343697|FG000|Overall Study|Lost to Follow-up|0|||
162077976|NCT04243538|585343698|FG001|Overall Study|Lost to Follow-up|3|||
162077977|NCT04536727|585343699|FG000|Overall Study|Lost to Follow-up|1|||
162077978|NCT04536727|585343700|FG001|Overall Study|Lost to Follow-up|1|||
162077979|NCT04536727|585343699|FG000|Overall Study|Death|0|||
162077980|NCT04536727|585343700|FG001|Overall Study|Death|1|||
162077981|NCT00500370|585343701|FG000|Overall Study|Adverse Event|9|||
162077982|NCT00500370|585343702|FG001|Overall Study|Adverse Event|3|||
162077983|NCT00500370|585343701|FG000|Overall Study|Lost to Follow-up|10|||
162077984|NCT00500370|585343702|FG001|Overall Study|Lost to Follow-up|10|||
162077985|NCT00500370|585343701|FG000|Overall Study|Protocol Violation|2|||
162077986|NCT00500370|585343702|FG001|Overall Study|Protocol Violation|4|||
162077987|NCT00500370|585343701|FG000|Overall Study|Sponsor Decision|2|||
162077988|NCT00500370|585343702|FG001|Overall Study|Sponsor Decision|0|||
162077989|NCT00500370|585343701|FG000|Overall Study|Subject Decision|10|||
162077990|NCT00500370|585343702|FG001|Overall Study|Subject Decision|17|||
162077991|NCT05308901|585345240|FG000|Overall Study|Death|6|||
162077992|NCT02586012|585345241|FG000|Overall Study|Withdrawal by Subject|1|||
162077993|NCT02586012|585345242|FG001|Overall Study|Withdrawal by Subject|1|||
162077994|NCT02586012|585345243|FG002|Overall Study|Withdrawal by Subject|0|||
162077995|NCT02586012|585345244|FG003|Overall Study|Withdrawal by Subject|1|||
162077996|NCT02586012|585345245|FG004|Overall Study|Withdrawal by Subject|0|||
162077997|NCT02586012|585345246|FG005|Overall Study|Withdrawal by Subject|2|||
162077998|NCT02586012|585345241|FG000|Overall Study|Protocol Violation|0|||
162077999|NCT02586012|585345242|FG001|Overall Study|Protocol Violation|0|||
162078000|NCT02586012|585345243|FG002|Overall Study|Protocol Violation|0|||
162078001|NCT02586012|585345244|FG003|Overall Study|Protocol Violation|0|||
162078002|NCT02586012|585345245|FG004|Overall Study|Protocol Violation|0|||
162078003|NCT02586012|585345246|FG005|Overall Study|Protocol Violation|1|||
162078004|NCT02586012|585345241|FG000|Overall Study|study terminated|0|||
162078005|NCT02586012|585345242|FG001|Overall Study|study terminated|2|||
162078006|NCT02586012|585345243|FG002|Overall Study|study terminated|1|||
162078007|NCT02586012|585345244|FG003|Overall Study|study terminated|1|||
162078008|NCT02586012|585345245|FG004|Overall Study|study terminated|1|||
162078009|NCT02586012|585345246|FG005|Overall Study|study terminated|0|||
162078010|NCT01816139|585345247|FG000|Overall Study|Adverse Event|6|||
162078011|NCT01816139|585345248|FG001|Overall Study|Adverse Event|8|||
162078012|NCT01816139|585345247|FG000|Overall Study|Lack of Efficacy|1|||
162078013|NCT01816139|585345248|FG001|Overall Study|Lack of Efficacy|2|||
162078014|NCT01816139|585345247|FG000|Overall Study|Lost to Follow-up|5|||
162078015|NCT01816139|585345248|FG001|Overall Study|Lost to Follow-up|3|||
162078016|NCT01816139|585345247|FG000|Overall Study|Withdrew Consent|6|||
162078017|NCT01816139|585345248|FG001|Overall Study|Withdrew Consent|4|||
162078018|NCT01816139|585345247|FG000|Overall Study|Protocol Violation|6|||
162078019|NCT01816139|585345248|FG001|Overall Study|Protocol Violation|3|||
162078020|NCT01816139|585345247|FG000|Overall Study|Reason not Specified|4|||
162078021|NCT01816139|585345248|FG001|Overall Study|Reason not Specified|2|||
162078022|NCT01572038|585345249|FG000|Overall Study|Death|648|||
162078023|NCT01572038|585345249|FG000|Overall Study|Withdrawal by Subject|204|||
162078024|NCT01572038|585345249|FG000|Overall Study|Lost to Follow-up|81|||
162078025|NCT01572038|585345249|FG000|Overall Study|Physician Decision|20|||
162078026|NCT01572038|585345249|FG000|Overall Study|Patient Decision|14|||
162078027|NCT01572038|585345249|FG000|Overall Study|Progressive Disease|8|||
162078028|NCT01572038|585345249|FG000|Overall Study|Site Closed Before Completing Form|6|||
162078029|NCT01572038|585345249|FG000|Overall Study|Enrolled into Another Trial|3|||
162078030|NCT01572038|585345249|FG000|Overall Study|Participated in Another Trial|3|||
162078031|NCT01572038|585345249|FG000|Overall Study|Termination by Sponsor|2|||
162078032|NCT01572038|585345249|FG000|Overall Study|Patient Deterioration|1|||
162078033|NCT01572038|585345249|FG000|Overall Study|Sponsor Decision|1|||
162078034|NCT02554656|585345250|FG000|Overall Study|Protocol Violation|3|||
162078035|NCT01888497|585345251|FG000|Washout Period 1|Withdrawal by Subject|0|||
162078036|NCT01888497|585345252|FG001|Washout Period 1|Withdrawal by Subject|0|||
162078037|NCT01888497|585345253|FG002|Washout Period 1|Withdrawal by Subject|1|||
162078038|NCT01888497|585345254|FG003|Washout Period 1|Withdrawal by Subject|1|||
162078039|NCT01888497|585345251|FG000|Washout Period 2|Adverse Event|0|||
162078040|NCT01888497|585345252|FG001|Washout Period 2|Adverse Event|0|||
162078041|NCT01888497|585345253|FG002|Washout Period 2|Adverse Event|0|||
162078042|NCT01888497|585345254|FG003|Washout Period 2|Adverse Event|1|||
162078043|NCT01888497|585345251|FG000|Washout Period 2|Withdrawal by Subject|0|||
162078044|NCT01888497|585345252|FG001|Washout Period 2|Withdrawal by Subject|0|||
162078045|NCT01888497|585345253|FG002|Washout Period 2|Withdrawal by Subject|0|||
162078046|NCT01888497|585345254|FG003|Washout Period 2|Withdrawal by Subject|1|||
162078047|NCT01140477|585345257|FG000|Overall Study|Lost to Follow-up|4|||
162078048|NCT01140477|585345258|FG001|Overall Study|Lost to Follow-up|0|||
162078049|NCT01140477|585345257|FG000|Overall Study|Withdrawal by Subject|1|||
162078050|NCT01140477|585345258|FG001|Overall Study|Withdrawal by Subject|4|||
162078051|NCT01140477|585345257|FG000|Overall Study|Surgical complication preventing implant|2|||
162078052|NCT01140477|585345258|FG001|Overall Study|Surgical complication preventing implant|0|||
162078053|NCT01140477|585345257|FG000|Overall Study|Death|1|||
162078054|NCT01140477|585345258|FG001|Overall Study|Death|1|||
162078055|NCT01140477|585345257|FG000|Overall Study|Subject explanted|0|||
162078056|NCT01140477|585345258|FG001|Overall Study|Subject explanted|1|||
162078057|NCT04127786|585345263|FG000|Primary Series|Adverse Event|1|||
162078058|NCT04127786|585345264|FG001|Primary Series|Adverse Event|0|||
162078059|NCT04127786|585345265|FG002|Primary Series|Adverse Event|0|||
162078060|NCT04127786|585345266|FG003|Primary Series|Adverse Event|1|||
162078061|NCT04127786|585345267|FG004|Primary Series|Adverse Event|0|||
162078062|NCT04127786|585345268|FG005|Primary Series|Adverse Event|1|||
162078063|NCT04127786|585345263|FG000|Primary Series|Protocol Violation|5|||
162078064|NCT04127786|585345264|FG001|Primary Series|Protocol Violation|3|||
162078065|NCT04127786|585345265|FG002|Primary Series|Protocol Violation|4|||
162078066|NCT04127786|585345266|FG003|Primary Series|Protocol Violation|3|||
162078067|NCT04127786|585345267|FG004|Primary Series|Protocol Violation|2|||
162078068|NCT04127786|585345268|FG005|Primary Series|Protocol Violation|0|||
162078069|NCT04127786|585345263|FG000|Primary Series|Withdrawal by Subject|0|||
162078070|NCT04127786|585345264|FG001|Primary Series|Withdrawal by Subject|0|||
162078071|NCT04127786|585345265|FG002|Primary Series|Withdrawal by Subject|0|||
162078072|NCT04127786|585345266|FG003|Primary Series|Withdrawal by Subject|1|||
162078073|NCT04127786|585345267|FG004|Primary Series|Withdrawal by Subject|0|||
162078074|NCT04127786|585345268|FG005|Primary Series|Withdrawal by Subject|0|||
162078075|NCT04127786|585345263|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
162078076|NCT04127786|585345264|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
162078077|NCT04127786|585345265|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
162078078|NCT04127786|585345266|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
162078079|NCT04127786|585345267|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
162078080|NCT04127786|585345268|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
162078081|NCT04127786|585345263|FG000|Booster Phase|Withdrawal by Subject|2|||
162078082|NCT04127786|585345264|FG001|Booster Phase|Withdrawal by Subject|0|||
162078083|NCT04127786|585345265|FG002|Booster Phase|Withdrawal by Subject|0|||
162078084|NCT04127786|585345266|FG003|Booster Phase|Withdrawal by Subject|0|||
162078085|NCT04127786|585345267|FG004|Booster Phase|Withdrawal by Subject|0|||
162078086|NCT04127786|585345268|FG005|Booster Phase|Withdrawal by Subject|0|||
162078087|NCT01904604|585345269|FG000|Overall Study|Withdrew before receiving dosing|0|||
162078088|NCT01904604|585345270|FG001|Overall Study|Withdrew before receiving dosing|1|||
162078089|NCT01904604|585345271|FG002|Overall Study|Withdrew before receiving dosing|0|||
162078090|NCT01904604|585345269|FG000|Overall Study|Non-compliance|1|||
162078091|NCT01904604|585345270|FG001|Overall Study|Non-compliance|0|||
162078092|NCT01904604|585345271|FG002|Overall Study|Non-compliance|0|||
162078093|NCT01904604|585345269|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
162078094|NCT01904604|585345270|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
162078095|NCT01904604|585345271|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
162078096|NCT01904604|585345269|FG000|Overall Study|Patch site reactions|1|||
162078097|NCT01904604|585345270|FG001|Overall Study|Patch site reactions|1|||
162078098|NCT01904604|585345271|FG002|Overall Study|Patch site reactions|0|||
162078099|NCT01904604|585345269|FG000|Overall Study|Increased syncope|0|||
162078100|NCT01904604|585345270|FG001|Overall Study|Increased syncope|1|||
162078101|NCT01904604|585345271|FG002|Overall Study|Increased syncope|0|||
162078102|NCT01904604|585345269|FG000|Overall Study|Unrelated illness|0|||
162078103|NCT01904604|585345270|FG001|Overall Study|Unrelated illness|1|||
162078104|NCT01904604|585345271|FG002|Overall Study|Unrelated illness|0|||
162078105|NCT01904604|585345269|FG000|Overall Study|Passed Week 52 OFC|1|||
162078106|NCT01904604|585345270|FG001|Overall Study|Passed Week 52 OFC|0|||
162078107|NCT01904604|585345271|FG002|Overall Study|Passed Week 52 OFC|0|||
162078108|NCT01904604|585345269|FG000|Overall Study|Withdrawal by Subject|1|||
162078109|NCT01904604|585345270|FG001|Overall Study|Withdrawal by Subject|2|||
162078110|NCT01904604|585345271|FG002|Overall Study|Withdrawal by Subject|0|||
162078111|NCT01904604|585345269|FG000|Overall Study|Participant Relocated|1|||
162078112|NCT01904604|585345270|FG001|Overall Study|Participant Relocated|1|||
162078113|NCT01904604|585345271|FG002|Overall Study|Participant Relocated|1|||
162078114|NCT01904604|585345269|FG000|Overall Study|Lost to Follow-up|0|||
162078115|NCT01904604|585345270|FG001|Overall Study|Lost to Follow-up|0|||
162078116|NCT01904604|585345271|FG002|Overall Study|Lost to Follow-up|1|||
162078117|NCT02118428|585345278|FG000|Overall Study|Physician Decision|0|||
162078118|NCT02118428|585345279|FG001|Overall Study|Physician Decision|1|||
162078119|NCT02118428|585345280|FG002|Overall Study|Physician Decision|0|||
162078120|NCT02118428|585345278|FG000|Overall Study|Withdrawal by Subject|2|||
162078121|NCT02118428|585345279|FG001|Overall Study|Withdrawal by Subject|2|||
162078122|NCT02118428|585345280|FG002|Overall Study|Withdrawal by Subject|0|||
162078123|NCT02118428|585345278|FG000|Overall Study|Death|7|||
162078124|NCT02118428|585345279|FG001|Overall Study|Death|5|||
162078125|NCT02118428|585345280|FG002|Overall Study|Death|0|||
162078126|NCT02118428|585345278|FG000|Overall Study|Lost to Follow-up|3|||
162078127|NCT02118428|585345279|FG001|Overall Study|Lost to Follow-up|1|||
162078128|NCT02118428|585345280|FG002|Overall Study|Lost to Follow-up|0|||
162078129|NCT02118428|585345278|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
162078130|NCT02118428|585345279|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
162078131|NCT02118428|585345280|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
162078132|NCT03325166|585345281|FG000|Overall Study|Adverse Event|1|||
162078133|NCT01633944|585345282|FG000|Open-label Titration Phase|Adverse Event|109|||
162078134|NCT01633944|585345283|FG001|Open-label Titration Phase|Adverse Event|0|||
162078135|NCT01633944|585345284|FG002|Open-label Titration Phase|Adverse Event|0|||
162078136|NCT01633944|585345282|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
162078137|NCT01633944|585345283|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
162078138|NCT01633944|585345284|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
162078139|NCT01633944|585345282|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
162078140|NCT01633944|585345283|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
162078141|NCT01633944|585345284|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
162078142|NCT01633944|585345282|FG000|Open-label Titration Phase|Protocol Violation|24|||
162078143|NCT01633944|585345283|FG001|Open-label Titration Phase|Protocol Violation|0|||
162078144|NCT01633944|585345284|FG002|Open-label Titration Phase|Protocol Violation|0|||
162078145|NCT01633944|585345282|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
162078146|NCT01633944|585345283|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
162078147|NCT01633944|585345284|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
162078148|NCT01633944|585345282|FG000|Open-label Titration Phase|Other|68|||
162078149|NCT01633944|585345283|FG001|Open-label Titration Phase|Other|0|||
162078150|NCT01633944|585345284|FG002|Open-label Titration Phase|Other|0|||
162078151|NCT01633944|585345282|FG000|Double-blind Treatment Phase|Adverse Event|0|||
162078152|NCT01633944|585345283|FG001|Double-blind Treatment Phase|Adverse Event|13|||
162078153|NCT01633944|585345284|FG002|Double-blind Treatment Phase|Adverse Event|7|||
162078154|NCT01633944|585345282|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
162078155|NCT01633944|585345283|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
162078156|NCT01633944|585345284|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
162078157|NCT01633944|585345282|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
162078158|NCT01633944|585345283|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
162078159|NCT01633944|585345284|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
162078160|NCT01633944|585345282|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
162078161|NCT01633944|585345283|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
162078162|NCT01633944|585345284|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
162078163|NCT01633944|585345282|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
162078164|NCT01633944|585345283|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
162078165|NCT01633944|585345284|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
162078166|NCT01633944|585345282|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
162078167|NCT01633944|585345283|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
162078168|NCT01633944|585345284|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
162078169|NCT01633944|585345282|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
162078170|NCT01633944|585345283|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
162078171|NCT01633944|585345284|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
162078172|NCT01633944|585345282|FG000|Double-blind Treatment Phase|Other|0|||
162078173|NCT01633944|585345283|FG001|Double-blind Treatment Phase|Other|7|||
162078174|NCT01633944|585345284|FG002|Double-blind Treatment Phase|Other|0|||
162078175|NCT03354429|585345286|FG000|Overall Study|Withdrawal by Subject|8|||
162078176|NCT03354429|585345287|FG001|Overall Study|Withdrawal by Subject|7|||
162078177|NCT03354429|585345286|FG000|Overall Study|Lost to Follow-up|1|||
162078178|NCT03354429|585345287|FG001|Overall Study|Lost to Follow-up|0|||
162078179|NCT00782210|585345289|FG000|Overall Study|Adverse Event|21|||
162078180|NCT00782210|585345290|FG001|Overall Study|Adverse Event|17|||
162078181|NCT00782210|585345291|FG002|Overall Study|Adverse Event|16|||
162078182|NCT00782210|585345289|FG000|Overall Study|Lost to Follow-up|2|||
162078183|NCT00782210|585345290|FG001|Overall Study|Lost to Follow-up|1|||
162078184|NCT00782210|585345291|FG002|Overall Study|Lost to Follow-up|2|||
162078185|NCT00782210|585345289|FG000|Overall Study|Withdrawal by Subject|11|||
162078186|NCT00782210|585345290|FG001|Overall Study|Withdrawal by Subject|8|||
162078187|NCT00782210|585345291|FG002|Overall Study|Withdrawal by Subject|11|||
162078188|NCT00782210|585345289|FG000|Overall Study|Non compliance with protocol|0|||
162078189|NCT00782210|585345290|FG001|Overall Study|Non compliance with protocol|3|||
162078190|NCT00782210|585345291|FG002|Overall Study|Non compliance with protocol|2|||
162078191|NCT00782210|585345289|FG000|Overall Study|Lack of Efficacy|13|||
162078192|NCT00782210|585345290|FG001|Overall Study|Lack of Efficacy|4|||
162078193|NCT00782210|585345291|FG002|Overall Study|Lack of Efficacy|1|||
162078194|NCT00782210|585345289|FG000|Overall Study|Other reason not described above|3|||
162078195|NCT00782210|585345290|FG001|Overall Study|Other reason not described above|2|||
162078196|NCT00782210|585345291|FG002|Overall Study|Other reason not described above|3|||
162078197|NCT05923229|585345298|FG000|Overall Study|Withdrawal by Subject|3|||
162078198|NCT05923229|585345299|FG001|Overall Study|Withdrawal by Subject|0|||
162078199|NCT05923229|585345298|FG000|Overall Study|Health related|2|||
162078200|NCT05923229|585345299|FG001|Overall Study|Health related|1|||
162078201|NCT05040152|585345300|FG000|Overall Study|Withdrawal by Subject|5|||
162078202|NCT05040152|585345301|FG001|Overall Study|Withdrawal by Subject|0|||
162078203|NCT05040152|585345300|FG000|Overall Study|Lost to Follow-up|0|||
162078204|NCT05040152|585345301|FG001|Overall Study|Lost to Follow-up|2|||
162078205|NCT04098458|585345304|FG000|Overall Study|Death|1|||
162078206|NCT04098458|585345304|FG000|Overall Study|did not meet study inclusion criteria|3|||
162078207|NCT02272413|585345309|FG000|Randomized Through Treatment Start|Not treated|3|||
162078208|NCT02272413|585345310|FG001|Randomized Through Treatment Start|Not treated|5|||
162078209|NCT02272413|585345309|FG000|Pre-switch Period|Adverse Event|38|||
162078210|NCT02272413|585345310|FG001|Pre-switch Period|Adverse Event|37|||
162078211|NCT02272413|585345309|FG000|Pre-switch Period|Death|26|||
162078212|NCT02272413|585345310|FG001|Pre-switch Period|Death|26|||
162078213|NCT02272413|585345309|FG000|Pre-switch Period|Withdrawal by Subject|27|||
162078214|NCT02272413|585345310|FG001|Pre-switch Period|Withdrawal by Subject|15|||
162078215|NCT02272413|585345309|FG000|Pre-switch Period|Physician Decision|6|||
162078216|NCT02272413|585345310|FG001|Pre-switch Period|Physician Decision|18|||
162078217|NCT02272413|585345309|FG000|Pre-switch Period|Progressive disease|185|||
162078218|NCT02272413|585345310|FG001|Pre-switch Period|Progressive disease|173|||
162078219|NCT02272413|585345309|FG000|Pre-switch Period|Lost to Follow-up|0|||
162078220|NCT02272413|585345310|FG001|Pre-switch Period|Lost to Follow-up|2|||
162078221|NCT02272413|585345309|FG000|Pre-switch Period|Protocol Violation|1|||
162078222|NCT02272413|585345310|FG001|Pre-switch Period|Protocol Violation|0|||
162078223|NCT02272413|585345309|FG000|Pre-switch Period|Other than listed|10|||
162078224|NCT02272413|585345310|FG001|Pre-switch Period|Other than listed|11|||
162078225|NCT02272413|585345309|FG000|Post-switch Period|Adverse Event|4|||
162078226|NCT02272413|585345310|FG001|Post-switch Period|Adverse Event|4|||
162078227|NCT02272413|585345309|FG000|Post-switch Period|Death|3|||
162078228|NCT02272413|585345310|FG001|Post-switch Period|Death|2|||
162078229|NCT02272413|585345309|FG000|Post-switch Period|Withdrawal by Subject|1|||
162078230|NCT02272413|585345310|FG001|Post-switch Period|Withdrawal by Subject|2|||
162078231|NCT02272413|585345309|FG000|Post-switch Period|Physician Decision|1|||
162078232|NCT02272413|585345310|FG001|Post-switch Period|Physician Decision|1|||
162078233|NCT02272413|585345309|FG000|Post-switch Period|Progressive disease|21|||
162078234|NCT02272413|585345310|FG001|Post-switch Period|Progressive disease|21|||
162078235|NCT02272413|585345309|FG000|Post-switch Period|Study terminated by sponsor|8|||
162078236|NCT02272413|585345310|FG001|Post-switch Period|Study terminated by sponsor|11|||
162078237|NCT02272413|585345309|FG000|Post-switch Period|Other than listed|4|||
162078238|NCT02272413|585345310|FG001|Post-switch Period|Other than listed|5|||
162078239|NCT04327999|585345311|FG000|Overall Study|Protocol Violation|1|||
162078240|NCT02872116|585345312|FG000|Pre-Treatment|Disease Progression|0|||
162078241|NCT02872116|585345313|FG001|Pre-Treatment|Disease Progression|1|||
162078242|NCT02872116|585345314|FG002|Pre-Treatment|Disease Progression|0|||
162078243|NCT02872116|585345312|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
162078244|NCT02872116|585345313|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
162078245|NCT02872116|585345314|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
162078246|NCT02872116|585345312|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
162078247|NCT02872116|585345313|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
162078248|NCT02872116|585345314|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
162078249|NCT02872116|585345312|FG000|Pre-Treatment|Participant withdrew consent|2|||
162078250|NCT02872116|585345313|FG001|Pre-Treatment|Participant withdrew consent|20|||
162078251|NCT02872116|585345314|FG002|Pre-Treatment|Participant withdrew consent|3|||
162078252|NCT02872116|585345312|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
162078253|NCT02872116|585345313|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
162078254|NCT02872116|585345314|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
162078255|NCT02872116|585345312|FG000|Pre-Treatment|Other reasons|1|||
162078256|NCT02872116|585345313|FG001|Pre-Treatment|Other reasons|2|||
162078257|NCT02872116|585345314|FG002|Pre-Treatment|Other reasons|2|||
162078258|NCT02872116|585345312|FG000|Treatment|Death|121|||
162078259|NCT02872116|585345313|FG001|Treatment|Death|94|||
162078260|NCT02872116|585345314|FG002|Treatment|Death|68|||
162078261|NCT02872116|585345312|FG000|Treatment|Lost to Follow-up|5|||
162078262|NCT02872116|585345313|FG001|Treatment|Lost to Follow-up|7|||
162078263|NCT02872116|585345314|FG002|Treatment|Lost to Follow-up|3|||
162078264|NCT02872116|585345312|FG000|Treatment|Participant withdrew consent|20|||
162078265|NCT02872116|585345313|FG001|Treatment|Participant withdrew consent|40|||
162078266|NCT02872116|585345314|FG002|Treatment|Participant withdrew consent|8|||
162078267|NCT02872116|585345312|FG000|Treatment|Other reasons|13|||
162078268|NCT02872116|585345313|FG001|Treatment|Other reasons|12|||
162078269|NCT02872116|585345314|FG002|Treatment|Other reasons|5|||
162078270|NCT03792672|585345319|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
162078271|NCT03792672|585345320|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
162078272|NCT03792672|585345321|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
162078273|NCT03792672|585345322|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
162078274|NCT03792672|585345323|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
162078275|NCT03792672|585345324|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
162078276|NCT03792672|585345319|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
162078277|NCT03792672|585345320|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
162078278|NCT03792672|585345321|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
162078279|NCT03792672|585345322|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
162078280|NCT03792672|585345323|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
162078281|NCT03792672|585345324|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
162078282|NCT03792672|585345319|FG000|Treatment Period 4 (2 Days)|Other|1|||
162078283|NCT03792672|585345320|FG001|Treatment Period 4 (2 Days)|Other|0|||
162078284|NCT03792672|585345321|FG002|Treatment Period 4 (2 Days)|Other|0|||
162078285|NCT03792672|585345322|FG003|Treatment Period 4 (2 Days)|Other|0|||
162078286|NCT03792672|585345323|FG004|Treatment Period 4 (2 Days)|Other|0|||
162078287|NCT03792672|585345324|FG005|Treatment Period 4 (2 Days)|Other|0|||
162078288|NCT00453999|585345325|FG000|Overall Study|Adverse Event|1|||
162078289|NCT00453999|585345326|FG001|Overall Study|Adverse Event|2|||
162078290|NCT00453999|585345327|FG002|Overall Study|Adverse Event|1|||
162078291|NCT00453999|585345325|FG000|Overall Study|Lost to Follow-up|0|||
162078292|NCT00453999|585345326|FG001|Overall Study|Lost to Follow-up|1|||
162078293|NCT00453999|585345327|FG002|Overall Study|Lost to Follow-up|1|||
162078294|NCT00453999|585345325|FG000|Overall Study|Withdrawal by Subject|2|||
162078295|NCT00453999|585345326|FG001|Overall Study|Withdrawal by Subject|1|||
162078296|NCT00453999|585345327|FG002|Overall Study|Withdrawal by Subject|1|||
162078297|NCT00453999|585345325|FG000|Overall Study|Subject Request|2|||
162078298|NCT00453999|585345326|FG001|Overall Study|Subject Request|1|||
162078299|NCT00453999|585345327|FG002|Overall Study|Subject Request|0|||
162078300|NCT04238728|585345330|FG000|Overall Study|Withdrawal by Subject|1|||
162078301|NCT04238728|585345330|FG000|Overall Study|Lost to Follow-up|2|||
162078302|NCT04225923|585345337|FG000|Overall Study|Protocol Violation|1|||
162078303|NCT04225923|585345338|FG001|Overall Study|Protocol Violation|0|||
162078304|NCT04225923|585345339|FG002|Overall Study|Protocol Violation|1|||
162078305|NCT04225923|585345337|FG000|Overall Study|Withdrawal by Subject|4|||
162078306|NCT04225923|585345338|FG001|Overall Study|Withdrawal by Subject|1|||
162078307|NCT04225923|585345339|FG002|Overall Study|Withdrawal by Subject|3|||
162078308|NCT04225923|585345337|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
162078309|NCT04225923|585345338|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
162078310|NCT04225923|585345339|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
162078311|NCT01907828|585345345|FG000|Overall Study|Exclusion criteria not met|0|||
162078312|NCT01907828|585345346|FG001|Overall Study|Exclusion criteria not met|1|||
162078313|NCT01907828|585345345|FG000|Overall Study|Withdrawal by Subject|3|||
162078314|NCT01907828|585345346|FG001|Overall Study|Withdrawal by Subject|4|||
162078315|NCT01907828|585345345|FG000|Overall Study|Lost to Follow-up|3|||
162078316|NCT01907828|585345346|FG001|Overall Study|Lost to Follow-up|0|||
162078317|NCT01907828|585345345|FG000|Overall Study|Participant refused 24-month follow-up|1|||
162078318|NCT01907828|585345346|FG001|Overall Study|Participant refused 24-month follow-up|0|||
162078319|NCT01907828|585345345|FG000|Overall Study|Participant met exclusion criteria|0|||
162078320|NCT01907828|585345346|FG001|Overall Study|Participant met exclusion criteria|1|||
162078321|NCT04180020|585345353|FG000|Overall Study|missed visit|18|||
162078322|NCT04180020|585345354|FG001|Overall Study|missed visit|16|||
162078323|NCT04180020|585345353|FG000|Overall Study|Death|2|||
162078324|NCT04180020|585345354|FG001|Overall Study|Death|3|||
162078325|NCT04180020|585345353|FG000|Overall Study|Withdrawal by Subject|1|||
162078326|NCT04180020|585345354|FG001|Overall Study|Withdrawal by Subject|5|||
162078327|NCT04180020|585345353|FG000|Overall Study|incarcerated|1|||
162078328|NCT04180020|585345354|FG001|Overall Study|incarcerated|1|||
162078329|NCT04180020|585345353|FG000|Overall Study|Physician Decision|0|||
162078330|NCT04180020|585345354|FG001|Overall Study|Physician Decision|2|||
162078331|NCT03216850|585345359|FG000|Overall Study|Pre-analytical error|6|||
162078332|NCT03554291|585345362|FG000|Overall Study|Death|2|||
162078333|NCT03554291|585345363|FG001|Overall Study|Death|1|||
162078334|NCT03554291|585345362|FG000|Overall Study|Lost to Follow-up|1|||
162078335|NCT03554291|585345363|FG001|Overall Study|Lost to Follow-up|0|||
162078336|NCT03554291|585345362|FG000|Overall Study|Withdrawal by Subject|1|||
162078337|NCT03554291|585345363|FG001|Overall Study|Withdrawal by Subject|0|||
162078338|NCT03554291|585345362|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
162078339|NCT03554291|585345363|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
162078340|NCT01228747|585345364|FG000|Overall Study|Adverse Event|8|||
162078341|NCT01228747|585345365|FG001|Overall Study|Adverse Event|4|||
162078342|NCT01228747|585345364|FG000|Overall Study|Lack of Efficacy|40|||
162078343|NCT01228747|585345365|FG001|Overall Study|Lack of Efficacy|27|||
162078344|NCT01228747|585345364|FG000|Overall Study|Protocol Violation|6|||
162078345|NCT01228747|585345365|FG001|Overall Study|Protocol Violation|5|||
162078346|NCT01228747|585345364|FG000|Overall Study|Lost to Follow-up|4|||
162078347|NCT01228747|585345365|FG001|Overall Study|Lost to Follow-up|3|||
162078348|NCT01228747|585345364|FG000|Overall Study|Withdrawal by Subject|5|||
162078349|NCT01228747|585345365|FG001|Overall Study|Withdrawal by Subject|1|||
162078350|NCT01228747|585345364|FG000|Overall Study|Other Reason|2|||
162078351|NCT01228747|585345365|FG001|Overall Study|Other Reason|5|||
162078352|NCT04258605|585345371|FG000|Overall Study|Death|1|||
162078353|NCT04258605|585345372|FG001|Overall Study|Death|0|||
162078354|NCT04258605|585345371|FG000|Overall Study|Early study termination|21|||
162078355|NCT04258605|585345372|FG001|Overall Study|Early study termination|2|||
162078356|NCT02910167|585345373|FG000|Overall Study|Adverse Event|1|||
162078357|NCT02910167|585345373|FG000|Overall Study|Lost to Follow-up|18|||
162078358|NCT00842348|585345381|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
162078359|NCT00842348|585345382|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
162078360|NCT00842348|585345381|FG000|Study 729|Disease progression/death|19|||
162078361|NCT00842348|585345382|FG001|Study 729|Disease progression/death|30|||
162078362|NCT00842348|585345381|FG000|Study 729|Adverse Event|1|||
162078363|NCT00842348|585345382|FG001|Study 729|Adverse Event|1|||
162078364|NCT00842348|585345381|FG000|Study 729|Protocol Violation|1|||
162078365|NCT00842348|585345382|FG001|Study 729|Protocol Violation|1|||
162078366|NCT00842348|585345381|FG000|Study 729|Withdrawal by Subject|2|||
162078367|NCT00842348|585345382|FG001|Study 729|Withdrawal by Subject|4|||
162078368|NCT00842348|585345381|FG000|Study 729|Due to Sponsor stopping the study|1|||
162078369|NCT00842348|585345382|FG001|Study 729|Due to Sponsor stopping the study|1|||
162078370|NCT00842348|585345381|FG000|Study 729|Due to non-availability of IP|0|||
162078371|NCT00842348|585345382|FG001|Study 729|Due to non-availability of IP|1|||
162078372|NCT00842348|585345381|FG000|Study 729|Sponsor's decision|1|||
162078373|NCT00842348|585345382|FG001|Study 729|Sponsor's decision|0|||
162078374|NCT00842348|585345381|FG000|Study 729|Surgical resection|1|||
162078375|NCT00842348|585345382|FG001|Study 729|Surgical resection|0|||
162078376|NCT00026793|585345387|FG000|Overall Study|Death on study due to underlying disease|4|||
162078377|NCT00026793|585345387|FG000|Overall Study|Physician Decision|2|||
162078378|NCT00026793|585345387|FG000|Overall Study|Off study|2|||
162078379|NCT01449526|585345388|FG000|Overall Study|Lost to Follow-up|1|||
162078380|NCT01449526|585345389|FG001|Overall Study|Lost to Follow-up|2|||
162078381|NCT01449526|585345388|FG000|Overall Study|Withdrawal by Subject|1|||
162078382|NCT01449526|585345389|FG001|Overall Study|Withdrawal by Subject|1|||
162078383|NCT01449526|585345388|FG000|Overall Study|Symptoms/complaints|0|||
162078384|NCT01449526|585345389|FG001|Overall Study|Symptoms/complaints|1|||
162078385|NCT01449526|585345388|FG000|Overall Study|Lack of Motivation|0|||
162078386|NCT01449526|585345389|FG001|Overall Study|Lack of Motivation|1|||
162078387|NCT01449526|585345388|FG000|Overall Study|Cannot maintain visits|0|||
162078388|NCT01449526|585345389|FG001|Overall Study|Cannot maintain visits|1|||
162078389|NCT01132495|585345390|FG000|Overall Study|Various reasons|40|||
162078390|NCT01132495|585345391|FG001|Overall Study|Various reasons|38|||
162078391|NCT01132495|585345392|FG002|Overall Study|Various reasons|20|||
162078392|NCT01132495|585345393|FG003|Overall Study|Various reasons|12|||
162078393|NCT03913091|585345394|FG000|Overall Study|Lost to Follow-up|18|||
162078394|NCT03913091|585345395|FG001|Overall Study|Lost to Follow-up|11|||
162078395|NCT03913091|585345394|FG000|Overall Study|Required additional meds/surgery|1|||
162078396|NCT03913091|585345395|FG001|Overall Study|Required additional meds/surgery|2|||
162078397|NCT03913091|585345394|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
162078398|NCT03913091|585345395|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
162078399|NCT00655564|585345396|FG000|Overall Study|Adverse Event|1|||
162078400|NCT00655564|585345396|FG000|Overall Study|Lost to Follow-up|1|||
162078401|NCT00655564|585345396|FG000|Overall Study|Desired Alternate Therapy|1|||
162078402|NCT04144166|585347846|FG000|Overall Study|Discharged before study start|1|||
162078403|NCT04144166|585347846|FG000|Overall Study|Pregnancy|1|||
162078404|NCT04144166|585347846|FG000|Overall Study|Nail polish could not be removed from finger|1|||
162078405|NCT01236755|585347848|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
162078406|NCT01236755|585347848|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
162078407|NCT01236755|585347848|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
162078408|NCT01236755|585347848|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
162078409|NCT01481116|585347849|FG000|Overall Study|Adverse Event|26|||
162078410|NCT01481116|585347850|FG001|Overall Study|Adverse Event|26|||
162078411|NCT01481116|585347851|FG002|Overall Study|Adverse Event|42|||
162078412|NCT01481116|585347849|FG000|Overall Study|Major Protocol Deviation|3|||
162078413|NCT01481116|585347850|FG001|Overall Study|Major Protocol Deviation|7|||
162078414|NCT01481116|585347851|FG002|Overall Study|Major Protocol Deviation|1|||
162078415|NCT01481116|585347849|FG000|Overall Study|Lost to Follow-up|8|||
162078416|NCT01481116|585347850|FG001|Overall Study|Lost to Follow-up|12|||
162078417|NCT01481116|585347851|FG002|Overall Study|Lost to Follow-up|11|||
162078418|NCT01481116|585347849|FG000|Overall Study|Withdrawal by Subject|37|||
162078419|NCT01481116|585347850|FG001|Overall Study|Withdrawal by Subject|33|||
162078420|NCT01481116|585347851|FG002|Overall Study|Withdrawal by Subject|37|||
162078421|NCT01481116|585347849|FG000|Overall Study|Study Termination|730|||
162078422|NCT01481116|585347850|FG001|Overall Study|Study Termination|729|||
162078423|NCT01481116|585347851|FG002|Overall Study|Study Termination|713|||
162078424|NCT01481116|585347849|FG000|Overall Study|Pregnancy|0|||
162078425|NCT01481116|585347850|FG001|Overall Study|Pregnancy|0|||
162078426|NCT01481116|585347851|FG002|Overall Study|Pregnancy|1|||
162078427|NCT01481116|585347849|FG000|Overall Study|Lack of Efficacy|3|||
162078428|NCT01481116|585347850|FG001|Overall Study|Lack of Efficacy|3|||
162078429|NCT01481116|585347851|FG002|Overall Study|Lack of Efficacy|1|||
162078430|NCT01481116|585347849|FG000|Overall Study|Contraindications|1|||
162078431|NCT01481116|585347850|FG001|Overall Study|Contraindications|1|||
162078432|NCT01481116|585347851|FG002|Overall Study|Contraindications|0|||
162078433|NCT01481116|585347849|FG000|Overall Study|Other|1|||
162078434|NCT01481116|585347850|FG001|Overall Study|Other|1|||
162078435|NCT01481116|585347851|FG002|Overall Study|Other|0|||
162078436|NCT01481116|585347849|FG000|Overall Study|Participant Started Taking Glipizide|1|||
162078437|NCT01481116|585347850|FG001|Overall Study|Participant Started Taking Glipizide|0|||
162078438|NCT01481116|585347851|FG002|Overall Study|Participant Started Taking Glipizide|0|||
162078439|NCT01481116|585347849|FG000|Overall Study|Participant Moved Out of Area|2|||
162078440|NCT01481116|585347850|FG001|Overall Study|Participant Moved Out of Area|0|||
162078441|NCT01481116|585347851|FG002|Overall Study|Participant Moved Out of Area|1|||
162078442|NCT01481116|585347849|FG000|Overall Study|Participant Moved Out of Country|1|||
162078443|NCT01481116|585347850|FG001|Overall Study|Participant Moved Out of Country|0|||
162078444|NCT01481116|585347851|FG002|Overall Study|Participant Moved Out of Country|1|||
162078445|NCT01481116|585347849|FG000|Overall Study|Investigator Decision|3|||
162078446|NCT01481116|585347850|FG001|Overall Study|Investigator Decision|2|||
162078447|NCT01481116|585347851|FG002|Overall Study|Investigator Decision|1|||
162078448|NCT01481116|585347849|FG000|Overall Study|Sponsor Decision|0|||
162078449|NCT01481116|585347850|FG001|Overall Study|Sponsor Decision|1|||
162078450|NCT01481116|585347851|FG002|Overall Study|Sponsor Decision|3|||
162078451|NCT01481116|585347849|FG000|Overall Study|Non-Compliant With Study Drug|0|||
162078452|NCT01481116|585347850|FG001|Overall Study|Non-Compliant With Study Drug|1|||
162078453|NCT01481116|585347851|FG002|Overall Study|Non-Compliant With Study Drug|1|||
162078454|NCT01481116|585347849|FG000|Overall Study|Investigator's Discretion|2|||
162078455|NCT01481116|585347850|FG001|Overall Study|Investigator's Discretion|0|||
162078456|NCT01481116|585347851|FG002|Overall Study|Investigator's Discretion|0|||
162078457|NCT01481116|585347849|FG000|Overall Study|Death|2|||
162078458|NCT01481116|585347850|FG001|Overall Study|Death|1|||
162078459|NCT01481116|585347851|FG002|Overall Study|Death|0|||
162078460|NCT01481116|585347849|FG000|Overall Study|Hypoglycemic Event|4|||
162078461|NCT01481116|585347850|FG001|Overall Study|Hypoglycemic Event|0|||
162078462|NCT01481116|585347851|FG002|Overall Study|Hypoglycemic Event|0|||
162078463|NCT03848845|585347852|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
162078464|NCT03848845|585347853|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
162078465|NCT03848845|585347854|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
162078466|NCT03848845|585347855|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
162078467|NCT03848845|585347852|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
162078468|NCT03848845|585347853|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
162078469|NCT03848845|585347854|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
162078470|NCT03848845|585347855|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
162078471|NCT03848845|585347852|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
162078472|NCT03848845|585347853|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
162078473|NCT03848845|585347854|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
162078474|NCT03848845|585347855|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
162078475|NCT03848845|585347852|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
162078476|NCT03848845|585347853|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
162078477|NCT03848845|585347854|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
162078478|NCT03848845|585347855|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
162078479|NCT02433834|585347857|FG000|Overall Study|Protocol-specified criteria|7|||
162078480|NCT02433834|585347857|FG000|Overall Study|Protocol Violation|3|||
162078481|NCT02433834|585347857|FG000|Overall Study|Lost to Follow-up|6|||
162078482|NCT02433834|585347857|FG000|Overall Study|Withdrawal by Subject|14|||
162078483|NCT02433834|585347857|FG000|Overall Study|Adverse Event|6|||
162078484|NCT02433834|585347857|FG000|Overall Study|Physician Decision|1|||
162078485|NCT00934544|585347858|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
162078486|NCT00934544|585347859|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
162078487|NCT00934544|585347860|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
162078488|NCT00934544|585347858|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
162078489|NCT00934544|585347859|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
162078490|NCT00934544|585347860|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
162078491|NCT00934544|585347858|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
162078492|NCT00934544|585347859|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
162078493|NCT00934544|585347860|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
162078494|NCT00934544|585347858|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
162078495|NCT00934544|585347859|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
162078496|NCT00934544|585347860|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
162078497|NCT00934544|585347858|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
162078498|NCT00934544|585347859|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
162078499|NCT00934544|585347860|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
162078500|NCT00934544|585347858|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
162078501|NCT00934544|585347859|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
162078502|NCT00934544|585347860|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
162078503|NCT00934544|585347858|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
162078504|NCT00934544|585347859|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
162078505|NCT00934544|585347860|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
162078506|NCT00934544|585347858|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
162078507|NCT00934544|585347859|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
162078508|NCT00934544|585347860|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
162078509|NCT00934544|585347858|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
162078510|NCT00934544|585347859|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
162078511|NCT00934544|585347860|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
162078512|NCT00934544|585347858|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
162078513|NCT00934544|585347859|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
162078514|NCT00934544|585347860|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
162078515|NCT00934544|585347858|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
162078516|NCT00934544|585347859|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
162078517|NCT00934544|585347860|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
162078518|NCT00934544|585347858|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
162078519|NCT00934544|585347859|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
162078520|NCT00934544|585347860|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
162078521|NCT00934544|585347858|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
162078522|NCT00934544|585347859|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
162078523|NCT00934544|585347860|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
162078524|NCT00934544|585347858|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
162078525|NCT00934544|585347859|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
162078526|NCT00934544|585347860|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
162078527|NCT00934544|585347858|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
162078528|NCT00934544|585347859|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
162078529|NCT00934544|585347860|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
162078530|NCT00934544|585347858|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
162078531|NCT00934544|585347859|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
162078532|NCT00934544|585347860|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
162078533|NCT02643251|585347861|FG000|Overall Study|Adverse Event|3|||
162078534|NCT02643251|585347862|FG001|Overall Study|Adverse Event|1|||
162078535|NCT02643251|585347861|FG000|Overall Study|Withdrawal by Subject|2|||
162078536|NCT02643251|585347862|FG001|Overall Study|Withdrawal by Subject|0|||
162078537|NCT02643251|585347861|FG000|Overall Study|Lost to Follow-up|4|||
162078538|NCT02643251|585347862|FG001|Overall Study|Lost to Follow-up|1|||
162078539|NCT02643251|585347861|FG000|Overall Study|Protocol Violation|1|||
162078540|NCT02643251|585347862|FG001|Overall Study|Protocol Violation|0|||
162078541|NCT02643251|585347861|FG000|Overall Study|PI Decision to terminate patient|1|||
162078542|NCT02643251|585347862|FG001|Overall Study|PI Decision to terminate patient|0|||
162078543|NCT00348556|585347863|FG000|Overall Study|Adverse Event|1|||
162078544|NCT00192075|585347864|FG000|Overall Study|Disease Progression|23|||
162078545|NCT00192075|585347865|FG001|Overall Study|Disease Progression|6|||
162078546|NCT00192075|585347864|FG000|Overall Study|Adverse Event|1|||
162078547|NCT00192075|585347865|FG001|Overall Study|Adverse Event|3|||
162078548|NCT00192075|585347864|FG000|Overall Study|Death|0|||
162078549|NCT00192075|585347865|FG001|Overall Study|Death|1|||
162078550|NCT00192075|585347864|FG000|Overall Study|Lack of Efficacy|0|||
162078551|NCT00192075|585347865|FG001|Overall Study|Lack of Efficacy|0|||
162078552|NCT00192075|585347864|FG000|Overall Study|Physician Decision|3|||
162078553|NCT00192075|585347865|FG001|Overall Study|Physician Decision|0|||
162078554|NCT00192075|585347864|FG000|Overall Study|Withdrawal by Subject|5|||
162078555|NCT00192075|585347865|FG001|Overall Study|Withdrawal by Subject|5|||
162078556|NCT00192075|585347864|FG000|Overall Study|Patient Non-Compliance|0|||
162078557|NCT00192075|585347865|FG001|Overall Study|Patient Non-Compliance|1|||
162078558|NCT00192075|585347864|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
162078559|NCT00192075|585347865|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
162078560|NCT00192075|585347864|FG000|Overall Study|Other|5|||
162078561|NCT00192075|585347865|FG001|Overall Study|Other|2|||
162078562|NCT00779675|585347866|FG000|Treatment Period|Adverse Event|87|||
162078563|NCT00779675|585347866|FG000|Treatment Period|Treatment Failure|80|||
162078564|NCT00779675|585347866|FG000|Treatment Period|Transferred to Another Study|38|||
162078565|NCT00779675|585347866|FG000|Treatment Period|Lost to Follow-up|23|||
162078566|NCT00779675|585347866|FG000|Treatment Period|Withdrawal by Subject|46|||
162078567|NCT00779675|585347866|FG000|Treatment Period|Protocol Violation|54|||
162078568|NCT00779675|585347866|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
162078569|NCT00779675|585347866|FG000|Treatment Period|Administrative|3|||
162078570|NCT00779675|585347866|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
162078571|NCT00779675|585347866|FG000|Extended Treatment Period|Protocol Violation|13|||
162078572|NCT00779675|585347866|FG000|Extended Treatment Period|Adverse Event|6|||
162078573|NCT00779675|585347866|FG000|Extended Treatment Period|Treatment Failure|11|||
162078574|NCT00779675|585347866|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
162078575|NCT00779675|585347866|FG000|Extended Treatment Period|Lost to Follow-up|6|||
162078576|NCT01944059|585347867|FG000|Overall Study|Lost to Follow-up|1|||
162078577|NCT01944059|585347867|FG000|Overall Study|Physician Decision|3|||
162078578|NCT01944059|585347867|FG000|Overall Study|Withdrawal by Subject|1|||
162078579|NCT01944059|585347867|FG000|Overall Study|Adverse Event|2|||
162078580|NCT00430092|585347874|FG000|Overall Study|Adverse Event|0|||
162078581|NCT00430092|585347875|FG001|Overall Study|Adverse Event|0|||
162078582|NCT00430092|585347876|FG002|Overall Study|Adverse Event|1|||
162078583|NCT00430092|585347874|FG000|Overall Study|Lack of Efficacy|5|||
162078584|NCT00430092|585347875|FG001|Overall Study|Lack of Efficacy|2|||
162078585|NCT00430092|585347876|FG002|Overall Study|Lack of Efficacy|54|||
162078586|NCT00430092|585347874|FG000|Overall Study|Lost to Follow-up|1|||
162078587|NCT00430092|585347875|FG001|Overall Study|Lost to Follow-up|0|||
162078588|NCT00430092|585347876|FG002|Overall Study|Lost to Follow-up|0|||
162078589|NCT00430092|585347874|FG000|Overall Study|Protocol Violation|0|||
162078590|NCT00430092|585347875|FG001|Overall Study|Protocol Violation|1|||
162078591|NCT00430092|585347876|FG002|Overall Study|Protocol Violation|1|||
162078592|NCT00430092|585347874|FG000|Overall Study|Withdrawal by Subject|0|||
162078593|NCT00430092|585347875|FG001|Overall Study|Withdrawal by Subject|1|||
162078594|NCT00430092|585347876|FG002|Overall Study|Withdrawal by Subject|1|||
162078595|NCT01956110|585347877|FG000|Overall Study|Protocol Violation|25|||
162078596|NCT01956110|585347878|FG001|Overall Study|Protocol Violation|11|||
162078597|NCT01956110|585347877|FG000|Overall Study|Adverse Event|9|||
162078598|NCT01956110|585347878|FG001|Overall Study|Adverse Event|10|||
162078599|NCT01956110|585347877|FG000|Overall Study|Personal reasons|1|||
162078600|NCT01956110|585347878|FG001|Overall Study|Personal reasons|1|||
162078601|NCT00463060|585347885|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
162078602|NCT00463060|585347885|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
162078603|NCT01400841|585347886|FG000|Initial Study Phase (6 Months)|Death|1|||
162078604|NCT01400841|585347886|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
162078605|NCT00701129|585347887|FG000|Overall Study|Death|2|||
162078606|NCT00910715|585347890|FG000|Overall Study|Lost to Follow-up|22|||
162078607|NCT00910715|585347891|FG001|Overall Study|Lost to Follow-up|26|||
162078608|NCT00910715|585347892|FG002|Overall Study|Lost to Follow-up|0|||
162078609|NCT02412631|585347893|FG000|Overall Study|Adverse Event|1|||
162078610|NCT02412631|585347894|FG001|Overall Study|Adverse Event|2|||
162078611|NCT02412631|585347893|FG000|Overall Study|Lost to Follow-up|5|||
162078612|NCT02412631|585347894|FG001|Overall Study|Lost to Follow-up|9|||
162078613|NCT02412631|585347893|FG000|Overall Study|Withdrawal by Subject|9|||
162078614|NCT02412631|585347894|FG001|Overall Study|Withdrawal by Subject|3|||
162078615|NCT02412631|585347893|FG000|Overall Study|Early stop by FDA|5|||
162078616|NCT02412631|585347894|FG001|Overall Study|Early stop by FDA|2|||
162078617|NCT02412631|585347893|FG000|Overall Study|Unspecified reason|6|||
162078618|NCT02412631|585347894|FG001|Overall Study|Unspecified reason|8|||
162078619|NCT00706966|585347895|FG000|Overall Study|Adverse Event|1|||
162078620|NCT02884089|585347896|FG000|Period 1|Dosing error|2|||
162078621|NCT02884089|585347897|FG001|Period 1|Dosing error|2|||
162078622|NCT02884089|585347898|FG002|Period 1|Dosing error|0|||
162078623|NCT02884089|585347899|FG003|Period 1|Dosing error|0|||
162078624|NCT02884089|585347896|FG000|Washout Period 1|Lost to Follow-up|0|||
162078625|NCT02884089|585347897|FG001|Washout Period 1|Lost to Follow-up|1|||
162078626|NCT02884089|585347898|FG002|Washout Period 1|Lost to Follow-up|0|||
162078627|NCT02884089|585347899|FG003|Washout Period 1|Lost to Follow-up|1|||
162078628|NCT02884089|585347896|FG000|Washout Period 1|Withdrawal by Subject|0|||
162078629|NCT02884089|585347897|FG001|Washout Period 1|Withdrawal by Subject|1|||
162078630|NCT02884089|585347898|FG002|Washout Period 1|Withdrawal by Subject|0|||
162078631|NCT02884089|585347899|FG003|Washout Period 1|Withdrawal by Subject|0|||
162078632|NCT02884089|585347896|FG000|Period 2|Adverse Event|1|||
162078633|NCT02884089|585347897|FG001|Period 2|Adverse Event|0|||
162078634|NCT02884089|585347898|FG002|Period 2|Adverse Event|0|||
162078635|NCT02884089|585347899|FG003|Period 2|Adverse Event|0|||
162078636|NCT02884089|585347896|FG000|Period 3|Withdrawal by Subject|0|||
162078637|NCT02884089|585347897|FG001|Period 3|Withdrawal by Subject|0|||
162078638|NCT02884089|585347898|FG002|Period 3|Withdrawal by Subject|1|||
162078639|NCT02884089|585347899|FG003|Period 3|Withdrawal by Subject|0|||
162078640|NCT02884089|585347896|FG000|Washout Period 3|Withdrawal by Subject|0|||
162078641|NCT02884089|585347897|FG001|Washout Period 3|Withdrawal by Subject|0|||
162078642|NCT02884089|585347898|FG002|Washout Period 3|Withdrawal by Subject|1|||
162078643|NCT02884089|585347899|FG003|Washout Period 3|Withdrawal by Subject|0|||
162078644|NCT02884089|585347896|FG000|Washout Period 3|Lost to Follow-up|0|||
162078645|NCT02884089|585347897|FG001|Washout Period 3|Lost to Follow-up|0|||
162078646|NCT02884089|585347898|FG002|Washout Period 3|Lost to Follow-up|0|||
162078647|NCT02884089|585347899|FG003|Washout Period 3|Lost to Follow-up|1|||
162078648|NCT02884089|585347896|FG000|Period 4|Withdrawal by Subject|0|||
162078649|NCT02884089|585347897|FG001|Period 4|Withdrawal by Subject|1|||
162078650|NCT02884089|585347898|FG002|Period 4|Withdrawal by Subject|0|||
162078651|NCT02884089|585347899|FG003|Period 4|Withdrawal by Subject|0|||
162078652|NCT02884089|585347896|FG000|Period 4|Lost to Follow-up|1|||
162078653|NCT02884089|585347897|FG001|Period 4|Lost to Follow-up|0|||
162078654|NCT02884089|585347898|FG002|Period 4|Lost to Follow-up|0|||
162078655|NCT02884089|585347899|FG003|Period 4|Lost to Follow-up|0|||
162078656|NCT02884089|585347896|FG000|Follow-up Visit|Withdrawal by Subject|1|||
162078657|NCT02884089|585347897|FG001|Follow-up Visit|Withdrawal by Subject|0|||
162078658|NCT02884089|585347898|FG002|Follow-up Visit|Withdrawal by Subject|0|||
162078659|NCT02884089|585347899|FG003|Follow-up Visit|Withdrawal by Subject|1|||
162078660|NCT01631474|585347904|FG000|Overall Study|Lost to Follow-up|8|||
162078661|NCT01631474|585347905|FG001|Overall Study|Lost to Follow-up|5|||
162078662|NCT01631474|585347906|FG002|Overall Study|Lost to Follow-up|7|||
162078663|NCT01631474|585347907|FG003|Overall Study|Lost to Follow-up|5|||
162078664|NCT01631474|585347908|FG004|Overall Study|Lost to Follow-up|5|||
162078665|NCT01631474|585347904|FG000|Overall Study|Withdrawal by Subject|4|||
162078666|NCT01631474|585347905|FG001|Overall Study|Withdrawal by Subject|4|||
162078667|NCT01631474|585347906|FG002|Overall Study|Withdrawal by Subject|2|||
162078668|NCT01631474|585347907|FG003|Overall Study|Withdrawal by Subject|6|||
162078669|NCT01631474|585347908|FG004|Overall Study|Withdrawal by Subject|5|||
162078670|NCT01631474|585347904|FG000|Overall Study|Lack of Efficacy|2|||
162078671|NCT01631474|585347905|FG001|Overall Study|Lack of Efficacy|2|||
162078672|NCT01631474|585347906|FG002|Overall Study|Lack of Efficacy|0|||
162078673|NCT01631474|585347907|FG003|Overall Study|Lack of Efficacy|0|||
162078674|NCT01631474|585347908|FG004|Overall Study|Lack of Efficacy|2|||
162078675|NCT01631474|585347904|FG000|Overall Study|Noncompliance with Study Drug|0|||
162078676|NCT01631474|585347905|FG001|Overall Study|Noncompliance with Study Drug|0|||
162078677|NCT01631474|585347906|FG002|Overall Study|Noncompliance with Study Drug|0|||
162078678|NCT01631474|585347907|FG003|Overall Study|Noncompliance with Study Drug|0|||
162078679|NCT01631474|585347908|FG004|Overall Study|Noncompliance with Study Drug|1|||
162078680|NCT01631474|585347904|FG000|Overall Study|Adverse Event|0|||
162078681|NCT01631474|585347905|FG001|Overall Study|Adverse Event|1|||
162078682|NCT01631474|585347906|FG002|Overall Study|Adverse Event|0|||
162078683|NCT01631474|585347907|FG003|Overall Study|Adverse Event|0|||
162078684|NCT01631474|585347908|FG004|Overall Study|Adverse Event|0|||
162078685|NCT01467076|585347909|FG000|Overall Study|Lost to Follow-up|1|||
162078686|NCT01467076|585347910|FG001|Overall Study|Lost to Follow-up|0|||
162078687|NCT01467076|585347911|FG002|Overall Study|Lost to Follow-up|0|||
162078688|NCT00654381|585347916|FG000|1st Stage|Adverse Event|3|||
162078689|NCT00654381|585347917|FG001|1st Stage|Adverse Event|3|||
162078690|NCT00654381|585347918|FG002|1st Stage|Adverse Event|3|||
162078691|NCT00654381|585347919|FG003|1st Stage|Adverse Event|3|||
162078692|NCT00654381|585347920|FG004|1st Stage|Adverse Event|2|||
162078693|NCT00654381|585347921|FG005|1st Stage|Adverse Event|1|||
162078694|NCT00654381|585347916|FG000|1st Stage|Withdrawal by Subject|0|||
162078695|NCT00654381|585347917|FG001|1st Stage|Withdrawal by Subject|0|||
162078696|NCT00654381|585347918|FG002|1st Stage|Withdrawal by Subject|0|||
162078697|NCT00654381|585347919|FG003|1st Stage|Withdrawal by Subject|1|||
162078698|NCT00654381|585347920|FG004|1st Stage|Withdrawal by Subject|0|||
162078699|NCT00654381|585347921|FG005|1st Stage|Withdrawal by Subject|1|||
162078700|NCT00654381|585347916|FG000|1st Stage|Investigator's decision|0|||
162078701|NCT00654381|585347917|FG001|1st Stage|Investigator's decision|0|||
162078702|NCT00654381|585347918|FG002|1st Stage|Investigator's decision|0|||
162078703|NCT00654381|585347919|FG003|1st Stage|Investigator's decision|1|||
162078704|NCT00654381|585347920|FG004|1st Stage|Investigator's decision|0|||
162078705|NCT00654381|585347921|FG005|1st Stage|Investigator's decision|0|||
162078706|NCT00654381|585347916|FG000|2nd Stage|Adverse Event|2|||
162078707|NCT00654381|585347917|FG001|2nd Stage|Adverse Event|0|||
162078708|NCT00654381|585347918|FG002|2nd Stage|Adverse Event|2|||
162078709|NCT00654381|585347919|FG003|2nd Stage|Adverse Event|3|||
162078710|NCT00654381|585347920|FG004|2nd Stage|Adverse Event|7|||
162078711|NCT00654381|585347921|FG005|2nd Stage|Adverse Event|2|||
162078712|NCT00654381|585347916|FG000|2nd Stage|Withdrawal by Subject|0|||
162078713|NCT00654381|585347917|FG001|2nd Stage|Withdrawal by Subject|0|||
162078714|NCT00654381|585347918|FG002|2nd Stage|Withdrawal by Subject|0|||
162078715|NCT00654381|585347919|FG003|2nd Stage|Withdrawal by Subject|0|||
162078716|NCT00654381|585347920|FG004|2nd Stage|Withdrawal by Subject|1|||
162078717|NCT00654381|585347921|FG005|2nd Stage|Withdrawal by Subject|1|||
162078718|NCT00654381|585347916|FG000|2nd Stage|Investigator's decision|0|||
162078719|NCT00654381|585347917|FG001|2nd Stage|Investigator's decision|0|||
162078720|NCT00654381|585347918|FG002|2nd Stage|Investigator's decision|1|||
162078721|NCT00654381|585347919|FG003|2nd Stage|Investigator's decision|1|||
162078722|NCT00654381|585347920|FG004|2nd Stage|Investigator's decision|0|||
162078723|NCT00654381|585347921|FG005|2nd Stage|Investigator's decision|0|||
162078724|NCT00654381|585347916|FG000|Extension Stage|Adverse Event|1|||
162078725|NCT00654381|585347917|FG001|Extension Stage|Adverse Event|2|||
162078726|NCT00654381|585347918|FG002|Extension Stage|Adverse Event|9|||
162078727|NCT00654381|585347919|FG003|Extension Stage|Adverse Event|7|||
162078728|NCT00654381|585347920|FG004|Extension Stage|Adverse Event|1|||
162078729|NCT00654381|585347921|FG005|Extension Stage|Adverse Event|1|||
162078730|NCT00654381|585347916|FG000|Extension Stage|Protocol Violation|0|||
162078731|NCT00654381|585347917|FG001|Extension Stage|Protocol Violation|0|||
162078732|NCT00654381|585347918|FG002|Extension Stage|Protocol Violation|0|||
162078733|NCT00654381|585347919|FG003|Extension Stage|Protocol Violation|1|||
162078734|NCT00654381|585347920|FG004|Extension Stage|Protocol Violation|0|||
162078735|NCT00654381|585347921|FG005|Extension Stage|Protocol Violation|0|||
162078736|NCT00654381|585347916|FG000|Extension Stage|Lack of Efficacy|0|||
162078737|NCT00654381|585347917|FG001|Extension Stage|Lack of Efficacy|0|||
162078738|NCT00654381|585347918|FG002|Extension Stage|Lack of Efficacy|1|||
162078739|NCT00654381|585347919|FG003|Extension Stage|Lack of Efficacy|0|||
162078740|NCT00654381|585347920|FG004|Extension Stage|Lack of Efficacy|0|||
162078741|NCT00654381|585347921|FG005|Extension Stage|Lack of Efficacy|0|||
162078742|NCT00654381|585347916|FG000|Extension Stage|Withdrawal by Subject|0|||
162078743|NCT00654381|585347917|FG001|Extension Stage|Withdrawal by Subject|0|||
162078744|NCT00654381|585347918|FG002|Extension Stage|Withdrawal by Subject|1|||
162078745|NCT00654381|585347919|FG003|Extension Stage|Withdrawal by Subject|1|||
162078746|NCT00654381|585347920|FG004|Extension Stage|Withdrawal by Subject|1|||
162078747|NCT00654381|585347921|FG005|Extension Stage|Withdrawal by Subject|1|||
162078748|NCT00654381|585347916|FG000|Extension Stage|Closure of the trial site|0|||
162078749|NCT00654381|585347917|FG001|Extension Stage|Closure of the trial site|0|||
162078750|NCT00654381|585347918|FG002|Extension Stage|Closure of the trial site|0|||
162078751|NCT00654381|585347919|FG003|Extension Stage|Closure of the trial site|0|||
162078752|NCT00654381|585347920|FG004|Extension Stage|Closure of the trial site|1|||
162078753|NCT00654381|585347921|FG005|Extension Stage|Closure of the trial site|1|||
162078754|NCT03100825|585347922|FG000|Overall Study|Participant/Guardian Decision|7|||
162078755|NCT03100825|585347922|FG000|Overall Study|Physician Decision|1|||
162078756|NCT00994448|585347924|FG000|Overall Study|Adverse Event|1|||
162078757|NCT00994448|585347925|FG001|Overall Study|Adverse Event|0|||
162078758|NCT00994448|585347924|FG000|Overall Study|Lost to Follow-up|5|||
162078759|NCT00994448|585347925|FG001|Overall Study|Lost to Follow-up|1|||
162078760|NCT00994448|585347924|FG000|Overall Study|Withdrawal by Subject|1|||
162078761|NCT00994448|585347925|FG001|Overall Study|Withdrawal by Subject|1|||
162078762|NCT00994448|585347924|FG000|Overall Study|Physician Decision|1|||
162078763|NCT00994448|585347925|FG001|Overall Study|Physician Decision|0|||
162078764|NCT05288556|585347927|FG000|Overall Study|Protocol Violation|1|||
162078765|NCT05288556|585347927|FG000|Overall Study|Withdrawal by Subject|1|||
162078766|NCT02704364|585347928|FG000|Overall Study|Adverse Event|1|||
162078767|NCT02704364|585347929|FG001|Overall Study|Adverse Event|1|||
162078768|NCT02704364|585347930|FG002|Overall Study|Adverse Event|0|||
162078769|NCT02704364|585347928|FG000|Overall Study|Noncompliance with study drug|1|||
162078770|NCT02704364|585347929|FG001|Overall Study|Noncompliance with study drug|1|||
162078771|NCT02704364|585347930|FG002|Overall Study|Noncompliance with study drug|0|||
162078772|NCT02704364|585347928|FG000|Overall Study|Other|0|||
162078773|NCT02704364|585347929|FG001|Overall Study|Other|1|||
162078774|NCT02704364|585347930|FG002|Overall Study|Other|1|||
162078775|NCT00006489|585347931|FG000|Overall Study|Adverse Event|3|||
162078776|NCT00006489|585347932|FG001|Overall Study|Adverse Event|2|||
162078777|NCT00006489|585347933|FG002|Overall Study|Adverse Event|4|||
162078778|NCT00006489|585347934|FG003|Overall Study|Adverse Event|3|||
162078779|NCT00006489|585347931|FG000|Overall Study|Withdrawal by Subject|10|||
162078780|NCT00006489|585347932|FG001|Overall Study|Withdrawal by Subject|9|||
162078781|NCT00006489|585347933|FG002|Overall Study|Withdrawal by Subject|9|||
162078782|NCT00006489|585347934|FG003|Overall Study|Withdrawal by Subject|6|||
162078783|NCT00006489|585347931|FG000|Overall Study|Scheduling Conflict|0|||
162078784|NCT00006489|585347932|FG001|Overall Study|Scheduling Conflict|3|||
162078785|NCT00006489|585347933|FG002|Overall Study|Scheduling Conflict|2|||
162078786|NCT00006489|585347934|FG003|Overall Study|Scheduling Conflict|1|||
162078787|NCT00006489|585347931|FG000|Overall Study|Death|0|||
162078788|NCT00006489|585347932|FG001|Overall Study|Death|0|||
162078789|NCT00006489|585347933|FG002|Overall Study|Death|0|||
162078790|NCT00006489|585347934|FG003|Overall Study|Death|1|||
162078791|NCT00578175|585347935|FG000|Overall Study|Adverse Event|0|||
162078792|NCT00578175|585347936|FG001|Overall Study|Adverse Event|1|||
162078793|NCT00578175|585347937|FG002|Overall Study|Adverse Event|1|||
162078794|NCT00578175|585347935|FG000|Overall Study|Other reasons|70|||
162078795|NCT00578175|585347936|FG001|Overall Study|Other reasons|42|||
162078796|NCT00578175|585347937|FG002|Overall Study|Other reasons|23|||
162078797|NCT01479621|585347943|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
162078798|NCT01479621|585347944|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162078799|NCT01479621|585347945|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162078800|NCT01479621|585347946|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162078801|NCT01479621|585347947|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162078802|NCT01479621|585347948|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162078803|NCT01479621|585347949|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162078804|NCT01479621|585347943|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
162078805|NCT01479621|585347944|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162078806|NCT01479621|585347945|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162078807|NCT01479621|585347946|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162078808|NCT01479621|585347947|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162078809|NCT01479621|585347948|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162078810|NCT01479621|585347949|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162078811|NCT01479621|585347943|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
162078812|NCT01479621|585347944|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162078813|NCT01479621|585347945|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162078814|NCT01479621|585347946|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162078815|NCT01479621|585347947|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162078816|NCT01479621|585347948|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162078817|NCT01479621|585347949|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162078818|NCT01479621|585347943|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
162078819|NCT01479621|585347944|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162078820|NCT01479621|585347945|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162078821|NCT01479621|585347946|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162078822|NCT01479621|585347947|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162078823|NCT01479621|585347948|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162078824|NCT01479621|585347949|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162078825|NCT01479621|585347943|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
162078826|NCT01479621|585347944|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162078827|NCT01479621|585347945|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162078828|NCT01479621|585347946|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162078829|NCT01479621|585347947|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162078830|NCT01479621|585347948|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162078831|NCT01479621|585347949|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162078832|NCT01479621|585347943|FG000|Treatment Period|Adverse Event|0|||
162078833|NCT01479621|585347944|FG001|Treatment Period|Adverse Event|0|||
162078834|NCT01479621|585347945|FG002|Treatment Period|Adverse Event|0|||
162078835|NCT01479621|585347946|FG003|Treatment Period|Adverse Event|0|||
162078836|NCT01479621|585347947|FG004|Treatment Period|Adverse Event|1|||
162078837|NCT01479621|585347948|FG005|Treatment Period|Adverse Event|2|||
162078838|NCT01479621|585347949|FG006|Treatment Period|Adverse Event|2|||
162078839|NCT01479621|585347943|FG000|Treatment Period|Withdrawal by Subject|0|||
162078840|NCT01479621|585347944|FG001|Treatment Period|Withdrawal by Subject|4|||
162078841|NCT01479621|585347945|FG002|Treatment Period|Withdrawal by Subject|2|||
162078842|NCT01479621|585347946|FG003|Treatment Period|Withdrawal by Subject|2|||
162078843|NCT01479621|585347947|FG004|Treatment Period|Withdrawal by Subject|5|||
162078844|NCT01479621|585347948|FG005|Treatment Period|Withdrawal by Subject|5|||
162078845|NCT01479621|585347949|FG006|Treatment Period|Withdrawal by Subject|1|||
162078846|NCT01479621|585347943|FG000|Treatment Period|Physician Decision|0|||
162078847|NCT01479621|585347944|FG001|Treatment Period|Physician Decision|0|||
162078848|NCT01479621|585347945|FG002|Treatment Period|Physician Decision|0|||
162078849|NCT01479621|585347946|FG003|Treatment Period|Physician Decision|0|||
162078850|NCT01479621|585347947|FG004|Treatment Period|Physician Decision|1|||
162078851|NCT01479621|585347948|FG005|Treatment Period|Physician Decision|1|||
162078852|NCT01479621|585347949|FG006|Treatment Period|Physician Decision|0|||
162078853|NCT01479621|585347943|FG000|Treatment Period|Non-compliance to study drug|0|||
162078854|NCT01479621|585347944|FG001|Treatment Period|Non-compliance to study drug|1|||
162078855|NCT01479621|585347945|FG002|Treatment Period|Non-compliance to study drug|0|||
162078856|NCT01479621|585347946|FG003|Treatment Period|Non-compliance to study drug|0|||
162078857|NCT01479621|585347947|FG004|Treatment Period|Non-compliance to study drug|0|||
162078858|NCT01479621|585347948|FG005|Treatment Period|Non-compliance to study drug|0|||
162078859|NCT01479621|585347949|FG006|Treatment Period|Non-compliance to study drug|1|||
162078860|NCT01479621|585347943|FG000|Treatment Period|Protocol Violation|0|||
162078861|NCT01479621|585347944|FG001|Treatment Period|Protocol Violation|9|||
162078862|NCT01479621|585347945|FG002|Treatment Period|Protocol Violation|6|||
162078863|NCT01479621|585347946|FG003|Treatment Period|Protocol Violation|5|||
162078864|NCT01479621|585347947|FG004|Treatment Period|Protocol Violation|2|||
162078865|NCT01479621|585347948|FG005|Treatment Period|Protocol Violation|10|||
162078866|NCT01479621|585347949|FG006|Treatment Period|Protocol Violation|6|||
162078867|NCT01479621|585347943|FG000|Treatment Period|Pregnancy|0|||
162078868|NCT01479621|585347944|FG001|Treatment Period|Pregnancy|0|||
162078869|NCT01479621|585347945|FG002|Treatment Period|Pregnancy|2|||
162078870|NCT01479621|585347946|FG003|Treatment Period|Pregnancy|0|||
162078871|NCT01479621|585347947|FG004|Treatment Period|Pregnancy|0|||
162078872|NCT01479621|585347948|FG005|Treatment Period|Pregnancy|0|||
162078873|NCT01479621|585347949|FG006|Treatment Period|Pregnancy|0|||
162078874|NCT01479621|585347943|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
162078875|NCT01479621|585347944|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
162078876|NCT01479621|585347945|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
162078877|NCT01479621|585347946|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
162078878|NCT01479621|585347947|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
162078879|NCT01479621|585347948|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
162078880|NCT01479621|585347949|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
162078881|NCT01479621|585347943|FG000|Treatment Period|Lost to Follow-up|0|||
162078882|NCT01479621|585347944|FG001|Treatment Period|Lost to Follow-up|0|||
162078883|NCT01479621|585347945|FG002|Treatment Period|Lost to Follow-up|1|||
162078884|NCT01479621|585347946|FG003|Treatment Period|Lost to Follow-up|0|||
162078885|NCT01479621|585347947|FG004|Treatment Period|Lost to Follow-up|2|||
162078886|NCT01479621|585347948|FG005|Treatment Period|Lost to Follow-up|2|||
162078887|NCT01479621|585347949|FG006|Treatment Period|Lost to Follow-up|1|||
162078888|NCT01479621|585347943|FG000|Treatment Period|Met stopping criteria|0|||
162078889|NCT01479621|585347944|FG001|Treatment Period|Met stopping criteria|8|||
162078890|NCT01479621|585347945|FG002|Treatment Period|Met stopping criteria|7|||
162078891|NCT01479621|585347946|FG003|Treatment Period|Met stopping criteria|4|||
162078892|NCT01479621|585347947|FG004|Treatment Period|Met stopping criteria|9|||
162078893|NCT01479621|585347948|FG005|Treatment Period|Met stopping criteria|20|||
162078894|NCT01479621|585347949|FG006|Treatment Period|Met stopping criteria|6|||
162078895|NCT02308735|585347952|FG000|Overall Study|Physician Decision|2|||
162078896|NCT02308735|585347953|FG001|Overall Study|Physician Decision|0|||
162078897|NCT02308735|585347954|FG002|Overall Study|Physician Decision|0|||
162078898|NCT02308735|585347955|FG003|Overall Study|Physician Decision|2|||
162078899|NCT01417481|585347958|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
162078900|NCT01417481|585347959|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
162078901|NCT03029624|585347962|FG000|Overall Study|Adverse Event|1|||
162078902|NCT03029624|585347962|FG000|Overall Study|Withdrawal by Subject|1|||
162078903|NCT03029624|585347962|FG000|Overall Study|Lack of Efficacy|1|||
162078904|NCT03029624|585347962|FG000|Overall Study|MRI need|2|||
162078905|NCT01371656|585347964|FG000|Overall Study|Death|7|||
162078906|NCT01371656|585347965|FG001|Overall Study|Death|4|||
162078907|NCT01371656|585347964|FG000|Overall Study|Physician Decision|46|||
162078908|NCT01371656|585347965|FG001|Overall Study|Physician Decision|7|||
162078909|NCT01371656|585347964|FG000|Overall Study|Withdrawal by Subject|7|||
162078910|NCT01371656|585347965|FG001|Overall Study|Withdrawal by Subject|0|||
162078911|NCT01371656|585347964|FG000|Overall Study|Ineligible|4|||
162078912|NCT01371656|585347965|FG001|Overall Study|Ineligible|3|||
162078913|NCT00974571|585347966|FG000|Overall Study|Adverse Event|31|||
162078914|NCT00974571|585347967|FG001|Overall Study|Adverse Event|4|||
162078915|NCT00974571|585347968|FG002|Overall Study|Adverse Event|27|||
162078916|NCT00974571|585347966|FG000|Overall Study|Lack of Efficacy|3|||
162078917|NCT00974571|585347967|FG001|Overall Study|Lack of Efficacy|2|||
162078918|NCT00974571|585347968|FG002|Overall Study|Lack of Efficacy|9|||
162078919|NCT00974571|585347966|FG000|Overall Study|Lost to Follow-up|2|||
162078920|NCT00974571|585347967|FG001|Overall Study|Lost to Follow-up|1|||
162078921|NCT00974571|585347968|FG002|Overall Study|Lost to Follow-up|2|||
162078922|NCT00974571|585347966|FG000|Overall Study|Protocol Violation|13|||
162078923|NCT00974571|585347967|FG001|Overall Study|Protocol Violation|4|||
162078924|NCT00974571|585347968|FG002|Overall Study|Protocol Violation|18|||
162078925|NCT00974571|585347966|FG000|Overall Study|Withdrawal by Subject|14|||
162078926|NCT00974571|585347967|FG001|Overall Study|Withdrawal by Subject|5|||
162078927|NCT00974571|585347968|FG002|Overall Study|Withdrawal by Subject|16|||
162078928|NCT00974571|585347966|FG000|Overall Study|Patient Moved|1|||
162078929|NCT00974571|585347967|FG001|Overall Study|Patient Moved|0|||
162078930|NCT00974571|585347968|FG002|Overall Study|Patient Moved|1|||
162078931|NCT00974571|585347966|FG000|Overall Study|Other|4|||
162078932|NCT00974571|585347967|FG001|Overall Study|Other|0|||
162078933|NCT00974571|585347968|FG002|Overall Study|Other|10|||
162078934|NCT04334460|585347981|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
162078935|NCT04334460|585347982|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
162078936|NCT04334460|585347981|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
162078937|NCT04334460|585347982|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
162078938|NCT03778931|585347983|FG000|Overall Study|Withdrawal by Subject|12|||
162078939|NCT03778931|585347984|FG001|Overall Study|Withdrawal by Subject|25|||
162078940|NCT03778931|585347983|FG000|Overall Study|Physician Decision|1|||
162078941|NCT03778931|585347984|FG001|Overall Study|Physician Decision|3|||
162078942|NCT03778931|585347983|FG000|Overall Study|Participant Noncompliance|1|||
162078943|NCT03778931|585347984|FG001|Overall Study|Participant Noncompliance|1|||
162078944|NCT03778931|585347983|FG000|Overall Study|Lost to Follow-up|4|||
162078945|NCT03778931|585347984|FG001|Overall Study|Lost to Follow-up|1|||
162078946|NCT03778931|585347983|FG000|Overall Study|Death|69|||
162078947|NCT03778931|585347984|FG001|Overall Study|Death|79|||
162078948|NCT00775437|585347985|FG000|Overall Study|Loss of efficacy|2|||
162078949|NCT00775437|585347985|FG000|Overall Study|Withdrawal by Subject|3|||
162078950|NCT00775437|585347985|FG000|Overall Study|Lost to Follow-up|1|||
162078951|NCT02357940|585347992|FG000|Overall Study|Adverse Event|0|||
162078952|NCT02357940|585347993|FG001|Overall Study|Adverse Event|1|||
162078953|NCT02357940|585347992|FG000|Overall Study|Investigator's judgement|0|||
162078954|NCT02357940|585347993|FG001|Overall Study|Investigator's judgement|1|||
162078955|NCT02442778|585347994|FG000|Overall Study|Adverse Event|2|||
162078956|NCT02442778|585347995|FG001|Overall Study|Adverse Event|6|||
162078957|NCT02442778|585347996|FG002|Overall Study|Adverse Event|6|||
162078958|NCT02442778|585347994|FG000|Overall Study|Death|0|||
162078959|NCT02442778|585347995|FG001|Overall Study|Death|2|||
162078960|NCT02442778|585347996|FG002|Overall Study|Death|0|||
162078961|NCT02442778|585347994|FG000|Overall Study|Lack of Efficacy|1|||
162078962|NCT02442778|585347995|FG001|Overall Study|Lack of Efficacy|0|||
162078963|NCT02442778|585347996|FG002|Overall Study|Lack of Efficacy|0|||
162078964|NCT02442778|585347994|FG000|Overall Study|Lost to Follow-up|1|||
162078965|NCT02442778|585347995|FG001|Overall Study|Lost to Follow-up|1|||
162078966|NCT02442778|585347996|FG002|Overall Study|Lost to Follow-up|1|||
162078967|NCT02442778|585347994|FG000|Overall Study|Non-compliance with study drug|2|||
162078968|NCT02442778|585347995|FG001|Overall Study|Non-compliance with study drug|0|||
162078969|NCT02442778|585347996|FG002|Overall Study|Non-compliance with study drug|1|||
162078970|NCT02442778|585347994|FG000|Overall Study|Physician Decision|1|||
162078971|NCT02442778|585347995|FG001|Overall Study|Physician Decision|1|||
162078972|NCT02442778|585347996|FG002|Overall Study|Physician Decision|1|||
162078973|NCT02442778|585347994|FG000|Overall Study|Protocol Deviation|3|||
162078974|NCT02442778|585347995|FG001|Overall Study|Protocol Deviation|0|||
162078975|NCT02442778|585347996|FG002|Overall Study|Protocol Deviation|1|||
162078976|NCT02442778|585347994|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
162078977|NCT02442778|585347995|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
162078978|NCT02442778|585347996|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
162078979|NCT02442778|585347994|FG000|Overall Study|Withdrawal by Subject|4|||
162078980|NCT02442778|585347995|FG001|Overall Study|Withdrawal by Subject|4|||
162078981|NCT02442778|585347996|FG002|Overall Study|Withdrawal by Subject|3|||
162078982|NCT02442778|585347994|FG000|Overall Study|Reason not specified|1|||
162078983|NCT02442778|585347995|FG001|Overall Study|Reason not specified|4|||
162078984|NCT02442778|585347996|FG002|Overall Study|Reason not specified|0|||
162078985|NCT02641379|585347999|FG000|Overall Study|Exclusion criterion during screening|1|||
162078986|NCT02641379|585348000|FG001|Overall Study|Exclusion criterion during screening|0|||
162078987|NCT02641379|585348001|FG002|Overall Study|Exclusion criterion during screening|0|||
162078988|NCT02641379|585348002|FG003|Overall Study|Exclusion criterion during screening|1|||
162078989|NCT02641379|585348003|FG004|Overall Study|Exclusion criterion during screening|2|||
162078990|NCT02641379|585348004|FG005|Overall Study|Exclusion criterion during screening|0|||
162078991|NCT02641379|585348005|FG006|Overall Study|Exclusion criterion during screening|0|||
162078992|NCT02641379|585348006|FG007|Overall Study|Exclusion criterion during screening|0|||
162078993|NCT02641379|585348007|FG008|Overall Study|Exclusion criterion during screening|0|||
162078994|NCT02641379|585348008|FG009|Overall Study|Exclusion criterion during screening|0|||
162078995|NCT02641379|585348009|FG010|Overall Study|Exclusion criterion during screening|0|||
162078996|NCT02641379|585347999|FG000|Overall Study|Withdrawal of informed consent|0|||
162078997|NCT02641379|585348000|FG001|Overall Study|Withdrawal of informed consent|1|||
162078998|NCT02641379|585348001|FG002|Overall Study|Withdrawal of informed consent|0|||
162078999|NCT02641379|585348002|FG003|Overall Study|Withdrawal of informed consent|0|||
162079000|NCT02641379|585348003|FG004|Overall Study|Withdrawal of informed consent|0|||
162079001|NCT02641379|585348004|FG005|Overall Study|Withdrawal of informed consent|0|||
162079002|NCT02641379|585348005|FG006|Overall Study|Withdrawal of informed consent|0|||
162079003|NCT02641379|585348006|FG007|Overall Study|Withdrawal of informed consent|1|||
162079004|NCT02641379|585348007|FG008|Overall Study|Withdrawal of informed consent|0|||
162079005|NCT02641379|585348008|FG009|Overall Study|Withdrawal of informed consent|0|||
162079006|NCT02641379|585348009|FG010|Overall Study|Withdrawal of informed consent|0|||
162079007|NCT02641379|585347999|FG000|Overall Study|Adverse Event|7|||
162079008|NCT02641379|585348000|FG001|Overall Study|Adverse Event|8|||
162079009|NCT02641379|585348001|FG002|Overall Study|Adverse Event|2|||
162079010|NCT02641379|585348002|FG003|Overall Study|Adverse Event|2|||
162079011|NCT02641379|585348003|FG004|Overall Study|Adverse Event|5|||
162079012|NCT02641379|585348004|FG005|Overall Study|Adverse Event|1|||
162079013|NCT02641379|585348005|FG006|Overall Study|Adverse Event|5|||
162079014|NCT02641379|585348006|FG007|Overall Study|Adverse Event|0|||
162079015|NCT02641379|585348007|FG008|Overall Study|Adverse Event|1|||
162079016|NCT02641379|585348008|FG009|Overall Study|Adverse Event|1|||
162079017|NCT02641379|585348009|FG010|Overall Study|Adverse Event|5|||
162079018|NCT02641379|585347999|FG000|Overall Study|Lack of Efficacy|0|||
162079019|NCT02641379|585348000|FG001|Overall Study|Lack of Efficacy|0|||
162079020|NCT02641379|585348001|FG002|Overall Study|Lack of Efficacy|2|||
162079021|NCT02641379|585348002|FG003|Overall Study|Lack of Efficacy|0|||
162079022|NCT02641379|585348003|FG004|Overall Study|Lack of Efficacy|0|||
162079023|NCT02641379|585348004|FG005|Overall Study|Lack of Efficacy|2|||
162079024|NCT02641379|585348005|FG006|Overall Study|Lack of Efficacy|0|||
162079025|NCT02641379|585348006|FG007|Overall Study|Lack of Efficacy|5|||
162079026|NCT02641379|585348007|FG008|Overall Study|Lack of Efficacy|0|||
162079027|NCT02641379|585348008|FG009|Overall Study|Lack of Efficacy|0|||
162079028|NCT02641379|585348009|FG010|Overall Study|Lack of Efficacy|0|||
162079029|NCT02641379|585347999|FG000|Overall Study|Participant unable to attend study visit|4|||
162079030|NCT02641379|585348000|FG001|Overall Study|Participant unable to attend study visit|10|||
162079031|NCT02641379|585348001|FG002|Overall Study|Participant unable to attend study visit|1|||
162079032|NCT02641379|585348002|FG003|Overall Study|Participant unable to attend study visit|2|||
162079033|NCT02641379|585348003|FG004|Overall Study|Participant unable to attend study visit|5|||
162079034|NCT02641379|585348004|FG005|Overall Study|Participant unable to attend study visit|1|||
162079035|NCT02641379|585348005|FG006|Overall Study|Participant unable to attend study visit|1|||
162079036|NCT02641379|585348006|FG007|Overall Study|Participant unable to attend study visit|1|||
162079037|NCT02641379|585348007|FG008|Overall Study|Participant unable to attend study visit|0|||
162079038|NCT02641379|585348008|FG009|Overall Study|Participant unable to attend study visit|2|||
162079039|NCT02641379|585348009|FG010|Overall Study|Participant unable to attend study visit|0|||
162079040|NCT02641379|585347999|FG000|Overall Study|Participant's compliance|0|||
162079041|NCT02641379|585348000|FG001|Overall Study|Participant's compliance|1|||
162079042|NCT02641379|585348001|FG002|Overall Study|Participant's compliance|0|||
162079043|NCT02641379|585348002|FG003|Overall Study|Participant's compliance|1|||
162079044|NCT02641379|585348003|FG004|Overall Study|Participant's compliance|0|||
162079045|NCT02641379|585348004|FG005|Overall Study|Participant's compliance|2|||
162079046|NCT02641379|585348005|FG006|Overall Study|Participant's compliance|0|||
162079047|NCT02641379|585348006|FG007|Overall Study|Participant's compliance|0|||
162079048|NCT02641379|585348007|FG008|Overall Study|Participant's compliance|1|||
162079049|NCT02641379|585348008|FG009|Overall Study|Participant's compliance|1|||
162079050|NCT02641379|585348009|FG010|Overall Study|Participant's compliance|1|||
162079051|NCT02641379|585347999|FG000|Overall Study|Participant cannot be reached|4|||
162079052|NCT02641379|585348000|FG001|Overall Study|Participant cannot be reached|4|||
162079053|NCT02641379|585348001|FG002|Overall Study|Participant cannot be reached|0|||
162079054|NCT02641379|585348002|FG003|Overall Study|Participant cannot be reached|8|||
162079055|NCT02641379|585348003|FG004|Overall Study|Participant cannot be reached|2|||
162079056|NCT02641379|585348004|FG005|Overall Study|Participant cannot be reached|1|||
162079057|NCT02641379|585348005|FG006|Overall Study|Participant cannot be reached|0|||
162079058|NCT02641379|585348006|FG007|Overall Study|Participant cannot be reached|1|||
162079059|NCT02641379|585348007|FG008|Overall Study|Participant cannot be reached|0|||
162079060|NCT02641379|585348008|FG009|Overall Study|Participant cannot be reached|2|||
162079061|NCT02641379|585348009|FG010|Overall Study|Participant cannot be reached|1|||
162079062|NCT02641379|585347999|FG000|Overall Study|PCR positive at Week 24|15|||
162079063|NCT02641379|585348000|FG001|Overall Study|PCR positive at Week 24|21|||
162079064|NCT02641379|585348001|FG002|Overall Study|PCR positive at Week 24|62|||
162079065|NCT02641379|585348002|FG003|Overall Study|PCR positive at Week 24|0|||
162079066|NCT02641379|585348003|FG004|Overall Study|PCR positive at Week 24|0|||
162079067|NCT02641379|585348004|FG005|Overall Study|PCR positive at Week 24|6|||
162079068|NCT02641379|585348005|FG006|Overall Study|PCR positive at Week 24|3|||
162079069|NCT02641379|585348006|FG007|Overall Study|PCR positive at Week 24|8|||
162079070|NCT02641379|585348007|FG008|Overall Study|PCR positive at Week 24|0|||
162079071|NCT02641379|585348008|FG009|Overall Study|PCR positive at Week 24|1|||
162079072|NCT02641379|585348009|FG010|Overall Study|PCR positive at Week 24|0|||
162079073|NCT02641379|585347999|FG000|Overall Study|PCR positive at follow up 2|1|||
162079074|NCT02641379|585348000|FG001|Overall Study|PCR positive at follow up 2|0|||
162079075|NCT02641379|585348001|FG002|Overall Study|PCR positive at follow up 2|0|||
162079076|NCT02641379|585348002|FG003|Overall Study|PCR positive at follow up 2|0|||
162079077|NCT02641379|585348003|FG004|Overall Study|PCR positive at follow up 2|0|||
162079078|NCT02641379|585348004|FG005|Overall Study|PCR positive at follow up 2|0|||
162079079|NCT02641379|585348005|FG006|Overall Study|PCR positive at follow up 2|0|||
162079080|NCT02641379|585348006|FG007|Overall Study|PCR positive at follow up 2|0|||
162079081|NCT02641379|585348007|FG008|Overall Study|PCR positive at follow up 2|0|||
162079082|NCT02641379|585348008|FG009|Overall Study|PCR positive at follow up 2|0|||
162079083|NCT02641379|585348009|FG010|Overall Study|PCR positive at follow up 2|0|||
162079084|NCT02641379|585347999|FG000|Overall Study|Participant showed relapse|1|||
162079085|NCT02641379|585348000|FG001|Overall Study|Participant showed relapse|0|||
162079086|NCT02641379|585348001|FG002|Overall Study|Participant showed relapse|0|||
162079087|NCT02641379|585348002|FG003|Overall Study|Participant showed relapse|0|||
162079088|NCT02641379|585348003|FG004|Overall Study|Participant showed relapse|0|||
162079089|NCT02641379|585348004|FG005|Overall Study|Participant showed relapse|0|||
162079090|NCT02641379|585348005|FG006|Overall Study|Participant showed relapse|1|||
162079091|NCT02641379|585348006|FG007|Overall Study|Participant showed relapse|0|||
162079092|NCT02641379|585348007|FG008|Overall Study|Participant showed relapse|0|||
162079093|NCT02641379|585348008|FG009|Overall Study|Participant showed relapse|0|||
162079094|NCT02641379|585348009|FG010|Overall Study|Participant showed relapse|0|||
162079095|NCT02641379|585347999|FG000|Overall Study|Participant stopped study/treatment|1|||
162079096|NCT02641379|585348000|FG001|Overall Study|Participant stopped study/treatment|3|||
162079097|NCT02641379|585348001|FG002|Overall Study|Participant stopped study/treatment|1|||
162079098|NCT02641379|585348002|FG003|Overall Study|Participant stopped study/treatment|0|||
162079099|NCT02641379|585348003|FG004|Overall Study|Participant stopped study/treatment|0|||
162079100|NCT02641379|585348004|FG005|Overall Study|Participant stopped study/treatment|1|||
162079101|NCT02641379|585348005|FG006|Overall Study|Participant stopped study/treatment|2|||
162079102|NCT02641379|585348006|FG007|Overall Study|Participant stopped study/treatment|0|||
162079103|NCT02641379|585348007|FG008|Overall Study|Participant stopped study/treatment|1|||
162079104|NCT02641379|585348008|FG009|Overall Study|Participant stopped study/treatment|0|||
162079105|NCT02641379|585348009|FG010|Overall Study|Participant stopped study/treatment|0|||
162079106|NCT02641379|585347999|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
162079107|NCT02641379|585348000|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
162079108|NCT02641379|585348001|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
162079109|NCT02641379|585348002|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
162079110|NCT02641379|585348003|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
162079111|NCT02641379|585348004|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
162079112|NCT02641379|585348005|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
162079113|NCT02641379|585348006|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
162079114|NCT02641379|585348007|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
162079115|NCT02641379|585348008|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
162079116|NCT02641379|585348009|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
162079117|NCT02641379|585347999|FG000|Overall Study|Financial problems|0|||
162079118|NCT02641379|585348000|FG001|Overall Study|Financial problems|1|||
162079119|NCT02641379|585348001|FG002|Overall Study|Financial problems|0|||
162079120|NCT02641379|585348002|FG003|Overall Study|Financial problems|0|||
162079121|NCT02641379|585348003|FG004|Overall Study|Financial problems|0|||
162079122|NCT02641379|585348004|FG005|Overall Study|Financial problems|0|||
162079123|NCT02641379|585348005|FG006|Overall Study|Financial problems|0|||
162079124|NCT02641379|585348006|FG007|Overall Study|Financial problems|0|||
162079125|NCT02641379|585348007|FG008|Overall Study|Financial problems|0|||
162079126|NCT02641379|585348008|FG009|Overall Study|Financial problems|0|||
162079127|NCT02641379|585348009|FG010|Overall Study|Financial problems|0|||
162079128|NCT02641379|585347999|FG000|Overall Study|PCR positive at Week 68|0|||
162079129|NCT02641379|585348000|FG001|Overall Study|PCR positive at Week 68|1|||
162079130|NCT02641379|585348001|FG002|Overall Study|PCR positive at Week 68|0|||
162079131|NCT02641379|585348002|FG003|Overall Study|PCR positive at Week 68|0|||
162079132|NCT02641379|585348003|FG004|Overall Study|PCR positive at Week 68|0|||
162079133|NCT02641379|585348004|FG005|Overall Study|PCR positive at Week 68|0|||
162079134|NCT02641379|585348005|FG006|Overall Study|PCR positive at Week 68|0|||
162079135|NCT02641379|585348006|FG007|Overall Study|PCR positive at Week 68|0|||
162079136|NCT02641379|585348007|FG008|Overall Study|PCR positive at Week 68|0|||
162079137|NCT02641379|585348008|FG009|Overall Study|PCR positive at Week 68|0|||
162079138|NCT02641379|585348009|FG010|Overall Study|PCR positive at Week 68|0|||
162079139|NCT02641379|585347999|FG000|Overall Study|PCR positive at Week 48|0|||
162079140|NCT02641379|585348000|FG001|Overall Study|PCR positive at Week 48|1|||
162079141|NCT02641379|585348001|FG002|Overall Study|PCR positive at Week 48|0|||
162079142|NCT02641379|585348002|FG003|Overall Study|PCR positive at Week 48|0|||
162079143|NCT02641379|585348003|FG004|Overall Study|PCR positive at Week 48|0|||
162079144|NCT02641379|585348004|FG005|Overall Study|PCR positive at Week 48|0|||
162079145|NCT02641379|585348005|FG006|Overall Study|PCR positive at Week 48|0|||
162079146|NCT02641379|585348006|FG007|Overall Study|PCR positive at Week 48|0|||
162079147|NCT02641379|585348007|FG008|Overall Study|PCR positive at Week 48|0|||
162079148|NCT02641379|585348008|FG009|Overall Study|PCR positive at Week 48|0|||
162079149|NCT02641379|585348009|FG010|Overall Study|PCR positive at Week 48|0|||
162079150|NCT02641379|585347999|FG000|Overall Study|PCR not performed at Week 12|0|||
162079151|NCT02641379|585348000|FG001|Overall Study|PCR not performed at Week 12|0|||
162079152|NCT02641379|585348001|FG002|Overall Study|PCR not performed at Week 12|1|||
162079153|NCT02641379|585348002|FG003|Overall Study|PCR not performed at Week 12|0|||
162079154|NCT02641379|585348003|FG004|Overall Study|PCR not performed at Week 12|0|||
162079155|NCT02641379|585348004|FG005|Overall Study|PCR not performed at Week 12|0|||
162079156|NCT02641379|585348005|FG006|Overall Study|PCR not performed at Week 12|0|||
162079157|NCT02641379|585348006|FG007|Overall Study|PCR not performed at Week 12|0|||
162079158|NCT02641379|585348007|FG008|Overall Study|PCR not performed at Week 12|0|||
162079159|NCT02641379|585348008|FG009|Overall Study|PCR not performed at Week 12|0|||
162079160|NCT02641379|585348009|FG010|Overall Study|PCR not performed at Week 12|0|||
162079161|NCT02641379|585347999|FG000|Overall Study|No PCR at baseline|0|||
162079162|NCT02641379|585348000|FG001|Overall Study|No PCR at baseline|0|||
162079163|NCT02641379|585348001|FG002|Overall Study|No PCR at baseline|1|||
162079164|NCT02641379|585348002|FG003|Overall Study|No PCR at baseline|0|||
162079165|NCT02641379|585348003|FG004|Overall Study|No PCR at baseline|0|||
162079166|NCT02641379|585348004|FG005|Overall Study|No PCR at baseline|0|||
162079167|NCT02641379|585348005|FG006|Overall Study|No PCR at baseline|0|||
162079168|NCT02641379|585348006|FG007|Overall Study|No PCR at baseline|0|||
162079169|NCT02641379|585348007|FG008|Overall Study|No PCR at baseline|0|||
162079170|NCT02641379|585348008|FG009|Overall Study|No PCR at baseline|0|||
162079171|NCT02641379|585348009|FG010|Overall Study|No PCR at baseline|0|||
162079172|NCT02641379|585347999|FG000|Overall Study|PCR positive at Week 28|0|||
162079173|NCT02641379|585348000|FG001|Overall Study|PCR positive at Week 28|0|||
162079174|NCT02641379|585348001|FG002|Overall Study|PCR positive at Week 28|1|||
162079175|NCT02641379|585348002|FG003|Overall Study|PCR positive at Week 28|0|||
162079176|NCT02641379|585348003|FG004|Overall Study|PCR positive at Week 28|0|||
162079177|NCT02641379|585348004|FG005|Overall Study|PCR positive at Week 28|0|||
162079178|NCT02641379|585348005|FG006|Overall Study|PCR positive at Week 28|0|||
162079179|NCT02641379|585348006|FG007|Overall Study|PCR positive at Week 28|0|||
162079180|NCT02641379|585348007|FG008|Overall Study|PCR positive at Week 28|0|||
162079181|NCT02641379|585348008|FG009|Overall Study|PCR positive at Week 28|0|||
162079182|NCT02641379|585348009|FG010|Overall Study|PCR positive at Week 28|0|||
162079183|NCT02641379|585347999|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
162079184|NCT02641379|585348000|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
162079185|NCT02641379|585348001|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
162079186|NCT02641379|585348002|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
162079187|NCT02641379|585348003|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
162079188|NCT02641379|585348004|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
162079189|NCT02641379|585348005|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
162079190|NCT02641379|585348006|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
162079191|NCT02641379|585348007|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
162079192|NCT02641379|585348008|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
162079193|NCT02641379|585348009|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
162079194|NCT02641379|585347999|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
162079195|NCT02641379|585348000|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
162079196|NCT02641379|585348001|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
162079197|NCT02641379|585348002|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
162079198|NCT02641379|585348003|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
162079199|NCT02641379|585348004|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
162079200|NCT02641379|585348005|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
162079201|NCT02641379|585348006|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
162079202|NCT02641379|585348007|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
162079203|NCT02641379|585348008|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
162079204|NCT02641379|585348009|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
162079205|NCT02641379|585347999|FG000|Overall Study|Baseline viral load unavailable|0|||
162079206|NCT02641379|585348000|FG001|Overall Study|Baseline viral load unavailable|0|||
162079207|NCT02641379|585348001|FG002|Overall Study|Baseline viral load unavailable|0|||
162079208|NCT02641379|585348002|FG003|Overall Study|Baseline viral load unavailable|1|||
162079209|NCT02641379|585348003|FG004|Overall Study|Baseline viral load unavailable|0|||
162079210|NCT02641379|585348004|FG005|Overall Study|Baseline viral load unavailable|0|||
162079211|NCT02641379|585348005|FG006|Overall Study|Baseline viral load unavailable|0|||
162079212|NCT02641379|585348006|FG007|Overall Study|Baseline viral load unavailable|0|||
162079213|NCT02641379|585348007|FG008|Overall Study|Baseline viral load unavailable|0|||
162079214|NCT02641379|585348008|FG009|Overall Study|Baseline viral load unavailable|0|||
162079215|NCT02641379|585348009|FG010|Overall Study|Baseline viral load unavailable|0|||
162079216|NCT02641379|585347999|FG000|Overall Study|Blood could not be drawn|0|||
162079217|NCT02641379|585348000|FG001|Overall Study|Blood could not be drawn|0|||
162079218|NCT02641379|585348001|FG002|Overall Study|Blood could not be drawn|0|||
162079219|NCT02641379|585348002|FG003|Overall Study|Blood could not be drawn|0|||
162079220|NCT02641379|585348003|FG004|Overall Study|Blood could not be drawn|1|||
162079221|NCT02641379|585348004|FG005|Overall Study|Blood could not be drawn|0|||
162079222|NCT02641379|585348005|FG006|Overall Study|Blood could not be drawn|0|||
162079223|NCT02641379|585348006|FG007|Overall Study|Blood could not be drawn|0|||
162079224|NCT02641379|585348007|FG008|Overall Study|Blood could not be drawn|0|||
162079225|NCT02641379|585348008|FG009|Overall Study|Blood could not be drawn|0|||
162079226|NCT02641379|585348009|FG010|Overall Study|Blood could not be drawn|0|||
162079227|NCT02641379|585347999|FG000|Overall Study|Protocol Violation|0|||
162079228|NCT02641379|585348000|FG001|Overall Study|Protocol Violation|0|||
162079229|NCT02641379|585348001|FG002|Overall Study|Protocol Violation|0|||
162079230|NCT02641379|585348002|FG003|Overall Study|Protocol Violation|0|||
162079231|NCT02641379|585348003|FG004|Overall Study|Protocol Violation|2|||
162079232|NCT02641379|585348004|FG005|Overall Study|Protocol Violation|0|||
162079233|NCT02641379|585348005|FG006|Overall Study|Protocol Violation|0|||
162079234|NCT02641379|585348006|FG007|Overall Study|Protocol Violation|0|||
162079235|NCT02641379|585348007|FG008|Overall Study|Protocol Violation|1|||
162079236|NCT02641379|585348008|FG009|Overall Study|Protocol Violation|0|||
162079237|NCT02641379|585348009|FG010|Overall Study|Protocol Violation|0|||
162079238|NCT02641379|585347999|FG000|Overall Study|Participation in sili rescue study|0|||
162079239|NCT02641379|585348000|FG001|Overall Study|Participation in sili rescue study|0|||
162079240|NCT02641379|585348001|FG002|Overall Study|Participation in sili rescue study|0|||
162079241|NCT02641379|585348002|FG003|Overall Study|Participation in sili rescue study|0|||
162079242|NCT02641379|585348003|FG004|Overall Study|Participation in sili rescue study|0|||
162079243|NCT02641379|585348004|FG005|Overall Study|Participation in sili rescue study|1|||
162079244|NCT02641379|585348005|FG006|Overall Study|Participation in sili rescue study|0|||
162079245|NCT02641379|585348006|FG007|Overall Study|Participation in sili rescue study|0|||
162079246|NCT02641379|585348007|FG008|Overall Study|Participation in sili rescue study|0|||
162079247|NCT02641379|585348008|FG009|Overall Study|Participation in sili rescue study|0|||
162079248|NCT02641379|585348009|FG010|Overall Study|Participation in sili rescue study|0|||
162079249|NCT02641379|585347999|FG000|Overall Study|Lost to Follow-up|0|||
162079250|NCT02641379|585348000|FG001|Overall Study|Lost to Follow-up|0|||
162079251|NCT02641379|585348001|FG002|Overall Study|Lost to Follow-up|0|||
162079252|NCT02641379|585348002|FG003|Overall Study|Lost to Follow-up|0|||
162079253|NCT02641379|585348003|FG004|Overall Study|Lost to Follow-up|0|||
162079254|NCT02641379|585348004|FG005|Overall Study|Lost to Follow-up|0|||
162079255|NCT02641379|585348005|FG006|Overall Study|Lost to Follow-up|0|||
162079256|NCT02641379|585348006|FG007|Overall Study|Lost to Follow-up|0|||
162079257|NCT02641379|585348007|FG008|Overall Study|Lost to Follow-up|1|||
162079258|NCT02641379|585348008|FG009|Overall Study|Lost to Follow-up|0|||
162079259|NCT02641379|585348009|FG010|Overall Study|Lost to Follow-up|0|||
162079260|NCT02641379|585347999|FG000|Overall Study|Source data not found|0|||
162079261|NCT02641379|585348000|FG001|Overall Study|Source data not found|0|||
162079262|NCT02641379|585348001|FG002|Overall Study|Source data not found|0|||
162079263|NCT02641379|585348002|FG003|Overall Study|Source data not found|0|||
162237445|NCT00600886|585921096|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
162079264|NCT02641379|585348003|FG004|Overall Study|Source data not found|0|||
162079265|NCT02641379|585348004|FG005|Overall Study|Source data not found|1|||
162079266|NCT02641379|585348005|FG006|Overall Study|Source data not found|0|||
162079267|NCT02641379|585348006|FG007|Overall Study|Source data not found|0|||
162079268|NCT02641379|585348007|FG008|Overall Study|Source data not found|0|||
162079269|NCT02641379|585348008|FG009|Overall Study|Source data not found|0|||
162079270|NCT02641379|585348009|FG010|Overall Study|Source data not found|0|||
162079271|NCT02641379|585347999|FG000|Overall Study|Participant showed weight reduction|0|||
162079272|NCT02641379|585348000|FG001|Overall Study|Participant showed weight reduction|0|||
162079273|NCT02641379|585348001|FG002|Overall Study|Participant showed weight reduction|0|||
162079274|NCT02641379|585348002|FG003|Overall Study|Participant showed weight reduction|0|||
162079275|NCT02641379|585348003|FG004|Overall Study|Participant showed weight reduction|0|||
162079276|NCT02641379|585348004|FG005|Overall Study|Participant showed weight reduction|0|||
162079277|NCT02641379|585348005|FG006|Overall Study|Participant showed weight reduction|0|||
162079278|NCT02641379|585348006|FG007|Overall Study|Participant showed weight reduction|1|||
162079279|NCT02641379|585348007|FG008|Overall Study|Participant showed weight reduction|0|||
162079280|NCT02641379|585348008|FG009|Overall Study|Participant showed weight reduction|0|||
162079281|NCT02641379|585348009|FG010|Overall Study|Participant showed weight reduction|0|||
162079282|NCT02641379|585347999|FG000|Overall Study|Non-response Week 12|0|||
162079283|NCT02641379|585348000|FG001|Overall Study|Non-response Week 12|0|||
162079284|NCT02641379|585348001|FG002|Overall Study|Non-response Week 12|0|||
162079285|NCT02641379|585348002|FG003|Overall Study|Non-response Week 12|0|||
162079286|NCT02641379|585348003|FG004|Overall Study|Non-response Week 12|0|||
162079287|NCT02641379|585348004|FG005|Overall Study|Non-response Week 12|0|||
162079288|NCT02641379|585348005|FG006|Overall Study|Non-response Week 12|0|||
162079289|NCT02641379|585348006|FG007|Overall Study|Non-response Week 12|1|||
162079290|NCT02641379|585348007|FG008|Overall Study|Non-response Week 12|0|||
162079291|NCT02641379|585348008|FG009|Overall Study|Non-response Week 12|0|||
162079292|NCT02641379|585348009|FG010|Overall Study|Non-response Week 12|0|||
162079293|NCT02641379|585347999|FG000|Overall Study|No 2 Log drop at Week 12|0|||
162079294|NCT02641379|585348000|FG001|Overall Study|No 2 Log drop at Week 12|0|||
162079295|NCT02641379|585348001|FG002|Overall Study|No 2 Log drop at Week 12|0|||
162079296|NCT02641379|585348002|FG003|Overall Study|No 2 Log drop at Week 12|0|||
162079297|NCT02641379|585348003|FG004|Overall Study|No 2 Log drop at Week 12|0|||
162079298|NCT02641379|585348004|FG005|Overall Study|No 2 Log drop at Week 12|0|||
162079299|NCT02641379|585348005|FG006|Overall Study|No 2 Log drop at Week 12|0|||
162079300|NCT02641379|585348006|FG007|Overall Study|No 2 Log drop at Week 12|0|||
162079301|NCT02641379|585348007|FG008|Overall Study|No 2 Log drop at Week 12|0|||
162079302|NCT02641379|585348008|FG009|Overall Study|No 2 Log drop at Week 12|0|||
162079303|NCT02641379|585348009|FG010|Overall Study|No 2 Log drop at Week 12|1|||
162079304|NCT02641379|585347999|FG000|Overall Study|Negative PCR result|0|||
162079305|NCT02641379|585348000|FG001|Overall Study|Negative PCR result|0|||
162079306|NCT02641379|585348001|FG002|Overall Study|Negative PCR result|0|||
162079307|NCT02641379|585348002|FG003|Overall Study|Negative PCR result|0|||
162079308|NCT02641379|585348003|FG004|Overall Study|Negative PCR result|0|||
162079309|NCT02641379|585348004|FG005|Overall Study|Negative PCR result|0|||
162079310|NCT02641379|585348005|FG006|Overall Study|Negative PCR result|0|||
162079311|NCT02641379|585348006|FG007|Overall Study|Negative PCR result|0|||
162079312|NCT02641379|585348007|FG008|Overall Study|Negative PCR result|0|||
162079313|NCT02641379|585348008|FG009|Overall Study|Negative PCR result|1|||
162079314|NCT02641379|585348009|FG010|Overall Study|Negative PCR result|0|||
162079315|NCT02641379|585347999|FG000|Overall Study|Participant's PCR high|0|||
162079316|NCT02641379|585348000|FG001|Overall Study|Participant's PCR high|0|||
162079317|NCT02641379|585348001|FG002|Overall Study|Participant's PCR high|0|||
162079318|NCT02641379|585348002|FG003|Overall Study|Participant's PCR high|0|||
162079319|NCT02641379|585348003|FG004|Overall Study|Participant's PCR high|0|||
162079320|NCT02641379|585348004|FG005|Overall Study|Participant's PCR high|0|||
162079321|NCT02641379|585348005|FG006|Overall Study|Participant's PCR high|0|||
162079322|NCT02641379|585348006|FG007|Overall Study|Participant's PCR high|1|||
162079323|NCT02641379|585348007|FG008|Overall Study|Participant's PCR high|0|||
162079324|NCT02641379|585348008|FG009|Overall Study|Participant's PCR high|0|||
162079325|NCT02641379|585348009|FG010|Overall Study|Participant's PCR high|0|||
162079326|NCT02641379|585347999|FG000|Overall Study|Participant treated after Week 24|0|||
162079327|NCT02641379|585348000|FG001|Overall Study|Participant treated after Week 24|0|||
162079328|NCT02641379|585348001|FG002|Overall Study|Participant treated after Week 24|0|||
162079329|NCT02641379|585348002|FG003|Overall Study|Participant treated after Week 24|0|||
162079330|NCT02641379|585348003|FG004|Overall Study|Participant treated after Week 24|0|||
162079331|NCT02641379|585348004|FG005|Overall Study|Participant treated after Week 24|0|||
162079332|NCT02641379|585348005|FG006|Overall Study|Participant treated after Week 24|0|||
162079333|NCT02641379|585348006|FG007|Overall Study|Participant treated after Week 24|0|||
162079334|NCT02641379|585348007|FG008|Overall Study|Participant treated after Week 24|1|||
162079335|NCT02641379|585348008|FG009|Overall Study|Participant treated after Week 24|0|||
162079336|NCT02641379|585348009|FG010|Overall Study|Participant treated after Week 24|0|||
162079337|NCT02641379|585347999|FG000|Overall Study|Missing PCR result at Week 8|0|||
162079338|NCT02641379|585348000|FG001|Overall Study|Missing PCR result at Week 8|0|||
162079339|NCT02641379|585348001|FG002|Overall Study|Missing PCR result at Week 8|0|||
162079340|NCT02641379|585348002|FG003|Overall Study|Missing PCR result at Week 8|0|||
162079341|NCT02641379|585348003|FG004|Overall Study|Missing PCR result at Week 8|0|||
162079342|NCT02641379|585348004|FG005|Overall Study|Missing PCR result at Week 8|0|||
162079343|NCT02641379|585348005|FG006|Overall Study|Missing PCR result at Week 8|0|||
162079344|NCT02641379|585348006|FG007|Overall Study|Missing PCR result at Week 8|0|||
162079345|NCT02641379|585348007|FG008|Overall Study|Missing PCR result at Week 8|0|||
162079346|NCT02641379|585348008|FG009|Overall Study|Missing PCR result at Week 8|1|||
162079347|NCT02641379|585348009|FG010|Overall Study|Missing PCR result at Week 8|0|||
162079348|NCT02641379|585347999|FG000|Overall Study|PCR positive|0|||
162079349|NCT02641379|585348000|FG001|Overall Study|PCR positive|0|||
162079350|NCT02641379|585348001|FG002|Overall Study|PCR positive|0|||
162079351|NCT02641379|585348002|FG003|Overall Study|PCR positive|0|||
162079352|NCT02641379|585348003|FG004|Overall Study|PCR positive|0|||
162079353|NCT02641379|585348004|FG005|Overall Study|PCR positive|0|||
162079354|NCT02641379|585348005|FG006|Overall Study|PCR positive|1|||
162079355|NCT02641379|585348006|FG007|Overall Study|PCR positive|0|||
162079356|NCT02641379|585348007|FG008|Overall Study|PCR positive|0|||
162079357|NCT02641379|585348008|FG009|Overall Study|PCR positive|0|||
162079358|NCT02641379|585348009|FG010|Overall Study|PCR positive|0|||
162079359|NCT01165138|585348010|FG000|Overall Study|Adverse Event|0|||
162079360|NCT01165138|585348011|FG001|Overall Study|Adverse Event|1|||
162079361|NCT01165138|585348012|FG002|Overall Study|Adverse Event|0|||
162079362|NCT01165138|585348013|FG003|Overall Study|Adverse Event|2|||
162079363|NCT01165138|585348010|FG000|Overall Study|Lack of Efficacy|0|||
162079364|NCT01165138|585348011|FG001|Overall Study|Lack of Efficacy|32|||
162079365|NCT01165138|585348012|FG002|Overall Study|Lack of Efficacy|6|||
162079366|NCT01165138|585348013|FG003|Overall Study|Lack of Efficacy|7|||
162079367|NCT01165138|585348010|FG000|Overall Study|Protocol Violation|0|||
162079368|NCT01165138|585348011|FG001|Overall Study|Protocol Violation|7|||
162079369|NCT01165138|585348012|FG002|Overall Study|Protocol Violation|0|||
162079370|NCT01165138|585348013|FG003|Overall Study|Protocol Violation|2|||
162079371|NCT01165138|585348010|FG000|Overall Study|Lost to Follow-up|0|||
162079372|NCT01165138|585348011|FG001|Overall Study|Lost to Follow-up|0|||
162079373|NCT01165138|585348012|FG002|Overall Study|Lost to Follow-up|1|||
162079374|NCT01165138|585348013|FG003|Overall Study|Lost to Follow-up|2|||
162079375|NCT01165138|585348010|FG000|Overall Study|Physician Decision|0|||
162079376|NCT01165138|585348011|FG001|Overall Study|Physician Decision|6|||
162079377|NCT01165138|585348012|FG002|Overall Study|Physician Decision|7|||
162079378|NCT01165138|585348013|FG003|Overall Study|Physician Decision|6|||
162079379|NCT01165138|585348010|FG000|Overall Study|Withdrawal by Subject|0|||
162079380|NCT01165138|585348011|FG001|Overall Study|Withdrawal by Subject|6|||
162079381|NCT01165138|585348012|FG002|Overall Study|Withdrawal by Subject|6|||
162079382|NCT01165138|585348013|FG003|Overall Study|Withdrawal by Subject|3|||
162079383|NCT01644175|585348016|FG000|Overall Study|Randomized But Not Treated|0|||
162079384|NCT01644175|585348017|FG001|Overall Study|Randomized But Not Treated|2|||
162079385|NCT01644175|585348016|FG000|Overall Study|Adverse Event|8|||
162079386|NCT01644175|585348017|FG001|Overall Study|Adverse Event|13|||
162079387|NCT01644175|585348016|FG000|Overall Study|Death|1|||
162079388|NCT01644175|585348017|FG001|Overall Study|Death|2|||
162079389|NCT01644175|585348016|FG000|Overall Study|Poor compliance to protocol|9|||
162079390|NCT01644175|585348017|FG001|Overall Study|Poor compliance to protocol|10|||
162079391|NCT01644175|585348016|FG000|Overall Study|Physician Decision|1|||
162079392|NCT01644175|585348017|FG001|Overall Study|Physician Decision|2|||
162079393|NCT01644175|585348016|FG000|Overall Study|Participant Moved|1|||
162079394|NCT01644175|585348017|FG001|Overall Study|Participant Moved|2|||
162079395|NCT01644175|585348016|FG000|Overall Study|Consent withdrawn by participant|3|||
162079396|NCT01644175|585348017|FG001|Overall Study|Consent withdrawn by participant|4|||
162079397|NCT01644175|585348016|FG000|Overall Study|Related to Autoinjector Administration|2|||
162079398|NCT01644175|585348017|FG001|Overall Study|Related to Autoinjector Administration|1|||
162079399|NCT01644175|585348016|FG000|Overall Study|Last visit outside protocol visit window|4|||
162079400|NCT01644175|585348017|FG001|Overall Study|Last visit outside protocol visit window|11|||
162079401|NCT01644175|585348016|FG000|Overall Study|Selection criteria finally not met|0|||
162079402|NCT01644175|585348017|FG001|Overall Study|Selection criteria finally not met|1|||
162079403|NCT01644175|585348016|FG000|Overall Study|Site closure|2|||
162079404|NCT01644175|585348017|FG001|Overall Study|Site closure|2|||
162079405|NCT01644175|585348016|FG000|Overall Study|Lost to Follow-up|1|||
162079406|NCT01644175|585348017|FG001|Overall Study|Lost to Follow-up|0|||
162079407|NCT01644175|585348016|FG000|Overall Study|Other than specified above|0|||
162079408|NCT01644175|585348017|FG001|Overall Study|Other than specified above|3|||
162079409|NCT01398956|585348021|FG000|Overall Study|Withdrawal by Subject|4|||
162079410|NCT01398956|585348021|FG000|Overall Study|AE, non-serious non-fatal|4|||
162079411|NCT01398956|585348021|FG000|Overall Study|Withdrawal Criteria No.3|1|||
162079412|NCT01398956|585348021|FG000|Overall Study|Subject moved a long distance|1|||
162079413|NCT00856908|585348025|FG000|Overall Study|Lost to Follow-up|1|||
162079414|NCT00856908|585348026|FG001|Overall Study|Lost to Follow-up|0|||
162079415|NCT01063595|585348027|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
162079416|NCT01063595|585348028|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
162079417|NCT01063595|585348027|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
162079418|NCT01063595|585348028|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
162079419|NCT01063595|585348027|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
162079420|NCT01063595|585348028|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
162079421|NCT01063595|585348027|FG000|First Intervention|Adverse Event|1|||
162079422|NCT01063595|585348028|FG001|First Intervention|Adverse Event|4|||
162079423|NCT01063595|585348027|FG000|First Intervention|Withdrawal by Subject|1|||
162079424|NCT01063595|585348028|FG001|First Intervention|Withdrawal by Subject|0|||
162079425|NCT01063595|585348027|FG000|First Intervention|Reason not Specified|0|||
162079426|NCT01063595|585348028|FG001|First Intervention|Reason not Specified|1|||
162079427|NCT01623596|585348029|FG000|Overall Study|Abnormal laboratory values|2|||
162079428|NCT01623596|585348030|FG001|Overall Study|Abnormal laboratory values|0|||
162079429|NCT01623596|585348029|FG000|Overall Study|Administrative problems|9|||
162079430|NCT01623596|585348030|FG001|Overall Study|Administrative problems|13|||
162079431|NCT01623596|585348029|FG000|Overall Study|Adverse Event|20|||
162079432|NCT01623596|585348030|FG001|Overall Study|Adverse Event|29|||
162079433|NCT01623596|585348029|FG000|Overall Study|Death|0|||
162079434|NCT01623596|585348030|FG001|Overall Study|Death|2|||
162079435|NCT01623596|585348029|FG000|Overall Study|Lost to Follow-up|12|||
162079436|NCT01623596|585348030|FG001|Overall Study|Lost to Follow-up|16|||
162079437|NCT01623596|585348029|FG000|Overall Study|Withdrawal by Subject|13|||
162079438|NCT01623596|585348030|FG001|Overall Study|Withdrawal by Subject|31|||
162079439|NCT01623596|585348029|FG000|Overall Study|Patient no longer requires study drug|1|||
162079440|NCT01623596|585348030|FG001|Overall Study|Patient no longer requires study drug|0|||
162079441|NCT01623596|585348029|FG000|Overall Study|Protocol Violation|0|||
162079442|NCT01623596|585348030|FG001|Overall Study|Protocol Violation|6|||
162079443|NCT01623596|585348029|FG000|Overall Study|Lack of Efficacy|5|||
162079444|NCT01623596|585348030|FG001|Overall Study|Lack of Efficacy|3|||
162079445|NCT00451035|585348031|FG000|Overall Study|Disease progression|11|||
162079446|NCT00451035|585348031|FG000|Overall Study|Death|3|||
162079447|NCT00451035|585348031|FG000|Overall Study|New anti-neoplastic therapy|3|||
162079448|NCT04059146|585348035|FG000|Overall Study|Withdrawal by Subject|0|||
162079449|NCT04059146|585348036|FG001|Overall Study|Withdrawal by Subject|1|||
162079450|NCT01712256|585348039|FG000|Overall Study|Lost to Follow-up|1|||
162079451|NCT00962104|585348042|FG000|Overall Study|Adverse Event|10|||
162079452|NCT00962104|585348043|FG001|Overall Study|Adverse Event|3|||
162079453|NCT00962104|585348042|FG000|Overall Study|Entry Criteria Not Met|1|||
162079454|NCT00962104|585348043|FG001|Overall Study|Entry Criteria Not Met|2|||
162079455|NCT00962104|585348042|FG000|Overall Study|Lack of Efficacy|0|||
162079456|NCT00962104|585348043|FG001|Overall Study|Lack of Efficacy|1|||
162079457|NCT00962104|585348042|FG000|Overall Study|Lost to Follow-up|10|||
162079458|NCT00962104|585348043|FG001|Overall Study|Lost to Follow-up|4|||
162079459|NCT00962104|585348042|FG000|Overall Study|Physician Decision|1|||
162079460|NCT00962104|585348043|FG001|Overall Study|Physician Decision|0|||
162079461|NCT00962104|585348042|FG000|Overall Study|Protocol Violation|6|||
162079462|NCT00962104|585348043|FG001|Overall Study|Protocol Violation|8|||
162079463|NCT00962104|585348042|FG000|Overall Study|Sponsor Decision|0|||
162079464|NCT00962104|585348043|FG001|Overall Study|Sponsor Decision|1|||
162079465|NCT00962104|585348042|FG000|Overall Study|Withdrawal by Subject|10|||
162079466|NCT00962104|585348043|FG001|Overall Study|Withdrawal by Subject|6|||
162079467|NCT00962104|585348042|FG000|Overall Study|Other|2|||
162079468|NCT00962104|585348043|FG001|Overall Study|Other|0|||
162079469|NCT03274986|585348044|FG000|Overall Study|Withdrawal by Subject|0|||
162079470|NCT03274986|585348045|FG001|Overall Study|Withdrawal by Subject|1|||
162079471|NCT03274986|585348044|FG000|Overall Study|Lost to Follow-up|0|||
162079472|NCT03274986|585348045|FG001|Overall Study|Lost to Follow-up|1|||
162079473|NCT00603746|585348046|FG000|Overall Study|Adverse Event|2|||
162079474|NCT00603746|585348047|FG001|Overall Study|Adverse Event|3|||
162079475|NCT00603746|585348048|FG002|Overall Study|Adverse Event|0|||
162079476|NCT00603746|585348049|FG003|Overall Study|Adverse Event|1|||
162079477|NCT00603746|585348050|FG004|Overall Study|Adverse Event|0|||
162079478|NCT00603746|585348051|FG005|Overall Study|Adverse Event|4|||
162079479|NCT00603746|585348046|FG000|Overall Study|Lack of Efficacy|34|||
162079480|NCT00603746|585348047|FG001|Overall Study|Lack of Efficacy|11|||
162079481|NCT00603746|585348048|FG002|Overall Study|Lack of Efficacy|6|||
162079482|NCT00603746|585348049|FG003|Overall Study|Lack of Efficacy|11|||
162079483|NCT00603746|585348050|FG004|Overall Study|Lack of Efficacy|12|||
162079484|NCT00603746|585348051|FG005|Overall Study|Lack of Efficacy|8|||
162079485|NCT00603746|585348046|FG000|Overall Study|Protocol Violation|0|||
162079486|NCT00603746|585348047|FG001|Overall Study|Protocol Violation|3|||
162079487|NCT00603746|585348048|FG002|Overall Study|Protocol Violation|1|||
162079488|NCT00603746|585348049|FG003|Overall Study|Protocol Violation|0|||
162079489|NCT00603746|585348050|FG004|Overall Study|Protocol Violation|1|||
162079490|NCT00603746|585348051|FG005|Overall Study|Protocol Violation|0|||
162079491|NCT00603746|585348046|FG000|Overall Study|Lost to Follow-up|0|||
162079492|NCT00603746|585348047|FG001|Overall Study|Lost to Follow-up|1|||
162079493|NCT00603746|585348048|FG002|Overall Study|Lost to Follow-up|1|||
162079494|NCT00603746|585348049|FG003|Overall Study|Lost to Follow-up|0|||
162079495|NCT00603746|585348050|FG004|Overall Study|Lost to Follow-up|0|||
162079496|NCT00603746|585348051|FG005|Overall Study|Lost to Follow-up|0|||
162079497|NCT00603746|585348046|FG000|Overall Study|Physician Decision|1|||
162079498|NCT00603746|585348047|FG001|Overall Study|Physician Decision|0|||
162079499|NCT00603746|585348048|FG002|Overall Study|Physician Decision|0|||
162079500|NCT00603746|585348049|FG003|Overall Study|Physician Decision|0|||
162079501|NCT00603746|585348050|FG004|Overall Study|Physician Decision|1|||
162079502|NCT00603746|585348051|FG005|Overall Study|Physician Decision|0|||
162079503|NCT00603746|585348046|FG000|Overall Study|Withdrawal by Subject|1|||
162079504|NCT00603746|585348047|FG001|Overall Study|Withdrawal by Subject|0|||
162079505|NCT00603746|585348048|FG002|Overall Study|Withdrawal by Subject|0|||
162079506|NCT00603746|585348049|FG003|Overall Study|Withdrawal by Subject|1|||
162079507|NCT00603746|585348050|FG004|Overall Study|Withdrawal by Subject|3|||
162079508|NCT00603746|585348051|FG005|Overall Study|Withdrawal by Subject|1|||
162079509|NCT01524627|585348053|FG000|Overall Study|Physician Decision|0|||
162079510|NCT01524627|585348054|FG001|Overall Study|Physician Decision|1|||
162079511|NCT01524627|585348053|FG000|Overall Study|Lost to Follow-up|1|||
162079512|NCT01524627|585348054|FG001|Overall Study|Lost to Follow-up|1|||
162079513|NCT03323658|585348055|FG000|Overall Study|Adverse Event|0|||
162079514|NCT03323658|585348056|FG001|Overall Study|Adverse Event|1|||
162079515|NCT03323658|585348057|FG002|Overall Study|Adverse Event|0|||
162079516|NCT00615056|585348058|FG000|Overall Study|Death|31|||
162079517|NCT00615056|585348059|FG001|Overall Study|Death|31|||
162079518|NCT00615056|585348060|FG002|Overall Study|Death|21|||
162079519|NCT00615056|585348061|FG003|Overall Study|Death|23|||
162079520|NCT00615056|585348058|FG000|Overall Study|Lost to Follow-up|1|||
162079521|NCT00615056|585348059|FG001|Overall Study|Lost to Follow-up|2|||
162079522|NCT00615056|585348060|FG002|Overall Study|Lost to Follow-up|4|||
162079523|NCT00615056|585348061|FG003|Overall Study|Lost to Follow-up|5|||
162079524|NCT00615056|585348058|FG000|Overall Study|Other|13|||
162079525|NCT00615056|585348059|FG001|Overall Study|Other|15|||
162079526|NCT00615056|585348060|FG002|Overall Study|Other|10|||
162079527|NCT00615056|585348061|FG003|Overall Study|Other|7|||
162079528|NCT00615056|585348058|FG000|Overall Study|Objective progression or relapse|0|||
162079529|NCT00615056|585348059|FG001|Overall Study|Objective progression or relapse|2|||
162079530|NCT00615056|585348060|FG002|Overall Study|Objective progression or relapse|0|||
162079531|NCT00615056|585348061|FG003|Overall Study|Objective progression or relapse|0|||
162079532|NCT00615056|585348058|FG000|Overall Study|Withdrawal by Subject|0|||
162079533|NCT00615056|585348059|FG001|Overall Study|Withdrawal by Subject|1|||
162079534|NCT00615056|585348060|FG002|Overall Study|Withdrawal by Subject|1|||
162079535|NCT00615056|585348061|FG003|Overall Study|Withdrawal by Subject|0|||
162079536|NCT00615056|585348058|FG000|Overall Study|Discontinued by Sponsor|1|||
162079537|NCT00615056|585348059|FG001|Overall Study|Discontinued by Sponsor|0|||
162079538|NCT00615056|585348060|FG002|Overall Study|Discontinued by Sponsor|0|||
162079539|NCT00615056|585348061|FG003|Overall Study|Discontinued by Sponsor|0|||
162079540|NCT00615056|585348058|FG000|Overall Study|Randomized but not treated|3|||
162079541|NCT00615056|585348059|FG001|Overall Study|Randomized but not treated|0|||
162079542|NCT00615056|585348060|FG002|Overall Study|Randomized but not treated|0|||
162079543|NCT00615056|585348061|FG003|Overall Study|Randomized but not treated|0|||
162079544|NCT05627518|585348062|FG000|Treatment Period 1|Adverse Event|0|||
162079545|NCT05627518|585348063|FG001|Treatment Period 1|Adverse Event|0|||
162079546|NCT05627518|585348064|FG002|Treatment Period 1|Adverse Event|1|||
162079547|NCT05627518|585348065|FG003|Treatment Period 1|Adverse Event|0|||
162079548|NCT05627518|585348066|FG004|Treatment Period 1|Adverse Event|0|||
162079549|NCT05627518|585348067|FG005|Treatment Period 1|Adverse Event|0|||
162079550|NCT05627518|585348068|FG006|Treatment Period 1|Adverse Event|0|||
162079551|NCT05627518|585348069|FG007|Treatment Period 1|Adverse Event|1|||
162079552|NCT05627518|585348062|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162079553|NCT05627518|585348063|FG001|Treatment Period 1|Withdrawal by Subject|0|||
162079554|NCT05627518|585348064|FG002|Treatment Period 1|Withdrawal by Subject|1|||
162079555|NCT05627518|585348065|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162079556|NCT05627518|585348066|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162079557|NCT05627518|585348067|FG005|Treatment Period 1|Withdrawal by Subject|1|||
162079558|NCT05627518|585348068|FG006|Treatment Period 1|Withdrawal by Subject|0|||
162079559|NCT05627518|585348069|FG007|Treatment Period 1|Withdrawal by Subject|0|||
162079560|NCT05627518|585348062|FG000|Treatment Period 1|Protocol Violation|0|||
162079561|NCT05627518|585348063|FG001|Treatment Period 1|Protocol Violation|0|||
162079562|NCT05627518|585348064|FG002|Treatment Period 1|Protocol Violation|0|||
162079563|NCT05627518|585348065|FG003|Treatment Period 1|Protocol Violation|0|||
162079564|NCT05627518|585348066|FG004|Treatment Period 1|Protocol Violation|0|||
162079565|NCT05627518|585348067|FG005|Treatment Period 1|Protocol Violation|0|||
162079566|NCT05627518|585348068|FG006|Treatment Period 1|Protocol Violation|6|||
162079567|NCT05627518|585348069|FG007|Treatment Period 1|Protocol Violation|6|||
162079568|NCT05627518|585348062|FG000|Treatment Period 2|Adverse Event|1|||
162079569|NCT05627518|585348063|FG001|Treatment Period 2|Adverse Event|0|||
162079570|NCT05627518|585348064|FG002|Treatment Period 2|Adverse Event|0|||
162079571|NCT05627518|585348065|FG003|Treatment Period 2|Adverse Event|0|||
162079572|NCT05627518|585348066|FG004|Treatment Period 2|Adverse Event|0|||
162079573|NCT05627518|585348067|FG005|Treatment Period 2|Adverse Event|0|||
162079574|NCT05627518|585348068|FG006|Treatment Period 2|Adverse Event|0|||
162079575|NCT05627518|585348069|FG007|Treatment Period 2|Adverse Event|0|||
162079576|NCT05627518|585348062|FG000|Treatment Period 2|Withdrawal by Subject|1|||
162079577|NCT05627518|585348063|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162079578|NCT05627518|585348064|FG002|Treatment Period 2|Withdrawal by Subject|0|||
162079579|NCT05627518|585348065|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162079580|NCT05627518|585348066|FG004|Treatment Period 2|Withdrawal by Subject|0|||
162079581|NCT05627518|585348067|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162079582|NCT05627518|585348068|FG006|Treatment Period 2|Withdrawal by Subject|0|||
162079583|NCT05627518|585348069|FG007|Treatment Period 2|Withdrawal by Subject|0|||
162079584|NCT03756558|585350019|FG000|Overall Study|Death|1|||
162079585|NCT03756558|585350019|FG000|Overall Study|Lost to Follow-up|2|||
162079586|NCT03756558|585350019|FG000|Overall Study|Withdrawal by Subject|2|||
162079587|NCT01700179|585350021|FG000|Overall Study|Physician Decision|2|||
162079588|NCT04013191|585350022|FG000|Overall Study|Adverse Event|1|||
162079589|NCT04013191|585350023|FG001|Overall Study|Adverse Event|0|||
162079590|NCT01945489|585350032|FG000|Cycle 1|Adverse Event|2|||
162079591|NCT01945489|585350033|FG001|Cycle 1|Adverse Event|0|||
162079592|NCT01945489|585350032|FG000|Cycle 1|Lost to Follow-up|4|||
162079593|NCT01945489|585350033|FG001|Cycle 1|Lost to Follow-up|0|||
162079594|NCT01945489|585350032|FG000|Cycle 1|Personal Reasons|4|||
162079595|NCT01945489|585350033|FG001|Cycle 1|Personal Reasons|2|||
162079596|NCT01945489|585350032|FG000|Cycle 1|Protocol Violation|0|||
162079597|NCT01945489|585350033|FG001|Cycle 1|Protocol Violation|1|||
162079598|NCT01945489|585350032|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
162079599|NCT01945489|585350033|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
162079600|NCT01945489|585350032|FG000|Cycle 2|Adverse Event|1|||
162079601|NCT01945489|585350033|FG001|Cycle 2|Adverse Event|0|||
162079602|NCT01945489|585350032|FG000|Cycle 2|Lost to Follow-up|0|||
162079603|NCT01945489|585350033|FG001|Cycle 2|Lost to Follow-up|1|||
162079604|NCT00394212|585350036|FG000|Overall Study|Lost to Follow-up|3|||
162079605|NCT00394212|585350037|FG001|Overall Study|Lost to Follow-up|0|||
162079606|NCT00394212|585350036|FG000|Overall Study|Withdrawal by Subject|4|||
162079607|NCT00394212|585350037|FG001|Overall Study|Withdrawal by Subject|1|||
162079608|NCT00588445|585350038|FG000|Overall Study|Protocol Violation|1|||
162079609|NCT00588445|585350038|FG000|Overall Study|Withdrawal by Subject|3|||
162079610|NCT00588445|585350038|FG000|Overall Study|Disease Progression|1|||
162079611|NCT00588445|585350038|FG000|Overall Study|Not Treated|10|||
162079612|NCT00358527|585350039|FG000|Overall Study|Adverse Event|4|||
162079613|NCT00358527|585350040|FG001|Overall Study|Adverse Event|0|||
162079614|NCT00358527|585350039|FG000|Overall Study|Withdrawal by Subject|1|||
162079615|NCT00358527|585350040|FG001|Overall Study|Withdrawal by Subject|1|||
162079616|NCT00358527|585350039|FG000|Overall Study|Non-compliance with protocol|6|||
162079617|NCT00358527|585350040|FG001|Overall Study|Non-compliance with protocol|1|||
162079618|NCT00358527|585350039|FG000|Overall Study|Administrative|2|||
162079619|NCT00358527|585350040|FG001|Overall Study|Administrative|1|||
162079620|NCT00145509|585350043|FG000|Overall Study|Adverse Event|10|||
162079621|NCT00145509|585350044|FG001|Overall Study|Adverse Event|3|||
162079622|NCT00145509|585350043|FG000|Overall Study|Lack of Efficacy|3|||
162079623|NCT00145509|585350044|FG001|Overall Study|Lack of Efficacy|1|||
162079624|NCT00145509|585350043|FG000|Overall Study|Lost to Follow-up|5|||
162079625|NCT00145509|585350044|FG001|Overall Study|Lost to Follow-up|9|||
162079626|NCT00145509|585350043|FG000|Overall Study|Withdrew Consent|2|||
162079627|NCT00145509|585350044|FG001|Overall Study|Withdrew Consent|7|||
162079628|NCT00145509|585350043|FG000|Overall Study|Reason not provided|2|||
162079629|NCT00145509|585350044|FG001|Overall Study|Reason not provided|1|||
162079630|NCT00697346|585350050|FG000|Overall Study|Adverse Event|4|||
162079631|NCT00697346|585350051|FG001|Overall Study|Adverse Event|5|||
162079632|NCT00697346|585350052|FG002|Overall Study|Adverse Event|0|||
162079633|NCT00697346|585350050|FG000|Overall Study|Progressive Disease|19|||
162079634|NCT00697346|585350051|FG001|Overall Study|Progressive Disease|18|||
162079635|NCT00697346|585350052|FG002|Overall Study|Progressive Disease|0|||
162079636|NCT00697346|585350050|FG000|Overall Study|Symptomatic Deterioration|0|||
162079637|NCT00697346|585350051|FG001|Overall Study|Symptomatic Deterioration|1|||
162079638|NCT00697346|585350052|FG002|Overall Study|Symptomatic Deterioration|0|||
162079639|NCT00697346|585350050|FG000|Overall Study|Withdrawal by Subject|2|||
162079640|NCT00697346|585350051|FG001|Overall Study|Withdrawal by Subject|2|||
162079641|NCT00697346|585350052|FG002|Overall Study|Withdrawal by Subject|0|||
162079642|NCT00697346|585350050|FG000|Overall Study|Reason not Specified|3|||
162079643|NCT00697346|585350051|FG001|Overall Study|Reason not Specified|0|||
162079644|NCT00697346|585350052|FG002|Overall Study|Reason not Specified|1|||
162079645|NCT03569371|585350053|FG000|Overall Study|Lack of Efficacy|1|||
162079646|NCT03569371|585350053|FG000|Overall Study|Lost to Follow-up|1|||
162079647|NCT03569371|585350053|FG000|Overall Study|Adverse Event|1|||
162079648|NCT03643562|585350056|FG000|Overall Study|Adverse Event|1|||
162079649|NCT03643562|585350057|FG001|Overall Study|Adverse Event|0|||
162079650|NCT03643562|585350056|FG000|Overall Study|Lack of Efficacy|0|||
162079651|NCT03643562|585350057|FG001|Overall Study|Lack of Efficacy|1|||
162079652|NCT03643562|585350056|FG000|Overall Study|Physician Decision|0|||
162079653|NCT03643562|585350057|FG001|Overall Study|Physician Decision|1|||
162079654|NCT03643562|585350056|FG000|Overall Study|Study Terminated by Sponsor|2|||
162079655|NCT03643562|585350057|FG001|Overall Study|Study Terminated by Sponsor|10|||
162079656|NCT03643562|585350056|FG000|Overall Study|Withdrawal by Subject|2|||
162079657|NCT03643562|585350057|FG001|Overall Study|Withdrawal by Subject|2|||
162079658|NCT03643562|585350056|FG000|Overall Study|Other than specified|3|||
162079659|NCT03643562|585350057|FG001|Overall Study|Other than specified|2|||
162079660|NCT01982253|585350058|FG000|Overall Study|Withdrawal by Subject|1|||
162079661|NCT01982253|585350059|FG001|Overall Study|Withdrawal by Subject|0|||
162079662|NCT01982253|585350060|FG002|Overall Study|Withdrawal by Subject|0|||
162079663|NCT01982253|585350058|FG000|Overall Study|Study terminated by sponsor|1|||
162079664|NCT01982253|585350059|FG001|Overall Study|Study terminated by sponsor|4|||
162079665|NCT01982253|585350060|FG002|Overall Study|Study terminated by sponsor|4|||
162079666|NCT02789176|585350064|FG000|Overall Study|Death|0|||
162079667|NCT02789176|585350065|FG001|Overall Study|Death|0|||
162079668|NCT02789176|585350066|FG002|Overall Study|Death|3|||
162079669|NCT02789176|585350067|FG003|Overall Study|Death|0|||
162079670|NCT02789176|585350064|FG000|Overall Study|Withdrawal by Subject|0|||
162079671|NCT02789176|585350065|FG001|Overall Study|Withdrawal by Subject|0|||
162079672|NCT02789176|585350066|FG002|Overall Study|Withdrawal by Subject|1|||
162079673|NCT02789176|585350067|FG003|Overall Study|Withdrawal by Subject|0|||
162079674|NCT02789176|585350064|FG000|Overall Study|Lost to Follow-up|8|||
162079675|NCT02789176|585350065|FG001|Overall Study|Lost to Follow-up|2|||
162079676|NCT02789176|585350066|FG002|Overall Study|Lost to Follow-up|6|||
162079677|NCT02789176|585350067|FG003|Overall Study|Lost to Follow-up|1|||
162079678|NCT02223767|585350068|FG000|Overall Study|Withdrawal by Subject|4|||
162079679|NCT02223767|585350069|FG001|Overall Study|Withdrawal by Subject|4|||
162079680|NCT00770120|585350073|FG000|Overall Study|Progression|31|||
162079681|NCT00770120|585350073|FG000|Overall Study|Adverse Event|11|||
162079682|NCT00770120|585350073|FG000|Overall Study|Not Protocol Specified|11|||
162079683|NCT00770120|585350073|FG000|Overall Study|Death|3|||
162079684|NCT00770120|585350073|FG000|Overall Study|Withdrawal by Subject|2|||
162079685|NCT00770120|585350073|FG000|Overall Study|Ineligible|1|||
162079686|NCT00770120|585350073|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
162079687|NCT00770120|585350073|FG000|Overall Study|Reason under Review|1|||
162079688|NCT01232296|585350074|FG000|Overall Study|Adverse Event|24|||
162079689|NCT01232296|585350075|FG001|Overall Study|Adverse Event|12|||
162079690|NCT01232296|585350074|FG000|Overall Study|Physician Decision|1|||
162079691|NCT01232296|585350075|FG001|Overall Study|Physician Decision|1|||
162079692|NCT01232296|585350074|FG000|Overall Study|Progressive disease|43|||
162079693|NCT01232296|585350075|FG001|Overall Study|Progressive disease|61|||
162079694|NCT01232296|585350074|FG000|Overall Study|Study terminated by sponsor|0|||
162079695|NCT01232296|585350075|FG001|Overall Study|Study terminated by sponsor|1|||
162079696|NCT01232296|585350074|FG000|Overall Study|Technical problems|3|||
162079697|NCT01232296|585350075|FG001|Overall Study|Technical problems|0|||
162079698|NCT01232296|585350074|FG000|Overall Study|Subject/guardian decision|10|||
162079699|NCT01232296|585350075|FG001|Overall Study|Subject/guardian decision|2|||
162079700|NCT01232296|585350074|FG000|Overall Study|Death|1|||
162079701|NCT01232296|585350075|FG001|Overall Study|Death|6|||
162079702|NCT01461096|585350077|FG000|Overall Study|Death|3|||
162079703|NCT01461096|585350078|FG001|Overall Study|Death|6|||
162079704|NCT01461096|585350077|FG000|Overall Study|Severe debilitation, unable to continue|1|||
162079705|NCT01461096|585350078|FG001|Overall Study|Severe debilitation, unable to continue|1|||
162079706|NCT01461096|585350077|FG000|Overall Study|Subj not able to get to clinic|15|||
162079707|NCT01461096|585350078|FG001|Overall Study|Subj not able to get to clinic|13|||
162079708|NCT01461096|585350077|FG000|Overall Study|Site is closing|27|||
162079709|NCT01461096|585350078|FG001|Overall Study|Site is closing|30|||
162079710|NCT01461096|585350077|FG000|Overall Study|Withdrawal by Subject|5|||
162079711|NCT01461096|585350078|FG001|Overall Study|Withdrawal by Subject|3|||
162079712|NCT01461096|585350077|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
162079713|NCT01461096|585350078|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
162079714|NCT01461096|585350077|FG000|Overall Study|Lost to Follow-up|8|||
162079715|NCT01461096|585350078|FG001|Overall Study|Lost to Follow-up|4|||
162079716|NCT04889625|585350080|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
162079717|NCT04889625|585350081|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
162079718|NCT04889625|585350080|FG000|Period 1|Subject out of window|0|||
162079719|NCT04889625|585350081|FG001|Period 1|Subject out of window|1|||
162079720|NCT04889625|585350080|FG000|Period 1|Wrong add power dispensed|0|||
162079721|NCT04889625|585350081|FG001|Period 1|Wrong add power dispensed|1|||
162079722|NCT04889625|585350080|FG000|Period 1|Discontinued due to fitting guide error|1|||
162079723|NCT04889625|585350081|FG001|Period 1|Discontinued due to fitting guide error|1|||
162079724|NCT04889625|585350080|FG000|Period 2|Test article no longer available|1|||
162079725|NCT04889625|585350081|FG001|Period 2|Test article no longer available|0|||
162079726|NCT04889625|585350080|FG000|Period 2|Incorrect lens dispensed|1|||
162079727|NCT04889625|585350081|FG001|Period 2|Incorrect lens dispensed|0|||
162079728|NCT04889625|585350080|FG000|Period 2|Wrong add power dispensed|0|||
162079729|NCT04889625|585350081|FG001|Period 2|Wrong add power dispensed|1|||
162079730|NCT00404352|585350084|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
162079731|NCT00404352|585350085|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
162079732|NCT00404352|585350086|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
162079733|NCT00404352|585350087|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
162079734|NCT00404352|585350088|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
162079735|NCT00404352|585350089|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
162079736|NCT00404352|585350090|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
162079737|NCT00404352|585350091|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
162079738|NCT00404352|585350092|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
162079739|NCT00404352|585350084|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
162079740|NCT00404352|585350085|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
162079741|NCT00404352|585350086|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
162079742|NCT00404352|585350087|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
162079743|NCT00404352|585350088|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
162079744|NCT00404352|585350089|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
162079745|NCT00404352|585350090|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
162079746|NCT00404352|585350091|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
162079747|NCT00404352|585350092|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
162079748|NCT00404352|585350084|FG000|Double Blind (up to 24 Month)|Death|0|||
162079749|NCT00404352|585350085|FG001|Double Blind (up to 24 Month)|Death|0|||
162079750|NCT00404352|585350086|FG002|Double Blind (up to 24 Month)|Death|1|||
162079751|NCT00404352|585350087|FG003|Double Blind (up to 24 Month)|Death|0|||
162079752|NCT00404352|585350088|FG004|Double Blind (up to 24 Month)|Death|0|||
162079753|NCT00404352|585350089|FG005|Double Blind (up to 24 Month)|Death|0|||
162079754|NCT00404352|585350090|FG006|Double Blind (up to 24 Month)|Death|0|||
162079755|NCT00404352|585350091|FG007|Double Blind (up to 24 Month)|Death|0|||
162079756|NCT00404352|585350092|FG008|Double Blind (up to 24 Month)|Death|0|||
162079757|NCT00404352|585350084|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
162079758|NCT00404352|585350085|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
162079759|NCT00404352|585350086|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
162079760|NCT00404352|585350087|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
162079761|NCT00404352|585350088|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
162079762|NCT00404352|585350089|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
162079763|NCT00404352|585350090|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
162079764|NCT00404352|585350091|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
162079765|NCT00404352|585350092|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
162079766|NCT00404352|585350084|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
162079767|NCT00404352|585350085|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
162079768|NCT00404352|585350086|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
162079769|NCT00404352|585350087|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
162079770|NCT00404352|585350088|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
162079771|NCT00404352|585350089|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
162079772|NCT00404352|585350090|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
162079773|NCT00404352|585350091|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
162079774|NCT00404352|585350092|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
162079775|NCT00404352|585350084|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
162079776|NCT00404352|585350085|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
162079777|NCT00404352|585350086|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
162079778|NCT00404352|585350087|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
162079779|NCT00404352|585350088|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
162079780|NCT00404352|585350089|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
162079781|NCT00404352|585350090|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
162079782|NCT00404352|585350091|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
162079783|NCT00404352|585350092|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
162079784|NCT00404352|585350084|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
162079785|NCT00404352|585350085|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
162079786|NCT00404352|585350086|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
162079787|NCT00404352|585350087|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
162079788|NCT00404352|585350088|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
162079789|NCT00404352|585350089|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
162079790|NCT00404352|585350090|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
162079791|NCT00404352|585350091|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
162079792|NCT00404352|585350092|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
162079793|NCT00404352|585350084|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
162079794|NCT00404352|585350085|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
162079795|NCT00404352|585350086|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
162079796|NCT00404352|585350087|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
162079797|NCT00404352|585350088|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
162079798|NCT00404352|585350089|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
162079799|NCT00404352|585350090|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
162079800|NCT00404352|585350091|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
162079801|NCT00404352|585350092|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
162079802|NCT00404352|585350084|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162079803|NCT00404352|585350085|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
162079804|NCT00404352|585350086|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162079805|NCT00404352|585350087|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162079806|NCT00404352|585350088|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162079807|NCT00404352|585350089|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162079808|NCT00404352|585350090|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162079809|NCT00404352|585350091|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162079810|NCT00404352|585350092|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
162079811|NCT00404352|585350084|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
162079812|NCT00404352|585350085|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
162079813|NCT00404352|585350086|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
162079814|NCT00404352|585350087|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
162079815|NCT00404352|585350088|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
162079816|NCT00404352|585350089|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
162079817|NCT00404352|585350090|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
162079818|NCT00404352|585350091|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
162079819|NCT00404352|585350092|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
162079820|NCT00404352|585350084|FG000|Double Blind (up to 24 Month)|Other|0|||
162079821|NCT00404352|585350085|FG001|Double Blind (up to 24 Month)|Other|1|||
162079822|NCT00404352|585350086|FG002|Double Blind (up to 24 Month)|Other|0|||
162079823|NCT00404352|585350087|FG003|Double Blind (up to 24 Month)|Other|0|||
162079824|NCT00404352|585350088|FG004|Double Blind (up to 24 Month)|Other|0|||
162079825|NCT00404352|585350089|FG005|Double Blind (up to 24 Month)|Other|0|||
162079826|NCT00404352|585350090|FG006|Double Blind (up to 24 Month)|Other|0|||
162079827|NCT00404352|585350091|FG007|Double Blind (up to 24 Month)|Other|0|||
162079828|NCT00404352|585350092|FG008|Double Blind (up to 24 Month)|Other|0|||
162079829|NCT00404352|585350084|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
162079830|NCT00404352|585350085|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
162079831|NCT00404352|585350086|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
162079832|NCT00404352|585350087|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
162079833|NCT00404352|585350088|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
162079834|NCT00404352|585350089|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
162079835|NCT00404352|585350090|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
162079836|NCT00404352|585350091|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
162079837|NCT00404352|585350092|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
162079838|NCT00404352|585350084|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
162079839|NCT00404352|585350085|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
162079840|NCT00404352|585350086|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
162079841|NCT00404352|585350087|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
162079842|NCT00404352|585350088|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
162079843|NCT00404352|585350089|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
162079844|NCT00404352|585350090|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
162079845|NCT00404352|585350091|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
162079846|NCT00404352|585350092|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
162079847|NCT00404352|585350084|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162079848|NCT00404352|585350085|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162079849|NCT00404352|585350086|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162079850|NCT00404352|585350087|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162079851|NCT00404352|585350088|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
162079852|NCT00404352|585350089|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162079853|NCT00404352|585350090|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162079854|NCT00404352|585350091|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162079855|NCT00404352|585350092|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
162079856|NCT00404352|585350084|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162079857|NCT00404352|585350085|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162079858|NCT00404352|585350086|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162079859|NCT00404352|585350087|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162079860|NCT00404352|585350088|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162079861|NCT00404352|585350089|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
162079862|NCT00404352|585350090|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162079863|NCT00404352|585350091|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162079864|NCT00404352|585350092|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
162079865|NCT00404352|585350084|FG000|Open Label (up to 24 Month)|Disease progression|0|||
162079866|NCT00404352|585350085|FG001|Open Label (up to 24 Month)|Disease progression|0|||
162079867|NCT00404352|585350086|FG002|Open Label (up to 24 Month)|Disease progression|0|||
162079868|NCT00404352|585350087|FG003|Open Label (up to 24 Month)|Disease progression|1|||
162079869|NCT00404352|585350088|FG004|Open Label (up to 24 Month)|Disease progression|0|||
162079870|NCT00404352|585350089|FG005|Open Label (up to 24 Month)|Disease progression|0|||
162079871|NCT00404352|585350090|FG006|Open Label (up to 24 Month)|Disease progression|0|||
162079872|NCT00404352|585350091|FG007|Open Label (up to 24 Month)|Disease progression|0|||
162079873|NCT00404352|585350092|FG008|Open Label (up to 24 Month)|Disease progression|0|||
162079874|NCT00404352|585350084|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162079875|NCT00404352|585350085|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162079876|NCT00404352|585350086|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162079877|NCT00404352|585350087|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162079878|NCT00404352|585350088|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162079879|NCT00404352|585350089|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162079880|NCT00404352|585350090|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
162079881|NCT00404352|585350091|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
162079882|NCT00404352|585350092|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
162079883|NCT00404352|585350084|FG000|Open Label Extension (up to 36 Months)|Other|0|||
162079884|NCT00404352|585350085|FG001|Open Label Extension (up to 36 Months)|Other|0|||
162079885|NCT00404352|585350086|FG002|Open Label Extension (up to 36 Months)|Other|0|||
162079886|NCT00404352|585350087|FG003|Open Label Extension (up to 36 Months)|Other|0|||
162079887|NCT00404352|585350088|FG004|Open Label Extension (up to 36 Months)|Other|0|||
162079888|NCT00404352|585350089|FG005|Open Label Extension (up to 36 Months)|Other|0|||
162079889|NCT00404352|585350090|FG006|Open Label Extension (up to 36 Months)|Other|0|||
162079890|NCT00404352|585350091|FG007|Open Label Extension (up to 36 Months)|Other|0|||
162079891|NCT00404352|585350092|FG008|Open Label Extension (up to 36 Months)|Other|2|||
162079892|NCT02346136|585350093|FG000|Overall Study|Withdrawal by Subject|7|||
162079893|NCT02346136|585350094|FG001|Overall Study|Withdrawal by Subject|5|||
162079894|NCT02346136|585350093|FG000|Overall Study|Death|1|||
162079895|NCT02346136|585350094|FG001|Overall Study|Death|0|||
162079896|NCT02346136|585350093|FG000|Overall Study|Study termination|14|||
162079897|NCT02346136|585350094|FG001|Overall Study|Study termination|18|||
162079898|NCT00582933|585350098|FG000|Overall Study|Physician Decision|3|||
162079899|NCT03316885|585350101|FG000|Overall Study|Adverse Event|1|||
162079900|NCT03316885|585350101|FG000|Overall Study|Death|10|||
162079901|NCT03316885|585350101|FG000|Overall Study|Lost to Follow-up|4|||
162079902|NCT03316885|585350101|FG000|Overall Study|Withdrawal by Subject|9|||
162079903|NCT03316885|585350101|FG000|Overall Study|COVID related|8|||
162079904|NCT01736696|585350109|FG000|Overall Study|Withdrawal by Subject|0|||
162079905|NCT01736696|585350110|FG001|Overall Study|Withdrawal by Subject|0|||
162079906|NCT01736696|585350111|FG002|Overall Study|Withdrawal by Subject|1|||
162079907|NCT01736696|585350112|FG003|Overall Study|Withdrawal by Subject|0|||
162079908|NCT01736696|585350113|FG004|Overall Study|Withdrawal by Subject|0|||
162079909|NCT01736696|585350114|FG005|Overall Study|Withdrawal by Subject|0|||
162079910|NCT01736696|585350115|FG006|Overall Study|Withdrawal by Subject|0|||
162079911|NCT00405548|585350116|FG000|Overall Study|Cognitive Memory problems on study day|1|||
162079912|NCT00405548|585350117|FG001|Overall Study|Cognitive Memory problems on study day|0|||
162079913|NCT00405548|585350116|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
162079914|NCT00405548|585350117|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
162079915|NCT00405548|585350116|FG000|Overall Study|Unable to self-administer shots|1|||
162079916|NCT00405548|585350117|FG001|Overall Study|Unable to self-administer shots|0|||
162079917|NCT00405548|585350116|FG000|Overall Study|Venous access failed during study day|1|||
162079918|NCT00405548|585350117|FG001|Overall Study|Venous access failed during study day|0|||
162079919|NCT00405548|585350116|FG000|Overall Study|Withdrawal by Subject|1|||
162079920|NCT00405548|585350117|FG001|Overall Study|Withdrawal by Subject|0|||
162079921|NCT01116232|585350118|FG000|Overall Study|Progressive diease|4|||
162079922|NCT02036502|585350119|FG000|Part 1:Dose Determination/Escalation|Death|3|||
162079923|NCT02036502|585350120|FG001|Part 1:Dose Determination/Escalation|Death|2|||
162079924|NCT02036502|585350121|FG002|Part 1:Dose Determination/Escalation|Death|0|||
162079925|NCT02036502|585350122|FG003|Part 1:Dose Determination/Escalation|Death|0|||
162079926|NCT02036502|585350123|FG004|Part 1:Dose Determination/Escalation|Death|0|||
162079927|NCT02036502|585350124|FG005|Part 1:Dose Determination/Escalation|Death|0|||
162079928|NCT02036502|585350125|FG006|Part 1:Dose Determination/Escalation|Death|0|||
162079929|NCT02036502|585350126|FG007|Part 1:Dose Determination/Escalation|Death|0|||
162079930|NCT02036502|585350119|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
162079931|NCT02036502|585350120|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162079932|NCT02036502|585350121|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162079933|NCT02036502|585350122|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162079934|NCT02036502|585350123|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162079935|NCT02036502|585350124|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162079936|NCT02036502|585350125|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162079937|NCT02036502|585350126|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
162079938|NCT02036502|585350119|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
162079939|NCT02036502|585350120|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
162079940|NCT02036502|585350121|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
162079941|NCT02036502|585350122|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
162079942|NCT02036502|585350123|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
162079943|NCT02036502|585350124|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
162079944|NCT02036502|585350125|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
162079945|NCT02036502|585350126|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
162079946|NCT02036502|585350119|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
162079947|NCT02036502|585350120|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
162079948|NCT02036502|585350121|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
162079949|NCT02036502|585350122|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
162079950|NCT02036502|585350123|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
162079951|NCT02036502|585350124|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
162079952|NCT02036502|585350125|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
162079953|NCT02036502|585350126|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
162079954|NCT02036502|585350119|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
162079955|NCT02036502|585350120|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
162079956|NCT02036502|585350121|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
162079957|NCT02036502|585350122|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
162079958|NCT02036502|585350123|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
162079959|NCT02036502|585350124|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
162079960|NCT02036502|585350125|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
162079961|NCT02036502|585350126|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
162079962|NCT02036502|585350119|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162079963|NCT02036502|585350120|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162079964|NCT02036502|585350121|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
162079965|NCT02036502|585350122|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162079966|NCT02036502|585350123|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162079967|NCT02036502|585350124|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162079968|NCT02036502|585350125|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162079969|NCT02036502|585350126|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
162079970|NCT02036502|585350119|FG000|Part 2:Dose Confirmation|Death|0|||
162079971|NCT02036502|585350120|FG001|Part 2:Dose Confirmation|Death|0|||
162079972|NCT02036502|585350121|FG002|Part 2:Dose Confirmation|Death|1|||
162079973|NCT02036502|585350122|FG003|Part 2:Dose Confirmation|Death|0|||
162079974|NCT02036502|585350123|FG004|Part 2:Dose Confirmation|Death|0|||
162079975|NCT02036502|585350124|FG005|Part 2:Dose Confirmation|Death|0|||
162079976|NCT02036502|585350125|FG006|Part 2:Dose Confirmation|Death|0|||
162079977|NCT02036502|585350126|FG007|Part 2:Dose Confirmation|Death|0|||
162079978|NCT02036502|585350119|FG000|Part 2:Dose Confirmation|Not treated|0|||
162079979|NCT02036502|585350120|FG001|Part 2:Dose Confirmation|Not treated|0|||
162079980|NCT02036502|585350121|FG002|Part 2:Dose Confirmation|Not treated|0|||
162079981|NCT02036502|585350122|FG003|Part 2:Dose Confirmation|Not treated|1|||
162079982|NCT02036502|585350123|FG004|Part 2:Dose Confirmation|Not treated|0|||
162079983|NCT02036502|585350124|FG005|Part 2:Dose Confirmation|Not treated|0|||
162079984|NCT02036502|585350125|FG006|Part 2:Dose Confirmation|Not treated|0|||
162079985|NCT02036502|585350126|FG007|Part 2:Dose Confirmation|Not treated|0|||
162079986|NCT02036502|585350119|FG000|Part 3:Dose Expansion|Adverse Event|0|||
162079987|NCT02036502|585350120|FG001|Part 3:Dose Expansion|Adverse Event|0|||
162079988|NCT02036502|585350121|FG002|Part 3:Dose Expansion|Adverse Event|0|||
162079989|NCT02036502|585350122|FG003|Part 3:Dose Expansion|Adverse Event|0|||
162079990|NCT02036502|585350123|FG004|Part 3:Dose Expansion|Adverse Event|0|||
162079991|NCT02036502|585350124|FG005|Part 3:Dose Expansion|Adverse Event|4|||
162079992|NCT02036502|585350125|FG006|Part 3:Dose Expansion|Adverse Event|0|||
162079993|NCT02036502|585350126|FG007|Part 3:Dose Expansion|Adverse Event|2|||
162079994|NCT02036502|585350119|FG000|Part 3:Dose Expansion|Death|0|||
162079995|NCT02036502|585350120|FG001|Part 3:Dose Expansion|Death|0|||
162079996|NCT02036502|585350121|FG002|Part 3:Dose Expansion|Death|0|||
162079997|NCT02036502|585350122|FG003|Part 3:Dose Expansion|Death|0|||
162079998|NCT02036502|585350123|FG004|Part 3:Dose Expansion|Death|0|||
162079999|NCT02036502|585350124|FG005|Part 3:Dose Expansion|Death|24|||
162080000|NCT02036502|585350125|FG006|Part 3:Dose Expansion|Death|0|||
162080001|NCT02036502|585350126|FG007|Part 3:Dose Expansion|Death|3|||
162080002|NCT02036502|585350119|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
162080003|NCT02036502|585350120|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
162080004|NCT02036502|585350121|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
162080005|NCT02036502|585350122|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
162080006|NCT02036502|585350123|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
162080007|NCT02036502|585350124|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
162080008|NCT02036502|585350125|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
162080009|NCT02036502|585350126|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
162080010|NCT02036502|585350119|FG000|Part 3:Dose Expansion|Physician Decision|0|||
162080011|NCT02036502|585350120|FG001|Part 3:Dose Expansion|Physician Decision|0|||
162080012|NCT02036502|585350121|FG002|Part 3:Dose Expansion|Physician Decision|0|||
162080013|NCT02036502|585350122|FG003|Part 3:Dose Expansion|Physician Decision|0|||
162080014|NCT02036502|585350123|FG004|Part 3:Dose Expansion|Physician Decision|0|||
162080015|NCT02036502|585350124|FG005|Part 3:Dose Expansion|Physician Decision|1|||
162080016|NCT02036502|585350125|FG006|Part 3:Dose Expansion|Physician Decision|0|||
162080017|NCT02036502|585350126|FG007|Part 3:Dose Expansion|Physician Decision|0|||
162080018|NCT02036502|585350119|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
162080019|NCT02036502|585350120|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
162080020|NCT02036502|585350121|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
162080021|NCT02036502|585350122|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
162080022|NCT02036502|585350123|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
162080023|NCT02036502|585350124|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
162080024|NCT02036502|585350125|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
162080025|NCT02036502|585350126|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
162080026|NCT02036502|585350119|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
162080027|NCT02036502|585350120|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
162080028|NCT02036502|585350121|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
162080029|NCT02036502|585350122|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
162080030|NCT02036502|585350123|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
162080031|NCT02036502|585350124|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
162080032|NCT02036502|585350125|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
162080033|NCT02036502|585350126|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
162080034|NCT02036502|585350119|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
162080035|NCT02036502|585350120|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
162080036|NCT02036502|585350121|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
162080037|NCT02036502|585350122|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
162080038|NCT02036502|585350123|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
162080039|NCT02036502|585350124|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
162080040|NCT02036502|585350125|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
162080041|NCT02036502|585350126|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
162080042|NCT02036502|585350119|FG000|Part 3:Dose Expansion|Not Treated|0|||
162080043|NCT02036502|585350120|FG001|Part 3:Dose Expansion|Not Treated|0|||
162080044|NCT02036502|585350121|FG002|Part 3:Dose Expansion|Not Treated|0|||
162080045|NCT02036502|585350122|FG003|Part 3:Dose Expansion|Not Treated|0|||
162080046|NCT02036502|585350123|FG004|Part 3:Dose Expansion|Not Treated|0|||
162080047|NCT02036502|585350124|FG005|Part 3:Dose Expansion|Not Treated|2|||
162080048|NCT02036502|585350125|FG006|Part 3:Dose Expansion|Not Treated|0|||
162080049|NCT02036502|585350126|FG007|Part 3:Dose Expansion|Not Treated|0|||
162080050|NCT00811577|585350132|FG000|Overall Study|Lost to Follow-up|7|||
162080051|NCT00811577|585350133|FG001|Overall Study|Lost to Follow-up|1|||
162080052|NCT00811577|585350132|FG000|Overall Study|Withdrawal by Subject|3|||
162080053|NCT00811577|585350133|FG001|Overall Study|Withdrawal by Subject|0|||
162080054|NCT04011410|585350134|FG000|Overall Study|Withdrawal by Subject|1|||
162080055|NCT01068509|585350135|FG000|Overall Study|Death|0|||
162080056|NCT01068509|585350136|FG001|Overall Study|Death|0|||
162080057|NCT01068509|585350137|FG002|Overall Study|Death|1|||
162080058|NCT01068509|585350135|FG000|Overall Study|Disease Progression|5|||
162080059|NCT01068509|585350136|FG001|Overall Study|Disease Progression|20|||
162080060|NCT01068509|585350137|FG002|Overall Study|Disease Progression|18|||
162080061|NCT01068509|585350135|FG000|Overall Study|Lost to Follow-up|1|||
162080062|NCT01068509|585350136|FG001|Overall Study|Lost to Follow-up|0|||
162080063|NCT01068509|585350137|FG002|Overall Study|Lost to Follow-up|0|||
162080064|NCT01068509|585350135|FG000|Overall Study|Withdrew Consent|0|||
162080065|NCT01068509|585350136|FG001|Overall Study|Withdrew Consent|1|||
162080066|NCT01068509|585350137|FG002|Overall Study|Withdrew Consent|2|||
162080067|NCT01068509|585350135|FG000|Overall Study|Reason Not Specified|0|||
162080068|NCT01068509|585350136|FG001|Overall Study|Reason Not Specified|1|||
162080069|NCT01068509|585350137|FG002|Overall Study|Reason Not Specified|0|||
162080070|NCT01455012|585350138|FG000|Overall Study|Adverse Event|0|||
162080071|NCT01455012|585350139|FG001|Overall Study|Adverse Event|2|||
162080072|NCT01455012|585350138|FG000|Overall Study|Lack of Efficacy|6|||
162080073|NCT01455012|585350139|FG001|Overall Study|Lack of Efficacy|1|||
162080074|NCT01455012|585350138|FG000|Overall Study|Withdrawal by Subject|3|||
162080075|NCT01455012|585350139|FG001|Overall Study|Withdrawal by Subject|1|||
162080076|NCT01455012|585350138|FG000|Overall Study|Unknown reason|2|||
162080077|NCT01455012|585350139|FG001|Overall Study|Unknown reason|0|||
162080078|NCT01418937|585350142|FG000|Overall Study|Lost to Follow-up|5|||
162080079|NCT01418937|585350142|FG000|Overall Study|Protocol Violation|1|||
162080080|NCT01418937|585350142|FG000|Overall Study|Pregnancy|1|||
162080081|NCT01418937|585350142|FG000|Overall Study|Withdrawal by Subject|1|||
162080082|NCT00717769|585350163|FG000|Overall Study|Adverse Event|9|||
162080083|NCT00717769|585350164|FG001|Overall Study|Adverse Event|6|||
162080084|NCT00717769|585350165|FG002|Overall Study|Adverse Event|1|||
162080085|NCT00717769|585350163|FG000|Overall Study|Lack of compliance|0|||
162080086|NCT00717769|585350164|FG001|Overall Study|Lack of compliance|2|||
162080087|NCT00717769|585350165|FG002|Overall Study|Lack of compliance|0|||
162080088|NCT00717769|585350163|FG000|Overall Study|Lost to Follow-up|3|||
162080089|NCT00717769|585350164|FG001|Overall Study|Lost to Follow-up|4|||
162080090|NCT00717769|585350165|FG002|Overall Study|Lost to Follow-up|0|||
162080091|NCT00717769|585350163|FG000|Overall Study|Lack of Efficacy|1|||
162080092|NCT00717769|585350164|FG001|Overall Study|Lack of Efficacy|2|||
162080093|NCT00717769|585350165|FG002|Overall Study|Lack of Efficacy|0|||
162080094|NCT00717769|585350163|FG000|Overall Study|Protocol Violation|0|||
162080095|NCT00717769|585350164|FG001|Overall Study|Protocol Violation|2|||
162080096|NCT00717769|585350165|FG002|Overall Study|Protocol Violation|0|||
162080097|NCT00717769|585350163|FG000|Overall Study|Sponsor decision|1|||
162080098|NCT00717769|585350164|FG001|Overall Study|Sponsor decision|0|||
162080099|NCT00717769|585350165|FG002|Overall Study|Sponsor decision|10|||
162080100|NCT00717769|585350163|FG000|Overall Study|Withdrew consent|2|||
162080101|NCT00717769|585350164|FG001|Overall Study|Withdrew consent|2|||
162080102|NCT00717769|585350165|FG002|Overall Study|Withdrew consent|0|||
162080103|NCT02196324|585350169|FG000|Overall Study|Withdrawal by Subject|8|||
162080104|NCT02196324|585350170|FG001|Overall Study|Withdrawal by Subject|4|||
162080105|NCT02196324|585350169|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
162080106|NCT02196324|585350170|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
162080107|NCT02196324|585350169|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
162080108|NCT02196324|585350170|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
162080109|NCT02196324|585350169|FG000|Overall Study|Other|1|||
162080110|NCT02196324|585350170|FG001|Overall Study|Other|0|||
162080111|NCT01380184|585350171|FG000|Part 1 (19 Days)|Adverse Event|1|||
162080112|NCT01380184|585350171|FG000|Part 2|Adverse Event|5|||
162080113|NCT01380184|585350171|FG000|Part 2|Disease Progression|8|||
162080114|NCT01380184|585350171|FG000|Part 2|Lost to Follow-up|1|||
162080115|NCT04248816|585350176|FG000|Overall Study|Ineligible post-randomization|7|||
162080116|NCT04248816|585350177|FG001|Overall Study|Ineligible post-randomization|21|||
162080117|NCT04248816|585350178|FG002|Overall Study|Ineligible post-randomization|25|||
162080118|NCT04327986|585350179|FG000|Overall Study|Physician Decision|2|||
162080119|NCT04327986|585350180|FG001|Overall Study|Physician Decision|0|||
162080120|NCT04327986|585350181|FG002|Overall Study|Physician Decision|0|||
162080121|NCT04327986|585350179|FG000|Overall Study|Death|1|||
162080122|NCT04327986|585350180|FG001|Overall Study|Death|0|||
162080123|NCT04327986|585350181|FG002|Overall Study|Death|0|||
162080124|NCT03350503|585350182|FG000|Overall Study|Adverse Event|5|||
162080125|NCT03350503|585350182|FG000|Overall Study|Withdrawal by Subject|5|||
162080126|NCT03350503|585350182|FG000|Overall Study|Continuation impossible due to move|4|||
162080127|NCT03350503|585350182|FG000|Overall Study|Physician Decision|3|||
162080128|NCT03829046|585350187|FG000|Overall Study|Withdrawal by Subject|1|||
162080129|NCT03829046|585350188|FG001|Overall Study|Withdrawal by Subject|0|||
162080130|NCT00262067|585350189|FG000|Overall Study|Death|190|||
162080131|NCT00262067|585350190|FG001|Overall Study|Death|89|||
162080132|NCT00262067|585350191|FG002|Overall Study|Death|186|||
162080133|NCT00262067|585350192|FG003|Overall Study|Death|99|||
162080134|NCT00262067|585350189|FG000|Overall Study|Lost to Follow-up|5|||
162080135|NCT00262067|585350190|FG001|Overall Study|Lost to Follow-up|4|||
162080136|NCT00262067|585350191|FG002|Overall Study|Lost to Follow-up|7|||
162080137|NCT00262067|585350192|FG003|Overall Study|Lost to Follow-up|5|||
162080138|NCT00262067|585350189|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
162080139|NCT00262067|585350190|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
162080140|NCT00262067|585350191|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
162080141|NCT00262067|585350192|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
162080142|NCT00262067|585350189|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
162080143|NCT00262067|585350190|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
162080144|NCT00262067|585350191|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
162080145|NCT00262067|585350192|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
162080146|NCT04804813|585350195|FG000|Overall Study|Protocol Violation|2|||
162080147|NCT04804813|585350196|FG001|Overall Study|Protocol Violation|0|||
162080148|NCT04804813|585350195|FG000|Overall Study|Withdrawal by Subject|1|||
162080149|NCT04804813|585350196|FG001|Overall Study|Withdrawal by Subject|0|||
162080150|NCT01581593|585352096|FG000|Overall Study|Withdrawal by Subject|1|||
162080151|NCT01101841|585352097|FG000|Overall Study|Adverse Event|15|||
162080152|NCT01101841|585352098|FG001|Overall Study|Adverse Event|15|||
162080153|NCT01101841|585352097|FG000|Overall Study|Lost to Follow-up|9|||
162080154|NCT01101841|585352098|FG001|Overall Study|Lost to Follow-up|3|||
162080155|NCT01101841|585352097|FG000|Overall Study|Withdrawal by Subject|21|||
162080156|NCT01101841|585352098|FG001|Overall Study|Withdrawal by Subject|40|||
162080157|NCT01101841|585352097|FG000|Overall Study|Protocol Violation|1|||
162080158|NCT01101841|585352098|FG001|Overall Study|Protocol Violation|1|||
162080159|NCT01101841|585352097|FG000|Overall Study|Physician Decision|0|||
162080160|NCT01101841|585352098|FG001|Overall Study|Physician Decision|2|||
162080161|NCT01101841|585352097|FG000|Overall Study|Lack of Efficacy|0|||
162080162|NCT01101841|585352098|FG001|Overall Study|Lack of Efficacy|2|||
162080163|NCT01101841|585352097|FG000|Overall Study|Other|0|||
162080164|NCT01101841|585352098|FG001|Overall Study|Other|1|||
162080165|NCT01101841|585352097|FG000|Overall Study|Suicidality Tracking Scale|3|||
162080166|NCT01101841|585352098|FG001|Overall Study|Suicidality Tracking Scale|1|||
162080167|NCT01101841|585352097|FG000|Overall Study|Eligibility Criteria|1|||
162080168|NCT01101841|585352098|FG001|Overall Study|Eligibility Criteria|2|||
162080169|NCT00653224|585352099|FG000|Overall Study|Adverse Event|2|||
162080170|NCT00653224|585352100|FG001|Overall Study|Adverse Event|1|||
162080171|NCT00653224|585352099|FG000|Overall Study|Lack of Efficacy|1|||
162080172|NCT00653224|585352100|FG001|Overall Study|Lack of Efficacy|2|||
162080173|NCT00653224|585352099|FG000|Overall Study|Loss of efficacy|1|||
162080174|NCT00653224|585352100|FG001|Overall Study|Loss of efficacy|0|||
162080175|NCT00653224|585352099|FG000|Overall Study|Lost to Follow-up|1|||
162080176|NCT00653224|585352100|FG001|Overall Study|Lost to Follow-up|0|||
162080177|NCT00653224|585352099|FG000|Overall Study|Other|2|||
162080178|NCT00653224|585352100|FG001|Overall Study|Other|4|||
162080179|NCT02896400|585352101|FG000|1 Month Follow-up|Lost to Follow-up|7|||
162080180|NCT02896400|585352102|FG001|1 Month Follow-up|Lost to Follow-up|7|||
162080181|NCT02896400|585352103|FG002|1 Month Follow-up|Lost to Follow-up|5|||
162080182|NCT02896400|585352104|FG003|1 Month Follow-up|Lost to Follow-up|8|||
162080183|NCT02896400|585352105|FG004|1 Month Follow-up|Lost to Follow-up|9|||
162080184|NCT02896400|585352106|FG005|1 Month Follow-up|Lost to Follow-up|6|||
162080185|NCT02896400|585352107|FG006|1 Month Follow-up|Lost to Follow-up|5|||
162080186|NCT02896400|585352108|FG007|1 Month Follow-up|Lost to Follow-up|6|||
162080187|NCT02896400|585352109|FG008|1 Month Follow-up|Lost to Follow-up|4|||
162080188|NCT02896400|585352110|FG009|1 Month Follow-up|Lost to Follow-up|7|||
162080189|NCT02896400|585352111|FG010|1 Month Follow-up|Lost to Follow-up|5|||
162080190|NCT02896400|585352112|FG011|1 Month Follow-up|Lost to Follow-up|5|||
162080191|NCT02896400|585352113|FG012|1 Month Follow-up|Lost to Follow-up|3|||
162080192|NCT02896400|585352114|FG013|1 Month Follow-up|Lost to Follow-up|4|||
162080193|NCT02896400|585352115|FG014|1 Month Follow-up|Lost to Follow-up|1|||
162080194|NCT02896400|585352116|FG015|1 Month Follow-up|Lost to Follow-up|2|||
162080195|NCT02896400|585352101|FG000|1 Month Follow-up|Death|0|||
162080196|NCT02896400|585352102|FG001|1 Month Follow-up|Death|0|||
162080197|NCT02896400|585352103|FG002|1 Month Follow-up|Death|0|||
162080198|NCT02896400|585352104|FG003|1 Month Follow-up|Death|0|||
162080199|NCT02896400|585352105|FG004|1 Month Follow-up|Death|0|||
162080200|NCT02896400|585352106|FG005|1 Month Follow-up|Death|0|||
162080201|NCT02896400|585352107|FG006|1 Month Follow-up|Death|0|||
162080202|NCT02896400|585352108|FG007|1 Month Follow-up|Death|0|||
162080203|NCT02896400|585352109|FG008|1 Month Follow-up|Death|0|||
162080204|NCT02896400|585352110|FG009|1 Month Follow-up|Death|0|||
162080205|NCT02896400|585352111|FG010|1 Month Follow-up|Death|0|||
162080206|NCT02896400|585352112|FG011|1 Month Follow-up|Death|0|||
162080207|NCT02896400|585352113|FG012|1 Month Follow-up|Death|0|||
162080208|NCT02896400|585352114|FG013|1 Month Follow-up|Death|0|||
162080209|NCT02896400|585352115|FG014|1 Month Follow-up|Death|0|||
162080210|NCT02896400|585352116|FG015|1 Month Follow-up|Death|1|||
162080211|NCT02896400|585352101|FG000|3 Month Follow-up|Lost to Follow-up|6|||
162080212|NCT02896400|585352102|FG001|3 Month Follow-up|Lost to Follow-up|3|||
162080213|NCT02896400|585352103|FG002|3 Month Follow-up|Lost to Follow-up|6|||
162080214|NCT02896400|585352104|FG003|3 Month Follow-up|Lost to Follow-up|11|||
162080215|NCT02896400|585352105|FG004|3 Month Follow-up|Lost to Follow-up|12|||
162080216|NCT02896400|585352106|FG005|3 Month Follow-up|Lost to Follow-up|6|||
162080217|NCT02896400|585352107|FG006|3 Month Follow-up|Lost to Follow-up|4|||
162080218|NCT02896400|585352108|FG007|3 Month Follow-up|Lost to Follow-up|3|||
162080219|NCT02896400|585352109|FG008|3 Month Follow-up|Lost to Follow-up|6|||
162080220|NCT02896400|585352110|FG009|3 Month Follow-up|Lost to Follow-up|5|||
162080221|NCT02896400|585352111|FG010|3 Month Follow-up|Lost to Follow-up|6|||
162080222|NCT02896400|585352112|FG011|3 Month Follow-up|Lost to Follow-up|6|||
162080223|NCT02896400|585352113|FG012|3 Month Follow-up|Lost to Follow-up|3|||
162080224|NCT02896400|585352114|FG013|3 Month Follow-up|Lost to Follow-up|5|||
162080225|NCT02896400|585352115|FG014|3 Month Follow-up|Lost to Follow-up|3|||
162080226|NCT02896400|585352116|FG015|3 Month Follow-up|Lost to Follow-up|2|||
162080227|NCT02896400|585352101|FG000|3 Month Follow-up|Death|0|||
162080228|NCT02896400|585352102|FG001|3 Month Follow-up|Death|0|||
162080229|NCT02896400|585352103|FG002|3 Month Follow-up|Death|0|||
162080230|NCT02896400|585352104|FG003|3 Month Follow-up|Death|0|||
162080231|NCT02896400|585352105|FG004|3 Month Follow-up|Death|0|||
162080232|NCT02896400|585352106|FG005|3 Month Follow-up|Death|0|||
162080233|NCT02896400|585352107|FG006|3 Month Follow-up|Death|0|||
162080234|NCT02896400|585352108|FG007|3 Month Follow-up|Death|0|||
162080235|NCT02896400|585352109|FG008|3 Month Follow-up|Death|0|||
162080236|NCT02896400|585352110|FG009|3 Month Follow-up|Death|0|||
162080237|NCT02896400|585352111|FG010|3 Month Follow-up|Death|0|||
162080238|NCT02896400|585352112|FG011|3 Month Follow-up|Death|0|||
162080239|NCT02896400|585352113|FG012|3 Month Follow-up|Death|0|||
162080240|NCT02896400|585352114|FG013|3 Month Follow-up|Death|1|||
162080241|NCT02896400|585352115|FG014|3 Month Follow-up|Death|1|||
162080242|NCT02896400|585352116|FG015|3 Month Follow-up|Death|0|||
162080243|NCT02896400|585352101|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162080244|NCT02896400|585352102|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
162080245|NCT02896400|585352103|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162080246|NCT02896400|585352104|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162080247|NCT02896400|585352105|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
162080248|NCT02896400|585352106|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162080249|NCT02896400|585352107|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
162080250|NCT02896400|585352108|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
162080251|NCT02896400|585352109|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162080252|NCT02896400|585352110|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162080253|NCT02896400|585352111|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
162080254|NCT02896400|585352112|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
162080255|NCT02896400|585352113|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162080256|NCT02896400|585352114|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
162080257|NCT02896400|585352115|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
162080258|NCT02896400|585352116|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
162080259|NCT02896400|585352101|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
162080260|NCT02896400|585352102|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
162080261|NCT02896400|585352103|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
162080262|NCT02896400|585352104|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
162080263|NCT02896400|585352105|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
162080264|NCT02896400|585352106|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
162080265|NCT02896400|585352107|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
162080266|NCT02896400|585352108|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
162080267|NCT02896400|585352109|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
162080268|NCT02896400|585352110|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
162080269|NCT02896400|585352111|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
162080270|NCT02896400|585352112|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
162080271|NCT02896400|585352113|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
162080272|NCT02896400|585352114|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
162080273|NCT02896400|585352115|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
162080274|NCT02896400|585352116|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
162080275|NCT02984020|585352117|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
162080276|NCT02984020|585352117|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
162080277|NCT02984020|585352117|FG000|Overall Study|Other significant protocol violation|2|||
162080278|NCT01896895|585352118|FG000|Double-blind MP|Physician Decision|0|||
162080279|NCT01896895|585352119|FG001|Double-blind MP|Physician Decision|0|||
162080280|NCT01896895|585352120|FG002|Double-blind MP|Physician Decision|1|||
162080281|NCT01896895|585352121|FG003|Double-blind MP|Physician Decision|0|||
162080282|NCT01896895|585352118|FG000|Double-blind MP|Withdrawal by Subject|0|||
162080283|NCT01896895|585352119|FG001|Double-blind MP|Withdrawal by Subject|2|||
162080284|NCT01896895|585352120|FG002|Double-blind MP|Withdrawal by Subject|1|||
162080285|NCT01896895|585352121|FG003|Double-blind MP|Withdrawal by Subject|0|||
162080286|NCT01896895|585352118|FG000|Double-blind MP|Lost to Follow-up|1|||
162080287|NCT01896895|585352119|FG001|Double-blind MP|Lost to Follow-up|0|||
162080288|NCT01896895|585352120|FG002|Double-blind MP|Lost to Follow-up|1|||
162080289|NCT01896895|585352121|FG003|Double-blind MP|Lost to Follow-up|0|||
162080290|NCT03277846|585352122|FG000|Overall Study|Inpatient stay too brief|12|||
162080291|NCT03277846|585352123|FG001|Overall Study|Inpatient stay too brief|11|||
162080292|NCT01207778|585352124|FG000|Overall Study|Lost to Follow-up|0|||
162080293|NCT01207778|585352125|FG001|Overall Study|Lost to Follow-up|3|||
162080294|NCT01207778|585352126|FG002|Overall Study|Lost to Follow-up|3|||
162080295|NCT05168475|585352129|FG000|Period 1|Protocol Violation|1|||
162080296|NCT05168475|585352129|FG000|Period 1|IMP shortage|2|||
162080297|NCT05168475|585352129|FG000|Period 1|Not randomised|2|||
162080298|NCT05168475|585352129|FG000|Period 2|IMP shortage|1|||
162080299|NCT01589822|585352130|FG000|Overall Study|Withdrawal by Subject|1|||
162080300|NCT01589822|585352131|FG001|Overall Study|Withdrawal by Subject|2|||
162080301|NCT01589822|585352132|FG002|Overall Study|Withdrawal by Subject|0|||
162080302|NCT01589822|585352130|FG000|Overall Study|Death|1|||
162080303|NCT01589822|585352131|FG001|Overall Study|Death|0|||
162080304|NCT01589822|585352132|FG002|Overall Study|Death|0|||
162080305|NCT01589822|585352130|FG000|Overall Study|Missed 90 day visit|2|||
162080306|NCT01589822|585352131|FG001|Overall Study|Missed 90 day visit|1|||
162080307|NCT01589822|585352132|FG002|Overall Study|Missed 90 day visit|1|||
162080308|NCT00646204|585352133|FG000|Overall Study|Adverse Event|3|||
162080309|NCT00646204|585352134|FG001|Overall Study|Adverse Event|0|||
162080310|NCT00646204|585352133|FG000|Overall Study|Withdrawal by Subject|1|||
162080311|NCT00646204|585352134|FG001|Overall Study|Withdrawal by Subject|0|||
162080312|NCT00773175|585352138|FG000|Overall Study|Adverse Event|2|||
162080313|NCT00773175|585352139|FG001|Overall Study|Adverse Event|0|||
162080314|NCT00773175|585352138|FG000|Overall Study|Consent Withdrawn|0|||
162080315|NCT00773175|585352139|FG001|Overall Study|Consent Withdrawn|2|||
162080316|NCT00503841|585352140|FG000|Overall Study|All screen failures|44|||
162080317|NCT01302964|585352141|FG000|Overall Study|Adverse Event|1|||
162080318|NCT01302964|585352142|FG001|Overall Study|Adverse Event|0|||
162080319|NCT02347527|585352143|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
162080320|NCT02347527|585352144|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
162080321|NCT02347527|585352145|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
162080322|NCT02347527|585352146|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
162080323|NCT02347527|585352143|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
162080324|NCT02347527|585352144|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
162080325|NCT02347527|585352145|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
162080326|NCT02347527|585352146|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
162080327|NCT02347527|585352143|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
162080328|NCT02347527|585352144|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
162080329|NCT02347527|585352145|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
162080330|NCT02347527|585352146|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
162080331|NCT02347527|585352143|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
162080332|NCT02347527|585352144|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
162080333|NCT02347527|585352145|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
162080334|NCT02347527|585352146|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
162080335|NCT02347527|585352143|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
162080336|NCT02347527|585352144|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
162080337|NCT02347527|585352145|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
162080338|NCT02347527|585352146|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
162080339|NCT00596011|585352147|FG000|Overall Study|Withdrawal by Subject|2|||
162080340|NCT00596011|585352148|FG001|Overall Study|Withdrawal by Subject|3|||
162080341|NCT00596011|585352147|FG000|Overall Study|Adverse Event|11|||
162080342|NCT00596011|585352148|FG001|Overall Study|Adverse Event|7|||
162080343|NCT01466270|585352153|FG000|Overall Study|Withdrawal by Subject|4|||
162080344|NCT01466270|585352154|FG001|Overall Study|Withdrawal by Subject|1|||
162080345|NCT01466270|585352153|FG000|Overall Study|Physician Decision|1|||
162080346|NCT01466270|585352154|FG001|Overall Study|Physician Decision|0|||
162080347|NCT01466270|585352153|FG000|Overall Study|Lost to Follow-up|1|||
162080348|NCT01466270|585352154|FG001|Overall Study|Lost to Follow-up|3|||
162080349|NCT01466270|585352153|FG000|Overall Study|Progression|1|||
162080350|NCT01466270|585352154|FG001|Overall Study|Progression|0|||
162080351|NCT01466270|585352153|FG000|Overall Study|Toxicity|4|||
162080352|NCT01466270|585352154|FG001|Overall Study|Toxicity|1|||
162080353|NCT01466270|585352153|FG000|Overall Study|Multiple|1|||
162080354|NCT01466270|585352154|FG001|Overall Study|Multiple|1|||
162080355|NCT00749775|585352161|FG000|Overall Study|Protocol Violation|24|||
162080356|NCT00749775|585352161|FG000|Overall Study|Lost to Follow-up|36|||
162080357|NCT00749775|585352161|FG000|Overall Study|No visit after first day of treatment|44|||
162080358|NCT00749775|585352161|FG000|Overall Study|No drug administration|3|||
162080359|NCT03364049|585352171|FG000|Overall Study|Death|6|||
162080360|NCT03364049|585352172|FG001|Overall Study|Death|4|||
162080361|NCT03364049|585352173|FG002|Overall Study|Death|5|||
162080362|NCT03364049|585352174|FG003|Overall Study|Death|14|||
162080363|NCT03364049|585352171|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
162080364|NCT03364049|585352172|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
162080365|NCT03364049|585352173|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
162080366|NCT03364049|585352174|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
162080367|NCT03364049|585352171|FG000|Overall Study|Withdrawal by Subject|0|||
162080368|NCT03364049|585352172|FG001|Overall Study|Withdrawal by Subject|1|||
162080369|NCT03364049|585352173|FG002|Overall Study|Withdrawal by Subject|1|||
162080370|NCT03364049|585352174|FG003|Overall Study|Withdrawal by Subject|1|||
162080371|NCT01340976|585352175|FG000|Overall Study|Physician Decision|2|||
162080372|NCT01340976|585352176|FG001|Overall Study|Physician Decision|0|||
162080373|NCT01340976|585352177|FG002|Overall Study|Physician Decision|1|||
162080374|NCT01340976|585352178|FG003|Overall Study|Physician Decision|1|||
162080375|NCT01340976|585352179|FG004|Overall Study|Physician Decision|1|||
162080376|NCT01340976|585352180|FG005|Overall Study|Physician Decision|0|||
162080377|NCT01340976|585352175|FG000|Overall Study|Death|0|||
162080378|NCT01340976|585352176|FG001|Overall Study|Death|1|||
162080379|NCT01340976|585352177|FG002|Overall Study|Death|0|||
162080380|NCT01340976|585352178|FG003|Overall Study|Death|0|||
162080381|NCT01340976|585352179|FG004|Overall Study|Death|0|||
162080382|NCT01340976|585352180|FG005|Overall Study|Death|0|||
162080383|NCT01340976|585352175|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
162080384|NCT01340976|585352176|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
162080385|NCT01340976|585352177|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
162080386|NCT01340976|585352178|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
162080387|NCT01340976|585352179|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
162080388|NCT01340976|585352180|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
162080389|NCT01340976|585352175|FG000|Overall Study|Withdrawal by Subject|0|||
162080390|NCT01340976|585352176|FG001|Overall Study|Withdrawal by Subject|0|||
162080391|NCT01340976|585352177|FG002|Overall Study|Withdrawal by Subject|0|||
162080392|NCT01340976|585352178|FG003|Overall Study|Withdrawal by Subject|1|||
162080393|NCT01340976|585352179|FG004|Overall Study|Withdrawal by Subject|1|||
162080394|NCT01340976|585352180|FG005|Overall Study|Withdrawal by Subject|0|||
162080395|NCT01340976|585352175|FG000|Overall Study|Other anemia treatment|1|||
162080396|NCT01340976|585352176|FG001|Overall Study|Other anemia treatment|0|||
162080397|NCT01340976|585352177|FG002|Overall Study|Other anemia treatment|2|||
162080398|NCT01340976|585352178|FG003|Overall Study|Other anemia treatment|1|||
162080399|NCT01340976|585352179|FG004|Overall Study|Other anemia treatment|0|||
162080400|NCT01340976|585352180|FG005|Overall Study|Other anemia treatment|1|||
162080401|NCT01340976|585352175|FG000|Overall Study|Adverse Event|0|||
162080402|NCT01340976|585352176|FG001|Overall Study|Adverse Event|1|||
162080403|NCT01340976|585352177|FG002|Overall Study|Adverse Event|0|||
162080404|NCT01340976|585352178|FG003|Overall Study|Adverse Event|0|||
162080405|NCT01340976|585352179|FG004|Overall Study|Adverse Event|0|||
162080406|NCT01340976|585352180|FG005|Overall Study|Adverse Event|0|||
162080407|NCT02953821|585352181|FG000|Overall Study|Adverse Event|0|||
162080408|NCT02953821|585352182|FG001|Overall Study|Adverse Event|4|||
162080409|NCT02953821|585352181|FG000|Overall Study|Death|1|||
162080410|NCT02953821|585352182|FG001|Overall Study|Death|0|||
162080411|NCT02953821|585352181|FG000|Overall Study|Progressive Disease|5|||
162080412|NCT02953821|585352182|FG001|Overall Study|Progressive Disease|1|||
162080413|NCT02953821|585352181|FG000|Overall Study|Lost to Follow-up|2|||
162080414|NCT02953821|585352182|FG001|Overall Study|Lost to Follow-up|0|||
162080415|NCT02953821|585352181|FG000|Overall Study|Physician Decision|1|||
162080416|NCT02953821|585352182|FG001|Overall Study|Physician Decision|1|||
162080417|NCT02953821|585352181|FG000|Overall Study|Withdrawal by Subject|3|||
162080418|NCT02953821|585352182|FG001|Overall Study|Withdrawal by Subject|3|||
162080419|NCT02953821|585352181|FG000|Overall Study|Change of address|0|||
162080420|NCT02953821|585352182|FG001|Overall Study|Change of address|1|||
162080421|NCT02953821|585352181|FG000|Overall Study|Lack of Efficacy|1|||
162080422|NCT02953821|585352182|FG001|Overall Study|Lack of Efficacy|0|||
162080423|NCT02953821|585352181|FG000|Overall Study|Out of state for indeterminate time|0|||
162080424|NCT02953821|585352182|FG001|Overall Study|Out of state for indeterminate time|1|||
162080425|NCT02953821|585352181|FG000|Overall Study|No improvement|0|||
162080426|NCT02953821|585352182|FG001|Overall Study|No improvement|1|||
162080427|NCT02953821|585352181|FG000|Overall Study|Refused follow-up visit|2|||
162080428|NCT02953821|585352182|FG001|Overall Study|Refused follow-up visit|1|||
162080429|NCT03064126|585352183|FG000|Overall Study|Death|40|||
162080430|NCT03064126|585352184|FG001|Overall Study|Death|16|||
162080431|NCT03064126|585352185|FG002|Overall Study|Death|4|||
162080432|NCT03064126|585352186|FG003|Overall Study|Death|2|||
162080433|NCT03064126|585352183|FG000|Overall Study|Withdrawal by Subject|17|||
162080434|NCT03064126|585352184|FG001|Overall Study|Withdrawal by Subject|9|||
162080435|NCT03064126|585352185|FG002|Overall Study|Withdrawal by Subject|0|||
162080436|NCT03064126|585352186|FG003|Overall Study|Withdrawal by Subject|2|||
162080437|NCT03064126|585352183|FG000|Overall Study|Lost to Follow-up|7|||
162080438|NCT03064126|585352184|FG001|Overall Study|Lost to Follow-up|3|||
162080439|NCT03064126|585352185|FG002|Overall Study|Lost to Follow-up|0|||
162080440|NCT03064126|585352186|FG003|Overall Study|Lost to Follow-up|0|||
162080441|NCT03064126|585352183|FG000|Overall Study|Adverse Event|2|||
162080442|NCT03064126|585352184|FG001|Overall Study|Adverse Event|0|||
162080443|NCT03064126|585352185|FG002|Overall Study|Adverse Event|0|||
162080444|NCT03064126|585352186|FG003|Overall Study|Adverse Event|0|||
162080445|NCT03064126|585352183|FG000|Overall Study|Physician Decision|3|||
162080446|NCT03064126|585352184|FG001|Overall Study|Physician Decision|0|||
162080447|NCT03064126|585352185|FG002|Overall Study|Physician Decision|0|||
162080448|NCT03064126|585352186|FG003|Overall Study|Physician Decision|0|||
162080449|NCT03064126|585352183|FG000|Overall Study|Other reason for early termination|3|||
162080450|NCT03064126|585352184|FG001|Overall Study|Other reason for early termination|2|||
162080451|NCT03064126|585352185|FG002|Overall Study|Other reason for early termination|0|||
162080452|NCT03064126|585352186|FG003|Overall Study|Other reason for early termination|0|||
162080453|NCT03064126|585352183|FG000|Overall Study|Missed Visit|3|||
162080454|NCT03064126|585352184|FG001|Overall Study|Missed Visit|1|||
162080455|NCT03064126|585352185|FG002|Overall Study|Missed Visit|0|||
162080456|NCT03064126|585352186|FG003|Overall Study|Missed Visit|0|||
162080457|NCT03907683|585352192|FG000|Overall Study|Pregnancy|1|||
162080458|NCT03907683|585352192|FG000|Overall Study|Withdrawal by Subject|1|||
162080459|NCT03400332|585352193|FG000|Pre-Treatment|Other reasons|0|||
162080460|NCT03400332|585352194|FG001|Pre-Treatment|Other reasons|0|||
162080461|NCT03400332|585352195|FG002|Pre-Treatment|Other reasons|0|||
162080462|NCT03400332|585352196|FG003|Pre-Treatment|Other reasons|0|||
162080463|NCT03400332|585352197|FG004|Pre-Treatment|Other reasons|0|||
162080464|NCT03400332|585352198|FG005|Pre-Treatment|Other reasons|0|||
162080465|NCT03400332|585352199|FG006|Pre-Treatment|Other reasons|0|||
162080466|NCT03400332|585352200|FG007|Pre-Treatment|Other reasons|0|||
162080467|NCT03400332|585352201|FG008|Pre-Treatment|Other reasons|1|||
162080468|NCT03400332|585352193|FG000|Pre-Treatment|No longer met study criteria|0|||
162080469|NCT03400332|585352194|FG001|Pre-Treatment|No longer met study criteria|0|||
162080470|NCT03400332|585352195|FG002|Pre-Treatment|No longer met study criteria|0|||
162080471|NCT03400332|585352196|FG003|Pre-Treatment|No longer met study criteria|0|||
162080472|NCT03400332|585352197|FG004|Pre-Treatment|No longer met study criteria|0|||
162080473|NCT03400332|585352198|FG005|Pre-Treatment|No longer met study criteria|0|||
162080474|NCT03400332|585352199|FG006|Pre-Treatment|No longer met study criteria|0|||
162080475|NCT03400332|585352200|FG007|Pre-Treatment|No longer met study criteria|0|||
162080476|NCT03400332|585352201|FG008|Pre-Treatment|No longer met study criteria|1|||
162080477|NCT03400332|585352193|FG000|Pre-Treatment|Withdrawal by Subject|0|||
162080478|NCT03400332|585352194|FG001|Pre-Treatment|Withdrawal by Subject|0|||
162080479|NCT03400332|585352195|FG002|Pre-Treatment|Withdrawal by Subject|0|||
162080480|NCT03400332|585352196|FG003|Pre-Treatment|Withdrawal by Subject|0|||
162080481|NCT03400332|585352197|FG004|Pre-Treatment|Withdrawal by Subject|0|||
162080482|NCT03400332|585352198|FG005|Pre-Treatment|Withdrawal by Subject|0|||
162080483|NCT03400332|585352199|FG006|Pre-Treatment|Withdrawal by Subject|0|||
162080484|NCT03400332|585352200|FG007|Pre-Treatment|Withdrawal by Subject|0|||
162080485|NCT03400332|585352201|FG008|Pre-Treatment|Withdrawal by Subject|1|||
162080486|NCT03400332|585352193|FG000|Treatment|Participant withdrew consent|2|||
162080487|NCT03400332|585352194|FG001|Treatment|Participant withdrew consent|2|||
162080488|NCT03400332|585352195|FG002|Treatment|Participant withdrew consent|0|||
162080489|NCT03400332|585352196|FG003|Treatment|Participant withdrew consent|0|||
162080490|NCT03400332|585352197|FG004|Treatment|Participant withdrew consent|3|||
162080491|NCT03400332|585352198|FG005|Treatment|Participant withdrew consent|3|||
162080492|NCT03400332|585352199|FG006|Treatment|Participant withdrew consent|1|||
162080493|NCT03400332|585352200|FG007|Treatment|Participant withdrew consent|1|||
162080494|NCT03400332|585352201|FG008|Treatment|Participant withdrew consent|1|||
162080495|NCT03400332|585352193|FG000|Treatment|Other reasons|0|||
162080496|NCT03400332|585352194|FG001|Treatment|Other reasons|1|||
162080497|NCT03400332|585352195|FG002|Treatment|Other reasons|1|||
162080498|NCT03400332|585352196|FG003|Treatment|Other reasons|0|||
162080499|NCT03400332|585352197|FG004|Treatment|Other reasons|3|||
162080500|NCT03400332|585352198|FG005|Treatment|Other reasons|1|||
162080501|NCT03400332|585352199|FG006|Treatment|Other reasons|2|||
162080502|NCT03400332|585352200|FG007|Treatment|Other reasons|0|||
162080503|NCT03400332|585352201|FG008|Treatment|Other reasons|1|||
162080504|NCT03400332|585352193|FG000|Treatment|Lost to Follow-up|0|||
162080505|NCT03400332|585352194|FG001|Treatment|Lost to Follow-up|1|||
162080506|NCT03400332|585352195|FG002|Treatment|Lost to Follow-up|0|||
162080507|NCT03400332|585352196|FG003|Treatment|Lost to Follow-up|0|||
162080508|NCT03400332|585352197|FG004|Treatment|Lost to Follow-up|0|||
162080509|NCT03400332|585352198|FG005|Treatment|Lost to Follow-up|0|||
162080510|NCT03400332|585352199|FG006|Treatment|Lost to Follow-up|0|||
162080511|NCT03400332|585352200|FG007|Treatment|Lost to Follow-up|0|||
162080512|NCT03400332|585352201|FG008|Treatment|Lost to Follow-up|0|||
162080513|NCT03400332|585352193|FG000|Treatment|Death|3|||
162080514|NCT03400332|585352194|FG001|Treatment|Death|1|||
162080515|NCT03400332|585352195|FG002|Treatment|Death|2|||
162080516|NCT03400332|585352196|FG003|Treatment|Death|3|||
162080517|NCT03400332|585352197|FG004|Treatment|Death|6|||
162080518|NCT03400332|585352198|FG005|Treatment|Death|2|||
162080519|NCT03400332|585352199|FG006|Treatment|Death|1|||
162080520|NCT03400332|585352200|FG007|Treatment|Death|3|||
162080521|NCT03400332|585352201|FG008|Treatment|Death|6|||
162080522|NCT00048542|585352202|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
162080523|NCT00048542|585352203|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
162080524|NCT00048542|585352204|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
162080525|NCT00048542|585352205|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
162080526|NCT00048542|585352206|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
162080527|NCT00048542|585352207|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
162080528|NCT00048542|585352208|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
162080529|NCT00048542|585352209|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
162080530|NCT00048542|585352202|FG000|Double-Blind Phase|Protocol Violation|0|||
162080531|NCT00048542|585352203|FG001|Double-Blind Phase|Protocol Violation|0|||
162080532|NCT00048542|585352204|FG002|Double-Blind Phase|Protocol Violation|1|||
162080533|NCT00048542|585352205|FG003|Double-Blind Phase|Protocol Violation|0|||
162080534|NCT00048542|585352206|FG004|Double-Blind Phase|Protocol Violation|0|||
162080535|NCT00048542|585352207|FG005|Double-Blind Phase|Protocol Violation|0|||
162080536|NCT00048542|585352208|FG006|Double-Blind Phase|Protocol Violation|0|||
162080537|NCT00048542|585352209|FG007|Double-Blind Phase|Protocol Violation|0|||
162080538|NCT00048542|585352202|FG000|Double-Blind Phase|Sponsor request or decision|2|||
162080539|NCT00048542|585352203|FG001|Double-Blind Phase|Sponsor request or decision|0|||
162080540|NCT00048542|585352204|FG002|Double-Blind Phase|Sponsor request or decision|0|||
162080541|NCT00048542|585352205|FG003|Double-Blind Phase|Sponsor request or decision|0|||
162080542|NCT00048542|585352206|FG004|Double-Blind Phase|Sponsor request or decision|0|||
162080543|NCT00048542|585352207|FG005|Double-Blind Phase|Sponsor request or decision|0|||
162080544|NCT00048542|585352208|FG006|Double-Blind Phase|Sponsor request or decision|0|||
162080545|NCT00048542|585352209|FG007|Double-Blind Phase|Sponsor request or decision|0|||
162080546|NCT00048542|585352202|FG000|Double-Blind Phase|Randomized in error|1|||
162080547|NCT00048542|585352203|FG001|Double-Blind Phase|Randomized in error|0|||
162080548|NCT00048542|585352204|FG002|Double-Blind Phase|Randomized in error|0|||
162080549|NCT00048542|585352205|FG003|Double-Blind Phase|Randomized in error|0|||
162080550|NCT00048542|585352206|FG004|Double-Blind Phase|Randomized in error|0|||
162080551|NCT00048542|585352207|FG005|Double-Blind Phase|Randomized in error|0|||
162080552|NCT00048542|585352208|FG006|Double-Blind Phase|Randomized in error|0|||
162080553|NCT00048542|585352209|FG007|Double-Blind Phase|Randomized in error|0|||
162080554|NCT00048542|585352202|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
162080555|NCT00048542|585352203|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
162080556|NCT00048542|585352204|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
162080557|NCT00048542|585352205|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
162080558|NCT00048542|585352206|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
162080559|NCT00048542|585352207|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
162080560|NCT00048542|585352208|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
162080561|NCT00048542|585352209|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
162080562|NCT00048542|585352202|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
162080563|NCT00048542|585352203|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
162080564|NCT00048542|585352204|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
162080565|NCT00048542|585352205|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
162080566|NCT00048542|585352206|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
162080567|NCT00048542|585352207|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
162080568|NCT00048542|585352208|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
162080569|NCT00048542|585352209|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
162080570|NCT00048542|585352202|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
162080571|NCT00048542|585352203|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
162080572|NCT00048542|585352204|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
162080573|NCT00048542|585352205|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
162080574|NCT00048542|585352206|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
162080575|NCT00048542|585352207|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
162080576|NCT00048542|585352208|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
162080577|NCT00048542|585352209|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
162080578|NCT00048542|585352202|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
162080579|NCT00048542|585352203|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
162080580|NCT00048542|585352204|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
162080581|NCT00048542|585352205|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
162080582|NCT00048542|585352206|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
162080583|NCT00048542|585352207|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
162080584|NCT00048542|585352208|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
162080585|NCT00048542|585352209|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
162080586|NCT00048542|585352202|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
162080587|NCT00048542|585352203|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
162080588|NCT00048542|585352204|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
162080589|NCT00048542|585352205|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
162080590|NCT00048542|585352206|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
162080591|NCT00048542|585352207|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
162080592|NCT00048542|585352208|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
162080593|NCT00048542|585352209|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
162080594|NCT00048542|585352202|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
162080595|NCT00048542|585352203|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
162080596|NCT00048542|585352204|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
162080597|NCT00048542|585352205|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
162080598|NCT00048542|585352206|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
162080599|NCT00048542|585352207|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
162080600|NCT00048542|585352208|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
162080601|NCT00048542|585352209|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
162080602|NCT00048542|585352202|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
162080603|NCT00048542|585352203|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
162080604|NCT00048542|585352204|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
162080605|NCT00048542|585352205|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
162080606|NCT00048542|585352206|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
162080607|NCT00048542|585352207|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
162080608|NCT00048542|585352208|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
162080609|NCT00048542|585352209|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
162080610|NCT00048542|585352202|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
162080611|NCT00048542|585352203|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
162080612|NCT00048542|585352204|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
162080613|NCT00048542|585352205|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
162080614|NCT00048542|585352206|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
162080615|NCT00048542|585352207|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
162080616|NCT00048542|585352208|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
162080617|NCT00048542|585352209|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
162080618|NCT00048542|585352202|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
162080619|NCT00048542|585352203|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
162080620|NCT00048542|585352204|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
162080621|NCT00048542|585352205|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
162080622|NCT00048542|585352206|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
162080623|NCT00048542|585352207|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
162080624|NCT00048542|585352208|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
162080625|NCT00048542|585352209|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
162080626|NCT00048542|585352202|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
162080627|NCT00048542|585352203|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
162080628|NCT00048542|585352204|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
162080629|NCT00048542|585352205|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
162080630|NCT00048542|585352206|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
162080631|NCT00048542|585352207|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
162080632|NCT00048542|585352208|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
162080633|NCT00048542|585352209|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
162080634|NCT00048542|585352202|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
162080635|NCT00048542|585352203|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
162080636|NCT00048542|585352204|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
162080637|NCT00048542|585352205|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
162080638|NCT00048542|585352206|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
162080639|NCT00048542|585352207|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
162080640|NCT00048542|585352208|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
162080641|NCT00048542|585352209|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
162080642|NCT04033159|585352213|FG000|Washout Period|Physician Decision|0|||
162080643|NCT04033159|585352214|FG001|Washout Period|Physician Decision|1|||
162080644|NCT04033159|585352215|FG002|Washout Period|Physician Decision|0|||
162080645|NCT04033159|585352213|FG000|Washout Period|Study terminated by Sponsor|0|||
162080646|NCT04033159|585352214|FG001|Washout Period|Study terminated by Sponsor|7|||
162080647|NCT04033159|585352215|FG002|Washout Period|Study terminated by Sponsor|0|||
162080648|NCT04033159|585352213|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
162080649|NCT04033159|585352214|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
162080650|NCT04033159|585352215|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
162080651|NCT01452412|585352226|FG000|Overall Study|Withdrawal by Subject|15|||
162080652|NCT01452412|585352227|FG001|Overall Study|Withdrawal by Subject|11|||
162080653|NCT01452412|585352226|FG000|Overall Study|Adverse Event|4|||
162080654|NCT01452412|585352227|FG001|Overall Study|Adverse Event|3|||
162080655|NCT01452412|585352226|FG000|Overall Study|Lost to Follow-up|5|||
162080656|NCT01452412|585352227|FG001|Overall Study|Lost to Follow-up|3|||
162080657|NCT01452412|585352226|FG000|Overall Study|Death|1|||
162080658|NCT01452412|585352227|FG001|Overall Study|Death|0|||
162080659|NCT01452412|585352226|FG000|Overall Study|Initiated dialysis|1|||
162080660|NCT01452412|585352227|FG001|Overall Study|Initiated dialysis|0|||
162080661|NCT01452412|585352226|FG000|Overall Study|Other|2|||
162080662|NCT01452412|585352227|FG001|Overall Study|Other|0|||
162080663|NCT03047135|585352228|FG000|Overall Study|Still being treated|3|||
162080664|NCT00323414|585352229|FG000|Overall Study|Withdrawal by Subject|0|||
162080665|NCT00323414|585352230|FG001|Overall Study|Withdrawal by Subject|1|||
162080666|NCT01256593|585352233|FG000|Overall Study|Protocol Violation|26|||
162080667|NCT01256593|585352233|FG000|Overall Study|No Drug Administration Information|2|||
162080668|NCT01256593|585352233|FG000|Overall Study|No Visit After Treatment|186|||
162080669|NCT05619692|585352240|FG000|Overall Study|Adverse Event|2|||
162080670|NCT05619692|585352241|FG001|Overall Study|Adverse Event|2|||
162080671|NCT05619692|585352240|FG000|Overall Study|Withdrawal by Participant|3|||
162080672|NCT05619692|585352241|FG001|Overall Study|Withdrawal by Participant|4|||
162080673|NCT05619692|585352240|FG000|Overall Study|Lost to Follow-up|2|||
162080674|NCT05619692|585352241|FG001|Overall Study|Lost to Follow-up|1|||
162080675|NCT05619692|585352240|FG000|Overall Study|Randomized but not treated|1|||
162080676|NCT05619692|585352241|FG001|Overall Study|Randomized but not treated|3|||
162080677|NCT02457598|585352242|FG000|Overall Study|Progressive Disease|2|||
162080678|NCT02457598|585352243|FG001|Overall Study|Progressive Disease|2|||
162080679|NCT02457598|585352244|FG002|Overall Study|Progressive Disease|1|||
162080680|NCT02457598|585352245|FG003|Overall Study|Progressive Disease|11|||
162080681|NCT02457598|585352246|FG004|Overall Study|Progressive Disease|7|||
162080682|NCT02457598|585352247|FG005|Overall Study|Progressive Disease|3|||
162080683|NCT02457598|585352248|FG006|Overall Study|Progressive Disease|2|||
162080684|NCT02457598|585352249|FG007|Overall Study|Progressive Disease|1|||
162080685|NCT02457598|585352250|FG008|Overall Study|Progressive Disease|1|||
162080686|NCT02457598|585352251|FG009|Overall Study|Progressive Disease|2|||
162080687|NCT02457598|585352252|FG010|Overall Study|Progressive Disease|45|||
162080688|NCT02457598|585352253|FG011|Overall Study|Progressive Disease|6|||
162080689|NCT02457598|585352254|FG012|Overall Study|Progressive Disease|2|||
162080690|NCT02457598|585352255|FG013|Overall Study|Progressive Disease|2|||
162080691|NCT02457598|585352256|FG014|Overall Study|Progressive Disease|10|||
162080692|NCT02457598|585352257|FG015|Overall Study|Progressive Disease|1|||
162080693|NCT02457598|585352258|FG016|Overall Study|Progressive Disease|1|||
162080694|NCT02457598|585352242|FG000|Overall Study|Investigator's Discretion|0|||
162080695|NCT02457598|585352243|FG001|Overall Study|Investigator's Discretion|2|||
162080696|NCT02457598|585352244|FG002|Overall Study|Investigator's Discretion|2|||
162080697|NCT02457598|585352245|FG003|Overall Study|Investigator's Discretion|2|||
162080698|NCT02457598|585352246|FG004|Overall Study|Investigator's Discretion|0|||
162080699|NCT02457598|585352247|FG005|Overall Study|Investigator's Discretion|0|||
162080700|NCT02457598|585352248|FG006|Overall Study|Investigator's Discretion|0|||
162080701|NCT02457598|585352249|FG007|Overall Study|Investigator's Discretion|1|||
162080702|NCT02457598|585352250|FG008|Overall Study|Investigator's Discretion|2|||
162080703|NCT02457598|585352251|FG009|Overall Study|Investigator's Discretion|0|||
162080704|NCT02457598|585352252|FG010|Overall Study|Investigator's Discretion|10|||
162080705|NCT02457598|585352253|FG011|Overall Study|Investigator's Discretion|2|||
162080706|NCT02457598|585352254|FG012|Overall Study|Investigator's Discretion|2|||
162080707|NCT02457598|585352255|FG013|Overall Study|Investigator's Discretion|1|||
162080708|NCT02457598|585352256|FG014|Overall Study|Investigator's Discretion|5|||
162080709|NCT02457598|585352257|FG015|Overall Study|Investigator's Discretion|0|||
162080710|NCT02457598|585352258|FG016|Overall Study|Investigator's Discretion|0|||
162080711|NCT02457598|585352242|FG000|Overall Study|Study Terminated by Sponsor|0|||
162080712|NCT02457598|585352243|FG001|Overall Study|Study Terminated by Sponsor|1|||
162080713|NCT02457598|585352244|FG002|Overall Study|Study Terminated by Sponsor|0|||
162080714|NCT02457598|585352245|FG003|Overall Study|Study Terminated by Sponsor|4|||
162080715|NCT02457598|585352246|FG004|Overall Study|Study Terminated by Sponsor|1|||
162080716|NCT02457598|585352247|FG005|Overall Study|Study Terminated by Sponsor|0|||
162080717|NCT02457598|585352248|FG006|Overall Study|Study Terminated by Sponsor|1|||
162080718|NCT02457598|585352249|FG007|Overall Study|Study Terminated by Sponsor|0|||
162080719|NCT02457598|585352250|FG008|Overall Study|Study Terminated by Sponsor|0|||
162080720|NCT02457598|585352251|FG009|Overall Study|Study Terminated by Sponsor|0|||
162080721|NCT02457598|585352252|FG010|Overall Study|Study Terminated by Sponsor|4|||
162080722|NCT02457598|585352253|FG011|Overall Study|Study Terminated by Sponsor|0|||
162080723|NCT02457598|585352254|FG012|Overall Study|Study Terminated by Sponsor|1|||
162080724|NCT02457598|585352255|FG013|Overall Study|Study Terminated by Sponsor|0|||
162080725|NCT02457598|585352256|FG014|Overall Study|Study Terminated by Sponsor|8|||
162080726|NCT02457598|585352257|FG015|Overall Study|Study Terminated by Sponsor|1|||
162080727|NCT02457598|585352258|FG016|Overall Study|Study Terminated by Sponsor|0|||
162080728|NCT02457598|585352242|FG000|Overall Study|Adverse Event|0|||
162080729|NCT02457598|585352243|FG001|Overall Study|Adverse Event|1|||
162080730|NCT02457598|585352244|FG002|Overall Study|Adverse Event|1|||
162080731|NCT02457598|585352245|FG003|Overall Study|Adverse Event|4|||
162080732|NCT02457598|585352246|FG004|Overall Study|Adverse Event|1|||
162080733|NCT02457598|585352247|FG005|Overall Study|Adverse Event|0|||
162080734|NCT02457598|585352248|FG006|Overall Study|Adverse Event|0|||
162080735|NCT02457598|585352249|FG007|Overall Study|Adverse Event|1|||
162080736|NCT02457598|585352250|FG008|Overall Study|Adverse Event|0|||
162080737|NCT02457598|585352251|FG009|Overall Study|Adverse Event|1|||
162080738|NCT02457598|585352252|FG010|Overall Study|Adverse Event|6|||
162080739|NCT02457598|585352253|FG011|Overall Study|Adverse Event|0|||
162080740|NCT02457598|585352254|FG012|Overall Study|Adverse Event|0|||
162080741|NCT02457598|585352255|FG013|Overall Study|Adverse Event|1|||
162080742|NCT02457598|585352256|FG014|Overall Study|Adverse Event|2|||
162080743|NCT02457598|585352257|FG015|Overall Study|Adverse Event|0|||
162080744|NCT02457598|585352258|FG016|Overall Study|Adverse Event|0|||
162080745|NCT02457598|585352242|FG000|Overall Study|Death|0|||
162080746|NCT02457598|585352243|FG001|Overall Study|Death|0|||
162080747|NCT02457598|585352244|FG002|Overall Study|Death|0|||
162080748|NCT02457598|585352245|FG003|Overall Study|Death|3|||
162080749|NCT02457598|585352246|FG004|Overall Study|Death|0|||
162080750|NCT02457598|585352247|FG005|Overall Study|Death|1|||
162080751|NCT02457598|585352248|FG006|Overall Study|Death|0|||
162080752|NCT02457598|585352249|FG007|Overall Study|Death|0|||
162080753|NCT02457598|585352250|FG008|Overall Study|Death|0|||
162080754|NCT02457598|585352251|FG009|Overall Study|Death|0|||
162080755|NCT02457598|585352252|FG010|Overall Study|Death|3|||
162080756|NCT02457598|585352253|FG011|Overall Study|Death|0|||
162080757|NCT02457598|585352254|FG012|Overall Study|Death|0|||
162080758|NCT02457598|585352255|FG013|Overall Study|Death|1|||
162080759|NCT02457598|585352256|FG014|Overall Study|Death|2|||
162080760|NCT02457598|585352257|FG015|Overall Study|Death|0|||
162080761|NCT02457598|585352258|FG016|Overall Study|Death|1|||
162080762|NCT02457598|585352242|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
162080763|NCT02457598|585352243|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
162080764|NCT02457598|585352244|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
162080765|NCT02457598|585352245|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
162080766|NCT02457598|585352246|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
162080767|NCT02457598|585352247|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
162080768|NCT02457598|585352248|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
162080769|NCT02457598|585352249|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
162080770|NCT02457598|585352250|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
162080771|NCT02457598|585352251|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
162080772|NCT02457598|585352252|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
162080773|NCT02457598|585352253|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
162080774|NCT02457598|585352254|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
162080775|NCT02457598|585352255|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
162080776|NCT02457598|585352256|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
162080777|NCT02457598|585352257|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
162080778|NCT02457598|585352258|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
162080779|NCT02457598|585352242|FG000|Overall Study|Withdrew Consent|0|||
162080780|NCT02457598|585352243|FG001|Overall Study|Withdrew Consent|0|||
162080781|NCT02457598|585352244|FG002|Overall Study|Withdrew Consent|0|||
162080782|NCT02457598|585352245|FG003|Overall Study|Withdrew Consent|0|||
162080783|NCT02457598|585352246|FG004|Overall Study|Withdrew Consent|0|||
162080784|NCT02457598|585352247|FG005|Overall Study|Withdrew Consent|0|||
162080785|NCT02457598|585352248|FG006|Overall Study|Withdrew Consent|0|||
162080786|NCT02457598|585352249|FG007|Overall Study|Withdrew Consent|2|||
162080787|NCT02457598|585352250|FG008|Overall Study|Withdrew Consent|0|||
162080788|NCT02457598|585352251|FG009|Overall Study|Withdrew Consent|0|||
162080789|NCT02457598|585352252|FG010|Overall Study|Withdrew Consent|3|||
162080790|NCT02457598|585352253|FG011|Overall Study|Withdrew Consent|0|||
162080791|NCT02457598|585352254|FG012|Overall Study|Withdrew Consent|0|||
162080792|NCT02457598|585352255|FG013|Overall Study|Withdrew Consent|1|||
162080793|NCT02457598|585352256|FG014|Overall Study|Withdrew Consent|0|||
162080794|NCT02457598|585352257|FG015|Overall Study|Withdrew Consent|0|||
162080795|NCT02457598|585352258|FG016|Overall Study|Withdrew Consent|0|||
162080796|NCT02457598|585352242|FG000|Overall Study|Unacceptable Toxicity|0|||
162080797|NCT02457598|585352243|FG001|Overall Study|Unacceptable Toxicity|0|||
162080798|NCT02457598|585352244|FG002|Overall Study|Unacceptable Toxicity|0|||
162080799|NCT02457598|585352245|FG003|Overall Study|Unacceptable Toxicity|0|||
162080800|NCT02457598|585352246|FG004|Overall Study|Unacceptable Toxicity|0|||
162080801|NCT02457598|585352247|FG005|Overall Study|Unacceptable Toxicity|0|||
162080802|NCT02457598|585352248|FG006|Overall Study|Unacceptable Toxicity|0|||
162080803|NCT02457598|585352249|FG007|Overall Study|Unacceptable Toxicity|0|||
162080804|NCT02457598|585352250|FG008|Overall Study|Unacceptable Toxicity|0|||
162080805|NCT02457598|585352251|FG009|Overall Study|Unacceptable Toxicity|0|||
162080806|NCT02457598|585352252|FG010|Overall Study|Unacceptable Toxicity|1|||
162080807|NCT02457598|585352253|FG011|Overall Study|Unacceptable Toxicity|0|||
162080808|NCT02457598|585352254|FG012|Overall Study|Unacceptable Toxicity|1|||
162080809|NCT02457598|585352255|FG013|Overall Study|Unacceptable Toxicity|1|||
162080810|NCT02457598|585352256|FG014|Overall Study|Unacceptable Toxicity|1|||
162080811|NCT02457598|585352257|FG015|Overall Study|Unacceptable Toxicity|0|||
162080812|NCT02457598|585352258|FG016|Overall Study|Unacceptable Toxicity|0|||
162080813|NCT02457598|585352242|FG000|Overall Study|Intercurrent Illness|0|||
162080814|NCT02457598|585352243|FG001|Overall Study|Intercurrent Illness|0|||
162080815|NCT02457598|585352244|FG002|Overall Study|Intercurrent Illness|0|||
162080816|NCT02457598|585352245|FG003|Overall Study|Intercurrent Illness|0|||
162080817|NCT02457598|585352246|FG004|Overall Study|Intercurrent Illness|0|||
162080818|NCT02457598|585352247|FG005|Overall Study|Intercurrent Illness|0|||
162080819|NCT02457598|585352248|FG006|Overall Study|Intercurrent Illness|0|||
162080820|NCT02457598|585352249|FG007|Overall Study|Intercurrent Illness|0|||
162080821|NCT02457598|585352250|FG008|Overall Study|Intercurrent Illness|0|||
162080822|NCT02457598|585352251|FG009|Overall Study|Intercurrent Illness|0|||
162080823|NCT02457598|585352252|FG010|Overall Study|Intercurrent Illness|1|||
162080824|NCT02457598|585352253|FG011|Overall Study|Intercurrent Illness|0|||
162080825|NCT02457598|585352254|FG012|Overall Study|Intercurrent Illness|0|||
162080826|NCT02457598|585352255|FG013|Overall Study|Intercurrent Illness|0|||
162080827|NCT02457598|585352256|FG014|Overall Study|Intercurrent Illness|0|||
162080828|NCT02457598|585352257|FG015|Overall Study|Intercurrent Illness|0|||
162080829|NCT02457598|585352258|FG016|Overall Study|Intercurrent Illness|0|||
162080830|NCT02457598|585352242|FG000|Overall Study|Protocol Violation|0|||
162080831|NCT02457598|585352243|FG001|Overall Study|Protocol Violation|0|||
162080832|NCT02457598|585352244|FG002|Overall Study|Protocol Violation|0|||
162080833|NCT02457598|585352245|FG003|Overall Study|Protocol Violation|0|||
162080834|NCT02457598|585352246|FG004|Overall Study|Protocol Violation|0|||
162080835|NCT02457598|585352247|FG005|Overall Study|Protocol Violation|0|||
162080836|NCT02457598|585352248|FG006|Overall Study|Protocol Violation|0|||
162080837|NCT02457598|585352249|FG007|Overall Study|Protocol Violation|0|||
162080838|NCT02457598|585352250|FG008|Overall Study|Protocol Violation|0|||
162080839|NCT02457598|585352251|FG009|Overall Study|Protocol Violation|0|||
162080840|NCT02457598|585352252|FG010|Overall Study|Protocol Violation|1|||
162080841|NCT02457598|585352253|FG011|Overall Study|Protocol Violation|0|||
162080842|NCT02457598|585352254|FG012|Overall Study|Protocol Violation|0|||
162080843|NCT02457598|585352255|FG013|Overall Study|Protocol Violation|0|||
162080844|NCT02457598|585352256|FG014|Overall Study|Protocol Violation|0|||
162080845|NCT02457598|585352257|FG015|Overall Study|Protocol Violation|0|||
162080846|NCT02457598|585352258|FG016|Overall Study|Protocol Violation|0|||
162080847|NCT02703636|585352260|FG000|Overall Study|Adverse Event|14|||
162080848|NCT02703636|585352260|FG000|Overall Study|Study stopped by sponsor|1|||
162080849|NCT02703636|585352260|FG000|Overall Study|Withdrawal by Subject|1|||
162080850|NCT01110915|585352268|FG000|Overall Study|Death|2|||
162080851|NCT01110915|585352269|FG001|Overall Study|Death|1|||
162080852|NCT01110915|585352268|FG000|Overall Study|Lost to Follow-up|1|||
162080853|NCT01110915|585352269|FG001|Overall Study|Lost to Follow-up|0|||
162080854|NCT01110915|585352268|FG000|Overall Study|Withdrawal by Subject|7|||
162080855|NCT01110915|585352269|FG001|Overall Study|Withdrawal by Subject|1|||
162080856|NCT00692770|585352275|FG000|Overall Study|Protocol Violation|2|||
162080857|NCT00692770|585352276|FG001|Overall Study|Protocol Violation|7|||
162080858|NCT00692770|585352275|FG000|Overall Study|Withdrawal by Subject|97|||
162080859|NCT00692770|585352276|FG001|Overall Study|Withdrawal by Subject|36|||
162080860|NCT00692770|585352275|FG000|Overall Study|Adverse Event|136|||
162080861|NCT00692770|585352276|FG001|Overall Study|Adverse Event|41|||
162080862|NCT00692770|585352275|FG000|Overall Study|Death|10|||
162080863|NCT00692770|585352276|FG001|Overall Study|Death|5|||
162080864|NCT00692770|585352275|FG000|Overall Study|Lost to Follow-up|7|||
162080865|NCT00692770|585352276|FG001|Overall Study|Lost to Follow-up|3|||
162080866|NCT00692770|585352275|FG000|Overall Study|Non-compliant with study medication|11|||
162080867|NCT00692770|585352276|FG001|Overall Study|Non-compliant with study medication|5|||
162080868|NCT00692770|585352275|FG000|Overall Study|Progression by clinical judgment|2|||
162080869|NCT00692770|585352276|FG001|Overall Study|Progression by clinical judgment|3|||
162080870|NCT00692770|585352275|FG000|Overall Study|Physician decision not protocol driven|10|||
162080871|NCT00692770|585352276|FG001|Overall Study|Physician decision not protocol driven|14|||
162080872|NCT00692770|585352275|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
162080873|NCT00692770|585352276|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
162080874|NCT00692770|585352275|FG000|Overall Study|Protocol driven decision point|3|||
162080875|NCT00692770|585352276|FG001|Overall Study|Protocol driven decision point|7|||
162080876|NCT00692770|585352275|FG000|Overall Study|Completed all planned assessments|79|||
162080877|NCT00692770|585352276|FG001|Overall Study|Completed all planned assessments|101|||
162080878|NCT00692770|585352275|FG000|Overall Study|Radiological and clinical progression|8|||
162080879|NCT00692770|585352276|FG001|Overall Study|Radiological and clinical progression|8|||
162080880|NCT00692770|585352275|FG000|Overall Study|Clinical endpoint reached|16|||
162080881|NCT00692770|585352276|FG001|Overall Study|Clinical endpoint reached|43|||
162080882|NCT00692770|585352275|FG000|Overall Study|Study terminated by sponsor|2|||
162080883|NCT00692770|585352276|FG001|Overall Study|Study terminated by sponsor|2|||
162080884|NCT00692770|585352275|FG000|Overall Study|Randomized but not treated|3|||
162080885|NCT00692770|585352276|FG001|Overall Study|Randomized but not treated|4|||
162080886|NCT00344773|585352277|FG000|Overall Study|Adverse Event|2|||
162080887|NCT00344773|585352277|FG000|Overall Study|Objective Disease Progression|16|||
162080888|NCT00344773|585352277|FG000|Overall Study|Withdrawal by Subject|1|||
162080889|NCT00344773|585352277|FG000|Overall Study|Not Eligible for the study|2|||
162080890|NCT02849548|585352285|FG000|Overall Study|Lost to Follow-up|1|||
162080891|NCT02849548|585352286|FG001|Overall Study|Lost to Follow-up|2|||
162080892|NCT02849548|585352285|FG000|Overall Study|Protocol Violation|1|||
162080893|NCT02849548|585352286|FG001|Overall Study|Protocol Violation|0|||
162080894|NCT00714259|585352287|FG000|Overall Study|Death|2|||
162080895|NCT02357147|585352288|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
162080896|NCT02357147|585352289|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
162080897|NCT02357147|585352288|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
162080898|NCT02357147|585352289|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
162080899|NCT02357147|585352288|FG000|Combination Treatment Phase|Investigator Discretion|1|||
162080900|NCT02357147|585352289|FG001|Combination Treatment Phase|Investigator Discretion|1|||
162080901|NCT02357147|585352288|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
162080902|NCT02357147|585352289|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
162080903|NCT02357147|585352288|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
162080904|NCT02357147|585352289|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
162080905|NCT02357147|585352288|FG000|Combination Treatment Phase|Adverse Event|12|||
162080906|NCT02357147|585352289|FG001|Combination Treatment Phase|Adverse Event|4|||
162080907|NCT02357147|585352288|FG000|Combination Treatment Phase|Death|1|||
162080908|NCT02357147|585352289|FG001|Combination Treatment Phase|Death|1|||
162080909|NCT02357147|585352288|FG000|Combination Treatment Phase|Sponsor Decision|0|||
162080910|NCT02357147|585352289|FG001|Combination Treatment Phase|Sponsor Decision|12|||
162080911|NCT02357147|585352288|FG000|Combination Treatment Phase|Other|1|||
162080912|NCT02357147|585352289|FG001|Combination Treatment Phase|Other|0|||
162080913|NCT02357147|585352288|FG000|Combination Treatment Phase|Not treated|0|||
162080914|NCT02357147|585352289|FG001|Combination Treatment Phase|Not treated|2|||
162080915|NCT02357147|585352288|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
162080916|NCT02357147|585352289|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
162080917|NCT02357147|585352288|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
162080918|NCT02357147|585352289|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
162080919|NCT02357147|585352288|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
162080920|NCT02357147|585352289|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
162080921|NCT02357147|585352288|FG000|Maintenance Treatment Phase|Adverse Event|0|||
162080922|NCT02357147|585352289|FG001|Maintenance Treatment Phase|Adverse Event|3|||
162080923|NCT02357147|585352288|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
162080924|NCT02357147|585352289|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
162080925|NCT02357147|585352288|FG000|Maintenance Treatment Phase|Not Treated|1|||
162080926|NCT02357147|585352289|FG001|Maintenance Treatment Phase|Not Treated|0|||
162080927|NCT01067352|585354197|FG000|Overall Study|Withdrawal by Subject|1|||
162080928|NCT01067352|585354198|FG001|Overall Study|Withdrawal by Subject|2|||
162080929|NCT01067352|585354199|FG002|Overall Study|Withdrawal by Subject|1|||
162080930|NCT01067352|585354197|FG000|Overall Study|Physician Decision|0|||
162080931|NCT01067352|585354198|FG001|Overall Study|Physician Decision|1|||
162080932|NCT01067352|585354199|FG002|Overall Study|Physician Decision|0|||
162080933|NCT00976898|585354200|FG000|Overall Study|Protocol Violation|1|||
162080934|NCT00976898|585354200|FG000|Overall Study|Adverse Event|1|||
162080935|NCT00976898|585354200|FG000|Overall Study|Physician Decision|1|||
162080936|NCT00976898|585354200|FG000|Overall Study|Liver Transplant|1|||
162080937|NCT00976898|585354200|FG000|Overall Study|Progressive Disease|1|||
162080938|NCT05107128|585354201|FG000|Overall Study|Adverse Event|2|||
162080939|NCT05107128|585354202|FG001|Overall Study|Adverse Event|0|||
162080940|NCT05107128|585354201|FG000|Overall Study|Withdrawal by Subject|3|||
162080941|NCT05107128|585354202|FG001|Overall Study|Withdrawal by Subject|3|||
162080942|NCT05107128|585354201|FG000|Overall Study|Withdrawal of Consent|0|||
162080943|NCT05107128|585354202|FG001|Overall Study|Withdrawal of Consent|1|||
162080944|NCT05107128|585354201|FG000|Overall Study|Reason Not Specified|2|||
162080945|NCT05107128|585354202|FG001|Overall Study|Reason Not Specified|0|||
162080946|NCT03761628|585354203|FG000|Overall Study|Withdrawal by Subject|3|||
162080947|NCT03761628|585354203|FG000|Overall Study|Physician Decision|1|||
162080948|NCT03761628|585354203|FG000|Overall Study|Pregnancy|1|||
162080949|NCT03761628|585354203|FG000|Overall Study|Lost to Follow-up|1|||
162080950|NCT01470469|585354206|FG000|Overall Study|Withdrawal by Subject|4|||
162080951|NCT01470469|585354207|FG001|Overall Study|Withdrawal by Subject|6|||
162080952|NCT01470469|585354206|FG000|Overall Study|Lack of Efficacy|1|||
162080953|NCT01470469|585354207|FG001|Overall Study|Lack of Efficacy|7|||
162080954|NCT01470469|585354206|FG000|Overall Study|Adverse Event|0|||
162080955|NCT01470469|585354207|FG001|Overall Study|Adverse Event|7|||
162080956|NCT01470469|585354206|FG000|Overall Study|Lost to Follow-up|2|||
162080957|NCT01470469|585354207|FG001|Overall Study|Lost to Follow-up|2|||
162080958|NCT01470469|585354206|FG000|Overall Study|Protocol Violation|1|||
162080959|NCT01470469|585354207|FG001|Overall Study|Protocol Violation|1|||
162080960|NCT01470469|585354206|FG000|Overall Study|Other|2|||
162080961|NCT01470469|585354207|FG001|Overall Study|Other|1|||
162080962|NCT05459129|585354208|FG000|Overall Study|Death|1|||
162080963|NCT05459129|585354209|FG001|Overall Study|Death|0|||
162080964|NCT05459129|585354208|FG000|Overall Study|Study Terminated By Sponsor|5|||
162080965|NCT05459129|585354209|FG001|Overall Study|Study Terminated By Sponsor|6|||
162080966|NCT04649151|585354217|FG000|Overall Study|Pregnancy|0|||
162080967|NCT04649151|585354218|FG001|Overall Study|Pregnancy|0|||
162080968|NCT04649151|585354219|FG002|Overall Study|Pregnancy|0|||
162080969|NCT04649151|585354220|FG003|Overall Study|Pregnancy|0|||
162080970|NCT04649151|585354221|FG004|Overall Study|Pregnancy|3|||
162080971|NCT04649151|585354217|FG000|Overall Study|Physician Decision|10|||
162080972|NCT04649151|585354218|FG001|Overall Study|Physician Decision|0|||
162080973|NCT04649151|585354219|FG002|Overall Study|Physician Decision|0|||
162080974|NCT04649151|585354220|FG003|Overall Study|Physician Decision|1|||
162080975|NCT04649151|585354221|FG004|Overall Study|Physician Decision|1|||
162080976|NCT04649151|585354217|FG000|Overall Study|Protocol Deviation|25|||
162080977|NCT04649151|585354218|FG001|Overall Study|Protocol Deviation|3|||
162080978|NCT04649151|585354219|FG002|Overall Study|Protocol Deviation|0|||
162080979|NCT04649151|585354220|FG003|Overall Study|Protocol Deviation|0|||
162080980|NCT04649151|585354221|FG004|Overall Study|Protocol Deviation|0|||
162080981|NCT04649151|585354217|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
162080982|NCT04649151|585354218|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
162080983|NCT04649151|585354219|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
162080984|NCT04649151|585354220|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
162080985|NCT04649151|585354221|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
162080986|NCT04649151|585354217|FG000|Overall Study|Withdrawal by Subject|370|||
162080987|NCT04649151|585354218|FG001|Overall Study|Withdrawal by Subject|113|||
162080988|NCT04649151|585354219|FG002|Overall Study|Withdrawal by Subject|2|||
162080989|NCT04649151|585354220|FG003|Overall Study|Withdrawal by Subject|7|||
162080990|NCT04649151|585354221|FG004|Overall Study|Withdrawal by Subject|15|||
162080991|NCT04649151|585354217|FG000|Overall Study|Adverse Event|1|||
162080992|NCT04649151|585354218|FG001|Overall Study|Adverse Event|0|||
162080993|NCT04649151|585354219|FG002|Overall Study|Adverse Event|0|||
162080994|NCT04649151|585354220|FG003|Overall Study|Adverse Event|0|||
162080995|NCT04649151|585354221|FG004|Overall Study|Adverse Event|0|||
162080996|NCT04649151|585354217|FG000|Overall Study|Lost to Follow-up|256|||
162080997|NCT04649151|585354218|FG001|Overall Study|Lost to Follow-up|29|||
162080998|NCT04649151|585354219|FG002|Overall Study|Lost to Follow-up|10|||
162080999|NCT04649151|585354220|FG003|Overall Study|Lost to Follow-up|3|||
162081000|NCT04649151|585354221|FG004|Overall Study|Lost to Follow-up|6|||
162081001|NCT04649151|585354217|FG000|Overall Study|Other than specified|59|||
162081002|NCT04649151|585354218|FG001|Overall Study|Other than specified|294|||
162081003|NCT04649151|585354219|FG002|Overall Study|Other than specified|0|||
162081004|NCT04649151|585354220|FG003|Overall Study|Other than specified|0|||
162081005|NCT04649151|585354221|FG004|Overall Study|Other than specified|4|||
162081006|NCT04649151|585354217|FG000|Overall Study|Death|0|||
162081007|NCT04649151|585354218|FG001|Overall Study|Death|0|||
162081008|NCT04649151|585354219|FG002|Overall Study|Death|0|||
162081009|NCT04649151|585354220|FG003|Overall Study|Death|0|||
162081010|NCT04649151|585354221|FG004|Overall Study|Death|1|||
162081011|NCT03752619|585354222|FG000|Overall Study|Lost to Follow-up|2|||
162081012|NCT03752619|585354223|FG001|Overall Study|Lost to Follow-up|1|||
162081013|NCT03752619|585354222|FG000|Overall Study|Withdrawal by Subject|1|||
162081014|NCT03752619|585354223|FG001|Overall Study|Withdrawal by Subject|1|||
162081015|NCT03752619|585354222|FG000|Overall Study|Adverse Event|0|||
162081016|NCT03752619|585354223|FG001|Overall Study|Adverse Event|1|||
162081017|NCT04476017|585354224|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
162081018|NCT04476017|585354225|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
162081019|NCT03362502|585354226|FG000|Overall Study|Death|0|||
162081020|NCT03362502|585354227|FG001|Overall Study|Death|0|||
162081021|NCT03362502|585354228|FG002|Overall Study|Death|1|||
162081022|NCT03795610|585354232|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
162081023|NCT03795610|585354232|FG000|Overall Study|Withdrawal by Subject|1|||
162081024|NCT03795610|585354232|FG000|Overall Study|Screen Failure (Unknown)|1|||
162081025|NCT02775344|585354233|FG000|Overall Study|No ovarian cyst identified|3|||
162081026|NCT02775344|585354234|FG001|Overall Study|No ovarian cyst identified|2|||
162081027|NCT03909165|585354245|FG000|Overall Study|Physician Decision|0|||
162081028|NCT03909165|585354246|FG001|Overall Study|Physician Decision|1|||
162081029|NCT03909165|585354247|FG002|Overall Study|Physician Decision|0|||
162081030|NCT03909165|585354248|FG003|Overall Study|Physician Decision|0|||
162081031|NCT03909165|585354249|FG004|Overall Study|Physician Decision|0|||
162081032|NCT03909165|585354245|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162081033|NCT03909165|585354246|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162081034|NCT03909165|585354247|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162081035|NCT03909165|585354248|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
162081036|NCT03909165|585354249|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
162081037|NCT03909165|585354245|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
162081038|NCT03909165|585354246|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
162081039|NCT03909165|585354247|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
162081040|NCT03909165|585354248|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
162081041|NCT03909165|585354249|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
162081042|NCT03909165|585354245|FG000|Overall Study|Previous Drug Exposure|0|||
162081043|NCT03909165|585354246|FG001|Overall Study|Previous Drug Exposure|0|||
162081044|NCT03909165|585354247|FG002|Overall Study|Previous Drug Exposure|1|||
162081045|NCT03909165|585354248|FG003|Overall Study|Previous Drug Exposure|0|||
162081046|NCT03909165|585354249|FG004|Overall Study|Previous Drug Exposure|0|||
162081047|NCT03909165|585354245|FG000|Overall Study|Early Discharge|1|||
162081048|NCT03909165|585354246|FG001|Overall Study|Early Discharge|0|||
162081049|NCT03909165|585354247|FG002|Overall Study|Early Discharge|0|||
162081050|NCT03909165|585354248|FG003|Overall Study|Early Discharge|0|||
162081051|NCT03909165|585354249|FG004|Overall Study|Early Discharge|0|||
162081052|NCT06034496|585354250|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
162081053|NCT06034496|585354251|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
162081054|NCT06034496|585354250|FG000|Overall Study|Withdrawal by Subject|5|||
162081055|NCT06034496|585354251|FG001|Overall Study|Withdrawal by Subject|4|||
162081056|NCT02018458|585354252|FG000|Overall Study|Death|4|||
162081057|NCT03277261|585354259|FG000|Overall Study|Adverse Event|17|||
162081058|NCT03277261|585354260|FG001|Overall Study|Adverse Event|1|||
162081059|NCT03277261|585354259|FG000|Overall Study|Participant Withdrawal of Consent|6|||
162081060|NCT03277261|585354260|FG001|Overall Study|Participant Withdrawal of Consent|15|||
162081061|NCT03277261|585354259|FG000|Overall Study|Investigator / Sponsor Decision|4|||
162081062|NCT03277261|585354260|FG001|Overall Study|Investigator / Sponsor Decision|2|||
162081063|NCT03277261|585354259|FG000|Overall Study|Pregnancy|2|||
162081064|NCT03277261|585354260|FG001|Overall Study|Pregnancy|0|||
162081065|NCT03277261|585354259|FG000|Overall Study|Lost to Follow-up|2|||
162081066|NCT03277261|585354260|FG001|Overall Study|Lost to Follow-up|2|||
162081067|NCT03277261|585354259|FG000|Overall Study|Lack of Efficacy|2|||
162081068|NCT03277261|585354260|FG001|Overall Study|Lack of Efficacy|2|||
162081069|NCT03277261|585354259|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
162081070|NCT03277261|585354260|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
162081071|NCT03762083|585354261|FG000|Overall Study|Withdrawal by Subject|2|||
162081072|NCT03762083|585354261|FG000|Overall Study|Physician Decision|1|||
162081073|NCT01203072|585354262|FG000|Overall Study|Adverse Event|5|||
162081074|NCT01203072|585354263|FG001|Overall Study|Adverse Event|3|||
162081075|NCT01203072|585354264|FG002|Overall Study|Adverse Event|2|||
162081076|NCT01203072|585354265|FG003|Overall Study|Adverse Event|4|||
162081077|NCT01203072|585354266|FG004|Overall Study|Adverse Event|2|||
162081078|NCT01203072|585354262|FG000|Overall Study|Lack of Efficacy|1|||
162081079|NCT01203072|585354263|FG001|Overall Study|Lack of Efficacy|0|||
162081080|NCT01203072|585354264|FG002|Overall Study|Lack of Efficacy|0|||
162081081|NCT01203072|585354265|FG003|Overall Study|Lack of Efficacy|0|||
162081082|NCT01203072|585354266|FG004|Overall Study|Lack of Efficacy|0|||
162081083|NCT01203072|585354262|FG000|Overall Study|Lost to Follow-up|0|||
162081084|NCT01203072|585354263|FG001|Overall Study|Lost to Follow-up|1|||
162081085|NCT01203072|585354264|FG002|Overall Study|Lost to Follow-up|0|||
162081086|NCT01203072|585354265|FG003|Overall Study|Lost to Follow-up|0|||
162081087|NCT01203072|585354266|FG004|Overall Study|Lost to Follow-up|0|||
162081088|NCT01203072|585354262|FG000|Overall Study|Protocol Violation|2|||
162081089|NCT01203072|585354263|FG001|Overall Study|Protocol Violation|0|||
162081090|NCT01203072|585354264|FG002|Overall Study|Protocol Violation|0|||
162081091|NCT01203072|585354265|FG003|Overall Study|Protocol Violation|0|||
162081092|NCT01203072|585354266|FG004|Overall Study|Protocol Violation|1|||
162081093|NCT01203072|585354262|FG000|Overall Study|Withdrawal by Subject|2|||
162081094|NCT01203072|585354263|FG001|Overall Study|Withdrawal by Subject|2|||
162081095|NCT01203072|585354264|FG002|Overall Study|Withdrawal by Subject|1|||
162081096|NCT01203072|585354265|FG003|Overall Study|Withdrawal by Subject|2|||
162081097|NCT01203072|585354266|FG004|Overall Study|Withdrawal by Subject|3|||
162081098|NCT00235872|585354267|FG000|Overall Study|Adverse Event|34|||
162081099|NCT00235872|585354267|FG000|Overall Study|Death|1|||
162081100|NCT00235872|585354267|FG000|Overall Study|Lost to Follow-up|1|||
162081101|NCT00235872|585354267|FG000|Overall Study|Withdrawal by Subject|50|||
162081102|NCT00235872|585354267|FG000|Overall Study|Administrative reason|61|||
162081103|NCT00116558|585354268|FG000|Overall Study|Death|11|||
162081104|NCT00116558|585354269|FG001|Overall Study|Death|5|||
162081105|NCT00116558|585354270|FG002|Overall Study|Death|3|||
162081106|NCT00116558|585354268|FG000|Overall Study|Withdrawal by Subject|17|||
162081107|NCT00116558|585354269|FG001|Overall Study|Withdrawal by Subject|3|||
162081108|NCT00116558|585354270|FG002|Overall Study|Withdrawal by Subject|12|||
162081109|NCT00116558|585354268|FG000|Overall Study|disease progression|3|||
162081110|NCT00116558|585354269|FG001|Overall Study|disease progression|7|||
162081111|NCT00116558|585354270|FG002|Overall Study|disease progression|18|||
162081112|NCT02027844|585354271|FG000|Overall Study|Withdrawal by Subject|3|||
162081113|NCT02027844|585354272|FG001|Overall Study|Withdrawal by Subject|2|||
162081114|NCT02027844|585354273|FG002|Overall Study|Withdrawal by Subject|1|||
162081115|NCT02027844|585354271|FG000|Overall Study|Lost to Follow-up|0|||
162081116|NCT02027844|585354272|FG001|Overall Study|Lost to Follow-up|2|||
162081117|NCT02027844|585354273|FG002|Overall Study|Lost to Follow-up|1|||
162081118|NCT02027844|585354271|FG000|Overall Study|Protocol Violation|0|||
162081119|NCT02027844|585354272|FG001|Overall Study|Protocol Violation|2|||
162081120|NCT02027844|585354273|FG002|Overall Study|Protocol Violation|0|||
162081121|NCT02027844|585354271|FG000|Overall Study|Incomlete data|2|||
162081122|NCT02027844|585354272|FG001|Overall Study|Incomlete data|0|||
162081123|NCT02027844|585354273|FG002|Overall Study|Incomlete data|0|||
162081124|NCT00378014|585354274|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
162081125|NCT00378014|585354275|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
162081126|NCT00378014|585354274|FG000|Core (Randomization to Month 11)|Graft loss|1|||
162081127|NCT00378014|585354275|FG001|Core (Randomization to Month 11)|Graft loss|2|||
162081128|NCT00378014|585354274|FG000|Core (Randomization to Month 11)|Death|5|||
162081129|NCT00378014|585354275|FG001|Core (Randomization to Month 11)|Death|3|||
162081130|NCT00378014|585354274|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
162081131|NCT00378014|585354275|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
162081132|NCT00378014|585354274|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
162081133|NCT00378014|585354275|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
162081134|NCT00378014|585354274|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
162081135|NCT00378014|585354275|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
162081136|NCT00378014|585354274|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
162081137|NCT00378014|585354275|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
162081138|NCT00378014|585354274|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
162081139|NCT00378014|585354275|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
162081140|NCT00378014|585354274|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
162081141|NCT00378014|585354275|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
162081142|NCT00378014|585354274|FG000|Extension (Month 12 to Month 59)|Death|1|||
162081143|NCT00378014|585354275|FG001|Extension (Month 12 to Month 59)|Death|2|||
162081144|NCT00378014|585354274|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
162081145|NCT00378014|585354275|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
162081146|NCT00378014|585354274|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
162081147|NCT00378014|585354275|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
162081148|NCT00378014|585354274|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
162081149|NCT00378014|585354275|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
162081150|NCT00378014|585354274|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
162081151|NCT00378014|585354275|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
162081152|NCT00414661|585354276|FG000|Overall Study|Death|2|||
162081153|NCT00414661|585354277|FG001|Overall Study|Death|5|||
162081154|NCT00414661|585354278|FG002|Overall Study|Death|0|||
162081155|NCT00414661|585354279|FG003|Overall Study|Death|0|||
162081156|NCT00414661|585354276|FG000|Overall Study|Lost to Follow-up|1|||
162081157|NCT00414661|585354277|FG001|Overall Study|Lost to Follow-up|4|||
162081158|NCT00414661|585354278|FG002|Overall Study|Lost to Follow-up|0|||
162081159|NCT00414661|585354279|FG003|Overall Study|Lost to Follow-up|1|||
162081160|NCT00414661|585354276|FG000|Overall Study|Withdrawal by Subject|5|||
162081161|NCT00414661|585354277|FG001|Overall Study|Withdrawal by Subject|2|||
162081162|NCT00414661|585354278|FG002|Overall Study|Withdrawal by Subject|2|||
162081163|NCT00414661|585354279|FG003|Overall Study|Withdrawal by Subject|2|||
162081164|NCT00414661|585354276|FG000|Overall Study|Other|6|||
162081165|NCT00414661|585354277|FG001|Overall Study|Other|3|||
162081166|NCT00414661|585354278|FG002|Overall Study|Other|0|||
162081167|NCT00414661|585354279|FG003|Overall Study|Other|0|||
162081168|NCT02852265|585354283|FG000|3-month Follow-up|Lost to Follow-up|1|||
162081169|NCT02852265|585354284|FG001|3-month Follow-up|Lost to Follow-up|1|||
162081170|NCT01143090|585354285|FG000|Overall Study|Lack of Efficacy|2|||
162081171|NCT01143090|585354285|FG000|Overall Study|Adverse Event|17|||
162081172|NCT01143090|585354285|FG000|Overall Study|Lost to Follow-up|9|||
162081173|NCT01143090|585354285|FG000|Overall Study|Protocol Violation|2|||
162081174|NCT01143090|585354285|FG000|Overall Study|Withdrawal by Subject|18|||
162081175|NCT01143090|585354285|FG000|Overall Study|Non-compliance with study drug|1|||
162081176|NCT01143090|585354285|FG000|Overall Study|Failure to meet eligibility criteria|1|||
162081177|NCT01143090|585354285|FG000|Overall Study|Administrative|1|||
162081178|NCT01800916|585354288|FG000|Test Period 1 (1 Week)|Convex product user|0|||
162081179|NCT01800916|585354289|FG001|Test Period 1 (1 Week)|Convex product user|0|||
162081180|NCT01800916|585354290|FG002|Test Period 1 (1 Week)|Convex product user|0|||
162081181|NCT01800916|585354291|FG003|Test Period 1 (1 Week)|Convex product user|1|||
162081182|NCT01800916|585354292|FG004|Test Period 1 (1 Week)|Convex product user|0|||
162081183|NCT01800916|585354293|FG005|Test Period 1 (1 Week)|Convex product user|0|||
162081184|NCT01800916|585354294|FG006|Test Period 1 (1 Week)|Convex product user|0|||
162081185|NCT01800916|585354295|FG007|Test Period 1 (1 Week)|Convex product user|0|||
162081186|NCT01800916|585354296|FG008|Test Period 1 (1 Week)|Convex product user|0|||
162081187|NCT01800916|585354288|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
162081188|NCT01800916|585354289|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
162081189|NCT01800916|585354290|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
162081190|NCT01800916|585354291|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
162081191|NCT01800916|585354292|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
162081192|NCT01800916|585354293|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
162081193|NCT01800916|585354294|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
162081194|NCT01800916|585354295|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
162081195|NCT01800916|585354296|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
162081196|NCT00559962|585354304|FG000|Overall Study|Adverse Event|1|||
162081197|NCT00559962|585354305|FG001|Overall Study|Adverse Event|7|||
162081198|NCT00559962|585354306|FG002|Overall Study|Adverse Event|8|||
162081199|NCT00559962|585354307|FG003|Overall Study|Adverse Event|5|||
162081200|NCT00559962|585354308|FG004|Overall Study|Adverse Event|11|||
162081201|NCT00559962|585354309|FG005|Overall Study|Adverse Event|4|||
162081202|NCT00559962|585354310|FG006|Overall Study|Adverse Event|4|||
162081203|NCT00559962|585354311|FG007|Overall Study|Adverse Event|2|||
162081204|NCT00559962|585354304|FG000|Overall Study|Lost to Follow-up|0|||
162081205|NCT00559962|585354305|FG001|Overall Study|Lost to Follow-up|1|||
162081206|NCT00559962|585354306|FG002|Overall Study|Lost to Follow-up|0|||
162081207|NCT00559962|585354307|FG003|Overall Study|Lost to Follow-up|0|||
162081208|NCT00559962|585354308|FG004|Overall Study|Lost to Follow-up|0|||
162081209|NCT00559962|585354309|FG005|Overall Study|Lost to Follow-up|0|||
162081210|NCT00559962|585354310|FG006|Overall Study|Lost to Follow-up|0|||
162081211|NCT00559962|585354311|FG007|Overall Study|Lost to Follow-up|0|||
162081212|NCT00559962|585354304|FG000|Overall Study|Withdrawal by Subject|1|||
162081213|NCT00559962|585354305|FG001|Overall Study|Withdrawal by Subject|1|||
162081214|NCT00559962|585354306|FG002|Overall Study|Withdrawal by Subject|2|||
162081215|NCT00559962|585354307|FG003|Overall Study|Withdrawal by Subject|0|||
162081216|NCT00559962|585354308|FG004|Overall Study|Withdrawal by Subject|3|||
162081217|NCT00559962|585354309|FG005|Overall Study|Withdrawal by Subject|1|||
162081218|NCT00559962|585354310|FG006|Overall Study|Withdrawal by Subject|0|||
162081219|NCT00559962|585354311|FG007|Overall Study|Withdrawal by Subject|2|||
162081220|NCT00559962|585354304|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
162081221|NCT00559962|585354305|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
162081222|NCT00559962|585354306|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
162081223|NCT00559962|585354307|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
162081224|NCT00559962|585354308|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
162081225|NCT00559962|585354309|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
162081226|NCT00559962|585354310|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
162081227|NCT00559962|585354311|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
162081228|NCT01639040|585354321|FG000|Overall Study|Adverse Event|1|||
162081229|NCT01639040|585354322|FG001|Overall Study|Adverse Event|0|||
162081230|NCT04370691|585354323|FG000|Overall Study|Pending visit|48|||
162081231|NCT04370691|585354323|FG000|Overall Study|Have Not Reached Lower Window|15|||
162081232|NCT04370691|585354323|FG000|Overall Study|Termination|14|||
162081233|NCT04370691|585354323|FG000|Overall Study|Missed or Overdue|10|||
162081234|NCT00486265|585354324|FG000|Overall Study|Adverse Event|1|||
162081235|NCT00486265|585354324|FG000|Overall Study|Lack of Efficacy|8|||
162081236|NCT03013543|585354325|FG000|Overall Study|Withdrawal by Subject|0|||
162081237|NCT03013543|585354326|FG001|Overall Study|Withdrawal by Subject|2|||
162081238|NCT03013543|585354327|FG002|Overall Study|Withdrawal by Subject|0|||
162081239|NCT03013543|585354328|FG003|Overall Study|Withdrawal by Subject|5|||
162081240|NCT03013543|585354329|FG004|Overall Study|Withdrawal by Subject|6|||
162081241|NCT03013543|585354330|FG005|Overall Study|Withdrawal by Subject|2|||
162081242|NCT03013543|585354331|FG006|Overall Study|Withdrawal by Subject|3|||
162081243|NCT03013543|585354332|FG007|Overall Study|Withdrawal by Subject|1|||
162081244|NCT03013543|585354333|FG008|Overall Study|Withdrawal by Subject|0|||
162081245|NCT03013543|585354334|FG009|Overall Study|Withdrawal by Subject|4|||
162081246|NCT03013543|585354325|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
162081247|NCT03013543|585354326|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
162081248|NCT03013543|585354327|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
162081249|NCT03013543|585354328|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
162081250|NCT03013543|585354329|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
162081251|NCT03013543|585354330|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
162081252|NCT03013543|585354331|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
162081253|NCT03013543|585354332|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
162081254|NCT03013543|585354333|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
162081255|NCT03013543|585354334|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
162081256|NCT03013543|585354325|FG000|Overall Study|Other|0|||
162081257|NCT03013543|585354326|FG001|Overall Study|Other|0|||
162081258|NCT03013543|585354327|FG002|Overall Study|Other|2|||
162081259|NCT03013543|585354328|FG003|Overall Study|Other|0|||
162081260|NCT03013543|585354329|FG004|Overall Study|Other|2|||
162081261|NCT03013543|585354330|FG005|Overall Study|Other|0|||
162081262|NCT03013543|585354331|FG006|Overall Study|Other|0|||
162081263|NCT03013543|585354332|FG007|Overall Study|Other|0|||
162081264|NCT03013543|585354333|FG008|Overall Study|Other|1|||
162081265|NCT03013543|585354334|FG009|Overall Study|Other|0|||
162081266|NCT03013543|585354325|FG000|Overall Study|Adverse Event|0|||
162081267|NCT03013543|585354326|FG001|Overall Study|Adverse Event|0|||
162081268|NCT03013543|585354327|FG002|Overall Study|Adverse Event|0|||
162081269|NCT03013543|585354328|FG003|Overall Study|Adverse Event|3|||
162081270|NCT03013543|585354329|FG004|Overall Study|Adverse Event|2|||
162081271|NCT03013543|585354330|FG005|Overall Study|Adverse Event|1|||
162081272|NCT03013543|585354331|FG006|Overall Study|Adverse Event|3|||
162081273|NCT03013543|585354332|FG007|Overall Study|Adverse Event|8|||
162081274|NCT03013543|585354333|FG008|Overall Study|Adverse Event|0|||
162081275|NCT03013543|585354334|FG009|Overall Study|Adverse Event|2|||
162081276|NCT03013543|585354325|FG000|Overall Study|Death|0|||
162081277|NCT03013543|585354326|FG001|Overall Study|Death|0|||
162081278|NCT03013543|585354327|FG002|Overall Study|Death|0|||
162081279|NCT03013543|585354328|FG003|Overall Study|Death|1|||
162081280|NCT03013543|585354329|FG004|Overall Study|Death|0|||
162081281|NCT03013543|585354330|FG005|Overall Study|Death|0|||
162081282|NCT03013543|585354331|FG006|Overall Study|Death|0|||
162081283|NCT03013543|585354332|FG007|Overall Study|Death|0|||
162081284|NCT03013543|585354333|FG008|Overall Study|Death|0|||
162081285|NCT03013543|585354334|FG009|Overall Study|Death|0|||
162081286|NCT03013543|585354325|FG000|Overall Study|Lack of Efficacy|0|||
162081287|NCT03013543|585354326|FG001|Overall Study|Lack of Efficacy|0|||
162081288|NCT03013543|585354327|FG002|Overall Study|Lack of Efficacy|0|||
162081289|NCT03013543|585354328|FG003|Overall Study|Lack of Efficacy|1|||
162081290|NCT03013543|585354329|FG004|Overall Study|Lack of Efficacy|0|||
162081291|NCT03013543|585354330|FG005|Overall Study|Lack of Efficacy|0|||
162081292|NCT03013543|585354331|FG006|Overall Study|Lack of Efficacy|0|||
162081293|NCT03013543|585354332|FG007|Overall Study|Lack of Efficacy|0|||
162081294|NCT03013543|585354333|FG008|Overall Study|Lack of Efficacy|0|||
162081295|NCT03013543|585354334|FG009|Overall Study|Lack of Efficacy|0|||
162081296|NCT03013543|585354325|FG000|Overall Study|Lost to Follow-up|0|||
162081297|NCT03013543|585354326|FG001|Overall Study|Lost to Follow-up|0|||
162081298|NCT03013543|585354327|FG002|Overall Study|Lost to Follow-up|0|||
162081299|NCT03013543|585354328|FG003|Overall Study|Lost to Follow-up|1|||
162081300|NCT03013543|585354329|FG004|Overall Study|Lost to Follow-up|0|||
162081301|NCT03013543|585354330|FG005|Overall Study|Lost to Follow-up|0|||
162081302|NCT03013543|585354331|FG006|Overall Study|Lost to Follow-up|1|||
162081303|NCT03013543|585354332|FG007|Overall Study|Lost to Follow-up|0|||
162081304|NCT03013543|585354333|FG008|Overall Study|Lost to Follow-up|0|||
162081305|NCT03013543|585354334|FG009|Overall Study|Lost to Follow-up|2|||
162081306|NCT03013543|585354325|FG000|Overall Study|Non-Compliance With Study Drug|0|||
162081307|NCT03013543|585354326|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162081308|NCT03013543|585354327|FG002|Overall Study|Non-Compliance With Study Drug|0|||
162081309|NCT03013543|585354328|FG003|Overall Study|Non-Compliance With Study Drug|0|||
162081310|NCT03013543|585354329|FG004|Overall Study|Non-Compliance With Study Drug|0|||
162081311|NCT03013543|585354330|FG005|Overall Study|Non-Compliance With Study Drug|0|||
162081312|NCT03013543|585354331|FG006|Overall Study|Non-Compliance With Study Drug|0|||
162081313|NCT03013543|585354332|FG007|Overall Study|Non-Compliance With Study Drug|0|||
162081314|NCT03013543|585354333|FG008|Overall Study|Non-Compliance With Study Drug|1|||
162081315|NCT03013543|585354334|FG009|Overall Study|Non-Compliance With Study Drug|0|||
162081316|NCT03013543|585354325|FG000|Overall Study|Physician Decision|0|||
162081317|NCT03013543|585354326|FG001|Overall Study|Physician Decision|0|||
162081318|NCT03013543|585354327|FG002|Overall Study|Physician Decision|0|||
162081319|NCT03013543|585354328|FG003|Overall Study|Physician Decision|0|||
162081320|NCT03013543|585354329|FG004|Overall Study|Physician Decision|1|||
162081321|NCT03013543|585354330|FG005|Overall Study|Physician Decision|0|||
162081322|NCT03013543|585354331|FG006|Overall Study|Physician Decision|0|||
162081323|NCT03013543|585354332|FG007|Overall Study|Physician Decision|0|||
162081324|NCT03013543|585354333|FG008|Overall Study|Physician Decision|0|||
162081325|NCT03013543|585354334|FG009|Overall Study|Physician Decision|0|||
162081326|NCT03013543|585354325|FG000|Overall Study|Protocol Violation|0|||
162081327|NCT03013543|585354326|FG001|Overall Study|Protocol Violation|0|||
162081328|NCT03013543|585354327|FG002|Overall Study|Protocol Violation|0|||
162081329|NCT03013543|585354328|FG003|Overall Study|Protocol Violation|0|||
162081330|NCT03013543|585354329|FG004|Overall Study|Protocol Violation|0|||
162081331|NCT03013543|585354330|FG005|Overall Study|Protocol Violation|0|||
162081332|NCT03013543|585354331|FG006|Overall Study|Protocol Violation|0|||
162081333|NCT03013543|585354332|FG007|Overall Study|Protocol Violation|0|||
162081334|NCT03013543|585354333|FG008|Overall Study|Protocol Violation|0|||
162081335|NCT03013543|585354334|FG009|Overall Study|Protocol Violation|1|||
162081336|NCT02552316|585354335|FG000|Overall Study|Withdrawal by Subject|1|||
162081337|NCT02552316|585354335|FG000|Overall Study|Withdrawal due to non-compliance|1|||
162081338|NCT04382911|585354336|FG000|Overall Study|unable to be imaged prior to surgery|2|||
162081339|NCT04116710|585354339|FG000|Overall Study|Death|4|||
162081340|NCT04116710|585354340|FG001|Overall Study|Death|6|||
162081341|NCT04116710|585354341|FG002|Overall Study|Death|3|||
162081342|NCT04116710|585354342|FG003|Overall Study|Death|1|||
162081343|NCT04116710|585354339|FG000|Overall Study|Withdrawal by Subject|0|||
162081344|NCT04116710|585354340|FG001|Overall Study|Withdrawal by Subject|0|||
162081345|NCT04116710|585354341|FG002|Overall Study|Withdrawal by Subject|0|||
162081346|NCT04116710|585354342|FG003|Overall Study|Withdrawal by Subject|1|||
162081347|NCT02161718|585354345|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
162081348|NCT02161718|585354346|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
162081349|NCT02161718|585354347|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
162081350|NCT02161718|585354345|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
162081351|NCT02161718|585354346|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
162081352|NCT02161718|585354347|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
162081353|NCT02161718|585354345|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
162081354|NCT02161718|585354346|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
162081355|NCT02161718|585354347|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
162081356|NCT02161718|585354345|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
162081357|NCT02161718|585354346|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
162081358|NCT02161718|585354347|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
162081359|NCT02161718|585354345|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
162081360|NCT02161718|585354346|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
162081361|NCT02161718|585354347|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
162081362|NCT02161718|585354345|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
162081363|NCT02161718|585354346|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
162081364|NCT02161718|585354347|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
162081365|NCT02161718|585354345|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
162081366|NCT02161718|585354346|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
162081367|NCT02161718|585354347|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
162081368|NCT02161718|585354345|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
162081369|NCT02161718|585354346|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
162081370|NCT02161718|585354347|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
162081371|NCT02161718|585354345|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
162081372|NCT02161718|585354346|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
162081373|NCT02161718|585354347|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
162081374|NCT02161718|585354345|FG000|Post- Randomization Period|Lost to Follow-up|0|||
162081375|NCT02161718|585354346|FG001|Post- Randomization Period|Lost to Follow-up|9|||
162081376|NCT02161718|585354347|FG002|Post- Randomization Period|Lost to Follow-up|15|||
162081377|NCT02161718|585354345|FG000|Post- Randomization Period|Adverse Event|0|||
162081378|NCT02161718|585354346|FG001|Post- Randomization Period|Adverse Event|9|||
162081379|NCT02161718|585354347|FG002|Post- Randomization Period|Adverse Event|10|||
162081380|NCT02161718|585354345|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
162081381|NCT02161718|585354346|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
162081382|NCT02161718|585354347|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
162081383|NCT02161718|585354345|FG000|Post- Randomization Period|Physician Decision|0|||
162081384|NCT02161718|585354346|FG001|Post- Randomization Period|Physician Decision|2|||
162081385|NCT02161718|585354347|FG002|Post- Randomization Period|Physician Decision|4|||
162081386|NCT02161718|585354345|FG000|Post- Randomization Period|Protocol Violation|0|||
162081387|NCT02161718|585354346|FG001|Post- Randomization Period|Protocol Violation|2|||
162081388|NCT02161718|585354347|FG002|Post- Randomization Period|Protocol Violation|3|||
162081389|NCT02161718|585354345|FG000|Post- Randomization Period|Lack of Efficacy|0|||
162081390|NCT02161718|585354346|FG001|Post- Randomization Period|Lack of Efficacy|0|||
162081391|NCT02161718|585354347|FG002|Post- Randomization Period|Lack of Efficacy|1|||
162081392|NCT02161718|585354345|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
162081393|NCT02161718|585354346|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
162081394|NCT02161718|585354347|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
162081395|NCT02161718|585354345|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
162081396|NCT02161718|585354346|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
162081397|NCT02161718|585354347|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
162081398|NCT02161718|585354345|FG000|Post- Randomization Period|Relocation|0|||
162081399|NCT02161718|585354346|FG001|Post- Randomization Period|Relocation|3|||
162081400|NCT02161718|585354347|FG002|Post- Randomization Period|Relocation|0|||
162081401|NCT02948842|585354349|FG000|Overall Study|Withdrawal by Subject|4|||
162081402|NCT01537783|585354350|FG000|Overall Study|Lost to Follow-up|11|||
162081403|NCT01537783|585354351|FG001|Overall Study|Lost to Follow-up|2|||
162081404|NCT02350309|585354353|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
162081405|NCT02350309|585354354|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
162081406|NCT02350309|585354355|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
162081407|NCT02350309|585354356|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
162081408|NCT02350309|585354357|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
162081409|NCT02350309|585354358|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
162081410|NCT02350309|585354353|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
162081411|NCT02350309|585354354|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
162081412|NCT02350309|585354355|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
162081413|NCT02350309|585354356|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
162081414|NCT02350309|585354357|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
162081415|NCT02350309|585354358|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
162081416|NCT00207142|585354359|FG000|Induction Phase|Adverse Event|9|||
162081417|NCT00207142|585354360|FG001|Induction Phase|Adverse Event|0|||
162081418|NCT00207142|585354361|FG002|Induction Phase|Adverse Event|0|||
162081419|NCT00207142|585354362|FG003|Induction Phase|Adverse Event|0|||
162081420|NCT00207142|585354359|FG000|Induction Phase|Death|1|||
162081421|NCT00207142|585354360|FG001|Induction Phase|Death|0|||
162081422|NCT00207142|585354361|FG002|Induction Phase|Death|0|||
162081423|NCT00207142|585354362|FG003|Induction Phase|Death|0|||
162081424|NCT00207142|585354359|FG000|Induction Phase|Lack of Efficacy|1|||
162081425|NCT00207142|585354360|FG001|Induction Phase|Lack of Efficacy|0|||
162081426|NCT00207142|585354361|FG002|Induction Phase|Lack of Efficacy|0|||
162081427|NCT00207142|585354362|FG003|Induction Phase|Lack of Efficacy|0|||
162081428|NCT00207142|585354359|FG000|Induction Phase|Lost to Follow-up|5|||
162081429|NCT00207142|585354360|FG001|Induction Phase|Lost to Follow-up|0|||
162081430|NCT00207142|585354361|FG002|Induction Phase|Lost to Follow-up|0|||
162081431|NCT00207142|585354362|FG003|Induction Phase|Lost to Follow-up|0|||
162081432|NCT00207142|585354359|FG000|Induction Phase|Physician Decision|2|||
162081433|NCT00207142|585354360|FG001|Induction Phase|Physician Decision|0|||
162081434|NCT00207142|585354361|FG002|Induction Phase|Physician Decision|0|||
162081435|NCT00207142|585354362|FG003|Induction Phase|Physician Decision|0|||
162081436|NCT00207142|585354359|FG000|Induction Phase|Poor/noncompliance|2|||
162081437|NCT00207142|585354360|FG001|Induction Phase|Poor/noncompliance|0|||
162081438|NCT00207142|585354361|FG002|Induction Phase|Poor/noncompliance|0|||
162081439|NCT00207142|585354362|FG003|Induction Phase|Poor/noncompliance|0|||
162081440|NCT00207142|585354359|FG000|Induction Phase|Pregnancy|1|||
162081441|NCT00207142|585354360|FG001|Induction Phase|Pregnancy|0|||
162081442|NCT00207142|585354361|FG002|Induction Phase|Pregnancy|0|||
162081443|NCT00207142|585354362|FG003|Induction Phase|Pregnancy|0|||
162081444|NCT00207142|585354359|FG000|Induction Phase|Subject no longer meets study criteria|3|||
162081445|NCT00207142|585354360|FG001|Induction Phase|Subject no longer meets study criteria|0|||
162081446|NCT00207142|585354361|FG002|Induction Phase|Subject no longer meets study criteria|0|||
162081447|NCT00207142|585354362|FG003|Induction Phase|Subject no longer meets study criteria|0|||
162081448|NCT00207142|585354359|FG000|Induction Phase|Withdrawal by Subject|4|||
162081449|NCT00207142|585354360|FG001|Induction Phase|Withdrawal by Subject|0|||
162081450|NCT00207142|585354361|FG002|Induction Phase|Withdrawal by Subject|0|||
162081451|NCT00207142|585354362|FG003|Induction Phase|Withdrawal by Subject|0|||
162081452|NCT00207142|585354359|FG000|Induction Phase|Incarceration|1|||
162081453|NCT00207142|585354360|FG001|Induction Phase|Incarceration|0|||
162081454|NCT00207142|585354361|FG002|Induction Phase|Incarceration|0|||
162081455|NCT00207142|585354362|FG003|Induction Phase|Incarceration|0|||
162081456|NCT00207142|585354359|FG000|Induction Phase|Missing lab data|1|||
162081457|NCT00207142|585354360|FG001|Induction Phase|Missing lab data|0|||
162081458|NCT00207142|585354361|FG002|Induction Phase|Missing lab data|0|||
162081459|NCT00207142|585354362|FG003|Induction Phase|Missing lab data|0|||
162081460|NCT00207142|585354359|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
162081461|NCT00207142|585354360|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
162081462|NCT00207142|585354361|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
162081463|NCT00207142|585354362|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
162081464|NCT00207142|585354359|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
162081465|NCT00207142|585354360|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
162081466|NCT00207142|585354361|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
162081467|NCT00207142|585354362|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
162081468|NCT00207142|585354359|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
162081469|NCT00207142|585354360|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
162081470|NCT00207142|585354361|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
162081471|NCT00207142|585354362|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
162081472|NCT00207142|585354359|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
162081473|NCT00207142|585354360|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
162081474|NCT00207142|585354361|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
162081475|NCT00207142|585354362|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
162081476|NCT00207142|585354359|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
162081477|NCT00207142|585354360|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
162081478|NCT00207142|585354361|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
162081479|NCT00207142|585354362|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
162081480|NCT00207142|585354359|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
162081481|NCT00207142|585354360|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
162081482|NCT00207142|585354361|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
162081483|NCT00207142|585354362|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
162081484|NCT00207142|585354359|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
162081485|NCT00207142|585354360|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
162081486|NCT00207142|585354361|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
162081487|NCT00207142|585354362|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
162081488|NCT00207142|585354359|FG000|Maintenance Phase/Rescue Phase|Death|0|||
162081489|NCT00207142|585354360|FG001|Maintenance Phase/Rescue Phase|Death|0|||
162081490|NCT00207142|585354361|FG002|Maintenance Phase/Rescue Phase|Death|0|||
162081491|NCT00207142|585354362|FG003|Maintenance Phase/Rescue Phase|Death|1|||
162081492|NCT00207142|585354359|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
162081493|NCT00207142|585354360|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
162081494|NCT00207142|585354361|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
162081495|NCT00207142|585354362|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
162081496|NCT01554618|585354363|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
162081497|NCT01554618|585354364|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
162081498|NCT01554618|585354363|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
162081499|NCT01554618|585354364|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
162081500|NCT01554618|585354363|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
162081501|NCT01554618|585354364|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
162081502|NCT01554618|585354363|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
162081503|NCT01554618|585354364|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
162081504|NCT01554618|585354363|FG000|Open-Label Extension Period|Physician Decision|0|||
162081505|NCT01554618|585354364|FG001|Open-Label Extension Period|Physician Decision|1|||
162081506|NCT01554618|585354363|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
162081507|NCT01554618|585354364|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
162081508|NCT01857063|585354365|FG000|Period 1 (7 Days)|Adverse Event|0|||
162081509|NCT01857063|585354366|FG001|Period 1 (7 Days)|Adverse Event|1|||
162081510|NCT01857063|585354365|FG000|Period 1 (7 Days)|Physician Decision|1|||
162081511|NCT01857063|585354366|FG001|Period 1 (7 Days)|Physician Decision|0|||
162081512|NCT01857063|585354365|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
162081513|NCT01857063|585354366|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
162081514|NCT01857063|585354365|FG000|Period 2 (7 Days)|Adverse Event|2|||
162081515|NCT01857063|585354366|FG001|Period 2 (7 Days)|Adverse Event|1|||
162081516|NCT01857063|585354365|FG000|Period 2 (7 Days)|Physician Decision|1|||
162081517|NCT01857063|585354366|FG001|Period 2 (7 Days)|Physician Decision|1|||
162081518|NCT01857063|585354365|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
162081519|NCT01857063|585354366|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
162081520|NCT01256710|585354367|FG000|Overall Study|Death|449|||
162081521|NCT01256710|585354367|FG000|Overall Study|System Explant|67|||
162081522|NCT01256710|585354367|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
162081523|NCT01256710|585354367|FG000|Overall Study|Lost to Follow-up|67|||
162081524|NCT01256710|585354367|FG000|Overall Study|Withdrawal by Subject|29|||
162081525|NCT01256710|585354367|FG000|Overall Study|Physician Decision|9|||
162081526|NCT01256710|585354367|FG000|Overall Study|Subject Noncompliance|2|||
162081527|NCT01256710|585354367|FG000|Overall Study|Study Terminated by Sponsor|273|||
162081528|NCT00058825|585354368|FG000|Overall Study|Relapse|9|||
162081529|NCT00058825|585354368|FG000|Overall Study|Progressive Disease|5|||
162081530|NCT00058825|585354368|FG000|Overall Study|Graft Failure|5|||
162081531|NCT00058825|585354368|FG000|Overall Study|Death|3|||
162081532|NCT01205165|585354369|FG000|Overall Study|Lost to Follow-up|2|||
162081533|NCT00329407|585354377|FG000|Overall Study|Withdrawal by Subject|1|||
162081534|NCT00978068|585354378|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
162081535|NCT00978068|585354379|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
162081536|NCT00978068|585354378|FG000|Overall Study|Death|1|||
162081537|NCT00978068|585354379|FG001|Overall Study|Death|2|||
162081538|NCT00978068|585354378|FG000|Overall Study|Lost to Follow-up|1|||
162081539|NCT00978068|585354379|FG001|Overall Study|Lost to Follow-up|2|||
162081540|NCT00978068|585354378|FG000|Overall Study|Physician Decision|0|||
162081541|NCT00978068|585354379|FG001|Overall Study|Physician Decision|1|||
162081542|NCT00978068|585354378|FG000|Overall Study|Unable to Comply with Study|0|||
162081543|NCT00978068|585354379|FG001|Overall Study|Unable to Comply with Study|2|||
162081544|NCT02275481|585354380|FG000|Overall Study|Death|2|||
162081545|NCT02275481|585354381|FG001|Overall Study|Death|1|||
162081546|NCT02275481|585354380|FG000|Overall Study|Lost to Follow-up|2|||
162081547|NCT02275481|585354381|FG001|Overall Study|Lost to Follow-up|0|||
162081548|NCT02275481|585354380|FG000|Overall Study|Withdrawal by Subject|3|||
162081549|NCT02275481|585354381|FG001|Overall Study|Withdrawal by Subject|0|||
162081550|NCT02275481|585354380|FG000|Overall Study|all other reasons combined|2|||
162081551|NCT02275481|585354381|FG001|Overall Study|all other reasons combined|1|||
162081552|NCT02275481|585354380|FG000|Overall Study|Physician Decision|0|||
162081553|NCT02275481|585354381|FG001|Overall Study|Physician Decision|1|||
162081554|NCT01215227|585354382|FG000|Overall Study|Adverse Event|11|||
162081555|NCT01215227|585354383|FG001|Overall Study|Adverse Event|11|||
162081556|NCT01215227|585354384|FG002|Overall Study|Adverse Event|4|||
162081557|NCT01215227|585354385|FG003|Overall Study|Adverse Event|8|||
162081558|NCT01215227|585354386|FG004|Overall Study|Adverse Event|7|||
162081559|NCT01215227|585354387|FG005|Overall Study|Adverse Event|6|||
162081560|NCT01215227|585354382|FG000|Overall Study|Treatment Failure|8|||
162081561|NCT01215227|585354383|FG001|Overall Study|Treatment Failure|4|||
162081562|NCT01215227|585354384|FG002|Overall Study|Treatment Failure|1|||
162081563|NCT01215227|585354385|FG003|Overall Study|Treatment Failure|5|||
162081564|NCT01215227|585354386|FG004|Overall Study|Treatment Failure|1|||
162081565|NCT01215227|585354387|FG005|Overall Study|Treatment Failure|1|||
162081566|NCT01215227|585354382|FG000|Overall Study|Lost to Follow-up|1|||
162081567|NCT01215227|585354383|FG001|Overall Study|Lost to Follow-up|4|||
162081568|NCT01215227|585354384|FG002|Overall Study|Lost to Follow-up|1|||
162081569|NCT01215227|585354385|FG003|Overall Study|Lost to Follow-up|1|||
162081570|NCT01215227|585354386|FG004|Overall Study|Lost to Follow-up|1|||
162081571|NCT01215227|585354387|FG005|Overall Study|Lost to Follow-up|2|||
162081572|NCT01215227|585354382|FG000|Overall Study|Subject Withdrew Consent|16|||
162081573|NCT01215227|585354383|FG001|Overall Study|Subject Withdrew Consent|20|||
162081574|NCT01215227|585354384|FG002|Overall Study|Subject Withdrew Consent|7|||
162081575|NCT01215227|585354385|FG003|Overall Study|Subject Withdrew Consent|10|||
162081576|NCT01215227|585354386|FG004|Overall Study|Subject Withdrew Consent|11|||
162081577|NCT01215227|585354387|FG005|Overall Study|Subject Withdrew Consent|8|||
162081578|NCT01215227|585354382|FG000|Overall Study|Non-Compliance With Protocol|2|||
162081579|NCT01215227|585354383|FG001|Overall Study|Non-Compliance With Protocol|6|||
162081580|NCT01215227|585354384|FG002|Overall Study|Non-Compliance With Protocol|1|||
162081581|NCT01215227|585354385|FG003|Overall Study|Non-Compliance With Protocol|0|||
162081582|NCT01215227|585354386|FG004|Overall Study|Non-Compliance With Protocol|0|||
162081583|NCT01215227|585354387|FG005|Overall Study|Non-Compliance With Protocol|0|||
162081584|NCT01215227|585354382|FG000|Overall Study|Administrative|83|||
162081585|NCT01215227|585354383|FG001|Overall Study|Administrative|73|||
162081586|NCT01215227|585354384|FG002|Overall Study|Administrative|42|||
162081587|NCT01215227|585354385|FG003|Overall Study|Administrative|24|||
162081588|NCT01215227|585354386|FG004|Overall Study|Administrative|28|||
162081589|NCT01215227|585354387|FG005|Overall Study|Administrative|40|||
162081590|NCT01215227|585354382|FG000|Overall Study|Missing Status|0|||
162081591|NCT01215227|585354383|FG001|Overall Study|Missing Status|1|||
162081592|NCT01215227|585354384|FG002|Overall Study|Missing Status|0|||
162081593|NCT01215227|585354385|FG003|Overall Study|Missing Status|0|||
162081594|NCT01215227|585354386|FG004|Overall Study|Missing Status|0|||
162081595|NCT01215227|585354387|FG005|Overall Study|Missing Status|0|||
162081596|NCT01215227|585354382|FG000|Overall Study|Randomized but not treated|0|||
162081597|NCT01215227|585354383|FG001|Overall Study|Randomized but not treated|0|||
162081598|NCT01215227|585354384|FG002|Overall Study|Randomized but not treated|1|||
162081599|NCT01215227|585354385|FG003|Overall Study|Randomized but not treated|1|||
162081600|NCT01215227|585354386|FG004|Overall Study|Randomized but not treated|0|||
162081601|NCT01215227|585354387|FG005|Overall Study|Randomized but not treated|1|||
162081602|NCT01393405|585354388|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
162081603|NCT01393405|585354389|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
162081604|NCT01393405|585354390|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
162081605|NCT01393405|585354388|FG000|Induction Period (week1-16)|Adverse Event|16|||
162081606|NCT01393405|585354389|FG001|Induction Period (week1-16)|Adverse Event|0|||
162081607|NCT01393405|585354390|FG002|Induction Period (week1-16)|Adverse Event|0|||
162081608|NCT01393405|585354388|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
162081609|NCT01393405|585354389|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
162081610|NCT01393405|585354390|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
162081611|NCT01393405|585354388|FG000|Maintenance Period Week|Lack of Efficacy|0|||
162081612|NCT01393405|585354389|FG001|Maintenance Period Week|Lack of Efficacy|22|||
162081613|NCT01393405|585354390|FG002|Maintenance Period Week|Lack of Efficacy|22|||
162081614|NCT01393405|585354388|FG000|Maintenance Period Week|Adverse Event|0|||
162081615|NCT01393405|585354389|FG001|Maintenance Period Week|Adverse Event|5|||
162081616|NCT01393405|585354390|FG002|Maintenance Period Week|Adverse Event|2|||
162081617|NCT01393405|585354388|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
162081618|NCT01393405|585354389|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
162081619|NCT01393405|585354390|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
162081620|NCT01393405|585354388|FG000|Maintenance Period Week|Lost to Follow-up|0|||
162081621|NCT01393405|585354389|FG001|Maintenance Period Week|Lost to Follow-up|1|||
162081622|NCT01393405|585354390|FG002|Maintenance Period Week|Lost to Follow-up|0|||
162081623|NCT02281552|585354391|FG000|Overall Study|Medication error|1|||
162081624|NCT02281552|585354392|FG001|Overall Study|Medication error|0|||
162081625|NCT02281552|585354391|FG000|Overall Study|Insufficient clinical response|0|||
162081626|NCT02281552|585354392|FG001|Overall Study|Insufficient clinical response|1|||
162081627|NCT02281552|585354391|FG000|Overall Study|Adverse Event|3|||
162081628|NCT02281552|585354392|FG001|Overall Study|Adverse Event|9|||
162081629|NCT01434290|585354393|FG000|Overall Study|Protocol Violation|6|||
162081630|NCT01434290|585354394|FG001|Overall Study|Protocol Violation|3|||
162081631|NCT01434290|585354393|FG000|Overall Study|No protocol treatment|2|||
162081632|NCT01434290|585354394|FG001|Overall Study|No protocol treatment|4|||
162081633|NCT01224639|585354395|FG000|Overall Study|Withdrawal by Subject|0|||
162081634|NCT01224639|585354396|FG001|Overall Study|Withdrawal by Subject|0|||
162081635|NCT01224639|585354397|FG002|Overall Study|Withdrawal by Subject|0|||
162081636|NCT01224639|585354398|FG003|Overall Study|Withdrawal by Subject|0|||
162081637|NCT01224639|585354399|FG004|Overall Study|Withdrawal by Subject|2|||
162081638|NCT01224639|585354400|FG005|Overall Study|Withdrawal by Subject|0|||
162081639|NCT01224639|585354401|FG006|Overall Study|Withdrawal by Subject|1|||
162081640|NCT01224639|585354402|FG007|Overall Study|Withdrawal by Subject|1|||
162081641|NCT01224639|585354395|FG000|Overall Study|Adverse Event|0|||
162081642|NCT01224639|585354396|FG001|Overall Study|Adverse Event|0|||
162081643|NCT01224639|585354397|FG002|Overall Study|Adverse Event|0|||
162081644|NCT01224639|585354398|FG003|Overall Study|Adverse Event|0|||
162081645|NCT01224639|585354399|FG004|Overall Study|Adverse Event|0|||
162081646|NCT01224639|585354400|FG005|Overall Study|Adverse Event|0|||
162081647|NCT01224639|585354401|FG006|Overall Study|Adverse Event|0|||
162081648|NCT01224639|585354402|FG007|Overall Study|Adverse Event|1|||
162081649|NCT04656132|585354403|FG000|Overall Study|Lost to Follow-up|4|||
162081650|NCT04656132|585354403|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
162081651|NCT04365699|585354404|FG000|Overall Study|Death|2|||
162081652|NCT04365699|585354405|FG001|Overall Study|Death|5|||
162081653|NCT04365699|585354406|FG002|Overall Study|Death|15|||
162081654|NCT00834912|585354408|FG000|Treatment Period 1|Adverse Event|0|||
162081655|NCT00834912|585354409|FG001|Treatment Period 1|Adverse Event|1|||
162081656|NCT00834912|585354410|FG002|Treatment Period 1|Adverse Event|0|||
162081657|NCT00834912|585354411|FG003|Treatment Period 1|Adverse Event|1|||
162081658|NCT00834912|585354412|FG004|Treatment Period 1|Adverse Event|0|||
162081659|NCT00834912|585354413|FG005|Treatment Period 1|Adverse Event|0|||
162081660|NCT00834912|585354408|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162081661|NCT00834912|585354409|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162081662|NCT00834912|585354410|FG002|Treatment Period 2|Withdrawal by Subject|1|||
162081663|NCT00834912|585354411|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162081664|NCT00834912|585354412|FG004|Treatment Period 2|Withdrawal by Subject|1|||
162081665|NCT00834912|585354413|FG005|Treatment Period 2|Withdrawal by Subject|0|||
162081666|NCT01399593|585354417|FG000|Overall Study|Physician Decision|1|||
162081667|NCT01399593|585354418|FG001|Overall Study|Physician Decision|0|||
162081668|NCT01399593|585354417|FG000|Overall Study|Adverse Event|1|||
162081669|NCT01399593|585354418|FG001|Overall Study|Adverse Event|0|||
162081670|NCT01399593|585354417|FG000|Overall Study|Death|1|||
162081671|NCT01399593|585354418|FG001|Overall Study|Death|1|||
162081672|NCT01399593|585354417|FG000|Overall Study|Transplantectomy|0|||
162081673|NCT01399593|585354418|FG001|Overall Study|Transplantectomy|1|||
162081674|NCT01012817|585356090|FG000|Overall Study|Withdrawal by Subject|0|||
162081675|NCT01012817|585356091|FG001|Overall Study|Withdrawal by Subject|0|||
162081676|NCT01012817|585356092|FG002|Overall Study|Withdrawal by Subject|0|||
162081677|NCT01012817|585356093|FG003|Overall Study|Withdrawal by Subject|1|||
162081678|NCT01012817|585356094|FG004|Overall Study|Withdrawal by Subject|0|||
162081679|NCT01012817|585356095|FG005|Overall Study|Withdrawal by Subject|0|||
162081680|NCT01012817|585356096|FG006|Overall Study|Withdrawal by Subject|0|||
162081681|NCT01012817|585356097|FG007|Overall Study|Withdrawal by Subject|1|||
162081682|NCT01012817|585356098|FG008|Overall Study|Withdrawal by Subject|0|||
162081683|NCT01012817|585356099|FG009|Overall Study|Withdrawal by Subject|0|||
162081684|NCT01012817|585356100|FG010|Overall Study|Withdrawal by Subject|1|||
162081685|NCT01012817|585356101|FG011|Overall Study|Withdrawal by Subject|1|||
162081686|NCT01012817|585356102|FG012|Overall Study|Withdrawal by Subject|0|||
162081687|NCT01012817|585356103|FG013|Overall Study|Withdrawal by Subject|1|||
162081688|NCT01012817|585356090|FG000|Overall Study|Adverse Event|0|||
162081689|NCT01012817|585356091|FG001|Overall Study|Adverse Event|0|||
162081690|NCT01012817|585356092|FG002|Overall Study|Adverse Event|0|||
162081691|NCT01012817|585356093|FG003|Overall Study|Adverse Event|0|||
162081692|NCT01012817|585356094|FG004|Overall Study|Adverse Event|0|||
162081693|NCT01012817|585356095|FG005|Overall Study|Adverse Event|1|||
162081694|NCT01012817|585356096|FG006|Overall Study|Adverse Event|0|||
162081695|NCT01012817|585356097|FG007|Overall Study|Adverse Event|0|||
162081696|NCT01012817|585356098|FG008|Overall Study|Adverse Event|0|||
162081697|NCT01012817|585356099|FG009|Overall Study|Adverse Event|0|||
162081698|NCT01012817|585356100|FG010|Overall Study|Adverse Event|1|||
162081699|NCT01012817|585356101|FG011|Overall Study|Adverse Event|0|||
162081700|NCT01012817|585356102|FG012|Overall Study|Adverse Event|0|||
162081701|NCT01012817|585356103|FG013|Overall Study|Adverse Event|1|||
162081702|NCT00634647|585356104|FG000|Overall Study|death on study|3|||
162081703|NCT00634647|585356104|FG000|Overall Study|refused further treatment|3|||
162081704|NCT00634647|585356104|FG000|Overall Study|declined to participate before treatment|1|||
162081705|NCT00293384|585356105|FG000|Overall Study|Non-compliance|2|||
162081706|NCT00293384|585356105|FG000|Overall Study|Missed dosage/study drug|1|||
162081707|NCT00293384|585356105|FG000|Overall Study|Ineligible|2|||
162081708|NCT05723770|585356106|FG000|Overall Study|Lost to Follow-up|4|||
162081709|NCT05723770|585356106|FG000|Overall Study|Withdrawal by Subject|2|||
162081710|NCT01359592|585356107|FG000|Initial Registration|Adverse Event|1|||
162081711|NCT01359592|585356108|FG001|Initial Registration|Adverse Event|0|||
162081712|NCT01359592|585356109|FG002|Initial Registration|Adverse Event|0|||
162081713|NCT01359592|585356110|FG003|Initial Registration|Adverse Event|0|||
162081714|NCT01359592|585356107|FG000|Initial Registration|Death|1|||
162081715|NCT01359592|585356108|FG001|Initial Registration|Death|0|||
162081716|NCT01359592|585356109|FG002|Initial Registration|Death|0|||
162081717|NCT01359592|585356110|FG003|Initial Registration|Death|0|||
162081718|NCT01359592|585356107|FG000|Initial Registration|Other reason not protocol specified|1|||
162081719|NCT01359592|585356108|FG001|Initial Registration|Other reason not protocol specified|0|||
162081720|NCT01359592|585356109|FG002|Initial Registration|Other reason not protocol specified|0|||
162081721|NCT01359592|585356110|FG003|Initial Registration|Other reason not protocol specified|0|||
162081722|NCT01359592|585356107|FG000|Initial Registration|Ineligible|26|||
162081723|NCT01359592|585356108|FG001|Initial Registration|Ineligible|0|||
162081724|NCT01359592|585356109|FG002|Initial Registration|Ineligible|0|||
162081725|NCT01359592|585356110|FG003|Initial Registration|Ineligible|0|||
162081726|NCT01359592|585356107|FG000|PET-Directed Therapy|Adverse Event|0|||
162081727|NCT01359592|585356108|FG001|PET-Directed Therapy|Adverse Event|0|||
162081728|NCT01359592|585356109|FG002|PET-Directed Therapy|Adverse Event|1|||
162081729|NCT01359592|585356110|FG003|PET-Directed Therapy|Adverse Event|0|||
162081730|NCT01359592|585356107|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
162081731|NCT01359592|585356108|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
162081732|NCT01359592|585356109|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
162081733|NCT01359592|585356110|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
162081734|NCT01359592|585356107|FG000|PET-Directed Therapy|Ineligible|0|||
162081735|NCT01359592|585356108|FG001|PET-Directed Therapy|Ineligible|0|||
162081736|NCT01359592|585356109|FG002|PET-Directed Therapy|Ineligible|24|||
162081737|NCT01359592|585356110|FG003|PET-Directed Therapy|Ineligible|0|||
162081738|NCT00326612|585356113|FG000|Overall Study|They did not have a seizure requiring tx|129|||
162081739|NCT00326612|585356114|FG001|Overall Study|They did not have a seizure requiring tx|137|||
162081740|NCT00419562|585356115|FG000|Overall Study|Lost to Follow-up|12|||
162081741|NCT00419562|585356116|FG001|Overall Study|Lost to Follow-up|13|||
162081742|NCT00419562|585356115|FG000|Overall Study|Withdrawal by Subject|20|||
162081743|NCT00419562|585356116|FG001|Overall Study|Withdrawal by Subject|18|||
162081744|NCT00419562|585356115|FG000|Overall Study|Participant Institutionalized|1|||
162081745|NCT00419562|585356116|FG001|Overall Study|Participant Institutionalized|0|||
162081746|NCT02365636|585356117|FG000|Overall Study|Adverse Event|3|||
162081747|NCT02365636|585356118|FG001|Overall Study|Adverse Event|3|||
162081748|NCT02365636|585356119|FG002|Overall Study|Adverse Event|2|||
162081749|NCT02365636|585356117|FG000|Overall Study|Protocol Violation|1|||
162081750|NCT02365636|585356118|FG001|Overall Study|Protocol Violation|4|||
162081751|NCT02365636|585356119|FG002|Overall Study|Protocol Violation|0|||
162081752|NCT02365636|585356117|FG000|Overall Study|Lost to Follow-up|0|||
162081753|NCT02365636|585356118|FG001|Overall Study|Lost to Follow-up|0|||
162081754|NCT02365636|585356119|FG002|Overall Study|Lost to Follow-up|1|||
162081755|NCT02365636|585356117|FG000|Overall Study|Other|2|||
162081756|NCT02365636|585356118|FG001|Overall Study|Other|0|||
162081757|NCT02365636|585356119|FG002|Overall Study|Other|0|||
162081758|NCT00355238|585356120|FG000|Overall Study|Adverse event unrelated to study drug|2|||
162081759|NCT00355238|585356121|FG001|Overall Study|Adverse event unrelated to study drug|2|||
162081760|NCT00355238|585356122|FG002|Overall Study|Adverse event unrelated to study drug|0|||
162081761|NCT00355238|585356123|FG003|Overall Study|Adverse event unrelated to study drug|1|||
162081762|NCT00355238|585356120|FG000|Overall Study|Death|1|||
162081763|NCT00355238|585356121|FG001|Overall Study|Death|0|||
162081764|NCT00355238|585356122|FG002|Overall Study|Death|0|||
162081765|NCT00355238|585356123|FG003|Overall Study|Death|0|||
162081766|NCT00355238|585356120|FG000|Overall Study|Disease progression|37|||
162081767|NCT00355238|585356121|FG001|Overall Study|Disease progression|36|||
162081768|NCT00355238|585356122|FG002|Overall Study|Disease progression|16|||
162081769|NCT00355238|585356123|FG003|Overall Study|Disease progression|11|||
162081770|NCT00355238|585356120|FG000|Overall Study|Study drug toxicity|11|||
162081771|NCT00355238|585356121|FG001|Overall Study|Study drug toxicity|7|||
162081772|NCT00355238|585356122|FG002|Overall Study|Study drug toxicity|5|||
162081773|NCT00355238|585356123|FG003|Overall Study|Study drug toxicity|2|||
162081774|NCT00355238|585356120|FG000|Overall Study|Participant withdrew consent|3|||
162081775|NCT00355238|585356121|FG001|Overall Study|Participant withdrew consent|1|||
162081776|NCT00355238|585356122|FG002|Overall Study|Participant withdrew consent|0|||
162081777|NCT00355238|585356123|FG003|Overall Study|Participant withdrew consent|0|||
162081778|NCT00355238|585356120|FG000|Overall Study|Participant request to discontinue study treatment|1|||
162081779|NCT00355238|585356121|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162081780|NCT00355238|585356122|FG002|Overall Study|Participant request to discontinue study treatment|1|||
162081781|NCT00355238|585356123|FG003|Overall Study|Participant request to discontinue study treatment|0|||
162081782|NCT01454934|585356124|FG000|Overall Study|Clinical progression|28|||
162081783|NCT01454934|585356125|FG001|Overall Study|Clinical progression|25|||
162081784|NCT01454934|585356124|FG000|Overall Study|Other|6|||
162081785|NCT01454934|585356125|FG001|Overall Study|Other|17|||
162081786|NCT01454934|585356124|FG000|Overall Study|Adverse Event|28|||
162081787|NCT01454934|585356125|FG001|Overall Study|Adverse Event|24|||
162081788|NCT01454934|585356124|FG000|Overall Study|Withdrawn consent|2|||
162081789|NCT01454934|585356125|FG001|Overall Study|Withdrawn consent|5|||
162081790|NCT01454934|585356124|FG000|Overall Study|Withdrawal by Subject|11|||
162081791|NCT01454934|585356125|FG001|Overall Study|Withdrawal by Subject|15|||
162081792|NCT01454934|585356124|FG000|Overall Study|Disease progression|194|||
162081793|NCT01454934|585356125|FG001|Overall Study|Disease progression|181|||
162081794|NCT01454934|585356124|FG000|Overall Study|Lost to Follow-up|0|||
162081795|NCT01454934|585356125|FG001|Overall Study|Lost to Follow-up|1|||
162081796|NCT01454934|585356124|FG000|Overall Study|Not treated|1|||
162081797|NCT01454934|585356125|FG001|Overall Study|Not treated|2|||
162081798|NCT00480636|585356126|FG000|Overall Study|Death|12|||
162081799|NCT00480636|585356126|FG000|Overall Study|Lost to Follow-up|4|||
162081800|NCT00480636|585356126|FG000|Overall Study|Other|2|||
162081801|NCT00480636|585356126|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
162081802|NCT03912233|585356127|FG000|Overall Study|Adverse Event|1|||
162081803|NCT03912233|585356128|FG001|Overall Study|Adverse Event|0|||
162081804|NCT03912233|585356129|FG002|Overall Study|Adverse Event|0|||
162081805|NCT03912233|585356130|FG003|Overall Study|Adverse Event|0|||
162081806|NCT03912233|585356131|FG004|Overall Study|Adverse Event|0|||
162081807|NCT03912233|585356132|FG005|Overall Study|Adverse Event|0|||
162081808|NCT03912233|585356127|FG000|Overall Study|Physician Decision|1|||
162081809|NCT03912233|585356128|FG001|Overall Study|Physician Decision|0|||
162081810|NCT03912233|585356129|FG002|Overall Study|Physician Decision|0|||
162081811|NCT03912233|585356130|FG003|Overall Study|Physician Decision|0|||
162081812|NCT03912233|585356131|FG004|Overall Study|Physician Decision|0|||
162081813|NCT03912233|585356132|FG005|Overall Study|Physician Decision|0|||
162081814|NCT03912233|585356127|FG000|Overall Study|Other|0|||
162081815|NCT03912233|585356128|FG001|Overall Study|Other|0|||
162081816|NCT03912233|585356129|FG002|Overall Study|Other|0|||
162081817|NCT03912233|585356130|FG003|Overall Study|Other|0|||
162081818|NCT03912233|585356131|FG004|Overall Study|Other|7|||
162081819|NCT03912233|585356132|FG005|Overall Study|Other|12|||
162081820|NCT02583256|585356135|FG000|Overall Study|Withdrawal by Subject|0|||
162081821|NCT02583256|585356136|FG001|Overall Study|Withdrawal by Subject|1|||
162081822|NCT02583256|585356137|FG002|Overall Study|Withdrawal by Subject|1|||
162081823|NCT02583256|585356138|FG003|Overall Study|Withdrawal by Subject|0|||
162081824|NCT02583256|585356135|FG000|Overall Study|Lost to Follow-up|1|||
162081825|NCT02583256|585356136|FG001|Overall Study|Lost to Follow-up|1|||
162081826|NCT02583256|585356137|FG002|Overall Study|Lost to Follow-up|0|||
162081827|NCT02583256|585356138|FG003|Overall Study|Lost to Follow-up|1|||
162081828|NCT02583256|585356135|FG000|Overall Study|Administrative/Other|2|||
162081829|NCT02583256|585356136|FG001|Overall Study|Administrative/Other|0|||
162081830|NCT02583256|585356137|FG002|Overall Study|Administrative/Other|1|||
162081831|NCT02583256|585356138|FG003|Overall Study|Administrative/Other|2|||
162081832|NCT02177266|585356144|FG000|Overall Study|Adverse Event|0|||
162081833|NCT02177266|585356145|FG001|Overall Study|Adverse Event|1|||
162081834|NCT02177266|585356144|FG000|Overall Study|Withdrawal by Subject|1|||
162081835|NCT02177266|585356145|FG001|Overall Study|Withdrawal by Subject|0|||
162081836|NCT01023659|585356146|FG000|Overall Study|Lost to Follow-up|73|||
162081837|NCT01023659|585356147|FG001|Overall Study|Lost to Follow-up|228|||
162081838|NCT01023659|585356148|FG002|Overall Study|Lost to Follow-up|99|||
162081839|NCT04537806|585356151|FG000|Overall Study|Randomized but not treated|1|||
162081840|NCT04537806|585356152|FG001|Overall Study|Randomized but not treated|0|||
162081841|NCT04537806|585356151|FG000|Overall Study|Adverse Event|1|||
162081842|NCT04537806|585356152|FG001|Overall Study|Adverse Event|1|||
162081843|NCT03019627|585356153|FG000|Overall Study|Adverse Event|8|||
162081844|NCT03019627|585356154|FG001|Overall Study|Adverse Event|0|||
162081845|NCT03019627|585356153|FG000|Overall Study|Unrelated to adverse event|1|||
162081846|NCT03019627|585356154|FG001|Overall Study|Unrelated to adverse event|3|||
162081847|NCT03019627|585356153|FG000|Overall Study|Lost to Follow-up|2|||
162081848|NCT03019627|585356154|FG001|Overall Study|Lost to Follow-up|1|||
162081849|NCT03019627|585356153|FG000|Overall Study|not compliance|2|||
162081850|NCT03019627|585356154|FG001|Overall Study|not compliance|2|||
162081851|NCT03019627|585356153|FG000|Overall Study|Other|2|||
162081852|NCT03019627|585356154|FG001|Overall Study|Other|2|||
162081853|NCT01802775|585356157|FG000|Overall Study|Death|0|||
162081854|NCT01802775|585356158|FG001|Overall Study|Death|3|||
162081855|NCT01802775|585356157|FG000|Overall Study|Reason not provided|0|||
162081856|NCT01802775|585356158|FG001|Overall Study|Reason not provided|1|||
162081857|NCT01802775|585356157|FG000|Overall Study|Physician Decision|1|||
162081858|NCT01802775|585356158|FG001|Overall Study|Physician Decision|0|||
162081859|NCT01802775|585356157|FG000|Overall Study|Adverse Event|1|||
162081860|NCT01802775|585356158|FG001|Overall Study|Adverse Event|1|||
162081861|NCT01802775|585356157|FG000|Overall Study|Withdrawal by Subject|3|||
162081862|NCT01802775|585356158|FG001|Overall Study|Withdrawal by Subject|5|||
162081863|NCT01802775|585356157|FG000|Overall Study|Lost to Follow-up|1|||
162081864|NCT01802775|585356158|FG001|Overall Study|Lost to Follow-up|2|||
162081865|NCT00519649|585356159|FG000|Overall Study|Withdrawal by Subject|1|||
162081866|NCT01465802|585356160|FG000|Overall Study|Study terminated by sponsor|1|||
162081867|NCT01465802|585356161|FG001|Overall Study|Study terminated by sponsor|0|||
162081868|NCT01465802|585356162|FG002|Overall Study|Study terminated by sponsor|0|||
162081869|NCT01465802|585356163|FG003|Overall Study|Study terminated by sponsor|1|||
162081870|NCT01465802|585356164|FG004|Overall Study|Study terminated by sponsor|7|||
162081871|NCT01465802|585356160|FG000|Overall Study|Withdrawal by Subject|7|||
162081872|NCT01465802|585356161|FG001|Overall Study|Withdrawal by Subject|7|||
162081873|NCT01465802|585356162|FG002|Overall Study|Withdrawal by Subject|0|||
162081874|NCT01465802|585356163|FG003|Overall Study|Withdrawal by Subject|8|||
162081875|NCT01465802|585356164|FG004|Overall Study|Withdrawal by Subject|1|||
162081876|NCT01465802|585356160|FG000|Overall Study|Lost to Follow-up|1|||
162081877|NCT01465802|585356161|FG001|Overall Study|Lost to Follow-up|1|||
162081878|NCT01465802|585356162|FG002|Overall Study|Lost to Follow-up|0|||
162081879|NCT01465802|585356163|FG003|Overall Study|Lost to Follow-up|0|||
162081880|NCT01465802|585356164|FG004|Overall Study|Lost to Follow-up|0|||
162081881|NCT01465802|585356160|FG000|Overall Study|Reason not specified|9|||
162081882|NCT01465802|585356161|FG001|Overall Study|Reason not specified|4|||
162081883|NCT01465802|585356162|FG002|Overall Study|Reason not specified|0|||
162081884|NCT01465802|585356163|FG003|Overall Study|Reason not specified|10|||
162081885|NCT01465802|585356164|FG004|Overall Study|Reason not specified|2|||
162081886|NCT01465802|585356160|FG000|Overall Study|Death|15|||
162081887|NCT01465802|585356161|FG001|Overall Study|Death|12|||
162081888|NCT01465802|585356162|FG002|Overall Study|Death|0|||
162081889|NCT01465802|585356163|FG003|Overall Study|Death|10|||
162081890|NCT01465802|585356164|FG004|Overall Study|Death|2|||
162081891|NCT02103478|585356165|FG000|Overall Study|Adverse Event|0|||
162081892|NCT02103478|585356166|FG001|Overall Study|Adverse Event|0|||
162081893|NCT02103478|585356167|FG002|Overall Study|Adverse Event|1|||
162081894|NCT02103478|585356168|FG003|Overall Study|Adverse Event|1|||
162081895|NCT02103478|585356169|FG004|Overall Study|Adverse Event|2|||
162081896|NCT02103478|585356170|FG005|Overall Study|Adverse Event|1|||
162081897|NCT02103478|585356171|FG006|Overall Study|Adverse Event|0|||
162081898|NCT02103478|585356172|FG007|Overall Study|Adverse Event|0|||
162081899|NCT02103478|585356173|FG008|Overall Study|Adverse Event|0|||
162081900|NCT02103478|585356165|FG000|Overall Study|Death|2|||
162081901|NCT02103478|585356166|FG001|Overall Study|Death|2|||
162081902|NCT02103478|585356167|FG002|Overall Study|Death|1|||
162081903|NCT02103478|585356168|FG003|Overall Study|Death|1|||
162081904|NCT02103478|585356169|FG004|Overall Study|Death|5|||
162081905|NCT02103478|585356170|FG005|Overall Study|Death|15|||
162081906|NCT02103478|585356171|FG006|Overall Study|Death|14|||
162081907|NCT02103478|585356172|FG007|Overall Study|Death|10|||
162081908|NCT02103478|585356173|FG008|Overall Study|Death|11|||
162081909|NCT02103478|585356165|FG000|Overall Study|Progressive Disease|2|||
162081910|NCT02103478|585356166|FG001|Overall Study|Progressive Disease|1|||
162081911|NCT02103478|585356167|FG002|Overall Study|Progressive Disease|2|||
162081912|NCT02103478|585356168|FG003|Overall Study|Progressive Disease|0|||
162081913|NCT02103478|585356169|FG004|Overall Study|Progressive Disease|9|||
162081914|NCT02103478|585356170|FG005|Overall Study|Progressive Disease|1|||
162081915|NCT02103478|585356171|FG006|Overall Study|Progressive Disease|2|||
162081916|NCT02103478|585356172|FG007|Overall Study|Progressive Disease|0|||
162081917|NCT02103478|585356173|FG008|Overall Study|Progressive Disease|1|||
162081918|NCT02103478|585356165|FG000|Overall Study|Withdrawal by Subject|2|||
162081919|NCT02103478|585356166|FG001|Overall Study|Withdrawal by Subject|0|||
162081920|NCT02103478|585356167|FG002|Overall Study|Withdrawal by Subject|0|||
162081921|NCT02103478|585356168|FG003|Overall Study|Withdrawal by Subject|4|||
162081922|NCT02103478|585356169|FG004|Overall Study|Withdrawal by Subject|0|||
162081923|NCT02103478|585356170|FG005|Overall Study|Withdrawal by Subject|0|||
162081924|NCT02103478|585356171|FG006|Overall Study|Withdrawal by Subject|1|||
162081925|NCT02103478|585356172|FG007|Overall Study|Withdrawal by Subject|1|||
162081926|NCT02103478|585356173|FG008|Overall Study|Withdrawal by Subject|0|||
162081927|NCT02103478|585356165|FG000|Overall Study|Lost to Follow-up|0|||
162081928|NCT02103478|585356166|FG001|Overall Study|Lost to Follow-up|0|||
162081929|NCT02103478|585356167|FG002|Overall Study|Lost to Follow-up|0|||
162081930|NCT02103478|585356168|FG003|Overall Study|Lost to Follow-up|0|||
162081931|NCT02103478|585356169|FG004|Overall Study|Lost to Follow-up|0|||
162081932|NCT02103478|585356170|FG005|Overall Study|Lost to Follow-up|0|||
162081933|NCT02103478|585356171|FG006|Overall Study|Lost to Follow-up|0|||
162081934|NCT02103478|585356172|FG007|Overall Study|Lost to Follow-up|1|||
162081935|NCT02103478|585356173|FG008|Overall Study|Lost to Follow-up|0|||
162081936|NCT02103478|585356165|FG000|Overall Study|Other|1|||
162081937|NCT02103478|585356166|FG001|Overall Study|Other|3|||
162081938|NCT02103478|585356167|FG002|Overall Study|Other|2|||
162081939|NCT02103478|585356168|FG003|Overall Study|Other|0|||
162081940|NCT02103478|585356169|FG004|Overall Study|Other|3|||
162081941|NCT02103478|585356170|FG005|Overall Study|Other|8|||
162081942|NCT02103478|585356171|FG006|Overall Study|Other|8|||
162081943|NCT02103478|585356172|FG007|Overall Study|Other|4|||
162081944|NCT02103478|585356173|FG008|Overall Study|Other|2|||
162081945|NCT03219333|585356174|FG000|Overall Study|Withdrawal by Subject|9|||
162081946|NCT03219333|585356175|FG001|Overall Study|Withdrawal by Subject|4|||
162081947|NCT03219333|585356174|FG000|Overall Study|Lost to Follow-up|1|||
162081948|NCT03219333|585356175|FG001|Overall Study|Lost to Follow-up|1|||
162081949|NCT03219333|585356174|FG000|Overall Study|Death|104|||
162081950|NCT03219333|585356175|FG001|Overall Study|Death|72|||
162081951|NCT03219333|585356174|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
162081952|NCT03219333|585356175|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
162081953|NCT03219333|585356174|FG000|Overall Study|Other|2|||
162081954|NCT03219333|585356175|FG001|Overall Study|Other|2|||
162081955|NCT00723606|585356176|FG000|Overall Study|Adverse Event|2|||
162081956|NCT00723606|585356177|FG001|Overall Study|Adverse Event|5|||
162081957|NCT00723606|585356176|FG000|Overall Study|Other|2|||
162081958|NCT00723606|585356177|FG001|Overall Study|Other|0|||
162081959|NCT00723606|585356176|FG000|Overall Study|Withdrawal by Subject|0|||
162081960|NCT00723606|585356177|FG001|Overall Study|Withdrawal by Subject|2|||
162081961|NCT02566759|585356178|FG000|All Parts|Withdrawal by Subject|0|||
162081962|NCT02566759|585356179|FG001|All Parts|Withdrawal by Subject|1|||
162081963|NCT02566759|585356180|FG002|All Parts|Withdrawal by Subject|0|||
162081964|NCT02566759|585356181|FG003|All Parts|Withdrawal by Subject|0|||
162081965|NCT02566759|585356182|FG004|All Parts|Withdrawal by Subject|0|||
162081966|NCT02566759|585356183|FG005|All Parts|Withdrawal by Subject|0|||
162081967|NCT02566759|585356184|FG006|All Parts|Withdrawal by Subject|0|||
162081968|NCT02566759|585356185|FG007|All Parts|Withdrawal by Subject|0|||
162081969|NCT02566759|585356186|FG008|All Parts|Withdrawal by Subject|0|||
162081970|NCT02566759|585356187|FG009|All Parts|Withdrawal by Subject|0|||
162081971|NCT02566759|585356188|FG010|All Parts|Withdrawal by Subject|0|||
162081972|NCT02566759|585356189|FG011|All Parts|Withdrawal by Subject|0|||
162081973|NCT02566759|585356190|FG012|All Parts|Withdrawal by Subject|0|||
162081974|NCT02566759|585356191|FG013|All Parts|Withdrawal by Subject|0|||
162081975|NCT02566759|585356192|FG014|All Parts|Withdrawal by Subject|0|||
162081976|NCT02566759|585356193|FG015|All Parts|Withdrawal by Subject|0|||
162081977|NCT02566759|585356194|FG016|All Parts|Withdrawal by Subject|0|||
162081978|NCT02566759|585356178|FG000|All Parts|Adverse Event|0|||
162081979|NCT02566759|585356179|FG001|All Parts|Adverse Event|0|||
162081980|NCT02566759|585356180|FG002|All Parts|Adverse Event|0|||
162081981|NCT02566759|585356181|FG003|All Parts|Adverse Event|0|||
162081982|NCT02566759|585356182|FG004|All Parts|Adverse Event|0|||
162081983|NCT02566759|585356183|FG005|All Parts|Adverse Event|0|||
162081984|NCT02566759|585356184|FG006|All Parts|Adverse Event|0|||
162081985|NCT02566759|585356185|FG007|All Parts|Adverse Event|0|||
162081986|NCT02566759|585356186|FG008|All Parts|Adverse Event|0|||
162081987|NCT02566759|585356187|FG009|All Parts|Adverse Event|0|||
162081988|NCT02566759|585356188|FG010|All Parts|Adverse Event|0|||
162081989|NCT02566759|585356189|FG011|All Parts|Adverse Event|0|||
162081990|NCT02566759|585356190|FG012|All Parts|Adverse Event|1|||
162081991|NCT02566759|585356191|FG013|All Parts|Adverse Event|3|||
162081992|NCT02566759|585356192|FG014|All Parts|Adverse Event|0|||
162081993|NCT02566759|585356193|FG015|All Parts|Adverse Event|0|||
162081994|NCT02566759|585356194|FG016|All Parts|Adverse Event|0|||
162081995|NCT02566759|585356178|FG000|All Parts|Other|0|||
162081996|NCT02566759|585356179|FG001|All Parts|Other|0|||
162081997|NCT02566759|585356180|FG002|All Parts|Other|0|||
162081998|NCT02566759|585356181|FG003|All Parts|Other|0|||
162081999|NCT02566759|585356182|FG004|All Parts|Other|0|||
162082000|NCT02566759|585356183|FG005|All Parts|Other|0|||
162082001|NCT02566759|585356184|FG006|All Parts|Other|0|||
162082002|NCT02566759|585356185|FG007|All Parts|Other|0|||
162082003|NCT02566759|585356186|FG008|All Parts|Other|0|||
162082004|NCT02566759|585356187|FG009|All Parts|Other|0|||
162082005|NCT02566759|585356188|FG010|All Parts|Other|0|||
162082006|NCT02566759|585356189|FG011|All Parts|Other|0|||
162082007|NCT02566759|585356190|FG012|All Parts|Other|0|||
162082008|NCT02566759|585356191|FG013|All Parts|Other|2|||
162082009|NCT02566759|585356192|FG014|All Parts|Other|0|||
162082010|NCT02566759|585356193|FG015|All Parts|Other|0|||
162082011|NCT02566759|585356194|FG016|All Parts|Other|0|||
162082012|NCT02566759|585356178|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082013|NCT02566759|585356179|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082014|NCT02566759|585356180|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082015|NCT02566759|585356181|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082016|NCT02566759|585356182|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082017|NCT02566759|585356183|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082018|NCT02566759|585356184|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082019|NCT02566759|585356185|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082020|NCT02566759|585356186|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082021|NCT02566759|585356187|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082022|NCT02566759|585356188|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082023|NCT02566759|585356189|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082024|NCT02566759|585356190|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082025|NCT02566759|585356191|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082026|NCT02566759|585356192|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082027|NCT02566759|585356193|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
162082028|NCT02566759|585356194|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
162082029|NCT01096784|585356195|FG000|Overall Study|Withdrawal by Subject|2|||
162082030|NCT01096784|585356196|FG001|Overall Study|Withdrawal by Subject|1|||
162082031|NCT01096784|585356195|FG000|Overall Study|Adverse Event|11|||
162082032|NCT01096784|585356196|FG001|Overall Study|Adverse Event|9|||
162082033|NCT01096784|585356195|FG000|Overall Study|Protocol Deviation|2|||
162082034|NCT01096784|585356196|FG001|Overall Study|Protocol Deviation|2|||
162082035|NCT01096784|585356195|FG000|Overall Study|Administrative Decision|0|||
162082036|NCT01096784|585356196|FG001|Overall Study|Administrative Decision|1|||
162082037|NCT01096784|585356195|FG000|Overall Study|Other Unspecified|0|||
162082038|NCT01096784|585356196|FG001|Overall Study|Other Unspecified|1|||
162082039|NCT00727714|585356197|FG000|Overall Study|Lost to Follow-up|2|||
162082040|NCT00325234|585356200|FG000|Overall Study|Adverse Event|10|||
162082041|NCT00325234|585356201|FG001|Overall Study|Adverse Event|7|||
162082042|NCT00325234|585356200|FG000|Overall Study|Death due to Study Disease|1|||
162082043|NCT00325234|585356201|FG001|Overall Study|Death due to Study Disease|0|||
162082044|NCT00325234|585356200|FG000|Overall Study|Entry Criteria Not Met|1|||
162082045|NCT00325234|585356201|FG001|Overall Study|Entry Criteria Not Met|2|||
162082046|NCT00325234|585356200|FG000|Overall Study|Subject Decision|6|||
162082047|NCT00325234|585356201|FG001|Overall Study|Subject Decision|8|||
162082048|NCT00325234|585356200|FG000|Overall Study|Physician Decision|17|||
162082049|NCT00325234|585356201|FG001|Overall Study|Physician Decision|12|||
162082050|NCT00325234|585356200|FG000|Overall Study|Progressive Disease|34|||
162082051|NCT00325234|585356201|FG001|Overall Study|Progressive Disease|37|||
162082052|NCT01234467|585356202|FG000|Overall Study|Adverse Event|3|||
162082053|NCT01234467|585356202|FG000|Overall Study|Death|2|||
162082054|NCT01234467|585356202|FG000|Overall Study|Withdrawal by Subject|2|||
162082055|NCT01234467|585356202|FG000|Overall Study|Disease Progression|2|||
162082056|NCT01234467|585356202|FG000|Overall Study|Clinical deterioration|1|||
162082057|NCT01234467|585356202|FG000|Overall Study|Physician Decision|1|||
162082058|NCT01234467|585356202|FG000|Overall Study|Other complicating disease (stroke)|1|||
162082059|NCT01120210|585356205|FG000|MAIN INFUSION|Adverse Event|1|||
162082060|NCT01120210|585356206|FG001|MAIN INFUSION|Adverse Event|0|||
162082061|NCT01120210|585356205|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
162082062|NCT01120210|585356206|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
162082063|NCT04049760|585356214|FG000|Overall Study|Withdrawal by Subject|1|||
162082064|NCT03995953|585356217|FG000|Overall Study|Death|3|||
162082065|NCT03995953|585356218|FG001|Overall Study|Death|0|||
162082066|NCT03995953|585356219|FG002|Overall Study|Death|3|||
162082067|NCT03995953|585356220|FG003|Overall Study|Death|0|||
162082068|NCT03995953|585356221|FG004|Overall Study|Death|3|||
162082069|NCT03995953|585356222|FG005|Overall Study|Death|0|||
162082070|NCT03995953|585356223|FG006|Overall Study|Death|0|||
162082071|NCT03995953|585356224|FG007|Overall Study|Death|0|||
162082072|NCT03995953|585356225|FG008|Overall Study|Death|1|||
162082073|NCT03995953|585356226|FG009|Overall Study|Death|0|||
162082074|NCT03995953|585356227|FG010|Overall Study|Death|0|||
162082075|NCT03995953|585356228|FG011|Overall Study|Death|0|||
162082076|NCT03995953|585356217|FG000|Overall Study|Lost to Follow-up|6|||
162082077|NCT03995953|585356218|FG001|Overall Study|Lost to Follow-up|54|||
162082078|NCT03995953|585356219|FG002|Overall Study|Lost to Follow-up|3|||
162082079|NCT03995953|585356220|FG003|Overall Study|Lost to Follow-up|32|||
162082080|NCT03995953|585356221|FG004|Overall Study|Lost to Follow-up|5|||
162082081|NCT03995953|585356222|FG005|Overall Study|Lost to Follow-up|44|||
162082082|NCT03995953|585356223|FG006|Overall Study|Lost to Follow-up|0|||
162082083|NCT03995953|585356224|FG007|Overall Study|Lost to Follow-up|31|||
162082084|NCT03995953|585356225|FG008|Overall Study|Lost to Follow-up|8|||
162082085|NCT03995953|585356226|FG009|Overall Study|Lost to Follow-up|36|||
162082086|NCT03995953|585356227|FG010|Overall Study|Lost to Follow-up|5|||
162082087|NCT03995953|585356228|FG011|Overall Study|Lost to Follow-up|41|||
162082088|NCT03995953|585356217|FG000|Overall Study|Withdrawal by Subject|4|||
162082089|NCT03995953|585356218|FG001|Overall Study|Withdrawal by Subject|0|||
162082090|NCT03995953|585356219|FG002|Overall Study|Withdrawal by Subject|1|||
162082091|NCT03995953|585356220|FG003|Overall Study|Withdrawal by Subject|0|||
162082092|NCT03995953|585356221|FG004|Overall Study|Withdrawal by Subject|1|||
162082093|NCT03995953|585356222|FG005|Overall Study|Withdrawal by Subject|0|||
162082094|NCT03995953|585356223|FG006|Overall Study|Withdrawal by Subject|1|||
162082095|NCT03995953|585356224|FG007|Overall Study|Withdrawal by Subject|0|||
162082096|NCT03995953|585356225|FG008|Overall Study|Withdrawal by Subject|3|||
162082097|NCT03995953|585356226|FG009|Overall Study|Withdrawal by Subject|0|||
162082098|NCT03995953|585356227|FG010|Overall Study|Withdrawal by Subject|3|||
162082099|NCT03995953|585356228|FG011|Overall Study|Withdrawal by Subject|0|||
162082100|NCT03995953|585356217|FG000|Overall Study|Health Issues|0|||
162082101|NCT03995953|585356218|FG001|Overall Study|Health Issues|0|||
162082102|NCT03995953|585356219|FG002|Overall Study|Health Issues|0|||
162082103|NCT03995953|585356220|FG003|Overall Study|Health Issues|0|||
162082104|NCT03995953|585356221|FG004|Overall Study|Health Issues|1|||
162082105|NCT03995953|585356222|FG005|Overall Study|Health Issues|0|||
162082106|NCT03995953|585356223|FG006|Overall Study|Health Issues|0|||
162082107|NCT03995953|585356224|FG007|Overall Study|Health Issues|0|||
162082108|NCT03995953|585356225|FG008|Overall Study|Health Issues|4|||
162082109|NCT03995953|585356226|FG009|Overall Study|Health Issues|0|||
162082110|NCT03995953|585356227|FG010|Overall Study|Health Issues|0|||
162082111|NCT03995953|585356228|FG011|Overall Study|Health Issues|0|||
162082112|NCT03995953|585356217|FG000|Overall Study|Relocated|11|||
162082113|NCT03995953|585356218|FG001|Overall Study|Relocated|0|||
162082114|NCT03995953|585356219|FG002|Overall Study|Relocated|16|||
162082115|NCT03995953|585356220|FG003|Overall Study|Relocated|0|||
162082116|NCT03995953|585356221|FG004|Overall Study|Relocated|14|||
162082117|NCT03995953|585356222|FG005|Overall Study|Relocated|0|||
162082118|NCT03995953|585356223|FG006|Overall Study|Relocated|16|||
162082119|NCT03995953|585356224|FG007|Overall Study|Relocated|0|||
162082120|NCT03995953|585356225|FG008|Overall Study|Relocated|14|||
162082121|NCT03995953|585356226|FG009|Overall Study|Relocated|0|||
162082122|NCT03995953|585356227|FG010|Overall Study|Relocated|15|||
162082123|NCT03995953|585356228|FG011|Overall Study|Relocated|0|||
162082124|NCT02388997|585356229|FG000|Overall Study|Adverse Event|1|||
162082125|NCT02388997|585356230|FG001|Overall Study|Adverse Event|2|||
162082126|NCT02388997|585356229|FG000|Overall Study|Withdrawal by Subject|2|||
162082127|NCT02388997|585356230|FG001|Overall Study|Withdrawal by Subject|1|||
162082128|NCT02388997|585356229|FG000|Overall Study|Lung function exclusion criteria|0|||
162082129|NCT02388997|585356230|FG001|Overall Study|Lung function exclusion criteria|2|||
162082130|NCT02388997|585356229|FG000|Overall Study|Tested positive for virus during run-in|0|||
162082131|NCT02388997|585356230|FG001|Overall Study|Tested positive for virus during run-in|1|||
162082132|NCT02130765|585356231|FG000|Overall Study|Did not receive treatment|4|||
162082133|NCT02130765|585356232|FG001|Overall Study|Did not receive treatment|0|||
162082134|NCT02130765|585356233|FG002|Overall Study|Did not receive treatment|0|||
162082135|NCT02130765|585356234|FG003|Overall Study|Did not receive treatment|0|||
162082136|NCT00006184|585356237|FG000|Overall Study|Death|1|||
162082137|NCT00006184|585356238|FG001|Overall Study|Death|0|||
162082138|NCT01838642|585356239|FG000|Overall Study|Died on study|1|||
162082139|NCT04019041|585356242|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
162082140|NCT04019041|585356243|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
162082141|NCT04019041|585356244|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
162082142|NCT04019041|585356245|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
162082143|NCT04019041|585356246|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
162082144|NCT04019041|585356247|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
162082145|NCT04019041|585356242|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
162082146|NCT04019041|585356243|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
162082147|NCT04019041|585356244|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
162082148|NCT04019041|585356245|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
162082149|NCT04019041|585356246|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
162082150|NCT04019041|585356247|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
162082151|NCT04019041|585356242|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
162082152|NCT04019041|585356243|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
162082153|NCT04019041|585356244|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
162082154|NCT04019041|585356245|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
162082155|NCT04019041|585356246|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
162082156|NCT04019041|585356247|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
162082157|NCT04019041|585356242|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
162082158|NCT04019041|585356243|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
162082159|NCT04019041|585356244|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
162082160|NCT04019041|585356245|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
162082161|NCT04019041|585356246|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
162082162|NCT04019041|585356247|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
162082163|NCT04019041|585356242|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
162082164|NCT04019041|585356243|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
162082165|NCT04019041|585356244|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
162082166|NCT04019041|585356245|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
162082167|NCT04019041|585356246|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
162082168|NCT04019041|585356247|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
162082169|NCT04019041|585356242|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
162082170|NCT04019041|585356243|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
162082171|NCT04019041|585356244|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
162082172|NCT04019041|585356245|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
162082173|NCT04019041|585356246|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
162082174|NCT04019041|585356247|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
162082175|NCT04019041|585356242|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
162082176|NCT04019041|585356243|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
162082177|NCT04019041|585356244|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
162082178|NCT04019041|585356245|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
162082179|NCT04019041|585356246|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
162082180|NCT04019041|585356247|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
162082181|NCT04019041|585356242|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
162082182|NCT04019041|585356243|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
162082183|NCT04019041|585356244|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
162082184|NCT04019041|585356245|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
162082185|NCT04019041|585356246|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
162082186|NCT04019041|585356247|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
162082187|NCT04019041|585356242|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162082188|NCT04019041|585356243|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162082189|NCT04019041|585356244|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162082190|NCT04019041|585356245|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162082191|NCT04019041|585356246|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
162082192|NCT04019041|585356247|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
162082193|NCT03925727|585356248|FG000|Overall Study|Adverse Event|4|||
162082194|NCT03925727|585356249|FG001|Overall Study|Adverse Event|0|||
162082195|NCT03925727|585356250|FG002|Overall Study|Adverse Event|3|||
162082196|NCT03925727|585356248|FG000|Overall Study|Protocol Violation|1|||
162082197|NCT03925727|585356249|FG001|Overall Study|Protocol Violation|2|||
162082198|NCT03925727|585356250|FG002|Overall Study|Protocol Violation|2|||
162082199|NCT03925727|585356248|FG000|Overall Study|Withdrawal by Subject|3|||
162082200|NCT03925727|585356249|FG001|Overall Study|Withdrawal by Subject|2|||
162082201|NCT03925727|585356250|FG002|Overall Study|Withdrawal by Subject|4|||
162082202|NCT03925727|585356248|FG000|Overall Study|Administrative Reasons|3|||
162082203|NCT03925727|585356249|FG001|Overall Study|Administrative Reasons|1|||
162082204|NCT03925727|585356250|FG002|Overall Study|Administrative Reasons|2|||
162082205|NCT03925727|585356248|FG000|Overall Study|Randomized in error or Disqualified|8|||
162082206|NCT03925727|585356249|FG001|Overall Study|Randomized in error or Disqualified|1|||
162082207|NCT03925727|585356250|FG002|Overall Study|Randomized in error or Disqualified|7|||
162082208|NCT00213148|585356251|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
162082209|NCT00213148|585356252|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
162082210|NCT00213148|585356253|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
162082211|NCT00213148|585356254|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
162082212|NCT00213148|585356255|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
162082213|NCT00213148|585356251|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
162082214|NCT00213148|585356252|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
162082215|NCT00213148|585356253|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
162082216|NCT00213148|585356254|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
162082217|NCT00213148|585356255|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
162082218|NCT00213148|585356251|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
162082219|NCT00213148|585356252|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
162082220|NCT00213148|585356253|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
162082221|NCT00213148|585356254|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
162082222|NCT00213148|585356255|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
162082223|NCT00213148|585356251|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
162082224|NCT00213148|585356252|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
162082225|NCT00213148|585356253|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
162082226|NCT00213148|585356254|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
162082227|NCT00213148|585356255|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
162082228|NCT00213148|585356251|FG000|Cycle 1 (1 Month)|Other|3|||
162082229|NCT00213148|585356252|FG001|Cycle 1 (1 Month)|Other|0|||
162082230|NCT00213148|585356253|FG002|Cycle 1 (1 Month)|Other|2|||
162082231|NCT00213148|585356254|FG003|Cycle 1 (1 Month)|Other|2|||
162082232|NCT00213148|585356255|FG004|Cycle 1 (1 Month)|Other|7|||
162082233|NCT00213148|585356251|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162082234|NCT00213148|585356252|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162082235|NCT00213148|585356253|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162082236|NCT00213148|585356254|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
162082237|NCT00213148|585356255|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162082238|NCT00213148|585356251|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
162082239|NCT00213148|585356252|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
162082240|NCT00213148|585356253|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
162082241|NCT00213148|585356254|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
162082242|NCT00213148|585356255|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
162082243|NCT00213148|585356251|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
162082244|NCT00213148|585356252|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
162082245|NCT00213148|585356253|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
162082246|NCT00213148|585356254|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
162082247|NCT00213148|585356255|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
162082248|NCT00213148|585356251|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
162082249|NCT00213148|585356252|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
162082250|NCT00213148|585356253|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
162082251|NCT00213148|585356254|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
162082252|NCT00213148|585356255|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
162082253|NCT00213148|585356251|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
162082254|NCT00213148|585356252|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
162082255|NCT00213148|585356253|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
162082256|NCT00213148|585356254|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
162082257|NCT00213148|585356255|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
162082258|NCT00213148|585356251|FG000|Cycle 2 (1 Month)|Other|2|||
162082259|NCT00213148|585356252|FG001|Cycle 2 (1 Month)|Other|1|||
162082260|NCT00213148|585356253|FG002|Cycle 2 (1 Month)|Other|2|||
162082261|NCT00213148|585356254|FG003|Cycle 2 (1 Month)|Other|8|||
162082262|NCT00213148|585356255|FG004|Cycle 2 (1 Month)|Other|7|||
162082263|NCT00213148|585356251|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162082264|NCT00213148|585356252|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
162082265|NCT00213148|585356253|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162082266|NCT00213148|585356254|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162082267|NCT00213148|585356255|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
162082268|NCT00213148|585356251|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
162082269|NCT00213148|585356252|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
162082270|NCT00213148|585356253|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
162082271|NCT00213148|585356254|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
162082272|NCT00213148|585356255|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
162082273|NCT00213148|585356251|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
162082274|NCT00213148|585356252|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
162082275|NCT00213148|585356253|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
162082276|NCT00213148|585356254|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
162082277|NCT00213148|585356255|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
162082278|NCT00213148|585356251|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
162082279|NCT00213148|585356252|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
162082280|NCT00213148|585356253|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
162082281|NCT00213148|585356254|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
162082282|NCT00213148|585356255|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
162082283|NCT00213148|585356251|FG000|Cycle 3 (1 Month)|Other|0|||
162082284|NCT00213148|585356252|FG001|Cycle 3 (1 Month)|Other|0|||
162082285|NCT00213148|585356253|FG002|Cycle 3 (1 Month)|Other|1|||
162082286|NCT00213148|585356254|FG003|Cycle 3 (1 Month)|Other|1|||
162082287|NCT00213148|585356255|FG004|Cycle 3 (1 Month)|Other|0|||
162082288|NCT02321462|585356258|FG000|Overall Study|Withdrawal by Subject|5|||
162082289|NCT02321462|585356259|FG001|Overall Study|Withdrawal by Subject|2|||
162082290|NCT02321462|585356258|FG000|Overall Study|Subject withdrawn before any treatment|1|||
162082291|NCT02321462|585356259|FG001|Overall Study|Subject withdrawn before any treatment|1|||
162082292|NCT03044197|585356270|FG000|Overall Study|Withdrawal by Subject|3|||
162082293|NCT03044197|585356271|FG001|Overall Study|Withdrawal by Subject|1|||
162082294|NCT01574352|585356275|FG000|Overall Study|Withdrawal by Subject|6|||
162082295|NCT01574352|585356276|FG001|Overall Study|Withdrawal by Subject|13|||
162082296|NCT01574352|585356275|FG000|Overall Study|Injury in non-camp related sport|1|||
162082297|NCT01574352|585356276|FG001|Overall Study|Injury in non-camp related sport|0|||
162082298|NCT00660348|585356277|FG000|Overall Study|Withdrawal by Subject|1|||
162082299|NCT00660348|585356278|FG001|Overall Study|Withdrawal by Subject|0|||
162082300|NCT02741115|585356279|FG000|Overall Study|Adverse Event|1|||
162082301|NCT02741115|585356280|FG001|Overall Study|Adverse Event|0|||
162082302|NCT02741115|585356279|FG000|Overall Study|Lost to Follow-up|7|||
162082303|NCT02741115|585356280|FG001|Overall Study|Lost to Follow-up|4|||
162082304|NCT02741115|585356279|FG000|Overall Study|Withdrawal by Subject|4|||
162082305|NCT02741115|585356280|FG001|Overall Study|Withdrawal by Subject|2|||
162082306|NCT03945981|585356281|FG000|Overall Study|Lost to Follow-up|12|||
162082307|NCT03945981|585356281|FG000|Overall Study|Physician Decision|4|||
162082308|NCT03945981|585356281|FG000|Overall Study|Withdrawal by Subject|6|||
162082309|NCT03945981|585356281|FG000|Overall Study|Protocol Violation|1|||
162082310|NCT00256698|585356284|FG000|Overall Study|Withdrawal by Subject|7|||
162082311|NCT00256698|585356285|FG001|Overall Study|Withdrawal by Subject|7|||
162082312|NCT00256698|585356284|FG000|Overall Study|Adverse Event|13|||
162082313|NCT00256698|585356285|FG001|Overall Study|Adverse Event|6|||
162082314|NCT00256698|585356284|FG000|Overall Study|Protocol Violation|6|||
162082315|NCT00256698|585356285|FG001|Overall Study|Protocol Violation|5|||
162082316|NCT00256698|585356284|FG000|Overall Study|Lost to Follow-up|1|||
162082317|NCT00256698|585356285|FG001|Overall Study|Lost to Follow-up|3|||
162082318|NCT00256698|585356284|FG000|Overall Study|disease progression|97|||
162082319|NCT00256698|585356285|FG001|Overall Study|disease progression|105|||
162082320|NCT00256698|585356284|FG000|Overall Study|still ongoing at data cut-off|41|||
162082321|NCT00256698|585356285|FG001|Overall Study|still ongoing at data cut-off|46|||
162082322|NCT00256698|585356284|FG000|Overall Study|withdrawn due to osteoporosis|1|||
162082323|NCT00256698|585356285|FG001|Overall Study|withdrawn due to osteoporosis|0|||
162082324|NCT00256698|585356284|FG000|Overall Study|Prematurely Discontinued|1|||
162082325|NCT00256698|585356285|FG001|Overall Study|Prematurely Discontinued|0|||
162082326|NCT03548584|585358247|FG000|Overall Study|Lost to Follow-up|0|||
162082327|NCT03548584|585358248|FG001|Overall Study|Lost to Follow-up|0|||
162082328|NCT03548584|585358249|FG002|Overall Study|Lost to Follow-up|1|||
162082329|NCT03548584|585358247|FG000|Overall Study|Adverse Event|1|||
162082330|NCT03548584|585358248|FG001|Overall Study|Adverse Event|11|||
162082331|NCT03548584|585358249|FG002|Overall Study|Adverse Event|5|||
162082332|NCT03548584|585358247|FG000|Overall Study|Site Terminated by Sponsor|1|||
162082333|NCT03548584|585358248|FG001|Overall Study|Site Terminated by Sponsor|3|||
162082334|NCT03548584|585358249|FG002|Overall Study|Site Terminated by Sponsor|2|||
162082335|NCT03548584|585358247|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
162082336|NCT03548584|585358248|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
162082337|NCT03548584|585358249|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
162082338|NCT03548584|585358247|FG000|Overall Study|Lack of Efficacy|0|||
162082339|NCT03548584|585358248|FG001|Overall Study|Lack of Efficacy|1|||
162082340|NCT03548584|585358249|FG002|Overall Study|Lack of Efficacy|0|||
162082341|NCT03548584|585358247|FG000|Overall Study|Non-compliance with Study Drug|0|||
162082342|NCT03548584|585358248|FG001|Overall Study|Non-compliance with Study Drug|1|||
162082343|NCT03548584|585358249|FG002|Overall Study|Non-compliance with Study Drug|0|||
162082344|NCT03548584|585358247|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
162082345|NCT03548584|585358248|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
162082346|NCT03548584|585358249|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
162082347|NCT04346615|585358250|FG000|Overall Study|Lost to Follow-up|0|||
162082348|NCT04346615|585358251|FG001|Overall Study|Lost to Follow-up|2|||
162082349|NCT04346615|585358250|FG000|Overall Study|Withdrawal by Subject|1|||
162082350|NCT04346615|585358251|FG001|Overall Study|Withdrawal by Subject|0|||
162082351|NCT04346615|585358250|FG000|Overall Study|Death|5|||
162082352|NCT04346615|585358251|FG001|Overall Study|Death|1|||
162082353|NCT04346615|585358250|FG000|Overall Study|Other|0|||
162082354|NCT04346615|585358251|FG001|Overall Study|Other|2|||
162082355|NCT04346615|585358250|FG000|Overall Study|Randomized not treated|1|||
162082356|NCT04346615|585358251|FG001|Overall Study|Randomized not treated|0|||
162082357|NCT02096835|585358257|FG000|Overall Study|Withdrawal by Subject|1|||
162082358|NCT02096835|585358258|FG001|Overall Study|Withdrawal by Subject|0|||
162082359|NCT02096835|585358259|FG002|Overall Study|Withdrawal by Subject|0|||
162082360|NCT02096835|585358257|FG000|Overall Study|converted to open procedures|1|||
162082361|NCT02096835|585358258|FG001|Overall Study|converted to open procedures|0|||
162082362|NCT02096835|585358259|FG002|Overall Study|converted to open procedures|0|||
162082363|NCT02096835|585358257|FG000|Overall Study|Lost to Follow-up|1|||
162082364|NCT02096835|585358258|FG001|Overall Study|Lost to Follow-up|0|||
162082365|NCT02096835|585358259|FG002|Overall Study|Lost to Follow-up|1|||
162082366|NCT01677195|585358260|FG000|Overall Study|Lost to Follow-up|14|||
162082367|NCT01677195|585358261|FG001|Overall Study|Lost to Follow-up|22|||
162082368|NCT01677195|585358262|FG002|Overall Study|Lost to Follow-up|22|||
162082369|NCT01677195|585358260|FG000|Overall Study|Withdrawal by Subject|1|||
162082370|NCT01677195|585358261|FG001|Overall Study|Withdrawal by Subject|0|||
162082371|NCT01677195|585358262|FG002|Overall Study|Withdrawal by Subject|1|||
162082372|NCT01677195|585358260|FG000|Overall Study|Adverse Event|6|||
162082373|NCT01677195|585358261|FG001|Overall Study|Adverse Event|4|||
162082374|NCT01677195|585358262|FG002|Overall Study|Adverse Event|1|||
162082375|NCT01677195|585358260|FG000|Overall Study|Physician Decision|1|||
162082376|NCT01677195|585358261|FG001|Overall Study|Physician Decision|2|||
162082377|NCT01677195|585358262|FG002|Overall Study|Physician Decision|2|||
162082378|NCT01677195|585358260|FG000|Overall Study|Pregnancy|0|||
162082379|NCT01677195|585358261|FG001|Overall Study|Pregnancy|1|||
162082380|NCT01677195|585358262|FG002|Overall Study|Pregnancy|0|||
162082381|NCT01677195|585358260|FG000|Overall Study|Protocol Violation|7|||
162082382|NCT01677195|585358261|FG001|Overall Study|Protocol Violation|3|||
162082383|NCT01677195|585358262|FG002|Overall Study|Protocol Violation|4|||
162082384|NCT04368429|585358263|FG000|Overall Study|Adverse Event|1|||
162082385|NCT04368429|585358264|FG001|Overall Study|Adverse Event|0|||
162082386|NCT03633396|585358267|FG000|Overall Study|Withdrawal by Subject|4|||
162082387|NCT03633396|585358268|FG001|Overall Study|Withdrawal by Subject|4|||
162082388|NCT03633396|585358267|FG000|Overall Study|Adverse Event|1|||
162082389|NCT03633396|585358268|FG001|Overall Study|Adverse Event|1|||
162082390|NCT03633396|585358267|FG000|Overall Study|Lack of Efficacy|1|||
162082391|NCT03633396|585358268|FG001|Overall Study|Lack of Efficacy|0|||
162082392|NCT03633396|585358267|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
162082393|NCT03633396|585358268|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
162082394|NCT00023673|585358269|FG000|Overall Study|Ineligible / no protocol treatment|0|||
162082395|NCT00023673|585358270|FG001|Overall Study|Ineligible / no protocol treatment|0|||
162082396|NCT00023673|585358271|FG002|Overall Study|Ineligible / no protocol treatment|0|||
162082397|NCT00023673|585358272|FG003|Overall Study|Ineligible / no protocol treatment|1|||
162082398|NCT00023673|585358269|FG000|Overall Study|Patient withdrew consent|0|||
162082399|NCT00023673|585358270|FG001|Overall Study|Patient withdrew consent|0|||
162082400|NCT00023673|585358271|FG002|Overall Study|Patient withdrew consent|0|||
162082401|NCT00023673|585358272|FG003|Overall Study|Patient withdrew consent|1|||
162082402|NCT00110266|585358273|FG000|Overall Study|Adverse Event|27|||
162082403|NCT00110266|585358273|FG000|Overall Study|Abnormal laboratory value|15|||
162082404|NCT00110266|585358273|FG000|Overall Study|Withdrawal by Subject|16|||
162082405|NCT00110266|585358273|FG000|Overall Study|Death|17|||
162082406|NCT00110266|585358273|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162082407|NCT00110266|585358273|FG000|Overall Study|Participant condition no longer requires study drug|1|||
162082408|NCT00667342|585358278|FG000|Overall Study|Protocol Violation|1|||
162082409|NCT00667342|585358279|FG001|Overall Study|Protocol Violation|0|||
162082410|NCT00667342|585358280|FG002|Overall Study|Protocol Violation|0|||
162082411|NCT00667342|585358278|FG000|Overall Study|Withdrawal by Subject|1|||
162082412|NCT00667342|585358279|FG001|Overall Study|Withdrawal by Subject|0|||
162082413|NCT00667342|585358280|FG002|Overall Study|Withdrawal by Subject|0|||
162082414|NCT00667342|585358278|FG000|Overall Study|Physician Decision|3|||
162082415|NCT00667342|585358279|FG001|Overall Study|Physician Decision|0|||
162082416|NCT00667342|585358280|FG002|Overall Study|Physician Decision|0|||
162082417|NCT00667342|585358278|FG000|Overall Study|Relapse or tumor progression|9|||
162082418|NCT00667342|585358279|FG001|Overall Study|Relapse or tumor progression|0|||
162082419|NCT00667342|585358280|FG002|Overall Study|Relapse or tumor progression|7|||
162082420|NCT00667342|585358278|FG000|Overall Study|Adverse Event|0|||
162082421|NCT00667342|585358279|FG001|Overall Study|Adverse Event|0|||
162082422|NCT00667342|585358280|FG002|Overall Study|Adverse Event|1|||
162082423|NCT00667342|585358278|FG000|Overall Study|Ineligible|0|||
162082424|NCT00667342|585358279|FG001|Overall Study|Ineligible|0|||
162082425|NCT00667342|585358280|FG002|Overall Study|Ineligible|1|||
162082426|NCT01433263|585358281|FG000|Overall Study|Adverse Event|3|||
162082427|NCT01433263|585358282|FG001|Overall Study|Adverse Event|1|||
162082428|NCT01433263|585358281|FG000|Overall Study|Death|5|||
162082429|NCT01433263|585358282|FG001|Overall Study|Death|3|||
162082430|NCT01433263|585358281|FG000|Overall Study|Lost to Follow-up|0|||
162082431|NCT01433263|585358282|FG001|Overall Study|Lost to Follow-up|1|||
162082432|NCT01433263|585358281|FG000|Overall Study|Protocol Deviation|1|||
162082433|NCT01433263|585358282|FG001|Overall Study|Protocol Deviation|0|||
162082434|NCT01433263|585358281|FG000|Overall Study|Withdrawal by Subject|10|||
162082435|NCT01433263|585358282|FG001|Overall Study|Withdrawal by Subject|7|||
162082436|NCT04709237|585358284|FG000|Overall Study|Lost to Follow-up|1|||
162082437|NCT04709237|585358285|FG001|Overall Study|Lost to Follow-up|0|||
162082438|NCT04709237|585358286|FG002|Overall Study|Lost to Follow-up|0|||
162082439|NCT02610192|585358287|FG000|Overall Study|Received other treatment|8|||
162082440|NCT02610192|585358287|FG000|Overall Study|Physician Decision|1|||
162082441|NCT00546715|585358293|FG000|Overall Study|Withdrawal by Subject|0|||
162082442|NCT00546715|585358294|FG001|Overall Study|Withdrawal by Subject|1|||
162082443|NCT00546715|585358295|FG002|Overall Study|Withdrawal by Subject|0|||
162082444|NCT00546715|585358296|FG003|Overall Study|Withdrawal by Subject|0|||
162082445|NCT03852316|585358297|FG000|Overall Study|Protocol Violation|1|||
162082446|NCT03852316|585358297|FG000|Overall Study|Withdrawal by Subject|2|||
162082447|NCT03852316|585358297|FG000|Overall Study|Enrolled but Device not Utilized|1|||
162082448|NCT01018264|585358298|FG000|Overall Study|Withdrawal by Subject|1|||
162082449|NCT01018264|585358299|FG001|Overall Study|Withdrawal by Subject|0|||
162082450|NCT01018264|585358298|FG000|Overall Study|Lost to Follow-up|0|||
162082451|NCT01018264|585358299|FG001|Overall Study|Lost to Follow-up|1|||
162082452|NCT02075840|585358300|FG000|Overall Study|Withdrawal by Subject|13|||
162082453|NCT02075840|585358301|FG001|Overall Study|Withdrawal by Subject|22|||
162082454|NCT02075840|585358300|FG000|Overall Study|Reason not specified|1|||
162082455|NCT02075840|585358301|FG001|Overall Study|Reason not specified|0|||
162082456|NCT02075840|585358300|FG000|Overall Study|Adverse Event|0|||
162082457|NCT02075840|585358301|FG001|Overall Study|Adverse Event|2|||
162082458|NCT02075840|585358300|FG000|Overall Study|Death|35|||
162082459|NCT02075840|585358301|FG001|Overall Study|Death|40|||
162082460|NCT02075840|585358300|FG000|Overall Study|Lost to Follow-up|3|||
162082461|NCT02075840|585358301|FG001|Overall Study|Lost to Follow-up|2|||
162082462|NCT02075840|585358300|FG000|Overall Study|Physician Decision|1|||
162082463|NCT02075840|585358301|FG001|Overall Study|Physician Decision|3|||
162082464|NCT02075840|585358300|FG000|Overall Study|Ongoing at CCOD|99|||
162082465|NCT02075840|585358301|FG001|Overall Study|Ongoing at CCOD|82|||
162082466|NCT03491150|585358302|FG000|Overall Study|Adverse Event|1|||
162082467|NCT03491150|585358303|FG001|Overall Study|Adverse Event|0|||
162082468|NCT03491150|585358302|FG000|Overall Study|Study Terminated by Sponsor|74|||
162082469|NCT03491150|585358303|FG001|Overall Study|Study Terminated by Sponsor|70|||
162082470|NCT03491150|585358302|FG000|Overall Study|Other|0|||
162082471|NCT03491150|585358303|FG001|Overall Study|Other|1|||
162082472|NCT03491150|585358302|FG000|Overall Study|Withdrawal by Subject|1|||
162082473|NCT03491150|585358303|FG001|Overall Study|Withdrawal by Subject|2|||
162082474|NCT02644967|585358306|FG000|Overall Study|Death|26|||
162082475|NCT02644967|585358306|FG000|Overall Study|Physician Decision|1|||
162082476|NCT02644967|585358306|FG000|Overall Study|Withdrawal by Subject|2|||
162082477|NCT02644967|585358306|FG000|Overall Study|Protocol Violation|1|||
162082478|NCT02644967|585358306|FG000|Overall Study|Progressive Disease|1|||
162082479|NCT02644967|585358306|FG000|Overall Study|Study Terminated by Sponsor|4|||
162082480|NCT02287896|585358307|FG000|Second Injection Visit|Withdrawal by Subject|0|||
162082481|NCT02287896|585358308|FG001|Second Injection Visit|Withdrawal by Subject|1|||
162082482|NCT05179421|585358309|FG000|First Infusion Day|Adverse Event|1|||
162082483|NCT05179421|585358310|FG001|First Infusion Day|Adverse Event|0|||
162082484|NCT03746522|585358312|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
162082485|NCT03746522|585358313|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
162082486|NCT03746522|585358314|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
162082487|NCT03746522|585358312|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
162082488|NCT03746522|585358313|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
162082489|NCT03746522|585358314|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
162082490|NCT03746522|585358312|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
162082491|NCT03746522|585358313|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
162082492|NCT03746522|585358314|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
162082493|NCT03746522|585358312|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
162082494|NCT03746522|585358313|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
162082495|NCT03746522|585358314|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
162082496|NCT03746522|585358312|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
162082497|NCT03746522|585358313|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
162082498|NCT03746522|585358314|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
162082499|NCT03323099|585358315|FG000|Overall Study|Withdrawal by Subject|6|||
162082500|NCT03323099|585358316|FG001|Overall Study|Withdrawal by Subject|12|||
162082501|NCT03323099|585358315|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
162082502|NCT03323099|585358316|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
162082503|NCT00767676|585358317|FG000|Overall Study|Investigator error|54|||
162082504|NCT05132127|585358323|FG000|Overall Study|Adverse Event|1|||
162082505|NCT05220397|585358324|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
162082506|NCT05220397|585358325|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
162082507|NCT05220397|585358326|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
162082508|NCT05220397|585358327|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
162082509|NCT05220397|585358328|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
162082510|NCT02659020|585358329|FG000|Overall Study|Adverse Event|0|||
162082511|NCT02659020|585358330|FG001|Overall Study|Adverse Event|0|||
162082512|NCT02659020|585358331|FG002|Overall Study|Adverse Event|0|||
162082513|NCT02659020|585358332|FG003|Overall Study|Adverse Event|2|||
162082514|NCT02659020|585358333|FG004|Overall Study|Adverse Event|0|||
162082515|NCT02659020|585358334|FG005|Overall Study|Adverse Event|0|||
162082516|NCT02659020|585358335|FG006|Overall Study|Adverse Event|2|||
162082517|NCT02659020|585358329|FG000|Overall Study|Lost to Follow-up|1|||
162082518|NCT02659020|585358330|FG001|Overall Study|Lost to Follow-up|2|||
162082519|NCT02659020|585358331|FG002|Overall Study|Lost to Follow-up|1|||
162082520|NCT02659020|585358332|FG003|Overall Study|Lost to Follow-up|6|||
162082521|NCT02659020|585358333|FG004|Overall Study|Lost to Follow-up|1|||
162082522|NCT02659020|585358334|FG005|Overall Study|Lost to Follow-up|5|||
162082523|NCT02659020|585358335|FG006|Overall Study|Lost to Follow-up|0|||
162082524|NCT02659020|585358329|FG000|Overall Study|Physician Decision|0|||
162082525|NCT02659020|585358330|FG001|Overall Study|Physician Decision|0|||
162082526|NCT02659020|585358331|FG002|Overall Study|Physician Decision|0|||
162082527|NCT02659020|585358332|FG003|Overall Study|Physician Decision|1|||
162082528|NCT02659020|585358333|FG004|Overall Study|Physician Decision|1|||
162082529|NCT02659020|585358334|FG005|Overall Study|Physician Decision|0|||
162082530|NCT02659020|585358335|FG006|Overall Study|Physician Decision|1|||
162082531|NCT02659020|585358329|FG000|Overall Study|Withdrawal by Subject|2|||
162082532|NCT02659020|585358330|FG001|Overall Study|Withdrawal by Subject|1|||
162082533|NCT02659020|585358331|FG002|Overall Study|Withdrawal by Subject|0|||
162082534|NCT02659020|585358332|FG003|Overall Study|Withdrawal by Subject|3|||
162082535|NCT02659020|585358333|FG004|Overall Study|Withdrawal by Subject|3|||
162082536|NCT02659020|585358334|FG005|Overall Study|Withdrawal by Subject|6|||
162082537|NCT02659020|585358335|FG006|Overall Study|Withdrawal by Subject|3|||
162082538|NCT02659020|585358329|FG000|Overall Study|Progressive Disease|0|||
162082539|NCT02659020|585358330|FG001|Overall Study|Progressive Disease|0|||
162082540|NCT02659020|585358331|FG002|Overall Study|Progressive Disease|0|||
162082541|NCT02659020|585358332|FG003|Overall Study|Progressive Disease|4|||
162082542|NCT02659020|585358333|FG004|Overall Study|Progressive Disease|1|||
162082543|NCT02659020|585358334|FG005|Overall Study|Progressive Disease|0|||
162082544|NCT02659020|585358335|FG006|Overall Study|Progressive Disease|2|||
162082545|NCT02052739|585358336|FG000|Overall Study|Withdrew due to Adverse Event|3|||
162082546|NCT02052739|585358337|FG001|Overall Study|Withdrew due to Adverse Event|0|||
162082547|NCT02052739|585358336|FG000|Overall Study|Participant Died|2|||
162082548|NCT02052739|585358337|FG001|Overall Study|Participant Died|1|||
162082549|NCT02043015|585358338|FG000|Overall Study|Lost to Follow-up|4|||
162082550|NCT02043015|585358338|FG000|Overall Study|Withdrawal by Subject|4|||
162082551|NCT02043015|585358338|FG000|Overall Study|Removed once target enrollment reached|15|||
162082552|NCT02043015|585358338|FG000|Overall Study|Participant moved away from study city|4|||
162082553|NCT02043015|585358338|FG000|Overall Study|Incarceration|1|||
162082554|NCT01077960|585358339|FG000|Overall Study|Adverse Event|6|||
162082555|NCT01077960|585358339|FG000|Overall Study|Protocol Violation|3|||
162082556|NCT01077960|585358339|FG000|Overall Study|Lost to Follow-up|5|||
162082557|NCT01077960|585358339|FG000|Overall Study|Subject decision|1|||
162082558|NCT01077960|585358339|FG000|Overall Study|Reason unspecified|1|||
162082559|NCT03837899|585358340|FG000|Overall Study|Death|6|||
162082560|NCT03837899|585358341|FG001|Overall Study|Death|8|||
162082561|NCT03837899|585358342|FG002|Overall Study|Death|3|||
162082562|NCT03837899|585358343|FG003|Overall Study|Death|7|||
162082563|NCT03837899|585358344|FG004|Overall Study|Death|8|||
162082564|NCT03837899|585358345|FG005|Overall Study|Death|7|||
162082565|NCT03837899|585358340|FG000|Overall Study|Moved to post-trial access program|0|||
162082566|NCT03837899|585358341|FG001|Overall Study|Moved to post-trial access program|1|||
162082567|NCT03837899|585358342|FG002|Overall Study|Moved to post-trial access program|0|||
162082568|NCT03837899|585358343|FG003|Overall Study|Moved to post-trial access program|0|||
162082569|NCT03837899|585358344|FG004|Overall Study|Moved to post-trial access program|0|||
162082570|NCT03837899|585358345|FG005|Overall Study|Moved to post-trial access program|0|||
162082571|NCT03837899|585358340|FG000|Overall Study|Other|0|||
162082572|NCT03837899|585358341|FG001|Overall Study|Other|0|||
162082573|NCT03837899|585358342|FG002|Overall Study|Other|0|||
162082574|NCT03837899|585358343|FG003|Overall Study|Other|0|||
162082575|NCT03837899|585358344|FG004|Overall Study|Other|0|||
162082576|NCT03837899|585358345|FG005|Overall Study|Other|2|||
162082577|NCT03837899|585358340|FG000|Overall Study|Lost to Follow-up|0|||
162082578|NCT03837899|585358341|FG001|Overall Study|Lost to Follow-up|1|||
162082579|NCT03837899|585358342|FG002|Overall Study|Lost to Follow-up|0|||
162082580|NCT03837899|585358343|FG003|Overall Study|Lost to Follow-up|0|||
162082581|NCT03837899|585358344|FG004|Overall Study|Lost to Follow-up|0|||
162082582|NCT03837899|585358345|FG005|Overall Study|Lost to Follow-up|0|||
162082583|NCT03837899|585358340|FG000|Overall Study|Withdrawal by Subject|0|||
162082584|NCT03837899|585358341|FG001|Overall Study|Withdrawal by Subject|0|||
162082585|NCT03837899|585358342|FG002|Overall Study|Withdrawal by Subject|0|||
162082586|NCT03837899|585358343|FG003|Overall Study|Withdrawal by Subject|1|||
162082587|NCT03837899|585358344|FG004|Overall Study|Withdrawal by Subject|0|||
162082588|NCT03837899|585358345|FG005|Overall Study|Withdrawal by Subject|0|||
162082589|NCT03837899|585358340|FG000|Overall Study|Study specific discontinuation criteria|0|||
162082590|NCT03837899|585358341|FG001|Overall Study|Study specific discontinuation criteria|1|||
162082591|NCT03837899|585358342|FG002|Overall Study|Study specific discontinuation criteria|0|||
162082592|NCT03837899|585358343|FG003|Overall Study|Study specific discontinuation criteria|0|||
162082593|NCT03837899|585358344|FG004|Overall Study|Study specific discontinuation criteria|3|||
162082594|NCT03837899|585358345|FG005|Overall Study|Study specific discontinuation criteria|1|||
162082595|NCT01403974|585358346|FG000|Overall Study|Progressive disease according to RECIST|3|||
162082596|NCT01403974|585358347|FG001|Overall Study|Progressive disease according to RECIST|3|||
162082597|NCT01403974|585358348|FG002|Overall Study|Progressive disease according to RECIST|2|||
162082598|NCT01403974|585358349|FG003|Overall Study|Progressive disease according to RECIST|3|||
162082599|NCT01403974|585358350|FG004|Overall Study|Progressive disease according to RECIST|3|||
162082600|NCT01403974|585358351|FG005|Overall Study|Progressive disease according to RECIST|2|||
162082601|NCT01403974|585358352|FG006|Overall Study|Progressive disease according to RECIST|3|||
162082602|NCT01403974|585358353|FG007|Overall Study|Progressive disease according to RECIST|2|||
162082603|NCT01403974|585358354|FG008|Overall Study|Progressive disease according to RECIST|6|||
162082604|NCT01403974|585358355|FG009|Overall Study|Progressive disease according to RECIST|2|||
162082605|NCT01403974|585358356|FG010|Overall Study|Progressive disease according to RECIST|3|||
162082606|NCT01403974|585358357|FG011|Overall Study|Progressive disease according to RECIST|2|||
162082607|NCT01403974|585358358|FG012|Overall Study|Progressive disease according to RECIST|2|||
162082608|NCT01403974|585358359|FG013|Overall Study|Progressive disease according to RECIST|3|||
162082609|NCT01403974|585358360|FG014|Overall Study|Progressive disease according to RECIST|1|||
162082610|NCT01403974|585358361|FG015|Overall Study|Progressive disease according to RECIST|8|||
162082611|NCT01403974|585358346|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
162082612|NCT01403974|585358347|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
162082613|NCT01403974|585358348|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
162082614|NCT01403974|585358349|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
162082615|NCT01403974|585358350|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
162082616|NCT01403974|585358351|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
162082617|NCT01403974|585358352|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
162082618|NCT01403974|585358353|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
162082619|NCT01403974|585358354|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
162082620|NCT01403974|585358355|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
162082621|NCT01403974|585358356|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
162082622|NCT01403974|585358357|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
162082623|NCT01403974|585358358|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
162082624|NCT01403974|585358359|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
162082625|NCT01403974|585358360|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
162082626|NCT01403974|585358361|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
162082627|NCT01403974|585358346|FG000|Overall Study|Refused to continue study medication|0|||
162082628|NCT01403974|585358347|FG001|Overall Study|Refused to continue study medication|0|||
162082629|NCT01403974|585358348|FG002|Overall Study|Refused to continue study medication|0|||
162082630|NCT01403974|585358349|FG003|Overall Study|Refused to continue study medication|0|||
162082631|NCT01403974|585358350|FG004|Overall Study|Refused to continue study medication|0|||
162082632|NCT01403974|585358351|FG005|Overall Study|Refused to continue study medication|1|||
162082633|NCT01403974|585358352|FG006|Overall Study|Refused to continue study medication|0|||
162082634|NCT01403974|585358353|FG007|Overall Study|Refused to continue study medication|0|||
162082635|NCT01403974|585358354|FG008|Overall Study|Refused to continue study medication|1|||
162082636|NCT01403974|585358355|FG009|Overall Study|Refused to continue study medication|0|||
162082637|NCT01403974|585358356|FG010|Overall Study|Refused to continue study medication|1|||
162082638|NCT01403974|585358357|FG011|Overall Study|Refused to continue study medication|0|||
162082639|NCT01403974|585358358|FG012|Overall Study|Refused to continue study medication|0|||
162082640|NCT01403974|585358359|FG013|Overall Study|Refused to continue study medication|0|||
162082641|NCT01403974|585358360|FG014|Overall Study|Refused to continue study medication|0|||
162082642|NCT01403974|585358361|FG015|Overall Study|Refused to continue study medication|4|||
162082643|NCT01403974|585358346|FG000|Overall Study|Adverse Event|0|||
162082644|NCT01403974|585358347|FG001|Overall Study|Adverse Event|0|||
162082645|NCT01403974|585358348|FG002|Overall Study|Adverse Event|1|||
162082646|NCT01403974|585358349|FG003|Overall Study|Adverse Event|0|||
162082647|NCT01403974|585358350|FG004|Overall Study|Adverse Event|0|||
162082648|NCT01403974|585358351|FG005|Overall Study|Adverse Event|0|||
162082649|NCT01403974|585358352|FG006|Overall Study|Adverse Event|0|||
162082650|NCT01403974|585358353|FG007|Overall Study|Adverse Event|1|||
162082651|NCT01403974|585358354|FG008|Overall Study|Adverse Event|0|||
162082652|NCT01403974|585358355|FG009|Overall Study|Adverse Event|0|||
162082653|NCT01403974|585358356|FG010|Overall Study|Adverse Event|0|||
162082654|NCT01403974|585358357|FG011|Overall Study|Adverse Event|0|||
162082655|NCT01403974|585358358|FG012|Overall Study|Adverse Event|1|||
162082656|NCT01403974|585358359|FG013|Overall Study|Adverse Event|0|||
162082657|NCT01403974|585358360|FG014|Overall Study|Adverse Event|0|||
162082658|NCT01403974|585358361|FG015|Overall Study|Adverse Event|0|||
162082659|NCT01403974|585358346|FG000|Overall Study|Other than specified|0|||
162082660|NCT01403974|585358347|FG001|Overall Study|Other than specified|0|||
162082661|NCT01403974|585358348|FG002|Overall Study|Other than specified|0|||
162082662|NCT01403974|585358349|FG003|Overall Study|Other than specified|0|||
162082663|NCT01403974|585358350|FG004|Overall Study|Other than specified|0|||
162082664|NCT01403974|585358351|FG005|Overall Study|Other than specified|0|||
162082665|NCT01403974|585358352|FG006|Overall Study|Other than specified|0|||
162082666|NCT01403974|585358353|FG007|Overall Study|Other than specified|0|||
162082667|NCT01403974|585358354|FG008|Overall Study|Other than specified|0|||
162082668|NCT01403974|585358355|FG009|Overall Study|Other than specified|1|||
162082669|NCT01403974|585358356|FG010|Overall Study|Other than specified|0|||
162082670|NCT01403974|585358357|FG011|Overall Study|Other than specified|1|||
162082671|NCT01403974|585358358|FG012|Overall Study|Other than specified|0|||
162082672|NCT01403974|585358359|FG013|Overall Study|Other than specified|0|||
162082673|NCT01403974|585358360|FG014|Overall Study|Other than specified|0|||
162082674|NCT01403974|585358361|FG015|Overall Study|Other than specified|0|||
162082675|NCT01526889|585358362|FG000|Treatment Period|Adverse Event|2|||
162082676|NCT01526889|585358363|FG001|Treatment Period|Adverse Event|0|||
162082677|NCT01526889|585358362|FG000|Treatment Extension Period|Administrative problems|1|||
162082678|NCT01526889|585358363|FG001|Treatment Extension Period|Administrative problems|0|||
162082679|NCT00393939|585358369|FG000|Overall Study|Protocol Violation|1|||
162082680|NCT00393939|585358370|FG001|Overall Study|Protocol Violation|1|||
162082681|NCT00393939|585358369|FG000|Overall Study|Lost to Follow-up|2|||
162082682|NCT00393939|585358370|FG001|Overall Study|Lost to Follow-up|4|||
162082683|NCT00393939|585358369|FG000|Overall Study|Death|10|||
162082684|NCT00393939|585358370|FG001|Overall Study|Death|4|||
162082685|NCT00393939|585358369|FG000|Overall Study|Sponsor|5|||
162082686|NCT00393939|585358370|FG001|Overall Study|Sponsor|13|||
162082687|NCT00393939|585358369|FG000|Overall Study|Objective progression or relapse|239|||
162082688|NCT00393939|585358370|FG001|Overall Study|Objective progression or relapse|223|||
162082689|NCT00393939|585358369|FG000|Overall Study|Withdrawal by Subject|2|||
162082690|NCT00393939|585358370|FG001|Overall Study|Withdrawal by Subject|7|||
162082691|NCT00393939|585358369|FG000|Overall Study|Other|37|||
162082692|NCT00393939|585358370|FG001|Overall Study|Other|45|||
162082693|NCT01494610|585358371|FG000|Period 1|Withdrawal by Subject|1|||
162082694|NCT01494610|585358372|FG001|Period 1|Withdrawal by Subject|1|||
162082695|NCT01494610|585358371|FG000|Period 3|Adverse Event|1|||
162082696|NCT01494610|585358372|FG001|Period 3|Adverse Event|0|||
162082697|NCT01494610|585358371|FG000|Period 3|Withdrawal by Subject|1|||
162082698|NCT01494610|585358372|FG001|Period 3|Withdrawal by Subject|0|||
162082699|NCT01494610|585358371|FG000|Period 4|Protocol Violation|1|||
162082700|NCT01494610|585358372|FG001|Period 4|Protocol Violation|0|||
162082701|NCT02385799|585358373|FG000|Overall Study|Lost to Follow-up|1|||
162082702|NCT02385799|585358374|FG001|Overall Study|Lost to Follow-up|2|||
162082703|NCT02385799|585358373|FG000|Overall Study|Adverse Event|4|||
162082704|NCT02385799|585358374|FG001|Overall Study|Adverse Event|2|||
162082705|NCT02385799|585358373|FG000|Overall Study|Withdrawal by Subject|0|||
162082706|NCT02385799|585358374|FG001|Overall Study|Withdrawal by Subject|4|||
162082707|NCT04958109|585358375|FG000|Overall Study|Withdrawal by Subject|0|||
162082708|NCT04958109|585358376|FG001|Overall Study|Withdrawal by Subject|1|||
162082709|NCT04958109|585358375|FG000|Overall Study|Lost to Follow-up|0|||
162082710|NCT04958109|585358376|FG001|Overall Study|Lost to Follow-up|1|||
162082711|NCT00715793|585358377|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
162082712|NCT00715793|585358378|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
162082713|NCT00715793|585358377|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
162082714|NCT00715793|585358378|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
162082715|NCT02346240|585358379|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082716|NCT02346240|585358380|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
162082717|NCT02346240|585358381|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
162082718|NCT02346240|585358382|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
162082719|NCT02346240|585358383|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082720|NCT02346240|585358384|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082721|NCT02346240|585358385|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082722|NCT02346240|585358386|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082723|NCT02346240|585358387|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082724|NCT02346240|585358388|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082725|NCT02346240|585358389|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082726|NCT02346240|585358390|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082727|NCT02346240|585358391|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082728|NCT02346240|585358392|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082729|NCT02346240|585358393|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082730|NCT02346240|585358394|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082731|NCT02346240|585358395|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082732|NCT02346240|585358396|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082733|NCT02346240|585358397|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082734|NCT02346240|585358398|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082735|NCT02346240|585358399|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082736|NCT02346240|585358400|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082737|NCT02346240|585358401|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082738|NCT02346240|585358402|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
162082739|NCT02346240|585358379|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082740|NCT02346240|585358380|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
162082741|NCT02346240|585358381|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082742|NCT02346240|585358382|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082743|NCT02346240|585358383|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082744|NCT02346240|585358384|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082745|NCT02346240|585358385|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082746|NCT02346240|585358386|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082747|NCT02346240|585358387|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082748|NCT02346240|585358388|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082749|NCT02346240|585358389|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082750|NCT02346240|585358390|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082751|NCT02346240|585358391|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082752|NCT02346240|585358392|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082753|NCT02346240|585358393|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082754|NCT02346240|585358394|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082755|NCT02346240|585358395|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082756|NCT02346240|585358396|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082757|NCT02346240|585358397|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082758|NCT02346240|585358398|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082759|NCT02346240|585358399|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082760|NCT02346240|585358400|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082761|NCT02346240|585358401|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082762|NCT02346240|585358402|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
162082763|NCT02346240|585358379|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082764|NCT02346240|585358380|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
162082765|NCT02346240|585358381|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082766|NCT02346240|585358382|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082767|NCT02346240|585358383|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082768|NCT02346240|585358384|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082769|NCT02346240|585358385|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082770|NCT02346240|585358386|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082771|NCT02346240|585358387|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082772|NCT02346240|585358388|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082773|NCT02346240|585358389|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082774|NCT02346240|585358390|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082775|NCT02346240|585358391|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082776|NCT02346240|585358392|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082777|NCT02346240|585358393|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082778|NCT02346240|585358394|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082779|NCT02346240|585358395|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082780|NCT02346240|585358396|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082781|NCT02346240|585358397|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082782|NCT02346240|585358398|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082783|NCT02346240|585358399|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082784|NCT02346240|585358400|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082785|NCT02346240|585358401|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082786|NCT02346240|585358402|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
162082787|NCT02346240|585358379|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
162082788|NCT02346240|585358380|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
162082789|NCT02346240|585358381|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
162082790|NCT02346240|585358382|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
162082791|NCT02346240|585358383|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082792|NCT02346240|585358384|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082793|NCT02346240|585358385|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082794|NCT02346240|585358386|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082795|NCT02346240|585358387|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082796|NCT02346240|585358388|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082797|NCT02346240|585358389|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082798|NCT02346240|585358390|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082799|NCT02346240|585358391|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082800|NCT02346240|585358392|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082801|NCT02346240|585358393|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082802|NCT02346240|585358394|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082803|NCT02346240|585358395|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082804|NCT02346240|585358396|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082805|NCT02346240|585358397|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082806|NCT02346240|585358398|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082807|NCT02346240|585358399|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082808|NCT02346240|585358400|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082809|NCT02346240|585358401|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082810|NCT02346240|585358402|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
162082811|NCT02346240|585358379|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
162082812|NCT02346240|585358380|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
162082813|NCT02346240|585358381|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
162082814|NCT02346240|585358382|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
162082815|NCT02346240|585358383|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082816|NCT02346240|585358384|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082817|NCT02346240|585358385|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082818|NCT02346240|585358386|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082819|NCT02346240|585358387|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082820|NCT02346240|585358388|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082821|NCT02346240|585358389|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082822|NCT02346240|585358390|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082823|NCT02346240|585358391|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082824|NCT02346240|585358392|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082825|NCT02346240|585358393|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082826|NCT02346240|585358394|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082827|NCT02346240|585358395|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082828|NCT02346240|585358396|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082829|NCT02346240|585358397|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082830|NCT02346240|585358398|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082831|NCT02346240|585358399|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082832|NCT02346240|585358400|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082833|NCT02346240|585358401|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082834|NCT02346240|585358402|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
162082835|NCT02346240|585358379|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082836|NCT02346240|585358380|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
162082837|NCT02346240|585358381|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082838|NCT02346240|585358382|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
162082839|NCT02346240|585358383|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082840|NCT02346240|585358384|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082841|NCT02346240|585358385|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082842|NCT02346240|585358386|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082843|NCT02346240|585358387|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082844|NCT02346240|585358388|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082845|NCT02346240|585358389|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082846|NCT02346240|585358390|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082847|NCT02346240|585358391|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082848|NCT02346240|585358392|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082849|NCT02346240|585358393|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082850|NCT02346240|585358394|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082851|NCT02346240|585358395|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082852|NCT02346240|585358396|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082853|NCT02346240|585358397|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082854|NCT02346240|585358398|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082855|NCT02346240|585358399|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082856|NCT02346240|585358400|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082857|NCT02346240|585358401|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082858|NCT02346240|585358402|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
162082859|NCT02346240|585358379|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082860|NCT02346240|585358380|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082861|NCT02346240|585358381|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
162082862|NCT02346240|585358382|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082863|NCT02346240|585358383|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082864|NCT02346240|585358384|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082865|NCT02346240|585358385|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082866|NCT02346240|585358386|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082867|NCT02346240|585358387|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082868|NCT02346240|585358388|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082869|NCT02346240|585358389|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082870|NCT02346240|585358390|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082871|NCT02346240|585358391|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082872|NCT02346240|585358392|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082873|NCT02346240|585358393|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082874|NCT02346240|585358394|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082875|NCT02346240|585358395|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082876|NCT02346240|585358396|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082877|NCT02346240|585358397|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082878|NCT02346240|585358398|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082879|NCT02346240|585358399|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082880|NCT02346240|585358400|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082881|NCT02346240|585358401|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082882|NCT02346240|585358402|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
162082883|NCT02346240|585358379|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082884|NCT02346240|585358380|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082885|NCT02346240|585358381|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082886|NCT02346240|585358382|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082887|NCT02346240|585358383|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082888|NCT02346240|585358384|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082889|NCT02346240|585358385|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082890|NCT02346240|585358386|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
162082891|NCT02346240|585358387|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
162082892|NCT02346240|585358388|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082893|NCT02346240|585358389|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082894|NCT02346240|585358390|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082895|NCT02346240|585358391|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082896|NCT02346240|585358392|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
162082897|NCT02346240|585358393|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
162082898|NCT02346240|585358394|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
162082899|NCT02346240|585358395|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
162082900|NCT02346240|585358396|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082901|NCT02346240|585358397|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082902|NCT02346240|585358398|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082903|NCT02346240|585358399|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082904|NCT02346240|585358400|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082905|NCT02346240|585358401|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082906|NCT02346240|585358402|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
162082907|NCT02346240|585358379|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082908|NCT02346240|585358380|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082909|NCT02346240|585358381|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082910|NCT02346240|585358382|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082911|NCT02346240|585358383|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082912|NCT02346240|585358384|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082913|NCT02346240|585358385|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082914|NCT02346240|585358386|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082915|NCT02346240|585358387|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082916|NCT02346240|585358388|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082917|NCT02346240|585358389|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082918|NCT02346240|585358390|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082919|NCT02346240|585358391|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082920|NCT02346240|585358392|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
162082921|NCT02346240|585358393|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082922|NCT02346240|585358394|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
162082923|NCT02346240|585358395|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082924|NCT02346240|585358396|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082925|NCT02346240|585358397|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082926|NCT02346240|585358398|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082927|NCT02346240|585358399|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082928|NCT02346240|585358400|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082929|NCT02346240|585358401|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082930|NCT02346240|585358402|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
162082931|NCT02346240|585358379|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082932|NCT02346240|585358380|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082933|NCT02346240|585358381|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082934|NCT02346240|585358382|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082935|NCT02346240|585358383|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082936|NCT02346240|585358384|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082937|NCT02346240|585358385|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082938|NCT02346240|585358386|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082939|NCT02346240|585358387|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082940|NCT02346240|585358388|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082941|NCT02346240|585358389|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082942|NCT02346240|585358390|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082943|NCT02346240|585358391|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082944|NCT02346240|585358392|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082945|NCT02346240|585358393|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
162082946|NCT02346240|585358394|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082947|NCT02346240|585358395|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082948|NCT02346240|585358396|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082949|NCT02346240|585358397|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082950|NCT02346240|585358398|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082951|NCT02346240|585358399|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082952|NCT02346240|585358400|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082953|NCT02346240|585358401|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082954|NCT02346240|585358402|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
162082955|NCT02346240|585358379|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082956|NCT02346240|585358380|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082957|NCT02346240|585358381|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082958|NCT02346240|585358382|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082959|NCT02346240|585358383|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082960|NCT02346240|585358384|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
162082961|NCT02346240|585358385|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
162082962|NCT02346240|585358386|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
162082963|NCT02346240|585358387|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
162082964|NCT02346240|585358388|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082965|NCT02346240|585358389|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
162082966|NCT02346240|585358390|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
162082967|NCT02346240|585358391|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082968|NCT02346240|585358392|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
162082969|NCT02346240|585358393|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
162082970|NCT02346240|585358394|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
162082971|NCT02346240|585358395|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
162082972|NCT02346240|585358396|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082973|NCT02346240|585358397|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082974|NCT02346240|585358398|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082975|NCT02346240|585358399|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082976|NCT02346240|585358400|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082977|NCT02346240|585358401|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082978|NCT02346240|585358402|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
162082979|NCT02346240|585358379|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082980|NCT02346240|585358380|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082981|NCT02346240|585358381|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082982|NCT02346240|585358382|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082983|NCT02346240|585358383|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082984|NCT02346240|585358384|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082985|NCT02346240|585358385|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082986|NCT02346240|585358386|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082987|NCT02346240|585358387|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082988|NCT02346240|585358388|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082989|NCT02346240|585358389|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082990|NCT02346240|585358390|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082991|NCT02346240|585358391|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082992|NCT02346240|585358392|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
162082993|NCT02346240|585358393|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
162082994|NCT02346240|585358394|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
162082995|NCT02346240|585358395|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
162082996|NCT02346240|585358396|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082997|NCT02346240|585358397|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082998|NCT02346240|585358398|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162082999|NCT02346240|585358399|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162083000|NCT02346240|585358400|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162083001|NCT02346240|585358401|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162083002|NCT02346240|585358402|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
162083003|NCT02346240|585358379|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083004|NCT02346240|585358380|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083005|NCT02346240|585358381|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083006|NCT02346240|585358382|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083007|NCT02346240|585358383|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083008|NCT02346240|585358384|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083009|NCT02346240|585358385|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
162083010|NCT02346240|585358386|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083011|NCT02346240|585358387|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083012|NCT02346240|585358388|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083013|NCT02346240|585358389|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083014|NCT02346240|585358390|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083015|NCT02346240|585358391|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083016|NCT02346240|585358392|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083017|NCT02346240|585358393|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083018|NCT02346240|585358394|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083019|NCT02346240|585358395|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083020|NCT02346240|585358396|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083021|NCT02346240|585358397|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083022|NCT02346240|585358398|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083023|NCT02346240|585358399|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083024|NCT02346240|585358400|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083025|NCT02346240|585358401|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083026|NCT02346240|585358402|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
162083027|NCT02346240|585358379|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083028|NCT02346240|585358380|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083029|NCT02346240|585358381|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083030|NCT02346240|585358382|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083031|NCT02346240|585358383|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083032|NCT02346240|585358384|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083033|NCT02346240|585358385|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083034|NCT02346240|585358386|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083035|NCT02346240|585358387|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
162083036|NCT02346240|585358388|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083037|NCT02346240|585358389|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083038|NCT02346240|585358390|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
162083039|NCT02346240|585358391|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083040|NCT02346240|585358392|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
162083041|NCT02346240|585358393|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
162083042|NCT02346240|585358394|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083043|NCT02346240|585358395|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083044|NCT02346240|585358396|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083045|NCT02346240|585358397|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083046|NCT02346240|585358398|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083047|NCT02346240|585358399|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083048|NCT02346240|585358400|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083049|NCT02346240|585358401|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083050|NCT02346240|585358402|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
162083051|NCT02346240|585358379|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083052|NCT02346240|585358380|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083053|NCT02346240|585358381|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083054|NCT02346240|585358382|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083055|NCT02346240|585358383|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083056|NCT02346240|585358384|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083057|NCT02346240|585358385|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083058|NCT02346240|585358386|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083059|NCT02346240|585358387|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083060|NCT02346240|585358388|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
162083061|NCT02346240|585358389|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083062|NCT02346240|585358390|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083063|NCT02346240|585358391|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083064|NCT02346240|585358392|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083065|NCT02346240|585358393|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083066|NCT02346240|585358394|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083067|NCT02346240|585358395|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083068|NCT02346240|585358396|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083069|NCT02346240|585358397|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083070|NCT02346240|585358398|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083071|NCT02346240|585358399|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083072|NCT02346240|585358400|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083073|NCT02346240|585358401|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083074|NCT02346240|585358402|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
162083075|NCT02346240|585358379|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083076|NCT02346240|585358380|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083077|NCT02346240|585358381|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083078|NCT02346240|585358382|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083079|NCT02346240|585358383|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083080|NCT02346240|585358384|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083081|NCT02346240|585358385|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083082|NCT02346240|585358386|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083083|NCT02346240|585358387|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083084|NCT02346240|585358388|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083085|NCT02346240|585358389|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
162083086|NCT02346240|585358390|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083087|NCT02346240|585358391|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083088|NCT02346240|585358392|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083089|NCT02346240|585358393|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083090|NCT02346240|585358394|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083091|NCT02346240|585358395|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083092|NCT02346240|585358396|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083093|NCT02346240|585358397|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083094|NCT02346240|585358398|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083095|NCT02346240|585358399|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083096|NCT02346240|585358400|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083097|NCT02346240|585358401|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083098|NCT02346240|585358402|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
162083099|NCT02346240|585358379|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083100|NCT02346240|585358380|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083101|NCT02346240|585358381|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083102|NCT02346240|585358382|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083103|NCT02346240|585358383|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083104|NCT02346240|585358384|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083105|NCT02346240|585358385|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083106|NCT02346240|585358386|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083107|NCT02346240|585358387|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083108|NCT02346240|585358388|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083109|NCT02346240|585358389|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083110|NCT02346240|585358390|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083111|NCT02346240|585358391|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083112|NCT02346240|585358392|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083113|NCT02346240|585358393|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
162083114|NCT02346240|585358394|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083115|NCT02346240|585358395|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083116|NCT02346240|585358396|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083117|NCT02346240|585358397|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083118|NCT02346240|585358398|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083119|NCT02346240|585358399|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083120|NCT02346240|585358400|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083121|NCT02346240|585358401|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083122|NCT02346240|585358402|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
162083123|NCT02346240|585358379|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083124|NCT02346240|585358380|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083125|NCT02346240|585358381|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083126|NCT02346240|585358382|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083127|NCT02346240|585358383|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083128|NCT02346240|585358384|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083129|NCT02346240|585358385|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083130|NCT02346240|585358386|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083131|NCT02346240|585358387|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083132|NCT02346240|585358388|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083133|NCT02346240|585358389|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083134|NCT02346240|585358390|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083135|NCT02346240|585358391|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083136|NCT02346240|585358392|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083137|NCT02346240|585358393|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
162083138|NCT02346240|585358394|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083139|NCT02346240|585358395|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083140|NCT02346240|585358396|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083141|NCT02346240|585358397|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083142|NCT02346240|585358398|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083143|NCT02346240|585358399|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083144|NCT02346240|585358400|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083145|NCT02346240|585358401|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083146|NCT02346240|585358402|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
162083147|NCT02346240|585358379|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083148|NCT02346240|585358380|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083149|NCT02346240|585358381|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083150|NCT02346240|585358382|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083151|NCT02346240|585358383|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083152|NCT02346240|585358384|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083153|NCT02346240|585358385|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083154|NCT02346240|585358386|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083155|NCT02346240|585358387|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083156|NCT02346240|585358388|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083157|NCT02346240|585358389|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083158|NCT02346240|585358390|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083159|NCT02346240|585358391|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083160|NCT02346240|585358392|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083161|NCT02346240|585358393|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
162083162|NCT02346240|585358394|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083163|NCT02346240|585358395|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083164|NCT02346240|585358396|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083165|NCT02346240|585358397|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083166|NCT02346240|585358398|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083167|NCT02346240|585358399|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083168|NCT02346240|585358400|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083169|NCT02346240|585358401|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083170|NCT02346240|585358402|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
162083171|NCT02346240|585358379|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083172|NCT02346240|585358380|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083173|NCT02346240|585358381|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083174|NCT02346240|585358382|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083175|NCT02346240|585358383|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083176|NCT02346240|585358384|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083177|NCT02346240|585358385|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083178|NCT02346240|585358386|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083179|NCT02346240|585358387|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083180|NCT02346240|585358388|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083181|NCT02346240|585358389|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083182|NCT02346240|585358390|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083183|NCT02346240|585358391|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083184|NCT02346240|585358392|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083185|NCT02346240|585358393|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083186|NCT02346240|585358394|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083187|NCT02346240|585358395|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
162083188|NCT02346240|585358396|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
162083189|NCT02346240|585358397|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
162083190|NCT02346240|585358398|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
162083191|NCT02346240|585358399|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
162083192|NCT02346240|585358400|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
162083193|NCT02346240|585358401|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
162083194|NCT02346240|585358402|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
162083195|NCT02346240|585358379|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083196|NCT02346240|585358380|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083197|NCT02346240|585358381|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083198|NCT02346240|585358382|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083199|NCT02346240|585358383|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083200|NCT02346240|585358384|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083201|NCT02346240|585358385|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083202|NCT02346240|585358386|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083203|NCT02346240|585358387|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083204|NCT02346240|585358388|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083205|NCT02346240|585358389|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083206|NCT02346240|585358390|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083207|NCT02346240|585358391|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083208|NCT02346240|585358392|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083209|NCT02346240|585358393|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083210|NCT02346240|585358394|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083211|NCT02346240|585358395|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083212|NCT02346240|585358396|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083213|NCT02346240|585358397|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
162083214|NCT02346240|585358398|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
162083215|NCT02346240|585358399|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083216|NCT02346240|585358400|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
162083217|NCT02346240|585358401|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083218|NCT02346240|585358402|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
162083219|NCT02346240|585358379|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083220|NCT02346240|585358380|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083221|NCT02346240|585358381|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083222|NCT02346240|585358382|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083223|NCT02346240|585358383|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083224|NCT02346240|585358384|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083225|NCT02346240|585358385|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083226|NCT02346240|585358386|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083227|NCT02346240|585358387|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083228|NCT02346240|585358388|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083229|NCT02346240|585358389|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083230|NCT02346240|585358390|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083231|NCT02346240|585358391|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083232|NCT02346240|585358392|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083233|NCT02346240|585358393|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083234|NCT02346240|585358394|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083235|NCT02346240|585358395|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083236|NCT02346240|585358396|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083237|NCT02346240|585358397|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
162083238|NCT02346240|585358398|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083239|NCT02346240|585358399|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083240|NCT02346240|585358400|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
162083241|NCT02346240|585358401|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083242|NCT02346240|585358402|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
162083243|NCT02346240|585358379|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083244|NCT02346240|585358380|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083245|NCT02346240|585358381|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083246|NCT02346240|585358382|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083247|NCT02346240|585358383|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083248|NCT02346240|585358384|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083249|NCT02346240|585358385|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083250|NCT02346240|585358386|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083251|NCT02346240|585358387|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083252|NCT02346240|585358388|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083253|NCT02346240|585358389|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083254|NCT02346240|585358390|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083255|NCT02346240|585358391|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083256|NCT02346240|585358392|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083257|NCT02346240|585358393|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083258|NCT02346240|585358394|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083259|NCT02346240|585358395|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083260|NCT02346240|585358396|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083261|NCT02346240|585358397|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083262|NCT02346240|585358398|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083263|NCT02346240|585358399|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083264|NCT02346240|585358400|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
162083265|NCT02346240|585358401|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083266|NCT02346240|585358402|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
162083267|NCT02346240|585358379|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083268|NCT02346240|585358380|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083269|NCT02346240|585358381|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083270|NCT02346240|585358382|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083271|NCT02346240|585358383|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083272|NCT02346240|585358384|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083273|NCT02346240|585358385|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083274|NCT02346240|585358386|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083275|NCT02346240|585358387|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083276|NCT02346240|585358388|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083277|NCT02346240|585358389|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083278|NCT02346240|585358390|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083279|NCT02346240|585358391|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083280|NCT02346240|585358392|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083281|NCT02346240|585358393|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083282|NCT02346240|585358394|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083283|NCT02346240|585358395|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083284|NCT02346240|585358396|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
162083285|NCT02346240|585358397|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
162083286|NCT02346240|585358398|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
162083287|NCT02346240|585358399|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
162083288|NCT02346240|585358400|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
162083289|NCT02346240|585358401|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
162083290|NCT02346240|585358402|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
162083291|NCT02346240|585358379|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083292|NCT02346240|585358380|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083293|NCT02346240|585358381|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083294|NCT02346240|585358382|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083295|NCT02346240|585358383|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083296|NCT02346240|585358384|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083297|NCT02346240|585358385|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083298|NCT02346240|585358386|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083299|NCT02346240|585358387|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083300|NCT02346240|585358388|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083301|NCT02346240|585358389|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083302|NCT02346240|585358390|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083303|NCT02346240|585358391|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083304|NCT02346240|585358392|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083305|NCT02346240|585358393|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083306|NCT02346240|585358394|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083307|NCT02346240|585358395|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083308|NCT02346240|585358396|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083309|NCT02346240|585358397|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
162083310|NCT02346240|585358398|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
162083311|NCT02346240|585358399|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
162083312|NCT02346240|585358400|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
162083313|NCT02346240|585358401|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
162083314|NCT02346240|585358402|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
162083315|NCT02346240|585358379|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083316|NCT02346240|585358380|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083317|NCT02346240|585358381|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083318|NCT02346240|585358382|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083319|NCT02346240|585358383|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083320|NCT02346240|585358384|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083321|NCT02346240|585358385|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083322|NCT02346240|585358386|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083323|NCT02346240|585358387|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083324|NCT02346240|585358388|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083325|NCT02346240|585358389|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083326|NCT02346240|585358390|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083327|NCT02346240|585358391|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083328|NCT02346240|585358392|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083329|NCT02346240|585358393|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083330|NCT02346240|585358394|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083331|NCT02346240|585358395|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083332|NCT02346240|585358396|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083333|NCT02346240|585358397|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
162083334|NCT02346240|585358398|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083335|NCT02346240|585358399|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
162083336|NCT02346240|585358400|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
162083337|NCT02346240|585358401|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
162083338|NCT02346240|585358402|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
162083339|NCT02346240|585358379|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083340|NCT02346240|585358380|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083341|NCT02346240|585358381|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083342|NCT02346240|585358382|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083343|NCT02346240|585358383|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083344|NCT02346240|585358384|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083345|NCT02346240|585358385|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083346|NCT02346240|585358386|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083347|NCT02346240|585358387|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083348|NCT02346240|585358388|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083349|NCT02346240|585358389|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083350|NCT02346240|585358390|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083351|NCT02346240|585358391|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083352|NCT02346240|585358392|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083353|NCT02346240|585358393|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083354|NCT02346240|585358394|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083355|NCT02346240|585358395|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083356|NCT02346240|585358396|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083357|NCT02346240|585358397|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
162083358|NCT02346240|585358398|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083359|NCT02346240|585358399|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083360|NCT02346240|585358400|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083361|NCT02346240|585358401|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083362|NCT02346240|585358402|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
162083363|NCT02681302|585358403|FG000|Overall Study|Withdrawal by Subject|1|||
162083364|NCT02681302|585358404|FG001|Overall Study|Withdrawal by Subject|1|||
162083365|NCT02681302|585358405|FG002|Overall Study|Withdrawal by Subject|0|||
162083366|NCT02681302|585358406|FG003|Overall Study|Withdrawal by Subject|0|||
162083367|NCT02681302|585358407|FG004|Overall Study|Withdrawal by Subject|1|||
162083368|NCT02681302|585358408|FG005|Overall Study|Withdrawal by Subject|0|||
162083369|NCT02681302|585358403|FG000|Overall Study|Screen Failure|2|||
162083370|NCT02681302|585358404|FG001|Overall Study|Screen Failure|4|||
162083371|NCT02681302|585358405|FG002|Overall Study|Screen Failure|2|||
162083372|NCT02681302|585358406|FG003|Overall Study|Screen Failure|0|||
162083373|NCT02681302|585358407|FG004|Overall Study|Screen Failure|1|||
162083374|NCT02681302|585358408|FG005|Overall Study|Screen Failure|1|||
162083375|NCT02681302|585358403|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
162083376|NCT02681302|585358404|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
162083377|NCT02681302|585358405|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
162083378|NCT02681302|585358406|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
162083379|NCT02681302|585358407|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
162083380|NCT02681302|585358408|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
162083381|NCT02942017|585358409|FG000|Overall Study|Adverse Event|0|||
162083382|NCT02942017|585358410|FG001|Overall Study|Adverse Event|1|||
162083383|NCT02942017|585358409|FG000|Overall Study|Withdrawal by Subject|0|||
162083384|NCT02942017|585358410|FG001|Overall Study|Withdrawal by Subject|1|||
162083385|NCT02942017|585358409|FG000|Overall Study|Lost to Follow-up|1|||
162083386|NCT02942017|585358410|FG001|Overall Study|Lost to Follow-up|1|||
162083387|NCT02942017|585358409|FG000|Overall Study|Randomized but not dosed|1|||
162083388|NCT02942017|585358410|FG001|Overall Study|Randomized but not dosed|3|||
162083389|NCT00477672|585358411|FG000|Overall Study|Adverse Event|3|||
162083390|NCT00477672|585358412|FG001|Overall Study|Adverse Event|5|||
162083391|NCT00477672|585358413|FG002|Overall Study|Adverse Event|6|||
162083392|NCT00477672|585358411|FG000|Overall Study|Death|0|||
162083393|NCT00477672|585358412|FG001|Overall Study|Death|1|||
162083394|NCT00477672|585358413|FG002|Overall Study|Death|0|||
162083395|NCT00477672|585358411|FG000|Overall Study|Disease progression|0|||
162083396|NCT00477672|585358412|FG001|Overall Study|Disease progression|1|||
162083397|NCT00477672|585358413|FG002|Overall Study|Disease progression|0|||
162083398|NCT00477672|585358411|FG000|Overall Study|Physician Decision|1|||
162083399|NCT00477672|585358412|FG001|Overall Study|Physician Decision|0|||
162083400|NCT00477672|585358413|FG002|Overall Study|Physician Decision|0|||
162083401|NCT00477672|585358411|FG000|Overall Study|Protocol noncompliance|0|||
162083402|NCT00477672|585358412|FG001|Overall Study|Protocol noncompliance|2|||
162083403|NCT00477672|585358413|FG002|Overall Study|Protocol noncompliance|0|||
162083404|NCT00477672|585358411|FG000|Overall Study|Consent withdrawn|2|||
162083405|NCT00477672|585358412|FG001|Overall Study|Consent withdrawn|5|||
162083406|NCT00477672|585358413|FG002|Overall Study|Consent withdrawn|10|||
162083407|NCT00477672|585358411|FG000|Overall Study|Discretion of Sponsor|1|||
162083408|NCT00477672|585358412|FG001|Overall Study|Discretion of Sponsor|2|||
162083409|NCT00477672|585358413|FG002|Overall Study|Discretion of Sponsor|0|||
162083410|NCT00838565|585358414|FG000|Overall Study|Withdrawal by Subject|0|||
162083411|NCT00838565|585358415|FG001|Overall Study|Withdrawal by Subject|0|||
162083412|NCT00838565|585358416|FG002|Overall Study|Withdrawal by Subject|1|||
162083413|NCT00838565|585358417|FG003|Overall Study|Withdrawal by Subject|0|||
162083414|NCT00838565|585358418|FG004|Overall Study|Withdrawal by Subject|0|||
162083415|NCT00838565|585358419|FG005|Overall Study|Withdrawal by Subject|2|||
162083416|NCT00838565|585358414|FG000|Overall Study|Other|0|||
162083417|NCT00838565|585358415|FG001|Overall Study|Other|2|||
162083418|NCT00838565|585358416|FG002|Overall Study|Other|0|||
162083419|NCT00838565|585358417|FG003|Overall Study|Other|0|||
162083420|NCT00838565|585358418|FG004|Overall Study|Other|0|||
162083421|NCT00838565|585358419|FG005|Overall Study|Other|0|||
162083422|NCT00838565|585358414|FG000|Overall Study|Randomized but not Treated|0|||
162083423|NCT00838565|585358415|FG001|Overall Study|Randomized but not Treated|1|||
162083424|NCT00838565|585358416|FG002|Overall Study|Randomized but not Treated|0|||
162083425|NCT00838565|585358417|FG003|Overall Study|Randomized but not Treated|0|||
162083426|NCT00838565|585358418|FG004|Overall Study|Randomized but not Treated|0|||
162083427|NCT00838565|585358419|FG005|Overall Study|Randomized but not Treated|0|||
162083428|NCT00458484|585358420|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
162083429|NCT00458484|585358421|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
162083430|NCT00458484|585358422|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
162083431|NCT00458484|585358423|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
162083432|NCT00458484|585358424|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
162083433|NCT00458484|585358425|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
162083434|NCT00458484|585358426|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
162083435|NCT04907032|585358427|FG000|Overall Study|Withdrawal by Subject|7|||
162083436|NCT04907032|585358428|FG001|Overall Study|Withdrawal by Subject|1|||
162083437|NCT02253810|585358429|FG000|Overall Study|Withdrawal by Subject|2|||
162083438|NCT02253810|585358430|FG001|Overall Study|Withdrawal by Subject|1|||
162083439|NCT02253810|585358429|FG000|Overall Study|Unknown concomitant procedure|3|||
162083440|NCT02253810|585358430|FG001|Overall Study|Unknown concomitant procedure|2|||
162083441|NCT00291668|585358432|FG000|Overall Study|Lack of Efficacy|1|||
162083442|NCT00291668|585358433|FG001|Overall Study|Lack of Efficacy|0|||
162083443|NCT00291668|585358434|FG002|Overall Study|Lack of Efficacy|0|||
162083444|NCT00291668|585358432|FG000|Overall Study|SAE, non-fatal|1|||
162083445|NCT00291668|585358433|FG001|Overall Study|SAE, non-fatal|1|||
162083446|NCT00291668|585358434|FG002|Overall Study|SAE, non-fatal|1|||
162083447|NCT00291668|585358432|FG000|Overall Study|AE, non-serious non-fatal|1|||
162083448|NCT00291668|585358433|FG001|Overall Study|AE, non-serious non-fatal|0|||
162083449|NCT00291668|585358434|FG002|Overall Study|AE, non-serious non-fatal|0|||
162083450|NCT00291668|585358432|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
162083451|NCT00291668|585358433|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
162083452|NCT00291668|585358434|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
162083453|NCT01557400|585358435|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
162083454|NCT01557400|585358435|FG000|Overall Study|Adverse Event|3|||
162083455|NCT01557400|585358435|FG000|Overall Study|Lost to Follow-up|5|||
162083456|NCT01557400|585358435|FG000|Overall Study|Withdrawal by Subject|9|||
162083457|NCT00245765|585358442|FG000|Overall Study|Adverse Event|1|||
162083458|NCT00245765|585358443|FG001|Overall Study|Adverse Event|1|||
162083459|NCT00245765|585358444|FG002|Overall Study|Adverse Event|0|||
162083460|NCT00245765|585358442|FG000|Overall Study|Lack of Efficacy|14|||
162083461|NCT00245765|585358443|FG001|Overall Study|Lack of Efficacy|7|||
162083462|NCT00245765|585358444|FG002|Overall Study|Lack of Efficacy|0|||
162083463|NCT00245765|585358442|FG000|Overall Study|Lost to Follow-up|1|||
162083464|NCT00245765|585358443|FG001|Overall Study|Lost to Follow-up|2|||
162083465|NCT00245765|585358444|FG002|Overall Study|Lost to Follow-up|0|||
162083466|NCT00245765|585358442|FG000|Overall Study|Withdrawal by Subject|1|||
162083467|NCT00245765|585358443|FG001|Overall Study|Withdrawal by Subject|0|||
162083468|NCT00245765|585358444|FG002|Overall Study|Withdrawal by Subject|3|||
162083469|NCT00245765|585358442|FG000|Overall Study|Other reason|2|||
162083470|NCT00245765|585358443|FG001|Overall Study|Other reason|0|||
162083471|NCT00245765|585358444|FG002|Overall Study|Other reason|1|||
162083472|NCT00245765|585358442|FG000|Overall Study|Other|13|||
162083473|NCT00245765|585358443|FG001|Overall Study|Other|4|||
162083474|NCT00245765|585358444|FG002|Overall Study|Other|4|||
162083475|NCT06425458|585358445|FG000|Overall Study|Removed by study team|2|||
162083476|NCT06425458|585358445|FG000|Overall Study|Lost to Follow-up|5|||
162083477|NCT03962543|585358448|FG000|Treatment Phase|Death|0|||
162083478|NCT03962543|585358449|FG001|Treatment Phase|Death|1|||
162083479|NCT03962543|585358448|FG000|Treatment Phase|Withdrawal by Subject|3|||
162083480|NCT03962543|585358449|FG001|Treatment Phase|Withdrawal by Subject|0|||
162083481|NCT03962543|585358448|FG000|Treatment Phase|Adverse Event|3|||
162083482|NCT03962543|585358449|FG001|Treatment Phase|Adverse Event|12|||
162083483|NCT03962543|585358448|FG000|Treatment Phase|Lost to Follow-up|1|||
162083484|NCT03962543|585358449|FG001|Treatment Phase|Lost to Follow-up|2|||
162083485|NCT03962543|585358448|FG000|Treatment Phase|Radiographic PD|9|||
162083486|NCT03962543|585358449|FG001|Treatment Phase|Radiographic PD|3|||
162083487|NCT03962543|585358448|FG000|Treatment Phase|Participant Decision|3|||
162083488|NCT03962543|585358449|FG001|Treatment Phase|Participant Decision|8|||
162083489|NCT03962543|585358448|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
162083490|NCT03962543|585358449|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
162083491|NCT03962543|585358448|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
162083492|NCT03962543|585358449|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
162083493|NCT03962543|585358448|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
162083494|NCT03962543|585358449|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
162083495|NCT03962543|585358448|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
162083496|NCT03962543|585358449|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
162083497|NCT03962543|585358448|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
162083498|NCT03962543|585358449|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
162083499|NCT03962543|585358448|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
162083500|NCT03962543|585358449|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
162083501|NCT03962543|585358448|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
162083502|NCT03962543|585358449|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
162083503|NCT03962543|585358448|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
162083504|NCT03962543|585358449|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
162083505|NCT03962543|585358448|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
162083506|NCT03962543|585358449|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
162083507|NCT03962543|585358448|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
162083508|NCT03962543|585358449|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
162083509|NCT02777125|585358450|FG000|Overall Study|Consent form violation|14|||
162083510|NCT02777125|585358451|FG001|Overall Study|Consent form violation|12|||
162083511|NCT02777125|585358450|FG000|Overall Study|Assent form violation|21|||
162083512|NCT02777125|585358451|FG001|Overall Study|Assent form violation|23|||
162083513|NCT02777125|585358450|FG000|Overall Study|Protocol Violation|8|||
162083514|NCT02777125|585358451|FG001|Overall Study|Protocol Violation|12|||
162083515|NCT02917031|585358452|FG000|Overall Study|Reason not specified|7|||
162083516|NCT02917031|585358453|FG001|Overall Study|Reason not specified|5|||
162083517|NCT02917031|585358454|FG002|Overall Study|Reason not specified|6|||
162083518|NCT02917031|585358452|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
162083519|NCT02917031|585358453|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
162083520|NCT02917031|585358454|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
162083521|NCT02917031|585358452|FG000|Overall Study|Withdrawal by Subject|3|||
162083522|NCT02917031|585358453|FG001|Overall Study|Withdrawal by Subject|3|||
162083523|NCT02917031|585358454|FG002|Overall Study|Withdrawal by Subject|0|||
162083524|NCT02917031|585358452|FG000|Overall Study|Physician Decision|1|||
162083525|NCT02917031|585358453|FG001|Overall Study|Physician Decision|0|||
162083526|NCT02917031|585358454|FG002|Overall Study|Physician Decision|0|||
162083527|NCT02917031|585358452|FG000|Overall Study|Adverse Event|4|||
162083528|NCT02917031|585358453|FG001|Overall Study|Adverse Event|1|||
162083529|NCT02917031|585358454|FG002|Overall Study|Adverse Event|5|||
162083530|NCT02917031|585358452|FG000|Overall Study|Death|2|||
162083531|NCT02917031|585358453|FG001|Overall Study|Death|3|||
162083532|NCT02917031|585358454|FG002|Overall Study|Death|4|||
162083533|NCT00640510|585359638|FG000|Overall Study|Lack of Efficacy|0|||
162083534|NCT00640510|585359639|FG001|Overall Study|Lack of Efficacy|1|||
162083535|NCT00640510|585359638|FG000|Overall Study|Protocol Violation|1|||
162083536|NCT00640510|585359639|FG001|Overall Study|Protocol Violation|0|||
162083537|NCT00640510|585359638|FG000|Overall Study|Physician Decision|0|||
162083538|NCT00640510|585359639|FG001|Overall Study|Physician Decision|1|||
162083539|NCT01440322|585359640|FG000|Overall Study|Discomfort|2|||
162083540|NCT01440322|585359641|FG001|Overall Study|Discomfort|0|||
162083541|NCT01440322|585359640|FG000|Overall Study|Biomicroscopy|1|||
162083542|NCT01440322|585359641|FG001|Overall Study|Biomicroscopy|0|||
162083543|NCT01440322|585359640|FG000|Overall Study|Symptoms and Problems|1|||
162083544|NCT01440322|585359641|FG001|Overall Study|Symptoms and Problems|0|||
162083545|NCT01440322|585359640|FG000|Overall Study|Unacceptable Subjective Vision|1|||
162083546|NCT01440322|585359641|FG001|Overall Study|Unacceptable Subjective Vision|0|||
162083547|NCT01440322|585359640|FG000|Overall Study|Other Product Related|1|||
162083548|NCT01440322|585359641|FG001|Overall Study|Other Product Related|0|||
162083549|NCT01440322|585359640|FG000|Overall Study|Unrelated Medical Problem|0|||
162083550|NCT01440322|585359641|FG001|Overall Study|Unrelated Medical Problem|1|||
162083551|NCT01440322|585359640|FG000|Overall Study|Other Non-Product Related|1|||
162083552|NCT01440322|585359641|FG001|Overall Study|Other Non-Product Related|0|||
162083553|NCT04300296|585359645|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
162083554|NCT04300296|585359646|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
162083555|NCT04300296|585359647|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
162083556|NCT04300296|585359648|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
162083557|NCT04300296|585359649|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
162083558|NCT04300296|585359650|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
162083559|NCT04300296|585359645|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
162083560|NCT04300296|585359646|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
162083561|NCT04300296|585359647|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
162083562|NCT04300296|585359648|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
162083563|NCT04300296|585359649|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
162083564|NCT04300296|585359650|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
162083565|NCT04300296|585359645|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
162083566|NCT04300296|585359646|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
162083567|NCT04300296|585359647|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
162083568|NCT04300296|585359648|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
162083569|NCT04300296|585359649|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
162083570|NCT04300296|585359650|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
162083571|NCT04300296|585359645|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
162083572|NCT04300296|585359646|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
162083573|NCT04300296|585359647|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
162083574|NCT04300296|585359648|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
162083575|NCT04300296|585359649|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
162083576|NCT04300296|585359650|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
162083577|NCT04300296|585359645|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
162083578|NCT04300296|585359646|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
162083579|NCT04300296|585359647|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
162083580|NCT04300296|585359648|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
162083581|NCT04300296|585359649|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
162083582|NCT04300296|585359650|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
162083583|NCT04300296|585359645|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
162083584|NCT04300296|585359646|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
162083585|NCT04300296|585359647|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
162083586|NCT04300296|585359648|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
162083587|NCT04300296|585359649|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
162083588|NCT04300296|585359650|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
162083589|NCT04300296|585359645|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
162083590|NCT04300296|585359646|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
162083591|NCT04300296|585359647|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
162083592|NCT04300296|585359648|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
162083593|NCT04300296|585359649|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
162083594|NCT04300296|585359650|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
162083595|NCT05044234|585359651|FG000|Overall Study|Lost to Follow-up|2|||
162083596|NCT05044234|585359652|FG001|Overall Study|Lost to Follow-up|1|||
162083597|NCT05044234|585359653|FG002|Overall Study|Lost to Follow-up|1|||
162083598|NCT05044234|585359654|FG003|Overall Study|Lost to Follow-up|2|||
162083599|NCT05044234|585359651|FG000|Overall Study|Withdrawal by Subject|6|||
162083600|NCT05044234|585359652|FG001|Overall Study|Withdrawal by Subject|4|||
162083601|NCT05044234|585359653|FG002|Overall Study|Withdrawal by Subject|5|||
162083602|NCT05044234|585359654|FG003|Overall Study|Withdrawal by Subject|8|||
162083603|NCT05044234|585359651|FG000|Overall Study|Study terminated by Sponsor|21|||
162083604|NCT05044234|585359652|FG001|Overall Study|Study terminated by Sponsor|21|||
162083605|NCT05044234|585359653|FG002|Overall Study|Study terminated by Sponsor|20|||
162083606|NCT05044234|585359654|FG003|Overall Study|Study terminated by Sponsor|14|||
162083607|NCT05044234|585359651|FG000|Overall Study|Other, not specified|0|||
162083608|NCT05044234|585359652|FG001|Overall Study|Other, not specified|0|||
162083609|NCT05044234|585359653|FG002|Overall Study|Other, not specified|1|||
162083610|NCT05044234|585359654|FG003|Overall Study|Other, not specified|2|||
162083611|NCT05044234|585359651|FG000|Overall Study|Delayed data entry|0|||
162083612|NCT05044234|585359652|FG001|Overall Study|Delayed data entry|0|||
162083613|NCT05044234|585359653|FG002|Overall Study|Delayed data entry|0|||
162083614|NCT05044234|585359654|FG003|Overall Study|Delayed data entry|1|||
162083615|NCT00279708|585359660|FG000|Overall Study|Withdrawal by Subject|2|||
162083616|NCT00279708|585359661|FG001|Overall Study|Withdrawal by Subject|3|||
162083617|NCT00279708|585359660|FG000|Overall Study|Adverse Event|1|||
162083618|NCT00279708|585359661|FG001|Overall Study|Adverse Event|1|||
162083619|NCT02624284|585359662|FG000|Overall Study|Withdrawal by Subject|3|||
162083620|NCT02624284|585359663|FG001|Overall Study|Withdrawal by Subject|6|||
162083621|NCT02624284|585359664|FG002|Overall Study|Withdrawal by Subject|3|||
162083622|NCT02624284|585359662|FG000|Overall Study|Protocol Violation|9|||
162083623|NCT02624284|585359663|FG001|Overall Study|Protocol Violation|10|||
162083624|NCT02624284|585359664|FG002|Overall Study|Protocol Violation|7|||
162083625|NCT02624284|585359662|FG000|Overall Study|Revealed exclusionary condition|2|||
162083626|NCT02624284|585359663|FG001|Overall Study|Revealed exclusionary condition|2|||
162083627|NCT02624284|585359664|FG002|Overall Study|Revealed exclusionary condition|0|||
162083628|NCT02624284|585359662|FG000|Overall Study|Adverse Event|0|||
162083629|NCT02624284|585359663|FG001|Overall Study|Adverse Event|0|||
162083630|NCT02624284|585359664|FG002|Overall Study|Adverse Event|1|||
162083631|NCT02940691|585359665|FG000|Overall Study|Lost to Follow-up|5|||
162083632|NCT02940691|585359665|FG000|Overall Study|Incarceration|1|||
162083633|NCT02506816|585359666|FG000|Overall Study|Adverse Event|3|||
162083634|NCT02477020|585359673|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
162083635|NCT02477020|585359674|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
162083636|NCT02477020|585359673|FG000|Overall Study|Voluntary Withdrawal|7|||
162083637|NCT02477020|585359674|FG001|Overall Study|Voluntary Withdrawal|16|||
162083638|NCT02477020|585359673|FG000|Overall Study|Reason not Specified|3|||
162083639|NCT02477020|585359674|FG001|Overall Study|Reason not Specified|1|||
162083640|NCT02477020|585359673|FG000|Overall Study|Lack of Efficacy|14|||
162083641|NCT02477020|585359674|FG001|Overall Study|Lack of Efficacy|5|||
162083642|NCT01049919|585359675|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
162083643|NCT01049919|585359676|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
162083644|NCT01049919|585359675|FG000|Overall Study|Withdrawal by Subject|5|||
162083645|NCT01049919|585359676|FG001|Overall Study|Withdrawal by Subject|0|||
162083646|NCT01049919|585359675|FG000|Overall Study|Lost to Follow-up|6|||
162083647|NCT01049919|585359676|FG001|Overall Study|Lost to Follow-up|1|||
162083648|NCT01049919|585359675|FG000|Overall Study|Physician Decision|2|||
162083649|NCT01049919|585359676|FG001|Overall Study|Physician Decision|0|||
162083650|NCT01049919|585359675|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
162083651|NCT01049919|585359676|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
162083652|NCT01049919|585359675|FG000|Overall Study|Early study termination by sponsor.|2|||
162083653|NCT01049919|585359676|FG001|Overall Study|Early study termination by sponsor.|0|||
162083654|NCT04354831|585359677|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
162083655|NCT04354831|585359678|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
162083656|NCT00812929|585359679|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
162083657|NCT00812929|585359680|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
162083658|NCT00812929|585359681|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
162083659|NCT00812929|585359682|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
162083660|NCT00812929|585359683|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
162083661|NCT00812929|585359684|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
162083662|NCT00812929|585359685|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
162083663|NCT00812929|585359686|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
162083664|NCT00812929|585359687|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
162083665|NCT00812929|585359688|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
162083666|NCT00812929|585359679|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
162083667|NCT00812929|585359680|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
162083668|NCT00812929|585359681|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
162083669|NCT00812929|585359682|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
162083670|NCT00812929|585359683|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
162083671|NCT00812929|585359684|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
162083672|NCT00812929|585359685|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
162083673|NCT00812929|585359686|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
162083674|NCT00812929|585359687|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
162083675|NCT00812929|585359688|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
162083676|NCT00812929|585359679|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
162083677|NCT00812929|585359680|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
162083678|NCT00812929|585359681|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
162083679|NCT00812929|585359682|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
162083680|NCT00812929|585359683|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
162083681|NCT00812929|585359684|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
162083682|NCT00812929|585359685|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
162083683|NCT00812929|585359686|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
162083684|NCT00812929|585359687|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
162083685|NCT00812929|585359688|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
162083686|NCT02504372|585359690|FG000|Overall Study|Death|136|||
162083687|NCT02504372|585359691|FG001|Overall Study|Death|154|||
162083688|NCT02504372|585359690|FG000|Overall Study|Lost to Follow-up|0|||
162083689|NCT02504372|585359691|FG001|Overall Study|Lost to Follow-up|2|||
162083690|NCT02504372|585359690|FG000|Overall Study|Withdrawal of consent|25|||
162083691|NCT02504372|585359691|FG001|Overall Study|Withdrawal of consent|16|||
162083692|NCT02504372|585359690|FG000|Overall Study|Participants ongoing|429|||
162083693|NCT02504372|585359691|FG001|Overall Study|Participants ongoing|415|||
162083694|NCT02975934|585359692|FG000|Treatment Phase|Never initiated study drug|0|||
162083695|NCT02975934|585359693|FG001|Treatment Phase|Never initiated study drug|5|||
162083696|NCT02975934|585359694|FG002|Treatment Phase|Never initiated study drug|0|||
162083697|NCT00499603|585359698|FG000|Overall Study|Adverse Event|0|||
162083698|NCT00499603|585359699|FG001|Overall Study|Adverse Event|1|||
162083699|NCT01302392|585359703|FG000|Overall Study|Lost to Follow-up|1|||
162083700|NCT01302392|585359704|FG001|Overall Study|Lost to Follow-up|0|||
162083701|NCT01302392|585359703|FG000|Overall Study|Withdrawal by Subject|6|||
162083702|NCT01302392|585359704|FG001|Overall Study|Withdrawal by Subject|1|||
162083703|NCT00547703|585359708|FG000|Overall Study|Lost to Follow-up|1|||
162083704|NCT00547703|585359709|FG001|Overall Study|Lost to Follow-up|0|||
162083705|NCT04399161|585359713|FG000|Overall Study|Withdrawal by Subject|1|||
162083706|NCT04399161|585359714|FG001|Overall Study|Withdrawal by Subject|0|||
162083707|NCT04399161|585359715|FG002|Overall Study|Withdrawal by Subject|2|||
162083708|NCT04399161|585359713|FG000|Overall Study|Protocol Violation|1|||
162083709|NCT04399161|585359714|FG001|Overall Study|Protocol Violation|2|||
162083710|NCT04399161|585359715|FG002|Overall Study|Protocol Violation|0|||
162083711|NCT03417141|585359716|FG000|Overall Study|Withdrawal by Subject|1|||
162083712|NCT03417141|585359716|FG000|Overall Study|Protocol Violation|3|||
162083713|NCT03571516|585359717|FG000|Overall Study|Severe diarrhea|1|||
162083714|NCT03571516|585359718|FG001|Overall Study|Severe diarrhea|0|||
162083715|NCT03571516|585359717|FG000|Overall Study|Withdrawal by Subject|0|||
162083716|NCT03571516|585359718|FG001|Overall Study|Withdrawal by Subject|1|||
162083717|NCT00613509|585359722|FG000|Cycle 1|Adverse Event|2|||
162083718|NCT00613509|585359723|FG001|Cycle 1|Adverse Event|1|||
162083719|NCT00613509|585359722|FG000|Cycle 1|Disease Progression|2|||
162083720|NCT00613509|585359723|FG001|Cycle 1|Disease Progression|6|||
162083721|NCT00613509|585359722|FG000|Cycle 1|Unacceptable Toxicity|1|||
162083722|NCT00613509|585359723|FG001|Cycle 1|Unacceptable Toxicity|0|||
162083723|NCT00613509|585359722|FG000|Cycle 1|Other administrative reason|0|||
162083724|NCT00613509|585359723|FG001|Cycle 1|Other administrative reason|1|||
162083725|NCT03465878|585359724|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
162083726|NCT03465878|585359725|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
162083727|NCT03465878|585359726|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
162083728|NCT03465878|585359727|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
162083729|NCT03465878|585359724|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
162083730|NCT03465878|585359725|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
162083731|NCT03465878|585359726|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
162083732|NCT03465878|585359727|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
162083733|NCT03465878|585359724|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
162083734|NCT03465878|585359725|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
162083735|NCT03465878|585359726|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
162083736|NCT03465878|585359727|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
162083737|NCT02540954|585359728|FG000|Overall Study|Physician Decision|3|||
162083738|NCT02540954|585359729|FG001|Overall Study|Physician Decision|1|||
162083739|NCT02540954|585359728|FG000|Overall Study|Withdrawal by Subject|6|||
162083740|NCT02540954|585359729|FG001|Overall Study|Withdrawal by Subject|5|||
162083741|NCT02540954|585359728|FG000|Overall Study|Lost to Follow-up|1|||
162083742|NCT02540954|585359729|FG001|Overall Study|Lost to Follow-up|1|||
162083743|NCT02540954|585359728|FG000|Overall Study|Adverse Event|4|||
162083744|NCT02540954|585359729|FG001|Overall Study|Adverse Event|2|||
162083745|NCT02540954|585359728|FG000|Overall Study|Death|0|||
162083746|NCT02540954|585359729|FG001|Overall Study|Death|3|||
162083747|NCT02540954|585359728|FG000|Overall Study|Treatment failure|1|||
162083748|NCT02540954|585359729|FG001|Overall Study|Treatment failure|0|||
162083749|NCT02540954|585359728|FG000|Overall Study|Other reason|4|||
162083750|NCT02540954|585359729|FG001|Overall Study|Other reason|2|||
162083751|NCT01723228|585359733|FG000|Overall Study|Adverse Event|2|||
162083752|NCT01723228|585359734|FG001|Overall Study|Adverse Event|6|||
162083753|NCT01723228|585359733|FG000|Overall Study|Withdrawal by Subject|2|||
162083754|NCT01723228|585359734|FG001|Overall Study|Withdrawal by Subject|1|||
162083755|NCT01723228|585359733|FG000|Overall Study|Protocol Violation|0|||
162083756|NCT01723228|585359734|FG001|Overall Study|Protocol Violation|2|||
162083757|NCT01723228|585359733|FG000|Overall Study|Lost to Follow-up|2|||
162083758|NCT01723228|585359734|FG001|Overall Study|Lost to Follow-up|1|||
162083759|NCT01723228|585359733|FG000|Overall Study|Other|2|||
162083760|NCT01723228|585359734|FG001|Overall Study|Other|1|||
162083761|NCT01282216|585359735|FG000|Overall Study|Graft failure|0|||
162083762|NCT01282216|585359736|FG001|Overall Study|Graft failure|0|||
162083763|NCT01282216|585359737|FG002|Overall Study|Graft failure|3|||
162083764|NCT01282216|585359738|FG003|Overall Study|Graft failure|2|||
162083765|NCT01282216|585359735|FG000|Overall Study|Physician Decision|0|||
162083766|NCT01282216|585359736|FG001|Overall Study|Physician Decision|0|||
162083767|NCT01282216|585359737|FG002|Overall Study|Physician Decision|11|||
162083768|NCT01282216|585359738|FG003|Overall Study|Physician Decision|0|||
162083769|NCT01282216|585359735|FG000|Overall Study|Relapse|0|||
162083770|NCT01282216|585359736|FG001|Overall Study|Relapse|0|||
162083771|NCT01282216|585359737|FG002|Overall Study|Relapse|17|||
162083772|NCT01282216|585359738|FG003|Overall Study|Relapse|6|||
162083773|NCT01282216|585359735|FG000|Overall Study|Death|0|||
162083774|NCT01282216|585359736|FG001|Overall Study|Death|0|||
162083775|NCT01282216|585359737|FG002|Overall Study|Death|2|||
162083776|NCT01282216|585359738|FG003|Overall Study|Death|0|||
162083777|NCT01806896|585359739|FG000|Overall Study|Adverse Event|2|||
162083778|NCT01806896|585359740|FG001|Overall Study|Adverse Event|0|||
162083779|NCT01806896|585359739|FG000|Overall Study|Other|1|||
162083780|NCT01806896|585359740|FG001|Overall Study|Other|0|||
162083781|NCT01864291|585359741|FG000|Overall Study|need for revision surgery|2|||
162083782|NCT02448875|585359742|FG000|Overall Study|Adverse Event|2|||
162083783|NCT02448875|585359743|FG001|Overall Study|Adverse Event|1|||
162083784|NCT02448875|585359744|FG002|Overall Study|Adverse Event|0|||
162083785|NCT02448875|585359742|FG000|Overall Study|Lost to Follow-up|1|||
162083786|NCT02448875|585359743|FG001|Overall Study|Lost to Follow-up|0|||
162083787|NCT02448875|585359744|FG002|Overall Study|Lost to Follow-up|0|||
162083788|NCT02448875|585359742|FG000|Overall Study|Investigator Decision|3|||
162083789|NCT02448875|585359743|FG001|Overall Study|Investigator Decision|0|||
162083790|NCT02448875|585359744|FG002|Overall Study|Investigator Decision|1|||
162083791|NCT02448875|585359742|FG000|Overall Study|Withdrawal by Subject|1|||
162083792|NCT02448875|585359743|FG001|Overall Study|Withdrawal by Subject|0|||
162083793|NCT02448875|585359744|FG002|Overall Study|Withdrawal by Subject|0|||
162083794|NCT02434770|585359746|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
162083795|NCT02434770|585359747|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
162083796|NCT02434770|585359748|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
162083797|NCT02434770|585359746|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
162083798|NCT02434770|585359747|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
162083799|NCT02434770|585359748|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
162083800|NCT02434770|585359746|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
162083801|NCT02434770|585359747|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
162083802|NCT02434770|585359748|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
162083803|NCT02434770|585359746|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
162083804|NCT02434770|585359747|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
162083805|NCT02434770|585359748|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
162083806|NCT02434770|585359746|FG000|Week 1 to Week 18|Death|1|||
162083807|NCT02434770|585359747|FG001|Week 1 to Week 18|Death|0|||
162083808|NCT02434770|585359748|FG002|Week 1 to Week 18|Death|0|||
162083809|NCT02434770|585359746|FG000|Week 18 to Week|Lost to Follow-up|2|||
162083810|NCT02434770|585359747|FG001|Week 18 to Week|Lost to Follow-up|2|||
162083811|NCT02434770|585359748|FG002|Week 18 to Week|Lost to Follow-up|1|||
162083812|NCT02434770|585359746|FG000|Week 18 to Week|Withdrawal by Subject|0|||
162083813|NCT02434770|585359747|FG001|Week 18 to Week|Withdrawal by Subject|0|||
162083814|NCT02434770|585359748|FG002|Week 18 to Week|Withdrawal by Subject|2|||
162083815|NCT02434770|585359746|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
162083816|NCT02434770|585359747|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
162083817|NCT02434770|585359748|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
162083818|NCT01282424|585359754|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
162083819|NCT01282424|585359754|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
162083820|NCT01282424|585359754|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
162083821|NCT01282424|585359754|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
162083822|NCT01282424|585359754|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
162083823|NCT01282424|585359754|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
162083824|NCT01282424|585359754|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
162083825|NCT01282424|585359754|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
162083826|NCT03316872|585359756|FG000|Overall Study|Death|1|||
162083827|NCT02239536|585359757|FG000|Overall Study|Non-neoplastic polyp|23|||
162083828|NCT02239536|585359758|FG001|Overall Study|Non-neoplastic polyp|17|||
162083829|NCT04074317|585359759|FG000|Third Period|Withdrawal by Subject|0|||
162083830|NCT04074317|585359760|FG001|Third Period|Withdrawal by Subject|0|||
162083831|NCT04074317|585359761|FG002|Third Period|Withdrawal by Subject|0|||
162083832|NCT04074317|585359762|FG003|Third Period|Withdrawal by Subject|1|||
162083833|NCT04074317|585359763|FG004|Third Period|Withdrawal by Subject|0|||
162083834|NCT04074317|585359764|FG005|Third Period|Withdrawal by Subject|0|||
162083835|NCT02283788|585359767|FG000|Overall Study|Adverse Event|1|||
162083836|NCT02283788|585359768|FG001|Overall Study|Adverse Event|3|||
162083837|NCT02283788|585359769|FG002|Overall Study|Adverse Event|5|||
162083838|NCT02283788|585359770|FG003|Overall Study|Adverse Event|1|||
162083839|NCT02283788|585359767|FG000|Overall Study|Withdrawal by Subject|0|||
162083840|NCT02283788|585359768|FG001|Overall Study|Withdrawal by Subject|1|||
162083841|NCT02283788|585359769|FG002|Overall Study|Withdrawal by Subject|0|||
162083842|NCT02283788|585359770|FG003|Overall Study|Withdrawal by Subject|1|||
162083843|NCT02742103|585361383|FG000|Overall Study|Protocol Violation|1|||
162083844|NCT02742103|585361384|FG001|Overall Study|Protocol Violation|0|||
162083845|NCT02742103|585361383|FG000|Overall Study|Death|2|||
162083846|NCT02742103|585361384|FG001|Overall Study|Death|2|||
162083847|NCT02742103|585361383|FG000|Overall Study|Adverse Event|1|||
162083848|NCT02742103|585361384|FG001|Overall Study|Adverse Event|0|||
162083849|NCT02742103|585361383|FG000|Overall Study|Moved to another town|0|||
162083850|NCT02742103|585361384|FG001|Overall Study|Moved to another town|1|||
162083851|NCT02742103|585361383|FG000|Overall Study|Withdrawal by Subject|5|||
162083852|NCT02742103|585361384|FG001|Overall Study|Withdrawal by Subject|2|||
162083853|NCT00533949|585361387|FG000|Overall Study|Protocol Violation|12|||
162083854|NCT00533949|585361388|FG001|Overall Study|Protocol Violation|12|||
162083855|NCT00533949|585361389|FG002|Overall Study|Protocol Violation|9|||
162083856|NCT00533949|585361390|FG003|Overall Study|Protocol Violation|9|||
162083857|NCT00533949|585361387|FG000|Overall Study|Withdrawal by Subject|3|||
162083858|NCT00533949|585361388|FG001|Overall Study|Withdrawal by Subject|2|||
162083859|NCT00533949|585361389|FG002|Overall Study|Withdrawal by Subject|1|||
162083860|NCT00533949|585361390|FG003|Overall Study|Withdrawal by Subject|1|||
162083861|NCT00727194|585361391|FG000|Screening Period|Low QMG scores|0|||
162083862|NCT00727194|585361392|FG001|Screening Period|Low QMG scores|0|||
162083863|NCT00727194|585361393|FG002|Screening Period|Low QMG scores|6|||
162083864|NCT00727194|585361391|FG000|Screening Period|Lacked AChR antibodies|0|||
162083865|NCT00727194|585361392|FG001|Screening Period|Lacked AChR antibodies|0|||
162083866|NCT00727194|585361393|FG002|Screening Period|Lacked AChR antibodies|5|||
162083867|NCT00727194|585361391|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
162083868|NCT00727194|585361392|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
162083869|NCT00727194|585361393|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
162083870|NCT00727194|585361391|FG000|Screening Period|Severe infections|0|||
162083871|NCT00727194|585361392|FG001|Screening Period|Severe infections|0|||
162083872|NCT00727194|585361393|FG002|Screening Period|Severe infections|2|||
162083873|NCT00727194|585361391|FG000|Screening Period|History of thymoma|0|||
162083874|NCT00727194|585361392|FG001|Screening Period|History of thymoma|0|||
162083875|NCT00727194|585361393|FG002|Screening Period|History of thymoma|1|||
162083876|NCT00727194|585361391|FG000|Treatment Period 2|Lack of Efficacy|0|||
162083877|NCT00727194|585361392|FG001|Treatment Period 2|Lack of Efficacy|1|||
162083878|NCT00727194|585361393|FG002|Treatment Period 2|Lack of Efficacy|0|||
162083879|NCT04269161|585361400|FG000|Overall Study|Change of modality and no longer eligible|3|||
162083880|NCT04269161|585361401|FG001|Overall Study|Change of modality and no longer eligible|3|||
162083881|NCT04269161|585361400|FG000|Overall Study|Required procedure outside of NICU|1|||
162083882|NCT04269161|585361401|FG001|Overall Study|Required procedure outside of NICU|0|||
162083883|NCT04269161|585361400|FG000|Overall Study|Equipment issue|1|||
162083884|NCT04269161|585361401|FG001|Overall Study|Equipment issue|1|||
162083885|NCT02472756|585361402|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
162083886|NCT02472756|585361402|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
162083887|NCT02472756|585361402|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
162083888|NCT02472756|585361402|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
162083889|NCT02472756|585361402|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
162083890|NCT02649972|585361407|FG000|Overall Study|Not treated|1|||
162083891|NCT02896127|585361410|FG000|COMPLETED WEEK 52|Adverse Event|9|||
162083892|NCT02896127|585361411|FG001|COMPLETED WEEK 52|Adverse Event|2|||
162083893|NCT02896127|585361410|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
162083894|NCT02896127|585361411|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
162083895|NCT02896127|585361410|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
162083896|NCT02896127|585361411|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
162083897|NCT02896127|585361410|FG000|COMPLETED WEEK 52|Physician Decision|1|||
162083898|NCT02896127|585361411|FG001|COMPLETED WEEK 52|Physician Decision|1|||
162083899|NCT02896127|585361410|FG000|COMPLETED WEEK 52|Pregnancy|2|||
162083900|NCT02896127|585361411|FG001|COMPLETED WEEK 52|Pregnancy|0|||
162083901|NCT02896127|585361410|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
162083902|NCT02896127|585361411|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
162083903|NCT02896127|585361410|FG000|COMPLETED WEEK 52|Technical problems|1|||
162083904|NCT02896127|585361411|FG001|COMPLETED WEEK 52|Technical problems|0|||
162083905|NCT02896127|585361410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
162083906|NCT02896127|585361411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
162083907|NCT02896127|585361410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
162083908|NCT02896127|585361411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
162083909|NCT02896127|585361410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
162083910|NCT02896127|585361411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
162083911|NCT02896127|585361410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
162083912|NCT02896127|585361411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
162083913|NCT02896127|585361410|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
162083914|NCT02896127|585361411|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
162083915|NCT01782313|585361412|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
162083916|NCT01782313|585361412|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
162083917|NCT01782313|585361412|FG000|Treated Cycle 3|Progressive Disease|21|||
162083918|NCT01782313|585361412|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
162083919|NCT01782313|585361412|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
162083920|NCT01782313|585361412|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
162083921|NCT01782313|585361412|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
162083922|NCT01782313|585361412|FG000|Survival Follow up|Lost to Follow-up|1|||
162083923|NCT00958776|585361413|FG000|Overall Study|Adverse Event|0|||
162083924|NCT00958776|585361414|FG001|Overall Study|Adverse Event|1|||
162083925|NCT00958776|585361413|FG000|Overall Study|Physician Decision|1|||
162083926|NCT00958776|585361414|FG001|Overall Study|Physician Decision|0|||
162083927|NCT00958776|585361413|FG000|Overall Study|Lost to Follow-up|2|||
162083928|NCT00958776|585361414|FG001|Overall Study|Lost to Follow-up|6|||
162083929|NCT00958776|585361413|FG000|Overall Study|Withdrawal by Subject|7|||
162083930|NCT00958776|585361414|FG001|Overall Study|Withdrawal by Subject|16|||
162083931|NCT00958776|585361413|FG000|Overall Study|Protocol Violation|1|||
162083932|NCT00958776|585361414|FG001|Overall Study|Protocol Violation|1|||
162083933|NCT00958776|585361413|FG000|Overall Study|Death|2|||
162083934|NCT00958776|585361414|FG001|Overall Study|Death|1|||
162083935|NCT00958776|585361413|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
162083936|NCT00958776|585361414|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
162083937|NCT00958776|585361413|FG000|Overall Study|Missing|1|||
162083938|NCT00958776|585361414|FG001|Overall Study|Missing|1|||
162083939|NCT00326911|585361415|FG000|Overall Study|Hospitalization prior to treatment|0|||
162083940|NCT00326911|585361416|FG001|Overall Study|Hospitalization prior to treatment|1|||
162083941|NCT00326911|585361415|FG000|Overall Study|Physician decision prior to treatment|1|||
162083942|NCT00326911|585361416|FG001|Overall Study|Physician decision prior to treatment|0|||
162083943|NCT00326911|585361415|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
162083944|NCT00326911|585361416|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
162083945|NCT00418691|585361425|FG000|Overall Study|Lost to Follow-up|1|||
162083946|NCT00418691|585361426|FG001|Overall Study|Lost to Follow-up|2|||
162083947|NCT00418691|585361427|FG002|Overall Study|Lost to Follow-up|3|||
162083948|NCT00418691|585361425|FG000|Overall Study|Started new medication voiding entry|0|||
162083949|NCT00418691|585361426|FG001|Overall Study|Started new medication voiding entry|0|||
162083950|NCT00418691|585361427|FG002|Overall Study|Started new medication voiding entry|1|||
162083951|NCT00418691|585361425|FG000|Overall Study|Progressive Disease|1|||
162083952|NCT00418691|585361426|FG001|Overall Study|Progressive Disease|0|||
162083953|NCT00418691|585361427|FG002|Overall Study|Progressive Disease|1|||
162083954|NCT00501540|585361428|FG000|Overall Study|Death|5|||
162083955|NCT02331446|585361429|FG000|Overall Study|Lost to Follow-up|2|||
162083956|NCT02331446|585361430|FG001|Overall Study|Lost to Follow-up|1|||
162083957|NCT02331446|585361431|FG002|Overall Study|Lost to Follow-up|0|||
162083958|NCT02331446|585361432|FG003|Overall Study|Lost to Follow-up|1|||
162083959|NCT02331446|585361429|FG000|Overall Study|Personal Problem|2|||
162083960|NCT02331446|585361430|FG001|Overall Study|Personal Problem|0|||
162083961|NCT02331446|585361431|FG002|Overall Study|Personal Problem|0|||
162083962|NCT02331446|585361432|FG003|Overall Study|Personal Problem|0|||
162083963|NCT02331446|585361429|FG000|Overall Study|Disease|0|||
162083964|NCT02331446|585361430|FG001|Overall Study|Disease|2|||
162083965|NCT02331446|585361431|FG002|Overall Study|Disease|2|||
162083966|NCT02331446|585361432|FG003|Overall Study|Disease|1|||
162083967|NCT02331446|585361429|FG000|Overall Study|Physician Decision|0|||
162083968|NCT02331446|585361430|FG001|Overall Study|Physician Decision|1|||
162083969|NCT02331446|585361431|FG002|Overall Study|Physician Decision|0|||
162083970|NCT02331446|585361432|FG003|Overall Study|Physician Decision|1|||
162083971|NCT02331446|585361429|FG000|Overall Study|Lost before baseline analysis|0|||
162083972|NCT02331446|585361430|FG001|Overall Study|Lost before baseline analysis|1|||
162083973|NCT02331446|585361431|FG002|Overall Study|Lost before baseline analysis|1|||
162083974|NCT02331446|585361432|FG003|Overall Study|Lost before baseline analysis|0|||
162083975|NCT02984995|585361433|FG000|Overall Study|Required stem cell transplant|13|||
162083976|NCT02984995|585361434|FG001|Overall Study|Required stem cell transplant|2|||
162083977|NCT02984995|585361433|FG000|Overall Study|Progressive disease|11|||
162083978|NCT02984995|585361434|FG001|Overall Study|Progressive disease|1|||
162083979|NCT02984995|585361433|FG000|Overall Study|Adverse Event|1|||
162083980|NCT02984995|585361434|FG001|Overall Study|Adverse Event|0|||
162083981|NCT04182100|585361435|FG000|Overall Study|Adverse Event|1|||
162083982|NCT04182100|585361435|FG000|Overall Study|Withdrawal by Subject|1|||
162083983|NCT00433654|585361437|FG000|Overall Study|Death|4|||
162083984|NCT00433654|585361438|FG001|Overall Study|Death|0|||
162083985|NCT00433654|585361437|FG000|Overall Study|Missed visit|6|||
162083986|NCT00433654|585361438|FG001|Overall Study|Missed visit|3|||
162083987|NCT00433654|585361437|FG000|Overall Study|Subject not yet due for visit|4|||
162083988|NCT00433654|585361438|FG001|Overall Study|Subject not yet due for visit|0|||
162083989|NCT00433654|585361437|FG000|Overall Study|Withdrawal by Subject|1|||
162083990|NCT00433654|585361438|FG001|Overall Study|Withdrawal by Subject|2|||
162083991|NCT01428193|585361462|FG000|Overall Study|Physician Decision|1|||
162083992|NCT01428193|585361462|FG000|Overall Study|Elevated screening liver enzymes|1|||
162083993|NCT00357370|585361469|FG000|Cohort 2|Lack of Efficacy|0|||
162083994|NCT00357370|585361470|FG001|Cohort 2|Lack of Efficacy|2|||
162083995|NCT00357370|585361471|FG002|Cohort 2|Lack of Efficacy|1|||
162083996|NCT00357370|585361469|FG000|Cohort 2|Adverse Event|1|||
162083997|NCT00357370|585361470|FG001|Cohort 2|Adverse Event|1|||
162083998|NCT00357370|585361471|FG002|Cohort 2|Adverse Event|1|||
162083999|NCT00357370|585361469|FG000|Cohort 2|Lost to Follow-up|0|||
162084000|NCT00357370|585361470|FG001|Cohort 2|Lost to Follow-up|1|||
162084001|NCT00357370|585361471|FG002|Cohort 2|Lost to Follow-up|0|||
162084002|NCT00357370|585361469|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
162084003|NCT00357370|585361470|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
162084004|NCT00357370|585361471|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
162084005|NCT00357370|585361469|FG000|Cohort 2|Withdrawal by Subject|0|||
162084006|NCT00357370|585361470|FG001|Cohort 2|Withdrawal by Subject|2|||
162084007|NCT00357370|585361471|FG002|Cohort 2|Withdrawal by Subject|0|||
162084008|NCT01632800|585361473|FG000|Overall Study|Subject did not fit in apparatus|1|||
162084009|NCT00937547|585361474|FG000|Overall Study|misdiagnosis|1|||
162084010|NCT00937547|585361475|FG001|Overall Study|misdiagnosis|6|||
162084011|NCT00937547|585361476|FG002|Overall Study|misdiagnosis|7|||
162084012|NCT04439240|585361477|FG000|Overall Study|Ineligible|2|||
162084013|NCT04439240|585361477|FG000|Overall Study|Never started treatment|2|||
162084014|NCT04439240|585361477|FG000|Overall Study|Adverse Event|12|||
162084015|NCT04439240|585361477|FG000|Overall Study|Death|2|||
162084016|NCT04439240|585361477|FG000|Overall Study|Disease progression|25|||
162084017|NCT04439240|585361477|FG000|Overall Study|Other diseases|2|||
162084018|NCT04439240|585361477|FG000|Overall Study|Withdrawal by Subject|3|||
162084019|NCT04439240|585361477|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
162084020|NCT04439240|585361477|FG000|Overall Study|Symptomatic decline|1|||
162084021|NCT04439240|585361477|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
162084022|NCT04439240|585361477|FG000|Overall Study|Clinical progression|1|||
162084023|NCT00813124|585361478|FG000|Overall Study|Death|2|||
162084024|NCT00813124|585361478|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
162084025|NCT00813124|585361478|FG000|Overall Study|Withdrawal by Subject|1|||
162084026|NCT00079274|585361479|FG000|Overall Study|Withdrawal by Subject|111|||
162084027|NCT00079274|585361480|FG001|Overall Study|Withdrawal by Subject|10|||
162084028|NCT00079274|585361481|FG002|Overall Study|Withdrawal by Subject|12|||
162084029|NCT00079274|585361482|FG003|Overall Study|Withdrawal by Subject|163|||
162084030|NCT00079274|585361483|FG004|Overall Study|Withdrawal by Subject|7|||
162084031|NCT00079274|585361484|FG005|Overall Study|Withdrawal by Subject|8|||
162084032|NCT00079274|585361485|FG006|Overall Study|Withdrawal by Subject|0|||
162084033|NCT00079274|585361479|FG000|Overall Study|Adverse Event|130|||
162084034|NCT00079274|585361480|FG001|Overall Study|Adverse Event|8|||
162084035|NCT00079274|585361481|FG002|Overall Study|Adverse Event|8|||
162084036|NCT00079274|585361482|FG003|Overall Study|Adverse Event|184|||
162084037|NCT00079274|585361483|FG004|Overall Study|Adverse Event|7|||
162084038|NCT00079274|585361484|FG005|Overall Study|Adverse Event|8|||
162084039|NCT00079274|585361485|FG006|Overall Study|Adverse Event|0|||
162084040|NCT00079274|585361479|FG000|Overall Study|Recurrence|21|||
162084041|NCT00079274|585361480|FG001|Overall Study|Recurrence|0|||
162084042|NCT00079274|585361481|FG002|Overall Study|Recurrence|1|||
162084043|NCT00079274|585361482|FG003|Overall Study|Recurrence|15|||
162084044|NCT00079274|585361483|FG004|Overall Study|Recurrence|0|||
162084045|NCT00079274|585361484|FG005|Overall Study|Recurrence|2|||
162084046|NCT00079274|585361485|FG006|Overall Study|Recurrence|0|||
162084047|NCT00079274|585361479|FG000|Overall Study|Alternate Treatment|6|||
162084048|NCT00079274|585361480|FG001|Overall Study|Alternate Treatment|1|||
162084049|NCT00079274|585361481|FG002|Overall Study|Alternate Treatment|0|||
162084050|NCT00079274|585361482|FG003|Overall Study|Alternate Treatment|3|||
162084051|NCT00079274|585361483|FG004|Overall Study|Alternate Treatment|0|||
162084052|NCT00079274|585361484|FG005|Overall Study|Alternate Treatment|0|||
162084053|NCT00079274|585361485|FG006|Overall Study|Alternate Treatment|0|||
162084054|NCT00079274|585361479|FG000|Overall Study|Other Medical Problems|6|||
162084055|NCT00079274|585361480|FG001|Overall Study|Other Medical Problems|1|||
162084056|NCT00079274|585361481|FG002|Overall Study|Other Medical Problems|0|||
162084057|NCT00079274|585361482|FG003|Overall Study|Other Medical Problems|7|||
162084058|NCT00079274|585361483|FG004|Overall Study|Other Medical Problems|0|||
162084059|NCT00079274|585361484|FG005|Overall Study|Other Medical Problems|0|||
162084060|NCT00079274|585361485|FG006|Overall Study|Other Medical Problems|0|||
162084061|NCT00079274|585361479|FG000|Overall Study|Death|4|||
162084062|NCT00079274|585361480|FG001|Overall Study|Death|0|||
162084063|NCT00079274|585361481|FG002|Overall Study|Death|1|||
162084064|NCT00079274|585361482|FG003|Overall Study|Death|15|||
162084065|NCT00079274|585361483|FG004|Overall Study|Death|0|||
162084066|NCT00079274|585361484|FG005|Overall Study|Death|0|||
162084067|NCT00079274|585361485|FG006|Overall Study|Death|0|||
162084068|NCT00079274|585361479|FG000|Overall Study|Cytogenetic resistance|0|||
162084069|NCT00079274|585361480|FG001|Overall Study|Cytogenetic resistance|0|||
162084070|NCT00079274|585361481|FG002|Overall Study|Cytogenetic resistance|0|||
162084071|NCT00079274|585361482|FG003|Overall Study|Cytogenetic resistance|2|||
162084072|NCT00079274|585361483|FG004|Overall Study|Cytogenetic resistance|0|||
162084073|NCT00079274|585361484|FG005|Overall Study|Cytogenetic resistance|0|||
162084074|NCT00079274|585361485|FG006|Overall Study|Cytogenetic resistance|0|||
162084075|NCT00079274|585361479|FG000|Overall Study|Other|43|||
162084076|NCT00079274|585361480|FG001|Overall Study|Other|7|||
162084077|NCT00079274|585361481|FG002|Overall Study|Other|5|||
162084078|NCT00079274|585361482|FG003|Overall Study|Other|55|||
162084079|NCT00079274|585361483|FG004|Overall Study|Other|1|||
162084080|NCT00079274|585361484|FG005|Overall Study|Other|2|||
162084081|NCT00079274|585361485|FG006|Overall Study|Other|0|||
162084082|NCT01502644|585361492|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
162084083|NCT01502644|585361493|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
162084084|NCT01502644|585361494|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
162084085|NCT01502644|585361495|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
162084086|NCT01502644|585361492|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
162084087|NCT01502644|585361493|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
162084088|NCT01502644|585361494|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
162084089|NCT01502644|585361495|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
162084090|NCT01502644|585361492|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
162084091|NCT01502644|585361493|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
162084092|NCT01502644|585361494|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
162084093|NCT01502644|585361495|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
162084094|NCT01502644|585361492|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
162084095|NCT01502644|585361493|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
162084096|NCT01502644|585361494|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
162084097|NCT01502644|585361495|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
162084098|NCT01502644|585361492|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
162084099|NCT01502644|585361493|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
162084100|NCT01502644|585361494|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
162084101|NCT01502644|585361495|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
162084102|NCT01147653|585361496|FG000|Year 2|Withdrawal by Subject|2|||
162084103|NCT01147653|585361497|FG001|Year 2|Withdrawal by Subject|3|||
162084104|NCT00280566|585361498|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
162084105|NCT00280566|585361499|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
162084106|NCT00280566|585361500|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
162084107|NCT00280566|585361498|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
162084108|NCT00280566|585361499|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
162084109|NCT00280566|585361500|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
162084110|NCT00280566|585361498|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
162084111|NCT00280566|585361499|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
162084112|NCT00280566|585361500|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
162084113|NCT00280566|585361498|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
162084114|NCT00280566|585361499|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
162084115|NCT00280566|585361500|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
162084116|NCT00280566|585361498|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
162084117|NCT00280566|585361499|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
162084118|NCT00280566|585361500|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
162084119|NCT00280566|585361498|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
162084120|NCT00280566|585361499|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
162084121|NCT00280566|585361500|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
162084122|NCT00280566|585361498|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
162084123|NCT00280566|585361499|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
162084124|NCT00280566|585361500|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
162084125|NCT00280566|585361498|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
162084126|NCT00280566|585361499|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
162084127|NCT00280566|585361500|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
162084128|NCT00280566|585361498|FG000|Period 2 Double Blind|Adverse Event|0|||
162084129|NCT00280566|585361499|FG001|Period 2 Double Blind|Adverse Event|11|||
162084130|NCT00280566|585361500|FG002|Period 2 Double Blind|Adverse Event|15|||
162084131|NCT00280566|585361498|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
162084132|NCT00280566|585361499|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
162084133|NCT00280566|585361500|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
162084134|NCT00280566|585361498|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
162084135|NCT00280566|585361499|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
162084136|NCT00280566|585361500|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
162084137|NCT00280566|585361498|FG000|Period 2 Double Blind|miscellaneous|0|||
162084138|NCT00280566|585361499|FG001|Period 2 Double Blind|miscellaneous|10|||
162084139|NCT00280566|585361500|FG002|Period 2 Double Blind|miscellaneous|5|||
162084140|NCT00670228|585361501|FG000|Overall Study|Adverse Event|1|||
162084141|NCT00670228|585361502|FG001|Overall Study|Adverse Event|0|||
162084142|NCT00670228|585361501|FG000|Overall Study|Death or MACE|0|||
162084143|NCT00670228|585361502|FG001|Overall Study|Death or MACE|1|||
162084144|NCT00670228|585361501|FG000|Overall Study|Not treated|2|||
162084145|NCT00670228|585361502|FG001|Overall Study|Not treated|2|||
162084146|NCT00670228|585361501|FG000|Overall Study|Not meeting the selection criteria|2|||
162084147|NCT00670228|585361502|FG001|Overall Study|Not meeting the selection criteria|0|||
162084148|NCT03604692|585361503|FG000|Overall Study|Investigator's Decision|0|||
162084149|NCT03604692|585361504|FG001|Overall Study|Investigator's Decision|0|||
162084150|NCT03604692|585361505|FG002|Overall Study|Investigator's Decision|0|||
162084151|NCT03604692|585361506|FG003|Overall Study|Investigator's Decision|1|||
162084152|NCT03604692|585361507|FG004|Overall Study|Investigator's Decision|0|||
162084153|NCT03604692|585361508|FG005|Overall Study|Investigator's Decision|7|||
162084154|NCT03604692|585361503|FG000|Overall Study|Withdrawal by Subject|0|||
162084155|NCT03604692|585361504|FG001|Overall Study|Withdrawal by Subject|0|||
162084156|NCT03604692|585361505|FG002|Overall Study|Withdrawal by Subject|0|||
162084157|NCT03604692|585361506|FG003|Overall Study|Withdrawal by Subject|0|||
162084158|NCT03604692|585361507|FG004|Overall Study|Withdrawal by Subject|0|||
162084159|NCT03604692|585361508|FG005|Overall Study|Withdrawal by Subject|2|||
162084160|NCT03604692|585361503|FG000|Overall Study|Progressive Disease|1|||
162084161|NCT03604692|585361504|FG001|Overall Study|Progressive Disease|0|||
162084162|NCT03604692|585361505|FG002|Overall Study|Progressive Disease|1|||
162084163|NCT03604692|585361506|FG003|Overall Study|Progressive Disease|0|||
162084164|NCT03604692|585361507|FG004|Overall Study|Progressive Disease|3|||
162084165|NCT03604692|585361508|FG005|Overall Study|Progressive Disease|4|||
162084166|NCT03604692|585361503|FG000|Overall Study|Difficulty Coming into Site|0|||
162084167|NCT03604692|585361504|FG001|Overall Study|Difficulty Coming into Site|0|||
162084168|NCT03604692|585361505|FG002|Overall Study|Difficulty Coming into Site|0|||
162084169|NCT03604692|585361506|FG003|Overall Study|Difficulty Coming into Site|0|||
162084170|NCT03604692|585361507|FG004|Overall Study|Difficulty Coming into Site|0|||
162084171|NCT03604692|585361508|FG005|Overall Study|Difficulty Coming into Site|1|||
162084172|NCT03604692|585361503|FG000|Overall Study|Death|0|||
162084173|NCT03604692|585361504|FG001|Overall Study|Death|0|||
162084174|NCT03604692|585361505|FG002|Overall Study|Death|1|||
162084175|NCT03604692|585361506|FG003|Overall Study|Death|0|||
162084176|NCT03604692|585361507|FG004|Overall Study|Death|0|||
162084177|NCT03604692|585361508|FG005|Overall Study|Death|0|||
162084178|NCT03604692|585361503|FG000|Overall Study|Drug Intolerance|0|||
162084179|NCT03604692|585361504|FG001|Overall Study|Drug Intolerance|0|||
162084180|NCT03604692|585361505|FG002|Overall Study|Drug Intolerance|0|||
162084181|NCT03604692|585361506|FG003|Overall Study|Drug Intolerance|1|||
162084182|NCT03604692|585361507|FG004|Overall Study|Drug Intolerance|0|||
162084183|NCT03604692|585361508|FG005|Overall Study|Drug Intolerance|0|||
162084184|NCT03604692|585361503|FG000|Overall Study|Noncompliance with follow-up visit|0|||
162084185|NCT03604692|585361504|FG001|Overall Study|Noncompliance with follow-up visit|0|||
162084186|NCT03604692|585361505|FG002|Overall Study|Noncompliance with follow-up visit|0|||
162084187|NCT03604692|585361506|FG003|Overall Study|Noncompliance with follow-up visit|1|||
162084188|NCT03604692|585361507|FG004|Overall Study|Noncompliance with follow-up visit|0|||
162084189|NCT03604692|585361508|FG005|Overall Study|Noncompliance with follow-up visit|0|||
162084190|NCT03604692|585361503|FG000|Overall Study|Not Treated|0|||
162084191|NCT03604692|585361504|FG001|Overall Study|Not Treated|0|||
162084192|NCT03604692|585361505|FG002|Overall Study|Not Treated|0|||
162084193|NCT03604692|585361506|FG003|Overall Study|Not Treated|0|||
162084194|NCT03604692|585361507|FG004|Overall Study|Not Treated|1|||
162084195|NCT03604692|585361508|FG005|Overall Study|Not Treated|0|||
162084196|NCT00637195|585361509|FG000|Overall Study|Lost to Follow-up|1|||
162084197|NCT00637195|585361510|FG001|Overall Study|Lost to Follow-up|0|||
162084198|NCT00637195|585361509|FG000|Overall Study|Other|2|||
162084199|NCT00637195|585361510|FG001|Overall Study|Other|0|||
162084200|NCT00637195|585361509|FG000|Overall Study|Withdrawal by Subject|0|||
162084201|NCT00637195|585361510|FG001|Overall Study|Withdrawal by Subject|1|||
162084202|NCT01193556|585361515|FG000|Overall Study|Study termination|26|||
162084203|NCT01193556|585361516|FG001|Overall Study|Study termination|25|||
162084204|NCT01696032|585361517|FG000|Overall Study|Withdrawal by Subject|0|||
162084205|NCT01696032|585361518|FG001|Overall Study|Withdrawal by Subject|0|||
162084206|NCT01696032|585361519|FG002|Overall Study|Withdrawal by Subject|1|||
162084207|NCT01696032|585361520|FG003|Overall Study|Withdrawal by Subject|2|||
162084208|NCT01696032|585361517|FG000|Overall Study|Death|14|||
162084209|NCT01696032|585361518|FG001|Overall Study|Death|4|||
162084210|NCT01696032|585361519|FG002|Overall Study|Death|43|||
162084211|NCT01696032|585361520|FG003|Overall Study|Death|18|||
162084212|NCT01696032|585361517|FG000|Overall Study|Lost to Follow-up|0|||
162084213|NCT01696032|585361518|FG001|Overall Study|Lost to Follow-up|1|||
162084214|NCT01696032|585361519|FG002|Overall Study|Lost to Follow-up|0|||
162084215|NCT01696032|585361520|FG003|Overall Study|Lost to Follow-up|0|||
162084216|NCT01696032|585361517|FG000|Overall Study|Database lock|0|||
162084217|NCT01696032|585361518|FG001|Overall Study|Database lock|1|||
162084218|NCT01696032|585361519|FG002|Overall Study|Database lock|7|||
162084219|NCT01696032|585361520|FG003|Overall Study|Database lock|2|||
162084220|NCT00376168|585361523|FG000|Overall Study|Adverse Event|1|||
162084221|NCT00376168|585361524|FG001|Overall Study|Adverse Event|1|||
162084222|NCT00376168|585361523|FG000|Overall Study|Pregnancy|1|||
162084223|NCT00376168|585361524|FG001|Overall Study|Pregnancy|0|||
162084224|NCT01020019|585361525|FG000|Overall Study|Lost to Follow-up|21|||
162084225|NCT01020019|585361526|FG001|Overall Study|Lost to Follow-up|18|||
162084226|NCT01020019|585361525|FG000|Overall Study|Adverse Event|1|||
162084227|NCT01020019|585361526|FG001|Overall Study|Adverse Event|5|||
162084228|NCT01020019|585361525|FG000|Overall Study|not interested in treatment|4|||
162084229|NCT01020019|585361526|FG001|Overall Study|not interested in treatment|4|||
162084230|NCT01020019|585361525|FG000|Overall Study|moving|0|||
162084231|NCT01020019|585361526|FG001|Overall Study|moving|2|||
162084232|NCT05091528|585361527|FG000|Overall Study|Study Termination by Sponsor|0|||
162084233|NCT05091528|585361528|FG001|Overall Study|Study Termination by Sponsor|1|||
162084234|NCT05091528|585361529|FG002|Overall Study|Study Termination by Sponsor|0|||
162084235|NCT05091528|585361530|FG003|Overall Study|Study Termination by Sponsor|1|||
162084236|NCT02214121|585361533|FG000|Part A|Patient decision|2|||
162084237|NCT02214121|585361534|FG001|Part A|Patient decision|0|||
162084238|NCT02214121|585361535|FG002|Part A|Patient decision|0|||
162084239|NCT02214121|585361533|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
162084240|NCT02214121|585361534|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
162084241|NCT02214121|585361535|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
162084242|NCT02214121|585361533|FG000|Part A|Other|1|||
162084243|NCT02214121|585361534|FG001|Part A|Other|0|||
162084244|NCT02214121|585361535|FG002|Part A|Other|0|||
162084245|NCT02214121|585361533|FG000|Part B|Patient decision|0|||
162084246|NCT02214121|585361534|FG001|Part B|Patient decision|1|||
162084247|NCT02214121|585361535|FG002|Part B|Patient decision|0|||
162084248|NCT02214121|585361533|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
162084249|NCT02214121|585361534|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
162084250|NCT02214121|585361535|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
162084251|NCT02214121|585361533|FG000|Part B|Lost to Follow-up|0|||
162084252|NCT02214121|585361534|FG001|Part B|Lost to Follow-up|0|||
162084253|NCT02214121|585361535|FG002|Part B|Lost to Follow-up|1|||
162084254|NCT02375672|585361536|FG000|Overall Study|remain on follow up|20|||
162084255|NCT02203591|585361537|FG000|Overall Study|Did not meet treatment day baseline|147|||
162084256|NCT02203591|585361538|FG001|Overall Study|Did not meet treatment day baseline|141|||
162084257|NCT02203591|585361539|FG002|Overall Study|Did not meet treatment day baseline|150|||
162084258|NCT02203591|585361540|FG003|Overall Study|Did not meet treatment day baseline|45|||
162084259|NCT02203591|585361541|FG004|Overall Study|Did not meet treatment day baseline|33|||
162084260|NCT02203591|585361542|FG005|Overall Study|Did not meet treatment day baseline|35|||
162084261|NCT02203591|585361543|FG006|Overall Study|Did not meet treatment day baseline|29|||
162084262|NCT02203591|585361544|FG007|Overall Study|Did not meet treatment day baseline|12|||
162084263|NCT02203591|585361537|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
162084264|NCT02203591|585361538|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
162084265|NCT02203591|585361539|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
162084266|NCT02203591|585361540|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
162084267|NCT02203591|585361541|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
162084268|NCT02203591|585361542|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
162084269|NCT02203591|585361543|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
162084270|NCT02203591|585361544|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
162084271|NCT04115358|585361545|FG000|Overall Study|exfoliation|0|||
162084272|NCT04115358|585361546|FG001|Overall Study|exfoliation|0|||
162084273|NCT04115358|585361547|FG002|Overall Study|exfoliation|1|||
162084274|NCT01573624|585361550|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
162084275|NCT01573624|585361551|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
162084276|NCT01573624|585361552|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
162084277|NCT01573624|585361553|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
162084278|NCT01573624|585361554|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
162084279|NCT01573624|585361555|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
162084280|NCT01573624|585361556|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
162084281|NCT01573624|585361550|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
162084282|NCT01573624|585361551|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
162084283|NCT01573624|585361552|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
162084284|NCT01573624|585361553|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
162084285|NCT01573624|585361554|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
162084286|NCT01573624|585361555|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
162084287|NCT01573624|585361556|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
162084288|NCT01573624|585361550|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
162084289|NCT01573624|585361551|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
162084290|NCT01573624|585361552|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
162084291|NCT01573624|585361553|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
162084292|NCT01573624|585361554|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
162084293|NCT01573624|585361555|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
162084294|NCT01573624|585361556|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
162084295|NCT01573624|585361550|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
162084296|NCT01573624|585361551|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162084297|NCT01573624|585361552|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
162084298|NCT01573624|585361553|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162084299|NCT01573624|585361554|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162084300|NCT01573624|585361555|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
162084301|NCT01573624|585361556|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
162084302|NCT01573624|585361550|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
162084303|NCT01573624|585361551|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
162084304|NCT01573624|585361552|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
162084305|NCT01573624|585361553|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
162084306|NCT01573624|585361554|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
162084307|NCT01573624|585361555|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
162084308|NCT01573624|585361556|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
162084309|NCT01573624|585361550|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
162084310|NCT01573624|585361551|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
162084311|NCT01573624|585361552|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
162084312|NCT01573624|585361553|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
162084313|NCT01573624|585361554|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
162084314|NCT01573624|585361555|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
162084315|NCT01573624|585361556|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
162084316|NCT01573624|585361550|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
162084317|NCT01573624|585361551|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
162084318|NCT01573624|585361552|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
162084319|NCT01573624|585361553|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
162084320|NCT01573624|585361554|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
162084321|NCT01573624|585361555|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
162084322|NCT01573624|585361556|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
162084323|NCT01573624|585361550|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
162084324|NCT01573624|585361551|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162084325|NCT01573624|585361552|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
162084326|NCT01573624|585361553|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
162084327|NCT01573624|585361554|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162084328|NCT01573624|585361555|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162084329|NCT01573624|585361556|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
162084330|NCT01573624|585361550|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
162084331|NCT01573624|585361551|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
162084332|NCT01573624|585361552|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
162084333|NCT01573624|585361553|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
162084334|NCT01573624|585361554|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
162084335|NCT01573624|585361555|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
162084336|NCT01573624|585361556|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
162084337|NCT01573624|585361550|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162084338|NCT01573624|585361551|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162084339|NCT01573624|585361552|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162084340|NCT01573624|585361553|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
162084341|NCT01573624|585361554|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162084342|NCT01573624|585361555|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
162084343|NCT01573624|585361556|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
162084344|NCT01573624|585361550|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
162084345|NCT01573624|585361551|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
162084346|NCT01573624|585361552|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
162084347|NCT01573624|585361553|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
162084348|NCT01573624|585361554|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
162084349|NCT01573624|585361555|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
162084350|NCT01573624|585361556|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
162084351|NCT01573624|585361550|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
162084352|NCT01573624|585361551|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
162084353|NCT01573624|585361552|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
162084354|NCT01573624|585361553|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
162084355|NCT01573624|585361554|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
162084356|NCT01573624|585361555|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
162084357|NCT01573624|585361556|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
162084358|NCT01573624|585361550|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
162084359|NCT01573624|585361551|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
162084360|NCT01573624|585361552|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
162084361|NCT01573624|585361553|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
162084362|NCT01573624|585361554|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
162084363|NCT01573624|585361555|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
162084364|NCT01573624|585361556|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
162084365|NCT01573624|585361550|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
162084366|NCT01573624|585361551|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
162084367|NCT01573624|585361552|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
162084368|NCT01573624|585361553|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
162084369|NCT01573624|585361554|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
162084370|NCT01573624|585361555|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
162084371|NCT01573624|585361556|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
162084372|NCT01573624|585361550|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
162084373|NCT01573624|585361551|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
162084374|NCT01573624|585361552|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
162084375|NCT01573624|585361553|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
162084376|NCT01573624|585361554|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
162084377|NCT01573624|585361555|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
162084378|NCT01573624|585361556|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
162084379|NCT01573624|585361550|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
162084380|NCT01573624|585361551|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
162084381|NCT01573624|585361552|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
162084382|NCT01573624|585361553|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
162084383|NCT01573624|585361554|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
162084384|NCT01573624|585361555|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
162084385|NCT01573624|585361556|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
162084386|NCT01573624|585361550|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
162084387|NCT01573624|585361551|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
162084388|NCT01573624|585361552|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
162084389|NCT01573624|585361553|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
162084390|NCT01573624|585361554|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
162084391|NCT01573624|585361555|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
162084392|NCT01573624|585361556|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
162084393|NCT01573624|585361550|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
162084394|NCT01573624|585361551|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
162084395|NCT01573624|585361552|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
162084396|NCT01573624|585361553|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
162084397|NCT01573624|585361554|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
162084398|NCT01573624|585361555|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
162084399|NCT01573624|585361556|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
162084400|NCT01573624|585361550|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
162084401|NCT01573624|585361551|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
162084402|NCT01573624|585361552|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
162084403|NCT01573624|585361553|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
162084404|NCT01573624|585361554|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
162084405|NCT01573624|585361555|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
162084406|NCT01573624|585361556|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
162084407|NCT01573624|585361550|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
162084408|NCT01573624|585361551|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
162084409|NCT01573624|585361552|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
162084410|NCT01573624|585361553|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
162084411|NCT01573624|585361554|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
162084412|NCT01573624|585361555|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
162084413|NCT01573624|585361556|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
162084414|NCT01573624|585361550|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162084415|NCT01573624|585361551|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162084416|NCT01573624|585361552|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162084417|NCT01573624|585361553|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162084418|NCT01573624|585361554|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
162084419|NCT01573624|585361555|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
162084420|NCT01573624|585361556|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
162084421|NCT01573624|585361550|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
162084422|NCT01573624|585361551|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
162084423|NCT01573624|585361552|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
162084424|NCT01573624|585361553|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
162084425|NCT01573624|585361554|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
162084426|NCT01573624|585361555|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
162084427|NCT01573624|585361556|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
162084428|NCT01573624|585361550|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
162084429|NCT01573624|585361551|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
162084430|NCT01573624|585361552|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
162084431|NCT01573624|585361553|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
162084432|NCT01573624|585361554|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
162084433|NCT01573624|585361555|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
162084434|NCT01573624|585361556|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
162084435|NCT01573624|585361550|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
162084436|NCT01573624|585361551|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
162084437|NCT01573624|585361552|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
162084438|NCT01573624|585361553|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
162084439|NCT01573624|585361554|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
162084440|NCT01573624|585361555|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
162084441|NCT01573624|585361556|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
162084442|NCT01573624|585361550|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
162084443|NCT01573624|585361551|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
162084444|NCT01573624|585361552|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
162084445|NCT01573624|585361553|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
162084446|NCT01573624|585361554|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
162084447|NCT01573624|585361555|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
162084448|NCT01573624|585361556|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
162084449|NCT01573624|585361550|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
162084450|NCT01573624|585361551|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
162084451|NCT01573624|585361552|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
162084452|NCT01573624|585361553|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
162084453|NCT01573624|585361554|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
162084454|NCT01573624|585361555|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
162084455|NCT01573624|585361556|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
162084456|NCT01573624|585361550|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
162084457|NCT01573624|585361551|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
162084458|NCT01573624|585361552|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
162084459|NCT01573624|585361553|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
162084460|NCT01573624|585361554|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
162084461|NCT01573624|585361555|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
162084462|NCT01573624|585361556|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
162084463|NCT01038778|585361557|FG000|Overall Study|Withdrawal by Subject|0|||
162084464|NCT01038778|585361558|FG001|Overall Study|Withdrawal by Subject|2|||
162084465|NCT01038778|585361559|FG002|Overall Study|Withdrawal by Subject|3|||
162084466|NCT02349711|585363072|FG000|Overall Study|Withdrawal by Subject|2|||
162084467|NCT02349711|585363073|FG001|Overall Study|Withdrawal by Subject|1|||
162084468|NCT02349711|585363072|FG000|Overall Study|Lost to Follow-up|1|||
162084469|NCT02349711|585363073|FG001|Overall Study|Lost to Follow-up|1|||
162084470|NCT01610700|585363077|FG000|Overall Study|Adverse Event|3|||
162084471|NCT01610700|585363078|FG001|Overall Study|Adverse Event|1|||
162084472|NCT01610700|585363077|FG000|Overall Study|Withdrawal by Subject|0|||
162084473|NCT01610700|585363078|FG001|Overall Study|Withdrawal by Subject|1|||
162084474|NCT01610700|585363077|FG000|Overall Study|subject took one dose of street cannabis|0|||
162084475|NCT01610700|585363078|FG001|Overall Study|subject took one dose of street cannabis|1|||
162084476|NCT02143414|585363080|FG000|Induction|Adverse Event|1|||
162084477|NCT02143414|585363081|FG001|Induction|Adverse Event|2|||
162084478|NCT02143414|585363080|FG000|Induction|Death|1|||
162084479|NCT02143414|585363081|FG001|Induction|Death|2|||
162084480|NCT02143414|585363080|FG000|Induction|Patient refusal|1|||
162084481|NCT02143414|585363081|FG001|Induction|Patient refusal|1|||
162084482|NCT02143414|585363080|FG000|Induction|Refractory|1|||
162084483|NCT02143414|585363081|FG001|Induction|Refractory|0|||
162084484|NCT02143414|585363080|FG000|Induction|Began alternative treatment|1|||
162084485|NCT02143414|585363081|FG001|Induction|Began alternative treatment|0|||
162084486|NCT02143414|585363080|FG000|Induction|Ineligible for postremission|5|||
162084487|NCT02143414|585363081|FG001|Induction|Ineligible for postremission|1|||
162084488|NCT02143414|585363080|FG000|Post-remission|Adverse Event|0|||
162084489|NCT02143414|585363081|FG001|Post-remission|Adverse Event|2|||
162084490|NCT02143414|585363080|FG000|Post-remission|Disease progression/relapse|5|||
162084491|NCT02143414|585363081|FG001|Post-remission|Disease progression/relapse|0|||
162084492|NCT02143414|585363080|FG000|Maintenance|Adverse Event|4|||
162084493|NCT02143414|585363081|FG001|Maintenance|Adverse Event|6|||
162084494|NCT02143414|585363080|FG000|Maintenance|Disease progression/relapse|3|||
162084495|NCT02143414|585363081|FG001|Maintenance|Disease progression/relapse|2|||
162084496|NCT02143414|585363080|FG000|Maintenance|Patient refusal|2|||
162084497|NCT02143414|585363081|FG001|Maintenance|Patient refusal|1|||
162084498|NCT02143414|585363080|FG000|Maintenance|Physician Decision|1|||
162084499|NCT02143414|585363081|FG001|Maintenance|Physician Decision|0|||
162084500|NCT02143414|585363080|FG000|Maintenance|Death|0|||
162084501|NCT02143414|585363081|FG001|Maintenance|Death|1|||
162084502|NCT02143414|585363080|FG000|Maintenance|On protocol treatment|0|||
162084503|NCT02143414|585363081|FG001|Maintenance|On protocol treatment|6|||
162084504|NCT00978731|585363085|FG000|Overall Study|Death|4|||
162084505|NCT00978731|585363086|FG001|Overall Study|Death|1|||
162084506|NCT00978731|585363087|FG002|Overall Study|Death|1|||
162084507|NCT00978731|585363088|FG003|Overall Study|Death|0|||
162084508|NCT00978731|585363085|FG000|Overall Study|Lost to Follow-up|0|||
162084509|NCT00978731|585363086|FG001|Overall Study|Lost to Follow-up|0|||
162084510|NCT00978731|585363087|FG002|Overall Study|Lost to Follow-up|0|||
162084511|NCT00978731|585363088|FG003|Overall Study|Lost to Follow-up|1|||
162084512|NCT00978731|585363085|FG000|Overall Study|Adverse Event|5|||
162084513|NCT00978731|585363086|FG001|Overall Study|Adverse Event|2|||
162084514|NCT00978731|585363087|FG002|Overall Study|Adverse Event|0|||
162084515|NCT00978731|585363088|FG003|Overall Study|Adverse Event|0|||
162084516|NCT00978731|585363085|FG000|Overall Study|Participant's request|1|||
162084517|NCT00978731|585363086|FG001|Overall Study|Participant's request|0|||
162084518|NCT00978731|585363087|FG002|Overall Study|Participant's request|0|||
162084519|NCT00978731|585363088|FG003|Overall Study|Participant's request|0|||
162084520|NCT00978731|585363085|FG000|Overall Study|Administrative reason|3|||
162084521|NCT00978731|585363086|FG001|Overall Study|Administrative reason|3|||
162084522|NCT00978731|585363087|FG002|Overall Study|Administrative reason|1|||
162084523|NCT00978731|585363088|FG003|Overall Study|Administrative reason|0|||
162084524|NCT00978731|585363085|FG000|Overall Study|Deterioration without progression|0|||
162084525|NCT00978731|585363086|FG001|Overall Study|Deterioration without progression|1|||
162084526|NCT00978731|585363087|FG002|Overall Study|Deterioration without progression|0|||
162084527|NCT00978731|585363088|FG003|Overall Study|Deterioration without progression|0|||
162084528|NCT00978731|585363085|FG000|Overall Study|Disease progression/relapse|5|||
162084529|NCT00978731|585363086|FG001|Overall Study|Disease progression/relapse|4|||
162084530|NCT00978731|585363087|FG002|Overall Study|Disease progression/relapse|2|||
162084531|NCT00978731|585363088|FG003|Overall Study|Disease progression/relapse|2|||
162084532|NCT00978731|585363085|FG000|Overall Study|Study closure|3|||
162084533|NCT00978731|585363086|FG001|Overall Study|Study closure|4|||
162084534|NCT00978731|585363087|FG002|Overall Study|Study closure|1|||
162084535|NCT00978731|585363088|FG003|Overall Study|Study closure|1|||
162084536|NCT00978731|585363085|FG000|Overall Study|No response|1|||
162084537|NCT00978731|585363086|FG001|Overall Study|No response|0|||
162084538|NCT00978731|585363087|FG002|Overall Study|No response|0|||
162084539|NCT00978731|585363088|FG003|Overall Study|No response|0|||
162084540|NCT03306264|585363093|FG000|Overall Study|Death|33|||
162084541|NCT03306264|585363094|FG001|Overall Study|Death|25|||
162084542|NCT03306264|585363095|FG002|Overall Study|Death|34|||
162084543|NCT03306264|585363096|FG003|Overall Study|Death|34|||
162084544|NCT03306264|585363093|FG000|Overall Study|Complete Consent Withdrawal|4|||
162084545|NCT03306264|585363094|FG001|Overall Study|Complete Consent Withdrawal|4|||
162084546|NCT03306264|585363095|FG002|Overall Study|Complete Consent Withdrawal|1|||
162084547|NCT03306264|585363096|FG003|Overall Study|Complete Consent Withdrawal|8|||
162084548|NCT03306264|585363093|FG000|Overall Study|Lost to Follow-up|1|||
162084549|NCT03306264|585363094|FG001|Overall Study|Lost to Follow-up|0|||
162084550|NCT03306264|585363095|FG002|Overall Study|Lost to Follow-up|1|||
162084551|NCT03306264|585363096|FG003|Overall Study|Lost to Follow-up|0|||
162084552|NCT03306264|585363093|FG000|Overall Study|Rollover to ASTX727-06|10|||
162084553|NCT03306264|585363094|FG001|Overall Study|Rollover to ASTX727-06|18|||
162084554|NCT03306264|585363095|FG002|Overall Study|Rollover to ASTX727-06|4|||
162084555|NCT03306264|585363096|FG003|Overall Study|Rollover to ASTX727-06|2|||
162084556|NCT03306264|585363093|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
162084557|NCT03306264|585363094|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
162084558|NCT03306264|585363095|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
162084559|NCT03306264|585363096|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
162084560|NCT02722928|585363100|FG000|Overall Study|Standard CT was not as required per prot|5|||
162084561|NCT02722928|585363101|FG001|Overall Study|Standard CT was not as required per prot|13|||
162084562|NCT02722928|585363100|FG000|Overall Study|Required Intraoperative MRI|5|||
162084563|NCT02722928|585363101|FG001|Overall Study|Required Intraoperative MRI|7|||
162084564|NCT00094653|585363104|FG000|Overall Study|Death|306|||
162084565|NCT00094653|585363105|FG001|Overall Study|Death|100|||
162084566|NCT00094653|585363106|FG002|Overall Study|Death|119|||
162084567|NCT00094653|585363104|FG000|Overall Study|Subject Withdrew Consent|10|||
162084568|NCT00094653|585363105|FG001|Overall Study|Subject Withdrew Consent|2|||
162084569|NCT00094653|585363106|FG002|Overall Study|Subject Withdrew Consent|3|||
162084570|NCT00094653|585363104|FG000|Overall Study|Other|2|||
162084571|NCT00094653|585363105|FG001|Overall Study|Other|2|||
162084572|NCT00094653|585363106|FG002|Overall Study|Other|2|||
162084573|NCT00094653|585363104|FG000|Overall Study|Lost to Follow-up|3|||
162084574|NCT00094653|585363105|FG001|Overall Study|Lost to Follow-up|2|||
162084575|NCT00094653|585363106|FG002|Overall Study|Lost to Follow-up|1|||
162084576|NCT00094653|585363104|FG000|Overall Study|Protocol Violation|0|||
162084577|NCT00094653|585363105|FG001|Overall Study|Protocol Violation|0|||
162084578|NCT00094653|585363106|FG002|Overall Study|Protocol Violation|1|||
162084579|NCT03921411|585363107|FG000|Overall Study|Withdrawal by Subject|1|||
162084580|NCT03921411|585363107|FG000|Overall Study|Protocol Deviation|2|||
162084581|NCT03921411|585363107|FG000|Overall Study|Enrolled, but never treated|2|||
162084582|NCT02114879|585363108|FG000|Overall Study|Withdrawal by Subject|9|||
162084583|NCT02114879|585363109|FG001|Overall Study|Withdrawal by Subject|5|||
162084584|NCT02114879|585363108|FG000|Overall Study|Death|6|||
162084585|NCT02114879|585363109|FG001|Overall Study|Death|11|||
162084586|NCT02114879|585363108|FG000|Overall Study|Lost to Follow-up|4|||
162084587|NCT02114879|585363109|FG001|Overall Study|Lost to Follow-up|6|||
162084588|NCT02114879|585363108|FG000|Overall Study|Physician Decision|0|||
162084589|NCT02114879|585363109|FG001|Overall Study|Physician Decision|2|||
162084590|NCT05059600|585363112|FG000|Overall Study|Enrolled but not Treated|10|||
162084591|NCT02152995|585363113|FG000|Overall Study|Withdrawal by Subject|1|||
162084592|NCT02152995|585363114|FG001|Overall Study|Withdrawal by Subject|0|||
162084593|NCT01565291|585363115|FG000|Overall Study|Withdrawal by Subject|1|||
162084594|NCT01565291|585363116|FG001|Overall Study|Withdrawal by Subject|0|||
162084595|NCT04552587|585363122|FG000|Overall Study|Lost to Follow-up|4|||
162084596|NCT01822132|585363123|FG000|Overall Study|Lost to Follow-up|4|||
162084597|NCT01822132|585363124|FG001|Overall Study|Lost to Follow-up|2|||
162084598|NCT00313612|585363125|FG000|Overall Study|Patient never received treatment|0|||
162084599|NCT00313612|585363126|FG001|Overall Study|Patient never received treatment|1|||
162084600|NCT04847674|585363127|FG000|Overall Study|Withdrawal by Subject|0|||
162084601|NCT04847674|585363128|FG001|Overall Study|Withdrawal by Subject|1|||
162084602|NCT04847674|585363129|FG002|Overall Study|Withdrawal by Subject|0|||
162084603|NCT04847674|585363127|FG000|Overall Study|Lost to Follow-up|0|||
162084604|NCT04847674|585363128|FG001|Overall Study|Lost to Follow-up|0|||
162084605|NCT04847674|585363129|FG002|Overall Study|Lost to Follow-up|2|||
162084606|NCT04847674|585363127|FG000|Overall Study|Other than specified|21|||
162084607|NCT04847674|585363128|FG001|Overall Study|Other than specified|20|||
162084608|NCT04847674|585363129|FG002|Overall Study|Other than specified|20|||
162084609|NCT00677807|585363132|FG000|Overall Study|Adverse Event|4|||
162084610|NCT00677807|585363133|FG001|Overall Study|Adverse Event|1|||
162084611|NCT00677807|585363134|FG002|Overall Study|Adverse Event|6|||
162084612|NCT00677807|585363132|FG000|Overall Study|Lack of Efficacy|0|||
162084613|NCT00677807|585363133|FG001|Overall Study|Lack of Efficacy|0|||
162084614|NCT00677807|585363134|FG002|Overall Study|Lack of Efficacy|2|||
162084615|NCT00677807|585363132|FG000|Overall Study|Participant no longer needs study drug|0|||
162084616|NCT00677807|585363133|FG001|Overall Study|Participant no longer needs study drug|0|||
162084617|NCT00677807|585363134|FG002|Overall Study|Participant no longer needs study drug|1|||
162084618|NCT00677807|585363132|FG000|Overall Study|Withdrawal by Subject|10|||
162084619|NCT00677807|585363133|FG001|Overall Study|Withdrawal by Subject|3|||
162084620|NCT00677807|585363134|FG002|Overall Study|Withdrawal by Subject|6|||
162084621|NCT00677807|585363132|FG000|Overall Study|Lost to Follow-up|2|||
162084622|NCT00677807|585363133|FG001|Overall Study|Lost to Follow-up|2|||
162084623|NCT00677807|585363134|FG002|Overall Study|Lost to Follow-up|2|||
162084624|NCT00677807|585363132|FG000|Overall Study|Administrative problems|1|||
162084625|NCT00677807|585363133|FG001|Overall Study|Administrative problems|1|||
162084626|NCT00677807|585363134|FG002|Overall Study|Administrative problems|2|||
162084627|NCT00677807|585363132|FG000|Overall Study|Death|0|||
162084628|NCT00677807|585363133|FG001|Overall Study|Death|1|||
162084629|NCT00677807|585363134|FG002|Overall Study|Death|1|||
162084630|NCT00677807|585363132|FG000|Overall Study|Protocol Deviation|1|||
162084631|NCT00677807|585363133|FG001|Overall Study|Protocol Deviation|3|||
162084632|NCT00677807|585363134|FG002|Overall Study|Protocol Deviation|0|||
162084633|NCT01393743|585363135|FG000|Core Study|Adverse Event|5|||
162084634|NCT01393743|585363136|FG001|Core Study|Adverse Event|9|||
162084635|NCT01393743|585363137|FG002|Core Study|Adverse Event|0|||
162084636|NCT01393743|585363135|FG000|Core Study|Lost to Follow-up|1|||
162084637|NCT01393743|585363136|FG001|Core Study|Lost to Follow-up|1|||
162084638|NCT01393743|585363137|FG002|Core Study|Lost to Follow-up|0|||
162084639|NCT01393743|585363135|FG000|Core Study|Participant's Choice|2|||
162084640|NCT01393743|585363136|FG001|Core Study|Participant's Choice|3|||
162084641|NCT01393743|585363137|FG002|Core Study|Participant's Choice|0|||
162084642|NCT01393743|585363135|FG000|Core Study|Inadequate therapeutic effect|2|||
162084643|NCT01393743|585363136|FG001|Core Study|Inadequate therapeutic effect|0|||
162084644|NCT01393743|585363137|FG002|Core Study|Inadequate therapeutic effect|0|||
162084645|NCT01393743|585363135|FG000|Extension Phase|Adverse Event|0|||
162084646|NCT01393743|585363136|FG001|Extension Phase|Adverse Event|0|||
162084647|NCT01393743|585363137|FG002|Extension Phase|Adverse Event|12|||
162084648|NCT01393743|585363135|FG000|Extension Phase|Lost to Follow-up|0|||
162084649|NCT01393743|585363136|FG001|Extension Phase|Lost to Follow-up|0|||
162084650|NCT01393743|585363137|FG002|Extension Phase|Lost to Follow-up|2|||
162084651|NCT01393743|585363135|FG000|Extension Phase|Participant choice|0|||
162084652|NCT01393743|585363136|FG001|Extension Phase|Participant choice|0|||
162084653|NCT01393743|585363137|FG002|Extension Phase|Participant choice|16|||
162084654|NCT01393743|585363135|FG000|Extension Phase|Inadequate therapeutic effect|0|||
162084655|NCT01393743|585363136|FG001|Extension Phase|Inadequate therapeutic effect|0|||
162084656|NCT01393743|585363137|FG002|Extension Phase|Inadequate therapeutic effect|7|||
162084657|NCT01393743|585363135|FG000|Extension Phase|Withdrawal by Subject|0|||
162084658|NCT01393743|585363136|FG001|Extension Phase|Withdrawal by Subject|0|||
162084659|NCT01393743|585363137|FG002|Extension Phase|Withdrawal by Subject|8|||
162084660|NCT01393743|585363135|FG000|Extension Phase|Pregnancy|0|||
162084661|NCT01393743|585363136|FG001|Extension Phase|Pregnancy|0|||
162084662|NCT01393743|585363137|FG002|Extension Phase|Pregnancy|1|||
162084663|NCT01393743|585363135|FG000|Extension Phase|Other|0|||
162084664|NCT01393743|585363136|FG001|Extension Phase|Other|0|||
162084665|NCT01393743|585363137|FG002|Extension Phase|Other|14|||
162084666|NCT01524770|585363143|FG000|First Intervention|Withdrawal by Subject|1|||
162084667|NCT01524770|585363144|FG001|First Intervention|Withdrawal by Subject|0|||
162084668|NCT01524770|585363143|FG000|First Intervention|Adverse Event|1|||
162084669|NCT01524770|585363144|FG001|First Intervention|Adverse Event|1|||
162084670|NCT01524770|585363143|FG000|First Intervention|Protocol Violation|1|||
162084671|NCT01524770|585363144|FG001|First Intervention|Protocol Violation|0|||
162084672|NCT00989833|585363145|FG000|Overall Study|Lost to Follow-up|0|||
162084673|NCT00989833|585363146|FG001|Overall Study|Lost to Follow-up|1|||
162084674|NCT00989833|585363147|FG002|Overall Study|Lost to Follow-up|0|||
162084675|NCT00989833|585363145|FG000|Overall Study|Protocol Violation|1|||
162084676|NCT00989833|585363146|FG001|Overall Study|Protocol Violation|2|||
162084677|NCT00989833|585363147|FG002|Overall Study|Protocol Violation|1|||
162084678|NCT00989833|585363145|FG000|Overall Study|Withdrawal by Subject|0|||
162084679|NCT00989833|585363146|FG001|Overall Study|Withdrawal by Subject|0|||
162084680|NCT00989833|585363147|FG002|Overall Study|Withdrawal by Subject|1|||
162084681|NCT00989833|585363145|FG000|Overall Study|Incorrectly randomized|1|||
162084682|NCT00989833|585363146|FG001|Overall Study|Incorrectly randomized|0|||
162084683|NCT00989833|585363147|FG002|Overall Study|Incorrectly randomized|0|||
162084684|NCT01420081|585363149|FG000|Overall Study|Death|1|||
162084685|NCT01420081|585363150|FG001|Overall Study|Death|0|||
162084686|NCT01420081|585363151|FG002|Overall Study|Death|8|||
162084687|NCT01420081|585363152|FG003|Overall Study|Death|0|||
162084688|NCT01420081|585363153|FG004|Overall Study|Death|7|||
162084689|NCT01420081|585363154|FG005|Overall Study|Death|12|||
162084690|NCT01420081|585363155|FG006|Overall Study|Death|0|||
162084691|NCT01420081|585363156|FG007|Overall Study|Death|1|||
162084692|NCT01420081|585363157|FG008|Overall Study|Death|1|||
162084693|NCT01420081|585363149|FG000|Overall Study|Lost to Follow-up|0|||
162084694|NCT01420081|585363150|FG001|Overall Study|Lost to Follow-up|0|||
162084695|NCT01420081|585363151|FG002|Overall Study|Lost to Follow-up|0|||
162084696|NCT01420081|585363152|FG003|Overall Study|Lost to Follow-up|0|||
162084697|NCT01420081|585363153|FG004|Overall Study|Lost to Follow-up|1|||
162084698|NCT01420081|585363154|FG005|Overall Study|Lost to Follow-up|1|||
162084699|NCT01420081|585363155|FG006|Overall Study|Lost to Follow-up|0|||
162084700|NCT01420081|585363156|FG007|Overall Study|Lost to Follow-up|0|||
162084701|NCT01420081|585363157|FG008|Overall Study|Lost to Follow-up|0|||
162084702|NCT01420081|585363149|FG000|Overall Study|Study Terminated by Sponsor|2|||
162084703|NCT01420081|585363150|FG001|Overall Study|Study Terminated by Sponsor|1|||
162084704|NCT01420081|585363151|FG002|Overall Study|Study Terminated by Sponsor|1|||
162084705|NCT01420081|585363152|FG003|Overall Study|Study Terminated by Sponsor|3|||
162084706|NCT01420081|585363153|FG004|Overall Study|Study Terminated by Sponsor|11|||
162084707|NCT01420081|585363154|FG005|Overall Study|Study Terminated by Sponsor|7|||
162084708|NCT01420081|585363155|FG006|Overall Study|Study Terminated by Sponsor|3|||
162084709|NCT01420081|585363156|FG007|Overall Study|Study Terminated by Sponsor|2|||
162084710|NCT01420081|585363157|FG008|Overall Study|Study Terminated by Sponsor|2|||
162084711|NCT01420081|585363149|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
162084712|NCT01420081|585363150|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
162084713|NCT01420081|585363151|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
162084714|NCT01420081|585363152|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
162084715|NCT01420081|585363153|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
162084716|NCT01420081|585363154|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
162084717|NCT01420081|585363155|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
162084718|NCT01420081|585363156|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
162084719|NCT01420081|585363157|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
162084720|NCT01420081|585363149|FG000|Overall Study|Other Reasons|0|||
162084721|NCT01420081|585363150|FG001|Overall Study|Other Reasons|0|||
162084722|NCT01420081|585363151|FG002|Overall Study|Other Reasons|1|||
162084723|NCT01420081|585363152|FG003|Overall Study|Other Reasons|0|||
162084724|NCT01420081|585363153|FG004|Overall Study|Other Reasons|0|||
162084725|NCT01420081|585363154|FG005|Overall Study|Other Reasons|0|||
162084726|NCT01420081|585363155|FG006|Overall Study|Other Reasons|0|||
162084727|NCT01420081|585363156|FG007|Overall Study|Other Reasons|0|||
162084728|NCT01420081|585363157|FG008|Overall Study|Other Reasons|0|||
162084729|NCT00678561|585363159|FG000|Overall Study|Adverse Event|0|||
162084730|NCT00678561|585363160|FG001|Overall Study|Adverse Event|1|||
162084731|NCT00678561|585363161|FG002|Overall Study|Adverse Event|1|||
162084732|NCT00678561|585363162|FG003|Overall Study|Adverse Event|0|||
162084733|NCT00678561|585363163|FG004|Overall Study|Adverse Event|1|||
162084734|NCT00678561|585363164|FG005|Overall Study|Adverse Event|0|||
162084735|NCT00678561|585363165|FG006|Overall Study|Adverse Event|0|||
162084736|NCT00678561|585363166|FG007|Overall Study|Adverse Event|0|||
162084737|NCT00678561|585363159|FG000|Overall Study|Protocol Violation|0|||
162084738|NCT00678561|585363160|FG001|Overall Study|Protocol Violation|0|||
162084739|NCT00678561|585363161|FG002|Overall Study|Protocol Violation|0|||
162084740|NCT00678561|585363162|FG003|Overall Study|Protocol Violation|0|||
162084741|NCT00678561|585363163|FG004|Overall Study|Protocol Violation|1|||
162084742|NCT00678561|585363164|FG005|Overall Study|Protocol Violation|1|||
162084743|NCT00678561|585363165|FG006|Overall Study|Protocol Violation|0|||
162084744|NCT00678561|585363166|FG007|Overall Study|Protocol Violation|0|||
162084745|NCT00678561|585363159|FG000|Overall Study|Withdrawal by Subject|0|||
162084746|NCT00678561|585363160|FG001|Overall Study|Withdrawal by Subject|0|||
162084747|NCT00678561|585363161|FG002|Overall Study|Withdrawal by Subject|0|||
162084748|NCT00678561|585363162|FG003|Overall Study|Withdrawal by Subject|0|||
162084749|NCT00678561|585363163|FG004|Overall Study|Withdrawal by Subject|0|||
162084750|NCT00678561|585363164|FG005|Overall Study|Withdrawal by Subject|0|||
162084751|NCT00678561|585363165|FG006|Overall Study|Withdrawal by Subject|0|||
162084752|NCT00678561|585363166|FG007|Overall Study|Withdrawal by Subject|1|||
162084753|NCT03080961|585363167|FG000|Overall Study|Withdrawal by Subject|3|||
162084754|NCT00689481|585363168|FG000|Overall Study|Adverse Event|7|||
162084755|NCT00689481|585363169|FG001|Overall Study|Adverse Event|1|||
162084756|NCT00689481|585363168|FG000|Overall Study|Lost to Follow-up|4|||
162084757|NCT00689481|585363169|FG001|Overall Study|Lost to Follow-up|3|||
162084758|NCT00689481|585363168|FG000|Overall Study|Lack of Efficacy|4|||
162084759|NCT00689481|585363169|FG001|Overall Study|Lack of Efficacy|3|||
162084760|NCT00689481|585363168|FG000|Overall Study|Non-compliance with study treatment|1|||
162084761|NCT00689481|585363169|FG001|Overall Study|Non-compliance with study treatment|1|||
162084762|NCT00689481|585363168|FG000|Overall Study|Withdrawal by Subject|8|||
162084763|NCT00689481|585363169|FG001|Overall Study|Withdrawal by Subject|4|||
162084764|NCT00689481|585363168|FG000|Overall Study|Excluded medication started during study|0|||
162084765|NCT00689481|585363169|FG001|Overall Study|Excluded medication started during study|1|||
162084766|NCT00689481|585363168|FG000|Overall Study|Subject early term, left on vacation|0|||
162084767|NCT00689481|585363169|FG001|Overall Study|Subject early term, left on vacation|1|||
162084768|NCT03337724|585363172|FG000|Overall Study|Reason not Specified|12|||
162084769|NCT03337724|585363173|FG001|Overall Study|Reason not Specified|21|||
162084770|NCT03337724|585363174|FG002|Overall Study|Reason not Specified|9|||
162084771|NCT03337724|585363175|FG003|Overall Study|Reason not Specified|9|||
162084772|NCT03337724|585363176|FG004|Overall Study|Reason not Specified|29|||
162084773|NCT03337724|585363172|FG000|Overall Study|Withdrawal by Subject|13|||
162084774|NCT03337724|585363173|FG001|Overall Study|Withdrawal by Subject|15|||
162084775|NCT03337724|585363174|FG002|Overall Study|Withdrawal by Subject|4|||
162084776|NCT03337724|585363175|FG003|Overall Study|Withdrawal by Subject|15|||
162084777|NCT03337724|585363176|FG004|Overall Study|Withdrawal by Subject|6|||
162084778|NCT03337724|585363172|FG000|Overall Study|Protocol Deviation|0|||
162084779|NCT03337724|585363173|FG001|Overall Study|Protocol Deviation|1|||
162084780|NCT03337724|585363174|FG002|Overall Study|Protocol Deviation|1|||
162084781|NCT03337724|585363175|FG003|Overall Study|Protocol Deviation|1|||
162084782|NCT03337724|585363176|FG004|Overall Study|Protocol Deviation|0|||
162084783|NCT03337724|585363172|FG000|Overall Study|Adverse Event|1|||
162084784|NCT03337724|585363173|FG001|Overall Study|Adverse Event|1|||
162084785|NCT03337724|585363174|FG002|Overall Study|Adverse Event|0|||
162084786|NCT03337724|585363175|FG003|Overall Study|Adverse Event|1|||
162084787|NCT03337724|585363176|FG004|Overall Study|Adverse Event|0|||
162084788|NCT03337724|585363172|FG000|Overall Study|Death|40|||
162084789|NCT03337724|585363173|FG001|Overall Study|Death|89|||
162084790|NCT03337724|585363174|FG002|Overall Study|Death|43|||
162084791|NCT03337724|585363175|FG003|Overall Study|Death|76|||
162084792|NCT03337724|585363176|FG004|Overall Study|Death|50|||
162084793|NCT03337724|585363172|FG000|Overall Study|Lost to Follow-up|5|||
162084794|NCT03337724|585363173|FG001|Overall Study|Lost to Follow-up|5|||
162084795|NCT03337724|585363174|FG002|Overall Study|Lost to Follow-up|4|||
162084796|NCT03337724|585363175|FG003|Overall Study|Lost to Follow-up|7|||
162084797|NCT03337724|585363176|FG004|Overall Study|Lost to Follow-up|4|||
162084798|NCT03337724|585363172|FG000|Overall Study|Physician Decision|16|||
162084799|NCT03337724|585363173|FG001|Overall Study|Physician Decision|34|||
162084800|NCT03337724|585363174|FG002|Overall Study|Physician Decision|14|||
162084801|NCT03337724|585363175|FG003|Overall Study|Physician Decision|34|||
162084802|NCT03337724|585363176|FG004|Overall Study|Physician Decision|13|||
162084803|NCT03337724|585363172|FG000|Overall Study|Progressive Disease|0|||
162084804|NCT03337724|585363173|FG001|Overall Study|Progressive Disease|2|||
162084805|NCT03337724|585363174|FG002|Overall Study|Progressive Disease|1|||
162084806|NCT03337724|585363175|FG003|Overall Study|Progressive Disease|2|||
162084807|NCT03337724|585363176|FG004|Overall Study|Progressive Disease|0|||
162084808|NCT03337724|585363172|FG000|Overall Study|Symptomatic Deterioration|0|||
162084809|NCT03337724|585363173|FG001|Overall Study|Symptomatic Deterioration|0|||
162084810|NCT03337724|585363174|FG002|Overall Study|Symptomatic Deterioration|0|||
162084811|NCT03337724|585363175|FG003|Overall Study|Symptomatic Deterioration|1|||
162084812|NCT03337724|585363176|FG004|Overall Study|Symptomatic Deterioration|0|||
162084813|NCT00528528|585363177|FG000|Overall Study|Lost to Follow-up|0|||
162084814|NCT00528528|585363178|FG001|Overall Study|Lost to Follow-up|0|||
162084815|NCT00528528|585363179|FG002|Overall Study|Lost to Follow-up|1|||
162084816|NCT00528528|585363180|FG003|Overall Study|Lost to Follow-up|1|||
162084817|NCT00528528|585363177|FG000|Overall Study|Ineligible to continue the trial|0|||
162084818|NCT00528528|585363178|FG001|Overall Study|Ineligible to continue the trial|0|||
162084819|NCT00528528|585363179|FG002|Overall Study|Ineligible to continue the trial|0|||
162084820|NCT00528528|585363180|FG003|Overall Study|Ineligible to continue the trial|1|||
162084821|NCT00528528|585363177|FG000|Overall Study|Other|0|||
162084822|NCT00528528|585363178|FG001|Overall Study|Other|1|||
162084823|NCT00528528|585363179|FG002|Overall Study|Other|0|||
162084824|NCT00528528|585363180|FG003|Overall Study|Other|0|||
162084825|NCT00528528|585363177|FG000|Overall Study|Withdrawal by Subject|3|||
162084826|NCT00528528|585363178|FG001|Overall Study|Withdrawal by Subject|2|||
162084827|NCT00528528|585363179|FG002|Overall Study|Withdrawal by Subject|1|||
162084828|NCT00528528|585363180|FG003|Overall Study|Withdrawal by Subject|1|||
162084829|NCT00528528|585363177|FG000|Overall Study|Ongoing participant|0|||
162084830|NCT00528528|585363178|FG001|Overall Study|Ongoing participant|0|||
162084831|NCT00528528|585363179|FG002|Overall Study|Ongoing participant|1|||
162084832|NCT00528528|585363180|FG003|Overall Study|Ongoing participant|0|||
162084833|NCT00773097|585363181|FG000|Overall Study|Withdrawal by Subject|1|||
162084834|NCT00773097|585363181|FG000|Overall Study|Physician Decision|6|||
162084835|NCT04602624|585363188|FG000|Overall Study|Protocol Deviation|1|||
162084836|NCT04602624|585363188|FG000|Overall Study|Withdrawal by Participant|1|||
162084837|NCT04084769|585363189|FG000|Overall Study|Protocol Violation|1|||
162084838|NCT04084769|585363190|FG001|Overall Study|Protocol Violation|3|||
162084839|NCT04084769|585363191|FG002|Overall Study|Protocol Violation|0|||
162084840|NCT04084769|585363192|FG003|Overall Study|Protocol Violation|1|||
162084841|NCT04084769|585363189|FG000|Overall Study|Withdrawal by Subject|0|||
162084842|NCT04084769|585363190|FG001|Overall Study|Withdrawal by Subject|1|||
162084843|NCT04084769|585363191|FG002|Overall Study|Withdrawal by Subject|0|||
162084844|NCT04084769|585363192|FG003|Overall Study|Withdrawal by Subject|0|||
162084845|NCT04084769|585363189|FG000|Overall Study|Withdrawal by parent/guardian|1|||
162084846|NCT04084769|585363190|FG001|Overall Study|Withdrawal by parent/guardian|0|||
162084847|NCT04084769|585363191|FG002|Overall Study|Withdrawal by parent/guardian|0|||
162084848|NCT04084769|585363192|FG003|Overall Study|Withdrawal by parent/guardian|1|||
162084849|NCT04084769|585363189|FG000|Overall Study|Lost to Follow-up|2|||
162084850|NCT04084769|585363190|FG001|Overall Study|Lost to Follow-up|0|||
162084851|NCT04084769|585363191|FG002|Overall Study|Lost to Follow-up|0|||
162084852|NCT04084769|585363192|FG003|Overall Study|Lost to Follow-up|0|||
162084853|NCT03508219|585363193|FG000|Overall Study|Death|2|||
162084854|NCT03508219|585363193|FG000|Overall Study|Withdrawal by Subject|1|||
162084855|NCT03508219|585363193|FG000|Overall Study|Lost to Follow-up|4|||
162084856|NCT03508219|585363193|FG000|Overall Study|Missed visit|2|||
162084857|NCT04466891|585363194|FG000|Overall Study|Death|60|||
162084858|NCT04466891|585363195|FG001|Overall Study|Death|6|||
162084859|NCT04466891|585363194|FG000|Overall Study|Withdrawal by Subject|8|||
162084860|NCT04466891|585363195|FG001|Overall Study|Withdrawal by Subject|1|||
162084861|NCT04466891|585363194|FG000|Overall Study|Study terminated by sponsor|5|||
162084862|NCT04466891|585363195|FG001|Overall Study|Study terminated by sponsor|0|||
162084863|NCT04466891|585363194|FG000|Overall Study|Lost to Follow-up|2|||
162084864|NCT04466891|585363195|FG001|Overall Study|Lost to Follow-up|0|||
162084865|NCT04466891|585363194|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
162084866|NCT04466891|585363195|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
162084867|NCT00445328|585363196|FG000|Overall Study|Death|0|||
162084868|NCT00445328|585363197|FG001|Overall Study|Death|1|||
162084869|NCT00445328|585363196|FG000|Overall Study|Adverse Event|0|||
162084870|NCT00445328|585363197|FG001|Overall Study|Adverse Event|3|||
162084871|NCT00445328|585363196|FG000|Overall Study|Other|0|||
162084872|NCT00445328|585363197|FG001|Overall Study|Other|2|||
162084873|NCT00445328|585363196|FG000|Overall Study|Withdrawal by Subject|2|||
162084874|NCT00445328|585363197|FG001|Overall Study|Withdrawal by Subject|0|||
162084875|NCT00445328|585363196|FG000|Overall Study|Protocol Violation|1|||
162084876|NCT00445328|585363197|FG001|Overall Study|Protocol Violation|0|||
162084877|NCT00316199|585363200|FG000|Overall Study|Adverse Event|2|||
162084878|NCT00316199|585363200|FG000|Overall Study|Death|8|||
162084879|NCT00316199|585363200|FG000|Overall Study|Lost to Follow-up|2|||
162084880|NCT04477304|585363201|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
162084881|NCT04477304|585363202|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
162084882|NCT05645432|585363203|FG000|Overall Study|Withdrawal by Subject|1|||
162084883|NCT03107988|585364271|FG000|Overall Study|Adverse Event|0|||
162084884|NCT03107988|585364272|FG001|Overall Study|Adverse Event|0|||
162084885|NCT03107988|585364273|FG002|Overall Study|Adverse Event|0|||
162084886|NCT03107988|585364274|FG003|Overall Study|Adverse Event|1|||
162084887|NCT03107988|585364275|FG004|Overall Study|Adverse Event|0|||
162084888|NCT03107988|585364276|FG005|Overall Study|Adverse Event|1|||
162084889|NCT03107988|585364277|FG006|Overall Study|Adverse Event|0|||
162084890|NCT03107988|585364278|FG007|Overall Study|Adverse Event|1|||
162084891|NCT03107988|585364279|FG008|Overall Study|Adverse Event|0|||
162084892|NCT03107988|585364280|FG009|Overall Study|Adverse Event|0|||
162084893|NCT03107988|585364281|FG010|Overall Study|Adverse Event|0|||
162084894|NCT03107988|585364282|FG011|Overall Study|Adverse Event|0|||
162084895|NCT03107988|585364283|FG012|Overall Study|Adverse Event|0|||
162084896|NCT03107988|585364271|FG000|Overall Study|Disease Progression or Relapse|1|||
162084897|NCT03107988|585364272|FG001|Overall Study|Disease Progression or Relapse|2|||
162084898|NCT03107988|585364273|FG002|Overall Study|Disease Progression or Relapse|2|||
162084899|NCT03107988|585364274|FG003|Overall Study|Disease Progression or Relapse|5|||
162084900|NCT03107988|585364275|FG004|Overall Study|Disease Progression or Relapse|1|||
162084901|NCT03107988|585364276|FG005|Overall Study|Disease Progression or Relapse|1|||
162084902|NCT03107988|585364277|FG006|Overall Study|Disease Progression or Relapse|0|||
162084903|NCT03107988|585364278|FG007|Overall Study|Disease Progression or Relapse|0|||
162084904|NCT03107988|585364279|FG008|Overall Study|Disease Progression or Relapse|0|||
162084905|NCT03107988|585364280|FG009|Overall Study|Disease Progression or Relapse|1|||
162084906|NCT03107988|585364281|FG010|Overall Study|Disease Progression or Relapse|4|||
162084907|NCT03107988|585364282|FG011|Overall Study|Disease Progression or Relapse|0|||
162084908|NCT03107988|585364283|FG012|Overall Study|Disease Progression or Relapse|0|||
162084909|NCT03107988|585364271|FG000|Overall Study|Ineligible|0|||
162084910|NCT03107988|585364272|FG001|Overall Study|Ineligible|0|||
162084911|NCT03107988|585364273|FG002|Overall Study|Ineligible|0|||
162084912|NCT03107988|585364274|FG003|Overall Study|Ineligible|0|||
162084913|NCT03107988|585364275|FG004|Overall Study|Ineligible|0|||
162084914|NCT03107988|585364276|FG005|Overall Study|Ineligible|0|||
162084915|NCT03107988|585364277|FG006|Overall Study|Ineligible|0|||
162084916|NCT03107988|585364278|FG007|Overall Study|Ineligible|0|||
162084917|NCT03107988|585364279|FG008|Overall Study|Ineligible|1|||
162084918|NCT03107988|585364280|FG009|Overall Study|Ineligible|0|||
162084919|NCT03107988|585364281|FG010|Overall Study|Ineligible|0|||
162084920|NCT03107988|585364282|FG011|Overall Study|Ineligible|0|||
162084921|NCT03107988|585364283|FG012|Overall Study|Ineligible|0|||
162084922|NCT01344057|585364284|FG000|Overall Study|Premature Withdrawal|1|||
162084923|NCT00548808|585364285|FG000|Overall Study|Lost to Follow-up|9|||
162084924|NCT00548808|585364286|FG001|Overall Study|Lost to Follow-up|3|||
162084925|NCT00548808|585364285|FG000|Overall Study|Protocol Violation|8|||
162084926|NCT00548808|585364286|FG001|Overall Study|Protocol Violation|8|||
162084927|NCT00548808|585364285|FG000|Overall Study|Withdrawal by Subject|8|||
162084928|NCT00548808|585364286|FG001|Overall Study|Withdrawal by Subject|4|||
162084929|NCT00548808|585364285|FG000|Overall Study|Physician Decision|6|||
162084930|NCT00548808|585364286|FG001|Overall Study|Physician Decision|3|||
162084931|NCT00548808|585364285|FG000|Overall Study|Adverse Event|4|||
162084932|NCT00548808|585364286|FG001|Overall Study|Adverse Event|5|||
162084933|NCT00548808|585364285|FG000|Overall Study|Death|2|||
162084934|NCT00548808|585364286|FG001|Overall Study|Death|0|||
162084935|NCT00548808|585364285|FG000|Overall Study|Entry Criteria Not Met|2|||
162084936|NCT00548808|585364286|FG001|Overall Study|Entry Criteria Not Met|2|||
162084937|NCT00548808|585364285|FG000|Overall Study|Lack of Efficacy|2|||
162084938|NCT00548808|585364286|FG001|Overall Study|Lack of Efficacy|0|||
162084939|NCT00548808|585364285|FG000|Overall Study|Sponsor Decision|1|||
162084940|NCT00548808|585364286|FG001|Overall Study|Sponsor Decision|1|||
162084941|NCT00529386|585364287|FG000|Overall Study|Lost to Follow-up|1|||
162084942|NCT04027686|585364288|FG000|Overall Study|Lost to Follow-up|2|||
162084943|NCT04027686|585364289|FG001|Overall Study|Lost to Follow-up|0|||
162084944|NCT04027686|585364288|FG000|Overall Study|Withdrawal by Subject|0|||
162084945|NCT04027686|585364289|FG001|Overall Study|Withdrawal by Subject|1|||
162084946|NCT02939404|585364290|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
162084947|NCT02939404|585364291|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
162084948|NCT02939404|585364290|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
162084949|NCT02939404|585364291|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
162084950|NCT04456699|585364297|FG000|Overall Study|Death|48|||
162084951|NCT04456699|585364298|FG001|Overall Study|Death|50|||
162084952|NCT04456699|585364299|FG002|Overall Study|Death|52|||
162084953|NCT04456699|585364297|FG000|Overall Study|Physician Decision|0|||
162084954|NCT04456699|585364298|FG001|Overall Study|Physician Decision|0|||
162084955|NCT04456699|585364299|FG002|Overall Study|Physician Decision|2|||
162084956|NCT04456699|585364297|FG000|Overall Study|Sponsor Decision|55|||
162084957|NCT04456699|585364298|FG001|Overall Study|Sponsor Decision|61|||
162084958|NCT04456699|585364299|FG002|Overall Study|Sponsor Decision|50|||
162084959|NCT04456699|585364297|FG000|Overall Study|Withdrawal by Subject|8|||
162084960|NCT04456699|585364298|FG001|Overall Study|Withdrawal by Subject|4|||
162084961|NCT04456699|585364299|FG002|Overall Study|Withdrawal by Subject|5|||
162084962|NCT02075437|585364304|FG000|Overall Study|Withdrawal by Subject|5|||
162084963|NCT02075437|585364304|FG000|Overall Study|Lost to Follow-up|1|||
162084964|NCT03120013|585364308|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
162084965|NCT03120013|585364309|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
162084966|NCT02098109|585364310|FG000|Overall Study|Protocol Violation|3|||
162084967|NCT02098109|585364311|FG001|Overall Study|Protocol Violation|0|||
162084968|NCT01541826|585364312|FG000|Overall Study|Lost to Follow-up|2|||
162084969|NCT01541826|585364313|FG001|Overall Study|Lost to Follow-up|3|||
162084970|NCT01541826|585364314|FG002|Overall Study|Lost to Follow-up|0|||
162084971|NCT01541826|585364312|FG000|Overall Study|Withdrawal by Subject|2|||
162084972|NCT01541826|585364313|FG001|Overall Study|Withdrawal by Subject|0|||
162084973|NCT01541826|585364314|FG002|Overall Study|Withdrawal by Subject|0|||
162084974|NCT00480779|585364318|FG000|Overall Study|Other|2|||
162084975|NCT00480779|585364319|FG001|Overall Study|Other|0|||
162084976|NCT00480779|585364318|FG000|Overall Study|Job and Health-related|0|||
162084977|NCT00480779|585364319|FG001|Overall Study|Job and Health-related|3|||
162084978|NCT01365273|585364320|FG000|Overall Study|Lost to Follow-up|1|||
162084979|NCT01365273|585364321|FG001|Overall Study|Lost to Follow-up|0|||
162084980|NCT01365273|585364320|FG000|Overall Study|Protocol Violation|0|||
162084981|NCT01365273|585364321|FG001|Overall Study|Protocol Violation|1|||
162084982|NCT01365273|585364320|FG000|Overall Study|Physician Decision|1|||
162084983|NCT01365273|585364321|FG001|Overall Study|Physician Decision|0|||
162084984|NCT00854581|585364326|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
162084985|NCT00854581|585364326|FG000|Induction (Up to Day 21)|Death|1|||
162084986|NCT00854581|585364326|FG000|Induction (Up to Day 21)|Physician Decision|1|||
162084987|NCT00854581|585364326|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
162084988|NCT02705820|585364329|FG000|Overall Study|Death|2|||
162084989|NCT02705820|585364329|FG000|Overall Study|Disease Progression|34|||
162084990|NCT02705820|585364329|FG000|Overall Study|Clinical Deterioration|3|||
162084991|NCT02702401|585364331|FG000|Overall Study|Death|242|||
162084992|NCT02702401|585364332|FG001|Overall Study|Death|125|||
162084993|NCT02702401|585364331|FG000|Overall Study|Withdrawal by Subject|15|||
162084994|NCT02702401|585364332|FG001|Overall Study|Withdrawal by Subject|5|||
162084995|NCT02702401|585364331|FG000|Overall Study|Sponsor Decision|19|||
162084996|NCT02702401|585364332|FG001|Overall Study|Sponsor Decision|3|||
162084997|NCT02702401|585364331|FG000|Overall Study|Physician Decision|1|||
162084998|NCT02702401|585364332|FG001|Overall Study|Physician Decision|2|||
162084999|NCT02702401|585364331|FG000|Overall Study|Lost to Follow-up|1|||
162085000|NCT02702401|585364332|FG001|Overall Study|Lost to Follow-up|0|||
162085001|NCT00590954|585364343|FG000|Overall Study|Inevaluable|2|||
162085002|NCT04579679|585364344|FG000|Overall Study|New Antitumor Therapy|6|||
162085003|NCT04579679|585364345|FG001|Overall Study|New Antitumor Therapy|4|||
162085004|NCT04579679|585364346|FG002|Overall Study|New Antitumor Therapy|7|||
162085005|NCT04579679|585364347|FG003|Overall Study|New Antitumor Therapy|0|||
162085006|NCT04579679|585364344|FG000|Overall Study|Withdrawal of Consent|1|||
162085007|NCT04579679|585364345|FG001|Overall Study|Withdrawal of Consent|1|||
162085008|NCT04579679|585364346|FG002|Overall Study|Withdrawal of Consent|2|||
162085009|NCT04579679|585364347|FG003|Overall Study|Withdrawal of Consent|4|||
162085010|NCT04579679|585364344|FG000|Overall Study|Death|2|||
162085011|NCT04579679|585364345|FG001|Overall Study|Death|2|||
162085012|NCT04579679|585364346|FG002|Overall Study|Death|2|||
162085013|NCT04579679|585364347|FG003|Overall Study|Death|0|||
162085014|NCT04579679|585364344|FG000|Overall Study|Adverse Event|0|||
162085015|NCT04579679|585364345|FG001|Overall Study|Adverse Event|4|||
162085016|NCT04579679|585364346|FG002|Overall Study|Adverse Event|0|||
162085017|NCT04579679|585364347|FG003|Overall Study|Adverse Event|0|||
162085018|NCT04579679|585364344|FG000|Overall Study|Disease Progression|9|||
162085019|NCT04579679|585364345|FG001|Overall Study|Disease Progression|13|||
162085020|NCT04579679|585364346|FG002|Overall Study|Disease Progression|7|||
162085021|NCT04579679|585364347|FG003|Overall Study|Disease Progression|0|||
162085022|NCT04579679|585364344|FG000|Overall Study|Physician Decision|0|||
162085023|NCT04579679|585364345|FG001|Overall Study|Physician Decision|0|||
162085024|NCT04579679|585364346|FG002|Overall Study|Physician Decision|1|||
162085025|NCT04579679|585364347|FG003|Overall Study|Physician Decision|0|||
162085026|NCT04579679|585364344|FG000|Overall Study|Study Terminated by Sponsor|2|||
162085027|NCT04579679|585364345|FG001|Overall Study|Study Terminated by Sponsor|7|||
162085028|NCT04579679|585364346|FG002|Overall Study|Study Terminated by Sponsor|1|||
162085029|NCT04579679|585364347|FG003|Overall Study|Study Terminated by Sponsor|0|||
162085030|NCT02782949|585364349|FG000|Overall Study|Protocol Violation|1|||
162085031|NCT02782949|585364350|FG001|Overall Study|Protocol Violation|0|||
162085032|NCT02782949|585364349|FG000|Overall Study|Withdrawal by Subject|0|||
162085033|NCT02782949|585364350|FG001|Overall Study|Withdrawal by Subject|1|||
162085034|NCT03238911|585364356|FG000|Overall Study|Withdrawal by Subject|1|||
162085035|NCT03238911|585364357|FG001|Overall Study|Withdrawal by Subject|2|||
162085036|NCT03238911|585364356|FG000|Overall Study|Lost to Follow-up|2|||
162085037|NCT03238911|585364357|FG001|Overall Study|Lost to Follow-up|1|||
162085038|NCT03091192|585364361|FG000|Overall Study|Study terminated by sponsor|21|||
162085039|NCT03091192|585364362|FG001|Overall Study|Study terminated by sponsor|14|||
162085040|NCT03091192|585364361|FG000|Overall Study|Death|9|||
162085041|NCT03091192|585364362|FG001|Overall Study|Death|13|||
162085042|NCT03091192|585364361|FG000|Overall Study|Withdrawal by Subject|2|||
162085043|NCT03091192|585364362|FG001|Overall Study|Withdrawal by Subject|0|||
162085044|NCT03091192|585364361|FG000|Overall Study|Lost to Follow-up|1|||
162085045|NCT03091192|585364362|FG001|Overall Study|Lost to Follow-up|0|||
162085046|NCT06023394|585364363|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
162085047|NCT06023394|585364364|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
162085048|NCT06023394|585364363|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
162085049|NCT06023394|585364364|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
162085050|NCT06023394|585364363|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
162085051|NCT06023394|585364364|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
162085052|NCT06023394|585364363|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
162085053|NCT06023394|585364364|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
162085054|NCT03195478|585364365|FG000|Overall Study|Disease Progression|5|||
162085055|NCT03195478|585364366|FG001|Overall Study|Disease Progression|4|||
162085056|NCT03195478|585364367|FG002|Overall Study|Disease Progression|6|||
162085057|NCT03195478|585364368|FG003|Overall Study|Disease Progression|1|||
162085058|NCT03195478|585364365|FG000|Overall Study|Study Drug Toxicity|2|||
162085059|NCT03195478|585364366|FG001|Overall Study|Study Drug Toxicity|0|||
162085060|NCT03195478|585364367|FG002|Overall Study|Study Drug Toxicity|0|||
162085061|NCT03195478|585364368|FG003|Overall Study|Study Drug Toxicity|1|||
162085062|NCT03195478|585364365|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
162085063|NCT03195478|585364366|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
162085064|NCT03195478|585364367|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
162085065|NCT03195478|585364368|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
162085066|NCT03195478|585364365|FG000|Overall Study|Participant Withdrew Consent|1|||
162085067|NCT03195478|585364366|FG001|Overall Study|Participant Withdrew Consent|0|||
162085068|NCT03195478|585364367|FG002|Overall Study|Participant Withdrew Consent|0|||
162085069|NCT03195478|585364368|FG003|Overall Study|Participant Withdrew Consent|0|||
162085070|NCT03195478|585364365|FG000|Overall Study|Maximum Clinical benefit|0|||
162085071|NCT03195478|585364366|FG001|Overall Study|Maximum Clinical benefit|0|||
162085072|NCT03195478|585364367|FG002|Overall Study|Maximum Clinical benefit|1|||
162085073|NCT03195478|585364368|FG003|Overall Study|Maximum Clinical benefit|0|||
162085074|NCT03195478|585364365|FG000|Overall Study|Other Reasons|0|||
162085075|NCT03195478|585364366|FG001|Overall Study|Other Reasons|0|||
162085076|NCT03195478|585364367|FG002|Overall Study|Other Reasons|1|||
162085077|NCT03195478|585364368|FG003|Overall Study|Other Reasons|0|||
162085078|NCT03370341|585365938|FG000|Overall Study|Lost to Follow-up|0|||
162085079|NCT03370341|585365939|FG001|Overall Study|Lost to Follow-up|1|||
162085080|NCT01707004|585365942|FG000|Overall Study|Physician Decision|3|||
162085081|NCT02573324|585365946|FG000|Overall Study|Withdrawal by Subject|26|||
162085082|NCT02573324|585365947|FG001|Overall Study|Withdrawal by Subject|23|||
162085083|NCT02573324|585365948|FG002|Overall Study|Withdrawal by Subject|3|||
162085084|NCT02573324|585365946|FG000|Overall Study|Lost to Follow-up|4|||
162085085|NCT02573324|585365947|FG001|Overall Study|Lost to Follow-up|5|||
162085086|NCT02573324|585365948|FG002|Overall Study|Lost to Follow-up|0|||
162085087|NCT02573324|585365946|FG000|Overall Study|Study Terminated by Sponsor|107|||
162085088|NCT02573324|585365947|FG001|Overall Study|Study Terminated by Sponsor|89|||
162085089|NCT02573324|585365948|FG002|Overall Study|Study Terminated by Sponsor|2|||
162085090|NCT02573324|585365946|FG000|Overall Study|Death|182|||
162085091|NCT02573324|585365947|FG001|Overall Study|Death|200|||
162085092|NCT02573324|585365948|FG002|Overall Study|Death|1|||
162085093|NCT02573324|585365946|FG000|Overall Study|Other, Not Specified|20|||
162085094|NCT02573324|585365947|FG001|Overall Study|Other, Not Specified|27|||
162085095|NCT02573324|585365948|FG002|Overall Study|Other, Not Specified|0|||
162085096|NCT02573324|585365946|FG000|Overall Study|Unknown Reason|2|||
162085097|NCT02573324|585365947|FG001|Overall Study|Unknown Reason|0|||
162085098|NCT02573324|585365948|FG002|Overall Study|Unknown Reason|0|||
162085099|NCT01607905|585365949|FG000|Overall Study|Withdrawal by participant|7|||
162085100|NCT01607905|585365950|FG001|Overall Study|Withdrawal by participant|2|||
162085101|NCT01607905|585365951|FG002|Overall Study|Withdrawal by participant|4|||
162085102|NCT01607905|585365952|FG003|Overall Study|Withdrawal by participant|6|||
162085103|NCT01607905|585365953|FG004|Overall Study|Withdrawal by participant|0|||
162085104|NCT01607905|585365954|FG005|Overall Study|Withdrawal by participant|4|||
162085105|NCT01607905|585365955|FG006|Overall Study|Withdrawal by participant|12|||
162085106|NCT01607905|585365949|FG000|Overall Study|Incidence or severity of AEs|5|||
162085107|NCT01607905|585365950|FG001|Overall Study|Incidence or severity of AEs|1|||
162085108|NCT01607905|585365951|FG002|Overall Study|Incidence or severity of AEs|1|||
162085109|NCT01607905|585365952|FG003|Overall Study|Incidence or severity of AEs|3|||
162085110|NCT01607905|585365953|FG004|Overall Study|Incidence or severity of AEs|0|||
162085111|NCT01607905|585365954|FG005|Overall Study|Incidence or severity of AEs|2|||
162085112|NCT01607905|585365955|FG006|Overall Study|Incidence or severity of AEs|8|||
162085113|NCT01607905|585365949|FG000|Overall Study|Disease progression|44|||
162085114|NCT01607905|585365950|FG001|Overall Study|Disease progression|16|||
162085115|NCT01607905|585365951|FG002|Overall Study|Disease progression|15|||
162085116|NCT01607905|585365952|FG003|Overall Study|Disease progression|11|||
162085117|NCT01607905|585365953|FG004|Overall Study|Disease progression|6|||
162085118|NCT01607905|585365954|FG005|Overall Study|Disease progression|7|||
162085119|NCT01607905|585365955|FG006|Overall Study|Disease progression|21|||
162085120|NCT01607905|585365949|FG000|Overall Study|Non-compliance with study procedures|0|||
162085121|NCT01607905|585365950|FG001|Overall Study|Non-compliance with study procedures|0|||
162085122|NCT01607905|585365951|FG002|Overall Study|Non-compliance with study procedures|0|||
162085123|NCT01607905|585365952|FG003|Overall Study|Non-compliance with study procedures|0|||
162085124|NCT01607905|585365953|FG004|Overall Study|Non-compliance with study procedures|0|||
162085125|NCT01607905|585365954|FG005|Overall Study|Non-compliance with study procedures|0|||
162085126|NCT01607905|585365955|FG006|Overall Study|Non-compliance with study procedures|1|||
162085127|NCT01607905|585365949|FG000|Overall Study|Death|1|||
162085128|NCT01607905|585365950|FG001|Overall Study|Death|1|||
162085129|NCT01607905|585365951|FG002|Overall Study|Death|1|||
162085130|NCT01607905|585365952|FG003|Overall Study|Death|1|||
162085131|NCT01607905|585365953|FG004|Overall Study|Death|0|||
162085132|NCT01607905|585365954|FG005|Overall Study|Death|0|||
162085133|NCT01607905|585365955|FG006|Overall Study|Death|3|||
162085134|NCT01607905|585365949|FG000|Overall Study|Other treatments become available|1|||
162085135|NCT01607905|585365950|FG001|Overall Study|Other treatments become available|0|||
162085136|NCT01607905|585365951|FG002|Overall Study|Other treatments become available|0|||
162085137|NCT01607905|585365952|FG003|Overall Study|Other treatments become available|0|||
162085138|NCT01607905|585365953|FG004|Overall Study|Other treatments become available|0|||
162085139|NCT01607905|585365954|FG005|Overall Study|Other treatments become available|0|||
162085140|NCT01607905|585365955|FG006|Overall Study|Other treatments become available|1|||
162085141|NCT01607905|585365949|FG000|Overall Study|Investigator discretion|0|||
162085142|NCT01607905|585365950|FG001|Overall Study|Investigator discretion|0|||
162085143|NCT01607905|585365951|FG002|Overall Study|Investigator discretion|0|||
162085144|NCT01607905|585365952|FG003|Overall Study|Investigator discretion|0|||
162085145|NCT01607905|585365953|FG004|Overall Study|Investigator discretion|0|||
162085146|NCT01607905|585365954|FG005|Overall Study|Investigator discretion|1|||
162085147|NCT01607905|585365955|FG006|Overall Study|Investigator discretion|0|||
162085148|NCT01607905|585365949|FG000|Overall Study|Other|1|||
162085149|NCT01607905|585365950|FG001|Overall Study|Other|0|||
162085150|NCT01607905|585365951|FG002|Overall Study|Other|0|||
162085151|NCT01607905|585365952|FG003|Overall Study|Other|0|||
162085152|NCT01607905|585365953|FG004|Overall Study|Other|0|||
162085153|NCT01607905|585365954|FG005|Overall Study|Other|0|||
162085154|NCT01607905|585365955|FG006|Overall Study|Other|1|||
162085155|NCT01607905|585365949|FG000|Overall Study|Randomized but not treated|1|||
162085156|NCT01607905|585365950|FG001|Overall Study|Randomized but not treated|0|||
162085157|NCT01607905|585365951|FG002|Overall Study|Randomized but not treated|0|||
162085158|NCT01607905|585365952|FG003|Overall Study|Randomized but not treated|0|||
162085159|NCT01607905|585365953|FG004|Overall Study|Randomized but not treated|1|||
162085160|NCT01607905|585365954|FG005|Overall Study|Randomized but not treated|1|||
162085161|NCT01607905|585365955|FG006|Overall Study|Randomized but not treated|0|||
162085162|NCT00941733|585365956|FG000|Overall Study|Death|24|||
162085163|NCT00941733|585365957|FG001|Overall Study|Death|10|||
162085164|NCT00941733|585365956|FG000|Overall Study|Withdrawal by Subject|14|||
162085165|NCT00941733|585365957|FG001|Overall Study|Withdrawal by Subject|6|||
162085166|NCT00941733|585365956|FG000|Overall Study|Adverse Event|20|||
162085167|NCT00941733|585365957|FG001|Overall Study|Adverse Event|4|||
162085168|NCT00941733|585365956|FG000|Overall Study|Lost to Follow-up|1|||
162085169|NCT00941733|585365957|FG001|Overall Study|Lost to Follow-up|2|||
162085170|NCT00941733|585365956|FG000|Overall Study|Protocol Violation|15|||
162085171|NCT00941733|585365957|FG001|Overall Study|Protocol Violation|6|||
162085172|NCT00194012|585365958|FG000|Randomized Phase|Lack of Efficacy|8|||
162085173|NCT00194012|585365959|FG001|Randomized Phase|Lack of Efficacy|18|||
162085174|NCT00194012|585365958|FG000|Randomized Phase|Study nonadherence|2|||
162085175|NCT00194012|585365959|FG001|Randomized Phase|Study nonadherence|1|||
162085176|NCT00194012|585365958|FG000|Randomized Phase|Withdrawal by Subject|3|||
162085177|NCT00194012|585365959|FG001|Randomized Phase|Withdrawal by Subject|3|||
162085178|NCT00194012|585365958|FG000|Randomized Phase|Adverse Event|2|||
162085179|NCT00194012|585365959|FG001|Randomized Phase|Adverse Event|1|||
162085180|NCT00194012|585365958|FG000|Randomized Phase|Participant reported having a rash|1|||
162085181|NCT00194012|585365959|FG001|Randomized Phase|Participant reported having a rash|0|||
162085182|NCT00194012|585365958|FG000|Randomized Phase|Emesis and enuresis|0|||
162085183|NCT00194012|585365959|FG001|Randomized Phase|Emesis and enuresis|1|||
162085184|NCT00194012|585365958|FG000|Randomized Phase|Oral/nasal twitching|0|||
162085185|NCT00194012|585365959|FG001|Randomized Phase|Oral/nasal twitching|1|||
162085186|NCT00194012|585365958|FG000|Open Label Extension (OLE)|Weight Gain|1|||
162085187|NCT00194012|585365959|FG001|Open Label Extension (OLE)|Weight Gain|0|||
162085188|NCT00194012|585365958|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
162085189|NCT00194012|585365959|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
162085190|NCT00194012|585365958|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
162085191|NCT00194012|585365959|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
162085192|NCT00194012|585365958|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
162085193|NCT00194012|585365959|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
162085194|NCT01105533|585365960|FG000|Overall Study|Death|0|||
162085195|NCT01105533|585365961|FG001|Overall Study|Death|0|||
162085196|NCT01105533|585365962|FG002|Overall Study|Death|0|||
162085197|NCT01105533|585365963|FG003|Overall Study|Death|0|||
162085198|NCT01105533|585365964|FG004|Overall Study|Death|1|||
162085199|NCT01105533|585365965|FG005|Overall Study|Death|0|||
162085200|NCT01105533|585365966|FG006|Overall Study|Death|0|||
162085201|NCT01105533|585365967|FG007|Overall Study|Death|0|||
162085202|NCT01105533|585365968|FG008|Overall Study|Death|0|||
162085203|NCT01105533|585365960|FG000|Overall Study|Lack of Efficacy|1|||
162085204|NCT01105533|585365961|FG001|Overall Study|Lack of Efficacy|1|||
162085205|NCT01105533|585365962|FG002|Overall Study|Lack of Efficacy|3|||
162085206|NCT01105533|585365963|FG003|Overall Study|Lack of Efficacy|3|||
162085207|NCT01105533|585365964|FG004|Overall Study|Lack of Efficacy|4|||
162085208|NCT01105533|585365965|FG005|Overall Study|Lack of Efficacy|5|||
162085209|NCT01105533|585365966|FG006|Overall Study|Lack of Efficacy|3|||
162085210|NCT01105533|585365967|FG007|Overall Study|Lack of Efficacy|2|||
162085211|NCT01105533|585365968|FG008|Overall Study|Lack of Efficacy|9|||
162085212|NCT01105533|585365960|FG000|Overall Study|Adverse Event|0|||
162085213|NCT01105533|585365961|FG001|Overall Study|Adverse Event|0|||
162085214|NCT01105533|585365962|FG002|Overall Study|Adverse Event|0|||
162085215|NCT01105533|585365963|FG003|Overall Study|Adverse Event|0|||
162085216|NCT01105533|585365964|FG004|Overall Study|Adverse Event|1|||
162085217|NCT01105533|585365965|FG005|Overall Study|Adverse Event|2|||
162085218|NCT01105533|585365966|FG006|Overall Study|Adverse Event|2|||
162085219|NCT01105533|585365967|FG007|Overall Study|Adverse Event|0|||
162085220|NCT01105533|585365968|FG008|Overall Study|Adverse Event|1|||
162085221|NCT01105533|585365960|FG000|Overall Study|Other|0|||
162085222|NCT01105533|585365961|FG001|Overall Study|Other|0|||
162085223|NCT01105533|585365962|FG002|Overall Study|Other|0|||
162085224|NCT01105533|585365963|FG003|Overall Study|Other|0|||
162085225|NCT01105533|585365964|FG004|Overall Study|Other|1|||
162085226|NCT01105533|585365965|FG005|Overall Study|Other|0|||
162085227|NCT01105533|585365966|FG006|Overall Study|Other|3|||
162085228|NCT01105533|585365967|FG007|Overall Study|Other|1|||
162085229|NCT01105533|585365968|FG008|Overall Study|Other|2|||
162085230|NCT01105533|585365960|FG000|Overall Study|Physician Decision|0|||
162085231|NCT01105533|585365961|FG001|Overall Study|Physician Decision|0|||
162085232|NCT01105533|585365962|FG002|Overall Study|Physician Decision|0|||
162085233|NCT01105533|585365963|FG003|Overall Study|Physician Decision|0|||
162085234|NCT01105533|585365964|FG004|Overall Study|Physician Decision|0|||
162085235|NCT01105533|585365965|FG005|Overall Study|Physician Decision|0|||
162085236|NCT01105533|585365966|FG006|Overall Study|Physician Decision|0|||
162085237|NCT01105533|585365967|FG007|Overall Study|Physician Decision|1|||
162085238|NCT01105533|585365968|FG008|Overall Study|Physician Decision|0|||
162085239|NCT03892889|585365969|FG000|Overall Study|Adverse Event|17|||
162085240|NCT03892889|585365969|FG000|Overall Study|Lack of Efficacy|1|||
162085241|NCT03892889|585365969|FG000|Overall Study|Lost to Follow-up|46|||
162085242|NCT03892889|585365969|FG000|Overall Study|Non-compliance with study drug|22|||
162085243|NCT03892889|585365969|FG000|Overall Study|Pregnancy|1|||
162085244|NCT03892889|585365969|FG000|Overall Study|Protocol Deviation|3|||
162085245|NCT03892889|585365969|FG000|Overall Study|Withdrawal by Subject|50|||
162085246|NCT03892889|585365969|FG000|Overall Study|Withdrawal by Caregiver|1|||
162085247|NCT03892889|585365969|FG000|Overall Study|Study Terminated by Sponsor|50|||
162085248|NCT03892889|585365969|FG000|Overall Study|Physician Decision|8|||
162085249|NCT03892889|585365969|FG000|Overall Study|Reason not Specified|5|||
162085250|NCT01639001|585365978|FG000|Overall Study|Refused further follow-up|9|||
162085251|NCT01639001|585365979|FG001|Overall Study|Refused further follow-up|12|||
162085252|NCT01639001|585365978|FG000|Overall Study|Lost to Follow-up|3|||
162085253|NCT01639001|585365979|FG001|Overall Study|Lost to Follow-up|0|||
162085254|NCT01639001|585365978|FG000|Overall Study|Death|62|||
162085255|NCT01639001|585365979|FG001|Overall Study|Death|61|||
162085256|NCT01639001|585365978|FG000|Overall Study|Randomized but not treated|0|||
162085257|NCT01639001|585365979|FG001|Overall Study|Randomized but not treated|2|||
162085258|NCT01639001|585365978|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
162085259|NCT01639001|585365979|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
162085260|NCT02097134|585365980|FG000|Overall Study|Physician Decision|4|||
162085261|NCT02097134|585365980|FG000|Overall Study|Non-Protocol Therapy|1|||
162085262|NCT02097134|585365980|FG000|Overall Study|Progressive Disease|3|||
162085263|NCT02097134|585365980|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
162085264|NCT00679341|585365982|FG000|Overall Study|Disease progression|42|||
162085265|NCT00679341|585365983|FG001|Overall Study|Disease progression|36|||
162085266|NCT00679341|585365982|FG000|Overall Study|Adverse Event|5|||
162085267|NCT00679341|585365983|FG001|Overall Study|Adverse Event|6|||
162085268|NCT00679341|585365982|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
162085269|NCT00679341|585365983|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
162085270|NCT00679341|585365982|FG000|Overall Study|Death|1|||
162085271|NCT00679341|585365983|FG001|Overall Study|Death|1|||
162085272|NCT00679341|585365982|FG000|Overall Study|Other|1|||
162085273|NCT00679341|585365983|FG001|Overall Study|Other|0|||
162085274|NCT00679341|585365982|FG000|Overall Study|Physician Decision|1|||
162085275|NCT00679341|585365983|FG001|Overall Study|Physician Decision|0|||
162085276|NCT00679341|585365982|FG000|Overall Study|Not treated|0|||
162085277|NCT00679341|585365983|FG001|Overall Study|Not treated|2|||
162085278|NCT00679341|585365982|FG000|Overall Study|Physician/patient decision to withdraw|0|||
162085279|NCT00679341|585365983|FG001|Overall Study|Physician/patient decision to withdraw|6|||
162085280|NCT00298896|585365987|FG000|Overall Study|Death|3|||
162085281|NCT00298896|585365987|FG000|Overall Study|Physician Decision|2|||
162085282|NCT00298896|585365987|FG000|Overall Study|Intercurrent Illness|1|||
162085283|NCT00298896|585365987|FG000|Overall Study|Disease Progression|41|||
162085284|NCT00298896|585365987|FG000|Overall Study|Withdrawal by Subject|2|||
162085285|NCT00298896|585365987|FG000|Overall Study|Assigned to treatment in error|1|||
162085286|NCT02880371|585365988|FG000|Phase 1b|Lost to Follow-up|1|||
162085287|NCT02880371|585365989|FG001|Phase 1b|Lost to Follow-up|0|||
162085288|NCT02880371|585365990|FG002|Phase 1b|Lost to Follow-up|0|||
162085289|NCT02880371|585365991|FG003|Phase 1b|Lost to Follow-up|0|||
162085290|NCT02880371|585365992|FG004|Phase 1b|Lost to Follow-up|0|||
162085291|NCT02880371|585365993|FG005|Phase 1b|Lost to Follow-up|0|||
162085292|NCT02880371|585365994|FG006|Phase 1b|Lost to Follow-up|0|||
162085293|NCT02880371|585365995|FG007|Phase 1b|Lost to Follow-up|0|||
162085294|NCT02880371|585365988|FG000|Phase 1b|Participants terminated by Sponsor|1|||
162085295|NCT02880371|585365989|FG001|Phase 1b|Participants terminated by Sponsor|0|||
162085296|NCT02880371|585365990|FG002|Phase 1b|Participants terminated by Sponsor|0|||
162085297|NCT02880371|585365991|FG003|Phase 1b|Participants terminated by Sponsor|0|||
162085298|NCT02880371|585365992|FG004|Phase 1b|Participants terminated by Sponsor|0|||
162085299|NCT02880371|585365993|FG005|Phase 1b|Participants terminated by Sponsor|0|||
162085300|NCT02880371|585365994|FG006|Phase 1b|Participants terminated by Sponsor|0|||
162085301|NCT02880371|585365995|FG007|Phase 1b|Participants terminated by Sponsor|0|||
162085302|NCT02880371|585365988|FG000|Phase 1b|Withdrawal by Subject|0|||
162085303|NCT02880371|585365989|FG001|Phase 1b|Withdrawal by Subject|0|||
162085304|NCT02880371|585365990|FG002|Phase 1b|Withdrawal by Subject|1|||
162085305|NCT02880371|585365991|FG003|Phase 1b|Withdrawal by Subject|0|||
162085306|NCT02880371|585365992|FG004|Phase 1b|Withdrawal by Subject|0|||
162085307|NCT02880371|585365993|FG005|Phase 1b|Withdrawal by Subject|0|||
162085308|NCT02880371|585365994|FG006|Phase 1b|Withdrawal by Subject|0|||
162085309|NCT02880371|585365995|FG007|Phase 1b|Withdrawal by Subject|0|||
162085310|NCT02880371|585365988|FG000|Phase 1b|Death|4|||
162085311|NCT02880371|585365989|FG001|Phase 1b|Death|6|||
162085312|NCT02880371|585365990|FG002|Phase 1b|Death|5|||
162085313|NCT02880371|585365991|FG003|Phase 1b|Death|1|||
162085314|NCT02880371|585365992|FG004|Phase 1b|Death|0|||
162085315|NCT02880371|585365993|FG005|Phase 1b|Death|0|||
162085316|NCT02880371|585365994|FG006|Phase 1b|Death|0|||
162085317|NCT02880371|585365995|FG007|Phase 1b|Death|0|||
162085318|NCT02880371|585365988|FG000|Phase 1b|Enrolled but not Treated|0|||
162085319|NCT02880371|585365989|FG001|Phase 1b|Enrolled but not Treated|1|||
162085320|NCT02880371|585365990|FG002|Phase 1b|Enrolled but not Treated|0|||
162085321|NCT02880371|585365991|FG003|Phase 1b|Enrolled but not Treated|0|||
162085322|NCT02880371|585365992|FG004|Phase 1b|Enrolled but not Treated|0|||
162085323|NCT02880371|585365993|FG005|Phase 1b|Enrolled but not Treated|0|||
162085324|NCT02880371|585365994|FG006|Phase 1b|Enrolled but not Treated|0|||
162085325|NCT02880371|585365995|FG007|Phase 1b|Enrolled but not Treated|0|||
162085326|NCT02880371|585365988|FG000|Phase 2|Enrolled but not Treated|0|||
162085327|NCT02880371|585365989|FG001|Phase 2|Enrolled but not Treated|0|||
162085328|NCT02880371|585365990|FG002|Phase 2|Enrolled but not Treated|0|||
162085329|NCT02880371|585365991|FG003|Phase 2|Enrolled but not Treated|0|||
162085330|NCT02880371|585365992|FG004|Phase 2|Enrolled but not Treated|0|||
162085331|NCT02880371|585365993|FG005|Phase 2|Enrolled but not Treated|1|||
162085332|NCT02880371|585365994|FG006|Phase 2|Enrolled but not Treated|1|||
162085333|NCT02880371|585365995|FG007|Phase 2|Enrolled but not Treated|0|||
162085334|NCT02880371|585365988|FG000|Phase 2|Other|0|||
162085335|NCT02880371|585365989|FG001|Phase 2|Other|0|||
162085336|NCT02880371|585365990|FG002|Phase 2|Other|0|||
162085337|NCT02880371|585365991|FG003|Phase 2|Other|0|||
162085338|NCT02880371|585365992|FG004|Phase 2|Other|0|||
162085339|NCT02880371|585365993|FG005|Phase 2|Other|1|||
162085340|NCT02880371|585365994|FG006|Phase 2|Other|2|||
162085341|NCT02880371|585365995|FG007|Phase 2|Other|1|||
162085342|NCT02880371|585365988|FG000|Phase 2|Participants terminated by Sponsor|0|||
162085343|NCT02880371|585365989|FG001|Phase 2|Participants terminated by Sponsor|0|||
162085344|NCT02880371|585365990|FG002|Phase 2|Participants terminated by Sponsor|0|||
162085345|NCT02880371|585365991|FG003|Phase 2|Participants terminated by Sponsor|0|||
162085346|NCT02880371|585365992|FG004|Phase 2|Participants terminated by Sponsor|1|||
162085347|NCT02880371|585365993|FG005|Phase 2|Participants terminated by Sponsor|6|||
162085348|NCT02880371|585365994|FG006|Phase 2|Participants terminated by Sponsor|1|||
162085349|NCT02880371|585365995|FG007|Phase 2|Participants terminated by Sponsor|5|||
162085350|NCT02880371|585365988|FG000|Phase 2|Death|0|||
162085351|NCT02880371|585365989|FG001|Phase 2|Death|0|||
162085352|NCT02880371|585365990|FG002|Phase 2|Death|0|||
162085353|NCT02880371|585365991|FG003|Phase 2|Death|0|||
162085354|NCT02880371|585365992|FG004|Phase 2|Death|1|||
162085355|NCT02880371|585365993|FG005|Phase 2|Death|10|||
162085356|NCT02880371|585365994|FG006|Phase 2|Death|20|||
162085357|NCT02880371|585365995|FG007|Phase 2|Death|5|||
162085358|NCT02880371|585365988|FG000|Phase 2|Lost to Follow-up|0|||
162085359|NCT02880371|585365989|FG001|Phase 2|Lost to Follow-up|0|||
162085360|NCT02880371|585365990|FG002|Phase 2|Lost to Follow-up|0|||
162085361|NCT02880371|585365991|FG003|Phase 2|Lost to Follow-up|0|||
162085362|NCT02880371|585365992|FG004|Phase 2|Lost to Follow-up|0|||
162085363|NCT02880371|585365993|FG005|Phase 2|Lost to Follow-up|0|||
162085364|NCT02880371|585365994|FG006|Phase 2|Lost to Follow-up|3|||
162085365|NCT02880371|585365995|FG007|Phase 2|Lost to Follow-up|0|||
162085366|NCT02880371|585365988|FG000|Phase 2|Withdrawal by Subject|0|||
162085367|NCT02880371|585365989|FG001|Phase 2|Withdrawal by Subject|0|||
162085368|NCT02880371|585365990|FG002|Phase 2|Withdrawal by Subject|0|||
162085369|NCT02880371|585365991|FG003|Phase 2|Withdrawal by Subject|0|||
162085370|NCT02880371|585365992|FG004|Phase 2|Withdrawal by Subject|0|||
162085371|NCT02880371|585365993|FG005|Phase 2|Withdrawal by Subject|1|||
162085372|NCT02880371|585365994|FG006|Phase 2|Withdrawal by Subject|1|||
162085373|NCT02880371|585365995|FG007|Phase 2|Withdrawal by Subject|0|||
162085374|NCT02880371|585365988|FG000|Phase 2|End of Study page not completed by error|0|||
162085375|NCT02880371|585365989|FG001|Phase 2|End of Study page not completed by error|0|||
162085376|NCT02880371|585365990|FG002|Phase 2|End of Study page not completed by error|0|||
162085377|NCT02880371|585365991|FG003|Phase 2|End of Study page not completed by error|0|||
162085378|NCT02880371|585365992|FG004|Phase 2|End of Study page not completed by error|0|||
162085379|NCT02880371|585365993|FG005|Phase 2|End of Study page not completed by error|1|||
162085380|NCT02880371|585365994|FG006|Phase 2|End of Study page not completed by error|0|||
162085381|NCT02880371|585365995|FG007|Phase 2|End of Study page not completed by error|0|||
162085382|NCT03285646|585366000|FG000|Overall Study|Adverse Event|1|||
162085383|NCT03285646|585366001|FG001|Overall Study|Adverse Event|0|||
162085384|NCT03285646|585366000|FG000|Overall Study|Withdrawal by Subject|10|||
162085385|NCT03285646|585366001|FG001|Overall Study|Withdrawal by Subject|2|||
162085386|NCT03285646|585366000|FG000|Overall Study|Lost to Follow-up|2|||
162085387|NCT03285646|585366001|FG001|Overall Study|Lost to Follow-up|1|||
162085388|NCT03285646|585366000|FG000|Overall Study|Investigator/Sponsor Decision|0|||
162085389|NCT03285646|585366001|FG001|Overall Study|Investigator/Sponsor Decision|1|||
162085390|NCT02660359|585366002|FG000|Overall Study|Protocol Deviation|0|||
162085391|NCT02660359|585366003|FG001|Overall Study|Protocol Deviation|0|||
162085392|NCT02660359|585366004|FG002|Overall Study|Protocol Deviation|1|||
162085393|NCT02660359|585366002|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
162085394|NCT02660359|585366003|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
162085395|NCT02660359|585366004|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
162085396|NCT02660359|585366002|FG000|Overall Study|Lack of Efficacy|1|||
162085397|NCT02660359|585366003|FG001|Overall Study|Lack of Efficacy|1|||
162085398|NCT02660359|585366004|FG002|Overall Study|Lack of Efficacy|1|||
162085399|NCT02660359|585366002|FG000|Overall Study|Adverse Event|0|||
162085400|NCT02660359|585366003|FG001|Overall Study|Adverse Event|1|||
162085401|NCT02660359|585366004|FG002|Overall Study|Adverse Event|0|||
162085402|NCT02660359|585366002|FG000|Overall Study|Other|2|||
162085403|NCT02660359|585366003|FG001|Overall Study|Other|1|||
162085404|NCT02660359|585366004|FG002|Overall Study|Other|3|||
162085405|NCT02660359|585366002|FG000|Overall Study|Withdrawal by Subject|7|||
162085406|NCT02660359|585366003|FG001|Overall Study|Withdrawal by Subject|5|||
162085407|NCT02660359|585366004|FG002|Overall Study|Withdrawal by Subject|8|||
162085408|NCT02660359|585366002|FG000|Overall Study|Lost to Follow-up|3|||
162085409|NCT02660359|585366003|FG001|Overall Study|Lost to Follow-up|3|||
162085410|NCT02660359|585366004|FG002|Overall Study|Lost to Follow-up|0|||
162085411|NCT04101526|585366007|FG000|Overall Study|Did not complete all sleep diary entries|0|||
162085412|NCT04101526|585366008|FG001|Overall Study|Did not complete all sleep diary entries|1|||
162085413|NCT02944578|585366009|FG000|Overall Study|Physician Decision|1|||
162085414|NCT02944578|585366010|FG001|Overall Study|Physician Decision|0|||
162085415|NCT00424372|585366014|FG000|Overall Study|Death|1|||
162085416|NCT00424372|585366014|FG000|Overall Study|Adverse Event|18|||
162085417|NCT00424372|585366014|FG000|Overall Study|Lack of Efficacy|6|||
162085418|NCT00424372|585366014|FG000|Overall Study|Withdrawal by Subject|4|||
162085419|NCT00424372|585366014|FG000|Overall Study|Protocol Violation|1|||
162085420|NCT00424372|585366014|FG000|Overall Study|Health deterioration|1|||
162085421|NCT00451282|585366016|FG000|Overall Study|Lost to Follow-up|6|||
162085422|NCT00451282|585366017|FG001|Overall Study|Lost to Follow-up|5|||
162085423|NCT01797536|585366018|FG000|Overall Study|Adverse Event|0|||
162085424|NCT01797536|585366019|FG001|Overall Study|Adverse Event|1|||
162085425|NCT01797536|585366020|FG002|Overall Study|Adverse Event|0|||
162085426|NCT01797536|585366021|FG003|Overall Study|Adverse Event|0|||
162085427|NCT00098839|585366022|FG000|Overall Study|Adverse Event|5|||
162085428|NCT00098839|585366023|FG001|Overall Study|Adverse Event|2|||
162085429|NCT00098839|585366022|FG000|Overall Study|Death|1|||
162085430|NCT00098839|585366023|FG001|Overall Study|Death|2|||
162085431|NCT00098839|585366022|FG000|Overall Study|Physician Decision|4|||
162085432|NCT00098839|585366023|FG001|Overall Study|Physician Decision|14|||
162085433|NCT00098839|585366022|FG000|Overall Study|Withdrawal by Subject|1|||
162085434|NCT00098839|585366023|FG001|Overall Study|Withdrawal by Subject|0|||
162085435|NCT00098839|585366022|FG000|Overall Study|Refusal of further protocol therapy|3|||
162085436|NCT00098839|585366023|FG001|Overall Study|Refusal of further protocol therapy|1|||
162085437|NCT00098839|585366022|FG000|Overall Study|Relapse|6|||
162085438|NCT00098839|585366023|FG001|Overall Study|Relapse|3|||
162085439|NCT00098839|585366022|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
162085440|NCT00098839|585366023|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
162085441|NCT00098839|585366022|FG000|Overall Study|Ineligible|2|||
162085442|NCT00098839|585366023|FG001|Overall Study|Ineligible|0|||
162085443|NCT04879745|585366024|FG000|Overall Study|Lost to Follow-up|4|||
162085444|NCT04879745|585366025|FG001|Overall Study|Lost to Follow-up|1|||
162085445|NCT00120042|585366026|FG000|Overall Study|all completed protocl|0|||
162085446|NCT00120042|585366027|FG001|Overall Study|all completed protocl|0|||
162085447|NCT00120042|585366028|FG002|Overall Study|all completed protocl|0|||
162085448|NCT04532112|585366031|FG000|Overall Study|Adverse Event|3|||
162085449|NCT04532112|585366032|FG001|Overall Study|Adverse Event|0|||
162085450|NCT03592641|585366033|FG000|Overall Study|Withdrawal by Subject|1|||
162085451|NCT01126541|585366035|FG000|Overall Study|Adverse Event|0|||
162085452|NCT01126541|585366036|FG001|Overall Study|Adverse Event|2|||
162085453|NCT01126541|585366037|FG002|Overall Study|Adverse Event|4|||
162085454|NCT01126541|585366035|FG000|Overall Study|Death|0|||
162085455|NCT01126541|585366036|FG001|Overall Study|Death|1|||
162085456|NCT01126541|585366037|FG002|Overall Study|Death|0|||
162085457|NCT01126541|585366035|FG000|Overall Study|Lack of Efficacy|6|||
162085458|NCT01126541|585366036|FG001|Overall Study|Lack of Efficacy|1|||
162085459|NCT01126541|585366037|FG002|Overall Study|Lack of Efficacy|11|||
162085460|NCT01126541|585366035|FG000|Overall Study|Lost to Follow-up|1|||
162085461|NCT01126541|585366036|FG001|Overall Study|Lost to Follow-up|2|||
162085462|NCT01126541|585366037|FG002|Overall Study|Lost to Follow-up|2|||
162085463|NCT01126541|585366035|FG000|Overall Study|Withdrawal by Subject|2|||
162085464|NCT01126541|585366036|FG001|Overall Study|Withdrawal by Subject|5|||
162085465|NCT01126541|585366037|FG002|Overall Study|Withdrawal by Subject|6|||
162085466|NCT01126541|585366035|FG000|Overall Study|Protocol Violation|0|||
162085467|NCT01126541|585366036|FG001|Overall Study|Protocol Violation|0|||
162085468|NCT01126541|585366037|FG002|Overall Study|Protocol Violation|1|||
162085469|NCT01126541|585366035|FG000|Overall Study|Administrative reason or other|1|||
162085470|NCT01126541|585366036|FG001|Overall Study|Administrative reason or other|1|||
162085471|NCT01126541|585366037|FG002|Overall Study|Administrative reason or other|2|||
162085472|NCT02664038|585366039|FG000|13 Week|Lost to Follow-up|7|||
162085473|NCT02664038|585366040|FG001|13 Week|Lost to Follow-up|14|||
162085474|NCT02664038|585366039|FG000|13 Week|Withdrawal by Subject|1|||
162085475|NCT02664038|585366040|FG001|13 Week|Withdrawal by Subject|0|||
162085476|NCT02664038|585366039|FG000|26 Week|Lost to Follow-up|5|||
162085477|NCT02664038|585366040|FG001|26 Week|Lost to Follow-up|4|||
162085478|NCT06640829|585366045|FG000|Overall Study|Withdrawal by Subject|1|||
162085479|NCT06640829|585366045|FG000|Overall Study|Lost to Follow-up|1|||
162085480|NCT00673452|585366047|FG000|Acute Double-Blind Phase|Adverse Event|41|||
162085481|NCT00673452|585366048|FG001|Acute Double-Blind Phase|Adverse Event|24|||
162085482|NCT00673452|585366047|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
162085483|NCT00673452|585366048|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
162085484|NCT00673452|585366047|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
162085485|NCT00673452|585366048|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
162085486|NCT00673452|585366047|FG000|Acute Double-Blind Phase|Physician Decision|0|||
162085487|NCT00673452|585366048|FG001|Acute Double-Blind Phase|Physician Decision|6|||
162085488|NCT00673452|585366047|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
162085489|NCT00673452|585366048|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
162085490|NCT00673452|585366047|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
162085491|NCT00673452|585366048|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
162085492|NCT00673452|585366047|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
162085493|NCT00673452|585366048|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
162085494|NCT00673452|585366047|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
162085495|NCT00673452|585366048|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
162085496|NCT00673452|585366047|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
162085497|NCT00673452|585366048|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
162085498|NCT00673452|585366047|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
162085499|NCT00673452|585366048|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
162085500|NCT00673452|585366047|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
162085501|NCT00673452|585366048|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
162085502|NCT00673452|585366047|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
162085503|NCT00673452|585366048|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
162085504|NCT00673452|585366047|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
162085505|NCT00673452|585366048|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
162085506|NCT00673452|585366047|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
162085507|NCT00673452|585366048|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
162085508|NCT00673452|585366047|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
162085509|NCT00673452|585366048|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
162085510|NCT03025828|585366049|FG000|Overall Study|Lost to Follow-up|1|||
162085511|NCT02519712|585366052|FG000|Overall Study|Disease Relapse|1|||
162085512|NCT02519712|585366052|FG000|Overall Study|Disease Progression|1|||
162085513|NCT02519712|585366052|FG000|Overall Study|Accruals are donors|2|||
162085514|NCT02908529|585366063|FG000|Overall Study|Lost to Follow-up|0|||
162085515|NCT02908529|585366064|FG001|Overall Study|Lost to Follow-up|2|||
162085516|NCT04497987|585366065|FG000|Overall Study|Adverse Event|1|||
162085517|NCT04497987|585366066|FG001|Overall Study|Adverse Event|0|||
162085518|NCT04497987|585366065|FG000|Overall Study|Death|21|||
162085519|NCT04497987|585366066|FG001|Overall Study|Death|13|||
162085520|NCT04497987|585366065|FG000|Overall Study|Lost to Follow-up|19|||
162085521|NCT04497987|585366066|FG001|Overall Study|Lost to Follow-up|17|||
162085522|NCT04497987|585366065|FG000|Overall Study|Other - as reported by the investigator|22|||
162085523|NCT04497987|585366066|FG001|Overall Study|Other - as reported by the investigator|16|||
162085524|NCT04497987|585366065|FG000|Overall Study|Physician Decision|1|||
162085525|NCT04497987|585366066|FG001|Overall Study|Physician Decision|0|||
162085526|NCT04497987|585366065|FG000|Overall Study|Withdrawal by Subject|35|||
162085527|NCT04497987|585366066|FG001|Overall Study|Withdrawal by Subject|21|||
162085528|NCT02553421|585366071|FG000|Overall Study|Lost to Follow-up|21|||
162085529|NCT02553421|585366072|FG001|Overall Study|Lost to Follow-up|1|||
162085530|NCT02553421|585366071|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
162085531|NCT02553421|585366072|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
162085532|NCT02553421|585366071|FG000|Overall Study|Improper Device Placement|3|||
162085533|NCT02553421|585366072|FG001|Overall Study|Improper Device Placement|0|||
162085534|NCT02453594|585368650|FG000|Overall Study|Protocol Violation|0|||
162085535|NCT02453594|585368651|FG001|Overall Study|Protocol Violation|0|||
162085536|NCT02453594|585368652|FG002|Overall Study|Protocol Violation|1|||
162085537|NCT02453594|585368650|FG000|Overall Study|Cohort Was Closed|17|||
162085538|NCT02453594|585368651|FG001|Overall Study|Cohort Was Closed|21|||
162085539|NCT02453594|585368652|FG002|Overall Study|Cohort Was Closed|14|||
162085540|NCT02453594|585368650|FG000|Overall Study|Death|20|||
162085541|NCT02453594|585368651|FG001|Overall Study|Death|24|||
162085542|NCT02453594|585368652|FG002|Overall Study|Death|16|||
162085543|NCT02453594|585368650|FG000|Overall Study|Lost to Follow-up|6|||
162085544|NCT02453594|585368651|FG001|Overall Study|Lost to Follow-up|14|||
162085545|NCT02453594|585368652|FG002|Overall Study|Lost to Follow-up|2|||
162085546|NCT02453594|585368650|FG000|Overall Study|Physician Decision|2|||
162085547|NCT02453594|585368651|FG001|Overall Study|Physician Decision|4|||
162085548|NCT02453594|585368652|FG002|Overall Study|Physician Decision|0|||
162085549|NCT02453594|585368650|FG000|Overall Study|Site Terminated by Sponsor|1|||
162085550|NCT02453594|585368651|FG001|Overall Study|Site Terminated by Sponsor|0|||
162085551|NCT02453594|585368652|FG002|Overall Study|Site Terminated by Sponsor|1|||
162085552|NCT02453594|585368650|FG000|Overall Study|Transitioned to Extension Study|16|||
162085553|NCT02453594|585368651|FG001|Overall Study|Transitioned to Extension Study|9|||
162085554|NCT02453594|585368652|FG002|Overall Study|Transitioned to Extension Study|16|||
162085555|NCT02453594|585368650|FG000|Overall Study|Withdrawal by Subject|7|||
162085556|NCT02453594|585368651|FG001|Overall Study|Withdrawal by Subject|9|||
162085557|NCT02453594|585368652|FG002|Overall Study|Withdrawal by Subject|11|||
162085558|NCT01694706|585368661|FG000|Overall Study|Adverse Event|0|||
162085559|NCT01694706|585368662|FG001|Overall Study|Adverse Event|1|||
162085560|NCT01694706|585368663|FG002|Overall Study|Adverse Event|0|||
162085561|NCT01694706|585368661|FG000|Overall Study|other reason not defined above|1|||
162085562|NCT01694706|585368662|FG001|Overall Study|other reason not defined above|0|||
162085563|NCT01694706|585368663|FG002|Overall Study|other reason not defined above|0|||
162085564|NCT01923181|585368664|FG000|Overall Study|Protocol Violation|2|||
162085565|NCT01923181|585368665|FG001|Overall Study|Protocol Violation|2|||
162085566|NCT01923181|585368666|FG002|Overall Study|Protocol Violation|0|||
162085567|NCT01923181|585368667|FG003|Overall Study|Protocol Violation|2|||
162085568|NCT01923181|585368668|FG004|Overall Study|Protocol Violation|2|||
162085569|NCT01923181|585368669|FG005|Overall Study|Protocol Violation|1|||
162085570|NCT01923181|585368670|FG006|Overall Study|Protocol Violation|1|||
162085571|NCT01923181|585368671|FG007|Overall Study|Protocol Violation|2|||
162085572|NCT01923181|585368672|FG008|Overall Study|Protocol Violation|1|||
162085573|NCT01923181|585368664|FG000|Overall Study|Withdrawal by Subject|0|||
162085574|NCT01923181|585368665|FG001|Overall Study|Withdrawal by Subject|1|||
162085575|NCT01923181|585368666|FG002|Overall Study|Withdrawal by Subject|0|||
162085576|NCT01923181|585368667|FG003|Overall Study|Withdrawal by Subject|1|||
162085577|NCT01923181|585368668|FG004|Overall Study|Withdrawal by Subject|4|||
162085578|NCT01923181|585368669|FG005|Overall Study|Withdrawal by Subject|2|||
162085579|NCT01923181|585368670|FG006|Overall Study|Withdrawal by Subject|4|||
162085580|NCT01923181|585368671|FG007|Overall Study|Withdrawal by Subject|3|||
162085581|NCT01923181|585368672|FG008|Overall Study|Withdrawal by Subject|1|||
162085582|NCT01923181|585368664|FG000|Overall Study|Other|1|||
162085583|NCT01923181|585368665|FG001|Overall Study|Other|0|||
162085584|NCT01923181|585368666|FG002|Overall Study|Other|0|||
162085585|NCT01923181|585368667|FG003|Overall Study|Other|1|||
162085586|NCT01923181|585368668|FG004|Overall Study|Other|0|||
162085587|NCT01923181|585368669|FG005|Overall Study|Other|0|||
162085588|NCT01923181|585368670|FG006|Overall Study|Other|0|||
162085589|NCT01923181|585368671|FG007|Overall Study|Other|0|||
162085590|NCT01923181|585368672|FG008|Overall Study|Other|0|||
162085591|NCT01923181|585368664|FG000|Overall Study|Lost to Follow-up|0|||
162085592|NCT01923181|585368665|FG001|Overall Study|Lost to Follow-up|3|||
162085593|NCT01923181|585368666|FG002|Overall Study|Lost to Follow-up|2|||
162085594|NCT01923181|585368667|FG003|Overall Study|Lost to Follow-up|1|||
162085595|NCT01923181|585368668|FG004|Overall Study|Lost to Follow-up|2|||
162085596|NCT01923181|585368669|FG005|Overall Study|Lost to Follow-up|1|||
162085597|NCT01923181|585368670|FG006|Overall Study|Lost to Follow-up|3|||
162085598|NCT01923181|585368671|FG007|Overall Study|Lost to Follow-up|3|||
162085599|NCT01923181|585368672|FG008|Overall Study|Lost to Follow-up|1|||
162085600|NCT00654628|585368674|FG000|6-week Active Treatment Period|Adverse Event|9|||
162085601|NCT00654628|585368674|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
162085602|NCT00654628|585368674|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
162085603|NCT00654628|585368674|FG000|6-week Active Treatment Period|Out of window period|1|||
162085604|NCT00654628|585368674|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
162085605|NCT00654628|585368674|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
162085606|NCT00912405|585368677|FG000|Overall Study|Lost to Follow-up|5|||
162085607|NCT00953329|585368678|FG000|Overall Study|Lack of Efficacy|1|||
162085608|NCT01434823|585368681|FG000|Overall Study|Incomplete data in medical record|4|||
162085609|NCT01434823|585368682|FG001|Overall Study|Incomplete data in medical record|7|||
162085610|NCT00456092|585368687|FG000|Extension Phase|Grade 2 or Greater AE|2|||
162085611|NCT00456092|585368688|FG001|Extension Phase|Grade 2 or Greater AE|2|||
162085612|NCT00456092|585368689|FG002|Extension Phase|Grade 2 or Greater AE|0|||
162085613|NCT00456092|585368690|FG003|Extension Phase|Grade 2 or Greater AE|0|||
162085614|NCT00456092|585368691|FG004|Extension Phase|Grade 2 or Greater AE|2|||
162085615|NCT00456092|585368687|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
162085616|NCT00456092|585368688|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
162085617|NCT00456092|585368689|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
162085618|NCT00456092|585368690|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
162085619|NCT00456092|585368691|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
162085620|NCT00456092|585368687|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
162085621|NCT00456092|585368688|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
162085622|NCT00456092|585368689|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
162085623|NCT00456092|585368690|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
162085624|NCT00456092|585368691|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
162085625|NCT00456092|585368687|FG000|Extension Phase|Withdrew Consent|2|||
162085626|NCT00456092|585368688|FG001|Extension Phase|Withdrew Consent|0|||
162085627|NCT00456092|585368689|FG002|Extension Phase|Withdrew Consent|0|||
162085628|NCT00456092|585368690|FG003|Extension Phase|Withdrew Consent|0|||
162085629|NCT00456092|585368691|FG004|Extension Phase|Withdrew Consent|0|||
162085630|NCT00456092|585368687|FG000|Extension Phase|Lost to Follow-up|1|||
162085631|NCT00456092|585368688|FG001|Extension Phase|Lost to Follow-up|1|||
162085632|NCT00456092|585368689|FG002|Extension Phase|Lost to Follow-up|0|||
162085633|NCT00456092|585368690|FG003|Extension Phase|Lost to Follow-up|0|||
162085634|NCT00456092|585368691|FG004|Extension Phase|Lost to Follow-up|1|||
162085635|NCT00456092|585368687|FG000|Extension Phase|Other|2|||
162085636|NCT00456092|585368688|FG001|Extension Phase|Other|0|||
162085637|NCT00456092|585368689|FG002|Extension Phase|Other|0|||
162085638|NCT00456092|585368690|FG003|Extension Phase|Other|1|||
162085639|NCT00456092|585368691|FG004|Extension Phase|Other|1|||
162085640|NCT00456092|585368687|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
162085641|NCT00456092|585368688|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
162085642|NCT00456092|585368689|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
162085643|NCT00456092|585368690|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
162085644|NCT00456092|585368691|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
162085645|NCT00456092|585368687|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
162085646|NCT00456092|585368688|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
162085647|NCT00456092|585368689|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
162085648|NCT00456092|585368690|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
162085649|NCT00456092|585368691|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
162085650|NCT00456092|585368687|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
162085651|NCT00456092|585368688|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
162085652|NCT00456092|585368689|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
162085653|NCT00456092|585368690|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
162085654|NCT00456092|585368691|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
162085655|NCT00456092|585368687|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
162085656|NCT00456092|585368688|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
162085657|NCT00456092|585368689|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
162085658|NCT00456092|585368690|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
162085659|NCT00456092|585368691|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
162085660|NCT00456092|585368687|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
162085661|NCT00456092|585368688|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
162085662|NCT00456092|585368689|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
162085663|NCT00456092|585368690|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
162085664|NCT00456092|585368691|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
162085665|NCT00456092|585368687|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
162085666|NCT00456092|585368688|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
162085667|NCT00456092|585368689|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
162085668|NCT00456092|585368690|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
162085669|NCT00456092|585368691|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
162085670|NCT00456092|585368687|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
162085671|NCT00456092|585368688|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
162085672|NCT00456092|585368689|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
162085673|NCT00456092|585368690|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
162085674|NCT00456092|585368691|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
162085675|NCT00456092|585368687|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
162085676|NCT00456092|585368688|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
162085677|NCT00456092|585368689|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
162085678|NCT00456092|585368690|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
162085679|NCT00456092|585368691|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
162085680|NCT00456092|585368687|FG000|Treatment Phase (12 Weeks)|Other|1|||
162085681|NCT00456092|585368688|FG001|Treatment Phase (12 Weeks)|Other|0|||
162085682|NCT00456092|585368689|FG002|Treatment Phase (12 Weeks)|Other|1|||
162085683|NCT00456092|585368690|FG003|Treatment Phase (12 Weeks)|Other|0|||
162085684|NCT00456092|585368691|FG004|Treatment Phase (12 Weeks)|Other|0|||
162085685|NCT01252290|585368696|FG000|Overall Study|Withdrawal by Subject|1|||
162085686|NCT02247349|585368697|FG000|Overall Study|Disease Progression|7|||
162085687|NCT02247349|585368698|FG001|Overall Study|Disease Progression|4|||
162085688|NCT02247349|585368699|FG002|Overall Study|Disease Progression|26|||
162085689|NCT02247349|585368700|FG003|Overall Study|Disease Progression|31|||
162085690|NCT02247349|585368701|FG004|Overall Study|Disease Progression|16|||
162085691|NCT02247349|585368702|FG005|Overall Study|Disease Progression|6|||
162085692|NCT02247349|585368697|FG000|Overall Study|Study drug toxicity|0|||
162085693|NCT02247349|585368698|FG001|Overall Study|Study drug toxicity|1|||
162085694|NCT02247349|585368699|FG002|Overall Study|Study drug toxicity|1|||
162085695|NCT02247349|585368700|FG003|Overall Study|Study drug toxicity|1|||
162085696|NCT02247349|585368701|FG004|Overall Study|Study drug toxicity|2|||
162085697|NCT02247349|585368702|FG005|Overall Study|Study drug toxicity|2|||
162085698|NCT02247349|585368697|FG000|Overall Study|Death|0|||
162085699|NCT02247349|585368698|FG001|Overall Study|Death|0|||
162085700|NCT02247349|585368699|FG002|Overall Study|Death|0|||
162085701|NCT02247349|585368700|FG003|Overall Study|Death|1|||
162085702|NCT02247349|585368701|FG004|Overall Study|Death|0|||
162085703|NCT02247349|585368702|FG005|Overall Study|Death|0|||
162085704|NCT02247349|585368697|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
162085705|NCT02247349|585368698|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
162085706|NCT02247349|585368699|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
162085707|NCT02247349|585368700|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
162085708|NCT02247349|585368701|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
162085709|NCT02247349|585368702|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
162085710|NCT02247349|585368697|FG000|Overall Study|Participant request to discontinue study treatment|0|||
162085711|NCT02247349|585368698|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162085712|NCT02247349|585368699|FG002|Overall Study|Participant request to discontinue study treatment|1|||
162085713|NCT02247349|585368700|FG003|Overall Study|Participant request to discontinue study treatment|2|||
162085714|NCT02247349|585368701|FG004|Overall Study|Participant request to discontinue study treatment|1|||
162085715|NCT02247349|585368702|FG005|Overall Study|Participant request to discontinue study treatment|0|||
162085716|NCT02247349|585368697|FG000|Overall Study|Withdrawal by Subject|0|||
162085717|NCT02247349|585368698|FG001|Overall Study|Withdrawal by Subject|1|||
162085718|NCT02247349|585368699|FG002|Overall Study|Withdrawal by Subject|0|||
162085719|NCT02247349|585368700|FG003|Overall Study|Withdrawal by Subject|0|||
162085720|NCT02247349|585368701|FG004|Overall Study|Withdrawal by Subject|0|||
162085721|NCT02247349|585368702|FG005|Overall Study|Withdrawal by Subject|0|||
162085722|NCT02247349|585368697|FG000|Overall Study|Administrative reason by sponsor|0|||
162085723|NCT02247349|585368698|FG001|Overall Study|Administrative reason by sponsor|0|||
162085724|NCT02247349|585368699|FG002|Overall Study|Administrative reason by sponsor|0|||
162085725|NCT02247349|585368700|FG003|Overall Study|Administrative reason by sponsor|0|||
162085726|NCT02247349|585368701|FG004|Overall Study|Administrative reason by sponsor|1|||
162085727|NCT02247349|585368702|FG005|Overall Study|Administrative reason by sponsor|0|||
162085728|NCT02247349|585368697|FG000|Overall Study|Other reasons|0|||
162085729|NCT02247349|585368698|FG001|Overall Study|Other reasons|0|||
162085730|NCT02247349|585368699|FG002|Overall Study|Other reasons|1|||
162085731|NCT02247349|585368700|FG003|Overall Study|Other reasons|0|||
162085732|NCT02247349|585368701|FG004|Overall Study|Other reasons|0|||
162085733|NCT02247349|585368702|FG005|Overall Study|Other reasons|0|||
162085734|NCT00617240|585368703|FG000|Overall Study|Lack of Efficacy|1|||
162085735|NCT00617240|585368704|FG001|Overall Study|Lack of Efficacy|0|||
162085736|NCT01611259|585368705|FG000|Overall Study|Physician Decision|1|||
162085737|NCT01611259|585368705|FG000|Overall Study|Lack of Efficacy|2|||
162085738|NCT01611259|585368705|FG000|Overall Study|Adverse Event|4|||
162085739|NCT01611259|585368705|FG000|Overall Study|Withdrawal by Subject|7|||
162085740|NCT04936685|585368706|FG000|Overall Study|Protocol Violation|1|||
162085741|NCT04936685|585368707|FG001|Overall Study|Protocol Violation|0|||
162085742|NCT02410811|585368711|FG000|Overall Study|Withdrawal by Subject|0|||
162085743|NCT02410811|585368712|FG001|Overall Study|Withdrawal by Subject|0|||
162085744|NCT02410811|585368713|FG002|Overall Study|Withdrawal by Subject|1|||
162085745|NCT02410811|585368714|FG003|Overall Study|Withdrawal by Subject|0|||
162085746|NCT00353366|585368715|FG000|Overall Study|Adverse Event|8|||
162085747|NCT00353366|585368715|FG000|Overall Study|Protocol Violation|12|||
162085748|NCT00353366|585368715|FG000|Overall Study|Withdrawal by Subject|12|||
162085749|NCT00353366|585368715|FG000|Overall Study|Lost to Follow-up|92|||
162085750|NCT00353366|585368715|FG000|Overall Study|Other|19|||
162085751|NCT00259857|585368716|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
162085752|NCT00259857|585368717|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
162085753|NCT00259857|585368716|FG000|24 Months Treatment|Lost to Follow-up|0|||
162085754|NCT00259857|585368717|FG001|24 Months Treatment|Lost to Follow-up|3|||
162085755|NCT05267054|585368718|FG000|Overall Study|Death|13|||
162085756|NCT05267054|585368719|FG001|Overall Study|Death|14|||
162085757|NCT05267054|585368718|FG000|Overall Study|Study Ended by Sponsor|9|||
162085758|NCT05267054|585368719|FG001|Overall Study|Study Ended by Sponsor|13|||
162085759|NCT05267054|585368718|FG000|Overall Study|Lost to Follow-up|1|||
162085760|NCT05267054|585368719|FG001|Overall Study|Lost to Follow-up|1|||
162085761|NCT05267054|585368718|FG000|Overall Study|Withdrawal by Subject|1|||
162085762|NCT05267054|585368719|FG001|Overall Study|Withdrawal by Subject|1|||
162085763|NCT01552226|585368722|FG000|Overall Study|Withdrawal by Subject|4|||
162085764|NCT01552226|585368723|FG001|Overall Study|Withdrawal by Subject|4|||
162085765|NCT01469065|585368727|FG000|Overall Study|Lack of Efficacy|0|||
162085766|NCT01469065|585368728|FG001|Overall Study|Lack of Efficacy|0|||
162085767|NCT01469065|585368729|FG002|Overall Study|Lack of Efficacy|0|||
162085768|NCT01469065|585368730|FG003|Overall Study|Lack of Efficacy|0|||
162085769|NCT01469065|585368731|FG004|Overall Study|Lack of Efficacy|1|||
162085770|NCT01469065|585368727|FG000|Overall Study|Other|0|||
162085771|NCT01469065|585368728|FG001|Overall Study|Other|1|||
162085772|NCT01469065|585368729|FG002|Overall Study|Other|0|||
162085773|NCT01469065|585368730|FG003|Overall Study|Other|0|||
162085774|NCT01469065|585368731|FG004|Overall Study|Other|0|||
162085775|NCT04542070|585368732|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
162085776|NCT04542070|585368733|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
162085777|NCT04542070|585368734|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
162085778|NCT04542070|585368735|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
162085779|NCT04542070|585368732|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
162085780|NCT04542070|585368733|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
162085781|NCT04542070|585368734|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
162085782|NCT04542070|585368735|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
162085783|NCT04542070|585368732|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
162085784|NCT04542070|585368733|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
162085785|NCT04542070|585368734|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
162085786|NCT04542070|585368735|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
162085787|NCT04542070|585368732|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
162085788|NCT04542070|585368733|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
162085789|NCT04542070|585368734|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
162085790|NCT04542070|585368735|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
162085791|NCT04542070|585368732|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
162085792|NCT04542070|585368733|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
162085793|NCT04542070|585368734|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
162085794|NCT04542070|585368735|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
162085795|NCT04542070|585368732|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
162085796|NCT04542070|585368733|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
162085797|NCT04542070|585368734|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
162085798|NCT04542070|585368735|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
162085799|NCT04542070|585368732|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
162085800|NCT04542070|585368733|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
162085801|NCT04542070|585368734|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
162085802|NCT04542070|585368735|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
162085803|NCT04542070|585368732|FG000|Maintenance + Extension Period|Adverse Event|10|||
162085804|NCT04542070|585368733|FG001|Maintenance + Extension Period|Adverse Event|2|||
162085805|NCT04542070|585368734|FG002|Maintenance + Extension Period|Adverse Event|0|||
162085806|NCT04542070|585368735|FG003|Maintenance + Extension Period|Adverse Event|0|||
162085807|NCT04542070|585368732|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
162085808|NCT04542070|585368733|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
162085809|NCT04542070|585368734|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
162085810|NCT04542070|585368735|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
162085811|NCT04542070|585368732|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
162085812|NCT04542070|585368733|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
162085813|NCT04542070|585368734|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
162085814|NCT04542070|585368735|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
162085815|NCT04542070|585368732|FG000|Maintenance + Extension Period|Physician Decision|1|||
162085816|NCT04542070|585368733|FG001|Maintenance + Extension Period|Physician Decision|1|||
162085817|NCT04542070|585368734|FG002|Maintenance + Extension Period|Physician Decision|0|||
162085818|NCT04542070|585368735|FG003|Maintenance + Extension Period|Physician Decision|0|||
162085819|NCT04542070|585368732|FG000|Maintenance + Extension Period|Protocol Violation|2|||
162085820|NCT04542070|585368733|FG001|Maintenance + Extension Period|Protocol Violation|5|||
162085821|NCT04542070|585368734|FG002|Maintenance + Extension Period|Protocol Violation|0|||
162085822|NCT04542070|585368735|FG003|Maintenance + Extension Period|Protocol Violation|0|||
162085823|NCT04542070|585368732|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
162085824|NCT04542070|585368733|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
162085825|NCT04542070|585368734|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
162085826|NCT04542070|585368735|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
162085827|NCT04542070|585368732|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
162085828|NCT04542070|585368733|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
162085829|NCT04542070|585368734|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
162085830|NCT04542070|585368735|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
162085831|NCT04542070|585368732|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
162085832|NCT04542070|585368733|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
162085833|NCT04542070|585368734|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
162085834|NCT04542070|585368735|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
162085835|NCT04542070|585368732|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
162085836|NCT04542070|585368733|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
162085837|NCT04542070|585368734|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
162085838|NCT04542070|585368735|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
162085839|NCT04542070|585368732|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
162085840|NCT04542070|585368733|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
162085841|NCT04542070|585368734|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
162085842|NCT04542070|585368735|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
162085843|NCT04542070|585368732|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
162085844|NCT04542070|585368733|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
162085845|NCT04542070|585368734|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
162085846|NCT04542070|585368735|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
162085847|NCT04542070|585368732|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
162085848|NCT04542070|585368733|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
162085849|NCT04542070|585368734|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
162085850|NCT04542070|585368735|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
162085851|NCT03511560|585368738|FG000|Overall Study|Death|0|||
162085852|NCT03511560|585368739|FG001|Overall Study|Death|1|||
162085853|NCT03511560|585368738|FG000|Overall Study|Adverse Event|0|||
162085854|NCT03511560|585368739|FG001|Overall Study|Adverse Event|2|||
162085855|NCT03511560|585368738|FG000|Overall Study|Transplant cancelled|0|||
162085856|NCT03511560|585368739|FG001|Overall Study|Transplant cancelled|1|||
162085857|NCT03511560|585368738|FG000|Overall Study|Patient switched to another drug|1|||
162085858|NCT03511560|585368739|FG001|Overall Study|Patient switched to another drug|0|||
162085859|NCT00382733|585368745|FG000|Overall Study|Withdrawal by Subject|0|||
162085860|NCT00382733|585368746|FG001|Overall Study|Withdrawal by Subject|1|||
162085861|NCT00382733|585368747|FG002|Overall Study|Withdrawal by Subject|0|||
162085862|NCT00382733|585368748|FG003|Overall Study|Withdrawal by Subject|0|||
162085863|NCT00382733|585368749|FG004|Overall Study|Withdrawal by Subject|0|||
162085864|NCT03049813|585368750|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
162085865|NCT03049813|585368751|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
162085866|NCT03049813|585368752|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
162085867|NCT03049813|585368753|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
162085868|NCT03049813|585368750|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
162085869|NCT03049813|585368751|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
162085870|NCT03049813|585368752|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
162085871|NCT03049813|585368753|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
162085872|NCT03049813|585368750|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
162085873|NCT03049813|585368751|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
162085874|NCT03049813|585368752|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
162085875|NCT03049813|585368753|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
162085876|NCT03049813|585368750|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
162085877|NCT03049813|585368751|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
162085878|NCT03049813|585368752|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
162085879|NCT03049813|585368753|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
162085880|NCT00179413|585368754|FG000|Overall Study|Adverse Event|38|||
162085881|NCT00179413|585368755|FG001|Overall Study|Adverse Event|20|||
162085882|NCT00179413|585368754|FG000|Overall Study|Withdrawal by Subject|87|||
162085883|NCT00179413|585368755|FG001|Overall Study|Withdrawal by Subject|95|||
162085884|NCT01813019|585368758|FG000|Overall Study|Adverse Event|0|||
162085885|NCT01813019|585368759|FG001|Overall Study|Adverse Event|3|||
162085886|NCT01813019|585368758|FG000|Overall Study|Withdrawal by Subject|3|||
162085887|NCT01813019|585368759|FG001|Overall Study|Withdrawal by Subject|2|||
162085888|NCT01813019|585368758|FG000|Overall Study|administrative problems|2|||
162085889|NCT01813019|585368759|FG001|Overall Study|administrative problems|0|||
162085890|NCT01813019|585368758|FG000|Overall Study|Protocol Deviation|2|||
162085891|NCT01813019|585368759|FG001|Overall Study|Protocol Deviation|1|||
162085892|NCT03075644|585368760|FG000|Overall Study|Withdrawal by Subject|1|||
162085893|NCT03075644|585368761|FG001|Overall Study|Withdrawal by Subject|1|||
162085894|NCT00439140|585368762|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
162085895|NCT00439140|585368763|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
162085896|NCT00439140|585368764|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
162085897|NCT00439140|585368762|FG000|Treatment Cycle 1|Personal reasons|0|||
162085898|NCT00439140|585368763|FG001|Treatment Cycle 1|Personal reasons|2|||
162085899|NCT00439140|585368764|FG002|Treatment Cycle 1|Personal reasons|0|||
162085900|NCT00439140|585368762|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
162085901|NCT00439140|585368763|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
162085902|NCT00439140|585368764|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
162085903|NCT00439140|585368762|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
162085904|NCT00439140|585368763|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
162085905|NCT00439140|585368764|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
162085906|NCT00439140|585368762|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
162085907|NCT00439140|585368763|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
162085908|NCT00439140|585368764|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
162085909|NCT01458171|585368770|FG000|Overall Study|Adverse Event|1|||
162085910|NCT00578565|585368775|FG000|Overall Study|Adverse Event|3|||
162085911|NCT01192152|585368776|FG000|Period 1|left prematurely (while on treatment B)|0|||
162085912|NCT01192152|585368777|FG001|Period 1|left prematurely (while on treatment B)|1|||
162085913|NCT01192152|585368776|FG000|Period 3|family emergency|1|||
162085914|NCT01192152|585368777|FG001|Period 3|family emergency|0|||
162085915|NCT02143843|585368779|FG000|Overall Study|Adverse Event|8|||
162085916|NCT02143843|585368779|FG000|Overall Study|Lack of Efficacy|2|||
162085917|NCT02143843|585368779|FG000|Overall Study|Withdrawal by Subject|2|||
162085918|NCT01339390|585368780|FG000|Overall Study|Death|32|||
162085919|NCT01339390|585368781|FG001|Overall Study|Death|29|||
162085920|NCT01339390|585368780|FG000|Overall Study|Lost to Follow-up|125|||
162085921|NCT01339390|585368781|FG001|Overall Study|Lost to Follow-up|127|||
162085922|NCT00378703|585368782|FG000|Overall Study|Disease progression|59|||
162085923|NCT00378703|585368783|FG001|Overall Study|Disease progression|43|||
162085924|NCT00378703|585368784|FG002|Overall Study|Disease progression|48|||
162085925|NCT00378703|585368785|FG003|Overall Study|Disease progression|49|||
162085926|NCT00378703|585368782|FG000|Overall Study|Adverse Event|11|||
162085927|NCT00378703|585368783|FG001|Overall Study|Adverse Event|17|||
162085928|NCT00378703|585368784|FG002|Overall Study|Adverse Event|20|||
162085929|NCT00378703|585368785|FG003|Overall Study|Adverse Event|18|||
162085930|NCT00378703|585368782|FG000|Overall Study|Death|2|||
162085931|NCT00378703|585368783|FG001|Overall Study|Death|2|||
162085932|NCT00378703|585368784|FG002|Overall Study|Death|4|||
162085933|NCT00378703|585368785|FG003|Overall Study|Death|3|||
162085934|NCT00378703|585368782|FG000|Overall Study|Withdrawal by Subject|4|||
162085935|NCT00378703|585368783|FG001|Overall Study|Withdrawal by Subject|8|||
162085936|NCT00378703|585368784|FG002|Overall Study|Withdrawal by Subject|5|||
162085937|NCT00378703|585368785|FG003|Overall Study|Withdrawal by Subject|7|||
162085938|NCT00378703|585368782|FG000|Overall Study|Physician Decision|1|||
162085939|NCT00378703|585368783|FG001|Overall Study|Physician Decision|4|||
162085940|NCT00378703|585368784|FG002|Overall Study|Physician Decision|1|||
162085941|NCT00378703|585368785|FG003|Overall Study|Physician Decision|0|||
162085942|NCT00378703|585368782|FG000|Overall Study|Alternative therapy|4|||
162085943|NCT00378703|585368783|FG001|Overall Study|Alternative therapy|2|||
162085944|NCT00378703|585368784|FG002|Overall Study|Alternative therapy|0|||
162085945|NCT00378703|585368785|FG003|Overall Study|Alternative therapy|0|||
162085946|NCT00378703|585368782|FG000|Overall Study|Other complicated disease|0|||
162085947|NCT00378703|585368783|FG001|Overall Study|Other complicated disease|2|||
162085948|NCT00378703|585368784|FG002|Overall Study|Other complicated disease|2|||
162085949|NCT00378703|585368785|FG003|Overall Study|Other complicated disease|0|||
162085950|NCT00378703|585368782|FG000|Overall Study|Symptomatic deterioration|0|||
162085951|NCT00378703|585368783|FG001|Overall Study|Symptomatic deterioration|1|||
162085952|NCT00378703|585368784|FG002|Overall Study|Symptomatic deterioration|0|||
162085953|NCT00378703|585368785|FG003|Overall Study|Symptomatic deterioration|2|||
162085954|NCT00378703|585368782|FG000|Overall Study|Surgery|1|||
162085955|NCT00378703|585368783|FG001|Overall Study|Surgery|0|||
162085956|NCT00378703|585368784|FG002|Overall Study|Surgery|0|||
162085957|NCT00378703|585368785|FG003|Overall Study|Surgery|1|||
162085958|NCT00378703|585368782|FG000|Overall Study|Joint decision of physician and patient|1|||
162085959|NCT00378703|585368783|FG001|Overall Study|Joint decision of physician and patient|0|||
162085960|NCT00378703|585368784|FG002|Overall Study|Joint decision of physician and patient|0|||
162085961|NCT00378703|585368785|FG003|Overall Study|Joint decision of physician and patient|0|||
162085962|NCT00378703|585368782|FG000|Overall Study|Adverse events and progressive disease|0|||
162085963|NCT00378703|585368783|FG001|Overall Study|Adverse events and progressive disease|0|||
162085964|NCT00378703|585368784|FG002|Overall Study|Adverse events and progressive disease|0|||
162085965|NCT00378703|585368785|FG003|Overall Study|Adverse events and progressive disease|1|||
162085966|NCT00378703|585368782|FG000|Overall Study|Relocation|0|||
162085967|NCT00378703|585368783|FG001|Overall Study|Relocation|0|||
162085968|NCT00378703|585368784|FG002|Overall Study|Relocation|1|||
162085969|NCT00378703|585368785|FG003|Overall Study|Relocation|0|||
162085970|NCT00378703|585368782|FG000|Overall Study|Ineligible|4|||
162085971|NCT00378703|585368783|FG001|Overall Study|Ineligible|7|||
162085972|NCT00378703|585368784|FG002|Overall Study|Ineligible|7|||
162085973|NCT00378703|585368785|FG003|Overall Study|Ineligible|7|||
162085974|NCT00378703|585368782|FG000|Overall Study|Never started treatment|1|||
162085975|NCT00378703|585368783|FG001|Overall Study|Never started treatment|4|||
162085976|NCT00378703|585368784|FG002|Overall Study|Never started treatment|0|||
162085977|NCT00378703|585368785|FG003|Overall Study|Never started treatment|0|||
162085978|NCT00378703|585368782|FG000|Overall Study|Other|1|||
162085979|NCT00378703|585368783|FG001|Overall Study|Other|1|||
162085980|NCT00378703|585368784|FG002|Overall Study|Other|2|||
162085981|NCT00378703|585368785|FG003|Overall Study|Other|3|||
162085982|NCT03181542|585368788|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
162085983|NCT03181542|585368789|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
162085984|NCT01462357|585368796|FG000|Overall Study|Death|0|||
162085985|NCT01462357|585368797|FG001|Overall Study|Death|0|||
162085986|NCT01462357|585368798|FG002|Overall Study|Death|1|||
162085987|NCT01462357|585368796|FG000|Overall Study|Withdrawal by Subject|3|||
162085988|NCT01462357|585368797|FG001|Overall Study|Withdrawal by Subject|11|||
162085989|NCT01462357|585368798|FG002|Overall Study|Withdrawal by Subject|3|||
162085990|NCT01462357|585368796|FG000|Overall Study|Migrated/moved from study area|2|||
162085991|NCT01462357|585368797|FG001|Overall Study|Migrated/moved from study area|3|||
162085992|NCT01462357|585368798|FG002|Overall Study|Migrated/moved from study area|1|||
162085993|NCT01462357|585368796|FG000|Overall Study|Lost to Follow-up|3|||
162085994|NCT01462357|585368797|FG001|Overall Study|Lost to Follow-up|5|||
162085995|NCT01462357|585368798|FG002|Overall Study|Lost to Follow-up|7|||
162085996|NCT04292730|585368807|FG000|Overall Study|Lost to Follow-up|8|||
162085997|NCT04292730|585368808|FG001|Overall Study|Lost to Follow-up|12|||
162085998|NCT04292730|585368809|FG002|Overall Study|Lost to Follow-up|12|||
162085999|NCT04292730|585368810|FG003|Overall Study|Lost to Follow-up|48|||
162086000|NCT04292730|585368807|FG000|Overall Study|Death|2|||
162086001|NCT04292730|585368808|FG001|Overall Study|Death|2|||
162086002|NCT04292730|585368809|FG002|Overall Study|Death|4|||
162086003|NCT04292730|585368810|FG003|Overall Study|Death|12|||
162086004|NCT04292730|585368807|FG000|Overall Study|Withdrew Consent|2|||
162086005|NCT04292730|585368808|FG001|Overall Study|Withdrew Consent|2|||
162086006|NCT04292730|585368809|FG002|Overall Study|Withdrew Consent|5|||
162086007|NCT04292730|585368810|FG003|Overall Study|Withdrew Consent|6|||
162086008|NCT04292730|585368807|FG000|Overall Study|Non-Compliance with Study Drug|0|||
162086009|NCT04292730|585368808|FG001|Overall Study|Non-Compliance with Study Drug|1|||
162086010|NCT04292730|585368809|FG002|Overall Study|Non-Compliance with Study Drug|0|||
162086011|NCT04292730|585368810|FG003|Overall Study|Non-Compliance with Study Drug|0|||
162086012|NCT04292730|585368807|FG000|Overall Study|Protocol Violation|0|||
162086013|NCT04292730|585368808|FG001|Overall Study|Protocol Violation|0|||
162086014|NCT04292730|585368809|FG002|Overall Study|Protocol Violation|1|||
162086015|NCT04292730|585368810|FG003|Overall Study|Protocol Violation|0|||
162086016|NCT04292730|585368807|FG000|Overall Study|Randomized but not Treated|8|||
162086017|NCT04292730|585368808|FG001|Overall Study|Randomized but not Treated|4|||
162086018|NCT04292730|585368809|FG002|Overall Study|Randomized but not Treated|0|||
162086019|NCT04292730|585368810|FG003|Overall Study|Randomized but not Treated|14|||
162086020|NCT01527292|585368811|FG000|Overall Study|Physician Decision|0|||
162086021|NCT01527292|585368812|FG001|Overall Study|Physician Decision|3|||
162086022|NCT01482767|585368815|FG000|Overall Study|Death|1|||
162086023|NCT01482767|585368816|FG001|Overall Study|Death|1|||
162086024|NCT01482767|585368815|FG000|Overall Study|Withdrawal by Subject|7|||
162086025|NCT01482767|585368816|FG001|Overall Study|Withdrawal by Subject|5|||
162086026|NCT01482767|585368815|FG000|Overall Study|Lost to Follow-up|12|||
162086027|NCT01482767|585368816|FG001|Overall Study|Lost to Follow-up|6|||
162086028|NCT01482767|585368815|FG000|Overall Study|Adverse Event|0|||
162086029|NCT01482767|585368816|FG001|Overall Study|Adverse Event|3|||
162086030|NCT01482767|585368815|FG000|Overall Study|Site closure|22|||
162086031|NCT01482767|585368816|FG001|Overall Study|Site closure|14|||
162086032|NCT01482767|585368815|FG000|Overall Study|Non-adherence to study requirements|4|||
162086033|NCT01482767|585368816|FG001|Overall Study|Non-adherence to study requirements|7|||
162086034|NCT01482767|585368815|FG000|Overall Study|Alternate HCV treatment|7|||
162086035|NCT01482767|585368816|FG001|Overall Study|Alternate HCV treatment|8|||
162086036|NCT01482767|585368815|FG000|Overall Study|Ineligible|0|||
162086037|NCT01482767|585368816|FG001|Overall Study|Ineligible|5|||
162086038|NCT01482767|585368815|FG000|Overall Study|Nurse error|1|||
162086039|NCT01482767|585368816|FG001|Overall Study|Nurse error|0|||
162086040|NCT00314366|585368817|FG000|Overall Study|not treated due to patient medical condi|1|||
162086041|NCT00314366|585368818|FG001|Overall Study|not treated due to patient medical condi|0|||
162086042|NCT03400033|585368828|FG000|Overall Study|Withdrawal by Subject|1|||
162086043|NCT03400033|585368829|FG001|Overall Study|Withdrawal by Subject|2|||
162086044|NCT01247090|585368832|FG000|Overall Study|Physician Decision|1|||
162086045|NCT01247090|585368833|FG001|Overall Study|Physician Decision|0|||
162086046|NCT01247090|585368834|FG002|Overall Study|Physician Decision|0|||
162086047|NCT01247090|585368832|FG000|Overall Study|Withdrawal by Subject|0|||
162086048|NCT01247090|585368833|FG001|Overall Study|Withdrawal by Subject|1|||
162086049|NCT01247090|585368834|FG002|Overall Study|Withdrawal by Subject|0|||
162086050|NCT00006916|585368836|FG000|Overall Study|Device not inserted|4|||
162086051|NCT00006916|585368836|FG000|Overall Study|Complication of device insertion|1|||
162086052|NCT02457325|585368841|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
162086053|NCT02457325|585368842|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
162086054|NCT01541930|585368847|FG000|Overall Study|Withdrawal by Subject|1|||
162086055|NCT03385239|585368848|FG000|Overall Study|Voluntary Withdrawal|2|||
162086056|NCT03385239|585368849|FG001|Overall Study|Voluntary Withdrawal|3|||
162086057|NCT03385239|585368850|FG002|Overall Study|Voluntary Withdrawal|2|||
162086058|NCT03385239|585368851|FG003|Overall Study|Voluntary Withdrawal|3|||
162086059|NCT03385239|585368852|FG004|Overall Study|Voluntary Withdrawal|0|||
162086060|NCT03385239|585368848|FG000|Overall Study|Adverse Event|0|||
162086061|NCT03385239|585368849|FG001|Overall Study|Adverse Event|0|||
162086062|NCT03385239|585368850|FG002|Overall Study|Adverse Event|1|||
162086063|NCT03385239|585368851|FG003|Overall Study|Adverse Event|0|||
162086064|NCT03385239|585368852|FG004|Overall Study|Adverse Event|0|||
162086065|NCT03385239|585368848|FG000|Overall Study|Other|0|||
162086066|NCT03385239|585368849|FG001|Overall Study|Other|0|||
162086067|NCT03385239|585368850|FG002|Overall Study|Other|0|||
162086068|NCT03385239|585368851|FG003|Overall Study|Other|1|||
162086069|NCT03385239|585368852|FG004|Overall Study|Other|0|||
162086070|NCT01574703|585368853|FG000|Overall Study|Adverse Event|0|||
162086071|NCT01574703|585368854|FG001|Overall Study|Adverse Event|2|||
162086072|NCT01574703|585368855|FG002|Overall Study|Adverse Event|1|||
162086073|NCT01574703|585368856|FG003|Overall Study|Adverse Event|1|||
162086074|NCT01574703|585368853|FG000|Overall Study|Protocol Violation|0|||
162086075|NCT01574703|585368854|FG001|Overall Study|Protocol Violation|0|||
162086076|NCT01574703|585368855|FG002|Overall Study|Protocol Violation|0|||
162086077|NCT01574703|585368856|FG003|Overall Study|Protocol Violation|1|||
162086078|NCT01574703|585368853|FG000|Overall Study|Unspecified Reason|27|||
162086079|NCT01574703|585368854|FG001|Overall Study|Unspecified Reason|15|||
162086080|NCT01574703|585368855|FG002|Overall Study|Unspecified Reason|20|||
162086081|NCT01574703|585368856|FG003|Overall Study|Unspecified Reason|16|||
162086082|NCT01574703|585368853|FG000|Overall Study|Withdrawal by Subject|53|||
162086083|NCT01574703|585368854|FG001|Overall Study|Withdrawal by Subject|52|||
162086084|NCT01574703|585368855|FG002|Overall Study|Withdrawal by Subject|36|||
162086085|NCT01574703|585368856|FG003|Overall Study|Withdrawal by Subject|61|||
162086086|NCT01574703|585368853|FG000|Overall Study|Met Withdrawal Criteria|0|||
162086087|NCT01574703|585368854|FG001|Overall Study|Met Withdrawal Criteria|1|||
162086088|NCT01574703|585368855|FG002|Overall Study|Met Withdrawal Criteria|1|||
162086089|NCT01574703|585368856|FG003|Overall Study|Met Withdrawal Criteria|0|||
162086090|NCT01574703|585368853|FG000|Overall Study|Lost to Follow-up|43|||
162086091|NCT01574703|585368854|FG001|Overall Study|Lost to Follow-up|41|||
162086092|NCT01574703|585368855|FG002|Overall Study|Lost to Follow-up|46|||
162086093|NCT01574703|585368856|FG003|Overall Study|Lost to Follow-up|35|||
162086094|NCT01574703|585368853|FG000|Overall Study|Death|2|||
162086095|NCT01574703|585368854|FG001|Overall Study|Death|1|||
162086096|NCT01574703|585368855|FG002|Overall Study|Death|1|||
162086097|NCT01574703|585368856|FG003|Overall Study|Death|0|||
162086098|NCT03890367|585368867|FG000|Overall Study|Withdrawal by parent/guardian|1|||
162086099|NCT03890367|585368868|FG001|Overall Study|Withdrawal by parent/guardian|3|||
162086100|NCT03890367|585368869|FG002|Overall Study|Withdrawal by parent/guardian|0|||
162086101|NCT03890367|585368867|FG000|Overall Study|Protocol deviation|2|||
162086102|NCT03890367|585368868|FG001|Overall Study|Protocol deviation|2|||
162086103|NCT03890367|585368869|FG002|Overall Study|Protocol deviation|1|||
162086104|NCT03890367|585368867|FG000|Overall Study|Lost to Follow-up|1|||
162086105|NCT03890367|585368868|FG001|Overall Study|Lost to Follow-up|1|||
162086106|NCT03890367|585368869|FG002|Overall Study|Lost to Follow-up|0|||
162086107|NCT02556710|585370378|FG000|Overall Study|Surgical treatment|3|||
162086108|NCT02556710|585370379|FG001|Overall Study|Surgical treatment|0|||
162086109|NCT02556710|585370378|FG000|Overall Study|Required proscribed pain medication|2|||
162086110|NCT02556710|585370379|FG001|Overall Study|Required proscribed pain medication|1|||
162086111|NCT02556710|585370378|FG000|Overall Study|Lack of Efficacy|1|||
162086112|NCT02556710|585370379|FG001|Overall Study|Lack of Efficacy|0|||
162086113|NCT02556710|585370378|FG000|Overall Study|Worsening osteoarthritis|1|||
162086114|NCT02556710|585370379|FG001|Overall Study|Worsening osteoarthritis|0|||
162086115|NCT02556710|585370378|FG000|Overall Study|Moved out of state|1|||
162086116|NCT02556710|585370379|FG001|Overall Study|Moved out of state|0|||
162086117|NCT02556710|585370378|FG000|Overall Study|Missing reason|3|||
162086118|NCT02556710|585370379|FG001|Overall Study|Missing reason|1|||
162086119|NCT02556710|585370378|FG000|Overall Study|Pain as lack of efficacy|0|||
162086120|NCT02556710|585370379|FG001|Overall Study|Pain as lack of efficacy|4|||
162086121|NCT04524403|585370382|FG000|Overall Study|Withdrawal by Subject|10|||
162086122|NCT04524403|585370383|FG001|Overall Study|Withdrawal by Subject|3|||
162086123|NCT04524403|585370384|FG002|Overall Study|Withdrawal by Subject|8|||
162086124|NCT04524403|585370382|FG000|Overall Study|Lost to Follow-up|3|||
162086125|NCT04524403|585370383|FG001|Overall Study|Lost to Follow-up|4|||
162086126|NCT04524403|585370384|FG002|Overall Study|Lost to Follow-up|3|||
162086127|NCT04524403|585370382|FG000|Overall Study|Adverse Event|3|||
162086128|NCT04524403|585370383|FG001|Overall Study|Adverse Event|1|||
162086129|NCT04524403|585370384|FG002|Overall Study|Adverse Event|4|||
162086130|NCT04524403|585370382|FG000|Overall Study|Non-compliant with study drug|1|||
162086131|NCT04524403|585370383|FG001|Overall Study|Non-compliant with study drug|2|||
162086132|NCT04524403|585370384|FG002|Overall Study|Non-compliant with study drug|3|||
162086133|NCT04524403|585370382|FG000|Overall Study|Moved|0|||
162086134|NCT04524403|585370383|FG001|Overall Study|Moved|1|||
162086135|NCT04524403|585370384|FG002|Overall Study|Moved|0|||
162086136|NCT00991302|585370385|FG000|Overall Study|Death|0|||
162086137|NCT00991302|585370386|FG001|Overall Study|Death|1|||
162086138|NCT00991302|585370385|FG000|Overall Study|Lost to Follow-up|14|||
162086139|NCT00991302|585370386|FG001|Overall Study|Lost to Follow-up|12|||
162086140|NCT01709318|585370387|FG000|Overall Study|Adverse Event|3|||
162086141|NCT01709318|585370388|FG001|Overall Study|Adverse Event|4|||
162086142|NCT01709318|585370389|FG002|Overall Study|Adverse Event|2|||
162086143|NCT01709318|585370390|FG003|Overall Study|Adverse Event|2|||
162086144|NCT01709318|585370391|FG004|Overall Study|Adverse Event|0|||
162086145|NCT01709318|585370392|FG005|Overall Study|Adverse Event|1|||
162086146|NCT01709318|585370393|FG006|Overall Study|Adverse Event|2|||
162086147|NCT01709318|585370387|FG000|Overall Study|Lost to Follow-up|2|||
162086148|NCT01709318|585370388|FG001|Overall Study|Lost to Follow-up|0|||
162086149|NCT01709318|585370389|FG002|Overall Study|Lost to Follow-up|0|||
162086150|NCT01709318|585370390|FG003|Overall Study|Lost to Follow-up|0|||
162086151|NCT01709318|585370391|FG004|Overall Study|Lost to Follow-up|1|||
162086152|NCT01709318|585370392|FG005|Overall Study|Lost to Follow-up|1|||
162086153|NCT01709318|585370393|FG006|Overall Study|Lost to Follow-up|1|||
162086154|NCT01709318|585370387|FG000|Overall Study|Non-compliance with Study Drug|0|||
162086155|NCT01709318|585370388|FG001|Overall Study|Non-compliance with Study Drug|2|||
162086156|NCT01709318|585370389|FG002|Overall Study|Non-compliance with Study Drug|1|||
162086157|NCT01709318|585370390|FG003|Overall Study|Non-compliance with Study Drug|1|||
162086158|NCT01709318|585370391|FG004|Overall Study|Non-compliance with Study Drug|0|||
162086159|NCT01709318|585370392|FG005|Overall Study|Non-compliance with Study Drug|0|||
162086160|NCT01709318|585370393|FG006|Overall Study|Non-compliance with Study Drug|2|||
162086161|NCT01709318|585370387|FG000|Overall Study|Physician Decision|0|||
162086162|NCT01709318|585370388|FG001|Overall Study|Physician Decision|0|||
162086163|NCT01709318|585370389|FG002|Overall Study|Physician Decision|0|||
162086164|NCT01709318|585370390|FG003|Overall Study|Physician Decision|0|||
162086165|NCT01709318|585370391|FG004|Overall Study|Physician Decision|0|||
162086166|NCT01709318|585370392|FG005|Overall Study|Physician Decision|0|||
162086167|NCT01709318|585370393|FG006|Overall Study|Physician Decision|1|||
162086168|NCT01709318|585370387|FG000|Overall Study|Pregnancy|0|||
162086169|NCT01709318|585370388|FG001|Overall Study|Pregnancy|0|||
162086170|NCT01709318|585370389|FG002|Overall Study|Pregnancy|0|||
162086171|NCT01709318|585370390|FG003|Overall Study|Pregnancy|0|||
162086172|NCT01709318|585370391|FG004|Overall Study|Pregnancy|1|||
162086173|NCT01709318|585370392|FG005|Overall Study|Pregnancy|0|||
162086174|NCT01709318|585370393|FG006|Overall Study|Pregnancy|0|||
162086175|NCT01709318|585370387|FG000|Overall Study|Protocol Violation|0|||
162086176|NCT01709318|585370388|FG001|Overall Study|Protocol Violation|0|||
162086177|NCT01709318|585370389|FG002|Overall Study|Protocol Violation|0|||
162086178|NCT01709318|585370390|FG003|Overall Study|Protocol Violation|0|||
162086179|NCT01709318|585370391|FG004|Overall Study|Protocol Violation|2|||
162086180|NCT01709318|585370392|FG005|Overall Study|Protocol Violation|0|||
162086181|NCT01709318|585370393|FG006|Overall Study|Protocol Violation|1|||
162086182|NCT01709318|585370387|FG000|Overall Study|Technical Problems|1|||
162086183|NCT01709318|585370388|FG001|Overall Study|Technical Problems|0|||
162086184|NCT01709318|585370389|FG002|Overall Study|Technical Problems|0|||
162086185|NCT01709318|585370390|FG003|Overall Study|Technical Problems|0|||
162086186|NCT01709318|585370391|FG004|Overall Study|Technical Problems|0|||
162086187|NCT01709318|585370392|FG005|Overall Study|Technical Problems|0|||
162086188|NCT01709318|585370393|FG006|Overall Study|Technical Problems|0|||
162086189|NCT01709318|585370387|FG000|Overall Study|Withdrawal by Subject|3|||
162086190|NCT01709318|585370388|FG001|Overall Study|Withdrawal by Subject|0|||
162086191|NCT01709318|585370389|FG002|Overall Study|Withdrawal by Subject|3|||
162086192|NCT01709318|585370390|FG003|Overall Study|Withdrawal by Subject|3|||
162086193|NCT01709318|585370391|FG004|Overall Study|Withdrawal by Subject|0|||
162086194|NCT01709318|585370392|FG005|Overall Study|Withdrawal by Subject|2|||
162086195|NCT01709318|585370393|FG006|Overall Study|Withdrawal by Subject|4|||
162086196|NCT01709318|585370387|FG000|Overall Study|Other Protocol Specified Criteria|0|||
162086197|NCT01709318|585370388|FG001|Overall Study|Other Protocol Specified Criteria|1|||
162086198|NCT01709318|585370389|FG002|Overall Study|Other Protocol Specified Criteria|0|||
162086199|NCT01709318|585370390|FG003|Overall Study|Other Protocol Specified Criteria|0|||
162086200|NCT01709318|585370391|FG004|Overall Study|Other Protocol Specified Criteria|0|||
162086201|NCT01709318|585370392|FG005|Overall Study|Other Protocol Specified Criteria|0|||
162086202|NCT01709318|585370393|FG006|Overall Study|Other Protocol Specified Criteria|0|||
162086203|NCT00646958|585370398|FG000|Overall Study|Lack of Efficacy|1|||
162086204|NCT00646958|585370399|FG001|Overall Study|Lack of Efficacy|0|||
162086205|NCT00646958|585370400|FG002|Overall Study|Lack of Efficacy|0|||
162086206|NCT00646958|585370398|FG000|Overall Study|Adverse Event|4|||
162086207|NCT00646958|585370399|FG001|Overall Study|Adverse Event|0|||
162086208|NCT00646958|585370400|FG002|Overall Study|Adverse Event|0|||
162086209|NCT00646958|585370398|FG000|Overall Study|Lost to Follow-up|1|||
162086210|NCT00646958|585370399|FG001|Overall Study|Lost to Follow-up|5|||
162086211|NCT00646958|585370400|FG002|Overall Study|Lost to Follow-up|7|||
162086212|NCT00646958|585370398|FG000|Overall Study|Protocol Violation|1|||
162086213|NCT00646958|585370399|FG001|Overall Study|Protocol Violation|1|||
162086214|NCT00646958|585370400|FG002|Overall Study|Protocol Violation|0|||
162086215|NCT00646958|585370398|FG000|Overall Study|Abnormal screening lab tests|1|||
162086216|NCT00646958|585370399|FG001|Overall Study|Abnormal screening lab tests|1|||
162086217|NCT00646958|585370400|FG002|Overall Study|Abnormal screening lab tests|0|||
162086218|NCT00646958|585370398|FG000|Overall Study|Withdrawal by Subject|1|||
162086219|NCT00646958|585370399|FG001|Overall Study|Withdrawal by Subject|2|||
162086220|NCT00646958|585370400|FG002|Overall Study|Withdrawal by Subject|0|||
162086221|NCT00646958|585370398|FG000|Overall Study|Did not receive study drug|2|||
162086222|NCT00646958|585370399|FG001|Overall Study|Did not receive study drug|0|||
162086223|NCT00646958|585370400|FG002|Overall Study|Did not receive study drug|2|||
162086224|NCT02139644|585370401|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
162086225|NCT02139644|585370402|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162086226|NCT02139644|585370403|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162086227|NCT02139644|585370404|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162086228|NCT02139644|585370405|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162086229|NCT02139644|585370406|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
162086230|NCT02139644|585370401|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
162086231|NCT02139644|585370402|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162086232|NCT02139644|585370403|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162086233|NCT02139644|585370404|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162086234|NCT02139644|585370405|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162086235|NCT02139644|585370406|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
162086236|NCT02139644|585370401|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
162086237|NCT02139644|585370402|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162086238|NCT02139644|585370403|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162086239|NCT02139644|585370404|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162086240|NCT02139644|585370405|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162086241|NCT02139644|585370406|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
162086242|NCT02139644|585370401|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
162086243|NCT02139644|585370402|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162086244|NCT02139644|585370403|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162086245|NCT02139644|585370404|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162086246|NCT02139644|585370405|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162086247|NCT02139644|585370406|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
162086248|NCT02139644|585370401|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
162086249|NCT02139644|585370402|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162086250|NCT02139644|585370403|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162086251|NCT02139644|585370404|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162086252|NCT02139644|585370405|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162086253|NCT02139644|585370406|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
162086254|NCT02139644|585370401|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
162086255|NCT02139644|585370402|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
162086256|NCT02139644|585370403|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
162086257|NCT02139644|585370404|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
162086258|NCT02139644|585370405|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
162086259|NCT02139644|585370406|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
162086260|NCT02139644|585370401|FG000|Run-In Period (Pre-assignment)|Other|6|||
162086261|NCT02139644|585370402|FG001|Run-In Period (Pre-assignment)|Other|0|||
162086262|NCT02139644|585370403|FG002|Run-In Period (Pre-assignment)|Other|0|||
162086263|NCT02139644|585370404|FG003|Run-In Period (Pre-assignment)|Other|0|||
162086264|NCT02139644|585370405|FG004|Run-In Period (Pre-assignment)|Other|0|||
162086265|NCT02139644|585370406|FG005|Run-In Period (Pre-assignment)|Other|0|||
162086266|NCT02139644|585370401|FG000|Treatment Period|Adverse Event|0|||
162086267|NCT02139644|585370402|FG001|Treatment Period|Adverse Event|0|||
162086268|NCT02139644|585370403|FG002|Treatment Period|Adverse Event|3|||
162086269|NCT02139644|585370404|FG003|Treatment Period|Adverse Event|2|||
162086270|NCT02139644|585370405|FG004|Treatment Period|Adverse Event|1|||
162086271|NCT02139644|585370406|FG005|Treatment Period|Adverse Event|6|||
162086272|NCT02139644|585370401|FG000|Treatment Period|Withdrawal by Subject|0|||
162086273|NCT02139644|585370402|FG001|Treatment Period|Withdrawal by Subject|0|||
162086274|NCT02139644|585370403|FG002|Treatment Period|Withdrawal by Subject|2|||
162086275|NCT02139644|585370404|FG003|Treatment Period|Withdrawal by Subject|2|||
162086276|NCT02139644|585370405|FG004|Treatment Period|Withdrawal by Subject|3|||
162086277|NCT02139644|585370406|FG005|Treatment Period|Withdrawal by Subject|2|||
162086278|NCT02139644|585370401|FG000|Treatment Period|Non-compliance|0|||
162086279|NCT02139644|585370402|FG001|Treatment Period|Non-compliance|0|||
162086280|NCT02139644|585370403|FG002|Treatment Period|Non-compliance|0|||
162086281|NCT02139644|585370404|FG003|Treatment Period|Non-compliance|1|||
162086282|NCT02139644|585370405|FG004|Treatment Period|Non-compliance|0|||
162086283|NCT02139644|585370406|FG005|Treatment Period|Non-compliance|0|||
162086284|NCT02139644|585370401|FG000|Treatment Period|Protocol Violation|0|||
162086285|NCT02139644|585370402|FG001|Treatment Period|Protocol Violation|0|||
162086286|NCT02139644|585370403|FG002|Treatment Period|Protocol Violation|0|||
162086287|NCT02139644|585370404|FG003|Treatment Period|Protocol Violation|1|||
162086288|NCT02139644|585370405|FG004|Treatment Period|Protocol Violation|1|||
162086289|NCT02139644|585370406|FG005|Treatment Period|Protocol Violation|1|||
162086290|NCT02139644|585370401|FG000|Treatment Period|Disease progression|0|||
162086291|NCT02139644|585370402|FG001|Treatment Period|Disease progression|0|||
162086292|NCT02139644|585370403|FG002|Treatment Period|Disease progression|0|||
162086293|NCT02139644|585370404|FG003|Treatment Period|Disease progression|1|||
162086294|NCT02139644|585370405|FG004|Treatment Period|Disease progression|1|||
162086295|NCT02139644|585370406|FG005|Treatment Period|Disease progression|2|||
162086296|NCT02139644|585370401|FG000|Treatment Period|Lost to Follow-up|0|||
162086297|NCT02139644|585370402|FG001|Treatment Period|Lost to Follow-up|0|||
162086298|NCT02139644|585370403|FG002|Treatment Period|Lost to Follow-up|1|||
162086299|NCT02139644|585370404|FG003|Treatment Period|Lost to Follow-up|1|||
162086300|NCT02139644|585370405|FG004|Treatment Period|Lost to Follow-up|1|||
162086301|NCT02139644|585370406|FG005|Treatment Period|Lost to Follow-up|1|||
162086302|NCT02139644|585370401|FG000|Treatment Period|Lack of Efficacy|0|||
162086303|NCT02139644|585370402|FG001|Treatment Period|Lack of Efficacy|0|||
162086304|NCT02139644|585370403|FG002|Treatment Period|Lack of Efficacy|1|||
162086305|NCT02139644|585370404|FG003|Treatment Period|Lack of Efficacy|0|||
162086306|NCT02139644|585370405|FG004|Treatment Period|Lack of Efficacy|1|||
162086307|NCT02139644|585370406|FG005|Treatment Period|Lack of Efficacy|4|||
162086308|NCT02139644|585370401|FG000|Treatment Period|Other|0|||
162086309|NCT02139644|585370402|FG001|Treatment Period|Other|3|||
162086310|NCT02139644|585370403|FG002|Treatment Period|Other|1|||
162086311|NCT02139644|585370404|FG003|Treatment Period|Other|1|||
162086312|NCT02139644|585370405|FG004|Treatment Period|Other|0|||
162086313|NCT02139644|585370406|FG005|Treatment Period|Other|1|||
162086314|NCT00630877|585370409|FG000|Overall Study|Adverse Event|11|||
162086315|NCT00630877|585370410|FG001|Overall Study|Adverse Event|8|||
162086316|NCT00630877|585370411|FG002|Overall Study|Adverse Event|7|||
162086317|NCT00630877|585370409|FG000|Overall Study|Withdrawal by Subject|3|||
162086318|NCT00630877|585370410|FG001|Overall Study|Withdrawal by Subject|4|||
162086319|NCT00630877|585370411|FG002|Overall Study|Withdrawal by Subject|0|||
162086320|NCT00630877|585370409|FG000|Overall Study|Lost to Follow-up|2|||
162086321|NCT00630877|585370410|FG001|Overall Study|Lost to Follow-up|0|||
162086322|NCT00630877|585370411|FG002|Overall Study|Lost to Follow-up|0|||
162086323|NCT00630877|585370409|FG000|Overall Study|Noncompliance|2|||
162086324|NCT00630877|585370410|FG001|Overall Study|Noncompliance|3|||
162086325|NCT00630877|585370411|FG002|Overall Study|Noncompliance|1|||
162086326|NCT00630877|585370409|FG000|Overall Study|Protocol violation|1|||
162086327|NCT00630877|585370410|FG001|Overall Study|Protocol violation|0|||
162086328|NCT00630877|585370411|FG002|Overall Study|Protocol violation|1|||
162086329|NCT00630877|585370409|FG000|Overall Study|Personal reasons|0|||
162086330|NCT00630877|585370410|FG001|Overall Study|Personal reasons|0|||
162086331|NCT00630877|585370411|FG002|Overall Study|Personal reasons|1|||
162086332|NCT01312909|585370412|FG000|Overall Study|Randomized but not treated|1|||
162086333|NCT01312909|585370413|FG001|Overall Study|Randomized but not treated|3|||
162086334|NCT01312909|585370414|FG002|Overall Study|Randomized but not treated|1|||
162086335|NCT01312909|585370412|FG000|Overall Study|Adverse Event|1|||
162086336|NCT01312909|585370413|FG001|Overall Study|Adverse Event|0|||
162086337|NCT01312909|585370414|FG002|Overall Study|Adverse Event|3|||
162086338|NCT01312909|585370412|FG000|Overall Study|Protocol Violation|2|||
162086339|NCT01312909|585370413|FG001|Overall Study|Protocol Violation|0|||
162086340|NCT01312909|585370414|FG002|Overall Study|Protocol Violation|2|||
162086341|NCT01312909|585370412|FG000|Overall Study|Other|9|||
162086342|NCT01312909|585370413|FG001|Overall Study|Other|6|||
162086343|NCT01312909|585370414|FG002|Overall Study|Other|11|||
162086344|NCT01312909|585370412|FG000|Overall Study|Withdrawal by Subject|8|||
162086345|NCT01312909|585370413|FG001|Overall Study|Withdrawal by Subject|10|||
162086346|NCT01312909|585370414|FG002|Overall Study|Withdrawal by Subject|7|||
162086347|NCT01312909|585370412|FG000|Overall Study|Lost to Follow-up|21|||
162086348|NCT01312909|585370413|FG001|Overall Study|Lost to Follow-up|17|||
162086349|NCT01312909|585370414|FG002|Overall Study|Lost to Follow-up|20|||
162086350|NCT01312909|585370412|FG000|Overall Study|Insufficient clinical response|0|||
162086351|NCT01312909|585370413|FG001|Overall Study|Insufficient clinical response|0|||
162086352|NCT01312909|585370414|FG002|Overall Study|Insufficient clinical response|1|||
162086353|NCT01312909|585370412|FG000|Overall Study|Entrance criteria not met|0|||
162086354|NCT01312909|585370413|FG001|Overall Study|Entrance criteria not met|0|||
162086355|NCT01312909|585370414|FG002|Overall Study|Entrance criteria not met|2|||
162086356|NCT02200042|585370415|FG000|Overall Study|Withdrawal by Subject|0|||
162086357|NCT02200042|585370416|FG001|Overall Study|Withdrawal by Subject|1|||
162086358|NCT00306592|585370419|FG000|Overall Study|Adverse Event|8|||
162086359|NCT00306592|585370420|FG001|Overall Study|Adverse Event|15|||
162086360|NCT00306592|585370419|FG000|Overall Study|Lost to Follow-up|1|||
162086361|NCT00306592|585370420|FG001|Overall Study|Lost to Follow-up|0|||
162086362|NCT00306592|585370419|FG000|Overall Study|Noncompliance|0|||
162086363|NCT00306592|585370420|FG001|Overall Study|Noncompliance|2|||
162086364|NCT00306592|585370419|FG000|Overall Study|Persistent Antibodies|6|||
162086365|NCT00306592|585370420|FG001|Overall Study|Persistent Antibodies|3|||
162086366|NCT00306592|585370419|FG000|Overall Study|Voluntary|10|||
162086367|NCT00306592|585370420|FG001|Overall Study|Voluntary|6|||
162086368|NCT00306592|585370419|FG000|Overall Study|Other|5|||
162086369|NCT00306592|585370420|FG001|Overall Study|Other|10|||
162086370|NCT00306592|585370419|FG000|Overall Study|Other|1|||
162086371|NCT00306592|585370420|FG001|Overall Study|Other|2|||
162086372|NCT00306592|585370419|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
162086373|NCT00306592|585370420|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
162086374|NCT00796861|585370428|FG000|Overall Study|Withdrawal by Subject|2|||
162086375|NCT00796861|585370428|FG000|Overall Study|Death|2|||
162086376|NCT00844545|585370433|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
162086377|NCT00844545|585370433|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
162086378|NCT00844545|585370433|FG000|Extension Treatment Period|Adverse Event|2|||
162086379|NCT00844545|585370433|FG000|Post Treatment Period|Withdrawal by Subject|1|||
162086380|NCT00403455|585370434|FG000|Overall Study|Withdrawal by Subject|1|||
162086381|NCT01358981|585370435|FG000|Period 1|Withdrawal by Subject|0|||
162086382|NCT01358981|585370436|FG001|Period 1|Withdrawal by Subject|0|||
162086383|NCT01358981|585370437|FG002|Period 1|Withdrawal by Subject|0|||
162086384|NCT01358981|585370438|FG003|Period 1|Withdrawal by Subject|1|||
162086385|NCT01358981|585370439|FG004|Period 1|Withdrawal by Subject|0|||
162086386|NCT01358981|585370440|FG005|Period 1|Withdrawal by Subject|0|||
162086387|NCT01358981|585370441|FG006|Period 1|Withdrawal by Subject|0|||
162086388|NCT04574362|585370442|FG000|Overall Study|Other|0|||
162086389|NCT04574362|585370443|FG001|Overall Study|Other|5|||
162086390|NCT04574362|585370442|FG000|Overall Study|COVID-19|0|||
162086391|NCT04574362|585370443|FG001|Overall Study|COVID-19|1|||
162086392|NCT04574362|585370442|FG000|Overall Study|Adverse Event|1|||
162086393|NCT04574362|585370443|FG001|Overall Study|Adverse Event|1|||
162086394|NCT04574362|585370442|FG000|Overall Study|Withdrawal by Subject|2|||
162086395|NCT04574362|585370443|FG001|Overall Study|Withdrawal by Subject|4|||
162086396|NCT04574362|585370442|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
162086397|NCT04574362|585370443|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
162086398|NCT04574362|585370442|FG000|Overall Study|Participant refused to come to the hospital|1|||
162086399|NCT04574362|585370443|FG001|Overall Study|Participant refused to come to the hospital|0|||
162086400|NCT04574362|585370442|FG000|Overall Study|Participant refused the visit|1|||
162086401|NCT04574362|585370443|FG001|Overall Study|Participant refused the visit|0|||
162086402|NCT04574362|585370442|FG000|Overall Study|Participant quit early because of business trip|1|||
162086403|NCT04574362|585370443|FG001|Overall Study|Participant quit early because of business trip|0|||
162086404|NCT01785524|585370444|FG000|Overall Study|Withdrawal by Subject|2|||
162086405|NCT01785524|585370445|FG001|Overall Study|Withdrawal by Subject|2|||
162086406|NCT01060384|585370446|FG000|Overall Study|Withdrawal by Subject|0|||
162086407|NCT01060384|585370447|FG001|Overall Study|Withdrawal by Subject|1|||
162086408|NCT01060384|585370448|FG002|Overall Study|Withdrawal by Subject|0|||
162086409|NCT01060384|585370449|FG003|Overall Study|Withdrawal by Subject|0|||
162086410|NCT01060384|585370450|FG004|Overall Study|Withdrawal by Subject|0|||
162086411|NCT01060384|585370446|FG000|Overall Study|Death|0|||
162086412|NCT01060384|585370447|FG001|Overall Study|Death|0|||
162086413|NCT01060384|585370448|FG002|Overall Study|Death|0|||
162086414|NCT01060384|585370449|FG003|Overall Study|Death|0|||
162086415|NCT01060384|585370450|FG004|Overall Study|Death|1|||
162086416|NCT01060384|585370446|FG000|Overall Study|Intercurrent illness|0|||
162086417|NCT01060384|585370447|FG001|Overall Study|Intercurrent illness|0|||
162086418|NCT01060384|585370448|FG002|Overall Study|Intercurrent illness|0|||
162086419|NCT01060384|585370449|FG003|Overall Study|Intercurrent illness|0|||
162086420|NCT01060384|585370450|FG004|Overall Study|Intercurrent illness|1|||
162086421|NCT01332305|585370451|FG000|Overall Study|Adverse Event|1|||
162086422|NCT01332305|585370452|FG001|Overall Study|Adverse Event|4|||
162086423|NCT01332305|585370453|FG002|Overall Study|Adverse Event|6|||
162086424|NCT01332305|585370454|FG003|Overall Study|Adverse Event|3|||
162086425|NCT01332305|585370455|FG004|Overall Study|Adverse Event|5|||
162086426|NCT01332305|585370451|FG000|Overall Study|Withdrawal by Subject|6|||
162086427|NCT01332305|585370452|FG001|Overall Study|Withdrawal by Subject|5|||
162086428|NCT01332305|585370453|FG002|Overall Study|Withdrawal by Subject|4|||
162086429|NCT01332305|585370454|FG003|Overall Study|Withdrawal by Subject|1|||
162086430|NCT01332305|585370455|FG004|Overall Study|Withdrawal by Subject|0|||
162086431|NCT01332305|585370451|FG000|Overall Study|Lost to Follow-up|0|||
162086432|NCT01332305|585370452|FG001|Overall Study|Lost to Follow-up|2|||
162086433|NCT01332305|585370453|FG002|Overall Study|Lost to Follow-up|3|||
162086434|NCT01332305|585370454|FG003|Overall Study|Lost to Follow-up|2|||
162086435|NCT01332305|585370455|FG004|Overall Study|Lost to Follow-up|3|||
162086436|NCT01332305|585370451|FG000|Overall Study|Protocol Violation|1|||
162086437|NCT01332305|585370452|FG001|Overall Study|Protocol Violation|2|||
162086438|NCT01332305|585370453|FG002|Overall Study|Protocol Violation|1|||
162086439|NCT01332305|585370454|FG003|Overall Study|Protocol Violation|0|||
162086440|NCT01332305|585370455|FG004|Overall Study|Protocol Violation|3|||
162086441|NCT01332305|585370451|FG000|Overall Study|Withdrawal by Sponsor|1|||
162086442|NCT01332305|585370452|FG001|Overall Study|Withdrawal by Sponsor|0|||
162086443|NCT01332305|585370453|FG002|Overall Study|Withdrawal by Sponsor|0|||
162086444|NCT01332305|585370454|FG003|Overall Study|Withdrawal by Sponsor|1|||
162086445|NCT01332305|585370455|FG004|Overall Study|Withdrawal by Sponsor|1|||
162086446|NCT01332305|585370451|FG000|Overall Study|Treatment Failure|1|||
162086447|NCT01332305|585370452|FG001|Overall Study|Treatment Failure|1|||
162086448|NCT01332305|585370453|FG002|Overall Study|Treatment Failure|0|||
162086449|NCT01332305|585370454|FG003|Overall Study|Treatment Failure|0|||
162086450|NCT01332305|585370455|FG004|Overall Study|Treatment Failure|0|||
162086451|NCT01332305|585370451|FG000|Overall Study|Physician Decision|0|||
162086452|NCT01332305|585370452|FG001|Overall Study|Physician Decision|0|||
162086453|NCT01332305|585370453|FG002|Overall Study|Physician Decision|0|||
162086454|NCT01332305|585370454|FG003|Overall Study|Physician Decision|1|||
162086455|NCT01332305|585370455|FG004|Overall Study|Physician Decision|0|||
162086456|NCT01600040|585370456|FG000|Overall Study|Withdrawal by Subject|1|||
162086457|NCT01401530|585370462|FG000|Overall Study|Disease Progression|1|||
162086458|NCT01401530|585370463|FG001|Overall Study|Disease Progression|2|||
162086459|NCT01401530|585370464|FG002|Overall Study|Disease Progression|1|||
162086460|NCT01401530|585370462|FG000|Overall Study|Adverse Event|1|||
162086461|NCT01401530|585370463|FG001|Overall Study|Adverse Event|1|||
162086462|NCT01401530|585370464|FG002|Overall Study|Adverse Event|1|||
162086463|NCT01401530|585370462|FG000|Overall Study|Participant Choice|1|||
162086464|NCT01401530|585370463|FG001|Overall Study|Participant Choice|2|||
162086465|NCT01401530|585370464|FG002|Overall Study|Participant Choice|1|||
162086466|NCT01401530|585370462|FG000|Overall Study|Physician Decision|0|||
162086467|NCT01401530|585370463|FG001|Overall Study|Physician Decision|1|||
162086468|NCT01401530|585370464|FG002|Overall Study|Physician Decision|0|||
162086469|NCT03670810|585370465|FG000|Main Study|Adverse Event|37|||
162086470|NCT03670810|585370466|FG001|Main Study|Adverse Event|38|||
162086471|NCT03670810|585370467|FG002|Main Study|Adverse Event|3|||
162086472|NCT03670810|585370468|FG003|Main Study|Adverse Event|4|||
162086473|NCT03670810|585370469|FG004|Main Study|Adverse Event|4|||
162086474|NCT03670810|585370470|FG005|Main Study|Adverse Event|5|||
162086475|NCT03670810|585370471|FG006|Main Study|Adverse Event|0|||
162086476|NCT03670810|585370472|FG007|Main Study|Adverse Event|0|||
162086477|NCT03670810|585370473|FG008|Main Study|Adverse Event|0|||
162086478|NCT03670810|585370465|FG000|Main Study|Lack of Efficacy|8|||
162086479|NCT03670810|585370466|FG001|Main Study|Lack of Efficacy|9|||
162086480|NCT03670810|585370467|FG002|Main Study|Lack of Efficacy|3|||
162086481|NCT03670810|585370468|FG003|Main Study|Lack of Efficacy|4|||
162086482|NCT03670810|585370469|FG004|Main Study|Lack of Efficacy|0|||
162086483|NCT03670810|585370470|FG005|Main Study|Lack of Efficacy|0|||
162086484|NCT03670810|585370471|FG006|Main Study|Lack of Efficacy|0|||
162086485|NCT03670810|585370472|FG007|Main Study|Lack of Efficacy|0|||
162086486|NCT03670810|585370473|FG008|Main Study|Lack of Efficacy|0|||
162086487|NCT03670810|585370465|FG000|Main Study|Lost to Follow-up|9|||
162086488|NCT03670810|585370466|FG001|Main Study|Lost to Follow-up|7|||
162086489|NCT03670810|585370467|FG002|Main Study|Lost to Follow-up|4|||
162086490|NCT03670810|585370468|FG003|Main Study|Lost to Follow-up|6|||
162086491|NCT03670810|585370469|FG004|Main Study|Lost to Follow-up|1|||
162086492|NCT03670810|585370470|FG005|Main Study|Lost to Follow-up|0|||
162086493|NCT03670810|585370471|FG006|Main Study|Lost to Follow-up|0|||
162086494|NCT03670810|585370472|FG007|Main Study|Lost to Follow-up|0|||
162086495|NCT03670810|585370473|FG008|Main Study|Lost to Follow-up|0|||
162086496|NCT03670810|585370465|FG000|Main Study|Non-compliance with Study Drug|0|||
162086497|NCT03670810|585370466|FG001|Main Study|Non-compliance with Study Drug|2|||
162086498|NCT03670810|585370467|FG002|Main Study|Non-compliance with Study Drug|3|||
162086499|NCT03670810|585370468|FG003|Main Study|Non-compliance with Study Drug|0|||
162086500|NCT03670810|585370469|FG004|Main Study|Non-compliance with Study Drug|0|||
162086501|NCT03670810|585370470|FG005|Main Study|Non-compliance with Study Drug|0|||
162086502|NCT03670810|585370471|FG006|Main Study|Non-compliance with Study Drug|0|||
162086503|NCT03670810|585370472|FG007|Main Study|Non-compliance with Study Drug|1|||
162086504|NCT03670810|585370473|FG008|Main Study|Non-compliance with Study Drug|0|||
162086505|NCT03670810|585370465|FG000|Main Study|Physician Decision|3|||
162086506|NCT03670810|585370466|FG001|Main Study|Physician Decision|0|||
162086507|NCT03670810|585370467|FG002|Main Study|Physician Decision|1|||
162086508|NCT03670810|585370468|FG003|Main Study|Physician Decision|0|||
162086509|NCT03670810|585370469|FG004|Main Study|Physician Decision|0|||
162086510|NCT03670810|585370470|FG005|Main Study|Physician Decision|0|||
162086511|NCT03670810|585370471|FG006|Main Study|Physician Decision|1|||
162086512|NCT03670810|585370472|FG007|Main Study|Physician Decision|1|||
162086513|NCT03670810|585370473|FG008|Main Study|Physician Decision|0|||
162086514|NCT03670810|585370465|FG000|Main Study|Pregnancy|1|||
162086515|NCT03670810|585370466|FG001|Main Study|Pregnancy|2|||
162086516|NCT03670810|585370467|FG002|Main Study|Pregnancy|0|||
162086517|NCT03670810|585370468|FG003|Main Study|Pregnancy|0|||
162086518|NCT03670810|585370469|FG004|Main Study|Pregnancy|0|||
162086519|NCT03670810|585370470|FG005|Main Study|Pregnancy|0|||
162086520|NCT03670810|585370471|FG006|Main Study|Pregnancy|0|||
162086521|NCT03670810|585370472|FG007|Main Study|Pregnancy|0|||
162086522|NCT03670810|585370473|FG008|Main Study|Pregnancy|0|||
162086523|NCT03670810|585370465|FG000|Main Study|Protocol Deviation|2|||
162086524|NCT03670810|585370466|FG001|Main Study|Protocol Deviation|12|||
162086525|NCT03670810|585370467|FG002|Main Study|Protocol Deviation|8|||
162086526|NCT03670810|585370468|FG003|Main Study|Protocol Deviation|4|||
162086527|NCT03670810|585370469|FG004|Main Study|Protocol Deviation|0|||
162086528|NCT03670810|585370470|FG005|Main Study|Protocol Deviation|0|||
162086529|NCT03670810|585370471|FG006|Main Study|Protocol Deviation|0|||
162086530|NCT03670810|585370472|FG007|Main Study|Protocol Deviation|0|||
162086531|NCT03670810|585370473|FG008|Main Study|Protocol Deviation|0|||
162086532|NCT03670810|585370465|FG000|Main Study|Withdrawal by Subject|21|||
162086533|NCT03670810|585370466|FG001|Main Study|Withdrawal by Subject|21|||
162086534|NCT03670810|585370467|FG002|Main Study|Withdrawal by Subject|8|||
162086535|NCT03670810|585370468|FG003|Main Study|Withdrawal by Subject|9|||
162086536|NCT03670810|585370469|FG004|Main Study|Withdrawal by Subject|5|||
162086537|NCT03670810|585370470|FG005|Main Study|Withdrawal by Subject|2|||
162086538|NCT03670810|585370471|FG006|Main Study|Withdrawal by Subject|1|||
162086539|NCT03670810|585370472|FG007|Main Study|Withdrawal by Subject|1|||
162086540|NCT03670810|585370473|FG008|Main Study|Withdrawal by Subject|0|||
162086541|NCT03670810|585370465|FG000|Main Study|Participant did not want to take the three other treatments|1|||
162086542|NCT03670810|585370466|FG001|Main Study|Participant did not want to take the three other treatments|0|||
162086543|NCT03670810|585370467|FG002|Main Study|Participant did not want to take the three other treatments|0|||
162086544|NCT03670810|585370468|FG003|Main Study|Participant did not want to take the three other treatments|0|||
162086545|NCT03670810|585370469|FG004|Main Study|Participant did not want to take the three other treatments|0|||
162086546|NCT03670810|585370470|FG005|Main Study|Participant did not want to take the three other treatments|0|||
162086547|NCT03670810|585370471|FG006|Main Study|Participant did not want to take the three other treatments|0|||
162086548|NCT03670810|585370472|FG007|Main Study|Participant did not want to take the three other treatments|0|||
162086549|NCT03670810|585370473|FG008|Main Study|Participant did not want to take the three other treatments|0|||
162086550|NCT03670810|585370465|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162086551|NCT03670810|585370466|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
162086552|NCT03670810|585370467|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162086553|NCT03670810|585370468|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162086554|NCT03670810|585370469|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162086555|NCT03670810|585370470|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162086556|NCT03670810|585370471|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162086557|NCT03670810|585370472|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162086558|NCT03670810|585370473|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
162086559|NCT03670810|585370465|FG000|Main Study|Travel and Coronavirus issues|0|||
162086560|NCT03670810|585370466|FG001|Main Study|Travel and Coronavirus issues|0|||
162086561|NCT03670810|585370467|FG002|Main Study|Travel and Coronavirus issues|0|||
162086562|NCT03670810|585370468|FG003|Main Study|Travel and Coronavirus issues|1|||
162086563|NCT03670810|585370469|FG004|Main Study|Travel and Coronavirus issues|0|||
162086564|NCT03670810|585370470|FG005|Main Study|Travel and Coronavirus issues|0|||
162086565|NCT03670810|585370471|FG006|Main Study|Travel and Coronavirus issues|0|||
162086566|NCT03670810|585370472|FG007|Main Study|Travel and Coronavirus issues|0|||
162086567|NCT03670810|585370473|FG008|Main Study|Travel and Coronavirus issues|0|||
162086568|NCT03670810|585370465|FG000|Open Label Extension|Protocol Deviation|0|||
162086569|NCT03670810|585370466|FG001|Open Label Extension|Protocol Deviation|0|||
162086570|NCT03670810|585370467|FG002|Open Label Extension|Protocol Deviation|0|||
162086571|NCT03670810|585370468|FG003|Open Label Extension|Protocol Deviation|0|||
162086572|NCT03670810|585370469|FG004|Open Label Extension|Protocol Deviation|0|||
162086573|NCT03670810|585370470|FG005|Open Label Extension|Protocol Deviation|0|||
162086574|NCT03670810|585370471|FG006|Open Label Extension|Protocol Deviation|0|||
162086575|NCT03670810|585370472|FG007|Open Label Extension|Protocol Deviation|0|||
162086576|NCT03670810|585370473|FG008|Open Label Extension|Protocol Deviation|5|||
162086577|NCT03670810|585370465|FG000|Open Label Extension|Death|0|||
162086578|NCT03670810|585370466|FG001|Open Label Extension|Death|0|||
162086579|NCT03670810|585370467|FG002|Open Label Extension|Death|0|||
162086580|NCT03670810|585370468|FG003|Open Label Extension|Death|0|||
162086581|NCT03670810|585370469|FG004|Open Label Extension|Death|0|||
162086582|NCT03670810|585370470|FG005|Open Label Extension|Death|0|||
162086583|NCT03670810|585370471|FG006|Open Label Extension|Death|0|||
162086584|NCT03670810|585370472|FG007|Open Label Extension|Death|0|||
162086585|NCT03670810|585370473|FG008|Open Label Extension|Death|1|||
162086586|NCT03670810|585370465|FG000|Open Label Extension|COVID-19|0|||
162086587|NCT03670810|585370466|FG001|Open Label Extension|COVID-19|0|||
162086588|NCT03670810|585370467|FG002|Open Label Extension|COVID-19|0|||
162086589|NCT03670810|585370468|FG003|Open Label Extension|COVID-19|0|||
162086590|NCT03670810|585370469|FG004|Open Label Extension|COVID-19|0|||
162086591|NCT03670810|585370470|FG005|Open Label Extension|COVID-19|0|||
162086592|NCT03670810|585370471|FG006|Open Label Extension|COVID-19|0|||
162086593|NCT03670810|585370472|FG007|Open Label Extension|COVID-19|0|||
162086594|NCT03670810|585370473|FG008|Open Label Extension|COVID-19|1|||
162086595|NCT03670810|585370465|FG000|Open Label Extension|Lack of Efficacy|0|||
162086596|NCT03670810|585370466|FG001|Open Label Extension|Lack of Efficacy|0|||
162086597|NCT03670810|585370467|FG002|Open Label Extension|Lack of Efficacy|0|||
162086598|NCT03670810|585370468|FG003|Open Label Extension|Lack of Efficacy|0|||
162086599|NCT03670810|585370469|FG004|Open Label Extension|Lack of Efficacy|0|||
162086600|NCT03670810|585370470|FG005|Open Label Extension|Lack of Efficacy|0|||
162086601|NCT03670810|585370471|FG006|Open Label Extension|Lack of Efficacy|0|||
162086602|NCT03670810|585370472|FG007|Open Label Extension|Lack of Efficacy|0|||
162086603|NCT03670810|585370473|FG008|Open Label Extension|Lack of Efficacy|39|||
162086604|NCT03670810|585370465|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
162086605|NCT03670810|585370466|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
162086606|NCT03670810|585370467|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
162086607|NCT03670810|585370468|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
162086608|NCT03670810|585370469|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
162086609|NCT03670810|585370470|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
162086610|NCT03670810|585370471|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
162086611|NCT03670810|585370472|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
162086612|NCT03670810|585370473|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
162086613|NCT03670810|585370465|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162086614|NCT03670810|585370466|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162086615|NCT03670810|585370467|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162086616|NCT03670810|585370468|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162086617|NCT03670810|585370469|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162086618|NCT03670810|585370470|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162086619|NCT03670810|585370471|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162086620|NCT03670810|585370472|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
162086621|NCT03670810|585370473|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
162086622|NCT03670810|585370465|FG000|Open Label Extension|Withdrawal by Subject|0|||
162086623|NCT03670810|585370466|FG001|Open Label Extension|Withdrawal by Subject|0|||
162086624|NCT03670810|585370467|FG002|Open Label Extension|Withdrawal by Subject|0|||
162086625|NCT03670810|585370468|FG003|Open Label Extension|Withdrawal by Subject|0|||
162086626|NCT03670810|585370469|FG004|Open Label Extension|Withdrawal by Subject|0|||
162086627|NCT03670810|585370470|FG005|Open Label Extension|Withdrawal by Subject|0|||
162086628|NCT03670810|585370471|FG006|Open Label Extension|Withdrawal by Subject|0|||
162086629|NCT03670810|585370472|FG007|Open Label Extension|Withdrawal by Subject|0|||
162086630|NCT03670810|585370473|FG008|Open Label Extension|Withdrawal by Subject|46|||
162086631|NCT03670810|585370465|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162086632|NCT03670810|585370466|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162086633|NCT03670810|585370467|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162086634|NCT03670810|585370468|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162086635|NCT03670810|585370469|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162086636|NCT03670810|585370470|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162086637|NCT03670810|585370471|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162086638|NCT03670810|585370472|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
162086639|NCT03670810|585370473|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
162086640|NCT03670810|585370465|FG000|Open Label Extension|Physician Decision|0|||
162086641|NCT03670810|585370466|FG001|Open Label Extension|Physician Decision|0|||
162086642|NCT03670810|585370467|FG002|Open Label Extension|Physician Decision|0|||
162086643|NCT03670810|585370468|FG003|Open Label Extension|Physician Decision|0|||
162086644|NCT03670810|585370469|FG004|Open Label Extension|Physician Decision|0|||
162086645|NCT03670810|585370470|FG005|Open Label Extension|Physician Decision|0|||
162086646|NCT03670810|585370471|FG006|Open Label Extension|Physician Decision|0|||
162086647|NCT03670810|585370472|FG007|Open Label Extension|Physician Decision|0|||
162086648|NCT03670810|585370473|FG008|Open Label Extension|Physician Decision|2|||
162086649|NCT03670810|585370465|FG000|Open Label Extension|Non-compliance with study drug|0|||
162086650|NCT03670810|585370466|FG001|Open Label Extension|Non-compliance with study drug|0|||
162086651|NCT03670810|585370467|FG002|Open Label Extension|Non-compliance with study drug|0|||
162086652|NCT03670810|585370468|FG003|Open Label Extension|Non-compliance with study drug|0|||
162086653|NCT03670810|585370469|FG004|Open Label Extension|Non-compliance with study drug|0|||
162086654|NCT03670810|585370470|FG005|Open Label Extension|Non-compliance with study drug|0|||
162086655|NCT03670810|585370471|FG006|Open Label Extension|Non-compliance with study drug|0|||
162086656|NCT03670810|585370472|FG007|Open Label Extension|Non-compliance with study drug|0|||
162086657|NCT03670810|585370473|FG008|Open Label Extension|Non-compliance with study drug|5|||
162086658|NCT03670810|585370465|FG000|Open Label Extension|Pregnancy|0|||
162086659|NCT03670810|585370466|FG001|Open Label Extension|Pregnancy|0|||
162086660|NCT03670810|585370467|FG002|Open Label Extension|Pregnancy|0|||
162086661|NCT03670810|585370468|FG003|Open Label Extension|Pregnancy|0|||
162086662|NCT03670810|585370469|FG004|Open Label Extension|Pregnancy|0|||
162086663|NCT03670810|585370470|FG005|Open Label Extension|Pregnancy|0|||
162086664|NCT03670810|585370471|FG006|Open Label Extension|Pregnancy|0|||
162086665|NCT03670810|585370472|FG007|Open Label Extension|Pregnancy|0|||
162086666|NCT03670810|585370473|FG008|Open Label Extension|Pregnancy|3|||
162086667|NCT03670810|585370465|FG000|Open Label Extension|Adverse Event|0|||
162086668|NCT03670810|585370466|FG001|Open Label Extension|Adverse Event|0|||
162086669|NCT03670810|585370467|FG002|Open Label Extension|Adverse Event|0|||
162086670|NCT03670810|585370468|FG003|Open Label Extension|Adverse Event|0|||
162086671|NCT03670810|585370469|FG004|Open Label Extension|Adverse Event|0|||
162086672|NCT03670810|585370470|FG005|Open Label Extension|Adverse Event|0|||
162086673|NCT03670810|585370471|FG006|Open Label Extension|Adverse Event|0|||
162086674|NCT03670810|585370472|FG007|Open Label Extension|Adverse Event|0|||
162086675|NCT03670810|585370473|FG008|Open Label Extension|Adverse Event|24|||
162086676|NCT03670810|585370465|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
162086677|NCT03670810|585370466|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
162086678|NCT03670810|585370467|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
162086679|NCT03670810|585370468|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
162086680|NCT03670810|585370469|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
162086681|NCT03670810|585370470|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
162086682|NCT03670810|585370471|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
162086683|NCT03670810|585370472|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
162086684|NCT03670810|585370473|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
162086685|NCT03670810|585370465|FG000|Open Label Extension|Lost to Follow-up|0|||
162086686|NCT03670810|585370466|FG001|Open Label Extension|Lost to Follow-up|0|||
162086687|NCT03670810|585370467|FG002|Open Label Extension|Lost to Follow-up|0|||
162086688|NCT03670810|585370468|FG003|Open Label Extension|Lost to Follow-up|0|||
162086689|NCT03670810|585370469|FG004|Open Label Extension|Lost to Follow-up|0|||
162086690|NCT03670810|585370470|FG005|Open Label Extension|Lost to Follow-up|0|||
162086691|NCT03670810|585370471|FG006|Open Label Extension|Lost to Follow-up|0|||
162086692|NCT03670810|585370472|FG007|Open Label Extension|Lost to Follow-up|0|||
162086693|NCT03670810|585370473|FG008|Open Label Extension|Lost to Follow-up|23|||
162086694|NCT00678691|585370474|FG000|Overall Study|Adverse Event|6|||
162086695|NCT00678691|585370475|FG001|Overall Study|Adverse Event|4|||
162086696|NCT03192150|585370482|FG000|Overall Study|Adverse Event|14|||
162086697|NCT03192150|585370483|FG001|Overall Study|Adverse Event|12|||
162086698|NCT03192150|585370482|FG000|Overall Study|Lack of Efficacy|23|||
162086699|NCT03192150|585370483|FG001|Overall Study|Lack of Efficacy|30|||
162086700|NCT03192150|585370482|FG000|Overall Study|Lost to Follow-up|1|||
162086701|NCT03192150|585370483|FG001|Overall Study|Lost to Follow-up|1|||
162086702|NCT03192150|585370482|FG000|Overall Study|Withdrawal by Subject|4|||
162086703|NCT03192150|585370483|FG001|Overall Study|Withdrawal by Subject|2|||
162086704|NCT03192150|585370482|FG000|Overall Study|Protocol Violation|5|||
162086705|NCT03192150|585370483|FG001|Overall Study|Protocol Violation|2|||
162086706|NCT03192150|585370482|FG000|Overall Study|Surgery Canceled|6|||
162086707|NCT03192150|585370483|FG001|Overall Study|Surgery Canceled|2|||
162086708|NCT03192150|585370482|FG000|Overall Study|Other-Various Administrative Reasons|2|||
162086709|NCT03192150|585370483|FG001|Overall Study|Other-Various Administrative Reasons|5|||
162086710|NCT00779766|585370484|FG000|Month 24|Serious Adverse Event|2|||
162086711|NCT00779766|585370485|FG001|Month 24|Serious Adverse Event|3|||
162086712|NCT00779766|585370484|FG000|Month 24|Adverse Event|3|||
162086713|NCT00779766|585370485|FG001|Month 24|Adverse Event|3|||
162086714|NCT00779766|585370484|FG000|Month 24|Protocol Violation|3|||
162086715|NCT00779766|585370485|FG001|Month 24|Protocol Violation|1|||
162086716|NCT00779766|585370484|FG000|Month 24|Withdrawal by Subject|159|||
162086717|NCT00779766|585370485|FG001|Month 24|Withdrawal by Subject|127|||
162086718|NCT00779766|585370484|FG000|Month 24|Migrated/moved from study area|138|||
162086719|NCT00779766|585370485|FG001|Month 24|Migrated/moved from study area|162|||
162086720|NCT00779766|585370484|FG000|Month 24|Lost to Follow-up|9|||
162086721|NCT00779766|585370485|FG001|Month 24|Lost to Follow-up|9|||
162086722|NCT00779766|585370484|FG000|Month 24|Other|18|||
162086723|NCT00779766|585370485|FG001|Month 24|Other|27|||
162086724|NCT00779766|585370484|FG000|Month 48|Withdrawal by Subject|68|||
162086725|NCT00779766|585370485|FG001|Month 48|Withdrawal by Subject|63|||
162086726|NCT00779766|585370484|FG000|Month 48|Migrated/moved from study area|76|||
162086727|NCT00779766|585370485|FG001|Month 48|Migrated/moved from study area|75|||
162086728|NCT00779766|585370484|FG000|Month 48|Lost to Follow-up|29|||
162086729|NCT00779766|585370485|FG001|Month 48|Lost to Follow-up|30|||
162086730|NCT00779766|585370484|FG000|Month 48|Other|1|||
162086731|NCT00779766|585370485|FG001|Month 48|Other|0|||
162086732|NCT00779766|585370484|FG000|Month 72|Withdrawal by Subject|55|||
162086733|NCT00779766|585370485|FG001|Month 72|Withdrawal by Subject|71|||
162086734|NCT00779766|585370484|FG000|Month 72|Migrated/moved from study area|124|||
162086735|NCT00779766|585370485|FG001|Month 72|Migrated/moved from study area|109|||
162086736|NCT00779766|585370484|FG000|Month 72|Lost to Follow-up|6|||
162086737|NCT00779766|585370485|FG001|Month 72|Lost to Follow-up|8|||
162086738|NCT00779766|585370484|FG000|Month 72|Other|0|||
162086739|NCT00779766|585370485|FG001|Month 72|Other|1|||
162086740|NCT01412424|585370486|FG000|Core Treatment Period|Treatment Failure|24|||
162086741|NCT01412424|585370486|FG000|Core Treatment Period|Adverse Event|21|||
162086742|NCT01412424|585370486|FG000|Core Treatment Period|Patient Request|5|||
162086743|NCT01412424|585370486|FG000|Core Treatment Period|Lost to Follow-up|2|||
162086744|NCT01412424|585370486|FG000|Core Treatment Period|Sponsor Request|1|||
162086745|NCT01412424|585370486|FG000|Extension Treatment Period|Adverse Event|2|||
162086746|NCT01412424|585370486|FG000|Extension Treatment Period|Treatment Failure|2|||
162086747|NCT01412424|585370486|FG000|Extension Treatment Period|Patient Request|2|||
162086748|NCT01274637|585370487|FG000|Overall Study|Withdrawal by Subject|0|||
162086749|NCT01274637|585370488|FG001|Overall Study|Withdrawal by Subject|1|||
162086750|NCT01274637|585370487|FG000|Overall Study|Lost to Follow-up|0|||
162086751|NCT01274637|585370488|FG001|Overall Study|Lost to Follow-up|1|||
162086752|NCT00806546|585370489|FG000|Overall Study|Enrolled, not treated|35|||
162086753|NCT00806546|585370489|FG000|Overall Study|Lost to Follow-up|32|||
162086754|NCT00806546|585370489|FG000|Overall Study|Adverse Event|74|||
162086755|NCT00806546|585370489|FG000|Overall Study|Withdrawal by Subject|75|||
162086756|NCT00806546|585370489|FG000|Overall Study|Protocol Violation|49|||
162086757|NCT00806546|585370489|FG000|Overall Study|Various|42|||
162086758|NCT00558103|585370492|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
162086759|NCT00558103|585370493|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
162086760|NCT00558103|585370494|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
162086761|NCT00558103|585370495|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
162086762|NCT00558103|585370496|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
162086763|NCT00558103|585370497|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
162086764|NCT00558103|585370492|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
162086765|NCT00558103|585370493|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
162086766|NCT00558103|585370494|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
162086767|NCT00558103|585370495|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
162086768|NCT00558103|585370496|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
162086769|NCT00558103|585370497|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
162086770|NCT00558103|585370492|FG000|Randomized Treatment Phase|Disease Progression|1|||
162086771|NCT00558103|585370493|FG001|Randomized Treatment Phase|Disease Progression|0|||
162086772|NCT00558103|585370494|FG002|Randomized Treatment Phase|Disease Progression|1|||
162086773|NCT00558103|585370495|FG003|Randomized Treatment Phase|Disease Progression|0|||
162086774|NCT00558103|585370496|FG004|Randomized Treatment Phase|Disease Progression|0|||
162086775|NCT00558103|585370497|FG005|Randomized Treatment Phase|Disease Progression|0|||
162086776|NCT00558103|585370492|FG000|Randomized Treatment Phase|Adverse Event|0|||
162086777|NCT00558103|585370493|FG001|Randomized Treatment Phase|Adverse Event|0|||
162086778|NCT00558103|585370494|FG002|Randomized Treatment Phase|Adverse Event|0|||
162086779|NCT00558103|585370495|FG003|Randomized Treatment Phase|Adverse Event|1|||
162086780|NCT00558103|585370496|FG004|Randomized Treatment Phase|Adverse Event|1|||
162086781|NCT00558103|585370497|FG005|Randomized Treatment Phase|Adverse Event|0|||
162086782|NCT00558103|585370492|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
162086783|NCT00558103|585370493|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
162086784|NCT00558103|585370494|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
162086785|NCT00558103|585370495|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
162086786|NCT00558103|585370496|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
162086787|NCT00558103|585370497|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
162086788|NCT00558103|585370492|FG000|Monotherapy Extension Phase|Disease Progression|0|||
162086789|NCT00558103|585370493|FG001|Monotherapy Extension Phase|Disease Progression|0|||
162086790|NCT00558103|585370494|FG002|Monotherapy Extension Phase|Disease Progression|0|||
162086791|NCT00558103|585370495|FG003|Monotherapy Extension Phase|Disease Progression|0|||
162086792|NCT00558103|585370496|FG004|Monotherapy Extension Phase|Disease Progression|0|||
162086793|NCT00558103|585370497|FG005|Monotherapy Extension Phase|Disease Progression|8|||
162086794|NCT02751983|585370500|FG000|Treatment|Stopped ACT, but Remained in study|2|||
162086795|NCT02751983|585370501|FG001|Treatment|Stopped ACT, but Remained in study|0|||
162086796|NCT02751983|585370500|FG000|Treatment|Discharged prior to beginning ACT|2|||
162086797|NCT02751983|585370501|FG001|Treatment|Discharged prior to beginning ACT|0|||
162086798|NCT02751983|585370500|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
162086799|NCT02751983|585370501|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
162086800|NCT02751983|585370500|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
162086801|NCT02751983|585370501|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
162086802|NCT02751983|585370500|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
162086803|NCT02751983|585370501|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
162086804|NCT00308711|585370502|FG000|Overall Study|Withdrawal by Subject|1|||
162086805|NCT00308711|585370503|FG001|Overall Study|Withdrawal by Subject|0|||
162086806|NCT00308711|585370504|FG002|Overall Study|Withdrawal by Subject|1|||
162086807|NCT00308711|585370502|FG000|Overall Study|Protocol Violation|0|||
162086808|NCT00308711|585370503|FG001|Overall Study|Protocol Violation|1|||
162086809|NCT00308711|585370504|FG002|Overall Study|Protocol Violation|1|||
162086810|NCT00308711|585370502|FG000|Overall Study|Lost to Follow-up|0|||
162086811|NCT00308711|585370503|FG001|Overall Study|Lost to Follow-up|1|||
162086812|NCT00308711|585370504|FG002|Overall Study|Lost to Follow-up|0|||
162086813|NCT00308711|585370502|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
162086814|NCT00308711|585370503|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
162086815|NCT00308711|585370504|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
162086816|NCT00308711|585370502|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
162086817|NCT00308711|585370503|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
162086818|NCT00308711|585370504|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
162086819|NCT02167256|585370507|FG000|Overall Study|Adverse Event|13|||
162086820|NCT02167256|585370508|FG001|Overall Study|Adverse Event|6|||
162086821|NCT02167256|585370507|FG000|Overall Study|Withdrawal by Subject|4|||
162086822|NCT02167256|585370508|FG001|Overall Study|Withdrawal by Subject|4|||
162086823|NCT02167256|585370507|FG000|Overall Study|non-compliance|3|||
162086824|NCT02167256|585370508|FG001|Overall Study|non-compliance|0|||
162086825|NCT02167256|585370507|FG000|Overall Study|Study partner unable to participate|1|||
162086826|NCT02167256|585370508|FG001|Overall Study|Study partner unable to participate|0|||
162086827|NCT03139916|585370509|FG000|Overall Study|Withdrawal by Subject|2|||
162086828|NCT03139916|585370509|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
162086829|NCT01957475|585370510|FG000|Test Period 1|Withdrawal by Subject|1|||
162086830|NCT01957475|585370511|FG001|Test Period 1|Withdrawal by Subject|0|||
162086831|NCT01957475|585370510|FG000|Test Period 1|Other|1|||
162086832|NCT01957475|585370511|FG001|Test Period 1|Other|0|||
162086833|NCT01957475|585370510|FG000|Test Period 1|Lack of Efficacy|0|||
162086834|NCT01957475|585370511|FG001|Test Period 1|Lack of Efficacy|1|||
162086835|NCT01957475|585370510|FG000|Test Period 2|Adverse Event|1|||
162086836|NCT01957475|585370511|FG001|Test Period 2|Adverse Event|0|||
162086837|NCT02469610|585370512|FG000|Overall Study|Death|1|||
162086838|NCT02469610|585370513|FG001|Overall Study|Death|0|||
162086839|NCT02469610|585370512|FG000|Overall Study|Lost to Follow-up|1|||
162086840|NCT02469610|585370513|FG001|Overall Study|Lost to Follow-up|0|||
162086841|NCT02469610|585370512|FG000|Overall Study|exclusion criteria|2|||
162086842|NCT02469610|585370513|FG001|Overall Study|exclusion criteria|1|||
162086843|NCT00414388|585370516|FG000|Overall Study|Adverse Event|1|||
162086844|NCT03467425|585370517|FG000|Overall Study|Adverse Event|9|||
162086845|NCT03467425|585370518|FG001|Overall Study|Adverse Event|9|||
162086846|NCT03467425|585370517|FG000|Overall Study|Lack of Efficacy|3|||
162086847|NCT03467425|585370518|FG001|Overall Study|Lack of Efficacy|1|||
162086848|NCT03467425|585370517|FG000|Overall Study|Protocol Violation|0|||
162086849|NCT03467425|585370518|FG001|Overall Study|Protocol Violation|1|||
162086850|NCT03467425|585370517|FG000|Overall Study|Lost to Follow-up|18|||
162086851|NCT03467425|585370518|FG001|Overall Study|Lost to Follow-up|25|||
162086852|NCT03467425|585370517|FG000|Overall Study|Physician Decision|2|||
162086853|NCT03467425|585370518|FG001|Overall Study|Physician Decision|1|||
162086854|NCT03467425|585370517|FG000|Overall Study|Withdrawal by Subject|15|||
162086855|NCT03467425|585370518|FG001|Overall Study|Withdrawal by Subject|17|||
162086856|NCT02318693|585370519|FG000|Overall Study|Protocol Violation|0|||
162086857|NCT02318693|585370520|FG001|Overall Study|Protocol Violation|1|||
162086858|NCT03591575|585370523|FG000|Overall Study|Adverse Event|2|||
162086859|NCT03591575|585370524|FG001|Overall Study|Adverse Event|0|||
162086860|NCT03591575|585370523|FG000|Overall Study|Withdrawal by Subject|4|||
162086861|NCT03591575|585370524|FG001|Overall Study|Withdrawal by Subject|1|||
162086862|NCT00025883|585370525|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
162086863|NCT00025883|585370525|FG000|Overall Study|no baseline data|1|||
162086864|NCT00025883|585370525|FG000|Overall Study|Death|1|||
162086865|NCT00025883|585370525|FG000|Overall Study|Adverse Event|1|||
162086866|NCT00025883|585370525|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
162086867|NCT00813358|585370526|FG000|Overall Study|Death|32|||
162086868|NCT00813358|585370526|FG000|Overall Study|Lost to Follow-up|12|||
162086869|NCT00813358|585370526|FG000|Overall Study|other endpoints|5|||
162086870|NCT00813358|585370526|FG000|Overall Study|Withdrawal by Subject|20|||
162086871|NCT00218543|585370527|FG000|Overall Study|Lost to Follow-up|8|||
162086872|NCT00218543|585370527|FG000|Overall Study|relocated|1|||
162086873|NCT00218543|585370527|FG000|Overall Study|Withdrawal by Subject|1|||
162086874|NCT00218543|585370527|FG000|Overall Study|Physician Decision|3|||
162086875|NCT00218543|585370527|FG000|Overall Study|Adverse Event|2|||
162086876|NCT02920983|585370528|FG000|Dispense 1|Unacceptable Lens Fit|0|||
162086877|NCT02920983|585370529|FG001|Dispense 1|Unacceptable Lens Fit|0|||
162086878|NCT02920983|585370530|FG002|Dispense 1|Unacceptable Lens Fit|0|||
162086879|NCT02920983|585370531|FG003|Dispense 1|Unacceptable Lens Fit|0|||
162086880|NCT02920983|585370532|FG004|Dispense 1|Unacceptable Lens Fit|1|||
162086881|NCT02920983|585370533|FG005|Dispense 1|Unacceptable Lens Fit|0|||
162086882|NCT02920983|585370528|FG000|Dispense 2|Unscceptable lens fit|1|||
162086883|NCT02920983|585370529|FG001|Dispense 2|Unscceptable lens fit|0|||
162086884|NCT02920983|585370530|FG002|Dispense 2|Unscceptable lens fit|0|||
162086885|NCT02920983|585370531|FG003|Dispense 2|Unscceptable lens fit|0|||
162086886|NCT02920983|585370532|FG004|Dispense 2|Unscceptable lens fit|1|||
162086887|NCT02920983|585370533|FG005|Dispense 2|Unscceptable lens fit|0|||
162086888|NCT02920983|585370528|FG000|Dispense 3|Unacceptable Lens Fit|1|||
162086889|NCT02920983|585370529|FG001|Dispense 3|Unacceptable Lens Fit|1|||
162086890|NCT02920983|585370530|FG002|Dispense 3|Unacceptable Lens Fit|0|||
162086891|NCT02920983|585370531|FG003|Dispense 3|Unacceptable Lens Fit|0|||
162086892|NCT02920983|585370532|FG004|Dispense 3|Unacceptable Lens Fit|1|||
162086893|NCT02920983|585370533|FG005|Dispense 3|Unacceptable Lens Fit|0|||
162086894|NCT01451424|585370534|FG000|Overall Study|Withdrawal by Subject|1|||
162086895|NCT01451424|585370535|FG001|Overall Study|Withdrawal by Subject|1|||
162086896|NCT01451424|585370536|FG002|Overall Study|Withdrawal by Subject|0|||
162086897|NCT01451424|585370537|FG003|Overall Study|Withdrawal by Subject|2|||
162086898|NCT01451424|585370534|FG000|Overall Study|Lost to Follow-up|0|||
162086899|NCT01451424|585370535|FG001|Overall Study|Lost to Follow-up|1|||
162086900|NCT01451424|585370536|FG002|Overall Study|Lost to Follow-up|0|||
162086901|NCT01451424|585370537|FG003|Overall Study|Lost to Follow-up|1|||
162086902|NCT01451424|585370534|FG000|Overall Study|Physician Decision|0|||
162086903|NCT01451424|585370535|FG001|Overall Study|Physician Decision|0|||
162086904|NCT01451424|585370536|FG002|Overall Study|Physician Decision|1|||
162086905|NCT01451424|585370537|FG003|Overall Study|Physician Decision|1|||
162086906|NCT01451424|585370534|FG000|Overall Study|Adverse Event|0|||
162086907|NCT01451424|585370535|FG001|Overall Study|Adverse Event|0|||
162086908|NCT01451424|585370536|FG002|Overall Study|Adverse Event|0|||
162086909|NCT01451424|585370537|FG003|Overall Study|Adverse Event|1|||
162086910|NCT01387607|585370543|FG000|Overall Study|Adverse Event|23|||
162086911|NCT01387607|585370544|FG001|Overall Study|Adverse Event|11|||
162086912|NCT01387607|585370543|FG000|Overall Study|Lack of Efficacy|8|||
162086913|NCT01387607|585370544|FG001|Overall Study|Lack of Efficacy|6|||
162086914|NCT01387607|585370543|FG000|Overall Study|Lost to Follow-up|2|||
162086915|NCT01387607|585370544|FG001|Overall Study|Lost to Follow-up|1|||
162086916|NCT01387607|585370543|FG000|Overall Study|No longer meets eligibility criteria|0|||
162086917|NCT01387607|585370544|FG001|Overall Study|No longer meets eligibility criteria|1|||
162086918|NCT01387607|585370543|FG000|Overall Study|Protocol Violation|1|||
162086919|NCT01387607|585370544|FG001|Overall Study|Protocol Violation|5|||
162086920|NCT01387607|585370543|FG000|Overall Study|Withdrawal by Subject|13|||
162086921|NCT01387607|585370544|FG001|Overall Study|Withdrawal by Subject|14|||
162086922|NCT01387607|585370543|FG000|Overall Study|Other|1|||
162086923|NCT01387607|585370544|FG001|Overall Study|Other|1|||
162086924|NCT01387607|585370543|FG000|Overall Study|Randomized, not treated|3|||
162086925|NCT01387607|585370544|FG001|Overall Study|Randomized, not treated|6|||
162086926|NCT03665038|585370545|FG000|Overall Study|Lost to Follow-up|0|||
162086927|NCT03665038|585370546|FG001|Overall Study|Lost to Follow-up|0|||
162086928|NCT03665038|585370547|FG002|Overall Study|Lost to Follow-up|1|||
162086929|NCT03013491|585370548|FG000|Main Study|Death|2|||
162086930|NCT03013491|585370549|FG001|Main Study|Death|2|||
162086931|NCT03013491|585370550|FG002|Main Study|Death|5|||
162086932|NCT03013491|585370551|FG003|Main Study|Death|3|||
162086933|NCT03013491|585370552|FG004|Main Study|Death|9|||
162086934|NCT03013491|585370553|FG005|Main Study|Death|12|||
162086935|NCT03013491|585370554|FG006|Main Study|Death|3|||
162086936|NCT03013491|585370555|FG007|Main Study|Death|5|||
162086937|NCT03013491|585370556|FG008|Main Study|Death|1|||
162086938|NCT03013491|585370557|FG009|Main Study|Death|2|||
162086939|NCT03013491|585370558|FG010|Main Study|Death|4|||
162086940|NCT03013491|585370559|FG011|Main Study|Death|1|||
162086941|NCT03013491|585370560|FG012|Main Study|Death|1|||
162086942|NCT03013491|585370561|FG013|Main Study|Death|4|||
162086943|NCT03013491|585370562|FG014|Main Study|Death|0|||
162086944|NCT03013491|585370563|FG015|Main Study|Death|3|||
162086945|NCT03013491|585370564|FG016|Main Study|Death|5|||
162086946|NCT03013491|585370565|FG017|Main Study|Death|1|||
162086947|NCT03013491|585370566|FG018|Main Study|Death|47|||
162086948|NCT03013491|585370548|FG000|Main Study|Lost to Follow-up|0|||
162086949|NCT03013491|585370549|FG001|Main Study|Lost to Follow-up|0|||
162086950|NCT03013491|585370550|FG002|Main Study|Lost to Follow-up|1|||
162086951|NCT03013491|585370551|FG003|Main Study|Lost to Follow-up|0|||
162086952|NCT03013491|585370552|FG004|Main Study|Lost to Follow-up|1|||
162086953|NCT03013491|585370553|FG005|Main Study|Lost to Follow-up|0|||
162086954|NCT03013491|585370554|FG006|Main Study|Lost to Follow-up|0|||
162086955|NCT03013491|585370555|FG007|Main Study|Lost to Follow-up|0|||
162086956|NCT03013491|585370556|FG008|Main Study|Lost to Follow-up|0|||
162086957|NCT03013491|585370557|FG009|Main Study|Lost to Follow-up|0|||
162086958|NCT03013491|585370558|FG010|Main Study|Lost to Follow-up|0|||
162086959|NCT03013491|585370559|FG011|Main Study|Lost to Follow-up|0|||
162086960|NCT03013491|585370560|FG012|Main Study|Lost to Follow-up|0|||
162086961|NCT03013491|585370561|FG013|Main Study|Lost to Follow-up|0|||
162086962|NCT03013491|585370562|FG014|Main Study|Lost to Follow-up|0|||
162086963|NCT03013491|585370563|FG015|Main Study|Lost to Follow-up|0|||
162086964|NCT03013491|585370564|FG016|Main Study|Lost to Follow-up|0|||
162086965|NCT03013491|585370565|FG017|Main Study|Lost to Follow-up|0|||
162086966|NCT03013491|585370566|FG018|Main Study|Lost to Follow-up|3|||
162086967|NCT03013491|585370548|FG000|Main Study|Termination of the study by Sponsor|0|||
162086968|NCT03013491|585370549|FG001|Main Study|Termination of the study by Sponsor|0|||
162086969|NCT03013491|585370550|FG002|Main Study|Termination of the study by Sponsor|2|||
162086970|NCT03013491|585370551|FG003|Main Study|Termination of the study by Sponsor|0|||
162086971|NCT03013491|585370552|FG004|Main Study|Termination of the study by Sponsor|1|||
162086972|NCT03013491|585370553|FG005|Main Study|Termination of the study by Sponsor|2|||
162086973|NCT03013491|585370554|FG006|Main Study|Termination of the study by Sponsor|0|||
162086974|NCT03013491|585370555|FG007|Main Study|Termination of the study by Sponsor|0|||
162086975|NCT03013491|585370556|FG008|Main Study|Termination of the study by Sponsor|1|||
162086976|NCT03013491|585370557|FG009|Main Study|Termination of the study by Sponsor|1|||
162086977|NCT03013491|585370558|FG010|Main Study|Termination of the study by Sponsor|1|||
162086978|NCT03013491|585370559|FG011|Main Study|Termination of the study by Sponsor|2|||
162086979|NCT03013491|585370560|FG012|Main Study|Termination of the study by Sponsor|0|||
162086980|NCT03013491|585370561|FG013|Main Study|Termination of the study by Sponsor|0|||
162086981|NCT03013491|585370562|FG014|Main Study|Termination of the study by Sponsor|0|||
162086982|NCT03013491|585370563|FG015|Main Study|Termination of the study by Sponsor|0|||
162086983|NCT03013491|585370564|FG016|Main Study|Termination of the study by Sponsor|0|||
162086984|NCT03013491|585370565|FG017|Main Study|Termination of the study by Sponsor|1|||
162086985|NCT03013491|585370566|FG018|Main Study|Termination of the study by Sponsor|13|||
162086986|NCT03013491|585370548|FG000|Main Study|Withdrawal by Subject|0|||
162086987|NCT03013491|585370549|FG001|Main Study|Withdrawal by Subject|0|||
162086988|NCT03013491|585370550|FG002|Main Study|Withdrawal by Subject|0|||
162086989|NCT03013491|585370551|FG003|Main Study|Withdrawal by Subject|4|||
162086990|NCT03013491|585370552|FG004|Main Study|Withdrawal by Subject|2|||
162086991|NCT03013491|585370553|FG005|Main Study|Withdrawal by Subject|1|||
162086992|NCT03013491|585370554|FG006|Main Study|Withdrawal by Subject|0|||
162086993|NCT03013491|585370555|FG007|Main Study|Withdrawal by Subject|0|||
162086994|NCT03013491|585370556|FG008|Main Study|Withdrawal by Subject|0|||
162086995|NCT03013491|585370557|FG009|Main Study|Withdrawal by Subject|0|||
162086996|NCT03013491|585370558|FG010|Main Study|Withdrawal by Subject|1|||
162086997|NCT03013491|585370559|FG011|Main Study|Withdrawal by Subject|2|||
162086998|NCT03013491|585370560|FG012|Main Study|Withdrawal by Subject|0|||
162086999|NCT03013491|585370561|FG013|Main Study|Withdrawal by Subject|2|||
162087000|NCT03013491|585370562|FG014|Main Study|Withdrawal by Subject|0|||
162087001|NCT03013491|585370563|FG015|Main Study|Withdrawal by Subject|0|||
162087002|NCT03013491|585370564|FG016|Main Study|Withdrawal by Subject|0|||
162087003|NCT03013491|585370565|FG017|Main Study|Withdrawal by Subject|0|||
162087004|NCT03013491|585370566|FG018|Main Study|Withdrawal by Subject|18|||
162087005|NCT03013491|585370548|FG000|Main Study|Disease progression|0|||
162087006|NCT03013491|585370549|FG001|Main Study|Disease progression|0|||
162087007|NCT03013491|585370550|FG002|Main Study|Disease progression|0|||
162087008|NCT03013491|585370551|FG003|Main Study|Disease progression|1|||
162087009|NCT03013491|585370552|FG004|Main Study|Disease progression|0|||
162087010|NCT03013491|585370553|FG005|Main Study|Disease progression|0|||
162087011|NCT03013491|585370554|FG006|Main Study|Disease progression|0|||
162087012|NCT03013491|585370555|FG007|Main Study|Disease progression|0|||
162087013|NCT03013491|585370556|FG008|Main Study|Disease progression|1|||
162087014|NCT03013491|585370557|FG009|Main Study|Disease progression|0|||
162087015|NCT03013491|585370558|FG010|Main Study|Disease progression|1|||
162087016|NCT03013491|585370559|FG011|Main Study|Disease progression|0|||
162087017|NCT03013491|585370560|FG012|Main Study|Disease progression|0|||
162087018|NCT03013491|585370561|FG013|Main Study|Disease progression|0|||
162087019|NCT03013491|585370562|FG014|Main Study|Disease progression|0|||
162087020|NCT03013491|585370563|FG015|Main Study|Disease progression|0|||
162087021|NCT03013491|585370564|FG016|Main Study|Disease progression|0|||
162087022|NCT03013491|585370565|FG017|Main Study|Disease progression|0|||
162087023|NCT03013491|585370566|FG018|Main Study|Disease progression|4|||
162087024|NCT03013491|585370548|FG000|Main Study|Symptomatic deterioration|0|||
162087025|NCT03013491|585370549|FG001|Main Study|Symptomatic deterioration|0|||
162087026|NCT03013491|585370550|FG002|Main Study|Symptomatic deterioration|0|||
162087027|NCT03013491|585370551|FG003|Main Study|Symptomatic deterioration|0|||
162087028|NCT03013491|585370552|FG004|Main Study|Symptomatic deterioration|0|||
162087029|NCT03013491|585370553|FG005|Main Study|Symptomatic deterioration|1|||
162087030|NCT03013491|585370554|FG006|Main Study|Symptomatic deterioration|0|||
162087031|NCT03013491|585370555|FG007|Main Study|Symptomatic deterioration|0|||
162087032|NCT03013491|585370556|FG008|Main Study|Symptomatic deterioration|0|||
162087033|NCT03013491|585370557|FG009|Main Study|Symptomatic deterioration|0|||
162087034|NCT03013491|585370558|FG010|Main Study|Symptomatic deterioration|0|||
162087035|NCT03013491|585370559|FG011|Main Study|Symptomatic deterioration|0|||
162087036|NCT03013491|585370560|FG012|Main Study|Symptomatic deterioration|0|||
162087037|NCT03013491|585370561|FG013|Main Study|Symptomatic deterioration|0|||
162087038|NCT03013491|585370562|FG014|Main Study|Symptomatic deterioration|0|||
162087039|NCT03013491|585370563|FG015|Main Study|Symptomatic deterioration|0|||
162087040|NCT03013491|585370564|FG016|Main Study|Symptomatic deterioration|0|||
162087041|NCT03013491|585370565|FG017|Main Study|Symptomatic deterioration|0|||
162087042|NCT03013491|585370566|FG018|Main Study|Symptomatic deterioration|0|||
162087043|NCT03013491|585370548|FG000|Main Study|Protocol version 8.0 approval|0|||
162087044|NCT03013491|585370549|FG001|Main Study|Protocol version 8.0 approval|0|||
162087045|NCT03013491|585370550|FG002|Main Study|Protocol version 8.0 approval|0|||
162087046|NCT03013491|585370551|FG003|Main Study|Protocol version 8.0 approval|0|||
162087047|NCT03013491|585370552|FG004|Main Study|Protocol version 8.0 approval|0|||
162087048|NCT03013491|585370553|FG005|Main Study|Protocol version 8.0 approval|0|||
162087049|NCT03013491|585370554|FG006|Main Study|Protocol version 8.0 approval|0|||
162087050|NCT03013491|585370555|FG007|Main Study|Protocol version 8.0 approval|0|||
162087051|NCT03013491|585370556|FG008|Main Study|Protocol version 8.0 approval|0|||
162087052|NCT03013491|585370557|FG009|Main Study|Protocol version 8.0 approval|0|||
162087053|NCT03013491|585370558|FG010|Main Study|Protocol version 8.0 approval|1|||
162087054|NCT03013491|585370559|FG011|Main Study|Protocol version 8.0 approval|0|||
162087055|NCT03013491|585370560|FG012|Main Study|Protocol version 8.0 approval|0|||
162087056|NCT03013491|585370561|FG013|Main Study|Protocol version 8.0 approval|0|||
162087057|NCT03013491|585370562|FG014|Main Study|Protocol version 8.0 approval|0|||
162087058|NCT03013491|585370563|FG015|Main Study|Protocol version 8.0 approval|0|||
162087059|NCT03013491|585370564|FG016|Main Study|Protocol version 8.0 approval|0|||
162087060|NCT03013491|585370565|FG017|Main Study|Protocol version 8.0 approval|0|||
162087061|NCT03013491|585370566|FG018|Main Study|Protocol version 8.0 approval|0|||
162087062|NCT03013491|585370548|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
162087063|NCT03013491|585370549|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
162087064|NCT03013491|585370550|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
162087065|NCT03013491|585370551|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
162087066|NCT03013491|585370552|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
162087067|NCT03013491|585370553|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
162087068|NCT03013491|585370554|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
162087069|NCT03013491|585370555|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
162087070|NCT03013491|585370556|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
162087071|NCT03013491|585370557|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
162087072|NCT03013491|585370558|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
162087073|NCT03013491|585370559|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
162087074|NCT03013491|585370560|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
162087075|NCT03013491|585370561|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
162087076|NCT03013491|585370562|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
162087077|NCT03013491|585370563|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
162087078|NCT03013491|585370564|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
162087079|NCT03013491|585370565|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
162087080|NCT03013491|585370566|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
162087081|NCT03013491|585370548|FG000|Main Study|Start of new anticancer therapy|0|||
162087082|NCT03013491|585370549|FG001|Main Study|Start of new anticancer therapy|0|||
162087083|NCT03013491|585370550|FG002|Main Study|Start of new anticancer therapy|0|||
162087084|NCT03013491|585370551|FG003|Main Study|Start of new anticancer therapy|0|||
162087085|NCT03013491|585370552|FG004|Main Study|Start of new anticancer therapy|0|||
162087086|NCT03013491|585370553|FG005|Main Study|Start of new anticancer therapy|0|||
162087087|NCT03013491|585370554|FG006|Main Study|Start of new anticancer therapy|0|||
162087088|NCT03013491|585370555|FG007|Main Study|Start of new anticancer therapy|0|||
162087089|NCT03013491|585370556|FG008|Main Study|Start of new anticancer therapy|0|||
162087090|NCT03013491|585370557|FG009|Main Study|Start of new anticancer therapy|0|||
162087091|NCT03013491|585370558|FG010|Main Study|Start of new anticancer therapy|0|||
162087092|NCT03013491|585370559|FG011|Main Study|Start of new anticancer therapy|0|||
162087093|NCT03013491|585370560|FG012|Main Study|Start of new anticancer therapy|0|||
162087094|NCT03013491|585370561|FG013|Main Study|Start of new anticancer therapy|0|||
162087095|NCT03013491|585370562|FG014|Main Study|Start of new anticancer therapy|0|||
162087096|NCT03013491|585370563|FG015|Main Study|Start of new anticancer therapy|0|||
162087097|NCT03013491|585370564|FG016|Main Study|Start of new anticancer therapy|0|||
162087098|NCT03013491|585370565|FG017|Main Study|Start of new anticancer therapy|0|||
162087099|NCT03013491|585370566|FG018|Main Study|Start of new anticancer therapy|2|||
162087100|NCT03013491|585370548|FG000|Long-term Extension|Disease progression|0|||
162087101|NCT03013491|585370549|FG001|Long-term Extension|Disease progression|0|||
162087102|NCT03013491|585370550|FG002|Long-term Extension|Disease progression|0|||
162087103|NCT03013491|585370551|FG003|Long-term Extension|Disease progression|1|||
162087104|NCT03013491|585370552|FG004|Long-term Extension|Disease progression|0|||
162087105|NCT03013491|585370553|FG005|Long-term Extension|Disease progression|0|||
162087106|NCT03013491|585370554|FG006|Long-term Extension|Disease progression|0|||
162087107|NCT03013491|585370555|FG007|Long-term Extension|Disease progression|0|||
162087108|NCT03013491|585370556|FG008|Long-term Extension|Disease progression|0|||
162087109|NCT03013491|585370557|FG009|Long-term Extension|Disease progression|0|||
162087110|NCT03013491|585370558|FG010|Long-term Extension|Disease progression|0|||
162087111|NCT03013491|585370559|FG011|Long-term Extension|Disease progression|0|||
162087112|NCT03013491|585370560|FG012|Long-term Extension|Disease progression|0|||
162087113|NCT03013491|585370561|FG013|Long-term Extension|Disease progression|0|||
162087114|NCT03013491|585370562|FG014|Long-term Extension|Disease progression|0|||
162087115|NCT03013491|585370563|FG015|Long-term Extension|Disease progression|0|||
162087116|NCT03013491|585370564|FG016|Long-term Extension|Disease progression|0|||
162087117|NCT03013491|585370565|FG017|Long-term Extension|Disease progression|0|||
162087118|NCT03013491|585370566|FG018|Long-term Extension|Disease progression|1|||
162087119|NCT03013491|585370548|FG000|Long-term Extension|Withdrawal by Subject|0|||
162087120|NCT03013491|585370549|FG001|Long-term Extension|Withdrawal by Subject|0|||
162087121|NCT03013491|585370550|FG002|Long-term Extension|Withdrawal by Subject|0|||
162087122|NCT03013491|585370551|FG003|Long-term Extension|Withdrawal by Subject|0|||
162087123|NCT03013491|585370552|FG004|Long-term Extension|Withdrawal by Subject|0|||
162087124|NCT03013491|585370553|FG005|Long-term Extension|Withdrawal by Subject|0|||
162087125|NCT03013491|585370554|FG006|Long-term Extension|Withdrawal by Subject|0|||
162087126|NCT03013491|585370555|FG007|Long-term Extension|Withdrawal by Subject|1|||
162087127|NCT03013491|585370556|FG008|Long-term Extension|Withdrawal by Subject|0|||
162087128|NCT03013491|585370557|FG009|Long-term Extension|Withdrawal by Subject|0|||
162087129|NCT03013491|585370558|FG010|Long-term Extension|Withdrawal by Subject|0|||
162087130|NCT03013491|585370559|FG011|Long-term Extension|Withdrawal by Subject|0|||
162087131|NCT03013491|585370560|FG012|Long-term Extension|Withdrawal by Subject|0|||
162087132|NCT03013491|585370561|FG013|Long-term Extension|Withdrawal by Subject|0|||
162087133|NCT03013491|585370562|FG014|Long-term Extension|Withdrawal by Subject|0|||
162087134|NCT03013491|585370563|FG015|Long-term Extension|Withdrawal by Subject|0|||
162087135|NCT03013491|585370564|FG016|Long-term Extension|Withdrawal by Subject|0|||
162087136|NCT03013491|585370565|FG017|Long-term Extension|Withdrawal by Subject|0|||
162087137|NCT03013491|585370566|FG018|Long-term Extension|Withdrawal by Subject|0|||
162087138|NCT03013491|585370548|FG000|Long-term Extension|Adverse Event|0|||
162087139|NCT03013491|585370549|FG001|Long-term Extension|Adverse Event|0|||
162087140|NCT03013491|585370550|FG002|Long-term Extension|Adverse Event|0|||
162087141|NCT03013491|585370551|FG003|Long-term Extension|Adverse Event|0|||
162087142|NCT03013491|585370552|FG004|Long-term Extension|Adverse Event|0|||
162087143|NCT03013491|585370553|FG005|Long-term Extension|Adverse Event|0|||
162087144|NCT03013491|585370554|FG006|Long-term Extension|Adverse Event|0|||
162087145|NCT03013491|585370555|FG007|Long-term Extension|Adverse Event|0|||
162087146|NCT03013491|585370556|FG008|Long-term Extension|Adverse Event|0|||
162087147|NCT03013491|585370557|FG009|Long-term Extension|Adverse Event|0|||
162087148|NCT03013491|585370558|FG010|Long-term Extension|Adverse Event|0|||
162087149|NCT03013491|585370559|FG011|Long-term Extension|Adverse Event|0|||
162087150|NCT03013491|585370560|FG012|Long-term Extension|Adverse Event|0|||
162087151|NCT03013491|585370561|FG013|Long-term Extension|Adverse Event|0|||
162087152|NCT03013491|585370562|FG014|Long-term Extension|Adverse Event|0|||
162087153|NCT03013491|585370563|FG015|Long-term Extension|Adverse Event|0|||
162087154|NCT03013491|585370564|FG016|Long-term Extension|Adverse Event|0|||
162087155|NCT03013491|585370565|FG017|Long-term Extension|Adverse Event|0|||
162087156|NCT03013491|585370566|FG018|Long-term Extension|Adverse Event|1|||
162087157|NCT03013491|585370548|FG000|Long-term Extension|Death|0|||
162087158|NCT03013491|585370549|FG001|Long-term Extension|Death|0|||
162087159|NCT03013491|585370550|FG002|Long-term Extension|Death|0|||
162087160|NCT03013491|585370551|FG003|Long-term Extension|Death|0|||
162087161|NCT03013491|585370552|FG004|Long-term Extension|Death|0|||
162087162|NCT03013491|585370553|FG005|Long-term Extension|Death|0|||
162087163|NCT03013491|585370554|FG006|Long-term Extension|Death|0|||
162087164|NCT03013491|585370555|FG007|Long-term Extension|Death|0|||
162087165|NCT03013491|585370556|FG008|Long-term Extension|Death|0|||
162087166|NCT03013491|585370557|FG009|Long-term Extension|Death|0|||
162087167|NCT03013491|585370558|FG010|Long-term Extension|Death|0|||
162087168|NCT03013491|585370559|FG011|Long-term Extension|Death|0|||
162087169|NCT03013491|585370560|FG012|Long-term Extension|Death|0|||
162087170|NCT03013491|585370561|FG013|Long-term Extension|Death|0|||
162087171|NCT03013491|585370562|FG014|Long-term Extension|Death|0|||
162087172|NCT03013491|585370563|FG015|Long-term Extension|Death|0|||
162087173|NCT03013491|585370564|FG016|Long-term Extension|Death|0|||
162087174|NCT03013491|585370565|FG017|Long-term Extension|Death|0|||
162087175|NCT03013491|585370566|FG018|Long-term Extension|Death|1|||
162087176|NCT02383758|585372584|FG000|Overall Study|Withdrawal by Subject|0|||
162087177|NCT02383758|585372585|FG001|Overall Study|Withdrawal by Subject|2|||
162087178|NCT00827372|585372586|FG000|Overall Study|Adverse Event|5|||
162087179|NCT00827372|585372586|FG000|Overall Study|Lack of Efficacy|3|||
162087180|NCT03085927|585372587|FG000|Overall Study|Withdrawal by Subject|1|||
162087181|NCT03085927|585372588|FG001|Overall Study|Withdrawal by Subject|4|||
162087182|NCT03085927|585372587|FG000|Overall Study|Lost to Follow-up|3|||
162087183|NCT03085927|585372588|FG001|Overall Study|Lost to Follow-up|1|||
162087184|NCT03085927|585372587|FG000|Overall Study|Death|1|||
162087185|NCT03085927|585372588|FG001|Overall Study|Death|0|||
162087186|NCT03085927|585372587|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
162087187|NCT03085927|585372588|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
162087188|NCT03085927|585372587|FG000|Overall Study|Dyad Became Ineligible|0|||
162087189|NCT03085927|585372588|FG001|Overall Study|Dyad Became Ineligible|1|||
162087190|NCT02564471|585372589|FG000|Overall Study|Adverse Event|1|||
162087191|NCT02564471|585372590|FG001|Overall Study|Adverse Event|0|||
162087192|NCT02564471|585372591|FG002|Overall Study|Adverse Event|0|||
162087193|NCT02564471|585372592|FG003|Overall Study|Adverse Event|0|||
162087194|NCT02564471|585372589|FG000|Overall Study|Withdrawal by Subject|2|||
162087195|NCT02564471|585372590|FG001|Overall Study|Withdrawal by Subject|1|||
162087196|NCT02564471|585372591|FG002|Overall Study|Withdrawal by Subject|3|||
162087197|NCT02564471|585372592|FG003|Overall Study|Withdrawal by Subject|0|||
162087198|NCT02564471|585372589|FG000|Overall Study|Lost to Follow-up|0|||
162087199|NCT02564471|585372590|FG001|Overall Study|Lost to Follow-up|2|||
162087200|NCT02564471|585372591|FG002|Overall Study|Lost to Follow-up|0|||
162087201|NCT02564471|585372592|FG003|Overall Study|Lost to Follow-up|0|||
162087202|NCT01643473|585372595|FG000|Overall Study|Lost to Follow-up|1|||
162087203|NCT01643473|585372596|FG001|Overall Study|Lost to Follow-up|0|||
162087204|NCT01519518|585372598|FG000|Overall Study|Consent not available|7|||
162087205|NCT01519518|585372599|FG001|Overall Study|Consent not available|10|||
162087206|NCT02033889|585372600|FG000|Overall Study|Adverse Event|3|||
162087207|NCT02033889|585372601|FG001|Overall Study|Adverse Event|1|||
162087208|NCT02033889|585372602|FG002|Overall Study|Adverse Event|3|||
162087209|NCT02033889|585372600|FG000|Overall Study|Death|3|||
162087210|NCT02033889|585372601|FG001|Overall Study|Death|1|||
162087211|NCT02033889|585372602|FG002|Overall Study|Death|2|||
162087212|NCT02033889|585372600|FG000|Overall Study|Excluded Medication|1|||
162087213|NCT02033889|585372601|FG001|Overall Study|Excluded Medication|1|||
162087214|NCT02033889|585372602|FG002|Overall Study|Excluded Medication|0|||
162087215|NCT02033889|585372600|FG000|Overall Study|Lost to Follow-up|8|||
162087216|NCT02033889|585372601|FG001|Overall Study|Lost to Follow-up|5|||
162087217|NCT02033889|585372602|FG002|Overall Study|Lost to Follow-up|6|||
162087218|NCT02033889|585372600|FG000|Overall Study|Non-Compliance With Study Drug|1|||
162087219|NCT02033889|585372601|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162087220|NCT02033889|585372602|FG002|Overall Study|Non-Compliance With Study Drug|0|||
162087221|NCT02033889|585372600|FG000|Overall Study|Physician Decision|0|||
162087222|NCT02033889|585372601|FG001|Overall Study|Physician Decision|1|||
162087223|NCT02033889|585372602|FG002|Overall Study|Physician Decision|1|||
162087224|NCT02033889|585372600|FG000|Overall Study|Participant moved|0|||
162087225|NCT02033889|585372601|FG001|Overall Study|Participant moved|1|||
162087226|NCT02033889|585372602|FG002|Overall Study|Participant moved|0|||
162087227|NCT02033889|585372600|FG000|Overall Study|Withdrawal by Subject|18|||
162087228|NCT02033889|585372601|FG001|Overall Study|Withdrawal by Subject|10|||
162087229|NCT02033889|585372602|FG002|Overall Study|Withdrawal by Subject|13|||
162087230|NCT00182689|585372608|FG000|Overall Study|Adverse Event|8|||
162087231|NCT00182689|585372609|FG001|Overall Study|Adverse Event|11|||
162087232|NCT00182689|585372608|FG000|Overall Study|Withdrawal by Subject|2|||
162087233|NCT00182689|585372609|FG001|Overall Study|Withdrawal by Subject|2|||
162087234|NCT00182689|585372608|FG000|Overall Study|Progression|27|||
162087235|NCT00182689|585372609|FG001|Overall Study|Progression|29|||
162087236|NCT00182689|585372608|FG000|Overall Study|Death|1|||
162087237|NCT00182689|585372609|FG001|Overall Study|Death|0|||
162087238|NCT00182689|585372608|FG000|Overall Study|not protocol specified|0|||
162087239|NCT00182689|585372609|FG001|Overall Study|not protocol specified|3|||
162087240|NCT00182689|585372608|FG000|Overall Study|Ineligible|1|||
162087241|NCT00182689|585372609|FG001|Overall Study|Ineligible|4|||
162087242|NCT00182689|585372608|FG000|Overall Study|Never received treatment|1|||
162087243|NCT00182689|585372609|FG001|Overall Study|Never received treatment|0|||
162087244|NCT00659646|585372610|FG000|Overall Study|Protocol Violation|12|||
162087245|NCT00659646|585372611|FG001|Overall Study|Protocol Violation|8|||
162087246|NCT00659646|585372610|FG000|Overall Study|Adverse Event|1|||
162087247|NCT00659646|585372611|FG001|Overall Study|Adverse Event|0|||
162087248|NCT00659646|585372610|FG000|Overall Study|Lost to Follow-up|1|||
162087249|NCT00659646|585372611|FG001|Overall Study|Lost to Follow-up|0|||
162087250|NCT00659646|585372610|FG000|Overall Study|protocol noncompliance after randomized|1|||
162087251|NCT00659646|585372611|FG001|Overall Study|protocol noncompliance after randomized|0|||
162087252|NCT01640301|585372612|FG000|Overall Study|Death|0|||
162087253|NCT01640301|585372613|FG001|Overall Study|Death|8|||
162087254|NCT02391948|585372619|FG000|6-month Assessment|Death|0|||
162087255|NCT02391948|585372620|FG001|6-month Assessment|Death|0|||
162087256|NCT02391948|585372621|FG002|6-month Assessment|Death|0|||
162087257|NCT02391948|585372622|FG003|6-month Assessment|Death|0|||
162087258|NCT02391948|585372623|FG004|6-month Assessment|Death|1|||
162087259|NCT02391948|585372619|FG000|6-month Assessment|Withdrawal by Subject|0|||
162087260|NCT02391948|585372620|FG001|6-month Assessment|Withdrawal by Subject|0|||
162087261|NCT02391948|585372621|FG002|6-month Assessment|Withdrawal by Subject|1|||
162087262|NCT02391948|585372622|FG003|6-month Assessment|Withdrawal by Subject|2|||
162087263|NCT02391948|585372623|FG004|6-month Assessment|Withdrawal by Subject|0|||
162087264|NCT02391948|585372619|FG000|6-month Assessment|Lost to Follow-up|4|||
162087265|NCT02391948|585372620|FG001|6-month Assessment|Lost to Follow-up|5|||
162087266|NCT02391948|585372621|FG002|6-month Assessment|Lost to Follow-up|2|||
162087267|NCT02391948|585372622|FG003|6-month Assessment|Lost to Follow-up|3|||
162087268|NCT02391948|585372623|FG004|6-month Assessment|Lost to Follow-up|1|||
162087269|NCT02391948|585372619|FG000|6-month Assessment|Medical issue/illness|1|||
162087270|NCT02391948|585372620|FG001|6-month Assessment|Medical issue/illness|1|||
162087271|NCT02391948|585372621|FG002|6-month Assessment|Medical issue/illness|0|||
162087272|NCT02391948|585372622|FG003|6-month Assessment|Medical issue/illness|0|||
162087273|NCT02391948|585372623|FG004|6-month Assessment|Medical issue/illness|0|||
162087274|NCT02391948|585372619|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
162087275|NCT02391948|585372620|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
162087276|NCT02391948|585372621|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
162087277|NCT02391948|585372622|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
162087278|NCT02391948|585372623|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
162087279|NCT02391948|585372619|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
162087280|NCT02391948|585372620|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
162087281|NCT02391948|585372621|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
162087282|NCT02391948|585372622|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
162087283|NCT02391948|585372623|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
162087284|NCT02391948|585372619|FG000|12-month Assessment|Death|0|||
162087285|NCT02391948|585372620|FG001|12-month Assessment|Death|0|||
162087286|NCT02391948|585372621|FG002|12-month Assessment|Death|0|||
162087287|NCT02391948|585372622|FG003|12-month Assessment|Death|1|||
162087288|NCT02391948|585372623|FG004|12-month Assessment|Death|0|||
162087289|NCT02391948|585372619|FG000|12-month Assessment|Withdrawal by Subject|1|||
162087290|NCT02391948|585372620|FG001|12-month Assessment|Withdrawal by Subject|0|||
162087291|NCT02391948|585372621|FG002|12-month Assessment|Withdrawal by Subject|0|||
162087292|NCT02391948|585372622|FG003|12-month Assessment|Withdrawal by Subject|1|||
162087293|NCT02391948|585372623|FG004|12-month Assessment|Withdrawal by Subject|0|||
162087294|NCT02391948|585372619|FG000|12-month Assessment|Lost to Follow-up|5|||
162087295|NCT02391948|585372620|FG001|12-month Assessment|Lost to Follow-up|4|||
162087296|NCT02391948|585372621|FG002|12-month Assessment|Lost to Follow-up|4|||
162087297|NCT02391948|585372622|FG003|12-month Assessment|Lost to Follow-up|4|||
162087298|NCT02391948|585372623|FG004|12-month Assessment|Lost to Follow-up|5|||
162087299|NCT02391948|585372619|FG000|12-month Assessment|Medical issue/illness|0|||
162087300|NCT02391948|585372620|FG001|12-month Assessment|Medical issue/illness|1|||
162087301|NCT02391948|585372621|FG002|12-month Assessment|Medical issue/illness|0|||
162087302|NCT02391948|585372622|FG003|12-month Assessment|Medical issue/illness|1|||
162087303|NCT02391948|585372623|FG004|12-month Assessment|Medical issue/illness|0|||
162087304|NCT02391948|585372619|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
162087305|NCT02391948|585372620|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
162087306|NCT02391948|585372621|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
162087307|NCT02391948|585372622|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
162087308|NCT02391948|585372623|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
162087309|NCT02391948|585372619|FG000|18-month Assessment|Death|0|||
162087310|NCT02391948|585372620|FG001|18-month Assessment|Death|0|||
162087311|NCT02391948|585372621|FG002|18-month Assessment|Death|0|||
162087312|NCT02391948|585372622|FG003|18-month Assessment|Death|1|||
162087313|NCT02391948|585372623|FG004|18-month Assessment|Death|1|||
162087314|NCT02391948|585372619|FG000|18-month Assessment|Withdrawal by Subject|1|||
162087315|NCT02391948|585372620|FG001|18-month Assessment|Withdrawal by Subject|0|||
162087316|NCT02391948|585372621|FG002|18-month Assessment|Withdrawal by Subject|0|||
162087317|NCT02391948|585372622|FG003|18-month Assessment|Withdrawal by Subject|1|||
162087318|NCT02391948|585372623|FG004|18-month Assessment|Withdrawal by Subject|0|||
162087319|NCT02391948|585372619|FG000|18-month Assessment|Lost to Follow-up|2|||
162087320|NCT02391948|585372620|FG001|18-month Assessment|Lost to Follow-up|6|||
162087321|NCT02391948|585372621|FG002|18-month Assessment|Lost to Follow-up|2|||
162087322|NCT02391948|585372622|FG003|18-month Assessment|Lost to Follow-up|2|||
162087323|NCT02391948|585372623|FG004|18-month Assessment|Lost to Follow-up|3|||
162087324|NCT02391948|585372619|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
162087325|NCT02391948|585372620|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
162087326|NCT02391948|585372621|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
162087327|NCT02391948|585372622|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
162087328|NCT02391948|585372623|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
162087329|NCT02391948|585372619|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
162087330|NCT02391948|585372620|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
162087331|NCT02391948|585372621|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
162087332|NCT02391948|585372622|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
162087333|NCT02391948|585372623|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
162087334|NCT02391948|585372619|FG000|24-month Assessment|Death|0|||
162087335|NCT02391948|585372620|FG001|24-month Assessment|Death|0|||
162087336|NCT02391948|585372621|FG002|24-month Assessment|Death|0|||
162087337|NCT02391948|585372622|FG003|24-month Assessment|Death|0|||
162087338|NCT02391948|585372623|FG004|24-month Assessment|Death|1|||
162087339|NCT02391948|585372619|FG000|24-month Assessment|Withdrawal by Subject|1|||
162087340|NCT02391948|585372620|FG001|24-month Assessment|Withdrawal by Subject|1|||
162087341|NCT02391948|585372621|FG002|24-month Assessment|Withdrawal by Subject|0|||
162087342|NCT02391948|585372622|FG003|24-month Assessment|Withdrawal by Subject|0|||
162087343|NCT02391948|585372623|FG004|24-month Assessment|Withdrawal by Subject|1|||
162087344|NCT02391948|585372619|FG000|24-month Assessment|Lost to Follow-up|5|||
162087345|NCT02391948|585372620|FG001|24-month Assessment|Lost to Follow-up|4|||
162087346|NCT02391948|585372621|FG002|24-month Assessment|Lost to Follow-up|0|||
162087347|NCT02391948|585372622|FG003|24-month Assessment|Lost to Follow-up|0|||
162087348|NCT02391948|585372623|FG004|24-month Assessment|Lost to Follow-up|0|||
162087349|NCT02391948|585372619|FG000|24-month Assessment|Medical issue/illness|0|||
162087350|NCT02391948|585372620|FG001|24-month Assessment|Medical issue/illness|0|||
162087351|NCT02391948|585372621|FG002|24-month Assessment|Medical issue/illness|1|||
162087352|NCT02391948|585372622|FG003|24-month Assessment|Medical issue/illness|0|||
162087353|NCT02391948|585372623|FG004|24-month Assessment|Medical issue/illness|0|||
162087354|NCT02391948|585372619|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
162087355|NCT02391948|585372620|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
162087356|NCT02391948|585372621|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
162087357|NCT02391948|585372622|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
162087358|NCT02391948|585372623|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
162087359|NCT02348489|585372624|FG000|Overall Study|Death|336|||
162087360|NCT02348489|585372625|FG001|Overall Study|Death|335|||
162087361|NCT02348489|585372624|FG000|Overall Study|Withdrawal by Subject|14|||
162087362|NCT02348489|585372625|FG001|Overall Study|Withdrawal by Subject|27|||
162087363|NCT02348489|585372624|FG000|Overall Study|Lost to Follow-up|3|||
162087364|NCT02348489|585372625|FG001|Overall Study|Lost to Follow-up|5|||
162087365|NCT01969838|585372628|FG000|Double-blind Phase|Adverse Event|10|||
162087366|NCT01969838|585372629|FG001|Double-blind Phase|Adverse Event|4|||
162087367|NCT01969838|585372630|FG002|Double-blind Phase|Adverse Event|0|||
162087368|NCT01969838|585372631|FG003|Double-blind Phase|Adverse Event|0|||
162087369|NCT01969838|585372628|FG000|Double-blind Phase|Death|5|||
162087370|NCT01969838|585372629|FG001|Double-blind Phase|Death|2|||
162087371|NCT01969838|585372630|FG002|Double-blind Phase|Death|0|||
162087372|NCT01969838|585372631|FG003|Double-blind Phase|Death|0|||
162087373|NCT01969838|585372628|FG000|Double-blind Phase|Physician Decision|5|||
162087374|NCT01969838|585372629|FG001|Double-blind Phase|Physician Decision|1|||
162087375|NCT01969838|585372630|FG002|Double-blind Phase|Physician Decision|0|||
162087376|NCT01969838|585372631|FG003|Double-blind Phase|Physician Decision|0|||
162087377|NCT01969838|585372628|FG000|Double-blind Phase|Subject Decision|4|||
162087378|NCT01969838|585372629|FG001|Double-blind Phase|Subject Decision|2|||
162087379|NCT01969838|585372630|FG002|Double-blind Phase|Subject Decision|0|||
162087380|NCT01969838|585372631|FG003|Double-blind Phase|Subject Decision|0|||
162087381|NCT01969838|585372628|FG000|Double-blind Phase|Disease Progression|2|||
162087382|NCT01969838|585372629|FG001|Double-blind Phase|Disease Progression|0|||
162087383|NCT01969838|585372630|FG002|Double-blind Phase|Disease Progression|0|||
162087384|NCT01969838|585372631|FG003|Double-blind Phase|Disease Progression|0|||
162087385|NCT01969838|585372628|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
162087386|NCT01969838|585372629|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
162087387|NCT01969838|585372630|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
162087388|NCT01969838|585372631|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
162087389|NCT01969838|585372628|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
162087390|NCT01969838|585372629|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
162087391|NCT01969838|585372630|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
162087392|NCT01969838|585372631|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
162087393|NCT01969838|585372628|FG000|Open-label Phase|Adverse Event|0|||
162087394|NCT01969838|585372629|FG001|Open-label Phase|Adverse Event|0|||
162087395|NCT01969838|585372630|FG002|Open-label Phase|Adverse Event|37|||
162087396|NCT01969838|585372631|FG003|Open-label Phase|Adverse Event|49|||
162087397|NCT01969838|585372628|FG000|Open-label Phase|Disease Progression|0|||
162087398|NCT01969838|585372629|FG001|Open-label Phase|Disease Progression|0|||
162087399|NCT01969838|585372630|FG002|Open-label Phase|Disease Progression|26|||
162087400|NCT01969838|585372631|FG003|Open-label Phase|Disease Progression|27|||
162087401|NCT01969838|585372628|FG000|Open-label Phase|Lack of Efficacy|0|||
162087402|NCT01969838|585372629|FG001|Open-label Phase|Lack of Efficacy|0|||
162087403|NCT01969838|585372630|FG002|Open-label Phase|Lack of Efficacy|17|||
162087404|NCT01969838|585372631|FG003|Open-label Phase|Lack of Efficacy|19|||
162087405|NCT01969838|585372628|FG000|Open-label Phase|Subject Decision|0|||
162087406|NCT01969838|585372629|FG001|Open-label Phase|Subject Decision|0|||
162087407|NCT01969838|585372630|FG002|Open-label Phase|Subject Decision|14|||
162087408|NCT01969838|585372631|FG003|Open-label Phase|Subject Decision|15|||
162087409|NCT01969838|585372628|FG000|Open-label Phase|Death|0|||
162087410|NCT01969838|585372629|FG001|Open-label Phase|Death|0|||
162087411|NCT01969838|585372630|FG002|Open-label Phase|Death|13|||
162087412|NCT01969838|585372631|FG003|Open-label Phase|Death|11|||
162087413|NCT01969838|585372628|FG000|Open-label Phase|Physician Decision|0|||
162087414|NCT01969838|585372629|FG001|Open-label Phase|Physician Decision|0|||
162087415|NCT01969838|585372630|FG002|Open-label Phase|Physician Decision|9|||
162087416|NCT01969838|585372631|FG003|Open-label Phase|Physician Decision|14|||
162087417|NCT01969838|585372628|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
162087418|NCT01969838|585372629|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
162087419|NCT01969838|585372630|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
162087420|NCT01969838|585372631|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
162087421|NCT00408993|585372632|FG000|Overall Study|Adverse Event|15|||
162087422|NCT00408993|585372633|FG001|Overall Study|Adverse Event|4|||
162087423|NCT00408993|585372632|FG000|Overall Study|Protocol Violation|1|||
162087424|NCT00408993|585372633|FG001|Overall Study|Protocol Violation|6|||
162087425|NCT00408993|585372632|FG000|Overall Study|Lack of Efficacy|1|||
162087426|NCT00408993|585372633|FG001|Overall Study|Lack of Efficacy|4|||
162087427|NCT00408993|585372632|FG000|Overall Study|Withdrawal by Subject|2|||
162087428|NCT00408993|585372633|FG001|Overall Study|Withdrawal by Subject|3|||
162087429|NCT04193202|585372634|FG000|Overall Study|Adverse Event|2|||
162087430|NCT04193202|585372635|FG001|Overall Study|Adverse Event|1|||
162087431|NCT04193202|585372634|FG000|Overall Study|Death|0|||
162087432|NCT04193202|585372635|FG001|Overall Study|Death|1|||
162087433|NCT04193202|585372634|FG000|Overall Study|Physician Decision|1|||
162087434|NCT04193202|585372635|FG001|Overall Study|Physician Decision|1|||
162087435|NCT04193202|585372634|FG000|Overall Study|Protocol Violation|2|||
162087436|NCT04193202|585372635|FG001|Overall Study|Protocol Violation|2|||
162087437|NCT04193202|585372634|FG000|Overall Study|Withdrawal by Subject|11|||
162087438|NCT04193202|585372635|FG001|Overall Study|Withdrawal by Subject|5|||
162087439|NCT01777997|585372636|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
162087440|NCT01777997|585372636|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
162087441|NCT01777997|585372636|FG000|Weeks 48 to 72/96 on ART|Death|1|||
162087442|NCT01777997|585372636|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
162087443|NCT02488629|585372638|FG000|Overall Study|Lack of Efficacy|3|||
162087444|NCT02488629|585372639|FG001|Overall Study|Lack of Efficacy|1|||
162087445|NCT02488629|585372640|FG002|Overall Study|Lack of Efficacy|0|||
162087446|NCT02488629|585372641|FG003|Overall Study|Lack of Efficacy|0|||
162087447|NCT02488629|585372638|FG000|Overall Study|Withdrawal by Subject|0|||
162087448|NCT02488629|585372639|FG001|Overall Study|Withdrawal by Subject|1|||
162087449|NCT02488629|585372640|FG002|Overall Study|Withdrawal by Subject|0|||
162087450|NCT02488629|585372641|FG003|Overall Study|Withdrawal by Subject|0|||
162087451|NCT02932891|585372642|FG000|Overall Study|Lost to Follow-up|2|||
162087452|NCT02932891|585372642|FG000|Overall Study|HPA Suppress|2|||
162087453|NCT04622254|585372643|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
162087454|NCT04622254|585372644|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
162087455|NCT04622254|585372645|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
162087456|NCT04622254|585372646|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
162087457|NCT04622254|585372647|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
162087458|NCT04622254|585372648|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
162087459|NCT04622254|585372643|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
162087460|NCT04622254|585372644|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
162087461|NCT04622254|585372645|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
162087462|NCT04622254|585372646|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
162087463|NCT04622254|585372647|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
162087464|NCT04622254|585372648|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
162087465|NCT04622254|585372643|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
162087466|NCT04622254|585372644|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
162087467|NCT04622254|585372645|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
162087468|NCT04622254|585372646|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
162087469|NCT04622254|585372647|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
162087470|NCT04622254|585372648|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
162087471|NCT04622254|585372643|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
162087472|NCT04622254|585372644|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
162237446|NCT00600886|585921097|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
162087473|NCT04622254|585372645|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
162087474|NCT04622254|585372646|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
162087475|NCT04622254|585372647|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
162087476|NCT04622254|585372648|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
162087477|NCT04622254|585372643|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162087478|NCT04622254|585372644|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162087479|NCT04622254|585372645|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162087480|NCT04622254|585372646|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
162087481|NCT04622254|585372647|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162087482|NCT04622254|585372648|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
162087483|NCT04622254|585372643|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
162087484|NCT04622254|585372644|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
162087485|NCT04622254|585372645|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
162087486|NCT04622254|585372646|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
162087487|NCT04622254|585372647|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
162087488|NCT04622254|585372648|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
162087489|NCT04622254|585372643|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162087490|NCT04622254|585372644|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162087491|NCT04622254|585372645|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162087492|NCT04622254|585372646|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
162087493|NCT04622254|585372647|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162087494|NCT04622254|585372648|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
162087495|NCT04622254|585372643|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162087496|NCT04622254|585372644|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162087497|NCT04622254|585372645|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162087498|NCT04622254|585372646|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
162087499|NCT04622254|585372647|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162087500|NCT04622254|585372648|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
162087501|NCT04622254|585372643|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
162087502|NCT04622254|585372644|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
162087503|NCT04622254|585372645|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
162087504|NCT04622254|585372646|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
162087505|NCT04622254|585372647|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
162087506|NCT04622254|585372648|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
162087507|NCT04622254|585372643|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
162087508|NCT04622254|585372644|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
162087509|NCT04622254|585372645|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
162087510|NCT04622254|585372646|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
162087511|NCT04622254|585372647|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
162087512|NCT04622254|585372648|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
162087513|NCT04622254|585372643|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
162087514|NCT04622254|585372644|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
162087515|NCT04622254|585372645|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
162087516|NCT04622254|585372646|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
162087517|NCT04622254|585372647|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
162087518|NCT04622254|585372648|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
162087519|NCT02652624|585372649|FG000|Randomized Phase|Pregnancy|3|||
162087520|NCT02652624|585372650|FG001|Randomized Phase|Pregnancy|1|||
162087521|NCT02652624|585372649|FG000|Randomized Phase|Investigator's Discretion|0|||
162087522|NCT02652624|585372650|FG001|Randomized Phase|Investigator's Discretion|2|||
162087523|NCT02652624|585372649|FG000|Randomized Phase|Death|0|||
162087524|NCT02652624|585372650|FG001|Randomized Phase|Death|1|||
162087525|NCT02652624|585372649|FG000|Randomized Phase|Lost to Follow-up|0|||
162087526|NCT02652624|585372650|FG001|Randomized Phase|Lost to Follow-up|1|||
162087527|NCT02652624|585372649|FG000|Extension Phase|Lost to Follow-up|3|||
162087528|NCT02652624|585372650|FG001|Extension Phase|Lost to Follow-up|1|||
162087529|NCT02652624|585372649|FG000|Extension Phase|Pregnancy|1|||
162087530|NCT02652624|585372650|FG001|Extension Phase|Pregnancy|1|||
162087531|NCT02652624|585372649|FG000|Extension Phase|Adverse Event|0|||
162087532|NCT02652624|585372650|FG001|Extension Phase|Adverse Event|1|||
162087533|NCT02652624|585372649|FG000|Extension Phase|Withdrew Consent|0|||
162087534|NCT02652624|585372650|FG001|Extension Phase|Withdrew Consent|1|||
162087535|NCT00577122|585372651|FG000|Overall Study|Adverse Event|0|||
162087536|NCT00577122|585372652|FG001|Overall Study|Adverse Event|2|||
162087537|NCT00577122|585372651|FG000|Overall Study|Progression, relapse during active trt|6|||
162087538|NCT00577122|585372652|FG001|Overall Study|Progression, relapse during active trt|8|||
162087539|NCT00577122|585372651|FG000|Overall Study|Prog, refract disease during active trt|8|||
162087540|NCT00577122|585372652|FG001|Overall Study|Prog, refract disease during active trt|5|||
162087541|NCT00577122|585372651|FG000|Overall Study|Alternative Therapy|0|||
162087542|NCT00577122|585372652|FG001|Overall Study|Alternative Therapy|1|||
162087543|NCT03228680|585372653|FG000|Overall Study|Adverse Event|13|||
162087544|NCT03228680|585372654|FG001|Overall Study|Adverse Event|18|||
162087545|NCT03228680|585372653|FG000|Overall Study|Randomization failure|0|||
162087546|NCT03228680|585372654|FG001|Overall Study|Randomization failure|1|||
162087547|NCT03228680|585372653|FG000|Overall Study|Withdrawal by Subject|1|||
162087548|NCT03228680|585372654|FG001|Overall Study|Withdrawal by Subject|0|||
162087549|NCT03228680|585372653|FG000|Overall Study|Other|9|||
162087550|NCT03228680|585372654|FG001|Overall Study|Other|16|||
162087551|NCT02167035|585372655|FG000|Overall Study|Adverse Event|2|||
162087552|NCT02167035|585372656|FG001|Overall Study|Adverse Event|2|||
162087553|NCT02167035|585372655|FG000|Overall Study|Lost to Follow-up|3|||
162087554|NCT02167035|585372656|FG001|Overall Study|Lost to Follow-up|3|||
162087555|NCT02167035|585372655|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
162087556|NCT02167035|585372656|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
162087557|NCT02252081|585372657|FG000|Overall Study|Withdrawal by Subject|2|||
162087558|NCT02252081|585372658|FG001|Overall Study|Withdrawal by Subject|1|||
162087559|NCT02252081|585372657|FG000|Overall Study|Adverse Event|4|||
162087560|NCT02252081|585372658|FG001|Overall Study|Adverse Event|1|||
162087561|NCT02252081|585372657|FG000|Overall Study|non compliance & others|0|||
162087562|NCT02252081|585372658|FG001|Overall Study|non compliance & others|2|||
162087563|NCT03732638|585372665|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
162087564|NCT03732638|585372666|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
162087565|NCT03732638|585372665|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
162087566|NCT03732638|585372666|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
162087567|NCT03732638|585372665|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
162087568|NCT03732638|585372666|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
162087569|NCT03732638|585372665|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
162087570|NCT03732638|585372666|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
162087571|NCT03732638|585372665|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
162087572|NCT03732638|585372666|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
162087573|NCT03732638|585372665|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
162087574|NCT03732638|585372666|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
162087575|NCT03732638|585372665|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
162087576|NCT03732638|585372666|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
162087577|NCT03732638|585372665|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
162087578|NCT03732638|585372666|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
162087579|NCT03732638|585372665|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
162087580|NCT03732638|585372666|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
162087581|NCT03732638|585372665|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
162087582|NCT03732638|585372666|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
162087583|NCT03732638|585372665|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
162087584|NCT03732638|585372666|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
162087585|NCT03732638|585372665|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
162087586|NCT03732638|585372666|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
162087587|NCT03732638|585372665|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
162087588|NCT03732638|585372666|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
162087589|NCT03732638|585372665|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
162087590|NCT03732638|585372666|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
162087591|NCT03732638|585372665|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
162087592|NCT03732638|585372666|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
162087593|NCT03732638|585372665|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
162087594|NCT03732638|585372666|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
162087595|NCT03732638|585372665|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
162087596|NCT03732638|585372666|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
162087597|NCT03732638|585372665|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
162087598|NCT03732638|585372666|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
162087599|NCT03732638|585372665|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
162087600|NCT03732638|585372666|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
162087601|NCT03732638|585372665|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
162087602|NCT03732638|585372666|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
162087603|NCT03732638|585372665|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
162087604|NCT03732638|585372666|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
162087605|NCT03732638|585372665|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
162087606|NCT03732638|585372666|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
162087607|NCT03732638|585372665|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
162087608|NCT03732638|585372666|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
162087609|NCT03732638|585372665|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
162087610|NCT03732638|585372666|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
162087611|NCT00642304|585372667|FG000|Overall Study|Adverse Event|1|||
162087612|NCT00642304|585372667|FG000|Overall Study|Death|1|||
162087613|NCT00642304|585372667|FG000|Overall Study|Blood transfusion|2|||
162087614|NCT00642304|585372667|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
162087615|NCT00642304|585372667|FG000|Overall Study|Transplantation|1|||
162087616|NCT00482391|585372668|FG000|Overall Study|Withdrawal by Subject|1|||
162087617|NCT00482391|585372668|FG000|Overall Study|Adverse Event|1|||
162087618|NCT00482391|585372668|FG000|Overall Study|Death|1|||
162087619|NCT02606136|585372690|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
162087620|NCT02606136|585372690|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
162087621|NCT02606136|585372690|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
162087622|NCT02606136|585372690|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
162087623|NCT03296696|585372691|FG000|Overall Study|Started Other Antitumor Therapy|1|||
162087624|NCT03296696|585372692|FG001|Overall Study|Started Other Antitumor Therapy|2|||
162087625|NCT03296696|585372693|FG002|Overall Study|Started Other Antitumor Therapy|1|||
162087626|NCT03296696|585372694|FG003|Overall Study|Started Other Antitumor Therapy|2|||
162087627|NCT03296696|585372695|FG004|Overall Study|Started Other Antitumor Therapy|1|||
162087628|NCT03296696|585372696|FG005|Overall Study|Started Other Antitumor Therapy|1|||
162087629|NCT03296696|585372697|FG006|Overall Study|Started Other Antitumor Therapy|2|||
162087630|NCT03296696|585372698|FG007|Overall Study|Started Other Antitumor Therapy|3|||
162087631|NCT03296696|585372699|FG008|Overall Study|Started Other Antitumor Therapy|1|||
162087632|NCT03296696|585372700|FG009|Overall Study|Started Other Antitumor Therapy|0|||
162087633|NCT03296696|585372691|FG000|Overall Study|Death|0|||
162087634|NCT03296696|585372692|FG001|Overall Study|Death|1|||
162087635|NCT03296696|585372693|FG002|Overall Study|Death|1|||
162087636|NCT03296696|585372694|FG003|Overall Study|Death|2|||
162087637|NCT03296696|585372695|FG004|Overall Study|Death|2|||
162087638|NCT03296696|585372696|FG005|Overall Study|Death|3|||
162087639|NCT03296696|585372697|FG006|Overall Study|Death|1|||
162087640|NCT03296696|585372698|FG007|Overall Study|Death|2|||
162087641|NCT03296696|585372699|FG008|Overall Study|Death|0|||
162087642|NCT03296696|585372700|FG009|Overall Study|Death|0|||
162087643|NCT03296696|585372691|FG000|Overall Study|Withdrawal by Subject|0|||
162087644|NCT03296696|585372692|FG001|Overall Study|Withdrawal by Subject|0|||
162087645|NCT03296696|585372693|FG002|Overall Study|Withdrawal by Subject|1|||
162087646|NCT03296696|585372694|FG003|Overall Study|Withdrawal by Subject|0|||
162087647|NCT03296696|585372695|FG004|Overall Study|Withdrawal by Subject|1|||
162087648|NCT03296696|585372696|FG005|Overall Study|Withdrawal by Subject|0|||
162087649|NCT03296696|585372697|FG006|Overall Study|Withdrawal by Subject|0|||
162087650|NCT03296696|585372698|FG007|Overall Study|Withdrawal by Subject|0|||
162087651|NCT03296696|585372699|FG008|Overall Study|Withdrawal by Subject|0|||
162087652|NCT03296696|585372700|FG009|Overall Study|Withdrawal by Subject|1|||
162087653|NCT04694131|585372703|FG000|Overall Study|Withdrawal by Subject|7|||
162087654|NCT04694131|585372703|FG000|Overall Study|Screen Failure|1|||
162087655|NCT04694131|585372703|FG000|Overall Study|High stimulation threshold|3|||
162087656|NCT01350128|585372704|FG000|Overall Study|Withdrawal by Subject|3|||
162087657|NCT01350128|585372704|FG000|Overall Study|Protocol discontinuation criteria|8|||
162087658|NCT01350128|585372704|FG000|Overall Study|Physician Decision|1|||
162087659|NCT01350128|585372704|FG000|Overall Study|Lost to Follow-up|2|||
162087660|NCT02399085|585372708|FG000|Overall Study|Adverse Event|16|||
162087661|NCT02399085|585372708|FG000|Overall Study|Death|2|||
162087662|NCT02399085|585372708|FG000|Overall Study|Withdrawal by Subject|8|||
162087663|NCT02399085|585372708|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
162087664|NCT02399085|585372708|FG000|Overall Study|Physician Decision|5|||
162087665|NCT01859715|585372709|FG000|Overall Study|No 2nd VAS|16|||
162087666|NCT01859715|585372710|FG001|Overall Study|No 2nd VAS|8|||
162087667|NCT01859715|585372711|FG002|Overall Study|No 2nd VAS|23|||
162087668|NCT00086580|585372715|FG000|Treatment Period|Disease progression|9|||
162087669|NCT00086580|585372716|FG001|Treatment Period|Disease progression|8|||
162087670|NCT00086580|585372715|FG000|Treatment Period|Unable to comply with protocol|3|||
162087671|NCT00086580|585372716|FG001|Treatment Period|Unable to comply with protocol|1|||
162087672|NCT00086580|585372715|FG000|Treatment Period|Withdrawal by Subject|7|||
162087673|NCT00086580|585372716|FG001|Treatment Period|Withdrawal by Subject|8|||
162087674|NCT00086580|585372715|FG000|Treatment Period|Physician Decision|13|||
162087675|NCT00086580|585372716|FG001|Treatment Period|Physician Decision|7|||
162087676|NCT00086580|585372715|FG000|Treatment Period|AE - not treatment related|7|||
162087677|NCT00086580|585372716|FG001|Treatment Period|AE - not treatment related|7|||
162087678|NCT00086580|585372715|FG000|Treatment Period|Toxicity - treatment related|15|||
162087679|NCT00086580|585372716|FG001|Treatment Period|Toxicity - treatment related|15|||
162087680|NCT00086580|585372715|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
162087681|NCT00086580|585372716|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
162087682|NCT00086580|585372715|FG000|Treatment Period|Death|5|||
162087683|NCT00086580|585372716|FG001|Treatment Period|Death|7|||
162087684|NCT00086580|585372715|FG000|Treatment Period|Other|5|||
162087685|NCT00086580|585372716|FG001|Treatment Period|Other|3|||
162087686|NCT00086580|585372715|FG000|Follow-up Period|Disease progression|72|||
162087687|NCT00086580|585372716|FG001|Follow-up Period|Disease progression|99|||
162087688|NCT00086580|585372715|FG000|Follow-up Period|Unable to comply with protocol|5|||
162087689|NCT00086580|585372716|FG001|Follow-up Period|Unable to comply with protocol|0|||
162087690|NCT00086580|585372715|FG000|Follow-up Period|Withdrawal by Subject|6|||
162087691|NCT00086580|585372716|FG001|Follow-up Period|Withdrawal by Subject|6|||
162087692|NCT00086580|585372715|FG000|Follow-up Period|Physician Decision|0|||
162087693|NCT00086580|585372716|FG001|Follow-up Period|Physician Decision|1|||
162087694|NCT00086580|585372715|FG000|Follow-up Period|AE - not related|1|||
162087695|NCT00086580|585372716|FG001|Follow-up Period|AE - not related|0|||
162087696|NCT00086580|585372715|FG000|Follow-up Period|Death|13|||
162087697|NCT00086580|585372716|FG001|Follow-up Period|Death|7|||
162087698|NCT00086580|585372715|FG000|Follow-up Period|Other|7|||
162087699|NCT00086580|585372716|FG001|Follow-up Period|Other|6|||
162087700|NCT00086580|585372715|FG000|Observation Period|Unable to comply with protocol|1|||
162087701|NCT00086580|585372716|FG001|Observation Period|Unable to comply with protocol|1|||
162087702|NCT00086580|585372715|FG000|Observation Period|Withdrawal by Subject|4|||
162087703|NCT00086580|585372716|FG001|Observation Period|Withdrawal by Subject|2|||
162087704|NCT00086580|585372715|FG000|Observation Period|Death|33|||
162087705|NCT00086580|585372716|FG001|Observation Period|Death|55|||
162087706|NCT00086580|585372715|FG000|Observation Period|Other|8|||
162087707|NCT00086580|585372716|FG001|Observation Period|Other|7|||
162087708|NCT03235024|585372718|FG000|Overall Study|Adverse Event|2|||
162087709|NCT03235024|585372719|FG001|Overall Study|Adverse Event|2|||
162087710|NCT03235024|585372718|FG000|Overall Study|Death|1|||
162087711|NCT03235024|585372719|FG001|Overall Study|Death|0|||
162087712|NCT03235024|585372718|FG000|Overall Study|Lost to Follow-up|2|||
162087713|NCT03235024|585372719|FG001|Overall Study|Lost to Follow-up|5|||
162087714|NCT03235024|585372718|FG000|Overall Study|Protocol Violation|1|||
162087715|NCT03235024|585372719|FG001|Overall Study|Protocol Violation|0|||
162087716|NCT03235024|585372718|FG000|Overall Study|Withdrawal by Subject|0|||
162087717|NCT03235024|585372719|FG001|Overall Study|Withdrawal by Subject|3|||
162087718|NCT02357576|585372720|FG000|Treatment Period|Withdrawal by Subject|0|||
162087719|NCT02357576|585372721|FG001|Treatment Period|Withdrawal by Subject|1|||
162087720|NCT02357576|585372720|FG000|Treatment Period|Physician Decision|0|||
162087721|NCT02357576|585372721|FG001|Treatment Period|Physician Decision|1|||
162087722|NCT02357576|585372720|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
162087723|NCT02357576|585372721|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
162087724|NCT02357576|585372720|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
162087725|NCT02357576|585372721|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
162087726|NCT02357576|585372720|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
162087727|NCT02357576|585372721|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
162087728|NCT02357576|585372720|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
162087729|NCT02357576|585372721|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
162087730|NCT00261716|585372722|FG000|Overall Study|Withdrawal by Subject|6|||
162087731|NCT00261716|585372723|FG001|Overall Study|Withdrawal by Subject|8|||
162087732|NCT00261716|585372722|FG000|Overall Study|Lost to Follow-up|0|||
162087733|NCT00261716|585372723|FG001|Overall Study|Lost to Follow-up|2|||
162087734|NCT02047110|585372726|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
162087735|NCT02047110|585372727|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
162087736|NCT02047110|585372728|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
162087737|NCT02047110|585372729|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
162087738|NCT02047110|585372726|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
162087739|NCT02047110|585372727|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
162087740|NCT02047110|585372728|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
162087741|NCT02047110|585372729|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
162087742|NCT02047110|585372726|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
162087743|NCT02047110|585372727|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
162087744|NCT02047110|585372728|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
162087745|NCT02047110|585372729|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
162087746|NCT02047110|585372726|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
162087747|NCT02047110|585372727|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
162087748|NCT02047110|585372728|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
162087749|NCT02047110|585372729|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
162087750|NCT02047110|585372726|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
162087751|NCT02047110|585372727|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
162087752|NCT02047110|585372728|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
162087753|NCT02047110|585372729|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
162087754|NCT02047110|585372726|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
162087755|NCT02047110|585372727|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
162087756|NCT02047110|585372728|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
162087757|NCT02047110|585372729|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
162087758|NCT02047110|585372726|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
162087759|NCT02047110|585372727|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
162087760|NCT02047110|585372728|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
162087761|NCT02047110|585372729|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
162087762|NCT02047110|585372726|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
162087763|NCT02047110|585372727|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
162087764|NCT02047110|585372728|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
162087765|NCT02047110|585372729|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
162087766|NCT02047110|585372726|FG000|Escape Treatment Period|Adverse Event|1|||
162087767|NCT02047110|585372727|FG001|Escape Treatment Period|Adverse Event|2|||
162087768|NCT02047110|585372728|FG002|Escape Treatment Period|Adverse Event|2|||
162087769|NCT02047110|585372729|FG003|Escape Treatment Period|Adverse Event|0|||
162087770|NCT02047110|585372726|FG000|Escape Treatment Period|Other than specified|1|||
162087771|NCT02047110|585372727|FG001|Escape Treatment Period|Other than specified|2|||
162087772|NCT02047110|585372728|FG002|Escape Treatment Period|Other than specified|0|||
162087773|NCT02047110|585372729|FG003|Escape Treatment Period|Other than specified|1|||
162087774|NCT02047110|585372726|FG000|OLE Treatment Period|Other than specified|0|||
162087775|NCT02047110|585372727|FG001|OLE Treatment Period|Other than specified|0|||
162087776|NCT02047110|585372728|FG002|OLE Treatment Period|Other than specified|1|||
162087777|NCT02047110|585372729|FG003|OLE Treatment Period|Other than specified|0|||
162087778|NCT00699699|585372730|FG000|Overall Study|Adverse Event|36|||
162087779|NCT00699699|585372730|FG000|Overall Study|Individual different reasons|21|||
162087780|NCT00705575|585372731|FG000|Overall Study|Abnormal laboratory value(s)|0|||
162087781|NCT00705575|585372732|FG001|Overall Study|Abnormal laboratory value(s)|3|||
162087782|NCT00705575|585372731|FG000|Overall Study|Abnormal test procedure result(s)|2|||
162087783|NCT00705575|585372732|FG001|Overall Study|Abnormal test procedure result(s)|12|||
162087784|NCT00705575|585372731|FG000|Overall Study|Adverse Event|11|||
162087785|NCT00705575|585372732|FG001|Overall Study|Adverse Event|15|||
162087786|NCT00705575|585372731|FG000|Overall Study|Lost to Follow-up|3|||
162087787|NCT00705575|585372732|FG001|Overall Study|Lost to Follow-up|4|||
162087788|NCT00705575|585372731|FG000|Overall Study|Protocol Violation|2|||
162087789|NCT00705575|585372732|FG001|Overall Study|Protocol Violation|2|||
162087790|NCT00705575|585372731|FG000|Overall Study|Withdrawal by Subject|5|||
162087791|NCT00705575|585372732|FG001|Overall Study|Withdrawal by Subject|10|||
162087792|NCT02170727|585372735|FG000|Overall Study|Lost to Follow-up|1|||
162087793|NCT02170727|585372736|FG001|Overall Study|Lost to Follow-up|0|||
162087794|NCT02170727|585372735|FG000|Overall Study|Withdrawal by Subject|2|||
162087795|NCT02170727|585372736|FG001|Overall Study|Withdrawal by Subject|0|||
162087796|NCT01959581|585372741|FG000|Overall Study|Lost to Follow-up|5|||
162087797|NCT00004031|585372744|FG000|Overall Study|Adverse Event|5|||
162087798|NCT00004031|585372745|FG001|Overall Study|Adverse Event|0|||
162087799|NCT00004031|585372744|FG000|Overall Study|Refusal unrelated to adverse events|2|||
162087800|NCT00004031|585372745|FG001|Overall Study|Refusal unrelated to adverse events|11|||
162087801|NCT00004031|585372744|FG000|Overall Study|Progression/relapse|9|||
162087802|NCT00004031|585372745|FG001|Overall Study|Progression/relapse|4|||
162087803|NCT00004031|585372744|FG000|Overall Study|Death|3|||
162087804|NCT00004031|585372745|FG001|Overall Study|Death|1|||
162087805|NCT00004031|585372744|FG000|Overall Study|Other- not protocol specified|3|||
162087806|NCT00004031|585372745|FG001|Overall Study|Other- not protocol specified|3|||
162087807|NCT00004031|585372744|FG000|Overall Study|Reason under review|3|||
162087808|NCT00004031|585372745|FG001|Overall Study|Reason under review|2|||
162087809|NCT03265119|585372746|FG000|Overall Study|Adverse Event|2|||
162087810|NCT03265119|585372747|FG001|Overall Study|Adverse Event|1|||
162087811|NCT03265119|585372746|FG000|Overall Study|Lack of Efficacy|3|||
162087812|NCT03265119|585372747|FG001|Overall Study|Lack of Efficacy|0|||
162087813|NCT03265119|585372746|FG000|Overall Study|Protocol Violation|1|||
162087814|NCT03265119|585372747|FG001|Overall Study|Protocol Violation|2|||
162087815|NCT03265119|585372746|FG000|Overall Study|Withdrawal by Subject|2|||
162087816|NCT03265119|585372747|FG001|Overall Study|Withdrawal by Subject|4|||
162087817|NCT03265119|585372746|FG000|Overall Study|Lost to Follow-up|1|||
162087818|NCT03265119|585372747|FG001|Overall Study|Lost to Follow-up|0|||
162087819|NCT03265119|585372746|FG000|Overall Study|Lack of Compliance|1|||
162087820|NCT03265119|585372747|FG001|Overall Study|Lack of Compliance|0|||
162087821|NCT04740034|585372748|FG000|Overall Study|Death|0|||
162087822|NCT04740034|585372749|FG001|Overall Study|Death|1|||
162087823|NCT04740034|585372750|FG002|Overall Study|Death|2|||
162087824|NCT04740034|585372751|FG003|Overall Study|Death|3|||
162087825|NCT04740034|585372752|FG004|Overall Study|Death|4|||
162087826|NCT04740034|585372753|FG005|Overall Study|Death|4|||
162087827|NCT04740034|585372754|FG006|Overall Study|Death|2|||
162087828|NCT04740034|585372755|FG007|Overall Study|Death|2|||
162087829|NCT04740034|585372756|FG008|Overall Study|Death|2|||
162087830|NCT04740034|585372757|FG009|Overall Study|Death|4|||
162087831|NCT04740034|585372758|FG010|Overall Study|Death|0|||
162087832|NCT04740034|585372748|FG000|Overall Study|Lost to Follow-up|0|||
162087833|NCT04740034|585372749|FG001|Overall Study|Lost to Follow-up|0|||
162087834|NCT04740034|585372750|FG002|Overall Study|Lost to Follow-up|0|||
162087835|NCT04740034|585372751|FG003|Overall Study|Lost to Follow-up|1|||
162087836|NCT04740034|585372752|FG004|Overall Study|Lost to Follow-up|2|||
162087837|NCT04740034|585372753|FG005|Overall Study|Lost to Follow-up|2|||
162087838|NCT04740034|585372754|FG006|Overall Study|Lost to Follow-up|0|||
162087839|NCT04740034|585372755|FG007|Overall Study|Lost to Follow-up|0|||
162087840|NCT04740034|585372756|FG008|Overall Study|Lost to Follow-up|0|||
162087841|NCT04740034|585372757|FG009|Overall Study|Lost to Follow-up|1|||
162087842|NCT04740034|585372758|FG010|Overall Study|Lost to Follow-up|0|||
162087843|NCT04740034|585372748|FG000|Overall Study|Withdrawal by Subject|1|||
162087844|NCT04740034|585372749|FG001|Overall Study|Withdrawal by Subject|0|||
162087845|NCT04740034|585372750|FG002|Overall Study|Withdrawal by Subject|0|||
162087846|NCT04740034|585372751|FG003|Overall Study|Withdrawal by Subject|0|||
162087847|NCT04740034|585372752|FG004|Overall Study|Withdrawal by Subject|0|||
162087848|NCT04740034|585372753|FG005|Overall Study|Withdrawal by Subject|0|||
162087849|NCT04740034|585372754|FG006|Overall Study|Withdrawal by Subject|0|||
162087850|NCT04740034|585372755|FG007|Overall Study|Withdrawal by Subject|1|||
162087851|NCT04740034|585372756|FG008|Overall Study|Withdrawal by Subject|0|||
162087852|NCT04740034|585372757|FG009|Overall Study|Withdrawal by Subject|1|||
162087853|NCT04740034|585372758|FG010|Overall Study|Withdrawal by Subject|0|||
162087854|NCT04740034|585372748|FG000|Overall Study|Decision by sponsor|0|||
162087855|NCT04740034|585372749|FG001|Overall Study|Decision by sponsor|0|||
162087856|NCT04740034|585372750|FG002|Overall Study|Decision by sponsor|1|||
162087857|NCT04740034|585372751|FG003|Overall Study|Decision by sponsor|0|||
162087858|NCT04740034|585372752|FG004|Overall Study|Decision by sponsor|0|||
162087859|NCT04740034|585372753|FG005|Overall Study|Decision by sponsor|0|||
162087860|NCT04740034|585372754|FG006|Overall Study|Decision by sponsor|1|||
162087861|NCT04740034|585372755|FG007|Overall Study|Decision by sponsor|2|||
162087862|NCT04740034|585372756|FG008|Overall Study|Decision by sponsor|1|||
162087863|NCT04740034|585372757|FG009|Overall Study|Decision by sponsor|1|||
162087864|NCT04740034|585372758|FG010|Overall Study|Decision by sponsor|2|||
162087865|NCT00600821|585374326|FG000|Overall Study|Death|45|||
162087866|NCT00600821|585374327|FG001|Overall Study|Death|46|||
162087867|NCT00600821|585374326|FG000|Overall Study|Lost to Follow-up|2|||
162087868|NCT00600821|585374327|FG001|Overall Study|Lost to Follow-up|2|||
162087869|NCT00600821|585374326|FG000|Overall Study|Withdrawal by Subject|1|||
162087870|NCT00600821|585374327|FG001|Overall Study|Withdrawal by Subject|1|||
162087871|NCT00600821|585374326|FG000|Overall Study|Terminated by sponsor|8|||
162087872|NCT00600821|585374327|FG001|Overall Study|Terminated by sponsor|6|||
162087873|NCT00600821|585374326|FG000|Overall Study|Objective progression or relapse|0|||
162087874|NCT00600821|585374327|FG001|Overall Study|Objective progression or relapse|1|||
162087875|NCT00600821|585374326|FG000|Overall Study|Randomized but not treated|0|||
162087876|NCT00600821|585374327|FG001|Overall Study|Randomized but not treated|1|||
162087877|NCT00600821|585374326|FG000|Overall Study|Other|2|||
162087878|NCT00600821|585374327|FG001|Overall Study|Other|3|||
162087879|NCT02602288|585374330|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
162087880|NCT02602288|585374331|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
162087881|NCT02602288|585374330|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
162087882|NCT02602288|585374331|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
162087883|NCT02602288|585374330|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
162087884|NCT02602288|585374331|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
162087885|NCT02602288|585374330|FG000|12 Month Follow-up|Lost to Follow-up|0|||
162087886|NCT02602288|585374331|FG001|12 Month Follow-up|Lost to Follow-up|4|||
162087887|NCT02602288|585374330|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
162087888|NCT02602288|585374331|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
162087889|NCT01310413|585374332|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
162087890|NCT01310413|585374333|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
162087891|NCT01310413|585374334|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
162087892|NCT01310413|585374335|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
162087893|NCT01310413|585374336|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
162087894|NCT01310413|585374337|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
162087895|NCT01310413|585374338|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
162087896|NCT01310413|585374332|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
162087897|NCT01310413|585374333|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
162087898|NCT01310413|585374334|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
162087899|NCT01310413|585374335|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
162087900|NCT01310413|585374336|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
162087901|NCT01310413|585374337|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
162087902|NCT01310413|585374338|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
162087903|NCT01310413|585374332|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
162087904|NCT01310413|585374333|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
162087905|NCT01310413|585374334|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
162087906|NCT01310413|585374335|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
162087907|NCT01310413|585374336|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
162087908|NCT01310413|585374337|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
162087909|NCT01310413|585374338|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
162087910|NCT01310413|585374332|FG000|Day 0 to Day 385|Other|1|||
162087911|NCT01310413|585374333|FG001|Day 0 to Day 385|Other|0|||
162087912|NCT01310413|585374334|FG002|Day 0 to Day 385|Other|3|||
162087913|NCT01310413|585374335|FG003|Day 0 to Day 385|Other|0|||
162087914|NCT01310413|585374336|FG004|Day 0 to Day 385|Other|0|||
162087915|NCT01310413|585374337|FG005|Day 0 to Day 385|Other|0|||
162087916|NCT01310413|585374338|FG006|Day 0 to Day 385|Other|0|||
162087917|NCT01310413|585374332|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
162087918|NCT01310413|585374333|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
162087919|NCT01310413|585374334|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
162087920|NCT01310413|585374335|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
162087921|NCT01310413|585374336|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
162087922|NCT01310413|585374337|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
162087923|NCT01310413|585374338|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
162087924|NCT01310413|585374332|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
162087925|NCT01310413|585374333|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
162087926|NCT01310413|585374334|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
162087927|NCT01310413|585374335|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
162087928|NCT01310413|585374336|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
162087929|NCT01310413|585374337|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
162087930|NCT01310413|585374338|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
162087931|NCT02066298|585374340|FG000|Overall Study|Lost to Follow-up|3|||
162087932|NCT02066298|585374341|FG001|Overall Study|Lost to Follow-up|2|||
162087933|NCT02066298|585374342|FG002|Overall Study|Lost to Follow-up|3|||
162087934|NCT02066298|585374343|FG003|Overall Study|Lost to Follow-up|2|||
162087935|NCT02066298|585374344|FG004|Overall Study|Lost to Follow-up|3|||
162087936|NCT02066298|585374345|FG005|Overall Study|Lost to Follow-up|4|||
162087937|NCT02066298|585374340|FG000|Overall Study|Withdrawal by Subject|6|||
162087938|NCT02066298|585374341|FG001|Overall Study|Withdrawal by Subject|6|||
162087939|NCT02066298|585374342|FG002|Overall Study|Withdrawal by Subject|6|||
162087940|NCT02066298|585374343|FG003|Overall Study|Withdrawal by Subject|4|||
162087941|NCT02066298|585374344|FG004|Overall Study|Withdrawal by Subject|5|||
162087942|NCT02066298|585374345|FG005|Overall Study|Withdrawal by Subject|8|||
162087943|NCT02066298|585374340|FG000|Overall Study|Physician Decision|0|||
162087944|NCT02066298|585374341|FG001|Overall Study|Physician Decision|0|||
162087945|NCT02066298|585374342|FG002|Overall Study|Physician Decision|1|||
162087946|NCT02066298|585374343|FG003|Overall Study|Physician Decision|0|||
162087947|NCT02066298|585374344|FG004|Overall Study|Physician Decision|1|||
162087948|NCT02066298|585374345|FG005|Overall Study|Physician Decision|0|||
162087949|NCT04260191|585374346|FG000|Overall Study|Decision by Sponsor|0|||
162087950|NCT04260191|585374347|FG001|Overall Study|Decision by Sponsor|1|||
162087951|NCT04260191|585374348|FG002|Overall Study|Decision by Sponsor|0|||
162087952|NCT04260191|585374346|FG000|Overall Study|Withdrawal by Subject|1|||
162087953|NCT04260191|585374347|FG001|Overall Study|Withdrawal by Subject|0|||
162087954|NCT04260191|585374348|FG002|Overall Study|Withdrawal by Subject|3|||
162087955|NCT04260191|585374346|FG000|Overall Study|Death|4|||
162087956|NCT04260191|585374347|FG001|Overall Study|Death|3|||
162087957|NCT04260191|585374348|FG002|Overall Study|Death|2|||
162087958|NCT01513317|585374349|FG000|Overall Study|Withdrawal by Subject|15|||
162087959|NCT01513317|585374350|FG001|Overall Study|Withdrawal by Subject|4|||
162087960|NCT01513317|585374349|FG000|Overall Study|Death|1|||
162087961|NCT01513317|585374350|FG001|Overall Study|Death|1|||
162087962|NCT01513317|585374349|FG000|Overall Study|Study terminated by sponsor|18|||
162087963|NCT01513317|585374350|FG001|Overall Study|Study terminated by sponsor|18|||
162087964|NCT01513317|585374349|FG000|Overall Study|Other|0|||
162087965|NCT01513317|585374350|FG001|Overall Study|Other|1|||
162087966|NCT01265953|585374351|FG000|Overall Study|Non compliance|5|||
162087967|NCT01265953|585374352|FG001|Overall Study|Non compliance|3|||
162087968|NCT02564198|585374353|FG000|Overall Study|Withdrawal by Subject|2|||
162087969|NCT02564198|585374354|FG001|Overall Study|Withdrawal by Subject|4|||
162087970|NCT02564198|585374355|FG002|Overall Study|Withdrawal by Subject|0|||
162087971|NCT02564198|585374353|FG000|Overall Study|Adverse Event|0|||
162087972|NCT02564198|585374354|FG001|Overall Study|Adverse Event|1|||
162087973|NCT02564198|585374355|FG002|Overall Study|Adverse Event|0|||
162087974|NCT00201006|585374356|FG000|Overall Study|Withdrawal by Subject|7|||
162087975|NCT00201006|585374357|FG001|Overall Study|Withdrawal by Subject|2|||
162087976|NCT00201006|585374358|FG002|Overall Study|Withdrawal by Subject|3|||
162087977|NCT00201006|585374356|FG000|Overall Study|Adverse Event|1|||
162087978|NCT00201006|585374357|FG001|Overall Study|Adverse Event|0|||
162087979|NCT00201006|585374358|FG002|Overall Study|Adverse Event|1|||
162087980|NCT00274716|585374365|FG000|Phase A|Other non-reported reason|4|||
162087981|NCT00274716|585374366|FG001|Phase A|Other non-reported reason|2|||
162087982|NCT00274716|585374367|FG002|Phase A|Other non-reported reason|1|||
162087983|NCT00274716|585374368|FG003|Phase A|Other non-reported reason|2|||
162087984|NCT00274716|585374369|FG004|Phase A|Other non-reported reason|0|||
162087985|NCT00274716|585374370|FG005|Phase A|Other non-reported reason|1|||
162087986|NCT00274716|585374365|FG000|Phase A|Participant moved|0|||
162087987|NCT00274716|585374366|FG001|Phase A|Participant moved|0|||
162087988|NCT00274716|585374367|FG002|Phase A|Participant moved|1|||
162087989|NCT00274716|585374368|FG003|Phase A|Participant moved|0|||
162087990|NCT00274716|585374369|FG004|Phase A|Participant moved|0|||
162087991|NCT00274716|585374370|FG005|Phase A|Participant moved|1|||
162087992|NCT00274716|585374365|FG000|Phase A|Site Terminated|0|||
162087993|NCT00274716|585374366|FG001|Phase A|Site Terminated|0|||
162087994|NCT00274716|585374367|FG002|Phase A|Site Terminated|0|||
162087995|NCT00274716|585374368|FG003|Phase A|Site Terminated|1|||
162087996|NCT00274716|585374369|FG004|Phase A|Site Terminated|0|||
162087997|NCT00274716|585374370|FG005|Phase A|Site Terminated|0|||
162087998|NCT00274716|585374365|FG000|Phase A|Protocol Violation|1|||
162087999|NCT00274716|585374366|FG001|Phase A|Protocol Violation|0|||
162088000|NCT00274716|585374367|FG002|Phase A|Protocol Violation|0|||
162088001|NCT00274716|585374368|FG003|Phase A|Protocol Violation|1|||
162088002|NCT00274716|585374369|FG004|Phase A|Protocol Violation|0|||
162088003|NCT00274716|585374370|FG005|Phase A|Protocol Violation|0|||
162088004|NCT00274716|585374365|FG000|Phase A|Met criteria for discontinuation|1|||
162088005|NCT00274716|585374366|FG001|Phase A|Met criteria for discontinuation|1|||
162088006|NCT00274716|585374367|FG002|Phase A|Met criteria for discontinuation|0|||
162088007|NCT00274716|585374368|FG003|Phase A|Met criteria for discontinuation|0|||
162088008|NCT00274716|585374369|FG004|Phase A|Met criteria for discontinuation|0|||
162088009|NCT00274716|585374370|FG005|Phase A|Met criteria for discontinuation|0|||
162088010|NCT00274716|585374365|FG000|Phase A|Withdrawal by Subject|2|||
162088011|NCT00274716|585374366|FG001|Phase A|Withdrawal by Subject|2|||
162088012|NCT00274716|585374367|FG002|Phase A|Withdrawal by Subject|1|||
162088013|NCT00274716|585374368|FG003|Phase A|Withdrawal by Subject|3|||
162088014|NCT00274716|585374369|FG004|Phase A|Withdrawal by Subject|0|||
162088015|NCT00274716|585374370|FG005|Phase A|Withdrawal by Subject|1|||
162088016|NCT00274716|585374365|FG000|Phase A|Adverse Event|2|||
162088017|NCT00274716|585374366|FG001|Phase A|Adverse Event|3|||
162088018|NCT00274716|585374367|FG002|Phase A|Adverse Event|3|||
162088019|NCT00274716|585374368|FG003|Phase A|Adverse Event|0|||
162088020|NCT00274716|585374369|FG004|Phase A|Adverse Event|2|||
162088021|NCT00274716|585374370|FG005|Phase A|Adverse Event|0|||
162088022|NCT00274716|585374365|FG000|Phase A|Completed but did not enter Phase B|1|||
162088023|NCT00274716|585374366|FG001|Phase A|Completed but did not enter Phase B|2|||
162088024|NCT00274716|585374367|FG002|Phase A|Completed but did not enter Phase B|2|||
162088025|NCT00274716|585374368|FG003|Phase A|Completed but did not enter Phase B|2|||
162088026|NCT00274716|585374369|FG004|Phase A|Completed but did not enter Phase B|1|||
162088027|NCT00274716|585374370|FG005|Phase A|Completed but did not enter Phase B|1|||
162088028|NCT00274716|585374365|FG000|Phase B|Adverse Event|0|||
162088029|NCT00274716|585374366|FG001|Phase B|Adverse Event|0|||
162088030|NCT00274716|585374367|FG002|Phase B|Adverse Event|2|||
162088031|NCT00274716|585374368|FG003|Phase B|Adverse Event|0|||
162088032|NCT00274716|585374369|FG004|Phase B|Adverse Event|0|||
162088033|NCT00274716|585374370|FG005|Phase B|Adverse Event|1|||
162088034|NCT00274716|585374365|FG000|Phase B|Protocol Violation|0|||
162088035|NCT00274716|585374366|FG001|Phase B|Protocol Violation|2|||
162088036|NCT00274716|585374367|FG002|Phase B|Protocol Violation|0|||
162088037|NCT00274716|585374368|FG003|Phase B|Protocol Violation|0|||
162088038|NCT00274716|585374369|FG004|Phase B|Protocol Violation|0|||
162088039|NCT00274716|585374370|FG005|Phase B|Protocol Violation|0|||
162088040|NCT00274716|585374365|FG000|Phase B|Withdrawal by Subject|0|||
162088041|NCT00274716|585374366|FG001|Phase B|Withdrawal by Subject|1|||
162088042|NCT00274716|585374367|FG002|Phase B|Withdrawal by Subject|0|||
162088043|NCT00274716|585374368|FG003|Phase B|Withdrawal by Subject|0|||
162088044|NCT00274716|585374369|FG004|Phase B|Withdrawal by Subject|0|||
162088045|NCT00274716|585374370|FG005|Phase B|Withdrawal by Subject|0|||
162088046|NCT00274716|585374365|FG000|Phase B|Participant moved|1|||
162088047|NCT00274716|585374366|FG001|Phase B|Participant moved|0|||
162088048|NCT00274716|585374367|FG002|Phase B|Participant moved|0|||
162088049|NCT00274716|585374368|FG003|Phase B|Participant moved|0|||
162088050|NCT00274716|585374369|FG004|Phase B|Participant moved|0|||
162088051|NCT00274716|585374370|FG005|Phase B|Participant moved|0|||
162088052|NCT00274716|585374365|FG000|Phase B|Other non-reported reason|0|||
162088053|NCT00274716|585374366|FG001|Phase B|Other non-reported reason|0|||
162088054|NCT00274716|585374367|FG002|Phase B|Other non-reported reason|1|||
162088055|NCT00274716|585374368|FG003|Phase B|Other non-reported reason|1|||
162088056|NCT00274716|585374369|FG004|Phase B|Other non-reported reason|0|||
162088057|NCT00274716|585374370|FG005|Phase B|Other non-reported reason|0|||
162088058|NCT00274716|585374365|FG000|Phase B|Lost to Follow-up|0|||
162088059|NCT00274716|585374366|FG001|Phase B|Lost to Follow-up|1|||
162088060|NCT00274716|585374367|FG002|Phase B|Lost to Follow-up|0|||
162088061|NCT00274716|585374368|FG003|Phase B|Lost to Follow-up|0|||
162088062|NCT00274716|585374369|FG004|Phase B|Lost to Follow-up|0|||
162088063|NCT00274716|585374370|FG005|Phase B|Lost to Follow-up|0|||
162088064|NCT01257204|585374371|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
162088065|NCT01257204|585374372|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
162088066|NCT01257204|585374373|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
162088067|NCT01257204|585374371|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
162088068|NCT01257204|585374372|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
162088069|NCT01257204|585374373|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
162088070|NCT01257204|585374371|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
162088071|NCT01257204|585374372|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
162088072|NCT01257204|585374373|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
162088073|NCT01257204|585374371|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
162088074|NCT01257204|585374372|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
162088075|NCT01257204|585374373|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
162088076|NCT01257204|585374371|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
162088077|NCT01257204|585374372|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
162088078|NCT01257204|585374373|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
162088079|NCT01257204|585374371|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
162088080|NCT01257204|585374372|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
162088081|NCT01257204|585374373|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
162088082|NCT01257204|585374371|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
162088083|NCT01257204|585374372|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
162088084|NCT01257204|585374373|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
162088085|NCT01257204|585374371|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
162088086|NCT01257204|585374372|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
162088087|NCT01257204|585374373|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
162088088|NCT01257204|585374371|FG000|Follow-up Period (up to Week 48)|Other|0|||
162088089|NCT01257204|585374372|FG001|Follow-up Period (up to Week 48)|Other|0|||
162088090|NCT01257204|585374373|FG002|Follow-up Period (up to Week 48)|Other|5|||
162088091|NCT03394391|585374374|FG000|Overall Study|Lost to Follow-up|1|||
162088092|NCT03394391|585374375|FG001|Overall Study|Lost to Follow-up|2|||
162088093|NCT00723801|585374377|FG000|Overall Study|Lost to Follow-up|1|||
162088094|NCT00723801|585374378|FG001|Overall Study|Lost to Follow-up|2|||
162088095|NCT00723801|585374377|FG000|Overall Study|Protocol Violation|2|||
162088096|NCT00723801|585374378|FG001|Overall Study|Protocol Violation|1|||
162088097|NCT02148003|585374379|FG000|Overall Study|Failed inclusion criteria|1|||
162088098|NCT02148003|585374380|FG001|Overall Study|Failed inclusion criteria|0|||
162088099|NCT02148003|585374379|FG000|Overall Study|Met exclusion criteria|0|||
162088100|NCT02148003|585374380|FG001|Overall Study|Met exclusion criteria|1|||
162088101|NCT02148003|585374379|FG000|Overall Study|Withdrawal by Subject|0|||
162088102|NCT02148003|585374380|FG001|Overall Study|Withdrawal by Subject|1|||
162088103|NCT02039427|585374382|FG000|Overall Study|Duration of surgery > 3h|1|||
162088104|NCT02039427|585374383|FG001|Overall Study|Duration of surgery > 3h|1|||
162088105|NCT02039427|585374384|FG002|Overall Study|Duration of surgery > 3h|0|||
162088106|NCT02039427|585374385|FG003|Overall Study|Duration of surgery > 3h|0|||
162088107|NCT02039427|585374382|FG000|Overall Study|Withdrawal on concent|0|||
162088108|NCT02039427|585374383|FG001|Overall Study|Withdrawal on concent|0|||
162088109|NCT02039427|585374384|FG002|Overall Study|Withdrawal on concent|0|||
162088110|NCT02039427|585374385|FG003|Overall Study|Withdrawal on concent|1|||
162088111|NCT02039427|585374382|FG000|Overall Study|Cancellation of surgery|0|||
162088112|NCT02039427|585374383|FG001|Overall Study|Cancellation of surgery|0|||
162088113|NCT02039427|585374384|FG002|Overall Study|Cancellation of surgery|1|||
162088114|NCT02039427|585374385|FG003|Overall Study|Cancellation of surgery|0|||
162088115|NCT02039427|585374382|FG000|Overall Study|Loss of follow - up|1|||
162088116|NCT02039427|585374383|FG001|Overall Study|Loss of follow - up|0|||
162088117|NCT02039427|585374384|FG002|Overall Study|Loss of follow - up|2|||
162088118|NCT02039427|585374385|FG003|Overall Study|Loss of follow - up|4|||
162088119|NCT02039427|585374382|FG000|Overall Study|Steroid Use|1|||
162088120|NCT02039427|585374383|FG001|Overall Study|Steroid Use|0|||
162088121|NCT02039427|585374384|FG002|Overall Study|Steroid Use|0|||
162088122|NCT02039427|585374385|FG003|Overall Study|Steroid Use|0|||
162088123|NCT03160703|585374387|FG000|Overall Study|Withdrawal by Subject|0|||
162088124|NCT03160703|585374388|FG001|Overall Study|Withdrawal by Subject|0|||
162088125|NCT03160703|585374389|FG002|Overall Study|Withdrawal by Subject|0|||
162088126|NCT03160703|585374390|FG003|Overall Study|Withdrawal by Subject|1|||
162088127|NCT00087568|585374391|FG000|Overall Study|Adverse Event|4|||
162088128|NCT00087568|585374392|FG001|Overall Study|Adverse Event|0|||
162088129|NCT00087568|585374391|FG000|Overall Study|Withdrawal by Subject|1|||
162088130|NCT00087568|585374392|FG001|Overall Study|Withdrawal by Subject|1|||
162088131|NCT00087568|585374391|FG000|Overall Study|Lost to Follow-up|1|||
162088132|NCT00087568|585374392|FG001|Overall Study|Lost to Follow-up|0|||
162088133|NCT00087568|585374391|FG000|Overall Study|Lack of Efficacy|24|||
162088134|NCT00087568|585374392|FG001|Overall Study|Lack of Efficacy|1|||
162088135|NCT01513291|585374393|FG000|Treatment Period|Adverse Event|8|||
162088136|NCT01513291|585374394|FG001|Treatment Period|Adverse Event|4|||
162088137|NCT01513291|585374395|FG002|Treatment Period|Adverse Event|0|||
162088138|NCT01513291|585374396|FG003|Treatment Period|Adverse Event|0|||
162088139|NCT01513291|585374397|FG004|Treatment Period|Adverse Event|0|||
162088140|NCT01513291|585374393|FG000|Treatment Period|Lack of Efficacy|3|||
162088141|NCT01513291|585374394|FG001|Treatment Period|Lack of Efficacy|0|||
162088142|NCT01513291|585374395|FG002|Treatment Period|Lack of Efficacy|0|||
162088143|NCT01513291|585374396|FG003|Treatment Period|Lack of Efficacy|0|||
162088144|NCT01513291|585374397|FG004|Treatment Period|Lack of Efficacy|0|||
162088145|NCT01513291|585374393|FG000|Treatment Period|Lost to Follow-up|2|||
162088146|NCT01513291|585374394|FG001|Treatment Period|Lost to Follow-up|3|||
162088147|NCT01513291|585374395|FG002|Treatment Period|Lost to Follow-up|0|||
162088148|NCT01513291|585374396|FG003|Treatment Period|Lost to Follow-up|0|||
162088149|NCT01513291|585374397|FG004|Treatment Period|Lost to Follow-up|0|||
162088150|NCT01513291|585374393|FG000|Treatment Period|Physician Decision|1|||
162088151|NCT01513291|585374394|FG001|Treatment Period|Physician Decision|0|||
162088152|NCT01513291|585374395|FG002|Treatment Period|Physician Decision|0|||
162088153|NCT01513291|585374396|FG003|Treatment Period|Physician Decision|0|||
162088154|NCT01513291|585374397|FG004|Treatment Period|Physician Decision|0|||
162088155|NCT01513291|585374393|FG000|Treatment Period|Protocol Violation|1|||
162088156|NCT01513291|585374394|FG001|Treatment Period|Protocol Violation|2|||
162088157|NCT01513291|585374395|FG002|Treatment Period|Protocol Violation|0|||
162088158|NCT01513291|585374396|FG003|Treatment Period|Protocol Violation|0|||
162088159|NCT01513291|585374397|FG004|Treatment Period|Protocol Violation|0|||
162088160|NCT01513291|585374393|FG000|Treatment Period|Withdrawal by Subject|8|||
162088161|NCT01513291|585374394|FG001|Treatment Period|Withdrawal by Subject|5|||
162088162|NCT01513291|585374395|FG002|Treatment Period|Withdrawal by Subject|0|||
162088163|NCT01513291|585374396|FG003|Treatment Period|Withdrawal by Subject|0|||
162088164|NCT01513291|585374397|FG004|Treatment Period|Withdrawal by Subject|0|||
162088165|NCT01513291|585374393|FG000|Treatment Period|Randomized not treated|0|||
162088166|NCT01513291|585374394|FG001|Treatment Period|Randomized not treated|2|||
162088167|NCT01513291|585374395|FG002|Treatment Period|Randomized not treated|0|||
162088168|NCT01513291|585374396|FG003|Treatment Period|Randomized not treated|0|||
162088169|NCT01513291|585374397|FG004|Treatment Period|Randomized not treated|0|||
162088170|NCT01513291|585374393|FG000|Run-out Period|Lost to Follow-up|0|||
162088171|NCT01513291|585374394|FG001|Run-out Period|Lost to Follow-up|0|||
162088172|NCT01513291|585374395|FG002|Run-out Period|Lost to Follow-up|0|||
162088173|NCT01513291|585374396|FG003|Run-out Period|Lost to Follow-up|1|||
162088174|NCT01513291|585374397|FG004|Run-out Period|Lost to Follow-up|0|||
162088175|NCT01513291|585374393|FG000|Run-out Period|Withdrawal by Subject|0|||
162088176|NCT01513291|585374394|FG001|Run-out Period|Withdrawal by Subject|0|||
162088177|NCT01513291|585374395|FG002|Run-out Period|Withdrawal by Subject|0|||
162088178|NCT01513291|585374396|FG003|Run-out Period|Withdrawal by Subject|1|||
162088179|NCT01513291|585374397|FG004|Run-out Period|Withdrawal by Subject|0|||
162088180|NCT03728582|585374402|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
162088181|NCT03728582|585374403|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
162088182|NCT03728582|585374402|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
162088183|NCT03728582|585374403|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
162088184|NCT02992899|585374404|FG000|Overall Study|Withdrawal by Subject|1|||
162088185|NCT02992899|585374405|FG001|Overall Study|Withdrawal by Subject|0|||
162088186|NCT02992899|585374404|FG000|Overall Study|Lost to Follow-up|1|||
162088187|NCT02992899|585374405|FG001|Overall Study|Lost to Follow-up|3|||
162088188|NCT02738775|585374406|FG000|Overall Study|Withdrawal by Subject|0|||
162088189|NCT02738775|585374407|FG001|Overall Study|Withdrawal by Subject|1|||
162088190|NCT02738775|585374408|FG002|Overall Study|Withdrawal by Subject|0|||
162088191|NCT02738775|585374409|FG003|Overall Study|Withdrawal by Subject|0|||
162088192|NCT02738775|585374410|FG004|Overall Study|Withdrawal by Subject|0|||
162088193|NCT02738775|585374411|FG005|Overall Study|Withdrawal by Subject|0|||
162088194|NCT02738775|585374406|FG000|Overall Study|Adverse Event|0|||
162088195|NCT02738775|585374407|FG001|Overall Study|Adverse Event|0|||
162088196|NCT02738775|585374408|FG002|Overall Study|Adverse Event|0|||
162088197|NCT02738775|585374409|FG003|Overall Study|Adverse Event|1|||
162088198|NCT02738775|585374410|FG004|Overall Study|Adverse Event|0|||
162088199|NCT02738775|585374411|FG005|Overall Study|Adverse Event|0|||
162088200|NCT02738775|585374406|FG000|Overall Study|Pregnancy|0|||
162088201|NCT02738775|585374407|FG001|Overall Study|Pregnancy|1|||
162088202|NCT02738775|585374408|FG002|Overall Study|Pregnancy|0|||
162088203|NCT02738775|585374409|FG003|Overall Study|Pregnancy|0|||
162088204|NCT02738775|585374410|FG004|Overall Study|Pregnancy|0|||
162088205|NCT02738775|585374411|FG005|Overall Study|Pregnancy|0|||
162088206|NCT02738775|585374406|FG000|Overall Study|Missing|0|||
162088207|NCT02738775|585374407|FG001|Overall Study|Missing|0|||
162088208|NCT02738775|585374408|FG002|Overall Study|Missing|0|||
162088209|NCT02738775|585374409|FG003|Overall Study|Missing|0|||
162088210|NCT02738775|585374410|FG004|Overall Study|Missing|0|||
162088211|NCT02738775|585374411|FG005|Overall Study|Missing|1|||
162088212|NCT02370888|585374412|FG000|Overall Study|disease progression|2|||
162088213|NCT02370888|585374412|FG000|Overall Study|did not meet chimerism criteria|6|||
162088214|NCT00047463|585374413|FG000|Overall Study|Withdrawal by Subject|0|||
162088215|NCT00047463|585374414|FG001|Overall Study|Withdrawal by Subject|3|||
162088216|NCT01824303|585374422|FG000|Randomized Study|Withdrawal by Subject|1|||
162088217|NCT01824303|585374423|FG001|Randomized Study|Withdrawal by Subject|1|||
162088218|NCT01824303|585374422|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
162088219|NCT01824303|585374423|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
162088220|NCT01000051|585374425|FG000|Overall Study|Withdrawal by Subject|1|||
162088221|NCT01000051|585374426|FG001|Overall Study|Withdrawal by Subject|1|||
162088222|NCT01000051|585374425|FG000|Overall Study|Disease Progression|1|||
162088223|NCT01000051|585374426|FG001|Overall Study|Disease Progression|0|||
162088224|NCT01000051|585374425|FG000|Overall Study|Serious noncompliance|1|||
162088225|NCT01000051|585374426|FG001|Overall Study|Serious noncompliance|0|||
162088226|NCT03304379|585374437|FG000|Overall Study|Protocol Violation|8|||
162088227|NCT03304379|585374438|FG001|Overall Study|Protocol Violation|10|||
162088228|NCT03304379|585374439|FG002|Overall Study|Protocol Violation|5|||
162088229|NCT03304379|585374440|FG003|Overall Study|Protocol Violation|0|||
162088230|NCT03304379|585374441|FG004|Overall Study|Protocol Violation|2|||
162088231|NCT03304379|585374437|FG000|Overall Study|Adverse Event|4|||
162088232|NCT03304379|585374438|FG001|Overall Study|Adverse Event|20|||
162088233|NCT03304379|585374439|FG002|Overall Study|Adverse Event|17|||
162088234|NCT03304379|585374440|FG003|Overall Study|Adverse Event|1|||
162088235|NCT03304379|585374441|FG004|Overall Study|Adverse Event|0|||
162088236|NCT03304379|585374437|FG000|Overall Study|Lack of Efficacy|17|||
162088237|NCT03304379|585374438|FG001|Overall Study|Lack of Efficacy|16|||
162088238|NCT03304379|585374439|FG002|Overall Study|Lack of Efficacy|20|||
162088239|NCT03304379|585374440|FG003|Overall Study|Lack of Efficacy|0|||
162088240|NCT03304379|585374441|FG004|Overall Study|Lack of Efficacy|0|||
162088241|NCT03304379|585374437|FG000|Overall Study|Physician Decision|6|||
162088242|NCT03304379|585374438|FG001|Overall Study|Physician Decision|10|||
162088243|NCT03304379|585374439|FG002|Overall Study|Physician Decision|6|||
162088244|NCT03304379|585374440|FG003|Overall Study|Physician Decision|9|||
162088245|NCT03304379|585374441|FG004|Overall Study|Physician Decision|10|||
162088246|NCT03304379|585374437|FG000|Overall Study|Withdrawal by Subject|26|||
162088247|NCT03304379|585374438|FG001|Overall Study|Withdrawal by Subject|58|||
162088248|NCT03304379|585374439|FG002|Overall Study|Withdrawal by Subject|66|||
162088249|NCT03304379|585374440|FG003|Overall Study|Withdrawal by Subject|3|||
162088250|NCT03304379|585374441|FG004|Overall Study|Withdrawal by Subject|5|||
162088251|NCT03304379|585374437|FG000|Overall Study|Lost to Follow-up|8|||
162088252|NCT03304379|585374438|FG001|Overall Study|Lost to Follow-up|24|||
162088253|NCT03304379|585374439|FG002|Overall Study|Lost to Follow-up|35|||
162088254|NCT03304379|585374440|FG003|Overall Study|Lost to Follow-up|4|||
162088255|NCT03304379|585374441|FG004|Overall Study|Lost to Follow-up|0|||
162088256|NCT03304379|585374437|FG000|Overall Study|Death|1|||
162088257|NCT03304379|585374438|FG001|Overall Study|Death|2|||
162088258|NCT03304379|585374439|FG002|Overall Study|Death|0|||
162088259|NCT03304379|585374440|FG003|Overall Study|Death|0|||
162088260|NCT03304379|585374441|FG004|Overall Study|Death|0|||
162088261|NCT03304379|585374437|FG000|Overall Study|Other|0|||
162088262|NCT03304379|585374438|FG001|Overall Study|Other|1|||
162088263|NCT03304379|585374439|FG002|Overall Study|Other|0|||
162088264|NCT03304379|585374440|FG003|Overall Study|Other|0|||
162088265|NCT03304379|585374441|FG004|Overall Study|Other|0|||
162088266|NCT02802345|585374449|FG000|Overall Study|Not Treated|0|||
162088267|NCT02802345|585374450|FG001|Overall Study|Not Treated|1|||
162088268|NCT02802345|585374449|FG000|Overall Study|Adverse Event|28|||
162088269|NCT02802345|585374450|FG001|Overall Study|Adverse Event|20|||
162088270|NCT02802345|585374449|FG000|Overall Study|Withdrawal by Subject|3|||
162088271|NCT02802345|585374450|FG001|Overall Study|Withdrawal by Subject|3|||
162088272|NCT02802345|585374449|FG000|Overall Study|Protocol Violation|0|||
162088273|NCT02802345|585374450|FG001|Overall Study|Protocol Violation|1|||
162088274|NCT02802345|585374449|FG000|Overall Study|Other than listed|1|||
162088275|NCT02802345|585374450|FG001|Overall Study|Other than listed|5|||
162088276|NCT03969212|585374451|FG000|Overall Study|Adverse Event|1|||
162088277|NCT03969212|585374452|FG001|Overall Study|Adverse Event|0|||
162088278|NCT03969212|585374453|FG002|Overall Study|Adverse Event|0|||
162088279|NCT03969212|585374454|FG003|Overall Study|Adverse Event|0|||
162088280|NCT03969212|585374451|FG000|Overall Study|Lost to Follow-up|2|||
162088281|NCT03969212|585374452|FG001|Overall Study|Lost to Follow-up|2|||
162088282|NCT03969212|585374453|FG002|Overall Study|Lost to Follow-up|2|||
162088283|NCT03969212|585374454|FG003|Overall Study|Lost to Follow-up|2|||
162088284|NCT03969212|585374451|FG000|Overall Study|Protocol Violation|0|||
162088285|NCT03969212|585374452|FG001|Overall Study|Protocol Violation|0|||
162088286|NCT03969212|585374453|FG002|Overall Study|Protocol Violation|0|||
162088287|NCT03969212|585374454|FG003|Overall Study|Protocol Violation|1|||
162088288|NCT03969212|585374451|FG000|Overall Study|Withdrawal by Subject|7|||
162088289|NCT03969212|585374452|FG001|Overall Study|Withdrawal by Subject|13|||
162088290|NCT03969212|585374453|FG002|Overall Study|Withdrawal by Subject|5|||
162088291|NCT03969212|585374454|FG003|Overall Study|Withdrawal by Subject|11|||
162088292|NCT03969212|585374451|FG000|Overall Study|Physician Decision|0|||
162088293|NCT03969212|585374452|FG001|Overall Study|Physician Decision|0|||
162088294|NCT03969212|585374453|FG002|Overall Study|Physician Decision|1|||
162088295|NCT03969212|585374454|FG003|Overall Study|Physician Decision|0|||
162088296|NCT03969212|585374451|FG000|Overall Study|Reason not Specified|22|||
162088297|NCT03969212|585374452|FG001|Overall Study|Reason not Specified|23|||
162088298|NCT03969212|585374453|FG002|Overall Study|Reason not Specified|28|||
162088299|NCT03969212|585374454|FG003|Overall Study|Reason not Specified|26|||
162088300|NCT02075320|585374455|FG000|Overall Study|Withdrawal by Subject|2|||
162088301|NCT03773757|585374457|FG000|Overall Study|Withdrawal by Subject|2|||
162088302|NCT03773757|585374458|FG001|Overall Study|Withdrawal by Subject|4|||
162088303|NCT00057746|585374459|FG000|Overall Study|Withdrawal by Subject|0|||
162088304|NCT00057746|585374460|FG001|Overall Study|Withdrawal by Subject|0|||
162088305|NCT00057746|585374461|FG002|Overall Study|Withdrawal by Subject|1|||
162088306|NCT02985736|585374466|FG000|Overall Study|Lost to Follow-up|3|||
162088307|NCT00550836|585374467|FG000|Overall Study|Withdrawal by Subject|3|||
162088308|NCT00550836|585374468|FG001|Overall Study|Withdrawal by Subject|9|||
162088309|NCT01856543|585374469|FG000|Overall Study|Treatment discontinued|6|||
162088310|NCT01856543|585374470|FG001|Overall Study|Treatment discontinued|3|||
162088311|NCT01856543|585374469|FG000|Overall Study|Withdrawn before start|7|||
162088312|NCT01856543|585374470|FG001|Overall Study|Withdrawn before start|3|||
162088313|NCT04545515|585374471|FG000|Overall Study|Adverse Event|1|||
162088314|NCT04545515|585374471|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
162088315|NCT04545515|585374471|FG000|Overall Study|Commercial drug is available for participant|7|||
162088316|NCT01552772|585374472|FG000|Overall Study|Lost to Follow-up|2|||
162088317|NCT01552772|585374472|FG000|Overall Study|Adverse Event|1|||
162088318|NCT01552772|585374472|FG000|Overall Study|Protocol Deviation|1|||
162088319|NCT01848990|585374473|FG000|Overall Study|Adverse Event|6|||
162088320|NCT01848990|585374474|FG001|Overall Study|Adverse Event|2|||
162088321|NCT01848990|585374475|FG002|Overall Study|Adverse Event|0|||
162088322|NCT01848990|585374473|FG000|Overall Study|Lost to Follow-up|6|||
162088323|NCT01848990|585374474|FG001|Overall Study|Lost to Follow-up|2|||
162088324|NCT01848990|585374475|FG002|Overall Study|Lost to Follow-up|2|||
162088325|NCT01848990|585374473|FG000|Overall Study|Protocol Violation|1|||
162088326|NCT01848990|585374474|FG001|Overall Study|Protocol Violation|1|||
162088327|NCT01848990|585374475|FG002|Overall Study|Protocol Violation|0|||
162088328|NCT01848990|585374473|FG000|Overall Study|Withdrawal by Subject|29|||
162088329|NCT01848990|585374474|FG001|Overall Study|Withdrawal by Subject|10|||
162088330|NCT01848990|585374475|FG002|Overall Study|Withdrawal by Subject|11|||
162088331|NCT01848990|585374473|FG000|Overall Study|Physician Decision|1|||
162088332|NCT01848990|585374474|FG001|Overall Study|Physician Decision|1|||
162088333|NCT01848990|585374475|FG002|Overall Study|Physician Decision|0|||
162088334|NCT01848990|585374473|FG000|Overall Study|Non Compliance|1|||
162088335|NCT01848990|585374474|FG001|Overall Study|Non Compliance|0|||
162088336|NCT01848990|585374475|FG002|Overall Study|Non Compliance|0|||
162088337|NCT01848990|585374473|FG000|Overall Study|Death|1|||
162088338|NCT01848990|585374474|FG001|Overall Study|Death|0|||
162088339|NCT01848990|585374475|FG002|Overall Study|Death|1|||
162088340|NCT01848990|585374473|FG000|Overall Study|Other|1|||
162088341|NCT01848990|585374474|FG001|Overall Study|Other|4|||
162088342|NCT01848990|585374475|FG002|Overall Study|Other|2|||
162088343|NCT00700011|585374476|FG000|Overall Study|Death|0|||
162088344|NCT00700011|585374477|FG001|Overall Study|Death|1|||
162088345|NCT00512096|585374481|FG000|Overall Study|Adverse Event|2|||
162088346|NCT00512096|585374481|FG000|Overall Study|Withdrawal by Subject|2|||
162088347|NCT00512096|585374481|FG000|Overall Study|Lack of Efficacy|3|||
162088348|NCT00298038|585374488|FG000|Overall Study|Lost to Follow-up|0|||
162088349|NCT00298038|585374489|FG001|Overall Study|Lost to Follow-up|1|||
162088350|NCT00298038|585374488|FG000|Overall Study|Liver Transplant|0|||
162088351|NCT00298038|585374489|FG001|Overall Study|Liver Transplant|1|||
162088352|NCT00298038|585374488|FG000|Overall Study|Protocol Violation|1|||
162088353|NCT00298038|585374489|FG001|Overall Study|Protocol Violation|3|||
162088354|NCT00298038|585374488|FG000|Overall Study|Death|6|||
162088355|NCT00298038|585374489|FG001|Overall Study|Death|3|||
162088356|NCT00298038|585374488|FG000|Overall Study|Withdrawal by Subject|6|||
162088357|NCT00298038|585374489|FG001|Overall Study|Withdrawal by Subject|9|||
162088358|NCT00298038|585374488|FG000|Overall Study|Adverse Event|8|||
162088359|NCT00298038|585374489|FG001|Overall Study|Adverse Event|7|||
162088360|NCT00298038|585374488|FG000|Overall Study|Breakthrough overt HE episode|28|||
162088361|NCT00298038|585374489|FG001|Overall Study|Breakthrough overt HE episode|69|||
162088362|NCT00298038|585374488|FG000|Overall Study|Noncompliance|1|||
162088363|NCT00298038|585374489|FG001|Overall Study|Noncompliance|0|||
162088364|NCT00298038|585374488|FG000|Overall Study|Cocaine Abuse|1|||
162088365|NCT00298038|585374489|FG001|Overall Study|Cocaine Abuse|0|||
162088366|NCT00298038|585374488|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
162088367|NCT00298038|585374489|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
162088368|NCT02696096|585374490|FG000|Overall Study|ruled out at screening|1|||
162088369|NCT02696096|585374490|FG000|Overall Study|did not attend second fMRI|1|||
162088370|NCT01940705|585374491|FG000|Overall Study|Lost to Follow-up|1|||
162088371|NCT01940705|585374492|FG001|Overall Study|Lost to Follow-up|3|||
162088372|NCT01940705|585374493|FG002|Overall Study|Lost to Follow-up|2|||
162088373|NCT01940705|585374494|FG003|Overall Study|Lost to Follow-up|2|||
162088374|NCT01940705|585374491|FG000|Overall Study|Withdrawal by Subject|2|||
162088375|NCT01940705|585374492|FG001|Overall Study|Withdrawal by Subject|2|||
162088376|NCT01940705|585374493|FG002|Overall Study|Withdrawal by Subject|3|||
162088377|NCT01940705|585374494|FG003|Overall Study|Withdrawal by Subject|2|||
162088378|NCT01940705|585374491|FG000|Overall Study|Intervention not given|0|||
162088379|NCT01940705|585374492|FG001|Overall Study|Intervention not given|3|||
162088380|NCT01940705|585374493|FG002|Overall Study|Intervention not given|3|||
162088381|NCT01940705|585374494|FG003|Overall Study|Intervention not given|0|||
162088382|NCT01940705|585374491|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
162088383|NCT01940705|585374492|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
162088384|NCT01940705|585374493|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
162088385|NCT01940705|585374494|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
162088386|NCT02447991|585374495|FG000|Overall Study|Withdrawn by subject - no data|0|||
162088387|NCT02447991|585374496|FG001|Overall Study|Withdrawn by subject - no data|2|||
162088388|NCT02447991|585374495|FG000|Overall Study|Withdrawn by Subject - with data|4|||
162088389|NCT02447991|585374496|FG001|Overall Study|Withdrawn by Subject - with data|4|||
162088390|NCT02447991|585374495|FG000|Overall Study|Lost to Follow-up - no data|3|||
162088391|NCT02447991|585374496|FG001|Overall Study|Lost to Follow-up - no data|6|||
162088392|NCT02447991|585374495|FG000|Overall Study|Lost to follow-up - with data|0|||
162088393|NCT02447991|585374496|FG001|Overall Study|Lost to follow-up - with data|3|||
162088394|NCT02447991|585374495|FG000|Overall Study|End of study - no treatment results|3|||
162088395|NCT02447991|585374496|FG001|Overall Study|End of study - no treatment results|6|||
162088396|NCT02447991|585374495|FG000|Overall Study|End of study - partial treatment results|0|||
162088397|NCT02447991|585374496|FG001|Overall Study|End of study - partial treatment results|9|||
162088398|NCT00829621|585374497|FG000|Overall Study|Death|1|||
162088399|NCT00829621|585374498|FG001|Overall Study|Death|0|||
162088400|NCT00829621|585374497|FG000|Overall Study|Lost to Follow-up|3|||
162088401|NCT00829621|585374498|FG001|Overall Study|Lost to Follow-up|4|||
162088402|NCT03551210|585374499|FG000|Overall Study|Adverse Event|5|||
162088403|NCT03551210|585374500|FG001|Overall Study|Adverse Event|6|||
162088404|NCT03551210|585374499|FG000|Overall Study|Withdrawal by Subject|1|||
162088405|NCT03551210|585374500|FG001|Overall Study|Withdrawal by Subject|7|||
162088406|NCT03551210|585374499|FG000|Overall Study|Needed in other antibiotic treatment|2|||
162088407|NCT03551210|585374500|FG001|Overall Study|Needed in other antibiotic treatment|5|||
162088408|NCT03551210|585374499|FG000|Overall Study|Lost to Follow-up|1|||
162088409|NCT03551210|585374500|FG001|Overall Study|Lost to Follow-up|1|||
162088410|NCT03551210|585374499|FG000|Overall Study|Absence of visit 4 and 5|1|||
162088411|NCT03551210|585374500|FG001|Overall Study|Absence of visit 4 and 5|0|||
162088412|NCT03551210|585374499|FG000|Overall Study|No drug for dispensing|0|||
162088413|NCT03551210|585374500|FG001|Overall Study|No drug for dispensing|1|||
162088414|NCT01076400|585376242|FG000|Overall Study|Adverse Event|2|||
162088415|NCT01076400|585376243|FG001|Overall Study|Adverse Event|0|||
162088416|NCT01076400|585376244|FG002|Overall Study|Adverse Event|0|||
162088417|NCT01076400|585376242|FG000|Overall Study|Progressive Disease|5|||
162088418|NCT01076400|585376243|FG001|Overall Study|Progressive Disease|0|||
162088419|NCT01076400|585376244|FG002|Overall Study|Progressive Disease|0|||
162088420|NCT02343458|585376247|FG000|Overall Study|Adverse Event|15|||
162088421|NCT02343458|585376248|FG001|Overall Study|Adverse Event|14|||
162088422|NCT02343458|585376249|FG002|Overall Study|Adverse Event|15|||
162088423|NCT02343458|585376250|FG003|Overall Study|Adverse Event|3|||
162088424|NCT02343458|585376247|FG000|Overall Study|Lack of Efficacy|3|||
162088425|NCT02343458|585376248|FG001|Overall Study|Lack of Efficacy|8|||
162088426|NCT02343458|585376249|FG002|Overall Study|Lack of Efficacy|4|||
162088427|NCT02343458|585376250|FG003|Overall Study|Lack of Efficacy|8|||
162088428|NCT02343458|585376247|FG000|Overall Study|Withdrawal by Subject|18|||
162088429|NCT02343458|585376248|FG001|Overall Study|Withdrawal by Subject|17|||
162088430|NCT02343458|585376249|FG002|Overall Study|Withdrawal by Subject|23|||
162088431|NCT02343458|585376250|FG003|Overall Study|Withdrawal by Subject|14|||
162088432|NCT02343458|585376247|FG000|Overall Study|Physician Decision|1|||
162088433|NCT02343458|585376248|FG001|Overall Study|Physician Decision|4|||
162088434|NCT02343458|585376249|FG002|Overall Study|Physician Decision|2|||
162088435|NCT02343458|585376250|FG003|Overall Study|Physician Decision|2|||
162088436|NCT02343458|585376247|FG000|Overall Study|Lost to Follow-up|5|||
162088437|NCT02343458|585376248|FG001|Overall Study|Lost to Follow-up|5|||
162088438|NCT02343458|585376249|FG002|Overall Study|Lost to Follow-up|3|||
162088439|NCT02343458|585376250|FG003|Overall Study|Lost to Follow-up|1|||
162088440|NCT02343458|585376247|FG000|Overall Study|Protocol Violation|2|||
162088441|NCT02343458|585376248|FG001|Overall Study|Protocol Violation|5|||
162088442|NCT02343458|585376249|FG002|Overall Study|Protocol Violation|2|||
162088443|NCT02343458|585376250|FG003|Overall Study|Protocol Violation|2|||
162088444|NCT02343458|585376247|FG000|Overall Study|Protocol Specified Criteria|17|||
162088445|NCT02343458|585376248|FG001|Overall Study|Protocol Specified Criteria|13|||
162088446|NCT02343458|585376249|FG002|Overall Study|Protocol Specified Criteria|14|||
162088447|NCT02343458|585376250|FG003|Overall Study|Protocol Specified Criteria|8|||
162088448|NCT01913041|585376251|FG000|Overall Study|Protocol Violation|35|||
162088449|NCT01913041|585376251|FG000|Overall Study|Withdrawal by Subject|3|||
162088450|NCT01913041|585376251|FG000|Overall Study|Physician Decision|1|||
162088451|NCT02866682|585376254|FG000|Overall Study|Death|0|||
162088452|NCT02866682|585376255|FG001|Overall Study|Death|1|||
162088453|NCT02866682|585376254|FG000|Overall Study|Lost to Follow-up|0|||
162088454|NCT02866682|585376255|FG001|Overall Study|Lost to Follow-up|4|||
162088455|NCT02866682|585376254|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
162088456|NCT02866682|585376255|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
162088457|NCT02866682|585376254|FG000|Overall Study|Other|0|||
162088458|NCT02866682|585376255|FG001|Overall Study|Other|1|||
162088459|NCT01750268|585376256|FG000|Overall Study|Lost to Follow-up|0|||
162088460|NCT01750268|585376257|FG001|Overall Study|Lost to Follow-up|2|||
162088461|NCT01750268|585376256|FG000|Overall Study|Physician Decision|0|||
162088462|NCT01750268|585376257|FG001|Overall Study|Physician Decision|3|||
162088463|NCT01750268|585376256|FG000|Overall Study|Withdrawal by Subject|2|||
162088464|NCT01750268|585376257|FG001|Overall Study|Withdrawal by Subject|0|||
162088465|NCT02086591|585376258|FG000|Overall Study|Adverse Event|1|||
162088466|NCT02086591|585376258|FG000|Overall Study|Withdrawal by Subject|1|||
162088467|NCT02086591|585376258|FG000|Overall Study|protocol terminated|3|||
162088468|NCT01529645|585376259|FG000|Overall Study|Lost to Follow-up|0|||
162088469|NCT01529645|585376260|FG001|Overall Study|Lost to Follow-up|1|||
162088470|NCT01529645|585376261|FG002|Overall Study|Lost to Follow-up|1|||
162088471|NCT01529645|585376262|FG003|Overall Study|Lost to Follow-up|1|||
162088472|NCT01529645|585376263|FG004|Overall Study|Lost to Follow-up|1|||
162088473|NCT01529645|585376264|FG005|Overall Study|Lost to Follow-up|0|||
162088474|NCT01529645|585376265|FG006|Overall Study|Lost to Follow-up|2|||
162088475|NCT01529645|585376266|FG007|Overall Study|Lost to Follow-up|0|||
162088476|NCT01529645|585376267|FG008|Overall Study|Lost to Follow-up|1|||
162088477|NCT01529645|585376268|FG009|Overall Study|Lost to Follow-up|0|||
162088478|NCT01529645|585376259|FG000|Overall Study|SAE - Premature contractions|0|||
162088479|NCT01529645|585376260|FG001|Overall Study|SAE - Premature contractions|0|||
162088480|NCT01529645|585376261|FG002|Overall Study|SAE - Premature contractions|1|||
162088481|NCT01529645|585376262|FG003|Overall Study|SAE - Premature contractions|0|||
162088482|NCT01529645|585376263|FG004|Overall Study|SAE - Premature contractions|0|||
162088483|NCT01529645|585376264|FG005|Overall Study|SAE - Premature contractions|0|||
162088484|NCT01529645|585376265|FG006|Overall Study|SAE - Premature contractions|0|||
162088485|NCT01529645|585376266|FG007|Overall Study|SAE - Premature contractions|0|||
162088486|NCT01529645|585376267|FG008|Overall Study|SAE - Premature contractions|0|||
162088487|NCT01529645|585376268|FG009|Overall Study|SAE - Premature contractions|0|||
162088488|NCT01529645|585376259|FG000|Overall Study|Withdrawal by Subject|2|||
162088489|NCT01529645|585376260|FG001|Overall Study|Withdrawal by Subject|0|||
162088490|NCT01529645|585376261|FG002|Overall Study|Withdrawal by Subject|0|||
162088491|NCT01529645|585376262|FG003|Overall Study|Withdrawal by Subject|1|||
162088492|NCT01529645|585376263|FG004|Overall Study|Withdrawal by Subject|1|||
162088493|NCT01529645|585376264|FG005|Overall Study|Withdrawal by Subject|1|||
162088494|NCT01529645|585376265|FG006|Overall Study|Withdrawal by Subject|0|||
162088495|NCT01529645|585376266|FG007|Overall Study|Withdrawal by Subject|0|||
162088496|NCT01529645|585376267|FG008|Overall Study|Withdrawal by Subject|0|||
162088497|NCT01529645|585376268|FG009|Overall Study|Withdrawal by Subject|0|||
162088498|NCT02489981|585376276|FG000|Overall Study|Adverse Event|21|||
162088499|NCT02489981|585376276|FG000|Overall Study|Insufficient effectiveness|16|||
162088500|NCT02489981|585376276|FG000|Overall Study|Improved|31|||
162088501|NCT02489981|585376276|FG000|Overall Study|Lost to Follow-up|31|||
162088502|NCT02489981|585376276|FG000|Overall Study|Other than listed|28|||
162088503|NCT01565993|585376284|FG000|Overall Study|Physician Decision|0|||
162088504|NCT01565993|585376285|FG001|Overall Study|Physician Decision|3|||
162088505|NCT04086472|585376288|FG000|Overall Study|Lost to Follow-up|1|||
162088506|NCT04086472|585376289|FG001|Overall Study|Lost to Follow-up|0|||
162088507|NCT04086472|585376290|FG002|Overall Study|Lost to Follow-up|0|||
162088508|NCT04086472|585376291|FG003|Overall Study|Lost to Follow-up|0|||
162088509|NCT04086472|585376292|FG004|Overall Study|Lost to Follow-up|1|||
162088510|NCT04086472|585376288|FG000|Overall Study|Physician Decision|0|||
162088511|NCT04086472|585376289|FG001|Overall Study|Physician Decision|1|||
162088512|NCT04086472|585376290|FG002|Overall Study|Physician Decision|1|||
162088513|NCT04086472|585376291|FG003|Overall Study|Physician Decision|0|||
162088514|NCT04086472|585376292|FG004|Overall Study|Physician Decision|0|||
162088515|NCT04086472|585376288|FG000|Overall Study|Withdrawal by Subject|1|||
162088516|NCT04086472|585376289|FG001|Overall Study|Withdrawal by Subject|1|||
162088517|NCT04086472|585376290|FG002|Overall Study|Withdrawal by Subject|1|||
162088518|NCT04086472|585376291|FG003|Overall Study|Withdrawal by Subject|0|||
162088519|NCT04086472|585376292|FG004|Overall Study|Withdrawal by Subject|0|||
162088520|NCT04086472|585376288|FG000|Overall Study|Various reasons|2|||
162088521|NCT04086472|585376289|FG001|Overall Study|Various reasons|0|||
162088522|NCT04086472|585376290|FG002|Overall Study|Various reasons|0|||
162088523|NCT04086472|585376291|FG003|Overall Study|Various reasons|3|||
162088524|NCT04086472|585376292|FG004|Overall Study|Various reasons|1|||
162088525|NCT03348904|585376293|FG000|Overall Study|Administrative reason by the sponsor|0|||
162088526|NCT03348904|585376294|FG001|Overall Study|Administrative reason by the sponsor|1|||
162088527|NCT03348904|585376295|FG002|Overall Study|Administrative reason by the sponsor|0|||
162088528|NCT00436280|585376301|FG000|Period 1: Induction|Adverse Event|8|||
162088529|NCT00436280|585376301|FG000|Period 1: Induction|Progressive Disease|12|||
162088530|NCT00436280|585376301|FG000|Period 1: Induction|Stable Disease|6|||
162088531|NCT00436280|585376301|FG000|Period 1: Induction|Withdrawal by Subject|1|||
162088532|NCT00436280|585376301|FG000|Period 1: Induction|Death|1|||
162088533|NCT00436280|585376301|FG000|Period 2: Consolidation|Adverse Event|1|||
162088534|NCT00436280|585376301|FG000|Period 2: Consolidation|Progressive Disease|10|||
162088535|NCT00436280|585376301|FG000|Period 2: Consolidation|Stable Disease|1|||
162088536|NCT00436280|585376301|FG000|Period 2: Consolidation|Physician Decision|2|||
162088537|NCT00436280|585376301|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
162088538|NCT00436280|585376301|FG000|Period 2: Consolidation|Death|1|||
162088539|NCT00436280|585376301|FG000|Period 3: Maintenance|Adverse Event|6|||
162088540|NCT00436280|585376301|FG000|Period 3: Maintenance|Progressive Disease|12|||
162088541|NCT01532687|585376305|FG000|Overall Study|Death|2|||
162088542|NCT01532687|585376306|FG001|Overall Study|Death|0|||
162088543|NCT01532687|585376305|FG000|Overall Study|Adverse Event|6|||
162088544|NCT01532687|585376306|FG001|Overall Study|Adverse Event|1|||
162088545|NCT01532687|585376305|FG000|Overall Study|Withdrawal by Subject|1|||
162088546|NCT01532687|585376306|FG001|Overall Study|Withdrawal by Subject|0|||
162088547|NCT01532687|585376305|FG000|Overall Study|Physician Decision|2|||
162088548|NCT01532687|585376306|FG001|Overall Study|Physician Decision|1|||
162088549|NCT01532687|585376305|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
162088550|NCT01532687|585376306|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
162088551|NCT04116229|585376307|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
162122720|NCT03915951|585500309|FG000|Overall Study|Disease progression (clinical)|4|||
162088552|NCT04116229|585376308|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
162088553|NCT04116229|585376307|FG000|Overall Study|Scheduling not possible.|0|||
162088554|NCT04116229|585376308|FG001|Overall Study|Scheduling not possible.|1|||
162088555|NCT02809976|585376311|FG000|Overall Study|Lost to Follow-up|1|||
162088556|NCT02809976|585376311|FG000|Overall Study|Withdrawal by Subject|1|||
162088557|NCT01034397|585376312|FG000|Overall Study|Lack of compliance|0|||
162088558|NCT01034397|585376313|FG001|Overall Study|Lack of compliance|1|||
162088559|NCT01034397|585376312|FG000|Overall Study|Lack of Efficacy|3|||
162088560|NCT01034397|585376313|FG001|Overall Study|Lack of Efficacy|0|||
162088561|NCT01034397|585376312|FG000|Overall Study|Adverse Event|4|||
162088562|NCT01034397|585376313|FG001|Overall Study|Adverse Event|0|||
162088563|NCT01034397|585376312|FG000|Overall Study|Other|0|||
162088564|NCT01034397|585376313|FG001|Overall Study|Other|1|||
162088565|NCT00211081|585376317|FG000|Overall Study|Withdrawal by Subject|2|||
162088566|NCT01931839|585376318|FG000|Overall Study|Death|0|||
162088567|NCT01931839|585376319|FG001|Overall Study|Death|1|||
162088568|NCT01931839|585376320|FG002|Overall Study|Death|2|||
162088569|NCT01931839|585376321|FG003|Overall Study|Death|0|||
162088570|NCT01931839|585376322|FG004|Overall Study|Death|0|||
162088571|NCT01931839|585376323|FG005|Overall Study|Death|0|||
162088572|NCT01931839|585376324|FG006|Overall Study|Death|0|||
162088573|NCT01931839|585376318|FG000|Overall Study|Physician Decision|1|||
162088574|NCT01931839|585376319|FG001|Overall Study|Physician Decision|0|||
162088575|NCT01931839|585376320|FG002|Overall Study|Physician Decision|1|||
162088576|NCT01931839|585376321|FG003|Overall Study|Physician Decision|0|||
162088577|NCT01931839|585376322|FG004|Overall Study|Physician Decision|0|||
162088578|NCT01931839|585376323|FG005|Overall Study|Physician Decision|0|||
162088579|NCT01931839|585376324|FG006|Overall Study|Physician Decision|1|||
162088580|NCT01931839|585376318|FG000|Overall Study|Withdrawal of consent|0|||
162088581|NCT01931839|585376319|FG001|Overall Study|Withdrawal of consent|0|||
162088582|NCT01931839|585376320|FG002|Overall Study|Withdrawal of consent|0|||
162088583|NCT01931839|585376321|FG003|Overall Study|Withdrawal of consent|0|||
162088584|NCT01931839|585376322|FG004|Overall Study|Withdrawal of consent|1|||
162088585|NCT01931839|585376323|FG005|Overall Study|Withdrawal of consent|0|||
162088586|NCT01931839|585376324|FG006|Overall Study|Withdrawal of consent|0|||
162088587|NCT01931839|585376318|FG000|Overall Study|Adverse Event|9|||
162088588|NCT01931839|585376319|FG001|Overall Study|Adverse Event|4|||
162088589|NCT01931839|585376320|FG002|Overall Study|Adverse Event|1|||
162088590|NCT01931839|585376321|FG003|Overall Study|Adverse Event|3|||
162088591|NCT01931839|585376322|FG004|Overall Study|Adverse Event|0|||
162088592|NCT01931839|585376323|FG005|Overall Study|Adverse Event|0|||
162088593|NCT01931839|585376324|FG006|Overall Study|Adverse Event|1|||
162088594|NCT01931839|585376318|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
162088595|NCT01931839|585376319|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
162088596|NCT01931839|585376320|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
162088597|NCT01931839|585376321|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
162088598|NCT01931839|585376322|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
162088599|NCT01931839|585376323|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
162088600|NCT01931839|585376324|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
162088601|NCT01931839|585376318|FG000|Overall Study|Other non-compliance|15|||
162088602|NCT01931839|585376319|FG001|Overall Study|Other non-compliance|9|||
162088603|NCT01931839|585376320|FG002|Overall Study|Other non-compliance|12|||
162088604|NCT01931839|585376321|FG003|Overall Study|Other non-compliance|3|||
162088605|NCT01931839|585376322|FG004|Overall Study|Other non-compliance|0|||
162088606|NCT01931839|585376323|FG005|Overall Study|Other non-compliance|3|||
162088607|NCT01931839|585376324|FG006|Overall Study|Other non-compliance|0|||
162088608|NCT01931839|585376318|FG000|Overall Study|Lost to Follow-up|1|||
162088609|NCT01931839|585376319|FG001|Overall Study|Lost to Follow-up|2|||
162088610|NCT01931839|585376320|FG002|Overall Study|Lost to Follow-up|4|||
162088611|NCT01931839|585376321|FG003|Overall Study|Lost to Follow-up|5|||
162088612|NCT01931839|585376322|FG004|Overall Study|Lost to Follow-up|0|||
162088613|NCT01931839|585376323|FG005|Overall Study|Lost to Follow-up|0|||
162088614|NCT01931839|585376324|FG006|Overall Study|Lost to Follow-up|0|||
162088615|NCT01931839|585376318|FG000|Overall Study|Other|4|||
162088616|NCT01931839|585376319|FG001|Overall Study|Other|2|||
162088617|NCT01931839|585376320|FG002|Overall Study|Other|6|||
162088618|NCT01931839|585376321|FG003|Overall Study|Other|0|||
162088619|NCT01931839|585376322|FG004|Overall Study|Other|0|||
162088620|NCT01931839|585376323|FG005|Overall Study|Other|0|||
162088621|NCT01931839|585376324|FG006|Overall Study|Other|0|||
162088622|NCT01263873|585376325|FG000|Overall Study|One provider unable to complete numbers|1|||
162088623|NCT01263873|585376326|FG001|Overall Study|One provider unable to complete numbers|1|||
162088624|NCT00113516|585376327|FG000|Part 1|Adverse Event|6|||
162088625|NCT00113516|585376328|FG001|Part 1|Adverse Event|0|||
162088626|NCT00113516|585376327|FG000|Part 1|Death|3|||
162088627|NCT00113516|585376328|FG001|Part 1|Death|0|||
162088628|NCT00113516|585376327|FG000|Part 1|Other|3|||
162088629|NCT00113516|585376328|FG001|Part 1|Other|0|||
162088630|NCT00113516|585376327|FG000|Part 1|Withdrawal by Subject|2|||
162088631|NCT00113516|585376328|FG001|Part 1|Withdrawal by Subject|0|||
162088632|NCT00113516|585376327|FG000|Part 1|Lack of Efficacy|2|||
162088633|NCT00113516|585376328|FG001|Part 1|Lack of Efficacy|0|||
162088634|NCT00113516|585376327|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
162088635|NCT00113516|585376328|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
162088636|NCT00113516|585376327|FG000|Part 1|Laboratory Abnormality|1|||
162088637|NCT00113516|585376328|FG001|Part 1|Laboratory Abnormality|0|||
162088638|NCT00113516|585376327|FG000|Part 1|Ongoing|1|||
162088639|NCT00113516|585376328|FG001|Part 1|Ongoing|0|||
162088640|NCT00113516|585376327|FG000|Part 1|Missing|65|||
162088641|NCT00113516|585376328|FG001|Part 1|Missing|0|||
162088642|NCT00113516|585376327|FG000|Part 2|Adverse Event|0|||
162088643|NCT00113516|585376328|FG001|Part 2|Adverse Event|16|||
162088644|NCT00113516|585376327|FG000|Part 2|Death|0|||
162088645|NCT00113516|585376328|FG001|Part 2|Death|5|||
162088646|NCT00113516|585376327|FG000|Part 2|Lack of Efficacy|0|||
162088647|NCT00113516|585376328|FG001|Part 2|Lack of Efficacy|37|||
162088648|NCT00113516|585376327|FG000|Part 2|Withdrawal by Subject|0|||
162088649|NCT00113516|585376328|FG001|Part 2|Withdrawal by Subject|3|||
162088650|NCT00113516|585376327|FG000|Part 2|Other|0|||
162088651|NCT00113516|585376328|FG001|Part 2|Other|3|||
162088652|NCT00113516|585376327|FG000|Part 2|Laboratory Abnormality|0|||
162088653|NCT00113516|585376328|FG001|Part 2|Laboratory Abnormality|1|||
162088654|NCT00113516|585376327|FG000|Part 2|Ongoing|0|||
162088655|NCT00113516|585376328|FG001|Part 2|Ongoing|1|||
162088656|NCT03217136|585376337|FG000|Overall Study|Lost to Follow-up|2|||
162088657|NCT03217136|585376338|FG001|Overall Study|Lost to Follow-up|1|||
162088658|NCT03217136|585376337|FG000|Overall Study|Site Randomized Participant in Error|0|||
162088659|NCT03217136|585376338|FG001|Overall Study|Site Randomized Participant in Error|1|||
162088660|NCT03217136|585376337|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
162088661|NCT03217136|585376338|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
162088662|NCT03217136|585376337|FG000|Overall Study|Dispensing Error|1|||
162088663|NCT03217136|585376338|FG001|Overall Study|Dispensing Error|0|||
162088664|NCT03217136|585376337|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
162088665|NCT03217136|585376338|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
162088666|NCT03755765|585376339|FG000|Overall Study|Withdrawal by Subject|2|||
162088667|NCT03755765|585376340|FG001|Overall Study|Withdrawal by Subject|4|||
162088668|NCT03755765|585376341|FG002|Overall Study|Withdrawal by Subject|4|||
162088669|NCT02104557|585376342|FG000|Overall Study|Adverse Event|24|||
162088670|NCT02104557|585376342|FG000|Overall Study|Lost to Follow-up|34|||
162088671|NCT02104557|585376342|FG000|Overall Study|Violated the usage and dosage|14|||
162088672|NCT02104557|585376342|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
162088673|NCT02104557|585376342|FG000|Overall Study|Administered Sayana prior to the contract|1|||
162088674|NCT02104557|585376342|FG000|Overall Study|Other|17|||
162088675|NCT02104557|585376342|FG000|Overall Study|Change to other contraception methods|5|||
162088676|NCT02104557|585376342|FG000|Overall Study|Discontinuation due to no pain|1|||
162088677|NCT02104557|585376342|FG000|Overall Study|Withdrawal consent|2|||
162088678|NCT02104557|585376342|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
162088679|NCT02104557|585376342|FG000|Overall Study|Discontinuation of contraception|9|||
162088680|NCT01158222|585376346|FG000|Overall Study|Not eligible for intermediate phase|17|||
162088681|NCT00111228|585376349|FG000|Overall Study|Withdrawal by Subject|5|||
162088682|NCT00111228|585376350|FG001|Overall Study|Withdrawal by Subject|1|||
162088683|NCT00111228|585376351|FG002|Overall Study|Withdrawal by Subject|0|||
162088684|NCT02579616|585376352|FG000|Overall Study|Participants did not receive treatment|3|||
162088685|NCT01430585|585376353|FG000|Overall Study|Death|1|||
162088686|NCT01430585|585376353|FG000|Overall Study|Objective Progression or Relapse|3|||
162088687|NCT01430585|585376353|FG000|Overall Study|Study Terminated by Sponsor|3|||
162088688|NCT01430585|585376353|FG000|Overall Study|Other|7|||
162088689|NCT01448850|585376354|FG000|Overall Study|Death|3|||
162088690|NCT01448850|585376355|FG001|Overall Study|Death|6|||
162088691|NCT01448850|585376354|FG000|Overall Study|Withdrawal by Subject|13|||
162088692|NCT01448850|585376355|FG001|Overall Study|Withdrawal by Subject|21|||
162088693|NCT01448850|585376354|FG000|Overall Study|Lost to Follow-up|3|||
162088694|NCT01448850|585376355|FG001|Overall Study|Lost to Follow-up|1|||
162088695|NCT01448850|585376354|FG000|Overall Study|Other|15|||
162088696|NCT01448850|585376355|FG001|Overall Study|Other|12|||
162088697|NCT01490060|585376358|FG000|Cycle 1|Change of Treatment|0|||
162088698|NCT01490060|585376359|FG001|Cycle 1|Change of Treatment|1|||
162088699|NCT01490060|585376360|FG002|Cycle 1|Change of Treatment|1|||
162088700|NCT01490060|585376361|FG003|Cycle 1|Change of Treatment|1|||
162088701|NCT01490060|585376358|FG000|Cycle 1|Insurance Denied|0|||
162088702|NCT01490060|585376359|FG001|Cycle 1|Insurance Denied|0|||
162088703|NCT01490060|585376360|FG002|Cycle 1|Insurance Denied|2|||
162088704|NCT01490060|585376361|FG003|Cycle 1|Insurance Denied|0|||
162088705|NCT01490060|585376358|FG000|Cycle 1|Withdrawal by Subject|0|||
162088706|NCT01490060|585376359|FG001|Cycle 1|Withdrawal by Subject|0|||
162088707|NCT01490060|585376360|FG002|Cycle 1|Withdrawal by Subject|0|||
162088708|NCT01490060|585376361|FG003|Cycle 1|Withdrawal by Subject|1|||
162088709|NCT01490060|585376358|FG000|Cycle 1|Treatment at Another Facility|0|||
162088710|NCT01490060|585376359|FG001|Cycle 1|Treatment at Another Facility|0|||
162088711|NCT01490060|585376360|FG002|Cycle 1|Treatment at Another Facility|0|||
162088712|NCT01490060|585376361|FG003|Cycle 1|Treatment at Another Facility|1|||
162088713|NCT01490060|585376358|FG000|Cycle 2|Change of Treatment|1|||
162088714|NCT01490060|585376359|FG001|Cycle 2|Change of Treatment|1|||
162088715|NCT01490060|585376360|FG002|Cycle 2|Change of Treatment|0|||
162088716|NCT01490060|585376361|FG003|Cycle 2|Change of Treatment|0|||
162088717|NCT01490060|585376358|FG000|Cycle 2|Non-Compliance|0|||
162088718|NCT01490060|585376359|FG001|Cycle 2|Non-Compliance|0|||
162088719|NCT01490060|585376360|FG002|Cycle 2|Non-Compliance|1|||
162088720|NCT01490060|585376361|FG003|Cycle 2|Non-Compliance|0|||
162088721|NCT01490060|585376358|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
162088722|NCT01490060|585376359|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
162088723|NCT01490060|585376360|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
162088724|NCT01490060|585376361|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
162088725|NCT02464969|585376362|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
162088726|NCT02464969|585376363|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
162088727|NCT02464969|585376362|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
162088728|NCT02464969|585376363|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
162088729|NCT02464969|585376362|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
162088730|NCT02464969|585376363|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
162088731|NCT02464969|585376362|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
162088732|NCT02464969|585376363|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
162088733|NCT02464969|585376362|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
162088734|NCT02464969|585376363|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
162088735|NCT02464969|585376362|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
162088736|NCT02464969|585376363|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
162088737|NCT02464969|585376362|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
162088738|NCT02464969|585376363|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
162088739|NCT02464969|585376362|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
162088740|NCT02464969|585376363|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
162088741|NCT02464969|585376362|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
162088742|NCT02464969|585376363|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
162088743|NCT02464969|585376362|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
162088744|NCT02464969|585376363|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
162088745|NCT02464969|585376362|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
162088746|NCT02464969|585376363|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
162088747|NCT02863354|585376364|FG000|Year 1|Lost to Follow-up|1|||
162088748|NCT02863354|585376365|FG001|Year 1|Lost to Follow-up|1|||
162088749|NCT02863354|585376364|FG000|Year 1|Withdrawal by Subject|3|||
162088750|NCT02863354|585376365|FG001|Year 1|Withdrawal by Subject|0|||
162088751|NCT02863354|585376364|FG000|Year 1|Death|0|||
162088752|NCT02863354|585376365|FG001|Year 1|Death|1|||
162088753|NCT02863354|585376364|FG000|Year 2|Lost to Follow-up|2|||
162088754|NCT02863354|585376365|FG001|Year 2|Lost to Follow-up|2|||
162088755|NCT00720876|585376371|FG000|Overall Study|found to be ineligible after starting tx|2|||
162088756|NCT03495908|585376373|FG000|Overall Study|Withdrawal by Subject|3|||
162088757|NCT03495908|585376374|FG001|Overall Study|Withdrawal by Subject|1|||
162088758|NCT03495908|585376373|FG000|Overall Study|Lost to Follow-up|1|||
162088759|NCT03495908|585376374|FG001|Overall Study|Lost to Follow-up|4|||
162088760|NCT03495908|585376373|FG000|Overall Study|Adverse Event|0|||
162088761|NCT03495908|585376374|FG001|Overall Study|Adverse Event|2|||
162088762|NCT03495908|585376373|FG000|Overall Study|Death|1|||
162088763|NCT03495908|585376374|FG001|Overall Study|Death|0|||
162088764|NCT03495908|585376373|FG000|Overall Study|Physician Decision|5|||
162088765|NCT03495908|585376374|FG001|Overall Study|Physician Decision|4|||
162088766|NCT03495908|585376373|FG000|Overall Study|No documented reason|0|||
162088767|NCT03495908|585376374|FG001|Overall Study|No documented reason|2|||
162088768|NCT01109316|585376375|FG000|Study Period 1|Adverse Event|0|||
162088769|NCT01109316|585376376|FG001|Study Period 1|Adverse Event|0|||
162088770|NCT01109316|585376377|FG002|Study Period 1|Adverse Event|1|||
162088771|NCT01109316|585376378|FG003|Study Period 1|Adverse Event|0|||
162088772|NCT01109316|585376379|FG004|Study Period 1|Adverse Event|0|||
162088773|NCT01109316|585376380|FG005|Study Period 1|Adverse Event|0|||
162088774|NCT01109316|585376375|FG000|Study Period 1|Lost to Follow-up|0|||
162088775|NCT01109316|585376376|FG001|Study Period 1|Lost to Follow-up|0|||
162088776|NCT01109316|585376377|FG002|Study Period 1|Lost to Follow-up|1|||
162088777|NCT01109316|585376378|FG003|Study Period 1|Lost to Follow-up|1|||
162088778|NCT01109316|585376379|FG004|Study Period 1|Lost to Follow-up|0|||
162088779|NCT01109316|585376380|FG005|Study Period 1|Lost to Follow-up|0|||
162088780|NCT01109316|585376375|FG000|Study Period 1|Withdrawal by Subject|0|||
162088781|NCT01109316|585376376|FG001|Study Period 1|Withdrawal by Subject|0|||
162088782|NCT01109316|585376377|FG002|Study Period 1|Withdrawal by Subject|1|||
162088783|NCT01109316|585376378|FG003|Study Period 1|Withdrawal by Subject|0|||
162088784|NCT01109316|585376379|FG004|Study Period 1|Withdrawal by Subject|2|||
162088785|NCT01109316|585376380|FG005|Study Period 1|Withdrawal by Subject|0|||
162088786|NCT01109316|585376375|FG000|Study Period 1|Sponsor Decision|0|||
162088787|NCT01109316|585376376|FG001|Study Period 1|Sponsor Decision|0|||
162088788|NCT01109316|585376377|FG002|Study Period 1|Sponsor Decision|0|||
162088789|NCT01109316|585376378|FG003|Study Period 1|Sponsor Decision|0|||
162088790|NCT01109316|585376379|FG004|Study Period 1|Sponsor Decision|0|||
162088791|NCT01109316|585376380|FG005|Study Period 1|Sponsor Decision|2|||
162088792|NCT01109316|585376375|FG000|Study Period 2|Entry Criteria Not Met|0|||
162088793|NCT01109316|585376376|FG001|Study Period 2|Entry Criteria Not Met|1|||
162088794|NCT01109316|585376377|FG002|Study Period 2|Entry Criteria Not Met|0|||
162088795|NCT01109316|585376378|FG003|Study Period 2|Entry Criteria Not Met|0|||
162088796|NCT01109316|585376379|FG004|Study Period 2|Entry Criteria Not Met|0|||
162088797|NCT01109316|585376380|FG005|Study Period 2|Entry Criteria Not Met|0|||
162088798|NCT01109316|585376375|FG000|Study Period 2|Physician Decision|0|||
162088799|NCT01109316|585376376|FG001|Study Period 2|Physician Decision|0|||
162088800|NCT01109316|585376377|FG002|Study Period 2|Physician Decision|0|||
162088801|NCT01109316|585376378|FG003|Study Period 2|Physician Decision|1|||
162088802|NCT01109316|585376379|FG004|Study Period 2|Physician Decision|0|||
162088803|NCT01109316|585376380|FG005|Study Period 2|Physician Decision|0|||
162088804|NCT01109316|585376375|FG000|Study Period 2|Protocol Violation|1|||
162088805|NCT01109316|585376376|FG001|Study Period 2|Protocol Violation|0|||
162088806|NCT01109316|585376377|FG002|Study Period 2|Protocol Violation|0|||
162088807|NCT01109316|585376378|FG003|Study Period 2|Protocol Violation|0|||
162088808|NCT01109316|585376379|FG004|Study Period 2|Protocol Violation|0|||
162088809|NCT01109316|585376380|FG005|Study Period 2|Protocol Violation|0|||
162088810|NCT01109316|585376375|FG000|Study Period 2|Withdrawal by Subject|0|||
162088811|NCT01109316|585376376|FG001|Study Period 2|Withdrawal by Subject|0|||
162088812|NCT01109316|585376377|FG002|Study Period 2|Withdrawal by Subject|1|||
162088813|NCT01109316|585376378|FG003|Study Period 2|Withdrawal by Subject|0|||
162088814|NCT01109316|585376379|FG004|Study Period 2|Withdrawal by Subject|0|||
162088815|NCT01109316|585376380|FG005|Study Period 2|Withdrawal by Subject|1|||
162088816|NCT01109316|585376375|FG000|Study Period 3|Lost to Follow-up|0|||
162088817|NCT01109316|585376376|FG001|Study Period 3|Lost to Follow-up|0|||
162088818|NCT01109316|585376377|FG002|Study Period 3|Lost to Follow-up|0|||
162088819|NCT01109316|585376378|FG003|Study Period 3|Lost to Follow-up|0|||
162088820|NCT01109316|585376379|FG004|Study Period 3|Lost to Follow-up|1|||
162088821|NCT01109316|585376380|FG005|Study Period 3|Lost to Follow-up|0|||
162088822|NCT01109316|585376375|FG000|Study Period 3|Withdrawal by Subject|1|||
162088823|NCT01109316|585376376|FG001|Study Period 3|Withdrawal by Subject|0|||
162088824|NCT01109316|585376377|FG002|Study Period 3|Withdrawal by Subject|0|||
162088825|NCT01109316|585376378|FG003|Study Period 3|Withdrawal by Subject|0|||
162088826|NCT01109316|585376379|FG004|Study Period 3|Withdrawal by Subject|1|||
162088827|NCT01109316|585376380|FG005|Study Period 3|Withdrawal by Subject|0|||
162088828|NCT01559311|585376383|FG000|Overall Study|Protocol Violation|0|||
162088829|NCT01559311|585376384|FG001|Overall Study|Protocol Violation|0|||
162088830|NCT01559311|585376385|FG002|Overall Study|Protocol Violation|2|||
162088831|NCT01559311|585376383|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
162088832|NCT01559311|585376384|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
162088833|NCT01559311|585376385|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
162088834|NCT01559311|585376383|FG000|Overall Study|Withdrawal by Subject|2|||
162088835|NCT01559311|585376384|FG001|Overall Study|Withdrawal by Subject|1|||
162088836|NCT01559311|585376385|FG002|Overall Study|Withdrawal by Subject|0|||
162088837|NCT01559311|585376383|FG000|Overall Study|Death|0|||
162088838|NCT01559311|585376384|FG001|Overall Study|Death|2|||
162088839|NCT01559311|585376385|FG002|Overall Study|Death|3|||
162088840|NCT01559311|585376383|FG000|Overall Study|Lost to Follow-up|0|||
162088841|NCT01559311|585376384|FG001|Overall Study|Lost to Follow-up|3|||
162088842|NCT01559311|585376385|FG002|Overall Study|Lost to Follow-up|2|||
162088843|NCT01559311|585376383|FG000|Overall Study|Adverse Event|0|||
162088844|NCT01559311|585376384|FG001|Overall Study|Adverse Event|0|||
162088845|NCT01559311|585376385|FG002|Overall Study|Adverse Event|1|||
162088846|NCT03027466|585376386|FG000|Overall Study|Opting out of the app|1869|||
162088847|NCT03027466|585376387|FG001|Overall Study|Opting out of the app|1819|||
162088848|NCT03027466|585376388|FG002|Overall Study|Opting out of the app|1743|||
162088849|NCT03027466|585376389|FG003|Overall Study|Opting out of the app|1821|||
162088850|NCT03286140|585376390|FG000|Overall Study|Withdrawal by Subject|10|||
162088851|NCT03286140|585376391|FG001|Overall Study|Withdrawal by Subject|5|||
162088852|NCT03286140|585376390|FG000|Overall Study|Lost to Follow-up|5|||
162088853|NCT03286140|585376391|FG001|Overall Study|Lost to Follow-up|10|||
162088854|NCT03286140|585376390|FG000|Overall Study|Failure to comply|0|||
162088855|NCT03286140|585376391|FG001|Overall Study|Failure to comply|1|||
162088856|NCT01826825|585376392|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
162088857|NCT01826825|585376393|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
162088858|NCT01858194|585376394|FG000|Overall Study|Total Artificial Heart Implant|0|||
162088859|NCT01858194|585376395|FG001|Overall Study|Total Artificial Heart Implant|1|||
162088860|NCT01858194|585376394|FG000|Overall Study|Lost to Follow-up|0|||
162088861|NCT01858194|585376395|FG001|Overall Study|Lost to Follow-up|1|||
162088862|NCT02158039|585376396|FG000|Overall Study|Withdrawal by Subject|1|||
162088863|NCT02158039|585376396|FG000|Overall Study|Screen Failure|9|||
162088864|NCT02563028|585376398|FG000|Overall Study|Lack of equipment|1|||
162088865|NCT02563028|585376398|FG000|Overall Study|Unable to elicit VEP post induction|1|||
162088866|NCT02188485|585376403|FG000|Overall Study|Withdrawal by Subject|2|||
162088867|NCT02188485|585376404|FG001|Overall Study|Withdrawal by Subject|1|||
162088868|NCT02188485|585376403|FG000|Overall Study|PI withdrew, lack of capacity|0|||
162088869|NCT02188485|585376404|FG001|Overall Study|PI withdrew, lack of capacity|2|||
162088870|NCT00799617|585376405|FG000|Main Testosterone Trial|Randomized in error|1|||
162088871|NCT00799617|585376406|FG001|Main Testosterone Trial|Randomized in error|1|||
162088872|NCT00799617|585376405|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
162088873|NCT00799617|585376406|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
162088874|NCT00799617|585376405|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
162088875|NCT00799617|585376406|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
162088876|NCT00799617|585376405|FG000|Sexual Funtion Trial|No Baseline Data|4|||
162088877|NCT00799617|585376406|FG001|Sexual Funtion Trial|No Baseline Data|7|||
162088878|NCT00799617|585376405|FG000|Physical Function Trial|Lost to Follow-up|6|||
162088879|NCT00799617|585376406|FG001|Physical Function Trial|Lost to Follow-up|11|||
162088880|NCT00799617|585376405|FG000|Vitality Trial|Lost to Follow-up|7|||
162088881|NCT00799617|585376406|FG001|Vitality Trial|Lost to Follow-up|22|||
162088882|NCT00799617|585376405|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
162088883|NCT00799617|585376406|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
162088884|NCT00799617|585376405|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
162088885|NCT00799617|585376406|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
162088886|NCT00799617|585376405|FG000|Bone Trial|Month 12 scan not available|6|||
162088887|NCT00799617|585376406|FG001|Bone Trial|Month 12 scan not available|16|||
162088888|NCT00799617|585376405|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
162088889|NCT00799617|585376406|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
162088890|NCT00799617|585376405|FG000|Anemia Trial|Withdrawal by Subject|3|||
162088891|NCT00799617|585376406|FG001|Anemia Trial|Withdrawal by Subject|3|||
162088892|NCT02052466|585376407|FG000|Overall Study|Withdrawal by Subject|1|||
162088893|NCT02052466|585376407|FG000|Overall Study|Acromial fracture|1|||
162088894|NCT03851016|585376409|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
162088895|NCT03851016|585376410|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
162088896|NCT01660412|585376418|FG000|Overall Study|Protocol Violation|0|||
162088897|NCT01660412|585376419|FG001|Overall Study|Protocol Violation|3|||
162088898|NCT02293005|585377924|FG000|Overall Study|Adverse Event|2|||
162088899|NCT02293005|585377924|FG000|Overall Study|Death|4|||
162088900|NCT02293005|585377924|FG000|Overall Study|Lost to Follow-up|1|||
162088901|NCT02293005|585377924|FG000|Overall Study|Withdrawal by Subject|2|||
162088902|NCT02293005|585377924|FG000|Overall Study|Progression|17|||
162088903|NCT00608829|585377925|FG000|Overall Study|Death|6|||
162088904|NCT00608829|585377925|FG000|Overall Study|Withdrawal by Subject|4|||
162088905|NCT00608829|585377925|FG000|Overall Study|Subject refuses to follow up or return.|5|||
162088906|NCT02766608|585377928|FG000|Overall Study|Adverse Event|27|||
162088907|NCT02766608|585377929|FG001|Overall Study|Adverse Event|22|||
162088908|NCT02766608|585377930|FG002|Overall Study|Adverse Event|17|||
162088909|NCT02766608|585377931|FG003|Overall Study|Adverse Event|13|||
162088910|NCT02766608|585377932|FG004|Overall Study|Adverse Event|12|||
162088911|NCT02766608|585377928|FG000|Overall Study|Withdrawal by Subject|21|||
162088912|NCT02766608|585377929|FG001|Overall Study|Withdrawal by Subject|20|||
162088913|NCT02766608|585377930|FG002|Overall Study|Withdrawal by Subject|24|||
162088914|NCT02766608|585377931|FG003|Overall Study|Withdrawal by Subject|13|||
162088915|NCT02766608|585377932|FG004|Overall Study|Withdrawal by Subject|10|||
162088916|NCT02766608|585377928|FG000|Overall Study|Lack of Efficacy|16|||
162088917|NCT02766608|585377929|FG001|Overall Study|Lack of Efficacy|15|||
162088918|NCT02766608|585377930|FG002|Overall Study|Lack of Efficacy|32|||
162088919|NCT02766608|585377931|FG003|Overall Study|Lack of Efficacy|8|||
162088920|NCT02766608|585377932|FG004|Overall Study|Lack of Efficacy|2|||
162088921|NCT02766608|585377928|FG000|Overall Study|Lost to Follow-up|6|||
162088922|NCT02766608|585377929|FG001|Overall Study|Lost to Follow-up|3|||
162088923|NCT02766608|585377930|FG002|Overall Study|Lost to Follow-up|5|||
162088924|NCT02766608|585377931|FG003|Overall Study|Lost to Follow-up|2|||
162088925|NCT02766608|585377932|FG004|Overall Study|Lost to Follow-up|2|||
162088926|NCT02766608|585377928|FG000|Overall Study|Physician Decision|3|||
162088927|NCT02766608|585377929|FG001|Overall Study|Physician Decision|2|||
162088928|NCT02766608|585377930|FG002|Overall Study|Physician Decision|3|||
162088929|NCT02766608|585377931|FG003|Overall Study|Physician Decision|1|||
162088930|NCT02766608|585377932|FG004|Overall Study|Physician Decision|2|||
162088931|NCT02766608|585377928|FG000|Overall Study|Protocol disc criteria|3|||
162088932|NCT02766608|585377929|FG001|Overall Study|Protocol disc criteria|3|||
162088933|NCT02766608|585377930|FG002|Overall Study|Protocol disc criteria|4|||
162088934|NCT02766608|585377931|FG003|Overall Study|Protocol disc criteria|0|||
162088935|NCT02766608|585377932|FG004|Overall Study|Protocol disc criteria|0|||
162088936|NCT02766608|585377928|FG000|Overall Study|Protocol Violation|0|||
162088937|NCT02766608|585377929|FG001|Overall Study|Protocol Violation|4|||
162088938|NCT02766608|585377930|FG002|Overall Study|Protocol Violation|4|||
162088939|NCT02766608|585377931|FG003|Overall Study|Protocol Violation|0|||
162088940|NCT02766608|585377932|FG004|Overall Study|Protocol Violation|1|||
162088941|NCT02766608|585377928|FG000|Overall Study|Administrative Reasons|3|||
162088942|NCT02766608|585377929|FG001|Overall Study|Administrative Reasons|1|||
162088943|NCT02766608|585377930|FG002|Overall Study|Administrative Reasons|1|||
162088944|NCT02766608|585377931|FG003|Overall Study|Administrative Reasons|0|||
162088945|NCT02766608|585377932|FG004|Overall Study|Administrative Reasons|0|||
162088946|NCT02080091|585377933|FG000|Overall Study|Study Terminated|22|||
162088947|NCT02080091|585377933|FG000|Overall Study|Death|1|||
162088948|NCT02080091|585377933|FG000|Overall Study|Withdrawal by Subject|1|||
162088949|NCT02080091|585377933|FG000|Overall Study|Other|1|||
162088950|NCT03019536|585377934|FG000|Overall Study|Withdrawal by Subject|1|||
162088951|NCT03019536|585377935|FG001|Overall Study|Withdrawal by Subject|1|||
162088952|NCT03019536|585377936|FG002|Overall Study|Withdrawal by Subject|0|||
162088953|NCT03019536|585377934|FG000|Overall Study|Adverse Event|0|||
162088954|NCT03019536|585377935|FG001|Overall Study|Adverse Event|0|||
162088955|NCT03019536|585377936|FG002|Overall Study|Adverse Event|2|||
162088956|NCT02648698|585377944|FG000|Overall Study|Protocol Violation|1|||
162088957|NCT02648698|585377945|FG001|Overall Study|Protocol Violation|5|||
162088958|NCT03143829|585377948|FG000|Overall Study|Withdrawal by Subject|2|||
162088959|NCT03143829|585377949|FG001|Overall Study|Withdrawal by Subject|5|||
162088960|NCT03143829|585377948|FG000|Overall Study|Lost to Follow-up|0|||
162088961|NCT03143829|585377949|FG001|Overall Study|Lost to Follow-up|2|||
162088962|NCT03143829|585377948|FG000|Overall Study|Death|1|||
162088963|NCT03143829|585377949|FG001|Overall Study|Death|1|||
162088964|NCT03143829|585377948|FG000|Overall Study|changed treatment, no longer eligible|2|||
162088965|NCT03143829|585377949|FG001|Overall Study|changed treatment, no longer eligible|2|||
162088966|NCT00672477|585377950|FG000|Overall Study|Adverse Event|10|||
162088967|NCT00672477|585377951|FG001|Overall Study|Adverse Event|7|||
162088968|NCT00672477|585377950|FG000|Overall Study|Death|7|||
162088969|NCT00672477|585377951|FG001|Overall Study|Death|11|||
162088970|NCT00672477|585377950|FG000|Overall Study|Physician Decision|2|||
162088971|NCT00672477|585377951|FG001|Overall Study|Physician Decision|0|||
162088972|NCT00672477|585377950|FG000|Overall Study|Protocol Violation|1|||
162088973|NCT00672477|585377951|FG001|Overall Study|Protocol Violation|1|||
162088974|NCT00672477|585377950|FG000|Overall Study|Withdrawal by Subject|5|||
162088975|NCT00672477|585377951|FG001|Overall Study|Withdrawal by Subject|3|||
162088976|NCT00672477|585377950|FG000|Overall Study|Lack of Efficacy|1|||
162088977|NCT00672477|585377951|FG001|Overall Study|Lack of Efficacy|1|||
162088978|NCT00672477|585377950|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
162088979|NCT00672477|585377951|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
162088980|NCT00938431|585377955|FG000|Overall Study|Adverse Event|5|||
162088981|NCT00938431|585377956|FG001|Overall Study|Adverse Event|8|||
162088982|NCT00938431|585377957|FG002|Overall Study|Adverse Event|6|||
162088983|NCT00938431|585377955|FG000|Overall Study|Lack of Efficacy|0|||
162088984|NCT00938431|585377956|FG001|Overall Study|Lack of Efficacy|1|||
162088985|NCT00938431|585377957|FG002|Overall Study|Lack of Efficacy|0|||
162088986|NCT00938431|585377955|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
162088987|NCT00938431|585377956|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
162088988|NCT00938431|585377957|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
162088989|NCT00938431|585377955|FG000|Overall Study|Dosing compliance issue|0|||
162088990|NCT00938431|585377956|FG001|Overall Study|Dosing compliance issue|0|||
162088991|NCT00938431|585377957|FG002|Overall Study|Dosing compliance issue|1|||
162088992|NCT00938431|585377955|FG000|Overall Study|Reached maximum dose early|0|||
162088993|NCT00938431|585377956|FG001|Overall Study|Reached maximum dose early|0|||
162088994|NCT00938431|585377957|FG002|Overall Study|Reached maximum dose early|1|||
162088995|NCT03738865|585377962|FG000|Overall Study|Withdrawal by Subject|3|||
162088996|NCT03738865|585377963|FG001|Overall Study|Withdrawal by Subject|3|||
162088997|NCT03738865|585377962|FG000|Overall Study|Adverse Event|2|||
162088998|NCT03738865|585377963|FG001|Overall Study|Adverse Event|0|||
162088999|NCT03738865|585377962|FG000|Overall Study|Physician Decision|0|||
162089000|NCT03738865|585377963|FG001|Overall Study|Physician Decision|1|||
162089001|NCT01175824|585377964|FG000|Overall Study|Adverse Event|2|||
162089002|NCT01175824|585377965|FG001|Overall Study|Adverse Event|1|||
162089003|NCT01175824|585377964|FG000|Overall Study|Lack of Efficacy|2|||
162089004|NCT01175824|585377965|FG001|Overall Study|Lack of Efficacy|0|||
162089005|NCT01175824|585377964|FG000|Overall Study|Lost to Follow-up|0|||
162089006|NCT01175824|585377965|FG001|Overall Study|Lost to Follow-up|1|||
162089007|NCT01175824|585377964|FG000|Overall Study|Physician Decision|0|||
162089008|NCT01175824|585377965|FG001|Overall Study|Physician Decision|4|||
162089009|NCT01175824|585377964|FG000|Overall Study|Protocol Violation|2|||
162089010|NCT01175824|585377965|FG001|Overall Study|Protocol Violation|5|||
162089011|NCT01175824|585377964|FG000|Overall Study|Withdrawal by Subject|3|||
162089012|NCT01175824|585377965|FG001|Overall Study|Withdrawal by Subject|7|||
162089013|NCT01175824|585377964|FG000|Overall Study|Sponsor Decision|1|||
162089014|NCT01175824|585377965|FG001|Overall Study|Sponsor Decision|0|||
162089015|NCT01175824|585377964|FG000|Overall Study|Entry Criteria Not Met|6|||
162089016|NCT01175824|585377965|FG001|Overall Study|Entry Criteria Not Met|4|||
162089017|NCT01774903|585377966|FG000|Overall Study|Adverse Event|7|||
162089018|NCT01774903|585377966|FG000|Overall Study|Withdrawal by Subject|2|||
162089019|NCT01774903|585377966|FG000|Overall Study|Lack of Efficacy|1|||
162089020|NCT01774903|585377966|FG000|Overall Study|Ineligible to continue the trial|1|||
162089021|NCT03455855|585377967|FG000|Overall Study|Lost to Follow-up|4|||
162089022|NCT03455855|585377968|FG001|Overall Study|Lost to Follow-up|2|||
162089023|NCT00924950|585377969|FG000|Overall Study|Lost to Follow-up|2|||
162089024|NCT01602315|585377970|FG000|Overall Study|Protocol Violation|0|||
162089025|NCT01602315|585377971|FG001|Overall Study|Protocol Violation|0|||
162089026|NCT01602315|585377972|FG002|Overall Study|Protocol Violation|0|||
162089027|NCT01602315|585377973|FG003|Overall Study|Protocol Violation|0|||
162089028|NCT01602315|585377974|FG004|Overall Study|Protocol Violation|0|||
162089029|NCT01602315|585377975|FG005|Overall Study|Protocol Violation|1|||
162089030|NCT01602315|585377976|FG006|Overall Study|Protocol Violation|0|||
162089031|NCT01602315|585377970|FG000|Overall Study|Physician Decision|2|||
162089032|NCT01602315|585377971|FG001|Overall Study|Physician Decision|0|||
162089033|NCT01602315|585377972|FG002|Overall Study|Physician Decision|0|||
162089034|NCT01602315|585377973|FG003|Overall Study|Physician Decision|0|||
162089035|NCT01602315|585377974|FG004|Overall Study|Physician Decision|2|||
162089036|NCT01602315|585377975|FG005|Overall Study|Physician Decision|1|||
162089037|NCT01602315|585377976|FG006|Overall Study|Physician Decision|1|||
162089038|NCT01602315|585377970|FG000|Overall Study|Disease progression|6|||
162089039|NCT01602315|585377971|FG001|Overall Study|Disease progression|3|||
162089040|NCT01602315|585377972|FG002|Overall Study|Disease progression|10|||
162089041|NCT01602315|585377973|FG003|Overall Study|Disease progression|1|||
162089042|NCT01602315|585377974|FG004|Overall Study|Disease progression|41|||
162089043|NCT01602315|585377975|FG005|Overall Study|Disease progression|12|||
162089044|NCT01602315|585377976|FG006|Overall Study|Disease progression|15|||
162089045|NCT01602315|585377970|FG000|Overall Study|Death|1|||
162089046|NCT01602315|585377971|FG001|Overall Study|Death|1|||
162089047|NCT01602315|585377972|FG002|Overall Study|Death|1|||
162089048|NCT01602315|585377973|FG003|Overall Study|Death|1|||
162089049|NCT01602315|585377974|FG004|Overall Study|Death|7|||
162089050|NCT01602315|585377975|FG005|Overall Study|Death|2|||
162089051|NCT01602315|585377976|FG006|Overall Study|Death|2|||
162089052|NCT01602315|585377970|FG000|Overall Study|Withdrawal by Subject|2|||
162089053|NCT01602315|585377971|FG001|Overall Study|Withdrawal by Subject|0|||
162089054|NCT01602315|585377972|FG002|Overall Study|Withdrawal by Subject|2|||
162089055|NCT01602315|585377973|FG003|Overall Study|Withdrawal by Subject|0|||
162089056|NCT01602315|585377974|FG004|Overall Study|Withdrawal by Subject|6|||
162089057|NCT01602315|585377975|FG005|Overall Study|Withdrawal by Subject|0|||
162089058|NCT01602315|585377976|FG006|Overall Study|Withdrawal by Subject|1|||
162089059|NCT01602315|585377970|FG000|Overall Study|Adverse Event|5|||
162089060|NCT01602315|585377971|FG001|Overall Study|Adverse Event|1|||
162089061|NCT01602315|585377972|FG002|Overall Study|Adverse Event|5|||
162089062|NCT01602315|585377973|FG003|Overall Study|Adverse Event|4|||
162089063|NCT01602315|585377974|FG004|Overall Study|Adverse Event|15|||
162089064|NCT01602315|585377975|FG005|Overall Study|Adverse Event|3|||
162089065|NCT01602315|585377976|FG006|Overall Study|Adverse Event|9|||
162089066|NCT01602315|585377970|FG000|Overall Study|Subject/guardian decision|0|||
162089067|NCT01602315|585377971|FG001|Overall Study|Subject/guardian decision|0|||
162089068|NCT01602315|585377972|FG002|Overall Study|Subject/guardian decision|0|||
162089069|NCT01602315|585377973|FG003|Overall Study|Subject/guardian decision|0|||
162089070|NCT01602315|585377974|FG004|Overall Study|Subject/guardian decision|0|||
162089071|NCT01602315|585377975|FG005|Overall Study|Subject/guardian decision|0|||
162089072|NCT01602315|585377976|FG006|Overall Study|Subject/guardian decision|1|||
162089073|NCT01602315|585377970|FG000|Overall Study|Cross-over patients to combo treatment|0|||
162089074|NCT01602315|585377971|FG001|Overall Study|Cross-over patients to combo treatment|0|||
162089075|NCT01602315|585377972|FG002|Overall Study|Cross-over patients to combo treatment|0|||
162089076|NCT01602315|585377973|FG003|Overall Study|Cross-over patients to combo treatment|0|||
162089077|NCT01602315|585377974|FG004|Overall Study|Cross-over patients to combo treatment|0|||
162089078|NCT01602315|585377975|FG005|Overall Study|Cross-over patients to combo treatment|16|||
162089079|NCT01602315|585377976|FG006|Overall Study|Cross-over patients to combo treatment|0|||
162089080|NCT02212730|585377979|FG000|Overall Study|Tumor not of the required cell histology|1|||
162089081|NCT02212730|585377980|FG001|Overall Study|Tumor not of the required cell histology|0|||
162089082|NCT02212730|585377979|FG000|Overall Study|Withdrawal by Subject|1|||
162089083|NCT02212730|585377980|FG001|Overall Study|Withdrawal by Subject|0|||
162089084|NCT02212730|585377979|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
162089085|NCT02212730|585377980|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
162089086|NCT00961259|585377981|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
162089087|NCT00961259|585377982|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
162089088|NCT00961259|585377983|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
162089089|NCT02691455|585377986|FG000|Overall Study|Withdrawal by Subject|1|||
162089090|NCT02691455|585377987|FG001|Overall Study|Withdrawal by Subject|2|||
162089091|NCT02691455|585377986|FG000|Overall Study|Lost to Follow-up|15|||
162089092|NCT02691455|585377987|FG001|Overall Study|Lost to Follow-up|15|||
162089093|NCT02057757|585377988|FG000|Overall Study|Withdrawal by Subject|3|||
162089094|NCT02057757|585377989|FG001|Overall Study|Withdrawal by Subject|5|||
162089095|NCT02057757|585377988|FG000|Overall Study|Death|2|||
162089096|NCT02057757|585377989|FG001|Overall Study|Death|0|||
162089097|NCT02057757|585377988|FG000|Overall Study|Lost to Follow-up|8|||
162089098|NCT02057757|585377989|FG001|Overall Study|Lost to Follow-up|3|||
162089099|NCT02057757|585377988|FG000|Overall Study|Non-compliance|1|||
162089100|NCT02057757|585377989|FG001|Overall Study|Non-compliance|0|||
162089101|NCT00440271|585377990|FG000|Overall Study|Protocol Violation|1|||
162089102|NCT00440271|585377991|FG001|Overall Study|Protocol Violation|1|||
162089103|NCT00440271|585377990|FG000|Overall Study|Adverse Event|0|||
162089104|NCT00440271|585377991|FG001|Overall Study|Adverse Event|1|||
162089105|NCT00440271|585377990|FG000|Overall Study|Lost to Follow-up|1|||
162089106|NCT00440271|585377991|FG001|Overall Study|Lost to Follow-up|0|||
162089107|NCT00440271|585377990|FG000|Overall Study|Withdrawal by Subject|0|||
162089108|NCT00440271|585377991|FG001|Overall Study|Withdrawal by Subject|2|||
162089109|NCT00440271|585377990|FG000|Overall Study|Lack of Efficacy|0|||
162089110|NCT00440271|585377991|FG001|Overall Study|Lack of Efficacy|1|||
162089111|NCT00440271|585377990|FG000|Overall Study|Due to closure of trial|8|||
162089112|NCT00440271|585377991|FG001|Overall Study|Due to closure of trial|10|||
162089113|NCT00440271|585377990|FG000|Overall Study|Other|2|||
162089114|NCT00440271|585377991|FG001|Overall Study|Other|0|||
162089115|NCT00048724|585377995|FG000|Overall Study|Adverse Event|53|||
162089116|NCT00048724|585377996|FG001|Overall Study|Adverse Event|12|||
162089117|NCT00048724|585377995|FG000|Overall Study|Withdrawal by Subject|34|||
162089118|NCT00048724|585377996|FG001|Overall Study|Withdrawal by Subject|54|||
162089119|NCT00048724|585377995|FG000|Overall Study|Lost to Follow-up|5|||
162089120|NCT00048724|585377996|FG001|Overall Study|Lost to Follow-up|5|||
162089121|NCT00048724|585377995|FG000|Overall Study|Protocol-defined Clinical Event|17|||
162089122|NCT00048724|585377996|FG001|Overall Study|Protocol-defined Clinical Event|32|||
162089123|NCT00048724|585377995|FG000|Overall Study|Noncompliance With Protocol|4|||
162089124|NCT00048724|585377996|FG001|Overall Study|Noncompliance With Protocol|12|||
162089125|NCT00048724|585377995|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
162089126|NCT00048724|585377996|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
162089127|NCT00048724|585377995|FG000|Overall Study|Administrative|1|||
162089128|NCT00048724|585377996|FG001|Overall Study|Administrative|1|||
162089129|NCT03586869|585377997|FG000|Overall Study|Progressive Disease|3|||
162089130|NCT00226941|585377998|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
162089131|NCT00226941|585377999|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
162089132|NCT00226941|585378000|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
162089133|NCT00226941|585378001|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
162089134|NCT00226941|585377998|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
162089135|NCT00226941|585377999|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
162089136|NCT00226941|585378000|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
162089137|NCT00226941|585378001|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
162089138|NCT02732847|585378002|FG000|Overall Study|some filled early|42|||
162089139|NCT02732847|585378003|FG001|Overall Study|some filled early|42|||
162089140|NCT01163682|585378005|FG000|Overall Study|Lost to Follow-up|6|||
162089141|NCT01163682|585378006|FG001|Overall Study|Lost to Follow-up|9|||
162089142|NCT00724451|585378007|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
162089143|NCT00724451|585378007|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
162089144|NCT00724451|585378007|FG000|Overall Study|Not Eligible for Treatment|431|||
162089145|NCT00724451|585378007|FG000|Overall Study|Participant Refused Treatment|89|||
162089146|NCT00724451|585378007|FG000|Overall Study|Never Started Treatment|89|||
162089147|NCT00724451|585378007|FG000|Overall Study|Unknown; No Data Sources Available|9|||
162089148|NCT00724451|585378007|FG000|Overall Study|Physician Decision|116|||
162089149|NCT00724451|585378007|FG000|Overall Study|Withdrawal by Subject|45|||
162089150|NCT00724451|585378007|FG000|Overall Study|Investigator + Participant Decision|13|||
162089151|NCT00414050|585378009|FG000|Overall Study|Adverse Event|1|||
162089152|NCT00414050|585378010|FG001|Overall Study|Adverse Event|1|||
162089153|NCT00414050|585378011|FG002|Overall Study|Adverse Event|1|||
162089154|NCT00414050|585378012|FG003|Overall Study|Adverse Event|1|||
162089155|NCT00414050|585378009|FG000|Overall Study|Lost to Follow-up|2|||
162089156|NCT00414050|585378010|FG001|Overall Study|Lost to Follow-up|2|||
162089157|NCT00414050|585378011|FG002|Overall Study|Lost to Follow-up|1|||
162089158|NCT00414050|585378012|FG003|Overall Study|Lost to Follow-up|1|||
162089159|NCT00414050|585378009|FG000|Overall Study|Withdrawal by Subject|5|||
162089160|NCT00414050|585378010|FG001|Overall Study|Withdrawal by Subject|3|||
162089161|NCT00414050|585378011|FG002|Overall Study|Withdrawal by Subject|2|||
162089162|NCT00414050|585378012|FG003|Overall Study|Withdrawal by Subject|4|||
162089163|NCT00414050|585378009|FG000|Overall Study|Subject discontinued for other reason|1|||
162089164|NCT00414050|585378010|FG001|Overall Study|Subject discontinued for other reason|2|||
162089165|NCT00414050|585378011|FG002|Overall Study|Subject discontinued for other reason|2|||
162089166|NCT00414050|585378012|FG003|Overall Study|Subject discontinued for other reason|1|||
162089167|NCT00414050|585378009|FG000|Overall Study|Subject Moved|0|||
162089168|NCT00414050|585378010|FG001|Overall Study|Subject Moved|0|||
162089169|NCT00414050|585378011|FG002|Overall Study|Subject Moved|0|||
162089170|NCT00414050|585378012|FG003|Overall Study|Subject Moved|1|||
162089171|NCT02550652|585378021|FG000|Overall Study|Death|1|||
162089172|NCT02550652|585378022|FG001|Overall Study|Death|4|||
162089173|NCT02550652|585378021|FG000|Overall Study|Lack of Efficacy|1|||
162089174|NCT02550652|585378022|FG001|Overall Study|Lack of Efficacy|0|||
162089175|NCT02550652|585378021|FG000|Overall Study|Withdrawal by Subject|4|||
162089176|NCT02550652|585378022|FG001|Overall Study|Withdrawal by Subject|7|||
162089177|NCT02550652|585378021|FG000|Overall Study|Post Trial Access|1|||
162089178|NCT02550652|585378022|FG001|Overall Study|Post Trial Access|0|||
162089179|NCT02550652|585378021|FG000|Overall Study|Lost to Follow-up|1|||
162089180|NCT02550652|585378022|FG001|Overall Study|Lost to Follow-up|3|||
162089181|NCT02550652|585378021|FG000|Overall Study|Physician Decision|0|||
162089182|NCT02550652|585378022|FG001|Overall Study|Physician Decision|2|||
162089183|NCT02550652|585378021|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
162089184|NCT02550652|585378022|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
162089185|NCT01706250|585378023|FG000|Overall Study|Lost to Follow-up|2|||
162089186|NCT00515827|585378039|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
162089187|NCT00515827|585378040|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
162089188|NCT00515827|585378039|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
162089189|NCT00515827|585378040|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
162089190|NCT03254134|585378042|FG000|Overall Study|Not eligible patients|599|||
162089191|NCT03254134|585378043|FG001|Overall Study|Not eligible patients|3630|||
162089192|NCT00205712|585378044|FG000|Overall Study|Lost to Follow-up|0|||
162089193|NCT00205712|585378045|FG001|Overall Study|Lost to Follow-up|1|||
162089194|NCT01009099|585378046|FG000|Overall Study|Lost to Follow-up|1|||
162089195|NCT01009099|585378047|FG001|Overall Study|Lost to Follow-up|0|||
162089196|NCT01009099|585378046|FG000|Overall Study|Physician Decision|3|||
162089197|NCT01009099|585378047|FG001|Overall Study|Physician Decision|2|||
162089198|NCT01009099|585378046|FG000|Overall Study|Withdrawal by Subject|1|||
162089199|NCT01009099|585378047|FG001|Overall Study|Withdrawal by Subject|1|||
162089200|NCT01009099|585378046|FG000|Overall Study|Death|0|||
162089201|NCT01009099|585378047|FG001|Overall Study|Death|1|||
162089202|NCT01712984|585378048|FG000|Overall Study|Adverse Event|0|||
162089203|NCT01712984|585378049|FG001|Overall Study|Adverse Event|0|||
162089204|NCT01712984|585378050|FG002|Overall Study|Adverse Event|1|||
162089205|NCT01712984|585378048|FG000|Overall Study|Protocol Violation|2|||
162089206|NCT01712984|585378049|FG001|Overall Study|Protocol Violation|0|||
162089207|NCT01712984|585378050|FG002|Overall Study|Protocol Violation|1|||
162089208|NCT01712984|585378048|FG000|Overall Study|Lost to Follow-up|8|||
162089209|NCT01712984|585378049|FG001|Overall Study|Lost to Follow-up|10|||
162089210|NCT01712984|585378050|FG002|Overall Study|Lost to Follow-up|1|||
162089211|NCT01712984|585378048|FG000|Overall Study|Withdrawal by Subject|6|||
162089212|NCT01712984|585378049|FG001|Overall Study|Withdrawal by Subject|6|||
162089213|NCT01712984|585378050|FG002|Overall Study|Withdrawal by Subject|7|||
162089214|NCT00096044|585378053|FG000|Overall Study|Withdrawal by Subject|9|||
162089215|NCT00096044|585378053|FG000|Overall Study|Adverse Event|21|||
162089216|NCT00096044|585378053|FG000|Overall Study|Disease Progression|4|||
162089217|NCT03149237|585378054|FG000|Overall Study|Withdrawal by Subject|4|||
162089218|NCT03149237|585378055|FG001|Overall Study|Withdrawal by Subject|5|||
162089219|NCT02442830|585378056|FG000|Overall Study|Technical Failure|0|||
162089220|NCT02442830|585378057|FG001|Overall Study|Technical Failure|1|||
162089221|NCT04587193|585378058|FG000|Overall Study|Screen failure after consent|3|||
162089222|NCT04587193|585378059|FG001|Overall Study|Screen failure after consent|0|||
162089223|NCT04587193|585378058|FG000|Overall Study|Device broke during study|3|||
162089224|NCT04587193|585378059|FG001|Overall Study|Device broke during study|2|||
162089225|NCT00508742|585378060|FG000|Period 1: Infant Series|Adverse Event|5|||
162089226|NCT00508742|585378061|FG001|Period 1: Infant Series|Adverse Event|4|||
162089227|NCT00508742|585378060|FG000|Period 1: Infant Series|Protocol Violation|1|||
162089228|NCT00508742|585378061|FG001|Period 1: Infant Series|Protocol Violation|0|||
162089229|NCT00508742|585378060|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
162089230|NCT00508742|585378061|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
162089231|NCT00508742|585378060|FG000|Period 1: Infant Series|Physician Decision|1|||
162089232|NCT00508742|585378061|FG001|Period 1: Infant Series|Physician Decision|0|||
162089233|NCT00508742|585378060|FG000|Period 1: Infant Series|Other|4|||
162089234|NCT00508742|585378061|FG001|Period 1: Infant Series|Other|1|||
162089235|NCT00508742|585378060|FG000|Period 2: After Infant Series|Adverse Event|2|||
162089236|NCT00508742|585378061|FG001|Period 2: After Infant Series|Adverse Event|6|||
162089237|NCT00508742|585378060|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
162089238|NCT00508742|585378061|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
162089239|NCT00508742|585378060|FG000|Period 2: After Infant Series|Protocol Violation|1|||
162089240|NCT00508742|585378061|FG001|Period 2: After Infant Series|Protocol Violation|0|||
162089241|NCT00508742|585378060|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
162089242|NCT00508742|585378061|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
162089243|NCT00508742|585378060|FG000|Period 2: After Infant Series|Failed to Return|1|||
162089244|NCT00508742|585378061|FG001|Period 2: After Infant Series|Failed to Return|0|||
162089245|NCT00508742|585378060|FG000|Period 2: After Infant Series|Other|2|||
162089246|NCT00508742|585378061|FG001|Period 2: After Infant Series|Other|1|||
162089247|NCT00508742|585378060|FG000|Period 3: Toddler Dose|Adverse Event|1|||
162089248|NCT00508742|585378061|FG001|Period 3: Toddler Dose|Adverse Event|0|||
162089249|NCT00508742|585378060|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
162089250|NCT00508742|585378061|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
162089251|NCT00508742|585378060|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
162089252|NCT00508742|585378061|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
162089253|NCT00508742|585378060|FG000|Period 3: Toddler Dose|Other|5|||
162089254|NCT00508742|585378061|FG001|Period 3: Toddler Dose|Other|4|||
162089255|NCT02501096|585378062|FG000|Overall Study|Lost to Follow-up|0|||
162089256|NCT02501096|585378063|FG001|Overall Study|Lost to Follow-up|0|||
162089257|NCT02501096|585378064|FG002|Overall Study|Lost to Follow-up|0|||
162089258|NCT02501096|585378065|FG003|Overall Study|Lost to Follow-up|0|||
162089259|NCT02501096|585378066|FG004|Overall Study|Lost to Follow-up|1|||
162089260|NCT02501096|585378067|FG005|Overall Study|Lost to Follow-up|1|||
162089261|NCT02501096|585378068|FG006|Overall Study|Lost to Follow-up|3|||
162089262|NCT02501096|585378069|FG007|Overall Study|Lost to Follow-up|0|||
162089263|NCT02501096|585378070|FG008|Overall Study|Lost to Follow-up|0|||
162089264|NCT02501096|585378062|FG000|Overall Study|Withdrawal by Subject|1|||
162089265|NCT02501096|585378063|FG001|Overall Study|Withdrawal by Subject|0|||
162089266|NCT02501096|585378064|FG002|Overall Study|Withdrawal by Subject|7|||
162089267|NCT02501096|585378065|FG003|Overall Study|Withdrawal by Subject|13|||
162089268|NCT02501096|585378066|FG004|Overall Study|Withdrawal by Subject|2|||
162089269|NCT02501096|585378067|FG005|Overall Study|Withdrawal by Subject|2|||
162089270|NCT02501096|585378068|FG006|Overall Study|Withdrawal by Subject|2|||
162089271|NCT02501096|585378069|FG007|Overall Study|Withdrawal by Subject|3|||
162089272|NCT02501096|585378070|FG008|Overall Study|Withdrawal by Subject|0|||
162089273|NCT02501096|585378062|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
162089274|NCT02501096|585378063|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
162089275|NCT02501096|585378064|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
162089276|NCT02501096|585378065|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
162089277|NCT02501096|585378066|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
162089278|NCT02501096|585378067|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
162089279|NCT02501096|585378068|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
162089280|NCT02501096|585378069|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
162089281|NCT02501096|585378070|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
162089282|NCT02501096|585378062|FG000|Overall Study|Death|1|||
162089283|NCT02501096|585378063|FG001|Overall Study|Death|1|||
162089284|NCT02501096|585378064|FG002|Overall Study|Death|88|||
162089285|NCT02501096|585378065|FG003|Overall Study|Death|74|||
162089286|NCT02501096|585378066|FG004|Overall Study|Death|15|||
162089287|NCT02501096|585378067|FG005|Overall Study|Death|16|||
162089288|NCT02501096|585378068|FG006|Overall Study|Death|15|||
162089289|NCT02501096|585378069|FG007|Overall Study|Death|16|||
162089290|NCT02501096|585378070|FG008|Overall Study|Death|1|||
162089291|NCT00437034|585378071|FG000|Overall Study|Adverse Event|1|||
162089292|NCT00437034|585378071|FG000|Overall Study|Disease progression during treatment|5|||
162089293|NCT00595582|585378072|FG000|Overall Study|Pilot study that PI terminated|2|||
162089294|NCT00595582|585378072|FG000|Overall Study|Lost to Follow-up|1|||
162089295|NCT00595582|585378072|FG000|Overall Study|Adverse Event|2|||
162089296|NCT00595582|585378072|FG000|Overall Study|Physician Decision|5|||
162089297|NCT03878134|585378073|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
162089298|NCT00586469|585378074|FG000|Overall Study|Adverse Event|0|||
162089299|NCT00586469|585378075|FG001|Overall Study|Adverse Event|1|||
162089300|NCT04055116|585378076|FG000|First Intervention|Physician Decision|2|||
162089301|NCT04055116|585378077|FG001|First Intervention|Physician Decision|7|||
162089302|NCT04258839|585379379|FG000|Overall Study|Adverse Event|2|||
162089303|NCT04258839|585379380|FG001|Overall Study|Adverse Event|4|||
162089304|NCT04258839|585379379|FG000|Overall Study|Lack of Efficacy|0|||
162089305|NCT04258839|585379380|FG001|Overall Study|Lack of Efficacy|2|||
162089306|NCT04258839|585379379|FG000|Overall Study|Lost to Follow-up|2|||
162089307|NCT04258839|585379380|FG001|Overall Study|Lost to Follow-up|0|||
162089308|NCT04258839|585379379|FG000|Overall Study|Withdrawal by Subject|1|||
162089309|NCT04258839|585379380|FG001|Overall Study|Withdrawal by Subject|2|||
162089310|NCT04258839|585379379|FG000|Overall Study|Withdrawal by Caregiver|5|||
162089311|NCT04258839|585379380|FG001|Overall Study|Withdrawal by Caregiver|6|||
162089312|NCT04258839|585379379|FG000|Overall Study|Reason not Specified|0|||
162089313|NCT04258839|585379380|FG001|Overall Study|Reason not Specified|1|||
162089314|NCT03328897|585379381|FG000|Randomized-treatment Epoch|Adverse Event|4|||
162089315|NCT03328897|585379382|FG001|Randomized-treatment Epoch|Adverse Event|1|||
162089316|NCT03328897|585379383|FG002|Randomized-treatment Epoch|Adverse Event|1|||
162089317|NCT03328897|585379381|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
162089318|NCT03328897|585379382|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
162089319|NCT03328897|585379383|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
162089320|NCT03328897|585379381|FG000|Randomized-treatment Epoch|Pregnancy|3|||
162089321|NCT03328897|585379382|FG001|Randomized-treatment Epoch|Pregnancy|0|||
162089322|NCT03328897|585379383|FG002|Randomized-treatment Epoch|Pregnancy|0|||
162089323|NCT03328897|585379381|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
162089324|NCT03328897|585379382|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
162089325|NCT03328897|585379383|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
162089326|NCT03328897|585379381|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
162089327|NCT03328897|585379382|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
162089328|NCT03328897|585379383|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
162089329|NCT03328897|585379381|FG000|Follow-up Epoch|Adverse Event|4|||
162089330|NCT03328897|585379382|FG001|Follow-up Epoch|Adverse Event|0|||
162089331|NCT03328897|585379383|FG002|Follow-up Epoch|Adverse Event|1|||
162089332|NCT03328897|585379381|FG000|Follow-up Epoch|Lack of Efficacy|1|||
162089333|NCT03328897|585379382|FG001|Follow-up Epoch|Lack of Efficacy|1|||
162089334|NCT03328897|585379383|FG002|Follow-up Epoch|Lack of Efficacy|1|||
162089335|NCT03328897|585379381|FG000|Follow-up Epoch|Lost to Follow-up|0|||
162089336|NCT03328897|585379382|FG001|Follow-up Epoch|Lost to Follow-up|1|||
162089337|NCT03328897|585379383|FG002|Follow-up Epoch|Lost to Follow-up|0|||
162089338|NCT03328897|585379381|FG000|Follow-up Epoch|Pregnancy|1|||
162089339|NCT03328897|585379382|FG001|Follow-up Epoch|Pregnancy|0|||
162089340|NCT03328897|585379383|FG002|Follow-up Epoch|Pregnancy|0|||
162089341|NCT03328897|585379381|FG000|Follow-up Epoch|Patient/guardian decision|2|||
162089342|NCT03328897|585379382|FG001|Follow-up Epoch|Patient/guardian decision|1|||
162089343|NCT03328897|585379383|FG002|Follow-up Epoch|Patient/guardian decision|0|||
162089344|NCT00317772|585379385|FG000|Overall Study|Adverse Event|0|||
162089345|NCT00317772|585379386|FG001|Overall Study|Adverse Event|0|||
162089346|NCT00317772|585379387|FG002|Overall Study|Adverse Event|0|||
162089347|NCT00317772|585379388|FG003|Overall Study|Adverse Event|2|||
162089348|NCT00317772|585379385|FG000|Overall Study|Disease Progression|2|||
162089349|NCT00317772|585379386|FG001|Overall Study|Disease Progression|2|||
162089350|NCT00317772|585379387|FG002|Overall Study|Disease Progression|1|||
162089351|NCT00317772|585379388|FG003|Overall Study|Disease Progression|7|||
162089352|NCT00966940|585379389|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
162089353|NCT00966940|585379390|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
162089354|NCT00966940|585379389|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
162089355|NCT00966940|585379390|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
162089356|NCT01040871|585379393|FG000|Overall Study|Adverse Event|6|||
162089357|NCT01040871|585379394|FG001|Overall Study|Adverse Event|2|||
162089358|NCT01040871|585379393|FG000|Overall Study|Withdrawal by Subject|2|||
162089359|NCT01040871|585379394|FG001|Overall Study|Withdrawal by Subject|0|||
162089360|NCT01040871|585379393|FG000|Overall Study|Death|1|||
162089361|NCT01040871|585379394|FG001|Overall Study|Death|3|||
162089362|NCT01040871|585379393|FG000|Overall Study|Lack of Efficacy|1|||
162089363|NCT01040871|585379394|FG001|Overall Study|Lack of Efficacy|1|||
162089364|NCT01040871|585379393|FG000|Overall Study|drug supply issue|1|||
162089365|NCT01040871|585379394|FG001|Overall Study|drug supply issue|0|||
162089366|NCT01040871|585379393|FG000|Overall Study|Randomized and Not Treated|2|||
162089367|NCT01040871|585379394|FG001|Overall Study|Randomized and Not Treated|1|||
162089368|NCT02886572|585379395|FG000|Overall Study|Death|8|||
162089369|NCT03087591|585379396|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
162089370|NCT03087591|585379396|FG000|Overall Study|Withdrawal by Subject|1|||
162089371|NCT02621606|585379397|FG000|Overall Study|Withdrawal by Subject|0|||
162089372|NCT02621606|585379398|FG001|Overall Study|Withdrawal by Subject|1|||
162089373|NCT02621606|585379399|FG002|Overall Study|Withdrawal by Subject|0|||
162089374|NCT00982319|585379400|FG000|Overall Study|Surgery date change|1|||
162089375|NCT00982319|585379401|FG001|Overall Study|Surgery date change|0|||
162089376|NCT00982319|585379400|FG000|Overall Study|Preop values out of acceptable range|1|||
162089377|NCT00982319|585379401|FG001|Overall Study|Preop values out of acceptable range|1|||
162089378|NCT00982319|585379400|FG000|Overall Study|Pregnancy|0|||
162089379|NCT00982319|585379401|FG001|Overall Study|Pregnancy|1|||
162089380|NCT00767000|585379402|FG000|54-week Study|Adverse Event|4|||
162089381|NCT00767000|585379403|FG001|54-week Study|Adverse Event|6|||
162089382|NCT00767000|585379404|FG002|54-week Study|Adverse Event|6|||
162089383|NCT00767000|585379405|FG003|54-week Study|Adverse Event|8|||
162089384|NCT00767000|585379406|FG004|54-week Study|Adverse Event|4|||
162089385|NCT00767000|585379402|FG000|54-week Study|Creaninine/creatinine clearance|2|||
162089386|NCT00767000|585379403|FG001|54-week Study|Creaninine/creatinine clearance|1|||
162089387|NCT00767000|585379404|FG002|54-week Study|Creaninine/creatinine clearance|2|||
162089388|NCT00767000|585379405|FG003|54-week Study|Creaninine/creatinine clearance|2|||
162089389|NCT00767000|585379406|FG004|54-week Study|Creaninine/creatinine clearance|4|||
162089390|NCT00767000|585379402|FG000|54-week Study|Hyperglycemia|0|||
162089391|NCT00767000|585379403|FG001|54-week Study|Hyperglycemia|0|||
162089392|NCT00767000|585379404|FG002|54-week Study|Hyperglycemia|1|||
162089393|NCT00767000|585379405|FG003|54-week Study|Hyperglycemia|0|||
162089394|NCT00767000|585379406|FG004|54-week Study|Hyperglycemia|1|||
162089395|NCT00767000|585379402|FG000|54-week Study|Hypoglycemia|0|||
162089396|NCT00767000|585379403|FG001|54-week Study|Hypoglycemia|1|||
162089397|NCT00767000|585379404|FG002|54-week Study|Hypoglycemia|0|||
162089398|NCT00767000|585379405|FG003|54-week Study|Hypoglycemia|0|||
162089399|NCT00767000|585379406|FG004|54-week Study|Hypoglycemia|0|||
162089400|NCT00767000|585379402|FG000|54-week Study|Interruption of study medication|0|||
162089401|NCT00767000|585379403|FG001|54-week Study|Interruption of study medication|0|||
162089402|NCT00767000|585379404|FG002|54-week Study|Interruption of study medication|1|||
162089403|NCT00767000|585379405|FG003|54-week Study|Interruption of study medication|0|||
162089404|NCT00767000|585379406|FG004|54-week Study|Interruption of study medication|0|||
162089405|NCT00767000|585379402|FG000|54-week Study|Lack of Efficacy|2|||
162089406|NCT00767000|585379403|FG001|54-week Study|Lack of Efficacy|0|||
162089407|NCT00767000|585379404|FG002|54-week Study|Lack of Efficacy|1|||
162089408|NCT00767000|585379405|FG003|54-week Study|Lack of Efficacy|0|||
162089409|NCT00767000|585379406|FG004|54-week Study|Lack of Efficacy|5|||
162089410|NCT00767000|585379402|FG000|54-week Study|Lost to Follow-up|4|||
162089411|NCT00767000|585379403|FG001|54-week Study|Lost to Follow-up|0|||
162089412|NCT00767000|585379404|FG002|54-week Study|Lost to Follow-up|1|||
162089413|NCT00767000|585379405|FG003|54-week Study|Lost to Follow-up|4|||
162089414|NCT00767000|585379406|FG004|54-week Study|Lost to Follow-up|2|||
162089415|NCT00767000|585379402|FG000|54-week Study|Physician Decision|4|||
162089416|NCT00767000|585379403|FG001|54-week Study|Physician Decision|0|||
162089417|NCT00767000|585379404|FG002|54-week Study|Physician Decision|1|||
162089418|NCT00767000|585379405|FG003|54-week Study|Physician Decision|1|||
162089419|NCT00767000|585379406|FG004|54-week Study|Physician Decision|1|||
162089420|NCT00767000|585379402|FG000|54-week Study|Progressive disease|0|||
162089421|NCT00767000|585379403|FG001|54-week Study|Progressive disease|0|||
162089422|NCT00767000|585379404|FG002|54-week Study|Progressive disease|1|||
162089423|NCT00767000|585379405|FG003|54-week Study|Progressive disease|0|||
162089424|NCT00767000|585379406|FG004|54-week Study|Progressive disease|0|||
162089425|NCT00767000|585379402|FG000|54-week Study|Protocol Violation|0|||
162089426|NCT00767000|585379403|FG001|54-week Study|Protocol Violation|0|||
162089427|NCT00767000|585379404|FG002|54-week Study|Protocol Violation|1|||
162089428|NCT00767000|585379405|FG003|54-week Study|Protocol Violation|2|||
162089429|NCT00767000|585379406|FG004|54-week Study|Protocol Violation|0|||
162089430|NCT00767000|585379402|FG000|54-week Study|Withdrawal by Subject|2|||
162089431|NCT00767000|585379403|FG001|54-week Study|Withdrawal by Subject|3|||
162089432|NCT00767000|585379404|FG002|54-week Study|Withdrawal by Subject|5|||
162089433|NCT00767000|585379405|FG003|54-week Study|Withdrawal by Subject|11|||
162089434|NCT00767000|585379406|FG004|54-week Study|Withdrawal by Subject|13|||
162089435|NCT00767000|585379402|FG000|54-week Study|Study terminated by sponsor|90|||
162089436|NCT00767000|585379403|FG001|54-week Study|Study terminated by sponsor|102|||
162089437|NCT00767000|585379404|FG002|54-week Study|Study terminated by sponsor|89|||
162089438|NCT00767000|585379405|FG003|54-week Study|Study terminated by sponsor|196|||
162089439|NCT00767000|585379406|FG004|54-week Study|Study terminated by sponsor|194|||
162089440|NCT00767000|585379402|FG000|54-week Study|Reason not reported|0|||
162089441|NCT00767000|585379403|FG001|54-week Study|Reason not reported|0|||
162089442|NCT00767000|585379404|FG002|54-week Study|Reason not reported|0|||
162089443|NCT00767000|585379405|FG003|54-week Study|Reason not reported|1|||
162089444|NCT00767000|585379406|FG004|54-week Study|Reason not reported|0|||
162089445|NCT00767000|585379402|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
162089446|NCT00767000|585379403|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
162089447|NCT00767000|585379404|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
162089448|NCT00767000|585379405|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
162089449|NCT00767000|585379406|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
162089450|NCT01252251|585379413|FG000|Overall Study|Withdrawal by Subject|1|||
162089451|NCT01324024|585379414|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
162089452|NCT01324024|585379415|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
162089453|NCT00097591|585379417|FG000|Overall Study|Withdrawal of consent|342|||
162089454|NCT00097591|585379418|FG001|Overall Study|Withdrawal of consent|323|||
162089455|NCT00097591|585379417|FG000|Overall Study|Less than 6 months on study drug|9|||
162089456|NCT00097591|585379418|FG001|Overall Study|Less than 6 months on study drug|7|||
162089457|NCT00097591|585379417|FG000|Overall Study|Unable to attend termination visit|53|||
162089458|NCT00097591|585379418|FG001|Overall Study|Unable to attend termination visit|51|||
162089459|NCT00097591|585379417|FG000|Overall Study|Lost to follow up|6|||
162089460|NCT00097591|585379418|FG001|Overall Study|Lost to follow up|10|||
162089461|NCT00097591|585379417|FG000|Overall Study|Other|0|||
162089462|NCT00097591|585379418|FG001|Overall Study|Other|3|||
162089463|NCT01743092|585379419|FG000|Overall Study|Lost to Follow-up|14|||
162089464|NCT01743092|585379420|FG001|Overall Study|Lost to Follow-up|15|||
162089465|NCT03603964|585379421|FG000|Overall Study|Death|9|||
162089466|NCT03603964|585379421|FG000|Overall Study|Withdrawal by participant|7|||
162089467|NCT03603964|585379421|FG000|Overall Study|Study terminated by Sponsor|19|||
162089468|NCT00563797|585379422|FG000|Overall Study|Lost to Follow-up|7|||
162089469|NCT00563797|585379423|FG001|Overall Study|Lost to Follow-up|2|||
162089470|NCT00009737|585379426|FG000|Overall Study|Adverse Event|112|||
162089471|NCT00009737|585379427|FG001|Overall Study|Adverse Event|75|||
162089472|NCT00009737|585379426|FG000|Overall Study|Death|4|||
162089473|NCT00009737|585379427|FG001|Overall Study|Death|6|||
162089474|NCT00009737|585379426|FG000|Overall Study|Lack of Efficacy|17|||
162089475|NCT00009737|585379427|FG001|Overall Study|Lack of Efficacy|15|||
162089476|NCT00009737|585379426|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
162089477|NCT00009737|585379427|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
162089478|NCT00009737|585379426|FG000|Overall Study|Other Protocol Violation|1|||
162089479|NCT00009737|585379427|FG001|Overall Study|Other Protocol Violation|0|||
162089480|NCT00009737|585379426|FG000|Overall Study|Refused Treatment|15|||
162089481|NCT00009737|585379427|FG001|Overall Study|Refused Treatment|16|||
162089482|NCT00009737|585379426|FG000|Overall Study|Lost to Follow-up|1|||
162089483|NCT00009737|585379427|FG001|Overall Study|Lost to Follow-up|1|||
162089484|NCT00009737|585379426|FG000|Overall Study|Administrative/Other Reasons|7|||
162089485|NCT00009737|585379427|FG001|Overall Study|Administrative/Other Reasons|1|||
162089486|NCT00530023|585379428|FG000|Overall Study|Withdrawal by Subject|0|||
162089487|NCT00530023|585379429|FG001|Overall Study|Withdrawal by Subject|1|||
162089488|NCT00003498|585379430|FG000|Overall Study|Not evaluable.|4|||
162089489|NCT01416805|585379440|FG000|Overall Study|Lost to Follow-up|4|||
162089490|NCT01416805|585379441|FG001|Overall Study|Lost to Follow-up|4|||
162089491|NCT02604589|585379448|FG000|Overall Study|catheter dislodgement|0|||
162089492|NCT02604589|585379449|FG001|Overall Study|catheter dislodgement|0|||
162089493|NCT02604589|585379450|FG002|Overall Study|catheter dislodgement|1|||
162089494|NCT01700946|585379456|FG000|Overall Study|Lost to Follow-up|1|||
162089495|NCT01700946|585379457|FG001|Overall Study|Lost to Follow-up|0|||
162089496|NCT01700946|585379456|FG000|Overall Study|Physician Decision|7|||
162089497|NCT01700946|585379457|FG001|Overall Study|Physician Decision|12|||
162089498|NCT01700946|585379456|FG000|Overall Study|Withdrawal by Subject|0|||
162089499|NCT01700946|585379457|FG001|Overall Study|Withdrawal by Subject|2|||
162089500|NCT01700946|585379456|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
162089501|NCT01700946|585379457|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
162089502|NCT01700946|585379456|FG000|Overall Study|Relapse|2|||
162089503|NCT01700946|585379457|FG001|Overall Study|Relapse|1|||
162089504|NCT01700946|585379456|FG000|Overall Study|Unacceptable toxicity|1|||
162089505|NCT01700946|585379457|FG001|Overall Study|Unacceptable toxicity|0|||
162089506|NCT04632940|585379461|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
162089507|NCT04632940|585379462|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
162089508|NCT04632940|585379461|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
162089509|NCT04632940|585379462|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
162089510|NCT04632940|585379461|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
162089511|NCT04632940|585379462|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
162089512|NCT04632940|585379461|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
162089513|NCT04632940|585379462|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
162089514|NCT04632940|585379461|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
162089515|NCT04632940|585379462|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
162089516|NCT04632940|585379461|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
162089517|NCT04632940|585379462|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
162089518|NCT04632940|585379461|FG000|OLE Period (52 Weeks)|Other than specified|0|||
162089519|NCT04632940|585379462|FG001|OLE Period (52 Weeks)|Other than specified|1|||
162089520|NCT04632940|585379461|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
162089521|NCT04632940|585379462|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
162089522|NCT00179647|585379466|FG000|Overall Study|Adverse Event|294|||
162089523|NCT00179647|585379466|FG000|Overall Study|Lack of Efficacy|478|||
162089524|NCT00179647|585379466|FG000|Overall Study|Withdrawal by Subject|83|||
162089525|NCT00179647|585379466|FG000|Overall Study|Lost to Follow-up|4|||
162089526|NCT00179647|585379466|FG000|Overall Study|Death|94|||
162089527|NCT00179647|585379466|FG000|Overall Study|Other|960|||
162089528|NCT00622635|585379467|FG000|Treatment Period 1|Adverse Event|0|||
162089529|NCT00622635|585379468|FG001|Treatment Period 1|Adverse Event|0|||
162089530|NCT00622635|585379469|FG002|Treatment Period 1|Adverse Event|1|||
162089531|NCT00622635|585379470|FG003|Treatment Period 1|Adverse Event|0|||
162089532|NCT00622635|585379471|FG004|Treatment Period 1|Adverse Event|0|||
162089533|NCT00622635|585379472|FG005|Treatment Period 1|Adverse Event|0|||
162089534|NCT00622635|585379467|FG000|Treatment Period 1|Withdrawal by Subject|0|||
162089535|NCT00622635|585379468|FG001|Treatment Period 1|Withdrawal by Subject|1|||
162089536|NCT00622635|585379469|FG002|Treatment Period 1|Withdrawal by Subject|0|||
162089537|NCT00622635|585379470|FG003|Treatment Period 1|Withdrawal by Subject|0|||
162089538|NCT00622635|585379471|FG004|Treatment Period 1|Withdrawal by Subject|0|||
162089539|NCT00622635|585379472|FG005|Treatment Period 1|Withdrawal by Subject|0|||
162089540|NCT00622635|585379467|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
162089541|NCT00622635|585379468|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
162089542|NCT00622635|585379469|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
162089543|NCT00622635|585379470|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
162089544|NCT00622635|585379471|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
162089545|NCT00622635|585379472|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
162089546|NCT00622635|585379467|FG000|Treatment Period 2|Adverse Event|1|||
162089547|NCT00622635|585379468|FG001|Treatment Period 2|Adverse Event|0|||
162089548|NCT00622635|585379469|FG002|Treatment Period 2|Adverse Event|0|||
162089549|NCT00622635|585379470|FG003|Treatment Period 2|Adverse Event|0|||
162089550|NCT00622635|585379471|FG004|Treatment Period 2|Adverse Event|0|||
162089551|NCT00622635|585379472|FG005|Treatment Period 2|Adverse Event|0|||
162089552|NCT00622635|585379467|FG000|Treatment Period 3|Adverse Event|0|||
162089553|NCT00622635|585379468|FG001|Treatment Period 3|Adverse Event|0|||
162089554|NCT00622635|585379469|FG002|Treatment Period 3|Adverse Event|0|||
162089555|NCT00622635|585379470|FG003|Treatment Period 3|Adverse Event|2|||
162089556|NCT00622635|585379471|FG004|Treatment Period 3|Adverse Event|0|||
162089557|NCT00622635|585379472|FG005|Treatment Period 3|Adverse Event|0|||
162089558|NCT00622635|585379467|FG000|Treatment Period 3|Withdrawal by Subject|0|||
162089559|NCT00622635|585379468|FG001|Treatment Period 3|Withdrawal by Subject|0|||
162089560|NCT00622635|585379469|FG002|Treatment Period 3|Withdrawal by Subject|0|||
162089561|NCT00622635|585379470|FG003|Treatment Period 3|Withdrawal by Subject|1|||
162089562|NCT00622635|585379471|FG004|Treatment Period 3|Withdrawal by Subject|0|||
162089563|NCT00622635|585379472|FG005|Treatment Period 3|Withdrawal by Subject|0|||
162089564|NCT05013905|585379475|FG000|Overall Study|Adverse Event|1|||
162089565|NCT05013905|585379475|FG000|Overall Study|Lack of Efficacy|1|||
162089566|NCT01849588|585379478|FG000|Overall Study|Lack of Efficacy|3|||
162089567|NCT02486406|585379486|FG000|Overall Study|Withdrew consent|1|||
162089568|NCT02486406|585379487|FG001|Overall Study|Withdrew consent|0|||
162089569|NCT02486406|585379488|FG002|Overall Study|Withdrew consent|0|||
162089570|NCT02486406|585379489|FG003|Overall Study|Withdrew consent|1|||
162089571|NCT02486406|585379486|FG000|Overall Study|Lost to Follow-up|1|||
162089572|NCT02486406|585379487|FG001|Overall Study|Lost to Follow-up|3|||
162089573|NCT02486406|585379488|FG002|Overall Study|Lost to Follow-up|1|||
162089574|NCT02486406|585379489|FG003|Overall Study|Lost to Follow-up|3|||
162089575|NCT02486406|585379486|FG000|Overall Study|Other, not specified|0|||
162089576|NCT02486406|585379487|FG001|Overall Study|Other, not specified|0|||
162089577|NCT02486406|585379488|FG002|Overall Study|Other, not specified|1|||
162089578|NCT02486406|585379489|FG003|Overall Study|Other, not specified|0|||
162089579|NCT03509948|585379501|FG000|Overall Study|Protocol Violation|0|||
162089580|NCT03509948|585379502|FG001|Overall Study|Protocol Violation|1|||
162089581|NCT01071512|585379513|FG000|Overall Study|Adverse Event|1|||
162089582|NCT01071512|585379513|FG000|Overall Study|Development of antibodies to drug|2|||
162089583|NCT01071512|585379513|FG000|Overall Study|positive anti-JC virus antibody test|2|||
162089584|NCT00183872|585379514|FG000|Overall Study|Death|3|||
162089585|NCT00183872|585379514|FG000|Overall Study|Adverse Event|9|||
162089586|NCT00183872|585379514|FG000|Overall Study|Withdrawal by Subject|2|||
162089587|NCT00183872|585379514|FG000|Overall Study|Drug delayed more than 28 days|2|||
162089588|NCT00853658|585379515|FG000|Overall Study|Death|713|||
162089589|NCT00853658|585379516|FG001|Overall Study|Death|768|||
162089590|NCT00853658|585379517|FG002|Overall Study|Death|753|||
162089591|NCT00853658|585379515|FG000|Overall Study|Lost to Follow-up|11|||
162089592|NCT00853658|585379516|FG001|Overall Study|Lost to Follow-up|6|||
162089593|NCT00853658|585379517|FG002|Overall Study|Lost to Follow-up|11|||
162089594|NCT00853658|585379515|FG000|Overall Study|H.A. Request|26|||
162089595|NCT00853658|585379516|FG001|Overall Study|H.A. Request|23|||
162089596|NCT00853658|585379517|FG002|Overall Study|H.A. Request|19|||
162089597|NCT00853658|585379515|FG000|Overall Study|IRB request|0|||
162089598|NCT00853658|585379516|FG001|Overall Study|IRB request|0|||
162089599|NCT00853658|585379517|FG002|Overall Study|IRB request|2|||
162089600|NCT00853658|585379515|FG000|Overall Study|Vital Status known (alive) at study end|2|||
162089601|NCT00853658|585379516|FG001|Overall Study|Vital Status known (alive) at study end|3|||
162089602|NCT00853658|585379517|FG002|Overall Study|Vital Status known (alive) at study end|3|||
162089603|NCT00853658|585379515|FG000|Overall Study|Vital Status unknown at study end|1|||
162089604|NCT00853658|585379516|FG001|Overall Study|Vital Status unknown at study end|1|||
162089605|NCT00853658|585379517|FG002|Overall Study|Vital Status unknown at study end|0|||
162089606|NCT00853658|585379515|FG000|Overall Study|Vital Status at study end N/A|8|||
162089607|NCT00853658|585379516|FG001|Overall Study|Vital Status at study end N/A|10|||
162089608|NCT00853658|585379517|FG002|Overall Study|Vital Status at study end N/A|10|||
162089609|NCT00853658|585379515|FG000|Overall Study|Patient's request|21|||
162089610|NCT00853658|585379516|FG001|Overall Study|Patient's request|17|||
162089611|NCT00853658|585379517|FG002|Overall Study|Patient's request|11|||
162089612|NCT00853658|585379515|FG000|Overall Study|Missing study completion information|5|||
162089613|NCT00853658|585379516|FG001|Overall Study|Missing study completion information|4|||
162089614|NCT00853658|585379517|FG002|Overall Study|Missing study completion information|6|||
162089615|NCT02797262|585379518|FG000|Overall Study|Withdrawal by Subject|5|||
162089616|NCT02797262|585379519|FG001|Overall Study|Withdrawal by Subject|1|||
162089617|NCT02797262|585379518|FG000|Overall Study|Lost to Follow-up|10|||
162089618|NCT02797262|585379519|FG001|Overall Study|Lost to Follow-up|7|||
162089619|NCT02797262|585379518|FG000|Overall Study|Death|1|||
162089620|NCT02797262|585379519|FG001|Overall Study|Death|2|||
162089621|NCT02797262|585379518|FG000|Overall Study|Adverse Event|1|||
162089622|NCT02797262|585379519|FG001|Overall Study|Adverse Event|0|||
162089623|NCT02797262|585379518|FG000|Overall Study|COVID-19|2|||
162089624|NCT02797262|585379519|FG001|Overall Study|COVID-19|1|||
162089625|NCT02797262|585379518|FG000|Overall Study|Out-of-country|1|||
162089626|NCT02797262|585379519|FG001|Overall Study|Out-of-country|0|||
162089627|NCT01600586|585379520|FG000|Overall Study|Physician Decision|3|||
162089628|NCT01600586|585379521|FG001|Overall Study|Physician Decision|3|||
162089629|NCT01227512|585379523|FG000|Overall Study|Physician Decision|6|||
162089630|NCT01227512|585379524|FG001|Overall Study|Physician Decision|6|||
162089631|NCT01227512|585379523|FG000|Overall Study|Adverse Event|4|||
162089632|NCT01227512|585379524|FG001|Overall Study|Adverse Event|3|||
162089633|NCT01227512|585379523|FG000|Overall Study|Withdrawal by Subject|3|||
162089634|NCT01227512|585379524|FG001|Overall Study|Withdrawal by Subject|0|||
162089635|NCT01227512|585379523|FG000|Overall Study|Participant met withdrawal criteria|0|||
162089636|NCT01227512|585379524|FG001|Overall Study|Participant met withdrawal criteria|1|||
162089637|NCT01978184|585379526|FG000|Overall Study|Progressive disease|5|||
162089638|NCT01978184|585379527|FG001|Overall Study|Progressive disease|5|||
162089639|NCT01978184|585379526|FG000|Overall Study|Other than PDA|2|||
162089640|NCT01978184|585379527|FG001|Overall Study|Other than PDA|2|||
162089641|NCT01978184|585379526|FG000|Overall Study|Physician Decision|0|||
162089642|NCT01978184|585379527|FG001|Overall Study|Physician Decision|3|||
162089643|NCT01978184|585379526|FG000|Overall Study|Noncompliance|1|||
162089644|NCT01978184|585379527|FG001|Overall Study|Noncompliance|2|||
162089645|NCT01978184|585379526|FG000|Overall Study|Death|1|||
162089646|NCT01978184|585379527|FG001|Overall Study|Death|0|||
162089647|NCT01978184|585379526|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
162089648|NCT01978184|585379527|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
162089649|NCT01069289|585379528|FG000|Overall Study|Withdrawal by Subject|15|||
162089650|NCT01069289|585379529|FG001|Overall Study|Withdrawal by Subject|26|||
162089651|NCT01069289|585379528|FG000|Overall Study|Adverse Event|21|||
162089652|NCT01069289|585379529|FG001|Overall Study|Adverse Event|28|||
162089653|NCT01069289|585379528|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
162089654|NCT01069289|585379529|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162089655|NCT01069289|585379528|FG000|Overall Study|Severe non-compliance to protocol|3|||
162089656|NCT01069289|585379529|FG001|Overall Study|Severe non-compliance to protocol|2|||
162089657|NCT01069289|585379528|FG000|Overall Study|Due to deteriorating health condition|1|||
162089658|NCT01069289|585379529|FG001|Overall Study|Due to deteriorating health condition|0|||
162089659|NCT02770391|585379530|FG000|Overall Study|Lost to Follow-up|2|||
162089660|NCT02770391|585379530|FG000|Overall Study|Withdrawal by Subject|1|||
162089661|NCT02770391|585379530|FG000|Overall Study|Surgery delayed unevaluable|2|||
162089662|NCT02770391|585379530|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
162089663|NCT01976845|585379533|FG000|Overall Study|Physician Decision|8|||
162089664|NCT01976845|585379534|FG001|Overall Study|Physician Decision|8|||
162089665|NCT01976845|585379535|FG002|Overall Study|Physician Decision|3|||
162089666|NCT01818336|585380843|FG000|Overall Study|Declined retest visit|0|||
162089667|NCT01818336|585380844|FG001|Overall Study|Declined retest visit|11|||
162089668|NCT01818336|585380843|FG000|Overall Study|Lost to Follow-up|0|||
162089669|NCT01818336|585380844|FG001|Overall Study|Lost to Follow-up|1|||
162089670|NCT03042312|585380847|FG000|Overall Study|Administrative Reason|1|||
162089671|NCT03042312|585380848|FG001|Overall Study|Administrative Reason|1|||
162089672|NCT03042312|585380847|FG000|Overall Study|Adverse Event|0|||
162089673|NCT03042312|585380848|FG001|Overall Study|Adverse Event|1|||
162089674|NCT03042312|585380847|FG000|Overall Study|Lost to Follow-up|1|||
162089675|NCT03042312|585380848|FG001|Overall Study|Lost to Follow-up|3|||
162089676|NCT03042312|585380847|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
162089677|NCT03042312|585380848|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
162089678|NCT03042312|585380847|FG000|Overall Study|Withdrawal by Subject|4|||
162089679|NCT03042312|585380848|FG001|Overall Study|Withdrawal by Subject|5|||
162089680|NCT03422003|585380858|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
162089681|NCT03422003|585380859|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
162089682|NCT03422003|585380858|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
162089683|NCT03422003|585380859|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
162089684|NCT01933334|585380861|FG000|Overall Study|Adverse Event|5|||
162089685|NCT01933334|585380862|FG001|Overall Study|Adverse Event|1|||
162089686|NCT01933334|585380861|FG000|Overall Study|Withdrawal by Subject|0|||
162089687|NCT01933334|585380862|FG001|Overall Study|Withdrawal by Subject|1|||
162089688|NCT00812812|585380870|FG000|Overall Study|Adverse Event|2|||
162089689|NCT00812812|585380871|FG001|Overall Study|Adverse Event|1|||
162089690|NCT00812812|585380870|FG000|Overall Study|Lack of Efficacy|1|||
162089691|NCT00812812|585380871|FG001|Overall Study|Lack of Efficacy|0|||
162089692|NCT00812812|585380870|FG000|Overall Study|Lost to Follow-up|0|||
162089693|NCT00812812|585380871|FG001|Overall Study|Lost to Follow-up|1|||
162089694|NCT00812812|585380870|FG000|Overall Study|Withdrawal by Subject|0|||
162089695|NCT00812812|585380871|FG001|Overall Study|Withdrawal by Subject|2|||
162089696|NCT02114892|585380872|FG000|Overall Study|Lost to Follow-up|1|||
162089697|NCT02114892|585380873|FG001|Overall Study|Lost to Follow-up|2|||
162089698|NCT02013765|585380874|FG000|Overall Study|Trial was terminated by sponsor|1|||
162089699|NCT02178475|585380880|FG000|Overall Study|Withdrawal by Subject|7|||
162089700|NCT02178475|585380880|FG000|Overall Study|Lost to Follow-up|10|||
162089701|NCT02178475|585380880|FG000|Overall Study|Death|13|||
162089702|NCT02178475|585380880|FG000|Overall Study|Protocol-specified Criteria|99|||
162089703|NCT00718042|585380881|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
162089704|NCT00718042|585380882|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
162089705|NCT00718042|585380883|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
162089706|NCT00718042|585380884|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
162089707|NCT00718042|585380885|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
162089708|NCT00718042|585380886|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
162089709|NCT00718042|585380881|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
162089710|NCT00718042|585380882|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
162089711|NCT00718042|585380883|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
162089712|NCT00718042|585380884|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
162089713|NCT00718042|585380885|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
162089714|NCT00718042|585380886|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
162089715|NCT00718042|585380881|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
162089716|NCT00718042|585380882|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
162089717|NCT00718042|585380883|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
162089718|NCT00718042|585380884|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
162089719|NCT00718042|585380885|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
162089720|NCT00718042|585380886|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
162089721|NCT00718042|585380881|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
162089722|NCT00718042|585380882|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
162089723|NCT00718042|585380883|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
162089724|NCT00718042|585380884|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
162089725|NCT00718042|585380885|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
162089726|NCT00718042|585380886|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
162089727|NCT00718042|585380881|FG000|Donor Follow-up|Lost to Follow-up|13|||
162089728|NCT00718042|585380882|FG001|Donor Follow-up|Lost to Follow-up|0|||
162089729|NCT00718042|585380883|FG002|Donor Follow-up|Lost to Follow-up|0|||
162089730|NCT00718042|585380884|FG003|Donor Follow-up|Lost to Follow-up|0|||
162089731|NCT00718042|585380885|FG004|Donor Follow-up|Lost to Follow-up|19|||
162089732|NCT00718042|585380886|FG005|Donor Follow-up|Lost to Follow-up|0|||
162089733|NCT04327934|585380887|FG000|Overall Study|Did not qualify|7|||
162089734|NCT04327934|585380888|FG001|Overall Study|Did not qualify|4|||
162089735|NCT04327934|585380887|FG000|Overall Study|Physician Decision|0|||
162089736|NCT04327934|585380888|FG001|Overall Study|Physician Decision|1|||
162089737|NCT02443298|585380889|FG000|Overall Study|Adverse Event|3|||
162089738|NCT02443298|585380890|FG001|Overall Study|Adverse Event|3|||
162089739|NCT02443298|585380889|FG000|Overall Study|Withdrawal by Subject|1|||
162089740|NCT02443298|585380890|FG001|Overall Study|Withdrawal by Subject|2|||
162089741|NCT03095417|585380891|FG000|Overall Study|missed|1|||
162089742|NCT03095417|585380892|FG001|Overall Study|missed|2|||
162089743|NCT03095417|585380893|FG002|Overall Study|missed|0|||
162089744|NCT03095417|585380894|FG003|Overall Study|missed|1|||
162089745|NCT03095417|585380891|FG000|Overall Study|Lost to Follow-up|2|||
162089746|NCT03095417|585380892|FG001|Overall Study|Lost to Follow-up|2|||
162089747|NCT03095417|585380893|FG002|Overall Study|Lost to Follow-up|1|||
162089748|NCT03095417|585380894|FG003|Overall Study|Lost to Follow-up|0|||
162089749|NCT03095417|585380891|FG000|Overall Study|refusal|0|||
162089750|NCT03095417|585380892|FG001|Overall Study|refusal|1|||
162089751|NCT03095417|585380893|FG002|Overall Study|refusal|0|||
162089752|NCT03095417|585380894|FG003|Overall Study|refusal|1|||
162089753|NCT03095417|585380891|FG000|Overall Study|Withdrawal by Subject|8|||
162089754|NCT03095417|585380892|FG001|Overall Study|Withdrawal by Subject|2|||
162089755|NCT03095417|585380893|FG002|Overall Study|Withdrawal by Subject|5|||
162089756|NCT03095417|585380894|FG003|Overall Study|Withdrawal by Subject|4|||
162089757|NCT03095417|585380891|FG000|Overall Study|Physician Decision|1|||
162089758|NCT03095417|585380892|FG001|Overall Study|Physician Decision|2|||
162089759|NCT03095417|585380893|FG002|Overall Study|Physician Decision|2|||
162089760|NCT03095417|585380894|FG003|Overall Study|Physician Decision|2|||
162089761|NCT03095417|585380891|FG000|Overall Study|Death|1|||
162089762|NCT03095417|585380892|FG001|Overall Study|Death|2|||
162089763|NCT03095417|585380893|FG002|Overall Study|Death|1|||
162089764|NCT03095417|585380894|FG003|Overall Study|Death|3|||
162089765|NCT02571452|585380895|FG000|Overall Study Treatment|Protocol Violation|0|||
162089766|NCT02571452|585380896|FG001|Overall Study Treatment|Protocol Violation|1|||
162089767|NCT02571452|585380895|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
162089768|NCT02571452|585380896|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
162089769|NCT02571452|585380895|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
162089770|NCT02571452|585380896|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
162089771|NCT01877421|585380897|FG000|Phase 2|Lost to Follow-up|0|||
162089772|NCT01877421|585380898|FG001|Phase 2|Lost to Follow-up|0|||
162089773|NCT01877421|585380899|FG002|Phase 2|Lost to Follow-up|0|||
162089774|NCT01877421|585380900|FG003|Phase 2|Lost to Follow-up|0|||
162089775|NCT01877421|585380901|FG004|Phase 2|Lost to Follow-up|0|||
162089776|NCT01877421|585380902|FG005|Phase 2|Lost to Follow-up|0|||
162089777|NCT01877421|585380903|FG006|Phase 2|Lost to Follow-up|1|||
162089778|NCT01877421|585380904|FG007|Phase 2|Lost to Follow-up|0|||
162089779|NCT01877421|585380905|FG008|Phase 2|Lost to Follow-up|0|||
162089780|NCT01877421|585380906|FG009|Phase 2|Lost to Follow-up|0|||
162089781|NCT01877421|585380907|FG010|Phase 2|Lost to Follow-up|0|||
162089782|NCT01877421|585380908|FG011|Phase 2|Lost to Follow-up|0|||
162089783|NCT01877421|585380909|FG012|Phase 2|Lost to Follow-up|0|||
162089784|NCT01877421|585380910|FG013|Phase 2|Lost to Follow-up|0|||
162089785|NCT01877421|585380911|FG014|Phase 2|Lost to Follow-up|0|||
162089786|NCT01877421|585380912|FG015|Phase 2|Lost to Follow-up|0|||
162089787|NCT01877421|585380913|FG016|Phase 2|Lost to Follow-up|0|||
162089788|NCT01877421|585380914|FG017|Phase 2|Lost to Follow-up|0|||
162089789|NCT01877421|585380897|FG000|Phase 2|Withdrawal by Subject|0|||
162089790|NCT01877421|585380898|FG001|Phase 2|Withdrawal by Subject|0|||
162089791|NCT01877421|585380899|FG002|Phase 2|Withdrawal by Subject|0|||
162089792|NCT01877421|585380900|FG003|Phase 2|Withdrawal by Subject|0|||
162089793|NCT01877421|585380901|FG004|Phase 2|Withdrawal by Subject|0|||
162089794|NCT01877421|585380902|FG005|Phase 2|Withdrawal by Subject|0|||
162089795|NCT01877421|585380903|FG006|Phase 2|Withdrawal by Subject|0|||
162089796|NCT01877421|585380904|FG007|Phase 2|Withdrawal by Subject|0|||
162089797|NCT01877421|585380905|FG008|Phase 2|Withdrawal by Subject|1|||
162089798|NCT01877421|585380906|FG009|Phase 2|Withdrawal by Subject|0|||
162089799|NCT01877421|585380907|FG010|Phase 2|Withdrawal by Subject|1|||
162089800|NCT01877421|585380908|FG011|Phase 2|Withdrawal by Subject|0|||
162089801|NCT01877421|585380909|FG012|Phase 2|Withdrawal by Subject|1|||
162089802|NCT01877421|585380910|FG013|Phase 2|Withdrawal by Subject|0|||
162089803|NCT01877421|585380911|FG014|Phase 2|Withdrawal by Subject|0|||
162089804|NCT01877421|585380912|FG015|Phase 2|Withdrawal by Subject|1|||
162089805|NCT01877421|585380913|FG016|Phase 2|Withdrawal by Subject|0|||
162089806|NCT01877421|585380914|FG017|Phase 2|Withdrawal by Subject|0|||
162089807|NCT01877421|585380897|FG000|Phase 2|Protocol Violation|0|||
162089808|NCT01877421|585380898|FG001|Phase 2|Protocol Violation|0|||
162089809|NCT01877421|585380899|FG002|Phase 2|Protocol Violation|0|||
162089810|NCT01877421|585380900|FG003|Phase 2|Protocol Violation|0|||
162089811|NCT01877421|585380901|FG004|Phase 2|Protocol Violation|0|||
162089812|NCT01877421|585380902|FG005|Phase 2|Protocol Violation|0|||
162089813|NCT01877421|585380903|FG006|Phase 2|Protocol Violation|0|||
162089814|NCT01877421|585380904|FG007|Phase 2|Protocol Violation|0|||
162089815|NCT01877421|585380905|FG008|Phase 2|Protocol Violation|0|||
162089816|NCT01877421|585380906|FG009|Phase 2|Protocol Violation|0|||
162089817|NCT01877421|585380907|FG010|Phase 2|Protocol Violation|1|||
162089818|NCT01877421|585380908|FG011|Phase 2|Protocol Violation|0|||
162089819|NCT01877421|585380909|FG012|Phase 2|Protocol Violation|0|||
162089820|NCT01877421|585380910|FG013|Phase 2|Protocol Violation|0|||
162089821|NCT01877421|585380911|FG014|Phase 2|Protocol Violation|0|||
162089822|NCT01877421|585380912|FG015|Phase 2|Protocol Violation|0|||
162089823|NCT01877421|585380913|FG016|Phase 2|Protocol Violation|0|||
162089824|NCT01877421|585380914|FG017|Phase 2|Protocol Violation|0|||
162089825|NCT03698773|585380928|FG000|Overall Study|Lost to Follow-up|2|||
162089826|NCT03698773|585380929|FG001|Overall Study|Lost to Follow-up|1|||
162089827|NCT01158924|585380931|FG000|Overall Study|Withdrawal by Subject|1|||
162089828|NCT01158924|585380932|FG001|Overall Study|Withdrawal by Subject|2|||
162089829|NCT01158924|585380931|FG000|Overall Study|Lost to Follow-up|0|||
162089830|NCT01158924|585380932|FG001|Overall Study|Lost to Follow-up|1|||
162089831|NCT01260922|585380936|FG000|First Intervention|Withdrawal by Subject|0|||
162089832|NCT01260922|585380937|FG001|First Intervention|Withdrawal by Subject|1|||
162089833|NCT01260922|585380936|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
162089834|NCT01260922|585380937|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
162089835|NCT01260922|585380936|FG000|Second Intervention|Emesis|0|||
162089836|NCT01260922|585380937|FG001|Second Intervention|Emesis|2|||
162089837|NCT03732248|585380940|FG000|Overall Study|Withdrawal by Subject|1|||
162089838|NCT03732248|585380941|FG001|Overall Study|Withdrawal by Subject|0|||
162089839|NCT01599650|585380942|FG000|Overall Study|Administrative issue|1|||
162089840|NCT01599650|585380943|FG001|Overall Study|Administrative issue|0|||
162089841|NCT01599650|585380944|FG002|Overall Study|Administrative issue|1|||
162089842|NCT01599650|585380942|FG000|Overall Study|Physician Decision|2|||
162089843|NCT01599650|585380943|FG001|Overall Study|Physician Decision|0|||
162089844|NCT01599650|585380944|FG002|Overall Study|Physician Decision|7|||
162089845|NCT01599650|585380942|FG000|Overall Study|Protocol Violation|0|||
162089846|NCT01599650|585380943|FG001|Overall Study|Protocol Violation|3|||
162089847|NCT01599650|585380944|FG002|Overall Study|Protocol Violation|0|||
162089848|NCT01599650|585380942|FG000|Overall Study|Death|2|||
162089849|NCT01599650|585380943|FG001|Overall Study|Death|1|||
162089850|NCT01599650|585380944|FG002|Overall Study|Death|2|||
162089851|NCT01599650|585380942|FG000|Overall Study|Lost to Follow-up|3|||
162089852|NCT01599650|585380943|FG001|Overall Study|Lost to Follow-up|3|||
162089853|NCT01599650|585380944|FG002|Overall Study|Lost to Follow-up|3|||
162089854|NCT01599650|585380942|FG000|Overall Study|Withdrawal by Subject|11|||
162089855|NCT01599650|585380943|FG001|Overall Study|Withdrawal by Subject|11|||
162089856|NCT01599650|585380944|FG002|Overall Study|Withdrawal by Subject|10|||
162089857|NCT01599650|585380942|FG000|Overall Study|Adverse Event|3|||
162089858|NCT01599650|585380943|FG001|Overall Study|Adverse Event|8|||
162089859|NCT01599650|585380944|FG002|Overall Study|Adverse Event|4|||
162089860|NCT01731171|585380945|FG000|Overall Study|Withdrawal by Subject|4|||
162089861|NCT01731171|585380946|FG001|Overall Study|Withdrawal by Subject|1|||
162089862|NCT01731171|585380945|FG000|Overall Study|Lost to Follow-up|3|||
162089863|NCT01731171|585380946|FG001|Overall Study|Lost to Follow-up|2|||
162089864|NCT01731171|585380945|FG000|Overall Study|Moved out of Area|0|||
162089865|NCT01731171|585380946|FG001|Overall Study|Moved out of Area|2|||
162089866|NCT01731171|585380945|FG000|Overall Study|Terminated for Lack of Adherence|0|||
162089867|NCT01731171|585380946|FG001|Overall Study|Terminated for Lack of Adherence|1|||
162089868|NCT01731171|585380945|FG000|Overall Study|Terminated for Safety Reasons|0|||
162089869|NCT01731171|585380946|FG001|Overall Study|Terminated for Safety Reasons|1|||
162089870|NCT01410110|585380947|FG000|Overall Study|Withdrawal by Subject|4|||
162089871|NCT01410110|585380948|FG001|Overall Study|Withdrawal by Subject|2|||
162089872|NCT00684424|585380949|FG000|Overall Study|Adverse Event|1|||
162089873|NCT00684424|585380949|FG000|Overall Study|Lost to Follow-up|2|||
162089874|NCT00684424|585380949|FG000|Overall Study|Other|2|||
162089875|NCT02520531|585380952|FG000|Overall Study|Revision of study device components|2|||
162089876|NCT02520531|585380953|FG001|Overall Study|Revision of study device components|2|||
162089877|NCT02520531|585380952|FG000|Overall Study|Death|1|||
162089878|NCT02520531|585380953|FG001|Overall Study|Death|2|||
162089879|NCT02520531|585380952|FG000|Overall Study|Lost to Follow-up|1|||
162089880|NCT02520531|585380953|FG001|Overall Study|Lost to Follow-up|1|||
162089881|NCT02520531|585380952|FG000|Overall Study|Meet exclusion criterion|0|||
162089882|NCT02520531|585380953|FG001|Overall Study|Meet exclusion criterion|1|||
162089883|NCT02520531|585380952|FG000|Overall Study|Withdrawal by Subject|1|||
162089884|NCT02520531|585380953|FG001|Overall Study|Withdrawal by Subject|0|||
162089885|NCT02520531|585380952|FG000|Overall Study|Not study device|1|||
162089886|NCT02520531|585380953|FG001|Overall Study|Not study device|0|||
162089887|NCT01649856|585380959|FG000|Overall Study|Withdrawal by Subject|14|||
162089888|NCT01649856|585380960|FG001|Overall Study|Withdrawal by Subject|14|||
162089889|NCT01649856|585380959|FG000|Overall Study|Protocol Violation|4|||
162089890|NCT01649856|585380960|FG001|Overall Study|Protocol Violation|4|||
162089891|NCT01649856|585380959|FG000|Overall Study|Treatment Failure|1|||
162089892|NCT01649856|585380960|FG001|Overall Study|Treatment Failure|1|||
162089893|NCT01649856|585380959|FG000|Overall Study|Death|69|||
162089894|NCT01649856|585380960|FG001|Overall Study|Death|34|||
162089895|NCT01649856|585380959|FG000|Overall Study|Stable or Progressed Disease|5|||
162089896|NCT01649856|585380960|FG001|Overall Study|Stable or Progressed Disease|3|||
162089897|NCT01649856|585380959|FG000|Overall Study|Lost to Follow-up|20|||
162089898|NCT01649856|585380960|FG001|Overall Study|Lost to Follow-up|16|||
162089899|NCT01649856|585380959|FG000|Overall Study|Lack of Compliance|6|||
162089900|NCT01649856|585380960|FG001|Overall Study|Lack of Compliance|1|||
162089901|NCT01649856|585380959|FG000|Overall Study|Other|20|||
162089902|NCT01649856|585380960|FG001|Overall Study|Other|5|||
162089903|NCT00835406|585380961|FG000|Period: First Intervention|Adverse Event|0|||
162089904|NCT00835406|585380962|FG001|Period: First Intervention|Adverse Event|1|||
162089905|NCT00835406|585380961|FG000|Period: First Intervention|Withdrawal by Subject|2|||
162089906|NCT00835406|585380962|FG001|Period: First Intervention|Withdrawal by Subject|0|||
162089907|NCT00835406|585380961|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
162089908|NCT00835406|585380962|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
162089909|NCT00281840|585380963|FG000|Overall Study|Adverse Event|12|||
162089910|NCT00281840|585380963|FG000|Overall Study|Physician Decision|6|||
162089911|NCT00281840|585380963|FG000|Overall Study|Withdrawal by Subject|3|||
162089912|NCT00281840|585380963|FG000|Overall Study|Disease Progression|2|||
162089913|NCT00281840|585380963|FG000|Overall Study|exceed maximum delay in treatment|1|||
162089914|NCT00281840|585380963|FG000|Overall Study|Complicating Disease|1|||
162089915|NCT02138214|585380964|FG000|Overall Study|Withdrawal by Subject|0|||
162089916|NCT02138214|585380965|FG001|Overall Study|Withdrawal by Subject|1|||
162089917|NCT02138214|585380966|FG002|Overall Study|Withdrawal by Subject|0|||
162089918|NCT02138214|585380964|FG000|Overall Study|Lost to Follow-up|0|||
162089919|NCT02138214|585380965|FG001|Overall Study|Lost to Follow-up|2|||
162089920|NCT02138214|585380966|FG002|Overall Study|Lost to Follow-up|4|||
162089921|NCT02138214|585380964|FG000|Overall Study|Screen Failure|0|||
162089922|NCT02138214|585380965|FG001|Overall Study|Screen Failure|1|||
162089923|NCT02138214|585380966|FG002|Overall Study|Screen Failure|0|||
162089924|NCT02185768|585380967|FG000|Overall Study|Patients were not treated|2|||
162089925|NCT01079234|585380968|FG000|Main: Week 0 to 26|Adverse Event|5|||
162089926|NCT01079234|585380969|FG001|Main: Week 0 to 26|Adverse Event|4|||
162089927|NCT01079234|585380970|FG002|Main: Week 0 to 26|Adverse Event|1|||
162089928|NCT01079234|585380971|FG003|Main: Week 0 to 26|Adverse Event|0|||
162089929|NCT01079234|585380968|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
162089930|NCT01079234|585380969|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
162089931|NCT01079234|585380970|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
162089932|NCT01079234|585380971|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
162089933|NCT01079234|585380968|FG000|Main: Week 0 to 26|Protocol Violation|6|||
162089934|NCT01079234|585380969|FG001|Main: Week 0 to 26|Protocol Violation|2|||
162089935|NCT01079234|585380970|FG002|Main: Week 0 to 26|Protocol Violation|4|||
162089936|NCT01079234|585380971|FG003|Main: Week 0 to 26|Protocol Violation|0|||
162089937|NCT01079234|585380968|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
162089938|NCT01079234|585380969|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
162089939|NCT01079234|585380970|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
162089940|NCT01079234|585380971|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
162089941|NCT01079234|585380968|FG000|Main: Week 0 to 26|Unclassified|7|||
162089942|NCT01079234|585380969|FG001|Main: Week 0 to 26|Unclassified|13|||
162089943|NCT01079234|585380970|FG002|Main: Week 0 to 26|Unclassified|4|||
162089944|NCT01079234|585380971|FG003|Main: Week 0 to 26|Unclassified|0|||
162089945|NCT01079234|585380968|FG000|Extension: Week 27 to 52|Adverse Event|0|||
162089946|NCT01079234|585380969|FG001|Extension: Week 27 to 52|Adverse Event|0|||
162089947|NCT01079234|585380970|FG002|Extension: Week 27 to 52|Adverse Event|1|||
162089948|NCT01079234|585380971|FG003|Extension: Week 27 to 52|Adverse Event|0|||
162089949|NCT01079234|585380968|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
162089950|NCT01079234|585380969|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
162089951|NCT01079234|585380970|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
162089952|NCT01079234|585380971|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
162089953|NCT01079234|585380968|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
162089954|NCT01079234|585380969|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
162089955|NCT01079234|585380970|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
162089956|NCT01079234|585380971|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
162089957|NCT01079234|585380968|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
162089958|NCT01079234|585380969|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
162089959|NCT01079234|585380970|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
162089960|NCT01079234|585380971|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
162089961|NCT01079234|585380968|FG000|Extension: Week 27 to 52|Unclassified|0|||
162089962|NCT01079234|585380969|FG001|Extension: Week 27 to 52|Unclassified|0|||
162089963|NCT01079234|585380970|FG002|Extension: Week 27 to 52|Unclassified|4|||
162089964|NCT01079234|585380971|FG003|Extension: Week 27 to 52|Unclassified|7|||
162089965|NCT02707640|585380973|FG000|Overall Study|Adverse Event|4|||
162089966|NCT02707640|585380974|FG001|Overall Study|Adverse Event|2|||
162089967|NCT02707640|585380973|FG000|Overall Study|Death|1|||
162089968|NCT02707640|585380974|FG001|Overall Study|Death|2|||
162089969|NCT02707640|585380973|FG000|Overall Study|Physician Decision|2|||
162089970|NCT02707640|585380974|FG001|Overall Study|Physician Decision|0|||
162089971|NCT02707640|585380973|FG000|Overall Study|Withdrawal by Subject|0|||
162089972|NCT02707640|585380974|FG001|Overall Study|Withdrawal by Subject|1|||
162089973|NCT02707640|585380973|FG000|Overall Study|Participant's Personal Decision|1|||
162089974|NCT02707640|585380974|FG001|Overall Study|Participant's Personal Decision|2|||
162089975|NCT02707640|585380973|FG000|Overall Study|Sponsor Discretion|1|||
162089976|NCT02707640|585380974|FG001|Overall Study|Sponsor Discretion|0|||
162089977|NCT02517905|585380975|FG000|Overall Study|Lost to Follow-up|4|||
162089978|NCT02517905|585380976|FG001|Overall Study|Lost to Follow-up|0|||
162089979|NCT02517905|585380975|FG000|Overall Study|Withdrawal by Subject|4|||
162089980|NCT02517905|585380976|FG001|Overall Study|Withdrawal by Subject|0|||
162089981|NCT02517905|585380975|FG000|Overall Study|Screen failure|2|||
162089982|NCT02517905|585380976|FG001|Overall Study|Screen failure|2|||
162089983|NCT00023452|585380977|FG000|Overall Study|Ineligible for Study|163|||
162089984|NCT00023452|585380978|FG001|Overall Study|Ineligible for Study|159|||
162089985|NCT00023452|585380977|FG000|Overall Study|Out of Window|129|||
162089986|NCT00023452|585380978|FG001|Overall Study|Out of Window|69|||
162089987|NCT00023452|585380977|FG000|Overall Study|Death|2|||
162089988|NCT00023452|585380978|FG001|Overall Study|Death|0|||
162089989|NCT00023452|585380977|FG000|Overall Study|Withdrawal by Subject|66|||
162089990|NCT00023452|585380978|FG001|Overall Study|Withdrawal by Subject|54|||
162089991|NCT00023452|585380977|FG000|Overall Study|Adverse Event|139|||
162089992|NCT00023452|585380978|FG001|Overall Study|Adverse Event|196|||
162089993|NCT00023452|585380977|FG000|Overall Study|Lost to Follow-up|293|||
162089994|NCT00023452|585380978|FG001|Overall Study|Lost to Follow-up|60|||
162089995|NCT00023452|585380977|FG000|Overall Study|Physician Decision|49|||
162089996|NCT00023452|585380978|FG001|Overall Study|Physician Decision|21|||
162089997|NCT00023452|585380977|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
162089998|NCT00023452|585380978|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
162089999|NCT00023452|585380977|FG000|Overall Study|Pregnant|53|||
162090000|NCT00023452|585380978|FG001|Overall Study|Pregnant|20|||
162090001|NCT00023452|585380977|FG000|Overall Study|Other|204|||
162090002|NCT00023452|585380978|FG001|Overall Study|Other|69|||
162090003|NCT05789875|585380979|FG000|Overall Study|Lost to Follow-up|6|||
162090004|NCT01994395|585380981|FG000|Overall Study|Withdrawal by Subject|1|||
162090005|NCT01994395|585380982|FG001|Overall Study|Withdrawal by Subject|2|||
162090006|NCT00459134|585380989|FG000|Overall Study|Physician Decision|1|||
162090007|NCT00459134|585380990|FG001|Overall Study|Physician Decision|1|||
162090008|NCT00459134|585380989|FG000|Overall Study|Withdrawal by Subject|8|||
162090009|NCT00459134|585380990|FG001|Overall Study|Withdrawal by Subject|7|||
162090010|NCT00459134|585380989|FG000|Overall Study|Lost to Follow-up|6|||
162090011|NCT00459134|585380990|FG001|Overall Study|Lost to Follow-up|7|||
162090012|NCT00459134|585380989|FG000|Overall Study|Surgery|1|||
162090013|NCT00459134|585380990|FG001|Overall Study|Surgery|2|||
162090014|NCT00459134|585380989|FG000|Overall Study|Toxicity|4|||
162090015|NCT00459134|585380990|FG001|Overall Study|Toxicity|5|||
162090016|NCT00459134|585380989|FG000|Overall Study|Progression|1|||
162090017|NCT00459134|585380990|FG001|Overall Study|Progression|0|||
162090018|NCT00459134|585380989|FG000|Overall Study|Multiple Reasons|2|||
162090019|NCT00459134|585380990|FG001|Overall Study|Multiple Reasons|3|||
162090020|NCT03333486|585380991|FG000|Overall Study|Withdrawal by Subject|1|||
162090021|NCT03333486|585380991|FG000|Overall Study|Lost to Follow-up|1|||
162090022|NCT01755416|585380995|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
162090023|NCT01755416|585380996|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
162090024|NCT02805257|585383493|FG000|Overall Study|Lost to Follow-up|7|||
162090025|NCT02805257|585383494|FG001|Overall Study|Lost to Follow-up|6|||
162090026|NCT02805257|585383493|FG000|Overall Study|Death|0|||
162090027|NCT02805257|585383494|FG001|Overall Study|Death|1|||
162090028|NCT00612066|585383495|FG000|Overall Study|Adverse Event|1|||
162090029|NCT01043874|585383499|FG000|Overall Study|Adverse Event|3|||
162090030|NCT01043874|585383499|FG000|Overall Study|Withdrawal by Subject|1|||
162090031|NCT01043874|585383499|FG000|Overall Study|Lack of Efficacy|1|||
162090032|NCT01043874|585383499|FG000|Overall Study|Administrative Problems|1|||
162090033|NCT01337089|585383500|FG000|Overall Study|Adverse Event|237|||
162090034|NCT01337089|585383500|FG000|Overall Study|Withdrawal by Subject|129|||
162090035|NCT01337089|585383500|FG000|Overall Study|Withdrawal by Investigator|33|||
162090036|NCT01337089|585383500|FG000|Overall Study|Met Withdrawal Criteria|3|||
162090037|NCT01337089|585383500|FG000|Overall Study|Lost to Follow-up|2|||
162090038|NCT01404312|585383501|FG000|Overall Study|Death|21|||
162090039|NCT01404312|585383502|FG001|Overall Study|Death|27|||
162090040|NCT01404312|585383501|FG000|Overall Study|Withdrawal by Subject|15|||
162090041|NCT01404312|585383502|FG001|Overall Study|Withdrawal by Subject|18|||
162090042|NCT01404312|585383501|FG000|Overall Study|Participant Unable to get to clinic|93|||
162090043|NCT01404312|585383502|FG001|Overall Study|Participant Unable to get to clinic|103|||
162090044|NCT01404312|585383501|FG000|Overall Study|Lost to Follow-up|115|||
162090045|NCT01404312|585383502|FG001|Overall Study|Lost to Follow-up|111|||
162090046|NCT01404312|585383501|FG000|Overall Study|Site closed|22|||
162090047|NCT01404312|585383502|FG001|Overall Study|Site closed|21|||
162090048|NCT01404312|585383501|FG000|Overall Study|Participant not willing to adhere to req|31|||
162090049|NCT01404312|585383502|FG001|Overall Study|Participant not willing to adhere to req|29|||
162090050|NCT01404312|585383501|FG000|Overall Study|Severe debilitation, unable to continue|1|||
162090051|NCT01404312|585383502|FG001|Overall Study|Severe debilitation, unable to continue|2|||
162090052|NCT02627677|585383504|FG000|Overall Study|Adverse event (not progressive disease)|1|||
162090053|NCT02627677|585383505|FG001|Overall Study|Adverse event (not progressive disease)|4|||
162090054|NCT02627677|585383506|FG002|Overall Study|Adverse event (not progressive disease)|1|||
162090055|NCT02627677|585383504|FG000|Overall Study|Progressive disease|1|||
162090056|NCT02627677|585383505|FG001|Overall Study|Progressive disease|3|||
162090057|NCT02627677|585383506|FG002|Overall Study|Progressive disease|0|||
162090058|NCT02627677|585383504|FG000|Overall Study|Lack of Efficacy|1|||
162090059|NCT02627677|585383505|FG001|Overall Study|Lack of Efficacy|2|||
162090060|NCT02627677|585383506|FG002|Overall Study|Lack of Efficacy|0|||
162090061|NCT02627677|585383504|FG000|Overall Study|Lost to Follow-up|0|||
162090062|NCT02627677|585383505|FG001|Overall Study|Lost to Follow-up|0|||
162090063|NCT02627677|585383506|FG002|Overall Study|Lost to Follow-up|1|||
162090064|NCT02627677|585383504|FG000|Overall Study|Pregnancy|0|||
162090065|NCT02627677|585383505|FG001|Overall Study|Pregnancy|1|||
162090066|NCT02627677|585383506|FG002|Overall Study|Pregnancy|0|||
162090067|NCT02627677|585383504|FG000|Overall Study|Study Terminated by Sponsor|5|||
162090068|NCT02627677|585383505|FG001|Overall Study|Study Terminated by Sponsor|10|||
162090069|NCT02627677|585383506|FG002|Overall Study|Study Terminated by Sponsor|6|||
162090070|NCT02627677|585383504|FG000|Overall Study|Physician Decision|0|||
162090071|NCT02627677|585383505|FG001|Overall Study|Physician Decision|0|||
162090072|NCT02627677|585383506|FG002|Overall Study|Physician Decision|2|||
162090073|NCT02627677|585383504|FG000|Overall Study|Withdrawal by Subject|2|||
162090074|NCT02627677|585383505|FG001|Overall Study|Withdrawal by Subject|1|||
162090075|NCT02627677|585383506|FG002|Overall Study|Withdrawal by Subject|1|||
162090076|NCT02627677|585383504|FG000|Overall Study|Reason not Specified|0|||
162090077|NCT02627677|585383505|FG001|Overall Study|Reason not Specified|0|||
162090078|NCT02627677|585383506|FG002|Overall Study|Reason not Specified|1|||
162090079|NCT02627677|585383504|FG000|Overall Study|Randomized but not Treated|1|||
162090080|NCT02627677|585383505|FG001|Overall Study|Randomized but not Treated|0|||
162090081|NCT02627677|585383506|FG002|Overall Study|Randomized but not Treated|0|||
162090082|NCT00071487|585383512|FG000|52-Week Double-Blind Period|Adverse Event|5|||
162090083|NCT00071487|585383513|FG001|52-Week Double-Blind Period|Adverse Event|8|||
162090084|NCT00071487|585383514|FG002|52-Week Double-Blind Period|Adverse Event|4|||
162090085|NCT00071487|585383515|FG003|52-Week Double-Blind Period|Adverse Event|8|||
162090086|NCT00071487|585383512|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
162090087|NCT00071487|585383513|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
162090088|NCT00071487|585383514|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
162090089|NCT00071487|585383515|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
162090090|NCT00071487|585383512|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
162090091|NCT00071487|585383513|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
162090092|NCT00071487|585383514|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
162090093|NCT00071487|585383515|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
162090094|NCT00071487|585383512|FG000|52-Week Double-Blind Period|Physician Decision|1|||
162090095|NCT00071487|585383513|FG001|52-Week Double-Blind Period|Physician Decision|0|||
162090096|NCT00071487|585383514|FG002|52-Week Double-Blind Period|Physician Decision|0|||
162090097|NCT00071487|585383515|FG003|52-Week Double-Blind Period|Physician Decision|0|||
162090098|NCT00071487|585383512|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
162090099|NCT00071487|585383513|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
162090100|NCT00071487|585383514|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
162090101|NCT00071487|585383515|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
162090102|NCT00071487|585383512|FG000|52-Week Double-Blind Period|Pregnancy|0|||
162090103|NCT00071487|585383513|FG001|52-Week Double-Blind Period|Pregnancy|1|||
162090104|NCT00071487|585383514|FG002|52-Week Double-Blind Period|Pregnancy|0|||
162090105|NCT00071487|585383515|FG003|52-Week Double-Blind Period|Pregnancy|0|||
162090106|NCT00071487|585383512|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
162090107|NCT00071487|585383513|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
162090108|NCT00071487|585383514|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
162090109|NCT00071487|585383515|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
162090110|NCT00071487|585383512|FG000|52-Week Double-Blind Period|Death|0|||
162090111|NCT00071487|585383513|FG001|52-Week Double-Blind Period|Death|1|||
162090112|NCT00071487|585383514|FG002|52-Week Double-Blind Period|Death|0|||
162090113|NCT00071487|585383515|FG003|52-Week Double-Blind Period|Death|0|||
162090114|NCT00071487|585383512|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
162090115|NCT00071487|585383513|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
162090116|NCT00071487|585383514|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
162090117|NCT00071487|585383515|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
162090118|NCT00071487|585383512|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
162090119|NCT00071487|585383513|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
162090120|NCT00071487|585383514|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
162090121|NCT00071487|585383515|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
162090122|NCT00071487|585383512|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
162090123|NCT00071487|585383513|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
162090124|NCT00071487|585383514|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
162090125|NCT00071487|585383515|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
162090126|NCT00071487|585383512|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162090127|NCT00071487|585383513|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162090128|NCT00071487|585383514|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
162090129|NCT00071487|585383515|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
162090130|NCT00071487|585383512|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
162090131|NCT00071487|585383513|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
162090132|NCT00071487|585383514|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
162090133|NCT00071487|585383515|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
162090134|NCT00071487|585383512|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
162090135|NCT00071487|585383513|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
162090136|NCT00071487|585383514|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
162090137|NCT00071487|585383515|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
162090138|NCT00071487|585383512|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
162090139|NCT00071487|585383513|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
162090140|NCT00071487|585383514|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
162090141|NCT00071487|585383515|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
162090142|NCT02696850|585383518|FG000|Overall Study|Withdrawal by Subject|3|||
162090143|NCT02696850|585383519|FG001|Overall Study|Withdrawal by Subject|3|||
162090144|NCT02696850|585383518|FG000|Overall Study|Lost to Follow-up|8|||
162090145|NCT02696850|585383519|FG001|Overall Study|Lost to Follow-up|5|||
162090146|NCT00673049|585383522|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
162090147|NCT00673049|585383523|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
162090148|NCT00673049|585383524|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
162090149|NCT00673049|585383525|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
162090150|NCT00673049|585383522|FG000|Before Progression on Erlotinib|Death|235|||
162090151|NCT00673049|585383523|FG001|Before Progression on Erlotinib|Death|167|||
162090152|NCT00673049|585383524|FG002|Before Progression on Erlotinib|Death|1|||
162090153|NCT00673049|585383525|FG003|Before Progression on Erlotinib|Death|0|||
162090154|NCT00673049|585383522|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
162090155|NCT00673049|585383523|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
162090156|NCT00673049|585383524|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
162090157|NCT00673049|585383525|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
162090158|NCT00673049|585383522|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
162090159|NCT00673049|585383523|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
162090160|NCT00673049|585383524|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
162090161|NCT00673049|585383525|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
162090162|NCT00673049|585383522|FG000|Before Progression on Erlotinib|Other|1|||
162090163|NCT00673049|585383523|FG001|Before Progression on Erlotinib|Other|2|||
162090164|NCT00673049|585383524|FG002|Before Progression on Erlotinib|Other|0|||
162090165|NCT00673049|585383525|FG003|Before Progression on Erlotinib|Other|0|||
162090166|NCT00673049|585383522|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
162090167|NCT00673049|585383523|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
162090168|NCT00673049|585383524|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
162090169|NCT00673049|585383525|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
162090170|NCT00673049|585383522|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
162090171|NCT00673049|585383523|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
162090172|NCT00673049|585383524|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
162090173|NCT00673049|585383525|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
162090174|NCT00673049|585383522|FG000|After Progression on Erlotinib|Death|0|||
162090175|NCT00673049|585383523|FG001|After Progression on Erlotinib|Death|0|||
162090176|NCT00673049|585383524|FG002|After Progression on Erlotinib|Death|0|||
162090177|NCT00673049|585383525|FG003|After Progression on Erlotinib|Death|71|||
162090178|NCT00673049|585383522|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
162090179|NCT00673049|585383523|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
162090180|NCT00673049|585383524|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
162090181|NCT00673049|585383525|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
162090182|NCT00673049|585383522|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
162090183|NCT00673049|585383523|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
162090184|NCT00673049|585383524|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
162090185|NCT00673049|585383525|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
162090186|NCT00673049|585383522|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
162090187|NCT00673049|585383523|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
162090188|NCT00673049|585383524|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
162090189|NCT00673049|585383525|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
162090190|NCT00975975|585383529|FG000|Overall Study|Death|6|||
162090191|NCT04265755|585383532|FG000|Overall Study|Withdrawal by Subject|39|||
162090192|NCT04265755|585383532|FG000|Overall Study|Decision by sponsor|2|||
162090193|NCT04265755|585383532|FG000|Overall Study|Lost to Follow-up|11|||
162090194|NCT04265755|585383532|FG000|Overall Study|Death|1|||
162090195|NCT01863446|585383535|FG000|Overall Study|Withdrawal by Subject|1|||
162090196|NCT01863446|585383536|FG001|Overall Study|Withdrawal by Subject|0|||
162090197|NCT01863446|585383537|FG002|Overall Study|Withdrawal by Subject|1|||
162090198|NCT01863446|585383538|FG003|Overall Study|Withdrawal by Subject|2|||
162090199|NCT01863446|585383535|FG000|Overall Study|Physician Decision|0|||
162090200|NCT01863446|585383536|FG001|Overall Study|Physician Decision|0|||
162090201|NCT01863446|585383537|FG002|Overall Study|Physician Decision|1|||
162090202|NCT01863446|585383538|FG003|Overall Study|Physician Decision|0|||
162090203|NCT02554773|585383539|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
162090204|NCT02554773|585383540|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
162090205|NCT02554773|585383539|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
162090206|NCT02554773|585383540|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
162090207|NCT02554773|585383539|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
162090208|NCT02554773|585383540|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
162090209|NCT02554773|585383539|FG000|Original Dose Regimen (SAS 1)|Death|1|||
162090210|NCT02554773|585383540|FG001|Original Dose Regimen (SAS 1)|Death|0|||
162090211|NCT02554773|585383539|FG000|Original Dose Regimen (SAS 1)|Other|4|||
162090212|NCT02554773|585383540|FG001|Original Dose Regimen (SAS 1)|Other|0|||
162090213|NCT02554773|585383539|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
162090214|NCT02554773|585383540|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
162090215|NCT02554773|585383539|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
162090216|NCT02554773|585383540|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
162090217|NCT02554773|585383539|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
162090218|NCT02554773|585383540|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
162090219|NCT02554773|585383539|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
162090220|NCT02554773|585383540|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
162090221|NCT02956629|585383544|FG000|Overall Study|Adverse Event|0|||
162090222|NCT02956629|585383545|FG001|Overall Study|Adverse Event|0|||
162090223|NCT02956629|585383546|FG002|Overall Study|Adverse Event|1|||
162090224|NCT02956629|585383547|FG003|Overall Study|Adverse Event|0|||
162090225|NCT02956629|585383548|FG004|Overall Study|Adverse Event|0|||
162090226|NCT02956629|585383549|FG005|Overall Study|Adverse Event|0|||
162090227|NCT02956629|585383544|FG000|Overall Study|Lost to Follow-up|2|||
162090228|NCT02956629|585383545|FG001|Overall Study|Lost to Follow-up|5|||
162090229|NCT02956629|585383546|FG002|Overall Study|Lost to Follow-up|3|||
162090230|NCT02956629|585383547|FG003|Overall Study|Lost to Follow-up|1|||
162090231|NCT02956629|585383548|FG004|Overall Study|Lost to Follow-up|0|||
162090232|NCT02956629|585383549|FG005|Overall Study|Lost to Follow-up|1|||
162090233|NCT02956629|585383544|FG000|Overall Study|Withdrawal by Subject|3|||
162090234|NCT02956629|585383545|FG001|Overall Study|Withdrawal by Subject|1|||
162090235|NCT02956629|585383546|FG002|Overall Study|Withdrawal by Subject|0|||
162090236|NCT02956629|585383547|FG003|Overall Study|Withdrawal by Subject|0|||
162090237|NCT02956629|585383548|FG004|Overall Study|Withdrawal by Subject|0|||
162090238|NCT02956629|585383549|FG005|Overall Study|Withdrawal by Subject|0|||
162090239|NCT03224468|585383553|FG000|Overall Study|Did not obtain MM card|53|||
162090240|NCT03224468|585383554|FG001|Overall Study|Did not obtain MM card|0|||
162090241|NCT03224468|585383553|FG000|Overall Study|Lost to Follow-up|4|||
162090242|NCT03224468|585383554|FG001|Overall Study|Lost to Follow-up|11|||
162090243|NCT03224468|585383553|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
162090244|NCT03224468|585383554|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
162090245|NCT04713748|585383555|FG000|Overall Study|Not enough kits allocated|35|||
162090246|NCT01557946|585383556|FG000|Overall Study|Adverse Event|3|||
162090247|NCT01557946|585383557|FG001|Overall Study|Adverse Event|0|||
162090248|NCT00406029|585383558|FG000|Overall Study|Adverse Event|12|||
162090249|NCT00406029|585383559|FG001|Overall Study|Adverse Event|2|||
162090250|NCT00406029|585383560|FG002|Overall Study|Adverse Event|5|||
162090251|NCT00406029|585383561|FG003|Overall Study|Adverse Event|10|||
162090252|NCT00406029|585383562|FG004|Overall Study|Adverse Event|7|||
162090253|NCT00406029|585383558|FG000|Overall Study|Withdrawal by Subject|3|||
162090254|NCT00406029|585383559|FG001|Overall Study|Withdrawal by Subject|4|||
162090255|NCT00406029|585383560|FG002|Overall Study|Withdrawal by Subject|2|||
162090256|NCT00406029|585383561|FG003|Overall Study|Withdrawal by Subject|2|||
162090257|NCT00406029|585383562|FG004|Overall Study|Withdrawal by Subject|0|||
162090258|NCT00406029|585383558|FG000|Overall Study|Protocol Violation|1|||
162090259|NCT00406029|585383559|FG001|Overall Study|Protocol Violation|2|||
162090260|NCT00406029|585383560|FG002|Overall Study|Protocol Violation|0|||
162090261|NCT00406029|585383561|FG003|Overall Study|Protocol Violation|2|||
162090262|NCT00406029|585383562|FG004|Overall Study|Protocol Violation|0|||
162090263|NCT00406029|585383558|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
162090264|NCT00406029|585383559|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
162090265|NCT00406029|585383560|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
162090266|NCT00406029|585383561|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
162090267|NCT00406029|585383562|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
162090268|NCT00406029|585383558|FG000|Overall Study|Randomized in Error|0|||
162090269|NCT00406029|585383559|FG001|Overall Study|Randomized in Error|0|||
162090270|NCT00406029|585383560|FG002|Overall Study|Randomized in Error|2|||
162090271|NCT00406029|585383561|FG003|Overall Study|Randomized in Error|3|||
162090272|NCT00406029|585383562|FG004|Overall Study|Randomized in Error|1|||
162090273|NCT04067141|585383563|FG000|First Intervention|Withdrawal by Subject|0|||
162090274|NCT04067141|585383564|FG001|First Intervention|Withdrawal by Subject|1|||
162090275|NCT04067141|585383563|FG000|Second Intervention|Adverse Event|0|||
162090276|NCT04067141|585383564|FG001|Second Intervention|Adverse Event|2|||
162090277|NCT02822794|585383565|FG000|Overall Study|Withdrew Consent|1|||
162090278|NCT02822794|585383566|FG001|Overall Study|Withdrew Consent|0|||
162090279|NCT04788147|585383567|FG000|Overall Study|Screen Failure|3|||
162090280|NCT04788147|585383568|FG001|Overall Study|Screen Failure|10|||
162090281|NCT04788147|585383567|FG000|Overall Study|Incomplete RMRS image session|2|||
162090282|NCT04788147|585383568|FG001|Overall Study|Incomplete RMRS image session|0|||
162090283|NCT05101252|585383569|FG000|Overall Study|Unsatisfactory Test Article|1|||
162090284|NCT05101252|585383570|FG001|Overall Study|Unsatisfactory Test Article|0|||
162090285|NCT05101252|585383569|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
162090286|NCT05101252|585383570|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
162090287|NCT05101252|585383569|FG000|Overall Study|Withdrew Consent during study|0|||
162090288|NCT05101252|585383570|FG001|Overall Study|Withdrew Consent during study|1|||
162090289|NCT05101252|585383569|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
162090290|NCT05101252|585383570|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
162090291|NCT02266381|585383571|FG000|Overall Study|Physician Decision|3|||
162090292|NCT02266381|585383572|FG001|Overall Study|Physician Decision|5|||
162090293|NCT02266381|585383573|FG002|Overall Study|Physician Decision|4|||
162090294|NCT03221257|585383578|FG000|Overall Study|Lost to Follow-up|0|||
162090295|NCT03221257|585383579|FG001|Overall Study|Lost to Follow-up|1|||
162090296|NCT03221257|585383578|FG000|Overall Study|Withdrawal by Subject|1|||
162090297|NCT03221257|585383579|FG001|Overall Study|Withdrawal by Subject|1|||
162090298|NCT01334866|585383580|FG000|Overall Study|Withdrawal by Subject|10|||
162090299|NCT01334866|585383580|FG000|Overall Study|Lost to Follow-up|3|||
162090300|NCT01334866|585383580|FG000|Overall Study|Physician Decision|3|||
162090301|NCT01334866|585383580|FG000|Overall Study|medically necessary prior to procedure|2|||
162090302|NCT01334866|585383580|FG000|Overall Study|medically necessary post-procedure|1|||
162090303|NCT01971346|585383584|FG000|Overall Study|Protocol Violation|3|||
162090304|NCT01971346|585383584|FG000|Overall Study|Lost to Follow-up|2|||
162090305|NCT01971346|585383584|FG000|Overall Study|Withdrawal by Subject|2|||
162090306|NCT01971346|585383584|FG000|Overall Study|Physician Decision|1|||
162090307|NCT04187196|585383587|FG000|Overall Study|Screen Failure|2|||
162090308|NCT04187196|585383588|FG001|Overall Study|Screen Failure|0|||
162090309|NCT01687166|585383589|FG000|Overall Study|Attempt subject|2|||
162090310|NCT01687166|585383590|FG001|Overall Study|Attempt subject|3|||
162090311|NCT01687166|585383591|FG002|Overall Study|Attempt subject|2|||
162090312|NCT01687166|585383592|FG003|Overall Study|Attempt subject|0|||
162090313|NCT01687166|585383589|FG000|Overall Study|Did not meet eligibility criteria|4|||
162090314|NCT01687166|585383590|FG001|Overall Study|Did not meet eligibility criteria|6|||
162090315|NCT01687166|585383591|FG002|Overall Study|Did not meet eligibility criteria|1|||
162090316|NCT01687166|585383592|FG003|Overall Study|Did not meet eligibility criteria|1|||
162090317|NCT01687166|585383589|FG000|Overall Study|Adverse Event|2|||
162090318|NCT01687166|585383590|FG001|Overall Study|Adverse Event|1|||
162090319|NCT01687166|585383591|FG002|Overall Study|Adverse Event|0|||
162090320|NCT01687166|585383592|FG003|Overall Study|Adverse Event|0|||
162090321|NCT01687166|585383589|FG000|Overall Study|Physician Decision|3|||
162090322|NCT01687166|585383590|FG001|Overall Study|Physician Decision|2|||
162090323|NCT01687166|585383591|FG002|Overall Study|Physician Decision|1|||
162090324|NCT01687166|585383592|FG003|Overall Study|Physician Decision|0|||
162090325|NCT01687166|585383589|FG000|Overall Study|Withdrawal by Subject|11|||
162090326|NCT01687166|585383590|FG001|Overall Study|Withdrawal by Subject|4|||
162090327|NCT01687166|585383591|FG002|Overall Study|Withdrawal by Subject|3|||
162090328|NCT01687166|585383592|FG003|Overall Study|Withdrawal by Subject|0|||
162090329|NCT01687166|585383589|FG000|Overall Study|Lost to Follow-up|2|||
162090330|NCT01687166|585383590|FG001|Overall Study|Lost to Follow-up|5|||
162090331|NCT01687166|585383591|FG002|Overall Study|Lost to Follow-up|1|||
162090332|NCT01687166|585383592|FG003|Overall Study|Lost to Follow-up|0|||
162090333|NCT01687166|585383589|FG000|Overall Study|Equipment/Device Availability|0|||
162090334|NCT01687166|585383590|FG001|Overall Study|Equipment/Device Availability|1|||
162090335|NCT01687166|585383591|FG002|Overall Study|Equipment/Device Availability|0|||
162090336|NCT01687166|585383592|FG003|Overall Study|Equipment/Device Availability|0|||
162090337|NCT01687166|585383589|FG000|Overall Study|Death|1|||
162090338|NCT01687166|585383590|FG001|Overall Study|Death|1|||
162090339|NCT01687166|585383591|FG002|Overall Study|Death|0|||
162090340|NCT01687166|585383592|FG003|Overall Study|Death|0|||
162090341|NCT01687166|585383589|FG000|Overall Study|Protocol Violation|1|||
162090342|NCT01687166|585383590|FG001|Overall Study|Protocol Violation|1|||
162090343|NCT01687166|585383591|FG002|Overall Study|Protocol Violation|1|||
162090344|NCT01687166|585383592|FG003|Overall Study|Protocol Violation|0|||
162090345|NCT01687166|585383589|FG000|Overall Study|Subject moved out of state|0|||
162090346|NCT01687166|585383590|FG001|Overall Study|Subject moved out of state|1|||
162090347|NCT01687166|585383591|FG002|Overall Study|Subject moved out of state|0|||
162090348|NCT01687166|585383592|FG003|Overall Study|Subject moved out of state|0|||
162090349|NCT01687166|585383589|FG000|Overall Study|Patient unable to be compliant|1|||
162090350|NCT01687166|585383590|FG001|Overall Study|Patient unable to be compliant|0|||
162090351|NCT01687166|585383591|FG002|Overall Study|Patient unable to be compliant|0|||
162090352|NCT01687166|585383592|FG003|Overall Study|Patient unable to be compliant|0|||
162090353|NCT01687166|585383589|FG000|Overall Study|Physician choice to use different device|1|||
162090354|NCT01687166|585383590|FG001|Overall Study|Physician choice to use different device|2|||
162090355|NCT01687166|585383591|FG002|Overall Study|Physician choice to use different device|4|||
162090356|NCT01687166|585383592|FG003|Overall Study|Physician choice to use different device|0|||
162090357|NCT01687166|585383589|FG000|Overall Study|Insurance|0|||
162090358|NCT01687166|585383590|FG001|Overall Study|Insurance|0|||
162090359|NCT01687166|585383591|FG002|Overall Study|Insurance|1|||
162090360|NCT01687166|585383592|FG003|Overall Study|Insurance|1|||
162090361|NCT02755831|585383593|FG000|Overall Study|Lost to Follow-up|3|||
162090362|NCT02755831|585383594|FG001|Overall Study|Lost to Follow-up|3|||
162090363|NCT02316717|585383595|FG000|Overall Study|Adverse Event|2|||
162090364|NCT02316717|585383596|FG001|Overall Study|Adverse Event|2|||
162090365|NCT02316717|585383597|FG002|Overall Study|Adverse Event|0|||
162090366|NCT02316717|585383595|FG000|Overall Study|Lost to Follow-up|1|||
162090367|NCT02316717|585383596|FG001|Overall Study|Lost to Follow-up|2|||
162090368|NCT02316717|585383597|FG002|Overall Study|Lost to Follow-up|1|||
162090369|NCT02316717|585383595|FG000|Overall Study|Non compliance|3|||
162090370|NCT02316717|585383596|FG001|Overall Study|Non compliance|1|||
162090371|NCT02316717|585383597|FG002|Overall Study|Non compliance|0|||
162090372|NCT02316717|585383595|FG000|Overall Study|Protocol Violation|2|||
162090373|NCT02316717|585383596|FG001|Overall Study|Protocol Violation|0|||
162090374|NCT02316717|585383597|FG002|Overall Study|Protocol Violation|0|||
162090375|NCT02316717|585383595|FG000|Overall Study|Withdrawal by Subject|2|||
162090376|NCT02316717|585383596|FG001|Overall Study|Withdrawal by Subject|1|||
162090377|NCT02316717|585383597|FG002|Overall Study|Withdrawal by Subject|1|||
162090378|NCT02316717|585383595|FG000|Overall Study|Death|0|||
162090379|NCT02316717|585383596|FG001|Overall Study|Death|0|||
162090380|NCT02316717|585383597|FG002|Overall Study|Death|1|||
162090381|NCT02316717|585383595|FG000|Overall Study|Physician Decision|0|||
162090382|NCT02316717|585383596|FG001|Overall Study|Physician Decision|1|||
162090383|NCT02316717|585383597|FG002|Overall Study|Physician Decision|0|||
162090384|NCT02316717|585383595|FG000|Overall Study|TBC|1|||
162090385|NCT02316717|585383596|FG001|Overall Study|TBC|0|||
162090386|NCT02316717|585383597|FG002|Overall Study|TBC|0|||
162090387|NCT02460224|585383598|FG000|Overall Study|Adverse Event|0|||
162090388|NCT02460224|585383599|FG001|Overall Study|Adverse Event|0|||
162090389|NCT02460224|585383600|FG002|Overall Study|Adverse Event|0|||
162090390|NCT02460224|585383601|FG003|Overall Study|Adverse Event|0|||
162090391|NCT02460224|585383602|FG004|Overall Study|Adverse Event|0|||
162090392|NCT02460224|585383603|FG005|Overall Study|Adverse Event|0|||
162090393|NCT02460224|585383604|FG006|Overall Study|Adverse Event|1|||
162090394|NCT02460224|585383605|FG007|Overall Study|Adverse Event|0|||
162090395|NCT02460224|585383606|FG008|Overall Study|Adverse Event|0|||
162090396|NCT02460224|585383607|FG009|Overall Study|Adverse Event|0|||
162090397|NCT02460224|585383608|FG010|Overall Study|Adverse Event|0|||
162090398|NCT02460224|585383609|FG011|Overall Study|Adverse Event|0|||
162090399|NCT02460224|585383610|FG012|Overall Study|Adverse Event|1|||
162090400|NCT02460224|585383611|FG013|Overall Study|Adverse Event|0|||
162090401|NCT02460224|585383612|FG014|Overall Study|Adverse Event|0|||
162090402|NCT02460224|585383613|FG015|Overall Study|Adverse Event|0|||
162090403|NCT02460224|585383614|FG016|Overall Study|Adverse Event|1|||
162090404|NCT02460224|585383615|FG017|Overall Study|Adverse Event|0|||
162090405|NCT02460224|585383616|FG018|Overall Study|Adverse Event|1|||
162090406|NCT02460224|585383617|FG019|Overall Study|Adverse Event|0|||
162090407|NCT02460224|585383618|FG020|Overall Study|Adverse Event|1|||
162090408|NCT02460224|585383619|FG021|Overall Study|Adverse Event|1|||
162090409|NCT02460224|585383620|FG022|Overall Study|Adverse Event|1|||
162090410|NCT02460224|585383621|FG023|Overall Study|Adverse Event|0|||
162090411|NCT02460224|585383622|FG024|Overall Study|Adverse Event|0|||
162090412|NCT02460224|585383623|FG025|Overall Study|Adverse Event|0|||
162090413|NCT02460224|585383624|FG026|Overall Study|Adverse Event|11|||
162090414|NCT02460224|585383625|FG027|Overall Study|Adverse Event|1|||
162090415|NCT02460224|585383626|FG028|Overall Study|Adverse Event|6|||
162090416|NCT02460224|585383598|FG000|Overall Study|Death|0|||
162090417|NCT02460224|585383599|FG001|Overall Study|Death|0|||
162090418|NCT02460224|585383600|FG002|Overall Study|Death|0|||
162090419|NCT02460224|585383601|FG003|Overall Study|Death|0|||
162090420|NCT02460224|585383602|FG004|Overall Study|Death|0|||
162090421|NCT02460224|585383603|FG005|Overall Study|Death|2|||
162090422|NCT02460224|585383604|FG006|Overall Study|Death|1|||
162090423|NCT02460224|585383605|FG007|Overall Study|Death|0|||
162090424|NCT02460224|585383606|FG008|Overall Study|Death|0|||
162090425|NCT02460224|585383607|FG009|Overall Study|Death|1|||
162090426|NCT02460224|585383608|FG010|Overall Study|Death|0|||
162090427|NCT02460224|585383609|FG011|Overall Study|Death|0|||
162090428|NCT02460224|585383610|FG012|Overall Study|Death|0|||
162090429|NCT02460224|585383611|FG013|Overall Study|Death|1|||
162090430|NCT02460224|585383612|FG014|Overall Study|Death|0|||
162090431|NCT02460224|585383613|FG015|Overall Study|Death|0|||
162090432|NCT02460224|585383614|FG016|Overall Study|Death|2|||
162090433|NCT02460224|585383615|FG017|Overall Study|Death|1|||
162090434|NCT02460224|585383616|FG018|Overall Study|Death|0|||
162090435|NCT02460224|585383617|FG019|Overall Study|Death|2|||
162090436|NCT02460224|585383618|FG020|Overall Study|Death|0|||
162090437|NCT02460224|585383619|FG021|Overall Study|Death|0|||
162090438|NCT02460224|585383620|FG022|Overall Study|Death|0|||
162090439|NCT02460224|585383621|FG023|Overall Study|Death|0|||
162090440|NCT02460224|585383622|FG024|Overall Study|Death|1|||
162090441|NCT02460224|585383623|FG025|Overall Study|Death|1|||
162090442|NCT02460224|585383624|FG026|Overall Study|Death|5|||
162090443|NCT02460224|585383625|FG027|Overall Study|Death|0|||
162090444|NCT02460224|585383626|FG028|Overall Study|Death|1|||
162090445|NCT02460224|585383598|FG000|Overall Study|Lost to Follow-up|0|||
162090446|NCT02460224|585383599|FG001|Overall Study|Lost to Follow-up|0|||
162090447|NCT02460224|585383600|FG002|Overall Study|Lost to Follow-up|0|||
162090448|NCT02460224|585383601|FG003|Overall Study|Lost to Follow-up|0|||
162090449|NCT02460224|585383602|FG004|Overall Study|Lost to Follow-up|0|||
162090450|NCT02460224|585383603|FG005|Overall Study|Lost to Follow-up|0|||
162090451|NCT02460224|585383604|FG006|Overall Study|Lost to Follow-up|0|||
162090452|NCT02460224|585383605|FG007|Overall Study|Lost to Follow-up|0|||
162090453|NCT02460224|585383606|FG008|Overall Study|Lost to Follow-up|0|||
162090454|NCT02460224|585383607|FG009|Overall Study|Lost to Follow-up|0|||
162090455|NCT02460224|585383608|FG010|Overall Study|Lost to Follow-up|0|||
162090456|NCT02460224|585383609|FG011|Overall Study|Lost to Follow-up|0|||
162090457|NCT02460224|585383610|FG012|Overall Study|Lost to Follow-up|0|||
162090458|NCT02460224|585383611|FG013|Overall Study|Lost to Follow-up|0|||
162090459|NCT02460224|585383612|FG014|Overall Study|Lost to Follow-up|0|||
162090460|NCT02460224|585383613|FG015|Overall Study|Lost to Follow-up|0|||
162090461|NCT02460224|585383614|FG016|Overall Study|Lost to Follow-up|0|||
162090462|NCT02460224|585383615|FG017|Overall Study|Lost to Follow-up|0|||
162090463|NCT02460224|585383616|FG018|Overall Study|Lost to Follow-up|0|||
162090464|NCT02460224|585383617|FG019|Overall Study|Lost to Follow-up|0|||
162090465|NCT02460224|585383618|FG020|Overall Study|Lost to Follow-up|0|||
162090466|NCT02460224|585383619|FG021|Overall Study|Lost to Follow-up|0|||
162090467|NCT02460224|585383620|FG022|Overall Study|Lost to Follow-up|1|||
162090468|NCT02460224|585383621|FG023|Overall Study|Lost to Follow-up|0|||
162090469|NCT02460224|585383622|FG024|Overall Study|Lost to Follow-up|0|||
162090470|NCT02460224|585383623|FG025|Overall Study|Lost to Follow-up|0|||
162090471|NCT02460224|585383624|FG026|Overall Study|Lost to Follow-up|0|||
162090472|NCT02460224|585383625|FG027|Overall Study|Lost to Follow-up|0|||
162090473|NCT02460224|585383626|FG028|Overall Study|Lost to Follow-up|0|||
162090474|NCT02460224|585383598|FG000|Overall Study|Physician Decision|0|||
162090475|NCT02460224|585383599|FG001|Overall Study|Physician Decision|1|||
162090476|NCT02460224|585383600|FG002|Overall Study|Physician Decision|0|||
162090477|NCT02460224|585383601|FG003|Overall Study|Physician Decision|0|||
162090478|NCT02460224|585383602|FG004|Overall Study|Physician Decision|1|||
162090479|NCT02460224|585383603|FG005|Overall Study|Physician Decision|0|||
162090480|NCT02460224|585383604|FG006|Overall Study|Physician Decision|0|||
162090481|NCT02460224|585383605|FG007|Overall Study|Physician Decision|1|||
162090482|NCT02460224|585383606|FG008|Overall Study|Physician Decision|0|||
162090483|NCT02460224|585383607|FG009|Overall Study|Physician Decision|0|||
162090484|NCT02460224|585383608|FG010|Overall Study|Physician Decision|0|||
162090485|NCT02460224|585383609|FG011|Overall Study|Physician Decision|1|||
162090486|NCT02460224|585383610|FG012|Overall Study|Physician Decision|0|||
162090487|NCT02460224|585383611|FG013|Overall Study|Physician Decision|1|||
162090488|NCT02460224|585383612|FG014|Overall Study|Physician Decision|0|||
162090489|NCT02460224|585383613|FG015|Overall Study|Physician Decision|0|||
162090490|NCT02460224|585383614|FG016|Overall Study|Physician Decision|2|||
162090491|NCT02460224|585383615|FG017|Overall Study|Physician Decision|1|||
162090492|NCT02460224|585383616|FG018|Overall Study|Physician Decision|1|||
162090493|NCT02460224|585383617|FG019|Overall Study|Physician Decision|2|||
162090494|NCT02460224|585383618|FG020|Overall Study|Physician Decision|1|||
162090495|NCT02460224|585383619|FG021|Overall Study|Physician Decision|1|||
162090496|NCT02460224|585383620|FG022|Overall Study|Physician Decision|0|||
162090497|NCT02460224|585383621|FG023|Overall Study|Physician Decision|0|||
162090498|NCT02460224|585383622|FG024|Overall Study|Physician Decision|1|||
162090499|NCT02460224|585383623|FG025|Overall Study|Physician Decision|0|||
162090500|NCT02460224|585383624|FG026|Overall Study|Physician Decision|14|||
162090501|NCT02460224|585383625|FG027|Overall Study|Physician Decision|1|||
162090502|NCT02460224|585383626|FG028|Overall Study|Physician Decision|6|||
162090503|NCT02460224|585383598|FG000|Overall Study|Progressive disease|15|||
162090504|NCT02460224|585383599|FG001|Overall Study|Progressive disease|11|||
162090505|NCT02460224|585383600|FG002|Overall Study|Progressive disease|5|||
162090506|NCT02460224|585383601|FG003|Overall Study|Progressive disease|6|||
162090507|NCT02460224|585383602|FG004|Overall Study|Progressive disease|3|||
162090508|NCT02460224|585383603|FG005|Overall Study|Progressive disease|26|||
162090509|NCT02460224|585383604|FG006|Overall Study|Progressive disease|28|||
162090510|NCT02460224|585383605|FG007|Overall Study|Progressive disease|4|||
162090511|NCT02460224|585383606|FG008|Overall Study|Progressive disease|5|||
162090512|NCT02460224|585383607|FG009|Overall Study|Progressive disease|9|||
162090513|NCT02460224|585383608|FG010|Overall Study|Progressive disease|5|||
162090514|NCT02460224|585383609|FG011|Overall Study|Progressive disease|4|||
162090515|NCT02460224|585383610|FG012|Overall Study|Progressive disease|5|||
162090516|NCT02460224|585383611|FG013|Overall Study|Progressive disease|4|||
162090517|NCT02460224|585383612|FG014|Overall Study|Progressive disease|5|||
162090518|NCT02460224|585383613|FG015|Overall Study|Progressive disease|5|||
162090519|NCT02460224|585383614|FG016|Overall Study|Progressive disease|15|||
162090520|NCT02460224|585383615|FG017|Overall Study|Progressive disease|3|||
162090521|NCT02460224|585383616|FG018|Overall Study|Progressive disease|8|||
162090522|NCT02460224|585383617|FG019|Overall Study|Progressive disease|3|||
162090523|NCT02460224|585383618|FG020|Overall Study|Progressive disease|4|||
162090524|NCT02460224|585383619|FG021|Overall Study|Progressive disease|9|||
162090525|NCT02460224|585383620|FG022|Overall Study|Progressive disease|4|||
162090526|NCT02460224|585383621|FG023|Overall Study|Progressive disease|11|||
162090527|NCT02460224|585383622|FG024|Overall Study|Progressive disease|4|||
162090528|NCT02460224|585383623|FG025|Overall Study|Progressive disease|5|||
162090529|NCT02460224|585383624|FG026|Overall Study|Progressive disease|85|||
162090530|NCT02460224|585383625|FG027|Overall Study|Progressive disease|17|||
162090531|NCT02460224|585383626|FG028|Overall Study|Progressive disease|77|||
162090532|NCT02460224|585383598|FG000|Overall Study|Subject/guardian decision|2|||
162090533|NCT02460224|585383599|FG001|Overall Study|Subject/guardian decision|0|||
162090534|NCT02460224|585383600|FG002|Overall Study|Subject/guardian decision|1|||
162090535|NCT02460224|585383601|FG003|Overall Study|Subject/guardian decision|0|||
162090536|NCT02460224|585383602|FG004|Overall Study|Subject/guardian decision|2|||
162090537|NCT02460224|585383603|FG005|Overall Study|Subject/guardian decision|2|||
162090538|NCT02460224|585383604|FG006|Overall Study|Subject/guardian decision|0|||
162090539|NCT02460224|585383605|FG007|Overall Study|Subject/guardian decision|0|||
162090540|NCT02460224|585383606|FG008|Overall Study|Subject/guardian decision|1|||
162090541|NCT02460224|585383607|FG009|Overall Study|Subject/guardian decision|1|||
162090542|NCT02460224|585383608|FG010|Overall Study|Subject/guardian decision|0|||
162090543|NCT02460224|585383609|FG011|Overall Study|Subject/guardian decision|1|||
162090544|NCT02460224|585383610|FG012|Overall Study|Subject/guardian decision|0|||
162090545|NCT02460224|585383611|FG013|Overall Study|Subject/guardian decision|0|||
162090546|NCT02460224|585383612|FG014|Overall Study|Subject/guardian decision|0|||
162090547|NCT02460224|585383613|FG015|Overall Study|Subject/guardian decision|1|||
162090548|NCT02460224|585383614|FG016|Overall Study|Subject/guardian decision|0|||
162090549|NCT02460224|585383615|FG017|Overall Study|Subject/guardian decision|1|||
162090550|NCT02460224|585383616|FG018|Overall Study|Subject/guardian decision|2|||
162090551|NCT02460224|585383617|FG019|Overall Study|Subject/guardian decision|0|||
162090552|NCT02460224|585383618|FG020|Overall Study|Subject/guardian decision|0|||
162090553|NCT02460224|585383619|FG021|Overall Study|Subject/guardian decision|1|||
162090554|NCT02460224|585383620|FG022|Overall Study|Subject/guardian decision|0|||
162090555|NCT02460224|585383621|FG023|Overall Study|Subject/guardian decision|0|||
162090556|NCT02460224|585383622|FG024|Overall Study|Subject/guardian decision|0|||
162090557|NCT02460224|585383623|FG025|Overall Study|Subject/guardian decision|0|||
162090558|NCT02460224|585383624|FG026|Overall Study|Subject/guardian decision|6|||
162090559|NCT02460224|585383625|FG027|Overall Study|Subject/guardian decision|2|||
162090560|NCT02460224|585383626|FG028|Overall Study|Subject/guardian decision|3|||
162090561|NCT02774681|585383633|FG000|Treatment on Study|Progressive Disease|7|||
162090562|NCT02774681|585383633|FG000|Follow-Up for 3 Years|Death|11|||
162090563|NCT02774681|585383633|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
162090564|NCT03146650|585383638|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
162090565|NCT03146650|585383638|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
162090566|NCT03146650|585383638|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
162090567|NCT03146650|585383638|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
162090568|NCT03146650|585383638|FG000|2 Year Follow-up|Death|11|||
162090569|NCT03146650|585383638|FG000|2 Year Follow-up|Still in follow-up|7|||
162090570|NCT03146650|585383638|FG000|2 Year Follow-up|Lost to Follow-up|1|||
162090571|NCT02460198|585383641|FG000|Overall Study|Adverse Event|1|||
162090572|NCT02460198|585383642|FG001|Overall Study|Adverse Event|3|||
162090573|NCT02460198|585383641|FG000|Overall Study|Death|36|||
162090574|NCT02460198|585383642|FG001|Overall Study|Death|28|||
162090575|NCT02460198|585383641|FG000|Overall Study|Lost to Follow-up|1|||
162090576|NCT02460198|585383642|FG001|Overall Study|Lost to Follow-up|1|||
162090577|NCT02460198|585383641|FG000|Overall Study|Transferred to Extension Study|15|||
162090578|NCT02460198|585383642|FG001|Overall Study|Transferred to Extension Study|15|||
162090579|NCT02460198|585383641|FG000|Overall Study|Withdrawal by Subject|2|||
162090580|NCT02460198|585383642|FG001|Overall Study|Withdrawal by Subject|4|||
162090581|NCT02460198|585383641|FG000|Overall Study|Site Terminated By Sponsor|0|||
162090582|NCT02460198|585383642|FG001|Overall Study|Site Terminated By Sponsor|1|||
162090583|NCT02460198|585383641|FG000|Overall Study|Did Not Continue on Extension Study|6|||
162090584|NCT02460198|585383642|FG001|Overall Study|Did Not Continue on Extension Study|11|||
162090585|NCT00931307|585383643|FG000|Overall Study|Lack of Efficacy|12|||
162090586|NCT00931307|585383643|FG000|Overall Study|Biomicroscopy|1|||
162090587|NCT00965848|585383646|FG000|Overall Study|Protocol Violation|3|||
162090588|NCT00965848|585383647|FG001|Overall Study|Protocol Violation|0|||
162090589|NCT00965848|585383648|FG002|Overall Study|Protocol Violation|1|||
162090590|NCT00965848|585383646|FG000|Overall Study|Death|11|||
162090591|NCT00965848|585383647|FG001|Overall Study|Death|1|||
162090592|NCT00965848|585383648|FG002|Overall Study|Death|5|||
162090593|NCT00965848|585383646|FG000|Overall Study|Lost to Follow-up|0|||
162090594|NCT00965848|585383647|FG001|Overall Study|Lost to Follow-up|0|||
162090595|NCT00965848|585383648|FG002|Overall Study|Lost to Follow-up|1|||
162090596|NCT00965848|585383646|FG000|Overall Study|Withdrawal by Subject|1|||
162090597|NCT00965848|585383647|FG001|Overall Study|Withdrawal by Subject|0|||
162090598|NCT00965848|585383648|FG002|Overall Study|Withdrawal by Subject|0|||
162090599|NCT00965848|585383646|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
162090600|NCT00965848|585383647|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
162090601|NCT00965848|585383648|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
162090602|NCT00965848|585383646|FG000|Overall Study|Not Clinically Evaluable|7|||
162090603|NCT00965848|585383647|FG001|Overall Study|Not Clinically Evaluable|1|||
162090604|NCT00965848|585383648|FG002|Overall Study|Not Clinically Evaluable|1|||
162090605|NCT00965848|585383646|FG000|Overall Study|Other|5|||
162090606|NCT00965848|585383647|FG001|Overall Study|Other|0|||
162090607|NCT00965848|585383648|FG002|Overall Study|Other|1|||
162090608|NCT00813761|585383649|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
162090609|NCT00813761|585383650|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
162090610|NCT00813761|585383651|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
162090611|NCT00813761|585383652|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
162090612|NCT00813761|585383649|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
162090613|NCT00813761|585383650|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
162090614|NCT00813761|585383651|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
162090615|NCT00813761|585383652|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
162090616|NCT00813761|585383649|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
162090617|NCT00813761|585383650|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
162090618|NCT00813761|585383651|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
162090619|NCT00813761|585383652|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
162090620|NCT00813761|585383649|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
162090621|NCT00813761|585383650|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
162090622|NCT00813761|585383651|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
162090623|NCT00813761|585383652|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
162090624|NCT00813761|585383649|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
162090625|NCT00813761|585383650|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
162090626|NCT00813761|585383651|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
162090627|NCT00813761|585383652|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
162090628|NCT00813761|585383649|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
162090629|NCT00813761|585383650|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
162090630|NCT00813761|585383651|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
162090631|NCT00813761|585383652|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
162090632|NCT00813761|585383649|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
162090633|NCT00813761|585383650|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
162090634|NCT00813761|585383651|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
162090635|NCT00813761|585383652|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
162090636|NCT00813761|585383649|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
162090637|NCT00813761|585383650|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
162090638|NCT00813761|585383651|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
162090639|NCT00813761|585383652|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
162090640|NCT00813761|585383649|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
162090641|NCT00813761|585383650|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
162090642|NCT00813761|585383651|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
162090643|NCT00813761|585383652|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
162090644|NCT00813761|585383649|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
162090645|NCT00813761|585383650|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
162090646|NCT00813761|585383651|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
162090647|NCT00813761|585383652|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
162090648|NCT00813761|585383649|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
162090649|NCT00813761|585383650|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
162090650|NCT00813761|585383651|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
162090651|NCT00813761|585383652|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
162090652|NCT00813761|585383649|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
162090653|NCT00813761|585383650|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
162090654|NCT00813761|585383651|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
162090655|NCT00813761|585383652|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
162090656|NCT00691210|585383653|FG000|Overall Study|Progression of Disease|0|||
162090657|NCT00691210|585383654|FG001|Overall Study|Progression of Disease|0|||
162090658|NCT00691210|585383655|FG002|Overall Study|Progression of Disease|0|||
162090659|NCT00691210|585383656|FG003|Overall Study|Progression of Disease|2|||
162090660|NCT00691210|585383657|FG004|Overall Study|Progression of Disease|0|||
162090661|NCT00691210|585383658|FG005|Overall Study|Progression of Disease|0|||
162090662|NCT00691210|585383659|FG006|Overall Study|Progression of Disease|0|||
162090663|NCT00691210|585383660|FG007|Overall Study|Progression of Disease|0|||
162090664|NCT00691210|585383653|FG000|Overall Study|Lack of Efficacy|0|||
162090665|NCT00691210|585383654|FG001|Overall Study|Lack of Efficacy|0|||
162090666|NCT00691210|585383655|FG002|Overall Study|Lack of Efficacy|0|||
162090667|NCT00691210|585383656|FG003|Overall Study|Lack of Efficacy|1|||
162090668|NCT00691210|585383657|FG004|Overall Study|Lack of Efficacy|0|||
162090669|NCT00691210|585383658|FG005|Overall Study|Lack of Efficacy|1|||
162090670|NCT00691210|585383659|FG006|Overall Study|Lack of Efficacy|0|||
162090671|NCT00691210|585383660|FG007|Overall Study|Lack of Efficacy|0|||
162090672|NCT02047604|585383663|FG000|Overall Study|Withdrawal by Subject|0|||
162090673|NCT02047604|585383664|FG001|Overall Study|Withdrawal by Subject|0|||
162090674|NCT02047604|585383665|FG002|Overall Study|Withdrawal by Subject|0|||
162090675|NCT02047604|585383666|FG003|Overall Study|Withdrawal by Subject|0|||
162090676|NCT02047604|585383667|FG004|Overall Study|Withdrawal by Subject|1|||
162090677|NCT02047604|585383668|FG005|Overall Study|Withdrawal by Subject|1|||
162090678|NCT00983814|585383669|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
162090679|NCT00983814|585383670|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
162090680|NCT00983814|585383671|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
162090681|NCT00983814|585383669|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
162090682|NCT00983814|585383670|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
162090683|NCT00983814|585383671|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
162090684|NCT00983814|585383669|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
162090685|NCT00983814|585383670|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
162090686|NCT00983814|585383671|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
162090687|NCT00983814|585383669|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
162090688|NCT00983814|585383670|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
162090689|NCT00983814|585383671|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
162090690|NCT00983814|585383669|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
162090691|NCT00983814|585383670|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
162090692|NCT00983814|585383671|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
162090693|NCT01181895|585383672|FG000|Overall Study|Adverse Event|3|||
162090694|NCT01181895|585383673|FG001|Overall Study|Adverse Event|1|||
162090695|NCT01181895|585383674|FG002|Overall Study|Adverse Event|1|||
162090696|NCT01181895|585383672|FG000|Overall Study|Lack of Efficacy|8|||
162090697|NCT01181895|585383673|FG001|Overall Study|Lack of Efficacy|9|||
162090698|NCT01181895|585383674|FG002|Overall Study|Lack of Efficacy|9|||
162090699|NCT01181895|585383672|FG000|Overall Study|Protocol Violation|2|||
162090700|NCT01181895|585383673|FG001|Overall Study|Protocol Violation|1|||
162090701|NCT01181895|585383674|FG002|Overall Study|Protocol Violation|0|||
162090702|NCT01181895|585383672|FG000|Overall Study|Lost to Follow-up|0|||
162090703|NCT01181895|585383673|FG001|Overall Study|Lost to Follow-up|1|||
162090704|NCT01181895|585383674|FG002|Overall Study|Lost to Follow-up|2|||
162090705|NCT01181895|585383672|FG000|Overall Study|Investigator Discretion|1|||
162090706|NCT01181895|585383673|FG001|Overall Study|Investigator Discretion|2|||
162090707|NCT01181895|585383674|FG002|Overall Study|Investigator Discretion|1|||
162090708|NCT01181895|585383672|FG000|Overall Study|Withdrawal by Subject|3|||
162090709|NCT01181895|585383673|FG001|Overall Study|Withdrawal by Subject|0|||
162090710|NCT01181895|585383674|FG002|Overall Study|Withdrawal by Subject|5|||
162090711|NCT00555438|585383675|FG000|10 Days Post-operative|Death|4|||
162090712|NCT00555438|585383675|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
162090713|NCT00441337|585383677|FG000|Overall Study|Disease Progression|6|||
162090714|NCT00441337|585383678|FG001|Overall Study|Disease Progression|6|||
162090715|NCT00441337|585383679|FG002|Overall Study|Disease Progression|4|||
162090716|NCT00441337|585383680|FG003|Overall Study|Disease Progression|18|||
162090717|NCT00441337|585383677|FG000|Overall Study|Lost to Follow-up|0|||
162090718|NCT00441337|585383678|FG001|Overall Study|Lost to Follow-up|0|||
162090719|NCT00441337|585383679|FG002|Overall Study|Lost to Follow-up|0|||
162090720|NCT00441337|585383680|FG003|Overall Study|Lost to Follow-up|1|||
162090721|NCT00441337|585383677|FG000|Overall Study|Sponsor Decision|0|||
162090722|NCT00441337|585383678|FG001|Overall Study|Sponsor Decision|0|||
162090723|NCT00441337|585383679|FG002|Overall Study|Sponsor Decision|1|||
162090724|NCT00441337|585383680|FG003|Overall Study|Sponsor Decision|2|||
162090725|NCT00441337|585383677|FG000|Overall Study|Did not meet inclusion criteria|0|||
162090726|NCT00441337|585383678|FG001|Overall Study|Did not meet inclusion criteria|0|||
162090727|NCT00441337|585383679|FG002|Overall Study|Did not meet inclusion criteria|1|||
162090728|NCT00441337|585383680|FG003|Overall Study|Did not meet inclusion criteria|0|||
162090729|NCT03655236|585383681|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
162090730|NCT03655236|585383682|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
162090731|NCT03655236|585383683|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
162090732|NCT03655236|585383681|FG000|Subject Disposition in Part 1 Period|Death|1|||
162090733|NCT03655236|585383682|FG001|Subject Disposition in Part 1 Period|Death|0|||
162090734|NCT03655236|585383683|FG002|Subject Disposition in Part 1 Period|Death|0|||
162090735|NCT03655236|585383681|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
162090736|NCT03655236|585383682|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
162090737|NCT03655236|585383683|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
162090738|NCT03655236|585383681|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
162090739|NCT03655236|585383682|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
162090740|NCT03655236|585383683|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
162090741|NCT03655236|585383681|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
162090742|NCT03655236|585383682|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
162090743|NCT03655236|585383683|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
162090744|NCT03655236|585383681|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
162090745|NCT03655236|585383682|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
162090746|NCT03655236|585383683|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
162090747|NCT03655236|585383681|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
162090748|NCT03655236|585383682|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
162090749|NCT03655236|585383683|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
162090750|NCT03655236|585383681|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
162090751|NCT03655236|585383682|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
162090752|NCT03655236|585383683|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
162090753|NCT03655236|585383681|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
162090754|NCT03655236|585383682|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
162090755|NCT03655236|585383683|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
162090756|NCT03655236|585383681|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
162090757|NCT03655236|585383682|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
162090758|NCT03655236|585383683|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
162090759|NCT03655236|585383681|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
162090760|NCT03655236|585383682|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
162090761|NCT03655236|585383683|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
162090762|NCT03655236|585383681|FG000|Subject Disposition in Part 1 Period|Other|0|||
162090763|NCT03655236|585383682|FG001|Subject Disposition in Part 1 Period|Other|2|||
162090764|NCT03655236|585383683|FG002|Subject Disposition in Part 1 Period|Other|2|||
162090765|NCT03655236|585383681|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
162090766|NCT03655236|585383682|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
162090767|NCT03655236|585383683|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
162090768|NCT03655236|585383681|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
162090769|NCT03655236|585383682|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
162090770|NCT03655236|585383683|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
162090771|NCT03655236|585383681|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
162090772|NCT03655236|585383682|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
162090773|NCT03655236|585383683|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
162090774|NCT03655236|585383681|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
162090775|NCT03655236|585383682|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
162090776|NCT03655236|585383683|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
162090777|NCT03655236|585383681|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
162090778|NCT03655236|585383682|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
162090779|NCT03655236|585383683|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
162090780|NCT03655236|585383681|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
162090781|NCT03655236|585383682|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
162090782|NCT03655236|585383683|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
162090783|NCT03655236|585383681|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
162090784|NCT03655236|585383682|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
162090785|NCT03655236|585383683|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
162090786|NCT03655236|585383681|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
162090787|NCT03655236|585383682|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
162090788|NCT03655236|585383683|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
162090789|NCT03655236|585383681|FG000|Subject Disposition in Part 2 Period|Other|1|||
162090790|NCT03655236|585383682|FG001|Subject Disposition in Part 2 Period|Other|0|||
162090791|NCT03655236|585383683|FG002|Subject Disposition in Part 2 Period|Other|0|||
162090792|NCT06748040|585383684|FG000|Overall Study|Death|3|||
162090793|NCT06748040|585383685|FG001|Overall Study|Death|4|||
162090794|NCT06748040|585383684|FG000|Overall Study|Lost to Follow-up|134|||
162090795|NCT06748040|585383685|FG001|Overall Study|Lost to Follow-up|132|||
162090796|NCT06748040|585383684|FG000|Overall Study|Withdrawal by Subject|3|||
162090797|NCT06748040|585383685|FG001|Overall Study|Withdrawal by Subject|5|||
162090798|NCT03136068|585385315|FG000|Overall Study|Lost to Follow-up|1|||
162090799|NCT03136068|585385316|FG001|Overall Study|Lost to Follow-up|1|||
162090800|NCT03136068|585385315|FG000|Overall Study|Protocol Violation|1|||
162090801|NCT03136068|585385316|FG001|Overall Study|Protocol Violation|0|||
162090802|NCT00432380|585385317|FG000|Overall Study|Migrated/moved from study area|3|||
162090803|NCT00432380|585385318|FG001|Overall Study|Migrated/moved from study area|4|||
162090804|NCT00432380|585385319|FG002|Overall Study|Migrated/moved from study area|1|||
162090805|NCT00432380|585385317|FG000|Overall Study|Adverse Event|1|||
162090806|NCT00432380|585385318|FG001|Overall Study|Adverse Event|0|||
162090807|NCT00432380|585385319|FG002|Overall Study|Adverse Event|0|||
162090808|NCT01071395|585385320|FG000|Overall Study|Withdrawal by Subject|2|||
162090809|NCT01071395|585385321|FG001|Overall Study|Withdrawal by Subject|1|||
162090810|NCT01071395|585385320|FG000|Overall Study|Adverse Event|3|||
162090811|NCT01071395|585385321|FG001|Overall Study|Adverse Event|1|||
162090812|NCT04419493|585385322|FG000|Wash-out After Period 1|Adverse Event|1|||
162090813|NCT04419493|585385323|FG001|Wash-out After Period 1|Adverse Event|2|||
162090814|NCT04419493|585385324|FG002|Wash-out After Period 1|Adverse Event|1|||
162090815|NCT04419493|585385325|FG003|Wash-out After Period 1|Adverse Event|0|||
162090816|NCT00524134|585385326|FG000|Overall Study|Withdrawal by Subject|1|||
162090817|NCT00524134|585385326|FG000|Overall Study|Physician Decision|1|||
162090818|NCT03794089|585385327|FG000|Overall Study|Lost to Follow-up|4|||
162090819|NCT03794089|585385328|FG001|Overall Study|Lost to Follow-up|1|||
162090820|NCT03794089|585385327|FG000|Overall Study|Withdrawal by Subject|2|||
162090821|NCT03794089|585385328|FG001|Overall Study|Withdrawal by Subject|0|||
162090822|NCT03985423|585385329|FG000|Overall Study|Adverse Event|1|||
162090823|NCT03985423|585385329|FG000|Overall Study|Death|2|||
162090824|NCT03985423|585385329|FG000|Overall Study|Physician Decision|1|||
162090825|NCT03985423|585385329|FG000|Overall Study|Withdrawal by Subject|2|||
162090826|NCT03985423|585385329|FG000|Overall Study|Lack of insurance and citizenship|1|||
162090827|NCT01045447|585385340|FG000|Overall Study|Adverse Event|0|||
162090828|NCT01045447|585385341|FG001|Overall Study|Adverse Event|1|||
162090829|NCT01045447|585385340|FG000|Overall Study|Lack of Efficacy|3|||
162090830|NCT01045447|585385341|FG001|Overall Study|Lack of Efficacy|1|||
162090831|NCT01045447|585385340|FG000|Overall Study|Protocol Violation|6|||
162090832|NCT01045447|585385341|FG001|Overall Study|Protocol Violation|3|||
162090833|NCT01045447|585385340|FG000|Overall Study|Withdrawal Criteria|10|||
162090834|NCT01045447|585385341|FG001|Overall Study|Withdrawal Criteria|10|||
162090835|NCT01045447|585385340|FG000|Overall Study|Unclassified|17|||
162090836|NCT01045447|585385341|FG001|Overall Study|Unclassified|13|||
162090837|NCT01782131|585385345|FG000|Overall Study|Death|93|||
162090838|NCT01782131|585385346|FG001|Overall Study|Death|96|||
162090839|NCT01782131|585385345|FG000|Overall Study|Lost to Follow-up|1|||
162090840|NCT01782131|585385346|FG001|Overall Study|Lost to Follow-up|3|||
162090841|NCT01782131|585385345|FG000|Overall Study|Withdrawal by Subject|10|||
162090842|NCT01782131|585385346|FG001|Overall Study|Withdrawal by Subject|10|||
162090843|NCT01782131|585385345|FG000|Overall Study|Randomized but not treated|5|||
162090844|NCT01782131|585385346|FG001|Overall Study|Randomized but not treated|5|||
162090845|NCT01782131|585385345|FG000|Overall Study|Reason not provided|0|||
162090846|NCT01782131|585385346|FG001|Overall Study|Reason not provided|1|||
162090847|NCT01627249|585385347|FG000|Overall Study|Death|3|||
162090848|NCT01627249|585385348|FG001|Overall Study|Death|5|||
162090849|NCT01627249|585385349|FG002|Overall Study|Death|3|||
162090850|NCT01627249|585385347|FG000|Overall Study|Withdrawal by Subject|12|||
162090851|NCT01627249|585385348|FG001|Overall Study|Withdrawal by Subject|6|||
162090852|NCT01627249|585385349|FG002|Overall Study|Withdrawal by Subject|9|||
162090853|NCT01627249|585385347|FG000|Overall Study|Missed Visit|1|||
162090854|NCT01627249|585385348|FG001|Overall Study|Missed Visit|1|||
162090855|NCT01627249|585385349|FG002|Overall Study|Missed Visit|0|||
162090856|NCT00796718|585385350|FG000|Overall Study|Adverse Event|2|||
162090857|NCT00796718|585385350|FG000|Overall Study|Exclusion Criteria|1|||
162090858|NCT00796718|585385350|FG000|Overall Study|Lost to Follow-up|5|||
162090859|NCT00796718|585385350|FG000|Overall Study|Withdrawal by Informed Consent|1|||
162090860|NCT03266588|585385351|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
162090861|NCT03266588|585385352|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
162090862|NCT03266588|585385353|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
162090863|NCT03266588|585385351|FG000|Observational Period|Withdrawal by Subject|44|||
162090864|NCT03266588|585385352|FG001|Observational Period|Withdrawal by Subject|22|||
162090865|NCT03266588|585385353|FG002|Observational Period|Withdrawal by Subject|13|||
162090866|NCT03266588|585385351|FG000|Observational Period|Non-compliance|18|||
162090867|NCT03266588|585385352|FG001|Observational Period|Non-compliance|12|||
162090868|NCT03266588|585385353|FG002|Observational Period|Non-compliance|10|||
162090869|NCT03266588|585385351|FG000|Observational Period|Lost to Follow-up|8|||
162090870|NCT03266588|585385352|FG001|Observational Period|Lost to Follow-up|12|||
162090871|NCT03266588|585385353|FG002|Observational Period|Lost to Follow-up|4|||
162090872|NCT03266588|585385351|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
162090873|NCT03266588|585385352|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
162090874|NCT03266588|585385353|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
162090875|NCT03266588|585385351|FG000|Observational Period|Protocol Deviation|1|||
162090876|NCT03266588|585385352|FG001|Observational Period|Protocol Deviation|0|||
162090877|NCT03266588|585385353|FG002|Observational Period|Protocol Deviation|0|||
162090878|NCT03266588|585385351|FG000|Observational Period|Other Reasons|3|||
162090879|NCT03266588|585385352|FG001|Observational Period|Other Reasons|0|||
162090880|NCT03266588|585385353|FG002|Observational Period|Other Reasons|1|||
162090881|NCT03266588|585385351|FG000|Long-term Treatment Period|Adverse Event|33|||
162090882|NCT03266588|585385352|FG001|Long-term Treatment Period|Adverse Event|17|||
162090883|NCT03266588|585385353|FG002|Long-term Treatment Period|Adverse Event|8|||
162090884|NCT03266588|585385351|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
162090885|NCT03266588|585385352|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
162090886|NCT03266588|585385353|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
162090887|NCT03266588|585385351|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
162090888|NCT03266588|585385352|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
162090889|NCT03266588|585385353|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
162090890|NCT03266588|585385351|FG000|Long-term Treatment Period|Non-Compliance|126|||
162090891|NCT03266588|585385352|FG001|Long-term Treatment Period|Non-Compliance|57|||
162090892|NCT03266588|585385353|FG002|Long-term Treatment Period|Non-Compliance|7|||
162090893|NCT03266588|585385351|FG000|Long-term Treatment Period|Pregnancy|11|||
162090894|NCT03266588|585385352|FG001|Long-term Treatment Period|Pregnancy|5|||
162090895|NCT03266588|585385353|FG002|Long-term Treatment Period|Pregnancy|0|||
162090896|NCT03266588|585385351|FG000|Long-term Treatment Period|Protocol Deviation|17|||
162090897|NCT03266588|585385352|FG001|Long-term Treatment Period|Protocol Deviation|10|||
162090898|NCT03266588|585385353|FG002|Long-term Treatment Period|Protocol Deviation|4|||
162090899|NCT03266588|585385351|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
162090900|NCT03266588|585385352|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
162090901|NCT03266588|585385353|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
162090902|NCT03266588|585385351|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
162090903|NCT03266588|585385352|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
162090904|NCT03266588|585385353|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
162090905|NCT03266588|585385351|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
162090906|NCT03266588|585385352|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
162090907|NCT03266588|585385353|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
162090908|NCT03266588|585385351|FG000|Long-term Treatment Period|Other Reasons|5|||
162090909|NCT03266588|585385352|FG001|Long-term Treatment Period|Other Reasons|0|||
162090910|NCT03266588|585385353|FG002|Long-term Treatment Period|Other Reasons|0|||
162090911|NCT03266588|585385351|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
162090912|NCT03266588|585385352|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
162090913|NCT03266588|585385353|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
162090914|NCT01073618|585385356|FG000|Overall Study|Death|208|||
162090915|NCT01073618|585385356|FG000|Overall Study|Adverse Event|19|||
162090916|NCT01073618|585385356|FG000|Overall Study|Other|80|||
162090917|NCT02044510|585385357|FG000|Overall Study|Adverse Event|1|||
162090918|NCT02044510|585385358|FG001|Overall Study|Adverse Event|2|||
162090919|NCT02039505|585385364|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
162090920|NCT02039505|585385365|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
162090921|NCT02039505|585385366|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
162090922|NCT02039505|585385367|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
162090923|NCT02039505|585385368|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
162090924|NCT02039505|585385369|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
162090925|NCT02039505|585385370|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
162090926|NCT02039505|585385364|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
162090927|NCT02039505|585385365|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
162090928|NCT02039505|585385366|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
162090929|NCT02039505|585385367|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
162090930|NCT02039505|585385368|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
162090931|NCT02039505|585385369|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
162090932|NCT02039505|585385370|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
162090933|NCT02039505|585385364|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
162090934|NCT02039505|585385365|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
162090935|NCT02039505|585385366|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
162090936|NCT02039505|585385367|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
162090937|NCT02039505|585385368|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
162090938|NCT02039505|585385369|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
162090939|NCT02039505|585385370|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
162090940|NCT02039505|585385364|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
162090941|NCT02039505|585385365|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
162090942|NCT02039505|585385366|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
162090943|NCT02039505|585385367|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
162090944|NCT02039505|585385368|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
162090945|NCT02039505|585385369|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
162090946|NCT02039505|585385370|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
162090947|NCT02039505|585385364|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
162090948|NCT02039505|585385365|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
162090949|NCT02039505|585385366|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
162090950|NCT02039505|585385367|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
162090951|NCT02039505|585385368|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
162090952|NCT02039505|585385369|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
162090953|NCT02039505|585385370|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
162090954|NCT02039505|585385364|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
162090955|NCT02039505|585385365|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
162090956|NCT02039505|585385366|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
162090957|NCT02039505|585385367|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
162090958|NCT02039505|585385368|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
162090959|NCT02039505|585385369|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
162090960|NCT02039505|585385370|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
162090961|NCT02039505|585385364|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
162090962|NCT02039505|585385365|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
162090963|NCT02039505|585385366|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
162090964|NCT02039505|585385367|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
162090965|NCT02039505|585385368|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
162090966|NCT02039505|585385369|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
162090967|NCT02039505|585385370|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
162090968|NCT02039505|585385364|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
162090969|NCT02039505|585385365|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
162090970|NCT02039505|585385366|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
162090971|NCT02039505|585385367|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
162090972|NCT02039505|585385368|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
162090973|NCT02039505|585385369|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
162090974|NCT02039505|585385370|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
162090975|NCT02039505|585385364|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
162090976|NCT02039505|585385365|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
162090977|NCT02039505|585385366|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
162090978|NCT02039505|585385367|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
162090979|NCT02039505|585385368|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
162090980|NCT02039505|585385369|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
162090981|NCT02039505|585385370|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
162090982|NCT02039505|585385364|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
162090983|NCT02039505|585385365|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
162090984|NCT02039505|585385366|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
162090985|NCT02039505|585385367|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
162090986|NCT02039505|585385368|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
162090987|NCT02039505|585385369|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
162090988|NCT02039505|585385370|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
162090989|NCT02039505|585385364|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
162090990|NCT02039505|585385365|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
162090991|NCT02039505|585385366|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
162090992|NCT02039505|585385367|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
162090993|NCT02039505|585385368|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
162090994|NCT02039505|585385369|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
162090995|NCT02039505|585385370|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
162090996|NCT00353704|585385377|FG000|Overall Study|Protocol Violation|3|||
162090997|NCT00353704|585385378|FG001|Overall Study|Protocol Violation|1|||
162090998|NCT01154166|585385379|FG000|Overall Study|Adverse Event|14|||
162090999|NCT01154166|585385380|FG001|Overall Study|Adverse Event|9|||
162091000|NCT01154166|585385379|FG000|Overall Study|Lost to Follow-up|1|||
162091001|NCT01154166|585385380|FG001|Overall Study|Lost to Follow-up|1|||
162091002|NCT01154166|585385379|FG000|Overall Study|Protocol Violation|4|||
162091003|NCT01154166|585385380|FG001|Overall Study|Protocol Violation|1|||
162091004|NCT01154166|585385379|FG000|Overall Study|Withdrawal by Subject|10|||
162091005|NCT01154166|585385380|FG001|Overall Study|Withdrawal by Subject|1|||
162091006|NCT01154166|585385379|FG000|Overall Study|Lack of Efficacy|3|||
162091007|NCT01154166|585385380|FG001|Overall Study|Lack of Efficacy|0|||
162091008|NCT01154166|585385379|FG000|Overall Study|Disease Progression|1|||
162091009|NCT01154166|585385380|FG001|Overall Study|Disease Progression|0|||
162091010|NCT01154166|585385379|FG000|Overall Study|Poor Compliance|1|||
162091011|NCT01154166|585385380|FG001|Overall Study|Poor Compliance|0|||
162091012|NCT01375049|585385381|FG000|Overall Study|Adverse Event|2|||
162091013|NCT01375049|585385381|FG000|Overall Study|Lost to Follow-up|1|||
162091014|NCT01375049|585385381|FG000|Overall Study|Withdrawal by Subject|2|||
162091015|NCT01375049|585385381|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
162091016|NCT03614793|585385382|FG000|Overall Study|Lost to Follow-up|1|||
162091017|NCT03614793|585385383|FG001|Overall Study|Lost to Follow-up|2|||
162091018|NCT03614793|585385382|FG000|Overall Study|Lack of Efficacy|0|||
162091019|NCT03614793|585385383|FG001|Overall Study|Lack of Efficacy|5|||
162091020|NCT03614793|585385382|FG000|Overall Study|Withdrawal by Subject|0|||
162091021|NCT03614793|585385383|FG001|Overall Study|Withdrawal by Subject|1|||
162091022|NCT03614793|585385382|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
162091023|NCT03614793|585385383|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
162091024|NCT02082522|585385384|FG000|Overall Study|Sponsor termination|5|||
162091025|NCT02082522|585385385|FG001|Overall Study|Sponsor termination|3|||
162091026|NCT02082522|585385384|FG000|Overall Study|Withdrawal by Subject|2|||
162091027|NCT02082522|585385385|FG001|Overall Study|Withdrawal by Subject|4|||
162091028|NCT02082522|585385384|FG000|Overall Study|Death|1|||
162091029|NCT02082522|585385385|FG001|Overall Study|Death|0|||
162091030|NCT02082522|585385384|FG000|Overall Study|Lost to Follow-up|1|||
162091031|NCT02082522|585385385|FG001|Overall Study|Lost to Follow-up|0|||
162091032|NCT02082522|585385384|FG000|Overall Study|Physician Decision|3|||
162091033|NCT02082522|585385385|FG001|Overall Study|Physician Decision|1|||
162091034|NCT02082522|585385384|FG000|Overall Study|Disease progression|2|||
162091035|NCT02082522|585385385|FG001|Overall Study|Disease progression|2|||
162091036|NCT02082522|585385384|FG000|Overall Study|Chemotherapy change|1|||
162091037|NCT02082522|585385385|FG001|Overall Study|Chemotherapy change|3|||
162091038|NCT00633984|585385386|FG000|Overall Study|Lost to Follow-up|0|||
162091039|NCT00633984|585385387|FG001|Overall Study|Lost to Follow-up|6|||
162091040|NCT00633984|585385386|FG000|Overall Study|Withdrawal by Subject|8|||
162091041|NCT00633984|585385387|FG001|Overall Study|Withdrawal by Subject|7|||
162091042|NCT00633984|585385386|FG000|Overall Study|Hospitalized|1|||
162091043|NCT00633984|585385387|FG001|Overall Study|Hospitalized|0|||
162091044|NCT02840877|585385388|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
162091045|NCT02840877|585385388|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
162091046|NCT02840877|585385388|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
162091047|NCT02840877|585385388|FG000|Baseline to 12 Weeks|Death|1|||
162091048|NCT02840877|585385388|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
162091049|NCT02840877|585385388|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
162091050|NCT02840877|585385388|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
162091051|NCT02840877|585385388|FG000|12 Weeks to 6 Months|Treatment failure|1|||
162091052|NCT02840877|585385388|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
162091053|NCT02840877|585385388|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
162091054|NCT02840877|585385388|FG000|12 Weeks to 6 Months|Death|1|||
162091055|NCT02840877|585385388|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
162091056|NCT02840877|585385388|FG000|6 Months to 18 Months|Treatment failure|7|||
162091057|NCT02840877|585385388|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
162091058|NCT02840877|585385388|FG000|6 Months to 18 Months|Moved/transferred out|6|||
162091059|NCT02840877|585385388|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
162091060|NCT02840877|585385388|FG000|6 Months to 18 Months|Death|4|||
162091061|NCT02840877|585385388|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
162091062|NCT02840877|585385388|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
162091063|NCT02840877|585385388|FG000|6 Months to 18 Months|Still in study.|14|||
162091064|NCT02496884|585385389|FG000|Overall Study|Counted twice as enrolled|2|||
162091065|NCT02496884|585385390|FG001|Overall Study|Counted twice as enrolled|0|||
162091066|NCT02496884|585385391|FG002|Overall Study|Counted twice as enrolled|0|||
162091067|NCT02496884|585385392|FG003|Overall Study|Counted twice as enrolled|0|||
162091068|NCT02496884|585385389|FG000|Overall Study|Withdrawal by Subject|0|||
162091069|NCT02496884|585385390|FG001|Overall Study|Withdrawal by Subject|3|||
162091070|NCT02496884|585385391|FG002|Overall Study|Withdrawal by Subject|0|||
162091071|NCT02496884|585385392|FG003|Overall Study|Withdrawal by Subject|0|||
162091072|NCT01168999|585385393|FG000|Overall Study|Lost to Follow-up|2|||
162091073|NCT01168999|585385394|FG001|Overall Study|Lost to Follow-up|1|||
162091074|NCT01168999|585385395|FG002|Overall Study|Lost to Follow-up|0|||
162091075|NCT01168999|585385396|FG003|Overall Study|Lost to Follow-up|0|||
162091076|NCT04317586|585385397|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
162091077|NCT04317586|585385397|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
162091078|NCT01276327|585385400|FG000|Overall Study|Adverse Event|1|||
162091079|NCT01276327|585385401|FG001|Overall Study|Adverse Event|3|||
162091080|NCT01276327|585385400|FG000|Overall Study|Withdrawal by Subject|1|||
162091081|NCT01276327|585385401|FG001|Overall Study|Withdrawal by Subject|0|||
162091082|NCT00807092|585385402|FG000|Overall Study|Adverse Event|0|||
162091083|NCT00807092|585385403|FG001|Overall Study|Adverse Event|1|||
162091084|NCT00807092|585385402|FG000|Overall Study|Protocol Violation|0|||
162091085|NCT00807092|585385403|FG001|Overall Study|Protocol Violation|2|||
162091086|NCT00807092|585385402|FG000|Overall Study|Withdrawal by Subject|1|||
162091087|NCT00807092|585385403|FG001|Overall Study|Withdrawal by Subject|0|||
162091088|NCT00807092|585385402|FG000|Overall Study|CGMS data collection failed|0|||
162091089|NCT00807092|585385403|FG001|Overall Study|CGMS data collection failed|1|||
162091090|NCT01794949|585385404|FG000|Overall Study|Lost to Follow-up|1|||
162091091|NCT01794949|585385405|FG001|Overall Study|Lost to Follow-up|0|||
162091092|NCT03003676|585385406|FG000|Overall Study|Lack of Efficacy|5|||
162091093|NCT03003676|585385407|FG001|Overall Study|Lack of Efficacy|7|||
162091094|NCT03003676|585385406|FG000|Overall Study|Withdrawal by Subject|0|||
162091095|NCT03003676|585385407|FG001|Overall Study|Withdrawal by Subject|1|||
162091096|NCT03003676|585385406|FG000|Overall Study|Hepatitis B infection|1|||
162091097|NCT03003676|585385407|FG001|Overall Study|Hepatitis B infection|0|||
162091098|NCT00887341|585385426|FG000|Overall Study|Refused treatment|1|||
162091099|NCT00887341|585385427|FG001|Overall Study|Refused treatment|0|||
162091100|NCT00887341|585385426|FG000|Overall Study|Withdrawal by Subject|1|||
162091101|NCT00887341|585385427|FG001|Overall Study|Withdrawal by Subject|1|||
162091102|NCT00887341|585385426|FG000|Overall Study|Adverse Event|0|||
162091103|NCT00887341|585385427|FG001|Overall Study|Adverse Event|1|||
162091104|NCT00887341|585385426|FG000|Overall Study|Lost to Follow-up|0|||
162091105|NCT00887341|585385427|FG001|Overall Study|Lost to Follow-up|1|||
162091106|NCT02617589|585385428|FG000|Randomization|Request to Discontinue Study Treatment|1|||
162091107|NCT02617589|585385429|FG001|Randomization|Request to Discontinue Study Treatment|3|||
162091108|NCT02617589|585385428|FG000|Randomization|Participant Withdrew Consent|1|||
162091109|NCT02617589|585385429|FG001|Randomization|Participant Withdrew Consent|2|||
162091110|NCT02617589|585385428|FG000|Treatment|Other Reasons|3|||
162091111|NCT02617589|585385429|FG001|Treatment|Other Reasons|3|||
162091112|NCT02617589|585385428|FG000|Treatment|Poor/Non Compliance|1|||
162091113|NCT02617589|585385429|FG001|Treatment|Poor/Non Compliance|1|||
162091114|NCT02617589|585385428|FG000|Treatment|Maximum Clinical Benefit|0|||
162091115|NCT02617589|585385429|FG001|Treatment|Maximum Clinical Benefit|2|||
162091116|NCT02617589|585385428|FG000|Treatment|Participant Withdrew Consent|2|||
162091117|NCT02617589|585385429|FG001|Treatment|Participant Withdrew Consent|6|||
162091118|NCT02617589|585385428|FG000|Treatment|Participant Request to Discontinue|12|||
162091119|NCT02617589|585385429|FG001|Treatment|Participant Request to Discontinue|21|||
162091120|NCT02617589|585385428|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
162091121|NCT02617589|585385429|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
162091122|NCT02617589|585385428|FG000|Treatment|Death|1|||
162091123|NCT02617589|585385429|FG001|Treatment|Death|1|||
162091124|NCT02617589|585385428|FG000|Treatment|Study Drug Toxicity|27|||
162091125|NCT02617589|585385429|FG001|Treatment|Study Drug Toxicity|20|||
162091126|NCT02617589|585385428|FG000|Treatment|Disease Progression|216|||
162091127|NCT02617589|585385429|FG001|Treatment|Disease Progression|136|||
162091128|NCT01752933|585385432|FG000|Treatment|Disease Progression|3|||
162091129|NCT01752933|585385433|FG001|Treatment|Disease Progression|29|||
162091130|NCT01752933|585385432|FG000|Treatment|Withdrawal by Subject|0|||
162091131|NCT01752933|585385433|FG001|Treatment|Withdrawal by Subject|5|||
162091132|NCT01752933|585385432|FG000|Treatment|Adverse Event|1|||
162091133|NCT01752933|585385433|FG001|Treatment|Adverse Event|4|||
162091134|NCT01752933|585385432|FG000|Treatment|Physician Decision|0|||
162091135|NCT01752933|585385433|FG001|Treatment|Physician Decision|3|||
162091136|NCT01752933|585385432|FG000|Treatment|Death|0|||
162091137|NCT01752933|585385433|FG001|Treatment|Death|2|||
162091138|NCT01752933|585385432|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
162091139|NCT01752933|585385433|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
162091140|NCT01752933|585385432|FG000|Treatment|Patient noncompliant|0|||
162091141|NCT01752933|585385433|FG001|Treatment|Patient noncompliant|1|||
162091142|NCT01752933|585385432|FG000|Treatment|Patient unable to travel to appointments|0|||
162091143|NCT01752933|585385433|FG001|Treatment|Patient unable to travel to appointments|1|||
162091144|NCT01752933|585385432|FG000|Overall Study and Follow-up|Death|4|||
162091145|NCT01752933|585385433|FG001|Overall Study and Follow-up|Death|34|||
162091146|NCT01752933|585385432|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
162091147|NCT01752933|585385433|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
162091148|NCT01752933|585385432|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
162091149|NCT01752933|585385433|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
162091150|NCT01752933|585385432|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
162091151|NCT01752933|585385433|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
162091152|NCT01591681|585385434|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
162091153|NCT01591681|585385434|FG000|Overall Study|Failed to use system during run-in|1|||
162091154|NCT03062891|585385435|FG000|Overall Study|Withdrawal by Subject|2|||
162091155|NCT03062891|585385436|FG001|Overall Study|Withdrawal by Subject|0|||
162091156|NCT03062891|585385435|FG000|Overall Study|Lost to Follow-up|50|||
162091157|NCT03062891|585385436|FG001|Overall Study|Lost to Follow-up|38|||
162091158|NCT05402995|585385440|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
162091159|NCT05402995|585385441|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
162091160|NCT05402995|585385442|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
162091161|NCT05402995|585385443|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
162091162|NCT00958880|585385450|FG000|Overall Study|Lost to Follow-up|2|||
162091163|NCT00958880|585385451|FG001|Overall Study|Lost to Follow-up|2|||
162091164|NCT00298831|585385452|FG000|Overall Study|Adverse Event|1|||
162091165|NCT00298831|585385452|FG000|Overall Study|Lost to Follow-up|3|||
162091166|NCT00298831|585385452|FG000|Overall Study|Withdrawal by Subject|1|||
162091167|NCT00298831|585385452|FG000|Overall Study|Participants did not receive treatment|27|||
162091168|NCT01516879|585385453|FG000|Overall Study|Withdrawal by Subject|9|||
162091169|NCT01516879|585385454|FG001|Overall Study|Withdrawal by Subject|11|||
162091170|NCT01516879|585385453|FG000|Overall Study|Death|0|||
162091171|NCT01516879|585385454|FG001|Overall Study|Death|2|||
162091172|NCT01516879|585385453|FG000|Overall Study|Lost to Follow-up|2|||
162091173|NCT01516879|585385454|FG001|Overall Study|Lost to Follow-up|11|||
162091174|NCT01516879|585385453|FG000|Overall Study|Other|5|||
162091175|NCT01516879|585385454|FG001|Overall Study|Other|10|||
162091176|NCT04568122|585385455|FG000|Overall Study|Lost to Follow-up|48|||
162091177|NCT04568122|585385456|FG001|Overall Study|Lost to Follow-up|44|||
162091178|NCT04568122|585385457|FG002|Overall Study|Lost to Follow-up|4|||
162091179|NCT04568122|585385458|FG003|Overall Study|Lost to Follow-up|0|||
162091180|NCT04568122|585385459|FG004|Overall Study|Lost to Follow-up|0|||
162091181|NCT01916304|585385465|FG000|Overall Study|Screening failure|17|||
162091182|NCT04666441|585385466|FG000|Overall Study|Lost to Follow-up|1|||
162091183|NCT04666441|585385467|FG001|Overall Study|Lost to Follow-up|4|||
162091184|NCT04666441|585385468|FG002|Overall Study|Lost to Follow-up|1|||
162091185|NCT04666441|585385469|FG003|Overall Study|Lost to Follow-up|3|||
162091186|NCT04666441|585385470|FG004|Overall Study|Lost to Follow-up|0|||
162091187|NCT04666441|585385471|FG005|Overall Study|Lost to Follow-up|2|||
162091188|NCT04666441|585385472|FG006|Overall Study|Lost to Follow-up|2|||
162091189|NCT04666441|585385473|FG007|Overall Study|Lost to Follow-up|2|||
162091190|NCT04666441|585385466|FG000|Overall Study|Subject Decision|1|||
162091191|NCT04666441|585385467|FG001|Overall Study|Subject Decision|1|||
162091192|NCT04666441|585385468|FG002|Overall Study|Subject Decision|3|||
162091193|NCT04666441|585385469|FG003|Overall Study|Subject Decision|1|||
162091194|NCT04666441|585385470|FG004|Overall Study|Subject Decision|0|||
162091195|NCT04666441|585385471|FG005|Overall Study|Subject Decision|1|||
162091196|NCT04666441|585385472|FG006|Overall Study|Subject Decision|3|||
162091197|NCT04666441|585385473|FG007|Overall Study|Subject Decision|2|||
162091198|NCT00766415|585385484|FG000|Overall Study|Withdrawal by Subject|0|||
162091199|NCT00766415|585385485|FG001|Overall Study|Withdrawal by Subject|1|||
162091200|NCT01114516|585385490|FG000|Overall Study|Lost to Follow-up|2|||
162091201|NCT01114516|585385491|FG001|Overall Study|Lost to Follow-up|1|||
162091202|NCT01431508|585385496|FG000|Overall Study|Lack of Efficacy|1|||
162091203|NCT01431508|585385496|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
162091204|NCT00132769|585385497|FG000|Overall Study|Withdrawal by Subject|1|||
162091205|NCT00132769|585385498|FG001|Overall Study|Withdrawal by Subject|3|||
162091206|NCT00132769|585385497|FG000|Overall Study|Lack of Efficacy|7|||
162091207|NCT00132769|585385498|FG001|Overall Study|Lack of Efficacy|6|||
162091208|NCT00132769|585385497|FG000|Overall Study|Adverse Event|2|||
162091209|NCT00132769|585385498|FG001|Overall Study|Adverse Event|1|||
162091210|NCT00132769|585385497|FG000|Overall Study|Protocol Violation|1|||
162091211|NCT00132769|585385498|FG001|Overall Study|Protocol Violation|1|||
162091212|NCT00129259|585385499|FG000|Overall Study|Lost to Follow-up|1|||
162091213|NCT00129259|585385500|FG001|Overall Study|Lost to Follow-up|1|||
162091214|NCT00129259|585385499|FG000|Overall Study|Withdrawal by Subject|2|||
162091215|NCT00129259|585385500|FG001|Overall Study|Withdrawal by Subject|1|||
162091216|NCT00129259|585385499|FG000|Overall Study|Only available minimal phone assessments|0|||
162091217|NCT00129259|585385500|FG001|Overall Study|Only available minimal phone assessments|1|||
162091218|NCT02758236|585385502|FG000|Overall Study|Investigator discretion|43|||
162091219|NCT01632579|585385505|FG000|Washout Period|Adverse Event|1|||
162091220|NCT01632579|585385506|FG001|Washout Period|Adverse Event|0|||
162091221|NCT01632579|585385507|FG002|Washout Period|Adverse Event|0|||
162091222|NCT01632579|585385508|FG003|Washout Period|Adverse Event|0|||
162091223|NCT01632579|585385509|FG004|Washout Period|Adverse Event|0|||
162091224|NCT01632579|585385510|FG005|Washout Period|Adverse Event|0|||
162091225|NCT01632579|585385511|FG006|Washout Period|Adverse Event|0|||
162091226|NCT01632579|585385512|FG007|Washout Period|Adverse Event|0|||
162091227|NCT01632579|585385513|FG008|Washout Period|Adverse Event|0|||
162091228|NCT01632579|585385505|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
162091229|NCT01632579|585385506|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
162091230|NCT01632579|585385507|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
162091231|NCT01632579|585385508|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
162091232|NCT01632579|585385509|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
162091233|NCT01632579|585385510|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
162091234|NCT01632579|585385511|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
162091235|NCT01632579|585385512|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
162091236|NCT01632579|585385513|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
162091237|NCT01722331|585387590|FG000|Part 1|Adverse Event|5|||
162091238|NCT01722331|585387591|FG001|Part 1|Adverse Event|0|||
162091239|NCT01722331|585387592|FG002|Part 1|Adverse Event|0|||
162091240|NCT01722331|585387593|FG003|Part 1|Adverse Event|0|||
162091241|NCT01722331|585387594|FG004|Part 1|Adverse Event|0|||
162091242|NCT01722331|585387595|FG005|Part 1|Adverse Event|0|||
162091243|NCT01722331|585387596|FG006|Part 1|Adverse Event|0|||
162091244|NCT01722331|585387590|FG000|Part 1|Lack of Efficacy|0|||
162091245|NCT01722331|585387591|FG001|Part 1|Lack of Efficacy|0|||
162091246|NCT01722331|585387592|FG002|Part 1|Lack of Efficacy|1|||
162091247|NCT01722331|585387593|FG003|Part 1|Lack of Efficacy|0|||
162091248|NCT01722331|585387594|FG004|Part 1|Lack of Efficacy|2|||
162091249|NCT01722331|585387595|FG005|Part 1|Lack of Efficacy|0|||
162091250|NCT01722331|585387596|FG006|Part 1|Lack of Efficacy|0|||
162091251|NCT01722331|585387590|FG000|Part 1|Lost to Follow-up|1|||
162091252|NCT01722331|585387591|FG001|Part 1|Lost to Follow-up|0|||
162091253|NCT01722331|585387592|FG002|Part 1|Lost to Follow-up|2|||
162091254|NCT01722331|585387593|FG003|Part 1|Lost to Follow-up|0|||
162091255|NCT01722331|585387594|FG004|Part 1|Lost to Follow-up|1|||
162091256|NCT01722331|585387595|FG005|Part 1|Lost to Follow-up|0|||
162091257|NCT01722331|585387596|FG006|Part 1|Lost to Follow-up|0|||
162091258|NCT01722331|585387590|FG000|Part 1|Physician Decision|0|||
162091259|NCT01722331|585387591|FG001|Part 1|Physician Decision|0|||
162091260|NCT01722331|585387592|FG002|Part 1|Physician Decision|3|||
162091261|NCT01722331|585387593|FG003|Part 1|Physician Decision|0|||
162091262|NCT01722331|585387594|FG004|Part 1|Physician Decision|1|||
162091263|NCT01722331|585387595|FG005|Part 1|Physician Decision|0|||
162091264|NCT01722331|585387596|FG006|Part 1|Physician Decision|0|||
162091265|NCT01722331|585387590|FG000|Part 1|Pregnancy|1|||
162091266|NCT01722331|585387591|FG001|Part 1|Pregnancy|0|||
162091267|NCT01722331|585387592|FG002|Part 1|Pregnancy|0|||
162091268|NCT01722331|585387593|FG003|Part 1|Pregnancy|0|||
162091269|NCT01722331|585387594|FG004|Part 1|Pregnancy|0|||
162091270|NCT01722331|585387595|FG005|Part 1|Pregnancy|0|||
162091271|NCT01722331|585387596|FG006|Part 1|Pregnancy|0|||
162091272|NCT01722331|585387590|FG000|Part 1|Progressive Disease|0|||
162091273|NCT01722331|585387591|FG001|Part 1|Progressive Disease|0|||
162091274|NCT01722331|585387592|FG002|Part 1|Progressive Disease|0|||
162091275|NCT01722331|585387593|FG003|Part 1|Progressive Disease|0|||
162091276|NCT01722331|585387594|FG004|Part 1|Progressive Disease|1|||
162091277|NCT01722331|585387595|FG005|Part 1|Progressive Disease|0|||
162091278|NCT01722331|585387596|FG006|Part 1|Progressive Disease|0|||
162091279|NCT01722331|585387590|FG000|Part 1|Protocol Violation|1|||
162091280|NCT01722331|585387591|FG001|Part 1|Protocol Violation|0|||
162091281|NCT01722331|585387592|FG002|Part 1|Protocol Violation|0|||
162091282|NCT01722331|585387593|FG003|Part 1|Protocol Violation|0|||
162091283|NCT01722331|585387594|FG004|Part 1|Protocol Violation|1|||
162091284|NCT01722331|585387595|FG005|Part 1|Protocol Violation|0|||
162091285|NCT01722331|585387596|FG006|Part 1|Protocol Violation|0|||
162091286|NCT01722331|585387590|FG000|Part 1|Withdrawal by Subject|2|||
162091287|NCT01722331|585387591|FG001|Part 1|Withdrawal by Subject|0|||
162091288|NCT01722331|585387592|FG002|Part 1|Withdrawal by Subject|3|||
162091289|NCT01722331|585387593|FG003|Part 1|Withdrawal by Subject|0|||
162091290|NCT01722331|585387594|FG004|Part 1|Withdrawal by Subject|3|||
162091291|NCT01722331|585387595|FG005|Part 1|Withdrawal by Subject|0|||
162091292|NCT01722331|585387596|FG006|Part 1|Withdrawal by Subject|0|||
162091293|NCT01722331|585387590|FG000|Part 2|Adverse Event|3|||
162091294|NCT01722331|585387591|FG001|Part 2|Adverse Event|0|||
162091295|NCT01722331|585387592|FG002|Part 2|Adverse Event|0|||
162091296|NCT01722331|585387593|FG003|Part 2|Adverse Event|0|||
162091297|NCT01722331|585387594|FG004|Part 2|Adverse Event|0|||
162091298|NCT01722331|585387595|FG005|Part 2|Adverse Event|1|||
162091299|NCT01722331|585387596|FG006|Part 2|Adverse Event|0|||
162091300|NCT01722331|585387590|FG000|Part 2|Lack of Efficacy|3|||
162091301|NCT01722331|585387591|FG001|Part 2|Lack of Efficacy|0|||
162091302|NCT01722331|585387592|FG002|Part 2|Lack of Efficacy|11|||
162091303|NCT01722331|585387593|FG003|Part 2|Lack of Efficacy|0|||
162091304|NCT01722331|585387594|FG004|Part 2|Lack of Efficacy|0|||
162091305|NCT01722331|585387595|FG005|Part 2|Lack of Efficacy|3|||
162091306|NCT01722331|585387596|FG006|Part 2|Lack of Efficacy|3|||
162091307|NCT01722331|585387590|FG000|Part 2|Lost to Follow-up|0|||
162091308|NCT01722331|585387591|FG001|Part 2|Lost to Follow-up|0|||
162091309|NCT01722331|585387592|FG002|Part 2|Lost to Follow-up|3|||
162091310|NCT01722331|585387593|FG003|Part 2|Lost to Follow-up|0|||
162091311|NCT01722331|585387594|FG004|Part 2|Lost to Follow-up|0|||
162091312|NCT01722331|585387595|FG005|Part 2|Lost to Follow-up|1|||
162091313|NCT01722331|585387596|FG006|Part 2|Lost to Follow-up|1|||
162091314|NCT01722331|585387590|FG000|Part 2|Non-Compliance with Study Drug|1|||
162091315|NCT01722331|585387591|FG001|Part 2|Non-Compliance with Study Drug|0|||
162091316|NCT01722331|585387592|FG002|Part 2|Non-Compliance with Study Drug|1|||
162091317|NCT01722331|585387593|FG003|Part 2|Non-Compliance with Study Drug|0|||
162091318|NCT01722331|585387594|FG004|Part 2|Non-Compliance with Study Drug|0|||
162091319|NCT01722331|585387595|FG005|Part 2|Non-Compliance with Study Drug|0|||
162091320|NCT01722331|585387596|FG006|Part 2|Non-Compliance with Study Drug|0|||
162091321|NCT01722331|585387590|FG000|Part 2|Physician Decision|0|||
162091322|NCT01722331|585387591|FG001|Part 2|Physician Decision|0|||
162091323|NCT01722331|585387592|FG002|Part 2|Physician Decision|2|||
162091324|NCT01722331|585387593|FG003|Part 2|Physician Decision|0|||
162091325|NCT01722331|585387594|FG004|Part 2|Physician Decision|0|||
162091326|NCT01722331|585387595|FG005|Part 2|Physician Decision|0|||
162091327|NCT01722331|585387596|FG006|Part 2|Physician Decision|0|||
162091328|NCT01722331|585387590|FG000|Part 2|Pregnancy|0|||
162091329|NCT01722331|585387591|FG001|Part 2|Pregnancy|0|||
162091330|NCT01722331|585387592|FG002|Part 2|Pregnancy|0|||
162091331|NCT01722331|585387593|FG003|Part 2|Pregnancy|0|||
162091332|NCT01722331|585387594|FG004|Part 2|Pregnancy|0|||
162091333|NCT01722331|585387595|FG005|Part 2|Pregnancy|1|||
162091334|NCT01722331|585387596|FG006|Part 2|Pregnancy|0|||
162091335|NCT01722331|585387590|FG000|Part 2|Progressive Disease|0|||
162091336|NCT01722331|585387591|FG001|Part 2|Progressive Disease|0|||
162091337|NCT01722331|585387592|FG002|Part 2|Progressive Disease|1|||
162091338|NCT01722331|585387593|FG003|Part 2|Progressive Disease|0|||
162091339|NCT01722331|585387594|FG004|Part 2|Progressive Disease|0|||
162091340|NCT01722331|585387595|FG005|Part 2|Progressive Disease|0|||
162091341|NCT01722331|585387596|FG006|Part 2|Progressive Disease|0|||
162091342|NCT01722331|585387590|FG000|Part 2|Protocol Violation|1|||
162091343|NCT01722331|585387591|FG001|Part 2|Protocol Violation|0|||
162091344|NCT01722331|585387592|FG002|Part 2|Protocol Violation|0|||
162091345|NCT01722331|585387593|FG003|Part 2|Protocol Violation|0|||
162091346|NCT01722331|585387594|FG004|Part 2|Protocol Violation|0|||
162091347|NCT01722331|585387595|FG005|Part 2|Protocol Violation|0|||
162091348|NCT01722331|585387596|FG006|Part 2|Protocol Violation|0|||
162091349|NCT01722331|585387590|FG000|Part 2|Withdrawal by Subject|5|||
162091350|NCT01722331|585387591|FG001|Part 2|Withdrawal by Subject|0|||
162091351|NCT01722331|585387592|FG002|Part 2|Withdrawal by Subject|3|||
162091352|NCT01722331|585387593|FG003|Part 2|Withdrawal by Subject|0|||
162091353|NCT01722331|585387594|FG004|Part 2|Withdrawal by Subject|0|||
162091354|NCT01722331|585387595|FG005|Part 2|Withdrawal by Subject|2|||
162091355|NCT01722331|585387596|FG006|Part 2|Withdrawal by Subject|2|||
162091356|NCT01722331|585387590|FG000|Part 2|Other Protocol Specified Criteria|6|||
162091357|NCT01722331|585387591|FG001|Part 2|Other Protocol Specified Criteria|0|||
162091358|NCT01722331|585387592|FG002|Part 2|Other Protocol Specified Criteria|10|||
162091359|NCT01722331|585387593|FG003|Part 2|Other Protocol Specified Criteria|0|||
162091360|NCT01722331|585387594|FG004|Part 2|Other Protocol Specified Criteria|0|||
162091361|NCT01722331|585387595|FG005|Part 2|Other Protocol Specified Criteria|2|||
162091362|NCT01722331|585387596|FG006|Part 2|Other Protocol Specified Criteria|1|||
162091363|NCT01722331|585387590|FG000|Part 3|Adverse Event|2|||
162091364|NCT01722331|585387591|FG001|Part 3|Adverse Event|2|||
162091365|NCT01722331|585387592|FG002|Part 3|Adverse Event|0|||
162091366|NCT01722331|585387593|FG003|Part 3|Adverse Event|1|||
162091367|NCT01722331|585387594|FG004|Part 3|Adverse Event|0|||
162091368|NCT01722331|585387595|FG005|Part 3|Adverse Event|0|||
162091369|NCT01722331|585387596|FG006|Part 3|Adverse Event|0|||
162091370|NCT01722331|585387590|FG000|Part 3|Death|1|||
162091371|NCT01722331|585387591|FG001|Part 3|Death|0|||
162091372|NCT01722331|585387592|FG002|Part 3|Death|0|||
162091373|NCT01722331|585387593|FG003|Part 3|Death|0|||
162091374|NCT01722331|585387594|FG004|Part 3|Death|0|||
162091375|NCT01722331|585387595|FG005|Part 3|Death|0|||
162091376|NCT01722331|585387596|FG006|Part 3|Death|0|||
162091377|NCT01722331|585387590|FG000|Part 3|Lack of Efficacy|1|||
162091378|NCT01722331|585387591|FG001|Part 3|Lack of Efficacy|0|||
162091379|NCT01722331|585387592|FG002|Part 3|Lack of Efficacy|0|||
162091380|NCT01722331|585387593|FG003|Part 3|Lack of Efficacy|0|||
162091381|NCT01722331|585387594|FG004|Part 3|Lack of Efficacy|0|||
162091382|NCT01722331|585387595|FG005|Part 3|Lack of Efficacy|0|||
162091383|NCT01722331|585387596|FG006|Part 3|Lack of Efficacy|0|||
162091384|NCT01722331|585387590|FG000|Part 3|Lost to Follow-up|3|||
162091385|NCT01722331|585387591|FG001|Part 3|Lost to Follow-up|4|||
162091386|NCT01722331|585387592|FG002|Part 3|Lost to Follow-up|0|||
162091387|NCT01722331|585387593|FG003|Part 3|Lost to Follow-up|0|||
162091388|NCT01722331|585387594|FG004|Part 3|Lost to Follow-up|0|||
162091389|NCT01722331|585387595|FG005|Part 3|Lost to Follow-up|1|||
162091390|NCT01722331|585387596|FG006|Part 3|Lost to Follow-up|0|||
162091391|NCT01722331|585387590|FG000|Part 3|Non-Compliance with Study Drug|0|||
162091392|NCT01722331|585387591|FG001|Part 3|Non-Compliance with Study Drug|1|||
162091393|NCT01722331|585387592|FG002|Part 3|Non-Compliance with Study Drug|0|||
162091394|NCT01722331|585387593|FG003|Part 3|Non-Compliance with Study Drug|0|||
162091395|NCT01722331|585387594|FG004|Part 3|Non-Compliance with Study Drug|0|||
162091396|NCT01722331|585387595|FG005|Part 3|Non-Compliance with Study Drug|0|||
162091397|NCT01722331|585387596|FG006|Part 3|Non-Compliance with Study Drug|0|||
162091398|NCT01722331|585387590|FG000|Part 3|Physician Decision|1|||
162091399|NCT01722331|585387591|FG001|Part 3|Physician Decision|1|||
162091400|NCT01722331|585387592|FG002|Part 3|Physician Decision|0|||
162091401|NCT01722331|585387593|FG003|Part 3|Physician Decision|0|||
162091402|NCT01722331|585387594|FG004|Part 3|Physician Decision|0|||
162091403|NCT01722331|585387595|FG005|Part 3|Physician Decision|0|||
162091404|NCT01722331|585387596|FG006|Part 3|Physician Decision|1|||
162091405|NCT01722331|585387590|FG000|Part 3|Protocol Violation|2|||
162091406|NCT01722331|585387591|FG001|Part 3|Protocol Violation|1|||
162091407|NCT01722331|585387592|FG002|Part 3|Protocol Violation|0|||
162091408|NCT01722331|585387593|FG003|Part 3|Protocol Violation|0|||
162091409|NCT01722331|585387594|FG004|Part 3|Protocol Violation|0|||
162091410|NCT01722331|585387595|FG005|Part 3|Protocol Violation|0|||
162091411|NCT01722331|585387596|FG006|Part 3|Protocol Violation|0|||
162091412|NCT01722331|585387590|FG000|Part 3|Withdrawal by Subject|4|||
162091413|NCT01722331|585387591|FG001|Part 3|Withdrawal by Subject|7|||
162091414|NCT01722331|585387592|FG002|Part 3|Withdrawal by Subject|0|||
162091415|NCT01722331|585387593|FG003|Part 3|Withdrawal by Subject|0|||
162091416|NCT01722331|585387594|FG004|Part 3|Withdrawal by Subject|0|||
162091417|NCT01722331|585387595|FG005|Part 3|Withdrawal by Subject|2|||
162091418|NCT01722331|585387596|FG006|Part 3|Withdrawal by Subject|1|||
162091419|NCT01722331|585387590|FG000|Part 3|Other Protocol Specified Criteria|1|||
162091420|NCT01722331|585387591|FG001|Part 3|Other Protocol Specified Criteria|1|||
162091421|NCT01722331|585387592|FG002|Part 3|Other Protocol Specified Criteria|0|||
162091422|NCT01722331|585387593|FG003|Part 3|Other Protocol Specified Criteria|0|||
162091423|NCT01722331|585387594|FG004|Part 3|Other Protocol Specified Criteria|0|||
162091424|NCT01722331|585387595|FG005|Part 3|Other Protocol Specified Criteria|0|||
162091425|NCT01722331|585387596|FG006|Part 3|Other Protocol Specified Criteria|0|||
162091426|NCT02807948|585387599|FG000|Overall Study|Physician Decision|1|||
162091427|NCT02807948|585387600|FG001|Overall Study|Physician Decision|0|||
162091428|NCT03727750|585387601|FG000|Overall Study|Death|45|||
162091429|NCT03727750|585387601|FG000|Overall Study|Withdrawal by Subject|2|||
162091430|NCT03727750|585387601|FG000|Overall Study|Lost to Follow-up|1|||
162091431|NCT03727750|585387601|FG000|Overall Study|Other|1|||
162091432|NCT03766646|585387603|FG000|Overall Study|Withdrawal by Subject|1|||
162091433|NCT03766646|585387604|FG001|Overall Study|Withdrawal by Subject|0|||
162091434|NCT03766646|585387603|FG000|Overall Study|Protocol Violation|0|||
162091435|NCT03766646|585387604|FG001|Overall Study|Protocol Violation|3|||
162091436|NCT02530619|585387614|FG000|Registered for Study|Withdrawal by Subject|2|||
162091437|NCT02530619|585387614|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
162091438|NCT02530619|585387614|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
162091439|NCT02530619|585387614|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
162091440|NCT02530619|585387614|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
162091441|NCT02530619|585387614|FG000|Follow-up Period (6 Months)|Death|4|||
162091442|NCT02530619|585387614|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
162091443|NCT02530619|585387614|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
162091444|NCT01854554|585387616|FG000|Overall Study|Denial of Insurance Coverage|12|||
162091445|NCT01854554|585387617|FG001|Overall Study|Denial of Insurance Coverage|0|||
162091446|NCT01854554|585387616|FG000|Overall Study|Decided to get treatment locally|1|||
162091447|NCT01854554|585387617|FG001|Overall Study|Decided to get treatment locally|5|||
162091448|NCT01854554|585387616|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
162091449|NCT01854554|585387617|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
162091450|NCT01854554|585387616|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
162091451|NCT01854554|585387617|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
162091452|NCT01854554|585387616|FG000|Overall Study|Progression|0|||
162091453|NCT01854554|585387617|FG001|Overall Study|Progression|1|||
162091454|NCT01854554|585387616|FG000|Overall Study|Lost to Follow-up|0|||
162091455|NCT01854554|585387617|FG001|Overall Study|Lost to Follow-up|1|||
162091456|NCT00359762|585387620|FG000|Period II|Adverse Event|17|||
162091457|NCT00359762|585387621|FG001|Period II|Adverse Event|0|||
162091458|NCT00359762|585387622|FG002|Period II|Adverse Event|0|||
162091459|NCT00359762|585387623|FG003|Period II|Adverse Event|0|||
162091460|NCT00359762|585387624|FG004|Period II|Adverse Event|49|||
162091461|NCT00359762|585387620|FG000|Period II|Protocol Violation|18|||
162091462|NCT00359762|585387621|FG001|Period II|Protocol Violation|0|||
162091463|NCT00359762|585387622|FG002|Period II|Protocol Violation|0|||
162091464|NCT00359762|585387623|FG003|Period II|Protocol Violation|0|||
162091465|NCT00359762|585387624|FG004|Period II|Protocol Violation|11|||
162091466|NCT00359762|585387620|FG000|Period II|Physician Decision|17|||
162091467|NCT00359762|585387621|FG001|Period II|Physician Decision|0|||
162091468|NCT00359762|585387622|FG002|Period II|Physician Decision|0|||
162091469|NCT00359762|585387623|FG003|Period II|Physician Decision|0|||
162091470|NCT00359762|585387624|FG004|Period II|Physician Decision|23|||
162091471|NCT00359762|585387620|FG000|Period II|Death|2|||
162091472|NCT00359762|585387621|FG001|Period II|Death|0|||
162091473|NCT00359762|585387622|FG002|Period II|Death|0|||
162091474|NCT00359762|585387623|FG003|Period II|Death|0|||
162091475|NCT00359762|585387624|FG004|Period II|Death|4|||
162091476|NCT00359762|585387620|FG000|Period II|Lack of Efficacy|11|||
162091477|NCT00359762|585387621|FG001|Period II|Lack of Efficacy|0|||
162091478|NCT00359762|585387622|FG002|Period II|Lack of Efficacy|0|||
162091479|NCT00359762|585387623|FG003|Period II|Lack of Efficacy|0|||
162091480|NCT00359762|585387624|FG004|Period II|Lack of Efficacy|8|||
162091481|NCT00359762|585387620|FG000|Period II|Lost to follow up|5|||
162091482|NCT00359762|585387621|FG001|Period II|Lost to follow up|0|||
162091483|NCT00359762|585387622|FG002|Period II|Lost to follow up|0|||
162091484|NCT00359762|585387623|FG003|Period II|Lost to follow up|0|||
162091485|NCT00359762|585387624|FG004|Period II|Lost to follow up|5|||
162091486|NCT00359762|585387620|FG000|Period II|Entry Criteria Not Met|8|||
162091487|NCT00359762|585387621|FG001|Period II|Entry Criteria Not Met|0|||
162091488|NCT00359762|585387622|FG002|Period II|Entry Criteria Not Met|0|||
162091489|NCT00359762|585387623|FG003|Period II|Entry Criteria Not Met|0|||
162091490|NCT00359762|585387624|FG004|Period II|Entry Criteria Not Met|4|||
162091491|NCT00359762|585387620|FG000|Period II|Subject Decision|50|||
162091492|NCT00359762|585387621|FG001|Period II|Subject Decision|0|||
162091493|NCT00359762|585387622|FG002|Period II|Subject Decision|0|||
162091494|NCT00359762|585387623|FG003|Period II|Subject Decision|0|||
162091495|NCT00359762|585387624|FG004|Period II|Subject Decision|70|||
162091496|NCT00359762|585387620|FG000|Period III|Protocol Violation|0|||
162091497|NCT00359762|585387621|FG001|Period III|Protocol Violation|5|||
162091498|NCT00359762|585387622|FG002|Period III|Protocol Violation|3|||
162091499|NCT00359762|585387623|FG003|Period III|Protocol Violation|8|||
162091500|NCT00359762|585387624|FG004|Period III|Protocol Violation|0|||
162091501|NCT00359762|585387620|FG000|Period III|Adverse Event|0|||
162091502|NCT00359762|585387621|FG001|Period III|Adverse Event|3|||
162091503|NCT00359762|585387622|FG002|Period III|Adverse Event|4|||
162091504|NCT00359762|585387623|FG003|Period III|Adverse Event|10|||
162091505|NCT00359762|585387624|FG004|Period III|Adverse Event|0|||
162091506|NCT00359762|585387620|FG000|Period III|Physician Decision|0|||
162091507|NCT00359762|585387621|FG001|Period III|Physician Decision|5|||
162091508|NCT00359762|585387622|FG002|Period III|Physician Decision|9|||
162091509|NCT00359762|585387623|FG003|Period III|Physician Decision|15|||
162091510|NCT00359762|585387624|FG004|Period III|Physician Decision|0|||
162091511|NCT00359762|585387620|FG000|Period III|Lack of Efficacy|0|||
162091512|NCT00359762|585387621|FG001|Period III|Lack of Efficacy|7|||
162091513|NCT00359762|585387622|FG002|Period III|Lack of Efficacy|5|||
162091514|NCT00359762|585387623|FG003|Period III|Lack of Efficacy|9|||
162091515|NCT00359762|585387624|FG004|Period III|Lack of Efficacy|0|||
162091516|NCT00359762|585387620|FG000|Period III|Lost to follow up|0|||
162091517|NCT00359762|585387621|FG001|Period III|Lost to follow up|1|||
162091518|NCT00359762|585387622|FG002|Period III|Lost to follow up|1|||
162091519|NCT00359762|585387623|FG003|Period III|Lost to follow up|2|||
162091520|NCT00359762|585387624|FG004|Period III|Lost to follow up|0|||
162091521|NCT00359762|585387620|FG000|Period III|Entry Criteria Not Met|0|||
162091522|NCT00359762|585387621|FG001|Period III|Entry Criteria Not Met|1|||
162091523|NCT00359762|585387622|FG002|Period III|Entry Criteria Not Met|0|||
162091524|NCT00359762|585387623|FG003|Period III|Entry Criteria Not Met|1|||
162091525|NCT00359762|585387624|FG004|Period III|Entry Criteria Not Met|0|||
162091526|NCT00359762|585387620|FG000|Period III|Subject Decision|0|||
162091527|NCT00359762|585387621|FG001|Period III|Subject Decision|7|||
162091528|NCT00359762|585387622|FG002|Period III|Subject Decision|8|||
162091529|NCT00359762|585387623|FG003|Period III|Subject Decision|20|||
162091530|NCT00359762|585387624|FG004|Period III|Subject Decision|0|||
162091531|NCT02819726|585387625|FG000|Part A (All Participants)|Lost to Follow-up|0|||
162091532|NCT02819726|585387626|FG001|Part A (All Participants)|Lost to Follow-up|1|||
162091533|NCT02819726|585387627|FG002|Part A (All Participants)|Lost to Follow-up|0|||
162091534|NCT02819726|585387628|FG003|Part A (All Participants)|Lost to Follow-up|0|||
162091535|NCT02819726|585387625|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
162091536|NCT02819726|585387626|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
162091537|NCT02819726|585387627|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
162091538|NCT02819726|585387628|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
162091539|NCT02819726|585387625|FG000|Part A (All Participants)|Protocol non-compliance|3|||
162091540|NCT02819726|585387626|FG001|Part A (All Participants)|Protocol non-compliance|4|||
162091541|NCT02819726|585387627|FG002|Part A (All Participants)|Protocol non-compliance|5|||
162091542|NCT02819726|585387628|FG003|Part A (All Participants)|Protocol non-compliance|0|||
162091543|NCT02819726|585387625|FG000|Part B (All Participants)|Lost to Follow-up|1|||
162091544|NCT02819726|585387626|FG001|Part B (All Participants)|Lost to Follow-up|1|||
162091545|NCT02819726|585387627|FG002|Part B (All Participants)|Lost to Follow-up|2|||
162091546|NCT02819726|585387628|FG003|Part B (All Participants)|Lost to Follow-up|2|||
162091547|NCT02819726|585387625|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
162091548|NCT02819726|585387626|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
162091549|NCT02819726|585387627|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
162091550|NCT02819726|585387628|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
162091551|NCT02819726|585387625|FG000|Part B (All Participants)|Protocol non-compliance|0|||
162091552|NCT02819726|585387626|FG001|Part B (All Participants)|Protocol non-compliance|0|||
162091553|NCT02819726|585387627|FG002|Part B (All Participants)|Protocol non-compliance|1|||
162091554|NCT02819726|585387628|FG003|Part B (All Participants)|Protocol non-compliance|0|||
162091555|NCT01172938|585387631|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
162091556|NCT01172938|585387632|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
162091557|NCT01172938|585387633|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
162091558|NCT01172938|585387634|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162091559|NCT01172938|585387635|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162091560|NCT01172938|585387636|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162091561|NCT01172938|585387637|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162091562|NCT01172938|585387638|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162091563|NCT01172938|585387639|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
162091564|NCT01172938|585387631|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
162091565|NCT01172938|585387632|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
162091566|NCT01172938|585387633|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
162091567|NCT01172938|585387634|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162091568|NCT01172938|585387635|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162091569|NCT01172938|585387636|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162091570|NCT01172938|585387637|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162091571|NCT01172938|585387638|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162091572|NCT01172938|585387639|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
162091573|NCT01172938|585387631|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162091574|NCT01172938|585387632|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
162091575|NCT01172938|585387633|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
162091576|NCT01172938|585387634|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162091577|NCT01172938|585387635|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162091578|NCT01172938|585387636|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162091579|NCT01172938|585387637|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162091580|NCT01172938|585387638|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162091581|NCT01172938|585387639|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
162091582|NCT01172938|585387631|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
162091583|NCT01172938|585387632|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
162091584|NCT01172938|585387633|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
162091585|NCT01172938|585387634|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162091586|NCT01172938|585387635|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162091587|NCT01172938|585387636|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162091588|NCT01172938|585387637|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162091589|NCT01172938|585387638|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162091590|NCT01172938|585387639|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
162091591|NCT01172938|585387631|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
162091592|NCT01172938|585387632|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
162091593|NCT01172938|585387633|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
162091594|NCT01172938|585387634|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
162091595|NCT01172938|585387635|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
162091596|NCT01172938|585387636|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
162091597|NCT01172938|585387637|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
162091598|NCT01172938|585387638|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
162091599|NCT01172938|585387639|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
162091600|NCT01172938|585387631|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
162091601|NCT01172938|585387632|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162091602|NCT01172938|585387633|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162091603|NCT01172938|585387634|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162091604|NCT01172938|585387635|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162091605|NCT01172938|585387636|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162091606|NCT01172938|585387637|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162091607|NCT01172938|585387638|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162091608|NCT01172938|585387639|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
162091609|NCT01172938|585387631|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
162091610|NCT01172938|585387632|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
162091611|NCT01172938|585387633|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
162091612|NCT01172938|585387634|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
162091613|NCT01172938|585387635|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
162091614|NCT01172938|585387636|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
162091615|NCT01172938|585387637|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
162091616|NCT01172938|585387638|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
162091617|NCT01172938|585387639|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
162091618|NCT01172938|585387631|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
162091619|NCT01172938|585387632|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
162091620|NCT01172938|585387633|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
162091621|NCT01172938|585387634|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
162091622|NCT01172938|585387635|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
162091623|NCT01172938|585387636|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
162091624|NCT01172938|585387637|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
162091625|NCT01172938|585387638|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
162091626|NCT01172938|585387639|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
162091627|NCT01172938|585387631|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
162091628|NCT01172938|585387632|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
162091629|NCT01172938|585387633|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
162091630|NCT01172938|585387634|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
162091631|NCT01172938|585387635|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
162091632|NCT01172938|585387636|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
162091633|NCT01172938|585387637|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
162091634|NCT01172938|585387638|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
162091635|NCT01172938|585387639|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
162091636|NCT01172938|585387631|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162091637|NCT01172938|585387632|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162091638|NCT01172938|585387633|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
162091639|NCT01172938|585387634|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162091640|NCT01172938|585387635|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162091641|NCT01172938|585387636|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162091642|NCT01172938|585387637|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162091643|NCT01172938|585387638|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162091644|NCT01172938|585387639|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
162091645|NCT01172938|585387631|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
162091646|NCT01172938|585387632|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
162091647|NCT01172938|585387633|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
162091648|NCT01172938|585387634|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
162091649|NCT01172938|585387635|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
162091650|NCT01172938|585387636|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
162091651|NCT01172938|585387637|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
162091652|NCT01172938|585387638|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
162091653|NCT01172938|585387639|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
162091654|NCT01172938|585387631|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
162091655|NCT01172938|585387632|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
162091656|NCT01172938|585387633|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
162091657|NCT01172938|585387634|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
162091658|NCT01172938|585387635|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
162091659|NCT01172938|585387636|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
162091660|NCT01172938|585387637|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
162091661|NCT01172938|585387638|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
162091662|NCT01172938|585387639|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
162091663|NCT01172938|585387631|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
162091664|NCT01172938|585387632|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
162091665|NCT01172938|585387633|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
162091666|NCT01172938|585387634|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
162091667|NCT01172938|585387635|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
162091668|NCT01172938|585387636|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
162091669|NCT01172938|585387637|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
162091670|NCT01172938|585387638|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
162091671|NCT01172938|585387639|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
162091672|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
162091673|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
162091674|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
162091675|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
162091676|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
162091677|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
162091678|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
162091679|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
162091680|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
162091681|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
162091682|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
162091683|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
162091684|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
162091685|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
162091686|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
162091687|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
162091688|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
162091689|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
162091690|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162091691|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162091692|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
162091693|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162091694|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162091695|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162091696|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162091697|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162091698|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
162091699|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
162091700|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
162091701|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
162091702|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
162091703|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
162091704|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
162091705|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
162091706|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
162091707|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
162091708|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162091709|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162091710|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
162091711|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162091712|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162091713|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162091714|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162091715|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162091716|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
162091717|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
162091718|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
162091719|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
162091720|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
162091721|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
162091722|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
162091723|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
162091724|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
162091725|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
162091726|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162091727|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
162091728|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162091729|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162091730|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162091731|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162091732|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162091733|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
162091734|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
162091735|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162091736|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
162091737|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162091738|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162091739|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162091740|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162091741|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162091742|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162091743|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
162091744|NCT01172938|585387631|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162091745|NCT01172938|585387632|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162091746|NCT01172938|585387633|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162091747|NCT01172938|585387634|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162091748|NCT01172938|585387635|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162091749|NCT01172938|585387636|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162091750|NCT01172938|585387637|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162091751|NCT01172938|585387638|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
162091752|NCT01172938|585387639|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
162091753|NCT01172938|585387631|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
162091754|NCT01172938|585387632|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
162091755|NCT01172938|585387633|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
162091756|NCT01172938|585387634|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
162091757|NCT01172938|585387635|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
162091758|NCT01172938|585387636|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
162091759|NCT01172938|585387637|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
162091760|NCT01172938|585387638|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
162091761|NCT01172938|585387639|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
162091762|NCT01172938|585387631|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
162091763|NCT01172938|585387632|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
162091764|NCT01172938|585387633|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
162091765|NCT01172938|585387634|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
162091766|NCT01172938|585387635|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
162091767|NCT01172938|585387636|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
162091768|NCT01172938|585387637|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
162091769|NCT01172938|585387638|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
162091770|NCT01172938|585387639|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
162091771|NCT01172938|585387631|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
162091772|NCT01172938|585387632|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
162091773|NCT01172938|585387633|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
162091774|NCT01172938|585387634|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
162091775|NCT01172938|585387635|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
162091776|NCT01172938|585387636|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
162091777|NCT01172938|585387637|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
162091778|NCT01172938|585387638|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
162091779|NCT01172938|585387639|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
162091780|NCT01172938|585387631|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162091781|NCT01172938|585387632|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
162091782|NCT01172938|585387633|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162091783|NCT01172938|585387634|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162091784|NCT01172938|585387635|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162091785|NCT01172938|585387636|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162091786|NCT01172938|585387637|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162091787|NCT01172938|585387638|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162091788|NCT01172938|585387639|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
162091789|NCT01172938|585387631|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162091790|NCT01172938|585387632|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162091791|NCT01172938|585387633|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
162091792|NCT01172938|585387634|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162091793|NCT01172938|585387635|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162091794|NCT01172938|585387636|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162091795|NCT01172938|585387637|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162091796|NCT01172938|585387638|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162091797|NCT01172938|585387639|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
162091798|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
162091799|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
162091800|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
162091801|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
162091802|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
162091803|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
162091804|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
162091805|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
162091806|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
162091807|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
162091808|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
162091809|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
162091810|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
162091811|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
162091812|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
162091813|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
162091814|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
162091815|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
162091816|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
162091817|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
162091818|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
162091819|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
162091820|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
162091821|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
162091822|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
162091823|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
162091824|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
162091825|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162091826|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162091827|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
162091828|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162091829|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162091830|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162091831|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162091832|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
162091833|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
162091834|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162091835|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162091836|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162091837|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162091838|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162091839|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162091840|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162091841|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
162091842|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
162091843|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
162091844|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
162091845|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
162091846|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
162091847|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
162091848|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
162091849|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
162091850|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
162091851|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
162091852|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162091853|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162091854|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
162091855|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162091856|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162091857|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162091858|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162091859|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162091860|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
162091861|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162091862|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
162091863|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162091864|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162091865|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162091866|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162091867|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162091868|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
162091869|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
162091870|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
162091871|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
162091872|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
162091873|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
162091874|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
162091875|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
162091876|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
162091877|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
162091878|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
162091879|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162091880|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162091881|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
162091882|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162091883|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162091884|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162091885|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162091886|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162091887|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
162091888|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162091889|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162091890|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
162091891|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162091892|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162091893|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162091894|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162091895|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162091896|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
162091897|NCT01172938|585387631|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162091898|NCT01172938|585387632|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162091899|NCT01172938|585387633|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162091900|NCT01172938|585387634|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162091901|NCT01172938|585387635|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162091902|NCT01172938|585387636|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162091903|NCT01172938|585387637|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162091904|NCT01172938|585387638|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
162091905|NCT01172938|585387639|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
162091906|NCT01033747|585387640|FG000|Overall Study|Adverse Event|9|||
162091907|NCT01033747|585387641|FG001|Overall Study|Adverse Event|4|||
162091908|NCT01033747|585387640|FG000|Overall Study|Abnormal Laboratory Value|1|||
162091909|NCT01033747|585387641|FG001|Overall Study|Abnormal Laboratory Value|0|||
162091910|NCT01033747|585387640|FG000|Overall Study|Abnormal test procedure|0|||
162091911|NCT01033747|585387641|FG001|Overall Study|Abnormal test procedure|1|||
162091912|NCT01033747|585387640|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
162091913|NCT01033747|585387641|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
162091914|NCT01033747|585387640|FG000|Overall Study|Protocol Violation|1|||
162091915|NCT01033747|585387641|FG001|Overall Study|Protocol Violation|0|||
162091916|NCT01033747|585387640|FG000|Overall Study|Withdrawal by Subject|9|||
162091917|NCT01033747|585387641|FG001|Overall Study|Withdrawal by Subject|6|||
162091918|NCT01033747|585387640|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
162091919|NCT01033747|585387641|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
162091920|NCT01033747|585387640|FG000|Overall Study|Stopped at end of Extension 1|2|||
162091921|NCT01033747|585387641|FG001|Overall Study|Stopped at end of Extension 1|0|||
162091922|NCT02613481|585387642|FG000|Overall Study|Lost to Follow-up|7|||
162091923|NCT02613481|585387642|FG000|Overall Study|Withdrawal by Subject|2|||
162091924|NCT00803023|585387647|FG000|Overall Study|Adverse Event|5|||
162091925|NCT00803023|585387648|FG001|Overall Study|Adverse Event|4|||
162091926|NCT00803023|585387649|FG002|Overall Study|Adverse Event|8|||
162091927|NCT00803023|585387650|FG003|Overall Study|Adverse Event|6|||
162091928|NCT00803023|585387647|FG000|Overall Study|Withdrawal by Subject|0|||
162091929|NCT00803023|585387648|FG001|Overall Study|Withdrawal by Subject|2|||
162091930|NCT00803023|585387649|FG002|Overall Study|Withdrawal by Subject|0|||
162091931|NCT00803023|585387650|FG003|Overall Study|Withdrawal by Subject|0|||
162091932|NCT00803023|585387647|FG000|Overall Study|Lost to Follow-up|0|||
162091933|NCT00803023|585387648|FG001|Overall Study|Lost to Follow-up|1|||
162091934|NCT00803023|585387649|FG002|Overall Study|Lost to Follow-up|2|||
162091935|NCT00803023|585387650|FG003|Overall Study|Lost to Follow-up|1|||
162091936|NCT00803023|585387647|FG000|Overall Study|Lack of Efficacy|0|||
162091937|NCT00803023|585387648|FG001|Overall Study|Lack of Efficacy|1|||
162091938|NCT00803023|585387649|FG002|Overall Study|Lack of Efficacy|1|||
162091939|NCT00803023|585387650|FG003|Overall Study|Lack of Efficacy|1|||
162091940|NCT02647658|585387651|FG000|Overall Study|Consent refusal|15|||
162091941|NCT02647658|585387652|FG001|Overall Study|Consent refusal|24|||
162091942|NCT01542528|585387653|FG000|Overall Study|Lost to Follow-up|2|||
162091943|NCT01542528|585387654|FG001|Overall Study|Lost to Follow-up|1|||
162091944|NCT01542528|585387653|FG000|Overall Study|Physician Decision|1|||
162091945|NCT01542528|585387654|FG001|Overall Study|Physician Decision|0|||
162091946|NCT01542528|585387653|FG000|Overall Study|Withdrawal by Subject|9|||
162091947|NCT01542528|585387654|FG001|Overall Study|Withdrawal by Subject|6|||
162091948|NCT04382326|585387655|FG000|Overall Study|Adverse Event, not serious|1|||
162091949|NCT04382326|585387656|FG001|Overall Study|Adverse Event, not serious|2|||
162091950|NCT04382326|585387655|FG000|Overall Study|Other|1|||
162091951|NCT04382326|585387656|FG001|Overall Study|Other|0|||
162091952|NCT04382326|585387655|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
162091953|NCT04382326|585387656|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
162091954|NCT04382326|585387655|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
162091955|NCT04382326|585387656|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
162091956|NCT04382326|585387655|FG000|Overall Study|Protocol Violation|29|||
162091957|NCT04382326|585387656|FG001|Overall Study|Protocol Violation|23|||
162091958|NCT04382326|585387655|FG000|Overall Study|Physician Decision|0|||
162091959|NCT04382326|585387656|FG001|Overall Study|Physician Decision|1|||
162091960|NCT04382326|585387655|FG000|Overall Study|Lost to Follow-up|48|||
162091961|NCT04382326|585387656|FG001|Overall Study|Lost to Follow-up|63|||
162091962|NCT04382326|585387655|FG000|Overall Study|Adverse Event, non-fatal|1|||
162091963|NCT04382326|585387656|FG001|Overall Study|Adverse Event, non-fatal|1|||
162091964|NCT01181921|585387659|FG000|Overall Study|Lost to Follow-up|1|||
162091965|NCT02461589|585387665|FG000|Overall Study|Withdrawal by Subject|5|||
162091966|NCT02461589|585387666|FG001|Overall Study|Withdrawal by Subject|1|||
162091967|NCT02461589|585387667|FG002|Overall Study|Withdrawal by Subject|3|||
162091968|NCT02461589|585387668|FG003|Overall Study|Withdrawal by Subject|2|||
162091969|NCT02461589|585387669|FG004|Overall Study|Withdrawal by Subject|1|||
162091970|NCT02461589|585387670|FG005|Overall Study|Withdrawal by Subject|2|||
162091971|NCT02461589|585387671|FG006|Overall Study|Withdrawal by Subject|1|||
162091972|NCT02461589|585387672|FG007|Overall Study|Withdrawal by Subject|3|||
162091973|NCT02461589|585387673|FG008|Overall Study|Withdrawal by Subject|3|||
162091974|NCT02461589|585387674|FG009|Overall Study|Withdrawal by Subject|1|||
162091975|NCT02461589|585387665|FG000|Overall Study|Lost to Follow-up|0|||
162091976|NCT02461589|585387666|FG001|Overall Study|Lost to Follow-up|0|||
162091977|NCT02461589|585387667|FG002|Overall Study|Lost to Follow-up|2|||
162091978|NCT02461589|585387668|FG003|Overall Study|Lost to Follow-up|3|||
162091979|NCT02461589|585387669|FG004|Overall Study|Lost to Follow-up|1|||
162091980|NCT02461589|585387670|FG005|Overall Study|Lost to Follow-up|1|||
162091981|NCT02461589|585387671|FG006|Overall Study|Lost to Follow-up|3|||
162091982|NCT02461589|585387672|FG007|Overall Study|Lost to Follow-up|1|||
162091983|NCT02461589|585387673|FG008|Overall Study|Lost to Follow-up|3|||
162091984|NCT02461589|585387674|FG009|Overall Study|Lost to Follow-up|1|||
162091985|NCT02461589|585387665|FG000|Overall Study|Death|0|||
162091986|NCT02461589|585387666|FG001|Overall Study|Death|0|||
162091987|NCT02461589|585387667|FG002|Overall Study|Death|0|||
162091988|NCT02461589|585387668|FG003|Overall Study|Death|0|||
162091989|NCT02461589|585387669|FG004|Overall Study|Death|0|||
162091990|NCT02461589|585387670|FG005|Overall Study|Death|0|||
162091991|NCT02461589|585387671|FG006|Overall Study|Death|0|||
162091992|NCT02461589|585387672|FG007|Overall Study|Death|1|||
162091993|NCT02461589|585387673|FG008|Overall Study|Death|0|||
162091994|NCT02461589|585387674|FG009|Overall Study|Death|0|||
162091995|NCT02461589|585387665|FG000|Overall Study|Unclassified|0|||
162091996|NCT02461589|585387666|FG001|Overall Study|Unclassified|0|||
162091997|NCT02461589|585387667|FG002|Overall Study|Unclassified|0|||
162091998|NCT02461589|585387668|FG003|Overall Study|Unclassified|0|||
162091999|NCT02461589|585387669|FG004|Overall Study|Unclassified|0|||
162092000|NCT02461589|585387670|FG005|Overall Study|Unclassified|0|||
162092001|NCT02461589|585387671|FG006|Overall Study|Unclassified|1|||
162092002|NCT02461589|585387672|FG007|Overall Study|Unclassified|0|||
162092003|NCT02461589|585387673|FG008|Overall Study|Unclassified|0|||
162092004|NCT02461589|585387674|FG009|Overall Study|Unclassified|2|||
162092005|NCT02461589|585387665|FG000|Overall Study|Missing follow-up information|1|||
162092006|NCT02461589|585387666|FG001|Overall Study|Missing follow-up information|1|||
162092007|NCT02461589|585387667|FG002|Overall Study|Missing follow-up information|0|||
162092008|NCT02461589|585387668|FG003|Overall Study|Missing follow-up information|0|||
162092009|NCT02461589|585387669|FG004|Overall Study|Missing follow-up information|0|||
162092010|NCT02461589|585387670|FG005|Overall Study|Missing follow-up information|0|||
162092011|NCT02461589|585387671|FG006|Overall Study|Missing follow-up information|1|||
162092012|NCT02461589|585387672|FG007|Overall Study|Missing follow-up information|0|||
162092013|NCT02461589|585387673|FG008|Overall Study|Missing follow-up information|0|||
162092014|NCT02461589|585387674|FG009|Overall Study|Missing follow-up information|0|||
162092015|NCT02461589|585387665|FG000|Overall Study|Withdrawal from trial before exposure|0|||
162092016|NCT02461589|585387666|FG001|Overall Study|Withdrawal from trial before exposure|0|||
162092017|NCT02461589|585387667|FG002|Overall Study|Withdrawal from trial before exposure|0|||
162092018|NCT02461589|585387668|FG003|Overall Study|Withdrawal from trial before exposure|0|||
162092019|NCT02461589|585387669|FG004|Overall Study|Withdrawal from trial before exposure|0|||
162092020|NCT02461589|585387670|FG005|Overall Study|Withdrawal from trial before exposure|0|||
162092021|NCT02461589|585387671|FG006|Overall Study|Withdrawal from trial before exposure|0|||
162092022|NCT02461589|585387672|FG007|Overall Study|Withdrawal from trial before exposure|0|||
162092023|NCT02461589|585387673|FG008|Overall Study|Withdrawal from trial before exposure|0|||
162092024|NCT02461589|585387674|FG009|Overall Study|Withdrawal from trial before exposure|1|||
162092025|NCT01978119|585387679|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
162092026|NCT01978119|585387680|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
162092027|NCT01978119|585387679|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
162092028|NCT01978119|585387680|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
162092029|NCT01978119|585387679|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
162092030|NCT01978119|585387680|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
162092031|NCT03295201|585387683|FG000|Overall Study|Lost to Follow-up|1|||
162092032|NCT03295201|585387684|FG001|Overall Study|Lost to Follow-up|1|||
162092033|NCT03295201|585387683|FG000|Overall Study|Hospital admission|0|||
162092034|NCT03295201|585387684|FG001|Overall Study|Hospital admission|1|||
162092035|NCT02519504|585387685|FG000|Overall Study|Protocol Violation|6|||
162092036|NCT02519504|585387686|FG001|Overall Study|Protocol Violation|5|||
162092037|NCT02519504|585387685|FG000|Overall Study|Ineligible for direct testing|12|||
162092038|NCT02519504|585387686|FG001|Overall Study|Ineligible for direct testing|12|||
162092039|NCT02519504|585387685|FG000|Overall Study|Did not participate in direct testing|95|||
162092040|NCT02519504|585387686|FG001|Overall Study|Did not participate in direct testing|86|||
162092041|NCT02548962|585387687|FG000|Overall Study|Withdrawal by Subject|1|||
162092042|NCT02548962|585387688|FG001|Overall Study|Withdrawal by Subject|0|||
162092043|NCT01958918|585387689|FG000|Overall Study|Death|1|||
162092044|NCT01958918|585387690|FG001|Overall Study|Death|3|||
162092045|NCT01958918|585387689|FG000|Overall Study|Lost to Follow-up|4|||
162092046|NCT01958918|585387690|FG001|Overall Study|Lost to Follow-up|7|||
162092047|NCT01958918|585387689|FG000|Overall Study|Withdrawal by Subject|13|||
162092048|NCT01958918|585387690|FG001|Overall Study|Withdrawal by Subject|8|||
162092049|NCT01958918|585387689|FG000|Overall Study|Lack of Efficacy|13|||
162092050|NCT01958918|585387690|FG001|Overall Study|Lack of Efficacy|10|||
162092051|NCT01958918|585387689|FG000|Overall Study|Adverse Event|12|||
162092052|NCT01958918|585387690|FG001|Overall Study|Adverse Event|12|||
162092053|NCT01958918|585387689|FG000|Overall Study|administrative problems|0|||
162092054|NCT01958918|585387690|FG001|Overall Study|administrative problems|2|||
162092055|NCT00659269|585387694|FG000|Overall Study|Physician Decision|1|||
162092056|NCT00659269|585387695|FG001|Overall Study|Physician Decision|1|||
162092057|NCT00908960|585387697|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
162092058|NCT00908960|585387698|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
162092059|NCT00908960|585387699|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
162092060|NCT02401672|585387702|FG000|Overall Study|Withdrawal by Subject|1|||
162092061|NCT02401672|585387703|FG001|Overall Study|Withdrawal by Subject|3|||
162092062|NCT03653429|585387706|FG000|Overall Study|Physician Decision|4|||
162092063|NCT03653429|585387707|FG001|Overall Study|Physician Decision|10|||
162092064|NCT00403546|585387708|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
162092065|NCT00403546|585387709|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
162092066|NCT00403546|585387710|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
162092067|NCT00403546|585387708|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
162092068|NCT00403546|585387709|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
162092069|NCT00403546|585387710|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
162092070|NCT00403546|585387708|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
162092071|NCT00403546|585387709|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
162092072|NCT00403546|585387710|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
162092073|NCT00403546|585387708|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
162092074|NCT00403546|585387709|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
162092075|NCT00403546|585387710|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
162092076|NCT00403546|585387708|FG000|Screening Phase|Screening Failure|22|||
162092077|NCT00403546|585387709|FG001|Screening Phase|Screening Failure|0|||
162092078|NCT00403546|585387710|FG002|Screening Phase|Screening Failure|0|||
162092079|NCT00403546|585387708|FG000|Screening Phase|Adverse Event|1|||
162092080|NCT00403546|585387709|FG001|Screening Phase|Adverse Event|0|||
162092081|NCT00403546|585387710|FG002|Screening Phase|Adverse Event|0|||
162092082|NCT00403546|585387708|FG000|Screening Phase|Terminated Prior to Randomization|5|||
162092083|NCT00403546|585387709|FG001|Screening Phase|Terminated Prior to Randomization|0|||
162092084|NCT00403546|585387710|FG002|Screening Phase|Terminated Prior to Randomization|0|||
162092085|NCT00403546|585387708|FG000|Randomized Trial|Early Terminations|0|||
162092086|NCT00403546|585387709|FG001|Randomized Trial|Early Terminations|17|||
162092087|NCT00403546|585387710|FG002|Randomized Trial|Early Terminations|16|||
162092088|NCT00793910|585387714|FG000|Overall Study|discarded study pills|0|||
162092089|NCT00793910|585387715|FG001|Overall Study|discarded study pills|1|||
162092090|NCT00793910|585387714|FG000|Overall Study|did not pick up medications|1|||
162092091|NCT00793910|585387715|FG001|Overall Study|did not pick up medications|1|||
162092092|NCT00793910|585387714|FG000|Overall Study|ineligible based on entry criteria|2|||
162092093|NCT00793910|585387715|FG001|Overall Study|ineligible based on entry criteria|3|||
162092094|NCT00793910|585387714|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
162092095|NCT00793910|585387715|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
162092096|NCT00793910|585387714|FG000|Overall Study|Withdrawal by Subject|0|||
162092097|NCT00793910|585387715|FG001|Overall Study|Withdrawal by Subject|1|||
162092098|NCT03634579|585387718|FG000|Overall Study|study termination|9|||
162092099|NCT02480621|585387719|FG000|Randomization|Withdrawal by Subject|1|||
162092100|NCT02480621|585387720|FG001|Randomization|Withdrawal by Subject|0|||
162092101|NCT02480621|585387719|FG000|Randomization|Surgeon did not give intervention|0|||
162092102|NCT02480621|585387720|FG001|Randomization|Surgeon did not give intervention|1|||
162092103|NCT02480621|585387719|FG000|Follow Up|Lost to Follow-up|4|||
162092104|NCT02480621|585387720|FG001|Follow Up|Lost to Follow-up|2|||
162092105|NCT05061446|585387721|FG000|Overall Study|Adverse Event|2|||
162092106|NCT05061446|585387722|FG001|Overall Study|Adverse Event|0|||
162092107|NCT05061446|585387723|FG002|Overall Study|Adverse Event|0|||
162092108|NCT05061446|585387721|FG000|Overall Study|Participant no longer available due to personal reason|0|||
162092109|NCT05061446|585387722|FG001|Overall Study|Participant no longer available due to personal reason|1|||
162092110|NCT05061446|585387723|FG002|Overall Study|Participant no longer available due to personal reason|0|||
162092111|NCT04111497|585387724|FG000|Overall Study|relapse of primary disease|1|||
162092112|NCT04111497|585387724|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
162092113|NCT01993719|585387727|FG000|First Drug Administration|Not treated|1|||
162092114|NCT01993719|585387728|FG001|First Drug Administration|Not treated|0|||
162092115|NCT01993719|585387729|FG002|First Drug Administration|Not treated|0|||
162092116|NCT01993719|585387730|FG003|First Drug Administration|Not treated|0|||
162092117|NCT01993719|585387731|FG004|First Drug Administration|Not treated|0|||
162092118|NCT05857527|585387732|FG000|Overall Study|Withdrawal by Subject|0|||
162092119|NCT05857527|585387733|FG001|Overall Study|Withdrawal by Subject|1|||
162092120|NCT02799082|585387734|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
162092121|NCT02799082|585387735|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
162092122|NCT02799082|585387734|FG000|Overall Study|Protocol Violation|0|||
162092123|NCT02799082|585387735|FG001|Overall Study|Protocol Violation|1|||
162092124|NCT01592708|585387737|FG000|Overall Study|Protocol Violation|3|||
162092125|NCT01592708|585387738|FG001|Overall Study|Protocol Violation|0|||
162092126|NCT01748994|585387740|FG000|Overall Study|Lost to Follow-up|8|||
162092127|NCT01748994|585387741|FG001|Overall Study|Lost to Follow-up|6|||
162092128|NCT03105362|585387742|FG000|Overall Study|Withdrawal by Subject|1|||
162092129|NCT03105362|585387742|FG000|Overall Study|Lost to Follow-up|1|||
162092130|NCT01723904|585387746|FG000|Overall Study|Noncompliant|3|||
162092131|NCT01723904|585387746|FG000|Overall Study|Adverse Event|5|||
162092132|NCT01723904|585387746|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
162092133|NCT02610140|585387757|FG000|Randomization and Treatment Period|Radiological progression|23|||
162092134|NCT02610140|585387758|FG001|Randomization and Treatment Period|Radiological progression|15|||
162092135|NCT02610140|585387757|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
162092136|NCT02610140|585387758|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
162092137|NCT02610140|585387757|FG000|Randomization and Treatment Period|Protocol Violation|1|||
162092138|NCT02610140|585387758|FG001|Randomization and Treatment Period|Protocol Violation|0|||
162092139|NCT02610140|585387757|FG000|Randomization and Treatment Period|Physician Decision|0|||
162092140|NCT02610140|585387758|FG001|Randomization and Treatment Period|Physician Decision|1|||
162092141|NCT02610140|585387757|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
162092142|NCT02610140|585387758|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
162092143|NCT02610140|585387757|FG000|Randomization and Treatment Period|Death|7|||
162092144|NCT02610140|585387758|FG001|Randomization and Treatment Period|Death|1|||
162092145|NCT02610140|585387757|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
162092146|NCT02610140|585387758|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
162092147|NCT02610140|585387757|FG000|Randomization and Treatment Period|Adverse Event|44|||
162092148|NCT02610140|585387758|FG001|Randomization and Treatment Period|Adverse Event|13|||
162092149|NCT02610140|585387757|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
162092150|NCT02610140|585387758|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
162092151|NCT02610140|585387757|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
162092152|NCT02610140|585387758|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
162092153|NCT02610140|585387757|FG000|Randomization and Treatment Period|Not treated|3|||
162092154|NCT02610140|585387758|FG001|Randomization and Treatment Period|Not treated|10|||
162092155|NCT02610140|585387757|FG000|Safety Follow-up|Other|0|||
162092156|NCT02610140|585387758|FG001|Safety Follow-up|Other|2|||
162092157|NCT02610140|585387757|FG000|Safety Follow-up|Lost to Follow-up|1|||
162092158|NCT02610140|585387758|FG001|Safety Follow-up|Lost to Follow-up|0|||
162092159|NCT02610140|585387757|FG000|Safety Follow-up|No follow-up|5|||
162092160|NCT02610140|585387758|FG001|Safety Follow-up|No follow-up|3|||
162092161|NCT02610140|585387757|FG000|Safety Follow-up|Death|12|||
162092162|NCT02610140|585387758|FG001|Safety Follow-up|Death|2|||
162092163|NCT02610140|585387757|FG000|Safety Follow-up|Deterioration of general conditions|15|||
162092164|NCT02610140|585387758|FG001|Safety Follow-up|Deterioration of general conditions|5|||
162092165|NCT02610140|585387757|FG000|Safety Follow-up|Withdrawal by Subject|12|||
162092166|NCT02610140|585387758|FG001|Safety Follow-up|Withdrawal by Subject|12|||
162092167|NCT02610140|585387757|FG000|Active Follow-up|Progressive disease - radiological|30|||
162092168|NCT02610140|585387758|FG001|Active Follow-up|Progressive disease - radiological|22|||
162092169|NCT02610140|585387757|FG000|Active Follow-up|Death|8|||
162092170|NCT02610140|585387758|FG001|Active Follow-up|Death|1|||
162092171|NCT02610140|585387757|FG000|Active Follow-up|Withdrawal by Subject|4|||
162092172|NCT02610140|585387758|FG001|Active Follow-up|Withdrawal by Subject|0|||
162092173|NCT02610140|585387757|FG000|Active Follow-up|Progressive disease - clinical|1|||
162092174|NCT02610140|585387758|FG001|Active Follow-up|Progressive disease - clinical|2|||
162092175|NCT02610140|585387757|FG000|Active Follow-up|Deterioration of general conditions|1|||
162092176|NCT02610140|585387758|FG001|Active Follow-up|Deterioration of general conditions|0|||
162092177|NCT02610140|585387757|FG000|Active Follow-up|Ongoing but not completed|4|||
162092178|NCT02610140|585387758|FG001|Active Follow-up|Ongoing but not completed|1|||
162092179|NCT02610140|585387757|FG000|Long-term Follow-up|Death|86|||
162092180|NCT02610140|585387758|FG001|Long-term Follow-up|Death|44|||
162092181|NCT02610140|585387757|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
162092182|NCT02610140|585387758|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
162092183|NCT02610140|585387757|FG000|Long-term Follow-up|Lost to Follow-up|1|||
162092184|NCT02610140|585387758|FG001|Long-term Follow-up|Lost to Follow-up|2|||
162092185|NCT02610140|585387757|FG000|Long-term Follow-up|Ongoing but not completed|30|||
162092186|NCT02610140|585387758|FG001|Long-term Follow-up|Ongoing but not completed|17|||
162092187|NCT01312961|585387760|FG000|Overall Study|Adverse Event|3|||
162092188|NCT01312961|585387761|FG001|Overall Study|Adverse Event|3|||
162092189|NCT01312961|585387760|FG000|Overall Study|Lack of Efficacy|11|||
162092190|NCT01312961|585387761|FG001|Overall Study|Lack of Efficacy|1|||
162092191|NCT01312961|585387760|FG000|Overall Study|Poor compliance to protocol|1|||
162092192|NCT01312961|585387761|FG001|Overall Study|Poor compliance to protocol|0|||
162092193|NCT01312961|585387760|FG000|Overall Study|Other than specified above|2|||
162092194|NCT01312961|585387761|FG001|Overall Study|Other than specified above|3|||
162092195|NCT01337297|585387766|FG000|Overall Study|They entered to single anodal tDCS|4|||
162092196|NCT01337297|585387767|FG001|Overall Study|They entered to single anodal tDCS|3|||
162092197|NCT01337297|585387766|FG000|Overall Study|Lost to Follow-up|1|||
162092198|NCT01337297|585387767|FG001|Overall Study|Lost to Follow-up|3|||
162092199|NCT01800903|585387768|FG000|Second Test Period|unable to catheterise|1|||
162092200|NCT01800903|585387769|FG001|Second Test Period|unable to catheterise|0|||
162092201|NCT01800903|585387770|FG002|Second Test Period|unable to catheterise|0|||
162092202|NCT01800903|585387771|FG003|Second Test Period|unable to catheterise|0|||
162092203|NCT01800903|585387772|FG004|Second Test Period|unable to catheterise|0|||
162092204|NCT01800903|585387773|FG005|Second Test Period|unable to catheterise|0|||
162092205|NCT02296112|585387774|FG000|Overall Study|Disease progression|7|||
162092206|NCT02296112|585387774|FG000|Overall Study|Toxicity|1|||
162092207|NCT02296112|585387774|FG000|Overall Study|Began an alternate therapy|1|||
162092208|NCT01306617|585387777|FG000|Overall Study|Adverse Event|1|||
162092209|NCT01306617|585387778|FG001|Overall Study|Adverse Event|0|||
162092210|NCT01306617|585387779|FG002|Overall Study|Adverse Event|0|||
162092211|NCT01306617|585387777|FG000|Overall Study|Virologic Failure|0|||
162092212|NCT01306617|585387778|FG001|Overall Study|Virologic Failure|0|||
162092213|NCT01306617|585387779|FG002|Overall Study|Virologic Failure|5|||
162092214|NCT01306617|585387777|FG000|Overall Study|Non-compliance|0|||
162092215|NCT01306617|585387778|FG001|Overall Study|Non-compliance|1|||
162092216|NCT01306617|585387779|FG002|Overall Study|Non-compliance|0|||
162092217|NCT01208233|585387780|FG000|Overall Study|Adverse Event|0|||
162092218|NCT01208233|585387781|FG001|Overall Study|Adverse Event|1|||
162092219|NCT01208233|585387782|FG002|Overall Study|Adverse Event|2|||
162092220|NCT01208233|585387783|FG003|Overall Study|Adverse Event|0|||
162092221|NCT01208233|585387784|FG004|Overall Study|Adverse Event|3|||
162092222|NCT01208233|585387785|FG005|Overall Study|Adverse Event|5|||
162092223|NCT01208233|585387780|FG000|Overall Study|Death|0|||
162092224|NCT01208233|585387781|FG001|Overall Study|Death|0|||
162092225|NCT01208233|585387782|FG002|Overall Study|Death|0|||
162092226|NCT01208233|585387783|FG003|Overall Study|Death|0|||
162092227|NCT01208233|585387784|FG004|Overall Study|Death|3|||
162092228|NCT01208233|585387785|FG005|Overall Study|Death|5|||
162092229|NCT01208233|585387780|FG000|Overall Study|Did not meet entrance criteria|2|||
162092230|NCT01208233|585387781|FG001|Overall Study|Did not meet entrance criteria|1|||
162092231|NCT01208233|585387782|FG002|Overall Study|Did not meet entrance criteria|1|||
162092232|NCT01208233|585387783|FG003|Overall Study|Did not meet entrance criteria|0|||
162092233|NCT01208233|585387784|FG004|Overall Study|Did not meet entrance criteria|1|||
162092234|NCT01208233|585387785|FG005|Overall Study|Did not meet entrance criteria|0|||
162092235|NCT01208233|585387780|FG000|Overall Study|Medication error without adverse event|0|||
162092236|NCT01208233|585387781|FG001|Overall Study|Medication error without adverse event|0|||
162092237|NCT01208233|585387782|FG002|Overall Study|Medication error without adverse event|0|||
162092238|NCT01208233|585387783|FG003|Overall Study|Medication error without adverse event|0|||
162092239|NCT01208233|585387784|FG004|Overall Study|Medication error without adverse event|0|||
162092240|NCT01208233|585387785|FG005|Overall Study|Medication error without adverse event|1|||
162092241|NCT01208233|585387780|FG000|Overall Study|Study terminated by sponsor|0|||
162092242|NCT01208233|585387781|FG001|Overall Study|Study terminated by sponsor|0|||
162092243|NCT01208233|585387782|FG002|Overall Study|Study terminated by sponsor|0|||
162092244|NCT01208233|585387783|FG003|Overall Study|Study terminated by sponsor|0|||
162092245|NCT01208233|585387784|FG004|Overall Study|Study terminated by sponsor|10|||
162092246|NCT01208233|585387785|FG005|Overall Study|Study terminated by sponsor|7|||
162092247|NCT01208233|585387780|FG000|Overall Study|Protocol Violation|0|||
162092248|NCT01208233|585387781|FG001|Overall Study|Protocol Violation|0|||
162092249|NCT01208233|585387782|FG002|Overall Study|Protocol Violation|0|||
162092250|NCT01208233|585387783|FG003|Overall Study|Protocol Violation|0|||
162092251|NCT01208233|585387784|FG004|Overall Study|Protocol Violation|3|||
162092252|NCT01208233|585387785|FG005|Overall Study|Protocol Violation|0|||
162092253|NCT01208233|585387780|FG000|Overall Study|Other|2|||
162092254|NCT01208233|585387781|FG001|Overall Study|Other|1|||
162092255|NCT01208233|585387782|FG002|Overall Study|Other|0|||
162092256|NCT01208233|585387783|FG003|Overall Study|Other|0|||
162092257|NCT01208233|585387784|FG004|Overall Study|Other|0|||
162092258|NCT01208233|585387785|FG005|Overall Study|Other|1|||
162092259|NCT01208233|585387780|FG000|Overall Study|Withdrawal by Subject|1|||
162092260|NCT01208233|585387781|FG001|Overall Study|Withdrawal by Subject|0|||
162092261|NCT01208233|585387782|FG002|Overall Study|Withdrawal by Subject|1|||
162092262|NCT01208233|585387783|FG003|Overall Study|Withdrawal by Subject|1|||
162092263|NCT01208233|585387784|FG004|Overall Study|Withdrawal by Subject|4|||
162092264|NCT01208233|585387785|FG005|Overall Study|Withdrawal by Subject|2|||
162092265|NCT04028388|585387790|FG000|Overall Study|Evaluations missing|3|||
162092266|NCT04028388|585387791|FG001|Overall Study|Evaluations missing|6|||
162092267|NCT04028388|585387790|FG000|Overall Study|Not started|2|||
162092268|NCT04028388|585387791|FG001|Overall Study|Not started|0|||
162092269|NCT01609556|585387792|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162092270|NCT01609556|585387793|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162092271|NCT01609556|585387794|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162092272|NCT01609556|585387795|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162092273|NCT01609556|585387796|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
162092274|NCT01609556|585387797|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162092275|NCT01609556|585387798|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162092276|NCT01609556|585387799|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
162092277|NCT01609556|585387800|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
162092278|NCT01609556|585387801|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162092279|NCT01609556|585387802|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
162092280|NCT01609556|585387803|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
162092281|NCT01609556|585387804|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162092282|NCT01609556|585387805|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162092283|NCT01609556|585387806|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162092284|NCT01609556|585387807|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
162092285|NCT01609556|585387792|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
162092286|NCT01609556|585387793|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
162092287|NCT01609556|585387794|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
162092288|NCT01609556|585387795|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
162092289|NCT01609556|585387796|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
162092290|NCT01609556|585387797|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
162092291|NCT01609556|585387798|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
162092292|NCT01609556|585387799|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
162092293|NCT01609556|585387800|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
162092294|NCT01609556|585387801|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
162092295|NCT01609556|585387802|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
162092296|NCT01609556|585387803|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
162092297|NCT01609556|585387804|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
162092298|NCT01609556|585387805|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
162092299|NCT01609556|585387806|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
162092300|NCT01609556|585387807|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
162092301|NCT01609556|585387792|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162092302|NCT01609556|585387793|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162092303|NCT01609556|585387794|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162092304|NCT01609556|585387795|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162092305|NCT01609556|585387796|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162092306|NCT01609556|585387797|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
162092307|NCT01609556|585387798|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
162092308|NCT01609556|585387799|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162092309|NCT01609556|585387800|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162092310|NCT01609556|585387801|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
162092311|NCT01609556|585387802|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
162092312|NCT01609556|585387803|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
162092313|NCT01609556|585387804|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162092314|NCT01609556|585387805|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162092315|NCT01609556|585387806|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162092316|NCT01609556|585387807|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
162092317|NCT01609556|585387792|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092318|NCT01609556|585387793|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092319|NCT01609556|585387794|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092320|NCT01609556|585387795|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092321|NCT01609556|585387796|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092322|NCT01609556|585387797|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
162092323|NCT01609556|585387798|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092324|NCT01609556|585387799|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092325|NCT01609556|585387800|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092326|NCT01609556|585387801|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092327|NCT01609556|585387802|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092328|NCT01609556|585387803|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
162092329|NCT01609556|585387804|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092330|NCT01609556|585387805|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092331|NCT01609556|585387806|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092332|NCT01609556|585387807|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
162092333|NCT01609556|585387792|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092334|NCT01609556|585387793|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092335|NCT01609556|585387794|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092336|NCT01609556|585387795|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092337|NCT01609556|585387796|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092338|NCT01609556|585387797|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
162092339|NCT01609556|585387798|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092340|NCT01609556|585387799|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092341|NCT01609556|585387800|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092342|NCT01609556|585387801|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092343|NCT01609556|585387802|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092344|NCT01609556|585387803|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092345|NCT01609556|585387804|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092346|NCT01609556|585387805|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092347|NCT01609556|585387806|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092348|NCT01609556|585387807|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
162092349|NCT01609556|585387792|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092350|NCT01609556|585387793|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092351|NCT01609556|585387794|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092352|NCT01609556|585387795|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092353|NCT01609556|585387796|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092354|NCT01609556|585387797|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092355|NCT01609556|585387798|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092356|NCT01609556|585387799|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092357|NCT01609556|585387800|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
162092358|NCT01609556|585387801|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092359|NCT01609556|585387802|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092360|NCT01609556|585387803|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092361|NCT01609556|585387804|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092362|NCT01609556|585387805|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092363|NCT01609556|585387806|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092364|NCT01609556|585387807|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
162092365|NCT01609556|585387792|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
162092366|NCT01609556|585387793|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092367|NCT01609556|585387794|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092368|NCT01609556|585387795|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092369|NCT01609556|585387796|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092370|NCT01609556|585387797|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
162092371|NCT01609556|585387798|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092372|NCT01609556|585387799|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092373|NCT01609556|585387800|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092374|NCT01609556|585387801|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092375|NCT01609556|585387802|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
162092376|NCT01609556|585387803|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092377|NCT01609556|585387804|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092378|NCT01609556|585387805|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092379|NCT01609556|585387806|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092380|NCT01609556|585387807|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
162092381|NCT01609556|585387792|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162092382|NCT01609556|585387793|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162092383|NCT01609556|585387794|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162092384|NCT01609556|585387795|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162092385|NCT01609556|585387796|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162092386|NCT01609556|585387797|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162092387|NCT01609556|585387798|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162092388|NCT01609556|585387799|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162092389|NCT01609556|585387800|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162092390|NCT01609556|585387801|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162092391|NCT01609556|585387802|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162092392|NCT01609556|585387803|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
162092393|NCT01609556|585387804|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
162092394|NCT01609556|585387805|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
162092395|NCT01609556|585387806|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
162092396|NCT01609556|585387807|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
162092397|NCT01609556|585387792|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162092398|NCT01609556|585387793|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162092399|NCT01609556|585387794|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162092400|NCT01609556|585387795|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162092401|NCT01609556|585387796|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162092402|NCT01609556|585387797|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162092403|NCT01609556|585387798|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162092404|NCT01609556|585387799|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162092405|NCT01609556|585387800|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162092406|NCT01609556|585387801|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162092407|NCT01609556|585387802|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162092408|NCT01609556|585387803|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
162092409|NCT01609556|585387804|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
162092410|NCT01609556|585387805|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
162092411|NCT01609556|585387806|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
162092412|NCT01609556|585387807|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
162092413|NCT01609556|585387792|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162092414|NCT01609556|585387793|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162092415|NCT01609556|585387794|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162092416|NCT01609556|585387795|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162092417|NCT01609556|585387796|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162092418|NCT01609556|585387797|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162092419|NCT01609556|585387798|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162092420|NCT01609556|585387799|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162092421|NCT01609556|585387800|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162092422|NCT01609556|585387801|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162092423|NCT01609556|585387802|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162092424|NCT01609556|585387803|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
162092425|NCT01609556|585387804|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
162092426|NCT01609556|585387805|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
162092427|NCT01609556|585387806|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
162092428|NCT01609556|585387807|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
162092429|NCT01609556|585387792|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092430|NCT01609556|585387793|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092431|NCT01609556|585387794|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092432|NCT01609556|585387795|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092433|NCT01609556|585387796|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092434|NCT01609556|585387797|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092435|NCT01609556|585387798|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092436|NCT01609556|585387799|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092437|NCT01609556|585387800|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092438|NCT01609556|585387801|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092439|NCT01609556|585387802|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092440|NCT01609556|585387803|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092441|NCT01609556|585387804|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
162092442|NCT01609556|585387805|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092443|NCT01609556|585387806|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092444|NCT01609556|585387807|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
162092445|NCT01609556|585387792|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162092446|NCT01609556|585387793|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162092447|NCT01609556|585387794|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162092448|NCT01609556|585387795|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162092449|NCT01609556|585387796|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162092450|NCT01609556|585387797|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162092451|NCT01609556|585387798|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162092452|NCT01609556|585387799|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162092453|NCT01609556|585387800|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162092454|NCT01609556|585387801|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162092455|NCT01609556|585387802|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162092456|NCT01609556|585387803|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
162092457|NCT01609556|585387804|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
162092458|NCT01609556|585387805|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
162092459|NCT01609556|585387806|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
162092460|NCT01609556|585387807|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
162092461|NCT01609556|585387792|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092462|NCT01609556|585387793|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092463|NCT01609556|585387794|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092464|NCT01609556|585387795|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092465|NCT01609556|585387796|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092466|NCT01609556|585387797|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092467|NCT01609556|585387798|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092468|NCT01609556|585387799|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092469|NCT01609556|585387800|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092470|NCT01609556|585387801|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092471|NCT01609556|585387802|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092472|NCT01609556|585387803|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092473|NCT01609556|585387804|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092474|NCT01609556|585387805|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092475|NCT01609556|585387806|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
162092476|NCT01609556|585387807|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
162092477|NCT01609556|585387792|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092478|NCT01609556|585387793|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092479|NCT01609556|585387794|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092480|NCT01609556|585387795|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092481|NCT01609556|585387796|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092482|NCT01609556|585387797|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092483|NCT01609556|585387798|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092484|NCT01609556|585387799|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092485|NCT01609556|585387800|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092486|NCT01609556|585387801|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092487|NCT01609556|585387802|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092488|NCT01609556|585387803|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092489|NCT01609556|585387804|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
162092490|NCT01609556|585387805|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
162092491|NCT01609556|585387806|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
162092492|NCT01609556|585387807|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
162092493|NCT01609556|585387792|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092494|NCT01609556|585387793|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092495|NCT01609556|585387794|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092496|NCT01609556|585387795|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092497|NCT01609556|585387796|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092498|NCT01609556|585387797|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092499|NCT01609556|585387798|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092500|NCT01609556|585387799|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092501|NCT01609556|585387800|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092502|NCT01609556|585387801|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092503|NCT01609556|585387802|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092504|NCT01609556|585387803|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092505|NCT01609556|585387804|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
162092506|NCT01609556|585387805|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092507|NCT01609556|585387806|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092508|NCT01609556|585387807|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
162092509|NCT01539291|585389659|FG000|Study GS-US-312-0116|Adverse Event|9|||
162092510|NCT01539291|585389660|FG001|Study GS-US-312-0116|Adverse Event|0|||
162092511|NCT01539291|585389661|FG002|Study GS-US-312-0116|Adverse Event|0|||
162092512|NCT01539291|585389662|FG003|Study GS-US-312-0116|Adverse Event|0|||
162092513|NCT01539291|585389659|FG000|Study GS-US-312-0116|Physician Decision|1|||
162092514|NCT01539291|585389660|FG001|Study GS-US-312-0116|Physician Decision|0|||
162092515|NCT01539291|585389661|FG002|Study GS-US-312-0116|Physician Decision|0|||
162092516|NCT01539291|585389662|FG003|Study GS-US-312-0116|Physician Decision|0|||
162092517|NCT01539291|585389659|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
162092518|NCT01539291|585389660|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
162092519|NCT01539291|585389661|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
162092520|NCT01539291|585389662|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
162092521|NCT01539291|585389659|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
162092522|NCT01539291|585389660|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
162092523|NCT01539291|585389661|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
162092524|NCT01539291|585389662|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
162092525|NCT01539291|585389659|FG000|Study GS-US-312-0116|Other|1|||
162092526|NCT01539291|585389660|FG001|Study GS-US-312-0116|Other|0|||
162092527|NCT01539291|585389661|FG002|Study GS-US-312-0116|Other|0|||
162092528|NCT01539291|585389662|FG003|Study GS-US-312-0116|Other|0|||
162092529|NCT01539291|585389659|FG000|Study GS-US-312-0117|Adverse Event|22|||
162092530|NCT01539291|585389660|FG001|Study GS-US-312-0117|Adverse Event|1|||
162092531|NCT01539291|585389661|FG002|Study GS-US-312-0117|Adverse Event|9|||
162092532|NCT01539291|585389662|FG003|Study GS-US-312-0117|Adverse Event|12|||
162092533|NCT01539291|585389659|FG000|Study GS-US-312-0117|Physician Decision|9|||
162092534|NCT01539291|585389660|FG001|Study GS-US-312-0117|Physician Decision|0|||
162092535|NCT01539291|585389661|FG002|Study GS-US-312-0117|Physician Decision|6|||
162092536|NCT01539291|585389662|FG003|Study GS-US-312-0117|Physician Decision|4|||
162092537|NCT01539291|585389659|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
162092538|NCT01539291|585389660|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
162092539|NCT01539291|585389661|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
162092540|NCT01539291|585389662|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
162092541|NCT01539291|585389659|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
162092542|NCT01539291|585389660|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
162092543|NCT01539291|585389661|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
162092544|NCT01539291|585389662|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
162092545|NCT01539291|585389659|FG000|Study GS-US-312-0117|Other|2|||
162092546|NCT01539291|585389660|FG001|Study GS-US-312-0117|Other|1|||
162092547|NCT01539291|585389661|FG002|Study GS-US-312-0117|Other|1|||
162092548|NCT01539291|585389662|FG003|Study GS-US-312-0117|Other|1|||
162092549|NCT00129987|585389667|FG000|1st Educational Session|Withdrawal by Subject|141|||
162092550|NCT00129987|585389668|FG001|1st Educational Session|Withdrawal by Subject|109|||
162092551|NCT00129987|585389667|FG000|1 Year|Withdrawal by Subject|32|||
162092552|NCT00129987|585389668|FG001|1 Year|Withdrawal by Subject|21|||
162092553|NCT00116805|585389669|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
162092554|NCT00116805|585389670|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
162092555|NCT00116805|585389669|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
162092556|NCT00116805|585389670|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
162092557|NCT00116805|585389669|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
162092558|NCT00116805|585389670|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
162092559|NCT00116805|585389669|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
162092560|NCT00116805|585389670|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
162092561|NCT00116805|585389669|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
162092562|NCT00116805|585389670|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
162092563|NCT00116805|585389669|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
162092564|NCT00116805|585389670|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
162092565|NCT00116805|585389669|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
162092566|NCT00116805|585389670|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
162092567|NCT00116805|585389669|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
162092568|NCT00116805|585389670|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
162092569|NCT00116805|585389669|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
162092570|NCT00116805|585389670|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
162092571|NCT00116805|585389669|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
162092572|NCT00116805|585389670|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
162092573|NCT00116805|585389669|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
162092574|NCT00116805|585389670|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
162092575|NCT00116805|585389669|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
162092576|NCT00116805|585389670|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
162092577|NCT00116805|585389669|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
162092578|NCT00116805|585389670|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
162092579|NCT00116805|585389669|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
162092580|NCT00116805|585389670|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
162092581|NCT00116805|585389669|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
162092582|NCT00116805|585389670|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
162092583|NCT00116805|585389669|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
162092584|NCT00116805|585389670|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
162092585|NCT00116805|585389669|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
162092586|NCT00116805|585389670|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
162092587|NCT00116805|585389669|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
162092588|NCT00116805|585389670|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
162092589|NCT00116805|585389669|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
162092590|NCT00116805|585389670|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
162092591|NCT00116805|585389669|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
162092592|NCT00116805|585389670|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
162092593|NCT00116805|585389669|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
162092594|NCT00116805|585389670|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
162092595|NCT00116805|585389669|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
162092596|NCT00116805|585389670|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
162092597|NCT00116805|585389669|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
162092598|NCT00116805|585389670|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
162092599|NCT00116805|585389669|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
162092600|NCT00116805|585389670|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
162092601|NCT00116805|585389669|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
162092602|NCT00116805|585389670|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
162092603|NCT00116805|585389669|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
162092604|NCT00116805|585389670|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
162092605|NCT00116805|585389669|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
162092606|NCT00116805|585389670|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
162092607|NCT00116805|585389669|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
162092608|NCT00116805|585389670|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
162092609|NCT00116805|585389669|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
162092610|NCT00116805|585389670|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
162092611|NCT00116805|585389669|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
162092612|NCT00116805|585389670|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
162092613|NCT00116805|585389669|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
162092614|NCT00116805|585389670|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
162092615|NCT00116805|585389669|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
162092616|NCT00116805|585389670|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
162092617|NCT00116805|585389669|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
162092618|NCT00116805|585389670|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
162092619|NCT00116805|585389669|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
162092620|NCT00116805|585389670|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
162092621|NCT00116805|585389669|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
162092622|NCT00116805|585389670|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
162092623|NCT00116805|585389669|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
162092624|NCT00116805|585389670|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
162092625|NCT00116805|585389669|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
162092626|NCT00116805|585389670|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
162092627|NCT00116805|585389669|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
162092628|NCT00116805|585389670|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
162092629|NCT00116805|585389669|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
162092630|NCT00116805|585389670|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
162092631|NCT00116805|585389669|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
162092632|NCT00116805|585389670|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
162092633|NCT00116805|585389669|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
162092634|NCT00116805|585389670|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
162092635|NCT00116805|585389669|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
162092636|NCT00116805|585389670|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
162092637|NCT00116805|585389669|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
162092638|NCT00116805|585389670|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
162092639|NCT00116805|585389669|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
162092640|NCT00116805|585389670|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
162092641|NCT00116805|585389669|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
162092642|NCT00116805|585389670|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
162092643|NCT01159938|585389671|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
162092644|NCT01159938|585389672|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
162092645|NCT01159938|585389673|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
162092646|NCT01159938|585389674|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
162092647|NCT01159938|585389675|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
162092648|NCT02105116|585389677|FG000|Overall Study|not eligible for step 2 of trial|5|||
162092649|NCT02105116|585389677|FG000|Overall Study|Death|1|||
162092650|NCT02318329|585389679|FG000|Overall Study|Progressive Disease|2|||
162092651|NCT02318329|585389680|FG001|Overall Study|Progressive Disease|3|||
162092652|NCT02318329|585389681|FG002|Overall Study|Progressive Disease|2|||
162092653|NCT02318329|585389682|FG003|Overall Study|Progressive Disease|3|||
162092654|NCT02318329|585389683|FG004|Overall Study|Progressive Disease|3|||
162092655|NCT02318329|585389684|FG005|Overall Study|Progressive Disease|3|||
162092656|NCT02318329|585389685|FG006|Overall Study|Progressive Disease|1|||
162092657|NCT02318329|585389686|FG007|Overall Study|Progressive Disease|1|||
162092658|NCT02318329|585389687|FG008|Overall Study|Progressive Disease|5|||
162092659|NCT02318329|585389688|FG009|Overall Study|Progressive Disease|39|||
162092660|NCT02318329|585389679|FG000|Overall Study|Death|0|||
162092661|NCT02318329|585389680|FG001|Overall Study|Death|0|||
162092662|NCT02318329|585389681|FG002|Overall Study|Death|0|||
162092663|NCT02318329|585389682|FG003|Overall Study|Death|0|||
162092664|NCT02318329|585389683|FG004|Overall Study|Death|0|||
162092665|NCT02318329|585389684|FG005|Overall Study|Death|0|||
162092666|NCT02318329|585389685|FG006|Overall Study|Death|0|||
162092667|NCT02318329|585389686|FG007|Overall Study|Death|0|||
162092668|NCT02318329|585389687|FG008|Overall Study|Death|0|||
162092669|NCT02318329|585389688|FG009|Overall Study|Death|5|||
162092670|NCT02318329|585389679|FG000|Overall Study|Lost to Follow-up|0|||
162092671|NCT02318329|585389680|FG001|Overall Study|Lost to Follow-up|0|||
162092672|NCT02318329|585389681|FG002|Overall Study|Lost to Follow-up|0|||
162092673|NCT02318329|585389682|FG003|Overall Study|Lost to Follow-up|0|||
162092674|NCT02318329|585389683|FG004|Overall Study|Lost to Follow-up|0|||
162092675|NCT02318329|585389684|FG005|Overall Study|Lost to Follow-up|0|||
162092676|NCT02318329|585389685|FG006|Overall Study|Lost to Follow-up|0|||
162092677|NCT02318329|585389686|FG007|Overall Study|Lost to Follow-up|0|||
162092678|NCT02318329|585389687|FG008|Overall Study|Lost to Follow-up|0|||
162092679|NCT02318329|585389688|FG009|Overall Study|Lost to Follow-up|1|||
162092680|NCT02318329|585389679|FG000|Overall Study|Withdrawal by Subject|0|||
162092681|NCT02318329|585389680|FG001|Overall Study|Withdrawal by Subject|0|||
162092682|NCT02318329|585389681|FG002|Overall Study|Withdrawal by Subject|0|||
162092683|NCT02318329|585389682|FG003|Overall Study|Withdrawal by Subject|0|||
162092684|NCT02318329|585389683|FG004|Overall Study|Withdrawal by Subject|0|||
162092685|NCT02318329|585389684|FG005|Overall Study|Withdrawal by Subject|0|||
162092686|NCT02318329|585389685|FG006|Overall Study|Withdrawal by Subject|0|||
162092687|NCT02318329|585389686|FG007|Overall Study|Withdrawal by Subject|0|||
162092688|NCT02318329|585389687|FG008|Overall Study|Withdrawal by Subject|0|||
162092689|NCT02318329|585389688|FG009|Overall Study|Withdrawal by Subject|6|||
162092690|NCT02318329|585389679|FG000|Overall Study|Other|1|||
162092691|NCT02318329|585389680|FG001|Overall Study|Other|1|||
162092692|NCT02318329|585389681|FG002|Overall Study|Other|1|||
162092693|NCT02318329|585389682|FG003|Overall Study|Other|0|||
162092694|NCT02318329|585389683|FG004|Overall Study|Other|0|||
162092695|NCT02318329|585389684|FG005|Overall Study|Other|0|||
162092696|NCT02318329|585389685|FG006|Overall Study|Other|0|||
162092697|NCT02318329|585389686|FG007|Overall Study|Other|0|||
162092698|NCT02318329|585389687|FG008|Overall Study|Other|1|||
162092699|NCT02318329|585389688|FG009|Overall Study|Other|1|||
162092700|NCT04837482|585389689|FG000|Period 2|Withdrawal by Subject|0|||
162092701|NCT04837482|585389690|FG001|Period 2|Withdrawal by Subject|1|||
162092702|NCT00581945|585389691|FG000|Overall Study|Adverse Event|4|||
162092703|NCT00581945|585389692|FG001|Overall Study|Adverse Event|4|||
162092704|NCT00581945|585389691|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162092705|NCT00581945|585389692|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
162092706|NCT00581945|585389691|FG000|Overall Study|Withdrawal by Subject|2|||
162092707|NCT00581945|585389692|FG001|Overall Study|Withdrawal by Subject|6|||
162092708|NCT00581945|585389691|FG000|Overall Study|Death|1|||
162092709|NCT00581945|585389692|FG001|Overall Study|Death|0|||
162092710|NCT02979535|585389693|FG000|Overall Study|Non compliance with the protocol|78|||
162092711|NCT02979535|585389694|FG001|Overall Study|Non compliance with the protocol|82|||
162092712|NCT02979535|585389693|FG000|Overall Study|Consent withdrawn by participant|11|||
162092713|NCT02979535|585389694|FG001|Overall Study|Consent withdrawn by participant|18|||
162092714|NCT02979535|585389693|FG000|Overall Study|Lost to Follow-up|6|||
162092715|NCT02979535|585389694|FG001|Overall Study|Lost to Follow-up|1|||
162092716|NCT04820673|585389695|FG000|Overall Study|Adverse Event|6|||
162092717|NCT04820673|585389695|FG000|Overall Study|Due to Lack of Effectiveness|1|||
162092718|NCT04820673|585389695|FG000|Overall Study|Pregnancy|1|||
162092719|NCT04820673|585389695|FG000|Overall Study|Voluntary Withdrawal|20|||
162092720|NCT04820673|585389695|FG000|Overall Study|Lost to Follow-up|10|||
162092721|NCT00587587|585389698|FG000|Overall Study|Lost to Follow-up|6|||
162092722|NCT00587587|585389699|FG001|Overall Study|Lost to Follow-up|1|||
162092723|NCT02032901|585389702|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
162092724|NCT02032901|585389703|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
162092725|NCT02032901|585389702|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
162092726|NCT02032901|585389703|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
162092727|NCT00466193|585389704|FG000|Overall Study|Adverse Event|0|||
162092728|NCT00466193|585389705|FG001|Overall Study|Adverse Event|1|||
162092729|NCT00466193|585389704|FG000|Overall Study|Lost to Follow-up|2|||
162092730|NCT00466193|585389705|FG001|Overall Study|Lost to Follow-up|4|||
162092731|NCT00466193|585389704|FG000|Overall Study|Physician Decision|1|||
162092732|NCT00466193|585389705|FG001|Overall Study|Physician Decision|0|||
162092733|NCT00466193|585389704|FG000|Overall Study|Protocol Violation|1|||
162092734|NCT00466193|585389705|FG001|Overall Study|Protocol Violation|1|||
162092735|NCT00466193|585389704|FG000|Overall Study|Withdrawal by Subject|7|||
162092736|NCT00466193|585389705|FG001|Overall Study|Withdrawal by Subject|2|||
162092737|NCT00466193|585389704|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
162092738|NCT00466193|585389705|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
162092739|NCT00086346|585389712|FG000|Randomization|Did not receive test article|4|||
162092740|NCT00086346|585389713|FG001|Randomization|Did not receive test article|4|||
162092741|NCT00086346|585389712|FG000|Patients Dosed With Test Article|Adverse Event|94|||
162092742|NCT00086346|585389713|FG001|Patients Dosed With Test Article|Adverse Event|11|||
162092743|NCT00086346|585389712|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
162092744|NCT00086346|585389713|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
162092745|NCT00086346|585389712|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
162092746|NCT00086346|585389713|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
162092747|NCT00086346|585389712|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
162092748|NCT00086346|585389713|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
162092749|NCT00086346|585389712|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
162092750|NCT00086346|585389713|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
162092751|NCT00086346|585389712|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
162092752|NCT00086346|585389713|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
162092753|NCT04495374|585389714|FG000|Overall Study|Protocol Violation|2|||
162092754|NCT04495374|585389715|FG001|Overall Study|Protocol Violation|1|||
162092755|NCT02473614|585389716|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
162092756|NCT02473614|585389717|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
162092757|NCT02525133|585389718|FG000|Overall Study|Adverse Event|0|||
162092758|NCT02525133|585389719|FG001|Overall Study|Adverse Event|1|||
162092759|NCT02525133|585389718|FG000|Overall Study|Death|0|||
162092760|NCT02525133|585389719|FG001|Overall Study|Death|1|||
162092761|NCT02525133|585389718|FG000|Overall Study|did not meet randomization criteria|1|||
162092762|NCT02525133|585389719|FG001|Overall Study|did not meet randomization criteria|0|||
162092763|NCT02525133|585389718|FG000|Overall Study|Lost to Follow-up|5|||
162092764|NCT02525133|585389719|FG001|Overall Study|Lost to Follow-up|1|||
162092765|NCT02525133|585389718|FG000|Overall Study|randomized not enrolled|3|||
162092766|NCT02525133|585389719|FG001|Overall Study|randomized not enrolled|0|||
162092767|NCT02525133|585389718|FG000|Overall Study|Withdrawal by Subject|1|||
162092768|NCT02525133|585389719|FG001|Overall Study|Withdrawal by Subject|0|||
162092769|NCT01343082|585389720|FG000|The run-in Period|Not meeting criteria|3|||
162092770|NCT01343082|585389721|FG001|The run-in Period|Not meeting criteria|4|||
162092771|NCT01343082|585389722|FG002|The run-in Period|Not meeting criteria|5|||
162092772|NCT01343082|585389720|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
162092773|NCT01343082|585389721|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
162092774|NCT01343082|585389722|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
162092775|NCT01343082|585389720|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
162092776|NCT01343082|585389721|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
162092777|NCT01343082|585389722|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
162092778|NCT01343082|585389720|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
162092779|NCT01343082|585389721|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
162092780|NCT01343082|585389722|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
162092781|NCT01343082|585389720|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
162092782|NCT01343082|585389721|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
162092783|NCT01343082|585389722|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
162092784|NCT01075074|585389723|FG000|Overall Study|Surgeon changed to open incisional case|1|||
162092785|NCT01075074|585389724|FG001|Overall Study|Surgeon changed to open incisional case|2|||
162092786|NCT01075074|585389725|FG002|Overall Study|Surgeon changed to open incisional case|2|||
162092787|NCT01575561|585389727|FG000|Overall Study|Adverse Event|9|||
162092788|NCT01575561|585389727|FG000|Overall Study|Lack of Efficacy|8|||
162092789|NCT01575561|585389727|FG000|Overall Study|Lost to Follow-up|6|||
162092790|NCT01575561|585389727|FG000|Overall Study|Protocol Violation|4|||
162092791|NCT01575561|585389727|FG000|Overall Study|Withdrawal by Subject|11|||
162092792|NCT01575561|585389727|FG000|Overall Study|administration|1|||
162092793|NCT00844194|585389728|FG000|Overall Study|Adverse Event|17|||
162092794|NCT00844194|585389729|FG001|Overall Study|Adverse Event|5|||
162092795|NCT00844194|585389728|FG000|Overall Study|Protocol Violation|1|||
162092796|NCT00844194|585389729|FG001|Overall Study|Protocol Violation|1|||
162092797|NCT00844194|585389728|FG000|Overall Study|Lost to Follow-up|1|||
162092798|NCT00844194|585389729|FG001|Overall Study|Lost to Follow-up|1|||
162092799|NCT00844194|585389728|FG000|Overall Study|Withdrawal by Subject|2|||
162092800|NCT00844194|585389729|FG001|Overall Study|Withdrawal by Subject|1|||
162092801|NCT00844194|585389728|FG000|Overall Study|Lack of Efficacy|3|||
162092802|NCT00844194|585389729|FG001|Overall Study|Lack of Efficacy|0|||
162092803|NCT00844194|585389728|FG000|Overall Study|Other reason (not specified)|1|||
162092804|NCT00844194|585389729|FG001|Overall Study|Other reason (not specified)|0|||
162092805|NCT05282004|585389730|FG000|Overall Study|Adverse Event|2|||
162092806|NCT04808609|585389731|FG000|Overall Study|Lost to Follow-up|0|||
162092807|NCT04808609|585389732|FG001|Overall Study|Lost to Follow-up|2|||
162092808|NCT04808609|585389731|FG000|Overall Study|Administrative Withdrawal|0|||
162092809|NCT04808609|585389732|FG001|Overall Study|Administrative Withdrawal|1|||
162092810|NCT00562159|585389734|FG000|Overall Study|Adverse Event|11|||
162092811|NCT00562159|585389735|FG001|Overall Study|Adverse Event|8|||
162092812|NCT00562159|585389734|FG000|Overall Study|Lost to Follow-up|5|||
162092813|NCT00562159|585389735|FG001|Overall Study|Lost to Follow-up|4|||
162092814|NCT00562159|585389734|FG000|Overall Study|Withdrawal by Subject|9|||
162092815|NCT00562159|585389735|FG001|Overall Study|Withdrawal by Subject|8|||
162092816|NCT00562159|585389734|FG000|Overall Study|Protocol Violation|12|||
162092817|NCT00562159|585389735|FG001|Overall Study|Protocol Violation|12|||
162092818|NCT00562159|585389734|FG000|Overall Study|Did not meet protocol eligibility|1|||
162092819|NCT00562159|585389735|FG001|Overall Study|Did not meet protocol eligibility|1|||
162092820|NCT01038921|585389738|FG000|Overall Study|Withdrawal by Subject|1|||
162092821|NCT01038921|585389739|FG001|Overall Study|Withdrawal by Subject|0|||
162092822|NCT01038921|585389738|FG000|Overall Study|Physician Decision|1|||
162092823|NCT01038921|585389739|FG001|Overall Study|Physician Decision|0|||
162092824|NCT00572572|585389740|FG000|Overall Study|Withdrawal by Subject|3|||
162092825|NCT00572572|585389741|FG001|Overall Study|Withdrawal by Subject|6|||
162092826|NCT01831089|585389742|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
162092827|NCT01831089|585389743|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
162092828|NCT01831089|585389744|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
162092829|NCT01831089|585389745|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
162092830|NCT01831089|585389746|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
162092831|NCT01831089|585389747|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
162092832|NCT01831089|585389742|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
162092833|NCT01831089|585389743|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
162092834|NCT01831089|585389744|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
162092835|NCT01831089|585389745|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
162092836|NCT01831089|585389746|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
162092837|NCT01831089|585389747|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
162092838|NCT01831089|585389742|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
162092839|NCT01831089|585389743|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
162092840|NCT01831089|585389744|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
162092841|NCT01831089|585389745|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
162092842|NCT01831089|585389746|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
162092843|NCT01831089|585389747|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
162092844|NCT01831089|585389742|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
162092845|NCT01831089|585389743|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
162092846|NCT01831089|585389744|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
162092847|NCT01831089|585389745|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
162092848|NCT01831089|585389746|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
162092849|NCT01831089|585389747|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
162092850|NCT01831089|585389742|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
162092851|NCT01831089|585389743|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
162092852|NCT01831089|585389744|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
162092853|NCT01831089|585389745|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
162092854|NCT01831089|585389746|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
162092855|NCT01831089|585389747|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
162092856|NCT01831089|585389742|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
162092857|NCT01831089|585389743|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
162092858|NCT01831089|585389744|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
162092859|NCT01831089|585389745|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
162092860|NCT01831089|585389746|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
162092861|NCT01831089|585389747|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
162092862|NCT01831089|585389742|FG000|Cohort III: Dose Level 3|Global end of study|0|||
162092863|NCT01831089|585389743|FG001|Cohort III: Dose Level 3|Global end of study|0|||
162092864|NCT01831089|585389744|FG002|Cohort III: Dose Level 3|Global end of study|1|||
162092865|NCT01831089|585389745|FG003|Cohort III: Dose Level 3|Global end of study|0|||
162092866|NCT01831089|585389746|FG004|Cohort III: Dose Level 3|Global end of study|0|||
162092867|NCT01831089|585389747|FG005|Cohort III: Dose Level 3|Global end of study|0|||
162092868|NCT01831089|585389742|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
162092869|NCT01831089|585389743|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
162092870|NCT01831089|585389744|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
162092871|NCT01831089|585389745|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
162092872|NCT01831089|585389746|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
162092873|NCT01831089|585389747|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
162092874|NCT01831089|585389742|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
162092875|NCT01831089|585389743|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
162092876|NCT01831089|585389744|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
162092877|NCT01831089|585389745|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
162092878|NCT01831089|585389746|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
162092879|NCT01831089|585389747|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
162092880|NCT01831089|585389742|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
162092881|NCT01831089|585389743|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
162092882|NCT01831089|585389744|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
162092883|NCT01831089|585389745|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
162092884|NCT01831089|585389746|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
162092885|NCT01831089|585389747|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
162092886|NCT01831089|585389742|FG000|Cohort V: Dose Level 5|Death|0|||
162092887|NCT01831089|585389743|FG001|Cohort V: Dose Level 5|Death|0|||
162092888|NCT01831089|585389744|FG002|Cohort V: Dose Level 5|Death|0|||
162092889|NCT01831089|585389745|FG003|Cohort V: Dose Level 5|Death|0|||
162092890|NCT01831089|585389746|FG004|Cohort V: Dose Level 5|Death|1|||
162092891|NCT01831089|585389747|FG005|Cohort V: Dose Level 5|Death|0|||
162092892|NCT01831089|585389742|FG000|Cohort V: Dose Level 5|Global end of study|0|||
162092893|NCT01831089|585389743|FG001|Cohort V: Dose Level 5|Global end of study|0|||
162092894|NCT01831089|585389744|FG002|Cohort V: Dose Level 5|Global end of study|0|||
162092895|NCT01831089|585389745|FG003|Cohort V: Dose Level 5|Global end of study|0|||
162092896|NCT01831089|585389746|FG004|Cohort V: Dose Level 5|Global end of study|2|||
162092897|NCT01831089|585389747|FG005|Cohort V: Dose Level 5|Global end of study|0|||
162092898|NCT01831089|585389742|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
162092899|NCT01831089|585389743|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
162092900|NCT01831089|585389744|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
162092901|NCT01831089|585389745|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
162092902|NCT01831089|585389746|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
162092903|NCT01831089|585389747|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
162092904|NCT01831089|585389742|FG000|Cohort B: Arm B|Progressive disease|0|||
162092905|NCT01831089|585389743|FG001|Cohort B: Arm B|Progressive disease|0|||
162092906|NCT01831089|585389744|FG002|Cohort B: Arm B|Progressive disease|0|||
162092907|NCT01831089|585389745|FG003|Cohort B: Arm B|Progressive disease|0|||
162092908|NCT01831089|585389746|FG004|Cohort B: Arm B|Progressive disease|0|||
162092909|NCT01831089|585389747|FG005|Cohort B: Arm B|Progressive disease|8|||
162092910|NCT01831089|585389742|FG000|Cohort B: Arm B|Physician Decision|0|||
162092911|NCT01831089|585389743|FG001|Cohort B: Arm B|Physician Decision|0|||
162092912|NCT01831089|585389744|FG002|Cohort B: Arm B|Physician Decision|0|||
162092913|NCT01831089|585389745|FG003|Cohort B: Arm B|Physician Decision|0|||
162092914|NCT01831089|585389746|FG004|Cohort B: Arm B|Physician Decision|0|||
162092915|NCT01831089|585389747|FG005|Cohort B: Arm B|Physician Decision|2|||
162092916|NCT01831089|585389742|FG000|Cohort B: Arm B|Never treated|0|||
162092917|NCT01831089|585389743|FG001|Cohort B: Arm B|Never treated|0|||
162092918|NCT01831089|585389744|FG002|Cohort B: Arm B|Never treated|0|||
162092919|NCT01831089|585389745|FG003|Cohort B: Arm B|Never treated|0|||
162092920|NCT01831089|585389746|FG004|Cohort B: Arm B|Never treated|0|||
162092921|NCT01831089|585389747|FG005|Cohort B: Arm B|Never treated|2|||
162092922|NCT01831089|585389742|FG000|Cohort B: Arm B|Adverse Event|0|||
162092923|NCT01831089|585389743|FG001|Cohort B: Arm B|Adverse Event|0|||
162092924|NCT01831089|585389744|FG002|Cohort B: Arm B|Adverse Event|0|||
162092925|NCT01831089|585389745|FG003|Cohort B: Arm B|Adverse Event|0|||
162092926|NCT01831089|585389746|FG004|Cohort B: Arm B|Adverse Event|0|||
162092927|NCT01831089|585389747|FG005|Cohort B: Arm B|Adverse Event|1|||
162092928|NCT01831089|585389742|FG000|Cohort B: Arm B|Global end of study|0|||
162092929|NCT01831089|585389743|FG001|Cohort B: Arm B|Global end of study|0|||
162092930|NCT01831089|585389744|FG002|Cohort B: Arm B|Global end of study|0|||
162092931|NCT01831089|585389745|FG003|Cohort B: Arm B|Global end of study|0|||
162092932|NCT01831089|585389746|FG004|Cohort B: Arm B|Global end of study|0|||
162092933|NCT01831089|585389747|FG005|Cohort B: Arm B|Global end of study|1|||
162092934|NCT00889421|585389751|FG000|Overall Study|Lack of Efficacy|3|||
162092935|NCT03551938|585389752|FG000|3-Month Follow Up|Lost to Follow-up|39|||
162092936|NCT03551938|585389753|FG001|3-Month Follow Up|Lost to Follow-up|38|||
162092937|NCT03551938|585389752|FG000|6-Month Follow Up|Lost to Follow-up|46|||
162092938|NCT03551938|585389753|FG001|6-Month Follow Up|Lost to Follow-up|42|||
162092939|NCT03551938|585389752|FG000|9-Month Follow Up|Lost to Follow-up|44|||
162092940|NCT03551938|585389753|FG001|9-Month Follow Up|Lost to Follow-up|43|||
162092941|NCT01114646|585389754|FG000|Overall Study|Withdrawal by Subject|3|||
162092942|NCT01114646|585389755|FG001|Overall Study|Withdrawal by Subject|2|||
162092943|NCT02667912|585389765|FG000|Overall Study|Death|3|||
162092944|NCT02667912|585389766|FG001|Overall Study|Death|1|||
162092945|NCT02667912|585389765|FG000|Overall Study|Withdrawal by Subject|1|||
162092946|NCT02667912|585389766|FG001|Overall Study|Withdrawal by Subject|2|||
162092947|NCT02667912|585389765|FG000|Overall Study|Withdrawal by Subject|1|||
162092948|NCT02667912|585389766|FG001|Overall Study|Withdrawal by Subject|0|||
162092949|NCT04443218|585389767|FG000|Overall Study|Exited study for other reasons|9|||
162092950|NCT04443218|585389767|FG000|Overall Study|Withdrawal by Subject|1|||
162092951|NCT04443218|585389767|FG000|Overall Study|Lost to Follow-up|4|||
162092952|NCT04443218|585389767|FG000|Overall Study|Death|19|||
162092953|NCT00781326|585389768|FG000|Phase I|Adverse Event|1|||
162092954|NCT00781326|585389768|FG000|Phase I|Withdrawal by Subject|1|||
162092955|NCT00781326|585389768|FG000|Phase I|Physician Decision|2|||
162092956|NCT00096941|585389769|FG000|Overall Study|disease progression|3|||
162092957|NCT00861341|585389777|FG000|Overall Study|Withdrawal by Subject|2|||
162092958|NCT01440946|585389778|FG000|Overall Study|Lost to Follow-up|1|||
162092959|NCT01440946|585389779|FG001|Overall Study|Lost to Follow-up|1|||
162092960|NCT01440946|585389778|FG000|Overall Study|Physician Decision|1|||
162092961|NCT01440946|585389779|FG001|Overall Study|Physician Decision|0|||
162092962|NCT01975389|585389780|FG000|Overall Study|Adverse Event|10|||
162092963|NCT01975389|585389781|FG001|Overall Study|Adverse Event|6|||
162092964|NCT01975389|585389780|FG000|Overall Study|Death|61|||
162092965|NCT01975389|585389781|FG001|Overall Study|Death|54|||
162092966|NCT01975389|585389780|FG000|Overall Study|Lost to Follow-up|81|||
162092967|NCT01975389|585389781|FG001|Overall Study|Lost to Follow-up|86|||
162092968|NCT01975389|585389780|FG000|Overall Study|Withdrawal by Subject|90|||
162092969|NCT01975389|585389781|FG001|Overall Study|Withdrawal by Subject|76|||
162092970|NCT01975389|585389780|FG000|Overall Study|Other|6|||
162092971|NCT01975389|585389781|FG001|Overall Study|Other|9|||
162092972|NCT01975389|585389780|FG000|Overall Study|Randomized, not treated|4|||
162092973|NCT01975389|585389781|FG001|Overall Study|Randomized, not treated|5|||
162092974|NCT02778204|585389786|FG000|Overall Study|Adverse Event|1|||
162092975|NCT02778204|585389787|FG001|Overall Study|Adverse Event|0|||
162092976|NCT02778204|585389788|FG002|Overall Study|Adverse Event|0|||
162092977|NCT02778204|585389789|FG003|Overall Study|Adverse Event|0|||
162092978|NCT02778204|585389786|FG000|Overall Study|Withdrawal by Subject|0|||
162092979|NCT02778204|585389787|FG001|Overall Study|Withdrawal by Subject|0|||
162092980|NCT02778204|585389788|FG002|Overall Study|Withdrawal by Subject|1|||
162092981|NCT02778204|585389789|FG003|Overall Study|Withdrawal by Subject|2|||
162092982|NCT02778204|585389786|FG000|Overall Study|Lost to Follow-up|1|||
162092983|NCT02778204|585389787|FG001|Overall Study|Lost to Follow-up|0|||
162092984|NCT02778204|585389788|FG002|Overall Study|Lost to Follow-up|2|||
162092985|NCT02778204|585389789|FG003|Overall Study|Lost to Follow-up|1|||
162092986|NCT02778204|585389786|FG000|Overall Study|Protocol Violation|0|||
162092987|NCT02778204|585389787|FG001|Overall Study|Protocol Violation|0|||
162092988|NCT02778204|585389788|FG002|Overall Study|Protocol Violation|1|||
162092989|NCT02778204|585389789|FG003|Overall Study|Protocol Violation|0|||
162092990|NCT02778204|585389786|FG000|Overall Study|Eligibility Violation|0|||
162092991|NCT02778204|585389787|FG001|Overall Study|Eligibility Violation|0|||
162092992|NCT02778204|585389788|FG002|Overall Study|Eligibility Violation|0|||
162092993|NCT02778204|585389789|FG003|Overall Study|Eligibility Violation|1|||
162092994|NCT01720069|585389790|FG000|Overall Study|Could not use e-diary correctly|0|||
162092995|NCT01720069|585389791|FG001|Overall Study|Could not use e-diary correctly|1|||
162092996|NCT01720069|585389792|FG002|Overall Study|Could not use e-diary correctly|1|||
162092997|NCT01720069|585389790|FG000|Overall Study|Randomised without baseline values|0|||
162092998|NCT01720069|585389791|FG001|Overall Study|Randomised without baseline values|0|||
162092999|NCT01720069|585389792|FG002|Overall Study|Randomised without baseline values|1|||
162093000|NCT01720069|585389790|FG000|Overall Study|Adverse Event|0|||
162093001|NCT01720069|585389791|FG001|Overall Study|Adverse Event|0|||
162093002|NCT01720069|585389792|FG002|Overall Study|Adverse Event|1|||
162093003|NCT01720069|585389790|FG000|Overall Study|Lack of Efficacy|0|||
162093004|NCT01720069|585389791|FG001|Overall Study|Lack of Efficacy|4|||
162093005|NCT01720069|585389792|FG002|Overall Study|Lack of Efficacy|0|||
162093006|NCT01720069|585389790|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
162093007|NCT01720069|585389791|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
162093008|NCT01720069|585389792|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
162093009|NCT01720069|585389790|FG000|Overall Study|Withdrawal by Subject|0|||
162093010|NCT01720069|585389791|FG001|Overall Study|Withdrawal by Subject|2|||
162093011|NCT01720069|585389792|FG002|Overall Study|Withdrawal by Subject|1|||
162093012|NCT01720069|585389790|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
162093013|NCT01720069|585389791|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
162093014|NCT01720069|585389792|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
162093015|NCT01720069|585389790|FG000|Overall Study|Non-compliance on using e-diary|0|||
162093016|NCT01720069|585389791|FG001|Overall Study|Non-compliance on using e-diary|0|||
162093017|NCT01720069|585389792|FG002|Overall Study|Non-compliance on using e-diary|1|||
162093018|NCT01720069|585389790|FG000|Overall Study|Lost to Follow-up|0|||
162093019|NCT01720069|585389791|FG001|Overall Study|Lost to Follow-up|0|||
162093020|NCT01720069|585389792|FG002|Overall Study|Lost to Follow-up|1|||
162093021|NCT00360334|585389793|FG000|Overall Study|Adverse Event|7|||
162093022|NCT00360334|585389794|FG001|Overall Study|Adverse Event|4|||
162093023|NCT00360334|585389793|FG000|Overall Study|Protocol Violation|1|||
162093024|NCT00360334|585389794|FG001|Overall Study|Protocol Violation|1|||
162093025|NCT00360334|585389793|FG000|Overall Study|Physician Decision|2|||
162093026|NCT00360334|585389794|FG001|Overall Study|Physician Decision|3|||
162093027|NCT00360334|585389793|FG000|Overall Study|Lack of Efficacy|0|||
162093028|NCT00360334|585389794|FG001|Overall Study|Lack of Efficacy|1|||
162093029|NCT00360334|585389793|FG000|Overall Study|Entry criterion not met|1|||
162093030|NCT00360334|585389794|FG001|Overall Study|Entry criterion not met|2|||
162093031|NCT00360334|585389793|FG000|Overall Study|Subject decision|8|||
162093032|NCT00360334|585389794|FG001|Overall Study|Subject decision|2|||
162093033|NCT01898793|585389796|FG000|Overall Study|Death|2|||
162093034|NCT01898793|585389797|FG001|Overall Study|Death|1|||
162093035|NCT01898793|585389798|FG002|Overall Study|Death|4|||
162093036|NCT01898793|585389799|FG003|Overall Study|Death|0|||
162093037|NCT01898793|585389800|FG004|Overall Study|Death|0|||
162093038|NCT01898793|585389801|FG005|Overall Study|Death|0|||
162093039|NCT01898793|585389802|FG006|Overall Study|Death|0|||
162093040|NCT00162136|585389804|FG000|Overall Study|Adverse Event|1|||
162093041|NCT00162136|585389804|FG000|Overall Study|Death|1|||
162093042|NCT00162136|585389804|FG000|Overall Study|Disease Progression/Relapse|23|||
162093043|NCT00162136|585389804|FG000|Overall Study|Investigator Request|5|||
162093044|NCT00162136|585389804|FG000|Overall Study|Study Drug Toxicity|4|||
162093045|NCT00162136|585389804|FG000|Overall Study|Withdrawal by Subject|1|||
162093046|NCT00836875|585389806|FG000|Overall Study|Death|3|||
162093047|NCT00836875|585389807|FG001|Overall Study|Death|2|||
162093048|NCT00836875|585389806|FG000|Overall Study|Withdrawal by Subject|0|||
162093049|NCT00836875|585389807|FG001|Overall Study|Withdrawal by Subject|1|||
162093050|NCT04450264|585391675|FG000|Overall Study|Incomplete survey|13|||
162093051|NCT04450264|585391676|FG001|Overall Study|Incomplete survey|19|||
162093052|NCT00982020|585391680|FG000|Overall Study|Adverse Event|19|||
162093053|NCT00982020|585391681|FG001|Overall Study|Adverse Event|15|||
162093054|NCT00982020|585391680|FG000|Overall Study|Withdrawal by Subject|11|||
162093055|NCT00982020|585391681|FG001|Overall Study|Withdrawal by Subject|14|||
162093056|NCT00982020|585391680|FG000|Overall Study|Lost to Follow-up|5|||
162093057|NCT00982020|585391681|FG001|Overall Study|Lost to Follow-up|11|||
162093058|NCT00982020|585391680|FG000|Overall Study|Lack of Efficacy|10|||
162093059|NCT00982020|585391681|FG001|Overall Study|Lack of Efficacy|4|||
162093060|NCT00982020|585391680|FG000|Overall Study|Parent/Caregiver Decision|5|||
162093061|NCT00982020|585391681|FG001|Overall Study|Parent/Caregiver Decision|5|||
162093062|NCT00982020|585391680|FG000|Overall Study|Treatment Non-compliance|3|||
162093063|NCT00982020|585391681|FG001|Overall Study|Treatment Non-compliance|6|||
162093064|NCT00982020|585391680|FG000|Overall Study|Physician Decision|2|||
162093065|NCT00982020|585391681|FG001|Overall Study|Physician Decision|5|||
162093066|NCT00982020|585391680|FG000|Overall Study|Entry Criteria Not Met|2|||
162093067|NCT00982020|585391681|FG001|Overall Study|Entry Criteria Not Met|1|||
162093068|NCT00982020|585391680|FG000|Overall Study|Protocol Violation|0|||
162093069|NCT00982020|585391681|FG001|Overall Study|Protocol Violation|2|||
162093070|NCT00982020|585391680|FG000|Overall Study|Clinical Relapse|0|||
162093071|NCT00982020|585391681|FG001|Overall Study|Clinical Relapse|1|||
162093072|NCT01992536|585391684|FG000|Overall Study|Administrative Reason|0|||
162093073|NCT01992536|585391685|FG001|Overall Study|Administrative Reason|0|||
162093074|NCT01992536|585391686|FG002|Overall Study|Administrative Reason|0|||
162093075|NCT01992536|585391687|FG003|Overall Study|Administrative Reason|0|||
162093076|NCT01992536|585391688|FG004|Overall Study|Administrative Reason|0|||
162093077|NCT01992536|585391689|FG005|Overall Study|Administrative Reason|0|||
162093078|NCT01992536|585391690|FG006|Overall Study|Administrative Reason|7|||
162093079|NCT01992536|585391691|FG007|Overall Study|Administrative Reason|0|||
162093080|NCT01992536|585391692|FG008|Overall Study|Administrative Reason|0|||
162093081|NCT01992536|585391693|FG009|Overall Study|Administrative Reason|0|||
162093082|NCT01992536|585391684|FG000|Overall Study|Lost to Follow-up|4|||
162093083|NCT01992536|585391685|FG001|Overall Study|Lost to Follow-up|2|||
162093084|NCT01992536|585391686|FG002|Overall Study|Lost to Follow-up|1|||
162093085|NCT01992536|585391687|FG003|Overall Study|Lost to Follow-up|0|||
162093086|NCT01992536|585391688|FG004|Overall Study|Lost to Follow-up|0|||
162093087|NCT01992536|585391689|FG005|Overall Study|Lost to Follow-up|1|||
162093088|NCT01992536|585391690|FG006|Overall Study|Lost to Follow-up|0|||
162093089|NCT01992536|585391691|FG007|Overall Study|Lost to Follow-up|0|||
162093090|NCT01992536|585391692|FG008|Overall Study|Lost to Follow-up|1|||
162093091|NCT01992536|585391693|FG009|Overall Study|Lost to Follow-up|1|||
162093092|NCT01992536|585391684|FG000|Overall Study|Withdrawal by Subject|0|||
162093093|NCT01992536|585391685|FG001|Overall Study|Withdrawal by Subject|1|||
162093094|NCT01992536|585391686|FG002|Overall Study|Withdrawal by Subject|0|||
162093095|NCT01992536|585391687|FG003|Overall Study|Withdrawal by Subject|2|||
162093096|NCT01992536|585391688|FG004|Overall Study|Withdrawal by Subject|0|||
162093097|NCT01992536|585391689|FG005|Overall Study|Withdrawal by Subject|0|||
162093098|NCT01992536|585391690|FG006|Overall Study|Withdrawal by Subject|0|||
162093099|NCT01992536|585391691|FG007|Overall Study|Withdrawal by Subject|0|||
162093100|NCT01992536|585391692|FG008|Overall Study|Withdrawal by Subject|0|||
162093101|NCT01992536|585391693|FG009|Overall Study|Withdrawal by Subject|0|||
162093102|NCT01762761|585391694|FG000|Overall Study|Adverse Event|15|||
162093103|NCT01762761|585391695|FG001|Overall Study|Adverse Event|17|||
162093104|NCT01762761|585391694|FG000|Overall Study|Lack of Efficacy|9|||
162093105|NCT01762761|585391695|FG001|Overall Study|Lack of Efficacy|25|||
162093106|NCT01762761|585391694|FG000|Overall Study|Protocol Violation|1|||
162093107|NCT01762761|585391695|FG001|Overall Study|Protocol Violation|1|||
162093108|NCT01762761|585391694|FG000|Overall Study|Study closed/terminated|0|||
162093109|NCT01762761|585391695|FG001|Overall Study|Study closed/terminated|2|||
162093110|NCT01762761|585391694|FG000|Overall Study|Lost to Follow-up|3|||
162093111|NCT01762761|585391695|FG001|Overall Study|Lost to Follow-up|6|||
162093112|NCT01762761|585391694|FG000|Overall Study|Physician Decision|4|||
162093113|NCT01762761|585391695|FG001|Overall Study|Physician Decision|6|||
162093114|NCT01762761|585391694|FG000|Overall Study|Withdrawal by Subject|7|||
162093115|NCT01762761|585391695|FG001|Overall Study|Withdrawal by Subject|8|||
162093116|NCT02352493|585391698|FG000|Overall Study|Pregnancy|0|||
162093117|NCT02352493|585391699|FG001|Overall Study|Pregnancy|0|||
162093118|NCT02352493|585391700|FG002|Overall Study|Pregnancy|0|||
162093119|NCT02352493|585391701|FG003|Overall Study|Pregnancy|0|||
162093120|NCT02352493|585391702|FG004|Overall Study|Pregnancy|0|||
162093121|NCT02352493|585391703|FG005|Overall Study|Pregnancy|0|||
162093122|NCT02352493|585391704|FG006|Overall Study|Pregnancy|1|||
162093123|NCT02352493|585391705|FG007|Overall Study|Pregnancy|0|||
162093124|NCT02352493|585391706|FG008|Overall Study|Pregnancy|1|||
162093125|NCT02352493|585391707|FG009|Overall Study|Pregnancy|0|||
162093126|NCT02352493|585391708|FG010|Overall Study|Pregnancy|0|||
162093127|NCT02352493|585391709|FG011|Overall Study|Pregnancy|0|||
162093128|NCT02352493|585391710|FG012|Overall Study|Pregnancy|0|||
162093129|NCT02352493|585391711|FG013|Overall Study|Pregnancy|0|||
162093130|NCT02352493|585391712|FG014|Overall Study|Pregnancy|0|||
162093131|NCT02352493|585391713|FG015|Overall Study|Pregnancy|0|||
162093132|NCT02352493|585391714|FG016|Overall Study|Pregnancy|0|||
162093133|NCT02352493|585391715|FG017|Overall Study|Pregnancy|0|||
162093134|NCT02352493|585391698|FG000|Overall Study|Withdrawal by Subject|0|||
162093135|NCT02352493|585391699|FG001|Overall Study|Withdrawal by Subject|0|||
162093136|NCT02352493|585391700|FG002|Overall Study|Withdrawal by Subject|0|||
162093137|NCT02352493|585391701|FG003|Overall Study|Withdrawal by Subject|0|||
162093138|NCT02352493|585391702|FG004|Overall Study|Withdrawal by Subject|0|||
162093139|NCT02352493|585391703|FG005|Overall Study|Withdrawal by Subject|0|||
162093140|NCT02352493|585391704|FG006|Overall Study|Withdrawal by Subject|0|||
162093141|NCT02352493|585391705|FG007|Overall Study|Withdrawal by Subject|0|||
162093142|NCT02352493|585391706|FG008|Overall Study|Withdrawal by Subject|1|||
162093143|NCT02352493|585391707|FG009|Overall Study|Withdrawal by Subject|0|||
162093144|NCT02352493|585391708|FG010|Overall Study|Withdrawal by Subject|0|||
162093145|NCT02352493|585391709|FG011|Overall Study|Withdrawal by Subject|0|||
162093146|NCT02352493|585391710|FG012|Overall Study|Withdrawal by Subject|0|||
162093147|NCT02352493|585391711|FG013|Overall Study|Withdrawal by Subject|0|||
162093148|NCT02352493|585391712|FG014|Overall Study|Withdrawal by Subject|1|||
162093149|NCT02352493|585391713|FG015|Overall Study|Withdrawal by Subject|0|||
162093150|NCT02352493|585391714|FG016|Overall Study|Withdrawal by Subject|0|||
162093151|NCT02352493|585391715|FG017|Overall Study|Withdrawal by Subject|0|||
162093152|NCT02352493|585391698|FG000|Overall Study|Lost to Follow-up|0|||
162093153|NCT02352493|585391699|FG001|Overall Study|Lost to Follow-up|0|||
162093154|NCT02352493|585391700|FG002|Overall Study|Lost to Follow-up|0|||
162093155|NCT02352493|585391701|FG003|Overall Study|Lost to Follow-up|0|||
162093156|NCT02352493|585391702|FG004|Overall Study|Lost to Follow-up|0|||
162093157|NCT02352493|585391703|FG005|Overall Study|Lost to Follow-up|0|||
162093158|NCT02352493|585391704|FG006|Overall Study|Lost to Follow-up|0|||
162093159|NCT02352493|585391705|FG007|Overall Study|Lost to Follow-up|0|||
162093160|NCT02352493|585391706|FG008|Overall Study|Lost to Follow-up|0|||
162093161|NCT02352493|585391707|FG009|Overall Study|Lost to Follow-up|1|||
162093162|NCT02352493|585391708|FG010|Overall Study|Lost to Follow-up|0|||
162093163|NCT02352493|585391709|FG011|Overall Study|Lost to Follow-up|0|||
162093164|NCT02352493|585391710|FG012|Overall Study|Lost to Follow-up|1|||
162093165|NCT02352493|585391711|FG013|Overall Study|Lost to Follow-up|2|||
162093166|NCT02352493|585391712|FG014|Overall Study|Lost to Follow-up|0|||
162093167|NCT02352493|585391713|FG015|Overall Study|Lost to Follow-up|0|||
162093168|NCT02352493|585391714|FG016|Overall Study|Lost to Follow-up|0|||
162093169|NCT02352493|585391715|FG017|Overall Study|Lost to Follow-up|0|||
162093170|NCT02162810|585391716|FG000|Overall Study|Protocol Violation|1|||
162093171|NCT02162810|585391717|FG001|Overall Study|Protocol Violation|0|||
162093172|NCT02162810|585391716|FG000|Overall Study|patients did not report compliance|4|||
162093173|NCT02162810|585391717|FG001|Overall Study|patients did not report compliance|1|||
162093174|NCT00389324|585391718|FG000|Run-In Phase|Adverse Event|1|||
162093175|NCT00389324|585391718|FG000|Run-In Phase|Lost to Follow-up|1|||
162093176|NCT00389324|585391718|FG000|Run-In Phase|Withdrawal by Subject|1|||
162093177|NCT00389324|585391718|FG000|Subcutaneous Phase|Adverse Event|2|||
162093178|NCT00389324|585391718|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
162093179|NCT00389324|585391718|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
162093180|NCT00389324|585391718|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
162093181|NCT02317575|585391719|FG000|Period 1|Difficulty with venous cannulation|0|||
162093182|NCT02317575|585391720|FG001|Period 1|Difficulty with venous cannulation|1|||
162093183|NCT02317575|585391721|FG002|Period 1|Difficulty with venous cannulation|0|||
162093184|NCT02317575|585391722|FG003|Period 1|Difficulty with venous cannulation|0|||
162093185|NCT02317575|585391723|FG004|Period 1|Difficulty with venous cannulation|0|||
162093186|NCT02317575|585391719|FG000|Period 1|Withdrawal by Subject|1|||
162093187|NCT02317575|585391720|FG001|Period 1|Withdrawal by Subject|0|||
162093188|NCT02317575|585391721|FG002|Period 1|Withdrawal by Subject|0|||
162093189|NCT02317575|585391722|FG003|Period 1|Withdrawal by Subject|0|||
162093190|NCT02317575|585391723|FG004|Period 1|Withdrawal by Subject|0|||
162093191|NCT01465334|585391724|FG000|Overall Study|Disease Progression|1|||
162093192|NCT01465334|585391725|FG001|Overall Study|Disease Progression|0|||
162093193|NCT01465334|585391724|FG000|Overall Study|Adverse Event|1|||
162093194|NCT01465334|585391725|FG001|Overall Study|Adverse Event|0|||
162093195|NCT01465334|585391724|FG000|Overall Study|Richter's transformation|0|||
162093196|NCT01465334|585391725|FG001|Overall Study|Richter's transformation|3|||
162093197|NCT01465334|585391724|FG000|Overall Study|Refractory Disease|0|||
162093198|NCT01465334|585391725|FG001|Overall Study|Refractory Disease|3|||
162093199|NCT03936244|585391729|FG000|Overall Study|Lost to Follow-up|5|||
162093200|NCT03936244|585391730|FG001|Overall Study|Lost to Follow-up|1|||
162093201|NCT03936244|585391729|FG000|Overall Study|Physician Decision|7|||
162093202|NCT03936244|585391730|FG001|Overall Study|Physician Decision|3|||
162093203|NCT01925183|585391733|FG000|Overall Study|Adverse Event|1|||
162093204|NCT01925183|585391734|FG001|Overall Study|Adverse Event|0|||
162093205|NCT01046110|585391735|FG000|Overall Study|Adverse Event|9|||
162093206|NCT01046110|585391736|FG001|Overall Study|Adverse Event|2|||
162093207|NCT01046110|585391735|FG000|Overall Study|Lack of Efficacy|0|||
162093208|NCT01046110|585391736|FG001|Overall Study|Lack of Efficacy|1|||
162093209|NCT01046110|585391735|FG000|Overall Study|Protocol Violation|7|||
162093210|NCT01046110|585391736|FG001|Overall Study|Protocol Violation|12|||
162093211|NCT01046110|585391735|FG000|Overall Study|Withdrawal Criteria|3|||
162093212|NCT01046110|585391736|FG001|Overall Study|Withdrawal Criteria|5|||
162093213|NCT01046110|585391735|FG000|Overall Study|Unclassified|36|||
162093214|NCT01046110|585391736|FG001|Overall Study|Unclassified|35|||
162093215|NCT01047683|585391741|FG000|Overall Study|Adverse Event|3|||
162093216|NCT01047683|585391742|FG001|Overall Study|Adverse Event|1|||
162093217|NCT01047683|585391743|FG002|Overall Study|Adverse Event|0|||
162093218|NCT01047683|585391741|FG000|Overall Study|Withdrew Consent|1|||
162093219|NCT01047683|585391742|FG001|Overall Study|Withdrew Consent|4|||
162093220|NCT01047683|585391743|FG002|Overall Study|Withdrew Consent|2|||
162093221|NCT01047683|585391741|FG000|Overall Study|Lost to Follow-up|0|||
162093222|NCT01047683|585391742|FG001|Overall Study|Lost to Follow-up|1|||
162093223|NCT01047683|585391743|FG002|Overall Study|Lost to Follow-up|0|||
162093224|NCT01047683|585391741|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
162093225|NCT01047683|585391742|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
162093226|NCT01047683|585391743|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
162093227|NCT03447769|585391744|FG000|Overall Study|Progressive disease|138|||
162093228|NCT03447769|585391745|FG001|Overall Study|Progressive disease|148|||
162093229|NCT03447769|585391744|FG000|Overall Study|Study terminated by Sponsor|60|||
162093230|NCT03447769|585391745|FG001|Overall Study|Study terminated by Sponsor|44|||
162093231|NCT03447769|585391744|FG000|Overall Study|Adverse Event|34|||
162093232|NCT03447769|585391745|FG001|Overall Study|Adverse Event|31|||
162093233|NCT03447769|585391744|FG000|Overall Study|Patient decision|27|||
162093234|NCT03447769|585391745|FG001|Overall Study|Patient decision|27|||
162093235|NCT03447769|585391744|FG000|Overall Study|Protocol deviation|4|||
162093236|NCT03447769|585391745|FG001|Overall Study|Protocol deviation|6|||
162093237|NCT03447769|585391744|FG000|Overall Study|Death|2|||
162093238|NCT03447769|585391745|FG001|Overall Study|Death|7|||
162093239|NCT03447769|585391744|FG000|Overall Study|Technical problems|1|||
162093240|NCT03447769|585391745|FG001|Overall Study|Technical problems|0|||
162093241|NCT03447769|585391744|FG000|Overall Study|Lost to Follow-up|0|||
162093242|NCT03447769|585391745|FG001|Overall Study|Lost to Follow-up|1|||
162093243|NCT03447769|585391744|FG000|Overall Study|Physician Decision|13|||
162093244|NCT03447769|585391745|FG001|Overall Study|Physician Decision|5|||
162093245|NCT01485861|585391748|FG000|Phase Ib|Death|1|||
162093246|NCT01485861|585391749|FG001|Phase Ib|Death|0|||
162093247|NCT01485861|585391750|FG002|Phase Ib|Death|0|||
162093248|NCT01485861|585391751|FG003|Phase Ib|Death|0|||
162093249|NCT01485861|585391752|FG004|Phase Ib|Death|0|||
162093250|NCT01485861|585391753|FG005|Phase Ib|Death|0|||
162093251|NCT01485861|585391748|FG000|Phase Ib|Physician Decision|1|||
162093252|NCT01485861|585391749|FG001|Phase Ib|Physician Decision|1|||
162093253|NCT01485861|585391750|FG002|Phase Ib|Physician Decision|0|||
162093254|NCT01485861|585391751|FG003|Phase Ib|Physician Decision|0|||
162093255|NCT01485861|585391752|FG004|Phase Ib|Physician Decision|0|||
162093256|NCT01485861|585391753|FG005|Phase Ib|Physician Decision|0|||
162093257|NCT01485861|585391748|FG000|Phase Ib|Adverse Event|0|||
162093258|NCT01485861|585391749|FG001|Phase Ib|Adverse Event|4|||
162093259|NCT01485861|585391750|FG002|Phase Ib|Adverse Event|0|||
162093260|NCT01485861|585391751|FG003|Phase Ib|Adverse Event|0|||
162093261|NCT01485861|585391752|FG004|Phase Ib|Adverse Event|0|||
162093262|NCT01485861|585391753|FG005|Phase Ib|Adverse Event|0|||
162093263|NCT01485861|585391748|FG000|Phase Ib|Progression of disease|5|||
162093264|NCT01485861|585391749|FG001|Phase Ib|Progression of disease|0|||
162093265|NCT01485861|585391750|FG002|Phase Ib|Progression of disease|0|||
162093266|NCT01485861|585391751|FG003|Phase Ib|Progression of disease|0|||
162093267|NCT01485861|585391752|FG004|Phase Ib|Progression of disease|0|||
162093268|NCT01485861|585391753|FG005|Phase Ib|Progression of disease|0|||
162093269|NCT01485861|585391748|FG000|Phase Ib|Other|3|||
162093270|NCT01485861|585391749|FG001|Phase Ib|Other|0|||
162093271|NCT01485861|585391750|FG002|Phase Ib|Other|0|||
162093272|NCT01485861|585391751|FG003|Phase Ib|Other|0|||
162093273|NCT01485861|585391752|FG004|Phase Ib|Other|0|||
162093274|NCT01485861|585391753|FG005|Phase Ib|Other|0|||
162093275|NCT01485861|585391748|FG000|Phase Ib|Withdrawal by Subject|4|||
162093276|NCT01485861|585391749|FG001|Phase Ib|Withdrawal by Subject|1|||
162093277|NCT01485861|585391750|FG002|Phase Ib|Withdrawal by Subject|0|||
162093278|NCT01485861|585391751|FG003|Phase Ib|Withdrawal by Subject|0|||
162093279|NCT01485861|585391752|FG004|Phase Ib|Withdrawal by Subject|0|||
162093280|NCT01485861|585391753|FG005|Phase Ib|Withdrawal by Subject|0|||
162093281|NCT01485861|585391748|FG000|Phase II|Death|0|||
162093282|NCT01485861|585391749|FG001|Phase II|Death|0|||
162093283|NCT01485861|585391750|FG002|Phase II|Death|67|||
162093284|NCT01485861|585391751|FG003|Phase II|Death|71|||
162093285|NCT01485861|585391752|FG004|Phase II|Death|68|||
162093286|NCT01485861|585391753|FG005|Phase II|Death|0|||
162093287|NCT01485861|585391748|FG000|Phase II|Progression of Disease|0|||
162093288|NCT01485861|585391749|FG001|Phase II|Progression of Disease|0|||
162093289|NCT01485861|585391750|FG002|Phase II|Progression of Disease|1|||
162093290|NCT01485861|585391751|FG003|Phase II|Progression of Disease|0|||
162093291|NCT01485861|585391752|FG004|Phase II|Progression of Disease|0|||
162093292|NCT01485861|585391753|FG005|Phase II|Progression of Disease|0|||
162093293|NCT01485861|585391748|FG000|Phase II|Other|0|||
162093294|NCT01485861|585391749|FG001|Phase II|Other|0|||
162093295|NCT01485861|585391750|FG002|Phase II|Other|0|||
162093296|NCT01485861|585391751|FG003|Phase II|Other|1|||
162093297|NCT01485861|585391752|FG004|Phase II|Other|0|||
162093298|NCT01485861|585391753|FG005|Phase II|Other|0|||
162093299|NCT01485861|585391748|FG000|Phase II|Withdrawal by Subject|0|||
162093300|NCT01485861|585391749|FG001|Phase II|Withdrawal by Subject|0|||
162093301|NCT01485861|585391750|FG002|Phase II|Withdrawal by Subject|6|||
162093302|NCT01485861|585391751|FG003|Phase II|Withdrawal by Subject|3|||
162093303|NCT01485861|585391752|FG004|Phase II|Withdrawal by Subject|4|||
162093304|NCT01485861|585391753|FG005|Phase II|Withdrawal by Subject|0|||
162093305|NCT01485861|585391748|FG000|Phase II|Lost to Follow-up|0|||
162093306|NCT01485861|585391749|FG001|Phase II|Lost to Follow-up|0|||
162093307|NCT01485861|585391750|FG002|Phase II|Lost to Follow-up|2|||
162093308|NCT01485861|585391751|FG003|Phase II|Lost to Follow-up|3|||
162093309|NCT01485861|585391752|FG004|Phase II|Lost to Follow-up|5|||
162093310|NCT01485861|585391753|FG005|Phase II|Lost to Follow-up|0|||
162093311|NCT01485861|585391748|FG000|Phase II|Study Ended|0|||
162093312|NCT01485861|585391749|FG001|Phase II|Study Ended|0|||
162093313|NCT01485861|585391750|FG002|Phase II|Study Ended|7|||
162093314|NCT01485861|585391751|FG003|Phase II|Study Ended|8|||
162093315|NCT01485861|585391752|FG004|Phase II|Study Ended|6|||
162093316|NCT01485861|585391753|FG005|Phase II|Study Ended|0|||
162093317|NCT01485861|585391748|FG000|Safety Phase|Death|0|||
162093318|NCT01485861|585391749|FG001|Safety Phase|Death|0|||
162093319|NCT01485861|585391750|FG002|Safety Phase|Death|0|||
162093320|NCT01485861|585391751|FG003|Safety Phase|Death|0|||
162093321|NCT01485861|585391752|FG004|Safety Phase|Death|0|||
162093322|NCT01485861|585391753|FG005|Safety Phase|Death|2|||
162093323|NCT01485861|585391748|FG000|Safety Phase|Adverse Event|0|||
162093324|NCT01485861|585391749|FG001|Safety Phase|Adverse Event|0|||
162093325|NCT01485861|585391750|FG002|Safety Phase|Adverse Event|0|||
162093326|NCT01485861|585391751|FG003|Safety Phase|Adverse Event|0|||
162093327|NCT01485861|585391752|FG004|Safety Phase|Adverse Event|0|||
162093328|NCT01485861|585391753|FG005|Safety Phase|Adverse Event|1|||
162093329|NCT01485861|585391748|FG000|Safety Phase|Other|0|||
162093330|NCT01485861|585391749|FG001|Safety Phase|Other|0|||
162093331|NCT01485861|585391750|FG002|Safety Phase|Other|0|||
162093332|NCT01485861|585391751|FG003|Safety Phase|Other|0|||
162093333|NCT01485861|585391752|FG004|Safety Phase|Other|0|||
162093334|NCT01485861|585391753|FG005|Safety Phase|Other|5|||
162093335|NCT01485861|585391748|FG000|Safety Phase|Progression of Disease|0|||
162093336|NCT01485861|585391749|FG001|Safety Phase|Progression of Disease|0|||
162093337|NCT01485861|585391750|FG002|Safety Phase|Progression of Disease|0|||
162093338|NCT01485861|585391751|FG003|Safety Phase|Progression of Disease|0|||
162093339|NCT01485861|585391752|FG004|Safety Phase|Progression of Disease|0|||
162093340|NCT01485861|585391753|FG005|Safety Phase|Progression of Disease|9|||
162093341|NCT01485861|585391748|FG000|Safety Phase|Withdrawal by Subject|0|||
162093342|NCT01485861|585391749|FG001|Safety Phase|Withdrawal by Subject|0|||
162093343|NCT01485861|585391750|FG002|Safety Phase|Withdrawal by Subject|0|||
162093344|NCT01485861|585391751|FG003|Safety Phase|Withdrawal by Subject|0|||
162093345|NCT01485861|585391752|FG004|Safety Phase|Withdrawal by Subject|0|||
162093346|NCT01485861|585391753|FG005|Safety Phase|Withdrawal by Subject|6|||
162093347|NCT01485861|585391748|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
162093348|NCT01485861|585391749|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
162093349|NCT01485861|585391750|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
162093350|NCT01485861|585391751|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
162093351|NCT01485861|585391752|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
162093352|NCT01485861|585391753|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
162093353|NCT03795922|585391754|FG000|Overall Study|Adverse Event|2|||
162093354|NCT03795922|585391755|FG001|Overall Study|Adverse Event|1|||
162093355|NCT03795922|585391754|FG000|Overall Study|Withdrawal by Subject|5|||
162093356|NCT03795922|585391755|FG001|Overall Study|Withdrawal by Subject|13|||
162093357|NCT03795922|585391754|FG000|Overall Study|Lost to Follow-up|2|||
162093358|NCT03795922|585391755|FG001|Overall Study|Lost to Follow-up|3|||
162093359|NCT03795922|585391754|FG000|Overall Study|Pregnancy|0|||
162093360|NCT03795922|585391755|FG001|Overall Study|Pregnancy|1|||
162093361|NCT03795922|585391754|FG000|Overall Study|Physician Decision|1|||
162093362|NCT03795922|585391755|FG001|Overall Study|Physician Decision|2|||
162093363|NCT03795922|585391754|FG000|Overall Study|Protocol Violation|0|||
162093364|NCT03795922|585391755|FG001|Overall Study|Protocol Violation|1|||
162093365|NCT03795922|585391754|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
162093366|NCT03795922|585391755|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
162093367|NCT00437489|585391761|FG000|Overall Study|Study terminated by sponsor|23|||
162093368|NCT00437489|585391762|FG001|Overall Study|Study terminated by sponsor|21|||
162093369|NCT00437489|585391761|FG000|Overall Study|Lost to Follow-up|0|||
162093370|NCT00437489|585391762|FG001|Overall Study|Lost to Follow-up|1|||
162093371|NCT01525082|585391767|FG000|Overall Study|Death|1|||
162093372|NCT00022516|585391775|FG000|Overall Study|Adverse Event|0|||
162093373|NCT00022516|585391776|FG001|Overall Study|Adverse Event|59|||
162093374|NCT00022516|585391775|FG000|Overall Study|Lack of Efficacy|0|||
162093375|NCT00022516|585391776|FG001|Overall Study|Lack of Efficacy|27|||
162093376|NCT00022516|585391775|FG000|Overall Study|Physician Decision|0|||
162093377|NCT00022516|585391776|FG001|Overall Study|Physician Decision|1|||
162093378|NCT00022516|585391775|FG000|Overall Study|Protocol Violation|1|||
162093379|NCT00022516|585391776|FG001|Overall Study|Protocol Violation|3|||
162093380|NCT00022516|585391775|FG000|Overall Study|Withdrawal by Subject|2|||
162093381|NCT00022516|585391776|FG001|Overall Study|Withdrawal by Subject|113|||
162093382|NCT00022516|585391775|FG000|Overall Study|Incomplete documentation|0|||
162093383|NCT00022516|585391776|FG001|Overall Study|Incomplete documentation|27|||
162093384|NCT01568047|585391779|FG000|Overall Study|Ineligibility|1|||
162093385|NCT01568047|585391780|FG001|Overall Study|Ineligibility|0|||
162093386|NCT01568047|585391781|FG002|Overall Study|Ineligibility|0|||
162093387|NCT01568047|585391782|FG003|Overall Study|Ineligibility|0|||
162093388|NCT01568047|585391779|FG000|Overall Study|Withdrawal by Subject|0|||
162093389|NCT01568047|585391780|FG001|Overall Study|Withdrawal by Subject|1|||
162093390|NCT01568047|585391781|FG002|Overall Study|Withdrawal by Subject|0|||
162093391|NCT01568047|585391782|FG003|Overall Study|Withdrawal by Subject|0|||
162093392|NCT01568047|585391779|FG000|Overall Study|Adverse Event|0|||
162093393|NCT01568047|585391780|FG001|Overall Study|Adverse Event|0|||
162093394|NCT01568047|585391781|FG002|Overall Study|Adverse Event|1|||
162093395|NCT01568047|585391782|FG003|Overall Study|Adverse Event|1|||
162093396|NCT03783923|585391783|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
162093397|NCT03783923|585391784|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
162093398|NCT03783923|585391783|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
162093399|NCT03783923|585391784|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
162093400|NCT03783923|585391783|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
162093401|NCT03783923|585391784|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
162093402|NCT03783923|585391783|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
162093403|NCT03783923|585391784|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
162093404|NCT03783923|585391783|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
162093405|NCT03783923|585391784|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
162093406|NCT02328326|585391789|FG000|Overall Study|Withdrawal by Subject|10|||
162093407|NCT02328326|585391790|FG001|Overall Study|Withdrawal by Subject|3|||
162093408|NCT02328326|585391789|FG000|Overall Study|Death|2|||
162093409|NCT02328326|585391790|FG001|Overall Study|Death|1|||
162093410|NCT02328326|585391789|FG000|Overall Study|Lost to Follow-up|10|||
162093411|NCT02328326|585391790|FG001|Overall Study|Lost to Follow-up|4|||
162093412|NCT02543346|585391791|FG000|Second Priming Visit|Withdrawal by Subject|0|||
162093413|NCT02543346|585391792|FG001|Second Priming Visit|Withdrawal by Subject|2|||
162093414|NCT02543346|585391793|FG002|Second Priming Visit|Withdrawal by Subject|2|||
162093415|NCT02543346|585391794|FG003|Second Priming Visit|Withdrawal by Subject|2|||
162093416|NCT02543346|585391791|FG000|Second Priming Visit|Adverse Event|1|||
162093417|NCT02543346|585391792|FG001|Second Priming Visit|Adverse Event|0|||
162093418|NCT02543346|585391793|FG002|Second Priming Visit|Adverse Event|0|||
162093419|NCT02543346|585391794|FG003|Second Priming Visit|Adverse Event|0|||
162093420|NCT02209324|585391797|FG000|Overall Study|Adverse Event|2|||
162093421|NCT02209324|585391797|FG000|Overall Study|Lack of Efficacy|1|||
162093422|NCT02209324|585391797|FG000|Overall Study|Lost to Follow-up|1|||
162093423|NCT02209324|585391797|FG000|Overall Study|Physician Decision|3|||
162093424|NCT02209324|585391797|FG000|Overall Study|Protocol Violation|14|||
162093425|NCT02209324|585391797|FG000|Overall Study|Withdrawal by Subject|8|||
162093426|NCT02209324|585391797|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
162093427|NCT02209324|585391797|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
162093428|NCT02209324|585391797|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
162093429|NCT01985126|585391798|FG000|Overall Study|Death|15|||
162093430|NCT01985126|585391799|FG001|Overall Study|Death|69|||
162093431|NCT01985126|585391798|FG000|Overall Study|Lost to Follow-up|0|||
162093432|NCT01985126|585391799|FG001|Overall Study|Lost to Follow-up|8|||
162093433|NCT01985126|585391798|FG000|Overall Study|Study Terminated By Sponsor|1|||
162093434|NCT01985126|585391799|FG001|Overall Study|Study Terminated By Sponsor|22|||
162093435|NCT01985126|585391798|FG000|Overall Study|Withdrawal by Subject|2|||
162093436|NCT01985126|585391799|FG001|Overall Study|Withdrawal by Subject|7|||
162093437|NCT03433456|585391802|FG000|Overall Study|Death|1|||
162093438|NCT03433456|585391803|FG001|Overall Study|Death|1|||
162093439|NCT03433456|585391802|FG000|Overall Study|Lost to Follow-up|14|||
162093440|NCT03433456|585391803|FG001|Overall Study|Lost to Follow-up|11|||
162093441|NCT03433456|585391802|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
162093442|NCT03433456|585391803|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
162093443|NCT01198600|585391808|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
162093444|NCT01198600|585391809|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
162093445|NCT01198600|585391810|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
162093446|NCT01198600|585391811|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
162093447|NCT01198600|585391808|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
162093448|NCT01198600|585391809|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
162093449|NCT01198600|585391810|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
162093450|NCT01198600|585391811|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
162093451|NCT01198600|585391808|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
162093452|NCT01198600|585391809|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
162093453|NCT01198600|585391810|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
162093454|NCT01198600|585391811|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
162093455|NCT01198600|585391808|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
162093456|NCT01198600|585391809|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
162093457|NCT01198600|585391810|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
162093458|NCT01198600|585391811|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
162093459|NCT01198600|585391808|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
162093460|NCT01198600|585391809|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
162093461|NCT01198600|585391810|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
162093462|NCT01198600|585391811|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
162093463|NCT01198600|585391808|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
162093464|NCT01198600|585391809|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
162093465|NCT01198600|585391810|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
162093466|NCT01198600|585391811|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
162093467|NCT01198600|585391808|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
162093468|NCT01198600|585391809|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
162093469|NCT01198600|585391810|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
162093470|NCT01198600|585391811|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
162093471|NCT01785602|585391812|FG000|Overall Study|Withdrawal by Subject|2|||
162093472|NCT01785602|585391813|FG001|Overall Study|Withdrawal by Subject|0|||
162093473|NCT01785602|585391812|FG000|Overall Study|Lost to Follow-up|1|||
162093474|NCT01785602|585391813|FG001|Overall Study|Lost to Follow-up|1|||
162093475|NCT01785602|585391812|FG000|Overall Study|Adverse Event|3|||
162093476|NCT01785602|585391813|FG001|Overall Study|Adverse Event|5|||
162093477|NCT01785602|585391812|FG000|Overall Study|Administrative problems|7|||
162093478|NCT01785602|585391813|FG001|Overall Study|Administrative problems|3|||
162093479|NCT02141516|585391816|FG000|Overall Study|Adverse Event|0|||
162093480|NCT02141516|585391817|FG001|Overall Study|Adverse Event|1|||
162093481|NCT02141516|585391818|FG002|Overall Study|Adverse Event|0|||
162093482|NCT02141516|585391816|FG000|Overall Study|Lost to Follow-up|0|||
162093483|NCT02141516|585391817|FG001|Overall Study|Lost to Follow-up|1|||
162093484|NCT02141516|585391818|FG002|Overall Study|Lost to Follow-up|0|||
162093485|NCT02141516|585391816|FG000|Overall Study|Other|0|||
162093486|NCT02141516|585391817|FG001|Overall Study|Other|3|||
162093487|NCT02141516|585391818|FG002|Overall Study|Other|0|||
162093488|NCT03251924|585391820|FG000|Overall Study|Disease Progression|6|||
162093489|NCT03251924|585391821|FG001|Overall Study|Disease Progression|6|||
162093490|NCT03251924|585391822|FG002|Overall Study|Disease Progression|7|||
162093491|NCT03251924|585391823|FG003|Overall Study|Disease Progression|8|||
162093492|NCT03251924|585391824|FG004|Overall Study|Disease Progression|8|||
162093493|NCT03251924|585391825|FG005|Overall Study|Disease Progression|7|||
162093494|NCT03251924|585391826|FG006|Overall Study|Disease Progression|6|||
162093495|NCT03251924|585391827|FG007|Overall Study|Disease Progression|10|||
162093496|NCT03251924|585391828|FG008|Overall Study|Disease Progression|6|||
162093497|NCT03251924|585391820|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
162093498|NCT03251924|585391821|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
162093499|NCT03251924|585391822|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
162093500|NCT03251924|585391823|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
162093501|NCT03251924|585391824|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
162093502|NCT03251924|585391825|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
162093503|NCT03251924|585391826|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
162093504|NCT03251924|585391827|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
162093505|NCT03251924|585391828|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
162093506|NCT03251924|585391820|FG000|Overall Study|Death|0|||
162093507|NCT03251924|585391821|FG001|Overall Study|Death|1|||
162093508|NCT03251924|585391822|FG002|Overall Study|Death|0|||
162093509|NCT03251924|585391823|FG003|Overall Study|Death|1|||
162093510|NCT03251924|585391824|FG004|Overall Study|Death|1|||
162093511|NCT03251924|585391825|FG005|Overall Study|Death|1|||
162093512|NCT03251924|585391826|FG006|Overall Study|Death|0|||
162093513|NCT03251924|585391827|FG007|Overall Study|Death|0|||
162093514|NCT03251924|585391828|FG008|Overall Study|Death|0|||
162093515|NCT03251924|585391820|FG000|Overall Study|Study Drug Toxicity|0|||
162093516|NCT03251924|585391821|FG001|Overall Study|Study Drug Toxicity|0|||
162093517|NCT03251924|585391822|FG002|Overall Study|Study Drug Toxicity|0|||
162093518|NCT03251924|585391823|FG003|Overall Study|Study Drug Toxicity|1|||
162093519|NCT03251924|585391824|FG004|Overall Study|Study Drug Toxicity|0|||
162093520|NCT03251924|585391825|FG005|Overall Study|Study Drug Toxicity|0|||
162093521|NCT03251924|585391826|FG006|Overall Study|Study Drug Toxicity|0|||
162093522|NCT03251924|585391827|FG007|Overall Study|Study Drug Toxicity|0|||
162093523|NCT03251924|585391828|FG008|Overall Study|Study Drug Toxicity|1|||
162093524|NCT03251924|585391820|FG000|Overall Study|Other Reasons|0|||
162093525|NCT03251924|585391821|FG001|Overall Study|Other Reasons|0|||
162093526|NCT03251924|585391822|FG002|Overall Study|Other Reasons|0|||
162093527|NCT03251924|585391823|FG003|Overall Study|Other Reasons|0|||
162093528|NCT03251924|585391824|FG004|Overall Study|Other Reasons|0|||
162093529|NCT03251924|585391825|FG005|Overall Study|Other Reasons|0|||
162093530|NCT03251924|585391826|FG006|Overall Study|Other Reasons|0|||
162093531|NCT03251924|585391827|FG007|Overall Study|Other Reasons|0|||
162093532|NCT03251924|585391828|FG008|Overall Study|Other Reasons|1|||
162093533|NCT03251924|585391820|FG000|Overall Study|Participant request to discontinue study treatment|0|||
162093534|NCT03251924|585391821|FG001|Overall Study|Participant request to discontinue study treatment|0|||
162093535|NCT03251924|585391822|FG002|Overall Study|Participant request to discontinue study treatment|0|||
162093536|NCT03251924|585391823|FG003|Overall Study|Participant request to discontinue study treatment|0|||
162093537|NCT03251924|585391824|FG004|Overall Study|Participant request to discontinue study treatment|0|||
162093538|NCT03251924|585391825|FG005|Overall Study|Participant request to discontinue study treatment|0|||
162093539|NCT03251924|585391826|FG006|Overall Study|Participant request to discontinue study treatment|0|||
162093540|NCT03251924|585391827|FG007|Overall Study|Participant request to discontinue study treatment|1|||
162093541|NCT03251924|585391828|FG008|Overall Study|Participant request to discontinue study treatment|0|||
162093542|NCT00784043|585391829|FG000|Overall Study|Withdrawal by Subject|8|||
162093543|NCT00784043|585391830|FG001|Overall Study|Withdrawal by Subject|5|||
162093544|NCT00784043|585391829|FG000|Overall Study|Protocol Terminated|23|||
162093545|NCT00784043|585391830|FG001|Overall Study|Protocol Terminated|1|||
162093546|NCT02127307|585391837|FG000|Overall Study|Protocol Violation|36|||
162093547|NCT02127307|585391837|FG000|Overall Study|Lost to Follow-up|2|||
162093548|NCT02127307|585391837|FG000|Overall Study|Death|101|||
162093549|NCT02127307|585391837|FG000|Overall Study|Other than specified above|169|||
162093550|NCT00235989|585391838|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
162093551|NCT00235989|585391839|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
162093552|NCT00235989|585391840|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
162093553|NCT00235989|585391841|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
162093554|NCT00235989|585391842|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
162093555|NCT00235989|585391843|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
162093556|NCT00235989|585391838|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
162093557|NCT00235989|585391839|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
162093558|NCT00235989|585391840|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
162093559|NCT00235989|585391841|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
162093560|NCT00235989|585391842|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
162093561|NCT00235989|585391843|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
162093562|NCT00235989|585391838|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
162093563|NCT00235989|585391839|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
162093564|NCT00235989|585391840|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
162093565|NCT00235989|585391841|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
162093566|NCT00235989|585391842|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
162093567|NCT00235989|585391843|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
162093568|NCT00235989|585391838|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
162093569|NCT00235989|585391839|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
162093570|NCT00235989|585391840|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
162093571|NCT00235989|585391841|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
162093572|NCT00235989|585391842|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
162093573|NCT00235989|585391843|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
162093574|NCT00235989|585391838|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
162093575|NCT00235989|585391839|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
162093576|NCT00235989|585391840|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
162093577|NCT00235989|585391841|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
162093578|NCT00235989|585391842|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
162093579|NCT00235989|585391843|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
162093580|NCT00983580|585391849|FG000|Overall Study|Cancel Prior to treatment|1|||
162093581|NCT00983580|585391850|FG001|Overall Study|Cancel Prior to treatment|3|||
162093582|NCT00983580|585391849|FG000|Overall Study|Protocol Violation|1|||
162093583|NCT00983580|585391850|FG001|Overall Study|Protocol Violation|1|||
162093584|NCT00983580|585391849|FG000|Overall Study|Ineligible|3|||
162093585|NCT00983580|585391850|FG001|Overall Study|Ineligible|0|||
162093586|NCT03964454|585391854|FG000|Overall Study|Lost to Follow-up|13|||
162093587|NCT03964454|585391855|FG001|Overall Study|Lost to Follow-up|7|||
162093588|NCT03964454|585391854|FG000|Overall Study|Withdrawal by Subject|4|||
162093589|NCT03964454|585391855|FG001|Overall Study|Withdrawal by Subject|11|||
162093590|NCT00074282|585393424|FG000|Step 1|Adverse Event|32|||
162093591|NCT00074282|585393425|FG001|Step 1|Adverse Event|0|||
162093592|NCT00074282|585393426|FG002|Step 1|Adverse Event|0|||
162093593|NCT00074282|585393424|FG000|Step 1|Death|6|||
162093594|NCT00074282|585393425|FG001|Step 1|Death|0|||
162093595|NCT00074282|585393426|FG002|Step 1|Death|0|||
162093596|NCT00074282|585393424|FG000|Step 1|Withdrawal by Subject|7|||
162093597|NCT00074282|585393425|FG001|Step 1|Withdrawal by Subject|0|||
162093598|NCT00074282|585393426|FG002|Step 1|Withdrawal by Subject|0|||
162093599|NCT00074282|585393424|FG000|Step 1|Disease progression|2|||
162093600|NCT00074282|585393425|FG001|Step 1|Disease progression|0|||
162093601|NCT00074282|585393426|FG002|Step 1|Disease progression|0|||
162093602|NCT00074282|585393424|FG000|Step 1|Alternative therapy|2|||
162093603|NCT00074282|585393425|FG001|Step 1|Alternative therapy|0|||
162093604|NCT00074282|585393426|FG002|Step 1|Alternative therapy|0|||
162093605|NCT00074282|585393424|FG000|Step 1|Other complicating disease|2|||
162093606|NCT00074282|585393425|FG001|Step 1|Other complicating disease|0|||
162093607|NCT00074282|585393426|FG002|Step 1|Other complicating disease|0|||
162093608|NCT00074282|585393424|FG000|Step 1|Physician Decision|1|||
162093609|NCT00074282|585393425|FG001|Step 1|Physician Decision|0|||
162093610|NCT00074282|585393426|FG002|Step 1|Physician Decision|0|||
162093611|NCT00074282|585393424|FG000|Step 1|Ineligible|4|||
162093612|NCT00074282|585393425|FG001|Step 1|Ineligible|0|||
162093613|NCT00074282|585393426|FG002|Step 1|Ineligible|0|||
162093614|NCT00074282|585393424|FG000|Step 1|Never started treatment|2|||
162093615|NCT00074282|585393425|FG001|Step 1|Never started treatment|0|||
162093616|NCT00074282|585393426|FG002|Step 1|Never started treatment|0|||
162093617|NCT00074282|585393424|FG000|Step 2|Adverse Event|0|||
162093618|NCT00074282|585393425|FG001|Step 2|Adverse Event|2|||
162093619|NCT00074282|585393426|FG002|Step 2|Adverse Event|12|||
162093620|NCT00074282|585393424|FG000|Step 2|Disease progression|0|||
162093621|NCT00074282|585393425|FG001|Step 2|Disease progression|0|||
162093622|NCT00074282|585393426|FG002|Step 2|Disease progression|5|||
162093623|NCT00074282|585393424|FG000|Step 2|Death|0|||
162093624|NCT00074282|585393425|FG001|Step 2|Death|0|||
162093625|NCT00074282|585393426|FG002|Step 2|Death|3|||
162093626|NCT00074282|585393424|FG000|Step 2|Withdrawal by Subject|0|||
162093627|NCT00074282|585393425|FG001|Step 2|Withdrawal by Subject|0|||
162093628|NCT00074282|585393426|FG002|Step 2|Withdrawal by Subject|2|||
162093629|NCT00074282|585393424|FG000|Step 2|Physician Decision|0|||
162093630|NCT00074282|585393425|FG001|Step 2|Physician Decision|0|||
162093631|NCT00074282|585393426|FG002|Step 2|Physician Decision|1|||
162093632|NCT00074282|585393424|FG000|Step 2|Ineligible|0|||
162093633|NCT00074282|585393425|FG001|Step 2|Ineligible|0|||
162093634|NCT00074282|585393426|FG002|Step 2|Ineligible|1|||
162093635|NCT00464542|585393427|FG000|Pre-treatment|Withdrawal by Subject|2|||
162093636|NCT01760954|585393429|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
162093637|NCT01760954|585393430|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
162093638|NCT01760954|585393431|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
162093639|NCT01760954|585393432|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
162093640|NCT01760954|585393429|FG000|Treatment Period (6 Months)|Adverse Event|5|||
162093641|NCT01760954|585393430|FG001|Treatment Period (6 Months)|Adverse Event|3|||
162093642|NCT01760954|585393431|FG002|Treatment Period (6 Months)|Adverse Event|4|||
162093643|NCT01760954|585393432|FG003|Treatment Period (6 Months)|Adverse Event|10|||
162093644|NCT01760954|585393429|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
162093645|NCT01760954|585393430|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
162093646|NCT01760954|585393431|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
162093647|NCT01760954|585393432|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
162093648|NCT01760954|585393429|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
162093649|NCT01760954|585393430|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
162093650|NCT01760954|585393431|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
162093651|NCT01760954|585393432|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
162093652|NCT01760954|585393429|FG000|Treatment Period (6 Months)|Pregnancy|5|||
162093653|NCT01760954|585393430|FG001|Treatment Period (6 Months)|Pregnancy|0|||
162093654|NCT01760954|585393431|FG002|Treatment Period (6 Months)|Pregnancy|3|||
162093655|NCT01760954|585393432|FG003|Treatment Period (6 Months)|Pregnancy|2|||
162093656|NCT01760954|585393429|FG000|Treatment Period (6 Months)|Non-compliance|1|||
162093657|NCT01760954|585393430|FG001|Treatment Period (6 Months)|Non-compliance|4|||
162093658|NCT01760954|585393431|FG002|Treatment Period (6 Months)|Non-compliance|0|||
162093659|NCT01760954|585393432|FG003|Treatment Period (6 Months)|Non-compliance|3|||
162093660|NCT01760954|585393429|FG000|Treatment Period (6 Months)|Other|0|||
162093661|NCT01760954|585393430|FG001|Treatment Period (6 Months)|Other|3|||
162093662|NCT01760954|585393431|FG002|Treatment Period (6 Months)|Other|3|||
162093663|NCT01760954|585393432|FG003|Treatment Period (6 Months)|Other|1|||
162093664|NCT01760954|585393429|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
162093665|NCT01760954|585393430|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
162093666|NCT01760954|585393431|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
162093667|NCT01760954|585393432|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
162093668|NCT01760954|585393429|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
162093669|NCT01760954|585393430|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
162093670|NCT01760954|585393431|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
162093671|NCT01760954|585393432|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
162093672|NCT01760954|585393429|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
162093673|NCT01760954|585393430|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
162093674|NCT01760954|585393431|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
162093675|NCT01760954|585393432|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
162093676|NCT01760954|585393429|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
162093677|NCT01760954|585393430|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
162093678|NCT01760954|585393431|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
162093679|NCT01760954|585393432|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
162093680|NCT01760954|585393429|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
162093681|NCT01760954|585393430|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
162093682|NCT01760954|585393431|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
162093683|NCT01760954|585393432|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
162093684|NCT01760954|585393429|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
162093685|NCT01760954|585393430|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
162093686|NCT01760954|585393431|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
162093687|NCT01760954|585393432|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
162093688|NCT01760954|585393429|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
162093689|NCT01760954|585393430|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
162093690|NCT01760954|585393431|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
162093691|NCT01760954|585393432|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
162093692|NCT01760954|585393429|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
162093693|NCT01760954|585393430|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
162093694|NCT01760954|585393431|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
162093695|NCT01760954|585393432|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
162093696|NCT01233817|585393434|FG000|Overall Study|Lost to Follow-up|1|||
162093697|NCT01233817|585393434|FG000|Overall Study|Withdrawal by Subject|2|||
162093698|NCT02159482|585393435|FG000|Overall Study|Withdrawal by Subject|2|||
162093699|NCT02159482|585393435|FG000|Overall Study|Physician Decision|3|||
162093700|NCT01248884|585393436|FG000|Overall Study|Withdrawal by Subject|1|||
162093701|NCT01248884|585393437|FG001|Overall Study|Withdrawal by Subject|3|||
162093702|NCT01248884|585393438|FG002|Overall Study|Withdrawal by Subject|1|||
162093703|NCT01248884|585393436|FG000|Overall Study|Adverse Event|1|||
162093704|NCT01248884|585393437|FG001|Overall Study|Adverse Event|0|||
162093705|NCT01248884|585393438|FG002|Overall Study|Adverse Event|0|||
162093706|NCT04479618|585393439|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
162093707|NCT04479618|585393440|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
162093708|NCT04479618|585393441|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
162093709|NCT04479618|585393439|FG000|Overall Study|Lack of Efficacy|1|||
162093710|NCT04479618|585393440|FG001|Overall Study|Lack of Efficacy|0|||
162093711|NCT04479618|585393441|FG002|Overall Study|Lack of Efficacy|0|||
162093712|NCT04479618|585393439|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
162093713|NCT04479618|585393440|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
162093714|NCT04479618|585393441|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
162093715|NCT04479618|585393439|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
162093716|NCT04479618|585393440|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
162093717|NCT04479618|585393441|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
162093718|NCT04479618|585393439|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
162093719|NCT04479618|585393440|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
162093720|NCT04479618|585393441|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
162093721|NCT04479618|585393439|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
162093722|NCT04479618|585393440|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
162093723|NCT04479618|585393441|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
162093724|NCT01430130|585393442|FG000|Overall Study|Lost to Follow-up|1|||
162093725|NCT01430130|585393442|FG000|Overall Study|Infection on Control Side of Incision|1|||
162093726|NCT00833924|585393443|FG000|Overall Study|Death|21|||
162093727|NCT00833924|585393443|FG000|Overall Study|Conversion|2|||
162093728|NCT00833924|585393443|FG000|Overall Study|Lost to Follow-up|2|||
162093729|NCT00833924|585393443|FG000|Overall Study|Withdrawal by Subject|13|||
162093730|NCT00833924|585393443|FG000|Overall Study|In study follow-up|71|||
162093731|NCT00797667|585393444|FG000|Overall Study|Lack of Efficacy|0|||
162093732|NCT00797667|585393445|FG001|Overall Study|Lack of Efficacy|1|||
162093733|NCT00797667|585393446|FG002|Overall Study|Lack of Efficacy|0|||
162093734|NCT00797667|585393444|FG000|Overall Study|Lost to Follow-up|8|||
162093735|NCT00797667|585393445|FG001|Overall Study|Lost to Follow-up|12|||
162093736|NCT00797667|585393446|FG002|Overall Study|Lost to Follow-up|2|||
162093737|NCT00797667|585393444|FG000|Overall Study|Physician Decision|3|||
162093738|NCT00797667|585393445|FG001|Overall Study|Physician Decision|1|||
162093739|NCT00797667|585393446|FG002|Overall Study|Physician Decision|0|||
162093740|NCT00797667|585393444|FG000|Overall Study|Pregnancy|2|||
162093741|NCT00797667|585393445|FG001|Overall Study|Pregnancy|0|||
162093742|NCT00797667|585393446|FG002|Overall Study|Pregnancy|0|||
162093743|NCT00797667|585393444|FG000|Overall Study|Protocol Violation|2|||
162093744|NCT00797667|585393445|FG001|Overall Study|Protocol Violation|7|||
162093745|NCT00797667|585393446|FG002|Overall Study|Protocol Violation|0|||
162093746|NCT00797667|585393444|FG000|Overall Study|Study Terminated by Sponsor|217|||
162093747|NCT00797667|585393445|FG001|Overall Study|Study Terminated by Sponsor|216|||
162093748|NCT00797667|585393446|FG002|Overall Study|Study Terminated by Sponsor|115|||
162093749|NCT00797667|585393444|FG000|Overall Study|Withdrawal by Subject|9|||
162093750|NCT00797667|585393445|FG001|Overall Study|Withdrawal by Subject|14|||
162093751|NCT00797667|585393446|FG002|Overall Study|Withdrawal by Subject|2|||
162093752|NCT00797667|585393444|FG000|Overall Study|Adverse Event|19|||
162093753|NCT00797667|585393445|FG001|Overall Study|Adverse Event|8|||
162093754|NCT00797667|585393446|FG002|Overall Study|Adverse Event|8|||
162093755|NCT01986829|585393451|FG000|Overall Study|Death|1|||
162093756|NCT00701051|585393456|FG000|Screening|Failed Screening|40|||
162093757|NCT00701051|585393457|FG001|Screening|Failed Screening|0|||
162093758|NCT00701051|585393458|FG002|Screening|Failed Screening|0|||
162093759|NCT00701051|585393456|FG000|Screening|Time conflicts|19|||
162093760|NCT00701051|585393457|FG001|Screening|Time conflicts|0|||
162093761|NCT00701051|585393458|FG002|Screening|Time conflicts|0|||
162093762|NCT00701051|585393456|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
162093763|NCT00701051|585393457|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
162093764|NCT00701051|585393458|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
162093765|NCT02059148|585393459|FG000|Treatment 1|Protocol Violation|0|||
162093766|NCT02059148|585393460|FG001|Treatment 1|Protocol Violation|0|||
162093767|NCT02059148|585393461|FG002|Treatment 1|Protocol Violation|0|||
162093768|NCT02059148|585393462|FG003|Treatment 1|Protocol Violation|0|||
162093769|NCT02059148|585393463|FG004|Treatment 1|Protocol Violation|0|||
162093770|NCT02059148|585393464|FG005|Treatment 1|Protocol Violation|1|||
162093771|NCT01243944|585393467|FG000|Overall Study|Adverse Event|15|||
162093772|NCT01243944|585393468|FG001|Overall Study|Adverse Event|13|||
162093773|NCT01243944|585393467|FG000|Overall Study|Lost to Follow-up|2|||
162093774|NCT01243944|585393468|FG001|Overall Study|Lost to Follow-up|1|||
162093775|NCT01243944|585393467|FG000|Overall Study|Physician Decision|2|||
162093776|NCT01243944|585393468|FG001|Overall Study|Physician Decision|7|||
162093777|NCT01243944|585393467|FG000|Overall Study|Disease progression|12|||
162093778|NCT01243944|585393468|FG001|Overall Study|Disease progression|11|||
162093779|NCT01243944|585393467|FG000|Overall Study|Protocol deviation|1|||
162093780|NCT01243944|585393468|FG001|Overall Study|Protocol deviation|1|||
162093781|NCT01243944|585393467|FG000|Overall Study|Participant decision|10|||
162093782|NCT01243944|585393468|FG001|Overall Study|Participant decision|15|||
162093783|NCT01243944|585393467|FG000|Overall Study|Death|2|||
162093784|NCT01243944|585393468|FG001|Overall Study|Death|3|||
162093785|NCT01243944|585393467|FG000|Overall Study|Non-compliance with study treatment|1|||
162093786|NCT01243944|585393468|FG001|Overall Study|Non-compliance with study treatment|0|||
162093787|NCT03029208|585393471|FG000|Overall Study|Withdrawal by Subject|2|||
162093788|NCT03029208|585393472|FG001|Overall Study|Withdrawal by Subject|3|||
162093789|NCT03029208|585393471|FG000|Overall Study|Lost to Follow-up|0|||
162093790|NCT03029208|585393472|FG001|Overall Study|Lost to Follow-up|1|||
162093791|NCT02673697|585393477|FG000|Overall Study|Adverse Event|2|||
162093792|NCT02673697|585393478|FG001|Overall Study|Adverse Event|0|||
162093793|NCT02673697|585393477|FG000|Overall Study|Death|32|||
162093794|NCT02673697|585393478|FG001|Overall Study|Death|24|||
162093795|NCT02673697|585393477|FG000|Overall Study|Lost to Follow-up|5|||
162093796|NCT02673697|585393478|FG001|Overall Study|Lost to Follow-up|2|||
162093797|NCT02673697|585393477|FG000|Overall Study|Physician Decision|2|||
162093798|NCT02673697|585393478|FG001|Overall Study|Physician Decision|1|||
162093799|NCT02673697|585393477|FG000|Overall Study|Withdrawal by Subject|10|||
162093800|NCT02673697|585393478|FG001|Overall Study|Withdrawal by Subject|7|||
162093801|NCT02673697|585393477|FG000|Overall Study|Change subj medical status|1|||
162093802|NCT02673697|585393478|FG001|Overall Study|Change subj medical status|2|||
162093803|NCT02673697|585393477|FG000|Overall Study|Explant|10|||
162093804|NCT02673697|585393478|FG001|Overall Study|Explant|5|||
162093805|NCT02673697|585393477|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
162093806|NCT02673697|585393478|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
162093807|NCT03893448|585393481|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
162093808|NCT03893448|585393482|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
162093809|NCT03893448|585393481|FG000|Overall Study|Physician Decision|8|||
162093810|NCT03893448|585393482|FG001|Overall Study|Physician Decision|14|||
162093811|NCT03893448|585393481|FG000|Overall Study|Lost to Follow-up|34|||
162093812|NCT03893448|585393482|FG001|Overall Study|Lost to Follow-up|27|||
162093813|NCT03893448|585393481|FG000|Overall Study|Death|1|||
162093814|NCT03893448|585393482|FG001|Overall Study|Death|0|||
162093815|NCT03321981|585393484|FG000|Overall Study|Progressive Disease (PD)|15|||
162093816|NCT03321981|585393485|FG001|Overall Study|Progressive Disease (PD)|30|||
162093817|NCT03321981|585393486|FG002|Overall Study|Progressive Disease (PD)|47|||
162093818|NCT03321981|585393484|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
162093819|NCT03321981|585393485|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
162093820|NCT03321981|585393486|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
162093821|NCT03321981|585393484|FG000|Overall Study|Adverse Event|0|||
162093822|NCT03321981|585393485|FG001|Overall Study|Adverse Event|0|||
162093823|NCT03321981|585393486|FG002|Overall Study|Adverse Event|2|||
162093824|NCT03321981|585393484|FG000|Overall Study|symptomatic deterioration|0|||
162093825|NCT03321981|585393485|FG001|Overall Study|symptomatic deterioration|1|||
162093826|NCT03321981|585393486|FG002|Overall Study|symptomatic deterioration|1|||
162093827|NCT03321981|585393484|FG000|Overall Study|Lack of compliance|0|||
162093828|NCT03321981|585393485|FG001|Overall Study|Lack of compliance|1|||
162093829|NCT03321981|585393486|FG002|Overall Study|Lack of compliance|0|||
162093830|NCT03321981|585393484|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
162093831|NCT03321981|585393485|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
162093832|NCT03321981|585393486|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
162093833|NCT03321981|585393484|FG000|Overall Study|Death|0|||
162093834|NCT03321981|585393485|FG001|Overall Study|Death|1|||
162093835|NCT03321981|585393486|FG002|Overall Study|Death|0|||
162093836|NCT03321981|585393484|FG000|Overall Study|Subject withdrawal of investigational product|0|||
162093837|NCT03321981|585393485|FG001|Overall Study|Subject withdrawal of investigational product|1|||
162093838|NCT03321981|585393486|FG002|Overall Study|Subject withdrawal of investigational product|0|||
162093839|NCT03321981|585393484|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
162093840|NCT03321981|585393485|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
162093841|NCT03321981|585393486|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
162093842|NCT03321981|585393484|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
162093843|NCT03321981|585393485|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
162093844|NCT03321981|585393486|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
162093845|NCT03321019|585393488|FG000|Overall Study|Withdrawal by Subject|0|||
162093846|NCT03321019|585393489|FG001|Overall Study|Withdrawal by Subject|6|||
162093847|NCT03321019|585393488|FG000|Overall Study|Lost to Follow-up|0|||
162093848|NCT03321019|585393489|FG001|Overall Study|Lost to Follow-up|22|||
162093849|NCT03880578|585393490|FG000|Overall Study|Withdrawal by Subject|0|||
162093850|NCT03880578|585393491|FG001|Overall Study|Withdrawal by Subject|3|||
162093851|NCT03880578|585393492|FG002|Overall Study|Withdrawal by Subject|1|||
162093852|NCT03880578|585393490|FG000|Overall Study|Death|0|||
162093853|NCT03880578|585393491|FG001|Overall Study|Death|1|||
162093854|NCT03880578|585393492|FG002|Overall Study|Death|0|||
162093855|NCT04934670|585393493|FG000|Overall Study|Death|4|||
162093856|NCT04934670|585393494|FG001|Overall Study|Death|0|||
162093857|NCT04934670|585393493|FG000|Overall Study|Lost to Follow-up|1|||
162093858|NCT04934670|585393494|FG001|Overall Study|Lost to Follow-up|4|||
162093859|NCT03056690|585393496|FG000|Overall Study|Adverse Event|3|||
162093860|NCT03056690|585393497|FG001|Overall Study|Adverse Event|2|||
162093861|NCT03056690|585393496|FG000|Overall Study|Lack of Efficacy|1|||
162093862|NCT03056690|585393497|FG001|Overall Study|Lack of Efficacy|2|||
162093863|NCT03056690|585393496|FG000|Overall Study|Lost to Follow-up|3|||
162093864|NCT03056690|585393497|FG001|Overall Study|Lost to Follow-up|2|||
162093865|NCT03056690|585393496|FG000|Overall Study|Protocol Violation|2|||
162093866|NCT03056690|585393497|FG001|Overall Study|Protocol Violation|2|||
162093867|NCT03056690|585393496|FG000|Overall Study|Withdrawal by Subject|3|||
162093868|NCT03056690|585393497|FG001|Overall Study|Withdrawal by Subject|6|||
162093869|NCT03056690|585393496|FG000|Overall Study|Non-compliance with Study Drug|1|||
162093870|NCT03056690|585393497|FG001|Overall Study|Non-compliance with Study Drug|0|||
162093871|NCT03056690|585393496|FG000|Overall Study|Miscellaneous|1|||
162093872|NCT03056690|585393497|FG001|Overall Study|Miscellaneous|2|||
162093873|NCT00856583|585393500|FG000|Overall Study|Lack of Efficacy|389|||
162093874|NCT00856583|585393501|FG001|Overall Study|Lack of Efficacy|377|||
162093875|NCT00856583|585393500|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
162093876|NCT00856583|585393501|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
162093877|NCT00856583|585393500|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
162093878|NCT00856583|585393501|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
162093879|NCT00856583|585393500|FG000|Overall Study|Non-compliance|305|||
162093880|NCT00856583|585393501|FG001|Overall Study|Non-compliance|262|||
162093881|NCT00856583|585393500|FG000|Overall Study|Withdrawal by Subject|1092|||
162093882|NCT00856583|585393501|FG001|Overall Study|Withdrawal by Subject|919|||
162093883|NCT00856583|585393500|FG000|Overall Study|Physician Decision|59|||
162093884|NCT00856583|585393501|FG001|Overall Study|Physician Decision|82|||
162093885|NCT00856583|585393500|FG000|Overall Study|Pregnancy|14|||
162093886|NCT00856583|585393501|FG001|Overall Study|Pregnancy|5|||
162093887|NCT00856583|585393500|FG000|Overall Study|Other|92|||
162093888|NCT00856583|585393501|FG001|Overall Study|Other|104|||
162093889|NCT00856583|585393500|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
162093890|NCT00856583|585393501|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
162093891|NCT01944046|585393506|FG000|Randomized to DB|Adverse Event|5|||
162093892|NCT01944046|585393507|FG001|Randomized to DB|Adverse Event|2|||
162093893|NCT01944046|585393506|FG000|Randomized to DB|Clinical Worsening|3|||
162093894|NCT01944046|585393507|FG001|Randomized to DB|Clinical Worsening|2|||
162093895|NCT01944046|585393506|FG000|Randomized to DB|Lost to Follow-up|3|||
162093896|NCT01944046|585393507|FG001|Randomized to DB|Lost to Follow-up|3|||
162093897|NCT01944046|585393506|FG000|Randomized to DB|Withdrawal by Subject|2|||
162093898|NCT01944046|585393507|FG001|Randomized to DB|Withdrawal by Subject|4|||
162093899|NCT01944046|585393506|FG000|Randomized to DB|Physician Decision|1|||
162093900|NCT01944046|585393507|FG001|Randomized to DB|Physician Decision|2|||
162093901|NCT01944046|585393506|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
162093902|NCT01944046|585393507|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
162093903|NCT01944046|585393506|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
162093904|NCT01944046|585393507|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
162093905|NCT01944046|585393506|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
162093906|NCT01944046|585393507|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
162093907|NCT01944046|585393506|FG000|Open Label Eligible and Consented|Adverse Event|6|||
162093908|NCT01944046|585393507|FG001|Open Label Eligible and Consented|Adverse Event|1|||
162093909|NCT01944046|585393506|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
162093910|NCT01944046|585393507|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
162093911|NCT01944046|585393506|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
162093912|NCT01944046|585393507|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
162093913|NCT02056301|585393511|FG000|Overall Study|Protocol Violation|1|||
162093914|NCT02056301|585393512|FG001|Overall Study|Protocol Violation|2|||
162093915|NCT02056301|585393511|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
162093916|NCT02056301|585393512|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
162093917|NCT02056301|585393511|FG000|Overall Study|Withdrawal by Subject|0|||
162093918|NCT02056301|585393512|FG001|Overall Study|Withdrawal by Subject|1|||
162093919|NCT02056301|585393511|FG000|Overall Study|Issues with epidural|0|||
162093920|NCT02056301|585393512|FG001|Overall Study|Issues with epidural|3|||
162093921|NCT04496258|585393520|FG000|Overall Study|Withdrawal by Subject|2|||
162093922|NCT04496258|585393521|FG001|Overall Study|Withdrawal by Subject|1|||
162093923|NCT02041429|585393522|FG000|Overall Study|Progressive Disease|2|||
162093924|NCT02041429|585393523|FG001|Overall Study|Progressive Disease|2|||
162093925|NCT02041429|585393524|FG002|Overall Study|Progressive Disease|3|||
162093926|NCT02041429|585393525|FG003|Overall Study|Progressive Disease|2|||
162093927|NCT02041429|585393522|FG000|Overall Study|Toxicity|0|||
162093928|NCT02041429|585393523|FG001|Overall Study|Toxicity|1|||
162093929|NCT02041429|585393524|FG002|Overall Study|Toxicity|4|||
162093930|NCT02041429|585393525|FG003|Overall Study|Toxicity|2|||
162093931|NCT02041429|585393522|FG000|Overall Study|Withdrawal by Subject|0|||
162093932|NCT02041429|585393523|FG001|Overall Study|Withdrawal by Subject|1|||
162093933|NCT02041429|585393524|FG002|Overall Study|Withdrawal by Subject|0|||
162093934|NCT02041429|585393525|FG003|Overall Study|Withdrawal by Subject|0|||
162093935|NCT02041429|585393522|FG000|Overall Study|On Maintenance Therapy|1|||
162093936|NCT02041429|585393523|FG001|Overall Study|On Maintenance Therapy|0|||
162093937|NCT02041429|585393524|FG002|Overall Study|On Maintenance Therapy|0|||
162093938|NCT02041429|585393525|FG003|Overall Study|On Maintenance Therapy|2|||
162093939|NCT01427712|585393526|FG000|Overall Study|Transfer to a different hospital|2|||
162093940|NCT01427712|585393526|FG000|Overall Study|Lost to Follow-up|1|||
162093941|NCT01427712|585393526|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
162093942|NCT01427712|585393526|FG000|Overall Study|Failure to visit|1|||
162093943|NCT00153101|585393527|FG000|Overall Study|Lost to Follow-up|14|||
162093944|NCT00153101|585393528|FG001|Overall Study|Lost to Follow-up|14|||
162093945|NCT00153101|585393529|FG002|Overall Study|Lost to Follow-up|12|||
162093946|NCT00153101|585393530|FG003|Overall Study|Lost to Follow-up|5|||
162093947|NCT00153101|585393531|FG004|Overall Study|Lost to Follow-up|5|||
162093948|NCT00153101|585393527|FG000|Overall Study|Withdrawal by Subject|3|||
162093949|NCT00153101|585393528|FG001|Overall Study|Withdrawal by Subject|4|||
162093950|NCT00153101|585393529|FG002|Overall Study|Withdrawal by Subject|3|||
162093951|NCT00153101|585393530|FG003|Overall Study|Withdrawal by Subject|3|||
162093952|NCT00153101|585393531|FG004|Overall Study|Withdrawal by Subject|5|||
162093953|NCT03169153|585393532|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
162093954|NCT03169153|585393533|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
162093955|NCT03169153|585393532|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
162093956|NCT03169153|585393533|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
162093957|NCT03169153|585393532|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
162093958|NCT03169153|585393533|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
162093959|NCT03169153|585393532|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
162093960|NCT03169153|585393533|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
162093961|NCT00439777|585393534|FG000|Treatment Period|Death|29|||
162093962|NCT00439777|585393535|FG001|Treatment Period|Death|21|||
162093963|NCT00439777|585393534|FG000|Treatment Period|Study terminated by sponsor|125|||
162093964|NCT00439777|585393535|FG001|Treatment Period|Study terminated by sponsor|132|||
162093965|NCT00439777|585393534|FG000|Treatment Period|Site closed by investigator|0|||
162093966|NCT00439777|585393535|FG001|Treatment Period|Site closed by investigator|1|||
162093967|NCT00439777|585393534|FG000|Treatment Period|Did not take study treatment|7|||
162093968|NCT00439777|585393535|FG001|Treatment Period|Did not take study treatment|8|||
162093969|NCT00439777|585393534|FG000|Treatment Period|Adverse Event|111|||
162093970|NCT00439777|585393535|FG001|Treatment Period|Adverse Event|92|||
162093971|NCT00439777|585393534|FG000|Treatment Period|Protocol Violation|23|||
162093972|NCT00439777|585393535|FG001|Treatment Period|Protocol Violation|30|||
162093973|NCT00439777|585393534|FG000|Treatment Period|Withdrawal by Subject|66|||
162093974|NCT00439777|585393535|FG001|Treatment Period|Withdrawal by Subject|118|||
162093975|NCT00439777|585393534|FG000|Treatment Period|Lack of Efficacy|1|||
162093976|NCT00439777|585393535|FG001|Treatment Period|Lack of Efficacy|4|||
162093977|NCT00439777|585393534|FG000|Treatment Period|Lost to Follow-up|8|||
162093978|NCT00439777|585393535|FG001|Treatment Period|Lost to Follow-up|10|||
162093979|NCT00439777|585393534|FG000|Treatment Period|Protocol driven decision point|1|||
162093980|NCT00439777|585393535|FG001|Treatment Period|Protocol driven decision point|3|||
162093981|NCT00439777|585393534|FG000|Treatment Period|Physician Decision|7|||
162093982|NCT00439777|585393535|FG001|Treatment Period|Physician Decision|18|||
162093983|NCT00439777|585393534|FG000|Treatment Period|Clinical endpoint reached|26|||
162093984|NCT00439777|585393535|FG001|Treatment Period|Clinical endpoint reached|13|||
162093985|NCT00439777|585393534|FG000|Treatment Period|Technical problems|3|||
162093986|NCT00439777|585393535|FG001|Treatment Period|Technical problems|1|||
162093987|NCT00439777|585393534|FG000|Treatment Period|Participant convenience|12|||
162093988|NCT00439777|585393535|FG001|Treatment Period|Participant convenience|8|||
162093989|NCT00439777|585393534|FG000|Observational Period|Protocol Violation|0|||
162093990|NCT00439777|585393535|FG001|Observational Period|Protocol Violation|2|||
162093991|NCT00439777|585393534|FG000|Observational Period|Withdrawal by Subject|9|||
162093992|NCT00439777|585393535|FG001|Observational Period|Withdrawal by Subject|5|||
162093993|NCT00439777|585393534|FG000|Observational Period|Lost to Follow-up|1|||
162093994|NCT00439777|585393535|FG001|Observational Period|Lost to Follow-up|11|||
162093995|NCT00439777|585393534|FG000|Observational Period|Death|27|||
162093996|NCT00439777|585393535|FG001|Observational Period|Death|20|||
162093997|NCT00439777|585393534|FG000|Observational Period|Study terminated by sponsor|3|||
162093998|NCT00439777|585393535|FG001|Observational Period|Study terminated by sponsor|1|||
162093999|NCT00439777|585393534|FG000|Observational Period|Protocol driven decision point|0|||
162094000|NCT00439777|585393535|FG001|Observational Period|Protocol driven decision point|1|||
162094001|NCT00439777|585393534|FG000|Observational Period|Lack of Efficacy|1|||
162094002|NCT00439777|585393535|FG001|Observational Period|Lack of Efficacy|0|||
162094003|NCT00439777|585393534|FG000|Observational Period|Technical problems|0|||
162094004|NCT00439777|585393535|FG001|Observational Period|Technical problems|1|||
162094005|NCT00661492|585393536|FG000|Overall Study|Adverse Event|16|||
162094006|NCT00661492|585393537|FG001|Overall Study|Adverse Event|13|||
162094007|NCT00661492|585393536|FG000|Overall Study|Disease Progression|44|||
162094008|NCT00661492|585393537|FG001|Overall Study|Disease Progression|14|||
162094009|NCT00661492|585393536|FG000|Overall Study|Patient Request|6|||
162094010|NCT00661492|585393537|FG001|Overall Study|Patient Request|1|||
162094011|NCT00661492|585393536|FG000|Overall Study|Investigator Request|1|||
162094012|NCT00661492|585393537|FG001|Overall Study|Investigator Request|0|||
162094013|NCT00661492|585393536|FG000|Overall Study|Lost to Follow-up|0|||
162094014|NCT00661492|585393537|FG001|Overall Study|Lost to Follow-up|1|||
162094015|NCT00661492|585393536|FG000|Overall Study|Other|1|||
162094016|NCT00661492|585393537|FG001|Overall Study|Other|0|||
162094017|NCT00803634|585393538|FG000|Overall Study|Withdrew Consent|1|||
162094018|NCT00803634|585393539|FG001|Overall Study|Withdrew Consent|0|||
162094019|NCT00803634|585393538|FG000|Overall Study|Lost to Follow-up|2|||
162094020|NCT00803634|585393539|FG001|Overall Study|Lost to Follow-up|3|||
162094021|NCT00803634|585393538|FG000|Overall Study|Death|3|||
162094022|NCT00803634|585393539|FG001|Overall Study|Death|2|||
162094023|NCT03791398|585393542|FG000|Overall Study|Progression of Disease Under Study|2|||
162094024|NCT03791398|585393543|FG001|Overall Study|Progression of Disease Under Study|0|||
162094025|NCT03791398|585393544|FG002|Overall Study|Progression of Disease Under Study|0|||
162094026|NCT00766376|585393545|FG000|Overall Study|Withdrawal by Subject|27|||
162094027|NCT01072201|585393546|FG000|Overall Study|Lost to Follow-up|0|||
162094028|NCT01072201|585393547|FG001|Overall Study|Lost to Follow-up|1|||
162094029|NCT04382612|585393548|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
162094030|NCT01328002|585393550|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
162094031|NCT01328002|585393551|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
162094032|NCT01328002|585393550|FG000|Open-Label Period|Adverse Event|8|||
162094033|NCT01328002|585393551|FG001|Open-Label Period|Adverse Event|0|||
162094034|NCT01328002|585393550|FG000|Open-Label Period|Lack of Efficacy|3|||
162094035|NCT01328002|585393551|FG001|Open-Label Period|Lack of Efficacy|0|||
162094036|NCT01328002|585393550|FG000|Open-Label Period|Protocol Violation|2|||
162094037|NCT01328002|585393551|FG001|Open-Label Period|Protocol Violation|0|||
162094038|NCT01328002|585393550|FG000|Open-Label Period|Withdrawal by Subject|9|||
162094039|NCT01328002|585393551|FG001|Open-Label Period|Withdrawal by Subject|0|||
162094040|NCT01328002|585393550|FG000|Open-Label Period|Lost to Follow-up|6|||
162094041|NCT01328002|585393551|FG001|Open-Label Period|Lost to Follow-up|0|||
162094042|NCT01328002|585393550|FG000|Open-Label Period|Other Reason|2|||
162094043|NCT01328002|585393551|FG001|Open-Label Period|Other Reason|0|||
162094044|NCT01328002|585393550|FG000|Double-Blind Period|Adverse Event|1|||
162094045|NCT01328002|585393551|FG001|Double-Blind Period|Adverse Event|0|||
162094046|NCT01328002|585393550|FG000|Double-Blind Period|Lack of Efficacy|1|||
162094047|NCT01328002|585393551|FG001|Double-Blind Period|Lack of Efficacy|0|||
162094048|NCT01578551|585393552|FG000|Overall Study|Adverse Event|1|||
162094049|NCT01578551|585393553|FG001|Overall Study|Adverse Event|0|||
162094050|NCT00061048|585393555|FG000|Overall Study|Adverse Event|2|||
162094051|NCT00061048|585393555|FG000|Overall Study|disease progression|20|||
162094052|NCT02752048|585393556|FG000|Overall Study|Withdrawal by Subject|0|||
162094053|NCT02752048|585393557|FG001|Overall Study|Withdrawal by Subject|0|||
162094054|NCT02752048|585393558|FG002|Overall Study|Withdrawal by Subject|3|||
162094055|NCT03779841|585393562|FG000|Randomized Population|Did Not Receive Treatment|3|||
162094056|NCT03779841|585393563|FG001|Randomized Population|Did Not Receive Treatment|1|||
162094057|NCT03779841|585393564|FG002|Randomized Population|Did Not Receive Treatment|0|||
162094058|NCT03779841|585393562|FG000|Treated (Safety) Population|Adverse Event|1|||
162094059|NCT03779841|585393563|FG001|Treated (Safety) Population|Adverse Event|1|||
162094060|NCT03779841|585393564|FG002|Treated (Safety) Population|Adverse Event|0|||
162094061|NCT03779841|585393562|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
162094062|NCT03779841|585393563|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
162094063|NCT03779841|585393564|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
162094064|NCT03779841|585393562|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
162094065|NCT03779841|585393563|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
162094066|NCT03779841|585393564|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
162094067|NCT03779841|585393562|FG000|Treated (Safety) Population|Death|1|||
162094068|NCT03779841|585393563|FG001|Treated (Safety) Population|Death|0|||
162094069|NCT03779841|585393564|FG002|Treated (Safety) Population|Death|2|||
162094070|NCT02788175|585393565|FG000|Overall Study|Protocol Violation|3|||
162094071|NCT02788175|585393565|FG000|Overall Study|Withdrawal by Subject|4|||
162094072|NCT02788175|585393565|FG000|Overall Study|Ineligible prior to study agent|6|||
162094073|NCT00818441|585393566|FG000|Overall Study|Death|69|||
162094074|NCT00818441|585393567|FG001|Overall Study|Death|26|||
162094075|NCT00818441|585393566|FG000|Overall Study|Other|5|||
162094076|NCT00818441|585393567|FG001|Overall Study|Other|0|||
162094077|NCT00818441|585393566|FG000|Overall Study|Lost to Follow-up|2|||
162094078|NCT00818441|585393567|FG001|Overall Study|Lost to Follow-up|1|||
162094079|NCT00818441|585393566|FG000|Overall Study|Withdrawal by Subject|2|||
162094080|NCT00818441|585393567|FG001|Overall Study|Withdrawal by Subject|0|||
162094081|NCT00818441|585393566|FG000|Overall Study|Adverse Event|0|||
162094082|NCT00818441|585393567|FG001|Overall Study|Adverse Event|1|||
162094083|NCT00818441|585393566|FG000|Overall Study|Study terminated by sponsor|11|||
162094084|NCT00818441|585393567|FG001|Overall Study|Study terminated by sponsor|2|||
162094085|NCT00898677|585393568|FG000|Overall Study|Adverse Event|0|||
162094086|NCT00898677|585393569|FG001|Overall Study|Adverse Event|0|||
162094087|NCT00898677|585393570|FG002|Overall Study|Adverse Event|1|||
162094088|NCT00898677|585393571|FG003|Overall Study|Adverse Event|0|||
162094089|NCT00898677|585393568|FG000|Overall Study|Lost to Follow-up|0|||
162094090|NCT00898677|585393569|FG001|Overall Study|Lost to Follow-up|0|||
162094091|NCT00898677|585393570|FG002|Overall Study|Lost to Follow-up|2|||
162094092|NCT00898677|585393571|FG003|Overall Study|Lost to Follow-up|0|||
162094093|NCT00898677|585393568|FG000|Overall Study|Protocol Violation|1|||
162094094|NCT00898677|585393569|FG001|Overall Study|Protocol Violation|1|||
162094095|NCT00898677|585393570|FG002|Overall Study|Protocol Violation|2|||
162094096|NCT00898677|585393571|FG003|Overall Study|Protocol Violation|0|||
162094097|NCT00898677|585393568|FG000|Overall Study|Withdrawal by Subject|0|||
162094098|NCT00898677|585393569|FG001|Overall Study|Withdrawal by Subject|0|||
162094099|NCT00898677|585393570|FG002|Overall Study|Withdrawal by Subject|0|||
162094100|NCT00898677|585393571|FG003|Overall Study|Withdrawal by Subject|1|||
162094101|NCT00898677|585393568|FG000|Overall Study|Not Treated: Adverse Event|0|||
162094102|NCT00898677|585393569|FG001|Overall Study|Not Treated: Adverse Event|2|||
162094103|NCT00898677|585393570|FG002|Overall Study|Not Treated: Adverse Event|1|||
162094104|NCT00898677|585393571|FG003|Overall Study|Not Treated: Adverse Event|0|||
162094105|NCT00898677|585393568|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
162094106|NCT00898677|585393569|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
162094107|NCT00898677|585393570|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
162094108|NCT00898677|585393571|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
162094109|NCT00898677|585393568|FG000|Overall Study|Not Treated: Pregnancy|0|||
162094110|NCT00898677|585393569|FG001|Overall Study|Not Treated: Pregnancy|0|||
162094111|NCT00898677|585393570|FG002|Overall Study|Not Treated: Pregnancy|1|||
162094112|NCT00898677|585393571|FG003|Overall Study|Not Treated: Pregnancy|0|||
162094113|NCT00898677|585393568|FG000|Overall Study|Not Treated: Protocol Violation|2|||
162094114|NCT00898677|585393569|FG001|Overall Study|Not Treated: Protocol Violation|0|||
162094115|NCT00898677|585393570|FG002|Overall Study|Not Treated: Protocol Violation|2|||
162094116|NCT00898677|585393571|FG003|Overall Study|Not Treated: Protocol Violation|0|||
162094117|NCT00898677|585393568|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
162094118|NCT00898677|585393569|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
162094119|NCT00898677|585393570|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
162094120|NCT00898677|585393571|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
162094121|NCT00898677|585393568|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
162094122|NCT00898677|585393569|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
162094123|NCT00898677|585393570|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
162094124|NCT00898677|585393571|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
162094125|NCT00898677|585393568|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
162094126|NCT00898677|585393569|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
162094127|NCT00898677|585393570|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
162094128|NCT00898677|585393571|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
162094129|NCT00898677|585393568|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
162094130|NCT00898677|585393569|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
162094131|NCT00898677|585393570|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
162094132|NCT00898677|585393571|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
162094133|NCT00898677|585393568|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
162094134|NCT00898677|585393569|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
162094135|NCT00898677|585393570|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
162094136|NCT00898677|585393571|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
162094137|NCT00898677|585393568|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
162094138|NCT00898677|585393569|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
162094139|NCT00898677|585393570|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
162094140|NCT00898677|585393571|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
162094141|NCT00898677|585393568|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
162094142|NCT00898677|585393569|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
162094143|NCT00898677|585393570|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
162094144|NCT00898677|585393571|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
162094145|NCT00852397|585393572|FG000|Overall Study|Adverse Event|4|||
162094146|NCT00852397|585393573|FG001|Overall Study|Adverse Event|6|||
162094147|NCT00852397|585393574|FG002|Overall Study|Adverse Event|4|||
162094148|NCT00852397|585393572|FG000|Overall Study|Death|0|||
162094149|NCT00852397|585393573|FG001|Overall Study|Death|0|||
162094150|NCT00852397|585393574|FG002|Overall Study|Death|1|||
162094151|NCT00852397|585393572|FG000|Overall Study|Withdrawal by Subject|4|||
162094152|NCT00852397|585393573|FG001|Overall Study|Withdrawal by Subject|1|||
162094153|NCT00852397|585393574|FG002|Overall Study|Withdrawal by Subject|2|||
162094154|NCT00852397|585393572|FG000|Overall Study|Study terminated by sponsor|2|||
162094155|NCT00852397|585393573|FG001|Overall Study|Study terminated by sponsor|1|||
162094156|NCT00852397|585393574|FG002|Overall Study|Study terminated by sponsor|6|||
162094157|NCT00852397|585393572|FG000|Overall Study|Difficulty in study site visit|1|||
162094158|NCT00852397|585393573|FG001|Overall Study|Difficulty in study site visit|0|||
162094159|NCT00852397|585393574|FG002|Overall Study|Difficulty in study site visit|0|||
162094160|NCT00852397|585393572|FG000|Overall Study|Protocol Violation|0|||
162094161|NCT00852397|585393573|FG001|Overall Study|Protocol Violation|0|||
162094162|NCT00852397|585393574|FG002|Overall Study|Protocol Violation|1|||
162094163|NCT00774995|585393579|FG000|Overall Study|Protocol Violation|0|||
162094164|NCT00774995|585393580|FG001|Overall Study|Protocol Violation|0|||
162094165|NCT00774995|585393581|FG002|Overall Study|Protocol Violation|1|||
162094166|NCT00774995|585393582|FG003|Overall Study|Protocol Violation|0|||
162094167|NCT02055352|585395375|FG000|Overall Study|Adverse Event|0|||
162094168|NCT02055352|585395376|FG001|Overall Study|Adverse Event|1|||
162094169|NCT02055352|585395375|FG000|Overall Study|Non-eligible|0|||
162094170|NCT02055352|585395376|FG001|Overall Study|Non-eligible|1|||
162094171|NCT02055352|585395375|FG000|Overall Study|Poor compliance|1|||
162094172|NCT02055352|585395376|FG001|Overall Study|Poor compliance|1|||
162094173|NCT02055352|585395375|FG000|Overall Study|Death|1|||
162094174|NCT02055352|585395376|FG001|Overall Study|Death|2|||
162094175|NCT02055352|585395375|FG000|Overall Study|Patient decision|1|||
162094176|NCT02055352|585395376|FG001|Overall Study|Patient decision|1|||
162094177|NCT02055352|585395375|FG000|Overall Study|Use of prohibited treatment|0|||
162094178|NCT02055352|585395376|FG001|Overall Study|Use of prohibited treatment|3|||
162094179|NCT02055352|585395375|FG000|Overall Study|AE, study drug would be detrimental|1|||
162094180|NCT02055352|585395376|FG001|Overall Study|AE, study drug would be detrimental|3|||
162094181|NCT02055352|585395375|FG000|Overall Study|Withdrawal of informed consent|1|||
162094182|NCT02055352|585395376|FG001|Overall Study|Withdrawal of informed consent|0|||
162094183|NCT02055352|585395375|FG000|Overall Study|Reason unknown|1|||
162094184|NCT02055352|585395376|FG001|Overall Study|Reason unknown|5|||
162094185|NCT04745169|585395377|FG000|Overall Study|Kidney transplantation|1|||
162094186|NCT04745169|585395377|FG000|Overall Study|Participant health problems|3|||
162094187|NCT04745169|585395377|FG000|Overall Study|Physician Decision|2|||
162094188|NCT00993447|585395378|FG000|Overall Study|Withdrawal by Subject|23|||
162094189|NCT00993447|585395379|FG001|Overall Study|Withdrawal by Subject|8|||
162094190|NCT00993447|585395378|FG000|Overall Study|Protocol Violation|12|||
162094191|NCT00993447|585395379|FG001|Overall Study|Protocol Violation|8|||
162094192|NCT00993447|585395378|FG000|Overall Study|Lost to Follow-up|1|||
162094193|NCT00993447|585395379|FG001|Overall Study|Lost to Follow-up|3|||
162094194|NCT00993447|585395378|FG000|Overall Study|Adverse Event|1|||
162094195|NCT00993447|585395379|FG001|Overall Study|Adverse Event|0|||
162094196|NCT02707055|585395380|FG000|Phase 1|Withdrawal by Subject|1|||
162094197|NCT02707055|585395381|FG001|Phase 1|Withdrawal by Subject|2|||
162094198|NCT02707055|585395380|FG000|Phase 1|Physician Decision|0|||
162094199|NCT02707055|585395381|FG001|Phase 1|Physician Decision|1|||
162094200|NCT02707055|585395380|FG000|Phase 2|Adverse Event|1|||
162094201|NCT02707055|585395381|FG001|Phase 2|Adverse Event|2|||
162094202|NCT01880424|585395382|FG000|Overall Study|Adverse Event|7|||
162094203|NCT01880424|585395383|FG001|Overall Study|Adverse Event|6|||
162094204|NCT01880424|585395382|FG000|Overall Study|Lack of Efficacy|1|||
162094205|NCT01880424|585395383|FG001|Overall Study|Lack of Efficacy|4|||
162094206|NCT01880424|585395382|FG000|Overall Study|Lost to Follow-up|3|||
162094207|NCT01880424|585395383|FG001|Overall Study|Lost to Follow-up|2|||
162094208|NCT01880424|585395382|FG000|Overall Study|Protocol Violation|11|||
162094209|NCT01880424|585395383|FG001|Overall Study|Protocol Violation|13|||
162094210|NCT01880424|585395382|FG000|Overall Study|Withdrawal by Subject|10|||
162094211|NCT01880424|585395383|FG001|Overall Study|Withdrawal by Subject|30|||
162094212|NCT01880424|585395382|FG000|Overall Study|Other|1|||
162094213|NCT01880424|585395383|FG001|Overall Study|Other|0|||
162094214|NCT02280044|585395386|FG000|Overall Study|Planned alternate|0|||
162094215|NCT02280044|585395387|FG001|Overall Study|Planned alternate|2|||
162094216|NCT05706506|585395388|FG000|Overall Study|Adverse Event|1|||
162094217|NCT05706506|585395388|FG000|Overall Study|Withdrawal by Subject|4|||
162094218|NCT05706506|585395388|FG000|Overall Study|Lost to Follow-up|2|||
162094219|NCT05706506|585395388|FG000|Overall Study|Inadvertent Enrolment|12|||
162094220|NCT05706506|585395388|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
162094221|NCT05706506|585395388|FG000|Overall Study|Participant Moved Out of State|1|||
162094222|NCT02246998|585395389|FG000|Overall Study|Adverse Event|0|||
162094223|NCT02246998|585395390|FG001|Overall Study|Adverse Event|1|||
162094224|NCT02246998|585395391|FG002|Overall Study|Adverse Event|1|||
162094225|NCT02246998|585395392|FG003|Overall Study|Adverse Event|0|||
162094226|NCT02246998|585395389|FG000|Overall Study|Lost to Follow-up|1|||
162094227|NCT02246998|585395390|FG001|Overall Study|Lost to Follow-up|0|||
162094228|NCT02246998|585395391|FG002|Overall Study|Lost to Follow-up|0|||
162094229|NCT02246998|585395392|FG003|Overall Study|Lost to Follow-up|1|||
162094230|NCT02246998|585395389|FG000|Overall Study|Randomized but Never Dosed|1|||
162094231|NCT02246998|585395390|FG001|Overall Study|Randomized but Never Dosed|2|||
162094232|NCT02246998|585395391|FG002|Overall Study|Randomized but Never Dosed|2|||
162094233|NCT02246998|585395392|FG003|Overall Study|Randomized but Never Dosed|1|||
162094234|NCT01303627|585395394|FG000|Overall Study|the failure while performing URS|0|||
162094235|NCT01303627|585395395|FG001|Overall Study|the failure while performing URS|1|||
162094236|NCT01709227|585395399|FG000|Overall Study|Physician Decision|1|||
162094237|NCT01709227|585395400|FG001|Overall Study|Physician Decision|0|||
162094238|NCT01709227|585395399|FG000|Overall Study|Pleural Peritoneal communication|0|||
162094239|NCT01709227|585395400|FG001|Overall Study|Pleural Peritoneal communication|9|||
162094240|NCT04831736|585395403|FG000|Overall Study|Withdrawal by Subject|0|||
162094241|NCT04831736|585395404|FG001|Overall Study|Withdrawal by Subject|1|||
162094242|NCT00795600|585395405|FG000|Overall Study|Adverse Event|1|||
162094243|NCT00795600|585395406|FG001|Overall Study|Adverse Event|1|||
162094244|NCT00795600|585395405|FG000|Overall Study|Protocol Violation|1|||
162094245|NCT00795600|585395406|FG001|Overall Study|Protocol Violation|2|||
162094246|NCT00795600|585395405|FG000|Overall Study|Withdrawal by Subject|1|||
162094247|NCT00795600|585395406|FG001|Overall Study|Withdrawal by Subject|0|||
162094248|NCT00795600|585395405|FG000|Overall Study|Unclassified|1|||
162094249|NCT00795600|585395406|FG001|Overall Study|Unclassified|1|||
162094250|NCT01659021|585395407|FG000|Main Study|Adverse Event|2|||
162094251|NCT01659021|585395408|FG001|Main Study|Adverse Event|3|||
162094252|NCT01659021|585395407|FG000|Main Study|Lost to Follow-up|1|||
162094253|NCT01659021|585395408|FG001|Main Study|Lost to Follow-up|0|||
162094254|NCT01659021|585395407|FG000|Main Study|Unknown Reasons|2|||
162094255|NCT01659021|585395408|FG001|Main Study|Unknown Reasons|1|||
162094256|NCT01659021|585395407|FG000|Main Study|Physician Decision|34|||
162094257|NCT01659021|585395408|FG001|Main Study|Physician Decision|16|||
162094258|NCT01659021|585395407|FG000|Main Study|Withdrawal by Subject|19|||
162094259|NCT01659021|585395408|FG001|Main Study|Withdrawal by Subject|16|||
162094260|NCT01659021|585395407|FG000|Main Study|Study Terminated by Sponsor|16|||
162094261|NCT01659021|585395408|FG001|Main Study|Study Terminated by Sponsor|1|||
162094262|NCT01659021|585395407|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
162094263|NCT01659021|585395408|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
162094264|NCT01659021|585395407|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
162094265|NCT01659021|585395408|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
162094266|NCT00840970|585395411|FG000|Overall Study|Adverse Event|0|||
162094267|NCT00840970|585395412|FG001|Overall Study|Adverse Event|0|||
162094268|NCT00840970|585395413|FG002|Overall Study|Adverse Event|1|||
162094269|NCT03465540|585395414|FG000|Overall Study|Withdrawal by Subject|0|||
162094270|NCT03465540|585395415|FG001|Overall Study|Withdrawal by Subject|0|||
162094271|NCT03465540|585395416|FG002|Overall Study|Withdrawal by Subject|1|||
162094272|NCT03465540|585395417|FG003|Overall Study|Withdrawal by Subject|1|||
162094273|NCT03465540|585395418|FG004|Overall Study|Withdrawal by Subject|1|||
162094274|NCT03465540|585395419|FG005|Overall Study|Withdrawal by Subject|0|||
162094275|NCT03465540|585395414|FG000|Overall Study|Lost to Follow-up|0|||
162094276|NCT03465540|585395415|FG001|Overall Study|Lost to Follow-up|1|||
162094277|NCT03465540|585395416|FG002|Overall Study|Lost to Follow-up|0|||
162094278|NCT03465540|585395417|FG003|Overall Study|Lost to Follow-up|0|||
162094279|NCT03465540|585395418|FG004|Overall Study|Lost to Follow-up|1|||
162094280|NCT03465540|585395419|FG005|Overall Study|Lost to Follow-up|0|||
162094281|NCT03465540|585395414|FG000|Overall Study|Death|1|||
162094282|NCT03465540|585395415|FG001|Overall Study|Death|1|||
162094283|NCT03465540|585395416|FG002|Overall Study|Death|0|||
162094284|NCT03465540|585395417|FG003|Overall Study|Death|2|||
162094285|NCT03465540|585395418|FG004|Overall Study|Death|0|||
162094286|NCT03465540|585395419|FG005|Overall Study|Death|2|||
162094287|NCT03465540|585395414|FG000|Overall Study|Protocol specified criteria|0|||
162094288|NCT03465540|585395415|FG001|Overall Study|Protocol specified criteria|2|||
162094289|NCT03465540|585395416|FG002|Overall Study|Protocol specified criteria|2|||
162094290|NCT03465540|585395417|FG003|Overall Study|Protocol specified criteria|0|||
162094291|NCT03465540|585395418|FG004|Overall Study|Protocol specified criteria|2|||
162094292|NCT03465540|585395419|FG005|Overall Study|Protocol specified criteria|0|||
162094293|NCT00504829|585395420|FG000|Overall Study|Protocol Violation|6|||
162094294|NCT00504829|585395421|FG001|Overall Study|Protocol Violation|4|||
162094295|NCT00504829|585395422|FG002|Overall Study|Protocol Violation|10|||
162094296|NCT01854827|585395423|FG000|Overall Study|Death|1|||
162094297|NCT00736996|585395424|FG000|Overall Study|Lost to Follow-up|1|||
162094298|NCT00736996|585395425|FG001|Overall Study|Lost to Follow-up|9|||
162094299|NCT00736996|585395426|FG002|Overall Study|Lost to Follow-up|2|||
162094300|NCT00462384|585395427|FG000|Overall Study|Adverse Event|2|||
162094301|NCT00462384|585395427|FG000|Overall Study|Death|2|||
162094302|NCT00462384|585395427|FG000|Overall Study|Withdrawal by Subject|1|||
162094303|NCT00462384|585395427|FG000|Overall Study|Other|4|||
162094304|NCT04000165|585395428|FG000|Overall Study|Physician Decision|1|||
162094305|NCT04000165|585395428|FG000|Overall Study|Withdrawal by Subject|1|||
162094306|NCT01751568|585395433|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
162094307|NCT01751568|585395434|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
162094308|NCT01751568|585395435|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
162094309|NCT02660944|585395444|FG000|Overall Study|Adverse Event|3|||
162094310|NCT02660944|585395445|FG001|Overall Study|Adverse Event|4|||
162094311|NCT02660944|585395444|FG000|Overall Study|Physician Decision|3|||
162094312|NCT02660944|585395445|FG001|Overall Study|Physician Decision|1|||
162094313|NCT02660944|585395444|FG000|Overall Study|Withdrawal by Subject|5|||
162094314|NCT02660944|585395445|FG001|Overall Study|Withdrawal by Subject|3|||
162094315|NCT02660944|585395444|FG000|Overall Study|Lost to Follow-up|4|||
162094316|NCT02660944|585395445|FG001|Overall Study|Lost to Follow-up|1|||
162094317|NCT02660944|585395444|FG000|Overall Study|Subject schedule|0|||
162094318|NCT02660944|585395445|FG001|Overall Study|Subject schedule|1|||
162094319|NCT02660944|585395444|FG000|Overall Study|Exclusion criteria met|2|||
162094320|NCT02660944|585395445|FG001|Overall Study|Exclusion criteria met|0|||
162094321|NCT02843568|585395446|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
162094322|NCT02843568|585395447|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
162094323|NCT02843568|585395446|FG000|Overall Study|Death|3|||
162094324|NCT02843568|585395447|FG001|Overall Study|Death|3|||
162094325|NCT02843568|585395446|FG000|Overall Study|Withdrawal by Subject|1|||
162094326|NCT02843568|585395447|FG001|Overall Study|Withdrawal by Subject|1|||
162094327|NCT02843568|585395446|FG000|Overall Study|Lost to Follow-up|2|||
162094328|NCT02843568|585395447|FG001|Overall Study|Lost to Follow-up|0|||
162094329|NCT03586999|585395448|FG000|Overall Study|Lack of Efficacy|2|||
162094330|NCT04096560|585395449|FG000|Overall Study|Reason not Specified|1|||
162094331|NCT04096560|585395450|FG001|Overall Study|Reason not Specified|0|||
162094332|NCT04096560|585395451|FG002|Overall Study|Reason not Specified|0|||
162094333|NCT04096560|585395452|FG003|Overall Study|Reason not Specified|0|||
162094334|NCT04096560|585395453|FG004|Overall Study|Reason not Specified|1|||
162094335|NCT04096560|585395454|FG005|Overall Study|Reason not Specified|1|||
162094336|NCT04096560|585395455|FG006|Overall Study|Reason not Specified|1|||
162094337|NCT04096560|585395456|FG007|Overall Study|Reason not Specified|0|||
162094338|NCT04096560|585395449|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
162094339|NCT04096560|585395450|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
162094340|NCT04096560|585395451|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
162094341|NCT04096560|585395452|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
162094342|NCT04096560|585395453|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
162094343|NCT04096560|585395454|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
162094344|NCT04096560|585395455|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
162094345|NCT04096560|585395456|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
162094346|NCT04096560|585395449|FG000|Overall Study|Study Terminated by Sponsor|0|||
162094347|NCT04096560|585395450|FG001|Overall Study|Study Terminated by Sponsor|0|||
162094348|NCT04096560|585395451|FG002|Overall Study|Study Terminated by Sponsor|0|||
162094349|NCT04096560|585395452|FG003|Overall Study|Study Terminated by Sponsor|5|||
162094350|NCT04096560|585395453|FG004|Overall Study|Study Terminated by Sponsor|6|||
162094351|NCT04096560|585395454|FG005|Overall Study|Study Terminated by Sponsor|4|||
162094352|NCT04096560|585395455|FG006|Overall Study|Study Terminated by Sponsor|6|||
162094353|NCT04096560|585395456|FG007|Overall Study|Study Terminated by Sponsor|1|||
162094354|NCT04096560|585395449|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162094355|NCT04096560|585395450|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162094356|NCT04096560|585395451|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162094357|NCT04096560|585395452|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162094358|NCT04096560|585395453|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162094359|NCT04096560|585395454|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162094360|NCT04096560|585395455|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
162094361|NCT04096560|585395456|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
162094362|NCT00534352|585395459|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
162094363|NCT00534352|585395459|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
162094364|NCT00534352|585395459|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
162094365|NCT00534352|585395459|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
162094366|NCT00534352|585395459|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
162094367|NCT00534352|585395459|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
162094368|NCT03264989|585395462|FG000|Overall Study|Lost to Follow-up|1|||
162094369|NCT03264989|585395463|FG001|Overall Study|Lost to Follow-up|0|||
162094370|NCT03264989|585395462|FG000|Overall Study|New Therapy for study Indication|1|||
162094371|NCT03264989|585395463|FG001|Overall Study|New Therapy for study Indication|0|||
162094372|NCT03264989|585395462|FG000|Overall Study|Protocol Violation|0|||
162094373|NCT03264989|585395463|FG001|Overall Study|Protocol Violation|1|||
162094374|NCT03264989|585395462|FG000|Overall Study|Patient decision|13|||
162094375|NCT03264989|585395463|FG001|Overall Study|Patient decision|0|||
162094376|NCT03264989|585395462|FG000|Overall Study|Physician Decision|6|||
162094377|NCT03264989|585395463|FG001|Overall Study|Physician Decision|4|||
162094378|NCT03264989|585395462|FG000|Overall Study|Adverse Event|2|||
162094379|NCT03264989|585395463|FG001|Overall Study|Adverse Event|1|||
162094380|NCT03264989|585395462|FG000|Overall Study|Death|1|||
162094381|NCT03264989|585395463|FG001|Overall Study|Death|1|||
162094382|NCT03264989|585395462|FG000|Overall Study|Pregnancy|2|||
162094383|NCT03264989|585395463|FG001|Overall Study|Pregnancy|0|||
162094384|NCT03264989|585395462|FG000|Overall Study|End of Study|19|||
162094385|NCT03264989|585395463|FG001|Overall Study|End of Study|5|||
162094386|NCT02504866|585395469|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
162094387|NCT02504866|585395470|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
162094388|NCT02504866|585395471|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
162094389|NCT01229436|585395472|FG000|Overall Study|Withdrawal by Subject|2|||
162094390|NCT01229436|585395472|FG000|Overall Study|Lost to Follow-up|3|||
162094391|NCT04796610|585395473|FG000|Overall Study|Withdrawal by Subject|1|||
162094392|NCT04796610|585395474|FG001|Overall Study|Withdrawal by Subject|0|||
162094393|NCT04796610|585395475|FG002|Overall Study|Withdrawal by Subject|0|||
162094394|NCT04796610|585395476|FG003|Overall Study|Withdrawal by Subject|0|||
162094395|NCT04796610|585395473|FG000|Overall Study|Lost to Follow-up|2|||
162094396|NCT04796610|585395474|FG001|Overall Study|Lost to Follow-up|0|||
162094397|NCT04796610|585395475|FG002|Overall Study|Lost to Follow-up|1|||
162094398|NCT04796610|585395476|FG003|Overall Study|Lost to Follow-up|1|||
162094399|NCT01775137|585395477|FG000|Overall Study|Death|1|||
162094400|NCT01775137|585395477|FG000|Overall Study|Protocol deviation|2|||
162094401|NCT01775137|585395477|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162094402|NCT01775137|585395477|FG000|Overall Study|Adverse Event|1|||
162094403|NCT01775137|585395477|FG000|Overall Study|Withdrawal by participants|5|||
162094404|NCT00733824|585395478|FG000|Phase I|Withdrawal by Subject|1|||
162094405|NCT00733824|585395479|FG001|Phase I|Withdrawal by Subject|0|||
162094406|NCT00733824|585395480|FG002|Phase I|Withdrawal by Subject|0|||
162094407|NCT00733824|585395481|FG003|Phase I|Withdrawal by Subject|0|||
162094408|NCT00733824|585395482|FG004|Phase I|Withdrawal by Subject|0|||
162094409|NCT01459796|585395483|FG000|Overall Study|Non compliance with protocol|2|||
162094410|NCT01459796|585395484|FG001|Overall Study|Non compliance with protocol|4|||
162094411|NCT01459796|585395483|FG000|Overall Study|Adverse Event|5|||
162094412|NCT01459796|585395484|FG001|Overall Study|Adverse Event|5|||
162094413|NCT01459796|585395483|FG000|Overall Study|Withdrawal by Subject|6|||
162094414|NCT01459796|585395484|FG001|Overall Study|Withdrawal by Subject|3|||
162094415|NCT01459796|585395483|FG000|Overall Study|Lost to Follow-up|5|||
162094416|NCT01459796|585395484|FG001|Overall Study|Lost to Follow-up|4|||
162094417|NCT01459796|585395483|FG000|Overall Study|Reason unspecified|1|||
162094418|NCT01459796|585395484|FG001|Overall Study|Reason unspecified|2|||
162094419|NCT01459796|585395483|FG000|Overall Study|Decision by the sponsor|75|||
162094420|NCT01459796|585395484|FG001|Overall Study|Decision by the sponsor|108|||
162094421|NCT01343056|585395485|FG000|Overall Study|Lost to Follow-up|7|||
162094422|NCT01343056|585395486|FG001|Overall Study|Lost to Follow-up|5|||
162094423|NCT01343056|585395487|FG002|Overall Study|Lost to Follow-up|3|||
162094424|NCT01343056|585395488|FG003|Overall Study|Lost to Follow-up|9|||
162094425|NCT03231371|585395490|FG000|Overall Study|Withdrawal by Subject|1|||
162094426|NCT03231371|585395490|FG000|Overall Study|chose or were ineligible to have MRI|12|||
162094427|NCT03067441|585395492|FG000|Overall Study|Withdrawal by Subject|16|||
162094428|NCT03067441|585395493|FG001|Overall Study|Withdrawal by Subject|34|||
162094429|NCT03067441|585395492|FG000|Overall Study|Lost to Follow-up|7|||
162094430|NCT03067441|585395493|FG001|Overall Study|Lost to Follow-up|5|||
162094431|NCT03067441|585395492|FG000|Overall Study|Adverse Event|7|||
162094432|NCT03067441|585395493|FG001|Overall Study|Adverse Event|14|||
162094433|NCT03067441|585395492|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
162094434|NCT03067441|585395493|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
162094435|NCT03067441|585395492|FG000|Overall Study|Physician Decision|1|||
162094436|NCT03067441|585395493|FG001|Overall Study|Physician Decision|3|||
162094437|NCT03067441|585395492|FG000|Overall Study|Other|1|||
162094438|NCT03067441|585395493|FG001|Overall Study|Other|1|||
162094439|NCT00499889|585395494|FG000|Overall Study|Infection prior to treatment|1|||
162094440|NCT03299192|585395495|FG000|Overall Study|Fell before classes started|1|||
162094441|NCT03299192|585395496|FG001|Overall Study|Fell before classes started|0|||
162094442|NCT03299192|585395497|FG002|Overall Study|Fell before classes started|0|||
162094443|NCT03299192|585395495|FG000|Overall Study|Other|0|||
162094444|NCT03299192|585395496|FG001|Overall Study|Other|2|||
162094445|NCT03299192|585395497|FG002|Overall Study|Other|1|||
162094446|NCT01418209|585395503|FG000|Overall Study|Withdrawal by Subject|1|||
162094447|NCT01418209|585395504|FG001|Overall Study|Withdrawal by Subject|0|||
162094448|NCT01418209|585395505|FG002|Overall Study|Withdrawal by Subject|1|||
162094449|NCT01418209|585395503|FG000|Overall Study|Did not provide hot flash diary data|1|||
162094450|NCT01418209|585395504|FG001|Overall Study|Did not provide hot flash diary data|3|||
162094451|NCT01418209|585395505|FG002|Overall Study|Did not provide hot flash diary data|3|||
162094452|NCT00101101|585395506|FG000|Overall Study|never received vaccine|20|||
162094453|NCT01603875|585395507|FG000|Overall Study|Preexisting rabies antibody|3|||
162094454|NCT01603875|585395508|FG001|Overall Study|Preexisting rabies antibody|4|||
162094455|NCT01603875|585395509|FG002|Overall Study|Preexisting rabies antibody|3|||
162094456|NCT01603875|585395507|FG000|Overall Study|Lost to Follow-up|4|||
162094457|NCT01603875|585395508|FG001|Overall Study|Lost to Follow-up|3|||
162094458|NCT01603875|585395509|FG002|Overall Study|Lost to Follow-up|6|||
162094459|NCT01603875|585395507|FG000|Overall Study|Protocol Violation|0|||
162094460|NCT01603875|585395508|FG001|Overall Study|Protocol Violation|1|||
162094461|NCT01603875|585395509|FG002|Overall Study|Protocol Violation|0|||
162094462|NCT01652716|585395513|FG000|Overall Study|Loss of glucose control|1|||
162094463|NCT01652716|585395514|FG001|Overall Study|Loss of glucose control|0|||
162094464|NCT01652716|585395513|FG000|Overall Study|Administrative|0|||
162094465|NCT01652716|585395514|FG001|Overall Study|Administrative|2|||
162094466|NCT01652716|585395513|FG000|Overall Study|Investigator decision|1|||
162094467|NCT01652716|585395514|FG001|Overall Study|Investigator decision|4|||
162094468|NCT01652716|585395513|FG000|Overall Study|Lost to Follow-up|12|||
162094469|NCT01652716|585395514|FG001|Overall Study|Lost to Follow-up|11|||
162094470|NCT01652716|585395513|FG000|Overall Study|Protocol Violation|2|||
162094471|NCT01652716|585395514|FG001|Overall Study|Protocol Violation|1|||
162094472|NCT01652716|585395513|FG000|Overall Study|Adverse Event|7|||
162094473|NCT01652716|585395514|FG001|Overall Study|Adverse Event|10|||
162094474|NCT01652716|585395513|FG000|Overall Study|Withdrawal by Subject|33|||
162094475|NCT01652716|585395514|FG001|Overall Study|Withdrawal by Subject|18|||
162094476|NCT04122443|585395517|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
162094477|NCT04122443|585395518|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
162094478|NCT04122443|585395519|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
162094479|NCT04122443|585395517|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
162094480|NCT04122443|585395518|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
162094481|NCT04122443|585395519|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
162094482|NCT05204134|585395520|FG000|Overall Study|Withdrawal by Subject|3|||
162094483|NCT05204134|585395520|FG000|Overall Study|Physician Decision|1|||
162094484|NCT01312467|585395524|FG000|Overall Study|Adverse Event|4|||
162094485|NCT01312467|585395524|FG000|Overall Study|Lost to Follow-up|1|||
162094486|NCT01312467|585395524|FG000|Overall Study|Withdrawal by Subject|2|||
162094487|NCT01312467|585395524|FG000|Overall Study|Deported to country of origin|1|||
162094488|NCT01312467|585395524|FG000|Overall Study|Another medical condition|1|||
162094489|NCT01312467|585395524|FG000|Overall Study|Ineligible|4|||
162094490|NCT01059617|585395525|FG000|Overall Study|Other|7|||
162094491|NCT01059617|585395526|FG001|Overall Study|Other|1|||
162094492|NCT01059617|585395527|FG002|Overall Study|Other|8|||
162094493|NCT01059617|585395528|FG003|Overall Study|Other|6|||
162094494|NCT01968434|585395531|FG000|Overall Study|Lost to Follow-up|3|||
162094495|NCT01968434|585395532|FG001|Overall Study|Lost to Follow-up|6|||
162094496|NCT02199691|585395533|FG000|Overall Study|Protocol Violation|3|||
162094497|NCT02199691|585395534|FG001|Overall Study|Protocol Violation|3|||
162094498|NCT02199691|585395535|FG002|Overall Study|Protocol Violation|6|||
162094499|NCT02199691|585395536|FG003|Overall Study|Protocol Violation|7|||
162094500|NCT02199691|585395533|FG000|Overall Study|Withdrawal by Subject|5|||
162094501|NCT02199691|585395534|FG001|Overall Study|Withdrawal by Subject|3|||
162094502|NCT02199691|585395535|FG002|Overall Study|Withdrawal by Subject|12|||
162094503|NCT02199691|585395536|FG003|Overall Study|Withdrawal by Subject|13|||
162094504|NCT02199691|585395533|FG000|Overall Study|Lost to Follow-up|2|||
162094505|NCT02199691|585395534|FG001|Overall Study|Lost to Follow-up|1|||
162094506|NCT02199691|585395535|FG002|Overall Study|Lost to Follow-up|9|||
162094507|NCT02199691|585395536|FG003|Overall Study|Lost to Follow-up|10|||
162094508|NCT00612313|585395539|FG000|Overall Study|Withdrawal by Subject|6|||
162094509|NCT00612313|585395540|FG001|Overall Study|Withdrawal by Subject|9|||
162094510|NCT00612313|585395539|FG000|Overall Study|Lost to Follow-up|11|||
162094511|NCT00612313|585395540|FG001|Overall Study|Lost to Follow-up|4|||
162094512|NCT02239510|585398233|FG000|Overall Study|Lost to Follow-up|2|||
162094513|NCT02239510|585398234|FG001|Overall Study|Lost to Follow-up|1|||
162094514|NCT05349617|585398238|FG000|Overall Study|Death|1|||
162094515|NCT05349617|585398239|FG001|Overall Study|Death|1|||
162094516|NCT05349617|585398238|FG000|Overall Study|Lost to Follow-up|3|||
162094517|NCT05349617|585398239|FG001|Overall Study|Lost to Follow-up|8|||
162094518|NCT05349617|585398238|FG000|Overall Study|Withdrawal by Subject|2|||
162094519|NCT05349617|585398239|FG001|Overall Study|Withdrawal by Subject|10|||
162094520|NCT04401579|585398244|FG000|Overall Study|Death|23|||
162094521|NCT04401579|585398245|FG001|Overall Study|Death|36|||
162094522|NCT04401579|585398244|FG000|Overall Study|Lost to Follow-up|40|||
162094523|NCT04401579|585398245|FG001|Overall Study|Lost to Follow-up|41|||
162094524|NCT04401579|585398244|FG000|Overall Study|Withdrawal by Subject|8|||
162094525|NCT04401579|585398245|FG001|Overall Study|Withdrawal by Subject|16|||
162094526|NCT04401579|585398244|FG000|Overall Study|Physician Decision|1|||
162094527|NCT04401579|585398245|FG001|Overall Study|Physician Decision|2|||
162094528|NCT04401579|585398244|FG000|Overall Study|Became ineligible after enrollment|1|||
162094529|NCT04401579|585398245|FG001|Overall Study|Became ineligible after enrollment|1|||
162094530|NCT04401579|585398244|FG000|Overall Study|Enrolled but treatment not administered|7|||
162094531|NCT04401579|585398245|FG001|Overall Study|Enrolled but treatment not administered|9|||
162094532|NCT04401579|585398244|FG000|Overall Study|Adverse Event|2|||
162094533|NCT04401579|585398245|FG001|Overall Study|Adverse Event|1|||
162094534|NCT04401579|585398244|FG000|Overall Study|Scheduling error|1|||
162094535|NCT04401579|585398245|FG001|Overall Study|Scheduling error|2|||
162094536|NCT04401579|585398244|FG000|Overall Study|Transferred to another hospital|1|||
162094537|NCT04401579|585398245|FG001|Overall Study|Transferred to another hospital|2|||
162094538|NCT00489970|585398246|FG000|Persistence Year 9|Lost to Follow-up|2|||
162094539|NCT00489970|585398247|FG001|Persistence Year 9|Lost to Follow-up|2|||
162094540|NCT00489970|585398248|FG002|Persistence Year 9|Lost to Follow-up|3|||
162094541|NCT00489970|585398246|FG000|Persistence Year 9|Other|1|||
162094542|NCT00489970|585398247|FG001|Persistence Year 9|Other|0|||
162094543|NCT00489970|585398248|FG002|Persistence Year 9|Other|2|||
162094544|NCT01075321|585398254|FG000|Overall Study|Withdrawal by Subject|0|||
162094545|NCT01075321|585398255|FG001|Overall Study|Withdrawal by Subject|0|||
162094546|NCT01075321|585398256|FG002|Overall Study|Withdrawal by Subject|1|||
162094547|NCT01075321|585398257|FG003|Overall Study|Withdrawal by Subject|1|||
162094548|NCT01075321|585398254|FG000|Overall Study|Protocol Violation|0|||
162094549|NCT01075321|585398255|FG001|Overall Study|Protocol Violation|0|||
162094550|NCT01075321|585398256|FG002|Overall Study|Protocol Violation|1|||
162094551|NCT01075321|585398257|FG003|Overall Study|Protocol Violation|0|||
162094552|NCT01075321|585398254|FG000|Overall Study|Treatment Incomplete due to progression|1|||
162094553|NCT01075321|585398255|FG001|Overall Study|Treatment Incomplete due to progression|0|||
162094554|NCT01075321|585398256|FG002|Overall Study|Treatment Incomplete due to progression|0|||
162094555|NCT01075321|585398257|FG003|Overall Study|Treatment Incomplete due to progression|0|||
162094556|NCT01075321|585398254|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
162094557|NCT01075321|585398255|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
162094558|NCT01075321|585398256|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
162094559|NCT01075321|585398257|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
162094560|NCT02646423|585398258|FG000|Overall Study|Adverse Event|5|||
162094561|NCT02646423|585398259|FG001|Overall Study|Adverse Event|7|||
162094562|NCT02646423|585398258|FG000|Overall Study|Ineligible|2|||
162237447|NCT00600886|585921096|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
162237448|NCT00600886|585921097|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
162237449|NCT00600886|585921096|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
162237450|NCT00600886|585921097|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
162237451|NCT00600886|585921096|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
162237452|NCT00600886|585921097|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
162237453|NCT00600886|585921096|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
162237454|NCT00600886|585921097|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
162237455|NCT00600886|585921096|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
162237456|NCT00600886|585921097|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
162237457|NCT00600886|585921096|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
162237458|NCT00600886|585921097|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
162237459|NCT00600886|585921096|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
162237460|NCT00600886|585921097|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
162237461|NCT00600886|585921096|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
162237462|NCT00600886|585921097|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
162237463|NCT00600886|585921096|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
162237464|NCT00600886|585921097|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
162237465|NCT00600886|585921096|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
162237466|NCT00600886|585921097|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
162237467|NCT00600886|585921096|FG000|Extension - Same Treatment (FAS)|Death|1|||
162237468|NCT00600886|585921097|FG001|Extension - Same Treatment (FAS)|Death|1|||
162237469|NCT00600886|585921096|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
162237470|NCT00600886|585921097|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
162237471|NCT00600886|585921096|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
162237472|NCT00600886|585921097|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
162237473|NCT00600886|585921096|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
162237474|NCT00600886|585921097|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
162237475|NCT00600886|585921096|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
162094563|NCT02646423|585398259|FG001|Overall Study|Ineligible|1|||
162094564|NCT00003457|585398260|FG000|Overall Study|Not evaluable|9|||
162094565|NCT01054729|585398264|FG000|Overall Study|Randomized but Not Treated|0|||
162094566|NCT01054729|585398265|FG001|Overall Study|Randomized but Not Treated|1|||
162094567|NCT01054729|585398266|FG002|Overall Study|Randomized but Not Treated|0|||
162094568|NCT01054729|585398267|FG003|Overall Study|Randomized but Not Treated|0|||
162094569|NCT01054729|585398264|FG000|Overall Study|Adverse Event|1|||
162094570|NCT01054729|585398265|FG001|Overall Study|Adverse Event|1|||
162094571|NCT01054729|585398266|FG002|Overall Study|Adverse Event|2|||
162094572|NCT01054729|585398267|FG003|Overall Study|Adverse Event|1|||
162094573|NCT01054729|585398264|FG000|Overall Study|Withdrawal by Subject|1|||
162094574|NCT01054729|585398265|FG001|Overall Study|Withdrawal by Subject|0|||
162094575|NCT01054729|585398266|FG002|Overall Study|Withdrawal by Subject|1|||
162094576|NCT01054729|585398267|FG003|Overall Study|Withdrawal by Subject|0|||
162094577|NCT01054729|585398264|FG000|Overall Study|Lost to Follow-up|0|||
162094578|NCT01054729|585398265|FG001|Overall Study|Lost to Follow-up|1|||
162094579|NCT01054729|585398266|FG002|Overall Study|Lost to Follow-up|0|||
162094580|NCT01054729|585398267|FG003|Overall Study|Lost to Follow-up|0|||
162094581|NCT01054729|585398264|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
162094582|NCT01054729|585398265|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
162094583|NCT01054729|585398266|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
162094584|NCT01054729|585398267|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
162094585|NCT01054729|585398264|FG000|Overall Study|Non-responder|1|||
162094586|NCT01054729|585398265|FG001|Overall Study|Non-responder|0|||
162094587|NCT01054729|585398266|FG002|Overall Study|Non-responder|1|||
162094588|NCT01054729|585398267|FG003|Overall Study|Non-responder|1|||
162094589|NCT01054729|585398264|FG000|Overall Study|PEG/RBV Non-responder|1|||
162094590|NCT01054729|585398265|FG001|Overall Study|PEG/RBV Non-responder|0|||
162094591|NCT01054729|585398266|FG002|Overall Study|PEG/RBV Non-responder|1|||
162094592|NCT01054729|585398267|FG003|Overall Study|PEG/RBV Non-responder|0|||
162094593|NCT01054729|585398264|FG000|Overall Study|Personal/Obligations|0|||
162094594|NCT01054729|585398265|FG001|Overall Study|Personal/Obligations|1|||
162094595|NCT01054729|585398266|FG002|Overall Study|Personal/Obligations|0|||
162094596|NCT01054729|585398267|FG003|Overall Study|Personal/Obligations|0|||
162094597|NCT01054729|585398264|FG000|Overall Study|Subject moved|0|||
162094598|NCT01054729|585398265|FG001|Overall Study|Subject moved|0|||
162094599|NCT01054729|585398266|FG002|Overall Study|Subject moved|1|||
162094600|NCT01054729|585398267|FG003|Overall Study|Subject moved|0|||
162094601|NCT01054729|585398264|FG000|Overall Study|Lack of Efficacy|0|||
162094602|NCT01054729|585398265|FG001|Overall Study|Lack of Efficacy|0|||
162094603|NCT01054729|585398266|FG002|Overall Study|Lack of Efficacy|0|||
162094604|NCT01054729|585398267|FG003|Overall Study|Lack of Efficacy|1|||
162094605|NCT00321919|585398268|FG000|Overall Study|Adverse Event|17|||
162094606|NCT00321919|585398269|FG001|Overall Study|Adverse Event|10|||
162094607|NCT00321919|585398268|FG000|Overall Study|Death|21|||
162094608|NCT00321919|585398269|FG001|Overall Study|Death|17|||
162094609|NCT00321919|585398268|FG000|Overall Study|Insufficient Therapeutic Response|1|||
162094610|NCT00321919|585398269|FG001|Overall Study|Insufficient Therapeutic Response|0|||
162094611|NCT00321919|585398268|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
162094612|NCT00321919|585398269|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
162094613|NCT00321919|585398268|FG000|Overall Study|Refused Treatment|23|||
162094614|NCT00321919|585398269|FG001|Overall Study|Refused Treatment|14|||
162094615|NCT00321919|585398268|FG000|Overall Study|Other Protocol Violation|2|||
162094616|NCT00321919|585398269|FG001|Overall Study|Other Protocol Violation|3|||
162094617|NCT00321919|585398268|FG000|Overall Study|Failure to Return|3|||
162094618|NCT00321919|585398269|FG001|Overall Study|Failure to Return|1|||
162094619|NCT00321919|585398268|FG000|Overall Study|Other withdrawal reason|7|||
162094620|NCT00321919|585398269|FG001|Overall Study|Other withdrawal reason|6|||
162094621|NCT02624804|585398270|FG000|Overall Study|Screen Failure|5|||
162094622|NCT02590354|585398271|FG000|Phase 1|Active hepatitis B or C infection|1|||
162094623|NCT02590354|585398271|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
162094624|NCT02590354|585398271|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
162094625|NCT02590354|585398271|FG000|Phase 1|Subject does not want to participate|20|||
162094626|NCT02590354|585398271|FG000|Phase 1|Lost to Follow-up|1|||
162094627|NCT02590354|585398271|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
162094628|NCT00996996|585398272|FG000|Overall Study|Progressive Disease|10|||
162094629|NCT00996996|585398272|FG000|Overall Study|Non-compliance|8|||
162094630|NCT00996996|585398272|FG000|Overall Study|Lost to Follow-up|9|||
162094631|NCT00996996|585398272|FG000|Overall Study|Death|5|||
162094632|NCT00996996|585398272|FG000|Overall Study|Did Not Receive Study Medications|1|||
162094633|NCT01227889|585398273|FG000|Randomized Phase (RP)|Adverse Event|13|||
162094634|NCT01227889|585398274|FG001|Randomized Phase (RP)|Adverse Event|0|||
162094635|NCT01227889|585398273|FG000|Randomized Phase (RP)|Physician Decision|13|||
162094636|NCT01227889|585398274|FG001|Randomized Phase (RP)|Physician Decision|5|||
162094637|NCT01227889|585398273|FG000|Randomized Phase (RP)|Progressive Disease|135|||
162094638|NCT01227889|585398274|FG001|Randomized Phase (RP)|Progressive Disease|52|||
162094639|NCT01227889|585398273|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
162094640|NCT01227889|585398274|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
162094641|NCT01227889|585398273|FG000|Randomized Phase (RP)|Missing|1|||
162094642|NCT01227889|585398274|FG001|Randomized Phase (RP)|Missing|3|||
162094643|NCT01227889|585398273|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
162094644|NCT01227889|585398274|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
162094645|NCT01227889|585398273|FG000|Crossover Phase|Adverse Event|0|||
162094646|NCT01227889|585398274|FG001|Crossover Phase|Adverse Event|1|||
162094647|NCT01227889|585398273|FG000|Crossover Phase|Physician Decision|0|||
162094648|NCT01227889|585398274|FG001|Crossover Phase|Physician Decision|3|||
162094649|NCT01227889|585398273|FG000|Crossover Phase|Progressive Disease|0|||
162094650|NCT01227889|585398274|FG001|Crossover Phase|Progressive Disease|31|||
162094651|NCT01227889|585398273|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
162094652|NCT01227889|585398274|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
162094653|NCT01227889|585398273|FG000|Crossover Phase|Withdrawal by Subject|0|||
162094654|NCT01227889|585398274|FG001|Crossover Phase|Withdrawal by Subject|1|||
162094655|NCT01148810|585398277|FG000|Overall Study|Adverse Event|0|||
162094656|NCT01148810|585398278|FG001|Overall Study|Adverse Event|2|||
162094657|NCT01148810|585398277|FG000|Overall Study|Lack of Efficacy|0|||
162094658|NCT01148810|585398278|FG001|Overall Study|Lack of Efficacy|1|||
162094659|NCT01148810|585398277|FG000|Overall Study|Withdrawal by Subject|0|||
162094660|NCT01148810|585398278|FG001|Overall Study|Withdrawal by Subject|2|||
162094661|NCT01148810|585398277|FG000|Overall Study|Protocol Violation|1|||
162094662|NCT01148810|585398278|FG001|Overall Study|Protocol Violation|0|||
162094663|NCT02731131|585398285|FG000|Overall Study|Psychiatric Disorder|0|||
162094664|NCT02731131|585398286|FG001|Overall Study|Psychiatric Disorder|1|||
162094665|NCT02731131|585398285|FG000|Overall Study|Refused Therapy|0|||
162094666|NCT02731131|585398286|FG001|Overall Study|Refused Therapy|1|||
162094667|NCT02348216|585398292|FG000|Overall Study|Death|5|||
162094668|NCT02348216|585398293|FG001|Overall Study|Death|53|||
162094669|NCT02348216|585398294|FG002|Overall Study|Death|11|||
162094670|NCT02348216|585398295|FG003|Overall Study|Death|20|||
162094671|NCT02348216|585398296|FG004|Overall Study|Death|16|||
162094672|NCT02348216|585398297|FG005|Overall Study|Death|32|||
162094673|NCT02348216|585398298|FG006|Overall Study|Death|17|||
162094674|NCT02348216|585398292|FG000|Overall Study|Full consent withdrawal|0|||
162094675|NCT02348216|585398293|FG001|Overall Study|Full consent withdrawal|0|||
162094676|NCT02348216|585398294|FG002|Overall Study|Full consent withdrawal|0|||
162094677|NCT02348216|585398295|FG003|Overall Study|Full consent withdrawal|1|||
162094678|NCT02348216|585398296|FG004|Overall Study|Full consent withdrawal|3|||
162094679|NCT02348216|585398297|FG005|Overall Study|Full consent withdrawal|0|||
162094680|NCT02348216|585398298|FG006|Overall Study|Full consent withdrawal|3|||
162094681|NCT02348216|585398292|FG000|Overall Study|Lost to Follow-up|0|||
162094682|NCT02348216|585398293|FG001|Overall Study|Lost to Follow-up|5|||
162094683|NCT02348216|585398294|FG002|Overall Study|Lost to Follow-up|2|||
162094684|NCT02348216|585398295|FG003|Overall Study|Lost to Follow-up|0|||
162094685|NCT02348216|585398296|FG004|Overall Study|Lost to Follow-up|1|||
162094686|NCT02348216|585398297|FG005|Overall Study|Lost to Follow-up|1|||
162094687|NCT02348216|585398298|FG006|Overall Study|Lost to Follow-up|1|||
162094688|NCT02348216|585398292|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
162094689|NCT02348216|585398293|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
162094690|NCT02348216|585398294|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
162094691|NCT02348216|585398295|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
162094692|NCT02348216|585398296|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
162094693|NCT02348216|585398297|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
162094694|NCT02348216|585398298|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
162094695|NCT02348216|585398292|FG000|Overall Study|Reason not specified|2|||
162094696|NCT02348216|585398293|FG001|Overall Study|Reason not specified|19|||
162094697|NCT02348216|585398294|FG002|Overall Study|Reason not specified|11|||
162094698|NCT02348216|585398295|FG003|Overall Study|Reason not specified|17|||
162094699|NCT02348216|585398296|FG004|Overall Study|Reason not specified|21|||
162094700|NCT02348216|585398297|FG005|Overall Study|Reason not specified|17|||
162094701|NCT02348216|585398298|FG006|Overall Study|Reason not specified|19|||
162094702|NCT01055639|585398299|FG000|Overall Study|Adverse Event|0|||
162094703|NCT01055639|585398300|FG001|Overall Study|Adverse Event|1|||
162094704|NCT01055639|585398299|FG000|Overall Study|Lack of Efficacy|0|||
162094705|NCT01055639|585398300|FG001|Overall Study|Lack of Efficacy|1|||
162094706|NCT01055639|585398299|FG000|Overall Study|Lost to Follow-up|8|||
162094707|NCT01055639|585398300|FG001|Overall Study|Lost to Follow-up|11|||
162094708|NCT01055639|585398299|FG000|Overall Study|Protocol Violation|5|||
162094709|NCT01055639|585398300|FG001|Overall Study|Protocol Violation|5|||
162094710|NCT01055639|585398299|FG000|Overall Study|Withdrawal by Subject|8|||
162094711|NCT01055639|585398300|FG001|Overall Study|Withdrawal by Subject|11|||
162094712|NCT01202773|585398302|FG000|Overall Study|Adverse Event|4|||
162094713|NCT01202773|585398303|FG001|Overall Study|Adverse Event|5|||
162094714|NCT01202773|585398304|FG002|Overall Study|Adverse Event|5|||
162094715|NCT01202773|585398302|FG000|Overall Study|Lack of Efficacy|5|||
162094716|NCT01202773|585398303|FG001|Overall Study|Lack of Efficacy|4|||
162094717|NCT01202773|585398304|FG002|Overall Study|Lack of Efficacy|9|||
162094718|NCT01202773|585398302|FG000|Overall Study|Entry Criteria Not Met|2|||
162094719|NCT01202773|585398303|FG001|Overall Study|Entry Criteria Not Met|0|||
162094720|NCT01202773|585398304|FG002|Overall Study|Entry Criteria Not Met|1|||
162094721|NCT01202773|585398302|FG000|Overall Study|Lost to Follow-up|1|||
162094722|NCT01202773|585398303|FG001|Overall Study|Lost to Follow-up|2|||
162094723|NCT01202773|585398304|FG002|Overall Study|Lost to Follow-up|2|||
162094724|NCT01202773|585398302|FG000|Overall Study|Withdrawal by Subject|13|||
162094725|NCT01202773|585398303|FG001|Overall Study|Withdrawal by Subject|6|||
162094726|NCT01202773|585398304|FG002|Overall Study|Withdrawal by Subject|5|||
162094727|NCT01202773|585398302|FG000|Overall Study|Physician Decision|2|||
162094728|NCT01202773|585398303|FG001|Overall Study|Physician Decision|0|||
162094729|NCT01202773|585398304|FG002|Overall Study|Physician Decision|0|||
162094730|NCT01202773|585398302|FG000|Overall Study|Protocol Violation|11|||
162094731|NCT01202773|585398303|FG001|Overall Study|Protocol Violation|6|||
162094732|NCT01202773|585398304|FG002|Overall Study|Protocol Violation|10|||
162094733|NCT01202773|585398302|FG000|Overall Study|Sponsor Decision|19|||
162094734|NCT01202773|585398303|FG001|Overall Study|Sponsor Decision|20|||
162094735|NCT01202773|585398304|FG002|Overall Study|Sponsor Decision|23|||
162094736|NCT03058679|585398305|FG000|Baseline to Week 6|Lost to Follow-up|3|||
162094737|NCT03058679|585398306|FG001|Baseline to Week 6|Lost to Follow-up|2|||
162094738|NCT03058679|585398305|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
162094739|NCT03058679|585398306|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
162094740|NCT03058679|585398305|FG000|Baseline to Week 6|Adverse Event|6|||
162094741|NCT03058679|585398306|FG001|Baseline to Week 6|Adverse Event|6|||
162094742|NCT03058679|585398305|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
162094743|NCT03058679|585398306|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
162094744|NCT03058679|585398305|FG000|Baseline to Week 6|Difficulty following the diet|0|||
162094745|NCT03058679|585398306|FG001|Baseline to Week 6|Difficulty following the diet|2|||
162094746|NCT03058679|585398305|FG000|Baseline to Week 6|Physician Decision|1|||
162094747|NCT03058679|585398306|FG001|Baseline to Week 6|Physician Decision|0|||
162094748|NCT03058679|585398305|FG000|Week 6 to Week 12|Change in medication|5|||
162094749|NCT03058679|585398306|FG001|Week 6 to Week 12|Change in medication|7|||
162094750|NCT03058679|585398305|FG000|Week 6 to Week 12|Adverse Event|4|||
162094751|NCT03058679|585398306|FG001|Week 6 to Week 12|Adverse Event|3|||
162094752|NCT03058679|585398305|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
162094753|NCT03058679|585398306|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
162094754|NCT03058679|585398305|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
162094755|NCT03058679|585398306|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
162094756|NCT04137380|585398311|FG000|Overall Study|Physician Decision|0|||
162094757|NCT04137380|585398312|FG001|Overall Study|Physician Decision|0|||
162094758|NCT04137380|585398313|FG002|Overall Study|Physician Decision|0|||
162094759|NCT04137380|585398314|FG003|Overall Study|Physician Decision|1|||
162094760|NCT04137380|585398315|FG004|Overall Study|Physician Decision|0|||
162094761|NCT04137380|585398316|FG005|Overall Study|Physician Decision|0|||
162094762|NCT04137380|585398317|FG006|Overall Study|Physician Decision|0|||
162094763|NCT00575588|585398323|FG000|Overall Study|Adverse Event|11|||
162094764|NCT00575588|585398324|FG001|Overall Study|Adverse Event|13|||
162094765|NCT00575588|585398323|FG000|Overall Study|Withdrawal by Subject|27|||
162094766|NCT00575588|585398324|FG001|Overall Study|Withdrawal by Subject|31|||
162094767|NCT00575588|585398323|FG000|Overall Study|Lost to Follow-up|1|||
162094768|NCT00575588|585398324|FG001|Overall Study|Lost to Follow-up|3|||
162094769|NCT00575588|585398323|FG000|Overall Study|Death|4|||
162094770|NCT00575588|585398324|FG001|Overall Study|Death|2|||
162094771|NCT00575588|585398323|FG000|Overall Study|Incorrect enrollment|8|||
162094772|NCT00575588|585398324|FG001|Overall Study|Incorrect enrollment|4|||
162094773|NCT00575588|585398323|FG000|Overall Study|Study specific discontinuation criteria|203|||
162094774|NCT00575588|585398324|FG001|Overall Study|Study specific discontinuation criteria|218|||
162094775|NCT00575588|585398323|FG000|Overall Study|Severe non-compliance to protocol|5|||
162094776|NCT00575588|585398324|FG001|Overall Study|Severe non-compliance to protocol|7|||
162094777|NCT00575588|585398323|FG000|Overall Study|Safety reasons|2|||
162094778|NCT00575588|585398324|FG001|Overall Study|Safety reasons|1|||
162094779|NCT00575588|585398323|FG000|Overall Study|Elevated triglyceride|1|||
162094780|NCT00575588|585398324|FG001|Overall Study|Elevated triglyceride|0|||
162094781|NCT00575588|585398323|FG000|Overall Study|Patient moved|1|||
162094782|NCT00575588|585398324|FG001|Overall Study|Patient moved|3|||
162094783|NCT00575588|585398323|FG000|Overall Study|Impossible to determine HbA1c|0|||
162094784|NCT00575588|585398324|FG001|Overall Study|Impossible to determine HbA1c|1|||
162094785|NCT02265705|585398325|FG000|Treatment Period Week 0-24|Adverse Event|3|||
162094786|NCT02265705|585398326|FG001|Treatment Period Week 0-24|Adverse Event|2|||
162094787|NCT02265705|585398327|FG002|Treatment Period Week 0-24|Adverse Event|0|||
162094788|NCT02265705|585398328|FG003|Treatment Period Week 0-24|Adverse Event|0|||
162094789|NCT02265705|585398329|FG004|Treatment Period Week 0-24|Adverse Event|0|||
162094790|NCT02265705|585398330|FG005|Treatment Period Week 0-24|Adverse Event|0|||
162094791|NCT02265705|585398331|FG006|Treatment Period Week 0-24|Adverse Event|0|||
162094792|NCT02265705|585398325|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
162094793|NCT02265705|585398326|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
162094794|NCT02265705|585398327|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
162094795|NCT02265705|585398328|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
162094796|NCT02265705|585398329|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
162094797|NCT02265705|585398330|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
162094798|NCT02265705|585398331|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
162094799|NCT02265705|585398325|FG000|Treatment Period Week 0-24|Physician Decision|1|||
162094800|NCT02265705|585398326|FG001|Treatment Period Week 0-24|Physician Decision|0|||
162094801|NCT02265705|585398327|FG002|Treatment Period Week 0-24|Physician Decision|0|||
162094802|NCT02265705|585398328|FG003|Treatment Period Week 0-24|Physician Decision|0|||
162094803|NCT02265705|585398329|FG004|Treatment Period Week 0-24|Physician Decision|0|||
162094804|NCT02265705|585398330|FG005|Treatment Period Week 0-24|Physician Decision|0|||
162094805|NCT02265705|585398331|FG006|Treatment Period Week 0-24|Physician Decision|0|||
162094806|NCT02265705|585398325|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
162094807|NCT02265705|585398326|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
162094808|NCT02265705|585398327|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
162094809|NCT02265705|585398328|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
162094810|NCT02265705|585398329|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
162094811|NCT02265705|585398330|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
162094812|NCT02265705|585398331|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
162094813|NCT02265705|585398325|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
162094814|NCT02265705|585398326|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
162094815|NCT02265705|585398327|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
162094816|NCT02265705|585398328|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
162094817|NCT02265705|585398329|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
162094818|NCT02265705|585398330|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
162094819|NCT02265705|585398331|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
162094820|NCT02265705|585398325|FG000|Rescue Period|Withdrawal by Subject|0|||
162094821|NCT02265705|585398326|FG001|Rescue Period|Withdrawal by Subject|0|||
162094822|NCT02265705|585398327|FG002|Rescue Period|Withdrawal by Subject|1|||
162094823|NCT02265705|585398328|FG003|Rescue Period|Withdrawal by Subject|0|||
162094824|NCT02265705|585398329|FG004|Rescue Period|Withdrawal by Subject|0|||
162094825|NCT02265705|585398330|FG005|Rescue Period|Withdrawal by Subject|0|||
162094826|NCT02265705|585398331|FG006|Rescue Period|Withdrawal by Subject|0|||
162094827|NCT02265705|585398325|FG000|Rescue Period|Death|0|||
162094828|NCT02265705|585398326|FG001|Rescue Period|Death|0|||
162094829|NCT02265705|585398327|FG002|Rescue Period|Death|1|||
162094830|NCT02265705|585398328|FG003|Rescue Period|Death|0|||
162094831|NCT02265705|585398329|FG004|Rescue Period|Death|0|||
162094832|NCT02265705|585398330|FG005|Rescue Period|Death|0|||
162094833|NCT02265705|585398331|FG006|Rescue Period|Death|0|||
162094834|NCT02265705|585398325|FG000|Rescue Period|Lack of Efficacy|0|||
162094835|NCT02265705|585398326|FG001|Rescue Period|Lack of Efficacy|0|||
162094836|NCT02265705|585398327|FG002|Rescue Period|Lack of Efficacy|1|||
162094837|NCT02265705|585398328|FG003|Rescue Period|Lack of Efficacy|0|||
162094838|NCT02265705|585398329|FG004|Rescue Period|Lack of Efficacy|0|||
162094839|NCT02265705|585398330|FG005|Rescue Period|Lack of Efficacy|0|||
162094840|NCT02265705|585398331|FG006|Rescue Period|Lack of Efficacy|0|||
162094841|NCT02265705|585398325|FG000|Open Label Period|Adverse Event|0|||
162094842|NCT02265705|585398326|FG001|Open Label Period|Adverse Event|0|||
162094843|NCT02265705|585398327|FG002|Open Label Period|Adverse Event|0|||
162094844|NCT02265705|585398328|FG003|Open Label Period|Adverse Event|2|||
162094845|NCT02265705|585398329|FG004|Open Label Period|Adverse Event|2|||
162094846|NCT02265705|585398330|FG005|Open Label Period|Adverse Event|0|||
162094847|NCT02265705|585398331|FG006|Open Label Period|Adverse Event|0|||
162094848|NCT02265705|585398325|FG000|Open Label Period|Physician Decision|0|||
162094849|NCT02265705|585398326|FG001|Open Label Period|Physician Decision|0|||
162094850|NCT02265705|585398327|FG002|Open Label Period|Physician Decision|0|||
162094851|NCT02265705|585398328|FG003|Open Label Period|Physician Decision|0|||
162094852|NCT02265705|585398329|FG004|Open Label Period|Physician Decision|1|||
162094853|NCT02265705|585398330|FG005|Open Label Period|Physician Decision|0|||
162094854|NCT02265705|585398331|FG006|Open Label Period|Physician Decision|0|||
162094855|NCT02265705|585398325|FG000|Open Label Period|Withdrawal by Subject|0|||
162094856|NCT02265705|585398326|FG001|Open Label Period|Withdrawal by Subject|0|||
162094857|NCT02265705|585398327|FG002|Open Label Period|Withdrawal by Subject|0|||
162094858|NCT02265705|585398328|FG003|Open Label Period|Withdrawal by Subject|0|||
162094859|NCT02265705|585398329|FG004|Open Label Period|Withdrawal by Subject|2|||
162094860|NCT02265705|585398330|FG005|Open Label Period|Withdrawal by Subject|0|||
162094861|NCT02265705|585398331|FG006|Open Label Period|Withdrawal by Subject|0|||
162094862|NCT02265705|585398325|FG000|Follow-up Period|Sponsor Decision|0|||
162094863|NCT02265705|585398326|FG001|Follow-up Period|Sponsor Decision|0|||
162094864|NCT02265705|585398327|FG002|Follow-up Period|Sponsor Decision|0|||
162094865|NCT02265705|585398328|FG003|Follow-up Period|Sponsor Decision|0|||
162094866|NCT02265705|585398329|FG004|Follow-up Period|Sponsor Decision|0|||
162094867|NCT02265705|585398330|FG005|Follow-up Period|Sponsor Decision|1|||
162094868|NCT02265705|585398331|FG006|Follow-up Period|Sponsor Decision|6|||
162094869|NCT02265705|585398325|FG000|Follow-up Period|Adverse Event|0|||
162094870|NCT02265705|585398326|FG001|Follow-up Period|Adverse Event|0|||
162094871|NCT02265705|585398327|FG002|Follow-up Period|Adverse Event|0|||
162094872|NCT02265705|585398328|FG003|Follow-up Period|Adverse Event|0|||
162094873|NCT02265705|585398329|FG004|Follow-up Period|Adverse Event|0|||
162094874|NCT02265705|585398330|FG005|Follow-up Period|Adverse Event|0|||
162094875|NCT02265705|585398331|FG006|Follow-up Period|Adverse Event|3|||
162094876|NCT02265705|585398325|FG000|Follow-up Period|Physician Decision|0|||
162094877|NCT02265705|585398326|FG001|Follow-up Period|Physician Decision|0|||
162094878|NCT02265705|585398327|FG002|Follow-up Period|Physician Decision|0|||
162094879|NCT02265705|585398328|FG003|Follow-up Period|Physician Decision|0|||
162094880|NCT02265705|585398329|FG004|Follow-up Period|Physician Decision|0|||
162094881|NCT02265705|585398330|FG005|Follow-up Period|Physician Decision|0|||
162094882|NCT02265705|585398331|FG006|Follow-up Period|Physician Decision|1|||
162094883|NCT02265705|585398325|FG000|Follow-up Period|Withdrawal by Subject|0|||
162094884|NCT02265705|585398326|FG001|Follow-up Period|Withdrawal by Subject|0|||
162094885|NCT02265705|585398327|FG002|Follow-up Period|Withdrawal by Subject|0|||
162094886|NCT02265705|585398328|FG003|Follow-up Period|Withdrawal by Subject|0|||
162094887|NCT02265705|585398329|FG004|Follow-up Period|Withdrawal by Subject|0|||
162094888|NCT02265705|585398330|FG005|Follow-up Period|Withdrawal by Subject|0|||
162094889|NCT02265705|585398331|FG006|Follow-up Period|Withdrawal by Subject|1|||
162094890|NCT02828111|585398336|FG000|Overall Study|Withdrawal by Subject|0|||
162094891|NCT02828111|585398337|FG001|Overall Study|Withdrawal by Subject|0|||
162094892|NCT02828111|585398338|FG002|Overall Study|Withdrawal by Subject|2|||
162094893|NCT02828111|585398339|FG003|Overall Study|Withdrawal by Subject|0|||
162094894|NCT02828111|585398340|FG004|Overall Study|Withdrawal by Subject|0|||
162094895|NCT02828111|585398336|FG000|Overall Study|Lost to Follow-up|0|||
162094896|NCT02828111|585398337|FG001|Overall Study|Lost to Follow-up|0|||
162094897|NCT02828111|585398338|FG002|Overall Study|Lost to Follow-up|0|||
162094898|NCT02828111|585398339|FG003|Overall Study|Lost to Follow-up|1|||
162094899|NCT02828111|585398340|FG004|Overall Study|Lost to Follow-up|1|||
162094900|NCT00614939|585398341|FG000|Overall Study|Withdrawal by Subject|10|||
162094901|NCT00614939|585398342|FG001|Overall Study|Withdrawal by Subject|17|||
162094902|NCT00614939|585398341|FG000|Overall Study|Study specific discontinuation criteris|13|||
162094903|NCT00614939|585398342|FG001|Overall Study|Study specific discontinuation criteris|16|||
162094904|NCT00614939|585398341|FG000|Overall Study|Adverse Event|2|||
162094905|NCT00614939|585398342|FG001|Overall Study|Adverse Event|5|||
162094906|NCT00614939|585398341|FG000|Overall Study|Incorrect enrollment|1|||
162094907|NCT00614939|585398342|FG001|Overall Study|Incorrect enrollment|2|||
162094908|NCT00614939|585398341|FG000|Overall Study|Death|4|||
162094909|NCT00614939|585398342|FG001|Overall Study|Death|3|||
162094910|NCT00614939|585398341|FG000|Overall Study|Poor/non-compliance|4|||
162094911|NCT00614939|585398342|FG001|Overall Study|Poor/non-compliance|0|||
162094912|NCT00614939|585398341|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
162094913|NCT00614939|585398342|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
162094914|NCT02079805|585398346|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
162094915|NCT02079805|585398347|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
162094916|NCT02079805|585398346|FG000|Overall Study|Voluntary Withdrawal|0|||
162094917|NCT02079805|585398347|FG001|Overall Study|Voluntary Withdrawal|1|||
162094918|NCT01753193|585398348|FG000|Overall Study|Withdrawal by Subject|23|||
162094919|NCT01753193|585398348|FG000|Overall Study|Lost to Follow-up|6|||
162094920|NCT01753193|585398348|FG000|Overall Study|Death|1|||
162094921|NCT01753193|585398348|FG000|Overall Study|Other|16|||
162094922|NCT00383435|585398349|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
162094923|NCT00383435|585398350|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
162094924|NCT00383435|585398351|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
162094925|NCT00383435|585398352|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
162094926|NCT00383435|585398353|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
162094927|NCT00383435|585398349|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
162094928|NCT00383435|585398350|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
162094929|NCT00383435|585398351|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
162094930|NCT00383435|585398352|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
162094931|NCT00383435|585398353|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
162094932|NCT00383435|585398349|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
162094933|NCT00383435|585398350|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
162094934|NCT00383435|585398351|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
162094935|NCT00383435|585398352|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
162094936|NCT00383435|585398353|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
162094937|NCT00383435|585398349|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
162094938|NCT00383435|585398350|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
162094939|NCT00383435|585398351|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
162094940|NCT00383435|585398352|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
162094941|NCT00383435|585398353|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
162094942|NCT00383435|585398349|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
162094943|NCT00383435|585398350|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
162094944|NCT00383435|585398351|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
162094945|NCT00383435|585398352|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
162094946|NCT00383435|585398353|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
162094947|NCT00383435|585398349|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
162094948|NCT00383435|585398350|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
162094949|NCT00383435|585398351|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
162094950|NCT00383435|585398352|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
162094951|NCT00383435|585398353|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
162094952|NCT00383435|585398349|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
162094953|NCT00383435|585398350|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
162094954|NCT00383435|585398351|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
162094955|NCT00383435|585398352|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
162094956|NCT00383435|585398353|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
162094957|NCT00383435|585398349|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
162094958|NCT00383435|585398350|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
162094959|NCT00383435|585398351|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
162094960|NCT00383435|585398352|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
162094961|NCT00383435|585398353|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
162094962|NCT00383435|585398349|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
162094963|NCT00383435|585398350|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
162094964|NCT00383435|585398351|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
162094965|NCT00383435|585398352|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
162094966|NCT00383435|585398353|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
162094967|NCT00383435|585398349|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
162094968|NCT00383435|585398350|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
162094969|NCT00383435|585398351|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
162094970|NCT00383435|585398352|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
162094971|NCT00383435|585398353|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
162094972|NCT00383435|585398349|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
162094973|NCT00383435|585398350|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
162094974|NCT00383435|585398351|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
162094975|NCT00383435|585398352|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
162094976|NCT00383435|585398353|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
162094977|NCT00383435|585398349|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
162094978|NCT00383435|585398350|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
162094979|NCT00383435|585398351|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
162094980|NCT00383435|585398352|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
162094981|NCT00383435|585398353|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
162094982|NCT00383435|585398349|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
162094983|NCT00383435|585398350|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
162094984|NCT00383435|585398351|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
162094985|NCT00383435|585398352|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
162094986|NCT00383435|585398353|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
162094987|NCT00383435|585398349|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
162094988|NCT00383435|585398350|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
162094989|NCT00383435|585398351|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
162094990|NCT00383435|585398352|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
162094991|NCT00383435|585398353|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
162094992|NCT00383435|585398349|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
162094993|NCT00383435|585398350|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
162094994|NCT00383435|585398351|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
162094995|NCT00383435|585398352|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
162094996|NCT00383435|585398353|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
162094997|NCT00383435|585398349|FG000|26-Week Treatment Safety Extension|Administrative|1|||
162094998|NCT00383435|585398350|FG001|26-Week Treatment Safety Extension|Administrative|1|||
162094999|NCT00383435|585398351|FG002|26-Week Treatment Safety Extension|Administrative|0|||
162095000|NCT00383435|585398352|FG003|26-Week Treatment Safety Extension|Administrative|1|||
162095001|NCT00383435|585398353|FG004|26-Week Treatment Safety Extension|Administrative|0|||
162095002|NCT00583557|585398354|FG000|Overall Study|Withdrawal by Subject|18|||
162095003|NCT00583557|585398354|FG000|Overall Study|Adverse Event|9|||
162095004|NCT00583557|585398354|FG000|Overall Study|Lack of Efficacy|31|||
162095005|NCT00583557|585398354|FG000|Overall Study|Lack of Compliance|5|||
162095006|NCT00583557|585398354|FG000|Overall Study|Other|5|||
162095007|NCT00583557|585398354|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
162095008|NCT02347761|585398355|FG000|All Collected|Death|1|||
162095009|NCT02347761|585398356|FG001|All Collected|Death|0|||
162095010|NCT02347761|585398357|FG002|All Collected|Death|0|||
162095011|NCT02347761|585398355|FG000|All Collected|Lost to Follow-up|3|||
162095012|NCT02347761|585398356|FG001|All Collected|Lost to Follow-up|2|||
162095013|NCT02347761|585398357|FG002|All Collected|Lost to Follow-up|3|||
162095014|NCT02347761|585398355|FG000|All Collected|Withdrawal by Subject|11|||
162095015|NCT02347761|585398356|FG001|All Collected|Withdrawal by Subject|11|||
162095016|NCT02347761|585398357|FG002|All Collected|Withdrawal by Subject|22|||
162095017|NCT02347761|585398355|FG000|All Collected|invetigator disretion|2|||
162095018|NCT02347761|585398356|FG001|All Collected|invetigator disretion|0|||
162095019|NCT02347761|585398357|FG002|All Collected|invetigator disretion|0|||
162095020|NCT02347761|585398355|FG000|All Collected|instillation site pain|0|||
162095021|NCT02347761|585398356|FG001|All Collected|instillation site pain|0|||
162095022|NCT02347761|585398357|FG002|All Collected|instillation site pain|1|||
162095023|NCT02347761|585398355|FG000|All Collected|exacerbation of COPD|0|||
162095024|NCT02347761|585398356|FG001|All Collected|exacerbation of COPD|0|||
162095025|NCT02347761|585398357|FG002|All Collected|exacerbation of COPD|1|||
162095026|NCT02347761|585398355|FG000|All Collected|moved/travel|0|||
162095027|NCT02347761|585398356|FG001|All Collected|moved/travel|1|||
162095028|NCT02347761|585398357|FG002|All Collected|moved/travel|0|||
162095029|NCT02347761|585398355|FG000|On Study Treatment|Lack of Efficacy|2|||
162095030|NCT02347761|585398356|FG001|On Study Treatment|Lack of Efficacy|3|||
162095031|NCT02347761|585398357|FG002|On Study Treatment|Lack of Efficacy|4|||
162095032|NCT02347761|585398355|FG000|On Study Treatment|non-compliance with study medication|0|||
162095033|NCT02347761|585398356|FG001|On Study Treatment|non-compliance with study medication|0|||
162095034|NCT02347761|585398357|FG002|On Study Treatment|non-compliance with study medication|2|||
162095035|NCT02347761|585398355|FG000|On Study Treatment|Withdrawal by Subject|7|||
162095036|NCT02347761|585398356|FG001|On Study Treatment|Withdrawal by Subject|3|||
162095037|NCT02347761|585398357|FG002|On Study Treatment|Withdrawal by Subject|5|||
162095038|NCT02347761|585398355|FG000|On Study Treatment|move/travel|2|||
162095039|NCT02347761|585398356|FG001|On Study Treatment|move/travel|6|||
162095040|NCT02347761|585398357|FG002|On Study Treatment|move/travel|5|||
162095041|NCT02347761|585398355|FG000|On Study Treatment|dissastisfaction with device|2|||
162095042|NCT02347761|585398356|FG001|On Study Treatment|dissastisfaction with device|1|||
162095043|NCT02347761|585398357|FG002|On Study Treatment|dissastisfaction with device|4|||
162095044|NCT02347761|585398355|FG000|On Study Treatment|Lost to Follow-up|2|||
162095045|NCT02347761|585398356|FG001|On Study Treatment|Lost to Follow-up|1|||
162095046|NCT02347761|585398357|FG002|On Study Treatment|Lost to Follow-up|1|||
162095047|NCT02347761|585398355|FG000|On Study Treatment|investigator discretion|2|||
162095048|NCT02347761|585398356|FG001|On Study Treatment|investigator discretion|0|||
162095049|NCT02347761|585398357|FG002|On Study Treatment|investigator discretion|0|||
162095050|NCT02347761|585398355|FG000|On Study Treatment|durg not working|0|||
162095051|NCT02347761|585398356|FG001|On Study Treatment|durg not working|1|||
162095052|NCT02347761|585398357|FG002|On Study Treatment|durg not working|1|||
162095053|NCT02347761|585398355|FG000|On Study Treatment|Adverse Event|10|||
162095054|NCT02347761|585398356|FG001|On Study Treatment|Adverse Event|8|||
162095055|NCT02347761|585398357|FG002|On Study Treatment|Adverse Event|20|||
162095056|NCT01131312|585398358|FG000|Overall Study|Lost to Follow-up|425|||
162095057|NCT01131312|585398359|FG001|Overall Study|Lost to Follow-up|229|||
162095058|NCT01131312|585398360|FG002|Overall Study|Lost to Follow-up|351|||
162095059|NCT02682264|585398361|FG000|Overall Study|Withdrawal by Subject|56|||
162095060|NCT02682264|585398362|FG001|Overall Study|Withdrawal by Subject|45|||
162095061|NCT02682264|585398361|FG000|Overall Study|Lost to Follow-up|49|||
162095062|NCT02682264|585398362|FG001|Overall Study|Lost to Follow-up|41|||
162095063|NCT02682264|585398361|FG000|Overall Study|Lack of Efficacy|14|||
162095064|NCT02682264|585398362|FG001|Overall Study|Lack of Efficacy|16|||
162095065|NCT02682264|585398361|FG000|Overall Study|Withdrawal by Parent|6|||
162095066|NCT02682264|585398362|FG001|Overall Study|Withdrawal by Parent|7|||
162095067|NCT02682264|585398361|FG000|Overall Study|Adverse Event|9|||
162095068|NCT02682264|585398362|FG001|Overall Study|Adverse Event|0|||
162095069|NCT02682264|585398361|FG000|Overall Study|Noncompliance with study drug|1|||
162095070|NCT02682264|585398362|FG001|Overall Study|Noncompliance with study drug|4|||
162095071|NCT02682264|585398361|FG000|Overall Study|Pregnancy|1|||
162095072|NCT02682264|585398362|FG001|Overall Study|Pregnancy|2|||
162095073|NCT02682264|585398361|FG000|Overall Study|Recovery|1|||
162095074|NCT02682264|585398362|FG001|Overall Study|Recovery|2|||
162095075|NCT02682264|585398361|FG000|Overall Study|Progressive Disease|1|||
162095076|NCT02682264|585398362|FG001|Overall Study|Progressive Disease|0|||
162095077|NCT02682264|585398361|FG000|Overall Study|Technical Problems|0|||
162095078|NCT02682264|585398362|FG001|Overall Study|Technical Problems|1|||
162095079|NCT02682264|585398361|FG000|Overall Study|Moved abroad and unable to continue|0|||
162095080|NCT02682264|585398362|FG001|Overall Study|Moved abroad and unable to continue|3|||
162095081|NCT02682264|585398361|FG000|Overall Study|Stopped test article application|0|||
162095082|NCT02682264|585398362|FG001|Overall Study|Stopped test article application|1|||
162095083|NCT01255358|585398363|FG000|Overall Study|Adverse Event|2|||
162095084|NCT01255358|585398363|FG000|Overall Study|Protocol Violation|2|||
162095085|NCT04079933|585398366|FG000|Overall Study|Withdrawal by Subject|3|||
162095086|NCT04079933|585398367|FG001|Overall Study|Withdrawal by Subject|4|||
162095087|NCT04079933|585398366|FG000|Overall Study|Lost to Follow-up|0|||
162095088|NCT04079933|585398367|FG001|Overall Study|Lost to Follow-up|1|||
162095089|NCT03207750|585398368|FG000|Overall Study|Adverse Event|3|||
162095090|NCT03207750|585398369|FG001|Overall Study|Adverse Event|2|||
162095091|NCT03207750|585398368|FG000|Overall Study|Lost to Follow-up|21|||
162095092|NCT03207750|585398369|FG001|Overall Study|Lost to Follow-up|29|||
162095093|NCT03207750|585398368|FG000|Overall Study|Protocol Violation|0|||
162095094|NCT03207750|585398369|FG001|Overall Study|Protocol Violation|1|||
162095095|NCT03207750|585398368|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
162095096|NCT03207750|585398369|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
162095097|NCT03207750|585398368|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
162095098|NCT03207750|585398369|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
162095099|NCT03207750|585398368|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
162095100|NCT03207750|585398369|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
162095101|NCT03207750|585398368|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
162095102|NCT03207750|585398369|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
162095103|NCT03207750|585398368|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
162095104|NCT03207750|585398369|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
162095105|NCT02493361|585398370|FG000|Overall Study|Withdrawal by Subject|3|||
162095106|NCT02937545|585398374|FG000|Overall Study|Withdrawal by Subject|1|||
162095107|NCT02937545|585398375|FG001|Overall Study|Withdrawal by Subject|2|||
162095108|NCT02937545|585398376|FG002|Overall Study|Withdrawal by Subject|6|||
162095109|NCT02937545|585398377|FG003|Overall Study|Withdrawal by Subject|7|||
162095110|NCT02937545|585398374|FG000|Overall Study|Lost to Follow-up|1|||
162095111|NCT02937545|585398375|FG001|Overall Study|Lost to Follow-up|0|||
162095112|NCT02937545|585398376|FG002|Overall Study|Lost to Follow-up|0|||
162095113|NCT02937545|585398377|FG003|Overall Study|Lost to Follow-up|0|||
162095114|NCT02504294|585398380|FG000|Overall Study|Adverse Event|15|||
162095115|NCT02504294|585398381|FG001|Overall Study|Adverse Event|12|||
162095116|NCT02504294|585398380|FG000|Overall Study|Withdrawal by Subject|7|||
162095117|NCT02504294|585398381|FG001|Overall Study|Withdrawal by Subject|1|||
162095118|NCT02504294|585398380|FG000|Overall Study|Protocol Violation|27|||
162095119|NCT02504294|585398381|FG001|Overall Study|Protocol Violation|26|||
162095120|NCT02504294|585398380|FG000|Overall Study|Physician Decision|1|||
162095121|NCT02504294|585398381|FG001|Overall Study|Physician Decision|2|||
162095122|NCT02504294|585398380|FG000|Overall Study|Lost to Follow-up|6|||
162095123|NCT02504294|585398381|FG001|Overall Study|Lost to Follow-up|7|||
162095124|NCT02252211|585398382|FG000|Overall Study|Adverse Event|0|||
162095125|NCT02252211|585398383|FG001|Overall Study|Adverse Event|1|||
162095126|NCT02252211|585398384|FG002|Overall Study|Adverse Event|0|||
162095127|NCT02252211|585398382|FG000|Overall Study|Progressive disease|3|||
162095128|NCT02252211|585398383|FG001|Overall Study|Progressive disease|2|||
162095129|NCT02252211|585398384|FG002|Overall Study|Progressive disease|0|||
162095130|NCT02252211|585398382|FG000|Overall Study|Withdrawal by Subject|1|||
162095131|NCT02252211|585398383|FG001|Overall Study|Withdrawal by Subject|0|||
162095132|NCT02252211|585398384|FG002|Overall Study|Withdrawal by Subject|0|||
162095133|NCT02252211|585398382|FG000|Overall Study|Serious Adverse Event During Screening|1|||
162095134|NCT02252211|585398383|FG001|Overall Study|Serious Adverse Event During Screening|0|||
162095135|NCT02252211|585398384|FG002|Overall Study|Serious Adverse Event During Screening|1|||
162095136|NCT05799495|585398391|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
162095137|NCT05799495|585398392|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
162095138|NCT05799495|585398393|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
162095139|NCT05799495|585398394|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
162095140|NCT05799495|585398391|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
162095141|NCT05799495|585398392|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
162095142|NCT05799495|585398393|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
162095143|NCT05799495|585398394|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
162095144|NCT05799495|585398391|FG000|Treatment (Up to 5 Days)|Other|0|||
162095145|NCT05799495|585398392|FG001|Treatment (Up to 5 Days)|Other|1|||
162095146|NCT05799495|585398393|FG002|Treatment (Up to 5 Days)|Other|0|||
162095147|NCT05799495|585398394|FG003|Treatment (Up to 5 Days)|Other|0|||
162095148|NCT05799495|585398391|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
162095149|NCT05799495|585398392|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
162095150|NCT05799495|585398393|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
162095151|NCT05799495|585398394|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
162095152|NCT05799495|585398391|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
162095153|NCT05799495|585398392|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
162095154|NCT05799495|585398393|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
162095155|NCT05799495|585398394|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
162095156|NCT05799495|585398391|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
162095157|NCT05799495|585398392|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
162095158|NCT05799495|585398393|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
162095159|NCT05799495|585398394|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
162095160|NCT03694548|585398398|FG000|Part A Survey|Protocol Violation|3|||
162095161|NCT03694548|585398399|FG001|Part A Survey|Protocol Violation|3|||
162095162|NCT03694548|585398400|FG002|Part A Survey|Protocol Violation|0|||
162095163|NCT03694548|585398398|FG000|Part B Yoga Program|Protocol Violation|0|||
162095164|NCT03694548|585398399|FG001|Part B Yoga Program|Protocol Violation|0|||
162095165|NCT03694548|585398400|FG002|Part B Yoga Program|Protocol Violation|3|||
162095166|NCT03694548|585398398|FG000|Part B Yoga Program|Did not attend intervention|0|||
162095167|NCT03694548|585398399|FG001|Part B Yoga Program|Did not attend intervention|0|||
162095168|NCT03694548|585398400|FG002|Part B Yoga Program|Did not attend intervention|8|||
162095169|NCT04177108|585398401|FG000|Overall Study|Withdrawal by Subject|4|||
162095170|NCT04177108|585398402|FG001|Overall Study|Withdrawal by Subject|8|||
162095171|NCT04177108|585398403|FG002|Overall Study|Withdrawal by Subject|9|||
162095172|NCT04177108|585398404|FG003|Overall Study|Withdrawal by Subject|11|||
162095173|NCT04177108|585398405|FG004|Overall Study|Withdrawal by Subject|13|||
162095174|NCT04177108|585398401|FG000|Overall Study|Physician Decision|23|||
162095175|NCT04177108|585398402|FG001|Overall Study|Physician Decision|15|||
162095176|NCT04177108|585398403|FG002|Overall Study|Physician Decision|18|||
162095177|NCT04177108|585398404|FG003|Overall Study|Physician Decision|29|||
162095178|NCT04177108|585398405|FG004|Overall Study|Physician Decision|23|||
162095179|NCT04177108|585398401|FG000|Overall Study|Reason Not Specified|0|||
162095180|NCT04177108|585398402|FG001|Overall Study|Reason Not Specified|1|||
162095181|NCT04177108|585398403|FG002|Overall Study|Reason Not Specified|0|||
162095182|NCT04177108|585398404|FG003|Overall Study|Reason Not Specified|0|||
162095183|NCT04177108|585398405|FG004|Overall Study|Reason Not Specified|2|||
162095184|NCT04177108|585398401|FG000|Overall Study|Lost to Follow-up|0|||
162095185|NCT04177108|585398402|FG001|Overall Study|Lost to Follow-up|0|||
162095186|NCT04177108|585398403|FG002|Overall Study|Lost to Follow-up|1|||
162095187|NCT04177108|585398404|FG003|Overall Study|Lost to Follow-up|1|||
162095188|NCT04177108|585398405|FG004|Overall Study|Lost to Follow-up|1|||
162095189|NCT04177108|585398401|FG000|Overall Study|Death|16|||
162095190|NCT04177108|585398402|FG001|Overall Study|Death|19|||
162095191|NCT04177108|585398403|FG002|Overall Study|Death|13|||
162095192|NCT04177108|585398404|FG003|Overall Study|Death|17|||
162095193|NCT04177108|585398405|FG004|Overall Study|Death|18|||
162095194|NCT00099983|585398406|FG000|Overall Study|Lost to Follow-up|2|||
162095195|NCT00099983|585398407|FG001|Overall Study|Lost to Follow-up|3|||
162095196|NCT00099983|585398406|FG000|Overall Study|Missing Source Documents|14|||
162095197|NCT00099983|585398407|FG001|Overall Study|Missing Source Documents|15|||
162095198|NCT00099983|585398406|FG000|Overall Study|Withdrawal by Subject|3|||
162095199|NCT00099983|585398407|FG001|Overall Study|Withdrawal by Subject|2|||
162095200|NCT00099983|585398406|FG000|Overall Study|Adverse Event|1|||
162095201|NCT00099983|585398407|FG001|Overall Study|Adverse Event|1|||
162095202|NCT00099983|585398406|FG000|Overall Study|Lack of Efficacy|0|||
162095203|NCT00099983|585398407|FG001|Overall Study|Lack of Efficacy|1|||
162095204|NCT00099983|585398406|FG000|Overall Study|Unable to return for appointments|1|||
162095205|NCT00099983|585398407|FG001|Overall Study|Unable to return for appointments|1|||
162095206|NCT00099983|585398406|FG000|Overall Study|Moved|1|||
162095207|NCT00099983|585398407|FG001|Overall Study|Moved|0|||
162095208|NCT00099983|585398406|FG000|Overall Study|Other psychiatric problem|1|||
162095209|NCT00099983|585398407|FG001|Overall Study|Other psychiatric problem|0|||
162095210|NCT00099983|585398406|FG000|Overall Study|Incarcerated|0|||
162095211|NCT00099983|585398407|FG001|Overall Study|Incarcerated|1|||
162095212|NCT00099983|585398406|FG000|Overall Study|Intolerant of burden of visits|0|||
162095213|NCT00099983|585398407|FG001|Overall Study|Intolerant of burden of visits|1|||
162095214|NCT00099983|585398406|FG000|Overall Study|Other issue|1|||
162095215|NCT00099983|585398407|FG001|Overall Study|Other issue|0|||
162095216|NCT02641080|585398408|FG000|Overall Study|Physician Decision|2|||
162095217|NCT02641080|585398409|FG001|Overall Study|Physician Decision|0|||
162095218|NCT02641080|585398408|FG000|Overall Study|Withdrawal by Subject|0|||
162095219|NCT02641080|585398409|FG001|Overall Study|Withdrawal by Subject|1|||
162095220|NCT02641080|585398408|FG000|Overall Study|Rehab Center denied use of pumps|0|||
162095221|NCT02641080|585398409|FG001|Overall Study|Rehab Center denied use of pumps|3|||
162095222|NCT02641080|585398408|FG000|Overall Study|Lost to Follow-up|0|||
162095223|NCT02641080|585398409|FG001|Overall Study|Lost to Follow-up|3|||
162095224|NCT03835533|585398410|FG000|Overall Study|Death|5|||
162095225|NCT03835533|585398411|FG001|Overall Study|Death|10|||
162095226|NCT03835533|585398412|FG002|Overall Study|Death|9|||
162095227|NCT03835533|585398410|FG000|Overall Study|Withdrawal by Subject|2|||
162095228|NCT03835533|585398411|FG001|Overall Study|Withdrawal by Subject|2|||
162095229|NCT03835533|585398412|FG002|Overall Study|Withdrawal by Subject|2|||
162095230|NCT03835533|585398410|FG000|Overall Study|Lost to Follow-up|1|||
162095231|NCT03835533|585398411|FG001|Overall Study|Lost to Follow-up|0|||
162095232|NCT03835533|585398412|FG002|Overall Study|Lost to Follow-up|0|||
162095233|NCT01866709|585398413|FG000|Overall Study|Adverse Event|1|||
162095234|NCT01866709|585398414|FG001|Overall Study|Adverse Event|0|||
162095235|NCT02207829|585398415|FG000|Overall Study|Adverse Event|10|||
162095236|NCT02207829|585398416|FG001|Overall Study|Adverse Event|9|||
162095237|NCT02207829|585398415|FG000|Overall Study|Lack of Efficacy|7|||
162095238|NCT02207829|585398416|FG001|Overall Study|Lack of Efficacy|5|||
162095239|NCT02207829|585398415|FG000|Overall Study|Lost to Follow-up|2|||
162095240|NCT02207829|585398416|FG001|Overall Study|Lost to Follow-up|2|||
162095241|NCT02207829|585398415|FG000|Overall Study|Protocol deviation|5|||
162095242|NCT02207829|585398416|FG001|Overall Study|Protocol deviation|4|||
162095243|NCT02207829|585398415|FG000|Overall Study|Withdrew consent|18|||
162095244|NCT02207829|585398416|FG001|Overall Study|Withdrew consent|14|||
162095245|NCT03285477|585398418|FG000|Treatment and Response Assessment Period|Death|1|||
162095246|NCT03285477|585398419|FG001|Treatment and Response Assessment Period|Death|0|||
162095247|NCT03285477|585398418|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
162095248|NCT03285477|585398419|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
162095249|NCT03285477|585398418|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
162095250|NCT03285477|585398419|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
162095251|NCT03285477|585398418|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
162095252|NCT03285477|585398419|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
162095253|NCT03285477|585398418|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
162095254|NCT03285477|585398419|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
162095255|NCT00560833|585398432|FG000|Overall Study|Adverse Event|16|||
162095256|NCT00560833|585398433|FG001|Overall Study|Adverse Event|10|||
162095257|NCT00560833|585398434|FG002|Overall Study|Adverse Event|25|||
162095258|NCT00560833|585398435|FG003|Overall Study|Adverse Event|23|||
162095259|NCT00560833|585398436|FG004|Overall Study|Adverse Event|35|||
162095260|NCT00560833|585398432|FG000|Overall Study|Lost to Follow-up|0|||
162095261|NCT00560833|585398433|FG001|Overall Study|Lost to Follow-up|0|||
162095262|NCT00560833|585398434|FG002|Overall Study|Lost to Follow-up|1|||
162095263|NCT00560833|585398435|FG003|Overall Study|Lost to Follow-up|0|||
162095264|NCT00560833|585398436|FG004|Overall Study|Lost to Follow-up|0|||
162095265|NCT00560833|585398432|FG000|Overall Study|Lack of Efficacy|22|||
162095266|NCT00560833|585398433|FG001|Overall Study|Lack of Efficacy|9|||
162095267|NCT00560833|585398434|FG002|Overall Study|Lack of Efficacy|6|||
162095268|NCT00560833|585398435|FG003|Overall Study|Lack of Efficacy|4|||
162095269|NCT00560833|585398436|FG004|Overall Study|Lack of Efficacy|4|||
162095270|NCT00560833|585398432|FG000|Overall Study|Participant uncooperative|5|||
162095271|NCT00560833|585398433|FG001|Overall Study|Participant uncooperative|5|||
162095272|NCT00560833|585398434|FG002|Overall Study|Participant uncooperative|4|||
162095273|NCT00560833|585398435|FG003|Overall Study|Participant uncooperative|4|||
162095274|NCT00560833|585398436|FG004|Overall Study|Participant uncooperative|2|||
162095275|NCT00560833|585398432|FG000|Overall Study|Other|1|||
162095276|NCT00560833|585398433|FG001|Overall Study|Other|1|||
162095277|NCT00560833|585398434|FG002|Overall Study|Other|3|||
162095278|NCT00560833|585398435|FG003|Overall Study|Other|0|||
162095279|NCT00560833|585398436|FG004|Overall Study|Other|0|||
162095280|NCT00560833|585398432|FG000|Overall Study|Never received drug|0|||
162095281|NCT00560833|585398433|FG001|Overall Study|Never received drug|1|||
162095282|NCT00560833|585398434|FG002|Overall Study|Never received drug|0|||
162095283|NCT00560833|585398435|FG003|Overall Study|Never received drug|0|||
162095284|NCT00560833|585398436|FG004|Overall Study|Never received drug|1|||
162095285|NCT03283670|585398437|FG000|Placebo Gas|Withdrawal by Subject|2|||
162095286|NCT03283670|585398437|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
162095287|NCT03283670|585398437|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
162095288|NCT01307501|585398440|FG000|Overall Study|Treatment Failure|1|||
162095289|NCT01307501|585398440|FG000|Overall Study|Death|20|||
162095290|NCT01307501|585398440|FG000|Overall Study|Lost to Follow-up|1|||
162095291|NCT01307501|585398440|FG000|Overall Study|Starting Hospice|1|||
162095292|NCT01209624|585398444|FG000|Overall Study|Death|2|||
162095293|NCT01209624|585398444|FG000|Overall Study|Adverse Event|13|||
162095294|NCT01209624|585398444|FG000|Overall Study|Lack of Efficacy|17|||
162095295|NCT01209624|585398444|FG000|Overall Study|Lost to Follow-up|290|||
162095296|NCT01209624|585398444|FG000|Overall Study|Other|4|||
162095297|NCT03564496|585398445|FG000|Overall Study|Withdrawal by Subject|1|||
162095298|NCT03564496|585398446|FG001|Overall Study|Withdrawal by Subject|1|||
162095299|NCT03564496|585398447|FG002|Overall Study|Withdrawal by Subject|0|||
162095300|NCT03564496|585398445|FG000|Overall Study|Screen failure|0|||
162095301|NCT03564496|585398446|FG001|Overall Study|Screen failure|3|||
162095302|NCT03564496|585398447|FG002|Overall Study|Screen failure|0|||
162095303|NCT00428610|585398448|FG000|Overall Study|Death Due to Adverse Event|3|||
162095304|NCT00428610|585398449|FG001|Overall Study|Death Due to Adverse Event|0|||
162095305|NCT00428610|585398450|FG002|Overall Study|Death Due to Adverse Event|5|||
162095306|NCT00428610|585398448|FG000|Overall Study|Death Due to Progressive Disease|0|||
162095307|NCT00428610|585398449|FG001|Overall Study|Death Due to Progressive Disease|0|||
162095308|NCT00428610|585398450|FG002|Overall Study|Death Due to Progressive Disease|2|||
162095309|NCT00428610|585398448|FG000|Overall Study|Adverse Event|2|||
162095310|NCT00428610|585398449|FG001|Overall Study|Adverse Event|3|||
162095311|NCT00428610|585398450|FG002|Overall Study|Adverse Event|2|||
162095312|NCT00428610|585398448|FG000|Overall Study|Investigator Decision|2|||
162095313|NCT00428610|585398449|FG001|Overall Study|Investigator Decision|1|||
162095314|NCT00428610|585398450|FG002|Overall Study|Investigator Decision|1|||
162095315|NCT00428610|585398448|FG000|Overall Study|Progressive Disease|42|||
162095316|NCT00428610|585398449|FG001|Overall Study|Progressive Disease|14|||
162095317|NCT00428610|585398450|FG002|Overall Study|Progressive Disease|22|||
162095318|NCT00428610|585398448|FG000|Overall Study|Withdrawal by Subject|4|||
162095319|NCT00428610|585398449|FG001|Overall Study|Withdrawal by Subject|0|||
162095320|NCT00428610|585398450|FG002|Overall Study|Withdrawal by Subject|0|||
162122721|NCT03915951|585500310|FG001|Overall Study|Disease progression (clinical)|1|||
162122722|NCT03915951|585500309|FG000|Overall Study|Patient decision|0|||
162122723|NCT03915951|585500310|FG001|Overall Study|Patient decision|4|||
162122724|NCT03915951|585500309|FG000|Overall Study|Investigator decision|0|||
162122725|NCT03915951|585500310|FG001|Overall Study|Investigator decision|1|||
162122726|NCT03915951|585500309|FG000|Overall Study|Consent withdrawn|1|||
162122727|NCT03915951|585500310|FG001|Overall Study|Consent withdrawn|1|||
162122728|NCT03915951|585500309|FG000|Overall Study|Death|0|||
162122729|NCT03915951|585500310|FG001|Overall Study|Death|3|||
162122730|NCT05408468|585500311|FG000|Overall Study|Lost to Follow-up|3|||
162122731|NCT05408468|585500312|FG001|Overall Study|Lost to Follow-up|1|||
162122732|NCT05408468|585500311|FG000|Overall Study|Physician Decision|1|||
162122733|NCT05408468|585500312|FG001|Overall Study|Physician Decision|0|||
162122734|NCT05408468|585500311|FG000|Overall Study|Overwhelmed by clinical situation|3|||
162122735|NCT05408468|585500312|FG001|Overall Study|Overwhelmed by clinical situation|0|||
162122736|NCT05408468|585500311|FG000|Overall Study|Personal illness precluding participation|1|||
162122737|NCT05408468|585500312|FG001|Overall Study|Personal illness precluding participation|0|||
162122738|NCT05408468|585500311|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
162122739|NCT05408468|585500312|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
162122740|NCT02204579|585500317|FG000|Overall Study|Screen failures|2|||
162122741|NCT01396395|585500318|FG000|Overall Study|Withdrawal by Subject|10|||
162122742|NCT01396395|585500319|FG001|Overall Study|Withdrawal by Subject|12|||
162122743|NCT01396395|585500318|FG000|Overall Study|Protocol Violation|3|||
162122744|NCT01396395|585500319|FG001|Overall Study|Protocol Violation|1|||
162122745|NCT01396395|585500318|FG000|Overall Study|Adverse Event|10|||
162122746|NCT01396395|585500319|FG001|Overall Study|Adverse Event|2|||
162122747|NCT01396395|585500318|FG000|Overall Study|Lost to Follow-up|17|||
162122748|NCT01396395|585500319|FG001|Overall Study|Lost to Follow-up|11|||
162122749|NCT01396395|585500318|FG000|Overall Study|Other|0|||
162122750|NCT01396395|585500319|FG001|Overall Study|Other|1|||
162122751|NCT02120664|585500320|FG000|Overall Study|Withdrawal by Subject|0|||
162122752|NCT02120664|585500321|FG001|Overall Study|Withdrawal by Subject|0|||
162122753|NCT02120664|585500322|FG002|Overall Study|Withdrawal by Subject|0|||
162122754|NCT02120664|585500323|FG003|Overall Study|Withdrawal by Subject|1|||
162122755|NCT02120664|585500324|FG004|Overall Study|Withdrawal by Subject|0|||
162122756|NCT02460263|585500325|FG000|Transition Period|Withdrawal by Subject|1|||
162122757|NCT02460263|585500325|FG000|Transition Period|Death|1|||
162122758|NCT03916744|585500326|FG000|Overall Study|Withdrawal by Subject|0|||
162122759|NCT03916744|585500327|FG001|Overall Study|Withdrawal by Subject|1|||
162122760|NCT03916744|585500328|FG002|Overall Study|Withdrawal by Subject|2|||
162122761|NCT03176238|585500331|FG000|Overall Study|Unacceptable AEs|15|||
162122762|NCT03176238|585500332|FG001|Overall Study|Unacceptable AEs|8|||
162122763|NCT03176238|585500331|FG000|Overall Study|Abnormal lab value(s)|2|||
162122764|NCT03176238|585500332|FG001|Overall Study|Abnormal lab value(s)|0|||
162122765|NCT03176238|585500331|FG000|Overall Study|Inter-current illness|0|||
162122766|NCT03176238|585500332|FG001|Overall Study|Inter-current illness|1|||
162122767|NCT03176238|585500331|FG000|Overall Study|Consent withdrawal|14|||
162122768|NCT03176238|585500332|FG001|Overall Study|Consent withdrawal|2|||
162122769|NCT03176238|585500331|FG000|Overall Study|Lost to Follow-up|3|||
162122770|NCT03176238|585500332|FG001|Overall Study|Lost to Follow-up|0|||
162122771|NCT03176238|585500331|FG000|Overall Study|Administrative problems|1|||
162122772|NCT03176238|585500332|FG001|Overall Study|Administrative problems|0|||
162122773|NCT03176238|585500331|FG000|Overall Study|Death|3|||
162122774|NCT03176238|585500332|FG001|Overall Study|Death|0|||
162122775|NCT03176238|585500331|FG000|Overall Study|Disease Progression|133|||
162122776|NCT03176238|585500332|FG001|Overall Study|Disease Progression|22|||
162122777|NCT03176238|585500331|FG000|Overall Study|Tx duration completed per EAP|0|||
162122778|NCT03176238|585500332|FG001|Overall Study|Tx duration completed per EAP|1|||
162122779|NCT03176238|585500331|FG000|Overall Study|Patient is switched to commercial drug|16|||
162122780|NCT03176238|585500332|FG001|Overall Study|Patient is switched to commercial drug|1|||
162122781|NCT03176238|585500331|FG000|Overall Study|Protocol Violation|1|||
162122782|NCT03176238|585500332|FG001|Overall Study|Protocol Violation|0|||
162122783|NCT03176238|585500331|FG000|Overall Study|Changes in the patient's condition|2|||
162122784|NCT03176238|585500332|FG001|Overall Study|Changes in the patient's condition|1|||
162122785|NCT03176238|585500331|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
162122786|NCT03176238|585500332|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
162095321|NCT00136955|585400429|FG000|Overall Study|Adverse Event|8|||
162095322|NCT00136955|585400429|FG000|Overall Study|Lost to Follow-up|1|||
162095323|NCT00136955|585400429|FG000|Overall Study|Withdrawal by Subject|2|||
162095324|NCT00136955|585400429|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
162095325|NCT01773226|585400430|FG000|Overall Study|Withdrawal by Subject|1|||
162095326|NCT00724282|585400433|FG000|Overall Study|Withdrawal by Subject|3|||
162095327|NCT00724282|585400433|FG000|Overall Study|Physician Decision|1|||
162095328|NCT00970502|585400434|FG000|Overall Study|Withdrawal by Subject|1|||
162095329|NCT01438411|585400435|FG000|Overall Study|Adverse Event|8|||
162095330|NCT01438411|585400435|FG000|Overall Study|Lost to Follow-up|1|||
162095331|NCT01438411|585400435|FG000|Overall Study|Lack of Efficacy|1|||
162095332|NCT01438411|585400435|FG000|Overall Study|Withdrawal by Subject|3|||
162095333|NCT01863680|585400436|FG000|Overall Study|Adverse Event|17|||
162095334|NCT01863680|585400436|FG000|Overall Study|Risk of OHSS|17|||
162095335|NCT01863680|585400436|FG000|Overall Study|Spontaneous pregnancy|2|||
162095336|NCT01863680|585400436|FG000|Overall Study|Withdrawal by Subject|1|||
162095337|NCT01863680|585400436|FG000|Overall Study|Did not undergo IVF/ET|14|||
162095338|NCT01863680|585400436|FG000|Overall Study|Other|6|||
162095339|NCT00618514|585400437|FG000|Overall Study|Lost to Follow-up|11|||
162095340|NCT00618514|585400438|FG001|Overall Study|Lost to Follow-up|12|||
162095341|NCT00618514|585400439|FG002|Overall Study|Lost to Follow-up|4|||
162095342|NCT00566228|585400446|FG000|Overall Study|Withdrawal by Subject|1|||
162095343|NCT00566228|585400447|FG001|Overall Study|Withdrawal by Subject|0|||
162095344|NCT00566228|585400446|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
162095345|NCT00566228|585400447|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
162095346|NCT00566228|585400446|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
162095347|NCT00566228|585400447|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
162095348|NCT00566228|585400446|FG000|Overall Study|progressed before infusion could occur|0|||
162095349|NCT00566228|585400447|FG001|Overall Study|progressed before infusion could occur|1|||
162095350|NCT03320070|585400450|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
162095351|NCT03320070|585400451|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
162095352|NCT03320070|585400450|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
162095353|NCT03320070|585400451|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
162095354|NCT03320070|585400450|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
162095355|NCT03320070|585400451|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
162095356|NCT03320070|585400450|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
162095357|NCT03320070|585400451|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
162095358|NCT03320070|585400450|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
162095359|NCT03320070|585400451|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
162095360|NCT03320070|585400450|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
162095361|NCT03320070|585400451|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
162095362|NCT03586648|585400452|FG000|Period 1|Withdrawal by Subject|0|||
162095363|NCT03586648|585400453|FG001|Period 1|Withdrawal by Subject|1|||
162095364|NCT03586648|585400452|FG000|Period 1|Lost to Follow-up|1|||
162095365|NCT03586648|585400453|FG001|Period 1|Lost to Follow-up|1|||
162095366|NCT03586648|585400452|FG000|Period 1|Adverse Event|1|||
162095367|NCT03586648|585400453|FG001|Period 1|Adverse Event|0|||
162095368|NCT03586648|585400452|FG000|Period 1|Study related symptoms or complaints|2|||
162095369|NCT03586648|585400453|FG001|Period 1|Study related symptoms or complaints|1|||
162095370|NCT03586648|585400452|FG000|Period 1|Physician Decision|0|||
162095371|NCT03586648|585400453|FG001|Period 1|Physician Decision|1|||
162095372|NCT03586648|585400452|FG000|Period 2|Adverse Event|1|||
162095373|NCT03586648|585400453|FG001|Period 2|Adverse Event|0|||
162095374|NCT02041195|585400454|FG000|Overall Study|Adverse Event|1|||
162095375|NCT02041195|585400455|FG001|Overall Study|Adverse Event|2|||
162095376|NCT02041195|585400456|FG002|Overall Study|Adverse Event|0|||
162095377|NCT02041195|585400457|FG003|Overall Study|Adverse Event|0|||
162095378|NCT02041195|585400458|FG004|Overall Study|Adverse Event|0|||
162095379|NCT02041195|585400459|FG005|Overall Study|Adverse Event|0|||
162095380|NCT02041195|585400460|FG006|Overall Study|Adverse Event|3|||
162095381|NCT02041195|585400461|FG007|Overall Study|Adverse Event|0|||
162095382|NCT02041195|585400454|FG000|Overall Study|Withdrawal by Subject|1|||
162095383|NCT02041195|585400455|FG001|Overall Study|Withdrawal by Subject|0|||
162095384|NCT02041195|585400456|FG002|Overall Study|Withdrawal by Subject|0|||
162095385|NCT02041195|585400457|FG003|Overall Study|Withdrawal by Subject|0|||
162095386|NCT02041195|585400458|FG004|Overall Study|Withdrawal by Subject|0|||
162095387|NCT02041195|585400459|FG005|Overall Study|Withdrawal by Subject|0|||
162095388|NCT02041195|585400460|FG006|Overall Study|Withdrawal by Subject|4|||
162095389|NCT02041195|585400461|FG007|Overall Study|Withdrawal by Subject|3|||
162095390|NCT02041195|585400454|FG000|Overall Study|Unable to comply with study visits|0|||
162095391|NCT02041195|585400455|FG001|Overall Study|Unable to comply with study visits|1|||
162095392|NCT02041195|585400456|FG002|Overall Study|Unable to comply with study visits|0|||
162095393|NCT02041195|585400457|FG003|Overall Study|Unable to comply with study visits|0|||
162095394|NCT02041195|585400458|FG004|Overall Study|Unable to comply with study visits|1|||
162095395|NCT02041195|585400459|FG005|Overall Study|Unable to comply with study visits|0|||
162095396|NCT02041195|585400460|FG006|Overall Study|Unable to comply with study visits|0|||
162095397|NCT02041195|585400461|FG007|Overall Study|Unable to comply with study visits|0|||
162095398|NCT02367911|585400464|FG000|Overall Study|Withdrawal by Subject|3|||
162095399|NCT02367911|585400465|FG001|Overall Study|Withdrawal by Subject|2|||
162095400|NCT02367911|585400464|FG000|Overall Study|Lost to Follow-up|2|||
162095401|NCT02367911|585400465|FG001|Overall Study|Lost to Follow-up|2|||
162095402|NCT00263666|585400466|FG000|Overall Study|Adverse Event|6|||
162095403|NCT00263666|585400467|FG001|Overall Study|Adverse Event|8|||
162095404|NCT00263666|585400466|FG000|Overall Study|Lost to Follow-up|1|||
162095405|NCT00263666|585400467|FG001|Overall Study|Lost to Follow-up|2|||
162095406|NCT00263666|585400466|FG000|Overall Study|Withdrawal by Subject|0|||
162095407|NCT00263666|585400467|FG001|Overall Study|Withdrawal by Subject|1|||
162095408|NCT00896168|585400468|FG000|Overall Study|Adverse Event|4|||
162095409|NCT00896168|585400469|FG001|Overall Study|Adverse Event|7|||
162095410|NCT00896168|585400468|FG000|Overall Study|Treatment failure|8|||
162095411|NCT00896168|585400469|FG001|Overall Study|Treatment failure|10|||
162095412|NCT00896168|585400468|FG000|Overall Study|Lost to Follow-up|1|||
162095413|NCT00896168|585400469|FG001|Overall Study|Lost to Follow-up|1|||
162095414|NCT00896168|585400468|FG000|Overall Study|Other|1|||
162095415|NCT00896168|585400469|FG001|Overall Study|Other|1|||
162095416|NCT00902304|585400470|FG000|Overall Study|Adverse Event|4|||
162095417|NCT00902304|585400471|FG001|Overall Study|Adverse Event|10|||
162095418|NCT00902304|585400472|FG002|Overall Study|Adverse Event|25|||
162095419|NCT00902304|585400470|FG000|Overall Study|Investigator discretion|3|||
162095420|NCT00902304|585400471|FG001|Overall Study|Investigator discretion|5|||
162095421|NCT00902304|585400472|FG002|Overall Study|Investigator discretion|13|||
162095422|NCT00902304|585400470|FG000|Overall Study|Lost to Follow-up|7|||
162095423|NCT00902304|585400471|FG001|Overall Study|Lost to Follow-up|7|||
162095424|NCT00902304|585400472|FG002|Overall Study|Lost to Follow-up|7|||
162095425|NCT00902304|585400470|FG000|Overall Study|Protocol Violation|9|||
162095426|NCT00902304|585400471|FG001|Overall Study|Protocol Violation|18|||
162095427|NCT00902304|585400472|FG002|Overall Study|Protocol Violation|20|||
162095428|NCT00902304|585400470|FG000|Overall Study|Withdrawal by Subject|32|||
162095429|NCT00902304|585400471|FG001|Overall Study|Withdrawal by Subject|22|||
162095430|NCT00902304|585400472|FG002|Overall Study|Withdrawal by Subject|43|||
162095431|NCT00902304|585400470|FG000|Overall Study|includes pregnancy|3|||
162095432|NCT00902304|585400471|FG001|Overall Study|includes pregnancy|9|||
162095433|NCT00902304|585400472|FG002|Overall Study|includes pregnancy|2|||
162095434|NCT02492100|585400473|FG000|Overall Study|Death|1|||
162095435|NCT03832010|585400474|FG000|Overall Study|Withdrawal by Subject|2|||
162095436|NCT03832010|585400475|FG001|Overall Study|Withdrawal by Subject|1|||
162095437|NCT03832010|585400476|FG002|Overall Study|Withdrawal by Subject|0|||
162095438|NCT03832010|585400474|FG000|Overall Study|Lost to Follow-up|2|||
162095439|NCT03832010|585400475|FG001|Overall Study|Lost to Follow-up|1|||
162095440|NCT03832010|585400476|FG002|Overall Study|Lost to Follow-up|1|||
162095441|NCT04969783|585400477|FG000|Overall Study|Lost to Follow-up|2|||
162095442|NCT04969783|585400478|FG001|Overall Study|Lost to Follow-up|0|||
162095443|NCT04969783|585400477|FG000|Overall Study|Withdrawal by Subject|4|||
162095444|NCT04969783|585400478|FG001|Overall Study|Withdrawal by Subject|0|||
162095445|NCT04969783|585400477|FG000|Overall Study|Physician Decision|6|||
162095446|NCT04969783|585400478|FG001|Overall Study|Physician Decision|0|||
162095447|NCT02489500|585400479|FG000|Overall Study|Death|1|||
162095448|NCT02489500|585400480|FG001|Overall Study|Death|1|||
162095449|NCT00987467|585400485|FG000|Overall Study|Lost to Follow-up|2|||
162095450|NCT00512135|585400486|FG000|Overall Study|Not Treated|5|||
162095451|NCT00512135|585400486|FG000|Overall Study|Lack of Efficacy|2|||
162095452|NCT00512135|585400486|FG000|Overall Study|Adverse Event|6|||
162095453|NCT00512135|585400486|FG000|Overall Study|Withdrawal by Subject|22|||
162095454|NCT00512135|585400486|FG000|Overall Study|Lost to Follow-up|27|||
162095455|NCT00512135|585400486|FG000|Overall Study|Other|22|||
162095456|NCT00262834|585400487|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
162095457|NCT00262834|585400488|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
162095458|NCT03422250|585400489|FG000|Intervention|Adverse Event|0|||
162095459|NCT03422250|585400490|FG001|Intervention|Adverse Event|1|||
162095460|NCT03422250|585400491|FG002|Intervention|Adverse Event|0|||
162095461|NCT03422250|585400492|FG003|Intervention|Adverse Event|1|||
162095462|NCT03422250|585400489|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
162095463|NCT03422250|585400490|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
162095464|NCT03422250|585400491|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
162095465|NCT03422250|585400492|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
162095466|NCT03422250|585400489|FG000|Follow-up|Withdrawal by Subject|0|||
162095467|NCT03422250|585400490|FG001|Follow-up|Withdrawal by Subject|0|||
162095468|NCT03422250|585400491|FG002|Follow-up|Withdrawal by Subject|0|||
162095469|NCT03422250|585400492|FG003|Follow-up|Withdrawal by Subject|1|||
162095470|NCT03422250|585400489|FG000|Follow-up|Adverse Event|0|||
162095471|NCT03422250|585400490|FG001|Follow-up|Adverse Event|0|||
162095472|NCT03422250|585400491|FG002|Follow-up|Adverse Event|0|||
162095473|NCT03422250|585400492|FG003|Follow-up|Adverse Event|1|||
162095474|NCT00377819|585400495|FG000|Overall Study|Adverse Event|2|||
162095475|NCT00377819|585400496|FG001|Overall Study|Adverse Event|3|||
162095476|NCT00377819|585400495|FG000|Overall Study|Withdrawal by Subject|10|||
162095477|NCT00377819|585400496|FG001|Overall Study|Withdrawal by Subject|4|||
162095478|NCT00377819|585400495|FG000|Overall Study|Death|0|||
162095479|NCT00377819|585400496|FG001|Overall Study|Death|1|||
162095480|NCT00377819|585400495|FG000|Overall Study|Lost to Follow-up|0|||
162095481|NCT00377819|585400496|FG001|Overall Study|Lost to Follow-up|1|||
162095482|NCT00377819|585400495|FG000|Overall Study|Protocol Violation|1|||
162095483|NCT00377819|585400496|FG001|Overall Study|Protocol Violation|1|||
162095484|NCT02416791|585400497|FG000|6 Months|Lost to Follow-up|0|||
162095485|NCT02416791|585400498|FG001|6 Months|Lost to Follow-up|0|||
162095486|NCT02416791|585400499|FG002|6 Months|Lost to Follow-up|1|||
162095487|NCT01054820|585400500|FG000|Overall Study|Withdrawal by Subject|2|||
162095488|NCT00467870|585400507|FG000|Overall Study|Adverse Event|13|||
162095489|NCT00467870|585400508|FG001|Overall Study|Adverse Event|9|||
162095490|NCT00467870|585400509|FG002|Overall Study|Adverse Event|1|||
162095491|NCT00467870|585400510|FG003|Overall Study|Adverse Event|15|||
162095492|NCT00467870|585400511|FG004|Overall Study|Adverse Event|15|||
162095493|NCT00467870|585400512|FG005|Overall Study|Adverse Event|1|||
162095494|NCT00467870|585400507|FG000|Overall Study|Protocol Violation|2|||
162095495|NCT00467870|585400508|FG001|Overall Study|Protocol Violation|1|||
162095496|NCT00467870|585400509|FG002|Overall Study|Protocol Violation|1|||
162095497|NCT00467870|585400510|FG003|Overall Study|Protocol Violation|2|||
162095498|NCT00467870|585400511|FG004|Overall Study|Protocol Violation|0|||
162095499|NCT00467870|585400512|FG005|Overall Study|Protocol Violation|0|||
162095500|NCT00467870|585400507|FG000|Overall Study|Withdrawal by Subject|14|||
162095501|NCT00467870|585400508|FG001|Overall Study|Withdrawal by Subject|21|||
162095502|NCT00467870|585400509|FG002|Overall Study|Withdrawal by Subject|0|||
162095503|NCT00467870|585400510|FG003|Overall Study|Withdrawal by Subject|9|||
162095504|NCT00467870|585400511|FG004|Overall Study|Withdrawal by Subject|10|||
162095505|NCT00467870|585400512|FG005|Overall Study|Withdrawal by Subject|1|||
162095506|NCT00467870|585400507|FG000|Overall Study|Lost to Follow-up|5|||
162095507|NCT00467870|585400508|FG001|Overall Study|Lost to Follow-up|3|||
162095508|NCT00467870|585400509|FG002|Overall Study|Lost to Follow-up|1|||
162095509|NCT00467870|585400510|FG003|Overall Study|Lost to Follow-up|1|||
162095510|NCT00467870|585400511|FG004|Overall Study|Lost to Follow-up|3|||
162095511|NCT00467870|585400512|FG005|Overall Study|Lost to Follow-up|0|||
162095512|NCT00467870|585400507|FG000|Overall Study|Subject Non-compliance|3|||
162095513|NCT00467870|585400508|FG001|Overall Study|Subject Non-compliance|4|||
162095514|NCT00467870|585400509|FG002|Overall Study|Subject Non-compliance|0|||
162095515|NCT00467870|585400510|FG003|Overall Study|Subject Non-compliance|1|||
162095516|NCT00467870|585400511|FG004|Overall Study|Subject Non-compliance|5|||
162095517|NCT00467870|585400512|FG005|Overall Study|Subject Non-compliance|0|||
162095518|NCT00467870|585400507|FG000|Overall Study|Other/Unknown|8|||
162095519|NCT00467870|585400508|FG001|Overall Study|Other/Unknown|5|||
162095520|NCT00467870|585400509|FG002|Overall Study|Other/Unknown|1|||
162095521|NCT00467870|585400510|FG003|Overall Study|Other/Unknown|5|||
162095522|NCT00467870|585400511|FG004|Overall Study|Other/Unknown|4|||
162095523|NCT00467870|585400512|FG005|Overall Study|Other/Unknown|0|||
162095524|NCT03489304|585400513|FG000|Overall Study|Lost to Follow-up|4|||
162095525|NCT02239679|585400514|FG000|Overall Study|Lost to Follow-up|1|||
162095526|NCT02239679|585400515|FG001|Overall Study|Lost to Follow-up|0|||
162095527|NCT02239679|585400516|FG002|Overall Study|Lost to Follow-up|0|||
162095528|NCT02239679|585400514|FG000|Overall Study|Withdrawal by Subject|2|||
162095529|NCT02239679|585400515|FG001|Overall Study|Withdrawal by Subject|3|||
162095530|NCT02239679|585400516|FG002|Overall Study|Withdrawal by Subject|1|||
162095531|NCT01917526|585400517|FG000|Overall Study|Protocol Violation|1|||
162095532|NCT01917526|585400518|FG001|Overall Study|Protocol Violation|1|||
162095533|NCT00760929|585400522|FG000|Overall Study|Adverse Event|2|||
162095534|NCT00760929|585400523|FG001|Overall Study|Adverse Event|0|||
162095535|NCT00760929|585400524|FG002|Overall Study|Adverse Event|6|||
162095536|NCT00760929|585400525|FG003|Overall Study|Adverse Event|10|||
162095537|NCT00760929|585400522|FG000|Overall Study|Lack of Efficacy|0|||
162095538|NCT00760929|585400523|FG001|Overall Study|Lack of Efficacy|2|||
162095539|NCT00760929|585400524|FG002|Overall Study|Lack of Efficacy|1|||
162095540|NCT00760929|585400525|FG003|Overall Study|Lack of Efficacy|0|||
162095541|NCT00760929|585400522|FG000|Overall Study|Withdrawal by Subject|1|||
162095542|NCT00760929|585400523|FG001|Overall Study|Withdrawal by Subject|0|||
162095543|NCT00760929|585400524|FG002|Overall Study|Withdrawal by Subject|9|||
162095544|NCT00760929|585400525|FG003|Overall Study|Withdrawal by Subject|1|||
162095545|NCT00760929|585400522|FG000|Overall Study|Lost to Follow-up|0|||
162095546|NCT00760929|585400523|FG001|Overall Study|Lost to Follow-up|0|||
162095547|NCT00760929|585400524|FG002|Overall Study|Lost to Follow-up|1|||
162095548|NCT00760929|585400525|FG003|Overall Study|Lost to Follow-up|0|||
162095549|NCT00760929|585400522|FG000|Overall Study|Progression of Disease|21|||
162095550|NCT00760929|585400523|FG001|Overall Study|Progression of Disease|26|||
162095551|NCT00760929|585400524|FG002|Overall Study|Progression of Disease|38|||
162095552|NCT00760929|585400525|FG003|Overall Study|Progression of Disease|42|||
162095553|NCT00760929|585400522|FG000|Overall Study|Other|2|||
162095554|NCT00760929|585400523|FG001|Overall Study|Other|0|||
162095555|NCT00760929|585400524|FG002|Overall Study|Other|2|||
162095556|NCT00760929|585400525|FG003|Overall Study|Other|1|||
162095557|NCT00760929|585400522|FG000|Overall Study|Death|0|||
162095558|NCT00760929|585400523|FG001|Overall Study|Death|0|||
162095559|NCT00760929|585400524|FG002|Overall Study|Death|1|||
162095560|NCT00760929|585400525|FG003|Overall Study|Death|0|||
162095561|NCT00760929|585400522|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
162095562|NCT00760929|585400523|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
162095563|NCT00760929|585400524|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
162095564|NCT00760929|585400525|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
162095565|NCT04121962|585400528|FG000|Overall Study|Lost to Follow-up|42|||
162095566|NCT04121962|585400529|FG001|Overall Study|Lost to Follow-up|39|||
162095567|NCT01175382|585400530|FG000|Overall Study|Lost to Follow-up|4|||
162095568|NCT01175382|585400531|FG001|Overall Study|Lost to Follow-up|3|||
162095569|NCT01175382|585400532|FG002|Overall Study|Lost to Follow-up|1|||
162095570|NCT01175382|585400530|FG000|Overall Study|Physician Decision|0|||
162095571|NCT01175382|585400531|FG001|Overall Study|Physician Decision|1|||
162095572|NCT01175382|585400532|FG002|Overall Study|Physician Decision|0|||
162095573|NCT01175382|585400530|FG000|Overall Study|Withdrawal by Subject|0|||
162095574|NCT01175382|585400531|FG001|Overall Study|Withdrawal by Subject|0|||
162095575|NCT01175382|585400532|FG002|Overall Study|Withdrawal by Subject|1|||
162095576|NCT01175382|585400530|FG000|Overall Study|No longer having problem|1|||
162095577|NCT01175382|585400531|FG001|Overall Study|No longer having problem|0|||
162095578|NCT01175382|585400532|FG002|Overall Study|No longer having problem|1|||
162095579|NCT01175382|585400530|FG000|Overall Study|Unable/unwilling to attend visits|3|||
162095580|NCT01175382|585400531|FG001|Overall Study|Unable/unwilling to attend visits|1|||
162095581|NCT01175382|585400532|FG002|Overall Study|Unable/unwilling to attend visits|2|||
162095582|NCT01175382|585400530|FG000|Overall Study|Unwilling to follow protocol|0|||
162095583|NCT01175382|585400531|FG001|Overall Study|Unwilling to follow protocol|1|||
162095584|NCT01175382|585400532|FG002|Overall Study|Unwilling to follow protocol|0|||
162095585|NCT01175382|585400530|FG000|Overall Study|Unable to tolerate study meds|0|||
162095586|NCT01175382|585400531|FG001|Overall Study|Unable to tolerate study meds|1|||
162095587|NCT01175382|585400532|FG002|Overall Study|Unable to tolerate study meds|1|||
162095588|NCT00774787|585400533|FG000|Overall Study|Lost to Follow-up|1|||
162095589|NCT02019719|585400534|FG000|Overall Study|Adverse Event|1|||
162095590|NCT02019719|585400535|FG001|Overall Study|Adverse Event|0|||
162095591|NCT02019719|585400536|FG002|Overall Study|Adverse Event|0|||
162095592|NCT02019719|585400537|FG003|Overall Study|Adverse Event|1|||
162095593|NCT02019719|585400538|FG004|Overall Study|Adverse Event|1|||
162095594|NCT02019719|585400534|FG000|Overall Study|Protocol Violation|1|||
162095595|NCT02019719|585400535|FG001|Overall Study|Protocol Violation|1|||
162095596|NCT02019719|585400536|FG002|Overall Study|Protocol Violation|0|||
162095597|NCT02019719|585400537|FG003|Overall Study|Protocol Violation|0|||
162095598|NCT02019719|585400538|FG004|Overall Study|Protocol Violation|0|||
162095599|NCT02019719|585400534|FG000|Overall Study|Protocol defined stopping criteria|2|||
162095600|NCT02019719|585400535|FG001|Overall Study|Protocol defined stopping criteria|0|||
162095601|NCT02019719|585400536|FG002|Overall Study|Protocol defined stopping criteria|0|||
162095602|NCT02019719|585400537|FG003|Overall Study|Protocol defined stopping criteria|1|||
162095603|NCT02019719|585400538|FG004|Overall Study|Protocol defined stopping criteria|1|||
162095604|NCT02019719|585400534|FG000|Overall Study|Physician Decision|2|||
162095605|NCT02019719|585400535|FG001|Overall Study|Physician Decision|0|||
162095606|NCT02019719|585400536|FG002|Overall Study|Physician Decision|0|||
162095607|NCT02019719|585400537|FG003|Overall Study|Physician Decision|0|||
162095608|NCT02019719|585400538|FG004|Overall Study|Physician Decision|0|||
162095609|NCT04535037|585400539|FG000|Overall Study|Protocol Violation|1|||
162095610|NCT04535037|585400540|FG001|Overall Study|Protocol Violation|0|||
162095611|NCT04535037|585400539|FG000|Overall Study|Withdrawal by Subject|8|||
162095612|NCT04535037|585400540|FG001|Overall Study|Withdrawal by Subject|9|||
162095613|NCT04535037|585400539|FG000|Overall Study|Migrated / moved from the study area|1|||
162095614|NCT04535037|585400540|FG001|Overall Study|Migrated / moved from the study area|4|||
162095615|NCT04535037|585400539|FG000|Overall Study|Other|2|||
162095616|NCT04535037|585400540|FG001|Overall Study|Other|5|||
162095617|NCT02031276|585400541|FG000|Period 1 Double-blind IV|Adverse Event|6|||
162095618|NCT02031276|585400542|FG001|Period 1 Double-blind IV|Adverse Event|5|||
162095619|NCT02031276|585400543|FG002|Period 1 Double-blind IV|Adverse Event|1|||
162095620|NCT02031276|585400541|FG000|Period 1 Double-blind IV|Other|0|||
162095621|NCT02031276|585400542|FG001|Period 1 Double-blind IV|Other|1|||
162095622|NCT02031276|585400543|FG002|Period 1 Double-blind IV|Other|0|||
162095623|NCT02031276|585400541|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
162095624|NCT02031276|585400542|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
162095625|NCT02031276|585400543|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
162095626|NCT02031276|585400541|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
162095627|NCT02031276|585400542|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
162095628|NCT02031276|585400543|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
162095629|NCT02031276|585400541|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
162095630|NCT02031276|585400542|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
162095631|NCT02031276|585400543|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
162095632|NCT02031276|585400541|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
162095633|NCT02031276|585400542|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
162095634|NCT02031276|585400543|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
162095635|NCT02031276|585400541|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
162095636|NCT02031276|585400542|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
162095637|NCT02031276|585400543|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
162095638|NCT02031276|585400541|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
162095639|NCT02031276|585400542|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
162095640|NCT02031276|585400543|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
162095641|NCT02031276|585400541|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
162095642|NCT02031276|585400542|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
162095643|NCT02031276|585400543|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
162095644|NCT00765245|585400545|FG000|Overall Study|disease progression|3|||
162095645|NCT00765245|585400546|FG001|Overall Study|disease progression|2|||
162095646|NCT00765245|585400545|FG000|Overall Study|Withdrawal by Subject|3|||
162095647|NCT00765245|585400546|FG001|Overall Study|Withdrawal by Subject|0|||
162095648|NCT00765245|585400545|FG000|Overall Study|Adverse Event|5|||
162095649|NCT00765245|585400546|FG001|Overall Study|Adverse Event|0|||
162095650|NCT00765245|585400545|FG000|Overall Study|Physician Decision|1|||
162095651|NCT00765245|585400546|FG001|Overall Study|Physician Decision|0|||
162095652|NCT00765245|585400545|FG000|Overall Study|Death|1|||
162095653|NCT00765245|585400546|FG001|Overall Study|Death|0|||
162095654|NCT02417246|585400548|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
162095655|NCT02417246|585400549|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
162095656|NCT02417246|585400548|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
162095657|NCT02417246|585400549|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
162095658|NCT02417246|585400548|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
162095659|NCT02417246|585400549|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
162095660|NCT02417246|585400548|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
162095661|NCT02417246|585400549|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
162095662|NCT04408469|585400558|FG000|Overall Study|Lost to Follow-up|6|||
162095663|NCT04408469|585400559|FG001|Overall Study|Lost to Follow-up|9|||
162095664|NCT04408469|585400558|FG000|Overall Study|Withdrawal by Subject|6|||
162095665|NCT04408469|585400559|FG001|Overall Study|Withdrawal by Subject|1|||
162095666|NCT04408469|585400558|FG000|Overall Study|Dismissal due to ineligibility|0|||
162095667|NCT04408469|585400559|FG001|Overall Study|Dismissal due to ineligibility|1|||
162095668|NCT04321460|585400560|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
162095669|NCT04321460|585400561|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
162095670|NCT03669081|585400564|FG000|Overall Study|Data could not be validated|1|||
162095671|NCT03669081|585400565|FG001|Overall Study|Data could not be validated|1|||
162095672|NCT01308749|585400570|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
162095673|NCT01308749|585400571|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
162095674|NCT01308749|585400570|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
162095675|NCT01308749|585400571|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
162095676|NCT01308749|585400570|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
162095677|NCT01308749|585400571|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
162095678|NCT02546544|585400572|FG000|Overall Study|Disease Progression|14|||
162095679|NCT02546544|585400572|FG000|Overall Study|Adverse Event|1|||
162095680|NCT02546544|585400572|FG000|Overall Study|Withdrawal by Subject|1|||
162095681|NCT02223390|585400573|FG000|Overall Study|Lost to Follow-up|9|||
162095682|NCT02223390|585400574|FG001|Overall Study|Lost to Follow-up|4|||
162095683|NCT01197950|585400578|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
162095684|NCT01197950|585400579|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
162095685|NCT01197950|585400580|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
162095686|NCT02553330|585400581|FG000|Overall Study|Study Terminated by Sponsor|2|||
162095687|NCT02553330|585400582|FG001|Overall Study|Study Terminated by Sponsor|13|||
162095688|NCT02553330|585400583|FG002|Overall Study|Study Terminated by Sponsor|12|||
162095689|NCT02553330|585400581|FG000|Overall Study|Withdrawal by Subject|3|||
162095690|NCT02553330|585400582|FG001|Overall Study|Withdrawal by Subject|19|||
162095691|NCT02553330|585400583|FG002|Overall Study|Withdrawal by Subject|21|||
162095692|NCT02553330|585400581|FG000|Overall Study|Other|0|||
162095693|NCT02553330|585400582|FG001|Overall Study|Other|1|||
162095694|NCT02553330|585400583|FG002|Overall Study|Other|0|||
162095695|NCT02553330|585400581|FG000|Overall Study|Non compliance to study treatment|0|||
162095696|NCT02553330|585400582|FG001|Overall Study|Non compliance to study treatment|1|||
162095697|NCT02553330|585400583|FG002|Overall Study|Non compliance to study treatment|0|||
162095698|NCT02553330|585400581|FG000|Overall Study|Adverse Event|0|||
162095699|NCT02553330|585400582|FG001|Overall Study|Adverse Event|1|||
162095700|NCT02553330|585400583|FG002|Overall Study|Adverse Event|0|||
162095701|NCT02553330|585400581|FG000|Overall Study|Lost to Follow-up|0|||
162095702|NCT02553330|585400582|FG001|Overall Study|Lost to Follow-up|4|||
162095703|NCT02553330|585400583|FG002|Overall Study|Lost to Follow-up|4|||
162095704|NCT01666002|585400584|FG000|Overall Study|Lost to Follow-up|5|||
162095705|NCT01666002|585400585|FG001|Overall Study|Lost to Follow-up|0|||
162095706|NCT02511431|585400586|FG000|Treatment|Lost to Follow-up|0|||
162095707|NCT02511431|585400587|FG001|Treatment|Lost to Follow-up|0|||
162095708|NCT02511431|585400588|FG002|Treatment|Lost to Follow-up|1|||
162095709|NCT02511431|585400589|FG003|Treatment|Lost to Follow-up|0|||
162095710|NCT02511431|585400590|FG004|Treatment|Lost to Follow-up|0|||
162095711|NCT02511431|585400591|FG005|Treatment|Lost to Follow-up|1|||
162095712|NCT03525834|585400610|FG000|Overall Study|Progressive disease|1|||
162095713|NCT00346034|585400613|FG000|Overall Study|Adverse Event|34|||
162095714|NCT00346034|585400613|FG000|Overall Study|Lack of Efficacy|8|||
162095715|NCT00346034|585400613|FG000|Overall Study|Withdrawal by Subject|13|||
162095716|NCT00346034|585400613|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
162095717|NCT00346034|585400613|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
162095718|NCT00941603|585400614|FG000|Overall Study|Adverse Event|10|||
162095719|NCT00941603|585400615|FG001|Overall Study|Adverse Event|15|||
162095720|NCT00941603|585400616|FG002|Overall Study|Adverse Event|5|||
162095721|NCT00941603|585400617|FG003|Overall Study|Adverse Event|1|||
162095722|NCT00941603|585400618|FG004|Overall Study|Adverse Event|4|||
162095723|NCT00941603|585400619|FG005|Overall Study|Adverse Event|0|||
162095724|NCT00941603|585400614|FG000|Overall Study|Lost to Follow-up|0|||
162095725|NCT00941603|585400615|FG001|Overall Study|Lost to Follow-up|0|||
162095726|NCT00941603|585400616|FG002|Overall Study|Lost to Follow-up|0|||
162095727|NCT00941603|585400617|FG003|Overall Study|Lost to Follow-up|1|||
162095728|NCT00941603|585400618|FG004|Overall Study|Lost to Follow-up|0|||
162095729|NCT00941603|585400619|FG005|Overall Study|Lost to Follow-up|2|||
162095730|NCT00941603|585400614|FG000|Overall Study|Withdrawal by Subject|0|||
162095731|NCT00941603|585400615|FG001|Overall Study|Withdrawal by Subject|0|||
162095732|NCT00941603|585400616|FG002|Overall Study|Withdrawal by Subject|0|||
162095733|NCT00941603|585400617|FG003|Overall Study|Withdrawal by Subject|2|||
162095734|NCT00941603|585400618|FG004|Overall Study|Withdrawal by Subject|0|||
162095735|NCT00941603|585400619|FG005|Overall Study|Withdrawal by Subject|1|||
162095736|NCT00941603|585400614|FG000|Overall Study|Protocol Violation|0|||
162095737|NCT00941603|585400615|FG001|Overall Study|Protocol Violation|1|||
162095738|NCT00941603|585400616|FG002|Overall Study|Protocol Violation|0|||
162095739|NCT00941603|585400617|FG003|Overall Study|Protocol Violation|0|||
162095740|NCT00941603|585400618|FG004|Overall Study|Protocol Violation|0|||
162095741|NCT00941603|585400619|FG005|Overall Study|Protocol Violation|0|||
162095742|NCT00941603|585400614|FG000|Overall Study|Did not meet protocol eligibility|1|||
162095743|NCT00941603|585400615|FG001|Overall Study|Did not meet protocol eligibility|0|||
162095744|NCT00941603|585400616|FG002|Overall Study|Did not meet protocol eligibility|0|||
162095745|NCT00941603|585400617|FG003|Overall Study|Did not meet protocol eligibility|0|||
162095746|NCT00941603|585400618|FG004|Overall Study|Did not meet protocol eligibility|0|||
162095747|NCT00941603|585400619|FG005|Overall Study|Did not meet protocol eligibility|0|||
162095748|NCT01732835|585400623|FG000|6-month Primary Endpoint|Did not receive device|19|||
162095749|NCT01732835|585400623|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
162095750|NCT01732835|585400623|FG000|6-month Primary Endpoint|Adverse Event|3|||
162095751|NCT01732835|585400623|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
162095752|NCT01732835|585400623|FG000|2-year Extended Follow-up|Adverse Event|3|||
162095753|NCT01732835|585400623|FG000|2-year Extended Follow-up|Death|1|||
162095754|NCT01143259|585400629|FG000|Overall Study|Withdrawal by Subject|3|||
162095755|NCT01143259|585400630|FG001|Overall Study|Withdrawal by Subject|2|||
162095756|NCT01143259|585400629|FG000|Overall Study|Protocol Violation|13|||
162095757|NCT01143259|585400630|FG001|Overall Study|Protocol Violation|9|||
162095758|NCT01143259|585400629|FG000|Overall Study|Screen Failure|7|||
162095759|NCT01143259|585400630|FG001|Overall Study|Screen Failure|9|||
162095760|NCT06281548|585400631|FG000|Overall Study|Lost to Follow-up|3|||
162095761|NCT04827576|585402624|FG000|Overall Study|Death|5|||
162095762|NCT04827576|585402625|FG001|Overall Study|Death|17|||
162095763|NCT04827576|585402626|FG002|Overall Study|Death|17|||
162095764|NCT04827576|585402627|FG003|Overall Study|Death|32|||
162095765|NCT04827576|585402624|FG000|Overall Study|Study Terminated by Sponsor|2|||
162095766|NCT04827576|585402625|FG001|Overall Study|Study Terminated by Sponsor|9|||
162095767|NCT04827576|585402626|FG002|Overall Study|Study Terminated by Sponsor|7|||
162095768|NCT04827576|585402627|FG003|Overall Study|Study Terminated by Sponsor|5|||
162095769|NCT04827576|585402624|FG000|Overall Study|Investigator's Discretion|1|||
162095770|NCT04827576|585402625|FG001|Overall Study|Investigator's Discretion|0|||
162095771|NCT04827576|585402626|FG002|Overall Study|Investigator's Discretion|2|||
162095772|NCT04827576|585402627|FG003|Overall Study|Investigator's Discretion|5|||
162095773|NCT04827576|585402624|FG000|Overall Study|Withdrew Consent|0|||
162095774|NCT04827576|585402625|FG001|Overall Study|Withdrew Consent|3|||
162095775|NCT04827576|585402626|FG002|Overall Study|Withdrew Consent|0|||
162095776|NCT04827576|585402627|FG003|Overall Study|Withdrew Consent|0|||
162095777|NCT04827576|585402624|FG000|Overall Study|Lost to Follow-up|1|||
162095778|NCT04827576|585402625|FG001|Overall Study|Lost to Follow-up|0|||
162095779|NCT04827576|585402626|FG002|Overall Study|Lost to Follow-up|0|||
162095780|NCT04827576|585402627|FG003|Overall Study|Lost to Follow-up|0|||
162095781|NCT00791765|585402628|FG000|Weeks 1 to 12|Adverse Event|0|||
162095782|NCT00791765|585402629|FG001|Weeks 1 to 12|Adverse Event|1|||
162095783|NCT00791765|585402628|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
162095784|NCT00791765|585402629|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
162095785|NCT00791765|585402628|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
162095786|NCT00791765|585402629|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
162095787|NCT00791765|585402628|FG000|Weeks 1 to 12|Physician Decision|1|||
162095788|NCT00791765|585402629|FG001|Weeks 1 to 12|Physician Decision|0|||
162095789|NCT00791765|585402628|FG000|Weeks 1 to 12|Disease progression|3|||
162095790|NCT00791765|585402629|FG001|Weeks 1 to 12|Disease progression|0|||
162095791|NCT00791765|585402628|FG000|Weeks 1 to 12|Ineligibility determined|0|||
162095792|NCT00791765|585402629|FG001|Weeks 1 to 12|Ineligibility determined|3|||
162095793|NCT00791765|585402628|FG000|Weeks 13 to 24|Protocol deviation|2|||
162095794|NCT00791765|585402629|FG001|Weeks 13 to 24|Protocol deviation|0|||
162095795|NCT00791765|585402628|FG000|Weeks 13 to 24|Adverse Event|0|||
162095796|NCT00791765|585402629|FG001|Weeks 13 to 24|Adverse Event|3|||
162095797|NCT00791765|585402628|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
162095798|NCT00791765|585402629|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
162095799|NCT00791765|585402628|FG000|Weeks 13 to 24|Disease progression|0|||
162095800|NCT00791765|585402629|FG001|Weeks 13 to 24|Disease progression|1|||
162095801|NCT00791765|585402628|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
162095802|NCT00791765|585402629|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
162095803|NCT00791765|585402628|FG000|Weeks 13 to 24|Other|0|||
162095804|NCT00791765|585402629|FG001|Weeks 13 to 24|Other|1|||
162095805|NCT04295564|585402630|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
162095806|NCT04295564|585402631|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
162095807|NCT04537923|585402632|FG000|Overall Study|Adverse Event|2|||
162095808|NCT04537923|585402633|FG001|Overall Study|Adverse Event|1|||
162095809|NCT04537923|585402634|FG002|Overall Study|Adverse Event|2|||
162095810|NCT04537923|585402635|FG003|Overall Study|Adverse Event|4|||
162095811|NCT04537923|585402632|FG000|Overall Study|Death|3|||
162095812|NCT04537923|585402633|FG001|Overall Study|Death|3|||
162095813|NCT04537923|585402634|FG002|Overall Study|Death|1|||
162095814|NCT04537923|585402635|FG003|Overall Study|Death|11|||
162095815|NCT04537923|585402632|FG000|Overall Study|Lost to Follow-up|1|||
162095816|NCT04537923|585402633|FG001|Overall Study|Lost to Follow-up|2|||
162095817|NCT04537923|585402634|FG002|Overall Study|Lost to Follow-up|1|||
162095818|NCT04537923|585402635|FG003|Overall Study|Lost to Follow-up|6|||
162095819|NCT04537923|585402632|FG000|Overall Study|Physician Decision|1|||
162095820|NCT04537923|585402633|FG001|Overall Study|Physician Decision|0|||
162095821|NCT04537923|585402634|FG002|Overall Study|Physician Decision|2|||
162095822|NCT04537923|585402635|FG003|Overall Study|Physician Decision|5|||
162095823|NCT04537923|585402632|FG000|Overall Study|Pregnancy|1|||
162095824|NCT04537923|585402633|FG001|Overall Study|Pregnancy|0|||
162095825|NCT04537923|585402634|FG002|Overall Study|Pregnancy|0|||
162095826|NCT04537923|585402635|FG003|Overall Study|Pregnancy|0|||
162095827|NCT04537923|585402632|FG000|Overall Study|Withdrawal by Subject|4|||
162095828|NCT04537923|585402633|FG001|Overall Study|Withdrawal by Subject|4|||
162095829|NCT04537923|585402634|FG002|Overall Study|Withdrawal by Subject|4|||
162095830|NCT04537923|585402635|FG003|Overall Study|Withdrawal by Subject|58|||
162095831|NCT04537923|585402632|FG000|Overall Study|Missed study visits|2|||
162095832|NCT04537923|585402633|FG001|Overall Study|Missed study visits|0|||
162095833|NCT04537923|585402634|FG002|Overall Study|Missed study visits|0|||
162095834|NCT04537923|585402635|FG003|Overall Study|Missed study visits|3|||
162095835|NCT04537923|585402632|FG000|Overall Study|Sponsor's decision|0|||
162095836|NCT04537923|585402633|FG001|Overall Study|Sponsor's decision|0|||
162095837|NCT04537923|585402634|FG002|Overall Study|Sponsor's decision|1|||
162095838|NCT04537923|585402635|FG003|Overall Study|Sponsor's decision|1|||
162095839|NCT04537923|585402632|FG000|Overall Study|Safety reasons|1|||
162095840|NCT04537923|585402633|FG001|Overall Study|Safety reasons|0|||
162095841|NCT04537923|585402634|FG002|Overall Study|Safety reasons|0|||
162095842|NCT04537923|585402635|FG003|Overall Study|Safety reasons|0|||
162095843|NCT01261611|585402636|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
162095844|NCT01261611|585402637|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
162095845|NCT01261611|585402638|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
162095846|NCT01261611|585402636|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
162095847|NCT01261611|585402637|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
162095848|NCT01261611|585402638|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
162095849|NCT01261611|585402636|FG000|Treatment Cycle 1|Adverse Event|0|||
162095850|NCT01261611|585402637|FG001|Treatment Cycle 1|Adverse Event|1|||
162095851|NCT01261611|585402638|FG002|Treatment Cycle 1|Adverse Event|0|||
162095852|NCT01261611|585402636|FG000|Treatment Cycle 1|Protocol Violation|0|||
162095853|NCT01261611|585402637|FG001|Treatment Cycle 1|Protocol Violation|0|||
162095854|NCT01261611|585402638|FG002|Treatment Cycle 1|Protocol Violation|2|||
162095855|NCT01261611|585402636|FG000|Treatment Cycle 2|Completed study|4|||
162095856|NCT01261611|585402637|FG001|Treatment Cycle 2|Completed study|0|||
162095857|NCT01261611|585402638|FG002|Treatment Cycle 2|Completed study|0|||
162095858|NCT01261611|585402636|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
162095859|NCT01261611|585402637|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
162095860|NCT01261611|585402638|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
162095861|NCT01261611|585402636|FG000|Treatment Cycle 2|Adverse Event|1|||
162095862|NCT01261611|585402637|FG001|Treatment Cycle 2|Adverse Event|0|||
162095863|NCT01261611|585402638|FG002|Treatment Cycle 2|Adverse Event|0|||
162095864|NCT01261611|585402636|FG000|Treatment Cycle 2|Protocol Violation|2|||
162095865|NCT01261611|585402637|FG001|Treatment Cycle 2|Protocol Violation|0|||
162095866|NCT01261611|585402638|FG002|Treatment Cycle 2|Protocol Violation|0|||
162095867|NCT01261611|585402636|FG000|Treatment Cycle 2|Not otherwise specified|2|||
162095868|NCT01261611|585402637|FG001|Treatment Cycle 2|Not otherwise specified|0|||
162095869|NCT01261611|585402638|FG002|Treatment Cycle 2|Not otherwise specified|0|||
162095870|NCT01261611|585402636|FG000|Treatment Cycle 3|Completed study|24|||
162095871|NCT01261611|585402637|FG001|Treatment Cycle 3|Completed study|0|||
162095872|NCT01261611|585402638|FG002|Treatment Cycle 3|Completed study|0|||
162095873|NCT01261611|585402636|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
162095874|NCT01261611|585402637|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
162095875|NCT01261611|585402638|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
162095876|NCT01261611|585402636|FG000|Treatment Cycle 3|Adverse Event|1|||
162095877|NCT01261611|585402637|FG001|Treatment Cycle 3|Adverse Event|0|||
162095878|NCT01261611|585402638|FG002|Treatment Cycle 3|Adverse Event|0|||
162095879|NCT01261611|585402636|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
162095880|NCT01261611|585402637|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
162095881|NCT01261611|585402638|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
162095882|NCT01261611|585402636|FG000|Treatment Cycle 4|Completed study|87|||
162095883|NCT01261611|585402637|FG001|Treatment Cycle 4|Completed study|0|||
162095884|NCT01261611|585402638|FG002|Treatment Cycle 4|Completed study|0|||
162095885|NCT01261611|585402636|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
162095886|NCT01261611|585402637|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
162095887|NCT01261611|585402638|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
162095888|NCT01261611|585402636|FG000|Treatment Cycle 4|Adverse Event|1|||
162095889|NCT01261611|585402637|FG001|Treatment Cycle 4|Adverse Event|0|||
162095890|NCT01261611|585402638|FG002|Treatment Cycle 4|Adverse Event|0|||
162095891|NCT01261611|585402636|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
162095892|NCT01261611|585402637|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
162095893|NCT01261611|585402638|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
162095894|NCT01261611|585402636|FG000|Treatment Cycle 4|Not otherwise specified|3|||
162095895|NCT01261611|585402637|FG001|Treatment Cycle 4|Not otherwise specified|0|||
162095896|NCT01261611|585402638|FG002|Treatment Cycle 4|Not otherwise specified|0|||
162095897|NCT01261611|585402636|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
162095898|NCT01261611|585402637|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
162095899|NCT01261611|585402638|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
162095900|NCT01261611|585402636|FG000|Treatment Cycle 5|Adverse Event|1|||
162095901|NCT01261611|585402637|FG001|Treatment Cycle 5|Adverse Event|0|||
162095902|NCT01261611|585402638|FG002|Treatment Cycle 5|Adverse Event|0|||
162095903|NCT01261611|585402636|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
162095904|NCT01261611|585402637|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
162095905|NCT01261611|585402638|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
162095906|NCT02527798|585402639|FG000|Overall Study|Physician Decision|1|||
162095907|NCT02527798|585402640|FG001|Overall Study|Physician Decision|0|||
162095908|NCT02527798|585402641|FG002|Overall Study|Physician Decision|1|||
162095909|NCT02527798|585402642|FG003|Overall Study|Physician Decision|1|||
162095910|NCT02527798|585402643|FG004|Overall Study|Physician Decision|0|||
162095911|NCT02527798|585402644|FG005|Overall Study|Physician Decision|0|||
162095912|NCT02527798|585402639|FG000|Overall Study|Death|0|||
162095913|NCT02527798|585402640|FG001|Overall Study|Death|0|||
162095914|NCT02527798|585402641|FG002|Overall Study|Death|1|||
162095915|NCT02527798|585402642|FG003|Overall Study|Death|0|||
162095916|NCT02527798|585402643|FG004|Overall Study|Death|0|||
162095917|NCT02527798|585402644|FG005|Overall Study|Death|0|||
162095918|NCT02527798|585402639|FG000|Overall Study|Withdrawal by Subject|0|||
162095919|NCT02527798|585402640|FG001|Overall Study|Withdrawal by Subject|1|||
162095920|NCT02527798|585402641|FG002|Overall Study|Withdrawal by Subject|2|||
162095921|NCT02527798|585402642|FG003|Overall Study|Withdrawal by Subject|0|||
162095922|NCT02527798|585402643|FG004|Overall Study|Withdrawal by Subject|0|||
162095923|NCT02527798|585402644|FG005|Overall Study|Withdrawal by Subject|0|||
162095924|NCT02527798|585402639|FG000|Overall Study|Reason undisclosed|1|||
162095925|NCT02527798|585402640|FG001|Overall Study|Reason undisclosed|0|||
162095926|NCT02527798|585402641|FG002|Overall Study|Reason undisclosed|1|||
162095927|NCT02527798|585402642|FG003|Overall Study|Reason undisclosed|0|||
162095928|NCT02527798|585402643|FG004|Overall Study|Reason undisclosed|0|||
162095929|NCT02527798|585402644|FG005|Overall Study|Reason undisclosed|0|||
162095930|NCT02527798|585402639|FG000|Overall Study|Did not receive intervention|1|||
162095931|NCT02527798|585402640|FG001|Overall Study|Did not receive intervention|1|||
162095932|NCT02527798|585402641|FG002|Overall Study|Did not receive intervention|0|||
162095933|NCT02527798|585402642|FG003|Overall Study|Did not receive intervention|0|||
162095934|NCT02527798|585402643|FG004|Overall Study|Did not receive intervention|0|||
162095935|NCT02527798|585402644|FG005|Overall Study|Did not receive intervention|0|||
162095936|NCT03859323|585402646|FG000|Overall Study|Lost to Follow-up|0|||
162095937|NCT03859323|585402647|FG001|Overall Study|Lost to Follow-up|0|||
162095938|NCT03859323|585402648|FG002|Overall Study|Lost to Follow-up|0|||
162095939|NCT03859323|585402649|FG003|Overall Study|Lost to Follow-up|0|||
162095940|NCT03859323|585402650|FG004|Overall Study|Lost to Follow-up|0|||
162095941|NCT03859323|585402651|FG005|Overall Study|Lost to Follow-up|0|||
162095942|NCT03859323|585402652|FG006|Overall Study|Lost to Follow-up|1|||
162095943|NCT03859323|585402653|FG007|Overall Study|Lost to Follow-up|0|||
162095944|NCT03859323|585402654|FG008|Overall Study|Lost to Follow-up|0|||
162095945|NCT03859323|585402655|FG009|Overall Study|Lost to Follow-up|0|||
162095946|NCT03859323|585402656|FG010|Overall Study|Lost to Follow-up|0|||
162095947|NCT03859323|585402657|FG011|Overall Study|Lost to Follow-up|0|||
162095948|NCT03859323|585402658|FG012|Overall Study|Lost to Follow-up|0|||
162095949|NCT03859323|585402646|FG000|Overall Study|Withdrawal by Subject|0|||
162095950|NCT03859323|585402647|FG001|Overall Study|Withdrawal by Subject|0|||
162095951|NCT03859323|585402648|FG002|Overall Study|Withdrawal by Subject|1|||
162095952|NCT03859323|585402649|FG003|Overall Study|Withdrawal by Subject|0|||
162095953|NCT03859323|585402650|FG004|Overall Study|Withdrawal by Subject|0|||
162095954|NCT03859323|585402651|FG005|Overall Study|Withdrawal by Subject|1|||
162095955|NCT03859323|585402652|FG006|Overall Study|Withdrawal by Subject|0|||
162095956|NCT03859323|585402653|FG007|Overall Study|Withdrawal by Subject|0|||
162095957|NCT03859323|585402654|FG008|Overall Study|Withdrawal by Subject|0|||
162095958|NCT03859323|585402655|FG009|Overall Study|Withdrawal by Subject|1|||
162095959|NCT03859323|585402656|FG010|Overall Study|Withdrawal by Subject|1|||
162095960|NCT03859323|585402657|FG011|Overall Study|Withdrawal by Subject|2|||
162095961|NCT03859323|585402658|FG012|Overall Study|Withdrawal by Subject|1|||
162095962|NCT03859323|585402646|FG000|Overall Study|Pregnancy|0|||
162095963|NCT03859323|585402647|FG001|Overall Study|Pregnancy|0|||
162095964|NCT03859323|585402648|FG002|Overall Study|Pregnancy|0|||
162095965|NCT03859323|585402649|FG003|Overall Study|Pregnancy|0|||
162095966|NCT03859323|585402650|FG004|Overall Study|Pregnancy|0|||
162095967|NCT03859323|585402651|FG005|Overall Study|Pregnancy|0|||
162095968|NCT03859323|585402652|FG006|Overall Study|Pregnancy|0|||
162095969|NCT03859323|585402653|FG007|Overall Study|Pregnancy|0|||
162095970|NCT03859323|585402654|FG008|Overall Study|Pregnancy|0|||
162095971|NCT03859323|585402655|FG009|Overall Study|Pregnancy|1|||
162095972|NCT03859323|585402656|FG010|Overall Study|Pregnancy|0|||
162095973|NCT03859323|585402657|FG011|Overall Study|Pregnancy|0|||
162095974|NCT03859323|585402658|FG012|Overall Study|Pregnancy|0|||
162095975|NCT01682460|585402660|FG000|Overall Study|Withdrawal by Subject|2|||
162095976|NCT01682460|585402660|FG000|Overall Study|Did not meet inclusion criteria|2|||
162095977|NCT01808690|585402664|FG000|Overall Study|Withdrawal by Subject|1|||
162095978|NCT01808690|585402665|FG001|Overall Study|Withdrawal by Subject|2|||
162095979|NCT03811912|585402666|FG000|Overall Study|Withdrew Consent|4|||
162095980|NCT03811912|585402667|FG001|Overall Study|Withdrew Consent|2|||
162095981|NCT02891187|585402668|FG000|Overall Study|Lost to Follow-up|1|||
162095982|NCT02891187|585402669|FG001|Overall Study|Lost to Follow-up|2|||
162095983|NCT00674986|585402670|FG000|Overall Study|Adverse Event|2|||
162095984|NCT00674986|585402671|FG001|Overall Study|Adverse Event|1|||
162095985|NCT00674986|585402670|FG000|Overall Study|Subject withdrew consent|12|||
162095986|NCT00674986|585402671|FG001|Overall Study|Subject withdrew consent|19|||
162095987|NCT00674986|585402670|FG000|Overall Study|Lost to Follow-up|25|||
162095988|NCT00674986|585402671|FG001|Overall Study|Lost to Follow-up|53|||
162095989|NCT00674986|585402670|FG000|Overall Study|Other reasons|4|||
162095990|NCT00674986|585402671|FG001|Overall Study|Other reasons|8|||
162095991|NCT00377234|585402672|FG000|Overall Study|Adverse Event|14|||
162095992|NCT00377234|585402673|FG001|Overall Study|Adverse Event|17|||
162095993|NCT00377234|585402672|FG000|Overall Study|Withdrawal by Subject|11|||
162095994|NCT00377234|585402673|FG001|Overall Study|Withdrawal by Subject|9|||
162095995|NCT00377234|585402672|FG000|Overall Study|Lost to Follow-up|4|||
162095996|NCT00377234|585402673|FG001|Overall Study|Lost to Follow-up|2|||
162095997|NCT00377234|585402672|FG000|Overall Study|Administrative|2|||
162095998|NCT00377234|585402673|FG001|Overall Study|Administrative|1|||
162095999|NCT00377234|585402672|FG000|Overall Study|Not assigned|3|||
162096000|NCT00377234|585402673|FG001|Overall Study|Not assigned|2|||
162096001|NCT02053350|585402680|FG000|Overall Study|Withdrawal by Subject|1|||
162096002|NCT02053350|585402680|FG000|Overall Study|Adverse Event|4|||
162096003|NCT01275625|585402681|FG000|Overall Study|Death|1|||
162096004|NCT01275625|585402681|FG000|Overall Study|Lack of Efficacy|2|||
162096005|NCT01275625|585402681|FG000|Overall Study|Lost to Follow-up|1|||
162096006|NCT01275625|585402681|FG000|Overall Study|Withdrawal by Subject|3|||
162096007|NCT01275625|585402681|FG000|Overall Study|Protocol Violation|1|||
162096008|NCT01275625|585402681|FG000|Overall Study|Adverse Event|4|||
162096009|NCT01275625|585402681|FG000|Overall Study|Other|1|||
162096010|NCT01585103|585402683|FG000|Overall Study|Unable to swallow Cytosponge|6|||
162096011|NCT03521635|585402684|FG000|Overall Study|Adverse Event|1|||
162096012|NCT03521635|585402685|FG001|Overall Study|Adverse Event|1|||
162096013|NCT03521635|585402684|FG000|Overall Study|Refused to complete study visit|1|||
162096014|NCT03521635|585402685|FG001|Overall Study|Refused to complete study visit|0|||
162096015|NCT03521635|585402684|FG000|Overall Study|Refused to continue trial medication|2|||
162096016|NCT03521635|585402685|FG001|Overall Study|Refused to continue trial medication|2|||
162096017|NCT03521635|585402684|FG000|Overall Study|Lost to Follow-up|0|||
162096018|NCT03521635|585402685|FG001|Overall Study|Lost to Follow-up|1|||
162096019|NCT03521635|585402684|FG000|Overall Study|Meet exclusion criteria|0|||
162096020|NCT03521635|585402685|FG001|Overall Study|Meet exclusion criteria|1|||
162096021|NCT03521635|585402684|FG000|Overall Study|Patient not taken study medicine|0|||
162096022|NCT03521635|585402685|FG001|Overall Study|Patient not taken study medicine|1|||
162096023|NCT02244944|585402686|FG000|Overall Study|Withdrawal by Subject|1|||
162096024|NCT02244944|585402686|FG000|Overall Study|Study Terminated|1|||
162096025|NCT01747772|585402687|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
162096026|NCT00626522|585402690|FG000|Overall Study|Protocol Violation|0|||
162096027|NCT00626522|585402691|FG001|Overall Study|Protocol Violation|0|||
162096028|NCT00626522|585402692|FG002|Overall Study|Protocol Violation|0|||
162096029|NCT00626522|585402693|FG003|Overall Study|Protocol Violation|0|||
162096030|NCT00626522|585402694|FG004|Overall Study|Protocol Violation|1|||
162096031|NCT00626522|585402695|FG005|Overall Study|Protocol Violation|0|||
162096032|NCT00626522|585402690|FG000|Overall Study|Adverse Event|2|||
162096033|NCT00626522|585402691|FG001|Overall Study|Adverse Event|1|||
162096034|NCT00626522|585402692|FG002|Overall Study|Adverse Event|2|||
162096035|NCT00626522|585402693|FG003|Overall Study|Adverse Event|0|||
162096036|NCT00626522|585402694|FG004|Overall Study|Adverse Event|1|||
162096037|NCT00626522|585402695|FG005|Overall Study|Adverse Event|1|||
162096038|NCT00626522|585402690|FG000|Overall Study|Withdrawal by Subject|2|||
162096039|NCT00626522|585402691|FG001|Overall Study|Withdrawal by Subject|5|||
162096040|NCT00626522|585402692|FG002|Overall Study|Withdrawal by Subject|5|||
162096041|NCT00626522|585402693|FG003|Overall Study|Withdrawal by Subject|0|||
162096042|NCT00626522|585402694|FG004|Overall Study|Withdrawal by Subject|4|||
162096043|NCT00626522|585402695|FG005|Overall Study|Withdrawal by Subject|1|||
162096044|NCT00626522|585402690|FG000|Overall Study|COPD exacerbation|0|||
162096045|NCT00626522|585402691|FG001|Overall Study|COPD exacerbation|0|||
162096046|NCT00626522|585402692|FG002|Overall Study|COPD exacerbation|0|||
162096047|NCT00626522|585402693|FG003|Overall Study|COPD exacerbation|1|||
162096048|NCT00626522|585402694|FG004|Overall Study|COPD exacerbation|1|||
162096049|NCT00626522|585402695|FG005|Overall Study|COPD exacerbation|0|||
162096050|NCT00626522|585402690|FG000|Overall Study|Lost to Follow-up|0|||
162096051|NCT00626522|585402691|FG001|Overall Study|Lost to Follow-up|1|||
162096052|NCT00626522|585402692|FG002|Overall Study|Lost to Follow-up|0|||
162096053|NCT00626522|585402693|FG003|Overall Study|Lost to Follow-up|0|||
162096054|NCT00626522|585402694|FG004|Overall Study|Lost to Follow-up|0|||
162096055|NCT00626522|585402695|FG005|Overall Study|Lost to Follow-up|0|||
162096056|NCT00626522|585402690|FG000|Overall Study|Inconsistent reason reported|1|||
162096057|NCT00626522|585402691|FG001|Overall Study|Inconsistent reason reported|0|||
162096058|NCT00626522|585402692|FG002|Overall Study|Inconsistent reason reported|0|||
162096059|NCT00626522|585402693|FG003|Overall Study|Inconsistent reason reported|0|||
162096060|NCT00626522|585402694|FG004|Overall Study|Inconsistent reason reported|0|||
162096061|NCT00626522|585402695|FG005|Overall Study|Inconsistent reason reported|0|||
162096062|NCT00626522|585402690|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
162096063|NCT00626522|585402691|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
162096064|NCT00626522|585402692|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
162096065|NCT00626522|585402693|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
162096066|NCT00626522|585402694|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
162096067|NCT00626522|585402695|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
162096068|NCT01928719|585402696|FG000|Overall Study|Lost to Follow-up|26|||
162096069|NCT01928719|585402697|FG001|Overall Study|Lost to Follow-up|11|||
162096070|NCT01928719|585402696|FG000|Overall Study|Withdrawal by Subject|22|||
162096071|NCT01928719|585402697|FG001|Overall Study|Withdrawal by Subject|7|||
162096072|NCT01928719|585402696|FG000|Overall Study|Protocol Violation|3|||
162096073|NCT01928719|585402697|FG001|Overall Study|Protocol Violation|1|||
162096074|NCT01928719|585402696|FG000|Overall Study|Adverse Event|1|||
162096075|NCT01928719|585402697|FG001|Overall Study|Adverse Event|0|||
162096076|NCT03725982|585402698|FG000|First Intervention|Withdrawal by Subject|0|||
162096077|NCT03725982|585402699|FG001|First Intervention|Withdrawal by Subject|1|||
162096078|NCT03725982|585402698|FG000|First Intervention|Physician Decision|1|||
162096079|NCT03725982|585402699|FG001|First Intervention|Physician Decision|1|||
162096080|NCT01003899|585402700|FG000|Overall Study|Other Adverse Event|8|||
162096081|NCT01003899|585402700|FG000|Overall Study|Not entered|4|||
162096082|NCT01003899|585402700|FG000|Overall Study|Not treated|1|||
162096083|NCT01003899|585402700|FG000|Overall Study|Progressive disease|34|||
162096084|NCT02099838|585402703|FG000|Overall Study|Death|1|||
162096085|NCT02099838|585402704|FG001|Overall Study|Death|0|||
162096086|NCT02099838|585402703|FG000|Overall Study|Lost to Follow-up|3|||
162096087|NCT02099838|585402704|FG001|Overall Study|Lost to Follow-up|1|||
162096088|NCT02099838|585402703|FG000|Overall Study|Withdrawal by Subject|0|||
162096089|NCT02099838|585402704|FG001|Overall Study|Withdrawal by Subject|1|||
162096090|NCT01921348|585402705|FG000|Overall Study|Withdrawal by Subject|1|||
162096091|NCT01921348|585402706|FG001|Overall Study|Withdrawal by Subject|0|||
162096092|NCT01921348|585402705|FG000|Overall Study|Lost to Follow-up|0|||
162096093|NCT01921348|585402706|FG001|Overall Study|Lost to Follow-up|2|||
162096094|NCT02896855|585402709|FG000|Overall Study|Death|50|||
162096095|NCT02896855|585402710|FG001|Overall Study|Death|40|||
162096096|NCT02896855|585402709|FG000|Overall Study|Lost to Follow-up|15|||
162096097|NCT02896855|585402710|FG001|Overall Study|Lost to Follow-up|9|||
162096098|NCT02896855|585402709|FG000|Overall Study|Withdrawal by Subject|7|||
162096099|NCT02896855|585402710|FG001|Overall Study|Withdrawal by Subject|4|||
162096100|NCT01205685|585402711|FG000|Overall Study|Disease Progression|10|||
162096101|NCT01205685|585402711|FG000|Overall Study|Withdrawal by Subject|1|||
162096102|NCT02169674|585402712|FG000|Overall Study|Withdrawal by Subject|2|||
162096103|NCT02169674|585402713|FG001|Overall Study|Withdrawal by Subject|1|||
162096104|NCT02169674|585402712|FG000|Overall Study|Seroprotected|30|||
162096105|NCT02169674|585402713|FG001|Overall Study|Seroprotected|76|||
162096106|NCT02169674|585402712|FG000|Overall Study|Lost to Follow-up|0|||
162096107|NCT02169674|585402713|FG001|Overall Study|Lost to Follow-up|1|||
162096108|NCT03879798|585402716|FG000|Overall Study|Adverse Event|0|||
162096109|NCT03879798|585402717|FG001|Overall Study|Adverse Event|0|||
162096110|NCT03879798|585402718|FG002|Overall Study|Adverse Event|0|||
162096111|NCT03879798|585402719|FG003|Overall Study|Adverse Event|0|||
162096112|NCT03879798|585402720|FG004|Overall Study|Adverse Event|0|||
162096113|NCT03879798|585402721|FG005|Overall Study|Adverse Event|1|||
162096114|NCT03879798|585402716|FG000|Overall Study|Lack of Efficacy|0|||
162096115|NCT03879798|585402717|FG001|Overall Study|Lack of Efficacy|0|||
162096116|NCT03879798|585402718|FG002|Overall Study|Lack of Efficacy|0|||
162096117|NCT03879798|585402719|FG003|Overall Study|Lack of Efficacy|0|||
162096118|NCT03879798|585402720|FG004|Overall Study|Lack of Efficacy|0|||
162096119|NCT03879798|585402721|FG005|Overall Study|Lack of Efficacy|1|||
162096120|NCT03879798|585402716|FG000|Overall Study|Withdrawal by Subject|0|||
162096121|NCT03879798|585402717|FG001|Overall Study|Withdrawal by Subject|0|||
162096122|NCT03879798|585402718|FG002|Overall Study|Withdrawal by Subject|0|||
162096123|NCT03879798|585402719|FG003|Overall Study|Withdrawal by Subject|0|||
162096124|NCT03879798|585402720|FG004|Overall Study|Withdrawal by Subject|0|||
162096125|NCT03879798|585402721|FG005|Overall Study|Withdrawal by Subject|1|||
162096126|NCT01343407|585402722|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
162096127|NCT01343407|585402723|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
162096128|NCT01343407|585402724|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
162096129|NCT01343407|585402725|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
162096130|NCT01343407|585402726|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
162096131|NCT01343407|585402727|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
162096132|NCT01343407|585402722|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
162096133|NCT01343407|585402723|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
162096134|NCT01343407|585402724|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
162096135|NCT01343407|585402725|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
162096136|NCT01343407|585402726|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
162096137|NCT01343407|585402727|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
162096138|NCT06027216|585402728|FG000|Overall Study|Did not qualify|8|||
162096139|NCT00874029|585402729|FG000|Overall Study|Withdrawal by Subject|10|||
162096140|NCT00874029|585402729|FG000|Overall Study|Pregnancy|4|||
162096141|NCT00874029|585402729|FG000|Overall Study|Physician Decision|1|||
162096142|NCT00874029|585402729|FG000|Overall Study|Adverse Event|1|||
162096143|NCT00874029|585402729|FG000|Overall Study|Lost to Follow-up|5|||
162096144|NCT01767116|585402730|FG000|Overall Study|Lost to Follow-up|2|||
162096145|NCT01767116|585402731|FG001|Overall Study|Lost to Follow-up|2|||
162096146|NCT00968669|585402732|FG000|Overall Study|Lost to Follow-up|5|||
162096147|NCT00968669|585402733|FG001|Overall Study|Lost to Follow-up|2|||
162096148|NCT00968669|585402734|FG002|Overall Study|Lost to Follow-up|1|||
162096149|NCT00968669|585402735|FG003|Overall Study|Lost to Follow-up|4|||
162096150|NCT00968669|585402732|FG000|Overall Study|Withdrawal by Subject|9|||
162096151|NCT00968669|585402733|FG001|Overall Study|Withdrawal by Subject|7|||
162096152|NCT00968669|585402734|FG002|Overall Study|Withdrawal by Subject|5|||
162096153|NCT00968669|585402735|FG003|Overall Study|Withdrawal by Subject|3|||
162096154|NCT00968669|585402732|FG000|Overall Study|Pregnancy|0|||
162096155|NCT00968669|585402733|FG001|Overall Study|Pregnancy|0|||
162096156|NCT00968669|585402734|FG002|Overall Study|Pregnancy|2|||
162096157|NCT00968669|585402735|FG003|Overall Study|Pregnancy|0|||
162096158|NCT00968669|585402732|FG000|Overall Study|AE|1|||
162096159|NCT00968669|585402733|FG001|Overall Study|AE|0|||
162096160|NCT00968669|585402734|FG002|Overall Study|AE|0|||
162096161|NCT00968669|585402735|FG003|Overall Study|AE|0|||
162096162|NCT00968669|585402732|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
162096163|NCT00968669|585402733|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
162096164|NCT00968669|585402734|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
162096165|NCT00968669|585402735|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
162096166|NCT00968669|585402732|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
162096167|NCT00968669|585402733|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
162096168|NCT00968669|585402734|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
162096169|NCT00968669|585402735|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
162122787|NCT01351025|585500335|FG000|Week 0 - 20|Lost to Follow-up|2|||
162096170|NCT00968669|585402732|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
162096171|NCT00968669|585402733|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
162096172|NCT00968669|585402734|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
162096173|NCT00968669|585402735|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
162096174|NCT00968669|585402732|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
162096175|NCT00968669|585402733|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
162096176|NCT00968669|585402734|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
162096177|NCT00968669|585402735|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
162096178|NCT00968669|585402732|FG000|Overall Study|EARLY WITHDRAWAL|0|||
162096179|NCT00968669|585402733|FG001|Overall Study|EARLY WITHDRAWAL|1|||
162096180|NCT00968669|585402734|FG002|Overall Study|EARLY WITHDRAWAL|0|||
162096181|NCT00968669|585402735|FG003|Overall Study|EARLY WITHDRAWAL|0|||
162096182|NCT00968669|585402732|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
162096183|NCT00968669|585402733|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
162096184|NCT00968669|585402734|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
162096185|NCT00968669|585402735|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
162096186|NCT00968669|585402732|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
162096187|NCT00968669|585402733|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
162096188|NCT00968669|585402734|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
162096189|NCT00968669|585402735|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
162096190|NCT00968669|585402732|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
162096191|NCT00968669|585402733|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
162096192|NCT00968669|585402734|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
162096193|NCT00968669|585402735|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
162096194|NCT00968669|585402732|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
162096195|NCT00968669|585402733|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
162096196|NCT00968669|585402734|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
162096197|NCT00968669|585402735|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
162096198|NCT00968669|585402732|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
162096199|NCT00968669|585402733|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
162096200|NCT00968669|585402734|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
162096201|NCT00968669|585402735|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
162096202|NCT00968669|585402732|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
162096203|NCT00968669|585402733|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
162096204|NCT00968669|585402734|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
162096205|NCT00968669|585402735|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
162096206|NCT00968669|585402732|FG000|Overall Study|SPONSOR DECISION|0|||
162096207|NCT00968669|585402733|FG001|Overall Study|SPONSOR DECISION|1|||
162096208|NCT00968669|585402734|FG002|Overall Study|SPONSOR DECISION|0|||
162096209|NCT00968669|585402735|FG003|Overall Study|SPONSOR DECISION|0|||
162096210|NCT00968669|585402732|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
162096211|NCT00968669|585402733|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
162096212|NCT00968669|585402734|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
162096213|NCT00968669|585402735|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
162096214|NCT00968669|585402732|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
162096215|NCT00968669|585402733|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
162096216|NCT00968669|585402734|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
162096217|NCT00968669|585402735|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
162096218|NCT00968669|585402732|FG000|Overall Study|SUBJECT INCARCERATED|0|||
162096219|NCT00968669|585402733|FG001|Overall Study|SUBJECT INCARCERATED|1|||
162096220|NCT00968669|585402734|FG002|Overall Study|SUBJECT INCARCERATED|0|||
162096221|NCT00968669|585402735|FG003|Overall Study|SUBJECT INCARCERATED|0|||
162096222|NCT00968669|585402732|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
162096223|NCT00968669|585402733|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
162096224|NCT00968669|585402734|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
162096225|NCT00968669|585402735|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
162096226|NCT00968669|585402732|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
162096227|NCT00968669|585402733|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
162096228|NCT00968669|585402734|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
162096229|NCT00968669|585402735|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
162096230|NCT01669343|585402738|FG000|Part A: All Patients|Withdrawal by Subject|7|||
162096231|NCT01669343|585402738|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
162096232|NCT01669343|585402738|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
162096233|NCT01669343|585402738|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
162096234|NCT01669343|585402738|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
162096235|NCT02371369|585402743|FG000|Part 1|Physician Decision|0|||
162096236|NCT02371369|585402744|FG001|Part 1|Physician Decision|3|||
162096237|NCT02371369|585402743|FG000|Part 1|Adverse Event|8|||
162096238|NCT02371369|585402744|FG001|Part 1|Adverse Event|0|||
162096239|NCT02371369|585402743|FG000|Part 1|Withdrawal by Subject|1|||
162096240|NCT02371369|585402744|FG001|Part 1|Withdrawal by Subject|6|||
162096241|NCT02371369|585402743|FG000|Part 1|Disease progression|0|||
162096242|NCT02371369|585402744|FG001|Part 1|Disease progression|1|||
162096243|NCT02371369|585402743|FG000|Part 1|Protocol Violation|0|||
162096244|NCT02371369|585402744|FG001|Part 1|Protocol Violation|1|||
162096245|NCT02371369|585402743|FG000|Part 2|Adverse Event|6|||
162096246|NCT02371369|585402744|FG001|Part 2|Adverse Event|5|||
162096247|NCT02371369|585402743|FG000|Part 2|Withdrawal by Subject|16|||
162096248|NCT02371369|585402744|FG001|Part 2|Withdrawal by Subject|6|||
162096249|NCT02371369|585402743|FG000|Part 2|Investigator decision|1|||
162096250|NCT02371369|585402744|FG001|Part 2|Investigator decision|2|||
162096251|NCT02371369|585402743|FG000|Part 2|Death|0|||
162096252|NCT02371369|585402744|FG001|Part 2|Death|1|||
162096253|NCT02371369|585402743|FG000|Part 2|Disease progression|1|||
162096254|NCT02371369|585402744|FG001|Part 2|Disease progression|0|||
162096255|NCT02371369|585402743|FG000|Part 2|Subject Noncompliance|1|||
162096256|NCT02371369|585402744|FG001|Part 2|Subject Noncompliance|0|||
162096257|NCT02371369|585402743|FG000|Part 2|Lost to Follow-up|1|||
162096258|NCT02371369|585402744|FG001|Part 2|Lost to Follow-up|1|||
162096259|NCT02371369|585402743|FG000|Part 2|Subject transitioned to commercial supply|6|||
162096260|NCT02371369|585402744|FG001|Part 2|Subject transitioned to commercial supply|4|||
162096261|NCT02371369|585402743|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
162096262|NCT02371369|585402744|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
162096263|NCT02371369|585402743|FG000|Part 2|Surgical resection of tumor|1|||
162096264|NCT02371369|585402744|FG001|Part 2|Surgical resection of tumor|1|||
162096265|NCT02371369|585402743|FG000|Part 2|Other|0|||
162096266|NCT02371369|585402744|FG001|Part 2|Other|1|||
162096267|NCT01024387|585402745|FG000|Overall Study|Radiographic Progression|29|||
162096268|NCT01024387|585402745|FG000|Overall Study|Symptomatic Progression|10|||
162096269|NCT01024387|585402745|FG000|Overall Study|Physician Decision|5|||
162096270|NCT01024387|585402745|FG000|Overall Study|Withdrawal by Subject|5|||
162096271|NCT01024387|585402745|FG000|Overall Study|Death|2|||
162096272|NCT01024387|585402745|FG000|Overall Study|Prolonged Treatment Delay|1|||
162096273|NCT01024387|585402745|FG000|Overall Study|Adverse Event|3|||
162096274|NCT01024387|585402745|FG000|Overall Study|Other|5|||
162096275|NCT03855189|585402746|FG000|Overall Study|Adverse Event|5|||
162096276|NCT03855189|585402747|FG001|Overall Study|Adverse Event|2|||
162096277|NCT03855189|585402748|FG002|Overall Study|Adverse Event|4|||
162096278|NCT03855189|585402746|FG000|Overall Study|Treatment Failure|1|||
162096279|NCT03855189|585402747|FG001|Overall Study|Treatment Failure|1|||
162096280|NCT03855189|585402748|FG002|Overall Study|Treatment Failure|2|||
162096281|NCT03855189|585402746|FG000|Overall Study|Noncompliance with Protocol|0|||
162096282|NCT03855189|585402747|FG001|Overall Study|Noncompliance with Protocol|1|||
162096283|NCT03855189|585402748|FG002|Overall Study|Noncompliance with Protocol|0|||
162096284|NCT03855189|585402746|FG000|Overall Study|Did Not Return|4|||
162096285|NCT03855189|585402747|FG001|Overall Study|Did Not Return|3|||
162096286|NCT03855189|585402748|FG002|Overall Study|Did Not Return|0|||
162096287|NCT04307186|585402751|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
162096288|NCT04307186|585402751|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
162096289|NCT04307186|585402751|FG000|Washout 3-14 Days|Progressive disease|1|||
162096290|NCT04307186|585402751|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
162096291|NCT04307186|585402751|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
162096292|NCT01618838|585402754|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
162096293|NCT01434602|585402755|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
162096294|NCT01434602|585402756|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
162096295|NCT01434602|585402757|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
162096296|NCT01434602|585402758|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
162096297|NCT01434602|585402759|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
162096298|NCT01434602|585402755|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
162096299|NCT01434602|585402756|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
162096300|NCT01434602|585402757|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
162096301|NCT01434602|585402758|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
162096302|NCT01434602|585402759|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
162096303|NCT01434602|585402755|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
162096304|NCT01434602|585402756|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
162096305|NCT01434602|585402757|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
162096306|NCT01434602|585402758|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
162096307|NCT01434602|585402759|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
162096308|NCT01434602|585402755|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
162096309|NCT01434602|585402756|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
162096310|NCT01434602|585402757|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
162096311|NCT01434602|585402758|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
162096312|NCT01434602|585402759|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
162096313|NCT01434602|585402755|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
162096314|NCT01434602|585402756|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
162096315|NCT01434602|585402757|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
162096316|NCT01434602|585402758|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
162096317|NCT01434602|585402759|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
162096318|NCT01434602|585402755|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
162096319|NCT01434602|585402756|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
162096320|NCT01434602|585402757|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
162096321|NCT01434602|585402758|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
162096322|NCT01434602|585402759|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
162096323|NCT01434602|585402755|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
162096324|NCT01434602|585402756|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
162096325|NCT01434602|585402757|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
162096326|NCT01434602|585402758|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
162096327|NCT01434602|585402759|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
162096328|NCT01434602|585402755|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
162096329|NCT01434602|585402756|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
162096330|NCT01434602|585402757|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
162096331|NCT01434602|585402758|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
162096332|NCT01434602|585402759|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
162096333|NCT01434602|585402755|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
162096334|NCT01434602|585402756|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
162096335|NCT01434602|585402757|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
162096336|NCT01434602|585402758|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
162096337|NCT01434602|585402759|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
162096338|NCT01434602|585402755|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
162096339|NCT01434602|585402756|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
162096340|NCT01434602|585402757|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
162096341|NCT01434602|585402758|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
162096342|NCT01434602|585402759|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
162096343|NCT01587651|585402764|FG000|Overall Study|Adverse Event|0|||
162096344|NCT01587651|585402765|FG001|Overall Study|Adverse Event|1|||
162096345|NCT01587651|585402766|FG002|Overall Study|Adverse Event|0|||
162096346|NCT01587651|585402764|FG000|Overall Study|Protocol Violation|0|||
162096347|NCT01587651|585402765|FG001|Overall Study|Protocol Violation|1|||
162096348|NCT01587651|585402766|FG002|Overall Study|Protocol Violation|1|||
162096349|NCT01587651|585402764|FG000|Overall Study|Withdrawal by Subject|0|||
162096350|NCT01587651|585402765|FG001|Overall Study|Withdrawal by Subject|1|||
162096351|NCT01587651|585402766|FG002|Overall Study|Withdrawal by Subject|0|||
162096352|NCT03864900|585402769|FG000|Overall Study|Withdrawal by Subject|1|||
162096353|NCT03864900|585402770|FG001|Overall Study|Withdrawal by Subject|1|||
162096354|NCT03864900|585402769|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
162096355|NCT03864900|585402770|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
162096356|NCT00759109|585402773|FG000|Overall Study|Adverse Event|17|||
162096357|NCT00759109|585402774|FG001|Overall Study|Adverse Event|12|||
162096358|NCT00759109|585402773|FG000|Overall Study|Inability to comply|1|||
162096359|NCT00759109|585402774|FG001|Overall Study|Inability to comply|1|||
162096360|NCT00759109|585402773|FG000|Overall Study|Withdrawal by Subject|9|||
162096361|NCT00759109|585402774|FG001|Overall Study|Withdrawal by Subject|5|||
162096362|NCT00759109|585402773|FG000|Overall Study|Death|4|||
162096363|NCT00759109|585402774|FG001|Overall Study|Death|3|||
162096364|NCT00759109|585402773|FG000|Overall Study|Lost to Follow-up|4|||
162096365|NCT00759109|585402774|FG001|Overall Study|Lost to Follow-up|6|||
162096366|NCT00759109|585402773|FG000|Overall Study|Started new therapy|2|||
162096367|NCT00759109|585402774|FG001|Overall Study|Started new therapy|6|||
162096368|NCT00759109|585402773|FG000|Overall Study|HCV RNA negative|1|||
162096369|NCT00759109|585402774|FG001|Overall Study|HCV RNA negative|0|||
162096370|NCT00759109|585402773|FG000|Overall Study|Participant moved to a different city|0|||
162096371|NCT00759109|585402774|FG001|Overall Study|Participant moved to a different city|1|||
162096372|NCT00759109|585402773|FG000|Overall Study|Participant had a liver transplant|0|||
162096373|NCT00759109|585402774|FG001|Overall Study|Participant had a liver transplant|1|||
162096374|NCT00759109|585402773|FG000|Overall Study|Lost during study|1|||
162096375|NCT00759109|585402774|FG001|Overall Study|Lost during study|0|||
162096376|NCT03238001|585402775|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
162096377|NCT03238001|585402775|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
162096378|NCT03238001|585402775|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
162096379|NCT03238001|585402775|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
162096380|NCT03238001|585402775|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
162096381|NCT03238001|585402775|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
162096382|NCT03238001|585402775|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
162096383|NCT03238001|585402775|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
162096384|NCT03325712|585402786|FG000|Overall Study|Protocol Violation|0|||
162096385|NCT03325712|585402787|FG001|Overall Study|Protocol Violation|0|||
162096386|NCT03325712|585402788|FG002|Overall Study|Protocol Violation|0|||
162096387|NCT03325712|585402789|FG003|Overall Study|Protocol Violation|0|||
162096388|NCT03325712|585402790|FG004|Overall Study|Protocol Violation|1|||
162096389|NCT03325712|585402791|FG005|Overall Study|Protocol Violation|0|||
162096390|NCT03325712|585402792|FG006|Overall Study|Protocol Violation|0|||
162096391|NCT03325712|585402793|FG007|Overall Study|Protocol Violation|0|||
162096392|NCT03325712|585402786|FG000|Overall Study|Adverse Event|0|||
162096393|NCT03325712|585402787|FG001|Overall Study|Adverse Event|0|||
162096394|NCT03325712|585402788|FG002|Overall Study|Adverse Event|0|||
162096395|NCT03325712|585402789|FG003|Overall Study|Adverse Event|0|||
162096396|NCT03325712|585402790|FG004|Overall Study|Adverse Event|1|||
162096397|NCT03325712|585402791|FG005|Overall Study|Adverse Event|0|||
162096398|NCT03325712|585402792|FG006|Overall Study|Adverse Event|0|||
162096399|NCT03325712|585402793|FG007|Overall Study|Adverse Event|0|||
162096400|NCT02265237|585402794|FG000|As Treated (Overall Study)|Adverse Event|1|||
162096401|NCT02265237|585402795|FG001|As Treated (Overall Study)|Adverse Event|1|||
162096402|NCT02265237|585402796|FG002|As Treated (Overall Study)|Adverse Event|0|||
162096403|NCT02265237|585402797|FG003|As Treated (Overall Study)|Adverse Event|0|||
162096404|NCT02265237|585402794|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
162096405|NCT02265237|585402795|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
162096406|NCT02265237|585402796|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
162096407|NCT02265237|585402797|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
162096408|NCT02265237|585402794|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
162096409|NCT02265237|585402795|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
162096410|NCT02265237|585402796|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
162096411|NCT02265237|585402797|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
162096412|NCT02265237|585402794|FG000|As Treated (Overall Study)|Other|2|||
162096413|NCT02265237|585402795|FG001|As Treated (Overall Study)|Other|0|||
162096414|NCT02265237|585402796|FG002|As Treated (Overall Study)|Other|3|||
162096415|NCT02265237|585402797|FG003|As Treated (Overall Study)|Other|1|||
162096416|NCT01178853|585402799|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
162096417|NCT01178853|585402800|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
162096418|NCT01178853|585402799|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
162096419|NCT01178853|585402800|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
162096420|NCT01178853|585402799|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
162096421|NCT01178853|585402800|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
162096422|NCT01178853|585402799|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
162096423|NCT01178853|585402800|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
162096424|NCT01178853|585402799|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
162096425|NCT01178853|585402800|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
162096426|NCT03550313|585402801|FG000|Overall Study|Adverse Event|0|||
162096427|NCT03550313|585402802|FG001|Overall Study|Adverse Event|1|||
162096428|NCT03550313|585402803|FG002|Overall Study|Adverse Event|0|||
162096429|NCT03550313|585402801|FG000|Overall Study|Lost to Follow-up|5|||
162096430|NCT03550313|585402802|FG001|Overall Study|Lost to Follow-up|7|||
162096431|NCT03550313|585402803|FG002|Overall Study|Lost to Follow-up|12|||
162096432|NCT03550313|585402801|FG000|Overall Study|Study terminated by sponsor|44|||
162096433|NCT03550313|585402802|FG001|Overall Study|Study terminated by sponsor|37|||
162096434|NCT03550313|585402803|FG002|Overall Study|Study terminated by sponsor|48|||
162096435|NCT03550313|585402801|FG000|Overall Study|No longer met eligibility criteria|3|||
162096436|NCT03550313|585402802|FG001|Overall Study|No longer met eligibility criteria|5|||
162096437|NCT03550313|585402803|FG002|Overall Study|No longer met eligibility criteria|6|||
162096438|NCT03550313|585402801|FG000|Overall Study|Withdrawal by parent/guardian|20|||
162096439|NCT03550313|585402802|FG001|Overall Study|Withdrawal by parent/guardian|18|||
162096440|NCT03550313|585402803|FG002|Overall Study|Withdrawal by parent/guardian|26|||
162096441|NCT03550313|585402801|FG000|Overall Study|Other|4|||
162096442|NCT03550313|585402802|FG001|Overall Study|Other|2|||
162096443|NCT03550313|585402803|FG002|Overall Study|Other|2|||
162096444|NCT03550313|585402801|FG000|Overall Study|Randomized but not vaccinated|3|||
162096445|NCT03550313|585402802|FG001|Overall Study|Randomized but not vaccinated|23|||
162096446|NCT03550313|585402803|FG002|Overall Study|Randomized but not vaccinated|2|||
162096447|NCT03550313|585402801|FG000|Overall Study|Sites terminated due to quality issues|18|||
162096448|NCT03550313|585402802|FG001|Overall Study|Sites terminated due to quality issues|17|||
162096449|NCT03550313|585402803|FG002|Overall Study|Sites terminated due to quality issues|18|||
162096450|NCT00839072|585402804|FG000|First Intervention Period|Withdrawal by Subject|1|||
162096451|NCT00839072|585402805|FG001|First Intervention Period|Withdrawal by Subject|0|||
162096452|NCT00839072|585402804|FG000|First Intervention Period|Adverse Event|1|||
162096453|NCT00839072|585402805|FG001|First Intervention Period|Adverse Event|1|||
162096454|NCT00839072|585402804|FG000|Second Intervention Period|Withdrawal by Subject|1|||
162096455|NCT00839072|585402805|FG001|Second Intervention Period|Withdrawal by Subject|0|||
162096456|NCT00380068|585402806|FG000|Overall Study|Adverse Event|40|||
162096457|NCT00380068|585402806|FG000|Overall Study|Withdrawal by Subject|10|||
162096458|NCT00380068|585402806|FG000|Overall Study|Not compliant|6|||
162096459|NCT00380068|585402806|FG000|Overall Study|Lost to Follow-up|1|||
162096460|NCT00380068|585402806|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
162096461|NCT00380068|585402806|FG000|Overall Study|Lung transplant|3|||
162096462|NCT00380068|585402806|FG000|Overall Study|Physician Decision|2|||
162096463|NCT00380068|585402806|FG000|Overall Study|Partipant moved away|1|||
162096464|NCT00380068|585402806|FG000|Overall Study|Lack of Efficacy|5|||
162096465|NCT01297062|585402807|FG000|Overall Study|Adverse Event|2|||
162096466|NCT01297062|585402808|FG001|Overall Study|Adverse Event|0|||
162096467|NCT01297062|585402809|FG002|Overall Study|Adverse Event|1|||
162096468|NCT01297062|585402810|FG003|Overall Study|Adverse Event|0|||
162096469|NCT01297062|585402811|FG004|Overall Study|Adverse Event|0|||
162096470|NCT01297062|585402812|FG005|Overall Study|Adverse Event|0|||
162096471|NCT01297062|585402813|FG006|Overall Study|Adverse Event|0|||
162096472|NCT01297062|585402807|FG000|Overall Study|Physician Decision|1|||
162096473|NCT01297062|585402808|FG001|Overall Study|Physician Decision|0|||
162096474|NCT01297062|585402809|FG002|Overall Study|Physician Decision|1|||
162096475|NCT01297062|585402810|FG003|Overall Study|Physician Decision|0|||
162096476|NCT01297062|585402811|FG004|Overall Study|Physician Decision|0|||
162096477|NCT01297062|585402812|FG005|Overall Study|Physician Decision|0|||
162096478|NCT01297062|585402813|FG006|Overall Study|Physician Decision|6|||
162096479|NCT01297062|585402807|FG000|Overall Study|Protocol Violation|0|||
162096480|NCT01297062|585402808|FG001|Overall Study|Protocol Violation|0|||
162096481|NCT01297062|585402809|FG002|Overall Study|Protocol Violation|0|||
162096482|NCT01297062|585402810|FG003|Overall Study|Protocol Violation|0|||
162096483|NCT01297062|585402811|FG004|Overall Study|Protocol Violation|1|||
162096484|NCT01297062|585402812|FG005|Overall Study|Protocol Violation|0|||
162096485|NCT01297062|585402813|FG006|Overall Study|Protocol Violation|0|||
162096486|NCT01297062|585402807|FG000|Overall Study|Subject Decision|1|||
162096487|NCT01297062|585402808|FG001|Overall Study|Subject Decision|1|||
162096488|NCT01297062|585402809|FG002|Overall Study|Subject Decision|0|||
162096489|NCT01297062|585402810|FG003|Overall Study|Subject Decision|1|||
162096490|NCT01297062|585402811|FG004|Overall Study|Subject Decision|1|||
162096491|NCT01297062|585402812|FG005|Overall Study|Subject Decision|1|||
162096492|NCT01297062|585402813|FG006|Overall Study|Subject Decision|2|||
162096493|NCT03191903|585402814|FG000|Overall Study|Withdrawal by Subject|6|||
162096494|NCT03191903|585402815|FG001|Overall Study|Withdrawal by Subject|5|||
162096495|NCT03191903|585402816|FG002|Overall Study|Withdrawal by Subject|4|||
162096496|NCT03191903|585402814|FG000|Overall Study|Adverse Event|1|||
162096497|NCT03191903|585402815|FG001|Overall Study|Adverse Event|0|||
162096498|NCT03191903|585402816|FG002|Overall Study|Adverse Event|0|||
162096499|NCT03149328|585402817|FG000|Overall Study|Withdrawal by Subject|30|||
162096500|NCT03149328|585402818|FG001|Overall Study|Withdrawal by Subject|26|||
162096501|NCT03149328|585402817|FG000|Overall Study|Changed Dialysis Modality|18|||
162096502|NCT03149328|585402818|FG001|Overall Study|Changed Dialysis Modality|1|||
162096503|NCT03149328|585402817|FG000|Overall Study|Transplant|9|||
162096504|NCT03149328|585402818|FG001|Overall Study|Transplant|1|||
162096505|NCT03149328|585402817|FG000|Overall Study|Lost to Follow-up|25|||
162096506|NCT03149328|585402818|FG001|Overall Study|Lost to Follow-up|16|||
162096507|NCT03149328|585402817|FG000|Overall Study|Left Study Site|1|||
162096508|NCT03149328|585402818|FG001|Overall Study|Left Study Site|2|||
162096509|NCT03149328|585402817|FG000|Overall Study|Language Barrier|1|||
162096510|NCT03149328|585402818|FG001|Overall Study|Language Barrier|0|||
162096511|NCT00503685|585402822|FG000|Overall Study|Adverse Event|0|||
162096512|NCT00503685|585402823|FG001|Overall Study|Adverse Event|0|||
162096513|NCT00503685|585402824|FG002|Overall Study|Adverse Event|2|||
162096514|NCT00503685|585402822|FG000|Overall Study|Withdrawal by Subject|0|||
162096515|NCT00503685|585402823|FG001|Overall Study|Withdrawal by Subject|1|||
162096516|NCT00503685|585402824|FG002|Overall Study|Withdrawal by Subject|0|||
162096517|NCT00503685|585402822|FG000|Overall Study|Protocol Violation|0|||
162096518|NCT00503685|585402823|FG001|Overall Study|Protocol Violation|1|||
162096519|NCT00503685|585402824|FG002|Overall Study|Protocol Violation|0|||
162096520|NCT00503685|585402822|FG000|Overall Study|Eligibility Criteria Not Met|0|||
162096521|NCT00503685|585402823|FG001|Overall Study|Eligibility Criteria Not Met|1|||
162096522|NCT00503685|585402824|FG002|Overall Study|Eligibility Criteria Not Met|0|||
162096523|NCT01110239|585402825|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
162096524|NCT01110239|585402826|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
162096525|NCT01110239|585402827|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
162096526|NCT01110239|585402828|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
162096527|NCT01110239|585402825|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
162096528|NCT01110239|585402826|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
162096529|NCT01110239|585402827|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
162096530|NCT01110239|585402828|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
162096531|NCT00080223|585402833|FG000|Overall Study|Adverse Event|23|||
162096532|NCT00080223|585402833|FG000|Overall Study|Death|21|||
162096533|NCT00080223|585402833|FG000|Overall Study|Withdrawal by Subject|13|||
162096534|NCT00080223|585402833|FG000|Overall Study|Lung Transplantation|9|||
162096535|NCT00080223|585402833|FG000|Overall Study|Non-compliance With Study Treatment|7|||
162096536|NCT00080223|585402833|FG000|Overall Study|Participant unwilling to continue|2|||
162096537|NCT00080223|585402833|FG000|Overall Study|Physician Decision|1|||
162096538|NCT01349569|585404818|FG000|Overall Study|Lack of Efficacy|4|||
162096539|NCT03581305|585404819|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
162096540|NCT03581305|585404820|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
162096541|NCT03581305|585404819|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
162096542|NCT03581305|585404820|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
162096543|NCT03581305|585404819|FG000|Serotonergic Study|Withdrawal by Subject|5|||
162096544|NCT03581305|585404820|FG001|Serotonergic Study|Withdrawal by Subject|1|||
162096545|NCT01490632|585404821|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
162096546|NCT01490632|585404822|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
162096547|NCT01490632|585404823|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
162096548|NCT01490632|585404824|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
162096549|NCT01490632|585404825|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
162096550|NCT01490632|585404826|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
162096551|NCT01490632|585404827|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
162096552|NCT01490632|585404828|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
162096553|NCT01490632|585404829|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
162096554|NCT01490632|585404830|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
162096555|NCT01490632|585404831|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
162096556|NCT01490632|585404832|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
162096557|NCT01490632|585404833|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
162096558|NCT01490632|585404834|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
162096559|NCT01490632|585404835|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
162096560|NCT01490632|585404836|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
162096561|NCT01490632|585404837|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
162096562|NCT01490632|585404838|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
162096563|NCT01490632|585404839|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
162096564|NCT01490632|585404840|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
162096565|NCT01490632|585404821|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
162096566|NCT01490632|585404822|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
162096567|NCT01490632|585404823|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
162096568|NCT01490632|585404824|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
162096569|NCT01490632|585404825|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096570|NCT01490632|585404826|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096571|NCT01490632|585404827|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096572|NCT01490632|585404828|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096573|NCT01490632|585404829|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096574|NCT01490632|585404830|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096575|NCT01490632|585404831|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096576|NCT01490632|585404832|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096577|NCT01490632|585404833|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096578|NCT01490632|585404834|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096579|NCT01490632|585404835|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096580|NCT01490632|585404836|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096581|NCT01490632|585404837|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096582|NCT01490632|585404838|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096583|NCT01490632|585404839|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096584|NCT01490632|585404840|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
162096585|NCT01490632|585404821|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096586|NCT01490632|585404822|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096587|NCT01490632|585404823|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
162096588|NCT01490632|585404824|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
162096589|NCT01490632|585404825|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
162096590|NCT01490632|585404826|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096591|NCT01490632|585404827|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096592|NCT01490632|585404828|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096593|NCT01490632|585404829|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096594|NCT01490632|585404830|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096595|NCT01490632|585404831|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096596|NCT01490632|585404832|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096597|NCT01490632|585404833|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096598|NCT01490632|585404834|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096599|NCT01490632|585404835|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096600|NCT01490632|585404836|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096601|NCT01490632|585404837|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096602|NCT01490632|585404838|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096603|NCT01490632|585404839|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096604|NCT01490632|585404840|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
162096605|NCT01490632|585404821|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
162096606|NCT01490632|585404822|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
162096607|NCT01490632|585404823|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
162096608|NCT01490632|585404824|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
162096609|NCT01490632|585404825|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
162096610|NCT01490632|585404826|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
162096611|NCT01490632|585404827|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
162096612|NCT01490632|585404828|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
162096613|NCT01490632|585404829|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
162096614|NCT01490632|585404830|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
162096615|NCT01490632|585404831|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
162096616|NCT01490632|585404832|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
162096617|NCT01490632|585404833|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
162096618|NCT01490632|585404834|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
162096619|NCT01490632|585404835|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
162096620|NCT01490632|585404836|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
162096621|NCT01490632|585404837|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
162096622|NCT01490632|585404838|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
162096623|NCT01490632|585404839|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
162096624|NCT01490632|585404840|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
162096625|NCT01490632|585404821|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
162096626|NCT01490632|585404822|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096627|NCT01490632|585404823|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096628|NCT01490632|585404824|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096629|NCT01490632|585404825|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096630|NCT01490632|585404826|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096631|NCT01490632|585404827|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096632|NCT01490632|585404828|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096633|NCT01490632|585404829|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096634|NCT01490632|585404830|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096635|NCT01490632|585404831|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096636|NCT01490632|585404832|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096637|NCT01490632|585404833|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096638|NCT01490632|585404834|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096639|NCT01490632|585404835|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096640|NCT01490632|585404836|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096641|NCT01490632|585404837|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096642|NCT01490632|585404838|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096643|NCT01490632|585404839|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096644|NCT01490632|585404840|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
162096645|NCT01490632|585404821|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
162096646|NCT01490632|585404822|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
162096647|NCT01490632|585404823|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096648|NCT01490632|585404824|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
162096649|NCT01490632|585404825|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
162096650|NCT01490632|585404826|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096651|NCT01490632|585404827|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096652|NCT01490632|585404828|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096653|NCT01490632|585404829|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096654|NCT01490632|585404830|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096655|NCT01490632|585404831|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096656|NCT01490632|585404832|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096657|NCT01490632|585404833|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096658|NCT01490632|585404834|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096659|NCT01490632|585404835|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096660|NCT01490632|585404836|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096661|NCT01490632|585404837|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096662|NCT01490632|585404838|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096663|NCT01490632|585404839|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096664|NCT01490632|585404840|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
162096665|NCT01490632|585404821|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162122788|NCT01351025|585500336|FG001|Week 0 - 20|Lost to Follow-up|1|||
162096666|NCT01490632|585404822|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096667|NCT01490632|585404823|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096668|NCT01490632|585404824|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096669|NCT01490632|585404825|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
162096670|NCT01490632|585404826|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096671|NCT01490632|585404827|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096672|NCT01490632|585404828|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096673|NCT01490632|585404829|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096674|NCT01490632|585404830|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096675|NCT01490632|585404831|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096676|NCT01490632|585404832|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096677|NCT01490632|585404833|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096678|NCT01490632|585404834|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096679|NCT01490632|585404835|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096680|NCT01490632|585404836|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096681|NCT01490632|585404837|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096682|NCT01490632|585404838|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096683|NCT01490632|585404839|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096684|NCT01490632|585404840|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
162096685|NCT01490632|585404821|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096686|NCT01490632|585404822|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096687|NCT01490632|585404823|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096688|NCT01490632|585404824|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096689|NCT01490632|585404825|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096690|NCT01490632|585404826|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
162096691|NCT01490632|585404827|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
162096692|NCT01490632|585404828|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096693|NCT01490632|585404829|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096694|NCT01490632|585404830|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
162096695|NCT01490632|585404831|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
162096696|NCT01490632|585404832|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
162096697|NCT01490632|585404833|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096698|NCT01490632|585404834|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096699|NCT01490632|585404835|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096700|NCT01490632|585404836|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096701|NCT01490632|585404837|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096702|NCT01490632|585404838|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096703|NCT01490632|585404839|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096704|NCT01490632|585404840|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
162096705|NCT01490632|585404821|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096706|NCT01490632|585404822|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096707|NCT01490632|585404823|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096708|NCT01490632|585404824|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096709|NCT01490632|585404825|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096710|NCT01490632|585404826|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096711|NCT01490632|585404827|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
162096712|NCT01490632|585404828|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096713|NCT01490632|585404829|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
162096714|NCT01490632|585404830|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
162096715|NCT01490632|585404831|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
162096716|NCT01490632|585404832|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096717|NCT01490632|585404833|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096718|NCT01490632|585404834|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096719|NCT01490632|585404835|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096720|NCT01490632|585404836|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096721|NCT01490632|585404837|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096722|NCT01490632|585404838|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096723|NCT01490632|585404839|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096724|NCT01490632|585404840|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
162096725|NCT01490632|585404821|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096726|NCT01490632|585404822|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096727|NCT01490632|585404823|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096728|NCT01490632|585404824|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096729|NCT01490632|585404825|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096730|NCT01490632|585404826|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096731|NCT01490632|585404827|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
162096732|NCT01490632|585404828|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096733|NCT01490632|585404829|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096734|NCT01490632|585404830|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
162096735|NCT01490632|585404831|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096736|NCT01490632|585404832|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096737|NCT01490632|585404833|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096738|NCT01490632|585404834|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096739|NCT01490632|585404835|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096740|NCT01490632|585404836|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096741|NCT01490632|585404837|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096742|NCT01490632|585404838|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096743|NCT01490632|585404839|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096744|NCT01490632|585404840|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
162096745|NCT01490632|585404821|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096746|NCT01490632|585404822|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096747|NCT01490632|585404823|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096748|NCT01490632|585404824|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096749|NCT01490632|585404825|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096750|NCT01490632|585404826|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096751|NCT01490632|585404827|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
162096752|NCT01490632|585404828|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096753|NCT01490632|585404829|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096754|NCT01490632|585404830|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096755|NCT01490632|585404831|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096756|NCT01490632|585404832|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096757|NCT01490632|585404833|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096758|NCT01490632|585404834|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096759|NCT01490632|585404835|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096760|NCT01490632|585404836|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096761|NCT01490632|585404837|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096762|NCT01490632|585404838|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096763|NCT01490632|585404839|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096764|NCT01490632|585404840|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
162096765|NCT01490632|585404821|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096766|NCT01490632|585404822|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096767|NCT01490632|585404823|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096768|NCT01490632|585404824|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096769|NCT01490632|585404825|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096770|NCT01490632|585404826|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
162096771|NCT01490632|585404827|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096772|NCT01490632|585404828|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096773|NCT01490632|585404829|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096774|NCT01490632|585404830|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096775|NCT01490632|585404831|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096776|NCT01490632|585404832|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096777|NCT01490632|585404833|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096778|NCT01490632|585404834|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096779|NCT01490632|585404835|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096780|NCT01490632|585404836|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096781|NCT01490632|585404837|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096782|NCT01490632|585404838|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096783|NCT01490632|585404839|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096784|NCT01490632|585404840|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
162096785|NCT01490632|585404821|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096786|NCT01490632|585404822|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096787|NCT01490632|585404823|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096788|NCT01490632|585404824|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096789|NCT01490632|585404825|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096790|NCT01490632|585404826|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096791|NCT01490632|585404827|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
162096792|NCT01490632|585404828|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096793|NCT01490632|585404829|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
162096794|NCT01490632|585404830|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162122789|NCT01351025|585500335|FG000|Week 0 - 20|Withdrawal by Subject|1|||
162096795|NCT01490632|585404831|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
162096796|NCT01490632|585404832|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
162096797|NCT01490632|585404833|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096798|NCT01490632|585404834|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096799|NCT01490632|585404835|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096800|NCT01490632|585404836|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096801|NCT01490632|585404837|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096802|NCT01490632|585404838|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096803|NCT01490632|585404839|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096804|NCT01490632|585404840|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
162096805|NCT01490632|585404821|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096806|NCT01490632|585404822|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096807|NCT01490632|585404823|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096808|NCT01490632|585404824|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096809|NCT01490632|585404825|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096810|NCT01490632|585404826|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
162096811|NCT01490632|585404827|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
162096812|NCT01490632|585404828|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
162096813|NCT01490632|585404829|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
162096814|NCT01490632|585404830|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
162096815|NCT01490632|585404831|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
162096816|NCT01490632|585404832|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
162096817|NCT01490632|585404833|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096818|NCT01490632|585404834|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096819|NCT01490632|585404835|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096820|NCT01490632|585404836|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096821|NCT01490632|585404837|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096822|NCT01490632|585404838|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096823|NCT01490632|585404839|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096824|NCT01490632|585404840|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
162096825|NCT01490632|585404821|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096826|NCT01490632|585404822|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096827|NCT01490632|585404823|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096828|NCT01490632|585404824|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096829|NCT01490632|585404825|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096830|NCT01490632|585404826|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096831|NCT01490632|585404827|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096832|NCT01490632|585404828|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096833|NCT01490632|585404829|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096834|NCT01490632|585404830|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096835|NCT01490632|585404831|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096836|NCT01490632|585404832|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096837|NCT01490632|585404833|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096838|NCT01490632|585404834|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096839|NCT01490632|585404835|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
162096840|NCT01490632|585404836|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
162096841|NCT01490632|585404837|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096842|NCT01490632|585404838|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096843|NCT01490632|585404839|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096844|NCT01490632|585404840|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
162096845|NCT01490632|585404821|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096846|NCT01490632|585404822|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096847|NCT01490632|585404823|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096848|NCT01490632|585404824|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096849|NCT01490632|585404825|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096850|NCT01490632|585404826|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096851|NCT01490632|585404827|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096852|NCT01490632|585404828|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096853|NCT01490632|585404829|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096854|NCT01490632|585404830|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096855|NCT01490632|585404831|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096856|NCT01490632|585404832|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096857|NCT01490632|585404833|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096858|NCT01490632|585404834|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
162096859|NCT01490632|585404835|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096860|NCT01490632|585404836|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096861|NCT01490632|585404837|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096862|NCT01490632|585404838|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096863|NCT01490632|585404839|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096864|NCT01490632|585404840|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
162096865|NCT01490632|585404821|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096866|NCT01490632|585404822|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096867|NCT01490632|585404823|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096868|NCT01490632|585404824|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096869|NCT01490632|585404825|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096870|NCT01490632|585404826|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096871|NCT01490632|585404827|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096872|NCT01490632|585404828|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096873|NCT01490632|585404829|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096874|NCT01490632|585404830|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096875|NCT01490632|585404831|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096876|NCT01490632|585404832|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096877|NCT01490632|585404833|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096878|NCT01490632|585404834|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096879|NCT01490632|585404835|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
162096880|NCT01490632|585404836|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
162096881|NCT01490632|585404837|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096882|NCT01490632|585404838|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096883|NCT01490632|585404839|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096884|NCT01490632|585404840|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
162096885|NCT01490632|585404821|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096886|NCT01490632|585404822|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096887|NCT01490632|585404823|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096888|NCT01490632|585404824|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096889|NCT01490632|585404825|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096890|NCT01490632|585404826|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096891|NCT01490632|585404827|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096892|NCT01490632|585404828|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096893|NCT01490632|585404829|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096894|NCT01490632|585404830|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096895|NCT01490632|585404831|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096896|NCT01490632|585404832|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096897|NCT01490632|585404833|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
162096898|NCT01490632|585404834|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
162096899|NCT01490632|585404835|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
162096900|NCT01490632|585404836|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
162096901|NCT01490632|585404837|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096902|NCT01490632|585404838|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096903|NCT01490632|585404839|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096904|NCT01490632|585404840|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
162096905|NCT01490632|585404821|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
162096906|NCT01490632|585404822|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
162096907|NCT01490632|585404823|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
162096908|NCT01490632|585404824|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
162096909|NCT01490632|585404825|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
162096910|NCT01490632|585404826|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
162096911|NCT01490632|585404827|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
162096912|NCT01490632|585404828|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
162096913|NCT01490632|585404829|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
162096914|NCT01490632|585404830|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
162096915|NCT01490632|585404831|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
162096916|NCT01490632|585404832|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
162096917|NCT01490632|585404833|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
162096918|NCT01490632|585404834|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
162096919|NCT01490632|585404835|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
162096920|NCT01490632|585404836|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
162096921|NCT01490632|585404837|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
162096922|NCT01490632|585404838|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
162096923|NCT01490632|585404839|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
162096924|NCT01490632|585404840|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
162096925|NCT01490632|585404821|FG000|Part D: Re-Treatment Period|Death|0|||
162096926|NCT01490632|585404822|FG001|Part D: Re-Treatment Period|Death|0|||
162096927|NCT01490632|585404823|FG002|Part D: Re-Treatment Period|Death|0|||
162096928|NCT01490632|585404824|FG003|Part D: Re-Treatment Period|Death|0|||
162096929|NCT01490632|585404825|FG004|Part D: Re-Treatment Period|Death|0|||
162096930|NCT01490632|585404826|FG005|Part D: Re-Treatment Period|Death|0|||
162096931|NCT01490632|585404827|FG006|Part D: Re-Treatment Period|Death|0|||
162096932|NCT01490632|585404828|FG007|Part D: Re-Treatment Period|Death|0|||
162096933|NCT01490632|585404829|FG008|Part D: Re-Treatment Period|Death|0|||
162096934|NCT01490632|585404830|FG009|Part D: Re-Treatment Period|Death|0|||
162096935|NCT01490632|585404831|FG010|Part D: Re-Treatment Period|Death|0|||
162096936|NCT01490632|585404832|FG011|Part D: Re-Treatment Period|Death|0|||
162096937|NCT01490632|585404833|FG012|Part D: Re-Treatment Period|Death|0|||
162096938|NCT01490632|585404834|FG013|Part D: Re-Treatment Period|Death|0|||
162096939|NCT01490632|585404835|FG014|Part D: Re-Treatment Period|Death|0|||
162096940|NCT01490632|585404836|FG015|Part D: Re-Treatment Period|Death|0|||
162096941|NCT01490632|585404837|FG016|Part D: Re-Treatment Period|Death|0|||
162096942|NCT01490632|585404838|FG017|Part D: Re-Treatment Period|Death|0|||
162096943|NCT01490632|585404839|FG018|Part D: Re-Treatment Period|Death|1|||
162096944|NCT01490632|585404840|FG019|Part D: Re-Treatment Period|Death|0|||
162096945|NCT01490632|585404821|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096946|NCT01490632|585404822|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096947|NCT01490632|585404823|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096948|NCT01490632|585404824|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096949|NCT01490632|585404825|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096950|NCT01490632|585404826|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096951|NCT01490632|585404827|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096952|NCT01490632|585404828|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096953|NCT01490632|585404829|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096954|NCT01490632|585404830|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096955|NCT01490632|585404831|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096956|NCT01490632|585404832|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096957|NCT01490632|585404833|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096958|NCT01490632|585404834|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096959|NCT01490632|585404835|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096960|NCT01490632|585404836|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096961|NCT01490632|585404837|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
162096962|NCT01490632|585404838|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
162096963|NCT01490632|585404839|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
162096964|NCT01490632|585404840|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
162096965|NCT01490632|585404821|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096966|NCT01490632|585404822|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096967|NCT01490632|585404823|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096968|NCT01490632|585404824|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096969|NCT01490632|585404825|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096970|NCT01490632|585404826|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096971|NCT01490632|585404827|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096972|NCT01490632|585404828|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096973|NCT01490632|585404829|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096974|NCT01490632|585404830|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096975|NCT01490632|585404831|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096976|NCT01490632|585404832|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096977|NCT01490632|585404833|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096978|NCT01490632|585404834|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096979|NCT01490632|585404835|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096980|NCT01490632|585404836|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096981|NCT01490632|585404837|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096982|NCT01490632|585404838|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096983|NCT01490632|585404839|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
162096984|NCT01490632|585404840|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
162096985|NCT01490632|585404821|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
162096986|NCT01490632|585404822|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
162096987|NCT01490632|585404823|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
162096988|NCT01490632|585404824|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
162096989|NCT01490632|585404825|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
162096990|NCT01490632|585404826|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
162096991|NCT01490632|585404827|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
162096992|NCT01490632|585404828|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
162096993|NCT01490632|585404829|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
162096994|NCT01490632|585404830|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
162096995|NCT01490632|585404831|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
162096996|NCT01490632|585404832|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
162096997|NCT01490632|585404833|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
162096998|NCT01490632|585404834|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
162096999|NCT01490632|585404835|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
162097000|NCT01490632|585404836|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
162097001|NCT01490632|585404837|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
162097002|NCT01490632|585404838|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
162097003|NCT01490632|585404839|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
162097004|NCT01490632|585404840|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
162097005|NCT01490632|585404821|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
162097006|NCT01490632|585404822|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
162097007|NCT01490632|585404823|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
162097008|NCT01490632|585404824|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
162097009|NCT01490632|585404825|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
162097010|NCT01490632|585404826|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
162097011|NCT01490632|585404827|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
162097012|NCT01490632|585404828|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
162097013|NCT01490632|585404829|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
162097014|NCT01490632|585404830|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
162097015|NCT01490632|585404831|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
162097016|NCT01490632|585404832|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
162097017|NCT01490632|585404833|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
162097018|NCT01490632|585404834|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
162097019|NCT01490632|585404835|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
162097020|NCT01490632|585404836|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
162097021|NCT01490632|585404837|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
162097022|NCT01490632|585404838|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
162097023|NCT01490632|585404839|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
162097024|NCT01490632|585404840|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
162097025|NCT01490632|585404821|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097026|NCT01490632|585404822|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097027|NCT01490632|585404823|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097028|NCT01490632|585404824|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097029|NCT01490632|585404825|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097030|NCT01490632|585404826|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097031|NCT01490632|585404827|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097032|NCT01490632|585404828|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097033|NCT01490632|585404829|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097034|NCT01490632|585404830|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097035|NCT01490632|585404831|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097036|NCT01490632|585404832|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097037|NCT01490632|585404833|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097038|NCT01490632|585404834|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097039|NCT01490632|585404835|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097040|NCT01490632|585404836|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097041|NCT01490632|585404837|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
162097042|NCT01490632|585404838|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
162097043|NCT01490632|585404839|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
162097044|NCT01490632|585404840|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
162097045|NCT02332720|585404841|FG000|Part A and Part B|Lost to Follow-up|1|||
162097046|NCT02332720|585404842|FG001|Part A and Part B|Lost to Follow-up|0|||
162097047|NCT02332720|585404843|FG002|Part A and Part B|Lost to Follow-up|0|||
162097048|NCT02332720|585404844|FG003|Part A and Part B|Lost to Follow-up|0|||
162097049|NCT02332720|585404845|FG004|Part A and Part B|Lost to Follow-up|0|||
162097050|NCT02332720|585404846|FG005|Part A and Part B|Lost to Follow-up|2|||
162097051|NCT02332720|585404847|FG006|Part A and Part B|Lost to Follow-up|1|||
162097052|NCT02332720|585404848|FG007|Part A and Part B|Lost to Follow-up|1|||
162097053|NCT02332720|585404849|FG008|Part A and Part B|Lost to Follow-up|0|||
162097054|NCT02332720|585404850|FG009|Part A and Part B|Lost to Follow-up|0|||
162097055|NCT02332720|585404851|FG010|Part A and Part B|Lost to Follow-up|0|||
162097056|NCT02332720|585404852|FG011|Part A and Part B|Lost to Follow-up|0|||
162097057|NCT02332720|585404853|FG012|Part A and Part B|Lost to Follow-up|0|||
162097058|NCT02332720|585404854|FG013|Part A and Part B|Lost to Follow-up|0|||
162097059|NCT02332720|585404855|FG014|Part A and Part B|Lost to Follow-up|0|||
162097060|NCT02332720|585404856|FG015|Part A and Part B|Lost to Follow-up|1|||
162097061|NCT02332720|585404857|FG016|Part A and Part B|Lost to Follow-up|0|||
162097062|NCT02332720|585404858|FG017|Part A and Part B|Lost to Follow-up|0|||
162097063|NCT02332720|585404859|FG018|Part A and Part B|Lost to Follow-up|0|||
162097064|NCT02332720|585404860|FG019|Part A and Part B|Lost to Follow-up|0|||
162097065|NCT02332720|585404861|FG020|Part A and Part B|Lost to Follow-up|0|||
162122790|NCT01351025|585500336|FG001|Week 0 - 20|Withdrawal by Subject|0|||
162097066|NCT02332720|585404862|FG021|Part A and Part B|Lost to Follow-up|0|||
162097067|NCT02332720|585404863|FG022|Part A and Part B|Lost to Follow-up|0|||
162097068|NCT02332720|585404841|FG000|Part A and Part B|Adverse Event|0|||
162097069|NCT02332720|585404842|FG001|Part A and Part B|Adverse Event|0|||
162097070|NCT02332720|585404843|FG002|Part A and Part B|Adverse Event|0|||
162097071|NCT02332720|585404844|FG003|Part A and Part B|Adverse Event|0|||
162097072|NCT02332720|585404845|FG004|Part A and Part B|Adverse Event|0|||
162097073|NCT02332720|585404846|FG005|Part A and Part B|Adverse Event|0|||
162097074|NCT02332720|585404847|FG006|Part A and Part B|Adverse Event|0|||
162097075|NCT02332720|585404848|FG007|Part A and Part B|Adverse Event|0|||
162097076|NCT02332720|585404849|FG008|Part A and Part B|Adverse Event|0|||
162097077|NCT02332720|585404850|FG009|Part A and Part B|Adverse Event|0|||
162097078|NCT02332720|585404851|FG010|Part A and Part B|Adverse Event|0|||
162097079|NCT02332720|585404852|FG011|Part A and Part B|Adverse Event|0|||
162097080|NCT02332720|585404853|FG012|Part A and Part B|Adverse Event|0|||
162097081|NCT02332720|585404854|FG013|Part A and Part B|Adverse Event|0|||
162097082|NCT02332720|585404855|FG014|Part A and Part B|Adverse Event|0|||
162097083|NCT02332720|585404856|FG015|Part A and Part B|Adverse Event|0|||
162097084|NCT02332720|585404857|FG016|Part A and Part B|Adverse Event|0|||
162097085|NCT02332720|585404858|FG017|Part A and Part B|Adverse Event|1|||
162097086|NCT02332720|585404859|FG018|Part A and Part B|Adverse Event|0|||
162097087|NCT02332720|585404860|FG019|Part A and Part B|Adverse Event|0|||
162097088|NCT02332720|585404861|FG020|Part A and Part B|Adverse Event|0|||
162097089|NCT02332720|585404862|FG021|Part A and Part B|Adverse Event|0|||
162097090|NCT02332720|585404863|FG022|Part A and Part B|Adverse Event|0|||
162097091|NCT02332720|585404841|FG000|Part A and Part B|Physician Decision|0|||
162097092|NCT02332720|585404842|FG001|Part A and Part B|Physician Decision|0|||
162097093|NCT02332720|585404843|FG002|Part A and Part B|Physician Decision|0|||
162097094|NCT02332720|585404844|FG003|Part A and Part B|Physician Decision|0|||
162097095|NCT02332720|585404845|FG004|Part A and Part B|Physician Decision|0|||
162097096|NCT02332720|585404846|FG005|Part A and Part B|Physician Decision|0|||
162097097|NCT02332720|585404847|FG006|Part A and Part B|Physician Decision|0|||
162097098|NCT02332720|585404848|FG007|Part A and Part B|Physician Decision|0|||
162097099|NCT02332720|585404849|FG008|Part A and Part B|Physician Decision|0|||
162097100|NCT02332720|585404850|FG009|Part A and Part B|Physician Decision|0|||
162097101|NCT02332720|585404851|FG010|Part A and Part B|Physician Decision|0|||
162097102|NCT02332720|585404852|FG011|Part A and Part B|Physician Decision|0|||
162097103|NCT02332720|585404853|FG012|Part A and Part B|Physician Decision|0|||
162097104|NCT02332720|585404854|FG013|Part A and Part B|Physician Decision|0|||
162097105|NCT02332720|585404855|FG014|Part A and Part B|Physician Decision|0|||
162097106|NCT02332720|585404856|FG015|Part A and Part B|Physician Decision|0|||
162097107|NCT02332720|585404857|FG016|Part A and Part B|Physician Decision|0|||
162097108|NCT02332720|585404858|FG017|Part A and Part B|Physician Decision|0|||
162097109|NCT02332720|585404859|FG018|Part A and Part B|Physician Decision|1|||
162097110|NCT02332720|585404860|FG019|Part A and Part B|Physician Decision|0|||
162097111|NCT02332720|585404861|FG020|Part A and Part B|Physician Decision|0|||
162097112|NCT02332720|585404862|FG021|Part A and Part B|Physician Decision|0|||
162097113|NCT02332720|585404863|FG022|Part A and Part B|Physician Decision|0|||
162097114|NCT02332720|585404841|FG000|Part A and Part B|Withdrawal by Subject|0|||
162097115|NCT02332720|585404842|FG001|Part A and Part B|Withdrawal by Subject|0|||
162097116|NCT02332720|585404843|FG002|Part A and Part B|Withdrawal by Subject|0|||
162097117|NCT02332720|585404844|FG003|Part A and Part B|Withdrawal by Subject|0|||
162097118|NCT02332720|585404845|FG004|Part A and Part B|Withdrawal by Subject|0|||
162097119|NCT02332720|585404846|FG005|Part A and Part B|Withdrawal by Subject|1|||
162097120|NCT02332720|585404847|FG006|Part A and Part B|Withdrawal by Subject|0|||
162097121|NCT02332720|585404848|FG007|Part A and Part B|Withdrawal by Subject|0|||
162097122|NCT02332720|585404849|FG008|Part A and Part B|Withdrawal by Subject|0|||
162097123|NCT02332720|585404850|FG009|Part A and Part B|Withdrawal by Subject|0|||
162097124|NCT02332720|585404851|FG010|Part A and Part B|Withdrawal by Subject|0|||
162097125|NCT02332720|585404852|FG011|Part A and Part B|Withdrawal by Subject|0|||
162097126|NCT02332720|585404853|FG012|Part A and Part B|Withdrawal by Subject|0|||
162097127|NCT02332720|585404854|FG013|Part A and Part B|Withdrawal by Subject|0|||
162097128|NCT02332720|585404855|FG014|Part A and Part B|Withdrawal by Subject|0|||
162097129|NCT02332720|585404856|FG015|Part A and Part B|Withdrawal by Subject|0|||
162097130|NCT02332720|585404857|FG016|Part A and Part B|Withdrawal by Subject|0|||
162097131|NCT02332720|585404858|FG017|Part A and Part B|Withdrawal by Subject|0|||
162097132|NCT02332720|585404859|FG018|Part A and Part B|Withdrawal by Subject|0|||
162097133|NCT02332720|585404860|FG019|Part A and Part B|Withdrawal by Subject|1|||
162097134|NCT02332720|585404861|FG020|Part A and Part B|Withdrawal by Subject|0|||
162097135|NCT02332720|585404862|FG021|Part A and Part B|Withdrawal by Subject|0|||
162097136|NCT02332720|585404863|FG022|Part A and Part B|Withdrawal by Subject|0|||
162097137|NCT05732454|585404864|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
162097138|NCT05732454|585404865|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
162097139|NCT05732454|585404864|FG000|Part 1: DB Period|Adverse Event|1|||
162097140|NCT05732454|585404865|FG001|Part 1: DB Period|Adverse Event|0|||
162097141|NCT05732454|585404864|FG000|Part 1: DB Period|Lost to Follow-up|1|||
162097142|NCT05732454|585404865|FG001|Part 1: DB Period|Lost to Follow-up|0|||
162097143|NCT05732454|585404864|FG000|Part 1: DB Period|Protocol Violation|0|||
162097144|NCT05732454|585404865|FG001|Part 1: DB Period|Protocol Violation|1|||
162097145|NCT05732454|585404864|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
162097146|NCT05732454|585404865|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
162097147|NCT05732454|585404864|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
162097148|NCT05732454|585404865|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
162097149|NCT05732454|585404864|FG000|Part 1: OLE Period|Adverse Event|0|||
162097150|NCT05732454|585404865|FG001|Part 1: OLE Period|Adverse Event|1|||
162097151|NCT05732454|585404864|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
162097152|NCT05732454|585404865|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
162097153|NCT00838110|585404868|FG000|Overall Study|Death|0|||
162097154|NCT00838110|585404869|FG001|Overall Study|Death|0|||
162097155|NCT00838110|585404870|FG002|Overall Study|Death|1|||
162097156|NCT00838110|585404871|FG003|Overall Study|Death|2|||
162097157|NCT00838110|585404868|FG000|Overall Study|Adverse Event|11|||
162097158|NCT00838110|585404869|FG001|Overall Study|Adverse Event|10|||
162097159|NCT00838110|585404870|FG002|Overall Study|Adverse Event|8|||
162097160|NCT00838110|585404871|FG003|Overall Study|Adverse Event|7|||
162097161|NCT00838110|585404868|FG000|Overall Study|Withdrawal by Subject|5|||
162097162|NCT00838110|585404869|FG001|Overall Study|Withdrawal by Subject|6|||
162097163|NCT00838110|585404870|FG002|Overall Study|Withdrawal by Subject|3|||
162097164|NCT00838110|585404871|FG003|Overall Study|Withdrawal by Subject|4|||
162097165|NCT00838110|585404868|FG000|Overall Study|Other|3|||
162097166|NCT00838110|585404869|FG001|Overall Study|Other|3|||
162097167|NCT00838110|585404870|FG002|Overall Study|Other|3|||
162097168|NCT00838110|585404871|FG003|Overall Study|Other|2|||
162097169|NCT00838110|585404868|FG000|Overall Study|Protocol Violation|0|||
162097170|NCT00838110|585404869|FG001|Overall Study|Protocol Violation|2|||
162097171|NCT00838110|585404870|FG002|Overall Study|Protocol Violation|1|||
162097172|NCT00838110|585404871|FG003|Overall Study|Protocol Violation|1|||
162097173|NCT00838110|585404868|FG000|Overall Study|Lost to Follow-up|3|||
162097174|NCT00838110|585404869|FG001|Overall Study|Lost to Follow-up|0|||
162097175|NCT00838110|585404870|FG002|Overall Study|Lost to Follow-up|0|||
162097176|NCT00838110|585404871|FG003|Overall Study|Lost to Follow-up|0|||
162097177|NCT00838110|585404868|FG000|Overall Study|Did not meet eligibility criteria|0|||
162097178|NCT00838110|585404869|FG001|Overall Study|Did not meet eligibility criteria|0|||
162097179|NCT00838110|585404870|FG002|Overall Study|Did not meet eligibility criteria|1|||
162097180|NCT00838110|585404871|FG003|Overall Study|Did not meet eligibility criteria|2|||
162097181|NCT00838110|585404868|FG000|Overall Study|Randomized but not treated|0|||
162097182|NCT00838110|585404869|FG001|Overall Study|Randomized but not treated|1|||
162097183|NCT00838110|585404870|FG002|Overall Study|Randomized but not treated|0|||
162097184|NCT00838110|585404871|FG003|Overall Study|Randomized but not treated|0|||
162097185|NCT00352365|585404872|FG000|Induction Therapy|Adverse Event|7|||
162097186|NCT00352365|585404872|FG000|Induction Therapy|Progression/Relapse|8|||
162097187|NCT00352365|585404872|FG000|Induction Therapy|Death|7|||
162097188|NCT00352365|585404872|FG000|Induction Therapy|Not protocol specified|1|||
162097189|NCT00352365|585404872|FG000|Induction Therapy|Not eligible|3|||
162097190|NCT00352365|585404872|FG000|Induction Therapy|Death before starting protocol therapy|1|||
162097191|NCT00352365|585404872|FG000|Maintenance Therapy|Progression/Relapse|3|||
162097192|NCT00352365|585404872|FG000|Maintenance Therapy|Death|2|||
162097193|NCT00352365|585404872|FG000|Maintenance Therapy|Not protocol specified|3|||
162097194|NCT00352365|585404872|FG000|Maintenance Therapy|Not eligible|4|||
162097195|NCT01262651|585404873|FG000|Overall Study|Adverse Event|40|||
162097196|NCT01262651|585404874|FG001|Overall Study|Adverse Event|35|||
162097197|NCT01262651|585404873|FG000|Overall Study|Withdrawal by Subject|15|||
162097198|NCT01262651|585404874|FG001|Overall Study|Withdrawal by Subject|11|||
162097199|NCT01262651|585404873|FG000|Overall Study|Withdrawal by Investigator|2|||
162097200|NCT01262651|585404874|FG001|Overall Study|Withdrawal by Investigator|2|||
162097201|NCT01262651|585404873|FG000|Overall Study|Met Withdrawal Criteria|1|||
162097202|NCT01262651|585404874|FG001|Overall Study|Met Withdrawal Criteria|0|||
162097203|NCT04743908|585404875|FG000|Overall Study|Death|1|||
162097204|NCT04743908|585404876|FG001|Overall Study|Death|0|||
162097205|NCT04743908|585404875|FG000|Overall Study|Lost to Follow-up|181|||
162097206|NCT04743908|585404876|FG001|Overall Study|Lost to Follow-up|180|||
162097207|NCT04743908|585404875|FG000|Overall Study|Withdrawal by Subject|1|||
162097208|NCT04743908|585404876|FG001|Overall Study|Withdrawal by Subject|2|||
162097209|NCT03822533|585404877|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
162097210|NCT03822533|585404878|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
162097211|NCT03822533|585404877|FG000|3 Month Follow-up|Lost to Follow-up|2|||
162097212|NCT03822533|585404878|FG001|3 Month Follow-up|Lost to Follow-up|2|||
162097213|NCT03822533|585404877|FG000|6 Month Follow-up|Lost to Follow-up|3|||
162097214|NCT03822533|585404878|FG001|6 Month Follow-up|Lost to Follow-up|0|||
162097215|NCT03822533|585404877|FG000|12 Month Follow-up|Lost to Follow-up|2|||
162097216|NCT03822533|585404878|FG001|12 Month Follow-up|Lost to Follow-up|3|||
162097217|NCT03822533|585404877|FG000|12 Month Follow-up|Pregnancy|0|||
162097218|NCT03822533|585404878|FG001|12 Month Follow-up|Pregnancy|1|||
162097219|NCT03822533|585404877|FG000|12 Month Follow-up|Surgery|2|||
162097220|NCT03822533|585404878|FG001|12 Month Follow-up|Surgery|0|||
162097221|NCT03822533|585404877|FG000|12 Month Follow-up|Wrong address|1|||
162097222|NCT03822533|585404878|FG001|12 Month Follow-up|Wrong address|0|||
162097223|NCT03822533|585404877|FG000|12 Month Follow-up|No symptoms|1|||
162097224|NCT03822533|585404878|FG001|12 Month Follow-up|No symptoms|0|||
162097225|NCT03822533|585404877|FG000|12 Month Follow-up|Changed primary care center|0|||
162097226|NCT03822533|585404878|FG001|12 Month Follow-up|Changed primary care center|1|||
162097227|NCT01412944|585404879|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
162097228|NCT01412944|585404880|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
162097229|NCT01412944|585404881|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
162097230|NCT01412944|585404882|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
162097231|NCT01412944|585404883|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
162097232|NCT01412944|585404884|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
162097233|NCT01412944|585404879|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
162097234|NCT01412944|585404880|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
162097235|NCT01412944|585404881|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
162097236|NCT01412944|585404882|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
162097237|NCT01412944|585404883|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
162097238|NCT01412944|585404884|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
162097239|NCT01412944|585404879|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
162097240|NCT01412944|585404880|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
162097241|NCT01412944|585404881|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
162097242|NCT01412944|585404882|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
162097243|NCT01412944|585404883|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
162097244|NCT01412944|585404884|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
162097245|NCT01412944|585404879|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
162097246|NCT01412944|585404880|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
162097247|NCT01412944|585404881|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
162097248|NCT01412944|585404882|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
162097249|NCT01412944|585404883|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
162097250|NCT01412944|585404884|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
162097251|NCT01412944|585404879|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
162097252|NCT01412944|585404880|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
162097253|NCT01412944|585404881|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
162097254|NCT01412944|585404882|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
162097255|NCT01412944|585404883|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
162097256|NCT01412944|585404884|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
162097257|NCT01412944|585404879|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
162097258|NCT01412944|585404880|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
162097259|NCT01412944|585404881|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
162097260|NCT01412944|585404882|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
162097261|NCT01412944|585404883|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
162097262|NCT01412944|585404884|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
162097263|NCT01412944|585404879|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162097264|NCT01412944|585404880|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162097265|NCT01412944|585404881|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
162097266|NCT01412944|585404882|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
162097267|NCT01412944|585404883|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
162097268|NCT01412944|585404884|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162097269|NCT01412944|585404879|FG000|Entire: IV + Maintenance|Adverse Event|0|||
162097270|NCT01412944|585404880|FG001|Entire: IV + Maintenance|Adverse Event|0|||
162097271|NCT01412944|585404881|FG002|Entire: IV + Maintenance|Adverse Event|0|||
162097272|NCT01412944|585404882|FG003|Entire: IV + Maintenance|Adverse Event|0|||
162097273|NCT01412944|585404883|FG004|Entire: IV + Maintenance|Adverse Event|1|||
162097274|NCT01412944|585404884|FG005|Entire: IV + Maintenance|Adverse Event|0|||
162097275|NCT01412944|585404879|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
162097276|NCT01412944|585404880|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
162097277|NCT01412944|585404881|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
162097278|NCT01412944|585404882|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
162097279|NCT01412944|585404883|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
162097280|NCT01412944|585404884|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
162097281|NCT01412944|585404879|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
162097282|NCT01412944|585404880|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
162097283|NCT01412944|585404881|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
162097284|NCT01412944|585404882|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
162097285|NCT01412944|585404883|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
162097286|NCT01412944|585404884|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
162097287|NCT01412944|585404879|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
162097288|NCT01412944|585404880|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
162097289|NCT01412944|585404881|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
162097290|NCT01412944|585404882|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
162097291|NCT01412944|585404883|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
162097292|NCT01412944|585404884|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
162097293|NCT01412944|585404879|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
162097294|NCT01412944|585404880|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
162097295|NCT01412944|585404881|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162097296|NCT01412944|585404882|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162097297|NCT01412944|585404883|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162097298|NCT01412944|585404884|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
162097299|NCT01412944|585404879|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
162097300|NCT01412944|585404880|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
162097301|NCT01412944|585404881|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
162097302|NCT01412944|585404882|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
162097303|NCT01412944|585404883|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
162097304|NCT01412944|585404884|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
162097305|NCT01412944|585404879|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
162097306|NCT01412944|585404880|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
162097307|NCT01412944|585404881|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
162097308|NCT01412944|585404882|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
162097309|NCT01412944|585404883|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
162097310|NCT01412944|585404884|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
162097311|NCT01412944|585404879|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
162097312|NCT01412944|585404880|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
162097313|NCT01412944|585404881|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
162097314|NCT01412944|585404882|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
162097315|NCT01412944|585404883|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
162097316|NCT01412944|585404884|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
162097317|NCT01412944|585404879|FG000|Entire: IV + Maintenance|Adverse Event|0|||
162097318|NCT01412944|585404880|FG001|Entire: IV + Maintenance|Adverse Event|1|||
162097319|NCT01412944|585404881|FG002|Entire: IV + Maintenance|Adverse Event|0|||
162097320|NCT01412944|585404882|FG003|Entire: IV + Maintenance|Adverse Event|0|||
162097321|NCT01412944|585404883|FG004|Entire: IV + Maintenance|Adverse Event|0|||
162097322|NCT01412944|585404884|FG005|Entire: IV + Maintenance|Adverse Event|0|||
162097323|NCT01990950|585404885|FG000|Overall Study|Death|3|||
162097324|NCT01990950|585404885|FG000|Overall Study|Lost to Follow-up|2|||
162097325|NCT01990950|585404885|FG000|Overall Study|Withdrawal by Subject|6|||
162097326|NCT02863926|585404886|FG000|Overall Study|Physician Decision|1|||
162097327|NCT02863926|585404887|FG001|Overall Study|Physician Decision|0|||
162097328|NCT02863926|585404886|FG000|Overall Study|Lost to Follow-up|1|||
162097329|NCT02863926|585404887|FG001|Overall Study|Lost to Follow-up|1|||
162097330|NCT02261363|585404892|FG000|Overall Study|Lost to Follow-up|21|||
162097331|NCT01517802|585404893|FG000|Overall Study|Death|1|||
162097332|NCT02605954|585404894|FG000|Overall Study|Adverse Event|5|||
162097333|NCT02605954|585404895|FG001|Overall Study|Adverse Event|1|||
162097334|NCT02605954|585404894|FG000|Overall Study|Investigator's Discretion|1|||
162097335|NCT02605954|585404895|FG001|Overall Study|Investigator's Discretion|0|||
162097336|NCT02605954|585404894|FG000|Overall Study|Non-Compliance with Study Drug|1|||
162097337|NCT02605954|585404895|FG001|Overall Study|Non-Compliance with Study Drug|0|||
162097338|NCT02605954|585404894|FG000|Overall Study|Withdrew Consent|2|||
162097339|NCT02605954|585404895|FG001|Overall Study|Withdrew Consent|2|||
162097340|NCT02605954|585404894|FG000|Overall Study|Lost to Follow-up|3|||
162097341|NCT02605954|585404895|FG001|Overall Study|Lost to Follow-up|0|||
162097342|NCT02605954|585404894|FG000|Overall Study|Randomized but not treated|0|||
162097343|NCT02605954|585404895|FG001|Overall Study|Randomized but not treated|1|||
162097344|NCT02301143|585404896|FG000|Induction Period|Enrolled But Not Treated|1|||
162097345|NCT02301143|585404897|FG001|Induction Period|Enrolled But Not Treated|0|||
162097346|NCT02301143|585404896|FG000|Induction Period|Death|1|||
162097347|NCT02301143|585404897|FG001|Induction Period|Death|0|||
162097348|NCT02301143|585404896|FG000|Induction Period|Adverse Event|22|||
162097349|NCT02301143|585404897|FG001|Induction Period|Adverse Event|0|||
162097350|NCT02301143|585404896|FG000|Induction Period|Progressive Disease|8|||
162097351|NCT02301143|585404897|FG001|Induction Period|Progressive Disease|0|||
162097352|NCT02301143|585404896|FG000|Induction Period|Withdrawal by Subject|3|||
162097353|NCT02301143|585404897|FG001|Induction Period|Withdrawal by Subject|0|||
162097354|NCT02301143|585404896|FG000|Induction Period|Noncompliance with Study Drug|1|||
162097355|NCT02301143|585404897|FG001|Induction Period|Noncompliance with Study Drug|0|||
162097356|NCT02301143|585404896|FG000|Induction Period|Physician Decision|4|||
162097357|NCT02301143|585404897|FG001|Induction Period|Physician Decision|0|||
162097358|NCT02301143|585404896|FG000|Induction Period|Symptomatic Deterioration|2|||
162097359|NCT02301143|585404897|FG001|Induction Period|Symptomatic Deterioration|0|||
162097360|NCT02301143|585404896|FG000|Induction Period|Protocol Violation|2|||
162097361|NCT02301143|585404897|FG001|Induction Period|Protocol Violation|0|||
162097362|NCT02301143|585404896|FG000|Induction Period|Other|1|||
162097363|NCT02301143|585404897|FG001|Induction Period|Other|0|||
162097364|NCT02301143|585404896|FG000|Investigator's Choice|Adverse Event|0|||
162097365|NCT02301143|585404897|FG001|Investigator's Choice|Adverse Event|3|||
162097366|NCT02301143|585404896|FG000|Investigator's Choice|Progressive Disease|0|||
162097367|NCT02301143|585404897|FG001|Investigator's Choice|Progressive Disease|3|||
162097368|NCT02301143|585404896|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
162097369|NCT02301143|585404897|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
162097370|NCT02301143|585404896|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
162097371|NCT02301143|585404897|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
162097372|NCT02301143|585404896|FG000|Investigator's Choice|Other|0|||
162097373|NCT02301143|585404897|FG001|Investigator's Choice|Other|1|||
162097374|NCT02301143|585404896|FG000|Investigator's Choice|Unresectable Surgery|0|||
162097375|NCT02301143|585404897|FG001|Investigator's Choice|Unresectable Surgery|1|||
162097376|NCT03214367|585404900|FG000|Lead-in Period|Withdrawal by Subject|50|||
162097377|NCT03214367|585404901|FG001|Lead-in Period|Withdrawal by Subject|0|||
162097378|NCT03214367|585404902|FG002|Lead-in Period|Withdrawal by Subject|0|||
162097379|NCT03214367|585404903|FG003|Lead-in Period|Withdrawal by Subject|0|||
162097380|NCT03214367|585404904|FG004|Lead-in Period|Withdrawal by Subject|2|||
162097381|NCT03214367|585404905|FG005|Lead-in Period|Withdrawal by Subject|0|||
162097382|NCT03214367|585404906|FG006|Lead-in Period|Withdrawal by Subject|0|||
162097383|NCT03214367|585404907|FG007|Lead-in Period|Withdrawal by Subject|0|||
162097384|NCT03214367|585404900|FG000|Lead-in Period|Adverse Event|3|||
162097385|NCT03214367|585404901|FG001|Lead-in Period|Adverse Event|0|||
162097386|NCT03214367|585404902|FG002|Lead-in Period|Adverse Event|0|||
162097387|NCT03214367|585404903|FG003|Lead-in Period|Adverse Event|0|||
162097388|NCT03214367|585404904|FG004|Lead-in Period|Adverse Event|0|||
162097389|NCT03214367|585404905|FG005|Lead-in Period|Adverse Event|0|||
162097390|NCT03214367|585404906|FG006|Lead-in Period|Adverse Event|0|||
162097391|NCT03214367|585404907|FG007|Lead-in Period|Adverse Event|0|||
162097392|NCT03214367|585404900|FG000|Lead-in Period|Lost to Follow-up|12|||
162097393|NCT03214367|585404901|FG001|Lead-in Period|Lost to Follow-up|0|||
162097394|NCT03214367|585404902|FG002|Lead-in Period|Lost to Follow-up|0|||
162097395|NCT03214367|585404903|FG003|Lead-in Period|Lost to Follow-up|0|||
162097396|NCT03214367|585404904|FG004|Lead-in Period|Lost to Follow-up|0|||
162097397|NCT03214367|585404905|FG005|Lead-in Period|Lost to Follow-up|0|||
162097398|NCT03214367|585404906|FG006|Lead-in Period|Lost to Follow-up|0|||
162097399|NCT03214367|585404907|FG007|Lead-in Period|Lost to Follow-up|0|||
162097400|NCT03214367|585404900|FG000|Lead-in Period|Sponsor Decision|11|||
162097401|NCT03214367|585404901|FG001|Lead-in Period|Sponsor Decision|0|||
162097402|NCT03214367|585404902|FG002|Lead-in Period|Sponsor Decision|0|||
162097403|NCT03214367|585404903|FG003|Lead-in Period|Sponsor Decision|0|||
162097404|NCT03214367|585404904|FG004|Lead-in Period|Sponsor Decision|0|||
162097405|NCT03214367|585404905|FG005|Lead-in Period|Sponsor Decision|0|||
162097406|NCT03214367|585404906|FG006|Lead-in Period|Sponsor Decision|0|||
162097407|NCT03214367|585404907|FG007|Lead-in Period|Sponsor Decision|0|||
162097408|NCT03214367|585404900|FG000|Lead-in Period|Physician Decision|12|||
162097409|NCT03214367|585404901|FG001|Lead-in Period|Physician Decision|0|||
162097410|NCT03214367|585404902|FG002|Lead-in Period|Physician Decision|0|||
162097411|NCT03214367|585404903|FG003|Lead-in Period|Physician Decision|0|||
162097412|NCT03214367|585404904|FG004|Lead-in Period|Physician Decision|0|||
162097413|NCT03214367|585404905|FG005|Lead-in Period|Physician Decision|0|||
162097414|NCT03214367|585404906|FG006|Lead-in Period|Physician Decision|0|||
162097415|NCT03214367|585404907|FG007|Lead-in Period|Physician Decision|0|||
162097416|NCT03214367|585404900|FG000|Lead-in Period|Protocol Violation|5|||
162097417|NCT03214367|585404901|FG001|Lead-in Period|Protocol Violation|0|||
162097418|NCT03214367|585404902|FG002|Lead-in Period|Protocol Violation|0|||
162097419|NCT03214367|585404903|FG003|Lead-in Period|Protocol Violation|0|||
162097420|NCT03214367|585404904|FG004|Lead-in Period|Protocol Violation|0|||
162097421|NCT03214367|585404905|FG005|Lead-in Period|Protocol Violation|0|||
162097422|NCT03214367|585404906|FG006|Lead-in Period|Protocol Violation|0|||
162097423|NCT03214367|585404907|FG007|Lead-in Period|Protocol Violation|0|||
162097424|NCT03214367|585404900|FG000|Lead-in Period|Treatment Interruption|1|||
162097425|NCT03214367|585404901|FG001|Lead-in Period|Treatment Interruption|0|||
162097426|NCT03214367|585404902|FG002|Lead-in Period|Treatment Interruption|0|||
162097427|NCT03214367|585404903|FG003|Lead-in Period|Treatment Interruption|0|||
162097428|NCT03214367|585404904|FG004|Lead-in Period|Treatment Interruption|0|||
162097429|NCT03214367|585404905|FG005|Lead-in Period|Treatment Interruption|0|||
162097430|NCT03214367|585404906|FG006|Lead-in Period|Treatment Interruption|0|||
162097431|NCT03214367|585404907|FG007|Lead-in Period|Treatment Interruption|0|||
162097432|NCT03214367|585404900|FG000|Treatment Period|Adverse Event|0|||
162097433|NCT03214367|585404901|FG001|Treatment Period|Adverse Event|1|||
162097434|NCT03214367|585404902|FG002|Treatment Period|Adverse Event|4|||
162097435|NCT03214367|585404903|FG003|Treatment Period|Adverse Event|2|||
162097436|NCT03214367|585404904|FG004|Treatment Period|Adverse Event|0|||
162097437|NCT03214367|585404905|FG005|Treatment Period|Adverse Event|0|||
162097438|NCT03214367|585404906|FG006|Treatment Period|Adverse Event|0|||
162097439|NCT03214367|585404907|FG007|Treatment Period|Adverse Event|0|||
162097440|NCT03214367|585404900|FG000|Treatment Period|Death|0|||
162097441|NCT03214367|585404901|FG001|Treatment Period|Death|1|||
162097442|NCT03214367|585404902|FG002|Treatment Period|Death|1|||
162097443|NCT03214367|585404903|FG003|Treatment Period|Death|1|||
162097444|NCT03214367|585404904|FG004|Treatment Period|Death|0|||
162097445|NCT03214367|585404905|FG005|Treatment Period|Death|0|||
162097446|NCT03214367|585404906|FG006|Treatment Period|Death|0|||
162097447|NCT03214367|585404907|FG007|Treatment Period|Death|0|||
162097448|NCT03214367|585404900|FG000|Treatment Period|Lost to Follow-up|0|||
162097449|NCT03214367|585404901|FG001|Treatment Period|Lost to Follow-up|5|||
162097450|NCT03214367|585404902|FG002|Treatment Period|Lost to Follow-up|3|||
162097451|NCT03214367|585404903|FG003|Treatment Period|Lost to Follow-up|2|||
162097452|NCT03214367|585404904|FG004|Treatment Period|Lost to Follow-up|0|||
162097453|NCT03214367|585404905|FG005|Treatment Period|Lost to Follow-up|2|||
162097454|NCT03214367|585404906|FG006|Treatment Period|Lost to Follow-up|1|||
162097455|NCT03214367|585404907|FG007|Treatment Period|Lost to Follow-up|0|||
162097456|NCT03214367|585404900|FG000|Treatment Period|Sponsor Decision|0|||
162097457|NCT03214367|585404901|FG001|Treatment Period|Sponsor Decision|3|||
162097458|NCT03214367|585404902|FG002|Treatment Period|Sponsor Decision|0|||
162097459|NCT03214367|585404903|FG003|Treatment Period|Sponsor Decision|0|||
162097460|NCT03214367|585404904|FG004|Treatment Period|Sponsor Decision|0|||
162097461|NCT03214367|585404905|FG005|Treatment Period|Sponsor Decision|0|||
162097462|NCT03214367|585404906|FG006|Treatment Period|Sponsor Decision|0|||
162097463|NCT03214367|585404907|FG007|Treatment Period|Sponsor Decision|0|||
162097464|NCT03214367|585404900|FG000|Treatment Period|Physician Decision|0|||
162097465|NCT03214367|585404901|FG001|Treatment Period|Physician Decision|1|||
162097466|NCT03214367|585404902|FG002|Treatment Period|Physician Decision|2|||
162097467|NCT03214367|585404903|FG003|Treatment Period|Physician Decision|0|||
162097468|NCT03214367|585404904|FG004|Treatment Period|Physician Decision|0|||
162097469|NCT03214367|585404905|FG005|Treatment Period|Physician Decision|0|||
162097470|NCT03214367|585404906|FG006|Treatment Period|Physician Decision|0|||
162097471|NCT03214367|585404907|FG007|Treatment Period|Physician Decision|0|||
162097472|NCT03214367|585404900|FG000|Treatment Period|Protocol Violation|0|||
162097473|NCT03214367|585404901|FG001|Treatment Period|Protocol Violation|3|||
162097474|NCT03214367|585404902|FG002|Treatment Period|Protocol Violation|0|||
162097475|NCT03214367|585404903|FG003|Treatment Period|Protocol Violation|0|||
162097476|NCT03214367|585404904|FG004|Treatment Period|Protocol Violation|0|||
162097477|NCT03214367|585404905|FG005|Treatment Period|Protocol Violation|0|||
162097478|NCT03214367|585404906|FG006|Treatment Period|Protocol Violation|0|||
162097479|NCT03214367|585404907|FG007|Treatment Period|Protocol Violation|0|||
162097480|NCT03214367|585404900|FG000|Treatment Period|Withdrawal by Subject|0|||
162097481|NCT03214367|585404901|FG001|Treatment Period|Withdrawal by Subject|20|||
162097482|NCT03214367|585404902|FG002|Treatment Period|Withdrawal by Subject|23|||
162097483|NCT03214367|585404903|FG003|Treatment Period|Withdrawal by Subject|14|||
162097484|NCT03214367|585404904|FG004|Treatment Period|Withdrawal by Subject|0|||
162097485|NCT03214367|585404905|FG005|Treatment Period|Withdrawal by Subject|1|||
162097486|NCT03214367|585404906|FG006|Treatment Period|Withdrawal by Subject|1|||
162097487|NCT03214367|585404907|FG007|Treatment Period|Withdrawal by Subject|1|||
162097488|NCT03268811|585404910|FG000|Overall Study|Adverse Event|0|||
162097489|NCT03268811|585404911|FG001|Overall Study|Adverse Event|1|||
162097490|NCT00455195|585404912|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
162097491|NCT00455195|585404913|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
162097492|NCT00455195|585404912|FG000|Double-blind Study AGLU02704|Death|1|||
162097493|NCT00455195|585404913|FG001|Double-blind Study AGLU02704|Death|0|||
162097494|NCT00455195|585404912|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
162097495|NCT00455195|585404913|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
162097496|NCT00455195|585404912|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
162097497|NCT00455195|585404913|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
162097498|NCT02117570|585404914|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
162097499|NCT02117570|585404915|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
162097500|NCT02117570|585404916|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
162097501|NCT02117570|585404914|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
162097502|NCT02117570|585404915|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
162097503|NCT02117570|585404916|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
162097504|NCT02117570|585404914|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
162097505|NCT02117570|585404915|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
162097506|NCT02117570|585404916|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
162097507|NCT02117570|585404914|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
162097508|NCT02117570|585404915|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
162097509|NCT02117570|585404916|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
162097510|NCT02117570|585404914|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
162097511|NCT02117570|585404915|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
162097512|NCT02117570|585404916|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
162097513|NCT02117570|585404914|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
162097514|NCT02117570|585404915|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
162097515|NCT02117570|585404916|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
162097516|NCT02117570|585404914|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
162097517|NCT02117570|585404915|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
162097518|NCT02117570|585404916|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
162097519|NCT02148250|585404917|FG000|Screening|Withdrawal by Subject|5|||
162097520|NCT02148250|585404918|FG001|Screening|Withdrawal by Subject|0|||
162097521|NCT01286779|585404919|FG000|Overall Study|Withdrawal by Subject|9|||
162097522|NCT01286779|585404919|FG000|Overall Study|Protocol Violation|5|||
162097523|NCT01286779|585404919|FG000|Overall Study|Physician Decision|2|||
162097524|NCT01286779|585404919|FG000|Overall Study|Participant had scheduled surgery|1|||
162097525|NCT01286779|585404919|FG000|Overall Study|Participant moved to another country|1|||
162097526|NCT01286779|585404919|FG000|Overall Study|Discontinued by sponsor|1|||
162097527|NCT00563784|585404920|FG000|Overall Study|Withdrawal by Subject|2|||
162097528|NCT00563784|585404920|FG000|Overall Study|Screen Failures|20|||
162097529|NCT04004611|585404921|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162097530|NCT04004611|585404922|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162097531|NCT04004611|585404923|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162097532|NCT04004611|585404924|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162097533|NCT04004611|585404925|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162097534|NCT04004611|585404926|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162097535|NCT04004611|585404927|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162097536|NCT04004611|585404928|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
162097537|NCT04004611|585404929|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
162097538|NCT04004611|585404921|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
162097539|NCT04004611|585404922|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
162097540|NCT04004611|585404923|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
162097541|NCT04004611|585404924|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
162097542|NCT04004611|585404925|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
162097543|NCT04004611|585404926|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
162097544|NCT04004611|585404927|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
162097545|NCT04004611|585404928|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
162097546|NCT04004611|585404929|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
162097547|NCT04004611|585404921|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162097548|NCT04004611|585404922|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162097549|NCT04004611|585404923|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162097550|NCT04004611|585404924|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162097551|NCT04004611|585404925|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
162097552|NCT04004611|585404926|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162097553|NCT04004611|585404927|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162097554|NCT04004611|585404928|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162097555|NCT04004611|585404929|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
162097556|NCT04004611|585404921|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
162097557|NCT04004611|585404922|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
162097558|NCT04004611|585404923|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
162097559|NCT04004611|585404924|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
162097560|NCT04004611|585404925|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
162097561|NCT04004611|585404926|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
162097562|NCT04004611|585404927|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
162097563|NCT04004611|585404928|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
162097564|NCT04004611|585404929|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
162097565|NCT04004611|585404921|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
162097566|NCT04004611|585404922|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162097567|NCT04004611|585404923|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
162097568|NCT04004611|585404924|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162097569|NCT04004611|585404925|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162097570|NCT04004611|585404926|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162097571|NCT04004611|585404927|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162097572|NCT04004611|585404928|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162097573|NCT04004611|585404929|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
162097574|NCT04004611|585404921|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162097575|NCT04004611|585404922|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
162097576|NCT04004611|585404923|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162097577|NCT04004611|585404924|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162097578|NCT04004611|585404925|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162097579|NCT04004611|585404926|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162097580|NCT04004611|585404927|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162097581|NCT04004611|585404928|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162097582|NCT04004611|585404929|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
162097583|NCT00304070|585404930|FG000|Overall Study|Death|0|||
162097584|NCT00304070|585404931|FG001|Overall Study|Death|0|||
162097585|NCT00304070|585404932|FG002|Overall Study|Death|3|||
162097586|NCT00304070|585404930|FG000|Overall Study|Lost to Follow-up|0|||
162097587|NCT00304070|585404931|FG001|Overall Study|Lost to Follow-up|0|||
162097588|NCT00304070|585404932|FG002|Overall Study|Lost to Follow-up|1|||
162097589|NCT00304070|585404930|FG000|Overall Study|Physician Decision|0|||
162097590|NCT00304070|585404931|FG001|Overall Study|Physician Decision|0|||
162097591|NCT00304070|585404932|FG002|Overall Study|Physician Decision|3|||
162097592|NCT00304070|585404930|FG000|Overall Study|Withdrawal by Subject|0|||
162097593|NCT00304070|585404931|FG001|Overall Study|Withdrawal by Subject|0|||
162097594|NCT00304070|585404932|FG002|Overall Study|Withdrawal by Subject|1|||
162097595|NCT00304070|585404930|FG000|Overall Study|Progressive Disease|3|||
162097596|NCT00304070|585404931|FG001|Overall Study|Progressive Disease|7|||
162097597|NCT00304070|585404932|FG002|Overall Study|Progressive Disease|4|||
162097598|NCT00320216|585404933|FG000|Overall Study|Adverse Event|0|||
162097599|NCT00320216|585404934|FG001|Overall Study|Adverse Event|6|||
162097600|NCT00320216|585404935|FG002|Overall Study|Adverse Event|0|||
162097601|NCT00320216|585404936|FG003|Overall Study|Adverse Event|2|||
162097602|NCT00320216|585404937|FG004|Overall Study|Adverse Event|2|||
162097603|NCT00320216|585404933|FG000|Overall Study|Lack of Efficacy|6|||
162097604|NCT00320216|585404934|FG001|Overall Study|Lack of Efficacy|2|||
162097605|NCT00320216|585404935|FG002|Overall Study|Lack of Efficacy|1|||
162097606|NCT00320216|585404936|FG003|Overall Study|Lack of Efficacy|0|||
162097607|NCT00320216|585404937|FG004|Overall Study|Lack of Efficacy|1|||
162097608|NCT00320216|585404933|FG000|Overall Study|Lost to Follow-up|3|||
162097609|NCT00320216|585404934|FG001|Overall Study|Lost to Follow-up|0|||
162097610|NCT00320216|585404935|FG002|Overall Study|Lost to Follow-up|0|||
162097611|NCT00320216|585404936|FG003|Overall Study|Lost to Follow-up|0|||
162097612|NCT00320216|585404937|FG004|Overall Study|Lost to Follow-up|0|||
162097613|NCT00320216|585404933|FG000|Overall Study|Other|7|||
162097614|NCT00320216|585404934|FG001|Overall Study|Other|2|||
162097615|NCT00320216|585404935|FG002|Overall Study|Other|5|||
162097616|NCT00320216|585404936|FG003|Overall Study|Other|1|||
162097617|NCT00320216|585404937|FG004|Overall Study|Other|3|||
162097618|NCT00779246|585404946|FG000|Overall Study|Missing sufficient data for analysis|33|||
162097619|NCT00779246|585404947|FG001|Overall Study|Missing sufficient data for analysis|53|||
162097620|NCT02844946|585404949|FG000|Overall Study|Lost to Follow-up|7|||
162097621|NCT02844946|585404950|FG001|Overall Study|Lost to Follow-up|0|||
162097622|NCT02806986|585404951|FG000|Treatment Stage 1|Adverse Event|1|||
162097623|NCT02806986|585404951|FG000|Treatment Stage 2|Adverse Event|3|||
162097624|NCT02806986|585404951|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
162097625|NCT03950739|585404953|FG000|Treatment Phase|Adverse Event|2|||
162097626|NCT03950739|585404953|FG000|Optional Extension Phase|Death|1|||
162097627|NCT03950739|585404953|FG000|Optional Extension Phase|Progressive Disease|5|||
162097628|NCT03950739|585404953|FG000|Optional Extension Phase|Adverse Event|7|||
162097629|NCT03950739|585404953|FG000|Optional Extension Phase|Lost to Follow-up|2|||
162097630|NCT03950739|585404953|FG000|Optional Extension Phase|Site Closure|2|||
162097631|NCT03950739|585404953|FG000|Optional Extension Phase|Pregnancy|1|||
162097632|NCT03625570|585404954|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
162097633|NCT03625570|585404955|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
162097634|NCT03625570|585404954|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
162097635|NCT03625570|585404955|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
162097636|NCT03625570|585404954|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
162097637|NCT03625570|585404955|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
162097638|NCT00345579|585404956|FG000|Overall Study|Adverse Event|9|||
162097639|NCT00345579|585404957|FG001|Overall Study|Adverse Event|6|||
162097640|NCT00345579|585404956|FG000|Overall Study|Protocol Violation|14|||
162097641|NCT00345579|585404957|FG001|Overall Study|Protocol Violation|5|||
162097642|NCT00345579|585404956|FG000|Overall Study|Withdrawal by Subject|50|||
162097643|NCT00345579|585404957|FG001|Overall Study|Withdrawal by Subject|17|||
162097644|NCT00345579|585404956|FG000|Overall Study|Lost to Follow-up|82|||
162097645|NCT00345579|585404957|FG001|Overall Study|Lost to Follow-up|36|||
162097646|NCT00345579|585404956|FG000|Overall Study|Other|9|||
162097647|NCT00345579|585404957|FG001|Overall Study|Other|1|||
162097648|NCT03646513|585404958|FG000|Overall Study|Premature study termination|4|||
162097649|NCT02334748|585404959|FG000|Overall Study|Adverse Event|1|||
162097650|NCT02334748|585404959|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
162097651|NCT02334748|585404959|FG000|Overall Study|Patient no longer required study drug|2|||
162097652|NCT02334748|585404959|FG000|Overall Study|Lack of Efficacy|4|||
162097653|NCT01046643|585404960|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
162097654|NCT01046643|585404961|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
162097655|NCT01046643|585404962|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
162097656|NCT01046643|585404963|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
162097657|NCT00093145|585404964|FG000|Overall Study|Unacceptable Toxicity Only|2|||
162097658|NCT00093145|585404964|FG000|Overall Study|Physician Decision|5|||
162097659|NCT00093145|585404964|FG000|Overall Study|Withdrawal by Subject|9|||
162097660|NCT00093145|585404964|FG000|Overall Study|Other|1|||
162097661|NCT01310036|585404965|FG000|Overall Study|Administrative/other|10|||
162097662|NCT01310036|585404965|FG000|Overall Study|Withdrew Consent|11|||
162097663|NCT01310036|585404965|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
162097664|NCT01310036|585404965|FG000|Overall Study|Progression of Disease|164|||
162097665|NCT01310036|585404965|FG000|Overall Study|Death|1|||
162097666|NCT01310036|585404965|FG000|Overall Study|Adverse event or intercurrent illness|12|||
162097667|NCT01175668|585404966|FG000|Overall Study|Withdrawal by Subject|2|||
162097668|NCT01175668|585404967|FG001|Overall Study|Withdrawal by Subject|0|||
162097669|NCT00817089|585404968|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
162097670|NCT00817089|585404969|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
162097671|NCT00817089|585404970|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
162097672|NCT00817089|585404971|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
162097673|NCT00817089|585404968|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
162097674|NCT00817089|585404969|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
162097675|NCT00817089|585404970|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
162097676|NCT00817089|585404971|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
162097677|NCT00709722|585404972|FG000|Overall Study|Adverse Event|1|||
162097678|NCT02043782|585404973|FG000|Period 1|Adverse Event|0|||
162097679|NCT02043782|585404974|FG001|Period 1|Adverse Event|0|||
162097680|NCT02043782|585404975|FG002|Period 1|Adverse Event|1|||
162097681|NCT02043782|585404976|FG003|Period 1|Adverse Event|0|||
162097682|NCT02043782|585404977|FG004|Period 1|Adverse Event|0|||
162097683|NCT02043782|585404978|FG005|Period 1|Adverse Event|0|||
162097684|NCT04667117|585404979|FG000|Investigational Period|Lost to Follow-up|0|||
162097685|NCT04667117|585404980|FG001|Investigational Period|Lost to Follow-up|0|||
162097686|NCT04667117|585404981|FG002|Investigational Period|Lost to Follow-up|1|||
162097687|NCT04667117|585404979|FG000|Investigational Period|Protocol Deviation|0|||
162097688|NCT04667117|585404980|FG001|Investigational Period|Protocol Deviation|1|||
162097689|NCT04667117|585404981|FG002|Investigational Period|Protocol Deviation|0|||
162097690|NCT04667117|585404979|FG000|Extension Period|Lost to Follow-up|1|||
162097691|NCT04667117|585404980|FG001|Extension Period|Lost to Follow-up|0|||
162097692|NCT04667117|585404981|FG002|Extension Period|Lost to Follow-up|0|||
162097693|NCT03359096|585404982|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
162097694|NCT03359096|585404983|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
162097695|NCT03359096|585404982|FG000|First Intervention (4 Weeks)|Death|1|||
162097696|NCT03359096|585404983|FG001|First Intervention (4 Weeks)|Death|0|||
162097697|NCT03359096|585404982|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
162097698|NCT03359096|585404983|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
162097699|NCT02007577|585404994|FG000|Overall Study|Adverse Event|1|||
162097700|NCT02007577|585404995|FG001|Overall Study|Adverse Event|0|||
162097701|NCT02007577|585404994|FG000|Overall Study|Withdrawal by Subject|0|||
162097702|NCT02007577|585404995|FG001|Overall Study|Withdrawal by Subject|1|||
162097703|NCT01953926|585404996|FG000|Overall Study|Withdrawal by Subject|23|||
162097704|NCT01953926|585404997|FG001|Overall Study|Withdrawal by Subject|3|||
162097705|NCT01953926|585404998|FG002|Overall Study|Withdrawal by Subject|3|||
162097706|NCT01953926|585404999|FG003|Overall Study|Withdrawal by Subject|5|||
162097707|NCT01953926|585405000|FG004|Overall Study|Withdrawal by Subject|6|||
162097708|NCT01953926|585405001|FG005|Overall Study|Withdrawal by Subject|0|||
162097709|NCT01953926|585405002|FG006|Overall Study|Withdrawal by Subject|1|||
162097710|NCT01953926|585404996|FG000|Overall Study|Physician Decision|1|||
162097711|NCT01953926|585404997|FG001|Overall Study|Physician Decision|0|||
162097712|NCT01953926|585404998|FG002|Overall Study|Physician Decision|0|||
162097713|NCT01953926|585404999|FG003|Overall Study|Physician Decision|0|||
162097714|NCT01953926|585405000|FG004|Overall Study|Physician Decision|2|||
162097715|NCT01953926|585405001|FG005|Overall Study|Physician Decision|0|||
162097716|NCT01953926|585405002|FG006|Overall Study|Physician Decision|0|||
162097717|NCT01953926|585404996|FG000|Overall Study|Lost to Follow-up|18|||
162097718|NCT01953926|585404997|FG001|Overall Study|Lost to Follow-up|3|||
162097719|NCT01953926|585404998|FG002|Overall Study|Lost to Follow-up|0|||
162097720|NCT01953926|585404999|FG003|Overall Study|Lost to Follow-up|5|||
162097721|NCT01953926|585405000|FG004|Overall Study|Lost to Follow-up|3|||
162097722|NCT01953926|585405001|FG005|Overall Study|Lost to Follow-up|0|||
162097723|NCT01953926|585405002|FG006|Overall Study|Lost to Follow-up|0|||
162097724|NCT01953926|585404996|FG000|Overall Study|Protocol Violation|1|||
162097725|NCT01953926|585404997|FG001|Overall Study|Protocol Violation|0|||
162097726|NCT01953926|585404998|FG002|Overall Study|Protocol Violation|0|||
162097727|NCT01953926|585404999|FG003|Overall Study|Protocol Violation|0|||
162097728|NCT01953926|585405000|FG004|Overall Study|Protocol Violation|0|||
162097729|NCT01953926|585405001|FG005|Overall Study|Protocol Violation|0|||
162097730|NCT01953926|585405002|FG006|Overall Study|Protocol Violation|0|||
162097731|NCT01953926|585404996|FG000|Overall Study|Other, Disease progression|2|||
162097732|NCT01953926|585404997|FG001|Overall Study|Other, Disease progression|1|||
162097733|NCT01953926|585404998|FG002|Overall Study|Other, Disease progression|0|||
162097734|NCT01953926|585404999|FG003|Overall Study|Other, Disease progression|0|||
162097735|NCT01953926|585405000|FG004|Overall Study|Other, Disease progression|1|||
162097736|NCT01953926|585405001|FG005|Overall Study|Other, Disease progression|0|||
162097737|NCT01953926|585405002|FG006|Overall Study|Other, Disease progression|0|||
162097738|NCT01953926|585404996|FG000|Overall Study|Discontinuation of study by sponsor|41|||
162097739|NCT01953926|585404997|FG001|Overall Study|Discontinuation of study by sponsor|7|||
162097740|NCT01953926|585404998|FG002|Overall Study|Discontinuation of study by sponsor|5|||
162097741|NCT01953926|585404999|FG003|Overall Study|Discontinuation of study by sponsor|12|||
162097742|NCT01953926|585405000|FG004|Overall Study|Discontinuation of study by sponsor|46|||
162097743|NCT01953926|585405001|FG005|Overall Study|Discontinuation of study by sponsor|5|||
162097744|NCT01953926|585405002|FG006|Overall Study|Discontinuation of study by sponsor|6|||
162097745|NCT01953926|585404996|FG000|Overall Study|Not Treated|1|||
162097746|NCT01953926|585404997|FG001|Overall Study|Not Treated|0|||
162097747|NCT01953926|585404998|FG002|Overall Study|Not Treated|1|||
162097748|NCT01953926|585404999|FG003|Overall Study|Not Treated|0|||
162097749|NCT01953926|585405000|FG004|Overall Study|Not Treated|0|||
162097750|NCT01953926|585405001|FG005|Overall Study|Not Treated|0|||
162097751|NCT01953926|585405002|FG006|Overall Study|Not Treated|0|||
162097752|NCT04102501|585405006|FG000|Overall Study|Withdrawal by Subject|7|||
162097753|NCT04102501|585405007|FG001|Overall Study|Withdrawal by Subject|9|||
162097754|NCT04102501|585405006|FG000|Overall Study|Adverse Event|1|||
162097755|NCT04102501|585405007|FG001|Overall Study|Adverse Event|3|||
162097756|NCT02338362|585405008|FG000|Overall Study|Withdrawal by Subject|1|||
162097757|NCT02338362|585405009|FG001|Overall Study|Withdrawal by Subject|1|||
162097758|NCT00968617|585405010|FG000|Overall Study|Study terminated by sponsor|6|||
162097759|NCT04433767|585405011|FG000|Overall Study|Adverse Event|1|||
162097760|NCT04964089|585405014|FG000|Overall Study|Adverse Event|8|||
162097761|NCT04964089|585405015|FG001|Overall Study|Adverse Event|6|||
162097762|NCT04964089|585405014|FG000|Overall Study|Non-compliance with study schedule|1|||
162097763|NCT04964089|585405015|FG001|Overall Study|Non-compliance with study schedule|0|||
162097764|NCT04964089|585405014|FG000|Overall Study|Withdrawal by Subject|6|||
162097765|NCT04964089|585405015|FG001|Overall Study|Withdrawal by Subject|5|||
162097766|NCT04964089|585405014|FG000|Overall Study|Lost to Follow-up|1|||
162097767|NCT04964089|585405015|FG001|Overall Study|Lost to Follow-up|1|||
162097768|NCT04964089|585405014|FG000|Overall Study|Progressive disease|4|||
162097769|NCT04964089|585405015|FG001|Overall Study|Progressive disease|0|||
162097770|NCT04964089|585405014|FG000|Overall Study|Physician Decision|1|||
162097771|NCT04964089|585405015|FG001|Overall Study|Physician Decision|0|||
162097772|NCT04964089|585405014|FG000|Overall Study|Participant did not want to continue study treatment|1|||
162097773|NCT04964089|585405015|FG001|Overall Study|Participant did not want to continue study treatment|0|||
162097774|NCT04964089|585405014|FG000|Overall Study|Participant moved to different state|1|||
162097775|NCT04964089|585405015|FG001|Overall Study|Participant moved to different state|0|||
162097776|NCT04964089|585405014|FG000|Overall Study|Participant decided to discontinue|0|||
162097777|NCT04964089|585405015|FG001|Overall Study|Participant decided to discontinue|1|||
162097778|NCT00927927|585405016|FG000|Overall Study|Withdrawal by Subject|0|||
162097779|NCT00927927|585405017|FG001|Overall Study|Withdrawal by Subject|0|||
162097780|NCT00927927|585405018|FG002|Overall Study|Withdrawal by Subject|0|||
162097781|NCT00927927|585405019|FG003|Overall Study|Withdrawal by Subject|0|||
162097782|NCT00927927|585405020|FG004|Overall Study|Withdrawal by Subject|0|||
162097783|NCT00927927|585405021|FG005|Overall Study|Withdrawal by Subject|0|||
162097784|NCT00927927|585405022|FG006|Overall Study|Withdrawal by Subject|0|||
162097785|NCT00927927|585405023|FG007|Overall Study|Withdrawal by Subject|2|||
162097786|NCT00927927|585405024|FG008|Overall Study|Withdrawal by Subject|0|||
162097787|NCT00927927|585405025|FG009|Overall Study|Withdrawal by Subject|0|||
162097788|NCT00927927|585405026|FG010|Overall Study|Withdrawal by Subject|0|||
162097789|NCT00927927|585405027|FG011|Overall Study|Withdrawal by Subject|2|||
162097790|NCT00927927|585405028|FG012|Overall Study|Withdrawal by Subject|0|||
162097791|NCT00927927|585405029|FG013|Overall Study|Withdrawal by Subject|0|||
162097792|NCT00927927|585405030|FG014|Overall Study|Withdrawal by Subject|0|||
162097793|NCT00924287|585406713|FG000|Overall Study|Death|1|||
162097794|NCT00156065|585406720|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
162097795|NCT00156065|585406721|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
162097796|NCT00156065|585406722|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
162097797|NCT00156065|585406720|FG000|Overall Study|Adverse Event|8|||
162097798|NCT00156065|585406721|FG001|Overall Study|Adverse Event|11|||
162097799|NCT00156065|585406722|FG002|Overall Study|Adverse Event|4|||
162097800|NCT00156065|585406720|FG000|Overall Study|Lack of Efficacy|2|||
162097801|NCT00156065|585406721|FG001|Overall Study|Lack of Efficacy|9|||
162097802|NCT00156065|585406722|FG002|Overall Study|Lack of Efficacy|3|||
162097803|NCT00156065|585406720|FG000|Overall Study|Withdrawal by Subject|13|||
162097804|NCT00156065|585406721|FG001|Overall Study|Withdrawal by Subject|26|||
162097805|NCT00156065|585406722|FG002|Overall Study|Withdrawal by Subject|16|||
162097806|NCT00156065|585406720|FG000|Overall Study|Lost to Follow-up|5|||
162097807|NCT00156065|585406721|FG001|Overall Study|Lost to Follow-up|7|||
162097808|NCT00156065|585406722|FG002|Overall Study|Lost to Follow-up|1|||
162097809|NCT00156065|585406720|FG000|Overall Study|Other|2|||
162097810|NCT00156065|585406721|FG001|Overall Study|Other|9|||
162097811|NCT00156065|585406722|FG002|Overall Study|Other|3|||
162097812|NCT01432366|585406723|FG000|Overall Study|Non-Responder|7|||
162097813|NCT01432366|585406723|FG000|Overall Study|Adverse Event|8|||
162097814|NCT01432366|585406723|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
162097815|NCT01432366|585406723|FG000|Overall Study|Pregnancy|1|||
162097816|NCT01432366|585406723|FG000|Overall Study|Lost to Follow-up|13|||
162097817|NCT01432366|585406723|FG000|Overall Study|Lack of Efficacy|1|||
162097818|NCT01432366|585406723|FG000|Overall Study|Site Closed|20|||
162097819|NCT01432366|585406723|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
162097820|NCT01432366|585406723|FG000|Overall Study|Other|14|||
162097821|NCT02395120|585406724|FG000|Overall Study|Missed follow-up dental exam|57|||
162097822|NCT02395120|585406725|FG001|Overall Study|Missed follow-up dental exam|62|||
162097823|NCT02395120|585406726|FG002|Overall Study|Missed follow-up dental exam|6|||
162097824|NCT02395120|585406727|FG003|Overall Study|Missed follow-up dental exam|6|||
162097825|NCT02395120|585406728|FG004|Overall Study|Missed follow-up dental exam|51|||
162097826|NCT04546581|585406730|FG000|Overall Study|Adverse Event|9|||
162097827|NCT04546581|585406731|FG001|Overall Study|Adverse Event|3|||
162097828|NCT04546581|585406730|FG000|Overall Study|Physician Decision|0|||
162097829|NCT04546581|585406731|FG001|Overall Study|Physician Decision|1|||
162097830|NCT04546581|585406730|FG000|Overall Study|Protocol Violation|1|||
162097831|NCT04546581|585406731|FG001|Overall Study|Protocol Violation|2|||
162097832|NCT04546581|585406730|FG000|Overall Study|Withdrawal by Subject|3|||
162097833|NCT04546581|585406731|FG001|Overall Study|Withdrawal by Subject|7|||
162097834|NCT02526693|585406732|FG000|Overall Study|Physician Decision|3|||
162097835|NCT02526693|585406733|FG001|Overall Study|Physician Decision|1|||
162097836|NCT01798927|585406734|FG000|Overall Study|Withdrawal by Subject|1|||
162097837|NCT01159691|585406735|FG000|Overall Study|Lost to Follow-up|2|||
162097838|NCT01159691|585406735|FG000|Overall Study|Unknown reasons|1|||
162097839|NCT01159691|585406735|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
162097840|NCT01159691|585406735|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
162097841|NCT01159691|585406735|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
162097842|NCT01159691|585406735|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
162097843|NCT01159691|585406735|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
162097844|NCT01159691|585406735|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
162097845|NCT04579757|585406746|FG000|Overall Study|Adverse Event|0|||
162097846|NCT04579757|585406747|FG001|Overall Study|Adverse Event|0|||
162097847|NCT04579757|585406748|FG002|Overall Study|Adverse Event|0|||
162097848|NCT04579757|585406749|FG003|Overall Study|Adverse Event|2|||
162097849|NCT04579757|585406750|FG004|Overall Study|Adverse Event|1|||
162097850|NCT04579757|585406751|FG005|Overall Study|Adverse Event|1|||
162097851|NCT04579757|585406752|FG006|Overall Study|Adverse Event|0|||
162097852|NCT04579757|585406753|FG007|Overall Study|Adverse Event|0|||
162097853|NCT04579757|585406754|FG008|Overall Study|Adverse Event|0|||
162097854|NCT04579757|585406746|FG000|Overall Study|Death|4|||
162097855|NCT04579757|585406747|FG001|Overall Study|Death|1|||
162097856|NCT04579757|585406748|FG002|Overall Study|Death|14|||
162097857|NCT04579757|585406749|FG003|Overall Study|Death|3|||
162097858|NCT04579757|585406750|FG004|Overall Study|Death|2|||
162097859|NCT04579757|585406751|FG005|Overall Study|Death|7|||
162097860|NCT04579757|585406752|FG006|Overall Study|Death|0|||
162097861|NCT04579757|585406753|FG007|Overall Study|Death|1|||
162097862|NCT04579757|585406754|FG008|Overall Study|Death|3|||
162097863|NCT04579757|585406746|FG000|Overall Study|Physician Decision|0|||
162097864|NCT04579757|585406747|FG001|Overall Study|Physician Decision|0|||
162097865|NCT04579757|585406748|FG002|Overall Study|Physician Decision|0|||
162097866|NCT04579757|585406749|FG003|Overall Study|Physician Decision|2|||
162097867|NCT04579757|585406750|FG004|Overall Study|Physician Decision|1|||
162097868|NCT04579757|585406751|FG005|Overall Study|Physician Decision|1|||
162097869|NCT04579757|585406752|FG006|Overall Study|Physician Decision|1|||
162097870|NCT04579757|585406753|FG007|Overall Study|Physician Decision|0|||
162097871|NCT04579757|585406754|FG008|Overall Study|Physician Decision|0|||
162097872|NCT04579757|585406746|FG000|Overall Study|Study Terminated By Sponsor|0|||
162097873|NCT04579757|585406747|FG001|Overall Study|Study Terminated By Sponsor|0|||
162097874|NCT04579757|585406748|FG002|Overall Study|Study Terminated By Sponsor|0|||
162097875|NCT04579757|585406749|FG003|Overall Study|Study Terminated By Sponsor|0|||
162097876|NCT04579757|585406750|FG004|Overall Study|Study Terminated By Sponsor|2|||
162097877|NCT04579757|585406751|FG005|Overall Study|Study Terminated By Sponsor|0|||
162097878|NCT04579757|585406752|FG006|Overall Study|Study Terminated By Sponsor|0|||
162097879|NCT04579757|585406753|FG007|Overall Study|Study Terminated By Sponsor|2|||
162097880|NCT04579757|585406754|FG008|Overall Study|Study Terminated By Sponsor|0|||
162097881|NCT04579757|585406746|FG000|Overall Study|Withdrawal by Subject|1|||
162097882|NCT04579757|585406747|FG001|Overall Study|Withdrawal by Subject|1|||
162097883|NCT04579757|585406748|FG002|Overall Study|Withdrawal by Subject|0|||
162097884|NCT04579757|585406749|FG003|Overall Study|Withdrawal by Subject|0|||
162097885|NCT04579757|585406750|FG004|Overall Study|Withdrawal by Subject|2|||
162097886|NCT04579757|585406751|FG005|Overall Study|Withdrawal by Subject|1|||
162097887|NCT04579757|585406752|FG006|Overall Study|Withdrawal by Subject|0|||
162097888|NCT04579757|585406753|FG007|Overall Study|Withdrawal by Subject|3|||
162097889|NCT04579757|585406754|FG008|Overall Study|Withdrawal by Subject|0|||
162097890|NCT04579757|585406746|FG000|Overall Study|Radiological or Clinical PD|1|||
162097891|NCT04579757|585406747|FG001|Overall Study|Radiological or Clinical PD|4|||
162097892|NCT04579757|585406748|FG002|Overall Study|Radiological or Clinical PD|1|||
162097893|NCT04579757|585406749|FG003|Overall Study|Radiological or Clinical PD|3|||
162097894|NCT04579757|585406750|FG004|Overall Study|Radiological or Clinical PD|9|||
162097895|NCT04579757|585406751|FG005|Overall Study|Radiological or Clinical PD|4|||
162097896|NCT04579757|585406752|FG006|Overall Study|Radiological or Clinical PD|2|||
162097897|NCT04579757|585406753|FG007|Overall Study|Radiological or Clinical PD|2|||
162097898|NCT04579757|585406754|FG008|Overall Study|Radiological or Clinical PD|0|||
162097899|NCT04579757|585406746|FG000|Overall Study|Start of New Therapy|0|||
162097900|NCT04579757|585406747|FG001|Overall Study|Start of New Therapy|0|||
162097901|NCT04579757|585406748|FG002|Overall Study|Start of New Therapy|0|||
162097902|NCT04579757|585406749|FG003|Overall Study|Start of New Therapy|0|||
162097903|NCT04579757|585406750|FG004|Overall Study|Start of New Therapy|2|||
162097904|NCT04579757|585406751|FG005|Overall Study|Start of New Therapy|1|||
162097905|NCT04579757|585406752|FG006|Overall Study|Start of New Therapy|0|||
162097906|NCT04579757|585406753|FG007|Overall Study|Start of New Therapy|0|||
162097907|NCT04579757|585406754|FG008|Overall Study|Start of New Therapy|0|||
162097908|NCT01153633|585406755|FG000|Overall Study|Protocol Violation|1|||
162097909|NCT01153633|585406756|FG001|Overall Study|Protocol Violation|1|||
162097910|NCT01153633|585406755|FG000|Overall Study|Therapeutic failure|3|||
162097911|NCT01153633|585406756|FG001|Overall Study|Therapeutic failure|3|||
162097912|NCT00384085|585406757|FG000|Overall Study|Adverse Event|5|||
162097913|NCT00384085|585406758|FG001|Overall Study|Adverse Event|5|||
162097914|NCT00384085|585406759|FG002|Overall Study|Adverse Event|4|||
162097915|NCT00384085|585406757|FG000|Overall Study|Lack of Efficacy|0|||
162097916|NCT00384085|585406758|FG001|Overall Study|Lack of Efficacy|3|||
162097917|NCT00384085|585406759|FG002|Overall Study|Lack of Efficacy|2|||
162097918|NCT00384085|585406757|FG000|Overall Study|No longer Requires Study Treatment|1|||
162097919|NCT00384085|585406758|FG001|Overall Study|No longer Requires Study Treatment|0|||
162097920|NCT00384085|585406759|FG002|Overall Study|No longer Requires Study Treatment|1|||
162097921|NCT00384085|585406757|FG000|Overall Study|Protocol Violation|2|||
162097922|NCT00384085|585406758|FG001|Overall Study|Protocol Violation|2|||
162097923|NCT00384085|585406759|FG002|Overall Study|Protocol Violation|2|||
162097924|NCT00384085|585406757|FG000|Overall Study|Lost to Follow-up|9|||
162097925|NCT00384085|585406758|FG001|Overall Study|Lost to Follow-up|9|||
162097926|NCT00384085|585406759|FG002|Overall Study|Lost to Follow-up|10|||
162097927|NCT00384085|585406757|FG000|Overall Study|Progressive Disease|0|||
162097928|NCT00384085|585406758|FG001|Overall Study|Progressive Disease|1|||
162097929|NCT00384085|585406759|FG002|Overall Study|Progressive Disease|0|||
162097930|NCT00384085|585406757|FG000|Overall Study|Withdrawal by Subject|14|||
162097931|NCT00384085|585406758|FG001|Overall Study|Withdrawal by Subject|19|||
162097932|NCT00384085|585406759|FG002|Overall Study|Withdrawal by Subject|29|||
162097933|NCT00384085|585406757|FG000|Overall Study|Patient non-compliant|4|||
162097934|NCT00384085|585406758|FG001|Overall Study|Patient non-compliant|4|||
162097935|NCT00384085|585406759|FG002|Overall Study|Patient non-compliant|5|||
162097936|NCT00384085|585406757|FG000|Overall Study|Physician Decision|1|||
162097937|NCT00384085|585406758|FG001|Overall Study|Physician Decision|0|||
162097938|NCT00384085|585406759|FG002|Overall Study|Physician Decision|0|||
162097939|NCT00384085|585406757|FG000|Overall Study|Loss of site personnel|1|||
162097940|NCT00384085|585406758|FG001|Overall Study|Loss of site personnel|0|||
162097941|NCT00384085|585406759|FG002|Overall Study|Loss of site personnel|1|||
162097942|NCT00384085|585406757|FG000|Overall Study|Sponsor decision|1|||
162097943|NCT00384085|585406758|FG001|Overall Study|Sponsor decision|2|||
162097944|NCT00384085|585406759|FG002|Overall Study|Sponsor decision|1|||
162097945|NCT00384085|585406757|FG000|Overall Study|Patient moved|1|||
162097946|NCT00384085|585406758|FG001|Overall Study|Patient moved|0|||
162097947|NCT00384085|585406759|FG002|Overall Study|Patient moved|1|||
162097948|NCT00384085|585406757|FG000|Overall Study|Patient required surgery|0|||
162097949|NCT00384085|585406758|FG001|Overall Study|Patient required surgery|1|||
162097950|NCT00384085|585406759|FG002|Overall Study|Patient required surgery|0|||
162097951|NCT05912400|585406760|FG000|Overall Study|Lost to Follow-up|1|||
162097952|NCT05912400|585406761|FG001|Overall Study|Lost to Follow-up|0|||
162097953|NCT05912400|585406760|FG000|Overall Study|Physician Decision|6|||
162097954|NCT05912400|585406761|FG001|Overall Study|Physician Decision|0|||
162097955|NCT05912400|585406760|FG000|Overall Study|Withdrawal by Subject|1|||
162097956|NCT05912400|585406761|FG001|Overall Study|Withdrawal by Subject|0|||
162097957|NCT01944631|585406765|FG000|Overall Study|Adverse Event|1|||
162097958|NCT01944631|585406766|FG001|Overall Study|Adverse Event|0|||
162097959|NCT01944631|585406765|FG000|Overall Study|Lost to Follow-up|3|||
162097960|NCT01944631|585406766|FG001|Overall Study|Lost to Follow-up|1|||
162097961|NCT01944631|585406765|FG000|Overall Study|Withdrawal by Subject|0|||
162097962|NCT01944631|585406766|FG001|Overall Study|Withdrawal by Subject|1|||
162097963|NCT01843192|585406767|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
162097964|NCT01843192|585406768|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
162097965|NCT01843192|585406769|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
162097966|NCT00328510|585406772|FG000|Overall Study|Gag disorder, could not use frame|4|||
162097967|NCT00328510|585406773|FG001|Overall Study|Gag disorder, could not use frame|0|||
162097968|NCT00328510|585406772|FG000|Overall Study|Dentition problems, could not use frame|1|||
162097969|NCT00328510|585406773|FG001|Overall Study|Dentition problems, could not use frame|0|||
162097970|NCT00328510|585406772|FG000|Overall Study|Withdrawal by Subject|4|||
162097971|NCT00328510|585406773|FG001|Overall Study|Withdrawal by Subject|2|||
162097972|NCT00328510|585406772|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
162097973|NCT00328510|585406773|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
162097974|NCT00328510|585406772|FG000|Overall Study|Treatment changed to a single fraction|1|||
162097975|NCT00328510|585406773|FG001|Overall Study|Treatment changed to a single fraction|1|||
162097976|NCT04726709|585406774|FG000|Overall Study|Withdrawal by Subject|2|||
162097977|NCT04726709|585406775|FG001|Overall Study|Withdrawal by Subject|2|||
162097978|NCT01949480|585406776|FG000|Overall Study|Physician Decision|5|||
162097979|NCT01949480|585406777|FG001|Overall Study|Physician Decision|8|||
162097980|NCT00144339|585406778|FG000|Overall Study|Adverse Event|746|||
162097981|NCT00144339|585406779|FG001|Overall Study|Adverse Event|627|||
162097982|NCT00144339|585406778|FG000|Overall Study|Protocol Violation|75|||
162097983|NCT00144339|585406779|FG001|Overall Study|Protocol Violation|48|||
162097984|NCT00144339|585406778|FG000|Overall Study|Withdrawal by Subject|403|||
162097985|NCT00144339|585406779|FG001|Overall Study|Withdrawal by Subject|300|||
162097986|NCT00144339|585406778|FG000|Overall Study|Lost to Follow-up|76|||
162097987|NCT00144339|585406779|FG001|Overall Study|Lost to Follow-up|64|||
162097988|NCT00144339|585406778|FG000|Overall Study|Other|58|||
162097989|NCT00144339|585406779|FG001|Overall Study|Other|60|||
162097990|NCT00305058|585406780|FG000|Overall Study|Participant too young|1|||
162097991|NCT00305058|585406781|FG001|Overall Study|Participant too young|0|||
162097992|NCT00305058|585406780|FG000|Overall Study|Missing data collection instrument|3|||
162097993|NCT00305058|585406781|FG001|Overall Study|Missing data collection instrument|2|||
162097994|NCT00305058|585406780|FG000|Overall Study|Missing outcome data|3|||
162097995|NCT00305058|585406781|FG001|Overall Study|Missing outcome data|2|||
162097996|NCT04798586|585406783|FG000|Overall Study|Death|2|||
162097997|NCT03538626|585406785|FG000|Overall Study|Withdrawal by Subject|0|||
162097998|NCT03538626|585406786|FG001|Overall Study|Withdrawal by Subject|1|||
162097999|NCT03538626|585406787|FG002|Overall Study|Withdrawal by Subject|0|||
162098000|NCT03538626|585406788|FG003|Overall Study|Withdrawal by Subject|0|||
162098001|NCT03538626|585406789|FG004|Overall Study|Withdrawal by Subject|0|||
162098002|NCT03538626|585406790|FG005|Overall Study|Withdrawal by Subject|0|||
162098003|NCT03538626|585406791|FG006|Overall Study|Withdrawal by Subject|0|||
162098004|NCT03538626|585406792|FG007|Overall Study|Withdrawal by Subject|0|||
162098005|NCT03538626|585406785|FG000|Overall Study|Lost to Follow-up|0|||
162098006|NCT03538626|585406786|FG001|Overall Study|Lost to Follow-up|0|||
162098007|NCT03538626|585406787|FG002|Overall Study|Lost to Follow-up|0|||
162098008|NCT03538626|585406788|FG003|Overall Study|Lost to Follow-up|0|||
162098009|NCT03538626|585406789|FG004|Overall Study|Lost to Follow-up|0|||
162098010|NCT03538626|585406790|FG005|Overall Study|Lost to Follow-up|0|||
162098011|NCT03538626|585406791|FG006|Overall Study|Lost to Follow-up|1|||
162098012|NCT03538626|585406792|FG007|Overall Study|Lost to Follow-up|0|||
162098013|NCT00288587|585406793|FG000|Overall Study|Death|4|||
162098014|NCT00288587|585406794|FG001|Overall Study|Death|4|||
162098015|NCT00288587|585406793|FG000|Overall Study|Transplant|0|||
162098016|NCT00288587|585406794|FG001|Overall Study|Transplant|3|||
162098017|NCT00288587|585406793|FG000|Overall Study|Adverse Event|0|||
162098018|NCT00288587|585406794|FG001|Overall Study|Adverse Event|1|||
162098019|NCT00288587|585406793|FG000|Overall Study|Physician Decision|0|||
162098020|NCT00288587|585406794|FG001|Overall Study|Physician Decision|2|||
162098021|NCT00288587|585406793|FG000|Overall Study|Severe Aortic Stenosis|1|||
162098022|NCT00288587|585406794|FG001|Overall Study|Severe Aortic Stenosis|0|||
162098023|NCT02232893|585406800|FG000|Overall Study|Withdrawal by Subject|4|||
162098024|NCT02232893|585406801|FG001|Overall Study|Withdrawal by Subject|1|||
162098025|NCT02232893|585406800|FG000|Overall Study|Adverse Event|0|||
162098026|NCT02232893|585406801|FG001|Overall Study|Adverse Event|1|||
162098027|NCT02232893|585406800|FG000|Overall Study|Sponsor request early termination|0|||
162098028|NCT02232893|585406801|FG001|Overall Study|Sponsor request early termination|1|||
162098029|NCT02232893|585406800|FG000|Overall Study|Developed exclusion criteria|0|||
162098030|NCT02232893|585406801|FG001|Overall Study|Developed exclusion criteria|1|||
162098031|NCT02232893|585406800|FG000|Overall Study|Other|0|||
162098032|NCT02232893|585406801|FG001|Overall Study|Other|3|||
162098033|NCT01764945|585406802|FG000|Overall Study|Adverse Event|0|||
162098034|NCT01764945|585406803|FG001|Overall Study|Adverse Event|1|||
162098035|NCT01764945|585406804|FG002|Overall Study|Adverse Event|0|||
162098036|NCT01764945|585406805|FG003|Overall Study|Adverse Event|0|||
162098037|NCT01764945|585406806|FG004|Overall Study|Adverse Event|0|||
162098038|NCT01764945|585406807|FG005|Overall Study|Adverse Event|0|||
162098039|NCT01764945|585406808|FG006|Overall Study|Adverse Event|1|||
162098040|NCT01764945|585406809|FG007|Overall Study|Adverse Event|0|||
162098041|NCT05077267|585406812|FG000|Treatment Period|Lost to Follow-up|0|||
162098042|NCT05077267|585406813|FG001|Treatment Period|Lost to Follow-up|1|||
162098043|NCT05077267|585406814|FG002|Treatment Period|Lost to Follow-up|0|||
162098044|NCT05077267|585406812|FG000|Treatment Period|Withdrawal by Subject|0|||
162098045|NCT05077267|585406813|FG001|Treatment Period|Withdrawal by Subject|1|||
162098046|NCT05077267|585406814|FG002|Treatment Period|Withdrawal by Subject|0|||
162098047|NCT05077267|585406812|FG000|Follow-up Period|Lost to Follow-up|0|||
162098048|NCT05077267|585406813|FG001|Follow-up Period|Lost to Follow-up|5|||
162098049|NCT05077267|585406814|FG002|Follow-up Period|Lost to Follow-up|7|||
162098050|NCT05077267|585406812|FG000|Follow-up Period|Withdrawal by Subject|0|||
162098051|NCT05077267|585406813|FG001|Follow-up Period|Withdrawal by Subject|2|||
162098052|NCT05077267|585406814|FG002|Follow-up Period|Withdrawal by Subject|5|||
162098053|NCT05077267|585406812|FG000|Follow-up Period|Study terminated by sponsor|0|||
162098054|NCT05077267|585406813|FG001|Follow-up Period|Study terminated by sponsor|27|||
162098055|NCT05077267|585406814|FG002|Follow-up Period|Study terminated by sponsor|23|||
162098056|NCT05077267|585406812|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
162098057|NCT05077267|585406813|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
162098058|NCT05077267|585406814|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
162098059|NCT05077267|585406812|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
162098060|NCT05077267|585406813|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
162098061|NCT05077267|585406814|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
162098062|NCT02911948|585406815|FG000|Overall Study|Protocol Violation|0|||
162098063|NCT02911948|585406816|FG001|Overall Study|Protocol Violation|1|||
162098064|NCT02911948|585406815|FG000|Overall Study|Withdrawal by Subject|0|||
162098065|NCT02911948|585406816|FG001|Overall Study|Withdrawal by Subject|2|||
162098066|NCT02911948|585406815|FG000|Overall Study|Lack of Efficacy|0|||
162098067|NCT02911948|585406816|FG001|Overall Study|Lack of Efficacy|1|||
162098068|NCT02911948|585406815|FG000|Overall Study|Unclassified|0|||
162098069|NCT02911948|585406816|FG001|Overall Study|Unclassified|3|||
162098070|NCT00586105|585406823|FG000|Overall Study|Adverse Event|4|||
162098071|NCT00586105|585406823|FG000|Overall Study|Death|2|||
162098072|NCT00586105|585406823|FG000|Overall Study|Protocol Violation|1|||
162098073|NCT00586105|585406823|FG000|Overall Study|Withdrawal by Subject|3|||
162098074|NCT00586105|585406823|FG000|Overall Study|Disease progression|19|||
162098075|NCT00586105|585406823|FG000|Overall Study|Switched to commercial drug|9|||
162098076|NCT00586105|585406823|FG000|Overall Study|Reason not reported|1|||
162098077|NCT01136291|585406827|FG000|Overall Study|Lost to Follow-up|1|||
162098078|NCT01136291|585406828|FG001|Overall Study|Lost to Follow-up|1|||
162098079|NCT03965052|585406829|FG000|Overall Study|Protocol Violation|1|||
162098080|NCT03965052|585406830|FG001|Overall Study|Protocol Violation|0|||
162098081|NCT03165045|585406840|FG000|Visit 1|No registration after visit 1|9|||
162098082|NCT03165045|585406840|FG000|Visit 1|No treatment documented|10|||
162098083|NCT03165045|585406840|FG000|Visit 1|No visit 1|10|||
162098084|NCT03165045|585406840|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
162098085|NCT03165045|585406840|FG000|Visit 2|No available total CCQ score at all|29|||
162098086|NCT03165045|585406840|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
162098087|NCT02308033|585406841|FG000|Overall Study|Normal Gram stain at Baseline|13|||
162098088|NCT02308033|585406842|FG001|Overall Study|Normal Gram stain at Baseline|10|||
162098089|NCT02308033|585406841|FG000|Overall Study|Positive for STD at Baseline|7|||
162098090|NCT02308033|585406842|FG001|Overall Study|Positive for STD at Baseline|4|||
162098091|NCT02308033|585406841|FG000|Overall Study|Lost to Follow-up|6|||
162098092|NCT02308033|585406842|FG001|Overall Study|Lost to Follow-up|5|||
162098093|NCT04323436|585406845|FG000|Overall Study|Adverse Event|7|||
162098094|NCT04323436|585406846|FG001|Overall Study|Adverse Event|0|||
162098095|NCT04323436|585406847|FG002|Overall Study|Adverse Event|0|||
162098096|NCT04323436|585406845|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
162098097|NCT04323436|585406846|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
162098098|NCT04323436|585406847|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
162098099|NCT04323436|585406845|FG000|Overall Study|Death|1|||
162098100|NCT04323436|585406846|FG001|Overall Study|Death|0|||
162098101|NCT04323436|585406847|FG002|Overall Study|Death|0|||
162098102|NCT04323436|585406845|FG000|Overall Study|Physician Decision|2|||
162098103|NCT04323436|585406846|FG001|Overall Study|Physician Decision|0|||
162098104|NCT04323436|585406847|FG002|Overall Study|Physician Decision|0|||
162098105|NCT04323436|585406845|FG000|Overall Study|Progressive disease|10|||
162098106|NCT04323436|585406846|FG001|Overall Study|Progressive disease|0|||
162098107|NCT04323436|585406847|FG002|Overall Study|Progressive disease|0|||
162098108|NCT04323436|585406845|FG000|Overall Study|Subject decision|3|||
162098109|NCT04323436|585406846|FG001|Overall Study|Subject decision|0|||
162098110|NCT04323436|585406847|FG002|Overall Study|Subject decision|0|||
162098111|NCT01682837|585406850|FG000|Baseline|Withdrawal by Subject|5|||
162098112|NCT01664078|585406851|FG000|Overall Study|Death|9|||
162098113|NCT01664078|585406851|FG000|Overall Study|Withdrawal by Subject|4|||
162098114|NCT01664078|585406851|FG000|Overall Study|Lost to Follow-up|2|||
162098115|NCT01664078|585406851|FG000|Overall Study|missed 5 year visit|1|||
162098116|NCT01664078|585406851|FG000|Overall Study|Other|53|||
162098117|NCT03135522|585406854|FG000|Overall Study|Adverse Event|1|||
162098118|NCT03135522|585406855|FG001|Overall Study|Adverse Event|0|||
162098119|NCT04095858|585406856|FG000|Overall Study|Death|1|||
162098120|NCT04095858|585406857|FG001|Overall Study|Death|0|||
162098121|NCT04095858|585406856|FG000|Overall Study|Study terminated by Sponsor|2|||
162098122|NCT04095858|585406857|FG001|Overall Study|Study terminated by Sponsor|4|||
162098123|NCT01344460|585406858|FG000|Overall Study|Withdrawal by Subject|1|||
162098124|NCT01344460|585406858|FG000|Overall Study|Lost to Follow-up|2|||
162098125|NCT02838017|585406860|FG000|Overall Study|Lost to Follow-up|14|||
162098126|NCT02838017|585406861|FG001|Overall Study|Lost to Follow-up|11|||
162098127|NCT01692197|585406862|FG000|Overall Study|Failed Screening|3|||
162098128|NCT02120924|585406863|FG000|Overall Study|Lack of Efficacy|1|||
162098129|NCT02120924|585406864|FG001|Overall Study|Lack of Efficacy|2|||
162098130|NCT02120924|585406865|FG002|Overall Study|Lack of Efficacy|3|||
162098131|NCT02120924|585406863|FG000|Overall Study|Adverse Event|0|||
162098132|NCT02120924|585406864|FG001|Overall Study|Adverse Event|1|||
162098133|NCT02120924|585406865|FG002|Overall Study|Adverse Event|3|||
162098134|NCT02120924|585406863|FG000|Overall Study|Withdrawal by Subject|16|||
162098135|NCT02120924|585406864|FG001|Overall Study|Withdrawal by Subject|20|||
162098136|NCT02120924|585406865|FG002|Overall Study|Withdrawal by Subject|8|||
162098137|NCT02120924|585406863|FG000|Overall Study|Lost to Follow-up|14|||
162098138|NCT02120924|585406864|FG001|Overall Study|Lost to Follow-up|14|||
162098139|NCT02120924|585406865|FG002|Overall Study|Lost to Follow-up|11|||
162098140|NCT02120924|585406863|FG000|Overall Study|Pregnancy|2|||
162098141|NCT02120924|585406864|FG001|Overall Study|Pregnancy|0|||
162098142|NCT02120924|585406865|FG002|Overall Study|Pregnancy|0|||
162098143|NCT02120924|585406863|FG000|Overall Study|Protocol Violation|3|||
162098144|NCT02120924|585406864|FG001|Overall Study|Protocol Violation|7|||
162098145|NCT02120924|585406865|FG002|Overall Study|Protocol Violation|2|||
162098146|NCT02120924|585406863|FG000|Overall Study|Physician Decision|0|||
162098147|NCT02120924|585406864|FG001|Overall Study|Physician Decision|1|||
162098148|NCT02120924|585406865|FG002|Overall Study|Physician Decision|1|||
162098149|NCT02120924|585406863|FG000|Overall Study|Death|1|||
162098150|NCT02120924|585406864|FG001|Overall Study|Death|0|||
162098151|NCT02120924|585406865|FG002|Overall Study|Death|0|||
162098152|NCT02120924|585406863|FG000|Overall Study|Compliance with IP|5|||
162098153|NCT02120924|585406864|FG001|Overall Study|Compliance with IP|1|||
162098154|NCT02120924|585406865|FG002|Overall Study|Compliance with IP|1|||
162098155|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
162098156|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
162098157|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
162098158|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
162098159|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
162098160|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
162098161|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
162098162|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
162098163|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
162098164|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
162098165|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
162098166|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
162098167|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
162098168|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
162098169|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
162098170|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
162098171|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
162098172|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
162098173|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
162098174|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
162098175|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
162098176|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
162098177|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
162098178|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
162098179|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
162098180|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
162098181|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
162098182|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
162098183|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
162098184|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
162098185|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
162098186|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
162098187|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
162098188|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
162098189|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
162098190|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
162098191|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
162098192|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
162098193|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
162098194|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
162098195|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
162098196|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
162098197|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
162098198|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
162098199|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
162098200|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
162098201|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
162098202|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
162098203|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
162098204|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
162098205|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
162098206|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
162098207|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
162098208|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
162098209|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
162098210|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
162098211|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
162098212|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
162098213|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
162098214|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
162098215|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
162098216|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
162098217|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
162098218|NCT01884350|585406866|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
162098219|NCT01884350|585406867|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
162098220|NCT01884350|585406868|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
162098221|NCT03403634|585406875|FG000|Overall Study|Disease progression|3|||
162098222|NCT03403634|585406875|FG000|Overall Study|Did not meet eligibility criteria|4|||
162098223|NCT04447404|585408593|FG000|Overall Study|Death|2|||
162098224|NCT04447404|585408594|FG001|Overall Study|Death|0|||
162098225|NCT00574080|585408595|FG000|Overall Study|Death|10|||
162098226|NCT00574080|585408596|FG001|Overall Study|Death|10|||
162098227|NCT01221597|585408597|FG000|Overall Study|Adverse Event|4|||
162098228|NCT01221597|585408598|FG001|Overall Study|Adverse Event|1|||
162098229|NCT01221597|585408597|FG000|Overall Study|Withdrawal by Subject|20|||
162098230|NCT01221597|585408598|FG001|Overall Study|Withdrawal by Subject|6|||
162098231|NCT01221597|585408597|FG000|Overall Study|Lost to Follow-up|6|||
162098232|NCT01221597|585408598|FG001|Overall Study|Lost to Follow-up|5|||
162098233|NCT01221597|585408597|FG000|Overall Study|Protocol Violation|1|||
162098234|NCT01221597|585408598|FG001|Overall Study|Protocol Violation|0|||
162098235|NCT01221597|585408597|FG000|Overall Study|Other|3|||
162098236|NCT01221597|585408598|FG001|Overall Study|Other|4|||
162098237|NCT01221597|585408597|FG000|Overall Study|Death|2|||
162098238|NCT01221597|585408598|FG001|Overall Study|Death|0|||
162098239|NCT00148343|585408602|FG000|Overall Study|Withdrawal by Subject|12|||
162098240|NCT00148343|585408603|FG001|Overall Study|Withdrawal by Subject|7|||
162098241|NCT00148343|585408602|FG000|Overall Study|Physician Decision|3|||
162098242|NCT00148343|585408603|FG001|Overall Study|Physician Decision|4|||
162098243|NCT02384759|585408614|FG000|Overall Study|Patients not treated|3|||
162098244|NCT02384759|585408615|FG001|Overall Study|Patients not treated|2|||
162098245|NCT01605617|585408616|FG000|First Intervention|Adverse Event|0|||
162098246|NCT01605617|585408617|FG001|First Intervention|Adverse Event|1|||
162098247|NCT01605617|585408616|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
162098248|NCT01605617|585408617|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
162098249|NCT00121238|585408618|FG000|Overall Study|disease progression before intervention|1|||
162098250|NCT00121238|585408618|FG000|Overall Study|Protocol Violation|2|||
162098251|NCT01380327|585408619|FG000|Overall Study|Lost to Follow-up|0|||
162098252|NCT01380327|585408620|FG001|Overall Study|Lost to Follow-up|1|||
162098253|NCT01380327|585408621|FG002|Overall Study|Lost to Follow-up|1|||
162098254|NCT01380327|585408619|FG000|Overall Study|Protocol Violation|3|||
162098255|NCT01380327|585408620|FG001|Overall Study|Protocol Violation|2|||
162098256|NCT01380327|585408621|FG002|Overall Study|Protocol Violation|3|||
162098257|NCT01380327|585408619|FG000|Overall Study|Withdrawal by Subject|0|||
162098258|NCT01380327|585408620|FG001|Overall Study|Withdrawal by Subject|0|||
162098259|NCT01380327|585408621|FG002|Overall Study|Withdrawal by Subject|1|||
162098260|NCT01380327|585408619|FG000|Overall Study|Housing situation precluded ability to k|0|||
162098261|NCT01380327|585408620|FG001|Overall Study|Housing situation precluded ability to k|0|||
162098262|NCT01380327|585408621|FG002|Overall Study|Housing situation precluded ability to k|1|||
162098263|NCT01380327|585408619|FG000|Overall Study|Questionable onset of epilepsy|0|||
162098264|NCT01380327|585408620|FG001|Overall Study|Questionable onset of epilepsy|0|||
162098265|NCT01380327|585408621|FG002|Overall Study|Questionable onset of epilepsy|1|||
162098266|NCT03043664|585408622|FG000|Overall Study|Lost to Follow-up|1|||
162098267|NCT01540851|585408623|FG000|Overall Study|Lost to Follow-up|14|||
162098268|NCT01540851|585408624|FG001|Overall Study|Lost to Follow-up|15|||
162098269|NCT01540851|585408623|FG000|Overall Study|Withdrawal by Subject|7|||
162098270|NCT01540851|585408624|FG001|Overall Study|Withdrawal by Subject|3|||
162098271|NCT00325468|585408625|FG000|Overall Study|Adverse Event|1|||
162098272|NCT00325468|585408626|FG001|Overall Study|Adverse Event|1|||
162098273|NCT00325468|585408627|FG002|Overall Study|Adverse Event|0|||
162098274|NCT00325468|585408628|FG003|Overall Study|Adverse Event|5|||
162098275|NCT00325468|585408629|FG004|Overall Study|Adverse Event|1|||
162098276|NCT00325468|585408625|FG000|Overall Study|Death|2|||
162098277|NCT00325468|585408626|FG001|Overall Study|Death|0|||
162098278|NCT00325468|585408627|FG002|Overall Study|Death|2|||
162098279|NCT00325468|585408628|FG003|Overall Study|Death|4|||
162098280|NCT00325468|585408629|FG004|Overall Study|Death|0|||
162098281|NCT00325468|585408625|FG000|Overall Study|Lost to Follow-up|0|||
162098282|NCT00325468|585408626|FG001|Overall Study|Lost to Follow-up|0|||
162098283|NCT00325468|585408627|FG002|Overall Study|Lost to Follow-up|1|||
162098284|NCT00325468|585408628|FG003|Overall Study|Lost to Follow-up|2|||
162098285|NCT00325468|585408629|FG004|Overall Study|Lost to Follow-up|2|||
162098286|NCT00325468|585408625|FG000|Overall Study|Physician Decision|1|||
162098287|NCT00325468|585408626|FG001|Overall Study|Physician Decision|1|||
162098288|NCT00325468|585408627|FG002|Overall Study|Physician Decision|0|||
162098289|NCT00325468|585408628|FG003|Overall Study|Physician Decision|1|||
162098290|NCT00325468|585408629|FG004|Overall Study|Physician Decision|0|||
162098291|NCT00325468|585408625|FG000|Overall Study|Withdrawal by Subject|3|||
162098292|NCT00325468|585408626|FG001|Overall Study|Withdrawal by Subject|1|||
162098293|NCT00325468|585408627|FG002|Overall Study|Withdrawal by Subject|0|||
162098294|NCT00325468|585408628|FG003|Overall Study|Withdrawal by Subject|14|||
162098295|NCT00325468|585408629|FG004|Overall Study|Withdrawal by Subject|4|||
162098296|NCT00325468|585408625|FG000|Overall Study|site closure etc|4|||
162098297|NCT00325468|585408626|FG001|Overall Study|site closure etc|2|||
162098298|NCT00325468|585408627|FG002|Overall Study|site closure etc|1|||
162098299|NCT00325468|585408628|FG003|Overall Study|site closure etc|8|||
162098300|NCT00325468|585408629|FG004|Overall Study|site closure etc|1|||
162098301|NCT03732209|585408630|FG000|Overall Study|Lost to Follow-up|4|||
162098302|NCT03732209|585408631|FG001|Overall Study|Lost to Follow-up|4|||
162098303|NCT03732209|585408630|FG000|Overall Study|Withdrawal by Subject|8|||
162098304|NCT03732209|585408631|FG001|Overall Study|Withdrawal by Subject|9|||
162098305|NCT05046795|585408632|FG000|Overall Study|Adverse Event|13|||
162098306|NCT05046795|585408633|FG001|Overall Study|Adverse Event|15|||
162098307|NCT05046795|585408632|FG000|Overall Study|Withdrawal by Subject|4|||
162098308|NCT05046795|585408633|FG001|Overall Study|Withdrawal by Subject|7|||
162098309|NCT05046795|585408632|FG000|Overall Study|Physician Decision|1|||
162098310|NCT05046795|585408633|FG001|Overall Study|Physician Decision|2|||
162098311|NCT05046795|585408632|FG000|Overall Study|Protocol Violation|1|||
162098312|NCT05046795|585408633|FG001|Overall Study|Protocol Violation|2|||
162098313|NCT05046795|585408632|FG000|Overall Study|Death|1|||
162098314|NCT05046795|585408633|FG001|Overall Study|Death|0|||
162098315|NCT05046795|585408632|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
162098316|NCT05046795|585408633|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
162098317|NCT01127178|585408634|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
162098318|NCT01127178|585408635|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
162098319|NCT01127178|585408634|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
162098320|NCT01127178|585408635|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
162098321|NCT01127178|585408634|FG000|Dose Escalation: Treatment Phase|Other|2|||
162098322|NCT01127178|585408635|FG001|Dose Escalation: Treatment Phase|Other|0|||
162098323|NCT01127178|585408634|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
162098324|NCT01127178|585408635|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
162098325|NCT01127178|585408634|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
162098326|NCT01127178|585408635|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
162098327|NCT01127178|585408634|FG000|Dose Escalation: Extension Phase|Other|1|||
162098328|NCT01127178|585408635|FG001|Dose Escalation: Extension Phase|Other|0|||
162098329|NCT04139317|585408636|FG000|Overall Study|Adverse Event|10|||
162098330|NCT04139317|585408637|FG001|Overall Study|Adverse Event|2|||
162098331|NCT04139317|585408636|FG000|Overall Study|Death|6|||
162098332|NCT04139317|585408637|FG001|Overall Study|Death|4|||
162098333|NCT04139317|585408636|FG000|Overall Study|Lost to Follow-up|1|||
162098334|NCT04139317|585408637|FG001|Overall Study|Lost to Follow-up|0|||
162098335|NCT04139317|585408636|FG000|Overall Study|Physician Decision|3|||
162098336|NCT04139317|585408637|FG001|Overall Study|Physician Decision|1|||
162098337|NCT04139317|585408636|FG000|Overall Study|Progressive Disease|19|||
162098338|NCT04139317|585408637|FG001|Overall Study|Progressive Disease|9|||
162098339|NCT04139317|585408636|FG000|Overall Study|Subject Decision|2|||
162098340|NCT04139317|585408637|FG001|Overall Study|Subject Decision|2|||
162098341|NCT00782340|585408640|FG000|Open Label Titration|Adverse Event|12|||
162098342|NCT00782340|585408641|FG001|Open Label Titration|Adverse Event|0|||
162098343|NCT00782340|585408642|FG002|Open Label Titration|Adverse Event|0|||
162098344|NCT00782340|585408640|FG000|Open Label Titration|Treatment failure|50|||
162098345|NCT00782340|585408641|FG001|Open Label Titration|Treatment failure|0|||
162098346|NCT00782340|585408642|FG002|Open Label Titration|Treatment failure|0|||
162098347|NCT00782340|585408640|FG000|Open Label Titration|Protocol Violation|5|||
162098348|NCT00782340|585408641|FG001|Open Label Titration|Protocol Violation|0|||
162098349|NCT00782340|585408642|FG002|Open Label Titration|Protocol Violation|0|||
162098350|NCT00782340|585408640|FG000|Open Label Titration|Withdrawal by Subject|5|||
162098351|NCT00782340|585408641|FG001|Open Label Titration|Withdrawal by Subject|0|||
162098352|NCT00782340|585408642|FG002|Open Label Titration|Withdrawal by Subject|0|||
162098353|NCT00782340|585408640|FG000|Open Label Titration|Enrollment capped|16|||
162098354|NCT00782340|585408641|FG001|Open Label Titration|Enrollment capped|0|||
162098355|NCT00782340|585408642|FG002|Open Label Titration|Enrollment capped|0|||
162098356|NCT00782340|585408640|FG000|Open Label Titration|Did not meet responder criteria|2|||
162098357|NCT00782340|585408641|FG001|Open Label Titration|Did not meet responder criteria|0|||
162098358|NCT00782340|585408642|FG002|Open Label Titration|Did not meet responder criteria|0|||
162098359|NCT00782340|585408640|FG000|Open Label Titration|Lost to Follow-up|5|||
162098360|NCT00782340|585408641|FG001|Open Label Titration|Lost to Follow-up|0|||
162098361|NCT00782340|585408642|FG002|Open Label Titration|Lost to Follow-up|0|||
162098362|NCT00782340|585408640|FG000|Open Label Titration|Randomized in error|6|||
162098363|NCT00782340|585408641|FG001|Open Label Titration|Randomized in error|0|||
162098364|NCT00782340|585408642|FG002|Open Label Titration|Randomized in error|0|||
162098365|NCT02365467|585408643|FG000|Overall Study|Death|3|||
162098366|NCT01306162|585408644|FG000|Period 1|Adverse Event|0|||
162098367|NCT01306162|585408645|FG001|Period 1|Adverse Event|0|||
162098368|NCT01306162|585408646|FG002|Period 1|Adverse Event|0|||
162098369|NCT01306162|585408647|FG003|Period 1|Adverse Event|1|||
162098370|NCT01306162|585408644|FG000|Washout 1|Non-compliance to protocol|0|||
162098371|NCT01306162|585408645|FG001|Washout 1|Non-compliance to protocol|1|||
162098372|NCT01306162|585408646|FG002|Washout 1|Non-compliance to protocol|0|||
162098373|NCT01306162|585408647|FG003|Washout 1|Non-compliance to protocol|0|||
162098374|NCT01109992|585408648|FG000|Overall Study|Withdrawal by Subject|0|||
162098375|NCT01109992|585408649|FG001|Overall Study|Withdrawal by Subject|1|||
162098376|NCT01109992|585408648|FG000|Overall Study|Movement during rest scan.|0|||
162098377|NCT01109992|585408649|FG001|Overall Study|Movement during rest scan.|1|||
162098378|NCT00690755|585408650|FG000|Overall Study|Physician Decision|2|||
162098379|NCT00690755|585408651|FG001|Overall Study|Physician Decision|0|||
162098380|NCT00690755|585408652|FG002|Overall Study|Physician Decision|46|||
162098381|NCT00690755|585408653|FG003|Overall Study|Physician Decision|5|||
162098382|NCT00690755|585408654|FG004|Overall Study|Physician Decision|0|||
162098383|NCT00690755|585408655|FG005|Overall Study|Physician Decision|4|||
162098384|NCT00690755|585408656|FG006|Overall Study|Physician Decision|0|||
162098385|NCT04287920|585408660|FG000|Overall Study|Lost to Follow-up|1|||
162098386|NCT04287920|585408661|FG001|Overall Study|Lost to Follow-up|1|||
162098387|NCT04287920|585408660|FG000|Overall Study|Withdrawal by Subject|0|||
162098388|NCT04287920|585408661|FG001|Overall Study|Withdrawal by Subject|3|||
162098389|NCT02952924|585408666|FG000|Overall Study|Protocol Violation|0|||
162098390|NCT02952924|585408667|FG001|Overall Study|Protocol Violation|0|||
162098391|NCT02952924|585408668|FG002|Overall Study|Protocol Violation|0|||
162098392|NCT02952924|585408669|FG003|Overall Study|Protocol Violation|0|||
162098393|NCT02952924|585408670|FG004|Overall Study|Protocol Violation|0|||
162098394|NCT02952924|585408671|FG005|Overall Study|Protocol Violation|0|||
162098395|NCT02952924|585408672|FG006|Overall Study|Protocol Violation|0|||
162098396|NCT02952924|585408673|FG007|Overall Study|Protocol Violation|0|||
162098397|NCT02952924|585408674|FG008|Overall Study|Protocol Violation|0|||
162098398|NCT02952924|585408675|FG009|Overall Study|Protocol Violation|0|||
162098399|NCT02952924|585408676|FG010|Overall Study|Protocol Violation|0|||
162098400|NCT02952924|585408677|FG011|Overall Study|Protocol Violation|0|||
162098401|NCT02952924|585408678|FG012|Overall Study|Protocol Violation|0|||
162098402|NCT02952924|585408679|FG013|Overall Study|Protocol Violation|0|||
162098403|NCT02952924|585408680|FG014|Overall Study|Protocol Violation|0|||
162098404|NCT02952924|585408681|FG015|Overall Study|Protocol Violation|0|||
162098405|NCT02952924|585408682|FG016|Overall Study|Protocol Violation|0|||
162098406|NCT02952924|585408683|FG017|Overall Study|Protocol Violation|0|||
162098407|NCT02952924|585408684|FG018|Overall Study|Protocol Violation|0|||
162098408|NCT02952924|585408685|FG019|Overall Study|Protocol Violation|1|||
162098409|NCT02952924|585408686|FG020|Overall Study|Protocol Violation|0|||
162098410|NCT02952924|585408687|FG021|Overall Study|Protocol Violation|0|||
162098411|NCT02952924|585408666|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
162098412|NCT02952924|585408667|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
162098413|NCT02952924|585408668|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
162098414|NCT02952924|585408669|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
162098415|NCT02952924|585408670|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
162122791|NCT01351025|585500335|FG000|Week 24 - 44|Lost to Follow-up|0|||
162098416|NCT02952924|585408671|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
162098417|NCT02952924|585408672|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
162098418|NCT02952924|585408673|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
162098419|NCT02952924|585408674|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
162098420|NCT02952924|585408675|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
162098421|NCT02952924|585408676|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
162098422|NCT02952924|585408677|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
162098423|NCT02952924|585408678|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
162098424|NCT02952924|585408679|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
162098425|NCT02952924|585408680|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
162098426|NCT02952924|585408681|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
162098427|NCT02952924|585408682|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
162098428|NCT02952924|585408683|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
162098429|NCT02952924|585408684|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
162098430|NCT02952924|585408685|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
162098431|NCT02952924|585408686|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
162098432|NCT02952924|585408687|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
162098433|NCT02952924|585408666|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098434|NCT02952924|585408667|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098435|NCT02952924|585408668|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098436|NCT02952924|585408669|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098437|NCT02952924|585408670|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098438|NCT02952924|585408671|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098439|NCT02952924|585408672|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098440|NCT02952924|585408673|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098441|NCT02952924|585408674|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098442|NCT02952924|585408675|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098443|NCT02952924|585408676|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098444|NCT02952924|585408677|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098445|NCT02952924|585408678|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098446|NCT02952924|585408679|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098447|NCT02952924|585408680|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098448|NCT02952924|585408681|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098449|NCT02952924|585408682|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098450|NCT02952924|585408683|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098451|NCT02952924|585408684|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098452|NCT02952924|585408685|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098453|NCT02952924|585408686|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
162098454|NCT02952924|585408687|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
162098455|NCT02952924|585408666|FG000|Overall Study|Noncompliance with study drug|0|||
162098456|NCT02952924|585408667|FG001|Overall Study|Noncompliance with study drug|0|||
162098457|NCT02952924|585408668|FG002|Overall Study|Noncompliance with study drug|0|||
162098458|NCT02952924|585408669|FG003|Overall Study|Noncompliance with study drug|0|||
162098459|NCT02952924|585408670|FG004|Overall Study|Noncompliance with study drug|0|||
162098460|NCT02952924|585408671|FG005|Overall Study|Noncompliance with study drug|0|||
162098461|NCT02952924|585408672|FG006|Overall Study|Noncompliance with study drug|0|||
162098462|NCT02952924|585408673|FG007|Overall Study|Noncompliance with study drug|0|||
162098463|NCT02952924|585408674|FG008|Overall Study|Noncompliance with study drug|0|||
162098464|NCT02952924|585408675|FG009|Overall Study|Noncompliance with study drug|0|||
162098465|NCT02952924|585408676|FG010|Overall Study|Noncompliance with study drug|0|||
162098466|NCT02952924|585408677|FG011|Overall Study|Noncompliance with study drug|0|||
162098467|NCT02952924|585408678|FG012|Overall Study|Noncompliance with study drug|0|||
162098468|NCT02952924|585408679|FG013|Overall Study|Noncompliance with study drug|0|||
162098469|NCT02952924|585408680|FG014|Overall Study|Noncompliance with study drug|0|||
162098470|NCT02952924|585408681|FG015|Overall Study|Noncompliance with study drug|0|||
162098471|NCT02952924|585408682|FG016|Overall Study|Noncompliance with study drug|0|||
162098472|NCT02952924|585408683|FG017|Overall Study|Noncompliance with study drug|0|||
162098473|NCT02952924|585408684|FG018|Overall Study|Noncompliance with study drug|0|||
162098474|NCT02952924|585408685|FG019|Overall Study|Noncompliance with study drug|0|||
162098475|NCT02952924|585408686|FG020|Overall Study|Noncompliance with study drug|0|||
162098476|NCT02952924|585408687|FG021|Overall Study|Noncompliance with study drug|1|||
162098477|NCT01435577|585408688|FG000|Overall Study|Adverse Event|10|||
162098478|NCT01435577|585408689|FG001|Overall Study|Adverse Event|0|||
162098479|NCT01435577|585408688|FG000|Overall Study|Lack of Efficacy|7|||
162098480|NCT01435577|585408689|FG001|Overall Study|Lack of Efficacy|51|||
162098481|NCT01435577|585408688|FG000|Overall Study|Alternative treatment started|0|||
162098482|NCT01435577|585408689|FG001|Overall Study|Alternative treatment started|1|||
162098483|NCT01934218|585408691|FG000|Double-blind Phase|Adverse Event|8|||
162098484|NCT01934218|585408692|FG001|Double-blind Phase|Adverse Event|8|||
162098485|NCT01934218|585408691|FG000|Double-blind Phase|Lack of Efficacy|6|||
162098486|NCT01934218|585408692|FG001|Double-blind Phase|Lack of Efficacy|7|||
162098487|NCT01934218|585408691|FG000|Double-blind Phase|Lost to Follow-up|7|||
162098488|NCT01934218|585408692|FG001|Double-blind Phase|Lost to Follow-up|14|||
162098489|NCT01934218|585408691|FG000|Double-blind Phase|Physician Decision|1|||
162098490|NCT01934218|585408692|FG001|Double-blind Phase|Physician Decision|2|||
162098491|NCT01934218|585408691|FG000|Double-blind Phase|Protocol Violation|4|||
162098492|NCT01934218|585408692|FG001|Double-blind Phase|Protocol Violation|0|||
162098493|NCT01934218|585408691|FG000|Double-blind Phase|Withdrawal by Subject|16|||
162098494|NCT01934218|585408692|FG001|Double-blind Phase|Withdrawal by Subject|13|||
162098495|NCT01934218|585408691|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
162098496|NCT01934218|585408692|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
162098497|NCT01934218|585408691|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
162098498|NCT01934218|585408692|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
162098499|NCT01934218|585408691|FG000|Open-Label Phase|Adverse Event|2|||
162098500|NCT01934218|585408692|FG001|Open-Label Phase|Adverse Event|4|||
162098501|NCT01934218|585408691|FG000|Open-Label Phase|Lack of Efficacy|1|||
162098502|NCT01934218|585408692|FG001|Open-Label Phase|Lack of Efficacy|4|||
162098503|NCT01934218|585408691|FG000|Open-Label Phase|Lost to Follow-up|4|||
162098504|NCT01934218|585408692|FG001|Open-Label Phase|Lost to Follow-up|2|||
162098505|NCT01934218|585408691|FG000|Open-Label Phase|Physician Decision|1|||
162098506|NCT01934218|585408692|FG001|Open-Label Phase|Physician Decision|0|||
162098507|NCT01934218|585408691|FG000|Open-Label Phase|Protocol Violation|1|||
162098508|NCT01934218|585408692|FG001|Open-Label Phase|Protocol Violation|0|||
162098509|NCT01934218|585408691|FG000|Open-Label Phase|Withdrawal by Subject|13|||
162098510|NCT01934218|585408692|FG001|Open-Label Phase|Withdrawal by Subject|11|||
162098511|NCT01934218|585408691|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
162098512|NCT01934218|585408692|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
162098513|NCT01934218|585408691|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
162098514|NCT01934218|585408692|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
162098515|NCT03273946|585408696|FG000|Overall Study|Withdrawal by Subject|5|||
162098516|NCT03273946|585408696|FG000|Overall Study|Unwillingness of the guardian|1|||
162098517|NCT03273946|585408696|FG000|Overall Study|Participant refused to use the drug|2|||
162098518|NCT03273946|585408696|FG000|Overall Study|Participant relative refused to use drug|1|||
162098519|NCT01220557|585408697|FG000|Overall Study|Lost to Follow-up|5|||
162098520|NCT01220557|585408698|FG001|Overall Study|Lost to Follow-up|3|||
162098521|NCT01220557|585408697|FG000|Overall Study|attended less than 6 lessons|1|||
162098522|NCT01220557|585408698|FG001|Overall Study|attended less than 6 lessons|2|||
162098523|NCT00142909|585408706|FG000|Randomization|Various Reasons|7|||
162098524|NCT00142909|585408707|FG001|Randomization|Various Reasons|10|||
162098525|NCT00142909|585408706|FG000|Medications Begin|Protocol Violation|2|||
162098526|NCT00142909|585408707|FG001|Medications Begin|Protocol Violation|0|||
162098527|NCT00142909|585408706|FG000|Medications Begin|Withdrawal by Subject|5|||
162098528|NCT00142909|585408707|FG001|Medications Begin|Withdrawal by Subject|3|||
162098529|NCT00142909|585408706|FG000|Medications Begin|Withdrawal by Subject|2|||
162098530|NCT00142909|585408707|FG001|Medications Begin|Withdrawal by Subject|0|||
162098531|NCT01660763|585408711|FG000|Overall Study|Lack of Efficacy|45|||
162098532|NCT01660763|585408712|FG001|Overall Study|Lack of Efficacy|50|||
162098533|NCT01660763|585408711|FG000|Overall Study|Adverse Event|22|||
162098534|NCT01660763|585408712|FG001|Overall Study|Adverse Event|7|||
162098535|NCT01660763|585408711|FG000|Overall Study|Protocol Violation|1|||
162098536|NCT01660763|585408712|FG001|Overall Study|Protocol Violation|0|||
162098537|NCT01660763|585408711|FG000|Overall Study|Withdrawal by Subject|4|||
162098538|NCT01660763|585408712|FG001|Overall Study|Withdrawal by Subject|0|||
162098539|NCT01660763|585408711|FG000|Overall Study|Patient ready for early discharge|28|||
162098540|NCT01660763|585408712|FG001|Overall Study|Patient ready for early discharge|4|||
162098541|NCT00345397|585408713|FG000|Overall Study|Death|1|||
162098542|NCT03021187|585408716|FG000|Overall Study|Death|0|||
162098543|NCT03021187|585408717|FG001|Overall Study|Death|0|||
162098544|NCT03021187|585408718|FG002|Overall Study|Death|3|||
162098545|NCT03021187|585408719|FG003|Overall Study|Death|0|||
162098546|NCT03021187|585408716|FG000|Overall Study|Withdrawal by Subject|0|||
162098547|NCT03021187|585408717|FG001|Overall Study|Withdrawal by Subject|6|||
162098548|NCT03021187|585408718|FG002|Overall Study|Withdrawal by Subject|2|||
162098549|NCT03021187|585408719|FG003|Overall Study|Withdrawal by Subject|5|||
162098550|NCT03021187|585408716|FG000|Overall Study|Lost to Follow-up|10|||
162098551|NCT03021187|585408717|FG001|Overall Study|Lost to Follow-up|3|||
162098552|NCT03021187|585408718|FG002|Overall Study|Lost to Follow-up|1|||
162098553|NCT03021187|585408719|FG003|Overall Study|Lost to Follow-up|4|||
162098554|NCT04782323|585408720|FG000|Overall Study|Death|1|||
162098555|NCT04782323|585408721|FG001|Overall Study|Death|0|||
162098556|NCT04782323|585408722|FG002|Overall Study|Death|0|||
162098557|NCT04782323|585408723|FG003|Overall Study|Death|0|||
162098558|NCT04782323|585408724|FG004|Overall Study|Death|1|||
162098559|NCT04782323|585408725|FG005|Overall Study|Death|1|||
162098560|NCT04782323|585408726|FG006|Overall Study|Death|1|||
162098561|NCT04782323|585408727|FG007|Overall Study|Death|0|||
162098562|NCT04782323|585408720|FG000|Overall Study|Withdrawal by Subject|0|||
162098563|NCT04782323|585408721|FG001|Overall Study|Withdrawal by Subject|0|||
162098564|NCT04782323|585408722|FG002|Overall Study|Withdrawal by Subject|1|||
162098565|NCT04782323|585408723|FG003|Overall Study|Withdrawal by Subject|0|||
162098566|NCT04782323|585408724|FG004|Overall Study|Withdrawal by Subject|0|||
162098567|NCT04782323|585408725|FG005|Overall Study|Withdrawal by Subject|1|||
162098568|NCT04782323|585408726|FG006|Overall Study|Withdrawal by Subject|0|||
162098569|NCT04782323|585408727|FG007|Overall Study|Withdrawal by Subject|1|||
162098570|NCT04782323|585408720|FG000|Overall Study|Lost to Follow-up|0|||
162098571|NCT04782323|585408721|FG001|Overall Study|Lost to Follow-up|1|||
162098572|NCT04782323|585408722|FG002|Overall Study|Lost to Follow-up|1|||
162098573|NCT04782323|585408723|FG003|Overall Study|Lost to Follow-up|0|||
162098574|NCT04782323|585408724|FG004|Overall Study|Lost to Follow-up|0|||
162098575|NCT04782323|585408725|FG005|Overall Study|Lost to Follow-up|1|||
162098576|NCT04782323|585408726|FG006|Overall Study|Lost to Follow-up|1|||
162098577|NCT04782323|585408727|FG007|Overall Study|Lost to Follow-up|2|||
162098578|NCT04782323|585408720|FG000|Overall Study|randomization in error|1|||
162098579|NCT04782323|585408721|FG001|Overall Study|randomization in error|0|||
162098580|NCT04782323|585408722|FG002|Overall Study|randomization in error|0|||
162098581|NCT04782323|585408723|FG003|Overall Study|randomization in error|0|||
162098582|NCT04782323|585408724|FG004|Overall Study|randomization in error|0|||
162098583|NCT04782323|585408725|FG005|Overall Study|randomization in error|0|||
162098584|NCT04782323|585408726|FG006|Overall Study|randomization in error|0|||
162098585|NCT04782323|585408727|FG007|Overall Study|randomization in error|0|||
162098586|NCT03351049|585408728|FG000|Overall Study|Withdrawal|26|||
162098587|NCT03351049|585408729|FG001|Overall Study|Withdrawal|22|||
162098588|NCT04369469|585408730|FG000|Overall Study|Lost to Follow-up|2|||
162098589|NCT04369469|585408731|FG001|Overall Study|Lost to Follow-up|4|||
162098590|NCT04369469|585408730|FG000|Overall Study|Physician Decision|2|||
162098591|NCT04369469|585408731|FG001|Overall Study|Physician Decision|1|||
162098592|NCT04369469|585408730|FG000|Overall Study|Withdrawal by Subject|2|||
162098593|NCT04369469|585408731|FG001|Overall Study|Withdrawal by Subject|3|||
162098594|NCT04369469|585408730|FG000|Overall Study|Adverse Event|1|||
162098595|NCT04369469|585408731|FG001|Overall Study|Adverse Event|0|||
162098596|NCT04369469|585408730|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
162098597|NCT04369469|585408731|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
162098598|NCT04369469|585408730|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
162098599|NCT04369469|585408731|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
162098600|NCT04369469|585408730|FG000|Overall Study|Unable to Provide Consent|0|||
162098601|NCT04369469|585408731|FG001|Overall Study|Unable to Provide Consent|1|||
162098602|NCT03832192|585408734|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
162098603|NCT03832192|585408735|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
162098604|NCT03099382|585408738|FG000|Overall Study|Protocol Violation|2|||
162098605|NCT03099382|585408739|FG001|Overall Study|Protocol Violation|3|||
162098606|NCT00499369|585408740|FG000|Overall Study|Adverse Event|2|||
162098607|NCT00499369|585408741|FG001|Overall Study|Adverse Event|2|||
162098608|NCT00499369|585408742|FG002|Overall Study|Adverse Event|3|||
162098609|NCT00499369|585408743|FG003|Overall Study|Adverse Event|1|||
162098610|NCT00499369|585408744|FG004|Overall Study|Adverse Event|2|||
162098611|NCT00499369|585408740|FG000|Overall Study|Withdrawal by Subject|0|||
162098612|NCT00499369|585408741|FG001|Overall Study|Withdrawal by Subject|1|||
162098613|NCT00499369|585408742|FG002|Overall Study|Withdrawal by Subject|1|||
162098614|NCT00499369|585408743|FG003|Overall Study|Withdrawal by Subject|0|||
162098615|NCT00499369|585408744|FG004|Overall Study|Withdrawal by Subject|0|||
162098616|NCT00499369|585408740|FG000|Overall Study|Progression|10|||
162098617|NCT00499369|585408741|FG001|Overall Study|Progression|12|||
162098618|NCT00499369|585408742|FG002|Overall Study|Progression|9|||
162098619|NCT00499369|585408743|FG003|Overall Study|Progression|6|||
162098620|NCT00499369|585408744|FG004|Overall Study|Progression|10|||
162098621|NCT00499369|585408740|FG000|Overall Study|Death|0|||
162098622|NCT00499369|585408741|FG001|Overall Study|Death|1|||
162098623|NCT00499369|585408742|FG002|Overall Study|Death|0|||
162098624|NCT00499369|585408743|FG003|Overall Study|Death|0|||
162098625|NCT00499369|585408744|FG004|Overall Study|Death|0|||
162098626|NCT00499369|585408740|FG000|Overall Study|Not protocol specified|2|||
162098627|NCT00499369|585408741|FG001|Overall Study|Not protocol specified|0|||
162098628|NCT00499369|585408742|FG002|Overall Study|Not protocol specified|3|||
162098629|NCT00499369|585408743|FG003|Overall Study|Not protocol specified|1|||
162098630|NCT00499369|585408744|FG004|Overall Study|Not protocol specified|0|||
162098631|NCT00499369|585408740|FG000|Overall Study|Ineligible|2|||
162098632|NCT00499369|585408741|FG001|Overall Study|Ineligible|2|||
162098633|NCT00499369|585408742|FG002|Overall Study|Ineligible|1|||
162098634|NCT00499369|585408743|FG003|Overall Study|Ineligible|1|||
162098635|NCT00499369|585408744|FG004|Overall Study|Ineligible|0|||
162098636|NCT01898195|585408746|FG000|Smoking Abstinence|Did not have good measurements|35|||
162098637|NCT01898195|585408747|FG001|Smoking Abstinence|Did not have good measurements|38|||
162098638|NCT01898195|585408748|FG002|Smoking Abstinence|Did not have good measurements|36|||
162098639|NCT01802411|585408750|FG000|Overall Study|Death|2|||
162098640|NCT01802411|585408751|FG001|Overall Study|Death|1|||
162098641|NCT01802411|585408750|FG000|Overall Study|Adverse Event|2|||
162098642|NCT01802411|585408751|FG001|Overall Study|Adverse Event|7|||
162098643|NCT01802411|585408750|FG000|Overall Study|Lack of Efficacy|8|||
162098644|NCT01802411|585408751|FG001|Overall Study|Lack of Efficacy|10|||
162098645|NCT01802411|585408750|FG000|Overall Study|Withdrawal by Subject|0|||
162098646|NCT01802411|585408751|FG001|Overall Study|Withdrawal by Subject|2|||
162098647|NCT01802411|585408750|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
162098648|NCT01802411|585408751|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
162098649|NCT01802411|585408750|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
162098650|NCT01802411|585408751|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
162098651|NCT01802411|585408750|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
162098652|NCT01802411|585408751|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
162098653|NCT01337245|585408754|FG000|Overall Study|Lost to Follow-up|1|||
162098654|NCT03483623|585408755|FG000|Overall Study|43 complete sets achieved|1|||
162098655|NCT03823651|585408756|FG000|Overall Study|Death|5|||
162098656|NCT03823651|585408757|FG001|Overall Study|Death|0|||
162098657|NCT03823651|585408756|FG000|Overall Study|Physician Decision|1|||
162098658|NCT03823651|585408757|FG001|Overall Study|Physician Decision|0|||
162098659|NCT03823651|585408756|FG000|Overall Study|Caregiver to patient who died|0|||
162098660|NCT03823651|585408757|FG001|Overall Study|Caregiver to patient who died|5|||
162098661|NCT03823651|585408756|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
162098662|NCT03823651|585408757|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
162098663|NCT01850004|585408758|FG000|Overall Study|Poor/Non-compliance|1|||
162098664|NCT01850004|585408758|FG000|Overall Study|Participant Withdrew Consent|9|||
162098665|NCT01850004|585408758|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
162098666|NCT01850004|585408758|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
162098667|NCT01850004|585408758|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
162098668|NCT01850004|585408758|FG000|Overall Study|Other Reasons|2|||
162098669|NCT01850004|585408758|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
162098670|NCT01850004|585408758|FG000|Overall Study|Maximum Clinical Benefit|4|||
162098671|NCT03147248|585410673|FG000|Overall Study|Adverse Event|0|||
162098672|NCT03147248|585410674|FG001|Overall Study|Adverse Event|2|||
162098673|NCT03147248|585410675|FG002|Overall Study|Adverse Event|2|||
162098674|NCT03147248|585410676|FG003|Overall Study|Adverse Event|2|||
162098675|NCT03147248|585410677|FG004|Overall Study|Adverse Event|6|||
162098676|NCT03147248|585410678|FG005|Overall Study|Adverse Event|11|||
162098677|NCT03147248|585410673|FG000|Overall Study|Disease progression|1|||
162098678|NCT03147248|585410674|FG001|Overall Study|Disease progression|0|||
162098679|NCT03147248|585410675|FG002|Overall Study|Disease progression|0|||
162098680|NCT03147248|585410676|FG003|Overall Study|Disease progression|0|||
162098681|NCT03147248|585410677|FG004|Overall Study|Disease progression|0|||
162098682|NCT03147248|585410678|FG005|Overall Study|Disease progression|2|||
162098683|NCT03147248|585410673|FG000|Overall Study|Withdrawal by Subject|0|||
162098684|NCT03147248|585410674|FG001|Overall Study|Withdrawal by Subject|0|||
162098685|NCT03147248|585410675|FG002|Overall Study|Withdrawal by Subject|0|||
162098686|NCT03147248|585410676|FG003|Overall Study|Withdrawal by Subject|0|||
162098687|NCT03147248|585410677|FG004|Overall Study|Withdrawal by Subject|12|||
162098688|NCT03147248|585410678|FG005|Overall Study|Withdrawal by Subject|9|||
162098689|NCT03147248|585410673|FG000|Overall Study|Protocol Violation|0|||
162098690|NCT03147248|585410674|FG001|Overall Study|Protocol Violation|0|||
162098691|NCT03147248|585410675|FG002|Overall Study|Protocol Violation|0|||
162098692|NCT03147248|585410676|FG003|Overall Study|Protocol Violation|0|||
162098693|NCT03147248|585410677|FG004|Overall Study|Protocol Violation|2|||
162098694|NCT03147248|585410678|FG005|Overall Study|Protocol Violation|0|||
162098695|NCT03147248|585410673|FG000|Overall Study|Lost to Follow-up|0|||
162098696|NCT03147248|585410674|FG001|Overall Study|Lost to Follow-up|0|||
162098697|NCT03147248|585410675|FG002|Overall Study|Lost to Follow-up|0|||
162098698|NCT03147248|585410676|FG003|Overall Study|Lost to Follow-up|0|||
162098699|NCT03147248|585410677|FG004|Overall Study|Lost to Follow-up|2|||
162098700|NCT03147248|585410678|FG005|Overall Study|Lost to Follow-up|0|||
162098701|NCT03147248|585410673|FG000|Overall Study|Pregnancy|0|||
162098702|NCT03147248|585410674|FG001|Overall Study|Pregnancy|0|||
162098703|NCT03147248|585410675|FG002|Overall Study|Pregnancy|0|||
162098704|NCT03147248|585410676|FG003|Overall Study|Pregnancy|0|||
162098705|NCT03147248|585410677|FG004|Overall Study|Pregnancy|1|||
162098706|NCT03147248|585410678|FG005|Overall Study|Pregnancy|0|||
162098707|NCT03147248|585410673|FG000|Overall Study|Death|0|||
162098708|NCT03147248|585410674|FG001|Overall Study|Death|0|||
162098709|NCT03147248|585410675|FG002|Overall Study|Death|0|||
162098710|NCT03147248|585410676|FG003|Overall Study|Death|0|||
162098711|NCT03147248|585410677|FG004|Overall Study|Death|0|||
162098712|NCT03147248|585410678|FG005|Overall Study|Death|4|||
162098713|NCT03147248|585410673|FG000|Overall Study|Physician Decision|0|||
162098714|NCT03147248|585410674|FG001|Overall Study|Physician Decision|0|||
162098715|NCT03147248|585410675|FG002|Overall Study|Physician Decision|0|||
162098716|NCT03147248|585410676|FG003|Overall Study|Physician Decision|0|||
162098717|NCT03147248|585410677|FG004|Overall Study|Physician Decision|2|||
162098718|NCT03147248|585410678|FG005|Overall Study|Physician Decision|4|||
162098719|NCT03147248|585410673|FG000|Overall Study|Prolonged Dosing Interval|0|||
162098720|NCT03147248|585410674|FG001|Overall Study|Prolonged Dosing Interval|0|||
162098721|NCT03147248|585410675|FG002|Overall Study|Prolonged Dosing Interval|0|||
162098722|NCT03147248|585410676|FG003|Overall Study|Prolonged Dosing Interval|0|||
162098723|NCT03147248|585410677|FG004|Overall Study|Prolonged Dosing Interval|1|||
162098724|NCT03147248|585410678|FG005|Overall Study|Prolonged Dosing Interval|1|||
162098725|NCT01914926|585410680|FG000|Overall Study|Adverse Event|1|||
162098726|NCT01914926|585410681|FG001|Overall Study|Adverse Event|0|||
162098727|NCT01914926|585410680|FG000|Overall Study|uncooperative, agitated and removed|0|||
162098728|NCT01914926|585410681|FG001|Overall Study|uncooperative, agitated and removed|1|||
162098729|NCT02536508|585410682|FG000|Overall Study|Withdrawal by Subject|18|||
162098730|NCT02536508|585410683|FG001|Overall Study|Withdrawal by Subject|13|||
162098731|NCT02536508|585410684|FG002|Overall Study|Withdrawal by Subject|7|||
162098732|NCT02536508|585410682|FG000|Overall Study|Adverse Event|14|||
162098733|NCT02536508|585410683|FG001|Overall Study|Adverse Event|13|||
162098734|NCT02536508|585410684|FG002|Overall Study|Adverse Event|6|||
162098735|NCT02536508|585410682|FG000|Overall Study|Lost to Follow-up|12|||
162098736|NCT02536508|585410683|FG001|Overall Study|Lost to Follow-up|4|||
162098737|NCT02536508|585410684|FG002|Overall Study|Lost to Follow-up|0|||
162098738|NCT02536508|585410682|FG000|Overall Study|Lack of Efficacy|3|||
162098739|NCT02536508|585410683|FG001|Overall Study|Lack of Efficacy|5|||
162098740|NCT02536508|585410684|FG002|Overall Study|Lack of Efficacy|4|||
162098741|NCT02536508|585410682|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
162098742|NCT02536508|585410683|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
162098743|NCT02536508|585410684|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
162098744|NCT02536508|585410682|FG000|Overall Study|Physician Decision|0|||
162098745|NCT02536508|585410683|FG001|Overall Study|Physician Decision|4|||
162098746|NCT02536508|585410684|FG002|Overall Study|Physician Decision|2|||
162098747|NCT02536508|585410682|FG000|Overall Study|Major Protocol Deviation|2|||
162098748|NCT02536508|585410683|FG001|Overall Study|Major Protocol Deviation|2|||
162098749|NCT02536508|585410684|FG002|Overall Study|Major Protocol Deviation|2|||
162098750|NCT02536508|585410682|FG000|Overall Study|Administrative Reasons|0|||
162098751|NCT02536508|585410683|FG001|Overall Study|Administrative Reasons|1|||
162098752|NCT02536508|585410684|FG002|Overall Study|Administrative Reasons|0|||
162098753|NCT00856856|585410690|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
162098754|NCT00856856|585410690|FG000|4-year Clinical Follow-up|Missed visit|1|||
162098755|NCT00434057|585410691|FG000|Overall Study|Withdrawal by Subject|1|||
162098756|NCT03073603|585410692|FG000|Overall Study|Noncompliance|3|||
162098757|NCT03073603|585410693|FG001|Overall Study|Noncompliance|1|||
162098758|NCT03073603|585410692|FG000|Overall Study|Adverse Event|5|||
162098759|NCT03073603|585410693|FG001|Overall Study|Adverse Event|3|||
162098760|NCT03073603|585410692|FG000|Overall Study|Physician Decision|1|||
162098761|NCT03073603|585410693|FG001|Overall Study|Physician Decision|2|||
162098762|NCT03073603|585410692|FG000|Overall Study|Required treatment not allowed by protocol|1|||
162098763|NCT03073603|585410693|FG001|Overall Study|Required treatment not allowed by protocol|0|||
162098764|NCT03073603|585410692|FG000|Overall Study|Financial or insurance-related|8|||
162098765|NCT03073603|585410693|FG001|Overall Study|Financial or insurance-related|0|||
162098766|NCT03073603|585410692|FG000|Overall Study|Withdrawal by Subject|0|||
162098767|NCT03073603|585410693|FG001|Overall Study|Withdrawal by Subject|1|||
162098768|NCT03073603|585410692|FG000|Overall Study|Discontinued DMT|4|||
162098769|NCT03073603|585410693|FG001|Overall Study|Discontinued DMT|0|||
162098770|NCT03073603|585410692|FG000|Overall Study|Restarted DMT|0|||
162098771|NCT03073603|585410693|FG001|Overall Study|Restarted DMT|1|||
162098772|NCT00823719|585410698|FG000|Overall Study|Adverse Event|1|||
162098773|NCT00823719|585410699|FG001|Overall Study|Adverse Event|2|||
162098774|NCT00823719|585410698|FG000|Overall Study|Physician Decision|1|||
162098775|NCT00823719|585410699|FG001|Overall Study|Physician Decision|4|||
162098776|NCT00823719|585410698|FG000|Overall Study|Withdrawal by Subject|0|||
162098777|NCT00823719|585410699|FG001|Overall Study|Withdrawal by Subject|1|||
162098778|NCT00823719|585410698|FG000|Overall Study|Disease Progression|4|||
162098779|NCT00823719|585410699|FG001|Overall Study|Disease Progression|4|||
162098780|NCT02370602|585410700|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
162098781|NCT02370602|585410701|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
162098782|NCT02370602|585410702|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
162098783|NCT02370602|585410703|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
162098784|NCT02370602|585410704|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
162098785|NCT02370602|585410705|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
162098786|NCT02103439|585410707|FG000|Overall Study|Adverse Event|0|||
162098787|NCT02103439|585410708|FG001|Overall Study|Adverse Event|2|||
162098788|NCT02103439|585410707|FG000|Overall Study|Withdrawal by Subject|3|||
162098789|NCT02103439|585410708|FG001|Overall Study|Withdrawal by Subject|1|||
162098790|NCT00784810|585410709|FG000|Overall Study|Adverse Event|32|||
162098791|NCT00784810|585410710|FG001|Overall Study|Adverse Event|20|||
162098792|NCT00784810|585410709|FG000|Overall Study|Lack of Efficacy|14|||
162098793|NCT00784810|585410710|FG001|Overall Study|Lack of Efficacy|11|||
162098794|NCT00784810|585410709|FG000|Overall Study|Withdrawal by Subject|11|||
162098795|NCT00784810|585410710|FG001|Overall Study|Withdrawal by Subject|9|||
162098796|NCT00784810|585410709|FG000|Overall Study|Administrative|5|||
162098797|NCT00784810|585410710|FG001|Overall Study|Administrative|8|||
162098798|NCT00784810|585410709|FG000|Overall Study|Lost to Follow-up|1|||
162098799|NCT00784810|585410710|FG001|Overall Study|Lost to Follow-up|1|||
162098800|NCT03305016|585410715|FG000|Overall Study|Withdrawal by Subject|2|||
162098801|NCT04969250|585410716|FG000|Overall Study|Protocol Violation|0|||
162098802|NCT04969250|585410717|FG001|Overall Study|Protocol Violation|2|||
162098803|NCT04969250|585410718|FG002|Overall Study|Protocol Violation|3|||
162098804|NCT04969250|585410719|FG003|Overall Study|Protocol Violation|8|||
162098805|NCT04969250|585410716|FG000|Overall Study|Withdrawal by Subject|0|||
162098806|NCT04969250|585410717|FG001|Overall Study|Withdrawal by Subject|1|||
162098807|NCT04969250|585410718|FG002|Overall Study|Withdrawal by Subject|0|||
162098808|NCT04969250|585410719|FG003|Overall Study|Withdrawal by Subject|0|||
162098809|NCT02119416|585410720|FG000|Overall Study|Protocol Violation|1|||
162098810|NCT02119416|585410721|FG001|Overall Study|Protocol Violation|1|||
162098811|NCT02119416|585410722|FG002|Overall Study|Protocol Violation|1|||
162098812|NCT02119416|585410720|FG000|Overall Study|wrong pubertal stage|1|||
162098813|NCT02119416|585410721|FG001|Overall Study|wrong pubertal stage|0|||
162098814|NCT02119416|585410722|FG002|Overall Study|wrong pubertal stage|1|||
162098815|NCT04420689|585410723|FG000|Overall Study|COVID-19 related hospitalization|0|||
162098816|NCT04420689|585410724|FG001|Overall Study|COVID-19 related hospitalization|0|||
162098817|NCT04420689|585410725|FG002|Overall Study|COVID-19 related hospitalization|0|||
162098818|NCT04420689|585410726|FG003|Overall Study|COVID-19 related hospitalization|0|||
162098819|NCT04420689|585410727|FG004|Overall Study|COVID-19 related hospitalization|1|||
162098820|NCT04420689|585410728|FG005|Overall Study|COVID-19 related hospitalization|0|||
162098821|NCT04420689|585410729|FG006|Overall Study|COVID-19 related hospitalization|0|||
162098822|NCT04420689|585410723|FG000|Overall Study|Physician Decision|0|||
162098823|NCT04420689|585410724|FG001|Overall Study|Physician Decision|0|||
162098824|NCT04420689|585410725|FG002|Overall Study|Physician Decision|0|||
162098825|NCT04420689|585410726|FG003|Overall Study|Physician Decision|0|||
162098826|NCT04420689|585410727|FG004|Overall Study|Physician Decision|0|||
162098827|NCT04420689|585410728|FG005|Overall Study|Physician Decision|1|||
162098828|NCT04420689|585410729|FG006|Overall Study|Physician Decision|0|||
162098829|NCT03434119|585410730|FG000|Overall Study|Randomized but not treated|1|||
162098830|NCT03434119|585410731|FG001|Overall Study|Randomized but not treated|0|||
162098831|NCT03434119|585410730|FG000|Overall Study|Adverse Event|1|||
162098832|NCT03434119|585410731|FG001|Overall Study|Adverse Event|0|||
162098833|NCT03434119|585410730|FG000|Overall Study|Poor Compliance to Protocol|0|||
162098834|NCT03434119|585410731|FG001|Overall Study|Poor Compliance to Protocol|1|||
162098835|NCT03434119|585410730|FG000|Overall Study|Study Terminated by Sponsor|91|||
162098836|NCT03434119|585410731|FG001|Overall Study|Study Terminated by Sponsor|102|||
162098837|NCT03434119|585410730|FG000|Overall Study|Withdrawal by Subject|7|||
162098838|NCT03434119|585410731|FG001|Overall Study|Withdrawal by Subject|5|||
162098839|NCT03434119|585410730|FG000|Overall Study|Other than specified|7|||
162098840|NCT03434119|585410731|FG001|Overall Study|Other than specified|5|||
162098841|NCT04360824|585410734|FG000|Overall Study|Withdrawal by Subject|2|||
162098842|NCT04360824|585410735|FG001|Overall Study|Withdrawal by Subject|1|||
162098843|NCT04360824|585410734|FG000|Overall Study|Did not receive assigned treatment|1|||
162098844|NCT04360824|585410735|FG001|Overall Study|Did not receive assigned treatment|3|||
162098845|NCT02278328|585410739|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
162098846|NCT02278328|585410740|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
162098847|NCT02278328|585410741|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
162098848|NCT02278328|585410739|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
162098849|NCT02278328|585410740|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
162098850|NCT02278328|585410741|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
162098851|NCT02278328|585410739|FG000|Neuropsych Screening|incomplete consent|0|||
162098852|NCT02278328|585410740|FG001|Neuropsych Screening|incomplete consent|0|||
162098853|NCT02278328|585410741|FG002|Neuropsych Screening|incomplete consent|2|||
162098854|NCT00377676|585410742|FG000|Overall Study|Adverse Event|498|||
162098855|NCT00377676|585410743|FG001|Overall Study|Adverse Event|107|||
162098856|NCT00377676|585410742|FG000|Overall Study|Protocol Violation|33|||
162098857|NCT00377676|585410743|FG001|Overall Study|Protocol Violation|27|||
162098858|NCT00377676|585410742|FG000|Overall Study|Death|5|||
162098859|NCT00377676|585410743|FG001|Overall Study|Death|2|||
162098860|NCT00377676|585410742|FG000|Overall Study|Withdrawal by Subject|187|||
162098861|NCT00377676|585410743|FG001|Overall Study|Withdrawal by Subject|72|||
162098862|NCT00377676|585410742|FG000|Overall Study|Lost to Follow-up|120|||
162098863|NCT00377676|585410743|FG001|Overall Study|Lost to Follow-up|56|||
162098864|NCT00377676|585410742|FG000|Overall Study|Other|118|||
162098865|NCT00377676|585410743|FG001|Overall Study|Other|58|||
162098866|NCT03834779|585410749|FG000|Overall Study|Death|1|||
162098867|NCT03834779|585410750|FG001|Overall Study|Death|2|||
162098868|NCT03834779|585410749|FG000|Overall Study|Lost to Follow-up|6|||
162098869|NCT03834779|585410750|FG001|Overall Study|Lost to Follow-up|4|||
162098870|NCT03579459|585410751|FG000|Overall Study|Adverse Event|7|||
162098871|NCT03579459|585410752|FG001|Overall Study|Adverse Event|6|||
162098872|NCT03579459|585410753|FG002|Overall Study|Adverse Event|2|||
162098873|NCT03579459|585410754|FG003|Overall Study|Adverse Event|6|||
162098874|NCT03579459|585410751|FG000|Overall Study|Death|1|||
162098875|NCT03579459|585410752|FG001|Overall Study|Death|0|||
162098876|NCT03579459|585410753|FG002|Overall Study|Death|1|||
162098877|NCT03579459|585410754|FG003|Overall Study|Death|2|||
162098878|NCT03579459|585410751|FG000|Overall Study|Lost to Follow-up|6|||
162098879|NCT03579459|585410752|FG001|Overall Study|Lost to Follow-up|2|||
162098880|NCT03579459|585410753|FG002|Overall Study|Lost to Follow-up|4|||
162098881|NCT03579459|585410754|FG003|Overall Study|Lost to Follow-up|1|||
162098882|NCT03579459|585410751|FG000|Overall Study|Physician Decision|0|||
162098883|NCT03579459|585410752|FG001|Overall Study|Physician Decision|1|||
162098884|NCT03579459|585410753|FG002|Overall Study|Physician Decision|0|||
162098885|NCT03579459|585410754|FG003|Overall Study|Physician Decision|1|||
162098886|NCT03579459|585410751|FG000|Overall Study|Protocol Violation|1|||
162098887|NCT03579459|585410752|FG001|Overall Study|Protocol Violation|2|||
162098888|NCT03579459|585410753|FG002|Overall Study|Protocol Violation|3|||
162098889|NCT03579459|585410754|FG003|Overall Study|Protocol Violation|5|||
162098890|NCT03579459|585410751|FG000|Overall Study|Withdrawal by Subject|12|||
162098891|NCT03579459|585410752|FG001|Overall Study|Withdrawal by Subject|8|||
162098892|NCT03579459|585410753|FG002|Overall Study|Withdrawal by Subject|11|||
162098893|NCT03579459|585410754|FG003|Overall Study|Withdrawal by Subject|8|||
162098894|NCT03579459|585410751|FG000|Overall Study|Medication error without associated adverse event|2|||
162098895|NCT03579459|585410752|FG001|Overall Study|Medication error without associated adverse event|1|||
162098896|NCT03579459|585410753|FG002|Overall Study|Medication error without associated adverse event|1|||
162098897|NCT03579459|585410754|FG003|Overall Study|Medication error without associated adverse event|0|||
162098898|NCT03579459|585410751|FG000|Overall Study|Other|0|||
162098899|NCT03579459|585410752|FG001|Overall Study|Other|1|||
162098900|NCT03579459|585410753|FG002|Overall Study|Other|1|||
162098901|NCT03579459|585410754|FG003|Overall Study|Other|0|||
162098902|NCT03579459|585410751|FG000|Overall Study|Randomized not vaccinated|0|||
162098903|NCT03579459|585410752|FG001|Overall Study|Randomized not vaccinated|2|||
162098904|NCT03579459|585410753|FG002|Overall Study|Randomized not vaccinated|0|||
162098905|NCT03579459|585410754|FG003|Overall Study|Randomized not vaccinated|1|||
162098906|NCT02528214|585410755|FG000|Overall Study|Protocol Violation|0|||
162098907|NCT02528214|585410756|FG001|Overall Study|Protocol Violation|1|||
162098908|NCT02528214|585410755|FG000|Overall Study|Adverse Event|0|||
162098909|NCT02528214|585410756|FG001|Overall Study|Adverse Event|1|||
162098910|NCT02528214|585410755|FG000|Overall Study|Other than specified above|0|||
162098911|NCT02528214|585410756|FG001|Overall Study|Other than specified above|1|||
162098912|NCT00407537|585410757|FG000|Overall Study|Death|5|||
162098913|NCT00407537|585410758|FG001|Overall Study|Death|2|||
162098914|NCT00407537|585410757|FG000|Overall Study|Adverse Event|36|||
162098915|NCT00407537|585410758|FG001|Overall Study|Adverse Event|0|||
162098916|NCT00407537|585410757|FG000|Overall Study|Lost to Follow-up|12|||
162098917|NCT00407537|585410758|FG001|Overall Study|Lost to Follow-up|19|||
162098918|NCT00407537|585410757|FG000|Overall Study|Other|6|||
162098919|NCT00407537|585410758|FG001|Overall Study|Other|7|||
162098920|NCT00407537|585410757|FG000|Overall Study|Withdrawal by Subject|34|||
162098921|NCT00407537|585410758|FG001|Overall Study|Withdrawal by Subject|16|||
162098922|NCT03593655|585410760|FG000|First Product Use Period|Withdrawal by Subject|1|||
162098923|NCT03593655|585410761|FG001|First Product Use Period|Withdrawal by Subject|1|||
162098924|NCT03593655|585410760|FG000|First Product Use Period|Lost to Follow-up|1|||
162098925|NCT03593655|585410761|FG001|First Product Use Period|Lost to Follow-up|3|||
162098926|NCT03593655|585410760|FG000|Second Product Use Period|Withdrawal by Subject|1|||
162098927|NCT03593655|585410761|FG001|Second Product Use Period|Withdrawal by Subject|1|||
162098928|NCT03593655|585410760|FG000|Second Product Use Period|Lost to Follow-up|1|||
162098929|NCT03593655|585410761|FG001|Second Product Use Period|Lost to Follow-up|0|||
162098930|NCT03593655|585410760|FG000|Third Product Use Period|Lost to Follow-up|1|||
162098931|NCT03593655|585410761|FG001|Third Product Use Period|Lost to Follow-up|2|||
162098932|NCT03593655|585410760|FG000|Third Product Use Period|Physician Decision|0|||
162098933|NCT03593655|585410761|FG001|Third Product Use Period|Physician Decision|1|||
162098934|NCT03593655|585410760|FG000|Third Product Use Period|Withdrawal by Subject|0|||
162098935|NCT03593655|585410761|FG001|Third Product Use Period|Withdrawal by Subject|1|||
162098936|NCT01090453|585410763|FG000|Overall Study|Withdrawal by Subject|1|||
162098937|NCT01090453|585410764|FG001|Overall Study|Withdrawal by Subject|2|||
162098938|NCT01090453|585410763|FG000|Overall Study|Lost to Follow-up|7|||
162098939|NCT01090453|585410764|FG001|Overall Study|Lost to Follow-up|7|||
162098940|NCT01090453|585410763|FG000|Overall Study|Non serious AEs|1|||
162098941|NCT01090453|585410764|FG001|Overall Study|Non serious AEs|0|||
162098942|NCT01090453|585410763|FG000|Overall Study|Protocol Violation|2|||
162098943|NCT01090453|585410764|FG001|Overall Study|Protocol Violation|0|||
162098944|NCT01090453|585410763|FG000|Overall Study|Other|2|||
162098945|NCT01090453|585410764|FG001|Overall Study|Other|4|||
162098946|NCT01090453|585410763|FG000|Overall Study|Eligibility Criteria|0|||
162098947|NCT01090453|585410764|FG001|Overall Study|Eligibility Criteria|1|||
162098948|NCT01870843|585410765|FG000|Overall Study|Adverse Event|10|||
162098949|NCT01870843|585410765|FG000|Overall Study|Lost to Follow-up|24|||
162098950|NCT01870843|585410765|FG000|Overall Study|Death|1|||
162098951|NCT01870843|585410765|FG000|Overall Study|Withdrawal by Subject|18|||
162098952|NCT01365494|585410767|FG000|Overall Study|Adverse Event|1|||
162098953|NCT01365494|585410768|FG001|Overall Study|Adverse Event|0|||
162098954|NCT01365494|585410767|FG000|Overall Study|Withdrawal by Subject|0|||
162098955|NCT01365494|585410768|FG001|Overall Study|Withdrawal by Subject|1|||
162098956|NCT01365494|585410767|FG000|Overall Study|Lost to Follow-up|1|||
162098957|NCT01365494|585410768|FG001|Overall Study|Lost to Follow-up|2|||
162098958|NCT00718718|585410769|FG000|Prior to Week 12|Adverse Event|0|||
162098959|NCT00718718|585410770|FG001|Prior to Week 12|Adverse Event|0|||
162098960|NCT00718718|585410771|FG002|Prior to Week 12|Adverse Event|0|||
162098961|NCT00718718|585410772|FG003|Prior to Week 12|Adverse Event|0|||
162098962|NCT00718718|585410773|FG004|Prior to Week 12|Adverse Event|0|||
162098963|NCT00718718|585410774|FG005|Prior to Week 12|Adverse Event|0|||
162098964|NCT00718718|585410775|FG006|Prior to Week 12|Adverse Event|0|||
162098965|NCT00718718|585410776|FG007|Prior to Week 12|Adverse Event|1|||
162098966|NCT00718718|585410777|FG008|Prior to Week 12|Adverse Event|1|||
162098967|NCT00718718|585410778|FG009|Prior to Week 12|Adverse Event|0|||
162098968|NCT00718718|585410769|FG000|Prior to Week 12|Withdrawal by Subject|0|||
162098969|NCT00718718|585410770|FG001|Prior to Week 12|Withdrawal by Subject|0|||
162098970|NCT00718718|585410771|FG002|Prior to Week 12|Withdrawal by Subject|0|||
162098971|NCT00718718|585410772|FG003|Prior to Week 12|Withdrawal by Subject|0|||
162098972|NCT00718718|585410773|FG004|Prior to Week 12|Withdrawal by Subject|3|||
162098973|NCT00718718|585410774|FG005|Prior to Week 12|Withdrawal by Subject|0|||
162098974|NCT00718718|585410775|FG006|Prior to Week 12|Withdrawal by Subject|1|||
162098975|NCT00718718|585410776|FG007|Prior to Week 12|Withdrawal by Subject|1|||
162098976|NCT00718718|585410777|FG008|Prior to Week 12|Withdrawal by Subject|1|||
162098977|NCT00718718|585410778|FG009|Prior to Week 12|Withdrawal by Subject|0|||
162098978|NCT00718718|585410769|FG000|Prior to Week 12|Other|1|||
162098979|NCT00718718|585410770|FG001|Prior to Week 12|Other|0|||
162098980|NCT00718718|585410771|FG002|Prior to Week 12|Other|1|||
162098981|NCT00718718|585410772|FG003|Prior to Week 12|Other|0|||
162098982|NCT00718718|585410773|FG004|Prior to Week 12|Other|0|||
162098983|NCT00718718|585410774|FG005|Prior to Week 12|Other|0|||
162098984|NCT00718718|585410775|FG006|Prior to Week 12|Other|0|||
162098985|NCT00718718|585410776|FG007|Prior to Week 12|Other|0|||
162098986|NCT00718718|585410777|FG008|Prior to Week 12|Other|0|||
162098987|NCT00718718|585410778|FG009|Prior to Week 12|Other|0|||
162098988|NCT00718718|585410769|FG000|Week 12 to End of Study|Adverse Event|0|||
162098989|NCT00718718|585410770|FG001|Week 12 to End of Study|Adverse Event|0|||
162098990|NCT00718718|585410771|FG002|Week 12 to End of Study|Adverse Event|0|||
162098991|NCT00718718|585410772|FG003|Week 12 to End of Study|Adverse Event|0|||
162098992|NCT00718718|585410773|FG004|Week 12 to End of Study|Adverse Event|0|||
162098993|NCT00718718|585410774|FG005|Week 12 to End of Study|Adverse Event|0|||
162098994|NCT00718718|585410775|FG006|Week 12 to End of Study|Adverse Event|0|||
162098995|NCT00718718|585410776|FG007|Week 12 to End of Study|Adverse Event|1|||
162098996|NCT00718718|585410777|FG008|Week 12 to End of Study|Adverse Event|0|||
162098997|NCT00718718|585410778|FG009|Week 12 to End of Study|Adverse Event|0|||
162098998|NCT00718718|585410769|FG000|Week 12 to End of Study|Death|0|||
162098999|NCT00718718|585410770|FG001|Week 12 to End of Study|Death|0|||
162099000|NCT00718718|585410771|FG002|Week 12 to End of Study|Death|0|||
162099001|NCT00718718|585410772|FG003|Week 12 to End of Study|Death|0|||
162099002|NCT00718718|585410773|FG004|Week 12 to End of Study|Death|0|||
162099003|NCT00718718|585410774|FG005|Week 12 to End of Study|Death|1|||
162099004|NCT00718718|585410775|FG006|Week 12 to End of Study|Death|0|||
162099005|NCT00718718|585410776|FG007|Week 12 to End of Study|Death|0|||
162099006|NCT00718718|585410777|FG008|Week 12 to End of Study|Death|0|||
162099007|NCT00718718|585410778|FG009|Week 12 to End of Study|Death|0|||
162099008|NCT00718718|585410769|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
162099009|NCT00718718|585410770|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
162099010|NCT00718718|585410771|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
162099011|NCT00718718|585410772|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
162099012|NCT00718718|585410773|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
162099013|NCT00718718|585410774|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
162099014|NCT00718718|585410775|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
162099015|NCT00718718|585410776|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
162099016|NCT00718718|585410777|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
162099017|NCT00718718|585410778|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
162099018|NCT00718718|585410769|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
162099019|NCT00718718|585410770|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
162099020|NCT00718718|585410771|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
162099021|NCT00718718|585410772|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
162099022|NCT00718718|585410773|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
162099023|NCT00718718|585410774|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
162099024|NCT00718718|585410775|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
162099025|NCT00718718|585410776|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
162099026|NCT00718718|585410777|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
162099027|NCT00718718|585410778|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
162099028|NCT00718718|585410769|FG000|Week 12 to End of Study|Other|0|||
162099029|NCT00718718|585410770|FG001|Week 12 to End of Study|Other|1|||
162099030|NCT00718718|585410771|FG002|Week 12 to End of Study|Other|0|||
162099031|NCT00718718|585410772|FG003|Week 12 to End of Study|Other|1|||
162099032|NCT00718718|585410773|FG004|Week 12 to End of Study|Other|0|||
162099033|NCT00718718|585410774|FG005|Week 12 to End of Study|Other|0|||
162099034|NCT00718718|585410775|FG006|Week 12 to End of Study|Other|1|||
162099035|NCT00718718|585410776|FG007|Week 12 to End of Study|Other|0|||
162099036|NCT00718718|585410777|FG008|Week 12 to End of Study|Other|0|||
162099037|NCT00718718|585410778|FG009|Week 12 to End of Study|Other|0|||
162099038|NCT03930745|585410782|FG000|Overall Study|Lost to Follow-up|10|||
162099039|NCT03930745|585410783|FG001|Overall Study|Lost to Follow-up|5|||
162099040|NCT03930745|585410782|FG000|Overall Study|Withdrawal by Subject|1|||
162099041|NCT03930745|585410783|FG001|Overall Study|Withdrawal by Subject|2|||
162099042|NCT03930745|585410782|FG000|Overall Study|Protocol Violation|2|||
162099043|NCT03930745|585410783|FG001|Overall Study|Protocol Violation|2|||
162099044|NCT03930745|585410782|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
162099045|NCT03930745|585410783|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
162099046|NCT03930745|585410782|FG000|Overall Study|Adverse Event|0|||
162099047|NCT03930745|585410783|FG001|Overall Study|Adverse Event|1|||
162099048|NCT03930745|585410782|FG000|Overall Study|Pregnancy|0|||
162099049|NCT03930745|585410783|FG001|Overall Study|Pregnancy|1|||
162099050|NCT02715765|585410786|FG000|Overall Study|Study Termination|3|||
162099051|NCT02715765|585410787|FG001|Overall Study|Study Termination|0|||
162099052|NCT02715765|585410788|FG002|Overall Study|Study Termination|0|||
162099053|NCT03588572|585410789|FG000|Visitation 1|Lack of Efficacy|1|||
162099054|NCT03588572|585410790|FG001|Visitation 1|Lack of Efficacy|1|||
162099055|NCT03588572|585410789|FG000|Visitation 2|Lost to Follow-up|1|||
162099056|NCT03588572|585410790|FG001|Visitation 2|Lost to Follow-up|1|||
162099057|NCT03588572|585410789|FG000|Visitation 2|Lack of Efficacy|0|||
162099058|NCT03588572|585410790|FG001|Visitation 2|Lack of Efficacy|1|||
162099059|NCT03588572|585410789|FG000|Visitation 2|Withdrawal by Subject|1|||
162099060|NCT03588572|585410790|FG001|Visitation 2|Withdrawal by Subject|0|||
162099061|NCT03588572|585410789|FG000|Visitation 3|Lost to Follow-up|1|||
162099062|NCT03588572|585410790|FG001|Visitation 3|Lost to Follow-up|1|||
162099063|NCT03588572|585410789|FG000|Visitation 3|Physician Decision|1|||
162099064|NCT03588572|585410790|FG001|Visitation 3|Physician Decision|1|||
162099065|NCT03588572|585410789|FG000|Visitation 3|Withdrawal by Subject|1|||
162099066|NCT03588572|585410790|FG001|Visitation 3|Withdrawal by Subject|0|||
162099067|NCT01165281|585410791|FG000|Overall Study|Adverse Event|12|||
162099068|NCT01165281|585410792|FG001|Overall Study|Adverse Event|14|||
162099069|NCT01165281|585410791|FG000|Overall Study|Death|3|||
162099070|NCT01165281|585410792|FG001|Overall Study|Death|4|||
162099071|NCT01165281|585410791|FG000|Overall Study|Lack of Efficacy|4|||
162099072|NCT01165281|585410792|FG001|Overall Study|Lack of Efficacy|1|||
162099073|NCT01165281|585410791|FG000|Overall Study|Lost to Follow-up|0|||
162099074|NCT01165281|585410792|FG001|Overall Study|Lost to Follow-up|1|||
162099075|NCT01165281|585410791|FG000|Overall Study|Physician Decision|8|||
162099076|NCT01165281|585410792|FG001|Overall Study|Physician Decision|1|||
162099077|NCT01165281|585410791|FG000|Overall Study|Protocol Violation|6|||
162099078|NCT01165281|585410792|FG001|Overall Study|Protocol Violation|5|||
162099079|NCT01165281|585410791|FG000|Overall Study|Withdrawal by Subject|8|||
162099080|NCT01165281|585410792|FG001|Overall Study|Withdrawal by Subject|7|||
162099081|NCT01165281|585410791|FG000|Overall Study|Noncompliance with Study Drug|1|||
162099082|NCT01165281|585410792|FG001|Overall Study|Noncompliance with Study Drug|4|||
162099083|NCT01165281|585410791|FG000|Overall Study|Progressive Disease|10|||
162099084|NCT01165281|585410792|FG001|Overall Study|Progressive Disease|14|||
162099085|NCT01165281|585410791|FG000|Overall Study|Other|6|||
162099086|NCT01165281|585410792|FG001|Overall Study|Other|0|||
162099087|NCT02863991|585410793|FG000|Overall Study|Death|0|||
162099088|NCT02863991|585410794|FG001|Overall Study|Death|3|||
162099089|NCT02863991|585410793|FG000|Overall Study|Lack of Efficacy|0|||
162099090|NCT02863991|585410794|FG001|Overall Study|Lack of Efficacy|1|||
162099091|NCT02863991|585410793|FG000|Overall Study|Study Terminated|2|||
162099092|NCT02863991|585410794|FG001|Overall Study|Study Terminated|8|||
162099093|NCT00364858|585410795|FG000|Overall Study|Adverse Event|1|||
162099094|NCT00364858|585410796|FG001|Overall Study|Adverse Event|5|||
162099095|NCT00364858|585410795|FG000|Overall Study|Withdrawal by Subject|1|||
162099096|NCT00364858|585410796|FG001|Overall Study|Withdrawal by Subject|1|||
162099097|NCT00364858|585410795|FG000|Overall Study|Pregnancy|1|||
162099098|NCT00364858|585410796|FG001|Overall Study|Pregnancy|1|||
162099099|NCT00364858|585410795|FG000|Overall Study|Clinical failure|2|||
162099100|NCT00364858|585410796|FG001|Overall Study|Clinical failure|13|||
162099101|NCT00364858|585410795|FG000|Overall Study|Discontinuation at baseline|1|||
162099102|NCT00364858|585410796|FG001|Overall Study|Discontinuation at baseline|0|||
162099103|NCT00364858|585410795|FG000|Overall Study|Non-compliant|1|||
162099104|NCT00364858|585410796|FG001|Overall Study|Non-compliant|0|||
162099105|NCT00364858|585410795|FG000|Overall Study|Return to Q2 regimen|0|||
162099106|NCT00364858|585410796|FG001|Overall Study|Return to Q2 regimen|1|||
162099107|NCT00364858|585410795|FG000|Overall Study|Clinical baseline issue|0|||
162099108|NCT00364858|585410796|FG001|Overall Study|Clinical baseline issue|1|||
162099109|NCT00363766|585410797|FG000|Overall Study|Progressive Disease|15|||
162099110|NCT00363766|585410798|FG001|Overall Study|Progressive Disease|9|||
162099111|NCT00363766|585410797|FG000|Overall Study|Adverse Event|10|||
162099112|NCT00363766|585410798|FG001|Overall Study|Adverse Event|2|||
162099113|NCT00363766|585410797|FG000|Overall Study|Disease Related Death|1|||
162099114|NCT00363766|585410798|FG001|Overall Study|Disease Related Death|3|||
162099115|NCT00363766|585410797|FG000|Overall Study|Not Disease Related Death|3|||
162099116|NCT00363766|585410798|FG001|Overall Study|Not Disease Related Death|4|||
162099117|NCT00363766|585410797|FG000|Overall Study|Withdrawal by Subject|2|||
162099118|NCT00363766|585410798|FG001|Overall Study|Withdrawal by Subject|0|||
162099119|NCT00363766|585410797|FG000|Overall Study|Physician Decision|1|||
162099120|NCT00363766|585410798|FG001|Overall Study|Physician Decision|2|||
162099121|NCT00558285|585410799|FG000|Overall Study|Adverse Event|1|||
162099122|NCT00558285|585410800|FG001|Overall Study|Adverse Event|1|||
162099123|NCT00558285|585410801|FG002|Overall Study|Adverse Event|4|||
162099124|NCT00558285|585410802|FG003|Overall Study|Adverse Event|1|||
162099125|NCT00558285|585410803|FG004|Overall Study|Adverse Event|2|||
162099126|NCT00558285|585410799|FG000|Overall Study|Abnormal test procedure result(s)|1|||
162099127|NCT00558285|585410800|FG001|Overall Study|Abnormal test procedure result(s)|0|||
162099128|NCT00558285|585410801|FG002|Overall Study|Abnormal test procedure result(s)|0|||
162099129|NCT00558285|585410802|FG003|Overall Study|Abnormal test procedure result(s)|0|||
162099130|NCT00558285|585410803|FG004|Overall Study|Abnormal test procedure result(s)|0|||
162099131|NCT00558285|585410799|FG000|Overall Study|Subject withdrew consent|2|||
162099132|NCT00558285|585410800|FG001|Overall Study|Subject withdrew consent|0|||
162099133|NCT00558285|585410801|FG002|Overall Study|Subject withdrew consent|1|||
162099134|NCT00558285|585410802|FG003|Overall Study|Subject withdrew consent|1|||
162099135|NCT00558285|585410803|FG004|Overall Study|Subject withdrew consent|1|||
162099136|NCT00558285|585410799|FG000|Overall Study|Lost to Follow-up|1|||
162099137|NCT00558285|585410800|FG001|Overall Study|Lost to Follow-up|1|||
162099138|NCT00558285|585410801|FG002|Overall Study|Lost to Follow-up|0|||
162099139|NCT00558285|585410802|FG003|Overall Study|Lost to Follow-up|0|||
162099140|NCT00558285|585410803|FG004|Overall Study|Lost to Follow-up|0|||
162099141|NCT00558285|585410799|FG000|Overall Study|Administrative problems|0|||
162099142|NCT00558285|585410800|FG001|Overall Study|Administrative problems|0|||
162099143|NCT00558285|585410801|FG002|Overall Study|Administrative problems|0|||
162099144|NCT00558285|585410802|FG003|Overall Study|Administrative problems|1|||
162099145|NCT00558285|585410803|FG004|Overall Study|Administrative problems|1|||
162099146|NCT00558285|585410799|FG000|Overall Study|Protocol deviation|1|||
162099147|NCT00558285|585410800|FG001|Overall Study|Protocol deviation|1|||
162099148|NCT00558285|585410801|FG002|Overall Study|Protocol deviation|0|||
162099149|NCT00558285|585410802|FG003|Overall Study|Protocol deviation|1|||
162099150|NCT00558285|585410803|FG004|Overall Study|Protocol deviation|0|||
162099151|NCT02730819|585410810|FG000|Overall Study|Lost to Follow-up|9|||
162099152|NCT02345512|585410811|FG000|Overall Study|Adverse Event|1|||
162099153|NCT02345512|585410811|FG000|Overall Study|Withdrawal by Subject|1|||
162099154|NCT01660906|585410812|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
162099155|NCT02121847|585410813|FG000|Overall Study|Administrative Reasons|1|||
162099156|NCT02121847|585410813|FG000|Overall Study|Adverse Event|2|||
162099157|NCT03478891|585410821|FG000|Overall Study|Enrolled, but product never administered|0|||
162099158|NCT03478891|585410822|FG001|Overall Study|Enrolled, but product never administered|0|||
162099159|NCT03478891|585410823|FG002|Overall Study|Enrolled, but product never administered|1|||
162099160|NCT03478891|585410821|FG000|Overall Study|Moved from area|0|||
162099161|NCT03478891|585410822|FG001|Overall Study|Moved from area|0|||
162099162|NCT03478891|585410823|FG002|Overall Study|Moved from area|1|||
162099163|NCT03478891|585410821|FG000|Overall Study|Lost to Follow-up|1|||
162099164|NCT03478891|585410822|FG001|Overall Study|Lost to Follow-up|0|||
162099165|NCT03478891|585410823|FG002|Overall Study|Lost to Follow-up|1|||
162099166|NCT01308580|585410825|FG000|Overall Study|Lost to Follow-up|12|||
162099167|NCT01308580|585410826|FG001|Overall Study|Lost to Follow-up|7|||
162099168|NCT03864614|585410830|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
162099169|NCT03864614|585410831|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
162099170|NCT03864614|585410832|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
162099171|NCT03864614|585410833|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
162099172|NCT03864614|585410830|FG000|Overall Study|Withdrawal by Subject|72|||
162099173|NCT03864614|585410831|FG001|Overall Study|Withdrawal by Subject|100|||
162099174|NCT03864614|585410832|FG002|Overall Study|Withdrawal by Subject|1|||
162099175|NCT03864614|585410833|FG003|Overall Study|Withdrawal by Subject|21|||
162099176|NCT03864614|585410830|FG000|Overall Study|Lost to Follow-up|45|||
162099177|NCT03864614|585410831|FG001|Overall Study|Lost to Follow-up|54|||
162099178|NCT03864614|585410832|FG002|Overall Study|Lost to Follow-up|0|||
162099179|NCT03864614|585410833|FG003|Overall Study|Lost to Follow-up|9|||
162099180|NCT03864614|585410830|FG000|Overall Study|Adverse Event|42|||
162099181|NCT03864614|585410831|FG001|Overall Study|Adverse Event|30|||
162099182|NCT03864614|585410832|FG002|Overall Study|Adverse Event|1|||
162099183|NCT03864614|585410833|FG003|Overall Study|Adverse Event|9|||
162099184|NCT03864614|585410830|FG000|Overall Study|Protocol Deviation|6|||
162099185|NCT03864614|585410831|FG001|Overall Study|Protocol Deviation|26|||
162099186|NCT03864614|585410832|FG002|Overall Study|Protocol Deviation|0|||
162099187|NCT03864614|585410833|FG003|Overall Study|Protocol Deviation|1|||
162099188|NCT03864614|585410830|FG000|Overall Study|Physician Decision|7|||
162099189|NCT03864614|585410831|FG001|Overall Study|Physician Decision|10|||
162099190|NCT03864614|585410832|FG002|Overall Study|Physician Decision|1|||
162099191|NCT03864614|585410833|FG003|Overall Study|Physician Decision|5|||
162099192|NCT03864614|585410830|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
162099193|NCT03864614|585410831|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
162099194|NCT03864614|585410832|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
162099195|NCT03864614|585410833|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
162099196|NCT03864614|585410830|FG000|Overall Study|Sponsor Decision|1|||
162099197|NCT03864614|585410831|FG001|Overall Study|Sponsor Decision|2|||
162099198|NCT03864614|585410832|FG002|Overall Study|Sponsor Decision|0|||
162099199|NCT03864614|585410833|FG003|Overall Study|Sponsor Decision|0|||
162099200|NCT03864614|585410830|FG000|Overall Study|Pregnancy|0|||
162099201|NCT03864614|585410831|FG001|Overall Study|Pregnancy|1|||
162099202|NCT03864614|585410832|FG002|Overall Study|Pregnancy|0|||
162099203|NCT03864614|585410833|FG003|Overall Study|Pregnancy|0|||
162099204|NCT03864614|585410830|FG000|Overall Study|Other|7|||
162099205|NCT03864614|585410831|FG001|Overall Study|Other|9|||
162099206|NCT03864614|585410832|FG002|Overall Study|Other|1|||
162099207|NCT03864614|585410833|FG003|Overall Study|Other|4|||
162099208|NCT03864614|585410830|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
162099209|NCT03864614|585410831|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
162099210|NCT03864614|585410832|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
162099211|NCT03864614|585410833|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
162099212|NCT01912612|585413261|FG000|Overall Study|Adverse Event|4|||
162099213|NCT01912612|585413262|FG001|Overall Study|Adverse Event|0|||
162099214|NCT01912612|585413263|FG002|Overall Study|Adverse Event|0|||
162099215|NCT01912612|585413261|FG000|Overall Study|Withdrew consent|1|||
162099216|NCT01912612|585413262|FG001|Overall Study|Withdrew consent|0|||
162099217|NCT01912612|585413263|FG002|Overall Study|Withdrew consent|0|||
162099218|NCT01912612|585413261|FG000|Overall Study|Study design change|0|||
162099219|NCT01912612|585413262|FG001|Overall Study|Study design change|0|||
162099220|NCT01912612|585413263|FG002|Overall Study|Study design change|3|||
162099221|NCT01588184|585413264|FG000|Overall Study|Death|1|||
162099222|NCT01588184|585413265|FG001|Overall Study|Death|0|||
162099223|NCT01588184|585413266|FG002|Overall Study|Death|0|||
162099224|NCT01588184|585413267|FG003|Overall Study|Death|1|||
162099225|NCT01588184|585413268|FG004|Overall Study|Death|1|||
162099226|NCT01588184|585413269|FG005|Overall Study|Death|1|||
162099227|NCT01588184|585413264|FG000|Overall Study|Withdrawal by Subject|2|||
162099228|NCT01588184|585413265|FG001|Overall Study|Withdrawal by Subject|4|||
162099229|NCT01588184|585413266|FG002|Overall Study|Withdrawal by Subject|0|||
162099230|NCT01588184|585413267|FG003|Overall Study|Withdrawal by Subject|1|||
162099231|NCT01588184|585413268|FG004|Overall Study|Withdrawal by Subject|0|||
162099232|NCT01588184|585413269|FG005|Overall Study|Withdrawal by Subject|0|||
162099233|NCT01588184|585413264|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
162099234|NCT01588184|585413265|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
162099235|NCT01588184|585413266|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
162099236|NCT01588184|585413267|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
162099237|NCT01588184|585413268|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
162099238|NCT01588184|585413269|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
162099239|NCT01588184|585413264|FG000|Overall Study|multiple reasons|0|||
162099240|NCT01588184|585413265|FG001|Overall Study|multiple reasons|3|||
162099241|NCT01588184|585413266|FG002|Overall Study|multiple reasons|0|||
162099242|NCT01588184|585413267|FG003|Overall Study|multiple reasons|1|||
162099243|NCT01588184|585413268|FG004|Overall Study|multiple reasons|0|||
162099244|NCT01588184|585413269|FG005|Overall Study|multiple reasons|0|||
162099245|NCT01983293|585413271|FG000|Overall Study|Withdrawal by Subject|29|||
162099246|NCT01983293|585413272|FG001|Overall Study|Withdrawal by Subject|15|||
162099247|NCT01983293|585413271|FG000|Overall Study|Missing 12-month visit|3|||
162099248|NCT01983293|585413272|FG001|Overall Study|Missing 12-month visit|3|||
162099249|NCT01983293|585413271|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
162099250|NCT01983293|585413272|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
162099251|NCT03750552|585413273|FG000|Overall Study|Adverse Event|5|||
162099252|NCT03750552|585413274|FG001|Overall Study|Adverse Event|1|||
162099253|NCT03750552|585413273|FG000|Overall Study|Withdrawal by Subject|1|||
162099254|NCT03750552|585413274|FG001|Overall Study|Withdrawal by Subject|1|||
162099255|NCT03750552|585413273|FG000|Overall Study|Other|2|||
162099256|NCT03750552|585413274|FG001|Overall Study|Other|0|||
162099257|NCT01259713|585413277|FG000|Overall Study|Adverse Event|54|||
162099258|NCT01259713|585413278|FG001|Overall Study|Adverse Event|23|||
162099259|NCT01259713|585413277|FG000|Overall Study|Death Not Related to IFI|8|||
162099260|NCT01259713|585413278|FG001|Overall Study|Death Not Related to IFI|1|||
162099261|NCT01259713|585413277|FG000|Overall Study|Investigators Discretion|14|||
162099262|NCT01259713|585413278|FG001|Overall Study|Investigators Discretion|6|||
162099263|NCT01259713|585413277|FG000|Overall Study|Lack of Efficacy|2|||
162099264|NCT01259713|585413278|FG001|Overall Study|Lack of Efficacy|0|||
162099265|NCT01259713|585413277|FG000|Overall Study|Protocol Violation|5|||
162099266|NCT01259713|585413278|FG001|Overall Study|Protocol Violation|4|||
162099267|NCT01259713|585413277|FG000|Overall Study|Subject Withdrew Consent|12|||
162099268|NCT01259713|585413278|FG001|Overall Study|Subject Withdrew Consent|7|||
162099269|NCT02091726|585413279|FG000|Overall Study|Lost to Follow-up|6|||
162099270|NCT06111742|585413286|FG000|Overall Study|Did not receive intervention|1|||
162099271|NCT06111742|585413287|FG001|Overall Study|Did not receive intervention|0|||
162099272|NCT06111742|585413288|FG002|Overall Study|Did not receive intervention|0|||
162099273|NCT06111742|585413286|FG000|Overall Study|Withdrawal by Subject|2|||
162099274|NCT06111742|585413287|FG001|Overall Study|Withdrawal by Subject|0|||
162099275|NCT06111742|585413288|FG002|Overall Study|Withdrawal by Subject|0|||
162099276|NCT02473952|585413295|FG000|Overall Study|Adverse Event|2|||
162099277|NCT02473952|585413296|FG001|Overall Study|Adverse Event|2|||
162099278|NCT02473952|585413295|FG000|Overall Study|Withdrawal by Subject|0|||
162099279|NCT02473952|585413296|FG001|Overall Study|Withdrawal by Subject|6|||
162099280|NCT00922428|585413299|FG000|Overall Study|retrospective/extremely implausible data|2|||
162099281|NCT00922428|585413299|FG000|Overall Study|no medication use or questionable use|13|||
162099282|NCT03701555|585413301|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
162099283|NCT03701555|585413302|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
162099284|NCT03701555|585413303|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
162099285|NCT03701555|585413304|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
162099286|NCT03701555|585413305|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
162099287|NCT03701555|585413306|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
162099288|NCT03701555|585413307|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
162099289|NCT03701555|585413308|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
162099290|NCT03701555|585413309|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
162099291|NCT03701555|585413310|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
162099292|NCT03701555|585413311|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
162099293|NCT03701555|585413312|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
162099294|NCT03701555|585413313|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
162099295|NCT03701555|585413314|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
162099296|NCT03701555|585413315|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
162099297|NCT03701555|585413316|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
162099298|NCT03701555|585413317|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
162099299|NCT03701555|585413318|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
162099300|NCT03701555|585413319|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
162099301|NCT03701555|585413320|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
162099302|NCT03701555|585413321|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
162099303|NCT03701555|585413322|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
162099304|NCT03701555|585413323|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
162099305|NCT03701555|585413324|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
162099306|NCT03701555|585413325|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
162099307|NCT03701555|585413326|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
162099308|NCT03701555|585413327|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
162099309|NCT03701555|585413328|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
162099310|NCT03701555|585413329|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
162099311|NCT03701555|585413330|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
162099312|NCT03701555|585413331|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
162099313|NCT03701555|585413332|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
162099314|NCT03701555|585413333|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
162099315|NCT03701555|585413334|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
162099316|NCT03701555|585413335|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
162099317|NCT03701555|585413336|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
162099318|NCT03701555|585413301|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
162099319|NCT03701555|585413302|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
162099320|NCT03701555|585413303|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
162099321|NCT03701555|585413304|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
162099322|NCT03701555|585413305|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
162099323|NCT03701555|585413306|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
162099324|NCT03701555|585413307|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
162099325|NCT03701555|585413308|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
162099326|NCT03701555|585413309|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
162099327|NCT03701555|585413310|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
162099328|NCT03701555|585413311|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
162099329|NCT03701555|585413312|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
162099330|NCT03701555|585413313|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
162099331|NCT03701555|585413314|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
162099332|NCT03701555|585413315|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
162099333|NCT03701555|585413316|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
162099334|NCT03701555|585413317|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
162099335|NCT03701555|585413318|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
162099336|NCT03701555|585413319|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
162099337|NCT03701555|585413320|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
162099338|NCT03701555|585413321|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
162099339|NCT03701555|585413322|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
162099340|NCT03701555|585413323|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
162099341|NCT03701555|585413324|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
162099342|NCT03701555|585413325|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
162099343|NCT03701555|585413326|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
162099344|NCT03701555|585413327|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
162099345|NCT03701555|585413328|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
162099346|NCT03701555|585413329|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
162099347|NCT03701555|585413330|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
162099348|NCT03701555|585413331|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
162099349|NCT03701555|585413332|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
162099350|NCT03701555|585413333|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
162099351|NCT03701555|585413334|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
162099352|NCT03701555|585413335|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
162099353|NCT03701555|585413336|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
162099354|NCT03701555|585413301|FG000|Part 2 (Day 1)|Other|0|||
162099355|NCT03701555|585413302|FG001|Part 2 (Day 1)|Other|0|||
162099356|NCT03701555|585413303|FG002|Part 2 (Day 1)|Other|0|||
162099357|NCT03701555|585413304|FG003|Part 2 (Day 1)|Other|0|||
162099358|NCT03701555|585413305|FG004|Part 2 (Day 1)|Other|0|||
162099359|NCT03701555|585413306|FG005|Part 2 (Day 1)|Other|0|||
162099360|NCT03701555|585413307|FG006|Part 2 (Day 1)|Other|0|||
162099361|NCT03701555|585413308|FG007|Part 2 (Day 1)|Other|0|||
162099362|NCT03701555|585413309|FG008|Part 2 (Day 1)|Other|0|||
162099363|NCT03701555|585413310|FG009|Part 2 (Day 1)|Other|0|||
162099364|NCT03701555|585413311|FG010|Part 2 (Day 1)|Other|3|||
162099365|NCT03701555|585413312|FG011|Part 2 (Day 1)|Other|1|||
162099366|NCT03701555|585413313|FG012|Part 2 (Day 1)|Other|0|||
162099367|NCT03701555|585413314|FG013|Part 2 (Day 1)|Other|1|||
162099368|NCT03701555|585413315|FG014|Part 2 (Day 1)|Other|0|||
162099369|NCT03701555|585413316|FG015|Part 2 (Day 1)|Other|2|||
162099370|NCT03701555|585413317|FG016|Part 2 (Day 1)|Other|2|||
162099371|NCT03701555|585413318|FG017|Part 2 (Day 1)|Other|0|||
162099372|NCT03701555|585413319|FG018|Part 2 (Day 1)|Other|0|||
162099373|NCT03701555|585413320|FG019|Part 2 (Day 1)|Other|0|||
162099374|NCT03701555|585413321|FG020|Part 2 (Day 1)|Other|0|||
162099375|NCT03701555|585413322|FG021|Part 2 (Day 1)|Other|0|||
162099376|NCT03701555|585413323|FG022|Part 2 (Day 1)|Other|0|||
162099377|NCT03701555|585413324|FG023|Part 2 (Day 1)|Other|0|||
162099378|NCT03701555|585413325|FG024|Part 2 (Day 1)|Other|0|||
162099379|NCT03701555|585413326|FG025|Part 2 (Day 1)|Other|0|||
162099380|NCT03701555|585413327|FG026|Part 2 (Day 1)|Other|0|||
162099381|NCT03701555|585413328|FG027|Part 2 (Day 1)|Other|0|||
162099382|NCT03701555|585413329|FG028|Part 2 (Day 1)|Other|0|||
162099383|NCT03701555|585413330|FG029|Part 2 (Day 1)|Other|0|||
162099384|NCT03701555|585413331|FG030|Part 2 (Day 1)|Other|0|||
162099385|NCT03701555|585413332|FG031|Part 2 (Day 1)|Other|0|||
162099386|NCT03701555|585413333|FG032|Part 2 (Day 1)|Other|0|||
162099387|NCT03701555|585413334|FG033|Part 2 (Day 1)|Other|0|||
162099388|NCT03701555|585413335|FG034|Part 2 (Day 1)|Other|0|||
162099389|NCT03701555|585413336|FG035|Part 2 (Day 1)|Other|0|||
162099390|NCT03701555|585413301|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
162099391|NCT03701555|585413302|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
162099392|NCT03701555|585413303|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
162099393|NCT03701555|585413304|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
162099394|NCT03701555|585413305|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
162099395|NCT03701555|585413306|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
162099396|NCT03701555|585413307|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
162099397|NCT03701555|585413308|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
162099398|NCT03701555|585413309|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
162099399|NCT03701555|585413310|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
162099400|NCT03701555|585413311|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
162099401|NCT03701555|585413312|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
162099402|NCT03701555|585413313|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
162099403|NCT03701555|585413314|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
162099404|NCT03701555|585413315|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
162099405|NCT03701555|585413316|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
162099406|NCT03701555|585413317|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
162099407|NCT03701555|585413318|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
162099408|NCT03701555|585413319|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
162099409|NCT03701555|585413320|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
162099410|NCT03701555|585413321|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
162099411|NCT03701555|585413322|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
162099412|NCT03701555|585413323|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
162099413|NCT03701555|585413324|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
162122792|NCT01351025|585500336|FG001|Week 24 - 44|Lost to Follow-up|2|||
162099414|NCT03701555|585413325|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
162099415|NCT03701555|585413326|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
162099416|NCT03701555|585413327|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
162099417|NCT03701555|585413328|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
162099418|NCT03701555|585413329|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
162099419|NCT03701555|585413330|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
162099420|NCT03701555|585413331|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
162099421|NCT03701555|585413332|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
162099422|NCT03701555|585413333|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
162099423|NCT03701555|585413334|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
162099424|NCT03701555|585413335|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
162099425|NCT03701555|585413336|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
162099426|NCT03701555|585413301|FG000|Part 3 (Day 1)|Subject Decision|0|||
162099427|NCT03701555|585413302|FG001|Part 3 (Day 1)|Subject Decision|0|||
162099428|NCT03701555|585413303|FG002|Part 3 (Day 1)|Subject Decision|0|||
162099429|NCT03701555|585413304|FG003|Part 3 (Day 1)|Subject Decision|0|||
162099430|NCT03701555|585413305|FG004|Part 3 (Day 1)|Subject Decision|0|||
162099431|NCT03701555|585413306|FG005|Part 3 (Day 1)|Subject Decision|0|||
162099432|NCT03701555|585413307|FG006|Part 3 (Day 1)|Subject Decision|0|||
162099433|NCT03701555|585413308|FG007|Part 3 (Day 1)|Subject Decision|0|||
162099434|NCT03701555|585413309|FG008|Part 3 (Day 1)|Subject Decision|0|||
162099435|NCT03701555|585413310|FG009|Part 3 (Day 1)|Subject Decision|0|||
162099436|NCT03701555|585413311|FG010|Part 3 (Day 1)|Subject Decision|0|||
162099437|NCT03701555|585413312|FG011|Part 3 (Day 1)|Subject Decision|0|||
162099438|NCT03701555|585413313|FG012|Part 3 (Day 1)|Subject Decision|0|||
162099439|NCT03701555|585413314|FG013|Part 3 (Day 1)|Subject Decision|0|||
162099440|NCT03701555|585413315|FG014|Part 3 (Day 1)|Subject Decision|0|||
162099441|NCT03701555|585413316|FG015|Part 3 (Day 1)|Subject Decision|0|||
162099442|NCT03701555|585413317|FG016|Part 3 (Day 1)|Subject Decision|0|||
162099443|NCT03701555|585413318|FG017|Part 3 (Day 1)|Subject Decision|0|||
162099444|NCT03701555|585413319|FG018|Part 3 (Day 1)|Subject Decision|0|||
162099445|NCT03701555|585413320|FG019|Part 3 (Day 1)|Subject Decision|0|||
162099446|NCT03701555|585413321|FG020|Part 3 (Day 1)|Subject Decision|0|||
162099447|NCT03701555|585413322|FG021|Part 3 (Day 1)|Subject Decision|0|||
162099448|NCT03701555|585413323|FG022|Part 3 (Day 1)|Subject Decision|0|||
162099449|NCT03701555|585413324|FG023|Part 3 (Day 1)|Subject Decision|0|||
162099450|NCT03701555|585413325|FG024|Part 3 (Day 1)|Subject Decision|0|||
162099451|NCT03701555|585413326|FG025|Part 3 (Day 1)|Subject Decision|0|||
162099452|NCT03701555|585413327|FG026|Part 3 (Day 1)|Subject Decision|1|||
162099453|NCT03701555|585413328|FG027|Part 3 (Day 1)|Subject Decision|0|||
162099454|NCT03701555|585413329|FG028|Part 3 (Day 1)|Subject Decision|0|||
162099455|NCT03701555|585413330|FG029|Part 3 (Day 1)|Subject Decision|0|||
162099456|NCT03701555|585413331|FG030|Part 3 (Day 1)|Subject Decision|0|||
162099457|NCT03701555|585413332|FG031|Part 3 (Day 1)|Subject Decision|2|||
162099458|NCT03701555|585413333|FG032|Part 3 (Day 1)|Subject Decision|1|||
162099459|NCT03701555|585413334|FG033|Part 3 (Day 1)|Subject Decision|1|||
162099460|NCT03701555|585413335|FG034|Part 3 (Day 1)|Subject Decision|0|||
162099461|NCT03701555|585413336|FG035|Part 3 (Day 1)|Subject Decision|0|||
162099462|NCT03701555|585413301|FG000|Part 3 (Day 1)|Other|0|||
162099463|NCT03701555|585413302|FG001|Part 3 (Day 1)|Other|0|||
162099464|NCT03701555|585413303|FG002|Part 3 (Day 1)|Other|0|||
162099465|NCT03701555|585413304|FG003|Part 3 (Day 1)|Other|0|||
162099466|NCT03701555|585413305|FG004|Part 3 (Day 1)|Other|0|||
162099467|NCT03701555|585413306|FG005|Part 3 (Day 1)|Other|0|||
162099468|NCT03701555|585413307|FG006|Part 3 (Day 1)|Other|0|||
162099469|NCT03701555|585413308|FG007|Part 3 (Day 1)|Other|0|||
162099470|NCT03701555|585413309|FG008|Part 3 (Day 1)|Other|0|||
162099471|NCT03701555|585413310|FG009|Part 3 (Day 1)|Other|0|||
162099472|NCT03701555|585413311|FG010|Part 3 (Day 1)|Other|0|||
162099473|NCT03701555|585413312|FG011|Part 3 (Day 1)|Other|0|||
162099474|NCT03701555|585413313|FG012|Part 3 (Day 1)|Other|0|||
162099475|NCT03701555|585413314|FG013|Part 3 (Day 1)|Other|0|||
162099476|NCT03701555|585413315|FG014|Part 3 (Day 1)|Other|0|||
162099477|NCT03701555|585413316|FG015|Part 3 (Day 1)|Other|0|||
162099478|NCT03701555|585413317|FG016|Part 3 (Day 1)|Other|0|||
162099479|NCT03701555|585413318|FG017|Part 3 (Day 1)|Other|0|||
162099480|NCT03701555|585413319|FG018|Part 3 (Day 1)|Other|0|||
162099481|NCT03701555|585413320|FG019|Part 3 (Day 1)|Other|0|||
162099482|NCT03701555|585413321|FG020|Part 3 (Day 1)|Other|0|||
162099483|NCT03701555|585413322|FG021|Part 3 (Day 1)|Other|0|||
162099484|NCT03701555|585413323|FG022|Part 3 (Day 1)|Other|0|||
162099485|NCT03701555|585413324|FG023|Part 3 (Day 1)|Other|0|||
162099486|NCT03701555|585413325|FG024|Part 3 (Day 1)|Other|1|||
162099487|NCT03701555|585413326|FG025|Part 3 (Day 1)|Other|1|||
162099488|NCT03701555|585413327|FG026|Part 3 (Day 1)|Other|0|||
162099489|NCT03701555|585413328|FG027|Part 3 (Day 1)|Other|0|||
162099490|NCT03701555|585413329|FG028|Part 3 (Day 1)|Other|0|||
162099491|NCT03701555|585413330|FG029|Part 3 (Day 1)|Other|1|||
162099492|NCT03701555|585413331|FG030|Part 3 (Day 1)|Other|1|||
162099493|NCT03701555|585413332|FG031|Part 3 (Day 1)|Other|0|||
162099494|NCT03701555|585413333|FG032|Part 3 (Day 1)|Other|1|||
162099495|NCT03701555|585413334|FG033|Part 3 (Day 1)|Other|1|||
162099496|NCT03701555|585413335|FG034|Part 3 (Day 1)|Other|0|||
162099497|NCT03701555|585413336|FG035|Part 3 (Day 1)|Other|0|||
162099498|NCT04757649|585413337|FG000|Overall Study|Withdrawal by Subject|1|||
162099499|NCT04757649|585413337|FG000|Overall Study|Adverse Event|1|||
162099500|NCT02508311|585413345|FG000|Overall Study|Withdrawal by Subject|1|||
162099501|NCT02508311|585413346|FG001|Overall Study|Withdrawal by Subject|0|||
162099502|NCT04862143|585413347|FG000|Overall Study|Adverse Event|1|||
162099503|NCT04862143|585413347|FG000|Overall Study|Study terminated by sponsor|1|||
162099504|NCT04955639|585413348|FG000|Overall Study|Withdrawal by Subject|2|||
162099505|NCT04955639|585413349|FG001|Overall Study|Withdrawal by Subject|2|||
162099506|NCT04955639|585413348|FG000|Overall Study|Week 26 survey not completed|2|||
162099507|NCT04955639|585413349|FG001|Overall Study|Week 26 survey not completed|2|||
162099508|NCT00413153|585413350|FG000|Overall Study|Withdrawal by Subject|1|||
162099509|NCT00413153|585413351|FG001|Overall Study|Withdrawal by Subject|1|||
162099510|NCT00413153|585413350|FG000|Overall Study|Adverse Event|1|||
162099511|NCT00413153|585413351|FG001|Overall Study|Adverse Event|0|||
162099512|NCT03204279|585413352|FG000|Overall Study|Withdrawal by Subject|0|||
162099513|NCT03204279|585413353|FG001|Overall Study|Withdrawal by Subject|1|||
162099514|NCT04827212|585413356|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
162099515|NCT04827212|585413357|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
162099516|NCT04827212|585413356|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
162099517|NCT04827212|585413357|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
162099518|NCT00599326|585413358|FG000|Overall Study|Lost to Follow-up|1|||
162099519|NCT00599326|585413358|FG000|Overall Study|Noncompliant|1|||
162099520|NCT02862106|585413361|FG000|Overall Study|Adverse Event|4|||
162099521|NCT02862106|585413362|FG001|Overall Study|Adverse Event|0|||
162099522|NCT02862106|585413361|FG000|Overall Study|Protocol Violation|16|||
162099523|NCT02862106|585413362|FG001|Overall Study|Protocol Violation|1|||
162099524|NCT02862106|585413361|FG000|Overall Study|Lost to Follow-up|15|||
162099525|NCT02862106|585413362|FG001|Overall Study|Lost to Follow-up|5|||
162099526|NCT02862106|585413361|FG000|Overall Study|Withdrawal by Subject|2|||
162099527|NCT02862106|585413362|FG001|Overall Study|Withdrawal by Subject|0|||
162099528|NCT02862106|585413361|FG000|Overall Study|Subjects moved to other city|1|||
162099529|NCT02862106|585413362|FG001|Overall Study|Subjects moved to other city|0|||
162099530|NCT03966157|585413363|FG000|Overall Study|Physician Decision|1|||
162099531|NCT03966157|585413364|FG001|Overall Study|Physician Decision|0|||
162099532|NCT03526250|585413365|FG000|Overall Study|Adverse Event|4|||
162099533|NCT03526250|585413365|FG000|Overall Study|Progressive Disease|16|||
162099534|NCT03526250|585413365|FG000|Overall Study|No Treatment|3|||
162099535|NCT04420221|585413366|FG000|Overall Study|Withdrawal by Subject|0|||
162099536|NCT04420221|585413367|FG001|Overall Study|Withdrawal by Subject|0|||
162099537|NCT04420221|585413368|FG002|Overall Study|Withdrawal by Subject|0|||
162099538|NCT04420221|585413369|FG003|Overall Study|Withdrawal by Subject|0|||
162099539|NCT04420221|585413370|FG004|Overall Study|Withdrawal by Subject|0|||
162099540|NCT04420221|585413371|FG005|Overall Study|Withdrawal by Subject|20|||
162099541|NCT04420221|585413372|FG006|Overall Study|Withdrawal by Subject|5|||
162099542|NCT04420221|585413366|FG000|Overall Study|Other|0|||
162099543|NCT04420221|585413367|FG001|Overall Study|Other|0|||
162099544|NCT04420221|585413368|FG002|Overall Study|Other|0|||
162099545|NCT04420221|585413369|FG003|Overall Study|Other|0|||
162099546|NCT04420221|585413370|FG004|Overall Study|Other|0|||
162099547|NCT04420221|585413371|FG005|Overall Study|Other|1|||
162099548|NCT04420221|585413372|FG006|Overall Study|Other|1|||
162099549|NCT04420221|585413366|FG000|Overall Study|Lost to Follow-up|0|||
162099550|NCT04420221|585413367|FG001|Overall Study|Lost to Follow-up|0|||
162099551|NCT04420221|585413368|FG002|Overall Study|Lost to Follow-up|0|||
162099552|NCT04420221|585413369|FG003|Overall Study|Lost to Follow-up|0|||
162099553|NCT04420221|585413370|FG004|Overall Study|Lost to Follow-up|0|||
162099554|NCT04420221|585413371|FG005|Overall Study|Lost to Follow-up|3|||
162099555|NCT04420221|585413372|FG006|Overall Study|Lost to Follow-up|2|||
162099556|NCT04420221|585413366|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
162099557|NCT04420221|585413367|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
162099558|NCT04420221|585413368|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
162099559|NCT04420221|585413369|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
162099560|NCT04420221|585413370|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
162099561|NCT04420221|585413371|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
162099562|NCT04420221|585413372|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
162099563|NCT05348681|585413373|FG000|Overall Study|Study terminated by Sponsor|8|||
162099564|NCT05348681|585413374|FG001|Overall Study|Study terminated by Sponsor|3|||
162099565|NCT05348681|585413373|FG000|Overall Study|Withdrawal by Subject|1|||
162099566|NCT05348681|585413374|FG001|Overall Study|Withdrawal by Subject|1|||
162099567|NCT05348681|585413373|FG000|Overall Study|Lost to Follow-up|1|||
162099568|NCT05348681|585413374|FG001|Overall Study|Lost to Follow-up|1|||
162099569|NCT05348681|585413373|FG000|Overall Study|Adverse Event|1|||
162099570|NCT05348681|585413374|FG001|Overall Study|Adverse Event|0|||
162099571|NCT05348681|585413373|FG000|Overall Study|Other|2|||
162099572|NCT05348681|585413374|FG001|Overall Study|Other|1|||
162099573|NCT01040130|585413375|FG000|Overall Study|Adverse Event|1|||
162099574|NCT01040130|585413376|FG001|Overall Study|Adverse Event|1|||
162099575|NCT01040130|585413377|FG002|Overall Study|Adverse Event|0|||
162099576|NCT01040130|585413378|FG003|Overall Study|Adverse Event|5|||
162099577|NCT01040130|585413379|FG004|Overall Study|Adverse Event|0|||
162099578|NCT01040130|585413380|FG005|Overall Study|Adverse Event|3|||
162099579|NCT01040130|585413375|FG000|Overall Study|Protocol Violation|0|||
162099580|NCT01040130|585413376|FG001|Overall Study|Protocol Violation|0|||
162099581|NCT01040130|585413377|FG002|Overall Study|Protocol Violation|2|||
162099582|NCT01040130|585413378|FG003|Overall Study|Protocol Violation|0|||
162099583|NCT01040130|585413379|FG004|Overall Study|Protocol Violation|0|||
162099584|NCT01040130|585413380|FG005|Overall Study|Protocol Violation|0|||
162099585|NCT01040130|585413375|FG000|Overall Study|Withdrawal by Subject|0|||
162099586|NCT01040130|585413376|FG001|Overall Study|Withdrawal by Subject|2|||
162099587|NCT01040130|585413377|FG002|Overall Study|Withdrawal by Subject|0|||
162099588|NCT01040130|585413378|FG003|Overall Study|Withdrawal by Subject|0|||
162099589|NCT01040130|585413379|FG004|Overall Study|Withdrawal by Subject|0|||
162099590|NCT01040130|585413380|FG005|Overall Study|Withdrawal by Subject|1|||
162099591|NCT01040130|585413375|FG000|Overall Study|Other reasons not listed above|2|||
162099592|NCT01040130|585413376|FG001|Overall Study|Other reasons not listed above|0|||
162099593|NCT01040130|585413377|FG002|Overall Study|Other reasons not listed above|0|||
162099594|NCT01040130|585413378|FG003|Overall Study|Other reasons not listed above|0|||
162099595|NCT01040130|585413379|FG004|Overall Study|Other reasons not listed above|0|||
162099596|NCT01040130|585413380|FG005|Overall Study|Other reasons not listed above|0|||
162099597|NCT00553267|585413385|FG000|Overall Study|Adverse Event|8|||
162099598|NCT00553267|585413386|FG001|Overall Study|Adverse Event|10|||
162099599|NCT00553267|585413387|FG002|Overall Study|Adverse Event|5|||
162099600|NCT00553267|585413385|FG000|Overall Study|Non compliant with protocol|3|||
162099601|NCT00553267|585413386|FG001|Overall Study|Non compliant with protocol|3|||
162099602|NCT00553267|585413387|FG002|Overall Study|Non compliant with protocol|2|||
162099603|NCT00553267|585413385|FG000|Overall Study|Lost to Follow-up|0|||
162099604|NCT00553267|585413386|FG001|Overall Study|Lost to Follow-up|0|||
162099605|NCT00553267|585413387|FG002|Overall Study|Lost to Follow-up|1|||
162099606|NCT00553267|585413385|FG000|Overall Study|Consent withdrawn|2|||
162099607|NCT00553267|585413386|FG001|Overall Study|Consent withdrawn|3|||
162099608|NCT00553267|585413387|FG002|Overall Study|Consent withdrawn|1|||
162099609|NCT00553267|585413385|FG000|Overall Study|Specified category|1|||
162099610|NCT00553267|585413386|FG001|Overall Study|Specified category|2|||
162099611|NCT00553267|585413387|FG002|Overall Study|Specified category|1|||
162099612|NCT04389840|585413388|FG000|Overall Study|Adverse Event|0|||
162099613|NCT04389840|585413389|FG001|Overall Study|Adverse Event|0|||
162099614|NCT04389840|585413390|FG002|Overall Study|Adverse Event|0|||
162099615|NCT04389840|585413391|FG003|Overall Study|Adverse Event|1|||
162099616|NCT04389840|585413392|FG004|Overall Study|Adverse Event|0|||
162099617|NCT04389840|585413393|FG005|Overall Study|Adverse Event|0|||
162099618|NCT04389840|585413388|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
162099619|NCT04389840|585413389|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
162099620|NCT04389840|585413390|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
162099621|NCT04389840|585413391|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
162099622|NCT04389840|585413392|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
162099623|NCT04389840|585413393|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
162099624|NCT04389840|585413388|FG000|Overall Study|Death|0|||
162099625|NCT04389840|585413389|FG001|Overall Study|Death|1|||
162099626|NCT04389840|585413390|FG002|Overall Study|Death|0|||
162099627|NCT04389840|585413391|FG003|Overall Study|Death|0|||
162099628|NCT04389840|585413392|FG004|Overall Study|Death|0|||
162099629|NCT04389840|585413393|FG005|Overall Study|Death|0|||
162099630|NCT01618864|585413394|FG000|Overall Study|Withdrawal by Subject|2|||
162099631|NCT01618864|585413394|FG000|Overall Study|Lost to Follow-up|2|||
162099632|NCT00096135|585413400|FG000|Overall Study|Physician Decision|20|||
162099633|NCT00096135|585413401|FG001|Overall Study|Physician Decision|4|||
162099634|NCT00096135|585413400|FG000|Overall Study|Refusal of further protocol therapy|4|||
162099635|NCT00096135|585413401|FG001|Overall Study|Refusal of further protocol therapy|1|||
162099636|NCT00096135|585413400|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
162099637|NCT00096135|585413401|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
162099638|NCT00096135|585413400|FG000|Overall Study|Other, specify|15|||
162099639|NCT00096135|585413401|FG001|Overall Study|Other, specify|3|||
162099640|NCT00096135|585413400|FG000|Overall Study|Ineligible|2|||
162099641|NCT00096135|585413401|FG001|Overall Study|Ineligible|0|||
162099642|NCT00833989|585413410|FG000|Overall Study|Physician Decision|0|||
162099643|NCT00833989|585413411|FG001|Overall Study|Physician Decision|0|||
162099644|NCT00833989|585413412|FG002|Overall Study|Physician Decision|0|||
162099645|NCT00833989|585413413|FG003|Overall Study|Physician Decision|1|||
162099646|NCT00833989|585413410|FG000|Overall Study|Withdrawal by Subject|3|||
162099647|NCT00833989|585413411|FG001|Overall Study|Withdrawal by Subject|0|||
162099648|NCT00833989|585413412|FG002|Overall Study|Withdrawal by Subject|1|||
162099649|NCT00833989|585413413|FG003|Overall Study|Withdrawal by Subject|1|||
162099650|NCT02310750|585413416|FG000|HP Period 1|Lost to Follow-up|0|||
162099651|NCT02310750|585413417|FG001|HP Period 1|Lost to Follow-up|0|||
162099652|NCT02310750|585413418|FG002|HP Period 1|Lost to Follow-up|0|||
162099653|NCT02310750|585413419|FG003|HP Period 1|Lost to Follow-up|0|||
162099654|NCT02310750|585413420|FG004|HP Period 1|Lost to Follow-up|0|||
162099655|NCT02310750|585413421|FG005|HP Period 1|Lost to Follow-up|0|||
162099656|NCT02310750|585413422|FG006|HP Period 1|Lost to Follow-up|1|||
162099657|NCT02310750|585413423|FG007|HP Period 1|Lost to Follow-up|0|||
162099658|NCT02310750|585413424|FG008|HP Period 1|Lost to Follow-up|0|||
162099659|NCT02310750|585413425|FG009|HP Period 1|Lost to Follow-up|0|||
162099660|NCT02310750|585413426|FG010|HP Period 1|Lost to Follow-up|0|||
162099661|NCT02310750|585413427|FG011|HP Period 1|Lost to Follow-up|0|||
162099662|NCT02310750|585413428|FG012|HP Period 1|Lost to Follow-up|0|||
162099663|NCT02310750|585413429|FG013|HP Period 1|Lost to Follow-up|0|||
162099664|NCT02310750|585413430|FG014|HP Period 1|Lost to Follow-up|0|||
162099665|NCT02310750|585413431|FG015|HP Period 1|Lost to Follow-up|0|||
162099666|NCT02310750|585413416|FG000|HP Period 1|Withdrawal by Subject|1|||
162099667|NCT02310750|585413417|FG001|HP Period 1|Withdrawal by Subject|0|||
162099668|NCT02310750|585413418|FG002|HP Period 1|Withdrawal by Subject|0|||
162099669|NCT02310750|585413419|FG003|HP Period 1|Withdrawal by Subject|1|||
162099670|NCT02310750|585413420|FG004|HP Period 1|Withdrawal by Subject|0|||
162099671|NCT02310750|585413421|FG005|HP Period 1|Withdrawal by Subject|0|||
162099672|NCT02310750|585413422|FG006|HP Period 1|Withdrawal by Subject|0|||
162099673|NCT02310750|585413423|FG007|HP Period 1|Withdrawal by Subject|0|||
162099674|NCT02310750|585413424|FG008|HP Period 1|Withdrawal by Subject|0|||
162099675|NCT02310750|585413425|FG009|HP Period 1|Withdrawal by Subject|0|||
162099676|NCT02310750|585413426|FG010|HP Period 1|Withdrawal by Subject|0|||
162099677|NCT02310750|585413427|FG011|HP Period 1|Withdrawal by Subject|0|||
162099678|NCT02310750|585413428|FG012|HP Period 1|Withdrawal by Subject|0|||
162099679|NCT02310750|585413429|FG013|HP Period 1|Withdrawal by Subject|0|||
162099680|NCT02310750|585413430|FG014|HP Period 1|Withdrawal by Subject|0|||
162099681|NCT02310750|585413431|FG015|HP Period 1|Withdrawal by Subject|0|||
162099682|NCT02310750|585413416|FG000|HP Washout 1|Lost to Follow-up|0|||
162099683|NCT02310750|585413417|FG001|HP Washout 1|Lost to Follow-up|0|||
162099684|NCT02310750|585413418|FG002|HP Washout 1|Lost to Follow-up|1|||
162099685|NCT02310750|585413419|FG003|HP Washout 1|Lost to Follow-up|1|||
162099686|NCT02310750|585413420|FG004|HP Washout 1|Lost to Follow-up|2|||
162099687|NCT02310750|585413421|FG005|HP Washout 1|Lost to Follow-up|2|||
162099688|NCT02310750|585413422|FG006|HP Washout 1|Lost to Follow-up|3|||
162099689|NCT02310750|585413423|FG007|HP Washout 1|Lost to Follow-up|0|||
162099690|NCT02310750|585413424|FG008|HP Washout 1|Lost to Follow-up|0|||
162099691|NCT02310750|585413425|FG009|HP Washout 1|Lost to Follow-up|0|||
162099692|NCT02310750|585413426|FG010|HP Washout 1|Lost to Follow-up|0|||
162099693|NCT02310750|585413427|FG011|HP Washout 1|Lost to Follow-up|0|||
162099694|NCT02310750|585413428|FG012|HP Washout 1|Lost to Follow-up|0|||
162099695|NCT02310750|585413429|FG013|HP Washout 1|Lost to Follow-up|0|||
162099696|NCT02310750|585413430|FG014|HP Washout 1|Lost to Follow-up|0|||
162099697|NCT02310750|585413431|FG015|HP Washout 1|Lost to Follow-up|0|||
162099698|NCT02310750|585413416|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162099699|NCT02310750|585413417|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162099700|NCT02310750|585413418|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162099701|NCT02310750|585413419|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
162099702|NCT02310750|585413420|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162099703|NCT02310750|585413421|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
162099704|NCT02310750|585413422|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162099705|NCT02310750|585413423|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162099706|NCT02310750|585413424|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
162099707|NCT02310750|585413425|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
162099708|NCT02310750|585413426|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162099709|NCT02310750|585413427|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162099710|NCT02310750|585413428|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162099711|NCT02310750|585413429|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162099712|NCT02310750|585413430|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162099713|NCT02310750|585413431|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
162099714|NCT02310750|585413416|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099715|NCT02310750|585413417|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099716|NCT02310750|585413418|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099717|NCT02310750|585413419|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099718|NCT02310750|585413420|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099719|NCT02310750|585413421|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099720|NCT02310750|585413422|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099721|NCT02310750|585413423|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099722|NCT02310750|585413424|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099723|NCT02310750|585413425|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
162099724|NCT02310750|585413426|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099725|NCT02310750|585413427|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099726|NCT02310750|585413428|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162122793|NCT01351025|585500335|FG000|Week 24 - 44|Site closed|0|||
162099727|NCT02310750|585413429|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099728|NCT02310750|585413430|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099729|NCT02310750|585413431|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
162099730|NCT02310750|585413416|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099731|NCT02310750|585413417|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099732|NCT02310750|585413418|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099733|NCT02310750|585413419|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099734|NCT02310750|585413420|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099735|NCT02310750|585413421|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099736|NCT02310750|585413422|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099737|NCT02310750|585413423|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
162099738|NCT02310750|585413424|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
162099739|NCT02310750|585413425|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
162099740|NCT02310750|585413426|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099741|NCT02310750|585413427|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099742|NCT02310750|585413428|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099743|NCT02310750|585413429|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099744|NCT02310750|585413430|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099745|NCT02310750|585413431|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
162099746|NCT02310750|585413416|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099747|NCT02310750|585413417|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099748|NCT02310750|585413418|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099749|NCT02310750|585413419|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099750|NCT02310750|585413420|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099751|NCT02310750|585413421|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099752|NCT02310750|585413422|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099753|NCT02310750|585413423|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
162099754|NCT02310750|585413424|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
162099755|NCT02310750|585413425|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099756|NCT02310750|585413426|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099757|NCT02310750|585413427|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099758|NCT02310750|585413428|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099759|NCT02310750|585413429|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099760|NCT02310750|585413430|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099761|NCT02310750|585413431|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
162099762|NCT02310750|585413416|FG000|HP Washout 2|Lost to Follow-up|0|||
162099763|NCT02310750|585413417|FG001|HP Washout 2|Lost to Follow-up|0|||
162099764|NCT02310750|585413418|FG002|HP Washout 2|Lost to Follow-up|0|||
162099765|NCT02310750|585413419|FG003|HP Washout 2|Lost to Follow-up|0|||
162099766|NCT02310750|585413420|FG004|HP Washout 2|Lost to Follow-up|1|||
162099767|NCT02310750|585413421|FG005|HP Washout 2|Lost to Follow-up|0|||
162099768|NCT02310750|585413422|FG006|HP Washout 2|Lost to Follow-up|7|||
162099769|NCT02310750|585413423|FG007|HP Washout 2|Lost to Follow-up|0|||
162099770|NCT02310750|585413424|FG008|HP Washout 2|Lost to Follow-up|0|||
162099771|NCT02310750|585413425|FG009|HP Washout 2|Lost to Follow-up|0|||
162099772|NCT02310750|585413426|FG010|HP Washout 2|Lost to Follow-up|0|||
162099773|NCT02310750|585413427|FG011|HP Washout 2|Lost to Follow-up|0|||
162099774|NCT02310750|585413428|FG012|HP Washout 2|Lost to Follow-up|0|||
162099775|NCT02310750|585413429|FG013|HP Washout 2|Lost to Follow-up|0|||
162099776|NCT02310750|585413430|FG014|HP Washout 2|Lost to Follow-up|0|||
162099777|NCT02310750|585413431|FG015|HP Washout 2|Lost to Follow-up|0|||
162099778|NCT03585244|585413432|FG000|Overall Study|Withdrawal by Subject|15|||
162099779|NCT02199028|585413437|FG000|Week 1|Adverse Event|1|||
162099780|NCT02199028|585413438|FG001|Week 1|Adverse Event|0|||
162099781|NCT02199028|585413437|FG000|Week 3|Adverse Event|1|||
162099782|NCT02199028|585413438|FG001|Week 3|Adverse Event|0|||
162099783|NCT01881126|585413439|FG000|Overall Study|Non-compliance|1|||
162099784|NCT01881126|585413440|FG001|Overall Study|Non-compliance|1|||
162099785|NCT01881126|585413439|FG000|Overall Study|Adverse Event|0|||
162099786|NCT01881126|585413440|FG001|Overall Study|Adverse Event|1|||
162099787|NCT05045625|585413443|FG000|Overall Study|Lost to Follow-up|3|||
162099788|NCT03867734|585413444|FG000|Overall Study|Lost to Follow-up|2|||
162099789|NCT01827904|585413445|FG000|Main Study|Withdrawal by Subject|1|||
162099790|NCT01827904|585413446|FG001|Main Study|Withdrawal by Subject|0|||
162099791|NCT01827904|585413447|FG002|Main Study|Withdrawal by Subject|0|||
162099792|NCT01827904|585413445|FG000|Main Study|Adverse Event|1|||
162099793|NCT01827904|585413446|FG001|Main Study|Adverse Event|0|||
162099794|NCT01827904|585413447|FG002|Main Study|Adverse Event|0|||
162099795|NCT01827904|585413445|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
162099796|NCT01827904|585413446|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
162099797|NCT01827904|585413447|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
162099798|NCT01827904|585413445|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
162099799|NCT01827904|585413446|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
162099800|NCT01827904|585413447|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
162099801|NCT01827904|585413445|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
162099802|NCT01827904|585413446|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
162099803|NCT01827904|585413447|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
162099804|NCT01827904|585413445|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
162099805|NCT01827904|585413446|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
162099806|NCT01827904|585413447|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
162099807|NCT01827904|585413445|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
162099808|NCT01827904|585413446|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
162099809|NCT01827904|585413447|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
162099810|NCT01827904|585413445|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
162099811|NCT01827904|585413446|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
162099812|NCT01827904|585413447|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
162099813|NCT01827904|585413445|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
162099814|NCT01827904|585413446|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
162099815|NCT01827904|585413447|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
162099816|NCT01827904|585413445|FG000|Long-term Annual Follow-up|Physician Decision|1|||
162099817|NCT01827904|585413446|FG001|Long-term Annual Follow-up|Physician Decision|0|||
162099818|NCT01827904|585413447|FG002|Long-term Annual Follow-up|Physician Decision|0|||
162099819|NCT01827904|585413445|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
162099820|NCT01827904|585413446|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
162099821|NCT01827904|585413447|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
162099822|NCT01827904|585413445|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
162099823|NCT01827904|585413446|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
162099824|NCT01827904|585413447|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
162099825|NCT01910519|585413448|FG000|Overall Study|Withdrawal by Subject|2|||
162099826|NCT01910519|585413449|FG001|Overall Study|Withdrawal by Subject|0|||
162099827|NCT01910519|585413448|FG000|Overall Study|Adverse Event|2|||
162099828|NCT01910519|585413449|FG001|Overall Study|Adverse Event|0|||
162099829|NCT04266028|585413450|FG000|Overall Study|Adverse Event|0|||
162099830|NCT04266028|585413451|FG001|Overall Study|Adverse Event|0|||
162099831|NCT04266028|585413452|FG002|Overall Study|Adverse Event|1|||
162099832|NCT04266028|585413453|FG003|Overall Study|Adverse Event|0|||
162099833|NCT04266028|585413454|FG004|Overall Study|Adverse Event|1|||
162099834|NCT04266028|585413455|FG005|Overall Study|Adverse Event|0|||
162099835|NCT04266028|585413456|FG006|Overall Study|Adverse Event|2|||
162099836|NCT04266028|585413457|FG007|Overall Study|Adverse Event|0|||
162099837|NCT04266028|585413450|FG000|Overall Study|temporary halt of the study|0|||
162099838|NCT04266028|585413451|FG001|Overall Study|temporary halt of the study|0|||
162099839|NCT04266028|585413452|FG002|Overall Study|temporary halt of the study|0|||
162099840|NCT04266028|585413453|FG003|Overall Study|temporary halt of the study|0|||
162099841|NCT04266028|585413454|FG004|Overall Study|temporary halt of the study|0|||
162099842|NCT04266028|585413455|FG005|Overall Study|temporary halt of the study|0|||
162099843|NCT04266028|585413456|FG006|Overall Study|temporary halt of the study|2|||
162099844|NCT04266028|585413457|FG007|Overall Study|temporary halt of the study|1|||
162099845|NCT04266028|585413450|FG000|Overall Study|Onset of birch pollen season|0|||
162099846|NCT04266028|585413451|FG001|Overall Study|Onset of birch pollen season|0|||
162099847|NCT04266028|585413452|FG002|Overall Study|Onset of birch pollen season|0|||
162099848|NCT04266028|585413453|FG003|Overall Study|Onset of birch pollen season|0|||
162099849|NCT04266028|585413454|FG004|Overall Study|Onset of birch pollen season|1|||
162099850|NCT04266028|585413455|FG005|Overall Study|Onset of birch pollen season|0|||
162099851|NCT04266028|585413456|FG006|Overall Study|Onset of birch pollen season|0|||
162099852|NCT04266028|585413457|FG007|Overall Study|Onset of birch pollen season|0|||
162099853|NCT01458574|585413458|FG000|Overall Study|Adverse Event|5|||
162099854|NCT01458574|585413459|FG001|Overall Study|Adverse Event|9|||
162099855|NCT01458574|585413460|FG002|Overall Study|Adverse Event|7|||
162099856|NCT01458574|585413458|FG000|Overall Study|Lack of Efficacy|70|||
162099857|NCT01458574|585413459|FG001|Overall Study|Lack of Efficacy|53|||
162099858|NCT01458574|585413460|FG002|Overall Study|Lack of Efficacy|132|||
162099859|NCT01458574|585413458|FG000|Overall Study|Lost to Follow-up|3|||
162099860|NCT01458574|585413459|FG001|Overall Study|Lost to Follow-up|2|||
162099861|NCT01458574|585413460|FG002|Overall Study|Lost to Follow-up|1|||
162099862|NCT01458574|585413458|FG000|Overall Study|Pregnancy|1|||
162099863|NCT01458574|585413459|FG001|Overall Study|Pregnancy|1|||
162099864|NCT01458574|585413460|FG002|Overall Study|Pregnancy|0|||
162099865|NCT01458574|585413458|FG000|Overall Study|Protocol Violation|0|||
162099866|NCT01458574|585413459|FG001|Overall Study|Protocol Violation|1|||
162099867|NCT01458574|585413460|FG002|Overall Study|Protocol Violation|0|||
162099868|NCT01458574|585413458|FG000|Overall Study|Withdrawal by Subject|6|||
162099869|NCT01458574|585413459|FG001|Overall Study|Withdrawal by Subject|3|||
162099870|NCT01458574|585413460|FG002|Overall Study|Withdrawal by Subject|5|||
162099871|NCT01458574|585413458|FG000|Overall Study|Other|2|||
162099872|NCT01458574|585413459|FG001|Overall Study|Other|1|||
162099873|NCT01458574|585413460|FG002|Overall Study|Other|0|||
162099874|NCT01458574|585413458|FG000|Overall Study|Randomized but not treated|0|||
162099875|NCT01458574|585413459|FG001|Overall Study|Randomized but not treated|1|||
162099876|NCT01458574|585413460|FG002|Overall Study|Randomized but not treated|0|||
162099877|NCT02125786|585413461|FG000|Overall Study|Still in Follow-up|3|||
162099878|NCT02125786|585413461|FG000|Overall Study|Screen Failure|2|||
162099879|NCT02125786|585413461|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
162099880|NCT02125786|585413461|FG000|Overall Study|Progressive Disease|44|||
162099881|NCT02125786|585413461|FG000|Overall Study|Death|8|||
162099882|NCT01617629|585413462|FG000|Overall Study|Death|2|||
162099883|NCT01617629|585413462|FG000|Overall Study|Investigator's Clinical Judgement|1|||
162099884|NCT01617629|585413462|FG000|Overall Study|Reason Not Specified|1|||
162099885|NCT01617629|585413462|FG000|Overall Study|Participant Withdrew Consent|2|||
162099886|NCT01663636|585413463|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
162099887|NCT01663636|585413464|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
162099888|NCT03832946|585413465|FG000|Overall Study|Adverse Event|3|||
162099889|NCT03832946|585413466|FG001|Overall Study|Adverse Event|1|||
162099890|NCT03832946|585413465|FG000|Overall Study|Lost to Follow-up|1|||
162099891|NCT03832946|585413466|FG001|Overall Study|Lost to Follow-up|0|||
162099892|NCT03832946|585413465|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
162099893|NCT03832946|585413466|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
162099894|NCT03832946|585413465|FG000|Overall Study|Lack of Efficacy|1|||
162099895|NCT03832946|585413466|FG001|Overall Study|Lack of Efficacy|0|||
162099896|NCT03832946|585413465|FG000|Overall Study|Withdrawal by Subject|12|||
162099897|NCT03832946|585413466|FG001|Overall Study|Withdrawal by Subject|9|||
162099898|NCT03394924|585413467|FG000|Overall Study|Adverse Event|0|||
162099899|NCT03394924|585413468|FG001|Overall Study|Adverse Event|5|||
162099900|NCT03394924|585413469|FG002|Overall Study|Adverse Event|0|||
162099901|NCT03394924|585413467|FG000|Overall Study|Withdrawal by Subject|2|||
162099902|NCT03394924|585413468|FG001|Overall Study|Withdrawal by Subject|0|||
162099903|NCT03394924|585413469|FG002|Overall Study|Withdrawal by Subject|0|||
162099904|NCT03394924|585413467|FG000|Overall Study|Lost to Follow-up|0|||
162099905|NCT03394924|585413468|FG001|Overall Study|Lost to Follow-up|1|||
162099906|NCT03394924|585413469|FG002|Overall Study|Lost to Follow-up|0|||
162099907|NCT03394924|585413467|FG000|Overall Study|Did not meet all inclusion criteria|1|||
162099908|NCT03394924|585413468|FG001|Overall Study|Did not meet all inclusion criteria|0|||
162099909|NCT03394924|585413469|FG002|Overall Study|Did not meet all inclusion criteria|0|||
162099910|NCT03277313|585413479|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
162099911|NCT03277313|585413480|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
162099912|NCT03277313|585413479|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
162099913|NCT03277313|585413480|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
162099914|NCT03277313|585413479|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
162099915|NCT03277313|585413480|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
162099916|NCT03277313|585413479|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
162099917|NCT03277313|585413480|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
162099918|NCT03277313|585413479|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
162099919|NCT03277313|585413480|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
162099920|NCT02663817|585413481|FG000|Overall Study|Screen failure|2|||
162099921|NCT00932893|585413486|FG000|Overall Study|Death|115|||
162099922|NCT00932893|585413487|FG001|Overall Study|Death|24|||
162099923|NCT00932893|585413486|FG000|Overall Study|Lost to Follow-up|8|||
162099924|NCT00932893|585413487|FG001|Overall Study|Lost to Follow-up|0|||
162099925|NCT00932893|585413486|FG000|Overall Study|Withdrawal by Subject|5|||
162099926|NCT00932893|585413487|FG001|Overall Study|Withdrawal by Subject|2|||
162099927|NCT00932893|585413486|FG000|Overall Study|Other|5|||
162099928|NCT00932893|585413487|FG001|Overall Study|Other|144|||
162099929|NCT05350449|585413488|FG000|Overall Study|Withdrawal by Subject|4|||
162099930|NCT05350449|585413489|FG001|Overall Study|Withdrawal by Subject|8|||
162099931|NCT02062632|585415666|FG000|Overall Study|No treatment data|1|||
162099932|NCT00773968|585415669|FG000|Overall Study|Adverse Event|2|||
162099933|NCT00773968|585415669|FG000|Overall Study|Death|1|||
162099934|NCT00773968|585415669|FG000|Overall Study|Failure to Return|2|||
162099935|NCT00773968|585415669|FG000|Overall Study|Lack of Efficacy|3|||
162099936|NCT00773968|585415669|FG000|Overall Study|Protocol Violation|1|||
162099937|NCT00773968|585415669|FG000|Overall Study|Withdrawal by Subject|11|||
162099938|NCT00773968|585415669|FG000|Overall Study|Screen Failure|17|||
162099939|NCT00773968|585415669|FG000|Overall Study|Other|8|||
162099940|NCT02008890|585415672|FG000|Period 1|Withdrawal by Subject|7|||
162099941|NCT02008890|585415673|FG001|Period 1|Withdrawal by Subject|7|||
162099942|NCT02008890|585415674|FG002|Period 1|Withdrawal by Subject|5|||
162099943|NCT02008890|585415675|FG003|Period 1|Withdrawal by Subject|0|||
162099944|NCT02008890|585415676|FG004|Period 1|Withdrawal by Subject|0|||
162099945|NCT02008890|585415672|FG000|Period 1|Pregnancy|1|||
162099946|NCT02008890|585415673|FG001|Period 1|Pregnancy|0|||
162099947|NCT02008890|585415674|FG002|Period 1|Pregnancy|0|||
162099948|NCT02008890|585415675|FG003|Period 1|Pregnancy|0|||
162099949|NCT02008890|585415676|FG004|Period 1|Pregnancy|0|||
162099950|NCT02008890|585415672|FG000|Period 1|Physician Decision|1|||
162099951|NCT02008890|585415673|FG001|Period 1|Physician Decision|0|||
162099952|NCT02008890|585415674|FG002|Period 1|Physician Decision|1|||
162099953|NCT02008890|585415675|FG003|Period 1|Physician Decision|0|||
162099954|NCT02008890|585415676|FG004|Period 1|Physician Decision|0|||
162099955|NCT02008890|585415672|FG000|Period 1|Adverse Event|6|||
162099956|NCT02008890|585415673|FG001|Period 1|Adverse Event|8|||
162099957|NCT02008890|585415674|FG002|Period 1|Adverse Event|6|||
162099958|NCT02008890|585415675|FG003|Period 1|Adverse Event|0|||
162099959|NCT02008890|585415676|FG004|Period 1|Adverse Event|0|||
162099960|NCT02008890|585415672|FG000|Period 2|Adverse Event|12|||
162099961|NCT02008890|585415673|FG001|Period 2|Adverse Event|7|||
162099962|NCT02008890|585415674|FG002|Period 2|Adverse Event|0|||
162099963|NCT02008890|585415675|FG003|Period 2|Adverse Event|5|||
162099964|NCT02008890|585415676|FG004|Period 2|Adverse Event|5|||
162099965|NCT02008890|585415672|FG000|Period 2|Withdrawal by Subject|11|||
162099966|NCT02008890|585415673|FG001|Period 2|Withdrawal by Subject|8|||
162099967|NCT02008890|585415674|FG002|Period 2|Withdrawal by Subject|0|||
162099968|NCT02008890|585415675|FG003|Period 2|Withdrawal by Subject|7|||
162099969|NCT02008890|585415676|FG004|Period 2|Withdrawal by Subject|2|||
162099970|NCT02008890|585415672|FG000|Period 2|Physician Decision|4|||
162099971|NCT02008890|585415673|FG001|Period 2|Physician Decision|0|||
162099972|NCT02008890|585415674|FG002|Period 2|Physician Decision|0|||
162099973|NCT02008890|585415675|FG003|Period 2|Physician Decision|2|||
162099974|NCT02008890|585415676|FG004|Period 2|Physician Decision|1|||
162099975|NCT02008890|585415672|FG000|Period 2|Lost to Follow-up|0|||
162099976|NCT02008890|585415673|FG001|Period 2|Lost to Follow-up|0|||
162099977|NCT02008890|585415674|FG002|Period 2|Lost to Follow-up|1|||
162099978|NCT02008890|585415675|FG003|Period 2|Lost to Follow-up|0|||
162099979|NCT02008890|585415676|FG004|Period 2|Lost to Follow-up|0|||
162099980|NCT02008890|585415672|FG000|Extension Period|Withdrawal by Subject|3|||
162099981|NCT02008890|585415673|FG001|Extension Period|Withdrawal by Subject|2|||
162099982|NCT02008890|585415674|FG002|Extension Period|Withdrawal by Subject|0|||
162099983|NCT02008890|585415675|FG003|Extension Period|Withdrawal by Subject|4|||
162099984|NCT02008890|585415676|FG004|Extension Period|Withdrawal by Subject|2|||
162099985|NCT02008890|585415672|FG000|Extension Period|Lost to Follow-up|1|||
162099986|NCT02008890|585415673|FG001|Extension Period|Lost to Follow-up|0|||
162099987|NCT02008890|585415674|FG002|Extension Period|Lost to Follow-up|0|||
162099988|NCT02008890|585415675|FG003|Extension Period|Lost to Follow-up|0|||
162099989|NCT02008890|585415676|FG004|Extension Period|Lost to Follow-up|0|||
162099990|NCT02008890|585415672|FG000|Extension Period|Adverse Event|1|||
162099991|NCT02008890|585415673|FG001|Extension Period|Adverse Event|3|||
162099992|NCT02008890|585415674|FG002|Extension Period|Adverse Event|0|||
162099993|NCT02008890|585415675|FG003|Extension Period|Adverse Event|0|||
162099994|NCT02008890|585415676|FG004|Extension Period|Adverse Event|2|||
162099995|NCT02207816|585415677|FG000|Overall Study|Serious Adverse Event|0|||
162099996|NCT02207816|585415678|FG001|Overall Study|Serious Adverse Event|5|||
162099997|NCT02207816|585415679|FG002|Overall Study|Serious Adverse Event|2|||
162099998|NCT02207816|585415677|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
162099999|NCT02207816|585415678|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
162100000|NCT02207816|585415679|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
162100001|NCT02207816|585415677|FG000|Overall Study|Withdrawal by Subject|4|||
162100002|NCT02207816|585415678|FG001|Overall Study|Withdrawal by Subject|9|||
162100003|NCT02207816|585415679|FG002|Overall Study|Withdrawal by Subject|7|||
162100004|NCT02207816|585415677|FG000|Overall Study|Migrated/Moved From Study Area|41|||
162100005|NCT02207816|585415678|FG001|Overall Study|Migrated/Moved From Study Area|60|||
162100006|NCT02207816|585415679|FG002|Overall Study|Migrated/Moved From Study Area|51|||
162100007|NCT02207816|585415677|FG000|Overall Study|Lost to Follow-up|3|||
162100008|NCT02207816|585415678|FG001|Overall Study|Lost to Follow-up|9|||
162100009|NCT02207816|585415679|FG002|Overall Study|Lost to Follow-up|1|||
162100010|NCT02207816|585415677|FG000|Overall Study|Other|1|||
162100011|NCT02207816|585415678|FG001|Overall Study|Other|2|||
162100012|NCT02207816|585415679|FG002|Overall Study|Other|4|||
162100013|NCT02522494|585415680|FG000|Overall Study|Lost to Follow-up|6|||
162100014|NCT02522494|585415681|FG001|Overall Study|Lost to Follow-up|2|||
162100015|NCT02522494|585415680|FG000|Overall Study|Withdrawal by Subject|1|||
162100016|NCT02522494|585415681|FG001|Overall Study|Withdrawal by Subject|0|||
162100017|NCT02522494|585415680|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
162100018|NCT02522494|585415681|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
162100019|NCT02522494|585415680|FG000|Overall Study|Participant did not watch the video|1|||
162100020|NCT02522494|585415681|FG001|Overall Study|Participant did not watch the video|0|||
162100021|NCT02522494|585415680|FG000|Overall Study|Death|0|||
162100022|NCT02522494|585415681|FG001|Overall Study|Death|1|||
162100023|NCT02349295|585415684|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
162100024|NCT02349295|585415685|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
162100025|NCT02349295|585415686|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
162100026|NCT02349295|585415687|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162100027|NCT02349295|585415688|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162100028|NCT02349295|585415689|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162100029|NCT02349295|585415690|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162100030|NCT02349295|585415691|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162100031|NCT02349295|585415692|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162100032|NCT02349295|585415693|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162100033|NCT02349295|585415694|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162100034|NCT02349295|585415695|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162100035|NCT02349295|585415696|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162100036|NCT02349295|585415697|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
162100037|NCT02349295|585415684|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
162100038|NCT02349295|585415685|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
162100039|NCT02349295|585415686|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
162100040|NCT02349295|585415687|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162100041|NCT02349295|585415688|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162100042|NCT02349295|585415689|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162100043|NCT02349295|585415690|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162100044|NCT02349295|585415691|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162100045|NCT02349295|585415692|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162100046|NCT02349295|585415693|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162100047|NCT02349295|585415694|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162100048|NCT02349295|585415695|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162100049|NCT02349295|585415696|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162100050|NCT02349295|585415697|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
162100051|NCT02349295|585415684|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
162100052|NCT02349295|585415685|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
162100053|NCT02349295|585415686|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
162100054|NCT02349295|585415687|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162100055|NCT02349295|585415688|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162100056|NCT02349295|585415689|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162100057|NCT02349295|585415690|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162100058|NCT02349295|585415691|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162100059|NCT02349295|585415692|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162100060|NCT02349295|585415693|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162100061|NCT02349295|585415694|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162100062|NCT02349295|585415695|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162100063|NCT02349295|585415696|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162100064|NCT02349295|585415697|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
162100065|NCT02349295|585415684|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
162100066|NCT02349295|585415685|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
162100067|NCT02349295|585415686|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
162100068|NCT02349295|585415687|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162100069|NCT02349295|585415688|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162100070|NCT02349295|585415689|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162100071|NCT02349295|585415690|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162100072|NCT02349295|585415691|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162100073|NCT02349295|585415692|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162100074|NCT02349295|585415693|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162100075|NCT02349295|585415694|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162100076|NCT02349295|585415695|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162100077|NCT02349295|585415696|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162100078|NCT02349295|585415697|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
162100079|NCT02349295|585415684|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162100080|NCT02349295|585415685|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
162100081|NCT02349295|585415686|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
162100082|NCT02349295|585415687|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162100083|NCT02349295|585415688|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162100084|NCT02349295|585415689|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162100085|NCT02349295|585415690|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162100086|NCT02349295|585415691|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162100087|NCT02349295|585415692|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162100088|NCT02349295|585415693|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162100089|NCT02349295|585415694|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162100090|NCT02349295|585415695|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162100091|NCT02349295|585415696|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162100092|NCT02349295|585415697|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
162100093|NCT02349295|585415684|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
162100094|NCT02349295|585415685|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
162100095|NCT02349295|585415686|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
162100096|NCT02349295|585415687|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
162100097|NCT02349295|585415688|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
162100098|NCT02349295|585415689|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
162100099|NCT02349295|585415690|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
162100100|NCT02349295|585415691|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
162100101|NCT02349295|585415692|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
162100102|NCT02349295|585415693|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
162100103|NCT02349295|585415694|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
162100104|NCT02349295|585415695|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
162100105|NCT02349295|585415696|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
162100106|NCT02349295|585415697|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
162100107|NCT02349295|585415684|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162100108|NCT02349295|585415685|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162100109|NCT02349295|585415686|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162100110|NCT02349295|585415687|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162100111|NCT02349295|585415688|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162100112|NCT02349295|585415689|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162100113|NCT02349295|585415690|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162100114|NCT02349295|585415691|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
162100115|NCT02349295|585415692|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
162100116|NCT02349295|585415693|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
162100117|NCT02349295|585415694|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
162100118|NCT02349295|585415695|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162100119|NCT02349295|585415696|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162100120|NCT02349295|585415697|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
162100121|NCT02349295|585415684|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162100122|NCT02349295|585415685|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162100123|NCT02349295|585415686|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162100124|NCT02349295|585415687|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162100125|NCT02349295|585415688|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162100126|NCT02349295|585415689|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162100127|NCT02349295|585415690|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162100128|NCT02349295|585415691|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
162100129|NCT02349295|585415692|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
162100130|NCT02349295|585415693|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
162100131|NCT02349295|585415694|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
162100132|NCT02349295|585415695|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162100133|NCT02349295|585415696|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162100134|NCT02349295|585415697|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
162100135|NCT02349295|585415684|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162100136|NCT02349295|585415685|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162100137|NCT02349295|585415686|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162100138|NCT02349295|585415687|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162100139|NCT02349295|585415688|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162100140|NCT02349295|585415689|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162100141|NCT02349295|585415690|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162100142|NCT02349295|585415691|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
162100143|NCT02349295|585415692|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162100144|NCT02349295|585415693|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
162100145|NCT02349295|585415694|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162100146|NCT02349295|585415695|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162100147|NCT02349295|585415696|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162100148|NCT02349295|585415697|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
162100149|NCT02349295|585415684|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
162100150|NCT02349295|585415685|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
162100151|NCT02349295|585415686|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
162100152|NCT02349295|585415687|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
162100153|NCT02349295|585415688|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
162100154|NCT02349295|585415689|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
162100155|NCT02349295|585415690|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
162100156|NCT02349295|585415691|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
162100157|NCT02349295|585415692|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
162100158|NCT02349295|585415693|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
162100159|NCT02349295|585415694|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
162100160|NCT02349295|585415695|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
162100161|NCT02349295|585415696|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
162100162|NCT02349295|585415697|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
162100163|NCT02349295|585415684|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162100164|NCT02349295|585415685|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162100165|NCT02349295|585415686|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162100166|NCT02349295|585415687|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162100167|NCT02349295|585415688|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162100168|NCT02349295|585415689|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162100169|NCT02349295|585415690|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162100170|NCT02349295|585415691|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
162100171|NCT02349295|585415692|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
162100172|NCT02349295|585415693|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
162100173|NCT02349295|585415694|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
162100174|NCT02349295|585415695|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162100175|NCT02349295|585415696|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162100176|NCT02349295|585415697|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
162100177|NCT02349295|585415684|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162100178|NCT02349295|585415685|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162100179|NCT02349295|585415686|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162100180|NCT02349295|585415687|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162100181|NCT02349295|585415688|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162100182|NCT02349295|585415689|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162100183|NCT02349295|585415690|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162100184|NCT02349295|585415691|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
162100185|NCT02349295|585415692|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
162100186|NCT02349295|585415693|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162100187|NCT02349295|585415694|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162100188|NCT02349295|585415695|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162100189|NCT02349295|585415696|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162100190|NCT02349295|585415697|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
162100191|NCT02349295|585415684|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162100192|NCT02349295|585415685|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162100193|NCT02349295|585415686|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162100194|NCT02349295|585415687|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162100195|NCT02349295|585415688|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162100196|NCT02349295|585415689|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162100197|NCT02349295|585415690|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162100198|NCT02349295|585415691|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
162100199|NCT02349295|585415692|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
162100200|NCT02349295|585415693|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162100201|NCT02349295|585415694|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162100202|NCT02349295|585415695|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162100203|NCT02349295|585415696|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162100204|NCT02349295|585415697|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
162100205|NCT02349295|585415684|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162100206|NCT02349295|585415685|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162100207|NCT02349295|585415686|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162100208|NCT02349295|585415687|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162100209|NCT02349295|585415688|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162100210|NCT02349295|585415689|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162100211|NCT02349295|585415690|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162100212|NCT02349295|585415691|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162100213|NCT02349295|585415692|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162100214|NCT02349295|585415693|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162100215|NCT02349295|585415694|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
162100216|NCT02349295|585415695|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
162100217|NCT02349295|585415696|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
162100218|NCT02349295|585415697|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
162100219|NCT02349295|585415684|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162100220|NCT02349295|585415685|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162100221|NCT02349295|585415686|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162100222|NCT02349295|585415687|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162100223|NCT02349295|585415688|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162100224|NCT02349295|585415689|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162100225|NCT02349295|585415690|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162100226|NCT02349295|585415691|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162100227|NCT02349295|585415692|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162100228|NCT02349295|585415693|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162100229|NCT02349295|585415694|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162100230|NCT02349295|585415695|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
162100231|NCT02349295|585415696|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
162100232|NCT02349295|585415697|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
162100233|NCT02349295|585415684|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162100234|NCT02349295|585415685|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162100235|NCT02349295|585415686|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162100236|NCT02349295|585415687|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162100237|NCT02349295|585415688|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162100238|NCT02349295|585415689|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162100239|NCT02349295|585415690|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162100240|NCT02349295|585415691|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162100241|NCT02349295|585415692|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162100242|NCT02349295|585415693|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162100243|NCT02349295|585415694|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162100244|NCT02349295|585415695|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
162100245|NCT02349295|585415696|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
162100246|NCT02349295|585415697|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
162100247|NCT02349295|585415684|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100248|NCT02349295|585415685|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100249|NCT02349295|585415686|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100250|NCT02349295|585415687|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100251|NCT02349295|585415688|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100252|NCT02349295|585415689|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100253|NCT02349295|585415690|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100254|NCT02349295|585415691|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100255|NCT02349295|585415692|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100256|NCT02349295|585415693|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100257|NCT02349295|585415694|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100258|NCT02349295|585415695|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
162100259|NCT02349295|585415696|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100260|NCT02349295|585415697|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
162100261|NCT02349295|585415684|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100262|NCT02349295|585415685|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100263|NCT02349295|585415686|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100264|NCT02349295|585415687|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100265|NCT02349295|585415688|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100266|NCT02349295|585415689|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100267|NCT02349295|585415690|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100268|NCT02349295|585415691|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100269|NCT02349295|585415692|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100270|NCT02349295|585415693|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100271|NCT02349295|585415694|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100272|NCT02349295|585415695|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
162100273|NCT02349295|585415696|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100274|NCT02349295|585415697|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
162100275|NCT03240588|585415698|FG000|Overall Study|Death|3|||
162100276|NCT03240588|585415699|FG001|Overall Study|Death|0|||
162100277|NCT03240588|585415700|FG002|Overall Study|Death|0|||
162100278|NCT03240588|585415698|FG000|Overall Study|Adverse Event|5|||
162100279|NCT03240588|585415699|FG001|Overall Study|Adverse Event|4|||
162100280|NCT03240588|585415700|FG002|Overall Study|Adverse Event|0|||
162100281|NCT03240588|585415698|FG000|Overall Study|Lost to Follow-up|9|||
162100282|NCT03240588|585415699|FG001|Overall Study|Lost to Follow-up|4|||
162100283|NCT03240588|585415700|FG002|Overall Study|Lost to Follow-up|0|||
162100284|NCT03240588|585415698|FG000|Overall Study|Physician Decision|3|||
162100285|NCT03240588|585415699|FG001|Overall Study|Physician Decision|2|||
162100286|NCT03240588|585415700|FG002|Overall Study|Physician Decision|0|||
162100287|NCT03240588|585415698|FG000|Overall Study|Did not meet eligibility criteria|0|||
162100288|NCT03240588|585415699|FG001|Overall Study|Did not meet eligibility criteria|6|||
162100289|NCT03240588|585415700|FG002|Overall Study|Did not meet eligibility criteria|0|||
162100290|NCT03240588|585415698|FG000|Overall Study|No longer meets protocol criteria|12|||
162100291|NCT03240588|585415699|FG001|Overall Study|No longer meets protocol criteria|7|||
162100292|NCT03240588|585415700|FG002|Overall Study|No longer meets protocol criteria|0|||
162100293|NCT03240588|585415698|FG000|Overall Study|Withdrawal by Subject|60|||
162100294|NCT03240588|585415699|FG001|Overall Study|Withdrawal by Subject|52|||
162100295|NCT03240588|585415700|FG002|Overall Study|Withdrawal by Subject|7|||
162100296|NCT03240588|585415698|FG000|Overall Study|Other, additional details not available.|0|||
162100297|NCT03240588|585415699|FG001|Overall Study|Other, additional details not available.|12|||
162100298|NCT03240588|585415700|FG002|Overall Study|Other, additional details not available.|1|||
162100299|NCT03240588|585415698|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
162100300|NCT03240588|585415699|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
162100301|NCT03240588|585415700|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
162100302|NCT03240588|585415698|FG000|Overall Study|Closure of study|55|||
162100303|NCT03240588|585415699|FG001|Overall Study|Closure of study|3|||
162100304|NCT03240588|585415700|FG002|Overall Study|Closure of study|0|||
162100305|NCT03240588|585415698|FG000|Overall Study|Subject non-compliance|23|||
162100306|NCT03240588|585415699|FG001|Overall Study|Subject non-compliance|2|||
162100307|NCT03240588|585415700|FG002|Overall Study|Subject non-compliance|1|||
162100308|NCT03240588|585415698|FG000|Overall Study|Device Deficiency|1|||
162100309|NCT03240588|585415699|FG001|Overall Study|Device Deficiency|0|||
162100310|NCT03240588|585415700|FG002|Overall Study|Device Deficiency|0|||
162100311|NCT03240588|585415698|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
162100312|NCT03240588|585415699|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
162100313|NCT03240588|585415700|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
162100314|NCT03461003|585415702|FG000|Overall Study|Lost to Follow-up|2|||
162100315|NCT03461003|585415703|FG001|Overall Study|Lost to Follow-up|2|||
162100316|NCT03461003|585415702|FG000|Overall Study|Withdrawal by Subject|3|||
162100317|NCT03461003|585415703|FG001|Overall Study|Withdrawal by Subject|1|||
162100318|NCT00620750|585415704|FG000|Overall Study|Lost to Follow-up|25|||
162100319|NCT04477187|585415705|FG000|Overall Study|Lost to Follow-up|2|||
162100320|NCT03508843|585415707|FG000|Overall Study|Withdrawal by Subject|1|||
162100321|NCT03508843|585415707|FG000|Overall Study|technical difficulties|2|||
162100322|NCT04717596|585415708|FG000|Overall Study|Withdrawal by Subject|4|||
162100323|NCT00765843|585415709|FG000|Overall Study|Lost to Follow-up|1|||
162100324|NCT00765843|585415710|FG001|Overall Study|Lost to Follow-up|3|||
162100325|NCT00765843|585415711|FG002|Overall Study|Lost to Follow-up|2|||
162100326|NCT00765843|585415709|FG000|Overall Study|did not return to receive intervention|0|||
162100327|NCT00765843|585415710|FG001|Overall Study|did not return to receive intervention|1|||
162100328|NCT00765843|585415711|FG002|Overall Study|did not return to receive intervention|0|||
162100329|NCT00765843|585415709|FG000|Overall Study|Adverse Event|0|||
162100330|NCT00765843|585415710|FG001|Overall Study|Adverse Event|0|||
162100331|NCT00765843|585415711|FG002|Overall Study|Adverse Event|1|||
162100332|NCT03555396|585415712|FG000|Overall Study|Death|3|||
162100333|NCT03555396|585415713|FG001|Overall Study|Death|1|||
162100334|NCT03555396|585415712|FG000|Overall Study|Lost to Follow-up|0|||
162100335|NCT03555396|585415713|FG001|Overall Study|Lost to Follow-up|2|||
162100336|NCT02460991|585415714|FG000|Overall Study|Withdrawal by Subject|0|||
162100337|NCT02460991|585415715|FG001|Overall Study|Withdrawal by Subject|2|||
162100338|NCT02564523|585415716|FG000|Overall Study|Withdrawal by Subject|3|||
162100339|NCT02564523|585415717|FG001|Overall Study|Withdrawal by Subject|0|||
162100340|NCT02564523|585415718|FG002|Overall Study|Withdrawal by Subject|1|||
162100341|NCT02564523|585415719|FG003|Overall Study|Withdrawal by Subject|0|||
162100342|NCT02564523|585415720|FG004|Overall Study|Withdrawal by Subject|1|||
162100343|NCT02564523|585415721|FG005|Overall Study|Withdrawal by Subject|0|||
162100344|NCT02564523|585415722|FG006|Overall Study|Withdrawal by Subject|1|||
162100345|NCT02564523|585415723|FG007|Overall Study|Withdrawal by Subject|0|||
162100346|NCT02564523|585415724|FG008|Overall Study|Withdrawal by Subject|0|||
162100347|NCT02564523|585415725|FG009|Overall Study|Withdrawal by Subject|0|||
162100348|NCT02564523|585415726|FG010|Overall Study|Withdrawal by Subject|1|||
162100349|NCT02564523|585415727|FG011|Overall Study|Withdrawal by Subject|0|||
162100350|NCT02564523|585415728|FG012|Overall Study|Withdrawal by Subject|1|||
162100351|NCT02564523|585415729|FG013|Overall Study|Withdrawal by Subject|0|||
162100352|NCT02564523|585415730|FG014|Overall Study|Withdrawal by Subject|0|||
162100353|NCT02564523|585415731|FG015|Overall Study|Withdrawal by Subject|0|||
162100354|NCT02564523|585415732|FG016|Overall Study|Withdrawal by Subject|0|||
162100355|NCT02564523|585415733|FG017|Overall Study|Withdrawal by Subject|0|||
162100356|NCT02564523|585415716|FG000|Overall Study|Adverse Event|0|||
162100357|NCT02564523|585415717|FG001|Overall Study|Adverse Event|0|||
162100358|NCT02564523|585415718|FG002|Overall Study|Adverse Event|0|||
162100359|NCT02564523|585415719|FG003|Overall Study|Adverse Event|0|||
162100360|NCT02564523|585415720|FG004|Overall Study|Adverse Event|0|||
162100361|NCT02564523|585415721|FG005|Overall Study|Adverse Event|0|||
162100362|NCT02564523|585415722|FG006|Overall Study|Adverse Event|0|||
162100363|NCT02564523|585415723|FG007|Overall Study|Adverse Event|0|||
162100364|NCT02564523|585415724|FG008|Overall Study|Adverse Event|0|||
162100365|NCT02564523|585415725|FG009|Overall Study|Adverse Event|0|||
162100366|NCT02564523|585415726|FG010|Overall Study|Adverse Event|0|||
162100367|NCT02564523|585415727|FG011|Overall Study|Adverse Event|0|||
162100368|NCT02564523|585415728|FG012|Overall Study|Adverse Event|0|||
162100369|NCT02564523|585415729|FG013|Overall Study|Adverse Event|0|||
162100370|NCT02564523|585415730|FG014|Overall Study|Adverse Event|0|||
162100371|NCT02564523|585415731|FG015|Overall Study|Adverse Event|0|||
162100372|NCT02564523|585415732|FG016|Overall Study|Adverse Event|0|||
162100373|NCT02564523|585415733|FG017|Overall Study|Adverse Event|1|||
162100374|NCT02564523|585415716|FG000|Overall Study|Death|0|||
162100375|NCT02564523|585415717|FG001|Overall Study|Death|0|||
162100376|NCT02564523|585415718|FG002|Overall Study|Death|0|||
162100377|NCT02564523|585415719|FG003|Overall Study|Death|0|||
162100378|NCT02564523|585415720|FG004|Overall Study|Death|0|||
162100379|NCT02564523|585415721|FG005|Overall Study|Death|0|||
162100380|NCT02564523|585415722|FG006|Overall Study|Death|1|||
162100381|NCT02564523|585415723|FG007|Overall Study|Death|0|||
162100382|NCT02564523|585415724|FG008|Overall Study|Death|0|||
162100383|NCT02564523|585415725|FG009|Overall Study|Death|0|||
162100384|NCT02564523|585415726|FG010|Overall Study|Death|1|||
162100385|NCT02564523|585415727|FG011|Overall Study|Death|0|||
162100386|NCT02564523|585415728|FG012|Overall Study|Death|0|||
162100387|NCT02564523|585415729|FG013|Overall Study|Death|0|||
162100388|NCT02564523|585415730|FG014|Overall Study|Death|0|||
162100389|NCT02564523|585415731|FG015|Overall Study|Death|0|||
162100390|NCT02564523|585415732|FG016|Overall Study|Death|0|||
162100391|NCT02564523|585415733|FG017|Overall Study|Death|0|||
162100392|NCT02564523|585415716|FG000|Overall Study|Lost to Follow-up|2|||
162100393|NCT02564523|585415717|FG001|Overall Study|Lost to Follow-up|1|||
162100394|NCT02564523|585415718|FG002|Overall Study|Lost to Follow-up|4|||
162100395|NCT02564523|585415719|FG003|Overall Study|Lost to Follow-up|0|||
162100396|NCT02564523|585415720|FG004|Overall Study|Lost to Follow-up|1|||
162100397|NCT02564523|585415721|FG005|Overall Study|Lost to Follow-up|0|||
162100398|NCT02564523|585415722|FG006|Overall Study|Lost to Follow-up|1|||
162100399|NCT02564523|585415723|FG007|Overall Study|Lost to Follow-up|0|||
162100400|NCT02564523|585415724|FG008|Overall Study|Lost to Follow-up|0|||
162100401|NCT02564523|585415725|FG009|Overall Study|Lost to Follow-up|0|||
162100402|NCT02564523|585415726|FG010|Overall Study|Lost to Follow-up|0|||
162100403|NCT02564523|585415727|FG011|Overall Study|Lost to Follow-up|1|||
162100404|NCT02564523|585415728|FG012|Overall Study|Lost to Follow-up|1|||
162100405|NCT02564523|585415729|FG013|Overall Study|Lost to Follow-up|0|||
162100406|NCT02564523|585415730|FG014|Overall Study|Lost to Follow-up|0|||
162100407|NCT02564523|585415731|FG015|Overall Study|Lost to Follow-up|0|||
162100408|NCT02564523|585415732|FG016|Overall Study|Lost to Follow-up|0|||
162100409|NCT02564523|585415733|FG017|Overall Study|Lost to Follow-up|0|||
162100410|NCT02564523|585415716|FG000|Overall Study|Physician Decision|0|||
162100411|NCT02564523|585415717|FG001|Overall Study|Physician Decision|0|||
162100412|NCT02564523|585415718|FG002|Overall Study|Physician Decision|0|||
162100413|NCT02564523|585415719|FG003|Overall Study|Physician Decision|0|||
162100414|NCT02564523|585415720|FG004|Overall Study|Physician Decision|1|||
162100415|NCT02564523|585415721|FG005|Overall Study|Physician Decision|0|||
162100416|NCT02564523|585415722|FG006|Overall Study|Physician Decision|0|||
162100417|NCT02564523|585415723|FG007|Overall Study|Physician Decision|0|||
162100418|NCT02564523|585415724|FG008|Overall Study|Physician Decision|0|||
162100419|NCT02564523|585415725|FG009|Overall Study|Physician Decision|0|||
162100420|NCT02564523|585415726|FG010|Overall Study|Physician Decision|1|||
162100421|NCT02564523|585415727|FG011|Overall Study|Physician Decision|0|||
162100422|NCT02564523|585415728|FG012|Overall Study|Physician Decision|0|||
162100423|NCT02564523|585415729|FG013|Overall Study|Physician Decision|0|||
162100424|NCT02564523|585415730|FG014|Overall Study|Physician Decision|0|||
162100425|NCT02564523|585415731|FG015|Overall Study|Physician Decision|0|||
162100426|NCT02564523|585415732|FG016|Overall Study|Physician Decision|0|||
162100427|NCT02564523|585415733|FG017|Overall Study|Physician Decision|0|||
162100428|NCT02564523|585415716|FG000|Overall Study|Protocol Violation|2|||
162100429|NCT02564523|585415717|FG001|Overall Study|Protocol Violation|2|||
162100430|NCT02564523|585415718|FG002|Overall Study|Protocol Violation|5|||
162100431|NCT02564523|585415719|FG003|Overall Study|Protocol Violation|0|||
162100432|NCT02564523|585415720|FG004|Overall Study|Protocol Violation|1|||
162100433|NCT02564523|585415721|FG005|Overall Study|Protocol Violation|0|||
162100434|NCT02564523|585415722|FG006|Overall Study|Protocol Violation|0|||
162100435|NCT02564523|585415723|FG007|Overall Study|Protocol Violation|0|||
162100436|NCT02564523|585415724|FG008|Overall Study|Protocol Violation|0|||
162100437|NCT02564523|585415725|FG009|Overall Study|Protocol Violation|0|||
162100438|NCT02564523|585415726|FG010|Overall Study|Protocol Violation|0|||
162100439|NCT02564523|585415727|FG011|Overall Study|Protocol Violation|0|||
162100440|NCT02564523|585415728|FG012|Overall Study|Protocol Violation|0|||
162100441|NCT02564523|585415729|FG013|Overall Study|Protocol Violation|0|||
162100442|NCT02564523|585415730|FG014|Overall Study|Protocol Violation|0|||
162100443|NCT02564523|585415731|FG015|Overall Study|Protocol Violation|0|||
162100444|NCT02564523|585415732|FG016|Overall Study|Protocol Violation|0|||
162100445|NCT02564523|585415733|FG017|Overall Study|Protocol Violation|0|||
162100446|NCT02564523|585415716|FG000|Overall Study|Other|3|||
162100447|NCT02564523|585415717|FG001|Overall Study|Other|0|||
162100448|NCT02564523|585415718|FG002|Overall Study|Other|0|||
162100449|NCT02564523|585415719|FG003|Overall Study|Other|1|||
162100450|NCT02564523|585415720|FG004|Overall Study|Other|0|||
162100451|NCT02564523|585415721|FG005|Overall Study|Other|0|||
162100452|NCT02564523|585415722|FG006|Overall Study|Other|0|||
162100453|NCT02564523|585415723|FG007|Overall Study|Other|0|||
162100454|NCT02564523|585415724|FG008|Overall Study|Other|0|||
162100455|NCT02564523|585415725|FG009|Overall Study|Other|0|||
162100456|NCT02564523|585415726|FG010|Overall Study|Other|0|||
162100457|NCT02564523|585415727|FG011|Overall Study|Other|0|||
162100458|NCT02564523|585415728|FG012|Overall Study|Other|0|||
162100459|NCT02564523|585415729|FG013|Overall Study|Other|0|||
162100460|NCT02564523|585415730|FG014|Overall Study|Other|0|||
162100461|NCT02564523|585415731|FG015|Overall Study|Other|0|||
162100462|NCT02564523|585415732|FG016|Overall Study|Other|0|||
162100463|NCT02564523|585415733|FG017|Overall Study|Other|0|||
162100464|NCT00448539|585415736|FG000|Overall Study|Medication non-compliance|4|||
162100465|NCT00448539|585415737|FG001|Overall Study|Medication non-compliance|1|||
162100466|NCT00448539|585415736|FG000|Overall Study|Protocol Violation|1|||
162100467|NCT00448539|585415737|FG001|Overall Study|Protocol Violation|0|||
162100468|NCT00448539|585415736|FG000|Overall Study|Request of the investigator or sponsor|67|||
162100469|NCT00448539|585415737|FG001|Overall Study|Request of the investigator or sponsor|54|||
162100470|NCT00448539|585415736|FG000|Overall Study|Withdrawal by Subject|20|||
162100471|NCT00448539|585415737|FG001|Overall Study|Withdrawal by Subject|24|||
162100472|NCT00448539|585415736|FG000|Overall Study|Diary non-compliance|1|||
162100473|NCT00448539|585415737|FG001|Overall Study|Diary non-compliance|0|||
162100474|NCT00448539|585415736|FG000|Overall Study|Adverse Event|9|||
162100475|NCT00448539|585415737|FG001|Overall Study|Adverse Event|26|||
162100476|NCT00448539|585415736|FG000|Overall Study|Lack of Efficacy|27|||
162100477|NCT00448539|585415737|FG001|Overall Study|Lack of Efficacy|40|||
162100478|NCT00448539|585415736|FG000|Overall Study|Miscellaneous|2|||
162100479|NCT00448539|585415737|FG001|Overall Study|Miscellaneous|1|||
162100480|NCT00448539|585415736|FG000|Overall Study|Change of meds|2|||
162100481|NCT00448539|585415737|FG001|Overall Study|Change of meds|3|||
162100482|NCT00448539|585415736|FG000|Overall Study|Lost to Follow-up|1|||
162100483|NCT00448539|585415737|FG001|Overall Study|Lost to Follow-up|3|||
162100484|NCT03349710|585415738|FG000|Treatment Period|Death|0|||
162100485|NCT03349710|585415739|FG001|Treatment Period|Death|0|||
162100486|NCT03349710|585415740|FG002|Treatment Period|Death|1|||
162100487|NCT03349710|585415741|FG003|Treatment Period|Death|0|||
162100488|NCT03349710|585415738|FG000|Treatment Period|Disease Progression|0|||
162100489|NCT03349710|585415739|FG001|Treatment Period|Disease Progression|2|||
162100490|NCT03349710|585415740|FG002|Treatment Period|Disease Progression|0|||
162100491|NCT03349710|585415741|FG003|Treatment Period|Disease Progression|1|||
162100492|NCT03349710|585415738|FG000|Treatment Period|Study Drug Toxicity|1|||
162100493|NCT03349710|585415739|FG001|Treatment Period|Study Drug Toxicity|0|||
162100494|NCT03349710|585415740|FG002|Treatment Period|Study Drug Toxicity|1|||
162100495|NCT03349710|585415741|FG003|Treatment Period|Study Drug Toxicity|1|||
162100496|NCT03349710|585415738|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
162100497|NCT03349710|585415739|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
162100498|NCT03349710|585415740|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
162100499|NCT03349710|585415741|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
162100500|NCT03349710|585415738|FG000|Treatment Period|admin reason by sponsor|0|||
162100501|NCT03349710|585415739|FG001|Treatment Period|admin reason by sponsor|7|||
162100502|NCT03349710|585415740|FG002|Treatment Period|admin reason by sponsor|0|||
162100503|NCT03349710|585415741|FG003|Treatment Period|admin reason by sponsor|19|||
162100504|NCT03349710|585415738|FG000|Treatment Period|Other Reason|2|||
162100505|NCT03349710|585415739|FG001|Treatment Period|Other Reason|0|||
162100506|NCT03349710|585415740|FG002|Treatment Period|Other Reason|2|||
162100507|NCT03349710|585415741|FG003|Treatment Period|Other Reason|1|||
162100508|NCT03349710|585415738|FG000|Treatment Period|completed|6|||
162100509|NCT03349710|585415739|FG001|Treatment Period|completed|0|||
162100510|NCT03349710|585415740|FG002|Treatment Period|completed|18|||
162100511|NCT03349710|585415741|FG003|Treatment Period|completed|1|||
162100512|NCT03349710|585415738|FG000|Treatment Period|participant request to discontinue|0|||
162100513|NCT03349710|585415739|FG001|Treatment Period|participant request to discontinue|0|||
162100514|NCT03349710|585415740|FG002|Treatment Period|participant request to discontinue|4|||
162100515|NCT03349710|585415741|FG003|Treatment Period|participant request to discontinue|0|||
162100516|NCT03349710|585415738|FG000|Treatment Period|participant withdrew consent|1|||
162100517|NCT03349710|585415739|FG001|Treatment Period|participant withdrew consent|0|||
162100518|NCT03349710|585415740|FG002|Treatment Period|participant withdrew consent|0|||
162100519|NCT03349710|585415741|FG003|Treatment Period|participant withdrew consent|0|||
162100520|NCT00695903|585415742|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
162100521|NCT00695903|585415743|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
162100522|NCT00695903|585415742|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
162100523|NCT00695903|585415743|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
162100524|NCT00695903|585415742|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
162100525|NCT00695903|585415743|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
162100526|NCT00695903|585415742|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
162100527|NCT00695903|585415743|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
162100528|NCT00695903|585415742|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
162100529|NCT00695903|585415743|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
162100530|NCT00695903|585415742|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
162100531|NCT00695903|585415743|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
162100532|NCT00695903|585415742|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
162100533|NCT00695903|585415743|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
162100534|NCT00695903|585415742|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
162100535|NCT00695903|585415743|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
162100536|NCT00695903|585415742|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
162100537|NCT00695903|585415743|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
162100538|NCT01296568|585415746|FG000|Continued Access Phase|Lost to Follow-up|1|||
162100539|NCT01296568|585415746|FG000|Continued Access Phase|Withdrawal by Subject|1|||
162100540|NCT01296568|585415746|FG000|Continued Access Phase|Disease Progression|1|||
162100541|NCT00321854|585415752|FG000|Overall Study|Adverse Event|41|||
162100542|NCT00321854|585415753|FG001|Overall Study|Adverse Event|43|||
162100543|NCT00321854|585415752|FG000|Overall Study|Lack of Efficacy|9|||
162100544|NCT00321854|585415753|FG001|Overall Study|Lack of Efficacy|14|||
162100545|NCT00321854|585415752|FG000|Overall Study|Protocol Violation|6|||
162100546|NCT00321854|585415753|FG001|Overall Study|Protocol Violation|5|||
162100547|NCT00321854|585415752|FG000|Overall Study|Lost to Follow-up|0|||
162100548|NCT00321854|585415753|FG001|Overall Study|Lost to Follow-up|2|||
162100549|NCT00321854|585415752|FG000|Overall Study|Withdrawal by Subject|6|||
162100550|NCT00321854|585415753|FG001|Overall Study|Withdrawal by Subject|17|||
162100551|NCT00321854|585415752|FG000|Overall Study|Other|1|||
162100552|NCT00321854|585415753|FG001|Overall Study|Other|1|||
162100553|NCT01369342|585415754|FG000|Overall Study|Withdrawal by Subject|7|||
162100554|NCT01369342|585415755|FG001|Overall Study|Withdrawal by Subject|7|||
162100555|NCT01369342|585415756|FG002|Overall Study|Withdrawal by Subject|2|||
162100556|NCT01369342|585415754|FG000|Overall Study|Lost to Follow-up|5|||
162100557|NCT01369342|585415755|FG001|Overall Study|Lost to Follow-up|2|||
162100558|NCT01369342|585415756|FG002|Overall Study|Lost to Follow-up|1|||
162100559|NCT01369342|585415754|FG000|Overall Study|Not Treated|1|||
162100560|NCT01369342|585415755|FG001|Overall Study|Not Treated|0|||
162100561|NCT01369342|585415756|FG002|Overall Study|Not Treated|0|||
162100562|NCT01816594|585415757|FG000|Overall Study|Local Progress|0|||
162100563|NCT01816594|585415758|FG001|Overall Study|Local Progress|2|||
162100564|NCT01816594|585415757|FG000|Overall Study|Adverse Event|9|||
162100565|NCT01816594|585415758|FG001|Overall Study|Adverse Event|0|||
162100566|NCT01816594|585415757|FG000|Overall Study|Withdrawal by Subject|1|||
162100567|NCT01816594|585415758|FG001|Overall Study|Withdrawal by Subject|0|||
162100568|NCT01816594|585415757|FG000|Overall Study|Physician Decision|1|||
162100569|NCT01816594|585415758|FG001|Overall Study|Physician Decision|0|||
162100570|NCT03905655|585415759|FG000|Overall Study|Adverse Event|1|||
162100571|NCT03905655|585415760|FG001|Overall Study|Adverse Event|0|||
162100572|NCT03905655|585415761|FG002|Overall Study|Adverse Event|1|||
162100573|NCT03905655|585415762|FG003|Overall Study|Adverse Event|1|||
162100574|NCT04723576|585415763|FG000|Overall Study|Withdrawal by Subject|2133|||
162100575|NCT04723576|585415764|FG001|Overall Study|Withdrawal by Subject|3234|||
162100576|NCT03927950|585415773|FG000|Overall Study|Adverse Event|9|||
162100577|NCT03263429|585415774|FG000|Overall Study|Withdrawal by Subject|0|||
162100578|NCT03263429|585415775|FG001|Overall Study|Withdrawal by Subject|1|||
162100579|NCT03263429|585415776|FG002|Overall Study|Withdrawal by Subject|0|||
162100580|NCT03263429|585415774|FG000|Overall Study|Follow-Up Period Completed|0|||
162100581|NCT03263429|585415775|FG001|Overall Study|Follow-Up Period Completed|2|||
162100582|NCT03263429|585415776|FG002|Overall Study|Follow-Up Period Completed|0|||
162100583|NCT03263429|585415774|FG000|Overall Study|Death|3|||
162100584|NCT03263429|585415775|FG001|Overall Study|Death|5|||
162100585|NCT03263429|585415776|FG002|Overall Study|Death|16|||
162100586|NCT03263429|585415774|FG000|Overall Study|Participant unable to return|0|||
162100587|NCT03263429|585415775|FG001|Overall Study|Participant unable to return|0|||
162100588|NCT03263429|585415776|FG002|Overall Study|Participant unable to return|1|||
162100589|NCT03263429|585415774|FG000|Overall Study|Study Closed|0|||
162100590|NCT03263429|585415775|FG001|Overall Study|Study Closed|0|||
162100591|NCT03263429|585415776|FG002|Overall Study|Study Closed|1|||
162100592|NCT04530448|585415777|FG000|Overall Study|Physician Decision|3|||
162100593|NCT04530448|585415778|FG001|Overall Study|Physician Decision|0|||
162100594|NCT01519206|585415779|FG000|Overall Study|Lost to Follow-up|3|||
162100595|NCT01519206|585415779|FG000|Overall Study|Missed Visit|2|||
162100596|NCT02014116|585415780|FG000|Overall Study|Progressive Disease|3|||
162100597|NCT02014116|585415781|FG001|Overall Study|Progressive Disease|4|||
162100598|NCT02014116|585415782|FG002|Overall Study|Progressive Disease|2|||
162100599|NCT02014116|585415783|FG003|Overall Study|Progressive Disease|6|||
162100600|NCT02014116|585415784|FG004|Overall Study|Progressive Disease|1|||
162100601|NCT02014116|585415785|FG005|Overall Study|Progressive Disease|13|||
162100602|NCT02014116|585415786|FG006|Overall Study|Progressive Disease|1|||
162100603|NCT02014116|585415787|FG007|Overall Study|Progressive Disease|3|||
162100604|NCT02014116|585415788|FG008|Overall Study|Progressive Disease|7|||
162100605|NCT02014116|585415780|FG000|Overall Study|Adverse Event|0|||
162100606|NCT02014116|585415781|FG001|Overall Study|Adverse Event|0|||
162100607|NCT02014116|585415782|FG002|Overall Study|Adverse Event|0|||
162100608|NCT02014116|585415783|FG003|Overall Study|Adverse Event|0|||
162100609|NCT02014116|585415784|FG004|Overall Study|Adverse Event|1|||
162100610|NCT02014116|585415785|FG005|Overall Study|Adverse Event|0|||
162100611|NCT02014116|585415786|FG006|Overall Study|Adverse Event|0|||
162100612|NCT02014116|585415787|FG007|Overall Study|Adverse Event|1|||
162100613|NCT02014116|585415788|FG008|Overall Study|Adverse Event|0|||
162100614|NCT02014116|585415780|FG000|Overall Study|Lost to Follow-up|0|||
162100615|NCT02014116|585415781|FG001|Overall Study|Lost to Follow-up|0|||
162100616|NCT02014116|585415782|FG002|Overall Study|Lost to Follow-up|0|||
162100617|NCT02014116|585415783|FG003|Overall Study|Lost to Follow-up|0|||
162100618|NCT02014116|585415784|FG004|Overall Study|Lost to Follow-up|0|||
162100619|NCT02014116|585415785|FG005|Overall Study|Lost to Follow-up|1|||
162100620|NCT02014116|585415786|FG006|Overall Study|Lost to Follow-up|0|||
162100621|NCT02014116|585415787|FG007|Overall Study|Lost to Follow-up|0|||
162100622|NCT02014116|585415788|FG008|Overall Study|Lost to Follow-up|1|||
162100623|NCT02014116|585415780|FG000|Overall Study|Death|0|||
162100624|NCT02014116|585415781|FG001|Overall Study|Death|0|||
162100625|NCT02014116|585415782|FG002|Overall Study|Death|0|||
162100626|NCT02014116|585415783|FG003|Overall Study|Death|0|||
162100627|NCT02014116|585415784|FG004|Overall Study|Death|0|||
162100628|NCT02014116|585415785|FG005|Overall Study|Death|0|||
162100629|NCT02014116|585415786|FG006|Overall Study|Death|0|||
162100630|NCT02014116|585415787|FG007|Overall Study|Death|1|||
162100631|NCT02014116|585415788|FG008|Overall Study|Death|1|||
162100632|NCT02014116|585415780|FG000|Overall Study|Withdrawal by Subject|0|||
162100633|NCT02014116|585415781|FG001|Overall Study|Withdrawal by Subject|0|||
162100634|NCT02014116|585415782|FG002|Overall Study|Withdrawal by Subject|1|||
162100635|NCT02014116|585415783|FG003|Overall Study|Withdrawal by Subject|1|||
162100636|NCT02014116|585415784|FG004|Overall Study|Withdrawal by Subject|0|||
162100637|NCT02014116|585415785|FG005|Overall Study|Withdrawal by Subject|1|||
162100638|NCT02014116|585415786|FG006|Overall Study|Withdrawal by Subject|0|||
162100639|NCT02014116|585415787|FG007|Overall Study|Withdrawal by Subject|0|||
162100640|NCT02014116|585415788|FG008|Overall Study|Withdrawal by Subject|0|||
162100641|NCT02014116|585415780|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
162100642|NCT02014116|585415781|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
162100643|NCT02014116|585415782|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
162100644|NCT02014116|585415783|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
162100645|NCT02014116|585415784|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
162100646|NCT02014116|585415785|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
162100647|NCT02014116|585415786|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
162100648|NCT02014116|585415787|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
162100649|NCT02014116|585415788|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
162100650|NCT02014116|585415780|FG000|Overall Study|Physician Decision|0|||
162100651|NCT02014116|585415781|FG001|Overall Study|Physician Decision|0|||
162100652|NCT02014116|585415782|FG002|Overall Study|Physician Decision|0|||
162100653|NCT02014116|585415783|FG003|Overall Study|Physician Decision|0|||
162100654|NCT02014116|585415784|FG004|Overall Study|Physician Decision|0|||
162100655|NCT02014116|585415785|FG005|Overall Study|Physician Decision|0|||
162100656|NCT02014116|585415786|FG006|Overall Study|Physician Decision|0|||
162100657|NCT02014116|585415787|FG007|Overall Study|Physician Decision|0|||
162100658|NCT02014116|585415788|FG008|Overall Study|Physician Decision|1|||
162100659|NCT01491854|585415789|FG000|Overall Study|mainly due to premature termination|93|||
162100660|NCT01491854|585415789|FG000|Overall Study|Death|1|||
162100661|NCT01491854|585415789|FG000|Overall Study|Withdrawal by Subject|3|||
162100662|NCT01491854|585415789|FG000|Overall Study|Lost to Follow-up|33|||
162100663|NCT02395042|585415791|FG000|Treatment 1 Period|Adverse Event|1|||
162100664|NCT02395042|585415792|FG001|Treatment 1 Period|Adverse Event|3|||
162100665|NCT02395042|585415793|FG002|Treatment 1 Period|Adverse Event|1|||
162100666|NCT02395042|585415791|FG000|Treatment 1 Period|Lack of Efficacy|1|||
162100667|NCT02395042|585415792|FG001|Treatment 1 Period|Lack of Efficacy|1|||
162100668|NCT02395042|585415793|FG002|Treatment 1 Period|Lack of Efficacy|0|||
162100669|NCT02395042|585415791|FG000|Treatment 1 Period|Lost to Follow-up|1|||
162100670|NCT02395042|585415792|FG001|Treatment 1 Period|Lost to Follow-up|0|||
162100671|NCT02395042|585415793|FG002|Treatment 1 Period|Lost to Follow-up|0|||
162100672|NCT02395042|585415791|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
162100673|NCT02395042|585415792|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
162100674|NCT02395042|585415793|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
162100675|NCT02395042|585415791|FG000|Treatment 2 Period|Lack of Efficacy|1|||
162100676|NCT02395042|585415792|FG001|Treatment 2 Period|Lack of Efficacy|1|||
162100677|NCT02395042|585415793|FG002|Treatment 2 Period|Lack of Efficacy|0|||
162100678|NCT03638141|585415794|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
162100679|NCT03579563|585415795|FG000|Overall Study|Lost to Follow-up|0|||
162100680|NCT03579563|585415796|FG001|Overall Study|Lost to Follow-up|0|||
162100681|NCT03579563|585415797|FG002|Overall Study|Lost to Follow-up|0|||
162100682|NCT03579563|585415798|FG003|Overall Study|Lost to Follow-up|0|||
162100683|NCT03579563|585415799|FG004|Overall Study|Lost to Follow-up|1|||
162100684|NCT03579563|585415800|FG005|Overall Study|Lost to Follow-up|0|||
162100685|NCT03579563|585415795|FG000|Overall Study|Lack of Efficacy|1|||
162100686|NCT03579563|585415796|FG001|Overall Study|Lack of Efficacy|1|||
162100687|NCT03579563|585415797|FG002|Overall Study|Lack of Efficacy|4|||
162100688|NCT03579563|585415798|FG003|Overall Study|Lack of Efficacy|1|||
162100689|NCT03579563|585415799|FG004|Overall Study|Lack of Efficacy|2|||
162100690|NCT03579563|585415800|FG005|Overall Study|Lack of Efficacy|3|||
162100691|NCT03579563|585415795|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
162100692|NCT03579563|585415796|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
162100693|NCT03579563|585415797|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
162100694|NCT03579563|585415798|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
162100695|NCT03579563|585415799|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
162100696|NCT03579563|585415800|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
162100697|NCT03579563|585415795|FG000|Overall Study|Time/distance concern|0|||
162100698|NCT03579563|585415796|FG001|Overall Study|Time/distance concern|0|||
162100699|NCT03579563|585415797|FG002|Overall Study|Time/distance concern|1|||
162100700|NCT03579563|585415798|FG003|Overall Study|Time/distance concern|0|||
162100701|NCT03579563|585415799|FG004|Overall Study|Time/distance concern|0|||
162100702|NCT03579563|585415800|FG005|Overall Study|Time/distance concern|1|||
162100703|NCT03579563|585415795|FG000|Overall Study|COVID shutdown|2|||
162100704|NCT03579563|585415796|FG001|Overall Study|COVID shutdown|3|||
162100705|NCT03579563|585415797|FG002|Overall Study|COVID shutdown|4|||
162100706|NCT03579563|585415798|FG003|Overall Study|COVID shutdown|3|||
162100707|NCT03579563|585415799|FG004|Overall Study|COVID shutdown|1|||
162100708|NCT03579563|585415800|FG005|Overall Study|COVID shutdown|2|||
162100709|NCT03579563|585415795|FG000|Overall Study|Protocol administration error|1|||
162100710|NCT03579563|585415796|FG001|Overall Study|Protocol administration error|0|||
162100711|NCT03579563|585415797|FG002|Overall Study|Protocol administration error|1|||
162100712|NCT03579563|585415798|FG003|Overall Study|Protocol administration error|0|||
162100713|NCT03579563|585415799|FG004|Overall Study|Protocol administration error|1|||
162100714|NCT03579563|585415800|FG005|Overall Study|Protocol administration error|5|||
162100715|NCT03621696|585415801|FG000|Overall Study|Not eligible|0|||
162100716|NCT03621696|585415802|FG001|Overall Study|Not eligible|0|||
162100717|NCT03621696|585415803|FG002|Overall Study|Not eligible|0|||
162100718|NCT03621696|585415804|FG003|Overall Study|Not eligible|5|||
162100719|NCT03621696|585415801|FG000|Overall Study|Withdrawal by Subject|1|||
162100720|NCT03621696|585415802|FG001|Overall Study|Withdrawal by Subject|1|||
162100721|NCT03621696|585415803|FG002|Overall Study|Withdrawal by Subject|1|||
162100722|NCT03621696|585415804|FG003|Overall Study|Withdrawal by Subject|0|||
162100723|NCT03621696|585415801|FG000|Overall Study|Physician Decision|0|||
162100724|NCT03621696|585415802|FG001|Overall Study|Physician Decision|0|||
162100725|NCT03621696|585415803|FG002|Overall Study|Physician Decision|1|||
162100726|NCT03621696|585415804|FG003|Overall Study|Physician Decision|0|||
162100727|NCT02663128|585415808|FG000|Period 2|Physician Decision|0|||
162100728|NCT02663128|585415809|FG001|Period 2|Physician Decision|0|||
162100729|NCT02663128|585415810|FG002|Period 2|Physician Decision|0|||
162100730|NCT02663128|585415811|FG003|Period 2|Physician Decision|0|||
162100731|NCT02663128|585415812|FG004|Period 2|Physician Decision|1|||
162100732|NCT02663128|585415813|FG005|Period 2|Physician Decision|0|||
162100733|NCT02720484|585415814|FG000|Treatment on Study|Adverse Event|1|||
162100734|NCT02720484|585415814|FG000|Treatment on Study|Withdrawal by Subject|1|||
162100735|NCT02720484|585415814|FG000|Treatment on Study|Progressive Disease|4|||
162100736|NCT02720484|585415814|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
162100737|NCT02720484|585415814|FG000|Follow Up for 2 Years|Death|3|||
162100738|NCT02720484|585415814|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
162100739|NCT05070897|585415815|FG000|Overall Study|Protocol Violation|123|||
162100740|NCT05070897|585415816|FG001|Overall Study|Protocol Violation|68|||
162100741|NCT01003249|585415819|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
162100742|NCT01003249|585415820|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
162100743|NCT01003249|585415819|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
162100744|NCT01003249|585415820|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
162100745|NCT01003249|585415819|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
162100746|NCT01003249|585415820|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
162100747|NCT01003249|585415819|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
162100748|NCT01003249|585415820|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
162100749|NCT01962974|585415823|FG000|Overall Study|Study termination|7|||
162100750|NCT02005471|585415830|FG000|Main Study|Adverse Event|0|||
162100751|NCT02005471|585415831|FG001|Main Study|Adverse Event|1|||
162100752|NCT02005471|585415832|FG002|Main Study|Adverse Event|0|||
162100753|NCT02005471|585415833|FG003|Main Study|Adverse Event|0|||
162100754|NCT02005471|585415830|FG000|Main Study|Death|83|||
162100755|NCT02005471|585415831|FG001|Main Study|Death|52|||
162100756|NCT02005471|585415832|FG002|Main Study|Death|0|||
162100757|NCT02005471|585415833|FG003|Main Study|Death|0|||
162100758|NCT02005471|585415830|FG000|Main Study|Lost to Follow-up|4|||
162100759|NCT02005471|585415831|FG001|Main Study|Lost to Follow-up|5|||
162100760|NCT02005471|585415832|FG002|Main Study|Lost to Follow-up|0|||
162100761|NCT02005471|585415833|FG003|Main Study|Lost to Follow-up|0|||
162100762|NCT02005471|585415830|FG000|Main Study|Physician Decision|3|||
162100763|NCT02005471|585415831|FG001|Main Study|Physician Decision|1|||
162100764|NCT02005471|585415832|FG002|Main Study|Physician Decision|0|||
162100765|NCT02005471|585415833|FG003|Main Study|Physician Decision|0|||
162100766|NCT02005471|585415830|FG000|Main Study|Withdrawal by Subject|26|||
162100767|NCT02005471|585415831|FG001|Main Study|Withdrawal by Subject|11|||
162100768|NCT02005471|585415832|FG002|Main Study|Withdrawal by Subject|0|||
162100769|NCT02005471|585415833|FG003|Main Study|Withdrawal by Subject|0|||
162100770|NCT02005471|585415830|FG000|Main Study|Reason not Specified|0|||
162100771|NCT02005471|585415831|FG001|Main Study|Reason not Specified|6|||
162100772|NCT02005471|585415832|FG002|Main Study|Reason not Specified|0|||
162100773|NCT02005471|585415833|FG003|Main Study|Reason not Specified|0|||
162100774|NCT02005471|585415830|FG000|Main Study|Randomized but not Dosed|8|||
162100775|NCT02005471|585415831|FG001|Main Study|Randomized but not Dosed|0|||
162100776|NCT02005471|585415832|FG002|Main Study|Randomized but not Dosed|0|||
162100777|NCT02005471|585415833|FG003|Main Study|Randomized but not Dosed|0|||
162100778|NCT02005471|585415830|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
162100779|NCT02005471|585415831|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
162100780|NCT02005471|585415832|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
162100781|NCT02005471|585415833|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
162100782|NCT02005471|585415830|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
162100783|NCT02005471|585415831|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
162100784|NCT02005471|585415832|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
162100785|NCT02005471|585415833|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
162100786|NCT02005471|585415830|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
162100787|NCT02005471|585415831|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
162100788|NCT02005471|585415832|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
162100789|NCT02005471|585415833|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
162100790|NCT00627705|585415835|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
162100791|NCT00627705|585415836|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
162100792|NCT00627705|585415835|FG000|Overall Study|Adverse Event|1|||
162100793|NCT00627705|585415836|FG001|Overall Study|Adverse Event|0|||
162100794|NCT00627705|585415835|FG000|Overall Study|Withdrawal by Subject|0|||
162100795|NCT00627705|585415836|FG001|Overall Study|Withdrawal by Subject|2|||
162100796|NCT00627705|585415835|FG000|Overall Study|Lost to Follow-up|0|||
162100797|NCT00627705|585415836|FG001|Overall Study|Lost to Follow-up|1|||
162100798|NCT02535065|585415839|FG000|Overall Study|Death|13|||
162100799|NCT02535065|585415839|FG000|Overall Study|Lost to Follow-up|1|||
162100800|NCT02535065|585415839|FG000|Overall Study|Withdrawal by Subject|6|||
162100801|NCT03712917|585415840|FG000|Overall Study|Pregnancy|0|||
162100802|NCT03712917|585415841|FG001|Overall Study|Pregnancy|0|||
162100803|NCT03712917|585415842|FG002|Overall Study|Pregnancy|1|||
162100804|NCT03712917|585415840|FG000|Overall Study|Adverse Event|0|||
162100805|NCT03712917|585415841|FG001|Overall Study|Adverse Event|4|||
162100806|NCT03712917|585415842|FG002|Overall Study|Adverse Event|3|||
162100807|NCT03712917|585415840|FG000|Overall Study|Lost to Follow-up|9|||
162100808|NCT03712917|585415841|FG001|Overall Study|Lost to Follow-up|4|||
162100809|NCT03712917|585415842|FG002|Overall Study|Lost to Follow-up|5|||
162100810|NCT00110617|585415843|FG000|Overall Study|Adverse Event|2|||
162100811|NCT00110617|585415844|FG001|Overall Study|Adverse Event|4|||
162100812|NCT00110617|585415843|FG000|Overall Study|Abnormal Laboratory Value|4|||
162100813|NCT00110617|585415844|FG001|Overall Study|Abnormal Laboratory Value|2|||
162100814|NCT00110617|585415843|FG000|Overall Study|Lack of Efficacy|1|||
162100815|NCT00110617|585415844|FG001|Overall Study|Lack of Efficacy|0|||
162100816|NCT00110617|585415843|FG000|Overall Study|Patient no longer requires study drug|1|||
162100817|NCT00110617|585415844|FG001|Overall Study|Patient no longer requires study drug|0|||
162100818|NCT00110617|585415843|FG000|Overall Study|Protocol Violation|5|||
162100819|NCT00110617|585415844|FG001|Overall Study|Protocol Violation|0|||
162100820|NCT00110617|585415843|FG000|Overall Study|Withdrawal by Subject|10|||
162100821|NCT00110617|585415844|FG001|Overall Study|Withdrawal by Subject|4|||
162100822|NCT00110617|585415843|FG000|Overall Study|Lost to Follow-up|9|||
162100823|NCT00110617|585415844|FG001|Overall Study|Lost to Follow-up|1|||
162100824|NCT00110617|585415843|FG000|Overall Study|Administrative problems|6|||
162100825|NCT00110617|585415844|FG001|Overall Study|Administrative problems|5|||
162100826|NCT00110617|585415843|FG000|Overall Study|Death|1|||
162100827|NCT00110617|585415844|FG001|Overall Study|Death|1|||
162100828|NCT00110617|585415843|FG000|Overall Study|Did not receive study drug|0|||
162100829|NCT00110617|585415844|FG001|Overall Study|Did not receive study drug|12|||
162100830|NCT04764396|585415845|FG000|Overall Study|Physician Decision|1|||
162100831|NCT04764396|585415846|FG001|Overall Study|Physician Decision|0|||
162100832|NCT03230916|585415848|FG000|Overall Study|Withdrawal by Subject|0|||
162100833|NCT03230916|585415849|FG001|Overall Study|Withdrawal by Subject|0|||
162100834|NCT03230916|585415850|FG002|Overall Study|Withdrawal by Subject|0|||
162100835|NCT03230916|585415851|FG003|Overall Study|Withdrawal by Subject|0|||
162100836|NCT03230916|585415852|FG004|Overall Study|Withdrawal by Subject|0|||
162100837|NCT03230916|585415853|FG005|Overall Study|Withdrawal by Subject|1|||
162100838|NCT03230916|585415854|FG006|Overall Study|Withdrawal by Subject|0|||
162100839|NCT03230916|585415855|FG007|Overall Study|Withdrawal by Subject|0|||
162100840|NCT03230916|585415856|FG008|Overall Study|Withdrawal by Subject|0|||
162100841|NCT03230916|585415857|FG009|Overall Study|Withdrawal by Subject|0|||
162100842|NCT03230916|585415858|FG010|Overall Study|Withdrawal by Subject|0|||
162100843|NCT01438541|585415861|FG000|Overall Study|Physician Decision|1|||
162100844|NCT01438541|585415861|FG000|Overall Study|Withdrawal by Subject|1|||
162100845|NCT01438541|585415861|FG000|Overall Study|discharge from the hospital|5|||
162100846|NCT02091167|585415862|FG000|Overall Study|Lost to Follow-up|0|||
162100847|NCT02091167|585415863|FG001|Overall Study|Lost to Follow-up|2|||
162100848|NCT01218646|585415864|FG000|Overall Study|Adverse Event|0|||
162100849|NCT01218646|585415865|FG001|Overall Study|Adverse Event|0|||
162100850|NCT01218646|585415866|FG002|Overall Study|Adverse Event|1|||
162100851|NCT01218646|585415867|FG003|Overall Study|Adverse Event|0|||
162100852|NCT01218646|585415864|FG000|Overall Study|Lost to Follow-up|1|||
162100853|NCT01218646|585415865|FG001|Overall Study|Lost to Follow-up|0|||
162100854|NCT01218646|585415866|FG002|Overall Study|Lost to Follow-up|0|||
162100855|NCT01218646|585415867|FG003|Overall Study|Lost to Follow-up|0|||
162100856|NCT01218646|585415864|FG000|Overall Study|Protocol Violation|0|||
162100857|NCT01218646|585415865|FG001|Overall Study|Protocol Violation|0|||
162100858|NCT01218646|585415866|FG002|Overall Study|Protocol Violation|1|||
162100859|NCT01218646|585415867|FG003|Overall Study|Protocol Violation|1|||
162100860|NCT00722761|585415868|FG000|Overall Study|Lost to Follow-up|1|||
162100861|NCT00722761|585415869|FG001|Overall Study|Lost to Follow-up|4|||
162100862|NCT00722761|585415868|FG000|Overall Study|Withdrawal by Subject|5|||
162100863|NCT00722761|585415869|FG001|Overall Study|Withdrawal by Subject|2|||
162100864|NCT02693665|585415875|FG000|Overall Study|Death|3|||
162100865|NCT02693665|585415876|FG001|Overall Study|Death|2|||
162100866|NCT02693665|585415875|FG000|Overall Study|Lost to Follow-up|7|||
162100867|NCT02693665|585415876|FG001|Overall Study|Lost to Follow-up|3|||
162100868|NCT02693665|585415875|FG000|Overall Study|Protocol Violation|1|||
162100869|NCT02693665|585415876|FG001|Overall Study|Protocol Violation|0|||
162100870|NCT02693665|585415875|FG000|Overall Study|Withdrawal by Subject|2|||
162100871|NCT02693665|585415876|FG001|Overall Study|Withdrawal by Subject|0|||
162100872|NCT02693665|585415875|FG000|Overall Study|patient wanted to leave it behind|1|||
162100873|NCT02693665|585415876|FG001|Overall Study|patient wanted to leave it behind|0|||
162100874|NCT02693665|585415875|FG000|Overall Study|anxiety|1|||
162100875|NCT02693665|585415876|FG001|Overall Study|anxiety|0|||
162100876|NCT02693665|585415875|FG000|Overall Study|family issues|1|||
162100877|NCT02693665|585415876|FG001|Overall Study|family issues|0|||
162100878|NCT02693665|585415875|FG000|Overall Study|no reason given|1|||
162100879|NCT02693665|585415876|FG001|Overall Study|no reason given|0|||
162100880|NCT03156023|585415877|FG000|Overall Study|Withdrawal by Subject|1|||
162100881|NCT03156023|585415878|FG001|Overall Study|Withdrawal by Subject|0|||
162100882|NCT03156023|585415879|FG002|Overall Study|Withdrawal by Subject|2|||
162100883|NCT03156023|585415880|FG003|Overall Study|Withdrawal by Subject|1|||
162100884|NCT03156023|585415881|FG004|Overall Study|Withdrawal by Subject|1|||
162100885|NCT03156023|585415877|FG000|Overall Study|Lost to Follow-up|0|||
162100886|NCT03156023|585415878|FG001|Overall Study|Lost to Follow-up|0|||
162100887|NCT03156023|585415879|FG002|Overall Study|Lost to Follow-up|0|||
162100888|NCT03156023|585415880|FG003|Overall Study|Lost to Follow-up|0|||
162100889|NCT03156023|585415881|FG004|Overall Study|Lost to Follow-up|1|||
162100890|NCT03069482|585418700|FG000|Overall Study|Lost to Follow-up|0|||
162100891|NCT03069482|585418701|FG001|Overall Study|Lost to Follow-up|1|||
162100892|NCT03069482|585418700|FG000|Overall Study|Physician Decision|1|||
162100893|NCT03069482|585418701|FG001|Overall Study|Physician Decision|0|||
162100894|NCT01949311|585418709|FG000|Overall Study|Lost to Follow-up|73|||
162100895|NCT01949311|585418709|FG000|Overall Study|Terminated by Sponsor|708|||
162100896|NCT01949311|585418709|FG000|Overall Study|Withdrawal by Subject|375|||
162100897|NCT01949311|585418709|FG000|Overall Study|Lack of Efficacy|50|||
162100898|NCT01949311|585418709|FG000|Overall Study|Protocol Deviation|34|||
162100899|NCT01949311|585418709|FG000|Overall Study|Pregnancy|20|||
162100900|NCT01949311|585418709|FG000|Overall Study|Physician Decision|9|||
162100901|NCT01949311|585418709|FG000|Overall Study|Other|4|||
162100902|NCT01949311|585418709|FG000|Overall Study|Adverse Event|107|||
162100903|NCT01559844|585418714|FG000|Overall Study|Consent Withdrawn|7|||
162100904|NCT01559844|585418714|FG000|Overall Study|Death|5|||
162100905|NCT01559844|585418714|FG000|Overall Study|Efficacy Failure|10|||
162100906|NCT01559844|585418714|FG000|Overall Study|No Longer A Transplant Candidate|3|||
162100907|NCT00951041|585418716|FG000|Overall Study|Withdrawal by Subject|1|||
162100908|NCT00951041|585418717|FG001|Overall Study|Withdrawal by Subject|1|||
162100909|NCT00951041|585418716|FG000|Overall Study|Lost to Follow-up|1|||
162100910|NCT00951041|585418717|FG001|Overall Study|Lost to Follow-up|0|||
162100911|NCT00951041|585418716|FG000|Overall Study|Other|3|||
162100912|NCT00951041|585418717|FG001|Overall Study|Other|0|||
162100913|NCT02388724|585418720|FG000|Overall Study|Reason not Specified|0|||
162100914|NCT02388724|585418721|FG001|Overall Study|Reason not Specified|1|||
162100915|NCT02388724|585418720|FG000|Overall Study|Major Protocol Deviation|3|||
162100916|NCT02388724|585418721|FG001|Overall Study|Major Protocol Deviation|3|||
162100917|NCT02388724|585418720|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
162100918|NCT02388724|585418721|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
162100919|NCT02388724|585418720|FG000|Overall Study|Voluntary Withdrawal|6|||
162100920|NCT02388724|585418721|FG001|Overall Study|Voluntary Withdrawal|5|||
162100921|NCT02388724|585418720|FG000|Overall Study|Randomized but not Treated|0|||
162100922|NCT02388724|585418721|FG001|Overall Study|Randomized but not Treated|2|||
162100923|NCT02047045|585418722|FG000|Baseline|Withdrawal by Subject|3|||
162100924|NCT02047045|585418723|FG001|Baseline|Withdrawal by Subject|2|||
162100925|NCT02047045|585418722|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
162100926|NCT02047045|585418723|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
162100927|NCT02047045|585418722|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
162100928|NCT02047045|585418723|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
162100929|NCT02047045|585418722|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
162100930|NCT02047045|585418723|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
162100931|NCT02047045|585418722|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
162100932|NCT02047045|585418723|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
162100933|NCT02047045|585418722|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
162100934|NCT02047045|585418723|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
162100935|NCT02047045|585418722|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
162100936|NCT02047045|585418723|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
162100937|NCT02047045|585418722|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
162100938|NCT02047045|585418723|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
162100939|NCT02047045|585418722|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
162100940|NCT02047045|585418723|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
162100941|NCT04066114|585418724|FG000|Overall Study|Adverse Event|1|||
162100942|NCT04066114|585418725|FG001|Overall Study|Adverse Event|0|||
162100943|NCT04066114|585418726|FG002|Overall Study|Adverse Event|0|||
162100944|NCT04066114|585418724|FG000|Overall Study|Withdrawal by Subject|1|||
162100945|NCT04066114|585418725|FG001|Overall Study|Withdrawal by Subject|0|||
162100946|NCT04066114|585418726|FG002|Overall Study|Withdrawal by Subject|0|||
162100947|NCT04066114|585418724|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
162100948|NCT04066114|585418725|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
162100949|NCT04066114|585418726|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
162100950|NCT02277106|585418727|FG000|Stage 2|Adverse Event|0|||
162100951|NCT02277106|585418728|FG001|Stage 2|Adverse Event|0|||
162100952|NCT02277106|585418729|FG002|Stage 2|Adverse Event|1|||
162100953|NCT01064739|585418730|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
162100954|NCT02479412|585418731|FG000|Overall Study|Adverse Event|0|||
162100955|NCT02479412|585418732|FG001|Overall Study|Adverse Event|0|||
162100956|NCT02479412|585418733|FG002|Overall Study|Adverse Event|1|||
162100957|NCT02479412|585418734|FG003|Overall Study|Adverse Event|0|||
162100958|NCT02479412|585418735|FG004|Overall Study|Adverse Event|0|||
162100959|NCT02479412|585418736|FG005|Overall Study|Adverse Event|0|||
162100960|NCT02479412|585418737|FG006|Overall Study|Adverse Event|0|||
162100961|NCT02479412|585418738|FG007|Overall Study|Adverse Event|0|||
162100962|NCT02479412|585418739|FG008|Overall Study|Adverse Event|0|||
162100963|NCT02479412|585418731|FG000|Overall Study|Study-specific withdrawal criteria|0|||
162100964|NCT02479412|585418732|FG001|Overall Study|Study-specific withdrawal criteria|0|||
162100965|NCT02479412|585418733|FG002|Overall Study|Study-specific withdrawal criteria|1|||
162100966|NCT02479412|585418734|FG003|Overall Study|Study-specific withdrawal criteria|1|||
162100967|NCT02479412|585418735|FG004|Overall Study|Study-specific withdrawal criteria|0|||
162100968|NCT02479412|585418736|FG005|Overall Study|Study-specific withdrawal criteria|0|||
162100969|NCT02479412|585418737|FG006|Overall Study|Study-specific withdrawal criteria|0|||
162100970|NCT02479412|585418738|FG007|Overall Study|Study-specific withdrawal criteria|1|||
162100971|NCT02479412|585418739|FG008|Overall Study|Study-specific withdrawal criteria|1|||
162100972|NCT02479412|585418731|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
162100973|NCT02479412|585418732|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
162100974|NCT02479412|585418733|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
162100975|NCT02479412|585418734|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
162100976|NCT02479412|585418735|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
162100977|NCT02479412|585418736|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
162100978|NCT02479412|585418737|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
162100979|NCT02479412|585418738|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
162100980|NCT02479412|585418739|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
162100981|NCT00454051|585418740|FG000|Overall Study|Adverse Event|1|||
162100982|NCT00454051|585418741|FG001|Overall Study|Adverse Event|2|||
162100983|NCT00454051|585418740|FG000|Overall Study|Withdrawal by Subject|1|||
162100984|NCT00454051|585418741|FG001|Overall Study|Withdrawal by Subject|0|||
162100985|NCT00454051|585418740|FG000|Overall Study|Protocol Violation|1|||
162100986|NCT00454051|585418741|FG001|Overall Study|Protocol Violation|1|||
162100987|NCT01571362|585418742|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
162100988|NCT01571362|585418743|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
162100989|NCT01571362|585418744|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
162100990|NCT01571362|585418742|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
162100991|NCT01571362|585418743|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
162100992|NCT01571362|585418744|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
162100993|NCT01571362|585418742|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
162100994|NCT01571362|585418743|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
162100995|NCT01571362|585418744|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
162100996|NCT01571362|585418742|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
162100997|NCT01571362|585418743|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
162100998|NCT01571362|585418744|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
162100999|NCT01571362|585418742|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
162101000|NCT01571362|585418743|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
162101001|NCT01571362|585418744|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
162101002|NCT01571362|585418742|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
162101003|NCT01571362|585418743|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
162101004|NCT01571362|585418744|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
162101005|NCT01571362|585418742|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
162101006|NCT01571362|585418743|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
162101007|NCT01571362|585418744|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
162101008|NCT01571362|585418742|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
162101009|NCT01571362|585418743|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
162101010|NCT01571362|585418744|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
162101011|NCT01571362|585418742|FG000|Double-Blind Treatment Period|Adverse Event|0|||
162101012|NCT01571362|585418743|FG001|Double-Blind Treatment Period|Adverse Event|9|||
162101013|NCT01571362|585418744|FG002|Double-Blind Treatment Period|Adverse Event|14|||
162101014|NCT01571362|585418742|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162101015|NCT01571362|585418743|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
162101016|NCT01571362|585418744|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
162101017|NCT01571362|585418742|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
162101018|NCT01571362|585418743|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
162101019|NCT01571362|585418744|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
162101020|NCT01571362|585418742|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
162101021|NCT01571362|585418743|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
162101022|NCT01571362|585418744|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
162101023|NCT04258020|585418745|FG000|Overall Study|Withdrawal by Subject|1|||
162101024|NCT04258020|585418746|FG001|Overall Study|Withdrawal by Subject|0|||
162101025|NCT02097472|585418749|FG000|Received Vaccination 2|Adverse Event|0|||
162101026|NCT02097472|585418750|FG001|Received Vaccination 2|Adverse Event|0|||
162101027|NCT02097472|585418751|FG002|Received Vaccination 2|Adverse Event|0|||
162101028|NCT02097472|585418752|FG003|Received Vaccination 2|Adverse Event|0|||
162101029|NCT02097472|585418753|FG004|Received Vaccination 2|Adverse Event|0|||
162101030|NCT02097472|585418754|FG005|Received Vaccination 2|Adverse Event|0|||
162101031|NCT02097472|585418755|FG006|Received Vaccination 2|Adverse Event|1|||
162101032|NCT02097472|585418756|FG007|Received Vaccination 2|Adverse Event|0|||
162101033|NCT03117738|585418757|FG000|Overall Study|Withdrawal by Subject|3|||
162101034|NCT03117738|585418758|FG001|Overall Study|Withdrawal by Subject|1|||
162101035|NCT03117738|585418757|FG000|Overall Study|Lost to Follow-up|1|||
162101036|NCT03117738|585418758|FG001|Overall Study|Lost to Follow-up|4|||
162101037|NCT01669629|585418759|FG000|Period 1|protocol deviation|1|||
162101038|NCT01669629|585418760|FG001|Period 1|protocol deviation|2|||
162101039|NCT04402866|585418763|FG000|Overall Study|Discontinued Prior to Treatment|0|||
162101040|NCT04402866|585418764|FG001|Overall Study|Discontinued Prior to Treatment|0|||
162101041|NCT04402866|585418765|FG002|Overall Study|Discontinued Prior to Treatment|0|||
162101042|NCT04402866|585418766|FG003|Overall Study|Discontinued Prior to Treatment|0|||
162101043|NCT04402866|585418767|FG004|Overall Study|Discontinued Prior to Treatment|2|||
162101044|NCT04402866|585418768|FG005|Overall Study|Discontinued Prior to Treatment|3|||
162101045|NCT04402866|585418763|FG000|Overall Study|Adverse Event|2|||
162101046|NCT04402866|585418764|FG001|Overall Study|Adverse Event|1|||
162101047|NCT04402866|585418765|FG002|Overall Study|Adverse Event|0|||
162101048|NCT04402866|585418766|FG003|Overall Study|Adverse Event|0|||
162101049|NCT04402866|585418767|FG004|Overall Study|Adverse Event|13|||
162101050|NCT04402866|585418768|FG005|Overall Study|Adverse Event|8|||
162101051|NCT04402866|585418763|FG000|Overall Study|Miscellaneous|0|||
162101052|NCT04402866|585418764|FG001|Overall Study|Miscellaneous|0|||
162101053|NCT04402866|585418765|FG002|Overall Study|Miscellaneous|1|||
162101054|NCT04402866|585418766|FG003|Overall Study|Miscellaneous|0|||
162101055|NCT04402866|585418767|FG004|Overall Study|Miscellaneous|0|||
162101056|NCT04402866|585418768|FG005|Overall Study|Miscellaneous|0|||
162101057|NCT04402866|585418763|FG000|Overall Study|Lost to Follow-up|0|||
162101058|NCT04402866|585418764|FG001|Overall Study|Lost to Follow-up|0|||
162101059|NCT04402866|585418765|FG002|Overall Study|Lost to Follow-up|0|||
162101060|NCT04402866|585418766|FG003|Overall Study|Lost to Follow-up|0|||
162101061|NCT04402866|585418767|FG004|Overall Study|Lost to Follow-up|0|||
162101062|NCT04402866|585418768|FG005|Overall Study|Lost to Follow-up|1|||
162101063|NCT04402866|585418763|FG000|Overall Study|Withdrawal by Subject|0|||
162101064|NCT04402866|585418764|FG001|Overall Study|Withdrawal by Subject|0|||
162101065|NCT04402866|585418765|FG002|Overall Study|Withdrawal by Subject|0|||
162101066|NCT04402866|585418766|FG003|Overall Study|Withdrawal by Subject|0|||
162101067|NCT04402866|585418767|FG004|Overall Study|Withdrawal by Subject|0|||
162101068|NCT04402866|585418768|FG005|Overall Study|Withdrawal by Subject|2|||
162101069|NCT03667053|585418769|FG000|Overall Study|Withdrawal by Subject|1|||
162101070|NCT03667053|585418770|FG001|Overall Study|Withdrawal by Subject|0|||
162101071|NCT03667053|585418771|FG002|Overall Study|Withdrawal by Subject|0|||
162101072|NCT01292928|585418773|FG000|Overall Study|Death|8|||
162101073|NCT01292928|585418773|FG000|Overall Study|Withdrawal by Subject|8|||
162101074|NCT01292928|585418773|FG000|Overall Study|Lost to Follow-up|6|||
162101075|NCT01292928|585418773|FG000|Overall Study|Physician Decision|2|||
162101076|NCT00130533|585418774|FG000|Overall Study|Withdrawal by Subject|33|||
162101077|NCT00130533|585418775|FG001|Overall Study|Withdrawal by Subject|6|||
162101078|NCT00130533|585418774|FG000|Overall Study|Adverse Event|34|||
162101079|NCT00130533|585418775|FG001|Overall Study|Adverse Event|1|||
162101080|NCT00130533|585418774|FG000|Overall Study|Disease relapse|9|||
162101081|NCT00130533|585418775|FG001|Overall Study|Disease relapse|13|||
162101082|NCT00130533|585418774|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
162101083|NCT00130533|585418775|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
162101084|NCT00130533|585418774|FG000|Overall Study|Death|4|||
162101085|NCT00130533|585418775|FG001|Overall Study|Death|2|||
162101086|NCT00130533|585418774|FG000|Overall Study|Protocol Violation|5|||
162101087|NCT00130533|585418775|FG001|Overall Study|Protocol Violation|1|||
162101088|NCT00130533|585418774|FG000|Overall Study|Lost to Follow-up|1|||
162101089|NCT00130533|585418775|FG001|Overall Study|Lost to Follow-up|1|||
162101090|NCT00130533|585418774|FG000|Overall Study|Sponsor´s decision|2|||
162101091|NCT00130533|585418775|FG001|Overall Study|Sponsor´s decision|0|||
162101092|NCT00130533|585418774|FG000|Overall Study|Second Primary Malignancy|0|||
162101093|NCT00130533|585418775|FG001|Overall Study|Second Primary Malignancy|1|||
162101094|NCT00130533|585418774|FG000|Overall Study|Other|12|||
162101095|NCT00130533|585418775|FG001|Overall Study|Other|5|||
162101096|NCT01059565|585418776|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
162101097|NCT01059565|585418777|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
162101098|NCT01059565|585418776|FG000|24-Week Randomized Phase|Adverse Event|5|||
162101099|NCT01059565|585418777|FG001|24-Week Randomized Phase|Adverse Event|0|||
162101100|NCT01059565|585418776|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
162101101|NCT01059565|585418777|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
162101102|NCT01059565|585418776|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
162101103|NCT01059565|585418777|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
162101104|NCT01059565|585418776|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
162101105|NCT01059565|585418777|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
162101106|NCT01059565|585418776|FG000|24-Week Open-Label Phase|Adverse Event|2|||
162101107|NCT01059565|585418777|FG001|24-Week Open-Label Phase|Adverse Event|0|||
162101108|NCT01059565|585418776|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
162101109|NCT01059565|585418777|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
162101110|NCT01059565|585418776|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
162101111|NCT01059565|585418777|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
162101112|NCT01059565|585418776|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
162101113|NCT01059565|585418777|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
162101114|NCT01059565|585418776|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
162101115|NCT01059565|585418777|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
162101116|NCT01059565|585418776|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
162101117|NCT01059565|585418777|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
162101118|NCT02732938|585418778|FG000|Overall Study|Death|0|||
162101119|NCT02732938|585418779|FG001|Overall Study|Death|11|||
162101120|NCT02732938|585418780|FG002|Overall Study|Death|0|||
162101121|NCT02732938|585418778|FG000|Overall Study|Randomized but did not receive treatment|0|||
162101122|NCT02732938|585418779|FG001|Overall Study|Randomized but did not receive treatment|1|||
162101123|NCT02732938|585418780|FG002|Overall Study|Randomized but did not receive treatment|0|||
162101124|NCT02732938|585418778|FG000|Overall Study|Refused further follow-up|1|||
162101125|NCT02732938|585418779|FG001|Overall Study|Refused further follow-up|0|||
162101126|NCT02732938|585418780|FG002|Overall Study|Refused further follow-up|0|||
162101127|NCT02732938|585418778|FG000|Overall Study|Study terminated by sponsor|3|||
162101128|NCT02732938|585418779|FG001|Overall Study|Study terminated by sponsor|6|||
162101129|NCT02732938|585418780|FG002|Overall Study|Study terminated by sponsor|0|||
162101130|NCT01026974|585418791|FG000|Overall Study|Withdrawal by Subject|0|||
162101131|NCT01026974|585418792|FG001|Overall Study|Withdrawal by Subject|1|||
162101132|NCT01026974|585418793|FG002|Overall Study|Withdrawal by Subject|7|||
162101133|NCT01026974|585418794|FG003|Overall Study|Withdrawal by Subject|2|||
162101134|NCT01026974|585418791|FG000|Overall Study|Lost to Follow-up|1|||
162101135|NCT01026974|585418792|FG001|Overall Study|Lost to Follow-up|1|||
162101136|NCT01026974|585418793|FG002|Overall Study|Lost to Follow-up|4|||
162101137|NCT01026974|585418794|FG003|Overall Study|Lost to Follow-up|0|||
162101138|NCT01026974|585418791|FG000|Overall Study|Adverse Event|0|||
162101139|NCT01026974|585418792|FG001|Overall Study|Adverse Event|0|||
162101140|NCT01026974|585418793|FG002|Overall Study|Adverse Event|0|||
162101141|NCT01026974|585418794|FG003|Overall Study|Adverse Event|1|||
162101142|NCT01026974|585418791|FG000|Overall Study|Inappropriate enrollment|0|||
162101143|NCT01026974|585418792|FG001|Overall Study|Inappropriate enrollment|0|||
162101144|NCT01026974|585418793|FG002|Overall Study|Inappropriate enrollment|1|||
162101145|NCT01026974|585418794|FG003|Overall Study|Inappropriate enrollment|0|||
162101146|NCT02864082|585418801|FG000|Overall Study|Adverse Event|1|||
162101147|NCT02864082|585418802|FG001|Overall Study|Adverse Event|1|||
162101148|NCT02864082|585418801|FG000|Overall Study|Lost to Follow-up|0|||
162101149|NCT02864082|585418802|FG001|Overall Study|Lost to Follow-up|1|||
162101150|NCT02864082|585418801|FG000|Overall Study|Withdrawal by Subject|2|||
162101151|NCT02864082|585418802|FG001|Overall Study|Withdrawal by Subject|2|||
162101152|NCT05545072|585418810|FG000|Overall Study|Lost to Follow-up|1|||
162101153|NCT05545072|585418811|FG001|Overall Study|Lost to Follow-up|0|||
162101154|NCT05545072|585418810|FG000|Overall Study|Study ended prematurely due to funding|2|||
162101155|NCT05545072|585418811|FG001|Overall Study|Study ended prematurely due to funding|2|||
162101156|NCT03996473|585418812|FG000|Treatment Assignment|Withdrawal by Subject|1|||
162101157|NCT03996473|585418812|FG000|Treatment Assignment|Progressive disease|6|||
162101158|NCT03996473|585418812|FG000|Treatment Assignment|Study drug never administered|1|||
162101159|NCT03996473|585418812|FG000|Active Follow-up|Death|1|||
162101160|NCT03996473|585418812|FG000|Long-term Follow-up|Death|5|||
162101161|NCT03759873|585418813|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
162101162|NCT03759873|585418814|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
162101163|NCT03759873|585418815|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
162101164|NCT03759873|585418816|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
162101165|NCT03759873|585418813|FG000|Overall Study|Moved outside eligible area|0|||
162101166|NCT03759873|585418814|FG001|Overall Study|Moved outside eligible area|2|||
162101167|NCT03759873|585418815|FG002|Overall Study|Moved outside eligible area|0|||
162101168|NCT03759873|585418816|FG003|Overall Study|Moved outside eligible area|0|||
162101169|NCT03759873|585418813|FG000|Overall Study|Withdrawal by Subject|0|||
162101170|NCT03759873|585418814|FG001|Overall Study|Withdrawal by Subject|0|||
162101171|NCT03759873|585418815|FG002|Overall Study|Withdrawal by Subject|1|||
162101172|NCT03759873|585418816|FG003|Overall Study|Withdrawal by Subject|0|||
162101173|NCT04349553|585418819|FG000|Overall Study|Withdrawal by Subject|1|||
162101174|NCT04349553|585418820|FG001|Overall Study|Withdrawal by Subject|0|||
162101175|NCT04349553|585418821|FG002|Overall Study|Withdrawal by Subject|1|||
162101176|NCT04349553|585418822|FG003|Overall Study|Withdrawal by Subject|0|||
162101177|NCT01869491|585418825|FG000|Overall Study|Adverse Event|3|||
162101178|NCT01869491|585418826|FG001|Overall Study|Adverse Event|5|||
162101179|NCT01869491|585418825|FG000|Overall Study|Lack of Efficacy|0|||
162101180|NCT01869491|585418826|FG001|Overall Study|Lack of Efficacy|3|||
162101181|NCT01869491|585418825|FG000|Overall Study|Withdrawal by Subject|6|||
162101182|NCT01869491|585418826|FG001|Overall Study|Withdrawal by Subject|7|||
162101183|NCT01869491|585418825|FG000|Overall Study|Lost to Follow-up|11|||
162101184|NCT01869491|585418826|FG001|Overall Study|Lost to Follow-up|9|||
162101185|NCT01869491|585418825|FG000|Overall Study|No further need of investigational product|1|||
162101186|NCT01869491|585418826|FG001|Overall Study|No further need of investigational product|0|||
162101187|NCT05177770|585418827|FG000|Overall Study|Death|4|||
162101188|NCT05177770|585418827|FG000|Overall Study|Withdrawal by Subject|1|||
162101189|NCT05177770|585418827|FG000|Overall Study|Adverse Event prior to dosing|1|||
162101190|NCT00214136|585418831|FG000|Overall Study|Death|5|||
162101191|NCT01272934|585418832|FG000|Overall Study|Adverse Event|0|||
162101192|NCT01272934|585418833|FG001|Overall Study|Adverse Event|1|||
162101193|NCT01272934|585418832|FG000|Overall Study|Abnormal Laboratory Value|0|||
162101194|NCT01272934|585418833|FG001|Overall Study|Abnormal Laboratory Value|1|||
162101195|NCT04313634|585418834|FG000|Overall Study|Adverse Event|2|||
162101196|NCT04313634|585418835|FG001|Overall Study|Adverse Event|2|||
162101197|NCT04313634|585418836|FG002|Overall Study|Adverse Event|0|||
162101198|NCT04313634|585418834|FG000|Overall Study|Withdrawal by Subject|1|||
162101199|NCT04313634|585418835|FG001|Overall Study|Withdrawal by Subject|0|||
162101200|NCT04313634|585418836|FG002|Overall Study|Withdrawal by Subject|1|||
162101201|NCT04313634|585418834|FG000|Overall Study|Protocol Violation|0|||
162101202|NCT04313634|585418835|FG001|Overall Study|Protocol Violation|0|||
162101203|NCT04313634|585418836|FG002|Overall Study|Protocol Violation|1|||
162101204|NCT00319098|585418839|FG000|Overall Study|Serious adverse event|3|||
162101205|NCT00319098|585418840|FG001|Overall Study|Serious adverse event|0|||
162101206|NCT00319098|585418839|FG000|Overall Study|Adverse Event|20|||
162101207|NCT00319098|585418840|FG001|Overall Study|Adverse Event|1|||
162101208|NCT00319098|585418839|FG000|Overall Study|Withdrawal by Subject|37|||
162101209|NCT00319098|585418840|FG001|Overall Study|Withdrawal by Subject|8|||
162101210|NCT00319098|585418839|FG000|Overall Study|Migrated/moved from study area|2|||
162101211|NCT00319098|585418840|FG001|Overall Study|Migrated/moved from study area|1|||
162101212|NCT00319098|585418839|FG000|Overall Study|Lost to Follow-up|37|||
162101213|NCT00319098|585418840|FG001|Overall Study|Lost to Follow-up|13|||
162101214|NCT00319098|585418839|FG000|Overall Study|Others|33|||
162101215|NCT00319098|585418840|FG001|Overall Study|Others|8|||
162101216|NCT00319098|585418839|FG000|Overall Study|Protocol Violation|3|||
162101217|NCT00319098|585418840|FG001|Overall Study|Protocol Violation|1|||
162101218|NCT03449030|585418841|FG000|Overall Study|Withdrawal by Subject|0|||
162101219|NCT03449030|585418842|FG001|Overall Study|Withdrawal by Subject|0|||
162101220|NCT03449030|585418843|FG002|Overall Study|Withdrawal by Subject|0|||
162101221|NCT03449030|585418844|FG003|Overall Study|Withdrawal by Subject|1|||
162101222|NCT03449030|585418845|FG004|Overall Study|Withdrawal by Subject|1|||
162101223|NCT03449030|585418846|FG005|Overall Study|Withdrawal by Subject|1|||
162101224|NCT03449030|585418847|FG006|Overall Study|Withdrawal by Subject|1|||
162101225|NCT03449030|585418848|FG007|Overall Study|Withdrawal by Subject|2|||
162101226|NCT03449030|585418849|FG008|Overall Study|Withdrawal by Subject|0|||
162101227|NCT03449030|585418850|FG009|Overall Study|Withdrawal by Subject|0|||
162101228|NCT03449030|585418841|FG000|Overall Study|Symptomatic Deterioration|0|||
162101229|NCT03449030|585418842|FG001|Overall Study|Symptomatic Deterioration|1|||
162101230|NCT03449030|585418843|FG002|Overall Study|Symptomatic Deterioration|0|||
162101231|NCT03449030|585418844|FG003|Overall Study|Symptomatic Deterioration|0|||
162101232|NCT03449030|585418845|FG004|Overall Study|Symptomatic Deterioration|0|||
162101233|NCT03449030|585418846|FG005|Overall Study|Symptomatic Deterioration|1|||
162101234|NCT03449030|585418847|FG006|Overall Study|Symptomatic Deterioration|1|||
162101235|NCT03449030|585418848|FG007|Overall Study|Symptomatic Deterioration|0|||
162101236|NCT03449030|585418849|FG008|Overall Study|Symptomatic Deterioration|2|||
162101237|NCT03449030|585418850|FG009|Overall Study|Symptomatic Deterioration|0|||
162101238|NCT03449030|585418841|FG000|Overall Study|Progressive Disease|1|||
162101239|NCT03449030|585418842|FG001|Overall Study|Progressive Disease|0|||
162101240|NCT03449030|585418843|FG002|Overall Study|Progressive Disease|1|||
162101241|NCT03449030|585418844|FG003|Overall Study|Progressive Disease|4|||
162101242|NCT03449030|585418845|FG004|Overall Study|Progressive Disease|5|||
162101243|NCT03449030|585418846|FG005|Overall Study|Progressive Disease|3|||
162101244|NCT03449030|585418847|FG006|Overall Study|Progressive Disease|0|||
162101245|NCT03449030|585418848|FG007|Overall Study|Progressive Disease|1|||
162101246|NCT03449030|585418849|FG008|Overall Study|Progressive Disease|1|||
162101247|NCT03449030|585418850|FG009|Overall Study|Progressive Disease|1|||
162101248|NCT03449030|585418841|FG000|Overall Study|Adverse Event|0|||
162101249|NCT03449030|585418842|FG001|Overall Study|Adverse Event|0|||
162101250|NCT03449030|585418843|FG002|Overall Study|Adverse Event|0|||
162101251|NCT03449030|585418844|FG003|Overall Study|Adverse Event|0|||
162101252|NCT03449030|585418845|FG004|Overall Study|Adverse Event|0|||
162101253|NCT03449030|585418846|FG005|Overall Study|Adverse Event|2|||
162101254|NCT03449030|585418847|FG006|Overall Study|Adverse Event|0|||
162101255|NCT03449030|585418848|FG007|Overall Study|Adverse Event|0|||
162101256|NCT03449030|585418849|FG008|Overall Study|Adverse Event|0|||
162101257|NCT03449030|585418850|FG009|Overall Study|Adverse Event|0|||
162101258|NCT03449030|585418841|FG000|Overall Study|Death|0|||
162101259|NCT03449030|585418842|FG001|Overall Study|Death|0|||
162101260|NCT03449030|585418843|FG002|Overall Study|Death|0|||
162101261|NCT03449030|585418844|FG003|Overall Study|Death|0|||
162101262|NCT03449030|585418845|FG004|Overall Study|Death|1|||
162101263|NCT03449030|585418846|FG005|Overall Study|Death|0|||
162101264|NCT03449030|585418847|FG006|Overall Study|Death|0|||
162101265|NCT03449030|585418848|FG007|Overall Study|Death|0|||
162101266|NCT03449030|585418849|FG008|Overall Study|Death|0|||
162101267|NCT03449030|585418850|FG009|Overall Study|Death|0|||
162101268|NCT02105948|585418851|FG000|Overall Study|Adverse Event|10|||
162101269|NCT02105948|585418852|FG001|Overall Study|Adverse Event|7|||
162101270|NCT02105948|585418853|FG002|Overall Study|Adverse Event|11|||
162101271|NCT02105948|585418854|FG003|Overall Study|Adverse Event|11|||
162101272|NCT02105948|585418851|FG000|Overall Study|Lack of Efficacy|0|||
162101273|NCT02105948|585418852|FG001|Overall Study|Lack of Efficacy|1|||
162101274|NCT02105948|585418853|FG002|Overall Study|Lack of Efficacy|3|||
162101275|NCT02105948|585418854|FG003|Overall Study|Lack of Efficacy|2|||
162101276|NCT02105948|585418851|FG000|Overall Study|Lost to Follow-up|0|||
162101277|NCT02105948|585418852|FG001|Overall Study|Lost to Follow-up|0|||
162101278|NCT02105948|585418853|FG002|Overall Study|Lost to Follow-up|2|||
162101279|NCT02105948|585418854|FG003|Overall Study|Lost to Follow-up|1|||
162101280|NCT02105948|585418851|FG000|Overall Study|Physician Decision|2|||
162101281|NCT02105948|585418852|FG001|Overall Study|Physician Decision|2|||
162101282|NCT02105948|585418853|FG002|Overall Study|Physician Decision|2|||
162101283|NCT02105948|585418854|FG003|Overall Study|Physician Decision|2|||
162101284|NCT02105948|585418851|FG000|Overall Study|Withdrawal by Subject|15|||
162101285|NCT02105948|585418852|FG001|Overall Study|Withdrawal by Subject|10|||
162101286|NCT02105948|585418853|FG002|Overall Study|Withdrawal by Subject|10|||
162101287|NCT02105948|585418854|FG003|Overall Study|Withdrawal by Subject|11|||
162101288|NCT04558346|585418863|FG000|Overall Study|Withdrawal by Subject|2|||
162101289|NCT04558346|585418864|FG001|Overall Study|Withdrawal by Subject|0|||
162101290|NCT04558346|585418863|FG000|Overall Study|Lost to Follow-up|0|||
162101291|NCT04558346|585418864|FG001|Overall Study|Lost to Follow-up|1|||
162101292|NCT04558346|585418863|FG000|Overall Study|Adverse Event|0|||
162101293|NCT04558346|585418864|FG001|Overall Study|Adverse Event|1|||
162101294|NCT00724971|585418867|FG000|Overall Study|Adverse Event|5|||
162101295|NCT00724971|585418867|FG000|Overall Study|Withdrawal by Subject|1|||
162101296|NCT01462344|585418868|FG000|Overall Study|Withdrawal by Subject|245|||
162101297|NCT01462344|585418869|FG001|Overall Study|Withdrawal by Subject|226|||
162101298|NCT01462344|585418868|FG000|Overall Study|Adverse Event|24|||
162101299|NCT01462344|585418869|FG001|Overall Study|Adverse Event|23|||
162101300|NCT01462344|585418868|FG000|Overall Study|Asthma Exacerbation|34|||
162101301|NCT01462344|585418869|FG001|Overall Study|Asthma Exacerbation|35|||
162101302|NCT01462344|585418868|FG000|Overall Study|Lack of Efficacy|5|||
162101303|NCT01462344|585418869|FG001|Overall Study|Lack of Efficacy|6|||
162101304|NCT01462344|585418868|FG000|Overall Study|Protocol Violation|68|||
162101305|NCT01462344|585418869|FG001|Overall Study|Protocol Violation|53|||
162101306|NCT01462344|585418868|FG000|Overall Study|Lost to Follow-up|7|||
162101307|NCT01462344|585418869|FG001|Overall Study|Lost to Follow-up|7|||
162101308|NCT02276482|585418870|FG000|Overall Study|Adverse Event|1|||
162101309|NCT02276482|585418871|FG001|Overall Study|Adverse Event|0|||
162101310|NCT02276482|585418870|FG000|Overall Study|Withdrawal by Subject|1|||
162101311|NCT02276482|585418871|FG001|Overall Study|Withdrawal by Subject|0|||
162101312|NCT02276482|585418870|FG000|Overall Study|Gram-negative infection|1|||
162101313|NCT02276482|585418871|FG001|Overall Study|Gram-negative infection|0|||
162101314|NCT02276482|585418870|FG000|Overall Study|Reason not specified|0|||
162101315|NCT02276482|585418871|FG001|Overall Study|Reason not specified|1|||
162101316|NCT01410448|585418877|FG000|Overall Study|No conversion to everolimus|0|||
162101317|NCT01410448|585418878|FG001|Overall Study|No conversion to everolimus|24|||
162101318|NCT01410448|585418877|FG000|Overall Study|Graft loss|4|||
162101319|NCT01410448|585418878|FG001|Overall Study|Graft loss|1|||
162101320|NCT01410448|585418877|FG000|Overall Study|Administrative issues|2|||
162101321|NCT01410448|585418878|FG001|Overall Study|Administrative issues|1|||
162101322|NCT01410448|585418877|FG000|Overall Study|Lost to Follow-up|1|||
162101323|NCT01410448|585418878|FG001|Overall Study|Lost to Follow-up|0|||
162101324|NCT01410448|585418877|FG000|Overall Study|Withdrawal by Subject|3|||
162101325|NCT01410448|585418878|FG001|Overall Study|Withdrawal by Subject|2|||
162101326|NCT01410448|585418877|FG000|Overall Study|Protocol Violation|0|||
162101327|NCT01410448|585418878|FG001|Overall Study|Protocol Violation|4|||
162101328|NCT01410448|585418877|FG000|Overall Study|Death|2|||
162101329|NCT01410448|585418878|FG001|Overall Study|Death|3|||
162101330|NCT03096782|585418882|FG000|Overall Study|Death|1|||
162101331|NCT03096782|585418882|FG000|Overall Study|Participant Relapsed|1|||
162101332|NCT02075593|585418883|FG000|Overall Study|Withdrawal by Subject|1|||
162101333|NCT05819749|585418888|FG000|Overall Study|Lost to Follow-up|1|||
162101334|NCT00844857|585421161|FG000|Overall Study|Adverse Event|24|||
162101335|NCT00844857|585421162|FG001|Overall Study|Adverse Event|5|||
162101336|NCT00844857|585421161|FG000|Overall Study|Sponsor Decision|1|||
162101337|NCT00844857|585421162|FG001|Overall Study|Sponsor Decision|1|||
162101338|NCT00844857|585421161|FG000|Overall Study|Physician Decision|2|||
162101339|NCT00844857|585421162|FG001|Overall Study|Physician Decision|0|||
162101340|NCT00844857|585421161|FG000|Overall Study|Parent/Caregiver Decision|6|||
162101341|NCT00844857|585421162|FG001|Overall Study|Parent/Caregiver Decision|2|||
162101342|NCT00844857|585421161|FG000|Overall Study|Withdrawal by Subject|8|||
162101343|NCT00844857|585421162|FG001|Overall Study|Withdrawal by Subject|7|||
162101344|NCT00844857|585421161|FG000|Overall Study|Protocol Violation|6|||
162101345|NCT00844857|585421162|FG001|Overall Study|Protocol Violation|0|||
162101346|NCT00844857|585421161|FG000|Overall Study|Lack of Efficacy|5|||
162101347|NCT00844857|585421162|FG001|Overall Study|Lack of Efficacy|5|||
162101348|NCT00844857|585421161|FG000|Overall Study|Clinical Relapse|0|||
162101349|NCT00844857|585421162|FG001|Overall Study|Clinical Relapse|1|||
162101350|NCT00844857|585421161|FG000|Overall Study|Entry Criteria Not Met|0|||
162101351|NCT00844857|585421162|FG001|Overall Study|Entry Criteria Not Met|1|||
162101352|NCT00844857|585421161|FG000|Overall Study|Lost to Follow-up|2|||
162101353|NCT00844857|585421162|FG001|Overall Study|Lost to Follow-up|3|||
162101354|NCT00844857|585421161|FG000|Overall Study|Did Not Take Study Drug|3|||
162101355|NCT00844857|585421162|FG001|Overall Study|Did Not Take Study Drug|1|||
162101356|NCT00844857|585421161|FG000|Overall Study|Good Clinical Practice Violations|21|||
162101357|NCT00844857|585421162|FG001|Overall Study|Good Clinical Practice Violations|11|||
162101358|NCT00570674|585421163|FG000|Overall Study|Withdrawal by Subject|0|||
162101359|NCT00570674|585421164|FG001|Overall Study|Withdrawal by Subject|0|||
162101360|NCT00570674|585421165|FG002|Overall Study|Withdrawal by Subject|1|||
162101361|NCT00570674|585421166|FG003|Overall Study|Withdrawal by Subject|0|||
162101362|NCT00570674|585421167|FG004|Overall Study|Withdrawal by Subject|0|||
162101363|NCT00570674|585421168|FG005|Overall Study|Withdrawal by Subject|0|||
162101364|NCT00570674|585421169|FG006|Overall Study|Withdrawal by Subject|0|||
162101365|NCT02338154|585421175|FG000|Overall Study|Death|46|||
162101366|NCT02338154|585421175|FG000|Overall Study|Valve Implant Failure|17|||
162101367|NCT02338154|585421175|FG000|Overall Study|Valve Explant|11|||
162101368|NCT02338154|585421175|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
162101369|NCT02338154|585421175|FG000|Overall Study|Lost to Follow-up|8|||
162101370|NCT02338154|585421175|FG000|Overall Study|Other Reason|3|||
162101371|NCT02338154|585421175|FG000|Overall Study|Patients Without Exit Form|47|||
162101372|NCT02338154|585421175|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
162101373|NCT03393000|585421178|FG000|Overall Study|Death|11|||
162101374|NCT03393000|585421178|FG000|Overall Study|Withdrawal by Subject|2|||
162101375|NCT03393000|585421178|FG000|Overall Study|Physician Decision|1|||
162101376|NCT01773070|585421179|FG000|Overall Study|Withdrawal by Subject|24|||
162101377|NCT01773070|585421179|FG000|Overall Study|Lost to Follow-up|39|||
162101378|NCT01773070|585421179|FG000|Overall Study|Other|15|||
162101379|NCT01773070|585421179|FG000|Overall Study|Death (unrelated to study procedures)|3|||
162101380|NCT02181803|585421180|FG000|Overall Study|Withdrawal by Subject|0|||
162101381|NCT02181803|585421181|FG001|Overall Study|Withdrawal by Subject|2|||
162101382|NCT02181803|585421182|FG002|Overall Study|Withdrawal by Subject|0|||
162101383|NCT02181803|585421183|FG003|Overall Study|Withdrawal by Subject|0|||
162101384|NCT02181803|585421184|FG004|Overall Study|Withdrawal by Subject|0|||
162101385|NCT02181803|585421185|FG005|Overall Study|Withdrawal by Subject|0|||
162101386|NCT02181803|585421186|FG006|Overall Study|Withdrawal by Subject|0|||
162101387|NCT02181803|585421187|FG007|Overall Study|Withdrawal by Subject|0|||
162101388|NCT02181803|585421188|FG008|Overall Study|Withdrawal by Subject|0|||
162101389|NCT02181803|585421180|FG000|Overall Study|Physician Decision|0|||
162101390|NCT02181803|585421181|FG001|Overall Study|Physician Decision|0|||
162101391|NCT02181803|585421182|FG002|Overall Study|Physician Decision|0|||
162101392|NCT02181803|585421183|FG003|Overall Study|Physician Decision|1|||
162101393|NCT02181803|585421184|FG004|Overall Study|Physician Decision|0|||
162101394|NCT02181803|585421185|FG005|Overall Study|Physician Decision|0|||
162101395|NCT02181803|585421186|FG006|Overall Study|Physician Decision|0|||
162101396|NCT02181803|585421187|FG007|Overall Study|Physician Decision|1|||
162101397|NCT02181803|585421188|FG008|Overall Study|Physician Decision|0|||
162101398|NCT02181803|585421180|FG000|Overall Study|Adverse Event|0|||
162101399|NCT02181803|585421181|FG001|Overall Study|Adverse Event|2|||
162101400|NCT02181803|585421182|FG002|Overall Study|Adverse Event|0|||
162101401|NCT02181803|585421183|FG003|Overall Study|Adverse Event|1|||
162101402|NCT02181803|585421184|FG004|Overall Study|Adverse Event|0|||
162101403|NCT02181803|585421185|FG005|Overall Study|Adverse Event|0|||
162101404|NCT02181803|585421186|FG006|Overall Study|Adverse Event|1|||
162101405|NCT02181803|585421187|FG007|Overall Study|Adverse Event|0|||
162101406|NCT02181803|585421188|FG008|Overall Study|Adverse Event|0|||
162101407|NCT04786444|585421190|FG000|Overall Study|Withdrawal by Subject|4|||
162101408|NCT04786444|585421191|FG001|Overall Study|Withdrawal by Subject|7|||
162101409|NCT04786444|585421192|FG002|Overall Study|Withdrawal by Subject|2|||
162101410|NCT04786444|585421190|FG000|Overall Study|Lost to Follow-up|11|||
162101411|NCT04786444|585421191|FG001|Overall Study|Lost to Follow-up|9|||
162101412|NCT04786444|585421192|FG002|Overall Study|Lost to Follow-up|10|||
162101413|NCT04786444|585421190|FG000|Overall Study|Subject would like to become pregnant|0|||
162101414|NCT04786444|585421191|FG001|Overall Study|Subject would like to become pregnant|1|||
162101415|NCT04786444|585421192|FG002|Overall Study|Subject would like to become pregnant|0|||
162101416|NCT03166618|585421193|FG000|Overall Study|Study was Terminated|0|||
162101417|NCT03166618|585421194|FG001|Overall Study|Study was Terminated|1|||
162101418|NCT01925950|585421195|FG000|Part 2|Withdrawal by Subject|1|||
162101419|NCT01925950|585421196|FG001|Part 2|Withdrawal by Subject|0|||
162101420|NCT03137303|585421198|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
162101421|NCT03137303|585421199|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
162101422|NCT03137303|585421198|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
162101423|NCT03137303|585421199|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
162101424|NCT03137303|585421198|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
162101425|NCT03137303|585421199|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
162101426|NCT03137303|585421198|FG000|T3: 9-month Follow-up|Death|1|||
162101427|NCT03137303|585421199|FG001|T3: 9-month Follow-up|Death|0|||
162101428|NCT03137303|585421198|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
162101429|NCT03137303|585421199|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
162101430|NCT03137303|585421198|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
162101431|NCT03137303|585421199|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
162101432|NCT03137303|585421198|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
162101433|NCT03137303|585421199|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
162101434|NCT01217073|585421200|FG000|Base Period|Adverse Event|1|||
162101435|NCT01217073|585421201|FG001|Base Period|Adverse Event|0|||
162101436|NCT01217073|585421202|FG002|Base Period|Adverse Event|1|||
162101437|NCT01217073|585421203|FG003|Base Period|Adverse Event|0|||
162101438|NCT01217073|585421204|FG004|Base Period|Adverse Event|4|||
162101439|NCT01217073|585421205|FG005|Base Period|Adverse Event|1|||
162101440|NCT01217073|585421206|FG006|Base Period|Adverse Event|0|||
162101441|NCT01217073|585421207|FG007|Base Period|Adverse Event|0|||
162101442|NCT01217073|585421200|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
162101443|NCT01217073|585421201|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162101444|NCT01217073|585421202|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162101445|NCT01217073|585421203|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162101446|NCT01217073|585421204|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162101447|NCT01217073|585421205|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162101448|NCT01217073|585421206|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162101449|NCT01217073|585421207|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
162101450|NCT01217073|585421200|FG000|Base Period|Excluded medication|0|||
162101451|NCT01217073|585421201|FG001|Base Period|Excluded medication|0|||
162101452|NCT01217073|585421202|FG002|Base Period|Excluded medication|0|||
162101453|NCT01217073|585421203|FG003|Base Period|Excluded medication|0|||
162101454|NCT01217073|585421204|FG004|Base Period|Excluded medication|1|||
162101455|NCT01217073|585421205|FG005|Base Period|Excluded medication|0|||
162101456|NCT01217073|585421206|FG006|Base Period|Excluded medication|0|||
162101457|NCT01217073|585421207|FG007|Base Period|Excluded medication|0|||
162101458|NCT01217073|585421200|FG000|Base Period|Lack of Efficacy|0|||
162101459|NCT01217073|585421201|FG001|Base Period|Lack of Efficacy|0|||
162101460|NCT01217073|585421202|FG002|Base Period|Lack of Efficacy|0|||
162101461|NCT01217073|585421203|FG003|Base Period|Lack of Efficacy|0|||
162101462|NCT01217073|585421204|FG004|Base Period|Lack of Efficacy|0|||
162101463|NCT01217073|585421205|FG005|Base Period|Lack of Efficacy|1|||
162101464|NCT01217073|585421206|FG006|Base Period|Lack of Efficacy|0|||
162101465|NCT01217073|585421207|FG007|Base Period|Lack of Efficacy|0|||
162101466|NCT01217073|585421200|FG000|Base Period|Lost to Follow-up|0|||
162101467|NCT01217073|585421201|FG001|Base Period|Lost to Follow-up|0|||
162101468|NCT01217073|585421202|FG002|Base Period|Lost to Follow-up|1|||
162101469|NCT01217073|585421203|FG003|Base Period|Lost to Follow-up|1|||
162101470|NCT01217073|585421204|FG004|Base Period|Lost to Follow-up|3|||
162101471|NCT01217073|585421205|FG005|Base Period|Lost to Follow-up|0|||
162101472|NCT01217073|585421206|FG006|Base Period|Lost to Follow-up|0|||
162101473|NCT01217073|585421207|FG007|Base Period|Lost to Follow-up|0|||
162101474|NCT01217073|585421200|FG000|Base Period|Physician Decision|0|||
162101475|NCT01217073|585421201|FG001|Base Period|Physician Decision|0|||
162101476|NCT01217073|585421202|FG002|Base Period|Physician Decision|0|||
162101477|NCT01217073|585421203|FG003|Base Period|Physician Decision|0|||
162101478|NCT01217073|585421204|FG004|Base Period|Physician Decision|1|||
162101479|NCT01217073|585421205|FG005|Base Period|Physician Decision|0|||
162101480|NCT01217073|585421206|FG006|Base Period|Physician Decision|0|||
162101481|NCT01217073|585421207|FG007|Base Period|Physician Decision|0|||
162101482|NCT01217073|585421200|FG000|Base Period|Protocol Violation|1|||
162101483|NCT01217073|585421201|FG001|Base Period|Protocol Violation|0|||
162101484|NCT01217073|585421202|FG002|Base Period|Protocol Violation|0|||
162101485|NCT01217073|585421203|FG003|Base Period|Protocol Violation|0|||
162101486|NCT01217073|585421204|FG004|Base Period|Protocol Violation|1|||
162101487|NCT01217073|585421205|FG005|Base Period|Protocol Violation|2|||
162101488|NCT01217073|585421206|FG006|Base Period|Protocol Violation|0|||
162101489|NCT01217073|585421207|FG007|Base Period|Protocol Violation|0|||
162101490|NCT01217073|585421200|FG000|Base Period|Withdrawal by Subject|4|||
162101491|NCT01217073|585421201|FG001|Base Period|Withdrawal by Subject|5|||
162101492|NCT01217073|585421202|FG002|Base Period|Withdrawal by Subject|5|||
162101493|NCT01217073|585421203|FG003|Base Period|Withdrawal by Subject|1|||
162101494|NCT01217073|585421204|FG004|Base Period|Withdrawal by Subject|5|||
162101495|NCT01217073|585421205|FG005|Base Period|Withdrawal by Subject|5|||
162101496|NCT01217073|585421206|FG006|Base Period|Withdrawal by Subject|0|||
162101497|NCT01217073|585421207|FG007|Base Period|Withdrawal by Subject|0|||
162101498|NCT01217073|585421200|FG000|Extension Period|Adverse Event|0|||
162101499|NCT01217073|585421201|FG001|Extension Period|Adverse Event|0|||
162101500|NCT01217073|585421202|FG002|Extension Period|Adverse Event|0|||
162101501|NCT01217073|585421203|FG003|Extension Period|Adverse Event|0|||
162101502|NCT01217073|585421204|FG004|Extension Period|Adverse Event|0|||
162101503|NCT01217073|585421205|FG005|Extension Period|Adverse Event|0|||
162101504|NCT01217073|585421206|FG006|Extension Period|Adverse Event|19|||
162101505|NCT01217073|585421207|FG007|Extension Period|Adverse Event|5|||
162101506|NCT01217073|585421200|FG000|Extension Period|ALT/AST|0|||
162101507|NCT01217073|585421201|FG001|Extension Period|ALT/AST|0|||
162101508|NCT01217073|585421202|FG002|Extension Period|ALT/AST|0|||
162101509|NCT01217073|585421203|FG003|Extension Period|ALT/AST|0|||
162101510|NCT01217073|585421204|FG004|Extension Period|ALT/AST|0|||
162101511|NCT01217073|585421205|FG005|Extension Period|ALT/AST|0|||
162101512|NCT01217073|585421206|FG006|Extension Period|ALT/AST|2|||
162101513|NCT01217073|585421207|FG007|Extension Period|ALT/AST|0|||
162101514|NCT01217073|585421200|FG000|Extension Period|Contraindication to study medication|0|||
162101515|NCT01217073|585421201|FG001|Extension Period|Contraindication to study medication|0|||
162101516|NCT01217073|585421202|FG002|Extension Period|Contraindication to study medication|0|||
162101517|NCT01217073|585421203|FG003|Extension Period|Contraindication to study medication|0|||
162101518|NCT01217073|585421204|FG004|Extension Period|Contraindication to study medication|0|||
162101519|NCT01217073|585421205|FG005|Extension Period|Contraindication to study medication|0|||
162101520|NCT01217073|585421206|FG006|Extension Period|Contraindication to study medication|1|||
162101521|NCT01217073|585421207|FG007|Extension Period|Contraindication to study medication|0|||
162101522|NCT01217073|585421200|FG000|Extension Period|Creatinine/eGFR|0|||
162101523|NCT01217073|585421201|FG001|Extension Period|Creatinine/eGFR|0|||
162101524|NCT01217073|585421202|FG002|Extension Period|Creatinine/eGFR|0|||
162101525|NCT01217073|585421203|FG003|Extension Period|Creatinine/eGFR|0|||
162101526|NCT01217073|585421204|FG004|Extension Period|Creatinine/eGFR|0|||
162101527|NCT01217073|585421205|FG005|Extension Period|Creatinine/eGFR|0|||
162101528|NCT01217073|585421206|FG006|Extension Period|Creatinine/eGFR|11|||
162101529|NCT01217073|585421207|FG007|Extension Period|Creatinine/eGFR|1|||
162101530|NCT01217073|585421200|FG000|Extension Period|Death|0|||
162101531|NCT01217073|585421201|FG001|Extension Period|Death|0|||
162101532|NCT01217073|585421202|FG002|Extension Period|Death|0|||
162101533|NCT01217073|585421203|FG003|Extension Period|Death|0|||
162101534|NCT01217073|585421204|FG004|Extension Period|Death|0|||
162101535|NCT01217073|585421205|FG005|Extension Period|Death|0|||
162101536|NCT01217073|585421206|FG006|Extension Period|Death|1|||
162101537|NCT01217073|585421207|FG007|Extension Period|Death|0|||
162101538|NCT01217073|585421200|FG000|Extension Period|Excluded medication|0|||
162101539|NCT01217073|585421201|FG001|Extension Period|Excluded medication|0|||
162101540|NCT01217073|585421202|FG002|Extension Period|Excluded medication|0|||
162101541|NCT01217073|585421203|FG003|Extension Period|Excluded medication|0|||
162101542|NCT01217073|585421204|FG004|Extension Period|Excluded medication|0|||
162101543|NCT01217073|585421205|FG005|Extension Period|Excluded medication|0|||
162101544|NCT01217073|585421206|FG006|Extension Period|Excluded medication|2|||
162101545|NCT01217073|585421207|FG007|Extension Period|Excluded medication|0|||
162101546|NCT01217073|585421200|FG000|Extension Period|Lack of Efficacy|0|||
162101547|NCT01217073|585421201|FG001|Extension Period|Lack of Efficacy|0|||
162101548|NCT01217073|585421202|FG002|Extension Period|Lack of Efficacy|0|||
162101549|NCT01217073|585421203|FG003|Extension Period|Lack of Efficacy|0|||
162101550|NCT01217073|585421204|FG004|Extension Period|Lack of Efficacy|0|||
162101551|NCT01217073|585421205|FG005|Extension Period|Lack of Efficacy|0|||
162101552|NCT01217073|585421206|FG006|Extension Period|Lack of Efficacy|3|||
162101553|NCT01217073|585421207|FG007|Extension Period|Lack of Efficacy|0|||
162101554|NCT01217073|585421200|FG000|Extension Period|Lost to Follow-up|0|||
162101555|NCT01217073|585421201|FG001|Extension Period|Lost to Follow-up|0|||
162101556|NCT01217073|585421202|FG002|Extension Period|Lost to Follow-up|0|||
162101557|NCT01217073|585421203|FG003|Extension Period|Lost to Follow-up|0|||
162101558|NCT01217073|585421204|FG004|Extension Period|Lost to Follow-up|0|||
162101559|NCT01217073|585421205|FG005|Extension Period|Lost to Follow-up|0|||
162101560|NCT01217073|585421206|FG006|Extension Period|Lost to Follow-up|9|||
162101561|NCT01217073|585421207|FG007|Extension Period|Lost to Follow-up|1|||
162101562|NCT01217073|585421200|FG000|Extension Period|Non-compliance with study drug|0|||
162101563|NCT01217073|585421201|FG001|Extension Period|Non-compliance with study drug|0|||
162101564|NCT01217073|585421202|FG002|Extension Period|Non-compliance with study drug|0|||
162101565|NCT01217073|585421203|FG003|Extension Period|Non-compliance with study drug|0|||
162101566|NCT01217073|585421204|FG004|Extension Period|Non-compliance with study drug|0|||
162101567|NCT01217073|585421205|FG005|Extension Period|Non-compliance with study drug|0|||
162101568|NCT01217073|585421206|FG006|Extension Period|Non-compliance with study drug|0|||
162101569|NCT01217073|585421207|FG007|Extension Period|Non-compliance with study drug|1|||
162101570|NCT01217073|585421200|FG000|Extension Period|Physician Decision|0|||
162101571|NCT01217073|585421201|FG001|Extension Period|Physician Decision|0|||
162101572|NCT01217073|585421202|FG002|Extension Period|Physician Decision|0|||
162101573|NCT01217073|585421203|FG003|Extension Period|Physician Decision|0|||
162101574|NCT01217073|585421204|FG004|Extension Period|Physician Decision|0|||
162101575|NCT01217073|585421205|FG005|Extension Period|Physician Decision|0|||
162101576|NCT01217073|585421206|FG006|Extension Period|Physician Decision|4|||
162101577|NCT01217073|585421207|FG007|Extension Period|Physician Decision|1|||
162101578|NCT01217073|585421200|FG000|Extension Period|Protocol Violation|0|||
162101579|NCT01217073|585421201|FG001|Extension Period|Protocol Violation|0|||
162101580|NCT01217073|585421202|FG002|Extension Period|Protocol Violation|0|||
162101581|NCT01217073|585421203|FG003|Extension Period|Protocol Violation|0|||
162101582|NCT01217073|585421204|FG004|Extension Period|Protocol Violation|0|||
162101583|NCT01217073|585421205|FG005|Extension Period|Protocol Violation|0|||
162101584|NCT01217073|585421206|FG006|Extension Period|Protocol Violation|2|||
162101585|NCT01217073|585421207|FG007|Extension Period|Protocol Violation|1|||
162101586|NCT01217073|585421200|FG000|Extension Period|Site discontinued study participation|0|||
162101587|NCT01217073|585421201|FG001|Extension Period|Site discontinued study participation|0|||
162101588|NCT01217073|585421202|FG002|Extension Period|Site discontinued study participation|0|||
162101589|NCT01217073|585421203|FG003|Extension Period|Site discontinued study participation|0|||
162101590|NCT01217073|585421204|FG004|Extension Period|Site discontinued study participation|0|||
162101591|NCT01217073|585421205|FG005|Extension Period|Site discontinued study participation|0|||
162101592|NCT01217073|585421206|FG006|Extension Period|Site discontinued study participation|7|||
162101593|NCT01217073|585421207|FG007|Extension Period|Site discontinued study participation|2|||
162101594|NCT01217073|585421200|FG000|Extension Period|Withdrawal by Subject|0|||
162101595|NCT01217073|585421201|FG001|Extension Period|Withdrawal by Subject|0|||
162101596|NCT01217073|585421202|FG002|Extension Period|Withdrawal by Subject|0|||
162101597|NCT01217073|585421203|FG003|Extension Period|Withdrawal by Subject|0|||
162101598|NCT01217073|585421204|FG004|Extension Period|Withdrawal by Subject|0|||
162101599|NCT01217073|585421205|FG005|Extension Period|Withdrawal by Subject|0|||
162101600|NCT01217073|585421206|FG006|Extension Period|Withdrawal by Subject|30|||
162101601|NCT01217073|585421207|FG007|Extension Period|Withdrawal by Subject|8|||
162101602|NCT03561090|585421208|FG000|Overall Study|Adverse Event|11|||
162101603|NCT03561090|585421209|FG001|Overall Study|Adverse Event|7|||
162101604|NCT03561090|585421208|FG000|Overall Study|Non-Compliance With Study Drug|2|||
162101605|NCT03561090|585421209|FG001|Overall Study|Non-Compliance With Study Drug|0|||
162101606|NCT03561090|585421208|FG000|Overall Study|Protocol Violation|2|||
162101607|NCT03561090|585421209|FG001|Overall Study|Protocol Violation|2|||
162101608|NCT03561090|585421208|FG000|Overall Study|Withdrawal by Subject|7|||
162101609|NCT03561090|585421209|FG001|Overall Study|Withdrawal by Subject|7|||
162101610|NCT03561090|585421208|FG000|Overall Study|Lost to Follow-up|7|||
162101611|NCT03561090|585421209|FG001|Overall Study|Lost to Follow-up|2|||
162101612|NCT03561090|585421208|FG000|Overall Study|Study Terminated by Sponsor|10|||
162101613|NCT03561090|585421209|FG001|Overall Study|Study Terminated by Sponsor|15|||
162101614|NCT03561090|585421208|FG000|Overall Study|Randomized by Mistake|1|||
162101615|NCT03561090|585421209|FG001|Overall Study|Randomized by Mistake|1|||
162101616|NCT03561090|585421208|FG000|Overall Study|Other Not Specified|0|||
162101617|NCT03561090|585421209|FG001|Overall Study|Other Not Specified|2|||
162101618|NCT00725452|585421218|FG000|Overall Study|Adverse Event|3|||
162101619|NCT00725452|585421218|FG000|Overall Study|Lack of Efficacy|2|||
162101620|NCT00725452|585421218|FG000|Overall Study|Reason not specified|1|||
162101621|NCT00725452|585421218|FG000|Overall Study|Physician Decision|1|||
162101622|NCT00725452|585421218|FG000|Overall Study|Withdrawal by Subject|3|||
162101623|NCT00725452|585421218|FG000|Overall Study|Lost to Follow-up|1|||
162101624|NCT02696317|585421222|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
162101625|NCT02696317|585421223|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
162101626|NCT02696317|585421222|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
162101627|NCT02696317|585421223|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
162101628|NCT01343368|585421224|FG000|Overall Study|Death|1|||
162101629|NCT01343368|585421225|FG001|Overall Study|Death|0|||
162101630|NCT01343368|585421224|FG000|Overall Study|Lost to Follow-up|1|||
162101631|NCT01343368|585421225|FG001|Overall Study|Lost to Follow-up|0|||
162101632|NCT00237744|585421226|FG000|Overall Study|Withdrawal by Subject|3|||
162101633|NCT00237744|585421227|FG001|Overall Study|Withdrawal by Subject|1|||
162101634|NCT00237744|585421228|FG002|Overall Study|Withdrawal by Subject|0|||
162101635|NCT02015676|585421229|FG000|Overall Study|Adverse Event|2|||
162101636|NCT02015676|585421230|FG001|Overall Study|Adverse Event|18|||
162101637|NCT02015676|585421231|FG002|Overall Study|Adverse Event|0|||
162101638|NCT02015676|585421229|FG000|Overall Study|Lack of Efficacy|2|||
162101639|NCT02015676|585421230|FG001|Overall Study|Lack of Efficacy|4|||
162101640|NCT02015676|585421231|FG002|Overall Study|Lack of Efficacy|0|||
162101641|NCT02015676|585421229|FG000|Overall Study|Protocol Violation|1|||
162101642|NCT02015676|585421230|FG001|Overall Study|Protocol Violation|0|||
162101643|NCT02015676|585421231|FG002|Overall Study|Protocol Violation|0|||
162101644|NCT02015676|585421229|FG000|Overall Study|Withdrawal by Subject|1|||
162101645|NCT02015676|585421230|FG001|Overall Study|Withdrawal by Subject|7|||
162101646|NCT02015676|585421231|FG002|Overall Study|Withdrawal by Subject|1|||
162101647|NCT02015676|585421229|FG000|Overall Study|Administrative reasons|0|||
162101648|NCT02015676|585421230|FG001|Overall Study|Administrative reasons|3|||
162101649|NCT02015676|585421231|FG002|Overall Study|Administrative reasons|1|||
162101650|NCT02015676|585421229|FG000|Overall Study|Death|0|||
162101651|NCT02015676|585421230|FG001|Overall Study|Death|1|||
162101652|NCT02015676|585421231|FG002|Overall Study|Death|0|||
162101653|NCT02015676|585421229|FG000|Overall Study|Disease progression|3|||
162101654|NCT02015676|585421230|FG001|Overall Study|Disease progression|1|||
162101655|NCT02015676|585421231|FG002|Overall Study|Disease progression|1|||
162101656|NCT00476476|585421233|FG000|Overall Study|Adverse Event|2|||
162101657|NCT00476476|585421234|FG001|Overall Study|Adverse Event|7|||
162101658|NCT00476476|585421233|FG000|Overall Study|Progressive Disease|0|||
162101659|NCT00476476|585421234|FG001|Overall Study|Progressive Disease|17|||
162101660|NCT00971048|585421235|FG000|Overall Study|Protocol Violation|1|||
162101661|NCT00971048|585421236|FG001|Overall Study|Protocol Violation|2|||
162101662|NCT00971048|585421237|FG002|Overall Study|Protocol Violation|0|||
162101663|NCT00971048|585421238|FG003|Overall Study|Protocol Violation|1|||
162101664|NCT00971048|585421235|FG000|Overall Study|Adverse Event|0|||
162101665|NCT00971048|585421236|FG001|Overall Study|Adverse Event|0|||
162101666|NCT00971048|585421237|FG002|Overall Study|Adverse Event|1|||
162101667|NCT00971048|585421238|FG003|Overall Study|Adverse Event|0|||
162101668|NCT00971048|585421235|FG000|Overall Study|Physician Decision|0|||
162101669|NCT00971048|585421236|FG001|Overall Study|Physician Decision|0|||
162101670|NCT00971048|585421237|FG002|Overall Study|Physician Decision|0|||
162101671|NCT00971048|585421238|FG003|Overall Study|Physician Decision|1|||
162101672|NCT01715805|585421245|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
162101673|NCT01715805|585421246|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
162101674|NCT01715805|585421247|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
162101675|NCT01715805|585421248|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
162101676|NCT01715805|585421245|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
162101677|NCT01715805|585421246|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
162101678|NCT01715805|585421247|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
162101679|NCT01715805|585421248|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
162101680|NCT01715805|585421245|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
162101681|NCT01715805|585421246|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
162101682|NCT01715805|585421247|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
162101683|NCT01715805|585421248|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
162101684|NCT01715805|585421245|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
162101685|NCT01715805|585421246|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
162101686|NCT01715805|585421247|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
162101687|NCT01715805|585421248|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
162101688|NCT01715805|585421245|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
162101689|NCT01715805|585421246|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
162101690|NCT01715805|585421247|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
162101691|NCT01715805|585421248|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
162101692|NCT01715805|585421245|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
162101693|NCT01715805|585421246|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
162101694|NCT01715805|585421247|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
162101695|NCT01715805|585421248|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
162101696|NCT01715805|585421245|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
162101697|NCT01715805|585421246|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
162101698|NCT01715805|585421247|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
162101699|NCT01715805|585421248|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
162101700|NCT01715805|585421245|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
162101701|NCT01715805|585421246|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
162101702|NCT01715805|585421247|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
162101703|NCT01715805|585421248|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
162101704|NCT01715805|585421245|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
162101705|NCT01715805|585421246|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
162101706|NCT01715805|585421247|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
162101707|NCT01715805|585421248|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
162101708|NCT01715805|585421245|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
162101709|NCT01715805|585421246|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
162101710|NCT01715805|585421247|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
162101711|NCT01715805|585421248|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
162101712|NCT01715805|585421245|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
162101713|NCT01715805|585421246|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
162101714|NCT01715805|585421247|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
162101715|NCT01715805|585421248|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
162101716|NCT01715805|585421245|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
162101717|NCT01715805|585421246|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
162101718|NCT01715805|585421247|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
162101719|NCT01715805|585421248|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
162101720|NCT01715805|585421245|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
162101721|NCT01715805|585421246|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
162101722|NCT01715805|585421247|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
162101723|NCT01715805|585421248|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
162101724|NCT01715805|585421245|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
162101725|NCT01715805|585421246|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
162101726|NCT01715805|585421247|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
162101727|NCT01715805|585421248|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
162101728|NCT02647359|585421251|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
162101729|NCT02647359|585421252|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
162101730|NCT02647359|585421251|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
162101731|NCT02647359|585421252|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
162101732|NCT02647359|585421251|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
162101733|NCT02647359|585421252|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
162101734|NCT02647359|585421251|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
162101735|NCT02647359|585421252|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
162101736|NCT02647359|585421251|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
162101737|NCT02647359|585421252|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
162101738|NCT02647359|585421251|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
162101739|NCT02647359|585421252|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
162101740|NCT00413413|585421253|FG000|Single-Blind|Adverse Event|0|||
162101741|NCT00413413|585421254|FG001|Single-Blind|Adverse Event|9|||
162101742|NCT00413413|585421255|FG002|Single-Blind|Adverse Event|0|||
162101743|NCT00413413|585421253|FG000|Single-Blind|Lack of Efficacy|0|||
162101744|NCT00413413|585421254|FG001|Single-Blind|Lack of Efficacy|5|||
162101745|NCT00413413|585421255|FG002|Single-Blind|Lack of Efficacy|0|||
162101746|NCT00413413|585421253|FG000|Single-Blind|Subject no longer requires study drug|0|||
162101747|NCT00413413|585421254|FG001|Single-Blind|Subject no longer requires study drug|151|||
162101748|NCT00413413|585421255|FG002|Single-Blind|Subject no longer requires study drug|0|||
162101749|NCT00413413|585421253|FG000|Single-Blind|Protocol Violation|0|||
162101750|NCT00413413|585421254|FG001|Single-Blind|Protocol Violation|16|||
162101751|NCT00413413|585421255|FG002|Single-Blind|Protocol Violation|0|||
162101752|NCT00413413|585421253|FG000|Single-Blind|Withdrawal by Subject|0|||
162101753|NCT00413413|585421254|FG001|Single-Blind|Withdrawal by Subject|27|||
162101754|NCT00413413|585421255|FG002|Single-Blind|Withdrawal by Subject|0|||
162101755|NCT00413413|585421253|FG000|Single-Blind|Lost to Follow-up|0|||
162101756|NCT00413413|585421254|FG001|Single-Blind|Lost to Follow-up|8|||
162101757|NCT00413413|585421255|FG002|Single-Blind|Lost to Follow-up|0|||
162101758|NCT00413413|585421253|FG000|Double-Blind|Adverse Event|6|||
162101759|NCT00413413|585421254|FG001|Double-Blind|Adverse Event|0|||
162101760|NCT00413413|585421255|FG002|Double-Blind|Adverse Event|5|||
162101761|NCT00413413|585421253|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
162101762|NCT00413413|585421254|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
162101763|NCT00413413|585421255|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
162101764|NCT00413413|585421253|FG000|Double-Blind|Protocol deviation|1|||
162101765|NCT00413413|585421254|FG001|Double-Blind|Protocol deviation|2|||
162101766|NCT00413413|585421255|FG002|Double-Blind|Protocol deviation|1|||
162101767|NCT00413413|585421253|FG000|Double-Blind|Subject withdrew consent|4|||
162101768|NCT00413413|585421254|FG001|Double-Blind|Subject withdrew consent|6|||
162101769|NCT00413413|585421255|FG002|Double-Blind|Subject withdrew consent|9|||
162101770|NCT00413413|585421253|FG000|Double-Blind|Lost to Follow-up|3|||
162101771|NCT00413413|585421254|FG001|Double-Blind|Lost to Follow-up|4|||
162101772|NCT00413413|585421255|FG002|Double-Blind|Lost to Follow-up|2|||
162101773|NCT02219932|585421262|FG000|Overall Study|Other|5|||
162101774|NCT02219932|585421263|FG001|Overall Study|Other|11|||
162101775|NCT02219932|585421262|FG000|Overall Study|Death|1|||
162101776|NCT02219932|585421263|FG001|Overall Study|Death|1|||
162101777|NCT02219932|585421262|FG000|Overall Study|Investigator Decision|0|||
162101778|NCT02219932|585421263|FG001|Overall Study|Investigator Decision|1|||
162101779|NCT02219932|585421262|FG000|Overall Study|Consent Withdrawn|11|||
162101780|NCT02219932|585421263|FG001|Overall Study|Consent Withdrawn|7|||
162101781|NCT02219932|585421262|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
162101782|NCT02219932|585421263|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
162101783|NCT02219932|585421262|FG000|Overall Study|Protocol Violation|10|||
162101784|NCT02219932|585421263|FG001|Overall Study|Protocol Violation|6|||
162101785|NCT02219932|585421262|FG000|Overall Study|Pregnancy|1|||
162101786|NCT02219932|585421263|FG001|Overall Study|Pregnancy|0|||
162101787|NCT02219932|585421262|FG000|Overall Study|Lost to Follow-up|4|||
162101788|NCT02219932|585421263|FG001|Overall Study|Lost to Follow-up|2|||
162101789|NCT02219932|585421262|FG000|Overall Study|Adverse Event|23|||
162101790|NCT02219932|585421263|FG001|Overall Study|Adverse Event|21|||
162101791|NCT04642638|585421266|FG000|Overall Study|Withdrawal by Subject|23|||
162101792|NCT04642638|585421267|FG001|Overall Study|Withdrawal by Subject|29|||
162101793|NCT04642638|585421268|FG002|Overall Study|Withdrawal by Subject|9|||
162101794|NCT04642638|585421269|FG003|Overall Study|Withdrawal by Subject|7|||
162101795|NCT04642638|585421270|FG004|Overall Study|Withdrawal by Subject|61|||
162101796|NCT04642638|585421271|FG005|Overall Study|Withdrawal by Subject|27|||
162101797|NCT04642638|585421266|FG000|Overall Study|Lost to Follow-up|17|||
162101798|NCT04642638|585421267|FG001|Overall Study|Lost to Follow-up|18|||
162101799|NCT04642638|585421268|FG002|Overall Study|Lost to Follow-up|5|||
162101800|NCT04642638|585421269|FG003|Overall Study|Lost to Follow-up|5|||
162101801|NCT04642638|585421270|FG004|Overall Study|Lost to Follow-up|6|||
162101802|NCT04642638|585421271|FG005|Overall Study|Lost to Follow-up|3|||
162101803|NCT04642638|585421266|FG000|Overall Study|Adverse Event|0|||
162101804|NCT04642638|585421267|FG001|Overall Study|Adverse Event|0|||
162101805|NCT04642638|585421268|FG002|Overall Study|Adverse Event|1|||
162101806|NCT04642638|585421269|FG003|Overall Study|Adverse Event|0|||
162101807|NCT04642638|585421270|FG004|Overall Study|Adverse Event|10|||
162101808|NCT04642638|585421271|FG005|Overall Study|Adverse Event|3|||
162101809|NCT04642638|585421266|FG000|Overall Study|Reason Not Specified|1|||
162101810|NCT04642638|585421267|FG001|Overall Study|Reason Not Specified|4|||
162101811|NCT04642638|585421268|FG002|Overall Study|Reason Not Specified|0|||
162101812|NCT04642638|585421269|FG003|Overall Study|Reason Not Specified|0|||
162101813|NCT04642638|585421270|FG004|Overall Study|Reason Not Specified|38|||
162101814|NCT04642638|585421271|FG005|Overall Study|Reason Not Specified|16|||
162101815|NCT04642638|585421266|FG000|Overall Study|Physician Decision|0|||
162101816|NCT04642638|585421267|FG001|Overall Study|Physician Decision|0|||
162101817|NCT04642638|585421268|FG002|Overall Study|Physician Decision|0|||
162101818|NCT04642638|585421269|FG003|Overall Study|Physician Decision|0|||
162101819|NCT04642638|585421270|FG004|Overall Study|Physician Decision|2|||
162101820|NCT04642638|585421271|FG005|Overall Study|Physician Decision|1|||
162101821|NCT04642638|585421266|FG000|Overall Study|Protocol Deviation|0|||
162101822|NCT04642638|585421267|FG001|Overall Study|Protocol Deviation|0|||
162101823|NCT04642638|585421268|FG002|Overall Study|Protocol Deviation|0|||
162101824|NCT04642638|585421269|FG003|Overall Study|Protocol Deviation|0|||
162101825|NCT04642638|585421270|FG004|Overall Study|Protocol Deviation|1|||
162101826|NCT04642638|585421271|FG005|Overall Study|Protocol Deviation|3|||
162101827|NCT04642638|585421266|FG000|Overall Study|Study Terminated|0|||
162101828|NCT04642638|585421267|FG001|Overall Study|Study Terminated|0|||
162101829|NCT04642638|585421268|FG002|Overall Study|Study Terminated|0|||
162101830|NCT04642638|585421269|FG003|Overall Study|Study Terminated|0|||
162101831|NCT04642638|585421270|FG004|Overall Study|Study Terminated|484|||
162101832|NCT04642638|585421271|FG005|Overall Study|Study Terminated|250|||
162101833|NCT04642638|585421266|FG000|Overall Study|Pregnancy|0|||
162101834|NCT04642638|585421267|FG001|Overall Study|Pregnancy|0|||
162101835|NCT04642638|585421268|FG002|Overall Study|Pregnancy|0|||
162101836|NCT04642638|585421269|FG003|Overall Study|Pregnancy|0|||
162101837|NCT04642638|585421270|FG004|Overall Study|Pregnancy|1|||
162101838|NCT04642638|585421271|FG005|Overall Study|Pregnancy|0|||
162101839|NCT01672801|585421273|FG000|Overall Study|Screen Failure|0|||
162101840|NCT01672801|585421274|FG001|Overall Study|Screen Failure|1|||
162101841|NCT06476366|585421275|FG000|Overall Study|Lost to Follow-up|1|||
162101842|NCT06476366|585421276|FG001|Overall Study|Lost to Follow-up|3|||
162101843|NCT06476366|585421275|FG000|Overall Study|Adverse Event|1|||
162101844|NCT06476366|585421276|FG001|Overall Study|Adverse Event|0|||
162101845|NCT04313881|585421281|FG000|Overall Study|Death|138|||
162101846|NCT04313881|585421282|FG001|Overall Study|Death|126|||
162101847|NCT04313881|585421281|FG000|Overall Study|Study terminated by sponsor|108|||
162101848|NCT04313881|585421282|FG001|Overall Study|Study terminated by sponsor|129|||
162101849|NCT04313881|585421281|FG000|Overall Study|Consent withdrawn|19|||
162101850|NCT04313881|585421282|FG001|Overall Study|Consent withdrawn|15|||
162101851|NCT04313881|585421281|FG000|Overall Study|Reason not Specified|3|||
162101852|NCT04313881|585421282|FG001|Overall Study|Reason not Specified|1|||
162101853|NCT00727272|585421283|FG000|Washout Period A|Adverse Event|0|||
162101854|NCT00727272|585421284|FG001|Washout Period A|Adverse Event|0|||
162101855|NCT00727272|585421285|FG002|Washout Period A|Adverse Event|1|||
162101856|NCT00727272|585421283|FG000|Washout Period B|Withdrawal by Subject|0|||
162101857|NCT00727272|585421284|FG001|Washout Period B|Withdrawal by Subject|0|||
162101858|NCT00727272|585421285|FG002|Washout Period B|Withdrawal by Subject|1|||
162101859|NCT00651664|585421286|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
162101860|NCT00651664|585421287|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
162101861|NCT00651664|585421288|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
162101862|NCT00651664|585421289|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
162101863|NCT00651664|585421290|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
162101864|NCT00651664|585421291|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
162101865|NCT00651664|585421292|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
162101866|NCT00651664|585421293|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
162101867|NCT00651664|585421294|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
162101868|NCT00651664|585421295|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
162101869|NCT00651664|585421286|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
162101870|NCT00651664|585421287|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
162101871|NCT00651664|585421288|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
162101872|NCT00651664|585421289|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
162101873|NCT00651664|585421290|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
162101874|NCT00651664|585421291|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
162101875|NCT00651664|585421292|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
162101876|NCT00651664|585421293|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
162101877|NCT00651664|585421294|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
162101878|NCT00651664|585421295|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
162101879|NCT00651664|585421286|FG000|Overall Study|Progressive Disease|3|||
162101880|NCT00651664|585421287|FG001|Overall Study|Progressive Disease|3|||
162101881|NCT00651664|585421288|FG002|Overall Study|Progressive Disease|3|||
162101882|NCT00651664|585421289|FG003|Overall Study|Progressive Disease|12|||
162101883|NCT00651664|585421290|FG004|Overall Study|Progressive Disease|4|||
162101884|NCT00651664|585421291|FG005|Overall Study|Progressive Disease|1|||
162101885|NCT00651664|585421292|FG006|Overall Study|Progressive Disease|3|||
162101886|NCT00651664|585421293|FG007|Overall Study|Progressive Disease|6|||
162101887|NCT00651664|585421294|FG008|Overall Study|Progressive Disease|5|||
162101888|NCT00651664|585421295|FG009|Overall Study|Progressive Disease|5|||
162101889|NCT00651664|585421286|FG000|Overall Study|Patient Declined Further Treatment|0|||
162101890|NCT00651664|585421287|FG001|Overall Study|Patient Declined Further Treatment|0|||
162101891|NCT00651664|585421288|FG002|Overall Study|Patient Declined Further Treatment|0|||
162101892|NCT00651664|585421289|FG003|Overall Study|Patient Declined Further Treatment|1|||
162101893|NCT00651664|585421290|FG004|Overall Study|Patient Declined Further Treatment|1|||
162101894|NCT00651664|585421291|FG005|Overall Study|Patient Declined Further Treatment|1|||
162101895|NCT00651664|585421292|FG006|Overall Study|Patient Declined Further Treatment|0|||
162101896|NCT00651664|585421293|FG007|Overall Study|Patient Declined Further Treatment|0|||
162101897|NCT00651664|585421294|FG008|Overall Study|Patient Declined Further Treatment|0|||
162101898|NCT00651664|585421295|FG009|Overall Study|Patient Declined Further Treatment|1|||
162101899|NCT00651664|585421286|FG000|Overall Study|Symptomatic Deterioration|0|||
162101900|NCT00651664|585421287|FG001|Overall Study|Symptomatic Deterioration|0|||
162101901|NCT00651664|585421288|FG002|Overall Study|Symptomatic Deterioration|0|||
162101902|NCT00651664|585421289|FG003|Overall Study|Symptomatic Deterioration|1|||
162101903|NCT00651664|585421290|FG004|Overall Study|Symptomatic Deterioration|0|||
162101904|NCT00651664|585421291|FG005|Overall Study|Symptomatic Deterioration|0|||
162101905|NCT00651664|585421292|FG006|Overall Study|Symptomatic Deterioration|1|||
162101906|NCT00651664|585421293|FG007|Overall Study|Symptomatic Deterioration|0|||
162101907|NCT00651664|585421294|FG008|Overall Study|Symptomatic Deterioration|1|||
162101908|NCT00651664|585421295|FG009|Overall Study|Symptomatic Deterioration|0|||
162101909|NCT00651664|585421286|FG000|Overall Study|Reason not Specified|0|||
162101910|NCT00651664|585421287|FG001|Overall Study|Reason not Specified|0|||
162101911|NCT00651664|585421288|FG002|Overall Study|Reason not Specified|0|||
162101912|NCT00651664|585421289|FG003|Overall Study|Reason not Specified|0|||
162101913|NCT00651664|585421290|FG004|Overall Study|Reason not Specified|0|||
162101914|NCT00651664|585421291|FG005|Overall Study|Reason not Specified|0|||
162101915|NCT00651664|585421292|FG006|Overall Study|Reason not Specified|1|||
162101916|NCT00651664|585421293|FG007|Overall Study|Reason not Specified|0|||
162101917|NCT00651664|585421294|FG008|Overall Study|Reason not Specified|0|||
162101918|NCT00651664|585421295|FG009|Overall Study|Reason not Specified|0|||
162101919|NCT00965523|585421298|FG000|Study 221|Progressive Disease|4|||
162101920|NCT00965523|585421298|FG000|Study 221|Physician Decision|3|||
162101921|NCT00965523|585421298|FG000|Study 224|Progressive Disease|5|||
162101922|NCT00965523|585421298|FG000|Study 224|Physician Decision|1|||
162101923|NCT03595904|585421303|FG000|Overall Study|Protocol Violation|3|||
162101924|NCT03595904|585421304|FG001|Overall Study|Protocol Violation|1|||
162101925|NCT03595904|585421303|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
162101926|NCT03595904|585421304|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
162101927|NCT03595904|585421303|FG000|Overall Study|Insurance complications|1|||
162101928|NCT03595904|585421304|FG001|Overall Study|Insurance complications|0|||
162101929|NCT03595904|585421303|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
162101930|NCT03595904|585421304|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
162101931|NCT01581281|585421305|FG000|Overall Study|Early Study Closure|15|||
162101932|NCT01581281|585421306|FG001|Overall Study|Early Study Closure|6|||
162101933|NCT01581281|585421307|FG002|Overall Study|Early Study Closure|12|||
162101934|NCT02187991|585421310|FG000|Overall Study|Adverse Event|13|||
162101935|NCT02187991|585421311|FG001|Overall Study|Adverse Event|14|||
162101936|NCT02187991|585421312|FG002|Overall Study|Adverse Event|3|||
162101937|NCT02187991|585421313|FG003|Overall Study|Adverse Event|2|||
162101938|NCT02187991|585421310|FG000|Overall Study|Withdrawal by Subject|9|||
162101939|NCT02187991|585421311|FG001|Overall Study|Withdrawal by Subject|6|||
162101940|NCT02187991|585421312|FG002|Overall Study|Withdrawal by Subject|3|||
162101941|NCT02187991|585421313|FG003|Overall Study|Withdrawal by Subject|2|||
162101942|NCT02187991|585421310|FG000|Overall Study|Physician Decision|4|||
162101943|NCT02187991|585421311|FG001|Overall Study|Physician Decision|4|||
162101944|NCT02187991|585421312|FG002|Overall Study|Physician Decision|0|||
162101945|NCT02187991|585421313|FG003|Overall Study|Physician Decision|2|||
162101946|NCT02187991|585421310|FG000|Overall Study|Other, unrelated complication|7|||
162101947|NCT02187991|585421311|FG001|Overall Study|Other, unrelated complication|1|||
162101948|NCT02187991|585421312|FG002|Overall Study|Other, unrelated complication|1|||
162101949|NCT02187991|585421313|FG003|Overall Study|Other, unrelated complication|2|||
162101950|NCT02187991|585421310|FG000|Overall Study|Death|1|||
162101951|NCT02187991|585421311|FG001|Overall Study|Death|3|||
162101952|NCT02187991|585421312|FG002|Overall Study|Death|0|||
162101953|NCT02187991|585421313|FG003|Overall Study|Death|0|||
162101954|NCT01392560|585421316|FG000|Overall Study|Adverse Event|2|||
162101955|NCT01392560|585421316|FG000|Overall Study|not entered|8|||
162101956|NCT01392560|585421316|FG000|Overall Study|discontinued during placebo run-in|2|||
162101957|NCT00522275|585421320|FG000|Overall Study|Adverse Event|35|||
162101958|NCT00522275|585421320|FG000|Overall Study|Lack of Efficacy|80|||
162101959|NCT00522275|585421320|FG000|Overall Study|Subject withdrew consent|16|||
162101960|NCT00522275|585421320|FG000|Overall Study|Protocol deviation|1|||
162101961|NCT00522275|585421320|FG000|Overall Study|Unsatisfactory compliance|11|||
162101962|NCT00522275|585421320|FG000|Overall Study|Lost to Follow-up|8|||
162101963|NCT00522275|585421320|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
162101964|NCT00522275|585421320|FG000|Overall Study|Other: Subject is pregnant|2|||
162101965|NCT00522275|585421320|FG000|Overall Study|Other: Subject relocated|2|||
162101966|NCT00522275|585421320|FG000|Overall Study|Other: Subject arrested|1|||
162101967|NCT00522275|585421320|FG000|Overall Study|Other: Site / clinic closed|4|||
162101968|NCT00522275|585421320|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
162101969|NCT00522275|585421320|FG000|Overall Study|Other: Sponsor request|2|||
162101970|NCT00522275|585421320|FG000|Overall Study|Other: Subject ran out of medication|1|||
162101971|NCT00522275|585421320|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
162101972|NCT04656847|585421322|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
162101973|NCT03301051|585421323|FG000|Overall Study|Adverse Event|0|||
162101974|NCT03301051|585421324|FG001|Overall Study|Adverse Event|4|||
162101975|NCT03301051|585421323|FG000|Overall Study|Withdrawal by Subject|59|||
162101976|NCT03301051|585421324|FG001|Overall Study|Withdrawal by Subject|65|||
162101977|NCT03301051|585421323|FG000|Overall Study|Lost to Follow-up|263|||
162101978|NCT03301051|585421324|FG001|Overall Study|Lost to Follow-up|282|||
162101979|NCT03301051|585421323|FG000|Overall Study|Protocol Violation|1|||
162101980|NCT03301051|585421324|FG001|Overall Study|Protocol Violation|3|||
162101981|NCT03301051|585421323|FG000|Overall Study|Physician Decision|1|||
162101982|NCT03301051|585421324|FG001|Overall Study|Physician Decision|3|||
162101983|NCT03301051|585421323|FG000|Overall Study|Death|1|||
162101984|NCT03301051|585421324|FG001|Overall Study|Death|1|||
162101985|NCT03301051|585421323|FG000|Overall Study|Miscellaneous|8|||
162101986|NCT03301051|585421324|FG001|Overall Study|Miscellaneous|4|||
162101987|NCT03301051|585421323|FG000|Overall Study|Randomized, not vaccinated|13|||
162101988|NCT03301051|585421324|FG001|Overall Study|Randomized, not vaccinated|10|||
162101989|NCT00047879|585421325|FG000|Overall Study|Progressive disease|4|||
162101990|NCT00047879|585421326|FG001|Overall Study|Progressive disease|3|||
162101991|NCT01196975|585421327|FG000|Overall Study|Adverse Event|2|||
162101992|NCT01196975|585421328|FG001|Overall Study|Adverse Event|2|||
162101993|NCT01196975|585421329|FG002|Overall Study|Adverse Event|0|||
162101994|NCT01196975|585421330|FG003|Overall Study|Adverse Event|0|||
162101995|NCT01196975|585421331|FG004|Overall Study|Adverse Event|2|||
162101996|NCT01196975|585421327|FG000|Overall Study|Withdrawal by Subject|2|||
162101997|NCT01196975|585421328|FG001|Overall Study|Withdrawal by Subject|1|||
162101998|NCT01196975|585421329|FG002|Overall Study|Withdrawal by Subject|0|||
162101999|NCT01196975|585421330|FG003|Overall Study|Withdrawal by Subject|1|||
162102000|NCT01196975|585421331|FG004|Overall Study|Withdrawal by Subject|0|||
162102001|NCT01196975|585421327|FG000|Overall Study|Lost to Follow-up|11|||
162102002|NCT01196975|585421328|FG001|Overall Study|Lost to Follow-up|6|||
162102003|NCT01196975|585421329|FG002|Overall Study|Lost to Follow-up|5|||
162102004|NCT01196975|585421330|FG003|Overall Study|Lost to Follow-up|5|||
162102005|NCT01196975|585421331|FG004|Overall Study|Lost to Follow-up|11|||
162102006|NCT01358526|585421335|FG000|Open-label Titration Period|Adverse Event|95|||
162102007|NCT01358526|585421336|FG001|Open-label Titration Period|Adverse Event|0|||
162102008|NCT01358526|585421337|FG002|Open-label Titration Period|Adverse Event|0|||
162102009|NCT01358526|585421335|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
162102010|NCT01358526|585421336|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
162102011|NCT01358526|585421337|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
162102012|NCT01358526|585421335|FG000|Open-label Titration Period|Lost to Follow-up|25|||
162102013|NCT01358526|585421336|FG001|Open-label Titration Period|Lost to Follow-up|0|||
162102014|NCT01358526|585421337|FG002|Open-label Titration Period|Lost to Follow-up|0|||
162102015|NCT01358526|585421335|FG000|Open-label Titration Period|Lack of Efficacy|107|||
162102016|NCT01358526|585421336|FG001|Open-label Titration Period|Lack of Efficacy|0|||
162102017|NCT01358526|585421337|FG002|Open-label Titration Period|Lack of Efficacy|0|||
162102018|NCT01358526|585421335|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
162102019|NCT01358526|585421336|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
162102020|NCT01358526|585421337|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
162102021|NCT01358526|585421335|FG000|Open-label Titration Period|Administrative|8|||
162102022|NCT01358526|585421336|FG001|Open-label Titration Period|Administrative|0|||
162102023|NCT01358526|585421337|FG002|Open-label Titration Period|Administrative|0|||
162102024|NCT01358526|585421335|FG000|Open-label Titration Period|Did not qualify|178|||
162102025|NCT01358526|585421336|FG001|Open-label Titration Period|Did not qualify|0|||
162102026|NCT01358526|585421337|FG002|Open-label Titration Period|Did not qualify|0|||
162102027|NCT01358526|585421335|FG000|Double-blind Phase|Adverse Event|0|||
162102028|NCT01358526|585421336|FG001|Double-blind Phase|Adverse Event|24|||
162102029|NCT01358526|585421337|FG002|Double-blind Phase|Adverse Event|23|||
162102030|NCT01358526|585421335|FG000|Double-blind Phase|Withdrawal by Subject|0|||
162102031|NCT01358526|585421336|FG001|Double-blind Phase|Withdrawal by Subject|10|||
162102032|NCT01358526|585421337|FG002|Double-blind Phase|Withdrawal by Subject|8|||
162102033|NCT01358526|585421335|FG000|Double-blind Phase|Lost to Follow-up|0|||
162102034|NCT01358526|585421336|FG001|Double-blind Phase|Lost to Follow-up|4|||
162102035|NCT01358526|585421337|FG002|Double-blind Phase|Lost to Follow-up|1|||
162102036|NCT01358526|585421335|FG000|Double-blind Phase|Lack of Efficacy|0|||
162102037|NCT01358526|585421336|FG001|Double-blind Phase|Lack of Efficacy|31|||
162102038|NCT01358526|585421337|FG002|Double-blind Phase|Lack of Efficacy|73|||
162102039|NCT01358526|585421335|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
162102040|NCT01358526|585421336|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
162102041|NCT01358526|585421337|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
162102042|NCT01358526|585421335|FG000|Double-blind Phase|Administrative|0|||
162102043|NCT01358526|585421336|FG001|Double-blind Phase|Administrative|6|||
162102044|NCT01358526|585421337|FG002|Double-blind Phase|Administrative|10|||
162102045|NCT00360529|585421338|FG000|Overall Study|Adverse Event|10|||
162102046|NCT00360529|585421339|FG001|Overall Study|Adverse Event|23|||
162102047|NCT00360529|585421340|FG002|Overall Study|Adverse Event|33|||
162102048|NCT00360529|585421338|FG000|Overall Study|Protocol Violation|3|||
162102049|NCT00360529|585421339|FG001|Overall Study|Protocol Violation|3|||
162102050|NCT00360529|585421340|FG002|Overall Study|Protocol Violation|11|||
162102051|NCT00360529|585421338|FG000|Overall Study|Lost to Follow-up|14|||
162102052|NCT00360529|585421339|FG001|Overall Study|Lost to Follow-up|10|||
162102053|NCT00360529|585421340|FG002|Overall Study|Lost to Follow-up|13|||
162102054|NCT00360529|585421338|FG000|Overall Study|Withdrawal by Subject|22|||
162102055|NCT00360529|585421339|FG001|Overall Study|Withdrawal by Subject|14|||
162102056|NCT00360529|585421340|FG002|Overall Study|Withdrawal by Subject|18|||
162102057|NCT00360529|585421338|FG000|Overall Study|Lack of Efficacy|8|||
162102058|NCT00360529|585421339|FG001|Overall Study|Lack of Efficacy|6|||
162102059|NCT00360529|585421340|FG002|Overall Study|Lack of Efficacy|5|||
162102060|NCT00360529|585421338|FG000|Overall Study|Reason discontinued not explained above|4|||
162102061|NCT00360529|585421339|FG001|Overall Study|Reason discontinued not explained above|9|||
162102062|NCT00360529|585421340|FG002|Overall Study|Reason discontinued not explained above|11|||
162102063|NCT01781572|585421345|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
162102064|NCT01781572|585421346|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
162102065|NCT01781572|585421347|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
162102066|NCT01781572|585421345|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
162102067|NCT01781572|585421346|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
162102068|NCT01781572|585421347|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
162102069|NCT01781572|585421345|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
162102070|NCT01781572|585421346|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
162102071|NCT01781572|585421347|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
162102072|NCT01781572|585421345|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
162102073|NCT01781572|585421346|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
162102074|NCT01781572|585421347|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
162102075|NCT01781572|585421345|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
162102076|NCT01781572|585421346|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
162102077|NCT01781572|585421347|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
162102078|NCT01781572|585421345|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
162102079|NCT01781572|585421346|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
162102080|NCT01781572|585421347|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
162102081|NCT01781572|585421345|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
162102082|NCT01781572|585421346|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
162102083|NCT01781572|585421347|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
162102084|NCT01781572|585421345|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
162102085|NCT01781572|585421346|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
162102086|NCT01781572|585421347|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
162102087|NCT01781572|585421345|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
162102088|NCT01781572|585421346|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
162102089|NCT01781572|585421347|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
162102090|NCT01781572|585421345|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
162102091|NCT01781572|585421346|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
162102092|NCT01781572|585421347|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
162102093|NCT01781572|585421345|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
162102094|NCT01781572|585421346|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
162102095|NCT01781572|585421347|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
162102096|NCT01781572|585421345|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
162102097|NCT01781572|585421346|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
162102098|NCT01781572|585421347|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
162102099|NCT01781572|585421345|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
162102100|NCT01781572|585421346|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
162102101|NCT01781572|585421347|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
162102102|NCT01781572|585421345|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
162102103|NCT01781572|585421346|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
162102104|NCT01781572|585421347|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
162102105|NCT01781572|585421345|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
162102106|NCT01781572|585421346|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
162102107|NCT01781572|585421347|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
162102108|NCT01781572|585421345|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
162102109|NCT01781572|585421346|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
162102110|NCT01781572|585421347|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
162102111|NCT01781572|585421345|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
162102112|NCT01781572|585421346|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
162102113|NCT01781572|585421347|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
162102114|NCT01781572|585421345|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
162102115|NCT01781572|585421346|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
162102116|NCT01781572|585421347|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
162102117|NCT01218438|585421348|FG000|Epoch 1|Physician Decision|2|||
162102118|NCT01218438|585421348|FG000|Epoch 1|Adverse Event|1|||
162102119|NCT01218438|585421348|FG000|Epoch 3|Withdrawal by Subject|3|||
162102120|NCT01218438|585421348|FG000|Epoch 3|Adverse Event|1|||
162102121|NCT01218438|585421348|FG000|Epoch 4|Physician Decision|1|||
162102122|NCT01218438|585421348|FG000|Epoch 4|Withdrawal by Subject|2|||
162102123|NCT06167031|585421351|FG000|Overall Study|Lost to Follow-up|5|||
162102124|NCT06167031|585421352|FG001|Overall Study|Lost to Follow-up|1|||
162102125|NCT00907153|585423187|FG000|Overall Study|Lost to Follow-up|1|||
162102126|NCT00907153|585423188|FG001|Overall Study|Lost to Follow-up|1|||
162102127|NCT00907153|585423187|FG000|Overall Study|Withdrawal by Subject|1|||
162102128|NCT00907153|585423188|FG001|Overall Study|Withdrawal by Subject|3|||
162102129|NCT00713648|585423194|FG000|Overall Study|Adverse Event|1|||
162102130|NCT00713648|585423194|FG000|Overall Study|Unclassified|2|||
162102131|NCT00713648|585423194|FG000|Overall Study|According to Protocol|2|||
162102132|NCT00713648|585423194|FG000|Overall Study|Development of antibodies|3|||
162102133|NCT02566031|585423197|FG000|Overall Study|Patient/guardian decision|14|||
162102134|NCT02566031|585423198|FG001|Overall Study|Patient/guardian decision|7|||
162102135|NCT02566031|585423197|FG000|Overall Study|Protocol deviation|2|||
162102136|NCT02566031|585423198|FG001|Overall Study|Protocol deviation|3|||
162102137|NCT02566031|585423197|FG000|Overall Study|Adverse Event|3|||
162102138|NCT02566031|585423198|FG001|Overall Study|Adverse Event|1|||
162102139|NCT02566031|585423197|FG000|Overall Study|Lost to Follow-up|1|||
162102140|NCT02566031|585423198|FG001|Overall Study|Lost to Follow-up|1|||
162102141|NCT03031938|585423199|FG000|Overall Study|Death|1|||
162102142|NCT03031938|585423200|FG001|Overall Study|Death|0|||
162102143|NCT00511004|585423207|FG000|Overall Study|Lost to Follow-up|0|||
162102144|NCT00511004|585423208|FG001|Overall Study|Lost to Follow-up|0|||
162102145|NCT00511004|585423209|FG002|Overall Study|Lost to Follow-up|4|||
162102146|NCT00990652|585423210|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
162102147|NCT00990652|585423210|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
162102148|NCT01910129|585423214|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
162102149|NCT01910129|585423215|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
162102150|NCT01910129|585423216|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
162102151|NCT01910129|585423214|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
162102152|NCT01910129|585423215|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
162102153|NCT01910129|585423216|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
162102154|NCT02415400|585423217|FG000|Overall Study|Adverse Event|0|||
162102155|NCT02415400|585423218|FG001|Overall Study|Adverse Event|1|||
162102156|NCT02415400|585423219|FG002|Overall Study|Adverse Event|1|||
162102157|NCT02415400|585423220|FG003|Overall Study|Adverse Event|2|||
162102158|NCT02415400|585423217|FG000|Overall Study|Participant request to stop therapy|4|||
162102159|NCT02415400|585423218|FG001|Overall Study|Participant request to stop therapy|3|||
162102160|NCT02415400|585423219|FG002|Overall Study|Participant request to stop therapy|8|||
162102161|NCT02415400|585423220|FG003|Overall Study|Participant request to stop therapy|6|||
162102162|NCT02415400|585423217|FG000|Overall Study|Participant withdrew consent|14|||
162102163|NCT02415400|585423218|FG001|Overall Study|Participant withdrew consent|12|||
162102164|NCT02415400|585423219|FG002|Overall Study|Participant withdrew consent|30|||
162102165|NCT02415400|585423220|FG003|Overall Study|Participant withdrew consent|21|||
162102166|NCT02415400|585423217|FG000|Overall Study|Death|39|||
162102167|NCT02415400|585423218|FG001|Overall Study|Death|41|||
162102168|NCT02415400|585423219|FG002|Overall Study|Death|35|||
162102169|NCT02415400|585423220|FG003|Overall Study|Death|42|||
162102170|NCT02415400|585423217|FG000|Overall Study|Lost to Follow-up|3|||
162102171|NCT02415400|585423218|FG001|Overall Study|Lost to Follow-up|3|||
162102172|NCT02415400|585423219|FG002|Overall Study|Lost to Follow-up|2|||
162102173|NCT02415400|585423220|FG003|Overall Study|Lost to Follow-up|5|||
162102174|NCT02415400|585423217|FG000|Overall Study|Poor/Non-Compliance|0|||
162102175|NCT02415400|585423218|FG001|Overall Study|Poor/Non-Compliance|1|||
162102176|NCT02415400|585423219|FG002|Overall Study|Poor/Non-Compliance|3|||
162102177|NCT02415400|585423220|FG003|Overall Study|Poor/Non-Compliance|4|||
162102178|NCT02415400|585423217|FG000|Overall Study|Participant no longer meets criteria|2|||
162102179|NCT02415400|585423218|FG001|Overall Study|Participant no longer meets criteria|0|||
162102180|NCT02415400|585423219|FG002|Overall Study|Participant no longer meets criteria|0|||
162102181|NCT02415400|585423220|FG003|Overall Study|Participant no longer meets criteria|1|||
162102182|NCT02415400|585423217|FG000|Overall Study|Participant doesn't answer phone|1|||
162102183|NCT02415400|585423218|FG001|Overall Study|Participant doesn't answer phone|0|||
162102184|NCT02415400|585423219|FG002|Overall Study|Participant doesn't answer phone|0|||
162102185|NCT02415400|585423220|FG003|Overall Study|Participant doesn't answer phone|0|||
162102186|NCT02415400|585423217|FG000|Overall Study|Participant wanted home visits|1|||
162102187|NCT02415400|585423218|FG001|Overall Study|Participant wanted home visits|0|||
162102188|NCT02415400|585423219|FG002|Overall Study|Participant wanted home visits|0|||
162102189|NCT02415400|585423220|FG003|Overall Study|Participant wanted home visits|0|||
162102190|NCT02415400|585423217|FG000|Overall Study|Randomized in error|2|||
162102191|NCT02415400|585423218|FG001|Overall Study|Randomized in error|0|||
162102192|NCT02415400|585423219|FG002|Overall Study|Randomized in error|0|||
162102193|NCT02415400|585423220|FG003|Overall Study|Randomized in error|0|||
162102194|NCT02415400|585423217|FG000|Overall Study|No study drug on site|0|||
162102195|NCT02415400|585423218|FG001|Overall Study|No study drug on site|1|||
162102196|NCT02415400|585423219|FG002|Overall Study|No study drug on site|0|||
162102197|NCT02415400|585423220|FG003|Overall Study|No study drug on site|0|||
162102198|NCT02415400|585423217|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
162102199|NCT02415400|585423218|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
162102200|NCT02415400|585423219|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
162102201|NCT02415400|585423220|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
162102202|NCT02415400|585423217|FG000|Overall Study|Coagulation values cannot be set|0|||
162102203|NCT02415400|585423218|FG001|Overall Study|Coagulation values cannot be set|0|||
162102204|NCT02415400|585423219|FG002|Overall Study|Coagulation values cannot be set|1|||
162102205|NCT02415400|585423220|FG003|Overall Study|Coagulation values cannot be set|0|||
162102206|NCT02415400|585423217|FG000|Overall Study|State regulations prevent participation|0|||
162102207|NCT02415400|585423218|FG001|Overall Study|State regulations prevent participation|0|||
162102208|NCT02415400|585423219|FG002|Overall Study|State regulations prevent participation|1|||
162102209|NCT02415400|585423220|FG003|Overall Study|State regulations prevent participation|0|||
162102210|NCT02415400|585423217|FG000|Overall Study|Poor treatment monitoring|0|||
162102211|NCT02415400|585423218|FG001|Overall Study|Poor treatment monitoring|0|||
162102212|NCT02415400|585423219|FG002|Overall Study|Poor treatment monitoring|1|||
162102213|NCT02415400|585423220|FG003|Overall Study|Poor treatment monitoring|0|||
162102214|NCT02415400|585423217|FG000|Overall Study|Participant in jail|0|||
162102215|NCT02415400|585423218|FG001|Overall Study|Participant in jail|0|||
162102216|NCT02415400|585423219|FG002|Overall Study|Participant in jail|1|||
162102217|NCT02415400|585423220|FG003|Overall Study|Participant in jail|0|||
162102218|NCT02415400|585423217|FG000|Overall Study|Investigator decision|0|||
162102219|NCT02415400|585423218|FG001|Overall Study|Investigator decision|0|||
162102220|NCT02415400|585423219|FG002|Overall Study|Investigator decision|1|||
162102221|NCT02415400|585423220|FG003|Overall Study|Investigator decision|1|||
162102222|NCT02415400|585423217|FG000|Overall Study|Site closure; participant won't transfer|0|||
162102223|NCT02415400|585423218|FG001|Overall Study|Site closure; participant won't transfer|0|||
162102224|NCT02415400|585423219|FG002|Overall Study|Site closure; participant won't transfer|0|||
162102225|NCT02415400|585423220|FG003|Overall Study|Site closure; participant won't transfer|1|||
162102226|NCT01226745|585423223|FG000|Overall Study|Did not complete schedule of assessments|8|||
162102227|NCT01226745|585423224|FG001|Overall Study|Did not complete schedule of assessments|3|||
162102228|NCT01226745|585423225|FG002|Overall Study|Did not complete schedule of assessments|6|||
162102229|NCT01226745|585423226|FG003|Overall Study|Did not complete schedule of assessments|0|||
162102230|NCT01226745|585423227|FG004|Overall Study|Did not complete schedule of assessments|0|||
162102231|NCT01226745|585423228|FG005|Overall Study|Did not complete schedule of assessments|1|||
162102232|NCT01226745|585423223|FG000|Overall Study|Lost to Follow-up|2|||
162102233|NCT01226745|585423224|FG001|Overall Study|Lost to Follow-up|6|||
162102234|NCT01226745|585423225|FG002|Overall Study|Lost to Follow-up|6|||
162102235|NCT01226745|585423226|FG003|Overall Study|Lost to Follow-up|1|||
162102236|NCT01226745|585423227|FG004|Overall Study|Lost to Follow-up|1|||
162102237|NCT01226745|585423228|FG005|Overall Study|Lost to Follow-up|2|||
162102238|NCT01226745|585423223|FG000|Overall Study|Death|1|||
162102239|NCT01226745|585423224|FG001|Overall Study|Death|0|||
162102240|NCT01226745|585423225|FG002|Overall Study|Death|0|||
162102241|NCT01226745|585423226|FG003|Overall Study|Death|0|||
162102242|NCT01226745|585423227|FG004|Overall Study|Death|0|||
162102243|NCT01226745|585423228|FG005|Overall Study|Death|1|||
162102244|NCT01226745|585423223|FG000|Overall Study|Other|6|||
162102245|NCT01226745|585423224|FG001|Overall Study|Other|7|||
162102246|NCT01226745|585423225|FG002|Overall Study|Other|8|||
162102247|NCT01226745|585423226|FG003|Overall Study|Other|4|||
162102248|NCT01226745|585423227|FG004|Overall Study|Other|3|||
162102249|NCT01226745|585423228|FG005|Overall Study|Other|1|||
162102250|NCT00295750|585423233|FG000|Overall Study|Adverse Event|19|||
162102251|NCT00295750|585423234|FG001|Overall Study|Adverse Event|15|||
162102252|NCT00295750|585423235|FG002|Overall Study|Adverse Event|12|||
162102253|NCT00295750|585423233|FG000|Overall Study|Lack of Efficacy|1|||
162102254|NCT00295750|585423234|FG001|Overall Study|Lack of Efficacy|1|||
162102255|NCT00295750|585423235|FG002|Overall Study|Lack of Efficacy|0|||
162102256|NCT00295750|585423233|FG000|Overall Study|Lost to Follow-up|1|||
162102257|NCT00295750|585423234|FG001|Overall Study|Lost to Follow-up|4|||
162102258|NCT00295750|585423235|FG002|Overall Study|Lost to Follow-up|1|||
162102259|NCT00295750|585423233|FG000|Overall Study|Taking prohibited therapy|2|||
162102260|NCT00295750|585423234|FG001|Overall Study|Taking prohibited therapy|3|||
162102261|NCT00295750|585423235|FG002|Overall Study|Taking prohibited therapy|2|||
162102262|NCT00295750|585423233|FG000|Overall Study|Administrative errors|2|||
162102263|NCT00295750|585423234|FG001|Overall Study|Administrative errors|4|||
162102264|NCT00295750|585423235|FG002|Overall Study|Administrative errors|5|||
162102265|NCT00295750|585423233|FG000|Overall Study|Trial drug errors|1|||
162102266|NCT00295750|585423234|FG001|Overall Study|Trial drug errors|1|||
162102267|NCT00295750|585423235|FG002|Overall Study|Trial drug errors|0|||
162102268|NCT00295750|585423233|FG000|Overall Study|Disease progression|2|||
162102269|NCT00295750|585423234|FG001|Overall Study|Disease progression|1|||
162102270|NCT00295750|585423235|FG002|Overall Study|Disease progression|0|||
162102271|NCT00295750|585423233|FG000|Overall Study|Personal reasons|0|||
162102272|NCT00295750|585423234|FG001|Overall Study|Personal reasons|1|||
162102273|NCT00295750|585423235|FG002|Overall Study|Personal reasons|0|||
162102274|NCT00295750|585423233|FG000|Overall Study|Randomized but never received trial drug|4|||
162102275|NCT00295750|585423234|FG001|Overall Study|Randomized but never received trial drug|3|||
162102276|NCT00295750|585423235|FG002|Overall Study|Randomized but never received trial drug|3|||
162102277|NCT00295750|585423233|FG000|Overall Study|Withdrawal by Subject|9|||
162102278|NCT00295750|585423234|FG001|Overall Study|Withdrawal by Subject|4|||
162102279|NCT00295750|585423235|FG002|Overall Study|Withdrawal by Subject|7|||
162102280|NCT00295750|585423233|FG000|Overall Study|Protocol Violation|2|||
162102281|NCT00295750|585423234|FG001|Overall Study|Protocol Violation|4|||
162102282|NCT00295750|585423235|FG002|Overall Study|Protocol Violation|2|||
162102283|NCT01650259|585423236|FG000|Overall Study|Improvement|105|||
162102284|NCT01650259|585423237|FG001|Overall Study|Improvement|0|||
162102285|NCT01650259|585423236|FG000|Overall Study|Adverse Event|127|||
162102286|NCT01650259|585423237|FG001|Overall Study|Adverse Event|0|||
162102287|NCT01650259|585423236|FG000|Overall Study|Lack of Efficacy|143|||
162102288|NCT01650259|585423237|FG001|Overall Study|Lack of Efficacy|0|||
162102289|NCT01650259|585423236|FG000|Overall Study|Lost to Follow-up|435|||
162102290|NCT01650259|585423237|FG001|Overall Study|Lost to Follow-up|0|||
162102291|NCT01650259|585423236|FG000|Overall Study|Patients had no visit after entry|70|||
162102292|NCT01650259|585423237|FG001|Overall Study|Patients had no visit after entry|0|||
162102293|NCT01650259|585423236|FG000|Overall Study|CRF not collected|98|||
162102294|NCT01650259|585423237|FG001|Overall Study|CRF not collected|82|||
162102295|NCT01650259|585423236|FG000|Overall Study|Not treated|1|||
162102296|NCT01650259|585423237|FG001|Overall Study|Not treated|7|||
162102297|NCT01650259|585423236|FG000|Overall Study|Other than listed|64|||
162102298|NCT01650259|585423237|FG001|Overall Study|Other than listed|146|||
162102299|NCT00584727|585423245|FG000|First Intervention|Discontinuation|0|||
162102300|NCT00584727|585423246|FG001|First Intervention|Discontinuation|0|||
162102301|NCT00584727|585423247|FG002|First Intervention|Discontinuation|1|||
162102302|NCT00584727|585423248|FG003|First Intervention|Discontinuation|0|||
162102303|NCT00584727|585423249|FG004|First Intervention|Discontinuation|0|||
162102304|NCT00584727|585423250|FG005|First Intervention|Discontinuation|0|||
162102305|NCT00584727|585423245|FG000|Third Intervention|Protocol Violation|0|||
162102306|NCT00584727|585423246|FG001|Third Intervention|Protocol Violation|0|||
162102307|NCT00584727|585423247|FG002|Third Intervention|Protocol Violation|1|||
162102308|NCT00584727|585423248|FG003|Third Intervention|Protocol Violation|0|||
162102309|NCT00584727|585423249|FG004|Third Intervention|Protocol Violation|4|||
162102310|NCT00584727|585423250|FG005|Third Intervention|Protocol Violation|2|||
162102311|NCT04072159|585423251|FG000|Overall Study|Lost to Follow-up|6|||
162102312|NCT04072159|585423252|FG001|Overall Study|Lost to Follow-up|6|||
162102313|NCT04072159|585423251|FG000|Overall Study|Withdrawal by Subject|2|||
162102314|NCT04072159|585423252|FG001|Overall Study|Withdrawal by Subject|0|||
162102315|NCT00989287|585423256|FG000|Overall Study|Adverse Event|1|||
162102316|NCT00989287|585423257|FG001|Overall Study|Adverse Event|0|||
162102317|NCT00989287|585423256|FG000|Overall Study|Lost to Follow-up|0|||
162102318|NCT00989287|585423257|FG001|Overall Study|Lost to Follow-up|1|||
162102319|NCT00695669|585423258|FG000|Overall Study|Adverse Event|0|||
162102320|NCT00695669|585423259|FG001|Overall Study|Adverse Event|0|||
162102321|NCT00695669|585423260|FG002|Overall Study|Adverse Event|2|||
162102322|NCT00695669|585423261|FG003|Overall Study|Adverse Event|0|||
162102323|NCT00695669|585423258|FG000|Overall Study|Lost to Follow-up|4|||
162102324|NCT00695669|585423259|FG001|Overall Study|Lost to Follow-up|4|||
162102325|NCT00695669|585423260|FG002|Overall Study|Lost to Follow-up|1|||
162102326|NCT00695669|585423261|FG003|Overall Study|Lost to Follow-up|4|||
162102327|NCT00092131|585423262|FG000|Treatment Period I|Adverse Event|1|||
162102328|NCT00092131|585423263|FG001|Treatment Period I|Adverse Event|0|||
162102329|NCT00092131|585423262|FG000|Treatment Period II|Adverse Event|0|||
162102330|NCT00092131|585423263|FG001|Treatment Period II|Adverse Event|1|||
162102331|NCT02341417|585423264|FG000|Overall Study|Withdrawal by Subject|0|||
162102332|NCT02341417|585423265|FG001|Overall Study|Withdrawal by Subject|2|||
162102333|NCT02341417|585423266|FG002|Overall Study|Withdrawal by Subject|0|||
162102334|NCT02341417|585423264|FG000|Overall Study|Decision by sponsor|2|||
162102335|NCT02341417|585423265|FG001|Overall Study|Decision by sponsor|0|||
162102336|NCT02341417|585423266|FG002|Overall Study|Decision by sponsor|0|||
162102337|NCT02341417|585423264|FG000|Overall Study|Death|0|||
162102338|NCT02341417|585423265|FG001|Overall Study|Death|0|||
162102339|NCT02341417|585423266|FG002|Overall Study|Death|1|||
162102340|NCT03570619|585423282|FG000|Overall Study|Adverse Event|2|||
162102341|NCT03570619|585423283|FG001|Overall Study|Adverse Event|0|||
162102342|NCT03570619|585423284|FG002|Overall Study|Adverse Event|1|||
162102343|NCT03570619|585423282|FG000|Overall Study|new diagnosis of new malignancy|1|||
162102344|NCT03570619|585423283|FG001|Overall Study|new diagnosis of new malignancy|0|||
162102345|NCT03570619|585423284|FG002|Overall Study|new diagnosis of new malignancy|0|||
162102346|NCT03570619|585423282|FG000|Overall Study|Physician Decision|1|||
162102347|NCT03570619|585423283|FG001|Overall Study|Physician Decision|1|||
162102348|NCT03570619|585423284|FG002|Overall Study|Physician Decision|0|||
162102349|NCT03570619|585423282|FG000|Overall Study|Withdrawal by Subject|0|||
162122794|NCT01351025|585500336|FG001|Week 24 - 44|Site closed|1|||
162102350|NCT03570619|585423283|FG001|Overall Study|Withdrawal by Subject|2|||
162102351|NCT03570619|585423284|FG002|Overall Study|Withdrawal by Subject|0|||
162102352|NCT04773587|585423285|FG000|Overall Study|Lost to Follow-up|11|||
162102353|NCT04773587|585423286|FG001|Overall Study|Lost to Follow-up|3|||
162102354|NCT04773587|585423285|FG000|Overall Study|Adverse Event|6|||
162102355|NCT04773587|585423286|FG001|Overall Study|Adverse Event|3|||
162102356|NCT04773587|585423285|FG000|Overall Study|Lack of Efficacy|5|||
162102357|NCT04773587|585423286|FG001|Overall Study|Lack of Efficacy|2|||
162102358|NCT04773587|585423285|FG000|Overall Study|Withdrawal by Subject|4|||
162102359|NCT04773587|585423286|FG001|Overall Study|Withdrawal by Subject|5|||
162102360|NCT04773587|585423285|FG000|Overall Study|Noncompliance|1|||
162102361|NCT04773587|585423286|FG001|Overall Study|Noncompliance|0|||
162102362|NCT04773587|585423285|FG000|Overall Study|Protocol Violation|1|||
162102363|NCT04773587|585423286|FG001|Overall Study|Protocol Violation|0|||
162102364|NCT04773587|585423285|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
162102365|NCT04773587|585423286|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
162102366|NCT02372409|585423287|FG000|Overall Study|Lost to Follow-up|1|||
162102367|NCT02372409|585423288|FG001|Overall Study|Lost to Follow-up|0|||
162102368|NCT02372409|585423287|FG000|Overall Study|Disease progression|1|||
162102369|NCT02372409|585423288|FG001|Overall Study|Disease progression|1|||
162102370|NCT01808313|585423289|FG000|Overall Study|Adverse Event|5|||
162102371|NCT01808313|585423289|FG000|Overall Study|Protocol Violation|2|||
162102372|NCT01808313|585423289|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
162102373|NCT01808313|585423289|FG000|Overall Study|Lost to Follow-up|1|||
162102374|NCT01808313|585423289|FG000|Overall Study|Physician Decision|1|||
162102375|NCT03086447|585423299|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
162102376|NCT03086447|585423300|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
162102377|NCT03086447|585423299|FG000|Overall Study|Lost Lens|2|||
162102378|NCT03086447|585423300|FG001|Overall Study|Lost Lens|5|||
162102379|NCT03086447|585423299|FG000|Overall Study|Product quality complaint|0|||
162102380|NCT03086447|585423300|FG001|Overall Study|Product quality complaint|1|||
162102381|NCT03086447|585423299|FG000|Overall Study|Lens Damage|1|||
162102382|NCT03086447|585423300|FG001|Overall Study|Lens Damage|6|||
162102383|NCT03086447|585423299|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
162102384|NCT03086447|585423300|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
162102385|NCT03086447|585423299|FG000|Overall Study|Test Article No Longer Available|1|||
162102386|NCT03086447|585423300|FG001|Overall Study|Test Article No Longer Available|0|||
162102387|NCT03086447|585423299|FG000|Overall Study|Protocol Violation|2|||
162102388|NCT03086447|585423300|FG001|Overall Study|Protocol Violation|4|||
162102389|NCT03086447|585423299|FG000|Overall Study|Lost to Follow-up|0|||
162102390|NCT03086447|585423300|FG001|Overall Study|Lost to Follow-up|1|||
162102391|NCT03086447|585423299|FG000|Overall Study|Adverse Event|3|||
162102392|NCT03086447|585423300|FG001|Overall Study|Adverse Event|0|||
162102393|NCT03086447|585423299|FG000|Overall Study|Lens Discomfort|2|||
162102394|NCT03086447|585423300|FG001|Overall Study|Lens Discomfort|1|||
162102395|NCT00435370|585423305|FG000|Overall Study|Adverse Event|8|||
162102396|NCT00435370|585423306|FG001|Overall Study|Adverse Event|8|||
162102397|NCT00435370|585423305|FG000|Overall Study|Withdrawal by Subject|10|||
162102398|NCT00435370|585423306|FG001|Overall Study|Withdrawal by Subject|10|||
162102399|NCT00435370|585423305|FG000|Overall Study|Antipsychotic medication changed|4|||
162102400|NCT00435370|585423306|FG001|Overall Study|Antipsychotic medication changed|2|||
162102401|NCT00659334|585423312|FG000|Overall Study|Screen Failure|8|||
162102402|NCT00659334|585423313|FG001|Overall Study|Screen Failure|5|||
162102403|NCT00659334|585423314|FG002|Overall Study|Screen Failure|0|||
162102404|NCT00659334|585423315|FG003|Overall Study|Screen Failure|0|||
162102405|NCT00659334|585423316|FG004|Overall Study|Screen Failure|0|||
162102406|NCT00659334|585423317|FG005|Overall Study|Screen Failure|0|||
162102407|NCT00659334|585423318|FG006|Overall Study|Screen Failure|1|||
162102408|NCT03034577|585423319|FG000|Overall Study|Withdrawal by Subject|6|||
162102409|NCT03034577|585423320|FG001|Overall Study|Withdrawal by Subject|9|||
162102410|NCT03034577|585423319|FG000|Overall Study|Lost to Follow-up|25|||
162102411|NCT03034577|585423320|FG001|Overall Study|Lost to Follow-up|26|||
162102412|NCT01174342|585423321|FG000|Overall Study|Conversion to cesarean section|4|||
162102413|NCT02625623|585423322|FG000|Overall Study|Participants randomized but not treated|9|||
162102414|NCT02625623|585423323|FG001|Overall Study|Participants randomized but not treated|1|||
162102415|NCT00744653|585423327|FG000|Overall Study|antineoplastic treatment|11|||
162102416|NCT00744653|585423327|FG000|Overall Study|Death|1|||
162102417|NCT00744653|585423327|FG000|Overall Study|Lost to Follow-up|1|||
162102418|NCT00744653|585423327|FG000|Overall Study|Physician Decision|3|||
162102419|NCT03826667|585423330|FG000|Overall Study|Protocol deviation|21|||
162102420|NCT00808808|585423331|FG000|Overall Study|Vaccinated; survey not completed|131|||
162102421|NCT00808808|585423332|FG001|Overall Study|Vaccinated; survey not completed|169|||
162102422|NCT00808808|585423333|FG002|Overall Study|Vaccinated; survey not completed|302|||
162102423|NCT00808808|585423331|FG000|Overall Study|Employee was not vaccinated.|2686|||
162102424|NCT00808808|585423332|FG001|Overall Study|Employee was not vaccinated.|2268|||
162102425|NCT00808808|585423333|FG002|Overall Study|Employee was not vaccinated.|2255|||
162102426|NCT02298192|585423337|FG000|Overall Study|Unclassified|3|||
162102427|NCT02298192|585423338|FG001|Overall Study|Unclassified|2|||
162102428|NCT02298192|585423337|FG000|Overall Study|Withdrawal criteria|2|||
162102429|NCT02298192|585423338|FG001|Overall Study|Withdrawal criteria|0|||
162102430|NCT02298192|585423337|FG000|Overall Study|Withdrawal by Subject|6|||
162102431|NCT02298192|585423338|FG001|Overall Study|Withdrawal by Subject|1|||
162102432|NCT02298192|585423337|FG000|Overall Study|Lost to Follow-up|2|||
162102433|NCT02298192|585423338|FG001|Overall Study|Lost to Follow-up|1|||
162102434|NCT02298192|585423337|FG000|Overall Study|Adverse Event|6|||
162102435|NCT02298192|585423338|FG001|Overall Study|Adverse Event|2|||
162102436|NCT02352948|585423340|FG000|Overall Study|Death|47|||
162102437|NCT02352948|585423341|FG001|Overall Study|Death|48|||
162102438|NCT02352948|585423342|FG002|Overall Study|Death|114|||
162102439|NCT02352948|585423343|FG003|Overall Study|Death|74|||
162102440|NCT02352948|585423344|FG004|Overall Study|Death|77|||
162102441|NCT02352948|585423345|FG005|Overall Study|Death|44|||
162102442|NCT02352948|585423340|FG000|Overall Study|Lost to Follow-up|1|||
162102443|NCT02352948|585423341|FG001|Overall Study|Lost to Follow-up|0|||
162102444|NCT02352948|585423342|FG002|Overall Study|Lost to Follow-up|2|||
162102445|NCT02352948|585423343|FG003|Overall Study|Lost to Follow-up|1|||
162102446|NCT02352948|585423344|FG004|Overall Study|Lost to Follow-up|2|||
162102447|NCT02352948|585423345|FG005|Overall Study|Lost to Follow-up|1|||
162102448|NCT02352948|585423340|FG000|Overall Study|Withdrawal by Subject|1|||
162102449|NCT02352948|585423341|FG001|Overall Study|Withdrawal by Subject|10|||
162102450|NCT02352948|585423342|FG002|Overall Study|Withdrawal by Subject|11|||
162102451|NCT02352948|585423343|FG003|Overall Study|Withdrawal by Subject|23|||
162102452|NCT02352948|585423344|FG004|Overall Study|Withdrawal by Subject|9|||
162102453|NCT02352948|585423345|FG005|Overall Study|Withdrawal by Subject|4|||
162102454|NCT02352948|585423340|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
162102455|NCT02352948|585423341|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
162102456|NCT02352948|585423342|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
162102457|NCT02352948|585423343|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
162102458|NCT02352948|585423344|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
162102459|NCT02352948|585423345|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
162102460|NCT02352948|585423340|FG000|Overall Study|Other|0|||
162102461|NCT02352948|585423341|FG001|Overall Study|Other|0|||
162102462|NCT02352948|585423342|FG002|Overall Study|Other|2|||
162102463|NCT02352948|585423343|FG003|Overall Study|Other|0|||
162102464|NCT02352948|585423344|FG004|Overall Study|Other|0|||
162102465|NCT02352948|585423345|FG005|Overall Study|Other|0|||
162102466|NCT01453595|585423351|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
162102467|NCT01453595|585423352|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162102468|NCT01453595|585423353|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
162102469|NCT01128413|585423358|FG000|Overall Study|Withdrawal by Subject|1|||
162102470|NCT01128413|585423359|FG001|Overall Study|Withdrawal by Subject|0|||
162102471|NCT01128413|585423358|FG000|Overall Study|NICOM Monitor Problems|2|||
162102472|NCT01128413|585423359|FG001|Overall Study|NICOM Monitor Problems|1|||
162102473|NCT01128413|585423358|FG000|Overall Study|Pt made DNR|1|||
162102474|NCT01128413|585423359|FG001|Overall Study|Pt made DNR|0|||
162102475|NCT03762473|585423360|FG000|Overall Study|Death|1|||
162102476|NCT03762473|585423361|FG001|Overall Study|Death|0|||
162102477|NCT00045110|585423362|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
162102478|NCT00045110|585423363|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
162102479|NCT00045110|585423364|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
162102480|NCT00045110|585423362|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
162102481|NCT00045110|585423363|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
162102482|NCT00045110|585423364|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
162102483|NCT00045110|585423362|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
162102484|NCT00045110|585423363|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
162102485|NCT00045110|585423364|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
162102486|NCT03662750|585423366|FG000|Overall Study|Withdrawal by Subject|1|||
162102487|NCT02010060|585423367|FG000|Overall Study|Lost to Follow-up|1|||
162102488|NCT02010060|585423368|FG001|Overall Study|Lost to Follow-up|2|||
162102489|NCT02010060|585423369|FG002|Overall Study|Lost to Follow-up|2|||
162102490|NCT02010060|585423367|FG000|Overall Study|Injury|0|||
162102491|NCT02010060|585423368|FG001|Overall Study|Injury|1|||
162102492|NCT02010060|585423369|FG002|Overall Study|Injury|0|||
162102493|NCT00660010|585423370|FG000|Overall Study|Withdrawal by Subject|2|||
162102494|NCT00660010|585423370|FG000|Overall Study|Lost to Follow-up|3|||
162102495|NCT00660010|585423370|FG000|Overall Study|Adverse Event|1|||
162102496|NCT00660010|585423370|FG000|Overall Study|Noncompliance with visit schedule|3|||
162102497|NCT00726752|585423371|FG000|Overall Study|Lack of Efficacy|6|||
162102498|NCT01292603|585425442|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
162102499|NCT01292603|585425443|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
162102500|NCT01292603|585425444|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
162102501|NCT01292603|585425445|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
162102502|NCT01292603|585425446|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
162102503|NCT01292603|585425447|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
162102504|NCT01292603|585425442|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
162102505|NCT01292603|585425443|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
162102506|NCT01292603|585425444|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
162102507|NCT01292603|585425445|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
162102508|NCT01292603|585425446|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
162102509|NCT01292603|585425447|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
162102510|NCT01292603|585425442|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
162102511|NCT01292603|585425443|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
162102512|NCT01292603|585425444|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
162102513|NCT01292603|585425445|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
162102514|NCT01292603|585425446|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
162102515|NCT01292603|585425447|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
162102516|NCT01292603|585425442|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
162102517|NCT01292603|585425443|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
162102518|NCT01292603|585425444|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
162102519|NCT01292603|585425445|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
162102520|NCT01292603|585425446|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
162102521|NCT01292603|585425447|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
162102522|NCT01292603|585425442|FG000|Part 1: Regular Follow-Up Period|Death|3|||
162102523|NCT01292603|585425443|FG001|Part 1: Regular Follow-Up Period|Death|1|||
162102524|NCT01292603|585425444|FG002|Part 1: Regular Follow-Up Period|Death|3|||
162102525|NCT01292603|585425445|FG003|Part 1: Regular Follow-Up Period|Death|1|||
162102526|NCT01292603|585425446|FG004|Part 1: Regular Follow-Up Period|Death|0|||
162102527|NCT01292603|585425447|FG005|Part 1: Regular Follow-Up Period|Death|0|||
162102528|NCT01292603|585425442|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
162102529|NCT01292603|585425443|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
162102530|NCT01292603|585425444|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
162102531|NCT01292603|585425445|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
162102532|NCT01292603|585425446|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
162102533|NCT01292603|585425447|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
162102534|NCT01292603|585425442|FG000|Part 2: Dose Confirmation Period|Death|0|||
162102535|NCT01292603|585425443|FG001|Part 2: Dose Confirmation Period|Death|0|||
162102536|NCT01292603|585425444|FG002|Part 2: Dose Confirmation Period|Death|0|||
162102537|NCT01292603|585425445|FG003|Part 2: Dose Confirmation Period|Death|0|||
162102538|NCT01292603|585425446|FG004|Part 2: Dose Confirmation Period|Death|1|||
162102539|NCT01292603|585425447|FG005|Part 2: Dose Confirmation Period|Death|0|||
162102540|NCT01292603|585425442|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
162102541|NCT01292603|585425443|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
162102542|NCT01292603|585425444|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
162102543|NCT01292603|585425445|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
162102544|NCT01292603|585425446|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
162102545|NCT01292603|585425447|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
162102546|NCT01292603|585425442|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
162102547|NCT01292603|585425443|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
162102548|NCT01292603|585425444|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
162102549|NCT01292603|585425445|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
162102550|NCT01292603|585425446|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
162102551|NCT01292603|585425447|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
162102552|NCT01292603|585425442|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
162102553|NCT01292603|585425443|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
162102554|NCT01292603|585425444|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
162102555|NCT01292603|585425445|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
162102556|NCT01292603|585425446|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
162102557|NCT01292603|585425447|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
162102558|NCT01292603|585425442|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
162102559|NCT01292603|585425443|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
162102560|NCT01292603|585425444|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
162102561|NCT01292603|585425445|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
162102562|NCT01292603|585425446|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
162102563|NCT01292603|585425447|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
162102564|NCT01292603|585425442|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
162102565|NCT01292603|585425443|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
162102566|NCT01292603|585425444|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
162102567|NCT01292603|585425445|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
162102568|NCT01292603|585425446|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
162102569|NCT01292603|585425447|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
162102570|NCT01292603|585425442|FG000|Part 2: Regular Follow-Up|Death|0|||
162102571|NCT01292603|585425443|FG001|Part 2: Regular Follow-Up|Death|0|||
162102572|NCT01292603|585425444|FG002|Part 2: Regular Follow-Up|Death|0|||
162102573|NCT01292603|585425445|FG003|Part 2: Regular Follow-Up|Death|0|||
162102574|NCT01292603|585425446|FG004|Part 2: Regular Follow-Up|Death|6|||
162102575|NCT01292603|585425447|FG005|Part 2: Regular Follow-Up|Death|3|||
162102576|NCT01292603|585425442|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
162102577|NCT01292603|585425443|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
162102578|NCT01292603|585425444|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
162102579|NCT01292603|585425445|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
162102580|NCT01292603|585425446|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
162102581|NCT01292603|585425447|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
162102582|NCT01292603|585425442|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
162102583|NCT01292603|585425443|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
162102584|NCT01292603|585425444|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
162102585|NCT01292603|585425445|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
162102586|NCT01292603|585425446|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
162102587|NCT01292603|585425447|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
162102588|NCT01292603|585425442|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
162102589|NCT01292603|585425443|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
162102590|NCT01292603|585425444|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
162102591|NCT01292603|585425445|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
162102592|NCT01292603|585425446|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
162102593|NCT01292603|585425447|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
162102594|NCT01292603|585425442|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
162102595|NCT01292603|585425443|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
162102596|NCT01292603|585425444|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
162102597|NCT01292603|585425445|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
162102598|NCT01292603|585425446|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
162102599|NCT01292603|585425447|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
162102600|NCT01292603|585425442|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
162102601|NCT01292603|585425443|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
162102602|NCT01292603|585425444|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
162102603|NCT01292603|585425445|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
162102604|NCT01292603|585425446|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
162102605|NCT01292603|585425447|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
162102606|NCT01292603|585425442|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
162102607|NCT01292603|585425443|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
162102608|NCT01292603|585425444|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
162102609|NCT01292603|585425445|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
162102610|NCT01292603|585425446|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
162102611|NCT01292603|585425447|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
162102612|NCT01292603|585425442|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
162102613|NCT01292603|585425443|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
162102614|NCT01292603|585425444|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
162102615|NCT01292603|585425445|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
162102616|NCT01292603|585425446|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
162102617|NCT01292603|585425447|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
162102618|NCT01292603|585425442|FG000|Overall Survival Status|Death|3|||
162102619|NCT01292603|585425443|FG001|Overall Survival Status|Death|1|||
162102620|NCT01292603|585425444|FG002|Overall Survival Status|Death|3|||
162102621|NCT01292603|585425445|FG003|Overall Survival Status|Death|1|||
162102622|NCT01292603|585425446|FG004|Overall Survival Status|Death|16|||
162102623|NCT01292603|585425447|FG005|Overall Survival Status|Death|10|||
162102624|NCT02120027|585425448|FG000|Overall Study|Adverse Event|4|||
162102625|NCT02120027|585425449|FG001|Overall Study|Adverse Event|5|||
162102626|NCT02120027|585425448|FG000|Overall Study|Lack of Efficacy|3|||
162102627|NCT02120027|585425449|FG001|Overall Study|Lack of Efficacy|5|||
162102628|NCT02120027|585425448|FG000|Overall Study|Lost to Follow-up|5|||
162102629|NCT02120027|585425449|FG001|Overall Study|Lost to Follow-up|13|||
162102630|NCT02120027|585425448|FG000|Overall Study|Other|4|||
162102631|NCT02120027|585425449|FG001|Overall Study|Other|0|||
162102632|NCT02120027|585425448|FG000|Overall Study|Physician Decision|4|||
162102633|NCT02120027|585425449|FG001|Overall Study|Physician Decision|3|||
162102634|NCT02120027|585425448|FG000|Overall Study|Protocol Violation|18|||
162102635|NCT02120027|585425449|FG001|Overall Study|Protocol Violation|21|||
162102636|NCT02120027|585425448|FG000|Overall Study|Study terminated by Sponsor|45|||
162102637|NCT02120027|585425449|FG001|Overall Study|Study terminated by Sponsor|47|||
162102638|NCT02120027|585425448|FG000|Overall Study|Withdrawal by Subject|33|||
162102639|NCT02120027|585425449|FG001|Overall Study|Withdrawal by Subject|25|||
162102640|NCT00082173|585425450|FG000|Overall Study|Withdrawal by Subject|3|||
162102641|NCT00082173|585425451|FG001|Overall Study|Withdrawal by Subject|5|||
162102642|NCT00082173|585425450|FG000|Overall Study|Lost to Follow-up|1|||
162102643|NCT00082173|585425451|FG001|Overall Study|Lost to Follow-up|0|||
162102644|NCT00082173|585425450|FG000|Overall Study|Adverse Event|1|||
162102645|NCT00082173|585425451|FG001|Overall Study|Adverse Event|0|||
162102646|NCT00082173|585425450|FG000|Overall Study|Culture negative or resistant at baselin|5|||
162102647|NCT00082173|585425451|FG001|Overall Study|Culture negative or resistant at baselin|6|||
162102648|NCT02633137|585425458|FG000|Overall Study|Adverse Event|1|||
162102649|NCT02633137|585425458|FG000|Overall Study|Lack of Efficacy|2|||
162102650|NCT02633137|585425458|FG000|Overall Study|Withdrawal by Subject|1|||
162102651|NCT04307004|585425459|FG000|Randomization 1|Withdrawal by Subject|25|||
162102652|NCT04307004|585425460|FG001|Randomization 1|Withdrawal by Subject|26|||
162102653|NCT04307004|585425461|FG002|Randomization 1|Withdrawal by Subject|0|||
162102654|NCT04307004|585425462|FG003|Randomization 1|Withdrawal by Subject|0|||
162102655|NCT04307004|585425459|FG000|Randomization 2|Withdrawal by Subject|0|||
162102656|NCT04307004|585425460|FG001|Randomization 2|Withdrawal by Subject|0|||
162102657|NCT04307004|585425461|FG002|Randomization 2|Withdrawal by Subject|28|||
162102658|NCT04307004|585425462|FG003|Randomization 2|Withdrawal by Subject|23|||
162102659|NCT02807558|585425463|FG000|Overall Study|Consent withdrawn by participant|4|||
162102660|NCT02807558|585425464|FG001|Overall Study|Consent withdrawn by participant|0|||
162102661|NCT02807558|585425465|FG002|Overall Study|Consent withdrawn by participant|4|||
162102662|NCT02807558|585425466|FG003|Overall Study|Consent withdrawn by participant|2|||
162102663|NCT02807558|585425467|FG004|Overall Study|Consent withdrawn by participant|1|||
162102664|NCT02807558|585425468|FG005|Overall Study|Consent withdrawn by participant|0|||
162102665|NCT02807558|585425463|FG000|Overall Study|Non-compliance with Study Drug|0|||
162102666|NCT02807558|585425464|FG001|Overall Study|Non-compliance with Study Drug|0|||
162102667|NCT02807558|585425465|FG002|Overall Study|Non-compliance with Study Drug|1|||
162102668|NCT02807558|585425466|FG003|Overall Study|Non-compliance with Study Drug|0|||
162102669|NCT02807558|585425467|FG004|Overall Study|Non-compliance with Study Drug|0|||
162102670|NCT02807558|585425468|FG005|Overall Study|Non-compliance with Study Drug|0|||
162102671|NCT02807558|585425463|FG000|Overall Study|Adverse Event|0|||
162102672|NCT02807558|585425464|FG001|Overall Study|Adverse Event|0|||
162102673|NCT02807558|585425465|FG002|Overall Study|Adverse Event|9|||
162102674|NCT02807558|585425466|FG003|Overall Study|Adverse Event|0|||
162102675|NCT02807558|585425467|FG004|Overall Study|Adverse Event|0|||
162102676|NCT02807558|585425468|FG005|Overall Study|Adverse Event|0|||
162102677|NCT02807558|585425463|FG000|Overall Study|Death|23|||
162102678|NCT02807558|585425464|FG001|Overall Study|Death|2|||
162102679|NCT02807558|585425465|FG002|Overall Study|Death|3|||
162102680|NCT02807558|585425466|FG003|Overall Study|Death|43|||
162102681|NCT02807558|585425467|FG004|Overall Study|Death|24|||
162102682|NCT02807558|585425468|FG005|Overall Study|Death|15|||
162102683|NCT02807558|585425463|FG000|Overall Study|Progressive Disease|0|||
162102684|NCT02807558|585425464|FG001|Overall Study|Progressive Disease|0|||
162102685|NCT02807558|585425465|FG002|Overall Study|Progressive Disease|1|||
162102686|NCT02807558|585425466|FG003|Overall Study|Progressive Disease|0|||
162102687|NCT02807558|585425467|FG004|Overall Study|Progressive Disease|0|||
162102688|NCT02807558|585425468|FG005|Overall Study|Progressive Disease|0|||
162102689|NCT02807558|585425463|FG000|Overall Study|Other than specified|1|||
162102690|NCT02807558|585425464|FG001|Overall Study|Other than specified|0|||
162102691|NCT02807558|585425465|FG002|Overall Study|Other than specified|2|||
162102692|NCT02807558|585425466|FG003|Overall Study|Other than specified|0|||
162102693|NCT02807558|585425467|FG004|Overall Study|Other than specified|1|||
162102694|NCT02807558|585425468|FG005|Overall Study|Other than specified|1|||
162102695|NCT02807558|585425463|FG000|Overall Study|Lack of Efficacy|0|||
162102696|NCT02807558|585425464|FG001|Overall Study|Lack of Efficacy|0|||
162102697|NCT02807558|585425465|FG002|Overall Study|Lack of Efficacy|9|||
162102698|NCT02807558|585425466|FG003|Overall Study|Lack of Efficacy|0|||
162102699|NCT02807558|585425467|FG004|Overall Study|Lack of Efficacy|0|||
162102700|NCT02807558|585425468|FG005|Overall Study|Lack of Efficacy|0|||
162102701|NCT01972841|585425469|FG000|Overall Study|Randomized but Never Received Treatment|2|||
162102702|NCT01972841|585425470|FG001|Overall Study|Randomized but Never Received Treatment|5|||
162102703|NCT01972841|585425471|FG002|Overall Study|Randomized but Never Received Treatment|4|||
162102704|NCT01972841|585425472|FG003|Overall Study|Randomized but Never Received Treatment|2|||
162102705|NCT01972841|585425473|FG004|Overall Study|Randomized but Never Received Treatment|6|||
162102706|NCT01972841|585425474|FG005|Overall Study|Randomized but Never Received Treatment|13|||
162102707|NCT01972841|585425469|FG000|Overall Study|Adverse Event|13|||
162102708|NCT01972841|585425470|FG001|Overall Study|Adverse Event|8|||
162102709|NCT01972841|585425471|FG002|Overall Study|Adverse Event|12|||
162102710|NCT01972841|585425472|FG003|Overall Study|Adverse Event|9|||
162102711|NCT01972841|585425473|FG004|Overall Study|Adverse Event|21|||
162102712|NCT01972841|585425474|FG005|Overall Study|Adverse Event|26|||
162102713|NCT01972841|585425469|FG000|Overall Study|Lack of Efficacy|1|||
162102714|NCT01972841|585425470|FG001|Overall Study|Lack of Efficacy|0|||
162102715|NCT01972841|585425471|FG002|Overall Study|Lack of Efficacy|0|||
162102716|NCT01972841|585425472|FG003|Overall Study|Lack of Efficacy|2|||
162102717|NCT01972841|585425473|FG004|Overall Study|Lack of Efficacy|4|||
162102718|NCT01972841|585425474|FG005|Overall Study|Lack of Efficacy|1|||
162102719|NCT01972841|585425469|FG000|Overall Study|Lost to Follow-up|4|||
162102720|NCT01972841|585425470|FG001|Overall Study|Lost to Follow-up|2|||
162102721|NCT01972841|585425471|FG002|Overall Study|Lost to Follow-up|4|||
162102722|NCT01972841|585425472|FG003|Overall Study|Lost to Follow-up|2|||
162102723|NCT01972841|585425473|FG004|Overall Study|Lost to Follow-up|9|||
162102724|NCT01972841|585425474|FG005|Overall Study|Lost to Follow-up|3|||
162102725|NCT01972841|585425469|FG000|Overall Study|Protocol Violation|2|||
162102726|NCT01972841|585425470|FG001|Overall Study|Protocol Violation|2|||
162102727|NCT01972841|585425471|FG002|Overall Study|Protocol Violation|3|||
162102728|NCT01972841|585425472|FG003|Overall Study|Protocol Violation|5|||
162102729|NCT01972841|585425473|FG004|Overall Study|Protocol Violation|9|||
162102730|NCT01972841|585425474|FG005|Overall Study|Protocol Violation|4|||
162102731|NCT01972841|585425469|FG000|Overall Study|Withdrawal by participants|21|||
162102732|NCT01972841|585425470|FG001|Overall Study|Withdrawal by participants|27|||
162102733|NCT01972841|585425471|FG002|Overall Study|Withdrawal by participants|23|||
162102734|NCT01972841|585425472|FG003|Overall Study|Withdrawal by participants|16|||
162102735|NCT01972841|585425473|FG004|Overall Study|Withdrawal by participants|33|||
162102736|NCT01972841|585425474|FG005|Overall Study|Withdrawal by participants|34|||
162102737|NCT01972841|585425469|FG000|Overall Study|Miscellaneous|0|||
162102738|NCT01972841|585425470|FG001|Overall Study|Miscellaneous|0|||
162102739|NCT01972841|585425471|FG002|Overall Study|Miscellaneous|4|||
162102740|NCT01972841|585425472|FG003|Overall Study|Miscellaneous|1|||
162102741|NCT01972841|585425473|FG004|Overall Study|Miscellaneous|0|||
162102742|NCT01972841|585425474|FG005|Overall Study|Miscellaneous|4|||
162102743|NCT01972841|585425469|FG000|Overall Study|Did not have end of treatment page|0|||
162102744|NCT01972841|585425470|FG001|Overall Study|Did not have end of treatment page|0|||
162102745|NCT01972841|585425471|FG002|Overall Study|Did not have end of treatment page|0|||
162102746|NCT01972841|585425472|FG003|Overall Study|Did not have end of treatment page|0|||
162102747|NCT01972841|585425473|FG004|Overall Study|Did not have end of treatment page|1|||
162102748|NCT01972841|585425474|FG005|Overall Study|Did not have end of treatment page|0|||
162102749|NCT02085408|585425477|FG000|Step 1: Induction|Disease Progression|19|||
162102750|NCT02085408|585425478|FG001|Step 1: Induction|Disease Progression|19|||
162102751|NCT02085408|585425477|FG000|Step 1: Induction|Adverse Event|18|||
162102752|NCT02085408|585425478|FG001|Step 1: Induction|Adverse Event|17|||
162102753|NCT02085408|585425477|FG000|Step 1: Induction|Death|33|||
162102754|NCT02085408|585425478|FG001|Step 1: Induction|Death|30|||
162102755|NCT02085408|585425477|FG000|Step 1: Induction|Withdrawal by Subject|16|||
162102756|NCT02085408|585425478|FG001|Step 1: Induction|Withdrawal by Subject|8|||
162102757|NCT02085408|585425477|FG000|Step 1: Induction|Alternative Therapy|15|||
162102758|NCT02085408|585425478|FG001|Step 1: Induction|Alternative Therapy|19|||
162102759|NCT02085408|585425477|FG000|Step 1: Induction|Complicating Disease|2|||
162102760|NCT02085408|585425478|FG001|Step 1: Induction|Complicating Disease|3|||
162102761|NCT02085408|585425477|FG000|Step 1: Induction|Other|27|||
162102762|NCT02085408|585425478|FG001|Step 1: Induction|Other|39|||
162102763|NCT02085408|585425477|FG000|Step 1: Induction|Never started treatment|6|||
162102764|NCT02085408|585425478|FG001|Step 1: Induction|Never started treatment|4|||
162102765|NCT02085408|585425477|FG000|Step 2: Consolidation|Disease Progression|5|||
162102766|NCT02085408|585425478|FG001|Step 2: Consolidation|Disease Progression|20|||
162102767|NCT02085408|585425477|FG000|Step 2: Consolidation|Adverse Event|9|||
162102768|NCT02085408|585425478|FG001|Step 2: Consolidation|Adverse Event|8|||
162102769|NCT02085408|585425477|FG000|Step 2: Consolidation|Death|4|||
162102770|NCT02085408|585425478|FG001|Step 2: Consolidation|Death|3|||
162102771|NCT02085408|585425477|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
162102772|NCT02085408|585425478|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
162102773|NCT02085408|585425477|FG000|Step 2: Consolidation|Alternative Therapy|9|||
162102774|NCT02085408|585425478|FG001|Step 2: Consolidation|Alternative Therapy|3|||
162102775|NCT02085408|585425477|FG000|Step 2: Consolidation|Complicating Disease|0|||
162102776|NCT02085408|585425478|FG001|Step 2: Consolidation|Complicating Disease|2|||
162102777|NCT02085408|585425477|FG000|Step 2: Consolidation|Other|6|||
162102778|NCT02085408|585425478|FG001|Step 2: Consolidation|Other|6|||
162102779|NCT02085408|585425477|FG000|Step 2: Consolidation|Never started treatment|4|||
162102780|NCT02085408|585425478|FG001|Step 2: Consolidation|Never started treatment|3|||
162102781|NCT02085408|585425477|FG000|Step 3: Maintenance|Disease Progression|13|||
162102782|NCT02085408|585425478|FG001|Step 3: Maintenance|Disease Progression|11|||
162102783|NCT02085408|585425477|FG000|Step 3: Maintenance|Adverse Event|2|||
162102784|NCT02085408|585425478|FG001|Step 3: Maintenance|Adverse Event|4|||
162102785|NCT02085408|585425477|FG000|Step 3: Maintenance|Death|1|||
162102786|NCT02085408|585425478|FG001|Step 3: Maintenance|Death|2|||
162102787|NCT02085408|585425477|FG000|Step 3: Maintenance|Alternative Therapy|1|||
162102788|NCT02085408|585425478|FG001|Step 3: Maintenance|Alternative Therapy|1|||
162102789|NCT02085408|585425477|FG000|Step 3: Maintenance|Complicating Disease|0|||
162102790|NCT02085408|585425478|FG001|Step 3: Maintenance|Complicating Disease|1|||
162102791|NCT02085408|585425477|FG000|Step 3: Maintenance|Other|3|||
162102792|NCT02085408|585425478|FG001|Step 3: Maintenance|Other|2|||
162102793|NCT02085408|585425477|FG000|Step 3: Maintenance|Never started treatment|5|||
162102794|NCT02085408|585425478|FG001|Step 3: Maintenance|Never started treatment|1|||
162102795|NCT02734212|585425479|FG000|Overall Study|Lost to Follow-up|5|||
162102796|NCT02734212|585425480|FG001|Overall Study|Lost to Follow-up|10|||
162102797|NCT00688636|585425483|FG000|Overall Study|Adverse Event|2|||
162102798|NCT00688636|585425484|FG001|Overall Study|Adverse Event|1|||
162102799|NCT01572727|585425485|FG000|Overall Study|Adverse Event|43|||
162102800|NCT01572727|585425486|FG001|Overall Study|Adverse Event|15|||
162102801|NCT01572727|585425485|FG000|Overall Study|Lost to Follow-up|1|||
162102802|NCT01572727|585425486|FG001|Overall Study|Lost to Follow-up|1|||
162102803|NCT01572727|585425485|FG000|Overall Study|Physician Decision|23|||
162102804|NCT01572727|585425486|FG001|Overall Study|Physician Decision|9|||
162102805|NCT01572727|585425485|FG000|Overall Study|Progressive disease|59|||
162102806|NCT01572727|585425486|FG001|Overall Study|Progressive disease|82|||
162102807|NCT01572727|585425485|FG000|Overall Study|Protocol Violation|0|||
162102808|NCT01572727|585425486|FG001|Overall Study|Protocol Violation|1|||
162102809|NCT01572727|585425485|FG000|Overall Study|Study terminated by sponsor|61|||
162102810|NCT01572727|585425486|FG001|Overall Study|Study terminated by sponsor|83|||
162102811|NCT01572727|585425485|FG000|Overall Study|Parent/guardian decision|14|||
162102812|NCT01572727|585425486|FG001|Overall Study|Parent/guardian decision|9|||
162102813|NCT01572727|585425485|FG000|Overall Study|Death|2|||
162102814|NCT01572727|585425486|FG001|Overall Study|Death|2|||
162102815|NCT01572727|585425485|FG000|Overall Study|Untreated|4|||
162102816|NCT01572727|585425486|FG001|Overall Study|Untreated|7|||
162102817|NCT04053764|585425487|FG000|Overall Study|Withdrawal by Subject|6|||
162102818|NCT04053764|585425488|FG001|Overall Study|Withdrawal by Subject|2|||
162102819|NCT04053764|585425487|FG000|Overall Study|Physician Decision|2|||
162102820|NCT04053764|585425488|FG001|Overall Study|Physician Decision|1|||
162102821|NCT04053764|585425487|FG000|Overall Study|Adverse Event|1|||
162102822|NCT04053764|585425488|FG001|Overall Study|Adverse Event|0|||
162102823|NCT04053764|585425487|FG000|Overall Study|Pregnancy|1|||
162102824|NCT04053764|585425488|FG001|Overall Study|Pregnancy|0|||
162102825|NCT02384954|585425492|FG000|Phase 1|Progressive Disease|2|||
162102826|NCT02384954|585425493|FG001|Phase 1|Progressive Disease|0|||
162102827|NCT02384954|585425494|FG002|Phase 1|Progressive Disease|1|||
162102828|NCT02384954|585425495|FG003|Phase 1|Progressive Disease|1|||
162102829|NCT02384954|585425496|FG004|Phase 1|Progressive Disease|0|||
162102830|NCT02384954|585425497|FG005|Phase 1|Progressive Disease|0|||
162102831|NCT02384954|585425498|FG006|Phase 1|Progressive Disease|0|||
162102832|NCT02384954|585425499|FG007|Phase 1|Progressive Disease|0|||
162102833|NCT02384954|585425500|FG008|Phase 1|Progressive Disease|0|||
162102834|NCT02384954|585425492|FG000|Phase 1|Adverse Event|0|||
162102835|NCT02384954|585425493|FG001|Phase 1|Adverse Event|0|||
162102836|NCT02384954|585425494|FG002|Phase 1|Adverse Event|1|||
162102837|NCT02384954|585425495|FG003|Phase 1|Adverse Event|0|||
162102838|NCT02384954|585425496|FG004|Phase 1|Adverse Event|0|||
162102839|NCT02384954|585425497|FG005|Phase 1|Adverse Event|0|||
162102840|NCT02384954|585425498|FG006|Phase 1|Adverse Event|0|||
162102841|NCT02384954|585425499|FG007|Phase 1|Adverse Event|0|||
162102842|NCT02384954|585425500|FG008|Phase 1|Adverse Event|0|||
162102843|NCT02384954|585425492|FG000|Phase 2|Progressive Disease|0|||
162102844|NCT02384954|585425493|FG001|Phase 2|Progressive Disease|0|||
162102845|NCT02384954|585425494|FG002|Phase 2|Progressive Disease|0|||
162102846|NCT02384954|585425495|FG003|Phase 2|Progressive Disease|0|||
162102847|NCT02384954|585425496|FG004|Phase 2|Progressive Disease|0|||
162102848|NCT02384954|585425497|FG005|Phase 2|Progressive Disease|0|||
162102849|NCT02384954|585425498|FG006|Phase 2|Progressive Disease|0|||
162102850|NCT02384954|585425499|FG007|Phase 2|Progressive Disease|1|||
162102851|NCT02384954|585425500|FG008|Phase 2|Progressive Disease|2|||
162102852|NCT02384954|585425492|FG000|Phase 2|Adverse Event|0|||
162102853|NCT02384954|585425493|FG001|Phase 2|Adverse Event|0|||
162102854|NCT02384954|585425494|FG002|Phase 2|Adverse Event|0|||
162102855|NCT02384954|585425495|FG003|Phase 2|Adverse Event|0|||
162102856|NCT02384954|585425496|FG004|Phase 2|Adverse Event|0|||
162102857|NCT02384954|585425497|FG005|Phase 2|Adverse Event|0|||
162102858|NCT02384954|585425498|FG006|Phase 2|Adverse Event|0|||
162102859|NCT02384954|585425499|FG007|Phase 2|Adverse Event|1|||
162102860|NCT02384954|585425500|FG008|Phase 2|Adverse Event|1|||
162102861|NCT02384954|585425492|FG000|Phase 2|Failure to meet continuation criteria|0|||
162102862|NCT02384954|585425493|FG001|Phase 2|Failure to meet continuation criteria|0|||
162102863|NCT02384954|585425494|FG002|Phase 2|Failure to meet continuation criteria|0|||
162102864|NCT02384954|585425495|FG003|Phase 2|Failure to meet continuation criteria|0|||
162102865|NCT02384954|585425496|FG004|Phase 2|Failure to meet continuation criteria|0|||
162102866|NCT02384954|585425497|FG005|Phase 2|Failure to meet continuation criteria|0|||
162102867|NCT02384954|585425498|FG006|Phase 2|Failure to meet continuation criteria|0|||
162102868|NCT02384954|585425499|FG007|Phase 2|Failure to meet continuation criteria|1|||
162102869|NCT02384954|585425500|FG008|Phase 2|Failure to meet continuation criteria|0|||
162102870|NCT04732286|585425501|FG000|Overall Study|Progressive Disease|2|||
162102871|NCT04732286|585425501|FG000|Overall Study|Physician Decision|1|||
162102872|NCT04732286|585425501|FG000|Overall Study|Study Terminated by Sponsor|31|||
162102873|NCT04732286|585425501|FG000|Overall Study|Withdrawal by Subject|10|||
162102874|NCT04732286|585425501|FG000|Overall Study|Non-compliance With Study Drug|1|||
162102875|NCT04732286|585425501|FG000|Overall Study|Lost to Follow-up|4|||
162102876|NCT04732286|585425501|FG000|Overall Study|Death|51|||
162102877|NCT01474681|585425505|FG000|Overall Study|Death|0|||
162102878|NCT01474681|585425506|FG001|Overall Study|Death|3|||
162102879|NCT01474681|585425507|FG002|Overall Study|Death|2|||
162102880|NCT01474681|585425508|FG003|Overall Study|Death|6|||
162102881|NCT02372396|585425514|FG000|Overall Study|Lost to Follow-up|7|||
162102882|NCT02372396|585425515|FG001|Overall Study|Lost to Follow-up|9|||
162102883|NCT01483924|585425518|FG000|Overall Study|Withdrawal by Subject|2|||
162102884|NCT01483924|585425519|FG001|Overall Study|Withdrawal by Subject|0|||
162102885|NCT01483924|585425520|FG002|Overall Study|Withdrawal by Subject|0|||
162102886|NCT01483924|585425521|FG003|Overall Study|Withdrawal by Subject|1|||
162102887|NCT01483924|585425522|FG004|Overall Study|Withdrawal by Subject|1|||
162102888|NCT01483924|585425518|FG000|Overall Study|Adverse Event|0|||
162102889|NCT01483924|585425519|FG001|Overall Study|Adverse Event|0|||
162102890|NCT01483924|585425520|FG002|Overall Study|Adverse Event|1|||
162102891|NCT01483924|585425521|FG003|Overall Study|Adverse Event|1|||
162102892|NCT01483924|585425522|FG004|Overall Study|Adverse Event|0|||
162102893|NCT01483924|585425518|FG000|Overall Study|Non-compliance|0|||
162102894|NCT01483924|585425519|FG001|Overall Study|Non-compliance|0|||
162102895|NCT01483924|585425520|FG002|Overall Study|Non-compliance|0|||
162102896|NCT01483924|585425521|FG003|Overall Study|Non-compliance|1|||
162102897|NCT01483924|585425522|FG004|Overall Study|Non-compliance|1|||
162102898|NCT01483924|585425518|FG000|Overall Study|Sponsor concern over ECG result|0|||
162102899|NCT01483924|585425519|FG001|Overall Study|Sponsor concern over ECG result|0|||
162102900|NCT01483924|585425520|FG002|Overall Study|Sponsor concern over ECG result|0|||
162102901|NCT01483924|585425521|FG003|Overall Study|Sponsor concern over ECG result|1|||
162102902|NCT01483924|585425522|FG004|Overall Study|Sponsor concern over ECG result|0|||
162102903|NCT00003298|585425523|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
162102904|NCT00003298|585425523|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
162102905|NCT00003298|585425523|FG000|Surgery|Unresectable at surgery|3|||
162102906|NCT00003298|585425523|FG000|Surgery|Progression before surgery|2|||
162102907|NCT00003298|585425523|FG000|Surgery|Unevaluable and off study|2|||
162102908|NCT00003298|585425523|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
162102909|NCT00003298|585425523|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
162102910|NCT00003298|585425523|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
162102911|NCT00003298|585425523|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
162102912|NCT00003298|585425523|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
162102913|NCT00003298|585425523|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
162102914|NCT00003298|585425523|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
162102915|NCT00003298|585425523|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
162102916|NCT00003298|585425523|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
162102917|NCT00003298|585425523|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
162102918|NCT00335322|585425527|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
162102919|NCT00335322|585425528|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
162102920|NCT00335322|585425529|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
162102921|NCT02195986|585425530|FG000|Overall Study|Adverse Event|3|||
162102922|NCT02195986|585425531|FG001|Overall Study|Adverse Event|0|||
162102923|NCT02195986|585425532|FG002|Overall Study|Adverse Event|0|||
162102924|NCT02195986|585425530|FG000|Overall Study|Withdrawal by Subject|0|||
162102925|NCT02195986|585425531|FG001|Overall Study|Withdrawal by Subject|3|||
162102926|NCT02195986|585425532|FG002|Overall Study|Withdrawal by Subject|0|||
162102927|NCT02195986|585425530|FG000|Overall Study|Family Emergency|0|||
162102928|NCT02195986|585425531|FG001|Overall Study|Family Emergency|0|||
162102929|NCT02195986|585425532|FG002|Overall Study|Family Emergency|1|||
162102930|NCT02195986|585425530|FG000|Overall Study|Protocol Violation|0|||
162102931|NCT02195986|585425531|FG001|Overall Study|Protocol Violation|1|||
162102932|NCT02195986|585425532|FG002|Overall Study|Protocol Violation|1|||
162102933|NCT02195986|585425530|FG000|Overall Study|Non-compliance|0|||
162102934|NCT02195986|585425531|FG001|Overall Study|Non-compliance|1|||
162102935|NCT02195986|585425532|FG002|Overall Study|Non-compliance|0|||
162102936|NCT02834780|585425535|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
162102937|NCT02834780|585425536|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
162102938|NCT02834780|585425537|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
162102939|NCT02834780|585425538|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
162102940|NCT02834780|585425539|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
162102941|NCT02834780|585425540|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
162102942|NCT02834780|585425541|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
162102943|NCT02834780|585425542|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
162102944|NCT02834780|585425543|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
162102945|NCT02834780|585425544|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
162102946|NCT02834780|585425545|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
162102947|NCT02834780|585425546|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
162102948|NCT02834780|585425547|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
162102949|NCT02834780|585425535|FG000|Overall Study|Withdrawal by Subject|0|||
162102950|NCT02834780|585425536|FG001|Overall Study|Withdrawal by Subject|0|||
162102951|NCT02834780|585425537|FG002|Overall Study|Withdrawal by Subject|1|||
162102952|NCT02834780|585425538|FG003|Overall Study|Withdrawal by Subject|0|||
162102953|NCT02834780|585425539|FG004|Overall Study|Withdrawal by Subject|0|||
162102954|NCT02834780|585425540|FG005|Overall Study|Withdrawal by Subject|0|||
162102955|NCT02834780|585425541|FG006|Overall Study|Withdrawal by Subject|0|||
162102956|NCT02834780|585425542|FG007|Overall Study|Withdrawal by Subject|0|||
162102957|NCT02834780|585425543|FG008|Overall Study|Withdrawal by Subject|0|||
162102958|NCT02834780|585425544|FG009|Overall Study|Withdrawal by Subject|0|||
162102959|NCT02834780|585425545|FG010|Overall Study|Withdrawal by Subject|1|||
162102960|NCT02834780|585425546|FG011|Overall Study|Withdrawal by Subject|0|||
162102961|NCT02834780|585425547|FG012|Overall Study|Withdrawal by Subject|0|||
162102962|NCT02834780|585425535|FG000|Overall Study|Adverse Event|0|||
162102963|NCT02834780|585425536|FG001|Overall Study|Adverse Event|0|||
162102964|NCT02834780|585425537|FG002|Overall Study|Adverse Event|0|||
162102965|NCT02834780|585425538|FG003|Overall Study|Adverse Event|0|||
162102966|NCT02834780|585425539|FG004|Overall Study|Adverse Event|1|||
162102967|NCT02834780|585425540|FG005|Overall Study|Adverse Event|0|||
162102968|NCT02834780|585425541|FG006|Overall Study|Adverse Event|1|||
162102969|NCT02834780|585425542|FG007|Overall Study|Adverse Event|1|||
162102970|NCT02834780|585425543|FG008|Overall Study|Adverse Event|0|||
162102971|NCT02834780|585425544|FG009|Overall Study|Adverse Event|2|||
162102972|NCT02834780|585425545|FG010|Overall Study|Adverse Event|0|||
162102973|NCT02834780|585425546|FG011|Overall Study|Adverse Event|3|||
162102974|NCT02834780|585425547|FG012|Overall Study|Adverse Event|2|||
162102975|NCT02834780|585425535|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
162102976|NCT02834780|585425536|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
162102977|NCT02834780|585425537|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
162102978|NCT02834780|585425538|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
162102979|NCT02834780|585425539|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
162102980|NCT02834780|585425540|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
162102981|NCT02834780|585425541|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
162102982|NCT02834780|585425542|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
162102983|NCT02834780|585425543|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
162102984|NCT02834780|585425544|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
162102985|NCT02834780|585425545|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
162102986|NCT02834780|585425546|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
162102987|NCT02834780|585425547|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
162102988|NCT02834780|585425535|FG000|Overall Study|Other|1|||
162102989|NCT02834780|585425536|FG001|Overall Study|Other|0|||
162102990|NCT02834780|585425537|FG002|Overall Study|Other|1|||
162102991|NCT02834780|585425538|FG003|Overall Study|Other|2|||
162102992|NCT02834780|585425539|FG004|Overall Study|Other|0|||
162102993|NCT02834780|585425540|FG005|Overall Study|Other|0|||
162102994|NCT02834780|585425541|FG006|Overall Study|Other|0|||
162102995|NCT02834780|585425542|FG007|Overall Study|Other|0|||
162102996|NCT02834780|585425543|FG008|Overall Study|Other|0|||
162102997|NCT02834780|585425544|FG009|Overall Study|Other|0|||
162102998|NCT02834780|585425545|FG010|Overall Study|Other|0|||
162102999|NCT02834780|585425546|FG011|Overall Study|Other|0|||
162103000|NCT02834780|585425547|FG012|Overall Study|Other|1|||
162103001|NCT03150056|585425548|FG000|Overall Study|Withdrawal by Subject|0|||
162103002|NCT03150056|585425549|FG001|Overall Study|Withdrawal by Subject|0|||
162103003|NCT03150056|585425550|FG002|Overall Study|Withdrawal by Subject|0|||
162103004|NCT03150056|585425551|FG003|Overall Study|Withdrawal by Subject|0|||
162103005|NCT03150056|585425552|FG004|Overall Study|Withdrawal by Subject|0|||
162103006|NCT03150056|585425553|FG005|Overall Study|Withdrawal by Subject|2|||
162103007|NCT03150056|585425548|FG000|Overall Study|Study terminated by Sponsor|1|||
162103008|NCT03150056|585425549|FG001|Overall Study|Study terminated by Sponsor|3|||
162103009|NCT03150056|585425550|FG002|Overall Study|Study terminated by Sponsor|1|||
162103010|NCT03150056|585425551|FG003|Overall Study|Study terminated by Sponsor|1|||
162103011|NCT03150056|585425552|FG004|Overall Study|Study terminated by Sponsor|5|||
162103012|NCT03150056|585425553|FG005|Overall Study|Study terminated by Sponsor|6|||
162103013|NCT03150056|585425548|FG000|Overall Study|Death|9|||
162103014|NCT03150056|585425549|FG001|Overall Study|Death|2|||
162103015|NCT03150056|585425550|FG002|Overall Study|Death|2|||
162103016|NCT03150056|585425551|FG003|Overall Study|Death|7|||
162103017|NCT03150056|585425552|FG004|Overall Study|Death|8|||
162103018|NCT03150056|585425553|FG005|Overall Study|Death|10|||
162103019|NCT02270450|585425558|FG000|Overall Study|Refusal unrelated to adverse event|3|||
162103020|NCT02270450|585425559|FG001|Overall Study|Refusal unrelated to adverse event|1|||
162103021|NCT02270450|585425560|FG002|Overall Study|Refusal unrelated to adverse event|5|||
162103022|NCT02270450|585425561|FG003|Overall Study|Refusal unrelated to adverse event|14|||
162103023|NCT02270450|585425558|FG000|Overall Study|Progression/relapse|1|||
162103024|NCT02270450|585425559|FG001|Overall Study|Progression/relapse|2|||
162103025|NCT02270450|585425560|FG002|Overall Study|Progression/relapse|4|||
162103026|NCT02270450|585425561|FG003|Overall Study|Progression/relapse|9|||
162103027|NCT02270450|585425558|FG000|Overall Study|Death|19|||
162103028|NCT02270450|585425559|FG001|Overall Study|Death|19|||
162103029|NCT02270450|585425560|FG002|Overall Study|Death|31|||
162103030|NCT02270450|585425561|FG003|Overall Study|Death|59|||
162103031|NCT02363738|585425562|FG000|Overall Study|Adverse Event|5|||
162103032|NCT02363738|585425563|FG001|Overall Study|Adverse Event|2|||
162103033|NCT02363738|585425562|FG000|Overall Study|Lack of Efficacy|1|||
162103034|NCT02363738|585425563|FG001|Overall Study|Lack of Efficacy|2|||
162103035|NCT02363738|585425562|FG000|Overall Study|Lost to Follow-up|2|||
162103036|NCT02363738|585425563|FG001|Overall Study|Lost to Follow-up|1|||
162103037|NCT02081846|585425568|FG000|Overall Study|Withdrawal by Subject|1|||
162103038|NCT02081846|585425569|FG001|Overall Study|Withdrawal by Subject|0|||
162103039|NCT02081846|585425568|FG000|Overall Study|invalid consent|1|||
162103040|NCT02081846|585425569|FG001|Overall Study|invalid consent|0|||
162103041|NCT03265600|585425570|FG000|Overall Study|Lost to Follow-up|17|||
162103042|NCT03265600|585425571|FG001|Overall Study|Lost to Follow-up|5|||
162103043|NCT03265600|585425570|FG000|Overall Study|Withdrawal by Subject|4|||
162103044|NCT03265600|585425571|FG001|Overall Study|Withdrawal by Subject|2|||
162103045|NCT03265600|585425570|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
162103046|NCT03265600|585425571|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
162103047|NCT00535730|585425572|FG000|Overall Study|Adverse Event|1|||
162103048|NCT00535730|585425573|FG001|Overall Study|Adverse Event|1|||
162103049|NCT00535730|585425572|FG000|Overall Study|Lost to Follow-up|0|||
162103050|NCT00535730|585425573|FG001|Overall Study|Lost to Follow-up|1|||
162103051|NCT00535730|585425572|FG000|Overall Study|Physician Decision|0|||
162103052|NCT00535730|585425573|FG001|Overall Study|Physician Decision|1|||
162103053|NCT00535730|585425572|FG000|Overall Study|Protocol Violation|1|||
162103054|NCT00535730|585425573|FG001|Overall Study|Protocol Violation|0|||
162103055|NCT00535730|585425572|FG000|Overall Study|Withdrawal by Subject|0|||
162103056|NCT00535730|585425573|FG001|Overall Study|Withdrawal by Subject|4|||
162103057|NCT00936858|585425574|FG000|Overall Study|Death|3|||
162103058|NCT00936858|585425574|FG000|Overall Study|Progression|29|||
162103059|NCT00936858|585425574|FG000|Overall Study|Withdrawal by Subject|5|||
162103060|NCT00936858|585425574|FG000|Overall Study|Adverse Event|1|||
162103061|NCT00936858|585425574|FG000|Overall Study|Physician Decision|7|||
162103062|NCT00936858|585425574|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
162103063|NCT00936858|585425574|FG000|Overall Study|Lost to Follow-up|1|||
162103064|NCT02132611|585425580|FG000|Overall Study|Death|2|||
162103065|NCT01965834|585425581|FG000|Overall Study|Lack of Efficacy|4|||
162103066|NCT03674177|585425585|FG000|Overall Study|Lost to Follow-up|2|||
162103067|NCT03674177|585425586|FG001|Overall Study|Lost to Follow-up|1|||
162103068|NCT03674177|585425587|FG002|Overall Study|Lost to Follow-up|0|||
162103069|NCT03674177|585425588|FG003|Overall Study|Lost to Follow-up|2|||
162103070|NCT03387852|585425589|FG000|Overall Study|Adverse event (AE)|3|||
162103071|NCT03387852|585425590|FG001|Overall Study|Adverse event (AE)|0|||
162103072|NCT03387852|585425591|FG002|Overall Study|Adverse event (AE)|2|||
162103073|NCT03387852|585425592|FG003|Overall Study|Adverse event (AE)|0|||
162103074|NCT03387852|585425589|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
162103075|NCT03387852|585425590|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
162103076|NCT03387852|585425591|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
162103077|NCT03387852|585425592|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
162103078|NCT03387852|585425589|FG000|Overall Study|Withdrawal by participant|1|||
162103079|NCT03387852|585425590|FG001|Overall Study|Withdrawal by participant|1|||
162103080|NCT03387852|585425591|FG002|Overall Study|Withdrawal by participant|3|||
162103081|NCT03387852|585425592|FG003|Overall Study|Withdrawal by participant|2|||
162103082|NCT03387852|585425589|FG000|Overall Study|Other- Unspecified|1|||
162103083|NCT03387852|585425590|FG001|Overall Study|Other- Unspecified|1|||
162103084|NCT03387852|585425591|FG002|Overall Study|Other- Unspecified|2|||
162103085|NCT03387852|585425592|FG003|Overall Study|Other- Unspecified|1|||
162103086|NCT03387852|585425589|FG000|Overall Study|Poor compliance to protocol|0|||
162103087|NCT03387852|585425590|FG001|Overall Study|Poor compliance to protocol|0|||
162103088|NCT03387852|585425591|FG002|Overall Study|Poor compliance to protocol|0|||
162103089|NCT03387852|585425592|FG003|Overall Study|Poor compliance to protocol|1|||
162103090|NCT03387852|585425589|FG000|Overall Study|Randomized and not treated|0|||
162103091|NCT03387852|585425590|FG001|Overall Study|Randomized and not treated|0|||
162103092|NCT03387852|585425591|FG002|Overall Study|Randomized and not treated|0|||
162103093|NCT03387852|585425592|FG003|Overall Study|Randomized and not treated|1|||
162103094|NCT02194621|585425600|FG000|Overall Study|6 withdrew prior to randomization|2|||
162103095|NCT02194621|585425601|FG001|Overall Study|6 withdrew prior to randomization|2|||
162103096|NCT02194621|585425602|FG002|Overall Study|6 withdrew prior to randomization|2|||
162103097|NCT02194621|585425600|FG000|Overall Study|Withdrawal by Subject|4|||
162103098|NCT02194621|585425601|FG001|Overall Study|Withdrawal by Subject|4|||
162103099|NCT02194621|585425602|FG002|Overall Study|Withdrawal by Subject|7|||
162103100|NCT02493127|585425603|FG000|Overall Study|Lost to Follow-up|1|||
162103101|NCT02493127|585425604|FG001|Overall Study|Lost to Follow-up|1|||
162103102|NCT00714168|585425605|FG000|Overall Study|Pregnancy|5|||
162103103|NCT00714168|585425606|FG001|Overall Study|Pregnancy|4|||
162103104|NCT00714168|585425605|FG000|Overall Study|Lost to Follow-up|32|||
162103105|NCT00714168|585425606|FG001|Overall Study|Lost to Follow-up|50|||
162103106|NCT00714168|585425605|FG000|Overall Study|Relocation|4|||
162103107|NCT00714168|585425606|FG001|Overall Study|Relocation|3|||
162103108|NCT00714168|585425605|FG000|Overall Study|Non-study medical condition|3|||
162103109|NCT00714168|585425606|FG001|Overall Study|Non-study medical condition|2|||
162103110|NCT00809757|585425607|FG000|Overall Study|Adverse Event|2|||
162103111|NCT00809757|585425608|FG001|Overall Study|Adverse Event|3|||
162103112|NCT00809757|585425609|FG002|Overall Study|Adverse Event|3|||
162103113|NCT00809757|585425607|FG000|Overall Study|Lost to Follow-up|0|||
162103114|NCT00809757|585425608|FG001|Overall Study|Lost to Follow-up|0|||
162103115|NCT00809757|585425609|FG002|Overall Study|Lost to Follow-up|1|||
162103116|NCT00809757|585425607|FG000|Overall Study|Protocol Violation|1|||
162103117|NCT00809757|585425608|FG001|Overall Study|Protocol Violation|1|||
162103118|NCT00809757|585425609|FG002|Overall Study|Protocol Violation|1|||
162103119|NCT00809757|585425607|FG000|Overall Study|Withdrawal by Subject|2|||
162103120|NCT00809757|585425608|FG001|Overall Study|Withdrawal by Subject|1|||
162103121|NCT00809757|585425609|FG002|Overall Study|Withdrawal by Subject|3|||
162103122|NCT00809757|585425607|FG000|Overall Study|Subject Uncooperative|1|||
162103123|NCT00809757|585425608|FG001|Overall Study|Subject Uncooperative|0|||
162103124|NCT00809757|585425609|FG002|Overall Study|Subject Uncooperative|2|||
162103125|NCT00809757|585425607|FG000|Overall Study|Noncompliance with Medication|0|||
162103126|NCT00809757|585425608|FG001|Overall Study|Noncompliance with Medication|0|||
162103127|NCT00809757|585425609|FG002|Overall Study|Noncompliance with Medication|1|||
162103128|NCT00253864|585425610|FG000|Overall Study|Lost to Follow-up|5|||
162103129|NCT00253864|585425611|FG001|Overall Study|Lost to Follow-up|8|||
162103130|NCT01864564|585425612|FG000|Overall Study|Lost to Follow-up|17|||
162103131|NCT01864564|585425613|FG001|Overall Study|Lost to Follow-up|23|||
162103132|NCT01864564|585425612|FG000|Overall Study|Withdrawal by Subject|20|||
162103133|NCT01864564|585425613|FG001|Overall Study|Withdrawal by Subject|11|||
162103134|NCT01864564|585425612|FG000|Overall Study|Protocol Violation|0|||
162103135|NCT01864564|585425613|FG001|Overall Study|Protocol Violation|27|||
162103136|NCT01864564|585425612|FG000|Overall Study|not reported|0|||
162103137|NCT01864564|585425613|FG001|Overall Study|not reported|34|||
162103138|NCT03077724|585425614|FG000|Overall Study|Lost to Follow-up|5|||
162103139|NCT03077724|585425615|FG001|Overall Study|Lost to Follow-up|1|||
162103140|NCT03077724|585425614|FG000|Overall Study|Withdrawal by Subject|3|||
162103141|NCT03077724|585425615|FG001|Overall Study|Withdrawal by Subject|1|||
162103142|NCT02269670|585425616|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
162103143|NCT00234065|585425617|FG000|Overall Study|Adverse Event|268|||
162103144|NCT00234065|585425618|FG001|Overall Study|Adverse Event|166|||
162103145|NCT00234065|585425617|FG000|Overall Study|Withdrawal by Subject|73|||
162103146|NCT00234065|585425618|FG001|Overall Study|Withdrawal by Subject|56|||
162103147|NCT00234065|585425617|FG000|Overall Study|Physician Decision|23|||
162103148|NCT00234065|585425618|FG001|Overall Study|Physician Decision|22|||
162103149|NCT00234065|585425617|FG000|Overall Study|Not Classified|111|||
162103150|NCT00234065|585425618|FG001|Overall Study|Not Classified|112|||
162103151|NCT00126438|585425619|FG000|Overall Study|Withdrawal due to adverse event|1|||
162103152|NCT00126438|585425620|FG001|Overall Study|Withdrawal due to adverse event|0|||
162103153|NCT00126438|585425619|FG000|Overall Study|Lost to Follow-up|22|||
162103154|NCT00126438|585425620|FG001|Overall Study|Lost to Follow-up|0|||
162103155|NCT00126438|585425619|FG000|Overall Study|Protocol Violation|8|||
162103156|NCT00126438|585425620|FG001|Overall Study|Protocol Violation|8|||
162103157|NCT00126438|585425619|FG000|Overall Study|Withdrawal by Subject|3|||
162103158|NCT00126438|585425620|FG001|Overall Study|Withdrawal by Subject|2|||
162103159|NCT02313428|585425621|FG000|Overall Study|Lost to Follow-up|1|||
162103160|NCT02313428|585425622|FG001|Overall Study|Lost to Follow-up|1|||
162103161|NCT05374421|585425623|FG000|Overall Study|Withdrawal by Subject|3|||
162103162|NCT05374421|585425624|FG001|Overall Study|Withdrawal by Subject|4|||
162103163|NCT04414696|585425626|FG000|3-month Follow up|Withdrawal by Subject|1|||
162103164|NCT04414696|585425627|FG001|3-month Follow up|Withdrawal by Subject|0|||
162103165|NCT04414696|585425626|FG000|3-month Follow up|Lost to Follow-up|22|||
162103166|NCT04414696|585425627|FG001|3-month Follow up|Lost to Follow-up|23|||
162103167|NCT04414696|585425626|FG000|6-month Follow up|Withdrawal by Subject|1|||
162103168|NCT04414696|585425627|FG001|6-month Follow up|Withdrawal by Subject|2|||
162103169|NCT04414696|585425626|FG000|6-month Follow up|Lost to Follow-up|5|||
162103170|NCT04414696|585425627|FG001|6-month Follow up|Lost to Follow-up|2|||
162103171|NCT00003508|585427450|FG000|Overall Study|Not evaluable|5|||
162103172|NCT02160314|585427451|FG000|Overall Study|Adverse Event|0|||
162103173|NCT02160314|585427452|FG001|Overall Study|Adverse Event|6|||
162103174|NCT02160314|585427451|FG000|Overall Study|Protocol Violation|0|||
162103175|NCT02160314|585427452|FG001|Overall Study|Protocol Violation|4|||
162103176|NCT02160314|585427451|FG000|Overall Study|Withdrawal by Subject|1|||
162103177|NCT02160314|585427452|FG001|Overall Study|Withdrawal by Subject|2|||
162103178|NCT02160314|585427451|FG000|Overall Study|Lost to Follow-up|0|||
162103179|NCT02160314|585427452|FG001|Overall Study|Lost to Follow-up|1|||
162103180|NCT00593567|585427453|FG000|Overall Study|Adverse Event|2|||
162103181|NCT00593567|585427454|FG001|Overall Study|Adverse Event|0|||
162103182|NCT00593567|585427453|FG000|Overall Study|Physician Decision|2|||
162103183|NCT00593567|585427454|FG001|Overall Study|Physician Decision|0|||
162103184|NCT00593567|585427453|FG000|Overall Study|Protocol Violation|13|||
162103185|NCT00593567|585427454|FG001|Overall Study|Protocol Violation|7|||
162103186|NCT00593567|585427453|FG000|Overall Study|Lack of Efficacy|2|||
162103187|NCT00593567|585427454|FG001|Overall Study|Lack of Efficacy|1|||
162103188|NCT00593567|585427453|FG000|Overall Study|Withdrawal by Subject|1|||
162103189|NCT00593567|585427454|FG001|Overall Study|Withdrawal by Subject|2|||
162103190|NCT00785291|585427459|FG000|Overall Study|Never began treatment|8|||
162103191|NCT00785291|585427460|FG001|Overall Study|Never began treatment|4|||
162103192|NCT00785291|585427461|FG002|Overall Study|Never began treatment|4|||
162103193|NCT00785291|585427459|FG000|Overall Study|Adverse Event|39|||
162103194|NCT00785291|585427460|FG001|Overall Study|Adverse Event|70|||
162103195|NCT00785291|585427461|FG002|Overall Study|Adverse Event|56|||
162103196|NCT00785291|585427459|FG000|Overall Study|Death|7|||
162103197|NCT00785291|585427460|FG001|Overall Study|Death|4|||
162103198|NCT00785291|585427461|FG002|Overall Study|Death|3|||
162103199|NCT00785291|585427459|FG000|Overall Study|Withdrawal by Subject|35|||
162103200|NCT00785291|585427460|FG001|Overall Study|Withdrawal by Subject|36|||
162103201|NCT00785291|585427461|FG002|Overall Study|Withdrawal by Subject|17|||
162103202|NCT00785291|585427459|FG000|Overall Study|Alternative Therapy|12|||
162103203|NCT00785291|585427460|FG001|Overall Study|Alternative Therapy|6|||
162103204|NCT00785291|585427461|FG002|Overall Study|Alternative Therapy|7|||
162103205|NCT00785291|585427459|FG000|Overall Study|Complicating illness|6|||
162103206|NCT00785291|585427460|FG001|Overall Study|Complicating illness|4|||
162103207|NCT00785291|585427461|FG002|Overall Study|Complicating illness|4|||
162103208|NCT00785291|585427459|FG000|Overall Study|Other Medical Reasons|29|||
162103209|NCT00785291|585427460|FG001|Overall Study|Other Medical Reasons|25|||
162103210|NCT00785291|585427461|FG002|Overall Study|Other Medical Reasons|15|||
162103211|NCT02119260|585427462|FG000|Overall Study|Adverse Event|1|||
162103212|NCT02119260|585427463|FG001|Overall Study|Adverse Event|0|||
162103213|NCT02119260|585427464|FG002|Overall Study|Adverse Event|0|||
162103214|NCT02119260|585427465|FG003|Overall Study|Adverse Event|0|||
162103215|NCT02119260|585427466|FG004|Overall Study|Adverse Event|0|||
162103216|NCT02119260|585427467|FG005|Overall Study|Adverse Event|0|||
162103217|NCT02119260|585427468|FG006|Overall Study|Adverse Event|0|||
162103218|NCT02119260|585427462|FG000|Overall Study|Withdrew consent|0|||
162103219|NCT02119260|585427463|FG001|Overall Study|Withdrew consent|1|||
162103220|NCT02119260|585427464|FG002|Overall Study|Withdrew consent|1|||
162103221|NCT02119260|585427465|FG003|Overall Study|Withdrew consent|0|||
162103222|NCT02119260|585427466|FG004|Overall Study|Withdrew consent|0|||
162103223|NCT02119260|585427467|FG005|Overall Study|Withdrew consent|0|||
162103224|NCT02119260|585427468|FG006|Overall Study|Withdrew consent|0|||
162103225|NCT01877408|585427473|FG000|Overall Study|Lost to Follow-up|0|||
162103226|NCT01877408|585427474|FG001|Overall Study|Lost to Follow-up|2|||
162103227|NCT03870763|585427477|FG000|Overall Study|Study terminated by sponsor|0|||
162103228|NCT03870763|585427478|FG001|Overall Study|Study terminated by sponsor|2|||
162103229|NCT03870763|585427479|FG002|Overall Study|Study terminated by sponsor|0|||
162103230|NCT03870763|585427477|FG000|Overall Study|Withdrawal by Subject|0|||
162103231|NCT03870763|585427478|FG001|Overall Study|Withdrawal by Subject|1|||
162103232|NCT03870763|585427479|FG002|Overall Study|Withdrawal by Subject|0|||
162103233|NCT03870763|585427477|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
162103234|NCT03870763|585427478|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
162103235|NCT03870763|585427479|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
162103236|NCT04279314|585427480|FG000|Overall Study|Adverse Event|55|||
162103237|NCT04279314|585427480|FG000|Overall Study|Withdrawal by Subject|5|||
162103238|NCT04279314|585427480|FG000|Overall Study|Lack of Efficacy|5|||
162103239|NCT04279314|585427480|FG000|Overall Study|Protocol Violation|3|||
162103240|NCT04279314|585427480|FG000|Overall Study|Other (not COVID-19 related)|2|||
162103241|NCT01471054|585427485|FG000|Overall Study|Study terminated prematurely|4|||
162103242|NCT01471054|585427486|FG001|Overall Study|Study terminated prematurely|0|||
162103243|NCT00360308|585427487|FG000|Overall Study|Adverse Event|15|||
162103244|NCT00360308|585427488|FG001|Overall Study|Adverse Event|14|||
162103245|NCT00360308|585427489|FG002|Overall Study|Adverse Event|25|||
162103246|NCT00360308|585427487|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
162103247|NCT00360308|585427488|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
162103248|NCT00360308|585427489|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
162103249|NCT00360308|585427487|FG000|Overall Study|Protocol Violation|2|||
162103250|NCT00360308|585427488|FG001|Overall Study|Protocol Violation|1|||
162103251|NCT00360308|585427489|FG002|Overall Study|Protocol Violation|2|||
162103252|NCT00360308|585427487|FG000|Overall Study|Withdrawal by Subject|11|||
162103253|NCT00360308|585427488|FG001|Overall Study|Withdrawal by Subject|7|||
162103254|NCT00360308|585427489|FG002|Overall Study|Withdrawal by Subject|14|||
162103255|NCT00360308|585427487|FG000|Overall Study|Lack of Efficacy|3|||
162103256|NCT00360308|585427488|FG001|Overall Study|Lack of Efficacy|0|||
162103257|NCT00360308|585427489|FG002|Overall Study|Lack of Efficacy|2|||
162103258|NCT00360308|585427487|FG000|Overall Study|Other|2|||
162103259|NCT00360308|585427488|FG001|Overall Study|Other|1|||
162103260|NCT00360308|585427489|FG002|Overall Study|Other|1|||
162103261|NCT00360308|585427487|FG000|Overall Study|Study termination by sponsor|43|||
162103262|NCT00360308|585427488|FG001|Overall Study|Study termination by sponsor|55|||
162103263|NCT00360308|585427489|FG002|Overall Study|Study termination by sponsor|44|||
162103264|NCT03162224|585427490|FG000|Overall Study|Death|4|||
162103265|NCT03162224|585427491|FG001|Overall Study|Death|5|||
162103266|NCT03162224|585427492|FG002|Overall Study|Death|8|||
162103267|NCT03162224|585427490|FG000|Overall Study|Withdrawal by Subject|1|||
162103268|NCT03162224|585427491|FG001|Overall Study|Withdrawal by Subject|0|||
162103269|NCT03162224|585427492|FG002|Overall Study|Withdrawal by Subject|1|||
162103270|NCT03162224|585427490|FG000|Overall Study|Lost to Follow-up|0|||
162103271|NCT03162224|585427491|FG001|Overall Study|Lost to Follow-up|1|||
162103272|NCT03162224|585427492|FG002|Overall Study|Lost to Follow-up|0|||
162103273|NCT03162224|585427490|FG000|Overall Study|Other|6|||
162103274|NCT03162224|585427491|FG001|Overall Study|Other|2|||
162103275|NCT03162224|585427492|FG002|Overall Study|Other|1|||
162103276|NCT04162769|585427493|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
162103277|NCT04162769|585427494|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
162103278|NCT04162769|585427495|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
162103279|NCT04162769|585427496|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
162103280|NCT04162769|585427493|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
162103281|NCT04162769|585427494|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
162103282|NCT04162769|585427495|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
162103283|NCT04162769|585427496|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
162103284|NCT04162769|585427493|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
162103285|NCT04162769|585427494|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
162103286|NCT04162769|585427495|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
162103287|NCT04162769|585427496|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
162103288|NCT04162769|585427493|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
162103289|NCT04162769|585427494|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
162103290|NCT04162769|585427495|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
162103291|NCT04162769|585427496|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
162103292|NCT04162769|585427493|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
162103293|NCT04162769|585427494|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
162103294|NCT04162769|585427495|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
162103295|NCT04162769|585427496|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
162103296|NCT04162769|585427493|FG000|Double-blind Treatment (12-Week)|Other|0|||
162103297|NCT04162769|585427494|FG001|Double-blind Treatment (12-Week)|Other|1|||
162103298|NCT04162769|585427495|FG002|Double-blind Treatment (12-Week)|Other|1|||
162103299|NCT04162769|585427496|FG003|Double-blind Treatment (12-Week)|Other|0|||
162103300|NCT04162769|585427493|FG000|OLE Period (52-Week)|Adverse Event|0|||
162103301|NCT04162769|585427494|FG001|OLE Period (52-Week)|Adverse Event|0|||
162103302|NCT04162769|585427495|FG002|OLE Period (52-Week)|Adverse Event|0|||
162103303|NCT04162769|585427496|FG003|OLE Period (52-Week)|Adverse Event|5|||
162103304|NCT04162769|585427493|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
162103305|NCT04162769|585427494|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
162103306|NCT04162769|585427495|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
162103307|NCT04162769|585427496|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
162103308|NCT04162769|585427493|FG000|OLE Period (52-Week)|Physician Decision|0|||
162103309|NCT04162769|585427494|FG001|OLE Period (52-Week)|Physician Decision|0|||
162103310|NCT04162769|585427495|FG002|OLE Period (52-Week)|Physician Decision|0|||
162103311|NCT04162769|585427496|FG003|OLE Period (52-Week)|Physician Decision|1|||
162103312|NCT04162769|585427493|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
162103313|NCT04162769|585427494|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
162103314|NCT04162769|585427495|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
162103315|NCT04162769|585427496|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
162103316|NCT04162769|585427493|FG000|OLE Period (52-Week)|Protocol deviation|0|||
162103317|NCT04162769|585427494|FG001|OLE Period (52-Week)|Protocol deviation|0|||
162103318|NCT04162769|585427495|FG002|OLE Period (52-Week)|Protocol deviation|0|||
162103319|NCT04162769|585427496|FG003|OLE Period (52-Week)|Protocol deviation|2|||
162103320|NCT01733732|585427497|FG000|Overall Study|Adverse Event|1|||
162103321|NCT01733732|585427498|FG001|Overall Study|Adverse Event|0|||
162103322|NCT01733732|585427497|FG000|Overall Study|Did not attend all study visits|1|||
162103323|NCT01733732|585427498|FG001|Overall Study|Did not attend all study visits|0|||
162103324|NCT03280121|585427502|FG000|Overall Study|Physician Decision|1|||
162103325|NCT03280121|585427502|FG000|Overall Study|Lost to Follow-up|1|||
162103326|NCT03280121|585427502|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
162103327|NCT01324271|585427515|FG000|Overall Study|Lost to Follow-up|3|||
162103328|NCT01324271|585427516|FG001|Overall Study|Lost to Follow-up|0|||
162103329|NCT01324271|585427515|FG000|Overall Study|Physician Decision|1|||
162103330|NCT01324271|585427516|FG001|Overall Study|Physician Decision|0|||
162103331|NCT06116591|585427517|FG000|Overall Study|No longer met eligibility criteria|0|||
162103332|NCT06116591|585427518|FG001|Overall Study|No longer met eligibility criteria|1|||
162103333|NCT06116591|585427517|FG000|Overall Study|Other: Change in life situation|0|||
162103334|NCT06116591|585427518|FG001|Overall Study|Other: Change in life situation|1|||
162103335|NCT05585307|585427519|FG000|Overall Study|Lost to Follow-up|0|||
162103336|NCT05585307|585427520|FG001|Overall Study|Lost to Follow-up|0|||
162103337|NCT05585307|585427521|FG002|Overall Study|Lost to Follow-up|0|||
162103338|NCT05585307|585427522|FG003|Overall Study|Lost to Follow-up|0|||
162103339|NCT05585307|585427523|FG004|Overall Study|Lost to Follow-up|0|||
162103340|NCT05585307|585427524|FG005|Overall Study|Lost to Follow-up|0|||
162103341|NCT05585307|585427525|FG006|Overall Study|Lost to Follow-up|1|||
162103342|NCT05585307|585427526|FG007|Overall Study|Lost to Follow-up|0|||
162103343|NCT04391023|585427527|FG000|Overall Study|Withdrawal by Subject|2|||
162103344|NCT04391023|585427528|FG001|Overall Study|Withdrawal by Subject|2|||
162103345|NCT01270347|585427530|FG000|Core Phase|Adverse Event|1|||
162103346|NCT01270347|585427531|FG001|Core Phase|Adverse Event|6|||
162103347|NCT01270347|585427530|FG000|Core Phase|Withdrawal by Subject|1|||
162103348|NCT01270347|585427531|FG001|Core Phase|Withdrawal by Subject|2|||
162103349|NCT01270347|585427530|FG000|Core Phase|Lost to Follow-up|0|||
162103350|NCT01270347|585427531|FG001|Core Phase|Lost to Follow-up|1|||
162103351|NCT01270347|585427530|FG000|Core Phase|Miscellaneous|8|||
162103352|NCT01270347|585427531|FG001|Core Phase|Miscellaneous|14|||
162103353|NCT01270347|585427530|FG000|Extension Phase|Adverse Event|1|||
162103354|NCT01270347|585427531|FG001|Extension Phase|Adverse Event|3|||
162103355|NCT01270347|585427530|FG000|Extension Phase|Withdrawal by Subject|3|||
162103356|NCT01270347|585427531|FG001|Extension Phase|Withdrawal by Subject|4|||
162103357|NCT01270347|585427530|FG000|Extension Phase|Miscellaneous|2|||
162103358|NCT01270347|585427531|FG001|Extension Phase|Miscellaneous|2|||
162103359|NCT00492284|585427532|FG000|Overall Study|Adverse Event|0|||
162103360|NCT00492284|585427533|FG001|Overall Study|Adverse Event|1|||
162103361|NCT00492284|585427534|FG002|Overall Study|Adverse Event|1|||
162103362|NCT00492284|585427535|FG003|Overall Study|Adverse Event|2|||
162103363|NCT00492284|585427532|FG000|Overall Study|Lost to Follow-up|0|||
162103364|NCT00492284|585427533|FG001|Overall Study|Lost to Follow-up|0|||
162103365|NCT00492284|585427534|FG002|Overall Study|Lost to Follow-up|3|||
162103366|NCT00492284|585427535|FG003|Overall Study|Lost to Follow-up|1|||
162103367|NCT00492284|585427532|FG000|Overall Study|Death|0|||
162103368|NCT00492284|585427533|FG001|Overall Study|Death|3|||
162103369|NCT00492284|585427534|FG002|Overall Study|Death|2|||
162103370|NCT00492284|585427535|FG003|Overall Study|Death|5|||
162103371|NCT00492284|585427532|FG000|Overall Study|Withdrawal by Subject|1|||
162103372|NCT00492284|585427533|FG001|Overall Study|Withdrawal by Subject|0|||
162103373|NCT00492284|585427534|FG002|Overall Study|Withdrawal by Subject|0|||
162103374|NCT00492284|585427535|FG003|Overall Study|Withdrawal by Subject|2|||
162103375|NCT01939028|585427538|FG000|Overall Study|Withdrawal by Subject|5|||
162103376|NCT01939028|585427538|FG000|Overall Study|Physician Decision|7|||
162103377|NCT03282227|585427541|FG000|Overall Study|Exposure Goals Achieved|60|||
162103378|NCT03282227|585427541|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
162103379|NCT03282227|585427541|FG000|Overall Study|Adverse Event|15|||
162103380|NCT03282227|585427541|FG000|Overall Study|Lost to Follow-up|21|||
162103381|NCT03282227|585427541|FG000|Overall Study|Withdrawal by Subject|20|||
162103382|NCT03282227|585427541|FG000|Overall Study|Lack of Efficacy|12|||
162103383|NCT03282227|585427541|FG000|Overall Study|Sponsor decision|3|||
162103384|NCT03282227|585427541|FG000|Overall Study|Physician Decision|2|||
162103385|NCT03282227|585427541|FG000|Overall Study|Pregnancy|2|||
162103386|NCT03282227|585427541|FG000|Overall Study|Other|1|||
162103387|NCT02576678|585427542|FG000|Overall Study|Adverse Event|0|||
162103388|NCT02576678|585427543|FG001|Overall Study|Adverse Event|0|||
162103389|NCT02576678|585427544|FG002|Overall Study|Adverse Event|2|||
162103390|NCT02576678|585427542|FG000|Overall Study|Withdrawal by Subject|3|||
162103391|NCT02576678|585427543|FG001|Overall Study|Withdrawal by Subject|1|||
162103392|NCT02576678|585427544|FG002|Overall Study|Withdrawal by Subject|2|||
162103393|NCT02576678|585427542|FG000|Overall Study|Lost to Follow-up|0|||
162103394|NCT02576678|585427543|FG001|Overall Study|Lost to Follow-up|0|||
162103395|NCT02576678|585427544|FG002|Overall Study|Lost to Follow-up|1|||
162103396|NCT02576678|585427542|FG000|Overall Study|Miscellaneous|2|||
162103397|NCT02576678|585427543|FG001|Overall Study|Miscellaneous|0|||
162103398|NCT02576678|585427544|FG002|Overall Study|Miscellaneous|0|||
162103399|NCT00700401|585427555|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
162103400|NCT00700401|585427555|FG000|Overall Study|Adverse Event|5|||
162103401|NCT00700401|585427555|FG000|Overall Study|Refused Treatment|2|||
162103402|NCT00700401|585427555|FG000|Overall Study|Lost to Follow-up|1|||
162103403|NCT00700401|585427555|FG000|Overall Study|Treatment never started|1|||
162103404|NCT00700401|585427555|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
162103405|NCT00700401|585427555|FG000|Overall Study|Withdrawal by Subject|2|||
162103406|NCT02491671|585427556|FG000|Overall Study|Adverse Event|6|||
162103407|NCT02491671|585427557|FG001|Overall Study|Adverse Event|8|||
162103408|NCT02491671|585427556|FG000|Overall Study|Death|0|||
162103409|NCT02491671|585427557|FG001|Overall Study|Death|2|||
162103410|NCT02491671|585427556|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
162103411|NCT02491671|585427557|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
162103412|NCT02251990|585427561|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
162103413|NCT02251990|585427562|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
162103414|NCT02251990|585427561|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
162103415|NCT02251990|585427562|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
162103416|NCT02251990|585427561|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
162103417|NCT02251990|585427562|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
162103418|NCT02251990|585427561|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
162103419|NCT02251990|585427562|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
162103420|NCT02251990|585427561|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
162103421|NCT02251990|585427562|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
162103422|NCT02251990|585427561|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
162103423|NCT02251990|585427562|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
162103424|NCT02293538|585427563|FG000|Overall Study|Adverse Event|0|||
162103425|NCT02293538|585427564|FG001|Overall Study|Adverse Event|1|||
162103426|NCT02293538|585427563|FG000|Overall Study|Lost to Follow-up|1|||
162103427|NCT02293538|585427564|FG001|Overall Study|Lost to Follow-up|0|||
162103428|NCT02293538|585427563|FG000|Overall Study|Withdrawal by Subject|0|||
162103429|NCT02293538|585427564|FG001|Overall Study|Withdrawal by Subject|1|||
162103430|NCT00322348|585427565|FG000|Overall Study|Adverse Event|0|||
162103431|NCT00322348|585427566|FG001|Overall Study|Adverse Event|1|||
162103432|NCT00322348|585427565|FG000|Overall Study|Withdrawal by Subject|1|||
162103433|NCT00322348|585427566|FG001|Overall Study|Withdrawal by Subject|4|||
162103434|NCT00322348|585427565|FG000|Overall Study|Lost to Follow-up|1|||
162103435|NCT00322348|585427566|FG001|Overall Study|Lost to Follow-up|0|||
162103436|NCT00322348|585427565|FG000|Overall Study|Death|0|||
162103437|NCT00322348|585427566|FG001|Overall Study|Death|2|||
162103438|NCT00322348|585427565|FG000|Overall Study|Disease Progression|30|||
162103439|NCT00322348|585427566|FG001|Overall Study|Disease Progression|25|||
162103440|NCT00322348|585427565|FG000|Overall Study|Reasons not specified|5|||
162103441|NCT00322348|585427566|FG001|Overall Study|Reasons not specified|1|||
162103442|NCT01041638|585427568|FG000|Overall Study|Adverse Event|4|||
162103443|NCT01041638|585427568|FG000|Overall Study|Death|1|||
162103444|NCT01041638|585427568|FG000|Overall Study|Lack of Efficacy|7|||
162103445|NCT01041638|585427568|FG000|Overall Study|Physician Decision|4|||
162103446|NCT01041638|585427568|FG000|Overall Study|Withdrawal by Subject|11|||
162103447|NCT03152552|585427569|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
162103448|NCT03152552|585427570|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
162103449|NCT03152552|585427571|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
162103450|NCT03152552|585427572|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
162103451|NCT03152552|585427573|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
162103452|NCT03152552|585427569|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
162103453|NCT03152552|585427570|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
162103454|NCT03152552|585427571|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
162103455|NCT03152552|585427572|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
162103456|NCT03152552|585427573|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
162103457|NCT03152552|585427569|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
162103458|NCT03152552|585427570|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
162103459|NCT03152552|585427571|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
162103460|NCT03152552|585427572|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
162103461|NCT03152552|585427573|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
162103462|NCT03152552|585427569|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162103463|NCT03152552|585427570|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162103464|NCT03152552|585427571|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
162103465|NCT03152552|585427572|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162103466|NCT03152552|585427573|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
162103467|NCT03152552|585427569|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
162103468|NCT03152552|585427570|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
162103469|NCT03152552|585427571|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
162103470|NCT03152552|585427572|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
162103471|NCT03152552|585427573|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
162103472|NCT03152552|585427569|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
162103473|NCT03152552|585427570|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
162103474|NCT03152552|585427571|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
162103475|NCT03152552|585427572|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
162103476|NCT03152552|585427573|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
162103477|NCT03152552|585427569|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
162103478|NCT03152552|585427570|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
162103479|NCT03152552|585427571|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
162103480|NCT03152552|585427572|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
162103481|NCT03152552|585427573|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
162103482|NCT01922076|585427577|FG000|Overall Study|Adverse Event|0|||
162103483|NCT01922076|585427578|FG001|Overall Study|Adverse Event|0|||
162103484|NCT01922076|585427579|FG002|Overall Study|Adverse Event|0|||
162103485|NCT01922076|585427580|FG003|Overall Study|Adverse Event|0|||
162103486|NCT01922076|585427581|FG004|Overall Study|Adverse Event|1|||
162103487|NCT01922076|585427582|FG005|Overall Study|Adverse Event|0|||
162103488|NCT01922076|585427583|FG006|Overall Study|Adverse Event|0|||
162103489|NCT01922076|585427577|FG000|Overall Study|Physician Decision|0|||
162103490|NCT01922076|585427578|FG001|Overall Study|Physician Decision|0|||
162103491|NCT01922076|585427579|FG002|Overall Study|Physician Decision|1|||
162103492|NCT01922076|585427580|FG003|Overall Study|Physician Decision|0|||
162103493|NCT01922076|585427581|FG004|Overall Study|Physician Decision|0|||
162103494|NCT01922076|585427582|FG005|Overall Study|Physician Decision|0|||
162103495|NCT01922076|585427583|FG006|Overall Study|Physician Decision|0|||
162103496|NCT01922076|585427577|FG000|Overall Study|Withdrawal by Subject|0|||
162103497|NCT01922076|585427578|FG001|Overall Study|Withdrawal by Subject|0|||
162103498|NCT01922076|585427579|FG002|Overall Study|Withdrawal by Subject|0|||
162103499|NCT01922076|585427580|FG003|Overall Study|Withdrawal by Subject|1|||
162103500|NCT01922076|585427581|FG004|Overall Study|Withdrawal by Subject|0|||
162103501|NCT01922076|585427582|FG005|Overall Study|Withdrawal by Subject|1|||
162103502|NCT01922076|585427583|FG006|Overall Study|Withdrawal by Subject|1|||
162103503|NCT00683644|585427589|FG000|Overall Study|Withdrawal by Subject|4|||
162103504|NCT00683644|585427590|FG001|Overall Study|Withdrawal by Subject|2|||
162103505|NCT00683644|585427589|FG000|Overall Study|Lost to Follow-up|1|||
162103506|NCT00683644|585427590|FG001|Overall Study|Lost to Follow-up|4|||
162103507|NCT00683644|585427589|FG000|Overall Study|Adverse Event|1|||
162103508|NCT00683644|585427590|FG001|Overall Study|Adverse Event|2|||
162103509|NCT00683644|585427589|FG000|Overall Study|Low copper, other health problems,|7|||
162103510|NCT00683644|585427590|FG001|Overall Study|Low copper, other health problems,|6|||
162103511|NCT03240692|585427591|FG000|Overall Study|Physician Decision|1|||
162103512|NCT03240692|585427591|FG000|Overall Study|Withdrawal by Subject|1|||
162103513|NCT01857531|585427592|FG000|Overall Study|Withdrawal by Subject|4|||
162103514|NCT00355082|585427593|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
162103515|NCT00355082|585427594|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
162103516|NCT00355082|585427595|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
162103517|NCT00355082|585427593|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
162103518|NCT00355082|585427594|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
162103519|NCT00355082|585427595|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
162103520|NCT00355082|585427593|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
162103521|NCT00355082|585427594|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
162103522|NCT00355082|585427595|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
162103523|NCT00355082|585427593|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
162103524|NCT00355082|585427594|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
162103525|NCT00355082|585427595|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
162103526|NCT00355082|585427593|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
162103527|NCT00355082|585427594|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
162103528|NCT00355082|585427595|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
162103529|NCT00355082|585427593|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
162103530|NCT00355082|585427594|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
162103531|NCT00355082|585427595|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
162103532|NCT00355082|585427593|FG000|Continuation Phase|Adverse Event|2|||
162103533|NCT00355082|585427594|FG001|Continuation Phase|Adverse Event|0|||
162103534|NCT00355082|585427595|FG002|Continuation Phase|Adverse Event|1|||
162103535|NCT00355082|585427593|FG000|Continuation Phase|Lost to Follow-up|2|||
162103536|NCT00355082|585427594|FG001|Continuation Phase|Lost to Follow-up|0|||
162103537|NCT00355082|585427595|FG002|Continuation Phase|Lost to Follow-up|1|||
162103538|NCT00355082|585427593|FG000|Continuation Phase|Protocol Violation|1|||
162103539|NCT00355082|585427594|FG001|Continuation Phase|Protocol Violation|0|||
162103540|NCT00355082|585427595|FG002|Continuation Phase|Protocol Violation|1|||
162103541|NCT00355082|585427593|FG000|Continuation Phase|Withdrawal by Subject|4|||
162103542|NCT00355082|585427594|FG001|Continuation Phase|Withdrawal by Subject|0|||
162103543|NCT00355082|585427595|FG002|Continuation Phase|Withdrawal by Subject|0|||
162103544|NCT00355082|585427593|FG000|Continuation Phase|Lack of Efficacy|5|||
162103545|NCT00355082|585427594|FG001|Continuation Phase|Lack of Efficacy|0|||
162103546|NCT00355082|585427595|FG002|Continuation Phase|Lack of Efficacy|0|||
162103547|NCT00355082|585427593|FG000|Continuation Phase|Site Closed by Sponsor|8|||
162103548|NCT00355082|585427594|FG001|Continuation Phase|Site Closed by Sponsor|0|||
162103549|NCT00355082|585427595|FG002|Continuation Phase|Site Closed by Sponsor|0|||
162103550|NCT00355082|585427593|FG000|Continuation Phase|Scheduling Error|1|||
162103551|NCT00355082|585427594|FG001|Continuation Phase|Scheduling Error|0|||
162103552|NCT00355082|585427595|FG002|Continuation Phase|Scheduling Error|0|||
162103553|NCT00355082|585427593|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
162103554|NCT00355082|585427594|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
162103555|NCT00355082|585427595|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
162103556|NCT02576067|585427596|FG000|Overall Study|Death|0|||
162103557|NCT02576067|585427597|FG001|Overall Study|Death|1|||
162103558|NCT02576067|585427596|FG000|Overall Study|Lack of Efficacy|1|||
162103559|NCT02576067|585427597|FG001|Overall Study|Lack of Efficacy|0|||
162103560|NCT02576067|585427596|FG000|Overall Study|Lost to Follow-up|11|||
162103561|NCT02576067|585427597|FG001|Overall Study|Lost to Follow-up|0|||
162103562|NCT02576067|585427596|FG000|Overall Study|Withdrawal by Subject|11|||
162103563|NCT02576067|585427597|FG001|Overall Study|Withdrawal by Subject|2|||
162103564|NCT02576067|585427596|FG000|Overall Study|study closure of main CIRT trial)|0|||
162103565|NCT02576067|585427597|FG001|Overall Study|study closure of main CIRT trial)|8|||
162103566|NCT02576067|585427596|FG000|Overall Study|not randomized, failed run-in|7|||
162103567|NCT02576067|585427597|FG001|Overall Study|not randomized, failed run-in|0|||
162103568|NCT02576067|585427596|FG000|Overall Study|screen failure/ re-enrolled|0|||
162103569|NCT02576067|585427597|FG001|Overall Study|screen failure/ re-enrolled|25|||
162103570|NCT02576067|585427596|FG000|Overall Study|Physician Decision|4|||
162103571|NCT02576067|585427597|FG001|Overall Study|Physician Decision|0|||
162103572|NCT04084314|585427598|FG000|Overall Study|Subject/guardian decision|91|||
162103573|NCT04084314|585427598|FG000|Overall Study|Adverse Event|24|||
162103574|NCT04084314|585427598|FG000|Overall Study|Lost to Follow-up|19|||
162103575|NCT04084314|585427598|FG000|Overall Study|New therapy for study indication|9|||
162103576|NCT04084314|585427598|FG000|Overall Study|Pregnancy|9|||
162103577|NCT04084314|585427598|FG000|Overall Study|Withdrawal of informed consent|8|||
162103578|NCT04084314|585427598|FG000|Overall Study|Physician Decision|4|||
162103579|NCT04084314|585427598|FG000|Overall Study|Protocol Deviation|3|||
162103580|NCT00622167|585427599|FG000|Overall Study|Did not meet angiographic criteria|20|||
162103581|NCT03738150|585427608|FG000|Base Study|Withdrawal by Subject|1|||
162103582|NCT03738150|585427608|FG000|Extension Study|Withdrawal by Subject|1|||
162103583|NCT04598152|585427611|FG000|Overall Study|Lost to Follow-up|0|||
162103584|NCT04598152|585427612|FG001|Overall Study|Lost to Follow-up|1|||
162103585|NCT03346759|585427613|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
162103586|NCT03346759|585427614|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
162103587|NCT03346759|585427613|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
162103588|NCT03346759|585427614|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
162103589|NCT03346759|585427613|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
162103590|NCT03346759|585427614|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
162103591|NCT03943095|585427615|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
162103592|NCT03943095|585427616|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
162103593|NCT03943095|585427615|FG000|Overall Study|Withdrawal by Subject|1|||
162103594|NCT03943095|585427616|FG001|Overall Study|Withdrawal by Subject|0|||
162103595|NCT04988308|585427617|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
162103596|NCT04988308|585427618|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
162103597|NCT04988308|585427619|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
162103598|NCT04988308|585427620|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
162103599|NCT04988308|585427621|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
162103600|NCT04988308|585427622|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
162103601|NCT04988308|585427617|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
162103602|NCT04988308|585427618|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
162103603|NCT04988308|585427619|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
162103604|NCT04988308|585427620|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
162103605|NCT04988308|585427621|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
162103606|NCT04988308|585427622|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
162103607|NCT04988308|585427617|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
162103608|NCT04988308|585427618|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
162103609|NCT04988308|585427619|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
162103610|NCT04988308|585427620|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
162103611|NCT04988308|585427621|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
162103612|NCT04988308|585427622|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
162103613|NCT04988308|585427617|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
162103614|NCT04988308|585427618|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
162103615|NCT04988308|585427619|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
162103616|NCT04988308|585427620|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
162103617|NCT04988308|585427621|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
162103618|NCT04988308|585427622|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
162103619|NCT04988308|585427617|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
162103620|NCT04988308|585427618|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
162103621|NCT04988308|585427619|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
162103622|NCT04988308|585427620|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
162103623|NCT04988308|585427621|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
162103624|NCT04988308|585427622|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
162103625|NCT04988308|585427617|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
162103626|NCT04988308|585427618|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
162103627|NCT04988308|585427619|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
162103628|NCT04988308|585427620|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
162103629|NCT04988308|585427621|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
162103630|NCT04988308|585427622|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
162103631|NCT04988308|585427617|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
162103632|NCT04988308|585427618|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
162103633|NCT04988308|585427619|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
162103634|NCT04988308|585427620|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
162103635|NCT04988308|585427621|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
162103636|NCT04988308|585427622|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
162103637|NCT04988308|585427617|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162103638|NCT04988308|585427618|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162103639|NCT04988308|585427619|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
162103640|NCT04988308|585427620|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
162103641|NCT04988308|585427621|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
162103642|NCT04988308|585427622|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
162103643|NCT04988308|585427617|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
162103644|NCT04988308|585427618|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
162103645|NCT04988308|585427619|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
162103646|NCT04988308|585427620|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
162103647|NCT04988308|585427621|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
162103648|NCT04988308|585427622|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
162103649|NCT04177758|585427632|FG000|Overall Study|Lost to Follow-up|19|||
162103650|NCT04177758|585427633|FG001|Overall Study|Lost to Follow-up|11|||
162103651|NCT02763384|585427634|FG000|Overall Study|Physician Decision|1|||
162103652|NCT02763384|585427634|FG000|Overall Study|Rapid decline - went on hospice|1|||
162103653|NCT03576768|585429775|FG000|Overall Study|Lost to Follow-up|3|||
162103654|NCT03576768|585429776|FG001|Overall Study|Lost to Follow-up|3|||
162103655|NCT03576768|585429777|FG002|Overall Study|Lost to Follow-up|0|||
162103656|NCT03576768|585429778|FG003|Overall Study|Lost to Follow-up|0|||
162103657|NCT00590902|585429779|FG000|Overall Study|Death|1|||
162103658|NCT02057874|585429780|FG000|Overall Study|participant did not return for scan|1|||
162103659|NCT02979639|585429781|FG000|Overall Study|Withdrawal based on medical judgement|1|||
162103660|NCT02979639|585429781|FG000|Overall Study|Lost to Follow-up|8|||
162103661|NCT02979639|585429781|FG000|Overall Study|Withdrawal by Subject|3|||
162103662|NCT02979639|585429781|FG000|Overall Study|Adverse Event|2|||
162103663|NCT01738984|585429784|FG000|Overall Study|Pregnancy|4|||
162103664|NCT01738984|585429785|FG001|Overall Study|Pregnancy|0|||
162103665|NCT01738984|585429784|FG000|Overall Study|Withdrawal by Subject|1|||
162103666|NCT01738984|585429785|FG001|Overall Study|Withdrawal by Subject|0|||
162103667|NCT01738984|585429784|FG000|Overall Study|Lost to Follow-up|59|||
162103668|NCT01738984|585429785|FG001|Overall Study|Lost to Follow-up|39|||
162103669|NCT02621931|585429790|FG000|Overall Study|Death|0|||
162103670|NCT02621931|585429791|FG001|Overall Study|Death|1|||
162103671|NCT02621931|585429792|FG002|Overall Study|Death|0|||
162103672|NCT02621931|585429790|FG000|Overall Study|Adverse Event|8|||
162103673|NCT02621931|585429791|FG001|Overall Study|Adverse Event|5|||
162103674|NCT02621931|585429792|FG002|Overall Study|Adverse Event|7|||
162103675|NCT02621931|585429790|FG000|Overall Study|Withdrawal by Subject|12|||
162103676|NCT02621931|585429791|FG001|Overall Study|Withdrawal by Subject|10|||
162103677|NCT02621931|585429792|FG002|Overall Study|Withdrawal by Subject|11|||
162103678|NCT02621931|585429790|FG000|Overall Study|Protocol Violation|2|||
162103679|NCT02621931|585429791|FG001|Overall Study|Protocol Violation|2|||
162103680|NCT02621931|585429792|FG002|Overall Study|Protocol Violation|2|||
162103681|NCT02621931|585429790|FG000|Overall Study|Pregnancy|2|||
162103682|NCT02621931|585429791|FG001|Overall Study|Pregnancy|0|||
162103683|NCT02621931|585429792|FG002|Overall Study|Pregnancy|0|||
162103684|NCT02621931|585429790|FG000|Overall Study|Noncompliance to study procedures|0|||
162103685|NCT02621931|585429791|FG001|Overall Study|Noncompliance to study procedures|1|||
162103686|NCT02621931|585429792|FG002|Overall Study|Noncompliance to study procedures|2|||
162103687|NCT02621931|585429790|FG000|Overall Study|Lost to Follow-up|8|||
162103688|NCT02621931|585429791|FG001|Overall Study|Lost to Follow-up|7|||
162103689|NCT02621931|585429792|FG002|Overall Study|Lost to Follow-up|10|||
162103690|NCT02621931|585429790|FG000|Overall Study|Lack of Efficacy|0|||
162103691|NCT02621931|585429791|FG001|Overall Study|Lack of Efficacy|0|||
162103692|NCT02621931|585429792|FG002|Overall Study|Lack of Efficacy|1|||
162103693|NCT02621931|585429790|FG000|Overall Study|Other|1|||
162103694|NCT02621931|585429791|FG001|Overall Study|Other|1|||
162103695|NCT02621931|585429792|FG002|Overall Study|Other|3|||
162103696|NCT00920426|585429793|FG000|ITZ111451|Adverse Event|1|||
162103697|NCT00920426|585429794|FG001|ITZ111451|Adverse Event|0|||
162103698|NCT00920426|585429795|FG002|ITZ111451|Adverse Event|0|||
162103699|NCT00920426|585429796|FG003|ITZ111451|Adverse Event|0|||
162103700|NCT00955357|585429801|FG000|Titration Phase|Adverse Event|9|||
162103701|NCT00955357|585429802|FG001|Titration Phase|Adverse Event|46|||
162103702|NCT00955357|585429801|FG000|Titration Phase|Lack of Efficacy|0|||
162103703|NCT00955357|585429802|FG001|Titration Phase|Lack of Efficacy|2|||
162103704|NCT00955357|585429801|FG000|Titration Phase|Protocol Violation|3|||
162103705|NCT00955357|585429802|FG001|Titration Phase|Protocol Violation|7|||
162103706|NCT00955357|585429801|FG000|Titration Phase|Lost to Follow-up|1|||
162103707|NCT00955357|585429802|FG001|Titration Phase|Lost to Follow-up|3|||
162103708|NCT00955357|585429801|FG000|Titration Phase|Withdrawal by Subject|3|||
162103709|NCT00955357|585429802|FG001|Titration Phase|Withdrawal by Subject|5|||
162103710|NCT00955357|585429801|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
162103711|NCT00955357|585429802|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
162103712|NCT00955357|585429801|FG000|Titration Phase|Study medication not tolerated|0|||
162103713|NCT00955357|585429802|FG001|Titration Phase|Study medication not tolerated|1|||
162103714|NCT00955357|585429801|FG000|Titration Phase|Non compliance to study procedures|0|||
162103715|NCT00955357|585429802|FG001|Titration Phase|Non compliance to study procedures|1|||
162103716|NCT00955357|585429801|FG000|Maintenance Phase|Adverse Event|3|||
162103717|NCT00955357|585429802|FG001|Maintenance Phase|Adverse Event|23|||
162103718|NCT00955357|585429801|FG000|Maintenance Phase|Lack of Efficacy|0|||
162103719|NCT00955357|585429802|FG001|Maintenance Phase|Lack of Efficacy|4|||
162103720|NCT00955357|585429801|FG000|Maintenance Phase|Protocol Violation|2|||
162103721|NCT00955357|585429802|FG001|Maintenance Phase|Protocol Violation|6|||
162103722|NCT00955357|585429801|FG000|Maintenance Phase|Lost to Follow-up|2|||
162103723|NCT00955357|585429802|FG001|Maintenance Phase|Lost to Follow-up|7|||
162103724|NCT00955357|585429801|FG000|Maintenance Phase|Withdrawal by Subject|4|||
162103725|NCT00955357|585429802|FG001|Maintenance Phase|Withdrawal by Subject|4|||
162103726|NCT00955357|585429801|FG000|Maintenance Phase|Patient moving out of area|0|||
162103727|NCT00955357|585429802|FG001|Maintenance Phase|Patient moving out of area|1|||
162103728|NCT00955357|585429801|FG000|Maintenance Phase|Non compliance to study procedures|1|||
162103729|NCT00955357|585429802|FG001|Maintenance Phase|Non compliance to study procedures|0|||
162103730|NCT00886340|585429803|FG000|Overall Study|Withdrawal by Subject|0|||
162103731|NCT00886340|585429804|FG001|Overall Study|Withdrawal by Subject|7|||
162103732|NCT02985866|585429805|FG000|Overall Study|Poor CGM data|1|||
162103733|NCT02985866|585429806|FG001|Overall Study|Poor CGM data|1|||
162103734|NCT03224182|585429807|FG000|Overall Study|Study Drug Not Instilled|6|||
162103735|NCT03224182|585429808|FG001|Overall Study|Study Drug Not Instilled|1|||
162103736|NCT03224182|585429807|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
162103737|NCT03224182|585429808|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
162103738|NCT03224182|585429807|FG000|Overall Study|Withdrew of Consent|4|||
162103739|NCT03224182|585429808|FG001|Overall Study|Withdrew of Consent|2|||
162103740|NCT03224182|585429807|FG000|Overall Study|Investigator Decision|3|||
162103741|NCT03224182|585429808|FG001|Overall Study|Investigator Decision|1|||
162103742|NCT03224182|585429807|FG000|Overall Study|Sponsor Decision|26|||
162103743|NCT03224182|585429808|FG001|Overall Study|Sponsor Decision|12|||
162103744|NCT03224182|585429807|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
162103745|NCT03224182|585429808|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
162103746|NCT03224182|585429807|FG000|Overall Study|Lost to Follow-up|1|||
162103747|NCT03224182|585429808|FG001|Overall Study|Lost to Follow-up|0|||
162103748|NCT03224182|585429807|FG000|Overall Study|Participant Had Recurrence|11|||
162103749|NCT03224182|585429808|FG001|Overall Study|Participant Had Recurrence|5|||
162103750|NCT03224182|585429807|FG000|Overall Study|Death|0|||
162103751|NCT03224182|585429808|FG001|Overall Study|Death|1|||
162103752|NCT03224182|585429807|FG000|Overall Study|Reason not Specified|3|||
162103753|NCT03224182|585429808|FG001|Overall Study|Reason not Specified|3|||
162103754|NCT03224182|585429807|FG000|Overall Study|Other|1|||
162103755|NCT03224182|585429808|FG001|Overall Study|Other|0|||
162103756|NCT02925455|585429812|FG000|Overall Study|Withdrawal by Subject|2|||
162103757|NCT02925455|585429813|FG001|Overall Study|Withdrawal by Subject|0|||
162103758|NCT00686166|585429817|FG000|Overall Study|Adverse Event|7|||
162103759|NCT00686166|585429817|FG000|Overall Study|Withdrawal by Subject|1|||
162103760|NCT00686166|585429817|FG000|Overall Study|Progression/Relapse|1|||
162103761|NCT00686166|585429817|FG000|Overall Study|Death|1|||
162103762|NCT00686166|585429817|FG000|Overall Study|Not Protocol Specified|1|||
162103763|NCT00686166|585429817|FG000|Overall Study|Ineligible|5|||
162103764|NCT00686166|585429817|FG000|Overall Study|Did not begin protocol therapy|4|||
162103765|NCT00985725|585429818|FG000|Overall Study|Adverse Event|4|||
162103766|NCT00985725|585429819|FG001|Overall Study|Adverse Event|1|||
162103767|NCT00985725|585429818|FG000|Overall Study|Protocol Violation|1|||
162103768|NCT00985725|585429819|FG001|Overall Study|Protocol Violation|3|||
162103769|NCT00985725|585429818|FG000|Overall Study|Withdrawal by Subject|4|||
162103770|NCT00985725|585429819|FG001|Overall Study|Withdrawal by Subject|4|||
162103771|NCT00985725|585429818|FG000|Overall Study|Lost to Follow-up|1|||
162103772|NCT00985725|585429819|FG001|Overall Study|Lost to Follow-up|1|||
162103773|NCT00985725|585429818|FG000|Overall Study|Lack of Efficacy|0|||
162103774|NCT00985725|585429819|FG001|Overall Study|Lack of Efficacy|1|||
162103775|NCT00985725|585429818|FG000|Overall Study|Non-compliance|1|||
162103776|NCT00985725|585429819|FG001|Overall Study|Non-compliance|2|||
162103777|NCT00985725|585429818|FG000|Overall Study|Out-of-window visits|0|||
162103778|NCT00985725|585429819|FG001|Overall Study|Out-of-window visits|1|||
162103779|NCT02314624|585429823|FG000|Overall Study|No participating patient|16|||
162103780|NCT02314624|585429824|FG001|Overall Study|No participating patient|13|||
162103781|NCT02314624|585429823|FG000|Overall Study|Participant withdrew|7|||
162103782|NCT02314624|585429824|FG001|Overall Study|Participant withdrew|2|||
162103783|NCT02314624|585429823|FG000|Overall Study|Lost to Follow-up|2|||
162103784|NCT02314624|585429824|FG001|Overall Study|Lost to Follow-up|5|||
162103785|NCT02314624|585429823|FG000|Overall Study|Dropped/Excluded by PI|6|||
162103786|NCT02314624|585429824|FG001|Overall Study|Dropped/Excluded by PI|6|||
162103787|NCT03151005|585429825|FG000|Overall Study|Lost to Follow-up|5|||
162103788|NCT03151005|585429826|FG001|Overall Study|Lost to Follow-up|5|||
162103789|NCT03912259|585429827|FG000|Overall Study|Adverse Event (AE)|2|||
162103790|NCT03912259|585429828|FG001|Overall Study|Adverse Event (AE)|4|||
162103791|NCT03912259|585429827|FG000|Overall Study|Lack of Efficacy|4|||
162103792|NCT03912259|585429828|FG001|Overall Study|Lack of Efficacy|1|||
162103793|NCT03912259|585429827|FG000|Overall Study|Withdrawal by Subject|11|||
162103794|NCT03912259|585429828|FG001|Overall Study|Withdrawal by Subject|1|||
162103795|NCT01549613|585429831|FG000|Overall Study|Lost to Follow-up|11|||
162103796|NCT01549613|585429832|FG001|Overall Study|Lost to Follow-up|11|||
162103797|NCT02131272|585429833|FG000|Overall Study|Withdrawal by parent|0|||
162103798|NCT02131272|585429834|FG001|Overall Study|Withdrawal by parent|1|||
162103799|NCT02131272|585429833|FG000|Overall Study|Withdrawal by Subject|0|||
162103800|NCT02131272|585429834|FG001|Overall Study|Withdrawal by Subject|1|||
162103801|NCT02131272|585429833|FG000|Overall Study|Withdrawal Criteria|1|||
162103802|NCT02131272|585429834|FG001|Overall Study|Withdrawal Criteria|0|||
162103803|NCT00381940|585429835|FG000|Overall Study|Lack of Efficacy|3|||
162103804|NCT00381940|585429835|FG000|Overall Study|Protocol Violation|1|||
162103805|NCT00381940|585429835|FG000|Overall Study|Ineligible|1|||
162103806|NCT00464815|585429836|FG000|Overall Study|Withdrawal by Subject|6|||
162103807|NCT00464815|585429837|FG001|Overall Study|Withdrawal by Subject|3|||
162103808|NCT03643952|585429841|FG000|Overall Study|Lack of Efficacy|1|||
162103809|NCT01358968|585429842|FG000|Period 2|Adverse Event|0|||
162103810|NCT01358968|585429843|FG001|Period 2|Adverse Event|1|||
162103811|NCT01358968|585429844|FG002|Period 2|Adverse Event|0|||
162103812|NCT01358968|585429845|FG003|Period 2|Adverse Event|0|||
162103813|NCT01358968|585429842|FG000|Continued Access Phase|Progression of Disease|0|||
162103814|NCT01358968|585429843|FG001|Continued Access Phase|Progression of Disease|0|||
162103815|NCT01358968|585429844|FG002|Continued Access Phase|Progression of Disease|8|||
162103816|NCT01358968|585429845|FG003|Continued Access Phase|Progression of Disease|4|||
162103817|NCT01358968|585429842|FG000|Continued Access Phase|Protocol Violation|0|||
162103818|NCT01358968|585429843|FG001|Continued Access Phase|Protocol Violation|0|||
162103819|NCT01358968|585429844|FG002|Continued Access Phase|Protocol Violation|0|||
162103820|NCT01358968|585429845|FG003|Continued Access Phase|Protocol Violation|2|||
162103821|NCT01358968|585429842|FG000|Continued Access Phase|Withdrawal by Subject|0|||
162103822|NCT01358968|585429843|FG001|Continued Access Phase|Withdrawal by Subject|0|||
162103823|NCT01358968|585429844|FG002|Continued Access Phase|Withdrawal by Subject|3|||
162103824|NCT01358968|585429845|FG003|Continued Access Phase|Withdrawal by Subject|0|||
162103825|NCT01358968|585429842|FG000|Continued Access Phase|Death|0|||
162103826|NCT01358968|585429843|FG001|Continued Access Phase|Death|0|||
162103827|NCT01358968|585429844|FG002|Continued Access Phase|Death|1|||
162103828|NCT01358968|585429845|FG003|Continued Access Phase|Death|1|||
162103829|NCT01597050|585429846|FG000|Overall Study|Withdrawal by Subject|1|||
162103830|NCT01597050|585429847|FG001|Overall Study|Withdrawal by Subject|0|||
162103831|NCT00483184|585429848|FG000|Overall Study|Withdrawal by Subject|2|||
162103832|NCT00483184|585429849|FG001|Overall Study|Withdrawal by Subject|2|||
162103833|NCT00483184|585429850|FG002|Overall Study|Withdrawal by Subject|0|||
162103834|NCT00483184|585429848|FG000|Overall Study|Lost to Follow-up|1|||
162103835|NCT00483184|585429849|FG001|Overall Study|Lost to Follow-up|0|||
162103836|NCT00483184|585429850|FG002|Overall Study|Lost to Follow-up|0|||
162103837|NCT00483184|585429848|FG000|Overall Study|Adverse Event|1|||
162103838|NCT00483184|585429849|FG001|Overall Study|Adverse Event|2|||
162103839|NCT00483184|585429850|FG002|Overall Study|Adverse Event|2|||
162103840|NCT00483184|585429848|FG000|Overall Study|Protocol Violation|1|||
162103841|NCT00483184|585429849|FG001|Overall Study|Protocol Violation|0|||
162103842|NCT00483184|585429850|FG002|Overall Study|Protocol Violation|1|||
162103843|NCT00515502|585429860|FG000|Treatment Period 1|Adverse Event|0|||
162103844|NCT00515502|585429861|FG001|Treatment Period 1|Adverse Event|0|||
162103845|NCT00515502|585429862|FG002|Treatment Period 1|Adverse Event|0|||
162103846|NCT00515502|585429863|FG003|Treatment Period 1|Adverse Event|0|||
162103847|NCT00515502|585429864|FG004|Treatment Period 1|Adverse Event|0|||
162103848|NCT00515502|585429865|FG005|Treatment Period 1|Adverse Event|0|||
162103849|NCT00515502|585429866|FG006|Treatment Period 1|Adverse Event|1|||
162103850|NCT00515502|585429867|FG007|Treatment Period 1|Adverse Event|0|||
162103851|NCT00515502|585429868|FG008|Treatment Period 1|Adverse Event|1|||
162103852|NCT00515502|585429869|FG009|Treatment Period 1|Adverse Event|0|||
162103853|NCT00515502|585429870|FG010|Treatment Period 1|Adverse Event|0|||
162103854|NCT00515502|585429871|FG011|Treatment Period 1|Adverse Event|1|||
162103855|NCT00515502|585429860|FG000|Treatment Period 2|Adverse Event|0|||
162103856|NCT00515502|585429861|FG001|Treatment Period 2|Adverse Event|1|||
162103857|NCT00515502|585429862|FG002|Treatment Period 2|Adverse Event|0|||
162103858|NCT00515502|585429863|FG003|Treatment Period 2|Adverse Event|0|||
162103859|NCT00515502|585429864|FG004|Treatment Period 2|Adverse Event|0|||
162103860|NCT00515502|585429865|FG005|Treatment Period 2|Adverse Event|0|||
162103861|NCT00515502|585429866|FG006|Treatment Period 2|Adverse Event|0|||
162103862|NCT00515502|585429867|FG007|Treatment Period 2|Adverse Event|0|||
162103863|NCT00515502|585429868|FG008|Treatment Period 2|Adverse Event|0|||
162103864|NCT00515502|585429869|FG009|Treatment Period 2|Adverse Event|0|||
162103865|NCT00515502|585429870|FG010|Treatment Period 2|Adverse Event|0|||
162103866|NCT00515502|585429871|FG011|Treatment Period 2|Adverse Event|0|||
162103867|NCT03252587|585429872|FG000|Overall Study|Adverse Event|3|||
162103868|NCT03252587|585429873|FG001|Overall Study|Adverse Event|8|||
162103869|NCT03252587|585429874|FG002|Overall Study|Adverse Event|6|||
162103870|NCT03252587|585429875|FG003|Overall Study|Adverse Event|12|||
162103871|NCT03252587|585429872|FG000|Overall Study|Lack of Efficacy|7|||
162103872|NCT03252587|585429873|FG001|Overall Study|Lack of Efficacy|2|||
162103873|NCT03252587|585429874|FG002|Overall Study|Lack of Efficacy|2|||
162103874|NCT03252587|585429875|FG003|Overall Study|Lack of Efficacy|4|||
162103875|NCT03252587|585429872|FG000|Overall Study|Lost to Follow-up|2|||
162103876|NCT03252587|585429873|FG001|Overall Study|Lost to Follow-up|0|||
162103877|NCT03252587|585429874|FG002|Overall Study|Lost to Follow-up|0|||
162103878|NCT03252587|585429875|FG003|Overall Study|Lost to Follow-up|2|||
162103879|NCT03252587|585429872|FG000|Overall Study|Pregnancy|2|||
162103880|NCT03252587|585429873|FG001|Overall Study|Pregnancy|1|||
162103881|NCT03252587|585429874|FG002|Overall Study|Pregnancy|0|||
162103882|NCT03252587|585429875|FG003|Overall Study|Pregnancy|1|||
162103883|NCT03252587|585429872|FG000|Overall Study|Withdrawal by Subject|8|||
162103884|NCT03252587|585429873|FG001|Overall Study|Withdrawal by Subject|4|||
162103885|NCT03252587|585429874|FG002|Overall Study|Withdrawal by Subject|4|||
162103886|NCT03252587|585429875|FG003|Overall Study|Withdrawal by Subject|4|||
162103887|NCT03252587|585429872|FG000|Overall Study|Other Reasons|2|||
162103888|NCT03252587|585429873|FG001|Overall Study|Other Reasons|5|||
162103889|NCT03252587|585429874|FG002|Overall Study|Other Reasons|5|||
162103890|NCT03252587|585429875|FG003|Overall Study|Other Reasons|4|||
162103891|NCT04052204|585429876|FG000|Overall Study|Death|1|||
162103892|NCT04052204|585429877|FG001|Overall Study|Death|0|||
162103893|NCT04052204|585429878|FG002|Overall Study|Death|0|||
162103894|NCT04052204|585429876|FG000|Overall Study|Progressive disease|1|||
162103895|NCT04052204|585429877|FG001|Overall Study|Progressive disease|0|||
162103896|NCT04052204|585429878|FG002|Overall Study|Progressive disease|0|||
162103897|NCT04052204|585429876|FG000|Overall Study|Other|1|||
162103898|NCT04052204|585429877|FG001|Overall Study|Other|0|||
162103899|NCT04052204|585429878|FG002|Overall Study|Other|0|||
162103900|NCT03647501|585429879|FG000|Overall Study|Lost to Follow-up|1|||
162103901|NCT03647501|585429880|FG001|Overall Study|Lost to Follow-up|1|||
162103902|NCT03647501|585429879|FG000|Overall Study|Withdrawal by Subject|0|||
162103903|NCT03647501|585429880|FG001|Overall Study|Withdrawal by Subject|1|||
162103904|NCT03945188|585429881|FG000|Overall Study|Protocol Violation|1|||
162103905|NCT03945188|585429882|FG001|Overall Study|Protocol Violation|0|||
162103906|NCT03945188|585429881|FG000|Overall Study|Disease worsening|79|||
162103907|NCT03945188|585429882|FG001|Overall Study|Disease worsening|73|||
162103908|NCT03945188|585429881|FG000|Overall Study|Physician Decision|2|||
162103909|NCT03945188|585429882|FG001|Overall Study|Physician Decision|2|||
162103910|NCT03945188|585429881|FG000|Overall Study|Lack of Efficacy|7|||
162103911|NCT03945188|585429882|FG001|Overall Study|Lack of Efficacy|4|||
162103912|NCT03945188|585429881|FG000|Overall Study|Pregnancy|2|||
162103913|NCT03945188|585429882|FG001|Overall Study|Pregnancy|0|||
162103914|NCT03945188|585429881|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
162103915|NCT03945188|585429882|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
162103916|NCT03945188|585429881|FG000|Overall Study|Adverse Event|10|||
162103917|NCT03945188|585429882|FG001|Overall Study|Adverse Event|5|||
162103918|NCT03945188|585429881|FG000|Overall Study|Other|2|||
162103919|NCT03945188|585429882|FG001|Overall Study|Other|2|||
162103920|NCT03945188|585429881|FG000|Overall Study|Lost to Follow-up|1|||
162103921|NCT03945188|585429882|FG001|Overall Study|Lost to Follow-up|2|||
162103922|NCT01613248|585429883|FG000|Overall Study|Adverse Event|0|||
162103923|NCT01613248|585429884|FG001|Overall Study|Adverse Event|0|||
162103924|NCT01613248|585429885|FG002|Overall Study|Adverse Event|0|||
162103925|NCT01613248|585429886|FG003|Overall Study|Adverse Event|1|||
162103926|NCT01613248|585429887|FG004|Overall Study|Adverse Event|0|||
162103927|NCT01613248|585429888|FG005|Overall Study|Adverse Event|0|||
162103928|NCT01613248|585429883|FG000|Overall Study|Withdrawal by Subject|3|||
162103929|NCT01613248|585429884|FG001|Overall Study|Withdrawal by Subject|2|||
162103930|NCT01613248|585429885|FG002|Overall Study|Withdrawal by Subject|2|||
162103931|NCT01613248|585429886|FG003|Overall Study|Withdrawal by Subject|5|||
162103932|NCT01613248|585429887|FG004|Overall Study|Withdrawal by Subject|0|||
162103933|NCT01613248|585429888|FG005|Overall Study|Withdrawal by Subject|1|||
162103934|NCT01613248|585429883|FG000|Overall Study|Lost to Follow-up|5|||
162103935|NCT01613248|585429884|FG001|Overall Study|Lost to Follow-up|7|||
162103936|NCT01613248|585429885|FG002|Overall Study|Lost to Follow-up|4|||
162103937|NCT01613248|585429886|FG003|Overall Study|Lost to Follow-up|8|||
162103938|NCT01613248|585429887|FG004|Overall Study|Lost to Follow-up|4|||
162103939|NCT01613248|585429888|FG005|Overall Study|Lost to Follow-up|2|||
162103940|NCT01613248|585429883|FG000|Overall Study|Study Terminated by Sponsor|4|||
162103941|NCT01613248|585429884|FG001|Overall Study|Study Terminated by Sponsor|6|||
162103942|NCT01613248|585429885|FG002|Overall Study|Study Terminated by Sponsor|8|||
162103943|NCT01613248|585429886|FG003|Overall Study|Study Terminated by Sponsor|8|||
162103944|NCT01613248|585429887|FG004|Overall Study|Study Terminated by Sponsor|9|||
162103945|NCT01613248|585429888|FG005|Overall Study|Study Terminated by Sponsor|11|||
162103946|NCT01613248|585429883|FG000|Overall Study|Physician Decision|8|||
162103947|NCT01613248|585429884|FG001|Overall Study|Physician Decision|8|||
162103948|NCT01613248|585429885|FG002|Overall Study|Physician Decision|9|||
162103949|NCT01613248|585429886|FG003|Overall Study|Physician Decision|4|||
162103950|NCT01613248|585429887|FG004|Overall Study|Physician Decision|7|||
162103951|NCT01613248|585429888|FG005|Overall Study|Physician Decision|6|||
162103952|NCT01613248|585429883|FG000|Overall Study|Lack of Qualifying Event|9|||
162103953|NCT01613248|585429884|FG001|Overall Study|Lack of Qualifying Event|11|||
162103954|NCT01613248|585429885|FG002|Overall Study|Lack of Qualifying Event|10|||
162103955|NCT01613248|585429886|FG003|Overall Study|Lack of Qualifying Event|11|||
162103956|NCT01613248|585429887|FG004|Overall Study|Lack of Qualifying Event|15|||
162103957|NCT01613248|585429888|FG005|Overall Study|Lack of Qualifying Event|18|||
162103958|NCT01613248|585429883|FG000|Overall Study|Pregnancy|0|||
162103959|NCT01613248|585429884|FG001|Overall Study|Pregnancy|0|||
162103960|NCT01613248|585429885|FG002|Overall Study|Pregnancy|0|||
162103961|NCT01613248|585429886|FG003|Overall Study|Pregnancy|1|||
162103962|NCT01613248|585429887|FG004|Overall Study|Pregnancy|0|||
162103963|NCT01613248|585429888|FG005|Overall Study|Pregnancy|0|||
162103964|NCT01433354|585429889|FG000|Overall Study|Adverse Event|6|||
162103965|NCT01433354|585429889|FG000|Overall Study|Lost to Follow-up|1|||
162103966|NCT01433354|585429889|FG000|Overall Study|Administrative problems|90|||
162103967|NCT01433354|585429889|FG000|Overall Study|Protocol Violation|2|||
162103968|NCT01433354|585429889|FG000|Overall Study|Lack of Efficacy|17|||
162103969|NCT01433354|585429889|FG000|Overall Study|Subject Withdrew Consent|3|||
162103970|NCT04794803|585429898|FG000|Overall Study|Death|1|||
162103971|NCT04794803|585429899|FG001|Overall Study|Death|3|||
162103972|NCT04794803|585429898|FG000|Overall Study|Lost to Follow-up|2|||
162103973|NCT04794803|585429899|FG001|Overall Study|Lost to Follow-up|2|||
162103974|NCT04794803|585429898|FG000|Overall Study|Withdrawal by Subject|1|||
162103975|NCT04794803|585429899|FG001|Overall Study|Withdrawal by Subject|0|||
162103976|NCT04794803|585429898|FG000|Overall Study|Physician Decision|1|||
162103977|NCT04794803|585429899|FG001|Overall Study|Physician Decision|1|||
162103978|NCT04794803|585429898|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
162103979|NCT04794803|585429899|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
162103980|NCT04794803|585429898|FG000|Overall Study|Refused to continue the treatment|1|||
162103981|NCT04794803|585429899|FG001|Overall Study|Refused to continue the treatment|0|||
162103982|NCT04794803|585429898|FG000|Overall Study|Patient admitted to ICU|0|||
162103983|NCT04794803|585429899|FG001|Overall Study|Patient admitted to ICU|1|||
162103984|NCT01618162|585429900|FG000|Overall Study|Protocol Violation|13|||
162103985|NCT01618162|585429901|FG001|Overall Study|Protocol Violation|10|||
162103986|NCT01618162|585429900|FG000|Overall Study|Adverse Event|9|||
162103987|NCT01618162|585429901|FG001|Overall Study|Adverse Event|2|||
162103988|NCT01618162|585429900|FG000|Overall Study|Withdrawal Criteria|2|||
162103989|NCT01618162|585429901|FG001|Overall Study|Withdrawal Criteria|10|||
162103990|NCT01618162|585429900|FG000|Overall Study|Unclassified|14|||
162103991|NCT01618162|585429901|FG001|Overall Study|Unclassified|13|||
162103992|NCT04124926|585429906|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
162103993|NCT04124926|585429907|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
162103994|NCT04124926|585429908|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
162103995|NCT04124926|585429909|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
162103996|NCT04124926|585429910|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
162103997|NCT04124926|585429906|FG000|Healing Phase|Protocol Violation|0|||
162103998|NCT04124926|585429907|FG001|Healing Phase|Protocol Violation|1|||
162103999|NCT04124926|585429908|FG002|Healing Phase|Protocol Violation|0|||
162104000|NCT04124926|585429909|FG003|Healing Phase|Protocol Violation|0|||
162104001|NCT04124926|585429910|FG004|Healing Phase|Protocol Violation|0|||
162104002|NCT04124926|585429906|FG000|Healing Phase|Lost to Follow-up|5|||
162104003|NCT04124926|585429907|FG001|Healing Phase|Lost to Follow-up|4|||
162104004|NCT04124926|585429908|FG002|Healing Phase|Lost to Follow-up|0|||
162104005|NCT04124926|585429909|FG003|Healing Phase|Lost to Follow-up|0|||
162104006|NCT04124926|585429910|FG004|Healing Phase|Lost to Follow-up|0|||
162104007|NCT04124926|585429906|FG000|Healing Phase|Voluntary Withdrawal|10|||
162104008|NCT04124926|585429907|FG001|Healing Phase|Voluntary Withdrawal|7|||
162104009|NCT04124926|585429908|FG002|Healing Phase|Voluntary Withdrawal|0|||
162104010|NCT04124926|585429909|FG003|Healing Phase|Voluntary Withdrawal|0|||
162104011|NCT04124926|585429910|FG004|Healing Phase|Voluntary Withdrawal|0|||
162104012|NCT04124926|585429906|FG000|Healing Phase|Withdrawal of Consent|5|||
162104013|NCT04124926|585429907|FG001|Healing Phase|Withdrawal of Consent|3|||
162104014|NCT04124926|585429908|FG002|Healing Phase|Withdrawal of Consent|0|||
162104015|NCT04124926|585429909|FG003|Healing Phase|Withdrawal of Consent|0|||
162104016|NCT04124926|585429910|FG004|Healing Phase|Withdrawal of Consent|0|||
162104017|NCT04124926|585429906|FG000|Healing Phase|Miscellaneous|8|||
162104018|NCT04124926|585429907|FG001|Healing Phase|Miscellaneous|7|||
162104019|NCT04124926|585429908|FG002|Healing Phase|Miscellaneous|0|||
162104020|NCT04124926|585429909|FG003|Healing Phase|Miscellaneous|0|||
162104021|NCT04124926|585429910|FG004|Healing Phase|Miscellaneous|0|||
162104022|NCT04124926|585429906|FG000|Healing Phase|Randomized but not Treated|0|||
162104023|NCT04124926|585429907|FG001|Healing Phase|Randomized but not Treated|3|||
162104024|NCT04124926|585429908|FG002|Healing Phase|Randomized but not Treated|0|||
162104025|NCT04124926|585429909|FG003|Healing Phase|Randomized but not Treated|0|||
162104026|NCT04124926|585429910|FG004|Healing Phase|Randomized but not Treated|0|||
162104027|NCT04124926|585429906|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
162104028|NCT04124926|585429907|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
162104029|NCT04124926|585429908|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
162104030|NCT04124926|585429909|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
162104031|NCT04124926|585429910|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
162104032|NCT04124926|585429906|FG000|Maintenance Phase|Protocol Violation|0|||
162104033|NCT04124926|585429907|FG001|Maintenance Phase|Protocol Violation|0|||
162104034|NCT04124926|585429908|FG002|Maintenance Phase|Protocol Violation|3|||
162104035|NCT04124926|585429909|FG003|Maintenance Phase|Protocol Violation|0|||
162104036|NCT04124926|585429910|FG004|Maintenance Phase|Protocol Violation|0|||
162104037|NCT04124926|585429906|FG000|Maintenance Phase|Lost to Follow-up|0|||
162104038|NCT04124926|585429907|FG001|Maintenance Phase|Lost to Follow-up|0|||
162104039|NCT04124926|585429908|FG002|Maintenance Phase|Lost to Follow-up|7|||
162104040|NCT04124926|585429909|FG003|Maintenance Phase|Lost to Follow-up|8|||
162104041|NCT04124926|585429910|FG004|Maintenance Phase|Lost to Follow-up|9|||
162104042|NCT04124926|585429906|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
162104043|NCT04124926|585429907|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
162104044|NCT04124926|585429908|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
162104045|NCT04124926|585429909|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
162104046|NCT04124926|585429910|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
162104047|NCT04124926|585429906|FG000|Maintenance Phase|Pregnancy|0|||
162104048|NCT04124926|585429907|FG001|Maintenance Phase|Pregnancy|0|||
162104049|NCT04124926|585429908|FG002|Maintenance Phase|Pregnancy|0|||
162104050|NCT04124926|585429909|FG003|Maintenance Phase|Pregnancy|1|||
162104051|NCT04124926|585429910|FG004|Maintenance Phase|Pregnancy|0|||
162104052|NCT04124926|585429906|FG000|Maintenance Phase|Lack of Efficacy|0|||
162104053|NCT04124926|585429907|FG001|Maintenance Phase|Lack of Efficacy|0|||
162104054|NCT04124926|585429908|FG002|Maintenance Phase|Lack of Efficacy|0|||
162104055|NCT04124926|585429909|FG003|Maintenance Phase|Lack of Efficacy|0|||
162104056|NCT04124926|585429910|FG004|Maintenance Phase|Lack of Efficacy|1|||
162104057|NCT04124926|585429906|FG000|Maintenance Phase|Withdrawal of Consent|0|||
162104058|NCT04124926|585429907|FG001|Maintenance Phase|Withdrawal of Consent|0|||
162104059|NCT04124926|585429908|FG002|Maintenance Phase|Withdrawal of Consent|5|||
162104060|NCT04124926|585429909|FG003|Maintenance Phase|Withdrawal of Consent|5|||
162104061|NCT04124926|585429910|FG004|Maintenance Phase|Withdrawal of Consent|5|||
162104062|NCT04124926|585429906|FG000|Maintenance Phase|Miscellaneous|0|||
162104063|NCT04124926|585429907|FG001|Maintenance Phase|Miscellaneous|0|||
162104064|NCT04124926|585429908|FG002|Maintenance Phase|Miscellaneous|1|||
162104065|NCT04124926|585429909|FG003|Maintenance Phase|Miscellaneous|2|||
162104066|NCT04124926|585429910|FG004|Maintenance Phase|Miscellaneous|4|||
162104067|NCT04124926|585429906|FG000|Maintenance Phase|Randomized but not Treated|0|||
162104068|NCT04124926|585429907|FG001|Maintenance Phase|Randomized but not Treated|0|||
162104069|NCT04124926|585429908|FG002|Maintenance Phase|Randomized but not Treated|2|||
162104070|NCT04124926|585429909|FG003|Maintenance Phase|Randomized but not Treated|2|||
162104071|NCT04124926|585429910|FG004|Maintenance Phase|Randomized but not Treated|0|||
162104072|NCT03321396|585429916|FG000|Overall Study|Physician Decision|1|||
162104073|NCT00937924|585429919|FG000|Overall Study|Lost to Follow-up|44|||
162104074|NCT00937924|585429920|FG001|Overall Study|Lost to Follow-up|44|||
162104075|NCT00937924|585429921|FG002|Overall Study|Lost to Follow-up|41|||
162104076|NCT00224874|585429922|FG000|Overall Study|Withdrawal by Subject|0|||
162104077|NCT00224874|585429923|FG001|Overall Study|Withdrawal by Subject|0|||
162104078|NCT00224874|585429924|FG002|Overall Study|Withdrawal by Subject|1|||
162104079|NCT00224874|585429925|FG003|Overall Study|Withdrawal by Subject|0|||
162104080|NCT02355002|585429928|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
162104081|NCT02355002|585429929|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
162104082|NCT02355002|585429928|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
162104083|NCT02355002|585429929|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
162104084|NCT02355002|585429928|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
162104085|NCT02355002|585429929|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
162104086|NCT02355002|585429928|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
162104087|NCT02355002|585429929|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
162104088|NCT02355002|585429928|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
162104089|NCT02355002|585429929|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
162104090|NCT02355002|585429928|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
162104091|NCT02355002|585429929|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
162104092|NCT02355002|585429928|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
162104093|NCT02355002|585429929|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
162104094|NCT03644186|585429930|FG000|Overall Study|Withdrawal by Subject|1|||
162104095|NCT03644186|585429931|FG001|Overall Study|Withdrawal by Subject|1|||
162104096|NCT04009291|585429932|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
162104097|NCT04009291|585429933|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
162104098|NCT04009291|585429934|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
162104099|NCT04009291|585429935|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
162104100|NCT04009291|585429936|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
162104101|NCT04009291|585429932|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
162104102|NCT04009291|585429933|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
162104103|NCT04009291|585429934|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
162104104|NCT04009291|585429935|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
162104105|NCT04009291|585429936|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
162104106|NCT01687257|585429942|FG000|Overall Study|Efficacy Failure|6|||
162104107|NCT01687257|585429943|FG001|Overall Study|Efficacy Failure|0|||
162104108|NCT01687257|585429944|FG002|Overall Study|Efficacy Failure|5|||
162104109|NCT01687257|585429942|FG000|Overall Study|Subject Withdrew Consent|1|||
162104110|NCT01687257|585429943|FG001|Overall Study|Subject Withdrew Consent|1|||
162104111|NCT01687257|585429944|FG002|Overall Study|Subject Withdrew Consent|1|||
162104112|NCT01687257|585429942|FG000|Overall Study|Adverse Event|1|||
162104113|NCT01687257|585429943|FG001|Overall Study|Adverse Event|0|||
162104114|NCT01687257|585429944|FG002|Overall Study|Adverse Event|0|||
162104115|NCT01687257|585429942|FG000|Overall Study|Investigator's Discretion|0|||
162104116|NCT01687257|585429943|FG001|Overall Study|Investigator's Discretion|3|||
162104117|NCT01687257|585429944|FG002|Overall Study|Investigator's Discretion|0|||
162104118|NCT05207813|585429947|FG000|Overall Study|Lost to Follow-up|2|||
162104119|NCT01954017|585429948|FG000|Overall Study|Adverse Event|0|||
162104120|NCT01954017|585429949|FG001|Overall Study|Adverse Event|0|||
162104121|NCT01954017|585429950|FG002|Overall Study|Adverse Event|1|||
162104122|NCT01954017|585429948|FG000|Overall Study|Death|2|||
162104123|NCT01954017|585429949|FG001|Overall Study|Death|1|||
162104124|NCT01954017|585429950|FG002|Overall Study|Death|1|||
162104125|NCT01954017|585429948|FG000|Overall Study|Withdrawal by Subject|0|||
162104126|NCT01954017|585429949|FG001|Overall Study|Withdrawal by Subject|1|||
162104127|NCT01954017|585429950|FG002|Overall Study|Withdrawal by Subject|0|||
162104128|NCT01954017|585429948|FG000|Overall Study|Protocol Violation|0|||
162104129|NCT01954017|585429949|FG001|Overall Study|Protocol Violation|3|||
162104130|NCT01954017|585429950|FG002|Overall Study|Protocol Violation|2|||
162104131|NCT01954017|585429948|FG000|Overall Study|Necrotizing enterocolitis|1|||
162104132|NCT01954017|585429949|FG001|Overall Study|Necrotizing enterocolitis|0|||
162104133|NCT01954017|585429950|FG002|Overall Study|Necrotizing enterocolitis|1|||
162104134|NCT01954017|585429948|FG000|Overall Study|Enteral intake stopped >7 days|0|||
162104135|NCT01954017|585429949|FG001|Overall Study|Enteral intake stopped >7 days|1|||
162104136|NCT01954017|585429950|FG002|Overall Study|Enteral intake stopped >7 days|1|||
162104137|NCT01954017|585429948|FG000|Overall Study|All other reasons|2|||
162104138|NCT01954017|585429949|FG001|Overall Study|All other reasons|2|||
162104139|NCT01954017|585429950|FG002|Overall Study|All other reasons|7|||
162104140|NCT00679939|585429955|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
162104141|NCT00679939|585429956|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
162104142|NCT00679939|585429955|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
162104143|NCT00679939|585429956|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
162104144|NCT00679939|585429955|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
162104145|NCT00679939|585429956|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
162104146|NCT00679939|585429955|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
162104147|NCT00679939|585429956|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
162104148|NCT00679939|585429955|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
162104149|NCT00679939|585429956|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
162104150|NCT00679939|585429955|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
162104151|NCT00679939|585429956|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
162104152|NCT00679939|585429955|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
162104153|NCT00679939|585429956|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
162104154|NCT00679939|585429955|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
162104155|NCT00679939|585429956|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
162104156|NCT00679939|585429955|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
162104157|NCT00679939|585429956|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
162104158|NCT00679939|585429955|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
162104159|NCT00679939|585429956|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
162104160|NCT04657211|585429959|FG000|Overall Study|Withdrawal by Subject|21|||
162104161|NCT04657211|585429959|FG000|Overall Study|Lost to Follow-up|113|||
162104162|NCT04657211|585429959|FG000|Overall Study|Death|47|||
162104163|NCT04657211|585429959|FG000|Overall Study|Transfer to another institution|21|||
162104164|NCT04657211|585429959|FG000|Overall Study|Other|29|||
162104165|NCT06273774|585429960|FG000|Overall Study|Participant was out of state.|0|||
162104166|NCT06273774|585429961|FG001|Overall Study|Participant was out of state.|0|||
162104167|NCT06273774|585429962|FG002|Overall Study|Participant was out of state.|0|||
162104168|NCT06273774|585429963|FG003|Overall Study|Participant was out of state.|0|||
162104169|NCT06273774|585429964|FG004|Overall Study|Participant was out of state.|0|||
162104170|NCT06273774|585429965|FG005|Overall Study|Participant was out of state.|1|||
162104171|NCT06273774|585429960|FG000|Overall Study|Lost to Follow-up|0|||
162104172|NCT06273774|585429961|FG001|Overall Study|Lost to Follow-up|0|||
162104173|NCT06273774|585429962|FG002|Overall Study|Lost to Follow-up|0|||
162104174|NCT06273774|585429963|FG003|Overall Study|Lost to Follow-up|0|||
162104175|NCT06273774|585429964|FG004|Overall Study|Lost to Follow-up|1|||
162104176|NCT06273774|585429965|FG005|Overall Study|Lost to Follow-up|0|||
162104177|NCT02943408|585431936|FG000|Overall Study|Lost to Follow-up|7|||
162104178|NCT02943408|585431937|FG001|Overall Study|Lost to Follow-up|1|||
162104179|NCT02943408|585431936|FG000|Overall Study|Withdrawal by Subject|0|||
162104180|NCT02943408|585431937|FG001|Overall Study|Withdrawal by Subject|1|||
162104181|NCT01621126|585431940|FG000|Overall Study|Physician Decision|6|||
162104182|NCT03751631|585431941|FG000|Overall Study|Withdrawal by Subject|0|||
162104183|NCT03751631|585431942|FG001|Overall Study|Withdrawal by Subject|0|||
162104184|NCT03751631|585431943|FG002|Overall Study|Withdrawal by Subject|1|||
162104185|NCT03751631|585431944|FG003|Overall Study|Withdrawal by Subject|1|||
162104186|NCT03751631|585431945|FG004|Overall Study|Withdrawal by Subject|0|||
162104187|NCT03751631|585431946|FG005|Overall Study|Withdrawal by Subject|0|||
162104188|NCT02481310|585431947|FG000|Follow up|Still in follow up|0|||
162104189|NCT02481310|585431948|FG001|Follow up|Still in follow up|3|||
162104190|NCT02481310|585431949|FG002|Follow up|Still in follow up|0|||
162104191|NCT00643916|585431951|FG000|Overall Study|Protocol Violation|0|||
162104192|NCT00643916|585431952|FG001|Overall Study|Protocol Violation|1|||
162104193|NCT00643916|585431953|FG002|Overall Study|Protocol Violation|1|||
162104194|NCT00643916|585431954|FG003|Overall Study|Protocol Violation|1|||
162104195|NCT00643916|585431955|FG004|Overall Study|Protocol Violation|0|||
162104196|NCT00643916|585431956|FG005|Overall Study|Protocol Violation|0|||
162104197|NCT00643916|585431951|FG000|Overall Study|Lost to Follow-up|0|||
162104198|NCT00643916|585431952|FG001|Overall Study|Lost to Follow-up|1|||
162104199|NCT00643916|585431953|FG002|Overall Study|Lost to Follow-up|0|||
162104200|NCT00643916|585431954|FG003|Overall Study|Lost to Follow-up|0|||
162104201|NCT00643916|585431955|FG004|Overall Study|Lost to Follow-up|0|||
162104202|NCT00643916|585431956|FG005|Overall Study|Lost to Follow-up|0|||
162104203|NCT00643916|585431951|FG000|Overall Study|Withdrawal by Subject|2|||
162104204|NCT00643916|585431952|FG001|Overall Study|Withdrawal by Subject|2|||
162104205|NCT00643916|585431953|FG002|Overall Study|Withdrawal by Subject|2|||
162104206|NCT00643916|585431954|FG003|Overall Study|Withdrawal by Subject|1|||
162104207|NCT00643916|585431955|FG004|Overall Study|Withdrawal by Subject|0|||
162104208|NCT00643916|585431956|FG005|Overall Study|Withdrawal by Subject|1|||
162104209|NCT00643916|585431951|FG000|Overall Study|Not Vaccinated|2|||
162104210|NCT00643916|585431952|FG001|Overall Study|Not Vaccinated|2|||
162104211|NCT00643916|585431953|FG002|Overall Study|Not Vaccinated|3|||
162104212|NCT00643916|585431954|FG003|Overall Study|Not Vaccinated|0|||
162104213|NCT00643916|585431955|FG004|Overall Study|Not Vaccinated|2|||
162104214|NCT00643916|585431956|FG005|Overall Study|Not Vaccinated|0|||
162104215|NCT00677833|585431958|FG000|Overall Study|Withdrawal by Subject|4|||
162104216|NCT00677833|585431959|FG001|Overall Study|Withdrawal by Subject|0|||
162104217|NCT00677833|585431960|FG002|Overall Study|Withdrawal by Subject|1|||
162104218|NCT00677833|585431961|FG003|Overall Study|Withdrawal by Subject|3|||
162104219|NCT00677833|585431958|FG000|Overall Study|Lost to Follow-up|0|||
162104220|NCT00677833|585431959|FG001|Overall Study|Lost to Follow-up|0|||
162104221|NCT00677833|585431960|FG002|Overall Study|Lost to Follow-up|1|||
162104222|NCT00677833|585431961|FG003|Overall Study|Lost to Follow-up|0|||
162104223|NCT02606279|585431966|FG000|Overall Study|Lost to Follow-up|0|||
162104224|NCT02606279|585431967|FG001|Overall Study|Lost to Follow-up|1|||
162104225|NCT02184611|585431968|FG000|Overall Study|Lack of Efficacy|11|||
162104226|NCT02184611|585431969|FG001|Overall Study|Lack of Efficacy|15|||
162104227|NCT02184611|585431968|FG000|Overall Study|Withdrawal by Subject|5|||
162104228|NCT02184611|585431969|FG001|Overall Study|Withdrawal by Subject|6|||
162104229|NCT02184611|585431968|FG000|Overall Study|Adverse Event|4|||
162104230|NCT02184611|585431969|FG001|Overall Study|Adverse Event|5|||
162104231|NCT02184611|585431968|FG000|Overall Study|Protocol Violation|1|||
162104232|NCT02184611|585431969|FG001|Overall Study|Protocol Violation|1|||
162104233|NCT02184611|585431968|FG000|Overall Study|Protocol defined stopping criteria|0|||
162104234|NCT02184611|585431969|FG001|Overall Study|Protocol defined stopping criteria|1|||
162104235|NCT01514448|585431972|FG000|Overall Study|Death|7|||
162104236|NCT01514448|585431973|FG001|Overall Study|Death|8|||
162104237|NCT01514448|585431972|FG000|Overall Study|Withdrawal by Subject|2|||
162104238|NCT01514448|585431973|FG001|Overall Study|Withdrawal by Subject|0|||
162104239|NCT01514448|585431972|FG000|Overall Study|Lost to Follow-up|2|||
162104240|NCT01514448|585431973|FG001|Overall Study|Lost to Follow-up|0|||
162104241|NCT01514448|585431972|FG000|Overall Study|New Cancer Therapy|1|||
162104242|NCT01514448|585431973|FG001|Overall Study|New Cancer Therapy|0|||
162104243|NCT05159622|585431974|FG000|Overall Study|Lost to Follow-up|4|||
162104244|NCT05159622|585431975|FG001|Overall Study|Lost to Follow-up|5|||
162104245|NCT03318523|585431976|FG000|PC Period: Up to Year 1|Adverse Event|1|||
162104246|NCT03318523|585431977|FG001|PC Period: Up to Year 1|Adverse Event|0|||
162104247|NCT03318523|585431978|FG002|PC Period: Up to Year 1|Adverse Event|2|||
162104248|NCT03318523|585431979|FG003|PC Period: Up to Year 1|Adverse Event|0|||
162104249|NCT03318523|585431980|FG004|PC Period: Up to Year 1|Adverse Event|0|||
162104250|NCT03318523|585431981|FG005|PC Period: Up to Year 1|Adverse Event|0|||
162104251|NCT03318523|585431982|FG006|PC Period: Up to Year 1|Adverse Event|0|||
162104252|NCT03318523|585431983|FG007|PC Period: Up to Year 1|Adverse Event|0|||
162104253|NCT03318523|585431984|FG008|PC Period: Up to Year 1|Adverse Event|0|||
162104254|NCT03318523|585431985|FG009|PC Period: Up to Year 1|Adverse Event|0|||
162104255|NCT03318523|585431976|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
162104256|NCT03318523|585431977|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
162104257|NCT03318523|585431978|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
162104258|NCT03318523|585431979|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
162104259|NCT03318523|585431980|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
162104260|NCT03318523|585431981|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
162104261|NCT03318523|585431982|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
162104262|NCT03318523|585431983|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
162104263|NCT03318523|585431984|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
162104264|NCT03318523|585431985|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
162104265|NCT03318523|585431976|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162104266|NCT03318523|585431977|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162104267|NCT03318523|585431978|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162104268|NCT03318523|585431979|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162104269|NCT03318523|585431980|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
162104270|NCT03318523|585431981|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162104271|NCT03318523|585431982|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162104272|NCT03318523|585431983|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
162104273|NCT03318523|585431984|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
162104274|NCT03318523|585431985|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
162104275|NCT03318523|585431976|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
162104276|NCT03318523|585431977|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
162104277|NCT03318523|585431978|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
162104278|NCT03318523|585431979|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
162104279|NCT03318523|585431980|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
162104280|NCT03318523|585431981|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
162104281|NCT03318523|585431982|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
162104282|NCT03318523|585431983|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
162104283|NCT03318523|585431984|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
162104284|NCT03318523|585431985|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
162104285|NCT03318523|585431976|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162104286|NCT03318523|585431977|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162104287|NCT03318523|585431978|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162104288|NCT03318523|585431979|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162104289|NCT03318523|585431980|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162104290|NCT03318523|585431981|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
162104291|NCT03318523|585431982|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162104292|NCT03318523|585431983|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162104293|NCT03318523|585431984|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162104294|NCT03318523|585431985|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
162104295|NCT03318523|585431976|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162104296|NCT03318523|585431977|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162104297|NCT03318523|585431978|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162104298|NCT03318523|585431979|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162104299|NCT03318523|585431980|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162104300|NCT03318523|585431981|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162104301|NCT03318523|585431982|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162104302|NCT03318523|585431983|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162104303|NCT03318523|585431984|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
162104304|NCT03318523|585431985|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
162104305|NCT03318523|585431976|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
162104306|NCT03318523|585431977|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
162104307|NCT03318523|585431978|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
162104308|NCT03318523|585431979|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
162104309|NCT03318523|585431980|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
162104310|NCT03318523|585431981|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
162104311|NCT03318523|585431982|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
162104312|NCT03318523|585431983|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
162104313|NCT03318523|585431984|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
162104314|NCT03318523|585431985|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
162104315|NCT03318523|585431976|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162104316|NCT03318523|585431977|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162104317|NCT03318523|585431978|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162104318|NCT03318523|585431979|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162104319|NCT03318523|585431980|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
162104320|NCT03318523|585431981|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162104321|NCT03318523|585431982|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162104322|NCT03318523|585431983|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
162104323|NCT03318523|585431984|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
162104324|NCT03318523|585431985|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
162104325|NCT02163733|585431986|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
162104326|NCT02163733|585431987|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
162104327|NCT02163733|585431988|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
162104328|NCT02163733|585431986|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
162104329|NCT02163733|585431987|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
162104330|NCT02163733|585431988|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
162104331|NCT02723864|585431989|FG000|Overall Study|Refused further treatment|1|||
162104332|NCT02723864|585431990|FG001|Overall Study|Refused further treatment|0|||
162104333|NCT02723864|585431991|FG002|Overall Study|Refused further treatment|0|||
162104334|NCT02723864|585431992|FG003|Overall Study|Refused further treatment|0|||
162104335|NCT02723864|585431993|FG004|Overall Study|Refused further treatment|1|||
162104336|NCT02723864|585431994|FG005|Overall Study|Refused further treatment|2|||
162104337|NCT02723864|585431995|FG006|Overall Study|Refused further treatment|0|||
162104338|NCT02723864|585431989|FG000|Overall Study|Exceed treatment hold time|0|||
162104339|NCT02723864|585431990|FG001|Overall Study|Exceed treatment hold time|1|||
162104340|NCT02723864|585431991|FG002|Overall Study|Exceed treatment hold time|0|||
162104341|NCT02723864|585431992|FG003|Overall Study|Exceed treatment hold time|0|||
162104342|NCT02723864|585431993|FG004|Overall Study|Exceed treatment hold time|0|||
162104343|NCT02723864|585431994|FG005|Overall Study|Exceed treatment hold time|0|||
162104344|NCT02723864|585431995|FG006|Overall Study|Exceed treatment hold time|0|||
162104345|NCT02723864|585431989|FG000|Overall Study|Clinical progression|0|||
162104346|NCT02723864|585431990|FG001|Overall Study|Clinical progression|0|||
162104347|NCT02723864|585431991|FG002|Overall Study|Clinical progression|1|||
162104348|NCT02723864|585431992|FG003|Overall Study|Clinical progression|0|||
162104349|NCT02723864|585431993|FG004|Overall Study|Clinical progression|0|||
162104350|NCT02723864|585431994|FG005|Overall Study|Clinical progression|3|||
162104351|NCT02723864|585431995|FG006|Overall Study|Clinical progression|1|||
162104352|NCT02723864|585431989|FG000|Overall Study|Physician Decision|0|||
162104353|NCT02723864|585431990|FG001|Overall Study|Physician Decision|0|||
162104354|NCT02723864|585431991|FG002|Overall Study|Physician Decision|0|||
162104355|NCT02723864|585431992|FG003|Overall Study|Physician Decision|0|||
162104356|NCT02723864|585431993|FG004|Overall Study|Physician Decision|0|||
162104357|NCT02723864|585431994|FG005|Overall Study|Physician Decision|0|||
162104358|NCT02723864|585431995|FG006|Overall Study|Physician Decision|1|||
162104359|NCT02723864|585431989|FG000|Overall Study|Changes in patient condition|0|||
162104360|NCT02723864|585431990|FG001|Overall Study|Changes in patient condition|0|||
162104361|NCT02723864|585431991|FG002|Overall Study|Changes in patient condition|0|||
162104362|NCT02723864|585431992|FG003|Overall Study|Changes in patient condition|0|||
162104363|NCT02723864|585431993|FG004|Overall Study|Changes in patient condition|0|||
162104364|NCT02723864|585431994|FG005|Overall Study|Changes in patient condition|1|||
162104365|NCT02723864|585431995|FG006|Overall Study|Changes in patient condition|0|||
162104366|NCT02723864|585431989|FG000|Overall Study|Patient choice|0|||
162104367|NCT02723864|585431990|FG001|Overall Study|Patient choice|0|||
162104368|NCT02723864|585431991|FG002|Overall Study|Patient choice|0|||
162104369|NCT02723864|585431992|FG003|Overall Study|Patient choice|0|||
162104370|NCT02723864|585431993|FG004|Overall Study|Patient choice|0|||
162104371|NCT02723864|585431994|FG005|Overall Study|Patient choice|1|||
162104372|NCT02723864|585431995|FG006|Overall Study|Patient choice|0|||
162104373|NCT02723864|585431989|FG000|Overall Study|Adverse Event|0|||
162104374|NCT02723864|585431990|FG001|Overall Study|Adverse Event|0|||
162104375|NCT02723864|585431991|FG002|Overall Study|Adverse Event|0|||
162104376|NCT02723864|585431992|FG003|Overall Study|Adverse Event|0|||
162104377|NCT02723864|585431993|FG004|Overall Study|Adverse Event|0|||
162104378|NCT02723864|585431994|FG005|Overall Study|Adverse Event|1|||
162104379|NCT02723864|585431995|FG006|Overall Study|Adverse Event|0|||
162104380|NCT02723864|585431989|FG000|Overall Study|Started new treatment|0|||
162104381|NCT02723864|585431990|FG001|Overall Study|Started new treatment|0|||
162104382|NCT02723864|585431991|FG002|Overall Study|Started new treatment|0|||
162104383|NCT02723864|585431992|FG003|Overall Study|Started new treatment|0|||
162104384|NCT02723864|585431993|FG004|Overall Study|Started new treatment|0|||
162104385|NCT02723864|585431994|FG005|Overall Study|Started new treatment|1|||
162104386|NCT02723864|585431995|FG006|Overall Study|Started new treatment|0|||
162104387|NCT02723864|585431989|FG000|Overall Study|Switched to alternative treatment|0|||
162104388|NCT02723864|585431990|FG001|Overall Study|Switched to alternative treatment|0|||
162104389|NCT02723864|585431991|FG002|Overall Study|Switched to alternative treatment|0|||
162104390|NCT02723864|585431992|FG003|Overall Study|Switched to alternative treatment|0|||
162104391|NCT02723864|585431993|FG004|Overall Study|Switched to alternative treatment|0|||
162104392|NCT02723864|585431994|FG005|Overall Study|Switched to alternative treatment|1|||
162104393|NCT02723864|585431995|FG006|Overall Study|Switched to alternative treatment|0|||
162104394|NCT02723864|585431989|FG000|Overall Study|Late determination of ineligibility|0|||
162104395|NCT02723864|585431990|FG001|Overall Study|Late determination of ineligibility|0|||
162104396|NCT02723864|585431991|FG002|Overall Study|Late determination of ineligibility|0|||
162104397|NCT02723864|585431992|FG003|Overall Study|Late determination of ineligibility|0|||
162104398|NCT02723864|585431993|FG004|Overall Study|Late determination of ineligibility|0|||
162104399|NCT02723864|585431994|FG005|Overall Study|Late determination of ineligibility|1|||
162104400|NCT02723864|585431995|FG006|Overall Study|Late determination of ineligibility|0|||
162104401|NCT03232983|585431996|FG000|Period 1|Physician Decision|0|||
162104402|NCT03232983|585431997|FG001|Period 1|Physician Decision|0|||
162104403|NCT03232983|585431998|FG002|Period 1|Physician Decision|1|||
162104404|NCT03232983|585431999|FG003|Period 1|Physician Decision|0|||
162104405|NCT03232983|585431996|FG000|Washout Period 2|Physician Decision|0|||
162104406|NCT03232983|585431997|FG001|Washout Period 2|Physician Decision|0|||
162104407|NCT03232983|585431998|FG002|Washout Period 2|Physician Decision|1|||
162104408|NCT03232983|585431999|FG003|Washout Period 2|Physician Decision|0|||
162104409|NCT03232983|585431996|FG000|Washout Period 2|Withdrawal by Subject|0|||
162104410|NCT03232983|585431997|FG001|Washout Period 2|Withdrawal by Subject|0|||
162104411|NCT03232983|585431998|FG002|Washout Period 2|Withdrawal by Subject|0|||
162104412|NCT03232983|585431999|FG003|Washout Period 2|Withdrawal by Subject|1|||
162104413|NCT03232983|585431996|FG000|Period 4|Withdrawal by Subject|1|||
162104414|NCT03232983|585431997|FG001|Period 4|Withdrawal by Subject|0|||
162104415|NCT03232983|585431998|FG002|Period 4|Withdrawal by Subject|0|||
162104416|NCT03232983|585431999|FG003|Period 4|Withdrawal by Subject|0|||
162104417|NCT00746590|585432000|FG000|Overall Study|Death|1|||
162104418|NCT02633800|585432003|FG000|Overall Study|Death|3|||
162104419|NCT02633800|585432004|FG001|Overall Study|Death|3|||
162104420|NCT02633800|585432003|FG000|Overall Study|Reason not provided|1|||
162104421|NCT02633800|585432004|FG001|Overall Study|Reason not provided|0|||
162104422|NCT02633800|585432003|FG000|Overall Study|Radiologic(al) progression|23|||
162104423|NCT02633800|585432004|FG001|Overall Study|Radiologic(al) progression|23|||
162104424|NCT02633800|585432003|FG000|Overall Study|Clinical progression|3|||
162104425|NCT02633800|585432004|FG001|Overall Study|Clinical progression|6|||
162104426|NCT02633800|585432003|FG000|Overall Study|Study terminated by sponsor|6|||
162104427|NCT02633800|585432004|FG001|Overall Study|Study terminated by sponsor|5|||
162104428|NCT02633800|585432003|FG000|Overall Study|Adverse event, non-fatal|7|||
162104429|NCT02633800|585432004|FG001|Overall Study|Adverse event, non-fatal|2|||
162104430|NCT02633800|585432003|FG000|Overall Study|Withdrawal by Subject|0|||
162104431|NCT02633800|585432004|FG001|Overall Study|Withdrawal by Subject|3|||
162104432|NCT02633800|585432003|FG000|Overall Study|Patient Request|1|||
162104433|NCT02633800|585432004|FG001|Overall Study|Patient Request|1|||
162104434|NCT00815295|585432008|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
162104435|NCT00815295|585432009|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
162104436|NCT00815295|585432010|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
162104437|NCT00530855|585432011|FG000|Overall Study|Lack of Efficacy|20|||
162104438|NCT00530855|585432011|FG000|Overall Study|Withdrawal by Subject|30|||
162104439|NCT00530855|585432011|FG000|Overall Study|Fatal Serious AE|3|||
162104440|NCT00530855|585432011|FG000|Overall Study|Non Fatal Serious AE|7|||
162104441|NCT00530855|585432011|FG000|Overall Study|Non Fatal Non Serious AE|12|||
162104442|NCT00530855|585432011|FG000|Overall Study|Protocol Violation|3|||
162104443|NCT00530855|585432011|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
162104444|NCT00530855|585432011|FG000|Overall Study|Lost to Follow-up|9|||
162104445|NCT00530855|585432011|FG000|Overall Study|Other reason for premature termination|17|||
162104446|NCT01654549|585432030|FG000|Overall Study|H.pylori eradication not successful|0|||
162104447|NCT01654549|585432031|FG001|Overall Study|H.pylori eradication not successful|1|||
162104448|NCT02013622|585432032|FG000|Overall Study|Lost to Follow-up|10|||
162104449|NCT02013622|585432032|FG000|Overall Study|Adverse Event|3|||
162104450|NCT02013622|585432032|FG000|Overall Study|Met Withdrawal Criteria|3|||
162104451|NCT02013622|585432032|FG000|Overall Study|Withdrawal by Subject|6|||
162104452|NCT02013622|585432032|FG000|Overall Study|Protocol Deviation|1|||
162104453|NCT02013622|585432032|FG000|Overall Study|Lack of Efficacy|1|||
162104454|NCT03152526|585432033|FG000|Overall Study|Withdrawal by Subject|0|||
162104455|NCT03152526|585432034|FG001|Overall Study|Withdrawal by Subject|1|||
162104456|NCT05554237|585432035|FG000|Part 2 (7 Days)|Adverse Event|0|||
162104457|NCT05554237|585432036|FG001|Part 2 (7 Days)|Adverse Event|0|||
162104458|NCT05554237|585432037|FG002|Part 2 (7 Days)|Adverse Event|0|||
162104459|NCT05554237|585432038|FG003|Part 2 (7 Days)|Adverse Event|0|||
162104460|NCT05554237|585432039|FG004|Part 2 (7 Days)|Adverse Event|2|||
162104461|NCT05554237|585432040|FG005|Part 2 (7 Days)|Adverse Event|0|||
162104462|NCT05554237|585432041|FG006|Part 2 (7 Days)|Adverse Event|0|||
162104463|NCT05554237|585432042|FG007|Part 2 (7 Days)|Adverse Event|0|||
162104464|NCT05554237|585432043|FG008|Part 2 (7 Days)|Adverse Event|0|||
162104465|NCT05554237|585432044|FG009|Part 2 (7 Days)|Adverse Event|1|||
162104466|NCT05554237|585432045|FG010|Part 2 (7 Days)|Adverse Event|0|||
162104467|NCT05554237|585432046|FG011|Part 2 (7 Days)|Adverse Event|0|||
162104468|NCT05554237|585432047|FG012|Part 2 (7 Days)|Adverse Event|1|||
162104469|NCT05554237|585432048|FG013|Part 2 (7 Days)|Adverse Event|0|||
162104470|NCT05130970|585432049|FG000|Overall Study|Adverse Event|1|||
162104471|NCT05130970|585432050|FG001|Overall Study|Adverse Event|1|||
162104472|NCT05130970|585432049|FG000|Overall Study|Death|0|||
162104473|NCT05130970|585432050|FG001|Overall Study|Death|1|||
162104474|NCT05130970|585432049|FG000|Overall Study|Lost to Follow-up|0|||
162104475|NCT05130970|585432050|FG001|Overall Study|Lost to Follow-up|1|||
162104476|NCT05130970|585432049|FG000|Overall Study|Physician Decision|0|||
162104477|NCT05130970|585432050|FG001|Overall Study|Physician Decision|1|||
162104478|NCT05130970|585432049|FG000|Overall Study|Withdrawal by Subject|1|||
162104479|NCT05130970|585432050|FG001|Overall Study|Withdrawal by Subject|1|||
162104480|NCT04969198|585432051|FG000|Overall Study|Withdrawal by Subject|20|||
162104481|NCT04969198|585432051|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
162104482|NCT04969198|585432051|FG000|Overall Study|Lost to Follow-up|20|||
162104483|NCT02701985|585432052|FG000|Overall Study|Withdrawal by Subject|1|||
162104484|NCT02701985|585432053|FG001|Overall Study|Withdrawal by Subject|1|||
162104485|NCT02701985|585432052|FG000|Overall Study|Lost to Follow-up|1|||
162104486|NCT02701985|585432053|FG001|Overall Study|Lost to Follow-up|0|||
162104487|NCT02701985|585432052|FG000|Overall Study|Death|1|||
162104488|NCT02701985|585432053|FG001|Overall Study|Death|0|||
162104489|NCT02701985|585432052|FG000|Overall Study|Adverse Event|0|||
162104490|NCT02701985|585432053|FG001|Overall Study|Adverse Event|5|||
162104491|NCT01640808|585432055|FG000|Overall Study|Unable to continue dynamic CT|14|||
162104492|NCT01640808|585432056|FG001|Overall Study|Unable to continue dynamic CT|4|||
162104493|NCT01640808|585432055|FG000|Overall Study|Withdrawal by Subject|12|||
162104494|NCT01640808|585432056|FG001|Overall Study|Withdrawal by Subject|4|||
162104495|NCT01640808|585432055|FG000|Overall Study|Lost to Follow-up|4|||
162104496|NCT01640808|585432056|FG001|Overall Study|Lost to Follow-up|0|||
162104497|NCT01640808|585432055|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
162104498|NCT01640808|585432056|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
162104499|NCT01640808|585432055|FG000|Overall Study|Administration of anticancer drugs|2|||
162104500|NCT01640808|585432056|FG001|Overall Study|Administration of anticancer drugs|1|||
162104501|NCT01640808|585432055|FG000|Overall Study|Physician Decision|19|||
162104502|NCT01640808|585432056|FG001|Overall Study|Physician Decision|5|||
162104503|NCT01640808|585432055|FG000|Overall Study|Randomized but not treated|4|||
162104504|NCT01640808|585432056|FG001|Overall Study|Randomized but not treated|2|||
162104505|NCT02477111|585432057|FG000|Overall Study|Death|28|||
162104506|NCT02477111|585432057|FG000|Overall Study|Withdrawal by Subject|19|||
162104507|NCT02477111|585432057|FG000|Overall Study|Lost to Follow-up|4|||
162104508|NCT02192502|585432059|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
162104509|NCT02192502|585432060|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
162104510|NCT02192502|585432059|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
162104511|NCT02192502|585432060|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
162104512|NCT02192502|585432059|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
162104513|NCT02192502|585432060|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
162104514|NCT01381692|585432061|FG000|Overall Study|Adverse Event|1|||
162104515|NCT01381692|585432062|FG001|Overall Study|Adverse Event|0|||
162104516|NCT01381692|585432063|FG002|Overall Study|Adverse Event|0|||
162104517|NCT01381692|585432064|FG003|Overall Study|Adverse Event|0|||
162104518|NCT01381692|585432065|FG004|Overall Study|Adverse Event|0|||
162104519|NCT01381692|585432066|FG005|Overall Study|Adverse Event|0|||
162104520|NCT02189798|585432067|FG000|Extended Use Phase|Withdrawal by Subject|0|||
162104521|NCT02189798|585432068|FG001|Extended Use Phase|Withdrawal by Subject|4|||
162104522|NCT02189798|585432067|FG000|Extended Use Phase|Physician Decision|1|||
162104523|NCT02189798|585432068|FG001|Extended Use Phase|Physician Decision|0|||
162104524|NCT02189798|585432067|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
162104525|NCT02189798|585432068|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
162104526|NCT02189798|585432067|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
162104527|NCT02189798|585432068|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
162104528|NCT02189798|585432067|FG000|Extended Use Phase|Travel Issues|2|||
162104529|NCT02189798|585432068|FG001|Extended Use Phase|Travel Issues|1|||
162104530|NCT02189798|585432067|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
162104531|NCT02189798|585432068|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
162104532|NCT04818346|585432072|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
162104533|NCT04818346|585432073|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
162104534|NCT04818346|585432074|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
162104535|NCT04818346|585432075|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
162104536|NCT04818346|585432072|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
162104537|NCT04818346|585432073|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
162104538|NCT04818346|585432074|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
162104539|NCT04818346|585432075|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
162104540|NCT04818346|585432072|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
162104541|NCT04818346|585432073|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
162104542|NCT04818346|585432074|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
162104543|NCT04818346|585432075|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
162104544|NCT04818346|585432072|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
162104545|NCT04818346|585432073|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
162104546|NCT04818346|585432074|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
162104547|NCT04818346|585432075|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
162104548|NCT04818346|585432072|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
162104549|NCT04818346|585432073|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
162104550|NCT04818346|585432074|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
162104551|NCT04818346|585432075|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
162104552|NCT04818346|585432072|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
162104553|NCT04818346|585432073|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
162104554|NCT04818346|585432074|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
162104555|NCT04818346|585432075|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
162104556|NCT04818346|585432072|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
162104557|NCT04818346|585432073|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
162104558|NCT04818346|585432074|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
162104559|NCT04818346|585432075|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
162104560|NCT04818346|585432072|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
162104561|NCT04818346|585432073|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
162104562|NCT04818346|585432074|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
162104563|NCT04818346|585432075|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
162104564|NCT04818346|585432072|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
162104565|NCT04818346|585432073|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
162104566|NCT04818346|585432074|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
162104567|NCT04818346|585432075|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
162104568|NCT04818346|585432072|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
162104569|NCT04818346|585432073|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
162104570|NCT04818346|585432074|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
162104571|NCT04818346|585432075|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
162104572|NCT04818346|585432072|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
162104573|NCT04818346|585432073|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
162104574|NCT04818346|585432074|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
162104575|NCT04818346|585432075|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
162104576|NCT04818346|585432072|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
162104577|NCT04818346|585432073|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
162104578|NCT04818346|585432074|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
162104579|NCT04818346|585432075|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
162104580|NCT04818346|585432072|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
162104581|NCT04818346|585432073|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
162104582|NCT04818346|585432074|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
162104583|NCT04818346|585432075|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
162104584|NCT04818346|585432072|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
162104585|NCT04818346|585432073|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
162104586|NCT04818346|585432074|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
162104587|NCT04818346|585432075|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
162104588|NCT04818346|585432072|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
162104589|NCT04818346|585432073|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
162104590|NCT04818346|585432074|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
162104591|NCT04818346|585432075|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
162104592|NCT05553808|585432076|FG000|Overall Study|Death|25|||
162104593|NCT05553808|585432077|FG001|Overall Study|Death|62|||
162104594|NCT05553808|585432076|FG000|Overall Study|Site Closed|6|||
162104595|NCT05553808|585432077|FG001|Overall Study|Site Closed|6|||
162104596|NCT05553808|585432076|FG000|Overall Study|Lost to Follow-up|1|||
162104597|NCT05553808|585432077|FG001|Overall Study|Lost to Follow-up|0|||
162104598|NCT05553808|585432076|FG000|Overall Study|Withdrawal by Subject|3|||
162104599|NCT05553808|585432077|FG001|Overall Study|Withdrawal by Subject|2|||
162104600|NCT02273141|585432078|FG000|Overall Study|Adverse Event|0|||
162104601|NCT02273141|585432079|FG001|Overall Study|Adverse Event|1|||
162104602|NCT02273141|585432078|FG000|Overall Study|Lost to Follow-up|1|||
162104603|NCT02273141|585432079|FG001|Overall Study|Lost to Follow-up|3|||
162104604|NCT02273141|585432078|FG000|Overall Study|Withdrawal by Subject|10|||
162104605|NCT02273141|585432079|FG001|Overall Study|Withdrawal by Subject|15|||
162104606|NCT02273141|585432078|FG000|Overall Study|Various|6|||
162104607|NCT02273141|585432079|FG001|Overall Study|Various|6|||
162104608|NCT00529399|585432082|FG000|Overall Study|Lost to Follow-up|1|||
162104609|NCT00529399|585432083|FG001|Overall Study|Lost to Follow-up|0|||
162104610|NCT00529399|585432084|FG002|Overall Study|Lost to Follow-up|1|||
162104611|NCT00529399|585432082|FG000|Overall Study|Withdrawal by Subject|1|||
162104612|NCT00529399|585432083|FG001|Overall Study|Withdrawal by Subject|0|||
162104613|NCT00529399|585432084|FG002|Overall Study|Withdrawal by Subject|1|||
162104614|NCT00529399|585432082|FG000|Overall Study|Non-compliant|0|||
162104615|NCT00529399|585432083|FG001|Overall Study|Non-compliant|1|||
162104616|NCT00529399|585432084|FG002|Overall Study|Non-compliant|0|||
162104617|NCT03695172|585432085|FG000|Overall Study|Withdrawal by Subject|1|||
162104618|NCT03695172|585432086|FG001|Overall Study|Withdrawal by Subject|1|||
162104619|NCT03695172|585432087|FG002|Overall Study|Withdrawal by Subject|0|||
162104620|NCT01506193|585432088|FG000|Overall Study|Protocol Violation|1|||
162104621|NCT01506193|585432089|FG001|Overall Study|Protocol Violation|0|||
162104622|NCT01506193|585432090|FG002|Overall Study|Protocol Violation|1|||
162104623|NCT01506193|585432088|FG000|Overall Study|Migrated/moved from study area|0|||
162104624|NCT01506193|585432089|FG001|Overall Study|Migrated/moved from study area|0|||
162104625|NCT01506193|585432090|FG002|Overall Study|Migrated/moved from study area|1|||
162104626|NCT01506193|585432088|FG000|Overall Study|Adverse event, non-fatal|0|||
162104627|NCT01506193|585432089|FG001|Overall Study|Adverse event, non-fatal|0|||
162104628|NCT01506193|585432090|FG002|Overall Study|Adverse event, non-fatal|1|||
162104629|NCT01506193|585432088|FG000|Overall Study|Withdrawal by Subject|5|||
162104630|NCT01506193|585432089|FG001|Overall Study|Withdrawal by Subject|1|||
162104631|NCT01506193|585432090|FG002|Overall Study|Withdrawal by Subject|8|||
162104632|NCT01506193|585432088|FG000|Overall Study|Lost to Follow-up|8|||
162104633|NCT01506193|585432089|FG001|Overall Study|Lost to Follow-up|3|||
162104634|NCT01506193|585432090|FG002|Overall Study|Lost to Follow-up|3|||
162104635|NCT04575467|585432107|FG000|Overall Study|Adverse Event|0|||
162104636|NCT04575467|585432108|FG001|Overall Study|Adverse Event|1|||
162104637|NCT04575467|585432109|FG002|Overall Study|Adverse Event|0|||
162104638|NCT04575467|585432110|FG003|Overall Study|Adverse Event|0|||
162104639|NCT00729833|585432113|FG000|Overall Study|Death|5|||
162104640|NCT00729833|585432114|FG001|Overall Study|Death|1|||
162104641|NCT00729833|585432115|FG002|Overall Study|Death|3|||
162104642|NCT00729833|585432116|FG003|Overall Study|Death|5|||
162104643|NCT00729833|585432113|FG000|Overall Study|Study Terminated by Sponsor|0|||
162104644|NCT00729833|585432114|FG001|Overall Study|Study Terminated by Sponsor|0|||
162104645|NCT00729833|585432115|FG002|Overall Study|Study Terminated by Sponsor|1|||
162104646|NCT00729833|585432116|FG003|Overall Study|Study Terminated by Sponsor|0|||
162104647|NCT00729833|585432113|FG000|Overall Study|Lost to Follow-up|1|||
162104648|NCT00729833|585432114|FG001|Overall Study|Lost to Follow-up|0|||
162104649|NCT00729833|585432115|FG002|Overall Study|Lost to Follow-up|0|||
162104650|NCT00729833|585432116|FG003|Overall Study|Lost to Follow-up|0|||
162104651|NCT00729833|585432113|FG000|Overall Study|Withdrawal by Subject|3|||
162104652|NCT00729833|585432114|FG001|Overall Study|Withdrawal by Subject|1|||
162104653|NCT00729833|585432115|FG002|Overall Study|Withdrawal by Subject|3|||
162104654|NCT00729833|585432116|FG003|Overall Study|Withdrawal by Subject|0|||
162104655|NCT00729833|585432113|FG000|Overall Study|Unspecified Reasons|11|||
162104656|NCT00729833|585432114|FG001|Overall Study|Unspecified Reasons|5|||
162104657|NCT00729833|585432115|FG002|Overall Study|Unspecified Reasons|5|||
162104658|NCT00729833|585432116|FG003|Overall Study|Unspecified Reasons|1|||
162104659|NCT04899349|585432117|FG000|Overall Study|Study terminated by Sponsor|2|||
162104660|NCT04899349|585432118|FG001|Overall Study|Study terminated by Sponsor|0|||
162104661|NCT03336619|585432120|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
162104662|NCT03336619|585432121|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
162104663|NCT03336619|585432120|FG000|Overall Study|Withdrawal by Subject|17|||
162104664|NCT03336619|585432121|FG001|Overall Study|Withdrawal by Subject|16|||
162104665|NCT03336619|585432120|FG000|Overall Study|Adverse Event|2|||
162104666|NCT03336619|585432121|FG001|Overall Study|Adverse Event|5|||
162104667|NCT03336619|585432120|FG000|Overall Study|Physician Decision|3|||
162104668|NCT03336619|585432121|FG001|Overall Study|Physician Decision|0|||
162104669|NCT01300546|585432122|FG000|Overall Study|Withdrawal by Subject|1|||
162104670|NCT01300546|585432123|FG001|Overall Study|Withdrawal by Subject|0|||
162104671|NCT01300546|585432122|FG000|Overall Study|Lost to Follow-up|0|||
162104672|NCT01300546|585432123|FG001|Overall Study|Lost to Follow-up|2|||
162104673|NCT01300546|585432122|FG000|Overall Study|Lack of Efficacy|0|||
162104674|NCT01300546|585432123|FG001|Overall Study|Lack of Efficacy|3|||
162104675|NCT01300546|585432122|FG000|Overall Study|Adverse Event|0|||
162104676|NCT01300546|585432123|FG001|Overall Study|Adverse Event|1|||
162104677|NCT02820623|585432124|FG000|Overall Study|Withdrawal by Subject|1|||
162104678|NCT02820623|585432125|FG001|Overall Study|Withdrawal by Subject|3|||
162104679|NCT02820623|585432126|FG002|Overall Study|Withdrawal by Subject|3|||
162104680|NCT02820623|585432124|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
162104681|NCT02820623|585432125|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
162104682|NCT02820623|585432126|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
162104683|NCT02820623|585432124|FG000|Overall Study|Therapist unable to enroll clients|1|||
162104684|NCT02820623|585432125|FG001|Overall Study|Therapist unable to enroll clients|1|||
162104685|NCT02820623|585432126|FG002|Overall Study|Therapist unable to enroll clients|3|||
162104686|NCT02820623|585432124|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
162104687|NCT02820623|585432125|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
162104688|NCT02820623|585432126|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
162104689|NCT02653482|585432129|FG000|Overall Study|Death|1|||
162104690|NCT02653482|585432130|FG001|Overall Study|Death|1|||
162104691|NCT05132699|585432132|FG000|Overall Study|Withdrawal by Subject|3|||
162104692|NCT05132699|585432133|FG001|Overall Study|Withdrawal by Subject|0|||
162104693|NCT04370054|585432134|FG000|Treatment Phase|Lost to Follow-up|1|||
162104694|NCT04370054|585432134|FG000|Treatment Phase|Withdrawal by Subject|1|||
162104695|NCT04370054|585432134|FG000|Follow-Up Phase|Ongoing|75|||
162104696|NCT02096900|585432135|FG000|Overall Study|Did not receive medication|3|||
162104697|NCT02096900|585432136|FG001|Overall Study|Did not receive medication|1|||
162104698|NCT02096900|585432135|FG000|Overall Study|Surgery cancelled- medication received|1|||
162104699|NCT02096900|585432136|FG001|Overall Study|Surgery cancelled- medication received|1|||
162104700|NCT00710424|585432139|FG000|Overall Study|Adverse Event|30|||
162104701|NCT00710424|585432140|FG001|Overall Study|Adverse Event|12|||
162104702|NCT00710424|585432139|FG000|Overall Study|Lack of Efficacy|4|||
162104703|NCT00710424|585432140|FG001|Overall Study|Lack of Efficacy|5|||
162104704|NCT00710424|585432139|FG000|Overall Study|Withdrawal by Subject|5|||
162104705|NCT00710424|585432140|FG001|Overall Study|Withdrawal by Subject|3|||
162104706|NCT00710424|585432139|FG000|Overall Study|Lost to Follow-up|0|||
162104707|NCT00710424|585432140|FG001|Overall Study|Lost to Follow-up|1|||
162104708|NCT00710424|585432139|FG000|Overall Study|Refused medication, no side effects|1|||
162104709|NCT00710424|585432140|FG001|Overall Study|Refused medication, no side effects|0|||
162104710|NCT00710424|585432139|FG000|Overall Study|Non-compliance with stable analgesia|1|||
162104711|NCT00710424|585432140|FG001|Overall Study|Non-compliance with stable analgesia|0|||
162104712|NCT00710424|585432139|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
162104713|NCT00710424|585432140|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
162104714|NCT00710424|585432139|FG000|Overall Study|Subject thought medication changed|1|||
162104715|NCT00710424|585432140|FG001|Overall Study|Subject thought medication changed|0|||
162104716|NCT00710424|585432139|FG000|Overall Study|Ceased treatment due to travel|1|||
162104717|NCT00710424|585432140|FG001|Overall Study|Ceased treatment due to travel|0|||
162104718|NCT00710424|585432139|FG000|Overall Study|Subject preferred paracetamol|0|||
162104719|NCT00710424|585432140|FG001|Overall Study|Subject preferred paracetamol|1|||
162104720|NCT00710424|585432139|FG000|Overall Study|Felt good so stopped treatment|0|||
162104721|NCT00710424|585432140|FG001|Overall Study|Felt good so stopped treatment|1|||
162104722|NCT04918784|585433841|FG000|Overall Study|Amputation - no longer eligible|1|||
162104723|NCT04918784|585433842|FG001|Overall Study|Amputation - no longer eligible|2|||
162104724|NCT04918784|585433841|FG000|Overall Study|Death|1|||
162104725|NCT04918784|585433842|FG001|Overall Study|Death|0|||
162104726|NCT04918784|585433841|FG000|Overall Study|patient non-compliance|3|||
162104727|NCT04918784|585433842|FG001|Overall Study|patient non-compliance|1|||
162104728|NCT04918784|585433841|FG000|Overall Study|Adverse Event|1|||
162104729|NCT04918784|585433842|FG001|Overall Study|Adverse Event|0|||
162104730|NCT01986881|585433843|FG000|Overall Study|Death|228|||
162104731|NCT01986881|585433844|FG001|Overall Study|Death|233|||
162104732|NCT01986881|585433845|FG002|Overall Study|Death|247|||
162104733|NCT01986881|585433843|FG000|Overall Study|Lost to Follow-up|51|||
162104734|NCT01986881|585433844|FG001|Overall Study|Lost to Follow-up|44|||
162104735|NCT01986881|585433845|FG002|Overall Study|Lost to Follow-up|55|||
162104736|NCT01986881|585433843|FG000|Overall Study|Physician Decision|7|||
162104737|NCT01986881|585433844|FG001|Overall Study|Physician Decision|4|||
162104738|NCT01986881|585433845|FG002|Overall Study|Physician Decision|6|||
162104739|NCT01986881|585433843|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
162104740|NCT01986881|585433844|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
162104741|NCT01986881|585433845|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
162104742|NCT01986881|585433843|FG000|Overall Study|Withdrawal by Subject|41|||
162104743|NCT01986881|585433844|FG001|Overall Study|Withdrawal by Subject|60|||
162104744|NCT01986881|585433845|FG002|Overall Study|Withdrawal by Subject|45|||
162104745|NCT01986881|585433843|FG000|Overall Study|Subject Moved|0|||
162104746|NCT01986881|585433844|FG001|Overall Study|Subject Moved|1|||
162104747|NCT01986881|585433845|FG002|Overall Study|Subject Moved|0|||
162104748|NCT01986881|585433843|FG000|Overall Study|Other|1|||
162104749|NCT01986881|585433844|FG001|Overall Study|Other|2|||
162104750|NCT01986881|585433845|FG002|Overall Study|Other|2|||
162104751|NCT04050865|585433846|FG000|Overall Study|Adverse Event|1|||
162104752|NCT04050865|585433847|FG001|Overall Study|Adverse Event|0|||
162104753|NCT04050865|585433846|FG000|Overall Study|no insert|1|||
162104754|NCT04050865|585433847|FG001|Overall Study|no insert|0|||
162104755|NCT04050865|585433846|FG000|Overall Study|Only 1 insert|2|||
162104756|NCT04050865|585433847|FG001|Overall Study|Only 1 insert|3|||
162104757|NCT04050865|585433846|FG000|Overall Study|Physician Decision|0|||
162104758|NCT04050865|585433847|FG001|Overall Study|Physician Decision|1|||
162104759|NCT04050865|585433846|FG000|Overall Study|Withdrawal by Subject|0|||
162104760|NCT04050865|585433847|FG001|Overall Study|Withdrawal by Subject|1|||
162104761|NCT02035332|585433848|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
162104762|NCT01258608|585433849|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
162104763|NCT01258608|585433850|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
162104764|NCT01258608|585433849|FG000|Overall Study|Clinical progression|1|||
162104765|NCT01258608|585433850|FG001|Overall Study|Clinical progression|0|||
162104766|NCT01258608|585433849|FG000|Overall Study|Sponsor decision|0|||
162104767|NCT01258608|585433850|FG001|Overall Study|Sponsor decision|1|||
162104768|NCT01258608|585433849|FG000|Overall Study|Physician Decision|6|||
162104769|NCT01258608|585433850|FG001|Overall Study|Physician Decision|1|||
162104770|NCT01258608|585433849|FG000|Overall Study|Lost to Follow-up|0|||
162104771|NCT01258608|585433850|FG001|Overall Study|Lost to Follow-up|1|||
162104772|NCT01258608|585433849|FG000|Overall Study|Lack of compliance|1|||
162104773|NCT01258608|585433850|FG001|Overall Study|Lack of compliance|0|||
162104774|NCT01258608|585433849|FG000|Overall Study|Lack of Efficacy|0|||
162104775|NCT01258608|585433850|FG001|Overall Study|Lack of Efficacy|1|||
162104776|NCT01258608|585433849|FG000|Overall Study|Adverse Event|6|||
162104777|NCT01258608|585433850|FG001|Overall Study|Adverse Event|10|||
162104778|NCT01258608|585433849|FG000|Overall Study|Withdrawal by Subject|6|||
162104779|NCT01258608|585433850|FG001|Overall Study|Withdrawal by Subject|5|||
162104780|NCT04205630|585433851|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
162104781|NCT04205630|585433851|FG000|Overall Study|Disease clinical progression|7|||
162104782|NCT04205630|585433851|FG000|Overall Study|Withdrawal by Subject|2|||
162104783|NCT04205630|585433851|FG000|Overall Study|Adverse Event|17|||
162104784|NCT04205630|585433851|FG000|Overall Study|Other|1|||
162104785|NCT00447057|585433858|FG000|Overall Study|Adverse Event|4|||
162104786|NCT00447057|585433859|FG001|Overall Study|Adverse Event|10|||
162104787|NCT00447057|585433860|FG002|Overall Study|Adverse Event|0|||
162104788|NCT00447057|585433861|FG003|Overall Study|Adverse Event|3|||
162104789|NCT00447057|585433858|FG000|Overall Study|Death due to study disease|6|||
162104790|NCT00447057|585433859|FG001|Overall Study|Death due to study disease|4|||
162104791|NCT00447057|585433860|FG002|Overall Study|Death due to study disease|1|||
162104792|NCT00447057|585433861|FG003|Overall Study|Death due to study disease|1|||
162104793|NCT00447057|585433858|FG000|Overall Study|Lost to Follow-up|0|||
162104794|NCT00447057|585433859|FG001|Overall Study|Lost to Follow-up|1|||
162104795|NCT00447057|585433860|FG002|Overall Study|Lost to Follow-up|0|||
162104796|NCT00447057|585433861|FG003|Overall Study|Lost to Follow-up|0|||
162104797|NCT00447057|585433858|FG000|Overall Study|Entry criteria not met|1|||
162104798|NCT00447057|585433859|FG001|Overall Study|Entry criteria not met|1|||
162104799|NCT00447057|585433860|FG002|Overall Study|Entry criteria not met|0|||
162104800|NCT00447057|585433861|FG003|Overall Study|Entry criteria not met|0|||
162104801|NCT00447057|585433858|FG000|Overall Study|Protocol Violation|0|||
162104802|NCT00447057|585433859|FG001|Overall Study|Protocol Violation|1|||
162104803|NCT00447057|585433860|FG002|Overall Study|Protocol Violation|0|||
162104804|NCT00447057|585433861|FG003|Overall Study|Protocol Violation|0|||
162104805|NCT00447057|585433858|FG000|Overall Study|Withdrawal by Subject|4|||
162104806|NCT00447057|585433859|FG001|Overall Study|Withdrawal by Subject|5|||
162104807|NCT00447057|585433860|FG002|Overall Study|Withdrawal by Subject|1|||
162104808|NCT00447057|585433861|FG003|Overall Study|Withdrawal by Subject|1|||
162104809|NCT00447057|585433858|FG000|Overall Study|Physician Decision|9|||
162104810|NCT00447057|585433859|FG001|Overall Study|Physician Decision|6|||
162104811|NCT00447057|585433860|FG002|Overall Study|Physician Decision|3|||
162104812|NCT00447057|585433861|FG003|Overall Study|Physician Decision|1|||
162104813|NCT00447057|585433858|FG000|Overall Study|Sponsor decision|1|||
162104814|NCT00447057|585433859|FG001|Overall Study|Sponsor decision|1|||
162104815|NCT00447057|585433860|FG002|Overall Study|Sponsor decision|0|||
162104816|NCT00447057|585433861|FG003|Overall Study|Sponsor decision|0|||
162104817|NCT00447057|585433858|FG000|Overall Study|Progressive disease|58|||
162104818|NCT00447057|585433859|FG001|Overall Study|Progressive disease|43|||
162104819|NCT00447057|585433860|FG002|Overall Study|Progressive disease|13|||
162104820|NCT00447057|585433861|FG003|Overall Study|Progressive disease|18|||
162104821|NCT00447057|585433858|FG000|Overall Study|Death due to adverse event|0|||
162104822|NCT00447057|585433859|FG001|Overall Study|Death due to adverse event|0|||
162104823|NCT00447057|585433860|FG002|Overall Study|Death due to adverse event|1|||
162104824|NCT00447057|585433861|FG003|Overall Study|Death due to adverse event|2|||
162104825|NCT00447057|585433858|FG000|Overall Study|Death, study drug related|0|||
162104826|NCT00447057|585433859|FG001|Overall Study|Death, study drug related|1|||
162104827|NCT00447057|585433860|FG002|Overall Study|Death, study drug related|0|||
162104828|NCT00447057|585433861|FG003|Overall Study|Death, study drug related|0|||
162104829|NCT00160680|585433862|FG000|Overall Study|Adverse Event|0|||
162104830|NCT00160680|585433863|FG001|Overall Study|Adverse Event|1|||
162104831|NCT00160680|585433862|FG000|Overall Study|Lack of Efficacy|2|||
162104832|NCT00160680|585433863|FG001|Overall Study|Lack of Efficacy|1|||
162104833|NCT00160680|585433862|FG000|Overall Study|Lost to Follow-up|3|||
162104834|NCT00160680|585433863|FG001|Overall Study|Lost to Follow-up|2|||
162104835|NCT00160680|585433862|FG000|Overall Study|Withdrawal by Subject|4|||
162104836|NCT00160680|585433863|FG001|Overall Study|Withdrawal by Subject|9|||
162104837|NCT04493216|585433864|FG000|Overall Study|Study terminated by sponsor|30|||
162104838|NCT04493216|585433865|FG001|Overall Study|Study terminated by sponsor|33|||
162104839|NCT04493216|585433866|FG002|Overall Study|Study terminated by sponsor|28|||
162104840|NCT04493216|585433867|FG003|Overall Study|Study terminated by sponsor|27|||
162104841|NCT04493216|585433864|FG000|Overall Study|Withdrawal by Subject|2|||
162104842|NCT04493216|585433865|FG001|Overall Study|Withdrawal by Subject|1|||
162104843|NCT04493216|585433866|FG002|Overall Study|Withdrawal by Subject|1|||
162104844|NCT04493216|585433867|FG003|Overall Study|Withdrawal by Subject|2|||
162104845|NCT04493216|585433864|FG000|Overall Study|Protocol Violation|1|||
162104846|NCT04493216|585433865|FG001|Overall Study|Protocol Violation|2|||
162104847|NCT04493216|585433866|FG002|Overall Study|Protocol Violation|0|||
162104848|NCT04493216|585433867|FG003|Overall Study|Protocol Violation|2|||
162104849|NCT04493216|585433864|FG000|Overall Study|Physician Decision|0|||
162104850|NCT04493216|585433865|FG001|Overall Study|Physician Decision|0|||
162104851|NCT04493216|585433866|FG002|Overall Study|Physician Decision|1|||
162104852|NCT04493216|585433867|FG003|Overall Study|Physician Decision|0|||
162104853|NCT04493216|585433864|FG000|Overall Study|Lost to Follow-up|2|||
162104854|NCT04493216|585433865|FG001|Overall Study|Lost to Follow-up|1|||
162104855|NCT04493216|585433866|FG002|Overall Study|Lost to Follow-up|0|||
162104856|NCT04493216|585433867|FG003|Overall Study|Lost to Follow-up|1|||
162104857|NCT04493216|585433864|FG000|Overall Study|Adverse Event|1|||
162104858|NCT04493216|585433865|FG001|Overall Study|Adverse Event|4|||
162104859|NCT04493216|585433866|FG002|Overall Study|Adverse Event|5|||
162104860|NCT04493216|585433867|FG003|Overall Study|Adverse Event|2|||
162104861|NCT04493216|585433864|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
162104862|NCT04493216|585433865|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
162104863|NCT04493216|585433866|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
162104864|NCT04493216|585433867|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
162104865|NCT04605978|585433873|FG000|Overall Study|Adverse Event|2|||
162104866|NCT04605978|585433874|FG001|Overall Study|Adverse Event|1|||
162104867|NCT04605978|585433873|FG000|Overall Study|Withdrawal nonmedical reason|1|||
162104868|NCT04605978|585433874|FG001|Overall Study|Withdrawal nonmedical reason|1|||
162104869|NCT02583425|585433875|FG000|Screening|Did not meet entry criteria|12|||
162104870|NCT02583425|585433875|FG000|Baseline|Did not meet continued criteria|5|||
162104871|NCT02583425|585433875|FG000|Treatment Period|Adverse Event|1|||
162104872|NCT01690130|585433876|FG000|Overall Study|Subject have cancelled visit.|1|||
162104873|NCT01690130|585433877|FG001|Overall Study|Subject have cancelled visit.|0|||
162104874|NCT01644734|585433878|FG000|Overall Study|Adverse Event|4|||
162104875|NCT01644734|585433878|FG000|Overall Study|Lost to Follow-up|17|||
162104876|NCT01644734|585433878|FG000|Overall Study|Reasons other than stated above|7|||
162104877|NCT01644734|585433878|FG000|Overall Study|Missing documentation|238|||
162104878|NCT02216123|585433879|FG000|Overall Study|Lost to Follow-up|4|||
162104879|NCT02216123|585433880|FG001|Overall Study|Lost to Follow-up|2|||
162104880|NCT02216123|585433879|FG000|Overall Study|Withdrawal by Subject|2|||
162104881|NCT02216123|585433880|FG001|Overall Study|Withdrawal by Subject|0|||
162104882|NCT01615328|585433887|FG000|Overall Study|Lost to Follow-up|3|||
162104883|NCT01615328|585433888|FG001|Overall Study|Lost to Follow-up|5|||
162104884|NCT02157779|585433889|FG000|Overall Study|Logistical|9|||
162104885|NCT02157779|585433890|FG001|Overall Study|Logistical|3|||
162104886|NCT02157779|585433889|FG000|Overall Study|Stopped attending, reason unknown|11|||
162104887|NCT02157779|585433890|FG001|Overall Study|Stopped attending, reason unknown|7|||
162104888|NCT02157779|585433889|FG000|Overall Study|No response to outreach after Baseline|1|||
162104889|NCT02157779|585433890|FG001|Overall Study|No response to outreach after Baseline|1|||
162104890|NCT02157779|585433889|FG000|Overall Study|Moved|1|||
162104891|NCT02157779|585433890|FG001|Overall Study|Moved|0|||
162104892|NCT02157779|585433889|FG000|Overall Study|Medical|1|||
162104893|NCT02157779|585433890|FG001|Overall Study|Medical|0|||
162104894|NCT02157779|585433889|FG000|Overall Study|Legal issue|1|||
162104895|NCT02157779|585433890|FG001|Overall Study|Legal issue|0|||
162104896|NCT02548455|585433891|FG000|Overall Study|Withdrawal by Subject|27|||
162104897|NCT02548455|585433891|FG000|Overall Study|Death|26|||
162104898|NCT02548455|585433891|FG000|Overall Study|Lost to Follow-up|14|||
162104899|NCT02548455|585433891|FG000|Overall Study|Visit not completed|173|||
162104900|NCT00487162|585433893|FG000|Overall Study|Adverse Event|0|||
162104901|NCT00487162|585433894|FG001|Overall Study|Adverse Event|1|||
162104902|NCT00487162|585433893|FG000|Overall Study|Physician Decision|0|||
162104903|NCT00487162|585433894|FG001|Overall Study|Physician Decision|1|||
162104904|NCT00487162|585433893|FG000|Overall Study|Withdrawal by Subject|2|||
162104905|NCT00487162|585433894|FG001|Overall Study|Withdrawal by Subject|3|||
162104906|NCT02794285|585433897|FG000|Overall Study|Adverse Event|11|||
162104907|NCT02794285|585433898|FG001|Overall Study|Adverse Event|4|||
162104908|NCT02794285|585433899|FG002|Overall Study|Adverse Event|5|||
162104909|NCT02794285|585433900|FG003|Overall Study|Adverse Event|8|||
162104910|NCT02794285|585433897|FG000|Overall Study|Condition Under Investigation Improved|1|||
162104911|NCT02794285|585433898|FG001|Overall Study|Condition Under Investigation Improved|0|||
162104912|NCT02794285|585433899|FG002|Overall Study|Condition Under Investigation Improved|0|||
162104913|NCT02794285|585433900|FG003|Overall Study|Condition Under Investigation Improved|0|||
162104914|NCT02794285|585433897|FG000|Overall Study|Condition Under Investigation Worsened|0|||
162104915|NCT02794285|585433898|FG001|Overall Study|Condition Under Investigation Worsened|2|||
162104916|NCT02794285|585433899|FG002|Overall Study|Condition Under Investigation Worsened|1|||
162104917|NCT02794285|585433900|FG003|Overall Study|Condition Under Investigation Worsened|0|||
162104918|NCT02794285|585433897|FG000|Overall Study|Death|2|||
162104919|NCT02794285|585433898|FG001|Overall Study|Death|1|||
162104920|NCT02794285|585433899|FG002|Overall Study|Death|2|||
162104921|NCT02794285|585433900|FG003|Overall Study|Death|0|||
162104922|NCT02794285|585433897|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
162104923|NCT02794285|585433898|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
162104924|NCT02794285|585433899|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
162104925|NCT02794285|585433900|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
162104926|NCT02794285|585433897|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
162104927|NCT02794285|585433898|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
162104928|NCT02794285|585433899|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
162104929|NCT02794285|585433900|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
162104930|NCT02794285|585433897|FG000|Overall Study|Lack of Efficacy|10|||
162104931|NCT02794285|585433898|FG001|Overall Study|Lack of Efficacy|6|||
162104932|NCT02794285|585433899|FG002|Overall Study|Lack of Efficacy|3|||
162104933|NCT02794285|585433900|FG003|Overall Study|Lack of Efficacy|3|||
162104934|NCT02794285|585433897|FG000|Overall Study|Lost to Follow-up|5|||
162104935|NCT02794285|585433898|FG001|Overall Study|Lost to Follow-up|6|||
162104936|NCT02794285|585433899|FG002|Overall Study|Lost to Follow-up|3|||
162104937|NCT02794285|585433900|FG003|Overall Study|Lost to Follow-up|1|||
162104938|NCT02794285|585433897|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
162104939|NCT02794285|585433898|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
162104940|NCT02794285|585433899|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
162104941|NCT02794285|585433900|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
162104942|NCT02794285|585433897|FG000|Overall Study|Withdrawal by Subject|38|||
162104943|NCT02794285|585433898|FG001|Overall Study|Withdrawal by Subject|29|||
162104944|NCT02794285|585433899|FG002|Overall Study|Withdrawal by Subject|20|||
162104945|NCT02794285|585433900|FG003|Overall Study|Withdrawal by Subject|12|||
162104946|NCT02794285|585433897|FG000|Overall Study|Missing|1|||
162104947|NCT02794285|585433898|FG001|Overall Study|Missing|0|||
162104948|NCT02794285|585433899|FG002|Overall Study|Missing|0|||
162104949|NCT02794285|585433900|FG003|Overall Study|Missing|0|||
162104950|NCT02794285|585433897|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
162104951|NCT02794285|585433898|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
162104952|NCT02794285|585433899|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
162104953|NCT02794285|585433900|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
162104954|NCT02794285|585433897|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
162104955|NCT02794285|585433898|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
162104956|NCT02794285|585433899|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
162104957|NCT02794285|585433900|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
162104958|NCT03896035|585433901|FG000|Overall Study|Lost to Follow-up|2|||
162104959|NCT03896035|585433902|FG001|Overall Study|Lost to Follow-up|6|||
162104960|NCT03896035|585433901|FG000|Overall Study|Withdrawal by Subject|0|||
162104961|NCT03896035|585433902|FG001|Overall Study|Withdrawal by Subject|1|||
162104962|NCT03896035|585433901|FG000|Overall Study|Health/family health issues during COVID|0|||
162104963|NCT03896035|585433902|FG001|Overall Study|Health/family health issues during COVID|4|||
162104964|NCT01362140|585433903|FG000|Overall Study|Noncompliance|1|||
162104965|NCT01362140|585433904|FG001|Overall Study|Noncompliance|0|||
162104966|NCT01362140|585433903|FG000|Overall Study|Adverse Event|2|||
162104967|NCT01362140|585433904|FG001|Overall Study|Adverse Event|2|||
162104968|NCT01362140|585433903|FG000|Overall Study|Withdrawal by Subject|3|||
162104969|NCT01362140|585433904|FG001|Overall Study|Withdrawal by Subject|3|||
162104970|NCT01362140|585433903|FG000|Overall Study|Administrative Decision|0|||
162104971|NCT01362140|585433904|FG001|Overall Study|Administrative Decision|1|||
162104972|NCT01362140|585433903|FG000|Overall Study|Death|2|||
162104973|NCT01362140|585433904|FG001|Overall Study|Death|1|||
162104974|NCT01362140|585433903|FG000|Overall Study|Other|1|||
162104975|NCT01362140|585433904|FG001|Overall Study|Other|1|||
162104976|NCT01362140|585433903|FG000|Overall Study|Protocol-specified Criteria|1|||
162104977|NCT01362140|585433904|FG001|Overall Study|Protocol-specified Criteria|2|||
162104978|NCT01362140|585433903|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
162104979|NCT01362140|585433904|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
162104980|NCT01556438|585433907|FG000|Overall Study|Adverse Event|4|||
162104981|NCT01556438|585433908|FG001|Overall Study|Adverse Event|2|||
162104982|NCT01556438|585433907|FG000|Overall Study|Sponsor Decision|0|||
162104983|NCT01556438|585433908|FG001|Overall Study|Sponsor Decision|2|||
162104984|NCT01556438|585433907|FG000|Overall Study|Progressive Disease|0|||
162104985|NCT01556438|585433908|FG001|Overall Study|Progressive Disease|6|||
162104986|NCT01556438|585433907|FG000|Overall Study|Death|0|||
162104987|NCT01556438|585433908|FG001|Overall Study|Death|1|||
162104988|NCT01388816|585433910|FG000|Overall Study|Adverse Event|0|||
162104989|NCT01388816|585433911|FG001|Overall Study|Adverse Event|2|||
162104990|NCT01388816|585433912|FG002|Overall Study|Adverse Event|0|||
162104991|NCT01388816|585433913|FG003|Overall Study|Adverse Event|0|||
162104992|NCT01388816|585433910|FG000|Overall Study|Lost to Follow-up|0|||
162104993|NCT01388816|585433911|FG001|Overall Study|Lost to Follow-up|1|||
162104994|NCT01388816|585433912|FG002|Overall Study|Lost to Follow-up|0|||
162104995|NCT01388816|585433913|FG003|Overall Study|Lost to Follow-up|0|||
162104996|NCT01388816|585433910|FG000|Overall Study|Withdrawal by Subject|2|||
162104997|NCT01388816|585433911|FG001|Overall Study|Withdrawal by Subject|1|||
162104998|NCT01388816|585433912|FG002|Overall Study|Withdrawal by Subject|1|||
162104999|NCT01388816|585433913|FG003|Overall Study|Withdrawal by Subject|0|||
162105000|NCT01388816|585433910|FG000|Overall Study|Protocol Violation|0|||
162105001|NCT01388816|585433911|FG001|Overall Study|Protocol Violation|0|||
162105002|NCT01388816|585433912|FG002|Overall Study|Protocol Violation|2|||
162105003|NCT01388816|585433913|FG003|Overall Study|Protocol Violation|0|||
162105004|NCT00743366|585433914|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
162105005|NCT00743366|585433915|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
162105006|NCT01328574|585433916|FG000|Overall Study|Refused further treatment|1|||
162105007|NCT03206203|585433917|FG000|Treatment|Death|38|||
162105008|NCT03206203|585433918|FG001|Treatment|Death|26|||
162105009|NCT03206203|585433919|FG002|Treatment|Death|0|||
162105010|NCT03206203|585433917|FG000|Treatment|Withdrawal by Subject|1|||
162105011|NCT03206203|585433918|FG001|Treatment|Withdrawal by Subject|0|||
162105012|NCT03206203|585433919|FG002|Treatment|Withdrawal by Subject|0|||
162105013|NCT03206203|585433917|FG000|Treatment|Lost to Follow-up|4|||
162105014|NCT03206203|585433918|FG001|Treatment|Lost to Follow-up|0|||
162105015|NCT03206203|585433919|FG002|Treatment|Lost to Follow-up|0|||
162105016|NCT03206203|585433917|FG000|Treatment|N/A in Follow-Up|8|||
162105017|NCT03206203|585433918|FG001|Treatment|N/A in Follow-Up|1|||
162105018|NCT03206203|585433919|FG002|Treatment|N/A in Follow-Up|0|||
162105019|NCT03206203|585433917|FG000|Treatment|Disease progression|0|||
162105020|NCT03206203|585433918|FG001|Treatment|Disease progression|1|||
162105021|NCT03206203|585433919|FG002|Treatment|Disease progression|0|||
162105022|NCT03206203|585433917|FG000|Treatment|Refused follow-up|0|||
162105023|NCT03206203|585433918|FG001|Treatment|Refused follow-up|1|||
162105024|NCT03206203|585433919|FG002|Treatment|Refused follow-up|0|||
162105025|NCT03206203|585433917|FG000|Treatment|Cross over to Arm 1|0|||
162105026|NCT03206203|585433918|FG001|Treatment|Cross over to Arm 1|19|||
162105027|NCT03206203|585433919|FG002|Treatment|Cross over to Arm 1|0|||
162105028|NCT03206203|585433917|FG000|Optional Cross-Over|Death|0|||
162105029|NCT03206203|585433918|FG001|Optional Cross-Over|Death|0|||
162105030|NCT03206203|585433919|FG002|Optional Cross-Over|Death|14|||
162105031|NCT03206203|585433917|FG000|Optional Cross-Over|Refused follow-up|0|||
162105032|NCT03206203|585433918|FG001|Optional Cross-Over|Refused follow-up|0|||
162105033|NCT03206203|585433919|FG002|Optional Cross-Over|Refused follow-up|2|||
162105034|NCT03998618|585433922|FG000|Overall Study|Death|7|||
162105035|NCT03998618|585433923|FG001|Overall Study|Death|11|||
162105036|NCT03998618|585433922|FG000|Overall Study|hospice enrollment|3|||
162105037|NCT03998618|585433923|FG001|Overall Study|hospice enrollment|3|||
162105038|NCT03998618|585433922|FG000|Overall Study|Not feeling well/health problems|3|||
162105039|NCT03998618|585433923|FG001|Overall Study|Not feeling well/health problems|5|||
162105040|NCT03998618|585433922|FG000|Overall Study|Lost to Follow-up|6|||
162105041|NCT03998618|585433923|FG001|Overall Study|Lost to Follow-up|6|||
162105042|NCT03998618|585433922|FG000|Overall Study|Withdrawal by Subject|0|||
162105043|NCT03998618|585433923|FG001|Overall Study|Withdrawal by Subject|4|||
162105044|NCT01152580|585433928|FG000|Overall Study|Withdrawal by Subject|0|||
162105045|NCT01152580|585433929|FG001|Overall Study|Withdrawal by Subject|1|||
162105046|NCT02308748|585433930|FG000|Period 1|Withdrawal by Subject|0|||
162105047|NCT02308748|585433931|FG001|Period 1|Withdrawal by Subject|0|||
162105048|NCT02308748|585433932|FG002|Period 1|Withdrawal by Subject|1|||
162105049|NCT02308748|585433933|FG003|Period 1|Withdrawal by Subject|0|||
162105050|NCT02308748|585433934|FG004|Period 1|Withdrawal by Subject|0|||
162105051|NCT02308748|585433935|FG005|Period 1|Withdrawal by Subject|0|||
162105052|NCT02308748|585433936|FG006|Period 1|Withdrawal by Subject|0|||
162105053|NCT02308748|585433937|FG007|Period 1|Withdrawal by Subject|0|||
162105054|NCT02308748|585433938|FG008|Period 1|Withdrawal by Subject|0|||
162105055|NCT02308748|585433939|FG009|Period 1|Withdrawal by Subject|0|||
162105056|NCT02308748|585433930|FG000|Period 2|Adverse Event|0|||
162105057|NCT02308748|585433931|FG001|Period 2|Adverse Event|0|||
162105058|NCT02308748|585433932|FG002|Period 2|Adverse Event|0|||
162105059|NCT02308748|585433933|FG003|Period 2|Adverse Event|0|||
162105060|NCT02308748|585433934|FG004|Period 2|Adverse Event|0|||
162105061|NCT02308748|585433935|FG005|Period 2|Adverse Event|0|||
162105062|NCT02308748|585433936|FG006|Period 2|Adverse Event|0|||
162105063|NCT02308748|585433937|FG007|Period 2|Adverse Event|1|||
162105064|NCT02308748|585433938|FG008|Period 2|Adverse Event|0|||
162105065|NCT02308748|585433939|FG009|Period 2|Adverse Event|0|||
162105066|NCT02308748|585433930|FG000|Period 3|Protocol Violation|0|||
162105067|NCT02308748|585433931|FG001|Period 3|Protocol Violation|0|||
162105068|NCT02308748|585433932|FG002|Period 3|Protocol Violation|0|||
162105069|NCT02308748|585433933|FG003|Period 3|Protocol Violation|0|||
162105070|NCT02308748|585433934|FG004|Period 3|Protocol Violation|0|||
162105071|NCT02308748|585433935|FG005|Period 3|Protocol Violation|0|||
162105072|NCT02308748|585433936|FG006|Period 3|Protocol Violation|0|||
162105073|NCT02308748|585433937|FG007|Period 3|Protocol Violation|0|||
162105074|NCT02308748|585433938|FG008|Period 3|Protocol Violation|0|||
162105075|NCT02308748|585433939|FG009|Period 3|Protocol Violation|1|||
162105076|NCT02308748|585433930|FG000|Period 5|Adverse Event|1|||
162105077|NCT02308748|585433931|FG001|Period 5|Adverse Event|0|||
162105078|NCT02308748|585433932|FG002|Period 5|Adverse Event|0|||
162105079|NCT02308748|585433933|FG003|Period 5|Adverse Event|0|||
162105080|NCT02308748|585433934|FG004|Period 5|Adverse Event|0|||
162105081|NCT02308748|585433935|FG005|Period 5|Adverse Event|0|||
162105082|NCT02308748|585433936|FG006|Period 5|Adverse Event|0|||
162105083|NCT02308748|585433937|FG007|Period 5|Adverse Event|0|||
162105084|NCT02308748|585433938|FG008|Period 5|Adverse Event|1|||
162105085|NCT02308748|585433939|FG009|Period 5|Adverse Event|0|||
162105086|NCT01994954|585433941|FG000|Overall Study|Death|1|||
162105087|NCT01994954|585433942|FG001|Overall Study|Death|0|||
162105088|NCT01994954|585433941|FG000|Overall Study|Withdrawal by Subject|9|||
162105089|NCT01994954|585433942|FG001|Overall Study|Withdrawal by Subject|14|||
162105090|NCT01994954|585433941|FG000|Overall Study|Physician Decision|2|||
162105091|NCT01994954|585433942|FG001|Overall Study|Physician Decision|2|||
162105092|NCT01994954|585433941|FG000|Overall Study|Lost to Follow-up|8|||
162105093|NCT01994954|585433942|FG001|Overall Study|Lost to Follow-up|10|||
162105094|NCT01994954|585433941|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
162105095|NCT01994954|585433942|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
162105096|NCT00449176|585433943|FG000|Overall Study|Withdrawal by Subject|39|||
162105097|NCT00449176|585433944|FG001|Overall Study|Withdrawal by Subject|43|||
162105098|NCT00449176|585433945|FG002|Overall Study|Withdrawal by Subject|59|||
162105099|NCT00449176|585433943|FG000|Overall Study|Lost to Follow-up|13|||
162105100|NCT00449176|585433944|FG001|Overall Study|Lost to Follow-up|8|||
162105101|NCT00449176|585433945|FG002|Overall Study|Lost to Follow-up|12|||
162105102|NCT00449176|585433943|FG000|Overall Study|Adverse Event|51|||
162105103|NCT00449176|585433944|FG001|Overall Study|Adverse Event|107|||
162105104|NCT00449176|585433945|FG002|Overall Study|Adverse Event|15|||
162105105|NCT00449176|585433943|FG000|Overall Study|Lack of Efficacy|13|||
162105106|NCT00449176|585433944|FG001|Overall Study|Lack of Efficacy|7|||
162105107|NCT00449176|585433945|FG002|Overall Study|Lack of Efficacy|50|||
162105108|NCT00449176|585433943|FG000|Overall Study|Study drug non-compliant|14|||
162105109|NCT00449176|585433944|FG001|Overall Study|Study drug non-compliant|11|||
162105110|NCT00449176|585433945|FG002|Overall Study|Study drug non-compliant|11|||
162105111|NCT00449176|585433943|FG000|Overall Study|all other|22|||
162105112|NCT00449176|585433944|FG001|Overall Study|all other|19|||
162105113|NCT00449176|585433945|FG002|Overall Study|all other|20|||
162105114|NCT02472964|585433946|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
162105115|NCT02472964|585433947|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
162105116|NCT02472964|585433946|FG000|Part 1 (up to Week 24)|disease progression|58|||
162105117|NCT02472964|585433947|FG001|Part 1 (up to Week 24)|disease progression|47|||
162105118|NCT02472964|585433946|FG000|Part 1 (up to Week 24)|Death|3|||
162105119|NCT02472964|585433947|FG001|Part 1 (up to Week 24)|Death|6|||
162105120|NCT02472964|585433946|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
162105121|NCT02472964|585433947|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
162105122|NCT02472964|585433946|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
162105123|NCT02472964|585433947|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
162105124|NCT02472964|585433946|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
162105125|NCT02472964|585433947|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
162105126|NCT02472964|585433946|FG000|Part 1 (up to Week 24)|Other|2|||
162105127|NCT02472964|585433947|FG001|Part 1 (up to Week 24)|Other|1|||
162105128|NCT02472964|585433946|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
162105129|NCT02472964|585433947|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
162105130|NCT02472964|585433946|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
162105131|NCT02472964|585433947|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
162105132|NCT02472964|585433946|FG000|Part 2 (Week 24-week 48)|Death|0|||
162105133|NCT02472964|585433947|FG001|Part 2 (Week 24-week 48)|Death|1|||
162105134|NCT02472964|585433946|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
162105135|NCT02472964|585433947|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
162105136|NCT02472964|585433946|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
162105137|NCT02472964|585433947|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
162105138|NCT02472964|585433946|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
162105139|NCT02472964|585433947|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
162105140|NCT02472964|585433946|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
162105141|NCT02472964|585433947|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
162105142|NCT01454583|585433948|FG000|1st Year|Lost to Follow-up|1057|||
162105143|NCT01454583|585433949|FG001|1st Year|Lost to Follow-up|318|||
162105144|NCT01454583|585433950|FG002|1st Year|Lost to Follow-up|180|||
162105145|NCT01454583|585433948|FG000|2nd Year|Lost to Follow-up|3965|||
162105146|NCT01454583|585433949|FG001|2nd Year|Lost to Follow-up|1049|||
162105147|NCT01454583|585433950|FG002|2nd Year|Lost to Follow-up|737|||
162105148|NCT01454583|585433948|FG000|3rd Year|Lost to Follow-up|1959|||
162105149|NCT01454583|585433949|FG001|3rd Year|Lost to Follow-up|512|||
162105150|NCT01454583|585433950|FG002|3rd Year|Lost to Follow-up|297|||
162105151|NCT04330638|585433953|FG000|Overall Study|Adverse Event|9|||
162105152|NCT04330638|585433954|FG001|Overall Study|Adverse Event|10|||
162105153|NCT04330638|585433955|FG002|Overall Study|Adverse Event|15|||
162105154|NCT04330638|585433956|FG003|Overall Study|Adverse Event|6|||
162105155|NCT04330638|585433957|FG004|Overall Study|Adverse Event|10|||
162105156|NCT04330638|585433958|FG005|Overall Study|Adverse Event|5|||
162105157|NCT04330638|585433953|FG000|Overall Study|Other|2|||
162105158|NCT04330638|585433954|FG001|Overall Study|Other|2|||
162105159|NCT04330638|585433955|FG002|Overall Study|Other|5|||
162105160|NCT04330638|585433956|FG003|Overall Study|Other|1|||
162105161|NCT04330638|585433957|FG004|Overall Study|Other|3|||
162105162|NCT04330638|585433958|FG005|Overall Study|Other|2|||
162105163|NCT04330638|585433953|FG000|Overall Study|Withdrawal by Subject|4|||
162105164|NCT04330638|585433954|FG001|Overall Study|Withdrawal by Subject|0|||
162105165|NCT04330638|585433955|FG002|Overall Study|Withdrawal by Subject|0|||
162105166|NCT04330638|585433956|FG003|Overall Study|Withdrawal by Subject|0|||
162105167|NCT04330638|585433957|FG004|Overall Study|Withdrawal by Subject|0|||
162105168|NCT04330638|585433958|FG005|Overall Study|Withdrawal by Subject|0|||
162105169|NCT04330638|585433953|FG000|Overall Study|Lost to Follow-up|3|||
162105170|NCT04330638|585433954|FG001|Overall Study|Lost to Follow-up|2|||
162105171|NCT04330638|585433955|FG002|Overall Study|Lost to Follow-up|3|||
162105172|NCT04330638|585433956|FG003|Overall Study|Lost to Follow-up|2|||
162105173|NCT04330638|585433957|FG004|Overall Study|Lost to Follow-up|3|||
162105174|NCT04330638|585433958|FG005|Overall Study|Lost to Follow-up|0|||
162105175|NCT01967732|585433960|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
162105176|NCT01967732|585433961|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
162105177|NCT01967732|585433962|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
162105178|NCT01967732|585433963|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
162105179|NCT01967732|585433960|FG000|First Intervention (Day 1)|Poor venous access|0|||
162105180|NCT01967732|585433961|FG001|First Intervention (Day 1)|Poor venous access|1|||
162105181|NCT01967732|585433962|FG002|First Intervention (Day 1)|Poor venous access|0|||
162105182|NCT01967732|585433963|FG003|First Intervention (Day 1)|Poor venous access|0|||
162105183|NCT01988779|585433972|FG000|Overall Study|Withdrawal by Subject|2|||
162105184|NCT01988779|585433973|FG001|Overall Study|Withdrawal by Subject|2|||
162105185|NCT01988779|585433972|FG000|Overall Study|Protocol Violation|1|||
162105186|NCT01988779|585433973|FG001|Overall Study|Protocol Violation|0|||
162105187|NCT00377403|585433974|FG000|Overall Study|Unable to contact for telephone intervie|4|||
162105188|NCT00377403|585433975|FG001|Overall Study|Unable to contact for telephone intervie|7|||
162105189|NCT02275065|585433976|FG000|Overall Study|Randomized but not treated|1|||
162105190|NCT02275065|585433977|FG001|Overall Study|Randomized but not treated|0|||
162105191|NCT02275065|585433978|FG002|Overall Study|Randomized but not treated|1|||
162105192|NCT02275065|585433979|FG003|Overall Study|Randomized but not treated|1|||
162105193|NCT02275065|585433980|FG004|Overall Study|Randomized but not treated|0|||
162105194|NCT00417079|585433982|FG000|Overall Study|Disease progression|267|||
162105195|NCT00417079|585433983|FG001|Overall Study|Disease progression|180|||
162105196|NCT00417079|585433982|FG000|Overall Study|Adverse Event|32|||
162105197|NCT00417079|585433983|FG001|Overall Study|Adverse Event|67|||
162105198|NCT00417079|585433982|FG000|Overall Study|Non-compliance to protocol|0|||
162105199|NCT00417079|585433983|FG001|Overall Study|Non-compliance to protocol|1|||
162105200|NCT00417079|585433982|FG000|Overall Study|Lost to Follow-up|2|||
162105201|NCT00417079|585433983|FG001|Overall Study|Lost to Follow-up|0|||
162105202|NCT00417079|585433982|FG000|Overall Study|Withdrawal by Subject|17|||
162105203|NCT00417079|585433983|FG001|Overall Study|Withdrawal by Subject|8|||
162105204|NCT00417079|585433982|FG000|Overall Study|Not treated|6|||
162105205|NCT00417079|585433983|FG001|Overall Study|Not treated|7|||
162105206|NCT00417079|585433982|FG000|Overall Study|Screened failure|2|||
162105207|NCT00417079|585433983|FG001|Overall Study|Screened failure|1|||
162105208|NCT00417079|585433982|FG000|Overall Study|Investigator's decision|1|||
162105209|NCT00417079|585433983|FG001|Overall Study|Investigator's decision|4|||
162105210|NCT00417079|585433982|FG000|Overall Study|Non-confirmed Disease progression|1|||
162105211|NCT00417079|585433983|FG001|Overall Study|Non-confirmed Disease progression|1|||
162105212|NCT00417079|585433982|FG000|Overall Study|Clinical deterioration|1|||
162105213|NCT00417079|585433983|FG001|Overall Study|Clinical deterioration|0|||
162105214|NCT00417079|585433982|FG000|Overall Study|Screening error|2|||
162105215|NCT00417079|585433983|FG001|Overall Study|Screening error|1|||
162105216|NCT00417079|585433982|FG000|Overall Study|Withdrawal by subject's family|0|||
162105217|NCT00417079|585433983|FG001|Overall Study|Withdrawal by subject's family|1|||
162105218|NCT00417079|585433982|FG000|Overall Study|Patient unable to come to the clinic|0|||
162105219|NCT00417079|585433983|FG001|Overall Study|Patient unable to come to the clinic|1|||
162105220|NCT00417079|585433982|FG000|Overall Study|abnormal liver function tests|0|||
162105221|NCT00417079|585433983|FG001|Overall Study|abnormal liver function tests|1|||
162105222|NCT00833638|585433984|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
162105223|NCT00833638|585433985|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
162105224|NCT00833638|585433986|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
162105225|NCT00833638|585433984|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
162105226|NCT00833638|585433985|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
162105227|NCT00833638|585433986|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
162105228|NCT00833638|585433984|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
162105229|NCT00833638|585433985|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
162105230|NCT00833638|585433986|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
162105231|NCT00833638|585433984|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
162105232|NCT00833638|585433985|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
162105233|NCT00833638|585433986|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
162105234|NCT00833638|585433984|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
162105235|NCT00833638|585433985|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
162105236|NCT00833638|585433986|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
162105237|NCT00833638|585433984|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
162105238|NCT00833638|585433985|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
162105239|NCT00833638|585433986|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
162105240|NCT00833638|585433984|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
162105241|NCT00833638|585433985|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
162105242|NCT00833638|585433986|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
162105243|NCT00833638|585433984|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
162105244|NCT00833638|585433985|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
162105245|NCT00833638|585433986|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
162105246|NCT00833638|585433984|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
162105247|NCT00833638|585433985|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
162105248|NCT00833638|585433986|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
162105249|NCT01178086|585433987|FG000|Overall Study|Participant refusal|7|||
162105250|NCT01178086|585433987|FG000|Overall Study|Physician Decision|44|||
162105251|NCT01178086|585433987|FG000|Overall Study|Switch to other CLL therapy|113|||
162105252|NCT01178086|585433987|FG000|Overall Study|Death|59|||
162105253|NCT01178086|585433987|FG000|Overall Study|Other unspecified|89|||
162105254|NCT01178086|585433987|FG000|Overall Study|Excluded from EAS|20|||
162105255|NCT02097108|585433988|FG000|Overall Study|Adverse Event|1|||
162105256|NCT02097108|585433988|FG000|Overall Study|patient was abroad for 6 months|1|||
162105257|NCT00127608|585433991|FG000|Overall Study|VZV DNA negative|1|||
162105258|NCT01712009|585435326|FG000|Overall Study|Withdrawal by Subject|24|||
162105259|NCT01712009|585435327|FG001|Overall Study|Withdrawal by Subject|15|||
162105260|NCT01712009|585435328|FG002|Overall Study|Withdrawal by Subject|8|||
162105261|NCT01712009|585435326|FG000|Overall Study|Lost to Follow-up|2|||
162105262|NCT01712009|585435327|FG001|Overall Study|Lost to Follow-up|0|||
162105263|NCT01712009|585435328|FG002|Overall Study|Lost to Follow-up|1|||
162105264|NCT01712009|585435326|FG000|Overall Study|Decision by Sponsor|12|||
162105265|NCT01712009|585435327|FG001|Overall Study|Decision by Sponsor|14|||
162105266|NCT01712009|585435328|FG002|Overall Study|Decision by Sponsor|12|||
162105267|NCT01111123|585435330|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
162105268|NCT01111123|585435331|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
162105269|NCT01111123|585435330|FG000|Maintenance Phase|Lost to Follow-up|0|||
162105270|NCT01111123|585435331|FG001|Maintenance Phase|Lost to Follow-up|2|||
162105271|NCT01627327|585435344|FG000|Overall Study|Adverse Event|6|||
162105272|NCT01627327|585435345|FG001|Overall Study|Adverse Event|12|||
162105273|NCT01627327|585435344|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
162105274|NCT01627327|585435345|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
162105275|NCT01627327|585435344|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
162105276|NCT01627327|585435345|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
162105277|NCT01627327|585435344|FG000|Overall Study|Protocol Violation|4|||
162105278|NCT01627327|585435345|FG001|Overall Study|Protocol Violation|10|||
162105279|NCT01627327|585435344|FG000|Overall Study|Lost to Follow-up|1|||
162105280|NCT01627327|585435345|FG001|Overall Study|Lost to Follow-up|3|||
162105281|NCT01627327|585435344|FG000|Overall Study|Physician Decision|1|||
162105282|NCT01627327|585435345|FG001|Overall Study|Physician Decision|0|||
162105283|NCT01627327|585435344|FG000|Overall Study|Withdrawal by Subject|3|||
162105284|NCT01627327|585435345|FG001|Overall Study|Withdrawal by Subject|3|||
162105285|NCT01137474|585435351|FG000|Overall Study|Adverse Event|3|||
162105286|NCT01137474|585435352|FG001|Overall Study|Adverse Event|5|||
162105287|NCT01137474|585435353|FG002|Overall Study|Adverse Event|1|||
162105288|NCT01137474|585435354|FG003|Overall Study|Adverse Event|3|||
162105289|NCT01137474|585435351|FG000|Overall Study|Withdrawal by Subject|7|||
162105290|NCT01137474|585435352|FG001|Overall Study|Withdrawal by Subject|2|||
162105291|NCT01137474|585435353|FG002|Overall Study|Withdrawal by Subject|6|||
162105292|NCT01137474|585435354|FG003|Overall Study|Withdrawal by Subject|9|||
162105293|NCT01137474|585435351|FG000|Overall Study|No longer met study criteria|6|||
162105294|NCT01137474|585435352|FG001|Overall Study|No longer met study criteria|1|||
162105295|NCT01137474|585435353|FG002|Overall Study|No longer met study criteria|0|||
162105296|NCT01137474|585435354|FG003|Overall Study|No longer met study criteria|5|||
162105297|NCT01137474|585435351|FG000|Overall Study|Lost to Follow-up|5|||
162105298|NCT01137474|585435352|FG001|Overall Study|Lost to Follow-up|1|||
162105299|NCT01137474|585435353|FG002|Overall Study|Lost to Follow-up|0|||
162105300|NCT01137474|585435354|FG003|Overall Study|Lost to Follow-up|2|||
162105301|NCT01137474|585435351|FG000|Overall Study|Lack of Efficacy|0|||
162105302|NCT01137474|585435352|FG001|Overall Study|Lack of Efficacy|0|||
162105303|NCT01137474|585435353|FG002|Overall Study|Lack of Efficacy|0|||
162105304|NCT01137474|585435354|FG003|Overall Study|Lack of Efficacy|2|||
162105305|NCT01137474|585435351|FG000|Overall Study|Other|3|||
162105306|NCT01137474|585435352|FG001|Overall Study|Other|1|||
162105307|NCT01137474|585435353|FG002|Overall Study|Other|0|||
162105308|NCT01137474|585435354|FG003|Overall Study|Other|0|||
162105309|NCT01137474|585435351|FG000|Overall Study|Pregnancy|0|||
162105310|NCT01137474|585435352|FG001|Overall Study|Pregnancy|1|||
162105311|NCT01137474|585435353|FG002|Overall Study|Pregnancy|0|||
162105312|NCT01137474|585435354|FG003|Overall Study|Pregnancy|0|||
162105313|NCT01137474|585435351|FG000|Overall Study|Administrative reason by sponsor|0|||
162105314|NCT01137474|585435352|FG001|Overall Study|Administrative reason by sponsor|1|||
162105315|NCT01137474|585435353|FG002|Overall Study|Administrative reason by sponsor|0|||
162105316|NCT01137474|585435354|FG003|Overall Study|Administrative reason by sponsor|0|||
162105317|NCT02525874|585435357|FG000|Overall Study|Other|1|||
162105318|NCT02525874|585435357|FG000|Overall Study|Investigator Decision|1|||
162105319|NCT02525874|585435357|FG000|Overall Study|Consent withdrawn|22|||
162105320|NCT02525874|585435357|FG000|Overall Study|Non-compliance with study drug|3|||
162105321|NCT02525874|585435357|FG000|Overall Study|Adverse Event|17|||
162105322|NCT02525874|585435357|FG000|Overall Study|Lost to Follow-up|7|||
162105323|NCT02525874|585435357|FG000|Overall Study|Disease progression, defined by protocol|2|||
162105324|NCT02525874|585435357|FG000|Overall Study|Disease relapse|4|||
162105325|NCT02525874|585435357|FG000|Overall Study|Alternative Treatment for MS|2|||
162105326|NCT02525874|585435357|FG000|Overall Study|New lesions in Brain|1|||
162105327|NCT00423176|585435358|FG000|Overall Study|Adverse Event|4|||
162105328|NCT00423176|585435359|FG001|Overall Study|Adverse Event|6|||
162105329|NCT00423176|585435358|FG000|Overall Study|Treatment Failure|1|||
162105330|NCT00423176|585435359|FG001|Overall Study|Treatment Failure|6|||
162105331|NCT00423176|585435358|FG000|Overall Study|Lost to Follow-up|4|||
162105332|NCT00423176|585435359|FG001|Overall Study|Lost to Follow-up|7|||
162105333|NCT00423176|585435358|FG000|Overall Study|Withdrawal by Subject|4|||
162105334|NCT00423176|585435359|FG001|Overall Study|Withdrawal by Subject|3|||
162105335|NCT00423176|585435358|FG000|Overall Study|Protocol Violation|1|||
162105336|NCT00423176|585435359|FG001|Overall Study|Protocol Violation|3|||
162105337|NCT00423176|585435358|FG000|Overall Study|Did not meet protocol eligibility|2|||
162105338|NCT00423176|585435359|FG001|Overall Study|Did not meet protocol eligibility|4|||
162105339|NCT04535947|585435360|FG000|Overall Study|Adverse Event|1|||
162105340|NCT04535947|585435361|FG001|Overall Study|Adverse Event|4|||
162105341|NCT04535947|585435360|FG000|Overall Study|Other reasons not specified|2|||
162105342|NCT04535947|585435361|FG001|Overall Study|Other reasons not specified|0|||
162105343|NCT04535947|585435360|FG000|Overall Study|Withdrawal by Subject|1|||
162105344|NCT04535947|585435361|FG001|Overall Study|Withdrawal by Subject|1|||
162105345|NCT04867369|585435367|FG000|Overall Study|Withdrawal by Subject|1|||
162105346|NCT04867369|585435368|FG001|Overall Study|Withdrawal by Subject|0|||
162105347|NCT03492281|585435374|FG000|Overall Study|Withdrawal by Subject|21|||
162105348|NCT03492281|585435375|FG001|Overall Study|Withdrawal by Subject|14|||
162105349|NCT03492281|585435376|FG002|Overall Study|Withdrawal by Subject|13|||
162105350|NCT03492281|585435374|FG000|Overall Study|Lost to Follow-up|14|||
162105351|NCT03492281|585435375|FG001|Overall Study|Lost to Follow-up|15|||
162105352|NCT03492281|585435376|FG002|Overall Study|Lost to Follow-up|10|||
162105353|NCT03492281|585435374|FG000|Overall Study|Adverse Event|6|||
162105354|NCT03492281|585435375|FG001|Overall Study|Adverse Event|8|||
162105355|NCT03492281|585435376|FG002|Overall Study|Adverse Event|13|||
162105356|NCT03492281|585435374|FG000|Overall Study|Lack of Efficacy|3|||
162105357|NCT03492281|585435375|FG001|Overall Study|Lack of Efficacy|0|||
162105358|NCT03492281|585435376|FG002|Overall Study|Lack of Efficacy|1|||
162105359|NCT03492281|585435374|FG000|Overall Study|Physician Decision|1|||
162105360|NCT03492281|585435375|FG001|Overall Study|Physician Decision|0|||
162105361|NCT03492281|585435376|FG002|Overall Study|Physician Decision|3|||
162105362|NCT03492281|585435374|FG000|Overall Study|Protocol Violation|0|||
162105363|NCT03492281|585435375|FG001|Overall Study|Protocol Violation|2|||
162105364|NCT03492281|585435376|FG002|Overall Study|Protocol Violation|1|||
162105365|NCT03492281|585435374|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
162105366|NCT03492281|585435375|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
162105367|NCT03492281|585435376|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
162105368|NCT03492281|585435374|FG000|Overall Study|Death|0|||
162105369|NCT03492281|585435375|FG001|Overall Study|Death|0|||
162105370|NCT03492281|585435376|FG002|Overall Study|Death|1|||
162105371|NCT03492281|585435374|FG000|Overall Study|Captured as Other in Database|8|||
162105372|NCT03492281|585435375|FG001|Overall Study|Captured as Other in Database|6|||
162105373|NCT03492281|585435376|FG002|Overall Study|Captured as Other in Database|3|||
162105374|NCT00675766|585435383|FG000|Overall Study|Lost to Follow-up|6|||
162105375|NCT00675766|585435384|FG001|Overall Study|Lost to Follow-up|5|||
162105376|NCT00675766|585435385|FG002|Overall Study|Lost to Follow-up|21|||
162105377|NCT00675766|585435386|FG003|Overall Study|Lost to Follow-up|26|||
162105378|NCT01749982|585435389|FG000|Overall Study|Physician Decision|0|||
162105379|NCT01749982|585435390|FG001|Overall Study|Physician Decision|0|||
162105380|NCT01749982|585435391|FG002|Overall Study|Physician Decision|0|||
162105381|NCT01749982|585435392|FG003|Overall Study|Physician Decision|1|||
162105382|NCT01749982|585435389|FG000|Overall Study|Lost to Follow-up|0|||
162105383|NCT01749982|585435390|FG001|Overall Study|Lost to Follow-up|0|||
162105384|NCT01749982|585435391|FG002|Overall Study|Lost to Follow-up|0|||
162105385|NCT01749982|585435392|FG003|Overall Study|Lost to Follow-up|1|||
162105386|NCT01749982|585435389|FG000|Overall Study|Withdrawal by Subject|0|||
162105387|NCT01749982|585435390|FG001|Overall Study|Withdrawal by Subject|0|||
162105388|NCT01749982|585435391|FG002|Overall Study|Withdrawal by Subject|0|||
162105389|NCT01749982|585435392|FG003|Overall Study|Withdrawal by Subject|1|||
162105390|NCT02677116|585435393|FG000|Overall Study|Adverse Event|0|||
162105391|NCT02677116|585435394|FG001|Overall Study|Adverse Event|1|||
162105392|NCT02677116|585435395|FG002|Overall Study|Adverse Event|0|||
162105393|NCT02677116|585435396|FG003|Overall Study|Adverse Event|0|||
162105394|NCT02677116|585435397|FG004|Overall Study|Adverse Event|0|||
162105395|NCT02677116|585435398|FG005|Overall Study|Adverse Event|1|||
162105396|NCT02677116|585435399|FG006|Overall Study|Adverse Event|1|||
162105397|NCT02677116|585435400|FG007|Overall Study|Adverse Event|0|||
162105398|NCT02677116|585435401|FG008|Overall Study|Adverse Event|0|||
162105399|NCT02677116|585435393|FG000|Overall Study|Physician Decision|0|||
162105400|NCT02677116|585435394|FG001|Overall Study|Physician Decision|2|||
162105401|NCT02677116|585435395|FG002|Overall Study|Physician Decision|3|||
162105402|NCT02677116|585435396|FG003|Overall Study|Physician Decision|2|||
162105403|NCT02677116|585435397|FG004|Overall Study|Physician Decision|1|||
162105404|NCT02677116|585435398|FG005|Overall Study|Physician Decision|3|||
162105405|NCT02677116|585435399|FG006|Overall Study|Physician Decision|1|||
162105406|NCT02677116|585435400|FG007|Overall Study|Physician Decision|1|||
162105407|NCT02677116|585435401|FG008|Overall Study|Physician Decision|2|||
162105408|NCT02677116|585435393|FG000|Overall Study|Withdrawal by parent or guardian|2|||
162105409|NCT02677116|585435394|FG001|Overall Study|Withdrawal by parent or guardian|1|||
162105410|NCT02677116|585435395|FG002|Overall Study|Withdrawal by parent or guardian|0|||
162105411|NCT02677116|585435396|FG003|Overall Study|Withdrawal by parent or guardian|1|||
162105412|NCT02677116|585435397|FG004|Overall Study|Withdrawal by parent or guardian|0|||
162105413|NCT02677116|585435398|FG005|Overall Study|Withdrawal by parent or guardian|0|||
162105414|NCT02677116|585435399|FG006|Overall Study|Withdrawal by parent or guardian|2|||
162105415|NCT02677116|585435400|FG007|Overall Study|Withdrawal by parent or guardian|1|||
162105416|NCT02677116|585435401|FG008|Overall Study|Withdrawal by parent or guardian|0|||
162105417|NCT02677116|585435393|FG000|Overall Study|Withdrawal by Subject|1|||
162105418|NCT02677116|585435394|FG001|Overall Study|Withdrawal by Subject|0|||
162105419|NCT02677116|585435395|FG002|Overall Study|Withdrawal by Subject|0|||
162105420|NCT02677116|585435396|FG003|Overall Study|Withdrawal by Subject|0|||
162105421|NCT02677116|585435397|FG004|Overall Study|Withdrawal by Subject|0|||
162105422|NCT02677116|585435398|FG005|Overall Study|Withdrawal by Subject|0|||
162105423|NCT02677116|585435399|FG006|Overall Study|Withdrawal by Subject|0|||
162105424|NCT02677116|585435400|FG007|Overall Study|Withdrawal by Subject|0|||
162105425|NCT02677116|585435401|FG008|Overall Study|Withdrawal by Subject|0|||
162105426|NCT01207102|585435406|FG000|Overall Study|Withdrawal by Subject|5|||
162105427|NCT01207102|585435406|FG000|Overall Study|Adverse Event|2|||
162105428|NCT01207102|585435406|FG000|Overall Study|progression|2|||
162105429|NCT01207102|585435406|FG000|Overall Study|Withdrawal by Treating Physician|1|||
162105430|NCT01018394|585435407|FG000|Overall Study|Withdrawal by Subject|5|||
162105431|NCT01018394|585435408|FG001|Overall Study|Withdrawal by Subject|5|||
162105432|NCT01018394|585435407|FG000|Overall Study|Lost to Follow-up|4|||
162105433|NCT01018394|585435408|FG001|Overall Study|Lost to Follow-up|3|||
162105434|NCT03792126|585435409|FG000|Overall Study|Adverse Event|1|||
162105435|NCT03792126|585435410|FG001|Overall Study|Adverse Event|2|||
162105436|NCT03792126|585435409|FG000|Overall Study|Death|0|||
162105437|NCT03792126|585435410|FG001|Overall Study|Death|1|||
162105438|NCT03792126|585435409|FG000|Overall Study|Lost to Follow-up|1|||
162105439|NCT03792126|585435410|FG001|Overall Study|Lost to Follow-up|0|||
162105440|NCT03792126|585435409|FG000|Overall Study|Withdrawal by Subject|0|||
162105441|NCT03792126|585435410|FG001|Overall Study|Withdrawal by Subject|1|||
162105442|NCT03792126|585435409|FG000|Overall Study|COVID-19 Restrictions|1|||
162105443|NCT03792126|585435410|FG001|Overall Study|COVID-19 Restrictions|3|||
162105444|NCT03792126|585435409|FG000|Overall Study|Symptoms resolved|0|||
162105445|NCT03792126|585435410|FG001|Overall Study|Symptoms resolved|3|||
162105446|NCT00617344|585435411|FG000|Overall Study|Serious adverse event|1|||
162105447|NCT00617344|585435412|FG001|Overall Study|Serious adverse event|0|||
162105448|NCT00617344|585435413|FG002|Overall Study|Serious adverse event|0|||
162105449|NCT00617344|585435411|FG000|Overall Study|Other Adverse Event|1|||
162105450|NCT00617344|585435412|FG001|Overall Study|Other Adverse Event|1|||
162105451|NCT00617344|585435413|FG002|Overall Study|Other Adverse Event|0|||
162105452|NCT00617344|585435411|FG000|Overall Study|Protocol Violation|10|||
162105453|NCT00617344|585435412|FG001|Overall Study|Protocol Violation|8|||
162105454|NCT00617344|585435413|FG002|Overall Study|Protocol Violation|5|||
162105455|NCT00617344|585435411|FG000|Overall Study|Lost to Follow-up|5|||
162105456|NCT00617344|585435412|FG001|Overall Study|Lost to Follow-up|4|||
162105457|NCT00617344|585435413|FG002|Overall Study|Lost to Follow-up|1|||
162105458|NCT00617344|585435411|FG000|Overall Study|Withdrawal by Subject|8|||
162105459|NCT00617344|585435412|FG001|Overall Study|Withdrawal by Subject|9|||
162105460|NCT00617344|585435413|FG002|Overall Study|Withdrawal by Subject|2|||
162105461|NCT00490646|585435415|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
162105462|NCT00490646|585435416|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
162105463|NCT00490646|585435415|FG000|Overall Study|Never Treated (had an adverse event)|1|||
162105464|NCT00490646|585435416|FG001|Overall Study|Never Treated (had an adverse event)|0|||
162105465|NCT00490646|585435415|FG000|Overall Study|Never Treated (withdrew consent)|0|||
162105466|NCT00490646|585435416|FG001|Overall Study|Never Treated (withdrew consent)|1|||
162105467|NCT01400503|585435418|FG000|Overall Study|Withdrawal by Subject|1|||
162105468|NCT01400503|585435418|FG000|Overall Study|Study Terminated by Sponsor|58|||
162105469|NCT01400503|585435418|FG000|Overall Study|Other|1|||
162105470|NCT00983073|585435419|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
162105471|NCT00983073|585435419|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
162105472|NCT00983073|585435419|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
162105473|NCT00983073|585435419|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
162105474|NCT00983073|585435419|FG000|Titration and Optimal Dose Period|Other reason|4|||
162105475|NCT00983073|585435419|FG000|Maintenance Period|Adverse Event|5|||
162105476|NCT00983073|585435419|FG000|Maintenance Period|Withdrawal by Subject|2|||
162105477|NCT00983073|585435419|FG000|Maintenance Period|Lack of Efficacy|2|||
162105478|NCT00983073|585435419|FG000|Maintenance Period|Other Reason|7|||
162105479|NCT01669122|585435422|FG000|Period I|Lost to Follow-up|1|||
162105480|NCT01669122|585435422|FG000|Washout Period II|Protocol Violation|2|||
162105481|NCT02962908|585435423|FG000|Overall Study|Lost to Follow-up|0|||
162105482|NCT02962908|585435424|FG001|Overall Study|Lost to Follow-up|3|||
162105483|NCT02962908|585435425|FG002|Overall Study|Lost to Follow-up|0|||
162105484|NCT02962908|585435426|FG003|Overall Study|Lost to Follow-up|1|||
162105485|NCT02962908|585435423|FG000|Overall Study|Withdrawal by Subject|0|||
162105486|NCT02962908|585435424|FG001|Overall Study|Withdrawal by Subject|3|||
162105487|NCT02962908|585435425|FG002|Overall Study|Withdrawal by Subject|0|||
162105488|NCT02962908|585435426|FG003|Overall Study|Withdrawal by Subject|2|||
162105489|NCT02962908|585435423|FG000|Overall Study|Protocol Violation|0|||
162105490|NCT02962908|585435424|FG001|Overall Study|Protocol Violation|1|||
162105491|NCT02962908|585435425|FG002|Overall Study|Protocol Violation|0|||
162105492|NCT02962908|585435426|FG003|Overall Study|Protocol Violation|0|||
162105493|NCT02962908|585435423|FG000|Overall Study|Physician Decision|0|||
162105494|NCT02962908|585435424|FG001|Overall Study|Physician Decision|1|||
162105495|NCT02962908|585435425|FG002|Overall Study|Physician Decision|0|||
162105496|NCT02962908|585435426|FG003|Overall Study|Physician Decision|0|||
162105497|NCT03543254|585435427|FG000|Overall Study|Lost to Follow-up|1|||
162105498|NCT02077166|585435428|FG000|Overall Study|Death|6|||
162105499|NCT02077166|585435429|FG001|Overall Study|Death|7|||
162105500|NCT02077166|585435430|FG002|Overall Study|Death|5|||
162105501|NCT02077166|585435431|FG003|Overall Study|Death|6|||
162105502|NCT02077166|585435432|FG004|Overall Study|Death|4|||
162105503|NCT02077166|585435433|FG005|Overall Study|Death|32|||
162105504|NCT02077166|585435434|FG006|Overall Study|Death|22|||
162105505|NCT02077166|585435428|FG000|Overall Study|Study Closure by Sponsor|3|||
162105506|NCT02077166|585435429|FG001|Overall Study|Study Closure by Sponsor|0|||
162105507|NCT02077166|585435430|FG002|Overall Study|Study Closure by Sponsor|2|||
162105508|NCT02077166|585435431|FG003|Overall Study|Study Closure by Sponsor|2|||
162105509|NCT02077166|585435432|FG004|Overall Study|Study Closure by Sponsor|2|||
162105510|NCT02077166|585435433|FG005|Overall Study|Study Closure by Sponsor|12|||
162105511|NCT02077166|585435434|FG006|Overall Study|Study Closure by Sponsor|4|||
162105512|NCT02077166|585435428|FG000|Overall Study|Lost to Follow-up|0|||
162105513|NCT02077166|585435429|FG001|Overall Study|Lost to Follow-up|0|||
162105514|NCT02077166|585435430|FG002|Overall Study|Lost to Follow-up|0|||
162105515|NCT02077166|585435431|FG003|Overall Study|Lost to Follow-up|0|||
162105516|NCT02077166|585435432|FG004|Overall Study|Lost to Follow-up|0|||
162105517|NCT02077166|585435433|FG005|Overall Study|Lost to Follow-up|1|||
162105518|NCT02077166|585435434|FG006|Overall Study|Lost to Follow-up|0|||
162105519|NCT02077166|585435428|FG000|Overall Study|Withdrawal by Subject|3|||
162105520|NCT02077166|585435429|FG001|Overall Study|Withdrawal by Subject|0|||
162105521|NCT02077166|585435430|FG002|Overall Study|Withdrawal by Subject|1|||
162105522|NCT02077166|585435431|FG003|Overall Study|Withdrawal by Subject|1|||
162105523|NCT02077166|585435432|FG004|Overall Study|Withdrawal by Subject|1|||
162105524|NCT02077166|585435433|FG005|Overall Study|Withdrawal by Subject|3|||
162105525|NCT02077166|585435434|FG006|Overall Study|Withdrawal by Subject|0|||
162105526|NCT02077166|585435428|FG000|Overall Study|Other, Not Specified|0|||
162105527|NCT02077166|585435429|FG001|Overall Study|Other, Not Specified|0|||
162105528|NCT02077166|585435430|FG002|Overall Study|Other, Not Specified|1|||
162105529|NCT02077166|585435431|FG003|Overall Study|Other, Not Specified|0|||
162105530|NCT02077166|585435432|FG004|Overall Study|Other, Not Specified|1|||
162105531|NCT02077166|585435433|FG005|Overall Study|Other, Not Specified|7|||
162105532|NCT02077166|585435434|FG006|Overall Study|Other, Not Specified|8|||
162105533|NCT01261338|585435435|FG000|Overall Study|Withdrawal by Subject|3|||
162105534|NCT01261338|585435436|FG001|Overall Study|Withdrawal by Subject|2|||
162105535|NCT02899728|585435442|FG000|Overall Study|Withdrawal by Subject|1|||
162105536|NCT02899728|585435443|FG001|Overall Study|Withdrawal by Subject|1|||
162105537|NCT05557942|585435444|FG000|Overall Study|Death|0|||
162105538|NCT05557942|585435445|FG001|Overall Study|Death|0|||
162105539|NCT05557942|585435446|FG002|Overall Study|Death|0|||
162105540|NCT05557942|585435447|FG003|Overall Study|Death|2|||
162105541|NCT05557942|585435448|FG004|Overall Study|Death|1|||
162105542|NCT05557942|585435449|FG005|Overall Study|Death|1|||
162105543|NCT05557942|585435444|FG000|Overall Study|Physician Decision|1|||
162105544|NCT05557942|585435445|FG001|Overall Study|Physician Decision|1|||
162105545|NCT05557942|585435446|FG002|Overall Study|Physician Decision|2|||
162105546|NCT05557942|585435447|FG003|Overall Study|Physician Decision|3|||
162105547|NCT05557942|585435448|FG004|Overall Study|Physician Decision|0|||
162105548|NCT05557942|585435449|FG005|Overall Study|Physician Decision|2|||
162105549|NCT05557942|585435444|FG000|Overall Study|Study terminated by sponsor|17|||
162105550|NCT05557942|585435445|FG001|Overall Study|Study terminated by sponsor|17|||
162105551|NCT05557942|585435446|FG002|Overall Study|Study terminated by sponsor|14|||
162105552|NCT05557942|585435447|FG003|Overall Study|Study terminated by sponsor|40|||
162105553|NCT05557942|585435448|FG004|Overall Study|Study terminated by sponsor|45|||
162105554|NCT05557942|585435449|FG005|Overall Study|Study terminated by sponsor|37|||
162105555|NCT05557942|585435444|FG000|Overall Study|Protocol Violation|0|||
162105556|NCT05557942|585435445|FG001|Overall Study|Protocol Violation|0|||
162105557|NCT05557942|585435446|FG002|Overall Study|Protocol Violation|0|||
162105558|NCT05557942|585435447|FG003|Overall Study|Protocol Violation|0|||
162105559|NCT05557942|585435448|FG004|Overall Study|Protocol Violation|0|||
162105560|NCT05557942|585435449|FG005|Overall Study|Protocol Violation|1|||
162105561|NCT05557942|585435444|FG000|Overall Study|Withdrawal by Subject|0|||
162105562|NCT05557942|585435445|FG001|Overall Study|Withdrawal by Subject|0|||
162105563|NCT05557942|585435446|FG002|Overall Study|Withdrawal by Subject|0|||
162105564|NCT05557942|585435447|FG003|Overall Study|Withdrawal by Subject|0|||
162105565|NCT05557942|585435448|FG004|Overall Study|Withdrawal by Subject|2|||
162105566|NCT05557942|585435449|FG005|Overall Study|Withdrawal by Subject|0|||
162105567|NCT01962493|585435450|FG000|Overall Study|Adverse Event|1|||
162105568|NCT01962493|585435451|FG001|Overall Study|Adverse Event|2|||
162105569|NCT01962493|585435450|FG000|Overall Study|Protocol Violation|0|||
162105570|NCT01962493|585435451|FG001|Overall Study|Protocol Violation|1|||
162105571|NCT01962493|585435450|FG000|Overall Study|Withdrawal by Subject|4|||
162105572|NCT01962493|585435451|FG001|Overall Study|Withdrawal by Subject|2|||
162105573|NCT01951625|585435452|FG000|Treatment Period|Protocol Violation|2|||
162105574|NCT01951625|585435453|FG001|Treatment Period|Protocol Violation|0|||
162105575|NCT01951625|585435454|FG002|Treatment Period|Protocol Violation|1|||
162105576|NCT01951625|585435455|FG003|Treatment Period|Protocol Violation|3|||
162105577|NCT01951625|585435456|FG004|Treatment Period|Protocol Violation|2|||
162105578|NCT01951625|585435452|FG000|Treatment Period|Physician Decision|0|||
162105579|NCT01951625|585435453|FG001|Treatment Period|Physician Decision|0|||
162105580|NCT01951625|585435454|FG002|Treatment Period|Physician Decision|0|||
162105581|NCT01951625|585435455|FG003|Treatment Period|Physician Decision|0|||
162105582|NCT01951625|585435456|FG004|Treatment Period|Physician Decision|1|||
162105583|NCT01951625|585435452|FG000|Treatment Period|Protocol driven decision point|0|||
162105584|NCT01951625|585435453|FG001|Treatment Period|Protocol driven decision point|5|||
162105585|NCT01951625|585435454|FG002|Treatment Period|Protocol driven decision point|0|||
162105586|NCT01951625|585435455|FG003|Treatment Period|Protocol driven decision point|2|||
162105587|NCT01951625|585435456|FG004|Treatment Period|Protocol driven decision point|1|||
162105588|NCT01951625|585435452|FG000|Treatment Period|Non compliance with study drug|1|||
162105589|NCT01951625|585435453|FG001|Treatment Period|Non compliance with study drug|2|||
162105590|NCT01951625|585435454|FG002|Treatment Period|Non compliance with study drug|2|||
162105591|NCT01951625|585435455|FG003|Treatment Period|Non compliance with study drug|0|||
162105592|NCT01951625|585435456|FG004|Treatment Period|Non compliance with study drug|0|||
162105593|NCT01951625|585435452|FG000|Treatment Period|Death|3|||
162105594|NCT01951625|585435453|FG001|Treatment Period|Death|2|||
162105595|NCT01951625|585435454|FG002|Treatment Period|Death|2|||
162105596|NCT01951625|585435455|FG003|Treatment Period|Death|1|||
162105597|NCT01951625|585435456|FG004|Treatment Period|Death|2|||
162105598|NCT01951625|585435452|FG000|Treatment Period|Adverse Event|7|||
162105599|NCT01951625|585435453|FG001|Treatment Period|Adverse Event|10|||
162105600|NCT01951625|585435454|FG002|Treatment Period|Adverse Event|9|||
162105601|NCT01951625|585435455|FG003|Treatment Period|Adverse Event|8|||
162105602|NCT01951625|585435456|FG004|Treatment Period|Adverse Event|8|||
162105603|NCT01951625|585435452|FG000|Treatment Period|Withdrawal by Subject|5|||
162105604|NCT01951625|585435453|FG001|Treatment Period|Withdrawal by Subject|2|||
162105605|NCT01951625|585435454|FG002|Treatment Period|Withdrawal by Subject|1|||
162105606|NCT01951625|585435455|FG003|Treatment Period|Withdrawal by Subject|7|||
162105607|NCT01951625|585435456|FG004|Treatment Period|Withdrawal by Subject|3|||
162105608|NCT01951625|585435452|FG000|Treatment Period|Lost to Follow-up|1|||
162105609|NCT01951625|585435453|FG001|Treatment Period|Lost to Follow-up|0|||
162105610|NCT01951625|585435454|FG002|Treatment Period|Lost to Follow-up|0|||
162105611|NCT01951625|585435455|FG003|Treatment Period|Lost to Follow-up|1|||
162105612|NCT01951625|585435456|FG004|Treatment Period|Lost to Follow-up|0|||
162105613|NCT01951625|585435452|FG000|Follow Up Period|Non-compliance with study drug|1|||
162105614|NCT01951625|585435453|FG001|Follow Up Period|Non-compliance with study drug|0|||
162105615|NCT01951625|585435454|FG002|Follow Up Period|Non-compliance with study drug|0|||
162105616|NCT01951625|585435455|FG003|Follow Up Period|Non-compliance with study drug|0|||
162105617|NCT01951625|585435456|FG004|Follow Up Period|Non-compliance with study drug|0|||
162105618|NCT01951625|585435452|FG000|Follow Up Period|Death|1|||
162105619|NCT01951625|585435453|FG001|Follow Up Period|Death|3|||
162105620|NCT01951625|585435454|FG002|Follow Up Period|Death|2|||
162105621|NCT01951625|585435455|FG003|Follow Up Period|Death|2|||
162105622|NCT01951625|585435456|FG004|Follow Up Period|Death|1|||
162105623|NCT01951625|585435452|FG000|Follow Up Period|Logistical difficulties|1|||
162105624|NCT01951625|585435453|FG001|Follow Up Period|Logistical difficulties|2|||
162105625|NCT01951625|585435454|FG002|Follow Up Period|Logistical difficulties|0|||
162105626|NCT01951625|585435455|FG003|Follow Up Period|Logistical difficulties|0|||
162105627|NCT01951625|585435456|FG004|Follow Up Period|Logistical difficulties|0|||
162105628|NCT01951625|585435452|FG000|Follow Up Period|Adverse Event|0|||
162105629|NCT01951625|585435453|FG001|Follow Up Period|Adverse Event|3|||
162105630|NCT01951625|585435454|FG002|Follow Up Period|Adverse Event|2|||
162105631|NCT01951625|585435455|FG003|Follow Up Period|Adverse Event|3|||
162105632|NCT01951625|585435456|FG004|Follow Up Period|Adverse Event|5|||
162105633|NCT01951625|585435452|FG000|Follow Up Period|Withdrawal by Subject|4|||
162105634|NCT01951625|585435453|FG001|Follow Up Period|Withdrawal by Subject|1|||
162105635|NCT01951625|585435454|FG002|Follow Up Period|Withdrawal by Subject|0|||
162105636|NCT01951625|585435455|FG003|Follow Up Period|Withdrawal by Subject|5|||
162105637|NCT01951625|585435456|FG004|Follow Up Period|Withdrawal by Subject|3|||
162105638|NCT01951625|585435452|FG000|Follow Up Period|Lost to Follow-up|1|||
162105639|NCT01951625|585435453|FG001|Follow Up Period|Lost to Follow-up|0|||
162105640|NCT01951625|585435454|FG002|Follow Up Period|Lost to Follow-up|0|||
162105641|NCT01951625|585435455|FG003|Follow Up Period|Lost to Follow-up|1|||
162105642|NCT01951625|585435456|FG004|Follow Up Period|Lost to Follow-up|1|||
162105643|NCT03754803|585435463|FG000|Overall Study|Withdrawal by Subject|2|||
162105644|NCT05338333|585435464|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
162105645|NCT05338333|585435465|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
162105646|NCT04348604|585435468|FG000|Week 8|Withdrawal by Subject|1|||
162105647|NCT04348604|585435469|FG001|Week 8|Withdrawal by Subject|1|||
162105648|NCT04348604|585435468|FG000|Week 8|Lost to Follow-up|1|||
162105649|NCT04348604|585435469|FG001|Week 8|Lost to Follow-up|2|||
162237476|NCT00600886|585921097|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
162105650|NCT04348604|585435468|FG000|Week 8|Suspended|0|||
162105651|NCT04348604|585435469|FG001|Week 8|Suspended|1|||
162105652|NCT04348604|585435468|FG000|Week 12|Lost to Follow-up|1|||
162105653|NCT04348604|585435469|FG001|Week 12|Lost to Follow-up|2|||
162105654|NCT04348604|585435468|FG000|Week 12|Withdrawal by Subject|1|||
162105655|NCT04348604|585435469|FG001|Week 12|Withdrawal by Subject|0|||
162105656|NCT04348604|585435468|FG000|Week 24|Lost to Follow-up|2|||
162105657|NCT04348604|585435469|FG001|Week 24|Lost to Follow-up|1|||
162105658|NCT05245864|585435470|FG000|Overall Study|Withdrawal by Subject|1|||
162105659|NCT05245864|585435471|FG001|Overall Study|Withdrawal by Subject|1|||
162105660|NCT00857207|585436838|FG000|Overall Study|Withdrawal by Subject|13|||
162105661|NCT00857207|585436839|FG001|Overall Study|Withdrawal by Subject|0|||
162105662|NCT00857207|585436838|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
162105663|NCT00857207|585436839|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
162105664|NCT00857207|585436838|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
162105665|NCT00857207|585436839|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
162105666|NCT02030015|585436840|FG000|Overall Study|Withdrawal by Subject|3|||
162105667|NCT02030015|585436840|FG000|Overall Study|Death|13|||
162105668|NCT03014674|585436842|FG000|Overall Study|Withdrawal by Subject|1|||
162105669|NCT03014674|585436843|FG001|Overall Study|Withdrawal by Subject|0|||
162105670|NCT03014674|585436844|FG002|Overall Study|Withdrawal by Subject|0|||
162105671|NCT01332227|585436846|FG000|Overall Study|Adverse Event|4|||
162105672|NCT01332227|585436847|FG001|Overall Study|Adverse Event|1|||
162105673|NCT01332227|585436846|FG000|Overall Study|Withdrawal by Subject|5|||
162105674|NCT01332227|585436847|FG001|Overall Study|Withdrawal by Subject|1|||
162105675|NCT01332227|585436846|FG000|Overall Study|Lost to Follow-up|2|||
162105676|NCT01332227|585436847|FG001|Overall Study|Lost to Follow-up|0|||
162105677|NCT01332227|585436846|FG000|Overall Study|Lack of Efficacy|3|||
162105678|NCT01332227|585436847|FG001|Overall Study|Lack of Efficacy|1|||
162105679|NCT01332227|585436846|FG000|Overall Study|Poor compliance/noncompliance|1|||
162105680|NCT01332227|585436847|FG001|Overall Study|Poor compliance/noncompliance|1|||
162105681|NCT01332227|585436846|FG000|Overall Study|Patient moved from area|1|||
162105682|NCT01332227|585436847|FG001|Overall Study|Patient moved from area|0|||
162105683|NCT01332227|585436846|FG000|Overall Study|Patient began prohibited medication|0|||
162105684|NCT01332227|585436847|FG001|Overall Study|Patient began prohibited medication|1|||
162105685|NCT02822222|585436856|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
162105686|NCT02822222|585436857|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
162105687|NCT00833560|585436858|FG000|Overall Study|Toxicity|13|||
162105688|NCT00833560|585436858|FG000|Overall Study|Adverse Event|11|||
162105689|NCT00833560|585436858|FG000|Overall Study|Protocol Violation|6|||
162105690|NCT00833560|585436858|FG000|Overall Study|Lack of Efficacy|4|||
162105691|NCT00833560|585436858|FG000|Overall Study|Death|2|||
162105692|NCT00833560|585436858|FG000|Overall Study|Pregression of other disease|1|||
162105693|NCT00833560|585436858|FG000|Overall Study|Other|5|||
162105694|NCT00440531|585436862|FG000|Overall Study|Adverse Event|1|||
162105695|NCT00440531|585436863|FG001|Overall Study|Adverse Event|0|||
162105696|NCT00440531|585436864|FG002|Overall Study|Adverse Event|2|||
162105697|NCT00440531|585436862|FG000|Overall Study|Withdrawal by Subject|2|||
162105698|NCT00440531|585436863|FG001|Overall Study|Withdrawal by Subject|0|||
162105699|NCT00440531|585436864|FG002|Overall Study|Withdrawal by Subject|0|||
162105700|NCT00440531|585436862|FG000|Overall Study|Protocol Violation|1|||
162105701|NCT00440531|585436863|FG001|Overall Study|Protocol Violation|2|||
162105702|NCT00440531|585436864|FG002|Overall Study|Protocol Violation|0|||
162105703|NCT00440531|585436862|FG000|Overall Study|Lost to Follow-up|4|||
162105704|NCT00440531|585436863|FG001|Overall Study|Lost to Follow-up|3|||
162105705|NCT00440531|585436864|FG002|Overall Study|Lost to Follow-up|5|||
162105706|NCT00440531|585436862|FG000|Overall Study|see pre-assignment details|2|||
162105707|NCT00440531|585436863|FG001|Overall Study|see pre-assignment details|0|||
162105708|NCT00440531|585436864|FG002|Overall Study|see pre-assignment details|0|||
162105709|NCT01791725|585436865|FG000|Overall Study|Withdrawal by Subject|0|||
162105710|NCT01791725|585436866|FG001|Overall Study|Withdrawal by Subject|1|||
162105711|NCT01791725|585436867|FG002|Overall Study|Withdrawal by Subject|0|||
162105712|NCT02690974|585436870|FG000|Overall Study|Adverse Event|16|||
162105713|NCT02690974|585436870|FG000|Overall Study|Death|9|||
162105714|NCT02690974|585436870|FG000|Overall Study|Subject/guardian decision|4|||
162105715|NCT02690974|585436870|FG000|Overall Study|Lost to Follow-up|3|||
162105716|NCT02690974|585436870|FG000|Overall Study|Withdrawal of Informed Consent|3|||
162105717|NCT02690974|585436870|FG000|Overall Study|Physician Decision|2|||
162105718|NCT02690974|585436870|FG000|Overall Study|Non-compliance with study treatment|1|||
162105719|NCT02690974|585436870|FG000|Overall Study|Protocol-defined stopping criteria|1|||
162105720|NCT02690974|585436870|FG000|Overall Study|Protocol Deviation|1|||
162105721|NCT01666951|585436873|FG000|Overall Study|Not dosed|1|||
162105722|NCT01666951|585436874|FG001|Overall Study|Not dosed|1|||
162105723|NCT00254982|585436890|FG000|Overall Study|Other|2|||
162105724|NCT00254982|585436891|FG001|Overall Study|Other|1|||
162105725|NCT00254982|585436890|FG000|Overall Study|Lack of Efficacy|5|||
162105726|NCT00254982|585436891|FG001|Overall Study|Lack of Efficacy|3|||
162105727|NCT00254982|585436890|FG000|Overall Study|Lost to Follow-up|5|||
162105728|NCT00254982|585436891|FG001|Overall Study|Lost to Follow-up|3|||
162105729|NCT00254982|585436890|FG000|Overall Study|Adverse Event|18|||
162105730|NCT00254982|585436891|FG001|Overall Study|Adverse Event|16|||
162105731|NCT00254982|585436890|FG000|Overall Study|Withdrawal by Subject|1|||
162105732|NCT00254982|585436891|FG001|Overall Study|Withdrawal by Subject|1|||
162105733|NCT00254982|585436890|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
162105734|NCT00254982|585436891|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
162105735|NCT00254982|585436890|FG000|Overall Study|Protocol deviation|1|||
162105736|NCT00254982|585436891|FG001|Overall Study|Protocol deviation|1|||
162105737|NCT00254982|585436890|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
162105738|NCT00254982|585436891|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
162105739|NCT00254982|585436890|FG000|Overall Study|Malignancy|0|||
162105740|NCT00254982|585436891|FG001|Overall Study|Malignancy|2|||
162105741|NCT00254982|585436890|FG000|Overall Study|Opportunistic infection|1|||
162105742|NCT00254982|585436891|FG001|Overall Study|Opportunistic infection|0|||
162105743|NCT00254982|585436890|FG000|Overall Study|Abnormal liver function tests|2|||
162105744|NCT00254982|585436891|FG001|Overall Study|Abnormal liver function tests|1|||
162105745|NCT02570126|585436892|FG000|Overall Study|Lost to Follow-up|2|||
162105746|NCT02570126|585436893|FG001|Overall Study|Lost to Follow-up|0|||
162105747|NCT02570126|585436892|FG000|Overall Study|Unable To Arrange Visit 3|1|||
162105748|NCT02570126|585436893|FG001|Overall Study|Unable To Arrange Visit 3|0|||
162105749|NCT02570126|585436892|FG000|Overall Study|Violation Of Procedures GSK|0|||
162105750|NCT02570126|585436893|FG001|Overall Study|Violation Of Procedures GSK|1|||
162105751|NCT02570126|585436892|FG000|Overall Study|Protocol Violation|0|||
162105752|NCT02570126|585436893|FG001|Overall Study|Protocol Violation|1|||
162105753|NCT02570126|585436892|FG000|Overall Study|Withdrawal by Subject|3|||
162105754|NCT02570126|585436893|FG001|Overall Study|Withdrawal by Subject|7|||
162105755|NCT00626028|585436894|FG000|Overall Study|Adverse Event|1|||
162105756|NCT00626028|585436895|FG001|Overall Study|Adverse Event|1|||
162105757|NCT00626028|585436894|FG000|Overall Study|Device Failure|0|||
162105758|NCT00626028|585436895|FG001|Overall Study|Device Failure|1|||
162105759|NCT00626028|585436894|FG000|Overall Study|Physician Decision|2|||
162105760|NCT00626028|585436895|FG001|Overall Study|Physician Decision|1|||
162105761|NCT00626028|585436894|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
162105762|NCT00626028|585436895|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
162105763|NCT05224050|585436897|FG000|Overall Study|Withdrawal by Subject|9|||
162105764|NCT05224050|585436897|FG000|Overall Study|Lost to Follow-up|3|||
162105765|NCT01292876|585436898|FG000|Overall Study|Physician Decision|4|||
162105766|NCT00917579|585436899|FG000|Washout >= 2 Weeks|Adverse Event|1|||
162105767|NCT00917579|585436900|FG001|Washout >= 2 Weeks|Adverse Event|0|||
162105768|NCT00917579|585436899|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
162105769|NCT00917579|585436900|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
162105770|NCT05763628|585436901|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
162105771|NCT05763628|585436902|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
162105772|NCT05763628|585436901|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
162105773|NCT05763628|585436902|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
162105774|NCT05763628|585436901|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
162105775|NCT05763628|585436902|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
162105776|NCT00868439|585436908|FG000|Overall Study|Adverse Event|4|||
162105777|NCT00868439|585436909|FG001|Overall Study|Adverse Event|3|||
162105778|NCT00868439|585436908|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
162105779|NCT00868439|585436909|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
162105780|NCT00868439|585436908|FG000|Overall Study|Death|0|||
162105781|NCT00868439|585436909|FG001|Overall Study|Death|1|||
162105782|NCT00868439|585436908|FG000|Overall Study|Protocol Violation|1|||
162105783|NCT00868439|585436909|FG001|Overall Study|Protocol Violation|1|||
162105784|NCT00868439|585436908|FG000|Overall Study|Physician Decision|1|||
162105785|NCT00868439|585436909|FG001|Overall Study|Physician Decision|0|||
162105786|NCT00868439|585436908|FG000|Overall Study|Withdrawal by Subject|0|||
162105787|NCT00868439|585436909|FG001|Overall Study|Withdrawal by Subject|1|||
162105788|NCT01132326|585436910|FG000|Overall Study|Lack of Efficacy|25|||
162105789|NCT01132326|585436910|FG000|Overall Study|Adverse Event|37|||
162105790|NCT01132326|585436910|FG000|Overall Study|Protocol Violation|1|||
162105791|NCT01132326|585436910|FG000|Overall Study|Lost to Follow-up|16|||
162105792|NCT01132326|585436910|FG000|Overall Study|Withdrawal by Subject|40|||
162105793|NCT01132326|585436910|FG000|Overall Study|Physician Decision|10|||
162105794|NCT01132326|585436910|FG000|Overall Study|Study Termination|80|||
162105795|NCT01132326|585436910|FG000|Overall Study|Declining Health|1|||
162105796|NCT01132326|585436910|FG000|Overall Study|Pregnancy|1|||
162105797|NCT01132326|585436910|FG000|Overall Study|Caregiver Withdrew Consent|1|||
162105798|NCT01132326|585436910|FG000|Overall Study|Death|5|||
162105799|NCT01132326|585436910|FG000|Overall Study|Subject Unable to Come To Visits|1|||
162105800|NCT00338884|585436913|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
162105801|NCT00338884|585436913|FG000|Overall Study|Adverse Event|14|||
162105802|NCT00338884|585436913|FG000|Overall Study|Death|8|||
162105803|NCT00338884|585436913|FG000|Overall Study|Other|4|||
162105804|NCT00338884|585436913|FG000|Overall Study|Global Deterioration of Health Status|3|||
162105805|NCT00338884|585436913|FG000|Overall Study|Withdrawal by Subject|3|||
162105806|NCT00338884|585436913|FG000|Overall Study|Lost to Follow-up|1|||
162105807|NCT00338884|585436913|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
162105808|NCT00911534|585436914|FG000|Overall Study|Adverse Event|4|||
162105809|NCT00911534|585436915|FG001|Overall Study|Adverse Event|4|||
162105810|NCT00911534|585436914|FG000|Overall Study|Lost to Follow-up|2|||
162105811|NCT00911534|585436915|FG001|Overall Study|Lost to Follow-up|4|||
162105812|NCT00911534|585436914|FG000|Overall Study|Withdrawal by Subject|2|||
162105813|NCT00911534|585436915|FG001|Overall Study|Withdrawal by Subject|1|||
162105814|NCT00911534|585436914|FG000|Overall Study|Lack of Efficacy|4|||
162105815|NCT00911534|585436915|FG001|Overall Study|Lack of Efficacy|1|||
162105816|NCT00911534|585436914|FG000|Overall Study|Withdrawal of consent|1|||
162105817|NCT00911534|585436915|FG001|Overall Study|Withdrawal of consent|4|||
162237477|NCT00600886|585921096|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
162105818|NCT00911534|585436914|FG000|Overall Study|Other|2|||
162105819|NCT00911534|585436915|FG001|Overall Study|Other|2|||
162105820|NCT03342638|585436917|FG000|Overall Study|Withdrawal by Subject|1|||
162105821|NCT03342638|585436918|FG001|Overall Study|Withdrawal by Subject|0|||
162105822|NCT03342638|585436917|FG000|Overall Study|Physician Decision|0|||
162105823|NCT03342638|585436918|FG001|Overall Study|Physician Decision|1|||
162105824|NCT00113568|585436930|FG000|Overall Study|Adverse Event|97|||
162105825|NCT00113568|585436930|FG000|Overall Study|Death|1|||
162105826|NCT00113568|585436930|FG000|Overall Study|Lack of Efficacy|30|||
162105827|NCT00113568|585436930|FG000|Overall Study|Lost to Follow-up|156|||
162105828|NCT00113568|585436930|FG000|Overall Study|Protocol Violation|32|||
162105829|NCT00113568|585436930|FG000|Overall Study|Withdrawal by Subject|117|||
162105830|NCT00113568|585436930|FG000|Overall Study|Other|112|||
162105831|NCT02191267|585436932|FG000|Overall Study|Withdrawal by Subject|1|||
162105832|NCT02191267|585436933|FG001|Overall Study|Withdrawal by Subject|0|||
162105833|NCT02191267|585436934|FG002|Overall Study|Withdrawal by Subject|0|||
162105834|NCT03213158|585436937|FG000|Overall Study|Withdrawal by Subject|1|||
162105835|NCT03213158|585436937|FG000|Overall Study|Physician Decision|2|||
162105836|NCT00587964|585436938|FG000|Overall Study|Withdrawal by Subject|1|||
162105837|NCT00587964|585436938|FG000|Overall Study|Lost to Follow-up|1|||
162105838|NCT00587964|585436938|FG000|Overall Study|Patient found to be ineligible|1|||
162105839|NCT00587964|585436938|FG000|Overall Study|Patient did not receive intervention|5|||
162105840|NCT00587964|585436938|FG000|Overall Study|Progression of Disease|4|||
162105841|NCT01569438|585436940|FG000|Overall Study|Lack of Efficacy|1|||
162105842|NCT01569438|585436941|FG001|Overall Study|Lack of Efficacy|2|||
162105843|NCT01569438|585436940|FG000|Overall Study|Withdrawal by Subject|0|||
162105844|NCT01569438|585436941|FG001|Overall Study|Withdrawal by Subject|3|||
162105845|NCT01569438|585436940|FG000|Overall Study|Adverse Event|2|||
162105846|NCT01569438|585436941|FG001|Overall Study|Adverse Event|15|||
162105847|NCT01569438|585436940|FG000|Overall Study|Protocol Violation|2|||
162105848|NCT01569438|585436941|FG001|Overall Study|Protocol Violation|0|||
162105849|NCT01569438|585436940|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
162105850|NCT01569438|585436941|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
162105851|NCT01569438|585436940|FG000|Overall Study|Sponsor/Physician decision|1|||
162105852|NCT01569438|585436941|FG001|Overall Study|Sponsor/Physician decision|1|||
162105853|NCT01569438|585436940|FG000|Overall Study|Unable to adhere to study schedule|0|||
162105854|NCT01569438|585436941|FG001|Overall Study|Unable to adhere to study schedule|1|||
162105855|NCT03649230|585436942|FG000|Overall Study|Adverse Event|12|||
162105856|NCT03649230|585436942|FG000|Overall Study|Death|8|||
162105857|NCT03649230|585436942|FG000|Overall Study|Withdrawal by Subject|6|||
162105858|NCT03649230|585436942|FG000|Overall Study|Physician Decision|5|||
162105859|NCT03649230|585436942|FG000|Overall Study|Disease progression|5|||
162105860|NCT03649230|585436942|FG000|Overall Study|Switched to non-HEC|5|||
162105861|NCT03649230|585436942|FG000|Overall Study|Chemotherapy discontinued|4|||
162105862|NCT03649230|585436942|FG000|Overall Study|Received only 3 HEC cycles|4|||
162105863|NCT03649230|585436942|FG000|Overall Study|Screen Failure|3|||
162105864|NCT03649230|585436942|FG000|Overall Study|Patient stopped treatment|2|||
162105865|NCT03649230|585436942|FG000|Overall Study|Protocol Violation|1|||
162105866|NCT03649230|585436942|FG000|Overall Study|Non-compliance|1|||
162105867|NCT03649230|585436942|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
162105868|NCT01693068|585436947|FG000|Randomization Period|On-study|2|||
162105869|NCT01693068|585436948|FG001|Randomization Period|On-study|5|||
162105870|NCT01693068|585436949|FG002|Randomization Period|On-study|0|||
162105871|NCT01693068|585436947|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
162105872|NCT01693068|585436948|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
162105873|NCT01693068|585436949|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
162105874|NCT00736645|585436953|FG000|Overall Study|Adverse Event|0|||
162105875|NCT00736645|585436954|FG001|Overall Study|Adverse Event|2|||
162105876|NCT00736645|585436955|FG002|Overall Study|Adverse Event|0|||
162105877|NCT00736645|585436956|FG003|Overall Study|Adverse Event|0|||
162105878|NCT04302350|585436957|FG000|Overall Study|Physician Decision|1|||
162105879|NCT04302350|585436958|FG001|Overall Study|Physician Decision|1|||
162105880|NCT04302350|585436959|FG002|Overall Study|Physician Decision|2|||
162105881|NCT04302350|585436957|FG000|Overall Study|Lack of Efficacy|1|||
162105882|NCT04302350|585436958|FG001|Overall Study|Lack of Efficacy|1|||
162105883|NCT04302350|585436959|FG002|Overall Study|Lack of Efficacy|4|||
162105884|NCT04302350|585436957|FG000|Overall Study|Adverse Event|0|||
162105885|NCT04302350|585436958|FG001|Overall Study|Adverse Event|1|||
162105886|NCT04302350|585436959|FG002|Overall Study|Adverse Event|2|||
162105887|NCT02137369|585436962|FG000|Overall Study|Withdrawal by Subject|3|||
162105888|NCT02137369|585436963|FG001|Overall Study|Withdrawal by Subject|2|||
162105889|NCT02137369|585436962|FG000|Overall Study|Adverse Event|2|||
162105890|NCT02137369|585436963|FG001|Overall Study|Adverse Event|0|||
162105891|NCT02137369|585436962|FG000|Overall Study|Lost to Follow-up|1|||
162105892|NCT02137369|585436963|FG001|Overall Study|Lost to Follow-up|0|||
162105893|NCT02137369|585436962|FG000|Overall Study|Moved away|2|||
162105894|NCT02137369|585436963|FG001|Overall Study|Moved away|0|||
162105895|NCT02747238|585436973|FG000|Overall Study|Lack of Efficacy|0|||
162105896|NCT02747238|585436974|FG001|Overall Study|Lack of Efficacy|1|||
162105897|NCT02747238|585436973|FG000|Overall Study|Data lost|3|||
162105898|NCT02747238|585436974|FG001|Overall Study|Data lost|5|||
162105899|NCT01475136|585436978|FG000|Overall Study|Sponsor Decision|0|||
162105900|NCT01475136|585436979|FG001|Overall Study|Sponsor Decision|1|||
162105901|NCT01475136|585436980|FG002|Overall Study|Sponsor Decision|0|||
162105902|NCT01475136|585436981|FG003|Overall Study|Sponsor Decision|0|||
162105903|NCT01475136|585436978|FG000|Overall Study|Entry Criteria Not Met|0|||
162105904|NCT01475136|585436979|FG001|Overall Study|Entry Criteria Not Met|2|||
162105905|NCT01475136|585436980|FG002|Overall Study|Entry Criteria Not Met|3|||
162105906|NCT01475136|585436981|FG003|Overall Study|Entry Criteria Not Met|1|||
162105907|NCT01475136|585436978|FG000|Overall Study|Withdrawal by Subject|0|||
162105908|NCT01475136|585436979|FG001|Overall Study|Withdrawal by Subject|0|||
162105909|NCT01475136|585436980|FG002|Overall Study|Withdrawal by Subject|0|||
162105910|NCT01475136|585436981|FG003|Overall Study|Withdrawal by Subject|2|||
162105911|NCT01475136|585436978|FG000|Overall Study|Adverse Event|1|||
162105912|NCT01475136|585436979|FG001|Overall Study|Adverse Event|0|||
162105913|NCT01475136|585436980|FG002|Overall Study|Adverse Event|0|||
162105914|NCT01475136|585436981|FG003|Overall Study|Adverse Event|1|||
162105915|NCT01475136|585436978|FG000|Overall Study|Death|0|||
162105916|NCT01475136|585436979|FG001|Overall Study|Death|0|||
162105917|NCT01475136|585436980|FG002|Overall Study|Death|0|||
162105918|NCT01475136|585436981|FG003|Overall Study|Death|1|||
162105919|NCT01329029|585436982|FG000|Overall Study|Withdrawal by Subject|117|||
162105920|NCT01329029|585436983|FG001|Overall Study|Withdrawal by Subject|87|||
162105921|NCT01329029|585436982|FG000|Overall Study|Adverse Event|82|||
162105922|NCT01329029|585436983|FG001|Overall Study|Adverse Event|29|||
162105923|NCT01329029|585436982|FG000|Overall Study|Death|16|||
162105924|NCT01329029|585436983|FG001|Overall Study|Death|19|||
162105925|NCT01329029|585436982|FG000|Overall Study|Other|14|||
162105926|NCT01329029|585436983|FG001|Overall Study|Other|20|||
162105927|NCT01329029|585436982|FG000|Overall Study|COPD Exacerbation|11|||
162105928|NCT01329029|585436983|FG001|Overall Study|COPD Exacerbation|18|||
162105929|NCT01329029|585436982|FG000|Overall Study|Physician Decision|16|||
162105930|NCT01329029|585436983|FG001|Overall Study|Physician Decision|13|||
162105931|NCT01329029|585436982|FG000|Overall Study|Lost to Follow-up|8|||
162105932|NCT01329029|585436983|FG001|Overall Study|Lost to Follow-up|5|||
162105933|NCT01329029|585436982|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
162105934|NCT01329029|585436983|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
162105935|NCT01323530|585439511|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
162105936|NCT01323530|585439512|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162105937|NCT01323530|585439513|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162105938|NCT01323530|585439514|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162105939|NCT01323530|585439515|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162105940|NCT01323530|585439516|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
162105941|NCT01323530|585439517|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
162105942|NCT01323530|585439511|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
162105943|NCT01323530|585439512|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
162105944|NCT01323530|585439513|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
162105945|NCT01323530|585439514|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
162105946|NCT01323530|585439515|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
162105947|NCT01323530|585439516|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
162105948|NCT01323530|585439517|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
162105949|NCT01323530|585439511|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
162105950|NCT01323530|585439512|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
162105951|NCT01323530|585439513|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
162105952|NCT01323530|585439514|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
162105953|NCT01323530|585439515|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
162105954|NCT01323530|585439516|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
162105955|NCT01323530|585439517|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
162105956|NCT01323530|585439511|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
162105957|NCT01323530|585439512|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
162105958|NCT01323530|585439513|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
162105959|NCT01323530|585439514|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
162105960|NCT01323530|585439515|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
162105961|NCT01323530|585439516|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
162105962|NCT01323530|585439517|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
162105963|NCT01323530|585439511|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
162105964|NCT01323530|585439512|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
162105965|NCT01323530|585439513|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
162105966|NCT01323530|585439514|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
162105967|NCT01323530|585439515|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
162105968|NCT01323530|585439516|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
162105969|NCT01323530|585439517|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
162105970|NCT01323530|585439511|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
162105971|NCT01323530|585439512|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
162105972|NCT01323530|585439513|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
162105973|NCT01323530|585439514|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
162105974|NCT01323530|585439515|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
162105975|NCT01323530|585439516|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
162105976|NCT01323530|585439517|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
162105977|NCT01323530|585439511|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
162105978|NCT01323530|585439512|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
162105979|NCT01323530|585439513|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
162105980|NCT01323530|585439514|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
162105981|NCT01323530|585439515|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
162105982|NCT01323530|585439516|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
162105983|NCT01323530|585439517|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
162105984|NCT01323530|585439511|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
162105985|NCT01323530|585439512|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
162105986|NCT01323530|585439513|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
162105987|NCT01323530|585439514|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
162105988|NCT01323530|585439515|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
162105989|NCT01323530|585439516|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
162105990|NCT01323530|585439517|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
162105991|NCT01194570|585439520|FG000|Overall Study|Adverse Event|22|||
162105992|NCT01194570|585439521|FG001|Overall Study|Adverse Event|40|||
162105993|NCT01194570|585439520|FG000|Overall Study|Death|6|||
162105994|NCT01194570|585439521|FG001|Overall Study|Death|20|||
162105995|NCT01194570|585439520|FG000|Overall Study|Lack of Efficacy|32|||
162105996|NCT01194570|585439521|FG001|Overall Study|Lack of Efficacy|33|||
162105997|NCT01194570|585439520|FG000|Overall Study|Lost to Follow-up|4|||
162105998|NCT01194570|585439521|FG001|Overall Study|Lost to Follow-up|15|||
162105999|NCT01194570|585439520|FG000|Overall Study|Non-Compliance|2|||
162106000|NCT01194570|585439521|FG001|Overall Study|Non-Compliance|2|||
162106001|NCT01194570|585439520|FG000|Overall Study|Non-Compliance With Study Drug|2|||
162106002|NCT01194570|585439521|FG001|Overall Study|Non-Compliance With Study Drug|2|||
162106003|NCT01194570|585439520|FG000|Overall Study|Other|18|||
162106004|NCT01194570|585439521|FG001|Overall Study|Other|47|||
162106005|NCT01194570|585439520|FG000|Overall Study|Physician Decision|10|||
162106006|NCT01194570|585439521|FG001|Overall Study|Physician Decision|25|||
162106007|NCT01194570|585439520|FG000|Overall Study|Protocol Violation|1|||
162106008|NCT01194570|585439521|FG001|Overall Study|Protocol Violation|2|||
162106009|NCT01194570|585439520|FG000|Overall Study|Study Terminated By Sponsor|0|||
162106010|NCT01194570|585439521|FG001|Overall Study|Study Terminated By Sponsor|1|||
162106011|NCT01194570|585439520|FG000|Overall Study|Withdrawal by Subject|57|||
162106012|NCT01194570|585439521|FG001|Overall Study|Withdrawal by Subject|82|||
162106013|NCT01194570|585439520|FG000|Overall Study|Pregnancy|1|||
162106014|NCT01194570|585439521|FG001|Overall Study|Pregnancy|1|||
162106015|NCT01377480|585439528|FG000|Overall Study|Protocol Violation|0|||
162106016|NCT01377480|585439529|FG001|Overall Study|Protocol Violation|0|||
162106017|NCT01377480|585439530|FG002|Overall Study|Protocol Violation|0|||
162106018|NCT01377480|585439531|FG003|Overall Study|Protocol Violation|4|||
162106019|NCT01377480|585439528|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
162106020|NCT01377480|585439529|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
162106021|NCT01377480|585439530|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
162106022|NCT01377480|585439531|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
162106023|NCT01377480|585439528|FG000|Overall Study|Withdrawal by Subject|0|||
162106024|NCT01377480|585439529|FG001|Overall Study|Withdrawal by Subject|0|||
162106025|NCT01377480|585439530|FG002|Overall Study|Withdrawal by Subject|1|||
162106026|NCT01377480|585439531|FG003|Overall Study|Withdrawal by Subject|0|||
162106027|NCT01377480|585439528|FG000|Overall Study|Serious adverse event|0|||
162106028|NCT01377480|585439529|FG001|Overall Study|Serious adverse event|0|||
162106029|NCT01377480|585439530|FG002|Overall Study|Serious adverse event|1|||
162106030|NCT01377480|585439531|FG003|Overall Study|Serious adverse event|1|||
162106031|NCT01377480|585439528|FG000|Overall Study|Other|0|||
162106032|NCT01377480|585439529|FG001|Overall Study|Other|0|||
162106033|NCT01377480|585439530|FG002|Overall Study|Other|7|||
162106034|NCT01377480|585439531|FG003|Overall Study|Other|6|||
162106035|NCT01203930|585439536|FG000|Overall Study|Disease Progression|0|||
162106036|NCT01203930|585439537|FG001|Overall Study|Disease Progression|4|||
162106037|NCT01203930|585439536|FG000|Overall Study|Death|3|||
162106038|NCT01203930|585439537|FG001|Overall Study|Death|1|||
162106039|NCT01203930|585439536|FG000|Overall Study|Withdrew Consent|1|||
162106040|NCT01203930|585439537|FG001|Overall Study|Withdrew Consent|10|||
162106041|NCT01203930|585439536|FG000|Overall Study|Investigator Request|0|||
162106042|NCT01203930|585439537|FG001|Overall Study|Investigator Request|8|||
162106043|NCT01203930|585439536|FG000|Overall Study|Study Terminated by Sponsor|0|||
162106044|NCT01203930|585439537|FG001|Overall Study|Study Terminated by Sponsor|12|||
162106045|NCT01203930|585439536|FG000|Overall Study|Poor tolerance of study drug|0|||
162106046|NCT01203930|585439537|FG001|Overall Study|Poor tolerance of study drug|1|||
162106047|NCT01203930|585439536|FG000|Overall Study|Adverse Event|17|||
162106048|NCT01203930|585439537|FG001|Overall Study|Adverse Event|5|||
162106049|NCT01266850|585439538|FG000|Overall Study|Lost to Follow-up|19|||
162106050|NCT01266850|585439539|FG001|Overall Study|Lost to Follow-up|19|||
162106051|NCT01266850|585439540|FG002|Overall Study|Lost to Follow-up|13|||
162106052|NCT01266850|585439541|FG003|Overall Study|Lost to Follow-up|13|||
162106053|NCT01266850|585439542|FG004|Overall Study|Lost to Follow-up|12|||
162106054|NCT01266850|585439538|FG000|Overall Study|Withdrawal by Subject|8|||
162106055|NCT01266850|585439539|FG001|Overall Study|Withdrawal by Subject|9|||
162106056|NCT01266850|585439540|FG002|Overall Study|Withdrawal by Subject|6|||
162106057|NCT01266850|585439541|FG003|Overall Study|Withdrawal by Subject|9|||
162106058|NCT01266850|585439542|FG004|Overall Study|Withdrawal by Subject|12|||
162106059|NCT01266850|585439538|FG000|Overall Study|Physician Decision|3|||
162106060|NCT01266850|585439539|FG001|Overall Study|Physician Decision|6|||
162106061|NCT01266850|585439540|FG002|Overall Study|Physician Decision|4|||
162106062|NCT01266850|585439541|FG003|Overall Study|Physician Decision|4|||
162106063|NCT01266850|585439542|FG004|Overall Study|Physician Decision|3|||
162106064|NCT01266850|585439538|FG000|Overall Study|Protocol Violation|0|||
162106065|NCT01266850|585439539|FG001|Overall Study|Protocol Violation|1|||
162106066|NCT01266850|585439540|FG002|Overall Study|Protocol Violation|0|||
162106067|NCT01266850|585439541|FG003|Overall Study|Protocol Violation|1|||
162106068|NCT01266850|585439542|FG004|Overall Study|Protocol Violation|2|||
162106069|NCT01266850|585439538|FG000|Overall Study|Adverse Event|0|||
162106070|NCT01266850|585439539|FG001|Overall Study|Adverse Event|0|||
162106071|NCT01266850|585439540|FG002|Overall Study|Adverse Event|0|||
162106072|NCT01266850|585439541|FG003|Overall Study|Adverse Event|0|||
162106073|NCT01266850|585439542|FG004|Overall Study|Adverse Event|1|||
162106074|NCT01266850|585439538|FG000|Overall Study|Site Closure|0|||
162106075|NCT01266850|585439539|FG001|Overall Study|Site Closure|1|||
162106076|NCT01266850|585439540|FG002|Overall Study|Site Closure|1|||
162106077|NCT01266850|585439541|FG003|Overall Study|Site Closure|1|||
162106078|NCT01266850|585439542|FG004|Overall Study|Site Closure|0|||
162106079|NCT04098406|585439546|FG000|Overall Study|Adverse Event|2|||
162106080|NCT04098406|585439547|FG001|Overall Study|Adverse Event|1|||
162106081|NCT04098406|585439546|FG000|Overall Study|Withdrawal by Subject|1|||
162106082|NCT04098406|585439547|FG001|Overall Study|Withdrawal by Subject|0|||
162106083|NCT03382782|585439550|FG000|Cohort 1|Withdrawal by Subject|11|||
162106084|NCT03382782|585439551|FG001|Cohort 1|Withdrawal by Subject|5|||
162106085|NCT03382782|585439552|FG002|Cohort 1|Withdrawal by Subject|0|||
162106086|NCT03382782|585439550|FG000|Cohort 2|Withdrawal by Subject|1|||
162106087|NCT03382782|585439551|FG001|Cohort 2|Withdrawal by Subject|1|||
162106088|NCT03382782|585439552|FG002|Cohort 2|Withdrawal by Subject|0|||
162106089|NCT03382782|585439550|FG000|Cohort 3|Withdrawal by Subject|1|||
162106090|NCT03382782|585439551|FG001|Cohort 3|Withdrawal by Subject|2|||
162106091|NCT03382782|585439552|FG002|Cohort 3|Withdrawal by Subject|0|||
162106092|NCT00428090|585439557|FG000|Overall Study|Adverse Event|10|||
162106093|NCT00428090|585439558|FG001|Overall Study|Adverse Event|8|||
162106094|NCT00428090|585439559|FG002|Overall Study|Adverse Event|10|||
162106095|NCT00428090|585439560|FG003|Overall Study|Adverse Event|11|||
162106096|NCT00428090|585439557|FG000|Overall Study|Lost to Follow-up|3|||
162106097|NCT00428090|585439558|FG001|Overall Study|Lost to Follow-up|6|||
162106098|NCT00428090|585439559|FG002|Overall Study|Lost to Follow-up|1|||
162106099|NCT00428090|585439560|FG003|Overall Study|Lost to Follow-up|4|||
162106100|NCT00428090|585439557|FG000|Overall Study|Protocol Violation|3|||
162106101|NCT00428090|585439558|FG001|Overall Study|Protocol Violation|1|||
162106102|NCT00428090|585439559|FG002|Overall Study|Protocol Violation|3|||
162106103|NCT00428090|585439560|FG003|Overall Study|Protocol Violation|3|||
162106104|NCT00428090|585439557|FG000|Overall Study|Withdrawal by Subject|10|||
162106105|NCT00428090|585439558|FG001|Overall Study|Withdrawal by Subject|12|||
162106106|NCT00428090|585439559|FG002|Overall Study|Withdrawal by Subject|15|||
162106107|NCT00428090|585439560|FG003|Overall Study|Withdrawal by Subject|5|||
162106108|NCT00428090|585439557|FG000|Overall Study|Sponsor terminated study|0|||
162106109|NCT00428090|585439558|FG001|Overall Study|Sponsor terminated study|1|||
162106110|NCT00428090|585439559|FG002|Overall Study|Sponsor terminated study|0|||
162106111|NCT00428090|585439560|FG003|Overall Study|Sponsor terminated study|0|||
162106112|NCT00428090|585439557|FG000|Overall Study|Non-compliance|4|||
162106113|NCT00428090|585439558|FG001|Overall Study|Non-compliance|0|||
162106114|NCT00428090|585439559|FG002|Overall Study|Non-compliance|1|||
162106115|NCT00428090|585439560|FG003|Overall Study|Non-compliance|3|||
162106116|NCT00428090|585439557|FG000|Overall Study|Par. did not returned to visit|1|||
162106117|NCT00428090|585439558|FG001|Overall Study|Par. did not returned to visit|0|||
162106118|NCT00428090|585439559|FG002|Overall Study|Par. did not returned to visit|0|||
162106119|NCT00428090|585439560|FG003|Overall Study|Par. did not returned to visit|1|||
162106120|NCT00428090|585439557|FG000|Overall Study|Follow-Up visit not possible|1|||
162106121|NCT00428090|585439558|FG001|Overall Study|Follow-Up visit not possible|0|||
162106122|NCT00428090|585439559|FG002|Overall Study|Follow-Up visit not possible|0|||
162106123|NCT00428090|585439560|FG003|Overall Study|Follow-Up visit not possible|0|||
162106124|NCT00428090|585439557|FG000|Overall Study|Prohibited medication used for SAE|1|||
162106125|NCT00428090|585439558|FG001|Overall Study|Prohibited medication used for SAE|0|||
162106126|NCT00428090|585439559|FG002|Overall Study|Prohibited medication used for SAE|0|||
162106127|NCT00428090|585439560|FG003|Overall Study|Prohibited medication used for SAE|0|||
162106128|NCT00428090|585439557|FG000|Overall Study|Death of par.|1|||
162106129|NCT00428090|585439558|FG001|Overall Study|Death of par.|0|||
162106130|NCT00428090|585439559|FG002|Overall Study|Death of par.|1|||
162106131|NCT00428090|585439560|FG003|Overall Study|Death of par.|0|||
162106132|NCT00428090|585439557|FG000|Overall Study|Visit 7 exceed the visit window|0|||
162106133|NCT00428090|585439558|FG001|Overall Study|Visit 7 exceed the visit window|1|||
162106134|NCT00428090|585439559|FG002|Overall Study|Visit 7 exceed the visit window|0|||
162106135|NCT00428090|585439560|FG003|Overall Study|Visit 7 exceed the visit window|0|||
162106136|NCT00428090|585439557|FG000|Overall Study|Medical monitor terminated par.|0|||
162106137|NCT00428090|585439558|FG001|Overall Study|Medical monitor terminated par.|1|||
162106138|NCT00428090|585439559|FG002|Overall Study|Medical monitor terminated par.|0|||
162106139|NCT00428090|585439560|FG003|Overall Study|Medical monitor terminated par.|0|||
162106140|NCT00428090|585439557|FG000|Overall Study|Mental status of par. was|0|||
162106141|NCT00428090|585439558|FG001|Overall Study|Mental status of par. was|1|||
162106142|NCT00428090|585439559|FG002|Overall Study|Mental status of par. was|0|||
162106143|NCT00428090|585439560|FG003|Overall Study|Mental status of par. was|0|||
162106144|NCT00428090|585439557|FG000|Overall Study|Worsening of AD|0|||
162106145|NCT00428090|585439558|FG001|Overall Study|Worsening of AD|0|||
162106146|NCT00428090|585439559|FG002|Overall Study|Worsening of AD|1|||
162106147|NCT00428090|585439560|FG003|Overall Study|Worsening of AD|0|||
162106148|NCT00428090|585439557|FG000|Overall Study|Excluded for concerning QTc value|0|||
162106149|NCT00428090|585439558|FG001|Overall Study|Excluded for concerning QTc value|0|||
162106150|NCT00428090|585439559|FG002|Overall Study|Excluded for concerning QTc value|1|||
162106151|NCT00428090|585439560|FG003|Overall Study|Excluded for concerning QTc value|0|||
162106152|NCT00428090|585439557|FG000|Overall Study|Insufficient AD documentation|0|||
162106153|NCT00428090|585439558|FG001|Overall Study|Insufficient AD documentation|0|||
162106154|NCT00428090|585439559|FG002|Overall Study|Insufficient AD documentation|1|||
162106155|NCT00428090|585439560|FG003|Overall Study|Insufficient AD documentation|0|||
162106156|NCT00428090|585439557|FG000|Overall Study|High MMSE scores|0|||
162106157|NCT00428090|585439558|FG001|Overall Study|High MMSE scores|0|||
162106158|NCT00428090|585439559|FG002|Overall Study|High MMSE scores|1|||
162106159|NCT00428090|585439560|FG003|Overall Study|High MMSE scores|0|||
162106160|NCT00428090|585439557|FG000|Overall Study|Deterioration of cognitive status|0|||
162106161|NCT00428090|585439558|FG001|Overall Study|Deterioration of cognitive status|0|||
162106162|NCT00428090|585439559|FG002|Overall Study|Deterioration of cognitive status|1|||
162106163|NCT00428090|585439560|FG003|Overall Study|Deterioration of cognitive status|0|||
162106164|NCT00428090|585439557|FG000|Overall Study|Serious adverse event|0|||
162106165|NCT00428090|585439558|FG001|Overall Study|Serious adverse event|0|||
162106166|NCT00428090|585439559|FG002|Overall Study|Serious adverse event|1|||
162106167|NCT00428090|585439560|FG003|Overall Study|Serious adverse event|0|||
162106168|NCT00428090|585439557|FG000|Overall Study|Excluded for heart insufficiency|0|||
162106169|NCT00428090|585439558|FG001|Overall Study|Excluded for heart insufficiency|0|||
162106170|NCT00428090|585439559|FG002|Overall Study|Excluded for heart insufficiency|1|||
162106171|NCT00428090|585439560|FG003|Overall Study|Excluded for heart insufficiency|0|||
162106172|NCT00428090|585439557|FG000|Overall Study|Raised Creatinine Value|0|||
162106173|NCT00428090|585439558|FG001|Overall Study|Raised Creatinine Value|0|||
162106174|NCT00428090|585439559|FG002|Overall Study|Raised Creatinine Value|0|||
162106175|NCT00428090|585439560|FG003|Overall Study|Raised Creatinine Value|1|||
162106176|NCT03409666|585439561|FG000|Overall Study|Physician Decision|0|||
162106177|NCT03409666|585439562|FG001|Overall Study|Physician Decision|1|||
162106178|NCT03409666|585439561|FG000|Overall Study|Protocol Violation|0|||
162106179|NCT03409666|585439562|FG001|Overall Study|Protocol Violation|3|||
162106180|NCT00512148|585439566|FG000|Primay Study Period|Withdrawal by Subject|1|||
162106181|NCT02623322|585439567|FG000|Overall Study|Lost to Follow-up|2|||
162106182|NCT02623322|585439568|FG001|Overall Study|Lost to Follow-up|1|||
162106183|NCT02623322|585439569|FG002|Overall Study|Lost to Follow-up|0|||
162106184|NCT03104699|585439570|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
162106185|NCT03104699|585439571|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
162106186|NCT03104699|585439572|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
162106187|NCT03104699|585439573|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
162106188|NCT03104699|585439574|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
162106189|NCT03104699|585439575|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
162106190|NCT03104699|585439570|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
162106191|NCT03104699|585439571|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
162106192|NCT03104699|585439572|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
162106193|NCT03104699|585439573|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
162106194|NCT03104699|585439574|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
162106195|NCT03104699|585439575|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
162106196|NCT03104699|585439570|FG000|Phase 1: Dose Escalation|Death|6|||
162106197|NCT03104699|585439571|FG001|Phase 1: Dose Escalation|Death|3|||
162106198|NCT03104699|585439572|FG002|Phase 1: Dose Escalation|Death|0|||
162106199|NCT03104699|585439573|FG003|Phase 1: Dose Escalation|Death|1|||
162106200|NCT03104699|585439574|FG004|Phase 1: Dose Escalation|Death|1|||
162106201|NCT03104699|585439575|FG005|Phase 1: Dose Escalation|Death|0|||
162106202|NCT03104699|585439570|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
162106203|NCT03104699|585439571|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
162106204|NCT03104699|585439572|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
162106205|NCT03104699|585439573|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
162106206|NCT03104699|585439574|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
162106207|NCT03104699|585439575|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
162106208|NCT03104699|585439570|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
162106209|NCT03104699|585439571|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
162106210|NCT03104699|585439572|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
162106211|NCT03104699|585439573|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
162106212|NCT03104699|585439574|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
162106213|NCT03104699|585439575|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
162106214|NCT03104699|585439570|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
162106215|NCT03104699|585439571|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
162106216|NCT03104699|585439572|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
162106217|NCT03104699|585439573|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
162106218|NCT03104699|585439574|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
162106219|NCT03104699|585439575|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
162106220|NCT03104699|585439570|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
162106221|NCT03104699|585439571|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
162106222|NCT03104699|585439572|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
162106223|NCT03104699|585439573|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
162106224|NCT03104699|585439574|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
162106225|NCT03104699|585439575|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
162106226|NCT03104699|585439570|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
162106227|NCT03104699|585439571|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
162106228|NCT03104699|585439572|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
162106229|NCT03104699|585439573|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
162106230|NCT03104699|585439574|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
162106231|NCT03104699|585439575|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
162106232|NCT03104699|585439570|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162106233|NCT03104699|585439571|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162106234|NCT03104699|585439572|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162106235|NCT03104699|585439573|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162106236|NCT03104699|585439574|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
162106237|NCT03104699|585439575|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
162106238|NCT03104699|585439570|FG000|Phase 2: Dose Expansion|Death|0|||
162106239|NCT03104699|585439571|FG001|Phase 2: Dose Expansion|Death|0|||
162106240|NCT03104699|585439572|FG002|Phase 2: Dose Expansion|Death|0|||
162106241|NCT03104699|585439573|FG003|Phase 2: Dose Expansion|Death|0|||
162106242|NCT03104699|585439574|FG004|Phase 2: Dose Expansion|Death|0|||
162106243|NCT03104699|585439575|FG005|Phase 2: Dose Expansion|Death|107|||
162106244|NCT03104699|585439570|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
162106245|NCT03104699|585439571|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
162106246|NCT03104699|585439572|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
162106247|NCT03104699|585439573|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
162106248|NCT03104699|585439574|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
162106249|NCT03104699|585439575|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
162106250|NCT03104699|585439570|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
162106251|NCT03104699|585439571|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
162106252|NCT03104699|585439572|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
162106253|NCT03104699|585439573|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
162106254|NCT03104699|585439574|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
162106255|NCT03104699|585439575|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
162106256|NCT03104699|585439570|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162106257|NCT03104699|585439571|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162106258|NCT03104699|585439572|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162106259|NCT03104699|585439573|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162106260|NCT03104699|585439574|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
162106261|NCT03104699|585439575|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
162106262|NCT03104699|585439570|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
162106263|NCT03104699|585439571|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
162106264|NCT03104699|585439572|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
162106265|NCT03104699|585439573|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
162106266|NCT03104699|585439574|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
162106267|NCT03104699|585439575|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
162106268|NCT02450331|585439576|FG000|Overall Study|Death|162|||
162106269|NCT02450331|585439577|FG001|Overall Study|Death|171|||
162106270|NCT02450331|585439576|FG000|Overall Study|Lost to Follow-up|14|||
162106271|NCT02450331|585439577|FG001|Overall Study|Lost to Follow-up|12|||
162106272|NCT02450331|585439576|FG000|Overall Study|Withdrawal by Subject|55|||
162106273|NCT02450331|585439577|FG001|Overall Study|Withdrawal by Subject|44|||
162106274|NCT02450331|585439576|FG000|Overall Study|Non-specified other|1|||
162106275|NCT02450331|585439577|FG001|Overall Study|Non-specified other|1|||
162106276|NCT02080871|585439578|FG000|Overall Study|Death|1|||
162106277|NCT02080871|585439578|FG000|Overall Study|Lost to Follow-up|1|||
162106278|NCT00234052|585439579|FG000|Treatment|Withdrawal by Subject|3|||
162106279|NCT00234052|585439579|FG000|Treatment|Adverse Event|5|||
162106280|NCT00234052|585439579|FG000|Treatment|Death|2|||
162106281|NCT00234052|585439579|FG000|Treatment|Progressive Disease|11|||
162106282|NCT00234052|585439579|FG000|Follow-up for 5 Years|Death|41|||
162106283|NCT00234052|585439579|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
162106284|NCT00234052|585439579|FG000|Follow-up for 5 Years|Other|7|||
162106285|NCT01410474|585439580|FG000|Overall Study|Withdrawal by Subject|0|||
162106286|NCT01410474|585439581|FG001|Overall Study|Withdrawal by Subject|1|||
162106287|NCT02428296|585439582|FG000|Overall Study|Adverse Event|7|||
162106288|NCT02428296|585439582|FG000|Overall Study|Withdrawal by Subject|2|||
162106289|NCT04493931|585439586|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
162106290|NCT04493931|585439587|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
162106291|NCT04493931|585439588|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
162106292|NCT04493931|585439589|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
162106293|NCT04493931|585439590|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
162106294|NCT04493931|585439591|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
162106295|NCT04493931|585439592|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
162106296|NCT04493931|585439586|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
162106297|NCT04493931|585439587|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
162106298|NCT04493931|585439588|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
162106299|NCT04493931|585439589|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
162106300|NCT04493931|585439590|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
162106301|NCT04493931|585439591|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
162106302|NCT04493931|585439592|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
162106303|NCT04493931|585439586|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
162106304|NCT04493931|585439587|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
162106305|NCT04493931|585439588|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
162106306|NCT04493931|585439589|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
162106307|NCT04493931|585439590|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
162106308|NCT04493931|585439591|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
162106309|NCT04493931|585439592|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
162106310|NCT04493931|585439586|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
162106311|NCT04493931|585439587|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
162106312|NCT04493931|585439588|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
162106313|NCT04493931|585439589|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
162106314|NCT04493931|585439590|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
162106315|NCT04493931|585439591|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
162106316|NCT04493931|585439592|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
162106317|NCT03338894|585439593|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
162106318|NCT00420199|585439595|FG000|Overall Study|Participant no longer met study criteria|1|||
162106319|NCT00420199|585439596|FG001|Overall Study|Participant no longer met study criteria|0|||
162106320|NCT02261493|585439597|FG000|Overall Study|Noncompliance|0|||
162106321|NCT02261493|585439598|FG001|Overall Study|Noncompliance|0|||
162106322|NCT02261493|585439599|FG002|Overall Study|Noncompliance|2|||
162106323|NCT02261493|585439597|FG000|Overall Study|Physician Decision|0|||
162106324|NCT02261493|585439598|FG001|Overall Study|Physician Decision|1|||
162106325|NCT02261493|585439599|FG002|Overall Study|Physician Decision|0|||
162106326|NCT02261493|585439597|FG000|Overall Study|Undisclosed alcohol abuse|0|||
162106327|NCT02261493|585439598|FG001|Overall Study|Undisclosed alcohol abuse|1|||
162106328|NCT02261493|585439599|FG002|Overall Study|Undisclosed alcohol abuse|0|||
162106329|NCT02261493|585439597|FG000|Overall Study|Protocol Violation|1|||
162106330|NCT02261493|585439598|FG001|Overall Study|Protocol Violation|0|||
162106331|NCT02261493|585439599|FG002|Overall Study|Protocol Violation|0|||
162106332|NCT02261493|585439597|FG000|Overall Study|Personal Reasons|14|||
162106333|NCT02261493|585439598|FG001|Overall Study|Personal Reasons|14|||
162106334|NCT02261493|585439599|FG002|Overall Study|Personal Reasons|16|||
162106335|NCT02261493|585439597|FG000|Overall Study|Lost to Follow-up|14|||
162106336|NCT02261493|585439598|FG001|Overall Study|Lost to Follow-up|27|||
162106337|NCT02261493|585439599|FG002|Overall Study|Lost to Follow-up|8|||
162106338|NCT02261493|585439597|FG000|Overall Study|Pregnancy|1|||
162106339|NCT02261493|585439598|FG001|Overall Study|Pregnancy|2|||
162106340|NCT02261493|585439599|FG002|Overall Study|Pregnancy|0|||
162106341|NCT02261493|585439597|FG000|Overall Study|Lack of Efficacy|0|||
162106342|NCT02261493|585439598|FG001|Overall Study|Lack of Efficacy|1|||
162106343|NCT02261493|585439599|FG002|Overall Study|Lack of Efficacy|0|||
162106344|NCT02261493|585439597|FG000|Overall Study|Adverse Event|0|||
162106345|NCT02261493|585439598|FG001|Overall Study|Adverse Event|1|||
162106346|NCT02261493|585439599|FG002|Overall Study|Adverse Event|0|||
162106347|NCT00558428|585439600|FG000|Overall Study|Adverse Event|6|||
162106348|NCT00558428|585439601|FG001|Overall Study|Adverse Event|22|||
162106349|NCT00558428|585439602|FG002|Overall Study|Adverse Event|3|||
162106350|NCT00558428|585439603|FG003|Overall Study|Adverse Event|4|||
162106351|NCT00558428|585439600|FG000|Overall Study|Lost to Follow-up|0|||
162106352|NCT00558428|585439601|FG001|Overall Study|Lost to Follow-up|1|||
162106353|NCT00558428|585439602|FG002|Overall Study|Lost to Follow-up|0|||
162106354|NCT00558428|585439603|FG003|Overall Study|Lost to Follow-up|0|||
162106355|NCT00558428|585439600|FG000|Overall Study|Lack of Efficacy|0|||
162106356|NCT00558428|585439601|FG001|Overall Study|Lack of Efficacy|0|||
162106357|NCT00558428|585439602|FG002|Overall Study|Lack of Efficacy|1|||
162106358|NCT00558428|585439603|FG003|Overall Study|Lack of Efficacy|2|||
162106359|NCT00558428|585439600|FG000|Overall Study|Non compliant with protocol|1|||
162106360|NCT00558428|585439601|FG001|Overall Study|Non compliant with protocol|0|||
162106361|NCT00558428|585439602|FG002|Overall Study|Non compliant with protocol|0|||
162106362|NCT00558428|585439603|FG003|Overall Study|Non compliant with protocol|3|||
162106363|NCT00558428|585439600|FG000|Overall Study|Consent withdrawn|2|||
162106364|NCT00558428|585439601|FG001|Overall Study|Consent withdrawn|1|||
162106365|NCT00558428|585439602|FG002|Overall Study|Consent withdrawn|0|||
162106366|NCT00558428|585439603|FG003|Overall Study|Consent withdrawn|1|||
162106367|NCT00558428|585439600|FG000|Overall Study|Other|3|||
162106368|NCT00558428|585439601|FG001|Overall Study|Other|0|||
162106369|NCT00558428|585439602|FG002|Overall Study|Other|0|||
162106370|NCT00558428|585439603|FG003|Overall Study|Other|1|||
162106371|NCT00754338|585439604|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
162106372|NCT00754338|585439605|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
162106373|NCT00754338|585439606|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
162106374|NCT00754338|585439607|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
162106375|NCT00754338|585439604|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
162106376|NCT00754338|585439605|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
162106377|NCT00754338|585439606|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
162106378|NCT00754338|585439607|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
162106379|NCT00831779|585439610|FG000|Overall Study|Lost to Follow-up|1|||
162106380|NCT00831779|585439611|FG001|Overall Study|Lost to Follow-up|0|||
162106381|NCT00831779|585439610|FG000|Overall Study|No longer met criteria|0|||
162106382|NCT00831779|585439611|FG001|Overall Study|No longer met criteria|1|||
162106383|NCT04020341|585439612|FG000|Overall Study|Adverse Event|8|||
162106384|NCT04020341|585439613|FG001|Overall Study|Adverse Event|6|||
162106385|NCT04020341|585439612|FG000|Overall Study|Lost to Follow-up|8|||
162106386|NCT04020341|585439613|FG001|Overall Study|Lost to Follow-up|2|||
162106387|NCT04020341|585439612|FG000|Overall Study|Withdrawal by Subject|16|||
162106388|NCT04020341|585439613|FG001|Overall Study|Withdrawal by Subject|16|||
162106389|NCT04020341|585439612|FG000|Overall Study|Participant not able to swallow the tablet|1|||
162106390|NCT04020341|585439613|FG001|Overall Study|Participant not able to swallow the tablet|0|||
162106391|NCT04020341|585439612|FG000|Overall Study|Physician Decision|0|||
162106392|NCT04020341|585439613|FG001|Overall Study|Physician Decision|2|||
162106393|NCT04020341|585439612|FG000|Overall Study|Protocol Deviation|0|||
162106394|NCT04020341|585439613|FG001|Overall Study|Protocol Deviation|2|||
162106395|NCT04528069|585439614|FG000|Overall Study|Adverse Event|1|||
162106396|NCT04528069|585439614|FG000|Overall Study|Lost to Follow-up|1|||
162106397|NCT04528069|585439614|FG000|Overall Study|Patient Unable to Come|1|||
162106398|NCT04528069|585439614|FG000|Overall Study|Patient Unable to Attend|1|||
162106399|NCT01814371|585439616|FG000|Overall Study|Lost to Follow-up|30|||
162106400|NCT01814371|585439617|FG001|Overall Study|Lost to Follow-up|27|||
162106401|NCT04683926|585439618|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
162106402|NCT04683926|585439619|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
162106403|NCT04683926|585439620|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
162106404|NCT04683926|585439621|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
162106405|NCT01692782|585439623|FG000|Overall Study|Adverse Event|12|||
162106406|NCT01692782|585439624|FG001|Overall Study|Adverse Event|32|||
162106407|NCT01692782|585439625|FG002|Overall Study|Adverse Event|2|||
162106408|NCT01692782|585439623|FG000|Overall Study|Lack of Efficacy|1|||
162106409|NCT01692782|585439624|FG001|Overall Study|Lack of Efficacy|2|||
162106410|NCT01692782|585439625|FG002|Overall Study|Lack of Efficacy|0|||
162106411|NCT01692782|585439623|FG000|Overall Study|Lost to Follow-up|2|||
162106412|NCT01692782|585439624|FG001|Overall Study|Lost to Follow-up|7|||
162106413|NCT01692782|585439625|FG002|Overall Study|Lost to Follow-up|1|||
162106414|NCT01692782|585439623|FG000|Overall Study|Pregnancy|1|||
162106415|NCT01692782|585439624|FG001|Overall Study|Pregnancy|0|||
162106416|NCT01692782|585439625|FG002|Overall Study|Pregnancy|0|||
162106417|NCT01692782|585439623|FG000|Overall Study|Protocol Violation|1|||
162106418|NCT01692782|585439624|FG001|Overall Study|Protocol Violation|0|||
162106419|NCT01692782|585439625|FG002|Overall Study|Protocol Violation|2|||
162106420|NCT01692782|585439623|FG000|Overall Study|Non-complance with study drug|0|||
162106421|NCT01692782|585439624|FG001|Overall Study|Non-complance with study drug|4|||
162106422|NCT01692782|585439625|FG002|Overall Study|Non-complance with study drug|1|||
162106423|NCT01692782|585439623|FG000|Overall Study|Non-compliant with study visits|0|||
162106424|NCT01692782|585439624|FG001|Overall Study|Non-compliant with study visits|0|||
162106425|NCT01692782|585439625|FG002|Overall Study|Non-compliant with study visits|1|||
162106426|NCT01692782|585439623|FG000|Overall Study|SAE not related to study drug|0|||
162106427|NCT01692782|585439624|FG001|Overall Study|SAE not related to study drug|1|||
162106428|NCT01692782|585439625|FG002|Overall Study|SAE not related to study drug|0|||
162106429|NCT01692782|585439623|FG000|Overall Study|Withdrawal by Subject|3|||
162106430|NCT01692782|585439624|FG001|Overall Study|Withdrawal by Subject|10|||
162106431|NCT01692782|585439625|FG002|Overall Study|Withdrawal by Subject|3|||
162106432|NCT00952367|585439634|FG000|Overall Study|Withdrawal by Subject|2|||
162106433|NCT00952367|585439634|FG000|Overall Study|Noncoordination|1|||
162106434|NCT00952367|585439634|FG000|Overall Study|Protocol Violation|3|||
162106435|NCT05072080|585439637|FG000|Overall Study|Death|0|||
162106436|NCT05072080|585439638|FG001|Overall Study|Death|0|||
162106437|NCT05072080|585439639|FG002|Overall Study|Death|1|||
162106438|NCT05072080|585439640|FG003|Overall Study|Death|0|||
162106439|NCT05072080|585439637|FG000|Overall Study|Lost to Follow-up|65|||
162106440|NCT05072080|585439638|FG001|Overall Study|Lost to Follow-up|70|||
162106441|NCT05072080|585439639|FG002|Overall Study|Lost to Follow-up|58|||
162106442|NCT05072080|585439640|FG003|Overall Study|Lost to Follow-up|23|||
162106443|NCT05072080|585439637|FG000|Overall Study|Physician Decision|2|||
162106444|NCT05072080|585439638|FG001|Overall Study|Physician Decision|1|||
162106445|NCT05072080|585439639|FG002|Overall Study|Physician Decision|1|||
162106446|NCT05072080|585439640|FG003|Overall Study|Physician Decision|0|||
162106447|NCT05072080|585439637|FG000|Overall Study|Withdrawal by Subject|45|||
162106448|NCT05072080|585439638|FG001|Overall Study|Withdrawal by Subject|30|||
162106449|NCT05072080|585439639|FG002|Overall Study|Withdrawal by Subject|27|||
162106450|NCT05072080|585439640|FG003|Overall Study|Withdrawal by Subject|7|||
162106451|NCT05072080|585439637|FG000|Overall Study|Sponsor Decision|0|||
162106452|NCT05072080|585439638|FG001|Overall Study|Sponsor Decision|1|||
162106453|NCT05072080|585439639|FG002|Overall Study|Sponsor Decision|0|||
162106454|NCT05072080|585439640|FG003|Overall Study|Sponsor Decision|0|||
162106455|NCT05072080|585439637|FG000|Overall Study|Subject moved|1|||
162106456|NCT05072080|585439638|FG001|Overall Study|Subject moved|3|||
162106457|NCT05072080|585439639|FG002|Overall Study|Subject moved|5|||
162106458|NCT05072080|585439640|FG003|Overall Study|Subject moved|2|||
162106459|NCT05072080|585439637|FG000|Overall Study|Withdrawal by parent|0|||
162106460|NCT05072080|585439638|FG001|Overall Study|Withdrawal by parent|0|||
162106461|NCT05072080|585439639|FG002|Overall Study|Withdrawal by parent|1|||
162106462|NCT05072080|585439640|FG003|Overall Study|Withdrawal by parent|0|||
162106463|NCT05072080|585439637|FG000|Overall Study|Subject was deployed|0|||
162106464|NCT05072080|585439638|FG001|Overall Study|Subject was deployed|1|||
162106465|NCT05072080|585439639|FG002|Overall Study|Subject was deployed|0|||
162106466|NCT05072080|585439640|FG003|Overall Study|Subject was deployed|0|||
162106467|NCT05072080|585439637|FG000|Overall Study|Subject left site without receiving dose|0|||
162106468|NCT05072080|585439638|FG001|Overall Study|Subject left site without receiving dose|1|||
162106469|NCT05072080|585439639|FG002|Overall Study|Subject left site without receiving dose|0|||
162106470|NCT05072080|585439640|FG003|Overall Study|Subject left site without receiving dose|0|||
162106471|NCT05072080|585439637|FG000|Overall Study|Subject incarcerated|0|||
162106472|NCT05072080|585439638|FG001|Overall Study|Subject incarcerated|1|||
162106473|NCT05072080|585439639|FG002|Overall Study|Subject incarcerated|0|||
162106474|NCT05072080|585439640|FG003|Overall Study|Subject incarcerated|1|||
162106475|NCT05072080|585439637|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
162106476|NCT05072080|585439638|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
162106477|NCT05072080|585439639|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
162106478|NCT05072080|585439640|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
162106479|NCT05072080|585439637|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
162106480|NCT05072080|585439638|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
162106481|NCT05072080|585439639|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
162106482|NCT05072080|585439640|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
162106483|NCT02300220|585439651|FG000|Overall Study|Lost to Follow-up|1|||
162106484|NCT02300220|585439652|FG001|Overall Study|Lost to Follow-up|2|||
162106485|NCT02300220|585439651|FG000|Overall Study|Death|1|||
162106486|NCT02300220|585439652|FG001|Overall Study|Death|1|||
162106487|NCT02300220|585439651|FG000|Overall Study|Adverse Event|1|||
162106488|NCT02300220|585439652|FG001|Overall Study|Adverse Event|1|||
162106489|NCT02300220|585439651|FG000|Overall Study|Protocol Violation|1|||
162106490|NCT02300220|585439652|FG001|Overall Study|Protocol Violation|0|||
162106491|NCT02300220|585439651|FG000|Overall Study|Withdrawal by Subject|0|||
162106492|NCT02300220|585439652|FG001|Overall Study|Withdrawal by Subject|2|||
162106493|NCT02300220|585439651|FG000|Overall Study|Did not tolerate IMP|0|||
162106494|NCT02300220|585439652|FG001|Overall Study|Did not tolerate IMP|1|||
162106495|NCT04322682|585439653|FG000|Overall Study|Withdrawal by Subject|33|||
162106496|NCT04322682|585439654|FG001|Overall Study|Withdrawal by Subject|47|||
162106497|NCT04322682|585439653|FG000|Overall Study|Death|5|||
162106498|NCT04322682|585439654|FG001|Overall Study|Death|9|||
162106499|NCT04322682|585439653|FG000|Overall Study|Lost to Follow-up|4|||
162106500|NCT04322682|585439654|FG001|Overall Study|Lost to Follow-up|8|||
162106501|NCT04322682|585439653|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
162106502|NCT04322682|585439654|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
162106503|NCT04123067|585439655|FG000|Overall Study|Lost to Follow-up|0|||
162106504|NCT04123067|585439656|FG001|Overall Study|Lost to Follow-up|1|||
162106505|NCT02238379|585439657|FG000|Overall Study|Lost to Follow-up|1|||
162106506|NCT02238379|585439658|FG001|Overall Study|Lost to Follow-up|0|||
162106507|NCT03085485|585439659|FG000|Overall Study|Death|1|||
162106508|NCT03085485|585439660|FG001|Overall Study|Death|0|||
162106509|NCT03085485|585439659|FG000|Overall Study|Lost to Follow-up|1|||
162106510|NCT03085485|585439660|FG001|Overall Study|Lost to Follow-up|0|||
162106511|NCT00605280|585439661|FG000|Year 1|Protocol Violation|0|||
162106512|NCT00605280|585439662|FG001|Year 1|Protocol Violation|0|||
162106513|NCT00605280|585439663|FG002|Year 1|Protocol Violation|0|||
162106514|NCT00605280|585439664|FG003|Year 1|Protocol Violation|1|||
162106515|NCT00605280|585439661|FG000|Year 1|Adverse Event|3|||
162106516|NCT00605280|585439662|FG001|Year 1|Adverse Event|1|||
162106517|NCT00605280|585439663|FG002|Year 1|Adverse Event|1|||
162106518|NCT00605280|585439664|FG003|Year 1|Adverse Event|5|||
162106519|NCT00605280|585439661|FG000|Year 1|Physician Decision|7|||
162106520|NCT00605280|585439662|FG001|Year 1|Physician Decision|4|||
162106521|NCT00605280|585439663|FG002|Year 1|Physician Decision|0|||
162106522|NCT00605280|585439664|FG003|Year 1|Physician Decision|6|||
162106523|NCT00605280|585439661|FG000|Year 1|Withdrawal by Subject|2|||
162106524|NCT00605280|585439662|FG001|Year 1|Withdrawal by Subject|4|||
162106525|NCT00605280|585439663|FG002|Year 1|Withdrawal by Subject|0|||
162106526|NCT00605280|585439664|FG003|Year 1|Withdrawal by Subject|4|||
162106527|NCT00605280|585439661|FG000|Year 1|Other|2|||
162106528|NCT00605280|585439662|FG001|Year 1|Other|1|||
162106529|NCT00605280|585439663|FG002|Year 1|Other|0|||
162106530|NCT00605280|585439664|FG003|Year 1|Other|1|||
162106531|NCT00605280|585439661|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
162106532|NCT00605280|585439662|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
162106533|NCT00605280|585439663|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
162106534|NCT00605280|585439664|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
162106535|NCT00605280|585439661|FG000|Year 2|Adverse Event|4|||
162106536|NCT00605280|585439662|FG001|Year 2|Adverse Event|0|||
162106537|NCT00605280|585439663|FG002|Year 2|Adverse Event|2|||
162106538|NCT00605280|585439664|FG003|Year 2|Adverse Event|4|||
162106539|NCT00605280|585439661|FG000|Year 2|Physician Decision|11|||
162106540|NCT00605280|585439662|FG001|Year 2|Physician Decision|6|||
162106541|NCT00605280|585439663|FG002|Year 2|Physician Decision|4|||
162106542|NCT00605280|585439664|FG003|Year 2|Physician Decision|11|||
162106543|NCT00605280|585439661|FG000|Year 2|Withdrawal by Subject|4|||
162106544|NCT00605280|585439662|FG001|Year 2|Withdrawal by Subject|0|||
162106545|NCT00605280|585439663|FG002|Year 2|Withdrawal by Subject|0|||
162106546|NCT00605280|585439664|FG003|Year 2|Withdrawal by Subject|4|||
162106547|NCT00605280|585439661|FG000|Year 2|Other|1|||
162106548|NCT00605280|585439662|FG001|Year 2|Other|0|||
162106549|NCT00605280|585439663|FG002|Year 2|Other|0|||
162106550|NCT00605280|585439664|FG003|Year 2|Other|1|||
162106551|NCT00605280|585439661|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
162106552|NCT00605280|585439662|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
162106553|NCT00605280|585439663|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
162106554|NCT00605280|585439664|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
162106555|NCT00605280|585439661|FG000|Year 3 Extension|Adverse Event|2|||
162106556|NCT00605280|585439662|FG001|Year 3 Extension|Adverse Event|0|||
162106557|NCT00605280|585439663|FG002|Year 3 Extension|Adverse Event|0|||
162106558|NCT00605280|585439664|FG003|Year 3 Extension|Adverse Event|2|||
162106559|NCT00605280|585439661|FG000|Year 3 Extension|Physician Decision|0|||
162106560|NCT00605280|585439662|FG001|Year 3 Extension|Physician Decision|0|||
162106561|NCT00605280|585439663|FG002|Year 3 Extension|Physician Decision|0|||
162106562|NCT00605280|585439664|FG003|Year 3 Extension|Physician Decision|2|||
162106563|NCT00605280|585439661|FG000|Year 3 Extension|Withdrawal by Subject|2|||
162106564|NCT00605280|585439662|FG001|Year 3 Extension|Withdrawal by Subject|0|||
162106565|NCT00605280|585439663|FG002|Year 3 Extension|Withdrawal by Subject|0|||
162106566|NCT00605280|585439664|FG003|Year 3 Extension|Withdrawal by Subject|5|||
162106567|NCT00605280|585439661|FG000|Year 3 Extension|Other|2|||
162106568|NCT00605280|585439662|FG001|Year 3 Extension|Other|0|||
162106569|NCT00605280|585439663|FG002|Year 3 Extension|Other|0|||
162106570|NCT00605280|585439664|FG003|Year 3 Extension|Other|0|||
162106571|NCT00605280|585439661|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
162106572|NCT00605280|585439662|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
162106573|NCT00605280|585439663|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
162106574|NCT00605280|585439664|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
162106575|NCT00518115|585439668|FG000|Overall Study|Adverse Event|6|||
162106576|NCT00518115|585439669|FG001|Overall Study|Adverse Event|1|||
162106577|NCT00518115|585439670|FG002|Overall Study|Adverse Event|5|||
162106578|NCT00518115|585439671|FG003|Overall Study|Adverse Event|6|||
162106579|NCT00518115|585439672|FG004|Overall Study|Adverse Event|5|||
162106580|NCT00518115|585439673|FG005|Overall Study|Adverse Event|5|||
162106581|NCT00518115|585439674|FG006|Overall Study|Adverse Event|5|||
162106582|NCT00518115|585439675|FG007|Overall Study|Adverse Event|10|||
162106583|NCT00518115|585439676|FG008|Overall Study|Adverse Event|2|||
162106584|NCT00518115|585439677|FG009|Overall Study|Adverse Event|9|||
162106585|NCT00518115|585439668|FG000|Overall Study|Lost to Follow-up|0|||
162106586|NCT00518115|585439669|FG001|Overall Study|Lost to Follow-up|0|||
162106587|NCT00518115|585439670|FG002|Overall Study|Lost to Follow-up|2|||
162106588|NCT00518115|585439671|FG003|Overall Study|Lost to Follow-up|3|||
162106589|NCT00518115|585439672|FG004|Overall Study|Lost to Follow-up|1|||
162106590|NCT00518115|585439673|FG005|Overall Study|Lost to Follow-up|3|||
162106591|NCT00518115|585439674|FG006|Overall Study|Lost to Follow-up|0|||
162106592|NCT00518115|585439675|FG007|Overall Study|Lost to Follow-up|1|||
162106593|NCT00518115|585439676|FG008|Overall Study|Lost to Follow-up|1|||
162106594|NCT00518115|585439677|FG009|Overall Study|Lost to Follow-up|1|||
162106595|NCT00518115|585439668|FG000|Overall Study|Protocol Violation|1|||
162106596|NCT00518115|585439669|FG001|Overall Study|Protocol Violation|3|||
162106597|NCT00518115|585439670|FG002|Overall Study|Protocol Violation|1|||
162106598|NCT00518115|585439671|FG003|Overall Study|Protocol Violation|0|||
162106599|NCT00518115|585439672|FG004|Overall Study|Protocol Violation|0|||
162106600|NCT00518115|585439673|FG005|Overall Study|Protocol Violation|0|||
162106601|NCT00518115|585439674|FG006|Overall Study|Protocol Violation|0|||
162106602|NCT00518115|585439675|FG007|Overall Study|Protocol Violation|0|||
162106603|NCT00518115|585439676|FG008|Overall Study|Protocol Violation|0|||
162106604|NCT00518115|585439677|FG009|Overall Study|Protocol Violation|0|||
162106605|NCT00518115|585439668|FG000|Overall Study|Withdrawal by Subject|1|||
162106606|NCT00518115|585439669|FG001|Overall Study|Withdrawal by Subject|1|||
162106607|NCT00518115|585439670|FG002|Overall Study|Withdrawal by Subject|5|||
162106608|NCT00518115|585439671|FG003|Overall Study|Withdrawal by Subject|0|||
162106609|NCT00518115|585439672|FG004|Overall Study|Withdrawal by Subject|2|||
162106610|NCT00518115|585439673|FG005|Overall Study|Withdrawal by Subject|1|||
162106611|NCT00518115|585439674|FG006|Overall Study|Withdrawal by Subject|0|||
162106612|NCT00518115|585439675|FG007|Overall Study|Withdrawal by Subject|2|||
162106613|NCT00518115|585439676|FG008|Overall Study|Withdrawal by Subject|1|||
162106614|NCT00518115|585439677|FG009|Overall Study|Withdrawal by Subject|3|||
162106615|NCT00518115|585439668|FG000|Overall Study|Lack of Efficacy|1|||
162106616|NCT00518115|585439669|FG001|Overall Study|Lack of Efficacy|0|||
162106617|NCT00518115|585439670|FG002|Overall Study|Lack of Efficacy|1|||
162106618|NCT00518115|585439671|FG003|Overall Study|Lack of Efficacy|1|||
162106619|NCT00518115|585439672|FG004|Overall Study|Lack of Efficacy|0|||
162106620|NCT00518115|585439673|FG005|Overall Study|Lack of Efficacy|0|||
162106621|NCT00518115|585439674|FG006|Overall Study|Lack of Efficacy|0|||
162106622|NCT00518115|585439675|FG007|Overall Study|Lack of Efficacy|1|||
162106623|NCT00518115|585439676|FG008|Overall Study|Lack of Efficacy|0|||
162106624|NCT00518115|585439677|FG009|Overall Study|Lack of Efficacy|0|||
162106625|NCT00518115|585439668|FG000|Overall Study|Non-Compliance|1|||
162106626|NCT00518115|585439669|FG001|Overall Study|Non-Compliance|0|||
162106627|NCT00518115|585439670|FG002|Overall Study|Non-Compliance|1|||
162106628|NCT00518115|585439671|FG003|Overall Study|Non-Compliance|0|||
162106629|NCT00518115|585439672|FG004|Overall Study|Non-Compliance|1|||
162106630|NCT00518115|585439673|FG005|Overall Study|Non-Compliance|1|||
162106631|NCT00518115|585439674|FG006|Overall Study|Non-Compliance|1|||
162106632|NCT00518115|585439675|FG007|Overall Study|Non-Compliance|1|||
162106633|NCT00518115|585439676|FG008|Overall Study|Non-Compliance|0|||
162106634|NCT00518115|585439677|FG009|Overall Study|Non-Compliance|1|||
162106635|NCT00518115|585439668|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
162106636|NCT00518115|585439669|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
162106637|NCT00518115|585439670|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162106638|NCT00518115|585439671|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162106639|NCT00518115|585439672|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162106640|NCT00518115|585439673|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
162106641|NCT00518115|585439674|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162106642|NCT00518115|585439675|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162106643|NCT00518115|585439676|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162106644|NCT00518115|585439677|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
162106645|NCT00518115|585439668|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
162106646|NCT00518115|585439669|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162106647|NCT00518115|585439670|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162106648|NCT00518115|585439671|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162106649|NCT00518115|585439672|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162106650|NCT00518115|585439673|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162106651|NCT00518115|585439674|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162106652|NCT00518115|585439675|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162106653|NCT00518115|585439676|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162106654|NCT00518115|585439677|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
162106655|NCT00518115|585439668|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
162106656|NCT00518115|585439669|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
162106657|NCT00518115|585439670|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
162106658|NCT00518115|585439671|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
162106659|NCT00518115|585439672|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
162106660|NCT00518115|585439673|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
162106661|NCT00518115|585439674|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
162106662|NCT00518115|585439675|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
162106663|NCT00518115|585439676|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
162106664|NCT00518115|585439677|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
162106665|NCT00518115|585439668|FG000|Overall Study|Wrong Monotherapy Administered|0|||
162106666|NCT00518115|585439669|FG001|Overall Study|Wrong Monotherapy Administered|0|||
162106667|NCT00518115|585439670|FG002|Overall Study|Wrong Monotherapy Administered|1|||
162106668|NCT00518115|585439671|FG003|Overall Study|Wrong Monotherapy Administered|0|||
162106669|NCT00518115|585439672|FG004|Overall Study|Wrong Monotherapy Administered|0|||
162106670|NCT00518115|585439673|FG005|Overall Study|Wrong Monotherapy Administered|0|||
162106671|NCT00518115|585439674|FG006|Overall Study|Wrong Monotherapy Administered|1|||
162106672|NCT00518115|585439675|FG007|Overall Study|Wrong Monotherapy Administered|0|||
162106673|NCT00518115|585439676|FG008|Overall Study|Wrong Monotherapy Administered|0|||
162106674|NCT00518115|585439677|FG009|Overall Study|Wrong Monotherapy Administered|0|||
162106675|NCT00518115|585439668|FG000|Overall Study|Violation of Exclusion Criteria|0|||
162106676|NCT00518115|585439669|FG001|Overall Study|Violation of Exclusion Criteria|0|||
162106677|NCT00518115|585439670|FG002|Overall Study|Violation of Exclusion Criteria|0|||
162106678|NCT00518115|585439671|FG003|Overall Study|Violation of Exclusion Criteria|1|||
162106679|NCT00518115|585439672|FG004|Overall Study|Violation of Exclusion Criteria|0|||
162106680|NCT00518115|585439673|FG005|Overall Study|Violation of Exclusion Criteria|0|||
162106681|NCT00518115|585439674|FG006|Overall Study|Violation of Exclusion Criteria|1|||
162106682|NCT00518115|585439675|FG007|Overall Study|Violation of Exclusion Criteria|0|||
162106683|NCT00518115|585439676|FG008|Overall Study|Violation of Exclusion Criteria|0|||
162106684|NCT00518115|585439677|FG009|Overall Study|Violation of Exclusion Criteria|0|||
162106685|NCT00518115|585439668|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
162106686|NCT00518115|585439669|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
162106687|NCT00518115|585439670|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
162106688|NCT00518115|585439671|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
162106689|NCT00518115|585439672|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
162106690|NCT00518115|585439673|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
162106691|NCT00518115|585439674|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
162106692|NCT00518115|585439675|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
162106693|NCT00518115|585439676|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
162106694|NCT00518115|585439677|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
162106695|NCT00518115|585439668|FG000|Overall Study|Withdrew Consent|0|||
162106696|NCT00518115|585439669|FG001|Overall Study|Withdrew Consent|0|||
162106697|NCT00518115|585439670|FG002|Overall Study|Withdrew Consent|0|||
162106698|NCT00518115|585439671|FG003|Overall Study|Withdrew Consent|0|||
162106699|NCT00518115|585439672|FG004|Overall Study|Withdrew Consent|0|||
162106700|NCT00518115|585439673|FG005|Overall Study|Withdrew Consent|1|||
162106701|NCT00518115|585439674|FG006|Overall Study|Withdrew Consent|0|||
162106702|NCT00518115|585439675|FG007|Overall Study|Withdrew Consent|0|||
162106703|NCT00518115|585439676|FG008|Overall Study|Withdrew Consent|0|||
162106704|NCT00518115|585439677|FG009|Overall Study|Withdrew Consent|0|||
162106705|NCT00518115|585439668|FG000|Overall Study|Moved Out of State|0|||
162106706|NCT00518115|585439669|FG001|Overall Study|Moved Out of State|0|||
162106707|NCT00518115|585439670|FG002|Overall Study|Moved Out of State|0|||
162106708|NCT00518115|585439671|FG003|Overall Study|Moved Out of State|0|||
162106709|NCT00518115|585439672|FG004|Overall Study|Moved Out of State|0|||
162106710|NCT00518115|585439673|FG005|Overall Study|Moved Out of State|0|||
162106711|NCT00518115|585439674|FG006|Overall Study|Moved Out of State|0|||
162106712|NCT00518115|585439675|FG007|Overall Study|Moved Out of State|0|||
162106713|NCT00518115|585439676|FG008|Overall Study|Moved Out of State|0|||
162106714|NCT00518115|585439677|FG009|Overall Study|Moved Out of State|1|||
162106715|NCT00827918|585439680|FG000|Overall Study|Adverse Event|4|||
162106716|NCT00827918|585439681|FG001|Overall Study|Adverse Event|0|||
162106717|NCT00827918|585439682|FG002|Overall Study|Adverse Event|0|||
162106718|NCT00827918|585439680|FG000|Overall Study|Lack of Efficacy|16|||
162106719|NCT00827918|585439681|FG001|Overall Study|Lack of Efficacy|4|||
162106720|NCT00827918|585439682|FG002|Overall Study|Lack of Efficacy|15|||
162106721|NCT00827918|585439680|FG000|Overall Study|Physician Decision|1|||
162106722|NCT00827918|585439681|FG001|Overall Study|Physician Decision|0|||
162106723|NCT00827918|585439682|FG002|Overall Study|Physician Decision|0|||
162106724|NCT00827918|585439680|FG000|Overall Study|Pregnancy|0|||
162106725|NCT00827918|585439681|FG001|Overall Study|Pregnancy|1|||
162106726|NCT00827918|585439682|FG002|Overall Study|Pregnancy|0|||
162106727|NCT00827918|585439680|FG000|Overall Study|Progressive Disease|1|||
162106728|NCT00827918|585439681|FG001|Overall Study|Progressive Disease|1|||
162106729|NCT00827918|585439682|FG002|Overall Study|Progressive Disease|0|||
162106730|NCT00827918|585439680|FG000|Overall Study|Protocol Violation|0|||
162106731|NCT00827918|585439681|FG001|Overall Study|Protocol Violation|1|||
162106732|NCT00827918|585439682|FG002|Overall Study|Protocol Violation|0|||
162106733|NCT00827918|585439680|FG000|Overall Study|Withdrawal by Subject|6|||
162106734|NCT00827918|585439681|FG001|Overall Study|Withdrawal by Subject|2|||
162106735|NCT00827918|585439682|FG002|Overall Study|Withdrawal by Subject|6|||
162106736|NCT00802074|585439683|FG000|Overall Study|Adverse Event|1|||
162106737|NCT00802074|585439684|FG001|Overall Study|Adverse Event|1|||
162106738|NCT00802074|585439685|FG002|Overall Study|Adverse Event|1|||
162106739|NCT00802074|585439686|FG003|Overall Study|Adverse Event|0|||
162106740|NCT00802074|585439687|FG004|Overall Study|Adverse Event|0|||
162106741|NCT00802074|585439688|FG005|Overall Study|Adverse Event|0|||
162106742|NCT00802074|585439683|FG000|Overall Study|Withdrawal by Subject|1|||
162106743|NCT00802074|585439684|FG001|Overall Study|Withdrawal by Subject|0|||
162106744|NCT00802074|585439685|FG002|Overall Study|Withdrawal by Subject|0|||
162106745|NCT00802074|585439686|FG003|Overall Study|Withdrawal by Subject|0|||
162106746|NCT00802074|585439687|FG004|Overall Study|Withdrawal by Subject|0|||
162106747|NCT00802074|585439688|FG005|Overall Study|Withdrawal by Subject|0|||
162106748|NCT02291614|585439691|FG000|Overall Study|Lost to Follow-up|0|||
162106749|NCT02291614|585439692|FG001|Overall Study|Lost to Follow-up|0|||
162106750|NCT02291614|585439693|FG002|Overall Study|Lost to Follow-up|0|||
162106751|NCT02291614|585439694|FG003|Overall Study|Lost to Follow-up|0|||
162106752|NCT02291614|585439695|FG004|Overall Study|Lost to Follow-up|0|||
162106753|NCT02291614|585439696|FG005|Overall Study|Lost to Follow-up|0|||
162106754|NCT02291614|585439697|FG006|Overall Study|Lost to Follow-up|0|||
162106755|NCT02291614|585439698|FG007|Overall Study|Lost to Follow-up|1|||
162106756|NCT02291614|585439699|FG008|Overall Study|Lost to Follow-up|0|||
162106757|NCT02291614|585439700|FG009|Overall Study|Lost to Follow-up|0|||
162106758|NCT02291614|585439701|FG010|Overall Study|Lost to Follow-up|0|||
162106759|NCT02291614|585439691|FG000|Overall Study|Withdrawal by Subject|0|||
162106760|NCT02291614|585439692|FG001|Overall Study|Withdrawal by Subject|1|||
162106761|NCT02291614|585439693|FG002|Overall Study|Withdrawal by Subject|0|||
162106762|NCT02291614|585439694|FG003|Overall Study|Withdrawal by Subject|0|||
162106763|NCT02291614|585439695|FG004|Overall Study|Withdrawal by Subject|0|||
162106764|NCT02291614|585439696|FG005|Overall Study|Withdrawal by Subject|0|||
162106765|NCT02291614|585439697|FG006|Overall Study|Withdrawal by Subject|0|||
162106766|NCT02291614|585439698|FG007|Overall Study|Withdrawal by Subject|0|||
162106767|NCT02291614|585439699|FG008|Overall Study|Withdrawal by Subject|0|||
162106768|NCT02291614|585439700|FG009|Overall Study|Withdrawal by Subject|2|||
162106769|NCT02291614|585439701|FG010|Overall Study|Withdrawal by Subject|2|||
162106770|NCT02291614|585439691|FG000|Overall Study|Decision by sponsor|0|||
162106771|NCT02291614|585439692|FG001|Overall Study|Decision by sponsor|0|||
162106772|NCT02291614|585439693|FG002|Overall Study|Decision by sponsor|0|||
162106773|NCT02291614|585439694|FG003|Overall Study|Decision by sponsor|1|||
162106774|NCT02291614|585439695|FG004|Overall Study|Decision by sponsor|0|||
162106775|NCT02291614|585439696|FG005|Overall Study|Decision by sponsor|0|||
162106776|NCT02291614|585439697|FG006|Overall Study|Decision by sponsor|0|||
162106777|NCT02291614|585439698|FG007|Overall Study|Decision by sponsor|0|||
162106778|NCT02291614|585439699|FG008|Overall Study|Decision by sponsor|0|||
162106779|NCT02291614|585439700|FG009|Overall Study|Decision by sponsor|0|||
162106780|NCT02291614|585439701|FG010|Overall Study|Decision by sponsor|0|||
162106781|NCT02291614|585439691|FG000|Overall Study|Death|0|||
162106782|NCT02291614|585439692|FG001|Overall Study|Death|0|||
162106783|NCT02291614|585439693|FG002|Overall Study|Death|1|||
162106784|NCT02291614|585439694|FG003|Overall Study|Death|0|||
162106785|NCT02291614|585439695|FG004|Overall Study|Death|1|||
162106786|NCT02291614|585439696|FG005|Overall Study|Death|1|||
162106787|NCT02291614|585439697|FG006|Overall Study|Death|1|||
162106788|NCT02291614|585439698|FG007|Overall Study|Death|0|||
162106789|NCT02291614|585439699|FG008|Overall Study|Death|0|||
162106790|NCT02291614|585439700|FG009|Overall Study|Death|0|||
162106791|NCT02291614|585439701|FG010|Overall Study|Death|0|||
162106792|NCT00127101|585439702|FG000|Base Protocol|Adverse Event|0|||
162106793|NCT00127101|585439703|FG001|Base Protocol|Adverse Event|2|||
162106794|NCT00127101|585439704|FG002|Base Protocol|Adverse Event|1|||
162106795|NCT00127101|585439705|FG003|Base Protocol|Adverse Event|0|||
162106796|NCT00127101|585439706|FG004|Base Protocol|Adverse Event|0|||
162106797|NCT00127101|585439707|FG005|Base Protocol|Adverse Event|0|||
162106798|NCT00127101|585439702|FG000|Base Protocol|Lack of Efficacy|1|||
162106799|NCT00127101|585439703|FG001|Base Protocol|Lack of Efficacy|0|||
162106800|NCT00127101|585439704|FG002|Base Protocol|Lack of Efficacy|0|||
162106801|NCT00127101|585439705|FG003|Base Protocol|Lack of Efficacy|0|||
162106802|NCT00127101|585439706|FG004|Base Protocol|Lack of Efficacy|2|||
162106803|NCT00127101|585439707|FG005|Base Protocol|Lack of Efficacy|0|||
162106804|NCT00127101|585439702|FG000|Base Protocol|Withdrawal by Subject|1|||
162106805|NCT00127101|585439703|FG001|Base Protocol|Withdrawal by Subject|2|||
162106806|NCT00127101|585439704|FG002|Base Protocol|Withdrawal by Subject|1|||
162106807|NCT00127101|585439705|FG003|Base Protocol|Withdrawal by Subject|0|||
162106808|NCT00127101|585439706|FG004|Base Protocol|Withdrawal by Subject|0|||
162106809|NCT00127101|585439707|FG005|Base Protocol|Withdrawal by Subject|1|||
162106810|NCT00127101|585439702|FG000|Continuation Phase|Adverse Event|0|||
162106811|NCT00127101|585439703|FG001|Continuation Phase|Adverse Event|0|||
162106812|NCT00127101|585439704|FG002|Continuation Phase|Adverse Event|0|||
162106813|NCT00127101|585439705|FG003|Continuation Phase|Adverse Event|0|||
162106814|NCT00127101|585439706|FG004|Continuation Phase|Adverse Event|1|||
162106815|NCT00127101|585439707|FG005|Continuation Phase|Adverse Event|1|||
162106816|NCT00127101|585439702|FG000|Continuation Phase|Lack of Efficacy|0|||
162106817|NCT00127101|585439703|FG001|Continuation Phase|Lack of Efficacy|0|||
162106818|NCT00127101|585439704|FG002|Continuation Phase|Lack of Efficacy|0|||
162106819|NCT00127101|585439705|FG003|Continuation Phase|Lack of Efficacy|0|||
162106820|NCT00127101|585439706|FG004|Continuation Phase|Lack of Efficacy|0|||
162106821|NCT00127101|585439707|FG005|Continuation Phase|Lack of Efficacy|1|||
162106822|NCT00127101|585439702|FG000|Continuation Phase|Withdrawal by Subject|0|||
162106823|NCT00127101|585439703|FG001|Continuation Phase|Withdrawal by Subject|0|||
162106824|NCT00127101|585439704|FG002|Continuation Phase|Withdrawal by Subject|1|||
162106825|NCT00127101|585439705|FG003|Continuation Phase|Withdrawal by Subject|0|||
162106826|NCT00127101|585439706|FG004|Continuation Phase|Withdrawal by Subject|2|||
162106827|NCT00127101|585439707|FG005|Continuation Phase|Withdrawal by Subject|1|||
162106828|NCT00843167|585439708|FG000|Treatment Period|Adverse Event|1|||
162106829|NCT00843167|585439709|FG001|Treatment Period|Adverse Event|5|||
162106830|NCT00843167|585439708|FG000|Treatment Period|Withdrawal by Subject|2|||
162106831|NCT00843167|585439709|FG001|Treatment Period|Withdrawal by Subject|3|||
162106832|NCT03743038|585439710|FG000|Overall Study|Physician Decision|1|||
162106833|NCT01830127|585439712|FG000|Overall Study|Adverse Event|1|||
162106834|NCT01830127|585439713|FG001|Overall Study|Adverse Event|6|||
162106835|NCT01830127|585439712|FG000|Overall Study|Lack of Efficacy|3|||
162106836|NCT01830127|585439713|FG001|Overall Study|Lack of Efficacy|0|||
162106837|NCT01830127|585439712|FG000|Overall Study|Withdrawal by Subject|1|||
162106838|NCT01830127|585439713|FG001|Overall Study|Withdrawal by Subject|1|||
162106839|NCT01830127|585439712|FG000|Overall Study|Other reason not defined above|0|||
162106840|NCT01830127|585439713|FG001|Overall Study|Other reason not defined above|2|||
162106841|NCT01302847|585439716|FG000|Overall Study|Death|0|||
162106842|NCT01302847|585439717|FG001|Overall Study|Death|1|||
162106843|NCT01302847|585439718|FG002|Overall Study|Death|0|||
162106844|NCT01302847|585439719|FG003|Overall Study|Death|0|||
162106845|NCT01302847|585439720|FG004|Overall Study|Death|0|||
162106846|NCT01302847|585439721|FG005|Overall Study|Death|1|||
162106847|NCT01302847|585439722|FG006|Overall Study|Death|1|||
162106848|NCT01302847|585439723|FG007|Overall Study|Death|0|||
162106849|NCT01302847|585439716|FG000|Overall Study|Pregnancy|2|||
162106850|NCT01302847|585439717|FG001|Overall Study|Pregnancy|0|||
162106851|NCT01302847|585439718|FG002|Overall Study|Pregnancy|0|||
162106852|NCT01302847|585439719|FG003|Overall Study|Pregnancy|0|||
162106853|NCT01302847|585439720|FG004|Overall Study|Pregnancy|0|||
162106854|NCT01302847|585439721|FG005|Overall Study|Pregnancy|0|||
162106855|NCT01302847|585439722|FG006|Overall Study|Pregnancy|0|||
162106856|NCT01302847|585439723|FG007|Overall Study|Pregnancy|0|||
162106857|NCT01302847|585439716|FG000|Overall Study|Virologic failure|0|||
162106858|NCT01302847|585439717|FG001|Overall Study|Virologic failure|2|||
162106859|NCT01302847|585439718|FG002|Overall Study|Virologic failure|0|||
162106860|NCT01302847|585439719|FG003|Overall Study|Virologic failure|2|||
162106861|NCT01302847|585439720|FG004|Overall Study|Virologic failure|1|||
162106862|NCT01302847|585439721|FG005|Overall Study|Virologic failure|3|||
162106863|NCT01302847|585439722|FG006|Overall Study|Virologic failure|1|||
162106864|NCT01302847|585439723|FG007|Overall Study|Virologic failure|2|||
162106865|NCT01302847|585439716|FG000|Overall Study|Severe debilitation, unable to continue|0|||
162106866|NCT01302847|585439717|FG001|Overall Study|Severe debilitation, unable to continue|0|||
162106867|NCT01302847|585439718|FG002|Overall Study|Severe debilitation, unable to continue|0|||
162106868|NCT01302847|585439719|FG003|Overall Study|Severe debilitation, unable to continue|0|||
162106869|NCT01302847|585439720|FG004|Overall Study|Severe debilitation, unable to continue|0|||
162106870|NCT01302847|585439721|FG005|Overall Study|Severe debilitation, unable to continue|1|||
162106871|NCT01302847|585439722|FG006|Overall Study|Severe debilitation, unable to continue|1|||
162106872|NCT01302847|585439723|FG007|Overall Study|Severe debilitation, unable to continue|0|||
162106873|NCT01302847|585439716|FG000|Overall Study|Not able to get to clinic|1|||
162106874|NCT01302847|585439717|FG001|Overall Study|Not able to get to clinic|1|||
162106875|NCT01302847|585439718|FG002|Overall Study|Not able to get to clinic|0|||
162106876|NCT01302847|585439719|FG003|Overall Study|Not able to get to clinic|0|||
162106877|NCT01302847|585439720|FG004|Overall Study|Not able to get to clinic|0|||
162106878|NCT01302847|585439721|FG005|Overall Study|Not able to get to clinic|0|||
162106879|NCT01302847|585439722|FG006|Overall Study|Not able to get to clinic|0|||
162106880|NCT01302847|585439723|FG007|Overall Study|Not able to get to clinic|0|||
162106881|NCT01302847|585439716|FG000|Overall Study|Site closing|2|||
162106882|NCT01302847|585439717|FG001|Overall Study|Site closing|2|||
162106883|NCT01302847|585439718|FG002|Overall Study|Site closing|0|||
162106884|NCT01302847|585439719|FG003|Overall Study|Site closing|0|||
162106885|NCT01302847|585439720|FG004|Overall Study|Site closing|0|||
162106886|NCT01302847|585439721|FG005|Overall Study|Site closing|0|||
162106887|NCT01302847|585439722|FG006|Overall Study|Site closing|0|||
162106888|NCT01302847|585439723|FG007|Overall Study|Site closing|0|||
162106889|NCT01302847|585439716|FG000|Overall Study|Withdrawal by Subject|1|||
162106890|NCT01302847|585439717|FG001|Overall Study|Withdrawal by Subject|0|||
162106891|NCT01302847|585439718|FG002|Overall Study|Withdrawal by Subject|0|||
162106892|NCT01302847|585439719|FG003|Overall Study|Withdrawal by Subject|0|||
162106893|NCT01302847|585439720|FG004|Overall Study|Withdrawal by Subject|1|||
162106894|NCT01302847|585439721|FG005|Overall Study|Withdrawal by Subject|0|||
162106895|NCT01302847|585439722|FG006|Overall Study|Withdrawal by Subject|0|||
162106896|NCT01302847|585439723|FG007|Overall Study|Withdrawal by Subject|1|||
162106897|NCT01302847|585439716|FG000|Overall Study|Not willing to adhere to requirements|5|||
162106898|NCT01302847|585439717|FG001|Overall Study|Not willing to adhere to requirements|0|||
162106899|NCT01302847|585439718|FG002|Overall Study|Not willing to adhere to requirements|1|||
162106900|NCT01302847|585439719|FG003|Overall Study|Not willing to adhere to requirements|0|||
162106901|NCT01302847|585439720|FG004|Overall Study|Not willing to adhere to requirements|0|||
162106902|NCT01302847|585439721|FG005|Overall Study|Not willing to adhere to requirements|0|||
162106903|NCT01302847|585439722|FG006|Overall Study|Not willing to adhere to requirements|0|||
162106904|NCT01302847|585439723|FG007|Overall Study|Not willing to adhere to requirements|2|||
162106905|NCT01302847|585439716|FG000|Overall Study|Site unable to contact participant|2|||
162106906|NCT01302847|585439717|FG001|Overall Study|Site unable to contact participant|1|||
162106907|NCT01302847|585439718|FG002|Overall Study|Site unable to contact participant|0|||
162106908|NCT01302847|585439719|FG003|Overall Study|Site unable to contact participant|0|||
162106909|NCT01302847|585439720|FG004|Overall Study|Site unable to contact participant|0|||
162106910|NCT01302847|585439721|FG005|Overall Study|Site unable to contact participant|0|||
162106911|NCT01302847|585439722|FG006|Overall Study|Site unable to contact participant|2|||
162106912|NCT01302847|585439723|FG007|Overall Study|Site unable to contact participant|0|||
162106913|NCT03776136|585439725|FG000|Overall Study|Death|85|||
162106914|NCT03776136|585439725|FG000|Overall Study|Withdrawal by Subject|3|||
162106915|NCT03776136|585439725|FG000|Overall Study|Sponsor Decision|15|||
162106916|NCT00680407|585439731|FG000|Overall Study|Lost to Follow-up|3|||
162106917|NCT00680407|585439732|FG001|Overall Study|Lost to Follow-up|3|||
162106918|NCT00680407|585439733|FG002|Overall Study|Lost to Follow-up|1|||
162106919|NCT00680407|585439731|FG000|Overall Study|Withdrawal by Subject|5|||
162106920|NCT00680407|585439732|FG001|Overall Study|Withdrawal by Subject|2|||
162106921|NCT00680407|585439733|FG002|Overall Study|Withdrawal by Subject|2|||
162106922|NCT01735201|585442067|FG000|Overall Study|Adverse Event|1|||
162106923|NCT01735201|585442068|FG001|Overall Study|Adverse Event|1|||
162106924|NCT01735201|585442069|FG002|Overall Study|Adverse Event|0|||
162106925|NCT01735201|585442070|FG003|Overall Study|Adverse Event|1|||
162106926|NCT01735201|585442071|FG004|Overall Study|Adverse Event|1|||
162106927|NCT01735201|585442072|FG005|Overall Study|Adverse Event|3|||
162106928|NCT01735201|585442073|FG006|Overall Study|Adverse Event|2|||
162106929|NCT01735201|585442074|FG007|Overall Study|Adverse Event|1|||
162106930|NCT01735201|585442067|FG000|Overall Study|Personal Reasons|1|||
162106931|NCT01735201|585442068|FG001|Overall Study|Personal Reasons|0|||
162106932|NCT01735201|585442069|FG002|Overall Study|Personal Reasons|0|||
162106933|NCT01735201|585442070|FG003|Overall Study|Personal Reasons|0|||
162106934|NCT01735201|585442071|FG004|Overall Study|Personal Reasons|0|||
162106935|NCT01735201|585442072|FG005|Overall Study|Personal Reasons|0|||
162106936|NCT01735201|585442073|FG006|Overall Study|Personal Reasons|0|||
162106937|NCT01735201|585442074|FG007|Overall Study|Personal Reasons|0|||
162106938|NCT01735201|585442067|FG000|Overall Study|Protocol Violation|1|||
162106939|NCT01735201|585442068|FG001|Overall Study|Protocol Violation|0|||
162106940|NCT01735201|585442069|FG002|Overall Study|Protocol Violation|0|||
162106941|NCT01735201|585442070|FG003|Overall Study|Protocol Violation|0|||
162106942|NCT01735201|585442071|FG004|Overall Study|Protocol Violation|0|||
162106943|NCT01735201|585442072|FG005|Overall Study|Protocol Violation|0|||
162106944|NCT01735201|585442073|FG006|Overall Study|Protocol Violation|0|||
162106945|NCT01735201|585442074|FG007|Overall Study|Protocol Violation|0|||
162106946|NCT01735201|585442067|FG000|Overall Study|Other Miscellaneous Reasons|0|||
162106947|NCT01735201|585442068|FG001|Overall Study|Other Miscellaneous Reasons|0|||
162106948|NCT01735201|585442069|FG002|Overall Study|Other Miscellaneous Reasons|0|||
162106949|NCT01735201|585442070|FG003|Overall Study|Other Miscellaneous Reasons|1|||
162106950|NCT01735201|585442071|FG004|Overall Study|Other Miscellaneous Reasons|0|||
162106951|NCT01735201|585442072|FG005|Overall Study|Other Miscellaneous Reasons|2|||
162106952|NCT01735201|585442073|FG006|Overall Study|Other Miscellaneous Reasons|1|||
162106953|NCT01735201|585442074|FG007|Overall Study|Other Miscellaneous Reasons|1|||
162106954|NCT02178059|585442080|FG000|Washout|Physician Decision|1|||
162106955|NCT02178059|585442081|FG001|Washout|Physician Decision|0|||
162106956|NCT04128293|585442082|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
162106957|NCT04128293|585442083|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
162106958|NCT04128293|585442084|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
162106959|NCT04128293|585442085|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
162106960|NCT00514943|585442088|FG000|Stage 1|Progressive disease|4|||
162106961|NCT00514943|585442089|FG001|Stage 1|Progressive disease|8|||
162106962|NCT00514943|585442088|FG000|Stage 1|Other Adverse Event|16|||
162106963|NCT00514943|585442089|FG001|Stage 1|Other Adverse Event|6|||
162106964|NCT00514943|585442088|FG000|Stage 1|Not treated|1|||
162106965|NCT00514943|585442089|FG001|Stage 1|Not treated|2|||
162106966|NCT00514943|585442088|FG000|Stage 1|Patient refused to continue study meds|8|||
162106967|NCT00514943|585442089|FG001|Stage 1|Patient refused to continue study meds|3|||
162106968|NCT00514943|585442088|FG000|Stage 1|Other than stated above|1|||
162106969|NCT00514943|585442089|FG001|Stage 1|Other than stated above|7|||
162106970|NCT00514943|585442088|FG000|Stage 2|Progressive disease|27|||
162106971|NCT00514943|585442089|FG001|Stage 2|Progressive disease|24|||
162106972|NCT00514943|585442088|FG000|Stage 2|Other Adverse Event|3|||
162106973|NCT00514943|585442089|FG001|Stage 2|Other Adverse Event|10|||
162106974|NCT00514943|585442088|FG000|Stage 2|Patient refused to continue study meds|2|||
162106975|NCT00514943|585442089|FG001|Stage 2|Patient refused to continue study meds|0|||
162106976|NCT00514943|585442088|FG000|Stage 2|Other than stated above|0|||
162106977|NCT00514943|585442089|FG001|Stage 2|Other than stated above|2|||
162106978|NCT00499031|585442090|FG000|Overall Study|Improper pre-protocol treatment|1|||
162106979|NCT00499031|585442090|FG000|Overall Study|Required test not done|1|||
162106980|NCT00499031|585442090|FG000|Overall Study|Never treated|1|||
162106981|NCT02001194|585442092|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
162106982|NCT02001194|585442093|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
162106983|NCT02001194|585442094|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
162106984|NCT02001194|585442095|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
162106985|NCT02001194|585442092|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
162106986|NCT02001194|585442093|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
162106987|NCT02001194|585442094|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
162106988|NCT02001194|585442095|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
162106989|NCT02366910|585442100|FG000|Overall Study|Withdrawal by Subject|2|||
162106990|NCT02366910|585442100|FG000|Overall Study|Screen Failure|3|||
162106991|NCT03284788|585442101|FG000|Overall Study|Withdrawal by Subject|2|||
162106992|NCT01786512|585442102|FG000|Overall Study|Lost to Follow-up|0|||
162106993|NCT01786512|585442103|FG001|Overall Study|Lost to Follow-up|0|||
162106994|NCT01786512|585442104|FG002|Overall Study|Lost to Follow-up|0|||
162106995|NCT01786512|585442105|FG003|Overall Study|Lost to Follow-up|0|||
162106996|NCT01786512|585442106|FG004|Overall Study|Lost to Follow-up|0|||
162106997|NCT01786512|585442107|FG005|Overall Study|Lost to Follow-up|0|||
162106998|NCT01786512|585442108|FG006|Overall Study|Lost to Follow-up|0|||
162106999|NCT01786512|585442109|FG007|Overall Study|Lost to Follow-up|0|||
162107000|NCT01786512|585442110|FG008|Overall Study|Lost to Follow-up|0|||
162107001|NCT01786512|585442111|FG009|Overall Study|Lost to Follow-up|1|||
162107002|NCT01786512|585442112|FG010|Overall Study|Lost to Follow-up|0|||
162107003|NCT01786512|585442102|FG000|Overall Study|Decision by sponsor|0|||
162107004|NCT01786512|585442103|FG001|Overall Study|Decision by sponsor|0|||
162107005|NCT01786512|585442104|FG002|Overall Study|Decision by sponsor|0|||
162107006|NCT01786512|585442105|FG003|Overall Study|Decision by sponsor|0|||
162107007|NCT01786512|585442106|FG004|Overall Study|Decision by sponsor|0|||
162107008|NCT01786512|585442107|FG005|Overall Study|Decision by sponsor|0|||
162107009|NCT01786512|585442108|FG006|Overall Study|Decision by sponsor|0|||
162107010|NCT01786512|585442109|FG007|Overall Study|Decision by sponsor|0|||
162107011|NCT01786512|585442110|FG008|Overall Study|Decision by sponsor|0|||
162107012|NCT01786512|585442111|FG009|Overall Study|Decision by sponsor|0|||
162107013|NCT01786512|585442112|FG010|Overall Study|Decision by sponsor|2|||
162107014|NCT01786512|585442102|FG000|Overall Study|Withdrawal by Subject|0|||
162107015|NCT01786512|585442103|FG001|Overall Study|Withdrawal by Subject|1|||
162107016|NCT01786512|585442104|FG002|Overall Study|Withdrawal by Subject|0|||
162107017|NCT01786512|585442105|FG003|Overall Study|Withdrawal by Subject|0|||
162107018|NCT01786512|585442106|FG004|Overall Study|Withdrawal by Subject|0|||
162107019|NCT01786512|585442107|FG005|Overall Study|Withdrawal by Subject|0|||
162107020|NCT01786512|585442108|FG006|Overall Study|Withdrawal by Subject|1|||
162107021|NCT01786512|585442109|FG007|Overall Study|Withdrawal by Subject|0|||
162107022|NCT01786512|585442110|FG008|Overall Study|Withdrawal by Subject|0|||
162107023|NCT01786512|585442111|FG009|Overall Study|Withdrawal by Subject|3|||
162107024|NCT01786512|585442112|FG010|Overall Study|Withdrawal by Subject|7|||
162107025|NCT01786512|585442102|FG000|Overall Study|Death|0|||
162107026|NCT01786512|585442103|FG001|Overall Study|Death|0|||
162107027|NCT01786512|585442104|FG002|Overall Study|Death|0|||
162107028|NCT01786512|585442105|FG003|Overall Study|Death|0|||
162107029|NCT01786512|585442106|FG004|Overall Study|Death|0|||
162107030|NCT01786512|585442107|FG005|Overall Study|Death|0|||
162107031|NCT01786512|585442108|FG006|Overall Study|Death|0|||
162107032|NCT01786512|585442109|FG007|Overall Study|Death|0|||
162107033|NCT01786512|585442110|FG008|Overall Study|Death|4|||
162107034|NCT01786512|585442111|FG009|Overall Study|Death|1|||
162107035|NCT01786512|585442112|FG010|Overall Study|Death|3|||
162107036|NCT00605293|585442113|FG000|Overall Study|Death|2|||
162107037|NCT00605293|585442114|FG001|Overall Study|Death|1|||
162107038|NCT00605293|585442113|FG000|Overall Study|Insufficient Therapeutic Response|2|||
162107039|NCT00605293|585442114|FG001|Overall Study|Insufficient Therapeutic Response|0|||
162107040|NCT00605293|585442113|FG000|Overall Study|Adverse Event|1|||
162107041|NCT00605293|585442114|FG001|Overall Study|Adverse Event|0|||
162107042|NCT00605293|585442113|FG000|Overall Study|Holidays Dialysis Out|1|||
162107043|NCT00605293|585442114|FG001|Overall Study|Holidays Dialysis Out|0|||
162107044|NCT00605293|585442113|FG000|Overall Study|Blood Transfusion|7|||
162107045|NCT00605293|585442114|FG001|Overall Study|Blood Transfusion|1|||
162107046|NCT00605293|585442113|FG000|Overall Study|Renal Transplantation|3|||
162107047|NCT00605293|585442114|FG001|Overall Study|Renal Transplantation|1|||
162107048|NCT00605293|585442113|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
162107049|NCT00605293|585442114|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
162107050|NCT00605293|585442113|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
162107051|NCT00605293|585442114|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
162107052|NCT00605293|585442113|FG000|Overall Study|Principal Investigator Decision|0|||
162107053|NCT00605293|585442114|FG001|Overall Study|Principal Investigator Decision|1|||
162107054|NCT00781391|585442117|FG000|Overall Study|never received study drug|24|||
162107055|NCT00781391|585442118|FG001|Overall Study|never received study drug|23|||
162107056|NCT00781391|585442119|FG002|Overall Study|never received study drug|32|||
162107057|NCT00781391|585442117|FG000|Overall Study|Protocol Violation|19|||
162107058|NCT00781391|585442118|FG001|Overall Study|Protocol Violation|17|||
162107059|NCT00781391|585442119|FG002|Overall Study|Protocol Violation|20|||
162107060|NCT00781391|585442117|FG000|Overall Study|Death|789|||
162107061|NCT00781391|585442118|FG001|Overall Study|Death|730|||
162107062|NCT00781391|585442119|FG002|Overall Study|Death|706|||
162107063|NCT00781391|585442117|FG000|Overall Study|Withdrawal by Subject|47|||
162107064|NCT00781391|585442118|FG001|Overall Study|Withdrawal by Subject|37|||
162107065|NCT00781391|585442119|FG002|Overall Study|Withdrawal by Subject|25|||
162107066|NCT00781391|585442117|FG000|Overall Study|Lost to Follow-up|0|||
162107067|NCT00781391|585442118|FG001|Overall Study|Lost to Follow-up|0|||
162107068|NCT00781391|585442119|FG002|Overall Study|Lost to Follow-up|1|||
162107069|NCT01984684|585442120|FG000|Overall Study|Lost to Follow-up|25|||
162107070|NCT01984684|585442121|FG001|Overall Study|Lost to Follow-up|24|||
162107071|NCT01984684|585442120|FG000|Overall Study|Adverse Event|8|||
162107072|NCT01984684|585442121|FG001|Overall Study|Adverse Event|12|||
162107073|NCT01984684|585442120|FG000|Overall Study|Withdrawal by Subject|9|||
162107074|NCT01984684|585442121|FG001|Overall Study|Withdrawal by Subject|9|||
162107075|NCT01984684|585442120|FG000|Overall Study|Lack of Efficacy|3|||
162107076|NCT01984684|585442121|FG001|Overall Study|Lack of Efficacy|6|||
162107077|NCT01984684|585442120|FG000|Overall Study|Physician Decision|4|||
162107078|NCT01984684|585442121|FG001|Overall Study|Physician Decision|2|||
162107079|NCT01984684|585442120|FG000|Overall Study|Protocol Violation|4|||
162107080|NCT01984684|585442121|FG001|Overall Study|Protocol Violation|2|||
162107081|NCT01984684|585442120|FG000|Overall Study|Death|0|||
162107082|NCT01984684|585442121|FG001|Overall Study|Death|1|||
162107083|NCT01984684|585442120|FG000|Overall Study|Noncompliance with study drug|2|||
162107084|NCT01984684|585442121|FG001|Overall Study|Noncompliance with study drug|1|||
162107085|NCT01984684|585442120|FG000|Overall Study|Subject incarcerated|1|||
162107086|NCT01984684|585442121|FG001|Overall Study|Subject incarcerated|0|||
162107087|NCT01984684|585442120|FG000|Overall Study|Study drug not available at site|1|||
162107088|NCT01984684|585442121|FG001|Overall Study|Study drug not available at site|1|||
162107089|NCT01984684|585442120|FG000|Overall Study|Subject had inadequate IV access|0|||
162107090|NCT01984684|585442121|FG001|Overall Study|Subject had inadequate IV access|1|||
162107091|NCT03205371|585442131|FG000|Overall Study|Withdrawal by Subject|4|||
162107092|NCT03205371|585442132|FG001|Overall Study|Withdrawal by Subject|1|||
162107093|NCT03205371|585442133|FG002|Overall Study|Withdrawal by Subject|0|||
162107094|NCT03205371|585442134|FG003|Overall Study|Withdrawal by Subject|0|||
162107095|NCT03205371|585442135|FG004|Overall Study|Withdrawal by Subject|0|||
162107096|NCT03205371|585442136|FG005|Overall Study|Withdrawal by Subject|0|||
162107097|NCT03205371|585442137|FG006|Overall Study|Withdrawal by Subject|4|||
162107098|NCT03205371|585442138|FG007|Overall Study|Withdrawal by Subject|0|||
162107099|NCT03205371|585442139|FG008|Overall Study|Withdrawal by Subject|2|||
162107100|NCT03205371|585442140|FG009|Overall Study|Withdrawal by Subject|0|||
162107101|NCT03205371|585442141|FG010|Overall Study|Withdrawal by Subject|0|||
162107102|NCT03205371|585442142|FG011|Overall Study|Withdrawal by Subject|1|||
162107103|NCT03205371|585442131|FG000|Overall Study|Lost to Follow-up|0|||
162107104|NCT03205371|585442132|FG001|Overall Study|Lost to Follow-up|0|||
162107105|NCT03205371|585442133|FG002|Overall Study|Lost to Follow-up|0|||
162107106|NCT03205371|585442134|FG003|Overall Study|Lost to Follow-up|0|||
162107107|NCT03205371|585442135|FG004|Overall Study|Lost to Follow-up|0|||
162107108|NCT03205371|585442136|FG005|Overall Study|Lost to Follow-up|0|||
162107109|NCT03205371|585442137|FG006|Overall Study|Lost to Follow-up|5|||
162107110|NCT03205371|585442138|FG007|Overall Study|Lost to Follow-up|2|||
162107111|NCT03205371|585442139|FG008|Overall Study|Lost to Follow-up|3|||
162107112|NCT03205371|585442140|FG009|Overall Study|Lost to Follow-up|0|||
162107113|NCT03205371|585442141|FG010|Overall Study|Lost to Follow-up|0|||
162107114|NCT03205371|585442142|FG011|Overall Study|Lost to Follow-up|0|||
162107115|NCT03205371|585442131|FG000|Overall Study|Protocol Violation|0|||
162107116|NCT03205371|585442132|FG001|Overall Study|Protocol Violation|0|||
162107117|NCT03205371|585442133|FG002|Overall Study|Protocol Violation|0|||
162107118|NCT03205371|585442134|FG003|Overall Study|Protocol Violation|0|||
162107119|NCT03205371|585442135|FG004|Overall Study|Protocol Violation|0|||
162107120|NCT03205371|585442136|FG005|Overall Study|Protocol Violation|0|||
162107121|NCT03205371|585442137|FG006|Overall Study|Protocol Violation|1|||
162107122|NCT03205371|585442138|FG007|Overall Study|Protocol Violation|0|||
162107123|NCT03205371|585442139|FG008|Overall Study|Protocol Violation|0|||
162107124|NCT03205371|585442140|FG009|Overall Study|Protocol Violation|0|||
162107125|NCT03205371|585442141|FG010|Overall Study|Protocol Violation|0|||
162107126|NCT03205371|585442142|FG011|Overall Study|Protocol Violation|0|||
162107127|NCT03205371|585442131|FG000|Overall Study|Adverse Event|0|||
162107128|NCT03205371|585442132|FG001|Overall Study|Adverse Event|0|||
162107129|NCT03205371|585442133|FG002|Overall Study|Adverse Event|0|||
162107130|NCT03205371|585442134|FG003|Overall Study|Adverse Event|0|||
162107131|NCT03205371|585442135|FG004|Overall Study|Adverse Event|0|||
162107132|NCT03205371|585442136|FG005|Overall Study|Adverse Event|0|||
162107133|NCT03205371|585442137|FG006|Overall Study|Adverse Event|0|||
162107134|NCT03205371|585442138|FG007|Overall Study|Adverse Event|1|||
162107135|NCT03205371|585442139|FG008|Overall Study|Adverse Event|0|||
162107136|NCT03205371|585442140|FG009|Overall Study|Adverse Event|0|||
162107137|NCT03205371|585442141|FG010|Overall Study|Adverse Event|0|||
162107138|NCT03205371|585442142|FG011|Overall Study|Adverse Event|0|||
162107139|NCT02835339|585442143|FG000|Overall Study|Did not receive allocated intervention|13|||
162107140|NCT02835339|585442144|FG001|Overall Study|Did not receive allocated intervention|16|||
162107141|NCT01077544|585442145|FG000|Overall Study|New Cancer Therapy|3|||
162107142|NCT01077544|585442146|FG001|Overall Study|New Cancer Therapy|3|||
162107143|NCT01077544|585442145|FG000|Overall Study|Adverse Event|0|||
162107144|NCT01077544|585442146|FG001|Overall Study|Adverse Event|1|||
162107145|NCT01077544|585442145|FG000|Overall Study|Disease Progression|0|||
162107146|NCT01077544|585442146|FG001|Overall Study|Disease Progression|1|||
162107147|NCT00295022|585442148|FG000|Overall Study|Adverse Event|1|||
162107148|NCT00295022|585442149|FG001|Overall Study|Adverse Event|1|||
162107149|NCT00295022|585442150|FG002|Overall Study|Adverse Event|2|||
162107150|NCT00295022|585442148|FG000|Overall Study|Lost to Follow-up|0|||
162107151|NCT00295022|585442149|FG001|Overall Study|Lost to Follow-up|0|||
162107152|NCT00295022|585442150|FG002|Overall Study|Lost to Follow-up|1|||
162107153|NCT00295022|585442148|FG000|Overall Study|Withdrawal by Subject|0|||
162107154|NCT00295022|585442149|FG001|Overall Study|Withdrawal by Subject|0|||
162107155|NCT00295022|585442150|FG002|Overall Study|Withdrawal by Subject|2|||
162107156|NCT00734630|585442152|FG000|Overall Study|Lack of Efficacy|4|||
162107157|NCT00734630|585442153|FG001|Overall Study|Lack of Efficacy|4|||
162107158|NCT00734630|585442152|FG000|Overall Study|Withdrawal by Subject|7|||
162107159|NCT00734630|585442153|FG001|Overall Study|Withdrawal by Subject|9|||
162107160|NCT00734630|585442152|FG000|Overall Study|Lost to Follow-up|13|||
162107161|NCT00734630|585442153|FG001|Overall Study|Lost to Follow-up|7|||
162107162|NCT00734630|585442152|FG000|Overall Study|Protocol Violation|0|||
162107163|NCT00734630|585442153|FG001|Overall Study|Protocol Violation|3|||
162107164|NCT00734630|585442152|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
162107165|NCT00734630|585442153|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
162107166|NCT00734630|585442152|FG000|Overall Study|Adverse Event|3|||
162107167|NCT00734630|585442153|FG001|Overall Study|Adverse Event|6|||
162107168|NCT00734630|585442152|FG000|Overall Study|Randomized in Error|0|||
162107169|NCT00734630|585442153|FG001|Overall Study|Randomized in Error|1|||
162107170|NCT00734630|585442152|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
162107171|NCT00734630|585442153|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
162107172|NCT00734630|585442152|FG000|Overall Study|Poor Compliance|1|||
162107173|NCT00734630|585442153|FG001|Overall Study|Poor Compliance|1|||
162107174|NCT01239030|585442154|FG000|Double Blind|Adverse Event|0|||
162107175|NCT01239030|585442155|FG001|Double Blind|Adverse Event|1|||
162107176|NCT01239030|585442156|FG002|Double Blind|Adverse Event|0|||
162107177|NCT01239030|585442157|FG003|Double Blind|Adverse Event|2|||
162107178|NCT01239030|585442158|FG004|Double Blind|Adverse Event|0|||
162107179|NCT01239030|585442154|FG000|Double Blind|Withdrawal by Subject|0|||
162107180|NCT01239030|585442155|FG001|Double Blind|Withdrawal by Subject|1|||
162107181|NCT01239030|585442156|FG002|Double Blind|Withdrawal by Subject|1|||
162107182|NCT01239030|585442157|FG003|Double Blind|Withdrawal by Subject|0|||
162107183|NCT01239030|585442158|FG004|Double Blind|Withdrawal by Subject|1|||
162107184|NCT01239030|585442154|FG000|Double Blind|Lost to Follow-up|1|||
162107185|NCT01239030|585442155|FG001|Double Blind|Lost to Follow-up|1|||
162107186|NCT01239030|585442156|FG002|Double Blind|Lost to Follow-up|0|||
162107187|NCT01239030|585442157|FG003|Double Blind|Lost to Follow-up|0|||
162107188|NCT01239030|585442158|FG004|Double Blind|Lost to Follow-up|0|||
162107189|NCT01239030|585442154|FG000|Double Blind|Physician Decision|0|||
162107190|NCT01239030|585442155|FG001|Double Blind|Physician Decision|1|||
162107191|NCT01239030|585442156|FG002|Double Blind|Physician Decision|0|||
162107192|NCT01239030|585442157|FG003|Double Blind|Physician Decision|0|||
162107193|NCT01239030|585442158|FG004|Double Blind|Physician Decision|0|||
162107194|NCT01239030|585442154|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
162107195|NCT01239030|585442155|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
162107196|NCT01239030|585442156|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
162107197|NCT01239030|585442157|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
162107198|NCT01239030|585442158|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
162107199|NCT01239030|585442154|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
162107200|NCT01239030|585442155|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
162107201|NCT01239030|585442156|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
162107202|NCT01239030|585442157|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
162107203|NCT01239030|585442158|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
162107204|NCT01239030|585442154|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
162107205|NCT01239030|585442155|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
162107206|NCT01239030|585442156|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
162107207|NCT01239030|585442157|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
162107208|NCT01239030|585442158|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
162107209|NCT01239030|585442154|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
162107210|NCT01239030|585442155|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
162107211|NCT01239030|585442156|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
162107212|NCT01239030|585442157|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
162107213|NCT01239030|585442158|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
162107214|NCT04403698|585442159|FG000|Overall Study|Adverse Event|1|||
162107215|NCT04403698|585442160|FG001|Overall Study|Adverse Event|1|||
162107216|NCT04403698|585442159|FG000|Overall Study|Lost to Follow-up|1|||
162107217|NCT04403698|585442160|FG001|Overall Study|Lost to Follow-up|0|||
162107218|NCT04403698|585442159|FG000|Overall Study|Protocol Violation|0|||
162107219|NCT04403698|585442160|FG001|Overall Study|Protocol Violation|1|||
162107220|NCT00977665|585442161|FG000|Overall Study|Withdrawal by Subject|1|||
162107221|NCT00977665|585442162|FG001|Overall Study|Withdrawal by Subject|3|||
162107222|NCT00977665|585442161|FG000|Overall Study|Physician Decision|2|||
162107223|NCT00977665|585442162|FG001|Overall Study|Physician Decision|1|||
162107224|NCT00977665|585442161|FG000|Overall Study|Sponsor requested withdrawal|0|||
162107225|NCT00977665|585442162|FG001|Overall Study|Sponsor requested withdrawal|1|||
162107226|NCT00977665|585442161|FG000|Overall Study|Lost to Follow-up|1|||
162107227|NCT00977665|585442162|FG001|Overall Study|Lost to Follow-up|0|||
162107228|NCT00977665|585442161|FG000|Overall Study|Death|3|||
162107229|NCT00977665|585442162|FG001|Overall Study|Death|2|||
162107230|NCT00977665|585442161|FG000|Overall Study|Adverse Event|14|||
162107231|NCT00977665|585442162|FG001|Overall Study|Adverse Event|7|||
162107232|NCT00977665|585442161|FG000|Overall Study|Treatment failure|0|||
162107233|NCT00977665|585442162|FG001|Overall Study|Treatment failure|1|||
162107234|NCT01330433|585442163|FG000|Overall Study|Death|1|||
162107235|NCT01330433|585442164|FG001|Overall Study|Death|3|||
162107236|NCT01330433|585442163|FG000|Overall Study|Lost to Follow-up|1|||
162107237|NCT01330433|585442164|FG001|Overall Study|Lost to Follow-up|0|||
162107238|NCT00441090|585442167|FG000|Overall Study|Adverse Event|0|||
162107239|NCT00441090|585442168|FG001|Overall Study|Adverse Event|1|||
162107240|NCT00441090|585442169|FG002|Overall Study|Adverse Event|1|||
162107241|NCT00441090|585442170|FG003|Overall Study|Adverse Event|0|||
162107242|NCT00441090|585442171|FG004|Overall Study|Adverse Event|0|||
162107243|NCT00441090|585442167|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
162107244|NCT00441090|585442168|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
162107245|NCT00441090|585442169|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
162107246|NCT00441090|585442170|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
162107247|NCT00441090|585442171|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
162107248|NCT00441090|585442167|FG000|Overall Study|Withdrawal by Subject|1|||
162107249|NCT00441090|585442168|FG001|Overall Study|Withdrawal by Subject|0|||
162107250|NCT00441090|585442169|FG002|Overall Study|Withdrawal by Subject|1|||
162107251|NCT00441090|585442170|FG003|Overall Study|Withdrawal by Subject|0|||
162107252|NCT00441090|585442171|FG004|Overall Study|Withdrawal by Subject|0|||
162107253|NCT00441090|585442167|FG000|Overall Study|Lack of Efficacy|1|||
162107254|NCT00441090|585442168|FG001|Overall Study|Lack of Efficacy|0|||
162107255|NCT00441090|585442169|FG002|Overall Study|Lack of Efficacy|0|||
162107256|NCT00441090|585442170|FG003|Overall Study|Lack of Efficacy|0|||
162107257|NCT00441090|585442171|FG004|Overall Study|Lack of Efficacy|0|||
162107258|NCT01441102|585442172|FG000|Overall Study|Adverse Event|1|||
162107259|NCT01441102|585442172|FG000|Overall Study|Withdrawal by Subject|2|||
162107260|NCT01022762|585442173|FG000|Overall Study|Adverse Event|3|||
162107261|NCT01022762|585442174|FG001|Overall Study|Adverse Event|1|||
162107262|NCT01022762|585442173|FG000|Overall Study|Lack of Efficacy|0|||
162107263|NCT01022762|585442174|FG001|Overall Study|Lack of Efficacy|1|||
162107264|NCT01022762|585442173|FG000|Overall Study|Protocol Violation|7|||
162107265|NCT01022762|585442174|FG001|Overall Study|Protocol Violation|6|||
162107266|NCT01022762|585442173|FG000|Overall Study|Unclassified|12|||
162107267|NCT01022762|585442174|FG001|Overall Study|Unclassified|20|||
162107268|NCT01775904|585442175|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
162107269|NCT01775904|585442175|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
162107270|NCT04891419|585442176|FG000|Overall Study|Withdrawal by Subject|4|||
162107271|NCT04891419|585442177|FG001|Overall Study|Withdrawal by Subject|0|||
162107272|NCT04891419|585442176|FG000|Overall Study|Lost to Follow-up|1|||
162107273|NCT04891419|585442177|FG001|Overall Study|Lost to Follow-up|3|||
162107274|NCT01565707|585442181|FG000|Overall Study|Adverse Event|1|||
162107275|NCT01565707|585442182|FG001|Overall Study|Adverse Event|6|||
162107276|NCT01565707|585442183|FG002|Overall Study|Adverse Event|2|||
162107277|NCT01565707|585442184|FG003|Overall Study|Adverse Event|1|||
162107278|NCT01565707|585442181|FG000|Overall Study|Lost to Follow-up|1|||
162107279|NCT01565707|585442182|FG001|Overall Study|Lost to Follow-up|0|||
162107280|NCT01565707|585442183|FG002|Overall Study|Lost to Follow-up|0|||
162107281|NCT01565707|585442184|FG003|Overall Study|Lost to Follow-up|0|||
162107282|NCT01565707|585442181|FG000|Overall Study|Protocol Violation|1|||
162107283|NCT01565707|585442182|FG001|Overall Study|Protocol Violation|0|||
162107284|NCT01565707|585442183|FG002|Overall Study|Protocol Violation|0|||
162107285|NCT01565707|585442184|FG003|Overall Study|Protocol Violation|1|||
162107286|NCT01565707|585442181|FG000|Overall Study|Withdrawal by Subject|3|||
162107287|NCT01565707|585442182|FG001|Overall Study|Withdrawal by Subject|1|||
162107288|NCT01565707|585442183|FG002|Overall Study|Withdrawal by Subject|1|||
162107289|NCT01565707|585442184|FG003|Overall Study|Withdrawal by Subject|1|||
162107290|NCT01565707|585442181|FG000|Overall Study|Randomized but not evaluable|2|||
162107291|NCT01565707|585442182|FG001|Overall Study|Randomized but not evaluable|0|||
162107292|NCT01565707|585442183|FG002|Overall Study|Randomized but not evaluable|0|||
162107293|NCT01565707|585442184|FG003|Overall Study|Randomized but not evaluable|0|||
162107294|NCT01565707|585442181|FG000|Overall Study|Miscellaneous|1|||
162107295|NCT01565707|585442182|FG001|Overall Study|Miscellaneous|1|||
162107296|NCT01565707|585442183|FG002|Overall Study|Miscellaneous|0|||
162107297|NCT01565707|585442184|FG003|Overall Study|Miscellaneous|2|||
162107298|NCT01371851|585442185|FG000|Overall Study|Lost to Follow-up|5|||
162107299|NCT01371851|585442186|FG001|Overall Study|Lost to Follow-up|8|||
162107300|NCT01371851|585442185|FG000|Overall Study|was arrested and put in jail|0|||
162107301|NCT01371851|585442186|FG001|Overall Study|was arrested and put in jail|1|||
162107302|NCT01371851|585442185|FG000|Overall Study|non study related adverse event|1|||
162107303|NCT01371851|585442186|FG001|Overall Study|non study related adverse event|0|||
162107304|NCT01371851|585442185|FG000|Overall Study|Blood Pressure outside study parameters|2|||
162107305|NCT01371851|585442186|FG001|Overall Study|Blood Pressure outside study parameters|0|||
162107306|NCT00450411|585442187|FG000|Overall Study|Protocol Violation|6|||
162107307|NCT00450411|585442187|FG000|Overall Study|No protocol treatment|2|||
162107308|NCT05608629|585442198|FG000|Overall Study|Lost to Follow-up|2|||
162107309|NCT03969719|585442199|FG000|Overall Study|Other reasons not specified|1|||
162107310|NCT03969719|585442200|FG001|Overall Study|Other reasons not specified|1|||
162107311|NCT03969719|585442201|FG002|Overall Study|Other reasons not specified|3|||
162107312|NCT03969719|585442199|FG000|Overall Study|Withdrawal by Subject|2|||
162107313|NCT03969719|585442200|FG001|Overall Study|Withdrawal by Subject|3|||
162107314|NCT03969719|585442201|FG002|Overall Study|Withdrawal by Subject|2|||
162107315|NCT03969719|585442199|FG000|Overall Study|Protocol Violation|1|||
162107316|NCT03969719|585442200|FG001|Overall Study|Protocol Violation|2|||
162107317|NCT03969719|585442201|FG002|Overall Study|Protocol Violation|0|||
162107318|NCT03969719|585442199|FG000|Overall Study|Adverse Event|0|||
162107319|NCT03969719|585442200|FG001|Overall Study|Adverse Event|2|||
162107320|NCT03969719|585442201|FG002|Overall Study|Adverse Event|0|||
162107321|NCT03969719|585442199|FG000|Overall Study|Lost to Follow-up|0|||
162107322|NCT03969719|585442200|FG001|Overall Study|Lost to Follow-up|1|||
162107323|NCT03969719|585442201|FG002|Overall Study|Lost to Follow-up|0|||
162107324|NCT02130193|585442202|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
162107325|NCT02130193|585442203|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
162107326|NCT02130193|585442204|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
162107327|NCT02130193|585442202|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
162107328|NCT02130193|585442203|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
162107329|NCT02130193|585442204|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
162107330|NCT02130193|585442202|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
162107331|NCT02130193|585442203|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
162107332|NCT02130193|585442204|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
162107333|NCT02130193|585442202|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
162107334|NCT02130193|585442203|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
162107335|NCT02130193|585442204|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
162107336|NCT01297959|585442205|FG000|Overall Study|Adverse Event|0|||
162107337|NCT01297959|585442206|FG001|Overall Study|Adverse Event|1|||
162107338|NCT01297959|585442205|FG000|Overall Study|Protocol Violation|2|||
162107339|NCT01297959|585442206|FG001|Overall Study|Protocol Violation|1|||
162107340|NCT01297959|585442205|FG000|Overall Study|Withdrawal by Subject|5|||
162107341|NCT01297959|585442206|FG001|Overall Study|Withdrawal by Subject|4|||
162107342|NCT01297959|585442205|FG000|Overall Study|Physician Decision|0|||
162107343|NCT01297959|585442206|FG001|Overall Study|Physician Decision|1|||
162107344|NCT01297959|585442205|FG000|Overall Study|Unrelated medical illness / complication|0|||
162107345|NCT01297959|585442206|FG001|Overall Study|Unrelated medical illness / complication|2|||
162107346|NCT01297959|585442205|FG000|Overall Study|Other|13|||
162107347|NCT01297959|585442206|FG001|Overall Study|Other|7|||
162107348|NCT01212770|585442207|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
162107349|NCT01212770|585442208|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
162107350|NCT01212770|585442209|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
162107351|NCT01212770|585442210|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162107352|NCT01212770|585442211|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162107353|NCT01212770|585442212|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162107354|NCT01212770|585442213|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162107355|NCT01212770|585442214|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162107356|NCT01212770|585442215|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
162107357|NCT01212770|585442207|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
162107358|NCT01212770|585442208|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
162107359|NCT01212770|585442209|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
162107360|NCT01212770|585442210|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162107361|NCT01212770|585442211|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162107362|NCT01212770|585442212|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162107363|NCT01212770|585442213|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162107364|NCT01212770|585442214|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162107365|NCT01212770|585442215|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
162107366|NCT01212770|585442207|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
162107367|NCT01212770|585442208|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
162107368|NCT01212770|585442209|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
162107369|NCT01212770|585442210|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162107370|NCT01212770|585442211|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162107371|NCT01212770|585442212|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162107372|NCT01212770|585442213|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162107373|NCT01212770|585442214|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162107374|NCT01212770|585442215|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
162107375|NCT01212770|585442207|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
162107376|NCT01212770|585442208|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162107377|NCT01212770|585442209|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
162107378|NCT01212770|585442210|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162107379|NCT01212770|585442211|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162107380|NCT01212770|585442212|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162107381|NCT01212770|585442213|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162107382|NCT01212770|585442214|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162107383|NCT01212770|585442215|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
162107384|NCT01212770|585442207|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162107385|NCT01212770|585442208|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162107386|NCT01212770|585442209|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
162107387|NCT01212770|585442210|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162107388|NCT01212770|585442211|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162107389|NCT01212770|585442212|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162107390|NCT01212770|585442213|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162107391|NCT01212770|585442214|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162107392|NCT01212770|585442215|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
162107393|NCT01212770|585442207|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
162107394|NCT01212770|585442208|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
162107395|NCT01212770|585442209|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
162107396|NCT01212770|585442210|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
162107397|NCT01212770|585442211|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
162107398|NCT01212770|585442212|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
162107399|NCT01212770|585442213|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
162107400|NCT01212770|585442214|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
162107401|NCT01212770|585442215|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
162107402|NCT01212770|585442207|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
162107403|NCT01212770|585442208|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
162107404|NCT01212770|585442209|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
162107405|NCT01212770|585442210|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
162107406|NCT01212770|585442211|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
162107407|NCT01212770|585442212|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
162107408|NCT01212770|585442213|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
162107409|NCT01212770|585442214|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
162107410|NCT01212770|585442215|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
162107411|NCT01212770|585442207|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
162107412|NCT01212770|585442208|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
162107413|NCT01212770|585442209|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
162107414|NCT01212770|585442210|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
162107415|NCT01212770|585442211|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
162107416|NCT01212770|585442212|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
162107417|NCT01212770|585442213|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
162107418|NCT01212770|585442214|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
162107419|NCT01212770|585442215|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
162107420|NCT01212770|585442207|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
162107421|NCT01212770|585442208|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
162107422|NCT01212770|585442209|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
162107423|NCT01212770|585442210|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
162107424|NCT01212770|585442211|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
162107425|NCT01212770|585442212|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
162107426|NCT01212770|585442213|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
162107427|NCT01212770|585442214|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
162107428|NCT01212770|585442215|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
162107429|NCT01212770|585442207|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162107430|NCT01212770|585442208|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162107431|NCT01212770|585442209|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
162107432|NCT01212770|585442210|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162107433|NCT01212770|585442211|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162107434|NCT01212770|585442212|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162107435|NCT01212770|585442213|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162107436|NCT01212770|585442214|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162107437|NCT01212770|585442215|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
162107438|NCT01212770|585442207|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162107439|NCT01212770|585442208|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162107440|NCT01212770|585442209|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162107441|NCT01212770|585442210|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
162107442|NCT01212770|585442211|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162107443|NCT01212770|585442212|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162107444|NCT01212770|585442213|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162107445|NCT01212770|585442214|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162107446|NCT01212770|585442215|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
162107447|NCT01212770|585442207|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162107448|NCT01212770|585442208|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162107449|NCT01212770|585442209|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
162107450|NCT01212770|585442210|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
162107451|NCT01212770|585442211|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162107452|NCT01212770|585442212|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162107453|NCT01212770|585442213|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162107454|NCT01212770|585442214|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162107455|NCT01212770|585442215|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
162107456|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162107457|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
162107458|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
162107459|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162107460|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162107461|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162107462|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162107463|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
162107464|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
162107465|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162107466|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
162107467|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
162107468|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162107469|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162107470|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162107471|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
162107472|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
162107473|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
162107474|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162107475|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
162107476|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162107477|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162107478|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162107479|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162107480|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162107481|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162107482|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
162107483|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162107484|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
162107485|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
162107486|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162107487|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162107488|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162107489|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
162107490|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
162107491|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
162107492|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
162107493|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
162107494|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
162107495|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
162107496|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
162107497|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
162107498|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
162107499|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
162107500|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
162107501|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162107502|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
162107503|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
162107504|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162107505|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162107506|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162107507|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162107508|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
162107509|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
162107510|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162107511|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
162107512|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
162107513|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162107514|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162107515|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162107516|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
162107517|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
162107518|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
162107519|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162107520|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
162107521|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
162107522|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162107523|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162107524|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162107525|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
162107526|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
162107527|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
162107528|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162107529|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
162107530|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
162107531|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162107532|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162107533|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162107534|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
162107535|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
162107536|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
162107537|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162107538|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
162107539|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162107540|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162107541|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162107542|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162107543|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162107544|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162107545|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
162107546|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162107547|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162107548|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162107549|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162107550|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162107551|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162107552|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162107553|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
162107554|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
162107555|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162107556|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
162107557|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
162107558|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162107559|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162107560|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162107561|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
162107562|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
162107563|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
162107564|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162107565|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
162107566|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
162107567|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162107568|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162107569|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162107570|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162107571|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
162107572|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
162107573|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162107574|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
162107575|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
162107576|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162107577|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162107578|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162107579|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162107580|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
162107581|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
162107582|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
162107583|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
162107584|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
162107585|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
162107586|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
162107587|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
162107588|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
162107589|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
162107590|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
162107591|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162107592|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
162107593|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
162107594|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162107595|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162107596|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162107597|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162107598|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162107599|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
162107600|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162107601|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162107602|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
162107603|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162107604|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162107605|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162107606|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162107607|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162107608|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
162107609|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162107610|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
162107611|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162107612|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162107613|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162107614|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162107615|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162107616|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
162107617|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
162107618|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
162107619|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
162107620|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
162107621|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
162107622|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
162107623|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
162107624|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
162107625|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
162107626|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
162107627|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162107628|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162107629|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
162107630|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162107631|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162107632|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162107633|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162107634|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162107635|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
162107636|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162107637|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162107638|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
162107639|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162107640|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162107641|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162107642|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162107643|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
162107644|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
162107645|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162107646|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162107647|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
162107648|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162107649|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162107650|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162107651|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162107652|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162107653|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
162107654|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162107655|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
162107656|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
162107657|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162107658|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162107659|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162107660|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162107661|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
162107662|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
162107663|NCT01212770|585442207|FG000|Long-term Safety Phase (Year 5)|Death|0|||
162107664|NCT01212770|585442208|FG001|Long-term Safety Phase (Year 5)|Death|0|||
162107665|NCT01212770|585442209|FG002|Long-term Safety Phase (Year 5)|Death|0|||
162107666|NCT01212770|585442210|FG003|Long-term Safety Phase (Year 5)|Death|0|||
162107667|NCT01212770|585442211|FG004|Long-term Safety Phase (Year 5)|Death|0|||
162107668|NCT01212770|585442212|FG005|Long-term Safety Phase (Year 5)|Death|0|||
162107669|NCT01212770|585442213|FG006|Long-term Safety Phase (Year 5)|Death|0|||
162107670|NCT01212770|585442214|FG007|Long-term Safety Phase (Year 5)|Death|1|||
162107671|NCT01212770|585442215|FG008|Long-term Safety Phase (Year 5)|Death|0|||
162107672|NCT00829387|585442218|FG000|Overall Study|Withdrawal by Subject|2|||
162107673|NCT00829387|585442219|FG001|Overall Study|Withdrawal by Subject|3|||
162107674|NCT00829387|585442218|FG000|Overall Study|Disqualified by PI|1|||
162107675|NCT00829387|585442219|FG001|Overall Study|Disqualified by PI|0|||
162107676|NCT03519854|585442220|FG000|Overall Study|Technical Error|0|||
162107677|NCT03519854|585442221|FG001|Overall Study|Technical Error|0|||
162107678|NCT03519854|585442222|FG002|Overall Study|Technical Error|1|||
162107679|NCT03519854|585442223|FG003|Overall Study|Technical Error|0|||
162107680|NCT03519854|585442224|FG004|Overall Study|Technical Error|0|||
162107681|NCT03519854|585442225|FG005|Overall Study|Technical Error|0|||
162107682|NCT03519854|585442226|FG006|Overall Study|Technical Error|0|||
162107683|NCT03519854|585442227|FG007|Overall Study|Technical Error|0|||
162107684|NCT03519854|585442228|FG008|Overall Study|Technical Error|0|||
162107685|NCT03519854|585442229|FG009|Overall Study|Technical Error|0|||
162107686|NCT03519854|585442230|FG010|Overall Study|Technical Error|0|||
162107687|NCT03519854|585442231|FG011|Overall Study|Technical Error|0|||
162107688|NCT03519854|585442232|FG012|Overall Study|Technical Error|0|||
162107689|NCT03519854|585442233|FG013|Overall Study|Technical Error|0|||
162107690|NCT03519854|585442234|FG014|Overall Study|Technical Error|0|||
162107691|NCT03519854|585442235|FG015|Overall Study|Technical Error|0|||
162107692|NCT03519854|585442236|FG016|Overall Study|Technical Error|0|||
162107693|NCT03519854|585442237|FG017|Overall Study|Technical Error|0|||
162107694|NCT00707031|585442238|FG000|Overall Study|Adverse Event|45|||
162107695|NCT00707031|585442239|FG001|Overall Study|Adverse Event|45|||
162107696|NCT00707031|585442238|FG000|Overall Study|Lack of Efficacy|19|||
162107697|NCT00707031|585442239|FG001|Overall Study|Lack of Efficacy|6|||
162107698|NCT00707031|585442238|FG000|Overall Study|Lost to Follow-up|2|||
162107699|NCT00707031|585442239|FG001|Overall Study|Lost to Follow-up|1|||
162107700|NCT00707031|585442238|FG000|Overall Study|Protocol Violation|1|||
162107701|NCT00707031|585442239|FG001|Overall Study|Protocol Violation|0|||
162107702|NCT00707031|585442238|FG000|Overall Study|Withdrawal by Subject|7|||
162107703|NCT00707031|585442239|FG001|Overall Study|Withdrawal by Subject|8|||
162107704|NCT00707031|585442238|FG000|Overall Study|Poor Compliance to Protocol|7|||
162107705|NCT00707031|585442239|FG001|Overall Study|Poor Compliance to Protocol|13|||
162107706|NCT00707031|585442238|FG000|Overall Study|Familial or Personal Reasons|12|||
162107707|NCT00707031|585442239|FG001|Overall Study|Familial or Personal Reasons|15|||
162107708|NCT00707031|585442238|FG000|Overall Study|Serious Noncompliance|2|||
162107709|NCT00707031|585442239|FG001|Overall Study|Serious Noncompliance|3|||
162107710|NCT00707031|585442238|FG000|Overall Study|Sponsor Decision|9|||
162107711|NCT00707031|585442239|FG001|Overall Study|Sponsor Decision|8|||
162107712|NCT00951275|585442241|FG000|Overall Study|Administrative Reason|1|||
162107713|NCT00951275|585442241|FG000|Overall Study|Adverse Event|7|||
162107714|NCT00951275|585442241|FG000|Overall Study|Withdrawal by Subject|4|||
162107715|NCT00951275|585442241|FG000|Overall Study|Protocol Violation|1|||
162107716|NCT03260868|585442242|FG000|Overall Study|Poor Compliance to Protocol|0|||
162107717|NCT03260868|585442243|FG001|Overall Study|Poor Compliance to Protocol|2|||
162107718|NCT03260868|585442242|FG000|Overall Study|Study Terminated By Sponsor|2|||
162107719|NCT03260868|585442243|FG001|Overall Study|Study Terminated By Sponsor|1|||
162107720|NCT03260868|585442242|FG000|Overall Study|Other than specified above|1|||
162107721|NCT03260868|585442243|FG001|Overall Study|Other than specified above|0|||
162107722|NCT02925676|585442244|FG000|Overall Study|Withdrawal by Subject|1|||
162107723|NCT02048072|585442248|FG000|Overall Study|Adverse Event|3|||
162107724|NCT02048072|585442248|FG000|Overall Study|Lost to Follow-up|1|||
162107725|NCT02693743|585442251|FG000|Overall Study|Physician Decision|1|||
162107726|NCT02693743|585442252|FG001|Overall Study|Physician Decision|0|||
162107727|NCT02626780|585442253|FG000|Overall Study|Withdrawal by Subject|3|||
162107728|NCT04304833|585442254|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
162107729|NCT04304833|585442255|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
162107730|NCT02858895|585442256|FG000|Overall Study|Disease progression|31|||
162107731|NCT02858895|585442256|FG000|Overall Study|Death|2|||
162107732|NCT02858895|585442256|FG000|Overall Study|Adverse Event|1|||
162107733|NCT02858895|585442256|FG000|Overall Study|Withdrawal by Subject|3|||
162107734|NCT02858895|585442256|FG000|Overall Study|hospice,|1|||
162107735|NCT02858895|585442256|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
162107736|NCT05540522|585442257|FG000|Overall Study|Adverse Event|1|||
162107737|NCT05540522|585442258|FG001|Overall Study|Adverse Event|0|||
162107738|NCT05540522|585442259|FG002|Overall Study|Adverse Event|2|||
162107739|NCT05540522|585442260|FG003|Overall Study|Adverse Event|5|||
162107740|NCT05540522|585442257|FG000|Overall Study|Lost to Follow-up|487|||
162107741|NCT05540522|585442258|FG001|Overall Study|Lost to Follow-up|427|||
162107742|NCT05540522|585442259|FG002|Overall Study|Lost to Follow-up|146|||
162107743|NCT05540522|585442260|FG003|Overall Study|Lost to Follow-up|166|||
162107744|NCT05540522|585442257|FG000|Overall Study|Physician Decision|11|||
162107745|NCT05540522|585442258|FG001|Overall Study|Physician Decision|19|||
162107746|NCT05540522|585442259|FG002|Overall Study|Physician Decision|8|||
162107747|NCT05540522|585442260|FG003|Overall Study|Physician Decision|13|||
162107748|NCT05540522|585442257|FG000|Overall Study|Pregnancy|1|||
162107749|NCT05540522|585442258|FG001|Overall Study|Pregnancy|0|||
162107750|NCT05540522|585442259|FG002|Overall Study|Pregnancy|0|||
162107751|NCT05540522|585442260|FG003|Overall Study|Pregnancy|0|||
162107752|NCT05540522|585442257|FG000|Overall Study|Protocol Violation|3|||
162107753|NCT05540522|585442258|FG001|Overall Study|Protocol Violation|1|||
162107754|NCT05540522|585442259|FG002|Overall Study|Protocol Violation|9|||
162107755|NCT05540522|585442260|FG003|Overall Study|Protocol Violation|7|||
162107756|NCT05540522|585442257|FG000|Overall Study|Withdrawal by Subject|168|||
162107757|NCT05540522|585442258|FG001|Overall Study|Withdrawal by Subject|134|||
162107758|NCT05540522|585442259|FG002|Overall Study|Withdrawal by Subject|331|||
162107759|NCT05540522|585442260|FG003|Overall Study|Withdrawal by Subject|322|||
162107760|NCT05540522|585442257|FG000|Overall Study|Death|7|||
162107761|NCT05540522|585442258|FG001|Overall Study|Death|9|||
162107762|NCT05540522|585442259|FG002|Overall Study|Death|49|||
162107763|NCT05540522|585442260|FG003|Overall Study|Death|46|||
162107764|NCT05540522|585442257|FG000|Overall Study|Not vaccinated|34|||
162107765|NCT05540522|585442258|FG001|Overall Study|Not vaccinated|53|||
162107766|NCT05540522|585442259|FG002|Overall Study|Not vaccinated|57|||
162107767|NCT05540522|585442260|FG003|Overall Study|Not vaccinated|50|||
162107768|NCT05540522|585442257|FG000|Overall Study|No longer meets eligibility criteria|0|||
162107769|NCT05540522|585442258|FG001|Overall Study|No longer meets eligibility criteria|0|||
162107770|NCT05540522|585442259|FG002|Overall Study|No longer meets eligibility criteria|3|||
162107771|NCT05540522|585442260|FG003|Overall Study|No longer meets eligibility criteria|2|||
162107772|NCT05540522|585442257|FG000|Overall Study|Other (Unspecified)|8|||
162107773|NCT05540522|585442258|FG001|Overall Study|Other (Unspecified)|10|||
162107774|NCT05540522|585442259|FG002|Overall Study|Other (Unspecified)|4|||
162107775|NCT05540522|585442260|FG003|Overall Study|Other (Unspecified)|2|||
162107776|NCT02543658|585443862|FG000|Overall Study|Lack of Efficacy|0|||
162107777|NCT02543658|585443863|FG001|Overall Study|Lack of Efficacy|4|||
162107778|NCT00789815|585443864|FG000|Overall Study|Protocol Violation|6|||
162107779|NCT00789815|585443865|FG001|Overall Study|Protocol Violation|1|||
162107780|NCT00789815|585443864|FG000|Overall Study|Intubation due to massive bleeding|1|||
162107781|NCT00789815|585443865|FG001|Overall Study|Intubation due to massive bleeding|0|||
162107782|NCT01699022|585443878|FG000|Overall Study|Early discontinuation from the study|3|||
162107783|NCT03563716|585443879|FG000|Overall Study|Death|20|||
162107784|NCT03563716|585443880|FG001|Overall Study|Death|14|||
162107785|NCT03563716|585443879|FG000|Overall Study|Withdrawal by Subject|3|||
162107786|NCT03563716|585443880|FG001|Overall Study|Withdrawal by Subject|3|||
162107787|NCT03563716|585443879|FG000|Overall Study|Still on Study|45|||
162107788|NCT03563716|585443880|FG001|Overall Study|Still on Study|50|||
162107789|NCT04539821|585443881|FG000|Overall Study|Withdrawal by Subject|2|||
162107790|NCT04539821|585443881|FG000|Overall Study|continued care with their physician|20|||
162107791|NCT04539821|585443881|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
162107792|NCT03813238|585443888|FG000|Overall Study|Adverse Event|0|||
162107793|NCT03813238|585443889|FG001|Overall Study|Adverse Event|6|||
162107794|NCT03813238|585443888|FG000|Overall Study|Withdrawal by parent/guardian|0|||
162107795|NCT03813238|585443889|FG001|Overall Study|Withdrawal by parent/guardian|2|||
162107796|NCT03813238|585443888|FG000|Overall Study|Lost to Follow-up|0|||
162107797|NCT03813238|585443889|FG001|Overall Study|Lost to Follow-up|1|||
162107798|NCT03813238|585443888|FG000|Overall Study|Other than specified|1|||
162107799|NCT03813238|585443889|FG001|Overall Study|Other than specified|2|||
162107800|NCT02066402|585443890|FG000|Overall Study|Adverse Event|1|||
162107801|NCT02066402|585443891|FG001|Overall Study|Adverse Event|2|||
162107802|NCT02066402|585443890|FG000|Overall Study|Lost to Follow-up|11|||
162107803|NCT02066402|585443891|FG001|Overall Study|Lost to Follow-up|8|||
162107804|NCT02066402|585443890|FG000|Overall Study|Withdrawal by Subject|14|||
162107805|NCT02066402|585443891|FG001|Overall Study|Withdrawal by Subject|11|||
162107806|NCT02066402|585443890|FG000|Overall Study|Progressive disease-clinical progression|0|||
162107807|NCT02066402|585443891|FG001|Overall Study|Progressive disease-clinical progression|1|||
162107808|NCT02066402|585443890|FG000|Overall Study|Protocol driven decision point|0|||
162107809|NCT02066402|585443891|FG001|Overall Study|Protocol driven decision point|1|||
162107810|NCT02462876|585443892|FG000|Overall Study|Death|3|||
162107811|NCT02462876|585443892|FG000|Overall Study|Lost to Follow-up|7|||
162107812|NCT02462876|585443892|FG000|Overall Study|Surgical Bypass|9|||
162107813|NCT02462876|585443892|FG000|Overall Study|Amputation Above the Metatarsals|1|||
162107814|NCT02462876|585443892|FG000|Overall Study|36 months follow-up visit missed|1|||
162107815|NCT02462876|585443892|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
162107816|NCT02462876|585443892|FG000|Overall Study|Patient did not come back to the vascular department|1|||
162107817|NCT02462876|585443892|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
162107818|NCT02462876|585443892|FG000|Overall Study|Patient refused to come back|1|||
162107819|NCT02462876|585443892|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
162107820|NCT02462876|585443892|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
162107821|NCT02565914|585443893|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
162107822|NCT02565914|585443893|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
162107823|NCT02565914|585443893|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
162107824|NCT02565914|585443893|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
162107825|NCT02565914|585443893|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
162107826|NCT02565914|585443893|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
162107827|NCT02565914|585443893|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
162107828|NCT02565914|585443893|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
162107829|NCT02565914|585443893|FG000|Part A (Up to 96 Weeks)|Other|18|||
162107830|NCT02565914|585443893|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
162107831|NCT02565914|585443893|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
162107832|NCT02565914|585443893|FG000|Part B (Up to 96 Weeks)|Other|1|||
162107833|NCT02565914|585443893|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
162107834|NCT02565914|585443893|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
162107835|NCT02565914|585443893|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
162107836|NCT02565914|585443893|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
162107837|NCT02565914|585443893|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
162107838|NCT02565914|585443893|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
162107839|NCT02565914|585443893|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
162107840|NCT02565914|585443893|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
162107841|NCT02565914|585443893|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
162107842|NCT02565914|585443893|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
162107843|NCT02565914|585443893|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
162107844|NCT02565914|585443893|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
162107845|NCT03581981|585443894|FG000|Overall Study|Withdrawal by Subject|12|||
162107846|NCT03581981|585443895|FG001|Overall Study|Withdrawal by Subject|13|||
162107847|NCT03581981|585443894|FG000|Overall Study|Physician Decision|1|||
162107848|NCT03581981|585443895|FG001|Overall Study|Physician Decision|2|||
162107849|NCT03581981|585443894|FG000|Overall Study|Lost to Follow-up|0|||
162107850|NCT03581981|585443895|FG001|Overall Study|Lost to Follow-up|4|||
162107851|NCT00828984|585443896|FG000|Overall Study|Adverse Event|2|||
162107852|NCT00828984|585443897|FG001|Overall Study|Adverse Event|3|||
162107853|NCT00828984|585443898|FG002|Overall Study|Adverse Event|0|||
162107854|NCT00828984|585443896|FG000|Overall Study|Lost to Follow-up|5|||
162107855|NCT00828984|585443897|FG001|Overall Study|Lost to Follow-up|3|||
162107856|NCT00828984|585443898|FG002|Overall Study|Lost to Follow-up|1|||
162107857|NCT00828984|585443896|FG000|Overall Study|Withdrawal by Subject|4|||
162107858|NCT00828984|585443897|FG001|Overall Study|Withdrawal by Subject|4|||
162107859|NCT00828984|585443898|FG002|Overall Study|Withdrawal by Subject|4|||
162107860|NCT00828984|585443896|FG000|Overall Study|Ineligable|1|||
162107861|NCT00828984|585443897|FG001|Overall Study|Ineligable|2|||
162107862|NCT00828984|585443898|FG002|Overall Study|Ineligable|0|||
162107863|NCT00828984|585443896|FG000|Overall Study|Medical Contraindication|0|||
162107864|NCT00828984|585443897|FG001|Overall Study|Medical Contraindication|1|||
162107865|NCT00828984|585443898|FG002|Overall Study|Medical Contraindication|0|||
162107866|NCT00828984|585443896|FG000|Overall Study|Noncompliant|1|||
162107867|NCT00828984|585443897|FG001|Overall Study|Noncompliant|2|||
162107868|NCT00828984|585443898|FG002|Overall Study|Noncompliant|3|||
162107869|NCT00828984|585443896|FG000|Overall Study|ConMed|1|||
162107870|NCT00828984|585443897|FG001|Overall Study|ConMed|1|||
162107871|NCT00828984|585443898|FG002|Overall Study|ConMed|1|||
162107872|NCT00863655|585443899|FG000|Overall Study|Protocol Violation|4|||
162107873|NCT00863655|585443900|FG001|Overall Study|Protocol Violation|0|||
162107874|NCT00863655|585443899|FG000|Overall Study|Adverse Event|52|||
162107875|NCT00863655|585443900|FG001|Overall Study|Adverse Event|8|||
162107876|NCT00863655|585443899|FG000|Overall Study|Withdrawal by Subject|47|||
162107877|NCT00863655|585443900|FG001|Overall Study|Withdrawal by Subject|7|||
162107878|NCT00863655|585443899|FG000|Overall Study|Administrative problems|1|||
162107879|NCT00863655|585443900|FG001|Overall Study|Administrative problems|0|||
162107880|NCT00863655|585443899|FG000|Overall Study|Death|7|||
162107881|NCT00863655|585443900|FG001|Overall Study|Death|1|||
162107882|NCT00863655|585443899|FG000|Overall Study|New cancer therapy|5|||
162107883|NCT00863655|585443900|FG001|Overall Study|New cancer therapy|1|||
162107884|NCT00863655|585443899|FG000|Overall Study|Disease progression|364|||
162107885|NCT00863655|585443900|FG001|Overall Study|Disease progression|221|||
162107886|NCT00863655|585443899|FG000|Overall Study|Treatment completed as per protocol|5|||
162107887|NCT00863655|585443900|FG001|Overall Study|Treatment completed as per protocol|1|||
162107888|NCT04465357|585443901|FG000|Overall Study|Adverse Event|2|||
162107889|NCT04465357|585443901|FG000|Overall Study|Lack of Efficacy|1|||
162107890|NCT04465357|585443901|FG000|Overall Study|Lost to Follow-up|2|||
162107891|NCT04465357|585443901|FG000|Overall Study|Withdrawal by Subject|6|||
162107892|NCT04465357|585443901|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
162107893|NCT04385368|585443918|FG000|Overall Study|Death|5|||
162107894|NCT04385368|585443919|FG001|Overall Study|Death|5|||
162107895|NCT04385368|585443918|FG000|Overall Study|Physician Decision|3|||
162107896|NCT04385368|585443919|FG001|Overall Study|Physician Decision|0|||
162107897|NCT04385368|585443918|FG000|Overall Study|Withdrawal by Subject|4|||
162107898|NCT04385368|585443919|FG001|Overall Study|Withdrawal by Subject|3|||
162107899|NCT00716092|585443924|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
162107900|NCT00716092|585443925|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
162107901|NCT00716092|585443926|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
162107902|NCT02436330|585443927|FG000|Cohort 1|Lost to Follow-up|5|||
162107903|NCT02436330|585443928|FG001|Cohort 1|Lost to Follow-up|2|||
162107904|NCT02436330|585443927|FG000|Cohort 1|Withdrawal by Subject|0|||
162107905|NCT02436330|585443928|FG001|Cohort 1|Withdrawal by Subject|1|||
162107906|NCT02436330|585443927|FG000|Cohort 2|Lost to Follow-up|2|||
162107907|NCT02436330|585443928|FG001|Cohort 2|Lost to Follow-up|0|||
162107908|NCT02436330|585443927|FG000|Cohort 2|Withdrawal by Subject|2|||
162107909|NCT02436330|585443928|FG001|Cohort 2|Withdrawal by Subject|3|||
162107910|NCT02436330|585443927|FG000|Cohort 3|Lost to Follow-up|1|||
162107911|NCT02436330|585443928|FG001|Cohort 3|Lost to Follow-up|0|||
162107912|NCT02436330|585443927|FG000|Cohort 3|Withdrawal by Subject|4|||
162107913|NCT02436330|585443928|FG001|Cohort 3|Withdrawal by Subject|0|||
162107914|NCT02436330|585443927|FG000|Cohort 4|Lost to Follow-up|1|||
162107915|NCT02436330|585443928|FG001|Cohort 4|Lost to Follow-up|0|||
162107916|NCT02436330|585443927|FG000|Cohort 4|Withdrawal by Subject|1|||
162107917|NCT02436330|585443928|FG001|Cohort 4|Withdrawal by Subject|0|||
162107918|NCT02436330|585443927|FG000|Cohort 5|Lost to Follow-up|3|||
162107919|NCT02436330|585443928|FG001|Cohort 5|Lost to Follow-up|2|||
162107920|NCT02436330|585443927|FG000|Cohort 5|Withdrawal by Subject|3|||
162107921|NCT02436330|585443928|FG001|Cohort 5|Withdrawal by Subject|2|||
162107922|NCT02436330|585443927|FG000|Cohort 6|Lost to Follow-up|2|||
162107923|NCT02436330|585443928|FG001|Cohort 6|Lost to Follow-up|0|||
162107924|NCT02436330|585443927|FG000|Cohort 6|Withdrawal by Subject|1|||
162107925|NCT02436330|585443928|FG001|Cohort 6|Withdrawal by Subject|1|||
162107926|NCT02054806|585443929|FG000|Overall Study|Sponsor Decision|31|||
162107927|NCT02054806|585443929|FG000|Overall Study|Withdrawal by Subject|43|||
162107928|NCT02054806|585443929|FG000|Overall Study|Protocol Violation|2|||
162107929|NCT02054806|585443929|FG000|Overall Study|Lost to Follow-up|10|||
162107930|NCT02054806|585443929|FG000|Overall Study|Death|391|||
162107931|NCT00677235|585443930|FG000|Overall Study|Withdrawal by Subject|1|||
162107932|NCT00677235|585443931|FG001|Overall Study|Withdrawal by Subject|1|||
162107933|NCT00677235|585443930|FG000|Overall Study|Lost to Follow-up|2|||
162107934|NCT00677235|585443931|FG001|Overall Study|Lost to Follow-up|1|||
162107935|NCT00677235|585443930|FG000|Overall Study|Death|37|||
162107936|NCT00677235|585443931|FG001|Overall Study|Death|36|||
162107937|NCT00677235|585443930|FG000|Overall Study|Adverse Experience|1|||
162107938|NCT00677235|585443931|FG001|Overall Study|Adverse Experience|0|||
162107939|NCT01040260|585443932|FG000|Overall Study|Withdrawal by Subject|12|||
162107940|NCT01040260|585443933|FG001|Overall Study|Withdrawal by Subject|6|||
162107941|NCT01040260|585443932|FG000|Overall Study|Lost to Follow-up|3|||
162107942|NCT01040260|585443933|FG001|Overall Study|Lost to Follow-up|5|||
162107943|NCT00708916|585443938|FG000|Overall Study|Subject Noncompliance|2|||
162107944|NCT00708916|585443938|FG000|Overall Study|Adverse Event|2|||
162107945|NCT03923959|585443941|FG000|Overall Study|Death|16|||
162107946|NCT03923959|585443942|FG001|Overall Study|Death|12|||
162107947|NCT03923959|585443941|FG000|Overall Study|Lost to Follow-up|56|||
162107948|NCT03923959|585443942|FG001|Overall Study|Lost to Follow-up|56|||
162107949|NCT03923959|585443941|FG000|Overall Study|Withdrawal by Subject|1|||
162107950|NCT03923959|585443942|FG001|Overall Study|Withdrawal by Subject|1|||
162107951|NCT03923959|585443941|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
162107952|NCT03923959|585443942|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
162107953|NCT04212091|585443943|FG000|Overall Study|Lost to Follow-up|0|||
162107954|NCT04212091|585443944|FG001|Overall Study|Lost to Follow-up|0|||
162107955|NCT04212091|585443945|FG002|Overall Study|Lost to Follow-up|0|||
162107956|NCT04212091|585443946|FG003|Overall Study|Lost to Follow-up|0|||
162107957|NCT04212091|585443947|FG004|Overall Study|Lost to Follow-up|1|||
162107958|NCT04212091|585443948|FG005|Overall Study|Lost to Follow-up|1|||
162107959|NCT04212091|585443943|FG000|Overall Study|Participant unable to adhere to visit|0|||
162107960|NCT04212091|585443944|FG001|Overall Study|Participant unable to adhere to visit|0|||
162107961|NCT04212091|585443945|FG002|Overall Study|Participant unable to adhere to visit|0|||
162107962|NCT04212091|585443946|FG003|Overall Study|Participant unable to adhere to visit|0|||
162107963|NCT04212091|585443947|FG004|Overall Study|Participant unable to adhere to visit|1|||
162107964|NCT04212091|585443948|FG005|Overall Study|Participant unable to adhere to visit|0|||
162107965|NCT04575051|585443949|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
162107966|NCT04575051|585443950|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
162107967|NCT04575051|585443951|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
162107968|NCT04575051|585443952|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
162107969|NCT04575051|585443953|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
162107970|NCT04575051|585443949|FG000|Time Period 1|Missing follow up|1|||
162107971|NCT04575051|585443950|FG001|Time Period 1|Missing follow up|3|||
162107972|NCT04575051|585443951|FG002|Time Period 1|Missing follow up|1|||
162107973|NCT04575051|585443952|FG003|Time Period 1|Missing follow up|3|||
162107974|NCT04575051|585443953|FG004|Time Period 1|Missing follow up|2|||
162107975|NCT04575051|585443949|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
162107976|NCT04575051|585443950|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
162107977|NCT04575051|585443951|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
162107978|NCT04575051|585443952|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
162107979|NCT04575051|585443953|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
162107980|NCT04575051|585443949|FG000|Time Period 2|Missing follow up|1|||
162107981|NCT04575051|585443950|FG001|Time Period 2|Missing follow up|8|||
162107982|NCT04575051|585443951|FG002|Time Period 2|Missing follow up|7|||
162107983|NCT04575051|585443952|FG003|Time Period 2|Missing follow up|0|||
162107984|NCT04575051|585443953|FG004|Time Period 2|Missing follow up|1|||
162107985|NCT04575051|585443949|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
162107986|NCT04575051|585443950|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
162107987|NCT04575051|585443951|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
162107988|NCT04575051|585443952|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
162107989|NCT04575051|585443953|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
162107990|NCT04575051|585443949|FG000|Time Period 3|Missing follow up|8|||
162107991|NCT04575051|585443950|FG001|Time Period 3|Missing follow up|6|||
162107992|NCT04575051|585443951|FG002|Time Period 3|Missing follow up|4|||
162107993|NCT04575051|585443952|FG003|Time Period 3|Missing follow up|3|||
162107994|NCT04575051|585443953|FG004|Time Period 3|Missing follow up|0|||
162107995|NCT04575051|585443949|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
162107996|NCT04575051|585443950|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
162107997|NCT04575051|585443951|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
162107998|NCT04575051|585443952|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
162107999|NCT04575051|585443953|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
162108000|NCT04575051|585443949|FG000|Time Period 4|Missing follow up|17|||
162108001|NCT04575051|585443950|FG001|Time Period 4|Missing follow up|3|||
162108002|NCT04575051|585443951|FG002|Time Period 4|Missing follow up|4|||
162108003|NCT04575051|585443952|FG003|Time Period 4|Missing follow up|2|||
162108004|NCT04575051|585443953|FG004|Time Period 4|Missing follow up|1|||
162108005|NCT04575051|585443949|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
162108006|NCT04575051|585443950|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
162108007|NCT04575051|585443951|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
162108008|NCT04575051|585443952|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
162108009|NCT04575051|585443953|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
162108010|NCT04575051|585443949|FG000|Time Period 5|Missing follow up|11|||
162108011|NCT04575051|585443950|FG001|Time Period 5|Missing follow up|8|||
162108012|NCT04575051|585443951|FG002|Time Period 5|Missing follow up|12|||
162108013|NCT04575051|585443952|FG003|Time Period 5|Missing follow up|3|||
162108014|NCT04575051|585443953|FG004|Time Period 5|Missing follow up|11|||
162108015|NCT00951483|585443954|FG000|Overall Study|Physician Decision|4|||
162108016|NCT00951483|585443955|FG001|Overall Study|Physician Decision|0|||
162108017|NCT00951483|585443954|FG000|Overall Study|Withdrawal by Subject|15|||
162108018|NCT00951483|585443955|FG001|Overall Study|Withdrawal by Subject|0|||
162108019|NCT03565887|585443956|FG000|Overall Study|Adverse Event|1|||
162108020|NCT03565887|585443957|FG001|Overall Study|Adverse Event|0|||
162108021|NCT03565887|585443956|FG000|Overall Study|Withdrawal by Subject|0|||
162108022|NCT03565887|585443957|FG001|Overall Study|Withdrawal by Subject|2|||
162108023|NCT00689221|585443958|FG000|Overall Study|Ongoing at cut-off date|39|||
162108024|NCT00689221|585443959|FG001|Overall Study|Ongoing at cut-off date|36|||
162108025|NCT03182868|585443960|FG000|Overall Study|Protocol Violation|3|||
162108026|NCT03182868|585443961|FG001|Overall Study|Protocol Violation|0|||
162108027|NCT03182868|585443962|FG002|Overall Study|Protocol Violation|4|||
162108028|NCT03182868|585443963|FG003|Overall Study|Protocol Violation|1|||
162108029|NCT03182868|585443964|FG004|Overall Study|Protocol Violation|8|||
162108030|NCT01292239|585443965|FG000|Overall Study|Other|1|||
162108031|NCT01292239|585443966|FG001|Overall Study|Other|1|||
162108032|NCT01292239|585443965|FG000|Overall Study|Withdrawal by Subject|3|||
162108033|NCT01292239|585443966|FG001|Overall Study|Withdrawal by Subject|6|||
162108034|NCT00262821|585443967|FG000|Overall Study|Ineligible - wrong stage|0|||
162108035|NCT00262821|585443968|FG001|Overall Study|Ineligible - wrong stage|3|||
162108036|NCT00262821|585443967|FG000|Overall Study|Ineligible - wrong cell type|2|||
162108037|NCT00262821|585443968|FG001|Overall Study|Ineligible - wrong cell type|2|||
162108038|NCT00262821|585443967|FG000|Overall Study|Ineligible - wrong primary|0|||
162108039|NCT00262821|585443968|FG001|Overall Study|Ineligible - wrong primary|1|||
162108040|NCT00262821|585443967|FG000|Overall Study|Ineligible - inadequate pathology|1|||
162108041|NCT00262821|585443968|FG001|Overall Study|Ineligible - inadequate pathology|3|||
162108042|NCT00262821|585443967|FG000|Overall Study|Ineligible - elevated creatinine|0|||
162108043|NCT00262821|585443968|FG001|Overall Study|Ineligible - elevated creatinine|2|||
162108044|NCT00262821|585443967|FG000|Overall Study|Ineligible - required test not done|1|||
162108045|NCT00262821|585443968|FG001|Overall Study|Ineligible - required test not done|4|||
162108046|NCT00262821|585443967|FG000|Overall Study|Inevaluable - inadequate data|0|||
162108047|NCT00262821|585443968|FG001|Overall Study|Inevaluable - inadequate data|4|||
162108048|NCT00765388|585443969|FG000|Period 1|Lack of Efficacy|1|||
162108049|NCT00765388|585443970|FG001|Period 1|Lack of Efficacy|2|||
162108050|NCT00765388|585443969|FG000|Period 1|Lost to Follow-up|0|||
162108051|NCT00765388|585443970|FG001|Period 1|Lost to Follow-up|1|||
162108052|NCT00765388|585443969|FG000|Period 1|Herpes Zoster|0|||
162108053|NCT00765388|585443970|FG001|Period 1|Herpes Zoster|1|||
162108054|NCT00765388|585443969|FG000|Period 1|Hip operation|0|||
162108055|NCT00765388|585443970|FG001|Period 1|Hip operation|1|||
162108056|NCT03923933|585443971|FG000|Overall Study|Lost to Follow-up|1|||
162108057|NCT03923933|585443972|FG001|Overall Study|Lost to Follow-up|0|||
162108058|NCT03923933|585443971|FG000|Overall Study|Withdrawal by Subject|0|||
162108059|NCT03923933|585443972|FG001|Overall Study|Withdrawal by Subject|1|||
162108060|NCT01995461|585443973|FG000|Overall Study|Death|1|||
162108061|NCT01995461|585443973|FG000|Overall Study|Lost to Follow-up|2|||
162108062|NCT01995461|585443973|FG000|Overall Study|Withdrawal by Subject|2|||
162108063|NCT01777854|585443975|FG000|Overall Study|Physician Decision|3|||
162108064|NCT01777854|585443976|FG001|Overall Study|Physician Decision|3|||
162108065|NCT03311373|585443977|FG000|Overall Study|Adverse Event|1|||
162108066|NCT03311373|585443977|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
162108067|NCT03311373|585443977|FG000|Overall Study|Lost to Follow-up|1|||
162108068|NCT03311373|585443977|FG000|Overall Study|Physician Decision|1|||
162108069|NCT03311373|585443977|FG000|Overall Study|Withdrawal by Subject|3|||
162108070|NCT01939548|585443978|FG000|Overall Study|Non compliance|0|||
162108071|NCT01939548|585443979|FG001|Overall Study|Non compliance|2|||
162108072|NCT01939548|585443980|FG002|Overall Study|Non compliance|0|||
162108073|NCT01939548|585443978|FG000|Overall Study|Study Terminated by Sponsor|17|||
162108074|NCT01939548|585443979|FG001|Overall Study|Study Terminated by Sponsor|19|||
162108075|NCT01939548|585443980|FG002|Overall Study|Study Terminated by Sponsor|12|||
162108076|NCT01939548|585443978|FG000|Overall Study|Insufficient Clinical Response|1|||
162108077|NCT01939548|585443979|FG001|Overall Study|Insufficient Clinical Response|0|||
162108078|NCT01939548|585443980|FG002|Overall Study|Insufficient Clinical Response|0|||
162108079|NCT01939548|585443978|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
162108080|NCT01939548|585443979|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
162108081|NCT01939548|585443980|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
162108082|NCT01939548|585443978|FG000|Overall Study|Withdrawal by Subject|4|||
162108083|NCT01939548|585443979|FG001|Overall Study|Withdrawal by Subject|4|||
162108084|NCT01939548|585443980|FG002|Overall Study|Withdrawal by Subject|1|||
162108085|NCT01939548|585443978|FG000|Overall Study|Protocol Violation|7|||
162108086|NCT01939548|585443979|FG001|Overall Study|Protocol Violation|6|||
162108087|NCT01939548|585443980|FG002|Overall Study|Protocol Violation|5|||
162108088|NCT01939548|585443978|FG000|Overall Study|Lost to Follow-up|5|||
162108089|NCT01939548|585443979|FG001|Overall Study|Lost to Follow-up|5|||
162108090|NCT01939548|585443980|FG002|Overall Study|Lost to Follow-up|3|||
162108091|NCT01939548|585443978|FG000|Overall Study|Adverse Event|2|||
162108092|NCT01939548|585443979|FG001|Overall Study|Adverse Event|9|||
162108093|NCT01939548|585443980|FG002|Overall Study|Adverse Event|7|||
162108094|NCT01939548|585443978|FG000|Overall Study|Death|0|||
162108095|NCT01939548|585443979|FG001|Overall Study|Death|0|||
162108096|NCT01939548|585443980|FG002|Overall Study|Death|1|||
162108097|NCT01939548|585443978|FG000|Overall Study|Participant dropped|0|||
162108098|NCT01939548|585443979|FG001|Overall Study|Participant dropped|0|||
162108099|NCT01939548|585443980|FG002|Overall Study|Participant dropped|1|||
162108100|NCT01939548|585443978|FG000|Overall Study|Participant unwilling to continue|0|||
162108101|NCT01939548|585443979|FG001|Overall Study|Participant unwilling to continue|1|||
162108102|NCT01939548|585443980|FG002|Overall Study|Participant unwilling to continue|0|||
162108103|NCT01939548|585443978|FG000|Overall Study|Participant withdrew consent|0|||
162108104|NCT01939548|585443979|FG001|Overall Study|Participant withdrew consent|2|||
162108105|NCT01939548|585443980|FG002|Overall Study|Participant withdrew consent|0|||
162108106|NCT01939548|585443978|FG000|Overall Study|Did not complete follow-up|0|||
162108107|NCT01939548|585443979|FG001|Overall Study|Did not complete follow-up|1|||
162108108|NCT01939548|585443980|FG002|Overall Study|Did not complete follow-up|0|||
162108109|NCT01302119|585443983|FG000|Overall Study|Withdrawal by Subject|30|||
162108110|NCT01302119|585443984|FG001|Overall Study|Withdrawal by Subject|20|||
162108111|NCT01302119|585443983|FG000|Overall Study|Lost to Follow-up|10|||
162108112|NCT01302119|585443984|FG001|Overall Study|Lost to Follow-up|4|||
162108113|NCT01302119|585443983|FG000|Overall Study|Adverse Event|2|||
162108114|NCT01302119|585443984|FG001|Overall Study|Adverse Event|1|||
162108115|NCT01302119|585443983|FG000|Overall Study|Non-compliance|4|||
162108116|NCT01302119|585443984|FG001|Overall Study|Non-compliance|2|||
162108117|NCT01302119|585443983|FG000|Overall Study|Non-specific|4|||
162108118|NCT01302119|585443984|FG001|Overall Study|Non-specific|1|||
162108119|NCT01662310|585443987|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
162108120|NCT01662310|585443988|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
162108121|NCT01662310|585443989|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
162108122|NCT01662310|585443990|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
162108123|NCT01662310|585443991|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
162108124|NCT01662310|585443987|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
162108125|NCT01662310|585443988|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
162108126|NCT01662310|585443989|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
162108127|NCT01662310|585443990|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
162108128|NCT01662310|585443991|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
162108129|NCT01662310|585443987|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
162108130|NCT01662310|585443988|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
162108131|NCT01662310|585443989|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
162108132|NCT01662310|585443990|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
162108133|NCT01662310|585443991|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
162108134|NCT01662310|585443987|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
162108135|NCT01662310|585443988|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
162108136|NCT01662310|585443989|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
162108137|NCT01662310|585443990|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
162108138|NCT01662310|585443991|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
162108139|NCT01662310|585443987|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
162108140|NCT01662310|585443988|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
162108141|NCT01662310|585443989|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
162108142|NCT01662310|585443990|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
162108143|NCT01662310|585443991|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
162108144|NCT01662310|585443987|FG000|Run-In or Stabilization Phase|Other|1|||
162108145|NCT01662310|585443988|FG001|Run-In or Stabilization Phase|Other|0|||
162108146|NCT01662310|585443989|FG002|Run-In or Stabilization Phase|Other|0|||
162108147|NCT01662310|585443990|FG003|Run-In or Stabilization Phase|Other|0|||
162108148|NCT01662310|585443991|FG004|Run-In or Stabilization Phase|Other|0|||
162108149|NCT01662310|585443987|FG000|Double-Blind Phase|Adverse Event|0|||
162108150|NCT01662310|585443988|FG001|Double-Blind Phase|Adverse Event|0|||
162108151|NCT01662310|585443989|FG002|Double-Blind Phase|Adverse Event|1|||
162108152|NCT01662310|585443990|FG003|Double-Blind Phase|Adverse Event|0|||
162108153|NCT01662310|585443991|FG004|Double-Blind Phase|Adverse Event|0|||
162108154|NCT01662310|585443987|FG000|Double-Blind Phase|Lost to Follow-up|0|||
162108155|NCT01662310|585443988|FG001|Double-Blind Phase|Lost to Follow-up|3|||
162108156|NCT01662310|585443989|FG002|Double-Blind Phase|Lost to Follow-up|0|||
162108157|NCT01662310|585443990|FG003|Double-Blind Phase|Lost to Follow-up|0|||
162108158|NCT01662310|585443991|FG004|Double-Blind Phase|Lost to Follow-up|0|||
162108159|NCT01662310|585443987|FG000|Double-Blind Phase|Pregnancy|0|||
162108160|NCT01662310|585443988|FG001|Double-Blind Phase|Pregnancy|2|||
162108161|NCT01662310|585443989|FG002|Double-Blind Phase|Pregnancy|0|||
162108162|NCT01662310|585443990|FG003|Double-Blind Phase|Pregnancy|0|||
162108163|NCT01662310|585443991|FG004|Double-Blind Phase|Pregnancy|0|||
162108164|NCT01662310|585443987|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
162108165|NCT01662310|585443988|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
162108166|NCT01662310|585443989|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
162108167|NCT01662310|585443990|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
162108168|NCT01662310|585443991|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
162108169|NCT01662310|585443987|FG000|Double-Blind Phase|Other|0|||
162108170|NCT01662310|585443988|FG001|Double-Blind Phase|Other|0|||
162108171|NCT01662310|585443989|FG002|Double-Blind Phase|Other|1|||
162108172|NCT01662310|585443990|FG003|Double-Blind Phase|Other|0|||
162108173|NCT01662310|585443991|FG004|Double-Blind Phase|Other|0|||
162108174|NCT01662310|585443987|FG000|Double-Blind Phase|Randomized but not treated|0|||
162108175|NCT01662310|585443988|FG001|Double-Blind Phase|Randomized but not treated|1|||
162108176|NCT01662310|585443989|FG002|Double-Blind Phase|Randomized but not treated|0|||
162108177|NCT01662310|585443990|FG003|Double-Blind Phase|Randomized but not treated|0|||
162108178|NCT01662310|585443991|FG004|Double-Blind Phase|Randomized but not treated|0|||
162108179|NCT01662310|585443987|FG000|Open-Label Extension Phase|Adverse Event|0|||
162108180|NCT01662310|585443988|FG001|Open-Label Extension Phase|Adverse Event|0|||
162108181|NCT01662310|585443989|FG002|Open-Label Extension Phase|Adverse Event|0|||
162108182|NCT01662310|585443990|FG003|Open-Label Extension Phase|Adverse Event|3|||
162108183|NCT01662310|585443991|FG004|Open-Label Extension Phase|Adverse Event|0|||
162108184|NCT01662310|585443987|FG000|Open-Label Extension Phase|Death|0|||
162108185|NCT01662310|585443988|FG001|Open-Label Extension Phase|Death|0|||
162108186|NCT01662310|585443989|FG002|Open-Label Extension Phase|Death|0|||
162108187|NCT01662310|585443990|FG003|Open-Label Extension Phase|Death|1|||
162108188|NCT01662310|585443991|FG004|Open-Label Extension Phase|Death|0|||
162108189|NCT01662310|585443987|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
162108190|NCT01662310|585443988|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
162108191|NCT01662310|585443989|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
162108192|NCT01662310|585443990|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
162108193|NCT01662310|585443991|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
162108194|NCT01662310|585443987|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
162108195|NCT01662310|585443988|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
162108196|NCT01662310|585443989|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
162108197|NCT01662310|585443990|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
162108198|NCT01662310|585443991|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
162108199|NCT01662310|585443987|FG000|Open-Label Extension Phase|Pregnancy|0|||
162108200|NCT01662310|585443988|FG001|Open-Label Extension Phase|Pregnancy|0|||
162108201|NCT01662310|585443989|FG002|Open-Label Extension Phase|Pregnancy|0|||
162108202|NCT01662310|585443990|FG003|Open-Label Extension Phase|Pregnancy|1|||
162108203|NCT01662310|585443991|FG004|Open-Label Extension Phase|Pregnancy|0|||
162108204|NCT01662310|585443987|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
162108205|NCT01662310|585443988|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
162108206|NCT01662310|585443989|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
162108207|NCT01662310|585443990|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
162108208|NCT01662310|585443991|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
162108209|NCT02432105|585443995|FG000|Overall Study|Lost to Follow-up|1|||
162108210|NCT02432105|585443996|FG001|Overall Study|Lost to Follow-up|1|||
162108211|NCT02432105|585443997|FG002|Overall Study|Lost to Follow-up|0|||
162108212|NCT02432105|585443995|FG000|Overall Study|Withdrawal by Subject|1|||
162108213|NCT02432105|585443996|FG001|Overall Study|Withdrawal by Subject|0|||
162108214|NCT02432105|585443997|FG002|Overall Study|Withdrawal by Subject|1|||
162108215|NCT02432105|585443995|FG000|Overall Study|Culture positive for yeast|0|||
162108216|NCT02432105|585443996|FG001|Overall Study|Culture positive for yeast|1|||
162108217|NCT02432105|585443997|FG002|Overall Study|Culture positive for yeast|0|||
162108218|NCT02432105|585443995|FG000|Overall Study|Randomized in error|0|||
162108219|NCT02432105|585443996|FG001|Overall Study|Randomized in error|0|||
162108220|NCT02432105|585443997|FG002|Overall Study|Randomized in error|2|||
162108221|NCT02085252|585444000|FG000|Overall Study|Withdrawal of Consent|1|||
162108222|NCT02085252|585444001|FG001|Overall Study|Withdrawal of Consent|0|||
162108223|NCT02085252|585444000|FG000|Overall Study|Adverse Event|0|||
162108224|NCT02085252|585444001|FG001|Overall Study|Adverse Event|1|||
162108225|NCT02085252|585444000|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
162108226|NCT02085252|585444001|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
162108227|NCT02085252|585444000|FG000|Overall Study|Reason Not Specified|0|||
162108228|NCT02085252|585444001|FG001|Overall Study|Reason Not Specified|1|||
162108229|NCT02085252|585444000|FG000|Overall Study|Reason Unknown|0|||
162108230|NCT02085252|585444001|FG001|Overall Study|Reason Unknown|1|||
162108231|NCT03645759|585444005|FG000|Overall Study|Lost to Follow-up|3|||
162108232|NCT03645759|585444006|FG001|Overall Study|Lost to Follow-up|2|||
162108233|NCT00251745|585444011|FG000|Overall Study|Adverse Event|7|||
162108234|NCT00251745|585444012|FG001|Overall Study|Adverse Event|9|||
162108235|NCT00251745|585444013|FG002|Overall Study|Adverse Event|11|||
162108236|NCT00251745|585444011|FG000|Overall Study|Lost to Follow-up|4|||
162108237|NCT00251745|585444012|FG001|Overall Study|Lost to Follow-up|2|||
162108238|NCT00251745|585444013|FG002|Overall Study|Lost to Follow-up|5|||
162108239|NCT00251745|585444011|FG000|Overall Study|Withdrawal by Subject|13|||
162108240|NCT00251745|585444012|FG001|Overall Study|Withdrawal by Subject|7|||
162108241|NCT00251745|585444013|FG002|Overall Study|Withdrawal by Subject|3|||
162108242|NCT00251745|585444011|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
162108243|NCT00251745|585444012|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
162108244|NCT00251745|585444013|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
162108245|NCT00251745|585444011|FG000|Overall Study|Lack of Efficacy|3|||
162108246|NCT00251745|585444012|FG001|Overall Study|Lack of Efficacy|0|||
162108247|NCT00251745|585444013|FG002|Overall Study|Lack of Efficacy|0|||
162108248|NCT00251745|585444011|FG000|Overall Study|Noncompliant|0|||
162108249|NCT00251745|585444012|FG001|Overall Study|Noncompliant|2|||
162108250|NCT00251745|585444013|FG002|Overall Study|Noncompliant|2|||
162108251|NCT00251745|585444011|FG000|Overall Study|Pregnancy|0|||
162108252|NCT00251745|585444012|FG001|Overall Study|Pregnancy|1|||
162108253|NCT00251745|585444013|FG002|Overall Study|Pregnancy|0|||
162108254|NCT00251745|585444011|FG000|Overall Study|Per Subject Request|0|||
162108255|NCT00251745|585444012|FG001|Overall Study|Per Subject Request|0|||
162108256|NCT00251745|585444013|FG002|Overall Study|Per Subject Request|1|||
162108257|NCT00251745|585444011|FG000|Overall Study|Per Investigator Request|1|||
162108258|NCT00251745|585444012|FG001|Overall Study|Per Investigator Request|0|||
162108259|NCT00251745|585444013|FG002|Overall Study|Per Investigator Request|0|||
162108260|NCT04508699|585444018|FG000|Overall Study|Lack of Efficacy|2|||
162108261|NCT04508699|585444019|FG001|Overall Study|Lack of Efficacy|15|||
162108262|NCT04508699|585444018|FG000|Overall Study|Withdrawal by Subject|0|||
162108263|NCT04508699|585444019|FG001|Overall Study|Withdrawal by Subject|2|||
162108264|NCT02586025|585445735|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
162108265|NCT02586025|585445736|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
162108266|NCT02586025|585445735|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
162108267|NCT02586025|585445736|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
162108268|NCT02586025|585445735|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
162108269|NCT02586025|585445736|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
162108270|NCT02586025|585445735|FG000|Neoadjuvant Treatment|Death|1|||
162108271|NCT02586025|585445736|FG001|Neoadjuvant Treatment|Death|0|||
162108272|NCT02586025|585445735|FG000|Neoadjuvant Treatment|Adverse Event|1|||
162108273|NCT02586025|585445736|FG001|Neoadjuvant Treatment|Adverse Event|0|||
162108274|NCT02586025|585445735|FG000|Neoadjuvant Treatment|Physician Decision|2|||
162108275|NCT02586025|585445736|FG001|Neoadjuvant Treatment|Physician Decision|1|||
162108276|NCT02586025|585445735|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
162108277|NCT02586025|585445736|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
162108278|NCT02586025|585445735|FG000|Adjuvant Treatment|Recurrent Disease|4|||
162108279|NCT02586025|585445736|FG001|Adjuvant Treatment|Recurrent Disease|5|||
162108280|NCT02586025|585445735|FG000|Adjuvant Treatment|Physician Decision|0|||
162108281|NCT02586025|585445736|FG001|Adjuvant Treatment|Physician Decision|1|||
162108282|NCT02586025|585445735|FG000|Adjuvant Treatment|Pregnancy|1|||
162108283|NCT02586025|585445736|FG001|Adjuvant Treatment|Pregnancy|0|||
162108284|NCT02586025|585445735|FG000|Treatment-Free Follow-Up|Death|11|||
162108285|NCT02586025|585445736|FG001|Treatment-Free Follow-Up|Death|11|||
162108286|NCT02586025|585445735|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
162108287|NCT02586025|585445736|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
162108288|NCT02586025|585445735|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
162108289|NCT02586025|585445736|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
162108290|NCT02586025|585445735|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
162108291|NCT02586025|585445736|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
162108292|NCT02586025|585445735|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
162108293|NCT02586025|585445736|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
162108294|NCT00175825|585445737|FG000|Overall Study|Adverse Event|3|||
162108295|NCT00175825|585445738|FG001|Overall Study|Adverse Event|2|||
162108296|NCT00175825|585445739|FG002|Overall Study|Adverse Event|1|||
162108297|NCT00175825|585445740|FG003|Overall Study|Adverse Event|1|||
162108298|NCT00175825|585445737|FG000|Overall Study|Lost to Follow-up|1|||
162108299|NCT00175825|585445738|FG001|Overall Study|Lost to Follow-up|2|||
162108300|NCT00175825|585445739|FG002|Overall Study|Lost to Follow-up|0|||
162108301|NCT00175825|585445740|FG003|Overall Study|Lost to Follow-up|0|||
162108302|NCT00175825|585445737|FG000|Overall Study|Withdrawal by Subject|1|||
162108303|NCT00175825|585445738|FG001|Overall Study|Withdrawal by Subject|0|||
162108304|NCT00175825|585445739|FG002|Overall Study|Withdrawal by Subject|0|||
162108305|NCT00175825|585445740|FG003|Overall Study|Withdrawal by Subject|0|||
162108306|NCT03704584|585445741|FG000|Overall Study|Withdrawal by Subject|1|||
162108307|NCT03704584|585445742|FG001|Overall Study|Withdrawal by Subject|0|||
162108308|NCT03412812|585445743|FG000|Level 1|Death|3|||
162108309|NCT03412812|585445744|FG001|Level 1|Death|0|||
162108310|NCT03412812|585445743|FG000|Level 1|Adverse Event|0|||
162108311|NCT03412812|585445744|FG001|Level 1|Adverse Event|1|||
162108312|NCT03548207|585445747|FG000|Overall Study|Death|10|||
162108313|NCT03548207|585445748|FG001|Overall Study|Death|23|||
162108314|NCT03548207|585445749|FG002|Overall Study|Death|3|||
162108315|NCT03548207|585445747|FG000|Overall Study|Lost to Follow-up|0|||
162108316|NCT03548207|585445748|FG001|Overall Study|Lost to Follow-up|2|||
162108317|NCT03548207|585445749|FG002|Overall Study|Lost to Follow-up|0|||
162108318|NCT03548207|585445747|FG000|Overall Study|Withdrawal by Subject|0|||
162108319|NCT03548207|585445748|FG001|Overall Study|Withdrawal by Subject|3|||
162108320|NCT03548207|585445749|FG002|Overall Study|Withdrawal by Subject|0|||
162108321|NCT03548207|585445747|FG000|Overall Study|Sponsor decision|19|||
162108322|NCT03548207|585445748|FG001|Overall Study|Sponsor decision|40|||
162108323|NCT03548207|585445749|FG002|Overall Study|Sponsor decision|6|||
162108324|NCT03548207|585445747|FG000|Overall Study|Randomized but not treated|6|||
162108325|NCT03548207|585445748|FG001|Overall Study|Randomized but not treated|10|||
162108326|NCT03548207|585445749|FG002|Overall Study|Randomized but not treated|4|||
162108327|NCT01756352|585445750|FG000|Overall Study|moved away and lost to followup|1|||
162108328|NCT03822117|585445751|FG000|Overall Study|Death|18|||
162108329|NCT03822117|585445752|FG001|Overall Study|Death|17|||
162108330|NCT03822117|585445753|FG002|Overall Study|Death|12|||
162108331|NCT03822117|585445754|FG003|Overall Study|Death|4|||
162108332|NCT03822117|585445751|FG000|Overall Study|Lost to Follow-up|1|||
162108333|NCT03822117|585445752|FG001|Overall Study|Lost to Follow-up|2|||
162108334|NCT03822117|585445753|FG002|Overall Study|Lost to Follow-up|3|||
162108335|NCT03822117|585445754|FG003|Overall Study|Lost to Follow-up|0|||
162108336|NCT03822117|585445751|FG000|Overall Study|Study Terminated by Sponsor|25|||
162108337|NCT03822117|585445752|FG001|Overall Study|Study Terminated by Sponsor|11|||
162108338|NCT03822117|585445753|FG002|Overall Study|Study Terminated by Sponsor|6|||
162108339|NCT03822117|585445754|FG003|Overall Study|Study Terminated by Sponsor|0|||
162108340|NCT03822117|585445751|FG000|Overall Study|Withdrawal by Subject|4|||
162108341|NCT03822117|585445752|FG001|Overall Study|Withdrawal by Subject|0|||
162108342|NCT03822117|585445753|FG002|Overall Study|Withdrawal by Subject|3|||
162108343|NCT03822117|585445754|FG003|Overall Study|Withdrawal by Subject|0|||
162108344|NCT03822117|585445751|FG000|Overall Study|Disease Progression|1|||
162108345|NCT03822117|585445752|FG001|Overall Study|Disease Progression|2|||
162108346|NCT03822117|585445753|FG002|Overall Study|Disease Progression|1|||
162108347|NCT03822117|585445754|FG003|Overall Study|Disease Progression|0|||
162108348|NCT03822117|585445751|FG000|Overall Study|Never Returned to Hospital|0|||
162108349|NCT03822117|585445752|FG001|Overall Study|Never Returned to Hospital|0|||
162108350|NCT03822117|585445753|FG002|Overall Study|Never Returned to Hospital|1|||
162108351|NCT03822117|585445754|FG003|Overall Study|Never Returned to Hospital|0|||
162108352|NCT00415610|585445756|FG000|Overall Study|Death|3|||
162108353|NCT00415610|585445757|FG001|Overall Study|Death|2|||
162108354|NCT00415610|585445758|FG002|Overall Study|Death|5|||
162108355|NCT01357616|585445762|FG000|Overall Study|Adverse Event|1|||
162108356|NCT01357616|585445763|FG001|Overall Study|Adverse Event|1|||
162108357|NCT01357616|585445762|FG000|Overall Study|Lost to Follow-up|4|||
162108358|NCT01357616|585445763|FG001|Overall Study|Lost to Follow-up|3|||
162108359|NCT01357616|585445762|FG000|Overall Study|Protocol Violation|0|||
162108360|NCT01357616|585445763|FG001|Overall Study|Protocol Violation|2|||
162108361|NCT01357616|585445762|FG000|Overall Study|Inadequate Control of IOP|1|||
162108362|NCT01357616|585445763|FG001|Overall Study|Inadequate Control of IOP|2|||
162108363|NCT01357616|585445762|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
162108364|NCT01357616|585445763|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
162108365|NCT01357616|585445762|FG000|Overall Study|Withdrawal by Subject|1|||
162108366|NCT01357616|585445763|FG001|Overall Study|Withdrawal by Subject|0|||
162108367|NCT03255824|585445770|FG000|Overall Study|Under-sedation|2|||
162108368|NCT03255824|585445771|FG001|Overall Study|Under-sedation|1|||
162108369|NCT03432364|585445774|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
162108370|NCT00522301|585445775|FG000|Overall Study|Withdrawal by Subject|1|||
162108371|NCT00522301|585445775|FG000|Overall Study|Adverse Event|5|||
162108372|NCT03040713|585445776|FG000|Overall Study|Positive amyloid scan|3|||
162108373|NCT02641392|585445781|FG000|Overall Study|Lost to Follow-up|0|||
162108374|NCT02641392|585445782|FG001|Overall Study|Lost to Follow-up|0|||
162108375|NCT02641392|585445783|FG002|Overall Study|Lost to Follow-up|2|||
162108376|NCT02641392|585445781|FG000|Overall Study|Withdrawal by Subject|0|||
162108377|NCT02641392|585445782|FG001|Overall Study|Withdrawal by Subject|0|||
162108378|NCT02641392|585445783|FG002|Overall Study|Withdrawal by Subject|17|||
162108379|NCT02641392|585445781|FG000|Overall Study|Adverse Event|0|||
162108380|NCT02641392|585445782|FG001|Overall Study|Adverse Event|1|||
162108381|NCT02641392|585445783|FG002|Overall Study|Adverse Event|25|||
162108382|NCT02641392|585445781|FG000|Overall Study|Study Terminated by Sponsor|4|||
162108383|NCT02641392|585445782|FG001|Overall Study|Study Terminated by Sponsor|12|||
162108384|NCT02641392|585445783|FG002|Overall Study|Study Terminated by Sponsor|144|||
162108385|NCT02641392|585445781|FG000|Overall Study|Lack of Efficacy|0|||
162108386|NCT02641392|585445782|FG001|Overall Study|Lack of Efficacy|0|||
162108387|NCT02641392|585445783|FG002|Overall Study|Lack of Efficacy|101|||
162108388|NCT02641392|585445781|FG000|Overall Study|Miscellaneous|0|||
162108389|NCT02641392|585445782|FG001|Overall Study|Miscellaneous|0|||
162108390|NCT02641392|585445783|FG002|Overall Study|Miscellaneous|3|||
162108391|NCT02641392|585445781|FG000|Overall Study|Death|0|||
162108392|NCT02641392|585445782|FG001|Overall Study|Death|0|||
162108393|NCT02641392|585445783|FG002|Overall Study|Death|1|||
162108394|NCT00152464|585445784|FG000|Overall Study|Adverse Event|3|||
162108395|NCT00152464|585445785|FG001|Overall Study|Adverse Event|6|||
162108396|NCT00152464|585445784|FG000|Overall Study|Lost to Follow-up|8|||
162108397|NCT00152464|585445785|FG001|Overall Study|Lost to Follow-up|4|||
162108398|NCT00152464|585445784|FG000|Overall Study|Protocol Violation|3|||
162108399|NCT00152464|585445785|FG001|Overall Study|Protocol Violation|1|||
162108400|NCT00152464|585445784|FG000|Overall Study|Withdrawal by Subject|21|||
162108401|NCT00152464|585445785|FG001|Overall Study|Withdrawal by Subject|22|||
162108402|NCT00152464|585445784|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
162108403|NCT00152464|585445785|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
162108404|NCT00152464|585445784|FG000|Overall Study|Eczema deterioration|0|||
162108405|NCT00152464|585445785|FG001|Overall Study|Eczema deterioration|1|||
162108406|NCT00152464|585445784|FG000|Overall Study|Parent decision|1|||
162108407|NCT00152464|585445785|FG001|Overall Study|Parent decision|1|||
162108408|NCT00152464|585445784|FG000|Overall Study|Investigator decision|1|||
162108409|NCT00152464|585445785|FG001|Overall Study|Investigator decision|0|||
162108410|NCT00152464|585445784|FG000|Overall Study|Lack of Efficacy|1|||
162108411|NCT00152464|585445785|FG001|Overall Study|Lack of Efficacy|0|||
162108412|NCT00152464|585445784|FG000|Overall Study|Eczema poorly controlled|1|||
162108413|NCT00152464|585445785|FG001|Overall Study|Eczema poorly controlled|0|||
162108414|NCT00152464|585445784|FG000|Overall Study|Patient relocated|1|||
162108415|NCT00152464|585445785|FG001|Overall Study|Patient relocated|0|||
162108416|NCT00430248|585445788|FG000|Overall Study|Adverse Event|49|||
162108417|NCT00430248|585445789|FG001|Overall Study|Adverse Event|61|||
162108418|NCT00430248|585445790|FG002|Overall Study|Adverse Event|64|||
162108419|NCT00430248|585445788|FG000|Overall Study|Protocol Violation|10|||
162108420|NCT00430248|585445789|FG001|Overall Study|Protocol Violation|2|||
162108421|NCT00430248|585445790|FG002|Overall Study|Protocol Violation|4|||
162108422|NCT00430248|585445788|FG000|Overall Study|Personal Reasons|12|||
162108423|NCT00430248|585445789|FG001|Overall Study|Personal Reasons|24|||
162108424|NCT00430248|585445790|FG002|Overall Study|Personal Reasons|9|||
162108425|NCT00430248|585445788|FG000|Overall Study|Lost to Follow-up|28|||
162108426|NCT00430248|585445789|FG001|Overall Study|Lost to Follow-up|33|||
162108427|NCT00430248|585445790|FG002|Overall Study|Lost to Follow-up|28|||
162108428|NCT00430248|585445788|FG000|Overall Study|Therapeutic Failure|1|||
162108429|NCT00430248|585445789|FG001|Overall Study|Therapeutic Failure|1|||
162108430|NCT00430248|585445790|FG002|Overall Study|Therapeutic Failure|1|||
162108431|NCT00430248|585445788|FG000|Overall Study|Withdrawal by Subject|14|||
162108432|NCT00430248|585445789|FG001|Overall Study|Withdrawal by Subject|20|||
162108433|NCT00430248|585445790|FG002|Overall Study|Withdrawal by Subject|16|||
162108434|NCT00430248|585445788|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162108435|NCT00430248|585445789|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
162108436|NCT00430248|585445790|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
162108437|NCT00430248|585445788|FG000|Overall Study|Gout Flare|3|||
162108438|NCT00430248|585445789|FG001|Overall Study|Gout Flare|7|||
162108439|NCT00430248|585445790|FG002|Overall Study|Gout Flare|2|||
162108440|NCT00430248|585445788|FG000|Overall Study|Reason Not Specified|8|||
162108441|NCT00430248|585445789|FG001|Overall Study|Reason Not Specified|8|||
162108442|NCT00430248|585445790|FG002|Overall Study|Reason Not Specified|11|||
162108443|NCT03466086|585445793|FG000|Period 1|Sponsor decision due to study timeline|1|||
162108444|NCT03466086|585445794|FG001|Period 1|Sponsor decision due to study timeline|0|||
162108445|NCT03466086|585445793|FG000|Period 1|Withdrawal by Subject|1|||
162108446|NCT03466086|585445794|FG001|Period 1|Withdrawal by Subject|0|||
162108447|NCT00002558|585445795|FG000|Overall Study|Withdrawal by Subject|0|||
162108448|NCT00002558|585445796|FG001|Overall Study|Withdrawal by Subject|1|||
162108449|NCT01260350|585445798|FG000|Overall Study|Lack of Efficacy|0|||
162108450|NCT01260350|585445799|FG001|Overall Study|Lack of Efficacy|0|||
162108451|NCT01260350|585445800|FG002|Overall Study|Lack of Efficacy|0|||
162108452|NCT01260350|585445801|FG003|Overall Study|Lack of Efficacy|0|||
162108453|NCT01260350|585445802|FG004|Overall Study|Lack of Efficacy|0|||
162108454|NCT01260350|585445803|FG005|Overall Study|Lack of Efficacy|0|||
162108455|NCT01260350|585445804|FG006|Overall Study|Lack of Efficacy|0|||
162108456|NCT01260350|585445805|FG007|Overall Study|Lack of Efficacy|0|||
162108457|NCT01260350|585445806|FG008|Overall Study|Lack of Efficacy|0|||
162108458|NCT01260350|585445807|FG009|Overall Study|Lack of Efficacy|0|||
162108459|NCT01260350|585445808|FG010|Overall Study|Lack of Efficacy|0|||
162108460|NCT01260350|585445809|FG011|Overall Study|Lack of Efficacy|0|||
162108461|NCT01260350|585445810|FG012|Overall Study|Lack of Efficacy|0|||
162108462|NCT01260350|585445811|FG013|Overall Study|Lack of Efficacy|0|||
162108463|NCT01260350|585445812|FG014|Overall Study|Lack of Efficacy|0|||
162108464|NCT01260350|585445813|FG015|Overall Study|Lack of Efficacy|0|||
162108465|NCT01260350|585445814|FG016|Overall Study|Lack of Efficacy|0|||
162108466|NCT01260350|585445815|FG017|Overall Study|Lack of Efficacy|1|||
162108467|NCT01260350|585445816|FG018|Overall Study|Lack of Efficacy|0|||
162108468|NCT01260350|585445817|FG019|Overall Study|Lack of Efficacy|0|||
162108469|NCT01260350|585445818|FG020|Overall Study|Lack of Efficacy|3|||
162108470|NCT01260350|585445819|FG021|Overall Study|Lack of Efficacy|0|||
162108471|NCT01260350|585445798|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108472|NCT01260350|585445799|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108473|NCT01260350|585445800|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108474|NCT01260350|585445801|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108475|NCT01260350|585445802|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108476|NCT01260350|585445803|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108477|NCT01260350|585445804|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108478|NCT01260350|585445805|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108479|NCT01260350|585445806|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
162108480|NCT01260350|585445807|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108481|NCT01260350|585445808|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108482|NCT01260350|585445809|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108483|NCT01260350|585445810|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108484|NCT01260350|585445811|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108485|NCT01260350|585445812|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108486|NCT01260350|585445813|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108487|NCT01260350|585445814|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108488|NCT01260350|585445815|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108489|NCT01260350|585445816|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108490|NCT01260350|585445817|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108491|NCT01260350|585445818|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108492|NCT01260350|585445819|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
162108493|NCT02123108|585445822|FG000|Overall Study|Death|2|||
162108494|NCT02123108|585445823|FG001|Overall Study|Death|3|||
162108495|NCT02219048|585445827|FG000|Overall Study|Adverse Event|2|||
162108496|NCT02219048|585445828|FG001|Overall Study|Adverse Event|5|||
162108497|NCT02219048|585445827|FG000|Overall Study|No longer meets eligibility criteria|1|||
162108498|NCT02219048|585445828|FG001|Overall Study|No longer meets eligibility criteria|0|||
162108499|NCT02219048|585445827|FG000|Overall Study|Study terminated by sponsor|16|||
162108500|NCT02219048|585445828|FG001|Overall Study|Study terminated by sponsor|15|||
162108501|NCT02219048|585445827|FG000|Overall Study|Withdrawal by Subject|2|||
162108502|NCT02219048|585445828|FG001|Overall Study|Withdrawal by Subject|0|||
162108503|NCT02219048|585445827|FG000|Overall Study|Other|0|||
162108504|NCT02219048|585445828|FG001|Overall Study|Other|1|||
162108505|NCT04721925|585445829|FG000|2-Month Assessment|Lost to Follow-up|5|||
162108506|NCT04721925|585445830|FG001|2-Month Assessment|Lost to Follow-up|3|||
162108507|NCT04721925|585445829|FG000|4-Month Assessment|Lost to Follow-up|3|||
162108508|NCT04721925|585445830|FG001|4-Month Assessment|Lost to Follow-up|6|||
162108509|NCT01274182|585445839|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
162108510|NCT01274182|585445840|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
162108511|NCT01274182|585445841|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
162108512|NCT01274182|585445839|FG000|Overall Study|Adverse Event|4|||
162108513|NCT01274182|585445840|FG001|Overall Study|Adverse Event|5|||
162108514|NCT01274182|585445841|FG002|Overall Study|Adverse Event|3|||
162108515|NCT01274182|585445839|FG000|Overall Study|Withdrawal by Subject|5|||
162108516|NCT01274182|585445840|FG001|Overall Study|Withdrawal by Subject|5|||
162108517|NCT01274182|585445841|FG002|Overall Study|Withdrawal by Subject|3|||
162108518|NCT01274182|585445839|FG000|Overall Study|Lost to Follow-up|2|||
162108519|NCT01274182|585445840|FG001|Overall Study|Lost to Follow-up|3|||
162108520|NCT01274182|585445841|FG002|Overall Study|Lost to Follow-up|1|||
162108521|NCT01274182|585445839|FG000|Overall Study|Protocol Violation|3|||
162108522|NCT01274182|585445840|FG001|Overall Study|Protocol Violation|2|||
162108523|NCT01274182|585445841|FG002|Overall Study|Protocol Violation|0|||
162108524|NCT01274182|585445839|FG000|Overall Study|Death|1|||
162108525|NCT01274182|585445840|FG001|Overall Study|Death|0|||
162108526|NCT01274182|585445841|FG002|Overall Study|Death|1|||
162108527|NCT01970982|585445842|FG000|Overall Study|Withdrawal by Subject|0|||
162108528|NCT01970982|585445843|FG001|Overall Study|Withdrawal by Subject|0|||
162108529|NCT01970982|585445844|FG002|Overall Study|Withdrawal by Subject|2|||
162108530|NCT04040751|585445849|FG000|Overall Study|Withdrawal by Subject|2|||
162108531|NCT04040751|585445850|FG001|Overall Study|Withdrawal by Subject|0|||
162108532|NCT04040751|585445851|FG002|Overall Study|Withdrawal by Subject|2|||
162108533|NCT04040751|585445852|FG003|Overall Study|Withdrawal by Subject|0|||
162108534|NCT02862457|585445853|FG000|Overall Study|Death|1|||
162108535|NCT02862457|585445854|FG001|Overall Study|Death|3|||
162108536|NCT02862457|585445855|FG002|Overall Study|Death|2|||
162108537|NCT02862457|585445856|FG003|Overall Study|Death|3|||
162108538|NCT02862457|585445857|FG004|Overall Study|Death|0|||
162108539|NCT02862457|585445858|FG005|Overall Study|Death|2|||
162108540|NCT02862457|585445859|FG006|Overall Study|Death|1|||
162108541|NCT02862457|585445853|FG000|Overall Study|Lost to Follow-up|1|||
162108542|NCT02862457|585445854|FG001|Overall Study|Lost to Follow-up|0|||
162108543|NCT02862457|585445855|FG002|Overall Study|Lost to Follow-up|0|||
162108544|NCT02862457|585445856|FG003|Overall Study|Lost to Follow-up|1|||
162108545|NCT02862457|585445857|FG004|Overall Study|Lost to Follow-up|0|||
162108546|NCT02862457|585445858|FG005|Overall Study|Lost to Follow-up|0|||
162108547|NCT02862457|585445859|FG006|Overall Study|Lost to Follow-up|0|||
162108548|NCT02862457|585445853|FG000|Overall Study|Withdrawal by Subject|0|||
162108549|NCT02862457|585445854|FG001|Overall Study|Withdrawal by Subject|0|||
162108550|NCT02862457|585445855|FG002|Overall Study|Withdrawal by Subject|1|||
162108551|NCT02862457|585445856|FG003|Overall Study|Withdrawal by Subject|0|||
162108552|NCT02862457|585445857|FG004|Overall Study|Withdrawal by Subject|0|||
162108553|NCT02862457|585445858|FG005|Overall Study|Withdrawal by Subject|1|||
162108554|NCT02862457|585445859|FG006|Overall Study|Withdrawal by Subject|0|||
162108555|NCT03364751|585445860|FG000|Overall Study|Withdrawal by Subject|1|||
162108556|NCT03364751|585445861|FG001|Overall Study|Withdrawal by Subject|0|||
162108557|NCT03364751|585445862|FG002|Overall Study|Withdrawal by Subject|0|||
162108558|NCT03364751|585445863|FG003|Overall Study|Withdrawal by Subject|0|||
162108559|NCT03364751|585445860|FG000|Overall Study|Lost to Follow-up|0|||
162108560|NCT03364751|585445861|FG001|Overall Study|Lost to Follow-up|1|||
162108561|NCT03364751|585445862|FG002|Overall Study|Lost to Follow-up|0|||
162108562|NCT03364751|585445863|FG003|Overall Study|Lost to Follow-up|0|||
162108563|NCT02342886|585445865|FG000|Overall Study|Treatment non-compliance|1|||
162108564|NCT02342886|585445866|FG001|Overall Study|Treatment non-compliance|0|||
162108565|NCT02342886|585445867|FG002|Overall Study|Treatment non-compliance|0|||
162108566|NCT02342886|585445868|FG003|Overall Study|Treatment non-compliance|1|||
162108567|NCT02342886|585445869|FG004|Overall Study|Treatment non-compliance|0|||
162108568|NCT02342886|585445865|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
162108569|NCT02342886|585445866|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
162108570|NCT02342886|585445867|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
162108571|NCT02342886|585445868|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
162108572|NCT02342886|585445869|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
162108573|NCT02342886|585445865|FG000|Overall Study|Adverse event/specific toxicity|4|||
162108574|NCT02342886|585445866|FG001|Overall Study|Adverse event/specific toxicity|3|||
162108575|NCT02342886|585445867|FG002|Overall Study|Adverse event/specific toxicity|11|||
162108576|NCT02342886|585445868|FG003|Overall Study|Adverse event/specific toxicity|2|||
162108577|NCT02342886|585445869|FG004|Overall Study|Adverse event/specific toxicity|1|||
162108578|NCT02342886|585445865|FG000|Overall Study|Lost to Follow-up|1|||
162108579|NCT02342886|585445866|FG001|Overall Study|Lost to Follow-up|0|||
162108580|NCT02342886|585445867|FG002|Overall Study|Lost to Follow-up|0|||
162108581|NCT02342886|585445868|FG003|Overall Study|Lost to Follow-up|0|||
162108582|NCT02342886|585445869|FG004|Overall Study|Lost to Follow-up|0|||
162108583|NCT02342886|585445865|FG000|Overall Study|Death|1|||
162108584|NCT02342886|585445866|FG001|Overall Study|Death|2|||
162108585|NCT02342886|585445867|FG002|Overall Study|Death|1|||
162108586|NCT02342886|585445868|FG003|Overall Study|Death|0|||
162108587|NCT02342886|585445869|FG004|Overall Study|Death|1|||
162108588|NCT02342886|585445865|FG000|Overall Study|Withdrawal by Subject|0|||
162108589|NCT02342886|585445866|FG001|Overall Study|Withdrawal by Subject|1|||
162108590|NCT02342886|585445867|FG002|Overall Study|Withdrawal by Subject|0|||
162108591|NCT02342886|585445868|FG003|Overall Study|Withdrawal by Subject|1|||
162108592|NCT02342886|585445869|FG004|Overall Study|Withdrawal by Subject|0|||
162108593|NCT02342886|585445865|FG000|Overall Study|Investigator/sponsor decision|0|||
162108594|NCT02342886|585445866|FG001|Overall Study|Investigator/sponsor decision|2|||
162108595|NCT02342886|585445867|FG002|Overall Study|Investigator/sponsor decision|0|||
162108596|NCT02342886|585445868|FG003|Overall Study|Investigator/sponsor decision|3|||
162108597|NCT02342886|585445869|FG004|Overall Study|Investigator/sponsor decision|1|||
162108598|NCT02342886|585445865|FG000|Overall Study|Pregnancy|0|||
162108599|NCT02342886|585445866|FG001|Overall Study|Pregnancy|0|||
162108600|NCT02342886|585445867|FG002|Overall Study|Pregnancy|2|||
162108601|NCT02342886|585445868|FG003|Overall Study|Pregnancy|0|||
162108602|NCT02342886|585445869|FG004|Overall Study|Pregnancy|0|||
162108603|NCT02342886|585445865|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
162108604|NCT02342886|585445866|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
162108605|NCT02342886|585445867|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
162108606|NCT02342886|585445868|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
162108607|NCT02342886|585445869|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
162108608|NCT02342886|585445865|FG000|Overall Study|Protocol Violation|0|||
162108609|NCT02342886|585445866|FG001|Overall Study|Protocol Violation|0|||
162108610|NCT02342886|585445867|FG002|Overall Study|Protocol Violation|0|||
162108611|NCT02342886|585445868|FG003|Overall Study|Protocol Violation|2|||
162108612|NCT02342886|585445869|FG004|Overall Study|Protocol Violation|0|||
162108613|NCT00862134|585445870|FG000|Overall Study|Death|1|||
162108614|NCT00862134|585445871|FG001|Overall Study|Death|0|||
162108615|NCT00862134|585445870|FG000|Overall Study|Physician Decision|0|||
162108616|NCT00862134|585445871|FG001|Overall Study|Physician Decision|1|||
162108617|NCT00862134|585445870|FG000|Overall Study|Withdrawal by Subject|1|||
162108618|NCT00862134|585445871|FG001|Overall Study|Withdrawal by Subject|2|||
162108619|NCT00862134|585445870|FG000|Overall Study|Sponsor terminated study|5|||
162108620|NCT00862134|585445871|FG001|Overall Study|Sponsor terminated study|7|||
162108621|NCT00862134|585445870|FG000|Overall Study|Adverse Event|2|||
162108622|NCT00862134|585445871|FG001|Overall Study|Adverse Event|2|||
162108623|NCT00862134|585445870|FG000|Overall Study|Withdrew prior to dosing|2|||
162108624|NCT00862134|585445871|FG001|Overall Study|Withdrew prior to dosing|0|||
162108625|NCT00765674|585445872|FG000|Overall Study|Adverse Event|7|||
162108626|NCT00765674|585445873|FG001|Overall Study|Adverse Event|2|||
162108627|NCT00765674|585445874|FG002|Overall Study|Adverse Event|8|||
162108628|NCT00765674|585445875|FG003|Overall Study|Adverse Event|11|||
162108629|NCT00765674|585445872|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
162108630|NCT00765674|585445873|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
162108631|NCT00765674|585445874|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
162108632|NCT00765674|585445875|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
162108633|NCT00765674|585445872|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
162108634|NCT00765674|585445873|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
162108635|NCT00765674|585445874|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
162108636|NCT00765674|585445875|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
162108637|NCT00765674|585445872|FG000|Overall Study|Lack of Efficacy|2|||
162108638|NCT00765674|585445873|FG001|Overall Study|Lack of Efficacy|3|||
162108639|NCT00765674|585445874|FG002|Overall Study|Lack of Efficacy|1|||
162108640|NCT00765674|585445875|FG003|Overall Study|Lack of Efficacy|2|||
162108641|NCT00765674|585445872|FG000|Overall Study|Protocol Violation|2|||
162108642|NCT00765674|585445873|FG001|Overall Study|Protocol Violation|0|||
162108643|NCT00765674|585445874|FG002|Overall Study|Protocol Violation|1|||
162108644|NCT00765674|585445875|FG003|Overall Study|Protocol Violation|0|||
162108645|NCT00765674|585445872|FG000|Overall Study|Withdrawal by Subject|5|||
162108646|NCT00765674|585445873|FG001|Overall Study|Withdrawal by Subject|7|||
162108647|NCT00765674|585445874|FG002|Overall Study|Withdrawal by Subject|3|||
162108648|NCT00765674|585445875|FG003|Overall Study|Withdrawal by Subject|8|||
162108649|NCT00765674|585445872|FG000|Overall Study|Lost to Follow-up|4|||
162108650|NCT00765674|585445873|FG001|Overall Study|Lost to Follow-up|6|||
162108651|NCT00765674|585445874|FG002|Overall Study|Lost to Follow-up|2|||
162108652|NCT00765674|585445875|FG003|Overall Study|Lost to Follow-up|1|||
162108653|NCT00765674|585445872|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
162108654|NCT00765674|585445873|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
162108655|NCT00765674|585445874|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
162108656|NCT00765674|585445875|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
162108657|NCT03015402|585445876|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
162108658|NCT03015402|585445877|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
162108659|NCT03015402|585445876|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
162108660|NCT03015402|585445877|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
162108661|NCT01813474|585445878|FG000|Overall Study|Withdrawal by Subject|0|||
162108662|NCT01813474|585445879|FG001|Overall Study|Withdrawal by Subject|0|||
162108663|NCT01813474|585445880|FG002|Overall Study|Withdrawal by Subject|1|||
162108664|NCT01813474|585445878|FG000|Overall Study|Adverse Event|1|||
162108665|NCT01813474|585445879|FG001|Overall Study|Adverse Event|1|||
162108666|NCT01813474|585445880|FG002|Overall Study|Adverse Event|0|||
162108667|NCT01813474|585445878|FG000|Overall Study|Lack of Efficacy|2|||
162108668|NCT01813474|585445879|FG001|Overall Study|Lack of Efficacy|6|||
162108669|NCT01813474|585445880|FG002|Overall Study|Lack of Efficacy|9|||
162108670|NCT01813474|585445878|FG000|Overall Study|Death|0|||
162108671|NCT01813474|585445879|FG001|Overall Study|Death|0|||
162108672|NCT01813474|585445880|FG002|Overall Study|Death|1|||
162108673|NCT00316082|585445886|FG000|Overall Study|Lack of Efficacy|2|||
162108674|NCT00316082|585445887|FG001|Overall Study|Lack of Efficacy|3|||
162108675|NCT00316082|585445888|FG002|Overall Study|Lack of Efficacy|3|||
162108676|NCT00316082|585445889|FG003|Overall Study|Lack of Efficacy|4|||
162108677|NCT00316082|585445890|FG004|Overall Study|Lack of Efficacy|6|||
162108678|NCT00316082|585445886|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
162108679|NCT00316082|585445887|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
162108680|NCT00316082|585445888|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
162108681|NCT00316082|585445889|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
162108682|NCT00316082|585445890|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
162108683|NCT00316082|585445886|FG000|Overall Study|Lost to Follow-up|7|||
162108684|NCT00316082|585445887|FG001|Overall Study|Lost to Follow-up|6|||
162108685|NCT00316082|585445888|FG002|Overall Study|Lost to Follow-up|7|||
162108686|NCT00316082|585445889|FG003|Overall Study|Lost to Follow-up|8|||
162108687|NCT00316082|585445890|FG004|Overall Study|Lost to Follow-up|6|||
162108688|NCT00316082|585445886|FG000|Overall Study|Poor/noncompliance|6|||
162108689|NCT00316082|585445887|FG001|Overall Study|Poor/noncompliance|1|||
162108690|NCT00316082|585445888|FG002|Overall Study|Poor/noncompliance|4|||
162108691|NCT00316082|585445889|FG003|Overall Study|Poor/noncompliance|1|||
162108692|NCT00316082|585445890|FG004|Overall Study|Poor/noncompliance|4|||
162108693|NCT00316082|585445886|FG000|Overall Study|Adverse Event|4|||
162108694|NCT00316082|585445887|FG001|Overall Study|Adverse Event|2|||
162108695|NCT00316082|585445888|FG002|Overall Study|Adverse Event|5|||
162108696|NCT00316082|585445889|FG003|Overall Study|Adverse Event|1|||
162108697|NCT00316082|585445890|FG004|Overall Study|Adverse Event|3|||
162108698|NCT00316082|585445886|FG000|Overall Study|Subject no longer meets study criteria|3|||
162108699|NCT00316082|585445887|FG001|Overall Study|Subject no longer meets study criteria|1|||
162108700|NCT00316082|585445888|FG002|Overall Study|Subject no longer meets study criteria|2|||
162108701|NCT00316082|585445889|FG003|Overall Study|Subject no longer meets study criteria|2|||
162108702|NCT00316082|585445890|FG004|Overall Study|Subject no longer meets study criteria|1|||
162108703|NCT00316082|585445886|FG000|Overall Study|Physician Decision|1|||
162108704|NCT00316082|585445887|FG001|Overall Study|Physician Decision|1|||
162108705|NCT00316082|585445888|FG002|Overall Study|Physician Decision|2|||
162108706|NCT00316082|585445889|FG003|Overall Study|Physician Decision|1|||
162108707|NCT00316082|585445890|FG004|Overall Study|Physician Decision|1|||
162108708|NCT00316082|585445886|FG000|Overall Study|Death|0|||
162108709|NCT00316082|585445887|FG001|Overall Study|Death|0|||
162108710|NCT00316082|585445888|FG002|Overall Study|Death|1|||
162108711|NCT00316082|585445889|FG003|Overall Study|Death|0|||
162108712|NCT00316082|585445890|FG004|Overall Study|Death|0|||
162108713|NCT00316082|585445886|FG000|Overall Study|Administrative reason by sponsor|0|||
162108714|NCT00316082|585445887|FG001|Overall Study|Administrative reason by sponsor|0|||
162108715|NCT00316082|585445888|FG002|Overall Study|Administrative reason by sponsor|1|||
162108716|NCT00316082|585445889|FG003|Overall Study|Administrative reason by sponsor|0|||
162108717|NCT00316082|585445890|FG004|Overall Study|Administrative reason by sponsor|0|||
162108718|NCT02216773|585445891|FG000|Overall Study|Disease progression|4|||
162108719|NCT02216773|585445892|FG001|Overall Study|Disease progression|2|||
162108720|NCT02216773|585445891|FG000|Overall Study|Insufficient FLRV|4|||
162108721|NCT02216773|585445892|FG001|Overall Study|Insufficient FLRV|0|||
162108722|NCT02216773|585445891|FG000|Overall Study|Abandoned|4|||
162108723|NCT02216773|585445892|FG001|Overall Study|Abandoned|3|||
162108724|NCT00528775|585445893|FG000|Overall Study|Other not specified|1|||
162108725|NCT02012491|585445906|FG000|Overall Study|Lost to Follow-up|1|||
162108726|NCT02012491|585445907|FG001|Overall Study|Lost to Follow-up|0|||
162108727|NCT02012491|585445906|FG000|Overall Study|Protocol Violation|0|||
162108728|NCT02012491|585445907|FG001|Overall Study|Protocol Violation|1|||
162108729|NCT02012491|585445906|FG000|Overall Study|Withdrawal by Subject|1|||
162108730|NCT02012491|585445907|FG001|Overall Study|Withdrawal by Subject|0|||
162108731|NCT00941330|585445911|FG000|Overall Study|Other|1|||
162108732|NCT00941330|585445912|FG001|Overall Study|Other|0|||
162108733|NCT00941330|585445911|FG000|Overall Study|Physician Decision|0|||
162108734|NCT00941330|585445912|FG001|Overall Study|Physician Decision|2|||
162108735|NCT00541450|585445913|FG000|Phase A|Adverse Event|3|||
162108736|NCT00541450|585445914|FG001|Phase A|Adverse Event|0|||
162108737|NCT00541450|585445913|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
162108738|NCT00541450|585445914|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
162108739|NCT00541450|585445913|FG000|Phase A|Hyperglycemia|0|||
162108740|NCT00541450|585445914|FG001|Phase A|Hyperglycemia|1|||
162108741|NCT00541450|585445913|FG000|Phase A|Lost to Follow-up|6|||
162108742|NCT00541450|585445914|FG001|Phase A|Lost to Follow-up|4|||
162108743|NCT00541450|585445913|FG000|Phase A|Physician Decision|2|||
162108744|NCT00541450|585445914|FG001|Phase A|Physician Decision|0|||
162108745|NCT00541450|585445913|FG000|Phase A|Protocol Violation|2|||
162108746|NCT00541450|585445914|FG001|Phase A|Protocol Violation|3|||
162108747|NCT00541450|585445913|FG000|Phase A|Withdrawal by Subject|7|||
162108748|NCT00541450|585445914|FG001|Phase A|Withdrawal by Subject|7|||
162108749|NCT00541450|585445913|FG000|Phase B|Adverse Event|6|||
162108750|NCT00541450|585445914|FG001|Phase B|Adverse Event|6|||
162108751|NCT00541450|585445913|FG000|Phase B|Hyperglycemia|10|||
162108752|NCT00541450|585445914|FG001|Phase B|Hyperglycemia|9|||
162108753|NCT00541450|585445913|FG000|Phase B|Lost to Follow-up|6|||
162108754|NCT00541450|585445914|FG001|Phase B|Lost to Follow-up|4|||
162108755|NCT00541450|585445913|FG000|Phase B|Physician Decision|4|||
162108756|NCT00541450|585445914|FG001|Phase B|Physician Decision|2|||
162108757|NCT00541450|585445913|FG000|Phase B|Pregnancy|0|||
162108758|NCT00541450|585445914|FG001|Phase B|Pregnancy|1|||
162108759|NCT00541450|585445913|FG000|Phase B|Protocol Violation|3|||
162108760|NCT00541450|585445914|FG001|Phase B|Protocol Violation|3|||
162108761|NCT00541450|585445913|FG000|Phase B|Withdrawal by Subject|8|||
162108762|NCT00541450|585445914|FG001|Phase B|Withdrawal by Subject|6|||
162108763|NCT02816138|585445915|FG000|Overall Study|Adverse Event|1|||
162108764|NCT00981084|585445916|FG000|Post Intervention (Data Analysis)|poor effort|1|||
162108765|NCT00981084|585445917|FG001|Post Intervention (Data Analysis)|poor effort|1|||
162108766|NCT00981084|585445916|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
162108767|NCT00981084|585445917|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
162108768|NCT01112579|585445918|FG000|Overall Study|Missed Visit|1|||
162108769|NCT01112579|585445919|FG001|Overall Study|Missed Visit|1|||
162108770|NCT01112579|585445918|FG000|Overall Study|Death|0|||
162108771|NCT01112579|585445919|FG001|Overall Study|Death|2|||
162108772|NCT01648270|585445920|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
162108773|NCT00818753|585445921|FG000|Overall Study|Protocol Violation|1|||
162108774|NCT00818753|585445922|FG001|Overall Study|Protocol Violation|0|||
162108775|NCT00818753|585445923|FG002|Overall Study|Protocol Violation|0|||
162108776|NCT00818753|585445921|FG000|Overall Study|Other reason (not specified)|0|||
162108777|NCT00818753|585445922|FG001|Overall Study|Other reason (not specified)|0|||
162108778|NCT00818753|585445923|FG002|Overall Study|Other reason (not specified)|1|||
162108779|NCT00818753|585445921|FG000|Overall Study|Randomised and not treated|2|||
162108780|NCT00818753|585445922|FG001|Overall Study|Randomised and not treated|0|||
162108781|NCT00818753|585445923|FG002|Overall Study|Randomised and not treated|0|||
162108782|NCT01389973|585445924|FG000|Overall Study|Lost to Follow-up|1|||
162108783|NCT01389973|585445924|FG000|Overall Study|Trial Stopped by Sponsor|9|||
162108784|NCT01389973|585445924|FG000|Overall Study|Other|10|||
162108785|NCT00725296|585445925|FG000|Overall Study|Adverse Event|11|||
162108786|NCT00725296|585445925|FG000|Overall Study|Lack of Efficacy|7|||
162108787|NCT00725296|585445925|FG000|Overall Study|Withdrawal by Subject|3|||
162108788|NCT00725296|585445925|FG000|Overall Study|Non-Compliance|2|||
162108789|NCT00725296|585445925|FG000|Overall Study|Lost to Follow-up|1|||
162108790|NCT00725296|585445925|FG000|Overall Study|Other|38|||
162108791|NCT03360942|585445926|FG000|Overall Study|Device explanted|2|||
162108792|NCT03360942|585445926|FG000|Overall Study|Study closure|1|||
162108793|NCT03360942|585445926|FG000|Overall Study|Withdrawal by Subject|2|||
162108794|NCT03456700|585445927|FG000|Overall Study|Withdrawal by Subject|1|||
162108795|NCT00613951|585445930|FG000|Overall Study|Adverse Event|1|||
162108796|NCT00613951|585445931|FG001|Overall Study|Adverse Event|0|||
162108797|NCT00613951|585445932|FG002|Overall Study|Adverse Event|1|||
162108798|NCT00613951|585445930|FG000|Overall Study|Lack of Efficacy|0|||
162108799|NCT00613951|585445931|FG001|Overall Study|Lack of Efficacy|1|||
162108800|NCT00613951|585445932|FG002|Overall Study|Lack of Efficacy|1|||
162108801|NCT00613951|585445930|FG000|Overall Study|Protocol Violation|1|||
162108802|NCT00613951|585445931|FG001|Overall Study|Protocol Violation|1|||
162108803|NCT00613951|585445932|FG002|Overall Study|Protocol Violation|1|||
162108804|NCT00613951|585445930|FG000|Overall Study|Unclassified|5|||
162108805|NCT00613951|585445931|FG001|Overall Study|Unclassified|3|||
162108806|NCT00613951|585445932|FG002|Overall Study|Unclassified|2|||
162108807|NCT03053050|585445934|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
162108808|NCT03053050|585445935|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
162108809|NCT03053050|585445936|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
162108810|NCT03053050|585445937|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
162108811|NCT03053050|585445934|FG000|Randomized Phase|Withdrew Consent|16|||
162108812|NCT03053050|585445935|FG001|Randomized Phase|Withdrew Consent|8|||
162108813|NCT03053050|585445936|FG002|Randomized Phase|Withdrew Consent|9|||
162108814|NCT03053050|585445937|FG003|Randomized Phase|Withdrew Consent|0|||
162108815|NCT03053050|585445934|FG000|Randomized Phase|Investigator's Discretion|6|||
162108816|NCT03053050|585445935|FG001|Randomized Phase|Investigator's Discretion|6|||
162108817|NCT03053050|585445936|FG002|Randomized Phase|Investigator's Discretion|3|||
162108818|NCT03053050|585445937|FG003|Randomized Phase|Investigator's Discretion|0|||
162108819|NCT03053050|585445934|FG000|Randomized Phase|Lost to Follow-up|5|||
162108820|NCT03053050|585445935|FG001|Randomized Phase|Lost to Follow-up|1|||
162108821|NCT03053050|585445936|FG002|Randomized Phase|Lost to Follow-up|1|||
162108822|NCT03053050|585445937|FG003|Randomized Phase|Lost to Follow-up|0|||
162108823|NCT03053050|585445934|FG000|Randomized Phase|Adverse Event|0|||
162108824|NCT03053050|585445935|FG001|Randomized Phase|Adverse Event|1|||
162108825|NCT03053050|585445936|FG002|Randomized Phase|Adverse Event|0|||
162108826|NCT03053050|585445937|FG003|Randomized Phase|Adverse Event|0|||
162108827|NCT03053050|585445934|FG000|Randomized Phase|Randomized but Never Treated|2|||
162108828|NCT03053050|585445935|FG001|Randomized Phase|Randomized but Never Treated|2|||
162108829|NCT03053050|585445936|FG002|Randomized Phase|Randomized but Never Treated|2|||
162108830|NCT03053050|585445937|FG003|Randomized Phase|Randomized but Never Treated|0|||
162108831|NCT03053050|585445934|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
162108832|NCT03053050|585445935|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
162108833|NCT03053050|585445936|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
162108834|NCT03053050|585445937|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
162108835|NCT03053050|585445934|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
162108836|NCT03053050|585445935|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
162108837|NCT03053050|585445936|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
162108838|NCT03053050|585445937|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
162108839|NCT03053050|585445934|FG000|Open-label Phase|Withdrew Consent|0|||
162108840|NCT03053050|585445935|FG001|Open-label Phase|Withdrew Consent|0|||
162108841|NCT03053050|585445936|FG002|Open-label Phase|Withdrew Consent|0|||
162108842|NCT03053050|585445937|FG003|Open-label Phase|Withdrew Consent|6|||
162108843|NCT03053050|585445934|FG000|Open-label Phase|Investigator's Discretion|0|||
162108844|NCT03053050|585445935|FG001|Open-label Phase|Investigator's Discretion|0|||
162108845|NCT03053050|585445936|FG002|Open-label Phase|Investigator's Discretion|0|||
162108846|NCT03053050|585445937|FG003|Open-label Phase|Investigator's Discretion|4|||
162108847|NCT00655980|585445938|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
162108848|NCT00655980|585445939|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
162108849|NCT00655980|585445940|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
162108850|NCT01553318|585447181|FG000|Overall Study|Protocol Violation|3|||
162108851|NCT01553318|585447182|FG001|Overall Study|Protocol Violation|2|||
162108852|NCT02293395|585447183|FG000|Overall Study|Lost to Follow-up|1|||
162108853|NCT02293395|585447184|FG001|Overall Study|Lost to Follow-up|0|||
162108854|NCT02293395|585447183|FG000|Overall Study|Withdrawal by Subject|8|||
162108855|NCT02293395|585447184|FG001|Overall Study|Withdrawal by Subject|7|||
162108856|NCT01464021|585447185|FG000|Overall Study|Withdrawal by Subject|13|||
162108857|NCT01464021|585447185|FG000|Overall Study|Lost to Follow-up|1|||
162108858|NCT01464021|585447185|FG000|Overall Study|Lack of Efficacy|1|||
162108859|NCT01464021|585447185|FG000|Overall Study|various|11|||
162108860|NCT00224770|585447191|FG000|Overall Study|Lost to Follow-up|4|||
162108861|NCT00224770|585447192|FG001|Overall Study|Lost to Follow-up|2|||
162108862|NCT00224770|585447193|FG002|Overall Study|Lost to Follow-up|0|||
162108863|NCT01106430|585447194|FG000|Overall Study|Adverse Event|8|||
162108864|NCT01106430|585447195|FG001|Overall Study|Adverse Event|10|||
162108865|NCT01106430|585447194|FG000|Overall Study|Lack of Efficacy|2|||
162108866|NCT01106430|585447195|FG001|Overall Study|Lack of Efficacy|13|||
162108867|NCT01106430|585447194|FG000|Overall Study|Lost to Follow-up|5|||
162108868|NCT01106430|585447195|FG001|Overall Study|Lost to Follow-up|1|||
162108869|NCT01106430|585447194|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
162108870|NCT01106430|585447195|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
162108871|NCT01106430|585447194|FG000|Overall Study|Moved Out Of State|0|||
162108872|NCT01106430|585447195|FG001|Overall Study|Moved Out Of State|1|||
162108873|NCT01106430|585447194|FG000|Overall Study|Refused To Take Medication|0|||
162108874|NCT01106430|585447195|FG001|Overall Study|Refused To Take Medication|1|||
162108875|NCT01106430|585447194|FG000|Overall Study|Noncompliance|0|||
162108876|NCT01106430|585447195|FG001|Overall Study|Noncompliance|1|||
162108877|NCT01106430|585447194|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
162108878|NCT01106430|585447195|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
162108879|NCT01106430|585447194|FG000|Overall Study|Previous Use Of Marijuana|1|||
162108880|NCT01106430|585447195|FG001|Overall Study|Previous Use Of Marijuana|0|||
162108881|NCT01106430|585447194|FG000|Overall Study|Protocol Violation|7|||
162108882|NCT01106430|585447195|FG001|Overall Study|Protocol Violation|2|||
162108883|NCT01106430|585447194|FG000|Overall Study|Withdrawal by Subject|8|||
162108884|NCT01106430|585447195|FG001|Overall Study|Withdrawal by Subject|4|||
162108885|NCT00437645|585447196|FG000|Overall Study|Adverse Event|15|||
162108886|NCT00437645|585447197|FG001|Overall Study|Adverse Event|84|||
162108887|NCT00437645|585447196|FG000|Overall Study|Withdrawal by Subject|10|||
162108888|NCT00437645|585447197|FG001|Overall Study|Withdrawal by Subject|22|||
162108889|NCT00437645|585447196|FG000|Overall Study|Protocol Violation|3|||
162108890|NCT00437645|585447197|FG001|Overall Study|Protocol Violation|3|||
162108891|NCT00437645|585447196|FG000|Overall Study|Lost to Follow-up|2|||
162108892|NCT00437645|585447197|FG001|Overall Study|Lost to Follow-up|3|||
162108893|NCT00437645|585447196|FG000|Overall Study|Administrative problems|2|||
162108894|NCT00437645|585447197|FG001|Overall Study|Administrative problems|1|||
162108895|NCT00437645|585447196|FG000|Overall Study|Lack of Efficacy|2|||
162108896|NCT00437645|585447197|FG001|Overall Study|Lack of Efficacy|1|||
162108897|NCT00437645|585447196|FG000|Overall Study|Condition no longer requires study drug|1|||
162108898|NCT00437645|585447197|FG001|Overall Study|Condition no longer requires study drug|1|||
162108899|NCT00989092|585447202|FG000|Overall Study|Physician Decision|9|||
162108900|NCT00989092|585447203|FG001|Overall Study|Physician Decision|6|||
162108901|NCT00989092|585447202|FG000|Overall Study|Adverse Event|20|||
162108902|NCT00989092|585447203|FG001|Overall Study|Adverse Event|1|||
162108903|NCT00989092|585447202|FG000|Overall Study|Chemotherapy initiated|12|||
162108904|NCT00989092|585447203|FG001|Overall Study|Chemotherapy initiated|4|||
162108905|NCT00989092|585447202|FG000|Overall Study|Withdrawal by Subject|17|||
162108906|NCT00989092|585447203|FG001|Overall Study|Withdrawal by Subject|9|||
162108907|NCT00989092|585447202|FG000|Overall Study|Death|14|||
162108908|NCT00989092|585447203|FG001|Overall Study|Death|2|||
162108909|NCT00989092|585447202|FG000|Overall Study|Ineligibility determined|3|||
162108910|NCT00989092|585447203|FG001|Overall Study|Ineligibility determined|3|||
162108911|NCT00989092|585447202|FG000|Overall Study|Lost to Follow-up|6|||
162108912|NCT00989092|585447203|FG001|Overall Study|Lost to Follow-up|2|||
162108913|NCT00989092|585447202|FG000|Overall Study|Other|3|||
162108914|NCT00989092|585447203|FG001|Overall Study|Other|1|||
162108915|NCT00989092|585447202|FG000|Overall Study|Protocol deviation|2|||
162108916|NCT00989092|585447203|FG001|Overall Study|Protocol deviation|0|||
162108917|NCT00989092|585447202|FG000|Overall Study|Erythropoietin therapy initiated|2|||
162108918|NCT00989092|585447203|FG001|Overall Study|Erythropoietin therapy initiated|0|||
162108919|NCT00989092|585447202|FG000|Overall Study|Did not receive study drug|2|||
162108920|NCT00989092|585447203|FG001|Overall Study|Did not receive study drug|0|||
162108921|NCT02127372|585447208|FG000|Overall Study|Withdrawal by Subject|1|||
162108922|NCT02127372|585447209|FG001|Overall Study|Withdrawal by Subject|0|||
162108923|NCT03837509|585447210|FG000|Phase 1|Death|5|||
162108924|NCT03837509|585447211|FG001|Phase 1|Death|2|||
162108925|NCT03837509|585447212|FG002|Phase 1|Death|0|||
162108926|NCT03837509|585447213|FG003|Phase 1|Death|0|||
162108927|NCT03837509|585447214|FG004|Phase 1|Death|0|||
162108928|NCT03837509|585447210|FG000|Phase 2|Death|0|||
162108929|NCT03837509|585447211|FG001|Phase 2|Death|0|||
162108930|NCT03837509|585447212|FG002|Phase 2|Death|0|||
162108931|NCT03837509|585447213|FG003|Phase 2|Death|1|||
162108932|NCT03837509|585447214|FG004|Phase 2|Death|1|||
162108933|NCT01113502|585447221|FG000|Overall Study|Withdrawal by Subject|1|||
162108934|NCT01113502|585447222|FG001|Overall Study|Withdrawal by Subject|0|||
162108935|NCT01113502|585447223|FG002|Overall Study|Withdrawal by Subject|1|||
162108936|NCT01113502|585447224|FG003|Overall Study|Withdrawal by Subject|1|||
162108937|NCT01113502|585447225|FG004|Overall Study|Withdrawal by Subject|0|||
162108938|NCT01113502|585447221|FG000|Overall Study|Adverse Event|0|||
162108939|NCT01113502|585447222|FG001|Overall Study|Adverse Event|0|||
162108940|NCT01113502|585447223|FG002|Overall Study|Adverse Event|3|||
162108941|NCT01113502|585447224|FG003|Overall Study|Adverse Event|2|||
162108942|NCT01113502|585447225|FG004|Overall Study|Adverse Event|0|||
162108943|NCT03802123|585447228|FG000|Overall Study|Withdrawal by Subject|3|||
162108944|NCT03802123|585447228|FG000|Overall Study|Physician Decision|1|||
162108945|NCT03802123|585447228|FG000|Overall Study|Subject moved to hospice care|1|||
162108946|NCT03802123|585447228|FG000|Overall Study|technician error|1|||
162108947|NCT03802123|585447228|FG000|Overall Study|Death|3|||
162108948|NCT04555096|585447230|FG000|Overall Study|Death|4|||
162108949|NCT04555096|585447231|FG001|Overall Study|Death|4|||
162108950|NCT04555096|585447230|FG000|Overall Study|Withdrawal by Subject|1|||
162108951|NCT04555096|585447231|FG001|Overall Study|Withdrawal by Subject|0|||
162108952|NCT04555096|585447230|FG000|Overall Study|Other|0|||
162108953|NCT04555096|585447231|FG001|Overall Study|Other|1|||
162108954|NCT06134180|585447233|FG000|Overall Study|Lost to Follow-up|4|||
162108955|NCT01362439|585447234|FG000|Overall Study|Adverse Event|1|||
162108956|NCT01362439|585447234|FG000|Overall Study|Lack of Efficacy|3|||
162108957|NCT01362439|585447234|FG000|Overall Study|Lost to Follow-up|2|||
162108958|NCT01362439|585447234|FG000|Overall Study|Study medication non-compliant|1|||
162108959|NCT01362439|585447234|FG000|Overall Study|Participant who withdrew consent|8|||
162108960|NCT03575325|585447238|FG000|Overall Study|Death|1|||
162108961|NCT03440372|585447239|FG000|Treatment|Adverse Event|16|||
162108962|NCT03440372|585447240|FG001|Treatment|Adverse Event|8|||
162108963|NCT03440372|585447239|FG000|Treatment|Lack of Efficacy|4|||
162108964|NCT03440372|585447240|FG001|Treatment|Lack of Efficacy|2|||
162108965|NCT03440372|585447239|FG000|Treatment|Withdrawal by Subject|12|||
162108966|NCT03440372|585447240|FG001|Treatment|Withdrawal by Subject|8|||
162108967|NCT03440372|585447239|FG000|Treatment|Lost to Follow-up|1|||
162108968|NCT03440372|585447240|FG001|Treatment|Lost to Follow-up|0|||
162108969|NCT03440372|585447239|FG000|Treatment|Pregnancy|1|||
162108970|NCT03440372|585447240|FG001|Treatment|Pregnancy|0|||
162108971|NCT03440372|585447239|FG000|Treatment|Study Terminated by Sponsor|2|||
162108972|NCT03440372|585447240|FG001|Treatment|Study Terminated by Sponsor|1|||
162108973|NCT03440372|585447239|FG000|Treatment|Other Reason|2|||
162108974|NCT03440372|585447240|FG001|Treatment|Other Reason|3|||
162108975|NCT05711641|585447241|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
162108976|NCT05711641|585447242|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
162108977|NCT05711641|585447241|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
162108978|NCT05711641|585447242|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
162108979|NCT03574597|585447243|FG000|Overall Study|Withdrawal by Subject|67|||
162108980|NCT03574597|585447244|FG001|Overall Study|Withdrawal by Subject|96|||
162108981|NCT03574597|585447243|FG000|Overall Study|Lost to Follow-up|192|||
162108982|NCT03574597|585447244|FG001|Overall Study|Lost to Follow-up|188|||
162108983|NCT03804710|585447245|FG000|Overall Study|Adverse Event|0|||
162108984|NCT03804710|585447246|FG001|Overall Study|Adverse Event|3|||
162108985|NCT03804710|585447245|FG000|Overall Study|Withdrawal by Subject|2|||
162108986|NCT03804710|585447246|FG001|Overall Study|Withdrawal by Subject|1|||
162108987|NCT03804710|585447245|FG000|Overall Study|Other|0|||
162108988|NCT03804710|585447246|FG001|Overall Study|Other|1|||
162108989|NCT04542018|585447247|FG000|Overall Study|Withdrawal by Subject|0|||
162108990|NCT04542018|585447248|FG001|Overall Study|Withdrawal by Subject|0|||
162108991|NCT04542018|585447249|FG002|Overall Study|Withdrawal by Subject|4|||
162108992|NCT04542018|585447247|FG000|Overall Study|Protocol Violation|0|||
162108993|NCT04542018|585447248|FG001|Overall Study|Protocol Violation|0|||
162108994|NCT04542018|585447249|FG002|Overall Study|Protocol Violation|2|||
162108995|NCT03583554|585447250|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
162108996|NCT03583554|585447251|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
162108997|NCT03583554|585447252|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
162108998|NCT03178266|585447253|FG000|Overall Study|Death|0|||
162108999|NCT03178266|585447254|FG001|Overall Study|Death|1|||
162109000|NCT03178266|585447253|FG000|Overall Study|Disont. Early|0|||
162109001|NCT03178266|585447254|FG001|Overall Study|Disont. Early|1|||
162109002|NCT03178266|585447253|FG000|Overall Study|Withdrawal by Subject|0|||
162109003|NCT03178266|585447254|FG001|Overall Study|Withdrawal by Subject|2|||
162109004|NCT01596582|585447266|FG000|Overall Study|Deemed ineligible after study visit|3|||
162109005|NCT01596582|585447267|FG001|Overall Study|Deemed ineligible after study visit|6|||
162109006|NCT01596582|585447266|FG000|Overall Study|Missing all outcome data|1|||
162109007|NCT01596582|585447267|FG001|Overall Study|Missing all outcome data|1|||
162109008|NCT02454101|585447271|FG000|Overall Study|Adverse Event|2|||
162109009|NCT02454101|585447272|FG001|Overall Study|Adverse Event|3|||
162109010|NCT02454101|585447271|FG000|Overall Study|Lost to Follow-up|3|||
162109011|NCT02454101|585447272|FG001|Overall Study|Lost to Follow-up|4|||
162109012|NCT02124265|585447276|FG000|Overall Study|Adverse Event|1|||
162109013|NCT01667432|585447278|FG000|Overall Study|Premature Study Termination|26|||
162109014|NCT01667432|585447278|FG000|Overall Study|Failure to Return|10|||
162109015|NCT01667432|585447278|FG000|Overall Study|Moved to Another Center|3|||
162109016|NCT01667432|585447278|FG000|Overall Study|Lost to Follow-up|3|||
162109017|NCT01667432|585447278|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
162109018|NCT01667432|585447278|FG000|Overall Study|Insufficient Therapeutic Response|4|||
162109019|NCT01667432|585447278|FG000|Overall Study|Adverse Event|1|||
162109020|NCT01667432|585447278|FG000|Overall Study|Protocol Deviation|2|||
162109021|NCT01667432|585447278|FG000|Overall Study|Principal Investigator Decision|1|||
162109022|NCT01667432|585447278|FG000|Overall Study|Reason Not Specified|2|||
162109023|NCT01667432|585447278|FG000|Overall Study|Missing Information|4|||
162109024|NCT00553696|585447285|FG000|Overall Study|Adverse Event|2|||
162109025|NCT00553696|585447286|FG001|Overall Study|Adverse Event|4|||
162109026|NCT00553696|585447287|FG002|Overall Study|Adverse Event|0|||
162109027|NCT00553696|585447288|FG003|Overall Study|Adverse Event|1|||
162109028|NCT00553696|585447285|FG000|Overall Study|Global deterioration of health status|0|||
162109029|NCT00553696|585447286|FG001|Overall Study|Global deterioration of health status|2|||
162109030|NCT00553696|585447287|FG002|Overall Study|Global deterioration of health status|0|||
162109031|NCT00553696|585447288|FG003|Overall Study|Global deterioration of health status|0|||
162109032|NCT00553696|585447285|FG000|Overall Study|Objective progression or relapse|2|||
162109033|NCT00553696|585447286|FG001|Overall Study|Objective progression or relapse|9|||
162109034|NCT00553696|585447287|FG002|Overall Study|Objective progression or relapse|6|||
162109035|NCT00553696|585447288|FG003|Overall Study|Objective progression or relapse|0|||
162109036|NCT00553696|585447285|FG000|Overall Study|Withdrawal by Subject|0|||
162109037|NCT00553696|585447286|FG001|Overall Study|Withdrawal by Subject|1|||
162109038|NCT00553696|585447287|FG002|Overall Study|Withdrawal by Subject|0|||
162109039|NCT00553696|585447288|FG003|Overall Study|Withdrawal by Subject|0|||
162109040|NCT00686881|585447293|FG000|Overall Study|Withdrawal by Subject|11|||
162109041|NCT00686881|585447294|FG001|Overall Study|Withdrawal by Subject|18|||
162109042|NCT00686881|585447293|FG000|Overall Study|Lost to Follow-up|0|||
162109043|NCT00686881|585447294|FG001|Overall Study|Lost to Follow-up|1|||
162109044|NCT00686881|585447293|FG000|Overall Study|Treatment-related adverse event|10|||
162109045|NCT00686881|585447294|FG001|Overall Study|Treatment-related adverse event|9|||
162109046|NCT00686881|585447293|FG000|Overall Study|Met discontinuation criteria|5|||
162109047|NCT00686881|585447294|FG001|Overall Study|Met discontinuation criteria|0|||
162109048|NCT00686881|585447293|FG000|Overall Study|Onset of malignant tumor|11|||
162109049|NCT00686881|585447294|FG001|Overall Study|Onset of malignant tumor|11|||
162109050|NCT00686881|585447293|FG000|Overall Study|Lack of Efficacy|4|||
162109051|NCT00686881|585447294|FG001|Overall Study|Lack of Efficacy|3|||
162109052|NCT00686881|585447293|FG000|Overall Study|Physician Decision|1|||
162109053|NCT00686881|585447294|FG001|Overall Study|Physician Decision|0|||
162109054|NCT00686881|585447293|FG000|Overall Study|Circumstances of site|1|||
162109055|NCT00686881|585447294|FG001|Overall Study|Circumstances of site|1|||
162109056|NCT00686881|585447293|FG000|Overall Study|Did not meet protocol eligibility|1|||
162109057|NCT00686881|585447294|FG001|Overall Study|Did not meet protocol eligibility|0|||
162109058|NCT00686881|585447293|FG000|Overall Study|Irregular visits|1|||
162109059|NCT00686881|585447294|FG001|Overall Study|Irregular visits|0|||
162109060|NCT00686881|585447293|FG000|Overall Study|Study discontinuation|35|||
162109061|NCT00686881|585447294|FG001|Overall Study|Study discontinuation|32|||
162109062|NCT00686881|585447293|FG000|Overall Study|Never received study drug|2|||
162109063|NCT00686881|585447294|FG001|Overall Study|Never received study drug|6|||
162109064|NCT00671931|585447295|FG000|Overall Study|Physician Decision|1|||
162109065|NCT00671931|585447296|FG001|Overall Study|Physician Decision|0|||
162109066|NCT00671931|585447297|FG002|Overall Study|Physician Decision|0|||
162109067|NCT00671931|585447298|FG003|Overall Study|Physician Decision|2|||
162109068|NCT00671931|585447299|FG004|Overall Study|Physician Decision|1|||
162109069|NCT01298999|585447300|FG000|Overall Study|Physician Decision|0|||
162109070|NCT01298999|585447301|FG001|Overall Study|Physician Decision|1|||
162109071|NCT01298999|585447300|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
162109072|NCT01298999|585447301|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
162109073|NCT00902694|585447302|FG000|Overall Study|Death|1|||
162109074|NCT00902694|585447303|FG001|Overall Study|Death|3|||
162109075|NCT00902694|585447302|FG000|Overall Study|Lost to Follow-up|1|||
162109076|NCT00902694|585447303|FG001|Overall Study|Lost to Follow-up|0|||
162109077|NCT00902694|585447302|FG000|Overall Study|Censored per protocol|3|||
162109078|NCT00902694|585447303|FG001|Overall Study|Censored per protocol|1|||
162109079|NCT00902694|585447302|FG000|Overall Study|Pregnancy|1|||
162109080|NCT00902694|585447303|FG001|Overall Study|Pregnancy|1|||
162109081|NCT00902694|585447302|FG000|Overall Study|Incarceration|1|||
162109082|NCT00902694|585447303|FG001|Overall Study|Incarceration|0|||
162109083|NCT04969263|585447304|FG000|Overall Study|Death|1|||
162109084|NCT04969263|585447304|FG000|Overall Study|Lost to Follow-up|2|||
162109085|NCT04969263|585447304|FG000|Overall Study|Withdrawal by Subject|5|||
162109086|NCT04969263|585447304|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
162109087|NCT04154787|585447305|FG000|Overall Study|Adverse Event|0|||
162109088|NCT04154787|585447306|FG001|Overall Study|Adverse Event|1|||
162109089|NCT04154787|585447307|FG002|Overall Study|Adverse Event|0|||
162109090|NCT04154787|585447305|FG000|Overall Study|Patient Requires Other Treatment|0|||
162109091|NCT04154787|585447306|FG001|Overall Study|Patient Requires Other Treatment|1|||
162109092|NCT04154787|585447307|FG002|Overall Study|Patient Requires Other Treatment|0|||
162109093|NCT04154787|585447305|FG000|Overall Study|Study Terminated By Sponsor|0|||
162109094|NCT04154787|585447306|FG001|Overall Study|Study Terminated By Sponsor|6|||
162109095|NCT04154787|585447307|FG002|Overall Study|Study Terminated By Sponsor|1|||
162109096|NCT04154787|585447305|FG000|Overall Study|Subject Decision|0|||
162109097|NCT04154787|585447306|FG001|Overall Study|Subject Decision|1|||
162109098|NCT04154787|585447307|FG002|Overall Study|Subject Decision|0|||
162109099|NCT04154787|585447305|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
162109100|NCT04154787|585447306|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
162109101|NCT04154787|585447307|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
162109102|NCT02459574|585447308|FG000|Overall Study|Withdrawal by Subject|6|||
162109103|NCT02459574|585447309|FG001|Overall Study|Withdrawal by Subject|6|||
162109104|NCT02459574|585447310|FG002|Overall Study|Withdrawal by Subject|2|||
162109105|NCT02459574|585447308|FG000|Overall Study|Lost to Follow-up|1|||
162109106|NCT02459574|585447309|FG001|Overall Study|Lost to Follow-up|1|||
162109107|NCT02459574|585447310|FG002|Overall Study|Lost to Follow-up|0|||
162109108|NCT02459574|585447308|FG000|Overall Study|Death|0|||
162109109|NCT02459574|585447309|FG001|Overall Study|Death|1|||
162109110|NCT02459574|585447310|FG002|Overall Study|Death|0|||
162109111|NCT04866017|585447311|FG000|Overall Study|Study Terminated by Sponsor|13|||
162109112|NCT04866017|585447312|FG001|Overall Study|Study Terminated by Sponsor|14|||
162109113|NCT04866017|585447313|FG002|Overall Study|Study Terminated by Sponsor|13|||
162109114|NCT04866017|585447311|FG000|Overall Study|Death|8|||
162109115|NCT04866017|585447312|FG001|Overall Study|Death|4|||
162109116|NCT04866017|585447313|FG002|Overall Study|Death|8|||
162109117|NCT04866017|585447311|FG000|Overall Study|Withdrawal by Subject|1|||
162109118|NCT04866017|585447312|FG001|Overall Study|Withdrawal by Subject|0|||
162109119|NCT04866017|585447313|FG002|Overall Study|Withdrawal by Subject|1|||
162109120|NCT04866017|585447311|FG000|Overall Study|Physician Decision|0|||
162109121|NCT04866017|585447312|FG001|Overall Study|Physician Decision|1|||
162109122|NCT04866017|585447313|FG002|Overall Study|Physician Decision|0|||
162109123|NCT01266642|585447314|FG000|Overall Study|Protocol Violation|0|||
162109124|NCT01266642|585447315|FG001|Overall Study|Protocol Violation|1|||
162109125|NCT01337674|585449040|FG000|Treatment Period 1|Adverse Event|0|||
162109126|NCT01337674|585449041|FG001|Treatment Period 1|Adverse Event|1|||
162109127|NCT01337674|585449042|FG002|Treatment Period 1|Adverse Event|0|||
162109128|NCT01337674|585449043|FG003|Treatment Period 1|Adverse Event|0|||
162109129|NCT01337674|585449040|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
162109130|NCT01337674|585449041|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
162109131|NCT01337674|585449042|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
162109132|NCT01337674|585449043|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
162109133|NCT01337674|585449040|FG000|Treatment Period 2|Withdrawal by Subject|0|||
162109134|NCT01337674|585449041|FG001|Treatment Period 2|Withdrawal by Subject|0|||
162109135|NCT01337674|585449042|FG002|Treatment Period 2|Withdrawal by Subject|1|||
162109136|NCT01337674|585449043|FG003|Treatment Period 2|Withdrawal by Subject|0|||
162109137|NCT00695786|585449044|FG000|Overall Study|Adverse Event|0|||
162109138|NCT00695786|585449045|FG001|Overall Study|Adverse Event|3|||
162109139|NCT00695786|585449046|FG002|Overall Study|Adverse Event|4|||
162109140|NCT00695786|585449047|FG003|Overall Study|Adverse Event|2|||
162109141|NCT00695786|585449044|FG000|Overall Study|Lost to Follow-up|0|||
162109142|NCT00695786|585449045|FG001|Overall Study|Lost to Follow-up|5|||
162109143|NCT00695786|585449046|FG002|Overall Study|Lost to Follow-up|1|||
162109144|NCT00695786|585449047|FG003|Overall Study|Lost to Follow-up|1|||
162109145|NCT00695786|585449044|FG000|Overall Study|Withdrawal by Subject|0|||
162109146|NCT00695786|585449045|FG001|Overall Study|Withdrawal by Subject|4|||
162109147|NCT00695786|585449046|FG002|Overall Study|Withdrawal by Subject|3|||
162109148|NCT00695786|585449047|FG003|Overall Study|Withdrawal by Subject|1|||
162109149|NCT00695786|585449044|FG000|Overall Study|Deemed Ineligible|1|||
162109150|NCT00695786|585449045|FG001|Overall Study|Deemed Ineligible|0|||
162109151|NCT00695786|585449046|FG002|Overall Study|Deemed Ineligible|0|||
162109152|NCT00695786|585449047|FG003|Overall Study|Deemed Ineligible|0|||
162109153|NCT00695786|585449044|FG000|Overall Study|Lack of Efficacy|0|||
162109154|NCT00695786|585449045|FG001|Overall Study|Lack of Efficacy|0|||
162109155|NCT00695786|585449046|FG002|Overall Study|Lack of Efficacy|0|||
162109156|NCT00695786|585449047|FG003|Overall Study|Lack of Efficacy|4|||
162109157|NCT04244396|585449051|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
162109158|NCT04244396|585449051|FG000|Overall Study|Withdrawal by Subject|2|||
162109159|NCT04244396|585449051|FG000|Overall Study|Study termination|37|||
162109160|NCT01787097|585449052|FG000|Overall Study|Withdrawal by Subject|1|||
162109161|NCT01787097|585449053|FG001|Overall Study|Withdrawal by Subject|0|||
162109162|NCT01787097|585449054|FG002|Overall Study|Withdrawal by Subject|0|||
162109163|NCT01787097|585449055|FG003|Overall Study|Withdrawal by Subject|0|||
162109164|NCT00245102|585449056|FG000|Overall Study|Not Treated|1|||
162109165|NCT00245102|585449057|FG001|Overall Study|Not Treated|0|||
162109166|NCT00245102|585449058|FG002|Overall Study|Not Treated|1|||
162109167|NCT00245102|585449059|FG003|Overall Study|Not Treated|0|||
162109168|NCT00245102|585449060|FG004|Overall Study|Not Treated|0|||
162109169|NCT00245102|585449061|FG005|Overall Study|Not Treated|0|||
162109170|NCT00245102|585449056|FG000|Overall Study|Protocol Violation|1|||
162109171|NCT00245102|585449057|FG001|Overall Study|Protocol Violation|0|||
162109172|NCT00245102|585449058|FG002|Overall Study|Protocol Violation|0|||
162109173|NCT00245102|585449059|FG003|Overall Study|Protocol Violation|0|||
162109174|NCT00245102|585449060|FG004|Overall Study|Protocol Violation|0|||
162109175|NCT00245102|585449061|FG005|Overall Study|Protocol Violation|0|||
162109176|NCT00245102|585449056|FG000|Overall Study|Death|0|||
162109177|NCT00245102|585449057|FG001|Overall Study|Death|0|||
162109178|NCT00245102|585449058|FG002|Overall Study|Death|0|||
162109179|NCT00245102|585449059|FG003|Overall Study|Death|1|||
162109180|NCT00245102|585449060|FG004|Overall Study|Death|0|||
162109181|NCT00245102|585449061|FG005|Overall Study|Death|0|||
162109182|NCT00245102|585449056|FG000|Overall Study|Adverse Event|4|||
162109183|NCT00245102|585449057|FG001|Overall Study|Adverse Event|2|||
162109184|NCT00245102|585449058|FG002|Overall Study|Adverse Event|5|||
162109185|NCT00245102|585449059|FG003|Overall Study|Adverse Event|1|||
162109186|NCT00245102|585449060|FG004|Overall Study|Adverse Event|0|||
162109187|NCT00245102|585449061|FG005|Overall Study|Adverse Event|2|||
162109188|NCT00245102|585449056|FG000|Overall Study|Decline in performance|0|||
162109189|NCT00245102|585449057|FG001|Overall Study|Decline in performance|2|||
162109190|NCT00245102|585449058|FG002|Overall Study|Decline in performance|0|||
162109191|NCT00245102|585449059|FG003|Overall Study|Decline in performance|1|||
162109192|NCT00245102|585449060|FG004|Overall Study|Decline in performance|0|||
162109193|NCT00245102|585449061|FG005|Overall Study|Decline in performance|2|||
162109194|NCT00245102|585449056|FG000|Overall Study|Participant needed surgery|0|||
162109195|NCT00245102|585449057|FG001|Overall Study|Participant needed surgery|0|||
162109196|NCT00245102|585449058|FG002|Overall Study|Participant needed surgery|1|||
162109197|NCT00245102|585449059|FG003|Overall Study|Participant needed surgery|0|||
162109198|NCT00245102|585449060|FG004|Overall Study|Participant needed surgery|0|||
162109199|NCT00245102|585449061|FG005|Overall Study|Participant needed surgery|0|||
162109200|NCT00245102|585449056|FG000|Overall Study|Clinical progression|1|||
162109201|NCT00245102|585449057|FG001|Overall Study|Clinical progression|0|||
162109202|NCT00245102|585449058|FG002|Overall Study|Clinical progression|0|||
162109203|NCT00245102|585449059|FG003|Overall Study|Clinical progression|0|||
162109204|NCT00245102|585449060|FG004|Overall Study|Clinical progression|0|||
162109205|NCT00245102|585449061|FG005|Overall Study|Clinical progression|0|||
162109206|NCT00289887|585449062|FG000|Overall Study|Adverse Event|3|||
162109207|NCT00289887|585449063|FG001|Overall Study|Adverse Event|3|||
162109208|NCT00289887|585449062|FG000|Overall Study|Lack of Efficacy|3|||
162109209|NCT00289887|585449063|FG001|Overall Study|Lack of Efficacy|11|||
162109210|NCT00289887|585449062|FG000|Overall Study|Lost to Follow-up|3|||
162109211|NCT00289887|585449063|FG001|Overall Study|Lost to Follow-up|3|||
162109212|NCT00289887|585449062|FG000|Overall Study|Protocol Violation|3|||
162109213|NCT00289887|585449063|FG001|Overall Study|Protocol Violation|1|||
162109214|NCT00289887|585449062|FG000|Overall Study|Withdrawal by Subject|3|||
162109215|NCT00289887|585449063|FG001|Overall Study|Withdrawal by Subject|8|||
162109216|NCT00289887|585449062|FG000|Overall Study|Other|7|||
162109217|NCT00289887|585449063|FG001|Overall Study|Other|3|||
162109218|NCT02472652|585449070|FG000|Overall Study|Lost to Follow-up|1|||
162109219|NCT03185832|585449071|FG000|Overall Study|Death|9|||
162109220|NCT03185832|585449072|FG001|Overall Study|Death|14|||
162109221|NCT03185832|585449073|FG002|Overall Study|Death|9|||
162109222|NCT03185832|585449074|FG003|Overall Study|Death|7|||
162109223|NCT03185832|585449071|FG000|Overall Study|Withdrawn - vital status available|0|||
162109224|NCT03185832|585449072|FG001|Overall Study|Withdrawn - vital status available|1|||
162109225|NCT03185832|585449073|FG002|Overall Study|Withdrawn - vital status available|1|||
162109226|NCT03185832|585449074|FG003|Overall Study|Withdrawn - vital status available|4|||
162109227|NCT01123382|585449077|FG000|Overall Study|Withdrawal by Subject|1|||
162109228|NCT01123382|585449078|FG001|Overall Study|Withdrawal by Subject|4|||
162109229|NCT01123382|585449077|FG000|Overall Study|Lost to Follow-up|1|||
162109230|NCT01123382|585449078|FG001|Overall Study|Lost to Follow-up|2|||
162109231|NCT01256411|585449079|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
162109232|NCT01256411|585449080|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
162109233|NCT01256411|585449081|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
162109234|NCT01256411|585449082|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
162109235|NCT01256411|585449083|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
162109236|NCT01256411|585449084|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
162109237|NCT01256411|585449079|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
162109238|NCT01256411|585449080|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
162109239|NCT01256411|585449081|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
162109240|NCT01256411|585449082|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
162109241|NCT01256411|585449083|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
162109242|NCT01256411|585449084|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
162109243|NCT01256411|585449079|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
162109244|NCT01256411|585449080|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
162109245|NCT01256411|585449081|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
162109246|NCT01256411|585449082|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
162109247|NCT01256411|585449083|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
162109248|NCT01256411|585449084|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
162109249|NCT01256411|585449079|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
162109250|NCT01256411|585449080|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
162109251|NCT01256411|585449081|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
162109252|NCT01256411|585449082|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
162109253|NCT01256411|585449083|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
162109254|NCT01256411|585449084|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
162109255|NCT01256411|585449079|FG000|Extension by Maximum Treatment|Adverse Event|4|||
162109256|NCT01256411|585449080|FG001|Extension by Maximum Treatment|Adverse Event|2|||
162109257|NCT01256411|585449081|FG002|Extension by Maximum Treatment|Adverse Event|1|||
162109258|NCT01256411|585449082|FG003|Extension by Maximum Treatment|Adverse Event|0|||
162109259|NCT01256411|585449083|FG004|Extension by Maximum Treatment|Adverse Event|0|||
162109260|NCT01256411|585449084|FG005|Extension by Maximum Treatment|Adverse Event|0|||
162109261|NCT01256411|585449079|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
162109262|NCT01256411|585449080|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
162109263|NCT01256411|585449081|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
162109264|NCT01256411|585449082|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
162109265|NCT01256411|585449083|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
162109266|NCT01256411|585449084|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
162109267|NCT01256411|585449079|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
162109268|NCT01256411|585449080|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
162109269|NCT01256411|585449081|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
162109270|NCT01256411|585449082|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
162109271|NCT01256411|585449083|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
162109272|NCT01256411|585449084|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
162109273|NCT01256411|585449079|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
162109274|NCT01256411|585449080|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
162109275|NCT01256411|585449081|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
162109276|NCT01256411|585449082|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
162109277|NCT01256411|585449083|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
162109278|NCT01256411|585449084|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
162109279|NCT01256411|585449079|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
162109280|NCT01256411|585449080|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
162109281|NCT01256411|585449081|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
162109282|NCT01256411|585449082|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
162109283|NCT01256411|585449083|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
162109284|NCT01256411|585449084|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
162109285|NCT01256411|585449079|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
162109286|NCT01256411|585449080|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
162109287|NCT01256411|585449081|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
162109288|NCT01256411|585449082|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
162109289|NCT01256411|585449083|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
162109290|NCT01256411|585449084|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
162109291|NCT02274857|585449085|FG000|Overall Study|Adverse Event|1|||
162109292|NCT02274857|585449086|FG001|Overall Study|Adverse Event|0|||
162109293|NCT02274857|585449085|FG000|Overall Study|Death|1|||
162109294|NCT02274857|585449086|FG001|Overall Study|Death|2|||
162109295|NCT02274857|585449085|FG000|Overall Study|Lost to Follow-up|3|||
162109296|NCT02274857|585449086|FG001|Overall Study|Lost to Follow-up|0|||
162109297|NCT02274857|585449085|FG000|Overall Study|Physician Decision|2|||
162109298|NCT02274857|585449086|FG001|Overall Study|Physician Decision|0|||
162109299|NCT02274857|585449085|FG000|Overall Study|Trial screen failure|0|||
162109300|NCT02274857|585449086|FG001|Overall Study|Trial screen failure|2|||
162109301|NCT02274857|585449085|FG000|Overall Study|Withdrawal by Subject|11|||
162109302|NCT02274857|585449086|FG001|Overall Study|Withdrawal by Subject|2|||
162109303|NCT02274857|585449085|FG000|Overall Study|Other|2|||
162109304|NCT02274857|585449086|FG001|Overall Study|Other|0|||
162109305|NCT02403180|585449087|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
162109306|NCT02403180|585449088|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
162109307|NCT02403180|585449087|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
162109308|NCT02403180|585449088|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
162109309|NCT02230956|585449091|FG000|Overall Study|Adverse Event|1|||
162109310|NCT02230956|585449092|FG001|Overall Study|Adverse Event|1|||
162109311|NCT02230956|585449093|FG002|Overall Study|Adverse Event|0|||
162109312|NCT02230956|585449091|FG000|Overall Study|Lack of Efficacy|1|||
162109313|NCT02230956|585449092|FG001|Overall Study|Lack of Efficacy|1|||
162109314|NCT02230956|585449093|FG002|Overall Study|Lack of Efficacy|1|||
162109315|NCT02230956|585449091|FG000|Overall Study|Lost to Follow-up|1|||
162109316|NCT02230956|585449092|FG001|Overall Study|Lost to Follow-up|1|||
162109317|NCT02230956|585449093|FG002|Overall Study|Lost to Follow-up|2|||
162109318|NCT02230956|585449091|FG000|Overall Study|Personal Reasons|2|||
162109319|NCT02230956|585449092|FG001|Overall Study|Personal Reasons|1|||
162109320|NCT02230956|585449093|FG002|Overall Study|Personal Reasons|1|||
162109321|NCT02230956|585449091|FG000|Overall Study|Protocol Violation|0|||
162109322|NCT02230956|585449092|FG001|Overall Study|Protocol Violation|1|||
162109323|NCT02230956|585449093|FG002|Overall Study|Protocol Violation|1|||
162109324|NCT02230956|585449091|FG000|Overall Study|Other Miscellaneous Reason|0|||
162109325|NCT02230956|585449092|FG001|Overall Study|Other Miscellaneous Reason|1|||
162109326|NCT02230956|585449093|FG002|Overall Study|Other Miscellaneous Reason|2|||
162109327|NCT01445652|585449094|FG000|Overall Study|Not comfortable in lenses|5|||
162109328|NCT01445652|585449095|FG001|Overall Study|Not comfortable in lenses|0|||
162109329|NCT01445652|585449094|FG000|Overall Study|Failed to attend scheduled visit|2|||
162109330|NCT01445652|585449095|FG001|Overall Study|Failed to attend scheduled visit|3|||
162109331|NCT01445652|585449094|FG000|Overall Study|Failed teach session|2|||
162109332|NCT01445652|585449095|FG001|Overall Study|Failed teach session|0|||
162109333|NCT01445652|585449094|FG000|Overall Study|Adverse Event|1|||
162109334|NCT01445652|585449095|FG001|Overall Study|Adverse Event|0|||
162109335|NCT03002610|585449096|FG000|Overall Study|Withdrawal by Subject|6|||
162109336|NCT03002610|585449097|FG001|Overall Study|Withdrawal by Subject|25|||
162109337|NCT03002610|585449098|FG002|Overall Study|Withdrawal by Subject|13|||
162109338|NCT00929162|585449099|FG000|Overall Study|Adverse Event|8|||
162109339|NCT00929162|585449100|FG001|Overall Study|Adverse Event|5|||
162109340|NCT00929162|585449099|FG000|Overall Study|Withdrawal by Subject|3|||
162109341|NCT00929162|585449100|FG001|Overall Study|Withdrawal by Subject|1|||
162109342|NCT00929162|585449099|FG000|Overall Study|Protocol Violation|32|||
162109343|NCT00929162|585449100|FG001|Overall Study|Protocol Violation|30|||
162109344|NCT00929162|585449099|FG000|Overall Study|Other termination reason|5|||
162109345|NCT00929162|585449100|FG001|Overall Study|Other termination reason|6|||
162109346|NCT01822587|585449101|FG000|Overall Study|Lost to Follow-up|7|||
162109347|NCT01822587|585449102|FG001|Overall Study|Lost to Follow-up|9|||
162109348|NCT01822587|585449103|FG002|Overall Study|Lost to Follow-up|12|||
162109349|NCT01822587|585449101|FG000|Overall Study|Physician Decision|9|||
162109350|NCT01822587|585449102|FG001|Overall Study|Physician Decision|6|||
162109351|NCT01822587|585449103|FG002|Overall Study|Physician Decision|6|||
162109352|NCT00117676|585449105|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
162109353|NCT00117676|585449106|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
162109354|NCT00117676|585449105|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
162109355|NCT00117676|585449106|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
162109356|NCT00117676|585449105|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
162109357|NCT00117676|585449106|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
162109358|NCT00117676|585449105|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
162109359|NCT00117676|585449106|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
162109360|NCT00117676|585449105|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
162109361|NCT00117676|585449106|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
162109362|NCT00117676|585449105|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
162109363|NCT00117676|585449106|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
162109364|NCT00117676|585449105|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
162109365|NCT00117676|585449106|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
162109366|NCT00117676|585449105|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
162109367|NCT00117676|585449106|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
162109368|NCT00117676|585449105|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
162109369|NCT00117676|585449106|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
162109370|NCT00117676|585449105|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
162109371|NCT00117676|585449106|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
162109372|NCT00117676|585449105|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
162109373|NCT00117676|585449106|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
162109374|NCT00117676|585449105|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
162109375|NCT00117676|585449106|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
162109376|NCT00117676|585449105|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
162109377|NCT00117676|585449106|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
162109378|NCT00117676|585449105|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
162109379|NCT00117676|585449106|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
162109380|NCT00117676|585449105|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
162109381|NCT00117676|585449106|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
162109382|NCT00117676|585449105|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
162109383|NCT00117676|585449106|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
162109384|NCT00117676|585449105|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
162109385|NCT00117676|585449106|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
162109386|NCT00117676|585449105|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
162109387|NCT00117676|585449106|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
162109388|NCT00117676|585449105|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
162109389|NCT00117676|585449106|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
162109390|NCT00117676|585449105|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
162109391|NCT00117676|585449106|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
162109392|NCT00117676|585449105|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
162109393|NCT00117676|585449106|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
162109394|NCT00117676|585449105|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
162109395|NCT00117676|585449106|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
162109396|NCT00117676|585449105|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
162109397|NCT00117676|585449106|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
162109398|NCT00117676|585449105|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
162109399|NCT00117676|585449106|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
162109400|NCT00117676|585449105|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
162109401|NCT00117676|585449106|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
162109402|NCT00117676|585449105|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
162109403|NCT00117676|585449106|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
162109404|NCT00117676|585449105|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
162109405|NCT00117676|585449106|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
162109406|NCT00117676|585449105|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
162109407|NCT00117676|585449106|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
162109408|NCT00117676|585449105|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
162109409|NCT00117676|585449106|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
162109410|NCT00117676|585449105|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
162109411|NCT00117676|585449106|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
162109412|NCT00117676|585449105|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
162109413|NCT00117676|585449106|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
162109414|NCT00117676|585449105|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
162109415|NCT00117676|585449106|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
162109416|NCT00117676|585449105|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
162109417|NCT00117676|585449106|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
162109418|NCT00117676|585449105|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
162109419|NCT00117676|585449106|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
162109420|NCT00117676|585449105|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
162109421|NCT00117676|585449106|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
162109422|NCT00952822|585449107|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
162109423|NCT00952822|585449108|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
162109424|NCT00952822|585449109|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
162109425|NCT00952822|585449110|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
162109426|NCT00952822|585449107|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
162109427|NCT00952822|585449108|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
162109428|NCT00952822|585449109|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
162109429|NCT00952822|585449110|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
162109430|NCT00658567|585449111|FG000|Overall Study|Adverse Event|5|||
162109431|NCT00658567|585449112|FG001|Overall Study|Adverse Event|2|||
162109432|NCT00658567|585449113|FG002|Overall Study|Adverse Event|3|||
162109433|NCT00658567|585449111|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
162109434|NCT00658567|585449112|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
162109435|NCT00658567|585449113|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
162109436|NCT00658567|585449111|FG000|Overall Study|Physician Decision|0|||
162109437|NCT00658567|585449112|FG001|Overall Study|Physician Decision|1|||
162109438|NCT00658567|585449113|FG002|Overall Study|Physician Decision|0|||
162109439|NCT00658567|585449111|FG000|Overall Study|At Discretion of Sponsor|1|||
162109440|NCT00658567|585449112|FG001|Overall Study|At Discretion of Sponsor|1|||
162109441|NCT00658567|585449113|FG002|Overall Study|At Discretion of Sponsor|1|||
162109442|NCT01755702|585449114|FG000|Wash Out Period I|Other Reason|3|||
162109443|NCT01755702|585449114|FG000|Washout Period II|Other Reason|5|||
162109444|NCT00691938|585449115|FG000|Overall Study|QTc prolongation|1|||
162109445|NCT00691938|585449116|FG001|Overall Study|QTc prolongation|0|||
162109446|NCT00691938|585449117|FG002|Overall Study|QTc prolongation|0|||
162109447|NCT00691938|585449118|FG003|Overall Study|QTc prolongation|0|||
162109448|NCT00691938|585449119|FG004|Overall Study|QTc prolongation|0|||
162109449|NCT00691938|585449120|FG005|Overall Study|QTc prolongation|0|||
162109450|NCT00691938|585449121|FG006|Overall Study|QTc prolongation|0|||
162109451|NCT04860518|585449123|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
162109452|NCT04860518|585449124|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
162109453|NCT00594854|585449128|FG000|Overall Study|Study terminated|7|||
162109454|NCT00594854|585449129|FG001|Overall Study|Study terminated|10|||
162109455|NCT04918147|585449140|FG000|Overall Study|Disease flare as defined in protocol|0|||
162109456|NCT04918147|585449141|FG001|Overall Study|Disease flare as defined in protocol|2|||
162109457|NCT03292146|585449142|FG000|Baseline to 12 months|Relocation|1|||
162109458|NCT03292146|585449143|FG001|Baseline to 12 months|Relocation|0|||
162109459|NCT03292146|585449142|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
162109460|NCT03292146|585449143|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
162109461|NCT03292146|585449142|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
162109462|NCT03292146|585449143|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
162109463|NCT03292146|585449142|FG000|12 months to 24 months|Planning pregnancy|2|||
162109464|NCT03292146|585449143|FG001|12 months to 24 months|Planning pregnancy|2|||
162109465|NCT03292146|585449142|FG000|12 months to 24 months|Personal reasons|1|||
162109466|NCT03292146|585449143|FG001|12 months to 24 months|Personal reasons|0|||
162109467|NCT03292146|585449142|FG000|12 months to 24 months|Lost to Follow-up|0|||
162109468|NCT03292146|585449143|FG001|12 months to 24 months|Lost to Follow-up|1|||
162109469|NCT02712905|585449146|FG000|Monotherapy|Death|2|||
162109470|NCT02712905|585449147|FG001|Monotherapy|Death|5|||
162109471|NCT02712905|585449148|FG002|Monotherapy|Death|0|||
162109472|NCT02712905|585449149|FG003|Monotherapy|Death|3|||
162109473|NCT02712905|585449150|FG004|Monotherapy|Death|15|||
162109474|NCT02712905|585449151|FG005|Monotherapy|Death|1|||
162109475|NCT02712905|585449152|FG006|Monotherapy|Death|3|||
162109476|NCT02712905|585449153|FG007|Monotherapy|Death|3|||
162109477|NCT02712905|585449154|FG008|Monotherapy|Death|0|||
162109478|NCT02712905|585449155|FG009|Monotherapy|Death|27|||
162109479|NCT02712905|585449156|FG010|Monotherapy|Death|2|||
162109480|NCT02712905|585449157|FG011|Monotherapy|Death|5|||
162109481|NCT02712905|585449158|FG012|Monotherapy|Death|0|||
162109482|NCT02712905|585449159|FG013|Monotherapy|Death|0|||
162109483|NCT02712905|585449160|FG014|Monotherapy|Death|0|||
162109484|NCT02712905|585449161|FG015|Monotherapy|Death|0|||
162109485|NCT02712905|585449162|FG016|Monotherapy|Death|0|||
162109486|NCT02712905|585449163|FG017|Monotherapy|Death|0|||
162109487|NCT02712905|585449146|FG000|Monotherapy|Lost to Follow-up|0|||
162109488|NCT02712905|585449147|FG001|Monotherapy|Lost to Follow-up|1|||
162109489|NCT02712905|585449148|FG002|Monotherapy|Lost to Follow-up|0|||
162109490|NCT02712905|585449149|FG003|Monotherapy|Lost to Follow-up|1|||
162109491|NCT02712905|585449150|FG004|Monotherapy|Lost to Follow-up|0|||
162109492|NCT02712905|585449151|FG005|Monotherapy|Lost to Follow-up|0|||
162109493|NCT02712905|585449152|FG006|Monotherapy|Lost to Follow-up|0|||
162109494|NCT02712905|585449153|FG007|Monotherapy|Lost to Follow-up|0|||
162109495|NCT02712905|585449154|FG008|Monotherapy|Lost to Follow-up|0|||
162109496|NCT02712905|585449155|FG009|Monotherapy|Lost to Follow-up|2|||
162109497|NCT02712905|585449156|FG010|Monotherapy|Lost to Follow-up|0|||
162109498|NCT02712905|585449157|FG011|Monotherapy|Lost to Follow-up|0|||
162109499|NCT02712905|585449158|FG012|Monotherapy|Lost to Follow-up|0|||
162109500|NCT02712905|585449159|FG013|Monotherapy|Lost to Follow-up|0|||
162109501|NCT02712905|585449160|FG014|Monotherapy|Lost to Follow-up|0|||
162109502|NCT02712905|585449161|FG015|Monotherapy|Lost to Follow-up|0|||
162109503|NCT02712905|585449162|FG016|Monotherapy|Lost to Follow-up|0|||
162109504|NCT02712905|585449163|FG017|Monotherapy|Lost to Follow-up|0|||
162109505|NCT02712905|585449146|FG000|Monotherapy|Physician Decision|1|||
162109506|NCT02712905|585449147|FG001|Monotherapy|Physician Decision|0|||
162109507|NCT02712905|585449148|FG002|Monotherapy|Physician Decision|0|||
162109508|NCT02712905|585449149|FG003|Monotherapy|Physician Decision|1|||
162109509|NCT02712905|585449150|FG004|Monotherapy|Physician Decision|0|||
162109510|NCT02712905|585449151|FG005|Monotherapy|Physician Decision|0|||
162109511|NCT02712905|585449152|FG006|Monotherapy|Physician Decision|0|||
162109512|NCT02712905|585449153|FG007|Monotherapy|Physician Decision|0|||
162109513|NCT02712905|585449154|FG008|Monotherapy|Physician Decision|0|||
162109514|NCT02712905|585449155|FG009|Monotherapy|Physician Decision|1|||
162109515|NCT02712905|585449156|FG010|Monotherapy|Physician Decision|0|||
162109516|NCT02712905|585449157|FG011|Monotherapy|Physician Decision|0|||
162109517|NCT02712905|585449158|FG012|Monotherapy|Physician Decision|0|||
162109518|NCT02712905|585449159|FG013|Monotherapy|Physician Decision|0|||
162109519|NCT02712905|585449160|FG014|Monotherapy|Physician Decision|0|||
162109520|NCT02712905|585449161|FG015|Monotherapy|Physician Decision|0|||
162109521|NCT02712905|585449162|FG016|Monotherapy|Physician Decision|0|||
162109522|NCT02712905|585449163|FG017|Monotherapy|Physician Decision|0|||
162109523|NCT02712905|585449146|FG000|Monotherapy|Study Terminated by Sponsor|0|||
162109524|NCT02712905|585449147|FG001|Monotherapy|Study Terminated by Sponsor|0|||
162109525|NCT02712905|585449148|FG002|Monotherapy|Study Terminated by Sponsor|0|||
162109526|NCT02712905|585449149|FG003|Monotherapy|Study Terminated by Sponsor|0|||
162109527|NCT02712905|585449150|FG004|Monotherapy|Study Terminated by Sponsor|1|||
162109528|NCT02712905|585449151|FG005|Monotherapy|Study Terminated by Sponsor|0|||
162109529|NCT02712905|585449152|FG006|Monotherapy|Study Terminated by Sponsor|0|||
162109530|NCT02712905|585449153|FG007|Monotherapy|Study Terminated by Sponsor|0|||
162109531|NCT02712905|585449154|FG008|Monotherapy|Study Terminated by Sponsor|0|||
162109532|NCT02712905|585449155|FG009|Monotherapy|Study Terminated by Sponsor|2|||
162109533|NCT02712905|585449156|FG010|Monotherapy|Study Terminated by Sponsor|0|||
162109534|NCT02712905|585449157|FG011|Monotherapy|Study Terminated by Sponsor|0|||
162109535|NCT02712905|585449158|FG012|Monotherapy|Study Terminated by Sponsor|0|||
162109536|NCT02712905|585449159|FG013|Monotherapy|Study Terminated by Sponsor|0|||
162109537|NCT02712905|585449160|FG014|Monotherapy|Study Terminated by Sponsor|0|||
162109538|NCT02712905|585449161|FG015|Monotherapy|Study Terminated by Sponsor|0|||
162109539|NCT02712905|585449162|FG016|Monotherapy|Study Terminated by Sponsor|0|||
162109540|NCT02712905|585449163|FG017|Monotherapy|Study Terminated by Sponsor|0|||
162109541|NCT02712905|585449146|FG000|Monotherapy|Withdrawal by Subject|0|||
162109542|NCT02712905|585449147|FG001|Monotherapy|Withdrawal by Subject|0|||
162109543|NCT02712905|585449148|FG002|Monotherapy|Withdrawal by Subject|1|||
162109544|NCT02712905|585449149|FG003|Monotherapy|Withdrawal by Subject|0|||
162109545|NCT02712905|585449150|FG004|Monotherapy|Withdrawal by Subject|2|||
162109546|NCT02712905|585449151|FG005|Monotherapy|Withdrawal by Subject|0|||
162109547|NCT02712905|585449152|FG006|Monotherapy|Withdrawal by Subject|0|||
162109548|NCT02712905|585449153|FG007|Monotherapy|Withdrawal by Subject|0|||
162109549|NCT02712905|585449154|FG008|Monotherapy|Withdrawal by Subject|0|||
162109550|NCT02712905|585449155|FG009|Monotherapy|Withdrawal by Subject|4|||
162109551|NCT02712905|585449156|FG010|Monotherapy|Withdrawal by Subject|1|||
162109552|NCT02712905|585449157|FG011|Monotherapy|Withdrawal by Subject|2|||
162109553|NCT02712905|585449158|FG012|Monotherapy|Withdrawal by Subject|0|||
162109554|NCT02712905|585449159|FG013|Monotherapy|Withdrawal by Subject|0|||
162109555|NCT02712905|585449160|FG014|Monotherapy|Withdrawal by Subject|0|||
162109556|NCT02712905|585449161|FG015|Monotherapy|Withdrawal by Subject|0|||
162109557|NCT02712905|585449162|FG016|Monotherapy|Withdrawal by Subject|0|||
162109558|NCT02712905|585449163|FG017|Monotherapy|Withdrawal by Subject|0|||
162109559|NCT02712905|585449146|FG000|Monotherapy|Started New Cancer Drug|0|||
162109560|NCT02712905|585449147|FG001|Monotherapy|Started New Cancer Drug|0|||
162109561|NCT02712905|585449148|FG002|Monotherapy|Started New Cancer Drug|0|||
162109562|NCT02712905|585449149|FG003|Monotherapy|Started New Cancer Drug|0|||
162109563|NCT02712905|585449150|FG004|Monotherapy|Started New Cancer Drug|0|||
162109564|NCT02712905|585449151|FG005|Monotherapy|Started New Cancer Drug|1|||
162109565|NCT02712905|585449152|FG006|Monotherapy|Started New Cancer Drug|0|||
162109566|NCT02712905|585449153|FG007|Monotherapy|Started New Cancer Drug|0|||
162109567|NCT02712905|585449154|FG008|Monotherapy|Started New Cancer Drug|0|||
162109568|NCT02712905|585449155|FG009|Monotherapy|Started New Cancer Drug|0|||
162109569|NCT02712905|585449156|FG010|Monotherapy|Started New Cancer Drug|0|||
162109570|NCT02712905|585449157|FG011|Monotherapy|Started New Cancer Drug|0|||
162109571|NCT02712905|585449158|FG012|Monotherapy|Started New Cancer Drug|0|||
162109572|NCT02712905|585449159|FG013|Monotherapy|Started New Cancer Drug|0|||
162109573|NCT02712905|585449160|FG014|Monotherapy|Started New Cancer Drug|0|||
162109574|NCT02712905|585449161|FG015|Monotherapy|Started New Cancer Drug|0|||
162109575|NCT02712905|585449162|FG016|Monotherapy|Started New Cancer Drug|0|||
162109576|NCT02712905|585449163|FG017|Monotherapy|Started New Cancer Drug|0|||
162109577|NCT02712905|585449146|FG000|Monotherapy|Adverse Event|0|||
162109578|NCT02712905|585449147|FG001|Monotherapy|Adverse Event|0|||
162109579|NCT02712905|585449148|FG002|Monotherapy|Adverse Event|0|||
162109580|NCT02712905|585449149|FG003|Monotherapy|Adverse Event|0|||
162109581|NCT02712905|585449150|FG004|Monotherapy|Adverse Event|0|||
162109582|NCT02712905|585449151|FG005|Monotherapy|Adverse Event|0|||
162109583|NCT02712905|585449152|FG006|Monotherapy|Adverse Event|0|||
162109584|NCT02712905|585449153|FG007|Monotherapy|Adverse Event|0|||
162109585|NCT02712905|585449154|FG008|Monotherapy|Adverse Event|1|||
162109586|NCT02712905|585449155|FG009|Monotherapy|Adverse Event|0|||
162109587|NCT02712905|585449156|FG010|Monotherapy|Adverse Event|0|||
162109588|NCT02712905|585449157|FG011|Monotherapy|Adverse Event|0|||
162109589|NCT02712905|585449158|FG012|Monotherapy|Adverse Event|0|||
162109590|NCT02712905|585449159|FG013|Monotherapy|Adverse Event|0|||
162109591|NCT02712905|585449160|FG014|Monotherapy|Adverse Event|0|||
162109592|NCT02712905|585449161|FG015|Monotherapy|Adverse Event|0|||
162109593|NCT02712905|585449162|FG016|Monotherapy|Adverse Event|0|||
162109594|NCT02712905|585449163|FG017|Monotherapy|Adverse Event|0|||
162109595|NCT02712905|585449146|FG000|Combination Therapy|Death|0|||
162109596|NCT02712905|585449147|FG001|Combination Therapy|Death|0|||
162109597|NCT02712905|585449148|FG002|Combination Therapy|Death|0|||
162109598|NCT02712905|585449149|FG003|Combination Therapy|Death|0|||
162109599|NCT02712905|585449150|FG004|Combination Therapy|Death|0|||
162109600|NCT02712905|585449151|FG005|Combination Therapy|Death|0|||
162109601|NCT02712905|585449152|FG006|Combination Therapy|Death|0|||
162109602|NCT02712905|585449153|FG007|Combination Therapy|Death|0|||
162109603|NCT02712905|585449154|FG008|Combination Therapy|Death|0|||
162109604|NCT02712905|585449155|FG009|Combination Therapy|Death|0|||
162109605|NCT02712905|585449156|FG010|Combination Therapy|Death|0|||
162109606|NCT02712905|585449157|FG011|Combination Therapy|Death|0|||
162109607|NCT02712905|585449158|FG012|Combination Therapy|Death|5|||
162109608|NCT02712905|585449159|FG013|Combination Therapy|Death|6|||
162109609|NCT02712905|585449160|FG014|Combination Therapy|Death|1|||
162109610|NCT02712905|585449161|FG015|Combination Therapy|Death|3|||
162109611|NCT02712905|585449162|FG016|Combination Therapy|Death|1|||
162109612|NCT02712905|585449163|FG017|Combination Therapy|Death|3|||
162109613|NCT02712905|585449146|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
162109614|NCT02712905|585449147|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
162109615|NCT02712905|585449148|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
162109616|NCT02712905|585449149|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
162109617|NCT02712905|585449150|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
162109618|NCT02712905|585449151|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
162109619|NCT02712905|585449152|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
162109620|NCT02712905|585449153|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
162109621|NCT02712905|585449154|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
162109622|NCT02712905|585449155|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
162109623|NCT02712905|585449156|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
162109624|NCT02712905|585449157|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
162109625|NCT02712905|585449158|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
162109626|NCT02712905|585449159|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
162109627|NCT02712905|585449160|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
162109628|NCT02712905|585449161|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
162109629|NCT02712905|585449162|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
162109630|NCT02712905|585449163|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
162109631|NCT02712905|585449146|FG000|Combination Therapy|Withdrawal by Subject|0|||
162109632|NCT02712905|585449147|FG001|Combination Therapy|Withdrawal by Subject|0|||
162109633|NCT02712905|585449148|FG002|Combination Therapy|Withdrawal by Subject|0|||
162109634|NCT02712905|585449149|FG003|Combination Therapy|Withdrawal by Subject|0|||
162109635|NCT02712905|585449150|FG004|Combination Therapy|Withdrawal by Subject|0|||
162109636|NCT02712905|585449151|FG005|Combination Therapy|Withdrawal by Subject|0|||
162109637|NCT02712905|585449152|FG006|Combination Therapy|Withdrawal by Subject|0|||
162109638|NCT02712905|585449153|FG007|Combination Therapy|Withdrawal by Subject|0|||
162109639|NCT02712905|585449154|FG008|Combination Therapy|Withdrawal by Subject|0|||
162109640|NCT02712905|585449155|FG009|Combination Therapy|Withdrawal by Subject|0|||
162109641|NCT02712905|585449156|FG010|Combination Therapy|Withdrawal by Subject|0|||
162109642|NCT02712905|585449157|FG011|Combination Therapy|Withdrawal by Subject|0|||
162109643|NCT02712905|585449158|FG012|Combination Therapy|Withdrawal by Subject|0|||
162109644|NCT02712905|585449159|FG013|Combination Therapy|Withdrawal by Subject|0|||
162109645|NCT02712905|585449160|FG014|Combination Therapy|Withdrawal by Subject|0|||
162109646|NCT02712905|585449161|FG015|Combination Therapy|Withdrawal by Subject|1|||
162109647|NCT02712905|585449162|FG016|Combination Therapy|Withdrawal by Subject|0|||
162109648|NCT02712905|585449163|FG017|Combination Therapy|Withdrawal by Subject|2|||
162109649|NCT02712905|585449146|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109650|NCT02712905|585449147|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109651|NCT02712905|585449148|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109652|NCT02712905|585449149|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109653|NCT02712905|585449150|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109654|NCT02712905|585449151|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109655|NCT02712905|585449152|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109656|NCT02712905|585449153|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109657|NCT02712905|585449154|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109658|NCT02712905|585449155|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109659|NCT02712905|585449156|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109660|NCT02712905|585449157|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109661|NCT02712905|585449158|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109662|NCT02712905|585449159|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109663|NCT02712905|585449160|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109664|NCT02712905|585449161|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
162109665|NCT02712905|585449162|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109666|NCT02712905|585449163|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
162109667|NCT03624504|585449164|FG000|Overall Study|Unsuccessful Implant|1|||
162109668|NCT02975973|585449165|FG000|Overall Study|Adverse Event|1|||
162109669|NCT02975973|585449166|FG001|Overall Study|Adverse Event|1|||
162109670|NCT02975973|585449167|FG002|Overall Study|Adverse Event|1|||
162109671|NCT02975973|585449168|FG003|Overall Study|Adverse Event|0|||
162109672|NCT01812655|585449169|FG000|Overall Study|Protocol Violation|1|||
162109673|NCT01812655|585449170|FG001|Overall Study|Protocol Violation|1|||
162109674|NCT01812655|585449171|FG002|Overall Study|Protocol Violation|0|||
162109675|NCT01428076|585449172|FG000|Overall Study|Adverse Event|0|||
162109676|NCT01428076|585449173|FG001|Overall Study|Adverse Event|1|||
162109677|NCT04435665|585449174|FG000|Overall Study|Lost to Follow-up|0|||
162109678|NCT04435665|585449175|FG001|Overall Study|Lost to Follow-up|0|||
162109679|NCT04435665|585449176|FG002|Overall Study|Lost to Follow-up|0|||
162109680|NCT04435665|585449177|FG003|Overall Study|Lost to Follow-up|1|||
162109681|NCT00419263|585449178|FG000|Overall Study|Lost to Follow-up|2|||
162109682|NCT00419263|585449179|FG001|Overall Study|Lost to Follow-up|1|||
162109683|NCT00419263|585449180|FG002|Overall Study|Lost to Follow-up|1|||
162109684|NCT00419263|585449178|FG000|Overall Study|Randomized in Error, Not Treated|1|||
162109685|NCT00419263|585449179|FG001|Overall Study|Randomized in Error, Not Treated|1|||
162109686|NCT00419263|585449180|FG002|Overall Study|Randomized in Error, Not Treated|0|||
162109687|NCT00419263|585449178|FG000|Overall Study|Adverse Event|0|||
162109688|NCT00419263|585449179|FG001|Overall Study|Adverse Event|0|||
162109689|NCT00419263|585449180|FG002|Overall Study|Adverse Event|1|||
162109690|NCT00419263|585449178|FG000|Overall Study|Withdrawal by Subject|0|||
162109691|NCT00419263|585449179|FG001|Overall Study|Withdrawal by Subject|0|||
162109692|NCT00419263|585449180|FG002|Overall Study|Withdrawal by Subject|1|||
162109693|NCT00540124|585449181|FG000|Overall Study|Adverse Event|0|||
162109694|NCT00540124|585449182|FG001|Overall Study|Adverse Event|2|||
162109695|NCT00540124|585449183|FG002|Overall Study|Adverse Event|1|||
162109696|NCT00540124|585449181|FG000|Overall Study|Entry Criteria Not Met|2|||
162109697|NCT00540124|585449182|FG001|Overall Study|Entry Criteria Not Met|0|||
162109698|NCT00540124|585449183|FG002|Overall Study|Entry Criteria Not Met|0|||
162109699|NCT00540124|585449181|FG000|Overall Study|Lack of Efficacy|1|||
162109700|NCT00540124|585449182|FG001|Overall Study|Lack of Efficacy|0|||
162109701|NCT00540124|585449183|FG002|Overall Study|Lack of Efficacy|0|||
162109702|NCT00540124|585449181|FG000|Overall Study|Withdrawal by Subject|1|||
162109703|NCT00540124|585449182|FG001|Overall Study|Withdrawal by Subject|1|||
162109704|NCT00540124|585449183|FG002|Overall Study|Withdrawal by Subject|0|||
162109705|NCT00058123|585449184|FG000|Overall Study|Wrong histology|9|||
162109706|NCT00058123|585449184|FG000|Overall Study|Received >3 prior treatments|1|||
162109707|NCT00344461|585449187|FG000|Overall Study|Adverse Event|6|||
162109708|NCT00344461|585449187|FG000|Overall Study|Death|1|||
162109709|NCT00344461|585449187|FG000|Overall Study|Lack of Efficacy|2|||
162109710|NCT00344461|585449187|FG000|Overall Study|Lost to Follow-up|2|||
162109711|NCT00344461|585449187|FG000|Overall Study|Physician Decision|2|||
162109712|NCT00344461|585449187|FG000|Overall Study|Protocol Violation|6|||
162109713|NCT00344461|585449187|FG000|Overall Study|Withdrawal by Subject|2|||
162109714|NCT04839965|585449190|FG000|Overall Study|Death|6|||
162109715|NCT04839965|585449191|FG001|Overall Study|Death|6|||
162109716|NCT04839965|585449190|FG000|Overall Study|Lost to Follow-up|1|||
162109717|NCT04839965|585449191|FG001|Overall Study|Lost to Follow-up|0|||
162109718|NCT02291679|585449192|FG000|Overall Study|Adverse Event|2|||
162109719|NCT02291679|585449193|FG001|Overall Study|Adverse Event|12|||
162109720|NCT02291679|585449194|FG002|Overall Study|Adverse Event|19|||
162109721|NCT02291679|585449192|FG000|Overall Study|Protocol Violation|5|||
162109722|NCT02291679|585449193|FG001|Overall Study|Protocol Violation|1|||
162109723|NCT02291679|585449194|FG002|Overall Study|Protocol Violation|7|||
162109724|NCT02291679|585449192|FG000|Overall Study|Withdrew Consent|18|||
162109725|NCT02291679|585449193|FG001|Overall Study|Withdrew Consent|10|||
162109726|NCT02291679|585449194|FG002|Overall Study|Withdrew Consent|15|||
162109727|NCT02291679|585449192|FG000|Overall Study|Lost to Follow-up|12|||
162109728|NCT02291679|585449193|FG001|Overall Study|Lost to Follow-up|10|||
162109729|NCT02291679|585449194|FG002|Overall Study|Lost to Follow-up|9|||
162109730|NCT02291679|585449192|FG000|Overall Study|Insufficient Therapeutic Response|5|||
162109731|NCT02291679|585449193|FG001|Overall Study|Insufficient Therapeutic Response|5|||
162109732|NCT02291679|585449194|FG002|Overall Study|Insufficient Therapeutic Response|7|||
162109733|NCT02291679|585449192|FG000|Overall Study|Other|2|||
162109734|NCT02291679|585449193|FG001|Overall Study|Other|4|||
162109735|NCT02291679|585449194|FG002|Overall Study|Other|2|||
162109736|NCT02355028|585449195|FG000|Overall Study|Adverse Event|2|||
162109737|NCT02355028|585449196|FG001|Overall Study|Adverse Event|0|||
162109738|NCT02355028|585449195|FG000|Overall Study|Withdrawal by Subject|1|||
162109739|NCT02355028|585449196|FG001|Overall Study|Withdrawal by Subject|1|||
162109740|NCT02355028|585449195|FG000|Overall Study|Deemed ineligible after randomization|8|||
162109741|NCT02355028|585449196|FG001|Overall Study|Deemed ineligible after randomization|4|||
162109742|NCT02276222|585449197|FG000|Overall Study|Adverse Event|62|||
162109743|NCT02276222|585449198|FG001|Overall Study|Adverse Event|11|||
162109744|NCT02276222|585449197|FG000|Overall Study|Death|3|||
162109745|NCT02276222|585449198|FG001|Overall Study|Death|4|||
162109746|NCT02276222|585449197|FG000|Overall Study|Lack of Efficacy|13|||
162109747|NCT02276222|585449198|FG001|Overall Study|Lack of Efficacy|3|||
162109748|NCT02276222|585449197|FG000|Overall Study|Protocol Violation|3|||
162109749|NCT02276222|585449198|FG001|Overall Study|Protocol Violation|2|||
162109750|NCT02276222|585449197|FG000|Overall Study|Withdrawal by Subject|79|||
162109751|NCT02276222|585449198|FG001|Overall Study|Withdrawal by Subject|33|||
162109752|NCT02276222|585449197|FG000|Overall Study|non compliance with study medication|6|||
162109753|NCT02276222|585449198|FG001|Overall Study|non compliance with study medication|2|||
162109754|NCT02276222|585449197|FG000|Overall Study|sponsor decision|0|||
162109755|NCT02276222|585449198|FG001|Overall Study|sponsor decision|3|||
162109756|NCT02276222|585449197|FG000|Overall Study|Lost to Follow-up|15|||
162109757|NCT02276222|585449198|FG001|Overall Study|Lost to Follow-up|5|||
162109758|NCT02276222|585449197|FG000|Overall Study|Physician Decision|2|||
162109759|NCT02276222|585449198|FG001|Overall Study|Physician Decision|1|||
162109760|NCT02276222|585449197|FG000|Overall Study|sheduling conflict|1|||
162109761|NCT02276222|585449198|FG001|Overall Study|sheduling conflict|0|||
162109762|NCT02276222|585449197|FG000|Overall Study|subject withdrew after randomization|1|||
162109763|NCT02276222|585449198|FG001|Overall Study|subject withdrew after randomization|0|||
162109764|NCT02170025|585449199|FG000|Overall Study|Adverse Event|2|||
162109765|NCT02170025|585449200|FG001|Overall Study|Adverse Event|0|||
162109766|NCT01525602|585449201|FG000|Overall Study|Adverse Event|1|||
162109767|NCT01525602|585449202|FG001|Overall Study|Adverse Event|0|||
162109768|NCT01525602|585449203|FG002|Overall Study|Adverse Event|1|||
162109769|NCT01525602|585449204|FG003|Overall Study|Adverse Event|1|||
162109770|NCT01525602|585449205|FG004|Overall Study|Adverse Event|3|||
162109771|NCT01525602|585449206|FG005|Overall Study|Adverse Event|3|||
162109772|NCT01525602|585449207|FG006|Overall Study|Adverse Event|0|||
162109773|NCT01525602|585449208|FG007|Overall Study|Adverse Event|1|||
162109774|NCT01525602|585449201|FG000|Overall Study|Disease progression|6|||
162109775|NCT01525602|585449202|FG001|Overall Study|Disease progression|3|||
162109776|NCT01525602|585449203|FG002|Overall Study|Disease progression|2|||
162109777|NCT01525602|585449204|FG003|Overall Study|Disease progression|5|||
162109778|NCT01525602|585449205|FG004|Overall Study|Disease progression|22|||
162109779|NCT01525602|585449206|FG005|Overall Study|Disease progression|2|||
162109780|NCT01525602|585449207|FG006|Overall Study|Disease progression|3|||
162109781|NCT01525602|585449208|FG007|Overall Study|Disease progression|3|||
162109782|NCT01525602|585449201|FG000|Overall Study|Clinical progression|2|||
162109783|NCT01525602|585449202|FG001|Overall Study|Clinical progression|0|||
162109784|NCT01525602|585449203|FG002|Overall Study|Clinical progression|0|||
162109785|NCT01525602|585449204|FG003|Overall Study|Clinical progression|0|||
162109786|NCT01525602|585449205|FG004|Overall Study|Clinical progression|0|||
162109787|NCT01525602|585449206|FG005|Overall Study|Clinical progression|0|||
162109788|NCT01525602|585449207|FG006|Overall Study|Clinical progression|1|||
162109789|NCT01525602|585449208|FG007|Overall Study|Clinical progression|1|||
162109790|NCT01525602|585449201|FG000|Overall Study|Non-compliance|0|||
162109791|NCT01525602|585449202|FG001|Overall Study|Non-compliance|0|||
162109792|NCT01525602|585449203|FG002|Overall Study|Non-compliance|0|||
162109793|NCT01525602|585449204|FG003|Overall Study|Non-compliance|0|||
162109794|NCT01525602|585449205|FG004|Overall Study|Non-compliance|1|||
162109795|NCT01525602|585449206|FG005|Overall Study|Non-compliance|0|||
162109796|NCT01525602|585449207|FG006|Overall Study|Non-compliance|0|||
162109797|NCT01525602|585449208|FG007|Overall Study|Non-compliance|0|||
162109798|NCT01525602|585449201|FG000|Overall Study|Withdrawal by Subject|0|||
162109799|NCT01525602|585449202|FG001|Overall Study|Withdrawal by Subject|0|||
162109800|NCT01525602|585449203|FG002|Overall Study|Withdrawal by Subject|0|||
162109801|NCT01525602|585449204|FG003|Overall Study|Withdrawal by Subject|0|||
162109802|NCT01525602|585449205|FG004|Overall Study|Withdrawal by Subject|3|||
162109803|NCT01525602|585449206|FG005|Overall Study|Withdrawal by Subject|1|||
162109804|NCT01525602|585449207|FG006|Overall Study|Withdrawal by Subject|0|||
162109805|NCT01525602|585449208|FG007|Overall Study|Withdrawal by Subject|1|||
162109806|NCT01525602|585449201|FG000|Overall Study|Physician Decision|0|||
162109807|NCT01525602|585449202|FG001|Overall Study|Physician Decision|0|||
162109808|NCT01525602|585449203|FG002|Overall Study|Physician Decision|0|||
162109809|NCT01525602|585449204|FG003|Overall Study|Physician Decision|0|||
162109810|NCT01525602|585449205|FG004|Overall Study|Physician Decision|3|||
162109811|NCT01525602|585449206|FG005|Overall Study|Physician Decision|0|||
162109812|NCT01525602|585449207|FG006|Overall Study|Physician Decision|1|||
162109813|NCT01525602|585449208|FG007|Overall Study|Physician Decision|0|||
162109814|NCT01525602|585449201|FG000|Overall Study|Death|0|||
162109815|NCT01525602|585449202|FG001|Overall Study|Death|0|||
162109816|NCT01525602|585449203|FG002|Overall Study|Death|0|||
162109817|NCT01525602|585449204|FG003|Overall Study|Death|0|||
162109818|NCT01525602|585449205|FG004|Overall Study|Death|1|||
162109819|NCT01525602|585449206|FG005|Overall Study|Death|1|||
162109820|NCT01525602|585449207|FG006|Overall Study|Death|0|||
162109821|NCT01525602|585449208|FG007|Overall Study|Death|0|||
162109822|NCT01525602|585449201|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
162109823|NCT01525602|585449202|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
162109824|NCT01525602|585449203|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
162109825|NCT01525602|585449204|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
162109826|NCT01525602|585449205|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
162109827|NCT01525602|585449206|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
162109828|NCT01525602|585449207|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
162109829|NCT01525602|585449208|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
162109830|NCT03703466|585449214|FG000|Overall Study|Death|2|||
162109831|NCT03703466|585449215|FG001|Overall Study|Death|1|||
162109832|NCT03703466|585449216|FG002|Overall Study|Death|0|||
162109833|NCT03703466|585449214|FG000|Overall Study|Withdrawal by Subject|0|||
162109834|NCT03703466|585449215|FG001|Overall Study|Withdrawal by Subject|3|||
162109835|NCT03703466|585449216|FG002|Overall Study|Withdrawal by Subject|0|||
162109836|NCT03703466|585449214|FG000|Overall Study|Completed < 3 Cycles|2|||
162109837|NCT03703466|585449215|FG001|Overall Study|Completed < 3 Cycles|2|||
162109838|NCT03703466|585449216|FG002|Overall Study|Completed < 3 Cycles|2|||
162109839|NCT02412137|585449217|FG000|Overall Study|Withdrawal by Subject|2|||
162109840|NCT02412137|585449218|FG001|Overall Study|Withdrawal by Subject|0|||
162109841|NCT02412137|585449217|FG000|Overall Study|Lost to Follow-up|21|||
162109842|NCT02412137|585449218|FG001|Overall Study|Lost to Follow-up|14|||
162109843|NCT02412137|585449217|FG000|Overall Study|Physician Decision|28|||
162109844|NCT02412137|585449218|FG001|Overall Study|Physician Decision|9|||
162109845|NCT00506493|585449219|FG000|Overall Study|Death|6|||
162109846|NCT00506493|585449219|FG000|Overall Study|Withdrawal by Subject|5|||
162109847|NCT02532179|585450866|FG000|Overall Study|Lost to Follow-up|1|||
162109848|NCT02532179|585450866|FG000|Overall Study|Pregnancy|1|||
162109849|NCT02532179|585450866|FG000|Overall Study|Subject received depot steroid injection|1|||
162109850|NCT02240108|585450867|FG000|Overall Study|Other than specified|8|||
162109851|NCT02240108|585450868|FG001|Overall Study|Other than specified|6|||
162109852|NCT02240108|585450867|FG000|Overall Study|Adverse Event|1|||
162109853|NCT02240108|585450868|FG001|Overall Study|Adverse Event|9|||
162109854|NCT02240108|585450867|FG000|Overall Study|Pregnancy|1|||
162109855|NCT02240108|585450868|FG001|Overall Study|Pregnancy|0|||
162109856|NCT02240108|585450867|FG000|Overall Study|Withdrawal by Subject|4|||
162109857|NCT02240108|585450868|FG001|Overall Study|Withdrawal by Subject|9|||
162109858|NCT02240108|585450867|FG000|Overall Study|StudyTerminated by Sponsor|0|||
162109859|NCT02240108|585450868|FG001|Overall Study|StudyTerminated by Sponsor|1|||
162109860|NCT00119405|585450869|FG000|Overall Study|Withdrawal by Subject|1|||
162109861|NCT00939484|585450871|FG000|Overall Study|Progression/Relapse|8|||
162109862|NCT00939484|585450872|FG001|Overall Study|Progression/Relapse|20|||
162109863|NCT00939484|585450873|FG002|Overall Study|Progression/Relapse|3|||
162109864|NCT04233372|585450874|FG000|Overall Study|Lost to Follow-up|104|||
162109865|NCT04233372|585450874|FG000|Overall Study|Adverse Event|8|||
162109866|NCT04233372|585450874|FG000|Overall Study|Withdrawal by Subject|2|||
162109867|NCT04958785|585450875|FG000|Overall Study|Study Terminated by Sponsor|4|||
162109868|NCT04958785|585450876|FG001|Overall Study|Study Terminated by Sponsor|10|||
162109869|NCT04958785|585450877|FG002|Overall Study|Study Terminated by Sponsor|7|||
162109870|NCT04958785|585450878|FG003|Overall Study|Study Terminated by Sponsor|6|||
162109871|NCT04958785|585450879|FG004|Overall Study|Study Terminated by Sponsor|34|||
162109872|NCT04958785|585450875|FG000|Overall Study|Death|2|||
162109873|NCT04958785|585450876|FG001|Overall Study|Death|3|||
162109874|NCT04958785|585450877|FG002|Overall Study|Death|4|||
162109875|NCT04958785|585450878|FG003|Overall Study|Death|5|||
162109876|NCT04958785|585450879|FG004|Overall Study|Death|5|||
162109877|NCT04958785|585450875|FG000|Overall Study|Withdrew consent|2|||
162109878|NCT04958785|585450876|FG001|Overall Study|Withdrew consent|0|||
162109879|NCT04958785|585450877|FG002|Overall Study|Withdrew consent|3|||
162109880|NCT04958785|585450878|FG003|Overall Study|Withdrew consent|1|||
162109881|NCT04958785|585450879|FG004|Overall Study|Withdrew consent|0|||
162109882|NCT04958785|585450875|FG000|Overall Study|Investigator's discretion|0|||
162109883|NCT04958785|585450876|FG001|Overall Study|Investigator's discretion|1|||
162109884|NCT04958785|585450877|FG002|Overall Study|Investigator's discretion|0|||
162109885|NCT04958785|585450878|FG003|Overall Study|Investigator's discretion|1|||
162109886|NCT04958785|585450879|FG004|Overall Study|Investigator's discretion|2|||
162109887|NCT04958785|585450875|FG000|Overall Study|Adverse Event|0|||
162109888|NCT04958785|585450876|FG001|Overall Study|Adverse Event|0|||
162109889|NCT04958785|585450877|FG002|Overall Study|Adverse Event|0|||
162109890|NCT04958785|585450878|FG003|Overall Study|Adverse Event|0|||
162109891|NCT04958785|585450879|FG004|Overall Study|Adverse Event|1|||
162109892|NCT04958785|585450875|FG000|Overall Study|Lost to Follow-up|0|||
162109893|NCT04958785|585450876|FG001|Overall Study|Lost to Follow-up|0|||
162109894|NCT04958785|585450877|FG002|Overall Study|Lost to Follow-up|0|||
162109895|NCT04958785|585450878|FG003|Overall Study|Lost to Follow-up|0|||
162109896|NCT04958785|585450879|FG004|Overall Study|Lost to Follow-up|1|||
162109897|NCT01090310|585450880|FG000|Core Study|Adverse Event|2|||
162109898|NCT01090310|585450881|FG001|Core Study|Adverse Event|2|||
162109899|NCT01090310|585450882|FG002|Core Study|Adverse Event|1|||
162109900|NCT01090310|585450883|FG003|Core Study|Adverse Event|1|||
162109901|NCT01090310|585450880|FG000|Core Study|Subject withdrew consent|0|||
162109902|NCT01090310|585450881|FG001|Core Study|Subject withdrew consent|3|||
162109903|NCT01090310|585450882|FG002|Core Study|Subject withdrew consent|1|||
162109904|NCT01090310|585450883|FG003|Core Study|Subject withdrew consent|1|||
162109905|NCT01090310|585450880|FG000|Core Study|Abnormal test procedure result|0|||
162109906|NCT01090310|585450881|FG001|Core Study|Abnormal test procedure result|0|||
162109907|NCT01090310|585450882|FG002|Core Study|Abnormal test procedure result|1|||
162109908|NCT01090310|585450883|FG003|Core Study|Abnormal test procedure result|0|||
162109909|NCT01090310|585450880|FG000|Core Study|Administrative reasons|5|||
162109910|NCT01090310|585450881|FG001|Core Study|Administrative reasons|6|||
162109911|NCT01090310|585450882|FG002|Core Study|Administrative reasons|4|||
162109912|NCT01090310|585450883|FG003|Core Study|Administrative reasons|4|||
162109913|NCT01090310|585450880|FG000|Core Study|Protocol deviation|1|||
162109914|NCT01090310|585450881|FG001|Core Study|Protocol deviation|0|||
162109915|NCT01090310|585450882|FG002|Core Study|Protocol deviation|0|||
162109916|NCT01090310|585450883|FG003|Core Study|Protocol deviation|1|||
162109917|NCT01090310|585450880|FG000|Extension Study|Aministrative problems|13|||
162109918|NCT01090310|585450881|FG001|Extension Study|Aministrative problems|15|||
162109919|NCT01090310|585450882|FG002|Extension Study|Aministrative problems|14|||
162109920|NCT01090310|585450883|FG003|Extension Study|Aministrative problems|18|||
162109921|NCT01090310|585450880|FG000|Extension Study|Adverse Event|0|||
162109922|NCT01090310|585450881|FG001|Extension Study|Adverse Event|0|||
162109923|NCT01090310|585450882|FG002|Extension Study|Adverse Event|0|||
162109924|NCT01090310|585450883|FG003|Extension Study|Adverse Event|1|||
162109925|NCT01090310|585450880|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
162109926|NCT01090310|585450881|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
162109927|NCT01090310|585450882|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
162109928|NCT01090310|585450883|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
162109929|NCT01090310|585450880|FG000|Extension Study|Subject withdrew consent|0|||
162109930|NCT01090310|585450881|FG001|Extension Study|Subject withdrew consent|1|||
162109931|NCT01090310|585450882|FG002|Extension Study|Subject withdrew consent|0|||
162109932|NCT01090310|585450883|FG003|Extension Study|Subject withdrew consent|0|||
162109933|NCT01224925|585450884|FG000|Overall Study|Lost to Follow-up|3|||
162109934|NCT01224925|585450885|FG001|Overall Study|Lost to Follow-up|2|||
162109935|NCT01083641|585450887|FG000|Overall Study|Withdrawal by Subject|2|||
162109936|NCT03439189|585450888|FG000|Overall Study|Protocol Violation|19|||
162109937|NCT03439189|585450888|FG000|Overall Study|Lack of Efficacy|63|||
162109938|NCT01777321|585450889|FG000|Overall Study|Withdrawal by Subject|0|||
162109939|NCT01777321|585450890|FG001|Overall Study|Withdrawal by Subject|1|||
162109940|NCT02173548|585450891|FG000|Overall Study|Lost to Follow-up|0|||
162109941|NCT02173548|585450892|FG001|Overall Study|Lost to Follow-up|2|||
162109942|NCT02173548|585450891|FG000|Overall Study|Withdrawal by Subject|1|||
162109943|NCT02173548|585450892|FG001|Overall Study|Withdrawal by Subject|0|||
162109944|NCT03597568|585450893|FG000|Overall Study|Withdrawal by Subject|1|||
162109945|NCT03597568|585450894|FG001|Overall Study|Withdrawal by Subject|1|||
162109946|NCT03597568|585450893|FG000|Overall Study|Unable to analyze vascular data|1|||
162109947|NCT03597568|585450894|FG001|Overall Study|Unable to analyze vascular data|1|||
162109948|NCT00999466|585450897|FG000|Main Part|Withdrawal by Subject|0|||
162109949|NCT00999466|585450898|FG001|Main Part|Withdrawal by Subject|0|||
162109950|NCT00999466|585450899|FG002|Main Part|Withdrawal by Subject|2|||
162109951|NCT00999466|585450897|FG000|Main Part|Adverse Event|0|||
162109952|NCT00999466|585450898|FG001|Main Part|Adverse Event|4|||
162109953|NCT00999466|585450899|FG002|Main Part|Adverse Event|2|||
162109954|NCT05131165|585450900|FG000|Overall Study|Death|1|||
162109955|NCT05131165|585450901|FG001|Overall Study|Death|1|||
162109956|NCT05131165|585450902|FG002|Overall Study|Death|0|||
162109957|NCT05131165|585450900|FG000|Overall Study|Lost to Follow-up|2|||
162109958|NCT05131165|585450901|FG001|Overall Study|Lost to Follow-up|2|||
162109959|NCT05131165|585450902|FG002|Overall Study|Lost to Follow-up|5|||
162109960|NCT05131165|585450900|FG000|Overall Study|Transferred out of clinic|1|||
162109961|NCT05131165|585450901|FG001|Overall Study|Transferred out of clinic|0|||
162109962|NCT05131165|585450902|FG002|Overall Study|Transferred out of clinic|3|||
162109963|NCT05131165|585450900|FG000|Overall Study|Dropped out|1|||
162109964|NCT05131165|585450901|FG001|Overall Study|Dropped out|2|||
162109965|NCT05131165|585450902|FG002|Overall Study|Dropped out|0|||
162109966|NCT00526630|585450903|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
162109967|NCT00526630|585450904|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
162109968|NCT00526630|585450903|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
162109969|NCT00526630|585450904|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
162109970|NCT00337272|585450905|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
162109971|NCT00337272|585450906|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
162109972|NCT00337272|585450905|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
162109973|NCT00337272|585450906|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
162109974|NCT00337272|585450905|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
162109975|NCT00337272|585450906|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
162109976|NCT00337272|585450905|FG000|Treatment Period|Non-compliance|1|||
162109977|NCT00337272|585450906|FG001|Treatment Period|Non-compliance|1|||
162109978|NCT00337272|585450905|FG000|Treatment Period|Withdrawal by Subject|0|||
162109979|NCT00337272|585450906|FG001|Treatment Period|Withdrawal by Subject|1|||
162109980|NCT00337272|585450905|FG000|Withdrawal Period|Non-compliance|0|||
162109981|NCT00337272|585450906|FG001|Withdrawal Period|Non-compliance|1|||
162109982|NCT03320018|585450912|FG000|Treatment Period|Withdrawal by Subject|1|||
162109983|NCT03320018|585450913|FG001|Treatment Period|Withdrawal by Subject|0|||
162109984|NCT03320018|585450912|FG000|Day 90 Follow up|Death|0|||
162109985|NCT03320018|585450913|FG001|Day 90 Follow up|Death|1|||
162109986|NCT00549757|585450914|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
162109987|NCT00549757|585450915|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
162109988|NCT00549757|585450914|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
162109989|NCT00549757|585450915|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
162109990|NCT00549757|585450914|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
162109991|NCT00549757|585450915|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
162109992|NCT00549757|585450914|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
162109993|NCT00549757|585450915|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
162109994|NCT00549757|585450914|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
162109995|NCT00549757|585450915|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
162109996|NCT00549757|585450914|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
162109997|NCT00549757|585450915|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
162109998|NCT00549757|585450914|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
162109999|NCT00549757|585450915|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
162110000|NCT00549757|585450914|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
162110001|NCT00549757|585450915|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
162110002|NCT00549757|585450914|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
162110003|NCT00549757|585450915|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
162110004|NCT00549757|585450914|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
162110005|NCT00549757|585450915|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
162110006|NCT00549757|585450914|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
162110007|NCT00549757|585450915|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
162110008|NCT00549757|585450914|FG000|Extension Period (in Average 9 Months)|Death|143|||
162110009|NCT00549757|585450915|FG001|Extension Period (in Average 9 Months)|Death|136|||
162110010|NCT00549757|585450914|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
162110011|NCT00549757|585450915|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
162110012|NCT00549757|585450914|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
162110013|NCT00549757|585450915|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
162110014|NCT00549757|585450914|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
162110015|NCT00549757|585450915|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
162110016|NCT05906368|585450930|FG000|Overall Study|Withdrawal by Subject|1|||
162110017|NCT05906368|585450931|FG001|Overall Study|Withdrawal by Subject|1|||
162110018|NCT05906368|585450930|FG000|Overall Study|Ineligibility criteria identified|2|||
162110019|NCT05906368|585450931|FG001|Overall Study|Ineligibility criteria identified|0|||
162110020|NCT01127646|585450932|FG000|Overall Study|Entry Criteria Not Met|1|||
162110021|NCT01127646|585450933|FG001|Overall Study|Entry Criteria Not Met|0|||
162110022|NCT01127646|585450932|FG000|Overall Study|Protocol Violation|0|||
162110023|NCT01127646|585450933|FG001|Overall Study|Protocol Violation|1|||
162110024|NCT00595504|585450937|FG000|Overall Study|Withdrawal by Subject|1|||
162110025|NCT00595504|585450938|FG001|Overall Study|Withdrawal by Subject|3|||
162110026|NCT00595504|585450937|FG000|Overall Study|Physician Decision|1|||
162110027|NCT00595504|585450938|FG001|Overall Study|Physician Decision|0|||
162110028|NCT01662063|585450939|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
162110029|NCT01662063|585450940|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
162110030|NCT01662063|585450941|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
162110031|NCT01662063|585450939|FG000|Overall Study|Lack of Efficacy|1|||
162110032|NCT01662063|585450940|FG001|Overall Study|Lack of Efficacy|6|||
162110033|NCT01662063|585450941|FG002|Overall Study|Lack of Efficacy|0|||
162110034|NCT01662063|585450939|FG000|Overall Study|Lost to Follow-up|0|||
162110035|NCT01662063|585450940|FG001|Overall Study|Lost to Follow-up|4|||
162110036|NCT01662063|585450941|FG002|Overall Study|Lost to Follow-up|0|||
162110037|NCT01662063|585450939|FG000|Overall Study|Protocol Violation|1|||
162110038|NCT01662063|585450940|FG001|Overall Study|Protocol Violation|0|||
162110039|NCT01662063|585450941|FG002|Overall Study|Protocol Violation|0|||
162110040|NCT01662063|585450939|FG000|Overall Study|Withdrawal by Subject|2|||
162110041|NCT01662063|585450940|FG001|Overall Study|Withdrawal by Subject|4|||
162110042|NCT01662063|585450941|FG002|Overall Study|Withdrawal by Subject|1|||
162110043|NCT01662063|585450939|FG000|Overall Study|Physician Decision|0|||
162110044|NCT01662063|585450940|FG001|Overall Study|Physician Decision|2|||
162110045|NCT01662063|585450941|FG002|Overall Study|Physician Decision|0|||
162110046|NCT01662063|585450939|FG000|Overall Study|Other|0|||
162110047|NCT01662063|585450940|FG001|Overall Study|Other|1|||
162110048|NCT01662063|585450941|FG002|Overall Study|Other|0|||
162110049|NCT00293267|585450945|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
162110050|NCT00293267|585450946|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
162110051|NCT00293267|585450945|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
162110052|NCT00293267|585450946|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
162110053|NCT00293267|585450945|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
162110054|NCT00293267|585450946|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
162110055|NCT00293267|585450945|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
162110056|NCT00293267|585450946|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
162110057|NCT00293267|585450945|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
162110058|NCT00293267|585450946|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
162110059|NCT00293267|585450945|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
162110060|NCT00293267|585450946|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
162110061|NCT00293267|585450945|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
162110062|NCT00293267|585450946|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
162110063|NCT00293267|585450945|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
162110064|NCT00293267|585450946|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
162110065|NCT00293267|585450945|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
162110066|NCT00293267|585450946|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
162110067|NCT00293267|585450945|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
162110068|NCT00293267|585450946|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
162110069|NCT00293267|585450945|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
162110070|NCT00293267|585450946|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
162110071|NCT00293267|585450945|FG000|Extension - Double-Blind Week 49-156|Death|3|||
162110072|NCT00293267|585450946|FG001|Extension - Double-Blind Week 49-156|Death|0|||
162110073|NCT00293267|585450945|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
162110074|NCT00293267|585450946|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
162110075|NCT00293267|585450945|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
162110076|NCT00293267|585450946|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
162110077|NCT00293267|585450945|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
162110078|NCT00293267|585450946|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
162110079|NCT00293267|585450945|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
162110080|NCT00293267|585450946|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
162110081|NCT00293267|585450945|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
162110082|NCT00293267|585450946|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
162110083|NCT00293267|585450945|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
162110084|NCT00293267|585450946|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
162110085|NCT00293267|585450945|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
162110086|NCT00293267|585450946|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
162110087|NCT00293267|585450945|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
162110088|NCT00293267|585450946|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
162110089|NCT00293267|585450945|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
162110090|NCT00293267|585450946|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
162110091|NCT00293267|585450945|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
162110092|NCT00293267|585450946|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
162110093|NCT00293267|585450945|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
162110094|NCT00293267|585450946|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
162110095|NCT00293267|585450945|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
162110096|NCT00293267|585450946|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
162110097|NCT00293267|585450945|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
162110098|NCT00293267|585450946|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
162110099|NCT00293267|585450945|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
162110100|NCT00293267|585450946|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
162110101|NCT00293267|585450945|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
162110102|NCT00293267|585450946|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
162110103|NCT00293267|585450945|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
162110104|NCT00293267|585450946|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
162110105|NCT01477853|585450947|FG000|Phase A|Adverse Event|1|||
162110106|NCT01477853|585450948|FG001|Phase A|Adverse Event|2|||
162110107|NCT01477853|585450949|FG002|Phase A|Adverse Event|2|||
162110108|NCT01477853|585450947|FG000|Phase A|Lost to Follow-up|4|||
162110109|NCT01477853|585450948|FG001|Phase A|Lost to Follow-up|3|||
162110110|NCT01477853|585450949|FG002|Phase A|Lost to Follow-up|2|||
162110111|NCT01477853|585450947|FG000|Phase A|Physician Decision|1|||
162110112|NCT01477853|585450948|FG001|Phase A|Physician Decision|0|||
162110113|NCT01477853|585450949|FG002|Phase A|Physician Decision|1|||
162110114|NCT01477853|585450947|FG000|Phase A|Study terminated by sponsor|37|||
162110115|NCT01477853|585450948|FG001|Phase A|Study terminated by sponsor|40|||
162110116|NCT01477853|585450949|FG002|Phase A|Study terminated by sponsor|39|||
162110117|NCT01477853|585450947|FG000|Phase B|Lost to Follow-up|0|||
162110118|NCT01477853|585450948|FG001|Phase B|Lost to Follow-up|1|||
162110119|NCT01477853|585450949|FG002|Phase B|Lost to Follow-up|0|||
162110120|NCT01477853|585450947|FG000|Phase B|Study terminated by sponsor|12|||
162110121|NCT01477853|585450948|FG001|Phase B|Study terminated by sponsor|10|||
162110122|NCT01477853|585450949|FG002|Phase B|Study terminated by sponsor|11|||
162110123|NCT01050816|585450950|FG000|Overall Study|Lost to Follow-up|2|||
162110124|NCT01050816|585450950|FG000|Overall Study|patient's refusal|2|||
162110125|NCT01804816|585450951|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
162110126|NCT01804816|585450951|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
162110127|NCT01754467|585450952|FG000|Overall Study|Lost to Follow-up|1|||
162110128|NCT01970462|585450955|FG000|Overall Study|Lost to Follow-up|0|||
162110129|NCT01970462|585450956|FG001|Overall Study|Lost to Follow-up|2|||
162110130|NCT02740049|585450957|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
162110131|NCT03172702|585450961|FG000|Overall Study|Adverse Event|9|||
162110132|NCT03172702|585450961|FG000|Overall Study|Death|2|||
162110133|NCT03172702|585450961|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
162110134|NCT03172702|585450961|FG000|Overall Study|Withdrawal by Subject|5|||
162110135|NCT03172702|585450961|FG000|Overall Study|Other|2|||
162110136|NCT02355743|585450962|FG000|Overall Study|Withdrawal by Subject|1|||
162110137|NCT02355743|585450962|FG000|Overall Study|Lost to Follow-up|1|||
162110138|NCT00374322|585450965|FG000|Overall Study|Lost to Follow-up|92|||
162110139|NCT00374322|585450966|FG001|Overall Study|Lost to Follow-up|90|||
162110140|NCT00374322|585450965|FG000|Overall Study|Protocol Violation|8|||
162110141|NCT00374322|585450966|FG001|Overall Study|Protocol Violation|3|||
162110142|NCT00374322|585450965|FG000|Overall Study|Withdrawal by Subject|235|||
162110143|NCT00374322|585450966|FG001|Overall Study|Withdrawal by Subject|167|||
162110144|NCT00374322|585450965|FG000|Overall Study|Sponsor Terminated Study|866|||
162110145|NCT00374322|585450966|FG001|Overall Study|Sponsor Terminated Study|990|||
162110146|NCT00374322|585450965|FG000|Overall Study|Physician Decision|36|||
162110147|NCT00374322|585450966|FG001|Overall Study|Physician Decision|32|||
162110148|NCT00374322|585450965|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
162110149|NCT00374322|585450966|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
162110150|NCT00374322|585450965|FG000|Overall Study|Sponsor Decision|2|||
162110151|NCT00374322|585450966|FG001|Overall Study|Sponsor Decision|3|||
162110152|NCT00374322|585450965|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
162110153|NCT00374322|585450966|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
162110154|NCT00374322|585450965|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
162110155|NCT00374322|585450966|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
162110156|NCT00374322|585450965|FG000|Overall Study|Severe Toxicity|1|||
162110157|NCT00374322|585450966|FG001|Overall Study|Severe Toxicity|0|||
162110158|NCT00374322|585450965|FG000|Overall Study|Site Closed|2|||
162110159|NCT00374322|585450966|FG001|Overall Study|Site Closed|2|||
162110160|NCT00374322|585450965|FG000|Overall Study|Participant Changed Physician|1|||
162110161|NCT00374322|585450966|FG001|Overall Study|Participant Changed Physician|0|||
162110162|NCT00374322|585450965|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
162110163|NCT00374322|585450966|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
162110164|NCT00374322|585450965|FG000|Overall Study|Noncompliance with Study Requirements|0|||
162110165|NCT00374322|585450966|FG001|Overall Study|Noncompliance with Study Requirements|1|||
162110166|NCT00374322|585450965|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
162110167|NCT00374322|585450966|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
162110168|NCT00374322|585450965|FG000|Overall Study|Did Not Receive Study Medication|8|||
162110169|NCT00374322|585450966|FG001|Overall Study|Did Not Receive Study Medication|6|||
162110170|NCT00636610|585450970|FG000|Overall Study|Adverse Event|4|||
162110171|NCT00636610|585450971|FG001|Overall Study|Adverse Event|4|||
162110172|NCT00636610|585450970|FG000|Overall Study|Death|6|||
162110173|NCT00636610|585450971|FG001|Overall Study|Death|3|||
162110174|NCT00636610|585450970|FG000|Overall Study|Physician decision to withdraw patient|15|||
162110175|NCT00636610|585450971|FG001|Overall Study|Physician decision to withdraw patient|9|||
162110176|NCT00636610|585450970|FG000|Overall Study|Subject decision to withdraw|15|||
162110177|NCT00636610|585450971|FG001|Overall Study|Subject decision to withdraw|11|||
162110178|NCT00636610|585450970|FG000|Overall Study|Disease progression - radiographic|41|||
162110179|NCT00636610|585450971|FG001|Overall Study|Disease progression - radiographic|51|||
162110180|NCT00636610|585450970|FG000|Overall Study|Disease progression - clinical|8|||
162110181|NCT00636610|585450971|FG001|Overall Study|Disease progression - clinical|3|||
162110182|NCT00636610|585450970|FG000|Overall Study|Reason for discontinuation not available|3|||
162110183|NCT00636610|585450971|FG001|Overall Study|Reason for discontinuation not available|2|||
162110184|NCT02495025|585450972|FG000|Overall Study|Lost to Follow-up|21|||
162110185|NCT02495025|585450973|FG001|Overall Study|Lost to Follow-up|14|||
162110186|NCT02495025|585450972|FG000|Overall Study|Withdrawal by Subject|5|||
162110187|NCT02495025|585450973|FG001|Overall Study|Withdrawal by Subject|0|||
162110188|NCT02151266|585450978|FG000|Overall Study|Lost to Follow-up|1|||
162110189|NCT02151266|585450979|FG001|Overall Study|Lost to Follow-up|4|||
162110190|NCT02151266|585450980|FG002|Overall Study|Lost to Follow-up|1|||
162110191|NCT02151266|585450978|FG000|Overall Study|Did NOT receive intervention|3|||
162110192|NCT02151266|585450979|FG001|Overall Study|Did NOT receive intervention|6|||
162110193|NCT02151266|585450980|FG002|Overall Study|Did NOT receive intervention|2|||
162110194|NCT02151266|585450978|FG000|Overall Study|Not able to exercise|4|||
162110195|NCT02151266|585450979|FG001|Overall Study|Not able to exercise|5|||
162110196|NCT02151266|585450980|FG002|Overall Study|Not able to exercise|4|||
162110197|NCT01169675|585450981|FG000|Overall Study|Progressive disease|13|||
162110198|NCT01169675|585450982|FG001|Overall Study|Progressive disease|2|||
162110199|NCT01169675|585450983|FG002|Overall Study|Progressive disease|5|||
162110200|NCT01169675|585450984|FG003|Overall Study|Progressive disease|15|||
162110201|NCT01169675|585450985|FG004|Overall Study|Progressive disease|1|||
162110202|NCT01169675|585450981|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
162110203|NCT01169675|585450982|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162110204|NCT01169675|585450983|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162110205|NCT01169675|585450984|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
162110206|NCT01169675|585450985|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
162110207|NCT01169675|585450981|FG000|Overall Study|Adverse Event|5|||
162110208|NCT01169675|585450982|FG001|Overall Study|Adverse Event|1|||
162110209|NCT01169675|585450983|FG002|Overall Study|Adverse Event|2|||
162110210|NCT01169675|585450984|FG003|Overall Study|Adverse Event|0|||
162110211|NCT01169675|585450985|FG004|Overall Study|Adverse Event|0|||
162110212|NCT01169675|585450981|FG000|Overall Study|Withdrawal by Subject|1|||
162110213|NCT01169675|585450982|FG001|Overall Study|Withdrawal by Subject|0|||
162110214|NCT01169675|585450983|FG002|Overall Study|Withdrawal by Subject|0|||
162110215|NCT01169675|585450984|FG003|Overall Study|Withdrawal by Subject|1|||
162110216|NCT01169675|585450985|FG004|Overall Study|Withdrawal by Subject|2|||
162110217|NCT01169675|585450981|FG000|Overall Study|Other Reason Not Defined Above|0|||
162110218|NCT01169675|585450982|FG001|Overall Study|Other Reason Not Defined Above|0|||
162110219|NCT01169675|585450983|FG002|Overall Study|Other Reason Not Defined Above|0|||
162110220|NCT01169675|585450984|FG003|Overall Study|Other Reason Not Defined Above|1|||
162110221|NCT01169675|585450985|FG004|Overall Study|Other Reason Not Defined Above|1|||
162110222|NCT04102579|585450988|FG000|Overall Study|Withdrawal by Subject|3|||
162110223|NCT04102579|585450989|FG001|Overall Study|Withdrawal by Subject|4|||
162110224|NCT04102579|585450988|FG000|Overall Study|Lost to Follow-up|0|||
162110225|NCT04102579|585450989|FG001|Overall Study|Lost to Follow-up|1|||
162110226|NCT04102579|585450988|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
162110227|NCT04102579|585450989|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
162110228|NCT04102579|585450988|FG000|Overall Study|Other than Specified|1|||
162110229|NCT04102579|585450989|FG001|Overall Study|Other than Specified|0|||
162110230|NCT04102579|585450988|FG000|Overall Study|Not Dosed with Study Drug|0|||
162110231|NCT04102579|585450989|FG001|Overall Study|Not Dosed with Study Drug|1|||
162110232|NCT05899686|585450990|FG000|Overall Study|Protocol Violation|1|||
162110233|NCT00572195|585450991|FG000|Overall Study|Withdrawal by Subject|50|||
162110234|NCT00572195|585450991|FG000|Overall Study|Death|9|||
162110235|NCT00572195|585450991|FG000|Overall Study|Adverse Event|4|||
162110236|NCT00572195|585450991|FG000|Overall Study|Lost to Follow-up|5|||
162110237|NCT03076970|585452733|FG000|Washout Period 2|Adverse Event|0|||
162110238|NCT03076970|585452734|FG001|Washout Period 2|Adverse Event|0|||
162110239|NCT03076970|585452735|FG002|Washout Period 2|Adverse Event|0|||
162110240|NCT03076970|585452736|FG003|Washout Period 2|Adverse Event|0|||
162110241|NCT03076970|585452737|FG004|Washout Period 2|Adverse Event|1|||
162110242|NCT03076970|585452738|FG005|Washout Period 2|Adverse Event|0|||
162110243|NCT03076970|585452733|FG000|Period 3|Withdrawal by Subject|0|||
162110244|NCT03076970|585452734|FG001|Period 3|Withdrawal by Subject|0|||
162110245|NCT03076970|585452735|FG002|Period 3|Withdrawal by Subject|0|||
162110246|NCT03076970|585452736|FG003|Period 3|Withdrawal by Subject|0|||
162110247|NCT03076970|585452737|FG004|Period 3|Withdrawal by Subject|0|||
162110248|NCT03076970|585452738|FG005|Period 3|Withdrawal by Subject|1|||
162110249|NCT03076970|585452733|FG000|Period 3|Failure to meet I/E criteria|0|||
162110250|NCT03076970|585452734|FG001|Period 3|Failure to meet I/E criteria|0|||
162110251|NCT03076970|585452735|FG002|Period 3|Failure to meet I/E criteria|0|||
162110252|NCT03076970|585452736|FG003|Period 3|Failure to meet I/E criteria|0|||
162110253|NCT03076970|585452737|FG004|Period 3|Failure to meet I/E criteria|1|||
162110254|NCT03076970|585452738|FG005|Period 3|Failure to meet I/E criteria|0|||
162110255|NCT01345630|585452739|FG000|Overall Study|Adverse Event|22|||
162110256|NCT01345630|585452740|FG001|Overall Study|Adverse Event|23|||
162110257|NCT01345630|585452739|FG000|Overall Study|Lost to Follow-up|17|||
162110258|NCT01345630|585452740|FG001|Overall Study|Lost to Follow-up|16|||
162110259|NCT01345630|585452739|FG000|Overall Study|Protocol Violation|4|||
162110260|NCT01345630|585452740|FG001|Overall Study|Protocol Violation|1|||
162110261|NCT01345630|585452739|FG000|Overall Study|Medication error without associated AE|0|||
162110262|NCT01345630|585452740|FG001|Overall Study|Medication error without associated AE|1|||
162110263|NCT01345630|585452739|FG000|Overall Study|Study terminated by sponsor|254|||
162110264|NCT01345630|585452740|FG001|Overall Study|Study terminated by sponsor|285|||
162110265|NCT01345630|585452739|FG000|Overall Study|Other reasons|6|||
162110266|NCT01345630|585452740|FG001|Overall Study|Other reasons|8|||
162110267|NCT01345630|585452739|FG000|Overall Study|Withdrawn due to pregnancy|1|||
162110268|NCT01345630|585452740|FG001|Overall Study|Withdrawn due to pregnancy|2|||
162110269|NCT01345630|585452739|FG000|Overall Study|No longer willing to participate|9|||
162110270|NCT01345630|585452740|FG001|Overall Study|No longer willing to participate|12|||
162110271|NCT01345630|585452739|FG000|Overall Study|Insufficient clinical response|48|||
162110272|NCT01345630|585452740|FG001|Overall Study|Insufficient clinical response|11|||
162110273|NCT01364922|585452748|FG000|Open-label (OL) Period|Adverse Event|7|||
162110274|NCT01364922|585452749|FG001|Open-label (OL) Period|Adverse Event|0|||
162110275|NCT01364922|585452750|FG002|Open-label (OL) Period|Adverse Event|0|||
162110276|NCT01364922|585452748|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
162110277|NCT01364922|585452749|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
162110278|NCT01364922|585452750|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
162110279|NCT01364922|585452748|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
162110280|NCT01364922|585452749|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
162110281|NCT01364922|585452750|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
162110282|NCT01364922|585452748|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
162110283|NCT01364922|585452749|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
162110284|NCT01364922|585452750|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
162110285|NCT01364922|585452748|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
162110286|NCT01364922|585452749|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
162110287|NCT01364922|585452750|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
162110288|NCT01364922|585452748|FG000|Open-label (OL) Period|Other, Unspecified|1|||
162110289|NCT01364922|585452749|FG001|Open-label (OL) Period|Other, Unspecified|0|||
162110290|NCT01364922|585452750|FG002|Open-label (OL) Period|Other, Unspecified|0|||
162110291|NCT01364922|585452748|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
162110292|NCT01364922|585452749|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
162110293|NCT01364922|585452750|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
162110294|NCT01364922|585452748|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
162110295|NCT01364922|585452749|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
162110296|NCT01364922|585452750|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
162110297|NCT01364922|585452748|FG000|Double-Blind (DB) Period|Adverse Event|0|||
162110298|NCT01364922|585452749|FG001|Double-Blind (DB) Period|Adverse Event|0|||
162110299|NCT01364922|585452750|FG002|Double-Blind (DB) Period|Adverse Event|1|||
162110300|NCT01364922|585452748|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
162110301|NCT01364922|585452749|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
162110302|NCT01364922|585452750|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
162110303|NCT00949884|585452751|FG000|Overall Study|Adverse Event|14|||
162110304|NCT00949884|585452752|FG001|Overall Study|Adverse Event|3|||
162110305|NCT00949884|585452753|FG002|Overall Study|Adverse Event|12|||
162110306|NCT00949884|585452751|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
162110307|NCT00949884|585452752|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
162110308|NCT00949884|585452753|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
162110309|NCT00949884|585452751|FG000|Overall Study|Lost to Follow-up|7|||
162110310|NCT00949884|585452752|FG001|Overall Study|Lost to Follow-up|5|||
162110311|NCT00949884|585452753|FG002|Overall Study|Lost to Follow-up|5|||
162110312|NCT00949884|585452751|FG000|Overall Study|Physician Decision|5|||
162110313|NCT00949884|585452752|FG001|Overall Study|Physician Decision|0|||
162110314|NCT00949884|585452753|FG002|Overall Study|Physician Decision|6|||
162110315|NCT00949884|585452751|FG000|Overall Study|Treatment non-compliance|5|||
162110316|NCT00949884|585452752|FG001|Overall Study|Treatment non-compliance|0|||
162110317|NCT00949884|585452753|FG002|Overall Study|Treatment non-compliance|8|||
162110318|NCT00949884|585452751|FG000|Overall Study|Withdrawal by Subject|13|||
162110319|NCT00949884|585452752|FG001|Overall Study|Withdrawal by Subject|4|||
162110320|NCT00949884|585452753|FG002|Overall Study|Withdrawal by Subject|16|||
162110321|NCT00949884|585452751|FG000|Overall Study|Lack of Efficacy|4|||
162110322|NCT00949884|585452752|FG001|Overall Study|Lack of Efficacy|2|||
162110323|NCT00949884|585452753|FG002|Overall Study|Lack of Efficacy|7|||
162110324|NCT00949884|585452751|FG000|Overall Study|Study terminated by sponsor|0|||
162110325|NCT00949884|585452752|FG001|Overall Study|Study terminated by sponsor|0|||
162110326|NCT00949884|585452753|FG002|Overall Study|Study terminated by sponsor|1|||
162110327|NCT01953003|585452754|FG000|Overall Study|Not treated|0|||
162110328|NCT01953003|585452755|FG001|Overall Study|Not treated|1|||
162110329|NCT01953003|585452754|FG000|Overall Study|Progressive disease|35|||
162110330|NCT01953003|585452755|FG001|Overall Study|Progressive disease|45|||
162110331|NCT01953003|585452754|FG000|Overall Study|Related Adverse events|7|||
162110332|NCT01953003|585452755|FG001|Overall Study|Related Adverse events|2|||
162110333|NCT01953003|585452754|FG000|Overall Study|Non-related adverse events|0|||
162110334|NCT01953003|585452755|FG001|Overall Study|Non-related adverse events|2|||
162110335|NCT01953003|585452754|FG000|Overall Study|Protocol Violation|0|||
162110336|NCT01953003|585452755|FG001|Overall Study|Protocol Violation|1|||
162110337|NCT01953003|585452754|FG000|Overall Study|Withdrawal by Subject|14|||
162110338|NCT01953003|585452755|FG001|Overall Study|Withdrawal by Subject|4|||
162110339|NCT01582789|585452763|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
162110340|NCT01582789|585452764|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
162110341|NCT03391765|585452765|FG000|Overall Study|Adverse Event|2|||
162110342|NCT03391765|585452766|FG001|Overall Study|Adverse Event|0|||
162110343|NCT03391765|585452767|FG002|Overall Study|Adverse Event|0|||
162110344|NCT03391765|585452768|FG003|Overall Study|Adverse Event|2|||
162110345|NCT03391765|585452765|FG000|Overall Study|Withdrew consent|5|||
162110346|NCT03391765|585452766|FG001|Overall Study|Withdrew consent|7|||
162110347|NCT03391765|585452767|FG002|Overall Study|Withdrew consent|2|||
162110348|NCT03391765|585452768|FG003|Overall Study|Withdrew consent|5|||
162110349|NCT03391765|585452765|FG000|Overall Study|Other, not specified|44|||
162110350|NCT03391765|585452766|FG001|Overall Study|Other, not specified|38|||
162110351|NCT03391765|585452767|FG002|Overall Study|Other, not specified|21|||
162110352|NCT03391765|585452768|FG003|Overall Study|Other, not specified|16|||
162110353|NCT00662857|585452773|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
162110354|NCT00662857|585452774|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
162110355|NCT00662857|585452773|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
162110356|NCT00662857|585452774|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
162110357|NCT00662857|585452773|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
162110358|NCT00662857|585452774|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
162110359|NCT03966053|585452775|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
162110360|NCT02832622|585452777|FG000|Overall Study|MPP not programmed|1259|||
162110361|NCT02832622|585452777|FG000|Overall Study|Withdrawal by Subject|123|||
162110362|NCT02832622|585452777|FG000|Overall Study|Death|119|||
162110363|NCT02832622|585452777|FG000|Overall Study|Unsuccessful CRT implant|93|||
162110364|NCT02832622|585452777|FG000|Overall Study|Lost to Follow-up|45|||
162110365|NCT02832622|585452777|FG000|Overall Study|Patient non-compliance|42|||
162110366|NCT02832622|585452777|FG000|Overall Study|Withdrawal by other reasons|25|||
162110367|NCT02832622|585452777|FG000|Overall Study|System explant|24|||
162110368|NCT02832622|585452777|FG000|Overall Study|Physician Decision|6|||
162110369|NCT04586569|585452778|FG000|Overall Study|Withdrawal by Subject|0|||
162110370|NCT04586569|585452779|FG001|Overall Study|Withdrawal by Subject|2|||
162110371|NCT04586569|585452778|FG000|Overall Study|No longer eligible|2|||
162110372|NCT04586569|585452779|FG001|Overall Study|No longer eligible|3|||
162110373|NCT04586569|585452778|FG000|Overall Study|Physician Decision|1|||
162110374|NCT04586569|585452779|FG001|Overall Study|Physician Decision|0|||
162110375|NCT00998400|585452780|FG000|Overall Study|Lack of interest/motivation|1|||
162110376|NCT00998400|585452781|FG001|Overall Study|Lack of interest/motivation|2|||
162110377|NCT00998400|585452780|FG000|Overall Study|Logistical problems|1|||
162110378|NCT00998400|585452781|FG001|Overall Study|Logistical problems|0|||
162110379|NCT00800202|585452783|FG000|Overall Study|Adverse Event|7|||
162110380|NCT00800202|585452784|FG001|Overall Study|Adverse Event|6|||
162110381|NCT00800202|585452783|FG000|Overall Study|Death|1|||
162110382|NCT00800202|585452784|FG001|Overall Study|Death|0|||
162110383|NCT00800202|585452783|FG000|Overall Study|Other|5|||
162110384|NCT00800202|585452784|FG001|Overall Study|Other|0|||
162110385|NCT00800202|585452783|FG000|Overall Study|Disease Progression|54|||
162110386|NCT00800202|585452784|FG001|Overall Study|Disease Progression|18|||
162110387|NCT05674890|585452787|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
162110388|NCT05674890|585452788|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
162110389|NCT05674890|585452787|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
162110390|NCT05674890|585452788|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
162110391|NCT05674890|585452787|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
162110392|NCT05674890|585452788|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
162110393|NCT02691182|585452789|FG000|Overall Study|Withdrawal by Subject|4|||
162110394|NCT02691182|585452790|FG001|Overall Study|Withdrawal by Subject|7|||
162110395|NCT02691182|585452791|FG002|Overall Study|Withdrawal by Subject|6|||
162110396|NCT02691182|585452792|FG003|Overall Study|Withdrawal by Subject|8|||
162110397|NCT02691182|585452789|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
162110398|NCT02691182|585452790|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
162110399|NCT02691182|585452791|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
162110400|NCT02691182|585452792|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
162110401|NCT02691182|585452789|FG000|Overall Study|Lost to Follow-up|8|||
162110402|NCT02691182|585452790|FG001|Overall Study|Lost to Follow-up|33|||
162110403|NCT02691182|585452791|FG002|Overall Study|Lost to Follow-up|19|||
162110404|NCT02691182|585452792|FG003|Overall Study|Lost to Follow-up|22|||
162110405|NCT02691182|585452789|FG000|Overall Study|Adverse Event|3|||
162110406|NCT02691182|585452790|FG001|Overall Study|Adverse Event|10|||
162110407|NCT02691182|585452791|FG002|Overall Study|Adverse Event|10|||
162110408|NCT02691182|585452792|FG003|Overall Study|Adverse Event|11|||
162110409|NCT02691182|585452789|FG000|Overall Study|Physician Decision|3|||
162110410|NCT02691182|585452790|FG001|Overall Study|Physician Decision|7|||
162110411|NCT02691182|585452791|FG002|Overall Study|Physician Decision|14|||
162110412|NCT02691182|585452792|FG003|Overall Study|Physician Decision|8|||
162110413|NCT02691182|585452789|FG000|Overall Study|Lack of Efficacy|0|||
162110414|NCT02691182|585452790|FG001|Overall Study|Lack of Efficacy|0|||
162110415|NCT02691182|585452791|FG002|Overall Study|Lack of Efficacy|0|||
162110416|NCT02691182|585452792|FG003|Overall Study|Lack of Efficacy|4|||
162110417|NCT02691182|585452789|FG000|Overall Study|Protocol Violation|2|||
162110418|NCT02691182|585452790|FG001|Overall Study|Protocol Violation|6|||
162110419|NCT02691182|585452791|FG002|Overall Study|Protocol Violation|6|||
162110420|NCT02691182|585452792|FG003|Overall Study|Protocol Violation|8|||
162110421|NCT02691182|585452789|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
162110422|NCT02691182|585452790|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
162110423|NCT02691182|585452791|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
162110424|NCT02691182|585452792|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
162110425|NCT02691182|585452789|FG000|Overall Study|Missing|0|||
162110426|NCT02691182|585452790|FG001|Overall Study|Missing|5|||
162110427|NCT02691182|585452791|FG002|Overall Study|Missing|1|||
162110428|NCT02691182|585452792|FG003|Overall Study|Missing|5|||
162110429|NCT00105235|585452793|FG000|Overall Study|Death|4|||
162110430|NCT00105235|585452793|FG000|Overall Study|Physician Decision|1|||
162110431|NCT00105235|585452793|FG000|Overall Study|Withdrawal by Subject|2|||
162110432|NCT02052310|585452794|FG000|Overall Study|Death|64|||
162110433|NCT02052310|585452795|FG001|Overall Study|Death|54|||
162110434|NCT02052310|585452794|FG000|Overall Study|Withdrawal by Subject|37|||
162110435|NCT02052310|585452795|FG001|Overall Study|Withdrawal by Subject|49|||
162110436|NCT02052310|585452794|FG000|Overall Study|Other than specified|32|||
162110437|NCT02052310|585452795|FG001|Overall Study|Other than specified|29|||
162110438|NCT02052310|585452794|FG000|Overall Study|Adverse Event|29|||
162110439|NCT02052310|585452795|FG001|Overall Study|Adverse Event|22|||
162110440|NCT02052310|585452794|FG000|Overall Study|Kidney Transplant|23|||
162110441|NCT02052310|585452795|FG001|Overall Study|Kidney Transplant|29|||
162110442|NCT02052310|585452794|FG000|Overall Study|Physician Decision|14|||
162110443|NCT02052310|585452795|FG001|Overall Study|Physician Decision|7|||
162110444|NCT02052310|585452794|FG000|Overall Study|Lack of Efficacy|6|||
162110445|NCT02052310|585452795|FG001|Overall Study|Lack of Efficacy|1|||
162110446|NCT02052310|585452794|FG000|Overall Study|Site Terminated by Sponsor|5|||
162110447|NCT02052310|585452795|FG001|Overall Study|Site Terminated by Sponsor|13|||
162110448|NCT02052310|585452794|FG000|Overall Study|Lost to Follow-up|4|||
162110449|NCT02052310|585452795|FG001|Overall Study|Lost to Follow-up|2|||
162110450|NCT02052310|585452794|FG000|Overall Study|Protocol Violation|1|||
162110451|NCT02052310|585452795|FG001|Overall Study|Protocol Violation|6|||
162110452|NCT01964326|585452796|FG000|Overall Study|Adverse Event|48|||
162110453|NCT01964326|585452796|FG000|Overall Study|Death|2|||
162110454|NCT01964326|585452796|FG000|Overall Study|Protocol Violation|4|||
162110455|NCT01964326|585452796|FG000|Overall Study|Lost to Follow-up|88|||
162110456|NCT01964326|585452796|FG000|Overall Study|Withdrawal by Subject|87|||
162110457|NCT01964326|585452796|FG000|Overall Study|Pregnancy|1|||
162110458|NCT01964326|585452796|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
162110459|NCT01964326|585452796|FG000|Overall Study|Physician Decision|55|||
162110460|NCT01964326|585452796|FG000|Overall Study|Investigator Discretion|1|||
162110461|NCT01964326|585452796|FG000|Overall Study|Other|9|||
162110462|NCT01964326|585452796|FG000|Overall Study|Did not meet eligibility criteria|1|||
162110463|NCT02563002|585452799|FG000|Overall Study|Death|72|||
162110464|NCT02563002|585452800|FG001|Overall Study|Death|87|||
162110465|NCT02563002|585452799|FG000|Overall Study|Lost to Follow-up|5|||
162110466|NCT02563002|585452800|FG001|Overall Study|Lost to Follow-up|0|||
162110467|NCT02563002|585452799|FG000|Overall Study|Physician Decision|0|||
162110468|NCT02563002|585452800|FG001|Overall Study|Physician Decision|2|||
162110469|NCT02563002|585452799|FG000|Overall Study|Withdrawal by Subject|2|||
162110470|NCT02563002|585452800|FG001|Overall Study|Withdrawal by Subject|10|||
162110471|NCT02563002|585452799|FG000|Overall Study|Sponsor decision|74|||
162110472|NCT02563002|585452800|FG001|Overall Study|Sponsor decision|55|||
162110473|NCT03518125|585452801|FG000|Overall Study|Lost to Follow-up|0|||
162110474|NCT03518125|585452802|FG001|Overall Study|Lost to Follow-up|2|||
162110475|NCT03518125|585452803|FG002|Overall Study|Lost to Follow-up|0|||
162110476|NCT03518125|585452804|FG003|Overall Study|Lost to Follow-up|0|||
162110477|NCT03518125|585452805|FG004|Overall Study|Lost to Follow-up|3|||
162110478|NCT03518125|585452806|FG005|Overall Study|Lost to Follow-up|5|||
162110479|NCT03518125|585452801|FG000|Overall Study|Physician Decision|0|||
162110480|NCT03518125|585452802|FG001|Overall Study|Physician Decision|1|||
162110481|NCT03518125|585452803|FG002|Overall Study|Physician Decision|0|||
162110482|NCT03518125|585452804|FG003|Overall Study|Physician Decision|0|||
162110483|NCT03518125|585452805|FG004|Overall Study|Physician Decision|0|||
162110484|NCT03518125|585452806|FG005|Overall Study|Physician Decision|0|||
162110485|NCT03518125|585452801|FG000|Overall Study|Withdrawal by Subject|1|||
162110486|NCT03518125|585452802|FG001|Overall Study|Withdrawal by Subject|1|||
162110487|NCT03518125|585452803|FG002|Overall Study|Withdrawal by Subject|0|||
162110488|NCT03518125|585452804|FG003|Overall Study|Withdrawal by Subject|1|||
162110489|NCT03518125|585452805|FG004|Overall Study|Withdrawal by Subject|1|||
162110490|NCT03518125|585452806|FG005|Overall Study|Withdrawal by Subject|3|||
162110491|NCT03518125|585452801|FG000|Overall Study|Missed Day 394 Visit|1|||
162110492|NCT03518125|585452802|FG001|Overall Study|Missed Day 394 Visit|0|||
162110493|NCT03518125|585452803|FG002|Overall Study|Missed Day 394 Visit|0|||
162110494|NCT03518125|585452804|FG003|Overall Study|Missed Day 394 Visit|0|||
162110495|NCT03518125|585452805|FG004|Overall Study|Missed Day 394 Visit|0|||
162110496|NCT03518125|585452806|FG005|Overall Study|Missed Day 394 Visit|0|||
162110497|NCT02093663|585452811|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
162110498|NCT02093663|585452812|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
162110499|NCT02093663|585452813|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
162110500|NCT02093663|585452814|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
162110501|NCT02093663|585452815|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
162110502|NCT02093663|585452811|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
162110503|NCT02093663|585452812|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162110504|NCT02093663|585452813|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162110505|NCT02093663|585452814|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162110506|NCT02093663|585452815|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162110507|NCT02093663|585452811|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
162110508|NCT02093663|585452812|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
162110509|NCT02093663|585452813|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
162110510|NCT02093663|585452814|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
162110511|NCT02093663|585452815|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
162110512|NCT02093663|585452811|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
162110513|NCT02093663|585452812|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
162110514|NCT02093663|585452813|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
162110515|NCT02093663|585452814|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
162110516|NCT02093663|585452815|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
162110517|NCT02093663|585452811|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162110518|NCT02093663|585452812|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162110519|NCT02093663|585452813|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
162110520|NCT02093663|585452814|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162110521|NCT02093663|585452815|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
162110522|NCT02093663|585452811|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
162110523|NCT02093663|585452812|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
162110524|NCT02093663|585452813|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
162110525|NCT02093663|585452814|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
162110526|NCT02093663|585452815|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
162110527|NCT02093663|585452811|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
162110528|NCT02093663|585452812|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
162110529|NCT02093663|585452813|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
162110530|NCT02093663|585452814|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
162110531|NCT02093663|585452815|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
162110532|NCT02093663|585452811|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
162110533|NCT02093663|585452812|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
162110534|NCT02093663|585452813|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
162110535|NCT02093663|585452814|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
162110536|NCT02093663|585452815|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
162110537|NCT02093663|585452811|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
162110538|NCT02093663|585452812|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
162110539|NCT02093663|585452813|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
162110540|NCT02093663|585452814|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
162110541|NCT02093663|585452815|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
162110542|NCT00508404|585452816|FG000|Overall Study|Ongoing at Data Cut-off|12|||
162110543|NCT00508404|585452816|FG000|Overall Study|Adverse Event|2|||
162110544|NCT00508404|585452816|FG000|Overall Study|Death|16|||
162110545|NCT00508404|585452816|FG000|Overall Study|Physician Decision|2|||
162110546|NCT00508404|585452816|FG000|Overall Study|Withdrawal by Subject|3|||
162110547|NCT00508404|585452816|FG000|Overall Study|Protocol-specified Criteria|2|||
162110548|NCT00508404|585452816|FG000|Overall Study|Lost to Follow-up|2|||
162110549|NCT00508404|585452816|FG000|Overall Study|Other - Not Specified|3|||
162110550|NCT05453110|585452817|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
162110551|NCT05453110|585452818|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
162110552|NCT05453110|585452819|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
162110553|NCT01505387|585452820|FG000|Overall Study|Protocol Violation|1|||
162110554|NCT01505387|585452821|FG001|Overall Study|Protocol Violation|0|||
162110555|NCT01505387|585452820|FG000|Overall Study|Withdrawal by Subject|1|||
162110556|NCT01505387|585452821|FG001|Overall Study|Withdrawal by Subject|1|||
162110557|NCT01197508|585452822|FG000|Overall Study|Withdrawal by Subject|8|||
162110558|NCT01197508|585452823|FG001|Overall Study|Withdrawal by Subject|7|||
162110559|NCT01197508|585452824|FG002|Overall Study|Withdrawal by Subject|15|||
162110560|NCT01197508|585452825|FG003|Overall Study|Withdrawal by Subject|4|||
162110561|NCT01197508|585452822|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
162110562|NCT01197508|585452823|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
162110563|NCT01197508|585452824|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
162110564|NCT01197508|585452825|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
162110565|NCT01197508|585452822|FG000|Overall Study|Adverse Event|10|||
162110566|NCT01197508|585452823|FG001|Overall Study|Adverse Event|13|||
162110567|NCT01197508|585452824|FG002|Overall Study|Adverse Event|23|||
162110568|NCT01197508|585452825|FG003|Overall Study|Adverse Event|3|||
162110569|NCT01197508|585452822|FG000|Overall Study|Severe non-compliance to protocol|0|||
162110570|NCT01197508|585452823|FG001|Overall Study|Severe non-compliance to protocol|3|||
162110571|NCT01197508|585452824|FG002|Overall Study|Severe non-compliance to protocol|1|||
162110572|NCT01197508|585452825|FG003|Overall Study|Severe non-compliance to protocol|3|||
162110573|NCT01197508|585452822|FG000|Overall Study|Condition under investigation worsened|1|||
162110574|NCT01197508|585452823|FG001|Overall Study|Condition under investigation worsened|1|||
162110575|NCT01197508|585452824|FG002|Overall Study|Condition under investigation worsened|1|||
162110576|NCT01197508|585452825|FG003|Overall Study|Condition under investigation worsened|1|||
162110577|NCT01197508|585452822|FG000|Overall Study|Lack of Efficacy|1|||
162110578|NCT01197508|585452823|FG001|Overall Study|Lack of Efficacy|2|||
162110579|NCT01197508|585452824|FG002|Overall Study|Lack of Efficacy|2|||
162110580|NCT01197508|585452825|FG003|Overall Study|Lack of Efficacy|1|||
162110581|NCT01197508|585452822|FG000|Overall Study|Study-specific withdrawal criteria|0|||
162110582|NCT01197508|585452823|FG001|Overall Study|Study-specific withdrawal criteria|0|||
162110583|NCT01197508|585452824|FG002|Overall Study|Study-specific withdrawal criteria|1|||
162110584|NCT01197508|585452825|FG003|Overall Study|Study-specific withdrawal criteria|2|||
162110585|NCT01197508|585452822|FG000|Overall Study|Lost to Follow-up|1|||
162110586|NCT01197508|585452823|FG001|Overall Study|Lost to Follow-up|1|||
162110587|NCT01197508|585452824|FG002|Overall Study|Lost to Follow-up|2|||
162110588|NCT01197508|585452825|FG003|Overall Study|Lost to Follow-up|0|||
162110589|NCT01197508|585452822|FG000|Overall Study|Other|2|||
162110590|NCT01197508|585452823|FG001|Overall Study|Other|3|||
162110591|NCT01197508|585452824|FG002|Overall Study|Other|2|||
162110592|NCT01197508|585452825|FG003|Overall Study|Other|2|||
162110593|NCT00266825|585452826|FG000|Completed Follow-Up|Lost to Follow-up|14|||
162110594|NCT00266825|585452827|FG001|Completed Follow-Up|Lost to Follow-up|19|||
162110595|NCT00266825|585452826|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
162110596|NCT00266825|585452827|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
162110597|NCT02799784|585452830|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
162110598|NCT02799784|585452831|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
162110599|NCT02799784|585452830|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
162110600|NCT02799784|585452831|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
162110601|NCT02799784|585452830|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
162110602|NCT02799784|585452831|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
162110603|NCT02799784|585452830|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
162110604|NCT02799784|585452831|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
162110605|NCT02799784|585452830|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
162110606|NCT02799784|585452831|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
162110607|NCT02799784|585452830|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
162110608|NCT02799784|585452831|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
162110609|NCT01949870|585452832|FG000|Overall Study|Lack of Efficacy|2|||
162110610|NCT01949870|585452832|FG000|Overall Study|Adverse Event|1|||
162110611|NCT01949870|585452832|FG000|Overall Study|Study termination|1|||
162110612|NCT01949870|585452832|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
162110613|NCT03086330|585452833|FG000|Overall Study|Withdrawal by Subject|3|||
162110614|NCT03086330|585452834|FG001|Overall Study|Withdrawal by Subject|2|||
162110615|NCT03086330|585452833|FG000|Overall Study|Lost to Follow-up|1|||
162110616|NCT03086330|585452834|FG001|Overall Study|Lost to Follow-up|2|||
162110617|NCT01235546|585452835|FG000|Overall Study|Staff error, medication not administered|1|||
162110618|NCT01235546|585452836|FG001|Overall Study|Staff error, medication not administered|0|||
162110619|NCT01235546|585452835|FG000|Overall Study|Protocol Violation|1|||
162110620|NCT01235546|585452836|FG001|Overall Study|Protocol Violation|1|||
162110621|NCT00330174|585452838|FG000|Overall Study|Withdrawal by Subject|7|||
162110622|NCT00330174|585452839|FG001|Overall Study|Withdrawal by Subject|7|||
162110623|NCT00330174|585452838|FG000|Overall Study|Lost to Follow-up|4|||
162110624|NCT00330174|585452839|FG001|Overall Study|Lost to Follow-up|1|||
162110625|NCT00330174|585452838|FG000|Overall Study|Clinical deterioration|1|||
162110626|NCT00330174|585452839|FG001|Overall Study|Clinical deterioration|2|||
162110627|NCT00330174|585452838|FG000|Overall Study|Excessive missed visits|3|||
162110628|NCT00330174|585452839|FG001|Overall Study|Excessive missed visits|8|||
162110629|NCT00330174|585452838|FG000|Overall Study|Miscellaneous reasons|7|||
162110630|NCT00330174|585452839|FG001|Overall Study|Miscellaneous reasons|1|||
162110631|NCT02316769|585452842|FG000|Overall Study|Physician Decision|1|||
162110632|NCT02316769|585452843|FG001|Overall Study|Physician Decision|0|||
162110633|NCT02316769|585452842|FG000|Overall Study|Withdrawal by Subject|1|||
162110634|NCT02316769|585452843|FG001|Overall Study|Withdrawal by Subject|0|||
162110635|NCT04570436|585452844|FG000|Overall Study|Adverse Event|0|||
162110636|NCT04570436|585452845|FG001|Overall Study|Adverse Event|0|||
162110637|NCT04570436|585452846|FG002|Overall Study|Adverse Event|1|||
162110638|NCT04570436|585452847|FG003|Overall Study|Adverse Event|0|||
162110639|NCT04570436|585452848|FG004|Overall Study|Adverse Event|0|||
162110640|NCT04570436|585452849|FG005|Overall Study|Adverse Event|0|||
162110641|NCT04570436|585452850|FG006|Overall Study|Adverse Event|0|||
162110642|NCT04570436|585452851|FG007|Overall Study|Adverse Event|0|||
162110643|NCT04570436|585452852|FG008|Overall Study|Adverse Event|0|||
162110644|NCT04570436|585452853|FG009|Overall Study|Adverse Event|0|||
162110645|NCT04570436|585452844|FG000|Overall Study|Physician Decision|1|||
162110646|NCT04570436|585452845|FG001|Overall Study|Physician Decision|0|||
162110647|NCT04570436|585452846|FG002|Overall Study|Physician Decision|0|||
162110648|NCT04570436|585452847|FG003|Overall Study|Physician Decision|0|||
162110649|NCT04570436|585452848|FG004|Overall Study|Physician Decision|0|||
162110650|NCT04570436|585452849|FG005|Overall Study|Physician Decision|0|||
162110651|NCT04570436|585452850|FG006|Overall Study|Physician Decision|0|||
162110652|NCT04570436|585452851|FG007|Overall Study|Physician Decision|0|||
162110653|NCT04570436|585452852|FG008|Overall Study|Physician Decision|0|||
162110654|NCT04570436|585452853|FG009|Overall Study|Physician Decision|0|||
162110655|NCT00645164|585452854|FG000|Overall Study|Lost to Follow-up|2|||
162110656|NCT00645164|585452854|FG000|Overall Study|Withdrawal by Subject|4|||
162110657|NCT00645164|585452854|FG000|Overall Study|Protocol Violation|1|||
162110658|NCT02954354|585452855|FG000|Overall Study|Adverse Event|2|||
162110659|NCT02954354|585452856|FG001|Overall Study|Adverse Event|2|||
162110660|NCT02954354|585452857|FG002|Overall Study|Adverse Event|4|||
162110661|NCT02954354|585452855|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
162110662|NCT02954354|585452856|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
162110663|NCT02954354|585452857|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
162110664|NCT02954354|585452855|FG000|Overall Study|Lack of Efficacy|0|||
162110665|NCT02954354|585452856|FG001|Overall Study|Lack of Efficacy|2|||
162110666|NCT02954354|585452857|FG002|Overall Study|Lack of Efficacy|0|||
162110667|NCT02954354|585452855|FG000|Overall Study|Withdrawal by Subject|17|||
162110668|NCT02954354|585452856|FG001|Overall Study|Withdrawal by Subject|9|||
162110669|NCT02954354|585452857|FG002|Overall Study|Withdrawal by Subject|11|||
162110670|NCT02954354|585452855|FG000|Overall Study|Lost to Follow-up|12|||
162110671|NCT02954354|585452856|FG001|Overall Study|Lost to Follow-up|5|||
162110672|NCT02954354|585452857|FG002|Overall Study|Lost to Follow-up|0|||
162110673|NCT02954354|585452855|FG000|Overall Study|Miscellaneous|2|||
162110674|NCT02954354|585452856|FG001|Overall Study|Miscellaneous|2|||
162110675|NCT02954354|585452857|FG002|Overall Study|Miscellaneous|1|||
162110676|NCT02279043|585452868|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
162110677|NCT02279043|585452869|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
162110678|NCT02279043|585452870|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
162110679|NCT02279043|585452868|FG000|Overall Study|Lost to Follow-up|46|||
162110680|NCT02279043|585452869|FG001|Overall Study|Lost to Follow-up|88|||
162110681|NCT02279043|585452870|FG002|Overall Study|Lost to Follow-up|0|||
162110682|NCT00490282|585452871|FG000|Overall Study|Withdrawal by Subject|3|||
162110683|NCT01494584|585452878|FG000|Overall Study|Study Closed/Terminated|1|||
162110684|NCT01256567|585452885|FG000|Overall Study|Withdrawal by Subject|1|||
162110685|NCT00567190|585452891|FG000|Overall Study|Death|235|||
162110686|NCT00567190|585452892|FG001|Overall Study|Death|280|||
162110687|NCT00567190|585452891|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
162110688|NCT00567190|585452892|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
162110689|NCT01984697|585455049|FG000|Overall Study|Adverse Event|0|||
162110690|NCT01984697|585455050|FG001|Overall Study|Adverse Event|0|||
162110691|NCT01984697|585455051|FG002|Overall Study|Adverse Event|2|||
162110692|NCT01984697|585455052|FG003|Overall Study|Adverse Event|0|||
162110693|NCT01984697|585455053|FG004|Overall Study|Adverse Event|0|||
162110694|NCT01984697|585455049|FG000|Overall Study|Lost to Follow-up|14|||
162110695|NCT01984697|585455050|FG001|Overall Study|Lost to Follow-up|5|||
162110696|NCT01984697|585455051|FG002|Overall Study|Lost to Follow-up|10|||
162110697|NCT01984697|585455052|FG003|Overall Study|Lost to Follow-up|6|||
162110698|NCT01984697|585455053|FG004|Overall Study|Lost to Follow-up|21|||
162110699|NCT01984697|585455049|FG000|Overall Study|Physician Decision|3|||
162110700|NCT01984697|585455050|FG001|Overall Study|Physician Decision|0|||
162110701|NCT01984697|585455051|FG002|Overall Study|Physician Decision|0|||
162110702|NCT01984697|585455052|FG003|Overall Study|Physician Decision|1|||
162110703|NCT01984697|585455053|FG004|Overall Study|Physician Decision|0|||
162110704|NCT01984697|585455049|FG000|Overall Study|Protocol Violation|8|||
162110705|NCT01984697|585455050|FG001|Overall Study|Protocol Violation|5|||
162110706|NCT01984697|585455051|FG002|Overall Study|Protocol Violation|3|||
162110707|NCT01984697|585455052|FG003|Overall Study|Protocol Violation|2|||
162110708|NCT01984697|585455053|FG004|Overall Study|Protocol Violation|0|||
162110709|NCT01984697|585455049|FG000|Overall Study|Withdrawal by Subject|15|||
162110710|NCT01984697|585455050|FG001|Overall Study|Withdrawal by Subject|21|||
162110711|NCT01984697|585455051|FG002|Overall Study|Withdrawal by Subject|13|||
162110712|NCT01984697|585455052|FG003|Overall Study|Withdrawal by Subject|11|||
162110713|NCT01984697|585455053|FG004|Overall Study|Withdrawal by Subject|13|||
162110714|NCT01984697|585455049|FG000|Overall Study|Missed last follow-up visit|1|||
162110715|NCT01984697|585455050|FG001|Overall Study|Missed last follow-up visit|0|||
162110716|NCT01984697|585455051|FG002|Overall Study|Missed last follow-up visit|0|||
162110717|NCT01984697|585455052|FG003|Overall Study|Missed last follow-up visit|0|||
162110718|NCT01984697|585455053|FG004|Overall Study|Missed last follow-up visit|0|||
162110719|NCT01984697|585455049|FG000|Overall Study|Death|0|||
162110720|NCT01984697|585455050|FG001|Overall Study|Death|0|||
162110721|NCT01984697|585455051|FG002|Overall Study|Death|0|||
162110722|NCT01984697|585455052|FG003|Overall Study|Death|1|||
162110723|NCT01984697|585455053|FG004|Overall Study|Death|0|||
162110724|NCT01984697|585455049|FG000|Overall Study|Pregnancy|2|||
162110725|NCT01984697|585455050|FG001|Overall Study|Pregnancy|0|||
162110726|NCT01984697|585455051|FG002|Overall Study|Pregnancy|1|||
162110727|NCT01984697|585455052|FG003|Overall Study|Pregnancy|0|||
162110728|NCT01984697|585455053|FG004|Overall Study|Pregnancy|1|||
162110729|NCT05178121|585455054|FG000|Overall Study|Other|4|||
162110730|NCT05178121|585455054|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
162110731|NCT04044456|585455062|FG000|Overall Study|Lost to Follow-up|4|||
162110732|NCT04044456|585455063|FG001|Overall Study|Lost to Follow-up|1|||
162110733|NCT04044456|585455062|FG000|Overall Study|Withdrawal by Subject|1|||
162110734|NCT04044456|585455063|FG001|Overall Study|Withdrawal by Subject|0|||
162110735|NCT04209725|585455070|FG000|Overall Study|Adverse Event|1|||
162110736|NCT01281644|585455073|FG000|Overall Study|Lost to Follow-up|3|||
162110737|NCT01281644|585455073|FG000|Overall Study|Withdrawal by Subject|2|||
162110738|NCT03039023|585455074|FG000|Overall Study|Withdrawal by Subject|1|||
162110739|NCT03039023|585455075|FG001|Overall Study|Withdrawal by Subject|0|||
162110740|NCT03039023|585455076|FG002|Overall Study|Withdrawal by Subject|1|||
162110741|NCT03039023|585455077|FG003|Overall Study|Withdrawal by Subject|1|||
162110742|NCT03039023|585455078|FG004|Overall Study|Withdrawal by Subject|0|||
162110743|NCT03039023|585455074|FG000|Overall Study|Physician Decision|0|||
162110744|NCT03039023|585455075|FG001|Overall Study|Physician Decision|0|||
162110745|NCT03039023|585455076|FG002|Overall Study|Physician Decision|0|||
162110746|NCT03039023|585455077|FG003|Overall Study|Physician Decision|1|||
162110747|NCT03039023|585455078|FG004|Overall Study|Physician Decision|0|||
162110748|NCT03338829|585455079|FG000|Overall Study|Lost to Follow-up|4|||
162110749|NCT03338829|585455080|FG001|Overall Study|Lost to Follow-up|2|||
162110750|NCT03338829|585455081|FG002|Overall Study|Lost to Follow-up|4|||
162110751|NCT03338829|585455079|FG000|Overall Study|Pregnancy loss|1|||
162110752|NCT03338829|585455080|FG001|Overall Study|Pregnancy loss|1|||
162110753|NCT03338829|585455081|FG002|Overall Study|Pregnancy loss|0|||
162110754|NCT03338829|585455079|FG000|Overall Study|Protocol Violation|0|||
162110755|NCT03338829|585455080|FG001|Overall Study|Protocol Violation|1|||
162110756|NCT03338829|585455081|FG002|Overall Study|Protocol Violation|0|||
162110757|NCT03701399|585455085|FG000|Overall Study|Adverse Event|3|||
162110758|NCT03701399|585455086|FG001|Overall Study|Adverse Event|5|||
162110759|NCT03701399|585455085|FG000|Overall Study|Withdrawal by Subject|6|||
162110760|NCT03701399|585455086|FG001|Overall Study|Withdrawal by Subject|3|||
162110761|NCT03701399|585455085|FG000|Overall Study|Investigators decision|1|||
162110762|NCT03701399|585455086|FG001|Overall Study|Investigators decision|2|||
162110763|NCT03701399|585455085|FG000|Overall Study|Lost to Follow-up|1|||
162110764|NCT03701399|585455086|FG001|Overall Study|Lost to Follow-up|2|||
162110765|NCT03701399|585455085|FG000|Overall Study|Death|1|||
162110766|NCT03701399|585455086|FG001|Overall Study|Death|1|||
162110767|NCT03701399|585455085|FG000|Overall Study|Randomized but not treated|1|||
162110768|NCT03701399|585455086|FG001|Overall Study|Randomized but not treated|0|||
162110769|NCT04179032|585455087|FG000|Part B (Up to Week 52)|Adverse Event|1|||
162110770|NCT04179032|585455087|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
162110771|NCT04179032|585455087|FG000|Access Extension Phase|Ongoing|11|||
162110772|NCT00448448|585455088|FG000|Overall Study|Withdrawal by Subject|13|||
162110773|NCT00448448|585455089|FG001|Overall Study|Withdrawal by Subject|2|||
162110774|NCT00448448|585455088|FG000|Overall Study|On protocol when study ended|83|||
162110775|NCT00448448|585455089|FG001|Overall Study|On protocol when study ended|36|||
162110776|NCT00448448|585455088|FG000|Overall Study|Lost to Follow-up|2|||
162110777|NCT00448448|585455089|FG001|Overall Study|Lost to Follow-up|1|||
162110778|NCT00448448|585455088|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
162110779|NCT00448448|585455089|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
162110780|NCT00448448|585455088|FG000|Overall Study|Signed consent lost|0|||
162110781|NCT00448448|585455089|FG001|Overall Study|Signed consent lost|1|||
162110782|NCT02340026|585455090|FG000|Treatment Phase|Withdrawal by Subject|2|||
162110783|NCT02340026|585455091|FG001|Treatment Phase|Withdrawal by Subject|2|||
162110784|NCT02340026|585455090|FG000|Follow-up Phase|Lost to Follow-up|1|||
162110785|NCT02340026|585455091|FG001|Follow-up Phase|Lost to Follow-up|0|||
162110786|NCT03945292|585455092|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
162110787|NCT03945292|585455093|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
162110788|NCT03945292|585455094|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
162110789|NCT03945292|585455095|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
162110790|NCT03945292|585455096|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
162110791|NCT03945292|585455097|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
162110792|NCT03945292|585455098|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
162110793|NCT03945292|585455099|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
162110794|NCT03945292|585455092|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162110795|NCT03945292|585455093|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162110796|NCT03945292|585455094|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
162110797|NCT03945292|585455095|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162110798|NCT03945292|585455096|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162110799|NCT03945292|585455097|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162110800|NCT03945292|585455098|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162110801|NCT03945292|585455099|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
162110802|NCT03945292|585455092|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162110803|NCT03945292|585455093|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162110804|NCT03945292|585455094|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162110805|NCT03945292|585455095|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162110806|NCT03945292|585455096|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162110807|NCT03945292|585455097|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162110808|NCT03945292|585455098|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
162110809|NCT03945292|585455099|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
162110810|NCT02684006|585455100|FG000|Overall Study|Other|18|||
162110811|NCT02684006|585455101|FG001|Overall Study|Other|6|||
162110812|NCT02684006|585455100|FG000|Overall Study|Protocol Violation|2|||
162110813|NCT02684006|585455101|FG001|Overall Study|Protocol Violation|1|||
162110814|NCT02684006|585455100|FG000|Overall Study|Non-compliance with study drug|1|||
162110815|NCT02684006|585455101|FG001|Overall Study|Non-compliance with study drug|1|||
162110816|NCT02684006|585455100|FG000|Overall Study|No longer met eligibility criteria|6|||
162110817|NCT02684006|585455101|FG001|Overall Study|No longer met eligibility criteria|2|||
162110818|NCT02684006|585455100|FG000|Overall Study|Lost to Follow-up|0|||
162110819|NCT02684006|585455101|FG001|Overall Study|Lost to Follow-up|1|||
162110820|NCT02684006|585455100|FG000|Overall Study|Death|25|||
162110821|NCT02684006|585455101|FG001|Overall Study|Death|22|||
162110822|NCT02684006|585455100|FG000|Overall Study|Global deterioration of health status|18|||
162110823|NCT02684006|585455101|FG001|Overall Study|Global deterioration of health status|20|||
162110824|NCT02684006|585455100|FG000|Overall Study|Physician Decision|15|||
162110825|NCT02684006|585455101|FG001|Overall Study|Physician Decision|8|||
162110826|NCT02684006|585455100|FG000|Overall Study|Adverse Event|86|||
162110827|NCT02684006|585455101|FG001|Overall Study|Adverse Event|65|||
162110828|NCT02684006|585455100|FG000|Overall Study|Withdrawal by Subject|29|||
162110829|NCT02684006|585455101|FG001|Overall Study|Withdrawal by Subject|43|||
162110830|NCT02684006|585455100|FG000|Overall Study|Progressive disease|236|||
162110831|NCT02684006|585455101|FG001|Overall Study|Progressive disease|266|||
162110832|NCT02684006|585455100|FG000|Overall Study|Participation terminated by sponsor|6|||
162110833|NCT02684006|585455101|FG001|Overall Study|Participation terminated by sponsor|9|||
162110834|NCT04642898|585455102|FG000|Overall Study|Withdrawal by Subject|2|||
162110835|NCT04642898|585455103|FG001|Overall Study|Withdrawal by Subject|4|||
162110836|NCT04642898|585455104|FG002|Overall Study|Withdrawal by Subject|4|||
162110837|NCT04642898|585455105|FG003|Overall Study|Withdrawal by Subject|6|||
162110838|NCT04642898|585455106|FG004|Overall Study|Withdrawal by Subject|2|||
162110839|NCT04642898|585455107|FG005|Overall Study|Withdrawal by Subject|6|||
162110840|NCT04642898|585455102|FG000|Overall Study|Lost to Follow-up|0|||
162110841|NCT04642898|585455103|FG001|Overall Study|Lost to Follow-up|0|||
162110842|NCT04642898|585455104|FG002|Overall Study|Lost to Follow-up|0|||
162110843|NCT04642898|585455105|FG003|Overall Study|Lost to Follow-up|2|||
162110844|NCT04642898|585455106|FG004|Overall Study|Lost to Follow-up|0|||
162110845|NCT04642898|585455107|FG005|Overall Study|Lost to Follow-up|1|||
162110846|NCT04642898|585455102|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
162110847|NCT04642898|585455103|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
162110848|NCT04642898|585455104|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
162110849|NCT04642898|585455105|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
162110850|NCT04642898|585455106|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
162110851|NCT04642898|585455107|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
162110852|NCT04642898|585455102|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
162110853|NCT04642898|585455103|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
162110854|NCT04642898|585455104|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
162110855|NCT04642898|585455105|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
162110856|NCT04642898|585455106|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
162110857|NCT04642898|585455107|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
162110858|NCT04495179|585455108|FG000|Overall Study|Lost to Follow-up|0|||
162110859|NCT04495179|585455109|FG001|Overall Study|Lost to Follow-up|1|||
162110860|NCT04495179|585455108|FG000|Overall Study|Withdrawal by Subject|2|||
162110861|NCT04495179|585455109|FG001|Overall Study|Withdrawal by Subject|4|||
162110862|NCT04495179|585455108|FG000|Overall Study|Study terminated by sponsor|0|||
162110863|NCT04495179|585455109|FG001|Overall Study|Study terminated by sponsor|18|||
162110864|NCT04495179|585455108|FG000|Overall Study|Death|0|||
162110865|NCT04495179|585455109|FG001|Overall Study|Death|4|||
162110866|NCT04495179|585455108|FG000|Overall Study|Adverse Event|0|||
162110867|NCT04495179|585455109|FG001|Overall Study|Adverse Event|1|||
162110868|NCT04280562|585455110|FG000|Study|Adverse Event|2|||
162110869|NCT04280562|585455111|FG001|Study|Adverse Event|0|||
162110870|NCT04280562|585455110|FG000|Study|Lost to Follow-up|3|||
162110871|NCT04280562|585455111|FG001|Study|Lost to Follow-up|3|||
162110872|NCT00946296|585455112|FG000|Overall Study|Physician Decision|3|||
162110873|NCT00946296|585455113|FG001|Overall Study|Physician Decision|0|||
162110874|NCT03434678|585455116|FG000|Overall Study|Withdrawal by Subject|13|||
162110875|NCT03434678|585455117|FG001|Overall Study|Withdrawal by Subject|13|||
162110876|NCT03434678|585455116|FG000|Overall Study|Found to be ineligible post randomization|2|||
162110877|NCT03434678|585455117|FG001|Overall Study|Found to be ineligible post randomization|1|||
162110878|NCT01368965|585455121|FG000|Overall Study|Lost to Follow-up|12|||
162110879|NCT06060457|585455122|FG000|Overall Study|Adverse Event|1|||
162110880|NCT06060457|585455123|FG001|Overall Study|Adverse Event|1|||
162110881|NCT06060457|585455122|FG000|Overall Study|Death|2|||
162110882|NCT06060457|585455123|FG001|Overall Study|Death|2|||
162110883|NCT06060457|585455122|FG000|Overall Study|Lost to Follow-up|17|||
162110884|NCT06060457|585455123|FG001|Overall Study|Lost to Follow-up|19|||
162110885|NCT06060457|585455122|FG000|Overall Study|Physician Decision|0|||
162110886|NCT06060457|585455123|FG001|Overall Study|Physician Decision|1|||
162110887|NCT06060457|585455122|FG000|Overall Study|Protocol Violation|1|||
162110888|NCT06060457|585455123|FG001|Overall Study|Protocol Violation|1|||
162110889|NCT06060457|585455122|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
162110890|NCT06060457|585455123|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
162110891|NCT06060457|585455122|FG000|Overall Study|Withdrawal by Subject|12|||
162110892|NCT06060457|585455123|FG001|Overall Study|Withdrawal by Subject|15|||
162110893|NCT06060457|585455122|FG000|Overall Study|Other Than Specified|2|||
162110894|NCT06060457|585455123|FG001|Overall Study|Other Than Specified|1|||
162110895|NCT00162370|585455124|FG000|Efficacy Population|Lost to Follow-up|51|||
162110896|NCT02061202|585455125|FG000|Overall Study|Lost to Follow-up|1|||
162110897|NCT02061202|585455126|FG001|Overall Study|Lost to Follow-up|1|||
162110898|NCT00569582|585455140|FG000|Overall Study|Withdrawal by Subject|5|||
162110899|NCT00569582|585455140|FG000|Overall Study|Death|2|||
162110900|NCT00569582|585455140|FG000|Overall Study|Adverse Event|7|||
162110901|NCT00569582|585455140|FG000|Overall Study|Subject was too ill to travel.|1|||
162110902|NCT00569582|585455140|FG000|Overall Study|Subject was non-compliant.|1|||
162110903|NCT04559568|585455141|FG000|Overall Study|Physician Decision|0|||
162110904|NCT04559568|585455142|FG001|Overall Study|Physician Decision|0|||
162110905|NCT04559568|585455143|FG002|Overall Study|Physician Decision|0|||
162110906|NCT04559568|585455144|FG003|Overall Study|Physician Decision|0|||
162110907|NCT04559568|585455145|FG004|Overall Study|Physician Decision|0|||
162110908|NCT04559568|585455146|FG005|Overall Study|Physician Decision|0|||
162110909|NCT04559568|585455147|FG006|Overall Study|Physician Decision|0|||
162110910|NCT04559568|585455148|FG007|Overall Study|Physician Decision|0|||
162110911|NCT04559568|585455149|FG008|Overall Study|Physician Decision|0|||
162110912|NCT04559568|585455150|FG009|Overall Study|Physician Decision|1|||
162110913|NCT04559568|585455151|FG010|Overall Study|Physician Decision|0|||
162110914|NCT04559568|585455141|FG000|Overall Study|Withdrawal by Subject|0|||
162110915|NCT04559568|585455142|FG001|Overall Study|Withdrawal by Subject|0|||
162110916|NCT04559568|585455143|FG002|Overall Study|Withdrawal by Subject|0|||
162110917|NCT04559568|585455144|FG003|Overall Study|Withdrawal by Subject|0|||
162110918|NCT04559568|585455145|FG004|Overall Study|Withdrawal by Subject|0|||
162110919|NCT04559568|585455146|FG005|Overall Study|Withdrawal by Subject|0|||
162110920|NCT04559568|585455147|FG006|Overall Study|Withdrawal by Subject|0|||
162110921|NCT04559568|585455148|FG007|Overall Study|Withdrawal by Subject|0|||
162110922|NCT04559568|585455149|FG008|Overall Study|Withdrawal by Subject|0|||
162110923|NCT04559568|585455150|FG009|Overall Study|Withdrawal by Subject|0|||
162110924|NCT04559568|585455151|FG010|Overall Study|Withdrawal by Subject|1|||
162110925|NCT03721965|585455154|FG000|Overall Study|Death|1|||
162110926|NCT03721965|585455154|FG000|Overall Study|Study Terminated by Sponsor|1|||
162110927|NCT04085328|585455159|FG000|Overall Study|Witihdrew Consent|16|||
162110928|NCT04085328|585455160|FG001|Overall Study|Witihdrew Consent|16|||
162110929|NCT04085328|585455159|FG000|Overall Study|Adverse Event|8|||
162110930|NCT04085328|585455160|FG001|Overall Study|Adverse Event|7|||
162110931|NCT04085328|585455159|FG000|Overall Study|Lost to Follow-up|7|||
162110932|NCT04085328|585455160|FG001|Overall Study|Lost to Follow-up|2|||
162110933|NCT04085328|585455159|FG000|Overall Study|Physician Decision|0|||
162110934|NCT04085328|585455160|FG001|Overall Study|Physician Decision|1|||
162110935|NCT04085328|585455159|FG000|Overall Study|Pregnancy|0|||
162110936|NCT04085328|585455160|FG001|Overall Study|Pregnancy|1|||
162110937|NCT04085328|585455159|FG000|Overall Study|Reasons Related to COVID-19|5|||
162110938|NCT04085328|585455160|FG001|Overall Study|Reasons Related to COVID-19|8|||
162110939|NCT04085328|585455159|FG000|Overall Study|Did not meet inclusion criteria|1|||
162110940|NCT04085328|585455160|FG001|Overall Study|Did not meet inclusion criteria|1|||
162110941|NCT04085328|585455159|FG000|Overall Study|Early termination|1|||
162110942|NCT04085328|585455160|FG001|Overall Study|Early termination|0|||
162110943|NCT05608499|585455161|FG000|Overall Study|Lack of Efficacy|1|||
162110944|NCT05608499|585455162|FG001|Overall Study|Lack of Efficacy|0|||
162110945|NCT05608499|585455161|FG000|Overall Study|Lost to Follow-up|0|||
162110946|NCT05608499|585455162|FG001|Overall Study|Lost to Follow-up|1|||
162110947|NCT00514735|585455163|FG000|Overall Study|Withdrawal by Subject|13|||
162110948|NCT00514735|585455164|FG001|Overall Study|Withdrawal by Subject|5|||
162110949|NCT00514735|585455163|FG000|Overall Study|Death|1|||
162110950|NCT00514735|585455164|FG001|Overall Study|Death|0|||
162110951|NCT00514735|585455163|FG000|Overall Study|Lost to Follow-up|0|||
162110952|NCT00514735|585455164|FG001|Overall Study|Lost to Follow-up|1|||
162110953|NCT01422408|585455167|FG000|Overall Study|Adverse Event|1|||
162110954|NCT01422408|585455167|FG000|Overall Study|Withdrawal by Subject|3|||
162110955|NCT00724152|585455174|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
162110956|NCT00724152|585455175|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
162110957|NCT00724152|585455176|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
162110958|NCT00724152|585455174|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
162110959|NCT00724152|585455175|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
162110960|NCT00724152|585455176|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
162110961|NCT01328080|585455178|FG000|Overall Study|Lost to Follow-up|5|||
162110962|NCT00045305|585455179|FG000|Overall Study|Lack of Efficacy|6|||
162110963|NCT00045305|585455179|FG000|Overall Study|Adverse Event|3|||
162110964|NCT00045305|585455179|FG000|Overall Study|Death|3|||
162110965|NCT00045305|585455179|FG000|Overall Study|site error|2|||
162110966|NCT03266770|585455180|FG000|Overall Study|Physician Decision|3|||
162110967|NCT03266770|585455180|FG000|Overall Study|Insufficient study supplies|1|||
162110968|NCT03266770|585455180|FG000|Overall Study|Adverse Event|1|||
162110969|NCT04274894|585455181|FG000|Overall Study|Adverse Event|7|||
162110970|NCT04274894|585455181|FG000|Overall Study|Withdrew consent|5|||
162110971|NCT04274894|585455181|FG000|Overall Study|Lost to Follow-up|9|||
162110972|NCT04274894|585455181|FG000|Overall Study|COVID-19 infection|1|||
162110973|NCT04274894|585455181|FG000|Overall Study|Other, not specified|20|||
162110974|NCT01936857|585455182|FG000|Overall Study|Sent to prison or 06 center|11|||
162110975|NCT01936857|585455183|FG001|Overall Study|Sent to prison or 06 center|12|||
162110976|NCT01936857|585455182|FG000|Overall Study|Lost to Follow-up|10|||
162110977|NCT01936857|585455183|FG001|Overall Study|Lost to Follow-up|7|||
162110978|NCT01936857|585455182|FG000|Overall Study|Death|7|||
162110979|NCT01936857|585455183|FG001|Overall Study|Death|3|||
162110980|NCT01936857|585455182|FG000|Overall Study|Moved|2|||
162110981|NCT01936857|585455183|FG001|Overall Study|Moved|1|||
162110982|NCT01936857|585455182|FG000|Overall Study|Withdrawal by Subject|1|||
162110983|NCT01936857|585455183|FG001|Overall Study|Withdrawal by Subject|0|||
162110984|NCT01936857|585455182|FG000|Overall Study|Side effect of medication|1|||
162110985|NCT01936857|585455183|FG001|Overall Study|Side effect of medication|0|||
162110986|NCT01936857|585455182|FG000|Overall Study|Other|2|||
162110987|NCT01936857|585455183|FG001|Overall Study|Other|2|||
162110988|NCT03848403|585455184|FG000|Period 2 (Day 8)|Adverse Event|1|||
162110989|NCT03848403|585455185|FG001|Period 2 (Day 8)|Adverse Event|2|||
162110990|NCT03848403|585455186|FG002|Period 2 (Day 8)|Adverse Event|2|||
162110991|NCT03848403|585455184|FG000|Period 2 (Day 8)|Physician Decision|0|||
162110992|NCT03848403|585455185|FG001|Period 2 (Day 8)|Physician Decision|1|||
162110993|NCT03848403|585455186|FG002|Period 2 (Day 8)|Physician Decision|0|||
162110994|NCT03848403|585455184|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
162110995|NCT03848403|585455185|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
162110996|NCT03848403|585455186|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
162110997|NCT00168038|585455187|FG000|Overall Study|Adverse Event|1|||
162110998|NCT00168038|585455187|FG000|Overall Study|Therapy failure|1|||
162110999|NCT01218126|585455195|FG000|Overall Study|Adverse Event|8|||
162111000|NCT01218126|585455196|FG001|Overall Study|Adverse Event|10|||
162111001|NCT01218126|585455197|FG002|Overall Study|Adverse Event|12|||
162111002|NCT01218126|585455198|FG003|Overall Study|Adverse Event|16|||
162111003|NCT01218126|585455195|FG000|Overall Study|Lack of Efficacy|7|||
162111004|NCT01218126|585455196|FG001|Overall Study|Lack of Efficacy|2|||
162111005|NCT01218126|585455197|FG002|Overall Study|Lack of Efficacy|2|||
162111006|NCT01218126|585455198|FG003|Overall Study|Lack of Efficacy|6|||
162111007|NCT01218126|585455195|FG000|Overall Study|Protocol Violation|5|||
162111008|NCT01218126|585455196|FG001|Overall Study|Protocol Violation|2|||
162111009|NCT01218126|585455197|FG002|Overall Study|Protocol Violation|2|||
162111010|NCT01218126|585455198|FG003|Overall Study|Protocol Violation|3|||
162111011|NCT01218126|585455195|FG000|Overall Study|Protocol-defined stopping criteria|1|||
162111012|NCT01218126|585455196|FG001|Overall Study|Protocol-defined stopping criteria|1|||
162111013|NCT01218126|585455197|FG002|Overall Study|Protocol-defined stopping criteria|0|||
162111014|NCT01218126|585455198|FG003|Overall Study|Protocol-defined stopping criteria|0|||
162111015|NCT01218126|585455195|FG000|Overall Study|Lost to Follow-up|0|||
162111016|NCT01218126|585455196|FG001|Overall Study|Lost to Follow-up|0|||
162111017|NCT01218126|585455197|FG002|Overall Study|Lost to Follow-up|0|||
162111018|NCT01218126|585455198|FG003|Overall Study|Lost to Follow-up|2|||
162111019|NCT01218126|585455195|FG000|Overall Study|Physician Decision|1|||
162111020|NCT01218126|585455196|FG001|Overall Study|Physician Decision|2|||
162111021|NCT01218126|585455197|FG002|Overall Study|Physician Decision|4|||
162111022|NCT01218126|585455198|FG003|Overall Study|Physician Decision|2|||
162111023|NCT01218126|585455195|FG000|Overall Study|Withdrawal by Subject|2|||
162111024|NCT01218126|585455196|FG001|Overall Study|Withdrawal by Subject|5|||
162111025|NCT01218126|585455197|FG002|Overall Study|Withdrawal by Subject|4|||
162111026|NCT01218126|585455198|FG003|Overall Study|Withdrawal by Subject|6|||
162111027|NCT05380947|585455199|FG000|Washout Period 1|Not attend visit|1|||
162111028|NCT05380947|585455200|FG001|Washout Period 1|Not attend visit|0|||
162111029|NCT05380947|585455201|FG002|Washout Period 1|Not attend visit|0|||
162111030|NCT05380947|585455202|FG003|Washout Period 1|Not attend visit|0|||
162111031|NCT05380947|585455199|FG000|Washout Period 2|Adverse Event|1|||
162111032|NCT05380947|585455200|FG001|Washout Period 2|Adverse Event|0|||
162111033|NCT05380947|585455201|FG002|Washout Period 2|Adverse Event|0|||
162111034|NCT05380947|585455202|FG003|Washout Period 2|Adverse Event|0|||
162111035|NCT05380947|585455199|FG000|Washout Period 3|Adverse Event|0|||
162111036|NCT05380947|585455200|FG001|Washout Period 3|Adverse Event|1|||
162111037|NCT05380947|585455201|FG002|Washout Period 3|Adverse Event|0|||
162111038|NCT05380947|585455202|FG003|Washout Period 3|Adverse Event|0|||
162111039|NCT05380947|585455199|FG000|Washout Period 3|Not attend visit|0|||
162111040|NCT05380947|585455200|FG001|Washout Period 3|Not attend visit|1|||
162111041|NCT05380947|585455201|FG002|Washout Period 3|Not attend visit|0|||
162111042|NCT05380947|585455202|FG003|Washout Period 3|Not attend visit|1|||
162111043|NCT01563536|585455203|FG000|Overall Study|Withdrawal by Subject|0|||
162111044|NCT01563536|585455204|FG001|Overall Study|Withdrawal by Subject|2|||
162111045|NCT01563536|585455203|FG000|Overall Study|Lost to Follow-up|1|||
162111046|NCT01563536|585455204|FG001|Overall Study|Lost to Follow-up|0|||
162111047|NCT01860703|585455205|FG000|Overall Study|Adverse Event|1|||
162111048|NCT01860703|585455206|FG001|Overall Study|Adverse Event|4|||
162111049|NCT01860703|585455207|FG002|Overall Study|Adverse Event|0|||
162111050|NCT01860703|585455208|FG003|Overall Study|Adverse Event|2|||
162111051|NCT01860703|585455205|FG000|Overall Study|Withdrawal by Subject|0|||
162111052|NCT01860703|585455206|FG001|Overall Study|Withdrawal by Subject|1|||
162111053|NCT01860703|585455207|FG002|Overall Study|Withdrawal by Subject|0|||
162111054|NCT01860703|585455208|FG003|Overall Study|Withdrawal by Subject|0|||
162111055|NCT01860703|585455205|FG000|Overall Study|Personal reason|1|||
162111056|NCT01860703|585455206|FG001|Overall Study|Personal reason|0|||
162111057|NCT01860703|585455207|FG002|Overall Study|Personal reason|1|||
162111058|NCT01860703|585455208|FG003|Overall Study|Personal reason|0|||
162111059|NCT06213701|585455212|FG000|Overall Study|Withdrawal by Subject|2|||
162111060|NCT06213701|585455213|FG001|Overall Study|Withdrawal by Subject|1|||
162111061|NCT06213701|585455214|FG002|Overall Study|Withdrawal by Subject|0|||
162111062|NCT00538590|585455215|FG000|Overall Study|Death|1|||
162111063|NCT00538590|585455216|FG001|Overall Study|Death|0|||
162111064|NCT03184792|585455221|FG000|Overall Study|Pandemic|2|||
162111065|NCT03184792|585455222|FG001|Overall Study|Pandemic|2|||
162111066|NCT00313820|585455223|FG000|Assigned to Treatment|Other|1|||
162111067|NCT00313820|585455224|FG001|Assigned to Treatment|Other|0|||
162111068|NCT00313820|585455223|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
162111069|NCT00313820|585455224|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
162111070|NCT00313820|585455223|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
162111071|NCT00313820|585455224|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
162111072|NCT00313820|585455223|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
162111073|NCT00313820|585455224|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
162111074|NCT00313820|585455223|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
162111075|NCT00313820|585455224|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
162111076|NCT00313820|585455223|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
162111077|NCT00313820|585455224|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
162111078|NCT02453685|585455228|FG000|Overall Study|Adverse Event|0|||
162111079|NCT02453685|585455229|FG001|Overall Study|Adverse Event|1|||
162111080|NCT02453685|585455228|FG000|Overall Study|Protocol Violation|7|||
162111081|NCT02453685|585455229|FG001|Overall Study|Protocol Violation|4|||
162111082|NCT02453685|585455228|FG000|Overall Study|Lost to Follow-up|0|||
162111083|NCT02453685|585455229|FG001|Overall Study|Lost to Follow-up|1|||
162111084|NCT02453685|585455228|FG000|Overall Study|Withdrawal by Subject|8|||
162111085|NCT02453685|585455229|FG001|Overall Study|Withdrawal by Subject|4|||
162111086|NCT02453685|585455228|FG000|Overall Study|Unclassified|4|||
162111087|NCT02453685|585455229|FG001|Overall Study|Unclassified|2|||
162111088|NCT02778100|585455232|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
162111089|NCT02778100|585455233|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
162111090|NCT01515748|585455239|FG000|Overall Study|Withdrawal by Subject|32|||
162111091|NCT01515748|585455240|FG001|Overall Study|Withdrawal by Subject|41|||
162111092|NCT01515748|585455239|FG000|Overall Study|Lost to Follow-up|2|||
162111093|NCT01515748|585455240|FG001|Overall Study|Lost to Follow-up|4|||
162111094|NCT01515748|585455239|FG000|Overall Study|Other than specified above|5|||
162111095|NCT01515748|585455240|FG001|Overall Study|Other than specified above|10|||
162111096|NCT03221387|585455241|FG000|Overall Study|Lost to Follow-up|1|||
162111097|NCT03221387|585455241|FG000|Overall Study|Lung transplant|1|||
162111098|NCT00522626|585455242|FG000|Overall Study|Lost to Follow-up|7|||
162111099|NCT00803452|585455243|FG000|Overall Study|Adverse Event|0|||
162111100|NCT00803452|585455244|FG001|Overall Study|Adverse Event|2|||
162111101|NCT00803452|585455243|FG000|Overall Study|Lost to Follow-up|0|||
162111102|NCT00803452|585455244|FG001|Overall Study|Lost to Follow-up|3|||
162111103|NCT02365519|585455245|FG000|Randomized and Treated|Adverse Event|0|||
162111104|NCT02365519|585455246|FG001|Randomized and Treated|Adverse Event|1|||
162111105|NCT02365519|585455247|FG002|Randomized and Treated|Adverse Event|0|||
162111106|NCT02365519|585455245|FG000|Randomized and Treated|Withdrawal by Subject|0|||
162111107|NCT02365519|585455246|FG001|Randomized and Treated|Withdrawal by Subject|1|||
162111108|NCT02365519|585455247|FG002|Randomized and Treated|Withdrawal by Subject|1|||
162111109|NCT01971723|585455248|FG000|Overall Study|Withdrawal by Subject|1|||
162111110|NCT01971723|585455249|FG001|Overall Study|Withdrawal by Subject|1|||
162111111|NCT01971723|585455248|FG000|Overall Study|Protocol Violation|1|||
162111112|NCT01971723|585455249|FG001|Overall Study|Protocol Violation|2|||
162111113|NCT03017079|585455253|FG000|Overall Study|Physician Decision|1|||
162111114|NCT03017079|585455254|FG001|Overall Study|Physician Decision|1|||
162111115|NCT03017079|585455253|FG000|Overall Study|Death|3|||
162111116|NCT03017079|585455254|FG001|Overall Study|Death|2|||
162111117|NCT03017079|585455253|FG000|Overall Study|Lack of Efficacy|2|||
162111118|NCT03017079|585455254|FG001|Overall Study|Lack of Efficacy|2|||
162111119|NCT03017079|585455253|FG000|Overall Study|Protocol Violation|0|||
162111120|NCT03017079|585455254|FG001|Overall Study|Protocol Violation|1|||
162111121|NCT04120233|585455260|FG000|Overall Study|Adverse Event|0|||
162111122|NCT04120233|585455261|FG001|Overall Study|Adverse Event|0|||
162111123|NCT04120233|585455262|FG002|Overall Study|Adverse Event|0|||
162111124|NCT04120233|585455263|FG003|Overall Study|Adverse Event|0|||
162111125|NCT04120233|585455264|FG004|Overall Study|Adverse Event|1|||
162111126|NCT04120233|585455265|FG005|Overall Study|Adverse Event|0|||
162111127|NCT06223373|585455266|FG000|Overall Study|Lost to Follow-up|1|||
162111128|NCT06223373|585455267|FG001|Overall Study|Lost to Follow-up|2|||
162111129|NCT05809596|585455270|FG000|Overall Study|Death|16|||
162111130|NCT05809596|585455270|FG000|Overall Study|Withdrawal by Subject|4|||
162111131|NCT05809596|585455270|FG000|Overall Study|Physician Decision|1|||
162111132|NCT05809596|585455270|FG000|Overall Study|Missed Visit|2|||
162111133|NCT05809596|585455270|FG000|Overall Study|Other|3|||
162111134|NCT03770494|585455271|FG000|Overall Study|Lost to Follow-up|0|||
162111135|NCT03770494|585455272|FG001|Overall Study|Lost to Follow-up|0|||
162111136|NCT03770494|585455273|FG002|Overall Study|Lost to Follow-up|1|||
162111137|NCT03770494|585455274|FG003|Overall Study|Lost to Follow-up|1|||
162111138|NCT03770494|585455275|FG004|Overall Study|Lost to Follow-up|1|||
162111139|NCT03770494|585455276|FG005|Overall Study|Lost to Follow-up|0|||
162111140|NCT03770494|585455277|FG006|Overall Study|Lost to Follow-up|0|||
162111141|NCT03770494|585455278|FG007|Overall Study|Lost to Follow-up|0|||
162111142|NCT03770494|585455279|FG008|Overall Study|Lost to Follow-up|0|||
162111143|NCT03770494|585455280|FG009|Overall Study|Lost to Follow-up|0|||
162111144|NCT03770494|585455281|FG010|Overall Study|Lost to Follow-up|0|||
162111145|NCT03770494|585455282|FG011|Overall Study|Lost to Follow-up|0|||
162111146|NCT03770494|585455283|FG012|Overall Study|Lost to Follow-up|0|||
162111147|NCT03770494|585455284|FG013|Overall Study|Lost to Follow-up|0|||
162111148|NCT03770494|585455271|FG000|Overall Study|Study terminated by sponsor|1|||
162111149|NCT03770494|585455272|FG001|Overall Study|Study terminated by sponsor|2|||
162111150|NCT03770494|585455273|FG002|Overall Study|Study terminated by sponsor|1|||
162111151|NCT03770494|585455274|FG003|Overall Study|Study terminated by sponsor|1|||
162111152|NCT03770494|585455275|FG004|Overall Study|Study terminated by sponsor|1|||
162111153|NCT03770494|585455276|FG005|Overall Study|Study terminated by sponsor|2|||
162111154|NCT03770494|585455277|FG006|Overall Study|Study terminated by sponsor|1|||
162111155|NCT03770494|585455278|FG007|Overall Study|Study terminated by sponsor|2|||
162111156|NCT03770494|585455279|FG008|Overall Study|Study terminated by sponsor|1|||
162111157|NCT03770494|585455280|FG009|Overall Study|Study terminated by sponsor|2|||
162111158|NCT03770494|585455281|FG010|Overall Study|Study terminated by sponsor|1|||
162111159|NCT03770494|585455282|FG011|Overall Study|Study terminated by sponsor|2|||
162111160|NCT03770494|585455283|FG012|Overall Study|Study terminated by sponsor|0|||
162111161|NCT03770494|585455284|FG013|Overall Study|Study terminated by sponsor|0|||
162111162|NCT03770494|585455271|FG000|Overall Study|Withdrawal by Subject|1|||
162111163|NCT03770494|585455272|FG001|Overall Study|Withdrawal by Subject|1|||
162111164|NCT03770494|585455273|FG002|Overall Study|Withdrawal by Subject|0|||
162111165|NCT03770494|585455274|FG003|Overall Study|Withdrawal by Subject|0|||
162111166|NCT03770494|585455275|FG004|Overall Study|Withdrawal by Subject|2|||
162111167|NCT03770494|585455276|FG005|Overall Study|Withdrawal by Subject|2|||
162111168|NCT03770494|585455277|FG006|Overall Study|Withdrawal by Subject|2|||
162111169|NCT03770494|585455278|FG007|Overall Study|Withdrawal by Subject|0|||
162111170|NCT03770494|585455279|FG008|Overall Study|Withdrawal by Subject|2|||
162111171|NCT03770494|585455280|FG009|Overall Study|Withdrawal by Subject|3|||
162111172|NCT03770494|585455281|FG010|Overall Study|Withdrawal by Subject|1|||
162111173|NCT03770494|585455282|FG011|Overall Study|Withdrawal by Subject|0|||
162111174|NCT03770494|585455283|FG012|Overall Study|Withdrawal by Subject|0|||
162111175|NCT03770494|585455284|FG013|Overall Study|Withdrawal by Subject|0|||
162111176|NCT00553501|585456940|FG000|Overall Study|Adverse Event|2|||
162111177|NCT00553501|585456940|FG000|Overall Study|Death|1|||
162111178|NCT00553501|585456940|FG000|Overall Study|Progression|1|||
162111179|NCT00949715|585456943|FG000|Overall Study|Physician Decision|1|||
162111180|NCT00949715|585456944|FG001|Overall Study|Physician Decision|0|||
162111181|NCT00949715|585456943|FG000|Overall Study|Lost to Follow-up|1|||
162111182|NCT00949715|585456944|FG001|Overall Study|Lost to Follow-up|0|||
162111183|NCT00949715|585456943|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
162111184|NCT00949715|585456944|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
162111185|NCT05050578|585456948|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
162111186|NCT05050578|585456949|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
162111187|NCT05050578|585456948|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
162111188|NCT05050578|585456949|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
162111189|NCT05050578|585456948|FG000|Period 2, 30 Days|Protocol Violation|0|||
162111190|NCT05050578|585456949|FG001|Period 2, 30 Days|Protocol Violation|1|||
162111191|NCT02243280|585456950|FG000|Treated|Adverse Event|1|||
162111192|NCT02243280|585456951|FG001|Treated|Adverse Event|0|||
162111193|NCT02243280|585456952|FG002|Treated|Adverse Event|0|||
162111194|NCT02243280|585456953|FG003|Treated|Adverse Event|0|||
162111195|NCT02243280|585456954|FG004|Treated|Adverse Event|0|||
162111196|NCT02243280|585456955|FG005|Treated|Adverse Event|0|||
162111197|NCT02243280|585456956|FG006|Treated|Adverse Event|0|||
162111198|NCT02243280|585456957|FG007|Treated|Adverse Event|0|||
162111199|NCT02243280|585456958|FG008|Treated|Adverse Event|0|||
162111200|NCT02243280|585456959|FG009|Treated|Adverse Event|0|||
162111201|NCT02243280|585456960|FG010|Treated|Adverse Event|1|||
162111202|NCT02243280|585456950|FG000|Treated|Lost to Follow-up|0|||
162111203|NCT02243280|585456951|FG001|Treated|Lost to Follow-up|0|||
162111204|NCT02243280|585456952|FG002|Treated|Lost to Follow-up|0|||
162111205|NCT02243280|585456953|FG003|Treated|Lost to Follow-up|0|||
162111206|NCT02243280|585456954|FG004|Treated|Lost to Follow-up|0|||
162111207|NCT02243280|585456955|FG005|Treated|Lost to Follow-up|0|||
162111208|NCT02243280|585456956|FG006|Treated|Lost to Follow-up|0|||
162111209|NCT02243280|585456957|FG007|Treated|Lost to Follow-up|0|||
162111210|NCT02243280|585456958|FG008|Treated|Lost to Follow-up|1|||
162111211|NCT02243280|585456959|FG009|Treated|Lost to Follow-up|0|||
162111212|NCT02243280|585456960|FG010|Treated|Lost to Follow-up|2|||
162111213|NCT03386032|585456969|FG000|Overall Study|Lack of Efficacy|6|||
162111214|NCT03386032|585456970|FG001|Overall Study|Lack of Efficacy|2|||
162111215|NCT03386032|585456971|FG002|Overall Study|Lack of Efficacy|0|||
162111216|NCT03386032|585456969|FG000|Overall Study|Adverse Event|2|||
162111217|NCT03386032|585456970|FG001|Overall Study|Adverse Event|2|||
162111218|NCT03386032|585456971|FG002|Overall Study|Adverse Event|0|||
162111219|NCT03386032|585456969|FG000|Overall Study|Withdrawal by Subject|1|||
162111220|NCT03386032|585456970|FG001|Overall Study|Withdrawal by Subject|0|||
162111221|NCT03386032|585456971|FG002|Overall Study|Withdrawal by Subject|0|||
162111222|NCT03386032|585456969|FG000|Overall Study|Lost to Follow-up|9|||
162111223|NCT03386032|585456970|FG001|Overall Study|Lost to Follow-up|3|||
162111224|NCT03386032|585456971|FG002|Overall Study|Lost to Follow-up|0|||
162111225|NCT04525547|585456980|FG000|Overall Study|Not treated with Ofev|2|||
162111226|NCT04525547|585456980|FG000|Overall Study|Off-label use|2|||
162111227|NCT04525547|585456980|FG000|Overall Study|Lost to Follow-up|1|||
162111228|NCT03122119|585456981|FG000|Overall Study|Did not meet eligibility critria|1|||
162111229|NCT01493687|585456988|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
162111230|NCT01493687|585456989|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
162111231|NCT01493687|585456988|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
162111232|NCT01493687|585456989|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
162111233|NCT01493687|585456988|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
162111234|NCT01493687|585456989|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
162111235|NCT01493687|585456988|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
162111236|NCT01493687|585456989|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
162111237|NCT01493687|585456988|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
162111238|NCT01493687|585456989|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
162111239|NCT01493687|585456988|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
162111240|NCT01493687|585456989|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
162111241|NCT01493687|585456988|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
162111242|NCT01493687|585456989|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
162111243|NCT01493687|585456988|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
162111244|NCT01493687|585456989|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
162111245|NCT01493687|585456988|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
162111246|NCT01493687|585456989|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
162111247|NCT01493687|585456988|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
162111248|NCT01493687|585456989|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
162111249|NCT01493687|585456988|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
162111250|NCT01493687|585456989|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
162111251|NCT01493687|585456988|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
162111252|NCT01493687|585456989|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
162111253|NCT01493687|585456988|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
162111254|NCT01493687|585456989|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
162111255|NCT01493687|585456988|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
162111256|NCT01493687|585456989|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
162111257|NCT01493687|585456988|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
162111258|NCT01493687|585456989|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
162111259|NCT02364180|585456990|FG000|Overall Study|Screen Fail|1|||
162111260|NCT01783418|585456991|FG000|Overall Study|Withdrawal by Subject|1|||
162111261|NCT01783418|585456992|FG001|Overall Study|Withdrawal by Subject|0|||
162111262|NCT00521144|585456993|FG000|Overall Study|Not Treated|0|||
162111263|NCT00521144|585456994|FG001|Overall Study|Not Treated|0|||
162111264|NCT00521144|585456995|FG002|Overall Study|Not Treated|0|||
162111265|NCT00521144|585456996|FG003|Overall Study|Not Treated|1|||
162111266|NCT00521144|585456997|FG004|Overall Study|Not Treated|0|||
162111267|NCT00521144|585456993|FG000|Overall Study|Adverse Event|0|||
162111268|NCT00521144|585456994|FG001|Overall Study|Adverse Event|1|||
162111269|NCT00521144|585456995|FG002|Overall Study|Adverse Event|0|||
162111270|NCT00521144|585456996|FG003|Overall Study|Adverse Event|0|||
162111271|NCT00521144|585456997|FG004|Overall Study|Adverse Event|1|||
162111272|NCT00521144|585456993|FG000|Overall Study|Progressive Disease|4|||
162111273|NCT00521144|585456994|FG001|Overall Study|Progressive Disease|2|||
162111274|NCT00521144|585456995|FG002|Overall Study|Progressive Disease|2|||
162111275|NCT00521144|585456996|FG003|Overall Study|Progressive Disease|0|||
162111276|NCT00521144|585456997|FG004|Overall Study|Progressive Disease|6|||
162111277|NCT00508261|585456999|FG000|Overall Study|Other|0|||
162111278|NCT00508261|585457000|FG001|Overall Study|Other|1|||
162111279|NCT00508261|585457001|FG002|Overall Study|Other|1|||
162111280|NCT00508261|585457002|FG003|Overall Study|Other|0|||
162111281|NCT00508261|585456999|FG000|Overall Study|Serious Adverse Event|0|||
162111282|NCT00508261|585457000|FG001|Overall Study|Serious Adverse Event|1|||
162111283|NCT00508261|585457001|FG002|Overall Study|Serious Adverse Event|0|||
162111284|NCT00508261|585457002|FG003|Overall Study|Serious Adverse Event|0|||
162111285|NCT00508261|585456999|FG000|Overall Study|Withdrawal by Subject|3|||
162111286|NCT00508261|585457000|FG001|Overall Study|Withdrawal by Subject|4|||
162111287|NCT00508261|585457001|FG002|Overall Study|Withdrawal by Subject|4|||
162111288|NCT00508261|585457002|FG003|Overall Study|Withdrawal by Subject|0|||
162111289|NCT00508261|585456999|FG000|Overall Study|Migrated/ moved from study area|0|||
162111290|NCT00508261|585457000|FG001|Overall Study|Migrated/ moved from study area|1|||
162111291|NCT00508261|585457001|FG002|Overall Study|Migrated/ moved from study area|0|||
162111292|NCT00508261|585457002|FG003|Overall Study|Migrated/ moved from study area|0|||
162111293|NCT00508261|585456999|FG000|Overall Study|Lost to Follow-up|0|||
162111294|NCT00508261|585457000|FG001|Overall Study|Lost to Follow-up|1|||
162111295|NCT00508261|585457001|FG002|Overall Study|Lost to Follow-up|1|||
162111296|NCT00508261|585457002|FG003|Overall Study|Lost to Follow-up|1|||
162111297|NCT00180479|585457003|FG000|Overall Study|Death|4|||
162111298|NCT00180479|585457004|FG001|Overall Study|Death|2|||
162111299|NCT00180479|585457003|FG000|Overall Study|Lost to Follow-up|9|||
162111300|NCT00180479|585457004|FG001|Overall Study|Lost to Follow-up|7|||
162111301|NCT00180479|585457003|FG000|Overall Study|Withdrawal by Subject|3|||
162111302|NCT00180479|585457004|FG001|Overall Study|Withdrawal by Subject|3|||
162111303|NCT00180479|585457003|FG000|Overall Study|Informed consent not signed|0|||
162111304|NCT00180479|585457004|FG001|Overall Study|Informed consent not signed|1|||
162111305|NCT03315143|585457009|FG000|Overall Study|Death|240|||
162111306|NCT03315143|585457010|FG001|Overall Study|Death|246|||
162111307|NCT03315143|585457009|FG000|Overall Study|Withdrawal by Subject|57|||
162111308|NCT03315143|585457010|FG001|Overall Study|Withdrawal by Subject|68|||
162111309|NCT03315143|585457009|FG000|Overall Study|Site Terminated by Sponsor|256|||
162111310|NCT03315143|585457010|FG001|Overall Study|Site Terminated by Sponsor|282|||
162111311|NCT03315143|585457009|FG000|Overall Study|Study Terminated by Sponsor|4723|||
162111312|NCT03315143|585457010|FG001|Overall Study|Study Terminated by Sponsor|4664|||
162111313|NCT03315143|585457009|FG000|Overall Study|Reason not Specified|16|||
162111314|NCT03315143|585457010|FG001|Overall Study|Reason not Specified|32|||
162111315|NCT00840801|585457011|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
162111316|NCT00840801|585457012|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
162111317|NCT00840801|585457013|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
162111318|NCT00840801|585457011|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
162111319|NCT00840801|585457012|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
162111320|NCT00840801|585457013|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
162111321|NCT00840801|585457011|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
162111322|NCT00840801|585457012|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
162111323|NCT00840801|585457013|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
162111324|NCT00840801|585457011|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
162111325|NCT00840801|585457012|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
162111326|NCT00840801|585457013|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
162111327|NCT00335452|585457014|FG000|Overall Study|Death|156|||
162111328|NCT00335452|585457015|FG001|Overall Study|Death|144|||
162111329|NCT00335452|585457016|FG002|Overall Study|Death|158|||
162111330|NCT00335452|585457017|FG003|Overall Study|Death|129|||
162111331|NCT00335452|585457014|FG000|Overall Study|Lost to Follow-up|2|||
162111332|NCT00335452|585457015|FG001|Overall Study|Lost to Follow-up|3|||
162111333|NCT00335452|585457016|FG002|Overall Study|Lost to Follow-up|1|||
162111334|NCT00335452|585457017|FG003|Overall Study|Lost to Follow-up|2|||
162111335|NCT02736825|585457018|FG000|Overall Study|Lost to Follow-up|10|||
162111336|NCT02736825|585457019|FG001|Overall Study|Lost to Follow-up|11|||
162111337|NCT02736825|585457018|FG000|Overall Study|Early Termination|0|||
162111338|NCT02736825|585457019|FG001|Overall Study|Early Termination|1|||
162111339|NCT00790452|585457020|FG000|Overall Study|Drug supply issue|1|||
162111340|NCT00790452|585457021|FG001|Overall Study|Drug supply issue|0|||
162111341|NCT02901626|585457022|FG000|Overall Study|Lost to Follow-up|1|||
162111342|NCT02901626|585457023|FG001|Overall Study|Lost to Follow-up|1|||
162111343|NCT04082884|585457024|FG000|Overall Study|Withdrawal by Subject|1|||
162111344|NCT02421666|585457027|FG000|6-month Follow-up|Lost to Follow-up|8|||
162111345|NCT02421666|585457028|FG001|6-month Follow-up|Lost to Follow-up|7|||
162111346|NCT02421666|585457027|FG000|6-month Follow-up|Withdrawal by Subject|5|||
162111347|NCT02421666|585457028|FG001|6-month Follow-up|Withdrawal by Subject|6|||
162111348|NCT02421666|585457027|FG000|12-month Follow-up|Lost to Follow-up|5|||
162111349|NCT02421666|585457028|FG001|12-month Follow-up|Lost to Follow-up|5|||
162111350|NCT02421666|585457027|FG000|12-month Follow-up|Withdrawal by Subject|6|||
162111351|NCT02421666|585457028|FG001|12-month Follow-up|Withdrawal by Subject|11|||
162111352|NCT01078155|585457030|FG000|Overall Study|Adverse Event|7|||
162111353|NCT01078155|585457030|FG000|Overall Study|Lack of Efficacy|16|||
162111354|NCT01078155|585457030|FG000|Overall Study|Participant's Decision|6|||
162111355|NCT01078155|585457030|FG000|Overall Study|Lost to Follow-up|15|||
162111356|NCT01621880|585457031|FG000|Overall Study|Adverse Event|5|||
162111357|NCT01621880|585457032|FG001|Overall Study|Adverse Event|1|||
162111358|NCT01621880|585457031|FG000|Overall Study|Withdrawal by Subject|5|||
162111359|NCT01621880|585457032|FG001|Overall Study|Withdrawal by Subject|4|||
162111360|NCT03033225|585457043|FG000|Overall Study|Withdrawal by Subject|5|||
162111361|NCT02618967|585457044|FG000|Overall Study|Lost to Follow-up|0|||
162111362|NCT02618967|585457045|FG001|Overall Study|Lost to Follow-up|0|||
162111363|NCT02618967|585457046|FG002|Overall Study|Lost to Follow-up|1|||
162111364|NCT02618967|585457047|FG003|Overall Study|Lost to Follow-up|0|||
162111365|NCT02618967|585457048|FG004|Overall Study|Lost to Follow-up|2|||
162111366|NCT02618967|585457049|FG005|Overall Study|Lost to Follow-up|0|||
162111367|NCT02618967|585457050|FG006|Overall Study|Lost to Follow-up|0|||
162111368|NCT02618967|585457051|FG007|Overall Study|Lost to Follow-up|0|||
162111369|NCT02618967|585457044|FG000|Overall Study|Withdrawal by Subject|1|||
162111370|NCT02618967|585457045|FG001|Overall Study|Withdrawal by Subject|0|||
162111371|NCT02618967|585457046|FG002|Overall Study|Withdrawal by Subject|0|||
162111372|NCT02618967|585457047|FG003|Overall Study|Withdrawal by Subject|0|||
162111373|NCT02618967|585457048|FG004|Overall Study|Withdrawal by Subject|0|||
162111374|NCT02618967|585457049|FG005|Overall Study|Withdrawal by Subject|0|||
162111375|NCT02618967|585457050|FG006|Overall Study|Withdrawal by Subject|0|||
162111376|NCT02618967|585457051|FG007|Overall Study|Withdrawal by Subject|0|||
162111377|NCT05103384|585457054|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
162111378|NCT02612311|585457055|FG000|Overall Study|Adverse Event|16|||
162111379|NCT02612311|585457056|FG001|Overall Study|Adverse Event|12|||
162111380|NCT02612311|585457057|FG002|Overall Study|Adverse Event|7|||
162111381|NCT02612311|585457058|FG003|Overall Study|Adverse Event|13|||
162111382|NCT02612311|585457055|FG000|Overall Study|Death|29|||
162111383|NCT02612311|585457056|FG001|Overall Study|Death|10|||
162111384|NCT02612311|585457057|FG002|Overall Study|Death|11|||
162111385|NCT02612311|585457058|FG003|Overall Study|Death|11|||
162111386|NCT02612311|585457055|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
162111387|NCT02612311|585457056|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
162111388|NCT02612311|585457057|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
162111389|NCT02612311|585457058|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
162111390|NCT02612311|585457055|FG000|Overall Study|Investigator's Decision|11|||
162111391|NCT02612311|585457056|FG001|Overall Study|Investigator's Decision|15|||
162111392|NCT02612311|585457057|FG002|Overall Study|Investigator's Decision|6|||
162111393|NCT02612311|585457058|FG003|Overall Study|Investigator's Decision|6|||
162111394|NCT02612311|585457055|FG000|Overall Study|Lack of Efficacy|0|||
162111395|NCT02612311|585457056|FG001|Overall Study|Lack of Efficacy|0|||
162111396|NCT02612311|585457057|FG002|Overall Study|Lack of Efficacy|1|||
162111397|NCT02612311|585457058|FG003|Overall Study|Lack of Efficacy|1|||
162111398|NCT02612311|585457055|FG000|Overall Study|Lost to Follow-up|2|||
162111399|NCT02612311|585457056|FG001|Overall Study|Lost to Follow-up|2|||
162111400|NCT02612311|585457057|FG002|Overall Study|Lost to Follow-up|1|||
162111401|NCT02612311|585457058|FG003|Overall Study|Lost to Follow-up|2|||
162111402|NCT02612311|585457055|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
162111403|NCT02612311|585457056|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
162111404|NCT02612311|585457057|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
162111405|NCT02612311|585457058|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
162111406|NCT02612311|585457055|FG000|Overall Study|Site Terminated by Sponsor|29|||
162111407|NCT02612311|585457056|FG001|Overall Study|Site Terminated by Sponsor|12|||
162111408|NCT02612311|585457057|FG002|Overall Study|Site Terminated by Sponsor|13|||
162111409|NCT02612311|585457058|FG003|Overall Study|Site Terminated by Sponsor|5|||
162111410|NCT02612311|585457055|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
162111411|NCT02612311|585457056|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
162111412|NCT02612311|585457057|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
162111413|NCT02612311|585457058|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
162111414|NCT02612311|585457055|FG000|Overall Study|Reason Not Specified|3|||
162111415|NCT02612311|585457056|FG001|Overall Study|Reason Not Specified|7|||
162111416|NCT02612311|585457057|FG002|Overall Study|Reason Not Specified|4|||
162111417|NCT02612311|585457058|FG003|Overall Study|Reason Not Specified|5|||
162111418|NCT02612311|585457055|FG000|Overall Study|Unknown/Missing|10|||
162111419|NCT02612311|585457056|FG001|Overall Study|Unknown/Missing|13|||
162111420|NCT02612311|585457057|FG002|Overall Study|Unknown/Missing|4|||
162111421|NCT02612311|585457058|FG003|Overall Study|Unknown/Missing|0|||
162111422|NCT02612311|585457055|FG000|Overall Study|Non-Compliance with Study|1|||
162111423|NCT02612311|585457056|FG001|Overall Study|Non-Compliance with Study|0|||
162111424|NCT02612311|585457057|FG002|Overall Study|Non-Compliance with Study|0|||
162111425|NCT02612311|585457058|FG003|Overall Study|Non-Compliance with Study|0|||
162111426|NCT04751942|585457060|FG000|Overall Study|Lost to Follow-up|9|||
162111427|NCT04751942|585457061|FG001|Overall Study|Lost to Follow-up|6|||
162111428|NCT04510675|585457062|FG000|Overall Study|Withdrawal by Subject|5|||
162111429|NCT01499082|585457063|FG000|Overall Study|Randomized but not Treated|0|||
162111430|NCT01499082|585457064|FG001|Overall Study|Randomized but not Treated|1|||
162111431|NCT01499082|585457063|FG000|Overall Study|Adverse Event|12|||
162111432|NCT01499082|585457064|FG001|Overall Study|Adverse Event|16|||
162111433|NCT01499082|585457063|FG000|Overall Study|Lack of Efficacy|1|||
162111434|NCT01499082|585457064|FG001|Overall Study|Lack of Efficacy|1|||
162111435|NCT01499082|585457063|FG000|Overall Study|Protocol Violation|6|||
162111436|NCT01499082|585457064|FG001|Overall Study|Protocol Violation|8|||
162111437|NCT01499082|585457063|FG000|Overall Study|Diverse Reasons|18|||
162111438|NCT01499082|585457064|FG001|Overall Study|Diverse Reasons|14|||
162111439|NCT01499082|585457063|FG000|Overall Study|Site Closure for Noncompliance|5|||
162111440|NCT01499082|585457064|FG001|Overall Study|Site Closure for Noncompliance|2|||
162111441|NCT01499082|585457063|FG000|Overall Study|Hypoglycemia|2|||
162111442|NCT01499082|585457064|FG001|Overall Study|Hypoglycemia|3|||
162111443|NCT01499082|585457063|FG000|Overall Study|Lost to Follow-up|1|||
162111444|NCT01499082|585457064|FG001|Overall Study|Lost to Follow-up|3|||
162111445|NCT03355326|585457083|FG000|Overall Study|Protocol Violation|3|||
162111446|NCT03355326|585457084|FG001|Overall Study|Protocol Violation|3|||
162111447|NCT00608582|585457089|FG000|Overall Study|Lost to Follow-up|2|||
162111448|NCT00608582|585457090|FG001|Overall Study|Lost to Follow-up|0|||
162111449|NCT00608582|585457089|FG000|Overall Study|No Best Response in Phase 1 located|1|||
162111450|NCT00608582|585457090|FG001|Overall Study|No Best Response in Phase 1 located|1|||
162111451|NCT00608582|585457089|FG000|Overall Study|Illicit Drug Use|1|||
162111452|NCT00608582|585457090|FG001|Overall Study|Illicit Drug Use|0|||
162111453|NCT00608582|585457089|FG000|Overall Study|Early stage Design Change|0|||
162111454|NCT00608582|585457090|FG001|Overall Study|Early stage Design Change|3|||
162111455|NCT04922554|585457091|FG000|Overall Study|Adverse Event|4|||
162111456|NCT04922554|585457092|FG001|Overall Study|Adverse Event|0|||
162111457|NCT04922554|585457091|FG000|Overall Study|Withdrawal by Subject|1|||
162111458|NCT04922554|585457092|FG001|Overall Study|Withdrawal by Subject|0|||
162111459|NCT03092375|585458832|FG000|Overall Study|Lack of Efficacy|0|||
162111460|NCT03092375|585458833|FG001|Overall Study|Lack of Efficacy|1|||
162111461|NCT03092375|585458834|FG002|Overall Study|Lack of Efficacy|1|||
162111462|NCT03092375|585458835|FG003|Overall Study|Lack of Efficacy|0|||
162111463|NCT01679301|585458836|FG000|Screening Period|screen failure|3|||
162111464|NCT01679301|585458837|FG001|Screening Period|screen failure|0|||
162111465|NCT01679301|585458838|FG002|Screening Period|screen failure|0|||
162111466|NCT00861614|585458841|FG000|Overall Study|Disease Progression|182|||
162111467|NCT00861614|585458842|FG001|Overall Study|Disease Progression|263|||
162111468|NCT00861614|585458841|FG000|Overall Study|Study Drug Toxicity|79|||
162111469|NCT00861614|585458842|FG001|Overall Study|Study Drug Toxicity|6|||
162111470|NCT00861614|585458841|FG000|Overall Study|Death|32|||
162111471|NCT00861614|585458842|FG001|Overall Study|Death|19|||
162111472|NCT00861614|585458841|FG000|Overall Study|Adverse Event|27|||
162111473|NCT00861614|585458842|FG001|Overall Study|Adverse Event|23|||
162111474|NCT00861614|585458841|FG000|Overall Study|Withdrawal by Subject|34|||
162111475|NCT00861614|585458842|FG001|Overall Study|Withdrawal by Subject|35|||
162111476|NCT00861614|585458841|FG000|Overall Study|Other|17|||
162111477|NCT00861614|585458842|FG001|Overall Study|Other|22|||
162111478|NCT00944658|585458843|FG000|Treatment 12 Weeks|Adverse Event|0|||
162111479|NCT00944658|585458844|FG001|Treatment 12 Weeks|Adverse Event|2|||
162111480|NCT01255592|585458845|FG000|Overall Study|Adverse Event|5|||
162111481|NCT01255592|585458846|FG001|Overall Study|Adverse Event|0|||
162111482|NCT01255592|585458845|FG000|Overall Study|Withdrawal by Subject|1|||
162111483|NCT01255592|585458846|FG001|Overall Study|Withdrawal by Subject|0|||
162111484|NCT01255592|585458845|FG000|Overall Study|Other|0|||
162111485|NCT01255592|585458846|FG001|Overall Study|Other|1|||
162111486|NCT02259517|585458847|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
162111487|NCT02259517|585458848|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
162111488|NCT02259517|585458849|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
162111489|NCT02259517|585458847|FG000|Overall Study|Withdrawal by Subject|0|||
162111490|NCT02259517|585458848|FG001|Overall Study|Withdrawal by Subject|0|||
162111491|NCT02259517|585458849|FG002|Overall Study|Withdrawal by Subject|3|||
162111492|NCT01289418|585458853|FG000|Day 8 Survey|email address invalid|283|||
162111493|NCT01289418|585458853|FG000|Day 8 Survey|participants did not complete the survey|1935|||
162111494|NCT01289418|585458853|FG000|Day 29 Survey|email address invalid|283|||
162111495|NCT01289418|585458853|FG000|Day 29 Survey|participants did not complete the survey|2185|||
162111496|NCT01352585|585458855|FG000|Overall Study|Adverse Event|2|||
162111497|NCT01352585|585458856|FG001|Overall Study|Adverse Event|1|||
162111498|NCT01352585|585458855|FG000|Overall Study|Lost to Follow-up|1|||
162111499|NCT01352585|585458856|FG001|Overall Study|Lost to Follow-up|0|||
162111500|NCT01352585|585458855|FG000|Overall Study|Other|5|||
162111501|NCT01352585|585458856|FG001|Overall Study|Other|2|||
162111502|NCT00838682|585458859|FG000|Overall Study|Lost to Follow-up|21|||
162111503|NCT00838682|585458860|FG001|Overall Study|Lost to Follow-up|14|||
162111504|NCT00838682|585458859|FG000|Overall Study|detection of exclusion criteria|4|||
162111505|NCT00838682|585458860|FG001|Overall Study|detection of exclusion criteria|3|||
162111506|NCT00838682|585458859|FG000|Overall Study|Protocol Violation|0|||
162111507|NCT00838682|585458860|FG001|Overall Study|Protocol Violation|1|||
162111508|NCT00838682|585458859|FG000|Overall Study|Withdrawal by Subject|0|||
162111509|NCT00838682|585458860|FG001|Overall Study|Withdrawal by Subject|1|||
162111510|NCT02305381|585458861|FG000|Overall Study|Unclassified|5|||
162111511|NCT02305381|585458862|FG001|Overall Study|Unclassified|5|||
162111512|NCT02305381|585458863|FG002|Overall Study|Unclassified|7|||
162111513|NCT02276066|585458864|FG000|Overall Study|Lost to Follow-up|21|||
162111514|NCT02276066|585458865|FG001|Overall Study|Lost to Follow-up|11|||
162111515|NCT02882282|585458866|FG000|Overall Study|Adverse Event|1|||
162111516|NCT02882282|585458867|FG001|Overall Study|Adverse Event|0|||
162111517|NCT01807156|585458868|FG000|Overall Study|Physician Decision|1|||
162111518|NCT03928028|585458869|FG000|Overall Study|Physician Decision|9|||
162111519|NCT03928028|585458870|FG001|Overall Study|Physician Decision|6|||
162111520|NCT03928028|585458871|FG002|Overall Study|Physician Decision|3|||
162111521|NCT03928028|585458869|FG000|Overall Study|Withdrawal by Subject|12|||
162111522|NCT03928028|585458870|FG001|Overall Study|Withdrawal by Subject|3|||
162111523|NCT03928028|585458871|FG002|Overall Study|Withdrawal by Subject|3|||
162111524|NCT02710292|585458878|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
162111525|NCT02710292|585458879|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
162111526|NCT02710292|585458878|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
162111527|NCT02710292|585458879|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
162111528|NCT02323646|585458890|FG000|Treatment Course 1|Adverse Event|1|||
162111529|NCT02323646|585458891|FG001|Treatment Course 1|Adverse Event|0|||
162111530|NCT02323646|585458892|FG002|Treatment Course 1|Adverse Event|1|||
162111531|NCT02323646|585458890|FG000|Treatment Course 1|Heavy Bleeding|1|||
162111532|NCT02323646|585458891|FG001|Treatment Course 1|Heavy Bleeding|1|||
162111533|NCT02323646|585458892|FG002|Treatment Course 1|Heavy Bleeding|0|||
162111534|NCT02323646|585458890|FG000|Treatment Course 1|Lost to Follow-up|1|||
162111535|NCT02323646|585458891|FG001|Treatment Course 1|Lost to Follow-up|0|||
162111536|NCT02323646|585458892|FG002|Treatment Course 1|Lost to Follow-up|2|||
162111537|NCT02323646|585458890|FG000|Treatment Course 1|Withdrawal by Subject|0|||
162111538|NCT02323646|585458891|FG001|Treatment Course 1|Withdrawal by Subject|2|||
162111539|NCT02323646|585458892|FG002|Treatment Course 1|Withdrawal by Subject|0|||
162111540|NCT02323646|585458890|FG000|Treatment Course 2|Adverse Event|1|||
162111541|NCT02323646|585458891|FG001|Treatment Course 2|Adverse Event|0|||
162111542|NCT02323646|585458892|FG002|Treatment Course 2|Adverse Event|1|||
162111543|NCT02323646|585458890|FG000|Treatment Course 2|Lost to Follow-up|0|||
162111544|NCT02323646|585458891|FG001|Treatment Course 2|Lost to Follow-up|0|||
162111545|NCT02323646|585458892|FG002|Treatment Course 2|Lost to Follow-up|1|||
162111546|NCT02323646|585458890|FG000|Treatment Course 2|Non-compliance|0|||
162111547|NCT02323646|585458891|FG001|Treatment Course 2|Non-compliance|1|||
162111548|NCT02323646|585458892|FG002|Treatment Course 2|Non-compliance|1|||
162111549|NCT00089141|585458893|FG000|Overall Study|Termination of trial|18|||
162111550|NCT00089141|585458894|FG001|Overall Study|Termination of trial|24|||
162111551|NCT02459262|585458897|FG000|Overall Study|Withdrawal by Subject|0|||
162111552|NCT02459262|585458898|FG001|Overall Study|Withdrawal by Subject|0|||
162111553|NCT02459262|585458899|FG002|Overall Study|Withdrawal by Subject|0|||
162111554|NCT02459262|585458900|FG003|Overall Study|Withdrawal by Subject|0|||
162111555|NCT02459262|585458901|FG004|Overall Study|Withdrawal by Subject|0|||
162111556|NCT02459262|585458902|FG005|Overall Study|Withdrawal by Subject|0|||
162111557|NCT02459262|585458903|FG006|Overall Study|Withdrawal by Subject|0|||
162111558|NCT02459262|585458904|FG007|Overall Study|Withdrawal by Subject|0|||
162111559|NCT02459262|585458905|FG008|Overall Study|Withdrawal by Subject|0|||
162111560|NCT02459262|585458906|FG009|Overall Study|Withdrawal by Subject|1|||
162111561|NCT02459262|585458907|FG010|Overall Study|Withdrawal by Subject|0|||
162111562|NCT05168579|585458908|FG000|Overall Study|Lack of Consent|1|||
162111563|NCT05168579|585458909|FG001|Overall Study|Lack of Consent|0|||
162111564|NCT05168579|585458908|FG000|Overall Study|Conflicts with time|2|||
162111565|NCT05168579|585458909|FG001|Overall Study|Conflicts with time|0|||
162111566|NCT05168579|585458908|FG000|Overall Study|Time slots were full|3|||
162111567|NCT05168579|585458909|FG001|Overall Study|Time slots were full|0|||
162111568|NCT05168579|585458908|FG000|Overall Study|Lost to Follow-up|0|||
162111569|NCT05168579|585458909|FG001|Overall Study|Lost to Follow-up|15|||
162111570|NCT01242748|585458910|FG000|Overall Study|Adverse Event|10|||
162111571|NCT01242748|585458911|FG001|Overall Study|Adverse Event|5|||
162111572|NCT01242748|585458910|FG000|Overall Study|Lost to Follow-up|6|||
162111573|NCT01242748|585458911|FG001|Overall Study|Lost to Follow-up|2|||
162111574|NCT01242748|585458910|FG000|Overall Study|Physician Decision|3|||
162111575|NCT01242748|585458911|FG001|Overall Study|Physician Decision|2|||
162111576|NCT01242748|585458910|FG000|Overall Study|Protocol Violation|1|||
162111577|NCT01242748|585458911|FG001|Overall Study|Protocol Violation|0|||
162111578|NCT01242748|585458910|FG000|Overall Study|Withdrawal by Subject|10|||
162111579|NCT01242748|585458911|FG001|Overall Study|Withdrawal by Subject|2|||
162111580|NCT01242748|585458910|FG000|Overall Study|Miscellaneous reasons|8|||
162111581|NCT01242748|585458911|FG001|Overall Study|Miscellaneous reasons|3|||
162111582|NCT00387894|585458912|FG000|Overall Study|Withdrawal by Subject|1|||
162111583|NCT00659490|585458915|FG000|Overall Study|Lost to Follow-up|2|||
162111584|NCT00659490|585458916|FG001|Overall Study|Lost to Follow-up|0|||
162111585|NCT00659490|585458917|FG002|Overall Study|Lost to Follow-up|1|||
162111586|NCT00827541|585458918|FG000|Overall Study|Exitus|1|||
162111587|NCT00827541|585458919|FG001|Overall Study|Exitus|8|||
162111588|NCT00827541|585458918|FG000|Overall Study|Other|1|||
162111589|NCT00827541|585458919|FG001|Overall Study|Other|3|||
162111590|NCT00827541|585458918|FG000|Overall Study|Pathogen not susceptible|1|||
162111591|NCT00827541|585458919|FG001|Overall Study|Pathogen not susceptible|0|||
162111592|NCT00827541|585458918|FG000|Overall Study|Lack of effectiveness|1|||
162111593|NCT00827541|585458919|FG001|Overall Study|Lack of effectiveness|0|||
162111594|NCT01649232|585458920|FG000|Overall Study|Physician Decision|2|||
162111595|NCT01649232|585458921|FG001|Overall Study|Physician Decision|0|||
162111596|NCT01750879|585458922|FG000|Overall Study|Adverse Event|8|||
162111597|NCT01750879|585458923|FG001|Overall Study|Adverse Event|0|||
162111598|NCT01750879|585458922|FG000|Overall Study|Lack of Efficacy|1|||
162111599|NCT01750879|585458923|FG001|Overall Study|Lack of Efficacy|0|||
162111600|NCT01750879|585458922|FG000|Overall Study|Withdrawal by Subject|1|||
162111601|NCT01750879|585458923|FG001|Overall Study|Withdrawal by Subject|0|||
162111602|NCT01750879|585458922|FG000|Overall Study|Did not complete per protocol|0|||
162111603|NCT01750879|585458923|FG001|Overall Study|Did not complete per protocol|3|||
162111604|NCT02347657|585458924|FG000|Overall Study|Physician Decision|0|||
162111605|NCT02347657|585458925|FG001|Overall Study|Physician Decision|1|||
162111606|NCT02347657|585458924|FG000|Overall Study|Adverse Event|8|||
162111607|NCT02347657|585458925|FG001|Overall Study|Adverse Event|4|||
162111608|NCT02347657|585458924|FG000|Overall Study|Withdrawal by Subject|6|||
162111609|NCT02347657|585458925|FG001|Overall Study|Withdrawal by Subject|7|||
162111610|NCT02347657|585458924|FG000|Overall Study|Randomized but not treated|1|||
162111611|NCT02347657|585458925|FG001|Overall Study|Randomized but not treated|0|||
162111612|NCT02347657|585458924|FG000|Overall Study|Other|3|||
162111613|NCT02347657|585458925|FG001|Overall Study|Other|3|||
162111614|NCT00677352|585458928|FG000|Treatment Phase|Adverse Event|14|||
162111615|NCT00677352|585458929|FG001|Treatment Phase|Adverse Event|22|||
162111616|NCT00677352|585458928|FG000|Treatment Phase|Lack of Efficacy|2|||
162111617|NCT00677352|585458929|FG001|Treatment Phase|Lack of Efficacy|3|||
162111618|NCT00677352|585458928|FG000|Treatment Phase|Lost to Follow-up|0|||
162111619|NCT00677352|585458929|FG001|Treatment Phase|Lost to Follow-up|1|||
162111620|NCT00677352|585458928|FG000|Treatment Phase|Withdrawal by Subject|7|||
162111621|NCT00677352|585458929|FG001|Treatment Phase|Withdrawal by Subject|7|||
162111622|NCT00677352|585458928|FG000|Treatment Phase|Physician Decision|1|||
162111623|NCT00677352|585458929|FG001|Treatment Phase|Physician Decision|0|||
162111624|NCT00677352|585458928|FG000|Treatment Phase|Pregnancy|0|||
162111625|NCT00677352|585458929|FG001|Treatment Phase|Pregnancy|1|||
162111626|NCT00677352|585458928|FG000|Treatment Phase|Protocol Violation|1|||
162111627|NCT00677352|585458929|FG001|Treatment Phase|Protocol Violation|1|||
162111628|NCT00677352|585458928|FG000|Treatment Phase|Transference or work related matter|0|||
162111629|NCT00677352|585458929|FG001|Treatment Phase|Transference or work related matter|5|||
162111630|NCT00677352|585458928|FG000|Treatment Phase|Not treated|0|||
162111631|NCT00677352|585458929|FG001|Treatment Phase|Not treated|2|||
162111632|NCT00677352|585458928|FG000|Tapering Phase|Adverse Event|1|||
162111633|NCT00677352|585458929|FG001|Tapering Phase|Adverse Event|5|||
162111634|NCT00677352|585458928|FG000|Tapering Phase|Withdrawal by Subject|5|||
162111635|NCT00677352|585458929|FG001|Tapering Phase|Withdrawal by Subject|3|||
162111636|NCT00677352|585458928|FG000|Tapering Phase|Pregnancy|0|||
162111637|NCT00677352|585458929|FG001|Tapering Phase|Pregnancy|1|||
162111638|NCT00677352|585458928|FG000|Tapering Phase|Job transfer|0|||
162111639|NCT00677352|585458929|FG001|Tapering Phase|Job transfer|1|||
162111640|NCT02182973|585458930|FG000|Overall Study|Withdrawal by Subject|3|||
162111641|NCT02182973|585458931|FG001|Overall Study|Withdrawal by Subject|0|||
162111642|NCT05614089|585458935|FG000|Overall Study|Pregnancy|5|||
162111643|NCT05614089|585458936|FG001|Overall Study|Pregnancy|2|||
162111644|NCT05614089|585458935|FG000|Overall Study|Lost to Follow-up|5|||
162111645|NCT05614089|585458936|FG001|Overall Study|Lost to Follow-up|1|||
162111646|NCT05614089|585458935|FG000|Overall Study|Death|0|||
162111647|NCT05614089|585458936|FG001|Overall Study|Death|1|||
162111648|NCT05614089|585458935|FG000|Overall Study|Adverse Event|1|||
162111649|NCT05614089|585458936|FG001|Overall Study|Adverse Event|0|||
162111650|NCT03937219|585458942|FG000|Overall Study|Death|223|||
162111651|NCT03937219|585458943|FG001|Overall Study|Death|211|||
162111652|NCT03937219|585458942|FG000|Overall Study|Withdrawal by Subject|17|||
162111653|NCT03937219|585458943|FG001|Overall Study|Withdrawal by Subject|25|||
162111654|NCT03937219|585458942|FG000|Overall Study|Lost to Follow-up|3|||
162111655|NCT03937219|585458943|FG001|Overall Study|Lost to Follow-up|4|||
162111656|NCT04393441|585458944|FG000|Overall Study|Adverse Event|0|||
162111657|NCT04393441|585458945|FG001|Overall Study|Adverse Event|3|||
162111658|NCT04393441|585458944|FG000|Overall Study|Withdrawal by Subject|5|||
162111659|NCT04393441|585458945|FG001|Overall Study|Withdrawal by Subject|7|||
162111660|NCT04393441|585458944|FG000|Overall Study|Lost to Follow-up|0|||
162111661|NCT04393441|585458945|FG001|Overall Study|Lost to Follow-up|2|||
162111662|NCT04393441|585458944|FG000|Overall Study|Protocol Deviation|2|||
162111663|NCT04393441|585458945|FG001|Overall Study|Protocol Deviation|1|||
162111664|NCT04393441|585458944|FG000|Overall Study|Reason not Specified|1|||
162111665|NCT04393441|585458945|FG001|Overall Study|Reason not Specified|1|||
162111666|NCT02782169|585458946|FG000|Overall Study|Lost to Follow-up|1|||
162111667|NCT02782169|585458947|FG001|Overall Study|Lost to Follow-up|2|||
162111668|NCT04003610|585458948|FG000|Overall Study|Lost to Follow-up|0|||
162111669|NCT04003610|585458949|FG001|Overall Study|Lost to Follow-up|1|||
162111670|NCT04003610|585458950|FG002|Overall Study|Lost to Follow-up|0|||
162111671|NCT04003610|585458948|FG000|Overall Study|Death|0|||
162111672|NCT04003610|585458949|FG001|Overall Study|Death|0|||
162111673|NCT04003610|585458950|FG002|Overall Study|Death|3|||
162111674|NCT04003610|585458948|FG000|Overall Study|Study Terminated by Sponsor|0|||
162111675|NCT04003610|585458949|FG001|Overall Study|Study Terminated by Sponsor|0|||
162111676|NCT04003610|585458950|FG002|Overall Study|Study Terminated by Sponsor|3|||
162111677|NCT00771810|585458951|FG000|Overall Study|Adverse Event|3|||
162111678|NCT00771810|585458952|FG001|Overall Study|Adverse Event|0|||
162111679|NCT00771810|585458953|FG002|Overall Study|Adverse Event|2|||
162111680|NCT00771810|585458951|FG000|Overall Study|Lost to Follow-up|0|||
162111681|NCT00771810|585458952|FG001|Overall Study|Lost to Follow-up|0|||
162111682|NCT00771810|585458953|FG002|Overall Study|Lost to Follow-up|1|||
162111683|NCT00771810|585458951|FG000|Overall Study|Physician Decision|1|||
162111684|NCT00771810|585458952|FG001|Overall Study|Physician Decision|2|||
162111685|NCT00771810|585458953|FG002|Overall Study|Physician Decision|2|||
162111686|NCT00771810|585458951|FG000|Overall Study|Protocol Violation|0|||
162111687|NCT00771810|585458952|FG001|Overall Study|Protocol Violation|1|||
162111688|NCT00771810|585458953|FG002|Overall Study|Protocol Violation|1|||
162111689|NCT00771810|585458951|FG000|Overall Study|Withdrawal by Subject|1|||
162111690|NCT00771810|585458952|FG001|Overall Study|Withdrawal by Subject|2|||
162237478|NCT00600886|585921097|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
162111691|NCT00771810|585458953|FG002|Overall Study|Withdrawal by Subject|0|||
162111692|NCT00771810|585458951|FG000|Overall Study|Other|0|||
162111693|NCT00771810|585458952|FG001|Overall Study|Other|0|||
162111694|NCT00771810|585458953|FG002|Overall Study|Other|1|||
162111695|NCT02660827|585458958|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
162111696|NCT02660827|585458958|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
162111697|NCT02660827|585458958|FG000|From Study to End of Continued Access|Adverse Event|3|||
162111698|NCT02660827|585458958|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
162111699|NCT02660827|585458958|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
162111700|NCT02660827|585458958|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
162111701|NCT02660827|585458958|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
162111702|NCT02660827|585458958|FG000|Period 2: Continued Access Period|Adverse Event|3|||
162111703|NCT02953938|585458959|FG000|Overall Study|Adverse Event|0|||
162111704|NCT02953938|585458960|FG001|Overall Study|Adverse Event|1|||
162111705|NCT02953938|585458959|FG000|Overall Study|Withdrawal by Subject|1|||
162111706|NCT02953938|585458960|FG001|Overall Study|Withdrawal by Subject|1|||
162111707|NCT02657031|585458967|FG000|Overall Study|Adverse Event|1|||
162111708|NCT02657031|585458968|FG001|Overall Study|Adverse Event|2|||
162111709|NCT04198805|585458969|FG000|Overall Study|Death|0|||
162111710|NCT04198805|585458970|FG001|Overall Study|Death|0|||
162111711|NCT04198805|585458971|FG002|Overall Study|Death|0|||
162111712|NCT04198805|585458972|FG003|Overall Study|Death|1|||
162111713|NCT04198805|585458969|FG000|Overall Study|Early Termination|8|||
162111714|NCT04198805|585458970|FG001|Overall Study|Early Termination|4|||
162111715|NCT04198805|585458971|FG002|Overall Study|Early Termination|6|||
162111716|NCT04198805|585458972|FG003|Overall Study|Early Termination|9|||
162111717|NCT03078816|585458973|FG000|Overall Study|Withdrawal by Subject|1|||
162111718|NCT02114151|585458974|FG000|Overall Study|Death|1|||
162111719|NCT02114151|585458974|FG000|Overall Study|Lost to Follow-up|1|||
162111720|NCT02114151|585458974|FG000|Overall Study|Withdrawal by Subject|5|||
162111721|NCT03599349|585458975|FG000|Overall Study|Lost to Follow-up|1|||
162111722|NCT00810264|585458978|FG000|Overall Study|Lost to Follow-up|191|||
162111723|NCT00810264|585458978|FG000|Overall Study|Withdrawal by subject or physician|721|||
162111724|NCT00810264|585458978|FG000|Overall Study|Death|641|||
162111725|NCT00500903|585458979|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
162111726|NCT00500903|585458980|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
162111727|NCT00500903|585458981|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
162111728|NCT00500903|585458979|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
162111729|NCT00500903|585458980|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
162111730|NCT00500903|585458981|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
162111731|NCT00500903|585458979|FG000|Overall Study|Progressive Disease|41|||
162111732|NCT00500903|585458980|FG001|Overall Study|Progressive Disease|2|||
162111733|NCT00500903|585458981|FG002|Overall Study|Progressive Disease|15|||
162111734|NCT00500903|585458979|FG000|Overall Study|Patient Declined Further Treatment|0|||
162111735|NCT00500903|585458980|FG001|Overall Study|Patient Declined Further Treatment|0|||
162111736|NCT00500903|585458981|FG002|Overall Study|Patient Declined Further Treatment|3|||
162111737|NCT00500903|585458979|FG000|Overall Study|Symptomatic Deterioration|2|||
162111738|NCT00500903|585458980|FG001|Overall Study|Symptomatic Deterioration|0|||
162111739|NCT00500903|585458981|FG002|Overall Study|Symptomatic Deterioration|0|||
162111740|NCT00500903|585458979|FG000|Overall Study|Reason Not Specified|10|||
162111741|NCT00500903|585458980|FG001|Overall Study|Reason Not Specified|0|||
162111742|NCT00500903|585458981|FG002|Overall Study|Reason Not Specified|2|||
162111743|NCT01648348|585458984|FG000|Overall Study|Cancel|1|||
162111744|NCT01648348|585458985|FG001|Overall Study|Cancel|0|||
162111745|NCT01648348|585458986|FG002|Overall Study|Cancel|0|||
162111746|NCT01648348|585458987|FG003|Overall Study|Cancel|0|||
162111747|NCT01648348|585458988|FG004|Overall Study|Cancel|3|||
162111748|NCT01648348|585458989|FG005|Overall Study|Cancel|6|||
162111749|NCT01648348|585458984|FG000|Overall Study|Replaced for MTD analysis|1|||
162111750|NCT01648348|585458985|FG001|Overall Study|Replaced for MTD analysis|0|||
162111751|NCT01648348|585458986|FG002|Overall Study|Replaced for MTD analysis|1|||
162111752|NCT01648348|585458987|FG003|Overall Study|Replaced for MTD analysis|0|||
162111753|NCT01648348|585458988|FG004|Overall Study|Replaced for MTD analysis|0|||
162111754|NCT01648348|585458989|FG005|Overall Study|Replaced for MTD analysis|0|||
162111755|NCT00696410|585458990|FG000|Overall Study|Lost to Follow-up|2|||
162111756|NCT00696410|585458991|FG001|Overall Study|Lost to Follow-up|0|||
162111757|NCT00696410|585458990|FG000|Overall Study|Withdrawal by Subject|8|||
162111758|NCT00696410|585458991|FG001|Overall Study|Withdrawal by Subject|0|||
162111759|NCT00696410|585458990|FG000|Overall Study|Physician Decision|3|||
162111760|NCT00696410|585458991|FG001|Overall Study|Physician Decision|0|||
162111761|NCT00265889|585458995|FG000|Overall Study|Physician Decision|1|||
162111762|NCT00265889|585458995|FG000|Overall Study|Protocol Violation|1|||
162111763|NCT00265889|585458995|FG000|Overall Study|Insurance denied the request|3|||
162111764|NCT02134587|585458996|FG000|Overall Study|Did not completed all meetings|30|||
162111765|NCT00453986|585458997|FG000|Overall Study|Lost to Follow-up|6|||
162111766|NCT00453986|585458998|FG001|Overall Study|Lost to Follow-up|5|||
162111767|NCT00453986|585458999|FG002|Overall Study|Lost to Follow-up|6|||
162111768|NCT00453986|585459000|FG003|Overall Study|Lost to Follow-up|2|||
162111769|NCT00453986|585459001|FG004|Overall Study|Lost to Follow-up|0|||
162111770|NCT03419364|585459008|FG000|Overall Study|Delivery due to maternal condition|2|||
162111771|NCT03419364|585459009|FG001|Overall Study|Delivery due to maternal condition|0|||
162111772|NCT03419364|585459010|FG002|Overall Study|Delivery due to maternal condition|0|||
162111773|NCT03308825|585460741|FG000|Overall Study|Lost to Follow-up|2|||
162111774|NCT03308825|585460742|FG001|Overall Study|Lost to Follow-up|2|||
162111775|NCT03308825|585460743|FG002|Overall Study|Lost to Follow-up|1|||
162111776|NCT03308825|585460744|FG003|Overall Study|Lost to Follow-up|0|||
162111777|NCT03308825|585460741|FG000|Overall Study|Protocol Violation|0|||
162111778|NCT03308825|585460742|FG001|Overall Study|Protocol Violation|2|||
162111779|NCT03308825|585460743|FG002|Overall Study|Protocol Violation|0|||
162111780|NCT03308825|585460744|FG003|Overall Study|Protocol Violation|0|||
162111781|NCT03559218|585460745|FG000|Overall Study|Withdrawal by Subject|1|||
162111782|NCT03559218|585460746|FG001|Overall Study|Withdrawal by Subject|0|||
162111783|NCT04737109|585460756|FG000|Study Treatment|Disease Progression|5|||
162111784|NCT04737109|585460757|FG001|Study Treatment|Disease Progression|0|||
162111785|NCT04737109|585460758|FG002|Study Treatment|Disease Progression|0|||
162111786|NCT04737109|585460759|FG003|Study Treatment|Disease Progression|0|||
162111787|NCT04737109|585460756|FG000|Study Treatment|Death on study|1|||
162111788|NCT04737109|585460757|FG001|Study Treatment|Death on study|0|||
162111789|NCT04737109|585460758|FG002|Study Treatment|Death on study|0|||
162111790|NCT04737109|585460759|FG003|Study Treatment|Death on study|0|||
162111791|NCT03328143|585460760|FG000|Overall Study|Declined|3|||
162111792|NCT03328143|585460760|FG000|Overall Study|Required increased sedation|4|||
162111793|NCT03328143|585460760|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
162111794|NCT03328143|585460760|FG000|Overall Study|Surgery cancelled|1|||
162111795|NCT01370525|585460761|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
162111796|NCT01370525|585460762|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
162111797|NCT01370525|585460761|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
162111798|NCT01370525|585460762|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
162111799|NCT01370525|585460761|FG000|Overall Study|Adverse Event|0|||
162111800|NCT01370525|585460762|FG001|Overall Study|Adverse Event|1|||
162111801|NCT01370525|585460761|FG000|Overall Study|Protocol Violation|2|||
162111802|NCT01370525|585460762|FG001|Overall Study|Protocol Violation|1|||
162111803|NCT01370525|585460761|FG000|Overall Study|Lost to follow up|2|||
162111804|NCT01370525|585460762|FG001|Overall Study|Lost to follow up|6|||
162111805|NCT03642938|585460764|FG000|Overall Study|Withdrawal by Subject|0|||
162111806|NCT03642938|585460765|FG001|Overall Study|Withdrawal by Subject|0|||
162111807|NCT03642938|585460766|FG002|Overall Study|Withdrawal by Subject|0|||
162111808|NCT03642938|585460767|FG003|Overall Study|Withdrawal by Subject|1|||
162111809|NCT01424930|585460768|FG000|Overall Study|Adverse Event|0|||
162111810|NCT01424930|585460769|FG001|Overall Study|Adverse Event|1|||
162111811|NCT01424930|585460768|FG000|Overall Study|Death|1|||
162111812|NCT01424930|585460769|FG001|Overall Study|Death|0|||
162111813|NCT01424930|585460768|FG000|Overall Study|Progressive Disease|3|||
162111814|NCT01424930|585460769|FG001|Overall Study|Progressive Disease|6|||
162111815|NCT01424930|585460768|FG000|Overall Study|Screen Failure|0|||
162111816|NCT01424930|585460769|FG001|Overall Study|Screen Failure|1|||
162111817|NCT01424930|585460768|FG000|Overall Study|Reason not specified|0|||
162111818|NCT01424930|585460769|FG001|Overall Study|Reason not specified|6|||
162111819|NCT03286751|585460774|FG000|Washout Period 1|Withdrawal by Subject|0|||
162111820|NCT03286751|585460775|FG001|Washout Period 1|Withdrawal by Subject|0|||
162111821|NCT03286751|585460776|FG002|Washout Period 1|Withdrawal by Subject|0|||
162111822|NCT03286751|585460777|FG003|Washout Period 1|Withdrawal by Subject|0|||
162111823|NCT03286751|585460778|FG004|Washout Period 1|Withdrawal by Subject|1|||
162111824|NCT03286751|585460779|FG005|Washout Period 1|Withdrawal by Subject|0|||
162111825|NCT03286751|585460774|FG000|Washout Period 2|Personal Reasons|0|||
162111826|NCT03286751|585460775|FG001|Washout Period 2|Personal Reasons|1|||
162111827|NCT03286751|585460776|FG002|Washout Period 2|Personal Reasons|0|||
162111828|NCT03286751|585460777|FG003|Washout Period 2|Personal Reasons|0|||
162111829|NCT03286751|585460778|FG004|Washout Period 2|Personal Reasons|0|||
162111830|NCT03286751|585460779|FG005|Washout Period 2|Personal Reasons|0|||
162111831|NCT03286751|585460774|FG000|Washout Period 5|Adverse Event|0|||
162111832|NCT03286751|585460775|FG001|Washout Period 5|Adverse Event|0|||
162111833|NCT03286751|585460776|FG002|Washout Period 5|Adverse Event|0|||
162111834|NCT03286751|585460777|FG003|Washout Period 5|Adverse Event|0|||
162111835|NCT03286751|585460778|FG004|Washout Period 5|Adverse Event|1|||
162111836|NCT03286751|585460779|FG005|Washout Period 5|Adverse Event|0|||
162111837|NCT01119768|585460780|FG000|Treatment Period|Lack of Efficacy|18|||
162111838|NCT01119768|585460781|FG001|Treatment Period|Lack of Efficacy|25|||
162111839|NCT01301391|585460782|FG000|Overall Study|Death|13|||
162111840|NCT01301391|585460782|FG000|Overall Study|Lost to Follow-up|3|||
162111841|NCT01301391|585460782|FG000|Overall Study|Physician Decision|2|||
162111842|NCT01301391|585460782|FG000|Overall Study|Sponsor's decision|8|||
162111843|NCT01059643|585460783|FG000|Overall Study|Adverse Event|3|||
162111844|NCT01059643|585460783|FG000|Overall Study|Withdrawal by Subject|2|||
162111845|NCT01059643|585460783|FG000|Overall Study|Physician Decision|1|||
162111846|NCT00106184|585460784|FG000|Overall Study|Withdrawal by Subject|3|||
162111847|NCT00106184|585460785|FG001|Overall Study|Withdrawal by Subject|2|||
162111848|NCT05292534|585460791|FG000|Overall Study|Protocol Violation|3|||
162111849|NCT05292534|585460792|FG001|Overall Study|Protocol Violation|4|||
162111850|NCT05292534|585460791|FG000|Overall Study|Withdrawal by Subject|0|||
162111851|NCT05292534|585460792|FG001|Overall Study|Withdrawal by Subject|1|||
162111852|NCT00238433|585460798|FG000|Overall Study|Screen failure|1|||
162111853|NCT00238433|585460798|FG000|Overall Study|Lost to Follow-up|1|||
162111854|NCT00238433|585460798|FG000|Overall Study|Death|1|||
162111855|NCT01814748|585460799|FG000|Overall Study|Lost to Follow-up|1|||
162111856|NCT01814748|585460800|FG001|Overall Study|Lost to Follow-up|2|||
162111857|NCT01814748|585460799|FG000|Overall Study|Study site terminated by sponsor|1|||
162111858|NCT01814748|585460800|FG001|Overall Study|Study site terminated by sponsor|1|||
162111859|NCT01814748|585460799|FG000|Overall Study|Withdrawal by Subject|6|||
162111860|NCT01814748|585460800|FG001|Overall Study|Withdrawal by Subject|4|||
162111861|NCT00409682|585460806|FG000|Open-label Induction Period|Adverse Event|1|||
162111862|NCT00409682|585460807|FG001|Open-label Induction Period|Adverse Event|0|||
162111863|NCT00409682|585460808|FG002|Open-label Induction Period|Adverse Event|0|||
162111864|NCT00409682|585460806|FG000|Open-label Induction Period|Lack of Efficacy|1|||
162111865|NCT00409682|585460807|FG001|Open-label Induction Period|Lack of Efficacy|0|||
162111866|NCT00409682|585460808|FG002|Open-label Induction Period|Lack of Efficacy|0|||
162111867|NCT00409682|585460806|FG000|Open-label Induction Period|Protocol Violation|1|||
162111868|NCT00409682|585460807|FG001|Open-label Induction Period|Protocol Violation|0|||
162111869|NCT00409682|585460808|FG002|Open-label Induction Period|Protocol Violation|0|||
162111870|NCT00409682|585460806|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
162111871|NCT00409682|585460807|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
162111872|NCT00409682|585460808|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
162111873|NCT00409682|585460806|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
162111874|NCT00409682|585460807|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
162111875|NCT00409682|585460808|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
162111876|NCT00409682|585460806|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
162111877|NCT00409682|585460807|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
162111878|NCT00409682|585460808|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
162111879|NCT00409682|585460806|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
162111880|NCT00409682|585460807|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
162111881|NCT00409682|585460808|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
162111882|NCT00409682|585460806|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
162111883|NCT00409682|585460807|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
162111884|NCT00409682|585460808|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
162111885|NCT00409682|585460806|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
162111886|NCT00409682|585460807|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
162111887|NCT00409682|585460808|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
162111888|NCT00409682|585460806|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
162111889|NCT00409682|585460807|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
162111890|NCT00409682|585460808|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
162111891|NCT01896869|585460810|FG000|Overall Study|Withdrawal by Subject|0|||
162111892|NCT01896869|585460811|FG001|Overall Study|Withdrawal by Subject|6|||
162111893|NCT01896869|585460810|FG000|Overall Study|Lost to Follow-up|1|||
162111894|NCT01896869|585460811|FG001|Overall Study|Lost to Follow-up|0|||
162111895|NCT04710927|585460817|FG000|Overall Study|Lost to Follow-up|7|||
162111896|NCT04710927|585460818|FG001|Overall Study|Lost to Follow-up|6|||
162111897|NCT04710927|585460819|FG002|Overall Study|Lost to Follow-up|5|||
162111898|NCT00454571|585460823|FG000|Overall Study|Adverse Event|2|||
162111899|NCT00454571|585460824|FG001|Overall Study|Adverse Event|0|||
162111900|NCT00454571|585460823|FG000|Overall Study|Physician Decision|0|||
162111901|NCT00454571|585460824|FG001|Overall Study|Physician Decision|1|||
162111902|NCT00454571|585460823|FG000|Overall Study|Protocol Violation|1|||
162111903|NCT00454571|585460824|FG001|Overall Study|Protocol Violation|0|||
162111904|NCT00454571|585460823|FG000|Overall Study|Withdrawal by Subject|10|||
162111905|NCT00454571|585460824|FG001|Overall Study|Withdrawal by Subject|5|||
162111906|NCT01376323|585460825|FG000|Overall Study|Adverse Event|1|||
162111907|NCT01376323|585460826|FG001|Overall Study|Adverse Event|0|||
162111908|NCT01376323|585460827|FG002|Overall Study|Adverse Event|0|||
162111909|NCT01376323|585460828|FG003|Overall Study|Adverse Event|2|||
162111910|NCT01376323|585460829|FG004|Overall Study|Adverse Event|0|||
162111911|NCT01376323|585460825|FG000|Overall Study|Lost to Follow-up|0|||
162111912|NCT01376323|585460826|FG001|Overall Study|Lost to Follow-up|0|||
162111913|NCT01376323|585460827|FG002|Overall Study|Lost to Follow-up|0|||
162111914|NCT01376323|585460828|FG003|Overall Study|Lost to Follow-up|2|||
162111915|NCT01376323|585460829|FG004|Overall Study|Lost to Follow-up|0|||
162111916|NCT01376323|585460825|FG000|Overall Study|Physician Decision|1|||
162111917|NCT01376323|585460826|FG001|Overall Study|Physician Decision|0|||
162111918|NCT01376323|585460827|FG002|Overall Study|Physician Decision|2|||
162111919|NCT01376323|585460828|FG003|Overall Study|Physician Decision|1|||
162111920|NCT01376323|585460829|FG004|Overall Study|Physician Decision|1|||
162111921|NCT01376323|585460825|FG000|Overall Study|Withdrawal by Subject|0|||
162111922|NCT01376323|585460826|FG001|Overall Study|Withdrawal by Subject|1|||
162111923|NCT01376323|585460827|FG002|Overall Study|Withdrawal by Subject|1|||
162111924|NCT01376323|585460828|FG003|Overall Study|Withdrawal by Subject|0|||
162111925|NCT01376323|585460829|FG004|Overall Study|Withdrawal by Subject|0|||
162111926|NCT02436811|585460830|FG000|Overall Study|Lost to Follow-up|2|||
162111927|NCT02436811|585460831|FG001|Overall Study|Lost to Follow-up|9|||
162111928|NCT02436811|585460832|FG002|Overall Study|Lost to Follow-up|7|||
162111929|NCT03595332|585460833|FG000|Overall Study|Lost to Follow-up|16|||
162111930|NCT03595332|585460834|FG001|Overall Study|Lost to Follow-up|22|||
162111931|NCT03595332|585460833|FG000|Overall Study|Unable to retrieve ID from school|0|||
162111932|NCT03595332|585460834|FG001|Overall Study|Unable to retrieve ID from school|2|||
162111933|NCT00792103|585460835|FG000|Overall Study|Enrolled, not treated|15|||
162111934|NCT00792103|585460835|FG000|Overall Study|Lost to Follow-up|17|||
162111935|NCT00792103|585460835|FG000|Overall Study|Adverse Event|25|||
162111936|NCT00792103|585460835|FG000|Overall Study|Withdrawal by Subject|52|||
162111937|NCT00792103|585460835|FG000|Overall Study|Protocol Violation|10|||
162111938|NCT00792103|585460835|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
162111939|NCT02227875|585460836|FG000|Overall Study|Protocol Violation|10|||
162111940|NCT02227875|585460837|FG001|Overall Study|Protocol Violation|7|||
162111941|NCT02227875|585460836|FG000|Overall Study|Other|1|||
162111942|NCT02227875|585460837|FG001|Overall Study|Other|3|||
162111943|NCT02227875|585460836|FG000|Overall Study|Physician Decision|1|||
162111944|NCT02227875|585460837|FG001|Overall Study|Physician Decision|0|||
162111945|NCT02227875|585460836|FG000|Overall Study|Adverse Event|3|||
162111946|NCT02227875|585460837|FG001|Overall Study|Adverse Event|0|||
162111947|NCT02227875|585460836|FG000|Overall Study|Withdrawal by Subject|12|||
162111948|NCT02227875|585460837|FG001|Overall Study|Withdrawal by Subject|13|||
162111949|NCT02227875|585460836|FG000|Overall Study|Lost to Follow-up|10|||
162111950|NCT02227875|585460837|FG001|Overall Study|Lost to Follow-up|10|||
162111951|NCT01201811|585460838|FG000|Overall Study|Adverse Event|6|||
162111952|NCT01201811|585460838|FG000|Overall Study|Disease progression|3|||
162111953|NCT01201811|585460838|FG000|Overall Study|Withdrawal by Subject|3|||
162111954|NCT01201811|585460838|FG000|Overall Study|Death|4|||
162111955|NCT01201811|585460838|FG000|Overall Study|Treatment Failure|2|||
162111956|NCT01201811|585460838|FG000|Overall Study|Physician Decision|1|||
162111957|NCT02856113|585460839|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
162111958|NCT02856113|585460840|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
162111959|NCT02856113|585460839|FG000|Overall Study|Significant Protocol Deviation|1|||
162111960|NCT02856113|585460840|FG001|Overall Study|Significant Protocol Deviation|0|||
162111961|NCT02856113|585460839|FG000|Overall Study|Lost to Follow-up|3|||
162111962|NCT02856113|585460840|FG001|Overall Study|Lost to Follow-up|5|||
162111963|NCT02856113|585460839|FG000|Overall Study|Voluntary Withdrawal|3|||
162111964|NCT02856113|585460840|FG001|Overall Study|Voluntary Withdrawal|5|||
162111965|NCT02856113|585460839|FG000|Overall Study|Pregnancy|0|||
162111966|NCT02856113|585460840|FG001|Overall Study|Pregnancy|1|||
162111967|NCT02856113|585460839|FG000|Overall Study|Principal Investigator Discretion|2|||
162111968|NCT02856113|585460840|FG001|Overall Study|Principal Investigator Discretion|1|||
162111969|NCT02856113|585460839|FG000|Overall Study|Randomized but not Treated|1|||
162111970|NCT02856113|585460840|FG001|Overall Study|Randomized but not Treated|0|||
162111971|NCT02856113|585460839|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
162111972|NCT02856113|585460840|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
162111973|NCT03494166|585460841|FG000|Overall Study|Death|0|||
162111974|NCT03494166|585460842|FG001|Overall Study|Death|0|||
162111975|NCT03494166|585460843|FG002|Overall Study|Death|0|||
162111976|NCT03494166|585460844|FG003|Overall Study|Death|1|||
162111977|NCT03494166|585460845|FG004|Overall Study|Death|3|||
162111978|NCT03494166|585460846|FG005|Overall Study|Death|0|||
162111979|NCT03494166|585460841|FG000|Overall Study|Lost to Follow-up|2|||
162111980|NCT03494166|585460842|FG001|Overall Study|Lost to Follow-up|2|||
162111981|NCT03494166|585460843|FG002|Overall Study|Lost to Follow-up|2|||
162111982|NCT03494166|585460844|FG003|Overall Study|Lost to Follow-up|2|||
162111983|NCT03494166|585460845|FG004|Overall Study|Lost to Follow-up|14|||
162111984|NCT03494166|585460846|FG005|Overall Study|Lost to Follow-up|0|||
162111985|NCT03494166|585460841|FG000|Overall Study|Withdrawal by Subject|10|||
162111986|NCT03494166|585460842|FG001|Overall Study|Withdrawal by Subject|7|||
162111987|NCT03494166|585460843|FG002|Overall Study|Withdrawal by Subject|0|||
162111988|NCT03494166|585460844|FG003|Overall Study|Withdrawal by Subject|5|||
162111989|NCT03494166|585460845|FG004|Overall Study|Withdrawal by Subject|3|||
162111990|NCT03494166|585460846|FG005|Overall Study|Withdrawal by Subject|17|||
162111991|NCT03494166|585460841|FG000|Overall Study|Screen failure|1|||
162111992|NCT03494166|585460842|FG001|Overall Study|Screen failure|0|||
162111993|NCT03494166|585460843|FG002|Overall Study|Screen failure|0|||
162111994|NCT03494166|585460844|FG003|Overall Study|Screen failure|0|||
162111995|NCT03494166|585460845|FG004|Overall Study|Screen failure|1|||
162111996|NCT03494166|585460846|FG005|Overall Study|Screen failure|0|||
162111997|NCT02857426|585460847|FG000|Overall Study|Disease progression|34|||
162111998|NCT02857426|585460848|FG001|Overall Study|Disease progression|13|||
162111999|NCT02857426|585460847|FG000|Overall Study|Study drug toxicity|4|||
162112000|NCT02857426|585460848|FG001|Overall Study|Study drug toxicity|1|||
162112001|NCT02857426|585460847|FG000|Overall Study|Death|1|||
162112002|NCT02857426|585460848|FG001|Overall Study|Death|0|||
162112003|NCT02857426|585460847|FG000|Overall Study|Adverse event unrelated to study drug|6|||
162112004|NCT02857426|585460848|FG001|Overall Study|Adverse event unrelated to study drug|2|||
162112005|NCT02857426|585460847|FG000|Overall Study|Participant withdrew consent|1|||
162112006|NCT02857426|585460848|FG001|Overall Study|Participant withdrew consent|1|||
162112007|NCT02857426|585460847|FG000|Overall Study|Maximum clinical benefit|1|||
162112008|NCT02857426|585460848|FG001|Overall Study|Maximum clinical benefit|0|||
162112009|NCT02857426|585460847|FG000|Overall Study|Completed treatment|0|||
162112010|NCT02857426|585460848|FG001|Overall Study|Completed treatment|2|||
162112011|NCT01960725|585460849|FG000|Overall Study|Lost to Follow-up|4|||
162112012|NCT01960725|585460850|FG001|Overall Study|Lost to Follow-up|3|||
162112013|NCT01960725|585460849|FG000|Overall Study|Withdrawal by Subject|1|||
162112014|NCT01960725|585460850|FG001|Overall Study|Withdrawal by Subject|0|||
162112015|NCT01960725|585460849|FG000|Overall Study|unable to obtain blood sample|1|||
162112016|NCT01960725|585460850|FG001|Overall Study|unable to obtain blood sample|2|||
162112017|NCT02831257|585460855|FG000|Overall Study|Lack of Efficacy|3|||
162112018|NCT02831257|585460855|FG000|Overall Study|Adverse Event|2|||
162112019|NCT02831257|585460855|FG000|Overall Study|Physician Decision|1|||
162112020|NCT02831257|585460855|FG000|Overall Study|Withdrawal by Subject|6|||
162112021|NCT00611858|585460856|FG000|Overall Study|Adverse Event|2|||
162112022|NCT00611858|585460856|FG000|Overall Study|Withdrawal by Subject|2|||
162112023|NCT01844284|585460857|FG000|Overall Study|Lost to Follow-up|12|||
162112024|NCT01844284|585460858|FG001|Overall Study|Lost to Follow-up|7|||
162112025|NCT01058304|585460860|FG000|Overall Study|Withdrawal by Subject|8|||
162112026|NCT01058304|585460861|FG001|Overall Study|Withdrawal by Subject|5|||
162112027|NCT01058304|585460860|FG000|Overall Study|Lost to Follow-up|13|||
162112028|NCT01058304|585460861|FG001|Overall Study|Lost to Follow-up|16|||
162112029|NCT01058304|585460860|FG000|Overall Study|Developed exclusion criterion|6|||
162112030|NCT01058304|585460861|FG001|Overall Study|Developed exclusion criterion|12|||
162112031|NCT01820559|585460862|FG000|Overall Study|Adverse Event|4|||
162112032|NCT01820559|585460863|FG001|Overall Study|Adverse Event|6|||
162112033|NCT01820559|585460864|FG002|Overall Study|Adverse Event|13|||
162112034|NCT01820559|585460862|FG000|Overall Study|Withdrawal by Subject|1|||
162112035|NCT01820559|585460863|FG001|Overall Study|Withdrawal by Subject|2|||
162112036|NCT01820559|585460864|FG002|Overall Study|Withdrawal by Subject|5|||
162112037|NCT01820559|585460862|FG000|Overall Study|Protocol Violation|2|||
162112038|NCT01820559|585460863|FG001|Overall Study|Protocol Violation|1|||
162112039|NCT01820559|585460864|FG002|Overall Study|Protocol Violation|3|||
162112040|NCT01820559|585460862|FG000|Overall Study|Subject's non-compliance|1|||
162112041|NCT01820559|585460863|FG001|Overall Study|Subject's non-compliance|0|||
162112042|NCT01820559|585460864|FG002|Overall Study|Subject's non-compliance|2|||
162112043|NCT01820559|585460862|FG000|Overall Study|Lost to Follow-up|3|||
162112044|NCT01820559|585460863|FG001|Overall Study|Lost to Follow-up|2|||
162112045|NCT01820559|585460864|FG002|Overall Study|Lost to Follow-up|2|||
162112046|NCT01820559|585460862|FG000|Overall Study|At sponsor request|0|||
162112047|NCT01820559|585460863|FG001|Overall Study|At sponsor request|0|||
162112048|NCT01820559|585460864|FG002|Overall Study|At sponsor request|1|||
162112049|NCT01820559|585460862|FG000|Overall Study|Lack of Efficacy|3|||
162112050|NCT01820559|585460863|FG001|Overall Study|Lack of Efficacy|2|||
162112051|NCT01820559|585460864|FG002|Overall Study|Lack of Efficacy|3|||
162112052|NCT02496767|585460866|FG000|Open-label Lead-in Phase|Adverse Event|176|||
162112053|NCT02496767|585460867|FG001|Open-label Lead-in Phase|Adverse Event|0|||
162112054|NCT02496767|585460868|FG002|Open-label Lead-in Phase|Adverse Event|0|||
162112055|NCT02496767|585460869|FG003|Open-label Lead-in Phase|Adverse Event|0|||
162112056|NCT02496767|585460870|FG004|Open-label Lead-in Phase|Adverse Event|0|||
162112057|NCT02496767|585460871|FG005|Open-label Lead-in Phase|Adverse Event|0|||
162112058|NCT02496767|585460872|FG006|Open-label Lead-in Phase|Adverse Event|0|||
162112059|NCT02496767|585460873|FG007|Open-label Lead-in Phase|Adverse Event|0|||
162112060|NCT02496767|585460866|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
162112061|NCT02496767|585460867|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
162112062|NCT02496767|585460868|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
162112063|NCT02496767|585460869|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
162112064|NCT02496767|585460870|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
162112065|NCT02496767|585460871|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
162112066|NCT02496767|585460872|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
162112067|NCT02496767|585460873|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
162112068|NCT02496767|585460866|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
162112069|NCT02496767|585460867|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
162112070|NCT02496767|585460868|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
162112071|NCT02496767|585460869|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
162112072|NCT02496767|585460870|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
162112073|NCT02496767|585460871|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
162112074|NCT02496767|585460872|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
162112075|NCT02496767|585460873|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
162112076|NCT02496767|585460866|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
162112077|NCT02496767|585460867|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
162112078|NCT02496767|585460868|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
162112079|NCT02496767|585460869|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
162112080|NCT02496767|585460870|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
162112081|NCT02496767|585460871|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
162112082|NCT02496767|585460872|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
162112083|NCT02496767|585460873|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
162112084|NCT02496767|585460866|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
162112085|NCT02496767|585460867|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
162112086|NCT02496767|585460868|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
162112087|NCT02496767|585460869|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
162112088|NCT02496767|585460870|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
162112089|NCT02496767|585460871|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
162112090|NCT02496767|585460872|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
162112091|NCT02496767|585460873|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
162112092|NCT02496767|585460866|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
162112093|NCT02496767|585460867|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
162112094|NCT02496767|585460868|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
162112095|NCT02496767|585460869|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
162112096|NCT02496767|585460870|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
162112097|NCT02496767|585460871|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
162112098|NCT02496767|585460872|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
162112099|NCT02496767|585460873|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
162112100|NCT02496767|585460866|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
162112101|NCT02496767|585460867|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
162112102|NCT02496767|585460868|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
162112103|NCT02496767|585460869|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
162112104|NCT02496767|585460870|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
162112105|NCT02496767|585460871|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
162112106|NCT02496767|585460872|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
162112107|NCT02496767|585460873|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
162112108|NCT02496767|585460866|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162112109|NCT02496767|585460867|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
162112110|NCT02496767|585460868|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
162112111|NCT02496767|585460869|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
162112112|NCT02496767|585460870|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
162112113|NCT02496767|585460871|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162112114|NCT02496767|585460872|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162112115|NCT02496767|585460873|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
162112116|NCT02496767|585460866|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162112117|NCT02496767|585460867|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
162112118|NCT02496767|585460868|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
162112119|NCT02496767|585460869|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162112120|NCT02496767|585460870|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162112121|NCT02496767|585460871|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162112122|NCT02496767|585460872|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162112123|NCT02496767|585460873|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
162112124|NCT02496767|585460866|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162112125|NCT02496767|585460867|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
162112126|NCT02496767|585460868|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162112127|NCT02496767|585460869|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
162112128|NCT02496767|585460870|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
162112129|NCT02496767|585460871|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162112130|NCT02496767|585460872|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162112131|NCT02496767|585460873|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
162112132|NCT02496767|585460866|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162112133|NCT02496767|585460867|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
162112134|NCT02496767|585460868|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162112135|NCT02496767|585460869|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162112136|NCT02496767|585460870|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162112137|NCT02496767|585460871|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162112138|NCT02496767|585460872|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162112139|NCT02496767|585460873|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
162112140|NCT02496767|585460866|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
162112141|NCT02496767|585460867|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
162112142|NCT02496767|585460868|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
162112143|NCT02496767|585460869|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
162112144|NCT02496767|585460870|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
162112145|NCT02496767|585460871|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
162112146|NCT02496767|585460872|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
162112147|NCT02496767|585460873|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
162112148|NCT02496767|585460866|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
162112149|NCT02496767|585460867|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
162112150|NCT02496767|585460868|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
162112151|NCT02496767|585460869|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
162112152|NCT02496767|585460870|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
162112153|NCT02496767|585460871|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
162112154|NCT02496767|585460872|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
162112155|NCT02496767|585460873|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
162112156|NCT02496767|585460866|FG000|Double-blind, Withdrawal Phase|Death|0|||
162112157|NCT02496767|585460867|FG001|Double-blind, Withdrawal Phase|Death|0|||
162112158|NCT02496767|585460868|FG002|Double-blind, Withdrawal Phase|Death|0|||
162112159|NCT02496767|585460869|FG003|Double-blind, Withdrawal Phase|Death|0|||
162112160|NCT02496767|585460870|FG004|Double-blind, Withdrawal Phase|Death|0|||
162112161|NCT02496767|585460871|FG005|Double-blind, Withdrawal Phase|Death|0|||
162112162|NCT02496767|585460872|FG006|Double-blind, Withdrawal Phase|Death|1|||
162112163|NCT02496767|585460873|FG007|Double-blind, Withdrawal Phase|Death|2|||
162112164|NCT02496767|585460866|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
162112165|NCT02496767|585460867|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
162112166|NCT02496767|585460868|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
162112167|NCT02496767|585460869|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
162112168|NCT02496767|585460870|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
162112169|NCT02496767|585460871|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
162112170|NCT02496767|585460872|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
162112171|NCT02496767|585460873|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
162112172|NCT00166296|585460874|FG000|Overall Study|Withdrawal by Subject|1|||
162112173|NCT00166296|585460875|FG001|Overall Study|Withdrawal by Subject|3|||
162112174|NCT00166296|585460874|FG000|Overall Study|Adverse Event|2|||
162112175|NCT00166296|585460875|FG001|Overall Study|Adverse Event|4|||
162112176|NCT00166296|585460874|FG000|Overall Study|Lost to Follow-up|4|||
162112177|NCT00166296|585460875|FG001|Overall Study|Lost to Follow-up|2|||
162112178|NCT04035200|585460881|FG000|Overall Study|Lost to Follow-up|0|||
162112179|NCT04035200|585460882|FG001|Overall Study|Lost to Follow-up|1|||
162112180|NCT04035200|585460883|FG002|Overall Study|Lost to Follow-up|0|||
162112181|NCT04035200|585460881|FG000|Overall Study|Withdrawal by Subject|1|||
162112182|NCT04035200|585460882|FG001|Overall Study|Withdrawal by Subject|4|||
162112183|NCT04035200|585460883|FG002|Overall Study|Withdrawal by Subject|4|||
162112184|NCT04035200|585460881|FG000|Overall Study|COVID-19|1|||
162112185|NCT04035200|585460882|FG001|Overall Study|COVID-19|0|||
162112186|NCT04035200|585460883|FG002|Overall Study|COVID-19|0|||
162112187|NCT04035200|585460881|FG000|Overall Study|Early Termination|0|||
162112188|NCT04035200|585460882|FG001|Overall Study|Early Termination|1|||
162112189|NCT04035200|585460883|FG002|Overall Study|Early Termination|0|||
162112190|NCT04035200|585460881|FG000|Overall Study|Non-compliance|0|||
162112191|NCT04035200|585460882|FG001|Overall Study|Non-compliance|1|||
162112192|NCT04035200|585460883|FG002|Overall Study|Non-compliance|0|||
162112193|NCT02277990|585460884|FG000|Overall Study|Death|170|||
162112194|NCT02277990|585460885|FG001|Overall Study|Death|188|||
162112195|NCT02277990|585460884|FG000|Overall Study|Withdrawal by Subject|64|||
162112196|NCT02277990|585460885|FG001|Overall Study|Withdrawal by Subject|53|||
162112197|NCT02277990|585460884|FG000|Overall Study|Physician Decision|40|||
162112198|NCT02277990|585460885|FG001|Overall Study|Physician Decision|34|||
162112199|NCT02277990|585460884|FG000|Overall Study|Lost to Follow-up|66|||
162112200|NCT02277990|585460885|FG001|Overall Study|Lost to Follow-up|69|||
162112201|NCT02277990|585460884|FG000|Overall Study|Had other reason|26|||
162112202|NCT02277990|585460885|FG001|Overall Study|Had other reason|32|||
162112203|NCT03351738|585460886|FG000|Overall Study|Withdrawal by Subject|0|||
162112204|NCT03351738|585460887|FG001|Overall Study|Withdrawal by Subject|1|||
162112205|NCT03351738|585460888|FG002|Overall Study|Withdrawal by Subject|0|||
162112206|NCT03351738|585460889|FG003|Overall Study|Withdrawal by Subject|1|||
162112207|NCT03351738|585460890|FG004|Overall Study|Withdrawal by Subject|0|||
162112208|NCT03351738|585460891|FG005|Overall Study|Withdrawal by Subject|0|||
162112209|NCT03138733|585460896|FG000|Overall Study|Death|17|||
162112210|NCT03138733|585460897|FG001|Overall Study|Death|18|||
162112211|NCT03138733|585460896|FG000|Overall Study|Withdrawal by Subject|11|||
162112212|NCT03138733|585460897|FG001|Overall Study|Withdrawal by Subject|6|||
162112213|NCT03138733|585460896|FG000|Overall Study|Lost to Follow-up|3|||
162112214|NCT03138733|585460897|FG001|Overall Study|Lost to Follow-up|2|||
162112215|NCT03138733|585460896|FG000|Overall Study|Adverse Event|1|||
162112216|NCT03138733|585460897|FG001|Overall Study|Adverse Event|0|||
162112217|NCT03138733|585460896|FG000|Overall Study|Protocol Violation|1|||
162112218|NCT03138733|585460897|FG001|Overall Study|Protocol Violation|3|||
162112219|NCT03138733|585460896|FG000|Overall Study|Administrative or logistical reason|1|||
162112220|NCT03138733|585460897|FG001|Overall Study|Administrative or logistical reason|0|||
162112221|NCT03138733|585460896|FG000|Overall Study|The patient was transferred to another hospital|1|||
162112222|NCT03138733|585460897|FG001|Overall Study|The patient was transferred to another hospital|0|||
162112223|NCT03641313|585460901|FG000|Overall Study|Death|1|||
162112224|NCT03641313|585460901|FG000|Overall Study|Withdrawal by Subject|2|||
162112225|NCT03641313|585460901|FG000|Overall Study|Declining health|1|||
162112226|NCT03641313|585460901|FG000|Overall Study|Adverse Event|1|||
162112227|NCT01533493|585460904|FG000|Overall Study|Adverse Event|2|||
162112228|NCT01533493|585460905|FG001|Overall Study|Adverse Event|1|||
162112229|NCT01533493|585460904|FG000|Overall Study|Withdrawal by Subject|1|||
162112230|NCT01533493|585460905|FG001|Overall Study|Withdrawal by Subject|2|||
162112231|NCT01533493|585460904|FG000|Overall Study|Lost to Follow-up|2|||
162112232|NCT01533493|585460905|FG001|Overall Study|Lost to Follow-up|0|||
162112233|NCT02521285|585460909|FG000|Overall Study|Lost to Follow-up|1|||
162112234|NCT02521285|585460910|FG001|Overall Study|Lost to Follow-up|1|||
162112235|NCT02521285|585460909|FG000|Overall Study|Withdrawal by Subject|1|||
162112236|NCT02521285|585460910|FG001|Overall Study|Withdrawal by Subject|1|||
162112237|NCT02521285|585460909|FG000|Overall Study|Adverse Event|0|||
162112238|NCT02521285|585460910|FG001|Overall Study|Adverse Event|1|||
162112239|NCT05701995|585460912|FG000|Pre-Treatment|Randomization Error|1|||
162112240|NCT05701995|585460913|FG001|Pre-Treatment|Randomization Error|1|||
162112241|NCT05701995|585460912|FG000|Treatment|Withdrawal by Subject|8|||
162112242|NCT05701995|585460913|FG001|Treatment|Withdrawal by Subject|4|||
162112243|NCT05701995|585460912|FG000|Treatment|Lost to Follow-up|2|||
162112244|NCT05701995|585460913|FG001|Treatment|Lost to Follow-up|3|||
162112245|NCT05701995|585460912|FG000|Treatment|Adverse Event|3|||
162112246|NCT05701995|585460913|FG001|Treatment|Adverse Event|1|||
162112247|NCT05701995|585460912|FG000|Treatment|Other Reason|1|||
162112248|NCT05701995|585460913|FG001|Treatment|Other Reason|1|||
162112249|NCT05701995|585460912|FG000|Treatment|Death|1|||
162112250|NCT05701995|585460913|FG001|Treatment|Death|0|||
162112251|NCT05701995|585460912|FG000|Treatment|Physician Decision|0|||
162112252|NCT05701995|585460913|FG001|Treatment|Physician Decision|1|||
162112253|NCT00715429|585460914|FG000|Overall Study|Did not complete the study diary|0|||
162112254|NCT00715429|585460915|FG001|Overall Study|Did not complete the study diary|1|||
162112255|NCT04899245|585460920|FG000|Overall Study|Withdrawal by Subject|3|||
162112256|NCT04899245|585460921|FG001|Overall Study|Withdrawal by Subject|5|||
162112257|NCT04899245|585460922|FG002|Overall Study|Withdrawal by Subject|2|||
162112258|NCT04899245|585460920|FG000|Overall Study|No longer eligible - Left staff position|0|||
162112259|NCT04899245|585460921|FG001|Overall Study|No longer eligible - Left staff position|0|||
162112260|NCT04899245|585460922|FG002|Overall Study|No longer eligible - Left staff position|1|||
162112261|NCT04899245|585460920|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
162112262|NCT04899245|585460921|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
162112263|NCT04899245|585460922|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
162112264|NCT04899245|585460920|FG000|Overall Study|No longer eligible - Moved away from area|2|||
162112265|NCT04899245|585460921|FG001|Overall Study|No longer eligible - Moved away from area|2|||
162112266|NCT04899245|585460922|FG002|Overall Study|No longer eligible - Moved away from area|0|||
162112267|NCT02790073|585462696|FG000|Overall Study|Death|1|||
162112268|NCT02790073|585462696|FG000|Overall Study|Withdrawal from HD|1|||
162112269|NCT02790073|585462696|FG000|Overall Study|Withdrawal by Subject|1|||
162112270|NCT00514683|585462697|FG000|Overall Study|Not treated|2|||
162112271|NCT00514683|585462698|FG001|Overall Study|Not treated|1|||
162112272|NCT00514683|585462699|FG002|Overall Study|Not treated|0|||
162112273|NCT00514683|585462700|FG003|Overall Study|Not treated|0|||
162112274|NCT00514683|585462701|FG004|Overall Study|Not treated|1|||
162112275|NCT00514683|585462697|FG000|Overall Study|Adverse Event|21|||
162112276|NCT00514683|585462698|FG001|Overall Study|Adverse Event|20|||
162112277|NCT00514683|585462699|FG002|Overall Study|Adverse Event|15|||
162112278|NCT00514683|585462700|FG003|Overall Study|Adverse Event|13|||
162112279|NCT00514683|585462701|FG004|Overall Study|Adverse Event|27|||
162112280|NCT00514683|585462697|FG000|Overall Study|Protocol Violation|1|||
162112281|NCT00514683|585462698|FG001|Overall Study|Protocol Violation|1|||
162112282|NCT00514683|585462699|FG002|Overall Study|Protocol Violation|0|||
162112283|NCT00514683|585462700|FG003|Overall Study|Protocol Violation|1|||
162112284|NCT00514683|585462701|FG004|Overall Study|Protocol Violation|0|||
162112285|NCT00514683|585462697|FG000|Overall Study|Withdrawal by Subject|2|||
162112286|NCT00514683|585462698|FG001|Overall Study|Withdrawal by Subject|2|||
162112287|NCT00514683|585462699|FG002|Overall Study|Withdrawal by Subject|1|||
162112288|NCT00514683|585462700|FG003|Overall Study|Withdrawal by Subject|0|||
162112289|NCT00514683|585462701|FG004|Overall Study|Withdrawal by Subject|4|||
162112290|NCT00514683|585462697|FG000|Overall Study|Reason other than listed above|0|||
162112291|NCT00514683|585462698|FG001|Overall Study|Reason other than listed above|1|||
162112292|NCT00514683|585462699|FG002|Overall Study|Reason other than listed above|2|||
162112293|NCT00514683|585462700|FG003|Overall Study|Reason other than listed above|0|||
162112294|NCT00514683|585462701|FG004|Overall Study|Reason other than listed above|1|||
162112295|NCT00643123|585462704|FG000|Overall Study|Lost to Follow-up|4|||
162112296|NCT00643123|585462705|FG001|Overall Study|Lost to Follow-up|0|||
162112297|NCT00643123|585462704|FG000|Overall Study|Withdrawal by Subject|1|||
162112298|NCT00643123|585462705|FG001|Overall Study|Withdrawal by Subject|1|||
162112299|NCT01538472|585462706|FG000|Overall Study|Disease Progression|3|||
162112300|NCT01538472|585462706|FG000|Overall Study|Death|1|||
162112301|NCT00118716|585462710|FG000|Overall Study|Adverse Event|2|||
162112302|NCT00118716|585462711|FG001|Overall Study|Adverse Event|7|||
162112303|NCT00118716|585462710|FG000|Overall Study|Protocol Violation|5|||
162112304|NCT00118716|585462711|FG001|Overall Study|Protocol Violation|4|||
162112305|NCT00118716|585462710|FG000|Overall Study|Withdrawal by Subject|0|||
162112306|NCT00118716|585462711|FG001|Overall Study|Withdrawal by Subject|1|||
162112307|NCT00118716|585462710|FG000|Overall Study|Exacerbation|2|||
162112308|NCT00118716|585462711|FG001|Overall Study|Exacerbation|2|||
162112309|NCT00118716|585462710|FG000|Overall Study|Discontinued by sponsor|1|||
162112310|NCT00118716|585462711|FG001|Overall Study|Discontinued by sponsor|1|||
162112311|NCT00118716|585462710|FG000|Overall Study|Non-compliance|1|||
162112312|NCT00118716|585462711|FG001|Overall Study|Non-compliance|3|||
162112313|NCT00118716|585462710|FG000|Overall Study|misrandomized|1|||
162112314|NCT00118716|585462711|FG001|Overall Study|misrandomized|1|||
162112315|NCT00118716|585462710|FG000|Overall Study|Expired drug use|1|||
162112316|NCT00118716|585462711|FG001|Overall Study|Expired drug use|2|||
162112317|NCT00118716|585462710|FG000|Overall Study|Investigator discretion|0|||
162112318|NCT00118716|585462711|FG001|Overall Study|Investigator discretion|1|||
162112319|NCT00855062|585462713|FG000|Step1|Early Study Closure|5|||
162112320|NCT00855062|585462714|FG001|Step1|Early Study Closure|7|||
162112321|NCT00855062|585462713|FG000|Step1|Adverse Event|1|||
162112322|NCT00855062|585462714|FG001|Step1|Adverse Event|1|||
162112323|NCT00855062|585462713|FG000|Step1|Protocol Violation|1|||
162112324|NCT00855062|585462714|FG001|Step1|Protocol Violation|0|||
162112325|NCT00855062|585462713|FG000|Step1|Pregnancy|1|||
162112326|NCT00855062|585462714|FG001|Step1|Pregnancy|0|||
162112327|NCT00855062|585462713|FG000|Step1|Withdrawal by Subject|2|||
162112328|NCT00855062|585462714|FG001|Step1|Withdrawal by Subject|3|||
162112329|NCT00855062|585462713|FG000|Step2|Early Study Closure|6|||
162112330|NCT00855062|585462714|FG001|Step2|Early Study Closure|2|||
162112331|NCT00855062|585462713|FG000|Step2|Adverse Event|0|||
162112332|NCT00855062|585462714|FG001|Step2|Adverse Event|3|||
162112333|NCT00855062|585462713|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
162112334|NCT00855062|585462714|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
162112335|NCT04681729|585462715|FG000|Overall Study|Lack of Efficacy|2|||
162112336|NCT04681729|585462716|FG001|Overall Study|Lack of Efficacy|2|||
162112337|NCT04681729|585462715|FG000|Overall Study|Withdrawal by Subject|8|||
162112338|NCT04681729|585462716|FG001|Overall Study|Withdrawal by Subject|9|||
162112339|NCT02110901|585462717|FG000|Overall Study|Death|6|||
162112340|NCT02110901|585462718|FG001|Overall Study|Death|3|||
162112341|NCT02110901|585462717|FG000|Overall Study|Lost to Follow-up|12|||
162112342|NCT02110901|585462718|FG001|Overall Study|Lost to Follow-up|8|||
162112343|NCT02110901|585462717|FG000|Overall Study|Withdrawal by Subject|7|||
162112344|NCT02110901|585462718|FG001|Overall Study|Withdrawal by Subject|3|||
162112345|NCT02110901|585462717|FG000|Overall Study|received a kidney transplant|5|||
162112346|NCT02110901|585462718|FG001|Overall Study|received a kidney transplant|0|||
162112347|NCT00855595|585462720|FG000|Overall Study|Withdrawal by Subject|1|||
162112348|NCT00855595|585462721|FG001|Overall Study|Withdrawal by Subject|2|||
162112349|NCT00855595|585462720|FG000|Overall Study|Lost to Follow-up|3|||
162112350|NCT00855595|585462721|FG001|Overall Study|Lost to Follow-up|3|||
162112351|NCT00855595|585462720|FG000|Overall Study|Adverse Event|1|||
162112352|NCT00855595|585462721|FG001|Overall Study|Adverse Event|1|||
162112353|NCT00855595|585462720|FG000|Overall Study|patient moved out of state|1|||
162112354|NCT00855595|585462721|FG001|Overall Study|patient moved out of state|0|||
162112355|NCT00855595|585462720|FG000|Overall Study|patient left country|0|||
162112356|NCT00855595|585462721|FG001|Overall Study|patient left country|1|||
162112357|NCT04581200|585462722|FG000|Overall Study|Lost to Follow-up|6|||
162112358|NCT04581200|585462723|FG001|Overall Study|Lost to Follow-up|5|||
162112359|NCT04711603|585462724|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
162112360|NCT04711603|585462725|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
162112361|NCT04711603|585462726|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
162112362|NCT04711603|585462727|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
162112363|NCT04711603|585462724|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
162112364|NCT04711603|585462725|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
162112365|NCT04711603|585462726|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
162112366|NCT04711603|585462727|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
162112367|NCT04711603|585462724|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
162112368|NCT04711603|585462725|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
162112369|NCT04711603|585462726|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
162112370|NCT04711603|585462727|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
162112371|NCT04711603|585462724|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
162112372|NCT04711603|585462725|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
162112373|NCT04711603|585462726|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
162112374|NCT04711603|585462727|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
162112375|NCT04711603|585462724|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
162112376|NCT04711603|585462725|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
162112377|NCT04711603|585462726|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
162112378|NCT04711603|585462727|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
162112379|NCT04711603|585462724|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
162112380|NCT04711603|585462725|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
162112381|NCT04711603|585462726|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
162112382|NCT04711603|585462727|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
162112383|NCT04711603|585462724|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
162112384|NCT04711603|585462725|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
162112385|NCT04711603|585462726|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
162112386|NCT04711603|585462727|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
162112387|NCT04711603|585462724|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
162112388|NCT04711603|585462725|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
162112389|NCT04711603|585462726|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
162112390|NCT04711603|585462727|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
162112391|NCT04711603|585462724|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
162112392|NCT04711603|585462725|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
162112393|NCT04711603|585462726|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
162112394|NCT04711603|585462727|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
162112395|NCT04711603|585462724|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
162112396|NCT04711603|585462725|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
162112397|NCT04711603|585462726|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
162112398|NCT04711603|585462727|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
162112399|NCT04711603|585462724|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
162112400|NCT04711603|585462725|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
162112401|NCT04711603|585462726|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
162112402|NCT04711603|585462727|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
162112403|NCT04711603|585462724|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
162112404|NCT04711603|585462725|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
162112405|NCT04711603|585462726|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
162112406|NCT04711603|585462727|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
162112407|NCT01089374|585462728|FG000|Overall Study|Lost to Follow-up|3|||
162112408|NCT01089374|585462729|FG001|Overall Study|Lost to Follow-up|0|||
162112409|NCT01089374|585462728|FG000|Overall Study|Withdrawal by Subject|1|||
162112410|NCT01089374|585462729|FG001|Overall Study|Withdrawal by Subject|0|||
162112411|NCT01089374|585462728|FG000|Overall Study|Study closed early - low accrual|6|||
162112412|NCT01089374|585462729|FG001|Overall Study|Study closed early - low accrual|0|||
162112413|NCT02597036|585462739|FG000|Overall Study|Progressive Disease|0|||
162112414|NCT02597036|585462740|FG001|Overall Study|Progressive Disease|0|||
162112415|NCT02597036|585462741|FG002|Overall Study|Progressive Disease|0|||
162112416|NCT02597036|585462742|FG003|Overall Study|Progressive Disease|0|||
162112417|NCT02597036|585462743|FG004|Overall Study|Progressive Disease|1|||
162112418|NCT02597036|585462744|FG005|Overall Study|Progressive Disease|1|||
162112419|NCT02597036|585462745|FG006|Overall Study|Progressive Disease|1|||
162112420|NCT02597036|585462746|FG007|Overall Study|Progressive Disease|0|||
162112421|NCT02597036|585462747|FG008|Overall Study|Progressive Disease|0|||
162112422|NCT02597036|585462748|FG009|Overall Study|Progressive Disease|0|||
162112423|NCT02597036|585462749|FG010|Overall Study|Progressive Disease|0|||
162112424|NCT02597036|585462750|FG011|Overall Study|Progressive Disease|0|||
162112425|NCT02597036|585462739|FG000|Overall Study|Adverse Event|0|||
162112426|NCT02597036|585462740|FG001|Overall Study|Adverse Event|0|||
162112427|NCT02597036|585462741|FG002|Overall Study|Adverse Event|0|||
162112428|NCT02597036|585462742|FG003|Overall Study|Adverse Event|0|||
162112429|NCT02597036|585462743|FG004|Overall Study|Adverse Event|0|||
162112430|NCT02597036|585462744|FG005|Overall Study|Adverse Event|0|||
162112431|NCT02597036|585462745|FG006|Overall Study|Adverse Event|0|||
162112432|NCT02597036|585462746|FG007|Overall Study|Adverse Event|1|||
162112433|NCT02597036|585462747|FG008|Overall Study|Adverse Event|0|||
162112434|NCT02597036|585462748|FG009|Overall Study|Adverse Event|0|||
162112435|NCT02597036|585462749|FG010|Overall Study|Adverse Event|0|||
162112436|NCT02597036|585462750|FG011|Overall Study|Adverse Event|1|||
162112437|NCT02597036|585462739|FG000|Overall Study|Death|0|||
162112438|NCT02597036|585462740|FG001|Overall Study|Death|0|||
162112439|NCT02597036|585462741|FG002|Overall Study|Death|0|||
162112440|NCT02597036|585462742|FG003|Overall Study|Death|0|||
162112441|NCT02597036|585462743|FG004|Overall Study|Death|0|||
162112442|NCT02597036|585462744|FG005|Overall Study|Death|0|||
162112443|NCT02597036|585462745|FG006|Overall Study|Death|0|||
162112444|NCT02597036|585462746|FG007|Overall Study|Death|0|||
162112445|NCT02597036|585462747|FG008|Overall Study|Death|0|||
162112446|NCT02597036|585462748|FG009|Overall Study|Death|1|||
162112447|NCT02597036|585462749|FG010|Overall Study|Death|1|||
162112448|NCT02597036|585462750|FG011|Overall Study|Death|0|||
162112449|NCT02597036|585462739|FG000|Overall Study|Lost to Follow-up|0|||
162112450|NCT02597036|585462740|FG001|Overall Study|Lost to Follow-up|0|||
162112451|NCT02597036|585462741|FG002|Overall Study|Lost to Follow-up|0|||
162112452|NCT02597036|585462742|FG003|Overall Study|Lost to Follow-up|0|||
162112453|NCT02597036|585462743|FG004|Overall Study|Lost to Follow-up|0|||
162112454|NCT02597036|585462744|FG005|Overall Study|Lost to Follow-up|0|||
162112455|NCT02597036|585462745|FG006|Overall Study|Lost to Follow-up|0|||
162112456|NCT02597036|585462746|FG007|Overall Study|Lost to Follow-up|0|||
162112457|NCT02597036|585462747|FG008|Overall Study|Lost to Follow-up|0|||
162112458|NCT02597036|585462748|FG009|Overall Study|Lost to Follow-up|0|||
162112459|NCT02597036|585462749|FG010|Overall Study|Lost to Follow-up|1|||
162112460|NCT02597036|585462750|FG011|Overall Study|Lost to Follow-up|0|||
162112461|NCT02597036|585462739|FG000|Overall Study|Withdrawal by Subject|0|||
162112462|NCT02597036|585462740|FG001|Overall Study|Withdrawal by Subject|0|||
162112463|NCT02597036|585462741|FG002|Overall Study|Withdrawal by Subject|0|||
162112464|NCT02597036|585462742|FG003|Overall Study|Withdrawal by Subject|0|||
162112465|NCT02597036|585462743|FG004|Overall Study|Withdrawal by Subject|0|||
162112466|NCT02597036|585462744|FG005|Overall Study|Withdrawal by Subject|0|||
162112467|NCT02597036|585462745|FG006|Overall Study|Withdrawal by Subject|0|||
162112468|NCT02597036|585462746|FG007|Overall Study|Withdrawal by Subject|0|||
162112469|NCT02597036|585462747|FG008|Overall Study|Withdrawal by Subject|0|||
162112470|NCT02597036|585462748|FG009|Overall Study|Withdrawal by Subject|0|||
162112471|NCT02597036|585462749|FG010|Overall Study|Withdrawal by Subject|0|||
162112472|NCT02597036|585462750|FG011|Overall Study|Withdrawal by Subject|1|||
162112473|NCT05163522|585462753|FG000|Overall Study|Withdrawal by Subject|0|||
162112474|NCT05163522|585462754|FG001|Overall Study|Withdrawal by Subject|0|||
162112475|NCT05163522|585462755|FG002|Overall Study|Withdrawal by Subject|1|||
162112476|NCT05163522|585462756|FG003|Overall Study|Withdrawal by Subject|0|||
162112477|NCT05163522|585462757|FG004|Overall Study|Withdrawal by Subject|0|||
162112478|NCT05163522|585462758|FG005|Overall Study|Withdrawal by Subject|0|||
162112479|NCT05163522|585462759|FG006|Overall Study|Withdrawal by Subject|0|||
162112480|NCT05163522|585462760|FG007|Overall Study|Withdrawal by Subject|0|||
162112481|NCT05163522|585462761|FG008|Overall Study|Withdrawal by Subject|0|||
162112482|NCT05163522|585462762|FG009|Overall Study|Withdrawal by Subject|0|||
162112483|NCT05163522|585462763|FG010|Overall Study|Withdrawal by Subject|0|||
162112484|NCT04672941|585462768|FG000|Overall Study|Investigator decision|1|||
162112485|NCT04672941|585462768|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
162112486|NCT04672941|585462768|FG000|Overall Study|COVID-19 related but no adverse event|1|||
162112487|NCT04672941|585462768|FG000|Overall Study|Adverse Event|2|||
162112488|NCT04672941|585462768|FG000|Overall Study|Lost to Follow-up|2|||
162112489|NCT00386022|585462774|FG000|Plus Estrogen|Lost to Follow-up|2|||
162112490|NCT00386022|585462775|FG001|Plus Estrogen|Lost to Follow-up|0|||
162112491|NCT00386022|585462774|FG000|Plus Estrogen|Adverse Event|0|||
162112492|NCT00386022|585462775|FG001|Plus Estrogen|Adverse Event|1|||
162112493|NCT00504426|585462778|FG000|Overall Study|Adverse Event|0|||
162112494|NCT00504426|585462779|FG001|Overall Study|Adverse Event|0|||
162112495|NCT00504426|585462780|FG002|Overall Study|Adverse Event|2|||
162112496|NCT00504426|585462781|FG003|Overall Study|Adverse Event|0|||
162112497|NCT00504426|585462778|FG000|Overall Study|Protocol Violation|1|||
162112498|NCT00504426|585462779|FG001|Overall Study|Protocol Violation|1|||
162112499|NCT00504426|585462780|FG002|Overall Study|Protocol Violation|2|||
162112500|NCT00504426|585462781|FG003|Overall Study|Protocol Violation|0|||
162112501|NCT00504426|585462778|FG000|Overall Study|Withdrawal by Subject|2|||
162112502|NCT00504426|585462779|FG001|Overall Study|Withdrawal by Subject|0|||
162112503|NCT00504426|585462780|FG002|Overall Study|Withdrawal by Subject|0|||
162112504|NCT00504426|585462781|FG003|Overall Study|Withdrawal by Subject|0|||
162112505|NCT03685591|585462785|FG000|Overall Study|Global Deterioration of Health Status|0|||
162112506|NCT03685591|585462786|FG001|Overall Study|Global Deterioration of Health Status|0|||
162112507|NCT03685591|585462787|FG002|Overall Study|Global Deterioration of Health Status|0|||
162112508|NCT03685591|585462788|FG003|Overall Study|Global Deterioration of Health Status|1|||
162112509|NCT03685591|585462789|FG004|Overall Study|Global Deterioration of Health Status|2|||
162112510|NCT03685591|585462790|FG005|Overall Study|Global Deterioration of Health Status|4|||
162112511|NCT03685591|585462791|FG006|Overall Study|Global Deterioration of Health Status|1|||
162112512|NCT03685591|585462792|FG007|Overall Study|Global Deterioration of Health Status|1|||
162112513|NCT03685591|585462793|FG008|Overall Study|Global Deterioration of Health Status|0|||
162112514|NCT03685591|585462785|FG000|Overall Study|Progressive Disease|1|||
162112515|NCT03685591|585462786|FG001|Overall Study|Progressive Disease|1|||
162112516|NCT03685591|585462787|FG002|Overall Study|Progressive Disease|0|||
162112517|NCT03685591|585462788|FG003|Overall Study|Progressive Disease|3|||
162112518|NCT03685591|585462789|FG004|Overall Study|Progressive Disease|5|||
162112519|NCT03685591|585462790|FG005|Overall Study|Progressive Disease|4|||
162112520|NCT03685591|585462791|FG006|Overall Study|Progressive Disease|3|||
162112521|NCT03685591|585462792|FG007|Overall Study|Progressive Disease|2|||
162112522|NCT03685591|585462793|FG008|Overall Study|Progressive Disease|1|||
162112523|NCT03685591|585462785|FG000|Overall Study|Other|0|||
162112524|NCT03685591|585462786|FG001|Overall Study|Other|0|||
162112525|NCT03685591|585462787|FG002|Overall Study|Other|1|||
162112526|NCT03685591|585462788|FG003|Overall Study|Other|0|||
162112527|NCT03685591|585462789|FG004|Overall Study|Other|2|||
162112528|NCT03685591|585462790|FG005|Overall Study|Other|3|||
162112529|NCT03685591|585462791|FG006|Overall Study|Other|0|||
162112530|NCT03685591|585462792|FG007|Overall Study|Other|0|||
162112531|NCT03685591|585462793|FG008|Overall Study|Other|0|||
162112532|NCT03685591|585462785|FG000|Overall Study|Withdrawal by Subject|0|||
162112533|NCT03685591|585462786|FG001|Overall Study|Withdrawal by Subject|0|||
162112534|NCT03685591|585462787|FG002|Overall Study|Withdrawal by Subject|0|||
162112535|NCT03685591|585462788|FG003|Overall Study|Withdrawal by Subject|0|||
162112536|NCT03685591|585462789|FG004|Overall Study|Withdrawal by Subject|3|||
162112537|NCT03685591|585462790|FG005|Overall Study|Withdrawal by Subject|2|||
162112538|NCT03685591|585462791|FG006|Overall Study|Withdrawal by Subject|0|||
162112539|NCT03685591|585462792|FG007|Overall Study|Withdrawal by Subject|0|||
162112540|NCT03685591|585462793|FG008|Overall Study|Withdrawal by Subject|1|||
162112541|NCT03685591|585462785|FG000|Overall Study|Adverse Event|0|||
162112542|NCT03685591|585462786|FG001|Overall Study|Adverse Event|0|||
162112543|NCT03685591|585462787|FG002|Overall Study|Adverse Event|0|||
162112544|NCT03685591|585462788|FG003|Overall Study|Adverse Event|1|||
162112545|NCT03685591|585462789|FG004|Overall Study|Adverse Event|1|||
162112546|NCT03685591|585462790|FG005|Overall Study|Adverse Event|4|||
162112547|NCT03685591|585462791|FG006|Overall Study|Adverse Event|0|||
162112548|NCT03685591|585462792|FG007|Overall Study|Adverse Event|1|||
162112549|NCT03685591|585462793|FG008|Overall Study|Adverse Event|1|||
162112550|NCT03988166|585462800|FG000|Overall Study|Lost to Follow-up|2|||
162112551|NCT03988166|585462800|FG000|Overall Study|Death|1|||
162112552|NCT03933826|585462802|FG000|Overall Study|Withdrawal by Subject|8|||
162112553|NCT03933826|585462803|FG001|Overall Study|Withdrawal by Subject|1|||
162112554|NCT03933826|585462802|FG000|Overall Study|Death|19|||
162112555|NCT03933826|585462803|FG001|Overall Study|Death|11|||
162112556|NCT03933826|585462802|FG000|Overall Study|Lost to Follow-up|41|||
162112557|NCT03933826|585462803|FG001|Overall Study|Lost to Follow-up|13|||
162112558|NCT02638948|585462804|FG000|Overall Study|Withdrawal by Subject|4|||
162112559|NCT02638948|585462805|FG001|Overall Study|Withdrawal by Subject|5|||
162112560|NCT02638948|585462806|FG002|Overall Study|Withdrawal by Subject|3|||
162112561|NCT02638948|585462807|FG003|Overall Study|Withdrawal by Subject|1|||
162112562|NCT02638948|585462804|FG000|Overall Study|Administrative Reason by Sponsor|0|||
162112563|NCT02638948|585462805|FG001|Overall Study|Administrative Reason by Sponsor|1|||
162112564|NCT02638948|585462806|FG002|Overall Study|Administrative Reason by Sponsor|0|||
162112565|NCT02638948|585462807|FG003|Overall Study|Administrative Reason by Sponsor|4|||
162112566|NCT02638948|585462804|FG000|Overall Study|Adverse Event|0|||
162112567|NCT02638948|585462805|FG001|Overall Study|Adverse Event|0|||
162112568|NCT02638948|585462806|FG002|Overall Study|Adverse Event|1|||
162112569|NCT02638948|585462807|FG003|Overall Study|Adverse Event|1|||
162112570|NCT02638948|585462804|FG000|Overall Study|Lack of Efficacy|1|||
162112571|NCT02638948|585462805|FG001|Overall Study|Lack of Efficacy|1|||
162112572|NCT02638948|585462806|FG002|Overall Study|Lack of Efficacy|0|||
162112573|NCT02638948|585462807|FG003|Overall Study|Lack of Efficacy|0|||
162112574|NCT02638948|585462804|FG000|Overall Study|Lost to Follow-up|0|||
162112575|NCT02638948|585462805|FG001|Overall Study|Lost to Follow-up|0|||
162112576|NCT02638948|585462806|FG002|Overall Study|Lost to Follow-up|1|||
162112577|NCT02638948|585462807|FG003|Overall Study|Lost to Follow-up|1|||
162112578|NCT02638948|585462804|FG000|Overall Study|Poor/Non-Compliance|0|||
162112579|NCT02638948|585462805|FG001|Overall Study|Poor/Non-Compliance|2|||
162112580|NCT02638948|585462806|FG002|Overall Study|Poor/Non-Compliance|1|||
162112581|NCT02638948|585462807|FG003|Overall Study|Poor/Non-Compliance|0|||
162112582|NCT02638948|585462804|FG000|Overall Study|Participant no longer met study criteria|0|||
162112583|NCT02638948|585462805|FG001|Overall Study|Participant no longer met study criteria|1|||
162112584|NCT02638948|585462806|FG002|Overall Study|Participant no longer met study criteria|0|||
162112585|NCT02638948|585462807|FG003|Overall Study|Participant no longer met study criteria|0|||
162112586|NCT02638948|585462804|FG000|Overall Study|Other than specified above|4|||
162112587|NCT02638948|585462805|FG001|Overall Study|Other than specified above|1|||
162112588|NCT02638948|585462806|FG002|Overall Study|Other than specified above|1|||
162112589|NCT02638948|585462807|FG003|Overall Study|Other than specified above|1|||
162112590|NCT04992546|585462808|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
162112591|NCT04992546|585462808|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
162112592|NCT04992546|585462808|FG000|Open-Label Treatment Period|Adverse Event|3|||
162112593|NCT04992546|585462808|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
162112594|NCT05007392|585462810|FG000|Overall Study|Randomized but not treated|1|||
162112595|NCT05007392|585462811|FG001|Overall Study|Randomized but not treated|2|||
162112596|NCT05007392|585462810|FG000|Overall Study|Other|5|||
162112597|NCT05007392|585462811|FG001|Overall Study|Other|4|||
162112598|NCT05007392|585462810|FG000|Overall Study|Lost to Follow-up|1|||
162112599|NCT05007392|585462811|FG001|Overall Study|Lost to Follow-up|2|||
162112600|NCT05007392|585462810|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
162112601|NCT05007392|585462811|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
162112602|NCT05007392|585462810|FG000|Overall Study|Use of prohibited concomitant drug|1|||
162112603|NCT05007392|585462811|FG001|Overall Study|Use of prohibited concomitant drug|1|||
162112604|NCT05007392|585462810|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
162112605|NCT05007392|585462811|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
162112606|NCT05007392|585462810|FG000|Overall Study|Adverse Event|10|||
162112607|NCT05007392|585462811|FG001|Overall Study|Adverse Event|6|||
162112608|NCT05007392|585462810|FG000|Overall Study|Participant choice|5|||
162112609|NCT05007392|585462811|FG001|Overall Study|Participant choice|10|||
162112610|NCT05007392|585462810|FG000|Overall Study|Withdrawal of consent|5|||
162112611|NCT05007392|585462811|FG001|Overall Study|Withdrawal of consent|4|||
162112612|NCT02703922|585462812|FG000|Overall Study|Death|5|||
162112613|NCT02703922|585462813|FG001|Overall Study|Death|8|||
162112614|NCT02703922|585462812|FG000|Overall Study|Lost to Follow-up|10|||
162112615|NCT02703922|585462813|FG001|Overall Study|Lost to Follow-up|10|||
162112616|NCT05805657|585462818|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
162112617|NCT05805657|585462819|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
162112618|NCT04058353|585462820|FG000|Overall Study|Adverse Event|2|||
162112619|NCT04058353|585462821|FG001|Overall Study|Adverse Event|1|||
162112620|NCT04058353|585462820|FG000|Overall Study|Physician Decision|1|||
162112621|NCT04058353|585462821|FG001|Overall Study|Physician Decision|0|||
162112622|NCT04058353|585462820|FG000|Overall Study|Other|1|||
162112623|NCT04058353|585462821|FG001|Overall Study|Other|0|||
162112624|NCT00316173|585462825|FG000|Run-in Phase|Adverse Event|1|||
162112625|NCT00316173|585462826|FG001|Run-in Phase|Adverse Event|0|||
162112626|NCT00316173|585462825|FG000|Run-in Phase|Protocol Violation|1|||
162112627|NCT00316173|585462826|FG001|Run-in Phase|Protocol Violation|0|||
162112628|NCT00316173|585462825|FG000|Run-in Phase|Study Follow-up Stopped|5|||
162112629|NCT00316173|585462826|FG001|Run-in Phase|Study Follow-up Stopped|0|||
162112630|NCT00316173|585462825|FG000|Treatment Phase|Adverse Event|0|||
162112631|NCT00316173|585462826|FG001|Treatment Phase|Adverse Event|1|||
162112632|NCT00316173|585462825|FG000|Treatment Phase|Lack of Efficacy|0|||
162112633|NCT00316173|585462826|FG001|Treatment Phase|Lack of Efficacy|3|||
162112634|NCT00316173|585462825|FG000|Treatment Phase|Lost to Follow-up|0|||
162112635|NCT00316173|585462826|FG001|Treatment Phase|Lost to Follow-up|3|||
162112636|NCT00316173|585462825|FG000|Treatment Phase|Withdrawal by Subject|0|||
162112637|NCT00316173|585462826|FG001|Treatment Phase|Withdrawal by Subject|1|||
162112638|NCT00316173|585462825|FG000|Treatment Phase|Study Follow-up Stopped|0|||
162112639|NCT00316173|585462826|FG001|Treatment Phase|Study Follow-up Stopped|34|||
162112640|NCT02390531|585462827|FG000|Overall Study|Death|0|||
162112641|NCT02390531|585462828|FG001|Overall Study|Death|2|||
162112642|NCT02390531|585462829|FG002|Overall Study|Death|0|||
162112643|NCT02390531|585462830|FG003|Overall Study|Death|1|||
162112644|NCT02390531|585462831|FG004|Overall Study|Death|0|||
162112645|NCT02390531|585462832|FG005|Overall Study|Death|0|||
162112646|NCT02390531|585462833|FG006|Overall Study|Death|0|||
162112647|NCT02390531|585462834|FG007|Overall Study|Death|1|||
162112648|NCT02390531|585462827|FG000|Overall Study|Protocol Violation|0|||
162112649|NCT02390531|585462828|FG001|Overall Study|Protocol Violation|0|||
162112650|NCT02390531|585462829|FG002|Overall Study|Protocol Violation|0|||
162112651|NCT02390531|585462830|FG003|Overall Study|Protocol Violation|0|||
162112652|NCT02390531|585462831|FG004|Overall Study|Protocol Violation|1|||
162112653|NCT02390531|585462832|FG005|Overall Study|Protocol Violation|0|||
162112654|NCT02390531|585462833|FG006|Overall Study|Protocol Violation|2|||
162112655|NCT02390531|585462834|FG007|Overall Study|Protocol Violation|0|||
162112656|NCT01951638|585462838|FG000|Treatment Period|Protocol Violation|0|||
162112657|NCT01951638|585462839|FG001|Treatment Period|Protocol Violation|0|||
162112658|NCT01951638|585462840|FG002|Treatment Period|Protocol Violation|0|||
162112659|NCT01951638|585462841|FG003|Treatment Period|Protocol Violation|2|||
162112660|NCT01951638|585462842|FG004|Treatment Period|Protocol Violation|0|||
162112661|NCT01951638|585462838|FG000|Treatment Period|Protocol-driven decision point|1|||
162112662|NCT01951638|585462839|FG001|Treatment Period|Protocol-driven decision point|3|||
162112663|NCT01951638|585462840|FG002|Treatment Period|Protocol-driven decision point|0|||
162112664|NCT01951638|585462841|FG003|Treatment Period|Protocol-driven decision point|0|||
162112665|NCT01951638|585462842|FG004|Treatment Period|Protocol-driven decision point|0|||
162112666|NCT01951638|585462838|FG000|Treatment Period|Logistical difficulties|0|||
162112667|NCT01951638|585462839|FG001|Treatment Period|Logistical difficulties|1|||
162112668|NCT01951638|585462840|FG002|Treatment Period|Logistical difficulties|1|||
162112669|NCT01951638|585462841|FG003|Treatment Period|Logistical difficulties|0|||
162112670|NCT01951638|585462842|FG004|Treatment Period|Logistical difficulties|0|||
162112671|NCT01951638|585462838|FG000|Treatment Period|Withdrawal by Subject|9|||
162112672|NCT01951638|585462839|FG001|Treatment Period|Withdrawal by Subject|6|||
162112673|NCT01951638|585462840|FG002|Treatment Period|Withdrawal by Subject|4|||
162112674|NCT01951638|585462841|FG003|Treatment Period|Withdrawal by Subject|5|||
162112675|NCT01951638|585462842|FG004|Treatment Period|Withdrawal by Subject|4|||
162112676|NCT01951638|585462838|FG000|Treatment Period|Death|0|||
162112677|NCT01951638|585462839|FG001|Treatment Period|Death|0|||
162112678|NCT01951638|585462840|FG002|Treatment Period|Death|0|||
162112679|NCT01951638|585462841|FG003|Treatment Period|Death|3|||
162112680|NCT01951638|585462842|FG004|Treatment Period|Death|1|||
162112681|NCT01951638|585462838|FG000|Treatment Period|Adverse Event|3|||
162112682|NCT01951638|585462839|FG001|Treatment Period|Adverse Event|4|||
162112683|NCT01951638|585462840|FG002|Treatment Period|Adverse Event|8|||
162112684|NCT01951638|585462841|FG003|Treatment Period|Adverse Event|6|||
162112685|NCT01951638|585462842|FG004|Treatment Period|Adverse Event|5|||
162112686|NCT01951638|585462838|FG000|Follow-up Period|Protocol Violation|0|||
162112687|NCT01951638|585462839|FG001|Follow-up Period|Protocol Violation|0|||
162112688|NCT01951638|585462840|FG002|Follow-up Period|Protocol Violation|0|||
162112689|NCT01951638|585462841|FG003|Follow-up Period|Protocol Violation|1|||
162112690|NCT01951638|585462842|FG004|Follow-up Period|Protocol Violation|0|||
162112691|NCT01951638|585462838|FG000|Follow-up Period|Logistical difficulties|0|||
162112692|NCT01951638|585462839|FG001|Follow-up Period|Logistical difficulties|2|||
162112693|NCT01951638|585462840|FG002|Follow-up Period|Logistical difficulties|0|||
162112694|NCT01951638|585462841|FG003|Follow-up Period|Logistical difficulties|0|||
162112695|NCT01951638|585462842|FG004|Follow-up Period|Logistical difficulties|1|||
162112696|NCT01951638|585462838|FG000|Follow-up Period|Withdrawal by Subject|1|||
162112697|NCT01951638|585462839|FG001|Follow-up Period|Withdrawal by Subject|5|||
162112698|NCT01951638|585462840|FG002|Follow-up Period|Withdrawal by Subject|2|||
162112699|NCT01951638|585462841|FG003|Follow-up Period|Withdrawal by Subject|1|||
162112700|NCT01951638|585462842|FG004|Follow-up Period|Withdrawal by Subject|2|||
162112701|NCT01951638|585462838|FG000|Follow-up Period|Lost to Follow-up|0|||
162112702|NCT01951638|585462839|FG001|Follow-up Period|Lost to Follow-up|1|||
162112703|NCT01951638|585462840|FG002|Follow-up Period|Lost to Follow-up|0|||
162112704|NCT01951638|585462841|FG003|Follow-up Period|Lost to Follow-up|1|||
162112705|NCT01951638|585462842|FG004|Follow-up Period|Lost to Follow-up|0|||
162112706|NCT01951638|585462838|FG000|Follow-up Period|Death|1|||
162112707|NCT01951638|585462839|FG001|Follow-up Period|Death|0|||
162112708|NCT01951638|585462840|FG002|Follow-up Period|Death|1|||
162112709|NCT01951638|585462841|FG003|Follow-up Period|Death|4|||
162112710|NCT01951638|585462842|FG004|Follow-up Period|Death|1|||
162112711|NCT01951638|585462838|FG000|Follow-up Period|Adverse Event|0|||
162112712|NCT01951638|585462839|FG001|Follow-up Period|Adverse Event|1|||
162112713|NCT01951638|585462840|FG002|Follow-up Period|Adverse Event|2|||
162112714|NCT01951638|585462841|FG003|Follow-up Period|Adverse Event|1|||
162112715|NCT01951638|585462842|FG004|Follow-up Period|Adverse Event|1|||
162112716|NCT03764072|585462843|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
162112717|NCT03764072|585462844|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
162112718|NCT03764072|585462845|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
162112719|NCT03764072|585462846|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
162112720|NCT03764072|585462847|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
162112721|NCT03764072|585462848|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
162112722|NCT03764072|585462843|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
162112723|NCT03764072|585462844|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
162112724|NCT03764072|585462845|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
162112725|NCT03764072|585462846|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
162112726|NCT03764072|585462847|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
162112727|NCT03764072|585462848|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
162112728|NCT03764072|585462843|FG000|Overall Study|Lost to Follow-up|0|||
162112729|NCT03764072|585462844|FG001|Overall Study|Lost to Follow-up|0|||
162112730|NCT03764072|585462845|FG002|Overall Study|Lost to Follow-up|0|||
162112731|NCT03764072|585462846|FG003|Overall Study|Lost to Follow-up|0|||
162112732|NCT03764072|585462847|FG004|Overall Study|Lost to Follow-up|1|||
162112733|NCT03764072|585462848|FG005|Overall Study|Lost to Follow-up|0|||
162112734|NCT00552084|585462849|FG000|Overall Study|Adverse Event|2|||
162112735|NCT00552084|585462850|FG001|Overall Study|Adverse Event|3|||
162112736|NCT00552084|585462849|FG000|Overall Study|Withdrawal by Subject|4|||
162112737|NCT00552084|585462850|FG001|Overall Study|Withdrawal by Subject|5|||
162112738|NCT00552084|585462849|FG000|Overall Study|Protocol Violation|1|||
162112739|NCT00552084|585462850|FG001|Overall Study|Protocol Violation|0|||
162112740|NCT00552084|585462849|FG000|Overall Study|change in anti-arrythmic drug|1|||
162112741|NCT00552084|585462850|FG001|Overall Study|change in anti-arrythmic drug|1|||
162112742|NCT01338025|585462851|FG000|Overall Study|Unexpected closure of study|10|||
162112743|NCT01338025|585462852|FG001|Overall Study|Unexpected closure of study|9|||
162112744|NCT01338025|585462851|FG000|Overall Study|Withdrawal by Subject|0|||
162112745|NCT01338025|585462852|FG001|Overall Study|Withdrawal by Subject|2|||
162112746|NCT01338025|585462851|FG000|Overall Study|Found ineligible after starting|1|||
162112747|NCT01338025|585462852|FG001|Overall Study|Found ineligible after starting|0|||
162112748|NCT03188055|585462853|FG000|Overall Study|Unavailable for training|0|||
162112749|NCT03188055|585462854|FG001|Overall Study|Unavailable for training|0|||
162112750|NCT03188055|585462855|FG002|Overall Study|Unavailable for training|19|||
162112751|NCT03188055|585462856|FG003|Overall Study|Unavailable for training|0|||
162112752|NCT03188055|585462857|FG004|Overall Study|Unavailable for training|0|||
162112753|NCT03188055|585462858|FG005|Overall Study|Unavailable for training|0|||
162112754|NCT03188055|585462853|FG000|Overall Study|Lost to Follow-up|0|||
162112755|NCT03188055|585462854|FG001|Overall Study|Lost to Follow-up|18|||
162112756|NCT03188055|585462855|FG002|Overall Study|Lost to Follow-up|0|||
162112757|NCT03188055|585462856|FG003|Overall Study|Lost to Follow-up|11|||
162112758|NCT03188055|585462857|FG004|Overall Study|Lost to Follow-up|0|||
162112759|NCT03188055|585462858|FG005|Overall Study|Lost to Follow-up|0|||
162112760|NCT03188055|585462853|FG000|Overall Study|Withdrawal by Subject|0|||
162112761|NCT03188055|585462854|FG001|Overall Study|Withdrawal by Subject|1|||
162112762|NCT03188055|585462855|FG002|Overall Study|Withdrawal by Subject|0|||
162112763|NCT03188055|585462856|FG003|Overall Study|Withdrawal by Subject|1|||
162112764|NCT03188055|585462857|FG004|Overall Study|Withdrawal by Subject|0|||
162112765|NCT03188055|585462858|FG005|Overall Study|Withdrawal by Subject|0|||
162112766|NCT03657277|585462859|FG000|Overall Study|Physician Decision|2|||
162112767|NCT03657277|585462859|FG000|Overall Study|Lost to Follow-up|1|||
162112768|NCT03657277|585462859|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
162112769|NCT01024608|585462862|FG000|Overall Study|Adverse Event|1|||
162112770|NCT01024608|585462863|FG001|Overall Study|Adverse Event|0|||
162112771|NCT01024608|585462862|FG000|Overall Study|Withdrawal by Subject|1|||
162112772|NCT01024608|585462863|FG001|Overall Study|Withdrawal by Subject|0|||
162112773|NCT01024608|585462862|FG000|Overall Study|Lost to Follow-up|0|||
162112774|NCT01024608|585462863|FG001|Overall Study|Lost to Follow-up|1|||
162112775|NCT01024608|585462862|FG000|Overall Study|Protocol Violation|0|||
162112776|NCT01024608|585462863|FG001|Overall Study|Protocol Violation|3|||
162112777|NCT01024608|585462862|FG000|Overall Study|Never received study treatment|2|||
162112778|NCT01024608|585462863|FG001|Overall Study|Never received study treatment|0|||
162112779|NCT04349280|585462864|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
162112780|NCT04349280|585462865|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
162112781|NCT04349280|585462864|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
162112782|NCT04349280|585462865|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
162112783|NCT04349280|585462864|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
162112784|NCT04349280|585462865|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
162112785|NCT02286089|585462866|FG000|Overall Study|Ongoing in Study|1|||
162112786|NCT02286089|585462867|FG001|Overall Study|Ongoing in Study|1|||
162112787|NCT02286089|585462868|FG002|Overall Study|Ongoing in Study|4|||
162112788|NCT02286089|585462869|FG003|Overall Study|Ongoing in Study|10|||
162112789|NCT02286089|585462866|FG000|Overall Study|Withdrawal by Subject|0|||
162112790|NCT02286089|585462867|FG001|Overall Study|Withdrawal by Subject|0|||
162112791|NCT02286089|585462868|FG002|Overall Study|Withdrawal by Subject|2|||
162112792|NCT02286089|585462869|FG003|Overall Study|Withdrawal by Subject|2|||
162112793|NCT00657618|585462872|FG000|Overall Study|Adverse Event|32|||
162112794|NCT00657618|585462872|FG000|Overall Study|Withdrawal by Subject|8|||
162112795|NCT00657618|585462872|FG000|Overall Study|negative for leishmaniasis|2|||
162112796|NCT00657618|585462872|FG000|Overall Study|didn't start due to schedule conflicts|1|||
162112797|NCT00045708|585464166|FG000|Phase 1|early progressive disease|0|||
162112798|NCT00045708|585464167|FG001|Phase 1|early progressive disease|1|||
162112799|NCT00045708|585464168|FG002|Phase 1|early progressive disease|0|||
162112800|NCT00685945|585464170|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
162112801|NCT00847405|585464172|FG000|First Intervention|Adverse Event|0|||
162112802|NCT00847405|585464173|FG001|First Intervention|Adverse Event|1|||
162112803|NCT00847405|585464172|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
162112804|NCT00847405|585464173|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
162112805|NCT01728792|585464174|FG000|Overall Study|Withdrawal of Consent|1|||
162112806|NCT01728792|585464175|FG001|Overall Study|Withdrawal of Consent|1|||
162112807|NCT01728792|585464176|FG002|Overall Study|Withdrawal of Consent|0|||
162112808|NCT01728792|585464177|FG003|Overall Study|Withdrawal of Consent|1|||
162112809|NCT01728792|585464178|FG004|Overall Study|Withdrawal of Consent|0|||
162112810|NCT01728792|585464174|FG000|Overall Study|Lost to Follow-up|2|||
162112811|NCT01728792|585464175|FG001|Overall Study|Lost to Follow-up|1|||
162112812|NCT01728792|585464176|FG002|Overall Study|Lost to Follow-up|4|||
162112813|NCT01728792|585464177|FG003|Overall Study|Lost to Follow-up|2|||
162112814|NCT01728792|585464178|FG004|Overall Study|Lost to Follow-up|0|||
162112815|NCT04277455|585464179|FG000|Overall Study|Lost to Follow-up|1|||
162112816|NCT04791761|585464181|FG000|Overall Study|Lost to Follow-up|8|||
162112817|NCT04791761|585464182|FG001|Overall Study|Lost to Follow-up|6|||
162112818|NCT04791761|585464183|FG002|Overall Study|Lost to Follow-up|10|||
162112819|NCT04791761|585464181|FG000|Overall Study|Withdrawal by Subject|0|||
162112820|NCT04791761|585464182|FG001|Overall Study|Withdrawal by Subject|1|||
162112821|NCT04791761|585464183|FG002|Overall Study|Withdrawal by Subject|1|||
162112822|NCT04791761|585464181|FG000|Overall Study|Protocol Violation|0|||
162112823|NCT04791761|585464182|FG001|Overall Study|Protocol Violation|1|||
162112824|NCT04791761|585464183|FG002|Overall Study|Protocol Violation|1|||
162112825|NCT04669600|585464184|FG000|Overall Study|Withdrawal by Subject|1|||
162112826|NCT04669600|585464184|FG000|Overall Study|Other|6|||
162112827|NCT00676130|585464193|FG000|Overall Study|Lost to Follow-up|0|||
162112828|NCT00676130|585464194|FG001|Overall Study|Lost to Follow-up|1|||
162112829|NCT00676130|585464193|FG000|Overall Study|Found ineligible|3|||
162112830|NCT00676130|585464194|FG001|Overall Study|Found ineligible|2|||
162112831|NCT00676130|585464193|FG000|Overall Study|Withdrawal by Subject|0|||
162112832|NCT00676130|585464194|FG001|Overall Study|Withdrawal by Subject|1|||
162112833|NCT01564368|585464195|FG000|Overall Study|Ineligible|18|||
162112834|NCT01564368|585464195|FG000|Overall Study|Not Randomized in Parent study|116|||
162112835|NCT01564368|585464195|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
162112836|NCT01564368|585464195|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
162112837|NCT01802437|585464199|FG000|Overall Study|Lost to Follow-up|1|||
162112838|NCT01802437|585464200|FG001|Overall Study|Lost to Follow-up|0|||
162112839|NCT01802437|585464199|FG000|Overall Study|Withdrawal by Subject|3|||
162112840|NCT01802437|585464200|FG001|Overall Study|Withdrawal by Subject|4|||
162112841|NCT04857034|585464206|FG000|Placebo-Controlled Period|Request to discontinue|2|||
162112842|NCT04857034|585464207|FG001|Placebo-Controlled Period|Request to discontinue|2|||
162112843|NCT04857034|585464208|FG002|Placebo-Controlled Period|Request to discontinue|0|||
162112844|NCT04857034|585464209|FG003|Placebo-Controlled Period|Request to discontinue|0|||
162112845|NCT04857034|585464210|FG004|Placebo-Controlled Period|Request to discontinue|0|||
162112846|NCT04857034|585464206|FG000|Placebo-Controlled Period|withdrew consent|1|||
162112847|NCT04857034|585464207|FG001|Placebo-Controlled Period|withdrew consent|1|||
162112848|NCT04857034|585464208|FG002|Placebo-Controlled Period|withdrew consent|2|||
162112849|NCT04857034|585464209|FG003|Placebo-Controlled Period|withdrew consent|0|||
162112850|NCT04857034|585464210|FG004|Placebo-Controlled Period|withdrew consent|0|||
162112851|NCT04857034|585464206|FG000|Placebo-Controlled Period|Pregnancy|1|||
162112852|NCT04857034|585464207|FG001|Placebo-Controlled Period|Pregnancy|1|||
162112853|NCT04857034|585464208|FG002|Placebo-Controlled Period|Pregnancy|0|||
162112854|NCT04857034|585464209|FG003|Placebo-Controlled Period|Pregnancy|0|||
162112855|NCT04857034|585464210|FG004|Placebo-Controlled Period|Pregnancy|0|||
162112856|NCT04857034|585464206|FG000|Placebo-Controlled Period|Ongoing study period|0|||
162112857|NCT04857034|585464207|FG001|Placebo-Controlled Period|Ongoing study period|1|||
162112858|NCT04857034|585464208|FG002|Placebo-Controlled Period|Ongoing study period|0|||
162112859|NCT04857034|585464209|FG003|Placebo-Controlled Period|Ongoing study period|0|||
162112860|NCT04857034|585464210|FG004|Placebo-Controlled Period|Ongoing study period|0|||
162112861|NCT04857034|585464206|FG000|Active Treatment Period|Lack of Efficacy|1|||
162112862|NCT04857034|585464207|FG001|Active Treatment Period|Lack of Efficacy|0|||
162112863|NCT04857034|585464208|FG002|Active Treatment Period|Lack of Efficacy|0|||
162112864|NCT04857034|585464209|FG003|Active Treatment Period|Lack of Efficacy|0|||
162112865|NCT04857034|585464210|FG004|Active Treatment Period|Lack of Efficacy|0|||
162112866|NCT04857034|585464206|FG000|Active Treatment Period|request to discontinue|0|||
162112867|NCT04857034|585464207|FG001|Active Treatment Period|request to discontinue|1|||
162112868|NCT04857034|585464208|FG002|Active Treatment Period|request to discontinue|0|||
162112869|NCT04857034|585464209|FG003|Active Treatment Period|request to discontinue|1|||
162112870|NCT04857034|585464210|FG004|Active Treatment Period|request to discontinue|0|||
162112871|NCT04857034|585464206|FG000|Active Treatment Period|administrative reason by sponsor|1|||
162112872|NCT04857034|585464207|FG001|Active Treatment Period|administrative reason by sponsor|5|||
162112873|NCT04857034|585464208|FG002|Active Treatment Period|administrative reason by sponsor|0|||
162112874|NCT04857034|585464209|FG003|Active Treatment Period|administrative reason by sponsor|2|||
162112875|NCT04857034|585464210|FG004|Active Treatment Period|administrative reason by sponsor|2|||
162112876|NCT04857034|585464206|FG000|Active Treatment Period|other reasons|1|||
162112877|NCT04857034|585464207|FG001|Active Treatment Period|other reasons|1|||
162112878|NCT04857034|585464208|FG002|Active Treatment Period|other reasons|0|||
162112879|NCT04857034|585464209|FG003|Active Treatment Period|other reasons|0|||
162112880|NCT04857034|585464210|FG004|Active Treatment Period|other reasons|1|||
162112881|NCT04857034|585464206|FG000|Active Treatment Period|Ongoing Study Period|2|||
162112882|NCT04857034|585464207|FG001|Active Treatment Period|Ongoing Study Period|4|||
162112883|NCT04857034|585464208|FG002|Active Treatment Period|Ongoing Study Period|0|||
162112884|NCT04857034|585464209|FG003|Active Treatment Period|Ongoing Study Period|1|||
162112885|NCT04857034|585464210|FG004|Active Treatment Period|Ongoing Study Period|0|||
162112886|NCT02940574|585464211|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
162112887|NCT02940574|585464212|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
162112888|NCT02940574|585464211|FG000|1-year Follow-up|Lost to Follow-up|3|||
162112889|NCT02940574|585464212|FG001|1-year Follow-up|Lost to Follow-up|4|||
162112890|NCT00520975|585464213|FG000|Overall Study|Disease progression|31|||
162112891|NCT00520975|585464214|FG001|Overall Study|Disease progression|23|||
162112892|NCT00520975|585464213|FG000|Overall Study|Adverse Event|7|||
162112893|NCT00520975|585464214|FG001|Overall Study|Adverse Event|10|||
162112894|NCT00520975|585464213|FG000|Overall Study|Death|0|||
162112895|NCT00520975|585464214|FG001|Overall Study|Death|2|||
162112896|NCT00520975|585464213|FG000|Overall Study|Withdrawal by Subject|3|||
162112897|NCT00520975|585464214|FG001|Overall Study|Withdrawal by Subject|5|||
162112898|NCT00520975|585464213|FG000|Overall Study|Other therapy|2|||
162112899|NCT00520975|585464214|FG001|Overall Study|Other therapy|4|||
162112900|NCT00520975|585464213|FG000|Overall Study|Other reasons|4|||
162112901|NCT00520975|585464214|FG001|Overall Study|Other reasons|2|||
162112902|NCT00520975|585464213|FG000|Overall Study|Not start protocol therapy|1|||
162112903|NCT00520975|585464214|FG001|Overall Study|Not start protocol therapy|2|||
162112904|NCT04810221|585464215|FG000|Overall Study|Physician Decision|3|||
162112905|NCT01682213|585464218|FG000|Overall Study|Withdrawal by Subject|2|||
162112906|NCT01181726|585464219|FG000|First Intervention|Adverse Event|1|||
162112907|NCT01181726|585464220|FG001|First Intervention|Adverse Event|0|||
162112908|NCT01264380|585464221|FG000|Period C|Disease Progression|0|||
162112909|NCT01264380|585464222|FG001|Period C|Disease Progression|0|||
162112910|NCT01264380|585464223|FG002|Period C|Disease Progression|4|||
162112911|NCT01264380|585464221|FG000|Period C|Death|0|||
162112912|NCT01264380|585464222|FG001|Period C|Death|0|||
162112913|NCT01264380|585464223|FG002|Period C|Death|2|||
162112914|NCT01264380|585464221|FG000|Period C|Follow-up for survival status|0|||
162112915|NCT01264380|585464222|FG001|Period C|Follow-up for survival status|0|||
162112916|NCT01264380|585464223|FG002|Period C|Follow-up for survival status|6|||
162112917|NCT01264380|585464221|FG000|Period C|Withdrawal by Subject|0|||
162112918|NCT01264380|585464222|FG001|Period C|Withdrawal by Subject|0|||
162112919|NCT01264380|585464223|FG002|Period C|Withdrawal by Subject|1|||
162112920|NCT01264380|585464221|FG000|Period C|Adverse Event|0|||
162112921|NCT01264380|585464222|FG001|Period C|Adverse Event|0|||
162112922|NCT01264380|585464223|FG002|Period C|Adverse Event|1|||
162112923|NCT04382924|585464225|FG000|Overall Study|Death|2|||
162112924|NCT04382924|585464226|FG001|Overall Study|Death|5|||
162112925|NCT04382924|585464227|FG002|Overall Study|Death|4|||
162112926|NCT04382924|585464225|FG000|Overall Study|Protocol Violation|0|||
162112927|NCT04382924|585464226|FG001|Overall Study|Protocol Violation|1|||
162112928|NCT04382924|585464227|FG002|Overall Study|Protocol Violation|1|||
162112929|NCT04382924|585464225|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
162112930|NCT04382924|585464226|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
162112931|NCT04382924|585464227|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
162112932|NCT04382924|585464225|FG000|Overall Study|Withdrawal by Subject|6|||
162112933|NCT04382924|585464226|FG001|Overall Study|Withdrawal by Subject|3|||
162112934|NCT04382924|585464227|FG002|Overall Study|Withdrawal by Subject|6|||
162112935|NCT04998604|585464228|FG000|Overall Study|Adverse Event|3|||
162112936|NCT04998604|585464229|FG001|Overall Study|Adverse Event|2|||
162112937|NCT04998604|585464228|FG000|Overall Study|Withdrawal by Subject|2|||
162112938|NCT04998604|585464229|FG001|Overall Study|Withdrawal by Subject|4|||
162112939|NCT04998604|585464228|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
162112940|NCT04998604|585464229|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
162112941|NCT00642902|585464232|FG000|Overall Study|Adverse Event|0|||
162112942|NCT00642902|585464233|FG001|Overall Study|Adverse Event|1|||
162112943|NCT00642902|585464234|FG002|Overall Study|Adverse Event|3|||
162112944|NCT00642902|585464235|FG003|Overall Study|Adverse Event|1|||
162112945|NCT00642902|585464232|FG000|Overall Study|Lost to Follow-up|1|||
162112946|NCT00642902|585464233|FG001|Overall Study|Lost to Follow-up|1|||
162112947|NCT00642902|585464234|FG002|Overall Study|Lost to Follow-up|0|||
162112948|NCT00642902|585464235|FG003|Overall Study|Lost to Follow-up|0|||
162112949|NCT00642902|585464232|FG000|Overall Study|Lack of Efficacy|0|||
162112950|NCT00642902|585464233|FG001|Overall Study|Lack of Efficacy|3|||
162112951|NCT00642902|585464234|FG002|Overall Study|Lack of Efficacy|3|||
162112952|NCT00642902|585464235|FG003|Overall Study|Lack of Efficacy|0|||
162112953|NCT00642902|585464232|FG000|Overall Study|Death|1|||
162112954|NCT00642902|585464233|FG001|Overall Study|Death|0|||
162112955|NCT00642902|585464234|FG002|Overall Study|Death|0|||
162112956|NCT00642902|585464235|FG003|Overall Study|Death|0|||
162112957|NCT00642902|585464232|FG000|Overall Study|Premature termination of clinical trial|37|||
162112958|NCT00642902|585464233|FG001|Overall Study|Premature termination of clinical trial|32|||
162112959|NCT00642902|585464234|FG002|Overall Study|Premature termination of clinical trial|35|||
162112960|NCT00642902|585464235|FG003|Overall Study|Premature termination of clinical trial|35|||
162112961|NCT00642902|585464232|FG000|Overall Study|Randomized, but not treated|0|||
162112962|NCT00642902|585464233|FG001|Overall Study|Randomized, but not treated|0|||
162112963|NCT00642902|585464234|FG002|Overall Study|Randomized, but not treated|1|||
162112964|NCT00642902|585464235|FG003|Overall Study|Randomized, but not treated|0|||
162112965|NCT00642902|585464232|FG000|Overall Study|Other|1|||
162112966|NCT00642902|585464233|FG001|Overall Study|Other|5|||
162112967|NCT00642902|585464234|FG002|Overall Study|Other|1|||
162112968|NCT00642902|585464235|FG003|Overall Study|Other|4|||
162112969|NCT03953898|585464236|FG000|Overall Study|Lack of Efficacy|8|||
162112970|NCT03953898|585464236|FG000|Overall Study|Death|3|||
162112971|NCT03953898|585464236|FG000|Overall Study|Withdrawal by Subject|2|||
162112972|NCT03953898|585464236|FG000|Overall Study|Adverse Event|1|||
162112973|NCT01226511|585464239|FG000|Acute Treatment Period|Adverse Event|7|||
162112974|NCT01226511|585464240|FG001|Acute Treatment Period|Adverse Event|6|||
162112975|NCT01226511|585464239|FG000|Acute Treatment Period|Lack of Efficacy|2|||
162112976|NCT01226511|585464240|FG001|Acute Treatment Period|Lack of Efficacy|1|||
162112977|NCT01226511|585464239|FG000|Acute Treatment Period|Lost to Follow-up|3|||
162112978|NCT01226511|585464240|FG001|Acute Treatment Period|Lost to Follow-up|6|||
162112979|NCT01226511|585464239|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
162112980|NCT01226511|585464240|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
162112981|NCT01226511|585464239|FG000|Acute Treatment Period|Protocol Violation|5|||
162112982|NCT01226511|585464240|FG001|Acute Treatment Period|Protocol Violation|5|||
162112983|NCT01226511|585464239|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
162112984|NCT01226511|585464240|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
162112985|NCT01226511|585464239|FG000|Extension Treatment Period|Adverse Event|8|||
162112986|NCT01226511|585464240|FG001|Extension Treatment Period|Adverse Event|8|||
162112987|NCT01226511|585464239|FG000|Extension Treatment Period|Lack of Efficacy|3|||
162112988|NCT01226511|585464240|FG001|Extension Treatment Period|Lack of Efficacy|2|||
162112989|NCT01226511|585464239|FG000|Extension Treatment Period|Lost to Follow-up|4|||
162112990|NCT01226511|585464240|FG001|Extension Treatment Period|Lost to Follow-up|3|||
162112991|NCT01226511|585464239|FG000|Extension Treatment Period|Protocol Violation|2|||
162112992|NCT01226511|585464240|FG001|Extension Treatment Period|Protocol Violation|2|||
162112993|NCT01226511|585464239|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
162112994|NCT01226511|585464240|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
162112995|NCT01226511|585464239|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
162112996|NCT01226511|585464240|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
162112997|NCT01226511|585464239|FG000|Extension Treatment Period|Sponsor Decision|1|||
162112998|NCT01226511|585464240|FG001|Extension Treatment Period|Sponsor Decision|1|||
162112999|NCT01226511|585464239|FG000|Taper Period|Adverse Event|1|||
162113000|NCT01226511|585464240|FG001|Taper Period|Adverse Event|0|||
162113001|NCT01226511|585464239|FG000|Taper Period|Lost to Follow-up|2|||
162113002|NCT01226511|585464240|FG001|Taper Period|Lost to Follow-up|2|||
162113003|NCT01226511|585464239|FG000|Taper Period|Protocol Violation|1|||
162113004|NCT01226511|585464240|FG001|Taper Period|Protocol Violation|0|||
162113005|NCT01226511|585464239|FG000|Taper Period|Parent/Caregiver Decision|1|||
162113006|NCT01226511|585464240|FG001|Taper Period|Parent/Caregiver Decision|1|||
162113007|NCT05267600|585464245|FG000|Overall Study|Adverse Event|1|||
162113008|NCT05267600|585464246|FG001|Overall Study|Adverse Event|4|||
162113009|NCT05267600|585464245|FG000|Overall Study|Death|1|||
162113010|NCT05267600|585464246|FG001|Overall Study|Death|2|||
162113011|NCT05267600|585464245|FG000|Overall Study|Lack of Efficacy|1|||
162113012|NCT05267600|585464246|FG001|Overall Study|Lack of Efficacy|2|||
162113013|NCT05267600|585464245|FG000|Overall Study|Lost to Follow-up|3|||
162113014|NCT05267600|585464246|FG001|Overall Study|Lost to Follow-up|0|||
162113015|NCT05267600|585464245|FG000|Overall Study|Physician Decision|4|||
162113016|NCT05267600|585464246|FG001|Overall Study|Physician Decision|0|||
162113017|NCT05267600|585464245|FG000|Overall Study|Treatment Unblinded|0|||
162113018|NCT05267600|585464246|FG001|Overall Study|Treatment Unblinded|1|||
162113019|NCT05267600|585464245|FG000|Overall Study|Withdrawal by Subject|5|||
162113020|NCT05267600|585464246|FG001|Overall Study|Withdrawal by Subject|4|||
162113021|NCT01520402|585464249|FG000|Overall Study|Withdrawal by Subject|2|||
162113022|NCT01520402|585464249|FG000|Overall Study|Physician Decision|3|||
162113023|NCT01722162|585464255|FG000|Overall Study|Withdrawal by Subject|1|||
162113024|NCT01722162|585464256|FG001|Overall Study|Withdrawal by Subject|1|||
162113025|NCT01722162|585464255|FG000|Overall Study|Found ineligible|1|||
162113026|NCT01722162|585464256|FG001|Overall Study|Found ineligible|0|||
162113027|NCT01722162|585464255|FG000|Overall Study|Unrelated to study adverse event|2|||
162113028|NCT01722162|585464256|FG001|Overall Study|Unrelated to study adverse event|2|||
162113029|NCT01722162|585464255|FG000|Overall Study|Adverse Event|1|||
162113030|NCT01722162|585464256|FG001|Overall Study|Adverse Event|1|||
162113031|NCT01722162|585464255|FG000|Overall Study|Insurance denial post enrollment|0|||
162113032|NCT01722162|585464256|FG001|Overall Study|Insurance denial post enrollment|1|||
162113033|NCT01722162|585464255|FG000|Overall Study|Noncompliance|0|||
162113034|NCT01722162|585464256|FG001|Overall Study|Noncompliance|1|||
162113035|NCT02133872|585464257|FG000|Overall Study|Withdrawal by Subject|5|||
162113036|NCT02133872|585464258|FG001|Overall Study|Withdrawal by Subject|3|||
162113037|NCT02133872|585464259|FG002|Overall Study|Withdrawal by Subject|0|||
162113038|NCT02923739|585464260|FG000|Overall Study|Withdrawal by Subject|2|||
162113039|NCT02923739|585464261|FG001|Overall Study|Withdrawal by Subject|0|||
162113040|NCT02923739|585464262|FG002|Overall Study|Withdrawal by Subject|0|||
162113041|NCT02923739|585464263|FG003|Overall Study|Withdrawal by Subject|0|||
162113042|NCT02923739|585464260|FG000|Overall Study|Failed Screening|3|||
162113043|NCT02923739|585464261|FG001|Overall Study|Failed Screening|0|||
162113044|NCT02923739|585464262|FG002|Overall Study|Failed Screening|0|||
162113045|NCT02923739|585464263|FG003|Overall Study|Failed Screening|0|||
162113046|NCT00948974|585464266|FG000|Overall Study|Lost to Follow-up|23|||
162113047|NCT00948974|585464267|FG001|Overall Study|Lost to Follow-up|20|||
162113048|NCT02487810|585464268|FG000|Overall Study|Withdrawal by Subject|1|||
162113049|NCT02487810|585464269|FG001|Overall Study|Withdrawal by Subject|0|||
162113050|NCT01972529|585464270|FG000|Overall Study|Adverse Event|0|||
162113051|NCT01972529|585464271|FG001|Overall Study|Adverse Event|1|||
162113052|NCT01972529|585464272|FG002|Overall Study|Adverse Event|0|||
162113053|NCT01972529|585464273|FG003|Overall Study|Adverse Event|0|||
162113054|NCT01972529|585464270|FG000|Overall Study|Lost to Follow-up|1|||
162113055|NCT01972529|585464271|FG001|Overall Study|Lost to Follow-up|0|||
162113056|NCT01972529|585464272|FG002|Overall Study|Lost to Follow-up|0|||
162113057|NCT01972529|585464273|FG003|Overall Study|Lost to Follow-up|0|||
162113058|NCT01972529|585464270|FG000|Overall Study|Participant Choice|0|||
162113059|NCT01972529|585464271|FG001|Overall Study|Participant Choice|1|||
162113060|NCT01972529|585464272|FG002|Overall Study|Participant Choice|0|||
162113061|NCT01972529|585464273|FG003|Overall Study|Participant Choice|0|||
162113062|NCT01972529|585464270|FG000|Overall Study|Withdrawl of Consent|1|||
162113063|NCT01972529|585464271|FG001|Overall Study|Withdrawl of Consent|2|||
162113064|NCT01972529|585464272|FG002|Overall Study|Withdrawl of Consent|0|||
162113065|NCT01972529|585464273|FG003|Overall Study|Withdrawl of Consent|1|||
162113066|NCT01972529|585464270|FG000|Overall Study|Other|0|||
162113067|NCT01972529|585464271|FG001|Overall Study|Other|0|||
162113068|NCT01972529|585464272|FG002|Overall Study|Other|0|||
162113069|NCT01972529|585464273|FG003|Overall Study|Other|2|||
162113070|NCT01972529|585464270|FG000|Overall Study|Not treated|0|||
162113071|NCT01972529|585464271|FG001|Overall Study|Not treated|1|||
162113072|NCT01972529|585464272|FG002|Overall Study|Not treated|2|||
162113073|NCT01972529|585464273|FG003|Overall Study|Not treated|1|||
162113074|NCT01889186|585464274|FG000|Overall Study|Adverse event- not related to progression|18|||
162113075|NCT01889186|585464275|FG001|Overall Study|Adverse event- not related to progression|5|||
162113076|NCT01889186|585464274|FG000|Overall Study|Adverse event- related to progression|7|||
162113077|NCT01889186|585464275|FG001|Overall Study|Adverse event- related to progression|2|||
162113078|NCT01889186|585464274|FG000|Overall Study|COVID-19 logistical restrictions|1|||
162113079|NCT01889186|585464275|FG001|Overall Study|COVID-19 logistical restrictions|0|||
162113080|NCT01889186|585464274|FG000|Overall Study|Investigator request|1|||
162113081|NCT01889186|585464275|FG001|Overall Study|Investigator request|1|||
162113082|NCT01889186|585464274|FG000|Overall Study|Progressive disease- Richter's|12|||
162113083|NCT01889186|585464275|FG001|Overall Study|Progressive disease- Richter's|7|||
162113084|NCT01889186|585464274|FG000|Overall Study|Progressive disease per protocol|46|||
162113085|NCT01889186|585464275|FG001|Overall Study|Progressive disease per protocol|17|||
162113086|NCT01889186|585464274|FG000|Overall Study|Stem cell transplant|2|||
162113087|NCT01889186|585464275|FG001|Overall Study|Stem cell transplant|1|||
162113088|NCT01889186|585464274|FG000|Overall Study|Withdrew consent|2|||
162113089|NCT01889186|585464275|FG001|Overall Study|Withdrew consent|3|||
162113090|NCT01889186|585464274|FG000|Overall Study|Other, not specified|18|||
162113091|NCT01889186|585464275|FG001|Overall Study|Other, not specified|15|||
162113092|NCT00621543|585464278|FG000|Overall Study|Lost to Follow-up|23|||
162113093|NCT02755597|585464279|FG000|Overall Study|Withdrew consent|27|||
162113094|NCT02755597|585464280|FG001|Overall Study|Withdrew consent|11|||
162113095|NCT02755597|585464279|FG000|Overall Study|Lost to Follow-up|1|||
162113096|NCT02755597|585464280|FG001|Overall Study|Lost to Follow-up|0|||
162113097|NCT02755597|585464279|FG000|Overall Study|Death|78|||
162113098|NCT02755597|585464280|FG001|Overall Study|Death|36|||
162113099|NCT02755597|585464279|FG000|Overall Study|Study terminated by Sponsor|67|||
162113100|NCT02755597|585464280|FG001|Overall Study|Study terminated by Sponsor|47|||
162113101|NCT02755597|585464279|FG000|Overall Study|Other, not specified|20|||
162113102|NCT02755597|585464280|FG001|Overall Study|Other, not specified|3|||
162113103|NCT02755597|585464279|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
162113104|NCT02755597|585464280|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
162113105|NCT04252742|585464281|FG000|Overall Study|Decision by sponsor|0|||
162113106|NCT04252742|585464282|FG001|Overall Study|Decision by sponsor|2|||
162113107|NCT04252742|585464281|FG000|Overall Study|Withdrawal by Subject|15|||
162113108|NCT04252742|585464282|FG001|Overall Study|Withdrawal by Subject|9|||
162113109|NCT04252742|585464281|FG000|Overall Study|Lost to Follow-up|0|||
162113110|NCT04252742|585464282|FG001|Overall Study|Lost to Follow-up|1|||
162113111|NCT03759834|585464283|FG000|Overall Study|Withdrawal by Subject|1|||
162113112|NCT00031486|585464286|FG000|Overall Study|Adverse Event|1|||
162113113|NCT00031486|585464287|FG001|Overall Study|Adverse Event|0|||
162113114|NCT00031486|585464286|FG000|Overall Study|Lost to Follow-up|0|||
162113115|NCT00031486|585464287|FG001|Overall Study|Lost to Follow-up|1|||
162113116|NCT00031486|585464286|FG000|Overall Study|Withdrawal by Subject|3|||
162113117|NCT00031486|585464287|FG001|Overall Study|Withdrawal by Subject|2|||
162113118|NCT00031486|585464286|FG000|Overall Study|Death|0|||
162113119|NCT00031486|585464287|FG001|Overall Study|Death|3|||
162113120|NCT00031486|585464286|FG000|Overall Study|Non-compliant|0|||
162113121|NCT00031486|585464287|FG001|Overall Study|Non-compliant|4|||
162113122|NCT00031486|585464286|FG000|Overall Study|Did not meet eligibility requirement|2|||
162113123|NCT00031486|585464287|FG001|Overall Study|Did not meet eligibility requirement|1|||
162113124|NCT00031486|585464286|FG000|Overall Study|Other|1|||
162113125|NCT00031486|585464287|FG001|Overall Study|Other|1|||
162113126|NCT01685138|585464288|FG000|Overall Study|Lost to Follow-up|1|||
162113127|NCT01685138|585464288|FG000|Overall Study|Protocol Violation|1|||
162113128|NCT01685138|585464288|FG000|Overall Study|No longer requires treatment|1|||
162113129|NCT01685138|585464288|FG000|Overall Study|Subject/guardian decision|2|||
162113130|NCT01685138|585464288|FG000|Overall Study|Physician Decision|6|||
162113131|NCT01685138|585464288|FG000|Overall Study|Death|10|||
162113132|NCT01685138|585464288|FG000|Overall Study|Adverse Event|18|||
162113133|NCT01685138|585464288|FG000|Overall Study|Progressive disease|53|||
162113134|NCT00689026|585464291|FG000|Overall Study|Withdrawal by Subject|13|||
162113135|NCT00689026|585464292|FG001|Overall Study|Withdrawal by Subject|6|||
162113136|NCT03996291|585464297|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
162113137|NCT03996291|585464298|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
162113138|NCT03996291|585464299|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
162113139|NCT03996291|585464300|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
162113140|NCT03996291|585464301|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
162113141|NCT03996291|585464302|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
162113142|NCT03996291|585464303|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
162113143|NCT03996291|585464304|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
162113144|NCT03996291|585464297|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
162113145|NCT03996291|585464298|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
162113146|NCT03996291|585464299|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
162113147|NCT03996291|585464300|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
162113148|NCT03996291|585464301|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
162113149|NCT03996291|585464302|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
162113150|NCT03996291|585464303|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
162113151|NCT03996291|585464304|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
162113152|NCT03996291|585464297|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
162113153|NCT03996291|585464298|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
162113154|NCT03996291|585464299|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
162113155|NCT03996291|585464300|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
162113156|NCT03996291|585464301|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
162113157|NCT03996291|585464302|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
162113158|NCT03996291|585464303|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
162113159|NCT03996291|585464304|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
162113160|NCT03996291|585464297|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
162113161|NCT03996291|585464298|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
162113162|NCT03996291|585464299|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
162113163|NCT03996291|585464300|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
162113164|NCT03996291|585464301|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
162113165|NCT03996291|585464302|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
162113166|NCT03996291|585464303|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
162113167|NCT03996291|585464304|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
162113168|NCT03996291|585464297|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162113169|NCT03996291|585464298|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162113170|NCT03996291|585464299|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162113171|NCT03996291|585464300|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162113172|NCT03996291|585464301|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
162113173|NCT03996291|585464302|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162113174|NCT03996291|585464303|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162113175|NCT03996291|585464304|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
162113176|NCT01659151|585464307|FG000|Overall Study|Inadequate TIL growth|1|||
162113177|NCT05774197|585464308|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
162113178|NCT05073133|585464311|FG000|Overall Study|Death|2|||
162113179|NCT04981678|585464312|FG000|Overall Study|Lost to Follow-up|0|||
162113180|NCT04981678|585464313|FG001|Overall Study|Lost to Follow-up|1|||
162113181|NCT03779906|585464314|FG000|Overall Study|Lost to Follow-up|7|||
162113182|NCT03779906|585464314|FG000|Overall Study|COVID pandemic|1|||
162113183|NCT02044848|585466126|FG000|Overall Study|Administrative Problems|2|||
162113184|NCT02044848|585466127|FG001|Overall Study|Administrative Problems|3|||
162113185|NCT03183388|585466128|FG000|Overall Study|Lost to Follow-up|3|||
162113186|NCT03183388|585466129|FG001|Overall Study|Lost to Follow-up|5|||
162113187|NCT03183388|585466128|FG000|Overall Study|Physician Decision|1|||
162113188|NCT03183388|585466129|FG001|Overall Study|Physician Decision|4|||
162113189|NCT03183388|585466128|FG000|Overall Study|Withdrawal by Subject|4|||
162113190|NCT03183388|585466129|FG001|Overall Study|Withdrawal by Subject|1|||
162113191|NCT03183388|585466128|FG000|Overall Study|Moved|1|||
162113192|NCT03183388|585466129|FG001|Overall Study|Moved|0|||
162113193|NCT03183388|585466128|FG000|Overall Study|Met Exclusion Criteria|2|||
162113194|NCT03183388|585466129|FG001|Overall Study|Met Exclusion Criteria|2|||
162113195|NCT03183388|585466128|FG000|Overall Study|COVID Pandemic Related|2|||
162113196|NCT03183388|585466129|FG001|Overall Study|COVID Pandemic Related|4|||
162113197|NCT00284141|585466134|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
162113198|NCT00284141|585466134|FG000|Overall Study|Adverse Event|19|||
162113199|NCT00284141|585466134|FG000|Overall Study|Participant's request|9|||
162113200|NCT00284141|585466134|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
162113201|NCT00284141|585466134|FG000|Overall Study|Clinical deterioration / death|2|||
162113202|NCT00284141|585466134|FG000|Overall Study|General decline|1|||
162113203|NCT00284141|585466134|FG000|Overall Study|Pneumonia|1|||
162113204|NCT00284141|585466134|FG000|Overall Study|Did not take study medication|2|||
162113205|NCT00284141|585466134|FG000|Overall Study|Ongoing treatment|2|||
162113206|NCT00803101|585466138|FG000|Overall Study|Death / Serious Adverse Event|4|||
162113207|NCT00803101|585466139|FG001|Overall Study|Death / Serious Adverse Event|6|||
162113208|NCT00803101|585466138|FG000|Overall Study|Withdrawal by Subject|6|||
162113209|NCT00803101|585466139|FG001|Overall Study|Withdrawal by Subject|4|||
162113210|NCT00803101|585466138|FG000|Overall Study|Lost to Follow-up|2|||
162113211|NCT00803101|585466139|FG001|Overall Study|Lost to Follow-up|2|||
162113212|NCT00803101|585466138|FG000|Overall Study|Protocol Violation|1|||
162113213|NCT00803101|585466139|FG001|Overall Study|Protocol Violation|7|||
162113214|NCT00803101|585466138|FG000|Overall Study|Surgery finished outside protocol window|1|||
162113215|NCT00803101|585466139|FG001|Overall Study|Surgery finished outside protocol window|1|||
162113216|NCT00803101|585466138|FG000|Overall Study|Patient died outside SAE report period|1|||
162113217|NCT00803101|585466139|FG001|Overall Study|Patient died outside SAE report period|0|||
162113218|NCT00803101|585466138|FG000|Overall Study|Patient did not attend scheduled visit|2|||
162113219|NCT00803101|585466139|FG001|Overall Study|Patient did not attend scheduled visit|1|||
162113220|NCT00803101|585466138|FG000|Overall Study|Patient did not have surgery|1|||
162113221|NCT00803101|585466139|FG001|Overall Study|Patient did not have surgery|1|||
162113222|NCT01782742|585466140|FG000|Double-blind Treatment Phase|Adverse Event|1|||
162113223|NCT01782742|585466141|FG001|Double-blind Treatment Phase|Adverse Event|0|||
162113224|NCT01529008|585466142|FG000|Bone Marrow Harvesting|Physician Decision|1|||
162113225|NCT01529008|585466143|FG001|Bone Marrow Harvesting|Physician Decision|1|||
162113226|NCT01529008|585466142|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
162113227|NCT01529008|585466143|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
162113228|NCT01529008|585466142|FG000|Treatment|Adverse Event|6|||
162113229|NCT01529008|585466143|FG001|Treatment|Adverse Event|0|||
162113230|NCT01529008|585466142|FG000|Treatment|Other|3|||
162113231|NCT01529008|585466143|FG001|Treatment|Other|1|||
162113232|NCT01529008|585466142|FG000|Efficacy Analysis|Protocol Violation|2|||
162113233|NCT01529008|585466143|FG001|Efficacy Analysis|Protocol Violation|0|||
162113234|NCT01529008|585466142|FG000|Efficacy Analysis|Physician Decision|0|||
162113235|NCT01529008|585466143|FG001|Efficacy Analysis|Physician Decision|1|||
162113236|NCT01529008|585466142|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
162113237|NCT01529008|585466143|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
162113238|NCT04170686|585466144|FG000|Screening|Physician Decision|12|||
162113239|NCT04170686|585466145|FG001|Screening|Physician Decision|13|||
162113240|NCT04170686|585466144|FG000|Randomization and Treatment|Lost to Follow-up|26|||
162113241|NCT04170686|585466145|FG001|Randomization and Treatment|Lost to Follow-up|15|||
162113242|NCT04425902|585466148|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
162113243|NCT01191840|585466149|FG000|Overall Study|withdrew consent|2|||
162113244|NCT01191840|585466150|FG001|Overall Study|withdrew consent|1|||
162113245|NCT01191840|585466149|FG000|Overall Study|Subject discontinued treatment|1|||
162113246|NCT01191840|585466150|FG001|Overall Study|Subject discontinued treatment|2|||
162113247|NCT01191840|585466149|FG000|Overall Study|Lost to Follow-up|4|||
162113248|NCT01191840|585466150|FG001|Overall Study|Lost to Follow-up|6|||
162113249|NCT01191840|585466149|FG000|Overall Study|Non Staph Infection|4|||
162113250|NCT01191840|585466150|FG001|Overall Study|Non Staph Infection|3|||
162113251|NCT01191840|585466149|FG000|Overall Study|ineligible at enrollment|1|||
162113252|NCT01191840|585466150|FG001|Overall Study|ineligible at enrollment|0|||
162113253|NCT01191840|585466149|FG000|Overall Study|IRB approval lapse|0|||
162113254|NCT01191840|585466150|FG001|Overall Study|IRB approval lapse|2|||
162113255|NCT01191840|585466149|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
162113256|NCT01191840|585466150|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
162113257|NCT01191840|585466149|FG000|Overall Study|Withdrawal by Subject|2|||
162113258|NCT01191840|585466150|FG001|Overall Study|Withdrawal by Subject|0|||
162113259|NCT02487498|585466151|FG000|Period: Period 1|Adverse Event|2|||
162113260|NCT02487498|585466152|FG001|Period: Period 1|Adverse Event|4|||
162113261|NCT02487498|585466151|FG000|Period: Period 1|Subject/guardian decision|2|||
162113262|NCT02487498|585466152|FG001|Period: Period 1|Subject/guardian decision|4|||
162113263|NCT02487498|585466151|FG000|Period: Period 1|Lost to Follow-up|0|||
162113264|NCT02487498|585466152|FG001|Period: Period 1|Lost to Follow-up|2|||
162113265|NCT02487498|585466151|FG000|Period: Period 1|Lack of Efficacy|1|||
162113266|NCT02487498|585466152|FG001|Period: Period 1|Lack of Efficacy|0|||
162113267|NCT02487498|585466151|FG000|Period: Period 1|Physician Decision|0|||
162113268|NCT02487498|585466152|FG001|Period: Period 1|Physician Decision|1|||
162113269|NCT02487498|585466151|FG000|Period: Period 1|Protocol deviation|1|||
162113270|NCT02487498|585466152|FG001|Period: Period 1|Protocol deviation|0|||
162113271|NCT02487498|585466151|FG000|Period: Washout|Subject/guardian decision|0|||
162113272|NCT02487498|585466152|FG001|Period: Washout|Subject/guardian decision|5|||
162113273|NCT02487498|585466151|FG000|Period: Washout|Lack of Efficacy|1|||
162113274|NCT02487498|585466152|FG001|Period: Washout|Lack of Efficacy|1|||
162113275|NCT02487498|585466151|FG000|Period: Washout|Physician Decision|1|||
162113276|NCT02487498|585466152|FG001|Period: Washout|Physician Decision|0|||
162113277|NCT02487498|585466151|FG000|Period: Washout|Non-compliance with study treatment|0|||
162113278|NCT02487498|585466152|FG001|Period: Washout|Non-compliance with study treatment|1|||
162113279|NCT02487498|585466151|FG000|Period: Period 2|Adverse Event|2|||
162113280|NCT02487498|585466152|FG001|Period: Period 2|Adverse Event|2|||
162113281|NCT02487498|585466151|FG000|Period: Period 2|Subject/guardian decision|2|||
162113282|NCT02487498|585466152|FG001|Period: Period 2|Subject/guardian decision|1|||
162113283|NCT02487498|585466151|FG000|Period: Period 2|Lost to Follow-up|1|||
162113284|NCT02487498|585466152|FG001|Period: Period 2|Lost to Follow-up|1|||
162113285|NCT02487498|585466151|FG000|Period: Period 2|Death|0|||
162113286|NCT02487498|585466152|FG001|Period: Period 2|Death|1|||
162113287|NCT02487498|585466151|FG000|Period: Period 2|Physician Decision|1|||
162113288|NCT02487498|585466152|FG001|Period: Period 2|Physician Decision|0|||
162113289|NCT00261495|585466155|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
162113290|NCT00261495|585466156|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
162113291|NCT00261495|585466155|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
162113292|NCT00261495|585466156|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
162113293|NCT00261495|585466155|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
162113294|NCT00261495|585466156|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
162113295|NCT00261495|585466155|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
162113296|NCT00261495|585466156|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
162113297|NCT00261495|585466155|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
162113298|NCT00261495|585466156|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
162113299|NCT00261495|585466155|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
162113300|NCT00261495|585466156|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
162113301|NCT00261495|585466155|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
162113302|NCT00261495|585466156|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
162113303|NCT00261495|585466155|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
162113304|NCT00261495|585466156|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
162113305|NCT00261495|585466155|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
162113306|NCT00261495|585466156|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
162113307|NCT00261495|585466155|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
162113308|NCT00261495|585466156|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
162113309|NCT00261495|585466155|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
162113310|NCT00261495|585466156|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
162113311|NCT00261495|585466155|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
162113312|NCT00261495|585466156|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
162113313|NCT00261495|585466155|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
162113314|NCT00261495|585466156|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
162113315|NCT00261495|585466155|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
162113316|NCT00261495|585466156|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
162113317|NCT00261495|585466155|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
162113318|NCT00261495|585466156|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
162113319|NCT00261495|585466155|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
162113320|NCT00261495|585466156|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
162113321|NCT00261495|585466155|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
162113322|NCT00261495|585466156|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
162113323|NCT00261495|585466155|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
162113324|NCT00261495|585466156|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
162113325|NCT00261495|585466155|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
162113326|NCT00261495|585466156|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
162113327|NCT00261495|585466155|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
162113328|NCT00261495|585466156|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
162113329|NCT00261495|585466155|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
162113330|NCT00261495|585466156|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
162113331|NCT00429663|585466157|FG000|Overall Study|Lost to Follow-up|24|||
162113332|NCT00429663|585466158|FG001|Overall Study|Lost to Follow-up|31|||
162113333|NCT00429663|585466157|FG000|Overall Study|Physician Decision|6|||
162113334|NCT00429663|585466158|FG001|Overall Study|Physician Decision|3|||
162113335|NCT00429663|585466157|FG000|Overall Study|Withdrawal by Subject|2|||
162113336|NCT00429663|585466158|FG001|Overall Study|Withdrawal by Subject|5|||
162113337|NCT00429663|585466157|FG000|Overall Study|Death|4|||
162113338|NCT00429663|585466158|FG001|Overall Study|Death|0|||
162113339|NCT04207840|585466159|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
162113340|NCT04207840|585466160|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
162113341|NCT04207840|585466161|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
162113342|NCT04207840|585466159|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
162113343|NCT04207840|585466160|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
162113344|NCT04207840|585466161|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
162113345|NCT03243422|585466164|FG000|Overall Study|Death|20|||
162113346|NCT03243422|585466165|FG001|Overall Study|Death|21|||
162113347|NCT03243422|585466164|FG000|Overall Study|Lost to Follow-up|9|||
162113348|NCT03243422|585466165|FG001|Overall Study|Lost to Follow-up|21|||
162113349|NCT03243422|585466164|FG000|Overall Study|Withdrawal by Subject|22|||
162113350|NCT03243422|585466165|FG001|Overall Study|Withdrawal by Subject|8|||
162113351|NCT03420781|585466168|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
162113352|NCT03420781|585466169|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
162113353|NCT03420781|585466170|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
162113354|NCT03420781|585466171|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
162113355|NCT03420781|585466172|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
162113356|NCT03420781|585466168|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
162113357|NCT03420781|585466169|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
162113358|NCT03420781|585466170|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
162113359|NCT03420781|585466171|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
162113360|NCT03420781|585466172|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
162113361|NCT03420781|585466168|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
162113362|NCT03420781|585466169|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
162113363|NCT03420781|585466170|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
162113364|NCT03420781|585466171|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
162113365|NCT03420781|585466172|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
162113366|NCT03420781|585466168|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
162113367|NCT03420781|585466169|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
162113368|NCT03420781|585466170|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
162113369|NCT03420781|585466171|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
162113370|NCT03420781|585466172|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
162113371|NCT03420781|585466168|FG000|Treatment Period (40 Weeks)|Death|2|||
162113372|NCT03420781|585466169|FG001|Treatment Period (40 Weeks)|Death|2|||
162113373|NCT03420781|585466170|FG002|Treatment Period (40 Weeks)|Death|0|||
162113374|NCT03420781|585466171|FG003|Treatment Period (40 Weeks)|Death|0|||
162113375|NCT03420781|585466172|FG004|Treatment Period (40 Weeks)|Death|0|||
162113376|NCT03420781|585466168|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
162113377|NCT03420781|585466169|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
162113378|NCT03420781|585466170|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
162113379|NCT03420781|585466171|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
162113380|NCT03420781|585466172|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
162113381|NCT03420781|585466168|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
162113382|NCT03420781|585466169|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
162113383|NCT03420781|585466170|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
162113384|NCT03420781|585466171|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
162113385|NCT03420781|585466172|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
162113386|NCT03420781|585466168|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
162113387|NCT03420781|585466169|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
162113388|NCT03420781|585466170|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
162113389|NCT03420781|585466171|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
162113390|NCT03420781|585466172|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
162113391|NCT03420781|585466168|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
162113392|NCT03420781|585466169|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
162113393|NCT03420781|585466170|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
162113394|NCT03420781|585466171|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
162113395|NCT03420781|585466172|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
162113396|NCT03420781|585466168|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
162113397|NCT03420781|585466169|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
162113398|NCT03420781|585466170|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
162113399|NCT03420781|585466171|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
162113400|NCT03420781|585466172|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
162113401|NCT03420781|585466168|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
162113402|NCT03420781|585466169|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
162113403|NCT03420781|585466170|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
162113404|NCT03420781|585466171|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
162113405|NCT03420781|585466172|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
162113406|NCT03420781|585466168|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
162113407|NCT03420781|585466169|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
162113408|NCT03420781|585466170|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
162113409|NCT03420781|585466171|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
162113410|NCT03420781|585466172|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
162113411|NCT03420781|585466168|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
162113412|NCT03420781|585466169|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
162113413|NCT03420781|585466170|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
162113414|NCT03420781|585466171|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
162113415|NCT03420781|585466172|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
162113416|NCT01330316|585466173|FG000|Overall Study|Adverse Event|2|||
162113417|NCT01330316|585466174|FG001|Overall Study|Adverse Event|2|||
162113418|NCT01330316|585466173|FG000|Overall Study|Lack of Efficacy|0|||
162113419|NCT01330316|585466174|FG001|Overall Study|Lack of Efficacy|10|||
162113420|NCT01330316|585466173|FG000|Overall Study|Lost to Follow-up|0|||
162113421|NCT01330316|585466174|FG001|Overall Study|Lost to Follow-up|1|||
162113422|NCT01330316|585466173|FG000|Overall Study|Withdrawal by Subject|0|||
162113423|NCT01330316|585466174|FG001|Overall Study|Withdrawal by Subject|1|||
162113424|NCT01330316|585466173|FG000|Overall Study|other than above|0|||
162113425|NCT01330316|585466174|FG001|Overall Study|other than above|1|||
162113426|NCT00246337|585466177|FG000|Overall Study|Lost to Follow-up|3|||
162113427|NCT00246337|585466178|FG001|Overall Study|Lost to Follow-up|0|||
162113428|NCT00246337|585466179|FG002|Overall Study|Lost to Follow-up|0|||
162113429|NCT00246337|585466180|FG003|Overall Study|Lost to Follow-up|0|||
162113430|NCT00246337|585466181|FG004|Overall Study|Lost to Follow-up|2|||
162113431|NCT00246337|585466182|FG005|Overall Study|Lost to Follow-up|2|||
162113432|NCT00246337|585466183|FG006|Overall Study|Lost to Follow-up|1|||
162113433|NCT00246337|585466184|FG007|Overall Study|Lost to Follow-up|2|||
162113434|NCT00246337|585466185|FG008|Overall Study|Lost to Follow-up|0|||
162113435|NCT00246337|585466177|FG000|Overall Study|Protocol Violation|1|||
162113436|NCT00246337|585466178|FG001|Overall Study|Protocol Violation|0|||
162113437|NCT00246337|585466179|FG002|Overall Study|Protocol Violation|0|||
162113438|NCT00246337|585466180|FG003|Overall Study|Protocol Violation|0|||
162113439|NCT00246337|585466181|FG004|Overall Study|Protocol Violation|1|||
162113440|NCT00246337|585466182|FG005|Overall Study|Protocol Violation|0|||
162113441|NCT00246337|585466183|FG006|Overall Study|Protocol Violation|1|||
162113442|NCT00246337|585466184|FG007|Overall Study|Protocol Violation|1|||
162113443|NCT00246337|585466185|FG008|Overall Study|Protocol Violation|0|||
162113444|NCT00246337|585466177|FG000|Overall Study|Withdrawal by Subject|2|||
162113445|NCT00246337|585466178|FG001|Overall Study|Withdrawal by Subject|0|||
162113446|NCT00246337|585466179|FG002|Overall Study|Withdrawal by Subject|0|||
162113447|NCT00246337|585466180|FG003|Overall Study|Withdrawal by Subject|0|||
162113448|NCT00246337|585466181|FG004|Overall Study|Withdrawal by Subject|0|||
162113449|NCT00246337|585466182|FG005|Overall Study|Withdrawal by Subject|0|||
162113450|NCT00246337|585466183|FG006|Overall Study|Withdrawal by Subject|1|||
162113451|NCT00246337|585466184|FG007|Overall Study|Withdrawal by Subject|1|||
162113452|NCT00246337|585466185|FG008|Overall Study|Withdrawal by Subject|0|||
162113453|NCT00246337|585466177|FG000|Overall Study|Lack of Qualifying Event|8|||
162113454|NCT00246337|585466178|FG001|Overall Study|Lack of Qualifying Event|2|||
162113455|NCT00246337|585466179|FG002|Overall Study|Lack of Qualifying Event|1|||
162113456|NCT00246337|585466180|FG003|Overall Study|Lack of Qualifying Event|1|||
162113457|NCT00246337|585466181|FG004|Overall Study|Lack of Qualifying Event|1|||
162113458|NCT00246337|585466182|FG005|Overall Study|Lack of Qualifying Event|3|||
162113459|NCT00246337|585466183|FG006|Overall Study|Lack of Qualifying Event|3|||
162113460|NCT00246337|585466184|FG007|Overall Study|Lack of Qualifying Event|2|||
162113461|NCT00246337|585466185|FG008|Overall Study|Lack of Qualifying Event|5|||
162113462|NCT00246337|585466177|FG000|Overall Study|Site Terminated|10|||
162113463|NCT00246337|585466178|FG001|Overall Study|Site Terminated|0|||
162113464|NCT00246337|585466179|FG002|Overall Study|Site Terminated|0|||
162113465|NCT00246337|585466180|FG003|Overall Study|Site Terminated|0|||
162113466|NCT00246337|585466181|FG004|Overall Study|Site Terminated|0|||
162113467|NCT00246337|585466182|FG005|Overall Study|Site Terminated|7|||
162113468|NCT00246337|585466183|FG006|Overall Study|Site Terminated|1|||
162113469|NCT00246337|585466184|FG007|Overall Study|Site Terminated|6|||
162113470|NCT00246337|585466185|FG008|Overall Study|Site Terminated|2|||
162113471|NCT00246337|585466177|FG000|Overall Study|Abnormal baseline lab values|7|||
162113472|NCT00246337|585466178|FG001|Overall Study|Abnormal baseline lab values|0|||
162113473|NCT00246337|585466179|FG002|Overall Study|Abnormal baseline lab values|2|||
162113474|NCT00246337|585466180|FG003|Overall Study|Abnormal baseline lab values|0|||
162113475|NCT00246337|585466181|FG004|Overall Study|Abnormal baseline lab values|0|||
162113476|NCT00246337|585466182|FG005|Overall Study|Abnormal baseline lab values|2|||
162113477|NCT00246337|585466183|FG006|Overall Study|Abnormal baseline lab values|2|||
162113478|NCT00246337|585466184|FG007|Overall Study|Abnormal baseline lab values|0|||
162113479|NCT00246337|585466185|FG008|Overall Study|Abnormal baseline lab values|4|||
162113480|NCT00246337|585466177|FG000|Overall Study|Overwhelmed|0|||
162113481|NCT00246337|585466178|FG001|Overall Study|Overwhelmed|0|||
162113482|NCT00246337|585466179|FG002|Overall Study|Overwhelmed|0|||
162113483|NCT00246337|585466180|FG003|Overall Study|Overwhelmed|0|||
162113484|NCT00246337|585466181|FG004|Overall Study|Overwhelmed|0|||
162113485|NCT00246337|585466182|FG005|Overall Study|Overwhelmed|1|||
162113486|NCT00246337|585466183|FG006|Overall Study|Overwhelmed|0|||
162113487|NCT00246337|585466184|FG007|Overall Study|Overwhelmed|0|||
162113488|NCT00246337|585466185|FG008|Overall Study|Overwhelmed|0|||
162113489|NCT00246337|585466177|FG000|Overall Study|Protocol Violator|1|||
162113490|NCT00246337|585466178|FG001|Overall Study|Protocol Violator|0|||
162113491|NCT00246337|585466179|FG002|Overall Study|Protocol Violator|0|||
162113492|NCT00246337|585466180|FG003|Overall Study|Protocol Violator|0|||
162113493|NCT00246337|585466181|FG004|Overall Study|Protocol Violator|0|||
162113494|NCT00246337|585466182|FG005|Overall Study|Protocol Violator|0|||
162113495|NCT00246337|585466183|FG006|Overall Study|Protocol Violator|0|||
162113496|NCT00246337|585466184|FG007|Overall Study|Protocol Violator|0|||
162113497|NCT00246337|585466185|FG008|Overall Study|Protocol Violator|0|||
162113498|NCT00246337|585466177|FG000|Overall Study|Reported as completing trial in error|0|||
162113499|NCT00246337|585466178|FG001|Overall Study|Reported as completing trial in error|0|||
162113500|NCT00246337|585466179|FG002|Overall Study|Reported as completing trial in error|0|||
162113501|NCT00246337|585466180|FG003|Overall Study|Reported as completing trial in error|0|||
162113502|NCT00246337|585466181|FG004|Overall Study|Reported as completing trial in error|0|||
162113503|NCT00246337|585466182|FG005|Overall Study|Reported as completing trial in error|0|||
162113504|NCT00246337|585466183|FG006|Overall Study|Reported as completing trial in error|0|||
162113505|NCT00246337|585466184|FG007|Overall Study|Reported as completing trial in error|1|||
162113506|NCT00246337|585466185|FG008|Overall Study|Reported as completing trial in error|0|||
162113507|NCT02696564|585466188|FG000|Overall Study|Death|1|||
162113508|NCT02696564|585466189|FG001|Overall Study|Death|2|||
162113509|NCT02696564|585466188|FG000|Overall Study|Withdrawal by Subject|3|||
162113510|NCT02696564|585466189|FG001|Overall Study|Withdrawal by Subject|2|||
162113511|NCT02696564|585466188|FG000|Overall Study|Lost to Follow-up|3|||
162113512|NCT02696564|585466189|FG001|Overall Study|Lost to Follow-up|3|||
162113513|NCT02696564|585466188|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
162113514|NCT02696564|585466189|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
162113515|NCT02696564|585466188|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
162113516|NCT02696564|585466189|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
162113517|NCT02696564|585466188|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
162113518|NCT02696564|585466189|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
162113519|NCT02696564|585466188|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
162113520|NCT02696564|585466189|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
162113521|NCT02696564|585466188|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
162113522|NCT02696564|585466189|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
162113523|NCT04067401|585466190|FG000|Overall Study|Withdrawal by Subject|7|||
162113524|NCT04067401|585466191|FG001|Overall Study|Withdrawal by Subject|0|||
162113525|NCT04067401|585466190|FG000|Overall Study|no data provided|1|||
162113526|NCT04067401|585466191|FG001|Overall Study|no data provided|0|||
162113527|NCT03633929|585466192|FG000|Overall Study|Lost to Follow-up|1|||
162113528|NCT03633929|585466192|FG000|Overall Study|Did not login to software. Did not participate|3|||
162113529|NCT02287584|585466194|FG000|the Double-blind Phase|Adverse Event|17|||
162113530|NCT02287584|585466195|FG001|the Double-blind Phase|Adverse Event|17|||
162113531|NCT02287584|585466196|FG002|the Double-blind Phase|Adverse Event|12|||
162113532|NCT02287584|585466197|FG003|the Double-blind Phase|Adverse Event|0|||
162113533|NCT02287584|585466198|FG004|the Double-blind Phase|Adverse Event|0|||
162113534|NCT02287584|585466199|FG005|the Double-blind Phase|Adverse Event|0|||
162113535|NCT02287584|585466194|FG000|the Double-blind Phase|Lack of Efficacy|18|||
162113536|NCT02287584|585466195|FG001|the Double-blind Phase|Lack of Efficacy|8|||
162113537|NCT02287584|585466196|FG002|the Double-blind Phase|Lack of Efficacy|8|||
162113538|NCT02287584|585466197|FG003|the Double-blind Phase|Lack of Efficacy|0|||
162113539|NCT02287584|585466198|FG004|the Double-blind Phase|Lack of Efficacy|0|||
162113540|NCT02287584|585466199|FG005|the Double-blind Phase|Lack of Efficacy|0|||
162113541|NCT02287584|585466194|FG000|the Double-blind Phase|Lost to Follow-up|0|||
162113542|NCT02287584|585466195|FG001|the Double-blind Phase|Lost to Follow-up|1|||
162113543|NCT02287584|585466196|FG002|the Double-blind Phase|Lost to Follow-up|1|||
162113544|NCT02287584|585466197|FG003|the Double-blind Phase|Lost to Follow-up|0|||
162113545|NCT02287584|585466198|FG004|the Double-blind Phase|Lost to Follow-up|0|||
162113546|NCT02287584|585466199|FG005|the Double-blind Phase|Lost to Follow-up|0|||
162113547|NCT02287584|585466194|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
162113548|NCT02287584|585466195|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
162113549|NCT02287584|585466196|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
162113550|NCT02287584|585466197|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
162113551|NCT02287584|585466198|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
162113552|NCT02287584|585466199|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
162113553|NCT02287584|585466194|FG000|the Double-blind Phase|Pregnancy|0|||
162113554|NCT02287584|585466195|FG001|the Double-blind Phase|Pregnancy|1|||
162113555|NCT02287584|585466196|FG002|the Double-blind Phase|Pregnancy|0|||
162113556|NCT02287584|585466197|FG003|the Double-blind Phase|Pregnancy|0|||
162113557|NCT02287584|585466198|FG004|the Double-blind Phase|Pregnancy|0|||
162113558|NCT02287584|585466199|FG005|the Double-blind Phase|Pregnancy|0|||
162113559|NCT02287584|585466194|FG000|the Double-blind Phase|Protocol Violation|0|||
162113560|NCT02287584|585466195|FG001|the Double-blind Phase|Protocol Violation|3|||
162113561|NCT02287584|585466196|FG002|the Double-blind Phase|Protocol Violation|0|||
162113562|NCT02287584|585466197|FG003|the Double-blind Phase|Protocol Violation|0|||
162113563|NCT02287584|585466198|FG004|the Double-blind Phase|Protocol Violation|0|||
162113564|NCT02287584|585466199|FG005|the Double-blind Phase|Protocol Violation|0|||
162113565|NCT02287584|585466194|FG000|the Double-blind Phase|other reasons|0|||
162113566|NCT02287584|585466195|FG001|the Double-blind Phase|other reasons|0|||
162113567|NCT02287584|585466196|FG002|the Double-blind Phase|other reasons|1|||
162113568|NCT02287584|585466197|FG003|the Double-blind Phase|other reasons|0|||
162113569|NCT02287584|585466198|FG004|the Double-blind Phase|other reasons|0|||
162113570|NCT02287584|585466199|FG005|the Double-blind Phase|other reasons|0|||
162113571|NCT02287584|585466194|FG000|the Open-label Phase|Did not receive drug|0|||
162113572|NCT02287584|585466195|FG001|the Open-label Phase|Did not receive drug|0|||
162113573|NCT02287584|585466196|FG002|the Open-label Phase|Did not receive drug|0|||
162113574|NCT02287584|585466197|FG003|the Open-label Phase|Did not receive drug|7|||
162113575|NCT02287584|585466198|FG004|the Open-label Phase|Did not receive drug|6|||
162113576|NCT02287584|585466199|FG005|the Open-label Phase|Did not receive drug|4|||
162113577|NCT02287584|585466194|FG000|the Open-label Phase|Adverse Event|0|||
162113578|NCT02287584|585466195|FG001|the Open-label Phase|Adverse Event|0|||
162113579|NCT02287584|585466196|FG002|the Open-label Phase|Adverse Event|0|||
162113580|NCT02287584|585466197|FG003|the Open-label Phase|Adverse Event|15|||
162113581|NCT02287584|585466198|FG004|the Open-label Phase|Adverse Event|12|||
162113582|NCT02287584|585466199|FG005|the Open-label Phase|Adverse Event|16|||
162113583|NCT02287584|585466194|FG000|the Open-label Phase|Lack of Efficacy|0|||
162113584|NCT02287584|585466195|FG001|the Open-label Phase|Lack of Efficacy|0|||
162113585|NCT02287584|585466196|FG002|the Open-label Phase|Lack of Efficacy|0|||
162113586|NCT02287584|585466197|FG003|the Open-label Phase|Lack of Efficacy|8|||
162113587|NCT02287584|585466198|FG004|the Open-label Phase|Lack of Efficacy|3|||
162113588|NCT02287584|585466199|FG005|the Open-label Phase|Lack of Efficacy|7|||
162113589|NCT02287584|585466194|FG000|the Open-label Phase|Lost to Follow-up|0|||
162113590|NCT02287584|585466195|FG001|the Open-label Phase|Lost to Follow-up|0|||
162113591|NCT02287584|585466196|FG002|the Open-label Phase|Lost to Follow-up|0|||
162113592|NCT02287584|585466197|FG003|the Open-label Phase|Lost to Follow-up|4|||
162113593|NCT02287584|585466198|FG004|the Open-label Phase|Lost to Follow-up|1|||
162113594|NCT02287584|585466199|FG005|the Open-label Phase|Lost to Follow-up|2|||
162113595|NCT02287584|585466194|FG000|the Open-label Phase|Withdrawal by Subject|0|||
162113596|NCT02287584|585466195|FG001|the Open-label Phase|Withdrawal by Subject|0|||
162113597|NCT02287584|585466196|FG002|the Open-label Phase|Withdrawal by Subject|0|||
162113598|NCT02287584|585466197|FG003|the Open-label Phase|Withdrawal by Subject|18|||
162113599|NCT02287584|585466198|FG004|the Open-label Phase|Withdrawal by Subject|29|||
162113600|NCT02287584|585466199|FG005|the Open-label Phase|Withdrawal by Subject|21|||
162113601|NCT02287584|585466194|FG000|the Open-label Phase|non-compliance|0|||
162113602|NCT02287584|585466195|FG001|the Open-label Phase|non-compliance|0|||
162113603|NCT02287584|585466196|FG002|the Open-label Phase|non-compliance|0|||
162113604|NCT02287584|585466197|FG003|the Open-label Phase|non-compliance|2|||
162113605|NCT02287584|585466198|FG004|the Open-label Phase|non-compliance|5|||
162113606|NCT02287584|585466199|FG005|the Open-label Phase|non-compliance|1|||
162113607|NCT02287584|585466194|FG000|the Open-label Phase|other reasons|0|||
162113608|NCT02287584|585466195|FG001|the Open-label Phase|other reasons|0|||
162113609|NCT02287584|585466196|FG002|the Open-label Phase|other reasons|0|||
162113610|NCT02287584|585466197|FG003|the Open-label Phase|other reasons|3|||
162113611|NCT02287584|585466198|FG004|the Open-label Phase|other reasons|6|||
162113612|NCT02287584|585466199|FG005|the Open-label Phase|other reasons|6|||
162113613|NCT03124199|585466200|FG000|Overall Study|Lost to Follow-up|4|||
162113614|NCT03086018|585466202|FG000|Final Testing for End of Trial|Adverse Event|1|||
162113615|NCT03086018|585466202|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
162113616|NCT02309112|585466203|FG000|Overall Study|Withdrawal by Subject|1|||
162113617|NCT02309112|585466204|FG001|Overall Study|Withdrawal by Subject|0|||
162113618|NCT02309112|585466205|FG002|Overall Study|Withdrawal by Subject|1|||
162113619|NCT02309112|585466203|FG000|Overall Study|Lost to Follow-up|0|||
162113620|NCT02309112|585466204|FG001|Overall Study|Lost to Follow-up|1|||
162113621|NCT02309112|585466205|FG002|Overall Study|Lost to Follow-up|0|||
162113622|NCT01892345|585466206|FG000|Overall Study|Adverse Event|0|||
162113623|NCT01892345|585466207|FG001|Overall Study|Adverse Event|2|||
162113624|NCT01892345|585466206|FG000|Overall Study|Death|1|||
162113625|NCT01892345|585466207|FG001|Overall Study|Death|0|||
162113626|NCT01892345|585466206|FG000|Overall Study|Lost to Follow-up|3|||
162113627|NCT01892345|585466207|FG001|Overall Study|Lost to Follow-up|0|||
162113628|NCT01892345|585466206|FG000|Overall Study|Withdrawal by Subject|12|||
162113629|NCT01892345|585466207|FG001|Overall Study|Withdrawal by Subject|1|||
162113630|NCT00659984|585466211|FG000|Overall Study|Adverse Event|1|||
162113631|NCT03745222|585466212|FG000|Overall Study|Withdrawal by Subject|0|||
162113632|NCT03745222|585466213|FG001|Overall Study|Withdrawal by Subject|1|||
162113633|NCT03745222|585466214|FG002|Overall Study|Withdrawal by Subject|0|||
162113634|NCT02657317|585466215|FG000|Overall Study|Withdrawal by Subject|2|||
162113635|NCT02657317|585466216|FG001|Overall Study|Withdrawal by Subject|0|||
162113636|NCT02657317|585466215|FG000|Overall Study|Lost to Follow-up|3|||
162113637|NCT02657317|585466216|FG001|Overall Study|Lost to Follow-up|3|||
162113638|NCT01784068|585466220|FG000|NTCS Phase|Adverse Event|5|||
162113639|NCT01784068|585466221|FG001|NTCS Phase|Adverse Event|0|||
162113640|NCT01784068|585466220|FG000|NTCS Phase|Physician Decision|2|||
162113641|NCT01784068|585466221|FG001|NTCS Phase|Physician Decision|0|||
162113642|NCT01784068|585466220|FG000|NTCS Phase|Patient/guardian decision|3|||
162113643|NCT01784068|585466221|FG001|NTCS Phase|Patient/guardian decision|0|||
162113644|NCT01784068|585466220|FG000|NTCS Phase|Death|2|||
162113645|NCT01784068|585466221|FG001|NTCS Phase|Death|0|||
162113646|NCT01784068|585466220|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
162113647|NCT01784068|585466221|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
162113648|NCT01784068|585466220|FG000|TFR Phase|Physician Decision|0|||
162113649|NCT01784068|585466221|FG001|TFR Phase|Physician Decision|1|||
162113650|NCT01784068|585466220|FG000|TFR Phase|Patient/guardian decision|0|||
162113651|NCT01784068|585466221|FG001|TFR Phase|Patient/guardian decision|3|||
162113652|NCT01784068|585466220|FG000|TFR Phase|Death|0|||
162113653|NCT01784068|585466221|FG001|TFR Phase|Death|1|||
162113654|NCT01784068|585466220|FG000|TFR Phase|Lack of Efficacy|0|||
162113655|NCT01784068|585466221|FG001|TFR Phase|Lack of Efficacy|88|||
162113656|NCT06351371|585466222|FG000|Overall Study|Mutation Status Not Confirmed|9|||
162113657|NCT06351371|585466222|FG000|Overall Study|Ineligible|1|||
162113658|NCT06351371|585466222|FG000|Overall Study|Adverse Event|4|||
162113659|NCT06351371|585466222|FG000|Overall Study|Death|1|||
162113660|NCT06351371|585466222|FG000|Overall Study|Disease progression|14|||
162113661|NCT06351371|585466222|FG000|Overall Study|Withdrawal by Subject|3|||
162113662|NCT06351371|585466222|FG000|Overall Study|Physician Decision|3|||
162113663|NCT04359784|585466223|FG000|Overall Study|Death|2|||
162113664|NCT02063828|585466224|FG000|Overall Study|Withdrawal by Subject|4|||
162113665|NCT02063828|585466225|FG001|Overall Study|Withdrawal by Subject|6|||
162113666|NCT02063828|585466226|FG002|Overall Study|Withdrawal by Subject|3|||
162113667|NCT02063828|585466224|FG000|Overall Study|Death|0|||
162113668|NCT02063828|585466225|FG001|Overall Study|Death|0|||
162113669|NCT02063828|585466226|FG002|Overall Study|Death|1|||
162113670|NCT02753595|585466227|FG000|Overall Study|Sponsor termination|2|||
162113671|NCT02753595|585466228|FG001|Overall Study|Sponsor termination|2|||
162113672|NCT02515279|585466232|FG000|Overall Study|Adverse Event|7|||
162113673|NCT02515279|585466232|FG000|Overall Study|Lack of Efficacy|31|||
162113674|NCT02515279|585466232|FG000|Overall Study|Lost to Follow-up|9|||
162113675|NCT02515279|585466232|FG000|Overall Study|Withdrawal by Subject|18|||
162113676|NCT02515279|585466232|FG000|Overall Study|End-of-treatment visit not attended|17|||
162113677|NCT02515279|585466232|FG000|Overall Study|Other|22|||
162113678|NCT01800968|585466233|FG000|Overall Study|Death|23|||
162113679|NCT01800968|585466234|FG001|Overall Study|Death|16|||
162113680|NCT01800968|585466233|FG000|Overall Study|Lost to Follow-up|5|||
162113681|NCT01800968|585466234|FG001|Overall Study|Lost to Follow-up|7|||
162113682|NCT01800968|585466233|FG000|Overall Study|Withdrawal by Subject|7|||
162113683|NCT01800968|585466234|FG001|Overall Study|Withdrawal by Subject|9|||
162113684|NCT01800968|585466233|FG000|Overall Study|Physician Decision|1|||
162113685|NCT01800968|585466234|FG001|Overall Study|Physician Decision|0|||
162113686|NCT04987762|585466236|FG000|Overall Study|Study was Terminated by Sponsor|103|||
162113687|NCT02068495|585466237|FG000|Overall Study|Case Report Forms Uncollected|60|||
162113688|NCT02068495|585466237|FG000|Overall Study|Protocol Deviation|49|||
162113689|NCT01666808|585466240|FG000|Overall Study|Lost to Follow-up|9|||
162113690|NCT01666808|585466241|FG001|Overall Study|Lost to Follow-up|15|||
162113691|NCT01666808|585466240|FG000|Overall Study|Withdrawal by Subject|3|||
162113692|NCT01666808|585466241|FG001|Overall Study|Withdrawal by Subject|1|||
162113693|NCT01666808|585466240|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
162113694|NCT01666808|585466241|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
162113695|NCT02220894|585466242|FG000|Overall Study|Adverse Event|127|||
162113696|NCT02220894|585466243|FG001|Overall Study|Adverse Event|74|||
162113697|NCT02220894|585466242|FG000|Overall Study|Death|418|||
162113698|NCT02220894|585466243|FG001|Overall Study|Death|508|||
162113699|NCT02220894|585466242|FG000|Overall Study|Lost to Follow-up|0|||
162113700|NCT02220894|585466243|FG001|Overall Study|Lost to Follow-up|4|||
162113701|NCT02220894|585466242|FG000|Overall Study|Site Terminated by Sponsor|2|||
162113702|NCT02220894|585466243|FG001|Overall Study|Site Terminated by Sponsor|0|||
162113703|NCT02220894|585466242|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
162113704|NCT02220894|585466243|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
162113705|NCT02220894|585466242|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
162113706|NCT02220894|585466243|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
162113707|NCT02220894|585466242|FG000|Overall Study|Withdrawal by Subject|10|||
162113708|NCT02220894|585466243|FG001|Overall Study|Withdrawal by Subject|9|||
162113709|NCT03217747|585466244|FG000|Overall Study|Adverse Event|0|||
162113710|NCT03217747|585466245|FG001|Overall Study|Adverse Event|1|||
162113711|NCT03217747|585466246|FG002|Overall Study|Adverse Event|0|||
162113712|NCT03217747|585466247|FG003|Overall Study|Adverse Event|0|||
162113713|NCT03217747|585466248|FG004|Overall Study|Adverse Event|0|||
162113714|NCT03217747|585466249|FG005|Overall Study|Adverse Event|0|||
162113715|NCT03217747|585466250|FG006|Overall Study|Adverse Event|0|||
162113716|NCT03217747|585466251|FG007|Overall Study|Adverse Event|0|||
162113717|NCT03217747|585466252|FG008|Overall Study|Adverse Event|0|||
162113718|NCT03217747|585466253|FG009|Overall Study|Adverse Event|0|||
162113719|NCT03217747|585466254|FG010|Overall Study|Adverse Event|0|||
162113720|NCT03217747|585466255|FG011|Overall Study|Adverse Event|0|||
162113721|NCT03217747|585466256|FG012|Overall Study|Adverse Event|1|||
162113722|NCT03217747|585466257|FG013|Overall Study|Adverse Event|1|||
162113723|NCT03217747|585466244|FG000|Overall Study|Death|0|||
162113724|NCT03217747|585466245|FG001|Overall Study|Death|0|||
162113725|NCT03217747|585466246|FG002|Overall Study|Death|0|||
162113726|NCT03217747|585466247|FG003|Overall Study|Death|0|||
162113727|NCT03217747|585466248|FG004|Overall Study|Death|0|||
162113728|NCT03217747|585466249|FG005|Overall Study|Death|0|||
162113729|NCT03217747|585466250|FG006|Overall Study|Death|0|||
162113730|NCT03217747|585466251|FG007|Overall Study|Death|0|||
162113731|NCT03217747|585466252|FG008|Overall Study|Death|1|||
162113732|NCT03217747|585466253|FG009|Overall Study|Death|0|||
162113733|NCT03217747|585466254|FG010|Overall Study|Death|0|||
162113734|NCT03217747|585466255|FG011|Overall Study|Death|0|||
162113735|NCT03217747|585466256|FG012|Overall Study|Death|0|||
162113736|NCT03217747|585466257|FG013|Overall Study|Death|0|||
162113737|NCT03217747|585466244|FG000|Overall Study|Lack of Efficacy|12|||
162113738|NCT03217747|585466245|FG001|Overall Study|Lack of Efficacy|6|||
162113739|NCT03217747|585466246|FG002|Overall Study|Lack of Efficacy|15|||
162113740|NCT03217747|585466247|FG003|Overall Study|Lack of Efficacy|11|||
162113741|NCT03217747|585466248|FG004|Overall Study|Lack of Efficacy|3|||
162113742|NCT03217747|585466249|FG005|Overall Study|Lack of Efficacy|14|||
162113743|NCT03217747|585466250|FG006|Overall Study|Lack of Efficacy|10|||
162113744|NCT03217747|585466251|FG007|Overall Study|Lack of Efficacy|4|||
162113745|NCT03217747|585466252|FG008|Overall Study|Lack of Efficacy|2|||
162113746|NCT03217747|585466253|FG009|Overall Study|Lack of Efficacy|7|||
162113747|NCT03217747|585466254|FG010|Overall Study|Lack of Efficacy|3|||
162113748|NCT03217747|585466255|FG011|Overall Study|Lack of Efficacy|1|||
162113749|NCT03217747|585466256|FG012|Overall Study|Lack of Efficacy|3|||
162113750|NCT03217747|585466257|FG013|Overall Study|Lack of Efficacy|1|||
162113751|NCT03217747|585466244|FG000|Overall Study|Withdrawal by Subject|2|||
162113752|NCT03217747|585466245|FG001|Overall Study|Withdrawal by Subject|1|||
162113753|NCT03217747|585466246|FG002|Overall Study|Withdrawal by Subject|1|||
162113754|NCT03217747|585466247|FG003|Overall Study|Withdrawal by Subject|1|||
162113755|NCT03217747|585466248|FG004|Overall Study|Withdrawal by Subject|1|||
162113756|NCT03217747|585466249|FG005|Overall Study|Withdrawal by Subject|2|||
162113757|NCT03217747|585466250|FG006|Overall Study|Withdrawal by Subject|1|||
162113758|NCT03217747|585466251|FG007|Overall Study|Withdrawal by Subject|0|||
162113759|NCT03217747|585466252|FG008|Overall Study|Withdrawal by Subject|0|||
162113760|NCT03217747|585466253|FG009|Overall Study|Withdrawal by Subject|0|||
162113761|NCT03217747|585466254|FG010|Overall Study|Withdrawal by Subject|0|||
162113762|NCT03217747|585466255|FG011|Overall Study|Withdrawal by Subject|1|||
162113763|NCT03217747|585466256|FG012|Overall Study|Withdrawal by Subject|0|||
162113764|NCT03217747|585466257|FG013|Overall Study|Withdrawal by Subject|1|||
162113765|NCT03217747|585466244|FG000|Overall Study|Toxicity and progression|1|||
162113766|NCT03217747|585466245|FG001|Overall Study|Toxicity and progression|0|||
162113767|NCT03217747|585466246|FG002|Overall Study|Toxicity and progression|0|||
162113768|NCT03217747|585466247|FG003|Overall Study|Toxicity and progression|0|||
162113769|NCT03217747|585466248|FG004|Overall Study|Toxicity and progression|0|||
162113770|NCT03217747|585466249|FG005|Overall Study|Toxicity and progression|0|||
162113771|NCT03217747|585466250|FG006|Overall Study|Toxicity and progression|0|||
162113772|NCT03217747|585466251|FG007|Overall Study|Toxicity and progression|0|||
162113773|NCT03217747|585466252|FG008|Overall Study|Toxicity and progression|0|||
162113774|NCT03217747|585466253|FG009|Overall Study|Toxicity and progression|0|||
162113775|NCT03217747|585466254|FG010|Overall Study|Toxicity and progression|0|||
162113776|NCT03217747|585466255|FG011|Overall Study|Toxicity and progression|0|||
162113777|NCT03217747|585466256|FG012|Overall Study|Toxicity and progression|0|||
162113778|NCT03217747|585466257|FG013|Overall Study|Toxicity and progression|0|||
162113779|NCT03217747|585466244|FG000|Overall Study|Removal of sole target lesion|1|||
162113780|NCT03217747|585466245|FG001|Overall Study|Removal of sole target lesion|0|||
162113781|NCT03217747|585466246|FG002|Overall Study|Removal of sole target lesion|0|||
162113782|NCT03217747|585466247|FG003|Overall Study|Removal of sole target lesion|0|||
162113783|NCT03217747|585466248|FG004|Overall Study|Removal of sole target lesion|0|||
162113784|NCT03217747|585466249|FG005|Overall Study|Removal of sole target lesion|0|||
162113785|NCT03217747|585466250|FG006|Overall Study|Removal of sole target lesion|0|||
162113786|NCT03217747|585466251|FG007|Overall Study|Removal of sole target lesion|0|||
162113787|NCT03217747|585466252|FG008|Overall Study|Removal of sole target lesion|0|||
162113788|NCT03217747|585466253|FG009|Overall Study|Removal of sole target lesion|0|||
162113789|NCT03217747|585466254|FG010|Overall Study|Removal of sole target lesion|0|||
162113790|NCT03217747|585466255|FG011|Overall Study|Removal of sole target lesion|0|||
162113791|NCT03217747|585466256|FG012|Overall Study|Removal of sole target lesion|0|||
162113792|NCT03217747|585466257|FG013|Overall Study|Removal of sole target lesion|0|||
162113793|NCT03217747|585466244|FG000|Overall Study|Stroke|0|||
162113794|NCT03217747|585466245|FG001|Overall Study|Stroke|0|||
162237479|NCT00600886|585921096|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
162113795|NCT03217747|585466246|FG002|Overall Study|Stroke|0|||
162113796|NCT03217747|585466247|FG003|Overall Study|Stroke|0|||
162113797|NCT03217747|585466248|FG004|Overall Study|Stroke|0|||
162113798|NCT03217747|585466249|FG005|Overall Study|Stroke|1|||
162113799|NCT03217747|585466250|FG006|Overall Study|Stroke|0|||
162113800|NCT03217747|585466251|FG007|Overall Study|Stroke|0|||
162113801|NCT03217747|585466252|FG008|Overall Study|Stroke|0|||
162113802|NCT03217747|585466253|FG009|Overall Study|Stroke|0|||
162113803|NCT03217747|585466254|FG010|Overall Study|Stroke|0|||
162113804|NCT03217747|585466255|FG011|Overall Study|Stroke|1|||
162113805|NCT03217747|585466256|FG012|Overall Study|Stroke|0|||
162113806|NCT03217747|585466257|FG013|Overall Study|Stroke|0|||
162113807|NCT03248375|585466258|FG000|Overall Study|Lost to Follow-up|5|||
162113808|NCT00394355|585466259|FG000|Overall Study|Adverse Event|10|||
162113809|NCT00394355|585466260|FG001|Overall Study|Adverse Event|6|||
162113810|NCT00394355|585466261|FG002|Overall Study|Adverse Event|7|||
162113811|NCT00394355|585466262|FG003|Overall Study|Adverse Event|8|||
162113812|NCT00394355|585466259|FG000|Overall Study|Did not meet protocol eligibility|1|||
162113813|NCT00394355|585466260|FG001|Overall Study|Did not meet protocol eligibility|5|||
162113814|NCT00394355|585466261|FG002|Overall Study|Did not meet protocol eligibility|4|||
162113815|NCT00394355|585466262|FG003|Overall Study|Did not meet protocol eligibility|2|||
162113816|NCT00394355|585466259|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
162113817|NCT00394355|585466260|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
162113818|NCT00394355|585466261|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
162113819|NCT00394355|585466262|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
162113820|NCT00394355|585466259|FG000|Overall Study|Subject withdrawal - related to drug|1|||
162113821|NCT00394355|585466260|FG001|Overall Study|Subject withdrawal - related to drug|0|||
162113822|NCT00394355|585466261|FG002|Overall Study|Subject withdrawal - related to drug|0|||
162113823|NCT00394355|585466262|FG003|Overall Study|Subject withdrawal - related to drug|0|||
162113824|NCT00394355|585466259|FG000|Overall Study|Lost to Follow-up|7|||
162113825|NCT00394355|585466260|FG001|Overall Study|Lost to Follow-up|5|||
162113826|NCT00394355|585466261|FG002|Overall Study|Lost to Follow-up|4|||
162113827|NCT00394355|585466262|FG003|Overall Study|Lost to Follow-up|3|||
162113828|NCT00394355|585466259|FG000|Overall Study|Noncompliance with protocol|4|||
162113829|NCT00394355|585466260|FG001|Overall Study|Noncompliance with protocol|3|||
162113830|NCT00394355|585466261|FG002|Overall Study|Noncompliance with protocol|10|||
162113831|NCT00394355|585466262|FG003|Overall Study|Noncompliance with protocol|8|||
162113832|NCT00394355|585466259|FG000|Overall Study|Administrative|0|||
162113833|NCT00394355|585466260|FG001|Overall Study|Administrative|1|||
162113834|NCT00394355|585466261|FG002|Overall Study|Administrative|1|||
162113835|NCT00394355|585466262|FG003|Overall Study|Administrative|1|||
162113836|NCT00394355|585466259|FG000|Overall Study|Lack of Efficacy|0|||
162113837|NCT00394355|585466260|FG001|Overall Study|Lack of Efficacy|0|||
162113838|NCT00394355|585466261|FG002|Overall Study|Lack of Efficacy|2|||
162113839|NCT00394355|585466262|FG003|Overall Study|Lack of Efficacy|3|||
162113840|NCT02618616|585466265|FG000|Overall Study|Lack of Efficacy|4|||
162113841|NCT02618616|585466266|FG001|Overall Study|Lack of Efficacy|0|||
162113842|NCT02618616|585466265|FG000|Overall Study|Pregnancy|0|||
162113843|NCT02618616|585466266|FG001|Overall Study|Pregnancy|1|||
162113844|NCT02618616|585466265|FG000|Overall Study|Adverse Event|8|||
162113845|NCT02618616|585466266|FG001|Overall Study|Adverse Event|0|||
162113846|NCT02618616|585466265|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
162113847|NCT02618616|585466266|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
162113848|NCT02618616|585466265|FG000|Overall Study|Consent withdrawn by subject|8|||
162113849|NCT02618616|585466266|FG001|Overall Study|Consent withdrawn by subject|5|||
162113850|NCT02618616|585466265|FG000|Overall Study|Lost to Follow-up|0|||
162113851|NCT02618616|585466266|FG001|Overall Study|Lost to Follow-up|1|||
162113852|NCT03904043|585466267|FG000|Overall Study|Adverse Event|1|||
162113853|NCT03904043|585466268|FG001|Overall Study|Adverse Event|1|||
162113854|NCT03904043|585466267|FG000|Overall Study|Withdrawal by Subject|1|||
162113855|NCT03904043|585466268|FG001|Overall Study|Withdrawal by Subject|0|||
162113856|NCT03904043|585466267|FG000|Overall Study|Non-compliance|1|||
162113857|NCT03904043|585466268|FG001|Overall Study|Non-compliance|0|||
162113858|NCT03904043|585466267|FG000|Overall Study|Did not start treatment|1|||
162113859|NCT03904043|585466268|FG001|Overall Study|Did not start treatment|0|||
162113860|NCT05002218|585466274|FG000|Overall Study|Lost to Follow-up|5|||
162113861|NCT05002218|585466275|FG001|Overall Study|Lost to Follow-up|6|||
162113862|NCT03421808|585466276|FG000|Overall Study|COVID related problems|2|||
162113863|NCT03421808|585466277|FG001|Overall Study|COVID related problems|0|||
162113864|NCT03421808|585466276|FG000|Overall Study|Withdrawal by Subject|1|||
162113865|NCT03421808|585466277|FG001|Overall Study|Withdrawal by Subject|0|||
162113866|NCT03421808|585466276|FG000|Overall Study|Protocol Violation|0|||
162113867|NCT03421808|585466277|FG001|Overall Study|Protocol Violation|1|||
162113868|NCT03764774|585466280|FG000|Overall Study|Withdrawal by Subject|0|||
162113869|NCT03764774|585466281|FG001|Overall Study|Withdrawal by Subject|0|||
162113870|NCT03764774|585466282|FG002|Overall Study|Withdrawal by Subject|0|||
162113871|NCT03764774|585466283|FG003|Overall Study|Withdrawal by Subject|0|||
162113872|NCT03764774|585466284|FG004|Overall Study|Withdrawal by Subject|0|||
162113873|NCT03764774|585466285|FG005|Overall Study|Withdrawal by Subject|0|||
162113874|NCT03764774|585466286|FG006|Overall Study|Withdrawal by Subject|0|||
162113875|NCT03764774|585466287|FG007|Overall Study|Withdrawal by Subject|0|||
162113876|NCT03764774|585466288|FG008|Overall Study|Withdrawal by Subject|0|||
162113877|NCT03764774|585466289|FG009|Overall Study|Withdrawal by Subject|0|||
162113878|NCT03764774|585466290|FG010|Overall Study|Withdrawal by Subject|1|||
162113879|NCT03764774|585466291|FG011|Overall Study|Withdrawal by Subject|0|||
162113880|NCT03764774|585466292|FG012|Overall Study|Withdrawal by Subject|0|||
162113881|NCT03764774|585466293|FG013|Overall Study|Withdrawal by Subject|0|||
162113882|NCT03764774|585466280|FG000|Overall Study|Adverse Event|0|||
162113883|NCT03764774|585466281|FG001|Overall Study|Adverse Event|0|||
162113884|NCT03764774|585466282|FG002|Overall Study|Adverse Event|0|||
162113885|NCT03764774|585466283|FG003|Overall Study|Adverse Event|0|||
162113886|NCT03764774|585466284|FG004|Overall Study|Adverse Event|0|||
162113887|NCT03764774|585466285|FG005|Overall Study|Adverse Event|0|||
162113888|NCT03764774|585466286|FG006|Overall Study|Adverse Event|0|||
162113889|NCT03764774|585466287|FG007|Overall Study|Adverse Event|0|||
162113890|NCT03764774|585466288|FG008|Overall Study|Adverse Event|0|||
162113891|NCT03764774|585466289|FG009|Overall Study|Adverse Event|0|||
162113892|NCT03764774|585466290|FG010|Overall Study|Adverse Event|0|||
162113893|NCT03764774|585466291|FG011|Overall Study|Adverse Event|0|||
162113894|NCT03764774|585466292|FG012|Overall Study|Adverse Event|2|||
162113895|NCT03764774|585466293|FG013|Overall Study|Adverse Event|0|||
162113896|NCT03764774|585466280|FG000|Overall Study|Lost to Follow-up|0|||
162113897|NCT03764774|585466281|FG001|Overall Study|Lost to Follow-up|0|||
162113898|NCT03764774|585466282|FG002|Overall Study|Lost to Follow-up|0|||
162113899|NCT03764774|585466283|FG003|Overall Study|Lost to Follow-up|0|||
162113900|NCT03764774|585466284|FG004|Overall Study|Lost to Follow-up|0|||
162113901|NCT03764774|585466285|FG005|Overall Study|Lost to Follow-up|0|||
162113902|NCT03764774|585466286|FG006|Overall Study|Lost to Follow-up|0|||
162113903|NCT03764774|585466287|FG007|Overall Study|Lost to Follow-up|0|||
162113904|NCT03764774|585466288|FG008|Overall Study|Lost to Follow-up|0|||
162113905|NCT03764774|585466289|FG009|Overall Study|Lost to Follow-up|0|||
162113906|NCT03764774|585466290|FG010|Overall Study|Lost to Follow-up|0|||
162113907|NCT03764774|585466291|FG011|Overall Study|Lost to Follow-up|0|||
162113908|NCT03764774|585466292|FG012|Overall Study|Lost to Follow-up|0|||
162113909|NCT03764774|585466293|FG013|Overall Study|Lost to Follow-up|1|||
162113910|NCT03764774|585466280|FG000|Overall Study|Physician Decision|0|||
162113911|NCT03764774|585466281|FG001|Overall Study|Physician Decision|0|||
162113912|NCT03764774|585466282|FG002|Overall Study|Physician Decision|0|||
162113913|NCT03764774|585466283|FG003|Overall Study|Physician Decision|0|||
162113914|NCT03764774|585466284|FG004|Overall Study|Physician Decision|0|||
162113915|NCT03764774|585466285|FG005|Overall Study|Physician Decision|0|||
162113916|NCT03764774|585466286|FG006|Overall Study|Physician Decision|0|||
162113917|NCT03764774|585466287|FG007|Overall Study|Physician Decision|0|||
162113918|NCT03764774|585466288|FG008|Overall Study|Physician Decision|0|||
162113919|NCT03764774|585466289|FG009|Overall Study|Physician Decision|4|||
162113920|NCT03764774|585466290|FG010|Overall Study|Physician Decision|1|||
162113921|NCT03764774|585466291|FG011|Overall Study|Physician Decision|4|||
162113922|NCT03764774|585466292|FG012|Overall Study|Physician Decision|9|||
162113923|NCT03764774|585466293|FG013|Overall Study|Physician Decision|0|||
162113924|NCT03764774|585466280|FG000|Overall Study|Study Termination|0|||
162113925|NCT03764774|585466281|FG001|Overall Study|Study Termination|0|||
162113926|NCT03764774|585466282|FG002|Overall Study|Study Termination|0|||
162113927|NCT03764774|585466283|FG003|Overall Study|Study Termination|0|||
162113928|NCT03764774|585466284|FG004|Overall Study|Study Termination|0|||
162113929|NCT03764774|585466285|FG005|Overall Study|Study Termination|0|||
162113930|NCT03764774|585466286|FG006|Overall Study|Study Termination|0|||
162113931|NCT03764774|585466287|FG007|Overall Study|Study Termination|0|||
162113932|NCT03764774|585466288|FG008|Overall Study|Study Termination|0|||
162113933|NCT03764774|585466289|FG009|Overall Study|Study Termination|1|||
162113934|NCT03764774|585466290|FG010|Overall Study|Study Termination|0|||
162113935|NCT03764774|585466291|FG011|Overall Study|Study Termination|0|||
162113936|NCT03764774|585466292|FG012|Overall Study|Study Termination|0|||
162113937|NCT03764774|585466293|FG013|Overall Study|Study Termination|2|||
162113938|NCT00766675|585467699|FG000|Overall Study|Adverse Event|16|||
162113939|NCT00766675|585467699|FG000|Overall Study|Lost to Follow-up|2|||
162113940|NCT00766675|585467699|FG000|Overall Study|Withdrawal by Subject|11|||
162113941|NCT00766675|585467699|FG000|Overall Study|Protocol Violation|8|||
162113942|NCT00766675|585467699|FG000|Overall Study|Participant took prohibited medication|1|||
162113943|NCT00766675|585467699|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
162113944|NCT00766675|585467699|FG000|Overall Study|Insufficient therapy|1|||
162113945|NCT01679236|585467700|FG000|Overall Study|Lost to Follow-up|15|||
162113946|NCT01679236|585467701|FG001|Overall Study|Lost to Follow-up|15|||
162113947|NCT03935217|585467704|FG000|Overall Study|Adverse Event|1|||
162113948|NCT03935217|585467705|FG001|Overall Study|Adverse Event|0|||
162113949|NCT03935217|585467704|FG000|Overall Study|Lost to Follow-up|0|||
162113950|NCT03935217|585467705|FG001|Overall Study|Lost to Follow-up|1|||
162113951|NCT03935217|585467704|FG000|Overall Study|Withdrawal by Subject|0|||
162113952|NCT03935217|585467705|FG001|Overall Study|Withdrawal by Subject|2|||
162113953|NCT02026232|585467714|FG000|Overall Study|incomplete visit/missing data|3|||
162113954|NCT02026232|585467715|FG001|Overall Study|incomplete visit/missing data|2|||
162113955|NCT00755222|585467716|FG000|Overall Study|Withdrawal by Subject|4|||
162113956|NCT00755222|585467717|FG001|Overall Study|Withdrawal by Subject|2|||
162113957|NCT00755222|585467716|FG000|Overall Study|Adverse Event|2|||
162113958|NCT00755222|585467717|FG001|Overall Study|Adverse Event|0|||
162113959|NCT00755222|585467716|FG000|Overall Study|Protocol Violation|2|||
162113960|NCT00755222|585467717|FG001|Overall Study|Protocol Violation|0|||
162113961|NCT00331344|585467718|FG000|Phase I|Adverse Event|0|||
162113962|NCT00331344|585467719|FG001|Phase I|Adverse Event|0|||
162113963|NCT00331344|585467720|FG002|Phase I|Adverse Event|0|||
162113964|NCT00331344|585467721|FG003|Phase I|Adverse Event|1|||
162113965|NCT00331344|585467722|FG004|Phase I|Adverse Event|2|||
162113966|NCT00331344|585467723|FG005|Phase I|Adverse Event|2|||
162113967|NCT00331344|585467724|FG006|Phase I|Adverse Event|0|||
162113968|NCT00331344|585467725|FG007|Phase I|Adverse Event|1|||
162113969|NCT00331344|585467726|FG008|Phase I|Adverse Event|0|||
162113970|NCT00331344|585467718|FG000|Phase II|Death|0|||
162113971|NCT00331344|585467719|FG001|Phase II|Death|0|||
162113972|NCT00331344|585467720|FG002|Phase II|Death|0|||
162113973|NCT00331344|585467721|FG003|Phase II|Death|0|||
162113974|NCT00331344|585467722|FG004|Phase II|Death|0|||
162113975|NCT00331344|585467723|FG005|Phase II|Death|0|||
162113976|NCT00331344|585467724|FG006|Phase II|Death|0|||
162113977|NCT00331344|585467725|FG007|Phase II|Death|0|||
162113978|NCT00331344|585467726|FG008|Phase II|Death|4|||
162113979|NCT04538144|585467732|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
162113980|NCT04538144|585467733|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
162113981|NCT04538144|585467734|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
162113982|NCT04538144|585467735|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
162113983|NCT02228967|585467736|FG000|Overall Study|Lost to Follow-up|146|||
162113984|NCT02228967|585467737|FG001|Overall Study|Lost to Follow-up|142|||
162113985|NCT02228967|585467736|FG000|Overall Study|Withdrawal by Subject|13|||
162113986|NCT02228967|585467737|FG001|Overall Study|Withdrawal by Subject|18|||
162113987|NCT01995539|585467740|FG000|Overall Study|Screening Failure|1|||
162113988|NCT01995539|585467740|FG000|Overall Study|Withdrawal by Investigator|15|||
162113989|NCT01995539|585467740|FG000|Overall Study|Withdrawal by Subject|11|||
162113990|NCT01995539|585467740|FG000|Overall Study|Lost to Follow-up|5|||
162113991|NCT01995539|585467740|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
162113992|NCT03261271|585467744|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
162113993|NCT03261271|585467745|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
162113994|NCT02173054|585467746|FG000|Overall Study|lack of compliance|1|||
162113995|NCT02173054|585467747|FG001|Overall Study|lack of compliance|0|||
162113996|NCT02173054|585467748|FG002|Overall Study|lack of compliance|0|||
162113997|NCT02173054|585467746|FG000|Overall Study|Withdrawal by Subject|0|||
162113998|NCT02173054|585467747|FG001|Overall Study|Withdrawal by Subject|0|||
162113999|NCT02173054|585467748|FG002|Overall Study|Withdrawal by Subject|1|||
162114000|NCT01932697|585467749|FG000|Overall Study|Received a different amount of tx|1|||
162114001|NCT01932697|585467750|FG001|Overall Study|Received a different amount of tx|0|||
162114002|NCT01932697|585467749|FG000|Overall Study|Ineligible|1|||
162114003|NCT01932697|585467750|FG001|Overall Study|Ineligible|0|||
162114004|NCT00215540|585467755|FG000|Overall Study|Withdrew from study medication|1|||
162114005|NCT00215540|585467756|FG001|Overall Study|Withdrew from study medication|0|||
162114006|NCT00215540|585467757|FG002|Overall Study|Withdrew from study medication|0|||
162114007|NCT00674570|585467759|FG000|Overall Study|Withdrawal by Subject|0|||
162114008|NCT00674570|585467760|FG001|Overall Study|Withdrawal by Subject|2|||
162114009|NCT00674570|585467761|FG002|Overall Study|Withdrawal by Subject|0|||
162114010|NCT01337986|585467762|FG000|Overall Study|Adverse Event|2|||
162114011|NCT01337986|585467763|FG001|Overall Study|Adverse Event|2|||
162114012|NCT01337986|585467762|FG000|Overall Study|Lost to Follow-up|1|||
162114013|NCT01337986|585467763|FG001|Overall Study|Lost to Follow-up|0|||
162114014|NCT01337986|585467762|FG000|Overall Study|Protocol Violation|0|||
162114015|NCT01337986|585467763|FG001|Overall Study|Protocol Violation|3|||
162114016|NCT02313909|585467764|FG000|Overall Study|Consent withdrawn by participant|33|||
162114017|NCT02313909|585467765|FG001|Overall Study|Consent withdrawn by participant|33|||
162114018|NCT02313909|585467764|FG000|Overall Study|Lost to Follow-up|24|||
162114019|NCT02313909|585467765|FG001|Overall Study|Lost to Follow-up|17|||
162114020|NCT03430063|585467766|FG000|Overall Study|Adverse Event|0|||
162114021|NCT03430063|585467767|FG001|Overall Study|Adverse Event|1|||
162114022|NCT03430063|585467768|FG002|Overall Study|Adverse Event|0|||
162114023|NCT03430063|585467766|FG000|Overall Study|Death|3|||
162114024|NCT03430063|585467767|FG001|Overall Study|Death|2|||
162114025|NCT03430063|585467768|FG002|Overall Study|Death|3|||
162114026|NCT03430063|585467766|FG000|Overall Study|Lost to Follow-up|0|||
162114027|NCT03430063|585467767|FG001|Overall Study|Lost to Follow-up|1|||
162114028|NCT03430063|585467768|FG002|Overall Study|Lost to Follow-up|0|||
162114029|NCT03430063|585467766|FG000|Overall Study|Withdrawal by Subject|0|||
162114030|NCT03430063|585467767|FG001|Overall Study|Withdrawal by Subject|0|||
162114031|NCT03430063|585467768|FG002|Overall Study|Withdrawal by Subject|1|||
162114032|NCT03430063|585467766|FG000|Overall Study|Withdrawal of consent|3|||
162114033|NCT03430063|585467767|FG001|Overall Study|Withdrawal of consent|1|||
162114034|NCT03430063|585467768|FG002|Overall Study|Withdrawal of consent|2|||
162114035|NCT03430063|585467766|FG000|Overall Study|Progressive disease|1|||
162114036|NCT03430063|585467767|FG001|Overall Study|Progressive disease|2|||
162114037|NCT03430063|585467768|FG002|Overall Study|Progressive disease|1|||
162114038|NCT03430063|585467766|FG000|Overall Study|Other un-specified|1|||
162114039|NCT03430063|585467767|FG001|Overall Study|Other un-specified|1|||
162114040|NCT03430063|585467768|FG002|Overall Study|Other un-specified|0|||
162114041|NCT03430063|585467766|FG000|Overall Study|Randomized, but never treated|0|||
162114042|NCT03430063|585467767|FG001|Overall Study|Randomized, but never treated|0|||
162114043|NCT03430063|585467768|FG002|Overall Study|Randomized, but never treated|1|||
162114044|NCT02798211|585467769|FG000|Period 1|Adverse Event|1|||
162114045|NCT02798211|585467770|FG001|Period 1|Adverse Event|1|||
162114046|NCT02798211|585467771|FG002|Period 1|Adverse Event|0|||
162114047|NCT02798211|585467772|FG003|Period 1|Adverse Event|0|||
162114048|NCT02798211|585467773|FG004|Period 1|Adverse Event|0|||
162114049|NCT02798211|585467774|FG005|Period 1|Adverse Event|0|||
162114050|NCT02798211|585467769|FG000|Period 1|Lost to Follow-up|2|||
162114051|NCT02798211|585467770|FG001|Period 1|Lost to Follow-up|1|||
162114052|NCT02798211|585467771|FG002|Period 1|Lost to Follow-up|0|||
162114053|NCT02798211|585467772|FG003|Period 1|Lost to Follow-up|0|||
162114054|NCT02798211|585467773|FG004|Period 1|Lost to Follow-up|0|||
162114055|NCT02798211|585467774|FG005|Period 1|Lost to Follow-up|0|||
162114056|NCT02798211|585467769|FG000|Period 1|Protocol Violation|0|||
162114057|NCT02798211|585467770|FG001|Period 1|Protocol Violation|0|||
162114058|NCT02798211|585467771|FG002|Period 1|Protocol Violation|2|||
162114059|NCT02798211|585467772|FG003|Period 1|Protocol Violation|0|||
162114060|NCT02798211|585467773|FG004|Period 1|Protocol Violation|0|||
162114061|NCT02798211|585467774|FG005|Period 1|Protocol Violation|0|||
162114062|NCT02798211|585467769|FG000|Period 1|Withdrawal by Subject|1|||
162114063|NCT02798211|585467770|FG001|Period 1|Withdrawal by Subject|1|||
162114064|NCT02798211|585467771|FG002|Period 1|Withdrawal by Subject|0|||
162114065|NCT02798211|585467772|FG003|Period 1|Withdrawal by Subject|0|||
162114066|NCT02798211|585467773|FG004|Period 1|Withdrawal by Subject|0|||
162114067|NCT02798211|585467774|FG005|Period 1|Withdrawal by Subject|0|||
162114068|NCT02798211|585467769|FG000|Period 1|Death|0|||
162114069|NCT02798211|585467770|FG001|Period 1|Death|0|||
162114070|NCT02798211|585467771|FG002|Period 1|Death|1|||
162114071|NCT02798211|585467772|FG003|Period 1|Death|0|||
162114072|NCT02798211|585467773|FG004|Period 1|Death|0|||
162114073|NCT02798211|585467774|FG005|Period 1|Death|0|||
162114074|NCT02798211|585467769|FG000|Period 1|Withdrawal of Informed Consent|2|||
162114075|NCT02798211|585467770|FG001|Period 1|Withdrawal of Informed Consent|7|||
162114076|NCT02798211|585467771|FG002|Period 1|Withdrawal of Informed Consent|3|||
162114077|NCT02798211|585467772|FG003|Period 1|Withdrawal of Informed Consent|0|||
162114078|NCT02798211|585467773|FG004|Period 1|Withdrawal of Informed Consent|0|||
162114079|NCT02798211|585467774|FG005|Period 1|Withdrawal of Informed Consent|0|||
162114080|NCT02798211|585467769|FG000|Period 2|Withdrawal by Subject|2|||
162114081|NCT02798211|585467770|FG001|Period 2|Withdrawal by Subject|0|||
162114082|NCT02798211|585467771|FG002|Period 2|Withdrawal by Subject|0|||
162114083|NCT02798211|585467772|FG003|Period 2|Withdrawal by Subject|0|||
162114084|NCT02798211|585467773|FG004|Period 2|Withdrawal by Subject|2|||
162114085|NCT02798211|585467774|FG005|Period 2|Withdrawal by Subject|2|||
162114086|NCT02798211|585467769|FG000|Period 2|Adverse Event|5|||
162114087|NCT02798211|585467770|FG001|Period 2|Adverse Event|0|||
162114088|NCT02798211|585467771|FG002|Period 2|Adverse Event|0|||
162114089|NCT02798211|585467772|FG003|Period 2|Adverse Event|0|||
162114090|NCT02798211|585467773|FG004|Period 2|Adverse Event|1|||
162114091|NCT02798211|585467774|FG005|Period 2|Adverse Event|0|||
162114092|NCT02798211|585467769|FG000|Period 2|Lack of Efficacy|1|||
162114093|NCT02798211|585467770|FG001|Period 2|Lack of Efficacy|0|||
162114094|NCT02798211|585467771|FG002|Period 2|Lack of Efficacy|0|||
162114095|NCT02798211|585467772|FG003|Period 2|Lack of Efficacy|1|||
162114096|NCT02798211|585467773|FG004|Period 2|Lack of Efficacy|0|||
162114097|NCT02798211|585467774|FG005|Period 2|Lack of Efficacy|1|||
162114098|NCT02798211|585467769|FG000|Period 2|Lost to Follow-up|3|||
162114099|NCT02798211|585467770|FG001|Period 2|Lost to Follow-up|0|||
162114100|NCT02798211|585467771|FG002|Period 2|Lost to Follow-up|0|||
162114101|NCT02798211|585467772|FG003|Period 2|Lost to Follow-up|0|||
162114102|NCT02798211|585467773|FG004|Period 2|Lost to Follow-up|2|||
162114103|NCT02798211|585467774|FG005|Period 2|Lost to Follow-up|0|||
162114104|NCT02798211|585467769|FG000|Period 2|Physician Decision|1|||
162114105|NCT02798211|585467770|FG001|Period 2|Physician Decision|0|||
162114106|NCT02798211|585467771|FG002|Period 2|Physician Decision|0|||
162114107|NCT02798211|585467772|FG003|Period 2|Physician Decision|1|||
162114108|NCT02798211|585467773|FG004|Period 2|Physician Decision|1|||
162114109|NCT02798211|585467774|FG005|Period 2|Physician Decision|0|||
162114110|NCT02798211|585467769|FG000|Period 2|Pregnancy|0|||
162114111|NCT02798211|585467770|FG001|Period 2|Pregnancy|0|||
162114112|NCT02798211|585467771|FG002|Period 2|Pregnancy|0|||
162114113|NCT02798211|585467772|FG003|Period 2|Pregnancy|2|||
162114114|NCT02798211|585467773|FG004|Period 2|Pregnancy|0|||
162114115|NCT02798211|585467774|FG005|Period 2|Pregnancy|0|||
162114116|NCT02798211|585467769|FG000|Period 2|Technical problems|1|||
162114117|NCT02798211|585467770|FG001|Period 2|Technical problems|0|||
162114118|NCT02798211|585467771|FG002|Period 2|Technical problems|0|||
162114119|NCT02798211|585467772|FG003|Period 2|Technical problems|1|||
162114120|NCT02798211|585467773|FG004|Period 2|Technical problems|0|||
162114121|NCT02798211|585467774|FG005|Period 2|Technical problems|0|||
162114122|NCT02798211|585467769|FG000|Period 2|Withdrawal of Informed Consent|1|||
162114123|NCT02798211|585467770|FG001|Period 2|Withdrawal of Informed Consent|0|||
162114124|NCT02798211|585467771|FG002|Period 2|Withdrawal of Informed Consent|0|||
162114125|NCT02798211|585467772|FG003|Period 2|Withdrawal of Informed Consent|2|||
162114126|NCT02798211|585467773|FG004|Period 2|Withdrawal of Informed Consent|2|||
162114127|NCT02798211|585467774|FG005|Period 2|Withdrawal of Informed Consent|3|||
162114128|NCT01782872|585467775|FG000|Overall Study|Protocol Violation|0|||
162114129|NCT01782872|585467776|FG001|Overall Study|Protocol Violation|0|||
162114130|NCT01782872|585467777|FG002|Overall Study|Protocol Violation|0|||
162114131|NCT01782872|585467778|FG003|Overall Study|Protocol Violation|1|||
162114132|NCT01782872|585467775|FG000|Overall Study|Withdrawal by Subject|0|||
162114133|NCT01782872|585467776|FG001|Overall Study|Withdrawal by Subject|1|||
162114134|NCT01782872|585467777|FG002|Overall Study|Withdrawal by Subject|0|||
162114135|NCT01782872|585467778|FG003|Overall Study|Withdrawal by Subject|0|||
162114136|NCT03505476|585467779|FG000|Overall Study|Physician Decision|18|||
162114137|NCT03505476|585467779|FG000|Overall Study|Device Malfunctioned|101|||
162114138|NCT03505476|585467779|FG000|Overall Study|Data Corrupt|6|||
162114139|NCT03505476|585467779|FG000|Overall Study|Device application insufficiant|3|||
162114140|NCT01287611|585467781|FG000|Overall Study|Lost to Follow-up|29|||
162114141|NCT01287611|585467782|FG001|Overall Study|Lost to Follow-up|16|||
162114142|NCT01287611|585467781|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
162114143|NCT01287611|585467782|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
162114144|NCT02255357|585467787|FG000|Overall Study|Physician Decision|10|||
162114145|NCT02255357|585467788|FG001|Overall Study|Physician Decision|24|||
162114146|NCT02192970|585467789|FG000|Overall Study|Lost to Follow-up|6|||
162114147|NCT02192970|585467790|FG001|Overall Study|Lost to Follow-up|0|||
162114148|NCT04074590|585467793|FG000|Overall Study|Adverse Event|1|||
162114149|NCT04074590|585467794|FG001|Overall Study|Adverse Event|0|||
162114150|NCT04074590|585467793|FG000|Overall Study|Physician Decision|1|||
162114151|NCT04074590|585467794|FG001|Overall Study|Physician Decision|0|||
162114152|NCT04074590|585467793|FG000|Overall Study|Withdrawal by Subject|2|||
162114153|NCT04074590|585467794|FG001|Overall Study|Withdrawal by Subject|0|||
162114154|NCT00509236|585467797|FG000|Overall Study|Adverse Event|7|||
162114155|NCT00509236|585467798|FG001|Overall Study|Adverse Event|9|||
162114156|NCT00509236|585467797|FG000|Overall Study|Withdrawal by Subject|5|||
162114157|NCT00509236|585467798|FG001|Overall Study|Withdrawal by Subject|10|||
162114158|NCT00509236|585467797|FG000|Overall Study|Protocol Violation|3|||
162114159|NCT00509236|585467798|FG001|Overall Study|Protocol Violation|0|||
162114160|NCT00509236|585467797|FG000|Overall Study|Excluded Medication|1|||
162114161|NCT00509236|585467798|FG001|Overall Study|Excluded Medication|1|||
162114162|NCT00509236|585467797|FG000|Overall Study|Scheduled Kidney Transplant|1|||
162114163|NCT00509236|585467798|FG001|Overall Study|Scheduled Kidney Transplant|0|||
162114164|NCT02709005|585467810|FG000|Overall Study|Lost to Follow-up|1|||
162114165|NCT02709005|585467811|FG001|Overall Study|Lost to Follow-up|1|||
162114166|NCT02709005|585467810|FG000|Overall Study|Withdrawal by Subject|3|||
162114167|NCT02709005|585467811|FG001|Overall Study|Withdrawal by Subject|0|||
162114168|NCT01572389|585467812|FG000|Overall Study|Death|1|||
162114169|NCT01572389|585467813|FG001|Overall Study|Death|3|||
162114170|NCT01572389|585467812|FG000|Overall Study|Withdrawal by Subject|14|||
162114171|NCT01572389|585467813|FG001|Overall Study|Withdrawal by Subject|2|||
162114172|NCT01572389|585467812|FG000|Overall Study|Lost to Follow-up|25|||
162114173|NCT01572389|585467813|FG001|Overall Study|Lost to Follow-up|14|||
162114174|NCT01572389|585467812|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
162114175|NCT01572389|585467813|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
162114176|NCT02634788|585467814|FG000|Overall Study|Adverse Event|0|||
162114177|NCT02634788|585467815|FG001|Overall Study|Adverse Event|8|||
162114178|NCT02634788|585467816|FG002|Overall Study|Adverse Event|3|||
162114179|NCT02634788|585467817|FG003|Overall Study|Adverse Event|1|||
162114180|NCT02634788|585467814|FG000|Overall Study|Lack of Efficacy|4|||
162114181|NCT02634788|585467815|FG001|Overall Study|Lack of Efficacy|0|||
162114182|NCT02634788|585467816|FG002|Overall Study|Lack of Efficacy|1|||
162114183|NCT02634788|585467817|FG003|Overall Study|Lack of Efficacy|4|||
162114184|NCT02634788|585467814|FG000|Overall Study|Lost to Follow-up|0|||
162114185|NCT02634788|585467815|FG001|Overall Study|Lost to Follow-up|1|||
162114186|NCT02634788|585467816|FG002|Overall Study|Lost to Follow-up|0|||
162114187|NCT02634788|585467817|FG003|Overall Study|Lost to Follow-up|0|||
162114188|NCT02634788|585467814|FG000|Overall Study|Withdrawal by Subject|0|||
162114189|NCT02634788|585467815|FG001|Overall Study|Withdrawal by Subject|1|||
162114190|NCT02634788|585467816|FG002|Overall Study|Withdrawal by Subject|1|||
162114191|NCT02634788|585467817|FG003|Overall Study|Withdrawal by Subject|0|||
162114192|NCT00758459|585467818|FG000|Overall Study|Adverse Event|3|||
162114193|NCT00758459|585467819|FG001|Overall Study|Adverse Event|2|||
162114194|NCT00758459|585467818|FG000|Overall Study|Protocol Violation|0|||
162114195|NCT00758459|585467819|FG001|Overall Study|Protocol Violation|1|||
162114196|NCT00758459|585467818|FG000|Overall Study|Withdrawal by Subject|0|||
162114197|NCT00758459|585467819|FG001|Overall Study|Withdrawal by Subject|1|||
162114198|NCT01780935|585467823|FG000|Overall Study|Admin problems due to early termination|321|||
162114199|NCT01780935|585467824|FG001|Overall Study|Admin problems due to early termination|309|||
162114200|NCT01780935|585467823|FG000|Overall Study|Adverse Event|2|||
162114201|NCT01780935|585467824|FG001|Overall Study|Adverse Event|4|||
162114202|NCT01780935|585467823|FG000|Overall Study|Death|1|||
162114203|NCT01780935|585467824|FG001|Overall Study|Death|6|||
162114204|NCT01780935|585467823|FG000|Overall Study|Lost to Follow-up|2|||
162114205|NCT01780935|585467824|FG001|Overall Study|Lost to Follow-up|6|||
162114206|NCT01780935|585467823|FG000|Overall Study|Physician Decision|1|||
162114207|NCT01780935|585467824|FG001|Overall Study|Physician Decision|1|||
162114208|NCT01780935|585467823|FG000|Overall Study|Protocol deviation|0|||
162114209|NCT01780935|585467824|FG001|Overall Study|Protocol deviation|1|||
162114210|NCT01780935|585467823|FG000|Overall Study|Patient withdrew consent|8|||
162114211|NCT01780935|585467824|FG001|Overall Study|Patient withdrew consent|9|||
162114212|NCT01281202|585467825|FG000|Overall Study|Adverse Event|2|||
162114213|NCT01281202|585467826|FG001|Overall Study|Adverse Event|0|||
162114214|NCT01281202|585467825|FG000|Overall Study|Withdrawal by Subject|2|||
162114215|NCT01281202|585467826|FG001|Overall Study|Withdrawal by Subject|2|||
162114216|NCT01281202|585467825|FG000|Overall Study|Protocol Violation|11|||
162114217|NCT01281202|585467826|FG001|Overall Study|Protocol Violation|10|||
162114218|NCT01281202|585467825|FG000|Overall Study|Administrative|2|||
162114219|NCT01281202|585467826|FG001|Overall Study|Administrative|8|||
162114220|NCT01281202|585467825|FG000|Overall Study|Lost to Follow-up|11|||
162114221|NCT01281202|585467826|FG001|Overall Study|Lost to Follow-up|13|||
162114222|NCT01281202|585467825|FG000|Overall Study|Incarceration|0|||
162114223|NCT01281202|585467826|FG001|Overall Study|Incarceration|3|||
162114224|NCT01215357|585467827|FG000|Overall Study|Withdrawal by Subject|3|||
162114225|NCT01215357|585467827|FG000|Overall Study|Protocol Violation|9|||
162114226|NCT05479604|585467828|FG000|Overall Study|Lost to Follow-up|1|||
162114227|NCT05479604|585467829|FG001|Overall Study|Lost to Follow-up|5|||
162114228|NCT01591382|585467830|FG000|Overall Study|Discharged Prior to Study Completion|2|||
162114229|NCT01591382|585467831|FG001|Overall Study|Discharged Prior to Study Completion|1|||
162114230|NCT01591382|585467830|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
162114231|NCT01591382|585467831|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
162114232|NCT03185481|585467834|FG000|Overall Study|Adverse Event|1|||
162114233|NCT03185481|585467834|FG000|Overall Study|Study Terminated by Sponsor|4|||
162114234|NCT00701038|585467838|FG000|Overall Study|study amended pilot group of patients|4|||
162114235|NCT00701038|585467839|FG001|Overall Study|study amended pilot group of patients|4|||
162114236|NCT03371940|585467842|FG000|Overall Study|Withdrawal by Subject|8|||
162114237|NCT03371940|585467843|FG001|Overall Study|Withdrawal by Subject|1|||
162114238|NCT03371940|585467844|FG002|Overall Study|Withdrawal by Subject|3|||
162114239|NCT03371940|585467845|FG003|Overall Study|Withdrawal by Subject|4|||
162114240|NCT05099926|585467848|FG000|Overall Study|Lost to Follow-up|1|||
162114241|NCT00459342|585467856|FG000|Overall Study|Not eligible|1|||
162114242|NCT02686034|585467857|FG000|Run-In Period 1|Eligibility|12|||
162114243|NCT02686034|585467858|FG001|Run-In Period 1|Eligibility|10|||
162114244|NCT02686034|585467857|FG000|Run-In Period 1|Withdrawal by Subject|4|||
162114245|NCT02686034|585467858|FG001|Run-In Period 1|Withdrawal by Subject|3|||
162114246|NCT02686034|585467857|FG000|Run-In Period 1|Lost to Follow-up|4|||
162114247|NCT02686034|585467858|FG001|Run-In Period 1|Lost to Follow-up|4|||
162114248|NCT02686034|585467857|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
162114249|NCT02686034|585467858|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
162114250|NCT02686034|585467857|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
162114251|NCT02686034|585467858|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
162114252|NCT02686034|585467857|FG000|Randomized Controlled Period 2|Adverse Event|0|||
162114253|NCT02686034|585467858|FG001|Randomized Controlled Period 2|Adverse Event|2|||
162114254|NCT02686034|585467857|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
162114255|NCT02686034|585467858|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
162114256|NCT02686034|585467857|FG000|Open Label Period 3|Lost to Follow-up|0|||
162114257|NCT02686034|585467858|FG001|Open Label Period 3|Lost to Follow-up|1|||
162114258|NCT01678131|585467859|FG000|Overall Study|Adverse Event|0|||
162114259|NCT01678131|585467860|FG001|Overall Study|Adverse Event|1|||
162114260|NCT01678131|585467861|FG002|Overall Study|Adverse Event|0|||
162114261|NCT01678131|585467859|FG000|Overall Study|Withdrawal by Subject|0|||
162114262|NCT01678131|585467860|FG001|Overall Study|Withdrawal by Subject|0|||
162114263|NCT01678131|585467861|FG002|Overall Study|Withdrawal by Subject|2|||
162114264|NCT00558064|585467863|FG000|Overall Study|Adverse Event|3|||
162114265|NCT00558064|585467864|FG001|Overall Study|Adverse Event|2|||
162114266|NCT00558064|585467863|FG000|Overall Study|Lack of Efficacy|0|||
162114267|NCT00558064|585467864|FG001|Overall Study|Lack of Efficacy|1|||
162114268|NCT00558064|585467863|FG000|Overall Study|Protocol Violation|1|||
162114269|NCT00558064|585467864|FG001|Overall Study|Protocol Violation|0|||
162114270|NCT00558064|585467863|FG000|Overall Study|Lost to Follow-up|0|||
162114271|NCT00558064|585467864|FG001|Overall Study|Lost to Follow-up|1|||
162114272|NCT00558064|585467863|FG000|Overall Study|Withdrawal by Subject|0|||
162114273|NCT00558064|585467864|FG001|Overall Study|Withdrawal by Subject|1|||
162114274|NCT00558064|585467863|FG000|Overall Study|No visit within allowance period|1|||
162114275|NCT00558064|585467864|FG001|Overall Study|No visit within allowance period|0|||
162114276|NCT02027402|585467865|FG000|Overall Study|Withdrawal by Subject|4|||
162114277|NCT02027402|585467866|FG001|Overall Study|Withdrawal by Subject|1|||
162114278|NCT00941798|585467867|FG000|Overall Study|Withdrawal by Subject|72|||
162114279|NCT00941798|585467868|FG001|Overall Study|Withdrawal by Subject|74|||
162114280|NCT00941798|585467867|FG000|Overall Study|Adverse Event|43|||
162114281|NCT00941798|585467868|FG001|Overall Study|Adverse Event|23|||
162114282|NCT00941798|585467867|FG000|Overall Study|Lost to Follow-up|29|||
162114283|NCT00941798|585467868|FG001|Overall Study|Lost to Follow-up|23|||
162114284|NCT00941798|585467867|FG000|Overall Study|Protocol Violation|17|||
162114285|NCT00941798|585467868|FG001|Overall Study|Protocol Violation|20|||
162114286|NCT00941798|585467867|FG000|Overall Study|Administrative problems|13|||
162114287|NCT00941798|585467868|FG001|Overall Study|Administrative problems|23|||
162114288|NCT00941798|585467867|FG000|Overall Study|Lack of Efficacy|10|||
162114289|NCT00941798|585467868|FG001|Overall Study|Lack of Efficacy|17|||
162114290|NCT00941798|585467867|FG000|Overall Study|Patient's inability to use device|6|||
162114291|NCT00941798|585467868|FG001|Overall Study|Patient's inability to use device|1|||
162114292|NCT00941798|585467867|FG000|Overall Study|Abnormal test procedure results|3|||
162114293|NCT00941798|585467868|FG001|Overall Study|Abnormal test procedure results|1|||
162114294|NCT00941798|585467867|FG000|Overall Study|Abnormal laboratory values|1|||
162114295|NCT00941798|585467868|FG001|Overall Study|Abnormal laboratory values|2|||
162114296|NCT00941798|585467867|FG000|Overall Study|Death|0|||
162114297|NCT00941798|585467868|FG001|Overall Study|Death|1|||
162114298|NCT05597722|585467871|FG000|Overall Study|Study was terminated|6|||
162114299|NCT05597722|585467872|FG001|Overall Study|Study was terminated|1|||
162114300|NCT00404495|585467873|FG000|Overall Study|Death|37|||
162114301|NCT00404495|585467874|FG001|Overall Study|Death|11|||
162114302|NCT00404495|585467873|FG000|Overall Study|Lost to Follow-up|5|||
162114303|NCT00404495|585467874|FG001|Overall Study|Lost to Follow-up|0|||
162114304|NCT00404495|585467873|FG000|Overall Study|Other|1|||
162114305|NCT00404495|585467874|FG001|Overall Study|Other|0|||
162114306|NCT00404495|585467873|FG000|Overall Study|Withdrawal by Subject|1|||
162114307|NCT00404495|585467874|FG001|Overall Study|Withdrawal by Subject|0|||
162114308|NCT04108000|585467875|FG000|Overall Study|Death of patient|1|||
162114309|NCT04108000|585467876|FG001|Overall Study|Death of patient|0|||
162114310|NCT04108000|585467877|FG002|Overall Study|Death of patient|1|||
162114311|NCT04108000|585467878|FG003|Overall Study|Death of patient|0|||
162114312|NCT04108000|585467875|FG000|Overall Study|Withdrawal by Subject|2|||
162114313|NCT04108000|585467876|FG001|Overall Study|Withdrawal by Subject|2|||
162114314|NCT04108000|585467877|FG002|Overall Study|Withdrawal by Subject|0|||
162114315|NCT04108000|585467878|FG003|Overall Study|Withdrawal by Subject|0|||
162114316|NCT04108000|585467875|FG000|Overall Study|Death of surrogate partner|0|||
162114317|NCT04108000|585467876|FG001|Overall Study|Death of surrogate partner|1|||
162114318|NCT04108000|585467877|FG002|Overall Study|Death of surrogate partner|0|||
162114319|NCT04108000|585467878|FG003|Overall Study|Death of surrogate partner|1|||
162114320|NCT03750006|585467881|FG000|Overall Study|Withdrawal by Subject|8|||
162114321|NCT03750006|585467881|FG000|Overall Study|COVID PANDEMIC|11|||
162114322|NCT01160484|585469595|FG000|Overall Study|Lack of Efficacy|9|||
162114323|NCT01160484|585469595|FG000|Overall Study|Adverse Event|6|||
162114324|NCT01160484|585469595|FG000|Overall Study|Withdrawal by Subject|2|||
162114325|NCT01160484|585469595|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
162114326|NCT01382602|585469596|FG000|Overall Study|Protocol Violation|0|||
162114327|NCT01382602|585469597|FG001|Overall Study|Protocol Violation|3|||
162114328|NCT01382602|585469596|FG000|Overall Study|Withdrawal by Subject|0|||
162114329|NCT01382602|585469597|FG001|Overall Study|Withdrawal by Subject|1|||
162114330|NCT01392300|585469605|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
162114331|NCT01392300|585469606|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
162114332|NCT01392300|585469607|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
162114333|NCT01392300|585469605|FG000|Main Period (MP)|Withdrawal by Subject|5|||
162114334|NCT01392300|585469606|FG001|Main Period (MP)|Withdrawal by Subject|1|||
162114335|NCT01392300|585469607|FG002|Main Period (MP)|Withdrawal by Subject|0|||
162114336|NCT01392300|585469605|FG000|Main Period (MP)|Lost to Follow-up|3|||
162114337|NCT01392300|585469606|FG001|Main Period (MP)|Lost to Follow-up|3|||
162114338|NCT01392300|585469607|FG002|Main Period (MP)|Lost to Follow-up|0|||
162114339|NCT01392300|585469605|FG000|Main Period (MP)|Non-compliance|1|||
162114340|NCT01392300|585469606|FG001|Main Period (MP)|Non-compliance|0|||
162114341|NCT01392300|585469607|FG002|Main Period (MP)|Non-compliance|0|||
162114342|NCT01392300|585469605|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
162114343|NCT01392300|585469606|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
162114344|NCT01392300|585469607|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
162114345|NCT01392300|585469605|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
162114346|NCT01392300|585469606|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
162114347|NCT01392300|585469607|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
162114348|NCT01392300|585469605|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
162114349|NCT01392300|585469606|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
162114350|NCT01392300|585469607|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
162114351|NCT01392300|585469605|FG000|Open Label Extension (OLEX) Period|Death|0|||
162114352|NCT01392300|585469606|FG001|Open Label Extension (OLEX) Period|Death|0|||
162114353|NCT01392300|585469607|FG002|Open Label Extension (OLEX) Period|Death|4|||
162114354|NCT01392300|585469605|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
162114355|NCT01392300|585469606|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
162114356|NCT01392300|585469607|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
162114357|NCT01392300|585469605|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
162114358|NCT01392300|585469606|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
162114359|NCT01392300|585469607|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
162114360|NCT01392300|585469605|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
162114361|NCT01392300|585469606|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
162114362|NCT01392300|585469607|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
162114363|NCT01147822|585469612|FG000|Overall Study|Lost to Follow-up|14|||
162114364|NCT01147822|585469613|FG001|Overall Study|Lost to Follow-up|6|||
162114365|NCT01147822|585469612|FG000|Overall Study|Withdrawal by Subject|10|||
162114366|NCT01147822|585469613|FG001|Overall Study|Withdrawal by Subject|16|||
162114367|NCT01147822|585469612|FG000|Overall Study|Physician Decision|9|||
162114368|NCT01147822|585469613|FG001|Overall Study|Physician Decision|8|||
162114369|NCT01147822|585469612|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
162114370|NCT01147822|585469613|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
162114371|NCT01147822|585469612|FG000|Overall Study|Protocol Violation|1|||
162114372|NCT01147822|585469613|FG001|Overall Study|Protocol Violation|1|||
162114373|NCT03010462|585469617|FG000|Overall Study|Withdrawal by Subject|3|||
162114374|NCT03010462|585469618|FG001|Overall Study|Withdrawal by Subject|1|||
162114375|NCT01966003|585469619|FG000|Overall Study|Death|43|||
162114376|NCT01966003|585469620|FG001|Overall Study|Death|36|||
162114377|NCT01966003|585469619|FG000|Overall Study|Protocol Violation|6|||
162114378|NCT01966003|585469620|FG001|Overall Study|Protocol Violation|4|||
162114379|NCT01966003|585469619|FG000|Overall Study|Lost to Follow-up|4|||
162114380|NCT01966003|585469620|FG001|Overall Study|Lost to Follow-up|3|||
162114381|NCT01966003|585469619|FG000|Overall Study|Physician Decision|12|||
162114382|NCT01966003|585469620|FG001|Overall Study|Physician Decision|13|||
162114383|NCT01966003|585469619|FG000|Overall Study|Withdrawal by Subject|29|||
162114384|NCT01966003|585469620|FG001|Overall Study|Withdrawal by Subject|19|||
162114385|NCT01966003|585469619|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
162114386|NCT01966003|585469620|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
162114387|NCT01966003|585469619|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
162114388|NCT01966003|585469620|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
162114389|NCT01966003|585469619|FG000|Overall Study|Other|1|||
162114390|NCT01966003|585469620|FG001|Overall Study|Other|1|||
162114391|NCT02748694|585469625|FG000|Overall Study|Voluntary Withdrawal|0|||
162114392|NCT02748694|585469626|FG001|Overall Study|Voluntary Withdrawal|0|||
162114393|NCT02748694|585469627|FG002|Overall Study|Voluntary Withdrawal|0|||
162114394|NCT02748694|585469628|FG003|Overall Study|Voluntary Withdrawal|0|||
162114395|NCT02748694|585469629|FG004|Overall Study|Voluntary Withdrawal|0|||
162114396|NCT02748694|585469630|FG005|Overall Study|Voluntary Withdrawal|0|||
162114397|NCT02748694|585469631|FG006|Overall Study|Voluntary Withdrawal|0|||
162114398|NCT02748694|585469632|FG007|Overall Study|Voluntary Withdrawal|0|||
162114399|NCT02748694|585469633|FG008|Overall Study|Voluntary Withdrawal|0|||
162114400|NCT02748694|585469634|FG009|Overall Study|Voluntary Withdrawal|0|||
162114401|NCT02748694|585469635|FG010|Overall Study|Voluntary Withdrawal|0|||
162114402|NCT02748694|585469636|FG011|Overall Study|Voluntary Withdrawal|0|||
162114403|NCT02748694|585469637|FG012|Overall Study|Voluntary Withdrawal|0|||
162114404|NCT02748694|585469638|FG013|Overall Study|Voluntary Withdrawal|0|||
162114405|NCT02748694|585469639|FG014|Overall Study|Voluntary Withdrawal|2|||
162114406|NCT04026165|585469640|FG000|Run-in Placebo Period|Enrollment Error|13|||
162114407|NCT04026165|585469641|FG001|Run-in Placebo Period|Enrollment Error|0|||
162114408|NCT04026165|585469642|FG002|Run-in Placebo Period|Enrollment Error|0|||
162114409|NCT04026165|585469643|FG003|Run-in Placebo Period|Enrollment Error|0|||
162114410|NCT04026165|585469640|FG000|Run-in Placebo Period|Run-in Failure|4|||
162114411|NCT04026165|585469641|FG001|Run-in Placebo Period|Run-in Failure|0|||
162114412|NCT04026165|585469642|FG002|Run-in Placebo Period|Run-in Failure|0|||
162114413|NCT04026165|585469643|FG003|Run-in Placebo Period|Run-in Failure|0|||
162114414|NCT04026165|585469640|FG000|Run-in Placebo Period|Protocol Violation|2|||
162114415|NCT04026165|585469641|FG001|Run-in Placebo Period|Protocol Violation|0|||
162114416|NCT04026165|585469642|FG002|Run-in Placebo Period|Protocol Violation|0|||
162114417|NCT04026165|585469643|FG003|Run-in Placebo Period|Protocol Violation|0|||
162114418|NCT04026165|585469640|FG000|Run-in Placebo Period|Withdrew Consent|2|||
162114419|NCT04026165|585469641|FG001|Run-in Placebo Period|Withdrew Consent|0|||
162114420|NCT04026165|585469642|FG002|Run-in Placebo Period|Withdrew Consent|0|||
162114421|NCT04026165|585469643|FG003|Run-in Placebo Period|Withdrew Consent|0|||
162114422|NCT04026165|585469640|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
162114423|NCT04026165|585469641|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
162114424|NCT04026165|585469642|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
162114425|NCT04026165|585469643|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
162114426|NCT04026165|585469640|FG000|Run-in SEL Period|Run-in Failure|0|||
162114427|NCT04026165|585469641|FG001|Run-in SEL Period|Run-in Failure|26|||
162114428|NCT04026165|585469642|FG002|Run-in SEL Period|Run-in Failure|0|||
162114429|NCT04026165|585469643|FG003|Run-in SEL Period|Run-in Failure|0|||
162114430|NCT04026165|585469640|FG000|Run-in SEL Period|Withdrew Consent|0|||
162114431|NCT04026165|585469641|FG001|Run-in SEL Period|Withdrew Consent|10|||
162114432|NCT04026165|585469642|FG002|Run-in SEL Period|Withdrew Consent|0|||
162114433|NCT04026165|585469643|FG003|Run-in SEL Period|Withdrew Consent|0|||
162114434|NCT04026165|585469640|FG000|Run-in SEL Period|Enrollment Error|0|||
162114435|NCT04026165|585469641|FG001|Run-in SEL Period|Enrollment Error|4|||
162114436|NCT04026165|585469642|FG002|Run-in SEL Period|Enrollment Error|0|||
162114437|NCT04026165|585469643|FG003|Run-in SEL Period|Enrollment Error|0|||
162114438|NCT04026165|585469640|FG000|Run-in SEL Period|Protocol Violation|0|||
162114439|NCT04026165|585469641|FG001|Run-in SEL Period|Protocol Violation|3|||
162114440|NCT04026165|585469642|FG002|Run-in SEL Period|Protocol Violation|0|||
162114441|NCT04026165|585469643|FG003|Run-in SEL Period|Protocol Violation|0|||
162114442|NCT04026165|585469640|FG000|Run-in SEL Period|Investigator's Discretion|0|||
162114443|NCT04026165|585469641|FG001|Run-in SEL Period|Investigator's Discretion|2|||
162114444|NCT04026165|585469642|FG002|Run-in SEL Period|Investigator's Discretion|0|||
162114445|NCT04026165|585469643|FG003|Run-in SEL Period|Investigator's Discretion|0|||
162114446|NCT04026165|585469640|FG000|Run-in SEL Period|Death|0|||
162114447|NCT04026165|585469641|FG001|Run-in SEL Period|Death|1|||
162114448|NCT04026165|585469642|FG002|Run-in SEL Period|Death|0|||
162114449|NCT04026165|585469643|FG003|Run-in SEL Period|Death|0|||
162114450|NCT04026165|585469640|FG000|Randomized Period|Withdrew Consent|0|||
162114451|NCT04026165|585469641|FG001|Randomized Period|Withdrew Consent|0|||
162114452|NCT04026165|585469642|FG002|Randomized Period|Withdrew Consent|5|||
162114453|NCT04026165|585469643|FG003|Randomized Period|Withdrew Consent|8|||
162114454|NCT04026165|585469640|FG000|Randomized Period|Death|0|||
162114455|NCT04026165|585469641|FG001|Randomized Period|Death|0|||
162114456|NCT04026165|585469642|FG002|Randomized Period|Death|5|||
162114457|NCT04026165|585469643|FG003|Randomized Period|Death|7|||
162114458|NCT04026165|585469640|FG000|Randomized Period|Investigator's Discretion|0|||
162114459|NCT04026165|585469641|FG001|Randomized Period|Investigator's Discretion|0|||
162114460|NCT04026165|585469642|FG002|Randomized Period|Investigator's Discretion|2|||
162114461|NCT04026165|585469643|FG003|Randomized Period|Investigator's Discretion|2|||
162114462|NCT04026165|585469640|FG000|Randomized Period|Lost to Follow-up|0|||
162114463|NCT04026165|585469641|FG001|Randomized Period|Lost to Follow-up|0|||
162114464|NCT04026165|585469642|FG002|Randomized Period|Lost to Follow-up|2|||
162114465|NCT04026165|585469643|FG003|Randomized Period|Lost to Follow-up|2|||
162114466|NCT01059630|585469646|FG000|Overall Study|Death|100|||
162114467|NCT01059630|585469647|FG001|Overall Study|Death|84|||
162114468|NCT01059630|585469646|FG000|Overall Study|Lost to Follow-up|4|||
162114469|NCT01059630|585469647|FG001|Overall Study|Lost to Follow-up|1|||
162114470|NCT01059630|585469646|FG000|Overall Study|Physician Decision|2|||
162114471|NCT01059630|585469647|FG001|Overall Study|Physician Decision|4|||
162114472|NCT01059630|585469646|FG000|Overall Study|Withdrawal by Subject|21|||
162114473|NCT01059630|585469647|FG001|Overall Study|Withdrawal by Subject|14|||
162114474|NCT02569437|585469648|FG000|Overall Study|Lost to Follow-up|12|||
162114475|NCT02569437|585469649|FG001|Overall Study|Lost to Follow-up|14|||
162114476|NCT00441701|585469650|FG000|Overall Study|Adverse Event|3|||
162114477|NCT00441701|585469651|FG001|Overall Study|Adverse Event|2|||
162114478|NCT00441701|585469652|FG002|Overall Study|Adverse Event|1|||
162114479|NCT00441701|585469653|FG003|Overall Study|Adverse Event|0|||
162114480|NCT00441701|585469654|FG004|Overall Study|Adverse Event|2|||
162114481|NCT00441701|585469655|FG005|Overall Study|Adverse Event|2|||
162114482|NCT00441701|585469656|FG006|Overall Study|Adverse Event|0|||
162114483|NCT00441701|585469657|FG007|Overall Study|Adverse Event|0|||
162114484|NCT00441701|585469658|FG008|Overall Study|Adverse Event|0|||
162114485|NCT00441701|585469659|FG009|Overall Study|Adverse Event|0|||
162114486|NCT00441701|585469650|FG000|Overall Study|Lack of Efficacy|2|||
162114487|NCT00441701|585469651|FG001|Overall Study|Lack of Efficacy|0|||
162114488|NCT00441701|585469652|FG002|Overall Study|Lack of Efficacy|2|||
162114489|NCT00441701|585469653|FG003|Overall Study|Lack of Efficacy|2|||
162114490|NCT00441701|585469654|FG004|Overall Study|Lack of Efficacy|0|||
162114491|NCT00441701|585469655|FG005|Overall Study|Lack of Efficacy|1|||
162114492|NCT00441701|585469656|FG006|Overall Study|Lack of Efficacy|0|||
162114493|NCT00441701|585469657|FG007|Overall Study|Lack of Efficacy|0|||
162114494|NCT00441701|585469658|FG008|Overall Study|Lack of Efficacy|0|||
162114495|NCT00441701|585469659|FG009|Overall Study|Lack of Efficacy|0|||
162114496|NCT00441701|585469650|FG000|Overall Study|Withdrawal by Subject|0|||
162114497|NCT00441701|585469651|FG001|Overall Study|Withdrawal by Subject|2|||
162114498|NCT00441701|585469652|FG002|Overall Study|Withdrawal by Subject|1|||
162114499|NCT00441701|585469653|FG003|Overall Study|Withdrawal by Subject|1|||
162114500|NCT00441701|585469654|FG004|Overall Study|Withdrawal by Subject|0|||
162114501|NCT00441701|585469655|FG005|Overall Study|Withdrawal by Subject|0|||
162114502|NCT00441701|585469656|FG006|Overall Study|Withdrawal by Subject|0|||
162114503|NCT00441701|585469657|FG007|Overall Study|Withdrawal by Subject|0|||
162114504|NCT00441701|585469658|FG008|Overall Study|Withdrawal by Subject|0|||
162114505|NCT00441701|585469659|FG009|Overall Study|Withdrawal by Subject|0|||
162114506|NCT00985985|585469663|FG000|Overall Study|Adverse Event|4|||
162114507|NCT00985985|585469664|FG001|Overall Study|Adverse Event|2|||
162114508|NCT00985985|585469665|FG002|Overall Study|Adverse Event|2|||
162114509|NCT00985985|585469666|FG003|Overall Study|Adverse Event|2|||
162114510|NCT00985985|585469663|FG000|Overall Study|Lost to Follow-up|4|||
162114511|NCT00985985|585469664|FG001|Overall Study|Lost to Follow-up|11|||
162114512|NCT00985985|585469665|FG002|Overall Study|Lost to Follow-up|2|||
162114513|NCT00985985|585469666|FG003|Overall Study|Lost to Follow-up|3|||
162114514|NCT00985985|585469663|FG000|Overall Study|Protocol Violation|1|||
162114515|NCT00985985|585469664|FG001|Overall Study|Protocol Violation|2|||
162114516|NCT00985985|585469665|FG002|Overall Study|Protocol Violation|0|||
162114517|NCT00985985|585469666|FG003|Overall Study|Protocol Violation|1|||
162114518|NCT00985985|585469663|FG000|Overall Study|Lack of Efficacy|5|||
162114519|NCT00985985|585469664|FG001|Overall Study|Lack of Efficacy|6|||
162114520|NCT00985985|585469665|FG002|Overall Study|Lack of Efficacy|1|||
162114521|NCT00985985|585469666|FG003|Overall Study|Lack of Efficacy|3|||
162114522|NCT00985985|585469663|FG000|Overall Study|Withdrawal by Subject|4|||
162114523|NCT00985985|585469664|FG001|Overall Study|Withdrawal by Subject|2|||
162114524|NCT00985985|585469665|FG002|Overall Study|Withdrawal by Subject|2|||
162114525|NCT00985985|585469666|FG003|Overall Study|Withdrawal by Subject|2|||
162114526|NCT00985985|585469663|FG000|Overall Study|Other Reason|6|||
162114527|NCT00985985|585469664|FG001|Overall Study|Other Reason|1|||
162114528|NCT00985985|585469665|FG002|Overall Study|Other Reason|4|||
162114529|NCT00985985|585469666|FG003|Overall Study|Other Reason|2|||
162114530|NCT02535364|585469674|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
162114531|NCT02535364|585469674|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
162114532|NCT02535364|585469674|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
162114533|NCT02535364|585469674|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
162114534|NCT02535364|585469674|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
162114535|NCT02535364|585469674|FG000|Part B Screening|Death|2|||
162114536|NCT02535364|585469674|FG000|Part B Screening|Physician Decision|1|||
162114537|NCT02535364|585469674|FG000|Part B Screening|Withdrawal by Subject|1|||
162114538|NCT02535364|585469674|FG000|Part B Screening|Adverse Event|1|||
162114539|NCT02535364|585469674|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
162114540|NCT02535364|585469674|FG000|Study Treatment|Death|1|||
162114541|NCT02535364|585469674|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
162114542|NCT02535364|585469674|FG000|12-Month Follow-up Period|Disease progression|22|||
162114543|NCT02535364|585469674|FG000|12-Month Follow-up Period|Death|5|||
162114544|NCT02535364|585469674|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
162114545|NCT02535364|585469674|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
162114546|NCT02535364|585469674|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
162114547|NCT00499863|585469675|FG000|Overall Study|Lack of Efficacy|21|||
162114548|NCT00499863|585469676|FG001|Overall Study|Lack of Efficacy|27|||
162114549|NCT00499863|585469675|FG000|Overall Study|Protocol Violation|12|||
162114550|NCT00499863|585469676|FG001|Overall Study|Protocol Violation|7|||
162114551|NCT00499863|585469675|FG000|Overall Study|Withdrawal by Subject|6|||
162114552|NCT00499863|585469676|FG001|Overall Study|Withdrawal by Subject|4|||
162114553|NCT00499863|585469675|FG000|Overall Study|Adverse Event|8|||
162114554|NCT00499863|585469676|FG001|Overall Study|Adverse Event|2|||
162114555|NCT00499863|585469675|FG000|Overall Study|Sponsor decision|2|||
162114556|NCT00499863|585469676|FG001|Overall Study|Sponsor decision|2|||
162114557|NCT00499863|585469675|FG000|Overall Study|Lost to Follow-up|1|||
162114558|NCT00499863|585469676|FG001|Overall Study|Lost to Follow-up|1|||
162114559|NCT00571701|585469677|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
162114560|NCT00571701|585469678|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
162114561|NCT00571701|585469677|FG000|First Intervention 12 Months|Death|1|||
162114562|NCT00571701|585469678|FG001|First Intervention 12 Months|Death|0|||
162114563|NCT00571701|585469677|FG000|Second Intervention 12 Months|Adverse Event|0|||
162114564|NCT00571701|585469678|FG001|Second Intervention 12 Months|Adverse Event|1|||
162114565|NCT00571701|585469677|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
162114566|NCT00571701|585469678|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
162114567|NCT00691132|585469679|FG000|Overall Study|Adverse Event|2|||
162114568|NCT00691132|585469680|FG001|Overall Study|Adverse Event|3|||
162114569|NCT00691132|585469679|FG000|Overall Study|Withdrawal by Subject|10|||
162114570|NCT00691132|585469680|FG001|Overall Study|Withdrawal by Subject|10|||
162114571|NCT01959347|585469691|FG000|Overall Study|Protocol Violation|9|||
162114572|NCT01959347|585469692|FG001|Overall Study|Protocol Violation|7|||
162114573|NCT01282801|585469693|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
162114574|NCT01282801|585469694|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
162114575|NCT02889133|585469698|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
162114576|NCT02889133|585469699|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
162114577|NCT02889133|585469698|FG000|Completed Primary Outcome|Manufacturing error|3|||
162114578|NCT02889133|585469699|FG001|Completed Primary Outcome|Manufacturing error|8|||
162114579|NCT02889133|585469698|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
162114580|NCT02889133|585469699|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
162114581|NCT02889133|585469698|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
162114582|NCT02889133|585469699|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
162114583|NCT02889133|585469698|FG000|Completed Primary Outcome|Protocol Violation|1|||
162114584|NCT02889133|585469699|FG001|Completed Primary Outcome|Protocol Violation|0|||
162114585|NCT02889133|585469698|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
162114586|NCT02889133|585469699|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
162114587|NCT02889133|585469698|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
162114588|NCT02889133|585469699|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
162114589|NCT02889133|585469698|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
162114590|NCT02889133|585469699|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
162114591|NCT02889133|585469698|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
162114592|NCT02889133|585469699|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
162114593|NCT02889133|585469698|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
162114594|NCT02889133|585469699|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
162114595|NCT01781390|585469701|FG000|Overall Study|Withdrawal of Consent|0|||
162114596|NCT01781390|585469702|FG001|Overall Study|Withdrawal of Consent|3|||
162114597|NCT01781390|585469703|FG002|Overall Study|Withdrawal of Consent|1|||
162114598|NCT01781390|585469701|FG000|Overall Study|Lost to Follow-up|1|||
162114599|NCT01781390|585469702|FG001|Overall Study|Lost to Follow-up|1|||
162114600|NCT01781390|585469703|FG002|Overall Study|Lost to Follow-up|1|||
162114601|NCT01781390|585469701|FG000|Overall Study|Adverse Event|1|||
162114602|NCT01781390|585469702|FG001|Overall Study|Adverse Event|2|||
162114603|NCT01781390|585469703|FG002|Overall Study|Adverse Event|1|||
162114604|NCT01781390|585469701|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
162114605|NCT01781390|585469702|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
162114606|NCT01781390|585469703|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
162114607|NCT01862796|585469704|FG000|Overall Study|Prohibited medications|0|||
162114608|NCT01862796|585469705|FG001|Overall Study|Prohibited medications|0|||
162114609|NCT01862796|585469706|FG002|Overall Study|Prohibited medications|1|||
162114610|NCT01375205|585469711|FG000|Overall Study|Lost to Follow-up|15|||
162114611|NCT01375205|585469712|FG001|Overall Study|Lost to Follow-up|12|||
162114612|NCT01375205|585469711|FG000|Overall Study|Withdrawal by Subject|6|||
162114613|NCT01375205|585469712|FG001|Overall Study|Withdrawal by Subject|1|||
162114614|NCT01859793|585469713|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
162114615|NCT01859793|585469714|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
162114616|NCT01859793|585469713|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
162114617|NCT01859793|585469714|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
162114618|NCT01859793|585469713|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
162114619|NCT01859793|585469714|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
162114620|NCT01859793|585469713|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
162114621|NCT01859793|585469714|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
162114622|NCT01064297|585469723|FG000|Overall Study|Lost to Follow-up|791|||
162114623|NCT01064297|585469724|FG001|Overall Study|Lost to Follow-up|48|||
162114624|NCT01064297|585469725|FG002|Overall Study|Lost to Follow-up|133|||
162114625|NCT00511875|585469735|FG000|Overall Study|Lost to Follow-up|4|||
162114626|NCT00511875|585469736|FG001|Overall Study|Lost to Follow-up|0|||
162114627|NCT00511875|585469735|FG000|Overall Study|Missing variables|1|||
162114628|NCT00511875|585469736|FG001|Overall Study|Missing variables|0|||
162114629|NCT00542880|585469738|FG000|Period 1|Eligibility criteria not fulfilled|2|||
162114630|NCT00542880|585469739|FG001|Period 1|Eligibility criteria not fulfilled|6|||
162114631|NCT00542880|585469738|FG000|Period 1|Adverse Event|2|||
162114632|NCT00542880|585469739|FG001|Period 1|Adverse Event|2|||
162114633|NCT00542880|585469738|FG000|Period 1|Development of study-specific criteria|1|||
162114634|NCT00542880|585469739|FG001|Period 1|Development of study-specific criteria|2|||
162114635|NCT00542880|585469738|FG000|Period 1|Withdrawal by Subject|1|||
162114636|NCT00542880|585469739|FG001|Period 1|Withdrawal by Subject|1|||
162114637|NCT00542880|585469738|FG000|Period 1|Protocol Violation|0|||
162114638|NCT00542880|585469739|FG001|Period 1|Protocol Violation|1|||
162114639|NCT00542880|585469738|FG000|Period 2|Adverse Event|5|||
162114640|NCT00542880|585469739|FG001|Period 2|Adverse Event|7|||
162114641|NCT00542880|585469738|FG000|Period 2|Eligibility not fulfilled|0|||
162114642|NCT00542880|585469739|FG001|Period 2|Eligibility not fulfilled|1|||
162114643|NCT00542880|585469738|FG000|Period 2|Discontinuation criteria|2|||
162114644|NCT00542880|585469739|FG001|Period 2|Discontinuation criteria|0|||
162114645|NCT00542880|585469738|FG000|Period 2|Severe non-compliance|0|||
162114646|NCT00542880|585469739|FG001|Period 2|Severe non-compliance|1|||
162114647|NCT00542880|585469738|FG000|Period 2|Other|0|||
162114648|NCT00542880|585469739|FG001|Period 2|Other|1|||
162114649|NCT00542880|585469738|FG000|Period 3|Adverse Event|0|||
162114650|NCT00542880|585469739|FG001|Period 3|Adverse Event|2|||
162114651|NCT00982930|585469744|FG000|Overall Study|Adverse Event|1|||
162114652|NCT00982930|585469744|FG000|Overall Study|Withdrawal by Subject|1|||
162114653|NCT00982930|585469744|FG000|Overall Study|Administrative Problems|2|||
162114654|NCT04179721|585469745|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
162114655|NCT04179721|585469746|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
162114656|NCT04179721|585469745|FG000|Overall Study|Lost to Follow-up|0|||
162114657|NCT04179721|585469746|FG001|Overall Study|Lost to Follow-up|1|||
162114658|NCT03538951|585469749|FG000|Overall Study|Withdrawal by Subject|1|||
162114659|NCT03538951|585469750|FG001|Overall Study|Withdrawal by Subject|2|||
162114660|NCT06027619|585469751|FG000|Overall Study|Adverse Event|0|||
162114661|NCT06027619|585469752|FG001|Overall Study|Adverse Event|0|||
162114662|NCT06027619|585469753|FG002|Overall Study|Adverse Event|1|||
162114663|NCT01493960|585470804|FG000|Overall Study|Adverse Event|0|||
162114664|NCT01493960|585470805|FG001|Overall Study|Adverse Event|1|||
162114665|NCT01493960|585470804|FG000|Overall Study|Lack of Efficacy|15|||
162114666|NCT01493960|585470805|FG001|Overall Study|Lack of Efficacy|9|||
162114667|NCT01493960|585470804|FG000|Overall Study|Protocol Violation|3|||
162114668|NCT01493960|585470805|FG001|Overall Study|Protocol Violation|0|||
162114669|NCT01493960|585470804|FG000|Overall Study|Withdrawal by Subject|10|||
162114670|NCT01493960|585470805|FG001|Overall Study|Withdrawal by Subject|4|||
162114671|NCT01493960|585470804|FG000|Overall Study|Non-specified|4|||
162114672|NCT01493960|585470805|FG001|Overall Study|Non-specified|4|||
162114673|NCT00871403|585470808|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
162114674|NCT00871403|585470809|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
162114675|NCT00871403|585470810|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
162114676|NCT00871403|585470808|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
162114677|NCT00871403|585470809|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
162114678|NCT00871403|585470810|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
162114679|NCT00871403|585470808|FG000|Combination Treatment Phase|Adverse Event|0|||
162114680|NCT00871403|585470809|FG001|Combination Treatment Phase|Adverse Event|17|||
162114681|NCT00871403|585470810|FG002|Combination Treatment Phase|Adverse Event|2|||
162114682|NCT00871403|585470808|FG000|Combination Treatment Phase|Disease Progression|0|||
162114683|NCT00871403|585470809|FG001|Combination Treatment Phase|Disease Progression|8|||
162114684|NCT00871403|585470810|FG002|Combination Treatment Phase|Disease Progression|5|||
162114685|NCT00871403|585470808|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
162114686|NCT00871403|585470809|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
162114687|NCT00871403|585470810|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
162114688|NCT00871403|585470808|FG000|Combination Treatment Phase|Physician Decision|0|||
162114689|NCT00871403|585470809|FG001|Combination Treatment Phase|Physician Decision|1|||
162114690|NCT00871403|585470810|FG002|Combination Treatment Phase|Physician Decision|3|||
162114691|NCT00871403|585470808|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
162114692|NCT00871403|585470809|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
162114693|NCT00871403|585470810|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
162114694|NCT00871403|585470808|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
162114695|NCT00871403|585470809|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
162114696|NCT00871403|585470810|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
162114697|NCT03170375|585470813|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
162114698|NCT03170375|585470814|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
162114699|NCT03170375|585470815|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
162114700|NCT03170375|585470813|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
162114701|NCT03170375|585470814|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
162114702|NCT03170375|585470815|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
162114703|NCT00077064|585470816|FG000|Overall Study|Adverse Event|0|||
162114704|NCT00077064|585470817|FG001|Overall Study|Adverse Event|4|||
162114705|NCT00077064|585470816|FG000|Overall Study|Patient refusal|0|||
162114706|NCT00077064|585470817|FG001|Overall Study|Patient refusal|2|||
162114707|NCT02007434|585470818|FG000|Overall Study|Lost to Follow-up|0|||
162114708|NCT02007434|585470819|FG001|Overall Study|Lost to Follow-up|1|||
162114709|NCT02007434|585470820|FG002|Overall Study|Lost to Follow-up|0|||
162114710|NCT02007434|585470821|FG003|Overall Study|Lost to Follow-up|0|||
162114711|NCT02007434|585470822|FG004|Overall Study|Lost to Follow-up|0|||
162114712|NCT02007434|585470823|FG005|Overall Study|Lost to Follow-up|0|||
162114713|NCT02007434|585470824|FG006|Overall Study|Lost to Follow-up|0|||
162114714|NCT02007434|585470825|FG007|Overall Study|Lost to Follow-up|0|||
162114715|NCT02007434|585470818|FG000|Overall Study|Non-compliance|1|||
162114716|NCT02007434|585470819|FG001|Overall Study|Non-compliance|0|||
162114717|NCT02007434|585470820|FG002|Overall Study|Non-compliance|1|||
162114718|NCT02007434|585470821|FG003|Overall Study|Non-compliance|0|||
162114719|NCT02007434|585470822|FG004|Overall Study|Non-compliance|0|||
162114720|NCT02007434|585470823|FG005|Overall Study|Non-compliance|0|||
162114721|NCT02007434|585470824|FG006|Overall Study|Non-compliance|0|||
162114722|NCT02007434|585470825|FG007|Overall Study|Non-compliance|0|||
162114723|NCT00763958|585470826|FG000|Overall Study|did not meet final criteria|4|||
162114724|NCT00763958|585470827|FG001|Overall Study|did not meet final criteria|4|||
162114725|NCT00763958|585470826|FG000|Overall Study|Lost to Follow-up|10|||
162114726|NCT00763958|585470827|FG001|Overall Study|Lost to Follow-up|2|||
162114727|NCT00763958|585470826|FG000|Overall Study|Believed they were receiving placebo|0|||
162114728|NCT00763958|585470827|FG001|Overall Study|Believed they were receiving placebo|5|||
162114729|NCT00927355|585470828|FG000|Overall Study|Adverse Event|1|||
162114730|NCT00927355|585470829|FG001|Overall Study|Adverse Event|1|||
162114731|NCT03299686|585470830|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
162114732|NCT03299686|585470831|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
162114733|NCT03299686|585470830|FG000|Treatment Epoch|Physician Decision|1|||
162114734|NCT03299686|585470831|FG001|Treatment Epoch|Physician Decision|0|||
162114735|NCT03299686|585470830|FG000|Treatment Epoch|Adverse Event|8|||
162114736|NCT03299686|585470831|FG001|Treatment Epoch|Adverse Event|4|||
162114737|NCT03299686|585470830|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
162114738|NCT03299686|585470831|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
162114739|NCT01060553|585470833|FG000|Overall Study|Lost to Follow-up|3|||
162114740|NCT01060553|585470834|FG001|Overall Study|Lost to Follow-up|5|||
162114741|NCT01060553|585470833|FG000|Overall Study|Withdrawal by Subject|5|||
162114742|NCT01060553|585470834|FG001|Overall Study|Withdrawal by Subject|5|||
162114743|NCT01060553|585470833|FG000|Overall Study|Lack of Efficacy|1|||
162114744|NCT01060553|585470834|FG001|Overall Study|Lack of Efficacy|0|||
162114745|NCT01446796|585470835|FG000|Overall Study|Withdrawal by Subject|1|||
162114746|NCT01446796|585470836|FG001|Overall Study|Withdrawal by Subject|0|||
162114747|NCT00954733|585470840|FG000|Overall Study|blood gas machine did not work|1|||
162114748|NCT03131960|585470841|FG000|Overall Study|Adverse Event|0|||
162114749|NCT03131960|585470842|FG001|Overall Study|Adverse Event|1|||
162114750|NCT04707196|585470843|FG000|Overall Study|Withdrawal by Subject|9|||
162114751|NCT04707196|585470844|FG001|Overall Study|Withdrawal by Subject|6|||
162114752|NCT04707196|585470843|FG000|Overall Study|Lost to Follow-up|1|||
162114753|NCT04707196|585470844|FG001|Overall Study|Lost to Follow-up|0|||
162114754|NCT04707196|585470843|FG000|Overall Study|Protocol Violation|4|||
162114755|NCT04707196|585470844|FG001|Overall Study|Protocol Violation|1|||
162114756|NCT04707196|585470843|FG000|Overall Study|Adverse Event|2|||
162114757|NCT04707196|585470844|FG001|Overall Study|Adverse Event|2|||
162114758|NCT04707196|585470843|FG000|Overall Study|Death|3|||
162114759|NCT04707196|585470844|FG001|Overall Study|Death|1|||
162114760|NCT04707196|585470843|FG000|Overall Study|Non-compliance with study drug|1|||
162114761|NCT04707196|585470844|FG001|Overall Study|Non-compliance with study drug|0|||
162114762|NCT04707196|585470843|FG000|Overall Study|Progressive disease|9|||
162114763|NCT04707196|585470844|FG001|Overall Study|Progressive disease|10|||
162114764|NCT01462162|585470848|FG000|Overall Study|Adverse Event|5|||
162114765|NCT01462162|585470848|FG000|Overall Study|Lack of Efficacy|4|||
162114766|NCT01462162|585470848|FG000|Overall Study|Abnormal laboratory parameters|1|||
162114767|NCT01462162|585470848|FG000|Overall Study|Other|2|||
162114768|NCT03485911|585470849|FG000|Part 1|Perceived lack of efficacy|1|||
162114769|NCT03485911|585470850|FG001|Part 1|Perceived lack of efficacy|1|||
162114770|NCT03485911|585470851|FG002|Part 1|Perceived lack of efficacy|2|||
162114771|NCT03485911|585470852|FG003|Part 1|Perceived lack of efficacy|0|||
162114772|NCT03485911|585470849|FG000|Part 1|Subject withdrew consent|0|||
162114773|NCT03485911|585470850|FG001|Part 1|Subject withdrew consent|1|||
162114774|NCT03485911|585470851|FG002|Part 1|Subject withdrew consent|0|||
162114775|NCT03485911|585470852|FG003|Part 1|Subject withdrew consent|1|||
162114776|NCT03485911|585470849|FG000|Part 1|Lab abnormalities/AEs|3|||
162114777|NCT03485911|585470850|FG001|Part 1|Lab abnormalities/AEs|1|||
162114778|NCT03485911|585470851|FG002|Part 1|Lab abnormalities/AEs|1|||
162114779|NCT03485911|585470852|FG003|Part 1|Lab abnormalities/AEs|0|||
162114780|NCT03485911|585470849|FG000|Part 1|Withdrew Consent prior to dosing|0|||
162114781|NCT03485911|585470850|FG001|Part 1|Withdrew Consent prior to dosing|0|||
162114782|NCT03485911|585470851|FG002|Part 1|Withdrew Consent prior to dosing|0|||
162114783|NCT03485911|585470852|FG003|Part 1|Withdrew Consent prior to dosing|1|||
162114784|NCT03485911|585470849|FG000|Part 1|Other NOS|0|||
162114785|NCT03485911|585470850|FG001|Part 1|Other NOS|0|||
162114786|NCT03485911|585470851|FG002|Part 1|Other NOS|0|||
162114787|NCT03485911|585470852|FG003|Part 1|Other NOS|1|||
162114788|NCT03485911|585470849|FG000|Part 2|Perceived lack of efficacy|5|||
162114789|NCT03485911|585470850|FG001|Part 2|Perceived lack of efficacy|3|||
162114790|NCT03485911|585470851|FG002|Part 2|Perceived lack of efficacy|0|||
162114791|NCT03485911|585470852|FG003|Part 2|Perceived lack of efficacy|2|||
162114792|NCT03485911|585470849|FG000|Part 2|Subject withdrew consent|1|||
162114793|NCT03485911|585470850|FG001|Part 2|Subject withdrew consent|0|||
162114794|NCT03485911|585470851|FG002|Part 2|Subject withdrew consent|2|||
162114795|NCT03485911|585470852|FG003|Part 2|Subject withdrew consent|1|||
162114796|NCT03485911|585470849|FG000|Part 2|Lab abnormalities/AEs|1|||
162114797|NCT03485911|585470850|FG001|Part 2|Lab abnormalities/AEs|2|||
162114798|NCT03485911|585470851|FG002|Part 2|Lab abnormalities/AEs|0|||
162114799|NCT03485911|585470852|FG003|Part 2|Lab abnormalities/AEs|0|||
162114800|NCT03485911|585470849|FG000|Part 2|Other NOS|0|||
162114801|NCT03485911|585470850|FG001|Part 2|Other NOS|1|||
162114802|NCT03485911|585470851|FG002|Part 2|Other NOS|0|||
162114803|NCT03485911|585470852|FG003|Part 2|Other NOS|0|||
162114804|NCT03485911|585470849|FG000|Part 2|Intercurrent illness/new medical condition|1|||
162114805|NCT03485911|585470850|FG001|Part 2|Intercurrent illness/new medical condition|0|||
162114806|NCT03485911|585470851|FG002|Part 2|Intercurrent illness/new medical condition|0|||
162114807|NCT03485911|585470852|FG003|Part 2|Intercurrent illness/new medical condition|0|||
162114808|NCT03485911|585470849|FG000|Part 2|Investigator judgement|1|||
162114809|NCT03485911|585470850|FG001|Part 2|Investigator judgement|0|||
162114810|NCT03485911|585470851|FG002|Part 2|Investigator judgement|0|||
162114811|NCT03485911|585470852|FG003|Part 2|Investigator judgement|0|||
162114812|NCT03485911|585470849|FG000|Part 3|Perceived lack of efficacy|2|||
162114813|NCT03485911|585470850|FG001|Part 3|Perceived lack of efficacy|2|||
162114814|NCT03485911|585470851|FG002|Part 3|Perceived lack of efficacy|2|||
162114815|NCT03485911|585470852|FG003|Part 3|Perceived lack of efficacy|0|||
162114816|NCT03485911|585470849|FG000|Part 3|Subject withdrew consent|1|||
162114817|NCT03485911|585470850|FG001|Part 3|Subject withdrew consent|4|||
162114818|NCT03485911|585470851|FG002|Part 3|Subject withdrew consent|0|||
162114819|NCT03485911|585470852|FG003|Part 3|Subject withdrew consent|1|||
162114820|NCT03485911|585470849|FG000|Part 3|Lab abnormalities/AEs|1|||
162114821|NCT03485911|585470850|FG001|Part 3|Lab abnormalities/AEs|1|||
162114822|NCT03485911|585470851|FG002|Part 3|Lab abnormalities/AEs|0|||
162114823|NCT03485911|585470852|FG003|Part 3|Lab abnormalities/AEs|2|||
162114824|NCT03485911|585470849|FG000|Part 3|Other NOS|1|||
162114825|NCT03485911|585470850|FG001|Part 3|Other NOS|1|||
162114826|NCT03485911|585470851|FG002|Part 3|Other NOS|0|||
162114827|NCT03485911|585470852|FG003|Part 3|Other NOS|0|||
162114828|NCT03485911|585470849|FG000|Part 3|Intercurrent illness/new medical condition|0|||
162114829|NCT03485911|585470850|FG001|Part 3|Intercurrent illness/new medical condition|1|||
162114830|NCT03485911|585470851|FG002|Part 3|Intercurrent illness/new medical condition|1|||
162114831|NCT03485911|585470852|FG003|Part 3|Intercurrent illness/new medical condition|0|||
162114832|NCT03485911|585470849|FG000|Part 3|Sponsor discontinuation|1|||
162114833|NCT03485911|585470850|FG001|Part 3|Sponsor discontinuation|0|||
162114834|NCT03485911|585470851|FG002|Part 3|Sponsor discontinuation|0|||
162114835|NCT03485911|585470852|FG003|Part 3|Sponsor discontinuation|0|||
162114836|NCT03485911|585470849|FG000|Part 3|Berotralstat provided by alternative means|13|||
162114837|NCT03485911|585470850|FG001|Part 3|Berotralstat provided by alternative means|13|||
162114838|NCT03485911|585470851|FG002|Part 3|Berotralstat provided by alternative means|7|||
162114839|NCT03485911|585470852|FG003|Part 3|Berotralstat provided by alternative means|7|||
162114840|NCT03333928|585470853|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
162114841|NCT03333928|585470854|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
162114842|NCT03333928|585470855|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
162114843|NCT03333928|585470853|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
162114844|NCT03333928|585470854|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
162114845|NCT03333928|585470855|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
162114846|NCT03333928|585470853|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
162114847|NCT03333928|585470854|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
162114848|NCT03333928|585470855|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
162114849|NCT03333928|585470853|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
162114850|NCT03333928|585470854|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
162114851|NCT03333928|585470855|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
162114852|NCT03333928|585470853|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
162114853|NCT03333928|585470854|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
162114854|NCT03333928|585470855|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
162114855|NCT03333928|585470853|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
162114856|NCT03333928|585470854|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
162114857|NCT03333928|585470855|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
162114858|NCT03333928|585470853|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
162114859|NCT03333928|585470854|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
162114860|NCT03333928|585470855|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
162114861|NCT03333928|585470853|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
162114862|NCT03333928|585470854|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
162114863|NCT03333928|585470855|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
162114864|NCT00728962|585470856|FG000|Implant Placement Surgery|Adverse Event|8|||
162114865|NCT00728962|585470856|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
162114866|NCT00728962|585470856|FG000|Implant Placement Surgery|Protocol Violation|1|||
162114867|NCT00728962|585470856|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
162114868|NCT00728962|585470856|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
162114869|NCT04954586|585470857|FG000|Overall Study|Withdrawal by Subject|5|||
162114870|NCT01987817|585470869|FG000|Overall Study|Adverse Event|4|||
162114871|NCT01987817|585470870|FG001|Overall Study|Adverse Event|0|||
162114872|NCT01987817|585470869|FG000|Overall Study|Withdrawal by Subject|1|||
162114873|NCT01987817|585470870|FG001|Overall Study|Withdrawal by Subject|1|||
162114874|NCT01987817|585470869|FG000|Overall Study|Physician Decision|1|||
162114875|NCT01987817|585470870|FG001|Overall Study|Physician Decision|0|||
162114876|NCT02612064|585470878|FG000|Overall Study|Withdrawal by Subject|1|||
162114877|NCT02612064|585470879|FG001|Overall Study|Withdrawal by Subject|1|||
162114878|NCT02612064|585470878|FG000|Overall Study|Other|0|||
162114879|NCT02612064|585470879|FG001|Overall Study|Other|2|||
162114880|NCT05918978|585470882|FG000|Overall Study|Study Terminated by Sponsor|17|||
162114881|NCT05918978|585470883|FG001|Overall Study|Study Terminated by Sponsor|11|||
162114882|NCT05918978|585470882|FG000|Overall Study|Withdrawal by Subject|1|||
162114883|NCT05918978|585470883|FG001|Overall Study|Withdrawal by Subject|1|||
162114884|NCT05918978|585470882|FG000|Overall Study|Adverse Event|1|||
162114885|NCT05918978|585470883|FG001|Overall Study|Adverse Event|0|||
162114886|NCT05918978|585470882|FG000|Overall Study|Other|0|||
162114887|NCT05918978|585470883|FG001|Overall Study|Other|1|||
162114888|NCT00622180|585470884|FG000|Overall Study|Lost to Follow-up|1|||
162114889|NCT00622180|585470885|FG001|Overall Study|Lost to Follow-up|2|||
162114890|NCT00696384|585470898|FG000|Open Label Phase|Adverse Event|27|||
162114891|NCT00696384|585470899|FG001|Open Label Phase|Adverse Event|0|||
162114892|NCT00696384|585470900|FG002|Open Label Phase|Adverse Event|0|||
162114893|NCT00696384|585470898|FG000|Open Label Phase|Protocol Violation|18|||
162114894|NCT00696384|585470899|FG001|Open Label Phase|Protocol Violation|0|||
162114895|NCT00696384|585470900|FG002|Open Label Phase|Protocol Violation|0|||
162114896|NCT00696384|585470898|FG000|Open Label Phase|Lost to Follow-up|24|||
162114897|NCT00696384|585470899|FG001|Open Label Phase|Lost to Follow-up|0|||
162114898|NCT00696384|585470900|FG002|Open Label Phase|Lost to Follow-up|0|||
162114899|NCT00696384|585470898|FG000|Open Label Phase|Withdrawal by Subject|37|||
162114900|NCT00696384|585470899|FG001|Open Label Phase|Withdrawal by Subject|0|||
162114901|NCT00696384|585470900|FG002|Open Label Phase|Withdrawal by Subject|0|||
162114902|NCT00696384|585470898|FG000|Open Label Phase|Other|6|||
162114903|NCT00696384|585470899|FG001|Open Label Phase|Other|0|||
162114904|NCT00696384|585470900|FG002|Open Label Phase|Other|0|||
162114905|NCT00696384|585470898|FG000|Open Label Phase|Lack of Efficacy|3|||
162114906|NCT00696384|585470899|FG001|Open Label Phase|Lack of Efficacy|0|||
162114907|NCT00696384|585470900|FG002|Open Label Phase|Lack of Efficacy|0|||
162114908|NCT00696384|585470898|FG000|Open Label Phase|Physician Decision|4|||
162114909|NCT00696384|585470899|FG001|Open Label Phase|Physician Decision|0|||
162114910|NCT00696384|585470900|FG002|Open Label Phase|Physician Decision|0|||
162114911|NCT00696384|585470898|FG000|Double Blind Phase|Adverse Event|0|||
162114912|NCT00696384|585470899|FG001|Double Blind Phase|Adverse Event|2|||
162114913|NCT00696384|585470900|FG002|Double Blind Phase|Adverse Event|2|||
162114914|NCT00696384|585470898|FG000|Double Blind Phase|Lost to Follow-up|0|||
162114915|NCT00696384|585470899|FG001|Double Blind Phase|Lost to Follow-up|2|||
162114916|NCT00696384|585470900|FG002|Double Blind Phase|Lost to Follow-up|1|||
162114917|NCT00696384|585470898|FG000|Double Blind Phase|Withdrawal by Subject|0|||
162114918|NCT00696384|585470899|FG001|Double Blind Phase|Withdrawal by Subject|4|||
162114919|NCT00696384|585470900|FG002|Double Blind Phase|Withdrawal by Subject|3|||
162114920|NCT00696384|585470898|FG000|Double Blind Phase|Lack of Efficacy|0|||
162114921|NCT00696384|585470899|FG001|Double Blind Phase|Lack of Efficacy|1|||
162114922|NCT00696384|585470900|FG002|Double Blind Phase|Lack of Efficacy|0|||
162114923|NCT00696384|585470898|FG000|Double Blind Phase|Physician Decision|0|||
162114924|NCT00696384|585470899|FG001|Double Blind Phase|Physician Decision|2|||
162114925|NCT00696384|585470900|FG002|Double Blind Phase|Physician Decision|0|||
162114926|NCT05559866|585470904|FG000|Overall Study|Withdrawal by Subject|1|||
162114927|NCT05559866|585470905|FG001|Overall Study|Withdrawal by Subject|0|||
162114928|NCT03444376|585470907|FG000|Part A|Disease relapse or Progression|1|||
162114929|NCT03444376|585470907|FG000|Part A|Withdrawal by Subject|2|||
162114930|NCT03444376|585470907|FG000|Part A|Adverse Event|1|||
162114931|NCT03444376|585470907|FG000|Part B|Disease relapse or Progression|18|||
162114932|NCT03444376|585470907|FG000|Part B|Withdrawal by Subject|2|||
162114933|NCT03444376|585470907|FG000|Part B|Adverse Event|2|||
162114934|NCT03444376|585470907|FG000|Part B|Physician Decision|1|||
162114935|NCT03444376|585470907|FG000|Part C|Disease relapse or Progression|43|||
162114936|NCT03444376|585470907|FG000|Part C|Withdrawal by Subject|5|||
162114937|NCT03444376|585470907|FG000|Part C|Adverse Event|2|||
162114938|NCT03444376|585470907|FG000|Part C|Physician Decision|2|||
162114939|NCT03444376|585470907|FG000|Part C|Death|1|||
162114940|NCT00856167|585470909|FG000|Period 1|Withdrawal by Subject|1|||
162114941|NCT00856167|585470910|FG001|Period 1|Withdrawal by Subject|4|||
162114942|NCT00856167|585470911|FG002|Period 1|Withdrawal by Subject|0|||
162114943|NCT00856167|585470912|FG003|Period 1|Withdrawal by Subject|0|||
162114944|NCT00856167|585470909|FG000|Period 1|Lost to Follow-up|2|||
162114945|NCT00856167|585470910|FG001|Period 1|Lost to Follow-up|1|||
162114946|NCT00856167|585470911|FG002|Period 1|Lost to Follow-up|0|||
162114947|NCT00856167|585470912|FG003|Period 1|Lost to Follow-up|0|||
162114948|NCT00856167|585470909|FG000|Period 2|Lost to Follow-up|0|||
162114949|NCT00856167|585470910|FG001|Period 2|Lost to Follow-up|0|||
162114950|NCT00856167|585470911|FG002|Period 2|Lost to Follow-up|3|||
162114951|NCT00856167|585470912|FG003|Period 2|Lost to Follow-up|1|||
162114952|NCT00856167|585470909|FG000|Period 2|Withdrawal by Subject|0|||
162114953|NCT00856167|585470910|FG001|Period 2|Withdrawal by Subject|0|||
162114954|NCT00856167|585470911|FG002|Period 2|Withdrawal by Subject|2|||
162114955|NCT00856167|585470912|FG003|Period 2|Withdrawal by Subject|4|||
162114956|NCT01061333|585470915|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
162114957|NCT01061333|585470916|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
162114958|NCT01816763|585472990|FG000|Overall Study|The main reason for an incomplete survey|4|||
162114959|NCT01816763|585472991|FG001|Overall Study|The main reason for an incomplete survey|15|||
162114960|NCT01816763|585472992|FG002|Overall Study|The main reason for an incomplete survey|11|||
162114961|NCT01186328|585472997|FG000|Overall Study|Death|1|||
162114962|NCT01186328|585472998|FG001|Overall Study|Death|0|||
162114963|NCT01186328|585472999|FG002|Overall Study|Death|0|||
162114964|NCT01691521|585473000|FG000|Overall Study|Adverse Event|4|||
162114965|NCT01691521|585473001|FG001|Overall Study|Adverse Event|0|||
162114966|NCT01691521|585473002|FG002|Overall Study|Adverse Event|1|||
162114967|NCT01691521|585473000|FG000|Overall Study|Lack of Efficacy|1|||
162114968|NCT01691521|585473001|FG001|Overall Study|Lack of Efficacy|1|||
162114969|NCT01691521|585473002|FG002|Overall Study|Lack of Efficacy|2|||
162114970|NCT01691521|585473000|FG000|Overall Study|Protocol Violation|0|||
162114971|NCT01691521|585473001|FG001|Overall Study|Protocol Violation|3|||
162114972|NCT01691521|585473002|FG002|Overall Study|Protocol Violation|0|||
162114973|NCT01691521|585473000|FG000|Overall Study|Lost to Follow-up|0|||
162114974|NCT01691521|585473001|FG001|Overall Study|Lost to Follow-up|2|||
162114975|NCT01691521|585473002|FG002|Overall Study|Lost to Follow-up|2|||
162114976|NCT01691521|585473000|FG000|Overall Study|Physician Decision|2|||
162114977|NCT01691521|585473001|FG001|Overall Study|Physician Decision|1|||
162114978|NCT01691521|585473002|FG002|Overall Study|Physician Decision|0|||
162114979|NCT01691521|585473000|FG000|Overall Study|Withdrawal by Subject|5|||
162114980|NCT01691521|585473001|FG001|Overall Study|Withdrawal by Subject|9|||
162114981|NCT01691521|585473002|FG002|Overall Study|Withdrawal by Subject|4|||
162114982|NCT02343003|585473003|FG000|Overall Study|Withdrawal by Subject|9|||
162114983|NCT02343003|585473004|FG001|Overall Study|Withdrawal by Subject|4|||
162114984|NCT02343003|585473003|FG000|Overall Study|Lost to Follow-up|5|||
162114985|NCT02343003|585473004|FG001|Overall Study|Lost to Follow-up|1|||
162114986|NCT02343003|585473003|FG000|Overall Study|Protocol Violation|1|||
162114987|NCT02343003|585473004|FG001|Overall Study|Protocol Violation|0|||
162114988|NCT02343003|585473003|FG000|Overall Study|Death|0|||
162114989|NCT02343003|585473004|FG001|Overall Study|Death|1|||
162114990|NCT02343003|585473003|FG000|Overall Study|exclusion criteria met|1|||
162114991|NCT02343003|585473004|FG001|Overall Study|exclusion criteria met|1|||
162114992|NCT02343003|585473003|FG000|Overall Study|terminated by sponsor|2|||
162114993|NCT02343003|585473004|FG001|Overall Study|terminated by sponsor|0|||
162114994|NCT00622713|585473009|FG000|Overall Study|Adverse Event|35|||
162114995|NCT00622713|585473009|FG000|Overall Study|Administrative problems|4|||
162114996|NCT00622713|585473009|FG000|Overall Study|Withdrawal by Subject|11|||
162114997|NCT00622713|585473009|FG000|Overall Study|Lost to Follow-up|5|||
162114998|NCT00622713|585473009|FG000|Overall Study|Death|2|||
162114999|NCT00622713|585473009|FG000|Overall Study|Subject no longer required study drug|1|||
162115000|NCT00622713|585473009|FG000|Overall Study|Did not meet eligibility criteria|1|||
162115001|NCT04404478|585473010|FG000|Overall Study|Withdrawal by Subject|1|||
162115002|NCT04404478|585473011|FG001|Overall Study|Withdrawal by Subject|3|||
162115003|NCT01674621|585473024|FG000|Overall Study|Adverse Event|3|||
162115004|NCT01674621|585473025|FG001|Overall Study|Adverse Event|2|||
162115005|NCT01674621|585473026|FG002|Overall Study|Adverse Event|5|||
162115006|NCT01674621|585473027|FG003|Overall Study|Adverse Event|5|||
162115007|NCT01674621|585473028|FG004|Overall Study|Adverse Event|1|||
162115008|NCT01674621|585473024|FG000|Overall Study|Inability to Complete Study Procedures|0|||
162115009|NCT01674621|585473025|FG001|Overall Study|Inability to Complete Study Procedures|0|||
162115010|NCT01674621|585473026|FG002|Overall Study|Inability to Complete Study Procedures|0|||
162115011|NCT01674621|585473027|FG003|Overall Study|Inability to Complete Study Procedures|0|||
162115012|NCT01674621|585473028|FG004|Overall Study|Inability to Complete Study Procedures|2|||
162115013|NCT01674621|585473024|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
162115014|NCT01674621|585473025|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
162115015|NCT01674621|585473026|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
162115016|NCT01674621|585473027|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
162115017|NCT01674621|585473028|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
162115018|NCT01674621|585473024|FG000|Overall Study|Withdrawal by Subject|2|||
162115019|NCT01674621|585473025|FG001|Overall Study|Withdrawal by Subject|5|||
162115020|NCT01674621|585473026|FG002|Overall Study|Withdrawal by Subject|2|||
162115021|NCT01674621|585473027|FG003|Overall Study|Withdrawal by Subject|0|||
162115022|NCT01674621|585473028|FG004|Overall Study|Withdrawal by Subject|1|||
162115023|NCT01674621|585473024|FG000|Overall Study|Other than specified|0|||
162115024|NCT01674621|585473025|FG001|Overall Study|Other than specified|1|||
162115025|NCT01674621|585473026|FG002|Overall Study|Other than specified|0|||
162115026|NCT01674621|585473027|FG003|Overall Study|Other than specified|0|||
162115027|NCT01674621|585473028|FG004|Overall Study|Other than specified|2|||
162115028|NCT01725386|585473029|FG000|Overall Study|Death|84|||
162115029|NCT01725386|585473030|FG001|Overall Study|Death|40|||
162115030|NCT01725386|585473029|FG000|Overall Study|Lost to Follow-up|81|||
162115031|NCT01725386|585473030|FG001|Overall Study|Lost to Follow-up|6|||
162115032|NCT01725386|585473029|FG000|Overall Study|Withdrawal by Subject|10|||
162115033|NCT01725386|585473030|FG001|Overall Study|Withdrawal by Subject|0|||
162115034|NCT00879996|585473038|FG000|Overall Study|Lost to Follow-up|7|||
162115035|NCT00879996|585473039|FG001|Overall Study|Lost to Follow-up|6|||
162115036|NCT00879996|585473038|FG000|Overall Study|non-compliance|6|||
162115037|NCT00879996|585473039|FG001|Overall Study|non-compliance|4|||
162115038|NCT00879996|585473038|FG000|Overall Study|Physician Decision|1|||
162115039|NCT00879996|585473039|FG001|Overall Study|Physician Decision|2|||
162115040|NCT00879996|585473038|FG000|Overall Study|psychiatric problem|0|||
162115041|NCT00879996|585473039|FG001|Overall Study|psychiatric problem|1|||
162115042|NCT00879996|585473038|FG000|Overall Study|put on parole|1|||
162115043|NCT00879996|585473039|FG001|Overall Study|put on parole|0|||
162115044|NCT01216163|585473040|FG000|Overall Study|Withdrawal by Subject|1|||
162115045|NCT01216163|585473041|FG001|Overall Study|Withdrawal by Subject|1|||
162115046|NCT01216163|585473042|FG002|Overall Study|Withdrawal by Subject|0|||
162115047|NCT02914314|585473043|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
162115048|NCT02914314|585473044|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
162115049|NCT02914314|585473045|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
162115050|NCT02914314|585473046|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
162115051|NCT02914314|585473043|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
162115052|NCT02914314|585473044|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
162115053|NCT02914314|585473045|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
162115054|NCT02914314|585473046|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
162115055|NCT02914314|585473043|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
162115056|NCT02914314|585473044|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
162115057|NCT02914314|585473045|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
162115058|NCT02914314|585473046|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
162115059|NCT02914314|585473043|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
162115060|NCT02914314|585473044|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
162115061|NCT02914314|585473045|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
162115062|NCT02914314|585473046|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
162115063|NCT02914314|585473043|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
162115064|NCT02914314|585473044|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
162115065|NCT02914314|585473045|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
162115066|NCT02914314|585473046|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
162115067|NCT01148862|585473051|FG000|Second Intervention|Withdrawal by Subject|0|||
162115068|NCT01148862|585473052|FG001|Second Intervention|Withdrawal by Subject|2|||
162115069|NCT03056534|585473053|FG000|Overall Study|Participant withdrew consent|8|||
162115070|NCT03056534|585473053|FG000|Overall Study|Participant not able to return|6|||
162115071|NCT03056534|585473053|FG000|Overall Study|Lost to Follow-up|37|||
162115072|NCT03056534|585473053|FG000|Overall Study|Investigator judgment|1|||
162115073|NCT03056534|585473053|FG000|Overall Study|Death|4|||
162115074|NCT03056534|585473053|FG000|Overall Study|Adverse Event|1|||
162115075|NCT03056534|585473053|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
162115076|NCT04543188|585473054|FG000|Phase 1a|Adverse Event|0|||
162115077|NCT04543188|585473055|FG001|Phase 1a|Adverse Event|0|||
162115078|NCT04543188|585473056|FG002|Phase 1a|Adverse Event|0|||
162115079|NCT04543188|585473057|FG003|Phase 1a|Adverse Event|1|||
162115080|NCT04543188|585473058|FG004|Phase 1a|Adverse Event|0|||
162115081|NCT04543188|585473059|FG005|Phase 1a|Adverse Event|0|||
162115082|NCT04543188|585473060|FG006|Phase 1a|Adverse Event|1|||
162115083|NCT04543188|585473061|FG007|Phase 1a|Adverse Event|0|||
162115084|NCT04543188|585473062|FG008|Phase 1a|Adverse Event|0|||
162115085|NCT04543188|585473063|FG009|Phase 1a|Adverse Event|0|||
162115086|NCT04543188|585473064|FG010|Phase 1a|Adverse Event|0|||
162115087|NCT04543188|585473065|FG011|Phase 1a|Adverse Event|0|||
162115088|NCT04543188|585473066|FG012|Phase 1a|Adverse Event|0|||
162115089|NCT04543188|585473067|FG013|Phase 1a|Adverse Event|0|||
162115090|NCT04543188|585473068|FG014|Phase 1a|Adverse Event|0|||
162115091|NCT04543188|585473054|FG000|Phase 1a|Other (Death)|0|||
162115092|NCT04543188|585473055|FG001|Phase 1a|Other (Death)|1|||
162115093|NCT04543188|585473056|FG002|Phase 1a|Other (Death)|0|||
162115094|NCT04543188|585473057|FG003|Phase 1a|Other (Death)|0|||
162115095|NCT04543188|585473058|FG004|Phase 1a|Other (Death)|1|||
162115096|NCT04543188|585473059|FG005|Phase 1a|Other (Death)|0|||
162115097|NCT04543188|585473060|FG006|Phase 1a|Other (Death)|0|||
162115098|NCT04543188|585473061|FG007|Phase 1a|Other (Death)|0|||
162115099|NCT04543188|585473062|FG008|Phase 1a|Other (Death)|0|||
162115100|NCT04543188|585473063|FG009|Phase 1a|Other (Death)|1|||
162115101|NCT04543188|585473064|FG010|Phase 1a|Other (Death)|0|||
162115102|NCT04543188|585473065|FG011|Phase 1a|Other (Death)|0|||
162115103|NCT04543188|585473066|FG012|Phase 1a|Other (Death)|0|||
162115104|NCT04543188|585473067|FG013|Phase 1a|Other (Death)|0|||
162115105|NCT04543188|585473068|FG014|Phase 1a|Other (Death)|0|||
162115106|NCT04543188|585473054|FG000|Phase 1a|Lost to Follow-up|0|||
162115107|NCT04543188|585473055|FG001|Phase 1a|Lost to Follow-up|0|||
162115108|NCT04543188|585473056|FG002|Phase 1a|Lost to Follow-up|0|||
162115109|NCT04543188|585473057|FG003|Phase 1a|Lost to Follow-up|0|||
162115110|NCT04543188|585473058|FG004|Phase 1a|Lost to Follow-up|0|||
162115111|NCT04543188|585473059|FG005|Phase 1a|Lost to Follow-up|0|||
162115112|NCT04543188|585473060|FG006|Phase 1a|Lost to Follow-up|0|||
162115113|NCT04543188|585473061|FG007|Phase 1a|Lost to Follow-up|0|||
162115114|NCT04543188|585473062|FG008|Phase 1a|Lost to Follow-up|0|||
162115115|NCT04543188|585473063|FG009|Phase 1a|Lost to Follow-up|0|||
162115116|NCT04543188|585473064|FG010|Phase 1a|Lost to Follow-up|1|||
162115117|NCT04543188|585473065|FG011|Phase 1a|Lost to Follow-up|0|||
162115118|NCT04543188|585473066|FG012|Phase 1a|Lost to Follow-up|0|||
162115119|NCT04543188|585473067|FG013|Phase 1a|Lost to Follow-up|0|||
162115120|NCT04543188|585473068|FG014|Phase 1a|Lost to Follow-up|0|||
162115121|NCT04543188|585473054|FG000|Phase 1a|Progressive Disease|2|||
162115122|NCT04543188|585473055|FG001|Phase 1a|Progressive Disease|2|||
162115123|NCT04543188|585473056|FG002|Phase 1a|Progressive Disease|3|||
162115124|NCT04543188|585473057|FG003|Phase 1a|Progressive Disease|1|||
162115125|NCT04543188|585473058|FG004|Phase 1a|Progressive Disease|4|||
162115126|NCT04543188|585473059|FG005|Phase 1a|Progressive Disease|2|||
162115127|NCT04543188|585473060|FG006|Phase 1a|Progressive Disease|3|||
162115128|NCT04543188|585473061|FG007|Phase 1a|Progressive Disease|4|||
162115129|NCT04543188|585473062|FG008|Phase 1a|Progressive Disease|1|||
162115130|NCT04543188|585473063|FG009|Phase 1a|Progressive Disease|0|||
162115131|NCT04543188|585473064|FG010|Phase 1a|Progressive Disease|4|||
162115132|NCT04543188|585473065|FG011|Phase 1a|Progressive Disease|0|||
162115133|NCT04543188|585473066|FG012|Phase 1a|Progressive Disease|0|||
162115134|NCT04543188|585473067|FG013|Phase 1a|Progressive Disease|0|||
162115135|NCT04543188|585473068|FG014|Phase 1a|Progressive Disease|0|||
162115136|NCT04543188|585473054|FG000|Phase 1a|Study terminated by sponsor|0|||
162115137|NCT04543188|585473055|FG001|Phase 1a|Study terminated by sponsor|0|||
162115138|NCT04543188|585473056|FG002|Phase 1a|Study terminated by sponsor|0|||
162115139|NCT04543188|585473057|FG003|Phase 1a|Study terminated by sponsor|0|||
162115140|NCT04543188|585473058|FG004|Phase 1a|Study terminated by sponsor|1|||
162115141|NCT04543188|585473059|FG005|Phase 1a|Study terminated by sponsor|0|||
162115142|NCT04543188|585473060|FG006|Phase 1a|Study terminated by sponsor|0|||
162115143|NCT04543188|585473061|FG007|Phase 1a|Study terminated by sponsor|0|||
162115144|NCT04543188|585473062|FG008|Phase 1a|Study terminated by sponsor|0|||
162115145|NCT04543188|585473063|FG009|Phase 1a|Study terminated by sponsor|0|||
162115146|NCT04543188|585473064|FG010|Phase 1a|Study terminated by sponsor|1|||
162115147|NCT04543188|585473065|FG011|Phase 1a|Study terminated by sponsor|0|||
162115148|NCT04543188|585473066|FG012|Phase 1a|Study terminated by sponsor|0|||
162115149|NCT04543188|585473067|FG013|Phase 1a|Study terminated by sponsor|0|||
162115150|NCT04543188|585473068|FG014|Phase 1a|Study terminated by sponsor|0|||
162115151|NCT04543188|585473054|FG000|Phase 1a|Withdrawal by Subject|0|||
162115152|NCT04543188|585473055|FG001|Phase 1a|Withdrawal by Subject|0|||
162115153|NCT04543188|585473056|FG002|Phase 1a|Withdrawal by Subject|0|||
162115154|NCT04543188|585473057|FG003|Phase 1a|Withdrawal by Subject|0|||
162115155|NCT04543188|585473058|FG004|Phase 1a|Withdrawal by Subject|3|||
162115156|NCT04543188|585473059|FG005|Phase 1a|Withdrawal by Subject|0|||
162115157|NCT04543188|585473060|FG006|Phase 1a|Withdrawal by Subject|0|||
162115158|NCT04543188|585473061|FG007|Phase 1a|Withdrawal by Subject|0|||
162115159|NCT04543188|585473062|FG008|Phase 1a|Withdrawal by Subject|1|||
162115160|NCT04543188|585473063|FG009|Phase 1a|Withdrawal by Subject|1|||
162115161|NCT04543188|585473064|FG010|Phase 1a|Withdrawal by Subject|2|||
162115162|NCT04543188|585473065|FG011|Phase 1a|Withdrawal by Subject|0|||
162115163|NCT04543188|585473066|FG012|Phase 1a|Withdrawal by Subject|0|||
162115164|NCT04543188|585473067|FG013|Phase 1a|Withdrawal by Subject|0|||
162115165|NCT04543188|585473068|FG014|Phase 1a|Withdrawal by Subject|0|||
162115166|NCT04543188|585473054|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
162115167|NCT04543188|585473055|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
162115168|NCT04543188|585473056|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
162115169|NCT04543188|585473057|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
162115170|NCT04543188|585473058|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
162115171|NCT04543188|585473059|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
162115172|NCT04543188|585473060|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
162115173|NCT04543188|585473061|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
162115174|NCT04543188|585473062|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
162115175|NCT04543188|585473063|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
162115176|NCT04543188|585473064|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
162115177|NCT04543188|585473065|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
162115178|NCT04543188|585473066|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
162115179|NCT04543188|585473067|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
162115180|NCT04543188|585473068|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
162115181|NCT04543188|585473054|FG000|Phase 1a|Other|0|||
162115182|NCT04543188|585473055|FG001|Phase 1a|Other|0|||
162115183|NCT04543188|585473056|FG002|Phase 1a|Other|0|||
162115184|NCT04543188|585473057|FG003|Phase 1a|Other|0|||
162115185|NCT04543188|585473058|FG004|Phase 1a|Other|0|||
162115186|NCT04543188|585473059|FG005|Phase 1a|Other|0|||
162115187|NCT04543188|585473060|FG006|Phase 1a|Other|0|||
162115188|NCT04543188|585473061|FG007|Phase 1a|Other|0|||
162115189|NCT04543188|585473062|FG008|Phase 1a|Other|0|||
162115190|NCT04543188|585473063|FG009|Phase 1a|Other|1|||
162115191|NCT04543188|585473064|FG010|Phase 1a|Other|0|||
162115192|NCT04543188|585473065|FG011|Phase 1a|Other|0|||
162115193|NCT04543188|585473066|FG012|Phase 1a|Other|0|||
162115194|NCT04543188|585473067|FG013|Phase 1a|Other|0|||
162115195|NCT04543188|585473068|FG014|Phase 1a|Other|0|||
162115196|NCT04543188|585473054|FG000|Phase 1b|Adverse Event|0|||
162115197|NCT04543188|585473055|FG001|Phase 1b|Adverse Event|0|||
162115198|NCT04543188|585473056|FG002|Phase 1b|Adverse Event|0|||
162115199|NCT04543188|585473057|FG003|Phase 1b|Adverse Event|0|||
162115200|NCT04543188|585473058|FG004|Phase 1b|Adverse Event|0|||
162115201|NCT04543188|585473059|FG005|Phase 1b|Adverse Event|0|||
162115202|NCT04543188|585473060|FG006|Phase 1b|Adverse Event|0|||
162115203|NCT04543188|585473061|FG007|Phase 1b|Adverse Event|0|||
162115204|NCT04543188|585473062|FG008|Phase 1b|Adverse Event|0|||
162115205|NCT04543188|585473063|FG009|Phase 1b|Adverse Event|0|||
162115206|NCT04543188|585473064|FG010|Phase 1b|Adverse Event|0|||
162115207|NCT04543188|585473065|FG011|Phase 1b|Adverse Event|0|||
162115208|NCT04543188|585473066|FG012|Phase 1b|Adverse Event|0|||
162115209|NCT04543188|585473067|FG013|Phase 1b|Adverse Event|0|||
162115210|NCT04543188|585473068|FG014|Phase 1b|Adverse Event|2|||
162115211|NCT04543188|585473054|FG000|Phase 1b|Other (Death)|0|||
162115212|NCT04543188|585473055|FG001|Phase 1b|Other (Death)|0|||
162115213|NCT04543188|585473056|FG002|Phase 1b|Other (Death)|0|||
162115214|NCT04543188|585473057|FG003|Phase 1b|Other (Death)|0|||
162115215|NCT04543188|585473058|FG004|Phase 1b|Other (Death)|0|||
162115216|NCT04543188|585473059|FG005|Phase 1b|Other (Death)|0|||
162115217|NCT04543188|585473060|FG006|Phase 1b|Other (Death)|0|||
162115218|NCT04543188|585473061|FG007|Phase 1b|Other (Death)|0|||
162115219|NCT04543188|585473062|FG008|Phase 1b|Other (Death)|0|||
162115220|NCT04543188|585473063|FG009|Phase 1b|Other (Death)|0|||
162115221|NCT04543188|585473064|FG010|Phase 1b|Other (Death)|0|||
162115222|NCT04543188|585473065|FG011|Phase 1b|Other (Death)|0|||
162115223|NCT04543188|585473066|FG012|Phase 1b|Other (Death)|1|||
162115224|NCT04543188|585473067|FG013|Phase 1b|Other (Death)|0|||
162115225|NCT04543188|585473068|FG014|Phase 1b|Other (Death)|1|||
162115226|NCT04543188|585473054|FG000|Phase 1b|Progressive Disease|0|||
162115227|NCT04543188|585473055|FG001|Phase 1b|Progressive Disease|0|||
162115228|NCT04543188|585473056|FG002|Phase 1b|Progressive Disease|0|||
162115229|NCT04543188|585473057|FG003|Phase 1b|Progressive Disease|0|||
162115230|NCT04543188|585473058|FG004|Phase 1b|Progressive Disease|0|||
162115231|NCT04543188|585473059|FG005|Phase 1b|Progressive Disease|0|||
162115232|NCT04543188|585473060|FG006|Phase 1b|Progressive Disease|0|||
162115233|NCT04543188|585473061|FG007|Phase 1b|Progressive Disease|0|||
162115234|NCT04543188|585473062|FG008|Phase 1b|Progressive Disease|0|||
162115235|NCT04543188|585473063|FG009|Phase 1b|Progressive Disease|0|||
162115236|NCT04543188|585473064|FG010|Phase 1b|Progressive Disease|0|||
162115237|NCT04543188|585473065|FG011|Phase 1b|Progressive Disease|0|||
162115238|NCT04543188|585473066|FG012|Phase 1b|Progressive Disease|2|||
162115239|NCT04543188|585473067|FG013|Phase 1b|Progressive Disease|1|||
162115240|NCT04543188|585473068|FG014|Phase 1b|Progressive Disease|5|||
162115241|NCT04543188|585473054|FG000|Phase 1b|Study Terminated By Sponsor|0|||
162115242|NCT04543188|585473055|FG001|Phase 1b|Study Terminated By Sponsor|0|||
162115243|NCT04543188|585473056|FG002|Phase 1b|Study Terminated By Sponsor|0|||
162115244|NCT04543188|585473057|FG003|Phase 1b|Study Terminated By Sponsor|0|||
162115245|NCT04543188|585473058|FG004|Phase 1b|Study Terminated By Sponsor|0|||
162115246|NCT04543188|585473059|FG005|Phase 1b|Study Terminated By Sponsor|0|||
162115247|NCT04543188|585473060|FG006|Phase 1b|Study Terminated By Sponsor|0|||
162115248|NCT04543188|585473061|FG007|Phase 1b|Study Terminated By Sponsor|0|||
162115249|NCT04543188|585473062|FG008|Phase 1b|Study Terminated By Sponsor|0|||
162115250|NCT04543188|585473063|FG009|Phase 1b|Study Terminated By Sponsor|0|||
162115251|NCT04543188|585473064|FG010|Phase 1b|Study Terminated By Sponsor|0|||
162115252|NCT04543188|585473065|FG011|Phase 1b|Study Terminated By Sponsor|1|||
162115253|NCT04543188|585473066|FG012|Phase 1b|Study Terminated By Sponsor|1|||
162115254|NCT04543188|585473067|FG013|Phase 1b|Study Terminated By Sponsor|0|||
162115255|NCT04543188|585473068|FG014|Phase 1b|Study Terminated By Sponsor|1|||
162115256|NCT04543188|585473054|FG000|Phase 1b|Withdrawal by Subject|0|||
162115257|NCT04543188|585473055|FG001|Phase 1b|Withdrawal by Subject|0|||
162115258|NCT04543188|585473056|FG002|Phase 1b|Withdrawal by Subject|0|||
162115259|NCT04543188|585473057|FG003|Phase 1b|Withdrawal by Subject|0|||
162115260|NCT04543188|585473058|FG004|Phase 1b|Withdrawal by Subject|0|||
162115261|NCT04543188|585473059|FG005|Phase 1b|Withdrawal by Subject|0|||
162115262|NCT04543188|585473060|FG006|Phase 1b|Withdrawal by Subject|0|||
162115263|NCT04543188|585473061|FG007|Phase 1b|Withdrawal by Subject|0|||
162115264|NCT04543188|585473062|FG008|Phase 1b|Withdrawal by Subject|0|||
162115265|NCT04543188|585473063|FG009|Phase 1b|Withdrawal by Subject|0|||
162115266|NCT04543188|585473064|FG010|Phase 1b|Withdrawal by Subject|0|||
162115267|NCT04543188|585473065|FG011|Phase 1b|Withdrawal by Subject|0|||
162115268|NCT04543188|585473066|FG012|Phase 1b|Withdrawal by Subject|0|||
162115269|NCT04543188|585473067|FG013|Phase 1b|Withdrawal by Subject|0|||
162115270|NCT04543188|585473068|FG014|Phase 1b|Withdrawal by Subject|2|||
162115271|NCT03815019|585473071|FG000|Overall Study|Withdrawal by Subject|6|||
162115272|NCT03815019|585473072|FG001|Overall Study|Withdrawal by Subject|8|||
162115273|NCT05398796|585473073|FG000|Overall Study|Participant moved from the area|0|||
162115274|NCT05398796|585473074|FG001|Overall Study|Participant moved from the area|1|||
162115275|NCT05398796|585473075|FG002|Overall Study|Participant moved from the area|0|||
162115276|NCT05398796|585473076|FG003|Overall Study|Participant moved from the area|0|||
162115277|NCT04270747|585473078|FG000|Through Week 16|Adverse Event|1|||
162115278|NCT04270747|585473079|FG001|Through Week 16|Adverse Event|2|||
162115279|NCT04270747|585473080|FG002|Through Week 16|Adverse Event|0|||
162115280|NCT04270747|585473078|FG000|Through Week 16|Death|0|||
162115281|NCT04270747|585473079|FG001|Through Week 16|Death|2|||
162115282|NCT04270747|585473080|FG002|Through Week 16|Death|0|||
162115283|NCT04270747|585473078|FG000|Through Week 16|Consent Withdrawn|3|||
162115284|NCT04270747|585473079|FG001|Through Week 16|Consent Withdrawn|3|||
162115285|NCT04270747|585473080|FG002|Through Week 16|Consent Withdrawn|0|||
162115286|NCT04270747|585473078|FG000|Through Week 16|Physician Decision|1|||
162115287|NCT04270747|585473079|FG001|Through Week 16|Physician Decision|1|||
162115288|NCT04270747|585473080|FG002|Through Week 16|Physician Decision|0|||
162115289|NCT04270747|585473078|FG000|Through Week 16|Lost to Follow-up|2|||
162115290|NCT04270747|585473079|FG001|Through Week 16|Lost to Follow-up|0|||
162115291|NCT04270747|585473080|FG002|Through Week 16|Lost to Follow-up|0|||
162115292|NCT04270747|585473078|FG000|Through Week 16|Protocol Violation|1|||
162115293|NCT04270747|585473079|FG001|Through Week 16|Protocol Violation|2|||
162115294|NCT04270747|585473080|FG002|Through Week 16|Protocol Violation|0|||
162115295|NCT04270747|585473078|FG000|Through Week 16|Protocol Specified Criteria|6|||
162115296|NCT04270747|585473079|FG001|Through Week 16|Protocol Specified Criteria|7|||
162115297|NCT04270747|585473080|FG002|Through Week 16|Protocol Specified Criteria|0|||
162115298|NCT04270747|585473078|FG000|Through Week 16|Miscellaneous|1|||
162115299|NCT04270747|585473079|FG001|Through Week 16|Miscellaneous|1|||
162115300|NCT04270747|585473080|FG002|Through Week 16|Miscellaneous|0|||
162115301|NCT04270747|585473078|FG000|Post Week 16|Adverse Event|7|||
162115302|NCT04270747|585473079|FG001|Post Week 16|Adverse Event|5|||
162115303|NCT04270747|585473080|FG002|Post Week 16|Adverse Event|1|||
162115304|NCT04270747|585473078|FG000|Post Week 16|Death|2|||
162115305|NCT04270747|585473079|FG001|Post Week 16|Death|0|||
162115306|NCT04270747|585473080|FG002|Post Week 16|Death|2|||
162115307|NCT04270747|585473078|FG000|Post Week 16|Consent Withdrawn|4|||
162115308|NCT04270747|585473079|FG001|Post Week 16|Consent Withdrawn|3|||
162115309|NCT04270747|585473080|FG002|Post Week 16|Consent Withdrawn|6|||
162115310|NCT04270747|585473078|FG000|Post Week 16|Physician Decision|3|||
162115311|NCT04270747|585473079|FG001|Post Week 16|Physician Decision|1|||
162115312|NCT04270747|585473080|FG002|Post Week 16|Physician Decision|1|||
162115313|NCT04270747|585473078|FG000|Post Week 16|Lost to Follow-up|2|||
162115314|NCT04270747|585473079|FG001|Post Week 16|Lost to Follow-up|1|||
162115315|NCT04270747|585473080|FG002|Post Week 16|Lost to Follow-up|0|||
162115316|NCT04270747|585473078|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
162115317|NCT04270747|585473079|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
162115318|NCT04270747|585473080|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
162115319|NCT04270747|585473078|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
162115320|NCT04270747|585473079|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
162115321|NCT04270747|585473080|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
162115322|NCT04270747|585473078|FG000|Post Week 16|Miscellaneous|1|||
162115323|NCT04270747|585473079|FG001|Post Week 16|Miscellaneous|0|||
162115324|NCT04270747|585473080|FG002|Post Week 16|Miscellaneous|1|||
162115325|NCT05004688|585473081|FG000|Overall Study|Protocol Violation|7|||
162115326|NCT05004688|585473081|FG000|Overall Study|Physician Decision|2|||
162115327|NCT05004688|585473081|FG000|Overall Study|Withdrawal by Subject|2|||
162115328|NCT05960097|585473082|FG000|Overall Study|Lost to Follow-up|3|||
162115329|NCT05960097|585473083|FG001|Overall Study|Lost to Follow-up|1|||
162115330|NCT05960097|585473084|FG002|Overall Study|Lost to Follow-up|1|||
162115331|NCT05960097|585473085|FG003|Overall Study|Lost to Follow-up|2|||
162115332|NCT05960097|585473086|FG004|Overall Study|Lost to Follow-up|1|||
162115333|NCT05960097|585473087|FG005|Overall Study|Lost to Follow-up|1|||
162115334|NCT05960097|585473088|FG006|Overall Study|Lost to Follow-up|2|||
162115335|NCT05960097|585473089|FG007|Overall Study|Lost to Follow-up|3|||
162115336|NCT05960097|585473082|FG000|Overall Study|Physician Decision|0|||
162115337|NCT05960097|585473083|FG001|Overall Study|Physician Decision|0|||
162115338|NCT05960097|585473084|FG002|Overall Study|Physician Decision|0|||
162115339|NCT05960097|585473085|FG003|Overall Study|Physician Decision|0|||
162115340|NCT05960097|585473086|FG004|Overall Study|Physician Decision|0|||
162115341|NCT05960097|585473087|FG005|Overall Study|Physician Decision|0|||
162115342|NCT05960097|585473088|FG006|Overall Study|Physician Decision|1|||
162115343|NCT05960097|585473089|FG007|Overall Study|Physician Decision|0|||
162115344|NCT05960097|585473082|FG000|Overall Study|Withdrawal by Subject|1|||
162115345|NCT05960097|585473083|FG001|Overall Study|Withdrawal by Subject|0|||
162115346|NCT05960097|585473084|FG002|Overall Study|Withdrawal by Subject|0|||
162115347|NCT05960097|585473085|FG003|Overall Study|Withdrawal by Subject|1|||
162115348|NCT05960097|585473086|FG004|Overall Study|Withdrawal by Subject|1|||
162115349|NCT05960097|585473087|FG005|Overall Study|Withdrawal by Subject|0|||
162115350|NCT05960097|585473088|FG006|Overall Study|Withdrawal by Subject|0|||
162115351|NCT05960097|585473089|FG007|Overall Study|Withdrawal by Subject|0|||
162115352|NCT05960097|585473082|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162115353|NCT05960097|585473083|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162115354|NCT05960097|585473084|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
162115355|NCT05960097|585473085|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162115356|NCT05960097|585473086|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162115357|NCT05960097|585473087|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162115358|NCT05960097|585473088|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162115359|NCT05960097|585473089|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
162115360|NCT02134925|585473090|FG000|Overall Study|Withdrawal by Subject|1|||
162115361|NCT02134925|585473091|FG001|Overall Study|Withdrawal by Subject|0|||
162115362|NCT02134925|585473090|FG000|Overall Study|Cancel|1|||
162115363|NCT02134925|585473091|FG001|Overall Study|Cancel|6|||
162115364|NCT02158884|585473092|FG000|Baseline Assessment|Missed performance assessment|3|||
162115365|NCT02158884|585473092|FG000|Baseline Assessment|Missed SMFA|1|||
162115366|NCT02158884|585473092|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
162115367|NCT02158884|585473092|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
162115368|NCT02158884|585473092|FG000|6 Month Assessment|Missed SMFA|20|||
162115369|NCT02158884|585473092|FG000|12 Month Assessment|Missed SMFA|17|||
162115370|NCT05158296|585473093|FG000|Overall Study|Sponsor Decision|2|||
162115371|NCT05158296|585473094|FG001|Overall Study|Sponsor Decision|3|||
162115372|NCT05158296|585473095|FG002|Overall Study|Sponsor Decision|2|||
162115373|NCT04098250|585473098|FG000|Overall Study|Withdrawal by Subject|1|||
162115374|NCT04098250|585473099|FG001|Overall Study|Withdrawal by Subject|0|||
162115375|NCT04098250|585473098|FG000|Overall Study|Lost to Follow-up|0|||
162115376|NCT04098250|585473099|FG001|Overall Study|Lost to Follow-up|1|||
162115377|NCT00633464|585473100|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
162115378|NCT00633464|585473101|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
162115379|NCT00633464|585473100|FG000|Overall Study|Never Treated (Randomized in error)|0|||
162115380|NCT00633464|585473101|FG001|Overall Study|Never Treated (Randomized in error)|1|||
162115381|NCT06387472|585473102|FG000|Overall Study|Withdrawal by Subject|1|||
162115382|NCT06387472|585473102|FG000|Overall Study|Lost to Follow-up|2|||
162115383|NCT06387472|585473102|FG000|Overall Study|Physician Decision|1|||
162115384|NCT04182880|585473103|FG000|Overall Study|Pregnancy|1|||
162115385|NCT04182880|585473104|FG001|Overall Study|Pregnancy|0|||
162115386|NCT02036645|585473105|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162115387|NCT02036645|585473106|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162115388|NCT02036645|585473107|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162115389|NCT02036645|585473108|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162115390|NCT02036645|585473109|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162115391|NCT02036645|585473110|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162115392|NCT02036645|585473111|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
162115393|NCT02036645|585473112|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162115394|NCT02036645|585473113|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162115395|NCT02036645|585473114|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162115396|NCT02036645|585473115|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162115397|NCT02036645|585473116|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
162115398|NCT02036645|585473105|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162115399|NCT02036645|585473106|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162115400|NCT02036645|585473107|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162115401|NCT02036645|585473108|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
162115402|NCT02036645|585473109|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162115403|NCT02036645|585473110|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162115404|NCT02036645|585473111|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162115405|NCT02036645|585473112|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162115406|NCT02036645|585473113|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162115407|NCT02036645|585473114|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162115408|NCT02036645|585473115|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162115409|NCT02036645|585473116|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
162115410|NCT00717860|585473121|FG000|Overall Study|Clinical adverse experience|5|||
162115411|NCT00717860|585473122|FG001|Overall Study|Clinical adverse experience|9|||
162115412|NCT00717860|585473121|FG000|Overall Study|Laboratory adverse experience|2|||
162115413|NCT00717860|585473122|FG001|Overall Study|Laboratory adverse experience|2|||
162115414|NCT00717860|585473121|FG000|Overall Study|Lack of Efficacy|7|||
162115415|NCT00717860|585473122|FG001|Overall Study|Lack of Efficacy|13|||
162115416|NCT00717860|585473121|FG000|Overall Study|Discontinued for other reason|6|||
162115417|NCT00717860|585473122|FG001|Overall Study|Discontinued for other reason|1|||
162115418|NCT00717860|585473121|FG000|Overall Study|Withdrew consent|7|||
162115419|NCT00717860|585473122|FG001|Overall Study|Withdrew consent|3|||
162115420|NCT00698646|585473123|FG000|Overall Study|Adverse Event|8|||
162115421|NCT00698646|585473124|FG001|Overall Study|Adverse Event|7|||
162115422|NCT00698646|585473125|FG002|Overall Study|Adverse Event|8|||
162115423|NCT00698646|585473123|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
162115424|NCT00698646|585473124|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
162115425|NCT00698646|585473125|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
162115426|NCT00698646|585473123|FG000|Overall Study|Protocol Deviation|6|||
162115427|NCT00698646|585473124|FG001|Overall Study|Protocol Deviation|2|||
162115428|NCT00698646|585473125|FG002|Overall Study|Protocol Deviation|3|||
162115429|NCT00698646|585473123|FG000|Overall Study|Withdrawal by Subject|10|||
162115430|NCT00698646|585473124|FG001|Overall Study|Withdrawal by Subject|11|||
162115431|NCT00698646|585473125|FG002|Overall Study|Withdrawal by Subject|8|||
162115432|NCT00698646|585473123|FG000|Overall Study|Lost to Follow-up|0|||
162115433|NCT00698646|585473124|FG001|Overall Study|Lost to Follow-up|0|||
162115434|NCT00698646|585473125|FG002|Overall Study|Lost to Follow-up|2|||
162115435|NCT00698646|585473123|FG000|Overall Study|Administrative problems|1|||
162115436|NCT00698646|585473124|FG001|Overall Study|Administrative problems|0|||
162115437|NCT00698646|585473125|FG002|Overall Study|Administrative problems|1|||
162115438|NCT00279201|585473128|FG000|Initiation|Death|1|||
162115439|NCT00279201|585473129|FG001|Initiation|Death|5|||
162115440|NCT00279201|585473130|FG002|Initiation|Death|0|||
162115441|NCT00279201|585473131|FG003|Initiation|Death|0|||
162115442|NCT00279201|585473132|FG004|Initiation|Death|0|||
162115443|NCT00279201|585473133|FG005|Initiation|Death|0|||
162115444|NCT00279201|585473128|FG000|Initiation|Adverse Event|6|||
162115445|NCT00279201|585473129|FG001|Initiation|Adverse Event|15|||
162115446|NCT00279201|585473130|FG002|Initiation|Adverse Event|0|||
162115447|NCT00279201|585473131|FG003|Initiation|Adverse Event|0|||
162115448|NCT00279201|585473132|FG004|Initiation|Adverse Event|0|||
162115449|NCT00279201|585473133|FG005|Initiation|Adverse Event|0|||
162115450|NCT00279201|585473128|FG000|Initiation|Lost to Follow-up|42|||
162115451|NCT00279201|585473129|FG001|Initiation|Lost to Follow-up|41|||
162115452|NCT00279201|585473130|FG002|Initiation|Lost to Follow-up|0|||
162115453|NCT00279201|585473131|FG003|Initiation|Lost to Follow-up|0|||
162115454|NCT00279201|585473132|FG004|Initiation|Lost to Follow-up|0|||
162115455|NCT00279201|585473133|FG005|Initiation|Lost to Follow-up|0|||
162115456|NCT00279201|585473128|FG000|Initiation|Entry Criteria Exclusion|7|||
162115457|NCT00279201|585473129|FG001|Initiation|Entry Criteria Exclusion|9|||
162115458|NCT00279201|585473130|FG002|Initiation|Entry Criteria Exclusion|0|||
162115459|NCT00279201|585473131|FG003|Initiation|Entry Criteria Exclusion|0|||
162115460|NCT00279201|585473132|FG004|Initiation|Entry Criteria Exclusion|0|||
162115461|NCT00279201|585473133|FG005|Initiation|Entry Criteria Exclusion|0|||
162115462|NCT00279201|585473128|FG000|Initiation|Protocol Violation|9|||
162115463|NCT00279201|585473129|FG001|Initiation|Protocol Violation|10|||
162115464|NCT00279201|585473130|FG002|Initiation|Protocol Violation|0|||
162115465|NCT00279201|585473131|FG003|Initiation|Protocol Violation|0|||
162115466|NCT00279201|585473132|FG004|Initiation|Protocol Violation|0|||
162115467|NCT00279201|585473133|FG005|Initiation|Protocol Violation|0|||
162115468|NCT00279201|585473128|FG000|Initiation|Withdrawal by Subject|35|||
162115469|NCT00279201|585473129|FG001|Initiation|Withdrawal by Subject|41|||
162115470|NCT00279201|585473130|FG002|Initiation|Withdrawal by Subject|0|||
162115471|NCT00279201|585473131|FG003|Initiation|Withdrawal by Subject|0|||
162115472|NCT00279201|585473132|FG004|Initiation|Withdrawal by Subject|0|||
162115473|NCT00279201|585473133|FG005|Initiation|Withdrawal by Subject|0|||
162115474|NCT00279201|585473128|FG000|Initiation|Physician Decision|15|||
162115475|NCT00279201|585473129|FG001|Initiation|Physician Decision|18|||
162115476|NCT00279201|585473130|FG002|Initiation|Physician Decision|0|||
162115477|NCT00279201|585473131|FG003|Initiation|Physician Decision|0|||
162115478|NCT00279201|585473132|FG004|Initiation|Physician Decision|0|||
162115479|NCT00279201|585473133|FG005|Initiation|Physician Decision|0|||
162115480|NCT00279201|585473128|FG000|Initiation|Sponsor Decision|13|||
162115481|NCT00279201|585473129|FG001|Initiation|Sponsor Decision|5|||
162115482|NCT00279201|585473130|FG002|Initiation|Sponsor Decision|0|||
162115483|NCT00279201|585473131|FG003|Initiation|Sponsor Decision|0|||
162115484|NCT00279201|585473132|FG004|Initiation|Sponsor Decision|0|||
162115485|NCT00279201|585473133|FG005|Initiation|Sponsor Decision|0|||
162115486|NCT00279201|585473128|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
162115487|NCT00279201|585473129|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
162115488|NCT00279201|585473130|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
162115489|NCT00279201|585473131|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
162115490|NCT00279201|585473132|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
162115491|NCT00279201|585473133|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
162115492|NCT00279201|585473128|FG000|Maintenance|Lack of Efficacy|32|||
162115493|NCT00279201|585473129|FG001|Maintenance|Lack of Efficacy|30|||
162115494|NCT00279201|585473130|FG002|Maintenance|Lack of Efficacy|0|||
162115495|NCT00279201|585473131|FG003|Maintenance|Lack of Efficacy|0|||
162115496|NCT00279201|585473132|FG004|Maintenance|Lack of Efficacy|0|||
162115497|NCT00279201|585473133|FG005|Maintenance|Lack of Efficacy|0|||
162115498|NCT00279201|585473128|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
162115499|NCT00279201|585473129|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
162115500|NCT00279201|585473130|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
162115501|NCT00279201|585473131|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
162115502|NCT00279201|585473132|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
162115503|NCT00279201|585473133|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
162115504|NCT00279201|585473128|FG000|Maintenance|Adverse Event|4|||
162115505|NCT00279201|585473129|FG001|Maintenance|Adverse Event|4|||
162115506|NCT00279201|585473130|FG002|Maintenance|Adverse Event|0|||
162115507|NCT00279201|585473131|FG003|Maintenance|Adverse Event|0|||
162115508|NCT00279201|585473132|FG004|Maintenance|Adverse Event|0|||
162115509|NCT00279201|585473133|FG005|Maintenance|Adverse Event|0|||
162115510|NCT00279201|585473128|FG000|Maintenance|Death|4|||
162115511|NCT00279201|585473129|FG001|Maintenance|Death|4|||
162115512|NCT00279201|585473130|FG002|Maintenance|Death|0|||
162115513|NCT00279201|585473131|FG003|Maintenance|Death|0|||
162115514|NCT00279201|585473132|FG004|Maintenance|Death|0|||
162115515|NCT00279201|585473133|FG005|Maintenance|Death|0|||
162115516|NCT00279201|585473128|FG000|Maintenance|Lost to Follow-up|17|||
162115517|NCT00279201|585473129|FG001|Maintenance|Lost to Follow-up|13|||
162115518|NCT00279201|585473130|FG002|Maintenance|Lost to Follow-up|0|||
162115519|NCT00279201|585473131|FG003|Maintenance|Lost to Follow-up|0|||
162115520|NCT00279201|585473132|FG004|Maintenance|Lost to Follow-up|0|||
162115521|NCT00279201|585473133|FG005|Maintenance|Lost to Follow-up|0|||
162115522|NCT00279201|585473128|FG000|Maintenance|Entry Criteria Exclusion|1|||
162115523|NCT00279201|585473129|FG001|Maintenance|Entry Criteria Exclusion|4|||
162115524|NCT00279201|585473130|FG002|Maintenance|Entry Criteria Exclusion|0|||
162115525|NCT00279201|585473131|FG003|Maintenance|Entry Criteria Exclusion|0|||
162115526|NCT00279201|585473132|FG004|Maintenance|Entry Criteria Exclusion|0|||
162115527|NCT00279201|585473133|FG005|Maintenance|Entry Criteria Exclusion|0|||
162115528|NCT00279201|585473128|FG000|Maintenance|Protocol Violation|16|||
162115529|NCT00279201|585473129|FG001|Maintenance|Protocol Violation|24|||
162115530|NCT00279201|585473130|FG002|Maintenance|Protocol Violation|0|||
162115531|NCT00279201|585473131|FG003|Maintenance|Protocol Violation|0|||
162115532|NCT00279201|585473132|FG004|Maintenance|Protocol Violation|0|||
162115533|NCT00279201|585473133|FG005|Maintenance|Protocol Violation|0|||
162115534|NCT00279201|585473128|FG000|Maintenance|Withdrawal by Subject|18|||
162115535|NCT00279201|585473129|FG001|Maintenance|Withdrawal by Subject|18|||
162115536|NCT00279201|585473130|FG002|Maintenance|Withdrawal by Subject|0|||
162115537|NCT00279201|585473131|FG003|Maintenance|Withdrawal by Subject|0|||
162115538|NCT00279201|585473132|FG004|Maintenance|Withdrawal by Subject|0|||
162115539|NCT00279201|585473133|FG005|Maintenance|Withdrawal by Subject|0|||
162115540|NCT00279201|585473128|FG000|Maintenance|Physician Decision|9|||
162115541|NCT00279201|585473129|FG001|Maintenance|Physician Decision|9|||
162115542|NCT00279201|585473130|FG002|Maintenance|Physician Decision|0|||
162115543|NCT00279201|585473131|FG003|Maintenance|Physician Decision|0|||
162115544|NCT00279201|585473132|FG004|Maintenance|Physician Decision|0|||
162115545|NCT00279201|585473133|FG005|Maintenance|Physician Decision|0|||
162115546|NCT00279201|585473128|FG000|Maintenance|Sponsor Decision|4|||
162115547|NCT00279201|585473129|FG001|Maintenance|Sponsor Decision|0|||
162115548|NCT00279201|585473130|FG002|Maintenance|Sponsor Decision|0|||
162115549|NCT00279201|585473131|FG003|Maintenance|Sponsor Decision|0|||
162115550|NCT00279201|585473132|FG004|Maintenance|Sponsor Decision|0|||
162115551|NCT00279201|585473133|FG005|Maintenance|Sponsor Decision|0|||
162115552|NCT00279201|585473128|FG000|Maintenance|HbA1c>7.5%|123|||
162115553|NCT00279201|585473129|FG001|Maintenance|HbA1c>7.5%|126|||
162115554|NCT00279201|585473130|FG002|Maintenance|HbA1c>7.5%|0|||
162115555|NCT00279201|585473131|FG003|Maintenance|HbA1c>7.5%|0|||
162115556|NCT00279201|585473132|FG004|Maintenance|HbA1c>7.5%|0|||
162115557|NCT00279201|585473133|FG005|Maintenance|HbA1c>7.5%|0|||
162115558|NCT00279201|585473128|FG000|Intensification Addendum|Withdrawal by Subject|0|||
162115559|NCT00279201|585473129|FG001|Intensification Addendum|Withdrawal by Subject|0|||
162115560|NCT00279201|585473130|FG002|Intensification Addendum|Withdrawal by Subject|12|||
162115561|NCT00279201|585473131|FG003|Intensification Addendum|Withdrawal by Subject|14|||
162115562|NCT00279201|585473132|FG004|Intensification Addendum|Withdrawal by Subject|9|||
162115563|NCT00279201|585473133|FG005|Intensification Addendum|Withdrawal by Subject|18|||
162115564|NCT00279201|585473128|FG000|Intensification Addendum|Lost to Follow-up|0|||
162115565|NCT00279201|585473129|FG001|Intensification Addendum|Lost to Follow-up|0|||
162115566|NCT00279201|585473130|FG002|Intensification Addendum|Lost to Follow-up|4|||
162115567|NCT00279201|585473131|FG003|Intensification Addendum|Lost to Follow-up|6|||
162115568|NCT00279201|585473132|FG004|Intensification Addendum|Lost to Follow-up|7|||
162115569|NCT00279201|585473133|FG005|Intensification Addendum|Lost to Follow-up|7|||
162115570|NCT00279201|585473128|FG000|Intensification Addendum|Protocol Violation|0|||
162115571|NCT00279201|585473129|FG001|Intensification Addendum|Protocol Violation|0|||
162115572|NCT00279201|585473130|FG002|Intensification Addendum|Protocol Violation|2|||
162115573|NCT00279201|585473131|FG003|Intensification Addendum|Protocol Violation|2|||
162115574|NCT00279201|585473132|FG004|Intensification Addendum|Protocol Violation|6|||
162115575|NCT00279201|585473133|FG005|Intensification Addendum|Protocol Violation|6|||
162115576|NCT00279201|585473128|FG000|Intensification Addendum|Adverse Event|0|||
162115577|NCT00279201|585473129|FG001|Intensification Addendum|Adverse Event|0|||
162115578|NCT00279201|585473130|FG002|Intensification Addendum|Adverse Event|0|||
162115579|NCT00279201|585473131|FG003|Intensification Addendum|Adverse Event|4|||
162115580|NCT00279201|585473132|FG004|Intensification Addendum|Adverse Event|1|||
162115581|NCT00279201|585473133|FG005|Intensification Addendum|Adverse Event|3|||
162115582|NCT00279201|585473128|FG000|Intensification Addendum|Physician Decision|0|||
162115583|NCT00279201|585473129|FG001|Intensification Addendum|Physician Decision|0|||
162115584|NCT00279201|585473130|FG002|Intensification Addendum|Physician Decision|4|||
162115585|NCT00279201|585473131|FG003|Intensification Addendum|Physician Decision|1|||
162115586|NCT00279201|585473132|FG004|Intensification Addendum|Physician Decision|3|||
162115587|NCT00279201|585473133|FG005|Intensification Addendum|Physician Decision|2|||
162115588|NCT00279201|585473128|FG000|Intensification Addendum|Sponsor Decision|0|||
162115589|NCT00279201|585473129|FG001|Intensification Addendum|Sponsor Decision|0|||
162115590|NCT00279201|585473130|FG002|Intensification Addendum|Sponsor Decision|0|||
162115591|NCT00279201|585473131|FG003|Intensification Addendum|Sponsor Decision|0|||
162115592|NCT00279201|585473132|FG004|Intensification Addendum|Sponsor Decision|1|||
162115593|NCT00279201|585473133|FG005|Intensification Addendum|Sponsor Decision|1|||
162115594|NCT00279201|585473128|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
162115595|NCT00279201|585473129|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
162115596|NCT00279201|585473130|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
162115597|NCT00279201|585473131|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
162115598|NCT00279201|585473132|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
162115599|NCT00279201|585473133|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
162115600|NCT00279201|585473128|FG000|Intensification Addendum|Lack of Efficacy|0|||
162115601|NCT00279201|585473129|FG001|Intensification Addendum|Lack of Efficacy|0|||
162115602|NCT00279201|585473130|FG002|Intensification Addendum|Lack of Efficacy|0|||
162115603|NCT00279201|585473131|FG003|Intensification Addendum|Lack of Efficacy|1|||
162115604|NCT00279201|585473132|FG004|Intensification Addendum|Lack of Efficacy|1|||
162115605|NCT00279201|585473133|FG005|Intensification Addendum|Lack of Efficacy|0|||
162115606|NCT00279201|585473128|FG000|Intensification Addendum|Death|0|||
162115607|NCT00279201|585473129|FG001|Intensification Addendum|Death|0|||
162115608|NCT00279201|585473130|FG002|Intensification Addendum|Death|0|||
162115609|NCT00279201|585473131|FG003|Intensification Addendum|Death|0|||
162115610|NCT00279201|585473132|FG004|Intensification Addendum|Death|1|||
162115611|NCT00279201|585473133|FG005|Intensification Addendum|Death|0|||
162115612|NCT03995784|585473134|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
162115613|NCT01489189|585473135|FG000|Overall Study|Withdrawal by Subject|20|||
162115614|NCT01489189|585473136|FG001|Overall Study|Withdrawal by Subject|23|||
162115615|NCT01489189|585473135|FG000|Overall Study|Death|10|||
162115616|NCT01489189|585473136|FG001|Overall Study|Death|8|||
162115617|NCT01489189|585473135|FG000|Overall Study|Missed Visit|1|||
162115618|NCT01489189|585473136|FG001|Overall Study|Missed Visit|4|||
162115619|NCT04225988|585473137|FG000|Overall Study|Withdrawal by Subject|2|||
162115620|NCT04225988|585473138|FG001|Overall Study|Withdrawal by Subject|0|||
162115621|NCT00112580|585473139|FG000|Overall Study|Adverse Event|1|||
162115622|NCT00112580|585473140|FG001|Overall Study|Adverse Event|2|||
162115623|NCT00112580|585473139|FG000|Overall Study|Disease progression|5|||
162115624|NCT00112580|585473140|FG001|Overall Study|Disease progression|16|||
162115625|NCT00112580|585473139|FG000|Overall Study|Participant withdrew consent|2|||
162115626|NCT00112580|585473140|FG001|Overall Study|Participant withdrew consent|1|||
162115627|NCT05619003|585473143|FG000|Overall Study|Adverse Event|1|||
162115628|NCT07018999|585473148|FG000|Overall Study|Protocol Violation|0|||
162115629|NCT07018999|585473149|FG001|Overall Study|Protocol Violation|1|||
162115630|NCT07018999|585473148|FG000|Overall Study|Incomplete data entry|4|||
162115631|NCT07018999|585473149|FG001|Overall Study|Incomplete data entry|7|||
162115632|NCT04739761|585473151|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
162115633|NCT04739761|585473152|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
162115634|NCT04739761|585473151|FG000|Overall Study|By complete response from the participant|1|||
162115635|NCT04739761|585473152|FG001|Overall Study|By complete response from the participant|0|||
162115636|NCT04739761|585473151|FG000|Overall Study|Lost to Follow-up|3|||
162115637|NCT04739761|585473152|FG001|Overall Study|Lost to Follow-up|3|||
162115638|NCT04739761|585473151|FG000|Overall Study|Death|13|||
162115639|NCT04739761|585473152|FG001|Overall Study|Death|13|||
162115640|NCT04739761|585473151|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
162115641|NCT04739761|585473152|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
162115642|NCT04739761|585473151|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
162115643|NCT04739761|585473152|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
162115644|NCT04739761|585473151|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
162115645|NCT04739761|585473152|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
162115646|NCT04739761|585473151|FG000|Overall Study|Adverse Event|0|||
162115647|NCT04739761|585473152|FG001|Overall Study|Adverse Event|3|||
162115648|NCT04739761|585473151|FG000|Overall Study|Participant decision|1|||
162115649|NCT04739761|585473152|FG001|Overall Study|Participant decision|0|||
162115650|NCT04739761|585473151|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
162115651|NCT04739761|585473152|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
162115652|NCT04739761|585473151|FG000|Overall Study|Participant immediately started next line of treatment|1|||
162115653|NCT04739761|585473152|FG001|Overall Study|Participant immediately started next line of treatment|0|||
162115654|NCT04739761|585473151|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
162115655|NCT04739761|585473152|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
162115656|NCT04739761|585473151|FG000|Overall Study|Lack of clinical benefit|1|||
162115657|NCT04739761|585473152|FG001|Overall Study|Lack of clinical benefit|0|||
162115658|NCT04739761|585473151|FG000|Overall Study|Disease progression|5|||
162115659|NCT04739761|585473152|FG001|Overall Study|Disease progression|5|||
162115660|NCT04739761|585473151|FG000|Overall Study|Withdrawal by Subject|14|||
162115661|NCT04739761|585473152|FG001|Overall Study|Withdrawal by Subject|13|||
162115662|NCT04739761|585473151|FG000|Overall Study|Protocol Violation|1|||
162115663|NCT04739761|585473152|FG001|Overall Study|Protocol Violation|0|||
162115664|NCT04739761|585473151|FG000|Overall Study|Physician Decision|2|||
162115665|NCT04739761|585473152|FG001|Overall Study|Physician Decision|0|||
162115666|NCT03881696|585473156|FG000|Overall Study|Adverse Event|2|||
162115667|NCT03881696|585473157|FG001|Overall Study|Adverse Event|0|||
162115668|NCT03881696|585473156|FG000|Overall Study|Withdrawal by Subject|2|||
162115669|NCT03881696|585473157|FG001|Overall Study|Withdrawal by Subject|0|||
162115670|NCT03881696|585473156|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
162115671|NCT03881696|585473157|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
162115672|NCT03881696|585473156|FG000|Overall Study|Failure to meet continuation criteria|1|||
162115673|NCT03881696|585473157|FG001|Overall Study|Failure to meet continuation criteria|0|||
162115674|NCT02202434|585474539|FG000|Overall Study|Death|70|||
162115675|NCT02202434|585474540|FG001|Overall Study|Death|39|||
162115676|NCT02202434|585474541|FG002|Overall Study|Death|13|||
162115677|NCT02202434|585474542|FG003|Overall Study|Death|27|||
162115678|NCT02202434|585474539|FG000|Overall Study|Lost to Follow-up|1|||
162115679|NCT02202434|585474540|FG001|Overall Study|Lost to Follow-up|1|||
162115680|NCT02202434|585474541|FG002|Overall Study|Lost to Follow-up|1|||
162115681|NCT02202434|585474542|FG003|Overall Study|Lost to Follow-up|0|||
162115682|NCT02202434|585474539|FG000|Overall Study|Physician Decision|2|||
162115683|NCT02202434|585474540|FG001|Overall Study|Physician Decision|3|||
162115684|NCT02202434|585474541|FG002|Overall Study|Physician Decision|0|||
162115685|NCT02202434|585474542|FG003|Overall Study|Physician Decision|0|||
162115686|NCT02202434|585474539|FG000|Overall Study|Withdrawal by Subject|13|||
162115687|NCT02202434|585474540|FG001|Overall Study|Withdrawal by Subject|14|||
162115688|NCT02202434|585474541|FG002|Overall Study|Withdrawal by Subject|1|||
162115689|NCT02202434|585474542|FG003|Overall Study|Withdrawal by Subject|4|||
162115690|NCT02202434|585474539|FG000|Overall Study|Completed Study|1|||
162115691|NCT02202434|585474540|FG001|Overall Study|Completed Study|0|||
162115692|NCT02202434|585474541|FG002|Overall Study|Completed Study|0|||
162115693|NCT02202434|585474542|FG003|Overall Study|Completed Study|0|||
162115694|NCT02202434|585474539|FG000|Overall Study|Visit Missed|21|||
162115695|NCT02202434|585474540|FG001|Overall Study|Visit Missed|12|||
162115696|NCT02202434|585474541|FG002|Overall Study|Visit Missed|0|||
162115697|NCT02202434|585474542|FG003|Overall Study|Visit Missed|5|||
162115698|NCT02202434|585474539|FG000|Overall Study|Other|1|||
162115699|NCT02202434|585474540|FG001|Overall Study|Other|0|||
162115700|NCT02202434|585474541|FG002|Overall Study|Other|0|||
162115701|NCT02202434|585474542|FG003|Overall Study|Other|1|||
162115702|NCT03237858|585474543|FG000|Overall Study|Death|19|||
162115703|NCT03237858|585474543|FG000|Overall Study|Withdrawal by Subject|37|||
162115704|NCT00332332|585474544|FG000|Overall Study|Adverse Event|13|||
162115705|NCT00332332|585474544|FG000|Overall Study|Death|1|||
162115706|NCT00332332|585474544|FG000|Overall Study|Withdrawal by Subject|8|||
162115707|NCT00332332|585474544|FG000|Overall Study|Physician Decision|1|||
162115708|NCT00332332|585474544|FG000|Overall Study|Lost to Follow-up|3|||
162115709|NCT00332332|585474544|FG000|Overall Study|Protocol deviation|4|||
162115710|NCT00332332|585474544|FG000|Overall Study|Noncompliance|2|||
162115711|NCT00332332|585474544|FG000|Overall Study|Disease progression|2|||
162115712|NCT00332332|585474544|FG000|Overall Study|Other|18|||
162115713|NCT00332332|585474544|FG000|Overall Study|Did not receive study treatment|16|||
162115714|NCT01108458|585474545|FG000|Overall Study|Withdrawal by Subject|1|||
162115715|NCT03075501|585474547|FG000|Overall Study|Scheduling difficulties|15|||
162115716|NCT03075501|585474548|FG001|Overall Study|Scheduling difficulties|9|||
162115717|NCT03610737|585474553|FG000|Overall Study|Withdrawal by Subject|1|||
162115718|NCT03610737|585474554|FG001|Overall Study|Withdrawal by Subject|5|||
162115719|NCT03610737|585474553|FG000|Overall Study|Death|1|||
162115720|NCT03610737|585474554|FG001|Overall Study|Death|0|||
162115721|NCT03610737|585474553|FG000|Overall Study|Not treated|5|||
162115722|NCT03610737|585474554|FG001|Overall Study|Not treated|2|||
162115723|NCT03610737|585474553|FG000|Overall Study|Missed Visit|1|||
162115724|NCT03610737|585474554|FG001|Overall Study|Missed Visit|2|||
162115725|NCT00710606|585474561|FG000|Overall Study|Adverse Event|0|||
162115726|NCT00710606|585474562|FG001|Overall Study|Adverse Event|2|||
162115727|NCT02670538|585474567|FG000|Overall Study|Withdrawal of Consent|8|||
162115728|NCT02670538|585474568|FG001|Overall Study|Withdrawal of Consent|6|||
162115729|NCT02670538|585474569|FG002|Overall Study|Withdrawal of Consent|5|||
162115730|NCT02670538|585474567|FG000|Overall Study|Lost to Follow-up|8|||
162115731|NCT02670538|585474568|FG001|Overall Study|Lost to Follow-up|12|||
162115732|NCT02670538|585474569|FG002|Overall Study|Lost to Follow-up|7|||
162115733|NCT02670538|585474567|FG000|Overall Study|Adverse Event|5|||
162115734|NCT02670538|585474568|FG001|Overall Study|Adverse Event|5|||
162115735|NCT02670538|585474569|FG002|Overall Study|Adverse Event|11|||
162115736|NCT02670538|585474567|FG000|Overall Study|Lack of Efficacy|7|||
162115737|NCT02670538|585474568|FG001|Overall Study|Lack of Efficacy|1|||
162115738|NCT02670538|585474569|FG002|Overall Study|Lack of Efficacy|2|||
162115739|NCT02670538|585474567|FG000|Overall Study|Protocol Violation|3|||
162115740|NCT02670538|585474568|FG001|Overall Study|Protocol Violation|4|||
162115741|NCT02670538|585474569|FG002|Overall Study|Protocol Violation|1|||
162115742|NCT02670538|585474567|FG000|Overall Study|Noncompliance with Study Drug|1|||
162115743|NCT02670538|585474568|FG001|Overall Study|Noncompliance with Study Drug|3|||
162115744|NCT02670538|585474569|FG002|Overall Study|Noncompliance with Study Drug|2|||
162115745|NCT02670538|585474567|FG000|Overall Study|Other Miscellaneous Reasons|0|||
162115746|NCT02670538|585474568|FG001|Overall Study|Other Miscellaneous Reasons|1|||
162115747|NCT02670538|585474569|FG002|Overall Study|Other Miscellaneous Reasons|2|||
162115748|NCT02243202|585474570|FG000|Overall Study|Adverse Event|5|||
162115749|NCT02243202|585474571|FG001|Overall Study|Adverse Event|6|||
162115750|NCT02243202|585474572|FG002|Overall Study|Adverse Event|10|||
162115751|NCT02243202|585474573|FG003|Overall Study|Adverse Event|4|||
162115752|NCT02243202|585474570|FG000|Overall Study|Lost to Follow-up|9|||
162115753|NCT02243202|585474571|FG001|Overall Study|Lost to Follow-up|9|||
162115754|NCT02243202|585474572|FG002|Overall Study|Lost to Follow-up|14|||
162115755|NCT02243202|585474573|FG003|Overall Study|Lost to Follow-up|11|||
162115756|NCT02243202|585474570|FG000|Overall Study|Protocol Violation|3|||
162115757|NCT02243202|585474571|FG001|Overall Study|Protocol Violation|1|||
162115758|NCT02243202|585474572|FG002|Overall Study|Protocol Violation|2|||
162115759|NCT02243202|585474573|FG003|Overall Study|Protocol Violation|1|||
162115760|NCT02243202|585474570|FG000|Overall Study|Withdrawal by Subject|7|||
162115761|NCT02243202|585474571|FG001|Overall Study|Withdrawal by Subject|6|||
162115762|NCT02243202|585474572|FG002|Overall Study|Withdrawal by Subject|4|||
162115763|NCT02243202|585474573|FG003|Overall Study|Withdrawal by Subject|4|||
162115764|NCT02243202|585474570|FG000|Overall Study|Other|1|||
162115765|NCT02243202|585474571|FG001|Overall Study|Other|3|||
162115766|NCT02243202|585474572|FG002|Overall Study|Other|1|||
162115767|NCT02243202|585474573|FG003|Overall Study|Other|2|||
162115768|NCT02243202|585474570|FG000|Overall Study|Randomized but not received treatment|0|||
162115769|NCT02243202|585474571|FG001|Overall Study|Randomized but not received treatment|0|||
162115770|NCT02243202|585474572|FG002|Overall Study|Randomized but not received treatment|0|||
162115771|NCT02243202|585474573|FG003|Overall Study|Randomized but not received treatment|1|||
162115772|NCT02207725|585474577|FG000|Overall Study|Did Not Receive Treatment|0|||
162115773|NCT02207725|585474578|FG001|Overall Study|Did Not Receive Treatment|1|||
162115774|NCT02207725|585474579|FG002|Overall Study|Did Not Receive Treatment|1|||
162115775|NCT02207725|585474580|FG003|Overall Study|Did Not Receive Treatment|1|||
162115776|NCT02799472|585474583|FG000|Overall Study|Withdrawal by Subject|2|||
162115777|NCT02799472|585474584|FG001|Overall Study|Withdrawal by Subject|4|||
162115778|NCT02799472|585474583|FG000|Overall Study|Lack of Efficacy|2|||
162115779|NCT02799472|585474584|FG001|Overall Study|Lack of Efficacy|0|||
162115780|NCT02799472|585474583|FG000|Overall Study|Lost to Follow-up|0|||
162115781|NCT02799472|585474584|FG001|Overall Study|Lost to Follow-up|1|||
162115782|NCT02801669|585474585|FG000|Overall Study|Death|66|||
162115783|NCT02801669|585474586|FG001|Overall Study|Death|69|||
162115784|NCT02801669|585474585|FG000|Overall Study|Withdrawal by Subject|81|||
162115785|NCT02801669|585474586|FG001|Overall Study|Withdrawal by Subject|77|||
162115786|NCT02801669|585474585|FG000|Overall Study|Other|4|||
162115787|NCT02801669|585474586|FG001|Overall Study|Other|6|||
162115788|NCT04461795|585474587|FG000|Overall Study|Lost to Follow-up|2|||
162115789|NCT04461795|585474587|FG000|Overall Study|Withdrawal by Subject|2|||
162115790|NCT04461795|585474587|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
162115791|NCT00615264|585474589|FG000|Overall Study|Withdrawal by Subject|17|||
162115792|NCT00615264|585474590|FG001|Overall Study|Withdrawal by Subject|19|||
162115793|NCT00615264|585474589|FG000|Overall Study|Lost to Follow-up|6|||
162115794|NCT00615264|585474590|FG001|Overall Study|Lost to Follow-up|13|||
162115795|NCT00615264|585474589|FG000|Overall Study|Adverse Event|8|||
162115796|NCT00615264|585474590|FG001|Overall Study|Adverse Event|5|||
162115797|NCT00615264|585474589|FG000|Overall Study|Death|1|||
162115798|NCT00615264|585474590|FG001|Overall Study|Death|1|||
162115799|NCT00615264|585474589|FG000|Overall Study|Protocol Violation|11|||
162115800|NCT00615264|585474590|FG001|Overall Study|Protocol Violation|7|||
162115801|NCT00615264|585474589|FG000|Overall Study|Not defined|7|||
162115802|NCT00615264|585474590|FG001|Overall Study|Not defined|4|||
162115803|NCT00615264|585474589|FG000|Overall Study|Dermal Hypersensitivity|0|||
162115804|NCT00615264|585474590|FG001|Overall Study|Dermal Hypersensitivity|3|||
162115805|NCT00058422|585474591|FG000|Overall Study|Not treated|2|||
162115806|NCT00185640|585474592|FG000|Overall Study|Not Eligible|4|||
162115807|NCT00185640|585474592|FG000|Overall Study|Withdrawal by Subject|3|||
162115808|NCT00185640|585474592|FG000|Overall Study|Death|138|||
162115809|NCT00633932|585474593|FG000|Overall Study|Adverse Event|1|||
162115810|NCT00633932|585474594|FG001|Overall Study|Adverse Event|3|||
162115811|NCT00633932|585474595|FG002|Overall Study|Adverse Event|4|||
162115812|NCT00633932|585474593|FG000|Overall Study|Withdrawal by Subject|3|||
162115813|NCT00633932|585474594|FG001|Overall Study|Withdrawal by Subject|9|||
162115814|NCT00633932|585474595|FG002|Overall Study|Withdrawal by Subject|1|||
162115815|NCT00633932|585474593|FG000|Overall Study|Lost to Follow-up|1|||
162115816|NCT00633932|585474594|FG001|Overall Study|Lost to Follow-up|0|||
162115817|NCT00633932|585474595|FG002|Overall Study|Lost to Follow-up|2|||
162115818|NCT00633932|585474593|FG000|Overall Study|Protocol Violation|5|||
162115819|NCT00633932|585474594|FG001|Overall Study|Protocol Violation|2|||
162115820|NCT00633932|585474595|FG002|Overall Study|Protocol Violation|3|||
162115821|NCT00633932|585474593|FG000|Overall Study|Physician Decision|0|||
162115822|NCT00633932|585474594|FG001|Overall Study|Physician Decision|0|||
162115823|NCT00633932|585474595|FG002|Overall Study|Physician Decision|1|||
162115824|NCT00633932|585474593|FG000|Overall Study|Doctor's judgement|1|||
162115825|NCT00633932|585474594|FG001|Overall Study|Doctor's judgement|0|||
162115826|NCT00633932|585474595|FG002|Overall Study|Doctor's judgement|0|||
162115827|NCT00633932|585474593|FG000|Overall Study|Moved Away|1|||
162115828|NCT00633932|585474594|FG001|Overall Study|Moved Away|0|||
162115829|NCT00633932|585474595|FG002|Overall Study|Moved Away|0|||
162115830|NCT04836858|585474596|FG000|Overall Study|Adverse Event|0|||
162115831|NCT04836858|585474597|FG001|Overall Study|Adverse Event|0|||
162115832|NCT04836858|585474598|FG002|Overall Study|Adverse Event|0|||
162115833|NCT04836858|585474599|FG003|Overall Study|Adverse Event|1|||
162115834|NCT04836858|585474596|FG000|Overall Study|Lost to Follow-up|1|||
162115835|NCT04836858|585474597|FG001|Overall Study|Lost to Follow-up|0|||
162115836|NCT04836858|585474598|FG002|Overall Study|Lost to Follow-up|0|||
162115837|NCT04836858|585474599|FG003|Overall Study|Lost to Follow-up|0|||
162115838|NCT04836858|585474596|FG000|Overall Study|Subject/Guardian decision|3|||
162115839|NCT04836858|585474597|FG001|Overall Study|Subject/Guardian decision|0|||
162115840|NCT04836858|585474598|FG002|Overall Study|Subject/Guardian decision|0|||
162115841|NCT04836858|585474599|FG003|Overall Study|Subject/Guardian decision|1|||
162115842|NCT04836858|585474596|FG000|Overall Study|Randomized but not treated|4|||
162115843|NCT04836858|585474597|FG001|Overall Study|Randomized but not treated|0|||
162115844|NCT04836858|585474598|FG002|Overall Study|Randomized but not treated|0|||
162115845|NCT04836858|585474599|FG003|Overall Study|Randomized but not treated|0|||
162115846|NCT01982435|585474602|FG000|Overall Study|Adverse Event|1|||
162115847|NCT01982435|585474603|FG001|Overall Study|Adverse Event|0|||
162115848|NCT00708435|585474605|FG000|Overall Study|Death / Serious Adverse Event|10|||
162115849|NCT00708435|585474606|FG001|Overall Study|Death / Serious Adverse Event|5|||
162115850|NCT00708435|585474605|FG000|Overall Study|Lost to Follow-up|9|||
162115851|NCT00708435|585474606|FG001|Overall Study|Lost to Follow-up|4|||
162115852|NCT00708435|585474605|FG000|Overall Study|Withdrawal by Subject|3|||
162115853|NCT00708435|585474606|FG001|Overall Study|Withdrawal by Subject|7|||
162115854|NCT00708435|585474605|FG000|Overall Study|Adverse Event|1|||
162115855|NCT00708435|585474606|FG001|Overall Study|Adverse Event|0|||
162115856|NCT00708435|585474605|FG000|Overall Study|Protocol Violation|0|||
162115857|NCT00708435|585474606|FG001|Overall Study|Protocol Violation|1|||
162115858|NCT00708435|585474605|FG000|Overall Study|Intervention by primary care physician|1|||
162115859|NCT00708435|585474606|FG001|Overall Study|Intervention by primary care physician|0|||
162115860|NCT00708435|585474605|FG000|Overall Study|Refused hospitalization|1|||
162115861|NCT00708435|585474606|FG001|Overall Study|Refused hospitalization|0|||
162115862|NCT04766086|585474607|FG000|Overall Study|Lost to Follow-up|3|||
162115863|NCT04766086|585474608|FG001|Overall Study|Lost to Follow-up|5|||
162115864|NCT04766086|585474609|FG002|Overall Study|Lost to Follow-up|3|||
162115865|NCT04766086|585474607|FG000|Overall Study|Withdrawal by Subject|1|||
162115866|NCT04766086|585474608|FG001|Overall Study|Withdrawal by Subject|1|||
162115867|NCT04766086|585474609|FG002|Overall Study|Withdrawal by Subject|2|||
162115868|NCT04766086|585474607|FG000|Overall Study|Other|0|||
162115869|NCT04766086|585474608|FG001|Overall Study|Other|0|||
162115870|NCT04766086|585474609|FG002|Overall Study|Other|1|||
162115871|NCT02635724|585474612|FG000|Overall Study|Withdrawal by Subject|0|||
162115872|NCT02635724|585474613|FG001|Overall Study|Withdrawal by Subject|1|||
162115873|NCT02635724|585474614|FG002|Overall Study|Withdrawal by Subject|0|||
162115874|NCT03579290|585474615|FG000|Overall Study|Lost to Follow-up|9|||
162115875|NCT00532155|585474616|FG000|Overall Study|Adverse Event|66|||
162115876|NCT00532155|585474617|FG001|Overall Study|Adverse Event|123|||
162115877|NCT00532155|585474616|FG000|Overall Study|Lack of Efficacy|332|||
162115878|NCT00532155|585474617|FG001|Overall Study|Lack of Efficacy|255|||
162115879|NCT00532155|585474616|FG000|Overall Study|Protocol Violation|1|||
162115880|NCT00532155|585474617|FG001|Overall Study|Protocol Violation|3|||
162115881|NCT00532155|585474616|FG000|Overall Study|Lost to Follow-up|2|||
162115882|NCT00532155|585474617|FG001|Overall Study|Lost to Follow-up|0|||
162115883|NCT00532155|585474616|FG000|Overall Study|Physician Decision|16|||
162115884|NCT00532155|585474617|FG001|Overall Study|Physician Decision|15|||
162115885|NCT00532155|585474616|FG000|Overall Study|Withdrawal by Subject|23|||
162115886|NCT00532155|585474617|FG001|Overall Study|Withdrawal by Subject|44|||
162115887|NCT00532155|585474616|FG000|Overall Study|Consent withdrawn|5|||
162115888|NCT00532155|585474617|FG001|Overall Study|Consent withdrawn|7|||
162115889|NCT00532155|585474616|FG000|Overall Study|Moved|1|||
162115890|NCT00532155|585474617|FG001|Overall Study|Moved|0|||
162115891|NCT00532155|585474616|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
162115892|NCT00532155|585474617|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
162115893|NCT00532155|585474616|FG000|Overall Study|Occurence of a second cancer|0|||
162115894|NCT00532155|585474617|FG001|Overall Study|Occurence of a second cancer|1|||
162115895|NCT00532155|585474616|FG000|Overall Study|Occurence of a secondary cancer|0|||
162115896|NCT00532155|585474617|FG001|Overall Study|Occurence of a secondary cancer|1|||
162115897|NCT00532155|585474616|FG000|Overall Study|Promotor ended study|1|||
162115898|NCT00532155|585474617|FG001|Overall Study|Promotor ended study|0|||
162115899|NCT00532155|585474616|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
162115900|NCT00532155|585474617|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
162115901|NCT00532155|585474616|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
162115902|NCT00532155|585474617|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
162115903|NCT00532155|585474616|FG000|Overall Study|Study stopped|1|||
162115904|NCT00532155|585474617|FG001|Overall Study|Study stopped|0|||
162115905|NCT00532155|585474616|FG000|Overall Study|Study terminated by sponsor|1|||
162115906|NCT00532155|585474617|FG001|Overall Study|Study terminated by sponsor|0|||
162115907|NCT00532155|585474616|FG000|Overall Study|Study termination stop further treatment|4|||
162115908|NCT00532155|585474617|FG001|Overall Study|Study termination stop further treatment|0|||
162115909|NCT00532155|585474616|FG000|Overall Study|Did not receive study medication|2|||
162115910|NCT00532155|585474617|FG001|Overall Study|Did not receive study medication|6|||
162115911|NCT03483038|585474618|FG000|Overall Study|Subjects still in follow-up|18|||
162115912|NCT00654901|585474619|FG000|Overall Study|Lost to Follow-up|1|||
162115913|NCT00654901|585474620|FG001|Overall Study|Lost to Follow-up|0|||
162115914|NCT00654901|585474621|FG002|Overall Study|Lost to Follow-up|1|||
162115915|NCT00654901|585474622|FG003|Overall Study|Lost to Follow-up|0|||
162115916|NCT00654901|585474619|FG000|Overall Study|Withdrawal by Subject|3|||
162115917|NCT00654901|585474620|FG001|Overall Study|Withdrawal by Subject|0|||
162115918|NCT00654901|585474621|FG002|Overall Study|Withdrawal by Subject|1|||
162115919|NCT00654901|585474622|FG003|Overall Study|Withdrawal by Subject|0|||
162115920|NCT04843930|585474624|FG000|Randomization|Withdrawal by Subject|6|||
162115921|NCT04843930|585474625|FG001|Randomization|Withdrawal by Subject|6|||
162115922|NCT04843930|585474626|FG002|Randomization|Withdrawal by Subject|0|||
162115923|NCT04843930|585474627|FG003|Randomization|Withdrawal by Subject|0|||
162115924|NCT04843930|585474624|FG000|Week 6 Assessment|Adverse Event|3|||
162115925|NCT04843930|585474625|FG001|Week 6 Assessment|Adverse Event|0|||
162115926|NCT04843930|585474626|FG002|Week 6 Assessment|Adverse Event|0|||
162115927|NCT04843930|585474627|FG003|Week 6 Assessment|Adverse Event|0|||
162115928|NCT04843930|585474624|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
162115929|NCT04843930|585474625|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
162115930|NCT04843930|585474626|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
162115931|NCT04843930|585474627|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
162115932|NCT04843930|585474624|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
162115933|NCT04843930|585474625|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
162115934|NCT04843930|585474626|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
162115935|NCT04843930|585474627|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
162115936|NCT02552238|585474628|FG000|Overall Study|Withdrawal by Subject|2|||
162115937|NCT02552238|585474628|FG000|Overall Study|Adverse Event|2|||
162115938|NCT01576718|585474629|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
162115939|NCT01576718|585474630|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162115940|NCT01576718|585474631|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162115941|NCT01576718|585474632|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162115942|NCT01576718|585474633|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162115943|NCT01576718|585474634|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162115944|NCT01576718|585474635|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
162115945|NCT01576718|585474629|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
162115946|NCT01576718|585474630|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162115947|NCT01576718|585474631|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162115948|NCT01576718|585474632|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162115949|NCT01576718|585474633|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162115950|NCT01576718|585474634|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162115951|NCT01576718|585474635|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
162115952|NCT01576718|585474629|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
162115953|NCT01576718|585474630|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162115954|NCT01576718|585474631|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162115955|NCT01576718|585474632|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162115956|NCT01576718|585474633|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162115957|NCT01576718|585474634|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162115958|NCT01576718|585474635|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
162115959|NCT01576718|585474629|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
162115960|NCT01576718|585474630|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162115961|NCT01576718|585474631|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162115962|NCT01576718|585474632|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162115963|NCT01576718|585474633|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162115964|NCT01576718|585474634|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162115965|NCT01576718|585474635|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
162115966|NCT01576718|585474629|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
162115967|NCT01576718|585474630|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162115968|NCT01576718|585474631|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162115969|NCT01576718|585474632|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162115970|NCT01576718|585474633|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162115971|NCT01576718|585474634|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162115972|NCT01576718|585474635|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
162115973|NCT01576718|585474629|FG000|Treatment Period|Adverse Event|0|||
162115974|NCT01576718|585474630|FG001|Treatment Period|Adverse Event|1|||
162115975|NCT01576718|585474631|FG002|Treatment Period|Adverse Event|1|||
162115976|NCT01576718|585474632|FG003|Treatment Period|Adverse Event|1|||
162115977|NCT01576718|585474633|FG004|Treatment Period|Adverse Event|1|||
162115978|NCT01576718|585474634|FG005|Treatment Period|Adverse Event|1|||
162115979|NCT01576718|585474635|FG006|Treatment Period|Adverse Event|0|||
162115980|NCT01576718|585474629|FG000|Treatment Period|Withdrawal by Subject|0|||
162115981|NCT01576718|585474630|FG001|Treatment Period|Withdrawal by Subject|1|||
162115982|NCT01576718|585474631|FG002|Treatment Period|Withdrawal by Subject|1|||
162115983|NCT01576718|585474632|FG003|Treatment Period|Withdrawal by Subject|0|||
162115984|NCT01576718|585474633|FG004|Treatment Period|Withdrawal by Subject|2|||
162115985|NCT01576718|585474634|FG005|Treatment Period|Withdrawal by Subject|4|||
162115986|NCT01576718|585474635|FG006|Treatment Period|Withdrawal by Subject|2|||
162115987|NCT01576718|585474629|FG000|Treatment Period|Physician Decision|0|||
162115988|NCT01576718|585474630|FG001|Treatment Period|Physician Decision|1|||
162115989|NCT01576718|585474631|FG002|Treatment Period|Physician Decision|1|||
162115990|NCT01576718|585474632|FG003|Treatment Period|Physician Decision|1|||
162115991|NCT01576718|585474633|FG004|Treatment Period|Physician Decision|1|||
162115992|NCT01576718|585474634|FG005|Treatment Period|Physician Decision|0|||
162115993|NCT01576718|585474635|FG006|Treatment Period|Physician Decision|0|||
162115994|NCT01576718|585474629|FG000|Treatment Period|Protocol Violation|0|||
162115995|NCT01576718|585474630|FG001|Treatment Period|Protocol Violation|5|||
162115996|NCT01576718|585474631|FG002|Treatment Period|Protocol Violation|4|||
162115997|NCT01576718|585474632|FG003|Treatment Period|Protocol Violation|10|||
162115998|NCT01576718|585474633|FG004|Treatment Period|Protocol Violation|6|||
162115999|NCT01576718|585474634|FG005|Treatment Period|Protocol Violation|8|||
162116000|NCT01576718|585474635|FG006|Treatment Period|Protocol Violation|12|||
162116001|NCT01576718|585474629|FG000|Treatment Period|Sponsor request|0|||
162116002|NCT01576718|585474630|FG001|Treatment Period|Sponsor request|1|||
162116003|NCT01576718|585474631|FG002|Treatment Period|Sponsor request|0|||
162116004|NCT01576718|585474632|FG003|Treatment Period|Sponsor request|0|||
162116005|NCT01576718|585474633|FG004|Treatment Period|Sponsor request|0|||
162116006|NCT01576718|585474634|FG005|Treatment Period|Sponsor request|1|||
162116007|NCT01576718|585474635|FG006|Treatment Period|Sponsor request|0|||
162116008|NCT01576718|585474629|FG000|Treatment Period|Met stopping criteria|0|||
162116009|NCT01576718|585474630|FG001|Treatment Period|Met stopping criteria|16|||
162116010|NCT01576718|585474631|FG002|Treatment Period|Met stopping criteria|13|||
162116011|NCT01576718|585474632|FG003|Treatment Period|Met stopping criteria|19|||
162116012|NCT01576718|585474633|FG004|Treatment Period|Met stopping criteria|16|||
162116013|NCT01576718|585474634|FG005|Treatment Period|Met stopping criteria|33|||
162116014|NCT01576718|585474635|FG006|Treatment Period|Met stopping criteria|15|||
162116015|NCT01576718|585474629|FG000|Treatment Period|Lost to Follow-up|0|||
162116016|NCT01576718|585474630|FG001|Treatment Period|Lost to Follow-up|0|||
162116017|NCT01576718|585474631|FG002|Treatment Period|Lost to Follow-up|0|||
162116018|NCT01576718|585474632|FG003|Treatment Period|Lost to Follow-up|0|||
162116019|NCT01576718|585474633|FG004|Treatment Period|Lost to Follow-up|1|||
162116020|NCT01576718|585474634|FG005|Treatment Period|Lost to Follow-up|0|||
162116021|NCT01576718|585474635|FG006|Treatment Period|Lost to Follow-up|0|||
162116022|NCT01576718|585474629|FG000|Treatment Period|Noncompliance to study medication|0|||
162116023|NCT01576718|585474630|FG001|Treatment Period|Noncompliance to study medication|0|||
162116024|NCT01576718|585474631|FG002|Treatment Period|Noncompliance to study medication|0|||
162116025|NCT01576718|585474632|FG003|Treatment Period|Noncompliance to study medication|0|||
162116026|NCT01576718|585474633|FG004|Treatment Period|Noncompliance to study medication|0|||
162116027|NCT01576718|585474634|FG005|Treatment Period|Noncompliance to study medication|1|||
162116028|NCT01576718|585474635|FG006|Treatment Period|Noncompliance to study medication|1|||
162116029|NCT04631705|585474636|FG000|Overall Study|Withdrawal by Subject|0|||
162116030|NCT04631705|585474637|FG001|Overall Study|Withdrawal by Subject|0|||
162116031|NCT04631705|585474638|FG002|Overall Study|Withdrawal by Subject|0|||
162116032|NCT04631705|585474639|FG003|Overall Study|Withdrawal by Subject|0|||
162116033|NCT04631705|585474640|FG004|Overall Study|Withdrawal by Subject|0|||
162116034|NCT04631705|585474641|FG005|Overall Study|Withdrawal by Subject|0|||
162116035|NCT04631705|585474642|FG006|Overall Study|Withdrawal by Subject|1|||
162116036|NCT04631705|585474643|FG007|Overall Study|Withdrawal by Subject|0|||
162116037|NCT04631705|585474644|FG008|Overall Study|Withdrawal by Subject|0|||
162116038|NCT02070484|585474650|FG000|Overall Study|Withdrawal by Subject|1|||
162116039|NCT02070484|585474651|FG001|Overall Study|Withdrawal by Subject|0|||
162116040|NCT01521884|585474652|FG000|Overall Study|Non Responders|10|||
162116041|NCT01521884|585474652|FG000|Overall Study|Adverse Event|5|||
162116042|NCT01521884|585474652|FG000|Overall Study|Pregnancy|1|||
162116043|NCT01521884|585474652|FG000|Overall Study|Withdrawal by Subject|1|||
162116044|NCT01521884|585474652|FG000|Overall Study|Physician Decision|2|||
162116045|NCT01521884|585474652|FG000|Overall Study|Protocol Violation|3|||
162116046|NCT01521884|585474652|FG000|Overall Study|Participant non-eligible|1|||
162116047|NCT01521884|585474652|FG000|Overall Study|Lost to Follow-up|4|||
162116048|NCT02821819|585474653|FG000|Overall Study|Protocol Violation|1|||
162116049|NCT04241094|585474654|FG000|Overall Study|Dropped out of treatment|4|||
162116050|NCT04241094|585474654|FG000|Overall Study|Ineligible after clinical assessment|2|||
162116051|NCT04241094|585474654|FG000|Overall Study|Lost to Follow-up|2|||
162116052|NCT01669798|585474655|FG000|Overall Study|Physician Decision|5|||
162116053|NCT02332590|585474659|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
162116054|NCT02332590|585474660|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
162116055|NCT02332590|585474659|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
162116056|NCT02332590|585474660|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
162116057|NCT02332590|585474659|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
162116058|NCT02332590|585474660|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
162116059|NCT02332590|585474659|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
162116060|NCT02332590|585474660|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
162116061|NCT02332590|585474659|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
162116062|NCT02332590|585474660|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
162116063|NCT02332590|585474659|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
162116064|NCT02332590|585474660|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
162116065|NCT02332590|585474659|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
162116066|NCT02332590|585474660|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
162116067|NCT02332590|585474659|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
162116068|NCT02332590|585474660|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
162116069|NCT02332590|585474659|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
162116070|NCT02332590|585474660|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
162116071|NCT01806584|585474661|FG000|Overall Study|Adverse Event|2|||
162116072|NCT01806584|585474662|FG001|Overall Study|Adverse Event|1|||
162116073|NCT01806584|585474661|FG000|Overall Study|Death|1|||
162116074|NCT01806584|585474662|FG001|Overall Study|Death|0|||
162116075|NCT01806584|585474661|FG000|Overall Study|Lost to Follow-up|0|||
162116076|NCT01806584|585474662|FG001|Overall Study|Lost to Follow-up|2|||
162116077|NCT01806584|585474661|FG000|Overall Study|Study terminated by sponsor|9|||
162116078|NCT01806584|585474662|FG001|Overall Study|Study terminated by sponsor|14|||
162116079|NCT01806584|585474661|FG000|Overall Study|Withdrawal by Subject|1|||
162116080|NCT01806584|585474662|FG001|Overall Study|Withdrawal by Subject|1|||
162116081|NCT01806584|585474661|FG000|Overall Study|Other unspecified|1|||
162116082|NCT01806584|585474662|FG001|Overall Study|Other unspecified|0|||
162116083|NCT02272725|585474665|FG000|Overall Study|equipment malfunction|2|||
162116084|NCT02272725|585474666|FG001|Overall Study|equipment malfunction|0|||
162116085|NCT02764775|585476765|FG000|Overall Study|Death|1|||
162116086|NCT02764775|585476765|FG000|Overall Study|Lost to Follow-up|2|||
162116087|NCT02764775|585476765|FG000|Overall Study|Withdrawal by Subject|3|||
162116088|NCT00975221|585476766|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
162116089|NCT00975221|585476767|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
162116090|NCT00975221|585476766|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
162116091|NCT00975221|585476767|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
162116092|NCT00975221|585476766|FG000|Titration Phase (Weeks 1-12)|Other|0|||
162116093|NCT00975221|585476767|FG001|Titration Phase (Weeks 1-12)|Other|1|||
162116094|NCT00975221|585476766|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
162116095|NCT00975221|585476767|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
162116096|NCT00975221|585476766|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
162116097|NCT00975221|585476767|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
162116098|NCT00975221|585476766|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
162116099|NCT00975221|585476767|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
162116100|NCT04022889|585476768|FG000|Stage 1: Period 1|Adverse Event|1|||
162116101|NCT04022889|585476769|FG001|Stage 1: Period 1|Adverse Event|0|||
162116102|NCT04022889|585476770|FG002|Stage 1: Period 1|Adverse Event|0|||
162116103|NCT04022889|585476768|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
162116104|NCT04022889|585476769|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
162116105|NCT04022889|585476770|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
162116106|NCT04022889|585476768|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
162116107|NCT04022889|585476769|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
162116108|NCT04022889|585476770|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
162116109|NCT04022889|585476768|FG000|Stage 2|Screen Failure|0|||
162116110|NCT04022889|585476769|FG001|Stage 2|Screen Failure|0|||
162116111|NCT04022889|585476770|FG002|Stage 2|Screen Failure|3|||
162116112|NCT04022889|585476768|FG000|Stage 2|Ineligible for apheresis donation|0|||
162116113|NCT04022889|585476769|FG001|Stage 2|Ineligible for apheresis donation|0|||
162116114|NCT04022889|585476770|FG002|Stage 2|Ineligible for apheresis donation|2|||
162116115|NCT04022889|585476768|FG000|Stage 2|Adverse Event|0|||
162116116|NCT04022889|585476769|FG001|Stage 2|Adverse Event|0|||
162116117|NCT04022889|585476770|FG002|Stage 2|Adverse Event|2|||
162116118|NCT04022889|585476768|FG000|Stage 2|Protocol Violation|0|||
162116119|NCT04022889|585476769|FG001|Stage 2|Protocol Violation|0|||
162116120|NCT04022889|585476770|FG002|Stage 2|Protocol Violation|1|||
162116121|NCT04022889|585476768|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
162116122|NCT04022889|585476769|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
162116123|NCT04022889|585476770|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
162116124|NCT03015116|585476771|FG000|Overall Study|Lost to Follow-up|3|||
162116125|NCT03015116|585476772|FG001|Overall Study|Lost to Follow-up|0|||
162116126|NCT03015116|585476773|FG002|Overall Study|Lost to Follow-up|2|||
162116127|NCT03015116|585476771|FG000|Overall Study|Withdrawal by Subject|3|||
162116128|NCT03015116|585476772|FG001|Overall Study|Withdrawal by Subject|1|||
162116129|NCT03015116|585476773|FG002|Overall Study|Withdrawal by Subject|0|||
162116130|NCT03015116|585476771|FG000|Overall Study|Subject has New Medical Status|1|||
162116131|NCT03015116|585476772|FG001|Overall Study|Subject has New Medical Status|0|||
162116132|NCT03015116|585476773|FG002|Overall Study|Subject has New Medical Status|0|||
162116133|NCT03015116|585476771|FG000|Overall Study|Physician Decision|0|||
162116134|NCT03015116|585476772|FG001|Overall Study|Physician Decision|1|||
162116135|NCT03015116|585476773|FG002|Overall Study|Physician Decision|0|||
162116136|NCT01862991|585476774|FG000|Overall Study|Lost to Follow-up|2|||
162116137|NCT01862991|585476775|FG001|Overall Study|Lost to Follow-up|1|||
162116138|NCT01862991|585476776|FG002|Overall Study|Lost to Follow-up|1|||
162116139|NCT01862991|585476774|FG000|Overall Study|Protocol Violation|1|||
162116140|NCT01862991|585476775|FG001|Overall Study|Protocol Violation|0|||
162116141|NCT01862991|585476776|FG002|Overall Study|Protocol Violation|0|||
162116142|NCT04858802|585476777|FG000|Overall Study|Lost to Follow-up|1|||
162116143|NCT04858802|585476778|FG001|Overall Study|Lost to Follow-up|1|||
162116144|NCT04858802|585476777|FG000|Overall Study|Withdrawal by Subject|1|||
162116145|NCT04858802|585476778|FG001|Overall Study|Withdrawal by Subject|1|||
162116146|NCT00857805|585476779|FG000|Overall Study|Withdrawal by Subject|1|||
162116147|NCT00857805|585476780|FG001|Overall Study|Withdrawal by Subject|1|||
162116148|NCT01289041|585476781|FG000|Overall Study|Adverse Event|24|||
162116149|NCT01289041|585476781|FG000|Overall Study|Physician Decision|1|||
162116150|NCT01289041|585476781|FG000|Overall Study|Progressive Disease|41|||
162116151|NCT01289041|585476781|FG000|Overall Study|Withdrawal by Subject|3|||
162116152|NCT01289041|585476781|FG000|Overall Study|Death|1|||
162116153|NCT02714868|585476786|FG000|Overall Study|Withdrawal by Subject|3|||
162116154|NCT02714868|585476787|FG001|Overall Study|Withdrawal by Subject|0|||
162116155|NCT02714868|585476786|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
162116156|NCT02714868|585476787|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
162116157|NCT02714868|585476786|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
162116158|NCT02714868|585476787|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
162116159|NCT05056870|585476792|FG000|Period 1|Site COVID-19 Related|3|||
162116160|NCT05056870|585476793|FG001|Period 1|Site COVID-19 Related|3|||
162116161|NCT05056870|585476792|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
162116162|NCT05056870|585476793|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
162116163|NCT05056870|585476792|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
162116164|NCT05056870|585476793|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
162116165|NCT05056870|585476792|FG000|Period 2|COVID-19 Related|1|||
162116166|NCT05056870|585476793|FG001|Period 2|COVID-19 Related|0|||
162116167|NCT05056870|585476792|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
162116168|NCT05056870|585476793|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
162116169|NCT05044325|585476796|FG000|Part A:Treatment Period 1|Adverse Event|0|||
162116170|NCT05044325|585476797|FG001|Part A:Treatment Period 1|Adverse Event|0|||
162116171|NCT05044325|585476798|FG002|Part A:Treatment Period 1|Adverse Event|0|||
162116172|NCT05044325|585476799|FG003|Part A:Treatment Period 1|Adverse Event|0|||
162116173|NCT05044325|585476800|FG004|Part A:Treatment Period 1|Adverse Event|0|||
162116174|NCT05044325|585476801|FG005|Part A:Treatment Period 1|Adverse Event|1|||
162116175|NCT05044325|585476802|FG006|Part A:Treatment Period 1|Adverse Event|0|||
162116176|NCT05044325|585476803|FG007|Part A:Treatment Period 1|Adverse Event|1|||
162116177|NCT05044325|585476804|FG008|Part A:Treatment Period 1|Adverse Event|0|||
162116178|NCT05044325|585476805|FG009|Part A:Treatment Period 1|Adverse Event|0|||
162116179|NCT05044325|585476796|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162116180|NCT05044325|585476797|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162116181|NCT05044325|585476798|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162116182|NCT05044325|585476799|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
162116183|NCT05044325|585476800|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
162116184|NCT05044325|585476801|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
162116185|NCT05044325|585476802|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162116186|NCT05044325|585476803|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162116187|NCT05044325|585476804|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162116188|NCT05044325|585476805|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
162116189|NCT05044325|585476796|FG000|Part A:Treatment Period 1|Physician Decision|0|||
162116190|NCT05044325|585476797|FG001|Part A:Treatment Period 1|Physician Decision|0|||
162116191|NCT05044325|585476798|FG002|Part A:Treatment Period 1|Physician Decision|0|||
162116192|NCT05044325|585476799|FG003|Part A:Treatment Period 1|Physician Decision|0|||
162116193|NCT05044325|585476800|FG004|Part A:Treatment Period 1|Physician Decision|0|||
162116194|NCT05044325|585476801|FG005|Part A:Treatment Period 1|Physician Decision|0|||
162116195|NCT05044325|585476802|FG006|Part A:Treatment Period 1|Physician Decision|1|||
162116196|NCT05044325|585476803|FG007|Part A:Treatment Period 1|Physician Decision|0|||
162116197|NCT05044325|585476804|FG008|Part A:Treatment Period 1|Physician Decision|0|||
162116198|NCT05044325|585476805|FG009|Part A:Treatment Period 1|Physician Decision|0|||
162116199|NCT05044325|585476796|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162116200|NCT05044325|585476797|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162116201|NCT05044325|585476798|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
162116202|NCT05044325|585476799|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162116203|NCT05044325|585476800|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162116204|NCT05044325|585476801|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162116205|NCT05044325|585476802|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162116206|NCT05044325|585476803|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162116207|NCT05044325|585476804|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162116208|NCT05044325|585476805|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
162116209|NCT05044325|585476796|FG000|Part A:Treatment Period 2|Adverse Event|0|||
162116210|NCT05044325|585476797|FG001|Part A:Treatment Period 2|Adverse Event|1|||
162116211|NCT05044325|585476798|FG002|Part A:Treatment Period 2|Adverse Event|0|||
162116212|NCT05044325|585476799|FG003|Part A:Treatment Period 2|Adverse Event|0|||
162116213|NCT05044325|585476800|FG004|Part A:Treatment Period 2|Adverse Event|1|||
162116214|NCT05044325|585476801|FG005|Part A:Treatment Period 2|Adverse Event|1|||
162116215|NCT05044325|585476802|FG006|Part A:Treatment Period 2|Adverse Event|0|||
162116216|NCT05044325|585476803|FG007|Part A:Treatment Period 2|Adverse Event|0|||
162116217|NCT05044325|585476804|FG008|Part A:Treatment Period 2|Adverse Event|0|||
162116218|NCT05044325|585476805|FG009|Part A:Treatment Period 2|Adverse Event|0|||
162116219|NCT05044325|585476796|FG000|Part A:Treatment Period 2|Physician Decision|0|||
162116220|NCT05044325|585476797|FG001|Part A:Treatment Period 2|Physician Decision|0|||
162116221|NCT05044325|585476798|FG002|Part A:Treatment Period 2|Physician Decision|0|||
162116222|NCT05044325|585476799|FG003|Part A:Treatment Period 2|Physician Decision|0|||
162116223|NCT05044325|585476800|FG004|Part A:Treatment Period 2|Physician Decision|0|||
162116224|NCT05044325|585476801|FG005|Part A:Treatment Period 2|Physician Decision|1|||
162116225|NCT05044325|585476802|FG006|Part A:Treatment Period 2|Physician Decision|0|||
162116226|NCT05044325|585476803|FG007|Part A:Treatment Period 2|Physician Decision|0|||
162116227|NCT05044325|585476804|FG008|Part A:Treatment Period 2|Physician Decision|0|||
162116228|NCT05044325|585476805|FG009|Part A:Treatment Period 2|Physician Decision|0|||
162116229|NCT05044325|585476796|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162116230|NCT05044325|585476797|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162116231|NCT05044325|585476798|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162116232|NCT05044325|585476799|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
162116233|NCT05044325|585476800|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
162116234|NCT05044325|585476801|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162116235|NCT05044325|585476802|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162116236|NCT05044325|585476803|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162116237|NCT05044325|585476804|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162116238|NCT05044325|585476805|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
162116239|NCT01373931|585476808|FG000|Lead-in Period|Adverse Event|2|||
162116240|NCT01373931|585476809|FG001|Lead-in Period|Adverse Event|0|||
162116241|NCT01373931|585476808|FG000|Period 1|Adverse Event|2|||
162116242|NCT01373931|585476809|FG001|Period 1|Adverse Event|0|||
162116243|NCT01373931|585476808|FG000|Period 1|Withdrawal by Subject|0|||
162116244|NCT01373931|585476809|FG001|Period 1|Withdrawal by Subject|2|||
162116245|NCT00674323|585476810|FG000|Overall Study|Adverse Event|0|||
162116246|NCT00674323|585476811|FG001|Overall Study|Adverse Event|1|||
162116247|NCT00674323|585476812|FG002|Overall Study|Adverse Event|0|||
162116248|NCT00674323|585476810|FG000|Overall Study|Protocol Violation|1|||
162116249|NCT00674323|585476811|FG001|Overall Study|Protocol Violation|0|||
162116250|NCT00674323|585476812|FG002|Overall Study|Protocol Violation|0|||
162116251|NCT00742079|585476813|FG000|Overall Study|Lost to Follow-up|0|||
162116252|NCT00742079|585476814|FG001|Overall Study|Lost to Follow-up|1|||
162116253|NCT02013388|585476820|FG000|Overall Study|work emergency|1|||
162116254|NCT02013388|585476821|FG001|Overall Study|work emergency|0|||
162116255|NCT02013388|585476822|FG002|Overall Study|work emergency|0|||
162116256|NCT02013388|585476823|FG003|Overall Study|work emergency|0|||
162116257|NCT02013388|585476824|FG004|Overall Study|work emergency|1|||
162116258|NCT02013388|585476825|FG005|Overall Study|work emergency|0|||
162116259|NCT02013388|585476826|FG006|Overall Study|work emergency|0|||
162116260|NCT02013388|585476827|FG007|Overall Study|work emergency|0|||
162116261|NCT01114204|585476831|FG000|Overall Study|Adverse Event|3|||
162116262|NCT01114204|585476832|FG001|Overall Study|Adverse Event|2|||
162116263|NCT01114204|585476831|FG000|Overall Study|Lost to Follow-up|1|||
162116264|NCT01114204|585476832|FG001|Overall Study|Lost to Follow-up|0|||
162116265|NCT01114204|585476831|FG000|Overall Study|Withdrawal by Subject|10|||
162116266|NCT01114204|585476832|FG001|Overall Study|Withdrawal by Subject|6|||
162116267|NCT01114204|585476831|FG000|Overall Study|Death|1|||
162116268|NCT01114204|585476832|FG001|Overall Study|Death|0|||
162116269|NCT01114204|585476831|FG000|Overall Study|Other-Personal reasons|2|||
162116270|NCT01114204|585476832|FG001|Overall Study|Other-Personal reasons|0|||
162116271|NCT01114204|585476831|FG000|Overall Study|Other-Medical monitor request|1|||
162116272|NCT01114204|585476832|FG001|Overall Study|Other-Medical monitor request|0|||
162116273|NCT01114204|585476831|FG000|Overall Study|Other-Participant request|2|||
162116274|NCT01114204|585476832|FG001|Overall Study|Other-Participant request|0|||
162116275|NCT01114204|585476831|FG000|Overall Study|Other-Protocol Violation|1|||
162116276|NCT01114204|585476832|FG001|Overall Study|Other-Protocol Violation|0|||
162116277|NCT00991341|585476837|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
162116278|NCT00991341|585476838|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
162116279|NCT00991341|585476837|FG000|Overall Study|Death|3|||
162116280|NCT00991341|585476838|FG001|Overall Study|Death|0|||
162116281|NCT00991341|585476837|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
162116282|NCT00991341|585476838|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
162116283|NCT00991341|585476837|FG000|Overall Study|Physician Decision|1|||
162116284|NCT00991341|585476838|FG001|Overall Study|Physician Decision|2|||
162116285|NCT00991341|585476837|FG000|Overall Study|Withdrawal by Subject|3|||
162116286|NCT00991341|585476838|FG001|Overall Study|Withdrawal by Subject|4|||
162116287|NCT03145766|585476849|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
162116288|NCT03145766|585476850|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
162116289|NCT03145766|585476851|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
162116290|NCT03145766|585476852|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
162116291|NCT03145766|585476853|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
162116292|NCT03145766|585476849|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
162116293|NCT03145766|585476850|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
162116294|NCT03145766|585476851|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
162116295|NCT03145766|585476852|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
162116296|NCT03145766|585476853|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
162116297|NCT03145766|585476849|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
162116298|NCT03145766|585476850|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
162116299|NCT03145766|585476851|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
162116300|NCT03145766|585476852|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
162116301|NCT03145766|585476853|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
162116302|NCT03145766|585476849|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
162116303|NCT03145766|585476850|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
162116304|NCT03145766|585476851|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
162116305|NCT03145766|585476852|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
162116306|NCT03145766|585476853|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
162116307|NCT03145766|585476849|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
162116308|NCT03145766|585476850|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
162116309|NCT03145766|585476851|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
162116310|NCT03145766|585476852|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
162116311|NCT03145766|585476853|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
162116312|NCT03145766|585476849|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
162116313|NCT03145766|585476850|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
162116314|NCT03145766|585476851|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
162116315|NCT03145766|585476852|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
162116316|NCT03145766|585476853|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
162116317|NCT03145766|585476849|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
162116318|NCT03145766|585476850|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
162116319|NCT03145766|585476851|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
162116320|NCT03145766|585476852|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
162116321|NCT03145766|585476853|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
162116322|NCT03954743|585476854|FG000|Overall Study|Adverse Event|1|||
162116323|NCT03954743|585476855|FG001|Overall Study|Adverse Event|0|||
162116324|NCT03954743|585476854|FG000|Overall Study|Lost to Follow-up|6|||
162116325|NCT03954743|585476855|FG001|Overall Study|Lost to Follow-up|4|||
162116326|NCT03954743|585476854|FG000|Overall Study|Protocol Violation|1|||
162116327|NCT03954743|585476855|FG001|Overall Study|Protocol Violation|0|||
162116328|NCT03954743|585476854|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
162116329|NCT03954743|585476855|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
162116330|NCT03954743|585476854|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
162116331|NCT03954743|585476855|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
162116332|NCT03541044|585476856|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
162116333|NCT03541044|585476857|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
162116334|NCT03541044|585476856|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
162116335|NCT03541044|585476857|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
162116336|NCT01153269|585476858|FG000|Overall Study|Withdrawal by Subject|1|||
162116337|NCT01153269|585476858|FG000|Overall Study|Antiretroviral therapy break|1|||
162116338|NCT02281760|585476869|FG000|Overall Study|Withdrawal by Subject|1|||
162116339|NCT00860067|585476870|FG000|Overall Study|Lost to Follow-up|46|||
162116340|NCT00860067|585476871|FG001|Overall Study|Lost to Follow-up|9|||
162116341|NCT00860067|585476872|FG002|Overall Study|Lost to Follow-up|9|||
162116342|NCT00860067|585476870|FG000|Overall Study|Withdrawal by Subject|4|||
162116343|NCT00860067|585476871|FG001|Overall Study|Withdrawal by Subject|0|||
162116344|NCT00860067|585476872|FG002|Overall Study|Withdrawal by Subject|0|||
162116345|NCT00860067|585476870|FG000|Overall Study|Pregnancy|1|||
162116346|NCT00860067|585476871|FG001|Overall Study|Pregnancy|0|||
162116347|NCT00860067|585476872|FG002|Overall Study|Pregnancy|0|||
162116348|NCT00100932|585476877|FG000|Overall Study|Adverse Event|11|||
162116349|NCT00100932|585476878|FG001|Overall Study|Adverse Event|2|||
162116350|NCT00100932|585476877|FG000|Overall Study|Withdrawal by Subject|6|||
162116351|NCT00100932|585476878|FG001|Overall Study|Withdrawal by Subject|0|||
162116352|NCT00100932|585476877|FG000|Overall Study|Progressive Disease|44|||
162116353|NCT00100932|585476878|FG001|Overall Study|Progressive Disease|18|||
162116354|NCT00100932|585476877|FG000|Overall Study|Physician Decision|7|||
162116355|NCT00100932|585476878|FG001|Overall Study|Physician Decision|5|||
162116356|NCT00100932|585476877|FG000|Overall Study|Other|5|||
162116357|NCT00100932|585476878|FG001|Overall Study|Other|2|||
162116358|NCT02387996|585476881|FG000|Overall Study|Disease Progression|167|||
162116359|NCT02387996|585476881|FG000|Overall Study|Study Drug Toxicity|31|||
162116360|NCT02387996|585476881|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
162116361|NCT02387996|585476881|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
162116362|NCT02387996|585476881|FG000|Overall Study|Subject Withdrew Consent|5|||
162116363|NCT02387996|585476881|FG000|Overall Study|Lost to Follow-up|1|||
162116364|NCT02387996|585476881|FG000|Overall Study|Poor/Non-Compliance|1|||
162116365|NCT02387996|585476881|FG000|Overall Study|Other Reasons|5|||
162116366|NCT02387996|585476881|FG000|Overall Study|Death|1|||
162116367|NCT00770432|585476882|FG000|Overall Study|Other|4|||
162116368|NCT00770432|585476883|FG001|Overall Study|Other|6|||
162116369|NCT00770432|585476882|FG000|Overall Study|Non-compliance|0|||
162116370|NCT00770432|585476883|FG001|Overall Study|Non-compliance|1|||
162116371|NCT00312702|585476884|FG000|Immunization Phase|Lost to Follow-up|0|||
162116372|NCT00312702|585476885|FG001|Immunization Phase|Lost to Follow-up|1|||
162116373|NCT00312702|585476886|FG002|Immunization Phase|Lost to Follow-up|0|||
162116374|NCT01453348|585476887|FG000|Overall Study|Death|0|||
162116375|NCT01453348|585476888|FG001|Overall Study|Death|0|||
162116376|NCT01453348|585476889|FG002|Overall Study|Death|1|||
162116377|NCT01453348|585476887|FG000|Overall Study|Withdrawal by Subject|0|||
162116378|NCT01453348|585476888|FG001|Overall Study|Withdrawal by Subject|1|||
162116379|NCT01453348|585476889|FG002|Overall Study|Withdrawal by Subject|0|||
162116380|NCT01453348|585476887|FG000|Overall Study|Protocol Violation|1|||
162116381|NCT01453348|585476888|FG001|Overall Study|Protocol Violation|0|||
162116382|NCT01453348|585476889|FG002|Overall Study|Protocol Violation|0|||
162116383|NCT00988221|585476890|FG000|Part I|Adverse Event|0|||
162116384|NCT00988221|585476891|FG001|Part I|Adverse Event|1|||
162116385|NCT00988221|585476892|FG002|Part I|Adverse Event|2|||
162116386|NCT00988221|585476893|FG003|Part I|Adverse Event|0|||
162116387|NCT00988221|585476890|FG000|Part I|Insufficient Therapeutic Response|4|||
162116388|NCT00988221|585476891|FG001|Part I|Insufficient Therapeutic Response|6|||
162116389|NCT00988221|585476892|FG002|Part I|Insufficient Therapeutic Response|5|||
162116390|NCT00988221|585476893|FG003|Part I|Insufficient Therapeutic Response|0|||
162116391|NCT00988221|585476890|FG000|Part I|Refused Treatment|0|||
162116392|NCT00988221|585476891|FG001|Part I|Refused Treatment|2|||
162116393|NCT00988221|585476892|FG002|Part I|Refused Treatment|1|||
162116394|NCT00988221|585476893|FG003|Part I|Refused Treatment|0|||
162116395|NCT00988221|585476890|FG000|Part I|Lost to Follow-up|0|||
162116396|NCT00988221|585476891|FG001|Part I|Lost to Follow-up|1|||
162116397|NCT00988221|585476892|FG002|Part I|Lost to Follow-up|0|||
162116398|NCT00988221|585476893|FG003|Part I|Lost to Follow-up|0|||
162116399|NCT00988221|585476890|FG000|Part II|Adverse Event|1|||
162116400|NCT00988221|585476891|FG001|Part II|Adverse Event|0|||
162116401|NCT00988221|585476892|FG002|Part II|Adverse Event|0|||
162116402|NCT00988221|585476893|FG003|Part II|Adverse Event|1|||
162116403|NCT00988221|585476890|FG000|Part II|Withdrawal by Subject|0|||
162116404|NCT00988221|585476891|FG001|Part II|Withdrawal by Subject|0|||
162116405|NCT00988221|585476892|FG002|Part II|Withdrawal by Subject|2|||
162116406|NCT00988221|585476893|FG003|Part II|Withdrawal by Subject|2|||
162116407|NCT00988221|585476890|FG000|Part II|Reason not Specified|0|||
162116408|NCT00988221|585476891|FG001|Part II|Reason not Specified|0|||
162116409|NCT00988221|585476892|FG002|Part II|Reason not Specified|1|||
162116410|NCT00988221|585476893|FG003|Part II|Reason not Specified|0|||
162116411|NCT00988221|585476890|FG000|Part III|Adverse Event|1|||
162116412|NCT00988221|585476891|FG001|Part III|Adverse Event|0|||
162116413|NCT00988221|585476892|FG002|Part III|Adverse Event|1|||
162116414|NCT00988221|585476893|FG003|Part III|Adverse Event|0|||
162116415|NCT00988221|585476890|FG000|Part III|Insufficient Therapeutic Response|0|||
162116416|NCT00988221|585476891|FG001|Part III|Insufficient Therapeutic Response|1|||
162116417|NCT00988221|585476892|FG002|Part III|Insufficient Therapeutic Response|1|||
162116418|NCT00988221|585476893|FG003|Part III|Insufficient Therapeutic Response|0|||
162116419|NCT00988221|585476890|FG000|Part III|Refused Treatment|0|||
162116420|NCT00988221|585476891|FG001|Part III|Refused Treatment|0|||
162116421|NCT00988221|585476892|FG002|Part III|Refused Treatment|1|||
162116422|NCT00988221|585476893|FG003|Part III|Refused Treatment|0|||
162116423|NCT02756832|585476894|FG000|Overall Study|Lost for Observation after Baseline|6|||
162116424|NCT02756832|585476894|FG000|Overall Study|Lost for Observation|13|||
162116425|NCT02756832|585476894|FG000|Overall Study|Patient's Unwillingness|12|||
162116426|NCT02756832|585476894|FG000|Overall Study|Insufficient Efficacy|2|||
162116427|NCT02756832|585476894|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
162116428|NCT02756832|585476894|FG000|Overall Study|Reason not Specified|9|||
162116429|NCT02756832|585476894|FG000|Overall Study|Protocol Deviation|10|||
162116430|NCT01498822|585476896|FG000|Overall Study|Protocol Violation|8|||
162116431|NCT01498822|585476897|FG001|Overall Study|Protocol Violation|4|||
162116432|NCT01498822|585476896|FG000|Overall Study|Other Reason|5|||
162116433|NCT01498822|585476897|FG001|Overall Study|Other Reason|2|||
162116434|NCT01498822|585476896|FG000|Overall Study|Lack of Efficacy|7|||
162116435|NCT01498822|585476897|FG001|Overall Study|Lack of Efficacy|2|||
162116436|NCT01498822|585476896|FG000|Overall Study|AE, non-serious non-fatal|8|||
162116437|NCT01498822|585476897|FG001|Overall Study|AE, non-serious non-fatal|17|||
162116438|NCT01498822|585476896|FG000|Overall Study|SAE, non-fatal|2|||
162116439|NCT01498822|585476897|FG001|Overall Study|SAE, non-fatal|2|||
162116440|NCT01498822|585476896|FG000|Overall Study|Adverse Event, serious fatal|1|||
162116441|NCT01498822|585476897|FG001|Overall Study|Adverse Event, serious fatal|1|||
162116442|NCT01498822|585476896|FG000|Overall Study|Withdrawal by Subject|15|||
162116443|NCT01498822|585476897|FG001|Overall Study|Withdrawal by Subject|25|||
162116444|NCT01498822|585476896|FG000|Overall Study|Lost to Follow-up|8|||
162116445|NCT01498822|585476897|FG001|Overall Study|Lost to Follow-up|3|||
162116446|NCT03592277|585476898|FG000|Overall Study|Withdrawal by Subject|6|||
162116447|NCT03592277|585476899|FG001|Overall Study|Withdrawal by Subject|8|||
162116448|NCT02917265|585476902|FG000|Overall Study|Physician Decision|1|||
162116449|NCT02917265|585476903|FG001|Overall Study|Physician Decision|0|||
162116450|NCT02917265|585476902|FG000|Overall Study|Withdrawal by Subject|1|||
162116451|NCT02917265|585476903|FG001|Overall Study|Withdrawal by Subject|0|||
162116452|NCT00979602|585476916|FG000|Overall Study|Serious Adverse Event|5|||
162116453|NCT00979602|585476917|FG001|Overall Study|Serious Adverse Event|3|||
162116454|NCT00979602|585476916|FG000|Overall Study|Protocol Violation|3|||
162116455|NCT00979602|585476917|FG001|Overall Study|Protocol Violation|0|||
162116456|NCT00979602|585476916|FG000|Overall Study|Withdrawal by Subject|31|||
162116457|NCT00979602|585476917|FG001|Overall Study|Withdrawal by Subject|25|||
162116458|NCT00979602|585476916|FG000|Overall Study|Lost to Follow-up|100|||
162116459|NCT00979602|585476917|FG001|Overall Study|Lost to Follow-up|96|||
162116460|NCT00979602|585476916|FG000|Overall Study|Migrated/moved from study area|3|||
162116461|NCT00979602|585476917|FG001|Overall Study|Migrated/moved from study area|6|||
162116462|NCT00979602|585476916|FG000|Overall Study|Others|3|||
162116463|NCT00979602|585476917|FG001|Overall Study|Others|3|||
162116464|NCT01719237|585476921|FG000|Overall Study|Physician Decision|0|||
162116465|NCT01719237|585476922|FG001|Overall Study|Physician Decision|1|||
162116466|NCT02712398|585476923|FG000|Overall Study|Withdrawal by Subject|6|||
162116467|NCT02712398|585476923|FG000|Overall Study|Lost to Follow-up|6|||
162116468|NCT02712398|585476923|FG000|Overall Study|Sponsor Decision|1|||
162116469|NCT02712398|585476923|FG000|Overall Study|Physician Decision|1|||
162116470|NCT02712398|585476923|FG000|Overall Study|Death|2|||
162116471|NCT02712398|585476923|FG000|Overall Study|Re-operation|21|||
162116472|NCT02002182|585476930|FG000|Overall Study|Withdraw from study|3|||
162116473|NCT02002182|585476931|FG001|Overall Study|Withdraw from study|1|||
162116474|NCT02002182|585476930|FG000|Overall Study|Health Reasons|1|||
162116475|NCT02002182|585476931|FG001|Overall Study|Health Reasons|0|||
162116476|NCT02002182|585476930|FG000|Overall Study|Death|1|||
162116477|NCT02002182|585476931|FG001|Overall Study|Death|0|||
162116478|NCT03787680|585476942|FG000|Overall Study|Physician Decision|2|||
162116479|NCT03787680|585476943|FG001|Overall Study|Physician Decision|3|||
162116480|NCT03787680|585476942|FG000|Overall Study|Adverse Event|7|||
162116481|NCT03787680|585476943|FG001|Overall Study|Adverse Event|3|||
162116482|NCT03787680|585476942|FG000|Overall Study|Withdrawal by Subject|2|||
162116483|NCT03787680|585476943|FG001|Overall Study|Withdrawal by Subject|1|||
162116484|NCT05454410|585476946|FG000|Overall Study|Withdrawal by Subject|0|||
162116485|NCT05454410|585476947|FG001|Overall Study|Withdrawal by Subject|0|||
162116486|NCT05454410|585476948|FG002|Overall Study|Withdrawal by Subject|1|||
162116487|NCT05454410|585476949|FG003|Overall Study|Withdrawal by Subject|1|||
162116488|NCT00895622|585476950|FG000|Overall Study|Protocol Violation|5|||
162116489|NCT00895622|585476951|FG001|Overall Study|Protocol Violation|4|||
162116490|NCT00895622|585476952|FG002|Overall Study|Protocol Violation|4|||
162116491|NCT03635489|585476960|FG000|Overall Study|Death|19|||
162116492|NCT03635489|585476961|FG001|Overall Study|Death|13|||
162116493|NCT03635489|585476960|FG000|Overall Study|Lost to Follow-up|1|||
162116494|NCT03635489|585476961|FG001|Overall Study|Lost to Follow-up|2|||
162116495|NCT03635489|585476960|FG000|Overall Study|Withdrawal by Subject|1|||
162116496|NCT03635489|585476961|FG001|Overall Study|Withdrawal by Subject|2|||
162116497|NCT03635489|585476960|FG000|Overall Study|Study Ended by Sponsor|28|||
162116498|NCT03635489|585476961|FG001|Overall Study|Study Ended by Sponsor|34|||
162116499|NCT01368900|585476962|FG000|Overall Study|Lost to Follow-up|7|||
162116500|NCT04027348|585476967|FG000|Overall Study|Adverse Event|2|||
162116501|NCT02487472|585476968|FG000|Overall Study|Did not complete telephonic interviews|9|||
162116502|NCT02487472|585476968|FG000|Overall Study|Other|2|||
162116503|NCT01313286|585476969|FG000|Period 1|Withdrawal by Subject|2|||
162116504|NCT01313286|585476970|FG001|Period 1|Withdrawal by Subject|0|||
162116505|NCT00311155|585478717|FG000|Overall Study|Adverse Event|21|||
162116506|NCT00311155|585478717|FG000|Overall Study|Withdrawal by Subject|17|||
162116507|NCT00311155|585478717|FG000|Overall Study|Did not meet entry criteria|55|||
162116508|NCT00429494|585478719|FG000|Overall Study|Withdrawal by Subject|9|||
162116509|NCT00429494|585478719|FG000|Overall Study|Death|6|||
162116510|NCT00976703|585478722|FG000|Overall Study|Physician Decision|1|||
162116511|NCT00976703|585478723|FG001|Overall Study|Physician Decision|1|||
162116512|NCT00976703|585478722|FG000|Overall Study|ineligible for study|2|||
162116513|NCT00976703|585478723|FG001|Overall Study|ineligible for study|2|||
162116514|NCT02243631|585478727|FG000|Overall Study|no synovial fluid on second aspirate|0|||
162116515|NCT02243631|585478728|FG001|Overall Study|no synovial fluid on second aspirate|1|||
162116516|NCT01992549|585478731|FG000|Overall Study|Lost to Follow-up|2|||
162116517|NCT01992549|585478731|FG000|Overall Study|Serious Adverse Event|1|||
162116518|NCT01992549|585478731|FG000|Overall Study|Product Switch to Extend Half Life|1|||
162116519|NCT01590771|585478732|FG000|Overall Study|Other Protocol Specified Criteria|5|||
162116520|NCT01590771|585478733|FG001|Overall Study|Other Protocol Specified Criteria|14|||
162116521|NCT01590771|585478732|FG000|Overall Study|Withdrawal by Subject|8|||
162116522|NCT01590771|585478733|FG001|Overall Study|Withdrawal by Subject|15|||
162116523|NCT01590771|585478732|FG000|Overall Study|Protocol Violation|1|||
162116524|NCT01590771|585478733|FG001|Overall Study|Protocol Violation|2|||
162116525|NCT01590771|585478732|FG000|Overall Study|Lost to Follow-up|1|||
162116526|NCT01590771|585478733|FG001|Overall Study|Lost to Follow-up|1|||
162116527|NCT01590771|585478732|FG000|Overall Study|Lack of Efficacy|1|||
162116528|NCT01590771|585478733|FG001|Overall Study|Lack of Efficacy|0|||
162116529|NCT01590771|585478732|FG000|Overall Study|Adverse Event|3|||
162116530|NCT01590771|585478733|FG001|Overall Study|Adverse Event|7|||
162116531|NCT01785628|585478734|FG000|Overall Study|Lost to Follow-up|2|||
162116532|NCT01785628|585478735|FG001|Overall Study|Lost to Follow-up|3|||
162116533|NCT01250119|585478744|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
162116534|NCT01250119|585478745|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
162116535|NCT01250119|585478744|FG000|Diagnostic Phase|Participants Not Tested|44|||
162116536|NCT01250119|585478745|FG001|Diagnostic Phase|Participants Not Tested|0|||
162116537|NCT01250119|585478744|FG000|Treatment Phase|Progressive Disease|0|||
162116538|NCT01250119|585478745|FG001|Treatment Phase|Progressive Disease|32|||
162116539|NCT01250119|585478744|FG000|Treatment Phase|Death|0|||
162116540|NCT01250119|585478745|FG001|Treatment Phase|Death|2|||
162116541|NCT01250119|585478744|FG000|Treatment Phase|Withdrawal by Subject|0|||
162116542|NCT01250119|585478745|FG001|Treatment Phase|Withdrawal by Subject|1|||
162116543|NCT01250119|585478744|FG000|Treatment Phase|Adverse Event|0|||
162116544|NCT01250119|585478745|FG001|Treatment Phase|Adverse Event|2|||
162116545|NCT01250119|585478744|FG000|Treatment Phase|Unknown reason|0|||
162116546|NCT01250119|585478745|FG001|Treatment Phase|Unknown reason|4|||
162116547|NCT02045433|585478751|FG000|Overall Study|Withdrawal by Subject|1|||
162116548|NCT01559454|585478752|FG000|Overall Study|Lost to Follow-up|3|||
162116549|NCT01559454|585478753|FG001|Overall Study|Lost to Follow-up|2|||
162116550|NCT01559454|585478752|FG000|Overall Study|Withdrawal by Subject|0|||
162116551|NCT01559454|585478753|FG001|Overall Study|Withdrawal by Subject|1|||
162116552|NCT01559454|585478752|FG000|Overall Study|Physician Decision|0|||
162116553|NCT01559454|585478753|FG001|Overall Study|Physician Decision|1|||
162116554|NCT01559454|585478752|FG000|Overall Study|Protocol Violation|0|||
162116555|NCT01559454|585478753|FG001|Overall Study|Protocol Violation|1|||
162116556|NCT01559454|585478752|FG000|Overall Study|Lack of Efficacy|0|||
162116557|NCT01559454|585478753|FG001|Overall Study|Lack of Efficacy|1|||
162116558|NCT00462670|585478759|FG000|Overall Study|Adverse Event|3|||
162116559|NCT00462670|585478760|FG001|Overall Study|Adverse Event|5|||
162116560|NCT00462670|585478759|FG000|Overall Study|Lack of Efficacy|1|||
162116561|NCT00462670|585478760|FG001|Overall Study|Lack of Efficacy|0|||
162116562|NCT00462670|585478759|FG000|Overall Study|Protocol Violation|1|||
162116563|NCT00462670|585478760|FG001|Overall Study|Protocol Violation|0|||
162116564|NCT00462670|585478759|FG000|Overall Study|Resolution of signs and symptoms|0|||
162116565|NCT00462670|585478760|FG001|Overall Study|Resolution of signs and symptoms|2|||
162116566|NCT00482274|585478765|FG000|Overall Study|Adverse Event|1|||
162116567|NCT02396537|585478766|FG000|Overall Study|Protocol Violation|0|||
162116568|NCT02396537|585478767|FG001|Overall Study|Protocol Violation|1|||
162116569|NCT02948959|585478771|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
162116570|NCT02948959|585478772|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
162116571|NCT02948959|585478771|FG000|52 Weeks Treatment Period|Adverse Event|2|||
162116572|NCT02948959|585478772|FG001|52 Weeks Treatment Period|Adverse Event|5|||
162116573|NCT02948959|585478771|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
162116574|NCT02948959|585478772|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
162116575|NCT02948959|585478771|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
162116576|NCT02948959|585478772|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
162116577|NCT02948959|585478771|FG000|52 Weeks Treatment Period|Randomized by error|0|||
162116578|NCT02948959|585478772|FG001|52 Weeks Treatment Period|Randomized by error|5|||
162116579|NCT02948959|585478771|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
162116580|NCT02948959|585478772|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
162116581|NCT02948959|585478771|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
162116582|NCT02948959|585478772|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
162116583|NCT02948959|585478771|FG000|52 Weeks Treatment Period|Change of residence location|0|||
162116584|NCT02948959|585478772|FG001|52 Weeks Treatment Period|Change of residence location|1|||
162116585|NCT02948959|585478771|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
162116586|NCT02948959|585478772|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
162116587|NCT02948959|585478771|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
162116588|NCT02948959|585478772|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
162116589|NCT02948959|585478771|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
162116590|NCT02948959|585478772|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
162116591|NCT02948959|585478771|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
162116592|NCT02948959|585478772|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
162116593|NCT02948959|585478771|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
162116594|NCT02948959|585478772|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
162116595|NCT02948959|585478771|FG000|12 Weeks Follow-up Period|Study site closure|1|||
162116596|NCT02948959|585478772|FG001|12 Weeks Follow-up Period|Study site closure|0|||
162116597|NCT00787319|585478773|FG000|Overall Study|Lost to Follow-up|2|||
162116598|NCT00787319|585478773|FG000|Overall Study|Withdrawal by Subject|15|||
162116599|NCT00787319|585478773|FG000|Overall Study|Adverse Event|3|||
162116600|NCT00787319|585478773|FG000|Overall Study|Objective progression or relapse|30|||
162116601|NCT00787319|585478773|FG000|Overall Study|Lack of Efficacy|1|||
162116602|NCT00787319|585478773|FG000|Overall Study|Budget exhausted/exceeded|1|||
162116603|NCT00787319|585478773|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
162116604|NCT00787319|585478773|FG000|Overall Study|No health insurance reimbursement|2|||
162116605|NCT00787319|585478773|FG000|Overall Study|Stabilized disease findings|3|||
162116606|NCT00787319|585478773|FG000|Overall Study|Inactive disease|5|||
162116607|NCT01932294|585478774|FG000|Overall Study|Death|43|||
162116608|NCT01932294|585478774|FG000|Overall Study|Lost to Follow-up|8|||
162116609|NCT01932294|585478774|FG000|Overall Study|VAD Implantation|20|||
162116610|NCT01932294|585478774|FG000|Overall Study|Heart Transplantation|16|||
162116611|NCT01932294|585478774|FG000|Overall Study|Transferred to other hospitals|12|||
162116612|NCT00409786|585478778|FG000|Overall Study|Withdrawal by Subject|3|||
162116613|NCT03075904|585478785|FG000|Overall Study|Physician Decision|3|||
162116614|NCT03075904|585478785|FG000|Overall Study|Need for Medication not Permitted|1|||
162116615|NCT00597714|585478786|FG000|Overall Study|Death|56|||
162116616|NCT00597714|585478787|FG001|Overall Study|Death|46|||
162116617|NCT00597714|585478788|FG002|Overall Study|Death|0|||
162116618|NCT00597714|585478786|FG000|Overall Study|Recipient death|0|||
162116619|NCT00597714|585478787|FG001|Overall Study|Recipient death|0|||
162116620|NCT00597714|585478788|FG002|Overall Study|Recipient death|10|||
162116621|NCT02228395|585478789|FG000|First Intervention Period|No longer willing to participate|1|||
162116622|NCT02228395|585478790|FG001|First Intervention Period|No longer willing to participate|0|||
162116623|NCT02228395|585478791|FG002|First Intervention Period|No longer willing to participate|0|||
162116624|NCT02228395|585478789|FG000|First Intervention Period|Unable to comply with study dates|0|||
162116625|NCT02228395|585478790|FG001|First Intervention Period|Unable to comply with study dates|1|||
162116626|NCT02228395|585478791|FG002|First Intervention Period|Unable to comply with study dates|1|||
162116627|NCT02424591|585478796|FG000|Overall Study|Protocol Violation|2|||
162116628|NCT02424591|585478797|FG001|Overall Study|Protocol Violation|3|||
162116629|NCT04772053|585478810|FG000|Overall Study|Physician Decision|2|||
162116630|NCT04772053|585478810|FG000|Overall Study|Withdrawal by Subject|3|||
162116631|NCT04772053|585478810|FG000|Overall Study|Study Terminated by Sponsor|1|||
162116632|NCT04146896|585478815|FG000|Overall Study|Adverse Event|5|||
162116633|NCT04146896|585478816|FG001|Overall Study|Adverse Event|8|||
162116634|NCT04146896|585478815|FG000|Overall Study|Lack of Efficacy|3|||
162116635|NCT04146896|585478816|FG001|Overall Study|Lack of Efficacy|2|||
162116636|NCT04146896|585478815|FG000|Overall Study|Lost to Follow-up|0|||
162116637|NCT04146896|585478816|FG001|Overall Study|Lost to Follow-up|1|||
162116638|NCT04146896|585478815|FG000|Overall Study|Non-compliance|5|||
162116639|NCT04146896|585478816|FG001|Overall Study|Non-compliance|4|||
162116640|NCT04146896|585478815|FG000|Overall Study|Withdrawal by Subject|3|||
162116641|NCT04146896|585478816|FG001|Overall Study|Withdrawal by Subject|5|||
162116642|NCT04146896|585478815|FG000|Overall Study|Randomized in error|1|||
162116643|NCT04146896|585478816|FG001|Overall Study|Randomized in error|2|||
162116644|NCT03107377|585478817|FG000|Overall Study|Adverse Event|3|||
162116645|NCT03107377|585478818|FG001|Overall Study|Adverse Event|3|||
162116646|NCT03107377|585478817|FG000|Overall Study|Protocol Violation|9|||
162116647|NCT03107377|585478818|FG001|Overall Study|Protocol Violation|12|||
162116648|NCT03107377|585478817|FG000|Overall Study|Physician Decision|3|||
162116649|NCT03107377|585478818|FG001|Overall Study|Physician Decision|6|||
162116650|NCT03107377|585478817|FG000|Overall Study|Pregnancy|7|||
162116651|NCT03107377|585478818|FG001|Overall Study|Pregnancy|7|||
162116652|NCT03107377|585478817|FG000|Overall Study|Withdrawal by Subject|16|||
162116653|NCT03107377|585478818|FG001|Overall Study|Withdrawal by Subject|22|||
162116654|NCT03107377|585478817|FG000|Overall Study|Lost to Follow-up|37|||
162116655|NCT03107377|585478818|FG001|Overall Study|Lost to Follow-up|34|||
162116656|NCT03107377|585478817|FG000|Overall Study|Other reason not specified|16|||
162116657|NCT03107377|585478818|FG001|Overall Study|Other reason not specified|15|||
162116658|NCT01597505|585478819|FG000|Overall Study|Physician Decision|5|||
162116659|NCT01597505|585478820|FG001|Overall Study|Physician Decision|0|||
162116660|NCT01597505|585478819|FG000|Overall Study|Adverse Event|19|||
162116661|NCT01597505|585478820|FG001|Overall Study|Adverse Event|7|||
162116662|NCT01597505|585478819|FG000|Overall Study|Lost to Follow-up|4|||
162116663|NCT01597505|585478820|FG001|Overall Study|Lost to Follow-up|2|||
162116664|NCT01597505|585478819|FG000|Overall Study|Withdrawal by Subject|10|||
162116665|NCT01597505|585478820|FG001|Overall Study|Withdrawal by Subject|18|||
162116666|NCT01597505|585478819|FG000|Overall Study|Other|5|||
162116667|NCT01597505|585478820|FG001|Overall Study|Other|6|||
162116668|NCT01597505|585478819|FG000|Overall Study|Missing|1|||
162116669|NCT01597505|585478820|FG001|Overall Study|Missing|0|||
162116670|NCT02675465|585478822|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
162116671|NCT02675465|585478823|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
162116672|NCT02675465|585478824|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
162116673|NCT02675465|585478825|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
162116674|NCT02675465|585478826|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
162116675|NCT02675465|585478827|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
162116676|NCT02675465|585478822|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
162116677|NCT02675465|585478823|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
162116678|NCT02675465|585478824|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
162116679|NCT02675465|585478825|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
162116680|NCT02675465|585478826|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
162116681|NCT02675465|585478827|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
162116682|NCT02675465|585478822|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
162116683|NCT02675465|585478823|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
162116684|NCT02675465|585478824|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
162116685|NCT02675465|585478825|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
162116686|NCT02675465|585478826|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
162116687|NCT02675465|585478827|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
162116688|NCT02675465|585478822|FG000|Stage 4: Long Term Extension|Death|0|||
162116689|NCT02675465|585478823|FG001|Stage 4: Long Term Extension|Death|0|||
162116690|NCT02675465|585478824|FG002|Stage 4: Long Term Extension|Death|0|||
162116691|NCT02675465|585478825|FG003|Stage 4: Long Term Extension|Death|1|||
162116692|NCT02675465|585478826|FG004|Stage 4: Long Term Extension|Death|0|||
162116693|NCT02675465|585478827|FG005|Stage 4: Long Term Extension|Death|0|||
162116694|NCT00453102|585478828|FG000|Overall Study|Withdrawal by Subject|2|||
162116695|NCT05031078|585478829|FG000|Overall Study|Withdrawal by Subject|0|||
162116696|NCT05031078|585478830|FG001|Overall Study|Withdrawal by Subject|1|||
162116697|NCT05031078|585478831|FG002|Overall Study|Withdrawal by Subject|0|||
162116698|NCT03728972|585478832|FG000|Overall Study|Death|1|||
162116699|NCT03728972|585478833|FG001|Overall Study|Death|0|||
162116700|NCT03728972|585478832|FG000|Overall Study|Lack of Efficacy|1|||
162116701|NCT03728972|585478833|FG001|Overall Study|Lack of Efficacy|0|||
162116702|NCT03728972|585478832|FG000|Overall Study|Physician Decision|3|||
162116703|NCT03728972|585478833|FG001|Overall Study|Physician Decision|0|||
162116704|NCT03728972|585478832|FG000|Overall Study|Disease progression|4|||
162116705|NCT03728972|585478833|FG001|Overall Study|Disease progression|3|||
162116706|NCT01320943|585478838|FG000|Overall Study|Lost to Follow-up|1|||
162116707|NCT01320943|585478839|FG001|Overall Study|Lost to Follow-up|0|||
162116708|NCT01320943|585478838|FG000|Overall Study|Physician Decision|0|||
162116709|NCT01320943|585478839|FG001|Overall Study|Physician Decision|1|||
162116710|NCT01320943|585478838|FG000|Overall Study|Randomized but not Treated|0|||
162116711|NCT01320943|585478839|FG001|Overall Study|Randomized but not Treated|1|||
162116712|NCT01490125|585478840|FG000|Period I|Adverse Event|4|||
162116713|NCT01490125|585478841|FG001|Period I|Adverse Event|1|||
162116714|NCT01490125|585478842|FG002|Period I|Adverse Event|1|||
162116715|NCT01490125|585478843|FG003|Period I|Adverse Event|3|||
162116716|NCT01490125|585478844|FG004|Period I|Adverse Event|2|||
162116717|NCT01490125|585478845|FG005|Period I|Adverse Event|4|||
162116718|NCT01490125|585478840|FG000|Period I|Protocol Violation|1|||
162116719|NCT01490125|585478841|FG001|Period I|Protocol Violation|1|||
162116720|NCT01490125|585478842|FG002|Period I|Protocol Violation|1|||
162116721|NCT01490125|585478843|FG003|Period I|Protocol Violation|1|||
162116722|NCT01490125|585478844|FG004|Period I|Protocol Violation|0|||
162116723|NCT01490125|585478845|FG005|Period I|Protocol Violation|0|||
162116724|NCT01490125|585478840|FG000|Period I|Withdrawal by Subject|1|||
162116725|NCT01490125|585478841|FG001|Period I|Withdrawal by Subject|3|||
162116726|NCT01490125|585478842|FG002|Period I|Withdrawal by Subject|2|||
162116727|NCT01490125|585478843|FG003|Period I|Withdrawal by Subject|1|||
162116728|NCT01490125|585478844|FG004|Period I|Withdrawal by Subject|2|||
162116729|NCT01490125|585478845|FG005|Period I|Withdrawal by Subject|1|||
162116730|NCT01490125|585478840|FG000|Period II|Adverse Event|2|||
162116731|NCT01490125|585478841|FG001|Period II|Adverse Event|3|||
162116732|NCT01490125|585478842|FG002|Period II|Adverse Event|2|||
162116733|NCT01490125|585478843|FG003|Period II|Adverse Event|2|||
162116734|NCT01490125|585478844|FG004|Period II|Adverse Event|4|||
162116735|NCT01490125|585478845|FG005|Period II|Adverse Event|2|||
162116736|NCT01490125|585478840|FG000|Period II|Protocol Violation|0|||
162116737|NCT01490125|585478841|FG001|Period II|Protocol Violation|0|||
162116738|NCT01490125|585478842|FG002|Period II|Protocol Violation|1|||
162116739|NCT01490125|585478843|FG003|Period II|Protocol Violation|1|||
162116740|NCT01490125|585478844|FG004|Period II|Protocol Violation|0|||
162116741|NCT01490125|585478845|FG005|Period II|Protocol Violation|0|||
162116742|NCT01490125|585478840|FG000|Period II|Lost to Follow-up|0|||
162116743|NCT01490125|585478841|FG001|Period II|Lost to Follow-up|1|||
162116744|NCT01490125|585478842|FG002|Period II|Lost to Follow-up|0|||
162116745|NCT01490125|585478843|FG003|Period II|Lost to Follow-up|0|||
162116746|NCT01490125|585478844|FG004|Period II|Lost to Follow-up|0|||
162116747|NCT01490125|585478845|FG005|Period II|Lost to Follow-up|0|||
162116748|NCT01490125|585478840|FG000|Period II|Withdrawal by Subject|1|||
162116749|NCT01490125|585478841|FG001|Period II|Withdrawal by Subject|0|||
162116750|NCT01490125|585478842|FG002|Period II|Withdrawal by Subject|0|||
162116751|NCT01490125|585478843|FG003|Period II|Withdrawal by Subject|0|||
162116752|NCT01490125|585478844|FG004|Period II|Withdrawal by Subject|0|||
162116753|NCT01490125|585478845|FG005|Period II|Withdrawal by Subject|0|||
162116754|NCT01490125|585478840|FG000|Period III|Adverse Event|3|||
162116755|NCT01490125|585478841|FG001|Period III|Adverse Event|1|||
162116756|NCT01490125|585478842|FG002|Period III|Adverse Event|0|||
162116757|NCT01490125|585478843|FG003|Period III|Adverse Event|1|||
162116758|NCT01490125|585478844|FG004|Period III|Adverse Event|0|||
162116759|NCT01490125|585478845|FG005|Period III|Adverse Event|0|||
162116760|NCT01490125|585478840|FG000|Period III|Death|0|||
162116761|NCT01490125|585478841|FG001|Period III|Death|0|||
162116762|NCT01490125|585478842|FG002|Period III|Death|0|||
162116763|NCT01490125|585478843|FG003|Period III|Death|1|||
162116764|NCT01490125|585478844|FG004|Period III|Death|0|||
162116765|NCT01490125|585478845|FG005|Period III|Death|0|||
162116766|NCT01490125|585478840|FG000|Period III|Lack of Efficacy|0|||
162116767|NCT01490125|585478841|FG001|Period III|Lack of Efficacy|0|||
162116768|NCT01490125|585478842|FG002|Period III|Lack of Efficacy|0|||
162116769|NCT01490125|585478843|FG003|Period III|Lack of Efficacy|0|||
162116770|NCT01490125|585478844|FG004|Period III|Lack of Efficacy|1|||
162116771|NCT01490125|585478845|FG005|Period III|Lack of Efficacy|0|||
162116772|NCT04522180|585478846|FG000|Overall Study|Investigator judgement|3|||
162116773|NCT04522180|585478847|FG001|Overall Study|Investigator judgement|4|||
162116774|NCT04522180|585478846|FG000|Overall Study|Voluntary withdrawal|1|||
162116775|NCT04522180|585478847|FG001|Overall Study|Voluntary withdrawal|0|||
162116776|NCT04522180|585478846|FG000|Overall Study|Pregnancy|0|||
162116777|NCT04522180|585478847|FG001|Overall Study|Pregnancy|1|||
162116778|NCT04522180|585478846|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
162116779|NCT04522180|585478847|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
162116780|NCT04522180|585478846|FG000|Overall Study|Reason not specified|8|||
162116781|NCT04522180|585478847|FG001|Overall Study|Reason not specified|5|||
162116782|NCT02010632|585478848|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
162116783|NCT02010632|585478849|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
162116784|NCT02404389|585478850|FG000|Overall Study|Adverse Event|1|||
162116785|NCT02404389|585478851|FG001|Overall Study|Adverse Event|0|||
162116786|NCT02404389|585478852|FG002|Overall Study|Adverse Event|1|||
162116787|NCT02404389|585478853|FG003|Overall Study|Adverse Event|0|||
162116788|NCT02404389|585478854|FG004|Overall Study|Adverse Event|2|||
162116789|NCT02404389|585478850|FG000|Overall Study|Subject/guardian decision|1|||
162116790|NCT02404389|585478851|FG001|Overall Study|Subject/guardian decision|0|||
162116791|NCT02404389|585478852|FG002|Overall Study|Subject/guardian decision|0|||
162116792|NCT02404389|585478853|FG003|Overall Study|Subject/guardian decision|1|||
162116793|NCT02404389|585478854|FG004|Overall Study|Subject/guardian decision|1|||
162116794|NCT01919970|585478860|FG000|Overall Study|Withdrawal by Subject|3|||
162116795|NCT01919970|585478861|FG001|Overall Study|Withdrawal by Subject|0|||
162116796|NCT00990340|585478862|FG000|First 14-day Treatment|Not Compliant|2|||
162116797|NCT00990340|585478863|FG001|First 14-day Treatment|Not Compliant|1|||
162116798|NCT00990340|585478862|FG000|First 14-day Treatment|Lost to Follow-up|2|||
162116799|NCT00990340|585478863|FG001|First 14-day Treatment|Lost to Follow-up|1|||
162116800|NCT00990340|585478862|FG000|First 14-day Treatment|Protocol Violation|2|||
162116801|NCT00990340|585478863|FG001|First 14-day Treatment|Protocol Violation|2|||
162116802|NCT04615182|585478864|FG000|Overall Study|Re-transplanted|2|||
162116803|NCT04615182|585478864|FG000|Overall Study|Protocol Violation|6|||
162116804|NCT04615182|585478864|FG000|Overall Study|Death|6|||
162116805|NCT04615182|585478864|FG000|Overall Study|Death and protocol violation|1|||
162116806|NCT01126060|585478865|FG000|Overall Study|Protocol Violation|0|||
162116807|NCT01126060|585478866|FG001|Overall Study|Protocol Violation|2|||
162116808|NCT03565068|585478867|FG000|Overall Study|Protocol Violation|0|||
162116809|NCT03565068|585478868|FG001|Overall Study|Protocol Violation|0|||
162116810|NCT03565068|585478869|FG002|Overall Study|Protocol Violation|0|||
162116811|NCT03565068|585478870|FG003|Overall Study|Protocol Violation|0|||
162116812|NCT03565068|585478871|FG004|Overall Study|Protocol Violation|1|||
162116813|NCT03565068|585478872|FG005|Overall Study|Protocol Violation|0|||
162116814|NCT03565068|585478873|FG006|Overall Study|Protocol Violation|0|||
162116815|NCT03565068|585478874|FG007|Overall Study|Protocol Violation|1|||
162116816|NCT03565068|585478875|FG008|Overall Study|Protocol Violation|0|||
162116817|NCT03565068|585478867|FG000|Overall Study|Sponsor decision|0|||
162116818|NCT03565068|585478868|FG001|Overall Study|Sponsor decision|0|||
162116819|NCT03565068|585478869|FG002|Overall Study|Sponsor decision|0|||
162116820|NCT03565068|585478870|FG003|Overall Study|Sponsor decision|0|||
162116821|NCT03565068|585478871|FG004|Overall Study|Sponsor decision|1|||
162116822|NCT03565068|585478872|FG005|Overall Study|Sponsor decision|1|||
162116823|NCT03565068|585478873|FG006|Overall Study|Sponsor decision|0|||
162116824|NCT03565068|585478874|FG007|Overall Study|Sponsor decision|0|||
162116825|NCT03565068|585478875|FG008|Overall Study|Sponsor decision|0|||
162116826|NCT03565068|585478867|FG000|Overall Study|Withdrawal by Subject|0|||
162116827|NCT03565068|585478868|FG001|Overall Study|Withdrawal by Subject|0|||
162116828|NCT03565068|585478869|FG002|Overall Study|Withdrawal by Subject|1|||
162116829|NCT03565068|585478870|FG003|Overall Study|Withdrawal by Subject|0|||
162116830|NCT03565068|585478871|FG004|Overall Study|Withdrawal by Subject|2|||
162116831|NCT03565068|585478872|FG005|Overall Study|Withdrawal by Subject|0|||
162116832|NCT03565068|585478873|FG006|Overall Study|Withdrawal by Subject|1|||
162116833|NCT03565068|585478874|FG007|Overall Study|Withdrawal by Subject|5|||
162116834|NCT03565068|585478875|FG008|Overall Study|Withdrawal by Subject|1|||
162116835|NCT03565068|585478867|FG000|Overall Study|Physician Decision|0|||
162116836|NCT03565068|585478868|FG001|Overall Study|Physician Decision|0|||
162116837|NCT03565068|585478869|FG002|Overall Study|Physician Decision|0|||
162116838|NCT03565068|585478870|FG003|Overall Study|Physician Decision|0|||
162116839|NCT03565068|585478871|FG004|Overall Study|Physician Decision|0|||
162116840|NCT03565068|585478872|FG005|Overall Study|Physician Decision|0|||
162116841|NCT03565068|585478873|FG006|Overall Study|Physician Decision|0|||
162116842|NCT03565068|585478874|FG007|Overall Study|Physician Decision|1|||
162116843|NCT03565068|585478875|FG008|Overall Study|Physician Decision|0|||
162116844|NCT03565068|585478867|FG000|Overall Study|Lost to Follow-up|0|||
162116845|NCT03565068|585478868|FG001|Overall Study|Lost to Follow-up|0|||
162116846|NCT03565068|585478869|FG002|Overall Study|Lost to Follow-up|0|||
162116847|NCT03565068|585478870|FG003|Overall Study|Lost to Follow-up|0|||
162116848|NCT03565068|585478871|FG004|Overall Study|Lost to Follow-up|0|||
162116849|NCT03565068|585478872|FG005|Overall Study|Lost to Follow-up|0|||
162116850|NCT03565068|585478873|FG006|Overall Study|Lost to Follow-up|0|||
162116851|NCT03565068|585478874|FG007|Overall Study|Lost to Follow-up|1|||
162116852|NCT03565068|585478875|FG008|Overall Study|Lost to Follow-up|0|||
162116853|NCT03285295|585481257|FG000|Alinity s HBsAg|Protocol Violation|11|||
162116854|NCT03285295|585481258|FG001|Alinity s HBsAg|Protocol Violation|0|||
162116855|NCT03285295|585481259|FG002|Alinity s HBsAg|Protocol Violation|0|||
162116856|NCT03285295|585481260|FG003|Alinity s HBsAg|Protocol Violation|0|||
162116857|NCT03285295|585481261|FG004|Alinity s HBsAg|Protocol Violation|0|||
162116858|NCT03285295|585481257|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
162116859|NCT03285295|585481258|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
162116860|NCT03285295|585481259|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
162116861|NCT03285295|585481260|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
162116862|NCT03285295|585481261|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
162116863|NCT03285295|585481257|FG000|Alinity s HBsAg|No Results Generated|74|||
162116864|NCT03285295|585481258|FG001|Alinity s HBsAg|No Results Generated|6|||
162116865|NCT03285295|585481259|FG002|Alinity s HBsAg|No Results Generated|0|||
162116866|NCT03285295|585481260|FG003|Alinity s HBsAg|No Results Generated|0|||
162116867|NCT03285295|585481261|FG004|Alinity s HBsAg|No Results Generated|0|||
162116868|NCT03285295|585481257|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
162116869|NCT03285295|585481258|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
162116870|NCT03285295|585481259|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
162116871|NCT03285295|585481260|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
162116872|NCT03285295|585481261|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
162116873|NCT03285295|585481257|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
162116874|NCT03285295|585481258|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
162116875|NCT03285295|585481259|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
162116876|NCT03285295|585481260|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
162116877|NCT03285295|585481261|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
162116878|NCT03285295|585481257|FG000|Alinity s HTLV I/II|No Results Generated|70|||
162116879|NCT03285295|585481258|FG001|Alinity s HTLV I/II|No Results Generated|0|||
162116880|NCT03285295|585481259|FG002|Alinity s HTLV I/II|No Results Generated|0|||
162116881|NCT03285295|585481260|FG003|Alinity s HTLV I/II|No Results Generated|0|||
162116882|NCT03285295|585481261|FG004|Alinity s HTLV I/II|No Results Generated|0|||
162116883|NCT03285295|585481257|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
162116884|NCT03285295|585481258|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
162116885|NCT03285295|585481259|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
162116886|NCT03285295|585481260|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
162116887|NCT03285295|585481261|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
162116888|NCT03285295|585481257|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
162116889|NCT03285295|585481258|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
162116890|NCT03285295|585481259|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
162116891|NCT03285295|585481260|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
162116892|NCT03285295|585481261|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
162116893|NCT03285295|585481257|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
162116894|NCT03285295|585481258|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
162116895|NCT03285295|585481259|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
162116896|NCT03285295|585481260|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
162116897|NCT03285295|585481261|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
162116898|NCT03285295|585481257|FG000|Alinity s Anti-HCV|No Results Generated|71|||
162116899|NCT03285295|585481258|FG001|Alinity s Anti-HCV|No Results Generated|0|||
162116900|NCT03285295|585481259|FG002|Alinity s Anti-HCV|No Results Generated|0|||
162116901|NCT03285295|585481260|FG003|Alinity s Anti-HCV|No Results Generated|0|||
162116902|NCT03285295|585481261|FG004|Alinity s Anti-HCV|No Results Generated|0|||
162116903|NCT03285295|585481257|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
162116904|NCT03285295|585481258|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
162116905|NCT03285295|585481259|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
162116906|NCT03285295|585481260|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
162116907|NCT03285295|585481261|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
162116908|NCT03285295|585481257|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
162116909|NCT03285295|585481258|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
162116910|NCT03285295|585481259|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
162116911|NCT03285295|585481260|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
162116912|NCT03285295|585481261|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
162116913|NCT03285295|585481257|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
162116914|NCT03285295|585481258|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
162116915|NCT03285295|585481259|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
162116916|NCT03285295|585481260|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
162116917|NCT03285295|585481261|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
162116918|NCT03285295|585481257|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
162116919|NCT03285295|585481258|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
162116920|NCT03285295|585481259|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
162116921|NCT03285295|585481260|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
162116922|NCT03285295|585481261|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
162116923|NCT03285295|585481257|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
162116924|NCT03285295|585481258|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
162116925|NCT03285295|585481259|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
162116926|NCT03285295|585481260|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
162116927|NCT03285295|585481261|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
162116928|NCT03285295|585481257|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
162116929|NCT03285295|585481258|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
162116930|NCT03285295|585481259|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
162116931|NCT03285295|585481260|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
162116932|NCT03285295|585481261|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
162116933|NCT03285295|585481257|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
162116934|NCT03285295|585481258|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
162116935|NCT03285295|585481259|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
162116936|NCT03285295|585481260|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
162116937|NCT03285295|585481261|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
162116938|NCT03285295|585481257|FG000|Alinity s Anti-HBc|No Results Generated|70|||
162116939|NCT03285295|585481258|FG001|Alinity s Anti-HBc|No Results Generated|0|||
162116940|NCT03285295|585481259|FG002|Alinity s Anti-HBc|No Results Generated|0|||
162116941|NCT03285295|585481260|FG003|Alinity s Anti-HBc|No Results Generated|0|||
162116942|NCT03285295|585481261|FG004|Alinity s Anti-HBc|No Results Generated|0|||
162116943|NCT03285295|585481257|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
162116944|NCT03285295|585481258|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
162116945|NCT03285295|585481259|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
162116946|NCT03285295|585481260|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
162116947|NCT03285295|585481261|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
162116948|NCT03285295|585481257|FG000|Alinity s Chagas|Protocol Violation|76|||
162116949|NCT03285295|585481258|FG001|Alinity s Chagas|Protocol Violation|0|||
162116950|NCT03285295|585481259|FG002|Alinity s Chagas|Protocol Violation|0|||
162116951|NCT03285295|585481260|FG003|Alinity s Chagas|Protocol Violation|0|||
162116952|NCT03285295|585481261|FG004|Alinity s Chagas|Protocol Violation|0|||
162116953|NCT03285295|585481257|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
162116954|NCT03285295|585481258|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
162116955|NCT03285295|585481259|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
162116956|NCT03285295|585481260|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
162116957|NCT03285295|585481261|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
162116958|NCT03285295|585481257|FG000|Alinity s Chagas|No Results Generated|105|||
162116959|NCT03285295|585481258|FG001|Alinity s Chagas|No Results Generated|0|||
162116960|NCT03285295|585481259|FG002|Alinity s Chagas|No Results Generated|0|||
162116961|NCT03285295|585481260|FG003|Alinity s Chagas|No Results Generated|0|||
162116962|NCT03285295|585481261|FG004|Alinity s Chagas|No Results Generated|0|||
162116963|NCT03285295|585481257|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
162116964|NCT03285295|585481258|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
162116965|NCT03285295|585481259|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
162116966|NCT03285295|585481260|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
162116967|NCT03285295|585481261|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
162116968|NCT02200939|585481265|FG000|Overall Study|Participant withdrew consent|0|||
162116969|NCT02200939|585481266|FG001|Overall Study|Participant withdrew consent|1|||
162116970|NCT02200939|585481265|FG000|Overall Study|Lost to Follow-up|2|||
162116971|NCT02200939|585481266|FG001|Overall Study|Lost to Follow-up|9|||
162116972|NCT02200939|585481265|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
162116973|NCT02200939|585481266|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
162116974|NCT04567693|585481267|FG000|Overall Study|Death|0|||
162116975|NCT04567693|585481268|FG001|Overall Study|Death|0|||
162116976|NCT04567693|585481269|FG002|Overall Study|Death|2|||
162116977|NCT04567693|585481267|FG000|Overall Study|Lost to Follow-up|1|||
162116978|NCT04567693|585481268|FG001|Overall Study|Lost to Follow-up|0|||
162116979|NCT04567693|585481269|FG002|Overall Study|Lost to Follow-up|2|||
162116980|NCT04567693|585481267|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
162116981|NCT04567693|585481268|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
162116982|NCT04567693|585481269|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
162116983|NCT03722264|585481275|FG000|Overall Study|Physician Decision|3|||
162116984|NCT00957931|585481277|FG000|Overall Study|Death|4|||
162116985|NCT04867785|585481278|FG000|Overall Study|Adverse Event|1|||
162116986|NCT04867785|585481279|FG001|Overall Study|Adverse Event|0|||
162116987|NCT04867785|585481280|FG002|Overall Study|Adverse Event|1|||
162116988|NCT04867785|585481281|FG003|Overall Study|Adverse Event|0|||
162116989|NCT04867785|585481282|FG004|Overall Study|Adverse Event|0|||
162116990|NCT04867785|585481283|FG005|Overall Study|Adverse Event|0|||
162116991|NCT04867785|585481284|FG006|Overall Study|Adverse Event|0|||
162116992|NCT04867785|585481285|FG007|Overall Study|Adverse Event|2|||
162116993|NCT04867785|585481278|FG000|Overall Study|Lost to Follow-up|4|||
162116994|NCT04867785|585481279|FG001|Overall Study|Lost to Follow-up|4|||
162116995|NCT04867785|585481280|FG002|Overall Study|Lost to Follow-up|3|||
162116996|NCT04867785|585481281|FG003|Overall Study|Lost to Follow-up|2|||
162116997|NCT04867785|585481282|FG004|Overall Study|Lost to Follow-up|0|||
162116998|NCT04867785|585481283|FG005|Overall Study|Lost to Follow-up|1|||
162116999|NCT04867785|585481284|FG006|Overall Study|Lost to Follow-up|0|||
162117000|NCT04867785|585481285|FG007|Overall Study|Lost to Follow-up|1|||
162117001|NCT04867785|585481278|FG000|Overall Study|Withdrawal by Subject|6|||
162117002|NCT04867785|585481279|FG001|Overall Study|Withdrawal by Subject|2|||
162117003|NCT04867785|585481280|FG002|Overall Study|Withdrawal by Subject|2|||
162117004|NCT04867785|585481281|FG003|Overall Study|Withdrawal by Subject|1|||
162117005|NCT04867785|585481282|FG004|Overall Study|Withdrawal by Subject|2|||
162117006|NCT04867785|585481283|FG005|Overall Study|Withdrawal by Subject|0|||
162117007|NCT04867785|585481284|FG006|Overall Study|Withdrawal by Subject|2|||
162117008|NCT04867785|585481285|FG007|Overall Study|Withdrawal by Subject|5|||
162117009|NCT04867785|585481278|FG000|Overall Study|Physician Decision|0|||
162117010|NCT04867785|585481279|FG001|Overall Study|Physician Decision|0|||
162117011|NCT04867785|585481280|FG002|Overall Study|Physician Decision|0|||
162117012|NCT04867785|585481281|FG003|Overall Study|Physician Decision|0|||
162117013|NCT04867785|585481282|FG004|Overall Study|Physician Decision|0|||
162117014|NCT04867785|585481283|FG005|Overall Study|Physician Decision|0|||
162117015|NCT04867785|585481284|FG006|Overall Study|Physician Decision|0|||
162117016|NCT04867785|585481285|FG007|Overall Study|Physician Decision|1|||
162117017|NCT04867785|585481278|FG000|Overall Study|Inadvertent Enrollment|0|||
162117018|NCT04867785|585481279|FG001|Overall Study|Inadvertent Enrollment|0|||
162117019|NCT04867785|585481280|FG002|Overall Study|Inadvertent Enrollment|0|||
162117020|NCT04867785|585481281|FG003|Overall Study|Inadvertent Enrollment|1|||
162117021|NCT04867785|585481282|FG004|Overall Study|Inadvertent Enrollment|1|||
162117022|NCT04867785|585481283|FG005|Overall Study|Inadvertent Enrollment|0|||
162117023|NCT04867785|585481284|FG006|Overall Study|Inadvertent Enrollment|0|||
162117024|NCT04867785|585481285|FG007|Overall Study|Inadvertent Enrollment|1|||
162117025|NCT04867785|585481278|FG000|Overall Study|Eligibility Criteria Not Met|0|||
162117026|NCT04867785|585481279|FG001|Overall Study|Eligibility Criteria Not Met|0|||
162117027|NCT04867785|585481280|FG002|Overall Study|Eligibility Criteria Not Met|0|||
162117028|NCT04867785|585481281|FG003|Overall Study|Eligibility Criteria Not Met|0|||
162117029|NCT04867785|585481282|FG004|Overall Study|Eligibility Criteria Not Met|0|||
162117030|NCT04867785|585481283|FG005|Overall Study|Eligibility Criteria Not Met|0|||
162117031|NCT04867785|585481284|FG006|Overall Study|Eligibility Criteria Not Met|0|||
162117032|NCT04867785|585481285|FG007|Overall Study|Eligibility Criteria Not Met|1|||
162117033|NCT01486758|585481286|FG000|Overall Study|Lost to Follow-up|0|||
162117034|NCT01486758|585481287|FG001|Overall Study|Lost to Follow-up|1|||
162117035|NCT01062763|585481288|FG000|Overall Study|Adverse Event|3|||
162117036|NCT01062763|585481289|FG001|Overall Study|Adverse Event|4|||
162117037|NCT02494921|585481291|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
162117038|NCT02494921|585481292|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
162117039|NCT02494921|585481293|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
162117040|NCT02494921|585481294|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
162117041|NCT02494921|585481295|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
162117042|NCT02494921|585481291|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
162117043|NCT02494921|585481292|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
162117044|NCT02494921|585481293|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
162117045|NCT02494921|585481294|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
162117046|NCT02494921|585481295|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
162117047|NCT02494921|585481291|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
162117048|NCT02494921|585481292|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
162117049|NCT02494921|585481293|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
162117050|NCT02494921|585481294|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
162117051|NCT02494921|585481295|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
162117052|NCT02392611|585481301|FG000|Overall Study|Adverse Event|0|||
162117053|NCT02392611|585481302|FG001|Overall Study|Adverse Event|0|||
162117054|NCT02392611|585481303|FG002|Overall Study|Adverse Event|0|||
162117055|NCT02392611|585481304|FG003|Overall Study|Adverse Event|1|||
162117056|NCT02392611|585481305|FG004|Overall Study|Adverse Event|0|||
162117057|NCT02392611|585481306|FG005|Overall Study|Adverse Event|0|||
162117058|NCT02392611|585481307|FG006|Overall Study|Adverse Event|0|||
162117059|NCT02392611|585481308|FG007|Overall Study|Adverse Event|0|||
162117060|NCT02392611|585481309|FG008|Overall Study|Adverse Event|0|||
162117061|NCT02392611|585481301|FG000|Overall Study|Progressive disease|0|||
162117062|NCT02392611|585481302|FG001|Overall Study|Progressive disease|0|||
162117063|NCT02392611|585481303|FG002|Overall Study|Progressive disease|0|||
162117064|NCT02392611|585481304|FG003|Overall Study|Progressive disease|2|||
162117065|NCT02392611|585481305|FG004|Overall Study|Progressive disease|1|||
162117066|NCT02392611|585481306|FG005|Overall Study|Progressive disease|0|||
162117067|NCT02392611|585481307|FG006|Overall Study|Progressive disease|0|||
162117068|NCT02392611|585481308|FG007|Overall Study|Progressive disease|0|||
162117069|NCT02392611|585481309|FG008|Overall Study|Progressive disease|0|||
162117070|NCT02392611|585481301|FG000|Overall Study|Death|1|||
162117071|NCT02392611|585481302|FG001|Overall Study|Death|0|||
162117072|NCT02392611|585481303|FG002|Overall Study|Death|0|||
162117073|NCT02392611|585481304|FG003|Overall Study|Death|0|||
162117074|NCT02392611|585481305|FG004|Overall Study|Death|0|||
162117075|NCT02392611|585481306|FG005|Overall Study|Death|1|||
162117076|NCT02392611|585481307|FG006|Overall Study|Death|0|||
162117077|NCT02392611|585481308|FG007|Overall Study|Death|0|||
162117078|NCT02392611|585481309|FG008|Overall Study|Death|0|||
162117079|NCT02392611|585481301|FG000|Overall Study|Withdrawal by Subject|0|||
162117080|NCT02392611|585481302|FG001|Overall Study|Withdrawal by Subject|0|||
162117081|NCT02392611|585481303|FG002|Overall Study|Withdrawal by Subject|0|||
162117082|NCT02392611|585481304|FG003|Overall Study|Withdrawal by Subject|1|||
162117083|NCT02392611|585481305|FG004|Overall Study|Withdrawal by Subject|0|||
162117084|NCT02392611|585481306|FG005|Overall Study|Withdrawal by Subject|0|||
162117085|NCT02392611|585481307|FG006|Overall Study|Withdrawal by Subject|0|||
162117086|NCT02392611|585481308|FG007|Overall Study|Withdrawal by Subject|0|||
162117087|NCT02392611|585481309|FG008|Overall Study|Withdrawal by Subject|0|||
162117088|NCT02392611|585481301|FG000|Overall Study|Lost to Follow-up|0|||
162117089|NCT02392611|585481302|FG001|Overall Study|Lost to Follow-up|0|||
162117090|NCT02392611|585481303|FG002|Overall Study|Lost to Follow-up|0|||
162117091|NCT02392611|585481304|FG003|Overall Study|Lost to Follow-up|0|||
162117092|NCT02392611|585481305|FG004|Overall Study|Lost to Follow-up|0|||
162117093|NCT02392611|585481306|FG005|Overall Study|Lost to Follow-up|0|||
162117094|NCT02392611|585481307|FG006|Overall Study|Lost to Follow-up|1|||
162117095|NCT02392611|585481308|FG007|Overall Study|Lost to Follow-up|0|||
162117096|NCT02392611|585481309|FG008|Overall Study|Lost to Follow-up|0|||
162117097|NCT02392611|585481301|FG000|Overall Study|Enrolled, not treated|0|||
162117098|NCT02392611|585481302|FG001|Overall Study|Enrolled, not treated|0|||
162117099|NCT02392611|585481303|FG002|Overall Study|Enrolled, not treated|0|||
162117100|NCT02392611|585481304|FG003|Overall Study|Enrolled, not treated|2|||
162117101|NCT02392611|585481305|FG004|Overall Study|Enrolled, not treated|0|||
162117102|NCT02392611|585481306|FG005|Overall Study|Enrolled, not treated|0|||
162117103|NCT02392611|585481307|FG006|Overall Study|Enrolled, not treated|0|||
162117104|NCT02392611|585481308|FG007|Overall Study|Enrolled, not treated|0|||
162117105|NCT02392611|585481309|FG008|Overall Study|Enrolled, not treated|0|||
162117106|NCT00553202|585481316|FG000|Overall Study|Death|16|||
162117107|NCT00553202|585481316|FG000|Overall Study|Lost to Follow-up|1|||
162117108|NCT00553202|585481316|FG000|Overall Study|Physician Decision|28|||
162117109|NCT00553202|585481316|FG000|Overall Study|Withdrawal by Subject|1|||
162117110|NCT00553202|585481316|FG000|Overall Study|No donor identified|16|||
162117111|NCT00553202|585481316|FG000|Overall Study|Fails to meet organ function|6|||
162117112|NCT00369681|585481317|FG000|Overall Study|Death|1|||
162117113|NCT03239873|585481320|FG000|Overall Study|Lost to Follow-up|15|||
162117114|NCT03239873|585481321|FG001|Overall Study|Lost to Follow-up|16|||
162117115|NCT03239873|585481320|FG000|Overall Study|Physician Decision|1|||
162117116|NCT03239873|585481321|FG001|Overall Study|Physician Decision|0|||
162117117|NCT03239873|585481320|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
162117118|NCT03239873|585481321|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
162117119|NCT03239873|585481320|FG000|Overall Study|Withdrawal by Subject|2|||
162117120|NCT03239873|585481321|FG001|Overall Study|Withdrawal by Subject|0|||
162117121|NCT03239873|585481320|FG000|Overall Study|Contraindication to study medication|1|||
162117122|NCT03239873|585481321|FG001|Overall Study|Contraindication to study medication|0|||
162117123|NCT03239873|585481320|FG000|Overall Study|Protocol Violation|1|||
162117124|NCT03239873|585481321|FG001|Overall Study|Protocol Violation|0|||
162117125|NCT01800201|585481322|FG000|Overall Study|Withdrawal by Subject|2|||
162117126|NCT01800201|585481323|FG001|Overall Study|Withdrawal by Subject|0|||
162117127|NCT01800201|585481322|FG000|Overall Study|patient privacy concerns|1|||
162117128|NCT01800201|585481323|FG001|Overall Study|patient privacy concerns|1|||
162117129|NCT01800201|585481322|FG000|Overall Study|did not want to use device|0|||
162117130|NCT01800201|585481323|FG001|Overall Study|did not want to use device|1|||
162117131|NCT01800201|585481322|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
162117132|NCT01800201|585481323|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
162117133|NCT01480596|585481324|FG000|Overall Study|Adverse Event|3|||
162117134|NCT01480596|585481325|FG001|Overall Study|Adverse Event|0|||
162117135|NCT01480596|585481324|FG000|Overall Study|MG exacerbation or change in medication|2|||
162117136|NCT01480596|585481325|FG001|Overall Study|MG exacerbation or change in medication|2|||
162117137|NCT02904902|585481326|FG000|Overall Study|Withdrawal by Subject|1|||
162117138|NCT05400746|585481331|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
162117139|NCT05400746|585481332|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
162117140|NCT05400746|585481333|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
162117141|NCT05375955|585481334|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
162117142|NCT05375955|585481335|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
162117143|NCT05375955|585481336|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
162117144|NCT05375955|585481337|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
162117145|NCT05375955|585481338|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
162117146|NCT05375955|585481339|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
162117147|NCT05375955|585481340|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
162117148|NCT05375955|585481334|FG000|Treatment (12 Weeks)|Physician Decision|4|||
162117149|NCT05375955|585481335|FG001|Treatment (12 Weeks)|Physician Decision|1|||
162117150|NCT05375955|585481336|FG002|Treatment (12 Weeks)|Physician Decision|3|||
162117151|NCT05375955|585481337|FG003|Treatment (12 Weeks)|Physician Decision|0|||
162117152|NCT05375955|585481338|FG004|Treatment (12 Weeks)|Physician Decision|0|||
162117153|NCT05375955|585481339|FG005|Treatment (12 Weeks)|Physician Decision|1|||
162117154|NCT05375955|585481340|FG006|Treatment (12 Weeks)|Physician Decision|0|||
162117155|NCT05375955|585481334|FG000|Treatment (12 Weeks)|Other|0|||
162117156|NCT05375955|585481335|FG001|Treatment (12 Weeks)|Other|1|||
162117157|NCT05375955|585481336|FG002|Treatment (12 Weeks)|Other|0|||
162117158|NCT05375955|585481337|FG003|Treatment (12 Weeks)|Other|0|||
162117159|NCT05375955|585481338|FG004|Treatment (12 Weeks)|Other|0|||
162117160|NCT05375955|585481339|FG005|Treatment (12 Weeks)|Other|0|||
162117161|NCT05375955|585481340|FG006|Treatment (12 Weeks)|Other|0|||
162117162|NCT05375955|585481334|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
162117163|NCT05375955|585481335|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
162117164|NCT05375955|585481336|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
162117165|NCT05375955|585481337|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
162117166|NCT05375955|585481338|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
162117167|NCT05375955|585481339|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
162117168|NCT05375955|585481340|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
162117169|NCT05375955|585481334|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
162117170|NCT05375955|585481335|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
162117171|NCT05375955|585481336|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
162117172|NCT05375955|585481337|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
162117173|NCT05375955|585481338|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
162117174|NCT05375955|585481339|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
162117175|NCT05375955|585481340|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
162117176|NCT05375955|585481334|FG000|Treatment (12 Weeks)|Pregnancy|0|||
162117177|NCT05375955|585481335|FG001|Treatment (12 Weeks)|Pregnancy|0|||
162117178|NCT05375955|585481336|FG002|Treatment (12 Weeks)|Pregnancy|1|||
162117179|NCT05375955|585481337|FG003|Treatment (12 Weeks)|Pregnancy|0|||
162117180|NCT05375955|585481338|FG004|Treatment (12 Weeks)|Pregnancy|0|||
162117181|NCT05375955|585481339|FG005|Treatment (12 Weeks)|Pregnancy|0|||
162117182|NCT05375955|585481340|FG006|Treatment (12 Weeks)|Pregnancy|0|||
162117183|NCT05375955|585481334|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
162117184|NCT05375955|585481335|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
162117185|NCT05375955|585481336|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
162117186|NCT05375955|585481337|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
162117187|NCT05375955|585481338|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
162117188|NCT05375955|585481339|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
162117189|NCT05375955|585481340|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
162117190|NCT05375955|585481334|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
162117191|NCT05375955|585481335|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
162117192|NCT05375955|585481336|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
162117193|NCT05375955|585481337|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
162117194|NCT05375955|585481338|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
162117195|NCT05375955|585481339|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
162117196|NCT05375955|585481340|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
162117197|NCT05375955|585481334|FG000|Follow-up (up to 5 Weeks)|Other|0|||
162117198|NCT05375955|585481335|FG001|Follow-up (up to 5 Weeks)|Other|1|||
162117199|NCT05375955|585481336|FG002|Follow-up (up to 5 Weeks)|Other|0|||
162117200|NCT05375955|585481337|FG003|Follow-up (up to 5 Weeks)|Other|0|||
162117201|NCT05375955|585481338|FG004|Follow-up (up to 5 Weeks)|Other|0|||
162117202|NCT05375955|585481339|FG005|Follow-up (up to 5 Weeks)|Other|0|||
162117203|NCT05375955|585481340|FG006|Follow-up (up to 5 Weeks)|Other|0|||
162117204|NCT05375955|585481334|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
162117205|NCT05375955|585481335|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
162117206|NCT05375955|585481336|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
162117207|NCT05375955|585481337|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
162117208|NCT05375955|585481338|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
162117209|NCT05375955|585481339|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
162117210|NCT05375955|585481340|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
162117211|NCT05375955|585481334|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
162117212|NCT05375955|585481335|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
162117213|NCT05375955|585481336|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
162117214|NCT05375955|585481337|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
162117215|NCT05375955|585481338|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
162117216|NCT05375955|585481339|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
162117217|NCT05375955|585481340|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
162117218|NCT03879408|585481350|FG000|Overall Study|Lost to Follow-up|0|||
162117219|NCT03879408|585481351|FG001|Overall Study|Lost to Follow-up|3|||
162117220|NCT03879408|585481352|FG002|Overall Study|Lost to Follow-up|2|||
162117221|NCT03879408|585481353|FG003|Overall Study|Lost to Follow-up|1|||
162117222|NCT03879408|585481354|FG004|Overall Study|Lost to Follow-up|0|||
162117223|NCT03879408|585481350|FG000|Overall Study|Withdrawal by Subject|2|||
162117224|NCT03879408|585481351|FG001|Overall Study|Withdrawal by Subject|1|||
162117225|NCT03879408|585481352|FG002|Overall Study|Withdrawal by Subject|1|||
162117226|NCT03879408|585481353|FG003|Overall Study|Withdrawal by Subject|0|||
162117227|NCT03879408|585481354|FG004|Overall Study|Withdrawal by Subject|1|||
162117228|NCT05458024|585481355|FG000|Overall Study|Withdrawal by Subject|1|||
162117229|NCT05458024|585481356|FG001|Overall Study|Withdrawal by Subject|1|||
162117230|NCT05807919|585481357|FG000|Overall Study|Received antibiotics - excluded|0|||
162117231|NCT05807919|585481358|FG001|Overall Study|Received antibiotics - excluded|1|||
162117232|NCT05807919|585481357|FG000|Overall Study|Withdrawal by Subject|0|||
162117233|NCT05807919|585481358|FG001|Overall Study|Withdrawal by Subject|3|||
162117234|NCT05807919|585481357|FG000|Overall Study|Adverse Event|1|||
162117235|NCT05807919|585481358|FG001|Overall Study|Adverse Event|1|||
162117236|NCT00747123|585481359|FG000|Overall Study|Investigator's request|0|||
162117237|NCT00747123|585481360|FG001|Overall Study|Investigator's request|0|||
162117238|NCT00747123|585481361|FG002|Overall Study|Investigator's request|1|||
162117239|NCT00747123|585481362|FG003|Overall Study|Investigator's request|0|||
162117240|NCT00747123|585481359|FG000|Overall Study|Withdrew consent|0|||
162117241|NCT00747123|585481360|FG001|Overall Study|Withdrew consent|1|||
162117242|NCT00747123|585481361|FG002|Overall Study|Withdrew consent|0|||
162117243|NCT00747123|585481362|FG003|Overall Study|Withdrew consent|0|||
162117244|NCT00747123|585481359|FG000|Overall Study|Adverse Event|0|||
162117245|NCT00747123|585481360|FG001|Overall Study|Adverse Event|1|||
162117246|NCT00747123|585481361|FG002|Overall Study|Adverse Event|0|||
162117247|NCT00747123|585481362|FG003|Overall Study|Adverse Event|1|||
162117248|NCT02277743|585481371|FG000|Overall Study|Protocol Violation|1|||
162117249|NCT02277743|585481372|FG001|Overall Study|Protocol Violation|1|||
162117250|NCT02277743|585481373|FG002|Overall Study|Protocol Violation|1|||
162117251|NCT02277743|585481371|FG000|Overall Study|Adverse Event|10|||
162117252|NCT02277743|585481372|FG001|Overall Study|Adverse Event|6|||
162117253|NCT02277743|585481373|FG002|Overall Study|Adverse Event|6|||
162117254|NCT02277743|585481371|FG000|Overall Study|Lack of Efficacy|11|||
162117255|NCT02277743|585481372|FG001|Overall Study|Lack of Efficacy|4|||
162117256|NCT02277743|585481373|FG002|Overall Study|Lack of Efficacy|3|||
162117257|NCT02277743|585481371|FG000|Overall Study|Other than specified above|18|||
162117258|NCT02277743|585481372|FG001|Overall Study|Other than specified above|5|||
162117259|NCT02277743|585481373|FG002|Overall Study|Other than specified above|16|||
162117260|NCT01224158|585481377|FG000|Overall Study|Withdrawal by Subject|1|||
162117261|NCT01224158|585481378|FG001|Overall Study|Withdrawal by Subject|0|||
162117262|NCT02055157|585481381|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
162117263|NCT02055157|585481382|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
162117264|NCT02055157|585481383|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
162117265|NCT02055157|585481384|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
162117266|NCT02055157|585481381|FG000|Initial 6 Months|Adverse Event|0|||
162117267|NCT02055157|585481382|FG001|Initial 6 Months|Adverse Event|0|||
162117268|NCT02055157|585481383|FG002|Initial 6 Months|Adverse Event|0|||
162117269|NCT02055157|585481384|FG003|Initial 6 Months|Adverse Event|1|||
162117270|NCT02055157|585481381|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
162117271|NCT02055157|585481382|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
162117272|NCT02055157|585481383|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
162117273|NCT02055157|585481384|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
162117274|NCT02055157|585481381|FG000|18-month Extension|Investigator decision|0|||
162117275|NCT02055157|585481382|FG001|18-month Extension|Investigator decision|1|||
162117276|NCT02055157|585481383|FG002|18-month Extension|Investigator decision|0|||
162117277|NCT02055157|585481384|FG003|18-month Extension|Investigator decision|0|||
162117278|NCT02055157|585481381|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
162117279|NCT02055157|585481382|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
162117280|NCT02055157|585481383|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
162117281|NCT02055157|585481384|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
162117282|NCT03976466|585481385|FG000|Overall Study|Lost to Follow-up|1|||
162117283|NCT03976466|585481386|FG001|Overall Study|Lost to Follow-up|3|||
162117284|NCT02034708|585481387|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
162117285|NCT02034708|585481388|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
162117286|NCT02034708|585481387|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
162117287|NCT02034708|585481388|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
162117288|NCT02034708|585481387|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
162117289|NCT02034708|585481388|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
162117290|NCT02034708|585481387|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
162117291|NCT02034708|585481388|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
162117292|NCT00733499|585481391|FG000|Pre-operative|Protocol Violation|0|||
162117293|NCT00733499|585481392|FG001|Pre-operative|Protocol Violation|1|||
162117294|NCT00733499|585481391|FG000|3 Months Follow-up|Death|1|||
162117295|NCT00733499|585481392|FG001|3 Months Follow-up|Death|2|||
162117296|NCT00733499|585481391|FG000|6 Months Follow-up|Death|0|||
162117297|NCT00733499|585481392|FG001|6 Months Follow-up|Death|2|||
162117298|NCT00733499|585481391|FG000|6 Months Follow-up|Adverse Event|0|||
162117299|NCT00733499|585481392|FG001|6 Months Follow-up|Adverse Event|1|||
162117300|NCT00733499|585481391|FG000|12 Months Follow-up|Death|2|||
162117301|NCT00733499|585481392|FG001|12 Months Follow-up|Death|1|||
162117302|NCT00733499|585481391|FG000|24 Months Follow-up|Death|0|||
162117303|NCT00733499|585481392|FG001|24 Months Follow-up|Death|1|||
162117304|NCT00733499|585481391|FG000|5 Year Followup|Adverse Event|2|||
162117305|NCT00733499|585481392|FG001|5 Year Followup|Adverse Event|2|||
162117306|NCT00733499|585481391|FG000|5 Year Followup|Non device related AE|0|||
162117307|NCT00733499|585481392|FG001|5 Year Followup|Non device related AE|1|||
162117308|NCT00733499|585481391|FG000|5 Year Followup|Revision of Study Implant|0|||
162117309|NCT00733499|585481392|FG001|5 Year Followup|Revision of Study Implant|1|||
162117310|NCT00733499|585481391|FG000|5 Year Followup|Lost to Follow-up|2|||
162117311|NCT00733499|585481392|FG001|5 Year Followup|Lost to Follow-up|0|||
162117312|NCT00733499|585481391|FG000|5 Year Followup|Death|13|||
162117313|NCT00733499|585481392|FG001|5 Year Followup|Death|19|||
162117314|NCT00733499|585481391|FG000|5 Year Followup|missing, unable to locate|0|||
162117315|NCT00733499|585481392|FG001|5 Year Followup|missing, unable to locate|1|||
162117316|NCT00733499|585481391|FG000|5 Year Followup|Withdrawal by Subject|4|||
162117317|NCT00733499|585481392|FG001|5 Year Followup|Withdrawal by Subject|1|||
162117318|NCT00733499|585481391|FG000|10 Year Followup|Death|9|||
162117319|NCT00733499|585481392|FG001|10 Year Followup|Death|7|||
162117320|NCT00733499|585481391|FG000|10 Year Followup|Adverse Event|3|||
162117321|NCT00733499|585481392|FG001|10 Year Followup|Adverse Event|3|||
162117322|NCT00733499|585481391|FG000|10 Year Followup|Lost to Follow-up|3|||
162117323|NCT00733499|585481392|FG001|10 Year Followup|Lost to Follow-up|2|||
162117324|NCT00733499|585481391|FG000|10 Year Followup|Withdrawal by Subject|5|||
162117325|NCT00733499|585481392|FG001|10 Year Followup|Withdrawal by Subject|5|||
162117326|NCT00733499|585481391|FG000|10 Year Followup|missing, unable to locate|0|||
162117327|NCT00733499|585481392|FG001|10 Year Followup|missing, unable to locate|2|||
162117328|NCT00943306|585481393|FG000|Overall Study|Physician Decision|1|||
162117329|NCT00943306|585481393|FG000|Overall Study|Death|1|||
162117330|NCT00943306|585481393|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
162117331|NCT00733980|585481394|FG000|Overall Study|Adverse Event|5|||
162117332|NCT00733980|585481395|FG001|Overall Study|Adverse Event|2|||
162117333|NCT00733980|585481394|FG000|Overall Study|Lack of Efficacy|0|||
162117334|NCT00733980|585481395|FG001|Overall Study|Lack of Efficacy|1|||
162117335|NCT00733980|585481394|FG000|Overall Study|Protocol Violation|2|||
162117336|NCT00733980|585481395|FG001|Overall Study|Protocol Violation|1|||
162117337|NCT00733980|585481394|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
162117338|NCT00733980|585481395|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
162117339|NCT00733980|585481394|FG000|Overall Study|Lost to Follow-up|6|||
162117340|NCT00733980|585481395|FG001|Overall Study|Lost to Follow-up|11|||
162117341|NCT00733980|585481394|FG000|Overall Study|Physician Decision|2|||
162117342|NCT00733980|585481395|FG001|Overall Study|Physician Decision|3|||
162117343|NCT00733980|585481394|FG000|Overall Study|Withdrawal by Subject|6|||
162117344|NCT00733980|585481395|FG001|Overall Study|Withdrawal by Subject|2|||
162117345|NCT02739347|585481396|FG000|Overall Study|Adverse Event|3|||
162117346|NCT02739347|585481397|FG001|Overall Study|Adverse Event|0|||
162117347|NCT02739347|585481396|FG000|Overall Study|Protocol Violation|0|||
162117348|NCT02739347|585481397|FG001|Overall Study|Protocol Violation|1|||
162117349|NCT02739347|585481396|FG000|Overall Study|Lost to Follow-up|0|||
162117350|NCT02739347|585481397|FG001|Overall Study|Lost to Follow-up|2|||
162117351|NCT01552954|585481398|FG000|Overall Study|Adverse Event|1|||
162117352|NCT01552954|585481399|FG001|Overall Study|Adverse Event|2|||
162117353|NCT01552954|585481398|FG000|Overall Study|Lost to Follow-up|1|||
162117354|NCT01552954|585481399|FG001|Overall Study|Lost to Follow-up|1|||
162117355|NCT01552954|585481398|FG000|Overall Study|Withdrawal by Subject|1|||
162117356|NCT01552954|585481399|FG001|Overall Study|Withdrawal by Subject|1|||
162117357|NCT01552954|585481398|FG000|Overall Study|Protocol Violation|1|||
162117358|NCT01552954|585481399|FG001|Overall Study|Protocol Violation|2|||
162117359|NCT01552954|585481398|FG000|Overall Study|diagnosed DM|1|||
162117360|NCT01552954|585481399|FG001|Overall Study|diagnosed DM|0|||
162117361|NCT01931735|585481400|FG000|Randomized Phase|Lost to Follow-up|2|||
162117362|NCT01931735|585481401|FG001|Randomized Phase|Lost to Follow-up|2|||
162117363|NCT01931735|585481402|FG002|Randomized Phase|Lost to Follow-up|5|||
162117364|NCT01931735|585481403|FG003|Randomized Phase|Lost to Follow-up|0|||
162117365|NCT01931735|585481400|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
162117366|NCT01931735|585481401|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
162117367|NCT01931735|585481402|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
162117368|NCT01931735|585481403|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
162117369|NCT01931735|585481400|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
162117370|NCT01931735|585481401|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
162117371|NCT01931735|585481402|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
162117372|NCT01931735|585481403|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
162117373|NCT02719990|585481407|FG000|Overall Study|Physician Decision|2|||
162117374|NCT02719990|585481407|FG000|Overall Study|Withdrawal by Subject|2|||
162117375|NCT02719990|585481407|FG000|Overall Study|Study Terminated By Sponsor|32|||
162117376|NCT00652938|585481408|FG000|Overall Study|Adverse Event|1|||
162117377|NCT00652938|585481409|FG001|Overall Study|Adverse Event|0|||
162117378|NCT00652938|585481410|FG002|Overall Study|Adverse Event|2|||
162117379|NCT00652938|585481408|FG000|Overall Study|Withdrawal by Subject|0|||
162117380|NCT00652938|585481409|FG001|Overall Study|Withdrawal by Subject|6|||
162117381|NCT00652938|585481410|FG002|Overall Study|Withdrawal by Subject|1|||
162117382|NCT00652938|585481408|FG000|Overall Study|Lost to Follow-up|0|||
162117383|NCT00652938|585481409|FG001|Overall Study|Lost to Follow-up|0|||
162117384|NCT00652938|585481410|FG002|Overall Study|Lost to Follow-up|2|||
162117385|NCT00652938|585481408|FG000|Overall Study|fear of blood sampling|0|||
162117386|NCT00652938|585481409|FG001|Overall Study|fear of blood sampling|1|||
162117387|NCT00652938|585481410|FG002|Overall Study|fear of blood sampling|0|||
162117388|NCT03324880|585481414|FG000|Overall Study|Adverse Event|0|||
162117389|NCT03324880|585481415|FG001|Overall Study|Adverse Event|2|||
162117390|NCT03324880|585481414|FG000|Overall Study|Withdrawal by Subject|2|||
162117391|NCT03324880|585481415|FG001|Overall Study|Withdrawal by Subject|2|||
162117392|NCT03324880|585481414|FG000|Overall Study|Lost to Follow-up|0|||
162117393|NCT03324880|585481415|FG001|Overall Study|Lost to Follow-up|1|||
162117394|NCT03324880|585481414|FG000|Overall Study|Product Recall|0|||
162117395|NCT03324880|585481415|FG001|Overall Study|Product Recall|1|||
162117396|NCT01412801|585481416|FG000|Overall Study|Death|0|||
162117397|NCT01412801|585481417|FG001|Overall Study|Death|1|||
162117398|NCT01412801|585481418|FG002|Overall Study|Death|0|||
162117399|NCT01412801|585481419|FG003|Overall Study|Death|4|||
162117400|NCT01412801|585481420|FG004|Overall Study|Death|2|||
162117401|NCT01412801|585481421|FG005|Overall Study|Death|2|||
162117402|NCT01412801|585481416|FG000|Overall Study|Lost to Follow-up|1|||
162117403|NCT01412801|585481417|FG001|Overall Study|Lost to Follow-up|2|||
162117404|NCT01412801|585481418|FG002|Overall Study|Lost to Follow-up|4|||
162117405|NCT01412801|585481419|FG003|Overall Study|Lost to Follow-up|0|||
162117406|NCT01412801|585481420|FG004|Overall Study|Lost to Follow-up|1|||
162117407|NCT01412801|585481421|FG005|Overall Study|Lost to Follow-up|1|||
162117408|NCT01412801|585481416|FG000|Overall Study|Withdrawal by Subject|3|||
162117409|NCT01412801|585481417|FG001|Overall Study|Withdrawal by Subject|2|||
162117410|NCT01412801|585481418|FG002|Overall Study|Withdrawal by Subject|1|||
162117411|NCT01412801|585481419|FG003|Overall Study|Withdrawal by Subject|0|||
162117412|NCT01412801|585481420|FG004|Overall Study|Withdrawal by Subject|0|||
162117413|NCT01412801|585481421|FG005|Overall Study|Withdrawal by Subject|0|||
162117414|NCT01412801|585481416|FG000|Overall Study|Relocated to another area|0|||
162117415|NCT01412801|585481417|FG001|Overall Study|Relocated to another area|0|||
162117416|NCT01412801|585481418|FG002|Overall Study|Relocated to another area|2|||
162117417|NCT01412801|585481419|FG003|Overall Study|Relocated to another area|0|||
162117418|NCT01412801|585481420|FG004|Overall Study|Relocated to another area|0|||
162117419|NCT01412801|585481421|FG005|Overall Study|Relocated to another area|0|||
162117420|NCT01235403|585481422|FG000|Overall Study|Adverse Event|14|||
162117421|NCT01235403|585481422|FG000|Overall Study|Lost to Follow-up|2|||
162117422|NCT01235403|585481422|FG000|Overall Study|Withdrawal by Subject|4|||
162117423|NCT01235403|585481422|FG000|Overall Study|Lack of Efficacy|2|||
162117424|NCT01235403|585481422|FG000|Overall Study|Other reasons for premature termination|4|||
162117425|NCT01547299|585481423|FG000|Overall Study|Withdrawal by Subject|2|||
162117426|NCT01547299|585481424|FG001|Overall Study|Withdrawal by Subject|2|||
162117427|NCT05076149|585481425|FG000|Overall Study|Adverse Event|3|||
162117428|NCT05076149|585481426|FG001|Overall Study|Adverse Event|9|||
162117429|NCT05076149|585481425|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
162117430|NCT05076149|585481426|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
162117431|NCT05076149|585481425|FG000|Overall Study|Lost to Follow-up|0|||
162117432|NCT05076149|585481426|FG001|Overall Study|Lost to Follow-up|1|||
162117433|NCT05076149|585481425|FG000|Overall Study|Commercial drug is available for participant|0|||
162117434|NCT05076149|585481426|FG001|Overall Study|Commercial drug is available for participant|1|||
162117435|NCT05076149|585481425|FG000|Overall Study|Other non compliance|1|||
162117436|NCT05076149|585481426|FG001|Overall Study|Other non compliance|1|||
162117437|NCT05076149|585481425|FG000|Overall Study|Physician Decision|0|||
162117438|NCT05076149|585481426|FG001|Overall Study|Physician Decision|1|||
162117439|NCT05076149|585481425|FG000|Overall Study|Other|5|||
162117440|NCT05076149|585481426|FG001|Overall Study|Other|4|||
162117441|NCT00782496|585481427|FG000|Overall Study|Lost to Follow-up|14|||
162117442|NCT00782496|585481428|FG001|Overall Study|Lost to Follow-up|15|||
162117443|NCT02087501|585481429|FG000|Overall Study|Death|7|||
162117444|NCT02087501|585481429|FG000|Overall Study|Open repair of aneurysm|1|||
162117445|NCT02087501|585481429|FG000|Overall Study|Lost to Follow-up|2|||
162117446|NCT00094328|585481432|FG000|Overall Study|Lost to Follow-up|1|||
162117447|NCT03682705|585481433|FG000|Overall Study|Adverse Event|1|||
162117448|NCT03682705|585481434|FG001|Overall Study|Adverse Event|1|||
162117449|NCT03682705|585481435|FG002|Overall Study|Adverse Event|1|||
162117450|NCT03682705|585481436|FG003|Overall Study|Adverse Event|0|||
162117451|NCT03682705|585481437|FG004|Overall Study|Adverse Event|1|||
162117452|NCT03682705|585481438|FG005|Overall Study|Adverse Event|1|||
162117453|NCT03682705|585481433|FG000|Overall Study|Withdrawal by Subject|1|||
162117454|NCT03682705|585481434|FG001|Overall Study|Withdrawal by Subject|3|||
162117455|NCT03682705|585481435|FG002|Overall Study|Withdrawal by Subject|2|||
162117456|NCT03682705|585481436|FG003|Overall Study|Withdrawal by Subject|4|||
162117457|NCT03682705|585481437|FG004|Overall Study|Withdrawal by Subject|0|||
162117458|NCT03682705|585481438|FG005|Overall Study|Withdrawal by Subject|1|||
162117459|NCT03682705|585481433|FG000|Overall Study|Other, not specified|0|||
162117460|NCT03682705|585481434|FG001|Overall Study|Other, not specified|0|||
162117461|NCT03682705|585481435|FG002|Overall Study|Other, not specified|0|||
162117462|NCT03682705|585481436|FG003|Overall Study|Other, not specified|1|||
162117463|NCT03682705|585481437|FG004|Overall Study|Other, not specified|2|||
162117464|NCT03682705|585481438|FG005|Overall Study|Other, not specified|0|||
162117465|NCT03682705|585481433|FG000|Overall Study|Lost to Follow-up|0|||
162117466|NCT03682705|585481434|FG001|Overall Study|Lost to Follow-up|0|||
162117467|NCT03682705|585481435|FG002|Overall Study|Lost to Follow-up|0|||
162117468|NCT03682705|585481436|FG003|Overall Study|Lost to Follow-up|0|||
162117469|NCT03682705|585481437|FG004|Overall Study|Lost to Follow-up|3|||
162117470|NCT03682705|585481438|FG005|Overall Study|Lost to Follow-up|0|||
162117471|NCT00117156|585481439|FG000|Overall Study|Adverse Event|9|||
162117472|NCT00117156|585481439|FG000|Overall Study|Physician Decision|1|||
162117473|NCT00117156|585481439|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
162117474|NCT02213328|585481440|FG000|Overall Study|Withdrawal by Subject|10|||
162117475|NCT02213328|585481440|FG000|Overall Study|Physician Decision|2|||
162117476|NCT02213328|585481440|FG000|Overall Study|Lost to Follow-up|16|||
162117477|NCT04043962|585481441|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
162117478|NCT04043962|585481441|FG000|Post-Treatment|Withdrawal by Subject|5|||
162117479|NCT04043962|585481441|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
162117480|NCT01874145|585481442|FG000|Core Period|Non-compliance|1|||
162117481|NCT01874145|585481443|FG001|Core Period|Non-compliance|0|||
162117482|NCT01874145|585481442|FG000|Core Period|Protocol Violation|1|||
162117483|NCT01874145|585481443|FG001|Core Period|Protocol Violation|1|||
162117484|NCT01874145|585481442|FG000|Core Period|Physician Decision|1|||
162117485|NCT01874145|585481443|FG001|Core Period|Physician Decision|1|||
162117486|NCT01874145|585481442|FG000|Core Period|Adverse Event|0|||
162117487|NCT01874145|585481443|FG001|Core Period|Adverse Event|1|||
162117488|NCT01874145|585481442|FG000|Core Period|Withdrawal by Subject|0|||
162117489|NCT01874145|585481443|FG001|Core Period|Withdrawal by Subject|4|||
162117490|NCT01874145|585481442|FG000|Extension Period|Adverse Event|3|||
162117491|NCT01874145|585481443|FG001|Extension Period|Adverse Event|2|||
162117492|NCT01874145|585481442|FG000|Extension Period|Withdrawal by Subject|2|||
162117493|NCT01874145|585481443|FG001|Extension Period|Withdrawal by Subject|1|||
162117494|NCT01874145|585481442|FG000|Extension Period|Lost to Follow-up|1|||
162117495|NCT01874145|585481443|FG001|Extension Period|Lost to Follow-up|1|||
162117496|NCT00402337|585481444|FG000|Overall Study|Adverse Event|0|||
162117497|NCT00402337|585481445|FG001|Overall Study|Adverse Event|2|||
162117498|NCT00402337|585481446|FG002|Overall Study|Adverse Event|2|||
162117499|NCT00402337|585481447|FG003|Overall Study|Adverse Event|3|||
162117500|NCT00402337|585481448|FG004|Overall Study|Adverse Event|2|||
162117501|NCT00402337|585481444|FG000|Overall Study|Noncompliance|0|||
162117502|NCT00402337|585481445|FG001|Overall Study|Noncompliance|0|||
162117503|NCT00402337|585481446|FG002|Overall Study|Noncompliance|0|||
162117504|NCT00402337|585481447|FG003|Overall Study|Noncompliance|0|||
162117505|NCT00402337|585481448|FG004|Overall Study|Noncompliance|2|||
162117506|NCT00402337|585481444|FG000|Overall Study|Withdrawal by Subject|5|||
162117507|NCT00402337|585481445|FG001|Overall Study|Withdrawal by Subject|3|||
162117508|NCT00402337|585481446|FG002|Overall Study|Withdrawal by Subject|1|||
162117509|NCT00402337|585481447|FG003|Overall Study|Withdrawal by Subject|6|||
162117510|NCT00402337|585481448|FG004|Overall Study|Withdrawal by Subject|4|||
162117511|NCT00402337|585481444|FG000|Overall Study|Lost to Follow-up|0|||
162117512|NCT00402337|585481445|FG001|Overall Study|Lost to Follow-up|0|||
162117513|NCT00402337|585481446|FG002|Overall Study|Lost to Follow-up|1|||
162117514|NCT00402337|585481447|FG003|Overall Study|Lost to Follow-up|2|||
162117515|NCT00402337|585481448|FG004|Overall Study|Lost to Follow-up|0|||
162117516|NCT00402337|585481444|FG000|Overall Study|Physician Decision|0|||
162117517|NCT00402337|585481445|FG001|Overall Study|Physician Decision|0|||
162117518|NCT00402337|585481446|FG002|Overall Study|Physician Decision|0|||
162117519|NCT00402337|585481447|FG003|Overall Study|Physician Decision|1|||
162117520|NCT00402337|585481448|FG004|Overall Study|Physician Decision|0|||
162117521|NCT00402337|585481444|FG000|Overall Study|Other Reason|0|||
162117522|NCT00402337|585481445|FG001|Overall Study|Other Reason|1|||
162117523|NCT00402337|585481446|FG002|Overall Study|Other Reason|0|||
162117524|NCT00402337|585481447|FG003|Overall Study|Other Reason|0|||
162117525|NCT00402337|585481448|FG004|Overall Study|Other Reason|0|||
162117526|NCT01654601|585481449|FG000|1st Administration|Withdrawal by Subject|2|||
162117527|NCT01654601|585481450|FG001|1st Administration|Withdrawal by Subject|0|||
162117528|NCT01654601|585481449|FG000|1st Administration|Protocol Violation|0|||
162117529|NCT01654601|585481450|FG001|1st Administration|Protocol Violation|2|||
162117530|NCT01654601|585481449|FG000|2nd Administration|Adverse Event|1|||
162117531|NCT01654601|585481450|FG001|2nd Administration|Adverse Event|0|||
162117532|NCT01654601|585481449|FG000|2nd Administration|Protocol Violation|0|||
162117533|NCT01654601|585481450|FG001|2nd Administration|Protocol Violation|1|||
162117534|NCT02636270|585481451|FG000|Overall Study|Adverse Event|1|||
162117535|NCT02636270|585481452|FG001|Overall Study|Adverse Event|0|||
162117536|NCT02636270|585481453|FG002|Overall Study|Adverse Event|0|||
162117537|NCT02636270|585481451|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
162122795|NCT01351025|585500335|FG000|Week 24 - 44|unable to get to clinic|1|||
162117538|NCT02636270|585481452|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
162117539|NCT02636270|585481453|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
162117540|NCT00767104|585483449|FG000|Overall Study|Lost to Follow-up|1|||
162117541|NCT00767104|585483450|FG001|Overall Study|Lost to Follow-up|2|||
162117542|NCT00840996|585483451|FG000|Overall Study|Withdrawal by Subject|1|||
162117543|NCT00840996|585483452|FG001|Overall Study|Withdrawal by Subject|0|||
162117544|NCT02762981|585483453|FG000|Overall Study|Adverse Event|2|||
162117545|NCT02762981|585483454|FG001|Overall Study|Adverse Event|3|||
162117546|NCT02762981|585483455|FG002|Overall Study|Adverse Event|1|||
162117547|NCT02762981|585483456|FG003|Overall Study|Adverse Event|1|||
162117548|NCT02762981|585483457|FG004|Overall Study|Adverse Event|3|||
162117549|NCT02762981|585483453|FG000|Overall Study|Physician Decision|0|||
162117550|NCT02762981|585483454|FG001|Overall Study|Physician Decision|1|||
162117551|NCT02762981|585483455|FG002|Overall Study|Physician Decision|0|||
162117552|NCT02762981|585483456|FG003|Overall Study|Physician Decision|0|||
162117553|NCT02762981|585483457|FG004|Overall Study|Physician Decision|1|||
162117554|NCT02762981|585483453|FG000|Overall Study|Disease progression|11|||
162117555|NCT02762981|585483454|FG001|Overall Study|Disease progression|23|||
162117556|NCT02762981|585483455|FG002|Overall Study|Disease progression|4|||
162117557|NCT02762981|585483456|FG003|Overall Study|Disease progression|10|||
162117558|NCT02762981|585483457|FG004|Overall Study|Disease progression|1|||
162117559|NCT02762981|585483453|FG000|Overall Study|Enrolled not treated|1|||
162117560|NCT02762981|585483454|FG001|Overall Study|Enrolled not treated|5|||
162117561|NCT02762981|585483455|FG002|Overall Study|Enrolled not treated|0|||
162117562|NCT02762981|585483456|FG003|Overall Study|Enrolled not treated|2|||
162117563|NCT02762981|585483457|FG004|Overall Study|Enrolled not treated|0|||
162117564|NCT02762981|585483453|FG000|Overall Study|Other|2|||
162117565|NCT02762981|585483454|FG001|Overall Study|Other|3|||
162117566|NCT02762981|585483455|FG002|Overall Study|Other|1|||
162117567|NCT02762981|585483456|FG003|Overall Study|Other|0|||
162117568|NCT02762981|585483457|FG004|Overall Study|Other|0|||
162117569|NCT02762981|585483453|FG000|Overall Study|Missing|1|||
162117570|NCT02762981|585483454|FG001|Overall Study|Missing|0|||
162117571|NCT02762981|585483455|FG002|Overall Study|Missing|0|||
162117572|NCT02762981|585483456|FG003|Overall Study|Missing|0|||
162117573|NCT02762981|585483457|FG004|Overall Study|Missing|0|||
162117574|NCT02762981|585483453|FG000|Overall Study|Withdrawal by Subject|0|||
162117575|NCT02762981|585483454|FG001|Overall Study|Withdrawal by Subject|5|||
162117576|NCT02762981|585483455|FG002|Overall Study|Withdrawal by Subject|1|||
162117577|NCT02762981|585483456|FG003|Overall Study|Withdrawal by Subject|3|||
162117578|NCT02762981|585483457|FG004|Overall Study|Withdrawal by Subject|0|||
162117579|NCT02991482|585483458|FG000|Overall Study|Disease progression|56|||
162117580|NCT02991482|585483459|FG001|Overall Study|Disease progression|47|||
162117581|NCT02991482|585483458|FG000|Overall Study|Death|4|||
162117582|NCT02991482|585483459|FG001|Overall Study|Death|4|||
162117583|NCT02991482|585483458|FG000|Overall Study|Adverse Event|1|||
162117584|NCT02991482|585483459|FG001|Overall Study|Adverse Event|6|||
162117585|NCT02991482|585483458|FG000|Overall Study|Patient decision|1|||
162117586|NCT02991482|585483459|FG001|Overall Study|Patient decision|1|||
162117587|NCT02991482|585483458|FG000|Overall Study|Physician Decision|0|||
162117588|NCT02991482|585483459|FG001|Overall Study|Physician Decision|6|||
162117589|NCT02991482|585483458|FG000|Overall Study|Clinical deterioration|1|||
162117590|NCT02991482|585483459|FG001|Overall Study|Clinical deterioration|0|||
162117591|NCT02991482|585483458|FG000|Overall Study|Patient feeling too unwell|1|||
162117592|NCT02991482|585483459|FG001|Overall Study|Patient feeling too unwell|0|||
162117593|NCT02991482|585483458|FG000|Overall Study|Worsening of performance status|0|||
162117594|NCT02991482|585483459|FG001|Overall Study|Worsening of performance status|1|||
162117595|NCT02991482|585483458|FG000|Overall Study|Death prior to study drug initiation|1|||
162117596|NCT02991482|585483459|FG001|Overall Study|Death prior to study drug initiation|0|||
162117597|NCT02991482|585483458|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
162117598|NCT02991482|585483459|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
162117599|NCT02887989|585483468|FG000|Overall Study|Withdrawal by Subject|8|||
162117600|NCT02887989|585483469|FG001|Overall Study|Withdrawal by Subject|11|||
162117601|NCT02887989|585483468|FG000|Overall Study|Death|1|||
162117602|NCT02887989|585483469|FG001|Overall Study|Death|0|||
162117603|NCT05648357|585483470|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
162117604|NCT00768430|585483471|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
162117605|NCT00768430|585483472|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
162117606|NCT03585296|585483475|FG000|Overall Study|Adverse Event|1|||
162117607|NCT03585296|585483475|FG000|Overall Study|Lost to Follow-up|2|||
162117608|NCT03585296|585483475|FG000|Overall Study|Withdrawal by Subject|2|||
162117609|NCT00041756|585483476|FG000|Overall Study|Adverse Event|4|||
162117610|NCT00041756|585483477|FG001|Overall Study|Adverse Event|10|||
162117611|NCT00041756|585483478|FG002|Overall Study|Adverse Event|6|||
162117612|NCT00041756|585483479|FG003|Overall Study|Adverse Event|11|||
162117613|NCT00041756|585483480|FG004|Overall Study|Adverse Event|34|||
162117614|NCT00041756|585483476|FG000|Overall Study|Protocol Violation|1|||
162117615|NCT00041756|585483477|FG001|Overall Study|Protocol Violation|1|||
162117616|NCT00041756|585483478|FG002|Overall Study|Protocol Violation|2|||
162117617|NCT00041756|585483479|FG003|Overall Study|Protocol Violation|2|||
162117618|NCT00041756|585483480|FG004|Overall Study|Protocol Violation|1|||
162117619|NCT00041756|585483476|FG000|Overall Study|Withdrawal by Subject|3|||
162117620|NCT00041756|585483477|FG001|Overall Study|Withdrawal by Subject|3|||
162117621|NCT00041756|585483478|FG002|Overall Study|Withdrawal by Subject|4|||
162117622|NCT00041756|585483479|FG003|Overall Study|Withdrawal by Subject|2|||
162117623|NCT00041756|585483480|FG004|Overall Study|Withdrawal by Subject|3|||
162117624|NCT00041756|585483476|FG000|Overall Study|Lost to Follow-up|0|||
162117625|NCT00041756|585483477|FG001|Overall Study|Lost to Follow-up|1|||
162117626|NCT00041756|585483478|FG002|Overall Study|Lost to Follow-up|0|||
162117627|NCT00041756|585483479|FG003|Overall Study|Lost to Follow-up|1|||
162117628|NCT00041756|585483480|FG004|Overall Study|Lost to Follow-up|0|||
162117629|NCT00041756|585483476|FG000|Overall Study|Unable to meet protocol criteria|0|||
162117630|NCT00041756|585483477|FG001|Overall Study|Unable to meet protocol criteria|0|||
162117631|NCT00041756|585483478|FG002|Overall Study|Unable to meet protocol criteria|1|||
162117632|NCT00041756|585483479|FG003|Overall Study|Unable to meet protocol criteria|0|||
162117633|NCT00041756|585483480|FG004|Overall Study|Unable to meet protocol criteria|1|||
162117634|NCT00041756|585483476|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
162117635|NCT00041756|585483477|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
162117636|NCT00041756|585483478|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
162117637|NCT00041756|585483479|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
162117638|NCT00041756|585483480|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
162117639|NCT02110732|585483481|FG000|Overall Study|Physician Decision|5|||
162117640|NCT02110732|585483482|FG001|Overall Study|Physician Decision|2|||
162117641|NCT02110732|585483481|FG000|Overall Study|Lost to Follow-up|1|||
162117642|NCT02110732|585483482|FG001|Overall Study|Lost to Follow-up|1|||
162117643|NCT04887948|585483486|FG000|Overall Study|Death|1|||
162117644|NCT04887948|585483487|FG001|Overall Study|Death|0|||
162117645|NCT04887948|585483488|FG002|Overall Study|Death|0|||
162117646|NCT04887948|585483486|FG000|Overall Study|Lost to Follow-up|1|||
162117647|NCT04887948|585483487|FG001|Overall Study|Lost to Follow-up|0|||
162117648|NCT04887948|585483488|FG002|Overall Study|Lost to Follow-up|3|||
162117649|NCT04887948|585483486|FG000|Overall Study|Physician Decision|0|||
162117650|NCT04887948|585483487|FG001|Overall Study|Physician Decision|4|||
162117651|NCT04887948|585483488|FG002|Overall Study|Physician Decision|1|||
162117652|NCT04887948|585483486|FG000|Overall Study|Protocol Violation|1|||
162117653|NCT04887948|585483487|FG001|Overall Study|Protocol Violation|1|||
162117654|NCT04887948|585483488|FG002|Overall Study|Protocol Violation|0|||
162117655|NCT04887948|585483486|FG000|Overall Study|Withdrawal by Subject|0|||
162117656|NCT04887948|585483487|FG001|Overall Study|Withdrawal by Subject|6|||
162117657|NCT04887948|585483488|FG002|Overall Study|Withdrawal by Subject|1|||
162117658|NCT04887948|585483486|FG000|Overall Study|No longer met eligibility criteria|1|||
162117659|NCT04887948|585483487|FG001|Overall Study|No longer met eligibility criteria|2|||
162117660|NCT04887948|585483488|FG002|Overall Study|No longer met eligibility criteria|1|||
162117661|NCT04887948|585483486|FG000|Overall Study|Other|2|||
162117662|NCT04887948|585483487|FG001|Overall Study|Other|1|||
162117663|NCT04887948|585483488|FG002|Overall Study|Other|1|||
162117664|NCT02312856|585483489|FG000|Overall Study|Death|1|||
162117665|NCT02312856|585483489|FG000|Overall Study|Lost to Follow-up|3|||
162117666|NCT04415151|585483490|FG000|Overall Study|Death|1|||
162117667|NCT04415151|585483491|FG001|Overall Study|Death|1|||
162117668|NCT04415151|585483490|FG000|Overall Study|Withdrawal by Subject|1|||
162117669|NCT04415151|585483491|FG001|Overall Study|Withdrawal by Subject|0|||
162117670|NCT00638235|585483492|FG000|Overall Study|Lost to Follow-up|31|||
162117671|NCT00638235|585483493|FG001|Overall Study|Lost to Follow-up|3|||
162117672|NCT00638235|585483494|FG002|Overall Study|Lost to Follow-up|18|||
162117673|NCT00638235|585483495|FG003|Overall Study|Lost to Follow-up|10|||
162117674|NCT00638235|585483496|FG004|Overall Study|Lost to Follow-up|13|||
162117675|NCT00638235|585483497|FG005|Overall Study|Lost to Follow-up|26|||
162117676|NCT00638235|585483498|FG006|Overall Study|Lost to Follow-up|0|||
162117677|NCT00638235|585483499|FG007|Overall Study|Lost to Follow-up|1|||
162117678|NCT00638235|585483500|FG008|Overall Study|Lost to Follow-up|18|||
162117679|NCT01588990|585483503|FG000|Phase A|Withdrawal by Subject|5|||
162117680|NCT01588990|585483503|FG000|Phase A|Physician Decision|11|||
162117681|NCT01588990|585483503|FG000|Phase A|Other|14|||
162117682|NCT01588990|585483503|FG000|Phase A|Lost to Follow-up|1|||
162117683|NCT01588990|585483503|FG000|Phase A|Death|5|||
162117684|NCT01588990|585483503|FG000|Phase A|Adverse Event|28|||
162117685|NCT01588990|585483503|FG000|Phase A|Still on therapy at end of study|6|||
162117686|NCT01588990|585483503|FG000|Phase B|Adverse Event|2|||
162117687|NCT01588990|585483503|FG000|Phase B|Still on therapy at end of study|5|||
162117688|NCT01588990|585483503|FG000|Phase B|Withdrawal by Subject|3|||
162117689|NCT01588990|585483503|FG000|Phase B|Physician Decision|4|||
162117690|NCT01588990|585483503|FG000|Phase B|Other|2|||
162117691|NCT02367716|585483504|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
162117692|NCT01473381|585483505|FG000|Overall Study|Adverse Event|8|||
162117693|NCT01473381|585483506|FG001|Overall Study|Adverse Event|20|||
162117694|NCT01473381|585483507|FG002|Overall Study|Adverse Event|25|||
162117695|NCT01473381|585483508|FG003|Overall Study|Adverse Event|17|||
162117696|NCT01473381|585483505|FG000|Overall Study|Insufficient Therapeutic Response|10|||
162117697|NCT01473381|585483506|FG001|Overall Study|Insufficient Therapeutic Response|1|||
162117698|NCT01473381|585483507|FG002|Overall Study|Insufficient Therapeutic Response|2|||
162117699|NCT01473381|585483508|FG003|Overall Study|Insufficient Therapeutic Response|3|||
162117700|NCT01473381|585483505|FG000|Overall Study|Protocol Violation|17|||
162117701|NCT01473381|585483506|FG001|Overall Study|Protocol Violation|23|||
162117702|NCT01473381|585483507|FG002|Overall Study|Protocol Violation|19|||
162117703|NCT01473381|585483508|FG003|Overall Study|Protocol Violation|17|||
162117704|NCT01473381|585483505|FG000|Overall Study|Withdrawal of Consent|20|||
162117705|NCT01473381|585483506|FG001|Overall Study|Withdrawal of Consent|21|||
162117706|NCT01473381|585483507|FG002|Overall Study|Withdrawal of Consent|20|||
162117707|NCT01473381|585483508|FG003|Overall Study|Withdrawal of Consent|26|||
162117708|NCT01473381|585483505|FG000|Overall Study|Lost to Follow-up|25|||
162117709|NCT01473381|585483506|FG001|Overall Study|Lost to Follow-up|28|||
162117710|NCT01473381|585483507|FG002|Overall Study|Lost to Follow-up|35|||
162117711|NCT01473381|585483508|FG003|Overall Study|Lost to Follow-up|23|||
162117712|NCT01473381|585483505|FG000|Overall Study|Other Reasons|0|||
162117713|NCT01473381|585483506|FG001|Overall Study|Other Reasons|0|||
162117714|NCT01473381|585483507|FG002|Overall Study|Other Reasons|1|||
162117715|NCT01473381|585483508|FG003|Overall Study|Other Reasons|3|||
162117716|NCT00539643|585483509|FG000|Overall Study|Adverse Event|1|||
162117717|NCT00539643|585483510|FG001|Overall Study|Adverse Event|0|||
162117718|NCT00539643|585483509|FG000|Overall Study|Death|2|||
162117719|NCT00539643|585483510|FG001|Overall Study|Death|1|||
162117720|NCT00539643|585483509|FG000|Overall Study|Physician Decision|3|||
162117721|NCT00539643|585483510|FG001|Overall Study|Physician Decision|1|||
162117722|NCT00539643|585483509|FG000|Overall Study|Withdrawal by Subject|0|||
162117723|NCT00539643|585483510|FG001|Overall Study|Withdrawal by Subject|1|||
162117724|NCT01641926|585483513|FG000|Overall Study|Adverse Event|5|||
162117725|NCT01641926|585483514|FG001|Overall Study|Adverse Event|2|||
162117726|NCT01641926|585483515|FG002|Overall Study|Adverse Event|3|||
162117727|NCT01641926|585483516|FG003|Overall Study|Adverse Event|1|||
162117728|NCT01641926|585483513|FG000|Overall Study|Lost to Follow-up|2|||
162117729|NCT01641926|585483514|FG001|Overall Study|Lost to Follow-up|2|||
162117730|NCT01641926|585483515|FG002|Overall Study|Lost to Follow-up|1|||
162117731|NCT01641926|585483516|FG003|Overall Study|Lost to Follow-up|0|||
162117732|NCT01641926|585483513|FG000|Overall Study|Physician Decision|6|||
162117733|NCT01641926|585483514|FG001|Overall Study|Physician Decision|5|||
162117734|NCT01641926|585483515|FG002|Overall Study|Physician Decision|0|||
162117735|NCT01641926|585483516|FG003|Overall Study|Physician Decision|1|||
162117736|NCT01641926|585483513|FG000|Overall Study|Protocol Violation|1|||
162117737|NCT01641926|585483514|FG001|Overall Study|Protocol Violation|0|||
162117738|NCT01641926|585483515|FG002|Overall Study|Protocol Violation|0|||
162117739|NCT01641926|585483516|FG003|Overall Study|Protocol Violation|1|||
162117740|NCT01641926|585483513|FG000|Overall Study|Withdrawal by Subject|13|||
162117741|NCT01641926|585483514|FG001|Overall Study|Withdrawal by Subject|5|||
162117742|NCT01641926|585483515|FG002|Overall Study|Withdrawal by Subject|6|||
162117743|NCT01641926|585483516|FG003|Overall Study|Withdrawal by Subject|1|||
162117744|NCT01641926|585483513|FG000|Overall Study|Not Treated|1|||
162117745|NCT01641926|585483514|FG001|Overall Study|Not Treated|1|||
162117746|NCT01641926|585483515|FG002|Overall Study|Not Treated|1|||
162117747|NCT01641926|585483516|FG003|Overall Study|Not Treated|0|||
162117748|NCT04399356|585483517|FG000|Overall Study|Lost to Follow-up|1|||
162117749|NCT04399356|585483518|FG001|Overall Study|Lost to Follow-up|1|||
162117750|NCT04399356|585483517|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
162117751|NCT04399356|585483518|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
162117752|NCT04399356|585483517|FG000|Overall Study|Withdrawal by Subject|1|||
162117753|NCT04399356|585483518|FG001|Overall Study|Withdrawal by Subject|0|||
162117754|NCT03812536|585483519|FG000|Overall Study|Protocol Violation|2|||
162117755|NCT03812536|585483520|FG001|Overall Study|Protocol Violation|0|||
162117756|NCT03812536|585483519|FG000|Overall Study|Withdrawal by Subject|1|||
162117757|NCT03812536|585483520|FG001|Overall Study|Withdrawal by Subject|1|||
162117758|NCT00152009|585483521|FG000|Overall Study|Adverse Event|9|||
162117759|NCT00152009|585483522|FG001|Overall Study|Adverse Event|13|||
162117760|NCT00152009|585483523|FG002|Overall Study|Adverse Event|20|||
162117761|NCT00152009|585483524|FG003|Overall Study|Adverse Event|1|||
162117762|NCT00152009|585483521|FG000|Overall Study|Protocol Violation|3|||
162117763|NCT00152009|585483522|FG001|Overall Study|Protocol Violation|0|||
162117764|NCT00152009|585483523|FG002|Overall Study|Protocol Violation|0|||
162117765|NCT00152009|585483524|FG003|Overall Study|Protocol Violation|1|||
162117766|NCT00152009|585483521|FG000|Overall Study|Withdrawal by Subject|2|||
162117767|NCT00152009|585483522|FG001|Overall Study|Withdrawal by Subject|3|||
162117768|NCT00152009|585483523|FG002|Overall Study|Withdrawal by Subject|4|||
162117769|NCT00152009|585483524|FG003|Overall Study|Withdrawal by Subject|9|||
162117770|NCT00152009|585483521|FG000|Overall Study|Lost to Follow-up|2|||
162117771|NCT00152009|585483522|FG001|Overall Study|Lost to Follow-up|4|||
162117772|NCT00152009|585483523|FG002|Overall Study|Lost to Follow-up|3|||
162117773|NCT00152009|585483524|FG003|Overall Study|Lost to Follow-up|3|||
162117774|NCT00152009|585483521|FG000|Overall Study|Lack of Efficacy|8|||
162117775|NCT00152009|585483522|FG001|Overall Study|Lack of Efficacy|6|||
162117776|NCT00152009|585483523|FG002|Overall Study|Lack of Efficacy|7|||
162117777|NCT00152009|585483524|FG003|Overall Study|Lack of Efficacy|15|||
162117778|NCT00152009|585483521|FG000|Overall Study|ECG abnormalities|2|||
162117779|NCT00152009|585483522|FG001|Overall Study|ECG abnormalities|2|||
162117780|NCT00152009|585483523|FG002|Overall Study|ECG abnormalities|2|||
162117781|NCT00152009|585483524|FG003|Overall Study|ECG abnormalities|1|||
162117782|NCT00152009|585483521|FG000|Overall Study|Sponsor's decision|3|||
162117783|NCT00152009|585483522|FG001|Overall Study|Sponsor's decision|3|||
162117784|NCT00152009|585483523|FG002|Overall Study|Sponsor's decision|1|||
162117785|NCT00152009|585483524|FG003|Overall Study|Sponsor's decision|3|||
162117786|NCT01306201|585483525|FG000|Overall Study|Arrhythmia|4|||
162117787|NCT01306201|585483525|FG000|Overall Study|Files could not be processed|3|||
162117788|NCT01306201|585483525|FG000|Overall Study|Files unreadable|3|||
162117789|NCT00393523|585483526|FG000|Overall Study|Lost to Follow-up|0|||
162117790|NCT00393523|585483527|FG001|Overall Study|Lost to Follow-up|0|||
162117791|NCT00393523|585483528|FG002|Overall Study|Lost to Follow-up|0|||
162117792|NCT00393523|585483529|FG003|Overall Study|Lost to Follow-up|2|||
162117793|NCT00393523|585483530|FG004|Overall Study|Lost to Follow-up|1|||
162117794|NCT00393523|585483526|FG000|Overall Study|Protocol Violation|6|||
162117795|NCT00393523|585483527|FG001|Overall Study|Protocol Violation|2|||
162117796|NCT00393523|585483528|FG002|Overall Study|Protocol Violation|0|||
162117797|NCT00393523|585483529|FG003|Overall Study|Protocol Violation|1|||
162117798|NCT00393523|585483530|FG004|Overall Study|Protocol Violation|0|||
162117799|NCT00393523|585483526|FG000|Overall Study|Withdrawal by Subject|6|||
162117800|NCT00393523|585483527|FG001|Overall Study|Withdrawal by Subject|7|||
162117801|NCT00393523|585483528|FG002|Overall Study|Withdrawal by Subject|2|||
162117802|NCT00393523|585483529|FG003|Overall Study|Withdrawal by Subject|3|||
162117803|NCT00393523|585483530|FG004|Overall Study|Withdrawal by Subject|0|||
162117804|NCT00393523|585483526|FG000|Overall Study|Difficulties in specimen collection|0|||
162117805|NCT00393523|585483527|FG001|Overall Study|Difficulties in specimen collection|0|||
162117806|NCT00393523|585483528|FG002|Overall Study|Difficulties in specimen collection|1|||
162117807|NCT00393523|585483529|FG003|Overall Study|Difficulties in specimen collection|0|||
162117808|NCT00393523|585483530|FG004|Overall Study|Difficulties in specimen collection|0|||
162117809|NCT00393523|585483526|FG000|Overall Study|Vaccine supply issue|0|||
162117810|NCT00393523|585483527|FG001|Overall Study|Vaccine supply issue|0|||
162117811|NCT00393523|585483528|FG002|Overall Study|Vaccine supply issue|1|||
162117812|NCT00393523|585483529|FG003|Overall Study|Vaccine supply issue|0|||
162117813|NCT00393523|585483530|FG004|Overall Study|Vaccine supply issue|0|||
162117814|NCT01735396|585483536|FG000|Overall Study|not evaluable|1|||
162117815|NCT00980005|585483539|FG000|Overall Study|Withdrawal by Subject|6|||
162117816|NCT00980005|585483540|FG001|Overall Study|Withdrawal by Subject|17|||
162117817|NCT00980005|585483539|FG000|Overall Study|Lost to Follow-up|37|||
162117818|NCT00980005|585483540|FG001|Overall Study|Lost to Follow-up|43|||
162117819|NCT00980005|585483539|FG000|Overall Study|Other|4|||
162117820|NCT00980005|585483540|FG001|Overall Study|Other|3|||
162117821|NCT00572624|585483541|FG000|Overall Study|Lost to Follow-up|10|||
162117822|NCT00572624|585483542|FG001|Overall Study|Lost to Follow-up|4|||
162117823|NCT00572624|585483541|FG000|Overall Study|Wanted to do a different diet program|1|||
162117824|NCT00572624|585483542|FG001|Overall Study|Wanted to do a different diet program|0|||
162117825|NCT00572624|585483541|FG000|Overall Study|Medication change|1|||
162117826|NCT00572624|585483542|FG001|Overall Study|Medication change|0|||
162117827|NCT00572624|585483541|FG000|Overall Study|Started a new job-- no time for study|1|||
162117828|NCT00572624|585483542|FG001|Overall Study|Started a new job-- no time for study|0|||
162117829|NCT00572624|585483541|FG000|Overall Study|Admitted to being a smoker|1|||
162117830|NCT00572624|585483542|FG001|Overall Study|Admitted to being a smoker|0|||
162117831|NCT00572624|585483541|FG000|Overall Study|Refused to do the stress test|1|||
162117832|NCT00572624|585483542|FG001|Overall Study|Refused to do the stress test|0|||
162117833|NCT00572624|585483541|FG000|Overall Study|Problem with vascular access|1|||
162117834|NCT00572624|585483542|FG001|Overall Study|Problem with vascular access|0|||
162117835|NCT00572624|585483541|FG000|Overall Study|Health issues unrelated to the study|1|||
162117836|NCT00572624|585483542|FG001|Overall Study|Health issues unrelated to the study|0|||
162117837|NCT00098254|585483547|FG000|Overall Study|Adverse Event|2|||
162117838|NCT00098254|585483547|FG000|Overall Study|Death|1|||
162117839|NCT02118337|585483548|FG000|Overall Study|Other|1|||
162117840|NCT02118337|585483549|FG001|Overall Study|Other|0|||
162117841|NCT02118337|585483550|FG002|Overall Study|Other|0|||
162117842|NCT02118337|585483551|FG003|Overall Study|Other|0|||
162117843|NCT02118337|585483552|FG004|Overall Study|Other|2|||
162117844|NCT02118337|585483553|FG005|Overall Study|Other|3|||
162117845|NCT02118337|585483554|FG006|Overall Study|Other|1|||
162117846|NCT02118337|585483555|FG007|Overall Study|Other|28|||
162117847|NCT02118337|585483556|FG008|Overall Study|Other|15|||
162117848|NCT02118337|585483548|FG000|Overall Study|Lost to Follow-up|0|||
162117849|NCT02118337|585483549|FG001|Overall Study|Lost to Follow-up|0|||
162117850|NCT02118337|585483550|FG002|Overall Study|Lost to Follow-up|0|||
162117851|NCT02118337|585483551|FG003|Overall Study|Lost to Follow-up|0|||
162117852|NCT02118337|585483552|FG004|Overall Study|Lost to Follow-up|0|||
162117853|NCT02118337|585483553|FG005|Overall Study|Lost to Follow-up|0|||
162117854|NCT02118337|585483554|FG006|Overall Study|Lost to Follow-up|0|||
162117855|NCT02118337|585483555|FG007|Overall Study|Lost to Follow-up|1|||
162117856|NCT02118337|585483556|FG008|Overall Study|Lost to Follow-up|0|||
162117857|NCT02118337|585483548|FG000|Overall Study|Withdrawal by Subject|1|||
162117858|NCT02118337|585483549|FG001|Overall Study|Withdrawal by Subject|3|||
162117859|NCT02118337|585483550|FG002|Overall Study|Withdrawal by Subject|2|||
162117860|NCT02118337|585483551|FG003|Overall Study|Withdrawal by Subject|1|||
162117861|NCT02118337|585483552|FG004|Overall Study|Withdrawal by Subject|2|||
162117862|NCT02118337|585483553|FG005|Overall Study|Withdrawal by Subject|2|||
162117863|NCT02118337|585483554|FG006|Overall Study|Withdrawal by Subject|1|||
162117864|NCT02118337|585483555|FG007|Overall Study|Withdrawal by Subject|4|||
162117865|NCT02118337|585483556|FG008|Overall Study|Withdrawal by Subject|2|||
162117866|NCT02118337|585483548|FG000|Overall Study|Death|2|||
162117867|NCT02118337|585483549|FG001|Overall Study|Death|2|||
162117868|NCT02118337|585483550|FG002|Overall Study|Death|1|||
162117869|NCT02118337|585483551|FG003|Overall Study|Death|2|||
162117870|NCT02118337|585483552|FG004|Overall Study|Death|5|||
162117871|NCT02118337|585483553|FG005|Overall Study|Death|1|||
162117872|NCT02118337|585483554|FG006|Overall Study|Death|2|||
162117873|NCT02118337|585483555|FG007|Overall Study|Death|9|||
162117874|NCT02118337|585483556|FG008|Overall Study|Death|4|||
162117875|NCT00130793|585483558|FG000|Overall Study|Lost to Follow-up|1|||
162117876|NCT00130793|585483559|FG001|Overall Study|Lost to Follow-up|4|||
162117877|NCT00130793|585483558|FG000|Overall Study|Withdrew consent|2|||
162117878|NCT00130793|585483559|FG001|Overall Study|Withdrew consent|0|||
162117879|NCT00211237|585483560|FG000|Baseline|Withdrew|1|||
162117880|NCT00211237|585483561|FG001|Baseline|Withdrew|3|||
162117881|NCT00211237|585483562|FG002|Baseline|Withdrew|0|||
162117882|NCT00211237|585483560|FG000|Baseline|Refused random assignment|1|||
162117883|NCT00211237|585483561|FG001|Baseline|Refused random assignment|0|||
162117884|NCT00211237|585483562|FG002|Baseline|Refused random assignment|0|||
162117885|NCT00211237|585483560|FG000|1 Month|Death|2|||
162117886|NCT00211237|585483561|FG001|1 Month|Death|1|||
162117887|NCT00211237|585483562|FG002|1 Month|Death|0|||
162117888|NCT00211237|585483560|FG000|1 Month|Lost to Follow-up|0|||
162117889|NCT00211237|585483561|FG001|1 Month|Lost to Follow-up|2|||
162117890|NCT00211237|585483562|FG002|1 Month|Lost to Follow-up|0|||
162117891|NCT00211237|585483560|FG000|1 Month|Withdrew|0|||
162117892|NCT00211237|585483561|FG001|1 Month|Withdrew|4|||
162117893|NCT00211237|585483562|FG002|1 Month|Withdrew|0|||
162117894|NCT00211237|585483560|FG000|1 Month|Additional surgery needed|1|||
162117895|NCT00211237|585483561|FG001|1 Month|Additional surgery needed|0|||
162117896|NCT00211237|585483562|FG002|1 Month|Additional surgery needed|0|||
162117897|NCT00211237|585483560|FG000|1 Month|Non-medical problem|0|||
162117898|NCT00211237|585483561|FG001|1 Month|Non-medical problem|2|||
162117899|NCT00211237|585483562|FG002|1 Month|Non-medical problem|0|||
162117900|NCT00211237|585483560|FG000|3 Months|Death|7|||
162117901|NCT00211237|585483561|FG001|3 Months|Death|3|||
162117902|NCT00211237|585483562|FG002|3 Months|Death|0|||
162117903|NCT00211237|585483560|FG000|3 Months|Could not comply with protocol|1|||
162117904|NCT00211237|585483561|FG001|3 Months|Could not comply with protocol|0|||
162117905|NCT00211237|585483562|FG002|3 Months|Could not comply with protocol|0|||
162117906|NCT00211237|585483560|FG000|3 Months|Withdrew|0|||
162117907|NCT00211237|585483561|FG001|3 Months|Withdrew|1|||
162117908|NCT00211237|585483562|FG002|3 Months|Withdrew|0|||
162117909|NCT00211237|585483560|FG000|3 Months|Non-medical problem|0|||
162117910|NCT00211237|585483561|FG001|3 Months|Non-medical problem|0|||
162117911|NCT00211237|585483562|FG002|3 Months|Non-medical problem|1|||
162117912|NCT00211237|585483560|FG000|6 Months|Death|6|||
162117913|NCT00211237|585483561|FG001|6 Months|Death|0|||
162117914|NCT00211237|585483562|FG002|6 Months|Death|3|||
162117915|NCT00211237|585483560|FG000|6 Months|Lost to Follow-up|2|||
162117916|NCT00211237|585483561|FG001|6 Months|Lost to Follow-up|0|||
162117917|NCT00211237|585483562|FG002|6 Months|Lost to Follow-up|0|||
162117918|NCT00211237|585483560|FG000|6 Months|Could not comply with protocol|0|||
162117919|NCT00211237|585483561|FG001|6 Months|Could not comply with protocol|2|||
162117920|NCT00211237|585483562|FG002|6 Months|Could not comply with protocol|0|||
162117921|NCT00211237|585483560|FG000|12 Months|Death|8|||
162117922|NCT00211237|585483561|FG001|12 Months|Death|2|||
162117923|NCT00211237|585483562|FG002|12 Months|Death|3|||
162117924|NCT00211237|585483560|FG000|12 Months|Lost to Follow-up|1|||
162117925|NCT00211237|585483561|FG001|12 Months|Lost to Follow-up|0|||
162117926|NCT00211237|585483562|FG002|12 Months|Lost to Follow-up|1|||
162117927|NCT00211237|585483560|FG000|12 Months|Withdrew|0|||
162117928|NCT00211237|585483561|FG001|12 Months|Withdrew|0|||
162117929|NCT00211237|585483562|FG002|12 Months|Withdrew|1|||
162117930|NCT00211237|585483560|FG000|12 Months|unrelated medical problem|0|||
162117931|NCT00211237|585483561|FG001|12 Months|unrelated medical problem|0|||
162117932|NCT00211237|585483562|FG002|12 Months|unrelated medical problem|1|||
162117933|NCT01003639|585483565|FG000|Overall Study|Lost to Follow-up|6|||
162117934|NCT01003639|585483566|FG001|Overall Study|Lost to Follow-up|9|||
162117935|NCT01003639|585483565|FG000|Overall Study|Withdrawal by Subject|9|||
162117936|NCT01003639|585483566|FG001|Overall Study|Withdrawal by Subject|5|||
162117937|NCT01003639|585483565|FG000|Overall Study|Lack of Efficacy|1|||
162117938|NCT01003639|585483566|FG001|Overall Study|Lack of Efficacy|6|||
162117939|NCT01003639|585483565|FG000|Overall Study|Adverse Event|0|||
162117940|NCT01003639|585483566|FG001|Overall Study|Adverse Event|1|||
162117941|NCT01003639|585483565|FG000|Overall Study|Protocol Violation|0|||
162117942|NCT01003639|585483566|FG001|Overall Study|Protocol Violation|1|||
162117943|NCT01003639|585483565|FG000|Overall Study|Physician Decision|1|||
162117944|NCT01003639|585483566|FG001|Overall Study|Physician Decision|0|||
162117945|NCT04000594|585483567|FG000|Overall Study|Withdrawal by Subject|1|||
162117946|NCT04000594|585483568|FG001|Overall Study|Withdrawal by Subject|0|||
162117947|NCT04000594|585483569|FG002|Overall Study|Withdrawal by Subject|0|||
162117948|NCT03489057|585483570|FG000|Overall Study|Lost to Follow-up|16|||
162117949|NCT03489057|585483571|FG001|Overall Study|Lost to Follow-up|16|||
162117950|NCT03489057|585483572|FG002|Overall Study|Lost to Follow-up|14|||
162117951|NCT03489057|585483573|FG003|Overall Study|Lost to Follow-up|14|||
162117952|NCT03489057|585483570|FG000|Overall Study|Withdrawal by Subject|12|||
162117953|NCT03489057|585483571|FG001|Overall Study|Withdrawal by Subject|12|||
162117954|NCT03489057|585483572|FG002|Overall Study|Withdrawal by Subject|8|||
162117955|NCT03489057|585483573|FG003|Overall Study|Withdrawal by Subject|8|||
162117956|NCT03489057|585483570|FG000|Overall Study|Protocol Violation|7|||
162117957|NCT03489057|585483571|FG001|Overall Study|Protocol Violation|7|||
162117958|NCT03489057|585483572|FG002|Overall Study|Protocol Violation|2|||
162117959|NCT03489057|585483573|FG003|Overall Study|Protocol Violation|2|||
162117960|NCT00779779|585483576|FG000|Overall Study|Adverse Event|1|||
162117961|NCT00779779|585483576|FG000|Overall Study|Protocol Violation|14|||
162117962|NCT00779779|585483576|FG000|Overall Study|Withdrawal by Subject|4|||
162117963|NCT00779779|585483576|FG000|Overall Study|Lost to Follow-up|5|||
162117964|NCT01395823|585483577|FG000|Overall Study|Death|4|||
162117965|NCT01395823|585483578|FG001|Overall Study|Death|4|||
162117966|NCT01395823|585483577|FG000|Overall Study|Physician Decision|3|||
162117967|NCT01395823|585483578|FG001|Overall Study|Physician Decision|1|||
162117968|NCT01395823|585483577|FG000|Overall Study|Lost to Follow-up|1|||
162117969|NCT01395823|585483578|FG001|Overall Study|Lost to Follow-up|0|||
162117970|NCT01395823|585483577|FG000|Overall Study|Transplant|1|||
162117971|NCT01395823|585483578|FG001|Overall Study|Transplant|0|||
162117972|NCT01395823|585483577|FG000|Overall Study|GI symptoms|1|||
162117973|NCT01395823|585483578|FG001|Overall Study|GI symptoms|0|||
162117974|NCT01395823|585483577|FG000|Overall Study|Withdrawal by Subject|5|||
162117975|NCT01395823|585483578|FG001|Overall Study|Withdrawal by Subject|4|||
162117976|NCT03300570|585483579|FG000|Overall Study|Adverse Event|0|||
162117977|NCT03300570|585483580|FG001|Overall Study|Adverse Event|1|||
162117978|NCT03300570|585483579|FG000|Overall Study|Withdrawal by Subject|1|||
162117979|NCT03300570|585483580|FG001|Overall Study|Withdrawal by Subject|0|||
162117980|NCT03300570|585483579|FG000|Overall Study|Inadequate bowel prep|1|||
162117981|NCT03300570|585483580|FG001|Overall Study|Inadequate bowel prep|0|||
162117982|NCT00116272|585483581|FG000|Overall Study|Lost to Follow-up|11|||
162117983|NCT00116272|585483582|FG001|Overall Study|Lost to Follow-up|6|||
162117984|NCT03188120|585483583|FG000|Overall Study|Adverse Event|4|||
162117985|NCT03188120|585483583|FG000|Overall Study|Insufficient Effectiveness|8|||
162117986|NCT03188120|585483583|FG000|Overall Study|Improved|12|||
162117987|NCT03188120|585483583|FG000|Overall Study|Lost to Follow-up|7|||
162117988|NCT03188120|585483583|FG000|Overall Study|Other than specified|3|||
162117989|NCT03188120|585483583|FG000|Overall Study|No visit after the first visit|13|||
162117990|NCT00717314|585483586|FG000|Overall Study|Adverse Event|3|||
162117991|NCT00717314|585483587|FG001|Overall Study|Adverse Event|2|||
162117992|NCT00717314|585483586|FG000|Overall Study|Protocol Violation|1|||
162117993|NCT00717314|585483587|FG001|Overall Study|Protocol Violation|0|||
162117994|NCT00717314|585483586|FG000|Overall Study|Lost to Follow-up|1|||
162117995|NCT00717314|585483587|FG001|Overall Study|Lost to Follow-up|5|||
162117996|NCT00717314|585483586|FG000|Overall Study|Withdrawal by Subject|1|||
162117997|NCT00717314|585483587|FG001|Overall Study|Withdrawal by Subject|3|||
162117998|NCT05096208|585483588|FG000|Overall Study|Lost to Follow-up|3|||
162117999|NCT05096208|585483589|FG001|Overall Study|Lost to Follow-up|5|||
162118000|NCT05096208|585483590|FG002|Overall Study|Lost to Follow-up|5|||
162118001|NCT05096208|585483591|FG003|Overall Study|Lost to Follow-up|2|||
162118002|NCT05096208|585483588|FG000|Overall Study|Withdrawal by Subject|0|||
162118003|NCT05096208|585483589|FG001|Overall Study|Withdrawal by Subject|1|||
162118004|NCT05096208|585483590|FG002|Overall Study|Withdrawal by Subject|2|||
162118005|NCT05096208|585483591|FG003|Overall Study|Withdrawal by Subject|3|||
162118006|NCT05096208|585483588|FG000|Overall Study|No longer met eligibility criteria|1|||
162118007|NCT05096208|585483589|FG001|Overall Study|No longer met eligibility criteria|0|||
162118008|NCT05096208|585483590|FG002|Overall Study|No longer met eligibility criteria|0|||
162118009|NCT05096208|585483591|FG003|Overall Study|No longer met eligibility criteria|0|||
162118010|NCT05096208|585483588|FG000|Overall Study|Other|0|||
162118011|NCT05096208|585483589|FG001|Overall Study|Other|0|||
162118012|NCT05096208|585483590|FG002|Overall Study|Other|1|||
162118013|NCT05096208|585483591|FG003|Overall Study|Other|0|||
162118014|NCT01483937|585483593|FG000|Overall Study|Withdrawal by Subject|4|||
162118015|NCT01483937|585483594|FG001|Overall Study|Withdrawal by Subject|3|||
162118016|NCT01833143|585483595|FG000|Overall Study|Not Treated|1|||
162118017|NCT00386308|585485172|FG000|Overall Study|Adverse Event|3|||
162118018|NCT00386308|585485173|FG001|Overall Study|Adverse Event|3|||
162118019|NCT00386308|585485172|FG000|Overall Study|Protocol Violation|2|||
162118020|NCT00386308|585485173|FG001|Overall Study|Protocol Violation|5|||
162118021|NCT00386308|585485172|FG000|Overall Study|Lack of Efficacy|0|||
162118022|NCT00386308|585485173|FG001|Overall Study|Lack of Efficacy|2|||
162118023|NCT00386308|585485172|FG000|Overall Study|Lost to Follow-up|10|||
162118024|NCT00386308|585485173|FG001|Overall Study|Lost to Follow-up|6|||
162118025|NCT00386308|585485172|FG000|Overall Study|Withdrawal by Subject|6|||
162118026|NCT00386308|585485173|FG001|Overall Study|Withdrawal by Subject|2|||
162118027|NCT00386308|585485172|FG000|Overall Study|Other Event|8|||
162118028|NCT00386308|585485173|FG001|Overall Study|Other Event|1|||
162118029|NCT03518658|585485174|FG000|Overall Study|Other|51|||
162118030|NCT03518658|585485175|FG001|Overall Study|Other|0|||
162118031|NCT00649389|585485176|FG000|Overall Study|Adverse Event|22|||
162118032|NCT00649389|585485177|FG001|Overall Study|Adverse Event|46|||
162118033|NCT00649389|585485178|FG002|Overall Study|Adverse Event|38|||
162118034|NCT00649389|585485179|FG003|Overall Study|Adverse Event|48|||
162118035|NCT00649389|585485176|FG000|Overall Study|Lost to Follow-up|15|||
162118036|NCT00649389|585485177|FG001|Overall Study|Lost to Follow-up|17|||
162118037|NCT00649389|585485178|FG002|Overall Study|Lost to Follow-up|21|||
162118038|NCT00649389|585485179|FG003|Overall Study|Lost to Follow-up|26|||
162118039|NCT00649389|585485176|FG000|Overall Study|Protocol Violation|11|||
162118040|NCT00649389|585485177|FG001|Overall Study|Protocol Violation|13|||
162118041|NCT00649389|585485178|FG002|Overall Study|Protocol Violation|9|||
162118042|NCT00649389|585485179|FG003|Overall Study|Protocol Violation|8|||
162118043|NCT00649389|585485176|FG000|Overall Study|Withdrawal by Subject|20|||
162118044|NCT00649389|585485177|FG001|Overall Study|Withdrawal by Subject|21|||
162118045|NCT00649389|585485178|FG002|Overall Study|Withdrawal by Subject|19|||
162118046|NCT00649389|585485179|FG003|Overall Study|Withdrawal by Subject|23|||
162118047|NCT00649389|585485176|FG000|Overall Study|Other|3|||
162118048|NCT00649389|585485177|FG001|Overall Study|Other|9|||
162118049|NCT00649389|585485178|FG002|Overall Study|Other|1|||
162118050|NCT00649389|585485179|FG003|Overall Study|Other|6|||
162118051|NCT02746575|585485182|FG000|Overall Study|Surgery cancelled or time chaned|13|||
162118052|NCT02746575|585485182|FG000|Overall Study|Received epidural|10|||
162118053|NCT02746575|585485182|FG000|Overall Study|Withdrawal by Subject|3|||
162118054|NCT02746575|585485182|FG000|Overall Study|Bradycardia/hypotension|9|||
162118055|NCT02746575|585485182|FG000|Overall Study|Study paused|8|||
162118056|NCT02746575|585485182|FG000|Overall Study|put on beta-blocker|3|||
162118057|NCT02746575|585485182|FG000|Overall Study|type of surgery|1|||
162118058|NCT02746575|585485182|FG000|Overall Study|typ of surgery|1|||
162118059|NCT02746575|585485182|FG000|Overall Study|PI unavailable|1|||
162118060|NCT02746575|585485182|FG000|Overall Study|Unknown history of CVA|1|||
162118061|NCT00976482|585485183|FG000|Overall Study|Death|208|||
162118062|NCT00976482|585485183|FG000|Overall Study|Withdrawal by Subject|45|||
162118063|NCT00976482|585485183|FG000|Overall Study|Center terminated|1|||
162118064|NCT00976482|585485183|FG000|Overall Study|Protocol Violation|5|||
162118065|NCT02959671|585485184|FG000|Overall Study|Adverse Event|2|||
162118066|NCT02959671|585485184|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
162118067|NCT00605319|585485190|FG000|Overall Study|Adverse Event|6|||
162118068|NCT00432835|585485193|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
162118069|NCT00432835|585485194|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
162118070|NCT02002884|585485196|FG000|Main Period (MP)|Other|0|||
162118071|NCT02002884|585485197|FG001|Main Period (MP)|Other|3|||
162118072|NCT02002884|585485198|FG002|Main Period (MP)|Other|3|||
162118073|NCT02002884|585485199|FG003|Main Period (MP)|Other|0|||
162118074|NCT02002884|585485196|FG000|Main Period (MP)|Adverse Event|0|||
162118075|NCT02002884|585485197|FG001|Main Period (MP)|Adverse Event|1|||
162118076|NCT02002884|585485198|FG002|Main Period (MP)|Adverse Event|1|||
162118077|NCT02002884|585485199|FG003|Main Period (MP)|Adverse Event|0|||
162118078|NCT02002884|585485196|FG000|Main Period (MP)|Withdrawal by Subject|6|||
162118079|NCT02002884|585485197|FG001|Main Period (MP)|Withdrawal by Subject|2|||
162118080|NCT02002884|585485198|FG002|Main Period (MP)|Withdrawal by Subject|2|||
162118081|NCT02002884|585485199|FG003|Main Period (MP)|Withdrawal by Subject|0|||
162118082|NCT02002884|585485196|FG000|Main Period (MP)|Lost to Follow-up|0|||
162118083|NCT02002884|585485197|FG001|Main Period (MP)|Lost to Follow-up|0|||
162118084|NCT02002884|585485198|FG002|Main Period (MP)|Lost to Follow-up|2|||
162118085|NCT02002884|585485199|FG003|Main Period (MP)|Lost to Follow-up|0|||
162118086|NCT02002884|585485196|FG000|Open-Label Extension Period (OLEX)|Other|0|||
162118087|NCT02002884|585485197|FG001|Open-Label Extension Period (OLEX)|Other|0|||
162118088|NCT02002884|585485198|FG002|Open-Label Extension Period (OLEX)|Other|0|||
162118089|NCT02002884|585485199|FG003|Open-Label Extension Period (OLEX)|Other|24|||
162118090|NCT02002884|585485196|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
162118091|NCT02002884|585485197|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
162118092|NCT02002884|585485198|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
162118093|NCT02002884|585485199|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
162118094|NCT02002884|585485196|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
162118095|NCT02002884|585485197|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
162118096|NCT02002884|585485198|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
162118097|NCT02002884|585485199|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
162118098|NCT02002884|585485196|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
162118099|NCT02002884|585485197|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
162118100|NCT02002884|585485198|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
162118101|NCT02002884|585485199|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
162118102|NCT02002884|585485196|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
162118103|NCT02002884|585485197|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
162118104|NCT02002884|585485198|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
162118105|NCT02002884|585485199|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
162118106|NCT02145078|585485200|FG000|Overall Study|Death|1|||
162118107|NCT02145078|585485200|FG000|Overall Study|Reason not given|3|||
162118108|NCT01350141|585485201|FG000|Overall Study|Lost to Follow-up|1|||
162118109|NCT01350141|585485202|FG001|Overall Study|Lost to Follow-up|0|||
162118110|NCT01350141|585485203|FG002|Overall Study|Lost to Follow-up|1|||
162118111|NCT01350141|585485201|FG000|Overall Study|Withdrawal by Subject|1|||
162118112|NCT01350141|585485202|FG001|Overall Study|Withdrawal by Subject|0|||
162118113|NCT01350141|585485203|FG002|Overall Study|Withdrawal by Subject|0|||
162118114|NCT01350141|585485201|FG000|Overall Study|Randomized but not treated|1|||
162118115|NCT01350141|585485202|FG001|Overall Study|Randomized but not treated|0|||
162118116|NCT01350141|585485203|FG002|Overall Study|Randomized but not treated|0|||
162118117|NCT00810082|585485204|FG000|Overall Study|Lost to Follow-up|0|||
162118118|NCT00810082|585485205|FG001|Overall Study|Lost to Follow-up|4|||
162118119|NCT02508532|585485210|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162118120|NCT02508532|585485211|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162118121|NCT02508532|585485212|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162118122|NCT02508532|585485213|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162118123|NCT02508532|585485214|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162118124|NCT02508532|585485215|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162118125|NCT02508532|585485216|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
162118126|NCT02508532|585485217|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162118127|NCT02508532|585485218|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
162118128|NCT02508532|585485210|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
162118129|NCT02508532|585485211|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
162118130|NCT02508532|585485212|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
162118131|NCT02508532|585485213|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
162118132|NCT02508532|585485214|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
162118133|NCT02508532|585485215|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
162118134|NCT02508532|585485216|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
162118135|NCT02508532|585485217|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
162118136|NCT02508532|585485218|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
162118137|NCT02508532|585485210|FG000|Part 2 - Treatment|Disease Progression|0|||
162118138|NCT02508532|585485211|FG001|Part 2 - Treatment|Disease Progression|0|||
162118139|NCT02508532|585485212|FG002|Part 2 - Treatment|Disease Progression|0|||
162118140|NCT02508532|585485213|FG003|Part 2 - Treatment|Disease Progression|0|||
162118141|NCT02508532|585485214|FG004|Part 2 - Treatment|Disease Progression|0|||
162118142|NCT02508532|585485215|FG005|Part 2 - Treatment|Disease Progression|0|||
162118143|NCT02508532|585485216|FG006|Part 2 - Treatment|Disease Progression|0|||
162118144|NCT02508532|585485217|FG007|Part 2 - Treatment|Disease Progression|0|||
162118145|NCT02508532|585485218|FG008|Part 2 - Treatment|Disease Progression|118|||
162118146|NCT02508532|585485210|FG000|Part 2 - Treatment|Adverse Event|0|||
162118147|NCT02508532|585485211|FG001|Part 2 - Treatment|Adverse Event|0|||
162118148|NCT02508532|585485212|FG002|Part 2 - Treatment|Adverse Event|0|||
162118149|NCT02508532|585485213|FG003|Part 2 - Treatment|Adverse Event|0|||
162118150|NCT02508532|585485214|FG004|Part 2 - Treatment|Adverse Event|0|||
162118151|NCT02508532|585485215|FG005|Part 2 - Treatment|Adverse Event|0|||
162118152|NCT02508532|585485216|FG006|Part 2 - Treatment|Adverse Event|0|||
162118153|NCT02508532|585485217|FG007|Part 2 - Treatment|Adverse Event|0|||
162118154|NCT02508532|585485218|FG008|Part 2 - Treatment|Adverse Event|49|||
162118155|NCT02508532|585485210|FG000|Part 2 - Treatment|Physician Decision|0|||
162118156|NCT02508532|585485211|FG001|Part 2 - Treatment|Physician Decision|0|||
162118157|NCT02508532|585485212|FG002|Part 2 - Treatment|Physician Decision|0|||
162118158|NCT02508532|585485213|FG003|Part 2 - Treatment|Physician Decision|0|||
162118159|NCT02508532|585485214|FG004|Part 2 - Treatment|Physician Decision|0|||
162118160|NCT02508532|585485215|FG005|Part 2 - Treatment|Physician Decision|0|||
162118161|NCT02508532|585485216|FG006|Part 2 - Treatment|Physician Decision|0|||
162118162|NCT02508532|585485217|FG007|Part 2 - Treatment|Physician Decision|0|||
162118163|NCT02508532|585485218|FG008|Part 2 - Treatment|Physician Decision|12|||
162118164|NCT02508532|585485210|FG000|Part 2 - Treatment|Administrative|0|||
162118165|NCT02508532|585485211|FG001|Part 2 - Treatment|Administrative|0|||
162118166|NCT02508532|585485212|FG002|Part 2 - Treatment|Administrative|0|||
162118167|NCT02508532|585485213|FG003|Part 2 - Treatment|Administrative|0|||
162118168|NCT02508532|585485214|FG004|Part 2 - Treatment|Administrative|0|||
162118169|NCT02508532|585485215|FG005|Part 2 - Treatment|Administrative|0|||
162118170|NCT02508532|585485216|FG006|Part 2 - Treatment|Administrative|0|||
162118171|NCT02508532|585485217|FG007|Part 2 - Treatment|Administrative|0|||
162118172|NCT02508532|585485218|FG008|Part 2 - Treatment|Administrative|3|||
162118173|NCT02508532|585485210|FG000|Part 2 - Treatment|Sponsor Decision|0|||
162118174|NCT02508532|585485211|FG001|Part 2 - Treatment|Sponsor Decision|0|||
162118175|NCT02508532|585485212|FG002|Part 2 - Treatment|Sponsor Decision|0|||
162118176|NCT02508532|585485213|FG003|Part 2 - Treatment|Sponsor Decision|0|||
162118177|NCT02508532|585485214|FG004|Part 2 - Treatment|Sponsor Decision|0|||
162118178|NCT02508532|585485215|FG005|Part 2 - Treatment|Sponsor Decision|0|||
162118179|NCT02508532|585485216|FG006|Part 2 - Treatment|Sponsor Decision|0|||
162118180|NCT02508532|585485217|FG007|Part 2 - Treatment|Sponsor Decision|0|||
162118181|NCT02508532|585485218|FG008|Part 2 - Treatment|Sponsor Decision|28|||
162118182|NCT02508532|585485210|FG000|Part 2 - Treatment|Death|0|||
162118183|NCT02508532|585485211|FG001|Part 2 - Treatment|Death|0|||
162118184|NCT02508532|585485212|FG002|Part 2 - Treatment|Death|0|||
162118185|NCT02508532|585485213|FG003|Part 2 - Treatment|Death|0|||
162118186|NCT02508532|585485214|FG004|Part 2 - Treatment|Death|0|||
162118187|NCT02508532|585485215|FG005|Part 2 - Treatment|Death|0|||
162118188|NCT02508532|585485216|FG006|Part 2 - Treatment|Death|0|||
162118189|NCT02508532|585485217|FG007|Part 2 - Treatment|Death|0|||
162118190|NCT02508532|585485218|FG008|Part 2 - Treatment|Death|1|||
162118191|NCT02508532|585485210|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
162118192|NCT02508532|585485211|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
162118193|NCT02508532|585485212|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
162118194|NCT02508532|585485213|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
162118195|NCT02508532|585485214|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
162118196|NCT02508532|585485215|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
162118197|NCT02508532|585485216|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
162118198|NCT02508532|585485217|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
162118199|NCT02508532|585485218|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
162118200|NCT02508532|585485210|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
162118201|NCT02508532|585485211|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
162118202|NCT02508532|585485212|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
162118203|NCT02508532|585485213|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
162118204|NCT02508532|585485214|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
162118205|NCT02508532|585485215|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
162118206|NCT02508532|585485216|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
162118207|NCT02508532|585485217|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
162118208|NCT02508532|585485218|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
162118209|NCT02508532|585485210|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
162118210|NCT02508532|585485211|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
162118211|NCT02508532|585485212|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
162118212|NCT02508532|585485213|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
162118213|NCT02508532|585485214|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
162118214|NCT02508532|585485215|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
162118215|NCT02508532|585485216|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
162118216|NCT02508532|585485217|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
162118217|NCT02508532|585485218|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
162118218|NCT02508532|585485210|FG000|Part 1 and Part 2 End of Study|Death|0|||
162118219|NCT02508532|585485211|FG001|Part 1 and Part 2 End of Study|Death|4|||
162118220|NCT02508532|585485212|FG002|Part 1 and Part 2 End of Study|Death|2|||
162118221|NCT02508532|585485213|FG003|Part 1 and Part 2 End of Study|Death|4|||
162118222|NCT02508532|585485214|FG004|Part 1 and Part 2 End of Study|Death|3|||
162118223|NCT02508532|585485215|FG005|Part 1 and Part 2 End of Study|Death|0|||
162118224|NCT02508532|585485216|FG006|Part 1 and Part 2 End of Study|Death|0|||
162118225|NCT02508532|585485217|FG007|Part 1 and Part 2 End of Study|Death|1|||
162118226|NCT02508532|585485218|FG008|Part 1 and Part 2 End of Study|Death|111|||
162118227|NCT02508532|585485210|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
162118228|NCT02508532|585485211|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
162118229|NCT02508532|585485212|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
162118230|NCT02508532|585485213|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
162118231|NCT02508532|585485214|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
162118232|NCT02508532|585485215|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
162118233|NCT02508532|585485216|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
162118234|NCT02508532|585485217|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
162118235|NCT02508532|585485218|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
162118236|NCT02508532|585485210|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162118237|NCT02508532|585485211|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162118238|NCT02508532|585485212|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162118239|NCT02508532|585485213|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162118240|NCT02508532|585485214|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162118241|NCT02508532|585485215|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162118242|NCT02508532|585485216|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162118243|NCT02508532|585485217|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
162118244|NCT02508532|585485218|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
162118245|NCT02508532|585485210|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
162118246|NCT02508532|585485211|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
162118247|NCT02508532|585485212|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
162118248|NCT02508532|585485213|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
162118249|NCT02508532|585485214|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
162118250|NCT02508532|585485215|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
162118251|NCT02508532|585485216|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
162118252|NCT02508532|585485217|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
162118253|NCT02508532|585485218|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
162118254|NCT02508532|585485210|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162118255|NCT02508532|585485211|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162118256|NCT02508532|585485212|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162118257|NCT02508532|585485213|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162118258|NCT02508532|585485214|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162118259|NCT02508532|585485215|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162118260|NCT02508532|585485216|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162118261|NCT02508532|585485217|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
162118262|NCT02508532|585485218|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
162118263|NCT02508532|585485210|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
162118264|NCT02508532|585485211|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
162118265|NCT02508532|585485212|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
162118266|NCT02508532|585485213|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
162118267|NCT02508532|585485214|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
162118268|NCT02508532|585485215|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
162118269|NCT02508532|585485216|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
162118270|NCT02508532|585485217|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
162118271|NCT02508532|585485218|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
162118272|NCT01111838|585485219|FG000|Overall Study|Patient Ineligible|2|||
162118273|NCT01111838|585485219|FG000|Overall Study|Not Treated|3|||
162118274|NCT01111838|585485219|FG000|Overall Study|Clinical deterioration|1|||
162118275|NCT01111838|585485219|FG000|Overall Study|Other Complicating Disease|1|||
162118276|NCT01616771|585485221|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
162118277|NCT04359771|585485226|FG000|Overall Study|Lack of Efficacy|2|||
162118278|NCT04359771|585485227|FG001|Overall Study|Lack of Efficacy|2|||
162118279|NCT04041440|585485229|FG000|Overall Study|Withdrawal by Subject|0|||
162118280|NCT04041440|585485230|FG001|Overall Study|Withdrawal by Subject|1|||
162118281|NCT04041440|585485229|FG000|Overall Study|Lost to Follow-up|0|||
162118282|NCT04041440|585485230|FG001|Overall Study|Lost to Follow-up|1|||
162118283|NCT02306265|585485231|FG000|Overall Study|Withdrawal by Subject|1|||
162118284|NCT02247804|585485236|FG000|Treatment Period 1|Adverse Event|9|||
162118285|NCT02247804|585485237|FG001|Treatment Period 1|Adverse Event|2|||
162118286|NCT02247804|585485238|FG002|Treatment Period 1|Adverse Event|0|||
162118287|NCT02247804|585485236|FG000|Treatment Period 1|Lack of Efficacy|0|||
162118288|NCT02247804|585485237|FG001|Treatment Period 1|Lack of Efficacy|0|||
162118289|NCT02247804|585485238|FG002|Treatment Period 1|Lack of Efficacy|2|||
162118290|NCT02247804|585485236|FG000|Treatment Period 1|Lost to Follow-up|1|||
162118291|NCT02247804|585485237|FG001|Treatment Period 1|Lost to Follow-up|0|||
162118292|NCT02247804|585485238|FG002|Treatment Period 1|Lost to Follow-up|2|||
162118293|NCT02247804|585485236|FG000|Treatment Period 1|Personal Reasons|7|||
162118294|NCT02247804|585485237|FG001|Treatment Period 1|Personal Reasons|1|||
162118295|NCT02247804|585485238|FG002|Treatment Period 1|Personal Reasons|2|||
162118296|NCT02247804|585485236|FG000|Treatment Period 1|Protocol Deviation|0|||
162118297|NCT02247804|585485237|FG001|Treatment Period 1|Protocol Deviation|0|||
162118298|NCT02247804|585485238|FG002|Treatment Period 1|Protocol Deviation|1|||
162118299|NCT02247804|585485236|FG000|Treatment Period 1|Randomized but not Treated|5|||
162118300|NCT02247804|585485237|FG001|Treatment Period 1|Randomized but not Treated|1|||
162118301|NCT02247804|585485238|FG002|Treatment Period 1|Randomized but not Treated|1|||
162118302|NCT02247804|585485236|FG000|Treatment Period 2|Adverse Event|6|||
162118303|NCT02247804|585485237|FG001|Treatment Period 2|Adverse Event|3|||
162118304|NCT02247804|585485238|FG002|Treatment Period 2|Adverse Event|3|||
162118305|NCT02247804|585485236|FG000|Treatment Period 2|Lack of Efficacy|0|||
162118306|NCT02247804|585485237|FG001|Treatment Period 2|Lack of Efficacy|0|||
162118307|NCT02247804|585485238|FG002|Treatment Period 2|Lack of Efficacy|1|||
162118308|NCT02247804|585485236|FG000|Treatment Period 2|Lost to Follow-up|0|||
162118309|NCT02247804|585485237|FG001|Treatment Period 2|Lost to Follow-up|1|||
162118310|NCT02247804|585485238|FG002|Treatment Period 2|Lost to Follow-up|1|||
162118311|NCT02247804|585485236|FG000|Treatment Period 2|Personal Reasons|2|||
162118312|NCT02247804|585485237|FG001|Treatment Period 2|Personal Reasons|1|||
162118313|NCT02247804|585485238|FG002|Treatment Period 2|Personal Reasons|1|||
162118314|NCT02247804|585485236|FG000|Treatment Period 2|Reason not Specified|0|||
162118315|NCT02247804|585485237|FG001|Treatment Period 2|Reason not Specified|0|||
162118316|NCT02247804|585485238|FG002|Treatment Period 2|Reason not Specified|2|||
162118317|NCT02247804|585485236|FG000|Treatment Period 3|Adverse Event|4|||
162118318|NCT02247804|585485237|FG001|Treatment Period 3|Adverse Event|3|||
162118319|NCT02247804|585485238|FG002|Treatment Period 3|Adverse Event|3|||
162118320|NCT02247804|585485236|FG000|Treatment Period 3|Lack of Efficacy|0|||
162118321|NCT02247804|585485237|FG001|Treatment Period 3|Lack of Efficacy|1|||
162118322|NCT02247804|585485238|FG002|Treatment Period 3|Lack of Efficacy|0|||
162118323|NCT02247804|585485236|FG000|Treatment Period 3|Lost to Follow-up|1|||
162118324|NCT02247804|585485237|FG001|Treatment Period 3|Lost to Follow-up|2|||
162118325|NCT02247804|585485238|FG002|Treatment Period 3|Lost to Follow-up|2|||
162118326|NCT02247804|585485236|FG000|Treatment Period 3|Personal Reasons|4|||
162118327|NCT02247804|585485237|FG001|Treatment Period 3|Personal Reasons|3|||
162118328|NCT02247804|585485238|FG002|Treatment Period 3|Personal Reasons|2|||
162118329|NCT02247804|585485236|FG000|Treatment Period 3|Reason not Specified|2|||
162118330|NCT02247804|585485237|FG001|Treatment Period 3|Reason not Specified|1|||
162118331|NCT02247804|585485238|FG002|Treatment Period 3|Reason not Specified|3|||
162118332|NCT01346514|585485241|FG000|Overall Study|Lost to Follow-up|19|||
162118333|NCT01346514|585485242|FG001|Overall Study|Lost to Follow-up|30|||
162118334|NCT01346514|585485241|FG000|Overall Study|Withdrawal by Subject|7|||
162118335|NCT01346514|585485242|FG001|Overall Study|Withdrawal by Subject|3|||
162118336|NCT01346514|585485241|FG000|Overall Study|Death|3|||
162118337|NCT01346514|585485242|FG001|Overall Study|Death|4|||
162118338|NCT00909480|585485243|FG000|Overall Study|Adverse Event|5|||
162118339|NCT00909480|585485244|FG001|Overall Study|Adverse Event|3|||
162118340|NCT00909480|585485243|FG000|Overall Study|Protocol Violation|6|||
162118341|NCT00909480|585485244|FG001|Overall Study|Protocol Violation|8|||
162118342|NCT00909480|585485243|FG000|Overall Study|Withdrawal criteria|9|||
162118343|NCT00909480|585485244|FG001|Overall Study|Withdrawal criteria|11|||
162118344|NCT00909480|585485243|FG000|Overall Study|Unclassified|18|||
162118345|NCT00909480|585485244|FG001|Overall Study|Unclassified|19|||
162118346|NCT03002038|585485248|FG000|Overall Study|Adverse Event|3|||
162118347|NCT03002038|585485249|FG001|Overall Study|Adverse Event|1|||
162118348|NCT03002038|585485248|FG000|Overall Study|Withdrawal by Subject|8|||
162118349|NCT03002038|585485249|FG001|Overall Study|Withdrawal by Subject|4|||
162118350|NCT03002038|585485248|FG000|Overall Study|Immigration to another region|0|||
162118351|NCT03002038|585485249|FG001|Overall Study|Immigration to another region|2|||
162118352|NCT01054573|585485250|FG000|Overall Study|Adverse Event|1|||
162118353|NCT01054573|585485251|FG001|Overall Study|Adverse Event|0|||
162118354|NCT01054573|585485252|FG002|Overall Study|Adverse Event|1|||
162118355|NCT01054573|585485253|FG003|Overall Study|Adverse Event|1|||
162118356|NCT01054573|585485250|FG000|Overall Study|Lost to Follow-up|0|||
162118357|NCT01054573|585485251|FG001|Overall Study|Lost to Follow-up|2|||
162118358|NCT01054573|585485252|FG002|Overall Study|Lost to Follow-up|0|||
162118359|NCT01054573|585485253|FG003|Overall Study|Lost to Follow-up|0|||
162118360|NCT01054573|585485250|FG000|Overall Study|Withdrawal by Subject|0|||
162118361|NCT01054573|585485251|FG001|Overall Study|Withdrawal by Subject|2|||
162118362|NCT01054573|585485252|FG002|Overall Study|Withdrawal by Subject|2|||
162118363|NCT01054573|585485253|FG003|Overall Study|Withdrawal by Subject|1|||
162118364|NCT03724396|585485254|FG000|Overall Study|Lost to Follow-up|1|||
162118365|NCT03724396|585485255|FG001|Overall Study|Lost to Follow-up|1|||
162118366|NCT03724396|585485254|FG000|Overall Study|Withdrawal by Subject|1|||
162118367|NCT03724396|585485255|FG001|Overall Study|Withdrawal by Subject|0|||
162118368|NCT02237508|585485257|FG000|Overall Study|Withdrawal by Subject|0|||
162118369|NCT02237508|585485258|FG001|Overall Study|Withdrawal by Subject|2|||
162118370|NCT02237508|585485259|FG002|Overall Study|Withdrawal by Subject|0|||
162118371|NCT02237508|585485260|FG003|Overall Study|Withdrawal by Subject|1|||
162118372|NCT02237508|585485261|FG004|Overall Study|Withdrawal by Subject|0|||
162118373|NCT02237508|585485262|FG005|Overall Study|Withdrawal by Subject|1|||
162118374|NCT02237508|585485263|FG006|Overall Study|Withdrawal by Subject|1|||
162118375|NCT02237508|585485264|FG007|Overall Study|Withdrawal by Subject|0|||
162118376|NCT02237508|585485265|FG008|Overall Study|Withdrawal by Subject|1|||
162118377|NCT02237508|585485266|FG009|Overall Study|Withdrawal by Subject|0|||
162118378|NCT02237508|585485257|FG000|Overall Study|Physician Decision|0|||
162118379|NCT02237508|585485258|FG001|Overall Study|Physician Decision|1|||
162118380|NCT02237508|585485259|FG002|Overall Study|Physician Decision|0|||
162118381|NCT02237508|585485260|FG003|Overall Study|Physician Decision|0|||
162118382|NCT02237508|585485261|FG004|Overall Study|Physician Decision|0|||
162118383|NCT02237508|585485262|FG005|Overall Study|Physician Decision|0|||
162118384|NCT02237508|585485263|FG006|Overall Study|Physician Decision|0|||
162118385|NCT02237508|585485264|FG007|Overall Study|Physician Decision|0|||
162118386|NCT02237508|585485265|FG008|Overall Study|Physician Decision|0|||
162118387|NCT02237508|585485266|FG009|Overall Study|Physician Decision|0|||
162118388|NCT02237508|585485257|FG000|Overall Study|Protocol Violation|0|||
162118389|NCT02237508|585485258|FG001|Overall Study|Protocol Violation|0|||
162118390|NCT02237508|585485259|FG002|Overall Study|Protocol Violation|1|||
162118391|NCT02237508|585485260|FG003|Overall Study|Protocol Violation|0|||
162118392|NCT02237508|585485261|FG004|Overall Study|Protocol Violation|0|||
162118393|NCT02237508|585485262|FG005|Overall Study|Protocol Violation|0|||
162118394|NCT02237508|585485263|FG006|Overall Study|Protocol Violation|0|||
162118395|NCT02237508|585485264|FG007|Overall Study|Protocol Violation|0|||
162118396|NCT02237508|585485265|FG008|Overall Study|Protocol Violation|0|||
162118397|NCT02237508|585485266|FG009|Overall Study|Protocol Violation|0|||
162118398|NCT01650519|585485267|FG000|Overall Study|Withdrawal by Subject|1|||
162118399|NCT01650519|585485268|FG001|Overall Study|Withdrawal by Subject|0|||
162118400|NCT01778556|585485270|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
162118401|NCT01778556|585485271|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
162118402|NCT01778556|585485270|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
162118403|NCT01778556|585485271|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
162118404|NCT01778556|585485270|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
162118405|NCT01778556|585485271|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
162118406|NCT01778556|585485270|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
162118407|NCT01778556|585485271|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
162118408|NCT00576732|585485273|FG000|DOUBLE BLIND|Adverse Event|0|||
162118409|NCT00576732|585485274|FG001|DOUBLE BLIND|Adverse Event|0|||
162118410|NCT00576732|585485275|FG002|DOUBLE BLIND|Adverse Event|1|||
162118411|NCT00576732|585485276|FG003|DOUBLE BLIND|Adverse Event|0|||
162118412|NCT00576732|585485277|FG004|DOUBLE BLIND|Adverse Event|0|||
162118413|NCT00576732|585485278|FG005|DOUBLE BLIND|Adverse Event|0|||
162118414|NCT00576732|585485273|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
162118415|NCT00576732|585485274|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
162118416|NCT00576732|585485275|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
162118417|NCT00576732|585485276|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
162118418|NCT00576732|585485277|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
162118419|NCT00576732|585485278|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
162118420|NCT00576732|585485273|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
162118421|NCT00576732|585485274|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
162118422|NCT00576732|585485275|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
162118423|NCT00576732|585485276|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
162118424|NCT00576732|585485277|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
162118425|NCT00576732|585485278|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
162118426|NCT00576732|585485273|FG000|DOUBLE BLIND|OTHER|0|||
162118427|NCT00576732|585485274|FG001|DOUBLE BLIND|OTHER|2|||
162118428|NCT00576732|585485275|FG002|DOUBLE BLIND|OTHER|1|||
162118429|NCT00576732|585485276|FG003|DOUBLE BLIND|OTHER|0|||
162118430|NCT00576732|585485277|FG004|DOUBLE BLIND|OTHER|0|||
162118431|NCT00576732|585485278|FG005|DOUBLE BLIND|OTHER|0|||
162118432|NCT00576732|585485273|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
162118433|NCT00576732|585485274|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
162118434|NCT00576732|585485275|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
162118435|NCT00576732|585485276|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
162118436|NCT00576732|585485277|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
162118437|NCT00576732|585485278|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
162118438|NCT00576732|585485273|FG000|DOUBLE BLIND|Protocol Violation|1|||
162118439|NCT00576732|585485274|FG001|DOUBLE BLIND|Protocol Violation|0|||
162118440|NCT00576732|585485275|FG002|DOUBLE BLIND|Protocol Violation|0|||
162118441|NCT00576732|585485276|FG003|DOUBLE BLIND|Protocol Violation|0|||
162118442|NCT00576732|585485277|FG004|DOUBLE BLIND|Protocol Violation|0|||
162118443|NCT00576732|585485278|FG005|DOUBLE BLIND|Protocol Violation|0|||
162118444|NCT00576732|585485273|FG000|OPEN LABEL|Adverse Event|0|||
162118445|NCT00576732|585485274|FG001|OPEN LABEL|Adverse Event|0|||
162118446|NCT00576732|585485275|FG002|OPEN LABEL|Adverse Event|0|||
162118447|NCT00576732|585485276|FG003|OPEN LABEL|Adverse Event|4|||
162118448|NCT00576732|585485277|FG004|OPEN LABEL|Adverse Event|0|||
162118449|NCT00576732|585485278|FG005|OPEN LABEL|Adverse Event|1|||
162118450|NCT00576732|585485273|FG000|OPEN LABEL|Lost to Follow-up|0|||
162118451|NCT00576732|585485274|FG001|OPEN LABEL|Lost to Follow-up|0|||
162118452|NCT00576732|585485275|FG002|OPEN LABEL|Lost to Follow-up|0|||
162118453|NCT00576732|585485276|FG003|OPEN LABEL|Lost to Follow-up|2|||
162118454|NCT00576732|585485277|FG004|OPEN LABEL|Lost to Follow-up|1|||
162118455|NCT00576732|585485278|FG005|OPEN LABEL|Lost to Follow-up|1|||
162118456|NCT00576732|585485273|FG000|OPEN LABEL|Withdrawal by Subject|0|||
162118457|NCT00576732|585485274|FG001|OPEN LABEL|Withdrawal by Subject|0|||
162118458|NCT00576732|585485275|FG002|OPEN LABEL|Withdrawal by Subject|0|||
162118459|NCT00576732|585485276|FG003|OPEN LABEL|Withdrawal by Subject|1|||
162118460|NCT00576732|585485277|FG004|OPEN LABEL|Withdrawal by Subject|0|||
162118461|NCT00576732|585485278|FG005|OPEN LABEL|Withdrawal by Subject|1|||
162118462|NCT00576732|585485273|FG000|OPEN LABEL|OTHER|0|||
162118463|NCT00576732|585485274|FG001|OPEN LABEL|OTHER|0|||
162118464|NCT00576732|585485275|FG002|OPEN LABEL|OTHER|0|||
162118465|NCT00576732|585485276|FG003|OPEN LABEL|OTHER|0|||
162118466|NCT00576732|585485277|FG004|OPEN LABEL|OTHER|0|||
162118467|NCT00576732|585485278|FG005|OPEN LABEL|OTHER|2|||
162118468|NCT00576732|585485273|FG000|OPEN LABEL|Lack of Efficacy|0|||
162118469|NCT00576732|585485274|FG001|OPEN LABEL|Lack of Efficacy|0|||
162118470|NCT00576732|585485275|FG002|OPEN LABEL|Lack of Efficacy|0|||
162118471|NCT00576732|585485276|FG003|OPEN LABEL|Lack of Efficacy|2|||
162118472|NCT00576732|585485277|FG004|OPEN LABEL|Lack of Efficacy|2|||
162118473|NCT00576732|585485278|FG005|OPEN LABEL|Lack of Efficacy|3|||
162118474|NCT00576732|585485273|FG000|OPEN LABEL|Protocol Violation|0|||
162118475|NCT00576732|585485274|FG001|OPEN LABEL|Protocol Violation|0|||
162118476|NCT00576732|585485275|FG002|OPEN LABEL|Protocol Violation|0|||
162118477|NCT00576732|585485276|FG003|OPEN LABEL|Protocol Violation|2|||
162118478|NCT00576732|585485277|FG004|OPEN LABEL|Protocol Violation|1|||
162118479|NCT00576732|585485278|FG005|OPEN LABEL|Protocol Violation|0|||
162118480|NCT02296190|585485279|FG000|Overall Study|Lost to Follow-up|0|||
162118481|NCT02296190|585485280|FG001|Overall Study|Lost to Follow-up|0|||
162118482|NCT02296190|585485281|FG002|Overall Study|Lost to Follow-up|0|||
162118483|NCT02296190|585485282|FG003|Overall Study|Lost to Follow-up|0|||
162118484|NCT02296190|585485283|FG004|Overall Study|Lost to Follow-up|1|||
162118485|NCT02296190|585485284|FG005|Overall Study|Lost to Follow-up|0|||
162118486|NCT02296190|585485279|FG000|Overall Study|Failure to induce PSVT|6|||
162118487|NCT02296190|585485280|FG001|Overall Study|Failure to induce PSVT|10|||
162118488|NCT02296190|585485281|FG002|Overall Study|Failure to induce PSVT|5|||
162118489|NCT02296190|585485282|FG003|Overall Study|Failure to induce PSVT|13|||
162118490|NCT02296190|585485283|FG004|Overall Study|Failure to induce PSVT|8|||
162118491|NCT02296190|585485284|FG005|Overall Study|Failure to induce PSVT|0|||
162118492|NCT02296190|585485279|FG000|Overall Study|Physician Decision|1|||
162118493|NCT02296190|585485280|FG001|Overall Study|Physician Decision|1|||
162118494|NCT02296190|585485281|FG002|Overall Study|Physician Decision|0|||
162118495|NCT02296190|585485282|FG003|Overall Study|Physician Decision|1|||
162118496|NCT02296190|585485283|FG004|Overall Study|Physician Decision|2|||
162118497|NCT02296190|585485284|FG005|Overall Study|Physician Decision|0|||
162118498|NCT02296190|585485279|FG000|Overall Study|Withdrawal by Subject|0|||
162118499|NCT02296190|585485280|FG001|Overall Study|Withdrawal by Subject|1|||
162118500|NCT02296190|585485281|FG002|Overall Study|Withdrawal by Subject|0|||
162118501|NCT02296190|585485282|FG003|Overall Study|Withdrawal by Subject|0|||
162118502|NCT02296190|585485283|FG004|Overall Study|Withdrawal by Subject|0|||
162118503|NCT02296190|585485284|FG005|Overall Study|Withdrawal by Subject|0|||
162118504|NCT02296190|585485279|FG000|Overall Study|PSVT < 5 minutes|5|||
162118505|NCT02296190|585485280|FG001|Overall Study|PSVT < 5 minutes|6|||
162118506|NCT02296190|585485281|FG002|Overall Study|PSVT < 5 minutes|6|||
162118507|NCT02296190|585485282|FG003|Overall Study|PSVT < 5 minutes|6|||
162118508|NCT02296190|585485283|FG004|Overall Study|PSVT < 5 minutes|5|||
162118509|NCT02296190|585485284|FG005|Overall Study|PSVT < 5 minutes|0|||
162118510|NCT02296190|585485279|FG000|Overall Study|Patient was given Propofol|0|||
162118511|NCT02296190|585485280|FG001|Overall Study|Patient was given Propofol|1|||
162118512|NCT02296190|585485281|FG002|Overall Study|Patient was given Propofol|0|||
162118513|NCT02296190|585485282|FG003|Overall Study|Patient was given Propofol|1|||
162118514|NCT02296190|585485283|FG004|Overall Study|Patient was given Propofol|0|||
162118515|NCT02296190|585485284|FG005|Overall Study|Patient was given Propofol|0|||
162118516|NCT02296190|585485279|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
162118517|NCT02296190|585485280|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
162118518|NCT02296190|585485281|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
162118519|NCT02296190|585485282|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
162118520|NCT02296190|585485283|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
162118521|NCT02296190|585485284|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
162118522|NCT02296190|585485279|FG000|Overall Study|Blood pressure <100 after sedation|0|||
162118523|NCT02296190|585485280|FG001|Overall Study|Blood pressure <100 after sedation|0|||
162118524|NCT02296190|585485281|FG002|Overall Study|Blood pressure <100 after sedation|0|||
162118525|NCT02296190|585485282|FG003|Overall Study|Blood pressure <100 after sedation|1|||
162118526|NCT02296190|585485283|FG004|Overall Study|Blood pressure <100 after sedation|0|||
162118527|NCT02296190|585485284|FG005|Overall Study|Blood pressure <100 after sedation|0|||
162118528|NCT02296190|585485279|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
162118529|NCT02296190|585485280|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
162118530|NCT02296190|585485281|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
162118531|NCT02296190|585485282|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
162118532|NCT02296190|585485283|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
162118533|NCT02296190|585485284|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
162118534|NCT02296190|585485279|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
162118535|NCT02296190|585485280|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
162118536|NCT02296190|585485281|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
162118537|NCT02296190|585485282|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
162118538|NCT02296190|585485283|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
162118539|NCT02296190|585485284|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
162118540|NCT02296190|585485279|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
162237480|NCT00600886|585921097|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
162118541|NCT02296190|585485280|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
162118542|NCT02296190|585485281|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
162118543|NCT02296190|585485282|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
162118544|NCT02296190|585485283|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
162118545|NCT02296190|585485284|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
162118546|NCT02296190|585485279|FG000|Overall Study|Lab result not available in time|1|||
162118547|NCT02296190|585485280|FG001|Overall Study|Lab result not available in time|0|||
162118548|NCT02296190|585485281|FG002|Overall Study|Lab result not available in time|0|||
162118549|NCT02296190|585485282|FG003|Overall Study|Lab result not available in time|0|||
162118550|NCT02296190|585485283|FG004|Overall Study|Lab result not available in time|0|||
162118551|NCT02296190|585485284|FG005|Overall Study|Lab result not available in time|0|||
162118552|NCT00265330|585485285|FG000|Overall Study|Adverse Event|41|||
162118553|NCT00265330|585485285|FG000|Overall Study|Lost to Follow-up|8|||
162118554|NCT00265330|585485285|FG000|Overall Study|Withdrawal by Subject|34|||
162118555|NCT00265330|585485285|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
162118556|NCT00265330|585485285|FG000|Overall Study|Lack of Efficacy|4|||
162118557|NCT00265330|585485285|FG000|Overall Study|Family Scheduling Conflicts|1|||
162118558|NCT00265330|585485285|FG000|Overall Study|Began Taking Formulary Geodon|1|||
162118559|NCT00265330|585485285|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
162118560|NCT00265330|585485285|FG000|Overall Study|Site Closed by Sponsor|1|||
162118561|NCT00265330|585485285|FG000|Overall Study|Principal Investigators Request|1|||
162118562|NCT00265330|585485285|FG000|Overall Study|Withdrew Consent|1|||
162118563|NCT00265330|585485285|FG000|Overall Study|Protocol Violation|1|||
162118564|NCT02178566|585485294|FG000|Overall Study|patient did not complete due to noncompliance|0|||
162118565|NCT02178566|585485295|FG001|Overall Study|patient did not complete due to noncompliance|1|||
162118566|NCT02658630|585485296|FG000|Overall Study|Withdrawal by Subject|4|||
162118567|NCT00682643|585485297|FG000|Overall Study|Adverse Event|12|||
162118568|NCT00682643|585485298|FG001|Overall Study|Adverse Event|23|||
162118569|NCT00682643|585485297|FG000|Overall Study|Lack of Efficacy|2|||
162118570|NCT00682643|585485298|FG001|Overall Study|Lack of Efficacy|0|||
162118571|NCT00682643|585485297|FG000|Overall Study|Protocol Violation|38|||
162118572|NCT00682643|585485298|FG001|Overall Study|Protocol Violation|76|||
162118573|NCT00682643|585485297|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
162118574|NCT00682643|585485298|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
162118575|NCT00682643|585485297|FG000|Overall Study|Lost to Follow-up|1|||
162118576|NCT00682643|585485298|FG001|Overall Study|Lost to Follow-up|6|||
162118577|NCT00682643|585485297|FG000|Overall Study|Physician Decision|2|||
162118578|NCT00682643|585485298|FG001|Overall Study|Physician Decision|6|||
162118579|NCT00682643|585485297|FG000|Overall Study|Withdrawal by Subject|19|||
162118580|NCT00682643|585485298|FG001|Overall Study|Withdrawal by Subject|53|||
162118581|NCT00682643|585485297|FG000|Overall Study|Did Not Receive Study Drug|1|||
162118582|NCT00682643|585485298|FG001|Overall Study|Did Not Receive Study Drug|1|||
162118583|NCT01875185|585485299|FG000|Overall Study|study was terminated|52|||
162118584|NCT01875185|585485300|FG001|Overall Study|study was terminated|48|||
162118585|NCT00085202|585485301|FG000|Overall Study|Still on therapy|2|||
162118586|NCT00085202|585485302|FG001|Overall Study|Still on therapy|0|||
162118587|NCT00085202|585485301|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
162118588|NCT00085202|585485302|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
162118589|NCT00085202|585485301|FG000|Overall Study|Excessive toxicity|6|||
162118590|NCT00085202|585485302|FG001|Overall Study|Excessive toxicity|5|||
162118591|NCT00085202|585485301|FG000|Overall Study|Non-specified|3|||
162118592|NCT00085202|585485302|FG001|Overall Study|Non-specified|5|||
162118593|NCT00085202|585485301|FG000|Overall Study|Withdrawal by Subject|2|||
162118594|NCT00085202|585485302|FG001|Overall Study|Withdrawal by Subject|1|||
162118595|NCT00085202|585485301|FG000|Overall Study|Physician Decision|4|||
162118596|NCT00085202|585485302|FG001|Overall Study|Physician Decision|1|||
162118597|NCT00085202|585485301|FG000|Overall Study|Progressive disease|1|||
162118598|NCT00085202|585485302|FG001|Overall Study|Progressive disease|11|||
162118599|NCT03238300|585485303|FG000|Baseline (Before Intervention)|Physician Decision|0|||
162118600|NCT03238300|585485304|FG001|Baseline (Before Intervention)|Physician Decision|1|||
162118601|NCT03238300|585485303|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
162118602|NCT03238300|585485304|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
162118603|NCT03238300|585485303|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
162118604|NCT03238300|585485304|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
162118605|NCT03238300|585485303|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
162118606|NCT03238300|585485304|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
162118607|NCT00399763|585485312|FG000|Overall Study|Lost to Follow-up|2|||
162118608|NCT00399763|585485313|FG001|Overall Study|Lost to Follow-up|3|||
162118609|NCT03389477|585485316|FG000|Step 1|Withdrawal by Subject|1|||
162118610|NCT03389477|585485317|FG001|Step 1|Withdrawal by Subject|0|||
162118611|NCT03389477|585485316|FG000|Step 2|Withdrawal by Subject|1|||
162118612|NCT03389477|585485317|FG001|Step 2|Withdrawal by Subject|2|||
162118613|NCT03389477|585485316|FG000|Step 2|Disease progression|1|||
162118614|NCT03389477|585485317|FG001|Step 2|Disease progression|0|||
162118615|NCT03389477|585485316|FG000|Step 2|Death|0|||
162118616|NCT03389477|585485317|FG001|Step 2|Death|1|||
162118617|NCT03389477|585485316|FG000|Step 2|Poor performance status and nutrition|0|||
162118618|NCT03389477|585485317|FG001|Step 2|Poor performance status and nutrition|1|||
162118619|NCT03389477|585485316|FG000|Step 3|Withdrawal after 3 cycles|0|||
162118620|NCT03389477|585485317|FG001|Step 3|Withdrawal after 3 cycles|1|||
162118621|NCT03389477|585485316|FG000|Step 3|Still receiving active treatment|4|||
162118622|NCT03389477|585485317|FG001|Step 3|Still receiving active treatment|0|||
162118623|NCT03389477|585485316|FG000|Step 3|Progressive disease after 2 cycles|1|||
162118624|NCT03389477|585485317|FG001|Step 3|Progressive disease after 2 cycles|0|||
162118625|NCT04512066|585485320|FG000|Double-blind Treatment Period|Adverse Event|6|||
162118626|NCT04512066|585485321|FG001|Double-blind Treatment Period|Adverse Event|4|||
162118627|NCT04512066|585485322|FG002|Double-blind Treatment Period|Adverse Event|5|||
162118628|NCT04512066|585485323|FG003|Double-blind Treatment Period|Adverse Event|1|||
162118629|NCT04512066|585485324|FG004|Double-blind Treatment Period|Adverse Event|0|||
162118630|NCT04512066|585485325|FG005|Double-blind Treatment Period|Adverse Event|0|||
162118631|NCT04512066|585485320|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
162118632|NCT04512066|585485321|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
162118633|NCT04512066|585485322|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
162118634|NCT04512066|585485323|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
162118635|NCT04512066|585485324|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
162118636|NCT04512066|585485325|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
162118637|NCT04512066|585485320|FG000|Double-blind Treatment Period|Physician Decision|1|||
162118638|NCT04512066|585485321|FG001|Double-blind Treatment Period|Physician Decision|0|||
162118639|NCT04512066|585485322|FG002|Double-blind Treatment Period|Physician Decision|1|||
162118640|NCT04512066|585485323|FG003|Double-blind Treatment Period|Physician Decision|0|||
162118641|NCT04512066|585485324|FG004|Double-blind Treatment Period|Physician Decision|0|||
162118642|NCT04512066|585485325|FG005|Double-blind Treatment Period|Physician Decision|0|||
162118643|NCT04512066|585485320|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
162118644|NCT04512066|585485321|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
162118645|NCT04512066|585485322|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
162118646|NCT04512066|585485323|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
162118647|NCT04512066|585485324|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
162118648|NCT04512066|585485325|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
162118649|NCT04512066|585485320|FG000|Extension Period|Adverse Event|0|||
162118650|NCT04512066|585485321|FG001|Extension Period|Adverse Event|1|||
162118651|NCT04512066|585485322|FG002|Extension Period|Adverse Event|4|||
162118652|NCT04512066|585485323|FG003|Extension Period|Adverse Event|3|||
162118653|NCT04512066|585485324|FG004|Extension Period|Adverse Event|1|||
162118654|NCT04512066|585485325|FG005|Extension Period|Adverse Event|3|||
162118655|NCT04512066|585485320|FG000|Extension Period|Death|0|||
162118656|NCT04512066|585485321|FG001|Extension Period|Death|0|||
162118657|NCT04512066|585485322|FG002|Extension Period|Death|0|||
162118658|NCT04512066|585485323|FG003|Extension Period|Death|0|||
162118659|NCT04512066|585485324|FG004|Extension Period|Death|0|||
162118660|NCT04512066|585485325|FG005|Extension Period|Death|1|||
162118661|NCT04512066|585485320|FG000|Extension Period|Lack of Efficacy|0|||
162118662|NCT04512066|585485321|FG001|Extension Period|Lack of Efficacy|4|||
162118663|NCT04512066|585485322|FG002|Extension Period|Lack of Efficacy|4|||
162118664|NCT04512066|585485323|FG003|Extension Period|Lack of Efficacy|1|||
162118665|NCT04512066|585485324|FG004|Extension Period|Lack of Efficacy|3|||
162118666|NCT04512066|585485325|FG005|Extension Period|Lack of Efficacy|3|||
162118667|NCT04512066|585485320|FG000|Extension Period|Lost to Follow-up|0|||
162118668|NCT04512066|585485321|FG001|Extension Period|Lost to Follow-up|1|||
162118669|NCT04512066|585485322|FG002|Extension Period|Lost to Follow-up|5|||
162118670|NCT04512066|585485323|FG003|Extension Period|Lost to Follow-up|2|||
162118671|NCT04512066|585485324|FG004|Extension Period|Lost to Follow-up|3|||
162118672|NCT04512066|585485325|FG005|Extension Period|Lost to Follow-up|2|||
162118673|NCT04512066|585485320|FG000|Extension Period|Non-compliance with study drug|0|||
162118674|NCT04512066|585485321|FG001|Extension Period|Non-compliance with study drug|1|||
162118675|NCT04512066|585485322|FG002|Extension Period|Non-compliance with study drug|0|||
162118676|NCT04512066|585485323|FG003|Extension Period|Non-compliance with study drug|0|||
162118677|NCT04512066|585485324|FG004|Extension Period|Non-compliance with study drug|0|||
162118678|NCT04512066|585485325|FG005|Extension Period|Non-compliance with study drug|1|||
162118679|NCT04512066|585485320|FG000|Extension Period|Other|0|||
162118680|NCT04512066|585485321|FG001|Extension Period|Other|2|||
162118681|NCT04512066|585485322|FG002|Extension Period|Other|0|||
162118682|NCT04512066|585485323|FG003|Extension Period|Other|0|||
162118683|NCT04512066|585485324|FG004|Extension Period|Other|0|||
162118684|NCT04512066|585485325|FG005|Extension Period|Other|0|||
162118685|NCT04512066|585485320|FG000|Extension Period|Physician Decision|0|||
162118686|NCT04512066|585485321|FG001|Extension Period|Physician Decision|2|||
162118687|NCT04512066|585485322|FG002|Extension Period|Physician Decision|0|||
162118688|NCT04512066|585485323|FG003|Extension Period|Physician Decision|1|||
162118689|NCT04512066|585485324|FG004|Extension Period|Physician Decision|1|||
162118690|NCT04512066|585485325|FG005|Extension Period|Physician Decision|0|||
162118691|NCT04512066|585485320|FG000|Extension Period|Withdrawal by Subject|0|||
162118692|NCT04512066|585485321|FG001|Extension Period|Withdrawal by Subject|3|||
162118693|NCT04512066|585485322|FG002|Extension Period|Withdrawal by Subject|7|||
162118694|NCT04512066|585485323|FG003|Extension Period|Withdrawal by Subject|11|||
162118695|NCT04512066|585485324|FG004|Extension Period|Withdrawal by Subject|8|||
162118696|NCT04512066|585485325|FG005|Extension Period|Withdrawal by Subject|4|||
162118697|NCT03403426|585485326|FG000|Overall Study|Death|1|||
162118698|NCT03403426|585485326|FG000|Overall Study|Lost to Follow-up|2|||
162118699|NCT01657266|585485331|FG000|Overall Study|Lost to Follow-up|2|||
162118700|NCT01657266|585485332|FG001|Overall Study|Lost to Follow-up|2|||
162118701|NCT01657266|585485331|FG000|Overall Study|Adverse Event|2|||
162118702|NCT01657266|585485332|FG001|Overall Study|Adverse Event|3|||
162118703|NCT03520400|585485333|FG000|Overall Study|Physician Decision|15|||
162118704|NCT03520400|585485334|FG001|Overall Study|Physician Decision|7|||
162118705|NCT00445679|585485335|FG000|Overall Study|Adverse Event|22|||
162118706|NCT00445679|585485336|FG001|Overall Study|Adverse Event|12|||
162118707|NCT00445679|585485337|FG002|Overall Study|Adverse Event|30|||
162118708|NCT00445679|585485338|FG003|Overall Study|Adverse Event|19|||
162118709|NCT00445679|585485335|FG000|Overall Study|Failed to return|1|||
162118710|NCT00445679|585485336|FG001|Overall Study|Failed to return|3|||
162118711|NCT00445679|585485337|FG002|Overall Study|Failed to return|2|||
162118712|NCT00445679|585485338|FG003|Overall Study|Failed to return|2|||
162118713|NCT00445679|585485335|FG000|Overall Study|Physician Decision|0|||
162118714|NCT00445679|585485336|FG001|Overall Study|Physician Decision|0|||
162118715|NCT00445679|585485337|FG002|Overall Study|Physician Decision|1|||
162118716|NCT00445679|585485338|FG003|Overall Study|Physician Decision|0|||
162118717|NCT00445679|585485335|FG000|Overall Study|Lost to Follow-up|10|||
162118718|NCT00445679|585485336|FG001|Overall Study|Lost to Follow-up|6|||
162118719|NCT00445679|585485337|FG002|Overall Study|Lost to Follow-up|6|||
162118720|NCT00445679|585485338|FG003|Overall Study|Lost to Follow-up|5|||
162118721|NCT00445679|585485335|FG000|Overall Study|Compliance|3|||
162118722|NCT00445679|585485336|FG001|Overall Study|Compliance|2|||
162118723|NCT00445679|585485337|FG002|Overall Study|Compliance|1|||
162118724|NCT00445679|585485338|FG003|Overall Study|Compliance|2|||
162118725|NCT00445679|585485335|FG000|Overall Study|Withdrawal of Informed Consent|0|||
162118726|NCT00445679|585485336|FG001|Overall Study|Withdrawal of Informed Consent|0|||
162118727|NCT00445679|585485337|FG002|Overall Study|Withdrawal of Informed Consent|1|||
162118728|NCT00445679|585485338|FG003|Overall Study|Withdrawal of Informed Consent|0|||
162118729|NCT00445679|585485335|FG000|Overall Study|Protocol Violation|2|||
162118730|NCT00445679|585485336|FG001|Overall Study|Protocol Violation|3|||
162118731|NCT00445679|585485337|FG002|Overall Study|Protocol Violation|3|||
162118732|NCT00445679|585485338|FG003|Overall Study|Protocol Violation|1|||
162118733|NCT00445679|585485335|FG000|Overall Study|Withdrawal by Subject|8|||
162118734|NCT00445679|585485336|FG001|Overall Study|Withdrawal by Subject|14|||
162118735|NCT00445679|585485337|FG002|Overall Study|Withdrawal by Subject|20|||
162118736|NCT00445679|585485338|FG003|Overall Study|Withdrawal by Subject|18|||
162118737|NCT00445679|585485335|FG000|Overall Study|Lack of Efficacy|2|||
162118738|NCT00445679|585485336|FG001|Overall Study|Lack of Efficacy|6|||
162118739|NCT00445679|585485337|FG002|Overall Study|Lack of Efficacy|2|||
162118740|NCT00445679|585485338|FG003|Overall Study|Lack of Efficacy|0|||
162118741|NCT00909428|585485344|FG000|Overall Study|Lost to Follow-up|13|||
162118742|NCT00909428|585485345|FG001|Overall Study|Lost to Follow-up|10|||
162118743|NCT00909428|585485346|FG002|Overall Study|Lost to Follow-up|9|||
162118744|NCT03021668|585485347|FG000|Overall Study|Physician Decision|0|||
162118745|NCT03021668|585485348|FG001|Overall Study|Physician Decision|1|||
162118746|NCT00116844|585485351|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
162118747|NCT00116844|585485352|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
162118748|NCT00116844|585485351|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
162118749|NCT00116844|585485352|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
162118750|NCT00116844|585485351|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
162118751|NCT00116844|585485352|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
162118752|NCT00116844|585485351|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
162118753|NCT00116844|585485352|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
162118754|NCT00116844|585485351|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
162118755|NCT00116844|585485352|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
162118756|NCT00116844|585485351|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
162118757|NCT00116844|585485352|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
162118758|NCT00116844|585485351|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
162118759|NCT00116844|585485352|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
162118760|NCT00116844|585485351|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
162118761|NCT00116844|585485352|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
162118762|NCT00116844|585485351|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
162118763|NCT00116844|585485352|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
162118764|NCT01933880|585485353|FG000|Overall Study|Withdrawal by Subject|5|||
162118765|NCT01933880|585485354|FG001|Overall Study|Withdrawal by Subject|0|||
162118766|NCT01933880|585485353|FG000|Overall Study|Lack of Efficacy|1|||
162118767|NCT01933880|585485354|FG001|Overall Study|Lack of Efficacy|0|||
162118768|NCT01933880|585485353|FG000|Overall Study|Concomitant medication Interference|0|||
162118769|NCT01933880|585485354|FG001|Overall Study|Concomitant medication Interference|1|||
162118770|NCT01933880|585485353|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
162118771|NCT01933880|585485354|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
162118772|NCT01933880|585485353|FG000|Overall Study|Other|4|||
162118773|NCT01933880|585485354|FG001|Overall Study|Other|0|||
162118774|NCT01933880|585485353|FG000|Overall Study|Protocol Violation|1|||
162118775|NCT01933880|585485354|FG001|Overall Study|Protocol Violation|0|||
162118776|NCT01125722|585485355|FG000|Overall Study|Withdrawal by Subject|2|||
162118777|NCT01125722|585485356|FG001|Overall Study|Withdrawal by Subject|1|||
162118778|NCT01125722|585485355|FG000|Overall Study|Lost to Follow-up|1|||
162118779|NCT01125722|585485356|FG001|Overall Study|Lost to Follow-up|0|||
162118780|NCT03474549|585485357|FG000|Overall Study|Death|31|||
162118781|NCT03474549|585485357|FG000|Overall Study|Lost to Follow-up|4|||
162118782|NCT03474549|585485357|FG000|Overall Study|Withdrawal by Subject|2|||
162118783|NCT00069784|585485358|FG000|Overall Study|Adverse Event|105|||
162118784|NCT00069784|585485359|FG001|Overall Study|Adverse Event|0|||
162118785|NCT00069784|585485358|FG000|Overall Study|Withdrawal by Subject|1090|||
162118786|NCT00069784|585485359|FG001|Overall Study|Withdrawal by Subject|0|||
162118787|NCT00069784|585485358|FG000|Overall Study|Other|17|||
162118788|NCT00069784|585485359|FG001|Overall Study|Other|0|||
162118789|NCT00926003|585485362|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
162118790|NCT00926003|585485363|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
162118791|NCT00926003|585485364|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
162118792|NCT00926003|585485362|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
162118793|NCT00926003|585485363|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
162118794|NCT00926003|585485364|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
162118795|NCT00709059|585485366|FG000|Overall Study|Lost to Follow-up|34|||
162118796|NCT00709059|585485366|FG000|Overall Study|Withdrawal by Subject|19|||
162118797|NCT00709059|585485366|FG000|Overall Study|Physician Decision|7|||
162118798|NCT00709059|585485366|FG000|Overall Study|Disease complication|3|||
162118799|NCT00709059|585485366|FG000|Overall Study|Side effects|20|||
162118800|NCT00709059|585485366|FG000|Overall Study|Serious side effects|11|||
162118801|NCT01786330|585485367|FG000|Overall Study|Withdrawal by Subject|0|||
162118802|NCT01786330|585485368|FG001|Overall Study|Withdrawal by Subject|1|||
162118803|NCT01786330|585485367|FG000|Overall Study|Lost to Follow-up|0|||
162118804|NCT01786330|585485368|FG001|Overall Study|Lost to Follow-up|1|||
162118805|NCT01786330|585485367|FG000|Overall Study|Excluded intraoperatively|0|||
162118806|NCT01786330|585485368|FG001|Overall Study|Excluded intraoperatively|1|||
162118807|NCT01786330|585485367|FG000|Overall Study|Protocol Violation|1|||
162118808|NCT01786330|585485368|FG001|Overall Study|Protocol Violation|0|||
162118809|NCT01167179|585487298|FG000|Overall Study|disease recurrence|4|||
162118810|NCT01167179|585487299|FG001|Overall Study|disease recurrence|4|||
162118811|NCT01167179|585487298|FG000|Overall Study|Death|4|||
162118812|NCT01167179|585487299|FG001|Overall Study|Death|10|||
162118813|NCT01167179|585487298|FG000|Overall Study|Withdrawal by Subject|1|||
162118814|NCT01167179|585487299|FG001|Overall Study|Withdrawal by Subject|2|||
162118815|NCT01167179|585487298|FG000|Overall Study|diverse|6|||
162118816|NCT01167179|585487299|FG001|Overall Study|diverse|5|||
162118817|NCT03017235|585487300|FG000|Overall Study|Withdrawal by Subject|4|||
162118818|NCT03017235|585487301|FG001|Overall Study|Withdrawal by Subject|3|||
162118819|NCT03017235|585487300|FG000|Overall Study|Lost to Follow-up|2|||
162118820|NCT03017235|585487301|FG001|Overall Study|Lost to Follow-up|7|||
162118821|NCT03017235|585487300|FG000|Overall Study|Adverse Event|0|||
162118822|NCT03017235|585487301|FG001|Overall Study|Adverse Event|1|||
162118823|NCT03017235|585487300|FG000|Overall Study|Protocol Violation|2|||
162118824|NCT03017235|585487301|FG001|Overall Study|Protocol Violation|1|||
162118825|NCT03017235|585487300|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
162118826|NCT03017235|585487301|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
162118827|NCT02254408|585487306|FG000|Overall Study|Randomized But Not Treated|1|||
162118828|NCT02254408|585487307|FG001|Overall Study|Randomized But Not Treated|3|||
162118829|NCT02254408|585487306|FG000|Overall Study|Adverse Event|1|||
162118830|NCT02254408|585487307|FG001|Overall Study|Adverse Event|0|||
162118831|NCT02254408|585487306|FG000|Overall Study|Death|2|||
162118832|NCT02254408|585487307|FG001|Overall Study|Death|3|||
162118833|NCT02254408|585487306|FG000|Overall Study|Investigator's Discretion|0|||
162118834|NCT02254408|585487307|FG001|Overall Study|Investigator's Discretion|1|||
162118835|NCT02254408|585487306|FG000|Overall Study|Withdrawal by Subject|3|||
162118836|NCT02254408|585487307|FG001|Overall Study|Withdrawal by Subject|3|||
162118837|NCT02254408|585487306|FG000|Overall Study|Lost to Follow-up|1|||
162118838|NCT02254408|585487307|FG001|Overall Study|Lost to Follow-up|0|||
162118839|NCT00917267|585487308|FG000|Overall Study|Adverse Event|15|||
162118840|NCT00917267|585487309|FG001|Overall Study|Adverse Event|36|||
162118841|NCT00917267|585487308|FG000|Overall Study|Physician Decision|2|||
162118842|NCT00917267|585487309|FG001|Overall Study|Physician Decision|4|||
162118843|NCT00917267|585487308|FG000|Overall Study|Protocol Violation|9|||
162118844|NCT00917267|585487309|FG001|Overall Study|Protocol Violation|18|||
162118845|NCT00917267|585487308|FG000|Overall Study|Withdrawal by Subject|5|||
162118846|NCT00917267|585487309|FG001|Overall Study|Withdrawal by Subject|12|||
162118847|NCT00917267|585487308|FG000|Overall Study|Lost to follow up|0|||
162118848|NCT00917267|585487309|FG001|Overall Study|Lost to follow up|2|||
162118849|NCT00917267|585487308|FG000|Overall Study|Entry Criteria Not Met|1|||
162118850|NCT00917267|585487309|FG001|Overall Study|Entry Criteria Not Met|0|||
162118851|NCT00917267|585487308|FG000|Overall Study|Sponsor Decision|5|||
162118852|NCT00917267|585487309|FG001|Overall Study|Sponsor Decision|5|||
162118853|NCT00917267|585487308|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
162118854|NCT00917267|585487309|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
162118855|NCT01478113|585487312|FG000|Overall Study|Withdrawal by Subject|0|||
162118856|NCT01478113|585487313|FG001|Overall Study|Withdrawal by Subject|1|||
162118857|NCT01478113|585487312|FG000|Overall Study|Physician Decision|1|||
162118858|NCT01478113|585487313|FG001|Overall Study|Physician Decision|0|||
162118859|NCT00289770|585487314|FG000|Year 15|Withdrawal by Subject|1|||
162118860|NCT00423293|585487315|FG000|Overall Study|Ineligible / No protocol treatment|11|||
162118861|NCT02966002|585487322|FG000|Overall Study|Withdrawal by Subject|2|||
162118862|NCT02966002|585487322|FG000|Overall Study|Adverse Event|1|||
162118863|NCT02966002|585487322|FG000|Overall Study|Lost to Follow-up|1|||
162118864|NCT00067990|585487324|FG000|Overall Study|Death|5|||
162118865|NCT00067990|585487325|FG001|Overall Study|Death|7|||
162118866|NCT00067990|585487324|FG000|Overall Study|ESRD, Non IF/TA|1|||
162118867|NCT00067990|585487325|FG001|Overall Study|ESRD, Non IF/TA|3|||
162118868|NCT00067990|585487324|FG000|Overall Study|Withdrawal by Subject|4|||
162118869|NCT00067990|585487325|FG001|Overall Study|Withdrawal by Subject|12|||
162118870|NCT02291432|585487326|FG000|Overall Study|Withdrawal by Subject|2|||
162118871|NCT00519896|585487330|FG000|Overall Study|Protocol Violation|1|||
162118872|NCT00519896|585487330|FG000|Overall Study|Adverse Event|1|||
162118873|NCT03327402|585487331|FG000|Overall Study|Withdrawal by Subject|1|||
162118874|NCT03327402|585487331|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
162118875|NCT01454830|585487334|FG000|Overall Study|Withdrawal by Subject|4|||
162118876|NCT01454830|585487335|FG001|Overall Study|Withdrawal by Subject|4|||
162118877|NCT01454830|585487334|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
162118878|NCT01454830|585487335|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
162118879|NCT01454830|585487334|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
162118880|NCT01454830|585487335|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
162118881|NCT01454830|585487334|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
162118882|NCT01454830|585487335|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
162118883|NCT01454830|585487334|FG000|Overall Study|Withdrawal - no polysomnography|3|||
162118884|NCT01454830|585487335|FG001|Overall Study|Withdrawal - no polysomnography|2|||
162118885|NCT03810313|585487336|FG000|Overall Study|Study terminated by sponsor|164|||
162118886|NCT03810313|585487337|FG001|Overall Study|Study terminated by sponsor|159|||
162118887|NCT03810313|585487336|FG000|Overall Study|Subject decision|10|||
162118888|NCT03810313|585487337|FG001|Overall Study|Subject decision|11|||
162118889|NCT03810313|585487336|FG000|Overall Study|Lost to Follow-up|3|||
162118890|NCT03810313|585487337|FG001|Overall Study|Lost to Follow-up|3|||
162118891|NCT03810313|585487336|FG000|Overall Study|Adverse Event|2|||
162118892|NCT03810313|585487337|FG001|Overall Study|Adverse Event|1|||
162118893|NCT03810313|585487336|FG000|Overall Study|Death|2|||
162118894|NCT03810313|585487337|FG001|Overall Study|Death|1|||
162118895|NCT03810313|585487336|FG000|Overall Study|Physician Decision|0|||
162118896|NCT03810313|585487337|FG001|Overall Study|Physician Decision|1|||
162118897|NCT00584805|585487338|FG000|Overall Study|No longer at risk of exposure|39|||
162118898|NCT00584805|585487338|FG000|Overall Study|Relocation|36|||
162118899|NCT00584805|585487338|FG000|Overall Study|Withdrawal by Subject|18|||
162118900|NCT00584805|585487338|FG000|Overall Study|Non-compliance|1|||
162118901|NCT00584805|585487338|FG000|Overall Study|Lost to follow up|3|||
162118902|NCT00584805|585487338|FG000|Overall Study|Screen failures|2|||
162118903|NCT02341456|585487344|FG000|Overall Study|Disease progression|2|||
162118904|NCT02341456|585487345|FG001|Overall Study|Disease progression|3|||
162118905|NCT02341456|585487346|FG002|Overall Study|Disease progression|1|||
162118906|NCT02341456|585487344|FG000|Overall Study|Death|1|||
162118907|NCT02341456|585487345|FG001|Overall Study|Death|1|||
162118908|NCT02341456|585487346|FG002|Overall Study|Death|1|||
162118909|NCT02341456|585487344|FG000|Overall Study|Withdrawal by Subject|0|||
162118910|NCT02341456|585487345|FG001|Overall Study|Withdrawal by Subject|1|||
162118911|NCT02341456|585487346|FG002|Overall Study|Withdrawal by Subject|1|||
162118912|NCT02341456|585487344|FG000|Overall Study|Moved to local access programme.|0|||
162118913|NCT02341456|585487345|FG001|Overall Study|Moved to local access programme.|1|||
162118914|NCT02341456|585487346|FG002|Overall Study|Moved to local access programme.|1|||
162118915|NCT02341456|585487344|FG000|Overall Study|Physician Decision|1|||
162118916|NCT02341456|585487345|FG001|Overall Study|Physician Decision|0|||
162118917|NCT02341456|585487346|FG002|Overall Study|Physician Decision|0|||
162118918|NCT01077362|585487347|FG000|Overall Study|Lack of Efficacy|13|||
162118919|NCT01077362|585487348|FG001|Overall Study|Lack of Efficacy|8|||
162118920|NCT01077362|585487349|FG002|Overall Study|Lack of Efficacy|10|||
162118921|NCT01077362|585487347|FG000|Overall Study|Lost to Follow-up|1|||
162118922|NCT01077362|585487348|FG001|Overall Study|Lost to Follow-up|0|||
162118923|NCT01077362|585487349|FG002|Overall Study|Lost to Follow-up|3|||
162118924|NCT01077362|585487347|FG000|Overall Study|Adverse Event|12|||
162118925|NCT01077362|585487348|FG001|Overall Study|Adverse Event|7|||
162118926|NCT01077362|585487349|FG002|Overall Study|Adverse Event|4|||
162118927|NCT01077362|585487347|FG000|Overall Study|Withdrawal by Subject|5|||
162118928|NCT01077362|585487348|FG001|Overall Study|Withdrawal by Subject|3|||
162118929|NCT01077362|585487349|FG002|Overall Study|Withdrawal by Subject|5|||
162118930|NCT01077362|585487347|FG000|Overall Study|Other|0|||
162118931|NCT01077362|585487348|FG001|Overall Study|Other|1|||
162118932|NCT01077362|585487349|FG002|Overall Study|Other|2|||
162118933|NCT00301080|585487356|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
162118934|NCT00301080|585487357|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
162118935|NCT00301080|585487358|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
162118936|NCT00301080|585487359|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
162118937|NCT00301080|585487360|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
162118938|NCT01287520|585487363|FG000|Overall Study|Adverse Event|2|||
162118939|NCT01287520|585487364|FG001|Overall Study|Adverse Event|2|||
162118940|NCT01287520|585487365|FG002|Overall Study|Adverse Event|2|||
162118941|NCT01287520|585487366|FG003|Overall Study|Adverse Event|1|||
162118942|NCT01287520|585487367|FG004|Overall Study|Adverse Event|1|||
162118943|NCT01287520|585487368|FG005|Overall Study|Adverse Event|2|||
162118944|NCT01287520|585487369|FG006|Overall Study|Adverse Event|0|||
162118945|NCT01287520|585487370|FG007|Overall Study|Adverse Event|2|||
162118946|NCT01287520|585487371|FG008|Overall Study|Adverse Event|0|||
162118947|NCT01287520|585487363|FG000|Overall Study|Physician Decision|1|||
162118948|NCT01287520|585487364|FG001|Overall Study|Physician Decision|1|||
162118949|NCT01287520|585487365|FG002|Overall Study|Physician Decision|2|||
162118950|NCT01287520|585487366|FG003|Overall Study|Physician Decision|0|||
162118951|NCT01287520|585487367|FG004|Overall Study|Physician Decision|1|||
162118952|NCT01287520|585487368|FG005|Overall Study|Physician Decision|1|||
162118953|NCT01287520|585487369|FG006|Overall Study|Physician Decision|0|||
162118954|NCT01287520|585487370|FG007|Overall Study|Physician Decision|1|||
162118955|NCT01287520|585487371|FG008|Overall Study|Physician Decision|0|||
162118956|NCT01287520|585487363|FG000|Overall Study|Progressive disease|0|||
162118957|NCT01287520|585487364|FG001|Overall Study|Progressive disease|4|||
162118958|NCT01287520|585487365|FG002|Overall Study|Progressive disease|1|||
162118959|NCT01287520|585487366|FG003|Overall Study|Progressive disease|6|||
162118960|NCT01287520|585487367|FG004|Overall Study|Progressive disease|1|||
162118961|NCT01287520|585487368|FG005|Overall Study|Progressive disease|0|||
162118962|NCT01287520|585487369|FG006|Overall Study|Progressive disease|2|||
162118963|NCT01287520|585487370|FG007|Overall Study|Progressive disease|2|||
162118964|NCT01287520|585487371|FG008|Overall Study|Progressive disease|4|||
162118965|NCT01287520|585487363|FG000|Overall Study|Withdrawal by Subject|0|||
162118966|NCT01287520|585487364|FG001|Overall Study|Withdrawal by Subject|0|||
162118967|NCT01287520|585487365|FG002|Overall Study|Withdrawal by Subject|0|||
162118968|NCT01287520|585487366|FG003|Overall Study|Withdrawal by Subject|0|||
162118969|NCT01287520|585487367|FG004|Overall Study|Withdrawal by Subject|0|||
162118970|NCT01287520|585487368|FG005|Overall Study|Withdrawal by Subject|1|||
162118971|NCT01287520|585487369|FG006|Overall Study|Withdrawal by Subject|0|||
162118972|NCT01287520|585487370|FG007|Overall Study|Withdrawal by Subject|0|||
162118973|NCT01287520|585487371|FG008|Overall Study|Withdrawal by Subject|1|||
162118974|NCT03587142|585487372|FG000|Overall Study|Lost to Follow-up|5|||
162118975|NCT03587142|585487373|FG001|Overall Study|Lost to Follow-up|3|||
162118976|NCT03587142|585487372|FG000|Overall Study|Did not complete the f4 visit|3|||
162118977|NCT03587142|585487373|FG001|Overall Study|Did not complete the f4 visit|7|||
162118978|NCT02768662|585487374|FG000|Overall Study|Adverse Event|1|||
162118979|NCT02768662|585487374|FG000|Overall Study|Lost to Follow-up|4|||
162118980|NCT02768662|585487374|FG000|Overall Study|Withdrawal by Subject|3|||
162118981|NCT02768662|585487374|FG000|Overall Study|Study terminated by Sponsor|78|||
162118982|NCT03673462|585487375|FG000|Overall Study|Adverse Event|11|||
162118983|NCT03673462|585487376|FG001|Overall Study|Adverse Event|1|||
162118984|NCT03673462|585487375|FG000|Overall Study|Protocol Violation|25|||
162118985|NCT03673462|585487376|FG001|Overall Study|Protocol Violation|11|||
162118986|NCT03673462|585487375|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
162118987|NCT03673462|585487376|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
162118988|NCT03673462|585487375|FG000|Overall Study|Lost to Follow-up|102|||
162118989|NCT03673462|585487376|FG001|Overall Study|Lost to Follow-up|19|||
162118990|NCT02567825|585487381|FG000|Overall Study|No follow-up post-randomization|5|||
162118991|NCT02567825|585487382|FG001|Overall Study|No follow-up post-randomization|1|||
162118992|NCT02567825|585487381|FG000|Overall Study|Follow-up less than 23 months|16|||
162118993|NCT02567825|585487382|FG001|Overall Study|Follow-up less than 23 months|20|||
162118994|NCT03097861|585487390|FG000|Overall Study|Adverse Event|3|||
162118995|NCT03097861|585487391|FG001|Overall Study|Adverse Event|8|||
162118996|NCT03097861|585487392|FG002|Overall Study|Adverse Event|4|||
162118997|NCT03097861|585487390|FG000|Overall Study|Investigator Decision|0|||
162118998|NCT03097861|585487391|FG001|Overall Study|Investigator Decision|1|||
162118999|NCT03097861|585487392|FG002|Overall Study|Investigator Decision|0|||
162119000|NCT03097861|585487390|FG000|Overall Study|Lost to Follow-up|0|||
162119001|NCT03097861|585487391|FG001|Overall Study|Lost to Follow-up|7|||
162119002|NCT03097861|585487392|FG002|Overall Study|Lost to Follow-up|1|||
162119003|NCT03097861|585487390|FG000|Overall Study|Withdrawal by Subject|1|||
162119004|NCT03097861|585487391|FG001|Overall Study|Withdrawal by Subject|5|||
162119005|NCT03097861|585487392|FG002|Overall Study|Withdrawal by Subject|3|||
162119006|NCT03097861|585487390|FG000|Overall Study|Reason not provided|3|||
162119007|NCT03097861|585487391|FG001|Overall Study|Reason not provided|1|||
162119008|NCT03097861|585487392|FG002|Overall Study|Reason not provided|1|||
162119009|NCT05061537|585487395|FG000|Treatment Phase|Progressive disease|0|||
162119010|NCT05061537|585487396|FG001|Treatment Phase|Progressive disease|1|||
162119011|NCT05061537|585487397|FG002|Treatment Phase|Progressive disease|2|||
162119012|NCT05061537|585487398|FG003|Treatment Phase|Progressive disease|0|||
162119013|NCT05061537|585487399|FG004|Treatment Phase|Progressive disease|0|||
162119014|NCT05061537|585487395|FG000|Treatment Phase|Adverse Event|0|||
162119015|NCT05061537|585487396|FG001|Treatment Phase|Adverse Event|0|||
162119016|NCT05061537|585487397|FG002|Treatment Phase|Adverse Event|2|||
162119017|NCT05061537|585487398|FG003|Treatment Phase|Adverse Event|0|||
162119018|NCT05061537|585487399|FG004|Treatment Phase|Adverse Event|0|||
162119019|NCT05061537|585487395|FG000|Treatment Phase|Global deterioration of health status|0|||
162119020|NCT05061537|585487396|FG001|Treatment Phase|Global deterioration of health status|1|||
162119021|NCT05061537|585487397|FG002|Treatment Phase|Global deterioration of health status|0|||
162119022|NCT05061537|585487398|FG003|Treatment Phase|Global deterioration of health status|0|||
162119023|NCT05061537|585487399|FG004|Treatment Phase|Global deterioration of health status|0|||
162119024|NCT05061537|585487395|FG000|Follow up|Other|2|||
162119025|NCT05061537|585487396|FG001|Follow up|Other|0|||
162119026|NCT05061537|585487397|FG002|Follow up|Other|2|||
162119027|NCT05061537|585487398|FG003|Follow up|Other|0|||
162119028|NCT05061537|585487399|FG004|Follow up|Other|0|||
162119029|NCT05061537|585487395|FG000|Follow up|Study terminated by sponsor|0|||
162119030|NCT05061537|585487396|FG001|Follow up|Study terminated by sponsor|0|||
162119031|NCT05061537|585487397|FG002|Follow up|Study terminated by sponsor|2|||
162119032|NCT05061537|585487398|FG003|Follow up|Study terminated by sponsor|0|||
162119033|NCT05061537|585487399|FG004|Follow up|Study terminated by sponsor|0|||
162119034|NCT05061537|585487395|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
162119035|NCT05061537|585487396|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
162119036|NCT05061537|585487397|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
162119037|NCT05061537|585487398|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
162119038|NCT05061537|585487399|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
162119039|NCT05061537|585487395|FG000|Long-term Follow-up|Death|0|||
162119040|NCT05061537|585487396|FG001|Long-term Follow-up|Death|1|||
162119041|NCT05061537|585487397|FG002|Long-term Follow-up|Death|0|||
162119042|NCT05061537|585487398|FG003|Long-term Follow-up|Death|0|||
162119043|NCT05061537|585487399|FG004|Long-term Follow-up|Death|0|||
162119044|NCT03502616|585487401|FG000|Up to Week 16|Withdrawal by Subject|1|||
162119045|NCT03502616|585487402|FG001|Up to Week 16|Withdrawal by Subject|2|||
162119046|NCT03502616|585487401|FG000|Up to Week 16|Lost to Follow-up|0|||
162119047|NCT03502616|585487402|FG001|Up to Week 16|Lost to Follow-up|1|||
162119048|NCT03502616|585487401|FG000|Up to Week 16|Randomized, but not treated|1|||
162119049|NCT03502616|585487402|FG001|Up to Week 16|Randomized, but not treated|0|||
162119050|NCT03502616|585487401|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
162119051|NCT03502616|585487402|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
162119052|NCT03502616|585487401|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
162119053|NCT03502616|585487402|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
162119054|NCT04503096|585487403|FG000|Overall Study|Withdrawal by Subject|3|||
162119055|NCT01785563|585487404|FG000|Overall Study|Physician Decision|10|||
162119056|NCT01785563|585487404|FG000|Overall Study|Withdrawal by Subject|1|||
162119057|NCT01785563|585487404|FG000|Overall Study|Protocol Violation|2|||
162119058|NCT01872910|585487406|FG000|Overall Study|Lost to Follow-up|2|||
162119059|NCT01872910|585487407|FG001|Overall Study|Lost to Follow-up|0|||
162119060|NCT01872910|585487408|FG002|Overall Study|Lost to Follow-up|2|||
162119061|NCT01872910|585487409|FG003|Overall Study|Lost to Follow-up|0|||
162119062|NCT01872910|585487410|FG004|Overall Study|Lost to Follow-up|0|||
162119063|NCT01872910|585487411|FG005|Overall Study|Lost to Follow-up|0|||
162119064|NCT00744328|585487414|FG000|Overall Study|Lost to Follow-up|2|||
162119065|NCT00744328|585487415|FG001|Overall Study|Lost to Follow-up|5|||
162119066|NCT00744328|585487416|FG002|Overall Study|Lost to Follow-up|3|||
162119067|NCT00744328|585487414|FG000|Overall Study|Withdrawal by Subject|5|||
162119068|NCT00744328|585487415|FG001|Overall Study|Withdrawal by Subject|3|||
162119069|NCT00744328|585487416|FG002|Overall Study|Withdrawal by Subject|4|||
162119070|NCT00744328|585487414|FG000|Overall Study|Found ineligible after randomization|0|||
162119071|NCT00744328|585487415|FG001|Overall Study|Found ineligible after randomization|0|||
162119072|NCT00744328|585487416|FG002|Overall Study|Found ineligible after randomization|1|||
162119073|NCT01576367|585487417|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
162119074|NCT01576367|585487417|FG000|Overall Study|Moved to commercial use after 6 months|1|||
162237481|NCT00600886|585921096|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
162119075|NCT02387216|585487421|FG000|Overall Study|Progressive disease|2|||
162119076|NCT02387216|585487422|FG001|Overall Study|Progressive disease|0|||
162119077|NCT02387216|585487421|FG000|Overall Study|Withdrawal by Subject|3|||
162119078|NCT02387216|585487422|FG001|Overall Study|Withdrawal by Subject|5|||
162119079|NCT02387216|585487421|FG000|Overall Study|Physician Decision|2|||
162119080|NCT02387216|585487422|FG001|Overall Study|Physician Decision|0|||
162119081|NCT02387216|585487421|FG000|Overall Study|Sponsor Decision|28|||
162119082|NCT02387216|585487422|FG001|Overall Study|Sponsor Decision|12|||
162119083|NCT02387216|585487421|FG000|Overall Study|Death|60|||
162119084|NCT02387216|585487422|FG001|Overall Study|Death|23|||
162119085|NCT02387216|585487421|FG000|Overall Study|Other|5|||
162119086|NCT02387216|585487422|FG001|Overall Study|Other|4|||
162119087|NCT02387216|585487421|FG000|Overall Study|Lost to Follow-up|0|||
162119088|NCT02387216|585487422|FG001|Overall Study|Lost to Follow-up|3|||
162119089|NCT02091739|585487423|FG000|MP: 16 Weeks|Adverse Event|1|||
162119090|NCT02091739|585487424|FG001|MP: 16 Weeks|Adverse Event|1|||
162119091|NCT02091739|585487425|FG002|MP: 16 Weeks|Adverse Event|1|||
162119092|NCT02091739|585487426|FG003|MP: 16 Weeks|Adverse Event|0|||
162119093|NCT02091739|585487427|FG004|MP: 16 Weeks|Adverse Event|0|||
162119094|NCT02091739|585487423|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
162119095|NCT02091739|585487424|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
162119096|NCT02091739|585487425|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
162119097|NCT02091739|585487426|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
162119098|NCT02091739|585487427|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
162119099|NCT02091739|585487423|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
162119100|NCT02091739|585487424|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
162119101|NCT02091739|585487425|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
162119102|NCT02091739|585487426|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
162119103|NCT02091739|585487427|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
162119104|NCT02091739|585487423|FG000|EP: 48 Weeks|Other|0|||
162119105|NCT02091739|585487424|FG001|EP: 48 Weeks|Other|0|||
162119106|NCT02091739|585487425|FG002|EP: 48 Weeks|Other|0|||
162119107|NCT02091739|585487426|FG003|EP: 48 Weeks|Other|1|||
162119108|NCT02091739|585487427|FG004|EP: 48 Weeks|Other|0|||
162119109|NCT02091739|585487423|FG000|EP: 48 Weeks|Death|0|||
162119110|NCT02091739|585487424|FG001|EP: 48 Weeks|Death|0|||
162119111|NCT02091739|585487425|FG002|EP: 48 Weeks|Death|0|||
162119112|NCT02091739|585487426|FG003|EP: 48 Weeks|Death|3|||
162119113|NCT02091739|585487427|FG004|EP: 48 Weeks|Death|2|||
162119114|NCT02091739|585487423|FG000|EP: 48 Weeks|Adverse Event|0|||
162119115|NCT02091739|585487424|FG001|EP: 48 Weeks|Adverse Event|0|||
162119116|NCT02091739|585487425|FG002|EP: 48 Weeks|Adverse Event|0|||
162119117|NCT02091739|585487426|FG003|EP: 48 Weeks|Adverse Event|2|||
162119118|NCT02091739|585487427|FG004|EP: 48 Weeks|Adverse Event|6|||
162119119|NCT02091739|585487423|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
162119120|NCT02091739|585487424|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
162119121|NCT02091739|585487425|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
162119122|NCT02091739|585487426|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
162119123|NCT02091739|585487427|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
162119124|NCT03528174|585487428|FG000|Overall Study|Adverse Event|1|||
162119125|NCT03528174|585487428|FG000|Overall Study|sensors dislodged|1|||
162119126|NCT04251065|585487429|FG000|Overall Study|Death|2|||
162119127|NCT04251065|585487429|FG000|Overall Study|Lack of Efficacy|3|||
162119128|NCT04251065|585487429|FG000|Overall Study|Death|1|||
162119129|NCT01436201|585487430|FG000|Overall Study|Adverse Event|2|||
162119130|NCT01436201|585487430|FG000|Overall Study|Withdrawal by Subject|1|||
162119131|NCT01436201|585487430|FG000|Overall Study|Protocol Violation|1|||
162119132|NCT00110890|585487431|FG000|Overall Study|Adverse Event|30|||
162119133|NCT00110890|585487432|FG001|Overall Study|Adverse Event|7|||
162119134|NCT00110890|585487431|FG000|Overall Study|Death|16|||
162119135|NCT00110890|585487432|FG001|Overall Study|Death|9|||
162119136|NCT00110890|585487431|FG000|Overall Study|Lost to Follow-up|3|||
162119137|NCT00110890|585487432|FG001|Overall Study|Lost to Follow-up|1|||
162119138|NCT00110890|585487431|FG000|Overall Study|Physician Decision|4|||
162119139|NCT00110890|585487432|FG001|Overall Study|Physician Decision|5|||
162119140|NCT00110890|585487431|FG000|Overall Study|Withdrawal by Subject|17|||
162119141|NCT00110890|585487432|FG001|Overall Study|Withdrawal by Subject|5|||
162119142|NCT00110890|585487431|FG000|Overall Study|Protocol Deviation|1|||
162119143|NCT00110890|585487432|FG001|Overall Study|Protocol Deviation|0|||
162119144|NCT00110890|585487431|FG000|Overall Study|Noncompliance|10|||
162119145|NCT00110890|585487432|FG001|Overall Study|Noncompliance|0|||
162119146|NCT00110890|585487431|FG000|Overall Study|Kidney Transplant|16|||
162119147|NCT00110890|585487432|FG001|Overall Study|Kidney Transplant|12|||
162119148|NCT00110890|585487431|FG000|Overall Study|Invest. Product Commercially Available|217|||
162119149|NCT00110890|585487432|FG001|Overall Study|Invest. Product Commercially Available|110|||
162119150|NCT00110890|585487431|FG000|Overall Study|Other|34|||
162119151|NCT00110890|585487432|FG001|Overall Study|Other|23|||
162119152|NCT00110890|585487431|FG000|Overall Study|Ineligibility determined|3|||
162119153|NCT00110890|585487432|FG001|Overall Study|Ineligibility determined|0|||
162119154|NCT00110890|585487431|FG000|Overall Study|Requirement for alternative therapy|0|||
162119155|NCT00110890|585487432|FG001|Overall Study|Requirement for alternative therapy|1|||
162119156|NCT00110890|585487431|FG000|Overall Study|Disease progression|0|||
162119157|NCT00110890|585487432|FG001|Overall Study|Disease progression|1|||
162119158|NCT00110890|585487431|FG000|Overall Study|Parathyroidectomy|0|||
162119159|NCT00110890|585487432|FG001|Overall Study|Parathyroidectomy|1|||
162119160|NCT00110890|585487431|FG000|Overall Study|Did not enter follow-up phase|10|||
162119161|NCT00110890|585487432|FG001|Overall Study|Did not enter follow-up phase|4|||
162119162|NCT01686581|585487433|FG000|Overall Study|Side-effects or Health Problems|15|||
162119163|NCT01686581|585487433|FG000|Overall Study|Lack of Efficacy|90|||
162119164|NCT01686581|585487433|FG000|Overall Study|Participant Concerned about Risks|6|||
162119165|NCT01686581|585487433|FG000|Overall Study|Thinks Injections Too Painful|8|||
162119166|NCT01686581|585487433|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
162119167|NCT01686581|585487433|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
162119168|NCT01686581|585487433|FG000|Overall Study|Thinks it is Inconvenient|17|||
162119169|NCT01686581|585487433|FG000|Overall Study|Other Miscellaneous Reasons|36|||
162119170|NCT01686581|585487433|FG000|Overall Study|Reason Missing|1|||
162119171|NCT01975220|585487434|FG000|Test Period 1|Not treated|0|||
162119172|NCT01975220|585487435|FG001|Test Period 1|Not treated|1|||
162119173|NCT01975220|585487436|FG002|Test Period 1|Not treated|0|||
162119174|NCT01975220|585487437|FG003|Test Period 1|Not treated|0|||
162119175|NCT01975220|585487438|FG004|Test Period 1|Not treated|0|||
162119176|NCT01975220|585487439|FG005|Test Period 1|Not treated|0|||
162119177|NCT00263328|585487443|FG000|Overall Study|Death|0|||
162119178|NCT00263328|585487444|FG001|Overall Study|Death|0|||
162119179|NCT00263328|585487445|FG002|Overall Study|Death|1|||
162119180|NCT00263328|585487443|FG000|Overall Study|Lost to Follow-up|1|||
162119181|NCT00263328|585487444|FG001|Overall Study|Lost to Follow-up|1|||
162119182|NCT00263328|585487445|FG002|Overall Study|Lost to Follow-up|0|||
162119183|NCT00263328|585487443|FG000|Overall Study|Withdrawal by Subject|3|||
162119184|NCT00263328|585487444|FG001|Overall Study|Withdrawal by Subject|0|||
162119185|NCT00263328|585487445|FG002|Overall Study|Withdrawal by Subject|1|||
162119186|NCT00263328|585487443|FG000|Overall Study|Other|3|||
162119187|NCT00263328|585487444|FG001|Overall Study|Other|0|||
162119188|NCT00263328|585487445|FG002|Overall Study|Other|1|||
162119189|NCT00263328|585487443|FG000|Overall Study|Adverse Event|1|||
162119190|NCT00263328|585487444|FG001|Overall Study|Adverse Event|1|||
162119191|NCT00263328|585487445|FG002|Overall Study|Adverse Event|4|||
162119192|NCT01008475|585487449|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
162119193|NCT01008475|585487450|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
162119194|NCT01008475|585487451|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
162119195|NCT01008475|585487452|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
162119196|NCT01008475|585487453|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
162119197|NCT01008475|585487454|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
162119198|NCT01008475|585487455|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
162119199|NCT01301274|585487456|FG000|Overall Study|Physician Decision|2|||
162119200|NCT01301274|585487457|FG001|Overall Study|Physician Decision|1|||
162119201|NCT00661661|585487458|FG000|Overall Study|Adverse Event|99|||
162119202|NCT00661661|585487459|FG001|Overall Study|Adverse Event|24|||
162119203|NCT00661661|585487458|FG000|Overall Study|Lack of Efficacy|3|||
162119204|NCT00661661|585487459|FG001|Overall Study|Lack of Efficacy|2|||
162119205|NCT00661661|585487458|FG000|Overall Study|Lost to Follow-up|0|||
162119206|NCT00661661|585487459|FG001|Overall Study|Lost to Follow-up|1|||
162119207|NCT00661661|585487458|FG000|Overall Study|Withdrawal by Subject|15|||
162119208|NCT00661661|585487459|FG001|Overall Study|Withdrawal by Subject|5|||
162119209|NCT00661661|585487458|FG000|Overall Study|Other|22|||
162119210|NCT00661661|585487459|FG001|Overall Study|Other|7|||
162119211|NCT00661661|585487458|FG000|Overall Study|Not assigned treatment|1|||
162119212|NCT00661661|585487459|FG001|Overall Study|Not assigned treatment|0|||
162119213|NCT01893827|585487460|FG000|Overall Study|Lost to Follow-up|19|||
162119214|NCT01893827|585487461|FG001|Overall Study|Lost to Follow-up|26|||
162119215|NCT02917941|585487462|FG000|Treatment Period|Adverse Event|11|||
162119216|NCT02917941|585487462|FG000|Treatment Period|Progressive Disease|11|||
162119217|NCT02917941|585487462|FG000|Treatment Period|Reason not Specified|2|||
162119218|NCT02917941|585487462|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
162119219|NCT02917941|585487462|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
162119220|NCT02769065|585489102|FG000|Overall Study|Voluntary Withdrawal|1|||
162119221|NCT02769065|585489103|FG001|Overall Study|Voluntary Withdrawal|0|||
162119222|NCT02769065|585489104|FG002|Overall Study|Voluntary Withdrawal|0|||
162119223|NCT02769065|585489105|FG003|Overall Study|Voluntary Withdrawal|0|||
162119224|NCT02769065|585489106|FG004|Overall Study|Voluntary Withdrawal|0|||
162119225|NCT02769065|585489107|FG005|Overall Study|Voluntary Withdrawal|0|||
162119226|NCT02769065|585489108|FG006|Overall Study|Voluntary Withdrawal|0|||
162119227|NCT02769065|585489109|FG007|Overall Study|Voluntary Withdrawal|0|||
162119228|NCT02769065|585489110|FG008|Overall Study|Voluntary Withdrawal|0|||
162119229|NCT02769065|585489111|FG009|Overall Study|Voluntary Withdrawal|0|||
162119230|NCT02769065|585489112|FG010|Overall Study|Voluntary Withdrawal|0|||
162119231|NCT02769065|585489113|FG011|Overall Study|Voluntary Withdrawal|0|||
162119232|NCT02769065|585489114|FG012|Overall Study|Voluntary Withdrawal|0|||
162119233|NCT02769065|585489115|FG013|Overall Study|Voluntary Withdrawal|0|||
162119234|NCT02769065|585489116|FG014|Overall Study|Voluntary Withdrawal|0|||
162119235|NCT02769065|585489117|FG015|Overall Study|Voluntary Withdrawal|0|||
162119236|NCT02769065|585489118|FG016|Overall Study|Voluntary Withdrawal|0|||
162119237|NCT02769065|585489119|FG017|Overall Study|Voluntary Withdrawal|0|||
162119238|NCT02769065|585489120|FG018|Overall Study|Voluntary Withdrawal|0|||
162119239|NCT02769065|585489121|FG019|Overall Study|Voluntary Withdrawal|0|||
162119240|NCT02769065|585489122|FG020|Overall Study|Voluntary Withdrawal|0|||
162119241|NCT02769065|585489123|FG021|Overall Study|Voluntary Withdrawal|0|||
162119242|NCT02769065|585489124|FG022|Overall Study|Voluntary Withdrawal|0|||
162119243|NCT02769065|585489125|FG023|Overall Study|Voluntary Withdrawal|0|||
162119244|NCT02769065|585489126|FG024|Overall Study|Voluntary Withdrawal|0|||
162119245|NCT02769065|585489127|FG025|Overall Study|Voluntary Withdrawal|0|||
162119246|NCT02769065|585489128|FG026|Overall Study|Voluntary Withdrawal|0|||
162119247|NCT02769065|585489129|FG027|Overall Study|Voluntary Withdrawal|0|||
162119248|NCT02769065|585489130|FG028|Overall Study|Voluntary Withdrawal|0|||
162119249|NCT02769065|585489131|FG029|Overall Study|Voluntary Withdrawal|0|||
162119250|NCT02769065|585489102|FG000|Overall Study|Reason Not Specified|0|||
162119251|NCT02769065|585489103|FG001|Overall Study|Reason Not Specified|0|||
162119252|NCT02769065|585489104|FG002|Overall Study|Reason Not Specified|0|||
162119253|NCT02769065|585489105|FG003|Overall Study|Reason Not Specified|0|||
162119254|NCT02769065|585489106|FG004|Overall Study|Reason Not Specified|0|||
162119255|NCT02769065|585489107|FG005|Overall Study|Reason Not Specified|0|||
162119256|NCT02769065|585489108|FG006|Overall Study|Reason Not Specified|1|||
162119257|NCT02769065|585489109|FG007|Overall Study|Reason Not Specified|0|||
162119258|NCT02769065|585489110|FG008|Overall Study|Reason Not Specified|0|||
162119259|NCT02769065|585489111|FG009|Overall Study|Reason Not Specified|0|||
162119260|NCT02769065|585489112|FG010|Overall Study|Reason Not Specified|0|||
162119261|NCT02769065|585489113|FG011|Overall Study|Reason Not Specified|0|||
162119262|NCT02769065|585489114|FG012|Overall Study|Reason Not Specified|0|||
162119263|NCT02769065|585489115|FG013|Overall Study|Reason Not Specified|0|||
162119264|NCT02769065|585489116|FG014|Overall Study|Reason Not Specified|0|||
162119265|NCT02769065|585489117|FG015|Overall Study|Reason Not Specified|0|||
162119266|NCT02769065|585489118|FG016|Overall Study|Reason Not Specified|0|||
162119267|NCT02769065|585489119|FG017|Overall Study|Reason Not Specified|0|||
162119268|NCT02769065|585489120|FG018|Overall Study|Reason Not Specified|0|||
162119269|NCT02769065|585489121|FG019|Overall Study|Reason Not Specified|0|||
162119270|NCT02769065|585489122|FG020|Overall Study|Reason Not Specified|0|||
162119271|NCT02769065|585489123|FG021|Overall Study|Reason Not Specified|0|||
162119272|NCT02769065|585489124|FG022|Overall Study|Reason Not Specified|0|||
162119273|NCT02769065|585489125|FG023|Overall Study|Reason Not Specified|0|||
162119274|NCT02769065|585489126|FG024|Overall Study|Reason Not Specified|0|||
162119275|NCT02769065|585489127|FG025|Overall Study|Reason Not Specified|0|||
162119276|NCT02769065|585489128|FG026|Overall Study|Reason Not Specified|0|||
162119277|NCT02769065|585489129|FG027|Overall Study|Reason Not Specified|0|||
162119278|NCT02769065|585489130|FG028|Overall Study|Reason Not Specified|0|||
162119279|NCT02769065|585489131|FG029|Overall Study|Reason Not Specified|0|||
162119280|NCT02769065|585489102|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119281|NCT02769065|585489103|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119282|NCT02769065|585489104|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119283|NCT02769065|585489105|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119284|NCT02769065|585489106|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119285|NCT02769065|585489107|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119286|NCT02769065|585489108|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119287|NCT02769065|585489109|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119288|NCT02769065|585489110|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119289|NCT02769065|585489111|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119290|NCT02769065|585489112|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
162119291|NCT02769065|585489113|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119292|NCT02769065|585489114|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119293|NCT02769065|585489115|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119294|NCT02769065|585489116|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119295|NCT02769065|585489117|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119296|NCT02769065|585489118|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119297|NCT02769065|585489119|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119298|NCT02769065|585489120|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119299|NCT02769065|585489121|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119300|NCT02769065|585489122|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119301|NCT02769065|585489123|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119302|NCT02769065|585489124|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119303|NCT02769065|585489125|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119304|NCT02769065|585489126|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119305|NCT02769065|585489127|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119306|NCT02769065|585489128|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119307|NCT02769065|585489129|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119308|NCT02769065|585489130|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119309|NCT02769065|585489131|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
162119310|NCT01382940|585489134|FG000|Overall Study|Adverse Event|19|||
162119311|NCT01382940|585489134|FG000|Overall Study|Lost to Follow-up|4|||
162119312|NCT01382940|585489134|FG000|Overall Study|Physician Decision|7|||
162119313|NCT01382940|585489134|FG000|Overall Study|Withdrawal by Subject|23|||
162119314|NCT01382940|585489134|FG000|Overall Study|Protocol Violation|20|||
162119315|NCT02105636|585489135|FG000|Pre-Treatment|Disease Progression|1|||
162119316|NCT02105636|585489136|FG001|Pre-Treatment|Disease Progression|0|||
162119317|NCT02105636|585489135|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
162119318|NCT02105636|585489136|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
162119319|NCT02105636|585489135|FG000|Pre-Treatment|Participant withdrew consent|0|||
162119320|NCT02105636|585489136|FG001|Pre-Treatment|Participant withdrew consent|6|||
162119321|NCT02105636|585489135|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
162119322|NCT02105636|585489136|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
162119323|NCT02105636|585489135|FG000|Treatment|Study Drug Toxicity|14|||
162119324|NCT02105636|585489136|FG001|Treatment|Study Drug Toxicity|10|||
162119325|NCT02105636|585489135|FG000|Treatment|Adverse event unrelated to study drug|19|||
162119326|NCT02105636|585489136|FG001|Treatment|Adverse event unrelated to study drug|3|||
162119327|NCT02105636|585489135|FG000|Treatment|Participant request to discontinue study treatment|8|||
162119328|NCT02105636|585489136|FG001|Treatment|Participant request to discontinue study treatment|6|||
162119329|NCT02105636|585489135|FG000|Treatment|Participant withdrew consent|5|||
162119330|NCT02105636|585489136|FG001|Treatment|Participant withdrew consent|1|||
162119331|NCT02105636|585489135|FG000|Treatment|Lost to Follow-up|1|||
162119332|NCT02105636|585489136|FG001|Treatment|Lost to Follow-up|0|||
162119333|NCT02105636|585489135|FG000|Treatment|Maximum Clinical Benefit|1|||
162119334|NCT02105636|585489136|FG001|Treatment|Maximum Clinical Benefit|3|||
162119335|NCT02105636|585489135|FG000|Treatment|Poor/Non-compliance|0|||
162119336|NCT02105636|585489136|FG001|Treatment|Poor/Non-compliance|1|||
162119337|NCT02105636|585489135|FG000|Treatment|Participant no longer meets study criteria|1|||
162119338|NCT02105636|585489136|FG001|Treatment|Participant no longer meets study criteria|0|||
162119339|NCT02105636|585489135|FG000|Treatment|Other reasons|1|||
162119340|NCT02105636|585489136|FG001|Treatment|Other reasons|0|||
162119341|NCT02105636|585489135|FG000|Treatment|Disease Progression|185|||
162119342|NCT02105636|585489136|FG001|Treatment|Disease Progression|87|||
162119343|NCT00720902|585489137|FG000|Overall Study|Withdrawal by Subject|1|||
162119344|NCT00720902|585489138|FG001|Overall Study|Withdrawal by Subject|0|||
162119345|NCT00720902|585489137|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
162119346|NCT00720902|585489138|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
162119347|NCT01993017|585489140|FG000|Overall Study|Death|23|||
162119348|NCT01993017|585489141|FG001|Overall Study|Death|26|||
162119349|NCT01993017|585489142|FG002|Overall Study|Death|18|||
162119350|NCT01993017|585489140|FG000|Overall Study|Could not be contacted|43|||
162119351|NCT01993017|585489141|FG001|Overall Study|Could not be contacted|42|||
162119352|NCT01993017|585489142|FG002|Overall Study|Could not be contacted|38|||
162119353|NCT01993017|585489140|FG000|Overall Study|Dropped out|19|||
162119354|NCT01993017|585489141|FG001|Overall Study|Dropped out|6|||
162119355|NCT01993017|585489142|FG002|Overall Study|Dropped out|11|||
162119356|NCT01993017|585489140|FG000|Overall Study|Other reasons|17|||
162119357|NCT01993017|585489141|FG001|Overall Study|Other reasons|11|||
162119358|NCT01993017|585489142|FG002|Overall Study|Other reasons|7|||
162119359|NCT01993017|585489140|FG000|Overall Study|Ineligible after randomization|4|||
162119360|NCT01993017|585489141|FG001|Overall Study|Ineligible after randomization|5|||
162119361|NCT01993017|585489142|FG002|Overall Study|Ineligible after randomization|5|||
162119362|NCT00003511|585489143|FG000|Overall Study|Not evaluable|4|||
162119363|NCT03638635|585489144|FG000|Initial Hospitalization|Study terminated prematurely|0|||
162119364|NCT03638635|585489145|FG001|Initial Hospitalization|Study terminated prematurely|1|||
162119365|NCT03638635|585489144|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
162119366|NCT03638635|585489145|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
162119367|NCT03638635|585489144|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
162119368|NCT03638635|585489145|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
162119369|NCT01540565|585489149|FG000|Overall Study|Ineligible|2|||
162119370|NCT03469349|585489150|FG000|Overall Study|Withdrawal by Subject|1|||
162119371|NCT03469349|585489151|FG001|Overall Study|Withdrawal by Subject|3|||
162119372|NCT03469349|585489150|FG000|Overall Study|Progressive Disease|0|||
162119373|NCT03469349|585489151|FG001|Overall Study|Progressive Disease|1|||
162119374|NCT03469349|585489150|FG000|Overall Study|Lost to Follow-up|2|||
162119375|NCT03469349|585489151|FG001|Overall Study|Lost to Follow-up|2|||
162119376|NCT03469349|585489150|FG000|Overall Study|Adverse Event|2|||
162119377|NCT03469349|585489151|FG001|Overall Study|Adverse Event|4|||
162119378|NCT01827254|585489152|FG000|Overall Study|Death|10|||
162119379|NCT01827254|585489152|FG000|Overall Study|Case report form not completed|4|||
162119380|NCT01827254|585489152|FG000|Overall Study|Invalidated centre|3|||
162119381|NCT01827254|585489152|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
162119382|NCT01827254|585489152|FG000|Overall Study|Did not complete re-challenge|1|||
162119383|NCT01827254|585489152|FG000|Overall Study|Disease progression|36|||
162119384|NCT01827254|585489152|FG000|Overall Study|Intolerance to treatment|4|||
162119385|NCT04145037|585489160|FG000|Overall Study|Study terminated|2|||
162119386|NCT04145037|585489161|FG001|Overall Study|Study terminated|0|||
162119387|NCT04145037|585489160|FG000|Overall Study|Withdrawal by Subject|1|||
162119388|NCT04145037|585489161|FG001|Overall Study|Withdrawal by Subject|0|||
162119389|NCT04145037|585489160|FG000|Overall Study|Lost to Follow-up|1|||
162119390|NCT04145037|585489161|FG001|Overall Study|Lost to Follow-up|0|||
162119391|NCT02307513|585489164|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
162119392|NCT02307513|585489165|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
162119393|NCT02307513|585489164|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
162119394|NCT02307513|585489165|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
162119395|NCT02307513|585489164|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
162119396|NCT02307513|585489165|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
162119397|NCT02307513|585489164|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
162119398|NCT02307513|585489165|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
162119399|NCT02307513|585489164|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
162119400|NCT02307513|585489165|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
162119401|NCT02307513|585489164|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
162119402|NCT02307513|585489165|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
162119403|NCT02307513|585489164|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
162119404|NCT02307513|585489165|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
162119405|NCT02307513|585489164|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
162119406|NCT02307513|585489165|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
162119407|NCT02307513|585489164|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
162119408|NCT02307513|585489165|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
162119409|NCT02307513|585489164|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
162119410|NCT02307513|585489165|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
162119411|NCT02307513|585489164|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
162119412|NCT02307513|585489165|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
162119413|NCT02307513|585489164|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
162119414|NCT02307513|585489165|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
162119415|NCT02307513|585489164|FG000|Long-term Extension|Physician Decision|1|||
162119416|NCT02307513|585489165|FG001|Long-term Extension|Physician Decision|0|||
162119417|NCT00525265|585489173|FG000|Overall Study|Protocol Violation|1|||
162119418|NCT00525265|585489174|FG001|Overall Study|Protocol Violation|0|||
162119419|NCT01107743|585489175|FG000|Overall Study|Protocol Violation|46|||
162119420|NCT00308737|585489176|FG000|Overall Study|Adverse Event|104|||
162119421|NCT00308737|585489177|FG001|Overall Study|Adverse Event|9|||
162119422|NCT00308737|585489178|FG002|Overall Study|Adverse Event|0|||
162119423|NCT00308737|585489176|FG000|Overall Study|Death|4|||
162119424|NCT00308737|585489177|FG001|Overall Study|Death|3|||
162119425|NCT00308737|585489178|FG002|Overall Study|Death|0|||
162119426|NCT00308737|585489176|FG000|Overall Study|Lost to Follow-up|56|||
162119427|NCT00308737|585489177|FG001|Overall Study|Lost to Follow-up|80|||
162119428|NCT00308737|585489178|FG002|Overall Study|Lost to Follow-up|5|||
162119429|NCT00308737|585489176|FG000|Overall Study|Physician Decision|15|||
162119430|NCT00308737|585489177|FG001|Overall Study|Physician Decision|2|||
162119431|NCT00308737|585489178|FG002|Overall Study|Physician Decision|1|||
162119432|NCT00308737|585489176|FG000|Overall Study|Protocol Violation|34|||
162119433|NCT00308737|585489177|FG001|Overall Study|Protocol Violation|9|||
162119434|NCT00308737|585489178|FG002|Overall Study|Protocol Violation|5|||
162119435|NCT00308737|585489176|FG000|Overall Study|Withdrawal by Subject|218|||
162119436|NCT00308737|585489177|FG001|Overall Study|Withdrawal by Subject|166|||
162119437|NCT00308737|585489178|FG002|Overall Study|Withdrawal by Subject|18|||
162119438|NCT00308737|585489176|FG000|Overall Study|Various|32|||
162119439|NCT00308737|585489177|FG001|Overall Study|Various|20|||
162119440|NCT00308737|585489178|FG002|Overall Study|Various|8|||
162119441|NCT00744263|585489181|FG000|Overall Study|Death|3006|||
162119442|NCT00744263|585489182|FG001|Overall Study|Death|3005|||
162119443|NCT00744263|585489181|FG000|Overall Study|Lost to Follow-up|2038|||
162119444|NCT00744263|585489182|FG001|Overall Study|Lost to Follow-up|2135|||
162119445|NCT00744263|585489181|FG000|Overall Study|Withdrawal by Subject|166|||
162119446|NCT00744263|585489182|FG001|Overall Study|Withdrawal by Subject|150|||
162119447|NCT00744263|585489181|FG000|Overall Study|Physician Decision|20|||
162119448|NCT00744263|585489182|FG001|Overall Study|Physician Decision|23|||
162119449|NCT00744263|585489181|FG000|Overall Study|Protocol Violation|3|||
162119450|NCT00744263|585489182|FG001|Overall Study|Protocol Violation|5|||
162119451|NCT00744263|585489181|FG000|Overall Study|Adverse Event|1|||
162119452|NCT00744263|585489182|FG001|Overall Study|Adverse Event|0|||
162119453|NCT00744263|585489181|FG000|Overall Study|Other|2|||
162119454|NCT00744263|585489182|FG001|Overall Study|Other|2|||
162119455|NCT01913639|585489183|FG000|Overall Study|Not Eligible|3|||
162119456|NCT01225822|585489193|FG000|Overall Study|Adverse Event|13|||
162119457|NCT01225822|585489194|FG001|Overall Study|Adverse Event|31|||
162119458|NCT01225822|585489195|FG002|Overall Study|Adverse Event|18|||
162119459|NCT01225822|585489196|FG003|Overall Study|Adverse Event|23|||
162119460|NCT01225822|585489197|FG004|Overall Study|Adverse Event|14|||
162119461|NCT01225822|585489193|FG000|Overall Study|Protocol Violation|6|||
162119462|NCT01225822|585489194|FG001|Overall Study|Protocol Violation|8|||
162119463|NCT01225822|585489195|FG002|Overall Study|Protocol Violation|6|||
162119464|NCT01225822|585489196|FG003|Overall Study|Protocol Violation|7|||
162119465|NCT01225822|585489197|FG004|Overall Study|Protocol Violation|4|||
162119466|NCT01225822|585489193|FG000|Overall Study|Lost to Follow-up|0|||
162119467|NCT01225822|585489194|FG001|Overall Study|Lost to Follow-up|0|||
162119468|NCT01225822|585489195|FG002|Overall Study|Lost to Follow-up|0|||
162119469|NCT01225822|585489196|FG003|Overall Study|Lost to Follow-up|1|||
162119470|NCT01225822|585489197|FG004|Overall Study|Lost to Follow-up|0|||
162119471|NCT01225822|585489193|FG000|Overall Study|Withdrawal by Subject|6|||
162119472|NCT01225822|585489194|FG001|Overall Study|Withdrawal by Subject|7|||
162119473|NCT01225822|585489195|FG002|Overall Study|Withdrawal by Subject|7|||
162119474|NCT01225822|585489196|FG003|Overall Study|Withdrawal by Subject|11|||
162119475|NCT01225822|585489197|FG004|Overall Study|Withdrawal by Subject|6|||
162119476|NCT01225822|585489193|FG000|Overall Study|Other|13|||
162119477|NCT01225822|585489194|FG001|Overall Study|Other|10|||
162119478|NCT01225822|585489195|FG002|Overall Study|Other|7|||
162119479|NCT01225822|585489196|FG003|Overall Study|Other|10|||
162119480|NCT01225822|585489197|FG004|Overall Study|Other|7|||
162119481|NCT01290822|585489200|FG000|Overall Study|Withdrawal by Subject|1|||
162119482|NCT01290822|585489200|FG000|Overall Study|Physician Decision|10|||
162119483|NCT04078035|585489201|FG000|Session 2|Lost to Follow-up|3|||
162119484|NCT04078035|585489202|FG001|Session 2|Lost to Follow-up|1|||
162119485|NCT04078035|585489201|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
162119486|NCT04078035|585489202|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
162119487|NCT04296890|585489205|FG000|Overall Study|Withdrawal by Subject|1|||
162119488|NCT04296890|585489205|FG000|Overall Study|Death|62|||
162119489|NCT04296890|585489205|FG000|Overall Study|Lost to Follow-up|3|||
162119490|NCT04296890|585489205|FG000|Overall Study|Other than specified|2|||
162119491|NCT02100722|585489206|FG000|Overall Study|Withdrawal pre-procedure|4|||
162119492|NCT02100722|585489207|FG001|Overall Study|Withdrawal pre-procedure|9|||
162119493|NCT02100722|585489206|FG000|Overall Study|Withdrawal post-procedure|0|||
162119494|NCT02100722|585489207|FG001|Overall Study|Withdrawal post-procedure|3|||
162119495|NCT02100722|585489206|FG000|Overall Study|Lost to Follow-up|2|||
162119496|NCT02100722|585489207|FG001|Overall Study|Lost to Follow-up|2|||
162119497|NCT02100722|585489206|FG000|Overall Study|Continuing on study|751|||
162119498|NCT02100722|585489207|FG001|Overall Study|Continuing on study|729|||
162119499|NCT04986982|585489209|FG000|Overall Study|Withdrawal by Subject|3|||
162119500|NCT04986982|585489210|FG001|Overall Study|Withdrawal by Subject|1|||
162119501|NCT04986982|585489209|FG000|Overall Study|Lack of Efficacy|0|||
162119502|NCT04986982|585489210|FG001|Overall Study|Lack of Efficacy|2|||
162119503|NCT04986982|585489209|FG000|Overall Study|Ineligibility|3|||
162119504|NCT04986982|585489210|FG001|Overall Study|Ineligibility|0|||
162119505|NCT04986982|585489209|FG000|Overall Study|Adverse Event|4|||
162119506|NCT04986982|585489210|FG001|Overall Study|Adverse Event|4|||
162119507|NCT04986982|585489209|FG000|Overall Study|Lost to Follow-up|0|||
162119508|NCT04986982|585489210|FG001|Overall Study|Lost to Follow-up|1|||
162119509|NCT04986982|585489209|FG000|Overall Study|Sponsor's discretion|1|||
162119510|NCT04986982|585489210|FG001|Overall Study|Sponsor's discretion|0|||
162119511|NCT03500640|585489211|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
162119512|NCT03500640|585489212|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
162119513|NCT03500640|585489213|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
162119514|NCT03500640|585489211|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
162119515|NCT03500640|585489212|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
162119516|NCT03500640|585489213|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
162119517|NCT03500640|585489211|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
162119518|NCT03500640|585489212|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
162119519|NCT03500640|585489213|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
162119520|NCT03500640|585489211|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
162119521|NCT03500640|585489212|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
162119522|NCT03500640|585489213|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
162119523|NCT03500640|585489211|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
162119524|NCT03500640|585489212|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
162119525|NCT03500640|585489213|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
162119526|NCT03500640|585489211|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
162119527|NCT03500640|585489212|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
162119528|NCT03500640|585489213|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
162119529|NCT03500640|585489211|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
162119530|NCT03500640|585489212|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
162119531|NCT03500640|585489213|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
162119532|NCT03500640|585489211|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
162119533|NCT03500640|585489212|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
162119534|NCT03500640|585489213|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
162119535|NCT03500640|585489211|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
162119536|NCT03500640|585489212|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
162119537|NCT03500640|585489213|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
162119538|NCT03500640|585489211|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
162119539|NCT03500640|585489212|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
162119540|NCT03500640|585489213|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
162119541|NCT02978443|585489214|FG000|Overall Study|Withdrawal by Subject|1|||
162119542|NCT02978443|585489214|FG000|Overall Study|Adverse Event|3|||
162119543|NCT02978443|585489214|FG000|Overall Study|Disease Progression on study|6|||
162119544|NCT02978443|585489214|FG000|Overall Study|Death|1|||
162119545|NCT02978443|585489214|FG000|Overall Study|Physician Decision|1|||
162119546|NCT02978443|585489214|FG000|Overall Study|Switch to alternative therapy|1|||
162119547|NCT02978443|585489214|FG000|Overall Study|Refused further treatment|1|||
162119548|NCT01852058|585489216|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
162119549|NCT01852058|585489217|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162119550|NCT01852058|585489218|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162119551|NCT01852058|585489219|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162119552|NCT01852058|585489220|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162119553|NCT01852058|585489221|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162119554|NCT01852058|585489222|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162119555|NCT01852058|585489223|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162119556|NCT01852058|585489224|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162119557|NCT01852058|585489225|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162119558|NCT01852058|585489226|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162119559|NCT01852058|585489227|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
162119560|NCT01852058|585489216|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162119561|NCT01852058|585489217|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162119562|NCT01852058|585489218|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162119563|NCT01852058|585489219|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162119564|NCT01852058|585489220|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
162119565|NCT01852058|585489221|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162119566|NCT01852058|585489222|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162119567|NCT01852058|585489223|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162119568|NCT01852058|585489224|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162119569|NCT01852058|585489225|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162119570|NCT01852058|585489226|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162119571|NCT01852058|585489227|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
162119572|NCT01852058|585489216|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162119573|NCT01852058|585489217|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162119574|NCT01852058|585489218|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162119575|NCT01852058|585489219|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162119576|NCT01852058|585489220|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
162119577|NCT01852058|585489221|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
162119578|NCT01852058|585489222|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162119579|NCT01852058|585489223|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162119580|NCT01852058|585489224|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162119581|NCT01852058|585489225|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162119582|NCT01852058|585489226|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162119583|NCT01852058|585489227|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
162119584|NCT01852058|585489216|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162119585|NCT01852058|585489217|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162119586|NCT01852058|585489218|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162119587|NCT01852058|585489219|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162119588|NCT01852058|585489220|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
162119589|NCT01852058|585489221|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162119590|NCT01852058|585489222|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162119591|NCT01852058|585489223|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162119592|NCT01852058|585489224|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162119593|NCT01852058|585489225|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162119594|NCT01852058|585489226|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162119595|NCT01852058|585489227|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
162119596|NCT01852058|585489216|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162119597|NCT01852058|585489217|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162119598|NCT01852058|585489218|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162119599|NCT01852058|585489219|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162119600|NCT01852058|585489220|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
162119601|NCT01852058|585489221|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
162119602|NCT01852058|585489222|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162119603|NCT01852058|585489223|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162119604|NCT01852058|585489224|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162119605|NCT01852058|585489225|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162119606|NCT01852058|585489226|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162119607|NCT01852058|585489227|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
162119608|NCT01852058|585489216|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162119609|NCT01852058|585489217|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162119610|NCT01852058|585489218|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162119611|NCT01852058|585489219|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
162119612|NCT01852058|585489220|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162119613|NCT01852058|585489221|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162119614|NCT01852058|585489222|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162119615|NCT01852058|585489223|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162119616|NCT01852058|585489224|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162119617|NCT01852058|585489225|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162119618|NCT01852058|585489226|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162119619|NCT01852058|585489227|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
162119620|NCT01852058|585489216|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162119621|NCT01852058|585489217|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162119622|NCT01852058|585489218|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162119623|NCT01852058|585489219|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162119624|NCT01852058|585489220|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
162119625|NCT01852058|585489221|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
162119626|NCT01852058|585489222|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162119627|NCT01852058|585489223|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162119628|NCT01852058|585489224|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162119629|NCT01852058|585489225|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162119630|NCT01852058|585489226|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162119631|NCT01852058|585489227|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
162119632|NCT01852058|585489216|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162119633|NCT01852058|585489217|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162119634|NCT01852058|585489218|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162119635|NCT01852058|585489219|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162119636|NCT01852058|585489220|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162119637|NCT01852058|585489221|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162119638|NCT01852058|585489222|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162119639|NCT01852058|585489223|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
162119640|NCT01852058|585489224|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162119641|NCT01852058|585489225|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162119642|NCT01852058|585489226|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162119643|NCT01852058|585489227|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
162119644|NCT01852058|585489216|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162119645|NCT01852058|585489217|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162119646|NCT01852058|585489218|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162119647|NCT01852058|585489219|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162119648|NCT01852058|585489220|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162119649|NCT01852058|585489221|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162119650|NCT01852058|585489222|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162119651|NCT01852058|585489223|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162119652|NCT01852058|585489224|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
162119653|NCT01852058|585489225|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162119654|NCT01852058|585489226|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162119655|NCT01852058|585489227|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
162119656|NCT01279343|585489228|FG000|Overall Study|Did not receive treatment|2|||
162119657|NCT01279343|585489229|FG001|Overall Study|Did not receive treatment|6|||
162119658|NCT03287414|585489230|FG000|Treatment Epoch|Adverse Event|0|||
162119659|NCT03287414|585489231|FG001|Treatment Epoch|Adverse Event|1|||
162119660|NCT03287414|585489230|FG000|Treatment Epoch|Study terminated by sponsor|2|||
162119661|NCT03287414|585489231|FG001|Treatment Epoch|Study terminated by sponsor|2|||
162119662|NCT03287414|585489230|FG000|Treatment Epoch|Subject/Guardian decision|4|||
162119663|NCT03287414|585489231|FG001|Treatment Epoch|Subject/Guardian decision|0|||
162119664|NCT03287414|585489230|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
162119665|NCT03287414|585489231|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
162119666|NCT03287414|585489230|FG000|Treatment Epoch|Withdrawal by Subject|1|||
162119667|NCT03287414|585489231|FG001|Treatment Epoch|Withdrawal by Subject|0|||
162119668|NCT03287414|585489230|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
162119669|NCT03287414|585489231|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
162119670|NCT03287414|585489230|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
162119671|NCT03287414|585489231|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
162119672|NCT02613221|585489234|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
162119673|NCT02613221|585489234|FG000|Overall Study|Adverse Event|2|||
162119674|NCT02613221|585489234|FG000|Overall Study|Voluntary Discontinuation|1|||
162119675|NCT02613221|585489234|FG000|Overall Study|Delayed Treatment|1|||
162119676|NCT02613221|585489234|FG000|Overall Study|Enrolled but Not Treated|1|||
162119677|NCT01353222|585489239|FG000|Overall Study|Death|30|||
162119678|NCT01353222|585489240|FG001|Overall Study|Death|30|||
162119679|NCT01353222|585489239|FG000|Overall Study|Withdrawal by Subject|8|||
162119680|NCT01353222|585489240|FG001|Overall Study|Withdrawal by Subject|5|||
162119681|NCT01353222|585489239|FG000|Overall Study|Study Terminated|31|||
162119682|NCT01353222|585489240|FG001|Overall Study|Study Terminated|37|||
162119683|NCT01353222|585489239|FG000|Overall Study|Site closed research department|1|||
162119684|NCT01353222|585489240|FG001|Overall Study|Site closed research department|0|||
162119685|NCT01119898|585489241|FG000|Overall Study|Adverse Event|4|||
162119686|NCT01119898|585489242|FG001|Overall Study|Adverse Event|5|||
162119687|NCT01119898|585489241|FG000|Overall Study|Withdrawal by Subject|1|||
162119688|NCT01119898|585489242|FG001|Overall Study|Withdrawal by Subject|4|||
162119689|NCT01119898|585489241|FG000|Overall Study|Lack of Efficacy|0|||
162119690|NCT01119898|585489242|FG001|Overall Study|Lack of Efficacy|2|||
162119691|NCT01119898|585489241|FG000|Overall Study|Protocol Violation|1|||
162119692|NCT01119898|585489242|FG001|Overall Study|Protocol Violation|1|||
162119693|NCT01119898|585489241|FG000|Overall Study|Medical procedure|1|||
162119694|NCT01119898|585489242|FG001|Overall Study|Medical procedure|0|||
162119695|NCT01119898|585489241|FG000|Overall Study|Randomized in error did not participate|1|||
162119696|NCT01119898|585489242|FG001|Overall Study|Randomized in error did not participate|0|||
162119697|NCT01807650|585489243|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
162119698|NCT01807650|585489243|FG000|Overall Study|Adverse Event|5|||
162119699|NCT01807650|585489243|FG000|Overall Study|Other|2|||
162119700|NCT02217280|585489246|FG000|Overall Study|Withdrawal by Subject|2|||
162119701|NCT02217280|585489246|FG000|Overall Study|Post-consent sceen fail|2|||
162119702|NCT03573908|585489252|FG000|Treatment Period|Adverse Event|4|||
162119703|NCT03573908|585489253|FG001|Treatment Period|Adverse Event|9|||
162119704|NCT03573908|585489254|FG002|Treatment Period|Adverse Event|0|||
162119705|NCT03573908|585489255|FG003|Treatment Period|Adverse Event|0|||
162119706|NCT03573908|585489256|FG004|Treatment Period|Adverse Event|0|||
162119707|NCT03573908|585489252|FG000|Treatment Period|Protocol Violation|1|||
162119708|NCT03573908|585489253|FG001|Treatment Period|Protocol Violation|0|||
162119709|NCT03573908|585489254|FG002|Treatment Period|Protocol Violation|0|||
162119710|NCT03573908|585489255|FG003|Treatment Period|Protocol Violation|0|||
162119711|NCT03573908|585489256|FG004|Treatment Period|Protocol Violation|0|||
162119712|NCT03573908|585489252|FG000|Treatment Period|Withdrawal by Subject|7|||
162119713|NCT03573908|585489253|FG001|Treatment Period|Withdrawal by Subject|5|||
162119714|NCT03573908|585489254|FG002|Treatment Period|Withdrawal by Subject|0|||
162119715|NCT03573908|585489255|FG003|Treatment Period|Withdrawal by Subject|0|||
162119716|NCT03573908|585489256|FG004|Treatment Period|Withdrawal by Subject|0|||
162119717|NCT03573908|585489252|FG000|Treatment Period|Lost to Follow-up|7|||
162119718|NCT03573908|585489253|FG001|Treatment Period|Lost to Follow-up|6|||
162119719|NCT03573908|585489254|FG002|Treatment Period|Lost to Follow-up|0|||
162119720|NCT03573908|585489255|FG003|Treatment Period|Lost to Follow-up|0|||
162119721|NCT03573908|585489256|FG004|Treatment Period|Lost to Follow-up|0|||
162119722|NCT03573908|585489252|FG000|Treatment Period|Pregnancy|1|||
162119723|NCT03573908|585489253|FG001|Treatment Period|Pregnancy|0|||
162119724|NCT03573908|585489254|FG002|Treatment Period|Pregnancy|0|||
162119725|NCT03573908|585489255|FG003|Treatment Period|Pregnancy|0|||
162119726|NCT03573908|585489256|FG004|Treatment Period|Pregnancy|0|||
162119727|NCT03573908|585489252|FG000|Treatment Period|Other, Not Specified|4|||
162119728|NCT03573908|585489253|FG001|Treatment Period|Other, Not Specified|6|||
162119729|NCT03573908|585489254|FG002|Treatment Period|Other, Not Specified|0|||
162119730|NCT03573908|585489255|FG003|Treatment Period|Other, Not Specified|0|||
162119731|NCT03573908|585489256|FG004|Treatment Period|Other, Not Specified|0|||
162119732|NCT03573908|585489252|FG000|Randomized Withdrawal Period|Adverse Event|0|||
162119733|NCT03573908|585489253|FG001|Randomized Withdrawal Period|Adverse Event|0|||
162119734|NCT03573908|585489254|FG002|Randomized Withdrawal Period|Adverse Event|3|||
162119735|NCT03573908|585489255|FG003|Randomized Withdrawal Period|Adverse Event|0|||
162119736|NCT03573908|585489256|FG004|Randomized Withdrawal Period|Adverse Event|0|||
162119737|NCT03573908|585489252|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162119738|NCT03573908|585489253|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162119739|NCT03573908|585489254|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162119740|NCT03573908|585489255|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
162119741|NCT03573908|585489256|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
162119742|NCT03573908|585489252|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
162119743|NCT03573908|585489253|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
162119744|NCT03573908|585489254|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
162119745|NCT03573908|585489255|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
162119746|NCT03573908|585489256|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
162119747|NCT03573908|585489252|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
162119748|NCT03573908|585489253|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
162119749|NCT03573908|585489254|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
162119750|NCT03573908|585489255|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
162119751|NCT03573908|585489256|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
162119752|NCT04006925|585489257|FG000|Overall Study|Side effects|2|||
162119753|NCT04006925|585489258|FG001|Overall Study|Side effects|0|||
162119754|NCT02906683|585490768|FG000|Overall Study|Adverse Event|0|||
162119755|NCT02906683|585490769|FG001|Overall Study|Adverse Event|1|||
162119756|NCT02906683|585490770|FG002|Overall Study|Adverse Event|0|||
162119757|NCT02906683|585490768|FG000|Overall Study|Physician Decision|0|||
162119758|NCT02906683|585490769|FG001|Overall Study|Physician Decision|1|||
162119759|NCT02906683|585490770|FG002|Overall Study|Physician Decision|1|||
162119760|NCT02906683|585490768|FG000|Overall Study|Withdrawal by Subject|0|||
162119761|NCT02906683|585490769|FG001|Overall Study|Withdrawal by Subject|2|||
162119762|NCT02906683|585490770|FG002|Overall Study|Withdrawal by Subject|1|||
162119763|NCT02906683|585490768|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
162119764|NCT02906683|585490769|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
162119765|NCT02906683|585490770|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
162119766|NCT02906683|585490768|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
162119767|NCT02906683|585490769|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
162119768|NCT02906683|585490770|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
162119769|NCT01158378|585490771|FG000|Overall Study|Death|4|||
162119770|NCT01158378|585490772|FG001|Overall Study|Death|5|||
162119771|NCT01158378|585490771|FG000|Overall Study|Lost to Follow-up|2|||
162119772|NCT01158378|585490772|FG001|Overall Study|Lost to Follow-up|4|||
162119773|NCT01158378|585490771|FG000|Overall Study|Withdrawal by Subject|4|||
162119774|NCT01158378|585490772|FG001|Overall Study|Withdrawal by Subject|0|||
162119775|NCT02531295|585490777|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
162119776|NCT02531295|585490778|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
162119777|NCT02531295|585490779|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
162119778|NCT02531295|585490780|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
162119779|NCT02531295|585490781|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
162119780|NCT02531295|585490782|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
162119781|NCT00453310|585490783|FG000|Overall Study|Progression of Disease|10|||
162119782|NCT01806740|585490784|FG000|Overall Study|Withdrawal by Subject|4|||
162119783|NCT01806740|585490784|FG000|Overall Study|Physician Decision|1|||
162119784|NCT01806740|585490784|FG000|Overall Study|Patient's refusal of treatment|1|||
162119785|NCT04666922|585490785|FG000|Overall Study|Withdrawal by Subject|1|||
162119786|NCT04666922|585490786|FG001|Overall Study|Withdrawal by Subject|0|||
162119787|NCT04666922|585490787|FG002|Overall Study|Withdrawal by Subject|0|||
162119788|NCT04666922|585490788|FG003|Overall Study|Withdrawal by Subject|0|||
162119789|NCT04666922|585490789|FG004|Overall Study|Withdrawal by Subject|0|||
162119790|NCT04666922|585490790|FG005|Overall Study|Withdrawal by Subject|0|||
162119791|NCT04666922|585490791|FG006|Overall Study|Withdrawal by Subject|0|||
162119792|NCT04651114|585490792|FG000|Overall Study|Withdrawal by Subject|8|||
162119793|NCT03980184|585490795|FG000|Overall Study|Dropped out before treatment|2|||
162119794|NCT03980184|585490796|FG001|Overall Study|Dropped out before treatment|2|||
162119795|NCT03980184|585490795|FG000|Overall Study|Lost to Follow-up|11|||
162119796|NCT03980184|585490796|FG001|Overall Study|Lost to Follow-up|13|||
162119797|NCT02176421|585490797|FG000|Overall Study|Lost to Follow-up|4|||
162119798|NCT02176421|585490797|FG000|Overall Study|Adverse Event|1|||
162119799|NCT01129336|585490801|FG000|Overall Study|Protocol Violation|1|||
162119800|NCT01129336|585490802|FG001|Overall Study|Protocol Violation|0|||
162119801|NCT01129336|585490801|FG000|Overall Study|Disease Progression|1|||
162119802|NCT01129336|585490802|FG001|Overall Study|Disease Progression|4|||
162119803|NCT01129336|585490801|FG000|Overall Study|Lost to Follow-up|1|||
162119804|NCT01129336|585490802|FG001|Overall Study|Lost to Follow-up|0|||
162119805|NCT01129336|585490801|FG000|Overall Study|Withdrawal by Subject|7|||
162119806|NCT01129336|585490802|FG001|Overall Study|Withdrawal by Subject|4|||
162119807|NCT01129336|585490801|FG000|Overall Study|Adverse Event|0|||
162119808|NCT01129336|585490802|FG001|Overall Study|Adverse Event|1|||
162119809|NCT01129336|585490801|FG000|Overall Study|Missing Study Completion Status|2|||
162119810|NCT01129336|585490802|FG001|Overall Study|Missing Study Completion Status|3|||
162119811|NCT01129336|585490801|FG000|Overall Study|Death|0|||
162119812|NCT01129336|585490802|FG001|Overall Study|Death|4|||
162119813|NCT00467142|585490805|FG000|Overall Study|Withdrawal by Subject|1|||
162119814|NCT00467142|585490805|FG000|Overall Study|Adverse Event|1|||
162119815|NCT00467142|585490805|FG000|Overall Study|Protocol Violation|1|||
162119816|NCT00154310|585490806|FG000|Overall Study|Adverse Event|19|||
162119817|NCT00154310|585490807|FG001|Overall Study|Adverse Event|9|||
162119818|NCT00154310|585490806|FG000|Overall Study|Lack of Efficacy|5|||
162119819|NCT00154310|585490807|FG001|Overall Study|Lack of Efficacy|4|||
162119820|NCT00154310|585490806|FG000|Overall Study|Protocol Violation|4|||
162119821|NCT00154310|585490807|FG001|Overall Study|Protocol Violation|2|||
162119822|NCT00154310|585490806|FG000|Overall Study|Withdrawal by Subject|9|||
162119823|NCT00154310|585490807|FG001|Overall Study|Withdrawal by Subject|3|||
162119824|NCT00154310|585490806|FG000|Overall Study|Lost to Follow-up|0|||
162119825|NCT00154310|585490807|FG001|Overall Study|Lost to Follow-up|8|||
162119826|NCT00154310|585490806|FG000|Overall Study|Administrative problems|0|||
162119827|NCT00154310|585490807|FG001|Overall Study|Administrative problems|1|||
162119828|NCT00154310|585490806|FG000|Overall Study|Death|0|||
162119829|NCT00154310|585490807|FG001|Overall Study|Death|1|||
162119830|NCT02086162|585490809|FG000|Overall Study|Withdrawal by Subject|4|||
162119831|NCT02086162|585490810|FG001|Overall Study|Withdrawal by Subject|4|||
162119832|NCT02086162|585490809|FG000|Overall Study|moved|1|||
162119833|NCT02086162|585490810|FG001|Overall Study|moved|1|||
162119834|NCT02086162|585490809|FG000|Overall Study|Lost to Follow-up|4|||
162119835|NCT02086162|585490810|FG001|Overall Study|Lost to Follow-up|2|||
162119836|NCT02086162|585490809|FG000|Overall Study|Death|1|||
162119837|NCT02086162|585490810|FG001|Overall Study|Death|0|||
162119838|NCT03447730|585490811|FG000|Overall Study|Adverse Event|0|||
162119839|NCT03447730|585490812|FG001|Overall Study|Adverse Event|2|||
162119840|NCT03447730|585490813|FG002|Overall Study|Adverse Event|0|||
162119841|NCT01248962|585490817|FG000|Overall Study|Withdrawal by Subject|1|||
162119842|NCT01248962|585490818|FG001|Overall Study|Withdrawal by Subject|1|||
162119843|NCT01248962|585490817|FG000|Overall Study|Adverse Event|2|||
162119844|NCT01248962|585490818|FG001|Overall Study|Adverse Event|1|||
162119845|NCT01248962|585490817|FG000|Overall Study|Complete Response after 4 Cycles|1|||
162119846|NCT01248962|585490818|FG001|Overall Study|Complete Response after 4 Cycles|0|||
162119847|NCT01248962|585490817|FG000|Overall Study|Complete Response after 3 Cycles|0|||
162119848|NCT01248962|585490818|FG001|Overall Study|Complete Response after 3 Cycles|1|||
162119849|NCT01248962|585490817|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
162119850|NCT01248962|585490818|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
162119851|NCT04848662|585490820|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
162119852|NCT04848662|585490821|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
162119853|NCT01350505|585490822|FG000|Overall Study|Lost to Follow-up|4|||
162119854|NCT01834222|585490823|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
162119855|NCT04702568|585490824|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
162119856|NCT04702568|585490825|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
162119857|NCT04702568|585490824|FG000|Overall Study|Pregnancy|1|||
162119858|NCT04702568|585490825|FG001|Overall Study|Pregnancy|0|||
162119859|NCT04702568|585490824|FG000|Overall Study|Bone marrow transplant|1|||
162119860|NCT04702568|585490825|FG001|Overall Study|Bone marrow transplant|0|||
162119861|NCT04702568|585490824|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
162119862|NCT04702568|585490825|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
162119863|NCT04702568|585490824|FG000|Overall Study|Withdrawal by Subject|0|||
162119864|NCT04702568|585490825|FG001|Overall Study|Withdrawal by Subject|2|||
162119865|NCT00423852|585490828|FG000|Overall Study|Removed pior to the high-dose portion|3|||
162119866|NCT00089895|585490829|FG000|Overall Study|Consent Withdrawn|11|||
162119867|NCT00089895|585490830|FG001|Overall Study|Consent Withdrawn|14|||
162119868|NCT00089895|585490829|FG000|Overall Study|Technical reason|7|||
162119869|NCT00089895|585490830|FG001|Overall Study|Technical reason|2|||
162119870|NCT00089895|585490829|FG000|Overall Study|Surgery|0|||
162119871|NCT00089895|585490830|FG001|Overall Study|Surgery|1|||
162119872|NCT00089895|585490829|FG000|Overall Study|Bleeding|0|||
162119873|NCT00089895|585490830|FG001|Overall Study|Bleeding|2|||
162119874|NCT00089895|585490829|FG000|Overall Study|Physician Decision|3|||
162119875|NCT00089895|585490830|FG001|Overall Study|Physician Decision|7|||
162119876|NCT00089895|585490829|FG000|Overall Study|Exclusion criteria met|6|||
162119877|NCT00089895|585490830|FG001|Overall Study|Exclusion criteria met|6|||
162119878|NCT00089895|585490829|FG000|Overall Study|Not otherwise specified|4|||
162119879|NCT00089895|585490830|FG001|Overall Study|Not otherwise specified|8|||
162119880|NCT00089895|585490829|FG000|Overall Study|Missing|4|||
162119881|NCT00089895|585490830|FG001|Overall Study|Missing|2|||
162119882|NCT05644353|585490831|FG000|Overall Study|Physician Decision|1|||
162119883|NCT05644353|585490832|FG001|Overall Study|Physician Decision|0|||
162119884|NCT05644353|585490833|FG002|Overall Study|Physician Decision|0|||
162119885|NCT05644353|585490834|FG003|Overall Study|Physician Decision|0|||
162119886|NCT05644353|585490835|FG004|Overall Study|Physician Decision|0|||
162119887|NCT05644353|585490836|FG005|Overall Study|Physician Decision|0|||
162119888|NCT05644353|585490831|FG000|Overall Study|Protocol Violation|1|||
162119889|NCT05644353|585490832|FG001|Overall Study|Protocol Violation|0|||
162119890|NCT05644353|585490833|FG002|Overall Study|Protocol Violation|0|||
162119891|NCT05644353|585490834|FG003|Overall Study|Protocol Violation|0|||
162119892|NCT05644353|585490835|FG004|Overall Study|Protocol Violation|0|||
162119893|NCT05644353|585490836|FG005|Overall Study|Protocol Violation|0|||
162119894|NCT05644353|585490831|FG000|Overall Study|Withdrawal by Subject|0|||
162119895|NCT05644353|585490832|FG001|Overall Study|Withdrawal by Subject|2|||
162119896|NCT05644353|585490833|FG002|Overall Study|Withdrawal by Subject|0|||
162119897|NCT05644353|585490834|FG003|Overall Study|Withdrawal by Subject|0|||
162119898|NCT05644353|585490835|FG004|Overall Study|Withdrawal by Subject|1|||
162119899|NCT05644353|585490836|FG005|Overall Study|Withdrawal by Subject|0|||
162119900|NCT05644353|585490831|FG000|Overall Study|Lost to Follow-up|0|||
162119901|NCT05644353|585490832|FG001|Overall Study|Lost to Follow-up|0|||
162119902|NCT05644353|585490833|FG002|Overall Study|Lost to Follow-up|1|||
162119903|NCT05644353|585490834|FG003|Overall Study|Lost to Follow-up|0|||
162119904|NCT05644353|585490835|FG004|Overall Study|Lost to Follow-up|0|||
162119905|NCT05644353|585490836|FG005|Overall Study|Lost to Follow-up|0|||
162119906|NCT01535274|585490837|FG000|Overall Study|Determined to be ineligible|0|||
162119907|NCT01535274|585490838|FG001|Overall Study|Determined to be ineligible|1|||
162119908|NCT01535274|585490837|FG000|Overall Study|Misallocated to propofol intervention|0|||
162119909|NCT01535274|585490838|FG001|Overall Study|Misallocated to propofol intervention|1|||
162119910|NCT02954458|585490841|FG000|Overall Study|Adverse Event|0|||
162119911|NCT02954458|585490842|FG001|Overall Study|Adverse Event|0|||
162119912|NCT02954458|585490843|FG002|Overall Study|Adverse Event|0|||
162119913|NCT02954458|585490844|FG003|Overall Study|Adverse Event|1|||
162119914|NCT02954458|585490841|FG000|Overall Study|Withdrawal by Subject|0|||
162119915|NCT02954458|585490842|FG001|Overall Study|Withdrawal by Subject|0|||
162119916|NCT02954458|585490843|FG002|Overall Study|Withdrawal by Subject|0|||
162119917|NCT02954458|585490844|FG003|Overall Study|Withdrawal by Subject|1|||
162119918|NCT02954458|585490841|FG000|Overall Study|Physician Decision|0|||
162119919|NCT02954458|585490842|FG001|Overall Study|Physician Decision|0|||
162119920|NCT02954458|585490843|FG002|Overall Study|Physician Decision|1|||
162119921|NCT02954458|585490844|FG003|Overall Study|Physician Decision|1|||
162119922|NCT02954458|585490841|FG000|Overall Study|Lost to Follow-up|1|||
162119923|NCT02954458|585490842|FG001|Overall Study|Lost to Follow-up|0|||
162119924|NCT02954458|585490843|FG002|Overall Study|Lost to Follow-up|0|||
162119925|NCT02954458|585490844|FG003|Overall Study|Lost to Follow-up|1|||
162119926|NCT02954458|585490841|FG000|Overall Study|Death|0|||
162119927|NCT02954458|585490842|FG001|Overall Study|Death|0|||
162119928|NCT02954458|585490843|FG002|Overall Study|Death|0|||
162119929|NCT02954458|585490844|FG003|Overall Study|Death|1|||
162119930|NCT02954458|585490841|FG000|Overall Study|Other|0|||
162119931|NCT02954458|585490842|FG001|Overall Study|Other|0|||
162119932|NCT02954458|585490843|FG002|Overall Study|Other|0|||
162119933|NCT02954458|585490844|FG003|Overall Study|Other|7|||
162119934|NCT02690077|585490847|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
162119935|NCT02690077|585490848|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
162119936|NCT02690077|585490847|FG000|Overall Study|Withdrawal by Subject|0|||
162119937|NCT02690077|585490848|FG001|Overall Study|Withdrawal by Subject|5|||
162119938|NCT02690077|585490847|FG000|Overall Study|Excluded by IRB|0|||
162119939|NCT02690077|585490848|FG001|Overall Study|Excluded by IRB|2|||
162119940|NCT01845974|585490849|FG000|Overall Study|screen failure|1|||
162119941|NCT01845974|585490850|FG001|Overall Study|screen failure|0|||
162119942|NCT02667886|585490851|FG000|Dose Escalation (Part A)|Adverse Event|1|||
162119943|NCT02667886|585490852|FG001|Dose Escalation (Part A)|Adverse Event|3|||
162119944|NCT02667886|585490853|FG002|Dose Escalation (Part A)|Adverse Event|1|||
162119945|NCT02667886|585490854|FG003|Dose Escalation (Part A)|Adverse Event|0|||
162119946|NCT02667886|585490855|FG004|Dose Escalation (Part A)|Adverse Event|0|||
162119947|NCT02667886|585490851|FG000|Dose Escalation (Part A)|Disease Progression|1|||
162119948|NCT02667886|585490852|FG001|Dose Escalation (Part A)|Disease Progression|4|||
162119949|NCT02667886|585490853|FG002|Dose Escalation (Part A)|Disease Progression|3|||
162119950|NCT02667886|585490854|FG003|Dose Escalation (Part A)|Disease Progression|0|||
162119951|NCT02667886|585490855|FG004|Dose Escalation (Part A)|Disease Progression|0|||
162119952|NCT02667886|585490851|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
162119953|NCT02667886|585490852|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
162119954|NCT02667886|585490853|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
162119955|NCT02667886|585490854|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
162119956|NCT02667886|585490855|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
162119957|NCT02667886|585490851|FG000|Dose Expansion (Part B)|Adverse Event|0|||
162119958|NCT02667886|585490852|FG001|Dose Expansion (Part B)|Adverse Event|0|||
162119959|NCT02667886|585490853|FG002|Dose Expansion (Part B)|Adverse Event|0|||
162119960|NCT02667886|585490854|FG003|Dose Expansion (Part B)|Adverse Event|9|||
162119961|NCT02667886|585490855|FG004|Dose Expansion (Part B)|Adverse Event|0|||
162119962|NCT02667886|585490851|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
162119963|NCT02667886|585490852|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
162119964|NCT02667886|585490853|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
162119965|NCT02667886|585490854|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
162119966|NCT02667886|585490855|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
162119967|NCT02667886|585490851|FG000|Dose Expansion (Part B)|Disease Progression|0|||
162119968|NCT02667886|585490852|FG001|Dose Expansion (Part B)|Disease Progression|0|||
162119969|NCT02667886|585490853|FG002|Dose Expansion (Part B)|Disease Progression|0|||
162119970|NCT02667886|585490854|FG003|Dose Expansion (Part B)|Disease Progression|38|||
162119971|NCT02667886|585490855|FG004|Dose Expansion (Part B)|Disease Progression|0|||
162119972|NCT02667886|585490851|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
162119973|NCT02667886|585490852|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
162119974|NCT02667886|585490853|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
162119975|NCT02667886|585490854|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
162119976|NCT02667886|585490855|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
162119977|NCT02667886|585490851|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
162119978|NCT02667886|585490852|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
162119979|NCT02667886|585490853|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
162119980|NCT02667886|585490854|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
162119981|NCT02667886|585490855|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
162119982|NCT02667886|585490851|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
162119983|NCT02667886|585490852|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
162119984|NCT02667886|585490853|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
162119985|NCT02667886|585490854|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
162119986|NCT02667886|585490855|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
162119987|NCT01905046|585490856|FG000|Months 13-24|Withdrawal by Subject|10|||
162119988|NCT01905046|585490857|FG001|Months 13-24|Withdrawal by Subject|10|||
162119989|NCT01905046|585490856|FG000|Months 13-24|Adverse Event|3|||
162119990|NCT01905046|585490857|FG001|Months 13-24|Adverse Event|2|||
162119991|NCT01905046|585490856|FG000|Months 13-24|Protocol Violation|3|||
162119992|NCT01905046|585490857|FG001|Months 13-24|Protocol Violation|3|||
162119993|NCT01905046|585490856|FG000|Months 13-24|Physician Decision|1|||
162119994|NCT01905046|585490857|FG001|Months 13-24|Physician Decision|0|||
162119995|NCT05672680|585490858|FG000|Overall Study|Patient Did Not Complete the Form|5|||
162119996|NCT05672680|585490859|FG001|Overall Study|Patient Did Not Complete the Form|4|||
162119997|NCT05672680|585490858|FG000|Overall Study|Procedure Aborted|1|||
162119998|NCT05672680|585490859|FG001|Overall Study|Procedure Aborted|0|||
162119999|NCT03929562|585490860|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
162120000|NCT03929562|585490861|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
162120001|NCT03929562|585490860|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
162120002|NCT03929562|585490861|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
162120003|NCT03929562|585490860|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
162120004|NCT03929562|585490861|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
162120005|NCT02778399|585490870|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
162120006|NCT02778399|585490871|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
162120007|NCT02778399|585490872|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
162120008|NCT02778399|585490873|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
162120009|NCT02778399|585490874|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
162120010|NCT02778399|585490875|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
162120011|NCT02778399|585490870|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
162120012|NCT02778399|585490871|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
162120013|NCT02778399|585490872|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
162120014|NCT02778399|585490873|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
162120015|NCT02778399|585490874|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
162120016|NCT02778399|585490875|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
162120017|NCT02778399|585490870|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
162120018|NCT02778399|585490871|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
162120019|NCT02778399|585490872|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
162120020|NCT02778399|585490873|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
162120021|NCT02778399|585490874|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
162120022|NCT02778399|585490875|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
162120023|NCT02778399|585490870|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
162120024|NCT02778399|585490871|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
162120025|NCT02778399|585490872|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
162120026|NCT02778399|585490873|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
162120027|NCT02778399|585490874|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
162120028|NCT02778399|585490875|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
162120029|NCT02778399|585490870|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
162120030|NCT02778399|585490871|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
162120031|NCT02778399|585490872|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
162120032|NCT02778399|585490873|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
162120033|NCT02778399|585490874|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
162120034|NCT02778399|585490875|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
162120035|NCT02778399|585490870|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
162120036|NCT02778399|585490871|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
162120037|NCT02778399|585490872|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
162120038|NCT02778399|585490873|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
162120039|NCT02778399|585490874|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
162120040|NCT02778399|585490875|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
162120041|NCT02778399|585490870|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
162120042|NCT02778399|585490871|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
162120043|NCT02778399|585490872|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
162120044|NCT02778399|585490873|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
162120045|NCT02778399|585490874|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
162120046|NCT02778399|585490875|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
162120047|NCT02778399|585490870|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
162120048|NCT02778399|585490871|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
162120049|NCT02778399|585490872|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
162120050|NCT02778399|585490873|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
162120051|NCT02778399|585490874|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
162120052|NCT02778399|585490875|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
162120053|NCT02778399|585490870|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
162120054|NCT02778399|585490871|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
162120055|NCT02778399|585490872|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
162120056|NCT02778399|585490873|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
162120057|NCT02778399|585490874|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
162120058|NCT02778399|585490875|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
162120059|NCT02778399|585490870|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
162120060|NCT02778399|585490871|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
162120061|NCT02778399|585490872|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
162120062|NCT02778399|585490873|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
162120063|NCT02778399|585490874|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
162120064|NCT02778399|585490875|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
162120065|NCT02778399|585490870|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
162120066|NCT02778399|585490871|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
162120067|NCT02778399|585490872|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
162120068|NCT02778399|585490873|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
162120069|NCT02778399|585490874|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
162120070|NCT02778399|585490875|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
162120071|NCT00405639|585490877|FG000|Overall Study|Withdrawal by Subject|1|||
162120072|NCT00405639|585490878|FG001|Overall Study|Withdrawal by Subject|0|||
162120073|NCT00405639|585490877|FG000|Overall Study|Adverse Event|1|||
162120074|NCT00405639|585490878|FG001|Overall Study|Adverse Event|0|||
162120075|NCT00405639|585490877|FG000|Overall Study|Seizure prior to receiving BNP|1|||
162120076|NCT00405639|585490878|FG001|Overall Study|Seizure prior to receiving BNP|0|||
162120077|NCT00612534|585490881|FG000|Overall Study|Adverse Event|0|||
162120078|NCT00612534|585490882|FG001|Overall Study|Adverse Event|4|||
162120079|NCT00612534|585490883|FG002|Overall Study|Adverse Event|2|||
162120080|NCT00612534|585490884|FG003|Overall Study|Adverse Event|1|||
162120081|NCT00612534|585490881|FG000|Overall Study|Lack of Efficacy|13|||
162120082|NCT00612534|585490882|FG001|Overall Study|Lack of Efficacy|12|||
162120083|NCT00612534|585490883|FG002|Overall Study|Lack of Efficacy|5|||
162120084|NCT00612534|585490884|FG003|Overall Study|Lack of Efficacy|16|||
162120085|NCT00612534|585490881|FG000|Overall Study|Other Reason|0|||
162120086|NCT00612534|585490882|FG001|Overall Study|Other Reason|1|||
162120087|NCT00612534|585490883|FG002|Overall Study|Other Reason|0|||
162120088|NCT00612534|585490884|FG003|Overall Study|Other Reason|0|||
162120089|NCT02130284|585490891|FG000|Overall Study|Withdrawal by Subject|3|||
162120090|NCT02130284|585490891|FG000|Overall Study|Subject Withdrew Consent|1|||
162120091|NCT02130284|585490891|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
162120092|NCT02130284|585490891|FG000|Overall Study|Subject was screened as backup for study|3|||
162120093|NCT02130284|585490891|FG000|Overall Study|Screen Failure|1|||
162120094|NCT01435655|585490893|FG000|Overall Study|Death|2|||
162120095|NCT01435655|585490893|FG000|Overall Study|Other|1|||
162120096|NCT02839343|585490896|FG000|Overall Study|Withdrawal by Subject|3|||
162120097|NCT02839343|585490897|FG001|Overall Study|Withdrawal by Subject|1|||
162120098|NCT02839343|585490896|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
162120099|NCT02839343|585490897|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
162120100|NCT02839343|585490896|FG000|Overall Study|Adverse Event|1|||
162120101|NCT02839343|585490897|FG001|Overall Study|Adverse Event|0|||
162120102|NCT02223754|585490898|FG000|Period 1|Adverse Event|1|||
162120103|NCT02223754|585490899|FG001|Period 1|Adverse Event|0|||
162120104|NCT02223754|585490898|FG000|Period 1|Lost to Follow-up|0|||
162120105|NCT02223754|585490899|FG001|Period 1|Lost to Follow-up|1|||
162120106|NCT02223754|585490898|FG000|Period 1|Protocol Violation|2|||
162120107|NCT02223754|585490899|FG001|Period 1|Protocol Violation|4|||
162120108|NCT02223754|585490898|FG000|Period 1|Withdrawal by Subject|0|||
162120109|NCT02223754|585490899|FG001|Period 1|Withdrawal by Subject|4|||
162120110|NCT02223754|585490898|FG000|Period 1|Test Article No Longer Available|1|||
162120111|NCT02223754|585490899|FG001|Period 1|Test Article No Longer Available|5|||
162120112|NCT02223754|585490898|FG000|Period 1|Unsatisfactory Visual Response|0|||
162120113|NCT02223754|585490899|FG001|Period 1|Unsatisfactory Visual Response|1|||
162120114|NCT02223754|585490898|FG000|Period 2|Adverse Event|0|||
162120115|NCT02223754|585490899|FG001|Period 2|Adverse Event|1|||
162120116|NCT02223754|585490898|FG000|Period 2|Protocol Violation|1|||
162120117|NCT02223754|585490899|FG001|Period 2|Protocol Violation|0|||
162120118|NCT02223754|585490898|FG000|Period 2|Lens Discomfort|1|||
162120119|NCT02223754|585490899|FG001|Period 2|Lens Discomfort|1|||
162120120|NCT02223754|585490898|FG000|Period 2|Lost to Follow-up|1|||
162120121|NCT02223754|585490899|FG001|Period 2|Lost to Follow-up|0|||
162120122|NCT02223754|585490898|FG000|Period 2|Test Article No Longer Available|0|||
162120123|NCT02223754|585490899|FG001|Period 2|Test Article No Longer Available|1|||
162120124|NCT04395183|585490900|FG000|Overall Study|Withdrawal by Subject|1|||
162120125|NCT04395183|585490901|FG001|Overall Study|Withdrawal by Subject|0|||
162120126|NCT04395183|585490902|FG002|Overall Study|Withdrawal by Subject|2|||
162120127|NCT04395183|585490903|FG003|Overall Study|Withdrawal by Subject|2|||
162120128|NCT02234063|585490904|FG000|Overall Study|Lost to Follow-up|235|||
162120129|NCT02234063|585490905|FG001|Overall Study|Lost to Follow-up|42|||
162120130|NCT02234063|585490904|FG000|Overall Study|Withdrawal by Subject|20|||
162120131|NCT02234063|585490905|FG001|Overall Study|Withdrawal by Subject|1|||
162120132|NCT00510458|585490906|FG000|Overall Study|5 year not evaluable/missed|21|||
162120133|NCT00510458|585490906|FG000|Overall Study|Death|1|||
162120134|NCT00510458|585490906|FG000|Overall Study|Terminated|14|||
162120135|NCT00510458|585490906|FG000|Overall Study|Lost to Follow-up|6|||
162120136|NCT00510458|585490906|FG000|Overall Study|Withdrawal by Subject|3|||
162120137|NCT00510458|585490906|FG000|Overall Study|Revision|2|||
162120138|NCT02569710|585490907|FG000|Overall Study|Adverse Event|1|||
162120139|NCT02569710|585490908|FG001|Overall Study|Adverse Event|0|||
162120140|NCT02569710|585490909|FG002|Overall Study|Adverse Event|0|||
162120141|NCT02569710|585490910|FG003|Overall Study|Adverse Event|0|||
162120142|NCT02569710|585490911|FG004|Overall Study|Adverse Event|0|||
162120143|NCT02569710|585490912|FG005|Overall Study|Adverse Event|0|||
162120144|NCT02569710|585490913|FG006|Overall Study|Adverse Event|0|||
162120145|NCT02569710|585490914|FG007|Overall Study|Adverse Event|0|||
162120146|NCT02569710|585490915|FG008|Overall Study|Adverse Event|0|||
162120147|NCT02569710|585490916|FG009|Overall Study|Adverse Event|0|||
162120148|NCT02569710|585490907|FG000|Overall Study|Lost to Follow-up|0|||
162120149|NCT02569710|585490908|FG001|Overall Study|Lost to Follow-up|0|||
162120150|NCT02569710|585490909|FG002|Overall Study|Lost to Follow-up|0|||
162120151|NCT02569710|585490910|FG003|Overall Study|Lost to Follow-up|0|||
162120152|NCT02569710|585490911|FG004|Overall Study|Lost to Follow-up|0|||
162120153|NCT02569710|585490912|FG005|Overall Study|Lost to Follow-up|0|||
162120154|NCT02569710|585490913|FG006|Overall Study|Lost to Follow-up|1|||
162120155|NCT02569710|585490914|FG007|Overall Study|Lost to Follow-up|0|||
162120156|NCT02569710|585490915|FG008|Overall Study|Lost to Follow-up|1|||
162120157|NCT02569710|585490916|FG009|Overall Study|Lost to Follow-up|0|||
162120158|NCT02569710|585490907|FG000|Overall Study|Virologic failure|0|||
162120159|NCT02569710|585490908|FG001|Overall Study|Virologic failure|0|||
162120160|NCT02569710|585490909|FG002|Overall Study|Virologic failure|0|||
162120161|NCT02569710|585490910|FG003|Overall Study|Virologic failure|0|||
162120162|NCT02569710|585490911|FG004|Overall Study|Virologic failure|1|||
162120163|NCT02569710|585490912|FG005|Overall Study|Virologic failure|0|||
162120164|NCT02569710|585490913|FG006|Overall Study|Virologic failure|1|||
162120165|NCT02569710|585490914|FG007|Overall Study|Virologic failure|0|||
162120166|NCT02569710|585490915|FG008|Overall Study|Virologic failure|0|||
162120167|NCT02569710|585490916|FG009|Overall Study|Virologic failure|0|||
162120168|NCT02569710|585490907|FG000|Overall Study|Withdrawal by Subject|0|||
162120169|NCT02569710|585490908|FG001|Overall Study|Withdrawal by Subject|0|||
162120170|NCT02569710|585490909|FG002|Overall Study|Withdrawal by Subject|0|||
162120171|NCT02569710|585490910|FG003|Overall Study|Withdrawal by Subject|0|||
162120172|NCT02569710|585490911|FG004|Overall Study|Withdrawal by Subject|0|||
162120173|NCT02569710|585490912|FG005|Overall Study|Withdrawal by Subject|1|||
162120174|NCT02569710|585490913|FG006|Overall Study|Withdrawal by Subject|0|||
162120175|NCT02569710|585490914|FG007|Overall Study|Withdrawal by Subject|0|||
162120176|NCT02569710|585490915|FG008|Overall Study|Withdrawal by Subject|0|||
162120177|NCT02569710|585490916|FG009|Overall Study|Withdrawal by Subject|0|||
162120178|NCT02946918|585490917|FG000|Overall Study|Patient unblinded himself|1|||
162120179|NCT02946918|585490918|FG001|Overall Study|Patient unblinded himself|0|||
162120180|NCT02946918|585490917|FG000|Overall Study|Physician Decision|0|||
162120181|NCT02946918|585490918|FG001|Overall Study|Physician Decision|2|||
162120182|NCT02946918|585490917|FG000|Overall Study|Ran out of study medication|0|||
162120183|NCT02946918|585490918|FG001|Overall Study|Ran out of study medication|1|||
162120184|NCT02669095|585490919|FG000|Overall Study|Adverse Event|1|||
162120185|NCT02669095|585490920|FG001|Overall Study|Adverse Event|0|||
162120186|NCT02669095|585490919|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
162120187|NCT02669095|585490920|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
162120188|NCT02669095|585490919|FG000|Overall Study|Torn Lens|0|||
162120189|NCT02669095|585490920|FG001|Overall Study|Torn Lens|1|||
162120190|NCT02669095|585490919|FG000|Overall Study|Visit 5 assessments not completed|0|||
162120191|NCT02669095|585490920|FG001|Overall Study|Visit 5 assessments not completed|1|||
162120192|NCT00738101|585490922|FG000|Overall Study|Physician Decision|5|||
162120193|NCT00738101|585490922|FG000|Overall Study|Death|1|||
162120194|NCT00738101|585490922|FG000|Overall Study|Repeat enrollment|1|||
162120195|NCT01396317|585490924|FG000|Overall Study|Adverse Event|1|||
162120196|NCT01396317|585490925|FG001|Overall Study|Adverse Event|0|||
162120197|NCT00663117|585493013|FG000|Overall Study|Lack of Efficacy|1|||
162120198|NCT00663117|585493014|FG001|Overall Study|Lack of Efficacy|0|||
162120199|NCT02781506|585493015|FG000|Overall Study|Adverse Event|5|||
162120200|NCT02593539|585493016|FG000|Overall Study|Adverse Event|1|||
162120201|NCT00437125|585493019|FG000|Overall Study|Adverse Event|12|||
162120202|NCT00437125|585493019|FG000|Overall Study|Death|1|||
162120203|NCT00437125|585493019|FG000|Overall Study|Clinical Relapse|1|||
162120204|NCT00437125|585493019|FG000|Overall Study|Lack of Efficacy|1|||
162120205|NCT00437125|585493019|FG000|Overall Study|Lost to Follow-up|1|||
162120206|NCT00437125|585493019|FG000|Overall Study|Withdrawal by Subject|13|||
162120207|NCT00437125|585493019|FG000|Overall Study|Withdrawal by Caregiver|2|||
162120208|NCT00437125|585493019|FG000|Overall Study|Physician Decision|1|||
162120209|NCT02248961|585493020|FG000|Overall Study|Adverse Event|1|||
162120210|NCT02248961|585493021|FG001|Overall Study|Adverse Event|0|||
162120211|NCT02248961|585493020|FG000|Overall Study|Withdrawal by Subject|1|||
162120212|NCT02248961|585493021|FG001|Overall Study|Withdrawal by Subject|2|||
162120213|NCT02248961|585493020|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
162120214|NCT02248961|585493021|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
162120215|NCT00244374|585493028|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
162120216|NCT00244374|585493029|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
162120217|NCT00244374|585493030|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
162120218|NCT00244374|585493031|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
162120219|NCT00244374|585493032|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
162120220|NCT00244374|585493028|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
162120221|NCT00244374|585493029|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
162120222|NCT00244374|585493030|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
162120223|NCT00244374|585493031|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
162120224|NCT00244374|585493032|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
162120225|NCT00244374|585493028|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
162120226|NCT00244374|585493029|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
162120227|NCT00244374|585493030|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
162120228|NCT00244374|585493031|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
162120229|NCT00244374|585493032|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
162120230|NCT00244374|585493028|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
162120231|NCT00244374|585493029|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
162120232|NCT00244374|585493030|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
162120233|NCT00244374|585493031|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
162120234|NCT00244374|585493032|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
162120235|NCT00244374|585493028|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
162120236|NCT00244374|585493029|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
162120237|NCT00244374|585493030|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
162120238|NCT00244374|585493031|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
162120239|NCT00244374|585493032|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
162120240|NCT00244374|585493028|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
162120241|NCT00244374|585493029|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
162120242|NCT00244374|585493030|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
162120243|NCT00244374|585493031|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
162120244|NCT00244374|585493032|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
162120245|NCT00244374|585493028|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
162120246|NCT00244374|585493029|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
162120247|NCT00244374|585493030|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
162120248|NCT00244374|585493031|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
162120249|NCT00244374|585493032|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
162120250|NCT00244374|585493028|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
162120251|NCT00244374|585493029|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
162120252|NCT00244374|585493030|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
162120253|NCT00244374|585493031|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
162120254|NCT00244374|585493032|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
162120255|NCT00244374|585493028|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
162120256|NCT00244374|585493029|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
162120257|NCT00244374|585493030|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
162120258|NCT00244374|585493031|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
162120259|NCT00244374|585493032|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
162120260|NCT03462706|585493034|FG000|Overall Study|Polyp was pedunculated|1|||
162120261|NCT03462706|585493035|FG001|Overall Study|Polyp was pedunculated|0|||
162120262|NCT03462706|585493036|FG002|Overall Study|Polyp was pedunculated|1|||
162120263|NCT03462706|585493037|FG003|Overall Study|Polyp was pedunculated|0|||
162120264|NCT03462706|585493034|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
162120265|NCT03462706|585493035|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
162120266|NCT03462706|585493036|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
162120267|NCT03462706|585493037|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
162120268|NCT04105972|585493047|FG000|Overall Study|Adverse Event|2|||
162120269|NCT04105972|585493048|FG001|Overall Study|Adverse Event|1|||
162120270|NCT02802319|585493049|FG000|Overall Study|Physician Decision|2|||
162120271|NCT02802319|585493050|FG001|Overall Study|Physician Decision|1|||
162120272|NCT02802319|585493049|FG000|Overall Study|Lost to Follow-up|0|||
162120273|NCT02802319|585493050|FG001|Overall Study|Lost to Follow-up|4|||
162120274|NCT01923896|585493055|FG000|Overall Study|Adverse Event|1|||
162120275|NCT01923896|585493056|FG001|Overall Study|Adverse Event|0|||
162120276|NCT03545113|585493059|FG000|Overall Study|Surgery Cancelled|1|||
162120277|NCT03545113|585493060|FG001|Overall Study|Surgery Cancelled|0|||
162120278|NCT03545113|585493059|FG000|Overall Study|Death|1|||
162120279|NCT03545113|585493060|FG001|Overall Study|Death|0|||
162120280|NCT03545113|585493059|FG000|Overall Study|Adverse Event|2|||
162120281|NCT03545113|585493060|FG001|Overall Study|Adverse Event|0|||
162120282|NCT03545113|585493059|FG000|Overall Study|Received different surgery|1|||
162120283|NCT03545113|585493060|FG001|Overall Study|Received different surgery|0|||
162120284|NCT00235443|585493061|FG000|Overall Study|Adverse Event|4|||
162120285|NCT00235443|585493062|FG001|Overall Study|Adverse Event|12|||
162120286|NCT00235443|585493063|FG002|Overall Study|Adverse Event|17|||
162120287|NCT00235443|585493064|FG003|Overall Study|Adverse Event|44|||
162120288|NCT00235443|585493065|FG004|Overall Study|Adverse Event|10|||
162120289|NCT00235443|585493066|FG005|Overall Study|Adverse Event|15|||
162120290|NCT00235443|585493061|FG000|Overall Study|Lack of Efficacy|0|||
162120291|NCT00235443|585493062|FG001|Overall Study|Lack of Efficacy|1|||
162120292|NCT00235443|585493063|FG002|Overall Study|Lack of Efficacy|5|||
162120293|NCT00235443|585493064|FG003|Overall Study|Lack of Efficacy|12|||
162120294|NCT00235443|585493065|FG004|Overall Study|Lack of Efficacy|2|||
162120295|NCT00235443|585493066|FG005|Overall Study|Lack of Efficacy|9|||
162120296|NCT00235443|585493061|FG000|Overall Study|Withdrawal by Subject|3|||
162120297|NCT00235443|585493062|FG001|Overall Study|Withdrawal by Subject|9|||
162120298|NCT00235443|585493063|FG002|Overall Study|Withdrawal by Subject|25|||
162120299|NCT00235443|585493064|FG003|Overall Study|Withdrawal by Subject|24|||
162120300|NCT00235443|585493065|FG004|Overall Study|Withdrawal by Subject|10|||
162120301|NCT00235443|585493066|FG005|Overall Study|Withdrawal by Subject|12|||
162120302|NCT00235443|585493061|FG000|Overall Study|Lost to Follow-up|0|||
162120303|NCT00235443|585493062|FG001|Overall Study|Lost to Follow-up|8|||
162120304|NCT00235443|585493063|FG002|Overall Study|Lost to Follow-up|6|||
162120305|NCT00235443|585493064|FG003|Overall Study|Lost to Follow-up|6|||
162120306|NCT00235443|585493065|FG004|Overall Study|Lost to Follow-up|4|||
162120307|NCT00235443|585493066|FG005|Overall Study|Lost to Follow-up|3|||
162120308|NCT00235443|585493061|FG000|Overall Study|Unsatisfactory compliance|0|||
162120309|NCT00235443|585493062|FG001|Overall Study|Unsatisfactory compliance|2|||
162120310|NCT00235443|585493063|FG002|Overall Study|Unsatisfactory compliance|3|||
162120311|NCT00235443|585493064|FG003|Overall Study|Unsatisfactory compliance|4|||
162120312|NCT00235443|585493065|FG004|Overall Study|Unsatisfactory compliance|1|||
162120313|NCT00235443|585493066|FG005|Overall Study|Unsatisfactory compliance|0|||
162120314|NCT00235443|585493061|FG000|Overall Study|Other reasons for premature termination|1|||
162120315|NCT00235443|585493062|FG001|Overall Study|Other reasons for premature termination|6|||
162120316|NCT00235443|585493063|FG002|Overall Study|Other reasons for premature termination|6|||
162120317|NCT00235443|585493064|FG003|Overall Study|Other reasons for premature termination|7|||
162120318|NCT00235443|585493065|FG004|Overall Study|Other reasons for premature termination|3|||
162120319|NCT00235443|585493066|FG005|Overall Study|Other reasons for premature termination|6|||
162120320|NCT03661996|585493070|FG000|Overall Study|Adverse Event|0|||
162120321|NCT03661996|585493071|FG001|Overall Study|Adverse Event|0|||
162120322|NCT03661996|585493072|FG002|Overall Study|Adverse Event|1|||
162120323|NCT03661996|585493073|FG003|Overall Study|Adverse Event|1|||
162120324|NCT03661996|585493074|FG004|Overall Study|Adverse Event|0|||
162120325|NCT03661996|585493070|FG000|Overall Study|Lost to Follow-up|5|||
162120326|NCT03661996|585493071|FG001|Overall Study|Lost to Follow-up|1|||
162120327|NCT03661996|585493072|FG002|Overall Study|Lost to Follow-up|2|||
162120328|NCT03661996|585493073|FG003|Overall Study|Lost to Follow-up|2|||
162120329|NCT03661996|585493074|FG004|Overall Study|Lost to Follow-up|6|||
162120330|NCT03661996|585493070|FG000|Overall Study|Physician Decision|1|||
162120331|NCT03661996|585493071|FG001|Overall Study|Physician Decision|1|||
162120332|NCT03661996|585493072|FG002|Overall Study|Physician Decision|1|||
162120333|NCT03661996|585493073|FG003|Overall Study|Physician Decision|2|||
162120334|NCT03661996|585493074|FG004|Overall Study|Physician Decision|0|||
162120335|NCT03661996|585493070|FG000|Overall Study|Protocol Violation|0|||
162120336|NCT03661996|585493071|FG001|Overall Study|Protocol Violation|0|||
162120337|NCT03661996|585493072|FG002|Overall Study|Protocol Violation|0|||
162120338|NCT03661996|585493073|FG003|Overall Study|Protocol Violation|0|||
162120339|NCT03661996|585493074|FG004|Overall Study|Protocol Violation|1|||
162120340|NCT03661996|585493070|FG000|Overall Study|Withdrawal by Subject|3|||
162120341|NCT03661996|585493071|FG001|Overall Study|Withdrawal by Subject|5|||
162120342|NCT03661996|585493072|FG002|Overall Study|Withdrawal by Subject|1|||
162120343|NCT03661996|585493073|FG003|Overall Study|Withdrawal by Subject|7|||
162120344|NCT03661996|585493074|FG004|Overall Study|Withdrawal by Subject|7|||
162120345|NCT03661996|585493070|FG000|Overall Study|Sponsors Decision|2|||
162120346|NCT03661996|585493071|FG001|Overall Study|Sponsors Decision|0|||
162120347|NCT03661996|585493072|FG002|Overall Study|Sponsors Decision|0|||
162120348|NCT03661996|585493073|FG003|Overall Study|Sponsors Decision|0|||
162120349|NCT03661996|585493074|FG004|Overall Study|Sponsors Decision|0|||
162120350|NCT03661996|585493070|FG000|Overall Study|Other|1|||
162120351|NCT03661996|585493071|FG001|Overall Study|Other|1|||
162120352|NCT03661996|585493072|FG002|Overall Study|Other|1|||
162120353|NCT03661996|585493073|FG003|Overall Study|Other|1|||
162120354|NCT03661996|585493074|FG004|Overall Study|Other|0|||
162120355|NCT03321513|585493075|FG000|Overall Study|Death|11|||
162120356|NCT03321513|585493076|FG001|Overall Study|Death|5|||
162120357|NCT03321513|585493075|FG000|Overall Study|Withdrawal by Subject|5|||
162120358|NCT03321513|585493076|FG001|Overall Study|Withdrawal by Subject|10|||
162120359|NCT03321513|585493075|FG000|Overall Study|Lost to Follow-up|10|||
162120360|NCT03321513|585493076|FG001|Overall Study|Lost to Follow-up|11|||
162120361|NCT01161472|585493077|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
162120362|NCT01161472|585493078|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
162120363|NCT01161472|585493079|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
162120364|NCT01161472|585493080|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
162120365|NCT00791921|585493098|FG000|Overall Study|Protocol planed|24|||
162120366|NCT00791921|585493099|FG001|Overall Study|Protocol planed|88|||
162120367|NCT00791921|585493098|FG000|Overall Study|Withdrawal by Subject|1|||
162120368|NCT00791921|585493099|FG001|Overall Study|Withdrawal by Subject|2|||
162120369|NCT00791921|585493098|FG000|Overall Study|Adverse Event|8|||
162120370|NCT00791921|585493099|FG001|Overall Study|Adverse Event|2|||
162120371|NCT00791921|585493098|FG000|Overall Study|Lack of Efficacy|0|||
162120372|NCT00791921|585493099|FG001|Overall Study|Lack of Efficacy|2|||
162120373|NCT00791921|585493098|FG000|Overall Study|Lack of study drug administration|1|||
162120374|NCT00791921|585493099|FG001|Overall Study|Lack of study drug administration|1|||
162120375|NCT00791921|585493098|FG000|Overall Study|Reason other than those above|0|||
162120376|NCT00791921|585493099|FG001|Overall Study|Reason other than those above|1|||
162120377|NCT01965158|585493100|FG000|Overall Study|Adverse Event|14|||
162120378|NCT01965158|585493101|FG001|Overall Study|Adverse Event|5|||
162120379|NCT01965158|585493100|FG000|Overall Study|Withdrawal by Subject|16|||
162120380|NCT01965158|585493101|FG001|Overall Study|Withdrawal by Subject|24|||
162120381|NCT01965158|585493100|FG000|Overall Study|Lost to Follow-up|7|||
162120382|NCT01965158|585493101|FG001|Overall Study|Lost to Follow-up|5|||
162120383|NCT01965158|585493100|FG000|Overall Study|Protocol Violation|1|||
162120384|NCT01965158|585493101|FG001|Overall Study|Protocol Violation|1|||
162120385|NCT01965158|585493100|FG000|Overall Study|Other - Miscellaneous|3|||
162120386|NCT01965158|585493101|FG001|Overall Study|Other - Miscellaneous|0|||
162120387|NCT02912468|585493102|FG000|Overall Study|Adverse Event|3|||
162120388|NCT02912468|585493103|FG001|Overall Study|Adverse Event|2|||
162120389|NCT02912468|585493102|FG000|Overall Study|Withdrawal by Subject|6|||
162120390|NCT02912468|585493103|FG001|Overall Study|Withdrawal by Subject|2|||
162120391|NCT02912468|585493102|FG000|Overall Study|Randomized and not treated|0|||
162120392|NCT02912468|585493103|FG001|Overall Study|Randomized and not treated|1|||
162120393|NCT01515189|585493104|FG000|Induction|Disease Progression|109|||
162120394|NCT01515189|585493105|FG001|Induction|Disease Progression|155|||
162120395|NCT01515189|585493104|FG000|Induction|Study drug toxicity|86|||
162120396|NCT01515189|585493105|FG001|Induction|Study drug toxicity|36|||
162120397|NCT01515189|585493104|FG000|Induction|Death|24|||
162120398|NCT01515189|585493105|FG001|Induction|Death|17|||
162120399|NCT01515189|585493104|FG000|Induction|Adverse Event|14|||
162120400|NCT01515189|585493105|FG001|Induction|Adverse Event|9|||
162120401|NCT01515189|585493104|FG000|Induction|Withdrawal by Subject|3|||
162120402|NCT01515189|585493105|FG001|Induction|Withdrawal by Subject|9|||
162120403|NCT01515189|585493104|FG000|Induction|No longer meets study criteria|0|||
162120404|NCT01515189|585493105|FG001|Induction|No longer meets study criteria|2|||
162120405|NCT01515189|585493104|FG000|Induction|Lost to Follow-up|1|||
162120406|NCT01515189|585493105|FG001|Induction|Lost to Follow-up|0|||
162120407|NCT01515189|585493104|FG000|Induction|Other|0|||
162120408|NCT01515189|585493105|FG001|Induction|Other|4|||
162120409|NCT01515189|585493104|FG000|First Re-Induction Phase|Disease progression|6|||
162120410|NCT01515189|585493105|FG001|First Re-Induction Phase|Disease progression|14|||
162120411|NCT01515189|585493104|FG000|First Re-Induction Phase|Study drug toxicity|5|||
162120412|NCT01515189|585493105|FG001|First Re-Induction Phase|Study drug toxicity|0|||
162120413|NCT01515189|585493104|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
162120414|NCT01515189|585493105|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
162120415|NCT01515189|585493104|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
162120416|NCT01515189|585493105|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
162120417|NCT01515189|585493104|FG000|First Re-Induction Phase|Other|1|||
162120418|NCT01515189|585493105|FG001|First Re-Induction Phase|Other|0|||
162120419|NCT00284089|585493106|FG000|Multiple Dose Phase|Adverse Event|1|||
162120420|NCT00284089|585493107|FG001|Multiple Dose Phase|Adverse Event|0|||
162120421|NCT00284089|585493108|FG002|Multiple Dose Phase|Adverse Event|1|||
162120422|NCT00284089|585493109|FG003|Multiple Dose Phase|Adverse Event|1|||
162120423|NCT00284089|585493106|FG000|Multiple Dose Phase|Protocol Violation|0|||
162120424|NCT00284089|585493107|FG001|Multiple Dose Phase|Protocol Violation|0|||
162120425|NCT00284089|585493108|FG002|Multiple Dose Phase|Protocol Violation|1|||
162120426|NCT00284089|585493109|FG003|Multiple Dose Phase|Protocol Violation|0|||
162120427|NCT00284089|585493106|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
162120428|NCT00284089|585493107|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
162120429|NCT00284089|585493108|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
162120430|NCT00284089|585493109|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
162120431|NCT00284089|585493106|FG000|Multiple Dose Phase|Death|0|||
162120432|NCT00284089|585493107|FG001|Multiple Dose Phase|Death|0|||
162120433|NCT00284089|585493108|FG002|Multiple Dose Phase|Death|1|||
162120434|NCT00284089|585493109|FG003|Multiple Dose Phase|Death|1|||
162120435|NCT00284089|585493106|FG000|Extension Phase|Adverse Event|0|||
162120436|NCT00284089|585493107|FG001|Extension Phase|Adverse Event|0|||
162120437|NCT00284089|585493108|FG002|Extension Phase|Adverse Event|2|||
162120438|NCT00284089|585493109|FG003|Extension Phase|Adverse Event|2|||
162120439|NCT00284089|585493106|FG000|Extension Phase|condition no longer requires study drug|2|||
162120440|NCT00284089|585493107|FG001|Extension Phase|condition no longer requires study drug|0|||
162120441|NCT00284089|585493108|FG002|Extension Phase|condition no longer requires study drug|2|||
162120442|NCT00284089|585493109|FG003|Extension Phase|condition no longer requires study drug|7|||
162120443|NCT00284089|585493106|FG000|Extension Phase|Protocol Violation|0|||
162120444|NCT00284089|585493107|FG001|Extension Phase|Protocol Violation|0|||
162120445|NCT00284089|585493108|FG002|Extension Phase|Protocol Violation|1|||
162120446|NCT00284089|585493109|FG003|Extension Phase|Protocol Violation|0|||
162120447|NCT00284089|585493106|FG000|Extension Phase|Withdrawal by Subject|0|||
162120448|NCT00284089|585493107|FG001|Extension Phase|Withdrawal by Subject|0|||
162120449|NCT00284089|585493108|FG002|Extension Phase|Withdrawal by Subject|1|||
162120450|NCT00284089|585493109|FG003|Extension Phase|Withdrawal by Subject|3|||
162120451|NCT02541383|585493110|FG000|Overall Study|Death|50|||
162120452|NCT02541383|585493111|FG001|Overall Study|Death|37|||
162120453|NCT02541383|585493112|FG002|Overall Study|Death|48|||
162120454|NCT02541383|585493113|FG003|Overall Study|Death|41|||
162120455|NCT02541383|585493114|FG004|Overall Study|Death|21|||
162120456|NCT02541383|585493115|FG005|Overall Study|Death|25|||
162120457|NCT02541383|585493110|FG000|Overall Study|Lost to Follow-up|5|||
162120458|NCT02541383|585493111|FG001|Overall Study|Lost to Follow-up|3|||
162237482|NCT00600886|585921097|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
162120459|NCT02541383|585493112|FG002|Overall Study|Lost to Follow-up|1|||
162120460|NCT02541383|585493113|FG003|Overall Study|Lost to Follow-up|1|||
162120461|NCT02541383|585493114|FG004|Overall Study|Lost to Follow-up|3|||
162120462|NCT02541383|585493115|FG005|Overall Study|Lost to Follow-up|0|||
162120463|NCT02541383|585493110|FG000|Overall Study|Consent withdrawn|5|||
162120464|NCT02541383|585493111|FG001|Overall Study|Consent withdrawn|6|||
162120465|NCT02541383|585493112|FG002|Overall Study|Consent withdrawn|1|||
162120466|NCT02541383|585493113|FG003|Overall Study|Consent withdrawn|1|||
162120467|NCT02541383|585493114|FG004|Overall Study|Consent withdrawn|0|||
162120468|NCT02541383|585493115|FG005|Overall Study|Consent withdrawn|0|||
162120469|NCT02541383|585493110|FG000|Overall Study|Sponsor's decision|1|||
162120470|NCT02541383|585493111|FG001|Overall Study|Sponsor's decision|1|||
162120471|NCT02541383|585493112|FG002|Overall Study|Sponsor's decision|0|||
162120472|NCT02541383|585493113|FG003|Overall Study|Sponsor's decision|0|||
162120473|NCT02541383|585493114|FG004|Overall Study|Sponsor's decision|0|||
162120474|NCT02541383|585493115|FG005|Overall Study|Sponsor's decision|0|||
162120475|NCT05796518|585493116|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
162120476|NCT00594217|585493117|FG000|Overall Study|Withdrawal by Subject|1|||
162120477|NCT00594217|585493118|FG001|Overall Study|Withdrawal by Subject|3|||
162120478|NCT05778526|585493121|FG000|Overall Study|Lost to Follow-up|0|||
162120479|NCT05778526|585493122|FG001|Overall Study|Lost to Follow-up|1|||
162120480|NCT05778526|585493123|FG002|Overall Study|Lost to Follow-up|3|||
162120481|NCT05778526|585493121|FG000|Overall Study|Protocol Violation|0|||
162120482|NCT05778526|585493122|FG001|Overall Study|Protocol Violation|0|||
162120483|NCT05778526|585493123|FG002|Overall Study|Protocol Violation|8|||
162120484|NCT03108157|585493126|FG000|Overall Study|Protocol Violation|15|||
162120485|NCT03108157|585493127|FG001|Overall Study|Protocol Violation|4|||
162120486|NCT02668016|585493129|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
162120487|NCT02668016|585493129|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
162120488|NCT02668016|585493129|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
162120489|NCT02668016|585493129|FG000|Month 4|Withdrawal due to severe symptoms|1|||
162120490|NCT02668016|585493129|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
162120491|NCT02668016|585493129|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
162120492|NCT02668016|585493129|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
162120493|NCT02668016|585493129|FG000|Month 6|Withdrawal due to severe symptoms|2|||
162120494|NCT02668016|585493129|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
162120495|NCT02668016|585493129|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
162120496|NCT02668016|585493129|FG000|Month 8|Withdrawal due to severe symptoms|1|||
162120497|NCT02668016|585493129|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
162120498|NCT02668016|585493129|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
162120499|NCT02668016|585493129|FG000|Month 10|Withdrawal due to severe symptoms|1|||
162120500|NCT02668016|585493129|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
162120501|NCT01122381|585493134|FG000|Overall Study|study terminated early|0|||
162120502|NCT01122381|585493135|FG001|Overall Study|study terminated early|1|||
162120503|NCT00736489|585493136|FG000|Period 1|Lost to Follow-up|1|||
162120504|NCT00736489|585493137|FG001|Period 1|Lost to Follow-up|0|||
162120505|NCT00736489|585493138|FG002|Period 1|Lost to Follow-up|0|||
162120506|NCT00736489|585493139|FG003|Period 1|Lost to Follow-up|0|||
162120507|NCT00736489|585493140|FG004|Period 1|Lost to Follow-up|0|||
162120508|NCT00736489|585493141|FG005|Period 1|Lost to Follow-up|0|||
162120509|NCT00736489|585493136|FG000|Period 1|Withdrawal by Subject|0|||
162120510|NCT00736489|585493137|FG001|Period 1|Withdrawal by Subject|0|||
162120511|NCT00736489|585493138|FG002|Period 1|Withdrawal by Subject|0|||
162120512|NCT00736489|585493139|FG003|Period 1|Withdrawal by Subject|0|||
162120513|NCT00736489|585493140|FG004|Period 1|Withdrawal by Subject|0|||
162120514|NCT00736489|585493141|FG005|Period 1|Withdrawal by Subject|1|||
162120515|NCT02395133|585493142|FG000|Overall Study|Adverse Event|4|||
162120516|NCT02395133|585493143|FG001|Overall Study|Adverse Event|1|||
162120517|NCT02395133|585493144|FG002|Overall Study|Adverse Event|3|||
162120518|NCT02395133|585493145|FG003|Overall Study|Adverse Event|0|||
162120519|NCT02395133|585493142|FG000|Overall Study|Lack of Efficacy|1|||
162120520|NCT02395133|585493143|FG001|Overall Study|Lack of Efficacy|0|||
162120521|NCT02395133|585493144|FG002|Overall Study|Lack of Efficacy|1|||
162120522|NCT02395133|585493145|FG003|Overall Study|Lack of Efficacy|1|||
162120523|NCT02395133|585493142|FG000|Overall Study|Protocol Violation|1|||
162120524|NCT02395133|585493143|FG001|Overall Study|Protocol Violation|1|||
162120525|NCT02395133|585493144|FG002|Overall Study|Protocol Violation|0|||
162120526|NCT02395133|585493145|FG003|Overall Study|Protocol Violation|3|||
162120527|NCT02395133|585493142|FG000|Overall Study|Lost to Follow-up|0|||
162120528|NCT02395133|585493143|FG001|Overall Study|Lost to Follow-up|1|||
162120529|NCT02395133|585493144|FG002|Overall Study|Lost to Follow-up|1|||
162120530|NCT02395133|585493145|FG003|Overall Study|Lost to Follow-up|0|||
162120531|NCT02395133|585493142|FG000|Overall Study|Pregnancy|0|||
162120532|NCT02395133|585493143|FG001|Overall Study|Pregnancy|0|||
162120533|NCT02395133|585493144|FG002|Overall Study|Pregnancy|3|||
162120534|NCT02395133|585493145|FG003|Overall Study|Pregnancy|0|||
162120535|NCT02395133|585493142|FG000|Overall Study|Consent withdrawn with no reason given|1|||
162120536|NCT02395133|585493143|FG001|Overall Study|Consent withdrawn with no reason given|3|||
162120537|NCT02395133|585493144|FG002|Overall Study|Consent withdrawn with no reason given|0|||
162120538|NCT02395133|585493145|FG003|Overall Study|Consent withdrawn with no reason given|2|||
162120539|NCT02395133|585493142|FG000|Overall Study|Consent withdrawn with personal reason|0|||
162120540|NCT02395133|585493143|FG001|Overall Study|Consent withdrawn with personal reason|1|||
162120541|NCT02395133|585493144|FG002|Overall Study|Consent withdrawn with personal reason|0|||
162120542|NCT02395133|585493145|FG003|Overall Study|Consent withdrawn with personal reason|3|||
162120543|NCT02395133|585493142|FG000|Overall Study|Sponsor decision|2|||
162120544|NCT02395133|585493143|FG001|Overall Study|Sponsor decision|0|||
162120545|NCT02395133|585493144|FG002|Overall Study|Sponsor decision|0|||
162120546|NCT02395133|585493145|FG003|Overall Study|Sponsor decision|1|||
162120547|NCT02395133|585493142|FG000|Overall Study|Other than specified above|5|||
162120548|NCT02395133|585493143|FG001|Overall Study|Other than specified above|2|||
162120549|NCT02395133|585493144|FG002|Overall Study|Other than specified above|2|||
162120550|NCT02395133|585493145|FG003|Overall Study|Other than specified above|4|||
162120551|NCT01555164|585493161|FG000|Overall Study|Adverse Event|5|||
162120552|NCT01555164|585493162|FG001|Overall Study|Adverse Event|7|||
162120553|NCT01555164|585493161|FG000|Overall Study|Hyperglycemia|0|||
162120554|NCT01555164|585493162|FG001|Overall Study|Hyperglycemia|1|||
162120555|NCT01555164|585493161|FG000|Overall Study|Investigator's Discretion|2|||
162120556|NCT01555164|585493162|FG001|Overall Study|Investigator's Discretion|2|||
162120557|NCT01555164|585493161|FG000|Overall Study|Lost to Follow-up|4|||
162120558|NCT01555164|585493162|FG001|Overall Study|Lost to Follow-up|3|||
162120559|NCT01555164|585493161|FG000|Overall Study|Protocol Violation|9|||
162120560|NCT01555164|585493162|FG001|Overall Study|Protocol Violation|5|||
162120561|NCT01555164|585493161|FG000|Overall Study|Subject Non-compliance|14|||
162120562|NCT01555164|585493162|FG001|Overall Study|Subject Non-compliance|6|||
162120563|NCT01555164|585493161|FG000|Overall Study|Subject Withdrew Consent|6|||
162120564|NCT01555164|585493162|FG001|Overall Study|Subject Withdrew Consent|11|||
162120565|NCT00886639|585493165|FG000|Overall Study|acute exacerbation|14|||
162120566|NCT00886639|585493165|FG000|Overall Study|non-compliance|2|||
162120567|NCT01871558|585493166|FG000|Overall Study|Other reason|0|||
162120568|NCT01871558|585493167|FG001|Overall Study|Other reason|1|||
162120569|NCT01871558|585493166|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
162120570|NCT01871558|585493167|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
162120571|NCT01871558|585493166|FG000|Overall Study|Withdrawal by Subject|2|||
162120572|NCT01871558|585493167|FG001|Overall Study|Withdrawal by Subject|0|||
162120573|NCT03203694|585493168|FG000|Overall Study|Withdrawal by Subject|2|||
162120574|NCT03203694|585493169|FG001|Overall Study|Withdrawal by Subject|0|||
162120575|NCT03203694|585493170|FG002|Overall Study|Withdrawal by Subject|0|||
162120576|NCT03203694|585493171|FG003|Overall Study|Withdrawal by Subject|0|||
162120577|NCT03203694|585493172|FG004|Overall Study|Withdrawal by Subject|0|||
162120578|NCT03203694|585493173|FG005|Overall Study|Withdrawal by Subject|0|||
162120579|NCT02969525|585493180|FG000|Double-Blind Period|Adverse Event|0|||
162120580|NCT02969525|585493181|FG001|Double-Blind Period|Adverse Event|0|||
162120581|NCT02969525|585493182|FG002|Double-Blind Period|Adverse Event|1|||
162120582|NCT02969525|585493183|FG003|Double-Blind Period|Adverse Event|1|||
162120583|NCT02969525|585493184|FG004|Double-Blind Period|Adverse Event|0|||
162120584|NCT02969525|585493185|FG005|Double-Blind Period|Adverse Event|0|||
162120585|NCT02969525|585493186|FG006|Double-Blind Period|Adverse Event|0|||
162120586|NCT02969525|585493187|FG007|Double-Blind Period|Adverse Event|0|||
162120587|NCT02969525|585493188|FG008|Double-Blind Period|Adverse Event|0|||
162120588|NCT02969525|585493189|FG009|Double-Blind Period|Adverse Event|0|||
162120589|NCT02969525|585493190|FG010|Double-Blind Period|Adverse Event|0|||
162120590|NCT02969525|585493191|FG011|Double-Blind Period|Adverse Event|0|||
162120591|NCT02969525|585493180|FG000|Double-Blind Period|LOW EGFR|0|||
162120592|NCT02969525|585493181|FG001|Double-Blind Period|LOW EGFR|0|||
162120593|NCT02969525|585493182|FG002|Double-Blind Period|LOW EGFR|0|||
162120594|NCT02969525|585493183|FG003|Double-Blind Period|LOW EGFR|1|||
162120595|NCT02969525|585493184|FG004|Double-Blind Period|LOW EGFR|0|||
162120596|NCT02969525|585493185|FG005|Double-Blind Period|LOW EGFR|0|||
162120597|NCT02969525|585493186|FG006|Double-Blind Period|LOW EGFR|0|||
162120598|NCT02969525|585493187|FG007|Double-Blind Period|LOW EGFR|0|||
162120599|NCT02969525|585493188|FG008|Double-Blind Period|LOW EGFR|0|||
162120600|NCT02969525|585493189|FG009|Double-Blind Period|LOW EGFR|0|||
162120601|NCT02969525|585493190|FG010|Double-Blind Period|LOW EGFR|0|||
162120602|NCT02969525|585493191|FG011|Double-Blind Period|LOW EGFR|0|||
162120603|NCT02969525|585493180|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
162120604|NCT02969525|585493181|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162120605|NCT02969525|585493182|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162120606|NCT02969525|585493183|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
162120607|NCT02969525|585493184|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162120608|NCT02969525|585493185|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162120609|NCT02969525|585493186|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162120610|NCT02969525|585493187|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162120611|NCT02969525|585493188|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162120612|NCT02969525|585493189|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162120613|NCT02969525|585493190|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162120614|NCT02969525|585493191|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
162120615|NCT02969525|585493180|FG000|Dose-Blind Period|Adverse Event|0|||
162120616|NCT02969525|585493181|FG001|Dose-Blind Period|Adverse Event|0|||
162120617|NCT02969525|585493182|FG002|Dose-Blind Period|Adverse Event|0|||
162120618|NCT02969525|585493183|FG003|Dose-Blind Period|Adverse Event|0|||
162120619|NCT02969525|585493184|FG004|Dose-Blind Period|Adverse Event|0|||
162120620|NCT02969525|585493185|FG005|Dose-Blind Period|Adverse Event|0|||
162120621|NCT02969525|585493186|FG006|Dose-Blind Period|Adverse Event|0|||
162120622|NCT02969525|585493187|FG007|Dose-Blind Period|Adverse Event|0|||
162120623|NCT02969525|585493188|FG008|Dose-Blind Period|Adverse Event|0|||
162120624|NCT02969525|585493189|FG009|Dose-Blind Period|Adverse Event|1|||
162120625|NCT02969525|585493190|FG010|Dose-Blind Period|Adverse Event|1|||
162120626|NCT02969525|585493191|FG011|Dose-Blind Period|Adverse Event|1|||
162120627|NCT02969525|585493180|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
162120628|NCT02969525|585493181|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
162120629|NCT02969525|585493182|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
162120630|NCT02969525|585493183|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
162120631|NCT02969525|585493184|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
162120632|NCT02969525|585493185|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
162120633|NCT02969525|585493186|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
162120634|NCT02969525|585493187|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
162120635|NCT02969525|585493188|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
162120636|NCT02969525|585493189|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
162120637|NCT02969525|585493190|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
162120638|NCT02969525|585493191|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
162120639|NCT02969525|585493180|FG000|Dose-Blind Period|Non-cooperating patient|0|||
162120640|NCT02969525|585493181|FG001|Dose-Blind Period|Non-cooperating patient|0|||
162120641|NCT02969525|585493182|FG002|Dose-Blind Period|Non-cooperating patient|0|||
162120642|NCT02969525|585493183|FG003|Dose-Blind Period|Non-cooperating patient|0|||
162120643|NCT02969525|585493184|FG004|Dose-Blind Period|Non-cooperating patient|0|||
162120644|NCT02969525|585493185|FG005|Dose-Blind Period|Non-cooperating patient|0|||
162120645|NCT02969525|585493186|FG006|Dose-Blind Period|Non-cooperating patient|0|||
162120646|NCT02969525|585493187|FG007|Dose-Blind Period|Non-cooperating patient|0|||
162120647|NCT02969525|585493188|FG008|Dose-Blind Period|Non-cooperating patient|0|||
162120648|NCT02969525|585493189|FG009|Dose-Blind Period|Non-cooperating patient|0|||
162120649|NCT02969525|585493190|FG010|Dose-Blind Period|Non-cooperating patient|0|||
162120650|NCT02969525|585493191|FG011|Dose-Blind Period|Non-cooperating patient|1|||
162120651|NCT02969525|585493180|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162120652|NCT02969525|585493181|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162120653|NCT02969525|585493182|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162120654|NCT02969525|585493183|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162120655|NCT02969525|585493184|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162120656|NCT02969525|585493185|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162120657|NCT02969525|585493186|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162120658|NCT02969525|585493187|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162120659|NCT02969525|585493188|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162120660|NCT02969525|585493189|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162120661|NCT02969525|585493190|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
162120662|NCT02969525|585493191|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
162120663|NCT02172625|585493192|FG000|Overall Study|Adverse Event|0|||
162120664|NCT02172625|585493193|FG001|Overall Study|Adverse Event|1|||
162120665|NCT02172625|585493192|FG000|Overall Study|Pregnancy|0|||
162120666|NCT02172625|585493193|FG001|Overall Study|Pregnancy|1|||
162120667|NCT02172625|585493192|FG000|Overall Study|car accident|0|||
162120668|NCT02172625|585493193|FG001|Overall Study|car accident|1|||
162120669|NCT03445065|585493194|FG000|Overall Study|Withdrawal by Subject|3|||
162120670|NCT03445065|585493195|FG001|Overall Study|Withdrawal by Subject|6|||
162120671|NCT03445065|585493196|FG002|Overall Study|Withdrawal by Subject|2|||
162120672|NCT03445065|585493197|FG003|Overall Study|Withdrawal by Subject|2|||
162120673|NCT03445065|585493194|FG000|Overall Study|Other|4|||
162120674|NCT03445065|585493195|FG001|Overall Study|Other|3|||
162120675|NCT03445065|585493196|FG002|Overall Study|Other|3|||
162120676|NCT03445065|585493197|FG003|Overall Study|Other|1|||
162120677|NCT03315130|585493198|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
162120678|NCT03315130|585493199|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
162120679|NCT03315130|585493200|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
162120680|NCT03315130|585493201|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
162120681|NCT03315130|585493198|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
162120682|NCT03315130|585493199|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
162120683|NCT03315130|585493200|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
162120684|NCT03315130|585493201|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
162120685|NCT03315130|585493198|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
162120686|NCT03315130|585493199|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
162120687|NCT03315130|585493200|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
162120688|NCT03315130|585493201|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
162120689|NCT03315130|585493198|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
162120690|NCT03315130|585493199|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
162120691|NCT03315130|585493200|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
162120692|NCT03315130|585493201|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
162120693|NCT03315130|585493198|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
162120694|NCT03315130|585493199|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
162120695|NCT03315130|585493200|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
162120696|NCT03315130|585493201|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
162120697|NCT03315130|585493198|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
162120698|NCT03315130|585493199|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
162120699|NCT03315130|585493200|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
162120700|NCT03315130|585493201|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
162120701|NCT00524030|585493202|FG000|Overall Study|Lack of Efficacy|10|||
162120702|NCT00524030|585493203|FG001|Overall Study|Lack of Efficacy|24|||
162120703|NCT00524030|585493202|FG000|Overall Study|Lost to Follow-up|0|||
162120704|NCT00524030|585493203|FG001|Overall Study|Lost to Follow-up|2|||
162120705|NCT00524030|585493202|FG000|Overall Study|Withdrawal by Subject|3|||
162120706|NCT00524030|585493203|FG001|Overall Study|Withdrawal by Subject|8|||
162120707|NCT00524030|585493202|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
162120708|NCT00524030|585493203|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
162120709|NCT00524030|585493202|FG000|Overall Study|Protocol Violation|0|||
162120710|NCT00524030|585493203|FG001|Overall Study|Protocol Violation|1|||
162120711|NCT00524030|585493202|FG000|Overall Study|Pregnancy|1|||
162120712|NCT00524030|585493203|FG001|Overall Study|Pregnancy|0|||
162120713|NCT00524030|585493202|FG000|Overall Study|Adverse Event|3|||
162120714|NCT00524030|585493203|FG001|Overall Study|Adverse Event|21|||
162120715|NCT00524030|585493202|FG000|Overall Study|Death|0|||
162120716|NCT00524030|585493203|FG001|Overall Study|Death|1|||
162120717|NCT02944656|585493204|FG000|Overall Study|No longer eligible|3|||
162120718|NCT02944656|585493205|FG001|Overall Study|No longer eligible|0|||
162120719|NCT02944656|585493204|FG000|Overall Study|Lost to Follow-up|7|||
162120720|NCT02944656|585493205|FG001|Overall Study|Lost to Follow-up|10|||
162120721|NCT04398537|585493206|FG000|Overall Study|Physician Decision|10|||
162120722|NCT04398537|585493207|FG001|Overall Study|Physician Decision|15|||
162120723|NCT03535337|585493208|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
162120724|NCT03535337|585493209|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
162120725|NCT03535337|585493210|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
162120726|NCT03535337|585493211|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
162120727|NCT03535337|585493212|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
162120728|NCT03535337|585493213|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
162120729|NCT03535337|585493214|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
162120730|NCT03535337|585493215|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
162120731|NCT03535337|585493216|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
162120732|NCT03535337|585493217|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
162120733|NCT05879198|585493218|FG000|Overall Study|Lost to Follow-up|1|||
162120734|NCT01598298|585493219|FG000|Overall Study|Not eligible|5|||
162120735|NCT01598298|585493220|FG001|Overall Study|Not eligible|5|||
162120736|NCT01598298|585493219|FG000|Overall Study|Adverse Event|21|||
162120737|NCT01598298|585493220|FG001|Overall Study|Adverse Event|19|||
162120738|NCT01598298|585493219|FG000|Overall Study|Progression/relapse|0|||
162120739|NCT01598298|585493220|FG001|Overall Study|Progression/relapse|2|||
162120740|NCT01598298|585493219|FG000|Overall Study|Withdrawal by Subject|10|||
162120741|NCT01598298|585493220|FG001|Overall Study|Withdrawal by Subject|15|||
162120742|NCT01598298|585493219|FG000|Overall Study|Other reason (not protocol specified)|4|||
162120743|NCT01598298|585493220|FG001|Overall Study|Other reason (not protocol specified)|0|||
162120744|NCT00474929|585495054|FG000|Overall Study|Withdrawal by Subject|0|||
162120745|NCT00474929|585495055|FG001|Overall Study|Withdrawal by Subject|1|||
162120746|NCT00474929|585495056|FG002|Overall Study|Withdrawal by Subject|0|||
162120747|NCT00474929|585495057|FG003|Overall Study|Withdrawal by Subject|0|||
162120748|NCT00474929|585495058|FG004|Overall Study|Withdrawal by Subject|0|||
162120749|NCT00474929|585495054|FG000|Overall Study|Unrelated medical condition|0|||
162120750|NCT00474929|585495055|FG001|Overall Study|Unrelated medical condition|0|||
162120751|NCT00474929|585495056|FG002|Overall Study|Unrelated medical condition|1|||
162120752|NCT00474929|585495057|FG003|Overall Study|Unrelated medical condition|0|||
162120753|NCT00474929|585495058|FG004|Overall Study|Unrelated medical condition|0|||
162120754|NCT00474929|585495054|FG000|Overall Study|Physician Decision|0|||
162120755|NCT00474929|585495055|FG001|Overall Study|Physician Decision|0|||
162120756|NCT00474929|585495056|FG002|Overall Study|Physician Decision|1|||
162120757|NCT00474929|585495057|FG003|Overall Study|Physician Decision|2|||
162120758|NCT00474929|585495058|FG004|Overall Study|Physician Decision|0|||
162120759|NCT03029247|585495061|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
162120760|NCT03029247|585495062|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
162120761|NCT03029247|585495061|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
162120762|NCT03029247|585495062|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
162120763|NCT03029247|585495061|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
162120764|NCT03029247|585495062|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
162120765|NCT03029247|585495061|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
162120766|NCT03029247|585495062|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
162120767|NCT02593305|585495063|FG000|Post 1|Comparison only group. No intervention.|0|||
162120768|NCT02593305|585495064|FG001|Post 1|Comparison only group. No intervention.|0|||
162120769|NCT02593305|585495065|FG002|Post 1|Comparison only group. No intervention.|10|||
162120770|NCT02757521|585495066|FG000|Overall Study|Adverse Event|1|||
162120771|NCT02757521|585495067|FG001|Overall Study|Adverse Event|0|||
162120772|NCT00999661|585495072|FG000|Overall Study|Lost to Follow-up|59|||
162120773|NCT00999661|585495072|FG000|Overall Study|Adverse Event|1|||
162120774|NCT00999661|585495072|FG000|Overall Study|Withdrawal by Subject|1|||
162120775|NCT00999661|585495072|FG000|Overall Study|Not meeting eligibility criteria|9|||
162120776|NCT00312858|585495073|FG000|Overall Study|Adverse Event|0|||
162120777|NCT00312858|585495074|FG001|Overall Study|Adverse Event|1|||
162120778|NCT00312858|585495073|FG000|Overall Study|Lost to Follow-up|25|||
162120779|NCT00312858|585495074|FG001|Overall Study|Lost to Follow-up|42|||
162120780|NCT00312858|585495073|FG000|Overall Study|Protocol Violation|3|||
162120781|NCT00312858|585495074|FG001|Overall Study|Protocol Violation|8|||
162120782|NCT00312858|585495073|FG000|Overall Study|Withdraw by Participant|20|||
162120783|NCT00312858|585495074|FG001|Overall Study|Withdraw by Participant|20|||
162120784|NCT00312858|585495073|FG000|Overall Study|Participant Moved|11|||
162120785|NCT00312858|585495074|FG001|Overall Study|Participant Moved|10|||
162120786|NCT00312858|585495073|FG000|Overall Study|Other|9|||
162120787|NCT00312858|585495074|FG001|Overall Study|Other|12|||
162120788|NCT00854295|585495080|FG000|Overall Study|Death|7|||
162120789|NCT00854295|585495081|FG001|Overall Study|Death|0|||
162120790|NCT00854295|585495082|FG002|Overall Study|Death|1|||
162120791|NCT00854295|585495083|FG003|Overall Study|Death|1|||
162120792|NCT00854295|585495080|FG000|Overall Study|Adverse Event|6|||
162120793|NCT00854295|585495081|FG001|Overall Study|Adverse Event|1|||
162120794|NCT00854295|585495082|FG002|Overall Study|Adverse Event|1|||
162120795|NCT00854295|585495083|FG003|Overall Study|Adverse Event|3|||
162120796|NCT00854295|585495080|FG000|Overall Study|Lost to Follow-up|18|||
162120797|NCT00854295|585495081|FG001|Overall Study|Lost to Follow-up|5|||
162120798|NCT00854295|585495082|FG002|Overall Study|Lost to Follow-up|21|||
162120799|NCT00854295|585495083|FG003|Overall Study|Lost to Follow-up|21|||
162120800|NCT00854295|585495080|FG000|Overall Study|Physician Decision|10|||
162120801|NCT00854295|585495081|FG001|Overall Study|Physician Decision|0|||
162120802|NCT00854295|585495082|FG002|Overall Study|Physician Decision|0|||
162120803|NCT00854295|585495083|FG003|Overall Study|Physician Decision|0|||
162120804|NCT02440594|585495085|FG000|Overall Study|Lost to Follow-up|34|||
162120805|NCT02440594|585495086|FG001|Overall Study|Lost to Follow-up|33|||
162120806|NCT02440594|585495087|FG002|Overall Study|Lost to Follow-up|54|||
162120807|NCT02440594|585495088|FG003|Overall Study|Lost to Follow-up|47|||
162120808|NCT02440594|585495089|FG004|Overall Study|Lost to Follow-up|5|||
162120809|NCT02440594|585495090|FG005|Overall Study|Lost to Follow-up|4|||
162120810|NCT02440594|585495091|FG006|Overall Study|Lost to Follow-up|28|||
162120811|NCT02440594|585495092|FG007|Overall Study|Lost to Follow-up|48|||
162120812|NCT02440594|585495085|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
162120813|NCT02440594|585495086|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
162120814|NCT02440594|585495087|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
162120815|NCT02440594|585495088|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
162120816|NCT02440594|585495089|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
162120817|NCT02440594|585495090|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
162120818|NCT02440594|585495091|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
162120819|NCT02440594|585495092|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
162120820|NCT02440594|585495085|FG000|Overall Study|Withdrawal by Subject|81|||
162120821|NCT02440594|585495086|FG001|Overall Study|Withdrawal by Subject|67|||
162120822|NCT02440594|585495087|FG002|Overall Study|Withdrawal by Subject|59|||
162120823|NCT02440594|585495088|FG003|Overall Study|Withdrawal by Subject|38|||
162120824|NCT02440594|585495089|FG004|Overall Study|Withdrawal by Subject|2|||
162120825|NCT02440594|585495090|FG005|Overall Study|Withdrawal by Subject|2|||
162120826|NCT02440594|585495091|FG006|Overall Study|Withdrawal by Subject|7|||
162120827|NCT02440594|585495092|FG007|Overall Study|Withdrawal by Subject|7|||
162120828|NCT02440594|585495085|FG000|Overall Study|Administratively w/drawn|3|||
162120829|NCT02440594|585495086|FG001|Overall Study|Administratively w/drawn|2|||
162120830|NCT02440594|585495087|FG002|Overall Study|Administratively w/drawn|0|||
162120831|NCT02440594|585495088|FG003|Overall Study|Administratively w/drawn|0|||
162120832|NCT02440594|585495089|FG004|Overall Study|Administratively w/drawn|0|||
162120833|NCT02440594|585495090|FG005|Overall Study|Administratively w/drawn|0|||
162120834|NCT02440594|585495091|FG006|Overall Study|Administratively w/drawn|2|||
162120835|NCT02440594|585495092|FG007|Overall Study|Administratively w/drawn|1|||
162120836|NCT00152763|585495093|FG000|Overall Study|Death|4|||
162120837|NCT00152763|585495094|FG001|Overall Study|Death|1|||
162120838|NCT00152763|585495095|FG002|Overall Study|Death|2|||
162120839|NCT00152763|585495096|FG003|Overall Study|Death|1|||
162120840|NCT00152763|585495093|FG000|Overall Study|Lost to Follow-up|6|||
162120841|NCT00152763|585495094|FG001|Overall Study|Lost to Follow-up|4|||
162120842|NCT00152763|585495095|FG002|Overall Study|Lost to Follow-up|2|||
162120843|NCT00152763|585495096|FG003|Overall Study|Lost to Follow-up|13|||
162120844|NCT04668989|585495099|FG000|First Intervention|Covid-19 related self-isolation|0|||
162120845|NCT04668989|585495100|FG001|First Intervention|Covid-19 related self-isolation|1|||
162120846|NCT04668989|585495099|FG000|Second Intervention|Adverse Event|0|||
162120847|NCT04668989|585495100|FG001|Second Intervention|Adverse Event|1|||
162120848|NCT01622348|585495106|FG000|Overall Study|Withdrawal by Subject|1|||
162120849|NCT01622348|585495107|FG001|Overall Study|Withdrawal by Subject|0|||
162120850|NCT01622348|585495108|FG002|Overall Study|Withdrawal by Subject|1|||
162120851|NCT00422799|585495111|FG000|Overall Study|Withdrawal by Subject|6|||
162120852|NCT00422799|585495111|FG000|Overall Study|Adverse Event|7|||
162120853|NCT00474175|585495112|FG000|Overall Study|Lack of Efficacy|0|||
162120854|NCT00474175|585495113|FG001|Overall Study|Lack of Efficacy|0|||
162120855|NCT00474175|585495114|FG002|Overall Study|Lack of Efficacy|1|||
162120856|NCT00474175|585495112|FG000|Overall Study|Withdrawal by Subject|0|||
162120857|NCT00474175|585495113|FG001|Overall Study|Withdrawal by Subject|1|||
162120858|NCT00474175|585495114|FG002|Overall Study|Withdrawal by Subject|1|||
162120859|NCT00474175|585495112|FG000|Overall Study|Ineligible|1|||
162120860|NCT00474175|585495113|FG001|Overall Study|Ineligible|3|||
162120861|NCT00474175|585495114|FG002|Overall Study|Ineligible|1|||
162120862|NCT00474175|585495112|FG000|Overall Study|Protocol Violation|0|||
162120863|NCT00474175|585495113|FG001|Overall Study|Protocol Violation|2|||
162120864|NCT00474175|585495114|FG002|Overall Study|Protocol Violation|1|||
162120865|NCT00474175|585495112|FG000|Overall Study|Administrative|0|||
162120866|NCT00474175|585495113|FG001|Overall Study|Administrative|1|||
162120867|NCT00474175|585495114|FG002|Overall Study|Administrative|0|||
162120868|NCT01619787|585495115|FG000|Overall Study|Lost to Follow-up|5|||
162120869|NCT04537897|585495116|FG000|Overall Study|Other than listed|0|||
162120870|NCT04537897|585495117|FG001|Overall Study|Other than listed|0|||
162120871|NCT04537897|585495118|FG002|Overall Study|Other than listed|0|||
162120872|NCT04537897|585495119|FG003|Overall Study|Other than listed|0|||
162120873|NCT04537897|585495120|FG004|Overall Study|Other than listed|0|||
162120874|NCT04537897|585495121|FG005|Overall Study|Other than listed|0|||
162120875|NCT04537897|585495122|FG006|Overall Study|Other than listed|1|||
162120876|NCT04537897|585495123|FG007|Overall Study|Other than listed|0|||
162120877|NCT04537897|585495124|FG008|Overall Study|Other than listed|0|||
162120878|NCT04537897|585495116|FG000|Overall Study|Adverse Event|0|||
162120879|NCT04537897|585495117|FG001|Overall Study|Adverse Event|0|||
162120880|NCT04537897|585495118|FG002|Overall Study|Adverse Event|0|||
162120881|NCT04537897|585495119|FG003|Overall Study|Adverse Event|1|||
162120882|NCT04537897|585495120|FG004|Overall Study|Adverse Event|0|||
162120883|NCT04537897|585495121|FG005|Overall Study|Adverse Event|0|||
162120884|NCT04537897|585495122|FG006|Overall Study|Adverse Event|0|||
162120885|NCT04537897|585495123|FG007|Overall Study|Adverse Event|0|||
162120886|NCT04537897|585495124|FG008|Overall Study|Adverse Event|0|||
162120887|NCT04537897|585495116|FG000|Overall Study|Withdrawal by Subject|0|||
162120888|NCT04537897|585495117|FG001|Overall Study|Withdrawal by Subject|1|||
162120889|NCT04537897|585495118|FG002|Overall Study|Withdrawal by Subject|0|||
162120890|NCT04537897|585495119|FG003|Overall Study|Withdrawal by Subject|0|||
162120891|NCT04537897|585495120|FG004|Overall Study|Withdrawal by Subject|0|||
162120892|NCT04537897|585495121|FG005|Overall Study|Withdrawal by Subject|0|||
162120893|NCT04537897|585495122|FG006|Overall Study|Withdrawal by Subject|0|||
162120894|NCT04537897|585495123|FG007|Overall Study|Withdrawal by Subject|0|||
162120895|NCT04537897|585495124|FG008|Overall Study|Withdrawal by Subject|0|||
162120896|NCT00197028|585495128|FG000|Overall Study|Adverse Event|2|||
162120897|NCT00197028|585495129|FG001|Overall Study|Adverse Event|2|||
162120898|NCT00197028|585495128|FG000|Overall Study|Protocol Violation|2|||
162120899|NCT00197028|585495129|FG001|Overall Study|Protocol Violation|1|||
162120900|NCT00197028|585495128|FG000|Overall Study|Withdrawal by Subject|8|||
162120901|NCT00197028|585495129|FG001|Overall Study|Withdrawal by Subject|12|||
162120902|NCT00197028|585495128|FG000|Overall Study|Lost to Follow-up|1|||
162120903|NCT00197028|585495129|FG001|Overall Study|Lost to Follow-up|0|||
162120904|NCT00197028|585495128|FG000|Overall Study|Other|3|||
162120905|NCT00197028|585495129|FG001|Overall Study|Other|6|||
162120906|NCT03893825|585495130|FG000|Overall Study|Death|2|||
162120907|NCT03893825|585495131|FG001|Overall Study|Death|1|||
162120908|NCT03893825|585495130|FG000|Overall Study|Adverse Event|0|||
162120909|NCT03893825|585495131|FG001|Overall Study|Adverse Event|2|||
162120910|NCT03893825|585495130|FG000|Overall Study|Withdrawal by Subject|19|||
162120911|NCT03893825|585495131|FG001|Overall Study|Withdrawal by Subject|21|||
162120912|NCT03893825|585495130|FG000|Overall Study|Protocol deviation|1|||
162120913|NCT03893825|585495131|FG001|Overall Study|Protocol deviation|0|||
162120914|NCT03893825|585495130|FG000|Overall Study|Lost to Follow-up|10|||
162120915|NCT03893825|585495131|FG001|Overall Study|Lost to Follow-up|10|||
162120916|NCT03893825|585495130|FG000|Overall Study|Other than specified|7|||
162120917|NCT03893825|585495131|FG001|Overall Study|Other than specified|6|||
162120918|NCT04488003|585495137|FG000|Assessed for Eligibility|Screen Failure|24|||
162120919|NCT04488003|585495138|FG001|Assessed for Eligibility|Screen Failure|0|||
162120920|NCT04488003|585495139|FG002|Assessed for Eligibility|Screen Failure|0|||
162120921|NCT04488003|585495137|FG000|Assessed for Eligibility|Adverse Event|1|||
162120922|NCT04488003|585495138|FG001|Assessed for Eligibility|Adverse Event|0|||
162120923|NCT04488003|585495139|FG002|Assessed for Eligibility|Adverse Event|0|||
162120924|NCT04488003|585495137|FG000|Assessed for Eligibility|Death|1|||
162120925|NCT04488003|585495138|FG001|Assessed for Eligibility|Death|0|||
162120926|NCT04488003|585495139|FG002|Assessed for Eligibility|Death|0|||
162120927|NCT04488003|585495137|FG000|Assessed for Eligibility|Physician Decision|1|||
162120928|NCT04488003|585495138|FG001|Assessed for Eligibility|Physician Decision|0|||
162120929|NCT04488003|585495139|FG002|Assessed for Eligibility|Physician Decision|0|||
162120930|NCT04488003|585495137|FG000|Allocated to Treatment|Progressive Disease|51|||
162120931|NCT04488003|585495138|FG001|Allocated to Treatment|Progressive Disease|0|||
162120932|NCT04488003|585495139|FG002|Allocated to Treatment|Progressive Disease|0|||
162120933|NCT04488003|585495137|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
162120934|NCT04488003|585495138|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
162120935|NCT04488003|585495139|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
162120936|NCT04488003|585495137|FG000|Allocated to Treatment|Adverse Event|6|||
162120937|NCT04488003|585495138|FG001|Allocated to Treatment|Adverse Event|0|||
162120938|NCT04488003|585495139|FG002|Allocated to Treatment|Adverse Event|0|||
162120939|NCT04488003|585495137|FG000|Allocated to Treatment|Other|5|||
162120940|NCT04488003|585495138|FG001|Allocated to Treatment|Other|0|||
162120941|NCT04488003|585495139|FG002|Allocated to Treatment|Other|0|||
162120942|NCT04488003|585495137|FG000|Allocated to Treatment|Physician Decision|4|||
162120943|NCT04488003|585495138|FG001|Allocated to Treatment|Physician Decision|0|||
162120944|NCT04488003|585495139|FG002|Allocated to Treatment|Physician Decision|0|||
162120945|NCT04488003|585495137|FG000|Allocated to Treatment|Death|4|||
162120946|NCT04488003|585495138|FG001|Allocated to Treatment|Death|0|||
162120947|NCT04488003|585495139|FG002|Allocated to Treatment|Death|0|||
162120948|NCT01737996|585495140|FG000|Overall Study|Adverse Event|0|||
162120949|NCT01737996|585495141|FG001|Overall Study|Adverse Event|1|||
162120950|NCT01737996|585495142|FG002|Overall Study|Adverse Event|1|||
162120951|NCT01737996|585495140|FG000|Overall Study|Withdrawal by Subject|0|||
162120952|NCT01737996|585495141|FG001|Overall Study|Withdrawal by Subject|0|||
162120953|NCT01737996|585495142|FG002|Overall Study|Withdrawal by Subject|1|||
162120954|NCT01468922|585495145|FG000|Overall Study|Screening failure|0|||
162120955|NCT01468922|585495146|FG001|Overall Study|Screening failure|0|||
162120956|NCT01468922|585495147|FG002|Overall Study|Screening failure|0|||
162120957|NCT01468922|585495148|FG003|Overall Study|Screening failure|0|||
162120958|NCT01468922|585495149|FG004|Overall Study|Screening failure|0|||
162120959|NCT01468922|585495150|FG005|Overall Study|Screening failure|0|||
162120960|NCT01468922|585495151|FG006|Overall Study|Screening failure|0|||
162120961|NCT01468922|585495152|FG007|Overall Study|Screening failure|0|||
162120962|NCT01468922|585495153|FG008|Overall Study|Screening failure|1|||
162120963|NCT01468922|585495145|FG000|Overall Study|Per patient choice|1|||
162120964|NCT01468922|585495146|FG001|Overall Study|Per patient choice|0|||
162120965|NCT01468922|585495147|FG002|Overall Study|Per patient choice|0|||
162120966|NCT01468922|585495148|FG003|Overall Study|Per patient choice|0|||
162120967|NCT01468922|585495149|FG004|Overall Study|Per patient choice|0|||
162120968|NCT01468922|585495150|FG005|Overall Study|Per patient choice|0|||
162120969|NCT01468922|585495151|FG006|Overall Study|Per patient choice|0|||
162120970|NCT01468922|585495152|FG007|Overall Study|Per patient choice|0|||
162120971|NCT01468922|585495153|FG008|Overall Study|Per patient choice|0|||
162120972|NCT01468922|585495145|FG000|Overall Study|Switched to alternative treatment|1|||
162120973|NCT01468922|585495146|FG001|Overall Study|Switched to alternative treatment|0|||
162120974|NCT01468922|585495147|FG002|Overall Study|Switched to alternative treatment|0|||
162120975|NCT01468922|585495148|FG003|Overall Study|Switched to alternative treatment|0|||
162120976|NCT01468922|585495149|FG004|Overall Study|Switched to alternative treatment|1|||
162120977|NCT01468922|585495150|FG005|Overall Study|Switched to alternative treatment|0|||
162120978|NCT01468922|585495151|FG006|Overall Study|Switched to alternative treatment|0|||
162120979|NCT01468922|585495152|FG007|Overall Study|Switched to alternative treatment|0|||
162120980|NCT01468922|585495153|FG008|Overall Study|Switched to alternative treatment|0|||
162120981|NCT01468922|585495145|FG000|Overall Study|Enrolled on new protocol|0|||
162120982|NCT01468922|585495146|FG001|Overall Study|Enrolled on new protocol|0|||
162120983|NCT01468922|585495147|FG002|Overall Study|Enrolled on new protocol|0|||
162120984|NCT01468922|585495148|FG003|Overall Study|Enrolled on new protocol|0|||
162120985|NCT01468922|585495149|FG004|Overall Study|Enrolled on new protocol|1|||
162120986|NCT01468922|585495150|FG005|Overall Study|Enrolled on new protocol|0|||
162120987|NCT01468922|585495151|FG006|Overall Study|Enrolled on new protocol|0|||
162120988|NCT01468922|585495152|FG007|Overall Study|Enrolled on new protocol|0|||
162120989|NCT01468922|585495153|FG008|Overall Study|Enrolled on new protocol|0|||
162120990|NCT01468922|585495145|FG000|Overall Study|Adverse Event|0|||
162120991|NCT01468922|585495146|FG001|Overall Study|Adverse Event|0|||
162120992|NCT01468922|585495147|FG002|Overall Study|Adverse Event|0|||
162120993|NCT01468922|585495148|FG003|Overall Study|Adverse Event|0|||
162120994|NCT01468922|585495149|FG004|Overall Study|Adverse Event|0|||
162120995|NCT01468922|585495150|FG005|Overall Study|Adverse Event|0|||
162120996|NCT01468922|585495151|FG006|Overall Study|Adverse Event|0|||
162120997|NCT01468922|585495152|FG007|Overall Study|Adverse Event|1|||
162120998|NCT01468922|585495153|FG008|Overall Study|Adverse Event|0|||
162120999|NCT01468922|585495145|FG000|Overall Study|Infection of blood|0|||
162121000|NCT01468922|585495146|FG001|Overall Study|Infection of blood|0|||
162121001|NCT01468922|585495147|FG002|Overall Study|Infection of blood|0|||
162121002|NCT01468922|585495148|FG003|Overall Study|Infection of blood|0|||
162121003|NCT01468922|585495149|FG004|Overall Study|Infection of blood|0|||
162121004|NCT01468922|585495150|FG005|Overall Study|Infection of blood|0|||
162121005|NCT01468922|585495151|FG006|Overall Study|Infection of blood|0|||
162121006|NCT01468922|585495152|FG007|Overall Study|Infection of blood|1|||
162121007|NCT01468922|585495153|FG008|Overall Study|Infection of blood|0|||
162121008|NCT01468922|585495145|FG000|Overall Study|Patient choice - surgery|0|||
162121009|NCT01468922|585495146|FG001|Overall Study|Patient choice - surgery|0|||
162121010|NCT01468922|585495147|FG002|Overall Study|Patient choice - surgery|0|||
162121011|NCT01468922|585495148|FG003|Overall Study|Patient choice - surgery|0|||
162121012|NCT01468922|585495149|FG004|Overall Study|Patient choice - surgery|0|||
162121013|NCT01468922|585495150|FG005|Overall Study|Patient choice - surgery|0|||
162121014|NCT01468922|585495151|FG006|Overall Study|Patient choice - surgery|0|||
162121015|NCT01468922|585495152|FG007|Overall Study|Patient choice - surgery|1|||
162121016|NCT01468922|585495153|FG008|Overall Study|Patient choice - surgery|0|||
162121017|NCT01468922|585495145|FG000|Overall Study|Refused further treatment|0|||
162121018|NCT01468922|585495146|FG001|Overall Study|Refused further treatment|0|||
162121019|NCT01468922|585495147|FG002|Overall Study|Refused further treatment|0|||
162121020|NCT01468922|585495148|FG003|Overall Study|Refused further treatment|0|||
162121021|NCT01468922|585495149|FG004|Overall Study|Refused further treatment|0|||
162121022|NCT01468922|585495150|FG005|Overall Study|Refused further treatment|0|||
162121023|NCT01468922|585495151|FG006|Overall Study|Refused further treatment|0|||
162121024|NCT01468922|585495152|FG007|Overall Study|Refused further treatment|1|||
162121025|NCT01468922|585495153|FG008|Overall Study|Refused further treatment|0|||
162121026|NCT01923389|585495154|FG000|Overall Study|Protocol Violation|1|||
162121027|NCT01923389|585495155|FG001|Overall Study|Protocol Violation|0|||
162121028|NCT00007475|585495158|FG000|Overall Study|Withdrawal by Subject|1|||
162121029|NCT00007475|585495159|FG001|Overall Study|Withdrawal by Subject|0|||
162121030|NCT00007475|585495160|FG002|Overall Study|Withdrawal by Subject|0|||
162121031|NCT00007475|585495161|FG003|Overall Study|Withdrawal by Subject|0|||
162121032|NCT00007475|585495158|FG000|Overall Study|Adverse Event|3|||
162121033|NCT00007475|585495159|FG001|Overall Study|Adverse Event|0|||
162121034|NCT00007475|585495160|FG002|Overall Study|Adverse Event|0|||
162121035|NCT00007475|585495161|FG003|Overall Study|Adverse Event|0|||
162121036|NCT01719224|585495162|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
162121037|NCT01719224|585495163|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
162121038|NCT00258440|585495164|FG000|Overall Study|Withdrawal by Subject|0|||
162121039|NCT00258440|585495165|FG001|Overall Study|Withdrawal by Subject|0|||
162121040|NCT00258440|585495166|FG002|Overall Study|Withdrawal by Subject|1|||
162121041|NCT00737061|585495167|FG000|Waiting Period|Lost to Follow-up|6|||
162121042|NCT00737061|585495167|FG000|Waiting Period|Withdrawal by Subject|1|||
162121043|NCT00737061|585495167|FG000|Waiting Period|Bilateral placement failure|34|||
162121044|NCT00737061|585495167|FG000|Waiting Period|Deemed patent following HSG|26|||
162121045|NCT00737061|585495167|FG000|Waiting Period|Alternative contraception failure|3|||
162121046|NCT00737061|585495167|FG000|Waiting Period|Elected surgical tubal ligation|5|||
162121047|NCT00737061|585495167|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
162121048|NCT00737061|585495167|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
162121049|NCT00737061|585495167|FG000|1 Year Wearing Period|Discontinued reilance|3|||
162121050|NCT00737061|585495167|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
162121051|NCT03000673|585495168|FG000|Overall Study|Withdrawal by Subject|1|||
162121052|NCT03000673|585495169|FG001|Overall Study|Withdrawal by Subject|0|||
162121053|NCT03000673|585495170|FG002|Overall Study|Withdrawal by Subject|0|||
162121054|NCT03000673|585495171|FG003|Overall Study|Withdrawal by Subject|0|||
162121055|NCT00692406|585495172|FG000|Overall Study|PI dropped, bad data|57|||
162121056|NCT02597933|585495173|FG000|Overall Study|Withdrawal by Subject|7|||
162121057|NCT02597933|585495174|FG001|Overall Study|Withdrawal by Subject|5|||
162121058|NCT02597933|585495173|FG000|Overall Study|Protocol Violation|2|||
162121059|NCT02597933|585495174|FG001|Overall Study|Protocol Violation|2|||
162121060|NCT02597933|585495173|FG000|Overall Study|Adverse Event|20|||
162121061|NCT02597933|585495174|FG001|Overall Study|Adverse Event|28|||
162121062|NCT02597933|585495173|FG000|Overall Study|Not treated|2|||
162121063|NCT02597933|585495174|FG001|Overall Study|Not treated|2|||
162121064|NCT02597933|585495173|FG000|Overall Study|Other than stated above|7|||
162121065|NCT02597933|585495174|FG001|Overall Study|Other than stated above|14|||
162121066|NCT01617005|585495175|FG000|Overall Study|Pregnancy|1|||
162121067|NCT01617005|585495175|FG000|Overall Study|Lack of motivation for treatment|1|||
162121068|NCT04186403|585495183|FG000|Overall Study|Adverse Event|1|||
162121069|NCT04186403|585495184|FG001|Overall Study|Adverse Event|8|||
162121070|NCT04186403|585495183|FG000|Overall Study|Lost to Follow-up|7|||
162121071|NCT04186403|585495184|FG001|Overall Study|Lost to Follow-up|3|||
162121072|NCT04186403|585495183|FG000|Overall Study|Physician Decision|1|||
162121073|NCT04186403|585495184|FG001|Overall Study|Physician Decision|0|||
162121074|NCT04186403|585495183|FG000|Overall Study|Withdrawal by Subject|7|||
162121075|NCT04186403|585495184|FG001|Overall Study|Withdrawal by Subject|8|||
162121076|NCT04186403|585495183|FG000|Overall Study|Other: Not Related to Covid-19|3|||
162121077|NCT04186403|585495184|FG001|Overall Study|Other: Not Related to Covid-19|0|||
162121078|NCT01407354|585495189|FG000|First Intervention|Withdrawal by Subject|0|||
162121079|NCT01407354|585495190|FG001|First Intervention|Withdrawal by Subject|2|||
162121080|NCT01407354|585495189|FG000|First Intervention|Adverse Event|1|||
162121081|NCT01407354|585495190|FG001|First Intervention|Adverse Event|0|||
162121082|NCT01407354|585495189|FG000|First Intervention|Physician Decision|1|||
162121083|NCT01407354|585495190|FG001|First Intervention|Physician Decision|0|||
162121084|NCT01036022|585495191|FG000|Overall Study|Adverse Event|1|||
162121085|NCT01036022|585495192|FG001|Overall Study|Adverse Event|3|||
162121086|NCT01036022|585495193|FG002|Overall Study|Adverse Event|2|||
162121087|NCT01036022|585495194|FG003|Overall Study|Adverse Event|1|||
162121088|NCT01036022|585495195|FG004|Overall Study|Adverse Event|0|||
162121089|NCT01036022|585495196|FG005|Overall Study|Adverse Event|2|||
162121090|NCT01036022|585495191|FG000|Overall Study|Lack of Efficacy|1|||
162121091|NCT01036022|585495192|FG001|Overall Study|Lack of Efficacy|1|||
162121092|NCT01036022|585495193|FG002|Overall Study|Lack of Efficacy|1|||
162121093|NCT01036022|585495194|FG003|Overall Study|Lack of Efficacy|0|||
162121094|NCT01036022|585495195|FG004|Overall Study|Lack of Efficacy|1|||
162121095|NCT01036022|585495196|FG005|Overall Study|Lack of Efficacy|1|||
162121096|NCT01036022|585495191|FG000|Overall Study|Physician Decision|0|||
162121097|NCT01036022|585495192|FG001|Overall Study|Physician Decision|0|||
162121098|NCT01036022|585495193|FG002|Overall Study|Physician Decision|1|||
162121099|NCT01036022|585495194|FG003|Overall Study|Physician Decision|0|||
162121100|NCT01036022|585495195|FG004|Overall Study|Physician Decision|0|||
162121101|NCT01036022|585495196|FG005|Overall Study|Physician Decision|0|||
162121102|NCT01036022|585495191|FG000|Overall Study|Withdrawal by Subject|0|||
162121103|NCT01036022|585495192|FG001|Overall Study|Withdrawal by Subject|0|||
162121104|NCT01036022|585495193|FG002|Overall Study|Withdrawal by Subject|0|||
162121105|NCT01036022|585495194|FG003|Overall Study|Withdrawal by Subject|1|||
162121106|NCT01036022|585495195|FG004|Overall Study|Withdrawal by Subject|2|||
162121107|NCT01036022|585495196|FG005|Overall Study|Withdrawal by Subject|0|||
162121108|NCT01336621|585495198|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
162121109|NCT01336621|585495198|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
162121110|NCT01336621|585495198|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
162121111|NCT01336621|585495198|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
162121112|NCT01336621|585495198|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
162121113|NCT01336621|585495198|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
162121114|NCT01336621|585495198|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
162121115|NCT01336621|585495198|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
162121116|NCT01336621|585495198|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
162121117|NCT01336621|585495198|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
162121118|NCT01336621|585495198|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
162121119|NCT01336621|585495198|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
162121120|NCT01336621|585495198|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
162121121|NCT01336621|585495198|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
162121122|NCT02487095|585495199|FG000|Dose Expansion|Unable to scan/restage participant|0|||
162121123|NCT02487095|585495200|FG001|Dose Expansion|Unable to scan/restage participant|0|||
162121124|NCT02487095|585495201|FG002|Dose Expansion|Unable to scan/restage participant|0|||
162121125|NCT02487095|585495202|FG003|Dose Expansion|Unable to scan/restage participant|0|||
162121126|NCT02487095|585495203|FG004|Dose Expansion|Unable to scan/restage participant|1|||
162121127|NCT04534114|585495204|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
162121128|NCT04534114|585495205|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
162121129|NCT04534114|585495206|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
162121130|NCT04534114|585495207|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
162121131|NCT04534114|585495204|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
162121132|NCT04534114|585495205|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
162121133|NCT04534114|585495206|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
162121134|NCT04534114|585495207|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
162121135|NCT04534114|585495204|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
162121136|NCT04534114|585495205|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
162121137|NCT04534114|585495206|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
162121138|NCT04534114|585495207|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
162121139|NCT04534114|585495204|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
162121140|NCT04534114|585495205|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
162121141|NCT04534114|585495206|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
162121142|NCT04534114|585495207|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
162121143|NCT04534114|585495204|FG000|Main Treatment Period|Physician Decision|0|||
162121144|NCT04534114|585495205|FG001|Main Treatment Period|Physician Decision|0|||
162121145|NCT04534114|585495206|FG002|Main Treatment Period|Physician Decision|0|||
162121146|NCT04534114|585495207|FG003|Main Treatment Period|Physician Decision|1|||
162121147|NCT04534114|585495204|FG000|Main Treatment Period|Death|1|||
162121148|NCT04534114|585495205|FG001|Main Treatment Period|Death|0|||
162121149|NCT04534114|585495206|FG002|Main Treatment Period|Death|0|||
162121150|NCT04534114|585495207|FG003|Main Treatment Period|Death|1|||
162121151|NCT04534114|585495204|FG000|Main Treatment Period|Other reason|1|||
162121152|NCT04534114|585495205|FG001|Main Treatment Period|Other reason|1|||
162121153|NCT04534114|585495206|FG002|Main Treatment Period|Other reason|0|||
162121154|NCT04534114|585495207|FG003|Main Treatment Period|Other reason|0|||
162121155|NCT04534114|585495204|FG000|Main Treatment Period|Participant decision|1|||
162121156|NCT04534114|585495205|FG001|Main Treatment Period|Participant decision|3|||
162121157|NCT04534114|585495206|FG002|Main Treatment Period|Participant decision|3|||
162121158|NCT04534114|585495207|FG003|Main Treatment Period|Participant decision|1|||
162121159|NCT04534114|585495204|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
162121160|NCT04534114|585495205|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
162121161|NCT04534114|585495206|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
162121162|NCT04534114|585495207|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
162121163|NCT04534114|585495204|FG000|Main Treatment Period|Adverse Event|4|||
162121164|NCT04534114|585495205|FG001|Main Treatment Period|Adverse Event|2|||
162121165|NCT04534114|585495206|FG002|Main Treatment Period|Adverse Event|1|||
162121166|NCT04534114|585495207|FG003|Main Treatment Period|Adverse Event|2|||
162121167|NCT04534114|585495204|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
162121168|NCT04534114|585495205|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
162121169|NCT04534114|585495206|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
162121170|NCT04534114|585495207|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
162121171|NCT04534114|585495204|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
162121172|NCT04534114|585495205|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
162121173|NCT04534114|585495206|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
162121174|NCT04534114|585495207|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
162121175|NCT04534114|585495204|FG000|Extension Treatment Period|Other reason|0|||
162121176|NCT04534114|585495205|FG001|Extension Treatment Period|Other reason|1|||
162121177|NCT04534114|585495206|FG002|Extension Treatment Period|Other reason|0|||
162121178|NCT04534114|585495207|FG003|Extension Treatment Period|Other reason|0|||
162121179|NCT04534114|585495204|FG000|Extension Treatment Period|Death|0|||
162121180|NCT04534114|585495205|FG001|Extension Treatment Period|Death|0|||
162121181|NCT04534114|585495206|FG002|Extension Treatment Period|Death|1|||
162121182|NCT04534114|585495207|FG003|Extension Treatment Period|Death|2|||
162121183|NCT04534114|585495204|FG000|Extension Treatment Period|Adverse Event|0|||
162121184|NCT04534114|585495205|FG001|Extension Treatment Period|Adverse Event|1|||
162121185|NCT04534114|585495206|FG002|Extension Treatment Period|Adverse Event|0|||
162121186|NCT04534114|585495207|FG003|Extension Treatment Period|Adverse Event|1|||
162121187|NCT04534114|585495204|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
162121188|NCT04534114|585495205|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
162121189|NCT04534114|585495206|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
162121190|NCT04534114|585495207|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
162121191|NCT02759185|585495208|FG000|Stage 1|Adverse Event|0|||
162121192|NCT02759185|585495209|FG001|Stage 1|Adverse Event|1|||
162121193|NCT02759185|585495210|FG002|Stage 1|Adverse Event|3|||
162121194|NCT02759185|585495211|FG003|Stage 1|Adverse Event|0|||
162121195|NCT02759185|585495212|FG004|Stage 1|Adverse Event|0|||
162121196|NCT02759185|585495213|FG005|Stage 1|Adverse Event|0|||
162121197|NCT02759185|585495214|FG006|Stage 1|Adverse Event|0|||
162121198|NCT02759185|585495208|FG000|Stage 1|Withdrawal by Subject|1|||
162121199|NCT02759185|585495209|FG001|Stage 1|Withdrawal by Subject|0|||
162121200|NCT02759185|585495210|FG002|Stage 1|Withdrawal by Subject|0|||
162121201|NCT02759185|585495211|FG003|Stage 1|Withdrawal by Subject|0|||
162121202|NCT02759185|585495212|FG004|Stage 1|Withdrawal by Subject|0|||
162121203|NCT02759185|585495213|FG005|Stage 1|Withdrawal by Subject|0|||
162121204|NCT02759185|585495214|FG006|Stage 1|Withdrawal by Subject|0|||
162121205|NCT02759185|585495208|FG000|Stage 2|Adverse Event|0|||
162121206|NCT02759185|585495209|FG001|Stage 2|Adverse Event|0|||
162121207|NCT02759185|585495210|FG002|Stage 2|Adverse Event|0|||
162121208|NCT02759185|585495211|FG003|Stage 2|Adverse Event|0|||
162121209|NCT02759185|585495212|FG004|Stage 2|Adverse Event|1|||
162121210|NCT02759185|585495213|FG005|Stage 2|Adverse Event|2|||
162121211|NCT02759185|585495214|FG006|Stage 2|Adverse Event|0|||
162121212|NCT02759185|585495208|FG000|Stage 2|Withdrawal by Subject|0|||
162121213|NCT02759185|585495209|FG001|Stage 2|Withdrawal by Subject|0|||
162121214|NCT02759185|585495210|FG002|Stage 2|Withdrawal by Subject|0|||
162121215|NCT02759185|585495211|FG003|Stage 2|Withdrawal by Subject|0|||
162121216|NCT02759185|585495212|FG004|Stage 2|Withdrawal by Subject|1|||
162121217|NCT02759185|585495213|FG005|Stage 2|Withdrawal by Subject|1|||
162121218|NCT02759185|585495214|FG006|Stage 2|Withdrawal by Subject|1|||
162121219|NCT00962247|585495221|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
162121220|NCT00962247|585495221|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
162121221|NCT01709305|585495224|FG000|Phase 1|Clinical Adverse Event|80|||
162121222|NCT01709305|585495225|FG001|Phase 1|Clinical Adverse Event|0|||
162121223|NCT01709305|585495226|FG002|Phase 1|Clinical Adverse Event|0|||
162121224|NCT01709305|585495227|FG003|Phase 1|Clinical Adverse Event|0|||
162121225|NCT01709305|585495228|FG004|Phase 1|Clinical Adverse Event|0|||
162121226|NCT01709305|585495224|FG000|Phase 1|Death|2|||
162121227|NCT01709305|585495225|FG001|Phase 1|Death|0|||
162121228|NCT01709305|585495226|FG002|Phase 1|Death|0|||
162121229|NCT01709305|585495227|FG003|Phase 1|Death|0|||
162121230|NCT01709305|585495228|FG004|Phase 1|Death|0|||
162121231|NCT01709305|585495224|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
162121232|NCT01709305|585495225|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
162121233|NCT01709305|585495226|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
162121234|NCT01709305|585495227|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
162121235|NCT01709305|585495228|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
162121236|NCT01709305|585495224|FG000|Phase 1|Laboratory Adverse Event|16|||
162121237|NCT01709305|585495225|FG001|Phase 1|Laboratory Adverse Event|0|||
162121238|NCT01709305|585495226|FG002|Phase 1|Laboratory Adverse Event|0|||
162121239|NCT01709305|585495227|FG003|Phase 1|Laboratory Adverse Event|0|||
162121240|NCT01709305|585495228|FG004|Phase 1|Laboratory Adverse Event|0|||
162121241|NCT01709305|585495224|FG000|Phase 1|Lost to Follow-up|147|||
162121242|NCT01709305|585495225|FG001|Phase 1|Lost to Follow-up|0|||
162121243|NCT01709305|585495226|FG002|Phase 1|Lost to Follow-up|0|||
162121244|NCT01709305|585495227|FG003|Phase 1|Lost to Follow-up|0|||
162121245|NCT01709305|585495228|FG004|Phase 1|Lost to Follow-up|0|||
162121246|NCT01709305|585495224|FG000|Phase 1|Travel, moving, etc.|30|||
162121247|NCT01709305|585495225|FG001|Phase 1|Travel, moving, etc.|0|||
162121248|NCT01709305|585495226|FG002|Phase 1|Travel, moving, etc.|0|||
162121249|NCT01709305|585495227|FG003|Phase 1|Travel, moving, etc.|0|||
162121250|NCT01709305|585495228|FG004|Phase 1|Travel, moving, etc.|0|||
162121251|NCT01709305|585495224|FG000|Phase 1|Physician Decision|13|||
162121252|NCT01709305|585495225|FG001|Phase 1|Physician Decision|0|||
162121253|NCT01709305|585495226|FG002|Phase 1|Physician Decision|0|||
162121254|NCT01709305|585495227|FG003|Phase 1|Physician Decision|0|||
162121255|NCT01709305|585495228|FG004|Phase 1|Physician Decision|0|||
162121256|NCT01709305|585495224|FG000|Phase 1|Protocol Violation|118|||
162121257|NCT01709305|585495225|FG001|Phase 1|Protocol Violation|0|||
162121258|NCT01709305|585495226|FG002|Phase 1|Protocol Violation|0|||
162121259|NCT01709305|585495227|FG003|Phase 1|Protocol Violation|0|||
162121260|NCT01709305|585495228|FG004|Phase 1|Protocol Violation|0|||
162121261|NCT01709305|585495224|FG000|Phase 1|Withdrawal by Subject|218|||
162121262|NCT01709305|585495225|FG001|Phase 1|Withdrawal by Subject|0|||
162121263|NCT01709305|585495226|FG002|Phase 1|Withdrawal by Subject|0|||
162121264|NCT01709305|585495227|FG003|Phase 1|Withdrawal by Subject|0|||
162121265|NCT01709305|585495228|FG004|Phase 1|Withdrawal by Subject|0|||
162121266|NCT01709305|585495224|FG000|Phase 2|Clinical Adverse Event|0|||
162121267|NCT01709305|585495225|FG001|Phase 2|Clinical Adverse Event|10|||
162121268|NCT01709305|585495226|FG002|Phase 2|Clinical Adverse Event|10|||
162121269|NCT01709305|585495227|FG003|Phase 2|Clinical Adverse Event|6|||
162121270|NCT01709305|585495228|FG004|Phase 2|Clinical Adverse Event|11|||
162121271|NCT01709305|585495224|FG000|Phase 2|Death|0|||
162121272|NCT01709305|585495225|FG001|Phase 2|Death|0|||
162121273|NCT01709305|585495226|FG002|Phase 2|Death|1|||
162121274|NCT01709305|585495227|FG003|Phase 2|Death|0|||
162121275|NCT01709305|585495228|FG004|Phase 2|Death|0|||
162121276|NCT01709305|585495224|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
162121277|NCT01709305|585495225|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
162121278|NCT01709305|585495226|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
162121279|NCT01709305|585495227|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
162121280|NCT01709305|585495228|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
162121281|NCT01709305|585495224|FG000|Phase 2|Laboratory Adverse Event|0|||
162121282|NCT01709305|585495225|FG001|Phase 2|Laboratory Adverse Event|1|||
162121283|NCT01709305|585495226|FG002|Phase 2|Laboratory Adverse Event|0|||
162121284|NCT01709305|585495227|FG003|Phase 2|Laboratory Adverse Event|1|||
162121285|NCT01709305|585495228|FG004|Phase 2|Laboratory Adverse Event|1|||
162121286|NCT01709305|585495224|FG000|Phase 2|Lost to Follow-up|0|||
162121287|NCT01709305|585495225|FG001|Phase 2|Lost to Follow-up|10|||
162121288|NCT01709305|585495226|FG002|Phase 2|Lost to Follow-up|6|||
162121289|NCT01709305|585495227|FG003|Phase 2|Lost to Follow-up|9|||
162121290|NCT01709305|585495228|FG004|Phase 2|Lost to Follow-up|5|||
162121291|NCT01709305|585495224|FG000|Phase 2|Travel, moving, etc.|0|||
162121292|NCT01709305|585495225|FG001|Phase 2|Travel, moving, etc.|2|||
162121293|NCT01709305|585495226|FG002|Phase 2|Travel, moving, etc.|3|||
162121294|NCT01709305|585495227|FG003|Phase 2|Travel, moving, etc.|3|||
162121295|NCT01709305|585495228|FG004|Phase 2|Travel, moving, etc.|5|||
162121296|NCT01709305|585495224|FG000|Phase 2|Physician Decision|0|||
162121297|NCT01709305|585495225|FG001|Phase 2|Physician Decision|2|||
162121298|NCT01709305|585495226|FG002|Phase 2|Physician Decision|0|||
162121299|NCT01709305|585495227|FG003|Phase 2|Physician Decision|1|||
162121300|NCT01709305|585495228|FG004|Phase 2|Physician Decision|2|||
162121301|NCT01709305|585495224|FG000|Phase 2|Protocol Violation|0|||
162121302|NCT01709305|585495225|FG001|Phase 2|Protocol Violation|19|||
162121303|NCT01709305|585495226|FG002|Phase 2|Protocol Violation|19|||
162121304|NCT01709305|585495227|FG003|Phase 2|Protocol Violation|13|||
162121305|NCT01709305|585495228|FG004|Phase 2|Protocol Violation|9|||
162121306|NCT01709305|585495224|FG000|Phase 2|Withdrawal by Subject|0|||
162121307|NCT01709305|585495225|FG001|Phase 2|Withdrawal by Subject|8|||
162121308|NCT01709305|585495226|FG002|Phase 2|Withdrawal by Subject|6|||
162121309|NCT01709305|585495227|FG003|Phase 2|Withdrawal by Subject|15|||
162121310|NCT01709305|585495228|FG004|Phase 2|Withdrawal by Subject|12|||
162121311|NCT03443713|585495229|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
162121312|NCT03443713|585495230|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
162121313|NCT03443713|585495231|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
162121314|NCT01672853|585495232|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
162121315|NCT01672853|585495233|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
162121316|NCT01672853|585495234|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
162121317|NCT01672853|585495232|FG000|Overall Study|Pregnancy|0|||
162121318|NCT01672853|585495233|FG001|Overall Study|Pregnancy|1|||
162121319|NCT01672853|585495234|FG002|Overall Study|Pregnancy|0|||
162121320|NCT01672853|585495232|FG000|Overall Study|Investigator's Discretion|1|||
162121321|NCT01672853|585495233|FG001|Overall Study|Investigator's Discretion|0|||
162121322|NCT01672853|585495234|FG002|Overall Study|Investigator's Discretion|0|||
162121323|NCT01672853|585495232|FG000|Overall Study|Withdrew Consent|5|||
162121324|NCT01672853|585495233|FG001|Overall Study|Withdrew Consent|5|||
162121325|NCT01672853|585495234|FG002|Overall Study|Withdrew Consent|5|||
162121326|NCT01672853|585495232|FG000|Overall Study|Adverse Event|4|||
162121327|NCT01672853|585495233|FG001|Overall Study|Adverse Event|6|||
162121328|NCT01672853|585495234|FG002|Overall Study|Adverse Event|8|||
162121329|NCT01672853|585495232|FG000|Overall Study|Lost to Follow-up|0|||
162121330|NCT01672853|585495233|FG001|Overall Study|Lost to Follow-up|1|||
162121331|NCT01672853|585495234|FG002|Overall Study|Lost to Follow-up|0|||
162121332|NCT01672853|585495232|FG000|Overall Study|Randomized but Never Treated|0|||
162121333|NCT01672853|585495233|FG001|Overall Study|Randomized but Never Treated|0|||
162121334|NCT01672853|585495234|FG002|Overall Study|Randomized but Never Treated|1|||
162121335|NCT00118898|585495235|FG000|Overall Study|Death|6|||
162121336|NCT00118898|585495236|FG001|Overall Study|Death|11|||
162121337|NCT00118898|585495237|FG002|Overall Study|Death|6|||
162121338|NCT00118898|585495238|FG003|Overall Study|Death|8|||
162121339|NCT00118898|585495235|FG000|Overall Study|Lost to Follow-up|26|||
162121340|NCT00118898|585495236|FG001|Overall Study|Lost to Follow-up|34|||
162121341|NCT00118898|585495237|FG002|Overall Study|Lost to Follow-up|33|||
162121342|NCT00118898|585495238|FG003|Overall Study|Lost to Follow-up|33|||
162121343|NCT00118898|585495235|FG000|Overall Study|Withdrawal by Subject|10|||
162121344|NCT00118898|585495236|FG001|Overall Study|Withdrawal by Subject|5|||
162121345|NCT00118898|585495237|FG002|Overall Study|Withdrawal by Subject|8|||
162121346|NCT00118898|585495238|FG003|Overall Study|Withdrawal by Subject|8|||
162121347|NCT00118898|585495235|FG000|Overall Study|Site Closure|33|||
162121348|NCT00118898|585495236|FG001|Overall Study|Site Closure|31|||
162121349|NCT00118898|585495237|FG002|Overall Study|Site Closure|28|||
162121350|NCT00118898|585495238|FG003|Overall Study|Site Closure|37|||
162121351|NCT00118898|585495235|FG000|Overall Study|Severe debilitation|1|||
162121352|NCT00118898|585495236|FG001|Overall Study|Severe debilitation|4|||
162121353|NCT00118898|585495237|FG002|Overall Study|Severe debilitation|6|||
162121354|NCT00118898|585495238|FG003|Overall Study|Severe debilitation|4|||
162121355|NCT00118898|585495235|FG000|Overall Study|Not compliant with requirements|11|||
162121356|NCT00118898|585495236|FG001|Overall Study|Not compliant with requirements|13|||
162121357|NCT00118898|585495237|FG002|Overall Study|Not compliant with requirements|11|||
162121358|NCT00118898|585495238|FG003|Overall Study|Not compliant with requirements|11|||
162121359|NCT00118898|585495235|FG000|Overall Study|Not able to get to clinic|34|||
162121360|NCT00118898|585495236|FG001|Overall Study|Not able to get to clinic|43|||
162121361|NCT00118898|585495237|FG002|Overall Study|Not able to get to clinic|31|||
162121362|NCT00118898|585495238|FG003|Overall Study|Not able to get to clinic|40|||
162121363|NCT02714205|585495241|FG000|Overall Study|Cannot tolerate medication|1|||
162121364|NCT02714205|585495242|FG001|Overall Study|Cannot tolerate medication|0|||
162121365|NCT02714205|585495241|FG000|Overall Study|Adverse Event|2|||
162121366|NCT02714205|585495242|FG001|Overall Study|Adverse Event|0|||
162121367|NCT02714205|585495241|FG000|Overall Study|Too busy|1|||
162121368|NCT02714205|585495242|FG001|Overall Study|Too busy|0|||
162121369|NCT02714205|585495241|FG000|Overall Study|Incomplete outcome data|0|||
162121370|NCT02714205|585495242|FG001|Overall Study|Incomplete outcome data|1|||
162121371|NCT02073097|585495243|FG000|Overall Study|Adverse Event|0|||
162121372|NCT02073097|585495244|FG001|Overall Study|Adverse Event|0|||
162121373|NCT02073097|585495245|FG002|Overall Study|Adverse Event|0|||
162121374|NCT02073097|585495246|FG003|Overall Study|Adverse Event|0|||
162121375|NCT02073097|585495247|FG004|Overall Study|Adverse Event|0|||
162121376|NCT02073097|585495248|FG005|Overall Study|Adverse Event|0|||
162121377|NCT02073097|585495249|FG006|Overall Study|Adverse Event|0|||
162121378|NCT02073097|585495250|FG007|Overall Study|Adverse Event|2|||
162121379|NCT02073097|585495243|FG000|Overall Study|Withdrawal by Subject|0|||
162121380|NCT02073097|585495244|FG001|Overall Study|Withdrawal by Subject|0|||
162121381|NCT02073097|585495245|FG002|Overall Study|Withdrawal by Subject|0|||
162121382|NCT02073097|585495246|FG003|Overall Study|Withdrawal by Subject|0|||
162121383|NCT02073097|585495247|FG004|Overall Study|Withdrawal by Subject|0|||
162121384|NCT02073097|585495248|FG005|Overall Study|Withdrawal by Subject|0|||
162121385|NCT02073097|585495249|FG006|Overall Study|Withdrawal by Subject|0|||
162121386|NCT02073097|585495250|FG007|Overall Study|Withdrawal by Subject|2|||
162121387|NCT02073097|585495243|FG000|Overall Study|Death|0|||
162121388|NCT02073097|585495244|FG001|Overall Study|Death|0|||
162121389|NCT02073097|585495245|FG002|Overall Study|Death|0|||
162121390|NCT02073097|585495246|FG003|Overall Study|Death|0|||
162121391|NCT02073097|585495247|FG004|Overall Study|Death|0|||
162121392|NCT02073097|585495248|FG005|Overall Study|Death|0|||
162121393|NCT02073097|585495249|FG006|Overall Study|Death|0|||
162121394|NCT02073097|585495250|FG007|Overall Study|Death|1|||
162121395|NCT02073097|585495243|FG000|Overall Study|Physician Decision|0|||
162121396|NCT02073097|585495244|FG001|Overall Study|Physician Decision|0|||
162121397|NCT02073097|585495245|FG002|Overall Study|Physician Decision|0|||
162121398|NCT02073097|585495246|FG003|Overall Study|Physician Decision|0|||
162121399|NCT02073097|585495247|FG004|Overall Study|Physician Decision|0|||
162121400|NCT02073097|585495248|FG005|Overall Study|Physician Decision|0|||
162121401|NCT02073097|585495249|FG006|Overall Study|Physician Decision|0|||
162121402|NCT02073097|585495250|FG007|Overall Study|Physician Decision|1|||
162121403|NCT03813147|585495253|FG000|Overall Study|Lack of Efficacy|4|||
162121404|NCT03813147|585495254|FG001|Overall Study|Lack of Efficacy|4|||
162121405|NCT03813147|585495253|FG000|Overall Study|Physician Decision|2|||
162121406|NCT03813147|585495254|FG001|Overall Study|Physician Decision|1|||
162121407|NCT01693692|585495255|FG000|Overall Study|Withdrawal by Subject|12|||
162121408|NCT01693692|585495256|FG001|Overall Study|Withdrawal by Subject|10|||
162121409|NCT01693692|585495257|FG002|Overall Study|Withdrawal by Subject|11|||
162121410|NCT01693692|585495255|FG000|Overall Study|Adverse Event|7|||
162121411|NCT01693692|585495256|FG001|Overall Study|Adverse Event|14|||
162121412|NCT01693692|585495257|FG002|Overall Study|Adverse Event|9|||
162121413|NCT01693692|585495255|FG000|Overall Study|Physician Decision|0|||
162121414|NCT01693692|585495256|FG001|Overall Study|Physician Decision|0|||
162121415|NCT01693692|585495257|FG002|Overall Study|Physician Decision|1|||
162121416|NCT01693692|585495255|FG000|Overall Study|Protocol Violation|5|||
162121417|NCT01693692|585495256|FG001|Overall Study|Protocol Violation|4|||
162121418|NCT01693692|585495257|FG002|Overall Study|Protocol Violation|6|||
162121419|NCT01693692|585495255|FG000|Overall Study|Lost to Follow-up|2|||
162121420|NCT01693692|585495256|FG001|Overall Study|Lost to Follow-up|2|||
162121421|NCT01693692|585495257|FG002|Overall Study|Lost to Follow-up|3|||
162121422|NCT01693692|585495255|FG000|Overall Study|Other|4|||
162121423|NCT01693692|585495256|FG001|Overall Study|Other|4|||
162121424|NCT01693692|585495257|FG002|Overall Study|Other|6|||
162121425|NCT04424290|585497042|FG000|Overall Study|Not treated|0|||
162121426|NCT04424290|585497043|FG001|Overall Study|Not treated|0|||
162121427|NCT04424290|585497044|FG002|Overall Study|Not treated|1|||
162121428|NCT04424290|585497045|FG003|Overall Study|Not treated|0|||
162121429|NCT04424290|585497046|FG004|Overall Study|Not treated|1|||
162121430|NCT04424290|585497042|FG000|Overall Study|Adverse Event|0|||
162121431|NCT04424290|585497043|FG001|Overall Study|Adverse Event|0|||
162121432|NCT04424290|585497044|FG002|Overall Study|Adverse Event|0|||
162121433|NCT04424290|585497045|FG003|Overall Study|Adverse Event|2|||
162121434|NCT04424290|585497046|FG004|Overall Study|Adverse Event|0|||
162121435|NCT04424290|585497042|FG000|Overall Study|Withdrawal by Subject|0|||
162121436|NCT04424290|585497043|FG001|Overall Study|Withdrawal by Subject|0|||
162121437|NCT04424290|585497044|FG002|Overall Study|Withdrawal by Subject|0|||
162121438|NCT04424290|585497045|FG003|Overall Study|Withdrawal by Subject|0|||
162121439|NCT04424290|585497046|FG004|Overall Study|Withdrawal by Subject|1|||
162121440|NCT04424290|585497042|FG000|Overall Study|Other than listed|0|||
162121441|NCT04424290|585497043|FG001|Overall Study|Other than listed|0|||
162121442|NCT04424290|585497044|FG002|Overall Study|Other than listed|0|||
162121443|NCT04424290|585497045|FG003|Overall Study|Other than listed|1|||
162121444|NCT04424290|585497046|FG004|Overall Study|Other than listed|0|||
162121445|NCT02914184|585497050|FG000|Overall Study|Lost to Follow-up|7|||
162121446|NCT02914184|585497051|FG001|Overall Study|Lost to Follow-up|10|||
162121447|NCT02914184|585497052|FG002|Overall Study|Lost to Follow-up|8|||
162121448|NCT02914184|585497053|FG003|Overall Study|Lost to Follow-up|7|||
162121449|NCT02914184|585497050|FG000|Overall Study|Withdrawal by Subject|4|||
162121450|NCT02914184|585497051|FG001|Overall Study|Withdrawal by Subject|2|||
162121451|NCT02914184|585497052|FG002|Overall Study|Withdrawal by Subject|7|||
162121452|NCT02914184|585497053|FG003|Overall Study|Withdrawal by Subject|3|||
162121453|NCT02914184|585497050|FG000|Overall Study|Other|1|||
162121454|NCT02914184|585497051|FG001|Overall Study|Other|0|||
162121455|NCT02914184|585497052|FG002|Overall Study|Other|0|||
162121456|NCT02914184|585497053|FG003|Overall Study|Other|0|||
162121457|NCT02914184|585497050|FG000|Overall Study|Migrated/moved from the study area|2|||
162121458|NCT02914184|585497051|FG001|Overall Study|Migrated/moved from the study area|1|||
162121459|NCT02914184|585497052|FG002|Overall Study|Migrated/moved from the study area|2|||
162121460|NCT02914184|585497053|FG003|Overall Study|Migrated/moved from the study area|1|||
162121461|NCT00798174|585497054|FG000|Overall Study|inability to implant azygos coil|3|||
162121462|NCT00798174|585497055|FG001|Overall Study|inability to implant azygos coil|3|||
162121463|NCT00798174|585497054|FG000|Overall Study|Inability to sedate for DFT testing|1|||
162121464|NCT00798174|585497055|FG001|Overall Study|Inability to sedate for DFT testing|0|||
162121465|NCT01683994|585497057|FG000|Overall Study|Withdrawal by Subject|1|||
162121466|NCT01683994|585497058|FG001|Overall Study|Withdrawal by Subject|0|||
162121467|NCT01683994|585497059|FG002|Overall Study|Withdrawal by Subject|0|||
162121468|NCT01683994|585497060|FG003|Overall Study|Withdrawal by Subject|1|||
162121469|NCT01683994|585497061|FG004|Overall Study|Withdrawal by Subject|0|||
162121470|NCT01683994|585497057|FG000|Overall Study|Intercurrent illness|0|||
162121471|NCT01683994|585497058|FG001|Overall Study|Intercurrent illness|0|||
162121472|NCT01683994|585497059|FG002|Overall Study|Intercurrent illness|0|||
162121473|NCT01683994|585497060|FG003|Overall Study|Intercurrent illness|2|||
162121474|NCT01683994|585497061|FG004|Overall Study|Intercurrent illness|1|||
162121475|NCT02318719|585497067|FG000|Double-blind Phase|Adverse Event|7|||
162121476|NCT02318719|585497068|FG001|Double-blind Phase|Adverse Event|6|||
162121477|NCT02318719|585497069|FG002|Double-blind Phase|Adverse Event|12|||
162121478|NCT02318719|585497070|FG003|Double-blind Phase|Adverse Event|4|||
162121479|NCT02318719|585497071|FG004|Double-blind Phase|Adverse Event|0|||
162121480|NCT02318719|585497067|FG000|Double-blind Phase|Lack of Efficacy|5|||
162121481|NCT02318719|585497068|FG001|Double-blind Phase|Lack of Efficacy|0|||
162121482|NCT02318719|585497069|FG002|Double-blind Phase|Lack of Efficacy|1|||
162121483|NCT02318719|585497070|FG003|Double-blind Phase|Lack of Efficacy|1|||
162121484|NCT02318719|585497071|FG004|Double-blind Phase|Lack of Efficacy|0|||
162121485|NCT02318719|585497067|FG000|Double-blind Phase|Protocol Violation|0|||
162121486|NCT02318719|585497068|FG001|Double-blind Phase|Protocol Violation|1|||
162121487|NCT02318719|585497069|FG002|Double-blind Phase|Protocol Violation|3|||
162121488|NCT02318719|585497070|FG003|Double-blind Phase|Protocol Violation|0|||
162121489|NCT02318719|585497071|FG004|Double-blind Phase|Protocol Violation|0|||
162121490|NCT02318719|585497067|FG000|Double-blind Phase|Withdrawal by Subject|25|||
162121491|NCT02318719|585497068|FG001|Double-blind Phase|Withdrawal by Subject|7|||
162121492|NCT02318719|585497069|FG002|Double-blind Phase|Withdrawal by Subject|9|||
162121493|NCT02318719|585497070|FG003|Double-blind Phase|Withdrawal by Subject|10|||
162121494|NCT02318719|585497071|FG004|Double-blind Phase|Withdrawal by Subject|0|||
162121495|NCT02318719|585497067|FG000|Double-blind Phase|Other|1|||
162121496|NCT02318719|585497068|FG001|Double-blind Phase|Other|2|||
162121497|NCT02318719|585497069|FG002|Double-blind Phase|Other|0|||
162121498|NCT02318719|585497070|FG003|Double-blind Phase|Other|0|||
162121499|NCT02318719|585497071|FG004|Double-blind Phase|Other|0|||
162121500|NCT02318719|585497067|FG000|Open-label Extension Phase|Adverse Event|0|||
162121501|NCT02318719|585497068|FG001|Open-label Extension Phase|Adverse Event|0|||
162121502|NCT02318719|585497069|FG002|Open-label Extension Phase|Adverse Event|0|||
162121503|NCT02318719|585497070|FG003|Open-label Extension Phase|Adverse Event|0|||
162121504|NCT02318719|585497071|FG004|Open-label Extension Phase|Adverse Event|15|||
162121505|NCT02318719|585497067|FG000|Open-label Extension Phase|Death|0|||
162121506|NCT02318719|585497068|FG001|Open-label Extension Phase|Death|0|||
162121507|NCT02318719|585497069|FG002|Open-label Extension Phase|Death|0|||
162121508|NCT02318719|585497070|FG003|Open-label Extension Phase|Death|0|||
162121509|NCT02318719|585497071|FG004|Open-label Extension Phase|Death|1|||
162121510|NCT02318719|585497067|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
162121511|NCT02318719|585497068|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
162121512|NCT02318719|585497069|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
162121513|NCT02318719|585497070|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
162121514|NCT02318719|585497071|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
162121515|NCT02318719|585497067|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
162121516|NCT02318719|585497068|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
162121517|NCT02318719|585497069|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
162121518|NCT02318719|585497070|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
162121519|NCT02318719|585497071|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
162121520|NCT02318719|585497067|FG000|Open-label Extension Phase|Other|0|||
162121521|NCT02318719|585497068|FG001|Open-label Extension Phase|Other|0|||
162121522|NCT02318719|585497069|FG002|Open-label Extension Phase|Other|0|||
162121523|NCT02318719|585497070|FG003|Open-label Extension Phase|Other|0|||
162121524|NCT02318719|585497071|FG004|Open-label Extension Phase|Other|7|||
162121525|NCT00802659|585497072|FG000|Overall Study|Physician Decision|0|||
162121526|NCT00802659|585497073|FG001|Overall Study|Physician Decision|1|||
162121527|NCT00802659|585497074|FG002|Overall Study|Physician Decision|0|||
162121528|NCT00802659|585497075|FG003|Overall Study|Physician Decision|0|||
162121529|NCT00806624|585497076|FG000|Overall Study|Adverse Event|2|||
162121530|NCT00806624|585497077|FG001|Overall Study|Adverse Event|8|||
162121531|NCT00806624|585497078|FG002|Overall Study|Adverse Event|0|||
162121532|NCT00806624|585497076|FG000|Overall Study|Death|0|||
162121533|NCT00806624|585497077|FG001|Overall Study|Death|1|||
162121534|NCT00806624|585497078|FG002|Overall Study|Death|1|||
162121535|NCT00806624|585497076|FG000|Overall Study|Lost to Follow-up|1|||
162121536|NCT00806624|585497077|FG001|Overall Study|Lost to Follow-up|0|||
162121537|NCT00806624|585497078|FG002|Overall Study|Lost to Follow-up|1|||
162121538|NCT00806624|585497076|FG000|Overall Study|Withdrawal by Subject|6|||
162121539|NCT00806624|585497077|FG001|Overall Study|Withdrawal by Subject|3|||
162121540|NCT00806624|585497078|FG002|Overall Study|Withdrawal by Subject|3|||
162121541|NCT00806624|585497076|FG000|Overall Study|discontinued before start of treatment|0|||
162121542|NCT00806624|585497077|FG001|Overall Study|discontinued before start of treatment|0|||
162121543|NCT00806624|585497078|FG002|Overall Study|discontinued before start of treatment|1|||
162121544|NCT03093428|585497079|FG000|Overall Study|Not eligible for treatment|2|||
162121545|NCT03093428|585497080|FG001|Overall Study|Not eligible for treatment|1|||
162121546|NCT03093428|585497079|FG000|Overall Study|Progression|14|||
162121547|NCT03093428|585497080|FG001|Overall Study|Progression|4|||
162121548|NCT03093428|585497079|FG000|Overall Study|Death|1|||
162121549|NCT03093428|585497080|FG001|Overall Study|Death|0|||
162121550|NCT03093428|585497079|FG000|Overall Study|Adverse Event|1|||
162121551|NCT03093428|585497080|FG001|Overall Study|Adverse Event|0|||
162121552|NCT03093428|585497079|FG000|Overall Study|Withdrawal by Subject|1|||
162121553|NCT03093428|585497080|FG001|Overall Study|Withdrawal by Subject|1|||
162121554|NCT01336634|585497084|FG000|Overall Study|Study closed/terminated|5|||
162121555|NCT01336634|585497085|FG001|Overall Study|Study closed/terminated|6|||
162121556|NCT01336634|585497086|FG002|Overall Study|Study closed/terminated|6|||
162121557|NCT01336634|585497084|FG000|Overall Study|Lost to Follow-up|2|||
162121558|NCT01336634|585497085|FG001|Overall Study|Lost to Follow-up|1|||
162121559|NCT01336634|585497086|FG002|Overall Study|Lost to Follow-up|1|||
162121560|NCT01336634|585497084|FG000|Overall Study|Physician Decision|1|||
162121561|NCT01336634|585497085|FG001|Overall Study|Physician Decision|1|||
162121562|NCT01336634|585497086|FG002|Overall Study|Physician Decision|0|||
162121563|NCT01336634|585497084|FG000|Overall Study|Withdrawal by Subject|6|||
162121564|NCT01336634|585497085|FG001|Overall Study|Withdrawal by Subject|0|||
162121565|NCT01336634|585497086|FG002|Overall Study|Withdrawal by Subject|2|||
162121566|NCT01973491|585497087|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
162121567|NCT01973491|585497087|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
162121568|NCT01973491|585497087|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
162121569|NCT01863043|585497091|FG000|Overall Study|Death|6|||
162121570|NCT01863043|585497092|FG001|Overall Study|Death|1|||
162121571|NCT01863043|585497091|FG000|Overall Study|Withdrawal by Subject|0|||
162121572|NCT01863043|585497092|FG001|Overall Study|Withdrawal by Subject|2|||
162121573|NCT01863043|585497091|FG000|Overall Study|Adverse Event|7|||
162121574|NCT01863043|585497092|FG001|Overall Study|Adverse Event|8|||
162121575|NCT01863043|585497091|FG000|Overall Study|exclusion criteria found after enrollment|0|||
162121576|NCT01863043|585497092|FG001|Overall Study|exclusion criteria found after enrollment|1|||
162121577|NCT00313911|585497093|FG000|Overall Study|Serious adverse event|6|||
162121578|NCT00313911|585497094|FG001|Overall Study|Serious adverse event|1|||
162121579|NCT00313911|585497093|FG000|Overall Study|Adverse Event|2|||
162121580|NCT00313911|585497094|FG001|Overall Study|Adverse Event|3|||
162121581|NCT00313911|585497093|FG000|Overall Study|Protocol Violation|19|||
162121582|NCT00313911|585497094|FG001|Overall Study|Protocol Violation|10|||
162121583|NCT00313911|585497093|FG000|Overall Study|Lost to Follow-up|27|||
162121584|NCT00313911|585497094|FG001|Overall Study|Lost to Follow-up|14|||
162121585|NCT00313911|585497093|FG000|Overall Study|Withdrawal by Subject|39|||
162121586|NCT00313911|585497094|FG001|Overall Study|Withdrawal by Subject|12|||
162121587|NCT00313911|585497093|FG000|Overall Study|Did not meet age criteria|1|||
162121588|NCT00313911|585497094|FG001|Overall Study|Did not meet age criteria|1|||
162121589|NCT01987596|585497095|FG000|Overall Study|Physician Decision|1|||
162121590|NCT01987596|585497096|FG001|Overall Study|Physician Decision|0|||
162121591|NCT01987596|585497095|FG000|Overall Study|Progressive Disease; missing all period|0|||
162121592|NCT01987596|585497096|FG001|Overall Study|Progressive Disease; missing all period|1|||
162121593|NCT02632786|585497097|FG000|Overall Study|Adverse Event|2|||
162121594|NCT02632786|585497098|FG001|Overall Study|Adverse Event|1|||
162121595|NCT02632786|585497097|FG000|Overall Study|Death|3|||
162121596|NCT02632786|585497098|FG001|Overall Study|Death|2|||
162121597|NCT02632786|585497097|FG000|Overall Study|Physician Decision|5|||
162121598|NCT02632786|585497098|FG001|Overall Study|Physician Decision|4|||
162121599|NCT02632786|585497097|FG000|Overall Study|Withdrawal by Subject|1|||
162121600|NCT02632786|585497098|FG001|Overall Study|Withdrawal by Subject|0|||
162121601|NCT00709592|585497099|FG000|Overall Study|Unable to proceed to transplant|0|||
162121602|NCT00709592|585497100|FG001|Overall Study|Unable to proceed to transplant|1|||
162121603|NCT00451217|585497101|FG000|Overall Study|Lost to Follow-up|0|||
162121604|NCT00451217|585497102|FG001|Overall Study|Lost to Follow-up|1|||
162121605|NCT00451217|585497103|FG002|Overall Study|Lost to Follow-up|1|||
162121606|NCT00451217|585497104|FG003|Overall Study|Lost to Follow-up|1|||
162121607|NCT00451217|585497101|FG000|Overall Study|Withdrawal by Subject|1|||
162121608|NCT00451217|585497102|FG001|Overall Study|Withdrawal by Subject|0|||
162121609|NCT00451217|585497103|FG002|Overall Study|Withdrawal by Subject|0|||
162121610|NCT00451217|585497104|FG003|Overall Study|Withdrawal by Subject|0|||
162121611|NCT00451217|585497101|FG000|Overall Study|Not Treated|1|||
162121612|NCT00451217|585497102|FG001|Overall Study|Not Treated|1|||
162121613|NCT00451217|585497103|FG002|Overall Study|Not Treated|3|||
162121614|NCT00451217|585497104|FG003|Overall Study|Not Treated|4|||
162121615|NCT03154359|585497107|FG000|Overall Study|Adverse Event|1|||
162121616|NCT03154359|585497107|FG000|Overall Study|Lack of Efficacy|2|||
162121617|NCT03154359|585497107|FG000|Overall Study|Lost to Follow-up|3|||
162121618|NCT03154359|585497107|FG000|Overall Study|Physician Decision|3|||
162121619|NCT03154359|585497107|FG000|Overall Study|Protocol Violation|4|||
162121620|NCT03154359|585497107|FG000|Overall Study|Withdrawal by Subject|5|||
162121621|NCT03154359|585497107|FG000|Overall Study|Disruption of study due to COVID-19|4|||
162121622|NCT04250337|585497108|FG000|Overall Study|Adverse Event|0|||
162121623|NCT04250337|585497109|FG001|Overall Study|Adverse Event|3|||
162121624|NCT04250337|585497108|FG000|Overall Study|Lack of Efficacy|1|||
162121625|NCT04250337|585497109|FG001|Overall Study|Lack of Efficacy|3|||
162121626|NCT04250337|585497108|FG000|Overall Study|Physician Decision|1|||
162121627|NCT04250337|585497109|FG001|Overall Study|Physician Decision|0|||
162121628|NCT04250337|585497108|FG000|Overall Study|Protocol Deviation|2|||
162121629|NCT04250337|585497109|FG001|Overall Study|Protocol Deviation|2|||
162121630|NCT04250337|585497108|FG000|Overall Study|Withdrawal by Subject|4|||
162121631|NCT04250337|585497109|FG001|Overall Study|Withdrawal by Subject|3|||
162121632|NCT00569803|585497110|FG000|Overall Study|Lost to Follow-up|1|||
162121633|NCT00569803|585497111|FG001|Overall Study|Lost to Follow-up|0|||
162121634|NCT00569803|585497112|FG002|Overall Study|Lost to Follow-up|0|||
162121635|NCT00569803|585497113|FG003|Overall Study|Lost to Follow-up|0|||
162121636|NCT00569803|585497114|FG004|Overall Study|Lost to Follow-up|0|||
162121637|NCT00569803|585497115|FG005|Overall Study|Lost to Follow-up|0|||
162121638|NCT00569803|585497116|FG006|Overall Study|Lost to Follow-up|0|||
162121639|NCT00569803|585497117|FG007|Overall Study|Lost to Follow-up|0|||
162121640|NCT00569803|585497110|FG000|Overall Study|injection syringe leaked during dosing|0|||
162121641|NCT00569803|585497111|FG001|Overall Study|injection syringe leaked during dosing|0|||
162121642|NCT00569803|585497112|FG002|Overall Study|injection syringe leaked during dosing|0|||
162121643|NCT00569803|585497113|FG003|Overall Study|injection syringe leaked during dosing|1|||
162121644|NCT00569803|585497114|FG004|Overall Study|injection syringe leaked during dosing|0|||
162121645|NCT00569803|585497115|FG005|Overall Study|injection syringe leaked during dosing|0|||
162121646|NCT00569803|585497116|FG006|Overall Study|injection syringe leaked during dosing|0|||
162121647|NCT00569803|585497117|FG007|Overall Study|injection syringe leaked during dosing|0|||
162121648|NCT00569803|585497110|FG000|Overall Study|Withdrawal by Subject|0|||
162121649|NCT00569803|585497111|FG001|Overall Study|Withdrawal by Subject|0|||
162121650|NCT00569803|585497112|FG002|Overall Study|Withdrawal by Subject|0|||
162121651|NCT00569803|585497113|FG003|Overall Study|Withdrawal by Subject|0|||
162121652|NCT00569803|585497114|FG004|Overall Study|Withdrawal by Subject|0|||
162121653|NCT00569803|585497115|FG005|Overall Study|Withdrawal by Subject|0|||
162121654|NCT00569803|585497116|FG006|Overall Study|Withdrawal by Subject|0|||
162121655|NCT00569803|585497117|FG007|Overall Study|Withdrawal by Subject|1|||
162121656|NCT01993823|585497118|FG000|Overall Study|Requested by the patient|6|||
162121657|NCT01993823|585497119|FG001|Overall Study|Requested by the patient|11|||
162121658|NCT01993823|585497118|FG000|Overall Study|Protocol Violation|0|||
162121659|NCT01993823|585497119|FG001|Overall Study|Protocol Violation|1|||
162121660|NCT01993823|585497118|FG000|Overall Study|Lost to Follow-up|1|||
162121661|NCT01993823|585497119|FG001|Overall Study|Lost to Follow-up|4|||
162121662|NCT01592695|585497123|FG000|Overall Study|Lost to Follow-up|8|||
162121663|NCT01592695|585497124|FG001|Overall Study|Lost to Follow-up|4|||
162121664|NCT03029780|585497128|FG000|Overall Study|Disease Progression|20|||
162121665|NCT03029780|585497129|FG001|Overall Study|Disease Progression|22|||
162121666|NCT03029780|585497128|FG000|Overall Study|Study Drug Toxicity|15|||
162121667|NCT03029780|585497129|FG001|Overall Study|Study Drug Toxicity|11|||
162121668|NCT03029780|585497128|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
162121669|NCT03029780|585497129|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
162121670|NCT03029780|585497128|FG000|Overall Study|Participant request to discontinue study treatment|4|||
162121671|NCT03029780|585497129|FG001|Overall Study|Participant request to discontinue study treatment|1|||
162121672|NCT03029780|585497128|FG000|Overall Study|Maximum clinical benefit|1|||
162121673|NCT03029780|585497129|FG001|Overall Study|Maximum clinical benefit|0|||
162121674|NCT03029780|585497128|FG000|Overall Study|Participant no longer meets study criteria|0|||
162121675|NCT03029780|585497129|FG001|Overall Study|Participant no longer meets study criteria|1|||
162121676|NCT03029780|585497128|FG000|Overall Study|Other reasons|6|||
162121677|NCT03029780|585497129|FG001|Overall Study|Other reasons|6|||
162121678|NCT03029780|585497128|FG000|Overall Study|Not reported|1|||
162121679|NCT03029780|585497129|FG001|Overall Study|Not reported|1|||
162121680|NCT03029780|585497128|FG000|Overall Study|Death|2|||
162121681|NCT03029780|585497129|FG001|Overall Study|Death|6|||
162121682|NCT00178256|585497130|FG000|Overall Study|Adverse Event|2|||
162121683|NCT00178256|585497131|FG001|Overall Study|Adverse Event|0|||
162121684|NCT00178256|585497132|FG002|Overall Study|Adverse Event|0|||
162121685|NCT00178256|585497133|FG003|Overall Study|Adverse Event|0|||
162121686|NCT00178256|585497130|FG000|Overall Study|Death|0|||
162121687|NCT00178256|585497131|FG001|Overall Study|Death|1|||
162121688|NCT00178256|585497132|FG002|Overall Study|Death|0|||
162121689|NCT00178256|585497133|FG003|Overall Study|Death|1|||
162121690|NCT00178256|585497130|FG000|Overall Study|Cancer progression|2|||
162121691|NCT00178256|585497131|FG001|Overall Study|Cancer progression|0|||
162121692|NCT00178256|585497132|FG002|Overall Study|Cancer progression|0|||
162121693|NCT00178256|585497133|FG003|Overall Study|Cancer progression|1|||
162121694|NCT03066622|585497134|FG000|Overall Study|Lost to Follow-up|24|||
162121695|NCT03066622|585497135|FG001|Overall Study|Lost to Follow-up|25|||
162121696|NCT03066622|585497134|FG000|Overall Study|Withdrawal by Subject|2|||
162121697|NCT03066622|585497135|FG001|Overall Study|Withdrawal by Subject|1|||
162121698|NCT01763788|585497136|FG000|Overall Study|Lost to Follow-up|0|||
162121699|NCT01763788|585497137|FG001|Overall Study|Lost to Follow-up|0|||
162121700|NCT01763788|585497138|FG002|Overall Study|Lost to Follow-up|1|||
162121701|NCT01763788|585497139|FG003|Overall Study|Lost to Follow-up|0|||
162121702|NCT00641719|585497140|FG000|Overall Study|Lack of Efficacy|1|||
162121703|NCT00641719|585497141|FG001|Overall Study|Lack of Efficacy|2|||
162121704|NCT00641719|585497140|FG000|Overall Study|Adverse Event|24|||
162121705|NCT00641719|585497141|FG001|Overall Study|Adverse Event|29|||
162121706|NCT00641719|585497140|FG000|Overall Study|Withdrawal by Subject|4|||
162121707|NCT00641719|585497141|FG001|Overall Study|Withdrawal by Subject|4|||
162121708|NCT00641719|585497140|FG000|Overall Study|Reason Not Specified|1|||
162121709|NCT00641719|585497141|FG001|Overall Study|Reason Not Specified|2|||
162121710|NCT03321006|585497142|FG000|Overall Study|Death|1|||
162121711|NCT03321006|585497143|FG001|Overall Study|Death|0|||
162121712|NCT03321006|585497142|FG000|Overall Study|Lack of Efficacy|1|||
162121713|NCT03321006|585497143|FG001|Overall Study|Lack of Efficacy|0|||
162121714|NCT03303469|585497144|FG000|Overall Study|Lost to Follow-up|2|||
162121715|NCT00885352|585497147|FG000|Overall Study|Adverse Event|2|||
162121716|NCT00885352|585497148|FG001|Overall Study|Adverse Event|3|||
162121717|NCT00885352|585497147|FG000|Overall Study|Lost to Follow-up|2|||
162121718|NCT00885352|585497148|FG001|Overall Study|Lost to Follow-up|2|||
162121719|NCT00885352|585497147|FG000|Overall Study|Physician Decision|0|||
162121720|NCT00885352|585497148|FG001|Overall Study|Physician Decision|3|||
162121721|NCT00885352|585497147|FG000|Overall Study|Protocol Violation|0|||
162121722|NCT00885352|585497148|FG001|Overall Study|Protocol Violation|2|||
162121723|NCT00885352|585497147|FG000|Overall Study|Withdrawal by Subject|1|||
162121724|NCT00885352|585497148|FG001|Overall Study|Withdrawal by Subject|5|||
162121725|NCT00885352|585497147|FG000|Overall Study|Contradiction to study medication|0|||
162121726|NCT00885352|585497148|FG001|Overall Study|Contradiction to study medication|2|||
162121727|NCT00885352|585497147|FG000|Overall Study|Excluded medication|2|||
162121728|NCT00885352|585497148|FG001|Overall Study|Excluded medication|2|||
162121729|NCT00885352|585497147|FG000|Overall Study|Lab abnormalities|1|||
162121730|NCT00885352|585497148|FG001|Overall Study|Lab abnormalities|1|||
162121731|NCT03560258|585497149|FG000|Overall Study|Lost to Follow-up|3|||
162121732|NCT03560258|585497150|FG001|Overall Study|Lost to Follow-up|0|||
162121733|NCT03560258|585497151|FG002|Overall Study|Lost to Follow-up|0|||
162121734|NCT03560258|585497149|FG000|Overall Study|Protocol Violation|0|||
162121735|NCT03560258|585497150|FG001|Overall Study|Protocol Violation|1|||
162121736|NCT03560258|585497151|FG002|Overall Study|Protocol Violation|0|||
162121737|NCT03560258|585497149|FG000|Overall Study|Withdrawal by Subject|0|||
162121738|NCT03560258|585497150|FG001|Overall Study|Withdrawal by Subject|0|||
162121739|NCT03560258|585497151|FG002|Overall Study|Withdrawal by Subject|1|||
162121740|NCT01460160|585497152|FG000|Treatment Phase|Lack of Efficacy|3|||
162121741|NCT01460160|585497152|FG000|Treatment Phase|Study Drug Toxicity|2|||
162121742|NCT01460160|585497152|FG000|Treatment Phase|Adverse Event|8|||
162121743|NCT01460160|585497152|FG000|Treatment Phase|Withdrawal by Subject|4|||
162121744|NCT01460160|585497152|FG000|Treatment Phase|Death|2|||
162121745|NCT01460160|585497152|FG000|Treatment Phase|Other reasons|9|||
162121746|NCT01460160|585497152|FG000|Follow-up Phase|Withdrawal by Subject|4|||
162121747|NCT01460160|585497152|FG000|Follow-up Phase|Death|14|||
162121748|NCT01460160|585497152|FG000|Follow-up Phase|Lost to Follow-up|7|||
162121749|NCT01460160|585497152|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
162121750|NCT01460160|585497152|FG000|Follow-up Phase|Other and not reported reasons|5|||
162121751|NCT02006121|585497153|FG000|Double Blind Phase|Adverse Event|6|||
162121752|NCT02006121|585497154|FG001|Double Blind Phase|Adverse Event|0|||
162121753|NCT02006121|585497153|FG000|Double Blind Phase|Lack of Efficacy|1|||
162121754|NCT02006121|585497154|FG001|Double Blind Phase|Lack of Efficacy|16|||
162121755|NCT02006121|585497153|FG000|Double Blind Phase|Withdrawal by Subject|3|||
162121756|NCT02006121|585497154|FG001|Double Blind Phase|Withdrawal by Subject|4|||
162121757|NCT02006121|585497153|FG000|Double Blind Phase|Non-compliance with study drug|1|||
162121758|NCT02006121|585497154|FG001|Double Blind Phase|Non-compliance with study drug|3|||
162121759|NCT02006121|585497153|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
162121760|NCT02006121|585497154|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
162121761|NCT02006121|585497153|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
162121762|NCT02006121|585497154|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
162121763|NCT02006121|585497153|FG000|Open Label Phase|Adverse Event|15|||
162121764|NCT02006121|585497154|FG001|Open Label Phase|Adverse Event|0|||
162121765|NCT02006121|585497153|FG000|Open Label Phase|Lack of Efficacy|2|||
162121766|NCT02006121|585497154|FG001|Open Label Phase|Lack of Efficacy|0|||
162121767|NCT02006121|585497153|FG000|Open Label Phase|Protocol Violation|2|||
162121768|NCT02006121|585497154|FG001|Open Label Phase|Protocol Violation|0|||
162121769|NCT02006121|585497153|FG000|Open Label Phase|Withdrawal by Subject|3|||
162121770|NCT02006121|585497154|FG001|Open Label Phase|Withdrawal by Subject|0|||
162121771|NCT02006121|585497153|FG000|Open Label Phase|Non-compliance with study drug|3|||
162121772|NCT02006121|585497154|FG001|Open Label Phase|Non-compliance with study drug|0|||
162121773|NCT04498247|585497158|FG000|Overall Study|Lost to Follow-up|0|||
162121774|NCT04498247|585497159|FG001|Overall Study|Lost to Follow-up|0|||
162121775|NCT04498247|585497160|FG002|Overall Study|Lost to Follow-up|0|||
162121776|NCT04498247|585497161|FG003|Overall Study|Lost to Follow-up|1|||
162121777|NCT04498247|585497162|FG004|Overall Study|Lost to Follow-up|0|||
162121778|NCT04498247|585497163|FG005|Overall Study|Lost to Follow-up|0|||
162121779|NCT04498247|585497164|FG006|Overall Study|Lost to Follow-up|0|||
162121780|NCT04498247|585497165|FG007|Overall Study|Lost to Follow-up|0|||
162121781|NCT04498247|585497158|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
162121782|NCT04498247|585497159|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
162121783|NCT04498247|585497160|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
162121784|NCT04498247|585497161|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
162121785|NCT04498247|585497162|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
162121786|NCT04498247|585497163|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
162121787|NCT04498247|585497164|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
162121788|NCT04498247|585497165|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
162121789|NCT04498247|585497158|FG000|Overall Study|Withdrawal by Subject|0|||
162121790|NCT04498247|585497159|FG001|Overall Study|Withdrawal by Subject|8|||
162121791|NCT04498247|585497160|FG002|Overall Study|Withdrawal by Subject|0|||
162121792|NCT04498247|585497161|FG003|Overall Study|Withdrawal by Subject|7|||
162121793|NCT04498247|585497162|FG004|Overall Study|Withdrawal by Subject|0|||
162121794|NCT04498247|585497163|FG005|Overall Study|Withdrawal by Subject|0|||
162121795|NCT04498247|585497164|FG006|Overall Study|Withdrawal by Subject|1|||
162121796|NCT04498247|585497165|FG007|Overall Study|Withdrawal by Subject|0|||
162121797|NCT04498247|585497158|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
162121798|NCT04498247|585497159|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
162121799|NCT04498247|585497160|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
162121800|NCT04498247|585497161|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
162121801|NCT04498247|585497162|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
162121802|NCT04498247|585497163|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
162121803|NCT04498247|585497164|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
162121804|NCT04498247|585497165|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
162121805|NCT01003184|585497166|FG000|Overall Study|Adverse Event|12|||
162121806|NCT01003184|585497167|FG001|Overall Study|Adverse Event|5|||
162121807|NCT01003184|585497166|FG000|Overall Study|Lost to Follow-up|1|||
162121808|NCT01003184|585497167|FG001|Overall Study|Lost to Follow-up|0|||
162121809|NCT01003184|585497166|FG000|Overall Study|Loss of glucose control|1|||
162121810|NCT01003184|585497167|FG001|Overall Study|Loss of glucose control|1|||
162121811|NCT01003184|585497166|FG000|Overall Study|Protocol Violation|3|||
162121812|NCT01003184|585497167|FG001|Overall Study|Protocol Violation|0|||
162121813|NCT01003184|585497166|FG000|Overall Study|Withdrawal by Subject|1|||
162121814|NCT01003184|585497167|FG001|Overall Study|Withdrawal by Subject|6|||
162121815|NCT01003184|585497166|FG000|Overall Study|Physician Decision|1|||
162121816|NCT01003184|585497167|FG001|Overall Study|Physician Decision|0|||
162121817|NCT00557622|585497168|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
162121818|NCT00557622|585497169|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
162121819|NCT00557622|585497168|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
162121820|NCT00557622|585497169|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
162121821|NCT00557622|585497168|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
162121822|NCT00557622|585497169|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
162121823|NCT02765490|585497170|FG000|Overall Study|Lost to Follow-up|1|||
162121824|NCT02765490|585497171|FG001|Overall Study|Lost to Follow-up|1|||
162121825|NCT02765490|585497170|FG000|Overall Study|Other|0|||
162121826|NCT02765490|585497171|FG001|Overall Study|Other|1|||
162121827|NCT02765490|585497170|FG000|Overall Study|Death|0|||
162121828|NCT02765490|585497171|FG001|Overall Study|Death|1|||
162121829|NCT03237013|585497172|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
162121830|NCT03237013|585497173|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
162121831|NCT03237013|585497174|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
162121832|NCT05266963|585497175|FG000|Drug Period A|Withdrawal by Subject|0|||
162121833|NCT05266963|585497176|FG001|Drug Period A|Withdrawal by Subject|1|||
162121834|NCT00152971|585497177|FG000|Overall Study|Adverse Event|12|||
162121835|NCT00152971|585497178|FG001|Overall Study|Adverse Event|10|||
162121836|NCT00152971|585497179|FG002|Overall Study|Adverse Event|9|||
162121837|NCT00152971|585497177|FG000|Overall Study|Protocol Violation|10|||
162121838|NCT00152971|585497178|FG001|Overall Study|Protocol Violation|11|||
162121839|NCT00152971|585497179|FG002|Overall Study|Protocol Violation|8|||
162121840|NCT00152971|585497177|FG000|Overall Study|Lost to Follow-up|17|||
162121841|NCT00152971|585497178|FG001|Overall Study|Lost to Follow-up|14|||
162121842|NCT00152971|585497179|FG002|Overall Study|Lost to Follow-up|13|||
162121843|NCT00152971|585497177|FG000|Overall Study|Withdrawal by Subject|9|||
162121844|NCT00152971|585497178|FG001|Overall Study|Withdrawal by Subject|8|||
162121845|NCT00152971|585497179|FG002|Overall Study|Withdrawal by Subject|14|||
162121846|NCT00152971|585497177|FG000|Overall Study|Other|3|||
162121847|NCT00152971|585497178|FG001|Overall Study|Other|5|||
162121848|NCT00152971|585497179|FG002|Overall Study|Other|5|||
162121849|NCT00152971|585497177|FG000|Treatment|Adverse Event|49|||
162121850|NCT00152971|585497178|FG001|Treatment|Adverse Event|40|||
162121851|NCT00152971|585497179|FG002|Treatment|Adverse Event|54|||
162121852|NCT00152971|585497177|FG000|Treatment|Protocol Violation|8|||
162121853|NCT00152971|585497178|FG001|Treatment|Protocol Violation|6|||
162121854|NCT00152971|585497179|FG002|Treatment|Protocol Violation|10|||
162121855|NCT00152971|585497177|FG000|Treatment|Lost to Follow-up|1|||
162121856|NCT00152971|585497178|FG001|Treatment|Lost to Follow-up|2|||
162121857|NCT00152971|585497179|FG002|Treatment|Lost to Follow-up|1|||
162121858|NCT00152971|585497177|FG000|Treatment|Withdrawal by Subject|4|||
162121859|NCT00152971|585497178|FG001|Treatment|Withdrawal by Subject|4|||
162121860|NCT00152971|585497179|FG002|Treatment|Withdrawal by Subject|5|||
162121861|NCT00152971|585497177|FG000|Treatment|Other|9|||
162121862|NCT00152971|585497178|FG001|Treatment|Other|11|||
162121863|NCT00152971|585497179|FG002|Treatment|Other|10|||
162121864|NCT04091360|585497180|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162121865|NCT04091360|585497181|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162121866|NCT04091360|585497182|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162121867|NCT04091360|585497183|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162121868|NCT04091360|585497184|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162121869|NCT04091360|585497185|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162121870|NCT04091360|585497186|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162121871|NCT04091360|585497187|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
162121872|NCT04091360|585497188|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
162121873|NCT04091360|585497189|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
162121874|NCT04091360|585497180|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162121875|NCT04091360|585497181|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162121876|NCT04091360|585497182|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162121877|NCT04091360|585497183|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162121878|NCT04091360|585497184|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162121879|NCT04091360|585497185|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162121880|NCT04091360|585497186|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
162121881|NCT04091360|585497187|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
162121882|NCT04091360|585497188|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162121883|NCT04091360|585497189|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
162121884|NCT04091360|585497180|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162121885|NCT04091360|585497181|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162121886|NCT04091360|585497182|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162121887|NCT04091360|585497183|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162121888|NCT04091360|585497184|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162121889|NCT04091360|585497185|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162121890|NCT04091360|585497186|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
162121891|NCT04091360|585497187|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162121892|NCT04091360|585497188|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
162121893|NCT04091360|585497189|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
162121894|NCT01320735|585497190|FG000|Overall Study|Adverse Event|3|||
162121895|NCT01320735|585497190|FG000|Overall Study|Withdrawal by Subject|3|||
162121896|NCT01320735|585497190|FG000|Overall Study|Lost to Follow-up|13|||
162121897|NCT01320735|585497190|FG000|Overall Study|Administrative Reason|6|||
162121898|NCT01320735|585497190|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
162121899|NCT01320735|585497190|FG000|Overall Study|Protocol Violation|1|||
162121900|NCT01320735|585497190|FG000|Overall Study|Other|1|||
162121901|NCT01320735|585497190|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
162121902|NCT01320735|585497190|FG000|Overall Study|Investigator Unable to be Contacted|17|||
162121903|NCT04599101|585497191|FG000|Overall Study|Lost to Follow-up|5|||
162121904|NCT04599101|585497192|FG001|Overall Study|Lost to Follow-up|5|||
162121905|NCT05952297|585497193|FG000|Overall Study|Withdrawal by Subject|1|||
162121906|NCT05952297|585497194|FG001|Overall Study|Withdrawal by Subject|0|||
162121907|NCT02875834|585497206|FG000|Open-label Phase|Withdrawal by Subject|3|||
162121908|NCT02875834|585497207|FG001|Open-label Phase|Withdrawal by Subject|0|||
162121909|NCT02875834|585497208|FG002|Open-label Phase|Withdrawal by Subject|0|||
162121910|NCT02875834|585497209|FG003|Open-label Phase|Withdrawal by Subject|0|||
162121911|NCT02875834|585497206|FG000|Open-label Phase|(Not collected)|4|||
162121912|NCT02875834|585497207|FG001|Open-label Phase|(Not collected)|0|||
162237483|NCT00600886|585921096|FG000|Extension - After Crossover (CAS)|Death|1|||
162121913|NCT02875834|585497208|FG002|Open-label Phase|(Not collected)|0|||
162121914|NCT02875834|585497209|FG003|Open-label Phase|(Not collected)|0|||
162121915|NCT02875834|585497206|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
162121916|NCT02875834|585497207|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
162121917|NCT02875834|585497208|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
162121918|NCT02875834|585497209|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
162121919|NCT02875834|585497206|FG000|Randomized Treatment Phase|Protocol Violation|0|||
162121920|NCT02875834|585497207|FG001|Randomized Treatment Phase|Protocol Violation|2|||
162121921|NCT02875834|585497208|FG002|Randomized Treatment Phase|Protocol Violation|0|||
162121922|NCT02875834|585497209|FG003|Randomized Treatment Phase|Protocol Violation|0|||
162121923|NCT02875834|585497206|FG000|Randomized Treatment Phase|(Not collected)|0|||
162121924|NCT02875834|585497207|FG001|Randomized Treatment Phase|(Not collected)|9|||
162121925|NCT02875834|585497208|FG002|Randomized Treatment Phase|(Not collected)|10|||
162121926|NCT02875834|585497209|FG003|Randomized Treatment Phase|(Not collected)|9|||
162121927|NCT01302938|585497210|FG000|Overall Study|Withdrawal by Subject|1|||
162121928|NCT01302938|585497211|FG001|Overall Study|Withdrawal by Subject|0|||
162121929|NCT01302938|585497210|FG000|Overall Study|Adverse Event|1|||
162121930|NCT01302938|585497211|FG001|Overall Study|Adverse Event|0|||
162121931|NCT00539279|585497213|FG000|Treatment|Withdrawal by Subject|10|||
162121932|NCT00539279|585497214|FG001|Treatment|Withdrawal by Subject|8|||
162121933|NCT00539279|585497213|FG000|Treatment|Death|1|||
162121934|NCT00539279|585497214|FG001|Treatment|Death|0|||
162121935|NCT00539279|585497213|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
162121936|NCT00539279|585497214|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
162121937|NCT00539279|585497213|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
162121938|NCT00539279|585497214|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
162121939|NCT01811563|585498751|FG000|Overall Study|Lost to Follow-up|5|||
162121940|NCT01811563|585498752|FG001|Overall Study|Lost to Follow-up|2|||
162121941|NCT01811563|585498751|FG000|Overall Study|Incorrect Randomization procedure|0|||
162121942|NCT01811563|585498752|FG001|Overall Study|Incorrect Randomization procedure|1|||
162121943|NCT02936037|585498753|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
162121944|NCT02936037|585498754|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
162121945|NCT02936037|585498753|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
162121946|NCT02936037|585498754|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
162121947|NCT02936037|585498753|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
162121948|NCT02936037|585498754|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
162121949|NCT02936037|585498753|FG000|Double-Blind Treatment Period|Death|0|||
162121950|NCT02936037|585498754|FG001|Double-Blind Treatment Period|Death|1|||
162121951|NCT02936037|585498753|FG000|Double-Blind Treatment Period|Adverse Event|11|||
162121952|NCT02936037|585498754|FG001|Double-Blind Treatment Period|Adverse Event|11|||
162121953|NCT02936037|585498753|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
162121954|NCT02936037|585498754|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
162121955|NCT02936037|585498753|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
162121956|NCT02936037|585498754|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
162121957|NCT02936037|585498753|FG000|Open Label Extension|Adverse Event|0|||
162121958|NCT02936037|585498754|FG001|Open Label Extension|Adverse Event|3|||
162121959|NCT02936037|585498753|FG000|Open Label Extension|Other|0|||
162121960|NCT02936037|585498754|FG001|Open Label Extension|Other|3|||
162121961|NCT02936037|585498753|FG000|Open Label Extension|Withdrawal by Subject|0|||
162121962|NCT02936037|585498754|FG001|Open Label Extension|Withdrawal by Subject|4|||
162121963|NCT01267825|585498755|FG000|Overall Study|study terminated. no data collected.|1|||
162121964|NCT01267825|585498756|FG001|Overall Study|study terminated. no data collected.|0|||
162121965|NCT04249336|585498757|FG000|Overall Study|Lost to Follow-up|3|||
162121966|NCT04249336|585498758|FG001|Overall Study|Lost to Follow-up|3|||
162121967|NCT04249336|585498759|FG002|Overall Study|Lost to Follow-up|3|||
162121968|NCT04249336|585498760|FG003|Overall Study|Lost to Follow-up|3|||
162121969|NCT01189890|585498764|FG000|Overall Study|Adverse Event|3|||
162121970|NCT01189890|585498765|FG001|Overall Study|Adverse Event|4|||
162121971|NCT01189890|585498764|FG000|Overall Study|Lack of Efficacy|7|||
162121972|NCT01189890|585498765|FG001|Overall Study|Lack of Efficacy|2|||
162121973|NCT01189890|585498764|FG000|Overall Study|Lost to Follow-up|1|||
162121974|NCT01189890|585498765|FG001|Overall Study|Lost to Follow-up|7|||
162121975|NCT01189890|585498764|FG000|Overall Study|Protocol Violation|1|||
162121976|NCT01189890|585498765|FG001|Overall Study|Protocol Violation|5|||
162121977|NCT01189890|585498764|FG000|Overall Study|Withdrawal by Subject|15|||
162121978|NCT01189890|585498765|FG001|Overall Study|Withdrawal by Subject|11|||
162121979|NCT01189890|585498764|FG000|Overall Study|Non Compliance|0|||
162121980|NCT01189890|585498765|FG001|Overall Study|Non Compliance|1|||
162121981|NCT01189890|585498764|FG000|Overall Study|Physician Decision|5|||
162121982|NCT01189890|585498765|FG001|Overall Study|Physician Decision|4|||
162121983|NCT01189890|585498764|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
162121984|NCT01189890|585498765|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
162121985|NCT00077636|585498766|FG000|Overall Study|Refused Treatment|9|||
162121986|NCT00077636|585498767|FG001|Overall Study|Refused Treatment|31|||
162121987|NCT00077636|585498766|FG000|Overall Study|Admin|3|||
162121988|NCT00077636|585498767|FG001|Overall Study|Admin|3|||
162121989|NCT00077636|585498766|FG000|Overall Study|Withdrawal by Subject|2|||
162121990|NCT00077636|585498767|FG001|Overall Study|Withdrawal by Subject|2|||
162121991|NCT00077636|585498766|FG000|Overall Study|Adverse Event|17|||
162121992|NCT00077636|585498767|FG001|Overall Study|Adverse Event|34|||
162121993|NCT00077636|585498766|FG000|Overall Study|Protocol Violation|0|||
162121994|NCT00077636|585498767|FG001|Overall Study|Protocol Violation|2|||
162121995|NCT00077636|585498766|FG000|Overall Study|Lost to Follow-up|10|||
162121996|NCT00077636|585498767|FG001|Overall Study|Lost to Follow-up|18|||
162121997|NCT00077636|585498766|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
162121998|NCT00077636|585498767|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
162121999|NCT00068380|585498768|FG000|Overall Study|Withdrawal by Subject|3|||
162122000|NCT00068380|585498768|FG000|Overall Study|Adverse Event|2|||
162122001|NCT01976364|585498769|FG000|Main Study (36 Months)|Adverse Event|63|||
162122002|NCT01976364|585498770|FG001|Main Study (36 Months)|Adverse Event|0|||
162122003|NCT01976364|585498771|FG002|Main Study (36 Months)|Adverse Event|0|||
162122004|NCT01976364|585498769|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
162122005|NCT01976364|585498770|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
162122006|NCT01976364|585498771|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
162122007|NCT01976364|585498769|FG000|Main Study (36 Months)|Other|13|||
162122008|NCT01976364|585498770|FG001|Main Study (36 Months)|Other|0|||
162122009|NCT01976364|585498771|FG002|Main Study (36 Months)|Other|0|||
162122010|NCT01976364|585498769|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
162122011|NCT01976364|585498770|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
162122012|NCT01976364|585498771|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
162122013|NCT01976364|585498769|FG000|Main Study (36 Months)|Medication error|1|||
162122014|NCT01976364|585498770|FG001|Main Study (36 Months)|Medication error|0|||
162122015|NCT01976364|585498771|FG002|Main Study (36 Months)|Medication error|0|||
162122016|NCT01976364|585498769|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
162122017|NCT01976364|585498770|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
162122018|NCT01976364|585498771|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
162122019|NCT01976364|585498769|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
162122020|NCT01976364|585498770|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
162122021|NCT01976364|585498771|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
162122022|NCT01976364|585498769|FG000|Main Study (36 Months)|Protocol Violation|13|||
162122023|NCT01976364|585498770|FG001|Main Study (36 Months)|Protocol Violation|0|||
162122024|NCT01976364|585498771|FG002|Main Study (36 Months)|Protocol Violation|0|||
162122025|NCT01976364|585498769|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
162122026|NCT01976364|585498770|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
162122027|NCT01976364|585498771|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
162122028|NCT01976364|585498769|FG000|Main Study (36 Months)|Death|5|||
162122029|NCT01976364|585498770|FG001|Main Study (36 Months)|Death|0|||
162122030|NCT01976364|585498771|FG002|Main Study (36 Months)|Death|0|||
162122031|NCT01976364|585498769|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
162122032|NCT01976364|585498770|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
162122033|NCT01976364|585498771|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
162122034|NCT01976364|585498769|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
162122035|NCT01976364|585498770|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
162122036|NCT01976364|585498771|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
162122037|NCT01976364|585498769|FG000|Sub-study (12 Months)|Protocol Violation|0|||
162122038|NCT01976364|585498770|FG001|Sub-study (12 Months)|Protocol Violation|1|||
162122039|NCT01976364|585498771|FG002|Sub-study (12 Months)|Protocol Violation|1|||
162122040|NCT01976364|585498769|FG000|Sub-study (12 Months)|Adverse Event|0|||
162122041|NCT01976364|585498770|FG001|Sub-study (12 Months)|Adverse Event|4|||
162122042|NCT01976364|585498771|FG002|Sub-study (12 Months)|Adverse Event|3|||
162122043|NCT01190215|585498772|FG000|Up to Month 6|Lost to Follow-up|2|||
162122044|NCT01190215|585498773|FG001|Up to Month 6|Lost to Follow-up|0|||
162122045|NCT02960763|585498774|FG000|Step 1|Withdrawal by Subject|10|||
162122046|NCT02960763|585498775|FG001|Step 1|Withdrawal by Subject|8|||
162122047|NCT02960763|585498776|FG002|Step 1|Withdrawal by Subject|13|||
162122048|NCT02960763|585498777|FG003|Step 1|Withdrawal by Subject|0|||
162122049|NCT02960763|585498778|FG004|Step 1|Withdrawal by Subject|0|||
162122050|NCT02960763|585498774|FG000|Step 1|Lost to Follow-up|7|||
162122051|NCT02960763|585498775|FG001|Step 1|Lost to Follow-up|9|||
162122052|NCT02960763|585498776|FG002|Step 1|Lost to Follow-up|12|||
162122053|NCT02960763|585498777|FG003|Step 1|Lost to Follow-up|0|||
162122054|NCT02960763|585498778|FG004|Step 1|Lost to Follow-up|0|||
162122055|NCT02960763|585498774|FG000|Step 1|Death|1|||
162122056|NCT02960763|585498775|FG001|Step 1|Death|1|||
162122057|NCT02960763|585498776|FG002|Step 1|Death|1|||
162122058|NCT02960763|585498777|FG003|Step 1|Death|0|||
162122059|NCT02960763|585498778|FG004|Step 1|Death|0|||
162122060|NCT02960763|585498774|FG000|Step 1|Investigator discretion|1|||
162122061|NCT02960763|585498775|FG001|Step 1|Investigator discretion|0|||
162122062|NCT02960763|585498776|FG002|Step 1|Investigator discretion|1|||
162122063|NCT02960763|585498777|FG003|Step 1|Investigator discretion|0|||
162122064|NCT02960763|585498778|FG004|Step 1|Investigator discretion|0|||
162122065|NCT02960763|585498774|FG000|Step 1|Other|0|||
162122066|NCT02960763|585498775|FG001|Step 1|Other|0|||
162122067|NCT02960763|585498776|FG002|Step 1|Other|1|||
162122068|NCT02960763|585498777|FG003|Step 1|Other|0|||
162122069|NCT02960763|585498778|FG004|Step 1|Other|0|||
162122070|NCT02960763|585498774|FG000|Step 2|Withdrawal by Subject|0|||
162122071|NCT02960763|585498775|FG001|Step 2|Withdrawal by Subject|0|||
162122072|NCT02960763|585498776|FG002|Step 2|Withdrawal by Subject|0|||
162122073|NCT02960763|585498777|FG003|Step 2|Withdrawal by Subject|7|||
162122074|NCT02960763|585498778|FG004|Step 2|Withdrawal by Subject|3|||
162122075|NCT02960763|585498774|FG000|Step 2|Lost to Follow-up|0|||
162122076|NCT02960763|585498775|FG001|Step 2|Lost to Follow-up|0|||
162122077|NCT02960763|585498776|FG002|Step 2|Lost to Follow-up|0|||
162122078|NCT02960763|585498777|FG003|Step 2|Lost to Follow-up|4|||
162122079|NCT02960763|585498778|FG004|Step 2|Lost to Follow-up|1|||
162122080|NCT02960763|585498774|FG000|Step 2|Investigator discretion|0|||
162122081|NCT02960763|585498775|FG001|Step 2|Investigator discretion|0|||
162122082|NCT02960763|585498776|FG002|Step 2|Investigator discretion|0|||
162122083|NCT02960763|585498777|FG003|Step 2|Investigator discretion|0|||
162122084|NCT02960763|585498778|FG004|Step 2|Investigator discretion|1|||
162122085|NCT05340751|585498779|FG000|Overall Study|Physician Decision|3|||
162122086|NCT01014975|585498792|FG000|Overall Study|Withdrawal by Subject|1|||
162122087|NCT01014975|585498793|FG001|Overall Study|Withdrawal by Subject|0|||
162122088|NCT01014975|585498794|FG002|Overall Study|Withdrawal by Subject|1|||
162122089|NCT01014975|585498792|FG000|Overall Study|Death|3|||
162122090|NCT01014975|585498793|FG001|Overall Study|Death|3|||
162122091|NCT01014975|585498794|FG002|Overall Study|Death|4|||
162122092|NCT01014975|585498792|FG000|Overall Study|Lost to Follow-up|0|||
162122093|NCT01014975|585498793|FG001|Overall Study|Lost to Follow-up|0|||
162122094|NCT01014975|585498794|FG002|Overall Study|Lost to Follow-up|1|||
162122095|NCT02961881|585498795|FG000|Overall Study|Adverse Event|1|||
162122096|NCT02961881|585498796|FG001|Overall Study|Adverse Event|2|||
162122097|NCT02961881|585498797|FG002|Overall Study|Adverse Event|2|||
162122098|NCT02961881|585498798|FG003|Overall Study|Adverse Event|0|||
162122099|NCT02961881|585498799|FG004|Overall Study|Adverse Event|1|||
162122100|NCT02961881|585498795|FG000|Overall Study|Participant request|0|||
162122101|NCT02961881|585498796|FG001|Overall Study|Participant request|2|||
162122102|NCT02961881|585498797|FG002|Overall Study|Participant request|0|||
162122103|NCT02961881|585498798|FG003|Overall Study|Participant request|0|||
162122104|NCT02961881|585498799|FG004|Overall Study|Participant request|0|||
162122105|NCT02961881|585498795|FG000|Overall Study|Disease progression|1|||
162122106|NCT02961881|585498796|FG001|Overall Study|Disease progression|0|||
162122107|NCT02961881|585498797|FG002|Overall Study|Disease progression|1|||
162122108|NCT02961881|585498798|FG003|Overall Study|Disease progression|0|||
162122109|NCT02961881|585498799|FG004|Overall Study|Disease progression|0|||
162122110|NCT00636792|585498800|FG000|Overall Study|Adverse Event|16|||
162122111|NCT00636792|585498800|FG000|Overall Study|Physician Decision|7|||
162122112|NCT00636792|585498800|FG000|Overall Study|Progressive Disease|4|||
162122113|NCT00636792|585498800|FG000|Overall Study|Withdrawal by Subject|3|||
162122114|NCT00636792|585498800|FG000|Overall Study|Other|3|||
162122115|NCT01928225|585498801|FG000|Overall Study|Pregnancy|1|||
162122116|NCT01928225|585498802|FG001|Overall Study|Pregnancy|0|||
162122117|NCT01928225|585498801|FG000|Overall Study|basaloid cervical cancer|1|||
162122118|NCT01928225|585498802|FG001|Overall Study|basaloid cervical cancer|0|||
162122119|NCT01928225|585498801|FG000|Overall Study|Lost to Follow-up|1|||
162122120|NCT01928225|585498802|FG001|Overall Study|Lost to Follow-up|3|||
162122121|NCT03101241|585498804|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
162122122|NCT03101241|585498805|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
162122123|NCT03101241|585498804|FG000|Overall Study|Participant withdrew consent|3|||
162122124|NCT03101241|585498805|FG001|Overall Study|Participant withdrew consent|1|||
162122125|NCT03101241|585498804|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
162122126|NCT03101241|585498805|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
162122127|NCT03101241|585498804|FG000|Overall Study|Lost to Follow-up|2|||
162122128|NCT03101241|585498805|FG001|Overall Study|Lost to Follow-up|0|||
162122129|NCT03101241|585498804|FG000|Overall Study|Lack of Efficacy|0|||
162122130|NCT03101241|585498805|FG001|Overall Study|Lack of Efficacy|1|||
162122131|NCT03101241|585498804|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
162122132|NCT03101241|585498805|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
162122133|NCT00669903|585498806|FG000|Overall Study|Adverse Event|0|||
162122134|NCT00669903|585498807|FG001|Overall Study|Adverse Event|1|||
162122135|NCT00669903|585498808|FG002|Overall Study|Adverse Event|3|||
162122136|NCT00669903|585498809|FG003|Overall Study|Adverse Event|1|||
162122137|NCT00669903|585498806|FG000|Overall Study|Withdrawal by Subject|0|||
162122138|NCT00669903|585498807|FG001|Overall Study|Withdrawal by Subject|2|||
162122139|NCT00669903|585498808|FG002|Overall Study|Withdrawal by Subject|2|||
162122140|NCT00669903|585498809|FG003|Overall Study|Withdrawal by Subject|2|||
162122141|NCT00669903|585498806|FG000|Overall Study|Lost to Follow-up|1|||
162122142|NCT00669903|585498807|FG001|Overall Study|Lost to Follow-up|1|||
162122143|NCT00669903|585498808|FG002|Overall Study|Lost to Follow-up|0|||
162122144|NCT00669903|585498809|FG003|Overall Study|Lost to Follow-up|1|||
162122145|NCT00669903|585498806|FG000|Overall Study|Protocol Violation|0|||
162122146|NCT00669903|585498807|FG001|Overall Study|Protocol Violation|1|||
162122147|NCT00669903|585498808|FG002|Overall Study|Protocol Violation|0|||
162122148|NCT00669903|585498809|FG003|Overall Study|Protocol Violation|0|||
162122149|NCT00251927|585498810|FG000|Overall Study|Adverse Event|3|||
162122150|NCT00251927|585498811|FG001|Overall Study|Adverse Event|15|||
162122151|NCT00251927|585498810|FG000|Overall Study|Lack of Efficacy|22|||
162122152|NCT00251927|585498811|FG001|Overall Study|Lack of Efficacy|16|||
162122153|NCT00251927|585498810|FG000|Overall Study|Lost to Follow-up|22|||
162122154|NCT00251927|585498811|FG001|Overall Study|Lost to Follow-up|8|||
162122155|NCT00251927|585498810|FG000|Overall Study|Protocol Violation|1|||
162122156|NCT00251927|585498811|FG001|Overall Study|Protocol Violation|2|||
162122157|NCT00251927|585498810|FG000|Overall Study|Pregnancy|2|||
162122158|NCT00251927|585498811|FG001|Overall Study|Pregnancy|0|||
162122159|NCT00251927|585498810|FG000|Overall Study|Withdrawal by Subject|40|||
162122160|NCT00251927|585498811|FG001|Overall Study|Withdrawal by Subject|25|||
162122161|NCT00251927|585498810|FG000|Overall Study|Study-specific discont. achieved|13|||
162122162|NCT00251927|585498811|FG001|Overall Study|Study-specific discont. achieved|2|||
162122163|NCT00251927|585498810|FG000|Overall Study|Study procedure non-compliance|5|||
162122164|NCT00251927|585498811|FG001|Overall Study|Study procedure non-compliance|6|||
162122165|NCT01678820|585498812|FG000|Overall Study|Study Terminated by Sponsor|45|||
162122166|NCT01678820|585498813|FG001|Overall Study|Study Terminated by Sponsor|43|||
162122167|NCT01678820|585498814|FG002|Overall Study|Study Terminated by Sponsor|43|||
162122168|NCT01678820|585498812|FG000|Overall Study|Withdrawal by Subject|2|||
162122169|NCT01678820|585498813|FG001|Overall Study|Withdrawal by Subject|5|||
162122170|NCT01678820|585498814|FG002|Overall Study|Withdrawal by Subject|2|||
162122171|NCT01678820|585498812|FG000|Overall Study|Protocol Specified Criteria|2|||
162122172|NCT01678820|585498813|FG001|Overall Study|Protocol Specified Criteria|3|||
162122173|NCT01678820|585498814|FG002|Overall Study|Protocol Specified Criteria|1|||
162122174|NCT01678820|585498812|FG000|Overall Study|Adverse Event|2|||
162122175|NCT01678820|585498813|FG001|Overall Study|Adverse Event|2|||
162122176|NCT01678820|585498814|FG002|Overall Study|Adverse Event|2|||
162122177|NCT01678820|585498812|FG000|Overall Study|Lost to Follow-up|7|||
162122178|NCT01678820|585498813|FG001|Overall Study|Lost to Follow-up|2|||
162122179|NCT01678820|585498814|FG002|Overall Study|Lost to Follow-up|2|||
162122180|NCT01678820|585498812|FG000|Overall Study|Non-compliance with study drug|0|||
162122181|NCT01678820|585498813|FG001|Overall Study|Non-compliance with study drug|1|||
162122182|NCT01678820|585498814|FG002|Overall Study|Non-compliance with study drug|0|||
162122183|NCT01678820|585498812|FG000|Overall Study|Physician Decision|0|||
162122184|NCT01678820|585498813|FG001|Overall Study|Physician Decision|0|||
162122185|NCT01678820|585498814|FG002|Overall Study|Physician Decision|1|||
162122186|NCT01678820|585498812|FG000|Overall Study|Protocol Violation|4|||
162122187|NCT01678820|585498813|FG001|Overall Study|Protocol Violation|5|||
162122188|NCT01678820|585498814|FG002|Overall Study|Protocol Violation|4|||
162122189|NCT01678820|585498812|FG000|Overall Study|Not treated with double-blind study drug|0|||
162122190|NCT01678820|585498813|FG001|Overall Study|Not treated with double-blind study drug|2|||
162122191|NCT01678820|585498814|FG002|Overall Study|Not treated with double-blind study drug|2|||
162122192|NCT03283696|585498815|FG000|Overall Study|Physician Decision|5|||
162122193|NCT03283696|585498816|FG001|Overall Study|Physician Decision|6|||
162122194|NCT03283696|585498815|FG000|Overall Study|Withdrawal by Subject|2|||
162122195|NCT03283696|585498816|FG001|Overall Study|Withdrawal by Subject|0|||
162122196|NCT00245856|585498817|FG000|Period Two|Withdrawal by Subject|0|||
162122197|NCT00245856|585498818|FG001|Period Two|Withdrawal by Subject|1|||
162237484|NCT00600886|585921097|FG001|Extension - After Crossover (CAS)|Death|0|||
162122198|NCT03662997|585498823|FG000|Overall Study|Adverse Event|0|||
162122199|NCT03662997|585498824|FG001|Overall Study|Adverse Event|2|||
162122200|NCT03662997|585498825|FG002|Overall Study|Adverse Event|0|||
162122201|NCT03662997|585498826|FG003|Overall Study|Adverse Event|0|||
162122202|NCT01512745|585498830|FG000|Overall Study|Adverse Event|22|||
162122203|NCT01512745|585498831|FG001|Overall Study|Adverse Event|3|||
162122204|NCT01512745|585498830|FG000|Overall Study|Death|9|||
162122205|NCT01512745|585498831|FG001|Overall Study|Death|13|||
162122206|NCT01512745|585498830|FG000|Overall Study|Withdrawal by Subject|2|||
162122207|NCT01512745|585498831|FG001|Overall Study|Withdrawal by Subject|2|||
162122208|NCT01512745|585498830|FG000|Overall Study|Lost to Follow-up|4|||
162122209|NCT01512745|585498831|FG001|Overall Study|Lost to Follow-up|0|||
162122210|NCT01512745|585498830|FG000|Overall Study|Lack of Efficacy|2|||
162122211|NCT01512745|585498831|FG001|Overall Study|Lack of Efficacy|2|||
162122212|NCT01512745|585498830|FG000|Overall Study|Protocol Violation|1|||
162122213|NCT01512745|585498831|FG001|Overall Study|Protocol Violation|0|||
162122214|NCT02357810|585498832|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
162122215|NCT02357810|585498832|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
162122216|NCT02357810|585498832|FG000|Reached 12 Weeks Response|Adverse Event|5|||
162122217|NCT02357810|585498832|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
162122218|NCT02357810|585498832|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
162122219|NCT02357810|585498832|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
162122220|NCT02357810|585498832|FG000|Reached 12 Weeks Response|Death|1|||
162122221|NCT02357810|585498832|FG000|Reached 12 Weeks Response|Physician Decision|1|||
162122222|NCT02357810|585498832|FG000|Reached 12 Weeks Response|Other|1|||
162122223|NCT02357810|585498832|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
162122224|NCT02357810|585498832|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
162122225|NCT02357810|585498832|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
162122226|NCT02357810|585498832|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
162237485|NCT03075410|585921098|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
162237486|NCT03075410|585921099|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
162237487|NCT03075410|585921100|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
162237488|NCT03075410|585921101|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
162237489|NCT03075410|585921102|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
162237490|NCT03075410|585921103|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
162237491|NCT03075410|585921104|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
162237492|NCT03075410|585921105|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
162237493|NCT03075410|585921106|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
162237494|NCT03075410|585921098|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
162237495|NCT03075410|585921099|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162237496|NCT03075410|585921100|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162237497|NCT03075410|585921101|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162237498|NCT03075410|585921102|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162122227|NCT02357810|585498832|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
162122228|NCT02357810|585498832|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
162122229|NCT00562978|585498833|FG000|Overall Study|Patient had imaging dose only|1|||
162122230|NCT00562978|585498834|FG001|Overall Study|Patient had imaging dose only|11|||
162122231|NCT00675506|585498836|FG000|Overall Study|Lost to Follow-up|1|||
162122232|NCT00675506|585498837|FG001|Overall Study|Lost to Follow-up|5|||
162122233|NCT00675506|585498836|FG000|Overall Study|Lost interest|3|||
162122234|NCT00675506|585498837|FG001|Overall Study|Lost interest|5|||
162122235|NCT00675506|585498836|FG000|Overall Study|Elevated fasting glucose|2|||
162122236|NCT00675506|585498837|FG001|Overall Study|Elevated fasting glucose|1|||
162122237|NCT00675506|585498836|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
162122238|NCT00675506|585498837|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
162122239|NCT00675506|585498836|FG000|Overall Study|Elevated IGF-1|2|||
162122240|NCT00675506|585498837|FG001|Overall Study|Elevated IGF-1|0|||
162122241|NCT00675506|585498836|FG000|Overall Study|Hypersensitivity Reaction|1|||
162122242|NCT00675506|585498837|FG001|Overall Study|Hypersensitivity Reaction|0|||
162122243|NCT00675506|585498836|FG000|Overall Study|Disclosed history of cancer|1|||
162122244|NCT00675506|585498837|FG001|Overall Study|Disclosed history of cancer|0|||
162122245|NCT00675506|585498836|FG000|Overall Study|Declined participation|1|||
162122246|NCT00675506|585498837|FG001|Overall Study|Declined participation|0|||
162122247|NCT00675506|585498836|FG000|Overall Study|Schedule conflict|0|||
162122248|NCT00675506|585498837|FG001|Overall Study|Schedule conflict|1|||
162122249|NCT06173570|585498838|FG000|Overall Study|Adverse Event|1|||
162122250|NCT06173570|585498839|FG001|Overall Study|Adverse Event|0|||
162122251|NCT06173570|585498840|FG002|Overall Study|Adverse Event|0|||
162122252|NCT06173570|585498841|FG003|Overall Study|Adverse Event|2|||
162122253|NCT06173570|585498842|FG004|Overall Study|Adverse Event|0|||
162122254|NCT06173570|585498838|FG000|Overall Study|Lost to Follow-up|1|||
162122255|NCT06173570|585498839|FG001|Overall Study|Lost to Follow-up|0|||
162122256|NCT06173570|585498840|FG002|Overall Study|Lost to Follow-up|0|||
162122257|NCT06173570|585498841|FG003|Overall Study|Lost to Follow-up|0|||
162122258|NCT06173570|585498842|FG004|Overall Study|Lost to Follow-up|2|||
162122259|NCT06173570|585498838|FG000|Overall Study|Protocol Violation|0|||
162122260|NCT06173570|585498839|FG001|Overall Study|Protocol Violation|2|||
162122261|NCT06173570|585498840|FG002|Overall Study|Protocol Violation|0|||
162122262|NCT06173570|585498841|FG003|Overall Study|Protocol Violation|0|||
162122263|NCT06173570|585498842|FG004|Overall Study|Protocol Violation|1|||
162122264|NCT06173570|585498838|FG000|Overall Study|Withdrawal by Subject|0|||
162122265|NCT06173570|585498839|FG001|Overall Study|Withdrawal by Subject|1|||
162122266|NCT06173570|585498840|FG002|Overall Study|Withdrawal by Subject|1|||
162122267|NCT06173570|585498841|FG003|Overall Study|Withdrawal by Subject|1|||
162122268|NCT06173570|585498842|FG004|Overall Study|Withdrawal by Subject|1|||
162122269|NCT06173570|585498838|FG000|Overall Study|Non-compliance with Study Drug|1|||
162122270|NCT06173570|585498839|FG001|Overall Study|Non-compliance with Study Drug|0|||
162122271|NCT06173570|585498840|FG002|Overall Study|Non-compliance with Study Drug|0|||
162122272|NCT06173570|585498841|FG003|Overall Study|Non-compliance with Study Drug|0|||
162122273|NCT06173570|585498842|FG004|Overall Study|Non-compliance with Study Drug|0|||
162122274|NCT06173570|585498838|FG000|Overall Study|Screen Failure|0|||
162122275|NCT06173570|585498839|FG001|Overall Study|Screen Failure|0|||
162122276|NCT06173570|585498840|FG002|Overall Study|Screen Failure|0|||
162122277|NCT06173570|585498841|FG003|Overall Study|Screen Failure|0|||
162122278|NCT06173570|585498842|FG004|Overall Study|Screen Failure|1|||
162122279|NCT06173570|585498838|FG000|Overall Study|Other|2|||
162122280|NCT06173570|585498839|FG001|Overall Study|Other|1|||
162122281|NCT06173570|585498840|FG002|Overall Study|Other|0|||
162122282|NCT06173570|585498841|FG003|Overall Study|Other|2|||
162122283|NCT06173570|585498842|FG004|Overall Study|Other|0|||
162122284|NCT03820323|585498843|FG000|Overall Study|Lost to Follow-up|2|||
162122285|NCT03820323|585498844|FG001|Overall Study|Lost to Follow-up|1|||
162122286|NCT03820323|585498843|FG000|Overall Study|Missed 12-month visit|22|||
162122287|NCT03820323|585498844|FG001|Overall Study|Missed 12-month visit|14|||
162122288|NCT03820323|585498843|FG000|Overall Study|Death|2|||
162122289|NCT03820323|585498844|FG001|Overall Study|Death|1|||
162122290|NCT03820323|585498843|FG000|Overall Study|Transferred out|13|||
162122291|NCT03820323|585498844|FG001|Overall Study|Transferred out|11|||
162122292|NCT03820323|585498843|FG000|Overall Study|Terminated|0|||
162122293|NCT03820323|585498844|FG001|Overall Study|Terminated|3|||
162122294|NCT03820323|585498843|FG000|Overall Study|Withdrawal by Subject|1|||
162122295|NCT03820323|585498844|FG001|Overall Study|Withdrawal by Subject|6|||
162122296|NCT03151395|585498845|FG000|Overall Study|Adverse Event|2|||
162122297|NCT03151395|585498845|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
162122298|NCT03151395|585498845|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
162122299|NCT03151395|585498845|FG000|Overall Study|Unspecified reason|4|||
162122300|NCT00366301|585498846|FG000|Overall Study|Lost to Follow-up|4|||
162122301|NCT00366301|585498847|FG001|Overall Study|Lost to Follow-up|4|||
162122302|NCT00366301|585498848|FG002|Overall Study|Lost to Follow-up|3|||
162122303|NCT00366301|585498849|FG003|Overall Study|Lost to Follow-up|7|||
162122304|NCT00366301|585498846|FG000|Overall Study|Withdrawal by Subject|4|||
162122305|NCT00366301|585498847|FG001|Overall Study|Withdrawal by Subject|2|||
162122306|NCT00366301|585498848|FG002|Overall Study|Withdrawal by Subject|1|||
162122307|NCT00366301|585498849|FG003|Overall Study|Withdrawal by Subject|1|||
162122308|NCT01348776|585498850|FG000|Overall Study|Lost to Follow-up|3|||
162122309|NCT01372605|585498851|FG000|Overall Study|Death|1|||
162122310|NCT01372605|585498852|FG001|Overall Study|Death|2|||
162122311|NCT01372605|585498851|FG000|Overall Study|Lost to Follow-up|2|||
162122312|NCT01372605|585498852|FG001|Overall Study|Lost to Follow-up|1|||
162122313|NCT01372605|585498851|FG000|Overall Study|Withdrawal by Subject|4|||
162122314|NCT01372605|585498852|FG001|Overall Study|Withdrawal by Subject|7|||
162122315|NCT01372605|585498851|FG000|Overall Study|Moved|3|||
162122316|NCT01372605|585498852|FG001|Overall Study|Moved|0|||
162122317|NCT01372605|585498851|FG000|Overall Study|Changed medical home|2|||
162122318|NCT01372605|585498852|FG001|Overall Study|Changed medical home|0|||
162122319|NCT01830881|585498853|FG000|Overall Study|Changed decision to have an abortion|0|||
162237499|NCT03075410|585921103|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162237500|NCT03075410|585921104|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162237501|NCT03075410|585921105|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162237502|NCT03075410|585921106|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
162237503|NCT02053792|585921107|FG000|Overall Study|Physician Decision|0|||
162237504|NCT02053792|585921108|FG001|Overall Study|Physician Decision|1|||
162237505|NCT02053792|585921107|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
162237506|NCT02053792|585921108|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
162237507|NCT02053792|585921107|FG000|Overall Study|Lack of Efficacy|1|||
162122320|NCT01830881|585498854|FG001|Overall Study|Changed decision to have an abortion|1|||
162122321|NCT03856996|585498855|FG000|Overall Study|Withdrawal by Subject|1|||
162122322|NCT03856996|585498856|FG001|Overall Study|Withdrawal by Subject|0|||
162122323|NCT03856996|585498855|FG000|Overall Study|Lost to Follow-up|0|||
162122324|NCT03856996|585498856|FG001|Overall Study|Lost to Follow-up|1|||
162122325|NCT03856996|585498855|FG000|Overall Study|Adverse Event|1|||
162122326|NCT03856996|585498856|FG001|Overall Study|Adverse Event|1|||
162122327|NCT03856996|585498855|FG000|Overall Study|Other|1|||
162122328|NCT03856996|585498856|FG001|Overall Study|Other|0|||
162122329|NCT04362137|585498859|FG000|Overall Study|Death|9|||
162122330|NCT04362137|585498860|FG001|Overall Study|Death|3|||
162122331|NCT04362137|585498859|FG000|Overall Study|Patient decision|6|||
162122332|NCT04362137|585498860|FG001|Overall Study|Patient decision|3|||
162122333|NCT04362137|585498859|FG000|Overall Study|Adverse Event|1|||
162122334|NCT04362137|585498860|FG001|Overall Study|Adverse Event|0|||
162122335|NCT04362137|585498859|FG000|Overall Study|Lost to Follow-up|1|||
162122336|NCT04362137|585498860|FG001|Overall Study|Lost to Follow-up|0|||
162122337|NCT04362137|585498859|FG000|Overall Study|Protocol deviation|1|||
162122338|NCT04362137|585498860|FG001|Overall Study|Protocol deviation|0|||
162122339|NCT03679767|585498864|FG000|Overall Study|Death|16|||
162122340|NCT03679767|585498865|FG001|Overall Study|Death|11|||
162122341|NCT03679767|585498866|FG002|Overall Study|Death|17|||
162122342|NCT03679767|585498867|FG003|Overall Study|Death|10|||
162122343|NCT03679767|585498864|FG000|Overall Study|Lost to Follow-up|1|||
162122344|NCT03679767|585498865|FG001|Overall Study|Lost to Follow-up|1|||
162122345|NCT03679767|585498866|FG002|Overall Study|Lost to Follow-up|1|||
162122346|NCT03679767|585498867|FG003|Overall Study|Lost to Follow-up|1|||
162122347|NCT03679767|585498864|FG000|Overall Study|Withdrawal by Subject|0|||
162122348|NCT03679767|585498865|FG001|Overall Study|Withdrawal by Subject|0|||
162122349|NCT03679767|585498866|FG002|Overall Study|Withdrawal by Subject|0|||
162122350|NCT03679767|585498867|FG003|Overall Study|Withdrawal by Subject|1|||
162122351|NCT03679767|585498864|FG000|Overall Study|Follow-up Completed|18|||
162122352|NCT03679767|585498865|FG001|Overall Study|Follow-up Completed|11|||
162122353|NCT03679767|585498866|FG002|Overall Study|Follow-up Completed|11|||
162122354|NCT03679767|585498867|FG003|Overall Study|Follow-up Completed|20|||
162122355|NCT03679767|585498864|FG000|Overall Study|Entered Hospice Care|0|||
162122356|NCT03679767|585498865|FG001|Overall Study|Entered Hospice Care|0|||
162122357|NCT03679767|585498866|FG002|Overall Study|Entered Hospice Care|0|||
162122358|NCT03679767|585498867|FG003|Overall Study|Entered Hospice Care|1|||
162122359|NCT03679767|585498864|FG000|Overall Study|Progressive Disease|0|||
162122360|NCT03679767|585498865|FG001|Overall Study|Progressive Disease|0|||
162122361|NCT03679767|585498866|FG002|Overall Study|Progressive Disease|0|||
162122362|NCT03679767|585498867|FG003|Overall Study|Progressive Disease|1|||
162122363|NCT03556358|585498868|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
162122364|NCT03556358|585498869|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
162122365|NCT03556358|585498868|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
162122366|NCT03556358|585498869|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
162122367|NCT03556358|585498868|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
162122368|NCT03556358|585498869|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
162122369|NCT03556358|585498868|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
162122370|NCT03556358|585498869|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
162122371|NCT03556358|585498868|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
162122372|NCT03556358|585498869|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
162122373|NCT03556358|585498868|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
162122374|NCT03556358|585498869|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
162122375|NCT03556358|585498868|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
162122376|NCT03556358|585498869|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
162122377|NCT05067933|585498876|FG000|Overall Study|Withdrawal by Subject|2|||
162122378|NCT05067933|585498877|FG001|Overall Study|Withdrawal by Subject|0|||
162122379|NCT05067933|585498878|FG002|Overall Study|Withdrawal by Subject|0|||
162122380|NCT05067933|585498879|FG003|Overall Study|Withdrawal by Subject|0|||
162122381|NCT05067933|585498880|FG004|Overall Study|Withdrawal by Subject|0|||
162122382|NCT05067933|585498881|FG005|Overall Study|Withdrawal by Subject|0|||
162122383|NCT05067933|585498876|FG000|Overall Study|Lost to Follow-up|1|||
162122384|NCT05067933|585498877|FG001|Overall Study|Lost to Follow-up|1|||
162122385|NCT05067933|585498878|FG002|Overall Study|Lost to Follow-up|1|||
162122386|NCT05067933|585498879|FG003|Overall Study|Lost to Follow-up|2|||
162122387|NCT05067933|585498880|FG004|Overall Study|Lost to Follow-up|1|||
162122388|NCT05067933|585498881|FG005|Overall Study|Lost to Follow-up|0|||
162122389|NCT05067933|585498876|FG000|Overall Study|Miscellaneous|1|||
162122390|NCT05067933|585498877|FG001|Overall Study|Miscellaneous|0|||
162122391|NCT05067933|585498878|FG002|Overall Study|Miscellaneous|0|||
162122392|NCT05067933|585498879|FG003|Overall Study|Miscellaneous|0|||
162122393|NCT05067933|585498880|FG004|Overall Study|Miscellaneous|0|||
162122394|NCT05067933|585498881|FG005|Overall Study|Miscellaneous|0|||
162122395|NCT05067933|585498876|FG000|Overall Study|Death|0|||
162122396|NCT05067933|585498877|FG001|Overall Study|Death|0|||
162122397|NCT05067933|585498878|FG002|Overall Study|Death|0|||
162122398|NCT05067933|585498879|FG003|Overall Study|Death|1|||
162122399|NCT05067933|585498880|FG004|Overall Study|Death|0|||
162122400|NCT05067933|585498881|FG005|Overall Study|Death|0|||
162122401|NCT01065350|585498882|FG000|Overall Study|Received incorrect drug allocation|0|||
162122402|NCT01065350|585498883|FG001|Overall Study|Received incorrect drug allocation|1|||
162122403|NCT02716038|585498884|FG000|Overall Study|Not evaluable|1|||
162122404|NCT02716038|585498884|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
162122405|NCT02716038|585498884|FG000|Overall Study|Unresectable|3|||
162122406|NCT00550550|585498885|FG000|Overall Study|Adverse Event|13|||
162122407|NCT00550550|585498886|FG001|Overall Study|Adverse Event|5|||
162122408|NCT00550550|585498885|FG000|Overall Study|Treatment Failure|0|||
162122409|NCT00550550|585498886|FG001|Overall Study|Treatment Failure|1|||
162122410|NCT00550550|585498885|FG000|Overall Study|Lost to Follow-up|4|||
162122411|NCT00550550|585498886|FG001|Overall Study|Lost to Follow-up|0|||
162122412|NCT00550550|585498885|FG000|Overall Study|Withdrawal by Subject|10|||
162122413|NCT00550550|585498886|FG001|Overall Study|Withdrawal by Subject|8|||
162122414|NCT00550550|585498885|FG000|Overall Study|Protocol Violation|5|||
162122415|NCT00550550|585498886|FG001|Overall Study|Protocol Violation|14|||
162122416|NCT00550550|585498885|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
162122417|NCT00550550|585498886|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
162122418|NCT00550550|585498885|FG000|Overall Study|Randomized But Not Treated|1|||
162122419|NCT00550550|585498886|FG001|Overall Study|Randomized But Not Treated|0|||
162122420|NCT02459093|585498887|FG000|Overall Study|Protocol Violation|6|||
162122421|NCT02459093|585498888|FG001|Overall Study|Protocol Violation|11|||
162122422|NCT02459093|585498887|FG000|Overall Study|Lost to Follow-up|6|||
162122423|NCT02459093|585498888|FG001|Overall Study|Lost to Follow-up|7|||
162122424|NCT00591864|585498889|FG000|Overall Study|Incomplete Imaging|5|||
162122425|NCT00118092|585498890|FG000|Overall Study|Withdrawal by Subject|1|||
162122426|NCT00118092|585498890|FG000|Overall Study|Protocol Violation|1|||
162122427|NCT01103960|585498897|FG000|Overall Study|Adverse Event|2|||
162122428|NCT01103960|585498898|FG001|Overall Study|Adverse Event|1|||
162122429|NCT01103960|585498897|FG000|Overall Study|Withdrawal by Subject|2|||
162122430|NCT01103960|585498898|FG001|Overall Study|Withdrawal by Subject|1|||
162122431|NCT01103960|585498897|FG000|Overall Study|Other|1|||
162122432|NCT01103960|585498898|FG001|Overall Study|Other|0|||
162122433|NCT04921969|585498899|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
162122434|NCT04921969|585498900|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
162122435|NCT04921969|585498901|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
162122436|NCT04921969|585498902|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
162122437|NCT04921969|585498903|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
162122438|NCT04921969|585498904|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
162122439|NCT04921969|585498905|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
162122440|NCT04921969|585498899|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
162122441|NCT04921969|585498900|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162122442|NCT04921969|585498901|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162122443|NCT04921969|585498902|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162122444|NCT04921969|585498903|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162122445|NCT04921969|585498904|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162122446|NCT04921969|585498905|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
162122447|NCT04921969|585498899|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
162122448|NCT04921969|585498900|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
162122449|NCT04921969|585498901|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
162122450|NCT04921969|585498902|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162122451|NCT04921969|585498903|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162122452|NCT04921969|585498904|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162122453|NCT04921969|585498905|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
162122454|NCT04921969|585498899|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
162122455|NCT04921969|585498900|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
162122456|NCT04921969|585498901|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
162122457|NCT04921969|585498902|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
162122458|NCT04921969|585498903|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
162122459|NCT04921969|585498904|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
162122460|NCT04921969|585498905|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
162122461|NCT04921969|585498899|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
162122462|NCT04921969|585498900|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
162122463|NCT04921969|585498901|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
162122464|NCT04921969|585498902|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
162122465|NCT04921969|585498903|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
162122466|NCT04921969|585498904|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
162122467|NCT04921969|585498905|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
162122468|NCT04921969|585498899|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
162122469|NCT04921969|585498900|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
162122470|NCT04921969|585498901|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
162122471|NCT04921969|585498902|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162122472|NCT04921969|585498903|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162122473|NCT04921969|585498904|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162122474|NCT04921969|585498905|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
162122475|NCT04921969|585498899|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
162122476|NCT04921969|585498900|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
162122477|NCT04921969|585498901|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
162122478|NCT04921969|585498902|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
162122479|NCT04921969|585498903|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
162122480|NCT04921969|585498904|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
162122481|NCT04921969|585498905|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
162122482|NCT04921969|585498899|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
162122483|NCT04921969|585498900|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
162122484|NCT04921969|585498901|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
162122485|NCT04921969|585498902|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
162122486|NCT04921969|585498903|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
162122487|NCT04921969|585498904|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
162122488|NCT04921969|585498905|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
162122489|NCT04921969|585498899|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162122490|NCT04921969|585498900|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162122491|NCT04921969|585498901|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162122492|NCT04921969|585498902|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
162122493|NCT04921969|585498903|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
162122494|NCT04921969|585498904|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
162122495|NCT04921969|585498905|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
162122496|NCT04921969|585498899|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
162122497|NCT04921969|585498900|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
162122498|NCT04921969|585498901|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
162122499|NCT04921969|585498902|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
162122500|NCT04921969|585498903|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
162122501|NCT04921969|585498904|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
162122502|NCT04921969|585498905|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
162122503|NCT04921969|585498899|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
162122504|NCT04921969|585498900|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
162122505|NCT04921969|585498901|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
162122506|NCT04921969|585498902|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
162122507|NCT04921969|585498903|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
162122508|NCT04921969|585498904|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
162122509|NCT04921969|585498905|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
162122510|NCT04921969|585498899|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
162122511|NCT04921969|585498900|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
162122512|NCT04921969|585498901|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
162122513|NCT04921969|585498902|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
162122514|NCT04921969|585498903|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
162122515|NCT04921969|585498904|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
162122516|NCT04921969|585498905|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
162122517|NCT04921969|585498899|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
162122518|NCT04921969|585498900|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
162122519|NCT04921969|585498901|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
162122520|NCT04921969|585498902|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
162122521|NCT04921969|585498903|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
162122522|NCT04921969|585498904|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
162122523|NCT04921969|585498905|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
162122524|NCT04921969|585498899|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
162122525|NCT04921969|585498900|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
162122526|NCT04921969|585498901|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
162122527|NCT04921969|585498902|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
162122528|NCT04921969|585498903|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
162122529|NCT04921969|585498904|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
162122530|NCT04921969|585498905|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
162122531|NCT04921969|585498899|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
162122532|NCT04921969|585498900|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
162122533|NCT04921969|585498901|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
162237508|NCT02053792|585921108|FG001|Overall Study|Lack of Efficacy|0|||
162237509|NCT02053792|585921107|FG000|Overall Study|Adverse Event|1|||
162237510|NCT02053792|585921108|FG001|Overall Study|Adverse Event|0|||
162237511|NCT02053792|585921107|FG000|Overall Study|Withdrawal by Subject|2|||
162237512|NCT02053792|585921108|FG001|Overall Study|Withdrawal by Subject|2|||
162237513|NCT02053792|585921107|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
162237514|NCT02053792|585921108|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
162237515|NCT02053792|585921107|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
162237516|NCT02053792|585921108|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
162237517|NCT01427751|585921109|FG000|Overall Study|Adverse Event|18|||
162237518|NCT01427751|585921110|FG001|Overall Study|Adverse Event|2|||
162237519|NCT01427751|585921109|FG000|Overall Study|No further treatment benefit expected|5|||
162237520|NCT01427751|585921110|FG001|Overall Study|No further treatment benefit expected|1|||
162237521|NCT01427751|585921109|FG000|Overall Study|Lost to Follow-up|3|||
162237522|NCT01427751|585921110|FG001|Overall Study|Lost to Follow-up|1|||
162237523|NCT01427751|585921109|FG000|Overall Study|Withdrawal of consent|2|||
162237524|NCT01427751|585921110|FG001|Overall Study|Withdrawal of consent|2|||
162237525|NCT01427751|585921109|FG000|Overall Study|Protocol Violation|6|||
162237526|NCT01427751|585921110|FG001|Overall Study|Protocol Violation|4|||
162237527|NCT01427751|585921109|FG000|Overall Study|Death|2|||
162237528|NCT01427751|585921110|FG001|Overall Study|Death|0|||
162237529|NCT01427751|585921109|FG000|Overall Study|Other miscellaneous reasons|6|||
162237530|NCT01427751|585921110|FG001|Overall Study|Other miscellaneous reasons|4|||
162237531|NCT01028027|585921111|FG000|Overall Study|Lost to Follow-up|4|||
162237532|NCT01028027|585921112|FG001|Overall Study|Lost to Follow-up|1|||
162237533|NCT01028027|585921111|FG000|Overall Study|Withdrawal by Subject|5|||
162237534|NCT01028027|585921112|FG001|Overall Study|Withdrawal by Subject|3|||
162237535|NCT01028027|585921111|FG000|Overall Study|Adverse Event|4|||
162237536|NCT01028027|585921112|FG001|Overall Study|Adverse Event|7|||
162237537|NCT01028027|585921111|FG000|Overall Study|Protocol Violation|3|||
162237538|NCT01028027|585921112|FG001|Overall Study|Protocol Violation|1|||
162237539|NCT01028027|585921111|FG000|Overall Study|Lack of Efficacy|0|||
162237540|NCT01028027|585921112|FG001|Overall Study|Lack of Efficacy|1|||
162237541|NCT00368992|585921123|FG000|Overall Study|Ineligible|5|||
162237542|NCT00368992|585921123|FG000|Overall Study|Refused treatment|3|||
162237543|NCT00368992|585921123|FG000|Overall Study|Lack of Efficacy|63|||
162237544|NCT00368992|585921123|FG000|Overall Study|Adverse Event|26|||
162122534|NCT04921969|585498902|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
162122535|NCT04921969|585498903|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
162122536|NCT04921969|585498904|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
162122537|NCT04921969|585498905|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
162122538|NCT04287868|585498906|FG000|Overall Study|Screening fail|1|||
162122539|NCT04287868|585498907|FG001|Overall Study|Screening fail|0|||
162122540|NCT02791490|585500217|FG000|Overall Study|Lost to Follow-up|1|||
162122541|NCT02791490|585500218|FG001|Overall Study|Lost to Follow-up|2|||
162122542|NCT02791490|585500217|FG000|Overall Study|Withdrawal by Subject|2|||
162122543|NCT02791490|585500218|FG001|Overall Study|Withdrawal by Subject|6|||
162122544|NCT01235975|585500223|FG000|Overall Study|Serious Adverse Event|0|||
162122545|NCT01235975|585500224|FG001|Overall Study|Serious Adverse Event|1|||
162122546|NCT01235975|585500223|FG000|Overall Study|Withdrawal by Subject|8|||
162122547|NCT01235975|585500224|FG001|Overall Study|Withdrawal by Subject|2|||
162122548|NCT01235975|585500223|FG000|Overall Study|Migrated/moved from study area|2|||
162122549|NCT01235975|585500224|FG001|Overall Study|Migrated/moved from study area|1|||
162122550|NCT01235975|585500223|FG000|Overall Study|Lost to Follow-up|7|||
162122551|NCT01235975|585500224|FG001|Overall Study|Lost to Follow-up|3|||
162122552|NCT01381874|585500225|FG000|Overall Study|Lost to Follow-up|1|||
162122553|NCT01381874|585500226|FG001|Overall Study|Lost to Follow-up|1|||
162122554|NCT01381874|585500227|FG002|Overall Study|Lost to Follow-up|0|||
162122555|NCT01381874|585500225|FG000|Overall Study|Withdrawal by Subject|9|||
162122556|NCT01381874|585500226|FG001|Overall Study|Withdrawal by Subject|10|||
162122557|NCT01381874|585500227|FG002|Overall Study|Withdrawal by Subject|9|||
162122558|NCT01381874|585500225|FG000|Overall Study|Other|67|||
162122559|NCT01381874|585500226|FG001|Overall Study|Other|52|||
162122560|NCT01381874|585500227|FG002|Overall Study|Other|67|||
162122561|NCT03119610|585500231|FG000|Overall Study|Adverse Event|1|||
162122562|NCT03119610|585500232|FG001|Overall Study|Adverse Event|0|||
162122563|NCT03119610|585500231|FG000|Overall Study|Lost to Follow-up|0|||
162122564|NCT03119610|585500232|FG001|Overall Study|Lost to Follow-up|1|||
162122565|NCT00114634|585500233|FG000|Overall Study|failure to return forms|3|||
162237545|NCT00368992|585921123|FG000|Overall Study|Death|4|||
162237546|NCT00368992|585921123|FG000|Overall Study|Other|9|||
162237547|NCT00790751|585921130|FG000|Overall Study|Protocol non-compliance|16|||
162237548|NCT00790751|585921131|FG001|Overall Study|Protocol non-compliance|16|||
162237549|NCT00790751|585921132|FG002|Overall Study|Protocol non-compliance|10|||
162237550|NCT00790751|585921133|FG003|Overall Study|Protocol non-compliance|11|||
162237551|NCT00790751|585921130|FG000|Overall Study|Lost to Follow-up|4|||
162237552|NCT00790751|585921131|FG001|Overall Study|Lost to Follow-up|9|||
162237553|NCT00790751|585921132|FG002|Overall Study|Lost to Follow-up|4|||
162237554|NCT00790751|585921133|FG003|Overall Study|Lost to Follow-up|5|||
162237555|NCT00790751|585921130|FG000|Overall Study|Adverse Event|5|||
162237556|NCT00790751|585921131|FG001|Overall Study|Adverse Event|3|||
162237557|NCT00790751|585921132|FG002|Overall Study|Adverse Event|5|||
162237558|NCT00790751|585921133|FG003|Overall Study|Adverse Event|4|||
162237559|NCT00790751|585921130|FG000|Overall Study|Requirement for restricted medication|0|||
162237560|NCT00790751|585921131|FG001|Overall Study|Requirement for restricted medication|2|||
162122566|NCT00684762|585500236|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
162122567|NCT00684762|585500237|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
162237561|NCT00790751|585921132|FG002|Overall Study|Requirement for restricted medication|0|||
162237562|NCT00790751|585921133|FG003|Overall Study|Requirement for restricted medication|0|||
162237563|NCT00790751|585921130|FG000|Overall Study|Death|0|||
162237564|NCT00790751|585921131|FG001|Overall Study|Death|0|||
162237565|NCT00790751|585921132|FG002|Overall Study|Death|1|||
162237566|NCT00790751|585921133|FG003|Overall Study|Death|0|||
162237567|NCT00790751|585921130|FG000|Overall Study|Physician Decision|0|||
162237568|NCT00790751|585921131|FG001|Overall Study|Physician Decision|0|||
162237569|NCT00790751|585921132|FG002|Overall Study|Physician Decision|0|||
162237570|NCT00790751|585921133|FG003|Overall Study|Physician Decision|1|||
162237571|NCT02427464|585921136|FG000|Overall Study|Adverse Event|6|||
162237572|NCT02427464|585921137|FG001|Overall Study|Adverse Event|1|||
162237573|NCT02427464|585921136|FG000|Overall Study|Lost to Follow-up|16|||
162237574|NCT02427464|585921137|FG001|Overall Study|Lost to Follow-up|5|||
162237575|NCT02427464|585921136|FG000|Overall Study|Physician Decision|2|||
162237576|NCT02427464|585921137|FG001|Overall Study|Physician Decision|0|||
162237577|NCT02427464|585921136|FG000|Overall Study|Withdrawal by Subject|10|||
162237578|NCT02427464|585921137|FG001|Overall Study|Withdrawal by Subject|8|||
162237579|NCT02427464|585921136|FG000|Overall Study|Noncompliance|16|||
162237580|NCT02427464|585921137|FG001|Overall Study|Noncompliance|10|||
162237581|NCT04443153|585921141|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
162237582|NCT04443153|585921142|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
162237583|NCT04443153|585921141|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
162237584|NCT04443153|585921142|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
162237585|NCT04443153|585921141|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
162237586|NCT04443153|585921142|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
162237587|NCT04443153|585921141|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
162237588|NCT04443153|585921142|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
162237589|NCT02572843|585921143|FG000|Accrual|Brain metastasis retrospectively detected|1|||
162237590|NCT02572843|585921143|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
162237591|NCT02572843|585921143|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
162237592|NCT02572843|585921143|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
162237593|NCT02572843|585921143|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
162237594|NCT02572843|585921143|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
162237595|NCT02572843|585921143|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
162237596|NCT02572843|585921143|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
162237597|NCT02572843|585921143|FG000|Surgery|lost to follow up|7|||
162237598|NCT02572843|585921143|FG000|Surgery|Death|1|||
162237599|NCT01078454|585921147|FG000|Overall Study|Adverse Event|1|||
162237600|NCT01078454|585921148|FG001|Overall Study|Adverse Event|1|||
162237601|NCT01078454|585921147|FG000|Overall Study|Death|0|||
162237602|NCT01078454|585921148|FG001|Overall Study|Death|1|||
162237603|NCT04737187|585921149|FG000|Overall Study|Switched to marketed drug|32|||
162237604|NCT04737187|585921150|FG001|Overall Study|Switched to marketed drug|4|||
162237605|NCT04737187|585921149|FG000|Overall Study|Radiological Progressive Disease|145|||
162237606|NCT04737187|585921150|FG001|Overall Study|Radiological Progressive Disease|146|||
162237607|NCT04737187|585921149|FG000|Overall Study|Clinical Progressive Disease|20|||
162237608|NCT04737187|585921150|FG001|Overall Study|Clinical Progressive Disease|20|||
162237609|NCT04737187|585921149|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
162237610|NCT04737187|585921150|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
162237611|NCT04737187|585921149|FG000|Overall Study|Adverse Event|16|||
162237612|NCT04737187|585921150|FG001|Overall Study|Adverse Event|16|||
162237613|NCT04737187|585921149|FG000|Overall Study|Physician Decision|2|||
162237614|NCT04737187|585921150|FG001|Overall Study|Physician Decision|0|||
162237615|NCT04737187|585921149|FG000|Overall Study|Withdrawal by Subject|5|||
162237616|NCT04737187|585921150|FG001|Overall Study|Withdrawal by Subject|8|||
162237617|NCT05227703|585921151|FG000|Overall Study|Adverse Event|2|||
162237618|NCT05227703|585921152|FG001|Overall Study|Adverse Event|6|||
162237619|NCT05227703|585921153|FG002|Overall Study|Adverse Event|4|||
162237620|NCT05227703|585921151|FG000|Overall Study|Lack of Efficacy|4|||
162237621|NCT05227703|585921152|FG001|Overall Study|Lack of Efficacy|0|||
162237622|NCT05227703|585921153|FG002|Overall Study|Lack of Efficacy|1|||
162237623|NCT05227703|585921151|FG000|Overall Study|Physician Decision|2|||
162237624|NCT05227703|585921152|FG001|Overall Study|Physician Decision|2|||
162237625|NCT05227703|585921153|FG002|Overall Study|Physician Decision|1|||
162237626|NCT05227703|585921151|FG000|Overall Study|Protocol Violation|2|||
162237627|NCT05227703|585921152|FG001|Overall Study|Protocol Violation|1|||
162237628|NCT05227703|585921153|FG002|Overall Study|Protocol Violation|0|||
162237629|NCT05227703|585921151|FG000|Overall Study|Withdrawal by Subject|17|||
162237630|NCT05227703|585921152|FG001|Overall Study|Withdrawal by Subject|26|||
162237631|NCT05227703|585921153|FG002|Overall Study|Withdrawal by Subject|32|||
162237632|NCT05227703|585921151|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
162237633|NCT05227703|585921152|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
162237634|NCT05227703|585921153|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
162237635|NCT05227703|585921151|FG000|Overall Study|Other|1|||
162237636|NCT05227703|585921152|FG001|Overall Study|Other|1|||
162237637|NCT05227703|585921153|FG002|Overall Study|Other|0|||
162237638|NCT03464097|585921160|FG000|Overall Study|Withdrawal by Subject|15|||
162237639|NCT03464097|585921161|FG001|Overall Study|Withdrawal by Subject|13|||
162237640|NCT03464097|585921162|FG002|Overall Study|Withdrawal by Subject|11|||
162237641|NCT03464097|585921160|FG000|Overall Study|Study terminated by sponsor|47|||
162237642|NCT03464097|585921161|FG001|Overall Study|Study terminated by sponsor|44|||
162237643|NCT03464097|585921162|FG002|Overall Study|Study terminated by sponsor|40|||
162237644|NCT03464097|585921160|FG000|Overall Study|Pregnancy|0|||
162237645|NCT03464097|585921161|FG001|Overall Study|Pregnancy|1|||
162237646|NCT03464097|585921162|FG002|Overall Study|Pregnancy|0|||
162237647|NCT03464097|585921160|FG000|Overall Study|Other reasons|5|||
162237648|NCT03464097|585921161|FG001|Overall Study|Other reasons|12|||
162237649|NCT03464097|585921162|FG002|Overall Study|Other reasons|14|||
162237650|NCT03464097|585921160|FG000|Overall Study|Lost to Follow-up|0|||
162237651|NCT03464097|585921161|FG001|Overall Study|Lost to Follow-up|1|||
162237652|NCT03464097|585921162|FG002|Overall Study|Lost to Follow-up|1|||
162237653|NCT03464097|585921160|FG000|Overall Study|Lack of Efficacy|11|||
162237654|NCT03464097|585921161|FG001|Overall Study|Lack of Efficacy|18|||
162237655|NCT03464097|585921162|FG002|Overall Study|Lack of Efficacy|30|||
162237656|NCT03464097|585921160|FG000|Overall Study|Death|1|||
162237657|NCT03464097|585921161|FG001|Overall Study|Death|0|||
162237658|NCT03464097|585921162|FG002|Overall Study|Death|0|||
162237659|NCT03464097|585921160|FG000|Overall Study|Adverse Event|13|||
162237660|NCT03464097|585921161|FG001|Overall Study|Adverse Event|6|||
162237661|NCT03464097|585921162|FG002|Overall Study|Adverse Event|8|||
162237662|NCT03035201|585921163|FG000|Overall Study|Death|9|||
162122568|NCT02310126|585500243|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
162122569|NCT02310126|585500244|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
162122570|NCT02310126|585500243|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
162122571|NCT02310126|585500244|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
162122572|NCT02693834|585500245|FG000|Baseline Measurement|Withdrawal by Subject|1|||
162122573|NCT02693834|585500246|FG001|Baseline Measurement|Withdrawal by Subject|0|||
162122574|NCT02693834|585500245|FG000|Baseline Measurement|Adverse Event|1|||
162122575|NCT02693834|585500246|FG001|Baseline Measurement|Adverse Event|0|||
162122576|NCT02693834|585500245|FG000|Week 2 Practice|Adverse Event|0|||
162122577|NCT02693834|585500246|FG001|Week 2 Practice|Adverse Event|1|||
162122578|NCT02111213|585500252|FG000|Overall Study|Withdrawal by Subject|3|||
162122579|NCT02111213|585500253|FG001|Overall Study|Withdrawal by Subject|2|||
162122580|NCT02111213|585500252|FG000|Overall Study|Lost to Follow-up|3|||
162122581|NCT02111213|585500253|FG001|Overall Study|Lost to Follow-up|4|||
162122582|NCT00439179|585500254|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
162122583|NCT00439179|585500255|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
162122584|NCT00439179|585500256|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
162122585|NCT00439179|585500257|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
162122586|NCT02761629|585500258|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
162122587|NCT02761629|585500259|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
162122588|NCT02761629|585500258|FG000|Overall Study|Insufficient Therapeutic Response|2|||
162122589|NCT02761629|585500259|FG001|Overall Study|Insufficient Therapeutic Response|7|||
162122590|NCT02761629|585500258|FG000|Overall Study|Failure to Return|2|||
162122591|NCT02761629|585500259|FG001|Overall Study|Failure to Return|4|||
162122592|NCT02761629|585500258|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
162122593|NCT02761629|585500259|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
162122594|NCT02761629|585500258|FG000|Overall Study|Protocol Violation|2|||
162122595|NCT02761629|585500259|FG001|Overall Study|Protocol Violation|2|||
162122596|NCT02761629|585500258|FG000|Overall Study|Withdrawal by Subject|0|||
162122597|NCT02761629|585500259|FG001|Overall Study|Withdrawal by Subject|3|||
162122598|NCT02761629|585500258|FG000|Overall Study|Other|0|||
162122599|NCT02761629|585500259|FG001|Overall Study|Other|2|||
162122600|NCT02761629|585500258|FG000|Overall Study|Lost to Follow-up|4|||
162122601|NCT02761629|585500259|FG001|Overall Study|Lost to Follow-up|1|||
162122602|NCT02761629|585500258|FG000|Overall Study|Randomized But Not Treated|8|||
162122603|NCT02761629|585500259|FG001|Overall Study|Randomized But Not Treated|4|||
162122604|NCT00936221|585500266|FG000|Overall Study|Withdrawal by Subject|1|||
162122605|NCT00936221|585500267|FG001|Overall Study|Withdrawal by Subject|1|||
162122606|NCT01844115|585500270|FG000|Overall Study|Adverse Event|4|||
162122607|NCT01844115|585500271|FG001|Overall Study|Adverse Event|22|||
162122608|NCT01844115|585500270|FG000|Overall Study|Lack of Efficacy|1|||
162122609|NCT01844115|585500271|FG001|Overall Study|Lack of Efficacy|4|||
162122610|NCT01844115|585500270|FG000|Overall Study|Protocol Violation|12|||
162122611|NCT01844115|585500271|FG001|Overall Study|Protocol Violation|10|||
162122612|NCT01844115|585500270|FG000|Overall Study|Withdrawal by Subject|11|||
162122613|NCT01844115|585500271|FG001|Overall Study|Withdrawal by Subject|11|||
162122614|NCT01844115|585500270|FG000|Overall Study|Lost to Follow-up|11|||
162122615|NCT01844115|585500271|FG001|Overall Study|Lost to Follow-up|10|||
162122616|NCT01844115|585500270|FG000|Overall Study|Pregnancy|0|||
162122617|NCT01844115|585500271|FG001|Overall Study|Pregnancy|1|||
162122618|NCT00545363|585500272|FG000|Overall Study|Adverse Event|6|||
162122619|NCT00545363|585500273|FG001|Overall Study|Adverse Event|7|||
162122620|NCT00545363|585500272|FG000|Overall Study|Withdrawal by Subject|6|||
162122621|NCT00545363|585500273|FG001|Overall Study|Withdrawal by Subject|5|||
162122622|NCT00545363|585500272|FG000|Overall Study|Non-compliance|3|||
162122623|NCT00545363|585500273|FG001|Overall Study|Non-compliance|1|||
162122624|NCT00545363|585500272|FG000|Overall Study|Did not meet entry criteria|1|||
162122625|NCT00545363|585500273|FG001|Overall Study|Did not meet entry criteria|1|||
162122626|NCT00545363|585500272|FG000|Overall Study|Lost to Follow-up|2|||
162122627|NCT00545363|585500273|FG001|Overall Study|Lost to Follow-up|0|||
162122628|NCT00545363|585500272|FG000|Overall Study|Other|1|||
162122629|NCT00545363|585500273|FG001|Overall Study|Other|1|||
162122630|NCT02153359|585500274|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
162122631|NCT02153359|585500275|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
162122632|NCT00210119|585500276|FG000|Overall Study|Protocol Violation|1|||
162122633|NCT00210119|585500276|FG000|Overall Study|Withdrawal by Subject|1|||
162122634|NCT00951509|585500277|FG000|Overall Study|Withdrawal by Subject|2|||
162122635|NCT03125941|585500282|FG000|Overall Study|did not receive intervention|1|||
162122636|NCT03125941|585500283|FG001|Overall Study|did not receive intervention|2|||
162122637|NCT00734214|585500284|FG000|Overall Study|Withdrawal by Subject|3|||
162122638|NCT00734214|585500285|FG001|Overall Study|Withdrawal by Subject|4|||
162122639|NCT00734214|585500284|FG000|Overall Study|MD withdrawal|1|||
162122640|NCT00734214|585500285|FG001|Overall Study|MD withdrawal|0|||
162122641|NCT00406419|585500292|FG000|Overall Study|Death|3|||
162122642|NCT00406419|585500293|FG001|Overall Study|Death|1|||
162237663|NCT03035201|585921164|FG001|Overall Study|Death|12|||
162237664|NCT03035201|585921165|FG002|Overall Study|Death|9|||
162237665|NCT03035201|585921166|FG003|Overall Study|Death|10|||
162237666|NCT03035201|585921163|FG000|Overall Study|Withdrawal by Subject|51|||
162237667|NCT03035201|585921164|FG001|Overall Study|Withdrawal by Subject|49|||
162237668|NCT03035201|585921165|FG002|Overall Study|Withdrawal by Subject|37|||
162237669|NCT03035201|585921166|FG003|Overall Study|Withdrawal by Subject|46|||
162237670|NCT03035201|585921163|FG000|Overall Study|Lost to Follow-up|67|||
162237671|NCT03035201|585921164|FG001|Overall Study|Lost to Follow-up|51|||
162237672|NCT03035201|585921165|FG002|Overall Study|Lost to Follow-up|64|||
162237673|NCT03035201|585921166|FG003|Overall Study|Lost to Follow-up|69|||
162237674|NCT05328167|585921174|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
162237675|NCT05328167|585921174|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
162237676|NCT03727438|585921175|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
162237677|NCT03727438|585921176|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
162237678|NCT03727438|585921175|FG000|Intervention Period|Excluded (health)|1|||
162237679|NCT03727438|585921176|FG001|Intervention Period|Excluded (health)|0|||
162237680|NCT03727438|585921175|FG000|Intervention Period|Withdrawal by Subject|3|||
162237681|NCT03727438|585921176|FG001|Intervention Period|Withdrawal by Subject|1|||
162237682|NCT03727438|585921175|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
162237683|NCT03727438|585921176|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
162237684|NCT03727438|585921175|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
162237685|NCT03727438|585921176|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
162237686|NCT03727438|585921175|FG000|8 Week Assessment|Withdrawal by Subject|6|||
162237687|NCT03727438|585921176|FG001|8 Week Assessment|Withdrawal by Subject|1|||
162237688|NCT03727438|585921175|FG000|6 mo Assessment|did not complete assessment|10|||
162237689|NCT03727438|585921176|FG001|6 mo Assessment|did not complete assessment|11|||
162237690|NCT06729606|585921177|FG000|Overall Study|Adverse Event|0|||
162237691|NCT06729606|585921178|FG001|Overall Study|Adverse Event|2|||
162237692|NCT06729606|585921177|FG000|Overall Study|Death|1|||
162237693|NCT06729606|585921178|FG001|Overall Study|Death|0|||
162237694|NCT06729606|585921177|FG000|Overall Study|Physician Decision|0|||
162237695|NCT06729606|585921178|FG001|Overall Study|Physician Decision|1|||
162237696|NCT06729606|585921177|FG000|Overall Study|Withdrawal by Subject|2|||
162237697|NCT06729606|585921178|FG001|Overall Study|Withdrawal by Subject|4|||
162237698|NCT03170349|585921185|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
162237699|NCT03170349|585921185|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
162237700|NCT03170349|585921185|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
162237701|NCT03170349|585921185|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
162237702|NCT03170349|585921185|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
162237703|NCT03170349|585921185|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
162237704|NCT03170349|585921185|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
162237705|NCT03170349|585921185|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
162237706|NCT03170349|585921185|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
162237707|NCT03170349|585921185|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
162237708|NCT03170349|585921185|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
162237709|NCT03170349|585921185|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
162237710|NCT03170349|585921185|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
162237711|NCT03170349|585921185|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
162237712|NCT03170349|585921185|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
162237713|NCT03170349|585921185|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
162122643|NCT00406419|585500294|FG002|Overall Study|Death|4|||
162122644|NCT00406419|585500292|FG000|Overall Study|Protocol Violation|6|||
162122645|NCT00406419|585500293|FG001|Overall Study|Protocol Violation|2|||
162122646|NCT00406419|585500294|FG002|Overall Study|Protocol Violation|5|||
162122647|NCT00406419|585500292|FG000|Overall Study|Study Terminated by Sponsor|260|||
162122648|NCT00406419|585500293|FG001|Overall Study|Study Terminated by Sponsor|288|||
162122649|NCT00406419|585500294|FG002|Overall Study|Study Terminated by Sponsor|282|||
162122650|NCT00406419|585500292|FG000|Overall Study|Withdrawal by Subject|17|||
162122651|NCT00406419|585500293|FG001|Overall Study|Withdrawal by Subject|24|||
162122652|NCT00406419|585500294|FG002|Overall Study|Withdrawal by Subject|26|||
162122653|NCT00406419|585500292|FG000|Overall Study|Lack of Efficacy|12|||
162122654|NCT00406419|585500293|FG001|Overall Study|Lack of Efficacy|1|||
162122655|NCT00406419|585500294|FG002|Overall Study|Lack of Efficacy|6|||
162122656|NCT00406419|585500292|FG000|Overall Study|Non-Compliance with Study Drug|5|||
162122657|NCT00406419|585500293|FG001|Overall Study|Non-Compliance with Study Drug|6|||
162122658|NCT00406419|585500294|FG002|Overall Study|Non-Compliance with Study Drug|3|||
162122659|NCT00406419|585500292|FG000|Overall Study|Adverse Event|10|||
162122660|NCT00406419|585500293|FG001|Overall Study|Adverse Event|12|||
162122796|NCT01351025|585500336|FG001|Week 24 - 44|unable to get to clinic|1|||
162122797|NCT00180713|585500341|FG000|Overall Study|Withdrawal by Subject|2|||
162122798|NCT00180713|585500342|FG001|Overall Study|Withdrawal by Subject|0|||
162122799|NCT00180713|585500341|FG000|Overall Study|Adverse Event|3|||
162122800|NCT00180713|585500342|FG001|Overall Study|Adverse Event|3|||
162122801|NCT05295732|585500345|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
162122802|NCT05295732|585500346|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
162122803|NCT05295732|585500347|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
162122804|NCT05295732|585500348|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
162122805|NCT05295732|585500349|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
162122806|NCT05295732|585500345|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
162122807|NCT05295732|585500346|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
162122808|NCT05295732|585500347|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
162122809|NCT05295732|585500348|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
162122810|NCT05295732|585500349|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
162122811|NCT03311230|585500352|FG000|Overall Study|Withdrawal by Subject|1|||
162122812|NCT03311230|585500353|FG001|Overall Study|Withdrawal by Subject|4|||
162122813|NCT03311230|585500354|FG002|Overall Study|Withdrawal by Subject|2|||
162122814|NCT03311230|585500355|FG003|Overall Study|Withdrawal by Subject|7|||
162122815|NCT03311230|585500352|FG000|Overall Study|Unrelated injury|0|||
162122816|NCT03311230|585500353|FG001|Overall Study|Unrelated injury|1|||
162122817|NCT03311230|585500354|FG002|Overall Study|Unrelated injury|0|||
162122818|NCT03311230|585500355|FG003|Overall Study|Unrelated injury|0|||
162122819|NCT05200936|585500357|FG000|Overall Study|Withdrawal by Subject|2|||
162122820|NCT05200936|585500358|FG001|Overall Study|Withdrawal by Subject|2|||
162122821|NCT05200936|585500357|FG000|Overall Study|Lost to Follow-up|2|||
162122822|NCT05200936|585500358|FG001|Overall Study|Lost to Follow-up|0|||
162122823|NCT05200936|585500357|FG000|Overall Study|Pregnancy|0|||
162122824|NCT05200936|585500358|FG001|Overall Study|Pregnancy|1|||
162122825|NCT01338012|585500359|FG000|Overall Study|Death|4|||
162122826|NCT01338012|585500359|FG000|Overall Study|Study terminated|4|||
162122827|NCT02089230|585500360|FG000|Overall Study|Death|0|||
162122828|NCT02089230|585500361|FG001|Overall Study|Death|0|||
162122829|NCT02089230|585500362|FG002|Overall Study|Death|2|||
162122830|NCT02089230|585500360|FG000|Overall Study|Seeking Alternative Therapy|0|||
162122831|NCT02089230|585500361|FG001|Overall Study|Seeking Alternative Therapy|0|||
162122832|NCT02089230|585500362|FG002|Overall Study|Seeking Alternative Therapy|4|||
